PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Deng, CW; Zhang, SL; Hu, CJ; Li, P; Wu, ZY; Chen, S; Li, J; Li, LB; Zhang, FC; Li, YZ				Deng, Chuiwen; Zhang, Shulan; Hu, Chaojun; Li, Ping; Wu, Ziyan; Chen, Si; Li, Jing; Li, Liubing; Zhang, Fengchun; Li, Yongzhe			Establishing a reference interval for serum anti-dsDNA antibody: A large Chinese Han population-based multi-center study	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; VALUES	Background A reference interval (RI) for the circulating concentration of anti-dsDNA antibody is essential for clinicians to interpret laboratory results and make clinical decisions. Therefore, we aimed to establish the RI for anti-dsDNA antibody in the Chinese Han population. Methods This study was designed and carried out in accordance with guideline C28-A3, which is proposed by the International Federation of Clinical Chemistry and the Clinical and Laboratory Standards Institute. A total of 2,880 apparently healthy individuals were enrolled using a posteriori sampling. These individuals were recruited from four hospitals, representing the Han populations of north, south, east, and west China. Serum anti-dsDNA antibody levels were measured using the three analytical systems AESKU, EUROIMMUNE, and INOVA, which are the most commonly used systems in China. Individuals were stratified by gender, age, and region, and the RIs were obtained by nonparametric methods. Results Gender-specific RIs for serum anti-dsDNA antibody in the Chinese Han population were established. Conclusion This is the first exploration of the RI for anti-dsDNA antibody in the Chinese Han population. We have established gender-specific RIs for each assay method commonly used in China.	[Deng, Chuiwen; Zhang, Shulan; Hu, Chaojun; Li, Ping; Wu, Ziyan; Chen, Si; Li, Jing; Li, Liubing; Zhang, Fengchun; Li, Yongzhe] Chinese Acad Med Sci, Dept Rheumatol & Clin Immunol, Peking Union Med Coll Hosp, Beijing, Peoples R China; [Deng, Chuiwen; Zhang, Shulan; Hu, Chaojun; Li, Ping; Wu, Ziyan; Chen, Si; Li, Jing; Li, Liubing; Zhang, Fengchun; Li, Yongzhe] Peking Union Med Coll, Beijing, Peoples R China; [Deng, Chuiwen; Zhang, Shulan; Hu, Chaojun; Li, Ping; Wu, Ziyan; Chen, Si; Li, Jing; Li, Liubing; Zhang, Fengchun; Li, Yongzhe] Minist Educ, Key Lab Rheumatol & Clin Immunol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhang, FC; Li, YZ (corresponding author), Chinese Acad Med Sci, Dept Rheumatol & Clin Immunol, Peking Union Med Coll Hosp, Beijing, Peoples R China.; Zhang, FC; Li, YZ (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.; Zhang, FC; Li, YZ (corresponding author), Minist Educ, Key Lab Rheumatol & Clin Immunol, Beijing, Peoples R China.	zhangfccra@aliyun.com; yongzhelipumch@126.com	zhang, shulan/AAS-6912-2020		Research Special Fund for Public Welfare Industry of Health [201202004]	Research Special Fund for Public Welfare Industry of Health	This study was supported by the Research Special Fund for Public Welfare Industry of Health (No. 201202004).	DIXON WJ, 1953, BIOMETRICS, V9, P74, DOI 10.2307/3001634; Fu Shu Man, 2015, F1000Res, V4, P939, DOI 10.12688/f1000research.6875.1; GRASBECK R, 1968, SCAND J CLIN LAB INV, V21, P193, DOI 10.3109/00365516809076984; HOLMAN HR, 1957, SCIENCE, V126, P162, DOI 10.1126/science.126.3265.162; Horowitz GL, 2008, DEFINING ESTABLISHIN; Isenberg DA, 2007, RHEUMATOLOGY, V46, P1052, DOI 10.1093/rheumatology/kem112; Mok CC, 2008, J RHEUMATOL, V35, P1978; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Schauer U, 2003, CLIN CHEM, V49, P1924, DOI 10.1373/clinchem.2003.022350; Sikaris Kenneth A, 2014, Clin Biochem Rev, V35, P3; Zou YF, 2014, RHEUMATOL INT, V34, P347, DOI 10.1007/s00296-013-2902-1	11	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0168871	10.1371/journal.pone.0168871	http://dx.doi.org/10.1371/journal.pone.0168871			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151970	gold, Green Submitted, Green Published			2022-12-27	WOS:000396161200007
J	Kwon, RJ; Kim, YH; Jeong, DC; Han, ME; Kim, JY; Liu, L; Jung, JS; Oh, SO				Kwon, Ryuk-Jun; Kim, Yun Hak; Jeong, Dae Cheon; Han, Myoung-Eun; Kim, Ji-Young; Liu, Liangwen; Jung, Jin-Sup; Oh, Sae-Ock			Expression and prognostic significance of zinc fingers and homeoboxes family members in renal cell carcinoma	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; SURVIVAL; CANCER; GENE; PROLIFERATION; GROWTH; ROLES; ZHX1	Zinc fingers and homeoboxes (ZHX) is a transcription repressor family that contains three members; ZHX1, ZHX2, and ZHX3. Although ZHX family members have been associated with the progression of cancer, their values as prognostic factors in cancer patients have been poorly examined. Renal cell carcinoma (RCC) is a highly heterogeneous, aggressive cancer that responds variably to treatment. Thus, prognostic molecular markers are required to evaluate disease progression and to improve the survival. In clear cell RCC (ccRCC), ZHX1 and ZHX3 expression were found to be down-regulated but ZHX2 was up-regulated, and the expressions of ZHX1 and ZHX3 were significantly associated with pathological stage. Furthermore, Kaplan-Meier and multivariate regression analysis showed that reduction in the mRNA expression of ZHX1 was associated with poorer survival. Taken together, the present study shows loss of ZHX1 is correlated with ccRCC progression and suggests it is an independent prognostic marker in ccRCC.	[Kwon, Ryuk-Jun; Kim, Yun Hak; Han, Myoung-Eun; Kim, Ji-Young; Liu, Liangwen; Oh, Sae-Ock] Pusan Natl Univ, Sch Med, Dept Anat, Yangsan, South Korea; [Kwon, Ryuk-Jun; Kim, Yun Hak; Han, Myoung-Eun; Kim, Ji-Young; Liu, Liangwen; Oh, Sae-Ock] Pusan Natl Univ, Gene & Therapy Res Ctr Vessel Associated Dis, Yangsan, South Korea; [Jeong, Dae Cheon] Korea Univ, Dept Stat, Seoul, South Korea; [Jung, Jin-Sup] Pusan Natl Univ, Sch Med, Dept Physiol, Yangsan, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Korea University; Pusan National University; Pusan National University Hospital	Oh, SO (corresponding author), Pusan Natl Univ, Sch Med, Dept Anat, Yangsan, South Korea.; Oh, SO (corresponding author), Pusan Natl Univ, Gene & Therapy Res Ctr Vessel Associated Dis, Yangsan, South Korea.	hedgehog@pusan.ac.kr		Liu, Liangwen/0000-0003-2918-8142; Kim, Yun Hak/0000-0002-9796-8266	National Research Foundation of Korea(NRF) grant - Korea government(MSIP) [NRF-2016R1A2B4014593]; Medical Research Center (MRC) Program through the National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [NRF-2015R1A5A2009656]; National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea [0920050]	National Research Foundation of Korea(NRF) grant - Korea government(MSIP); Medical Research Center (MRC) Program through the National Research Foundation of Korea (NRF) grant - Korea government (MSIP); National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by by the National Research Foundation of Korea(NRF) grant funded by the Korea government(MSIP) (NRF-2016R1A2B4014593), the Medical Research Center (MRC) Program through the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (NRF-2015R1A5A2009656) and a grant from the National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea (0920050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, NATURE, V499, P43, DOI DOI 10.1038/NATURE12222; Belldegrun AS, 2007, EUR UROL SUPPL, V6, P477, DOI 10.1016/j.eursup.2007.01.016; Bui MHT, 2004, J UROLOGY, V171, P2461, DOI 10.1097/01.ju.0000116444.08690.e2; Eichelberg C, 2009, EUR UROL, V55, P851, DOI 10.1016/j.eururo.2009.01.003; Finley DS, 2011, ONCOLOGIST, V16, P4, DOI 10.1634/theoncologist.2011-S2-04; Gunningham SP, 2001, CANCER RES, V61, P3206; Jiang Z, 2006, LANCET ONCOL, V7, P556, DOI 10.1016/S1470-2045(06)70732-X; Kinoshita T, 2012, INT J ONCOL, V40, P1770, DOI 10.3892/ijo.2012.1390; Kucuk U, 2015, ACTA CHIR BELG, V115, P202; Liu Y, 2015, CANCER GENE THER, V22, P223, DOI 10.1038/cgt.2015.16; Ma XJ, 2016, J CANCER, V7, P60, DOI 10.7150/jca.12973; Mignogna C, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-293; Minardi D, 2015, ANTICANCER RES, V35, P433; Ocejo-Garcia M, 2005, J PATHOL, V206, P151, DOI 10.1002/path.1775; Protzel C, 2012, EUR UROL SUPPL, V11, P52, DOI 10.1016/j.eursup.2012.05.002; Pruitt HC, 2016, INT J CANCER, V139, P491, DOI 10.1002/ijc.30043; Vermassen T, 2016, ACTA CLIN BELG, P1; Wang JP, 2013, MOL MED REP, V8, P1531, DOI 10.3892/mmr.2013.1700; Xing TY, 2016, CHINESE J CANCER RES, V28, P80, DOI 10.3978/j.issn.1000-9604.2016.02.09; Yue XT, 2012, GASTROENTEROLOGY, V142, P1559, DOI 10.1053/j.gastro.2012.02.049; Zhao HJ, 2006, PLOS MED, V3, P115, DOI 10.1371/journal.pmed.0030013	21	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171036	10.1371/journal.pone.0171036	http://dx.doi.org/10.1371/journal.pone.0171036			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152006	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161200077
J	Shinozaki, A; Misawa, K; Ikeda, Y; Haraguchi, A; Kamagata, M; Tahara, Y; Shibata, S				Shinozaki, Ayako; Misawa, Kenichiro; Ikeda, Yuko; Haraguchi, Atsushi; Kamagata, Mayo; Tahara, Yu; Shibata, Shigenobu			Potent Effects of Flavonoid Nobiletin on Amplitude, Period, and Phase of the Circadian Clock Rhythm in PER2::LUCIFERASE Mouse Embryonic Fibroblasts	PLOS ONE			English	Article							GENE-EXPRESSION; SUPRACHIASMATIC NUCLEUS; PERIPHERAL CLOCKS; IN-VIVO; REV-ERB; LIGHT; ENTRAINMENT; RESVERATROL; ACTIVATION; IMPAIRMENT	Flavonoids are natural polyphenols that are widely found in plants. The effects of flavonoids on obesity and numerous diseases such as cancer, diabetes, and Alzheimer's have been well studied. However, little is known about the relationships between flavonoids and the circadian clock. In this study, we show that continuous or transient application of flavonoids to the culture medium of embryonic fibroblasts from PER2::LUCIFERASE (PER2::LUC) mice induced various modifications in the circadian clock amplitude, period, and phase. Transient application of some of the tested flavonoids to cultured cells induced a phase delay of the PER2::LUC rhythm at the down slope phase. In addition, continuous application of the polymethoxy flavonoids nobiletin and tangeretin increased the amplitude and lengthened the period of the PER2:: LUC rhythm. The nobiletin-induced phase delay was blocked by co-treatment with U0126, an ERK inhibitor. In summary, among the tested flavonoids, polymethoxy flavones increased the amplitude, lengthened the period, and delayed the phase of the PER2::LUC circadian rhythm. Therefore, foods that contain polymethoxy flavones may have beneficial effects on circadian rhythm disorders and jet lag.	[Shinozaki, Ayako; Misawa, Kenichiro; Ikeda, Yuko; Haraguchi, Atsushi; Kamagata, Mayo; Tahara, Yu; Shibata, Shigenobu] Waseda Univ, Lab Physiol & Pharmacol, Sch Adv Sci & Engn, Shinjuku Ku, Tokyo, Japan	Waseda University	Shibata, S (corresponding author), Waseda Univ, Lab Physiol & Pharmacol, Sch Adv Sci & Engn, Shinjuku Ku, Tokyo, Japan.	shibatas@waseda.jp	Haraguchi, Atsushi/ABC-6337-2020; Tahara, Yu/Q-4324-2018	Tahara, Yu/0000-0002-3015-8883; Haraguchi, Atsushi/0000-0003-4162-2474	Council for Science, Technology, and Innovation; Cross-ministerial Strategic Innovation Promotion Program (SIP); Technologies for Creating Next-generation Agriculture, Forestry, and Fisheries (Bio-oriented Technology Research Advancement Institution, NARO)	Council for Science, Technology, and Innovation; Cross-ministerial Strategic Innovation Promotion Program (SIP); Technologies for Creating Next-generation Agriculture, Forestry, and Fisheries (Bio-oriented Technology Research Advancement Institution, NARO)	This work was partially supported by the Council for Science, Technology, and Innovation; Cross-ministerial Strategic Innovation Promotion Program (SIP); and Technologies for Creating Next-generation Agriculture, Forestry, and Fisheries (funding agency: Bio-oriented Technology Research Advancement Institution, NARO).	Antoun G, 2012, J NEUROSCI, V32, P4867, DOI 10.1523/JNEUROSCI.5650-11.2012; Brito R, 2016, J NEUROCHEMISTRY; Butcher GQ, 2005, J NEUROSCI, V25, P5305, DOI 10.1523/JNEUROSCI.4361-04.2005; Butcher GQ, 2002, J BIOL CHEM, V277, P29519, DOI 10.1074/jbc.M203301200; Chen Z, 2013, CELL MOL LIFE SCI, V70, P2985, DOI 10.1007/s00018-012-1207-y; Coogan AN, 2003, J NEUROSCI, V23, P3085; Dziema H, 2003, EUR J NEUROSCI, V17, P1617, DOI 10.1046/j.1460-9568.2003.02592.x; Eini H, 2015, BIOCHEM PHARMACOL, V98, P110, DOI 10.1016/j.bcp.2015.08.092; Gerhart-Hines Z, 2013, NATURE, V503, P410, DOI 10.1038/nature12642; Hamaguchi Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep14207; Hao Y, 2015, CELL PHYSIOL BIOCHEM, V37, P306, DOI 10.1159/000430355; Hayasaka N, 2007, ENDOCRINOLOGY, V148, P3316, DOI 10.1210/en.2007-0010; He BK, 2016, CELL METAB, V23, P610, DOI 10.1016/j.cmet.2016.03.007; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Jozefczuk J, 2012, JOVE-J VIS EXP, DOI 10.3791/3854; Kawahata I, 2013, J NEURAL TRANSM, V120, P1397, DOI 10.1007/s00702-013-1025-x; Kim DY, 2005, EUR J NEUROSCI, V21, P1215, DOI 10.1111/j.1460-9568.2005.03950.x; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kojetin DJ, 2014, NAT REV DRUG DISCOV, V13, P197, DOI 10.1038/nrd4100; Kowalska E, 2007, COLD SPRING HARB SYM, V72, P301, DOI 10.1101/sqb.2007.72.014; Lee Y, 2010, J CELL SCI, V123, P3547, DOI 10.1242/jcs.070300; Lee YS, 2013, J NUTR BIOCHEM, V24, P156, DOI 10.1016/j.jnutbio.2012.03.014; Liu M, 2007, ENDOCRINOLOGY, V148, P5348, DOI 10.1210/en.2007-0073; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Lu MF, 2013, BIOCHEM BIOPH RES CO, V434, P701, DOI 10.1016/j.bbrc.2013.04.035; Miean KH, 2001, J AGR FOOD CHEM, V49, P3106, DOI 10.1021/jf000892m; Miranda J, 2013, BRIT J NUTR, V110, P1421, DOI 10.1017/S0007114513000755; Moriya S, 2014, J PHARMACOL SCI, V125, P329, DOI 10.1254/jphs.14071SC; Nagase H, 2005, BIOCHEMISTRY-US, V44, P13683, DOI 10.1021/bi050643x; Nakajima A, 2007, J PHARMACOL EXP THER, V321, P784, DOI 10.1124/jpet.106.117010; Narishige S, 2014, BRIT J PHARMACOL, V171, P5858, DOI 10.1111/bph.12890; O'Neill John S, 2013, Handb Exp Pharmacol, P67, DOI 10.1007/978-3-642-25950-0_4; Ohta H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002601; Oike H, 2008, BIOSCI BIOTECH BIOCH, V72, P3038, DOI 10.1271/bbb.80426; Onozuka H, 2008, J PHARMACOL EXP THER, V326, P739, DOI 10.1124/jpet.108.140293; Poletini Maristela O, 2015, Temperature (Austin), V2, P522, DOI 10.1080/23328940.2015.1115803; Qiao LP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087766; Ribas-Latre A, 2015, J NUTR BIOCHEM, V26, P112, DOI 10.1016/j.jnutbio.2014.09.006; Ribas-Latre A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10954; Ribas-Latre A, 2015, MOL NUTR FOOD RES, V59, P865, DOI 10.1002/mnfr.201400571; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Schroeder AM, 2013, TRENDS PHARMACOL SCI, V34, P605, DOI 10.1016/j.tips.2013.09.002; Tahara Yu, 2016, Journal of Circadian Rhythms, V14, P4, DOI 10.5334/jcr.136; Tahara Y, 2012, CURR BIOL, V22, P1029, DOI 10.1016/j.cub.2012.04.009; Takito J, 2016, CANADIAN J PHYSL PHA, P1; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Wu X, 2015, J FUNCT FOODS, V19, P278, DOI 10.1016/j.jff.2015.09.035; Yanagihara N, 2014, J PHARMACOL SCI, V124, P123, DOI 10.1254/jphs.13R17CP; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zhang L, 2016, BRAIN RES, V1636, P130, DOI 10.1016/j.brainres.2016.02.013; Zhang N, 2016, MOL CELL BIOCHEM, V417, P87, DOI 10.1007/s11010-016-2716-z; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	55	54	56	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170904	10.1371/journal.pone.0170904	http://dx.doi.org/10.1371/journal.pone.0170904			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152057	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200057
J	Zhang, Z; Ordonez, AA; Smith-Jones, P; Wang, H; Gogarty, KR; Daryaee, F; Bambarger, LE; Chang, YS; Jain, SK; Tonge, PJ				Zhang, Zhuo; Ordonez, Alvaro A.; Smith-Jones, Peter; Wang, Hui; Gogarty, Kayla R.; Daryaee, Fereidoon; Bambarger, Lauren E.; Chang, Yong S.; Jain, Sanjay K.; Tonge, Peter J.			The biodistribution of 5-[F-18] fluoropyrazinamide in Mycobacterium tuberculosis-infected mice determined by positron emission tomography	PLOS ONE			English	Article							PYRAZINAMIDE SUSCEPTIBILITY; MOUSE MODEL; RESISTANCE; PHARMACOKINETICS; GENE; PNCA	5-[F-18]F-pyrazinamide (5-[18 F]F-PZA), a radiotracer analog of the first-line tuberculosis drug pyrazinamide (PZA), was employed to determine the biodistribution of PZA using PET imaging and ex vivo analysis. 5-[F-18]F-PZA was synthesized in 60 min using a halide exchange reaction. The overall decay-corrected yield of the reaction was 25% and average specific activity was 2.6 x 10(6) kBq (70 mCi)/mu mol. The biodistribution of 5-[F-18]F-PZA was examined in a pulmonary Mycobacterium tuberculosis mouse model, where rapid distribution of the tracer to the lung, heart, liver, kidney, muscle, and brain was observed. The concentration of 5-[F-18]F-PZA was not significantly different between infected and uninfected lung tissue. Biochemical and microbiological studies revealed substantial differences between 5-F-PZA and PZA. 5-F-PZA was not a substrate for pyrazinamidase, the bacterial enzyme that activates PZA, and the minimum inhibitory concentration for 5-F-PZA against M. tuberculosis was more than 100-fold higher than that for PZA.	[Zhang, Zhuo; Wang, Hui; Gogarty, Kayla R.; Daryaee, Fereidoon; Tonge, Peter J.] SUNY Stony Brook, Dept Chem, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA; [Zhang, Zhuo; Wang, Hui; Gogarty, Kayla R.; Daryaee, Fereidoon; Tonge, Peter J.] SUNY Stony Brook, Dept Radiol, Stony Brook, NY 11794 USA; [Ordonez, Alvaro A.; Bambarger, Lauren E.; Chang, Yong S.; Jain, Sanjay K.] Johns Hopkins Univ, Sch Med, Ctr Infect & Inflammat Imaging Res, Ctr TB Res, Baltimore, MD 21205 USA; [Ordonez, Alvaro A.; Bambarger, Lauren E.; Chang, Yong S.; Jain, Sanjay K.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Smith-Jones, Peter] SUNY Stony Brook, Dept Psychiat, Facil Expt Radiopharmaceut Mfg, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Johns Hopkins University; Johns Hopkins University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Tonge, PJ (corresponding author), SUNY Stony Brook, Dept Chem, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA.; Tonge, PJ (corresponding author), SUNY Stony Brook, Dept Radiol, Stony Brook, NY 11794 USA.; Jain, SK (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Infect & Inflammat Imaging Res, Ctr TB Res, Baltimore, MD 21205 USA.; Jain, SK (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA.	sjain5@jhmi.edu; peter.tonge@stonybrook.edu	Tonge, Peter J/A-7443-2009; Ordonez, Alvaro/AAC-9996-2022	Tonge, Peter J/0000-0003-1606-3471; Ordonez, Alvaro/0000-0002-8571-0655; Jain, Sanjay/0000-0001-9620-7070	NIH [GM102864]; NIH Director's Transformative Research Award [R01-EB020539]; NIH New Innovator Award [DP2-OD006492]; DAIDS ACTG Novel Formulations; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB020539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102864] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006492] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's Transformative Research Award; NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DAIDS ACTG Novel Formulations; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant GM102864 (PJT), a NIH Directors Transformative Research Award R01-EB020539 (SKJ), a NIH New Innovator Award DP2-OD006492 (SKJ) (https://www.nih.gov/) and a DAIDS ACTG Novel Formulations subcontract from Brigham and Womens Hospital (SKJ and PJT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Z, 2012, INDIAN J MED RES, V136, P808; [Anonymous], 1986, AM REV RESPIR DIS, V134, P355; [Anonymous], 2008, Tuberculosis (Edinb), V88, P141, DOI 10.1016/S1472-9792(08)70021-0; Baughn AD, 2010, ANTIMICROB AGENTS CH, V54, P5323, DOI 10.1128/AAC.00529-10; Boshoff HI, 2002, J BACTERIOL, V184, P2167, DOI 10.1128/JB.184.8.2167-2172.2002; Chang KC, 2011, ANTIMICROB AGENTS CH, V55, P4499, DOI 10.1128/AAC.00630-11; Cynamon MH, 1998, ANTIMICROB AGENTS CH, V42, P462; CYNAMON MH, 1995, J MED CHEM, V38, P3902, DOI 10.1021/jm00020a003; Davis SL, 2009, ANTIMICROB AGENTS CH, V53, P4879, DOI 10.1128/AAC.00789-09; Dawson R, 2011, P 931A PYRAZINAMIDE; DeMarco VP, 2015, ANTIMICROB AGENTS CH, V59, P5768, DOI 10.1128/AAC.01146-15; Furuya T, 2008, CURR OPIN DRUG DISC, V11, P803; Harper J, 2012, J INFECT DIS, V205, P595, DOI 10.1093/infdis/jir786; Heifets L, 2000, J CLIN MICROBIOL, V38, P1498, DOI 10.1128/JCM.38.4.1498-1501.2000; Irwin SM, 2016, ACS INFECT DIS, V2, P251, DOI 10.1021/acsinfecdis.5b00127; Manca C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074082; Ordonez AA, 2016, J NUCL MED; Ordonez AA, 2016, DIS MODEL MECH, V9, P779, DOI 10.1242/dmm.025643; Ordonez AA, 2015, MOL IMAGING BIOL, V17, P609, DOI 10.1007/s11307-015-0836-6; Preshlock S, 2016, CHEM REV, V116, P719, DOI 10.1021/acs.chemrev.5b00493; Prideaux B, 2015, NAT MED, V21, P1223, DOI 10.1038/nm.3937; Scorpio A, 1996, NAT MED, V2, P662, DOI 10.1038/nm0696-662; Shi WL, 2011, SCIENCE, V333, P1630, DOI 10.1126/science.1208813; Singh Pushpendra, 2006, J Commun Dis, V38, P288; Singh P, 2007, J CLIN MICROBIOL, V45, P76, DOI 10.1128/JCM.00951-06; Sun ZH, 1997, MICROBIOL-SGM, V143, P3367, DOI 10.1099/00221287-143-10-3367; Ungerstedt JS, 2003, CLIN EXP IMMUNOL, V131, P48, DOI 10.1046/j.1365-2249.2003.02031.x; Via LE, 2015, ACS INFECT DIS, V1, P203, DOI 10.1021/id500028m; WAYNE LG, 1974, AM REV RESPIR DIS, V109, P147; Weinstein EA, 2012, ANTIMICROB AGENTS CH, V56, P6284, DOI 10.1128/AAC.01644-12; Weinstein EA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009815; Zhang S, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.38; Zhang Y, 2003, INT J TUBERC LUNG D, V7, P6; Zimhony O, 2000, NAT MED, V6, P1043, DOI 10.1038/79558	34	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170871	10.1371/journal.pone.0170871	http://dx.doi.org/10.1371/journal.pone.0170871			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151985	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200052
J	Englebert, N; Bongaerts, P; Muir, PR; Hay, KB; Pichon, M; Hoegh-Guldberg, O				Englebert, Norbert; Bongaerts, Pim; Muir, Paul R.; Hay, Kyra B.; Pichon, Michel; Hoegh-Guldberg, Ove			Lower Mesophotic Coral Communities ( 60-125mDepth) of the Northern Great Barrier Reef and Coral Sea	PLOS ONE			English	Article							JOHNSTON ATOLL; DEEP; ZONATION; DIVERSITY; SLOPES; COVER; GENUS	Mesophotic coral ecosystems in the Indo-Pacific remain relatively unexplored, particularly at lower mesophotic depths ( >= 60m), despite their potentially large spatial extent. Here, we used a remotely operated vehicle to conduct a qualitative assessment of the zooxanthellate coral community at lower mesophotic depths ( 60-125 m) at 10 different locations in the Great Barrier Reef Marine Park and the Coral Sea Commonwealth Marine Reserve. Lower mesophotic coral communities were present at all 10 locations, with zooxanthellate scleractinian corals extending down to similar to 100 metres on walls and similar to 125 m on steep slopes. Lower mesophotic coral communities were most diverse in the 60-80 m zone, while at depths of >= 100 m the coral community consisted almost exclusively of the genus Leptoseris. Collections of coral specimens ( n = 213) between 60 and 125 m depth confirmed the presence of at least 29 different species belonging to 18 genera, including several potential new species and geographic/depth range extensions. Overall, this study highlights that lower mesophotic coral ecosystems are likely to be ubiquitous features on the outer reefs of the Great Barrier Reef and atolls of the Coral Sea, and harbour a generic and species richness of corals that is much higher than thus far reported. Further research efforts are urgently required to better understand and manage these ecosystems as part of the Great Barrier Reef Marine Park and Coral Sea Commonwealth Marine Reserve.	[Englebert, Norbert; Bongaerts, Pim; Hay, Kyra B.; Hoegh-Guldberg, Ove] Univ Queensland, Global Change Inst, St Lucia, Qld, Australia; [Englebert, Norbert; Bongaerts, Pim; Hoegh-Guldberg, Ove] Univ Queensland, Australian Res Council, Ctr Excellence Coral Reef Studies, St Lucia, Qld, Australia; [Englebert, Norbert] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Muir, Paul R.; Pichon, Michel] Queensland Museum, Townsville, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; Queensland Museum	Englebert, N (corresponding author), Univ Queensland, Global Change Inst, St Lucia, Qld, Australia.; Englebert, N (corresponding author), Univ Queensland, Australian Res Council, Ctr Excellence Coral Reef Studies, St Lucia, Qld, Australia.; Englebert, N (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.	n.englebert@uq.edu.au	Hoegh-Guldberg, Ove/ABA-5420-2020	Hoegh-Guldberg, Ove/0000-0001-7510-6713; Bongaerts, Pim/0000-0001-6747-6044	Catlin Group Limited; Global Change Institute	Catlin Group Limited; Global Change Institute	This work was supported by the Catlin Group Limited and the Global Change Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong RA, 2006, CONT SHELF RES, V26, P194, DOI 10.1016/j.csr.2005.10.004; Bare AY, 2010, CORAL REEFS, V29, P369, DOI 10.1007/s00338-010-0600-y; Benzoni F, 2012, SYST BIODIVERS, V10, P417, DOI 10.1080/14772000.2012.744369; Bongaerts P, 2011, CORAL REEFS, V30, P335, DOI 10.1007/s00338-011-0725-7; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Bongaerts P, 2013, CORAL REEFS; Bongaerts P, 2015, SCI REP-UK, V5, DOI 10.1038/srep07652; Bongaerts P, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-303; BRAKEL WH, 1979, B MAR SCI, V29, P406; Bridge TCL, 2011, CORAL REEFS, V30, P143, DOI 10.1007/s00338-010-0677-3; Bridge TCL, 2012, CORAL REEFS, P1; Bridge TCL, 2011, MAR ECOL PROG SER, V428, P63, DOI 10.3354/meps09046; Bridge TCL, 2013, NAT CLIM CHANGE, V3, P528, DOI 10.1038/nclimate1879; COLIN PL, 1986, B MAR SCI, V38, P111; DeVantier LM, 2006, CORAL REEFS, V25, P329, DOI 10.1007/s00338-006-0115-8; Done T.J., 1982, Coral Reefs, V1, P95, DOI 10.1007/BF00301691; Englebert N, 2014, MAR BIODIV; FRICKE H W, 1983, Marine Ecology, V4, P163, DOI 10.1111/j.1439-0485.1983.tb00294.x; FRICKE HW, 1987, OECOLOGIA, V73, P371, DOI 10.1007/BF00385253; FRICKE HW, 1986, OECOLOGIA, V71, P29, DOI 10.1007/BF00377316; Harris PT, 2012, ICES J MAR SCI; HEAD SM, 1983, J NAT HIST, V17, P419, DOI 10.1080/00222938300770281; Hinderstein LM, 2010, CORAL REEFS, V29, P247, DOI 10.1007/s00338-010-0614-5; Hoeksema BW, 2017, MAR BIODIVERS, V47, P67, DOI 10.1007/s12526-015-0431-8; Hopley D, 2007, GEOMORPHOLOGY OF THE GREAT BARRIER REEF: DEVELOPMENT, DIVERSITY, AND CHANGE, P1, DOI 10.1017/CBO9780511535543; Hopley D., 1989, J AUST GEOGR STUD, V27, P47, DOI 10.1111/j.1467-8470.1989.tb00591.x; Hopley D.H., 1982, GEOMORPHOLOGY GREAT; Kahng SE, 2007, CORAL REEFS, V26, P679, DOI 10.1007/s00338-007-0253-7; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Kahng SE, 2012, MAR ECOL PROG SER, V455, P65, DOI 10.3354/meps09657; Kahng SE, 2006, CORAL REEFS, V25, P254, DOI 10.1007/s00338-006-0098-5; KUHLMANN DHH, 1983, HELGOLANDER MEERESUN, V36, P183; Liddell W.D., 1988, PALAIOS, V3, P413, DOI DOI 10.2307/3514787; MARAGOS JE, 1986, CORAL REEFS, V4, P141, DOI 10.1007/BF00427935; Menza C, 2008, REV BIOL TROP, V56, P11; Muir P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117933; Rooney J, 2010, CORAL REEFS, V29, P361, DOI 10.1007/s00338-010-0596-3; Sarano F, 1988, P 6 INT COR REEF S T, V2, P607; SCHLICHTER D, 1986, MAR BIOL, V91, P403, DOI 10.1007/BF00428634; SHEPPARD CRC, 1980, MAR ECOL PROG SER, V2, P193, DOI 10.3354/meps002193; SHEPPARD CRC, 1982, MAR ECOL PROG SER, V7, P83, DOI 10.3354/meps007083; Sheppard CRC, 1998, BIODIVERS CONSERV, V7, P847, DOI 10.1023/A:1008830222860; Sherman C, 2010, CORAL REEFS, V29, P347, DOI 10.1007/s00338-010-0607-4; Smith TB, 2010, CORAL REEFS, V29, P289, DOI 10.1007/s00338-009-0575-8; Steinberg C., 2007, CLIMATE CHANGE GREAT, P51; VERON JEN, 1978, PHILOS T R SOC B, V284, P3, DOI 10.1098/rstb.1978.0050; Wagner Daniel, 2014, Marine Biodiversity Records, V7, pe68, DOI 10.1017/S1755267214000785; Yamazato K, 1972, P S COR COR REEFS	48	25	26	7	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0170336	10.1371/journal.pone.0170336	http://dx.doi.org/10.1371/journal.pone.0170336			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146574	Green Published, Green Submitted, gold			2022-12-27	WOS:000396131700021
J	Einarsson, R; Persson, UM				Einarsson, Rasmus; Persson, U. Martin			Analyzing key constraints to biogas production from crop residues and manure in the EU-A spatially explicit model	PLOS ONE			English	Article							ANAEROBIC CO-DIGESTION; ENVIRONMENTAL CONSEQUENCES; LIGNOCELLULOSIC BIOMASS; LIVESTOCK MANURES; RECIRCULATION	This paper presents a spatially explicit method for making regional estimates of the potential for biogas production from crop residues and manure, accounting for key technical, biochemical, environmental and economic constraints. Methods for making such estimates are important as biofuels from agricultural residues are receiving increasing policy support from the EU and major biogas producers, such as Germany and Italy, in response to concerns over unintended negative environmental and social impacts of conventional biofuels. This analysis comprises a spatially explicit estimate of crop residue and manure production for the EU at 250 m resolution, and a biogas production model accounting for local constraints such as the sustainable removal of residues, transportation of substrates, and the substrates' biochemical suitability for anaerobic digestion. In our base scenario, the EU biogas production potential from crop residues and manure is about 0.7 EJ/year, nearly double the current EU production of biogas from agricultural substrates, most of which does not come from residues or manure. An extensive sensitivity analysis of the model shows that the potential could easily be 50% higher or lower, depending on the stringency of economic, technical and biochemical constraints. We find that the potential is particularly sensitive to constraints on the substrate mixtures' carbon-to-nitrogen ratio and dry matter concentration. Hence, the potential to produce biogas from crop residues and manure in the EU depends to large extent on the possibility to overcome the challenges associated with these substrates, either by complementing them with suitable co-substrates (e.g. household waste and energy crops), or through further development of biogas technology (e.g. pretreatment of substrates and recirculation of effluent).	[Einarsson, Rasmus; Persson, U. Martin] Chalmers Univ Technol, Div Phys Resource Theory, Environm & Energy Dept, Gothenburg, Sweden	Chalmers University of Technology	Einarsson, R (corresponding author), Chalmers Univ Technol, Div Phys Resource Theory, Environm & Energy Dept, Gothenburg, Sweden.	rasmus.einarsson@chalmers.se	Einarsson, Rasmus/GXG-3568-2022	Einarsson, Rasmus/0000-0002-7587-6280; Persson, U. Martin/0000-0001-7069-6734	Swedish Knowledge Centre for Renewable Transportation Fuels, f3; Swedish Energy Agency; Norden Top-level Research Initiative subprogramme "Effect Studies and Adaptation to Climate Change" through Nordic Centre of Excellence for Strategic Adaptation Research (NORD-STAR); Goteborgs Handelskompanis deposition	Swedish Knowledge Centre for Renewable Transportation Fuels, f3; Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); Norden Top-level Research Initiative subprogramme "Effect Studies and Adaptation to Climate Change" through Nordic Centre of Excellence for Strategic Adaptation Research (NORD-STAR); Goteborgs Handelskompanis deposition	Funding was provided by The Swedish Knowledge Centre for Renewable Transportation Fuels, f3 (http://www.f3centre.se/); The Swedish Energy Agency (http://www.energimyndigheten.se/en); The Norden Top-level Research Initiative subprogramme "Effect Studies and Adaptation to Climate Change" through the Nordic Centre of Excellence for Strategic Adaptation Research (NORD-STAR) (no website); and Goteborgs Handelskompanis deposition (no website). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batzias FA, 2005, RENEW ENERG, V30, P1161, DOI 10.1016/j.renene.2004.10.001; Bauer A, 2010, CLEAN TECHNOL ENVIR, V12, P153, DOI 10.1007/s10098-009-0236-1; Bauer F, 2013, BIOFUEL BIOPROD BIOR, V7, P499, DOI 10.1002/bbb.1423; Bentsen NS, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-25; Berglund M, 2006, BIOMASS BIOENERG, V30, P254, DOI 10.1016/j.biombioe.2005.11.011; Bidart C, 2014, RENEW SUST ENERG REV, V38, P537, DOI 10.1016/j.rser.2014.06.005; Bossard M., 2000, 40 EUR ENV AG; Dagnall S, 2000, BIORESOURCE TECHNOL, V71, P225, DOI 10.1016/S0960-8524(99)00076-0; De Vries JW, 2012, J ENVIRON MANAGE, V102, P173, DOI 10.1016/j.jenvman.2012.02.032; EEA, 2007, EUROPEAN ENV; Estevez MM, 2014, J ENVIRON MANAGE, V136, P9, DOI 10.1016/j.jenvman.2014.01.028; Eur'Observer Biogas Barometer, 2014, BIOG BAR; European Commission, 2012, COM 2012 595 FINAL; European Commission, 2014, EUR COMM, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Hamelin L, 2014, APPL ENERG, V114, P774, DOI 10.1016/j.apenergy.2013.09.033; Hamelin L, 2011, ENVIRON SCI TECHNOL, V45, P5869, DOI 10.1021/es200273j; Hertel TW, 2013, GLOB FOOD SECUR-AGR, V2, P131, DOI 10.1016/j.gfs.2013.05.003; Hohn J, 2014, APPL ENERG, V113, P1, DOI 10.1016/j.apenergy.2013.07.005; IPCC, 2014, 2013 SUPPLEMENT 2006; Koch P., 2015, AGRIBALYSE RAPPORT M; Kreuger E, 2014, BIOGAS FRAN SKANSK B, P93; Lantz M, 2012, APPL ENERG, V98, P502, DOI 10.1016/j.apenergy.2012.04.015; Leip A., 2010, EVALUATION LIVESTOCK; Litorell O., 2005, FJADERFAGODSEL VARDE; Lugato E, 2014, GLOBAL CHANGE BIOL, V20, P313, DOI 10.1111/gcb.12292; Menzi H., 2002, P 10 INT C RAM NETW; Menzi H., 1998, SOLID MANURE EUROPE; Miranda ND, 2016, BIOMASS BIOENERG, V86, P65, DOI 10.1016/j.biombioe.2016.01.012; Moller HB, 2004, BIOMASS BIOENERG, V26, P485, DOI 10.1016/j.biombioe.2003.08.008; Monforti F, 2015, RENEW SUST ENERG REV, V44, P519, DOI 10.1016/j.rser.2014.12.033; Monforti F, 2013, RENEW SUST ENERG REV, V19, P666, DOI 10.1016/j.rser.2012.11.060; Nahm K. H., 2003, World's Poultry Science Journal, V59, P77, DOI 10.1079/WPS20030004; Nilsson D, 2009, HALM SOM BRANSLE; Nordberg A, 2007, BIORESOURCE TECHNOL, V98, P104, DOI 10.1016/j.biortech.2005.11.027; NRC, NUTR REQ DAIR CATTL; Perpina C, 2013, LAND USE POLICY, V31, P326, DOI 10.1016/j.landusepol.2012.07.014; Persson UM, 2015, WIRES ENERGY ENVIRON, V4, P410, DOI 10.1002/wene.155; Petersson A, 2009, IEA BIOENERGY TASK, V37; Petersson A, 2007, BIOMASS BIOENERG, V31, P812, DOI 10.1016/j.biombioe.2007.06.001; Rajagopal R, 2013, BIORESOURCE TECHNOL, V143, P632, DOI 10.1016/j.biortech.2013.06.030; Robinson TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096084; Scarlat N, 2010, WASTE MANAGE, V30, P1889, DOI 10.1016/j.wasman.2010.04.016; Scheftelowitz M., 2015, STROMERZEUGUNG BIOMA; Shanmugam P, 2009, BIORESOURCE TECHNOL, V100, P4117, DOI 10.1016/j.biortech.2009.03.052; Sommer SG, 2001, EUR J AGRON, V15, P1, DOI 10.1016/S1161-0301(01)00112-5; Van THV, 2009, ANIM FEED SCI TECH, V151, P97, DOI 10.1016/j.anifeedsci.2008.10.008; Walla C, 2008, BIOMASS BIOENERG, V32, P551, DOI 10.1016/j.biombioe.2007.11.009; Wang XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097265; Weiland P, 2010, APPL MICROBIOL BIOT, V85, P849, DOI 10.1007/s00253-009-2246-7; Zheng Y, 2014, PROG ENERG COMBUST, V42, P35, DOI 10.1016/j.pecs.2014.01.001; Zubaryeva A, 2012, RENEW ENERG, V39, P261, DOI 10.1016/j.renene.2011.08.021	51	35	35	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171001	10.1371/journal.pone.0171001	http://dx.doi.org/10.1371/journal.pone.0171001			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141827	Green Submitted, Green Published, gold			2022-12-27	WOS:000396129500032
J	Hong, Y; Luo, Y; Gao, Q; Ren, C; Yuan, Q; Yang, QE				Hong, Yu; Luo, Yan; Gao, Qi; Ren, Chen; Yuan, Qiong; Yang, Qin-Er			Phylogeny and reclassification of Aconitum subgenus Lycoctonum (Ranunculaceae)	PLOS ONE			English	Article							HYBRIDIZATION; MODEL; GENUS; HIMALAYAS; EVOLUTION; INFERENCE; SEQUENCE; CHINA	Phylogenetic analyses were performed using multiple nuclear (ITS and ETS) and chloroplast regions (ndhF-trnL, psbA-trnH, psbD-trnT, and trnT-trnL) to test the monophyly of Aconitum subgen. Lycoctonum (Ranunculaceae) and reconstruct the phylogenetic relationships within the subgenus. The subgenus as currently circumscribed is revealed to be polyphyletic. To achieve its monophyly, sect. Galeata and sect. Fletcherum, both being unispecific and each having a unique array of characters (the latter even having the aberrant base chromosome number of x= 6), must be removed from the subgenus. The subgenus Lycoctonum should thus be redefined to include only two sections, the unispecific sect. Alatospermum and the relatively species -rich sect. Lycoctonum. The section Alatospermum, which is both morphologically and karyologically in the primitive condition, is resolved as the first diverging lineage of the subgenus Lycoctonum Glade. The monophyly of sect. Lycoctonum is strongly supported, but all the ten series currently recognized within the section are revealed to be para- or poly-phyletic. Five major clades are recovered within the section. We propose to treat them as five series: ser. Crassiflora, ser. Scaposa, ser. Volubilia, ser. Longicassidata, and ser. Lycoctonia. Thus, a formal reclassification of subgen. Lycoctonum is presented, which involves segregating both sect. Galeata and sect. Fletcherum from the subgenus as two independent subgenera within the genus Aconitum, reinstating one series (ser. Crassiflora) and abolishing six series (ser. Laevia, ser. Longibracteolata, ser. Micrantha, ser. Ranunculoidea, ser. Reclinata, and ser. Umbrosa) within sect. Lycoctonum. The series affiliation of some species within the section is adjusted accordingly.	[Hong, Yu; Ren, Chen; Yuan, Qiong; Yang, Qin-Er] Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Hong, Yu] Univ Chinese Acad Sci, Beijing, Peoples R China; [Luo, Yan] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Mengla, Peoples R China; [Gao, Qi] Guangxi Zhuangzu Autonomous Reg, Guangxi Inst Bot, Guilin, Peoples R China; [Gao, Qi] Chinese Acad Sci, Guilin, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences	Yang, QE (corresponding author), Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.	qeyang@scib.ac.cn			National Natural Science Foundation of China [31470303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China [www.nsfc.gov.cn/] grant no 31470303.	Acosta MC, 2010, MOL PHYLOGENET EVOL, V54, P235, DOI 10.1016/j.ympev.2009.08.008; Borodina-Grabovskaya A. E, 2007, PLANTS CENTRAL ASIA, P22; Chaudhary L. B., 1998, Feddes Repertorium, V109, P527; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Farris JS, 1995, CLADISTICS, V10, P315, DOI [DOI 10.1111/J.1096-0031.1994.TB00181.X, DOI 10.1111/J.1096-0031.1996.TB00196.X]; Fehrer J, 2007, MOL PHYLOGENET EVOL, V42, P347, DOI 10.1016/j.ympev.2006.07.004; Gao Q, 2012, NORD J BOT, V30, P426, DOI 10.1111/j.1756-1051.2012.01506.x; GREGORY W. C., 1941, Phylogenetic and cytological studies in the Ranunculaceae Juss., V31, P443, DOI 10.2307/1005611; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Handel-Mazzetti H., 1939, ACTA HORTI GOTOB, V13, P39; Hong Y, 2016, NORD J BOT, V34, P442, DOI 10.1111/njb.00957; Iwatsuki K, 2006, FLORA OF JAPAN A, VIIa, P267; Jabbour F, 2012, MOL PHYLOGENET EVOL, V62, P928, DOI 10.1016/j.ympev.2011.12.005; Jee V, 1983, TAXON, VLXXIX, p[32, 320]; Joly S, 2009, AM NAT, V174, pE54, DOI 10.1086/600082; Kadota Yuichi, 2001, Journal of Japanese Botany, V76, P183; Kadota Yuichi, 1999, Journal of Japanese Botany, V74, P282; Kadota Yuichi, 2010, Journal of Japanese Botany, V86, P8; Kadota Yuichi, 2012, Journal of Japanese Botany, V87, P1; Kim YK, 2009, MOL CELLS, V27, P365, DOI 10.1007/s10059-009-0047-6; Kita Y, 1995, J PLANT RES, V108, P429, DOI 10.1007/BF02344231; Kong Hang-Hui, 2013, Plant Diversity and Resources, V35, P241; KRASNIKOV A A, 1986, Botanicheskii Zhurnal (St. Petersburg), V71, P116; Kubatko LS, 2009, SYST BIOL, V58, P478, DOI 10.1093/sysbio/syp055; Kurita M, 1957, REP BIOL I EHIME U, V3, P1; LANGLET OLOF, 1932, SVENSK BOT TIDSKR, V26, P381; LANGLET OLOF F. I., 1927, SVENSK BOT TIDSKR, V21, P1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAUENER L A, 1978, Notes from the Royal Botanic Garden Edinburgh, V37, P113; LEWITSKY G. A., 1931, Bull. Appl. Bot. Genet. and Plant-Breed., V27, P187; Li LQ., 2001, FLORA CHINA, V6, P149; Luo Y, 2005, ACTA PHYTOTAXON SIN, V43, P289, DOI 10.1360/aps040102; Luo Y, 2005, PLANT SYST EVOL, V252, P11, DOI 10.1007/s00606-004-0257-5; Mallet J, 2016, BIOESSAYS, V38, P140, DOI 10.1002/bies.201500149; MasonGamer RJ, 1996, SYST BIOL, V45, P524, DOI 10.1093/sysbio/45.4.524; Philippe H, 2006, TRENDS ECOL EVOL, V21, P614, DOI 10.1016/j.tree.2006.08.004; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schafer B, 1934, ANN BOT-LONDON, V48, P693, DOI 10.1093/oxfordjournals.aob.a090470; Seelanan T, 1997, SYST BOT, V22, P259, DOI 10.2307/2419457; Shang X-M., 1984, J SYS EVO, V22, P378; Shankar U, 2003, CURR SCI INDIA, V84, P148; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Steinberg EI, 1937, FLORA SSSR, VVII, P183; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Swofford David L., 1996, P407; TAMURA M, 1979, Notes from the Royal Botanic Garden Edinburgh, V37, P431; Tamura M., 1995, NATURLICHEN PFLANZEN; TAMURA MICHIO, 1966, SCI REP OSAKA UNIV, V15, P13; TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.1111/j.1558-5646.1983.tb05533.x; Than C, 2007, J COMPUT BIOL, V14, P517, DOI 10.1089/cmb.2007.A010; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsitrone A, 2003, EVOLUTION, V57, P1776, DOI 10.1111/j.0014-3820.2003.tb00585.x; Utelli AB, 2000, PLANT SYST EVOL, V224, P195, DOI 10.1007/BF00986343; Wang W. T., 1965, OBSERVATIONES FLORUL, P113; Wang W.T., 1965, ATA PHYTOTAXONOMICA, V1, P49; Wang W, 2013, TAXON, V62, P713, DOI 10.12705/624.10; WANG WT, 1979, FLORA REIPUBLICAE PO, V27, P113; Wendel J.F., 1998, MOL SYSTEMATICS PLAN, P265, DOI 10.1007/978-1-4615-5419-6_10; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Xiao PG, 2006, ACTA PHYTOTAXON SIN, V44, P1, DOI 10.1360/aps050046; Yang Q. E., 1993, Cathaya, V5, P89; Yang Q.E., 1999, J SYST EVOL, V37, P545; Yuan Q, 2006, BOT J LINN SOC, V150, P343, DOI 10.1111/j.1095-8339.2006.00468.x; Zwickl D. J, 2006, GENETIC ALGORITHM AP; 杨亲二, 2001, 植物分类学报, V39, P502	68	13	14	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171038	10.1371/journal.pone.0171038	http://dx.doi.org/10.1371/journal.pone.0171038			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141851	Green Submitted, Green Published, gold			2022-12-27	WOS:000396129500034
J	Yahata, I; Kawase, T; Kanno, A; Hidaka, H; Sakamoto, S; Nakasato, N; Kawashima, R; Katori, Y				Yahata, Izumi; Kawase, Tetsuaki; Kanno, Akitake; Hidaka, Hiroshi; Sakamoto, Shuichi; Nakasato, Nobukazu; Kawashima, Ryuta; Katori, Yukio			Effects of Visual Speech on Early Auditory Evoked Fields - From the Viewpoint of Individual Variance	PLOS ONE			English	Article							AUDIOVISUAL SPEECH; INTERINDIVIDUAL DIFFERENCES; MULTISENSORY INTEGRATION; CROSSMODAL BINDING; PERCEPTION; CORTEX; LANGUAGE; HEARING; IMPACT; SITES	The effects of visual speech (the moving image of the speaker's face uttering speech sound) on early auditory evoked fields (AEFs) were examined using a helmet-shaped magnetoencephalography system in 12 healthy volunteers (9 males, mean age 35.5 years). AEFs (N100m) in response to the monosyllabic sound/be/were recorded and analyzed under three different visual stimulus conditions, the moving image of the same speaker's face uttering/be/(congruent visual stimuli) or uttering/ge/(incongruent visual stimuli), and visual noise (still image processed from speaker's face using a strong Gaussian filter: control condition). On average, latency of N100m was significantly shortened in the bilateral hemispheres for both congruent and incongruent auditory/visual (A/V) stimuli, compared to the control A/V condition. However, the degree of N100m shortening was not significantly different between the congruent and incongruent A/V conditions, despite the significant differences in psychophysical responses between these two A/V conditions. Moreover, analysis of the magnitudes of these visual effects on AEFs in individuals showed that the lipreading effects on AEFs tended to be well correlated between the two different audio-visual conditions (congruent vs. incongruent visual stimuli) in the bilateral hemispheres but were not significantly correlated between right and left hemisphere. On the other hand, no significant correlation was observed between the magnitudes of visual speech effects and psychophysical responses. These results may indicate that the auditory-visual interaction observed on the N100m is a fundamental process which does not depend on the congruency of the visual information.	[Yahata, Izumi; Kawase, Tetsuaki; Hidaka, Hiroshi; Katori, Yukio] Tohoku Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med, Sendai, Miyagi, Japan; [Kawase, Tetsuaki] Tohoku Univ, Grad Sch Biomed Engn, Lab Rehabilitat Auditory Sci, Sendai, Miyagi, Japan; [Kawase, Tetsuaki] Tohoku Univ, Dept Audiol, Grad Sch Med, Sendai, Miyagi, Japan; [Kanno, Akitake; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Dept Funct Brain Imaging, Sendai, Miyagi, Japan; [Sakamoto, Shuichi] Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi, Japan; [Nakasato, Nobukazu] Tohoku Univ, Dept Epileptol, Grad Sch Med, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University	Kawase, T (corresponding author), Tohoku Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med, Sendai, Miyagi, Japan.	kawase@orl.med.tohoku.ac.jp	Nakasato, Nobukazu/AAC-3650-2019; Hidala, Hiroshi/N-2957-2016	Hidala, Hiroshi/0000-0001-5214-3159	Ministry of Education, Culture, Sports, Science and Technology Japan [24390386]; Grants-in-Aid for Scientific Research [16H05435] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology Japan (Grant-in-Aid for Scientific Research (B), 24390386); https://www.jsps.go.jp/english/e-grants/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnal LH, 2009, J NEUROSCI, V29, P13445, DOI 10.1523/JNEUROSCI.3194-09.2009; Mallick D, 2015, PSYCHON B REV, V22, P1299, DOI 10.3758/s13423-015-0817-4; Besle J, 2004, EUR J NEUROSCI, V20, P2225, DOI 10.1111/j.1460-9568.2004.03670.x; Callan DE, 2004, J COGNITIVE NEUROSCI, V16, P805, DOI 10.1162/089892904970771; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 1999, NEUROREPORT, V10, P2619, DOI 10.1097/00001756-199908200-00033; Calvert GA, 2003, J COGNITIVE NEUROSCI, V15, P57, DOI 10.1162/089892903321107828; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Davis C, 2008, BRAIN RES, V1242, P151, DOI 10.1016/j.brainres.2008.04.077; ERBER NP, 1971, J SPEECH HEAR RES, V14, P496, DOI 10.1044/jshr.1403.496; Jaaskelainen LP, 2008, NEUROREPORT, V19, P93, DOI 10.1097/WNR.0b013e3282f36f7a; Keil J, 2012, CEREB CORTEX, V22, P221, DOI 10.1093/cercor/bhr125; Klucharev V, 2003, COGNITIVE BRAIN RES, V18, P65, DOI 10.1016/j.cogbrainres.2003.09.004; MacSweeney M, 2002, NEUROPSYCHOLOGIA, V40, P801, DOI 10.1016/S0028-3932(01)00180-4; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Molloy K, 2015, J NEUROSCI, V35, P16046, DOI 10.1523/JNEUROSCI.2931-15.2015; Nath AR, 2012, NEUROIMAGE, V59, P781, DOI 10.1016/j.neuroimage.2011.07.024; Nath AR, 2011, J NEUROSCI, V31, P13963, DOI 10.1523/JNEUROSCI.2605-11.2011; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pekkola J, 2005, NEUROREPORT, V16, P125, DOI 10.1097/00001756-200502080-00010; Reale RA, 2007, NEUROSCIENCE, V145, P162, DOI 10.1016/j.neuroscience.2006.11.036; SARVAS J, 1987, PHYS MED BIOL, V32, P11, DOI 10.1088/0031-9155/32/1/004; Sekiyama K, 2003, NEUROSCI RES, V47, P277, DOI 10.1016/S0168-0102(03)00214-1; Sekiyama K, 2008, DEVELOPMENTAL SCI, V11, P306, DOI 10.1111/j.1467-7687.2008.00677.x; Shinozaki J, 2016, SCI REP-UK, V6, DOI 10.1038/srep31388; Stekelenburg JJ, 2007, J COGNITIVE NEUROSCI, V19, P1964, DOI 10.1162/jocn.2007.19.12.1964; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Usubuchi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099457; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; Wright TM, 2003, CEREB CORTEX, V13, P1034, DOI 10.1093/cercor/13.10.1034	31	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170166	10.1371/journal.pone.0170166	http://dx.doi.org/10.1371/journal.pone.0170166			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6QW	28141836	Green Published, gold, Green Submitted			2022-12-27	WOS:000396129500007
J	Alba-Tercedor, J; Sainz-Bariain, M; Poquet, JM; Rodriguez-Lopez, R				Alba-Tercedor, Javier; Sainz-Bariain, Marta; Manuel Poquet, Jose; Rodriguez-Lopez, Roberto			Predicting River Macroinvertebrate Communities Distributional Shifts under Future Global Change Scenarios in the Spanish Mediterranean Area	PLOS ONE			English	Article							FRESH-WATER ECOSYSTEMS; RECENT CLIMATE-CHANGE; STREAM MACROINVERTEBRATES; SPECIES RICHNESS; UNITED-STATES; BIODIVERSITY; IMPACTS; EXTINCTIONS; INSECTS; VULNERABILITY	Several studies on global change over the next century predict increases in mean air tem-peratures of between 1 degrees C to 5 degrees C that would affect not only water temperature but also river flow. Climate is the predominant environmental driver of thermal and flow regimes of fresh-water ecosystems, determining survival, growth, metabolism, phenology and behaviour as well as biotic interactions of aquatic fauna. Thus, these changes would also have consequences for species phenology, their distribution range, and the composition and dynamics of communities. These effects are expected to be especially severe in the Mediterranean basin due its particular climate conditions, seriously threatening Southern European ecosys-tems. In addition, species with restricted distributions and narrow ecological requirements, such as those living in the headwaters of rivers, will be severely affected. The study area corresponds to the Spanish Mediterranean and Balearic Islands, delimited by the Koppen climate boundary. With the application of the MEDPACS (MEDiterranean Pre-diction And Classification System) predictive approach, the macroinvertebrate community was pre-dicted for current conditions and compared with three posible scenarios of watertempera-ture increase and its associated water flow reductions. The results indicate that the aquatic macroinvertebrate communities will undergo a drastic impact, with reductions in taxa richness for each scenario in relation to simulated current conditions, accompanied by changes in the taxa distribution pattern. Accordingly, the distribution area of most of the taxa (65.96%) inhabiting the mid-high elevations would contract and rise in altitude. Thus, fami-lies containing a great number of generalist species will move upstream to colonize new zones with lower water temperatures. By contrast, more vulnerable taxa will undergo reduc-tions in their distribution area.	[Alba-Tercedor, Javier; Sainz-Bariain, Marta; Manuel Poquet, Jose; Rodriguez-Lopez, Roberto] Univ Granada, Dept Zool, Granada, Spain	University of Granada	Alba-Tercedor, J; Sainz-Bariain, M (corresponding author), Univ Granada, Dept Zool, Granada, Spain.	jalba@ugr.es; msainzb@ugr.es	Sáinz-Bariáin, Marta/B-4770-2018; Alba-Tercedor, Javier/C-3679-2015	Sáinz-Bariáin, Marta/0000-0001-9427-3680; Alba-Tercedor, Javier/0000-0002-3461-5340	GUADALMED-II [REN2001-3438-007-06/HID]; Junta de Andalucia [RNM-02654/FEDER]; Spanish "Ministerio de Ciencia e Innovacion" [CGL2007-61856/BOS]; Spanish Ministerio de Medio Am biente, Medio Rural y Marino [21.8120062/8511]; University of Granada [21.8120062/8511]	GUADALMED-II; Junta de Andalucia(Junta de Andalucia); Spanish "Ministerio de Ciencia e Innovacion"(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Spanish Ministerio de Medio Am biente, Medio Rural y Marino; University of Granada	This work was funded by GUADALMED-II (REN2001-3438-007-06/HID), a project of excellence from "Junta de Andalucia" (RNM-02654/FEDER), the Spanish "Ministerio de Ciencia e Innovacion" (CGL2007-61856/BOS), projects and a collaboration agreement between the "Spanish Ministerio de Medio Am biente, Medio Rural y Marino" and the University of Granada (21.8120062/8511). The preparation of the manuscript benefited by NIFA grant 'Developing an Infrastructure and Product Test Pipeline to Deliver Novel Therapies for Citrus Greening Disease', 2015, Lead Dr. S. Brown, Kansas State University & USDA.; This research was funded by the GUADALMED-II (REN2001-3438-007-06/HID), a project of excellence from "Junta de Andalucia" (RNM-02654/FEDER), the Spanish "Ministerio de Ciencia e Innovacion" (CGL2007-61856/BOS), projects and a collaboration agreement between the "Spanish Ministerio de Medio Ambiente, Medio Rural y Marino" and the University of Granada (21.812-0062/8511). Collection authorisations in protected areas were provided by: Direccion General de Gestion del Medio Natural, Consejeria de Medio Ambiente, Junta de Andalucia; Direccion General de Desarrollo Sostenible y Biodiversidad, Gobierno de Aragon; Consejeria de Industria, Energia y Medio Ambiente, Junta de Castilla-La Mancha; Direccion General del Medio Natural, Junta de Castilla y Leon; Departament de Medi Ambient i Habitatge, Direccio General del Medi Natural, Generalitat de Catalunya; Direccion General del Medio natural, Junta de Extremadura; Direccion General de Medio Ambiente, Consejeria de Medio Ambiente de la Comunidad de Madrid. The preparation of the manuscript benefited by NIFA grant 'Developing an Infrastructure and Product Test Pipeline to Deliver Novel Therapies for Citrus Greening Disease', 2015. Lead Dr. S. Brown, Kansas State University & USDA. The authors wish to thank Hydraena S.L.L personal and Marta Fernandez Plaza for field and laboratory assistance, and David Nesbitt for checking the English.	Abdul Malak D, 2008, 2008 REV IUCN RED LI, P1; Alba-Tercedor J, 2009, GEN MANUAL UTILIZACI; Alba-Tercedor J., 2002, LIMNETICA, V21, P175; ALBATERCEDOR J, 1988, LIMNETICA, V4, P51; Allan J D, 2007, STREAM ECOLOGY STRUC, V2nd; [Anonymous], 1999, BIOL WILDLIFE MEDITE; Bates B.C., 2008, CLIMATE CHANGE WATER; Bhowmik AK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130025; Blondel J, 2010, MEDITERRANEAN REGION; Bonada N, 2013, HYDROBIOLOGIA, V719, P1, DOI 10.1007/s10750-013-1634-2; Brown LE, 2007, GLOBAL CHANGE BIOL, V13, P958, DOI 10.1111/j.1365-2486.2007.01341.x; Climate Change, 2012, CLIM CHANG IMP VULN, DOI DOI 10.2800/66071; Daufresne M, 2007, OECOLOGIA, V151, P544, DOI 10.1007/s00442-006-0655-1; Domisch S, 2013, GLOBAL CHANGE BIOL, V19, P752, DOI 10.1111/gcb.12107; Domisch S, 2011, FRESHWATER BIOL, V56, P2009, DOI 10.1111/j.1365-2427.2011.02631.x; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Durance I, 2007, GLOBAL CHANGE BIOL, V13, P942, DOI 10.1111/j.1365-2486.2007.01340.x; EEA, 2008, 42008 EEA JRC WHO EE; Fajardo-Merlo MC, 2015, HUELLA CAMBIO GLOBAL, P70; Filipe AF, 2013, HYDROBIOLOGIA, V719, P331, DOI 10.1007/s10750-012-1244-4; Floury M, 2012, SCI TOTAL ENVIRON, V441, P220, DOI 10.1016/j.scitotenv.2012.09.051; Floury M, 2013, GLOBAL CHANGE BIOL, V19, P1085, DOI 10.1111/gcb.12124; Franco AMA, 2006, GLOBAL CHANGE BIOL, V12, P1545, DOI 10.1111/j.1365-2486.2006.01180.x; Garcia-Ruiz JM, 2011, EARTH-SCI REV, V105, P121, DOI 10.1016/j.earscirev.2011.01.006; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; Graf W, 2006, EUROLIMPACS PROJECT; Haidekker A, 2008, AQUAT ECOL, V42, P463, DOI 10.1007/s10452-007-9097-z; Hering D, 2009, AQUAT SCI, V71, P3, DOI 10.1007/s00027-009-9159-5; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hoffmann AA, 1997, EXTREME ENV CHANGE E; HYNES HBN, 1970, ANNU REV ENTOMOL, V15, P25, DOI 10.1146/annurev.en.15.010170.000325; IPCC, 2002, CLIMATE CHANGE BIODI; Isaak DJ, 2013, GLOBAL CHANGE BIOL, V19, P742, DOI 10.1111/gcb.12073; Jenkins M, 2003, SCIENCE, V302, P1175, DOI 10.1126/science.1088666; Konvicka M, 2003, GLOBAL ECOL BIOGEOGR, V12, P403, DOI 10.1046/j.1466-822X.2003.00053.x; Koppen W, 1923, DE KLIMATE DER ERDE; Kovats RS, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1267; Kullman L, 2001, AMBIO, V30, P72, DOI 10.1639/0044-7447(2001)030[0072:CCWATL]2.0.CO;2; Lytle DA, 2004, TRENDS ECOL EVOL, V19, P94, DOI 10.1016/j.tree.2003.10.002; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; Poquet JM, 2009, HYDROBIOLOGIA, V623, P153, DOI 10.1007/s10750-008-9655-y; Menendez R, 2006, P ROY SOC B-BIOL SCI, V273, P1465, DOI 10.1098/rspb.2006.3484; Mulholland PJ, 1997, HYDROL PROCESS, V11, P949; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Poff NL, 2006, GEOMORPHOLOGY, V79, P264, DOI 10.1016/j.geomorph.2006.06.032; Poff NL, 2010, J N AM BENTHOL SOC, V29, P1441, DOI 10.1899/10-030.1; Roudier P, 2016, CLIMATIC CHANGE, V135, P341, DOI 10.1007/s10584-015-1570-4; Sainz-Bariain M, 2015, HUELLA CAMBIO GLOBAL, P73; Sainz-Bariain M, 2015, AQUAT SCI, P1; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schwartz P., 1996, ART LONG VIEW PLANNI; Solheim AL, 2010, EUR ENV, P1; Solomon S, 2007, CLIMATE CHANGE 2007; Sweeney B.W., 1984, P56; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; de Figueroa JMT, 2010, BIODIVERS CONSERV, V19, P1269, DOI 10.1007/s10531-009-9753-9; Vannote R, 2007, AM NAT, V115, P667; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WARD J.V., 1992, AQUATIC INSECT ECOLO, V1, P1; Whitehead PG, 2009, HYDROLOG SCI J, V54, P101, DOI 10.1623/hysj.54.1.101; Wilson RJ, 2005, ECOL LETT, V8, P1346, DOI 10.1111/j.1461-0248.2005.00865.x; Wilson RJ, 2007, GLOBAL CHANGE BIOL, V13, P1873, DOI 10.1111/j.1365-2486.2007.01418.x; Woodward G, 2010, PHILOS T R SOC B, V365, P2093, DOI 10.1098/rstb.2010.0055; Xenopoulos MA, 2005, GLOBAL CHANGE BIOL, V11, P1557, DOI 10.1111/j.1365-2486.2005.001008.x	65	10	10	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0167904	10.1371/journal.pone.0167904	http://dx.doi.org/10.1371/journal.pone.0167904			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135280	Green Submitted, gold, Green Published			2022-12-27	WOS:000396124700002
J	Goch, W; Bal, W				Goch, Wojciech; Bal, Wojciech			Numerical Simulations Reveal Randomness of Cu(II) Induced A beta Peptide Dimerization under Conditions Present in Glutamatergic Synapses	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; METAL-IONS; SENILE PLAQUES; COPPER-BINDING; COORDINATION GEOMETRY; AGGREGATION KINETICS; CEREBROSPINAL-FLUID; FIBER FORMATION; IN-VIVO	The interactions between the A beta(1-40) molecules species and the copper ions (Cu(II)) were intensively investigated due to their potential role in the development of the Alzheimer Disease (AD). The rate and the mechanism of the Cu(II)-A beta complexes formation determines the aggregation pathway of the A beta species, starting from smaller but more cytotoxic oligomers and ending up in large A beta plaques, being the main hallmark of the AD. In our study we exploit the existing knowledge on the Cu(II)-A beta interactions and create the theoretical model of the initial phase of the copper-driven A beta aggregation mechanism. The model is based on the direct solution of the Chemical Master Equations, which capture the inherent stochastics of the considered system. In our work we argue that due to a strong Cu(II) affinity to A beta and temporal accessibility of the Cu(II) ions during normal synaptic activity the aggregation driven by Cu(II) dominates the pure A beta aggregation. We also demonstrate the dependence of the formation of different Cu(II)-A beta complexes on the concentrations of reagents and the synaptic activity. Our findings correspond to recent experimental results and give a sound hypothesis on the AD development mechanisms.	[Goch, Wojciech; Bal, Wojciech] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Goch, W (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	wojciech_goch@wp.pl		Goch, Wojciech/0000-0001-7230-7173; Bal, Wojciech/0000-0003-3780-083X	Polish National Science Centre [2015/19/N/NZ1/02021]; Foundation for Polish Science [TEAM/2009-4/1]	Polish National Science Centre; Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission)	The project was supported by the Polish National Science Centre grant Preludium10 no 2015/19/N/NZ1/02021 to WG (http://www.ncn.gov.pl/) and by the Foundation for Polish Science TEAM grant no TEAM/2009-4/1 (http://www.fnp.org.pl/). Both authors received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Agarwal R, 2012, ADV ALZHEIMERS DIS, V1, P30, DOI DOI 10.4236/aad.2012.13005; Alies B, 2013, ANAL CHEM, V85, P1501, DOI 10.1021/ac302629u; Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Arellano JI, 2007, FRONT NEUROSCI-SWITZ, V1, P131, DOI 10.3389/neuro.01.1.1.010.2007; Artells E, 2014, FEBS J, V281, P1659, DOI 10.1111/febs.12731; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Barnham KJ, 2003, J BIOL CHEM, V278, P42959, DOI 10.1074/jbc.M305494200; Bin YN, 2013, J INORG BIOCHEM, V119, P21, DOI 10.1016/j.jinorgbio.2012.10.013; Bouter Y, 2013, ACTA NEUROPATHOL, V126, P189, DOI 10.1007/s00401-013-1129-2; Branch T, 2015, ANGEW CHEM INT EDIT, V54, P1227, DOI 10.1002/anie.201408810; Capo CR, 2008, BIOMETALS, V21, P367, DOI 10.1007/s10534-007-9125-4; Chyung ASC, 1997, J CELL BIOL, V138, P671, DOI 10.1083/jcb.138.3.671; Cirrito JR, 2003, J NEUROSCI, V23, P8844; Crimins JL, 2013, AGEING RES REV, V12, P757, DOI 10.1016/j.arr.2013.03.002; Deshpande A, 2009, J NEUROSCI, V29, P4004, DOI 10.1523/JNEUROSCI.5980-08.2009; Drew SC, 2011, ACCOUNTS CHEM RES, V44, P1146, DOI 10.1021/ar200014u; Faller P, 2013, INORG CHEM, V52, P12193, DOI 10.1021/ic4003059; Fawzi NL, 2010, J AM CHEM SOC, V132, P9948, DOI 10.1021/ja1048253; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Garai K, 2013, P NATL ACAD SCI USA, V110, P3321, DOI 10.1073/pnas.1222478110; GarzonRodriguez W, 1997, J BIOL CHEM, V272, P21037, DOI 10.1074/jbc.272.34.21037; GILLESPIE DT, 1992, PHYSICA A, V188, P404, DOI 10.1016/0378-4371(92)90283-V; Gu L, 2013, J NEUROCHEM, V126, P305, DOI 10.1111/jnc.12202; Ha C, 2007, BIOCHEMISTRY-US, V46, P6118, DOI 10.1021/bi7000032; Hane F, 2014, BIOMOLECULES, V4, P101, DOI 10.3390/biom4010101; Holtta M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066381; Hopt A, 2003, J NEUROSCI METH, V128, P159, DOI 10.1016/S0165-0270(03)00173-0; Hortschansky P, 2005, PROTEIN SCI, V14, P1753, DOI 10.1110/ps.041266605; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Huang XD, 2004, J BIOL INORG CHEM, V9, P954, DOI 10.1007/s00775-004-0602-8; Hung LW, 2008, J NEUROSCI, V28, P11950, DOI 10.1523/JNEUROSCI.3916-08.2008; Hureau C, 2012, COORDIN CHEM REV, V256, P2164, DOI 10.1016/j.ccr.2012.03.037; Jiang DL, 2013, BIOCHEMISTRY-US, V52, P547, DOI 10.1021/bi301053h; Johnston I., 2012, SIGNIFICANCE, V9, P17, DOI DOI 10.1111/J.1740-9713.2012.00586.X; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; KARDOS J, 1989, NEUROSCI LETT, V103, P139, DOI 10.1016/0304-3940(89)90565-X; Karr JW, 2007, J AM CHEM SOC, V129, P3796, DOI 10.1021/ja068952d; Kepp KP, 2012, CHEM REV, V112, P5193, DOI 10.1021/cr300009x; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lewis H, 2006, NEUROPATH APPL NEURO, V32, P103, DOI 10.1111/j.1365-2990.2006.00696.x; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mccoll G, 2009, J BIOL CHEM, V284, P22697, DOI 10.1074/jbc.C109.028514; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Mital M, 2015, ANGEW CHEM INT EDIT, V54, P10460, DOI 10.1002/anie.201502644; Mo JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116802; Murphy RM, 2007, BBA-BIOMEMBRANES, V1768, P1923, DOI 10.1016/j.bbamem.2006.12.014; Nasica-Labouze J, 2015, CHEM REV, V115, P3518, DOI 10.1021/cr500638n; Neniskyte U, 2011, J BIOL CHEM, V286, P39904, DOI 10.1074/jbc.M111.267583; Nischwitz V, 2008, ANAL CHIM ACTA, V627, P258, DOI 10.1016/j.aca.2008.08.018; Nose Y, 2010, J BIOL CHEM, V285, P32385, DOI 10.1074/jbc.M110.143826; Pallitto MM, 2001, BIOPHYS J, V81, P1805, DOI 10.1016/S0006-3495(01)75831-6; Pedersen JT, 2011, J BIOL CHEM, V286, P26952, DOI 10.1074/jbc.M111.220863; Pedersen JT, 2011, ANGEW CHEM INT EDIT, V50, P2532, DOI 10.1002/anie.201006335; Pellarin R, 2006, J MOL BIOL, V360, P882, DOI 10.1016/j.jmb.2006.05.033; Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; Sarell CJ, 2010, J BIOL CHEM, V285, P41533, DOI 10.1074/jbc.M110.171355; Sarell CJ, 2009, BIOCHEMISTRY-US, V48, P4388, DOI 10.1021/bi900254n; Schlief ML, 2005, J NEUROSCI, V25, P239, DOI 10.1523/JNEUROSCI.3699-04.2005; Schreck JS, 2013, FIBRIL GROWTH LENGTH; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Shahrezaei V, 2008, CURR OPIN BIOTECH, V19, P369, DOI 10.1016/j.copbio.2008.06.011; Singh I, 2013, P NATL ACAD SCI USA, V110, P14771, DOI 10.1073/pnas.1302212110; Smith DP, 2007, BIOCHEMISTRY-US, V46, P2881, DOI 10.1021/bi0620961; Smith DP, 2006, J BIOL CHEM, V281, P15145, DOI 10.1074/jbc.M600417200; Syme CD, 2004, J BIOL CHEM, V279, P18169, DOI 10.1074/jbc.M313572200; Szaruga M, 2015, J EXP MED, V212, P2003, DOI 10.1084/jem.20150892; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Viles JH, 2012, COORDIN CHEM REV, V256, P2271, DOI 10.1016/j.ccr.2012.05.003; Walsh DM, 2005, J NEUROSCI, V25, P2455, DOI 10.1523/JNEUROSCI.4391-04.2005; Wang J, 1999, EXP NEUROL, V158, P328, DOI 10.1006/exnr.1999.7085; Warmlander S, 2013, CHEMBIOCHEM, V14, P1692, DOI 10.1002/cbic.201300262; Wezynfeld NE, 2016, ANGEW CHEM INT EDIT, V55, P8235, DOI 10.1002/anie.201511968; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748; Yamamoto N, 2007, J BIOL CHEM, V282, P2646, DOI 10.1074/jbc.M606202200; Yoshiike Y, 2001, J BIOL CHEM, V276, P32293, DOI 10.1074/jbc.M010706200; Young TR, 2014, METALLOMICS, V6, P505, DOI 10.1039/c4mt00001c	83	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170749	10.1371/journal.pone.0170749	http://dx.doi.org/10.1371/journal.pone.0170749			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125716	Green Submitted, gold, Green Published			2022-12-27	WOS:000396176100066
J	Szema, AM; Forsyth, E; Ying, B; Hamidi, SA; Chen, JJ; Hwang, S; Li, JC; Dwyer, DS; Ramiro-Diaz, JM; Giermakowska, W; Bosc, LVG				Szema, Anthony M.; Forsyth, Edward; Ying, Benjamin; Hamidi, Sayyed A.; Chen, John J.; Hwang, Sonya; Li, Jonathan C.; Dwyer, Debra Sabatini; Ramiro-Diaz, Juan M.; Giermakowska, Wieslawa; Bosc, Laura V. Gonzalez			NFATc3 and VIP in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; ACTIVATED T-CELLS; CHRONIC HYPOXIA; ARTERIAL-HYPERTENSION; NUCLEAR FACTOR; SMOOTH-MUSCLE; UP-REGULATION; COPD; ANGIOGENESIS; INHIBITION	Idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD) are both debilitating lung diseases which can lead to hypoxemia and pulmonary hypertension (PH). Nuclear Factor of Activated T-cells (NFAT) is a transcription factor implicated in the etiology of vascular remodeling in hypoxic PH. We have previously shown that mice lacking the ability to generate Vasoactive Intestinal Peptide (VIP) develop spontaneous PH, pulmonary arterial remodeling and lung inflammation. Inhibition of NFAT attenuated PH in these mice suggesting a connection between NFAT and VIP. To test the hypotheses that: 1) VIP inhibits NFAT isoform c3 (NFATc3) activity in pulmonary vascular smooth muscle cells; 2) lung NFATc3 activation is associated with disease severity in IPF and COPD patients, and 3) VIP and NFATc3 expression correlate in lung tissue from IPF and COPD patients. NFAT activity was determined in isolated pulmonary arteries from NFAT-luciferase reporter mice. The% of nuclei with NFAT nuclear accumulation was determined in primary human pulmonary artery smooth muscle cell (PASMC) cultures; in lung airway epithelia and smooth muscle and pulmonary endothelia and smooth muscle from IPF and COPD patients; and in PASMC from mouse lung sections by fluorescence microscopy. Both NFAT and VIP mRNA levels were measured in lungs from IPF and COPD patients. Empirical strategies applied to test hypotheses regarding VIP, NFATc3 expression and activity, and disease type and severity. This study shows a significant negative correlation between NFAT isoform c3 protein expression levels in PASMC, activity of NFATc3 in pulmonary endothelial cells,expression and activity of NFATc3 in bronchial epithelial cells and lung function in IPF patients, supporting the concept that NFATc3 is activated in the early stages of IPF. We further show that there is a significant positive correlation between NFATc3 mRNA expression and VIP RNA expression only in lungs from IPF patients. In addition, we found that VIP inhibits NFAT nuclear translocation in primary human pulmonary artery smooth muscle cells (PASMC). Early activation of NFATc3 in IPF patients may contribute to disease progression and the increase in VIP expression could be a protective compensatory mechanism.	[Szema, Anthony M.; Dwyer, Debra Sabatini] SUNY Stony Brook, Coll Engn & Appl Sci, Dept Technol & Soc, Stony Brook, NY 11794 USA; [Szema, Anthony M.] John T Mather Mem Hosp, Stony Brook Med SUNY, Stony Brook Internal Med Residency Program, Port Jefferson, NY USA; [Szema, Anthony M.] Hofstra Univ, Dept Occupat Med Epidemiol & Prevent Med, Hofstra Northwell Sch Med, Hempstead, NY 11550 USA; [Szema, Anthony M.] Hofstra Univ, Dept Occupat Med Epidemiol & Prevent Med, Hofstra Northwell Sch Med, Manhasset, NY USA; [Szema, Anthony M.; Li, Jonathan C.] Three Village Allergy & Asthma PLLC, South Setauket, NY USA; [Szema, Anthony M.] Columbia Univ, Child Psychiat Epidemiol Grp, New York, NY USA; [Forsyth, Edward; Ying, Benjamin] SUNY Stony Brook, Sch Med, MD Scholarly Recognit Program, Stony Brook, NY 11794 USA; [Hamidi, Sayyed A.] Bronx Vet Affairs Med Ctr, Internal Med Residency Program, Dept Internal Med, Bronx, NY USA; [Chen, John J.] Univ Hawaii, Biostat & Data Management Core, John A Burns Sch Med, Honolulu, HI 96822 USA; [Hwang, Sonya] SUNY Stony Brook, Sch Med, Dept Pathol, Stony Brook, NY 11794 USA; [Ramiro-Diaz, Juan M.; Giermakowska, Wieslawa; Bosc, Laura V. Gonzalez] Univ New Mexico, Hlth Sci Ctr, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Hofstra University; Northwell Health; Hofstra University; Northwell Health; Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; University of Hawaii System; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of New Mexico; University of New Mexico's Health Sciences Center	Bosc, LVG (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA.	lgonzalezbosc@salud.unm.edu	chen, JJ/HGB-6029-2022	Forsyth, Edward/0000-0002-8974-2929; Li, Jonathan/0000-0002-0916-6678	NIH Lung Tissue Research Consortium (LTRC) [08-99-0002]; NIH [R01 HL088151-05]; Three Village Allergy Asthma, PLLC; National Institute on Minority Health and Health Disparities [U54MD007584] Funding Source: NIH RePORTER	NIH Lung Tissue Research Consortium (LTRC); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Three Village Allergy Asthma, PLLC; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	NIH Lung Tissue Research Consortium (LTRC) concept sheet number 08-99-0002. "Gene deficiency of Vasoactive Intestinal Peptide in COPD patients with pulmonary artery hypertension" to Anthony Szema, M.D (PI). NIH R01 HL088151-05 "NFATc3 in Chronic Pulmonary Hypertension" to Laura Gonzalez Bosc, Ph.D (PI). Three Village Allergy & Asthma, PLLC provided support in the form of salaries only for A.M.S., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Adir Y, 2014, CURRENT OPINION PULM, V20; Amberg GC, 2004, J BIOL CHEM, V279, P47326, DOI 10.1074/jbc.M408789200; Bahr TM, 2013, AM J RESP CELL MOL, V49, P316, DOI 10.1165/rcmb.2012-0230OC; Bierer R, 2011, AM J PHYSL LUNG CELL; Bonnet S, 2007, P NATL ACAD SCI USA, V104, P11418, DOI 10.1073/pnas.0610467104; Bosc LVG, 2005, J BIOL CHEM, V280, P26113, DOI 10.1074/jbc.M411972200; Braz JC, 2003, J CLIN INVEST, V111, P1475, DOI 10.1172/JCI200317295; Burger CD, 2009, COPD, V6, P137, DOI 10.1080/15412550902754252; Chilosi M, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-3; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; de Frutos S, 2008, AM J PHYSIOL-HEART C, V294, pH2382, DOI 10.1152/ajpheart.00132.2008; de Frutos S, 2007, J BIOL CHEM, V282, P15081, DOI 10.1074/jbc.M702679200; de Frutos S, 2011, AM J PHYSIOL-CELL PH, V301, pC441, DOI 10.1152/ajpcell.00029.2011; de Frutos S, 2009, AM J PHYSIOL-LUNG C, V297, pL475, DOI 10.1152/ajplung.00060.2009; Friedman JK, 2014, VASC PHARMACOL, V60, P17, DOI 10.1016/j.vph.2013.11.001; Grundy S, 2014, CLIN SCI, V126, P223, DOI 10.1042/CS20130152; HAMASAKI Y, 1983, J APPL PHYSIOL, V54, P1607, DOI 10.1152/jappl.1983.54.6.1607; Hamidi SA, 2008, EUR RESP SOC ANN C; Hamidi SA, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-141; Hanumegowda C, 2012, CHEST, V142, P200, DOI 10.1378/chest.11-1962; Harkness LM, 2014, PULM PHARMACOL THER, V29, P144, DOI 10.1016/j.pupt.2014.09.003; Hilaire RCS, 2009, PEPTIDES, V30, P2323, DOI 10.1016/j.peptides.2009.08.010; Hou XH, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-2; KEITH IM, 1992, EXP LUNG RES, V18, P205, DOI 10.3109/01902149209031681; Koga M, 2014, J APPL PHYSIOL, V117, P383, DOI 10.1152/japplphysiol.00861.2013; MacNee William, 2005, Proc Am Thorac Soc, V2, P258, DOI 10.1513/pats.200504-045SR; Minami T, 2013, CELL REP, V4, P709, DOI 10.1016/j.celrep.2013.07.021; NANDIWADA PA, 1985, J APPL PHYSIOL, V58, P1723, DOI 10.1152/jappl.1985.58.5.1723; Nieves-Cintron M, 2007, J BIOL CHEM, V282, P3231, DOI 10.1074/jbc.M608822200; Paulin R, 2011, CIRCULATION, V123, P1205, DOI 10.1161/CIRCULATIONAHA.110.963314; Petkov V, 2003, J CLIN INVEST, V111, P1339, DOI 10.1172/JCI200317500; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; SAGA T, 1984, T ASSOC AM PHYSICIAN, V97, P304; Said SI, 2008, ANN NY ACAD SCI, V1144, P148, DOI 10.1196/annals.1418.014; Said SI, 1998, ANN NY ACAD SCI, V865, P582, DOI 10.1111/j.1749-6632.1998.tb11240.x; Senavirathna LK, 2016, FASEB J, V30; Suehiro J, 2014, J BIOL CHEM, V289, P29044, DOI 10.1074/jbc.M114.555235; Urso K, 2011, BLOOD, V118, P795, DOI 10.1182/blood-2010-12-322701; Wolters PJ, 2014, ANNU REV PATHOL-MECH, V9, P157, DOI 10.1146/annurev-pathol-012513-104706	39	11	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170606	10.1371/journal.pone.0170606	http://dx.doi.org/10.1371/journal.pone.0170606			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125639	gold, Green Published, Green Submitted			2022-12-27	WOS:000396176100088
J	Wang, KJ; Vijay, V; Fuscoe, JC				Wang, Kejian; Vijay, Vikrant; Fuscoe, James C.			Stably Expressed Genes Involved in Basic Cellular Functions	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; MOUSE PHENOTYPING CONSORTIUM; CANCER; VARIANTS; DISEASE	Stably Expressed Genes (SEGs) whose expression varies within a narrow range may be involved in core cellular processes necessary for basic functions. To identify such genes, we re-analyzed existing RNA-Seq gene expression profiles across 11 organs at 4 developmental stages (from immature to old age) in both sexes of F344 rats (n = 4/group; 320 samples). Expression changes (calculated as the maximum expression/minimum expression for each gene) of > 19000 genes across organs, ages, and sexes ranged from 2.35 to > 10(9) fold, with a median of 165-fold. The expression of 278 SEGs was found to vary <= 4-fold and these genes were significantly involved in protein catabolism (proteasome and ubiquitination), RNA transport, protein processing, and the spliceosome. Such stability of expression was further validated in human samples where the expression variability of the homologous human SEGs was significantly lower than that of other genes in the human genome. It was also found that the homologous human SEGs were generally less subject to non-synonymous mutation than other genes, as would be expected of stably expressed genes. We also found that knockout of SEG homologs in mouse models was more likely to cause complete preweaning lethality than non-SEG homologs, corroborating the fundamental roles played by SEGs in biological development. Such stably expressed genes and pathways across life-stages suggest that tight control of these processes is important in basic cellular functions and that perturbation by endogenous (e.g., genetics) or exogenous agents (e.g., drugs, environmental factors) may cause serious adverse effects.	[Wang, Kejian; Vijay, Vikrant; Fuscoe, James C.] US FDA, Div Syst Biol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA	US Food & Drug Administration (FDA)	Fuscoe, JC (corresponding author), US FDA, Div Syst Biol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.	James.Fuscoe@fda.hhs.gov	Vijay, Vikrant/E-7651-2010	Vijay, Vikrant/0000-0001-8425-1285; Wang, Kejian/0000-0003-4221-2485				Agarwal S, 2004, ARTHRITIS RHEUM-US, V50, P3541, DOI 10.1002/art.20601; Altintas DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066278; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bradley A, 2012, MAMM GENOME, V23, P580, DOI 10.1007/s00335-012-9422-2; Brown SDM, 2012, DIS MODEL MECH, V5, P289, DOI 10.1242/dmm.009878; Chen D, 2010, CURR PROTEIN PEPT SC, V11, P459, DOI 10.2174/138920310791824057; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Escrich E, 2004, MOL CARCINOGEN, V40, P73, DOI 10.1002/mc.20028; Fang H, 2009, METHODS MOL BIOL, V563, P379, DOI 10.1007/978-1-60761-175-2_20; Hasegawa Y, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005428; Hipp MS, 2012, METHODS MOL BIOL, V832, P463, DOI 10.1007/978-1-61779-474-2_33; Itan Y, 2015, P NATL ACAD SCI USA, V112, P13615, DOI 10.1073/pnas.1518646112; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Janssens Nico, 2004, Mol Diagn, V8, P107, DOI 10.2165/00066982-200408020-00005; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kaushik S, 2015, NAT MED, V21, P1406, DOI 10.1038/nm.4001; Kleiger G, 2014, TRENDS CELL BIOL, V24, P352, DOI 10.1016/j.tcb.2013.12.003; Kleinhammer A, 2010, METHOD ENZYMOL, V477, P387, DOI 10.1016/S0076-6879(10)77020-8; Koscielny G, 2014, NUCLEIC ACIDS RES, V42, pD802, DOI 10.1093/nar/gkt977; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Liu LX, 2002, WORLD J GASTROENTERO, V8, P580, DOI 10.3748/wjg.v8.i4.580; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mar JC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002207; Mason EA, 2014, STEM CELL REP, V3, P365, DOI 10.1016/j.stemcr.2014.06.008; Myers JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145322; Onken MD, 2014, CLIN CANCER RES, V20, P2873, DOI 10.1158/1078-0432.CCR-14-0205; Peixoto A, 2004, GENOME RES, V14, P1938, DOI 10.1101/gr.2890204; Prelich G, 2012, GENETICS, V190, P841, DOI 10.1534/genetics.111.136911; Shen M, 2013, EXPERT OPIN THER TAR, V17, P1091, DOI 10.1517/14728222.2013.815728; Shen YZ, 2014, MOL MED REP, V10, P1746, DOI 10.3892/mmr.2014.2396; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Wang JS, 2006, CELL MOL IMMUNOL, V3, P255; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Yang Z, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S14; Yu Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4230	37	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170813	10.1371/journal.pone.0170813	http://dx.doi.org/10.1371/journal.pone.0170813			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125669	Green Published, Green Submitted, gold			2022-12-27	WOS:000396176100045
J	Zilverstand, A; Sorger, B; Slaats-Willemse, D; Kan, CC; Goebel, R; Buitelaar, JK				Zilverstand, Anna; Sorger, Bettina; Slaats-Willemse, Dorine; Kan, Cornelis C.; Goebel, Rainer; Buitelaar, Jan K.			fMRI Neurofeedback Training for Increasing Anterior Cingulate Cortex Activation in Adult Attention Deficit Hyperactivity Disorder. An Exploratory Randomized, Single-Blinded Study	PLOS ONE			English	Article							REAL-TIME FMRI; MULTISOURCE INTERFERENCE TASK; RESONANCE-IMAGING FMRI; DEFICIT/HYPERACTIVITY DISORDER; SUSTAINED ATTENTION; CONTROLLED-TRIAL; CLINICAL-TRIALS; WORKING-MEMORY; ADHD; METAANALYSIS	Attention Deficit Hyperactivity Disorder (ADHD) is characterized by poor cognitive control/ attention and hypofunctioning of the dorsal anterior cingulate cortex (dACC). In the current study, we investigated for the first time whether real-time fMRI neurofeedback (rt-fMRI) training targeted at increasing activation levels within dACC in adults with ADHD leads to a reduction of clinical symptoms and improved cognitive functioning. An exploratory randomized controlled treatment study with blinding of the participants was conducted. Participants with ADHD (n = 7 in the neurofeedback group, and n = 6 in the control group) attended four weekly MRI training sessions (60-min training time/session), during which they performed a mental calculation task at varying levels of difficulty, in order to learn how to up-regulate dACC activation. Only neurofeedback participants received continuous feedback information on actual brain activation levels within dACC. Before and after the training, ADHD symptoms and relevant cognitive functioning was assessed. Results showed that both groups achieved a significant increase in dACC activation levels over sessions. While there was no significant difference between the neurofeedback and control group in clinical outcome, neurofeedback participants showed stronger improvement on cognitive functioning. The current study demonstrates the general feasibility of the suggested rt-fMRI neurofeedback training approach as a potential novel treatment option for ADHD patients. Due to the study's small sample size, potential clinical benefits need to be further investigated in future studies.	[Zilverstand, Anna; Sorger, Bettina; Goebel, Rainer] Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands; [Zilverstand, Anna] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Slaats-Willemse, Dorine; Buitelaar, Jan K.] Karakter Univ, Ctr Child & Adolescent Psychiat, Nijmegen, Netherlands; [Slaats-Willemse, Dorine; Buitelaar, Jan K.] Radboud Univ Nijmegen, Med Ctr, Dept Psychiat, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Kan, Cornelis C.] Radboud Univ Nijmegen, Med Ctr, Dept Psychiat, Nijmegen, Netherlands; [Goebel, Rainer] Netherlands Inst Neurosci, Dept Neuroimaging & Neuromodeling, Amsterdam, Netherlands; [Buitelaar, Jan K.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, Nijmegen, Netherlands	Maastricht University; Icahn School of Medicine at Mount Sinai; Radboud University Nijmegen; Radboud University Nijmegen; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Radboud University Nijmegen	Zilverstand, A (corresponding author), Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands.	anna.zilverstand@gmail.com	Zilverstand, Anna/AFR-0554-2022; Buitelaar, J.K./AAY-7522-2020	Zilverstand, Anna/0000-0002-4889-9700; Sorger, Bettina/0000-0003-1393-3144; Goebel, Rainer/0000-0003-1780-2467	Netherlands Organisation for Scientific Research (Rubicon fellowship) [446-14-015]; BrainGain Smart Mix Program of The Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science [SSM06011]	Netherlands Organisation for Scientific Research (Rubicon fellowship); BrainGain Smart Mix Program of The Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science	The authors gratefully acknowledge the support of Netherlands Organisation for Scientific Research (Rubicon fellowship 446-14-015 to A.Z.; http://www.nwo.nl/en) and the BrainGain Smart Mix Program of The Netherlands Ministry of Economic Affairs and The Netherlands Ministry of Education, Culture and Science (grant number: SSM06011 to A.Z., R.G., J.K.B.; http://www.rvo.nl/subsidies-regelingen/smart-mix SSM06011).	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; American Psychiatric Association, 2013, CAUT STAT FOR US DSM, V5th Edn; Borm GF, 2005, CONTEMP CLIN TRIALS, V26, P637, DOI 10.1016/j.cct.2005.09.002; Bray S, 2007, J NEUROSCI, V27, P7498, DOI 10.1523/JNEUROSCI.2118-07.2007; Bron TI, 2014, EUR NEUROPSYCHOPHARM, V24, P519, DOI 10.1016/j.euroneuro.2014.01.007; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Bush G, 2003, MOL PSYCHIATR, V8, P60, DOI 10.1038/sj.mp.4001217; Bush G, 1999, BIOL PSYCHIAT, V45, P1542, DOI 10.1016/S0006-3223(99)00083-9; Bush G, 2008, ARCH GEN PSYCHIAT, V65, P102, DOI 10.1001/archgenpsychiatry.2007.16; Bush G, 2006, NAT PROTOC, V1, P308, DOI 10.1038/nprot.2006.48; Bush G, 2011, BIOL PSYCHIAT, V69, P1160, DOI 10.1016/j.biopsych.2011.01.022; COHEN J, 1973, EDUC PSYCHOL MEAS, V33, P107, DOI 10.1177/001316447303300111; Cotan, 2012, WECHSLER ADULT INTEL; Cubillo A, 2010, J PSYCHIATR RES, V44, P629, DOI 10.1016/j.jpsychires.2009.11.016; DAUM I, 1993, J NEUROL NEUROSUR PS, V56, P94, DOI 10.1136/jnnp.56.1.94; De Sonneville L., 2005, TIJDSCHRIFT NEUROPSY, P27; de Sonneville LMJ, 1999, COMP PSYCH, V6, P187; deCharms RC, 2005, P NATL ACAD SCI USA, V102, P18626, DOI 10.1073/pnas.0505210102; Delazer M, 2003, COGNITIVE BRAIN RES, V18, P76, DOI 10.1016/j.cogbrainres.2003.09.005; Dickstein SG, 2006, J CHILD PSYCHOL PSYC, V47, P1051, DOI 10.1111/j.1469-7610.2006.01671.x; DuPaul G. J., 1998, ADHD RATING SCALE 4; Faraone SV, 2010, J CLIN PSYCHIAT, V71, P754, DOI 10.4088/JCP.08m04902pur; Fehr T, 2007, BRAIN RES, V1172, P93, DOI 10.1016/j.brainres.2007.07.043; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Goebel R., 2010, IMAGING MED, V2, P407; Graham J, 2011, EUR CHILD ADOLES PSY, V20, P17, DOI 10.1007/s00787-010-0140-6; Green CT, 2012, NEUROTHERAPEUTICS, V9, P639, DOI 10.1007/s13311-012-0124-y; Haller S, 2010, EUR RADIOL, V20, P696, DOI 10.1007/s00330-009-1595-z; Holzapfel S., 1998, PRADIKTOREN DER SELB; Hoogman M, 2012, DONDERS SERIES, P97; Iverson GL, 2001, ARCH CLIN NEUROPSYCH, V16, P183, DOI 10.1016/S0887-6177(00)00060-3; Johnson KA, 2012, J NEUROIMAGING, V22, P58, DOI 10.1111/j.1552-6569.2010.00529.x; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Kooij JJS, 2005, PSYCHOL MED, V35, P817, DOI 10.1017/S003329170400337X; Kooij JJS, 2003, INTRO DIAGNOSTIC ASS; Linden DEJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038115; Marchetta NDJ, 2008, J ATTEN DISORD, V11, P664, DOI 10.1177/1087054707305108; Murphy K, 1996, J ATTEN DISORD, P147; Murphy K, 2007, NEUROIMAGE, V34, P565, DOI 10.1016/j.neuroimage.2006.09.032; Nigg JT, 2005, BIOL PSYCHIAT, V57, P1424, DOI 10.1016/j.biopsych.2004.11.011; O'Connell RG, 2008, NEUROPSYCHOLOGIA, V46, P1379, DOI 10.1016/j.neuropsychologia.2007.12.018; Rheinberg F, 2001, DIAGNOSTICA, V47, P57, DOI 10.1026//0012-1924.47.2.57; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rota G, 2009, HUMAN BRAIN MAPPING, V1605; Sattler, 2001, ASSESSMENT CHILDREN; Scheinost D, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.24; Schneider MF, 2010, PSYCHIAT RES-NEUROIM, V183, P75, DOI 10.1016/j.pscychresns.2010.04.005; Scott NW, 2002, CONTROL CLIN TRIALS, V23, P662, DOI 10.1016/S0197-2456(02)00242-8; Simon V, 2009, BRIT J PSYCHIAT, V194, P204, DOI 10.1192/bjp.bp.107.048827; Sitaram R, 2012, NEUROREHAB NEURAL RE, V26, P256, DOI 10.1177/1545968311418345; Slaats-Willemse D, 2005, J AM ACAD CHILD PSY, V44, P385, DOI 10.1097/01.chi.0000153227.34473.c7; Smilek D, 2010, NEUROPSYCHOLOGIA, V48, P2564, DOI 10.1016/j.neuropsychologia.2010.05.002; Sonuga-Barke EJS, 2013, AM J PSYCHIAT, V170, P275, DOI 10.1176/appi.ajp.2012.12070991; Sorger B, NEUROSCIENCE IN PRES; Spencer TJ, 2007, J PEDIATR PSYCHOL, V32, P631, DOI 10.1093/jpepsy/jsm005; Stevens M.C., 2015, BRAIN IMAGING BEHAV; Stoeckel LE, 2014, NEUROIMAGE-CLIN, V5, P245, DOI 10.1016/j.nicl.2014.07.002; Subramanian L, 2011, J NEUROSCI, V31, P16309, DOI 10.1523/JNEUROSCI.3498-11.2011; Talairach J., 1988, NEUROPSYCHOLOGIA; Van de Loo-Neus GHH, 2011, EUROPEAN NEUROPSYCHO, P584; van Dongen-Boomsma M, 2013, J CLIN PSYCHIAT, V74, P821, DOI 10.4088/JCP.12m08321; Van Veen MM, 2010, BIOL PSYCHIAT, V67, P1091, DOI 10.1016/j.biopsych.2009.12.032; Vollebregt MA, 2013, J CHILD PSYCHOL PSYC; Wechsler D., 2012, WAIS 4 KASIKIRJA; Weiskopf N, 2012, NEUROIMAGE, V62, P682, DOI 10.1016/j.neuroimage.2011.10.009; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Young KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088785; Zilverstand A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00148	70	47	47	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170795	10.1371/journal.pone.0170795	http://dx.doi.org/10.1371/journal.pone.0170795			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125735	Green Published, Green Submitted, gold			2022-12-27	WOS:000396176100050
J	Kassouf, N; Syed, S; Larner, J; Amlot, R; Chilcott, RP				Kassouf, Nick; Syed, Sara; Larner, Joanne; Amlot, Richard; Chilcott, Robert P.			Evaluation of absorbent materials for use as ad hoc dry decontaminants during mass casualty incidents as part of the UK's Initial Operational Response (IOR)	PLOS ONE			English	Article							IN-VITRO SKIN; INVITRO PERCUTANEOUS-ABSORPTION; ORGANOPHOSPHORUS PESTICIDE; SULFUR MUSTARD; GUINEA-PIG; MULTICENTER; GLYPHOSATE; SIMULANT; EXPOSURE; BINDING	The UK's Initial Operational Response (IOR) is a revised process for the medical management of mass casualties potentially contaminated with hazardous materials. A critical element of the IOR is the introduction of immediate, on-scene disrobing and decontamination of casualties to limit the adverse health effects of exposure. Ad hoc cleansing of the skin with dry absorbent materials has previously been identified as a potential means of facilitating emergency decontamination. The purpose of this study was to evaluate the in vitro oil and water absorbency of a range of materials commonly found in the domestic and clinical environments and to determine the effectiveness of a small, but representative selection of such materials in skin decontamination, using an established ex vivo model. Five contaminants were used in the study: methyl salicylate, parathion, diethyl malonate, phorate and potassium cyanide. In vitro measurements of water and oil absorbency did not correlate with ex vivo measurements of skin decontamination. When measured ex vivo, dry decontamination was consistently more effective than a standard wet decontamination method ("rinsewipe-rinse") for removing liquid contaminants. However, dry decontamination was ineffective against particulate contamination. Collectively, these data confirm that absorbent materials such as wound dressings and tissue paper provide an effective, generic capability for emergency removal of liquid contaminants from the skin surface, but that wet decontamination should be used for non-liquid contaminants.	[Kassouf, Nick; Syed, Sara; Larner, Joanne; Chilcott, Robert P.] Univ Hertfordshire, Sch Pharm, Res Ctr Top Drug Delivery & Toxicol, Hatfield, Herts, England; [Amlot, Richard] Publ Hlth England, Microbial Risk Assessment & Behav Sci, Emergency Response Dept, Hlth Protect Directorate, Salisbury, Wilts, England	University of Hertfordshire; Public Health England	Chilcott, RP (corresponding author), Univ Hertfordshire, Sch Pharm, Res Ctr Top Drug Delivery & Toxicol, Hatfield, Herts, England.	tox.publications@herts.ac.uk	Kassouf, Nick/AAB-9994-2019; Kassouf, Nick/GVR-7186-2022	Kassouf, Nick/0000-0003-0519-1929; Chilcott, Robert/0000-0002-8845-9400	Department of Health Policy Research Programme (EDICTAS) [047/0200]	Department of Health Policy Research Programme (EDICTAS)	This report is independent research commissioned and funded by the Department of Health Policy Research Programme (EDICTAS 047/0200). The views expressed in this publication are those of the author(s) and not necessarily those of the Department of Health. All technical aspects of this work and the preparation of the manuscript were performed without sponsor input. The sponsor reviewed the final manuscript as part of a formal security approval process at the instigation of the authors.	[Anonymous], 2013, INITIAL OPERATIONAL; Ballantyne B, 1988, FUND APPL TOXICOL, V26, P325; BUCKS DAW, 1989, TOXICOL APPL PHARM, V100, P417, DOI 10.1016/0041-008X(89)90290-1; Butler D, 2014, NATURE, V506, P139, DOI 10.1038/506139a; Chilcott R. P., 2007, CHEM WARFARE AGENTS, V2, P409; Chilcott RP, 2014, ENVIRON INT, V72, P37, DOI 10.1016/j.envint.2014.02.006; Chilcott RP, 2005, J PHARM SCI-US, V94, P632, DOI 10.1002/jps.20229; Chilcott RP, 2001, J APPL TOXICOL, V21, P279, DOI 10.1002/jat.755; Edwards Falicia L, 2005, Int J Environ Res Public Health, V2, P430, DOI 10.3390/ijerph2005030007; Filon FL, 2006, J OCCUP ENVIRON MED, V48, P692, DOI 10.1097/01.jom.0000214474.61563.1c; HEWITT PG, 1995, FUND APPL TOXICOL, V26, P91, DOI 10.1006/faat.1995.1078; Hui XY, 2012, FOOD CHEM TOXICOL, V50, P2496, DOI 10.1016/j.fct.2012.03.069; Jones D. S., 2012, THESIS; Loke WK, 1999, J APPL TOXICOL, V19, P285, DOI 10.1002/(SICI)1099-1263(199907/08)19:4<285::AID-JAT580>3.0.CO;2-X; Matar H, 2014, TOXICOL IN VITRO, V28, P492, DOI 10.1016/j.tiv.2014.01.001; Matar H, 2012, THESIS; Matar H, 2016, CUTAN OCUL TOXICOL, V35, P137, DOI 10.3109/15569527.2015.1072544; Mircioiu C, 2013, TOXICOL LETT, V219, P99, DOI 10.1016/j.toxlet.2013.03.005; Misik J, 2012, TOXICOL MECH METHOD, V22, P520, DOI 10.3109/15376516.2012.686535; Moody RP, 2006, FOOD CHEM TOXICOL, V44, P1783, DOI 10.1016/j.fct.2006.05.020; Moody RP, 1997, TOXICOL IN VITRO, V11, P251, DOI 10.1016/S0887-2333(97)00013-1; REIFENRATH WG, 1984, J PHARM SCI, V73, P1388, DOI 10.1002/jps.2600731016; Riviere JE, 2001, J APPL TOXICOL, V21, P91, DOI 10.1002/jat.718; Rolland P, 2013, TOXICOL IN VITRO, V27, P358, DOI 10.1016/j.tiv.2012.08.014; Snider TH, 2016, J TOXICOL SCI, V41, P511, DOI 10.2131/jts.41.511; Vale JA, 2014, OXFORD DESK REFERENC, P31; van de Sandt JJM, 2004, REGUL TOXICOL PHARM, V39, P271, DOI 10.1016/j.yrtph.2004.02.004; WEBER LWD, 1992, ARCH ENVIRON HEALTH, V47, P302, DOI 10.1080/00039896.1992.9938366; WESTER RC, 1991, FUND APPL TOXICOL, V16, P725, DOI 10.1016/0272-0590(91)90158-Z; WESTER RC, 1990, J TOXICOL ENV HEALTH, V31, P235, DOI 10.1080/15287399009531453; WESTER RC, 1993, FUND APPL TOXICOL, V20, P336, DOI 10.1006/faat.1993.1043; Zhai H, 2008, FOOD CHEM TOXICOL, V46, P2258, DOI 10.1016/j.fct.2008.03.001	32	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170966	10.1371/journal.pone.0170966	http://dx.doi.org/10.1371/journal.pone.0170966			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152053	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000396161200062
J	Lin, PY; Huang, FJ; Kung, FT; Lin, YC; Chiang, HJ; Lin, YJ; Lan, KC				Lin, Pin-Yao; Huang, Fu-Jen; Kung, Fu-Tsai; Lin, Yi-Chi; Chiang, Hsin-Ju; Lin, Yu-Ju; Lan, Kuo-Chung			Reassessing the feasibility of the zygote score for predicting embryo viability in IVF/ICSI using the GnRH antagonist protocol compared to the long protocol	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; PRONUCLEAR MORPHOLOGY; BLASTOCYST DEVELOPMENT; OVARIAN STIMULATION; OOCYTE; AGONIST; PROGNOSIS; SURVIVAL; OUTCOMES; TIME	Background Many factors from the oocyte/sperm or the process of fertilization may affect the zygote formation. The zygote score (Z-score) describes the quality of a human zygote based on its pronuclear morphology, nucleolar precursor bodies, and alignment of polar bodies, and it can be used in the selection process at the zygote stage for embryo transfer or cryopreservation. Objective The aim of this retrospective cohort study was to investigate the relationship between different controlled ovarian stimulation (COS) protocols and the zygote score (Z-score) and to assess the feasibility of the Z-score for predicting embryo survival in the GnRH-antagonist (GnRH-ant) protocol. Methods It is a retrospective, single-center cohort study. A total of 3,826 zygotes with normal fertilization were analyzed from 744 in vitro fertilization /intra-cytoplasmic sperm injection (IVF/ICSI) cycles (long protocol n = 392; GnRH-ant n = 352) between Jan 2010 and April 2014 in the IVF unit of Chang-Gung Memorial Hospital Kaohsiung Medical Center. Results The Z-score distribution differed significantly between these two protocols. The overall Zscore was poorer for zygotes from GnRH-ant cycles (p<0.05). Univariate and multivariate analyses indicated the type of COS protocol is one of the main determinants of Z-score grading. Our study found good-quality day 3 embryo/blastocyst formation and the cumulative embryo survival rate were correlated with the Z-score but not the COS protocol. With the GnRH-ant protocol, the number of Z1 in the transferred cohort embryos was significantly correlated with the clinical pregnancy rate (r = 0.976; p = 0.024) and live birth rate (r = 0.971; p = 0.029). This correlation was not seen with the long protocol. Conclusions The Z-score distribution for the GnRH antagonist cycles was poorer than that of the long protocol, but the Z-score system is a valuable parameter for predicting embryo viability in the GnRH-ant protocol, providing a strong correlation with the clinical pregnancy rate and live birth rate.	[Lin, Pin-Yao; Huang, Fu-Jen; Kung, Fu-Tsai; Lin, Yi-Chi; Chiang, Hsin-Ju; Lin, Yu-Ju; Lan, Kuo-Chung] Kaohsiung Chang Gung Mem Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan; [Lin, Pin-Yao; Huang, Fu-Jen; Kung, Fu-Tsai; Lin, Yi-Chi; Chiang, Hsin-Ju; Lin, Yu-Ju; Lan, Kuo-Chung] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Lin, Pin-Yao] Chang Gung Univ, Grad Inst Clin Med Sci, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Lan, KC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan.; Lan, KC (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.	lankuochung@gmail.com		Kung, Fu-Tsai/0000-0003-0565-6976				Ajduk A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1424; Al-Inany HG, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001750.pub4; Braga DPAF, 2013, J ASSIST REPROD GEN, V30, P1327, DOI 10.1007/s10815-013-0073-3; Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology, 2011, Hum Reprod, V26, P1270, DOI 10.1093/humrep/der037; Arroyo G, 2007, J ASSIST REPROD GEN, V24, P173, DOI 10.1007/s10815-006-9099-0; Attaman J, 2014, J REPROD MED, V59, P103; Aydin S, 2011, GYNECOL ENDOCRINOL, V27, P742, DOI 10.3109/09513590.2010.509829; Azzarello A, 2012, HUM REPROD, V27, P2649, DOI 10.1093/humrep/des210; Berger DS, 2014, J ASSIST REPROD GEN, V31, P279, DOI 10.1007/s10815-013-0162-3; Zamora RB, 2011, ZYGOTE, V19, P339, DOI 10.1017/S0967199410000407; Bosch E, 2016, FERTIL STERIL, V105, P560, DOI 10.1016/j.fertnstert.2016.01.022; Brus L, 1997, HUM REPROD, V12, P769, DOI 10.1093/humrep/12.4.769; Cheung LWT, 2008, FEBS J, V275, P5479, DOI 10.1111/j.1742-4658.2008.06677.x; Cota AMM, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-33; Depalo R, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-26; Depalo R, 2009, GYNECOL ENDOCRINOL, V25, P328, DOI 10.1080/09513590802617762; Gianaroli L, 2003, FERTIL STERIL, V80, P341, DOI 10.1016/S0015-0282(03)00596-X; Gianaroli L, 2007, HUM REPROD, V22, P241, DOI 10.1093/humrep/del334; Grow D, 2014, REPROD BIOMED ONLINE, V29, P299, DOI 10.1016/j.rbmo.2014.05.007; Huirne JAF, 2001, LANCET, V358, P1793, DOI 10.1016/S0140-6736(01)06797-6; Khalaf M, 2010, REPROD BIOMED ONLINE, V21, P56, DOI 10.1016/j.rbmo.2010.03.017; Lan KC, 2003, HUM REPROD, V18, P1299, DOI 10.1093/humrep/deg239; Lin Y, 1999, HUM REPROD, V14, P885, DOI 10.1093/humrep/14.4.885; Lin YC, 2003, J ASSIST REPROD GEN, V20, P506, DOI 10.1023/B:JARG.0000013651.37866.0c; Ludwig A. K., 2006, Archives of Gynecology and Obstetrics, V273, P346, DOI 10.1007/s00404-005-0102-2; Maille L, 2009, REPROD BIOMED ONLINE, V18, P367, DOI 10.1016/S1472-6483(10)60095-8; Murber Akos, 2009, Reprod Biol Endocrinol, V7, P103, DOI 10.1186/1477-7827-7-103; Nicoli A, 2007, FERTIL STERIL, V88, P1167, DOI 10.1016/j.fertnstert.2007.01.066; Nicoli A, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-64; Olivennes F, 1998, HUM REPROD, V13, P1121, DOI 10.1093/humrep/13.5.1121; Orvieto R, 2013, REPROD BIOMED ONLINE, V26, P4, DOI 10.1016/j.rbmo.2012.11.001; Papale L, 2012, HUM REPROD, V27, P22, DOI 10.1093/humrep/des205; Payne JF, 2005, FERTIL STERIL, V84, P900, DOI 10.1016/j.fertnstert.2005.04.047; Rienzi L, 2008, FERTIL STERIL, V90, P1692, DOI 10.1016/j.fertnstert.2007.09.024; Rosner, 2010, ESTIMATION SURVIVAL, P761; Scott L, 2003, HUM REPROD UPDATE, V9, P237, DOI 10.1093/humupd/dmg023; Scott L, 2000, HUM REPROD, V15, P2394, DOI 10.1093/humrep/15.11.2394; Senn A, 2006, HUM REPROD, V21, P234, DOI 10.1093/humrep/dei282; Tsai YR, 2015, FERTIL STERIL, V103, P106, DOI 10.1016/j.fertnstert.2014.10.019; van Hooren HG, 2001, HUM REPROD, V16, P644; Veeck LL, 1986, ATLAS HUMAN OOCYTE E; Weitzman VN, 2010, FERTIL STERIL, V93, P658, DOI 10.1016/j.fertnstert.2009.02.032; Xiao JQ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095214, 10.1371/journal.pone.0090396]; Yanez LZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10809; Zegers-Hochschild F, 2009, HUM REPROD, V24, P2683, DOI 10.1093/humrep/dep343; Zollner U, 2003, J REPROD MED, V48, P365	46	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171465	10.1371/journal.pone.0171465	http://dx.doi.org/10.1371/journal.pone.0171465			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152037	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161200145
J	Nagel, S; Pommerenke, C; Scherr, M; Meyer, C; Kaufmann, M; Battmer, K; MacLeod, RAF; Drexler, HG				Nagel, Stefan; Pommerenke, Claudia; Scherr, Michaela; Meyer, Corinna; Kaufmann, Maren; Battmer, Karin; MacLeod, Roderick A. F.; Drexler, Hans G.			NKL homeobox gene activities in hematopoietic stem cells, T-cell development and T-cell leukemia	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; HOX CODE; PROGENITOR CELLS; B-CELL; EXPRESSION; ACTIVATION; BINDING; NKX2-3; MOUSE; HEX	T-cell acute lymphoblastic leukemia (T-ALL) cells represent developmentally arrested T-cell progenitors, subsets of which aberrantly express homeobox genes of the NKL subclass, including TLX1, TLX3, NKX2-1, NKX2-5, NKX3-1 and MSX1. Here, we analyzed the transcriptional landscape of all 48 members of the NKL homeobox gene subclass in CD34+ hematopoietic stem and progenitor cells (HSPCs) and during lymphopoiesis, identifying activities of nine particular genes. Four of these were expressed in HSPCs (HHEX, HLX1, NKX2-3 and NKX3-1) and three in common lymphoid progenitors (HHEX, HLX1 and MSX1). Interestingly, our data indicated downregulation of NKL homeobox gene transcripts in late progenitors and mature T-cells, a phenomenon which might explain the oncogenic impact of this group of genes in T-ALL. Using MSX1-expressing T-ALL cell lines as models, we showed that HHEX activates while HLX1, NKX2-3 and NKX3-1 repress MSX1 transcription, demonstrating the mutual regulation and differential activities of these homeobox genes. Analysis of a public T-ALL expression profiling data set comprising 117 patient samples identified 20 aberrantly activated members of the NKL subclass, extending the number of known NKL homeobox oncogene candidates. While 7/20 genes were also active during hematopoiesis, the remaining 13 showed ectopic expression. Finally, comparative analyses of T-ALL patient and cell line profiling data of NKL-positive and NKL-negative samples indicated absence of shared target genes but instead highlighted deregulation of apoptosis as common oncogenic effect. Taken together, we present a comprehensive survey of NKL homeobox genes in early hematopoiesis, T-cell development and T-ALL, showing that these genes generate an NKL-code for the diverse stages of lymphoid development which might be fundamental for regular differentiation.	[Nagel, Stefan; Pommerenke, Claudia; Meyer, Corinna; Kaufmann, Maren; MacLeod, Roderick A. F.; Drexler, Hans G.] Leibniz Inst DSMZ German Collect Microorganisms &, Dept Human & Anim Cell Lines, Braunschweig, Germany; [Scherr, Michaela; Battmer, Karin] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Hannover Medical School	Nagel, S (corresponding author), Leibniz Inst DSMZ German Collect Microorganisms &, Dept Human & Anim Cell Lines, Braunschweig, Germany.	sna@dsmz.de						Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Alberola-Ila J, 2003, IMMUNOL REV, V191, P79, DOI 10.1034/j.1600-065X.2003.00012.x; Alharbi RA, 2013, LEUKEMIA, V27, P1000, DOI 10.1038/leu.2012.356; Armstrong SA, 2005, J CLIN ONCOL, V23, P6306, DOI 10.1200/JCO.2005.05.047; Arnold R, 2006, EUR J IMMUNOL, V36, P1654, DOI 10.1002/eji.200636197; BEDFORD FK, 1993, NUCLEIC ACIDS RES, V21, P1245, DOI 10.1093/nar/21.5.1245; Bernard OA, 2001, LEUKEMIA, V15, P1495, DOI 10.1038/sj.leu.2402249; Brune V, 2008, J EXP MED, V205, P2251, DOI 10.1084/jem.20080809; Casero D, 2015, NAT IMMUNOL, V16, P1282, DOI 10.1038/ni.3299; Cejalvo T, 2007, IMMUNOLOGY, V121, P94, DOI 10.1111/j.1365-2567.2007.02541.x; De Keersmaecker K, 2010, NAT MED, V16, P1321, DOI 10.1038/nm.2246; Depew MJ, 2005, J ANAT, V207, P501, DOI 10.1111/j.1469-7580.2005.00487.x; Drexler HG, 2010, GUIDE TO LEUKEMIA LY; Du XL, 2006, GENOMICS, V87, P693, DOI 10.1016/j.ygeno.2006.02.003; Eklund EA, 2006, CURR OPIN HEMATOL, V13, P67, DOI 10.1097/01.moh.0000208467.63861.d6; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Gao ZH, 2014, NATURE, V516, P349, DOI 10.1038/nature13921; George A, 2003, ONCOGENE, V22, P6764, DOI 10.1038/sj.onc.1206822; Hager-Theodorides AL, 2002, J IMMUNOL, P169; HATANO M, 1991, SCIENCE, V253, P79, DOI 10.1126/science.1676542; He H, 2011, ONCOGENE, V30, P379, DOI 10.1038/onc.2010.484; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Holland PWH, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-47; Homminga I, 2012, LEUKEMIA, V26, P572, DOI 10.1038/leu.2011.330; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Hsu CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138782; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUNT P, 1991, CELL, V66, P1075, DOI 10.1016/0092-8674(91)90029-X; HUNT P, 1991, NATURE, V353, P861, DOI 10.1038/353861a0; John G, 2011, MOL GENET METAB, V104, P174, DOI 10.1016/j.ymgme.2011.06.023; Jojic V, 2013, NAT IMMUNOL, V14, P633, DOI 10.1038/ni.2587; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; KOMURO I, 1993, P NATL ACAD SCI USA, V90, P8145, DOI 10.1073/pnas.90.17.8145; Kuratani S, 2012, EVOL DEV, V14, P76, DOI 10.1111/j.1525-142X.2011.00523.x; Kusy S, 2010, J EXP MED, V207, P2141, DOI 10.1084/jem.20100745; Mack DL, 2002, IMMUNOLOGY, V107, P444, DOI 10.1046/j.1365-2567.2002.01523.x; MacLeod RAF, 2003, GENE CHROMOSOME CANC, V37, P84, DOI 10.1002/gcc.10194; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Nagel S, 2008, LEUKEMIA, V22, P600, DOI 10.1038/sj.leu.2405067; Nagel S, 2003, CANCER RES, V63, P5329; Nagel S, 2016, ONCOTARGET, V7, P45398, DOI 10.18632/oncotarget.9982; Nagel S, 2015, LEUKEMIA LYMPHOMA, V56, P480, DOI 10.3109/10428194.2014.924119; Nagel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061447; Nagel S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040747; Nagel S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-371; Nagel S, 2009, LEUKEMIA LYMPHOMA, V50, P101, DOI 10.1080/10428190802626632; Pabst O, 1999, DEVELOPMENT, V126, P2215; Reecy JM, 1997, DEV BIOL, V188, P295, DOI 10.1006/dbio.1997.8641; Rice KL, 2008, LEUKEMIA RES, V32, P873, DOI 10.1016/j.leukres.2007.11.001; Riz I, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-181; Riz I, 2009, BIOCHEM BIOPH RES CO, V380, P361, DOI 10.1016/j.bbrc.2009.01.099; Robles EF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11889; Rothenberg EV, 2016, IMMUNOL REV, V271, P72, DOI 10.1111/imr.12417; Rothenberg EV, 2012, CURR OPIN IMMUNOL, V24, P132, DOI 10.1016/j.coi.2011.12.012; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; Soulier J, 2005, BLOOD, V106, P274, DOI 10.1182/blood-2004-10-3900; Steadman DJ, 2000, NUCLEIC ACIDS RES, V28, P2389, DOI 10.1093/nar/28.12.2389; Taghon T, 2003, LEUKEMIA, V17, P1157, DOI 10.1038/sj.leu.2402947; Wang RQ, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/632837; Yu W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020454; Yu W, 2010, DIGEST DIS SCI, V55, P3171, DOI 10.1007/s10620-010-1138-0; Zhou F, 2016, NATURE, V533, P487, DOI 10.1038/nature17997	63	20	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171164	10.1371/journal.pone.0171164	http://dx.doi.org/10.1371/journal.pone.0171164			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151996	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200097
J	Rehm, J; Germann, T; Akbar, M; Pepke, W; Kauczor, HU; Weber, MA; Spira, D				Rehm, Johannes; Germann, Thomas; Akbar, Michael; Pepke, Wojciech; Kauczor, Hans-Ulrich; Weber, Marc-Andre; Spira, Daniel			3D-modeling of the spine using EOS imaging system: Inter-reader reproducibility and reliability	PLOS ONE			English	Article							ADOLESCENT IDIOPATHIC SCOLIOSIS; RADIATION	Objectives To retrospectively assess the interreader reproducibility and reliability of EOS 3D full spine reconstructions in patients with adolescent idiopathic scoliosis (AIS). Methods 73 patients with mean age of 17 years and a moderate AIS (median Cobb Angle 18.2) obtained low-dose standing biplanar radiographs with EOS. Two independent readers performed "full spine" 3D reconstructions of the spine with the "full-spine" method adjusting the bone contour of every thoracic and lumbar vertebra (Th1-L5). Interreader reproducibility was assessed regarding rotation of every single vertebra in the coronal (i.e. frontal), sagittal (i.e. lateral), and axial plane, T1/T12 kyphosis, T4/T12 kyphosis, L1/L5 lordosis, L1/S1 lordosis and pelvic parameters. Radiation exposure, scan-time and 3D reconstruction time were recorded. Results Interclass correlation (ICC) ranged between 0.83 and 0.98 for frontal vertebral rotation, between 0.94 and 0.99 for lateral vertebral rotation and between 0.51 and 0.88 for axial vertebral rotation. ICC was 0.92 for T1/T12 kyphosis, 0.95 for T4/T12 kyphosis, 0.90 for L1/L5 lordosis, 0.85 for L1/S1 lordosis, 0.97 for pelvic incidence, 0.96 for sacral slope, 0.98 for sagittal pelvic tilt and 0.94 for lateral pelvic tilt. The mean time for reconstruction was 14.9 minutes (reader 1: 14.6 minutes, reader 2: 15.2 minutes, p<0.0001). The mean total absorbed dose was 593.4pGy +/- 212.3 per patient. Conclusion EOS "full spine" 3D angle measurement of vertebral rotation proved to be reliable and was performed in an acceptable reconstruction time. Interreader reproducibility of axial rotation was limited to some degree in the upper and middle thoracic spine due the obtuse angulation of the pedicles and the processi spinosi in the frontal view somewhat complicating their delineation.	[Rehm, Johannes; Germann, Thomas; Kauczor, Hans-Ulrich; Weber, Marc-Andre; Spira, Daniel] Univ Hosp, Diagnost & Intervent Radiol, Heidelberg, Germany; [Akbar, Michael; Pepke, Wojciech] Univ Hosp, Clin Orthoped & Trauma Surg, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Rehm, J (corresponding author), Univ Hosp, Diagnost & Intervent Radiol, Heidelberg, Germany.	johannes.rehm@med.uni-heidelberg.de	Weber, Marc/GXA-0612-2022; Kauczor, HU/AAX-6033-2021; Kauczor, Hans-Ulrich/AAU-5955-2021		company EOS Imaging France	company EOS Imaging France	The department of Diagnostic and Interventional Radiology of University Hospital Heidelberg has received research funds from the company EOS Imaging France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abul-Kasim K, 2009, EUR RADIOL, V19, P610, DOI 10.1007/s00330-008-1178-4; Al-Aubaidi Z, 2013, J PEDIATR ORTHOP B, V22, P409, DOI 10.1097/BPB.0b013e328361ae5b; Bone CM, 2000, J PEDIATR ORTHOPED, V20, P251, DOI 10.1097/00004694-200003000-00023; Charpark G., 1981, RECHERCHE, V128, P1384; Deschenes S, 2010, SPINE, V35, P989, DOI 10.1097/BRS.0b013e3181bdcaa4; Dubousset J, 2005, B ACAD NAT MED PARIS, V189, P287, DOI 10.1016/S0001-4079(19)33584-8; Dubousset J., 1992, INT S 3D SCOL DEF JO, P302; Dumas R, 2004, MED ENG PHYS, V26, P415, DOI 10.1016/j.medengphy.2004.02.004; Gangnet N, 2006, SPINE, V31, pE507, DOI 10.1097/01.brs.0000224533.19359.89; Gille O, 2007, SPINE, V32, P568, DOI 10.1097/01.brs.0000256866.25747.b3; Harrison DE, 2001, SPINE, V26, P235, DOI DOI 10.1097/00007632-200106010-00003; Humbert L, 2009, MED ENG PHYS, V31, P681, DOI 10.1016/j.medengphy.2009.01.003; Ilharreborde B, 2014, EUR SPINE J S4, pS397; Ilharreborde B, 2016, EUR SPINE J, V25, P526, DOI 10.1007/s00586-015-3960-8; Ilharreborde B, 2011, SPINE, V36, pE1306, DOI 10.1097/BRS.0b013e3182293548; Kloth JK, 2012, ROFO FORTSCHR RONTG, V185-1, P48; PERDRIOLLE R, 1987, ORTHOPEDICS, V10, P909; Presciutti SM, 2014, SPINE J, V14, P1984, DOI 10.1016/j.spinee.2013.11.055; Richards PJ, 2010, SPINE, V35, P430, DOI 10.1097/BRS.0b013e3181cdde47; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Steib JP, 2004, SPINE, V29, P193, DOI 10.1097/01.BRS.0000107233.99835.A4	21	34	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171258	10.1371/journal.pone.0171258	http://dx.doi.org/10.1371/journal.pone.0171258			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152019	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161200117
J	Takase, Y; Usui, K; Shimizu, K; Kimura, Y; Ichihara, T; Ohkawa, T; Atsumi, J; Enokida, Y; Nakazawa, S; Obayashi, K; Ohtaki, Y; Nagashima, T; Mitani, Y; Takeyoshi, I				Takase, Yoshiaki; Usui, Kengo; Shimizu, Kimihiro; Kimura, Yasumasa; Ichihara, Tatsuo; Ohkawa, Takahiro; Atsumi, Jun; Enokida, Yasuaki; Nakazawa, Seshiru; Obayashi, Kai; Ohtaki, Yoichi; Nagashima, Toshiteru; Mitani, Yasumasa; Takeyoshi, Izumi			Highly sensitive detection of a HER2 12-base pair duplicated insertion mutation in lung cancer using the Eprobe-PCR method	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; SOMATIC MUTATIONS; GENE-MUTATIONS; ADENOCARCINOMAS; AMPLIFICATION	Somatic mutation in human epidermal growth factor receptor-related 2 gene (HER2) is one of the driver mutations in lung cancer. HER2 mutations are found in about 2% of lung adenocarcinomas (ADCs). Previous reports have been based mainly on diagnostic screening by Sanger sequencing or next-generation sequencing (NGS); however, these methods are time-consuming and complicated. We developed a rapid, simple, sensitive mutation detection assay for detecting HER2 12 base pair-duplicated insertion mutation based on the Eprobe-mediated PCR method (Eprobe-PCR) and validated the sensitivity of this assay system for clinical diagnostics. We examined 635 tumor samples and analyzed HER2 mutations using the EprobePCR method, NGS, and Sanger sequencing. In a serial dilution study, the Eprobe-PCR was able to detect mutant plasmid DNA when its concentration was reduced to 0.1% by mixing with wild-type DNA. We also confirmed amplification of the mutated plasmid DNA with only 10 copies per reaction. In ADCs, Eprobe-PCR detected the HER2 mutation in 2.02% (9/446), while Sanger sequencing detected it in 1.57% (7/446). Eprobe-PCR was able to detect the mutation in two samples that were undetectable by Sanger sequencing. All non-ADC samples were wild-type. There were no discrepancies between frozen and formalin-fixed paraffin-embedded tissues in the nine samples. HER2 mutations detected by NGS data validated the high sensitivity of the method. Therefore, this new technique can lead to precise molecular-targeted therapies.	[Takase, Yoshiaki; Shimizu, Kimihiro; Atsumi, Jun; Enokida, Yasuaki; Nakazawa, Seshiru; Obayashi, Kai; Ohtaki, Yoichi; Nagashima, Toshiteru; Takeyoshi, Izumi] Gunma Univ, Grad Sch Med, Dept Thorac & Visceral Organ Surg, Maebashi, Gunma, Japan; [Usui, Kengo; Kimura, Yasumasa; Ohkawa, Takahiro] RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan; [Kimura, Yasumasa; Ichihara, Tatsuo; Mitani, Yasumasa] KK DNAFORM, Yokohama, Kanagawa, Japan; [Kimura, Yasumasa] Univ Tokyo, Inst Med Sci, Div Syst Immunol, Minato Ku, Tokyo, Japan	Gunma University; RIKEN; University of Tokyo	Usui, K (corresponding author), RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan.	kengo.usui@riken.jp	Nakazawa, Seshiru/GLT-1855-2022; Takase, Yoshiaki/M-9908-2014	Takase, Yoshiaki/0000-0002-5159-4174	METI (Ministry of Economy, Trade and Industry, Japan); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); DNAFORM	METI (Ministry of Economy, Trade and Industry, Japan); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); DNAFORM	This work was supported by the subsidy of expenses by METI (Ministry of Economy, Trade and Industry, Japan) for measures for small business support to YM, and by a Research Grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) to the RIKEN Center for Life Science Technologies to PC. K.K. DNAFORM provided support in the form of salaries for authors (Tatsuo Ichihara [TI], Yasumasa Mitani [YM]], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arcila ME, 2012, CLIN CANCER RES, V18, P4910, DOI 10.1158/1078-0432.CCR-12-0912; Atsumi J, 2015, ONCOL REP, V33, P2719, DOI 10.3892/or.2015.3883; De Greve J, 2015, LUNG CANCER, V88, P63, DOI 10.1016/j.lungcan.2015.01.013; Gandhi L, 2014, J CLIN ONCOL, V32, P68, DOI 10.1200/JCO.2012.47.2787; Hanami T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070942; Kimura Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146950; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mar N, 2015, LUNG CANCER, V87, P220, DOI 10.1016/j.lungcan.2014.12.018; Mazieres J, 2015, ANN ONCOL; Mazieres J, 2013, J CLIN ONCOL, V31, P1997, DOI 10.1200/JCO.2012.45.6095; Miyamae Y, 2010, J MOL DIAGN, V12, P257, DOI 10.2353/jmoldx.2010.090105; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Ricciardi GRR, 2014, J THORAC ONCOL, V9, P1750, DOI 10.1097/JTO.0000000000000379; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Suzuki M, 2015, LUNG CANCER, V87, P14, DOI 10.1016/j.lungcan.2014.10.014; Tomizawa K, 2011, LUNG CANCER, V74, P139, DOI 10.1016/j.lungcan.2011.01.014; Yoshizawa A, 2014, LUNG CANCER, V85, P373, DOI 10.1016/j.lungcan.2014.06.007	20	4	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171225	10.1371/journal.pone.0171225	http://dx.doi.org/10.1371/journal.pone.0171225			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152008	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161200108
J	Xu, FF; Wang, KY; Wang, N; Li, GQ; Liu, DH				Xu, Fangfang; Wang, Kevin Yueju; Wang, Nan; Li, Gangqiang; Liu, Dehu			Bioactivity of a modified human Glucagon-like peptide-1	PLOS ONE			English	Article							IN-VIVO; EXPRESSION; GLUCOSE; DEGRADATION; PROTEIN	Diabetes has become the third largest cause of death in humans worldwide. Therefore, effective treatment for this disease remains a critical issue. Glucagon-like peptide-1 (GLP-1) plays an important role in glucose homeostasis, and therefore represents a promising candidate to use for the treatment of diabetes. Native GLP-1, however, is quickly degraded in in the circulatory system; which limits its clinical application. In the present study, a chemically-synthesized, modified analogue of human GLP-1 (mGLP-1) was designed. Our analyses indicated that, relative to native GLP-1, mGLP-1 is more resistant to trypsin and pancreatin degradation. mGLP-1 promotes mouse pancreatic beta-cell proliferation by up-regulating the expression level of cyclin E, CDK2, Bcl-2 and down-regulating Bax, p21, and stimulates insulin secretion. An oral glucose tolerance test indicated that mGLP-1 significantly improved glucose tolerance in mice. Intraperitoneal injections of mGLP-1 into streptozotocin (STZ)-induced type 2 diabetic mice significantly reduced blood sugar levels and stimulated insulin secretion. Oral gavages of mGLP-1 in diabetic mice did not result in significant hypoglycemic activity.	[Xu, Fangfang; Wang, Nan; Li, Gangqiang; Liu, Dehu] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China; [Wang, Kevin Yueju] Northeastern State Univ, Dept Nat Sci, Broken Arrow, OK USA	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Liu, DH (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China.	liudehu2006@126.com			National Biotechnology Development Plan [2016ZX08005-004]; Researcher Foundation of the Chinese Academy of Agricultural Sciences	National Biotechnology Development Plan; Researcher Foundation of the Chinese Academy of Agricultural Sciences	This work was supported by the National Biotechnology Development Plan (2016ZX08005-004), and the Researcher Foundation of the Chinese Academy of Agricultural Sciences.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; BELL GI, 1983, NATURE, V304, P368, DOI 10.1038/304368a0; Brandsma M., 2009, Open Biotechnology Journal, V3, P57, DOI 10.2174/1874070700903010057; Bulotta A, 2004, CELL BIOCHEM BIOPHYS, P65, DOI 10.1385/CBB:40:3S:065; Cho YM, 2014, ANNU REV PHYSIOL, V76, P535, DOI 10.1146/annurev-physiol-021113-170315; DALY MM, 1951, J GEN PHYSIOL, V34, P439, DOI 10.1085/jgp.34.4.439; DeFronzo RA, 2005, DIABETES CARE, V28, P1092, DOI 10.2337/diacare.28.5.1092; Frokjaer S, 2005, NAT REV DRUG DISCOV, V4, P298, DOI 10.1038/nrd1695; Furman Brian L, 2015, Curr Protoc Pharmacol, V70, DOI 10.1002/0471141755.ph0547s70; GIBALDI M, 1971, J PHARM SCI, V60, P1338, DOI 10.1002/jps.2600600909; Green BD, 2005, DIABETES OBES METAB, V7, P563, DOI 10.1111/j.1463-1326.2004.00430.x; Hagman DK, 2005, J BIOL CHEM, V280, P32413, DOI 10.1074/jbc.M506000200; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Jomori T, 2008, JOMORI T; KIEFFER TJ, 1995, ENDOCRINOLOGY, V136, P3585, DOI 10.1210/en.136.8.3585; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; Knudsen LB, 1996, EUR J PHARMACOL, V318, P429, DOI 10.1016/S0014-2999(96)00795-9; Knudsen LB, 2000, J MED CHEM, V43, P1664, DOI 10.1021/jm9909645; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Kong YL, 2016, ENZYME MICROB TECH, V82, P105, DOI 10.1016/j.enzmictec.2015.09.001; KREYMANN B, 1987, LANCET, V2, P1300; LeRoith D, 2002, AM J MED, V113, p3S; Ma BC, 2013, CURR PHARM BIOTECHNO, V14, P985; Marchetti P, 2012, DIABETOLOGIA, V55, P3262, DOI 10.1007/s00125-012-2716-9; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Perfetti R, 2000, EUR J ENDOCRINOL, V143, P717, DOI 10.1530/eje.0.1430717; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Scheen AJ, 2003, ACTA CLIN BELG, V58, P335, DOI 10.1179/acb.2003.58.6.001; Tozaki H, 1998, J PHARM PHARMACOL, V50, P913, DOI 10.1111/j.2042-7158.1998.tb04008.x; Tu PP, 2015, CURR PHARM BIOTECHNO, V16, P564, DOI 10.2174/138920101606150407114815; Wang H, 2005, DIABETOLOGIA, V48, P720, DOI 10.1007/s00125-005-1692-8; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0	33	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171601	10.1371/journal.pone.0171601	http://dx.doi.org/10.1371/journal.pone.0171601			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152036	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161200157
J	Traykova, D; Schneider, B; Chojkier, M; Buck, M				Traykova, Daniela; Schneider, Beacher; Chojkier, Mario; Buck, Martina			Blood Microbiome Quantity and the Hyperdynamic Circulation in Decompensated Cirrhotic Patients	PLOS ONE			English	Article							NITRIC-OXIDE; BACTERIAL-DNA; PORTAL-HYPERTENSION; SEPTIC SHOCK; LIVER-INJURY; MICE; IMMUNE; DYSFUNCTION; ASCITES	Background Recently, a complex microbiome was comprehensibly characterized in the serum and ascitic fluid of cirrhotic patients. In the current study, we investigated for the first time the induction of inflammatory pathways and Nitric Oxide, as well as the systemic hemodynamics in conjunction with the blood microbiome in a Child-Pugh class B cirrhotic cohort. Methods and Findings We used the Intestinal Infections Microbial DNA qPCR Array to screen for 53 bacterial DNA from the gut in the blood. Assays were designed using the 16S rRNA gene as a target, and PCR amplification primers (based on the Human Microbiome Project) and hydrolysis-probe detection. Eighteen systemic hemodynamic parameters were measured non-invasively by impedance cardiography using the BioZ ICG monitor. The inflammatory response was assessed by measuring blood cytokines, Nitric Oxide RNA arrays, and Nitric Oxide. In the blood of this cirrhotic cohort, we detected 19 of 53 bacterial species tested. The number of bacterial species was markedly increased in the blood of cirrhotic patients compared to control individuals (0.2+/-0.4 vs 3.1+/-2.3; 95% CI: 1.3 to 4.9; P = 0.0030). The total bacterial DNA was also increased in the blood of cirrhotic subjects compared to control subjects (0.2+/-1.1 vs 41.8+/-132.1; 95% CI: 6.0 to 77.2; P = 0.0022). In the cirrhotic cohort, the Cardiac Output increased by 37% and the Systemic Vascular Resistance decreased by 40% (P< 0.00001 for both compared to control subjects). Systemic Vascular Resistance was inversely correlated to blood bacterial DNA quantity (- 0.621; 95% CI - 0.843 to - 0.218; P = 0.0060), blood bacterial species number (- 0.593; 95% CI - 0.83 to - 0.175; P = 0.0095; logistic regression: Chi Square = 5.8877; P = 0.0152), and serum Nitric Oxide (- 0.705; 95% CI - 0.881 to - 0.355; P = 0.0011). Many members of the Nitric Oxide signaling pathway gene family were increased in cirrhotic subjects. Conclusions Our study identified blood bacterial DNA in similar to 90% of the cirrhotic patients without clinical evidences of infection, and suggests that the quantity of bacterial DNA in blood may stimulate signaling pathways, including Nitric Oxide, that could decrease systemic vascular resistance and increase cardiac output.	[Traykova, Daniela; Schneider, Beacher; Chojkier, Mario; Buck, Martina] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Traykova, Daniela; Schneider, Beacher; Chojkier, Mario; Buck, Martina] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA; [Chojkier, Mario; Buck, Martina] Univ Calif San Diego, Program Biomed Sci, La Jolla, CA 92093 USA; [Chojkier, Mario] Univ Calif San Diego, Clin Translat Res Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Diego	Buck, M (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.; Buck, M (corresponding author), Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA.; Buck, M (corresponding author), Univ Calif San Diego, Program Biomed Sci, La Jolla, CA 92093 USA.	buckmartina@gmail.com			University of California, San Diego, Department of Medicine; United States Department of Veterans Affairs Merit Review Award; United States National Institutes of Health (NIH) [1R41HL122022, 1R41HL127919, DK-87031, DK-46071, DK-84139]	University of California, San Diego, Department of Medicine; United States Department of Veterans Affairs Merit Review Award(US Department of Veterans Affairs); United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These studies were supported by the University of California, San Diego, Department of Medicine; the United States Department of Veterans Affairs Merit Review Award (MC); and grants from United States National Institutes of Health (NIH): 1R41HL122022, 1R41HL127919, DK-87031 (MB/MC), DK-46071 (MC), DK-84139 (MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraldes JG, 2003, HEPATOLOGY, V37, P902, DOI 10.1053/jhep.2003.50133; Albillos A, 2003, HEPATOLOGY, V37, P208, DOI 10.1053/jhep.2003.50038; Albillos A, 2014, J HEPATOL, V61, P1385, DOI 10.1016/j.jhep.2014.08.010; Bellot P, 2010, HEPATOLOGY, V52, P2044, DOI 10.1002/hep.23918; Berres ML, 2010, J CLIN INVEST, V120, P4129, DOI 10.1172/JCI41732; Beutler B, 2002, CURR TOP MICROBIOL, V270, P109; BOMZON A, 1994, HEPATOLOGY, V20, P1343, DOI 10.1002/hep.1840200535; Bosch J, 2008, SEMIN LIVER DIS, V28, P3, DOI 10.1055/s-2008-1040318; Buck M, 2016, SCI REPORTS; Buck M, 2014, HEPATOLOGY, V59, P1052, DOI 10.1002/hep.26755; Bunnell E, 2000, CRIT CARE MED, V28, P2713, DOI 10.1097/00003246-200008000-00005; CHOJKIER M, 1985, GASTROENTEROLOGY, V88, P115, DOI 10.1016/S0016-5085(85)80142-6; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Frances R, 2005, EUR J GASTROEN HEPAT, V17, P45, DOI 10.1097/00042737-200501000-00010; Frances R, 2008, HEPATOLOGY, V47, P978, DOI 10.1002/hep.22083; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Iwakiri Y, 2006, HEPATOLOGY, V43, pS121, DOI 10.1002/hep.20993; Jalan R, 2014, J HEPATOL, V60, P1310, DOI 10.1016/j.jhep.2014.01.024; NATHAN C, 1994, J BIOL CHEM, V269, P13725; NAVA E, 1991, LANCET, V338, P1555, DOI 10.1016/0140-6736(91)92375-C; Ouyang X, 2013, NATURE COMMUNICATION; Paisse S., 2016, TRANSFUSION; Petrasek J, 2012, J CLIN INVEST, V122, P3476, DOI 10.1172/JCI60777; PETROS A, 1991, LANCET, V338, P1557, DOI 10.1016/0140-6736(91)92376-D; Santiago A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25001; Szabo G, 2015, NATURE REV GASTROENT, P387; Tang WHW, 2009, AM HEART J, V157, P402, DOI 10.1016/j.ahj.2008.10.016; Tsutsui H, 1999, IMMUNITY, V11, P359, DOI 10.1016/S1074-7613(00)80111-9; Villanueva C, 2016, HEPATOLOGY, V63, P197, DOI 10.1002/hep.28264; WHITTLE BJR, 1992, HEPATOLOGY, V16, P1089, DOI 10.1002/hep.1840160437; Wiest R, 2012, J HEPATOL, V60, P197	32	23	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0169310	10.1371/journal.pone.0169310	http://dx.doi.org/10.1371/journal.pone.0169310			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146577	gold, Green Submitted, Green Published			2022-12-27	WOS:000396131700005
J	Lee, EJ; Kim, TW; Lee, KM; Lee, SH; Kim, H				Lee, Eun Ji; Kim, Tae-Woo; Lee, Kyoung Min; Lee, Seung Hyen; Kim, Hyunjoong			Factors Associated with the Retinal Nerve Fiber Layer Loss after Acute Primary Angle Closure: A Prospective EDI-OCT Study	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; INTRAOCULAR-PRESSURE ELEVATION; LAMINA-CRIBROSA DISPLACEMENT; CLEAR LENS EXTRACTION; VISUAL-FIELD; LONGITUDINAL CHANGES; AXONAL-TRANSPORT; ASIAN POPULATION; ANTERIOR-CHAMBER; GLAUCOMA	Purpose To determine the factors associated with retinal nerve fiber layer (RNFL) loss in eyes with acute primary angle-closure (APAC), particularly focusing on the influence of the change in the anterior lamina cribrosa surface depth (LCD). Methods After the initial presentation, 30 eyes with unilateral APAC were followed up at the following specific time points over a 12-month period: 1 week, 1-2 months, 2-3 months, 5-6 months, and 11-12 months. These follow-ups involved intraocular pressure measurements, enhanced depth-imaging spectral-domain optical coherence tomography (SD-OCT) scanning of the optic disc, and measurements of the circumpapillary RNFL thickness. The prelaminar tissue thickness (PLT) and LCD were determined in the SD-OCT images obtained at each follow-up visit. Results Repeated measures analysis of variance revealed a significant pattern of decrease in the global RNFL thickness, PLT, and LCD (all p<0.001). The global RNFL thickness decreased continuously throughout the follow-up period, while the PLT decreased until 5-6 months and did not change thereafter. The LCD reduced until 2-3 months and then also remained steady. Multivariable regression analysis revealed that symptoms with a longer duration before receiving laser peripheral iridotomy (LI) (p = 0.049) and a larger LCD reduction (p = 0.034) were significant factors associated with the conversion to an abnormal RNFL thickness defined using OCT normative data. Conclusion Early short-term decreases in the PLT and LCD and overall long-term decrease in the peripapillary RNFL were observed during a 12-month follow-up after an APAC episode. A longer duration of symptoms before receiving LI treatment and larger LCD reduction during follow-up were associated with the progressive RNFL loss. The LCD reduction may indicate a prior presence of significant pressure-induced stress that had been imposed on the optic nerve head at the time of APAC episode. Glaucomatous progression should be suspected in eyes showing LCD reduction after the APAC remission.	[Lee, Eun Ji; Kim, Tae-Woo; Lee, Kyoung Min; Lee, Seung Hyen] Seoul Natl Univ, Dept Ophthalmol, Coll Med, Bundang Hosp, Seoul, South Korea; [Kim, Hyunjoong] Yonsei Univ, Dept Appl Stat, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Yonsei University	Lee, EJ (corresponding author), Seoul Natl Univ, Dept Ophthalmol, Coll Med, Bundang Hosp, Seoul, South Korea.	opticdisc@gmail.com		Lee, Seung Hyen/0000-0003-2189-2821; Kim, Tae-Woo/0000-0002-5180-0978	Cheil-Nammyung Foundation Research Fund	Cheil-Nammyung Foundation Research Fund	This study was supported by the 2014 Cheil-Nammyung Foundation Research Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alasil T, 2013, J GLAUCOMA, V22, P532, DOI 10.1097/IJG.0b013e318255bb4a; Aung T, 2004, OPHTHALMOLOGY, V111, P1464, DOI 10.1016/j.ophtha.2003.12.061; Aung T, 2004, OPHTHALMOLOGY, V111, P1475, DOI 10.1016/j.ophtha.2003.12.055; Aung T, 2001, ACTA OPHTHALMOL SCAN, V79, P298, DOI 10.1034/j.1600-0420.2001.790318.x; Bellezza AJ, 2003, BRIT J OPHTHALMOL, V87, P1284, DOI 10.1136/bjo.87.10.1284; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Burgoyne CF, 2008, J GLAUCOMA, V17, P318, DOI 10.1097/IJG.0b013e31815a343b; Burgoyne CF, 2011, EXP EYE RES, V93, P120, DOI 10.1016/j.exer.2010.09.005; Chen YJ, 2012, J OCUL PHARMACOL TH, V28, P529, DOI 10.1089/jop.2012.0006; Chew SSL, 2011, OPHTHALMOLOGY, V118, P254, DOI 10.1016/j.ophtha.2010.06.026; Dada T, 2015, J CATARACT REFR SURG, V41, P1470, DOI 10.1016/j.jcrs.2014.10.029; Fang AW, 2007, J GLAUCOMA, V16, P178, DOI 10.1097/IJG.0b013e31802d6dd8; Faridi OS, 2014, OPHTHALMOLOGY, V121, P1524, DOI 10.1016/j.ophtha.2014.02.017; HAYREH SS, 1969, BRIT J OPHTHALMOL, V53, P721, DOI 10.1136/bjo.53.11.721; Inoue R, 2009, OPHTHALMOLOGY, V116, P214, DOI 10.1016/j.ophtha.2008.09.008; Jiang R, 2015, OPHTHALMOLOGY, V122, P730, DOI 10.1016/j.ophtha.2014.11.008; Johnstone J, 2014, INVEST OPHTH VIS SCI, V55, P2004, DOI 10.1167/iovs.13-12937; Jonas JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037499; Kaur C, 2006, INVEST OPHTH VIS SCI, V47, P1126, DOI 10.1167/iovs.05-0518; Lee EJ, 2015, OPHTHALMOLOGY; Lee EJ, 2015, OPHTHALMOLOGY, V122, P721, DOI 10.1016/j.ophtha.2014.10.007; Lee EJ, 2013, INVEST OPHTH VIS SCI, V54, P5392, DOI 10.1167/iovs.13-12205; Lee EJ, 2013, OPHTHALMOLOGY, V120, P553, DOI 10.1016/j.ophtha.2012.08.047; Lee EJ, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.01.034; Lee EJ, 2011, AM J OPHTHALMOL, V152, P87, DOI 10.1016/j.ajo.2011.01.024; Lee KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114935; Lee SH, 2015, JAMA OPHTHALMOL; Liu X, 2010, INT J OPHTHALMOL-CHI, V3, P152, DOI 10.3980/j.issn.2222-3959.2010.02.14; Man XF, 2015, GRAEF ARCH CLIN EXP, V253, P773, DOI 10.1007/s00417-015-2936-z; Park HYL, 2014, INVEST OPHTH VIS SCI, V55, P233, DOI 10.1167/iovs.12-10329; Park HYL, 2012, OPHTHALMOLOGY, V119, P10, DOI 10.1016/j.ophtha.2011.07.033; Park SC, 2015, INVEST OPHTH VIS SCI, V56, P2059, DOI 10.1167/iovs.14-15540; Quek DTL, 2011, AM J OPHTHALMOL, V152, P463, DOI 10.1016/j.ajo.2011.02.023; QUIGLEY HA, 1979, ARCH OPHTHALMOL-CHIC, V97, P525, DOI 10.1001/archopht.1979.01020010269018; QUIGLEY HA, 1977, INVEST OPHTH VIS SCI, V16, P640; Ren RJ, 2014, INVEST OPHTH VIS SCI, V55, P1531, DOI 10.1167/iovs.13-13382; Shen SY, 2006, OPHTHALMOLOGY, V113, P924, DOI 10.1016/j.ophtha.2006.01.070; Sng CCA, 2011, EYE, V25, P619, DOI 10.1038/eye.2011.31; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Sullivan-Mee M, 2015, AM J OPHTHALMOL, V160, P637, DOI 10.1016/j.ajo.2015.06.024; Tan AM, 2009, CLIN EXP OPHTHALMOL, V37, P467, DOI 10.1111/j.1442-9071.2009.02060.x; Thomas R, 2003, ACTA OPHTHALMOL SCAN, V81, P480, DOI 10.1034/j.1600-0420.2003.00135.x; Tojo N, 2014, GRAEF ARCH CLIN EXP, V252, P1463, DOI 10.1007/s00417-014-2666-7; Tsai JC, 2006, AM J OPHTHALMOL, V141, P970, DOI 10.1016/j.ajo.2005.12.020; Tsai JC, 2007, INVEST OPHTH VIS SCI, V48, P1659, DOI 10.1167/iovs.06-0950; VANHERICK W, 1969, AM J OPHTHALMOL, V68, P626, DOI 10.1016/0002-9394(69)91241-0; Wu HJ, 2011, J GLAUCOMA, V20, P470, DOI 10.1097/IJG.0b013e3181f3eb64; You JY, 2013, JAMA OPHTHALMOL, V131, P314, DOI 10.1001/jamaophthalmol.2013.1926	48	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0168678	10.1371/journal.pone.0168678	http://dx.doi.org/10.1371/journal.pone.0168678			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141872	Green Submitted, gold, Green Published			2022-12-27	WOS:000396129500003
J	Haegler, P; Grunig, D; Berger, B; Terracciano, L; Krahenbuhl, S; Bouitbir, J				Haegler, Patrizia; Grunig, David; Berger, Benjamin; Terracciano, Luigi; Krahenbuhl, Stephan; Bouitbir, Jamal			Hepatic Effects of Pharmacological Doses of Hydroxy-Cobalamin[c-lactam] in Mice	PLOS ONE			English	Article							METHYLMALONYL-COA MUTASE; LIVER-MITOCHONDRIA; RATS; METABOLISM; TOXICITY; VITAMIN-B-12; INHIBITION; MECHANISMS; CIRRHOSIS; SKELETAL	The vitamin B-12 analog hydroxy-cobalamin[c-lactam] (HCCL) impairs hepatic mitochondrial protein synthesis and function of the electron transport chain in rats. We aimed to establish an in vivo model for mitochondrial dysfunction in mice, which could be used to investigate hepatotoxicity of mitochondrial toxicants. In a first step, we performed a dose-finding study in mice treated with HCCL 0.4 mg/kg and 4 mg/kg i.p. for two to four weeks. The plasma methylmalonate concentration was strongly increased at 4 mg/kg starting at three weeks of treatment. We subsequently treated mice daily with 4 mg/kg HCCL i.p. for three weeks and characterized liver function and histology as well as liver mitochondrial function. We found an increase in liver weight in HCCL-treated mice, which was paralleled by hepatocellular accumulation of triglycerides. In liver homogenate of HCCL-treated mice, the complex I activity of the electron transport chain was reduced, most likely explaining hepatocellular triglyceride accumulation. The activity of CPT1 was not affected by methylmalonyl-CoA in isolated liver mitochondria. Despite impaired complex I activity, mitochondrial superoxide anion production was not increased and the hepatocellular glutathione (GSH) pool was maintained. Finally, the mitochondrial DNA content was not altered with HCCL treatment. In conclusion, treatment of mice with HCCL is associated with increased liver weight explained by hepatocellular triglyceride accumulation. Hepatocellular fat accumulation is most likely a consequence of impaired activity of the mitochondrial electron transport chain. The impairment of complex I activity is not strong enough to result in ROS accumulation and reduction of the GSH stores.	[Haegler, Patrizia; Grunig, David; Berger, Benjamin; Krahenbuhl, Stephan; Bouitbir, Jamal] Univ Hosp, Div Clin Pharmacol & Toxicol, Basel, Switzerland; [Haegler, Patrizia; Grunig, David; Berger, Benjamin; Krahenbuhl, Stephan; Bouitbir, Jamal] Univ Basel, Dept Biomed, Basel, Switzerland; [Terracciano, Luigi; Krahenbuhl, Stephan; Bouitbir, Jamal] SCAHT, Basel, Switzerland; [Terracciano, Luigi] Univ Hosp, Inst Pathol, Dept Mol Pathol, Basel, Switzerland	University of Basel	Krahenbuhl, S (corresponding author), Univ Hosp, Div Clin Pharmacol & Toxicol, Basel, Switzerland.; Krahenbuhl, S (corresponding author), Univ Basel, Dept Biomed, Basel, Switzerland.; Krahenbuhl, S (corresponding author), SCAHT, Basel, Switzerland.	kraehenbuehl@ubs.ch	Terracciano, Luigi M./AAB-5335-2022; Krähenbühl, Stephan/Z-4744-2019; BOUITBIR, Jamal/AAJ-6722-2020	Terracciano, Luigi M./0000-0002-9393-9660; Bouitbir, Jamal/0000-0003-4453-9457	Swiss National Science Foundation [31003A 156270]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by a grant to Stephan Krahenbuhl from the Swiss National Science Foundation (31003A 156270).	Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Ballhausen D, 2009, NEUROSCIENCE, V164, P578, DOI 10.1016/j.neuroscience.2009.08.028; Banerjee R, 2002, BIOCHEM SOC T, V30, P621, DOI 10.1042/bst0300621; BRASS EP, 1990, BIOCHEM J, V266, P809; Deodato F, 2006, AM J MED GENET C, V142C, P104, DOI 10.1002/ajmg.c.30090; Felser A, 2014, TOXICOLOGY, V323, P1, DOI 10.1016/j.tox.2014.05.011; Fowler B, 2008, J INHERIT METAB DIS, V31, P350, DOI 10.1007/s10545-008-0839-4; FRENKEL EP, 1975, BRIT J HAEMATOL, V31, P501, DOI 10.1111/j.1365-2141.1975.tb00885.x; Gerlach C, 1997, HEPATOLOGY, V26, P573, DOI 10.1053/jhep.1997.v26.pm0009303485; Haegler P, 2015, TOXICOLOGY; Haegler P, 2015, TOXICOLOGY, V336, P48, DOI 10.1016/j.tox.2015.07.015; HOPPEL C, 1979, J BIOL CHEM, V254, P4164; Kaufmann P, 2006, CELL MOL LIFE SCI, V63, P2415, DOI 10.1007/s00018-006-6235-z; Kennedy JA, 1996, BIOCHEM PHARMACOL, V52, P273, DOI 10.1016/0006-2952(96)00204-3; Knapp AC, 2008, J PHARMACOL EXP THER, V324, P568, DOI 10.1124/jpet.107.131185; KRAHENBUHL S, 1990, J CLIN INVEST, V86, P2054, DOI 10.1172/JCI114942; Krahenbuhl S, 2000, LIVER, V20, P346, DOI 10.1034/j.1600-0676.2000.020004346.x; KRAHENBUHL S, 1994, HEPATOLOGY, V19, P1272, DOI 10.1016/0270-9139(94)90877-X; KRAHENBUHL S, 1992, HEPATOLOGY, V15, P1167, DOI 10.1002/hep.1840150631; KRAHENBUHL S, 1991, J BIOL CHEM, V266, P20998; Krahenbuhl S, 2001, J HEPATOL, V34, P334, DOI 10.1016/S0168-8278(00)00106-9; KRAHLENBUHL S, 1990, HEPATOLOGY, V12, P526, DOI 10.1002/hep.1840120313; Leal NA, 2004, J BIOL CHEM, V279, P47536, DOI 10.1074/jbc.M405449200; LEDLEY FD, 1988, P NATL ACAD SCI USA, V85, P3518, DOI 10.1073/pnas.85.10.3518; Ledley FD, 1997, HUM MUTAT, V9, P1; LEEDS FS, 1994, J BIOL CHEM, V269, P3947; Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060; Mutti E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075312; Pecinova A, 2011, MITOCHONDRION, V11, P722, DOI 10.1016/j.mito.2011.05.006; Peters H, 2003, J BIOL CHEM, V278, P52909, DOI 10.1074/jbc.M310533200; Peters HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040609; Pieters N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063208; SAIDO H, 1993, BIOSCI BIOTECH BIOCH, V57, P607, DOI 10.1271/bbb.57.607; Stabler SP, 2013, NEW ENGL J MED, V368, P149, DOI [10.1056/NEJMc1304350, 10.1056/NEJMcp1113996]; STABLER SP, 1991, J CLIN INVEST, V87, P1422, DOI 10.1172/JCI115148; Stewart JD, 2010, HEPATOLOGY, V52, P1791, DOI 10.1002/hep.23891; Takahashi-Iniguez T, 2012, J ZHEJIANG UNIV-SC B, V13, P423, DOI 10.1631/jzus.B1100329; TANDLER B, 1991, ANAT RECORD, V231, P1, DOI 10.1002/ar.1092310102; WILKEMEYER MF, 1993, BIOCHEM J, V296, P663, DOI 10.1042/bj2960663	39	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171026	10.1371/journal.pone.0171026	http://dx.doi.org/10.1371/journal.pone.0171026			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135329	Green Published, gold, Green Submitted			2022-12-27	WOS:000396124700040
J	Ujvari, D; Jakson, I; Babayeva, S; Salamon, D; Rethi, B; Gidlof, S; Hirschberg, AL				Ujvari, Dorina; Jakson, Ivika; Babayeva, Shabnam; Salamon, Daniel; Rethi, Bence; Gidlof, Sebastian; Hirschberg, Angelica Linden			Dysregulation of In Vitro Decidualization of Human Endometrial Stromal Cells by Insulin via Transcriptional Inhibition of Forkhead Box Protein O1	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; FACTOR-BINDING PROTEIN-1; NONPREGNANT HUMAN ENDOMETRIUM; KINASE-B; PROGESTERONE-RECEPTOR; MENSTRUAL-CYCLE; EARLY-PREGNANCY; MESSENGER-RNA; FACTOR AFX; SIGNALING PATHWAYS	Insulin resistance and compensatory hyperinsulinemia are characteristic features of obesity and polycystic ovary syndrome, and both are associated with reduced fertility and implantation. There is little knowledge about the effect of insulin on the decidualization process and previous findings are contradictory. We investigated the effect of insulin on the regulation of forkhead box protein O1 (FOXO1), one of the most important transcription factors during decidualization. Endometrial stromal cells were isolated from six healthy, regularly menstruating women and decidualized in vitro. Gene expression levels of six putative FOXO1 target genes (including insulin-like growth factor binding protein-1 (IGFBP1) and prolactin (PRL)) were measured with Real-Time PCR following FOXO1 inhibition or insulin treatment. PI3K inhibition was used to identify the possible mechanism behind regulation. Subcellular localization of FOXO1 was analyzed with immunofluorescence. All the genes (IGFBP1, CTGF, INSR, DCN, LEFTY2), except prolactin, were evaluated as FOXO1 target genes in decidualizing stromal cells. Insulin caused a significant dose-dependent inhibition of the verified FOXO1 target genes. It was also demonstrated that insulin regulated FOXO1 target genes by transcriptional inactivation and nuclear export of FOXO1 via PI3K pathway. However, insulin did not inhibit the morphological transformation of endometrial stromal cells via transcriptional inactivation of FOXO1. This study provides new insights on the action of insulin on the endometrium via regulation of FOXO1. It is suggested that hyperinsulinemia results in dysregulation of a high number of FOXO1 controlled genes that may contribute to endometrial dysfunction and reproductive failure. Our findings may illuminate possible reasons for unexplained infertility.	[Ujvari, Dorina; Jakson, Ivika; Salamon, Daniel; Gidlof, Sebastian; Hirschberg, Angelica Linden] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Jakson, Ivika; Hirschberg, Angelica Linden] Karolinska Univ Hosp, Dept Obstet & Gynecol, Stockholm, Sweden; [Babayeva, Shabnam] Azerbaijan Med Univ, Dept Obstet & Gynecol 2, Baku, Azerbaijan; [Salamon, Daniel] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Rethi, Bence] Karolinska Univ Hosp, Dept Med, Stockholm, Sweden; [Gidlof, Sebastian] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Ministry of Education of Azerbaijan Republic; Azerbaijan Medical University; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Ujvari, D (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.	dorina.ujvari@ki.se	Hirschberg, Angelica/AAK-6693-2020; Ujvari, Dorina/AAS-8724-2021; Salamon, Daniel/AAZ-4807-2021; Rethi, Bence/C-5770-2013	Jakson, Ivika/0000-0003-4969-9871; Rethi, Bence/0000-0001-8220-5015	Swedish Research Council (Vetenskapsradet) [20324]; Stockholm County Council (Stockholms lans landsting)	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Stockholm County Council (Stockholms lans landsting)	Support was provided by the Swedish Research Council (Vetenskapsradet) 20324 to ALH [www.vr.se]; and the Stockholm County Council (Stockholms lans landsting) to ALH, SG [www.sll.se]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold JT, 2001, HUM REPROD, V16, P836, DOI 10.1093/humrep/16.5.836; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brar AK, 2001, PHYSIOL GENOMICS, V7, P135, DOI 10.1152/physiolgenomics.00061.2001; Brownawell AM, 2001, MOL CELL BIOL, V21, P3534, DOI 10.1128/MCB.21.10.3534-3546.2001; Buzzio OL, 2006, ENDOCRINOLOGY, V147, P3870, DOI 10.1210/en.2006-0167; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Christian M, 2002, J BIOL CHEM, P277; Bouzas ICD, 2014, J PEDIATR ADOL GYNEC, V27, P335, DOI 10.1016/j.jpag.2014.01.002; Diamanti-Kandarakis E, 2012, ENDOCR REV, V33, P981, DOI 10.1210/er.2011-1034; Dowell P, 2003, J BIOL CHEM, V278, P45485, DOI 10.1074/jbc.M309069200; Essaghir A, 2009, J BIOL CHEM, V284, P10334, DOI 10.1074/jbc.M808848200; Falsetti L, 1996, GYNECOL ENDOCRINOL, V10, P319, DOI 10.3109/09513599609012818; Fan W, 2012, GYNECOL OBSTET INVES, V74, P56, DOI 10.1159/000336633; Frolova AI, 2011, MOL ENDOCRINOL, V25, P1444, DOI 10.1210/me.2011-0026; Gellersen B, 2003, J ENDOCRINOL, V178, P357, DOI 10.1677/joe.0.1780357; GIUDICE LC, 1992, J CLIN ENDOCR METAB, V75, P1235, DOI 10.1210/jc.75.5.1235; Giudice LC, 2006, BEST PRACT RES CL EN, V20, P235, DOI 10.1016/j.beem.2006.03.005; Hinman RM, 2007, J IMMUNOL, V178, P740, DOI 10.4049/jimmunol.178.2.740; Hirota K, 2003, J BIOL CHEM, V278, P13056, DOI 10.1074/jbc.C200553200; Horseman ND, 1997, EMBO J, V16, P6926; Irwin JC, 1998, GROWTH HORM IGF RES, V8, P21, DOI 10.1016/S1096-6374(98)80318-3; Jabbour HN, 1999, J CLIN ENDOCR METAB, V84, P4260, DOI 10.1210/jc.84.11.4260; Jabbour HN, 1998, J CLIN ENDOCR METAB, V83, P2545, DOI 10.1210/jc.83.7.2545; Jiang YL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13735; Jung SJ, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0665-2; Kajihara T, 2006, MOL ENDOCRINOL, V20, P2444, DOI 10.1210/me.2006-0118; Kajihara T, 2013, MED MOL MORPHOL, V46, P61, DOI 10.1007/s00795-013-0018-z; Katulski K, 2015, GYNECOL ENDOCRINOL, V31, P87, DOI 10.3109/09513590.2014.974535; Kim JJ, 2005, BIOL REPROD, V73, P833, DOI 10.1095/biolreprod.105.043182; Kim JJ, 2003, BIOL REPROD, V68, P24, DOI 10.1095/biolreprod.102.009316; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; KRASNOW JS, 1990, MOL ENDOCRINOL, V4, P13, DOI 10.1210/mend-4-1-13; Labied S, 2006, MOL ENDOCRINOL, V20, P35, DOI 10.1210/me.2005-0275; LAHAT N, 1993, J NEUROIMMUNOL, V47, P35, DOI 10.1016/0165-5728(93)90282-4; Lathi RB, 2005, J CLIN ENDOCR METAB, V90, P1599, DOI 10.1210/jc.2004-1676; Mahmud DL, 2002, ONCOGENE, V21, P1556, DOI 10.1038/sj.onc.1205230; Matsui N, 2004, ACTA OBSTET GYN SCAN, V83, P138, DOI 10.1111/j.0001-6349.2004.00256.x; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; McAveney KM, 1996, ENDOCRINOLOGY, V137, P5723, DOI 10.1210/en.137.12.5723; MURPHY WJ, 1993, J EXP MED, V178, P231, DOI 10.1084/jem.178.1.231; Nasrin N, 2000, P NATL ACAD SCI USA, V97, P10412, DOI 10.1073/pnas.190326997; Nevalainen MT, 1997, FASEB J, V11, P1297, DOI 10.1096/fasebj.11.14.9409549; Nybacka A, 2011, FERTIL STERIL, V96, P1508, DOI 10.1016/j.fertnstert.2011.09.006; O'Brien TE, 2003, EPIDEMIOLOGY, V14, P368, DOI 10.1097/00001648-200305000-00020; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Roos N, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6309; Salker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010287; SATYASWAROOP PG, 1979, J CLIN ENDOCR METAB, V48, P639, DOI 10.1210/jcem-48-4-639; Schuur ER, 2001, J BIOL CHEM, V276, P33554, DOI 10.1074/jbc.M105555200; Siddiqui MF, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.03.020; Solomon CG, 2001, HYPERTENSION, V37, P232, DOI 10.1161/01.HYP.37.2.232; TABANELLI S, 1992, J STEROID BIOCHEM, V42, P337, DOI 10.1016/0960-0760(92)90137-8; Takaishi H, 1999, P NATL ACAD SCI USA, V96, P11836, DOI 10.1073/pnas.96.21.11836; Takano M, 2007, MOL ENDOCRINOL, V21, P2334, DOI 10.1210/me.2007-0058; Tang MY, 2010, ENDOCRINOLOGY, V151, P1320, DOI 10.1210/en.2009-1081; THRAILKILL KM, 1989, ENDOCRINOLOGY, V124, P3010, DOI 10.1210/endo-124-6-3010; Ujvari D, 2014, HUM REPROD, V29, P1526, DOI 10.1093/humrep/deu114; Waddell JM, 2011, HUM REPROD, V26, P67, DOI 10.1093/humrep/deq294; WEISS DJ, 1994, METABOLISM, V43, P803, DOI 10.1016/0026-0495(94)90257-7; Wolf M, 2002, J CLIN ENDOCR METAB, V87, P1563, DOI 10.1210/jc.87.4.1563; WU WX, 1995, J MOL ENDOCRINOL, V14, P255, DOI 10.1677/jme.0.0140255; Yuhki M, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-104; Zeng GY, 1996, J CLIN INVEST, V98, P894, DOI 10.1172/JCI118871; Zhao HH, 2001, J BIOL CHEM, V276, P27907, DOI 10.1074/jbc.M104278200	66	25	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171004	10.1371/journal.pone.0171004	http://dx.doi.org/10.1371/journal.pone.0171004			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135285	Green Submitted, Green Published, gold			2022-12-27	WOS:000396124700037
J	Bai, Y; Urushadze, L; Osikowicz, L; McKee, C; Kuzmin, I; Kandaurov, A; Babuadze, G; Natradze, I; Imnadze, P; Kosoy, M				Bai, Ying; Urushadze, Lela; Osikowicz, Lynn; McKee, Clifton; Kuzmin, Ivan; Kandaurov, Andrei; Babuadze, Giorgi; Natradze, Ioseb; Imnadze, Paata; Kosoy, Michael			Molecular Survey of Bacterial Zoonotic Agents in Bats from the Country of Georgia (Caucasus)	PLOS ONE			English	Article							RESERVOIR HOSTS; BARTONELLA SPP.; BRUCELLA; LEPTOSPIRA; DIVERSITY; PREVALENCE; PATTERNS; RODENTS; FOXES	are important reservoirs for many zoonotic pathogens. However, no surveys of bacterial pathogens in bats have been performed in the Caucasus region. To understand the occurrence and distribution of bacterial infections in these mammals, 218 bats belonging to eight species collected from four regions of Georgia were examined for Bartonella, Brucella, Leptospira, and Yersinia using molecular approaches. Bartonella DNA was detected in 77 (35%) bats from all eight species and was distributed in all four regions. The prevalence ranged 6-50% per bat species. The Bartonella DNA represented 25 unique genetic variants that clustered into 21 lineages. Brucella DNA was detected in two Miniopterus schreibersii bats and in two Myotis blythii bats, all of which were from Imereti (west-central region). Leptospira DNA was detected in 25 (13%) bats that included four M. schreibersii bats and 21 M. blythii bats collected from two regions. The Leptospira sequences represented five genetic variants with one of them being closely related to the zoonotic pathogen L. interrogans (98.6% genetic identity). No Yersinia DNA was detected in the bats. Mixed infections were observed in several cases. One M. blythii bat and one M. schreibersii bat were co-infected with Bartonella, Brucella, and Leptospira; one M. blythii bat and one M. schreibersii bat were co-infected with Bartonella and Brucella; 15 M. blythii bats and three M. schreibersii bats were co-infected with Bartonella and Leptospira. Our results suggest that bats in Georgia are exposed to multiple bacterial infections. Further studies are needed to evaluate pathogenicity of these agents to bats and their zoonotic potential.	[Bai, Ying; Osikowicz, Lynn; McKee, Clifton; Kosoy, Michael] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA; [Urushadze, Lela; Babuadze, Giorgi; Imnadze, Paata] Natl Ctr Dis Control & Publ Hlth, Tbilisi, Georgia; [Urushadze, Lela; Babuadze, Giorgi] Ilia State Univ, Inst Chem Biol, Tbilisi, Georgia; [McKee, Clifton] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Kuzmin, Ivan] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Kandaurov, Andrei; Natradze, Ioseb] Ilia State Univ, Inst Zool, Tbilisi, Georgia	Centers for Disease Control & Prevention - USA; National Center for Disease Control & Public Health - Georgia; Ilia State University; Colorado State University; University of Texas System; University of Texas Medical Branch Galveston; Ilia State University	Bai, Y (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA.	bby5@cdc.gov	Natradze, Ioseb/T-2066-2019; McKee, Clifton/I-4603-2019; Kandaurov, Andrei S./D-7965-2011	McKee, Clifton/0000-0002-6149-0598; 				Acha PN, 2001, ZOONOSES COMMUNICABL, V1, P3; Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Bai Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080894; Bai Y, 2011, EMERG INFECT DIS, V17, P1269, DOI 10.3201/eid1707.101867; Bai Y, 2011, APPL ENVIRON MICROB, V77, P1728, DOI 10.1128/AEM.02203-10; BAILY GG, 1992, J TROP MED HYG, V95, P271; BONDYREV I.V., 2015, GEOGRAPHY GEORGIA PR; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Carrasco SE, 2014, VET MICROBIOL, V170, P325, DOI 10.1016/j.vetmic.2014.02.021; Childs-Sanford SE, 2009, J ZOO WILDLIFE MED, V40, P8, DOI 10.1638/2007-0033.1; Cosson JF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002902; Cox TE, 2005, J WILDLIFE DIS, V41, P753, DOI 10.7589/0090-3558-41.4.753; Dietrich M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005176; Dollinger P, 1998, P EAZWV BVSII SCI M, P1; EVERARD COR, 1983, J WILDLIFE DIS, V19, P192, DOI 10.7589/0090-3558-19.3.192; EWALT DR, 1994, J VET DIAGN INVEST, V6, P448, DOI 10.1177/104063879400600408; FENNESTAD K L, 1972, Journal of Wildlife Diseases, V8, P343; Bessa TAF, 2010, AM J TROP MED HYG, V82, P315, DOI 10.4269/ajtmh.2010.09-0227; HALLING SM, 1993, GENE, V133, P123, DOI 10.1016/0378-1119(93)90236-V; Han BA, 2016, TRENDS PARASITOL, V32, P565, DOI 10.1016/j.pt.2016.04.007; Haque N, 2011, Mymensingh Med J, V20, P742; Hubalek Z, 2007, VECTOR-BORNE ZOONOT, V7, P679, DOI 10.1089/vbz.2007.0143; Kandelaki G, 2016, EMERG INFECT DIS, V22, P544, DOI 10.3201/eid2203.151823; Kosoy M, 2010, EMERG INFECT DIS, V16, P1875, DOI 10.3201/eid1612.100601; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Levett PN, 2005, J MED MICROBIOL, V54, P45, DOI 10.1099/jmm.0.45860-0; Lin EY, 2010, EMERG INFECT DIS, V16, P500, DOI 10.3201/eid1603.081673; Mair N.S., 1973, Journal Wildl Dis, V9, P64; Mair N.S., 1968, S ZOOL SOC LOND, V24, P107; Malania L, 2016, AM J TROP MED HYG, V95, P466, DOI 10.4269/ajtmh.16-0041; Mamuchishvili N, 2014, Georgian Med News, P63; Matthias MA, 2005, AM J TROP MED HYG, V73, P964, DOI 10.4269/ajtmh.2005.73.964; McKee CD, 2016, INFECT GENET EVOL, V44, P382, DOI 10.1016/j.meegid.2016.07.033; Messenger SL, 2003, EMERG INFECT DIS, V9, P151; Morse SF, 2012, INFECT GENET EVOL, V12, P1717, DOI 10.1016/j.meegid.2012.06.009; Muhldorfer K, 2013, ZOONOSES PUBLIC HLTH, V60, P93, DOI 10.1111/j.1863-2378.2012.01536.x; Muhldorfer K, 2010, EMERG INFECT DIS, V16, P578, DOI 10.3201/eid1603.091035; Olsen SC, 2014, VET PATHOL, V51, P1076, DOI 10.1177/0300985814540545; RICCIARDI I D, 1976, Journal of Wildlife Diseases, V12, P52; Sanodze L, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1761-y; Scholz HC, 2009, VECTOR-BORNE ZOONOT, V9, P153, DOI 10.1089/vbz.2008.0036; Stoddard Robyn Anne, 2013, Methods Mol Biol, V943, P257, DOI 10.1007/978-1-60327-353-4_17; STOENNER HG, 1957, AM J VET RES, V18, P947; Tiller RV, 2010, APPL ENVIRON MICROB, V76, P5837, DOI 10.1128/AEM.00620-10; Veikkolainen V, 2014, EMERG INFECT DIS, V20, P960, DOI 10.3201/eid2006.130956; Diniz PPVD, 2007, VET RES, V38, P697, DOI 10.1051/vetres:2007023; Whitaker John O. Jr, 2009, P806; Wibbelt Gudrun, 2009, P775; Yavruyan E, 2008, BATS CONSERVATION AC	49	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0171175	10.1371/journal.pone.0171175	http://dx.doi.org/10.1371/journal.pone.0171175			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129398	Green Submitted, Green Published, gold			2022-12-27	WOS:000396211400005
J	Goudin, N; Chappert, P; Megret, J; Gross, DA; Rocha, B; Azogui, O				Goudin, Nicolas; Chappert, Pascal; Megret, Jerome; Gross, David-Alexandre; Rocha, Benedita; Azogui, Orly			Depletion of Regulatory T Cells Induces High Numbers of Dendritic Cells and Unmasks a Subset of Anti-Tumour CD8(+) CD11c(+) PD-1(lo) Effector T Cells (vol 11, e0157822, 2016)	PLOS ONE			English	Correction														chappert, pascal/0000-0002-9799-4608				Goudin N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157822	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0171373	10.1371/journal.pone.0171373	http://dx.doi.org/10.1371/journal.pone.0171373			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129385	Green Published, gold, Green Submitted			2022-12-27	WOS:000396211400002
J	van der Horn, HJ; Liemburg, EJ; Scheenen, ME; de Koning, ME; Spikman, JM; van der Naalt, J				van der Horn, Harm J.; Liemburg, Edith J.; Scheenen, Myrthe E.; de Koning, Myrthe E.; Spikman, Jacoba M.; van der Naalt, Joukje			Graph Analysis of Functional Brain Networks in Patients with Mild Traumatic Brain Injury	PLOS ONE			English	Article							POSTERIOR CINGULATE CORTEX; STRUCTURAL CONNECTIVITY; POSTTRAUMATIC-STRESS; EMOTION REGULATION; MRI; SYMPTOMS; ABNORMALITIES; DYSFUNCTION; CONCUSSION; COMPLAINTS	Mild traumatic brain injury (mTBI) is one of the most common neurological disorders worldwide. Posttraumatic complaints are frequently reported, interfering with outcome. However, a consistent neural substrate has not yet been found. We used graph analysis to further unravel the complex interactions between functional brain networks, complaints, anxiety and depression in the sub-acute stage after mTBI. This study included 54 patients with uncomplicated mTBI and 20 matched healthy controls. Posttraumatic complaints, anxiety and depression were measured at two weeks post-injury. Patients were selected based on presence (n = 34) or absence (n = 20) of complaints. Resting-state fMRI scans were made approximately four weeks post-injury. High order independent component analysis resulted in 89 neural components that were included in subsequent graph analyses. No differences in graph measures were found between patients with mTBI and healthy controls. Regarding the two patient subgroups, degree, strength, local efficiency and eigenvector centrality of the bilateral posterior cingulate/precuneus and bilateral parahippocampal gyrus were higher, and eigenvector centrality of the frontal pole/bilateral middle & superior frontal gyrus was lower in patients with complaints compared to patients without complaints. In patients with mTBI, higher degree, strength and eigenvector centrality of default mode network components were related to higher depression scores, and higher degree and eigenvector centrality of executive network components were related to lower depression scores. In patients without complaints, one extra module was found compared to patients with complaints and healthy controls, consisting of the cingulate areas. In conclusion, this research extends the knowledge of functional network connectivity after mTBI. Specifically, our results suggest that an imbalance in the function of the default mode-and executive network plays a central role in the interaction between emotion regulation and the persistence of posttraumatic complaints.	[van der Horn, Harm J.; de Koning, Myrthe E.; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Liemburg, Edith J.] Univ Groningen, Univ Med Ctr Groningen, BCN NeuroImaging Ctr, Groningen, Netherlands; [Liemburg, Edith J.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands; [Scheenen, Myrthe E.; Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neuropsychol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	van der Horn, HJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands.	h.j.van.der.horn@umcg.nl		van der Naalt, Joukje/0000-0001-9873-2418; Spikman, Jacoba/0000-0002-6477-0763	Dutch Brain Foundation [Ps2012-06]	Dutch Brain Foundation	This work was supported by Dutch Brain Foundation, grant no. Ps2012-06. J.v.d.N. received the funding. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Elseoud A, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00037; Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Allen EA, 2012, NEUROIMAGE, V59, P4141, DOI 10.1016/j.neuroimage.2011.10.010; Barbey AK, 2015, CURR OPIN BEHAV SCI, V4, P92, DOI 10.1016/j.cobeha.2015.04.002; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cole MW, 2014, NEUROSCIENTIST, V20, P652, DOI 10.1177/1073858414525995; de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Fallani FD, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0521; Filippi M, 2013, LANCET NEUROL, V12, P1189, DOI 10.1016/S1474-4422(13)70144-3; Frank DW, 2014, NEUROSCI BIOBEHAV R, V45, P202, DOI 10.1016/j.neubiorev.2014.06.010; Geerligs L, 2015, CEREB CORTEX, V25, P1987, DOI 10.1093/cercor/bhu012; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Kiviniemi V, 2009, HUM BRAIN MAPP, V30, P3865, DOI 10.1002/hbm.20813; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Matuseviciene G, 2015, J REHABIL MED; Matuseviciene G, 2013, BRAIN INJURY, V27, P318, DOI 10.3109/02699052.2012.750740; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; MCGRAW KO, 1992, PSYCHOL BULL, V111, P361, DOI 10.1037/0033-2909.111.2.361; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Menon Vinod, 2010, Brain Struct Funct, V214, P655, DOI 10.1007/s00429-010-0262-0; Messe A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065470, 10.1371/annotation/fd9f9796-b42d-480d-b9f4-0adfbb919148]; Mulders PC, 2015, NEUROSCI BIOBEHAV R, V56, P330, DOI 10.1016/j.neubiorev.2015.07.014; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Quoidbach J, 2015, PSYCHOL BULL, V141, P655, DOI 10.1037/a0038648; Rigon A, 2015, J NEUROTRAUM, V1, P1; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Servaas MN, 2015, NEUROPSYCHOPHARMACOL, V40, P296, DOI 10.1038/npp.2014.169; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Sheppes G, 2015, ANNU REV CLIN PSYCHO, V11, P379, DOI 10.1146/annurev-clinpsy-032814-112739; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Spielberg JM, 2015, BIOL PSYCHIAT, V78, P210, DOI 10.1016/j.biopsych.2015.02.013; Sporns Olaf, 2013, Dialogues Clin Neurosci, V15, P247; Stam CJ, 2014, NAT REV NEUROSCI, V15, P683, DOI 10.1038/nrn3801; Stanley ML, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00169; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Sun Y, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/28004; Utevsky AV, 2014, J NEUROSCI, V34, P932, DOI 10.1523/JNEUROSCI.4227-13.2014; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; van der Horn HJ, 2016, HUM BRAIN MAPP, V37, P1645, DOI 10.1002/hbm.23126; van der Horn HJ, 2016, J NEUROTRAUM, V33, P1, DOI 10.1089/neu.2015.3905; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Ward AM, 2014, HUM BRAIN MAPP, V35, P1061, DOI 10.1002/hbm.22234; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	80	29	29	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0171031	10.1371/journal.pone.0171031	http://dx.doi.org/10.1371/journal.pone.0171031			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7VX	28129397	Green Published, Green Submitted, gold			2022-12-27	WOS:000396211400011
J	Yao, YG; Deng, HY; Ma, CZ; Yi, M; Ma, J				Yao, Yuangen; Deng, Haiyou; Ma, Chengzhang; Yi, Ming; Ma, Jun			Impact of Bounded Noise and Rewiring on the Formation and Instability of Spiral Waves in a Small-World Network of Hodgkin-Huxley Neurons	PLOS ONE			English	Article							SPREADING DEPRESSION; COHERENCE RESONANCE; EXCITABLE SYSTEM; BRAIN NETWORKS; CHICKEN RETINA; TRANSITION; DYNAMICS; MODEL; BREAKUP; MEDIA	Spiral waves are observed in the chemical, physical and biological systems, and the emergence of spiral waves in cardiac tissue is linked to some diseases such as heart ventricular fibrillation and epilepsy; thus it has importance in theoretical studies and potential medical applications. Noise is inevitable in neuronal systems and can change the electrical activities of neuron in different ways. Many previous theoretical studies about the impacts of noise on spiral waves focus an unbounded Gaussian noise and even colored noise. In this paper, the impacts of bounded noise and rewiring of network on the formation and instability of spiral waves are discussed in small-world (SW) network of Hodgkin-Huxley (HH) neurons through numerical simulations, and possible statistical analysis will be carried out. Firstly, we present SW network of HH neurons subjected to bounded noise. Then, it is numerically demonstrated that bounded noise with proper intensity sigma, amplitude A, or frequency f can facilitate the formation of spiral waves when rewiring probability p is below certain thresholds. In other words, bounded noise-induced resonant behavior can occur in the SW network of neurons. In addition, rewiring probability p always impairs spiral waves, while spiral waves are confirmed to be robust for small p, thus shortcut-induced phase transition of spiral wave with the increase of p is induced. Furthermore, statistical factors of synchronization are calculated to discern the phase transition of spatial pattern, and it is confirmed that larger factor of synchronization is approached with increasing of rewiring probability p, and the stability of spiral wave is destroyed.	[Yao, Yuangen; Deng, Haiyou; Ma, Chengzhang; Yi, Ming] Huazhong Agr Univ, Dept Phys, Coll Sci, Wuhan, Peoples R China; [Yao, Yuangen] Huazhong Agr Univ, Inst Appl Phys, Wuhan, Peoples R China; [Ma, Jun] Lanzhou Univ Technol, Dept Phys, Lanzhou, Peoples R China; [Ma, Jun] King Abdulaziz Univ, Dept Math, Fac Sci, NAAM Res Grp, Jeddah, Saudi Arabia	Huazhong Agricultural University; Huazhong Agricultural University; Lanzhou University of Technology; King Abdulaziz University	Ma, J (corresponding author), Lanzhou Univ Technol, Dept Phys, Lanzhou, Peoples R China.; Ma, J (corresponding author), King Abdulaziz Univ, Dept Math, Fac Sci, NAAM Res Grp, Jeddah, Saudi Arabia.	hyperchaos@163.com	Yi, Ming/B-5383-2011; Yao, Yuangen/D-9327-2018; Yi, Ming/AAB-7928-2022; Ma, Jun/G-2376-2010	Yi, Ming/0000-0001-7198-5511; Yao, Yuangen/0000-0001-6967-2487; Yi, Ming/0000-0001-7534-3049; Ma, Jun/0000-0002-6127-000X; Chengzhang, Ma/0000-0003-2742-1174	Fundamental Research Funds for the Central Universities [2662015QC041, 2662014BQ069]; National Natural Science Foundation of China [31601071, 11372122]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Fundamental Research Funds for the Central Universities (Grant No. 2662015QC041 and 2662014BQ069) and the National Natural Science Foundation of China (Grant No. 31601071, 11372122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Fundamental Research Funds for the Central Universities (Grant No. 2662015QC041 and 2662014BQ069) and the National Natural Science Foundation of China (Grant No. 31601071, 11372122).	[Anonymous], 1988, ACTA APPL MATH; BAR M, 1994, J CHEM PHYS, V100, P1202, DOI 10.1063/1.466650; BARKLEY D, 1991, PHYSICA D, V49, P61, DOI 10.1016/0167-2789(91)90194-E; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; BEZRUKOV SM, 1995, NATURE, V378, P362, DOI 10.1038/378362a0; Bobryk RV, 2005, PHYSICA A, V358, P263, DOI 10.1016/j.physa.2005.03.055; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Cai GQ, 2004, PROBABILIST ENG MECH, V19, P197, DOI 10.1016/j.probengmech.2004.02.002; Chai YZ, 2015, MOD PHYS LETT B, V29, DOI 10.1142/S0217984915501213; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; Dahlem MA, 1997, EXP BRAIN RES, V115, P319, DOI 10.1007/PL00005700; DAVIDENKO JM, 1992, NATURE, V355, P349, DOI 10.1038/355349a0; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Gerstner W, 2002, SPIKING NEURON MODEL; GORELOVA NA, 1983, J NEUROBIOL, V14, P353, DOI 10.1002/neu.480140503; Guo W, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-30116-1; Guo W, 2012, PHYSICA A, V391, P1270, DOI 10.1016/j.physa.2011.11.007; Holden AV, 2013, NONLINEAR WAVE PROCE; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Huang XY, 2004, J NEUROSCI, V24, P9897, DOI 10.1523/JNEUROSCI.2705-04.2004; Jia YB, 2015, CHAOS, V25, DOI 10.1063/1.4938733; Jung P, 1998, CHAOS, V8, P567, DOI 10.1063/1.166338; LECHLEITER J, 1991, SCIENCE, V252, P123, DOI 10.1126/science.2011747; Liang XM, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.031916; Ma J, 2016, NONLINEAR DYNAM, V84, P497, DOI 10.1007/s11071-015-2502-6; Ma J, 2015, SCI CHINA TECHNOL SC, V58, P2038, DOI 10.1007/s11431-015-5961-6; Ma J, 2015, INT J MOD PHYS B, V29, DOI 10.1142/S0217979214502397; Ma J, 2012, COMMUN NONLINEAR SCI, V17, P4281, DOI 10.1016/j.cnsns.2012.03.009; Ma J, 2012, CHINESE SCI BULL, V57, P2094, DOI 10.1007/s11434-012-5114-2; Ma J, 2011, INT J MOD PHYS B, V25, P1653, DOI 10.1142/S0217979211100266; Ma J, 2011, CHINESE SCI BULL, V56, P151, DOI 10.1007/s11434-010-4281-2; Ma J, 2010, COMMUN THEOR PHYS, V54, P583, DOI 10.1088/0253-6102/54/3/38; Ma J, 2010, SCI CHINA PHYS MECH, V53, P672, DOI 10.1007/s11433-010-0097-y; MIELKE A, 1995, ANN PHYS-LEIPZIG, V4, P476, DOI 10.1002/andp.19955070507; Ozer M, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/40008; Pikovsky AS, 1997, PHYS REV LETT, V78, P775, DOI 10.1103/PhysRevLett.78.775; Qin HX, 2015, COMMUN NONLINEAR SCI, V23, P164, DOI 10.1016/j.cnsns.2014.11.008; Sun XJ, 2011, EUR PHYS J B, V79, P61, DOI 10.1140/epjb/e2010-10031-3; Sun XJ, 2014, SCI CHINA TECHNOL SC, V57, P879, DOI 10.1007/s11431-014-5529-x; Szabo G, 2004, J PHYS A-MATH GEN, V37, P2599, DOI 10.1088/0305-4470/37/7/006; Wang QY, 2008, PHYS LETT A, V372, P5681, DOI 10.1016/j.physleta.2008.07.005; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wio HS, 2004, PHYSICA D, V193, P161, DOI 10.1016/j.physd.2004.01.017; Yang XL, 2014, PHYSICA A, V393, P617, DOI 10.1016/j.physa.2013.09.021; Yu Q, 2012, CHINESE PHYS B, V21; Zhou CS, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.230602	47	17	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0171273	10.1371/journal.pone.0171273	http://dx.doi.org/10.1371/journal.pone.0171273			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129401	gold, Green Published, Green Submitted			2022-12-27	WOS:000396211400004
J	Akimushkin, C; Amancio, DR; Oliveira, ON				Akimushkin, Camilo; Amancio, Diego Raphael; Oliveira, Osvaldo Novais, Jr.			Text Authorship Identified Using the Dynamics of Word Co-Occurrence Networks	PLOS ONE			English	Article							PUBLIC-GOODS GAME; COMPLEX NETWORK; TIME-SERIES; UNIT-ROOT; LANGUAGE; CHINESE; ORGANIZATION; ATTRIBUTION; INVENTORIES; VISIBILITY	Automatic identification of authorship in disputed documents has benefited from complex network theory as this approach does not require human expertise or detailed semantic knowledge. Networks modeling entire books can be used to discriminate texts from different sources and understand network growth mechanisms, but only a few studies have probed the suitability of networks in modeling small chunks of text to grasp stylistic features. In this study, we introduce a methodology based on the dynamics of word co-occurrence networks representing written texts to classify a corpus of 80 texts by 8 authors. The texts were divided into sections with equal number of linguistic tokens, from which time series were created for 12 topological metrics. Since 73% of all series were stationary (ARIMA(p, 0, q)) and the remaining were integrable of first order (ARIMA(p, 1, q)), probability distributions could be obtained for the global network metrics. The metrics exhibit bell-shaped non-Gaussian distributions, and therefore distribution moments were used as learning attributes. With an optimized supervised learning procedure based on a nonlinear transformation performed by Isomap, 71 out of 80 texts were correctly classified using the K-nearest neighbors algorithm, i.e. a remarkable 88.75% author matching success rate was achieved. Hence, purely dynamic fluctuations in network metrics can characterize authorship, thus paving the way for a robust description of large texts in terms of small evolving networks.	[Akimushkin, Camilo; Oliveira, Osvaldo Novais, Jr.] Univ Sao Paulo, Sao Carlos Inst Phys, Sao Carlos, SP, Brazil; [Amancio, Diego Raphael] Univ Sao Paulo, Inst Math & Comp Sci, Sao Carlos, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Amancio, DR (corresponding author), Univ Sao Paulo, Inst Math & Comp Sci, Sao Carlos, SP, Brazil.	diego.raphael@gmail.com	Amancio, Diego Raphael/I-1071-2012; Oliveira, Osvaldo N./A-1714-2008	Oliveira, Osvaldo N./0000-0002-5399-5860	CNPq (Brazil); Sao Paulo Research Foundation (FAPESP) [2014/20830-0, 2016/19069-9]	CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors acknowledge the financial support from CNPq (Brazil). DRA acknowledges financial support from Sao Paulo Research Foundation (FAPESP grant no. 2014/20830-0 and 2016/19069-9) (www.fapesp.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi A, 2005, IEEE INTELL SYST, V20, P67, DOI 10.1109/MIS.2005.81; Amancio DR, 2012, SCIENTOMETRICS, V91, P827, DOI 10.1007/s11192-012-0630-z; Amancio DR, 2015, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2015/03/P03005; Amancio DR, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/58002; Amancio DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136076; Amancio DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094137; Amancio DR, 2012, J INFORMETR, V6, P427, DOI 10.1016/j.joi.2012.02.005; Amancio DR, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/12/123024; [Anonymous], 2009, P 21 INN APPL ART IN; Barabasi AL, 2000, PHYSICA A, V281, P69, DOI 10.1016/S0378-4371(00)00018-2; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Basile C, 2008, J MATH PHYS, V49, DOI 10.1063/1.2996507; Berryman MJ, 2003, FLUCT NOISE LETT, V3, pL1, DOI 10.1142/S021947750300104X; Biemann C, 2009, MODEL SIMUL SCI ENG, P167, DOI 10.1007/978-0-8176-4751-3_10; Cancho RFI, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.051915; Cancho RFI, 2001, P ROY SOC B-BIOL SCI, V268, P2261, DOI 10.1098/rspb.2001.1800; Cancho RFI., 2001, J QUANT LINGUIST, V8, P165, DOI [10.1076/jqul.8.3.165.4101, DOI 10.1076/JQUL.8.3.165.4101]; Chaski Carole E., 2005, INT J DIGIT EVID, V4, P1; Chen MH, 2016, PHYS LETT A, V380, P40, DOI 10.1016/j.physleta.2015.09.047; Chen MH, 2015, APPL MATH COMPUT, V251, P192, DOI 10.1016/j.amc.2014.11.052; Choudhury M., 2010, P 23 INT C COMP LING, P162; Cong J, 2014, PHYS LIFE REV, V11, P598, DOI 10.1016/j.plrev.2014.04.004; Corominas-Murtra B, 2009, ADV COMPLEX SYST, V12, P371, DOI 10.1142/S0219525909002192; Dorogovtsev SN, 2001, P ROY SOC B-BIOL SCI, V268, P2603, DOI 10.1098/rspb.2001.1824; Ferrer-I-Cancho R, 2014, EPL-EUROPHYS LETT, V108, DOI 10.1209/0295-5075/108/58003; Gao YY, 2014, PHYSICA A, V393, P579, DOI 10.1016/j.physa.2013.08.075; Gao ZK, 2017, INT J NEURAL SYST, V27, DOI 10.1142/S0129065717500058; Gao ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep35622; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Ghanbarnejad F, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.1044; Greene B., 1979, AUTOMATED GRAMMATICA; HAVLIN S, 1995, PHYSICA A, V216, P148, DOI 10.1016/0378-4371(95)00069-J; Juola P, 2011, CEUR WORKSHOP P, V1177; Juola P, 2011, ADV DIGITAL FORENSIC, P115; Kaiser M, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/5/110; Kapatsinski V., 2006, SPEECH RES LAB PROG, V27, P133; Kulig A, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.032810; KWIATKOWSKI D, 1992, J ECONOMETRICS, V54, P159, DOI 10.1016/0304-4076(92)90104-Y; Li JY, 2007, PHYSICA A, V380, P629, DOI 10.1016/j.physa.2007.02.059; Li Q, 2013, J PARALLEL DISTR COM, V73, P293, DOI 10.1016/j.jpdc.2012.02.011; Liang W, 2014, PHYSICA A, V393, P268, DOI 10.1016/j.physa.2013.08.034; Liang W, 2009, PHYSICA A, V388, P4901, DOI 10.1016/j.physa.2009.07.047; Liu HT, 2013, CHINESE SCI BULL, V58, P1139, DOI 10.1007/s11434-013-5711-8; Mackinnon JG, 1996, J APPL ECONOMET, V11, P601, DOI 10.1002/(SICI)1099-1255(199611)11:6<601::AID-JAE417>3.0.CO;2-T; Martinez-Romo J, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046108; Masucci AP, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.026103; Masucci AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069469; Mehri A, 2012, PHYSICA A, V391, P2429, DOI 10.1016/j.physa.2011.12.011; Mosteller F, 1964, INFERENCE DISPUTED A; Mukherjee A, 2007, INT J MOD PHYS C, V18, P281, DOI 10.1142/S0129183107010395; Mukherjee A, 2009, J QUANT LINGUIST, V16, P157, DOI 10.1080/09296170902734222; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Newman MEJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.036122; Masucci AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017333; Paulovich FV, 2007, SIBGRAPI, P27, DOI 10.1109/SIBGRAPI.2007.21; PHILLIPS PCB, 1988, BIOMETRIKA, V75, P335, DOI 10.1093/biomet/75.2.335; Pomi A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066136; Roxas RM, 2010, INT J MOD PHYS C, V21, P503, DOI 10.1142/S0129183110015257; SAID SE, 1984, BIOMETRIKA, V71, P599; Samko O, 2006, PATTERN RECOGN LETT, V27, P968, DOI 10.1016/j.patrec.2005.11.017; Segarra S, 2013, INT CONF ACOUST SPEE, P5563, DOI 10.1109/ICASSP.2013.6638728; Sigman M, 2002, P NATL ACAD SCI USA, V99, P1742, DOI 10.1073/pnas.022341799; Silva TC, 2012, EPL-EUROPHYS LETT, V98, DOI 10.1209/0295-5075/98/58001; Stamatatos E, 2009, J AM SOC INF SCI TEC, V60, P538, DOI 10.1002/asi.21001; Sun SW, 2016, SCI REP-UK, V6, DOI 10.1038/srep32983; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Viana MP, 2013, J INFORMETR, V7, P371, DOI 10.1016/j.joi.2012.12.005; Wang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106132; Witten I. H., 2005, DATA MINING PRACTICA; Wong TT, 2015, PATTERN RECOGN, V48, P2839, DOI 10.1016/j.patcog.2015.03.009; Xia CY, 2013, PHYSICA A, V392, P1577, DOI 10.1016/j.physa.2012.11.043; Xia CY, 2012, NONLINEAR DYNAM, V69, P927, DOI 10.1007/s11071-011-0313-y; Yang MH, 2002, EIGHTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-02)/FOURTEENTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE (IAAI-02), PROCEEDINGS, P224; Zipf George, 1935, PSYCHOBIOLOGY LANGUA	76	51	54	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170527	10.1371/journal.pone.0170527	http://dx.doi.org/10.1371/journal.pone.0170527			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7IT	28125703	Green Published, gold, Green Submitted			2022-12-27	WOS:000396176100098
J	Li, TZ; Cai, WH; Zhan, JM				Li, Tianzeng; Cai, Wenhao; Zhan, Jiemin			Numerical Investigation of Swimmer's Gliding Stage with 6-DOF Movement	PLOS ONE			English	Article							DRAG	The purpose of this study is to analyze the motion status of swimmers during their gliding stage using a numerical simulation method. This simulation strategy is conducted by solving the 3D incompressible Navier-Stokes equations using the Realizable k-epsilon turbulence closure equations in combination with the Six Degrees of Freedom (6-DOF) method. The uneven mass distribution of a swimmer and the roughness of the surface of the body are taken into consideration. The hydrodynamic characteristics and movement characteristics of the swimmers at different launch speeds were analyzed. The calculated results suggest that an optimal instant for starting propulsive movement is when the velocity of the swimmer decreases by 1.75 m/s to 2.0 m/s from an initial horizontal velocity of 3.1 m/s to 3.5 m/s.	[Li, Tianzeng; Cai, Wenhao; Zhan, Jiemin] Sun Yat Sen Univ, Dept Appl Mech & Engn, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Zhan, JM (corresponding author), Sun Yat Sen Univ, Dept Appl Mech & Engn, Guangzhou, Guangdong, Peoples R China.	cejmzhan@gmail.com			Special Research Program of Public Welfare and Capacity Building in Guangdong Province [2015A020216008]; Science and Technology Project in Guangdong Province, China [2016A010104006]	Special Research Program of Public Welfare and Capacity Building in Guangdong Province; Science and Technology Project in Guangdong Province, China	This work is supported by Prof. Jiemin Zhan's project (Special Research Program of Public Welfare and Capacity Building in Guangdong Province, No. 2015A020216008). Also thanks to the suggestions from Dr. Ye-Jun Gong and the financial support from her project (Science and Technology Project in Guangdong Province, China, No. 2016A010104006).	ANSYS inc, 2016, ANSYS FLUENT THEOR G; Bixler B, 2007, SPORT BIOMECH, V6, P81, DOI 10.1080/14763140601058581; Cebeci T, 1977, MOMENTUM TRANSFER BO, P1; Clarys JP, 1979, SWIMMING, P3; Cossor JM, 2001, INT S BIOM SPORTS IS, P70; Dempster WT., 1955, 55159 WADC WRIGHT PA; Elipot M, 2009, J BIOMECH, V42, P1367, DOI 10.1016/j.jbiomech.2009.03.032; Elipot M, 2010, J APPL BIOMECH, V26, P501, DOI 10.1123/jab.26.4.501; Hertel H., 1966, STRUCTURE FORM MOVEM; Kakimpa B, 2012, J WIND ENG IND AEROD, V111, P95, DOI 10.1016/j.jweia.2012.07.008; KOROBKIN AA, 1988, ANNU REV FLUID MECH, V20, P159; Li TZ, 2015, ACTA BIOENG BIOMECH, V17, P3, DOI 10.5277/ABB-00200-2014-03; Lyttle A, 1999, ISBS C P ARCH, V1; Lyttle A, 1999, J SCI MED SPORT, V2, P430; Lyttle A.D., 1998, J SWIMMING RES, V13, P15; Lyttle AD, 2000, J SPORT SCI, V18, P801, DOI 10.1080/026404100419856; Marinho D. A., 2009, LECT NOTES COMPUTATI, V72, P33, DOI DOI 10.1007/978-3-642-04466-3_; Marinho DA, 2011, J HUM KINET, V29, P49, DOI 10.2478/v10078-011-0039-4; Marinho DA, 2012, BRAZ ARCH BIOL TECHN, V55, P851, DOI 10.1590/S1516-89132012000600007; Naemi R, 2010, J SCI MED SPORT, V13, P444, DOI 10.1016/j.jsams.2009.04.009; Naemi R, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.3002764; Novais ML, 2012, J HUM KINET, V33, P55, DOI 10.2478/v10078-012-0044-2; Pendergast D, 2005, UNDERSEA HYPERBAR M, V32, P45; Popa CV, 2011, ACTA BIOENG BIOMECH, V13, P3; Popa CV, 2014, COMPUT METHOD BIOMEC, V17, P344, DOI 10.1080/10255842.2012.683429; Saha CK, 2011, BIOSYST ENG, V108, P227, DOI 10.1016/j.biosystemseng.2010.12.005; Shabana AA, 1996, J MECH DESIGN, V118, P171, DOI 10.1115/1.2826866; Tor E, 2015, J SCI MED SPORT, V18, P725, DOI 10.1016/j.jsams.2014.10.005; WELTNER K, 1987, AM J PHYS, V55, P50, DOI 10.1119/1.14960; Zaidi H, 2010, J BIOMECH, V43, P405, DOI 10.1016/j.jbiomech.2009.10.010; Zhan JM, 2015, CHINA OCEAN ENG, V29, P265, DOI 10.1007/s13344-014-0080-x	31	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170894	10.1371/journal.pone.0170894	http://dx.doi.org/10.1371/journal.pone.0170894			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125724	Green Submitted, Green Published, gold			2022-12-27	WOS:000396176100030
J	Naud, A; Schmitt, E; Wirth, M; Hascoet, JM				Naud, Aurelie; Schmitt, Emmanuelle; Wirth, Maelle; Hascoet, Jean-Michel			Determinants of Indices of Cerebral Volume in Former Very Premature Infants at Term Equivalent Age	PLOS ONE			English	Article							PRETERM INFANTS; BRAIN VOLUMES; PERIVENTRICULAR LEUKOMALACIA; POSTNATAL DEXAMETHASONE; LUNG-DISEASE; SCHOOL-AGE; MATTER; INJURY; COMMON; PALSY	Conventional magnetic resonance imaging (MRI) at term equivalent age (TEA) is suggested to be a reliable tool to predict the outcome of very premature infants. The objective of this study was to determine simple reproducible MRI indices, in premature infants and to analyze their neonatal determinants at TEA. A cohort of infants born before 32 weeks gestational age (GA) underwent a MRI at TEA in our center. Two axial images (T2 weighted), were chosen to realize nine measures. We defined 4 linear indices (MAfhlv: thickness of lateral ventricle; CSI: cortex-skull index; VCI: ventricular-cortex index; BOI: bi occipital index) and 1 surface index (VS. A: volume slice area). Perinatal data were recorded. Sixty-nine infants had a GA (median (interquartile range)) of 30.0 weeks GA (27.0; 30.0) and a birth weight of 1240 grams (986; 1477). MRI was done at 41.0 (40.0; 42.0) weeks post menstrual age (PMA). The inter-investigator reproducibility was good. Twenty one MRI (30.5%) were quoted abnormal. We observed an association with retinopathy of prematurity (OR [95CI] = 4.205 [1.231-14.368]; p = 0.017), surgery for patent ductus arteriosus (OR = 4.688 [1.01- 21.89]; p = 0.036), early onset infection (OR = 4.688 [1.004-21.889]; p = 0.036) and neonatal treatment by cefotaxime (OR = 3.222 [1.093-9.497]; p = 0.03). There was a difference for VCI between normal and abnormal MRI (0.412 (0.388; 0.429) vs. 0.432 (0.418; 0.449); p = 0,019); BOI was higher when fossa posterior lesions were observed; VS. A seems to be the best surrogate for cerebral volume, 80% of VS. As' variance being explained by a multiple linear regression model including 7 variables (head circumference at birth and at TEA, PMA, dopamine, ibuprofen treatment, blood and platelets transfusions). These indices, easily and rapidly achievable, seem to be useful but need to be validated in a large population to allow generalization for diagnosis and follow-up of former premature infants.	[Naud, Aurelie; Hascoet, Jean-Michel] CHRU NANCY, Dept Neonatol, Maternite Reg, Nancy, France; [Schmitt, Emmanuelle] CHRU NANCY, Dept Neuroradiol, Nancy, France; [Wirth, Maelle; Hascoet, Jean-Michel] Univ Lorraine, EA DevAH 3450, Nancy, France	CHU de Nancy; CHU de Nancy; Universite de Lorraine	Hascoet, JM (corresponding author), CHRU NANCY, Dept Neonatol, Maternite Reg, Nancy, France.; Hascoet, JM (corresponding author), Univ Lorraine, EA DevAH 3450, Nancy, France.	j.hascoet@chru-nancy.fr						Bartholomeusz HH, 2002, NEUROPEDIATRICS, V33, P239, DOI 10.1055/s-2002-36735; Bhatt AJ, 2013, J NEUROSCI RES, V91, P1191, DOI 10.1002/jnr.23232; Bhutta AT, 2001, TRENDS NEUROSCI, V24, P129, DOI 10.1016/S0166-2236(00)01747-1; BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brouwer MJ, 2016, J PEDIATR-US, V168, P41, DOI 10.1016/j.jpeds.2015.09.083; Dammann O, 2001, TRENDS NEUROSCI, V24, P320, DOI 10.1016/S0166-2236(00)01811-7; de Vries LS, 2011, SEMIN FETAL NEONAT M, V16, P279, DOI 10.1016/j.siny.2011.04.004; Favrais G, 2014, NEONATOLOGY, V106, P163, DOI 10.1159/000363492; Galli KK, 2004, J THORAC CARDIOV SUR, V127, P692, DOI 10.1016/j.jtcvs.2003.09.053; Gao J, 2014, MED SCI MONITOR, V20, P499, DOI 10.12659/MSM.890589; Halliday HL, 2002, PEDIATRICS, V109, P1168, DOI 10.1542/peds.109.6.1168; Halliday HL, 2009, COCHRANE DB SYST REV, V1; Inder TE, 1999, ANN NEUROL, V46, P755, DOI 10.1002/1531-8249(199911)46:5<755::AID-ANA11>3.0.CO;2-0; Inder TE, 2003, J PEDIATR-US, V143, P171, DOI 10.1067/S0022-3476(03)00357-3; Inder TE, 2005, PEDIATRICS, V115, P286, DOI 10.1542/peds.2004-0326; Kersbergen KJ, 2015, J PEDIATR-US, V167, P260, DOI 10.1016/j.jpeds.2015.05.013; Keunen K, 2016, J PEDIATR-US, V172, P88, DOI 10.1016/j.jpeds.2015.12.023; Kidokoro H, 2013, AM J NEURORADIOL, V34, P2208, DOI 10.3174/ajnr.A3521; Kim JW, 2013, COMPARATIVE MED, V63, P48; Loeliger M, 2010, PEDIATR RES, V68, P298, DOI 10.1203/00006450-201011001-00582; McPherson C, 2015, ANN PHARMACOTHER, V49, P1291, DOI 10.1177/1060028015606732; Monson BB, 2016, JAMA PEDIATR, V170, P772, DOI 10.1001/jamapediatrics.2016.0781; Murphy BP, 2001, PEDIATRICS, V107, P217, DOI 10.1542/peds.107.2.217; Parikh NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062804; Peterson BS, 2000, JAMA-J AM MED ASSOC, V284, P1939, DOI 10.1001/jama.284.15.1939; Pineda RG, 2014, J PEDIATR-US, V164, P52, DOI 10.1016/j.jpeds.2013.08.047; Ragan DK, 2015, J NEUROSURG-PEDIATR, V15, P547, DOI 10.3171/2014.10.PEDS14209; Rand KM, 2011, J PEDIAT, V170, P97; Scratch SE, 2014, PEDIATRICS, V133, pE955, DOI 10.1542/peds.2013-2425; Singh K, 2003, EUR J VASC ENDOVASC, V25, P399, DOI 10.1053/ejvs.2002.1856; Treit S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150370; van Haastert IC, 2011, J PEDIATR-US, V159, P86, DOI 10.1016/j.jpeds.2010.12.053; Van Hus JWP, 2013, J PEDIATR-US, V162, P1112, DOI 10.1016/j.jpeds.2012.11.078; Yeh TF, 2004, NEW ENGL J MED, V350, P1304, DOI 10.1056/NEJMoa032089	35	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170797	10.1371/journal.pone.0170797	http://dx.doi.org/10.1371/journal.pone.0170797			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125676	Green Submitted, Green Published, gold			2022-12-27	WOS:000396176100049
J	Seyffert, M; Glauser, DL; Schraner, EM; de Oliveira, AP; Mansilla-Soto, J; Vogt, B; Buning, H; Linden, RM; Ackermann, M; Fraefel, C				Seyffert, Michael; Glauser, Daniel L.; Schraner, Elisabeth M.; de Oliveira, Anna-Paula; Mansilla-Soto, Jorge; Vogt, Bernd; Buening, Hildegard; Linden, R. Michael; Ackermann, Mathias; Fraefel, Cornel			Novel Mutant AAV2 Rep Proteins Support AAV2 Replication without Blocking HSV-1 Helpervirus Replication	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS TYPE-2; DNA-DAMAGE RESPONSE; BACTERIAL ARTIFICIAL CHROMOSOME; GREEN FLUORESCENT PROTEIN; SITE-SPECIFIC INTEGRATION; E2A GENE-EXPRESSION; AMPLICON VECTORS; IN-VITRO; ADENOVIRUS REPLICATION; TRANSGENE EXPRESSION	As their names imply, parvoviruses of the genus Dependovirus rely for their efficient replication on the concurrent presence of a helpervirus, such as herpesvirus, adenovirus, or papilloma virus. Adeno-associated virus 2 (AAV2) is such an example, which in turn can efficiently inhibit the replication of each helpervirus by distinct mechanisms. In a previous study we have shown that expression of the AAV2 rep gene is not compatible with efficient replication of herpes simplex virus 1 (HSV-1). In particular, the combined DNA-binding and ATPase/helicase activities of the Rep68/78 proteins have been shown to exert opposite effects on the replication of AAV2 and HSV-1. While essential for AAV2 DNA replication these protein activities account for the Rep-mediated inhibition of HSV-1 replication. Here, we describe a novel Rep mutant (Rep-D371Y), which displayed an unexpected phenotype. Rep-D371Y did not block HSV-1 replication, but still supported efficient AAV2 replication, at least when a double-stranded AAV2 genome template was used. We also found that the capacity of Rep-D371Y to induce apoptosis and a Rep-specific DNA damage response was significantly reduced compared to wild-type Rep. These findings suggest that AAV2 Rep-helicase subdomains exert diverging activities, which contribute to distinct steps of the AAV2 life cycle. More important, the novel AAV2 mutant Rep-D371Y may allow deciphering yet unsolved activities of the AAV2 Rep proteins such as DNA second-strand synthesis, genomic integration or packaging, which all involve the Rep-helicase activity.	[Seyffert, Michael; Glauser, Daniel L.; Schraner, Elisabeth M.; de Oliveira, Anna-Paula; Vogt, Bernd; Ackermann, Mathias; Fraefel, Cornel] Univ Zurich, Inst Virol, Zurich, Switzerland; [Seyffert, Michael] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Schraner, Elisabeth M.] Univ Zurich, Inst Vet Anat, Zurich, Switzerland; [Mansilla-Soto, Jorge] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, 1275 York Ave, New York, NY 10021 USA; [Buening, Hildegard] Univ Cologne, Ctr Mol Med Cologne, Cologne, Germany; [Buening, Hildegard] Hannover Med Sch, Inst Expt Hematol, Hannover, Germany; [Linden, R. Michael] Kings Coll London, Dept Infect Dis, London, England; [Glauser, Daniel L.] Suisselab AG, Bern, Switzerland; [de Oliveira, Anna-Paula] Deutsch Krebsforschungszentrum, Div Tumor Virol, F010, Heidelberg, Germany	University of Zurich; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Zurich; Memorial Sloan Kettering Cancer Center; University of Cologne; Hannover Medical School; University of London; King's College London; Helmholtz Association; German Cancer Research Center (DKFZ)	Fraefel, C (corresponding author), Univ Zurich, Inst Virol, Zurich, Switzerland.	cornel.fraefel@access.uzh.ch	Buening, Hildegard/AAJ-2352-2020; Buening, Hildegard/AAV-9928-2021	Buening, Hildegard/0000-0002-3365-6933; Fraefel, Cornel/0000-0001-7221-6706; Seyffert, Michael/0000-0001-7483-2430	Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung [31003A_144094/1, 31003A_166668/1]	Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF))	This work was supported by Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung, http://www.snf.ch, No. 31003A_144094/1 and No. 31003A_166668/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AboodyGuterman KS, 1997, NEUROREPORT, V8, P3801, DOI 10.1097/00001756-199712010-00029; BECERRA SP, 1988, J VIROL, V62, P2745, DOI 10.1128/JVI.62.8.2745-2754.1988; Berthet C, 2005, P NATL ACAD SCI USA, V102, P13634, DOI 10.1073/pnas.0504583102; Boutell C, 2003, J BIOL CHEM, V278, P36596, DOI 10.1074/jbc.M300776200; BULLER RML, 1981, J VIROL, V40, P241, DOI 10.1128/JVI.40.1.241-247.1981; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; CASSINOTTI P, 1988, VIROLOGY, V167, P176, DOI 10.1016/0042-6822(88)90067-0; CHEJANOVSKY N, 1989, VIROLOGY, V173, P120, DOI 10.1016/0042-6822(89)90227-4; CHEJANOVSKY N, 1990, J VIROL, V64, P1764, DOI 10.1128/JVI.64.4.1764-1770.1990; CHIORINI JA, 1994, J VIROL, V68, P7448, DOI 10.1128/JVI.68.11.7448-7457.1994; Conway JE, 1999, GENE THER, V6, P986, DOI 10.1038/sj.gt.3300937; Davis MD, 2000, J VIROL, V74, P2936, DOI 10.1128/JVI.74.6.2936-2942.2000; Davis MD, 1999, J VIROL, V73, P2084, DOI 10.1128/JVI.73.3.2084-2093.1999; de Oliveira AP, 2008, J VIROL, V82, P4974, DOI 10.1128/JVI.02431-07; Di Pasquale G, 2003, EMBO J, V22, P1716, DOI 10.1093/emboj/cdg153; Dubielzig R, 1999, J VIROL, V73, P8989, DOI 10.1128/JVI.73.11.8989-8998.1999; Fraefel C, 2004, J VIROL, V78, P389, DOI 10.1128/JVI.78.1.389-398.2004; Fraefel C, 1996, J VIROL, V70, P7190, DOI 10.1128/JVI.70.10.7190-7197.1996; Glauser DL, 2007, J VIROL, V81, P4732, DOI 10.1128/JVI.02476-06; Glauser DL, 2010, J VIROL, V84, P3808, DOI 10.1128/JVI.01503-09; Glauser DL, 2005, J VIROL, V79, P12218, DOI 10.1128/JVI.79.19.12218-12230.2005; GORBALENYA AE, 1990, FEBS LETT, V262, P145, DOI 10.1016/0014-5793(90)80175-I; Grieger JC, 2005, J VIROL, V79, P9933, DOI 10.1128/JVI.79.15.9933-9944.2005; Grimm D, 1998, HUM GENE THER, V9, P2745, DOI 10.1089/hum.1998.9.18-2745; HEILBRONN R, 1990, J VIROL, V64, P3012, DOI 10.1128/JVI.64.6.3012-3018.1990; Heister T, 2002, J VIROL, V76, P7163, DOI 10.1128/JVI.76.14.7163-7173.2002; Hickman AB, 2002, MOL CELL, V10, P327, DOI 10.1016/S1097-2765(02)00592-0; Hickman AB, 2004, MOL CELL, V13, P403, DOI 10.1016/S1097-2765(04)00023-1; Hickman AB, 2005, CURR OPIN STRUC BIOL, V15, P77, DOI 10.1016/j.sbi.2004.12.001; HIRT B, 1969, J MOL BIOL, V40, P141, DOI 10.1016/0022-2836(69)90302-7; HOGGAN MD, 1966, P NATL ACAD SCI USA, V55, P1467, DOI 10.1073/pnas.55.6.1467; HONG G, 1992, P NATL ACAD SCI USA, V89, P4673, DOI 10.1073/pnas.89.10.4673; HORER M, 1995, J VIROL, V69, P5485; IM DS, 1990, CELL, V61, P447, DOI 10.1016/0092-8674(90)90526-K; Iyer LM, 2004, NUCLEIC ACIDS RES, V32, P5260, DOI 10.1093/nar/gkh828; James JA, 2004, P NATL ACAD SCI USA, V101, P12455, DOI 10.1073/pnas.0403454101; Jing XJ, 2001, VIROLOGY, V291, P140, DOI 10.1006/viro.2001.1192; Johnston KM, 1997, HUM GENE THER, V8, P359, DOI 10.1089/hum.1997.8.3-359; King JA, 2001, EMBO J, V20, P3282, DOI 10.1093/emboj/20.12.3282; KLEINSCHMIDT JA, 1995, VIROLOGY, V206, P254, DOI 10.1016/S0042-6822(95)80040-9; KOTIN RM, 1991, GENOMICS, V10, P831, DOI 10.1016/0888-7543(91)90470-Y; KOTIN RM, 1992, EMBO J, V11, P5071, DOI 10.1002/j.1460-2075.1992.tb05614.x; Kyostio SRM, 1996, BIOCHEM BIOPH RES CO, V220, P294, DOI 10.1006/bbrc.1996.0399; LeesMiller SP, 1996, J VIROL, V70, P7471, DOI 10.1128/JVI.70.11.7471-7477.1996; Li Z, 2003, VIROLOGY, V313, P364, DOI 10.1016/S0042-6822(03)00340-4; Lilley CE, 2005, P NATL ACAD SCI USA, V102, P5844, DOI 10.1073/pnas.0501916102; Linden RM, 2000, MOL BIOLO ADENO ASS; Lux K, 2005, J VIROL, V79, P11776, DOI 10.1128/JVI.79.18.11776-11787.2005; Mansilla-Soto J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000513; Nada S, 2002, VIROLOGY, V293, P345, DOI 10.1006/viro.2001.1286; Naumer M, 2012, J VIROL, V86, P13038, DOI 10.1128/JVI.01675-12; Parkinson J, 2000, J VIROL, V74, P10006, DOI 10.1128/JVI.74.21.10006-10017.2000; Putnam CD, 2001, J MOL BIOL, V311, P297, DOI 10.1006/jmbi.2001.4852; Saeki Y, 1998, HUM GENE THER, V9, P2787, DOI 10.1089/hum.1998.9.18-2787; Saeki Y, 2001, MOL THER, V3, P591, DOI 10.1006/mthe.2001.0294; Saudan P, 2000, EMBO J, V19, P4351, DOI 10.1093/emboj/19.16.4351; Schmidt M, 2000, J VIROL, V74, P9441, DOI 10.1128/JVI.74.20.9441-9450.2000; Schwartz RA, 2009, J VIROL, V83, P6269, DOI 10.1128/JVI.00318-09; Seyffert M, 2015, J VIROL, V89, P11150, DOI 10.1128/JVI.01370-15; Shirata N, 2005, J BIOL CHEM, V280, P30336, DOI 10.1074/jbc.M500976200; SMITH IL, 1992, VIROLOGY, V186, P74, DOI 10.1016/0042-6822(92)90062-T; Smith RH, 2000, J VIROL, V74, P3122, DOI 10.1128/JVI.74.7.3122-3129.2000; SNYDER RO, 1990, J VIROL, V64, P6204, DOI 10.1128/JVI.64.12.6204-6213.1990; Sonntag F, 2010, P NATL ACAD SCI USA, V107, P10220, DOI 10.1073/pnas.1001673107; Sourvinos G, 2002, EMBO J, V21, P4989, DOI 10.1093/emboj/cdf458; Timpe JA, 2006, J VIROL, V80, P7807, DOI 10.1128/JVI.00198-06; Tsukamoto T, 2000, NAT CELL BIOL, V2, P871, DOI 10.1038/35046510; Urabe M, 1999, J VIROL, V73, P2682, DOI 10.1128/JVI.73.4.2682-2693.1999; Vogel Rebecca, 2013, Open Virol J, V7, P98, DOI 10.2174/1874357901307010098; Vogel R, 2012, J VIROL, V86, P143, DOI 10.1128/JVI.05694-11; Walz C, 1997, J GEN VIROL, V78, P1441, DOI 10.1099/0022-1317-78-6-1441; Wang Y, 2002, J VIROL, V76, P7150, DOI 10.1128/JVI.76.14.7150-7162.2002; Weitzman MD, 1996, J VIROL, V70, P1845, DOI 10.1128/JVI.70.3.1845-1854.1996; Wilkinson DE, 2004, J VIROL, V78, P4783, DOI 10.1128/JVI.78.9.4783-4796.2004; Wilkinson DE, 2006, J CELL SCI, V119, P2695, DOI 10.1242/jcs.02981; Yoon M, 2001, J VIROL, V75, P3230, DOI 10.1128/JVI.75.7.3230-3239.2001; Yoon-Robarts M, 2004, J BIOL CHEM, V279, P50472, DOI 10.1074/jbc.M403900200; Zarate-Perez F, 2013, J VIROL, V87, P1232, DOI 10.1128/JVI.02441-12; Zarate-Perez F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002764	79	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170908	10.1371/journal.pone.0170908	http://dx.doi.org/10.1371/journal.pone.0170908			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125695	Green Published, Green Accepted, gold			2022-12-27	WOS:000396176100026
J	Arem, H; Pfeiffer, RM; Moore, SC; Irwin, ML; LaMonte, MJ; Sarto, GE; Nassir, R; Luo, JH; Chlebowski, RT; Brinton, LA; Matthews, CE				Arem, Hannah; Pfeiffer, Ruth M.; Moore, Steven C.; Irwin, Melinda L.; LaMonte, Michael J.; Sarto, Gloria E.; Nassir, Rami; Luo, Juhua; Chlebowski, Rowan T.; Brinton, Louise A.; Matthews, Charles E.			Post-diagnosis body mass index and mortality among women diagnosed with endometrial cancer: Results from the Women's Health Initiative	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; OVERWEIGHT; CARCINOMA; SURVIVAL; OBESITY	Higher body mass index (BMI) measured before endometrial cancer diagnosis has been associated with greater risk of developing endometrial cancer and higher mortality, but the association between BMI measured after diagnosis and mortality risk is unclear. We identified 467 women (91 deaths) in the Women's Health Initiative (WHI) with information on BMI measured after diagnosis and used Cox proportional hazards regression to generate hazard ratios (HR) and 95% confidence intervals (CI) for all-cause mortality. Comparing BMI 35+ with <25 kg/m(2), we observed no association with all-cause mortality (HR = 1.02, 95% CI 0.55-1.91). Our study does not support the hypothesis that higher BMI after endometrial cancer diagnosis is associated with poorer survival.	[Arem, Hannah] George Washington Univ, Sch Publ Hlth, Milken Inst, Washington, DC 20052 USA; [Pfeiffer, Ruth M.; Moore, Steven C.; Brinton, Louise A.; Matthews, Charles E.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Irwin, Melinda L.] Yale Sch Publ Hlth, New Haven, CT USA; [Irwin, Melinda L.] Yale Canc Ctr, New Haven, CT USA; [LaMonte, Michael J.] SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Epidemiol & Environm Hlth, Buffalo, NY USA; [Sarto, Gloria E.] UW Madison Dept Obstet & Gynecol, Madison, WI USA; [Nassir, Rami] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Luo, Juhua] Indiana Univ, Dept Epidemiol & Biostat, Sch Publ Hlth Bloomington, Bloomington, IN 47405 USA; [Chlebowski, Rowan T.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA	George Washington University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yale University; Yale University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of California System; University of California Davis; Indiana University System; Indiana University Bloomington; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute	Arem, H (corresponding author), George Washington Univ, Sch Publ Hlth, Milken Inst, Washington, DC 20052 USA.	hannaharem@gwu.edu	LaMonte, Mike/AAC-9953-2021; Moore, Steven/D-8760-2016; Nassir, Rami/ABC-2996-2021; matthews, Charles e/E-8073-2015	Moore, Steven/0000-0002-8169-1661; matthews, Charles e/0000-0001-8037-3103; luo, juhua/0000-0002-8901-4462	Intramural Research Division of the National Cancer Institute; National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services [HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, HHSN271201100004C]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863, UL1TR001412] Funding Source: NIH RePORTER	Intramural Research Division of the National Cancer Institute; National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding was provided by the Intramural Research Division of the National Cancer Institute; The WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services (through contracts HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, and HHSN271201100004C).	Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Arem H, 2016, CANCER CAUSE CONTROL, V27, P1403, DOI 10.1007/s10552-016-0813-7; Arem H, 2013, JNCI-J NATL CANCER I, V105, P342, DOI 10.1093/jnci/djs530; Arem H, 2013, GYNECOL ONCOL, V128, P181, DOI 10.1016/j.ygyno.2012.10.029; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Courneya KS, 2005, GYNECOL ONCOL, V97, P422, DOI 10.1016/j.ygyno.2005.01.007; Demark-Wahnefried W, 2005, J CLIN ONCOL, V23, P5814, DOI 10.1200/JCO.2005.01.230; Food N, 2007, PHYS ACTIVITY PREVEN; Hewitt M., 2005, CANC PATIENT CANC SU; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Secord AA, 2016, GYNECOL ONCOL, V140, P184, DOI 10.1016/j.ygyno.2015.10.020; von Gruenigen VE, 2006, CANCER-AM CANCER SOC, V107, P2786, DOI 10.1002/cncr.22351; WOLFSON AH, 1992, GYNECOL ONCOL, V45, P142, DOI 10.1016/0090-8258(92)90276-O; World Cancer Research Fund International, 2014, DIET NUTR PHYS ACT B; Wyatt SB, 2006, AM J MED SCI, V331, P166, DOI 10.1097/00000441-200604000-00002	15	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171250	10.1371/journal.pone.0171250	http://dx.doi.org/10.1371/journal.pone.0171250			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152055	Green Submitted, gold, Green Published			2022-12-27	WOS:000396161200115
J	Chang, HC; Yang, HC; Chang, HY; Yeh, CJ; Chen, HH; Huang, KC; Pan, WH				Chang, Heng-Cheng; Yang, Hsin-Chou; Chang, Hsing-Yi; Yeh, Chih-Jung; Chen, Hsin-Hung; Huang, Kuo-Chin; Pan, Wen-Harn			Morbid obesity in Taiwan: Prevalence, trends, associated social demographics, and lifestyle factors	PLOS ONE			English	Article							BODY-MASS INDEX; DIETARY PATTERNS; PHYSICAL-ACTIVITY; NUTRITION TRANSITION; PUBLIC-HEALTH; RISK-FACTORS; EPIDEMIC; WEIGHT; ADULTS; OVERWEIGHT	Objective Obesity is one of the most important public health issues worldwide. Moreover, an extreme phenotype, morbid obesity (MO) has insidiously become a global problem. Therefore, we aimed to document the prevalence trend and to unveil the epidemiological characteristics of MO in Taiwan. Methods Nationally representative samples aged 19 years and above from three consecutive waves of Nutrition and Health survey in Taiwan: 1993-1996, 2005-2008, and 2013-2014 (n = 3,071; 1,673; and 1,440; respectively) were analyzed for prevalence trend. And 39 MO (BMI >= 35 kg/m(2)) cases from the two recent surveys compared with 156 age, gender, and survey-matched normal weight controls (BMI: 18.5-24 kg/m(2)) for epidemiological characteristics study. The reduced rank regression analysis was used to find dietary pattern associated with MO. Results The prevalence of overweight and obesity together (BMI >= 24 kg/m(2) was stabilized in the recent two surveys, but that of MO (0.4%, 0.6%, to 1.4%) and obesity (BMI >= 27 kg/m(2)) (11.8%, 17.9%, to 22.0%) increased sharply. MO cases tended to have lower levels of education, personal income, and physical activity. Furthermore, their dietary pattern featured with a higher consumption frequency of red meat, processed animal products, and sweets/sweetened beverage, but lower frequencies of fresh fruits, nuts, breakfast cereal, and dairy products. Conclusion This study documents a polarization phenomenon with smaller proportion of overweight people at the center and higher proportions of normal weight and obesity subjects at two extremes. MO was associated with low socioeconomic status and poor dietary pattern. The obesogenic dietary pattern became more prevalent in later time.	[Chang, Heng-Cheng; Pan, Wen-Harn] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chang, Heng-Cheng; Pan, Wen-Harn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Yang, Hsin-Chou] Acad Sinica, Inst Stat Sci, Taipei, Taiwan; [Chang, Hsing-Yi; Pan, Wen-Harn] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan Township, Miaoli County, Taiwan; [Yeh, Chih-Jung] Chung Shan Med Univ, Sch Publ Hlth, Taichung, Taiwan; [Chen, Hsin-Hung] Chang Jung Christian Univ, Dept Nutr & Hlth Sci, Tainan, Taiwan; [Huang, Kuo-Chin] Natl Taiwan Univ Hosp & Coll Med, Dept Family Med, Taipei, Taiwan	National Defense Medical Center; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Health Research Institutes - Taiwan; Chung Shan Medical University; Chang Jung Christian University; National Taiwan University; National Taiwan University Hospital	Pan, WH (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.; Pan, WH (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.; Pan, WH (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan Township, Miaoli County, Taiwan.	pan@ibms.sinica.edu.tw	Yang, Hsin-Chou/AAP-2547-2021; Pan, Wen-Harn/F-9972-2010; Yeh, Cj/AFC-0951-2022	Yang, Hsin-Chou/0000-0001-6853-7881; Pan, Wen-Harn/0000-0001-9136-0658; 	Department of Health [DOH FN8202, DOH-83-FS-41, DOH-84-FS-11, DOH-85-FS-11, DOH-86-FS-11, DOH-94-FS-6-4, DOH102-HP-1703]; Health Promotion Administration, Ministry of Health and Welfare in Taiwan [MOHW103-HPA-H-114-124710]	Department of Health; Health Promotion Administration, Ministry of Health and Welfare in Taiwan	This project was funded by Department of Health [DOH FN8202, DOH-83-FS-41, DOH-84-FS-11, DOH-85-FS-11, DOH-86-FS-11, DOH-94-FS-6-4, and DOH102-HP-1703] and Health Promotion Administration, Ministry of Health and Welfare in Taiwan [MOHW103-HPA-H-114-124710].	Appannah G, 2015, NUTR METAB CARDIOVAS, V25, P643, DOI 10.1016/j.numecd.2015.04.007; Bell LK, 2015, NUTRIENTS, V7, P6491, DOI 10.3390/nu7085295; BOUCHARD C, 1991, AM J CLIN NUTR, V53, pS1561, DOI 10.1093/ajcn/53.6.1561S; Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535; Bray GA, 2014, DIABETES CARE, V37, P950, DOI 10.2337/dc13-2085; Colquitt JL, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003641.pub4; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Drewnowski A, 2005, AM J CLIN NUTR, V82, p265S, DOI 10.1093/ajcn/82.1.265S; Finkelstein EA, 2012, AM J PREV MED, V42, P563, DOI 10.1016/j.amepre.2011.10.026; Fung TT, 2001, AM J CLIN NUTR, V73, P61; Giskes K, 2010, OBES REV, V11, P413, DOI 10.1111/j.1467-789X.2009.00658.x; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hawkes C, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-4; Hennekens C.H., 1987, EPIDEMIOLOGY MED; Hoffmann K, 2004, AM J EPIDEMIOL, V159, P935, DOI 10.1093/aje/kwh134; Hou XH, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-389; Lahti-Koski M, 2012, CLIN OBES, V2, P57, DOI 10.1111/j.1758-8111.2012.00035.x; Lao XQ, 2015, INT J OBESITY, V39, P288, DOI 10.1038/ijo.2014.95; Lee YS, 2009, ANN ACAD MED SINGAP, V38, P45; Lien N, 2010, PUBLIC HEALTH NUTR, V13, P1680, DOI 10.1017/S1368980010002223; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Manios Y, 2010, EUR J CLIN NUTR, V64, P1407, DOI 10.1038/ejcn.2010.168; Marques-Vidal P, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-87; Martin-Rodriguez E, 2015, OBES RES CLIN PRACT, V9, P435, DOI 10.1016/j.orcp.2015.04.003; Neovius M, 2008, INT J OBESITY, V32, P832, DOI 10.1038/sj.ijo.0803784; Ng SW, 2012, OBES REV, V13, P659, DOI 10.1111/j.1467-789X.2011.00982.x; Pan WH, 2012, ASIA PAC J CLIN NUTR, V21, P577; Pan WenHarn, 1999, Nutritional Sciences Journal, V24, P1; Pingali P, 2007, FOOD POLICY, V32, P281, DOI 10.1016/j.foodpol.2006.08.001; Popkin BM, 2014, OBES REV, V15, P60, DOI 10.1111/obr.12120; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Rokholm B, 2010, OBES REV, V11, P835, DOI 10.1111/j.1467-789X.2010.00810.x; SALLIS JF, 1985, AM J EPIDEMIOL, V121, P91, DOI 10.1093/oxfordjournals.aje.a113987; San-Cristobal R, 2015, NUTRIENTS, V7, P9523, DOI 10.3390/nu7115482; Shu L, 2015, NUTRIENTS, V7, P7995, DOI 10.3390/nu7095376; Ng SW, 2012, EMPIR ECON, V42, P413, DOI 10.1007/s00181-012-0547-7; Sturm R, 2007, PUBLIC HEALTH, V121, P492, DOI 10.1016/j.puhe.2007.01.006; Swinburn BA, 2004, PUBLIC HEALTH NUTR, V7, P123, DOI 10.1079/PHN2003585; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Tu SH, 2011, ASIA PAC J CLIN NUTR, V20, P225; Tucker C., 2013, NATIONS HLTH, V43, P23; Twells Laurie K, 2014, CMAJ Open, V2, pE18, DOI 10.9778/cmajo.20130016; Visscher TLS, 2015, INT J OBESITY, V39, P189, DOI 10.1038/ijo.2014.98; Visscher TLS, 2001, ANNU REV PUBL HEALTH, V22, P355, DOI 10.1146/annurev.publhealth.22.1.355; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; (WHO) WHO, 2002, DIET NUTR PREV CHRON, DOI [10.2337/dc13-2085, DOI 10.2337/DC13-2085]; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x; World Health Organization,, 2015, OB OV	53	100	101	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0169577	10.1371/journal.pone.0169577	http://dx.doi.org/10.1371/journal.pone.0169577			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152059	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200009
J	Diamantino-Miranda, J; Aguiar, SI; Carrico, JA; Melo-Cristino, J; Ramirez, M				Diamantino-Miranda, Jorge; Aguiar, Sandra Isabel; Carrico, Joao Andre; Melo-Cristino, Jose; Ramirez, Mario			Clonal and serotype dynamics of serogroup 6 isolates causing invasive pneumococcal disease in Portugal: 1999-2012	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; INFECTIONS; PREVALENCE; LOCUS	Although serogroup 6 was among the first to be recognized among Streptococcus pneumoniae, several new serotypes were identified since the introduction of pneumococcal conjugate vaccines (PCVs). A decrease of the 6B-2 variant among invasive pneumococcal disease (IPD), but not 6B-1, was noted post conjugate vaccine introduction, underpinned by a decrease of CC273 isolates. Serotype 6C was associated with adult IPD and increased in this age group representing two lineages (CC315 and CC395), while the same lineages expressed other serogroup 6 serotypes in children. Taken together, these findings suggest a potential cross-protection of PCVs against serotype 6C IPD among vaccinated children but not among adults. Serotype 6A became the most important serogroup 6 serotype in children but it decreased in adult IPD. No other serogroup 6 serotypes were detected, so available phenotypic or simple genotypic assays remain adequate for distinguishing serotypes within serogroup 6 isolates.	[Diamantino-Miranda, Jorge; Aguiar, Sandra Isabel; Carrico, Joao Andre; Melo-Cristino, Jose; Ramirez, Mario] Univ Lisbon, Fac Med, Inst Med Mol, Ave Prof Egas Moniz, Lisbon, Portugal; [Aguiar, Sandra Isabel] Univ Lisbon, Fac Med Vet, CIISA, Ave Univ Tecn, Lisbon, Portugal	Instituto Superior de Ciencias da Saude Egas Moniz; Universidade de Lisboa; Universidade de Lisboa	Ramirez, M (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, Ave Prof Egas Moniz, Lisbon, Portugal.	ramirez@medicina.ulisboa.pt	Melo-Cristino, Jose A G/H-3726-2013; Aguiar, Sandra Isabel Rodrigues/A-3500-2009; Carriço, Joao André/A-7367-2008; Ramirez, Mario/B-4993-2008	Melo-Cristino, Jose A G/0000-0001-8643-1722; Aguiar, Sandra Isabel Rodrigues/0000-0002-3041-383X; Carriço, Joao André/0000-0002-5274-2722; Ramirez, Mario/0000-0002-4084-6233; Miranda, Jorge/0000-0001-9128-2047	Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/81766/2011, SFRH/BPD/78376/2011, PTDC/DTP-EPI/1759/2012, PTDC/DTP-EPI/1555/2014]	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	J. Diamantino-Miranda and S.I. Aguiar were supported by grants SFRH/BD/81766/2011 and SFRH/BPD/78376/2011, respectively, from Fundacao para a Ciencia e Tecnologia, Portugal. The work was partly supported by Fundacao para a Ciencia e Tecnologia, Portugal (PTDC/DTP-EPI/1759/2012 and PTDC/DTP-EPI/1555/2014) and an unrestricted Investigator initiated project from Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar SI, 2008, CLIN MICROBIOL INFEC, V14, P835, DOI 10.1111/j.1469-0691.2008.02031.x; Aguiar SI, 2014, EUROSURVEILLANCE, V19, P18, DOI 10.2807/1560-7917.ES2014.19.12.20750; Aguiar SI, 2010, VACCINE, V28, P5167, DOI 10.1016/j.vaccine.2010.06.008; Baek JY, 2014, J CLIN MICROBIOL, V52, P2096, DOI 10.1128/JCM.00228-14; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bratcher PE, 2011, MICROBIOL-SGM, V157, P189, DOI 10.1099/mic.0.043901-0; Brito DA, 2003, J CLIN MICROBIOL, V41, P2378, DOI 10.1128/JCM.41.6.2378-2384.2003; Burton RL, 2016, J CLIN MICROBIOL, V54, P967, DOI 10.1128/JCM.03194-15; Carrico JA, 2006, J CLIN MICROBIOL, V44, P2524, DOI 10.1128/JCM.02536-05; Clinical and Laboratory Standards Institute, 2007, PERF STAND ANT SUS S; Clinical and Laboratory Standards Institute, 2014, PERF STAND ANT SUS S; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Horacio AN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153602; Horacio AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073704; Horacio AN, 2012, VACCINE, V30, P218, DOI 10.1016/j.vaccine.2011.11.022; Kawaguchiya M, 2015, MICROB DRUG RESIST, V21, P209, DOI 10.1089/mdr.2014.0181; Loman NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064731; Marimon JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149047; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Nascimento M, 2016, BIOINFORMAT IN PRESS; Nunes S, 2009, J CLIN MICROBIOL, V47, P472, DOI 10.1128/JCM.01984-08; Rolo D, 2011, J ANTIMICROB CHEMOTH, V66, P1712, DOI 10.1093/jac/dkr193; Serrano I, 2004, CLIN MICROBIOL INFEC, V10, P652, DOI 10.1111/j.1469-0691.2004.00869.x; van der Linden M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060848	24	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170354	10.1371/journal.pone.0170354	http://dx.doi.org/10.1371/journal.pone.0170354			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152029	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161200021
J	Huang, CJ; Sun, YC; Christopher, K; Pai, ASI; Lu, CJ; Hu, FR; Lin, SY; Chen, WL				Huang, Chien-Jung; Sun, Yi-Chen; Christopher, Karen; Pai, Amy Shih-I; Lu, Chia-Ju; Hu, Fung-Rong; Lin, Szu-Yuan; Chen, Wei-Li			Comparison of corneal epitheliotrophic capacities among human platelet lysates and other blood derivatives	PLOS ONE			English	Article							SERUM EYE DROPS; MESENCHYMAL STEM-CELLS; FETAL BOVINE SERUM; SEVERE DRY EYE; AUTOLOGOUS-SERUM; GROWTH-FACTORS; EPITHELIAL-CELLS; PLASMA; RICH; EXPANSION	Purpose To evaluate the corneal epitheliotropic abilities of two commercialized human platelet lysates (HPLs) and to compare the results with other blood derivatives, including human peripheral serum (HPS) and bovine fetal serum (FBS). Methods In vitro, human corneal epithelial cells were incubated in various concentrations (0%, 3%, 5% and 10%) of blood derivatives. Two commercialized HPLs, including UltraGRO TM (Helios, Atlanta, GA) and PLTMax (Mill Creek, Rochester, MI), were tested and compared with HPS and FBS. Scratch-induced directional wounding assay was performed to evaluate cellular migration. MTS assay was used to evaluate cellular proliferation. Cellular differentiation was examined by scanning electron microscopy, inverted microscopy and transepithelial electrical resistance. Sprague-Dawley rats were used to evaluate the effects of the blood derivatives on corneal epithelial wound healing in vivo. Different blood derivatives were applied topically every 2 hours for 2 days after corneal epithelial debridement. The concentrations of epidermal growth factor (EGF), transforming growth factor -beta 1 (TGF-beta 1), fibronectin, platelet-derived growth factor-AB (PDGF-AB), PDGF-BB, and hyaluronic acid in different blood derivatives were evaluated by enzyme-linked immunosorbent assay (ELISA). Results In vitro experiments demonstrated statistically comparable epitheliotropic characteristics in cellular proliferation, migration, and differentiation for the two commercialized HPLs compared to FBS and HPS. Cells cultured without any serum were used as control group. The epitheliotropic capacities were statistically higher in the two commercialized HPLs compared to the control group (p<0.05). Among the different concentrations of blood derivatives, the preparations with 3% yielded better outcomes compared to 5% and 10%. In rats, HPLs also caused improved but not statistically significant wound healing compared to HPS. All the blood derivatives had better wound healing ratios than the control group (p< 0.05). In the quantification of epitheliotropic factors, UltraGRO and PLTMax had significantly higher levels of EGF, TGF-beta 1, fibronectin than human peripheral serum (p< 0.05). Conclusions Both commercialized HPLs showed comparable corneal epitheliotropic abilities and wound healing rates compared to HPS and FBS in the in vivo and in vitro studies. Our results suggest that HPLs may have the potential to replace HPS in the treatment of corneal epithelial problems.	[Huang, Chien-Jung; Lu, Chia-Ju; Hu, Fung-Rong; Chen, Wei-Li] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan; [Sun, Yi-Chen] Taipei Tzu Chi Gen Hosp, Dept Ophthalmol, Buddhist Tzu Chi Med Fdn, New Taipei, Taiwan; [Christopher, Karen] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Pai, Amy Shih-I] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Hu, Fung-Rong; Chen, Wei-Li] Natl Taiwan Univ Hosp, Ctr Corneal Tissue Engn & Stem Cell Biol, Taipei, Taiwan; [Lin, Szu-Yuan] Cathay Gen Hosp, Dept Ophthalmol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; Buddhist Tzu Chi General Hospital; Taipei Tzu Chi Hospital; University of Michigan System; University of Michigan; University of Sydney; National Taiwan University; National Taiwan University Hospital; Cathay General Hospital	Chen, WL (corresponding author), Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan.; Chen, WL (corresponding author), Natl Taiwan Univ Hosp, Ctr Corneal Tissue Engn & Stem Cell Biol, Taipei, Taiwan.; Lin, SY (corresponding author), Cathay Gen Hosp, Dept Ophthalmol, Taipei, Taiwan.	szuyuan13@cgh.org.tw; chenweili@ntu.edu.tw		Sun, Yi-Chen/0000-0002-3247-0774; CHEN, WEI-LI/0000-0002-1538-2414; Christopher, Karen/0000-0001-6085-5412; HU, FUNG-RONG/0000-0002-2102-5317				Aggarwal S, 2015, OCUL SURF, V13, P250, DOI 10.1016/j.jtos.2015.01.005; Anitua E, 2006, TRENDS BIOTECHNOL, V24, P227, DOI 10.1016/j.tibtech.2006.02.010; Anitua E, 2015, ACTA OPHTHALMOL, V93, pE605, DOI 10.1111/aos.12710; [Anonymous], 2011, WHO TECH REP SERIES, P148; ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; Atashi F, 2015, TISSUE ENG PART C-ME, V21, P253, DOI [10.1089/ten.tec.2014.0206, 10.1089/ten.TEC.2014.0206]; Ben Azouna N, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt97; Bhowmick NA, 2001, J BIOL CHEM, V276, P46707, DOI 10.1074/jbc.M106176200; Bradley JC, 2009, CORNEA, V28, P200, DOI 10.1097/ICO.0b013e318186321e; Brown SM, 2005, AM J OPHTHALMOL, V140, P565, DOI 10.1016/j.ajo.2005.03.067; Chen YM, 2010, AM J OPHTHALMOL, V150, P352, DOI 10.1016/j.ajo.2010.03.024; Geremicca W, 2010, BLOOD TRANSFUS-ITALY, V8, P107, DOI 10.2450/2009.0091-09; Golebiewska EM, 2015, BLOOD REV, V29, P153, DOI 10.1016/j.blre.2014.10.003; Goto E, 2001, CORNEA, V20, P807, DOI 10.1097/00003226-200111000-00006; Haber M, 2003, VET OPHTHALMOL, V6, P211, DOI 10.1046/j.1463-5224.2003.00296.x; Hartwig D, 2005, TRANSFUSION MED, V15, P107, DOI 10.1111/j.0958-7578.2005.00559.x; Honma Y, 1997, EXP EYE RES, V65, P391, DOI 10.1006/exer.1997.0338; Hussain M, 2014, CORNEA, V33, P1245, DOI 10.1097/ICO.0000000000000271; Hwang J, 2014, CORNEA, V33, P663, DOI 10.1097/ICO.0000000000000147; Imanishi J, 2000, PROG RETIN EYE RES, V19, P113, DOI 10.1016/S1350-9462(99)00007-5; Iudicone P, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-28; Klenkler B, 2007, OCUL SURF, V5, P228, DOI 10.1016/S1542-0124(12)70613-4; Kojima T, 2008, CORNEA, V27, pS25, DOI 10.1097/ICO.0b013e31817f3a0e; Lekhanont K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/521315; Li HM, 2013, INT J NEUROSCI, V123, P184, DOI 10.3109/00207454.2012.742077; Lu L, 2001, EXP BIOL MED, V226, P653, DOI 10.1177/153537020222600711; Matsumoto Y, 2004, OPHTHALMOLOGY, V111, P1115, DOI 10.1016/j.ophtha.2003.10.019; Mojica-Henshaw MP, 2013, CYTOTHERAPY, V15, P1458, DOI 10.1016/j.jcyt.2013.06.014; Nishida T, 2010, EYE CONTACT LENS, V36, P300, DOI 10.1097/ICL.0b013e3181f016d0; Noda-Tsuruya T, 2006, J REFRACT SURG, V22, P61, DOI 10.3928/1081-597X-20060101-13; Nurden AT, 2008, FRONT BIOSCI-LANDMRK, V13, DOI 10.2741/2947; Ogawa Y, 2003, BONE MARROW TRANSPL, V31, P579, DOI 10.1038/sj.bmt.1703862; Perez-Ilzarbe M, 2009, TRANSFUSION, V49, P1901, DOI 10.1111/j.1537-2995.2009.02226.x; Van Pham P, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt277; Reichl S, 2008, J PHARM PHARMACOL, V60, P299, DOI 10.1211/jpp.60.3.0004; Rocha EM, 2000, BONE MARROW TRANSPL, V25, P1101, DOI 10.1038/sj.bmt.1702334; Saika S, 2004, AM J PATHOL, V164, P651, DOI 10.1016/S0002-9440(10)63153-7; Sandri G, 2012, INT J PHARMACEUT, V426, P1, DOI 10.1016/j.ijpharm.2011.12.059; Schallmoser K, 2007, TRANSFUSION, V47, P1436, DOI 10.1111/j.1537-2995.2007.01220.x; Semeraro F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/826970; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Shen EP, 2011, CORNEA, V30, P208, DOI 10.1097/ICO.0b013e3181eadb67; Shih DTB, 2015, NEW BIOTECHNOL, V32, P199, DOI 10.1016/j.nbt.2014.06.001; Soni NG, 2015, BRIT J OPHTHALMOLOGY; Stenwall PA, 2015, ACTA OPHTHALMOL, V93, P654, DOI 10.1111/aos.12801; Takamura E, 2002, ADV EXP MED BIOL, V506, P1247; Tsubota K, 1999, BRIT J OPHTHALMOL, V83, P390, DOI 10.1136/bjo.83.4.390; Tsubota K, 1999, OPHTHALMOLOGY, V106, P1984, DOI 10.1016/S0161-6420(99)90412-8; Vajpayee RB, 2003, BRIT J OPHTHALMOL, V87, P1312, DOI 10.1136/bjo.87.11.1312; Xia WJ, 2011, CELL BIOL INT, V35, P639, DOI 10.1042/CBI20100361; Ziakas NG, 2010, CLIN EXP OPHTHALMOL, V38, P683, DOI 10.1111/j.1442-9071.2010.02304.x	51	19	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171008	10.1371/journal.pone.0171008	http://dx.doi.org/10.1371/journal.pone.0171008			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152010	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161200070
J	Jorgensen, TS; Turesson, C; Kapetanovic, M; Englund, M; Turkiewicz, A; Christensen, R; Bliddal, H; Geborek, P; Kristensen, LE				Jorgensen, Tanja Schjodt; Turesson, Carl; Kapetanovic, Meliha; Englund, Martin; Turkiewicz, Aleksandra; Christensen, Robin; Bliddal, Henning; Geborek, Pierre; Kristensen, Lars Erik			EQ-5D utility, response and drug survival in rheumatoid arthritis patients on biologic monotherapy: A prospective observational study of patients registered in the south Swedish SSATG registry	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; MINIMALLY IMPORTANT DIFFERENCES; RANDOMIZED CONTROLLED-TRIALS; DANISH DANBIO REGISTRY; CLINICAL-PRACTICE; METHOTREXATE MONOTHERAPY; COMBINATION THERAPY; ETANERCEPT; EFFICACY; SWEDEN	Objectives Biologic agents have dramatically changed treatment of rheumatoid arthritis (RA). To date only scarce head-to-head data exist especially when the biological therapies are given as monotherapy without concomitant disease modifying drugs (DMARDs). Thus the objective of the current study is to evaluate treatment response of all available biological therapies with special focus on utility (EQ-5D-3L) and drug survival of biologic DMARDs (bDMARDs) prescribed as monotherapy in RA patients in southern Sweden. Materials and methods All RA patients registered in a regional database as initiating bDMARD as monotherapy, i.e. without concomitant conventional synthetic DMARDs (csDMARDs), from 1st of January 2006 through 31st of December 2012, were included. Patients were followed from initiation of the first dose of bDMARD monotherapy treatment until withdrawal from treatment, loss of follow-up or 31st of December 2012. Descriptive statistics for utility (EQ-5D-3L), effectiveness, and drug survival of bDMARD monotherapy were calculated. Results During the study period, a total of 554 patients were registered in SSATG as initiating bDMARD monotherapy. Most of the patients were women (81%), with a mean age of 57 years. The average disease duration was more than 12 years, and on average the patients had previously been treated with approximately four different csDMARDs. Fifty-five percent of the patients were initiating their first bDMARD, 26% their second, and 19% their third or more. At baseline the average EQ-5D-3L was 0.34. Most patients had moderate to high disease activity, with a mean DAS28 of 5.0, and were substantially disabled, with an average HAQ score of 1.4. At 6 months A follow-up, the EQ-5D-3L in patients still on the biologic drug had increased by mean 0.23 (SD 0.4) with no differences between type of bDMARD (p = 0.49). The mean change in EQ-5D-3L ranged from 0.11 (rituximab and infliximab) to 0.42 (tocilizumab). Although the changes were numerically different, no distinct pattern favored any particular bDMARD for EQ-5D-3L (p = 0.49) or other clinical outcomes. Overall, DAS28 defined remission and low disease activity were achieved in 20% and 43% of patients, respectively. Drug survival rates were statistically significantly different between bDMARDs (p = 0.01), with the highest rates observed for rituximab, followed by etanercept. After failing first course of anti-TNF, patients switching to another mode of action had significantly higher drug survival than those switching to a second course of anti-TNF therapy (p = 0.02). Conclusions Utility (EQ-5D-3L) increased after 6 months of all bDMARD treatments in monotherapy, indicating improvement of patients' quality of life. After failure of anti-TNF treatment in monotherapy, switching to another mode of action may be associated with better drug survival than starting a second TNF-inhibitor.	[Jorgensen, Tanja Schjodt; Christensen, Robin; Bliddal, Henning; Kristensen, Lars Erik] Copenhagen Univ Hosp, Parker Inst, Bispebjerg, Denmark; [Jorgensen, Tanja Schjodt; Christensen, Robin; Bliddal, Henning; Kristensen, Lars Erik] Copenhagen Univ Hosp, Parker Inst, Frederiksberg, Denmark; [Jorgensen, Tanja Schjodt; Christensen, Robin; Bliddal, Henning; Kristensen, Lars Erik] Copenhagen Univ Hosp, Parker Inst, Copenhagen, Denmark; [Turesson, Carl; Kristensen, Lars Erik] Lund Univ, Rheumatol, Dept Clin Sci, Malmo, Sweden; [Turesson, Carl; Kapetanovic, Meliha; Geborek, Pierre] Lund Univ, Dept Clin Sci, Rheumatol Sect, Lund, Sweden; [Turesson, Carl; Kapetanovic, Meliha; Geborek, Pierre] Skane Univ Hosp, Lund, Sweden; [Kapetanovic, Meliha; Geborek, Pierre] Lund Univ, Dept Clin Sci, Rheumatol, Lund, Sweden; [Englund, Martin; Turkiewicz, Aleksandra] Lund Univ, Dept Clin Sci, Clin Epidemiol Unit, Orthopaed, Lund, Sweden	University of Copenhagen; University of Copenhagen; University of Copenhagen; Lund University; Lund University; Lund University; Skane University Hospital; Lund University; Lund University	Jorgensen, TS (corresponding author), Copenhagen Univ Hosp, Parker Inst, Bispebjerg, Denmark.	Tanja.Schjoedt.Joergensen@regionh.dk	Kristensen, Lars Erik/AAZ-2615-2020; Bliddal, Henning/AAB-3168-2019; Turesson, Carl/HII-9728-2022; Englund, Martin/J-7245-2012; C Kapetanovic, Meliha/H-7818-2016	Bliddal, Henning/0000-0002-7951-1668; Englund, Martin/0000-0003-3320-2437; C Kapetanovic, Meliha/0000-0002-7853-514X; Christensen, Robin/0000-0002-6600-0631	Oak Foundation [OCAY-13-309]; NordForsk; Swedish Rheumatism Association; Swedish Research Council; Lund University	Oak Foundation; NordForsk; Swedish Rheumatism Association; Swedish Research Council(Swedish Research CouncilEuropean Commission); Lund University	This study was supported by a core grant from the Oak Foundation (OCAY-13-309), NordForsk, the Swedish Rheumatism Association, the Swedish Research Council and Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askling J, 2013, ANN RHEUM DIS, V72, P455; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Chatzidionysiou K, 2015, ANN RHEUM DIS, V74, P890, DOI 10.1136/annrheumdis-2013-204714; Dorner T, 2013, ANN RHEUM DIS, V72, P322, DOI 10.1136/annrheumdis-2012-202715; Emery P, 2014, ANN RHEUM DIS; Fleischmann R, 2009, ANN RHEUM DIS, V68, P805, DOI 10.1136/ard.2008.099291; Geborek P, 2005, ANN RHEUM DIS, V64, P1805, DOI 10.1136/ard.2005.036715; Gomez-Reino JJ, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1881; Gulfe A, 2010, ANN RHEUM DIS, V69, P352, DOI 10.1136/ard.2008.103473; Hetland ML, 2010, ARTHRITIS RHEUM-US, V62, P22, DOI 10.1002/art.27227; Hyrich KL, 2007, ARTHRITIS RHEUM-US, V56, P13, DOI 10.1002/art.22331; Jorgensen TS, 2015, RHEUMATOLOGY OXFORD; Karlsson JA, 2011, ANN RHEUM DIS, V70, P2163, DOI 10.1136/ard.2011.153437; Kay J, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4469; Keystone EC, 2009, ANN RHEUM DIS, V68, P789, DOI 10.1136/ard.2008.099010; Kim SK, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0227-3; Kobelt G, 2008, EUR J HEALTH ECON, V8, pS95, DOI 10.1007/s10198-007-0091-0; Kristensen LE, 2007, SCAND J RHEUMATOL, V36, P411, DOI 10.1080/03009740701607067; Kristensen LE, 2011, SCAND J RHEUMATOL, V40, P1, DOI 10.3109/03009742.2010.491834; Kristensen LE, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2084; Kristensen LE, 2006, ARTHRITIS RHEUM, V54, P600, DOI 10.1002/art.21570; Leffers HC, 2011, ANN RHEUM DIS, V70, P1216, DOI 10.1136/ard.2010.140129; Lie E, 2011, ANN RHEUM DIS, V70, P2103, DOI 10.1136/ard.2011.152363; Lundkvist J, 2008, EUR J HEALTH ECON, V8, pS49, DOI 10.1007/s10198-007-0088-8; Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Neovius M, 2013, ANN RHEUM DIS; Nixon RM, 2007, STAT MED, V26, P1237, DOI 10.1002/sim.2624; Pickard AS, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-70; Salliot C, 2009, ANN RHEUM DIS, V68, P1100, DOI 10.1136/ard.2008.093690; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; van der Heijde D, 2006, ARTHRITIS RHEUM-US, V54, P1063, DOI 10.1002/art.21655; van Riel PLCM, 2008, ANN RHEUM DIS, V67, P1104, DOI 10.1136/ard.2006.068585; van Riel PLCM, 2006, ANN RHEUM DIS, V65, P1478, DOI 10.1136/ard.2005.043299; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Walters SJ, 2005, QUAL LIFE RES, V14, P1523, DOI 10.1007/s11136-004-7713-0; Yazici Y, 2008, BULL HOSP JT DIS, V66, P77	37	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0169946	10.1371/journal.pone.0169946	http://dx.doi.org/10.1371/journal.pone.0169946			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151971	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161200011
J	Kim, KH; Yeo, SG; Yoo, BC; Myung, JK				Kim, Kyung-Hee; Yeo, Seung-Gu; Yoo, Byong Chul; Myung, Jae Kyung			Identification of calgranulin B interacting proteins and network analysis in gastrointestinal cancer cells	PLOS ONE			English	Article							RAPAMYCIN-BINDING-PROTEIN; QUANTITATIVE PROTEOMICS; PLASMA-MEMBRANE; NA+/K+-ATPASE; GENE; S100A8/A9; APOPTOSIS; DIFFERENTIATION; DEGRADATION; MRP-14	Calgranulin B is known to be involved in tumor development, but the underlying molecular mechanism is not clear. To gain insight into possible roles of calgranulin B, we screened for calgranulin B-interacting molecules in the SNU-484 gastric cancer and the SNU-81 colon cancer cells. Calgranulin B-interacting partners were identified by yeast two-hybrid and functional information was obtained by computational analysis. Most of the calgranulin B interacting partners were involved in metabolic and cellular processes, and found to have molecular function of binding and catalytic activities. Interestingly, 46 molecules in the network of the calgranulin B-interacting proteins are known to be associated with cancer and FKBP2 was found to interact with calgranulin B in both SNU-484 and SNU-81 cells. Polyubiquitin-C encoded by UBC, which exhibited an interaction with calgranulin B, has been associated with various molecules of the extracellular space and plasma membrane identified in our screening, including Na-K-CI cotransporter 1 and dystonin in SNU-484 cells, and ATPase subunit beta-1 in SNU-81 cells. Our data provide novel insight into the roles of calgranulin B of gastrointestinal cancer cells, and offer new clues suggesting calgranulin B acts as an effector molecule through which the cell can communicate with the tumor microenvironment via polyubiquitin-C.	[Kim, Kyung-Hee] Natl Canc Ctr, Omics Core Lab, Res Inst, Goyang Si, Gyeonggi Do, South Korea; [Kim, Kyung-Hee; Yoo, Byong Chul] Natl Canc Ctr, Colorectal Canc Branch, Res Inst, Goyang Si, Gyeonggi Do, South Korea; [Yeo, Seung-Gu] Soonchunhyang Univ, Coll Med, Dept Radiat Oncol, Cheonan, Chungnam, South Korea; [Myung, Jae Kyung] Natl Canc Ctr, Dept Syst Canc Sci, Grad Sch Canc Sci & Policy, Goyang Si, Gyeonggi Do, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Soonchunhyang University; National Cancer Center - Korea (NCC)	Myung, JK (corresponding author), Natl Canc Ctr, Dept Syst Canc Sci, Grad Sch Canc Sci & Policy, Goyang Si, Gyeonggi Do, South Korea.	jkmyung@ncc.re.kr	Kim, Hyung-Kwan/R-8375-2019; Yeo, Seung-Gu/ABC-1124-2021	Yeo, Seung-Gu/0000-0003-1371-1381; Kim, Kyung-Hee/0000-0003-0214-0296	National Cancer Center, Korea [NCC-1410870-3]; Soonchunhyang University	National Cancer Center, Korea; Soonchunhyang University	This work was supported by grants from the National Cancer Center, Korea (NCC-1410870-3) and the Soonchunhyang University Research Fund.	AguiarPasseti T, 1997, J LEUKOCYTE BIOL, V62, P852, DOI 10.1002/jlb.62.6.852; Algharabli J, 2012, CELL PHYSIOL BIOCHEM, V30, P33, DOI 10.1159/000339047; Andre H, 2008, J BIOL CHEM, V283, P29375, DOI 10.1074/jbc.M805919200; Borsy A, 2009, MOL GENET GENOMICS, V281, P301, DOI 10.1007/s00438-008-0413-7; Bulut GB, 2011, J BIOL CHEM, V286, P6449, DOI 10.1074/jbc.M110.186890; Chastagner P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002735; Dalpe G, 1998, MOL CELL NEUROSCI, V10, P243, DOI 10.1006/mcne.1997.0660; Danielsen JMR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003590; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Garzon-Muvdi T, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001320; Ghavami S, 2010, CELL RES, V20, P314, DOI 10.1038/cr.2009.129; GRIMMOND S, 1995, HUM GENET, V95, P455; Haas BR, 2010, CANCER RES, V70, P5597, DOI 10.1158/0008-5472.CAN-09-4666; HAAS M, 1994, AM J PHYSIOL-CELL PH, V267, pC869, DOI 10.1152/ajpcell.1994.267.4.C869; Hicke L, 1997, FASEB J, V11, P1215, DOI 10.1096/fasebj.11.14.9409540; Ivanchuk SM, 2008, CELL CYCLE, V7, P1836, DOI 10.4161/cc.7.12.6025; JIN YJ, 1991, P NATL ACAD SCI USA, V88, P6677, DOI 10.1073/pnas.88.15.6677; Kapoor S, 2009, INFLAMMATION, V32, P70, DOI 10.1007/s10753-009-9104-8; Kim BC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106182; Kim K, 2016, ONCOTARGET, V7, P20368, DOI 10.18632/oncotarget.7783; LAGASSE E, 1988, MOL CELL BIOL, V8, P2402, DOI 10.1128/MCB.8.6.2402; Lee KA, 2011, J BIOL CHEM, V286, P41530, DOI 10.1074/jbc.M111.248856; Li CS, 2009, BIOCHEM J, V422, P363, DOI 10.1042/BJ20090465; Li Y, 2011, J BIOL CHEM, V286, P32289, DOI 10.1074/jbc.M111.247825; Lorenz E, 2008, RESP MED, V102, P567, DOI 10.1016/j.rmed.2007.11.011; Lu HF, 2008, MOL CELL PROTEOMICS, V7, P1434, DOI 10.1074/mcp.M700478-MCP200; Matsumoto M, 2005, PROTEOMICS, V5, P4145, DOI 10.1002/pmic.200401280; Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Nakatani Y, 2005, MEDIAT INFLAMM, P280, DOI 10.1155/MI.2005.280; Newton RA, 1998, J IMMUNOL, V160, P1427; Piper RC, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016808; Qin FJ, 2010, PATHOL ONCOL RES, V16, P353, DOI 10.1007/s12253-009-9225-2; Rajasekaran SA, 2010, MOL CANCER THER, V9, P1515, DOI 10.1158/1535-7163.MCT-09-0832; ROTH J, 1992, IMMUNOBIOLOGY, V186, P304, DOI 10.1016/S0171-2985(11)80259-7; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Ryckman C, 2003, ARTHRITIS RHEUM-US, V48, P2310, DOI 10.1002/art.11079; Sehat B, 2008, CANCER RES, V68, P5669, DOI 10.1158/0008-5472.CAN-07-6364; Shibata F, 2004, EUR J BIOCHEM, V271, P2137, DOI 10.1111/j.1432-1033.2004.04129.x; Shiozaki A, 2014, WORLD J GASTROENTERO, V20, P6844, DOI 10.3748/wjg.v20.i22.6844; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Stes E, 2014, J PROTEOME RES, V13, P3107, DOI 10.1021/pr4012443; Sun PL, 2015, QJM; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tan FW, 2008, PROTEOMICS, V8, P2885, DOI 10.1002/pmic.200700887; Tummala R, 2009, CANCER CHEMOTH PHARM, V64, P1187, DOI 10.1007/s00280-009-0985-x; Wagemans J, 2015, METHODS MOL BIOL, V1278, P409, DOI 10.1007/978-1-4939-2425-7_27; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Yoo BC, 2008, DIS COLON RECTUM, V51, P1703, DOI 10.1007/s10350-008-9381-6; Yoshimura SH, 2008, J CELL SCI, V121, P2159, DOI 10.1242/jcs.022905; Zhou FF, 2008, J BIOL CHEM, V283, P14506, DOI 10.1074/jbc.M706136200	51	5	5	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171232	10.1371/journal.pone.0171232	http://dx.doi.org/10.1371/journal.pone.0171232			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152021	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161200112
J	Mayall, P; Pilbrow, V; Bitadze, L				Mayall, Peter; Pilbrow, Varsha; Bitadze, Liana			Migrating Huns and modified heads: Eigenshape analysis comparing intentionally modified crania from Hungary and Georgia in the Migration Period of Europe	PLOS ONE			English	Article							DEFORMATION; ARCHAEOLOGY	An intentionally modified head is a visually distinctive sign of group identity. In the Migration Period of Europe (4(th)-7(th) century AD) the practice of intentional cranial modification was common among several nomadic groups, but was strongly associated with the Huns from the Carpathian Basin in Hungary, where modified crania are abundant in archaeological sites. The frequency of modified crania increased substantially in the Mtskheta region of Georgia in this time period, but there are no records that Huns settled here. We compare the Migration Period modified skulls from Georgia with those from Hungary to test the hypothesis that the Huns were responsible for cranial modification in Georgia. We use extended eigenshape analysis to quantify cranial outlines, enabling a discriminant analysis to assess group separation and identify morphological differences. Twenty-one intentionally modified skulls from Georgia are compared with sixteen from Hungary, using nineteen unmodified crania from a modern population as a comparative baseline. Results indicate that modified crania can be differentiated from modern unmodified crania with 100% accuracy. The Hungarian and Georgian crania show some overlap in shape, but can be classified with 81% accuracy. Shape gradations along the main eigenvectors indicate that the Hungarian crania show little variation in cranial shape, in accordance with a two-bandage binding technique, whereas the Georgian crania had a wider range of variation, fitting with a diversity of binding styles. As modification style is a strong signifier of social identity, our results indicate weak Hunnic influence on cranial modification in Georgia and are equivocal about the presence of Huns in Georgia. We suggest instead that other nomadic groups such as Alans and Sarmatians living in this region were responsible for modified crania in Georgia.	[Mayall, Peter; Pilbrow, Varsha] Univ Melbourne, Parkville, Vic, Australia; [Bitadze, Liana] Ivane Javakhishvili Inst Hist & Ethnol, Tbilisi, Georgia	University of Melbourne; Ivane Javakhishvili Tbilisi State University	Pilbrow, V (corresponding author), Univ Melbourne, Parkville, Vic, Australia.	vpilbrow@unimelb.edu.au	Pilbrow, Varsha/AAI-9897-2020	Pilbrow, Varsha/0000-0002-6677-9390	American Association of Physical Anthropology Professional Development Grant	American Association of Physical Anthropology Professional Development Grant	VP received some funding from the American Association of Physical Anthropology Professional Development Grant.	Ascadi G., 1970, HIST HUMAN LIFESPAN; Barth F, 1998, PRISON THEATRE PERSP, P9; Blom DE, 2005, J ANTHROPOL ARCHAEOL, V24, P1, DOI 10.1016/j.jaa.2004.10.001; Buikstra J.E., 1994, STANDARDS DATA COLLE, DOI 10.1002/ajhb.1310070519; Clark JL, 2007, INT J OSTEOARCHAEOL, V17, P596, DOI 10.1002/oa.910; Dembo A., 1938, DEFORMACIONES INTENC; Dingwall EJ, 1931, ARTIFICIAL CRANIAL D; Friess M, 2003, AM J PHYS ANTHROPOL, V122, P11, DOI 10.1002/ajpa.10286; Furtwangler A., 2008, IBERIA ROME EXCAVATI; Gerszten PC, 1993, INT J OSTEOARCHEOL, V3, P87, DOI DOI 10.1002/OA.1390030205; Goffart W, 2006, MIDDLE AGES SER, P1; Halsall G, 2007, CAMB MEDIEV TEXTB, P371; Heinrich-Tamaska Orsolya, 2011, KESZTHELY FENEKPUSZT, P457; Jones R., 2006, HUMANITYS MIRROR 150; Joyce RA, 2005, ANNU REV ANTHROPOL, V34, P139, DOI 10.1146/annurev.anthro.33.070203.143729; Kallenberger L, 2012, J ANAT, V221, P459, DOI 10.1111/j.1469-7580.2012.01558.x; Khudaverdyan A., 2011, ANTHROPOL REV, V74, P39; Kiszely I., 1978, INT SERIES S, V50; Knudson KJ, 2008, J ARCHAEOL RES, V16, P397, DOI 10.1007/s10814-008-9024-4; Krieger J, 2008, EXTENDED EIGENSHAPE; Krieger J, 2008, INT MATH S; Lamont M, 2002, ANNU REV SOCIOL, V28, P167, DOI 10.1146/annurev.soc.28.110601.141107; MacLeod N, 1999, PALEOBIOLOGY, V25, P107; MacLeod N., 2012, PALAEONTOL NEWSL, V80, P32; MacLeod N, 2012, PALAEONTOL NEWSL, V81, P23; Martin R, 1957, SYSTEMATISSCHER DARS; Meikelejohn C., 1992, PAL ORIENT, V18, P83, DOI [10.3406/paleo.1992.4574, DOI 10.3406/PALEO.1992.4574]; Molnar M, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.1.FOCUS13466; Muller R., 2003, HUNGARIAN ARCHAEOLOG, P289; Odor JG, 2011, KESZTHELY FENEKPUSZT, P347; Ozbek M, 2001, AM J PHYS ANTHROPOL, V115, P238, DOI 10.1002/ajpa.1078; Perez SI, 2007, J ARCHAEOL SCI, V34, P1649, DOI 10.1016/j.jas.2006.12.003; Rohlf J., 2004, TPS SERIES SOFTWARE; SAGONA A., 2010, ANCIENT NEAR E STUDI, V47, P1; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Tiesler V, 2014, INTERD CONTRIB ARCH, V7, P1, DOI 10.1007/978-1-4614-8760-9; Tiesler V, 2012, J ANTHROPOL SCI, V90, P33, DOI 10.4436/jass.90007; Torres-Rouff C, 2002, CURR ANTHROPOL, V43, P163, DOI 10.1086/338290; Toth Agnes B., 2003, HUNGARIAN ARCHAEOLOG, P294; Weik TM, 2014, ANNU REV ANTHROPOL, V43, P291, DOI 10.1146/annurev-anthro-102313-025920; Werner J., 1956, THESIS; ZAHN CT, 1972, IEEE T COMPUT, VC 21, P269, DOI 10.1109/TC.1972.5008949; Zar JH, 1999, BIOSTATISTICAL ANAL; Zhirov E, 1940, KRATKIE SOOBSHENIZ I	44	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171064	10.1371/journal.pone.0171064	http://dx.doi.org/10.1371/journal.pone.0171064			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28152046	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161200082
J	Pan, X; Bowman, M; Scott, RJ; Fitter, J; Smith, R; Zakar, T				Pan, Xin; Bowman, Maria; Scott, Rodney J.; Fitter, John; Smith, Roger; Zakar, Tamas			Promoter Methylation Pattern Controls Corticotropin Releasing Hormone Gene Activity in Human Trophoblasts	PLOS ONE			English	Article							DNA METHYLATION; HISTONE ACETYLATION; CPG METHYLATION; HUMAN PLACENTA; EXPRESSION; TRANSCRIPTION; CHROMATIN; BINDING	Placental CRH production increases with advancing pregnancy in women and its course predicts gestational length. We hypothesized that CRH gene expression in the placenta is epigenetically controlled setting gestational trajectories characteristic of normal and pathological pregnancies. Here we determined histone modification and DNA methylation levels and DNA methylation patterns at the CRH promoter in primary trophoblast cultures by chromatin immunoprecipitation combined with clonal bisulfite sequencing and identified the transcriptionally active epialleles that associate with particular histone modifications and transcription factors during syncytialisation and cAMP-stimulation. CRH gene expression increased during syncytial differentiation and cAMP stimulation, which was associated with increased activating and decreased repressive histone modification levels at the promoter. DNA methylation levels remained unchanged. The nine CpGs of the CRH proximal promoter were partially and allele-independently methylated displaying many (>100) epialleles. RNA-polymerase-II (Pol-II) bound only to three particular epialleles in cAMP-stimulated cells, while phospho-cAMP response element-binding protein (pCREB) bound to only one epiallele, which was different from those selected by Pol-II. Binding of TATA-binding protein increased during syncytial differentiation preferentially at epialleles compatible with Pol-II and pCREB binding. Histone-3 acetylation was detected only at epialleles targeted by Pol-II and pCREB, while gene activating histone-4 acetylation and histone-3-lysine-4 trimethylation occurred at CRH epialleles not associated with Pol-II or pCREB. The suppressive histone-3-lysine-27 trimethyl and-lysine-9 trimethyl modifications showed little or no epiallele preference. The epiallele selectivity of activating histone modifications and transcription factor binding demonstrates the epigenetic and functional diversity of the CRH gene in trophoblasts, which is controlled predominantly by the patterns, not the overall extent, of promoter methylation. We propose that conditions impacting on epiallele distribution influence the number of transcriptionally active CRH gene copies in the trophoblast cell population determining the gestational trajectory of placental CRH production in normal and pathological pregnancies.	[Pan, Xin; Bowman, Maria; Fitter, John; Smith, Roger; Zakar, Tamas] Hunter Med Res Inst, Mothers & Babies Res Ctr, New Lambton Hts, NSW, Australia; [Pan, Xin; Scott, Rodney J.; Fitter, John; Smith, Roger; Zakar, Tamas] Univ Newcastle, Fac Hlth & Med, Prior Res Ctr Reprod Sci, Callaghan, NSW, Australia; [Scott, Rodney J.] Hunter Area Pathol Serv, Mol Med, New Lambton Hts, NSW, Australia; [Smith, Roger; Zakar, Tamas] John Hunter Hosp, New Lambton Hts, NSW, Australia; [Pan, Xin] Chongqing Med Univ, Dept Obstet & Gynaecol, Affiliated Hosp 2, Chongqing, Peoples R China	Hunter Medical Research Institute; University of Newcastle; University of Newcastle; John Hunter Hospital; Chongqing Medical University	Zakar, T (corresponding author), Hunter Med Res Inst, Mothers & Babies Res Ctr, New Lambton Hts, NSW, Australia.; Zakar, T (corresponding author), Univ Newcastle, Fac Hlth & Med, Prior Res Ctr Reprod Sci, Callaghan, NSW, Australia.; Zakar, T (corresponding author), John Hunter Hosp, New Lambton Hts, NSW, Australia.	Tamas.Zakar@newcastle.edu.au	Zakar, Tamas/G-7507-2013; Scott, Rodney/B-2827-2013	Smith, Roger/0000-0003-4720-0280; Scott, Rodney/0000-0001-7724-3404; Zakar, Tamas/0000-0002-1690-1159; Bowman, Maria/0000-0002-2333-7883	China Scholarship Council (CRC); School of Medicine and Public Health Research Training Scheme (RTS), The University of Newcastle, Australia	China Scholarship Council (CRC)(China Scholarship Council); School of Medicine and Public Health Research Training Scheme (RTS), The University of Newcastle, Australia	X.P. received support from the China Scholarship Council (CRC) and the School of Medicine and Public Health Research Training Scheme (RTS), The University of Newcastle, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER GK, 1990, MOL CELL ENDOCRINOL, V70, P165, DOI 10.1016/0303-7207(90)90156-3; Aparicio Oscar, 2005, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2103s69; Berger RL, 1996, AM STAT, V50, P314, DOI 10.2307/2684927; Cheng YH, 2000, J CLIN ENDOCR METAB, V85, P1239, DOI 10.1210/jc.85.3.1239; COUTIFARIS C, 1991, ANN NY ACAD SCI, V622, P191; Di Stefano V, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa9806; Elliott E, 2010, NAT NEUROSCI, V13, P1351, DOI 10.1038/nn.2642; Elliott G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7363; Fogarty NME, 2011, J ANAT, V219, P601, DOI 10.1111/j.1469-7580.2011.01417.x; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; King BR, 2002, MOL CELL ENDOCRINOL, V194, P19, DOI 10.1016/S0303-7207(02)00218-6; King BR, 2001, PEPTIDES, V22, P795, DOI 10.1016/S0196-9781(01)00393-X; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Landan G, 2012, NAT GENET, V44, P1207, DOI 10.1038/ng.2442; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Li YY, 2011, METHODS MOL BIOL, V791, P239, DOI 10.1007/978-1-61779-316-5_18; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majzoub JA, 1995, ANN NY ACAD SCI, V771, P293, DOI 10.1111/j.1749-6632.1995.tb44689.x; McGill BE, 2006, P NATL ACAD SCI USA, V103, P18267, DOI 10.1073/pnas.0608702103; MCLEAN M, 1995, NAT MED, V1, P460, DOI 10.1038/nm0595-460; Mitchell CM, 2008, MOL HUM REPROD, V14, P53, DOI 10.1093/molehr/gam086; Mitchell C, 2011, ENDOCRINOLOGY, V152, P2113, DOI 10.1210/en.2010-1327; Nicholson RC, 2004, FRONT BIOSCI, V9, P32, DOI 10.2741/1204; Nicholson RC, 2001, FRONT HORM RES, V27, P246; Pan X, 2015, INT J ENDOCRINOL, V2015, P1; RILEY SC, 1991, J CLIN ENDOCR METAB, V72, P1001, DOI 10.1210/jcem-72-5-1001; Rishi V, 2010, P NATL ACAD SCI USA, V107, P20311, DOI 10.1073/pnas.1008688107; Scatena CD, 1998, MOL ENDOCRINOL, V12, P1228, DOI 10.1210/me.12.8.1228; Schroeder DI, 2013, P NATL ACAD SCI USA, V110, P6037, DOI 10.1073/pnas.1215145110; Sehringer B, 2005, ANAL BIOANAL CHEM, V383, P768, DOI 10.1007/s00216-005-0067-9; Smith R, 1999, J CLIN ENDOCR METAB, V84, P2820, DOI 10.1210/jc.84.8.2820; Smith R, 2012, TRENDS ENDOCRIN MET, V23, P516, DOI 10.1016/j.tem.2012.05.002; Smolle M, 2013, BBA-GENE REGUL MECH, V1829, P84, DOI 10.1016/j.bbagrm.2012.08.008; SPENGLER D, 1992, MOL ENDOCRINOL, V6, P1931, DOI 10.1210/me.6.11.1931; Statham AL, 2012, GENOME RES, V22, P1120, DOI 10.1101/gr.132076.111; Wang AY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094394; Wang B, 2012, MOL ENDOCRINOLOGY; Wang BB, 2012, MOL ENDOCRINOL, V26, P1356, DOI 10.1210/me.2012-1035; Wang ZB, 2009, CURR OPIN GENET DEV, V19, P127, DOI 10.1016/j.gde.2009.02.001; Williamson DS, 1996, ACCIDENT ANAL PREV, V28, P571, DOI 10.1016/0001-4575(96)00023-1; Zinn RL, 2007, CANCER RES, V67, P194, DOI 10.1158/0008-5472.CAN-06-3396	43	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170671	10.1371/journal.pone.0170671	http://dx.doi.org/10.1371/journal.pone.0170671			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151936	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161200032
J	Perez, T; Fernandez, M; Hammer, SE; Dominguez, A				Perez, Trinidad; Fernandez, Margarita; Hammer, Sabine E.; Dominguez, Ana			Multilocus Intron Trees Reveal Extensive Male- Biased Homogenization of Ancient Populations of Chamois (Rupicapra spp.) across Europe during Late Pleistocene	PLOS ONE			English	Article							MITOCHONDRIAL GENOME; BAYESIAN-INFERENCE; PHYLOGENY; SEQUENCE; ORIGIN; PHYLOGEOGRAPHY; CONSERVATION; DIVERGENCE; DISPERSAL; SOFTWARE	The inferred phylogenetic relationships between organisms often depend on the molecular marker studied due to the diverse evolutionary mode and unlike evolutionary histories of different parts of the genome. Previous studies have shown conflicting patterns of differentiation of mtDNA and several nuclear markers in chamois (genus Rupicapra) that indicate a complex evolutionary picture. Chamois are mountain caprine that inhabit most of the medium to high altitude mountain ranges of southern Eurasia. The most accepted taxonomical classification considers two species, R.pyrenaica (with the subspecies parva, pyrenaica and ornata) from southwestern Europe and R. rupicapra (with the subspecies cartusiana, rupicapra, tatrica, carpatica, balcanica, asiatica and caucasica) from northeastern Europe. Phylogenies of mtDNA revealed three very old clades (from the early Pleistocene, 1.9 Mya) with a clear geographical signal. Here we analyze a set of 23 autosomal introns, comprising 15,411 nucleotides, in 14 individuals covering the 10 chamois subspecies. Introns offered an evolutionary scenario that contrasts with mtDNA. The nucleotidic diversity was 0.0013 +/- 0.0002, at the low range of what is found in other mammals even if a single species is considered. A coalescent multilocus analysis with * BEAST indicated that introns diversified 88 Kya, in the late Pleistocene, and the effective population size at the root was lower than 10,000 individuals. The dispersal of some few migrant males should have rapidly spread trough the populations of chamois, given the homogeneity of intron sequences. The striking differences between mitochondrial and nuclear markers can be attributed to strong female philopatry and extensive male dispersal. Our results highlight the need of analyzing multiple and varied genome components to capture the complex evolutionary history of organisms.	[Perez, Trinidad; Fernandez, Margarita; Dominguez, Ana] Univ Oviedo, Dept Biol Func, Julian Claveria 6, Oviedo, Spain; [Hammer, Sabine E.] Univ Vet Med Vienna, Dept Pathobiol, Inst Immunol, Vet Pl 1, Vienna, Austria	University of Oviedo; University of Veterinary Medicine Vienna	Dominguez, A (corresponding author), Univ Oviedo, Dept Biol Func, Julian Claveria 6, Oviedo, Spain.	sanjurjo@uniovi.es	Dominguez, Ana/E-4412-2010; Pérez, Trinidad/AAC-6729-2019	Dominguez, Ana/0000-0002-8610-5553; Pérez, Trinidad/0000-0003-1216-5593; Hammer, Sabine/0000-0003-1475-3938	Ministerio de Economia y Competitividad. Spain [CGL2011-25117]	Ministerio de Economia y Competitividad. Spain(Spanish Government)	Funded by Ministerio de Economia y Competitividad. Spain. (grant number CGL2011-25117).	Alves PC, 2008, PHILOS T R SOC B, V363, P2831, DOI 10.1098/rstb.2008.0053; Arnold M. L., 2004, WILSON Q, V2004, P60; Arnold ML, 2009, RETICULATE EVOLUTION, Vxii; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bibi F, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-166; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Bouckaert RR, 2010, BIOINFORMATICS, V26, P1372, DOI 10.1093/bioinformatics/btq110; Cabrera A., 1914, FAUNA IBERICA MAMIFE, Vxviii; Camerano A., 1914, MEM R ACCAD SCI SFMN, V64, P1; Cohen KM, 2013, EPISODES, V36, P199, DOI 10.18814/epiiugs/2013/v36i3/002; Corlatti L, 2011, MAMMAL REV, V41, P163, DOI 10.1111/j.1365-2907.2011.00187.x; Couturier MAJ, 1938, LE CHAMOIS; Cregut-Bonnoure E, 2007, QUATERNAIRE, V18, P73; Crestanello B, 2009, J HERED, V100, P691, DOI 10.1093/jhered/esp053; Dmitriev DA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000113; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fernandez Philippe, 2007, Revue de Paleobiologie, V26, P425; GAILLARD JM, 1992, ONGULES / UNGULATES 91, P493; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Groves C, 2011, UNGULATE TAXONOMY; Grubb P., 1993, MAMMAL SPECIES WORLD, P374; Hailer F, 2012, SCIENCE, V336, P344, DOI 10.1126/science.1216424; Hammer S, 1995, ACTA THERIOL, P145; Hassanin A, 2013, MOL PHYLOGENET EVOL, V66, P766, DOI 10.1016/j.ympev.2012.11.003; Hedrick PW, 2013, MOL ECOL, V22, P4606, DOI 10.1111/mec.12415; Heled J, 2013, BEAST BEAST 2 0 ESTI; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Ho SYW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001615; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Igea J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-369; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Kutschera VE, 2014, MOL BIOL EVOL, V31, P2004, DOI 10.1093/molbev/msu186; Kutschera VE, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-114; Lalueza-Fox C, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-70; Leffler EM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001388; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindqvist C, 2010, P NATL ACAD SCI USA, V107, P5053, DOI 10.1073/pnas.0914266107; Loison A, 1999, J MAMMAL, V80, P620, DOI 10.2307/1383306; Lovari S., 1987, P51; Lovari S, 1980, B ZOOL, V47, P12; Lovari S, 1985, SAUGETIERKUNDLICHE M, V32, P113; MASINI F, 1988, QUATERNARY RES, V30, P339, DOI 10.1016/0033-5894(88)90009-9; Miller C, 1986, Z JAGDWISS, V33, P220; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Nascetti G., 1985, P56; NEWTON MA, 1994, J R STAT SOC B, V56, P3; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PEMBERTON JM, 1989, Z SAUGETIERKD, V54, P243; Perez T, 1996, BIOCHEM GENET, V34, P313, DOI 10.1007/BF02399950; Perez T, 2002, MOL PHYLOGENET EVOL, V25, P524, DOI 10.1016/S1055-7903(02)00296-8; Perez T, 2014, MOL PHYLOGENET EVOL, V79, P375, DOI 10.1016/j.ympev.2014.07.004; Perez T, 2013, MOL PHYLOGENET EVOL, V67, P621, DOI 10.1016/j.ympev.2013.02.027; Perez T, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-272; PerezBarberia FJ, 1996, Z SAUGETIERKD, V61, P276; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A., 2009, FIGTREE TREE FIGURE; Rambaut A., 2007, TRACER V1 4; Rodriguez F, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-222; Rodriguez F, 2009, J HERED, V100, P47, DOI 10.1093/jhered/esn074; Rook L, 2010, QUATERN INT, V219, P134, DOI 10.1016/j.quaint.2010.01.007; Ropiquet A, 2005, MOL PHYLOGENET EVOL, V36, P154, DOI 10.1016/j.ympev.2005.01.002; Ropiquet A, 2006, MOL PHYLOGENET EVOL, V41, P395, DOI 10.1016/j.ympev.2006.05.033; Schaschl H, 2005, IMMUNOGENETICS, V57, P108, DOI 10.1007/s00251-005-0784-4; Schaschl H, 2003, HEREDITY, V91, P125, DOI 10.1038/sj.hdy.6800290; SLATKIN M, 1981, GENETICS, V99, P323; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; TAJIMA F, 1983, GENETICS, V105, P437; Tonini J, 2015, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.34260cc27551a527b124ec5f6334b6be; Valdez R., 2011, HDB MAMMALS WORLD HO, V2, P741; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107	76	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0170392	10.1371/journal.pone.0170392	http://dx.doi.org/10.1371/journal.pone.0170392			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146581	Green Published, gold, Green Submitted			2022-12-27	WOS:000396131700022
J	Sieuwerts, AM; Schrijver, WAME; Dalm, SU; de Weerd, V; Moelans, CB; ter Hoeve, N; van Diest, PJ; Martens, JWM; van Deurzen, CHM				Sieuwerts, Anieta M.; Schrijver, Willemijne A. M. E.; Dalm, Simone U.; de Weerd, Vanja; Moelans, Cathy B.; ter Hoeve, Natalie; van Diest, Paul J.; Martens, John W. M.; van Deurzen, Carolien H. M.			Progressive APOBEC3B mRNA expression in distant breast cancer metastases	PLOS ONE			English	Article							DELETION POLYMORPHISM; RECEPTOR CONVERSION; ENZYMATIC SOURCE; UP-REGULATION; MUTAGENESIS; DEAMINATION; MUTATIONS; CARCINOMA; PATTERNS; ALPHA	Background APOBEC3B was recently identified as a gain-of-function enzymatic source of mutagenesis, which may offer novel therapeutic options with molecules that specifically target this enzyme. In primary breast cancer, APOBEC3B mRNA is deregulated in a substantial proportion of cases and its expression is associated with poor prognosis. However, its expression in breast cancer metastases, which are the main causes of breast cancer-related death, remained to be elucidated. Patients and methods RNA was isolated from 55 primary breast cancers and paired metastases, including regional lymph node (N = 20) and distant metastases (N = 35). APOBEC3B mRNA levels were measured by RT-qPCR. Expression levels of the primary tumors and corresponding metastases were compared, including subgroup analysis by estrogen receptor (ER/ESR1) status. Results Overall, APOBEC3B mRNA levels of distant metastases were significantly higher as compared to the corresponding primary breast tumor (P = 0.0015), an effect that was not seen for loco-regional lymph node metastases (P = 0.23). Subgroup analysis by ER-status showed that increased APOBEC3B levels in distant metastases were restricted to metastases arising from ER-positive primary breast cancers (P = 0.002). However, regarding ERnegative primary tumors, only loco-regional lymph node metastases showed increased APOBEC3B expression when compared to the corresponding primary tumor (P = 0.028). Conclusion APOBEC3B mRNA levels are significantly higher in breast cancer metastases as compared to the corresponding ER-positive primary tumors. This suggests a potential role for APOBEC3B in luminal breast cancer progression, and consequently, a promising role for antiAPOBEC3B therapies in advanced stages of this frequent form of breast cancer.	[Sieuwerts, Anieta M.; de Weerd, Vanja; Martens, John W. M.] Erasmus MC, Erasmus MC Canc Inst, Dept Med Oncol, Rotterdam, Netherlands; [Sieuwerts, Anieta M.; Martens, John W. M.] Erasmus MC, Erasmus MC Canc Inst, Canc Genom Ctr, Rotterdam, Netherlands; [Schrijver, Willemijne A. M. E.; Moelans, Cathy B.; ter Hoeve, Natalie; van Diest, Paul J.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Dalm, Simone U.] Erasmus MC, Dept Radiol & Nucl Med, Rotterdam, Netherlands; [van Deurzen, Carolien H. M.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Sieuwerts, AM (corresponding author), Erasmus MC, Erasmus MC Canc Inst, Dept Med Oncol, Rotterdam, Netherlands.; Sieuwerts, AM (corresponding author), Erasmus MC, Erasmus MC Canc Inst, Canc Genom Ctr, Rotterdam, Netherlands.	a.sieuwerts@erasmusmc.nl		Dalm, Simone/0000-0002-6393-6901	Cancer Genomics Netherlands; Netherlands Organization of Scientific Research (NWO)	Cancer Genomics Netherlands; Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was supported by Cancer Genomics Netherlands (AMS and JWMM) and Netherlands Organization of Scientific Research (NWO) (JWMM). The supporters had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.	[Anonymous], 2012, BREAST CANCER GUIDEL; Burns MB, 2015, BIOMED J, V38, P102, DOI 10.4103/2319-4170.148904; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Cescon DW, 2015, P NATL ACAD SCI USA, V112, P2841, DOI 10.1073/pnas.1424869112; Chan K, 2015, NAT GENET, V47, P1067, DOI 10.1038/ng.3378; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Gwak M, 2014, TUMORI J, V100, pE112, DOI [10.1177/1636.17922, 10.1700/1636.17922]; Harris RS, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-014-0498-3; Henderson S, 2014, CELL REP, V7, P1833, DOI 10.1016/j.celrep.2014.05.012; Hoefnagel LDC, 2013, ANN ONCOL, V24, P3017, DOI 10.1093/annonc/mdt390; Hoefnagel LDC, 2012, CANCER-AM CANCER SOC, V118, P4929, DOI 10.1002/cncr.27518; Hoefnagel LDC, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2645; Jin Z, 2014, ONCOL REP, V32, P1867, DOI 10.3892/or.2014.3437; Jiwa LS, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-864; Kosumi K, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0739-7; Kroigard AB, 2016, BREAST J, V22, P420, DOI 10.1111/tbj.12596; Kuong KJ, 2013, NAT GENET, V45, P964, DOI 10.1038/ng.2736; Land AM, 2015, ONCOTARGET, V6, P39969, DOI 10.18632/oncotarget.5483; Leonard B, 2013, CANCER RES, V73, P7222, DOI 10.1158/0008-5472.CAN-13-1753; Morganella S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11383; Nowarski R, 2013, CANCER RES, V73, P3494, DOI 10.1158/0008-5472.CAN-13-0728; Periyasamy M, 2015, CELL REP, V13, P108, DOI 10.1016/j.celrep.2015.08.066; Rebhandl Stefan, 2015, Oncoscience, V2, P320; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Schrijver WAME, 2015, BREAST CANCER RES TR, V151, P41, DOI 10.1007/s10549-015-3362-y; Sieuwerts AM, 2014, HORM CANCER-US, V5, P405, DOI 10.1007/s12672-014-0196-8; Tsuboi M, 2016, BREAST CANCER-TOKYO, V23, P780, DOI 10.1007/s12282-015-0641-8; van Diest PJ, 2002, BMJ-BRIT MED J, V325, P648, DOI 10.1136/bmj.325.7365.648; Wolff AC, 2014, ARCH PATHOL LAB MED, V138, P241, DOI 10.5858/arpa.2013-0953-SA; Xuan D, 2013, CARCINOGENESIS, V34, P2240, DOI 10.1093/carcin/bgt185; Zhang J, 2015, INT J CLIN EXP PATHO, V8, P5089; Zhang YF, 2015, HUM GENOMICS, V9, DOI 10.1186/s40246-015-0056-9	35	18	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171343	10.1371/journal.pone.0171343	http://dx.doi.org/10.1371/journal.pone.0171343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141868	Green Published, gold, Green Submitted			2022-12-27	WOS:000396129500056
J	Karhula, SS; Finnila, MA; Lammi, MJ; Ylarinne, JH; Kauppinen, S; Rieppo, L; Pritzker, KPH; Nieminen, HJ; Saarakkala, S				Karhula, Sakari S.; Finnila, Mikko A.; Lammi, Mikko J.; Ylarinne, Janne H.; Kauppinen, Sami; Rieppo, Lassi; Pritzker, Kenneth P. H.; Nieminen, Heikki J.; Saarakkala, Simo			Effects of Articular Cartilage Constituents on Phosphotungstic Acid Enhanced Micro-Computed Tomography	PLOS ONE			English	Article							CT ARTHROGRAPHY; MATRIX METALLOPROTEINASES; GLYCOSAMINOGLYCAN CONTENT; COLLAGEN; QUANTITATION; CLEAVE; SITES	Contrast-enhanced micro-computed tomography (CE mu CT) with phosphotungstic acid (PTA) has shown potential for detecting collagen distribution of articular cartilage. However, the selectivity of the PTA staining to articular cartilage constituents remains to be elucidated. The aim of this study was to investigate the dependence of PTA for the collagen content in bovine articular cartilage. Adjacent bovine articular cartilage samples were treated with chondroitinase ABC and collagenase to degrade the proteoglycan and the collagen constituents in articular cartilage, respectively. Enzymatically degraded samples were compared to the untreated samples using CE mu CT and reference methods, such as Fourier-transform infrared imaging. Decrease in the X-ray attenuation of PTA in articular cartilage and collagen content was observed in cartilage depth of 0-13% and deeper in tissue after collagen degradation. Increase in the X-ray attenuation of PTA was observed in the cartilage depth of 13- 39% after proteoglycan degradation. The X-ray attenuation of PTA-labelled articular cartilage in CE mu CT is associated mainly with collagen content but the proteoglycans have a minor effect on the X-ray attenuation of the PTA-labelled articular cartilage. In conclusion, the PTA labeling provides a feasible CE mu CT method for 3D characterization of articular cartilage.	[Karhula, Sakari S.; Finnila, Mikko A.; Kauppinen, Sami; Rieppo, Lassi; Nieminen, Heikki J.; Saarakkala, Simo] Univ Oulu, Res Unit Med Imaging Phys & Technol, Fac Med, Oulu, Finland; [Karhula, Sakari S.] Univ Oulu, Infotech Doctoral Program, Oulu, Finland; [Finnila, Mikko A.] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland; [Finnila, Mikko A.; Rieppo, Lassi; Saarakkala, Simo] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland; [Finnila, Mikko A.; Rieppo, Lassi; Saarakkala, Simo] Univ Oulu, Oulu, Finland; [Lammi, Mikko J.; Ylarinne, Janne H.] Umea Univ, Dept Integrat Med Biol, Umea, Sweden; [Lammi, Mikko J.] Xi An Jiao Tong Univ, Key Lab Trace Elements & Endem Dis, Natl Hlth & Family Planning Commiss, Sch Publ Hlth,Hlth Sci Ctr, Xian, Peoples R China; [Pritzker, Kenneth P. H.; Nieminen, Heikki J.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Pritzker, Kenneth P. H.] Mt Sinai Hosp, Toronto, ON, Canada; [Nieminen, Heikki J.] Univ Helsinki, Dept Phys, Helsinki, Finland; [Saarakkala, Simo] Oulu Univ Hosp, Dept Diagnost Radiol, Oulu, Finland	University of Oulu; University of Oulu; University of Eastern Finland; University of Oulu; University of Oulu; Umea University; Xi'an Jiaotong University; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Helsinki; University of Oulu	Karhula, SS (corresponding author), Univ Oulu, Res Unit Med Imaging Phys & Technol, Fac Med, Oulu, Finland.; Karhula, SS (corresponding author), Univ Oulu, Infotech Doctoral Program, Oulu, Finland.	sakari.karhula@oulu.fi	Lammi, Mikko/B-9291-2008; Nieminen, Heikki J./AGX-8430-2022; Karhula, Sakari/AAL-8862-2021; Finnila, Mikko/X-6492-2019; Rieppo, Lassi/AAP-2538-2020; Saarakkala, Simo/F-5839-2013	Lammi, Mikko/0000-0002-6181-9904; Nieminen, Heikki J./0000-0001-6084-1272; Saarakkala, Simo/0000-0003-2850-5484; Finnila, Mikko/0000-0002-3348-5759	European Research Council [336267]; Suomen Akatemia (Academy of Finland) [273571, 253579, 268378]; Sigfrid Juselius Stiftelse (Sigfrid Juselius Foundation)	European Research Council(European Research Council (ERC)European Commission); Suomen Akatemia (Academy of Finland); Sigfrid Juselius Stiftelse (Sigfrid Juselius Foundation)	This work was supported by: European Research Council (https://erc.europa.eu/), grant no: 336267, SS; Suomen Akatemia (Academy of Finland, http://www.aka.fi/en/), grant no: 273571, SS; Suomen Akatemia (Academy of Finland, http://www.aka.fi/en/), grant no: 253579, HJN; Suomen Akatemia (Academy of Finland, http://www.aka.fi/en/), grant no: 268378, SS; Sigfrid Juselius Stiftelse (Sigfrid Juselius Foundation, http://www.sigridjuselius.fi/foundation), grant no: N/A, SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The financial support from the Academy of Finland (grants no. 268378, 273571, 253579); Sigrid Juselius Foundation; European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) / ERC Grant Agreement no. 336267; and the strategic funding of the University of Oulu are acknowledged. We thank Veljekset Ronka Oy (Kemi, Finland) for providing the bovine joints.	Bank RA, 2000, ARTHRITIS RHEUM-US, V43, P2202, DOI 10.1002/1529-0131(200010)43:10<2202::AID-ANR7>3.0.CO;2-E; Bansal PN, 2011, J ORTHOP RES, V29, P704, DOI 10.1002/jor.21312; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Boskey A, 2007, BIOMATERIALS, V28, P2465, DOI 10.1016/j.biomaterials.2006.11.043; Camacho NP, 2001, BIOPOLYMERS, V62, P1, DOI 10.1002/1097-0282(2001)62:1<1::AID-BIP10>3.0.CO;2-O; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; FOSANG AJ, 1993, BIOCHEM J, V295, P273, DOI 10.1042/bj2950273; Fox AJS, 2009, SPORTS HEALTH, V1, P461, DOI 10.1177/1941738109350438; Freedman JD, 2014, ANGEW CHEM INT EDIT, V53, P8406, DOI 10.1002/anie.201404519; Hirvasniemi J, 2013, OSTEOARTHR CARTILAGE, V21, P434, DOI 10.1016/j.joca.2012.12.009; Joshi NS, 2009, J AM CHEM SOC, V131, P13234, DOI 10.1021/ja9053306; Kallioniemi AS, 2007, PHYS MED BIOL, V52, P1209, DOI 10.1088/0031-9155/52/4/024; KIVIRANTA I, 1985, HISTOCHEMISTRY, V82, P249, DOI 10.1007/BF00501401; Lammi MJ, 2004, J RHEUMATOL, V31, P2449; Loret B, 2010, INT J SOLIDS STRUCT, V47, P2201, DOI 10.1016/j.ijsolstr.2010.04.010; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; NGUYEN Q, 1993, BIOCHEM J, V295, P595, DOI 10.1042/bj2950595; Nieminen HJ, 2015, OSTEOARTHR CARTILAGE, V23, P1613, DOI 10.1016/j.joca.2015.05.004; Omoumi P, 2015, OSTEOARTHR CARTILAGE, V23, P224, DOI 10.1016/j.joca.2014.08.017; Palmer AW, 2006, P NATL ACAD SCI USA, V103, P19255, DOI 10.1073/pnas.0606406103; Pritzker K, 2003, OSTEOARTHRITIS; Qu CJ, 2012, CELL TISSUE RES, V348, P109, DOI 10.1007/s00441-012-1366-z; Rieppo J, 2003, CELLS TISSUES ORGANS, V175, P121, DOI 10.1159/000074628; Saarakkala S, 2010, OSTEOARTHR CARTILAGE, V18, P73, DOI 10.1016/j.joca.2009.08.003; Schmitz N, 2010, OSTEOARTHR CARTILAGE, V18, pS113, DOI 10.1016/j.joca.2010.05.026; Siebelt M, 2011, OSTEOARTHR CARTILAGE, V19, P1183, DOI 10.1016/j.joca.2011.07.006; Silvast TS, 2009, ACTA RADIOL, V50, P78, DOI 10.1080/02841850802572526; Summers GC, 2008, BIORHEOLOGY, V45, P365, DOI 10.3233/BIR-2008-0495; Toyoshima T, 2001, CONNECT TISSUE RES, V42, P281, DOI 10.3109/03008200109016842; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Yoo HJ, 2011, RADIOLOGY, V261, P805, DOI 10.1148/radiol.11102495	31	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171075	10.1371/journal.pone.0171075	http://dx.doi.org/10.1371/journal.pone.0171075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135331	gold, Green Published			2022-12-27	WOS:000396124700046
J	Puccetti, A; Dolcino, M; Tinazzi, E; Moretta, F; D'Angelo, S; Olivieri, I; Lunardi, C				Puccetti, Antonio; Dolcino, Marzia; Tinazzi, Elisa; Moretta, Francesca; D'Angelo, Salvatore; Olivieri, Ignazio; Lunardi, Claudio			Antibodies Directed against a Peptide Epitope of a Klebsiella pneumoniae-Derived Protein Are Present in Ankylosing Spondylitis	PLOS ONE			English	Article							CLASSIFICATION CRITERIA; AXIAL SPONDYLOARTHRITIS; PSORIATIC-ARTHRITIS; AUTOANTIBODIES; COLLAGEN; CELLS; EXPRESSION; CARTILAGE; FEATURES; PROPOSAL	Ankylosing spondylitis (AS) is a chronic inflammatory arthritis of unknown origin. Its autoimmune origin has been suggested but never proven. Several reports have implicated Klebsiella pneumoniae as a triggering or perpetuating factor in AS; however, its role in the disease pathogenesis remains debated. Moreover, despite extensive investigations, a biomarker for AS has not yet been identified. To clarify these issues, we screened a random peptide library with pooled IgGs obtained from 40 patients with AS. A peptide (AS peptide) selected from the library was recognized by serum IgGs from 170 of 200 (85%) patients with AS but not by serum specimens from 100 healthy controls. Interestingly, the AS peptide shows a sequence similarity with several molecules expressed at the fibrocartilaginous sites that are primarily involved in the AS inflammatory process. Moreover, the peptide is highly homologous to a Klebsiella pneumoniae dipeptidase (DPP) protein. The antibody affinity purified against the AS peptide recognizes the autoantigens and the DPP protein. Furthermore, serum IgG antibodies against the Klebsiella DPP121-145 peptide epitope were detected in 190 of 200 patients with AS (95%), 3 of 200 patients with rheumatoid arthritis (1.5%) and only 1 of 100 (1%) patients with psoriatic arthritis. Such reactivity was not detected in healthy control donors. Our results show that antibodies directed against an epitope of a Klebsiella pneumoniae-derived protein are present in nearly all patients with AS. In the absence of serological biomarkers for AS, such antibodies may represent a useful tool in the diagnosis of the disease.	[Puccetti, Antonio; Dolcino, Marzia] Pediat Hosp Bambino Gesu, Immunol Area, Rome, Italy; [Tinazzi, Elisa; Moretta, Francesca; Lunardi, Claudio] Univ Verona, Dept Med, Verona, Italy; [D'Angelo, Salvatore; Olivieri, Ignazio] San Carlo Hosp Potenza, Rheumatol Dept Lucania, Potenza, Italy; [D'Angelo, Salvatore; Olivieri, Ignazio] Madonna delle Grazie Hosp Matera, Rheumatol Dept Lucania, Matera, Italy	IRCCS Bambino Gesu; University of Verona	Puccetti, A (corresponding author), Pediat Hosp Bambino Gesu, Immunol Area, Rome, Italy.	antonio.puccetti@opbg.net	Moretta, Francesca/Z-3169-2019; Tinazzi, Elisa/AAB-9450-2020; D'Angelo, Salvatore/H-9010-2012	Moretta, Francesca/0000-0002-1150-8622; D'Angelo, Salvatore/0000-0002-7442-1110				Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; Breban M, 2004, CURR MOL MED, V4, P31, DOI 10.2174/1566524043479347; Chou MY, 2002, GENOMICS, V79, P395, DOI 10.1006/geno.2002.6712; Coffre M, 2013, ARTHRITIS RHEUM-US, V65, P1510, DOI 10.1002/art.37936; Fert I, 2014, ARTHRITIS RHEUMATOL, V66, P841, DOI 10.1002/art.38318; Frulloni L, 2009, NEW ENGL J MED, V361, P2135, DOI 10.1056/NEJMoa0903068; Kirn-Safran C, 2009, CELL MOL LIFE SCI, V66, P3421, DOI 10.1007/s00018-009-0096-1; Koch M, 2003, J BIOL CHEM, V278, P43236, DOI 10.1074/jbc.M302112200; Locht H, 1999, CLIN EXP IMMUNOL, V117, P568; Lunardi C, 2002, LANCET, V360, P915, DOI 10.1016/S0140-6736(02)11028-2; Lunardi C, 2000, NAT MED, V6, P1183, DOI 10.1038/80533; MakiIkola O, 1996, BRIT J RHEUMATOL, V35, P125; Rashid T, 2007, CLIN RHEUMATOL, V26, P858, DOI 10.1007/s10067-006-0488-7; Rashid T, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/872632; Rashid T, 2011, DISCOV MED, V12, P187; ROSENBERG JN, 1979, ANN RHEUM DIS, V38, P526, DOI 10.1136/ard.38.6.526; Rysnik O, 2016, J AUTOIMMUN, V70, P12, DOI 10.1016/j.jaut.2016.03.009; Sieper J, 2006, BEST PRACT RES CL RH, V20, P401, DOI 10.1016/j.berh.2006.02.001; Talpin A, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0417-0; Tani Y, 1997, CLIN EXP RHEUMATOL, V15, P295; Taurog JD, 2016, NEW ENGL J MED, V374, P2563, DOI 10.1056/NEJMra1406182; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Tran TM, 2015, CURR OPIN RHEUMATOL, V27, P357, DOI 10.1097/BOR.0000000000000188; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Wang J, 2012, EMBO J, V31, P4057, DOI 10.1038/emboj.2012.253; Wellings DA, 1997, METHOD ENZYMOL, V289, P44; Wilusz RE, 2014, MATRIX BIOL, V39, P25, DOI 10.1016/j.matbio.2014.08.009; Wright C, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M9.00384; WU JJ, 1995, J BIOL CHEM, V270, P18865, DOI 10.1074/jbc.270.32.18865; Zanoni G, 2006, PLOS MED, V3, P1637, DOI 10.1371/journal.pmed.0030358	31	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171073	10.1371/journal.pone.0171073	http://dx.doi.org/10.1371/journal.pone.0171073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135336	gold, Green Published, Green Submitted			2022-12-27	WOS:000396124700045
J	Zhang, AG; Lai, HZ; Xu, JH; Huang, WK; Liu, YF; Zhao, DW; Chen, RA				Zhang, Aiguo; Lai, Hanzhang; Xu, Jiahua; Huang, Wenke; Liu, Yufu; Zhao, Dawei; Chen, Ruiai			Evaluation of the Protective Efficacy of Poly I:C as an Adjuvant for H9N2 Subtype Avian Influenza Inactivated Vaccine and Its Mechanism of Action in Ducks	PLOS ONE			English	Article							CELLULAR IMMUNE-RESPONSES; VIRUS INFECTION; INTRANASAL IMMUNIZATION; HUMAN HEALTH; A H9N2; H5N1; CHICKENS; CHINA; CELLS; MICE	Current commercial H9 avian influenza vaccines cannot provide satisfactory protective immunity against antigenic variant influenza viruses in ducks. Poly I:C, when used as an adjuvant, improves humoral and cellular immunity in many animals but has not been tested in ducks. In this study, we investigated the protective efficacy of Poly I:C as an adjuvant for an inactivated H9N2 Avian influenza vaccine in ducks. We found that an H9N2 vaccine administered with poly I:C (H9-PIC vaccine) induced a significantly more rapid response with higher anti-influenza antibody titers than those of the vaccine alone (H9 vaccine). Moreover, virus shedding was reduced in ducks immunized with the H9-PIC vaccine after challenge with an H9 subtype antigenic variant viruses. IFN-alpha, IFN-gamma, IL-6 and MHC-II mRNA levels were all elevated in ducks receiving the H9-PIC vaccine. In addition, lower expression level of MHC-I may be a reason for inefficient protective ability against heterologous influenza viruses in H9-PIC vaccination of ducks. In conclusion, poly I:C adjuvant enhanced both humoral and cellular immune responses in ducks induced by immunization of inactivated H9N2 vaccine.	[Zhang, Aiguo; Liu, Yufu; Zhao, Dawei; Chen, Ruiai] South China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China; [Lai, Hanzhang; Xu, Jiahua; Huang, Wenke] Guangdong Enterprise Key Lab Biotechnol R&D Vet B, Zhaoqing, Guangdong, Peoples R China	South China Agricultural University	Chen, RA (corresponding author), South China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China.	chensa727@126.com			Technology Planning Project of Guangdong Province [20156020230011]	Technology Planning Project of Guangdong Province	This study was supported by the Technology Planning Project of Guangdong Province (Grant No. 20156020230011). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Capua I, 2002, ACTA TROP, V83, P1, DOI 10.1016/S0001-706X(02)00050-5; Chen H, 2003, VACCINE, V21, P4430, DOI 10.1016/S0264-410X(03)00430-4; Deng GH, 2013, J VIROL, V87, P9452, DOI 10.1128/JVI.00776-13; Shen EX, 2007, CELL MOL IMMUNOL, V4, P113; Fusaro A, 2011, J VIROL, V85, P8413, DOI 10.1128/JVI.00219-11; He HQ, 2012, DEV COMP IMMUNOL, V36, P756, DOI 10.1016/j.dci.2011.11.006; Huang ZY, 2012, VET IMMUNOL IMMUNOP, V150, P169, DOI 10.1016/j.vetimm.2012.09.010; Ichinohe T, 2005, J VIROL, V79, P2910, DOI 10.1128/JVI.79.5.2910-2919.2005; Ichinohe T, 2007, J INFECT DIS, V196, P1313, DOI 10.1086/521304; Ichinohe T, 2009, VACCINE, V27, P6276, DOI 10.1016/j.vaccine.2009.04.074; Jin Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1110; Kang H, 2012, POULTRY SCI, V91, P1074, DOI 10.3382/ps.2011-01817; Kang YF, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01283; Kim ED, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137608; Kimble JB, 2011, P NATL ACAD SCI USA, V108, P12084, DOI 10.1073/pnas.1108058108; Kugel D, 2009, J VIROL, V83, P3843, DOI 10.1128/JVI.02453-08; Li XY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004508; Liang JF, 2013, POULTRY SCI, V92, P2651, DOI 10.3382/ps.2013-03193; Liu YF, 2016, AVIAN DIS, V60, P817, DOI 10.1637/11452-061616-Reg; Maas R, 2011, AVIAN PATHOL, V40, P87, DOI 10.1080/03079457.2010.541226; McNally B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051351; Meng SS, 2011, J INTERF CYTOK RES, V31, P533, DOI 10.1089/jir.2010.0123; Neeland MR, 2014, VACCINE, V32, P6183, DOI 10.1016/j.vaccine.2014.09.036; Overton ET, 2014, VACCINE, V32, P5490, DOI 10.1016/j.vaccine.2014.07.078; Park KJ, 2011, J GEN VIROL, V92, P36, DOI 10.1099/vir.0.024992-0; Paul MS, 2012, VACCINE, V30, P4524, DOI 10.1016/j.vaccine.2012.04.033; Sachan S, 2015, VACCINE, V33, P4526, DOI 10.1016/j.vaccine.2015.07.016; Salem ML, 2006, VACCINE, V24, P5119, DOI 10.1016/j.vaccine.2006.04.010; Singh SM, 2015, VACCINE, V33, P3947, DOI 10.1016/j.vaccine.2015.06.043; Sun YP, 2010, VET MICROBIOL, V146, P215, DOI 10.1016/j.vetmic.2010.05.010; Swayne DE, 2009, COMP IMMUNOL MICROB, V32, P351, DOI 10.1016/j.cimid.2008.01.006; Swayne DE, 2001, AVIAN DIS, V45, P355, DOI 10.2307/1592975; Tang YH, 2014, VET MICROBIOL, V172, P120, DOI 10.1016/j.vetmic.2014.05.007; Teng QY, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0372-7; Thomas M, 2015, VACCINE, V33, P542, DOI 10.1016/j.vaccine.2014.11.034; Uchida Y, 2014, J VET MED SCI, V76, P1111, DOI 10.1292/jvms.13-0620; Xu Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100792; Yu SH, 2010, MOL BIOL REP, V37, P1295, DOI 10.1007/s11033-009-9504-8; Zapala L, 2011, ONCOL REP, V25, P831, DOI 10.3892/or.2010.1128; Zhao JC, 2012, J VIROL, V86, P11416, DOI 10.1128/JVI.01410-12; Zhu YB, 2015, ARCH VIROL, V160, P917, DOI 10.1007/s00705-015-2337-y	41	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170681	10.1371/journal.pone.0170681	http://dx.doi.org/10.1371/journal.pone.0170681			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135294	gold, Green Submitted, Green Published			2022-12-27	WOS:000396124700017
J	Tsuji, A; Kuwamura, S; Shirai, A; Yuasa, K				Tsuji, Akihiko; Kuwamura, Shuji; Shirai, Akihiro; Yuasa, Keizo			Identification and Characterization of a 25 kDa Protein That Is Indispensable for the Efficient Saccharification of Eisenia bicyclis in the Digestive Fluid of Aplysia kurodai	PLOS ONE			English	Article							ECKLONIA-STOLONIFERA; ETHANOL-PRODUCTION; SALIVARY PROTEINS; PHLOROTANNINS; POLYPHENOLS; BINDING; MARINE; ENZYME; CLEAVAGE; CHITIN	The digestive fluid of the sea hare Aplysia kurodai can liberate approximately 2.5 mg of glucose from 10 mg of dried Eisenia bicyclis powder. Although laminaran, a major storage polysaccharide in E. bicyclis, is easily digested to glucose by the synergistic action of the 110 and 210 kDa A. kurodai beta-glucosidases (BGLs), glucose is not liberated from E. bicyclis by direct incubation with these BGLs. To clarify this discrepancy, we searched for an Eisenia hydrolysis enhancing protein (EHEP) in the digestive fluid of A. kurodai. A novel 25 kDa protein that enhances E. bicyclis saccharification by beta-glucosidases was purified to a homogeneous state from the digestive fluid of A. kurodai, and its cDNA was cloned from total cDNAs reverse-transcribed from hepatopancreas total RNA. The E. bicyclis extract strongly inhibited BGLs, suggesting some compound within this brown alga functioned as a feeding deterrent. However, when E. bicyclis was incubated with BGLs in the presence of EHEP, glucose production was markedly increased. As E. bicyclis is rich in phlorotannin, which are only found in brown algae, our study suggested that these compounds are the main BGL inhibitors in E. bicyclis extract. EHEP protects BGLs from phlorotannin inhibition by binding to phlorotannins and forming an insoluble complex with phloroglucinol and phlorotannins. These findings indicated that EHEP plays a key role in the saccharification of brown seaweeds containing phlorotannins in the digestive fluid of A. kurodai. This is the first report of EHEP as a phlorotannin-binding protein that protects BGLs from inhibition.	[Tsuji, Akihiko; Kuwamura, Shuji; Yuasa, Keizo] Univ Tokushima, Grad Sch Biosci & Bioind, Dept Biomol Funct & Technol, 2-1 Minamijosanjima, Tokushima, Japan; [Shirai, Akihiro] Univ Tokushima, Grad Sch Biosci & Bioind, Dept Bioresource Chem & Technol, 2-1 Minamijosanjima, Tokushima, Japan	Tokushima University; Tokushima University	Tsuji, A (corresponding author), Univ Tokushima, Grad Sch Biosci & Bioind, Dept Biomol Funct & Technol, 2-1 Minamijosanjima, Tokushima, Japan.	tsuji.akihiko@tokushima-u.ac.jp			Japan Society for the Promotion of Science [26450284]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (jsps.go.jp) to AT (No: 26450284).	Bennick A, 2002, CRIT REV ORAL BIOL M, V13, P184, DOI 10.1177/154411130201300208; Bhadury P, 2004, PLANTA, V219, P561, DOI 10.1007/s00425-004-1307-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brethauer S, 2010, BIORESOURCE TECHNOL, V101, P4862, DOI 10.1016/j.biortech.2009.11.009; CANNELL RJP, 1990, APPL BIOCHEM BIOTECH, V26, P85, DOI 10.1007/BF02798395; Carlsson AS, 2011, EUR J LIPID SCI TECH, V113, P812, DOI 10.1002/ejlt.201100032; Casu R, 1997, P NATL ACAD SCI USA, V94, P8939, DOI 10.1073/pnas.94.17.8939; Chowdhury MTH, 2014, J ENVIRON BIOL, V35, P713; Dutot M, 2012, APPL BIOCHEM BIOTECH, V167, P2234, DOI 10.1007/s12010-012-9761-1; Enquist-Newman M, 2014, NATURE, V505, P239, DOI 10.1038/nature12771; Eom SH, 2012, J SCI FOOD AGR, V92, P2084, DOI 10.1002/jsfa.5585; FUKUYAMA Y, 1989, CHEM PHARM BULL, V37, P349; GAO K, 1994, J APPL PHYCOL, V6, P45, DOI 10.1007/BF02185904; Hannon M, 2010, BIOFUELS-UK, V1, P763, DOI 10.4155/BFS.10.44; Harun R, 2014, BIOTECHNOL J, V9, P73, DOI 10.1002/biot.201200353; Hasunuma T, 2013, BIORESOURCE TECHNOL, V135, P513, DOI 10.1016/j.biortech.2012.10.047; Jasrapuria S, 2010, INSECT BIOCHEM MOLEC, V40, P214, DOI 10.1016/j.ibmb.2010.01.011; Jung HA, 2014, J PHARM PHARMACOL, V66, P1180, DOI 10.1111/jphp.12241; Kawabata S, 1996, J BIOCHEM-TOKYO, V120, P1253; Kellogg J, 2014, MAR DRUGS, V12, P5277, DOI 10.3390/md12105277; Kikuchi Y, 2008, J BIOCHEM, V144, P789, DOI 10.1093/jb/mvn132; Kim SM, 2011, APPL BIOCHEM BIOTECH, V165, P1296, DOI 10.1007/s12010-011-9347-3; Kumagai Y, 2010, COMP BIOCHEM PHYS B, V155, P138, DOI 10.1016/j.cbpb.2009.10.013; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liw Y, 2006, APPL MICROBIOL BIOT, V69, P627, DOI [10.1007/s00253-005-0229-x, DOI 10.1007/S00253-005-0229-X]; Menshova RV, 2014, CARBOHYD POLYM, V99, P101, DOI 10.1016/j.carbpol.2013.08.037; Nelson N, 1944, J BIOL CHEM, V153, P375; Nigam PS, 2011, PROG ENERG COMBUST, V37, P52, DOI 10.1016/j.pecs.2010.01.003; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Park JBK, 2011, BIORESOURCE TECHNOL, V102, P35, DOI 10.1016/j.biortech.2010.06.158; Pereira RC, 1999, BOT MAR, V42, P441, DOI 10.1515/BOT.1999.051; Shen ZC, 1998, J BIOL CHEM, V273, P17665, DOI 10.1074/jbc.273.28.17665; Shibata T, 2004, J APPL PHYCOL, V16, P291, DOI 10.1023/B:JAPH.0000047781.24993.0a; Shibata T., 2014, American Journal of Plant Sciences, V5, P387, DOI 10.4236/ajps.2014.53051; Shibata T, 2002, EUR J PHYCOL, V37, P493, DOI 10.1017/S0967026202003918; Shimada T, 2006, J CHEM ECOL, V32, P1149, DOI 10.1007/s10886-006-9077-0; Siegel B Z, 1973, CRC Crit Rev Microbiol, V3, P1, DOI 10.3109/10408417309108743; Skrt M, 2012, FOOD CHEM, V135, P2418, DOI 10.1016/j.foodchem.2012.06.114; Sotka E. E., 2008, P203, DOI 10.1007/978-3-540-74181-7_10; Sotka EE, 2009, INTEGR COMP BIOL, V49, P291, DOI 10.1093/icb/icp049; STEINBERG PD, 1988, J EXP MAR BIOL ECOL, V120, P221, DOI 10.1016/0022-0981(88)90003-2; SVENNERHOLM L, 1956, J NEUROCHEM, V1, P42, DOI 10.1111/j.1471-4159.1956.tb12053.x; Tsuji A, 2014, FEBS OPEN BIO, V4, P560, DOI 10.1016/j.fob.2014.06.002; Tsuji A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065418; Tsuji A, 2012, COMP BIOCHEM PHYS B, V163, P324, DOI 10.1016/j.cbpb.2012.08.005; Wei N, 2013, TRENDS BIOTECHNOL, V31, P70, DOI 10.1016/j.tibtech.2012.10.009; Yamashita Y, 2010, J BIOSCI BIOENG, V110, P79, DOI 10.1016/j.jbiosc.2009.12.009; YAN QY, 1995, BIOCHEM J, V311, P341, DOI 10.1042/bj3110341	48	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170669	10.1371/journal.pone.0170669	http://dx.doi.org/10.1371/journal.pone.0170669			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129373	Green Published, gold, Green Submitted			2022-12-27	WOS:000396211400047
J	Greer, YE; Gao, B; Yang, YZ; Nussenzweig, A; Rubin, JS				Greer, Yoshimi Endo; Gao, Bo; Yang, Yingzi; Nussenzweig, Andre; Rubin, Jeffrey S.			Lack of Casein Kinase 1 Delta Promotes Genomic Instability - The Accumulation of DNA Damage and Down-Regulation of Checkpoint Kinase 1	PLOS ONE			English	Article							MITOTIC SPINDLE FORMATION; BARDET-BIEDL SYNDROME; CELL-CYCLE ARREST; PROTEIN-KINASE; REPLICATION STRESS; BUDDING YEAST; PHOSPHORYLATION; CHK1; CANCER; ACTIVATION	Casein kinase 1 delta (CK1 delta) is a conserved serine/threonine protein kinase that regulates diverse cellular processes. Mice lacking CK1 delta have a perinatal lethal phenotype and typically weigh 30% less than their wild type littermates. However, the causes of death and small size are unknown. We observed cells with abnormally large nuclei in tissue from Csnk1d null embryos, and multiple centrosomes in mouse embryo fibroblasts (MEFs) deficient in CK1 delta (MEFCsnk1d null). Results from gamma-H2AX staining and the comet assay demonstrated significant DNA damage in MEFCsnk1d null cells. These cells often contain micronuclei, an indicator of genomic instability. Similarly, abrogation of CK1 delta expression in control MEFs stimulated micronuclei formation after doxorubicin treatment, suggesting that CK1 delta loss increases vulnerability to genotoxic stress. Cellular levels of total and activated checkpoint kinase 1 (Chk1), which functions in the DNA damage response and mitotic checkpoints, and its downstream effector, Cdc2/CDK1 kinase, were often decreased in MEFCsnk1d null cells as well as in control MEFs transfected with CK1 delta siRNA. Hydroxyureainduced Chk1 activation, as measured by Ser345 phosphorylation, and nuclear localization also were impaired in MEF cells following siRNA knockdown of CK1 delta. Similar results were observed in the MCF7 human breast cancer cell line. The decreases in phosphorylated Chk1 were rescued by concomitant expression of siRNA-resistant CK1 delta. Experiments with cycloheximide demonstrated that the stability of Chk1 protein was diminished in cells subjected to CK1 delta knockdown. Together, these findings suggest that CK1 delta contributes to the efficient repair of DNA damage and the proper functioning of mitotic checkpoints by maintaining appropriate levels of Chk1.	[Greer, Yoshimi Endo; Rubin, Jeffrey S.] NCI, Cellular & Mol Biol Lab, Bldg 37, Bethesda, MD 20892 USA; [Greer, Yoshimi Endo] NCI, Womens Malignancies Branch, Bethesda, MD 20892 USA; [Gao, Bo; Yang, Yingzi] NHGRI, Genet Dis Res Branch, Bethesda, MD 20892 USA; [Nussenzweig, Andre] NCI, Lab Genome Integr, Bethesda, MD 20892 USA; [Gao, Bo] Univ Hong Kong, Li Ka Shing Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Yang, Yingzi] Harvard Sch Dent Med, Dept Dev Biol, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Hong Kong; Harvard University; Harvard School of Dental Medicine	Greer, YE; Rubin, JS (corresponding author), NCI, Cellular & Mol Biol Lab, Bldg 37, Bethesda, MD 20892 USA.; Greer, YE (corresponding author), NCI, Womens Malignancies Branch, Bethesda, MD 20892 USA.	greery@mail.nih.gov; jeff535@verizon.net	Greer, Yoshimi/K-2155-2019	Gao, Bo/0000-0002-8684-5199	Intramural Research Program of the National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010959, ZIABC010283] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute. It paid the salaries of YEG, AN and JSR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARLTROP JA, 1991, BIOORG MED CHEM LETT, V1, P611, DOI 10.1016/S0960-894X(01)81162-8; Behrend L, 2000, ONCOGENE, V19, P5303, DOI 10.1038/sj.onc.1203939; Behrend L, 2000, EUR J CELL BIOL, V79, P240, DOI 10.1078/S0171-9335(04)70027-8; Bischof J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068803; Bischof J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020857; Calvo E, 2014, INVEST NEW DRUG, V32, P955, DOI 10.1007/s10637-014-0114-5; Chen P, 2000, CELL, V100, P681, DOI 10.1016/S0092-8674(00)80704-7; Cheong JK, 2011, ONCOGENE, V30, P2558, DOI 10.1038/onc.2010.627; Cheong JK, 2011, INT J BIOCHEM CELL B, V43, P465, DOI 10.1016/j.biocel.2010.12.004; Dagon Y, 2001, ONCOGENE, V20, P8045, DOI 10.1038/sj.onc.1204945; Dai Y, 2010, CLIN CANCER RES, V16, P376, DOI 10.1158/1078-0432.CCR-09-1029; Daud AI, 2015, J CLIN ONCOL, V33, P1060, DOI 10.1200/JCO.2014.57.5027; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; Dumaz N, 1999, FEBS LETT, V463, P312, DOI 10.1016/S0014-5793(99)01647-6; Etchegaray JP, 2009, MOL CELL BIOL, V29, P3853, DOI 10.1128/MCB.00338-09; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Filges I, 2016, HUM MUTAT, V37, P359, DOI 10.1002/humu.22960; Forsythe E, 2015, CLIN GENET, V87, P343, DOI 10.1111/cge.12373; Greer YE, 2014, MOL BIOL CELL, V25, P1629, DOI 10.1091/mbc.E13-10-0598; Greer YE, 2011, J CELL BIOL, V192, P993, DOI 10.1083/jcb.201011111; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Ho Y, 1997, P NATL ACAD SCI USA, V94, P581, DOI 10.1073/pnas.94.2.581; HOEKSTRA MF, 1991, SCIENCE, V253, P1031, DOI 10.1126/science.1887218; Honaker Y, 2010, ONCOGENE, V29, P3324, DOI 10.1038/onc.2010.96; Imhoff O, 2011, CLIN J AM SOC NEPHRO, V6, P22, DOI 10.2215/CJN.03320410; Inuzuka H, 2010, CANCER CELL, V18, P147, DOI 10.1016/j.ccr.2010.06.015; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; Jiang KC, 2003, J BIOL CHEM, V278, P25207, DOI 10.1074/jbc.M300070200; Johnson AE, 2013, CURR BIOL, V23, P1920, DOI 10.1016/j.cub.2013.07.077; Kim K., 2014, J MARKETING THOUGHT, V1, P1, DOI DOI 10.4161/15384047; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Knippschild U, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00096; Lecona E, 2014, EXP CELL RES, V329, P26, DOI 10.1016/j.yexcr.2014.09.019; Leung-Pineda V, 2009, CANCER RES, V69, P2630, DOI 10.1158/0008-5472.CAN-08-3382; Liu QH, 2000, GENE DEV, V14, P1448; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Loughery J., 2013, BIODISCOVERY, V8, pe8946, DOI [10.7750/BioDiscovery.2013.8.1, DOI 10.7750/BI0DISC0VERY.2013.8.1]; Lu XH, 2001, CLIN CANCER RES, V7, P2114; Luzhna Lidiya, 2013, Frontiers in Genetics, V4, P131, DOI 10.3389/fgene.2013.00131; Mehlgarten C, 2003, MOL GENET GENOMICS, V269, P188, DOI 10.1007/s00438-003-0807-5; Meng Z, 2011, MOL BIOL CELL, V22, P2834, DOI 10.1091/mbc.E11-01-0048; Mijaljica D, 2013, J CELL SCI, V126, P4325, DOI 10.1242/jcs.133090; Piao S, 2011, CELL CYCLE, V10, P531, DOI 10.4161/cc.10.3.14757; Probst FJ, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0291-0; Puigvert JC, 2016, FEBS J, V283, P232, DOI 10.1111/febs.13574; Sakaguchi K, 2000, J BIOL CHEM, V275, P9278, DOI 10.1074/jbc.275.13.9278; Sakurikar N, 2015, J CLIN ONCOL, V33, P1075, DOI 10.1200/JCO.2014.60.0767; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Smits VAJ, 2015, FEBS J, V282, P3681, DOI 10.1111/febs.13387; Stoter M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100090; Stoter M, 2005, ONCOGENE, V24, P7964, DOI 10.1038/sj.onc.1208941; Waters AM, 2015, J MED GENET, V52, P147, DOI 10.1136/jmedgenet-2014-102691; Willers H, 2015, SEMIN RADIAT ONCOL, V25, P237, DOI 10.1016/j.semradonc.2015.05.007; Winter M, 2004, BIOCHEMISTRY-US, V43, P16356, DOI 10.1021/bi0489255; Yoon CH, 2010, EMBO REP, V11, P393, DOI 10.1038/embor.2010.45; Zhang Y., 2012, SCI TOTAL ENVIRON, V442, P1, DOI DOI 10.1016/J.SCIT0TENV.2012.10.042; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	58	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170903	10.1371/journal.pone.0170903	http://dx.doi.org/10.1371/journal.pone.0170903			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125685	Green Published, gold, Green Submitted			2022-12-27	WOS:000396176100027
J	Peters, ITA; van Zwet, EW; Smit, VTHBM; Liefers, GJ; Kuppen, PJK; Hilders, CGJM; Trimbos, JB				Peters, Inge T. A.; van Zwet, Erik W.; Smit, Vincent T. H. B. M.; Liefers, Gerrit Jan; Kuppen, Peter J. K.; Hilders, Carina G. J. M.; Trimbos, J. Baptist			Prevalence and Risk Factors of Ovarian Metastases in Breast Cancer Patients < 41 Years of Age in the Netherlands: A Nationwide Retrospective Cohort Study	PLOS ONE			English	Article							TISSUE; TRANSPLANTATION; AUTOTRANSPLANTATION; MECHANISMS; PATHOLOGY; CORTEX	Purpose Breast cancer is one of the primary indications for cryopreservation and subsequent autotransplantation of ovarian tissue. The safety of this fertility preservation method remains questionable, as the presence of disseminated breast tumor cells cannot yet be excluded in the ovarian autografts. We explored the prevalence of ovarian metastases among young breast cancer patients and determined risk factors for the development of ovarian metastases. Methods Using the nationwide database of the Dutch Pathology Registry (PALGA), we identified a cohort of 2648 women with primary invasive breast cancer at age < 41 years in the period 2000-2010 in the Netherlands who subsequently underwent an oophorectomy. From this source population, all cases who had histologically confirmed ovarian metastases were included. For each case of whom clinical data were available, one control without ovarian metastases who matched the time interval between breast cancer diagnosis and oophorectomy was selected. Data were collected on patient characteristics, diagnosis, treatment and follow-up. Results Ovarian metastases were found in 63 out of 2648 patients who met the inclusion criteria. The risk of developing ovarian metastases increased with time passed since breast cancer diagnosis. Multivariate logistic regression analyses showed significant association between tumor stage and the development of ovarian metastases (p = 0.024). Conclusions The prevalence of ovarian metastases was 2.4% among young breast cancer patients. Early ovary removal may reduce the risk of developing ovarian metastases. In breast cancer patients with tumors > 5 cm and/or inflammatory carcinoma, we recommend a cautious approach to ovarian tissue autotransplantation.	[Peters, Inge T. A.; Trimbos, J. Baptist] Leiden Univ, Med Ctr, Dept Gynecol, Leiden, Netherlands; [van Zwet, Erik W.] Leiden Univ, Med Ctr, Dept Med Stat, Leiden, Netherlands; [Smit, Vincent T. H. B. M.] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [Liefers, Gerrit Jan; Kuppen, Peter J. K.] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands; [Hilders, Carina G. J. M.] Reinier da Graaf Hosp, Dept Gynecol, Delft, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Peters, ITA (corresponding author), Leiden Univ, Med Ctr, Dept Gynecol, Leiden, Netherlands.	i.t.a.peters@lumc.nl	Kuppen, Peter/J-2342-2016; Smit, Vincent/AAD-1811-2022	Kuppen, Peter/0000-0002-0294-3251; Smit, Vincent/0000-0003-3730-5652; Peters, Inge/0000-0001-8665-9487	DSW Health Insurance; Zabawas Foundation	DSW Health Insurance; Zabawas Foundation	This work was supported by a grant from DSW Health Insurance (https://ww.dsw.nl) and the Zabawas Foundation (http://zabawas.nl/). These funding sources were not involved in any part of the study.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Anderson WF, 2006, CANCER EPIDEM BIOMAR, V15, P1899, DOI 10.1158/1055-9965.EPI-06-0191; Azem F, 2010, INT J GYNECOL PATHOL, V29, P19, DOI 10.1097/PGP.0b013e3181ad1c52; Bastings L, 2013, HUM REPROD UPDATE, V19, P483, DOI 10.1093/humupd/dmt020; Bigorie V, 2010, CANCER-AM CANCER SOC, V116, P799, DOI 10.1002/cncr.24807; Casparie M, 2007, CELL ONCOL, V29, P19; Donnez J, 2015, J ASSIST REPROD GEN, V32, P1167, DOI 10.1007/s10815-015-0544-9; Donnez J, 2013, FERTIL STERIL, V99, P1503, DOI 10.1016/j.fertnstert.2013.03.030; Federa FMWV, 2011, COD PROP 2 US HUM TI; Finch APM, 2014, J CLIN ONCOL, V32, P1547, DOI 10.1200/JCO.2013.53.2820; Gamzatova Z, 2014, GYNECOL ENDOCRINOL, V30, P43, DOI 10.3109/09513590.2014.945789; Grogan TM, INTERPRETATION GUIDE; Kim SS, 2012, J ASSIST REPROD GEN, V29, P489, DOI 10.1007/s10815-012-9757-3; Luyckx V, 2013, J ASSIST REPROD GEN, V30, P1289, DOI 10.1007/s10815-013-0065-3; McCluggage WG, 2005, HISTOPATHOLOGY, V47, P231, DOI 10.1111/j.1365-2559.2005.02194.x; Morgan S, 2012, HUM REPROD UPDATE, V18, P525, DOI 10.1093/humupd/dms022; Oncoline, 2012, CANC CLIN PRACT GUID; Perrotin F, 2001, Gynecol Obstet Fertil, V29, P308, DOI 10.1016/S1297-9589(01)00131-X; Peters IT, 2016, ARCH GYNECOL OBSTET, V5; Rabban JT, 2009, AM J SURG PATHOL, V33, P1125, DOI 10.1097/PAS.0b013e31819e986a; Ridolfi RL, 2000, MODERN PATHOL, V13, P866, DOI 10.1038/modpathol.3880154; Rosendahl M, 2011, FERTIL STERIL, V95, P2158, DOI 10.1016/j.fertnstert.2010.12.019; Sanchez-Serrano M, 2009, HUM REPROD, V24, P2238, DOI 10.1093/humrep/dep196; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sosa MS, 2014, NAT REV CANCER, V14, P611, DOI 10.1038/nrc3793	25	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0168277	10.1371/journal.pone.0168277	http://dx.doi.org/10.1371/journal.pone.0168277			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125710	Green Published, gold, Green Submitted			2022-12-27	WOS:000396176100150
J	Barrenschee, M; Wedel, T; Lange, C; Hohmeier, I; Cossais, F; Ebsen, M; Vogel, I; Bottner, M				Barrenschee, Martina; Wedel, Thilo; Lange, Christina; Hohmeier, Ines; Cossais, Francois; Ebsen, Michael; Vogel, Ilka; Boettner, Martina			No neuronal loss, but alterations of the GDNF system in asymptomatic diverticulosis	PLOS ONE			English	Article							ENTERIC NERVOUS-SYSTEM; COLONIC MOTILITY; DISEASE; EXPRESSION; GUIDELINES; INTESTINE; BEHALF; PLEXUS	Background Glial cell line-derived neurotrophic factor (GDNF) is a potent neurotrophic factor known to promote the survival and maintenance of neurons not only in the developing but also in the adult enteric nervous system. As diverticular disease (DD) is associated with reduced myenteric neurons, alterations of the GDNF system were studied in asymptomatic diverticulosis (diverticulosis) and DD. Methods Morphometric analysis for quantifying myenteric ganglia and neurons were assessed in colonic full-thickness sections of patients with diverticulosis and controls. Samples of tunica muscularis (TM) and laser-microdissected myenteric ganglia from patients with diverticulosis, DD and controls were analyzed for mRNA expression levels of GDNF, GFRA1, and RET by RT-qPCR. Myenteric protein expression of both receptors was quantified by fluorescence-immunohistochemistry of patients with diverticulosis, DD, and controls. Results Although no myenteric morphometric alterations were found in patients with diverticulosis, GDNF, GFRA1 and RET mRNA expression was down-regulated in the TM of patients with diverticulosis as well as DD. Furthermore GFRA1 and RET myenteric plexus mRNA expression of patients with diverticulosis and DD was down-regulated, whereas GDNF remained unaltered. Myenteric immunoreactivity of the receptors GFR alpha 1 and RET was decreased in both asymptomatic diverticulosis and DD patients. Conclusion Our data provide evidence for an impaired GDNF system at gene and protein level not only in DD but also during early stages of diverticula formation. Thus, the results strengthen the idea of a disturbed GDNF-responsiveness as contributive factor for a primary enteric neuropathy involved in the pathogenesis and disturbed intestinal motility observed in DD.	[Barrenschee, Martina; Wedel, Thilo; Lange, Christina; Hohmeier, Ines; Cossais, Francois; Boettner, Martina] Univ Kiel, Inst Anat, Kiel, Germany; [Ebsen, Michael] Stadt Krankenhaus Kiel, Dept Pathol, Kiel, Germany; [Vogel, Ilka] Stadt Krankenhaus Kiel, Dept Surg, Kiel, Germany	University of Kiel	Barrenschee, M (corresponding author), Univ Kiel, Inst Anat, Kiel, Germany.	m.barrenschee@anat.uni-kiel.de	Cossais, François/AFP-6523-2022; Barrenschee, Martina/AAS-9945-2020	Cossais, François/0000-0001-8043-296X; Barrenschee, Martina/0000-0002-0244-9333; Wedel, Thilo/0000-0002-8146-2711	German Research Society (Deutsche Forschungsgemeinschaft, DFG) [WE 2366/4-2]; Faculty of Medicine, University of Kiel [F347022]	German Research Society (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); Faculty of Medicine, University of Kiel	This work was supported by research grants from the German Research Society (Deutsche Forschungsgemeinschaft, DFG WE 2366/4-2) and the Faculty of Medicine, University of Kiel (F347022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrenschee M, 2013, CELL TISSUE RES, V354, P371, DOI 10.1007/s00441-013-1690-y; Barrenschee M, 2015, HISTOCHEM CELL BIOL; Bassotti G, 2005, CLIN GASTROENTEROL H, V3, P248, DOI 10.1016/S1542-3565(04)00614-7; Bassotti G, 2001, DIS COLON RECTUM, V44, P1814, DOI 10.1007/BF02234460; Bottner M, 2013, GUT, V62, P1753, DOI 10.1136/gutjnl-2012-302660; Bottner M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066290; Bottner M, 2012, DIGEST DIS, V30, P19, DOI 10.1159/000335699; Bottner M, 2010, NEUROGASTROENT MOTIL, V22, P168, DOI [DOI 10.1111/J.1365-2982.2009.01424.X, 10. 1111/j. 1365-2982. 2009. 01424. x]; Burzynski G, 2009, NEUROGASTROENT MOTIL, V21, P113, DOI 10.1111/j.1365-2982.2008.01256.x; CORTESINI C, 1991, DIS COLON RECTUM, V34, P339, DOI 10.1007/BF02050595; Cromey DW, 2010, SCI ENG ETHICS, V16, P639, DOI 10.1007/s11948-010-9201-y; Deduchovas O, 2008, ANN ANAT, V190, P525, DOI 10.1016/j.aanat.2008.09.002; Espin F, 2014, NEUROGASTROENT MOTIL, V26, P1458, DOI 10.1111/nmo.12407; Feuerstein JD, 2016, MAYO CLIN P; Gallego D, 2013, INT J COLORECTAL DIS, V28, P1413, DOI 10.1007/s00384-013-1716-7; Golder M, 2003, LANCET, V361, P1945, DOI 10.1016/S0140-6736(03)13583-0; Iwase H, 2005, J CLIN GASTROENTEROL, V39, P674, DOI 10.1097/01.mcg.0000173856.84814.37; Knowles CH, 2010, GUT, V59, P882, DOI 10.1136/gut.2009.200444; Knowles CH, 2009, ACTA NEUROPATHOL, V118, P271, DOI 10.1007/s00401-009-0527-y; R Core Team, 2012, R LANG ENV STAT COMP; Rodrigues DM, 2011, NEUROGASTROENT MOTIL, V23, pe44, DOI 10.1111/j.1365-2982.2010.01626.x; Saavedra A, 2008, PROG NEUROBIOL, V86, P186, DOI 10.1016/j.pneurobio.2008.09.006; Sandler RS, 2002, GASTROENTEROLOGY, V122, P1500, DOI 10.1053/gast.2002.32978; Schafer KH, 1999, EXP BRAIN RES, V125, P447, DOI 10.1007/s002210050702; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Simpson J, 2009, NEUROGASTROENT MOTIL, V21, P847, DOI 10.1111/j.1365-2982.2009.01308.x; Stollman N, 2004, LANCET, V363, P631, DOI 10.1016/S0140-6736(04)15597-9; Tursi A, 2016, THER ADV GASTROENTER, V9, P213, DOI 10.1177/1756283X15621228; Unsicker K, 1996, CELL TISSUE RES, V286, P175, DOI 10.1007/s004410050686; von Boyen GBT, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-3; VORONINA TA, 1990, B EXP BIOL MED+, V109, P195, DOI 10.1007/BF00841669; Wedel T, 2010, NEUROGASTROENT MOTIL, V22, P407, DOI 10.1111/j.1365-2982.2009.01445.x; Wedel T, 2015, VISZERALMEDIZIN, V31, P76, DOI 10.1159/000381431	33	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171416	10.1371/journal.pone.0171416	http://dx.doi.org/10.1371/journal.pone.0171416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152033	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161200142
J	Glinge, C; Clauss, S; Boddum, K; Jabbari, R; Jabbari, J; Risgaard, B; Tomsits, P; Hildebrand, B; Kaab, S; Wakili, R; Jespersen, T; Tfelt-Hansen, J				Glinge, Charlotte; Clauss, Sebastian; Boddum, Kim; Jabbari, Reza; Jabbari, Javad; Risgaard, Bjarke; Tomsits, Philipp; Hildebrand, Bianca; Kaeaeb, Stefan; Wakili, Reza; Jespersen, Thomas; Tfelt-Hansen, Jacob			Stability of Circulating Blood-Based MicroRNAs - Pre-Analytic Methodological Considerations	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; BIOMARKERS; CANCER; SERUM; DIAGNOSIS	Background and aim The potential of microRNAs (miRNA) as non-invasive diagnostic, prognostic, and predictive biomarkers, as well as therapeutic targets, has recently been recognized. Previous studies have highlighted the importance of consistency in the methodology used, but to our knowledge, no study has described the methodology of sample preparation and storage systematically with respect to miRNAs as blood biomarkers. The aim of this study was to investigate the stability of miRNAs in blood under various relevant clinical and research conditions: different collection tubes, storage at different temperatures, physical disturbance, as well as serial freeze-thaw cycles. Methods Blood samples were collected from 12 healthy donors into different collection tubes containing anticoagulants, including EDTA, citrate and lithium-heparin, as well as into serum collection tubes. MiRNA stability was evaluated by measuring expression changes of miR-1, miR21 and miR-29b at different conditions: varying processing time of whole blood (up to 72 hours (h)), long-term storage (9 months at -80 degrees C), physical disturbance (1 and 8 h), as well as in a series of freeze/thaw cycles (1 and 4 times). Results Different collection tubes revealed comparable concentrations of miR-1, miR-21 and miR-29b. Tubes with lithium-heparin were found unsuitable for miRNA quantification. MiRNA levels were stable for at least 24 h at room temperature in whole blood, while separated fractions did show alterations within 24 h. There were significant changes in the miR-21 and miR-29b levels after 72 h incubation of whole blood at room temperature (p< 0.01 for both). Both miR-1 and miR-21 showed decreased levels after physical disturbance for 8 h in separated plasma and miR-1 in serum whole blood, while after 1 h of disturbance no changes were observed. Storage of samples at -80 degrees C extended the miRNA stability remarkably, however, miRNA levels in long-term stored (9 months) whole blood samples were significantly changed, which is in contrast to the plasma samples, where miR-21 or miR-29b levels were found to be stable. Repetitive (n = 4) freeze-thaw cycles resulted in a significant reduction of miRNA concentration both in plasma and serum samples. Conclusion This study highlights the importance of proper and systematic sample collection and preparation when measuring circulating miRNAs, e.g., in context of clinical trials. We demonstrated that the type of collection tubes, preparation, handling and storage of samples should be standardized to avoid confounding variables influencing the results.	[Glinge, Charlotte; Jabbari, Reza; Jabbari, Javad; Risgaard, Bjarke; Tfelt-Hansen, Jacob] Rigshosp, Dept Cardiol, Ctr Heart, Copenhagen Univ Hosp, Copenhagen, Denmark; [Clauss, Sebastian; Tomsits, Philipp; Hildebrand, Bianca; Kaeaeb, Stefan; Wakili, Reza] Ludwig Maximilians Univ Munich LMU, Dept Med 1, Univ Hosp Munich, Campus Grosshadern, Munich, Germany; [Clauss, Sebastian] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Clauss, Sebastian; Tomsits, Philipp; Kaeaeb, Stefan; Wakili, Reza] MHA, DZHK German Ctr Cardiovasc Res, Partner Site Munich, Munich, Germany; [Boddum, Kim; Jespersen, Thomas] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Munich; Harvard University; Massachusetts General Hospital; German Centre for Cardiovascular Research; Munich Heart Alliance; University of Copenhagen	Glinge, C (corresponding author), Rigshosp, Dept Cardiol, Ctr Heart, Copenhagen Univ Hosp, Copenhagen, Denmark.	cglinge@gmail.com	Jabbari, Reza/AAM-6649-2021; Clauss, Sebastian/HDL-7189-2022; Tfelt-Hansen, Jacob/AAU-8691-2020	Jabbari, Reza/0000-0002-9432-0632; Clauss, Sebastian/0000-0002-5675-6128; Tfelt-Hansen, Jacob/0000-0003-3895-9316; Jespersen, Thomas/0000-0001-6575-360X	Novo Nordic Foundation; Research Fund of Rigshospitalet, University Hospital of Copenhagen, Denmark; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme under REA grant [PIOF-GA-2012-328352]; German Centre for Cardiovascular Research (DZHK); German Centre for Cardiovascular Research (DZHK) [81X2600210, 81X2600204]; European Union [633193]; Danish Council for Independent Research Medical Sciences [DFF-1331-00313B]; Novo Nordisk Fonden [NNF13OC0007521, NNF14OC0011573] Funding Source: researchfish	Novo Nordic Foundation(Novo Nordisk Foundation); Research Fund of Rigshospitalet, University Hospital of Copenhagen, Denmark; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme under REA grant; German Centre for Cardiovascular Research (DZHK); German Centre for Cardiovascular Research (DZHK); European Union(European Commission); Danish Council for Independent Research Medical Sciences(Det Frie Forskningsrad (DFF)); Novo Nordisk Fonden(Novo Nordisk Foundation)	Support from the Novo Nordic Foundation to JTH made this study possible. CG has received funding from The Research Fund of Rigshospitalet, University Hospital of Copenhagen, Denmark. SC has received funding from The People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant agreement No PIOF-GA-2012-328352. SC, PT, SK, and RW were supported by The German Centre for Cardiovascular Research (DZHK). Dres. Clauss, Kaab, Wakili were supported by the German Centre for Cardiovascular Research (DZHK; 81X2600210, 81X2600204). RW and SK received funding from The European Union's Horizon 2020 research and innovation programme under grant agreement No 633193 (CATCH ME). Danish Council for Independent Research Medical Sciences (DFF-1331-00313B) to TJ.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chevillet JR, 2014, P NATL ACAD SCI USA, V111, P14888, DOI 10.1073/pnas.1408301111; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Farina NH, 2014, J CELL BIOCHEM, V115, P805, DOI 10.1002/jcb.24745; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gidlof O, 2011, CARDIOLOGY, V118, P217, DOI 10.1159/000328869; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Hanke M, 2010, UROL ONCOL-SEMIN ORI, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Park NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736; Perron Marjorie P, 2007, Methods Mol Biol, V361, P311; Rice J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121948; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tiberio P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/731479; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Weckbach LT, 2016, CURR OPIN PHARMACOL, V27, P24, DOI 10.1016/j.coph.2016.01.001; Zhao H, 2014, CANCER EPIDEM BIOMAR, V23, P2643, DOI 10.1158/1055-9965.EPI-14-0550	31	166	170	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0167969	10.1371/journal.pone.0167969	http://dx.doi.org/10.1371/journal.pone.0167969			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151938	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200003
J	Krieber, M; Bartl-Pokorny, KD; Pokorny, FB; Zhang, D; Landerl, K; Korner, C; Pernkopf, F; Pock, T; Einspieler, C; Marschik, PB				Krieber, Magdalena; Bartl-Pokorny, Katrin D.; Pokorny, Florian B.; Zhang, Dajie; Landerl, Karin; Koerner, Christof; Pernkopf, Franz; Pock, Thomas; Einspieler, Christa; Marschik, Peter B.			Eye Movements during Silent and Oral Reading in a Regular Orthography: Basic Characteristics and Correlations with Childhood Cognitive Abilities and Adolescent Reading Skills	PLOS ONE			English	Article							PERCEPTUAL SPAN; CONSISTENT ORTHOGRAPHY; DYSLEXIC-CHILDREN; WORD-LENGTH; READERS; GERMAN; ACQUISITION; COMPREHENSION; FREQUENCY; PATTERNS	The present study aimed to define differences between silent and oral reading with respect to spatial and temporal eye movement parameters. Eye movements of 22 German-speaking adolescents (14 females; mean age = 13; 6 years; months) were recorded while reading an age-appropriate text silently and orally. Preschool cognitive abilities were assessed at the participants' age of 5; 7 (years; months) using the Kaufman Assessment Battery for Children. The participants' reading speed and reading comprehension at the age of 13; 6 (years; months) were determined using a standardized inventory to evaluate silent reading skills in German readers (Lesegeschwindigkeits-und -verstaendnistest fur Klassen 6-12). The results show that (i) reading mode significantly influenced both spatial and temporal characteristics of eye movement patterns; (ii) articulation decreased the consistency of intraindividual reading performances with regard to a significant number of eye movement parameters; (iii) reading skills predicted the majority of eye movement parameters during silent reading, but influenced only a restricted number of eye movement parameters when reading orally; (iv) differences with respect to a subset of eye movement parameters increased with reading skills; (v) an overall preschool cognitive performance score predicted reading skills at the age of 13; 6 (years; months), but not eye movement patterns during either silent or oral reading. However, we found a few significant correlations between preschool performances on subscales of sequential and simultaneous processing and eye movement parameters for both reading modes. Overall, the findings suggest that eye movement patterns depend on the reading mode. Preschool cognitive abilities were more closely related to eye movement patterns of oral than silent reading, while reading skills predicted eye movement patterns during silent reading, but less so during oral reading.	[Krieber, Magdalena; Bartl-Pokorny, Katrin D.; Pokorny, Florian B.; Zhang, Dajie; Einspieler, Christa; Marschik, Peter B.] Med Univ Graz, Res Unit iDN Interdisciplinary Dev Neurosci, Inst Physiol, Ctr Physiol Med, Graz, Austria; [Pokorny, Florian B.; Pernkopf, Franz; Marschik, Peter B.] BioTechMed Graz, BEE PRI, Graz, Austria; [Pokorny, Florian B.] Tech Univ Munich, Machine Intelligence & Signal Proc Grp, Munich, Germany; [Landerl, Karin] Graz Univ, Inst Psychol, Dev Psychol, Graz, Austria; [Koerner, Christof] Graz Univ, Inst Psychol, Cognit Psychol & Neurosci, Graz, Austria; [Pernkopf, Franz] Graz Univ Technol, Signal Proc & Speech Commun Lab, Graz, Austria; [Pock, Thomas] Graz Univ Technol, Inst Comp Graph & Vis, Graz, Austria; [Marschik, Peter B.] Karolinska Inst, Ctr Neurodev Disorders KIND, Dept Womens & Childrens Hlth, Stockholm, Sweden	Medical University of Graz; Technical University of Munich; University of Graz; University of Graz; Graz University of Technology; Graz University of Technology; Karolinska Institutet	Marschik, PB (corresponding author), Med Univ Graz, Res Unit iDN Interdisciplinary Dev Neurosci, Inst Physiol, Ctr Physiol Med, Graz, Austria.; Marschik, PB (corresponding author), BioTechMed Graz, BEE PRI, Graz, Austria.; Marschik, PB (corresponding author), Karolinska Inst, Ctr Neurodev Disorders KIND, Dept Womens & Childrens Hlth, Stockholm, Sweden.	peter.marschik@medunigraz.at	Bartl-Pokorny, Katrin/C-5396-2014; Einspieler, Christa/HHS-6481-2022; Marschik, Peter B/F-8195-2011	Landerl, Karin/0000-0003-4074-0233; Korner, Christof/0000-0002-3846-2337; Pokorny, Florian/0000-0001-9203-2904; Zhang, Dajie/0000-0001-6050-7426; Bartl-Pokorny, Katrin D./0000-0002-2658-1056; Marschik, Peter B/0000-0001-8932-0980	Country of Styria; City of Graz; Brain, Ears & Eyes - Pattern Recognition Initiative (BEE-PRI); Lanyar Foundation [P337]	Country of Styria; City of Graz; Brain, Ears & Eyes - Pattern Recognition Initiative (BEE-PRI); Lanyar Foundation	The study was supported by the Country of Styria, the City of Graz, the Brain, Ears & Eyes - Pattern Recognition Initiative (BEE-PRI; BioTechMed-Graz), and the Lanyar Foundation (P337). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Special thanks to the participants of our longitudinal study and their parents for their continuous support. We are grateful to Nina Bartl and Gunter Vogrinec for assistance in data analysis and technical assistance, and Miha Tavcar (scriptophil) for copy-editing the manuscript. We would also like to thank the Editor and the Reviewers for their guidance and their valuable comments on our manuscript. The study was supported by the Country of Styria, the City of Graz, the Brain, Ears & Eyes Pattern Recognition Initiative (BEE-PRI; BioTechMed-Graz), and the Lanyar Foundation (P337).	Anderson I. H., 1937, PSYCHOL MONOGR, V48, P61, DOI [10.1037/h0093393, DOI 10.1037/H0093393]; Ashby J, 2005, Q J EXP PSYCHOL-A, V58, P1065, DOI 10.1080/02724980443000476; Ashby J, 2012, ATTEN PERCEPT PSYCHO, V74, P634, DOI 10.3758/s13414-012-0277-0; Bartl-Pokorny KD, 2013, DEV NEUROREHABIL, V16, P188, DOI 10.3109/17518423.2013.773101; Brunswick N, 2012, J EXP CHILD PSYCHOL, V111, P268, DOI 10.1016/j.jecp.2011.08.001; Buswell GT, 1922, S ED MONOGRAPH, V21; Buswell GT, 1920, S ED MONOGRAPHS, V17; De Luca M, 2002, BRAIN LANG, V80, P617, DOI 10.1006/brln.2001.2637; De Luca M, 1999, NEUROPSYCHOLOGIA, V37, P1407, DOI 10.1016/S0028-3932(99)00038-X; De Luca M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00696; Durrwachter U, 2010, ANN DYSLEXIA, V60, P86, DOI 10.1007/s11881-010-0034-9; Ferrer E, 2007, DEV PSYCHOL, V43, P1460, DOI 10.1037/0012-1649.43.6.1460; Hale AD, 2007, BEHAV ANAL TODAY, V8, P9, DOI [DOI 10.1037/H0100101, 10.1037/h0100101]; Hawelka S, 2005, VISION RES, V45, P855, DOI 10.1016/j.visres.2004.10.007; Hawelka S, 2010, COGNITION, V115, P367, DOI 10.1016/j.cognition.2009.11.004; Hohenstein S, 2014, J EXP PSYCHOL LEARN, V40, P166, DOI 10.1037/a0033670; Huestegge L, 2014, COGNITIVE PSYCHOL, V73, P72, DOI 10.1016/j.cogpsych.2014.06.001; Huestegge L, 2010, J EYE MOVEMENT RES, V3; Huestegge L, 2009, VISION RES, V49, P2948, DOI 10.1016/j.visres.2009.09.012; Hutzler F, 2004, BRAIN LANG, V89, P235, DOI 10.1016/S0093-934X(03)00401-2; HYONA J, 1995, J EXP PSYCHOL LEARN, V21, P1430, DOI 10.1037/0278-7393.21.6.1430; Inhoff AW, 2014, VIS COGN, V22, P354, DOI 10.1080/13506285.2013.879630; Joseph HSSL, 2009, VISION RES, V49, P2078, DOI 10.1016/j.visres.2009.05.015; JUEL C, 1981, READ RES QUART, V16, P545, DOI 10.2307/747315; Kragler S., 1995, READING PSYCHOL INT, V6, P395, DOI DOI 10.1080/0270271950160402; Krieber M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145934; Landerl K, 2008, J EDUC PSYCHOL, V100, P150, DOI 10.1037/0022-0663.100.1.150; Laubrock J, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01432; Marschik PB, 2007, EARLY HUM DEV, V83, P107, DOI 10.1016/j.earlhumdev.2006.05.009; McCallum RS, 2004, PSYCHOL SCHOOLS, V41, P241, DOI 10.1002/pits.10152; McConkie G.W., 1991, VISION VISUAL DYSLEX; Melchers P., 2003, K ABC KAUFMAN ASSESS, V6; MENG XL, 1992, PSYCHOL BULL, V111, P172, DOI 10.1037/0033-2909.111.1.172; MILLER SD, 1985, J EDUC PSYCHOL, V77, P341, DOI 10.1037/0022-0663.77.3.341; Paeglis R, 2008, PROC SPIE, V7142, DOI 10.1117/12.815343; Prior S. M., 2001, READING PSYCHOL, V22, P1, DOI [10.1080/02702710151130172, DOI 10.1080/02702710151130172]; Rau AK, 2016, SCI STUD READ, V20, P203, DOI 10.1080/10888438.2015.1136913; Rau AK, 2015, J EXP CHILD PSYCHOL, V130, P92, DOI 10.1016/j.jecp.2014.09.012; Rau AK, 2014, SCI STUD READ, V18, P224, DOI 10.1080/10888438.2013.857673; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1986, J EXP CHILD PSYCHOL, V41, P211, DOI 10.1016/0022-0965(86)90037-8; Rayner K, 2010, PSYCHON B REV, V17, P834, DOI 10.3758/PBR.17.6.834; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Schneider W., 2007, LESEGESCHWINDIGKEITS; Schotter E.R., 2015, OXFORD HDB READING, P44; Schullerer P, 1999, B U BIOL UMWELTKUNDE, V8, P7; Seymour PHK, 2003, BRIT J PSYCHOL, V94, P143, DOI 10.1348/000712603321661859; Trauzettel-Klosinski S, 2010, ACTA OPHTHALMOL, V88, P681, DOI 10.1111/j.1755-3768.2009.01523.x; van den Boer M, 2014, J EXP CHILD PSYCHOL, V128, P138, DOI 10.1016/j.jecp.2014.07.008; Vorstius C, 2014, VIS COGN, V22, P458, DOI 10.1080/13506285.2014.881445; Ziegler JC, 2005, PSYCHOL BULL, V131, P3, DOI 10.1037/0033-2909.131.1.3	51	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170986	10.1371/journal.pone.0170986	http://dx.doi.org/10.1371/journal.pone.0170986			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28151950	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200066
J	Chen, XL; Lin, JB; Liu, Y; Peng, J; Cao, Y; Su, Z; Wang, TQ; Cheng, JQ; Hu, DS				Chen, Xiaoliang; Lin, Jinbo; Liu, Yi; Peng, Ji; Cao, Yong; Su, Zhan; Wang, Tieqiang; Cheng, Jinquan; Hu, Dongsheng			AlncRNA HULC as an effective biomarker for surveillance of the outcome of cancer: A meta-analysis	PLOS ONE			English	Article							LONG NONCODING RNA; LYMPH-NODE METASTASIS; POOR-PROGNOSIS; PREDICT; PROGRESSION; CARCINOMA; H19	Purpose High expression of highly upregulated in iver cancer (HULC) has been found associated with increased metastasis and poor prognosis with cancer. This meta-analysis aimed to determine the pooled effect of HULC on metastasis and prognosis of cancers. Method The studies were accessed using multiple databases. RevMan5.3 and STATA14.0 were used to estimate pooled effects, the heterogeneity among studies, and publication bias for the association of HULC and overall survival (OS). Results A total of 9 studies of 966 cancer patients were included. Risk of lymph node metastasis was increased with high versus low HULC expression (pooled odds ratio [OR] = 4.83, 95% confidence interval [CI] 1.59-14.63) as was distant metastasis (pooled OR = 5.44, 95% CI 2.33-12.74). Furthermore, OS time was shortened with high HULC expression (pooled hazard ratio [HR] = 1.48, 95% CI 1.03-2.12), especially in Chinese patients (pooled HR = 2.04, 95% CI 1.55-2.68), and risk of recurrence was increased (pooled OR = 6.68, 95% CI 2.77-16.13). Conclusion HULC might be a potential biomarker for therapy and prognosis surveillance in cancers.	[Chen, Xiaoliang; Liu, Yi; Cao, Yong; Su, Zhan; Wang, Tieqiang] Shenzhen Guangming Dist Ctr Dis Control & Prevent, Shenzhen, Guangdong, Peoples R China; [Lin, Jinbo] Longgang Dist Cent Hosp Shenzhen, Shenzhen, Guangdong, Peoples R China; [Peng, Ji] Shenzhen Ctr Chron Dis Prevent, Shenzhen, Guangdong, Peoples R China; [Cheng, Jinquan] Shenzhen Ctr Dis Control & Prevent, Dept Mol Biol, Shenzhen, Guangdong, Peoples R China; [Hu, Dongsheng] Shenzhen Univ, Sch Med, Shenzhen, Guangdong, Peoples R China	Shenzhen Center for Disease Control & Prevention (SZCDC); Shenzhen University	Cheng, JQ (corresponding author), Shenzhen Ctr Dis Control & Prevent, Dept Mol Biol, Shenzhen, Guangdong, Peoples R China.; Hu, DS (corresponding author), Shenzhen Univ, Sch Med, Shenzhen, Guangdong, Peoples R China.	cjinquan@szcdc.net; hud@szu.edu.cn			Natural Science Grants of Guangdong Province [2014A030310091]; Shenzhen Technology Research and Development Funds [JCYJ20140411150916744, JCYJ20150403095530583, 201604130086]; Science AMP; Technology Project of Shenzhen Longgang District [YLWS20140606101914846]	Natural Science Grants of Guangdong Province; Shenzhen Technology Research and Development Funds; Science AMP; Technology Project of Shenzhen Longgang District	This study was supported by the Natural Science Grants of Guangdong Province (2014A030310091), Shenzhen Technology Research and Development Funds (JCYJ20140411150916744, JCYJ20150403095530583, 201604130086) and the Science & Technology Project of Shenzhen Longgang District (YLWS20140606101914846).	Chen T, 2016, MINERVA MED, V107, P251; Cui M, 2015, NEOPLASIA, V17, P79, DOI 10.1016/j.neo.2014.11.004; Dhamija S, 2016, INT J CANCER, V139, P269, DOI 10.1002/ijc.30039; Evans JR, 2016, J CLIN INVEST, V126, P2775, DOI 10.1172/JCI84421; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jin C, 2016, ONCOTARGET; Lai F, 2016, METHOD ENZYMOL, V573, P421, DOI 10.1016/bs.mie.2016.03.010; Lan XA, 2010, WORLD J GASTROENTERO, V16, P3457, DOI 10.3748/wjg.v16.i27.3457; Li CH, 2013, INT J BIOCHEM CELL B, V45, P1895, DOI 10.1016/j.biocel.2013.05.030; Li J, 2016, DNA CELL BIOL; Li SP, 2016, ONCOTARGET; Liu FT, 2016, ONCOTARGETS THER, V9, P4247, DOI 10.2147/OTT.S107188; Liu FT, 2016, PANMINERVA MED, V58, P160; Uzan VRM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156774; Panzitt K, 2007, GASTROENTEROLOGY, V132, P330, DOI 10.1053/j.gastro.2006.08.026; Peng W, 2016, BIOMED PHARMACOTHER, V79, P188, DOI 10.1016/j.biopha.2016.02.032; Peng W, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0346-4; Raveh E, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0458-2; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Schmitz SU, 2016, CELL MOL LIFE SCI, V73, P2491, DOI 10.1007/s00018-016-2174-5; Soeken KL, 2003, NURS RES, V52, P57, DOI 10.1097/00006199-200301000-00009; Sun W, 2016, J CANC RES CLIN ONCO; Sun XH, 2015, INT J CLIN EXP PATHO, V8, P2994; Veneziano D, 2016, HUMAN MUTATION; Wang YC, 2017, LUPUS, V26, P170, DOI 10.1177/0961203316657432; Xie H, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/136106; Yang XJ, 2016, GENE, V592, P172, DOI 10.1016/j.gene.2016.08.002; Yang XJ, 2016, GENE; Yang ZG, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/191029; Yu X, 2015, MOL MED REP, V12, P5611, DOI 10.3892/mmr.2015.4161; Zhang YF, 2016, J MED BIOCHEM, V35, P137, DOI 10.1515/jomb-2015-0016; Zhao Y, 2014, ONCOL REP, V31, P358, DOI 10.3892/or.2013.2850	32	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0171210	10.1371/journal.pone.0171210	http://dx.doi.org/10.1371/journal.pone.0171210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146578	Green Published, gold, Green Submitted			2022-12-27	WOS:000396131700027
J	Dey, S; Gupta, S; Sibanda, P; Chakraborty, A				Dey, Sharadia; Gupta, Srimanta; Sibanda, Precious; Chakraborty, Arun			Spatio-Temporal Variation and Futuristic Emission Scenario of Ambient Nitrogen Dioxide over an Urban Area of Eastern India Using GIS and Coupled AERMOD-WRF Model	PLOS ONE			English	Article							INDUSTRIAL SOURCE APPLICATIONS; DRIVERS BOUNDED RATIONALITY; AIR-QUALITY; SOURCE APPORTIONMENT; PARTICULATE MATTER; DISPERSION MODEL; POLLUTION; PREDICTION; POLLUTANTS; CITY	The present study focuses on the spatio-temporal variation of nitrogen dioxide (NO2) during June 2013 to May 2015 and its futuristic emission scenario over an urban area (Durgapur) of eastern India. The concentration of ambient NO2 shows seasonal as well as site specific characteristics. The site with high vehicular density (Muchipara) shows highest NO2 concentration followed by industrial site (DVC-DTPS Colony) and the residential site (B Zone), respectively. The seasonal variation of ambient NO2 over the study area is portrayed by means of Geographical Information System based Digital Elevation Model. Out of the total urban area under consideration (114.982 km(2)), the concentration of NO2 exceeded the National Ambient Air Quality Standard (NAAQS) permissible limit over an area of 5.000 km 2, 0.786 km(2) and 0.653 km(2) in post monsoon, winter and pre monsoon, respectively. Wind rose diagrams, correlation and regression analyses show that meteorology plays a crucial role in dilution and dispersion of NO2 near the earth's surface. Principal component analysis identifies vehicular source as the major source of NO2 in all the seasons over the urban region. Coupled AMS/EPA Regulatory Model (AERMOD)-Weather Research and Forecasting (WRF) model is used for predicting the concentration of NO2. Comparison of the observed and simulated data shows that the model overestimates the concentration of NO2 in all the seasons (except winter). The results show that coupled AERMOD-WRF model can overcome the unavailability of hourly surface as well as upper air meteorological data required for predicting the pollutant concentration, but improvement of emission inventory along with better understanding of the sinks and sources of ambient NO2 is essential for capturing the more realistic scenario.	[Dey, Sharadia; Sibanda, Precious] Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Private Bag X01 Scottsville, Pietermaritzburg, South Africa; [Gupta, Srimanta] Univ Burdwan, Dept Environm Sci, Burdwan, W Bengal, India; [Chakraborty, Arun] Indian Inst Technol, Ctr Oceans Rivers Atmosphere & Land Sci CORAL, Kharagpur, W Bengal, India	University of Kwazulu Natal; University of Burdwan; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur	Dey, S; Sibanda, P (corresponding author), Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Private Bag X01 Scottsville, Pietermaritzburg, South Africa.	sharadiadey1985@gmail.com; sibandap@ukzn.ac.za	Sibanda, Precious/F-9616-2010; Gupta, Srimanta/J-5632-2017; Gupta, Srimanta/AAD-6756-2021; Chakraborty, Arun/AAD-9814-2021	Sibanda, Precious/0000-0003-2115-4642; Gupta, Srimanta/0000-0001-8426-5388; 	University of KwaZulu-Natal	University of KwaZulu-Natal	This work is funded by the University of KwaZulu-Natal.	Ali M, 2008, ENVIRON MONIT ASSESS, V136, P219, DOI 10.1007/s10661-007-9677-3; ARAI, 2007, AFL200607IOCL ARAI, P1; Boadh R, 2016, ATMOSFERA, V29, P61, DOI 10.20937/ATM.2016.29.01.05; Borge Garcia R., 2014, J GEOSCI ENV PROTECT, V2, P6, DOI DOI 10.4236/GEP.2014.21002; Bruno P, 2001, FRESEN J ANAL CHEM, V371, P1119, DOI 10.1007/s002160101084; Ceron-Breton J. G., 2013, WSEAS Transactions on Systems, V12, P55; Chattopadhyay S, 2012, THESIS; Cimorelli A. J., 2004, 454R03002D US EPA; Cimorelli AJ, 2005, J APPL METEOROL, V44, P682, DOI 10.1175/JAM2227.1; Dey S, 2014, ENVIRON FORENSICS, V2014, P112; Guo H, 2004, ENVIRON POLLUT, V129, P489, DOI 10.1016/j.envpol.2003.11.006; Gupta AK, 2008, ATMOS RES, V87, P103, DOI 10.1016/j.atmosres.2007.07.008; Gurjar B., 2004, ATMOS ENVIRON, V38, P5663, DOI DOI 10.1016/J.ATM0SENV.2004.05.057; Gvozdic V, 2011, ENVIRON MODEL ASSESS, V16, P491, DOI 10.1007/s10666-011-9256-4; He HD, 2015, STOCH ENV RES RISK A, V29, P2107, DOI 10.1007/s00477-014-0989-x; He HD, 2014, BUILD ENVIRON, V78, P111, DOI 10.1016/j.buildenv.2014.04.011; Hong SY, 2006, MON WEATHER REV, V134, P2318, DOI 10.1175/MWR3199.1; JACOBS MB, 1958, ANAL CHEM, V30, P426, DOI 10.1021/ac60135a032; Kandlikar M, 2000, ANNU REV ENERG ENV, V25, P629, DOI 10.1146/annurev.energy.25.1.629; Kaushik CP, 2006, ENVIRON MONIT ASSESS, V122, P27, DOI 10.1007/s10661-005-9161-x; Kesarkar AP, 2007, ATMOS ENVIRON, V41, P1976, DOI 10.1016/j.atmosenv.2006.10.042; Mohan M, 2011, ASIA-PAC J CHEM ENG, V6, P85, DOI 10.1002/apj.468; Otte TL, 2005, WEATHER FORECAST, V20, P367, DOI 10.1175/WAF855.1; Perry SG, 2005, J APPL METEOROL, V44, P694, DOI 10.1175/JAM2228.1; Raghavan S.C., 2010, J NUCL ACIDS, V2010, P2010, DOI DOI 10.1109/INFC0M.2010.5462024; RAO ST, 1986, ATMOS ENVIRON, V20, P1095, DOI 10.1016/0004-6981(86)90141-1; Salem AA, 2009, AIR QUAL ATMOS HLTH, V2, P133, DOI 10.1007/s11869-009-0040-4; Sharma N, 2004, TRANSPORT REV, V24, P409, DOI 10.1080/0144164042000196071; Sistla G, 2001, B AM METEOROL SOC, V82, P945, DOI 10.1175/1520-0477(2001)082<0945:AOEOTR>2.3.CO;2; Skamarock W C, 2008, DESCRIPTION ADV RES, P1, DOI [DOI 10.5065/D68S4MVH, 10.5065/D68S4MVH]; Tang TQ, 2017, PHYSICA A, V468, P322, DOI 10.1016/j.physa.2016.10.092; Tang TQ, 2015, TRANSPORT RES D-TR E, V41, P423, DOI 10.1016/j.trd.2015.10.016; Verma A, 2003, B ENVIRON CONTAM TOX, V70, P166, DOI 10.1007/s00128-002-0171-x; Xu C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161992; Zhao H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131878	35	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							E0170928	10.1371/journal.pone.0170928	http://dx.doi.org/10.1371/journal.pone.0170928			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141866	Green Published, gold, Green Submitted			2022-12-27	WOS:000396129500027
J	Echeverri, A; Callahan, MM; Chan, KMA; Satterfield, T; Zhao, JY				Echeverri, Alejandra; Callahan, Megan M.; Chan, Kai M. A.; Satterfield, Terre; Zhao, Jiaying			Explicit Not Implicit Preferences Predict Conservation Intentions for Endangered Species and Biomes	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; SOUTH-AFRICA; COGNITION; BIODIVERSITY; ASSOCIATIONS; ATTITUDES; TABOOS	Conservation of biodiversity is determined in part by human preferences. Preferences relevant to conservation have been examined largely via explicit measures (e.g., a self-reported degree of liking), with implicit measures (e.g., preconscious, automatic evaluations) receiving relatively less attention. This is the case despite psychological evidence from other contexts that implicit preferences are more informative of behavior. Thus, the type of measure that predicts conservation intentions for biodiversity is unknown. We conducted three studies to examine conservation intentions in light of people's explicit and implicit preferences toward four endangered species (sea otter, American badger, caribou, yellow-breasted chat) and four biomes (forest, ocean, grassland, tundra). In Study 1 (n = 55), we found that people implicitly preferred caribou most, but explicitly preferred sea otter most, with a significant multiple regression where participants' explicit preferences dictated their stated intended donations for conservation of each species. In Study 2 (n = 57) we found that people implicitly and explicitly preferred forest and ocean over grassland and tundra. Explicit rather than implicit preferences predicted the intended donation for conservation of the ocean biome. Study 3 involved a broader online sample of participants (n = 463) and also found that explicit preferences dictated the intended donations for conservation of biomes and species. Our findings reveal discrepancies between implicit and explicit preferences toward species, but not toward biomes. Importantly, the results demonstrate that explicit rather than implicit preferences predict conservation intentions for biodiversity. The current findings have several implications for conservation and the communication of biodiversity initiatives.	[Echeverri, Alejandra; Callahan, Megan M.; Chan, Kai M. A.; Satterfield, Terre; Zhao, Jiaying] Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC, Canada; [Zhao, Jiaying] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Echeverri, A (corresponding author), Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC, Canada.	alejandra.echeverri@alumni.ubc.ca	Echeverri, Alejandra/GNP-5694-2022; Chan, Kai M A/C-1682-2009	Echeverri, Alejandra/0000-0002-8821-0509; Chan, Kai M A/0000-0002-7804-3276	Canada Research Chairs program; Leaders Opportunity Fund from the Canadian Foundation for Innovation [F07-0010, F14-05370]; NSERC Discovery Grant [RGPIN-2014-05617]; National Science Foundation [SES-0938099]; NSERC CREATE Grant-TerreWEB (Terrestrial Research on Ecosystems on Worldwide Education and Broadcast); Colfuturo (Programa credto beca)	Canada Research Chairs program(Canada Research Chairs); Leaders Opportunity Fund from the Canadian Foundation for Innovation; NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Science Foundation(National Science Foundation (NSF)); NSERC CREATE Grant-TerreWEB (Terrestrial Research on Ecosystems on Worldwide Education and Broadcast); Colfuturo (Programa credto beca)	This work was supported by Canada Research Chairs program and the Leaders Opportunity Fund from the Canadian Foundation for Innovation [grant numbers F07-0010 for KC, and F14-05370 for JZ] (https://www.innovation.ca/en/OurFunds/CFlFunds/LeadersOpportunityFund/LeadersOpportunityFund1M2M); NSERC Discovery Grant [grant number RGPIN-2014-05617 for JZ] (http://www.nserc-crsrg.gc.ca/Protessors-Professeurs/Grants-Subs/DGIGP-PSIGP_eng.asp); National Science Foundation [grant number SES-0938099 for TS and MC] (http://www.nst.gov/funding/aboutfunding.jsp); NSERC CREATE Grant-TerreWEB (Terrestrial Research on Ecosystems on Worldwide Education and Broadcast) for MC (http://terreweb.ubc.ca/about); and Colfuturo (Programa credto beca for AE) (http://www.colfuturo.org/financiacion-para-posgrados-en-el-exterior). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiot CE, 2015, PSYCHOL BULL, V141, P6, DOI 10.1037/a0038147; [Anonymous], 2012, GLOBE MAIL; Archer J, 2011, ETHOLOGY, V117, P217, DOI 10.1111/j.1439-0310.2010.01863.x; Arnett JJ., 2012, ADOLESCENCE EMERGING; Axt JR, 2014, PSYCHOL SCI, V25, P1804, DOI 10.1177/0956797614543801; BALLING JD, 1982, ENVIRON BEHAV, V14, P5, DOI 10.1177/0013916582141001; Bargh J. A., 1984, HDB SOCIAL COGNITION, V1, P1; Batt S., 2009, BIOSCIENCE HORIZONS, V2, P180, DOI [https://doi.org/10.1093/biohorizons/hzp021, DOI 10.1093/BIOHORIZONS/HZP021]; Berger LR, 1996, J HUM EVOL, V30, P343, DOI 10.1006/jhev.1996.0027; Campbell TH, 2014, J PERS SOC PSYCHOL, V107, P809, DOI 10.1037/a0037963; Che D, 2006, GEOFORUM, V37, P212, DOI 10.1016/j.geoforum.2005.02.010; Czech B, 1998, CONSERV BIOL, V12, P1103, DOI 10.1046/j.1523-1739.1998.97253.x; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Hall CM, 2011, J HERIT TOUR, V6, P309, DOI 10.1080/1743873X.2011.620116; Han KT, 2007, ENVIRON BEHAV, V39, P529, DOI 10.1177/0013916506292016; Heerwagen JH, 1995, BIOPHILIA HYPOTHESIS, V138, P138; Jones JPG, 2008, CONSERV BIOL, V22, P976, DOI 10.1111/j.1523-1739.2008.00970.x; Kaltenborn BP, 2002, LANDSCAPE URBAN PLAN, V59, P1, DOI 10.1016/S0169-2046(01)00243-2; Kampstra P., 2008, J STAT SOFTW, V28, P1, DOI [10.18637/jss.v028.c01, DOI 10.18637/JSS.V028.C01]; KAPLAN S, 1987, ENVIRON BEHAV, V19, P3, DOI 10.1177/0013916587191001; KELLERT SR, 1993, CONSERV BIOL, V7, P845, DOI 10.1046/j.1523-1739.1993.740845.x; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Lorenz K., 1943, Zeitschrift fuer Tierpsychologie Berlin, V5, P235; Manfredo MJ, 2009, WHO CARES WILDLIFE; Martin-Lopez B, 2007, BIOL CONSERV, V139, P67, DOI 10.1016/j.biocon.2007.06.005; Morse-Jones S, 2012, ECOL ECON, V78, P9, DOI 10.1016/j.ecolecon.2011.11.002; NAESS A, 1973, INQUIRY, V16, P95, DOI 10.1080/00201747308601682; Nosek BA, 2014, PLOS ONE, V9; Potts R, 1998, YEARB PHYS ANTHROPOL, V41, P93; RAYNER RJ, 1993, J HUM EVOL, V24, P219, DOI 10.1006/jhev.1993.1016; Schmidtz D., 1998, J APPL PHILOS, V15, P57, DOI [DOI 10.1111/1468-5930.00073, 10.1111/1468-5930.00073]; Schultz PW, 2004, J ENVIRON PSYCHOL, V24, P31, DOI 10.1016/S0272-4944(03)00022-7; Serpell JA, 2004, ANIM WELFARE, V13, pS145; Simons Elwyn L., 2001, Lemur News, V6, P11; Singer P, 1995, PEOPLE PENGUINS PLAS, P79; Slovic P, 2007, EUR J OPER RES, V177, P1333, DOI 10.1016/j.ejor.2005.04.006; Smith L, 2012, CURATOR, V55, P453, DOI 10.1111/j.2151-6952.2012.00168.x; Sriram N, 2009, EXP PSYCHOL, V56, P283, DOI 10.1027/1618-3169.56.4.283; Stokes DL, 2007, HUM ECOL, V35, P361, DOI 10.1007/s10745-006-9056-7; Szalay L.B., 1978, SUBJECTIVE MEANING C; Teachman BA, 2001, J ABNORM PSYCHOL, V110, P226, DOI 10.1037/0021-843X.110.2.226; Tengo M, 2007, AMBIO, V36, P683, DOI 10.1579/0044-7447(2007)36[683:TAFGIP]2.0.CO;2; Turpie JK, 2003, ECOL ECON, V46, P199, DOI 10.1016/S0921-8009(03)00122-8; Ulrich R. S., 1995, BIOPHILIA HYPOTHESIS, P73; Ward PI, 1998, CONSERV BIOL, V12, P1408, DOI 10.1046/j.1523-1739.1998.97402.x; Waters AM, 2011, MOTIV EMOTION, V35, P23, DOI 10.1007/s11031-010-9191-8; White PCL, 1999, J ENVIRON MANAGE, V55, P1, DOI 10.1006/jema.1998.0250; WOLDEGABRIEL G, 1994, NATURE, V371, P330, DOI 10.1038/371330a0; Woods B., 2000, J TOURISM STUDIES, V11, P25	52	9	9	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170973	10.1371/journal.pone.0170973	http://dx.doi.org/10.1371/journal.pone.0170973			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6PA	28135298	Green Published, Green Submitted, gold			2022-12-27	WOS:000396124700036
J	Hazzah, L; Bath, A; Dolrenry, S; Dickman, A; Frank, L				Hazzah, Leela; Bath, Alistair; Dolrenry, Stephanie; Dickman, Amy; Frank, Laurence			From Attitudes to Actions: Predictors of Lion Killing by Maasai Warriors	PLOS ONE			English	Article							LARGE CARNIVORES; PROTECTED AREAS; NATIONAL-PARK; PANTHERA-LEO; CONSERVATION; CONFLICT; LIVESTOCK; PREDATORS; COMMUNITY; DETERMINANTS	Despite legal protection, deliberate killing by local people is one of the major threats to the conservation of lions and other large carnivores in Africa. Addressing this problem poses particular challenges, mainly because it is difficult to uncover illicit behavior. This article examined two groups of Maasai warriors: individuals who have killed African lions (Panthera leo) and those who have not. We conducted interviews to explore the relationship between attitudes, intentions and known lion killing behavior. Factor analysis and logistic regression revealed that lion killing was mainly determined by: (a) general attitudes toward lions, (b) engagement in traditional customs, (c) lion killing intentions to defend property, and (d) socio- cultural killing intentions. Our results indicated that general attitudes toward lions were the strongest predictor of lion killing behavior. Influencing attitudes to encourage pro-conservation behavior may help reduce killing.	[Hazzah, Leela; Dolrenry, Stephanie] Univ Wisconsin, Nelson Inst Environm Studies, Madison, WI 53706 USA; [Hazzah, Leela; Dolrenry, Stephanie; Frank, Laurence] Living Lions, Nanyuki, Kenya; [Bath, Alistair] Mem Univ, Dept Geog, Human Dimens Wildlife Management, St John, NF, Canada; [Dickman, Amy] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Tubney House, Oxford, England; [Frank, Laurence] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Hazzah, Leela; Dolrenry, Stephanie] Lion Guardians, Nairobi, Kenya	University of Wisconsin System; University of Wisconsin Madison; Memorial University Newfoundland; University of Oxford; University of California System; University of California Berkeley	Hazzah, L (corresponding author), Univ Wisconsin, Nelson Inst Environm Studies, Madison, WI 53706 USA.; Hazzah, L (corresponding author), Living Lions, Nanyuki, Kenya.; Hazzah, L (corresponding author), Lion Guardians, Nairobi, Kenya.	Lhazzah@gmail.com			Panthera Kaplan Graduate Award; Fulbright-Hays Doctoral Dissertation Research Abroad (DDRA) Fellowship; Panthera	Panthera Kaplan Graduate Award; Fulbright-Hays Doctoral Dissertation Research Abroad (DDRA) Fellowship; Panthera	This research was funded by Panthera Kaplan Graduate Award (https://www.panthera.org/grants-and-fellowships) to LH and by the Fulbright-Hays Doctoral Dissertation Research Abroad (DDRA) Fellowship (http://www2.ed.gov/programs/iegpsddrap/index.html) to LH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Eselenkei, Olgulului, and Mbirikani communities for their participation and collaboration. This study was conducted with the permission of the Government of Kenya (Permit No. MOEST 13/C689). A special thanks to L. Maamai for his critical field assistance and to D. Kaplan for his statistical help. This research was funded by Panthera and the Fulbright-Hays Doctoral Dissertation Research Fellowship. This manuscript was substantially improved by comments from four anonymous reviewers.	Abade L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096261; Aiyadurai A, 2010, ORYX, V44, P564, DOI 10.1017/S0030605309990937; Albarracin D, 2005, HANDBOOK OF ATTITUDES, P3; Ale S, 1998, INT SNOW LEOPARD TRU, V16, P417; Allendorf T, 2006, ENVIRON CONSERV, V33, P344, DOI 10.1017/S0376892906003389; [Anonymous], 2016, CAMBRIDGE DICT; Anthony B, 2007, ENVIRON CONSERV, V34, P236, DOI 10.1017/S0376892907004018; Bangs EE, 2005, CONSERV BIOL SER, V9, P340; Baruch-Mordo S., 2009, Human Dimensions of Wildlife, V14, P219, DOI 10.1080/10871200902839324; Bauer H, 2015, IUCN RED LIST THREAT, DOI 10.2305/IUCN.UK.2015-2.RLTS.T15951A50658092.en; Bernard H. R., 1998, HDB METHODS CULTURAL; Blackburn S, 2016, J APPL ECOL; Breitenmoser U, 1998, BIOL CONSERV, V83, P279, DOI 10.1016/S0006-3207(97)00084-0; Browne-Nunez C., 2008, Human Dimensions of Wildlife, V13, P47, DOI 10.1080/10871200701812936; Browne-Nunez C.M, 2010, TOLERANCE WILDLIFE O; Conteh A, 2015, BIOL CONSERV, V189, P16, DOI 10.1016/j.biocon.2015.02.002; DECKER DJ, 1988, WILDLIFE SOC B, V16, P53; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Dickman AJ, 2016, PROBLEMATIC WILDLIFE, P339, DOI [10.1007/978-3-319-22246-2_16, DOI 10.1007/978-3-319-22246-2_16]; Dickman AJ, 2014, BIOL CONSERV, V178, P19, DOI 10.1016/j.biocon.2014.07.011; Dolrenry S., 2013, THESIS; Dolrenry S, 2016, CONSERV BIOL, V30, P467, DOI 10.1111/cobi.12703; Dunlap RE, 2000, J SOC ISSUES, V56, P425, DOI 10.1111/0022-4537.00176; Eliason Stephen L., 2004, Human Dimensions of Wildlife, V9, P119, DOI 10.1080/10871200490441775; Fishbein M., 1992, INFLUENCING HUMAN BE, P29; Fox Jr J., 2015, APPL REGRESSION ANAL; Frank Laurence, 2011, Smithsonian Contributions to Zoology, P73; Fulton D.C., 1996, HUMAN DIMENSIONS WIL, V1, P24, DOI DOI 10.1080/10871209609359060; Galaty J., 1993, BEING MAASAI; Goldman Mara J., 2010, Human Dimensions of Wildlife, V15, P332, DOI 10.1080/10871209.2010.506671; Gorden R. L., 1977, UNIDIMENSIONAL SCALI; Groom R, 2008, ENVIRON CONSERV, V35, P242, DOI 10.1017/S037689290800489X; Hazzah L, 2011, EXPLORING ATTITUDES; Hazzah L., 2011, THESIS; Hazzah L, 2014, CONSERV BIOL, V28, P851, DOI 10.1111/cobi.12244; Hazzah L, 2009, BIOL CONSERV, V142, P2428, DOI 10.1016/j.biocon.2009.06.006; Heberlein TA, 2012, CONSERV BIOL, V26, P583, DOI 10.1111/j.1523-1739.2012.01892.x; INFIELD M, 1988, BIOL CONSERV, V45, P21, DOI 10.1016/0006-3207(88)90050-X; Infield M, 2001, ORYX, V35, P48, DOI 10.1017/S0030605300031537; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; Iucn Cat Specialist Group, 2006, REG CONS STRAT LION; Jackson P., 1996, BIOL CONSERVATION; Jhamvar-Shingote Ramaa, 2013, Human Dimensions of Wildlife, V18, P32, DOI 10.1080/10871209.2012.694578; John FAVS, 2010, BIOL CONSERV, V143, P1025, DOI 10.1016/j.biocon.2010.01.018; Kahler JS, 2012, INT J COMP APPL CRIM, V36, P103, DOI 10.1080/01924036.2012.669913; Law K. S., 2000, TRANSLATING QUESTION, DOI 10.4135/9781412986373; Lee TM, 2009, ENVIRON CONSERV, V36, P157, DOI 10.1017/S0376892909990178; Linnell JDC, 1999, WILDLIFE SOC B, V27, P698; Liu F, 2011, BIOL CONSERV, V144, P538, DOI 10.1016/j.biocon.2010.10.009; Loveridge Andrew J., 2010, P161; Lyon K, 2009, NE RECR RES S BOLT L, P29; Maclennan S., 2009, BIOL CONSERV, V11, P2419; Maddox T., 2003, THESIS; Manfredo M.J., 2004, HUM DIMENS WILDL, V9, P1, DOI [10.1080/10871200490505765, DOI 10.1080/10871200490505765]; Manfredo Michael J., 2003, Human Dimensions of Wildlife, V8, P287, DOI 10.1080/716100425; Marchini S, 2012, BIOL CONSERV, V147, P213, DOI 10.1016/j.biocon.2012.01.002; Marker LL, 2003, CONSERV BIOL, V17, P1290, DOI 10.1046/j.1523-1739.2003.02077.x; McCleery RA, 2006, WILDLIFE SOC B, V34, P537, DOI 10.2193/0091-7648(2006)34[537:UAIARI]2.0.CO;2; McManus JS, 2015, ORYX, V49, P687, DOI 10.1017/S0030605313001610; Mishra C, 1997, ENVIRON CONSERV, V24, P338, DOI 10.1017/S0376892997000441; Muth RM, 1998, SOC NATUR RESOUR, V11, P9, DOI 10.1080/08941929809381058; Noss RF, 1996, CONSERV BIOL, V10, P949, DOI 10.1046/j.1523-1739.1996.10040949.x; Ogada MO, 2003, CONSERV BIOL, V17, P1521, DOI 10.1111/j.1523-1739.2003.00061.x; Okello Moses Makonjio, 2005, Human Dimensions of Wildlife, V10, P19, DOI 10.1080/10871200590904851; Okello MM, 2009, NAT RESOUR FORUM, V33, P123, DOI 10.1111/j.1477-8947.2009.01216.x; Ray J, 2013, LARGE CARNIVORES CON; Ray J.C., 2005, 24 WILDL CONS SOC; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Riley EP, 2010, ORYX, V44, P235, DOI 10.1017/S0030605309990925; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Romanach SS, 2007, ORYX, V41, P185, DOI 10.1017/S0030605307001779; Rust NA, 2016, SOC NATUR RESOUR, P1; Saitoti Tepilit Ole, 1986, WORLDS MAASAI WARRIO; SCHENSUL STEPHEN L., 1999, ESSENTIAL ETHNOGRAPH, V2; Sillero-Zubiri C, 2001, CONSERV BIOL SER, V5, P282; Solomon J., 2007, HUM DIMENS WILDL, V12, P75, DOI [10.1080/10871200701195365, DOI 10.1080/10871200701195365]; Spear T., 1993, BEING MAASAI; St John FAV, 2012, P ROY SOC B-BIOL SCI, V279, P804, DOI 10.1098/rspb.2011.1228; St John FAV, 2010, WILDLIFE RES, V37, P658, DOI 10.1071/WR10032; Tabachnick B. G., 2019, USING MULTIVARIATE S, V5; TAMBIAH SJ, 1969, ETHNOLOGY, V8, P423, DOI 10.2307/3772910; Tarayia G N, 2004, J INT COMP LAW, V21, P183; Teel TL, 2010, INT J SOCIOL, V40, P104, DOI 10.2753/IJS0020-7659400306; Thirgood S, 2005, CONSERV BIOL SER, V9, P13; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; WESTERN D, 1994, NATURAL CONNECTIONS, P15; WHITE L, 1967, SCIENCE, V155, P1203, DOI 10.1126/science.155.3767.1203; Woodroffe R, 2005, ANIM CONSERV, V8, P91, DOI 10.1017/S1367943004001829; Woodroffe R., 2005, CONSERV BIOL; Zimmermann A, 2005, ORYX, V39, P406, DOI 10.1017/S0030605305000992	90	38	38	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170796	10.1371/journal.pone.0170796	http://dx.doi.org/10.1371/journal.pone.0170796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6PA	28135338	gold, Green Published, Green Submitted			2022-12-27	WOS:000396124700021
J	Machova, I; Hubalek, M; Lepsik, M; Bednarova, L; Pazderkova, M; Kopecky, V; Snasel, J; Dostal, J; Pichova, I				Machova, Iva; Hubalek, Martin; Lepsik, Martin; Bednarova, Lucie; Pazderkova, Marketa; Kopecky, Vladimir, Jr.; Snasel, Jan; Dostal, Jiri; Pichova, Ival			The Role of Cysteine Residues in Catalysis of Phosphoenolpyruvate Carboxykinase from Mycobacterium tuberculosis	PLOS ONE			English	Article							STRUCTURAL INSIGHTS; METABOLISM; MECHANISM; PROTEINS; PEPCK; SITE	Mycobacterium tuberculosis (MTb), the causative agent of tuberculosis, can persist in macrophages for decades, maintaining its basic metabolic activities. Phosphoenolpyruvate carboxykinase (Pck; EC 4.1.1.32) is a key player in central carbon metabolism regulation. In replicating MTb, Pck is associated with gluconeogenesis, but in non-replicating MTb, it also catalyzes the reverse anaplerotic reaction. Here, we explored the role of selected cysteine residues in function of MTb Pck under different redox conditions. Using mass spectrometry analysis we confirmed formation of S-S bridge between cysteines C391 and C397 localized in the C-terminal subdomain. Molecular dynamics simulations of C391-C397 bridged model indicated local conformation changes needed for formation of the disulfide. Further, we used circular dichroism and Raman spectroscopy to analyze the influence of C391 and C397 mutations on Pck secondary and tertiary structures, and on enzyme activity and specificity. We demonstrate the regulatory role of C391 and C397 that form the S S bridge and in the reduced form stabilize Pck tertiary structure and conformation for gluconeogenic and anaplerotic reactions.	[Machova, Iva; Hubalek, Martin; Lepsik, Martin; Bednarova, Lucie; Pazderkova, Marketa; Snasel, Jan; Dostal, Jiri; Pichova, Ival] Czech Acad Sci, Inst Organ Chem & Biochem, Prague, Czech Republic; [Pazderkova, Marketa; Kopecky, Vladimir, Jr.] Charles Univ Prague, Inst Phys, Fac Math & Phys, Prague, Czech Republic	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Charles University Prague	Pichova, I (corresponding author), Czech Acad Sci, Inst Organ Chem & Biochem, Prague, Czech Republic.	iva.pichova@uochb.cas.cz	Lepšík, Martin/X-8603-2019; Kopecký, Vladimír/A-6965-2008; Pazderková, Markéta/AAH-7815-2020; Hubalek, Martin/H-1400-2014; Bednarova, Lucie/E-7622-2012; Machova, Iva/AAH-7522-2020; Machova, Iva/G-5578-2014; Dostal, Jiri/E-9584-2012; Lepsik, Martin/C-6614-2012	Lepšík, Martin/0000-0003-2607-8132; Kopecký, Vladimír/0000-0002-7331-9018; Pazderková, Markéta/0000-0003-1086-4497; Hubalek, Martin/0000-0003-0247-7956; Machova, Iva/0000-0003-3231-4509; Machova, Iva/0000-0003-3231-4509; Lepsik, Martin/0000-0003-2607-8132	Ministry of Education of the Czech Republic [LO1302]; Czech Science Foundation [P208/12/G016]; Large Infrastructures for Research, Experimental Development and Innovations project "IT4Innovations National Supercomputing Center" [LM2015070];  [RVO61388963]	Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); Large Infrastructures for Research, Experimental Development and Innovations project "IT4Innovations National Supercomputing Center"; 	This work was supported by NPU project LO1302 from the Ministry of Education of the Czech Republic and by project RVO61388963. ML was supported by the Czech Science Foundation (grant number P208/12/G016). This work was supported by NPU project LO1302 from the Ministry of Education of the Czech Republic and by project RVO61388963. ML was supported by the Czech Science Foundation (grant number P208/12/G016). This work was supported from the Large Infrastructures for Research, Experimental Development and Innovations project "IT4Innovations National Supercomputing Center LM2015070".	Beste DJV, 2013, CHEM BIOL, V20, P1012, DOI 10.1016/j.chembiol.2013.06.012; Beste DJV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002091; Carlson GM, 2009, J BIOL CHEM, V284, P27037, DOI 10.1074/jbc.R109.040568; CARLSON GM, 1978, BIOCHEMISTRY-US, V17, P5329, DOI 10.1021/bi00618a002; Case DA, 2014, AMBER 14; Holyoak T, 2006, BIOCHEMISTRY-US, V45, P8254, DOI 10.1021/bi060269g; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Kopecky V, 2006, VIB SPECTROSC, V42, P184, DOI 10.1016/j.vibspec.2006.04.019; KRAUTWURST H, 1995, BIOCHEMISTRY-US, V34, P6382, DOI 10.1021/bi00019a017; LEWIS CT, 1993, J BIOL CHEM, V268, P1628; Liu F, 2014, MOL CELL PROTEOMICS, V13, P2776, DOI 10.1074/mcp.O114.039057; Machova I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120682; Machova I, 2014, J BIOL CHEM, V289, P13066, DOI 10.1074/jbc.M113.536748; MAKINEN AL, 1989, J BIOL CHEM, V264, P12148; Pytelkova J, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-3; Rohde KH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002769; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; Shi LB, 2010, MOL MICROBIOL, V78, P1199, DOI 10.1111/j.1365-2958.2010.07399.x; Shi LB, 2005, P NATL ACAD SCI USA, V102, P15629, DOI 10.1073/pnas.0507850102; Srinivasan V, 2006, BIOL BULL-US, V210, P1, DOI 10.2307/4134531; Sullivan SM, 2007, BIOCHEMISTRY-US, V46, P10078, DOI 10.1021/bi701038x; Thomas GJ, 2002, BIOPOLYMERS, V67, P214, DOI 10.1002/bip.10105; Watanabe S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002287; Zakova L, 2013, J BIOL CHEM, V288, P10230, DOI 10.1074/jbc.M112.448050	27	0	0	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170373	10.1371/journal.pone.0170373	http://dx.doi.org/10.1371/journal.pone.0170373			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135343	Green Submitted, Green Published, gold			2022-12-27	WOS:000396124700012
J	Mirciov, CSG; Wilkins, SJ; Dunn, LA; Anderson, GJ; Frazer, DM				Mirciov, Cornel S. G.; Wilkins, Sarah J.; Dunn, Linda A.; Anderson, Gregory J.; Frazer, David M.			Characterization of Putative Erythroid Regulators of Hepcidin in Mouse Models of Anemia	PLOS ONE			English	Article							DIFFERENTIATION FACTOR 15; SOLUBLE TRANSFERRIN RECEPTOR; BETA-THALASSEMIA; HEMOGLOBIN-DEFICIT; IRON-ABSORPTION; ERYTHROFERRONE CONTRIBUTES; ERYTHROPOIESIS; MICE; EXPRESSION; FERROPORTIN	Iron is crucial for many biological functions, but quantitatively the most important use of iron is in the production of hemoglobin in red blood cell precursors. The amount of iron in the plasma, and hence its availability for hemoglobin synthesis, is determined by the liver-derived iron regulatory hormone hepcidin. When the iron supply to erythroid precursors is limited, as often occurs during stimulated erythropoiesis, these cells produce signals to inhibit hepatic hepcidin production, thereby increasing the amount of iron that enters the plasma. How stimulated erythropoiesis suppresses hepcidin production is incompletely understood, but erythroferrone, Gdf15 and Twsg1 have emerged as candidate regulatory molecules. To further examine the relationship between erythropoiesis and the candidate erythroid regulators, we have studied five mouse models of anemia, including two models of beta-thalassemia (Hbb(th3/+) and RBC14), the hemoglobin deficit mouse (hbd), dietary iron deficient mice and mice treated with phenylhydrazine to induce acute hemolysis. Hematological parameters, iron status and the expression of Erfe (the gene encoding erythroferrone), Gdf15 and Twsg1 in the bone marrow and spleen were examined. Erfe expression was the most consistently upregulated of the candidate erythroid regulators in all of the mouse models examined. Gene expression was particularly high in the bone marrow and spleen of iron deficient animals, making erythroferrone an ideal candidate erythroid regulator, as its influence is strongest when iron supply to developing erythroid cells is limited. Gdf15 expression was also upregulated in most of the anemia models studied although the magnitude of the increase was generally less than that of Erfe. In contrast, very little regulation of Twsg1 was observed. These results support the prevailing hypothesis that erythroferrone is a promising erythroid regulator and demonstrate that Erfe expression is stimulated most strongly when the iron supply to developing erythroid cells is compromised.	[Mirciov, Cornel S. G.; Wilkins, Sarah J.; Dunn, Linda A.; Anderson, Gregory J.; Frazer, David M.] QIMR Berghofer Med Res Inst, Iron Metab Lab, Herston, Qld, Australia; [Mirciov, Cornel S. G.; Anderson, Gregory J.] Univ Queensland, Sch Med, St Lucia, Qld, Australia; [Anderson, Gregory J.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia	QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland	Frazer, DM (corresponding author), QIMR Berghofer Med Res Inst, Iron Metab Lab, Herston, Qld, Australia.	david.frazer@qimrberghofer.edu.au	Frazer, David M/L-3570-2014; Anderson, Gregory/G-4148-2013	Frazer, David M/0000-0003-4098-1379; Mirciov, Cornel/0000-0002-9083-2614; Anderson, Gregory/0000-0002-8814-5866	National Health and Medical Research Council of Australia [APP1051764]; Australian Government Research Training Program Scholarship (CSGM); Top Up Award from the QIMR Berghofer Higher Degrees Committee (CSGM)	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Research Training Program Scholarship (CSGM)(Australian Government); Top Up Award from the QIMR Berghofer Higher Degrees Committee (CSGM)	This work was supported by a project grant (APP1051764) from the National Health and Medical Research Council of Australia (GJA and DMF), an Australian Government Research Training Program Scholarship (CSGM), and a Top Up Award from the QIMR Berghofer Higher Degrees Committee (CSGM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Aslam MF, 2014, FASEB J, V28, P3671, DOI 10.1096/fj.14-251520; Brown FC, 2013, BLOOD CELL MOL DIS, V50, P86, DOI 10.1016/j.bcmd.2012.09.004; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Casanovas G, 2013, HAEMATOLOGICA, V98, P444, DOI 10.3324/haematol.2012.069807; CAZZOLA M, 1987, J LAB CLIN MED, V110, P734; Daba A, 2013, J MOL MED, V91, P95, DOI 10.1007/s00109-012-0937-5; Fertrin KY, 2014, AM J HEMATOL, V89, P385, DOI 10.1002/ajh.23649; FINCH C, 1994, BLOOD, V84, P1697; Finkenstedt A, 2012, BLOOD CELL MOL DIS, V48, P233, DOI 10.1016/j.bcmd.2012.02.001; Flanagan JM, 2006, ACTA HAEMATOL-BASEL, V116, P249, DOI 10.1159/000095875; Frazer DM, 2016, BRIT J HAEMATOL, V175, P308, DOI 10.1111/bjh.14206; Frazer DM, 2014, BIOFACTORS, V40, P206, DOI 10.1002/biof.1148; Frazer DM, 2012, BRIT J HAEMATOL, V157, P615, DOI 10.1111/j.1365-2141.2012.09104.x; Frazer DM, 2003, BLOOD CELL MOL DIS, V30, P288, DOI 10.1016/S1079-9796(03)00039-1; Frazer DM, 2004, GUT, V53, P1509, DOI 10.1136/gut.2003.037416; Gardenghi S, 2007, BLOOD, V109, P5027, DOI 10.1182/blood-2006-09-048868; GARRICK LM, 1987, EXP HEMATOL, V15, P671; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kautz L, 2015, BLOOD, V126, P2031, DOI 10.1182/blood-2015-07-658419; Kautz L, 2014, BLOOD, V124, P2569, DOI 10.1182/blood-2014-06-584607; Kautz L, 2014, NAT GENET, V46, P678, DOI 10.1038/ng.2996; Koury MJ, 2004, ANNU REV NUTR, V24, P105, DOI 10.1146/annurev.nutr.24.012003.132306; Lim JE, 2005, NAT GENET, V37, P1270, DOI 10.1038/ng1659; Liu QD, 2012, J CLIN INVEST, V122, P4635, DOI 10.1172/JCI63924; Lukaszyk E, 2016, INT UROL NEPHROL, V48, P839, DOI 10.1007/s11255-016-1278-z; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pasricha SR, 2013, BLOOD, V122, P124, DOI 10.1182/blood-2012-12-471441; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; POOTRAKUL P, 1984, AM J CLIN PATHOL, V82, P289, DOI 10.1093/ajcp/82.3.289; Racz Z, 2011, NUCLEIC ACID THER, V21, P215, DOI 10.1089/nat.2010.0248; Ramirez JM, 2009, BRIT J HAEMATOL, V144, P251, DOI 10.1111/j.1365-2141.2008.07441.x; Rund D, 2005, NEW ENGL J MED, V353, P1135, DOI 10.1056/NEJMra050436; Salojin KV, 2011, BLOOD, V117, P4895, DOI 10.1182/blood-2010-04-279653; Seldin MM, 2012, ADIPOCYTE, V1, P200, DOI 10.4161/adip.20877; Seldin MM, 2012, J BIOL CHEM, V287, P11968, DOI 10.1074/jbc.M111.336834; Sharma N, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-90; Speeckaert MM, 2010, CRIT REV CL LAB SCI, V47, P213, DOI 10.3109/10408363.2010.550461; Tamary H, 2008, BLOOD, V112, P5241, DOI 10.1182/blood-2008-06-165738; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Tanno T, 2009, BLOOD, V114, P181, DOI 10.1182/blood-2008-12-195503; TORRANCE J D, 1968, South African Journal of Medical Sciences, V33, P9; YANG BL, 1995, P NATL ACAD SCI USA, V92, P11608, DOI 10.1073/pnas.92.25.11608; Zhang AS, 2006, EXP HEMATOL, V34, P593, DOI 10.1016/j.exphem.2006.02.004	45	14	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171054	10.1371/journal.pone.0171054	http://dx.doi.org/10.1371/journal.pone.0171054			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135344	gold, Green Submitted, Green Published			2022-12-27	WOS:000396124700044
J	Nowakiewicz, A; Ziolkowska, G; Zieba, P; Gnat, S; Troscianczyk, A; Adaszek, L				Nowakiewicz, Aneta; Ziolkowska, Grazyna; Zieba, Przemyslaw; Gnat, Sebastian; Troscianczyk, Aleksandra; Adaszek, Lukasz			Characterization of Multidrug Resistant E. faecalis Strains from Pigs of Local Origin by ADSRRS-Fingerprinting and MALDI-TOF MS; Evaluation of the Compatibility of Methods Employed for Multidrug Resistance Analysis	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; FIELD GEL-ELECTROPHORESIS; ANTIBIOTIC-RESISTANCE; ENTEROCOCCUS-FAECIUM; MOLECULAR CHARACTERIZATION; ANTIMICROBIAL RESISTANCE; TETRACYCLINE RESISTANCE; PLASMID COLOCALIZATION; ESCHERICHIA-COLI	The aim of this study was to characterize multidrug resistant E. faecalis strains from pigs of local origin and to analyse the relationship between resistance and genotypic and proteomic profiles by amplification of DNA fragments surrounding rare restriction sites (ADSRRS-fingerprinting) and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). From the total pool of Enterococcus spp. isolated from 90 pigs, we selected 36 multidrug resistant E. faecalis strains, which represented three different phenotypic resistance profiles. Phenotypic resistance to tetracycline, macrolides, phenicols, and lincomycin and high-level resistance to aminoglycosides were confirmed by the occurrence of at least one corresponding resistance gene in each strain. Based on the analysis of the genotypic and phenotypic resistance of the strains tested, five distinct resistance profiles were generated. As a complement of this analysis, profiles of virulence genes were determined and these profiles corresponded to the phenotypic resistance profiles. The demonstration of resistance to a wide panel of antimicrobials by the strains tested in this study indicates the need of typing to determine the spread of resistance also at the local level. It seems that in the case of E. faecalis, type and scope of resistance strongly determines the genotypic pattern obtained with the ADSRRS-fingerprinting method. The ADSRRS-fingerprinting analysis showed consistency of the genetic profiles with the resistance profiles, while analysis of data with the use of the MALDI-TOF MS method did not demonstrate direct reproduction of the clustering pattern obtained with this method. Our observations were confirmed by statistical analysis (Simpson's index of diversity, Rand and Wallace coefficients). Even though the MALDI-TOF MS method showed slightly higher discrimination power than ADSRRS-fingerprinting, only the latter method allowed reproduction of the clustering pattern of isolates based on phenotypic resistance and analysis of resistance and virulence genes (Wallace coefficient 1.0). This feature seems to be the most useful for epidemiological purposes and short-term analysis.	[Nowakiewicz, Aneta; Ziolkowska, Grazyna; Gnat, Sebastian; Troscianczyk, Aleksandra] Univ Life Sci, Inst Biol Bases Anim Dis, Sub Dept Vet Microbiol, Fac Vet Med, Lublin, Poland; [Zieba, Przemyslaw] State Vet Lab, Lublin, Poland; [Adaszek, Lukasz] Univ Life Sci, Dept Epizootiol, Fac Vet Med, Lublin, Poland; [Adaszek, Lukasz] Univ Life Sci, Clin Infect Dis, Fac Vet Med, Lublin, Poland		Nowakiewicz, A (corresponding author), Univ Life Sci, Inst Biol Bases Anim Dis, Sub Dept Vet Microbiol, Fac Vet Med, Lublin, Poland.	anowakiewicz@gmail.com	Trościańczyk, Aleksandra/T-6583-2018; Gnat, Sebastian/J-4340-2019; Nowakiewicz, Aneta/J-6308-2019	Trościańczyk, Aleksandra/0000-0002-6400-2131; Gnat, Sebastian/0000-0001-9872-0046; Nowakiewicz, Aneta/0000-0003-3961-5291; Zieba, Przemyslaw/0000-0003-1881-0311; Adaszek, Lukasz/0000-0003-0261-2695				Aarestrup FM, 2001, ANTIMICROB AGENTS CH, V45, P2054, DOI 10.1128/AAC.45.7.2054-2059.2001; Aarestrup FM, 2000, DIAGN MICR INFEC DIS, V37, P127, DOI 10.1016/S0732-8893(00)00130-9; Adaszek L, 2014, PARASITOL RES, V113, P4293, DOI 10.1007/s00436-014-4124-1; Becker PT, 2014, MED MYCOL, V52, P826, DOI 10.1093/mmy/myu064; Bozdogan B, 1999, ANTIMICROB AGENTS CH, V43, P925, DOI 10.1128/AAC.43.4.925; Chandler JR, 2004, PEPTIDES, V25, P1377, DOI 10.1016/j.peptides.2003.10.020; Choi JM, 2015, CURR MICROBIOL, V70, P476, DOI 10.1007/s00284-014-0742-1; Chow JW, 2000, CLIN INFECT DIS, V31, P586, DOI 10.1086/313949; Clinical and laboratory standards institute, 2014, M100S24 CLIN LAB STA, V34; Corso AC, 2007, INT J INFECT DIS, V11, P69, DOI 10.1016/j.ijid.2006.02.003; De Leener E, 2004, MICROB DRUG RESIST, V10, P341, DOI 10.1089/mdr.2004.10.341; Dicuonzo G, 2001, FEMS MICROBIOL LETT, V201, P205, DOI 10.1111/j.1574-6968.2001.tb10758.x; Eaton TJ, 2001, APPL ENVIRON MICROB, V67, P1628, DOI 10.1128/AEM.67.4.1628-1635.2001; Emonet S, 2010, CLIN MICROBIOL INFEC, V16, P1604, DOI 10.1111/j.1469-0691.2010.03368.x; Fard RMN, 2011, VET MICROBIOL, V148, P276, DOI 10.1016/j.vetmic.2010.09.002; Garrido AM., 2014, J INFECT DIS THERAPY, V2, P150, DOI DOI 10.4172/2332-0877.1000150; Giebel RA, 2008, WATER RES, V42, P931, DOI 10.1016/j.watres.2007.09.005; Gnat S, 2016, J MED MICROBIOL; Griffin PM, 2012, J CLIN MICROBIOL, V50, P2918, DOI 10.1128/JCM.01000-12; Hammerum AM, 2012, CLIN MICROBIOL INFEC, V18, P619, DOI 10.1111/j.1469-0691.2012.03829.x; Heuer OE, 2006, CLIN INFECT DIS, V43, P911, DOI 10.1086/507534; Hidano A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121189; Hoang TTT, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1754-3; Hrabak J, 2013, CLIN MICROBIOL REV, V26, P103, DOI 10.1128/CMR.00058-12; Hummel A, 2007, SYST APPL MICROBIOL, V30, P1, DOI 10.1016/j.syapm.2006.02.004; Huys G, 2004, APPL ENVIRON MICROB, V70, P1555, DOI 10.1128/AEM.70.3.1555-1562.2004; Jackson CR, 2010, J APPL MICROBIOL, V108, P2171, DOI 10.1111/j.1365-2672.2009.04619.x; Jackson CR, 2005, EPIDEMIOL INFECT, V133, P367, DOI 10.1017/S0950268804003395; Josten M, 2013, J CLIN MICROBIOL, V51, P1809, DOI 10.1128/JCM.00518-13; Katsunuma Y, 2008, J GEN APPL MICROBIOL, V54, P39, DOI 10.2323/jgam.54.39; Khan SA, 2005, MOL CELL PROBE, V19, P27, DOI 10.1016/j.mcp.2004.09.001; Kostrzewa M, 2013, PROTEOM CLIN APPL, V7, P767, DOI 10.1002/prca.201300042; Krawczyk B, 2003, FEMS IMMUNOL MED MIC, V38, P241, DOI 10.1016/S0928-8244(03)00149-4; Krawczyk B, 2003, J MICROBIOL METH, V52, P341, DOI 10.1016/S0167-7012(02)00187-2; Krawczyk B, 2007, J MICROBIOL METH, V71, P114, DOI 10.1016/j.mimet.2007.08.010; Krutkiewicz A, 2010, FOLIA MICROBIOL, V55, P167, DOI 10.1007/s12223-010-0025-6; Lasch P, 2014, J MICROBIOL METH, V100, P58, DOI 10.1016/j.mimet.2014.02.015; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Miller WR, 2014, EXPERT REV ANTI-INFE, V12, P1221, DOI 10.1586/14787210.2014.956092; Murray PR, 2010, CLIN MICROBIOL INFEC, V16, P1626, DOI 10.1111/j.1469-0691.2010.03364.x; Mutters NT, 2015, J MED DIAGN METH, V4; Nagy E, 2013, ANAEROBE, V20, P20, DOI 10.1016/j.anaerobe.2013.01.007; Nakano S, 2014, INT J ANTIMICROB AG, V44, P256, DOI 10.1016/j.ijantimicag.2014.05.006; Novais A, 2014, EUR J CLIN MICROBIOL, V33, P1391, DOI 10.1007/s10096-014-2071-5; Novais C, 2013, J ANTIMICROB CHEMOTH, V68, P2746, DOI 10.1093/jac/dkt289; Nowakiewicz A, 2016, POULTRY SCI, P1; Nowakiewicz A, 2016, COMP IMMUNOL MICROB, V44, P21, DOI 10.1016/j.cimid.2015.11.003; Nowakiewicz A, 2015, J MED MICROBIOL, V64, P217, DOI 10.1099/jmm.0.000008; Patel R, 2015, CLIN CHEM, V61, P100, DOI 10.1373/clinchem.2014.221770; Prieto AMG, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00788; Pulido MR, 2013, J ANTIMICROB CHEMOTH, V68, P2710, DOI 10.1093/jac/dkt253; Quintela-Baluja M, 2013, ELECTROPHORESIS, V34, P2240, DOI 10.1002/elps.201200699; Ramos S, 2012, ANN MICROBIOL, V62, P1485, DOI 10.1007/s13213-011-0402-7; Reiter KC, 2013, BRAZIL J INFECT CONT, V2, P112; Rice LB, 1998, ANTIMICROB AGENTS CH, V42, P1871, DOI 10.1128/AAC.42.8.1871; Rim JH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/535027; Sabat AJ, 2013, EUROSURVEILLANCE, V18, P17; Sandrin TR, 2012, MASS SPECTROM REV; Santos T, 2015, J PROTEOMICS, V127, P321, DOI 10.1016/j.jprot.2015.02.017; Sapkota AR, 2006, LETT APPL MICROBIOL, V43, P534, DOI 10.1111/j.1472-765X.2006.01996.x; Sava IG, 2010, CLIN MICROBIOL INFEC, V16, P533, DOI 10.1111/j.1469-0691.2010.03213.x; Schwaiger K, 2009, VET MICROBIOL, V139, P386, DOI 10.1016/j.vetmic.2009.06.005; Schwarz S, 2004, FEMS MICROBIOL REV, V28, P519, DOI 10.1016/j.femsre.2004.04.001; Seputiene V, 2012, POL J VET SCI, V15, P431, DOI 10.2478/v10181-012-0067-6; Shin HB, 2015, YONSEI MED J, V56, P550, DOI 10.3349/ymj.2015.56.2.550; Singhal N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00791; Spinali S, 2015, J CLIN MICROBIOL, V53, P760, DOI 10.1128/JCM.01635-14; Stepien-Pysniak D, 2016, ACTA VET HUNG, V64, P148, DOI 10.1556/004.2016.016; Tadesse DA, 2012, EMERG INFECT DIS, V18, P741, DOI 10.3201/eid1805.111153; Tremblay CL, 2012, J FOOD PROTECT, V75, P1595, DOI 10.4315/0362-028X.JFP-12-047; Tremblay CL, 2011, J FOOD PROTECT, V74, P1639, DOI 10.4315/0362-028X.JFP-10-451; Werner G, 2001, ANTIMICROB AGENTS CH, V45, P3267, DOI 10.1128/AAC.45.11.3267-3269.2001; Werner G., 2013, J BACTERIOL PARASITO, V5; Werner G, 2013, INT J MED MICROBIOL, V303, P360, DOI 10.1016/j.ijmm.2013.03.001; Werner G, 2012, VET MICROBIOL, V160, P162, DOI [10.1016/j.vetmic.2012.05.019, 10.1016/j.vetmic.2012.05.005]	75	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171160	10.1371/journal.pone.0171160	http://dx.doi.org/10.1371/journal.pone.0171160			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135327	Green Published, Green Submitted, gold			2022-12-27	WOS:000396124700054
J	Wuest, SL; Stern, P; Casartelli, E; Egli, M				Wuest, Simon L.; Stern, Philip; Casartelli, Ernesto; Egli, Marcel			Fluid Dynamics Appearing during Simulated Microgravity Using Random Positioning Machines	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL-CELLS; ACTIVATED PROTEIN-KINASE; SHEAR-STRESS; NITRIC-OXIDE; STEM-CELLS; BED REST; EXPRESSION; FORCE; PROLIFERATION; CHONDROCYTES	Random Positioning Machines (RPMs) are widely used as tools to simulate microgravity on ground. They consist of two gimbal mounted frames, which constantly rotate biological samples around two perpendicular axes and thus distribute the Earth's gravity vector in all directions over time. In recent years, the RPM is increasingly becoming appreciated as a laboratory instrument also in non-space-related research. For instance, it can be applied for the formation of scaffold-free spheroid cell clusters. The kinematic rotation of the RPM, however, does not only distribute the gravity vector in such a way that it averages to zero, but it also introduces local forces to the cell culture. These forces can be described by rigid body analysis. Although RPMs are commonly used in laboratories, the fluid motion in the cell culture flasks on the RPM and the possible effects of such on cells have not been examined until today; thus, such aspects have been widely neglected. In this study, we used a numerical approach to describe the fluid dynamic characteristic occurring inside a cell culture flask turning on an operating RPM. The simulations showed that the fluid motion within the cell culture flask never reached a steady state or neared a steady state condition. The fluid velocity depends on the rotational velocity of the RPM and is in the order of a few centimeters per second. The highest shear stresses are found along the flask walls; depending of the rotational velocity, they can reach up to a few 100 mPa. The shear stresses in the "bulk volume", however, are always smaller, and their magnitude is in the order of 10 mPa. In conclusion, RPMs are highly appreciated as reliable tools in microgravity research. They have even started to become useful instruments in new research fields of mechanobiology. Depending on the experiment, the fluid dynamic on the RPM cannot be neglected and needs to be taken into consideration. The results presented in this study elucidate the fluid motion and provide insight into the convection and shear stresses that occur inside a cell culture flask during RPM experiments.	[Wuest, Simon L.; Egli, Marcel] Lucerne Univ Appl Sci & Arts, Sch Engn & Architecture, CC Aerosp Biomed Sci & Technol, Space Biol Grp, Hergiswil, Switzerland; [Stern, Philip; Casartelli, Ernesto] Lucerne Univ Appl Sci & Arts, Sch Engn & Architecture, CC Fluid Mech & Hydraul Machines, Horw, Switzerland		Egli, M (corresponding author), Lucerne Univ Appl Sci & Arts, Sch Engn & Architecture, CC Aerosp Biomed Sci & Technol, Space Biol Grp, Hergiswil, Switzerland.	marcel.egli@hslu.ch	Wuest, Simon/AAI-8620-2020	Wuest, Simon/0000-0002-5495-6951; Egli, Marcel/0000-0002-4064-2871				Aleshcheva G, 2015, MICROGRAVITY SCI TEC, P1; Arunasri K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057860; Bailey JF, 2014, J BIOMECH, V47, P2983, DOI 10.1016/j.jbiomech.2014.07.005; BARBEE KA, 1995, AM J PHYSIOL-HEART C, V268, pH1765, DOI 10.1152/ajpheart.1995.268.4.H1765; BARBEE KA, 1994, CIRC RES, V74, P163, DOI 10.1161/01.RES.74.1.163; Becker JL, 2013, NAT REV CANCER, V13, P315, DOI 10.1038/nrc3507; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Borst AG, 2009, MICROGRAVITY SCI TEC, V21, P287, DOI 10.1007/s12217-008-9043-2; Brungs S., 2016, MICROGRAVITY SCI TEC, P1; Buravkova LB, 2008, ACTA ASTRONAUT, V63, P603, DOI 10.1016/j.actaastro.2008.04.012; Carattino MD, 2004, J BIOL CHEM, V279, P4120, DOI 10.1074/jbc.M311783200; Colombelli J, 2009, J CELL SCI, V122, P1665, DOI 10.1242/jcs.042986; DAVIES PF, 1986, P NATL ACAD SCI USA, V83, P2114, DOI 10.1073/pnas.83.7.2114; DAVIES PF, 1984, J CLIN INVEST, V73, P1121, DOI 10.1172/JCI111298; DEWEY CF, 1981, J BIOMECH ENG-T ASME, V103, P177, DOI 10.1115/1.3138276; Dimmeler S, 1998, CIRC RES, V83, P334, DOI 10.1161/01.RES.83.3.334; Donahue SW, 2001, AM J PHYSIOL-CELL PH, V281, pC1635, DOI 10.1152/ajpcell.2001.281.5.C1635; Fitts RH, 2010, J PHYSIOL-LONDON, V588, P3567, DOI 10.1113/jphysiol.2010.188508; FRANKE RP, 1984, NATURE, V307, P648, DOI 10.1038/307648a0; Galbraith CG, 1998, CELL MOTIL CYTOSKEL, V40, P317, DOI 10.1002/(SICI)1097-0169(1998)40:4<317::AID-CM1>3.0.CO;2-8; Garanich JS, 2005, AM J PHYSIOL-HEART C, V288, pH2244, DOI 10.1152/ajpheart.00428.2003; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Gershovich P M, 2009, Tsitologiia, V51, P896; Gershovich Yu. G., 2011, Human Physiology, V37, P860, DOI 10.1134/S0362119711070139; Grimm D, 2014, TISSUE ENG PART B-RE, V20, P555, DOI [10.1089/ten.teb.2013.0704, 10.1089/ten.TEB.2013.0704]; Hung CT, 2000, J BIOMECH, V33, P73, DOI 10.1016/S0021-9290(99)00176-1; Inoue N, 1996, CIRC RES, V79, P32, DOI 10.1161/01.RES.79.1.32; Kamal KY, 2015, LIFE SCI SPACE RES, V5, P47, DOI 10.1016/j.lssr.2015.04.004; Kapur S, 2005, J BIOL CHEM, V280, P20163, DOI 10.1074/jbc.M501460200; Klaus DM, 1998, ADV SPACE RES, V21, P1315, DOI 10.1016/S0273-1177(97)00404-3; KUCHAN MJ, 1994, AM J PHYSIOL, V267, pC753, DOI 10.1152/ajpcell.1994.267.3.C753; Langtry RB, 2005, 43 AIAA AER SCI M EX; Lee MS, 2003, J CELL BIOCHEM, V90, P80, DOI 10.1002/jcb.10611; Lee MS, 2002, J ORTHOP RES, V20, P556, DOI 10.1016/S0736-0266(01)00149-8; Leguy C. A., 2011, GRAVITATIONAL SPACE, V25; LEVESQUE MJ, 1985, J BIOMECH ENG-T ASME, V107, P341, DOI 10.1115/1.3138567; Little WC, 2008, MATRIX BIOL, V27, P451, DOI 10.1016/j.matbio.2008.02.003; Loon J.J.W.A.V, 2007, GRAVITATIONAL SPACE, V20; Majumder S, 2011, J CELL BIOCHEM, V112, P1898, DOI 10.1002/jcb.23110; Malaviya P, 2002, TISSUE ENG, V8, P581, DOI 10.1089/107632702760240508; Malek AM, 1996, J CELL SCI, V109, P713; Maynard J A, 1994, Iowa Orthop J, V14, P125; MENTER FR, 1994, AIAA J, V32, P1598, DOI 10.2514/3.12149; Mesland, 1996, ESA MICROGRAVITY NEW, V9, P5; Nagel T, 1999, ARTERIOSCL THROM VAS, V19, P1825, DOI 10.1161/01.ATV.19.8.1825; Norvell SM, 2004, CALCIFIED TISSUE INT, V75, P396, DOI 10.1007/s00223-004-0213-y; OLESEN SP, 1988, NATURE, V331, P168, DOI 10.1038/331168a0; Papadaki M, 1996, BIOTECHNOL BIOENG, V50, P555, DOI 10.1002/(SICI)1097-0290(19960605)50:5<555::AID-BIT10>3.0.CO;2-I; Patel MJ, 2009, J CELL BIOCHEM, V106, P306, DOI 10.1002/jcb.22007; Riley DA, 2000, J APPL PHYSIOL, V88, P567, DOI 10.1152/jappl.2000.88.2.567; Rudimov EG, 2015, B EXP BIOL MED+, V158, P573, DOI 10.1007/s10517-015-2809-9; Ryu HW, 2014, DNA CELL BIOL, V33, P128, DOI 10.1089/dna.2013.2089; Sakai K, 1998, CALCIFIED TISSUE INT, V63, P515, DOI 10.1007/s002239900567; SATO M, 1987, ARTERIOSCLEROSIS, V7, P276, DOI 10.1161/01.ATV.7.3.276; Sayson JV, 2008, AVIAT SPACE ENVIR MD, V79, P365, DOI 10.3357/ASEM.1994.2008; SHEN J, 1992, AM J PHYSIOL, V262, pC384, DOI 10.1152/ajpcell.1992.262.2.C384; Siamwala JH, 2010, FEBS LETT, V584, P3415, DOI 10.1016/j.febslet.2010.06.039; Siamwala JH, 2010, PROTOPLASMA, V242, P3, DOI 10.1007/s00709-010-0114-z; Sinha Raj K, 2002, Spine J, V2, P239, DOI 10.1016/S1529-9430(02)00197-3; Slentz DH, 2001, IN VITRO CELL DEV-AN, V37, P148; Smith RL, 1995, J ORTHOPAED RES, V13, P824, DOI 10.1002/jor.1100130604; Sokolovskaya AA, 2014, ACTA ASTRONAUT, V99, P16, DOI 10.1016/j.actaastro.2014.01.032; Trappe SW, 2001, J APPL PHYSIOL, V91, P57, DOI 10.1152/jappl.2001.91.1.57; TSENG H, 1995, CIRC RES, V77, P869, DOI 10.1161/01.RES.77.5.869; Uematsu M, 1995, AM J PHYSIOL-CELL PH, V269, pC1371, DOI 10.1152/ajpcell.1995.269.6.C1371; van Loon JJWA, 2003, J BIOMECH ENG-T ASME, V125, P342, DOI 10.1115/1.1574521; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Vogel V, 2006, ANNU REV BIOPH BIOM, V35, P459, DOI 10.1146/annurev.biophys.35.040405.102013; Vogel V, 2009, CURR OPIN CELL BIOL, V21, P38, DOI 10.1016/j.ceb.2009.01.002; Wang JHC, 2008, INT REV CEL MOL BIO, V271, P301, DOI 10.1016/S1937-6448(08)01207-0; Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z; Wang J, 2014, COMP BIOCHEM PHYS D, V11, P1, DOI 10.1016/j.cbd.2014.05.001; WECHEZAK AR, 1985, LAB INVEST, V53, P639; Williams D, 2009, CAN MED ASSOC J, V180, P1317, DOI 10.1503/cmaj.090628; Wuest SL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/971474; Wuest SL, 2014, MICROGRAVITY SCI TEC, V26, P77, DOI 10.1007/s12217-014-9364-2; Yamamoto K, 2005, AM J PHYSIOL-HEART C, V288, pH1915, DOI 10.1152/ajpheart.00956.2004; Zwart SR, 2010, J BONE MINER RES, V25, P1049, DOI 10.1359/jbmr.091041	78	45	45	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170826	10.1371/journal.pone.0170826	http://dx.doi.org/10.1371/journal.pone.0170826			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135286	Green Published, gold			2022-12-27	WOS:000396124700023
J	Enders, C; Braig, EM; Scherer, K; Werner, JU; Lang, GK; Lang, GE; Pfeiffer, F; Noel, P; Rummeny, E; Herzen, J				Enders, Christian; Braig, Eva-Maria; Scherer, Kai; Werner, Jens U.; Lang, Gerhard K.; Lang, Gabriele E.; Pfeiffer, Franz; Noel, Peter; Rummeny, Ernst; Herzen, Julia			Advanced Non-Destructive Ocular Visualization Methods by Improved X-Ray Imaging Techniques	PLOS ONE			English	Article							MICRO-CT; COMPUTED-TOMOGRAPHY; 7.1 T	Due to limited X-ray contrast, the use of micro-CT in histology is so far not as widespread as predicted. While specific staining procedures-mostly using iodine D address this shortcoming, long diffusion times restrict its use in the often time-constrained daily routine. Recently, a novel staining protocol has been proposed using a biochemical preconditioning step, which increases the permeability of the cells for the staining agent. This could enable the imaging of entire organs of small mammals at a yet unmatched image quality with reasonable preparation and scan times. We here propose an adaptation of this technique for virtual ophthalmology and histology by volumetrically assessing both human and porcine eyes. Hereby, we demonstrate that (contrast-enhanced) micro-CT can outperform conventional histology in the assessment of tumor entities, as well as functioning as a supplementary tool for surgeons in the positioning of intraocular implants in-vitro and as a general assessment tool for ophthalmologic specimens.	[Enders, Christian; Werner, Jens U.; Lang, Gerhard K.; Lang, Gabriele E.] Univ Ulm, Dept Ophthalmol, Prittwitzstr 43, D-89075 Ulm, Germany; [Braig, Eva-Maria; Scherer, Kai; Pfeiffer, Franz; Noel, Peter; Herzen, Julia] Tech Univ Munich, Dept Phys, Chair Biomed Phys, James Franck Str 1, D-85748 Garching, Germany; [Braig, Eva-Maria; Scherer, Kai; Pfeiffer, Franz; Noel, Peter; Herzen, Julia] Tech Univ Munich, Inst Med Engn IMETUM, James Franck Str 1, D-85748 Garching, Germany; [Braig, Eva-Maria; Pfeiffer, Franz; Noel, Peter; Rummeny, Ernst] Tech Univ Munich, Dept Diagnost & nterventionial Radiol, Ismaninger Str 22, D-81664 Munich, Germany	Ulm University; Technical University of Munich; Technical University of Munich; Technical University of Munich	Braig, EM (corresponding author), Tech Univ Munich, Dept Phys, Chair Biomed Phys, James Franck Str 1, D-85748 Garching, Germany.; Braig, EM (corresponding author), Tech Univ Munich, Inst Med Engn IMETUM, James Franck Str 1, D-85748 Garching, Germany.; Braig, EM (corresponding author), Tech Univ Munich, Dept Diagnost & nterventionial Radiol, Ismaninger Str 22, D-81664 Munich, Germany.	eva.braig@mytum.de		Noel, Peter/0000-0002-9671-6171	German Society of Ophthalmic Pathology [1/2016]	German Society of Ophthalmic Pathology	CE received a research grant (1/2016) from the German Society of Ophthalmic Pathology, http://www.dog.org/?cat=123. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Juliana Martins de S. e Silva for providing the staining protocols and for the help with the accomplishment of the tissue staining. The Authors thank Grazyna Prystasz for histological sample preparation. The authors thank Dr. Tarun Mehra for providing remunerated editorial assistance. This study was supported, in part, by a research grant from the German Society of Ophthalmic Pathology.	Aslanidi OV, 2013, IEEE T MED IMAGING, V32, P8, DOI 10.1109/TMI.2012.2209183; Cheng KC, 2011, CURR OPIN GENET DEV, V21, P620, DOI 10.1016/j.gde.2011.08.006; Cox PG, 2014, PEERJ, V2, DOI 10.7717/peerj.448; CROW W, 1982, J COMPUT ASSIST TOMO, V6, P708, DOI 10.1097/00004728-198208000-00008; Degenhardt K, 2010, CIRC-CARDIOVASC IMAG, V3, P314, DOI 10.1161/CIRCIMAGING.109.918482; Ewald AJ, 2002, DEV DYNAM, V225, P369, DOI 10.1002/dvdy.10169; Faulwetter S, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.263.4261; Gekeler F, 2010, BRIT J OPHTHALMOL, V94, P843, DOI 10.1136/bjo.2009.170654; Holdsworth DW, 2002, TRENDS BIOTECHNOL, V20, pS34, DOI 10.1016/S0167-7799(02)02004-8; Hong-qin Yang, 2007, Proceedings of the SPIE - The International Society for Optical Engineering, V6826, p68260T, DOI 10.1117/12.756303; Krueger PC, 2012, ORBIT, V31, P390, DOI 10.3109/01676830.2012.723783; Langheinrich AC, 2004, RADIOLOGY, V231, P675, DOI 10.1148/radiol.2313021718; Langner S, 2010, INVEST OPHTH VIS SCI, V51, P6575, DOI 10.1167/iovs.09-4865; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; Pauwels E, 2013, J MICROSC-OXFORD, V250, P21, DOI 10.1111/jmi.12013; Rau TS, 2013, INT J COMPUT ASS RAD, V8, P481, DOI 10.1007/s11548-013-0825-7; Rueckel J, 2014, APPL RADIAT ISOTOPES, V94, P230, DOI 10.1016/j.apradiso.2014.08.014; Schambach SJ, 2010, METHODS, V50, P2, DOI 10.1016/j.ymeth.2009.08.007; Silva JMDE, 2015, SCI REP-UK, V5, DOI 10.1038/srep14088; Stephenson RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035299; Vickerton P, 2013, J ANAT, V223, P185, DOI 10.1111/joa.12068; Weninger WJ, 2006, ANAT EMBRYOL, V211, P213, DOI 10.1007/s00429-005-0073-x; Wilke SA, 2013, J NEUROSCI, V33, P507, DOI 10.1523/JNEUROSCI.1600-12.2013; Winston Janet S, 2004, Breast J, V10, P200, DOI 10.1111/j.1075-122X.2004.21300.x	25	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170633	10.1371/journal.pone.0170633	http://dx.doi.org/10.1371/journal.pone.0170633			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129364	Green Published, gold, Green Submitted			2022-12-27	WOS:000396211400051
J	Hayward, AC				Hayward, Andrew C.			Influenza Vaccination of Healthcare Workers Is an Important Approach for Reducing Transmission of Influenza from Staff to Vulnerable Patients	PLOS ONE			English	Editorial Material							LONG-TERM-CARE; HOME STAFF; MORTALITY; INFECTIONS; RESIDENTS; OUTBREAKS; DISEASE		[Hayward, Andrew C.] UCL, Inst Epidemiol & Hlth Care, London, England	University of London; University College London	Hayward, AC (corresponding author), UCL, Inst Epidemiol & Hlth Care, London, England.	a.hayward@ucl.ac.uk	Hayward, Andrew/C-3268-2013	Hayward, Andrew/0000-0002-3549-6232	Department of Health Policy Research Programme	Department of Health Policy Research Programme	The study discussed was funded by the Department of Health Policy Research Programme. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carman WF, 2000, LANCET, V355, P93, DOI 10.1016/S0140-6736(99)05190-9; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Demicheli V, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub5; Green HK, 2015, J PUBLIC HLTH OXF, V37, P295; Hayward AC, 2014, LANCET RESP MED, V2, P445, DOI 10.1016/S2213-2600(14)70034-7; Hayward AC, 2006, BRIT MED J, V333, P1241, DOI 10.1136/bmj.39010.581354.55; Langley JM, 2011, VACCINE, V29, P1921, DOI 10.1016/j.vaccine.2010.12.100; Lemaitre M, 2009, J AM GERIATR SOC, V57, P1580, DOI 10.1111/j.1532-5415.2009.02402.x; Leung NHL, 2015, EPIDEMIOLOGY, V26, P862, DOI 10.1097/EDE.0000000000000340; Loeb M, 2000, CAN MED ASSOC J, V162, P1133; Matias G, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3128-4; Potter J, 1997, J INFECT DIS, V175, P1, DOI 10.1093/infdis/175.1.1; Strausbaugh LJ, 2003, CLIN INFECT DIS, V36, P870, DOI 10.1086/368197; Tricco AC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-153; Ward BJ, PLOS ONE	15	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0169023	10.1371/journal.pone.0169023	http://dx.doi.org/10.1371/journal.pone.0169023			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129326	Green Published, gold, Green Submitted			2022-12-27	WOS:000396211400071
J	Ren, F; Lu, YN; Li, SP; Jiang, XF; Zhong, LX; Qiu, T				Ren, Fei; Lu, Ya-Nan; Li, Sai-Ping; Jiang, Xiong-Fei; Zhong, Li-Xin; Qiu, Tian			Dynamic Portfolio Strategy Using Clustering Approach	PLOS ONE			English	Article							MARKET CORRELATIONS; MONETARY-POLICY; NETWORK; SELECTION; OPTIMIZATION; INFORMATION; VOLATILITY; STABILITY; RETURNS; MODEL	The problem of portfolio optimization is one of the most important issues in asset management. We here propose a new dynamic portfolio strategy based on the time-varying structures of MST networks in Chinese stock markets, where the market condition is further considered when using the optimal portfolios for investment. A portfolio strategy comprises two stages: First, select the portfolios by choosing central and peripheral stocks in the selection horizon using five topological parameters, namely degree, betweenness centrality, distance on degree criterion, distance on correlation criterion and distance on distance criterion. Second, use the portfolios for investment in the investment horizon. The optimal portfolio is chosen by comparing central and peripheral portfolios under different combinations of market conditions in the selection and investment horizons. Market conditions in our paper are identified by the ratios of the number of trading days with rising index to the total number of trading days, or the sum of the amplitudes of the trading days with rising index to the sum of the amplitudes of the total trading days. We find that central portfolios outperform peripheral portfolios when the market is under a drawup condition, or when the market is stable or drawup in the selection horizon and is under a stable condition in the investment horizon. We also find that peripheral portfolios gain more than central portfolios when the market is stable in the selection horizon and is drawdown in the investment horizon. Empirical tests are carried out based on the optimal portfolio strategy. Among all possible optimal portfolio strategies based on different parameters to select portfolios and different criteria to identify market conditions, 65% of our optimal portfolio strategies outperform the random strategy for the Shanghai A-Share market while the proportion is 70% for the Shenzhen AShare market.	[Ren, Fei; Lu, Ya-Nan] East China Univ Sci & Technol, Sch Business, Shanghai 200237, Peoples R China; [Ren, Fei] East China Univ Sci & Technol, Res Ctr Econophys, Shanghai 200237, Peoples R China; [Li, Sai-Ping] Acad Sinica, Inst Phys, Taipei 115, Taiwan; [Jiang, Xiong-Fei] Ningbo Dahongying Univ, Coll Informat Engn, Ningbo 315175, Zhejiang, Peoples R China; [Zhong, Li-Xin] Zhejiang Univ Finance & Econ, Sch Finance, Hangzhou 310018, Zhejiang, Peoples R China; [Qiu, Tian] Nanchang Hangkong Univ, Sch Informat Engn, Nanchang 330063, Jiangxi, Peoples R China	East China University of Science & Technology; East China University of Science & Technology; Academia Sinica - Taiwan; Ningbo University of Finance & Economics; Zhejiang University of Finance & Economics; Nanchang Hangkong University	Ren, F (corresponding author), East China Univ Sci & Technol, Sch Business, Shanghai 200237, Peoples R China.; Ren, F (corresponding author), East China Univ Sci & Technol, Res Ctr Econophys, Shanghai 200237, Peoples R China.	fren@ecust.edu.cn	Chanelian, Serena/ABE-4873-2021; Li, Sai-Ping/AAP-9189-2021	Chanelian, Serena/0000-0001-5727-6137; Li, Sai-Ping/0000-0002-3233-2339; Xiongfei, Jiang/0000-0001-5879-6409	National Natural Science Foundation [10905023, 71131007, 71371165, 11501199]; Fok Ying Tong Education Foundation [132013]; Ningbo Natural Science Foundation [2015A610160]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Fok Ying Tong Education Foundation(Fok Ying Tung Education Foundation); Ningbo Natural Science Foundation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was partially supported by the National Natural Science Foundation (Nos. 10905023, 71131007, 71371165, and 11501199), Fok Ying Tong Education Foundation Grant (No. 132013), Ningbo Natural Science Foundation (No. 2015A610160), and the Fundamental Research Funds for the Central Universities (2015). Fei Ren designed the study and performed the analysis. Sai-Ping Li prepared the manuscript.	Aste T, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/085009; Boginski V, 2014, ANN OPER RES, V216, P23, DOI 10.1007/s10479-013-1395-3; Bomfim AN, 2003, J BANK FINANC, V27, P133, DOI 10.1016/S0378-4266(01)00211-4; Brida JG, 2007, INT J MOD PHYS C, V18, P1783, DOI 10.1142/S0129183107011741; Case B, 2012, J REAL ESTATE FINANC, V44, P298, DOI 10.1007/s11146-010-9239-2; Chen Y, 2011, IEEJ T ELECTR ELECTR, V6, P403, DOI 10.1002/tee.20676; Chen Y, 2010, COMPUT OPER RES, V37, P1697, DOI 10.1016/j.cor.2009.12.003; Choudhury S, 2014, NEUROCOMPUTING, V131, P419, DOI 10.1016/j.neucom.2013.10.002; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Crama Y, 2003, EUR J OPER RES, V150, P546, DOI 10.1016/S0377-2217(02)00784-1; Dai YH, 2016, EMPIR ECON, V51, P1501, DOI 10.1007/s00181-015-1057-1; Daly J, 2008, PHYSICA A, V387, P4248, DOI 10.1016/j.physa.2008.02.045; DeMiguel V, 2009, REV FINANC STUD, V22, P1915, DOI 10.1093/rfs/hhm075; Drozdz S, 2000, PHYSICA A, V287, P440, DOI 10.1016/S0378-4371(00)00383-6; Fenn DJ, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.026109; Fernandez A, 2007, COMPUT OPER RES, V34, P1177, DOI 10.1016/j.cor.2005.06.017; Ferreira MA, 2007, J BANK FINANC, V31, P3162, DOI 10.1016/j.jbankfin.2006.12.006; Garas A, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/28005; Guo G., 2011, CHINA IND EC, V2011, P26; Jagannathan R, 2003, J FINANC, V58, P1651, DOI 10.1111/1540-6261.00580; Jiang XF, 2014, SCI REP-UK, V4, DOI 10.1038/srep05321; Jiang ZQ, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016106; Kasman S, 2011, ECON MODEL, V28, P1328, DOI 10.1016/j.econmod.2011.01.015; Kenett DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031144; Kenett DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015032; Kim HJ, 2002, J PHYS SOC JPN, V71, P2133, DOI 10.1143/JPSJ.71.2133; Ko PC, 2008, EXPERT SYST APPL, V35, P330, DOI 10.1016/j.eswa.2007.07.031; Kotkatvuori-Ornberg J, 2013, INT REV FINANC ANAL, V28, P70, DOI 10.1016/j.irfa.2013.01.009; Krings G, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds4; Kwapien J, 2012, PHYS REP, V515, P115, DOI 10.1016/j.physrep.2012.01.007; Ledoit O, 2004, J MULTIVARIATE ANAL, V88, P365, DOI 10.1016/S0047-259X(03)00096-4; Lee KE, 2007, COMPUT PHYS COMMUN, V177, P186, DOI 10.1016/j.cpc.2007.02.047; Liao SH, 2013, EXPERT SYST APPL, V40, P1542, DOI 10.1016/j.eswa.2012.08.075; Miralles-Marcelo JL, 2015, N AM J ECON FINANC, V32, P64, DOI 10.1016/j.najef.2015.01.005; Mantegna RN, 1999, EUR PHYS J B, V11, P193, DOI 10.1007/s100510050929; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; Micciche S, 2003, PHYSICA A, V324, P66, DOI 10.1016/S0378-4371(03)00002-5; Nanda SR, 2010, EXPERT SYST APPL, V37, P8793, DOI 10.1016/j.eswa.2010.06.026; Nanda SJ, 2014, SWARM EVOL COMPUT, V16, P1, DOI 10.1016/j.swevo.2013.11.003; Nazemi A, 2015, APPL INTELL, V42, P609, DOI 10.1007/s10489-014-0616-z; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Onnela JP, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.056110; Onnela JP, 2004, EUR PHYS J B, V38, P353, DOI 10.1140/epjb/e2004-00128-7; Onnela JP, 2002, EUR PHYS J B, V30, P285, DOI 10.1140/epjb/e2002-00380-9; Pai GAV, 2009, IEEE T EVOLUT COMPUT, V13, P1030, DOI 10.1109/TEVC.2009.2014360; Podobnik B, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/68001; Podobnik B, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.084102; Pozzi F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01665; Ren Fei, 2014, PLoS One, V9, pe97711, DOI 10.1371/journal.pone.0097711; Ross GJ, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.022809; Scholz H, 2007, J ASSET MANAG, V7, P347, DOI 10.1057/palgrave.jam.2250040; SHARPE WF, 1994, J PORTFOLIO MANAGE, V21, P49, DOI 10.3905/jpm.1994.409501; Song DM, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.026108; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Suganya NC, 2012, INT J SYST SCI, V43, P1367, DOI 10.1080/00207721.2011.601351; Sun XL, 2016, PHYSICA A, V444, P667, DOI 10.1016/j.physa.2015.10.065; Tang Y, 2013, PHYSICA A, V392, P4435, DOI 10.1016/j.physa.2013.05.023; Thorbecke W, 1997, J FINANC, V52, P635, DOI 10.1111/j.1540-6261.1997.tb04816.x; Tumminello M, 2007, EUR PHYS J B, V55, P209, DOI 10.1140/epjb/e2006-00414-4; Tumminello M, 2005, P NATL ACAD SCI USA, V102, P10421, DOI 10.1073/pnas.0500298102; Tumminello M, 2010, J ECON BEHAV ORGAN, V75, P40, DOI 10.1016/j.jebo.2010.01.004; West D.B., 1996, INTRO GRAPH THEORY, V2; Yang CX, 2014, PHYSICA A, V415, P1, DOI 10.1016/j.physa.2014.07.069; Zhang B, 2008, EC RES J, V9, P70; Zhou WX, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.066211	66	14	14	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0169299	10.1371/journal.pone.0169299	http://dx.doi.org/10.1371/journal.pone.0169299			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7VX	28129333	Green Published, gold			2022-12-27	WOS:000396211400070
J	Wang, XX; Huang, RF; Quan, RD				Wang, Xuexia; Huang, Rongfeng; Quan, Ruidang			Mutation in Mg-Protoporphyrin IX Monomethyl Ester Cyclase Decreases Photosynthesis Capacity in Rice	PLOS ONE			English	Article							CHLOROPHYLL BIOSYNTHESIS; OXIDATIVE CYCLASE; TETRAPYRROLE BIOSYNTHESIS; CHLOROPLAST DEVELOPMENT; ARABIDOPSIS CHL27; GENE-EXPRESSION; ISOCYCLIC RING; PHOTOSYSTEM-I; HIGHER-PLANTS; PROTEIN	In photosynthesis, the pigments chlorophyll a/b absorb light energy to convert to chemical energy in chloroplasts. Though most enzymes of chlorophyll biosynthesis from glutamyltRNA to chlorophyll a/b have been identified, the exact composition and regulation of the multimeric enzyme Mg-protoporphyrin IX monomethyl ester cyclase (MPEC) is largely unknown. In this study, we isolated a rice pale-green leaf mutant m167 with yellow-green leaf phenotype across the whole lifespan. Chlorophyll content decreases 43-51% and the granal stacks of chloroplasts becomes thinner in m167. Chlorophyll fluorescence parameters, including Fv/Fm (the maximum quantum efficiency of PSII) and quantum yield of PSII (Y(II)), were lower in m167 than those in wild type plants (WT), and photosynthesis rate decreases 40% in leaves of m167 mutant compared with WT plants, which lead to yield reduction in m167. Genetic analysis revealed that yellow-green leaf phenotype of m167 is controlled by a single recessive genetic locus. By positional cloning, a single mutated locus, G286A (Alanine 96 to Threonine in protein), was found in the coding sequence of LOC_ Os01g17170 (Rice Copper Response Defect 1, OsCRD1), encoding a putative subunit of MPEC. Expression profile analysis demonstrated that OsCRD1 is mainly expressed in green tissues of rice. Sequence alignment analysis of CRD1 indicated that Alanine 96 is very conserved in all green plants and photosynthetic bacteria. OsCRD1 protein mainly locates in chloroplast and the point mutation A96T in OsCRD1 does not change its location. Therefore, Alanine96 of OsCRD1 might be fundamental for MPEC activity, mutation of which leads to deficiency in chlorophyll biosynthesis and chloroplast development and decreases photosynthetic capacity in rice.	[Wang, Xuexia; Huang, Rongfeng; Quan, Ruidang] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China; [Wang, Xuexia; Huang, Rongfeng; Quan, Ruidang] Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Quan, RD (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China.; Quan, RD (corresponding author), Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China.	quanruidang@caas.cn			Ministry of Agriculture of China [2014ZX08009-005, 2016ZX08009-003-005]; National Natural Science Foundation of China [31172025]	Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Support was provided by the Ministry of Agriculture of China (2014ZX08009-005, 2016ZX08009-003-005 to RQ) [http://english.agri.gov.cn/] and the National Natural Science Foundation of China (31172025 to RQ) [http://www.nsfc.gov.cn/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Ministry of Agriculture of China (2014ZX08009-005, 2016ZX08009-003-005) and National Natural Science Foundation of China (31172025).	Adhikari ND, 2011, PLANT CELL, V23, P1449, DOI 10.1105/tpc.110.082503; Albus CA, 2012, PLANT PHYSIOL, V160, P1923, DOI 10.1104/pp.112.206045; Bang WY, 2008, PLANT CELL PHYSIOL, V49, P1350, DOI 10.1093/pcp/pcn111; Biswal UC, 2003, CHLOROPLAST BIOGENES, P19; Bollivar D, 2014, FEBS J, V281, P2377, DOI 10.1111/febs.12790; Bollivar DW, 2006, PHOTOSYNTH RES, V90, P173, DOI 10.1007/s11120-006-9076-6; Brzezowski P, 2015, BBA-BIOENERGETICS, V1847, P968, DOI 10.1016/j.bbabio.2015.05.007; Caffarri S, 2014, CURR PROTEIN PEPT SC, V15, P296, DOI 10.2174/1389203715666140327102218; DUGGAN J, 1974, PLANT PHYSIOL, V53, P206, DOI 10.1104/pp.53.2.206; GOUGH S, 1972, BIOCHIM BIOPHYS ACTA, V286, P36, DOI 10.1016/0304-4165(72)90086-4; HODGINS RR, 1986, J PLANT PHYSIOL, V125, P311, DOI 10.1016/S0176-1617(86)80153-5; Hollingshead S, 2012, J BIOL CHEM, V287, P27823, DOI 10.1074/jbc.M112.352526; Hung CY, 2010, J EXP BOT, V61, P1483, DOI 10.1093/jxb/erq020; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kahn VM, 1976, GENETICS BIOGENESIS, V184, P800; Larkin RM, 2003, SCIENCE, V299, P902, DOI 10.1126/science.1079978; Li RQ, 2014, THEOR APPL GENET, V127, P2491, DOI 10.1007/s00122-014-2393-9; MASCIA P, 1978, MOL GEN GENET, V161, P237, DOI 10.1007/BF00330996; Moseley J, 2000, EMBO J, V19, P2139, DOI 10.1093/emboj/19.10.2139; Park SY, 2007, PLANT CELL, V19, P1649, DOI 10.1105/tpc.106.044891; Peter E, 2009, MOL PLANT, V2, P1198, DOI 10.1093/mp/ssp072; Pinta V, 2002, J BACTERIOL, V184, P746, DOI 10.1128/JB.184.3.746-753.2002; Porra RJ, 1997, PHOTOCHEM PHOTOBIOL, V65, P492, DOI 10.1111/j.1751-1097.1997.tb08596.x; Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740; Rzeznicka K, 2005, P NATL ACAD SCI USA, V102, P5886, DOI 10.1073/pnas.0501784102; Sakuraba Y, 2013, PLANT J, V74, P122, DOI 10.1111/tpj.12110; Schlicke H, 2015, PROCEDIA CHEM, V14, P171, DOI 10.1016/j.proche.2015.03.025; Schreiber U., 1995, ECOPHYSIOLOGY PHOTOS, V100, P49, DOI [10.1007/978-3-642-79354-7_3, DOI 10.1007/978-3-642-79354-7_3]; Shan QW, 2014, NAT PROTOC, V9, P2395, DOI 10.1038/nprot.2014.157; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Tanaka Ryouichi, 2011, Arabidopsis Book, V9, pe0145, DOI 10.1199/tab.0145; Tottey S, 2003, P NATL ACAD SCI USA, V100, P16119, DOI 10.1073/pnas.2136793100; VON WETTSTEIN D, 1995, PLANT CELL, V7, P1039, DOI 10.1105/tpc.7.7.1039; WALKER CJ, 1991, BIOCHEM J, V276, P691, DOI 10.1042/bj2760691; WALKER CJ, 1989, BIOCHEM J, V257, P599, DOI 10.1042/bj2570599; WONG YS, 1984, PLANT PHYSIOL, V75, P658, DOI 10.1104/pp.75.3.658; Wu ZM, 2007, PLANT PHYSIOL, V145, P29, DOI 10.1104/pp.107.100321; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Zhang HT, 2006, PLANT MOL BIOL, V62, P325, DOI 10.1007/s11103-006-9024-z; Zhang Y, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-30; Zheng CC, 1998, PLANT PHYSIOL, V116, P27, DOI 10.1104/pp.116.1.27; Zhou K., 2013, COMPLEX ADAPTIVE SYS, V1, P1, DOI DOI 10.1007/S00425-012-1756-1; Zhu XY, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0821-5	43	7	12	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0171118	10.1371/journal.pone.0171118	http://dx.doi.org/10.1371/journal.pone.0171118			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129387	Green Published, Green Submitted, gold			2022-12-27	WOS:000396211400006
J	Ellis, H; Schoenberger, E				Ellis, Hugh; Schoenberger, Erica			On the Identification of Associations between Five World Health Organization Water, Sanitation and Hygiene Phenotypes and Six Predictors in Low and Middle-Income Countries	PLOS ONE			English	Article							FALSE DISCOVERY RATE; DIARRHEAL DISEASE; DRINKING-WATER; IMPACT; INTERVENTIONS; SETTINGS; BURDEN; ACCESS	Background According to the most recent estimates, 842,000 deaths in low-to middle-income countries were attributable to inadequate water, sanitation and hygiene in 2012. Despite billions of dollars and decades of effort, we still lack a sound understanding of which kinds of WASH interventions are most effective in improving public health outcomes, and an important corollary-whether the right things are being measured. The World Health Organization (WHO) has made a concerted effort to compile comprehensive data on drinking water quality and sanitation in the developing world. A recent 2014 report provides information on three phenotypes (responses): Unsafe Water Deaths, Unsafe Sanitation Deaths, Unsafe Hygiene Deaths; two grouped phenotypes: Unsafe Water and Sanitation Deaths and Unsafe Water, Sanitation and Hygiene Deaths; and six explanatory variables (predictors): Improved Sanitation, Unimproved Water Source, Piped Water To Premises, Other Improved Water Source, Filtered and Bottled Water in the Household and Handwashing. Methods and Findings Regression analyses were performed to identify statistically significant associations between these mortality responses and predictors. Good fitted-model performance required: (1) the use of population-normalized death fractions as opposed to number of deaths; (2) transformed response (logit or power); and (3) square-root predictor transformation. Given the complexity and heterogeneity of the relationships and countries being studied, these models exhibited remarkable performance and explained, for example, about 85% of the observed variance in population-normalized Unsafe Sanitation Death fraction, with a high F-statistic and highly statistically significant predictor p-values. Similar performance was found for all other responses, which was an unexpected result (the expected associations between responses and predictors-i.e., water-related with water-related, etc. did not occur). The set of statistically significant predictors remains the same across all responses. That is, Unsafe Water Source (UWS), Improved Sanitation (IS) and Filtered and Bottled Water in the Household (FBH) were the only statistically significant predictors whether the response was Unsafe Sanitation Death Fraction, Unsafe Hygiene Death Fraction or Unsafe Water Death Fraction. Moreover, the fraction of variance explained for all fitted models remained relatively high (adjusted R-2 ranges from 0.7605 to 0.8533). We find that two of the statistically significant predictors-Improved Sanitation and Unimproved Water Sources-are particularly influential. We also find that some predictors (Piped Water to Premises, Other Improved Water Sources) have very little explanatory power for predicting mortality and one (Other Improved Water Sources) has a counterintuitive effect on response (Unsafe Sanitary Death Fraction increases with increases in OIWS) and one predictor (Hand Washing) to have essentially no explanatory usefulness. Conclusions Our results suggest that a higher priority may need to be given to improved sanitation than has been the case. Nevertheless, while our focus in this paper is mortality, morbidity is a staggering consequence of inadequate water, sanitation and hygiene, and lower impact on mortality may not mean a similarly low impact on morbidity. More specifically, those predictors that we found uninfluential for predicting mortality-related responses may indeed be important when morbidity is the response.	[Ellis, Hugh; Schoenberger, Erica] Johns Hopkins Univ, Dept Geog & Environm Engn, Baltimore, MD 21218 USA	Johns Hopkins University	Ellis, H (corresponding author), Johns Hopkins Univ, Dept Geog & Environm Engn, Baltimore, MD 21218 USA.	hugh.ellis@jhu.edu						Bain R, 2014, TROP MED INT HEALTH, V19, P917, DOI 10.1111/tmi.12334; Bartram J, 2005, LANCET, V365, P810, DOI 10.1016/S0140-6736(05)71007-2; Bartram J., 2010, PLOS MED, V7; Bartram J, 2014, INT J ENV RES PUB HE, V11, P8137, DOI 10.3390/ijerph110808137; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLUM D, 1983, INT J EPIDEMIOL, V12, P357, DOI 10.1093/ije/12.3.357; Cairncross S, 2010, INT J EPIDEMIOL, V39, P193, DOI 10.1093/ije/dyq035; Clasen T, 2014, TROP MED INT HEALTH, V19, P884, DOI 10.1111/tmi.12330; Clasen TF, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004794.pub3; Cumming O, 2014, PLOS ONE, V9; Engell RE, 2013, LANCET, V381, P44; ESREY SA, 1985, B WORLD HEALTH ORGAN, V63, P757; ESREY SA, 1992, AM J EPIDEMIOL, V135, P659, DOI 10.1093/oxfordjournals.aje.a116345; ESREY SA, 1991, B WORLD HEALTH ORGAN, V69, P609; Esrey SA, 1996, AM J EPIDEMIOL, V143, P608, DOI 10.1093/oxfordjournals.aje.a008791; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Fox J., 2019, R COMPANION APPL REG, V.; Fox J., 2015, APPL REGRESSION ANAL; Freeman MC, 2014, TROP MED INT HEALTH, V19, P906, DOI 10.1111/tmi.12339; Fuller JA, 2015, TROP MED INT HEALTH, V20, P284, DOI 10.1111/tmi.12441; Godfrey S, 2011, ENVIRON MONIT ASSESS, V176, P561, DOI 10.1007/s10661-010-1604-3; HOLM S, 1979, SCAND J STAT, V6, P65; Hunter PR, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000361; Hutton G, 2007, J WATER HEALTH, V5, P481, DOI 10.2166/wh.2007.009; Jeuland MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074804; MacDonald L, 2016, HOUSEHOLD WATER TREA; Maindonald J. H., 2014, DAAG DATA ANAL GRAPH; Mosteller F., 1968, HDB SOC PSYCHOL, V2, P80; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; O'Hare BAM, 2007, J ROY SOC MED, V100, P564, DOI 10.1258/jrsm.100.12.564; Onda K, 2012, INT J ENV RES PUB HE, V9, P880, DOI 10.3390/ijerph9030880; Pruss-Ustun A, 2014, TROP MED INT HEALTH, V19, P894, DOI 10.1111/tmi.12329; Pruss A, 2002, ENVIRON HEALTH PERSP, V110, P537, DOI 10.1289/ehp.02110537; Rheingans R, 2014, TROP MED INT HEALTH, V19, P2, DOI 10.1111/tmi.12220; Saunders R. J., 1976, VILLAGE WATER SUPPLY; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Shaheed A, 2014, B WORLD HEALTH ORGAN, V92, P283, DOI 10.2471/BLT.13.119594; Stuart E., 2015, DATA REVOLUTION FIND; VANDERSLICE J, 1995, AM J EPIDEMIOL, V141, P135, DOI 10.1093/oxfordjournals.aje.a117401; Weisberg S, 2014, APPL LINEAR REGRESSI, V4th; Wolf J, 2014, TROP MED INT HEALTH, V19, P928, DOI 10.1111/tmi.12331; World Health Organization, 2014, PREVENTING DIARRHOEA; World Health Organization, 2015, PROGR SAN DRINK WAT	44	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170451	10.1371/journal.pone.0170451	http://dx.doi.org/10.1371/journal.pone.0170451			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125625	Green Published, Green Submitted, gold			2022-12-27	WOS:000396176100108
J	Ooi, DSQ; Tan, VMH; Ong, SG; Chan, YH; Heng, CK; Lee, YS				Ooi, Delicia Shu Qin; Tan, Verena Ming Hui; Ong, Siong Gim; Chan, Yiong Huak; Heng, Chew Kiat; Lee, Yung Seng			Differences in AMY1 Gene Copy Numbers Derived from Blood, Buccal Cells and Saliva Using Quantitative and Droplet Digital PCR Methods: Flagging the Pitfall	PLOS ONE			English	Article							GENOMIC DNA; COLLECTION; SAMPLES; QUALITY; OBESITY; COHORT; MAIL	Introduction The human salivary (AMY1) gene, encoding salivary a-amylase, has variable copy number variants (CNVs) in the human genome. We aimed to determine if real-time quantitative polymerase chain reaction (qPCR) and the more recently available Droplet Digital PCR (ddPCR) can provide a precise quantification of the AMY1 gene copy number in blood, buccal cells and saliva samples derived from the same individual. Methods Seven participants were recruited and DNA was extracted from the blood, buccal cells and saliva samples provided by each participant. Taqman assay real-time qPCR and ddPCR were conducted to quantify AMY1 gene copy numbers. Statistical analysis was carried out to determine the difference in AMY1 gene copy number between the different biological specimens and different assay methods. Results We found significant within-individual difference (p<0.01) in AMY1 gene copy number between different biological samples as determined by qPCR. However, there was no significant within-individual difference in AMY1 gene copy number between different biological samples as determined by ddPCR. We also found that AMY1 gene copy number of blood samples were comparable between qPCR and ddPCR, while there is a significant difference (p<0.01) between AMY1 gene copy numbers measured by qPCR and ddPCR for both buccal swab and saliva samples. Conclusions Despite buccal cells and saliva samples being possible sources of DNA, it is pertinent that ddPCR or a single biological sample, preferably blood sample, be used for determining highly polymorphic gene copy numbers like AMY1, due to the large within-individual variability between different biological samples if real time qPCR is employed.	[Ooi, Delicia Shu Qin; Tan, Verena Ming Hui; Ong, Siong Gim; Heng, Chew Kiat; Lee, Yung Seng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore, Singapore; [Ooi, Delicia Shu Qin; Tan, Verena Ming Hui; Ong, Siong Gim; Heng, Chew Kiat; Lee, Yung Seng] Natl Univ Hlth Syst, Khoo Teck Puat Natl Univ Childrens Med Inst, Natl Univ Hosp, Div Endocrinol & Diabet, Singapore, Singapore; [Tan, Verena Ming Hui; Lee, Yung Seng] ASTAR, Singapore Inst Clin Sci, Singapore, Singapore; [Chan, Yiong Huak] Natl Univ Singapore, Yong Loo Lin Sch Med, Biostat Unit, Singapore, Singapore	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); National University of Singapore	Lee, YS (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore, Singapore.; Lee, YS (corresponding author), Natl Univ Hlth Syst, Khoo Teck Puat Natl Univ Childrens Med Inst, Natl Univ Hosp, Div Endocrinol & Diabet, Singapore, Singapore.; Lee, YS (corresponding author), ASTAR, Singapore Inst Clin Sci, Singapore, Singapore.	paeleeys@nus.edu.sg	Lee, Yung Seng/F-2169-2014; Heng, Chew Kiat/A-5530-2009	Lee, Yung Seng/0000-0002-1253-0557; Heng, Chew Kiat/0000-0002-7309-9473; Ooi, Delicia Shu Qin/0000-0001-8677-0126	project: SICS [C8019]	project: SICS	Funding source of the project: SICS core funding of Yung Seng Lee (C8019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham JE, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-19; Cozier YC, 2004, ANN EPIDEMIOL, V14, P117, DOI 10.1016/S1047-2797(03)00132-7; Falchi M, 2014, NAT GENET, V46, P492, DOI 10.1038/ng.2939; Fernandez-Jimenez N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028910; Garcia-Closas M, 2001, CANCER EPIDEM BIOMAR, V10, P687; Hansen TVO, 2007, CANCER EPIDEM BIOMAR, V16, P2072, DOI 10.1158/1055-9965.EPI-07-0611; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Le Marchand L, 2001, CANCER EPIDEM BIOMAR, V10, P701; Livy A, 2012, INDIAN J CLIN BIOCHE, V27, P28, DOI 10.1007/s12291-011-0154-y; Mandel AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013352; Mandel AL, 2012, J NUTR; Marenne G, 2011, HUM MUTAT, V32, P240, DOI 10.1002/humu.21398; MEISLER MH, 1993, CRIT REV ORAL BIOL M, V4, P503, DOI 10.1177/10454411930040033501; Mejia-Bentez MA, 2015, DIABETOLOGIA, V58, P290, DOI 10.1007/s00125-014-3441-3; Mulot C, 2005, J BIOMED BIOTECHNOL, P291, DOI 10.1155/JBB.2005.291; Nunes AP, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-65; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Philibert RA, 2008, PSYCHIAT GENET, V18, P275, DOI 10.1097/YPG.0b013e3283060f81; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Piotrowski A, 2008, HUM MUTAT, V29, P1118, DOI 10.1002/humu.20815; Rogers NL, 2007, AM J HUM BIOL, V19, P319; Rylander-Rudqvist T, 2006, CANCER EPIDEM BIOMAR, V15, P1742, DOI 10.1158/1055-9965.EPI-05-0706; Satia-Abouta, 2002, CANCER EPIDEM BIOMAR, V11, P1130; Sedlackova T, 2013, BIOL PROCED ONLINE, V15, DOI 10.1186/1480-9222-15-5; Smith AK, 2015, AM J MED GENET B, V168, P36, DOI 10.1002/ajmg.b.32278; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Sun Fanyue, 2014, Oral Health Dent Manag, V13, P217; Tan VMH, 2015, BRIT J NUTR, V113, P1228, DOI 10.1017/S0007114515000586; Tan VMH, 2016, EUR J NUTR, V55, P1573, DOI 10.1007/s00394-015-0976-0; Usher CL, 2015, NAT GENET, V47, P921, DOI 10.1038/ng.3340; Viljakainen H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131883	31	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170767	10.1371/journal.pone.0170767	http://dx.doi.org/10.1371/journal.pone.0170767			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125683	Green Submitted, Green Published, gold			2022-12-27	WOS:000396176100057
J	Schmid, P; Rauber, D; Betsch, C; Lidolt, G; Denker, ML				Schmid, Philipp; Rauber, Dorothee; Betsch, Cornelia; Lidolt, Gianni; Denker, Marie-Luisa			Barriers of Influenza Vaccination Intention and Behavior - A Systematic Review of Influenza Vaccine Hesitancy, 2005-2016	PLOS ONE			English	Review							HEALTH-CARE WORKERS; PANDEMIC H1N1 INFLUENZA; CROSS-SECTIONAL ANALYSIS; WILLINGNESS-TO-PAY; CHILDREN AGED 6; SEASONAL INFLUENZA; PREGNANT-WOMEN; HONG-KONG; A H1N1; PNEUMOCOCCAL VACCINATION	Background Influenza vaccine hesitancy is a significant threat to global efforts to reduce the burden of seasonal and pandemic influenza. Potential barriers of influenza vaccination need to be identified to inform interventions to raise awareness, influenza vaccine acceptance and uptake. Objective This review aims to (1) identify relevant studies and extract individual barriers of seasonal and pandemic influenza vaccination for risk groups and the general public; and (2) map knowledge gaps in understanding influenza vaccine hesitancy to derive directions for further research and inform interventions in this area. Methods Thirteen databases covering the areas of Medicine, Bioscience, Psychology, Sociology and Public Health were searched for peer-reviewed articles published between the years 2005 and 2016. Following the PRISMA approach, 470 articles were selected and analyzed for significant barriers to influenza vaccine uptake or intention. The barriers for different risk groups and flu types were clustered according to a conceptual framework based on the Theory of Planned Behavior and discussed using the 4C model of reasons for non-vaccination. Results Most studies were conducted in the American and European region. Health care personnel (HCP) and the general public were the most studied populations, while parental decisions for children at high risk were under-represented. This study also identifies understudied concepts. A lack of confidence, inconvenience, calculation and complacency were identified to different extents as barriers to influenza vaccine uptake in risk groups. Conclusion Many different psychological, contextual, sociodemographic and physical barriers that are specific to certain risk groups were identified. While most sociodemographic and physical variables may be significantly related to influenza vaccine hesitancy, they cannot be used to explain its emergence or intensity. Psychological determinants were meaningfully related to uptake and should therefore be measured in a valid and comparable way. A compendium of measurements for future use is suggested as supporting information.	[Schmid, Philipp; Rauber, Dorothee; Betsch, Cornelia] Univ Erfurt, Ctr Empir Res Econ & Behav Sci, Erfurt, Germany; [Schmid, Philipp; Rauber, Dorothee; Betsch, Cornelia; Lidolt, Gianni; Denker, Marie-Luisa] Univ Erfurt, Dept Media & Commun Sci, Erfurt, Germany	University of Erfurt; University of Erfurt	Schmid, P (corresponding author), Univ Erfurt, Ctr Empir Res Econ & Behav Sci, Erfurt, Germany.	philipp.schmid@uni-erfurt.de	Schmid, Philipp/AAY-9398-2020	Schmid, Philipp/0000-0003-2966-0806; Betsch, Cornelia/0000-0002-2856-7303	World Health Organization Headquarters, Geneva (WHO) [2015/592427-0, TTi-15-APW-13]	World Health Organization Headquarters, Geneva (WHO)	This project was financed by the World Health Organization Headquarters, Geneva (WHO Registration Nr. 2015/592427-0; Reg. File TTi-15-APW-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Gharbieh Eman, 2010, Int J Med Sci, V7, P319; Achtymichuk KA, 2015, VACCINE, V33, P3549, DOI 10.1016/j.vaccine.2015.05.047; Agarwal V, 2014, J AM COLL HEALTH, V62, P416, DOI 10.1080/07448481.2014.917650; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Akis S, 2011, EUR J PEDIATR, V170, P1165, DOI 10.1007/s00431-011-1425-6; Al-Tawfiq J, 2009, VACCINE, V27, P5538, DOI 10.1016/j.vaccine.2009.06.108; Alhammadi A, 2015, VACCINE, V33, P3821, DOI 10.1016/j.vaccine.2015.06.082; Alkuwari MG, 2011, VACCINE, V29, P2206, DOI 10.1016/j.vaccine.2010.08.093; Althoff KN, 2010, PREV MED, V50, P223, DOI 10.1016/j.ypmed.2010.03.007; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Arda B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-87; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Arriola CS, 2015, VACCINE, V33, P3829, DOI 10.1016/j.vaccine.2015.06.093; Arriola CS, 2016, VACCINE; Askarian M, 2009, INT J INFECT DIS, V13, P476, DOI 10.1016/j.ijid.2008.09.013; Avelino-Silva VI, 2011, CLINICS, V66, P2031, DOI 10.1590/S1807-59322011001200006; Balicer RD, 2007, MIL MED, V172, P1093, DOI 10.7205/MILMED.172.10.1093; Barbadoro P, 2013, HUM VACC IMMUNOTHER, V9, P911, DOI 10.4161/hv.22997; Baron-Epel O, 2013, HUM VACC IMMUNOTHER, V9, P100, DOI 10.4161/hv.22503; Barriere J, 2010, VACCINE, V28, P7030, DOI 10.1016/j.vaccine.2010.08.021; Bautista D, 2006, INFECT CONT HOSP EP, V27, P73, DOI 10.1086/499148; Beattie A, 2013, VACCINES-BASEL, V1, P17, DOI 10.3390/vaccines1010017; Beel ER, 2014, VACCINE, V32, P2540, DOI 10.1016/j.vaccine.2014.03.056; Betsch C., 2015, POLICY INSIGHTS BEHA, V2, P61, DOI [10.1177/2372732215600716, DOI 10.1177/2372732215600716]; Betsch C, 2012, VACCINE, V30, P1143, DOI 10.1016/j.vaccine.2011.12.021; Betsch C, 2011, MED DECIS MAKING, V31, P742, DOI 10.1177/0272989X11400419; Biro A, 2013, PREV MED, V57, P140, DOI 10.1016/j.ypmed.2013.04.017; Bish A, 2011, VACCINE, V29, P6472, DOI 10.1016/j.vaccine.2011.06.107; Blank PR, 2009, INFECTION, V37, P390, DOI 10.1007/s15010-009-8467-y; Bodeker B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1970-4; Bodeker B, 2014, VACCINE, V32, P4131, DOI 10.1016/j.vaccine.2014.06.007; Boggavarapu S, 2014, VACCINE, V32, P7085, DOI 10.1016/j.vaccine.2014.10.068; Bonaccorsi G, 2013, HUM VACC IMMUNOTHER, V9, P2603, DOI 10.4161/hv.26036; Borjesson M, 2014, SCAND J PUBLIC HEALT, V42, P215, DOI 10.1177/1403494813510790; Bouadma L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038646; BOULWARE LE, PUBLIC HLTH REP, V118, P358; Bryant WK, 2006, PREV MED, V43, P60, DOI 10.1016/j.ypmed.2006.03.018; Burns VE, 2005, VACCINE, V23, P3604, DOI 10.1016/j.vaccine.2004.12.031; Byrne C, 2012, BRIT J HEALTH PSYCH, V17, P582, DOI 10.1111/j.2044-8287.2011.02057.x; Caballero P, 2013, PREV MED, V57, P725, DOI 10.1016/j.ypmed.2013.08.008; Caille-Brillet AL, 2014, VACCINE, V32, P2007, DOI 10.1016/j.vaccine.2013.12.045; Camurdan MO, 2012, BALK MED J, V29, P434, DOI 10.5152/balkanmedj.2012.066; Carrasco-Garrido P, 2009, HUM VACCINES, V5, P839, DOI 10.4161/hv.10042; Cassidy W, 2009, AM J EMERG MED, V27, P1027, DOI 10.1016/j.ajem.2008.05.014; Castilla J, 2013, PREV MED, V57, P206, DOI 10.1016/j.ypmed.2013.05.021; CDC, 2016, MISC SEAS FLU FLU VA; CDC, 2009, INT RES STAT SPEC IN; Chambers CT, 2010, CAN J PUBLIC HEALTH, V101, P15, DOI 10.1007/BF03405554; Chan TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101083; Chan TC, 2013, J AM MED DIR ASSOC, V14, P772, DOI 10.1016/j.jamda.2013.06.008; Chanel O, 2011, SOC SCI MED, V72, P142, DOI 10.1016/j.socscimed.2010.11.018; Chapman GB, 2006, HEALTH PSYCHOL, V25, P82, DOI 10.1037/0278-6133.25.1.82; Chen CH, 2015, VACCINE, V33, P1993, DOI 10.1016/j.vaccine.2015.01.032; Chen JY, 2007, J COMMUN HEALTH, V32, P5, DOI 10.1007/s10900-006-9031-7; Chen MF, 2011, J COMMUN HEALTH NURS, V28, P29, DOI 10.1080/07370016.2011.539087; Chen N-TN, 2013, PUBLIC HEAL YB 2011, P41; Cheung KW, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020155; Chi RC, 2006, J AM GERIATR SOC, V54, P217, DOI 10.1111/j.1532-5415.2005.00577.x; Chiatti C, 2010, PREV MED, V51, P332, DOI 10.1016/j.ypmed.2010.06.008; Chiatti C, 2011, HUM VACCINES, V7, P1021, DOI 10.4161/hv.7.10.16849; Chiatti C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-207; Chor JSY, 2011, VACCINE, V29, P7364, DOI 10.1016/j.vaccine.2011.07.079; Chow MYK, 2012, J PEDIAT INF DIS-GER, V7, P89, DOI 10.3233/JPI-120344; Chuang YC, 2015, PLOS ONE, V10; Chuang YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122970; Cole AP, 2015, HEALTH PSYCHOL, V34, P1185, DOI 10.1037/hea0000232; Corace K, 2013, AM J INFECT CONTROL, V41, P679, DOI 10.1016/j.ajic.2013.01.014; Cornally Nicola, 2013, Br J Nurs, V22, P1207; Costantino C, 2014, HUM VACC IMMUNOTHER, V10, P1204, DOI 10.4161/hv.28081; Cotte L, 2011, VACCINE, V29, P5638, DOI 10.1016/j.vaccine.2011.06.013; Coulibaly D, 2013, J INFECT DEV COUNTR, V7, P499, DOI 10.3855/jidc.2771; Cowan AE, 2006, AM J INFECT CONTROL, V34, P164, DOI 10.1016/j.ajic.2005.09.007; Cozza V, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2067-9; Crawford VLS, 2011, AGE AGEING, V40, P35, DOI 10.1093/ageing/afq152; Crowley KA, 2013, AM J INFECT CONTROL, V41, P824, DOI 10.1016/j.ajic.2012.11.020; Daley MF, 2007, CLIN PEDIATR, V46, P408, DOI 10.1177/0009922806298647; Daley MF, 2006, PEDIATRICS, V117, pE268, DOI 10.1542/peds.2005-1752; Damiani G, 2007, PREV MED, V45, P373, DOI 10.1016/j.ypmed.2007.07.007; Daniels NA, 2010, J IMMIGR MINOR HEALT, V12, P370, DOI 10.1007/s10903-008-9195-6; Daugherty JD, 2015, AM J INFECT CONTROL, V43, P100, DOI 10.1016/j.ajic.2014.08.021; de Barreto P Souto, 2014, VACCINE, P32; de Perio M A, 2014, J SCH HLTH, P84; de Perio MA, 2014, J SCHOOL HEALTH, V84, P586, DOI 10.1111/josh.12184; de Perio MA, 2012, J COMMUN HEALTH, V37, P272, DOI 10.1007/s10900-011-9478-z; Dedoukou X, 2010, VACCINE, V28, P5931, DOI 10.1016/j.vaccine.2010.06.108; Di Gregori V, 2014, J Prev Med Hyg, V55, P152; Ding H, 2011, AM J OBSTET GYNECOL, V204, pS96, DOI 10.1016/j.ajog.2011.03.003; Dip RM, 2010, CAD SAUDE PUBLICA, V26, P1035, DOI 10.1590/S0102-311X2010000500025; Dlugacz Y, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.027; Dominguez A, 2014, HUM VACC IMMUNOTHER, V10, P2378, DOI 10.4161/hv.29142; Donmez L, 2010, TURK KLIN TIP BILIM, V30, P48, DOI 10.5336/medsci.2008-8117; Dowera J, 2011, VACCINE, V29, P3031, DOI 10.1016/j.vaccine.2011.01.116; Dubnov J, 2010, ISR MED ASSOC J, V12, P338; Dyda A, 2015, VACCINE, V33, P3299, DOI 10.1016/j.vaccine.2015.05.046; Eastwood K, 2010, MED J AUSTRALIA, V192, P33, DOI 10.5694/j.1326-5377.2010.tb03399.x; Edmonds BMT, 2011, MATERN CHILD HLTH J, V15, P1203, DOI 10.1007/s10995-010-0693-5; El Khoury G, 2015, INT J ENV RES PUB HE, V12, P15486, DOI 10.3390/ijerph121215000; Endrich MM, 2009, VACCINE, V27, P4018, DOI 10.1016/j.vaccine.2009.04.029; Esteves-Jaramillo A, 2009, ARCH MED RES, V40, P705, DOI 10.1016/j.arcmed.2010.01.004; Fabry P, 2011, VACCINE, V29, P1824, DOI 10.1016/j.vaccine.2010.12.109; Falomir-Pichastor JM, 2009, APPL PSYCHOL-INT REV, V58, P42, DOI 10.1111/j.1464-0597.2008.00381.x; Ferrante G, 2011, EUR J EPIDEMIOL, V26, P211, DOI 10.1007/s10654-011-9576-3; Freund R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020900; Frew PM, 2014, HUM VACC IMMUNOTHER, V10, P2576, DOI 10.4161/hv.32248; Frew PM, 2014, VACCINE, V32, P1736, DOI 10.1016/j.vaccine.2014.01.030; Frew PM, 2012, VACCINE, V30, P4200, DOI 10.1016/j.vaccine.2012.04.053; Frew PM, 2011, PEDIATRICS, V127, pS113, DOI 10.1542/peds.2010-1722Q; Fridman D, 2011, AM J OBSTET GYNECOL, V204, pS124, DOI 10.1016/j.ajog.2011.04.011; Gaglia MA, 2007, CLIN INFECT DIS, V45, P1182, DOI 10.1086/522192; Galarce EM, 2011, VACCINE, V29, P5284, DOI 10.1016/j.vaccine.2011.05.014; Gallagher S, 2006, J PUBLIC HEALTH-UK, V28, P139, DOI 10.1093/pubmed/fdl008; Gargano LM, 2011, J SCHOOL HEALTH, V81, P297, DOI 10.1111/j.1746-1561.2011.00594.x; Gargano LM, 2011, HUM VACCINES, V7, P89, DOI 10.4161/hv.7.1.13460; Gidengil CA, 2012, AM J PUBLIC HEALTH, V102, P672, DOI 10.2105/AJPH.2011.300407; Gnanasekaran SK, 2006, PUBLIC HEALTH REP, V121, P181, DOI 10.1177/003335490612100213; Godin G, 2010, INFECT CONT HOSP EP, V31, P689, DOI 10.1086/653614; Gorman Jessica R, 2015, Prev Med Rep, V2, P333, DOI 10.1016/j.pmedr.2015.04.011; Gorman JR, 2012, VACCINE, V31, P213, DOI 10.1016/j.vaccine.2012.10.064; Guiney H, 2014, NEW ZEAL MED J, V127, P28; Ha C, 2013, J SCHOOL HEALTH, V83, P554, DOI 10.1111/josh.12065; Han YKJ, 2016, PREV MED, V84, P57, DOI 10.1016/j.ypmed.2015.12.018; Haroon M, 2011, JOINT BONE SPINE, V78, P374, DOI 10.1016/j.jbspin.2010.10.012; Hauri AM, 2006, INFECT CONT HOSP EP, V27, P638, DOI 10.1086/504361; Haviland AM, 2011, ARCH INTERN MED, V171, P158, DOI 10.1001/archinternmed.2010.499; Hebert PL, 2005, HEALTH SERV RES, V40, P517, DOI 10.1111/j.1475-6773.2005.0e371.x; Hellyer JMH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029478; Henninger M, 2013, OBSTET GYNECOL, V121, P741, DOI 10.1097/AOG.0b013e3182878a5a; Henninger ML, 2015, J WOMENS HEALTH, V24, P394, DOI 10.1089/jwh.2014.5105; Heo JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064230; Hilyard KM, 2014, HEALTH EDUC BEHAV, V41, P307, DOI 10.1177/1090198113515244; Hirdes JP, 2006, CAN J PUBLIC HEALTH, V97, P335, DOI 10.1007/BF03405616; Hobbs JL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-740; Hochbaum G, 1952, HLTH BELIEF MODEL, V4; Hollmeyer HG, 2009, VACCINE, V27, P3935, DOI 10.1016/j.vaccine.2009.03.056; Holm MV, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-144; Hopman CE, 2011, J HOSP INFECT, V77, P327, DOI 10.1016/j.jhin.2010.10.009; Horby PW, 2005, AUST NZ J PUBL HEAL, V29, P35, DOI 10.1111/j.1467-842X.2005.tb00745.x; Horney JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011226; Hothersall EJ, 2012, PRIM CARE RESP J, V21, P302, DOI 10.4104/pcrj.2012.00056; Hou ZY, 2014, VACCINE, V32, P4471, DOI 10.1016/j.vaccine.2014.06.047; Hu SS, 2011, HONG KONG J PAEDIATR, V16, P101; Huang JH, 2012, EUR J PUBLIC HEALTH, V22, P796, DOI 10.1093/eurpub/ckr167; Humiston SG, 2005, ARCH PEDIAT ADOL MED, V159, P108, DOI 10.1001/archpedi.159.2.108; Ibano L, 2014, BMC INFECT DIS, P14; Ibuka Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087164; Janks M, 2012, INFLUENZA RES TREAT, V2012; Jarrett C, 2015, VACCINE, V33, P4180, DOI 10.1016/j.vaccine.2015.04.040; Jasek JP, 2011, AM J MENS HEALTH, V5, P225, DOI 10.1177/1557988310375606; Jimenez-Garcia R, 2005, VACCINE, V23, P3679, DOI 10.1016/j.vaccine.2005.02.007; Jimenez-Garcia R, 2008, VACCINE, V26, P4218, DOI 10.1016/j.vaccine.2008.05.053; Jimenez-Garcia R, 2008, DIABETES RES CLIN PR, V79, P510, DOI 10.1016/j.diabres.2007.10.013; Jimenez-Garcia R, 2007, HUM VACCINES, V3, P33, DOI 10.4161/hv.3.1.3750; Jimenez-Garcia R, 2006, VACCINE, V24, P5073, DOI 10.1016/j.vaccine.2006.03.036; Jimenez-Garcia R, 2014, HUM VACC IMMUNOTHER, V10, P449, DOI 10.4161/hv.27152; Jimenez-Garcia R, 2010, HUM VACCINES, V6, P566, DOI 10.4161/hv.6.7.11884; Jimenez-Garcia R, 2010, VACCINE, V28, P6169, DOI 10.1016/j.vaccine.2010.07.029; Jimenez-Garcia R, 2009, RESP MED, V103, P1518, DOI 10.1016/j.rmed.2009.04.006; Johnston SS, 2010, AM J MANAG CARE, V16, pE205; Kaboli F, 2010, INFECT CONT HOSP EP, V31, P1017, DOI 10.1086/655465; Kadi Z, 2015, AM J INFECT CONTROL; Kaufman J, 2008, COMMUN DIS INTELL, V32, P443; Kay Meagan K, 2012, Am J Public Health, V102 Suppl 3, pS368, DOI 10.2105/AJPH.2012.300676; Kee SY, 2007, J INFECTION, V55, P273, DOI 10.1016/j.jinf.2007.04.354; Keenan H, 2007, BRIT J GEN PRACT, V57, P359; Keller JJ, 2014, ASIA-PAC J PUBLIC HE, V26, P42, DOI 10.1177/1010539513496842; Kelly DA, 2014, INTERN MED J, V44, P37; Kelly DA, 2014, HUM VACC IMMUNOTHER, V10, P1930, DOI 10.4161/hv.29071; Kiberd Mb, 2009, Can J Infect Dis Med Microbiol, V20, pe124; King WD, 2006, J GEN INTERN MED, V21, P181, DOI [10.1007/s11606-006-0255-0, 10.1111/j.1525-1497.2006.00325.x]; Kiviniemi MT, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-152; Koo KE, 2014, PROCD SOC BEHV, V116, P1513, DOI 10.1016/j.sbspro.2014.01.426; Kouassi DP, 2012, J INFECT DIS, V206, pS114, DOI 10.1093/infdis/jis532; Kraut A, 2011, VACCINE, V29, P8357, DOI 10.1016/j.vaccine.2011.08.084; Kravos A, 2015, ZDRAV VARST, V54, P204, DOI 10.1515/sjph-2015-0029; Kumar S, 2012, HEALTH EDUC BEHAV, V39, P229, DOI 10.1177/1090198111415105; Kwon Y, 2010, VACCINE, V29, P161, DOI 10.1016/j.vaccine.2010.10.063; Kwong EWY, 2009, J CLIN NURS, V18, P1816, DOI 10.1111/j.1365-2702.2009.02869.x; La Torre G, 2010, PUBLIC HEALTH, V124, P690, DOI 10.1016/j.puhe.2010.06.006; La Torre G, 2009, EURO SURVEILL B EUR, V14; Landelle C, 2012, VACCINE, V31, P23, DOI 10.1016/j.vaccine.2012.10.059; Landi F, 2005, VACCINE, V23, P3896, DOI 10.1016/j.vaccine.2005.03.008; Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081; Lau JTF, 2008, INFECTION, V36, P434, DOI [10.1007/s15010-008-7277-y, 10.1007/s15010-008-7277-Y]; Lau JTF, 2008, J INFECTION, V56, P460, DOI 10.1016/j.jinf.2008.03.008; Lau JTF, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1026; Lau JTF, 2012, AM J INFECT CONTROL, V40, pE225, DOI 10.1016/j.ajic.2012.01.036; Lau JTF, 2010, VACCINE, V28, P5389, DOI 10.1016/j.vaccine.2010.05.071; Lau JTF, 2010, VACCINE, V28, P4632, DOI 10.1016/j.vaccine.2010.04.076; Lau JS, 2013, J ADOLESCENT HEALTH, V52, P42, DOI 10.1016/j.jadohealth.2012.04.017; Lau JTF, 2006, VACCINE, V24, P5526, DOI 10.1016/j.vaccine.2006.04.014; Lau L, 2009, INT J NURS STUD, V46, P768, DOI 10.1016/j.ijnurstu.2008.12.006; Lavela Sherri L, 2012, Top Spinal Cord Inj Rehabil, V18, P306, DOI 10.1310/sci1804-306; Leder S, 2015, PSYCHOL HEALTH, V30, P165, DOI 10.1080/08870446.2014.954574; Lee KC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117305; Lee SI, 2012, INFLUENZA RES TREAT, V2012; Lehmann BA, 2015, J HOSP INFECT, V89, P202, DOI 10.1016/j.jhin.2014.11.009; Lehmann BA, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0929-5; Lehmann BA, 2014, VACCINE, V32, P6986, DOI 10.1016/j.vaccine.2014.10.034; Lewis M, 1972, HUM DEV; Li M, 2012, PSYCHOL HEALTH, V27, P101, DOI 10.1080/08870446.2011.554833; Li YC, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-275; Li Y, 2010, AM J PUBLIC HEALTH, V100, pS256, DOI 10.2105/AJPH.2009.173468; Li Z, 2010, VACCINE, V28, P3462, DOI 10.1016/j.vaccine.2010.02.068; Liao Q, 2013, VACCINE, V31, P4084, DOI 10.1016/j.vaccine.2013.07.009; Liao Q, 2013, PLOS ONE, V8; Liao QY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017713; Lim PL, 2013, ANN ACAD MED SINGAP, V42, P173; Lin CJ, 2006, J URBAN HEALTH, V83, P874, DOI 10.1007/s11524-006-9084-z; Lin CJ, 2010, VACCINE, V28, P7706, DOI 10.1016/j.vaccine.2010.07.009; Lin CJ, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-180; Lin YL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-128; Lindley MC, 2008, AM J PUBLIC HEALTH, V98, P932, DOI 10.2105/AJPH.2007.119321; Link MW, 2006, AM J EPIDEMIOL, V163, P571, DOI 10.1093/aje/kwj086; Liu N, 2012, CAN J PUBLIC HEALTH, V103, pE353, DOI 10.1007/BF03404440; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Looijmans-van den Akker I, 2009, VACCINE, V27, P4724, DOI 10.1016/j.vaccine.2009.05.013; de Andres A, 2007, EUR J PUBLIC HEALTH, V17, P272, DOI 10.1093/eurpub/ckl242; Lopez-de-Andres A, 2008, EUR J PUBLIC HEALTH, V18, P173, DOI 10.1093/eurpub/ckm093; Lorenz RA, 2013, INT J PSYCHIAT MED, V46, P1, DOI 10.2190/PM.46.1.a; Loubet P, 2015, VACCINE, V33, P3703, DOI 10.1016/j.vaccine.2015.06.012; Loulergue P, 2009, VACCINE, V27, P4240, DOI 10.1016/j.vaccine.2009.03.039; Lu PJ, 2015, VACCINE, V33, pD83, DOI 10.1016/j.vaccine.2015.09.031; Lu PJ, 2012, AM J PREV MED, V43, P282, DOI 10.1016/j.amepre.2012.05.005; Lu PJ, 2008, VACCINE, V26, P1786, DOI 10.1016/j.vaccine.2008.01.040; Lu PJ, 2005, ARCH INTERN MED, V165, P1849, DOI 10.1001/archinte.165.16.1849; Ludolph R., 2015, Journal of Public Health Research, V4, P142; Lyn-Cook Richard, 2007, Prim Care Respir J, V16, P229, DOI 10.3132/pcrj.2007.00056; Ma KK, 2006, PEDIATRICS, V117, pE157, DOI 10.1542/peds.2005-1079; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Machowicz R, 2010, EUR J MED RES, V15, P235; Maher L, 2013, VACCINE, V31, P5557, DOI 10.1016/j.vaccine.2013.08.081; Maier K, 2012, PLOS CURR, P1; Mak DB, 2015, AUST NZ J OBSTET GYN, V55, P131, DOI 10.1111/ajo.12292; Mak DB, 2010, MED J AUSTRALIA, V193, P401, DOI 10.5694/j.1326-5377.2010.tb03969.x; Mak KK, 2012, EUR J PUBLIC HEALTH, P23; Mak KK, 2013, EUR J PUBLIC HEALTH, V23, P257, DOI 10.1093/eurpub/cks014; Mallari J, 2007, J AM PHARM ASSOC, V47, P498, DOI 10.1331/JAPhA.2007.07018; Malosh R, 2014, VACCINE, V32, P1841, DOI 10.1016/j.vaccine.2014.01.075; Maltezou HC, 2007, J HOSP INFECT, V66, P156, DOI 10.1016/j.jhin.2007.03.005; Maltezou HC, 2010, J INFECTION, V61, P252, DOI 10.1016/j.jinf.2010.06.004; Mamelund SE, 2011, VACCINE, V29, P9441, DOI 10.1016/j.vaccine.2011.10.035; Mangtani P, 2005, PREV MED, V41, P545, DOI 10.1016/j.ypmed.2005.02.001; Marentette T, 2011, CLIN NURS RES, V20, P422, DOI 10.1177/1054773811409032; Santos-Sancho JM, 2012, HUM VACC IMMUNOTHER, V8, DOI 10.4161/hv.20204; Martinez-Baz I, 2012, PREV MED, V55, P246, DOI 10.1016/j.ypmed.2012.06.020; Matsui D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-149; Maurer J, 2011, PREV MED BALTIM, V52, P459; Maurer J, 2014, J GEN INTERN MED, V29, P1624, DOI 10.1007/s11606-014-2965-z; Mendiola Jennifer, 2016, Prev Med Rep, V3, P25, DOI 10.1016/j.pmedr.2015.11.006; Mendoza-Sassi RA, 2015, CAD SAUDE PUBLICA, V31, P1247, DOI 10.1590/0102-311X00084514; Mereckiene J, 2012, EURO SURVEILL B EUR, V17; Mereckiene J, 2008, EURO SURVEILL B EUR, V13; Merrill RM, 2010, MED SCI MONITOR, V16, pPH29; Mesch GS, 2015, AM J INFECT CONTROL, V43, P1161, DOI 10.1016/j.ajic.2015.06.031; Mesch GS, 2015, HEALTH PROMOT INT, V30, P213, DOI 10.1093/heapro/dau094; Milman U, 2005, PATIENT EDUC COUNS, V58, P203, DOI 10.1016/j.pec.2004.08.017; Milunic SL, 2010, INFECT CONT HOSP EP, V31, P85, DOI 10.1086/649219; Miyakis S, 2011, J HOSP INFECT, V78, P75, DOI 10.1016/j.jhin.2010.12.014; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Mok E, 2006, PUBLIC HEALTH NURS, V23, P506, DOI 10.1111/j.1525-1446.2006.00590.x; Montero EM, 2007, PUBLIC HEALTH, V121, P113, DOI 10.1016/j.puhe.2006.09.009; Moura RF, 2015, CAD SAUDE PUBLICA, V31; Mouthon L, 2010, RHEUMATOLOGY, V49, P600, DOI 10.1093/rheumatology/kep440; Myers LB, 2012, PUBLIC HEALTH, V126, pS53, DOI 10.1016/j.puhe.2012.05.024; Myers LB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-15; Mytton OT, 2013, OCCUP MED-OXFORD, V63, P189, DOI 10.1093/occmed/kqt002; Nagata JM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-388; Naing Cho, 2012, J Infect Public Health, V5, P412, DOI 10.1016/j.jiph.2012.07.005; Newcombe J, 2014, VACCINE, V32, P6364, DOI 10.1016/j.vaccine.2014.06.044; Njuguna H, 2013, VACCINE, V31, P4662, DOI 10.1016/j.vaccine.2013.07.005; Norbury M, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X583146; Norton SP, 2008, VACCINE, V26, P2942, DOI 10.1016/j.vaccine.2008.03.033; Nowalk MP, 2007, J NATL MED ASSOC, V99, P636; Nowalk MP, 2015, AM J HEALTH BEHAV, V39, P573, DOI 10.5993/AJHB.39.4.14; Nowrouzi-Kia B, 2014, VACCINE, V32, P3830, DOI 10.1016/j.vaccine.2014.04.067; Nyhan B, 2012, J ADOLESCENT HEALTH, V51, P302, DOI 10.1016/j.jadohealth.2012.02.014; O'Reilly FW, 2005, OCCUP MED-OXFORD, P55; Offutt-Powell TN, 2014, EPIDEMIOL INFECT, V142, P134, DOI 10.1017/S0950268813000782; Ojha RP, 2015, AM J PUBLIC HEALTH, V105, pE35, DOI 10.2105/AJPH.2015.302736; Opstelten W, 2008, VACCINE, V26, P5918, DOI 10.1016/j.vaccine.2008.08.049; Oria PA, 2011, VACCINE, V29, P3617, DOI 10.1016/j.vaccine.2011.01.063; Arjona MAO, 2011, VACCINE, V29, P6366, DOI 10.1016/j.vaccine.2011.04.117; Ortiz JR, 2010, CHEST, V138, P1448, DOI 10.1378/chest.10-0356; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Osterholm MT, 2012, COMPELLING NEED GAME, P160; Otieno NA, 2014, VACCINE, V32, P6699, DOI 10.1016/j.vaccine.2013.10.089; Ozer A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014177; Painter JE, 2011, HEALTH EDUC RES, V26, P751, DOI 10.1093/her/cyr025; Painter JE, 2010, HEALTH EDUC RES, V25, P853, DOI 10.1093/her/cyq037; Pareek M, 2009, VACCINE, V27, P1242, DOI 10.1016/j.vaccine.2008.12.006; Patel R, 2007, FAM PRACT, V24, P7, DOI 10.1093/fampra/cml064; Peleg N, 2015, VACCINE, V33, P182, DOI 10.1016/j.vaccine.2014.10.086; Peng Y, 2013, PUBLIC HEALTH, V127, P930, DOI 10.1016/j.puhe.2013.06.007; Peretti-Watel P, 2013, EUROSURVEILLANCE, V18, P15, DOI 10.2807/1560-7917.ES2013.18.44.20623; Pfeil A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-402; Phillips-Caesar E, 2008, J HEALTH CARE POOR U, V19, P611, DOI 10.1353/hpu.0.0006; Piccirillo B, 2006, INFECT CONT HOSP EP, V27, P618, DOI 10.1086/504448; Podlesek A, 2011, ZDRAV VARST, V50, P227, DOI 10.2478/v10152-011-0002-8; Poehling KA, 2010, PEDIATRICS, V126, P665, DOI 10.1542/peds.2009-2620; Poeppl W, 2015, VACCINE, V33, P1682, DOI 10.1016/j.vaccine.2015.02.029; Poland GA, 2010, VACCINE, V28, pD3, DOI 10.1016/j.vaccine.2010.08.024; Polisena J, 2012, VACCINE, V30, P1981, DOI 10.1016/j.vaccine.2012.01.009; Pomery EA, 2009, PERS SOC PSYCHOL B, V35, P894, DOI 10.1177/0146167209335166; Porter CK, 2013, HUM VACC IMMUNOTHER, V9, P2613, DOI 10.4161/hv.25910; Prati G, 2011, HEALTH EDUC RES, V26, P761, DOI 10.1093/her/cyr035; Prematunge C, 2012, VACCINE, V30, P4733, DOI 10.1016/j.vaccine.2012.05.018; Pulcini C, 2013, VACCINE, V31, P3943, DOI 10.1016/j.vaccine.2013.06.039; Quach S, 2012, CAN MED ASSOC J, V184, P1673, DOI 10.1503/cmaj.111628; Quinn SC, 2013, BIOSECUR BIOTERROR, V11, P96, DOI 10.1089/bsp.2012.0048; Quinn SC, 2009, BIOSECUR BIOTERROR, V7, P275, DOI 10.1089/bsp.2009.0041; Rachiotis G, 2010, EUROSURVEILLANCE, V15, P8; Rangel MC, 2005, J GEN INTERN MED, V20, P426, DOI 10.1111/j.1525-1497.2005.0097.x; Rashid ZZ, 2015, SE ASIAN J TROP MED, V46, P215; Rebmann T, 2012, AM J INFECT CONTROL, V40, P632, DOI 10.1016/j.ajic.2011.12.016; Rebmann T, 2012, INFECT CONT HOSP EP, V33, P737, DOI 10.1086/666336; Rebmann T, 2012, INFECT CONT HOSP EP, V33, P243, DOI 10.1086/664057; Redelings MD, 2012, VACCINE, V30, P454, DOI 10.1016/j.vaccine.2011.10.050; Rehmani R, 2010, VACCINE, V28, P4283, DOI 10.1016/j.vaccine.2010.04.031; Reiter PL, 2011, HUM VACCINES, V7, P191; Renner B, 2012, VACCINE, V30, P7019, DOI 10.1016/j.vaccine.2012.09.064; Rhodes Re, 2003, Psychol Health Med, V8, P57, DOI 10.1080/1354850021000059269; Rimple D, 2006, ACAD EMERG MED, V13, P922, DOI 10.1197/j.aem.2006.04.022; Rivis A, DESCRIPTIVE NORMS AD; Rodas JR, 2012, PUBLIC HEALTH, V126, P1007, DOI 10.1016/j.puhe.2012.09.011; Rodriguez-Rieiro C, 2011, HUM VACCINES, V7, P557, DOI 10.4161/hv.7.5.14984; Rodriguez-Rieiro C, 2011, VACCINE, V29, P1332, DOI 10.1016/j.vaccine.2010.10.061; Ronnerstrand B, 2013, SCAND J PUBLIC HEALT, V41, P853, DOI 10.1177/1403494813494975; Rubin GJ, 2011, VACCINE, V29, P2421, DOI 10.1016/j.vaccine.2011.01.035; Rudisill C, 2013, J RISK RES, V16, P959, DOI 10.1080/13669877.2012.761271; Saluja Inderpal, 2005, CJEM, V7, P17; Sambamoorthi U, 2005, PREV MED, V40, P469, DOI 10.1016/j.ypmed.2004.07.017; Sammon CJ, 2013, HUM VACC IMMUNOTHER, V9, P917; Sammon CJ, 2012, VACCINE, V30, P2483, DOI 10.1016/j.vaccine.2011.11.077; Sanossian N, 2009, NEUROEPIDEMIOLOGY, V32, P165, DOI 10.1159/000186500; Santibanez TA, 2006, PEDIATRICS, V118, P1167, DOI 10.1542/peds.2006-0831; Santibanez TA, 2010, AM J HEALTH BEHAV, V34, P77; Savas E, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-281; Sato APS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123840; Sbidian E, 2012, VACCINE, V30, P5703, DOI 10.1016/j.vaccine.2012.07.014; Schmiege SJ, 2009, J APPL SOC PSYCHOL, V39, P95, DOI 10.1111/j.1559-1816.2008.00431.x; Schmitz H, 2011, HEALTH ECON, V20, P1281, DOI 10.1002/hec.1672; Schoefer Y, 2007, J INFECTION, V55, P347, DOI 10.1016/j.jinf.2007.06.002; Schuller KA, 2013, J INFECT PUBLIC HEAL, V6, P80, DOI 10.1016/j.jiph.2012.12.001; Schult TM, 2012, INFECT CONT HOSP EP, V33, P924, DOI 10.1086/667370; Schwartz AW, 2013, PREV MED, V56, P337, DOI 10.1016/j.ypmed.2013.01.019; Schwarzinger M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010199; Schwarzinger M, 2010, VACCINE, V28, P2743, DOI 10.1016/j.vaccine.2010.01.027; Seale H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-99; Setbon M, 2010, EUR J PUBLIC HEALTH, V20, P490, DOI 10.1093/eurpub/ckq054; Shahrabani S, 2010, INT J ENV RES PUB HE, V7, P853, DOI 10.3390/ijerph7030853; Shavers VL, 2012, AM J PUBLIC HEALTH, V102, P953, DOI 10.2105/AJPH.2012.300773; Shemesh AA, 2008, ARCH GERONTOL GERIAT, V47, P63, DOI 10.1016/j.archger.2007.07.001; Shi LY, 2005, J GEN INTERN MED, V20, P148, DOI 10.1111/j.1525-1497.2005.40136.x; Shim E, 2012, J R SOC INTERFACE, V9, P2234, DOI 10.1098/rsif.2012.0115; Shin DW, 2012, INFLUENZA OTHER RESP, V6, pe120, DOI 10.1111/j.1750-2659.2012.00378.x; Shono A, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0821-3; Shono A, 2014, VACCINE, V32, P5071, DOI 10.1016/j.vaccine.2014.07.002; Shrikrishna D, 2015, BMJ OPEN RESPIR RES, V2, DOI 10.1136/bmjresp-2015-000079; Shroufi A, 2009, PUBLIC HEALTH, V123, P645, DOI 10.1016/j.puhe.2009.09.014; Shui IM, 2006, AM J PREV MED, V31, P244, DOI 10.1016/j.amepre.2006.04.006; Sibley LM, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-20; Singleton JA, 2005, AM J PREV MED, V29, P412, DOI 10.1016/j.amepre.2005.08.012; Sintes X, 2011, EPIDEMIOL INFECT, V139, P666, DOI 10.1017/S0950268810001846; Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x; Soyer OU, 2011, PEDIATR PULM, V46, P139, DOI 10.1002/ppul.21332; Stafford KA, 2013, J CANCER SURVIV, V7, P183, DOI 10.1007/s11764-012-0257-3; SteelFisher GK, 2015, INFLUENZA OTHER RESP, V9, P131, DOI 10.1111/irv.12306; Stockwell MS, 2013, VACCINE, V31, P2103, DOI [10.1016/j,vaccine.2011.03.062, DOI 10.1016/J,VACCINE.2011.03.062]; Straits-Troster KA, 2006, AM J PREV MED, V31, P375, DOI 10.1016/j.amepre.2006.07.018; Strelitz B, 2015, VACCINE, V33, P1802, DOI 10.1016/j.vaccine.2015.02.034; Strully KW, 2011, J HEALTH SOC BEHAV, V52, P510, DOI 10.1177/0022146511423544; Sunil TS, 2011, VACCINE, V29, P4687, DOI 10.1016/j.vaccine.2011.04.110; Suryadevara M, 2014, HUM VACC IMMUNOTHER, V10, P2098, DOI 10.4161/hv.28803; Sypsa V, 2009, EURO SURVEILL B EUR, V14; Szucs TD, 2005, VACCINE, V23, P5055, DOI 10.1016/j.vaccine.2005.06.005; Takayama M, 2013, LANCET, V381, P141; Takayama M, 2012, PREV MED, V54, P358, DOI 10.1016/j.ypmed.2012.03.008; Takayanagi IJ, 2007, AM J INFECT CONTROL, V35, P56, DOI 10.1016/j.ajic.2006.06.002; Taksdal SE, 2013, AUST FAM PHYSICIAN, V42, P582; Tarrant M, 2013, MATERN CHILD HLTH J, V17, P23, DOI 10.1007/s10995-011-0943-1; Thompson MG, 2012, VACCINE, V30, P3557, DOI 10.1016/j.vaccine.2012.03.062; Tilburt JC, 2008, VACCINE, V26, pD27, DOI 10.1016/j.vaccine.2008.07.068; To KW, 2010, AM J INFECT CONTROL, V38, P623, DOI 10.1016/j.ajic.2010.05.015; Tong A, 2008, J OBSTET GYNAECOL CA, V30, P404, DOI 10.1016/S1701-2163(16)32825-0; Torun SD, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-596; Torun SD, 2010, VACCINE, V28, P5703, DOI 10.1016/j.vaccine.2010.06.049; Trivalle C, 2006, INFECT CONT HOSP EP, V27, P1278, DOI 10.1086/508833; Tsai YY, 2014, VACCINE, V32, P6667, DOI 10.1016/j.vaccine.2014.08.080; Tsuchiya Y, 2014, PROCEDIA VACCINOL, V8, P12, DOI 10.1016/j.provac.2014.07.003; Tsutsui Y, 2012, J SOCIO-ECON, V41, P594, DOI 10.1016/j.socec.2012.05.001; Tuckerman JL, 2015, HUM VACC IMMUNOTHER, V11, P704, DOI 10.1080/21645515.2015.1008886; Turner Suzette, 2015, Can J Cardiovasc Nurs, V25, P17; Uddin M, 2010, J EPIDEMIOL COMMUN H, V64, P808, DOI 10.1136/jech.2009.090852; Uscher-Pines L, 2011, AM J PUBLIC HEALTH, V101, P1252, DOI 10.2105/AJPH.2011.300133; Uwemedimo OT, 2012, J COMMUN HEALTH, V37, P663, DOI 10.1007/s10900-011-9497-9; Valour F, 2013, VACCINE, V31, P592, DOI 10.1016/j.vaccine.2012.11.070; Valour F, 2014, VACCINE, V32, P4558, DOI 10.1016/j.vaccine.2014.06.015; van Delden JJM, 2008, VACCINE, V26, P5562, DOI 10.1016/j.vaccine.2008.08.002; Van den Broeck W, 2011, BMC INFECT DIS, V11, DOI [10.1186/1471-2334-11-37, 10.1186/1471-2458-11-575]; Van den Dool C, 2008, VACCINE, V26, P1297, DOI 10.1016/j.vaccine.2007.12.045; Vaux S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-30; Vaux S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-159; Velan B, 2011, VACCINE, V29, P1173, DOI 10.1016/j.vaccine.2010.12.006; Verger P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041837; Villacorta Reginald, 2015, Prev Med Rep, V2, P355, DOI 10.1016/j.pmedr.2015.04.017; Vinograd I, 2014, CLIN MICROBIOL INFEC, V20, P899, DOI 10.1111/1469-0691.12625; Virseda S, 2010, VACCINE, V28, P4751, DOI 10.1016/j.vaccine.2010.04.101; Wada K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059272; Walter D, 2011, VACCINE, V29, P4008, DOI 10.1016/j.vaccine.2011.03.069; Wan-Arfah N, 2012, SE ASIAN J TROP MED, V43, P1489; Wang JL, 2014, RES SOC ADMIN PHARM, V10, P126, DOI 10.1016/j.sapharm.2013.04.011; Wang WR, 2015, SOC INFLUENCE, V10, P137, DOI 10.1080/15534510.2015.1011227; Weaver FM, 2007, J SPINAL CORD MED, V30, P10, DOI 10.1080/10790268.2007.11753908; WHO, 2015, GLOB IND MED; WHO, 2014, SEAS INFL FACT SH; WHO, 2015, GLOB ACT PLAN INFL V; Wiese-Posselt M, 2006, VACCINE, V24, P2560, DOI 10.1016/j.vaccine.2005.12.020; Wiley KE, 2013, MED J AUSTRALIA, V198, P373, DOI 10.5694/mja12.11849; Wilson RJ, 2015, VACCINE, V33, P6420, DOI 10.1016/j.vaccine.2015.08.046; Winston CA, 2006, J AM GERIATR SOC, V54, P303, DOI 10.1111/j.1532-5415.2005.00585.x; Wong SYS, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-316; Wooten KG, 2012, VACCINE, V30, P6927, DOI 10.1016/j.vaccine.2012.08.036; World Health Organization, 2006, GLOB PAND INFL ACT P; Wu CST, 2014, INT J ENV RES PUB HE, V11, P1989, DOI 10.3390/ijerph110201989; Wu SQ, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-320, 10.1186/1471-2458-13-636]; Xakellis GC, 2005, J AM BOARD FAM PRACT, V18, P426, DOI 10.3122/jabfm.18.5.426; Yang HJ, 2014, INT J ENV RES PUB HE, V11, P12162, DOI 10.3390/ijerph111212162; Yen CF, 2012, RES DEV DISABIL, V33, P704, DOI 10.1016/j.ridd.2011.11.011; Yeung MPS, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1990-0; Yeung MPS, 2016, J PUBLIC HLTH OXF; Yi SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018893; Yu MC, 2014, HUM VACC IMMUNOTHER, V10, P1028, DOI 10.4161/hv.27816; Yuen CYS, 2014, VACCINE, V32, P4602, DOI 10.1016/j.vaccine.2014.06.067; Yuen CYS, 2013, VACCINE, V31, P5281, DOI 10.1016/j.vaccine.2013.08.063; Yun Hwan Sic, 2013, Korean J Gastroenterol, V61, P203; Zairina A R, 2011, Med J Malaysia, V66, P207; Zhang J, 2012, J CLIN NURS, V21, P2636, DOI 10.1111/j.1365-2702.2011.03794.x; Zhang J, 2012, VACCINE, V30, P4813, DOI 10.1016/j.vaccine.2012.05.012	439	535	541	17	136	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170550	10.1371/journal.pone.0170550	http://dx.doi.org/10.1371/journal.pone.0170550			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7IT	28125629	Green Published, Green Submitted, gold			2022-12-27	WOS:000396176100095
J	Stiebel-Kalish, H; Lotan, I; Brody, J; Chodick, G; Bialer, O; Marignier, R; Bach, M; Hellmann, MA				Stiebel-Kalish, Hadas; Lotan, Itay; Brody, Judith; Chodick, Gabriel; Bialer, Omer; Marignier, Romain; Bach, Michael; Hellmann, Mark Andrew			Retinal Nerve Fiber Layer May Be Better Preserved in MOG-IgG versus AQP4-IgG Optic Neuritis: A Cohort Study	PLOS ONE			English	Article							MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; VISUAL-ACUITY TEST; NEUROMYELITIS-OPTICA; COHERENCE TOMOGRAPHY; SPECTRUM DISORDERS; MULTIPLE-SCLEROSIS; COUNTING FINGERS; HAND MOTION; ANTIBODIES; NMO	Background Optic neuritis (ON) in patients with anti-myelin oligodendrocyte glycoprotein (MOG)-IgG antibodies has been associated with a better clinical outcome than anti-aquaporin 4 (AQP4)-IgG ON. Average retinal nerve fiber layer thickness (RNFL) correlates with visual outcome after ON. Objectives The aim of this study was to examine whether anti-MOG-IgG ON is associated with better average RNFL compared to anti-AQP4-IgG ON, and whether this corresponds with a better visual outcome. Methods A retrospective study was done in a consecutive cohort of patients following anti-AQP4-IgG and anti-MOG-IgG ON. A generalized estimating equation (GEE) models analysis was used to compare average RNFL outcomes in ON eyes of patients with MOG-IgG to AQP4-IgGpositive patients, after adjusting for the number of ON events. The final mean visual field defect and visual acuity were compared between ON eyes of MOG-IgG and AQP4-IgG-positive patients. A correlation between average RNFL and visual function was performed in all study eyes. Results Sixteen patients were analyzed; ten AQP4-IgG-positive and six MOG-IgG-positive. The six patients with MOG-IgG had ten ON events with disc edema, five of which were bilateral. In the AQP4-IgG-positive ON events, 1/10 patients had disc edema. Final average RNFL was significantly better in eyes following MOG-IgG-ON (75.33 mu m), compared to 63.63 mu m in AQP4-IgG-ON, after adjusting for the number of ON attacks (GEE, p = 0.023). Mean visual field defects were significantly smaller (GEE, p = 0.046) among MOG-IgG positive ON eyes compared to AQP-IgG positive ON eyes, but last visual acuity did not differ between the groups (GEE, p = 0.153). Among all eyes, average RNFL positively correlated with mean visual field defect (GEE, p = 0.00015) and negatively correlated with final visual acuity (GEE, p = 0.00005). Conclusions Following ON, RNFL is better preserved in eyes of patients with MOG-IgG antibodies compared to those with AQP4-IgG antibodies, correlating with better visual outcomes.	[Stiebel-Kalish, Hadas; Lotan, Itay; Brody, Judith; Chodick, Gabriel; Bialer, Omer; Hellmann, Mark Andrew] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Stiebel-Kalish, Hadas; Brody, Judith; Bialer, Omer] Rabin Med Ctr, Dept Ophthalmol, Neuroophthalmol Unit, Petah Tiqwa, Israel; [Lotan, Itay; Hellmann, Mark Andrew] Rabin Med Ctr, Neuroimmunol Serv, Petah Tiqwa, Israel; [Lotan, Itay; Hellmann, Mark Andrew] Rabin Med Ctr, Dept Neurol, Petah Tiqwa, Israel; [Chodick, Gabriel] Tel Aviv Univ, Sackler Sch Med, Dept Epidemiol & Prevent Med, Tel Aviv, Israel; [Marignier, Romain] Hosp Civils Lyon, Serv Neurol A, Hop Neurol Pierre Wertheimer, Lyon, France; [Bach, Michael] Univ Freiburg, Ctr Eye, Med Ctr, Freiburg, Germany; [Bach, Michael] Univ Freiburg, Fac Med, Freiburg, Germany	Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Rabin Medical Center; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; CHU Lyon; University of Freiburg; University of Freiburg	Stiebel-Kalish, H (corresponding author), Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.; Stiebel-Kalish, H (corresponding author), Rabin Med Ctr, Dept Ophthalmol, Neuroophthalmol Unit, Petah Tiqwa, Israel.	kalishhadas@gmail.com	lotan, Itay/Q-8028-2019; Bach, Michael/A-6637-2010; Stiebel-Kalish, Hadas/ABA-8583-2020	lotan, Itay/0000-0002-4015-9783; Bach, Michael/0000-0003-2028-535X; Stiebel-Kalish, Hadas/0000-0001-7715-6706; /0000-0002-5189-8995				Akaishi T, 2016, J NEUROL NEUROSUR PS, V87, P446, DOI 10.1136/jnnp-2014-310206; Boudreault K, 2016, SEMIN OPHTHALMOL, V31, P117, DOI 10.3109/08820538.2015.1114835; Cruz-Herranz A, 2016, NEUROLOGY, V86, P2303, DOI 10.1212/WNL.0000000000002774; Fan Q, 2011, INVEST OPHTH VIS SCI, V52, P6059, DOI 10.1167/iovs.10-7108; Hoftberger R, 2015, MULT SCLER J, V21, P866, DOI 10.1177/1352458514555785; Hokari M, 2016, ANN NEUROL, V79, P605, DOI 10.1002/ana.24608; Jarius S, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0718-0; Kaneko K, 2016, J NEUROL NEUROSURG P; Kitley J, 2012, NEUROLOGY, V79, P1273, DOI 10.1212/WNL.0b013e31826aac4e; Kleiter I, 2016, ANN NEUROL, V79, P206, DOI 10.1002/ana.24554; Lange C, 2009, GRAEF ARCH CLIN EXP, V247, P137, DOI 10.1007/s00417-008-0926-0; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Marignier R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0577-8; Pache F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0720-6; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Ramanathan S, 2014, NEUROL-NEUROIMMUNOL, V1, DOI 10.1212/NXI.0000000000000040; Sato DK, 2014, NEUROLOGY, V82, P474, DOI 10.1212/WNL.0000000000000101; Schulze-Bonsel K, 2006, INVEST OPHTH VIS SCI, V47, P1236, DOI 10.1167/iovs.05-0981; Tewarie P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034823; Wang JJ, 2016, NEUROLOGY; Willison HJ, 2012, NEUROLOGY, V79, P1198, DOI 10.1212/WNL.0b013e31826aadaf; Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729; Wingerchuk DM, 2015, NEUROLOGY	23	37	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170847	10.1371/journal.pone.0170847	http://dx.doi.org/10.1371/journal.pone.0170847			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125740	Green Published, gold, Green Submitted			2022-12-27	WOS:000396176100036
J	Wang, JJ; Wu, CC; Lee, CL; Hsieh, SL; Chen, JB; Lee, CI				Wang, Jyh-Jye; Wu, Chih-Chung; Lee, Chun-Lin; Hsieh, Shu-Ling; Chen, Jin-Bor; Lee, Chu-I			Antimelanogenic, Antioxidant and Antiproliferative Effects of Antrodia camphorata Fruiting Bodies on B16-F0 Melanoma Cells	PLOS ONE			English	Article							EXTRACT; BODY	Antrodia camphorata is a fungus that is endemic to Taiwan, and its fruiting body has been used as a folk medicine for the prevention or treatment of diverse diseases. The present study is aimed at investigating the antimelanogenesis and antioxidation effect of the ethanolic extract of Antrodia camphorata fruiting body (EE-AC), as well as its antiproliferation effects in B16-F0 melanoma cells. Regarding antimelanogenic effects, EE-AC had effective cupric ions reducing capacity and expressed more potent inhibitory effect than kojic acid on mushroom tyrosinase activity. Moreover, EE-AC significantly inhibited cellular tyrosinase activity and the melanin content in B16-F0 cells at 12.5 mu g/mL concentration without cell toxicities. Regarding antioxidant effects, EE-AC exhibited potent DPPH radical-and SOD-like-scavenging activities. Regarding antiproliferative effects, EE-AC exhibited a selective cytotoxic effect and markedly inhibited the migration ability of B16-F0 cells. EE-AC increased the population of B16-F0 cells at sub-G1 phase of the cell cycle. EE-AC also caused the increase of early apoptotic cells and chromatin condensation, which indicated the apoptotic effects in B16-F0 cells. We demonstrated that EE-AC possessed antimelanogenic, antioxidant and anti-skin cancer actions. The results would contribute to the development and application of cosmetics, healthy food and pharmaceuticals.	[Wang, Jyh-Jye] Fooyin Univ, Dept Nutr & Hlth Sci, Kaohsiung, Taiwan; [Wu, Chih-Chung] Chang Jung Christian Univ, Dept Nutr & Hlth Sci, Tainan, Taiwan; [Lee, Chun-Lin] Natl Taitung Univ, Dept Life Sci, Taitung, Taiwan; [Hsieh, Shu-Ling] Natl Kaohsiung Marine Univ, Dept Seafood Sci, Kaohsiung, Taiwan; [Chen, Jin-Bor] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan; [Chen, Jin-Bor] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Lee, Chu-I] Fooyin Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan	Fooyin University; Chang Jung Christian University; National Kaohsiung University of Science & Technology; Chang Gung Memorial Hospital; Chang Gung University; Fooyin University	Lee, CI (corresponding author), Fooyin Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan.	mt046@fy.edu.tw	Wu, Chih-Chung/AFB-8873-2022	Wu, Chih-Chung/0000-0002-6518-5312	Ministry of Education, Taiwan [99B-78-014]	Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This research was supported by the grant 99B-78-014 from the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanbi MHJ, 2013, APPL MICROBIOL BIOT, V97, P4385, DOI 10.1007/s00253-012-4311-x; Baurin N, 2002, J ETHNOPHARMACOL, V82, P155, DOI 10.1016/S0378-8741(02)00174-5; CHEN JS, 1991, J AGR FOOD CHEM, V39, P1897, DOI 10.1021/jf00011a001; Ding HY, 2011, PLANT FOOD HUM NUTR, V66, P275, DOI 10.1007/s11130-011-0235-3; Forni C, 2014, MOL BIOSYST, V10, P1255, DOI 10.1039/c3mb70316a; Galvan I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003335; Geethangili M, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep108; Hseu YC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/197309; Hsu YL, 2005, CANCER LETT, V221, P77, DOI 10.1016/j.canlet.2004.08.012; JAY D, 1991, ARCH BIOCHEM BIOPHYS, V290, P463, DOI 10.1016/0003-9861(91)90567-3; Kim YJ, 2005, BIOL PHARM BULL, V28, P323, DOI 10.1248/bpb.28.323; Lee CI, 2014, FOOD FUNCT, V5, P3224, DOI [10.1039/c4fo00720d, 10.1039/C4FO00720D]; Lee CI, 2013, APPL MICROBIOL BIOT, V97, P1269, DOI 10.1007/s00253-012-4279-6; Li YQ, 2011, J MED PLANTS RES, V5, P1066; Maity P, 2014, INT J BIOL MACROMOL, V63, P140, DOI 10.1016/j.ijbiomac.2013.10.040; Sapkota K, 2010, BIOSCI BIOTECH BIOCH, V74, P1527, DOI 10.1271/bbb.100058; Solano F, 2006, PIGM CELL RES, V19, P550, DOI 10.1111/j.1600-0749.2006.00334.x; Song TY, 2002, J AGR FOOD CHEM, V50, P3322, DOI 10.1021/jf011671z; Tsai Z-T., 1985, USE EFFECT GANODERMA, P116; Tu SH, 2012, J AGR FOOD CHEM, V60, P3612, DOI 10.1021/jf300221g; Wang LC, 2013, APPL MICROBIOL BIOT, V97, P9955, DOI 10.1007/s00253-013-5214-1; Wang LC, 2012, APPL MICROBIOL BIOT, V94, P1505, DOI 10.1007/s00253-012-3941-3; Wu MT, 2011, J AGR FOOD CHEM, V59, P4248, DOI 10.1021/jf104561h; Wu SH, 1997, BOT BULL ACAD SINICA, V38, P273; Yeh CT, 2009, CANCER LETT, V285, P73, DOI 10.1016/j.canlet.2009.05.002	25	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170924	10.1371/journal.pone.0170924	http://dx.doi.org/10.1371/journal.pone.0170924			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125738	Green Submitted, Green Published, gold			2022-12-27	WOS:000396176100023
J	Casciano, JC; Duchemin, NJ; Lamontagne, RJ; Steel, LF; Bouchard, MJ				Casciano, Jessica C.; Duchemin, Nicholas J.; Lamontagne, R. Jason; Steel, Laura F.; Bouchard, Michael J.			Hepatitis B virus modulates store-operated calcium entry to enhance viral replication in primary hepatocytes	PLOS ONE			English	Article							DEPENDENT ANION CHANNEL; PRIMARY RAT HEPATOCYTES; X-PROTEIN; HBX PROTEIN; CA2+ ENTRY; ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTORS; ACTIVATION; EXPRESSION; MITOCHONDRIA	Many viruses modulate calcium (Ca2+) signaling to create a cellular environment that is more permissive to viral replication, but for most viruses that regulate Ca2+ signaling, the mechanism underlying this regulation is not well understood. The hepatitis B virus (HBV) HBx protein modulates cytosolic Ca2+ levels to stimulate HBV replication in some liver cell lines. A chronic HBV infection is associated with life-threatening liver diseases, including hepatocellular carcinoma (HCC), and HBx modulation of cytosolic Ca2+ levels could have an important role in HBV pathogenesis. Whether HBx affects cytosolic Ca2+ in a normal hepatocyte, the natural site of an HBV infection, has not been addressed. Here, we report that HBx alters cytosolic Ca2+ signaling in cultured primary hepatocytes. We used single cell Ca2+ imaging of cultured primary rat hepatocytes to demonstrate that HBx elevates the cytosolic Ca2+ level in hepatocytes following an IP3-linked Ca2+ response; HBx effects were similar when expressed alone or in the context of replicating HBV. HBx elevation of the cytosolic Ca2+ level required extracellular Ca2+ influx and store-operated Ca2+ (SOC) entry and stimulated HBV replication in hepatocytes. We used both targeted RT-qPCR and transcriptome- wide RNAseq analyses to compare levels of SOC channel components and other Ca2+ signaling regulators in HBV-expressing and control hepatocytes and show that the transcript levels of these various proteins are not affected by HBV. We also show that HBx regulation of SOC-regulated Ca2+ accumulation is likely the consequence of HBV modulation of a SOC channel regulatory mechanism. In support of this, we link HBx enhancement of SOC-regulated Ca2+ accumulation to Ca2+ uptake by mitochondria and demonstrate that HBx stimulates mitochondrial Ca2+ uptake in primary hepatocytes. The results of our study may provide insights into viral mechanisms that affect Ca2+ signaling to regulate viral replication and virus-associated diseases.	[Casciano, Jessica C.; Duchemin, Nicholas J.] Drexel Univ, Program Mol & Cellular Biol & Genet, Grad Sch Biomed Sci & Profess Studies, Coll Med, Philadelphia, PA 19104 USA; [Lamontagne, R. Jason] Drexel Univ, Program Microbiol & Immunol, Grad Sch Biomed Sci & Profess Studies, Coll Med, Philadelphia, PA 19104 USA; [Steel, Laura F.] Drexel Univ, Dept Microbiol & Immunol, Coll Med, Philadelphia, PA 19104 USA; [Bouchard, Michael J.] Drexel Univ, Dept Biochem & Mol Biol, Coll Med, Philadelphia, PA 19104 USA	Drexel University; Drexel University; Drexel University; Drexel University	Bouchard, MJ (corresponding author), Drexel Univ, Dept Biochem & Mol Biol, Coll Med, Philadelphia, PA 19104 USA.	michael.bouchard@drexelmed.edu	Lamontagne, Jason/AAP-5542-2020	Lamontagne, Jason/0000-0002-9068-3348	National Cancer Institute [F31CA171850]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute grant F31CA171850 to JCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, ISOLATION OF HEPATOC, V1; Anzola M, 2004, J VIRAL HEPATITIS, V11, P383, DOI 10.1111/j.1365-2893.2004.00521.x; Aubart FC, 2009, MOL THER, V17, P455, DOI 10.1038/mt.2008.291; Berridge MJ, 2012, BIOCHEM SOC T, V40, P297, DOI 10.1042/BST20110766; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bird GS, 2008, METHODS, V46, P204, DOI 10.1016/j.ymeth.2008.09.009; Birnbaumer M, 2000, TRENDS ENDOCRIN MET, V11, P406, DOI 10.1016/S1043-2760(00)00304-0; Block GD, 1996, J CELL BIOL, V132, P1133, DOI 10.1083/jcb.132.6.1133; Block TM, 2003, ONCOGENE, V22, P5093, DOI 10.1038/sj.onc.1206557; Bootman MD, 2001, SEMIN CELL DEV BIOL, V12, P3, DOI 10.1006/scdb.2000.0211; Bouchard MJ, 2011, CANCER LETT, V305, P123, DOI 10.1016/j.canlet.2010.11.014; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Bouchard MJ, 2003, J VIROL, V77, P7713, DOI 10.1128/JVI.77.14.7713-7719.2003; Bouchard MJ, 2001, SCIENCE, V294, P2376, DOI 10.1126/science.294.5550.2376; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Casciano J, 2012, MODULATION CELL PROL; Chami M, 2003, J BIOL CHEM, V278, P31745, DOI 10.1074/jbc.M304202200; Chami M, 2006, BBA-MOL CELL RES, V1763, P1344, DOI 10.1016/j.bbamcr.2006.09.025; CHEN HS, 1993, J VIROL, V67, P1218, DOI 10.1128/JVI.67.3.1218-1226.1993; Chen JL, 2003, BIOCHEM J, V373, P327, DOI 10.1042/BJ20021904; Choi YW, 2005, VIROLOGY, V332, P454, DOI 10.1016/j.virol.2004.11.019; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Clippinger AJ, 2008, J VIROL, V82, P6798, DOI 10.1128/JVI.00154-08; Clippinger AJ, 2009, J VIROL, V83, P4718, DOI 10.1128/JVI.02590-08; Condit R., 2007, FIELDS VIROLOGY, V1; Csordas G, 2013, CELL METAB, V17, P976, DOI 10.1016/j.cmet.2013.04.020; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; Delgado-Coello B, 2010, MOL CELL BIOCHEM, V344, P117, DOI 10.1007/s11010-010-0535-1; Dellis O, 2011, J BIOL CHEM, V286, P18583, DOI 10.1074/jbc.M111.222257; Dixon CJ, 2005, J PHARMACOL EXP THER, V313, P1305, DOI 10.1124/jpet.104.082743; Dufour JF, 1999, HEPATOLOGY, V30, P1018, DOI 10.1002/hep.510300421; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; Enfissi A, 2004, CELL CALCIUM, V36, P459, DOI 10.1016/j.ceca.2004.04.004; Garcia RL, 1997, BIOCHEM BIOPH RES CO, V239, P279, DOI 10.1006/bbrc.1997.7458; Gearhart TL, 2011, VIRUS RES, V155, P363, DOI 10.1016/j.virusres.2010.09.023; Gearhart TL, 2010, VIROLOGY, V407, P14, DOI 10.1016/j.virol.2010.07.042; Gearhart TL, 2010, J VIROL, V84, P2675, DOI 10.1128/JVI.02196-09; Geng X, 2012, P NATL ACAD SCI USA, V109, P18471, DOI 10.1073/pnas.1204668109; Giacomello M, 2010, MOL CELL, V38, P280, DOI 10.1016/j.molcel.2010.04.003; Gincel D, 2001, BIOCHEM J, V358, P147, DOI 10.1042/0264-6021:3580147; Glitsch MD, 2002, EMBO J, V21, P6744, DOI 10.1093/emboj/cdf675; GRIFFIN D S, 1987, Journal of Biochemical Toxicology, V2, P155, DOI 10.1002/jbt.2570020302; Gyorgy H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016; Hajnoczky G, 1999, J BIOL CHEM, V274, P14157, DOI 10.1074/jbc.274.20.14157; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hajnoczky G, 2010, CURR BIOL, V20, pR888, DOI 10.1016/j.cub.2010.09.035; Huh KW, 2002, MITOCHONDRION, V1, P349, DOI 10.1016/S1567-7249(01)00040-X; Hyser JM, 2013, J VIROL, V87, P13579, DOI 10.1128/JVI.02629-13; Hyser JM, 2010, MBIO, V1, DOI 10.1128/mBio.00265-10; Jones BF, 2008, HEPATOLOGY, V48, P1273, DOI 10.1002/hep.22461; Jovanovic M, 2015, SCIENCE, V347, DOI 10.1126/science.1259038; Keasler VV, 2007, J VIROL, V81, P2656, DOI 10.1128/JVI.02020-06; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Koike K, 2009, CANCER LETT, V286, P60, DOI 10.1016/j.canlet.2009.04.010; Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159; Lamontagne J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005438; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan CV, 2014, NAT GENET, V46, P188, DOI 10.1038/ng.2851; Nieva JL, 2012, NAT REV MICROBIOL, V10, P563, DOI 10.1038/nrmicro2820; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; McClain SL, 2007, J VIROL, V81, P12061, DOI 10.1128/JVI.00740-07; Melegari M, 1998, J VIROL, V72, P1737, DOI 10.1128/JVI.72.3.1737-1743.1998; MINE T, 1988, BIOCHIM BIOPHYS ACTA, V970, P166, DOI 10.1016/0167-4889(88)90175-9; Ng SA, 2011, J GASTROENTEROL, V46, P974, DOI 10.1007/s00535-011-0415-9; Oh JC, 2003, EXP MOL MED, V35, P301, DOI 10.1038/emm.2003.41; Parekh AB, 2003, J PHYSIOL-LONDON, V547, P333, DOI 10.1113/jphysiol.2002.034140; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3033, DOI 10.1113/jphysiol.2008.156885; Parkash J, 2010, LIFE SCI, V87, P587, DOI 10.1016/j.lfs.2010.09.013; Paszty K, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005672; Patron M, 2014, MOL CELL, V53, P726, DOI 10.1016/j.molcel.2014.01.013; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Philippe R, 2015, BBA-MOL CELL RES, V1853, P892, DOI 10.1016/j.bbamcr.2015.01.010; Piechocki MP, 1999, CARCINOGENESIS, V20, P401, DOI 10.1093/carcin/20.3.401; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Putney JW, 2010, MOL INTERV, V10, P209, DOI 10.1124/mi.10.4.4; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Rahmani Z, 2000, J VIROL, V74, P2840, DOI 10.1128/JVI.74.6.2840-2846.2000; Rawat S, 2015, J VIROL, V89, P999, DOI 10.1128/JVI.02440-14; Rodrigues MA, 2008, HEPATOLOGY, V48, P1621, DOI 10.1002/hep.22424; Runge D, 2000, BIOCHEM BIOPH RES CO, V269, P46, DOI 10.1006/bbrc.2000.2215; Scaglioni PP, 1997, J VIROL, V71, P345, DOI 10.1128/JVI.71.1.345-353.1997; Scaglioni PP, 1997, VIROLOGY, V233, P374, DOI 10.1006/viro.1997.8594; Schofl C, 1999, AM J PHYSIOL-GASTR L, V276, pG164, DOI 10.1152/ajpgi.1999.276.1.G164; Seeger C, 2007, FIELDS VIROLOGY; Smyth JT, 2010, J CELL MOL MED, V14, P2337, DOI 10.1111/j.1582-4934.2010.01168.x; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Tan C, 2009, VIRUS RES, V145, P307, DOI 10.1016/j.virusres.2009.08.001; Tan WZ, 2007, BBA-BIOMEMBRANES, V1768, P2510, DOI 10.1016/j.bbamem.2007.06.002; Tsuge M, 2005, HEPATOLOGY, V42, P1046, DOI 10.1002/hep.20892; Tsuge M, 2010, J GEN VIROL, V91, P1854, DOI 10.1099/vir.0.019224-0; Watanabe A, 2011, CARDIOVASC RES, V90, P57, DOI 10.1093/cvr/cvq374; Worley PF, 2007, CELL CALCIUM, V42, P205, DOI 10.1016/j.ceca.2007.03.004; Xu ZM, 2002, J VIROL, V76, P2579, DOI 10.1128/JVI.76.5.2579-2584.2002; Yang B, 2011, J VIROL; Yang N, 2013, CANCER LETT, V330, P163, DOI 10.1016/j.canlet.2012.11.040; Zhang XD, 2006, J LAB CLIN MED, V147, P58, DOI 10.1016/j.lab.2005.10.003; Zhou YB, 2009, CELL CALCIUM, V46, P1, DOI 10.1016/j.ceca.2009.05.005; ZOULIM F, 1994, J VIROL, V68, P2026, DOI 10.1128/JVI.68.3.2026-2030.1994	101	20	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0168328	10.1371/journal.pone.0168328	http://dx.doi.org/10.1371/journal.pone.0168328			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151934	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161200004
J	Goulet, TL; Shirur, KP; Ramsby, BD; Iglesias-Prieto, R				Goulet, Tamar L.; Shirur, Kartick P.; Ramsby, Blake D.; Iglesias-Prieto, Roberto			The effects of elevated seawater temperatures on Caribbean gorgonian corals and their algal symbionts, Symbiodinium spp.	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; SEA FAN CORAL; REEF CORALS; BLEACHING SUSCEPTIBILITY; BIOCHEMICAL-COMPOSITION; ENVIRONMENTAL-STRESS; THERMAL-STRESS; CLIMATE-CHANGE; NITRIC-OXIDE; HOST	Global climate change not only leads to elevated seawater temperatures but also to episodic anomalously high or low temperatures lasting for several hours to days. Scleractinian corals are detrimentally affected by thermal fluctuations, which often lead to an uncoupling of their mutualism with Symbiodinium spp. (coral bleaching) and potentially coral death. Consequently, on many Caribbean reefs scleractinian coral cover has plummeted. Conversely, gorgonian corals persist, with their abundance even increasing. How gorgonians react to thermal anomalies has been investigated utilizing limited parameters of either the gorgonian, Symbiodinium or the combined symbiosis (holobiont). We employed a holistic approach to examine the effect of an experimental five-day elevated temperature episode on parameters of the host, symbiont, and the holobiont in Eunicea tourneforti, E. flexuosa and Pseudoplexaura porosa. These gorgonian corals reacted and coped with 32 degrees C seawater temperatures. Neither Symbiodinium genotypes nor densities differed between the ambient 29.5 degrees C and 32 degrees C. Chlorophyll a and c(2) per Symbiodinium cell, however, were lower at 32 degrees C leading to a reduction in chlorophyll content in the branches and an associated reduction in estimated absorbance and increase in the chlorophyll a specific absorption coefficient. The adjustments in the photochemical parameters led to changes in photochemical efficiencies, although these too showed that the gorgonians were coping. For example, the maximum excitation pressure, Q(m), was significantly lower at 32 degrees C than at 29.5 degrees C. In addition, although per dry weight the amount of protein and lipids were lower at 32 degrees C, the overall energy content in the tissues did not differ between the temperatures. Antioxidant activity either remained the same or increased following exposure to 32 degrees C further reiterating a response that dealt with the stressor. Taken together, the capability of Caribbean gorgonian corals to modify symbiont, host and consequently holobiont parameters may partially explain their persistence on reefs faced with climate change.	[Goulet, Tamar L.; Shirur, Kartick P.; Ramsby, Blake D.] Univ Mississippi, Dept Biol, University, MS 38677 USA; [Iglesias-Prieto, Roberto] Univ Nacl Autonoma Mexico, Unidad Acad Sistemas Arrecifales, Inst Ciencias Mar & Limnol, Puerto Morelos, Quintana Roo, Mexico; [Ramsby, Blake D.] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia; [Iglesias-Prieto, Roberto] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	University of Mississippi; Universidad Nacional Autonoma de Mexico; James Cook University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Goulet, TL (corresponding author), Univ Mississippi, Dept Biol, University, MS 38677 USA.	tlgoulet@olemiss.edu		Ramsby, Blake/0000-0001-9961-945X	Graduate Student Council at the University of Mississippi; Society for Integrative & Comparative Biology; Sigma Xi [G20101015155231]; Richard Gilder School at the American Museum of Natural History; National Science Foundation [IOS 0747205]; REU supplement; National Science Foundation under MRI [DBI 1126379]	Graduate Student Council at the University of Mississippi; Society for Integrative & Comparative Biology; Sigma Xi; Richard Gilder School at the American Museum of Natural History; National Science Foundation(National Science Foundation (NSF)); REU supplement; National Science Foundation under MRI	Funding for this work was provided by the Graduate Student Council at the University of Mississippi (http://gsc.olemiss.edu/research-grants/), the Society for Integrative & Comparative Biology (Fellowship for Graduate Student Travel, http://www.sicb.org/index.php3), Sigma Xi (Grants-in-Aid of Research, G20101015155231, https://www.sigmaxi.org/programs/grants-in-aid), and Richard Gilder School at the American Museum of Natural History (Lerner Gray Fund for Marine Research, http://www.amnh.org/our-research/richard-gilder-graduate-school/academics-and-research/fellowship-and-grant-opportunities/research-grants-and-student-exchange-fellowships/#grants) to KPS, and the National Science Foundation under Grant No. IOS 0747205 and REU supplement to TLG. The FIowCAM particle analyzer was funded by the National Science Foundation under MRI Grant No. DBI 1126379. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation (https://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Filip L, 2011, GLOBAL CHANGE BIOL, V17, P2470, DOI 10.1111/j.1365-2486.2010.02385.x; Anthony KRN, 2009, FUNCT ECOL, V23, P539, DOI 10.1111/j.1365-2435.2008.01531.x; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Baker DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055057; Ban SS, 2014, GLOBAL CHANGE BIOL, V20, P681, DOI 10.1111/gcb.12453; Bates D, LME4 LINEAR MIXED EF; BIRKELAND C, 1981, COPEIA, P169; Brown L, 2011, BIOPHARM INT, V24, pS4; Cary LR, 1915, P NATL ACAD SCI USA, V1, P285, DOI 10.1073/pnas.1.5.285; Colombo-Pallotta MF, 2010, CORAL REEFS, V29, P899, DOI 10.1007/s00338-010-0638-x; Colvard NB, 2011, J EXP MAR BIOL ECOL, V397, P153, DOI 10.1016/j.jembe.2010.11.015; Couch CS, 2008, MAR BIOL, V155, P281, DOI 10.1007/s00227-008-1024-x; DAHLGREN EJ, 1989, B MAR SCI, V45, P678; DeSalvo MK, 2010, MOL ECOL, V19, P1174, DOI 10.1111/j.1365-294X.2010.04534.x; Donner SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005712; Douglas AE, 2003, MAR POLLUT BULL, V46, P385, DOI 10.1016/S0025-326X(03)00037-7; Dove S, 2004, MAR ECOL PROG SER, V272, P99, DOI 10.3354/meps272099; Downs CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077173; Downs CA, 2002, FREE RADICAL BIO MED, V33, P533, DOI 10.1016/S0891-5849(02)00907-3; Drohan AF, 2005, B MAR SCI, V77, P257; Dunn SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039024; Finney JC, 2010, MICROB ECOL, V60, P250, DOI 10.1007/s00248-010-9681-y; Fisher PL, 2012, CORAL REEFS, V31, P473, DOI 10.1007/s00338-011-0853-0; Fitt WK, 2009, J EXP MAR BIOL ECOL, V373, P102, DOI 10.1016/j.jembe.2009.03.011; Fitt WK, 1995, BIOL BULL, V189, P298, DOI 10.2307/1542147; FITT WK, 1993, CORAL REEFS, V12, P57, DOI 10.1007/BF00302102; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gates RD, 1999, AM ZOOL, V39, P30; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; GNAIGER E, 1984, OECOLOGIA, V62, P289, DOI 10.1007/BF00384259; Goulet TL, 2008, MAR BIOL, V154, P795, DOI 10.1007/s00227-008-0972-5; Goulet TL, 2005, LIMNOL OCEANOGR, V50, P1490, DOI 10.4319/lo.2005.50.5.1490; Goulet TL, 2003, MAR ECOL PROG SER, V250, P117, DOI 10.3354/meps250117; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Grottoli AG, 2014, GLOBAL CHANGE BIOL, V20, P3823, DOI 10.1111/gcb.12658; Hannes AR, 2009, MAR ECOL PROG SER, V391, P65, DOI 10.3354/meps07990; Hawkins TD, 2014, CORAL REEFS, V33, P141, DOI 10.1007/s00338-013-1103-4; Hawkins TD, 2015, CORAL REEFS, V34, P1229, DOI 10.1007/s00338-015-1345-4; Hoadley KD, 2015, SCI REP-UK, V5, DOI 10.1038/srep18371; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoegh-Guldberg O, 2011, REG ENVIRON CHANGE, V11, pS215, DOI 10.1007/s10113-010-0189-2; HOLM S, 1979, SCAND J STAT, V6, P65; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hughes AD, 2010, MAR ECOL PROG SER, V420, P91, DOI 10.3354/meps08866; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; Imbs AB, 2012, CORAL REEFS, V31, P41, DOI 10.1007/s00338-011-0817-4; Imbs AB, 2014, PHYTOCHEMISTRY, V101, P76, DOI 10.1016/j.phytochem.2014.02.012; Janse I, 2004, J MICROBIOL METH, V57, P279, DOI 10.1016/j.mimet.2003.12.006; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Kemp DW, 2015, CORAL REEFS, V34, P535, DOI 10.1007/s00338-015-1277-z; Kemp DW, 2011, GLOBAL CHANGE BIOL, V17, P3468, DOI 10.1111/j.1365-2486.2011.02487.x; Kirk NL, 2005, BIOL BULL-US, V209, P227, DOI 10.2307/3593112; Kopp C, 2015, MBIO, V6, DOI 10.1128/mBio.02299-14; Kuznetsova A, 2014, LMERTEST TESTS RANDO; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; LaJeunesse TC, 2003, LIMNOL OCEANOGR, V48, P2046, DOI 10.4319/lo.2003.48.5.2046; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; Lajeunesse TC, 2012, J PHYCOL, V48, P1380, DOI 10.1111/j.1529-8817.2012.01217.x; LaJeunesse TC, 2010, P ROY SOC B-BIOL SCI, V277, P2925, DOI 10.1098/rspb.2010.0385; Lasker HR, 2003, CORAL REEFS, V22, P23, DOI 10.1007/s00338-003-0276-7; LASKER HR, 1988, BIOL BULL, V174, P254, DOI 10.2307/1541952; LASKER HR, 1984, CORAL REEFS, V3, P183, DOI 10.1007/BF00288253; Lenz EA, 2015, CORAL REEFS, V34, P1099, DOI 10.1007/s00338-015-1315-x; Lesser MP, 2013, CORAL REEFS, V32, P25, DOI 10.1007/s00338-012-0993-x; Lesser MP, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P405, DOI 10.1007/978-94-007-0114-4_23; Levas S, 2016, CORAL REEFS, V35, P495, DOI 10.1007/s00338-015-1390-z; Li AG, 2014, CORAL REEFS, V33, P847, DOI 10.1007/s00338-014-1162-1; Lutz A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139290; Magris RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140828; Mann WT, 2014, MAR BIOL, V161, P2213, DOI 10.1007/s00227-014-2499-2; McGinty ES, 2012, MICROB ECOL, V64, P1000, DOI 10.1007/s00248-012-0085-z; McWilliams JP, 2005, ECOLOGY, V86, P2055, DOI 10.1890/04-1657; Michalek-Wagner K, 2001, CORAL REEFS, V19, P240, DOI 10.1007/PL00006959; Mydlarz LD, 2007, COMP BIOCHEM PHYS A, V146, P54, DOI 10.1016/j.cbpa.2006.09.005; Mydlarz LD, 2006, MAR FRESHW BEHAV PHY, V39, P143, DOI 10.1080/10236240600708512; Mydlarz LD, 2011, COMP BIOCHEM PHYS A, V159, P372, DOI 10.1016/j.cbpa.2011.03.029; Mydlarz LD, 2009, DIS AQUAT ORGAN, V87, P67, DOI 10.3354/dao02088; Palmer CV, 2011, DEV COMP IMMUNOL, V35, P1096, DOI 10.1016/j.dci.2011.04.001; Palmer CV, 2011, J EXP BIOL, V214, P4240, DOI 10.1242/jeb.061267; Parkinson JE, 2015, J PHYCOL, V51, P850, DOI 10.1111/jpy.12340; Pettay DT, 2007, MOL ECOL NOTES, V7, P1271, DOI 10.1111/j.1471-8286.2007.01852.x; Pinzon JHC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104787; Pinzon CJH, 2014, PEERJ, V2, DOI 10.7717/peerj.628; Pontasch S, 2014, MAR ECOL PROG SER, V516, P195, DOI 10.3354/meps11038; PORTER JW, 1989, P NATL ACAD SCI USA, V86, P9342, DOI 10.1073/pnas.86.23.9342; Prada C, 2010, CORAL REEFS, V29, P41, DOI 10.1007/s00338-009-0547-z; Prada C, 2014, MOL ECOL, V23, P3330, DOI 10.1111/mec.12808; R Core Team, 2013, R LANG ENV STAT COMP; Ramsby BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106419; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; Rodriguez-Martinez RE, 2010, REV BIOL TROP, V58, P23; Rodriguez-Roman A, 2006, LIMNOL OCEANOGR, V51, P2702, DOI 10.4319/lo.2006.51.6.2702; Ross C, 2014, CORAL REEFS, V33, P513, DOI 10.1007/s00338-014-1142-5; Roth MS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00422; Roth MS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00240; Ruzicka R, 2013, MAR ECOL PROG SER; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; Schoepf V, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1887; Schoepf V, 2014, GEOCHIM COSMOCHIM AC, V146, P164, DOI 10.1016/j.gca.2014.09.033; Shick JM, 2002, ANNU REV PHYSIOL, V64, P223, DOI 10.1146/annurev.physiol.64.081501.155802; Shirur KP, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-3008-6; Shirur KP, 2014, J EXP MAR BIOL ECOL, V461, P275, DOI 10.1016/j.jembe.2014.08.016; Slattery M, 2008, MAR ECOL PROG SER, V354, P169, DOI 10.3354/meps07200; Stat M, 2009, CORAL REEFS, V28, P709, DOI 10.1007/s00338-009-0509-5; Strong AE, 2008, P 11 INT COR REEF S, P1324; Takahashi S, 2009, P NATL ACAD SCI USA, V106, P3237, DOI 10.1073/pnas.0808363106; Tanaka Y, 2015, ECOL MODEL, V309, P163, DOI 10.1016/j.ecolmodel.2015.04.017; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Thornhill DJ, 2006, CORAL REEFS, V25, P515, DOI 10.1007/s00338-006-0157-y; Thornhill DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006262; Thornhill DJ, 2006, MAR BIOL, V148, P711, DOI 10.1007/s00227-005-0114-2; Villamizar E, 2014, MAR ECOL-EVOL PERSP, V35, P425, DOI 10.1111/maec.12099; Voss G. L., 1956, Bulletin of Marine Science of the Gulf and Caribbean, V6, P359; VREELAND HV, 1989, J EXP MAR BIOL ECOL, V129, P265, DOI 10.1016/0022-0981(89)90108-1; Wang JT, 1999, MAR BIOL, V135, P219, DOI 10.1007/s002270050619; Ward JR, 2007, MAR ECOL PROG SER, V329, P115, DOI 10.3354/meps329115; Warner ME, 2010, DEVEL APPL PHYCOL, V4, P209, DOI 10.1007/978-90-481-9268-7_10; Warner ME, 1996, PLANT CELL ENVIRON, V19, P291, DOI 10.1111/j.1365-3040.1996.tb00251.x; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597	121	21	21	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171032	10.1371/journal.pone.0171032	http://dx.doi.org/10.1371/journal.pone.0171032			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152002	Green Published, Green Accepted, gold			2022-12-27	WOS:000396161200076
J	Morioka, Y; Nam, JM; Ohashi, T				Morioka, Yuka; Nam, Jin-Min; Ohashi, Takashi			Nik-related kinase regulates trophoblast proliferation and placental development by modulating AKT phosphorylation	PLOS ONE			English	Article							BECKWITH-WIEDEMANN-SYNDROME; EMBRYONIC STEM-CELLS; PROTEIN-KINASE; MICE LACKING; SKELETAL-MUSCLE; HOMEOBOX GENE; FETAL-GROWTH; MOUSE MODEL; B-ALPHA; DIFFERENTIATION	Nik-related kinase (Nrk) is a Ser/Thr kinase and was initially discovered as a molecule that was predominantly detected in skeletal muscles during development. A recent study using Nrk-null mice suggested the importance of Nrk in proper placental development; however, the molecular mechanism remains unknown. In this study, we demonstrated that differentiated trophoblasts from murine embryonic stem cells (ESCs) endogenously expressed Nrk and that Nrk disruption led to the enhanced proliferation of differentiated trophoblasts. This phenomenon may reflect the overproliferation of trophoblasts that has been reported in enlarged placentas of Nrk-null mice. Furthermore, we demonstrated that AKT phosphorylation at Ser473 was upregulated in Nrk-null trophoblasts and that inhibition of AKT phosphorylation cancelled the enhanced proliferation observed in differentiated Nrk-null trophoblasts. These results indicated that the upregulation of AKT phosphorylation was the possible cause of enhanced proliferation observed in Nrk-null trophoblasts. The upregulation of AKT phosphorylation was also confirmed in enlarged Nrk-null placentas in vivo, suggesting that proper regulation of AKT by Nrk was important for normal placental development. In addition, our detailed analysis on phosphorylation status of AKT isoforms in newly established trophoblast stem cells (TSCs) revealed that different levels of upregulation of AKT phosphorylation were occurred in Nrk-null TSCs depending on AKT isoforms. These results further support the importance of Nrk in proper development of trophoblast lineage cells and indicate the possible application of TSCs for the analysis of differently regulated activation mechanisms of AKT isoforms.	[Morioka, Yuka; Ohashi, Takashi] Hokkaido Univ, Inst Med Genet, Div Dis Model Innovat, Sapporo, Hokkaido, Japan; [Nam, Jin-Min] Hokkaido Univ, Global Stn Quantum Med Sci & Engn, Global Inst Collaborat Res & Educ GI CoRE, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Morioka, Y (corresponding author), Hokkaido Univ, Inst Med Genet, Div Dis Model Innovat, Sapporo, Hokkaido, Japan.	yukamorioka@igm.hokudai.ac.jp	Nam, Jin-Min/D-6468-2012; morioka, yuka/A-9926-2009		Japan Society for Promotion of Science [24592454, 15K15591]; Kanzawa medical research foundation; Takeda Science Foundation; Ichiro Kanehara Foundation; Inamori Foundation; Grants-in-Aid for Scientific Research [15K15591] Funding Source: KAKEN	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kanzawa medical research foundation(Kanzawa Medical Research Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Ichiro Kanehara Foundation; Inamori Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for Promotion of Science (https://www.jsps.go.jp) KAKENHI Grant Number 24592454 (Y.M.); Japan Society for Promotion of Science (https://www.jsps.go.jp) KAKENHI Grant Number 15K15591 (Y.M.); Kanzawa medical research foundation (http://www.takeda-sci.or.jp) (Y.M.); Takeda Science Foundation (http://www.takeda-sci.or.jp) (Y.M.); Ichiro Kanehara Foundation (http://www.kanehara-zaidan.or.jp) (Y.M.); and Inamori Foundation (http://www.inamori-f.or.jp) (Y.M.). The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Cerrato F, 2005, HUM MOL GENET, V14, P503, DOI 10.1093/hmg/ddi047; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Chiao E, 2002, DEV BIOL, V243, P185, DOI 10.1006/dbio.2001.0554; Chun JY, 1999, DEV DYNAM, V216, P257, DOI 10.1002/(SICI)1097-0177(199911)216:3<257::AID-DVDY4>3.0.CO;2-0; Cooper WN, 2005, EUR J HUM GENET, V13, P1025, DOI 10.1038/sj.ejhg.5201463; Cross JC, 2005, PLACENTA, V26, pS3, DOI 10.1016/j.placenta.2005.01.015; CROSS JC, 1995, DEVELOPMENT, V121, P2513; Denda K, 2011, J BIOL CHEM, V286, P28802, DOI 10.1074/jbc.M111.258160; Dummler B, 2006, MOL CELL BIOL, V26, P8042, DOI 10.1128/MCB.00722-06; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Eggenschwiler J, 1997, GENE DEV, V11, P3128, DOI 10.1101/gad.11.23.3128; Fisher SJ, 2015, AM J OBSTET GYNECOL, V213, pS115, DOI 10.1016/j.ajog.2015.08.042; Frank D, 2002, P NATL ACAD SCI USA, V99, P7490, DOI 10.1073/pnas.122039999; Fremin C, 2015, CELL REP, V12, P913, DOI 10.1016/j.celrep.2015.07.011; Fujihara Y, 2013, TRANSGENIC RES, V22, P195, DOI 10.1007/s11248-012-9635-x; Furue M, 2005, IN VITRO CELL DEV-AN, V41, P19; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; GUILLEMOT F, 1995, NAT GENET, V9, P235, DOI 10.1038/ng0395-235; Haslinger P, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104778; Hatano N, 2003, GENES CELLS, V8, P847, DOI 10.1046/j.1365-2443.2003.00680.x; Hayashi Y, 2010, IN VITRO CELL DEV-AN, V46, P416, DOI 10.1007/s11626-009-9266-6; Inoue K, 2010, SCIENCE, V330, P496, DOI 10.1126/science.1194174; Jackman SM, 2012, MOL REPROD DEV, V79, P564, DOI 10.1002/mrd.22062; Kakinuma H, 2005, CELL SIGNAL, V17, P1439, DOI 10.1016/j.cellsig.2005.03.004; Kanai-Azuma M, 1999, MECH DEVELOP, V89, P155, DOI 10.1016/S0925-4773(99)00193-8; Kettle JG, 2012, J MED CHEM, V55, P1261, DOI 10.1021/jm201394e; LESCISIN KR, 1988, GENE DEV, V2, P1639, DOI 10.1101/gad.2.12a.1639; Li YH, 1998, NAT GENET, V20, P309, DOI 10.1038/3129; Li YH, 1997, DEV BIOL, V188, P85, DOI 10.1006/dbio.1997.8640; Liao Y, 2010, AM J TRANSL RES, V2, P19; Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Morioka Y, 2014, GENESIS, V52, P68, DOI 10.1002/dvg.22727; Nagy A., 2003, MANIPULATING THE MOU; Nakano K, 2000, J BIOL CHEM, V275, P20533, DOI 10.1074/jbc.M001009200; Nakano K, 2003, EXP CELL RES, V287, P219, DOI 10.1016/S0014-4827(03)00136-8; NICOLSON GL, 1975, J CELL BIOL, V66, P263, DOI 10.1083/jcb.66.2.263; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Okada Y, 2009, GENESIS, V47, P217, DOI 10.1002/dvg.20469; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Rohrschneider LR, 2000, GENE DEV, V14, P505; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Simmons DG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-352; Singh AT, 2012, MOL CELL ENDOCRINOL, V362, P48, DOI 10.1016/j.mce.2012.05.009; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tolkunova E, 2006, STEM CELLS, V24, P139, DOI 10.1634/stemcells.2005-0240; Tunster SJ, 2011, DIS MODEL MECH, V4, P814, DOI 10.1242/dmm.007328; Wakayama T, 1999, NAT GENET, V22, P127, DOI 10.1038/9632; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315; Yang ZZ, 2005, MOL CELL BIOL, V25, P10407, DOI 10.1128/MCB.25.23.10407-10418.2005; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200	57	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171503	10.1371/journal.pone.0171503	http://dx.doi.org/10.1371/journal.pone.0171503			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152035	Green Submitted, gold, Green Published			2022-12-27	WOS:000396161200150
J	Piper, K; Youk, A; James, AE; Kumar, S				Piper, Kaitlin; Youk, Ada; James, A. Everette, III; Kumar, Supriya			Paid sick days and stay-at-home behavior for influenza	PLOS ONE			English	Article							HEALTH-CARE; ILLNESS; WORK; POLICIES; LEAVE; MODEL; PRESENTEEISM; ATTENDANCE; ACCESS; IMPACT	Access to paid sick days (PSD) differs by workplace size, race/ethnicity, gender, and income in the United States. It is not known to what extent decisions to stay home from work when sick with infectious illnesses such as influenza depend on PSD access, and whether access impacts certain demographic groups more than others. We examined demographic and workplace characteristics (including access to PSD) associated with employees' decisions to stay home from work for their own or a child's illness. Linking the 2009 Medical Expenditure Panel Survey (MEPS) consolidated data file to the medical conditions file, we used multivariate Poisson regression models with robust variance estimates to identify factors associated with missed work for an employee's own or a child's illness/injury, influenza-like-illness (ILI), and influenza. Controlling for gender, race/ethnicity, education, and income, access to PSD was associated with a higher probability of staying home for an employee's own illness/injury, ILI, or influenza, and for a child's illness/injury. Hispanic ethnicity was associated with a lower prevalence of staying home for the employee's own or a child's illness compared to non-Hispanic Whites. Access to PSD was associated with a significantly greater increase in the probability of staying home among Hispanics than among non-Hispanic Whites. Women had a significantly higher probability of staying home for their child's illness compared to men, suggesting that women remain the primary caregivers for ill children. Our results indicate that PSD access is important to encourage employees to stay home from work when sick with ILI or influenza. Also, PSD access may be important to enable stay-at-home behavior among Hispanics. We conclude that access to PSD is likely to reduce the spread of disease in workplaces by increasing the rate at which sick employees stay home from work, and reduce the economic burden of staying home on minorities, women, and families.	[Piper, Kaitlin] Univ Pittsburgh, Pittsburgh, PA USA; [Youk, Ada] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [James, A. Everette, III] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA USA; [Kumar, Supriya] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Behav & Community Hlth Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kumar, S (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Behav & Community Hlth Sci, Pittsburgh, PA 15260 USA.	supriya@pitt.edu		Youk, Ada/0000-0001-6912-9759; Kumar, Supriya/0000-0001-8373-105X; Piper, Kaitlin/0000-0001-9422-1565	Stern Family Foundation	Stern Family Foundation	This work was supported by the Stern Family Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2009, MEPS SURV BACKGR; [Anonymous], 2015, EMPL BEN US MAR 2015; [Anonymous], 2007, PAID SICK LEAVE ORDI; Aronsson G, 2005, J OCCUP ENVIRON MED, V47, P958, DOI 10.1097/01.jom.0000177219.75677.17; Asfaw Abay, 2012, Am J Public Health, V102, pe59, DOI 10.2105/AJPH.2011.300482; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Beemsterboer W, 2009, INT J OCCUP MED ENV, V22, P169, DOI 10.2478/v10001-009-0013-8; Blendon RJ, 2008, EMERG INFECT DIS, V14, P778, DOI 10.3201/eid1405.071437; Clemans-Cope L, 2008, PEDIATRICS, V122, pE480, DOI 10.1542/peds.2007-3294; Connolly C, 2002, WASHINGTON POST; Cook WK, 2011, AM J IND MED, V54, P771, DOI 10.1002/ajim.20988; DeRigne L, 2016, HEALTH AFFAIR, V35, P520, DOI 10.1377/hlthaff.2015.0965; Drago R, 2011, SAN FRANCISCOS PAID; Earle Alison., 2009, CONTAGION NATION COM; Hanley R, 2001, NY TIMES; Haughney C., 2002, WASHINGTON POST; Heymann SJ, 1999, ARCH PEDIAT ADOL MED, V153, P870, DOI 10.1001/archpedi.153.8.870; Heymann SJ, 1996, PEDIATRICS, V98, P226; Kumar S, 2013, AM J PUBLIC HEALTH, V103, P1406, DOI 10.2105/AJPH.2013.301269; Kumar S, 2012, AM J PUBLIC HEALTH, V102, P134, DOI 10.2105/AJPH.2011.300307; Lovell V., 2004, NO TIME BE SICK WHY; Marsden-Haug N, 2007, EMERG INFECT DIS, V13, P207, DOI 10.3201/eid1302.060557; Musich S, 2006, AM J HEALTH PROMOT, V21, P127, DOI 10.4278/0890-1171-21.2.127; Palmer LA, 2010, VACCINE, V28, P5049, DOI 10.1016/j.vaccine.2010.05.011; Quinn SC, 2011, AM J PUBLIC HEALTH, V101, P285, DOI 10.2105/AJPH.2009.188029; Rankin N., 2012, STILL SICK CITY WHAT; Rousculp MD, 2010, J OCCUP ENVIRON MED, V52, P1009, DOI 10.1097/JOM.0b013e3181f43844; Smith T.W., 2010, PAID SICK DAYS ATTIT; Spilerman SaHS, 1991, RES SOCIAL STRATIFIC, V10, P27; StataCorp, 2015, STAT SOFTW REL 14; STEERS RM, 1978, J APPL PSYCHOL, V63, P391, DOI 10.1037/0021-9010.63.4.391; Susser P, 2016, PROFILING US SICK LE; U.S. Department of Labor, 2021, MOTH FAM, DOI https://www.dol.gov/wb/stats/mother_families.htm; Vespa J., 2013, CURRENT POPULATION R, V20, P20; Vistnes JP, 1997, IND LABOR RELAT REV, V50, P304, DOI 10.2307/2525088; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	36	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170698	10.1371/journal.pone.0170698	http://dx.doi.org/10.1371/journal.pone.0170698			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28151940	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161200036
J	Tsujimoto, H; Hanley, KA; Sundararajan, A; Devitt, NP; Schilkey, FD; Hansen, IA				Tsujimoto, Hitoshi; Hanley, Kathryn A.; Sundararajan, Anitha; Devitt, Nicholas P.; Schilkey, Faye D.; Hansen, Immo A.			Dengue virus serotype 2 infection alters midgut and carcass gene expression in the Asian tiger mosquito, Aedes albopictus	PLOS ONE			English	Article							GLOBAL DISTRIBUTION; IMMUNE-RESPONSE; AEGYPTI; WOLBACHIA; TRANSMISSION; STRAINS; ACTIVATION; PROTEIN; SUSCEPTIBILITY; DISSEMINATION	Background The Asian tiger mosquito, Aedes albopictus is currently an important vector for dengue, chikungunya and Zika virus, and its role in transmission of arthropod-borne viruses (arboviruses) may increase in the future due to its ability to colonize temperate regions. In contrast to Aedes aegypti, the dominant vector of dengue, chikungunya and Zika virus, genetic responses of Ae. albopictus upon infection with an arbovirus are not well characterized. Here we present a study of the changes in transcript expression in Ae. albopictus exposed to dengue virus serotype 2 via feeding on an artificial bloodmeal. Methodology/Principal findings We isolated midguts and midgut-free carcasses of Ae. albopictus fed on bloodmeals containing dengue virus as well as controls fed on virus-free control meals at day 1 and day 5 post-feeding. We confirmed infection of midguts from mosquitoes sampled on day 5 post-feeding via RT-PCR. RNAseq analysis revealed dynamic modulation of the expression of several putative immunity and dengue virus-responsive genes, some of whose expression was verified by qRT-PCR. For example, a serine protease gene was up-regulated in the midgut at 1 day post infection, which may potentially enhance mosquito susceptibility to dengue infection, while 14 leucine-rich repeat genes, previously shown to be involved in mosquito antiviral defenses, were down-regulated in the carcass at 5 days post infection. The number of significantly modulated genes decreased over time in midguts and increased in carcasses. Conclusion/Significance Dengue virus exposure results in the modulation of genes in a time-and site-specific manner. Previous literature on the interaction between mosquitoes and mosquito-borne pathogens suggests that most of the changes that occurred in Ae. albopictus exposed to DENV would favor virus infection. Many genes identified in this study warrant further characterization to understand their role in viral manipulation of and antiviral response of Ae. albopictus.	[Tsujimoto, Hitoshi; Hanley, Kathryn A.; Hansen, Immo A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Sundararajan, Anitha; Devitt, Nicholas P.; Schilkey, Faye D.] Natl Ctr Genome Resources, NM INBRE Sequencing & Bioinformat Core, Santa Fe, NM USA; [Tsujimoto, Hitoshi] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	New Mexico State University; National Center for Genome Resources (NCGR); Texas A&M University System; Texas A&M University College Station	Tsujimoto, H (corresponding author), New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.; Tsujimoto, H (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	HitTsujimoto@gmail.com			National Center for Genome Resources (NCGR); NM-INBRE pilot grant; National Institutes of Health (NIH) [4SC1AI109055-04]; NIH [1R15AI113628-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI109055, R15AI113628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103451] Funding Source: NIH RePORTER	National Center for Genome Resources (NCGR); NM-INBRE pilot grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding by National Center for Genome Resources (NCGR), NM-INBRE pilot grant to HT, National Institutes of Health (NIH) 4SC1AI109055-04 to IAH, and NIH 1R15AI113628-01 to KAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Armbruster P, 2003, J MED ENTOMOL, V40, P356, DOI 10.1603/0022-2585-40.3.356; Armbruster PA, 2016, J MED ENTOMOL, V53, P1013, DOI 10.1093/jme/tjw037; Behura SK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001385; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Binggeli O, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004067; Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108; Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003; Bonizzoni M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050512; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Calvo E, 2007, J BIOL CHEM, V282, P26928, DOI 10.1074/jbc.M705669200; Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112; Chisenhall DM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-252; Chisenhall DM, 2014, AM J TROP MED HYG, V90, P431, DOI 10.4269/ajtmh.13-0412; Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543; Conway MJ, 2014, J VIROL, V88, P164, DOI 10.1128/JVI.02235-13; Dimopoulos G, 2000, P NATL ACAD SCI USA, V97, P6619, DOI 10.1073/pnas.97.12.6619; Dong YM, 2009, J BIOL CHEM, V284, P9835, DOI 10.1074/jbc.M807084200; Faraji A, 2016, J MED ENTOMOL, V53, P1029, DOI 10.1093/jme/tjw096; Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; GUBLER DJ, 1976, AM J TROP MED HYG, V25, P318, DOI 10.4269/ajtmh.1976.25.318; Guo XX, 2013, ACTA TROP, V128, P566, DOI 10.1016/j.actatropica.2013.08.006; Hanington PC, 2011, J INNATE IMMUN, V3, P17, DOI 10.1159/000321882; Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008; Hegde S, 2015, CURR OPIN VIROL, V15, P97, DOI 10.1016/j.coviro.2015.08.011; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Jupatanakul N, 2014, DEV COMP IMMUNOL, V43, P1, DOI 10.1016/j.dci.2013.10.002; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Levy F, 2004, MOL CELL PROTEOMICS, V3, P156, DOI 10.1074/mcp.M300114-MCP200; Liu YX, 2016, INSECT SCI, V23, P377, DOI 10.1111/1744-7917.12339; Liu YX, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0009-y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macours N, 2004, INSECT BIOCHEM MOLEC, V34, P501, DOI 10.1016/j.ibmb.2004.03.007; McCracken MK, 2014, VIROLOGY, V468, P133, DOI 10.1016/j.virol.2014.07.019; METSELAAR D, 1980, B WORLD HEALTH ORGAN, V58, P937; Miller N. A., 2008, ALPHEUS J COMPUT SCI, V1, P132, DOI DOI 10.4172/JCSB.1000013; Molina-Cruz A, 2005, AM J TROP MED HYG, V72, P631, DOI 10.4269/ajtmh.2005.72.631; Molloy JC, 2015, VIRUSES-BASEL, V7, P4624, DOI 10.3390/v7082836; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Mousson L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001989; Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108; Paskewitz SM, 2005, INSECT BIOCHEM MOLEC, V35, P815, DOI 10.1016/j.ibmb.2005.03.002; Pitisuttithum P, 2016, EXPERT REV VACCINES, V15, P795, DOI 10.1080/14760584.2016.1189331; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rodriguez-Andres J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002977; Salas-Benito JS, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/873404; Shin SW, 2011, EMBO REP, V12, P938, DOI 10.1038/embor.2011.130; Sim S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002295; Sim S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002631; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Tsetsarkin KA, 2016, CURR OPIN VIROL, V16, P143, DOI 10.1016/j.coviro.2016.02.007; Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vanlandingham DL, 2016, J MED ENTOMOL, V53, P1024, DOI 10.1093/jme/tjw025; Waldock J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001565; Wang YH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004931; Waterhouse RM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-531; WHITEHEAD RH, 1971, T ROY SOC TROP MED H, V65, P661, DOI 10.1016/0035-9203(71)90051-4; WHO, 2009, WHO TECH REP SER, V958, P1; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607; Yan H, 2014, J MED VIROL, V86, P1428, DOI 10.1002/jmv.23815; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324; Zhou YH, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0488-4	69	15	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171345	10.1371/journal.pone.0171345	http://dx.doi.org/10.1371/journal.pone.0171345			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152011	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200130
J	Zhang, BB; Yan, C; Fang, F; Du, Y; Ma, R; Li, XY; Yu, Q; Meng, D; Tang, RX; Zheng, KY				Zhang, Bei-Bei; Yan, Chao; Fang, Fan; Du, Ying; Ma, Rui; Li, Xiang-Yang; Yu, Qian; Meng, Di; Tang, Ren-Xian; Zheng, Kui-Yang			Increased hepatic Th2 and Treg subsets are associated with biliary fibrosis in different strains of mice caused by Clonorchis sinensis	PLOS ONE			English	Article							REGULATORY T-CELLS; MOUSE STRAINS; INFECTION; LIVER; PATHOLOGY; SUSCEPTIBILITY; EXPRESSION; RESISTANCE; PHENOTYPE; RESPONSES	Previous studies showed that CD4(+)T cells responses might be involved in the process of biliary fibrosis. However, the underlying mechanism resulting in biliary fibrosis caused by Clonorchis sinensis remains not yet fully elucidated. The objectives of the present study were to investigate the different profiles of hepatic CD4(+)T cell subsets (Th1, Th2, Th17 and Treg cells) and their possible roles in the biliary fibrosis of different strains of mice (C57BL/6, BALB/c and FVB mice) induced by C. sinensis infection. C57BL/6, BALB/c and FVB mice were orally gavaged with 45 metacercariae. All mice were sacrificed on 28 days post infection in deep anesthesia conditions. The leukocytes in the liver were separated to examine CD4(+)T cell subsets by flow cytometry and the left lobe of liver was used to observe pathological changes, collagen depositions and the concentrations of hydroxyproline. The most serious cystic and fibrotic changes appeared in FVB infected mice indicated by gross observation, Masson's trichrome staining and hydroxyproline content detection. In contrast to C57BL/6 infected mice, diffuse nodules and more intensive fibrosis were observed in the BALB/c infected mice. No differences of the hepatic Th1 subset and Th17 subset were found among the three strains, but the hepatic Th2 and Treg cells and their relative cytokines were dramatically increased in the BALB/c and FVB infected groups compared with the C57BL/6 infected group (P<0.01). Importantly, increased Th2 subset and Treg subset all positively correlated with hydroxyproline contents (P<0.01). This result for the first time implied that the increased hepatic Th2 and Treg cell subsets were likely to play potential roles in the formation of biliary fibrosis in C. sinensis-infected mice.	[Zhang, Bei-Bei; Yan, Chao; Fang, Fan; Du, Ying; Ma, Rui; Li, Xiang-Yang; Yu, Qian; Tang, Ren-Xian; Zheng, Kui-Yang] Xuzhou Med Univ, Jiangsu Key Lab Immun & Metab, Dept Pathogen Biol & Immunol, Lab Infect & Immun, Xuzhou, Jiangsu, Peoples R China; [Meng, Di] Xuzhou Med Univ, Dept Pathol, Affiliated Hosp, Xuzhou, Peoples R China	Xuzhou Medical University; Xuzhou Medical University	Tang, RX; Zheng, KY (corresponding author), Xuzhou Med Univ, Jiangsu Key Lab Immun & Metab, Dept Pathogen Biol & Immunol, Lab Infect & Immun, Xuzhou, Jiangsu, Peoples R China.	Tangrenxian-t@163.com; ZKY02@163.com	Yan, Chao/AAA-9403-2021		National Natural Science Foundation of China [81572019, 31302077]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Starting Foundation for Talents of Xuzhou Medical College [53591317]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Starting Foundation for Talents of Xuzhou Medical College	Project support was provided in part by the National Natural Science Foundation of China (Grant Nos. 81572019 and 31302077), a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) in the year of 2014, the Starting Foundation for Talents of Xuzhou Medical College (Grant No. 53591317). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anuradha R, 2015, J IMMUNOL, V195, P2241, DOI 10.4049/jimmunol.1500745; Birjandi SZ, 2016, AM J PATHOL, V186, P2008, DOI 10.1016/j.ajpath.2016.03.020; Bouchery T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00487; Breloer M, 2017, PARASITOLOGY, V144, P295, DOI 10.1017/S0031182016000111; Bryan MA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000733; Cao YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074955; Choi YK, 2003, PARASITOL RES, V91, P87, DOI 10.1007/s00436-003-0934-2; Clough D, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0189; D'Elia R, 2009, J IMMUNOL, V182, P2340, DOI 10.4049/jimmunol.0802767; Freitas JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005113; Guo QianQian, 2009, China Tropical Medicine, V9, P1187; Gupta S, 2005, CURR OPIN MICROBIOL, V8, P428, DOI 10.1016/j.mib.2005.06.011; Hannestad K, 2009, J IMMUNOL, V183, P3542, DOI 10.4049/jimmunol.0900579; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hirahara K, 2013, J ALLERGY CLIN IMMUN, V131, P1276, DOI 10.1016/j.jaci.2013.03.015; Kim EM, 2012, PARASITOL INT, V61, P124, DOI 10.1016/j.parint.2011.07.001; Knott ML, 2009, PARASITOLOGY, V136, P93, DOI 10.1017/S0031182008005192; Kumar R, 2015, AM J RESP CRIT CARE, V192, P998, DOI 10.1164/rccm.201410-1820OC; Layland LE, 2007, EUR J IMMUNOL, V37, P2174, DOI 10.1002/eji.200737063; Liappas G, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/416480; Liu FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015404; Maeng S, 2016, INT J PARASITOL, V46, P195, DOI 10.1016/j.ijpara.2015.11.003; Mbow M, 2013, J INFECT DIS, V207, P186, DOI 10.1093/infdis/jis654; McSorley HJ, 2012, CLIN MICROBIOL REV, V25, P585, DOI 10.1128/CMR.05040-11; Moosbrugger-Martinz V, 2016, J CELL MOL MED, V20, P930, DOI 10.1111/jcmm.12806; Mourglia-Ettlin G, 2016, IMMUNOBIOLOGY, V221, P418, DOI 10.1016/j.imbio.2015.11.012; Okada F, 2014, YONAGO ACTA MED, V57, P65; Peng H, 2016, SCI REP-UK, V6, DOI 10.1038/srep29844; Qian MB, 2016, LANCET, V387, P800, DOI 10.1016/S0140-6736(15)60313-0; Qian MB, 2012, INFECT DIS POVERTY, V1, DOI 10.1186/2049-9957-1-4; Qiao T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042471; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Schmid-Hempel P, 2008, TRENDS ECOL EVOL, V23, P318, DOI 10.1016/j.tree.2008.02.011; Shi WB, 2010, CIRC-CARDIOVASC GENE, V3, P409, DOI 10.1161/CIRCGENETICS.110.957449; Smith KA, 2014, EUR J IMMUNOL, V44, P150, DOI 10.1002/eji.201343746; Specht S, 2012, EXP PARASITOL, V132, P90, DOI 10.1016/j.exppara.2011.09.003; Uddin MH, 2012, PARASITOL INT, V61, P118, DOI 10.1016/j.parint.2011.07.002; Watanapa P, 2002, BRIT J SURG, V89, P962, DOI 10.1046/j.1365-2168.2002.02143.x; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Xu YQ, 2016, PARASITOL RES, V115, P2653, DOI 10.1007/s00436-016-5012-7; Yan C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143217; Yan C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0675-y; Yang QL, 2015, KOREAN J PARASITOL, V53, P777, DOI 10.3347/kjp.2015.53.6.777; Zhang GW, 2014, ANN SURG ONCOL, V21, P3628, DOI 10.1245/s10434-014-3710-x; Zhang WW, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0650-7	45	19	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171005	10.1371/journal.pone.0171005	http://dx.doi.org/10.1371/journal.pone.0171005			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151995	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161200069
J	Gimenez-Garzo, C; Garces, JJ; Urios, A; Mangas-Losada, A; Garcia-Garcia, R; Gonzalez-Lopez, O; Giner-Duran, R; Escudero-Garcia, D; Serra, MA; Soria, E; Felipo, V; Montoliu, C				Gimenez-Garzo, Carla; Garces, Juan Jose; Urios, Amparo; Mangas-Losada, Alba; Garcia-Garcia, Raquel; Gonzalez-Lopez, Olga; Giner-Duran, Remedios; Escudero-Garcia, Desamparados; Serra, Miguel Angel; Soria, Emilio; Felipo, Vicente; Montoliu, Carmina			The PHES battery does not detect all cirrhotic patients with early neurological deficits, which are different in different patients	PLOS ONE			English	Article							MINIMAL HEPATIC-ENCEPHALOPATHY; CRITICAL FLICKER FREQUENCY; BIMANUAL COORDINATION; VISUAL-ATTENTION; MOTOR IMPAIRMENT; LIVER-CIRRHOSIS; DIAGNOSIS; COVERT; CHALLENGE; VALIDITY	Background and aims The psychometric hepatic encephalopathy score (PHES) is the "gold standard" for minimal hepatic encephalopathy (MHE) diagnosis. Some reports suggest that some cirrhotic patients "without" MHE according to PHES show neurological deficits and other reports that neurological alterations are not homogeneous in all cirrhotic patients. This work aimed to assess whether: 1) a relevant proportion of cirrhotic patients show neurological deficits not detected by PHES; 2) cirrhotic patients with mild neurological deficits are a homogeneous population or may be classified in sub-groups according to specific deficits. Methods Cirrhotic patients "without" (n = 56) or "with" MHE (n = 41) according to PHES and controls (n = 52) performed psychometric tests assessing attention, concentration, mental processing speed, working memory and bimanual and visuomotor coordination. Heterogeneity of neurological alterations was analysed using Hierarchical Clustering Analysis. Results PHES classified as "with" MHE 42% of patients. Around 40% of patients "without" MHE according to PHES fail two psychometric tests. Oral SDMT, d2, bimanual and visuo-motor coordination tests are failed by 54, 51, 51 and 43% of patients, respectively. The earliest neurological alterations are different for different patients. Hierarchical clustering analysis shows that patients "without" MHE according to PHES may be classified in clusters according to the tests failed. In some patients coordination impairment appear before cognitive impairment while in others concentration and attention deficits appear before. Conclusions PHES is not sensitive enough to detect early neurological alterations in a relevant proportion of cirrhotic patients. Oral SDMT, d2 and bimanual and visuo-motor coordination tests are more sensitive. The earliest neurological alterations are different in different cirrhotic patients. These data also have relevant clinical implications. Patients classified as "without MHE" by PHES belonging to clusters 3 and 4 in our study have a high risk of suffering clinical complications, including overt HE and must be diagnosed and clinically followed.	[Gimenez-Garzo, Carla; Urios, Amparo; Garcia-Garcia, Raquel; Felipo, Vicente] Ctr Invest Principe Felipe Valencia, Lab Neurobiol, Valencia, Spain; [Garces, Juan Jose; Soria, Emilio] Escuela Tecn Super Ingn, IDAL, Valencia, Spain; [Urios, Amparo; Mangas-Losada, Alba; Montoliu, Carmina] Fdn Invest Hosp Clin Valencia, Inst Invest Sanitaria INCLIVA, Valencia, Spain; [Gonzalez-Lopez, Olga; Giner-Duran, Remedios] Hosp Arnau Vilanova, Serv Digest, Valencia, Spain; [Escudero-Garcia, Desamparados; Serra, Miguel Angel] Univ Valencia, Unidad Digest, Hosp Clin Valencia, Dept Med, Valencia, Spain; [Montoliu, Carmina] Univ Valencia, Dept Patol, Fac Med, Valencia, Spain	Prince Felipe Research Center; University of Valencia; University of Valencia	Felipo, V (corresponding author), Ctr Invest Principe Felipe Valencia, Lab Neurobiol, Valencia, Spain.	vfelipo@cipf.es	Montoliu, Carmina/ABB-1904-2021; Urios, Amparo/ABB-1879-2021; Escudero-Garcia, Desamparados/ABB-1929-2021; Felipo, Vicente/A-9265-2014	Felipo, Vicente/0000-0003-3145-9538; Garcia, Raquel/0000-0002-0911-1220; Urios, Amparo/0000-0003-2699-7040; Gimenez-Garzo, Carla/0000-0002-9748-443X; Soria Olivas, Emilio/0000-0002-9148-8405	Ministerio de Ciencia e Innovacion [SAF2011-23051, CSD2008-00005, SAF2014-51851-R, FIS PI12/00884, FIS PI15/00035]; Conselleria Educacion Generalitat Valenciana [PROMETEO-2009-027, PROMETEOII/2014/033, ACOMP/2014/026]; European Regional Development Funds (ERDF)	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Conselleria Educacion Generalitat Valenciana; European Regional Development Funds (ERDF)(European Commission)	This work was supported by Ministerio de Ciencia e Innovacion (SAF2011-23051, CSD2008-00005, SAF2014-51851-R) to VF and FIS PI12/00884 and FIS PI15/00035 to CM, Conselleria Educacion Generalitat Valenciana (PROMETEO-2009-027; PROMETEOII/2014/033 to VF and ACOMP/2014/026 to CM) and co-funded with European Regional Development Funds (ERDF).	Amodio P, 2005, METAB BRAIN DIS, V20, P115, DOI 10.1007/s11011-005-4149-3; Amodio P, 2004, METAB BRAIN DIS, V19, P253, DOI 10.1023/B:MEBR.0000043975.01841.de; Amodio P, 1995, METAB BRAIN DIS, V10, P335, DOI 10.1007/BF02109363; Amodio P, 1998, HEPATOLOGY, V27, P1517, DOI 10.1002/hep.510270608; Bajaj JS, 2008, GASTROENTEROLOGY, V135, P1591, DOI 10.1053/j.gastro.2008.07.021; Bajaj JS, 2013, HEPATOLOGY, V58, P1122, DOI 10.1002/hep.26309; Bajaj JS, 2012, HEPATOLOGY, V55, P1164, DOI 10.1002/hep.25507; Bajaj JS, 2009, HEPATOLOGY, V50, P1175, DOI 10.1002/hep.23128; Baltimore Williams and Wilkins. World Medical Organization, 1996, BMJ-BRIT MED J, V313, P1448; Bates ME, 2004, J INT NEUROPSYCH SOC, V10, P392, DOI 10.1017/S135561770410307X; Boix J, 2010, NEUROSCIENCE, V167, P994, DOI 10.1016/j.neuroscience.2010.02.068; Brickenkamp, 1998, THE D2 TEST OF ATTEN; Butz M, 2010, ACTA NEUROL SCAND, V122, P27, DOI 10.1111/j.1600-0404.2009.01246.x; Curran S, 2004, INT J GERIATR PSYCH, V19, P575, DOI 10.1002/gps.1134; Debaere F, 2004, NEUROIMAGE, V21, P1416, DOI 10.1016/j.neuroimage.2003.12.011; ELSASS P, 1978, SCAND J GASTROENTERO, V13, P241, DOI 10.3109/00365527809181755; Felipo V, 2014, WORLD J GASTROENTERO, V20, P11815, DOI 10.3748/wjg.v20.i33.11815; Felipo V, 2013, NAT REV NEUROSCI, V14, P851, DOI 10.1038/nrn3587; Felipo V, 2012, HEPATOLOGY, V55, P530, DOI 10.1002/hep.24704; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Groeneweg M, 1998, HEPATOLOGY, V28, P45, DOI 10.1002/hep.510280108; Groribaek L, 2014, J HEPATOL, V60, P612, DOI 10.1016/j.jhep.2013.10.020; Hanchar HJ, 2005, NAT NEUROSCI, V8, P339, DOI 10.1038/nn1398; Hastie T., 2009, THE ELEMENTS OF STAT, DOI DOI 10.1007/B94608; Lezak MD, 2012, NEUROPSYCHOLOGICAL A, V5; Logue SF, 2014, PHARMACOL BIOCHEM BE, V123, P45, DOI 10.1016/j.pbb.2013.08.007; Mardini H, 2008, GASTROENTEROLOGY, V135, P1582, DOI 10.1053/j.gastro.2008.06.043; Miall RC, 2001, NAT NEUROSCI, V4, P638, DOI 10.1038/88465; Montagnese S, 2014, WORLD J GASTROENTERO, V20, P15756, DOI 10.3748/wjg.v20.i42.15756; Montoliu C, 2007, J MOL MED, V85, P233, DOI 10.1007/s00109-006-0149-y; Montoliu C, 2009, J CLIN GASTROENTEROL, V43, P272, DOI 10.1097/MCG.0b013e31815e7f58; Patidar KR, 2015, CLIN GASTROENTEROL H, V13, P2048, DOI 10.1016/j.cgh.2015.06.039; Pollok B, 2007, J COGNITIVE NEUROSCI, V19, P704, DOI 10.1162/jocn.2007.19.4.704; Roman E, 2011, AM J GASTROENTEROL, V106, P476, DOI 10.1038/ajg.2010.413; Romero-Gomez M, 2004, HEPATOLOGY, V39, P939, DOI 10.1002/hep.20152; Romero-Gomez M, 2001, AM J GASTROENTEROL, V96, P2718, DOI 10.1016/S0002-9270(01)02692-2; Romero-Gomez M, 2007, HEPATOLOGY, V45, P879, DOI 10.1002/hep.21586; Sharma P, 2010, HEPATOB PANCREAT DIS, V9, P27; Smith A., 1968, LEARNING DISORDERS, P83, DOI DOI 10.1080/13803390591004428; SNEATH PHA, 1957, J GEN MICROBIOL, V17, P184, DOI 10.1099/00221287-17-1-184; Tukey JW, 1977, EXPLORATORY DATA ANA, VXVI, P688; Wechsler D., 2010, WAIS 4 WECHSLER ADUL; Wein C, 2004, HEPATOLOGY, V39, P739, DOI 10.1002/hep.20095; Weissenborn K, 2005, METAB BRAIN DIS, V20, P359, DOI 10.1007/s11011-005-7919-z; Weissenborn K, 2001, METAB BRAIN DIS, V16, P13, DOI 10.1023/A:1011654210096; Weissenborn K, 2001, J HEPATOL, V34, P768, DOI 10.1016/S0168-8278(01)00026-5	46	29	33	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0171211	10.1371/journal.pone.0171211	http://dx.doi.org/10.1371/journal.pone.0171211			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146589	gold, Green Published, Green Submitted			2022-12-27	WOS:000396131700028
J	Choi, HW; Hong, YJ; Kim, JS; Song, H; Cho, SG; Bae, H; Kim, C; Byun, SJ; Do, JT				Choi, Hyun Woo; Hong, Yean Ju; Kim, Jong Soo; Song, Hyuk; Cho, Ssang Gu; Bae, Hojae; Kim, Changsung; Byun, Sung June; Do, Jeong Tae			In vivo differentiation of induced pluripotent stem cells into neural stem cells by chimera formation	PLOS ONE			English	Article							TETRAPLOID MOUSE EMBRYOS; CENTRAL-NERVOUS-SYSTEM; TERATOMA FORMATION; SELF-RENEWAL; GENERATION; AGGREGATION; INDUCTION; NEURONS; CULTURE; NICHE	Like embryonic stem cells, induced pluripotent stem cells (iPSCs) can differentiate into all three germ layers in an in vitro system. Here, we developed a new technology for obtaining neural stem cells (NSCs) from iPSCs through chimera formation, in an in vivo environment. iPSCs contributed to the neural lineage in the chimera, which could be efficiently purified and directly cultured as NSCs in vitro. The iPSC-derived, in vivo-differentiated NSCs expressed NSC markers, and their gene-expression pattern more closely resembled that of fetal brain-derived NSCs than in vitro-differentiated NSCs. This system could be applied for differentiating pluripotent stem cells into specialized cell types whose differentiation protocols are not well established.	[Choi, Hyun Woo; Hong, Yean Ju; Kim, Jong Soo; Song, Hyuk; Cho, Ssang Gu; Do, Jeong Tae] Konkuk Univ, Coll Anim Biosci & Technol, Dept Anim Biotechnol, Seoul, South Korea; [Choi, Hyun Woo] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Munster, Germany; [Bae, Hojae] Konkuk Univ, Coll Anim Biosci & Technol, Dept Bioind Technol, Seoul, South Korea; [Kim, Changsung] Sejong Univ, Dept Biosci & Biotechnol, Seoul, South Korea; [Byun, Sung June] RDA, Natl Inst Anim Sci, Anim Biotechnol Div, Wanju Gun, Jeollabuk Do, South Korea	Konkuk University; Max Planck Society; Konkuk University; Sejong University; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea	Do, JT (corresponding author), Konkuk Univ, Coll Anim Biosci & Technol, Dept Anim Biotechnol, Seoul, South Korea.	dojt@konkuk.ac.kr		bae, hojae/0000-0003-3057-4999; Cho, Ssang-Goo/0000-0002-0968-7932; Do, Jeong Tae/0000-0001-6721-1441	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2015R1A2A2A01003604, 2015R1A5A1009701]; Next-Generation BioGreen 21 Program - Rural Development Administration, Republic of Korea [PJ01133802]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning; Next-Generation BioGreen 21 Program - Rural Development Administration, Republic of Korea	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (grant no. 2015R1A2A2A01003604 and 2015R1A5A1009701) and the Next-Generation BioGreen 21 Program (grant no. PJ01133802) funded by the Rural Development Administration, Republic of Korea.	Amabile G, 2013, BLOOD, V121, P1255, DOI 10.1182/blood-2012-06-434407; Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Artus J, 2011, METHODS MOL BIOL, V693, P37, DOI 10.1007/978-1-60761-974-1_3; Choi DH, 2002, CELL TRANSPLANT, V11, P359; Choi HW, 2014, STEM CELLS, V32, P2596, DOI 10.1002/stem.1757; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; De Waele J, 2015, BIOMATERIALS, V41, P122, DOI 10.1016/j.biomaterials.2014.11.025; Do JT, 2011, STEM CELLS DEV, V20, P1063, DOI 10.1089/scd.2010.0385; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; Eakin GS, 2006, NAT PROTOC, V1, P1145, DOI 10.1038/nprot.2006.173; Garcion E, 2004, DEVELOPMENT, V131, P3423, DOI 10.1242/dev.01202; Hong YJ, 2016, STEM CELLS DEV, V25, P1311, DOI 10.1089/scd.2016.0124; Kim H, 2012, TRENDS BIOTECHNOL, V30, P55, DOI 10.1016/j.tibtech.2011.07.002; Kim J., 2014, J ELECT MAT, V2014, P1, DOI DOI 10.1167/14.7.1.[; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602; Ma W, 2004, EXP NEUROL, V190, P276, DOI 10.1016/j.expneurol.2003.10.016; Reekmans K, 2012, REGEN MED, V7, P245, DOI [10.2217/rme.12.5, 10.2217/RME.12.5]; Reekmans K, 2012, STEM CELL REV REP, V8, P262, DOI 10.1007/s12015-011-9266-2; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rhee YH, 2011, J CLIN INVEST, V121, P2326, DOI 10.1172/JCI45794; Suzuki N, 2013, MOL THER, V21, P1424, DOI 10.1038/mt.2013.71; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang SG, 2005, SEMIN CANCER BIOL, V15, P413, DOI 10.1016/j.semcancer.2005.05.007	29	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170735	10.1371/journal.pone.0170735	http://dx.doi.org/10.1371/journal.pone.0170735			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141814	Green Published, gold, Green Submitted			2022-12-27	WOS:000396129500016
J	Sharma, J; Leslie, HH; Kundu, F; Kruk, ME				Sharma, Jigyasa; Leslie, Hannah H.; Kundu, Francis; Kruk, Margaret E.			Poor Quality for Poor Women? Inequities in the Quality of Antenatal and Delivery Care in Kenya	PLOS ONE			English	Article							UNIVERSAL HEALTH COVERAGE; OF-CARE; NEWBORN HEALTH; MEDICAL-CARE; INTERVENTIONS; AFRICA; INDIA	Background Quality of healthcare is an important determinant of future progress in global health. However, the distributional aspects of quality of care have received inadequate attention. We assessed whether high quality maternal care is equitably distributed by (1) mapping the quality of maternal care in facilities located in poorer versus wealthier areas of Kenya; and (2) comparing the quality of maternal care available to Kenyans in and not in poverty. Methods We assessed three measures of maternal care quality: facility infrastructure and clinical quality of antenatal care and delivery care, using indicators from the 2010 Kenya Service Provision Assessment (SPA), a standardized facility survey with direct observation of maternal care provision. We calculated poverty of the area served by antenatal or delivery care facilities using the Multidimensional Poverty Index. We used regression analyses and nonparametric tests to assess differences in maternal care quality in facilities located in more and less impoverished areas. We estimated effective coverage with a minimum standard of care for the full population and those in poverty. Results A total of 564 facilities offering at least one maternal care service were included in this analysis. Quality of maternal care was low, particularly clinical quality of antenatal and delivery care, which averaged 0.52 and 0.58 out of 1 respectively, compared to 0.68 for structural inputs to care. Maternal healthcare quality varied by poverty level: at the facility level, all quality metrics were lowest for the most impoverished areas and increased significantly with greater wealth. Population access to a minimum standard (>= 0.75 of 1.00) of quality maternal care was both low and inequitable: only 17% of all women and 8% of impoverished women had access to minimally adequate delivery care. Conclusion The quality of maternal care is low in Kenya, and care available to the impoverished is significantly worse than that for the better off. To achieve the national targets of maternal and neonatal mortality reduction, policy initiatives need to tackle low quality of care, starting with high-poverty areas.	[Sharma, Jigyasa; Leslie, Hannah H.; Kruk, Margaret E.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Kundu, Francis] Natl Council Populat & Dev, Nairobi, Kenya	Harvard University; Harvard T.H. Chan School of Public Health	Sharma, J (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.	jigyasa.sharma@mail.harvard.edu	Kruk, Margaret E/E-3058-2010	Kruk, Margaret E/0000-0002-9549-8432; Leslie, Hannah Hogan/0000-0002-7464-3645; Sharma, Jigyasa/0000-0001-8860-0710				[Anonymous], 2014, COUNTIES HIGHEST BUR; Barber SL, 2007, HEALTH AFFAIR, V26, pW352, DOI 10.1377/hlthaff.26.3.w352; Barber SL, 2007, HEALTH AFFAIR, V26, pW310, DOI 10.1377/hlthaff.26.3.w310; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Board on Global Health Institute of Medicine The National Academies of Sciences Engineering and Medicine., 2015, REV EV DIFF QUAL IMP; Das J, 2007, HEALTH AFFAIR, V26, pW338, DOI 10.1377/hlthaff.26.3.w338; Das J, 2014, ANNU REV ECON, V6, P525, DOI 10.1146/annurev-economics-080213-041350; Das J, 2012, HEALTH AFFAIR, V31, P2774, DOI 10.1377/hlthaff.2011.1356; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Hansen PM, 2008, INT J QUAL HEALTH C, V20, P375, DOI 10.1093/intqhc/mzn039; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; HerediaPi IB, 2016, B WHO, V94; Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI DOI 10.17226/10027; Jha AK, 2013, BMJ QUAL SAF, V22, P809, DOI 10.1136/bmjqs-2012-001748; Kitui J, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-40; Kruk ME, 2016, LANCET GLOB HEALTH, V4, pE594, DOI 10.1016/S2214-109X(16)30131-0; Kruk ME, 2014, B WORLD HEALTH ORGAN, V92, P246, DOI 10.2471/BLT.13.126417; Kruk ME, 2016, LANCET GLOBAL HLTH; Kyei NNA, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-151; Lee E, 2016, HLTH POLICY PLANNING; Leslie HH, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002151; Leslie HH, 2016, HEALTH AFFAIR, V35, P1716, DOI 10.1377/hlthaff.2016.0261; Maru DSR, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-41; Ministry of Health, 2014, KEN HLTH POL 2014 20; Nesbitt RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081089; Reidpath DD, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000062; Rosen HE, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0728-4; Sobel HL, 2016, HEALTH POLICY PLANN, V31, P547, DOI 10.1093/heapol/czv095; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; Stevens FR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0107042; Tangcharoensathien V, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0342-3; Tatem A, 2014, FINAL REPORT DEV HIG; The Partnership for Maternal Newborn and Child Health, 2006, OPP AFR NEWB; Tripathi V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129491; United Nations, 2015, 2030 AG SUST DEV; van den Broek NR, 2009, BJOG-INT J OBSTET GY, V116, P18, DOI 10.1111/j.1471-0528.2009.02333.x; Wirth Meg, 2008, East Afr J Public Health, V5, P133; World Bank, 2014, WORLD DEV IND 2014; World Health Organization, 2015, GLOB OBS DAT REP; World Health Organization, 2016, MAT CHILD HLTH; World Health Organization, 2016, NEON CHILD HLTH PROF	42	58	58	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171236	10.1371/journal.pone.0171236	http://dx.doi.org/10.1371/journal.pone.0171236			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6QW	28141840	gold, Green Published, Green Submitted			2022-12-27	WOS:000396129500051
J	Han, Y; Yue, LZ; Wei, M; Ren, XB; Shao, ZH; Zhang, L; Levine, RL; Epling-Burnette, PK				Han, Ying; Yue, Lanzhu; Wei, Max; Ren, Xiubao; Shao, Zonghong; Zhang, Ling; Levine, Ross L.; Epling-Burnette, Pearlie K.			Mesenchymal Cell Reprogramming in Experimental MPLW515L Mouse Model of Myelofibrosis	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; BONE-MARROW FIBROSIS; STEM-CELLS; STROMAL CELLS; MYELOPROLIFERATIVE NEOPLASMS; ACTIVATING MUTATION; MYELOID METAPLASIA; POLYCYTHEMIA-VERA; FACTOR-BETA; TGF-BETA	Myelofibrosis is an indicator of poor prognosis in myeloproliferative neoplasms (MPNs), but the precise mechanism(s) contributing to extracellular matrix remodeling and collagen deposition in the bone marrow (BM) niche remains unanswered. In this study, we isolated mesenchymal stromal cells (MSCs) from mice transplanted with wild-type thrombopoietin receptor (MPL (WT)) and MPL (W515L) retroviral-transduced bone marrow. Using MSCs derived from MPL (W515) -transplant recipients, excessive collagen deposition was maintained in the absence of the virus and neoplastic hematopoietic cells suggested that the MSCs were reprogrammed in vivo. TGF beta production by malignant megakaryocytes plays a definitive role promoting myelofibrosis in MPNs. However, TGF beta was equally expressed by MSCs derived from MPL (WT) and MPL (W515L) expressing mice and the addition of neutralizing anti-TGF beta antibody only partially reduced collagen secretion in vitro. Interestingly, profibrotic MSCs displayed increased levels of pSmad3 and pSTAT3 suggesting that inflammatory mediators cooperating with the TGF beta-receptor signaling may maintain the aberrant pheno-type ex vivo. FGFb is a known suppressor of TGF beta signaling. Reduced collagen deposition by FGFb-treated MSCs derived from MPL (W515L) mice suggests that the activating pathway is vulnerable to this suppressive mediator. Therefore, our findings have implications for the future investigation of therapies to reverse fibrosis in MPNs.	[Han, Ying; Yue, Lanzhu; Wei, Max; Epling-Burnette, Pearlie K.] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA; [Han, Ying; Ren, Xiubao] Tianjin Med Univ, Dept Biotherapy, Canc Inst & Hosp,Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy,Key Lab Canc Immun, Tianjin, Peoples R China; [Yue, Lanzhu; Shao, Zonghong] Tianjin Med Univ, Dept Hematol, Gen Hosp, Tianjin, Peoples R China; [Zhang, Ling] H Lee Moffitt Canc Ctr & Res Inst, Dept Hematopathol, Tampa, FL USA; [Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Leukemia Ctr, New York, NY 10021 USA	H Lee Moffitt Cancer Center & Research Institute; Tianjin Medical University; Tianjin Medical University; H Lee Moffitt Cancer Center & Research Institute; Memorial Sloan Kettering Cancer Center	Epling-Burnette, PK (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA.	Pearlie.Burnette@moffitt.org	levine, ross/AAE-7658-2019	yue, lanzhu/0000-0002-8578-7564	Myelofibrosis (MF) Challenge, a joint venture of the Leukemia & Lymphoma Society and Myeloproliferative Neoplasm (MPN) Research Foundation; Moffitt Cancer Center Imaging Core services - Moffitt Cancer Center Support grant [P30CA076292]; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER	Myelofibrosis (MF) Challenge, a joint venture of the Leukemia & Lymphoma Society and Myeloproliferative Neoplasm (MPN) Research Foundation; Moffitt Cancer Center Imaging Core services - Moffitt Cancer Center Support grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Myelofibrosis (MF) Challenge, a joint venture of the Leukemia & Lymphoma Society and Myeloproliferative Neoplasm (MPN) Research Foundation; Moffitt Cancer Center Imaging Core services, sponsored by the Moffitt Cancer Center Support grant (P30CA076292).	Akada H, 2010, BLOOD, V115, P3589, DOI 10.1182/blood-2009-04-215848; Berardis S, 2015, WORLD J GASTROENTERO, V21, P742, DOI 10.3748/wjg.v21.i3.742; Bianchi G, 2003, EXP CELL RES, V287, P98, DOI 10.1016/S0014-4827(03)00138-1; Bock O, 2005, J PATHOL, V205, P548, DOI 10.1002/path.1744; Branton MH, 1999, MICROBES INFECT, V1, P1349, DOI 10.1016/S1286-4579(99)00250-6; Chagraoui H, 2002, BLOOD, V100, P3495, DOI 10.1182/blood-2002-04-1133; Ciaffoni F, 2015, BLOOD CELL MOL DIS, V54, P234, DOI 10.1016/j.bcmd.2014.12.005; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Gastinne T, 2007, EXP HEMATOL, V35, P64, DOI 10.1016/j.exphem.2006.08.016; Gentile TC, 1996, LEUKEMIA LYMPHOMA, V23, P365, DOI 10.3109/10428199609054840; Grande JP, 1997, J LAB CLIN MED, V130, P476, DOI 10.1016/S0022-2143(97)90124-4; Gray MO, 1998, CARDIOVASC RES, V40, P352, DOI 10.1016/S0008-6363(98)00121-7; Horiguchi K, 2009, J BIOL CHEM, V284, P245, DOI 10.1074/jbc.M804777200; Ito T, 2007, BIOCHEM BIOPH RES CO, V359, P108, DOI 10.1016/j.bbrc.2007.05.067; KHALIL N, 1991, CIBA F SYMP, V157, P194; KINGREEN D, 1995, AM J HEMATOL, V50, P234, DOI 10.1002/ajh.2830500403; Klampfl T, 2013, NEW ENGL J MED, V369, P2379, DOI 10.1056/NEJMoa1311347; Koppikar P, 2012, NATURE, V489, P155, DOI 10.1038/nature11303; Koppikar P, 2010, BLOOD, V115, P2919, DOI 10.1182/blood-2009-04-218842; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kremyanskaya M, 2013, ONCOLOGY-NY, V27, P706; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Le Bousse-Kerdiles MC, 1999, ANN HEMATOL, V78, P437, DOI 10.1007/s002770050595; Lennon DP, 2001, J CELL PHYSIOL, V187, P345, DOI 10.1002/jcp.1081; Leslie K, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2725; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Liu JH, 2000, BLOOD, V95, P3219; Liu JH, 2002, BLOOD, V100, P1449, DOI 10.1182/blood.V100.4.1449.h81602001449_1449_1453; Mailloux AW, 2013, J IMMUNOL, V191, P3578, DOI 10.4049/jimmunol.1203424; Majumdar MK, 2000, J HEMATOTH STEM CELL, V9, P841, DOI 10.1089/152581600750062264; Manshouri T, 2011, CANCER RES, V71, P3831, DOI 10.1158/0008-5472.CAN-10-4002; Matsuzaki K, 2014, J GASTROENTEROL, V49, P971, DOI 10.1007/s00535-013-0910-2; Meindl-Beinker NM, 2012, DIGEST DIS, V30, P514, DOI 10.1159/000341704; Michiels JJ, 2015, ACTA HAEMATOL-BASEL, V133, P36, DOI 10.1159/000358580; Mudrabettu C, 2015, NEPHROLOGY, V20, P25, DOI 10.1111/nep.12338; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Papetti M, 2003, INVEST OPHTH VIS SCI, V44, P4994, DOI 10.1167/iovs.03-0291; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Popp Felix C, 2006, Curr Stem Cell Res Ther, V1, P411; Rolandsson S, 2014, PULM PHARMACOL THER, V29, P93, DOI 10.1016/j.pupt.2014.08.001; Roth S, 1998, HEPATOLOGY, V27, P1003, DOI 10.1002/hep.510270416; Sato Y, 2005, BLOOD, V106, P756, DOI 10.1182/blood-2005-02-0572; Schepers K, 2013, CELL STEM CELL, V13, P285, DOI 10.1016/j.stem.2013.06.009; Schmitt A, 2000, BLOOD, V96, P1342, DOI 10.1182/blood.V96.4.1342; Tefferi A, 2007, CELL CYCLE, V6, P550, DOI 10.4161/cc.6.5.3919; Thiele J, 2005, HAEMATOLOGICA, V90, P1128; Tsutsumi S, 2001, BIOCHEM BIOPH RES CO, V288, P413, DOI 10.1006/bbrc.2001.5777; Wlodarski MW, 2005, BLOOD, V106, P2769, DOI 10.1182/blood-2004-10-4045; Yoon SY, 2001, HAEMATOLOGICA, V86, P52; Zaragosi LE, 2006, STEM CELLS, V24, P2412, DOI 10.1634/stemcells.2006-0006	51	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0166014	10.1371/journal.pone.0166014	http://dx.doi.org/10.1371/journal.pone.0166014			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135282	Green Submitted, gold, Green Published			2022-12-27	WOS:000396124700001
J	Hawelka, B; Sitko, I; Kazakopoulos, P; Beinat, E				Hawelka, Bartosz; Sitko, Izabela; Kazakopoulos, Pavlos; Beinat, Euro			Collective Prediction of Individual Mobility Traces for Users with Short Data History	PLOS ONE			English	Article								We present and test a sequential learning algorithm for the prediction of human mobility that leverages large datasets of sequences to improve prediction accuracy, in particular for users with a short and non-repetitive data history such as tourists in a foreign country. The algorithm compensates for the difficulty of predicting the next location when there is limited evidence of past behavior by leveraging the availability of sequences of other users in the same system that provide redundant records of typical behavioral patterns. We test the method on a dataset of 10 million roaming mobile phone users in a European country. The average prediction accuracy is significantly higher than that of individual sequence prediction algorithms, primarily constant order Markov models derived from the user's own data, that have been shown to achieve high accuracy in previous studies of human mobility. The proposed algorithm is generally applicable to improve any sequential prediction when there is a sufficiently rich and diverse dataset of sequences.	[Hawelka, Bartosz; Sitko, Izabela; Beinat, Euro] Salzburg Univ, Dept Geoinformat Z GIS, Salzburg, Austria; [Hawelka, Bartosz; Sitko, Izabela; Kazakopoulos, Pavlos; Beinat, Euro] CS Res Fdn, Amsterdam, Netherlands	Salzburg University	Hawelka, B (corresponding author), Salzburg Univ, Dept Geoinformat Z GIS, Salzburg, Austria.; Hawelka, B (corresponding author), CS Res Fdn, Amsterdam, Netherlands.	bartosz.hawelka@sbg.ac.at		Hawelka, Bartosz/0000-0003-0566-2655	CS Research Foundation; Austrian Science Fund (FWF) through the Doctoral College GIScience, Department of Geoinformatics - Z GIS, University of Salzburg, Austria [DK W 1237-N23]	CS Research Foundation; Austrian Science Fund (FWF) through the Doctoral College GIScience, Department of Geoinformatics - Z GIS, University of Salzburg, Austria	This research was funded by the CS Research Foundation (www.coliectivesensing.org) and by the Austrian Science Fund (FWF) through the Doctoral College GIScience (DK W 1237-N23), Department of Geoinformatics - Z GIS, University of Salzburg, Austria.	Blum A, 2005, LECT NOTES COMPUT SC, V3559, P621, DOI 10.1007/11503415_42; Blum A, 1997, MACH LEARN, V26, P5, DOI 10.1023/A:1007335615132; Borodin A, 2000, LECT NOTES COMPUT SC, V1776, P173, DOI 10.1007/10719839_19; Cesa-Bianchi N., 2006, PREDICTION LEARNING, DOI DOI 10.1017/CBO9780511546921; Cohen WW, 1999, ACM T INFORM SYST, V17, P141, DOI 10.1145/306686.306688; Cutland N., 1991, MATH FINANC, V1, P1; De Domenico M, 2013, PERVASIVE MOB COMPUT, V9, P798, DOI 10.1016/j.pmcj.2013.07.008; de Montjoye Yves-Alexandre, 2013, Social Computing, Behavioral-Cultural Modeling and Prediction. 6th International Conference, SBP 2013. Proceedings, P48, DOI 10.1007/978-3-642-37210-0_6; Devaine M, 2009, AGGREGATION SLEEPING; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; FEDER M, 1992, IEEE T INFORM THEORY, V38, P1258, DOI 10.1109/18.144706; Freund Y., 1997, P 20 9 ANN ACM S THE, P334, DOI [10.1145/258533.258616, DOI 10.1145/258533.258616]; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Jacobs A., 2011, THESIS; Kleinberg R, 2010, MACH LEARN, V80, P245, DOI 10.1007/s10994-010-5178-7; Li B, 2014, ACM COMPUT SURV, V46, DOI 10.1145/2512962; Lu X, 2013, SCI REP-UK, V3, DOI 10.1038/srep02923; Lu X, 2012, P NATL ACAD SCI USA, V109, P11576, DOI 10.1073/pnas.1203882109; Mallet V, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014259; Mallet V, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD009978; Monteleoni Claire, 2011, Statistical Analysis and Data Mining, V4, P18, DOI 10.1002/sam.10126; Monteleoni C, 2003, ADV NEURAL INFORM PR; Noulas A, 2012, IEEE DATA MINING, P1038, DOI 10.1109/ICDM.2012.113; Quercia Daniele, 2010, Proceedings 2010 10th IEEE International Conference on Data Mining (ICDM 2010), P971, DOI 10.1109/ICDM.2010.152; Song LB, 2006, IEEE T MOBILE COMPUT, V5, P1633, DOI 10.1109/TMC.2006.185; Stoltz G, 2005, MACH LEARN, V59, P125, DOI 10.1007/s10994-005-0465-4; Tatem AJ, 2009, MALARIA J, V8, P10; Tizzoni M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003716; Vovk V, 2009, J MACH LEARN RES, V10, P2445; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467	33	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170907	10.1371/journal.pone.0170907	http://dx.doi.org/10.1371/journal.pone.0170907			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135289	Green Published, gold, Green Submitted			2022-12-27	WOS:000396124700030
J	Li, BI; Ababon, MR; Matteson, PG; Lin, Y; Nanda, V; Millonig, JH				Li, Bo I.; Ababon, Myka R.; Matteson, Paul G.; Lin, Yong; Nanda, Vikas; Millonig, James H.			Congenital Cataract in Mice Is Modified by Proximal Chromosome 15	PLOS ONE			English	Article							PROGRESSIVE-ANKYLOSIS GENE; PROTEIN-COUPLED RECEPTOR; QUANTITATIVE TRAIT LOCI; MOLECULAR-GENETICS; MOUSE MODELS; HETEROGENEITY; MUTATIONS; PATHWAY; GPR161; MICROCORNEA	The morphology and severity of human congenital cataract varies even among individuals with the same mutation, suggesting that genetic background modifies phenotypic penetrance. The spontaneous mouse mutant, vacuolated lens (vi), arose on the C3H/HeSnJ background. The mutation disrupts secondary lens fiber development by El 6.5, leading to full penetrance of congenital cataract. The v/locus was mapped to a frameshift deletion in the orphan G protein-coupled receptor, Gpr161, which is expressed in differentiating lens fiber cells. When Gpr161(vl/vl) C3H mice are crossed to MOLF/EiJ mice an unexpected rescue of cataract is observed, suggesting that MOLF modifiers affect cataract penetrance. Subsequent QTL analysis mapped three modifiers (Modvl3-5: Modifier of vl) and in this study we characterized Modvl4 (Chrl 5; LOD = 4.4). A Modv/4(MOLF) congenic was generated and is sufficient to rescue congenital cataract and the lens fiber defect at El 6.5. Additional phenotypic analysis on three subcongenic lines narrowed down the interval from 55 to 15Mb. In total only 18 protein-coding genes and 2 micro-RNAs are in this region. Fifteen of the 20 genes show detectable expression in the El 6.5 eye. Subsequent expression studies in Gpr161(vl/vl) and subcongenic El 6.5 eyes, bioinformatics analysis of C3H/MOLF polymorphisms, and the biological relevancy of the genes in the interval identified three genes (Cdh6, Ank and Trio) that likely contribute to the rescue of the lens phenotype. These studies demonstrate that modification of the Gpr161(vl/vl) cataract phenotype is likely due to genetic variants in at least one of three closely linked candidate genes on proximal Chr15.	[Li, Bo I.; Ababon, Myka R.; Matteson, Paul G.; Nanda, Vikas; Millonig, James H.] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ USA; [Li, Bo I.; Millonig, James H.] Rutgers State Univ, Dept Neurosci & Cell Biol, Piscataway, NJ USA; [Li, Bo I.; Ababon, Myka R.; Matteson, Paul G.; Nanda, Vikas; Millonig, James H.] Rutgers State Univ, Robert Wood Johnson Med Sch, Piscataway, NJ USA; [Lin, Yong] Rutgers State Univ, Rutgers Canc Inst New Jersey, Div Biometr, New Brunswick, NJ USA; [Nanda, Vikas] Rutgers State Univ, Dept Biochem, Piscataway, NJ USA; [Millonig, James H.] Rutgers State Univ, Dept Genet, Piscataway, NJ USA; [Li, Bo I.] Columbia Univ, Med Ctr, Irving Canc Res Ctr, New York, NY USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Columbia University	Millonig, JH (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ USA.; Millonig, JH (corresponding author), Rutgers State Univ, Dept Neurosci & Cell Biol, Piscataway, NJ USA.; Millonig, JH (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Piscataway, NJ USA.; Millonig, JH (corresponding author), Rutgers State Univ, Dept Genet, Piscataway, NJ USA.	millonig@cabm.rutgers.edu			New Jersey Commission on Spinal Cord Research [10-3092-SCR-E-0]	New Jersey Commission on Spinal Cord Research	This work was funded by the New Jersey Commission on Spinal Cord Research (http://www. state.nj.us/health/spinalcord/) (Grant number: 10-3092-SCR-E-0; Funding recipient: JHM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiola O, 2003, NAT REV GENET, V4, P911, DOI 10.1038/nrg1206; Abu-Elneel K, 2008, J BIOL CHEM, V283, P32781, DOI 10.1074/jbc.M804688200; Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Brigidi GS, 2011, CURR OPIN NEUROBIOL, V21, P208, DOI 10.1016/j.conb.2010.12.004; Cailotto F, 2010, J BIOL CHEM, V285, P10572, DOI 10.1074/jbc.M109.050534; Chakraborty A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001958; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; COWIE CC, 1989, NEW ENGL J MED, V321, P1074, DOI 10.1056/NEJM198910193211603; Deng H, 2014, EUR J MED GENET, V57, P113, DOI 10.1016/j.ejmg.2013.12.006; Forshew T, 2005, HUM GENET, V117, P452, DOI 10.1007/s00439-005-1309-9; Graw J, 1999, EYE, V13, P438, DOI 10.1038/eye.1999.118; Graw J, 2009, J GENET, V88, P469, DOI 10.1007/s12041-009-0066-2; Haddrill M, 2009, CONGENITAL CATARACTS; Hansen L, 2007, INVEST OPHTH VIS SCI, V48, P3937, DOI 10.1167/iovs.07-0013; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Jarquin VG, 2011, J DEV BEHAV PEDIATR, V32, P179, DOI 10.1097/DBP.0b013e31820b4260; Khan K, 2011, INVEST OPHTH VIS SCI, V52, P4294, DOI 10.1167/iovs.10-6776; Korstanje R, 2008, PHYSIOL GENOMICS, V35, P296, DOI 10.1152/physiolgenomics.90260.2008; Las Heras F, 2012, J RHEUMATOL, V39, P583, DOI DOI 10.3899/JRHEUM.110971; Li BI, 2015, DEV BIOL, V402, P17, DOI 10.1016/j.ydbio.2015.02.007; Liu Q, 2008, DEV NEUROBIOL, V68, P1107, DOI 10.1002/dneu.20646; Mandell DS, 2009, AM J PUBLIC HEALTH, V99, P493, DOI 10.2105/AJPH.2007.131243; Matteson PG, 2008, P NATL ACAD SCI USA, V105, P2088, DOI 10.1073/pnas.0705657105; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Mukhopadhyay S, 2013, CELL, V152, P210, DOI 10.1016/j.cell.2012.12.026; Murthy VH, 2004, JAMA-J AM MED ASSOC, V291, P2720, DOI 10.1001/jama.291.22.2720; Nurnberg P, 2001, NAT GENET, V28, P37, DOI 10.1038/ng0501-37; Osterhout JA, 2011, NEURON, V71, P632, DOI 10.1016/j.neuron.2011.07.006; Plageman TF, 2011, DEVELOPMENT, V138, P5177, DOI 10.1242/dev.067868; Pontoriero GF, 2009, DEV BIOL, V326, P403, DOI 10.1016/j.ydbio.2008.10.011; Raju I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028085; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Shafie SM, 2006, AM J OPHTHALMOL, V141, P750, DOI 10.1016/j.ajo.2005.10.050; Stewart DB, 2000, J BIOL CHEM, V275, P20707, DOI 10.1074/jbc.M000467200; Takiuchi T, 2014, GENES CELLS, V19, P254, DOI 10.1111/gtc.12128; Terkeltaub RA, 2001, AM J PHYSIOL-CELL PH, V281, pC1, DOI 10.1152/ajpcell.2001.281.1.C1; Vaque JP, 2013, MOL CELL, V49, P94, DOI 10.1016/j.molcel.2012.10.018; Walters RFS, 2006, P NATL ACAD SCI USA, V103, P13658, DOI 10.1073/pnas.0605878103; Williams LJ, 2005, PEDIATRICS, V116, P580, DOI 10.1542/peds.2005-0592; Xu W, 2014, MOL CARCINOGENESIS, DOI 10.1002/mc.22221; Zaka R, 2006, CURR OPIN RHEUMATOL, V18, P181, DOI 10.1097/01.bor.0000209432.36355.6e; Zhang SQ, 2015, STRUCTURE, V23, P527, DOI 10.1016/j.str.2015.01.009	42	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170724	10.1371/journal.pone.0170724	http://dx.doi.org/10.1371/journal.pone.0170724			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135291	Green Published, Green Submitted, gold			2022-12-27	WOS:000396124700020
J	Marley, JV; Kotz, J; Engelke, C; Williams, M; Stephen, D; Coutinho, S; Trust, SK				Marley, Julia V.; Kotz, Jayne; Engelke, Catherine; Williams, Melissa; Stephen, Donna; Coutinho, Sudha; Trust, Stephanie K.			Validity and Acceptability of Kimberley Mum's Mood Scale to Screen for Perinatal Anxiety and Depression in Remote Aboriginal Health Care Settings	PLOS ONE			English	Article							INDIGENOUS COGNITIVE ASSESSMENT; POSTNATAL-DEPRESSION; POSTPARTUM DEPRESSION; ANTENATAL DEPRESSION; MATERNAL DEPRESSION; INTERVENTIONS; AUSTRALIANS; ANTEPARTUM; IMPAIRMENT; SYMPTOMS	Background The Edinburgh Postnatal Depression Scale (EPDS) is widely recommended for perinatal anxiety and depression screening. However, many Aboriginal women find EPDS language complex and confusing, and providers find using it with Aboriginal women challenging. The two part Kimberley Mum's Mood Scale (KMMS) was developed to improve screening: Part 1 is a Kimberley version of EPDS; Part 2 is a psychosocial tool that enables contextualisa-tion of Part 1 scores. We aimed to determine if KMMS is a valid and acceptable method of identifying Kimberley Aboriginal perinatal women at risk of anxiety or depressive disorders compared to a semi- structured clinical interview. Methods Across 15 sites in the Kimberley, Western Australia, 97 Aboriginal women aged 16 years and older who intended to continue with their pregnancy or had a baby within the previous 12 months were administered the KMMS by trained healthcare providers who provided an overall assessment of no, low, moderate or high risk; 91 participants were then indepen-dently assessed by a blinded clinical expert using Diagnostic and Statistical Manual of Men-tal Disorders, 4th Edition criteria. A qualitative approach was used to determine KMMS' acceptability. Results Part 1 had high internal consistency (Cronbach's alpha, 0.89), and overall KMMS risk equiv-alence for screening for anxiety or depressive disorders was moderate (sensitivity, 83%; specificity, 87%; positive predictive value, 68%). Participants found the process easy and useful, and healthcare providers found KMMS more useful than EPDS. Part 2 allowed healthcare providers to ask questions that gave participants an opportunity to express them-selves, resulting in a deeper understanding between them. Conclusion KMMS is an effective tool for identifying Kimberley Aboriginal perinatal women at risk of anx-iety and depressive disorders. Adoption of KMMS with culturally safe training and support is likely to improve screening processes, and with further validation may have broader applica-bility across remote Australia.	[Marley, Julia V.] Univ Western Australia, Rural Clin Sch Western Australia, Broome, WA, Australia; [Marley, Julia V.; Engelke, Catherine; Stephen, Donna; Trust, Stephanie K.] Kimberley Aboriginal Med Serv Ltd, Broome, WA, Australia; [Kotz, Jayne] Murdoch Univ, Sch Psychol & Exercise Sci, Murdoch, WA, Australia; [Engelke, Catherine] Univ Western Australia, Rural Clin Sch Western Australia, Kununurra, WA, Australia; [Williams, Melissa] Western Australian Cty Hlth Serv, Broome, WA, Australia; [Trust, Stephanie K.] Kununurra Med, Kununurra, WA, Australia	University of Western Australia; Murdoch University; University of Western Australia	Marley, JV (corresponding author), Univ Western Australia, Rural Clin Sch Western Australia, Broome, WA, Australia.	Julia.Marley@rcswa.edu.au	Marley, Julia V/A-9515-2009	Marley, Julia V/0000-0003-1014-4860	Kimberley Aboriginal Medical Services Ltd; Rural Clinical School of Western Australia; Kimberley Pilbara Medicare Local	Kimberley Aboriginal Medical Services Ltd; Rural Clinical School of Western Australia; Kimberley Pilbara Medicare Local	Western Australia, and a grant for training by the Kimberley Pilbara Medicare Local. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.This project was funded in part through the Kimberley Aboriginal Medical Services Ltd, a Small Project Grant by the Rural Clinical School of Western Australia, and a grant for training by the Kimberley Pilbara Medicare Local. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Y, 2014, WORKING TOGETHER ABO, P271; Almeida OP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094983; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Austin MPV, 2011, MED J AUSTRALIA, V195, P112, DOI 10.5694/j.1326-5377.2011.tb03236.x; Austin MP, 2003, ACTA PSYCHIAT SCAND, V107, P10, DOI 10.1034/j.1600-0447.2003.02024.x; Australian Bureau of Statistics, 2013, HLTH WELF AUSTR AB T; [Australian Health Ministers Advisory Council Ageing AGDoHa], 2012, CLIN PRACT GUID ANT; Australian Institute of Health and Welfare, 2012, EXP PER DEPR DAT 201; Bowen A, 2014, TRANSCULT PSYCHIATRY, V51, P93, DOI 10.1177/1363461513501712; Boyd RC, 2005, ARCH WOMEN MENT HLTH, V8, P141, DOI 10.1007/s00737-005-0096-6; Brittain K, 2015, PAEDIATR PERINAT EP, V29, P505, DOI 10.1111/ppe.12216; Campbell A, 2008, AUST J RURAL HEALTH, V16, P124, DOI 10.1111/j.1440-1584.2007.00930.x; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P167; Dennis CL, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006309; Dingwall KM, 2010, AUST NZ J PSYCHIAT, V44, P20, DOI 10.3109/00048670903393670; Dudgeon P., 2000, WORKING INDIGENOUS A; Gibson J, 2009, ACTA PSYCHIAT SCAND, V119, P350, DOI 10.1111/j.1600-0447.2009.01363.x; Hay DF, 2008, J CHILD PSYCHOL PSYC, V49, P1079, DOI 10.1111/j.1469-7610.2008.01959.x; Hendrick V, 2003, BRIT MED J, V327, P1003, DOI 10.1136/bmj.327.7422.1003; Huizink AC, 2004, PSYCHOL BULL, V130, P115, DOI 10.1037/0033-2909.130.1.115; Jarde A, 2016, JAMA PSYCHIAT, V73, P826, DOI 10.1001/jamapsychiatry.2016.0934; Kettunen P, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0402-2; Kotz J, 2016, CONTEMP NURSE, V52, P42, DOI 10.1080/10376178.2016.1198710; Larson A, 2007, AUST NZ J PUBL HEAL, V31, P322, DOI 10.1111/j.1753-6405.2007.00079.x; LoGiudice D, 2006, INT PSYCHOGERIATR, V18, P269, DOI 10.1017/S1041610205002681; LoGiudice D, 2011, AUSTRALAS J AGEING, V30, P215, DOI 10.1111/j.1741-6612.2010.00486.x; Mc Loughlin F, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0517-1; Morrell CJ, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20370; Nolvi S, 2016, INFANT BEHAV DEV, V43, P13, DOI 10.1016/j.infbeh.2016.03.003; Nonnenmacher N, 2016, ARCH WOMEN MENT HLTH, V19, P927, DOI 10.1007/s00737-016-0648-y; Paradies Y, 2006, INT J EPIDEMIOL, V35, P888, DOI 10.1093/ije/dyl056; Parker R., 2014, WORKING TOGETHER ABO, P113; Patton GC, 2015, LANCET, V386, P875, DOI 10.1016/S0140-6736(14)62248-0; Smith K, 2008, NEUROLOGY, V71, P1470, DOI 10.1212/01.wnl.0000320508.11013.4f; Smith K, 2009, AUST PSYCHOL, V44, P54, DOI 10.1080/00050060802563463; Social Health Reference Group, 2004, NATL STRATEGIC FRAME; Straub H, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.033; The General Practice Mental Health Standards Collaboration, GP MENT HLTH TREATM; The KMMS Research team, 2016, KMMS 2015; WA Country Health Service the WA Perinatal Mental Health Unit., 2010, WA COUNTR HLTH SERV; Werner E, 2015, ARCH WOMEN MENT HLTH, V18, P41, DOI 10.1007/s00737-014-0475-y; Westeman T., 2004, AUST E J ADV MENT HL, V3, P88, DOI [DOI 10.5172/JAMH.3.3.88, https://doi.org/10.5172/jamh.3.3.88]; Zubrick S, 2005, W AUSTR ABORIGINAL C	43	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0168969	10.1371/journal.pone.0168969	http://dx.doi.org/10.1371/journal.pone.0168969			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6PA	28135275	Green Published, Green Submitted, gold			2022-12-27	WOS:000396124700003
J	Casadella, M; Cozzi-Lepri, A; Phillips, A; Noguera-Julian, M; Bickel, M; Sedlacek, D; Zilmer, K; Clotet, B; Lundgren, JD; Paredes, R				Casadella, Maria; Cozzi-Lepri, Alessandro; Phillips, Andrew; Noguera-Julian, Marc; Bickel, Markus; Sedlacek, Dalibor; Zilmer, Kai; Clotet, Bonaventura; Lundgren, Jens D.; Paredes, Roger		EuroSIDA EuroCOORD	Plasma HIV-1 Tropism and the Risk of Short-Term Clinical Progression to AIDS or Death	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; CORECEPTOR TROPISM; INFECTED PATIENTS; IMPACT; COHORT; PHENOTYPE; DEPLETION; USAGE	Objective To investigate if plasma HIV-1 tropism testing could identify subjects at higher risk for clinical progression and death in routine clinical management. Design Nested case-control study within the EuroSIDA cohort. Methods Cases were subjects with AIDS or who died from any cause, with a plasma sample with HIV-1 RNA >1000 copies/mL available for tropism testing 3 to 12 months prior to the event. At least 1 control matched for age, HIV-1 RNA and HCV status at the time of sampling were selected per each case. Conditional logistic regression was used to investigate exposures associated with clinical progression to AIDS or death. A linear mixed model with random intercept was used to compare CD4(+)T-cell slopes by HIV tropism over the 12 months following the date of sampling. Results The study included 266 subjects, 100 cases and 166 controls; one quarter had X4 HIV; 26% were ART-naive. Baseline factors independently associated with clinical progression or death were female gender (OR=2.13 vs. male, 95CI = 1.04, 4.36), p = 0.038), CD4(+)T-cell count (OR = 0.90 (95CI = 0.80, 1.00) per 100 cells/mm 3 higher, p = 0.058), being on ART (OR = 2.72 vs. being off-ART (95CI = 1.15, 6.41), p = 0.022) and calendar year of sample [OR = 0.84 (95CI = 0.77, 0.91) per more recent year, p<0.001). Baseline tropism was not associated with the risk of clinical progression or death. CD4(+)T-cell slopes did not differ within or between tropism groups. Conclusions The predictive role of plasma tropism determined using 454 sequencing in the context of people receiving cART with detectable VL is not helpful to identify subjects at higher risk for clinical progression to AIDS or death.	[Casadella, Maria; Noguera-Julian, Marc; Clotet, Bonaventura; Paredes, Roger] IrsiCaixa AIDS Res Inst, Badalona, Catalonia, Spain; [Casadella, Maria; Noguera-Julian, Marc; Clotet, Bonaventura; Paredes, Roger] Univ Autonoma Barcelona, Catalonia, Spain; [Cozzi-Lepri, Alessandro; Phillips, Andrew] Royal Free Hosp, London, England; [Noguera-Julian, Marc; Clotet, Bonaventura; Paredes, Roger] Univ Vic Univ Cent Catalunya, Vic, Catalonia, Spain; [Bickel, Markus] Goethe Univ, Frankfurt, Germany; [Sedlacek, Dalibor] Charles Univ Hosp, Plzen, Czech Republic; [Zilmer, Kai] West Tallinn Cent Hosp, Tallinn, Estonia; [Clotet, Bonaventura; Paredes, Roger] Hosp Badalona Germans Trias & Pujol, HIV Unit, Badalona, Catalonia, Spain; [Lundgren, Jens D.] Univ Copenhagen, Dept Infect Dis, CHIP, Rigshosp, Copenhagen, Denmark	Institut de Recerca de la Sida - IrsiCaixa; Autonomous University of Barcelona; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Goethe University Frankfurt; Charles University Prague; Hospital Germans Trias i Pujol; Rigshospitalet; University of Copenhagen	Casadella, M (corresponding author), IrsiCaixa AIDS Res Inst, Badalona, Catalonia, Spain.; Casadella, M (corresponding author), Univ Autonoma Barcelona, Catalonia, Spain.	mcasadella@irsicaixa.es	Noguera-Julian, Marc/F-8651-2016; Sedlacek, Dalibor/K-3035-2017; Sedlacek, Dalibor/P-6942-2019; Lundgren, Jens/AAE-6876-2019; Phillips, Andrew N/B-4427-2008; Casadella, Maria/L-8295-2016	Noguera-Julian, Marc/0000-0002-6194-1395; Sedlacek, Dalibor/0000-0003-4711-6679; Sedlacek, Dalibor/0000-0003-4711-6679; Phillips, Andrew N/0000-0003-2384-4807; Casadella, Maria/0000-0002-4115-2305	European Commission [CT94-1637, CT97-2713, QLK2-2000-00773, LSHP-CT-2006-018632, 260694]; Janssen RD; Merck and Co. Inc.; Pfizer Inc.; GlaxoSmithKline LLC; Swiss National Science Foundation [108787]; Redes Tematicas de Investigacion en SIDA [ISCIII RETIC RD12/0017/0002]; Accion Estrategica en Salud	European Commission(European CommissionEuropean Commission Joint Research Centre); Janssen RD; Merck and Co. Inc.(Merck & Company); Pfizer Inc.(Pfizer); GlaxoSmithKline LLC; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Redes Tematicas de Investigacion en SIDA; Accion Estrategica en Salud	Primary support for EuroSIDA was provided by the European Commission BIOMED 1 (CT94-1637), BIOMED 2 (CT97-2713), the 5th Framework (QLK2-2000-00773), the 6th Framework (LSHP-CT-2006-018632), and the 7th Framework (FP7/2007-2013, EuroCoord no 260694) programmes. Current support also includes unrestricted grants by Janssen R&D (www.janssen.com), Merck and Co. Inc. (www.merck.com), Pfizer Inc. (www.pfizer.com), GlaxoSmithKline LLC (www.gsk.com). The participation of centres from Switzerland was supported by The Swiss National Science Foundation (Grant 108787). It was also partially supported by Redes Tematicas de Investigacion en SIDA (ISCIII RETIC RD12/0017/0002); Accion Estrategica en Salud. Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica 2008-2011; Institute de Salud Carlos III, Fondos FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, HIV UK 2013 REPORT D; Briggs DR, 2000, AIDS, V14, P2937, DOI 10.1097/00002030-200012220-00016; Briz V, 2008, J ANTIMICROB CHEMOTH, V61, P405, DOI 10.1093/jac/dkm469; Brumme ZL, 2004, AIDS, V18, pF1, DOI 10.1097/00002030-200403050-00001; Buisker TR, AIDS BEHAV; Carrington M, INFLUENCE HLA GENOTY; Casadella M, 2015, AIDS, V29, P1493, DOI 10.1097/QAD.0000000000000748; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Daar ES, 2007, CLIN INFECT DIS, V45, P643, DOI 10.1086/520650; Dalmau J, 2014, AIDS, V28, P1261, DOI 10.1097/QAD.0000000000000293; Detels R, 2012, PUBLIC HEALTH, V126, P196, DOI 10.1016/j.puhe.2011.11.013; Este JA, 2007, LANCET, V370, P81, DOI 10.1016/S0140-6736(07)61052-6; Ford N, 2015, LANCET INFECT DIS, V15, P241, DOI 10.1016/S1473-3099(14)70896-5; Goetz MB, 2009, JAIDS-J ACQ IMM DEF, V50, P259, DOI 10.1097/QAI.0b013e3181989a8b; Hall HI, 2006, ANN EPIDEMIOL, V16, P824, DOI 10.1016/j.annepidem.2006.01.009; Hazenberg MD, 2003, AIDS, V17, P1419, DOI 10.1097/00002030-200307040-00001; Hunt PW, 2006, J INFECT DIS, V194, P926, DOI 10.1086/507312; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Kuniholm MH, 2011, J VIROL, V85, P10826, DOI 10.1128/JVI.00804-11; Kuritzkes DR, 2011, J INFECT DIS, V203, P146, DOI 10.1093/infdis/jiq034; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Moyle GJ, 2005, J INFECT DIS, V191, P866, DOI 10.1086/428096; Perez-Molina JA, 2012, HIV CLIN TRIALS, V13, P131, DOI 10.1310/hct1303-131; POLK BF, 1987, NEW ENGL J MED, V316, P61, DOI 10.1056/NEJM198701083160201; Porter K, 2003, LANCET, V362, P1267, DOI 10.1016/S0140-6736(03)14570-9; Pou C, 2014, CLIN INFECT DIS, V59, P578, DOI 10.1093/cid/ciu287; Pou C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067085; Saracino A, 2009, J MED VIROL, V81, P2036, DOI 10.1002/jmv.21598; Saunders P, HIV MED; Swenson LC, 2011, CLIN INFECT DIS, V53, P732, DOI 10.1093/cid/cir493; Thorsteinsson K, 2012, SCAND J INFECT DIS, V44, P766, DOI 10.3109/00365548.2012.684220; Tremblay C, 2013, CAN J INFECT DIS MED, V24, P202, DOI 10.1155/2013/982759; Waters L, 2008, CLIN INFECT DIS, V46, P1617, DOI 10.1086/587660; Weiser B, 2008, AIDS, V22, P469, DOI 10.1097/QAD.0b013e3282f4196c	34	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0166613	10.1371/journal.pone.0166613	http://dx.doi.org/10.1371/journal.pone.0166613			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129343	Green Published, Green Submitted, gold			2022-12-27	WOS:000396211400074
J	Gogoi-Tiwari, J; Williams, V; Waryah, CB; Costantino, P; Al-Salami, H; Mathavan, S; Wells, K; Tiwari, HK; Hegde, N; Isloor, S; Al-Sallami, H; Mukkur, T				Gogoi-Tiwari, Jully; Williams, Vincent; Waryah, Charlene Babra; Costantino, Paul; Al-Salami, Hani; Mathavan, Sangeetha; Wells, Kelsi; Tiwari, Harish Kumar; Hegde, Nagendra; Isloor, Shrikrishna; Al-Sallami, Hesham; Mukkur, Trilochan			Mammary Gland Pathology Subsequent to Acute Infection with Strong versus Weak Biofilm Forming Staphylococcus aureus Bovine Mastitis Isolates: A Pilot Study Using Non-Invasive Mouse Mastitis Model	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ESCHERICHIA-COLI; MOLECULAR CHARACTERIZATION; INFLAMMATORY RESPONSES; TNF-ALPHA; PATHOGENESIS; NEUTROPHIL; EXPRESSION; VIRULENCE; PROTEIN	Background Biofilm formation by Staphylococcus aureus is an important virulence attribute because of its potential to induce persistent antibiotic resistance, retard phagocytosis and either attenuate or promote inflammation, depending upon the disease syndrome, in vivo. This study was undertaken to evaluate the potential significance of strength of biofilm formation by clinical bovine mastitis-associated S. aureus in mammary tissue damage by using a mouse mastitis model. Methods Two S. aureus strains of the same capsular phenotype with different biofilm forming strengths were used to non-invasively infect mammary glands of lactating mice. Biofilm forming potential of these strains were determined by tissue culture plate method, ica typing and virulence gene profile per detection by PCR. Delivery of the infectious dose of S. aureus was directly through the teat lactiferous duct without invasive scraping of the teat surface. Both bacteriological and histological methods were used for analysis of mammary gland pathology of mice post-infection. Results Histopathological analysis of the infected mammary glands revealed that mice inoculated with the strong biofilm forming S. aureus strain produced marked acute mastitic lesions,showing profuse infiltration predominantly with neutrophils, with evidence of necrosis in the affected mammary glands. In contrast, the damage was significantly less severe in mammary glands of mice infected with the weak biofilm-forming S. aureus strain. Although both IL-1 beta and TNF-alpha inflammatory biomarkers were produced in infected mice, level of TNF-alpha produced was significantly higher (p<0.05) in mice inoculated with strong biofilm-forming S. aureus than the weak biofilm forming strain. Conclusion This finding suggests an important role of TNF-a in mammary gland pathology post-infection with strong biofilm-forming S. aureus in the acute mouse mastitis model, and offers an opportunity for the development of novel strategies for reduction of mammary tissue damage, with or without use of antimicrobials and/or anti-inflammatory compounds for the treatment of bovine mastitis.	[Gogoi-Tiwari, Jully; Williams, Vincent; Waryah, Charlene Babra; Costantino, Paul; Wells, Kelsi; Mukkur, Trilochan] Curtin Univ, Curtin Hlth Innovat Res Inst, Sch Biomed Sci, Perth, WA, Australia; [Gogoi-Tiwari, Jully] Cent Agr Univ, Coll Vet Sci & Anim Husb, Aizawl, Mizoram, India; [Waryah, Charlene Babra] Albert Einstein Coll Med, Dept Med & Cell Biol, Bronx, NY 10467 USA; [Al-Salami, Hani; Mathavan, Sangeetha] Curtin Univ, Curtin Hlth Innovat Res Inst, Sch Pharm, Perth, WA, Australia; [Tiwari, Harish Kumar] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Hegde, Nagendra] Ella Fdn, Hyderabad, Andhra Pradesh, India; [Isloor, Shrikrishna] Karnataka Vet, Anim & Fisheries Sci Univ, Vet Coll, Bangalore, Karnataka, India; [Al-Sallami, Hesham] Univ Otago, Sch Pharm, Dunedin, New Zealand	Curtin University; Yeshiva University; Albert Einstein College of Medicine; Curtin University; Murdoch University; West Bengal University of Animal & Fishery Sciences; University of Otago	Mukkur, T (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Sch Biomed Sci, Perth, WA, Australia.	tk_mukkur@hotmail.com	Al-Sallami, Hesham S/AAB-1671-2019; Hegde, Nagendra R/H-3132-2019; Al-Salami, Hani/C-3766-2019; Tiwari, Harish/AAU-9372-2021	Al-Sallami, Hesham S/0000-0002-0685-327X; Hegde, Nagendra R/0000-0001-5260-2159; Al-Salami, Hani/0000-0003-0049-6969; Tiwari, Harish/0000-0002-6950-8422; Tiwari, Harish/0000-0002-2911-9895; Waryah, Charlene/0000-0002-1295-320X	Department of Innovation, Industry, Science and Research, Commonwealth Government of Australia [BF040038]; Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/Indo-Aus./04/06/2009]; Curtin University; Australian Postgraduate Award	Department of Innovation, Industry, Science and Research, Commonwealth Government of Australia; Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Curtin University; Australian Postgraduate Award(Australian Government)	This work was supported by grants through the Australia India Strategic Research Fund [BF040038] from the Department of Innovation, Industry, Science and Research, Commonwealth Government of Australia (to TM), and the India-Australia Biotechnology Fund [BT/Indo-Aus./04/06/2009] from the Department of Biotechnology, Ministry of Science and Technology, Government of India (to NH). Thanks are also due to Curtin University for providing the International Postgraduate Research Scholarship and the Australian Postgraduate Award to JG-T in support of her doctoral studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript"	ANDERSON JC, 1975, J COMP PATHOL, V85, P499, DOI 10.1016/0021-9975(75)90117-6; Archer NK, 2011, VIRULENCE, V2, P445, DOI 10.4161/viru.2.5.17724; Babra C, 2014, J BASIC MICROB, V54, P721, DOI 10.1002/jobm.201200557; Babra C, 2013, FOLIA MICROBIOL, V58, P469, DOI 10.1007/s12223-013-0232-z; Bannerman DD, 2009, J ANIM SCI, V87, P10, DOI 10.2527/jas.2008-1187; Bannerman DD, 2004, CLIN DIAGN LAB IMMUN, V11, P463, DOI 10.1128/CDLI.11.3.463-472.2004; BASELGA R, 1993, INFECT IMMUN, V61, P4857, DOI 10.1128/IAI.61.11.4857-4862.1993; Bjarnsholt T, 2013, APMIS, V121, P1, DOI 10.1111/apm.12099; Blum JW, 2000, DOMEST ANIM ENDOCRIN, V19, P223, DOI 10.1016/S0739-7240(00)00079-5; Boonyayatra S., 2014, International Journal of Dairy Science, V9, P89, DOI 10.3923/ijds.2014.89.95; Boulanger V, 2002, J DAIRY SCI, V85, P562, DOI 10.3168/jds.S0022-0302(02)74109-X; Breyne K, 2015, J DAIRY SCI, V98, P1090, DOI 10.3168/jds.2014-8699; Brouillette E, 2005, MICROBES INFECT, V7, P560, DOI 10.1016/j.micinf.2004.11.008; Brouillette E, 2004, VET MICROBIOL, V101, P253, DOI 10.1016/j.vetmic.2004.04.008; Burow ME, 1999, CARCINOGENESIS, V20, P2057, DOI 10.1093/carcin/20.11.2057; Caiazza NC, 2003, J BACTERIOL, V185, P3214, DOI 10.1128/JB.185.10.3214-3217.2003; Cantero D, 2013, INT FORUM ALLERGY RH, V3, P556, DOI 10.1002/alr.21146; CHANDLER RL, 1973, J COMP PATHOL, V83, P233, DOI 10.1016/0021-9975(73)90047-9; CHANDLER RL, 1970, J MED MICROBIOL, V3, P273, DOI 10.1099/00222615-3-2-273; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Cucarella C, 2004, INFECT IMMUN, V72, P2177, DOI 10.1128/IAI.72.4.2177-2185.2004; Cucarella C, 2002, INFECT IMMUN, V70, P3180, DOI 10.1128/IAI.70.6.3180-3186.2002; Di Meglio P, 2011, IMMUNITY, V35, P857, DOI 10.1016/j.immuni.2011.12.003; Fitzpatrick F, 2005, CLIN MICROBIOL INFEC, V11, P967, DOI 10.1111/j.1469-0691.2005.01274.x; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; FOURNIER JM, 1984, INFECT IMMUN, V45, P87, DOI 10.1128/IAI.45.1.87-93.1984; FROST AJ, 1980, PROC R SOC SER B-BIO, V209, P431, DOI 10.1098/rspb.1980.0104; Gamble M., 2008, THEORY PRACTICE HIST, V6th, P121, DOI DOI 10.1016/B978-0-443-10279-0.50016-6; Gogoi-Tiwari J, 2015, Aust Vet J, V93, P278, DOI 10.1111/avj.12349; Gogoi-Tiwari J, 2015, BIOFOULING, V31, P543, DOI 10.1080/08927014.2015.1074681; Gogoi-Tiwari J, 2015, VIRULENCE, V6, P419, DOI 10.1080/21505594.2015.1043508; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Hanke ML, 2013, J IMMUNOL, V190, P2159, DOI 10.4049/jimmunol.1202348; Hanke ML, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00062; HEALD CW, 1979, AM J VET RES, V40, P1294; Huseby MJ, 2010, P NATL ACAD SCI USA, V107, P14407, DOI 10.1073/pnas.0911032107; Kauf ACW, 2007, RES VET SCI, V82, P39, DOI 10.1016/j.rvsc.2006.05.006; Kogan G, 2006, FEMS MICROBIOL LETT, V255, P11, DOI 10.1111/j.1574-6968.2005.00043.x; Kornalijnslijper JE, 2004, VET MICROBIOL, V101, P177, DOI 10.1016/j.vetmic.2004.04.005; Kropec A, 2005, INFECT IMMUN, V73, P6868, DOI 10.1128/IAI.73.10.6868-6876.2005; Kuroishi T, 2003, CLIN DIAGN LAB IMMUN, V10, P1011, DOI 10.1128/CDLI.10.6.1011-1018.2003; Lee SHI, 2014, J DAIRY SCI, V97, P1812, DOI 10.3168/jds.2013-7387; Leitner G, 2000, J VET MED B, V47, P581, DOI 10.1046/j.1439-0450.2000.00388.x; Lin MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034388; Liu HL, 2015, BRAZ J INFECT DIS, V19, P498, DOI 10.1016/j.bjid.2015.07.003; Lone AG, 2015, INFECT IMMUN, V83, P2531, DOI 10.1128/IAI.03075-14; Mathur T, 2006, Indian J Med Microbiol, V24, P25; MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x; Merino N, 2009, J BACTERIOL, V191, P832, DOI 10.1128/JB.01222-08; Messner UK, 1999, KIDNEY INT, V55, P2322, DOI 10.1046/j.1523-1755.1999.00473.x; Middleton JR, 2013, NMC 52 REG M P SAN D, P1; Moore PCL, 2001, J CLIN MICROBIOL, V39, P2760, DOI 10.1128/JCM.39.8.2760-2767.2001; Nakajima Y, 1997, RES VET SCI, V62, P297, DOI 10.1016/S0034-5288(97)90209-5; Nazemi S, 2014, J DAIRY RES, V81, P445, DOI 10.1017/S0022029914000454; NICKERSON SC, 1981, AM J VET RES, V42, P1351; Notebaert S, 2006, VET QUART, V28, P2, DOI 10.1080/01652176.2006.9695201; O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; OLLETT WS, 1947, J PATHOL BACTERIOL, V59, P357; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Otto M, 2013, ANNU REV MED, V64, P175, DOI 10.1146/annurev-med-042711-140023; Paape M, 2002, J MAMMARY GLAND BIOL, V7, P109, DOI 10.1023/A:1020343717817; Paape MJ, 2003, VET RES, V34, P597, DOI 10.1051/vetres:2003024; PATTI JM, 1992, J BIOL CHEM, V267, P4766; Pereira UP, 2011, VET MICROBIOL, V148, P117, DOI 10.1016/j.vetmic.2010.10.003; Periasamy S, 2012, P NATL ACAD SCI USA, V109, P1281, DOI 10.1073/pnas.1115006109; PERSSON K, 1993, VET IMMUNOL IMMUNOP, V37, P99, DOI 10.1016/0165-2427(93)90058-C; Petersson-Wolfe C MI, 2010, VCES, V404, P229; Peton V, 2014, VET RES, V45, DOI 10.1186/s13567-014-0106-7; Prabhakara R, 2011, INFECT IMMUN, V79, P1789, DOI 10.1128/IAI.01386-10; PRASAD LBM, 1968, CANADIAN VET J, V9, P170; Prenafeta A, 2010, VET IMMUNOL IMMUNOP, V134, P208, DOI 10.1016/j.vetimm.2009.09.020; Ramakrishnan Y, 2015, J LARYNGOL OTOL, P1; SANCHEZ MS, 1994, J DAIRY SCI, V77, P1259, DOI 10.3168/jds.S0022-0302(94)77065-X; Shemesh M, 2007, MICROBIOL-SGM, V153, P1307, DOI 10.1099/mic.0.2006/002030-0; Skipper R, 1989, J HISTOTECHNOL, V4, P303; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Tankersley A, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-17; Thurlow LR, 2011, J IMMUNOL, V186, P6585, DOI 10.4049/jimmunol.1002794; Tiwari J. G., 2013, Journal of Vaccines and Vaccination, V4, P1000176; Tung HS, 2000, BIOCHEM J, V345, P611, DOI 10.1042/0264-6021:3450611; Valle J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002843; Vasudevan P, 2003, VET MICROBIOL, V92, P179, DOI 10.1016/S0378-1135(02)00360-7; Verdier I, 2007, J CLIN MICROBIOL, V45, P725, DOI 10.1128/JCM.01572-06; Vieira SM, 2009, BRIT J PHARMACOL, V158, P779, DOI 10.1111/j.1476-5381.2009.00367.x; Waryah CB, 2014, J MED MICROBIOL, V63, P1427, DOI [10.1099/jmm.0.77024-0, 10.1099/jmm.0.077024-0]; Waryah CB, 2016, FOLIA MICROBIOL, V61, P473, DOI 10.1007/s12223-016-0459-6; Zecconi A, 2013, IMMUNOL LETT, V150, P12, DOI 10.1016/j.imlet.2013.01.004; Zhao G, 2013, ADV WOUND CARE, V2, P389, DOI 10.1089/wound.2012.0381; Zhao X, 2008, J ANIM SCI, V86, P57, DOI 10.2527/jas.2007-0302	91	21	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170668	10.1371/journal.pone.0170668	http://dx.doi.org/10.1371/journal.pone.0170668			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129375	Green Published, gold, Green Submitted			2022-12-27	WOS:000396211400048
J	Pan, X; Ping, YM; Cui, LJ; Li, W; Zhang, XD; Zhou, J; Yu, FH; Prinzing, A				Pan, Xu; Ping, Yunmei; Cui, Lijuan; Li, Wei; Zhang, Xiaodong; Zhou, Jian; Yu, Fei-Hai; Prinzing, Andreas			Plant Litter Submergence Affects the Water Quality of a Constructed Wetland	PLOS ONE			English	Article							DOMESTIC WASTE-WATER; LEAF-LITTER; DECOMPOSITION; PERFORMANCE; MACROPHYTES; NUTRIENTS; REMOVAL; BIOMASS	Plant litter is an indispensable component of constructed wetlands, but how the submergence of plant litter affects their ecosystem functions and services, such as water purification, is still unclear. Moreover, it is also unclear whether the effects of plant litter submergence depend on other factors such as the duration of litter submergence, water source or litter species identity. Here we conducted a greenhouse experiment by submerging the litter of 7 wetland plant species into three types of water substrates and monitoring changes in water nutrient concentrations. Litter submergence affected water quality positively via decreasing the concentration of nitrate nitrogen and negatively via increasing the concentrations of total nitrogen, ammonium nitrogen and total phosphorus. The effects of litter submergence depended on the duration of litter submergence, the water source, the litter species identity, and the plant life form. Different plant species had different effects on the water nutrient concentrations during litter submergence, and the effects of floating plants might be more negative than that of emergent plants. These results are novel evidence of how the submergence of different plant (life form) litter may affect the purification function of constructed wetlands. For water at low eutrophication levels, submerging a relative small amount of plant litter might improve water quality, via benefiting the denitrification process in water. These findings emphasized the management of floating plant litter (a potential removal) during the maintenance of human-controlled wetland ecosystems and provided a potential tool to improve the water quality of constructed wetlands via submerging plant litter of different types.	[Pan, Xu; Ping, Yunmei; Cui, Lijuan; Li, Wei; Zhang, Xiaodong; Zhou, Jian] Chinese Acad Forestry, Inst Wetland Res, Beijing, Peoples R China; [Pan, Xu; Ping, Yunmei; Cui, Lijuan; Li, Wei; Zhang, Xiaodong; Zhou, Jian] Beijing Key Lab Wetland Serv & Restorat, Beijing, Peoples R China; [Pan, Xu; Ping, Yunmei; Cui, Lijuan; Li, Wei; Zhang, Xiaodong; Zhou, Jian] Beijing Hanshiqiao Natl Wetland Ecosyst Res Stn, Beijing, Peoples R China; [Yu, Fei-Hai] Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China; [Prinzing, Andreas] Univ Rennes 1, CNRS, Campus Beaulieu,Batiment 14 A, Rennes, France	Chinese Academy of Forestry; Institute of Wetland Research, CAF; Chinese Academy of Forestry; Institute of Wetland Research, CAF; Beijing Forestry University; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Cui, LJ (corresponding author), Chinese Acad Forestry, Inst Wetland Res, Beijing, Peoples R China.; Cui, LJ (corresponding author), Beijing Key Lab Wetland Serv & Restorat, Beijing, Peoples R China.; Cui, LJ (corresponding author), Beijing Hanshiqiao Natl Wetland Ecosyst Res Stn, Beijing, Peoples R China.	lkyclj@126.com	Yu, Fei-Hai/O-9395-2016; Pan, Xu/W-1607-2017	Yu, Fei-Hai/0000-0001-5007-1745; Pan, Xu/0000-0003-3733-1981	Forestry Nonprofit Industry Scientific Research Special Project "The research of ecosystem service and evaluation techniques of coastal wetlands, China" [201404305]; Fundamental Research Funds for the Central Non-profit Research Institute of CAF [CAFYBB2014QB025]; China Postdoctoral Science Foundation [2015M571161]; National Natural Science Foundation of China [31300400]	Forestry Nonprofit Industry Scientific Research Special Project "The research of ecosystem service and evaluation techniques of coastal wetlands, China"; Fundamental Research Funds for the Central Non-profit Research Institute of CAF; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the Forestry Nonprofit Industry Scientific Research Special Project "The research of ecosystem service and evaluation techniques of coastal wetlands, China" (No.201404305), Fundamental Research Funds for the Central Non-profit Research Institute of CAF (CAFYBB2014QB025), China Postdoctoral Science Foundation (2015M571161) and National Natural Science Foundation of China (31300400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 1997, ECOLOGY, V78, P244, DOI 10.1890/0012-9658(1997)078[0244:NAPMCO]2.0.CO;2; Aerts R, 1996, J ECOL, V84, P597, DOI 10.2307/2261481; Bachand PAM, 2000, ECOL ENG, V14, P17; Bojcevska H, 2007, ECOL ENG, V29, P66, DOI 10.1016/j.ecoleng.2006.07.015; Brix H, 1997, WATER SCI TECHNOL, V35, P11, DOI 10.1016/S0273-1223(97)00047-4; Calheiros CSC, 2009, ECOL ENG, V35, P744, DOI 10.1016/j.ecoleng.2008.11.010; Chen Y, 2015, ECOL ENG, V84, P38, DOI 10.1016/j.ecoleng.2015.07.013; Chen Y, 2014, BIORESOURCE TECHNOL, V157, P341, DOI 10.1016/j.biortech.2014.01.137; Cornelissen JHC, 1997, NEW PHYTOL, V135, P109, DOI 10.1046/j.1469-8137.1997.00628.x; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Gaudet CL, 1988, COMP APPROACH PREDIC; Gottschall N, 2007, ECOL ENG, V29, P154, DOI 10.1016/j.ecoleng.2006.06.004; Gulis V, 2004, FRESHWATER BIOL, V49, P1437, DOI 10.1111/j.1365-2427.2004.01281.x; Guntenspergen GR, 1985, 7912516 NSF DEB, V791, P2516; Hobbie SE, 2014, URBAN ECOSYST, V17, P369, DOI 10.1007/s11252-013-0329-9; Huang Q, 2016, ENVIRON SCI POLLUT R, P1; IWA, 2001, CONSTR WETL POLL CON; JOHNSTON CA, 1991, CRIT REV ENV CONTR, V21, P491, DOI 10.1080/10643389109388425; Keddy P, 1998, J VEG SCI, V9, P777, DOI 10.2307/3237043; Killingbeck KT, 1996, ECOLOGY, V77, P1716, DOI 10.2307/2265777; Nurk K, 2005, J ENVIRON SCI HEAL A, V40, P1201, DOI 10.1081/ESE-200055659; Pan XF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123291; Park JBK, 2008, BIORESOURCE TECHNOL, V99, P2711, DOI 10.1016/j.biortech.2007.07.009; Srivastava Jatin, 2008, Reviews in Environmental Science and Bio/Technology, V7, P255, DOI 10.1007/s11157-008-9135-x; Tanner CC, 1996, ECOL ENG, V7, P59, DOI 10.1016/0925-8574(95)00066-6; Tanner CC, 2002, ECOL ENG, V18, P499, DOI 10.1016/S0925-8574(02)00011-3; TIAN G, 1992, SOIL BIOL BIOCHEM, V24, P1051, DOI 10.1016/0038-0717(92)90035-V; Verhoeven JTA, 2006, TRENDS ECOL EVOL, V21, P96, DOI 10.1016/j.tree.2005.11.015; Vymazal J, 2013, ECOL ENG, V61, P582, DOI 10.1016/j.ecoleng.2013.06.023; Vymazal J, 2011, HYDROBIOLOGIA, V674, P133, DOI 10.1007/s10750-011-0738-9; Wardle DA, 2002, FUNCT ECOL, V16, P585, DOI 10.1046/j.1365-2435.2002.00659.x; Yang Q, 2007, J INTEGR PLANT BIOL, V49, P437, DOI 10.1111/j.1744-7909.2007.00389.x; Zhang Y, 2014, WETL ECOL MANAG, V22, P493, DOI 10.1007/s11273-014-9347-5	33	9	11	5	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0171019	10.1371/journal.pone.0171019	http://dx.doi.org/10.1371/journal.pone.0171019			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129405	gold, Green Submitted, Green Published			2022-12-27	WOS:000396211400012
J	Borsuk, G; Ptaszynska, AA; Olszewski, K; Domaciuk, M; Krutmuang, P; Paleolog, J				Borsuk, Grzegorz; Ptaszynska, Aneta A.; Olszewski, Krzysztof; Domaciuk, Marcin; Krutmuang, Patcharin; Paleolog, Jerzy			A New Method for Quick and Easy Hemolymph Collection from Apidae Adults	PLOS ONE			English	Article							APIS-MELLIFERA; HONEYBEE HEMOLYMPH; BEES	Bio-analysis of insects is increasingly dependent on highly sensitive methods that require high quality biological material, such as hemolymph. However, it is difficult to collect fresh and uncontaminated hemolymph from adult bees since they are very active and have the potential to sting, and because hemolymph is rapidly melanized. Here we aimed to develop and test a quick and easy method for sterile and contamination-free hemolymph sampling from adult Apidae. Our novel antennae method for hemolymph sampling (AMHS), entailed the detachment of an antenna, followed by application of delicate pressure to the bee's abdomen. This resulted in the appearance of a drop of hemolymph at the base of the detached antenna, which was then aspirated using an automatic pipetter. Larger insect size corresponded to easier and faster hemolymph sampling, and to a greater sample volume. We obtained 80-100 mu L of sterile non-melanized hemolymph in 1 minute from one Bombus terrestris worker, in 6 minutes from 10 Apis mellifera workers, and in 15 minutes from 18 Apis cerana workers (+/-0.5 minutes). Compared to the most popular method of hemolymph collection, in which hemolymph is sampled by puncturing the dorsal sinus of the thorax with a capillary (TCHS), significantly fewer bees were required to collect 80-100 mu L hemolymph using our novel AMHS method. Moreover, the time required for hemolymph collection was significantly shorter using the AMHS compared to the TCHS, which protects the acquired hemolymph against melanization, thus providing the highest quality material for biological analysis.	[Borsuk, Grzegorz; Olszewski, Krzysztof] Univ Life Sci, Dept Biol Basis Anim Prod, Fac Biol Anim Sci & Bioecon, Lublin, Poland; [Ptaszynska, Aneta A.] Maria Curie Skfodowska Univ, Inst Biol & Biochem, Fac Biol & Biotechnol, Dept Bot & Mycol, Lublin, Poland; [Domaciuk, Marcin] Maria Curie Skfodowska Univ, Inst Biol & Biochem, Fac Biol & Biotechnol, Dept Plant Anat & Cytol, Lublin, Poland; [Krutmuang, Patcharin] Chang Mai Univ, Dept Entomol & Plant Pathol, Fac Agr, Chiang Mai, Thailand; [Paleolog, Jerzy] Univ Life Sci Lublin, Dept Zool Anim Ecol Wildlife Management, Fac Biol Anim Sci & Bioecon, Lublin, Poland	University of Life Sciences in Lublin	Borsuk, G (corresponding author), Univ Life Sci, Dept Biol Basis Anim Prod, Fac Biol Anim Sci & Bioecon, Lublin, Poland.	grzegorz.borsuk@up.lublin.pl	Krutmuang, Patcharin/AAN-9038-2021; Paleolog, Jerzy/U-5290-2018; Borsuk, Grzegorz/AAD-3268-2021; Ptaszynska, Aneta/AAG-7172-2021; Olszewski, Krzysztof/U-5281-2018	Krutmuang, Patcharin/0000-0003-3521-7659; Paleolog, Jerzy/0000-0002-4447-4318; Borsuk, Grzegorz/0000-0002-8407-3383; Ptaszynska, Aneta/0000-0001-6413-6028; Olszewski, Krzysztof/0000-0002-4968-4621	Ministry of Science and Higher Education [DS-2]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by the Ministry of Science and Higher Education under DS-2.	Antunez K, 2009, ENVIRON MICROBIOL, V11, P2284, DOI 10.1111/j.1462-2920.2009.01953.x; Borsuk G, 2011, J APIC SCI, V55, P53; Chan QWT, 2006, MOL CELL PROTEOMICS, V5, P2252, DOI 10.1074/mcp.M600197-MCP200; Dade HA, 2009, ANATOMY DISSECTION H, P70; Franco NH, 2014, LAB ANIM-UK, V48, P50, DOI 10.1177/0023677213498717; Garido MP, 2013, J APICULT RES, V52, P67; Kobmoo N., 2012, RES GATE, V8, P19; KOSTECKI R., 1965, J APICULT RES, V4, P49; Laughton AM, 2011, APIDOLOGIE, V42, P140, DOI 10.1051/apido/2010046; Mayack C, 2010, J INSECT PHYSIOL, V56, P1572, DOI 10.1016/j.jinsphys.2010.05.016; Mikulecky M, 1997, BRAZ J MED BIOL RES, V30, P275, DOI 10.1590/S0100-879X1997000200018; Ptaszynska AA, 2016, MED WETER, V72, P430, DOI 10.21521/mw.5534; Ptaszynska AA, 2016, PARASITOL RES, V115, P397, DOI 10.1007/s00436-015-4761-z; [Страческа А. Strachecka A.], 2014, [Биохимия, BIOCHEMISTRY (MOSCOW), Biokhimiya], V79, P1464; Strachecka A, 2014, ARCH INSECT BIOCHEM, V86, P165, DOI 10.1002/arch.21159; Szymas B, 2003, APIDOLOGIE, V34, P97, DOI 10.1051/apido:2003012	16	21	22	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170487	10.1371/journal.pone.0170487	http://dx.doi.org/10.1371/journal.pone.0170487			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125668	Green Published, gold, Green Submitted			2022-12-27	WOS:000396176100103
J	Chebaro, Y; Sirigu, S; Amal, I; Lutzing, R; Stote, RH; Rochette-Egly, C; Rochel, N; Dejaegere, A				Chebaro, Yassmine; Sirigu, Serena; Amal, Ismail; Lutzing, Regis; Stote, Roland H.; Rochette-Egly, Cecile; Rochel, Natacha; Dejaegere, Annick			Allosteric Regulation in the Ligand Binding Domain of Retinoic Acid Receptor gamma	PLOS ONE			English	Article							NUCLEAR RECEPTORS; MOLECULAR-DYNAMICS; STEM-CELLS; RAR-ALPHA; NEURONAL DIFFERENTIATION; HETERODIMERIC COMPLEX; SIGNALING PATHWAYS; CRYSTAL-STRUCTURE; PHOSPHORYLATION; PROTEINS	Retinoic acid (RA) plays key roles in cell differentiation and growth arrest through nuclear retinoic acid receptors (RARs), which are ligand-dependent transcription factors. While the main trigger of RAR activation is the binding of RA, phosphorylation of the receptors has also emerged as an important regulatory signal. Phosphorylation of the RAR. N-terminal domain (NTD) is known to play a functional role in neuronal differentiation. In this work, we investigated the phosphorylation of RAR. ligand binding domain (LBD), and present evidence that the phosphorylation status of the LBD affects the phosphorylation of the NTD region. We solved the X-ray structure of a phospho-mimetic mutant of the LBD (RAR. S371E), which we used in molecular dynamics simulations to characterize the consequences of the S371E mutation on the RAR. structural dynamics. Combined with simulations of the wild-type LBD, we show that the conformational equilibria of LBD salt bridges (notably R387-D340) are affected by the S371E mutation, which likely affects the recruitment of the kinase complex that phosphorylates the NTD. The molecular dynamics simulations also showed that a conservative mutation in this salt bridge (R387K) affects the dynamics of the LBD without inducing large conformational changes. Finally, cellular assays showed that the phosphorylation of the NTD of RAR. is differentially regulated by retinoic acid in RAR.WT and in the S371N, S371E and R387K mutants. This multidisciplinary work highlights an allosteric coupling between phosphorylations of the LBD and the NTD of RAR. and supports the importance of structural dynamics involving electrostatic interactions in the regulation of RARs activity.	[Chebaro, Yassmine; Sirigu, Serena; Amal, Ismail; Stote, Roland H.; Rochel, Natacha; Dejaegere, Annick] Univ Strasbourg, CNRS, Dept Integrat Struct Biol, IGBMC,INSERM,U964,UMR 7104, Illkirch Graffenstaden, France; [Lutzing, Regis; Rochette-Egly, Cecile] Univ Strasbourg, CNRS, Dept Funct Genom & Canc, IGBMC,INSERM,U964,UMR 7104, Illkirch Graffenstaden, France; [Sirigu, Serena] Synchrotron SOLEIL, LOrme Merisiers, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; SOLEIL Synchrotron	Dejaegere, A (corresponding author), Univ Strasbourg, CNRS, Dept Integrat Struct Biol, IGBMC,INSERM,U964,UMR 7104, Illkirch Graffenstaden, France.	annick@igbmc.fr	Chebaro, Yassmine/M-2174-2019; Rochel, Natacha/A-5718-2016	Chebaro, Yassmine/0000-0002-5970-2117; Rochel, Natacha/0000-0002-3573-5889; Regis, Lutzing/0000-0002-9927-1825	Centre National de Recherche Scientifique (CNRS), Institut National de la Sante et de la Recherche Medicale (INSERM), Universite de Strasbourg, Agence Nationale pour la Recherche [ANR-09-BLAN-0127-01]; Institut National du Cancer [INCa-PL09-194]; Instruct, part of the European Strategy Forum on Research Infrastructures (ESFRI); French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; French State fund [ANR-10-IDEX-0002-02]; project EQUIP@MESO;  [ANR-10-MABX-0030-INRT]	Centre National de Recherche Scientifique (CNRS), Institut National de la Sante et de la Recherche Medicale (INSERM), Universite de Strasbourg, Agence Nationale pour la Recherche(French National Research Agency (ANR)); Institut National du Cancer(Institut National du Cancer (INCA) France); Instruct, part of the European Strategy Forum on Research Infrastructures (ESFRI); French Infrastructure for Integrated Structural Biology (FRISBI); French State fund; project EQUIP@MESO; 	This work was supported by funds from the Centre National de Recherche Scientifique (CNRS), Institut National de la Sante et de la Recherche Medicale (INSERM), Universite de Strasbourg, Agence Nationale pour la Recherche (ANR-09-BLAN-0127-01) and the Institut National du Cancer (INCa-PL09-194), Instruct, part of the European Strategy Forum on Research Infrastructures (ESFRI) and supported by national member subscriptions, the French Infrastructure for Integrated Structural Biology (FRISBI) (Grant ANR-10-INSB-05-01). This study was also supported by the grant ANR-10-MABX-0030-INRT, a French State fund managed by the Agence Nationale de la Recherche under the frame program Investissements d'Avenir ANR-10-IDEX-0002-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Yoshiteru Sato and the beam-line staff at the ESRF (Grenoble, France) for help during data collection. Computing resources were provided by the Institut du Developpement et des Ressources en Informatique Scientifique (IDRIS), the Centre Informatique National de l'Enseignement Superieur (CINES) and the Meso-centre de Calcul de l'Universite de Strasbourg supported by the project EQUIP@MESO.	Al Tanoury Z, 2014, J CELL SCI, V127, P2095, DOI 10.1242/jcs.145979; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Bastien J, 2000, J BIOL CHEM, V275, P21896, DOI 10.1074/jbc.M001985200; Billas I, 2013, J MOL BIOL, V425, P2317, DOI 10.1016/j.jmb.2013.03.017; Bour G, 2005, P NATL ACAD SCI USA, V102, P16608, DOI 10.1073/pnas.0505556102; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; Brelivet Y, 2004, EMBO REP, V5, P423, DOI 10.1038/sj.embor.7400119; Brelivet Y, 2012, MOL CELL ENDOCRINOL, V348, P466, DOI 10.1016/j.mce.2011.08.015; Brooks BR, 2009, J COMPUT CHEM, V26, P1781; Bruck N, 2009, EMBO J, V28, P34, DOI 10.1038/emboj.2008.256; BRUNGER AT, 1988, PROTEINS, V4, P148, DOI 10.1002/prot.340040208; Burendahl S, 2012, PROTEINS, V80, P294, DOI 10.1002/prot.23209; Chebaro Y, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003012; Choi JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7968; CHOTHIA C, 1981, J MOL BIOL, V145, P215, DOI 10.1016/0022-2836(81)90341-7; Cunningham TJ, 2015, NAT REV MOL CELL BIO, V16, P110, DOI 10.1038/nrm3932; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Das BC, 2014, BIOORGAN MED CHEM, V22, P673, DOI 10.1016/j.bmc.2013.11.025; De Simone A, 2015, ELIFE, V4, DOI 10.7554/eLife.02777; Delacroix L, 2010, MOL CELL BIOL, V30, P231, DOI 10.1128/MCB.00756-09; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gaillard E, 2006, P NATL ACAD SCI USA, V103, P9548, DOI 10.1073/pnas.0509717103; Germain P, 2002, NATURE, V415, P187, DOI 10.1038/415187a; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Glass CK, 2000, GENE DEV, V14, P121; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Grosdidier S, 2012, MOL ENDOCRINOL, V26, P1078, DOI 10.1210/me.2011-1281; Hua SJ, 2009, CELL, V137, P1259, DOI 10.1016/j.cell.2009.04.043; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Janesick A, 2015, CELL MOL LIFE SCI, V72, P1559, DOI 10.1007/s00018-014-1815-9; Klaholz BP, 2000, ACTA CRYSTALLOGR D, V56, P933, DOI 10.1107/S090744490000634X; Klaholz BP, 1998, NAT STRUCT BIOL, V5, P199, DOI 10.1038/nsb0398-199; Lalevee S, 2010, FASEB J, V24, P4523, DOI 10.1096/fj.10-160572; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laudet V, 2002, THE NUCLEAR RECEPTOR; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mackinnon JAG, 2014, MOL CELL ENDOCRINOL, V393, P75, DOI 10.1016/j.mce.2014.05.017; Masunov A, 2003, J AM CHEM SOC, V125, P1722, DOI 10.1021/ja025521w; Mendoza-Parra MA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.73; Michielssens S, 2014, ANGEW CHEM INT EDIT, V53, P10367, DOI 10.1002/anie.201403102; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagy L, 1999, GENE DEV, V13, P3209, DOI 10.1101/gad.13.24.3209; Navaza J., 1994, ACTA CRYST; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pogenberg V, 2004, ACTA CRYSTALLOGR D, V60, P1170, DOI 10.1107/S0907444904009928; Rassam P, 2015, NATURE, V523, P333, DOI 10.1038/nature14461; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Rochette-Egly C, 2003, CELL SIGNAL, V15, P355, DOI 10.1016/S0898-6568(02)00115-8; Rochette-Egly C, 2015, BBA-MOL CELL BIOL L, V1851, P66, DOI 10.1016/j.bbalip.2014.04.003; Rochette-Egly Cecile, 2009, Nucl Recept Signal, V7, pe005, DOI 10.1621/nrs.07005; RochetteEgly C, 1997, CELL, V90, P97, DOI 10.1016/S0092-8674(00)80317-7; Rostkowski M, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-6; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Samarut E, 2012, MOL CELL ENDOCRINOL, V348, P348, DOI 10.1016/j.mce.2011.03.025; Samarut E, 2011, MOL BIOL EVOL, V28, P2125, DOI 10.1093/molbev/msr035; Sato Y, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012674, 10.1371/journal.pone.0015119, 10.1371/journal.pone.0013109]; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Su D, 2008, BIOCHEM PHARMACOL, V75, P1129, DOI 10.1016/j.bcp.2007.11.006; Tzeng SR, 2013, NAT CHEM BIOL, V9, P462, DOI [10.1038/NCHEMBIO.1250, 10.1038/nchembio.1250]; van Wijk SJL, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002754; WIGLEY DB, 1987, BIOCHEM BIOPH RES CO, V149, P927, DOI 10.1016/0006-291X(87)90497-9; Zhu Y, 2014, INTERNATIONAL CONFERENCE ON ENERGY AND POWER ENGINEERING (EPE 2014), P1	65	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0171043	10.1371/journal.pone.0171043	http://dx.doi.org/10.1371/journal.pone.0171043			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125680	Green Published, Green Submitted, gold			2022-12-27	WOS:000396176100009
J	Frouws, MA; Reimers, MS; Swets, M; Bastiaannet, E; Prinse, B; van Eijk, R; Lemmens, VEPP; van Herk-Sukel, MPP; van Wezel, T; Kuppen, PJK; Morreau, H; van de Velde, CJH; Liefers, GJ				Frouws, Martine A.; Reimers, Marlies S.; Swets, Marloes; Bastiaannet, Esther; Prinse, Bianca; van Eijk, Ronald; Lemmens, Valery E. P. P.; van Herk-Sukel, Myrthe P. P.; van Wezel, Tom; Kuppen, Peter J. K.; Morreau, Hans; van de Velde, Cornelis J. H.; Liefers, Gerrit-Jan			The Influence of BRAF and KRAS Mutation Status on the Association between Aspirin Use and Survival after Colon Cancer Diagnosis	PLOS ONE			English	Article							COLORECTAL-CANCER; RANDOMIZED-TRIALS; LYNCH SYNDROME; THERAPY; RISK; METAANALYSIS; METASTASIS; SUBTYPES; MAPK	Background Use of aspirin after diagnosis of colon cancer has been associated with improved survival. Identification of cancer subtypes that respond to aspirin treatment may help develop personalized treatment regimens. The aim of this study was to investigate the influence of BRAF and KRAS mutation status on the association between aspirin use and overall survival after colon cancer diagnosis. Methods A random selection of 599 patients with colon cancer were analyzed, selected from the Eindhoven Cancer Registry, and BRAF and KRAS mutation status was determined. Data on aspirin use (80 mg) were obtained from the PHARMO Database Network. Parametric survival models with exponential (Poisson) distribution were used. Results Aspirin use after colon cancer diagnosis was associated with improved overall survival in wild-type BRAF tumors, adjusted rate ratio (RR) of 0.60 (95% CI 0.44-0.83). In contrast, aspirin use in BRAF mutated tumors was not associated with an improved survival (RR 1.11, 95% CI 0.57-2.16). P-value for interaction was non-significant. KRAS mutational status did not differentiate in the association between aspirin use and survival. Conclusion Low-dose aspirin use after colon cancer diagnosis was associated with improved survival in BRAF wild-type tumors only. However, the large confidence interval of the rate ratio for the use of aspirin in patients with BRAF mutation does not rule out a possible benefit. These results preclude BRAF and KRAS mutation status to be used as a marker for individualized treatment with aspirin, if aspirin becomes regular adjuvant treatment for colon cancer patients in the future.	[Frouws, Martine A.; Reimers, Marlies S.; Swets, Marloes; Bastiaannet, Esther; Prinse, Bianca; Kuppen, Peter J. K.; van de Velde, Cornelis J. H.; Liefers, Gerrit-Jan] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands; [van Eijk, Ronald; van Wezel, Tom; Morreau, Hans] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [Lemmens, Valery E. P. P.] Comprehens Canc Org Netherlands, Eindhoven, Netherlands; [Lemmens, Valery E. P. P.] Erasmus MC Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [van Herk-Sukel, Myrthe P. P.] PHARMO Inst Drug Outcomes Res, Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC	Liefers, GJ (corresponding author), Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands.	v.lemmens@iknl.nl; myrthe.van.herk@pharmo.nl; g.j.liefers@lumc.nl	Kuppen, Peter/J-2342-2016; van Wezel, Tom/Z-3092-2019; van de Velde, Cornelis/AAY-8360-2020; van Wezel, Tom/AAL-5626-2021	Kuppen, Peter/0000-0002-0294-3251; van Wezel, Tom/0000-0001-5773-7730; van Eijk, Ronald/0000-0001-7955-6295				Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; Barault L, 2008, INT J CANCER, V122, P2255, DOI 10.1002/ijc.23388; Bastiaannet E, 2012, BRIT J CANCER, V106, P1564, DOI 10.1038/bjc.2012.101; Burn J, 2012, DIGEST DIS, V30, P39, DOI 10.1159/000341892; Chan AT, 2009, JAMA-J AM MED ASSOC, V302, P649, DOI 10.1001/jama.2009.1112; Chia WK, 2012, NAT REV CLIN ONCOL, V9, P561, DOI 10.1038/nrclinonc.2012.137; Cole BF, 2009, J NATL CANCER I, V101, P256, DOI 10.1093/jnci/djn485; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Coyle C, 2016, CURRENT COLORECTAL C; Coyle C, 2016, CONTEMP CLIN TRIALS, V51, P56, DOI 10.1016/j.cct.2016.10.004; Elwood PC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152402; Elwood PC, 2009, LANCET, V373, P1301, DOI 10.1016/S0140-6736(09)60243-9; Guillem-Llobat P, 2016, ONCOTARGET; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Lao VV, 2011, NAT REV GASTRO HEPAT, V8, P686, DOI 10.1038/nrgastro.2011.173; Linnekamp JF, 2015, CANCER RES, V75, P245, DOI 10.1158/0008-5472.CAN-14-2240; Nan HM, 2015, JAMA-J AM MED ASSOC, V313, P1133, DOI 10.1001/jama.2015.1815; Nishihara R, 2013, JAMA-J AM MED ASSOC, V309, P2563, DOI 10.1001/jama.2013.6599; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Paleari L, 2016, CLIN ONCOL-UK, V28, P317, DOI 10.1016/j.clon.2015.11.008; Reimers MS, 2013, GASTROENTEROL REP, V1, P166, DOI 10.1093/gastro/got022; Reimers MS, 2014, JAMA INT MED; Rothwell PM, 2012, LANCET, V379, P1591, DOI 10.1016/S0140-6736(12)60209-8; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Rothwell PM, 2012, LANCET; SIMON R, 1984, STAT MED, V3, P35, DOI 10.1002/sim.4780030106; Sinicrope FA, 2016, CLIN GASTROENTEROL H, V14, P651, DOI 10.1016/j.cgh.2016.02.008; Stricker BHC, 2010, EUR J EPIDEMIOL, V25, P245, DOI 10.1007/s10654-010-9451-7; van Eijk R, 2013, EXP MOL PATHOL, V94, P121, DOI 10.1016/j.yexmp.2012.06.004; van Eijk R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017791; van Herk-Sukel MPP, 2010, EUR J CANCER, V46, P395, DOI 10.1016/j.ejca.2009.09.010; van Lier MGF, 2012, J PATHOL, V226, P764, DOI 10.1002/path.3963; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Yood MU, 2007, PHARMACOEPIDEM DR S, V16, P961, DOI 10.1002/pds.1454	36	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170775	10.1371/journal.pone.0170775	http://dx.doi.org/10.1371/journal.pone.0170775			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125730	gold, Green Published, Green Submitted			2022-12-27	WOS:000396176100055
J	Qin, MB; Zhang, JX; Xu, CY; Peng, P; Tan, L; Liu, SQ; Huang, JA				Qin, Mengbin; Zhang, Jinxiu; Xu, Chunyan; Peng, Peng; Tan, Lin; Liu, Shiquan; Huang, Jiean			Knockdown of NIK and IKK beta-Binding Protein (NIBP) Reduces Colorectal Cancer Metastasis through Down-Regulation of the Canonical NF-kB Signaling Pathway and Suppression of MAPK Signaling Mediated through ERK and JNK	PLOS ONE			English	Article							KAPPA-B PATHWAY; CELLS; ACTIVATION; ASTROCYTES; CASCADES	Background Despite the identification of many signaling pathways involved in colorectal cancer (CRC) tumorigenesis, metastatic CRC still remains one of the major causes of cancer related death. NIK and IKK beta-binding protein (NIBP) is one of the key regulators of the NF-B signaling pathway, which has been implicated in CRC metastasis. The aim of this study was to investigate the possible role of NIBP in CRC metastasis through its regulation of NF-kB and extracellular regulated kinase/c-Janus kinase (ERK/JNK) signaling pathways. Methods In this study NIBP, phosphorylated (p)-p65, p-ERK1/2, and p-JNK1/2 expression was examined in 130 CRC, and 25 adenoma tissue samples were studied by immunohistochemistry. NIBP shRNA knockdown was performed in HCT116 cells, and NF-kB and ERK/JNK pathway activity was measured after TNF-alpha stimulation in vitro and in vivo. Results We found that NIBP, p-p65, p-ERK1/2, and p-JNK1/2 expression was higher in late stages of CRC compared to early stages or adenomas. Expression of p-p65, p-IkB alpha, p-IkB beta, pERK1/ 2, and p-JNK1/2 was inhibited in TNF-alpha stimulated HCT116 cells following NIBP knockdown. Nevertheless, p-ERK1/2 expression in un-transfected and NIBP knockdown HCT116 cells remained the same in the absence of TNF-alpha stimulation. Furthermore, cell motility and invasion were reduced in HCT116 cells following NIBP knockdown even after TNF-a treatment. Finally, primary tumor weight and liver metastasis were reduced in nude mice with orthotopically transplanted NIBP knockdown of HCT116 cells. Conclusion In conclusion, we demonstrated that NIBP knockdown reduces colorectal cancer metastasis through down-regulation of canonical NF-kB signaling and suppression of ERK and JNK signaling.	[Qin, Mengbin; Zhang, Jinxiu; Xu, Chunyan; Peng, Peng; Tan, Lin; Liu, Shiquan; Huang, Jiean] Guangxi Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanning, Peoples R China	Guangxi Medical University	Huang, JA (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanning, Peoples R China.	hjagxmu@163.com			National Natural Science Foundation of China [81260365]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81260365).	Blits B, 2005, RESTOR NEUROL NEUROS, V23, P313; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Dvoriantchikova G, 2014, EUR J NEUROSCI, V40, P3171, DOI 10.1111/ejn.12710; FRIEDRICHS K, 1993, CANCER, V72, P3641, DOI 10.1002/1097-0142(19931215)72:12<3641::AID-CNCR2820721215>3.0.CO;2-8; Jeong JB, 2013, ARCH BIOCHEM BIOPHYS, V537, P168, DOI 10.1016/j.abb.2013.07.016; Kim EK, 2015, ARCH TOXICOL, V89, P867, DOI 10.1007/s00204-015-1472-2; Kim JC, 2008, WORLD J GASTROENTERO, V14, P6662, DOI 10.3748/wjg.14.6662; Kraus S, 2014, CANCER LETT, V347, P15, DOI 10.1016/j.canlet.2014.01.025; Lewis DA, 2008, J INVEST DERMATOL, V128, P1022, DOI 10.1038/sj.jid.5701127; Liu SY, 2012, SCI WORLD J, DOI 10.1100/2012/614263; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Ongchin M, 2009, J SURG RES, V156, P250, DOI 10.1016/j.jss.2009.02.002; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Qin MB, 2016, TUMOR BIOL, V37, P5979, DOI 10.1007/s13277-015-4433-8; Rajput A, 2008, J SURG RES, V147, P276, DOI 10.1016/j.jss.2007.04.021; Saha RN, 2007, J IMMUNOL, V179, P7101, DOI 10.4049/jimmunol.179.10.7101; Shao HJ, 2015, BIOMOL THER, V23, P39, DOI 10.4062/biomolther.2014.088; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Yang Z, 2009, CURR CANCER DRUG TAR, V9, P915, DOI 10.2174/156800909790192383; Zahoor MA, 2010, J GEN VIROL, V91, P1939, DOI 10.1099/vir.0.020990-0; Zhang YL, 2015, ONCOTARGET, V6, P30439, DOI 10.18632/oncotarget.5900; Zong M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029995	24	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170595	10.1371/journal.pone.0170595	http://dx.doi.org/10.1371/journal.pone.0170595			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125661	Green Submitted, Green Published, gold			2022-12-27	WOS:000396176100090
J	Rajashekar, Y; Shivanandappa, T				Rajashekar, Yallappa; Shivanandappa, Thimmappa			Mode of Action of the Natural Insecticide, Decaleside Involves Sodium Pump Inhibition	PLOS ONE			English	Article							PALYTOXIN; NA+,K+-ATPASE; MECHANISM; ATPASE; BIOCHEMISTRY; PRODUCTS; TARGETS; DIPTERA	Decalesides are a new class of natural insecticides which are toxic to insects by contact via the tarsal gustatory chemosensilla. The symptoms of their toxicity to insects and the rapid knockdown effect suggest neurotoxic action, but the precise mode of action and the molecular targets for decaleside action are not known. We have presented experimental evidence for the involvement of sodium pump inhibition in the insecticidal action of decaleside in the cockroach and housefly. The knockdown effect of decaleside is concomitant with the in vivo inhibition of Na+, K+ -ATPase in the head and thorax. The lack of insecticidal action by experimental ablation of tarsi or blocking the tarsal sites with paraffin correlated with lack of inhibition of Na+- K+ ATPase in vivo. Maltotriose, a trisaccharide, partially rescued the toxic action of decaleside as well as inhibition of the enzyme, suggesting the possible involvement of gustatory sugar receptors. In vitro studies with crude insect enzyme preparation and purified porcine Na+, K+ -ATPase showed that decaleside competitively inhibited the enzyme involving the ATP binding site. Our study shows that the insecticidal action of decaleside via the tarsal gustatory sites is causally linked to the inhibition of sodium pump which represents a unique mode of action. The precise target(s) for decaleside in the tarsal chemosensilla and the pathway linked to inhibition of sodium pump and the insecticidal action remain to be understood.	[Rajashekar, Yallappa; Shivanandappa, Thimmappa] CSIR, Cent Food Technol Res Inst, Dept Food Protectants & Infestat Control, Mysore, Karnataka, India; [Rajashekar, Yallappa] Govt India, Anim Bioresources Programme, Inst Bioresources & Sustainable Dev, Dept Biotechnol, Imphal, Manipur, India; [Shivanandappa, Thimmappa] Univ Mysore, Dept Studies Zool, Mysore, Karnataka, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI); Department of Biotechnology (DBT) India; Institute of Bioresources & Sustainable Development (IBSD); University of Mysore	Shivanandappa, T (corresponding author), CSIR, Cent Food Technol Res Inst, Dept Food Protectants & Infestat Control, Mysore, Karnataka, India.	tshivanandappa@yahoo.com						ALBRECHT CP, 1987, J ECON ENTOMOL, V80, P344, DOI 10.1093/jee/80.2.344; BLOJ B, 1973, BIOCHIM BIOPHYS ACTA, V311, P67, DOI 10.1016/0005-2736(73)90255-1; Bloomquist JR, 1996, ANNU REV ENTOMOL, V41, P163, DOI 10.1146/annurev.en.41.010196.001115; Bonting SL, 1970, MEMBRANES ION TRANSP, V1, P257; Chandler D, 2011, PHILOS T R SOC B, V366, P1987, DOI 10.1098/rstb.2010.0390; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Cordova D, 2006, PESTIC BIOCHEM PHYS, V84, P196, DOI 10.1016/j.pestbp.2005.07.005; Dobler S, 2012, P NATL ACAD SCI USA, V109, P13040, DOI 10.1073/pnas.1202111109; Elbert A, 2008, MODERN CROP PROTECTI, V3, P753; Faulde MK, 2006, J STORED PROD RES, V42, P253, DOI 10.1016/j.jspr.2005.03.001; Finney D.J., 1971, PROBIT ANAL; Ford KA, 2010, P NATL ACAD SCI USA, V107, P17527, DOI 10.1073/pnas.1013020107; HARVEY WR, 1983, J EXP BIOL, V106, P91; Hemingway J, 2002, SCIENCE, V298, P96, DOI 10.1126/science.1078052; Inoshita T, 2006, P NATL ACAD SCI USA, V103, P1094, DOI 10.1073/pnas.0502376103; Ishaaya I, 2001, BIOCHEMICAL SITES OF INSECTICIDE ACTION AND RESISTANCE, P1; Ishaaya Isaac, 2007, Entomological Research, V37, P148, DOI 10.1111/j.1748-5967.2007.00104.x; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kaufman PE, 2010, PEST MANAG SCI, V66, P290, DOI 10.1002/ps.1872; Lahm GP, 2009, BIOORGAN MED CHEM, V17, P4127, DOI 10.1016/j.bmc.2009.01.018; LASOTA JA, 1991, ANNU REV ENTOMOL, V36, P91, DOI 10.1146/annurev.en.36.010191.000515; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matsumura F, 1985, TOXICOLOGY INSECTICI, V2; Millar Neil S., 2007, Invertebrate Neuroscience, V7, P53, DOI 10.1007/s10158-006-0040-0; Morgan ED, 2009, BIOORGAN MED CHEM, V17, P4096, DOI 10.1016/j.bmc.2008.11.081; Mori S, 2016, TETRAHEDRON LETT, V57, P3612, DOI 10.1016/j.tetlet.2016.06.108; Nauen R, 2006, PEST MANAG SCI, V62, P690, DOI 10.1002/ps.1254; NORRIS DM, 1981, INSECT BIOCHEM, V11, P743, DOI 10.1016/0020-1790(81)90067-6; Pavela R, 2008, PHYTOTHER RES, V22, P274, DOI 10.1002/ptr.2300; Petschenka G, 2012, J INSECT PHYSIOL, V58, P607, DOI 10.1016/j.jinsphys.2011.12.012; Rajashekar Y, 2010, J FOOD SCI TECH MYS, V47, P310, DOI 10.1007/s13197-010-0049-6; Rajashekar Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep20546; Rajashekar Y, 2012, NATURWISSENSCHAFTEN, V99, P843, DOI 10.1007/s00114-012-0966-5; Rattan RS, 2010, CROP PROT, V29, P913, DOI 10.1016/j.cropro.2010.05.008; Rossini GP, 2011, TOXICON, V57, P429, DOI 10.1016/j.toxicon.2010.09.011; Schmutterer H., 1995, P326; Shivanandappa T., 2014, ADV PLANT BIOPESTICI, V1st ed., P323; Sparks TC, 2001, PEST MANAG SCI, V57, P896, DOI 10.1002/ps.358; Takeuchi A, 2008, NATURE, V456, P413, DOI 10.1038/nature07350; Tang HJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep29155; Thompson GD, 2000, PEST MANAG SCI, V56, P696, DOI 10.1002/1526-4998(200008)56:8<696::AID-PS182>3.0.CO;2-5; Thorne N, 2008, J COMP NEUROL, V506, P548, DOI 10.1002/cne.21547; Tosteson M. T., 2000, SEAFOOD FRESHWATER T, p[549, 549]; Vale-Gonzalez C, 2007, TOXICON, V50, P541, DOI 10.1016/j.toxicon.2007.04.024; VIJVERBERG HPM, 1982, NATURE, V295, P601, DOI 10.1038/295601a0; VIJVERBERG HPM, 1990, CRIT REV TOXICOL, V21, P105, DOI 10.3109/10408449009089875; Wu CH, 2009, TOXICON, V54, P1183, DOI 10.1016/j.toxicon.2009.02.030; Yu S., 2008, TOXICOLOGY BIOCH INS, DOI 10.1201/9781420059762	49	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170836	10.1371/journal.pone.0170836	http://dx.doi.org/10.1371/journal.pone.0170836			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125742	Green Published, gold, Green Accepted			2022-12-27	WOS:000396176100039
J	Yao, G; Zhang, YF; Wang, D; Yang, RR; Sang, H; Han, LL; Zhu, YX; Lu, YY; Tan, YK; Shang, ZP				Yao, Guo; Zhang, Yafang; Wang, Di; Yang, Ruirui; Sang, Hui; Han, Linlin; Zhu, Yuexia; Lu, Yanyan; Tan, Yeke; Shang, Zhanping			GDM-Induced Macrosomia Is Reversed by Cav-1 via AMPK-Mediated Fatty Acid Transport and GLUT1-Mediated Glucose Transport in Placenta	PLOS ONE			English	Article							GESTATIONAL DIABETES-MELLITUS; RANDOMIZED-CONTROLLED-TRIAL; CHINESE WOMEN; NUTRIENT TRANSPORT; FETAL MACROSOMIA; MATERNAL OBESITY; GENE-EXPRESSION; BIRTH-WEIGHT; PREDICTORS; CAVEOLIN-1	Objective To investigate if the role of Cav-1 in GDM-induced macrosomia is through regulating AMPK signaling pathway in placenta. Methods We used diagnostic criteria of gestational diabetes mellitus (GDM) and macrosomia to separate and compare placental protein and mRNA levels from GDM with macrosomia group (GDMM), GDM with normal birth weight group (GDMN) and normal glucose tolerance (NGT) with normal birth weight group (CON). Western blotting was performed to examine differentially expressed proteins of caveolin-1 (Cav-1) and Adenosine monophosphate-activated protein kinase (AMPK) signaling pathway related proteins, including phosphorylated-AMPK alpha(Thr172), AMPK alpha, phosphorylated-Acetyl-CoA carboxylase(Ser79) (p-ACC (Ser79)), ACC and glucose transporter 1 (GLUT1) in placenta between the three groups. The mRNA levels of Cav-1, AMPKa, ACC and GLUT1 in placenta were measured by real time-PCR. Results In the GDMM placenta group, both protein and mRNA levels of Cav-1 were down-regulated, while GLUT1 was up-regulated; the phosphorylation and mRNA levels of ACC and AMPKa were decreased, but total ACC protein levels were increased compared to both the GDMN (p<0.05) and CON groups (p<0.05). In GDMM placenta group, there was a significant negative correlation observed between neonatal birth weight (NBW) and protein expression levels of Cav-1, p-ACC(Ser79) and p-AMPK alpha(Thr172) (p<0.05), while positive relationship with ACC and GLUT1 protein levels. Besides, in GDMM group placental mRNA levels, NBW had a positive correlation with GLUT1 (p<0.05), while negative with Cav-1, AMPK alpha and ACC expression (p<0.05). Cav-1 protein expression was positively associated with p-AMPK and p-ACC (p<0.05), and negatively associated with GLUT1 (p<0.05). Interestingly, p-AMPK protein expression was closely related to p-ACC (p<0.05), but not with GLUT1. Conclusion GDM-induced macrosomias have more severe inhibition of Cav-1 expression in placenta. Cav-1 is associated with placental glucose and fatty acid transport via the induction of AMPK signaling pathway and the reduction of GLUT1 signaling pathway to reverse GDM-induced macrosomia.	[Yao, Guo] Shandong Univ, Dept Pediat, Qilu Hosp, Jinan, Peoples R China; [Yao, Guo; Zhang, Yafang] Taian City Cent Hosp, Dept Pediat, Tai An, Shandong, Peoples R China; [Zhang, Yafang; Yang, Ruirui; Sang, Hui; Han, Linlin; Zhu, Yuexia; Shang, Zhanping] Taishan Med Univ, Dept Pathophysiol, Tai An, Shandong, Peoples R China; [Wang, Di; Lu, Yanyan; Tan, Yeke] Taian City Cent Hosp, Tai An, Shandong, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences	Shang, ZP (corresponding author), Taishan Med Univ, Dept Pathophysiol, Tai An, Shandong, Peoples R China.	Zhpshang@126.com			National Natural Science Foundation of China [81570410]; Shandong Education Department [03k10]; Ministry of Education of the People's Republic of China [201510439120]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Education Department; Ministry of Education of the People's Republic of China(Ministry of Education, China)	This work was funded by the National Natural Science Foundation of China (81570410), the project of Shandong Education Department (03k10), and the Ministry of Education of the People's Republic of China (201510439120).	Baumann MU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106037; Brett KE, 2016, J MATERN-FETAL NEO M, V29, P1399, DOI 10.3109/14767058.2015.1049522; Brett KE, 2014, INT J MOL SCI, V15, P16153, DOI 10.3390/ijms150916153; Briley AL, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-74; Codenotti S, 2016, EUR J CELL BIOL, V95, P252, DOI 10.1016/j.ejcb.2016.04.005; Fernandez-Real JM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-20; Gaccioli F, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109702; Hernandez TL, 2014, DIABETES CARE, V37, P1254, DOI 10.2337/dc13-2411; Holme AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117084; Huo Y, 2015, BRAZ J MED BIOL RES, V48, P273, DOI 10.1590/1414-431X20143432; Jarmuzek P, 2015, NEUROENDOCRINOL LETT, V36, P101; Javadian Pouya, 2014, Acta Med Iran, V52, P385; Karantanos T, 2016, ONCOTARGET; Kim HS, 2009, EUR J APPL PHYSIOL, V106, P173, DOI 10.1007/s00421-009-1001-1; King RG, 2003, J PERINAT MED, V31, P475, DOI 10.1515/JPM.2003.073; Larque E, 2014, ANN NUTR METAB, V64, P247, DOI 10.1159/000365028; Lee H, 2011, INT J MOL MED, V28, P65, DOI 10.3892/ijmm.2011.674; Lennon JC, 2016, INVEST NEW DRUG, V34, P663, DOI 10.1007/s10637-016-0366-3; Li J., 2015, OPEN FUEL ENERGY SCI, V8, P52, DOI [10.2174/1876973X01508010052, DOI 10.2174/1876973X01508010052]; Madiraju AK, 2016, P NATL ACAD SCI USA, V113, pE3423, DOI 10.1073/pnas.1606022113; Mai CY, 2015, INT J CLIN EXP MED, V8, P21694; Martino J, 2016, J CLIN ENDOCR METAB, V101, P58, DOI 10.1210/jc.2015-2590; Mirzamoradi Masoomeh, 2015, Acta Med Iran, V53, P97; Muir R, 2016, CLIN SCI, V130, P183, DOI 10.1042/CS20150539; Nobles C, 2015, OBSTET GYNECOL, V125, P1195, DOI 10.1097/AOG.0000000000000738; Oh YS, 2007, EXP MOL MED, V39, P395, DOI 10.1038/emm.2007.44; Palacios-Ortega S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095100; Park S, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0455-5; Peng X., 2014, IEEE GEOSCI REMOTE S, V11, P1, DOI DOI 10.1371/J0URNAL.P0NE.0113716; Penumathsa SV, 2008, J CELL MOL MED, V12, P2350, DOI 10.1111/j.1582-4934.2008.00251.x; Salis O, 2014, EUR REV MED PHARMACO, V18, P1602; Sciullo E, 1997, Early Pregnancy, V3, P172; Su RN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148399; Sun DM, 2014, INT J CLIN EXP MED, V7, P5784; Wahlberg J, 2016, DIABETES RES CLIN PR, V114, P99, DOI 10.1016/j.diabres.2015.12.017; Wilson BL, 2015, JOGNN-J OBST GYN NEO, V44, P760, DOI 10.1111/1552-6909.12754; Wysham WZ, 2016, TARGETED ONCOLOGY; Zhang Q, 2015, IEEE ENER CONV, P1, DOI 10.1109/ECCE.2015.7309661; Zhang Wei, 2015, Zhonghua Bing Li Xue Za Zhi, V44, P767; Zhu M, 2014, DIABETES-METAB RES, V30, P489, DOI 10.1002/dmrr.2544	40	24	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170490	10.1371/journal.pone.0170490	http://dx.doi.org/10.1371/journal.pone.0170490			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125642	Green Published, Green Submitted, gold			2022-12-27	WOS:000396176100102
J	Yuan, CH; Chu, CC; Yan, XJ; Bagnara, D; Chiorazzi, N; MacCarthy, T				Yuan, Chaohui; Chu, Charles C.; Yan, Xiao-Jie; Bagnara, Davide; Chiorazzi, Nicholas; MacCarthy, Thomas			The Number of Overlapping AID Hotspots in Germline IGHV Genes Is Inversely Correlated with Mutation Frequency in Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							CLASS SWITCH RECOMBINATION; B-CELL RECEPTORS; SOMATIC HYPERMUTATION; IMMUNOGLOBULIN HEAVY; ANTIGEN SELECTION; STRUCTURAL BASIS; ANTIBODIES; REARRANGEMENTS; SUBSET; HIV-1	The targeting of mutations by Activation-Induced Deaminase (AID) is a key step in generating antibody diversity at the Immunoglobulin (Ig) loci but is also implicated in B-cell malignancies such as chronic lymphocytic leukemia (CLL). AID has previously been shown to preferentially deaminate WRC (W = A/T, R = A/G) hotspots. WGCW sites, which contain an overlapping WRC hotspot on both DNA strands, mutate at much higher frequency than single hotspots. Human Ig heavy chain (IGHV) genes differ in terms ofWGCW numbers, ranging from 4 for IGHV3-48*03 to as many as 12 in IGHV1-69*01. An absence of V-region mutations in CLL patients ("IGHV unmutated", or U-CLL) is associated with a poorer prognosis compared to "IGHV mutated" (M-CLL) patients. The reasons for this difference are still unclear, but it has been noted that particular IGHV genes associate with U-CLL vs M-CLL. For example, patients with IGHV1-69 clones tend to be U-CLL with a poor prognosis, whereas patients with IGHV3-30 tend to be M-CLL and have a better prognosis. Another distinctive feature of CLL is that similar to 30% of (mostly poor prognosis) patients can be classified into " stereo-typed" subsets, each defined by HCDR3 similarity, suggesting selection, possibly for a self-antigen. We analyzed > 1000 IGHV genes from CLL patients and found a highly significant statistical relationship between the number ofWGCW hotspots in the germline V-region and the observed mutation frequency in patients. However, paradoxically, this correlation was inverse, with V-regions with moreWGCW hotspots being less likely to be mutated, i.e., more likely to be U-CLL. The number ofWGCW hotspots in particular, are more strongly correlated with mutation frequency than either non-overlapping (WRC) hotspots or more general models of mutability derived from somatic hypermutation data. Furthermore, this correlation is not observed in sequences from the B cell repertoires of normal individuals and those with autoimmune diseases.	[Yuan, Chaohui; MacCarthy, Thomas] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [Chu, Charles C.; Yan, Xiao-Jie; Bagnara, Davide; Chiorazzi, Nicholas] Northwell Hlth, Feinstein Inst Med Res, Manhasset, NY USA; [Chu, Charles C.; Chiorazzi, Nicholas] Hofstra Northwell Sch Med, Dept Med, Hempstead, NY USA; [Chu, Charles C.; Chiorazzi, Nicholas] Hofstra Northwell Sch Med, Dept Mol Med, Hempstead, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Northwell Health; Northwell Health; Northwell Health	MacCarthy, T (corresponding author), SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA.	thomas.maccarthy@stonybrook.edu	Bagnara, Davide/AAQ-4172-2021; Bagnara, Davide/S-2124-2019; Bagnara, Davide/L-2691-2016	Bagnara, Davide/0000-0001-7889-8103; Bagnara, Davide/0000-0001-7889-8103	National Institute for General Medical Sciences / NIH [1R01GM111741]; National Cancer Institute / NIH [CA081554]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111741] Funding Source: NIH RePORTER	National Institute for General Medical Sciences / NIH; National Cancer Institute / NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	TM was supported by the National Institute for General Medical Sciences / NIH (1R01GM111741), https://www.nigms.nih.gov/Pages/default.aspx. NC was supported by the National Cancer Institute / NIH (CA081554), http://www.cancer.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; Bagnara D, 2015, J IMMUNOL, V195, P3716, DOI 10.4049/jimmunol.1500753; Baliakas P, 2015, BLOOD, V125, P856, DOI 10.1182/blood-2014-09-600874; Baughn LB, 2011, MBIO, V2, DOI 10.1128/mBio.00186-11; Binder M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015992; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Chan CH, 2001, BLOOD, V97, P1023, DOI 10.1182/blood.V97.4.1023; Chan TD, 2012, IMMUNITY, V37, P893, DOI 10.1016/j.immuni.2012.07.017; Chen ZG, 2016, J IMMUNOL, V196, P2335, DOI 10.4049/jimmunol.1502184; Chen Zhiliang, 2010, Immunome Res, V6 Suppl 1, pS4, DOI 10.1186/1745-7580-6-S1-S4; Chu CC, 2008, BLOOD, V112, P5122, DOI 10.1182/blood-2008-06-162024; Dal-Bo M, 2011, BRIT J HAEMATOL, V153, P3, DOI 10.1111/j.1365-2141.2010.08440.x; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Darzentas N, 2010, LEUKEMIA, V24, P125, DOI 10.1038/leu.2009.186; Degan M, 2004, BRIT J HAEMATOL, V126, P29, DOI 10.1111/j.1365-2141.2004.04985.x; Efremov DG, 1996, J CLIN INVEST, V98, P290, DOI 10.1172/JCI118792; Fais F, 1998, J CLIN INVEST, V102, P1515, DOI 10.1172/JCI3009; Gelmez MY, 2014, LEUKEMIA LYMPHOMA, V55, P326, DOI 10.3109/10428194.2013.803225; Ghia P, 2008, J INTERN MED, V264, P549, DOI 10.1111/j.1365-2796.2008.02030.x; Ghiotto F, 2004, J CLIN INVEST, V113, P1008, DOI 10.1172/JCI200419399; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P695, DOI 10.1101/pdb.prot5633; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Han L, 2011, P NATL ACAD SCI USA, V108, P11584, DOI 10.1073/pnas.1018726108; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Herve M, 2005, J CLIN INVEST, V115, P1636, DOI 10.1172/JCI24387; Hoogeboom R, 2013, LEUKEMIA, V27, P738, DOI 10.1038/leu.2012.238; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; ICHIYOSHI Y, 1994, J EXP MED, V180, P885, DOI 10.1084/jem.180.3.885; Kasar S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9866; KIPPS TJ, 1989, P NATL ACAD SCI USA, V86, P5913, DOI 10.1073/pnas.86.15.5913; Kostareli E, 2009, LEUKEMIA, V23, P919, DOI 10.1038/leu.2008.379; Lefranc MP, 2001, NUCLEIC ACIDS RES, V29, P207, DOI 10.1093/nar/29.1.207; Lerner RA, 2011, MOL BIOSYST, V7, P1004, DOI 10.1039/c0mb00310g; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; Marantidou F, 2010, BLOOD CELL MOL DIS, V44, P262, DOI 10.1016/j.bcmd.2009.12.005; Martomo SA, 2004, J EXP MED, V200, P61, DOI 10.1084/jem.20040691; Matthews C, 2007, LEUKEMIA RES, V31, P231, DOI 10.1016/j.leukres.2006.03.028; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; Murray F, 2008, BLOOD, V111, P1524, DOI 10.1182/blood-2007-07-099564; Myhrinder AL, 2008, BLOOD, V111, P3838, DOI 10.1182/blood-2007-11-125450; Ohm-Laursen L, 2007, J IMMUNOL, V178, P4322, DOI 10.4049/jimmunol.178.7.4322; Oppezzo P, 2003, BLOOD, V101, P4029, DOI 10.1182/blood-2002-10-3175; Palacios F, 2012, MICROENVIRONMENT INT; Palacios F, 2010, BLOOD, V115, P4488, DOI 10.1182/blood-2009-12-257758; Patten PEM, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86288; Patten PEM, 2012, BLOOD, V120, P4802, DOI 10.1182/blood-2012-08-449744; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Perotti M, 2008, AUTOIMMUN REV, V7, P468, DOI 10.1016/j.autrev.2008.03.008; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Rene C, 2014, J CELL MOL MED, V18, P979, DOI 10.1111/jcmm.12215; Sabouri Z, 2014, P NATL ACAD SCI USA, V111, pE2567, DOI 10.1073/pnas.1406974111; SHLOMCHIK MJ, 1987, NATURE, V328, P805, DOI 10.1038/328805a0; Stamatopoulos K, 2007, BLOOD, V109, P259, DOI 10.1182/blood-2006-03-012948; Steininger C, 2012, BLOOD, V119, P2293, DOI 10.1182/blood-2011-08-374058; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Sutton LA, 2013, SEMIN CANCER BIOL, V23, P399, DOI 10.1016/j.semcancer.2013.07.006; Wang M, 2010, J EXP MED, V207, P141, DOI 10.1084/jem.20092238; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wei LR, 2015, P NATL ACAD SCI USA, V112, pE728, DOI 10.1073/pnas.1500788112; William J, 2002, SCIENCE, V297, P2066, DOI 10.1126/science.1073924; Yaari G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00358; Yang G, 2013, J EXP MED, V210, P241, DOI 10.1084/jem.20121977; Yeap LS, 2015, CELL, V163, P1124, DOI 10.1016/j.cell.2015.10.042; Zahn A, 2013, J IMMUNOL, V190, P5949, DOI 10.4049/jimmunol.1202711; Zwick C, 2013, BLOOD, V121, P4708, DOI 10.1182/blood-2012-08-447904	65	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0167602	10.1371/journal.pone.0167602	http://dx.doi.org/10.1371/journal.pone.0167602			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125682	Green Published, Green Submitted, gold			2022-12-27	WOS:000396176100153
J	Chaabane, A; Neifar, L; Justine, JL				Chaabane, Amira; Neifar, Lassad; Justine, Jean-Lou			Diplectanids from Mycteroperca spp. (Epinephelidae) in the Mediterranean Sea: Redescriptions of six species from material collected off Tunisia and Libya, proposal for the 'Pseudorhabdosynochus riouxi group', and a taxonomic key	PLOS ONE			English	Article							CORAL-REEF FISH; N. SP MONOGENEA; NEW-CALEDONIA; DICENTRARCHUS-LABRAX; NEMATODA PHILOMETRIDAE; PARASITE BIODIVERSITY; MACULATUS PERCIFORMES; POPULATION-DYNAMICS; CULTURED GROUPERS; VAL. PERCIFORMES	Diplectanid monogeneans are gill parasites that can infect fish in huge numbers and thus become harmful, especially in maricultured fish. It is therefore useful to have taxonomic tools, such as keys, to identify species. The following diplectanid species from groupers of the Mediterranean Sea were studied: five species of PseudorhabdosynochusYamaguti, 1958, including P. riouxi (Oliver, 1986) Kritsky & Beverley-Burton, 1986 from the dusky grouper Mycteroperca marginata, P. enitsujiNeifar & Euzet, 2007, P. bouaini Neifar & Euzet, 2007, P. dolicocolpos Neifar & Euzet, 2007 and P. sinediscus Neifar & Euzet, 2007 from the goldblotch grouper M. costae, and Echinoplectanum echinophallus (Euzet & Oliver, 1965) Justine & Euzet, 2006 from the dusky grouper. New material was obtained from fish collected from off Tunisia and Libya and compared to the type-material and voucher specimens in museum collections. Identifications of fish were confirmed by barcoding of cytochrome c oxidase subunit I (C01) sequences. The sclerotized vagina was considered the most important structure for systematics. The three species P. riouxi, P. bouaini, and P. enitsuji share a common general structure of the sclerotized vagina with a conspicuous spherical secondary chamber. We thus propose the Pseudorhabdosynochus riouxi group' to accommodate them. Pseudorhabdosynochus dolicocolpos has an elongate vaginal structure that is completely different from all its congeneric species reported from the Mediterranean Sea, and Pseudorhabdosynochus sinediscus has a sclerotized vagina in which the secondary chamber is not visible, and a haptor without squamodiscs. A taxonomic key to diplectanid species on Mycteroperca spp. in the Mediterranean Sea is proposed; it includes ten species of Pseudorhabdosynochus and one species of Echinoplectanum.	[Chaabane, Amira; Neifar, Lassad] Univ Sfax, Lab Biodiversite & Ecosyst Aquat, Fac Sci Sfax, Sfax, Tunisia; [Justine, Jean-Lou] Sorbonne Univ, Museum Natl Hist Nat, Inst Systemat, ISYEB,Evolut,Biodiversite,UMR7205,CNRS,EPHE,UPMC, Paris, France	Universite de Sfax; Faculty of Sciences Sfax; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite	Chaabane, A (corresponding author), Univ Sfax, Lab Biodiversite & Ecosyst Aquat, Fac Sci Sfax, Sfax, Tunisia.	amirachaabene@hotmail.fr	Chaabane, Amira/AAQ-3021-2021; Justine, Jean-Lou/B-1298-2010	Chaabane, Amira/0000-0002-2931-4113; Justine, Jean-Lou/0000-0002-7155-4540	Ministere des Affaires Etrangeres, France; Museum National d'Histoire Naturelle, France	Ministere des Affaires Etrangeres, France; Museum National d'Histoire Naturelle, France	This work was supported by Ministere des Affaires Etrangeres, France: grant BIOPARMED-ENVIMED, http://www.mistrals-home.org/spip.php?rubrique82; and Museum National d'Histoire Naturelle, France: Grant PARSUDMED, [https://www.mnhn.fr/fr]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli L, 2010, AQUACULTURE, V307, P179, DOI 10.1016/j.aquaculture.2010.07.028; BALASURIYA LKS, 1995, J BIOSCIENCE, V6, P30; Bu SSH, 1999, J HELMINTHOL, V73, P301; Chaabane A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159886; Chaabane A, 2016, PEERJ, V4, DOI 10.7717/peerj.2233; Chaabane A, 2015, PARASITE, V22, DOI 10.1051/parasite/2015005; Craig M. T., 2012, GROUPERS WORLD FIELD; Craig MT, 2007, ICHTHYOL RES, V54, P1, DOI 10.1007/s10228-006-0367-x; De Liberato C., 2000, PARASSITOLOGIA S1, V42, P166; Dezfuli BS, 2007, PARASITOL RES, V100, P707, DOI 10.1007/s00436-006-0343-4; Dyer William G., 1995, Journal of Aquatic Animal Health, V7, P337, DOI 10.1577/1548-8667(1995)007&lt;0337:KNSDOG&gt;2.3.CO;2; Euzet L., 1984, Archives de l'Institut Pasteur de Tunis, V61, P463; EUZET LOUIS, 1965, ANN PARASITOL HUM COMP, V40, P517; Gijon-Botella H, 1998, PARASITOLOGY INT S, V47, P289; GONZALEZLANZA C, 1991, PARASITOL RES, V77, P307, DOI 10.1007/BF00930906; Heemstra P.C., 1993, FAO FISH SYNOP, V125, P382, DOI [10.1016/j.rsma.2020.101388, DOI 10.1016/J.RSMA.2020.101388]; *INT COMM ZOOL NOM, 1999, INT COD ZOOL NOM INT; Isshiki T, 2007, FISH PATHOL, V42, P71, DOI 10.3147/jsfp.42.71; Journo C, 2006, SYST PARASITOL, V64, P173, DOI 10.1007/s11230-006-9029-7; Justine JL, 2008, SYST PARASITOL, V71, P145, DOI 10.1007/s11230-008-9156-4; Justine JL, 2008, ACTA PARASITOL, V53, P127, DOI 10.2478/s11686-008-0021-z; Justine JL, 2007, SYST PARASITOL, V68, P195, DOI 10.1007/s11230-007-9096-4; Justine JL, 2007, SYST PARASITOL, V66, P81, DOI 10.1007/s11230-006-9057-3; Justine JL, 2010, FOLIA PARASIT, V57, P237, DOI 10.14411/fp.2010.032; Justine JL, 2010, BELG J ZOOL, V140, P155; Justine JL, 2010, SYST PARASITOL, V77, P81, DOI 10.1007/s11230-010-9263-x; Justine Jean-Lou, 2007, Zootaxa, V1543, P1; Justine JL, 2006, SYST PARASITOL, V64, P147, DOI 10.1007/s11230-006-9028-8; Justine JL, 2005, SYST PARASITOL, V62, P1, DOI 10.1007/s11230-005-5480-0; KRITSKY DC, 1986, P BIOL SOC WASH, V99, P17; Kritsky DC, 2015, PARASITE, V22, DOI 10.1051/parasite/2015024; Luo YF, 2010, HELMINTHOLOGIA, V47, P241, DOI 10.2478/s11687-010-0038-3; Luo YF, 2010, J PARASITOL, V96, P541, DOI 10.1645/GE-2286.1; MALMBERG G, 1957, FOREKOMSTEN GYRODACT, P19; Moravec F, 2016, PARASITE, V23, DOI 10.1051/parasite/2016008; Moravec F, 2016, SYST PARASITOL, V93, P115, DOI 10.1007/s11230-015-9610-z; Neifar L, 2007, FOLIA PARASIT, V54, P117, DOI 10.14411/fp.2007.017; OLIVER G, 1986, SYST PARASITOL, V8, P317, DOI 10.1007/BF00009739; OLIVER G, 1992, TRAVAUX SCI PARC NAT, V37, P101; Oliver G, 1987, THESIS; Palm HW, 2011, PARASITOLOGY, V138, P1793, DOI 10.1017/S0031182011000011; PAPERNA I, 1979, AQUACULTURE, V16, P173, DOI 10.1016/0044-8486(79)90148-0; RADUJKOVIC B M, 1989, Acta Adriatica, V30, P51; Roumbedakis K, 2014, BRAZ J BIOL, V73, P871, DOI 10.1590/S1519-698420130004000025; Ruckert S, 2009, PARASITOL RES, V104, P523, DOI 10.1007/s00436-008-1226-7; Sanchez-Garcia N, 2015, J HELMINTHOL, V89, P217, DOI 10.1017/S0022149X13000813; Schoelinck C, 2012, PARASITOL INT, V61, P356, DOI 10.1016/j.parint.2012.01.009; Sigura A, 2008, ZOOTAXA, P1; Swan D. C., 1936, Bulletin of Entomological Research London, V27, P389, DOI 10.1017/S0007485300058259; Vidal-Martinez VM, 1998, FOLIA PARASIT, V45, P221; Yang TB, 2005, SYST PARASITOL, V62, P221, DOI 10.1007/s11230-005-5497-4; Yang TB, 2006, SYST PARASITOL, V63, P127, DOI 10.1007/s11230-005-9006-6	52	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171392	10.1371/journal.pone.0171392	http://dx.doi.org/10.1371/journal.pone.0171392			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152034	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200138
J	Park, JI; Baek, H; Kim, BR; Jung, HH				Park, Ji In; Baek, Hyunjeong; Kim, Bo Ra; Jung, Hae Hyuk			Comparison of urine dipstick and albumin: creatinine ratio for chronic kidney disease screening: A population-based study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; QUALITY-OF-LIFE; NATIONAL-HEALTH; GLOBAL BURDEN; PREVALENCE; EQUATION; STATES; KOREA; CKD	Chronic kidney disease (CKD) is usually diagnosed using the estimated glomerular filtration rate (eGFR) or kidney damage markers. The urine dipstick test is a widely used screening tool for albuminuria, a CKD marker. Although the urine albumin: creatinine ratio (ACR) has advantages over the dipstick test in sensitivity and quantification of levels, the two methods have not been compared in the general population. A total of 20,759 adults with urinalysis data in the Korea National Health and Nutrition Examination Survey 2011-2014 were examined. CKD risk categories were created using a combination of eGFR and albuminuria. Albuminuria was defined using an ACR cutoff of 30 mg/g or 300 mg/g and a urine dipstick cutoff of trace or 1+. The EQ-5D index was used for the health outcome. Prevalence estimates of ACR >= 30 mg/g and >300 mg/g vs dipstick >= trace and >= 1+ in adults aged >= 20 years were 7.2% and 0.9% vs 9.1% and 1.2%, respectively. For ACR >= 30 mg/g detection, the sensitivity, specificity, and positive/negative predictive values of dipstick >= trace were 43.6%, 93.6%, 34.6%, and 95.5%, respectively. When risk categories created based on dipstick cutoffs were compared with those based on ACR cutoffs, 10.4% of the total population was reclassified to different risk categories, with only 3.9% reclassified to the same CKD category. Akaike information criterion values were lower, and non-fatal disease burdens of CKD were larger, in models predicting EQ-5D index using ACR-based categories compared to those using dipstick-based categories, even after adjusting for confounders. In conclusion, the urine dipstick test had poor sensitivity and high false-discovery rates for ACR >= 30 mg/g detection, and classified a large number of individuals into different CKD risk categories compared with ACR-based categories. Therefore, ACR assessments in CKD screening appear beneficial for a more accurate prediction of worse quality of life.	[Park, Ji In; Baek, Hyunjeong; Kim, Bo Ra; Jung, Hae Hyuk] Kangwon Natl Univ, Sch Med, Dept Med, Kangwon Natl Univ Hosp, Chunchon, Gangwon Do, South Korea	Kangwon National University; Kangwon National University Hospital	Jung, HH (corresponding author), Kangwon Natl Univ, Sch Med, Dept Med, Kangwon Natl Univ Hosp, Chunchon, Gangwon Do, South Korea.	haehyuk@kangwon.ac.kr		Park, Ji In/0000-0003-4662-3759; Jung, Hae Hyuk/0000-0002-3202-6307	Kangwon National University Hospital Grant	Kangwon National University Hospital Grant	This study was supported by a 2016 Kangwon National University Hospital Grant.	[Anonymous], GUID GUID; Awuah KT, 2013, KIDNEY INT SUPPL, V3, P227, DOI 10.1038/kisup.2013.20; Chow FYF, 2003, AM J KIDNEY DIS, V41, P596, DOI 10.1053/ajkd.2003.50121; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Konta Tsuneo, 2007, Clin Exp Nephrol, V11, P51, DOI 10.1007/s10157-006-0458-z; Lee YK, 2009, VALUE HEALTH, V12, P1187, DOI 10.1111/j.1524-4733.2009.00579.x; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2014, KIDNEY INT, V85, P49, DOI 10.1038/ki.2013.444; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Mcdowell I., 2006, MEASURING HLTH GUIDE, V3, P37, DOI [DOI 10.1093/ACPROF:OSO/9780195165678.001.0001, 10.1093/acprof:oso/9780195165678.001.0001]; Mills KT, 2015, KIDNEY INT, V88, P950, DOI 10.1038/ki.2015.230; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Park JI, 2016, J KOREAN MED SCI, V31, P915, DOI 10.3346/jkms.2016.31.6.915; Park JI, 2016, AM J KIDNEY DIS, V67, P851, DOI 10.1053/j.ajkd.2015.11.005; Sato H, 2015, CLIN EXP NEPHROL; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; White SL, 2011, AM J KIDNEY DIS, V58, P19, DOI 10.1053/j.ajkd.2010.12.026; Who G., 2013, WHO METHODS DATA SOU; World Health Organization. WHO, 2014, GLOB BURD DIS GBD, DOI [10.1053/ajkd.2003.50121, DOI 10.1053/AJKD.2003.50121]; Wyld M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001307; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6	24	46	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171106	10.1371/journal.pone.0171106	http://dx.doi.org/10.1371/journal.pone.0171106			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151999	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161200090
J	Tournu, H; Carroll, J; Latimer, B; Dragoi, AM; Dykes, S; Cardelli, J; Peters, TL; Eberle, KE; Palmer, GE				Tournu, Helene; Carroll, Jennifer; Latimer, Brian; Dragoi, Ana-Maria; Dykes, Samantha; Cardelli, James; Peters, Tracy L.; Eberle, Karen E.; Palmer, Glen E.			Identification of small molecules that disrupt vacuolar function in the pathogen Candida albicans	PLOS ONE			English	Article							IN-VITRO; OROTIDINE-5'-PHOSPHATE DECARBOXYLASE; SACCHAROMYCES-CEREVISIAE; PREVACUOLAR COMPARTMENT; CRYPTOCOCCUS-NEOFORMANS; REDUCED SUSCEPTIBILITY; FUNGAL-INFECTIONS; AMPHOTERICIN-B; MURINE MODEL; CELL-CYCLE	The fungal vacuole is a large acidified organelle that performs a variety of cellular functions. At least a sub-set of these functions are crucial for pathogenic species of fungi, such as Candida albicans, to survive within and invade mammalian tissue as mutants with severe defects in vacuolar biogenesis are avirulent. We therefore sought to identify chemical probes that disrupt the normal function and/or integrity of the fungal vacuole to provide tools for the functional analysis of this organelle as well as potential experimental therapeutics. A convenient indicator of vacuolar integrity based upon the intracellular accumulation of an endogenously produced pigment was adapted to identify Vacuole Disrupting chemical Agents (VDAs). Several chemical libraries were screened and a set of 29 compounds demonstrated to reproducibly cause loss of pigmentation, including 9 azole antifungals, a statin and 3 NSAIDs. Quantitative analysis of vacuolar morphology revealed that (excluding the azoles) a sub-set of 14 VDAs significantly alter vacuolar number, size and/or shape. Many C. albicans mutants with impaired vacuolar function are deficient in the formation of hyphal elements, a process essential for its pathogenicity. Accordingly, all 14 VDAs negatively impact C. albicans hyphal morphogenesis. Fungal selectivity was observed for approximately half of the VDA compounds identified, since they did not alter the morphology of the equivalent mammalian organelle, the lysosome. Collectively, these compounds comprise of a new collection of chemical probes that directly or indirectly perturb normal vacuolar function in C. albicans.	[Tournu, Helene; Peters, Tracy L.; Palmer, Glen E.] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Dept Clin Pharm,Div Clin & Expt Therapeut, Memphis, TN 38163 USA; [Carroll, Jennifer; Latimer, Brian; Dragoi, Ana-Maria; Dykes, Samantha; Cardelli, James] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Dept Med, Shreveport, LA 71105 USA; [Eberle, Karen E.] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA	University of Tennessee System; University of Tennessee Health Science Center; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Palmer, GE (corresponding author), Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Dept Clin Pharm,Div Clin & Expt Therapeut, Memphis, TN 38163 USA.	gpalmer5@uthsc.edu			National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R21A1097664, R01A1099080]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099080] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Numbers R21A1097664 and R01A1099080 received by Dr. Glen E. Palmer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpan A, 2002, POSTGRAD MED J, V78, P455, DOI 10.1136/pmj.78.922.455; BANKAITIS VA, 1986, P NATL ACAD SCI USA, V83, P9075, DOI 10.1073/pnas.83.23.9075; Barelle CJ, 2003, EUKARYOT CELL, V2, P398, DOI 10.1128/EC.2.3.398-410.2003; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Chan CY, 2012, J BIOL CHEM, V287, P10236, DOI 10.1074/jbc.M111.321133; Chavez-Dozal AA, 2014, INT J ANTIMICROB AG, V43, P86, DOI 10.1016/j.ijantimicag.2013.08.018; Cohen BE, 2016, ANTIMICROB AGENTS CH, V60, P5122, DOI 10.1128/AAC.00878-16; Cornet M, 2006, ANTIMICROB AGENTS CH, V50, P3492, DOI 10.1128/AAC.00391-06; Costa-de-Oliveira S, 2015, ANTIMICROB AGENTS CH, V59, P4289, DOI 10.1128/AAC.05056-14; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; Erickson T, 2001, MOL MICROBIOL, V42, P1121, DOI 10.1046/j.1365-2958.2001.02712.x; FISHER CR, 1969, BIOCHEM BIOPH RES CO, V34, P306, DOI 10.1016/0006-291X(69)90832-8; FONZI WA, 1993, GENETICS, V134, P717; Gerami-Nejad M, 2009, YEAST, V26, P399, DOI 10.1002/yea.1674; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; GOODWIN SD, 1995, CLIN INFECT DIS, V20, P755, DOI 10.1093/clinids/20.4.755; GOW NAR, 1982, J GEN MICROBIOL, V128, P2195; Gustavsson M, 2008, MOL GENET GENOMICS, V280, P233, DOI 10.1007/s00438-008-0359-9; Hakki M, 2006, ANTIMICROB AGENTS CH, V50, P2522, DOI 10.1128/AAC.00148-06; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Hilty J, 2008, MOL MICROBIOL, V70, P127, DOI 10.1111/j.1365-2958.2008.06395.x; Johnson RM, 2010, ANAL BIOCHEM, V398, P203, DOI 10.1016/j.ab.2009.12.020; Johnston DA, 2009, INFECT IMMUN; Johnston DA, 2013, EUKARYOT CELL, V12, P1039, DOI 10.1128/EC.00359-12; Johnston DA, 2009, INFECT IMMUN, V77, P2343, DOI 10.1128/IAI.01458-08; Kato M, 2001, EMBO J, V20, P4035, DOI 10.1093/emboj/20.15.4035; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; Lay J, 1998, INFECT IMMUN, V66, P5301, DOI 10.1128/IAI.66.11.5301-5306.1998; Lichtenberger LM, 2012, BBA-MOL CELL BIOL L, V1821, P994, DOI 10.1016/j.bbalip.2012.04.002; Liu X, 2006, MOL MICROBIOL, V61, P1132, DOI 10.1111/j.1365-2958.2006.05299.x; Liu YP, 2014, EUKARYOT CELL, V13, P279, DOI 10.1128/EC.00295-13; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Luna-Tapia A, 2015, EUKARYOT CELL, V14, P1006, DOI 10.1128/EC.00116-15; Luna-Tapia A, 2015, ANTIMICROB AGENTS CH, V59, P2410, DOI 10.1128/AAC.04239-14; Maertens J, 2001, EUR J CANCER CARE, V10, P56, DOI 10.1046/j.1365-2354.2001.00241.x; McCormack PL, 2005, DRUGS, V65, P2049, DOI 10.2165/00003495-200565140-00009; Miller CD, 2006, PHARMACOTHERAPY, V26, P877, DOI 10.1592/phco.26.6.877; Palanisamy SKA, 2010, EUKARYOT CELL, V9, P266, DOI 10.1128/EC.00295-09; Palmer GE, 2005, EUKARYOT CELL, V4, P1677, DOI 10.1128/EC.4.10.1677-1686.2005; Palmer GE, 2003, EUKARYOT CELL, V2, P411, DOI 10.1128/EC.2.3.411-421.2003; Palmer GE, 2010, EUKARYOT CELL, V9, P1755, DOI 10.1128/EC.00029-10; Pereira-Leite C, 2013, PROG LIPID RES, V52, P571, DOI 10.1016/j.plipres.2013.08.003; PITTET D, 1995, ARCH INTERN MED, V155, P1177, DOI 10.1001/archinte.155.11.1177; POULTER RTM, 1983, J BACTERIOL, V156, P1066, DOI 10.1128/JB.156.3.1066-1077.1983; Ramon AM, 2003, EUKARYOT CELL, V2, P718, DOI 10.1128/EC.2.4.718-728.2003; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Roetzer A, 2010, CELL MICROBIOL, V12, P199, DOI 10.1111/j.1462-5822.2009.01391.x; ROMAN H, 1956, COLD SPRING HARB SYM, V21, P175, DOI 10.1101/SQB.1956.021.01.015; ROTHMAN JH, 1986, CELL, V47, P1041, DOI 10.1016/0092-8674(86)90819-6; Saville SP, 2003, EUKARYOT CELL, V2, P1053, DOI 10.1128/EC.2.5.1053-1060.2003; Saville SP, 2009, CLIN VACCINE IMMUNOL, V16, P430, DOI 10.1128/CVI.00480-08; SCOTT EM, 1995, ANTIMICROB AGENTS CH, V39, P2610, DOI 10.1128/AAC.39.12.2610; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; Shoji JY, 2006, EUKARYOT CELL, V5, P411, DOI 10.1128/EC.5.2.411-421.2006; Sobel JD, 2007, LANCET, V369, P1961, DOI 10.1016/S0140-6736(07)60917-9; Vanden Bossche H, 1998, MED MYCOL, V36, P119; Vermitsky JP, 2004, ANTIMICROB AGENTS CH, V48, P3773, DOI 10.1128/AAC.48.10.3773-3781.2004; WADA Y, 1992, J BIOL CHEM, V267, P18665; WEISMAN LS, 1987, J CELL BIOL, V105, P1539, DOI 10.1083/jcb.105.4.1539; Wilson RB, 2000, YEAST, V16, P65, DOI 10.1002/(SICI)1097-0061(20000115)16:1&lt;65::AID-YEA508&gt;3.0.CO;2-M; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; ZINSER E, 1993, J BACTERIOL, V175, P2853, DOI 10.1128/JB.175.10.2853-2858.1993; Zouhar J, 2004, P NATL ACAD SCI USA, V101, P9497, DOI 10.1073/pnas.0402121101	66	9	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171145	10.1371/journal.pone.0171145	http://dx.doi.org/10.1371/journal.pone.0171145			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151949	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161200093
J	Uranga, J; Arrizabalaga, H; Boyra, G; Hernandez, MC; Goni, N; Arregui, I; Fernandes, JA; Yurramendi, Y; Santiago, J				Uranga, Jon; Arrizabalaga, Haritz; Boyra, Guillermo; Hernandez, Maria Carmen; Goni, Nicolas; Arregui, Igor; Fernandes, Jose A.; Yurramendi, Yosu; Santiago, Josu			Detecting the presence-absence of bluefin tuna by automated analysis of medium-range sonars on fishing vessels	PLOS ONE			English	Article							THUNNUS-THYNNUS; UNIT EFFORT; FISHERIES; SCHOOLS; BISCAY; BAY; MANAGEMENT; ECOLOGY; STOCKS; CATCH	This study presents a methodology for the automated analysis of commercial medium range sonar signals for detecting presence/absence of bluefin tuna (Tunnus thynnus) in the Bay of Biscay. The approach uses image processing techniques to analyze sonar screen shots. For each sonar image we extracted measurable regions and analyzed their characteristics. Scientific data was used to classify each region into a class ("tuna" or "no-tuna") and build a dataset to train and evaluate classification models by using supervised learning. The methodology performed well when validated with commercial sonar screenshots, and has the potential to automatically analyze high volumes of data at a low cost. This represents a first milestone towards the development of acoustic, fishery-independent indices of abundance for bluefin tuna in the Bay of Biscay. Future research lines and additional alternatives to inform stock assessments are also discussed.	[Uranga, Jon; Arrizabalaga, Haritz; Boyra, Guillermo; Goni, Nicolas; Arregui, Igor; Santiago, Josu] AZTI Tecnalia, Div Marine Res, Pasaia, Spain; [Hernandez, Maria Carmen; Yurramendi, Yosu] Univ Basque Country, Comp Sci & Artificial Intelligence Dept, Donostia San Sebastian, Spain; [Hernandez, Maria Carmen] Univ Tras Os Montes & Alto Douro, Ctr Res & Technol Agroenvironm & Biol Sci, Vila Real, Portugal; [Fernandes, Jose A.] Plymouth Marine Lab, Plymouth, Devon, England	AZTI; University of Basque Country; University of Tras-os-Montes & Alto Douro; Plymouth Marine Laboratory	Uranga, J (corresponding author), AZTI Tecnalia, Div Marine Res, Pasaia, Spain.	juranga.research@gmail.com	Hernandez, María/GYU-3543-2022; Arrizabalaga, Haritz/B-8238-2009; Fernandes, Jose A./B-8985-2009; Salvador, Jose Antonio Fernandes/AAH-7939-2019; Romay, Manuel M. Graña/L-1341-2014; Hernández Gómez, Carmen/S-1239-2018; Boyra, GUILLERMO/AAB-2137-2019	Arrizabalaga, Haritz/0000-0002-3861-6316; Fernandes, Jose A./0000-0003-4677-6077; Salvador, Jose Antonio Fernandes/0000-0003-4677-6077; Romay, Manuel M. Graña/0000-0001-7373-4097; Hernandez Gomez, Carmen/0000-0002-6645-9880	Basque Government [0033-2011, GV 351NPVA00062]; Natural Environment Research Council [pml010005, pml010010] Funding Source: researchfish; NERC [pml010010, pml010005] Funding Source: UKRI	Basque Government(Basque Government); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by the Basque Government through PhD grant 0033-2011 to JU and grant GV 351NPVA00062 to HA (AZTI-Tecnalia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHA DW, 1991, MACH LEARN, V6, P37, DOI 10.1007/BF00153759; Arreguin-Sanchez F, 1997, OCEANOGRAPHIC LIT RE, V1, P58; Arrizabalaga H, 2015, DEEP-SEA RES PT II, V113, P102, DOI 10.1016/j.dsr2.2014.07.001; Bachiller E, 2012, LIMNOL OCEANOGR-METH, V10, P1, DOI 10.4319/lom.2012.10.1; Bauer RK, 2015, MAR ECOL PROG SER, V534, P221, DOI 10.3354/meps11392; Bishop C.M., 1995, NEURAL NETWORKS PATT; Brehmer P, 2007, AQUAT LIVING RESOUR, V20, P377, DOI 10.1051/alr:2008016; Brehmer P, 2006, FISH FISH, V7, P165, DOI 10.1111/j.1467-2979.2006.00218.x; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chapelle O., 2006, SEMISUPERVISED LEARN; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dalen J, 2007, COLLECTION ACOUSTIC, V287; Di Natale Antonio, 2014, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V70, P459; Dietterich TG, 1998, NEURAL COMPUT, V10, P1895, DOI 10.1162/089976698300017197; Dragesund O, 1965, PATTERN RECOGNITION; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fernandes JA, 2009, J PLANKTON RES, V31, P19, DOI 10.1093/plankt/fbn098; Freeman EA, 2008, J STAT SOFTW, V23, P1; Fromentin JM, 2014, MAR POLICY, V47, P8, DOI 10.1016/j.marpol.2014.01.018; Fromentin JM, 2005, FISH FISH, V6, P281, DOI 10.1111/j.1467-2979.2005.00197.x; Garcia A, 2005, COL VOL SCI PAP ICCA, V58, P1261; GERLOTTO F, 1992, FISH RES, V14, P251, DOI 10.1016/0165-7836(92)90035-R; Goni N, 2010, PROG OCEANOGR, V86, P115, DOI 10.1016/j.pocean.2010.04.016; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Haykin S., 2004, NEURAL NETWORKS, DOI DOI 10.5555/541500; HEWITT RP, 1976, FISH B-NOAA, V74, P281; ICCAT, 2013, INT COMM CONS ATL CO, V69, P1; Irigoien X, 2009, J PLANKTON RES, V31, P1, DOI 10.1093/plankt/fbn096; Itoh T, 2012, REPORT PISTON LINE T; Itoh T, 2004, REV ACOUSTIC MONITOR, P03; Kohavi R., 1995, P INT JOINT C ARTIFI, P1137, DOI DOI 10.1067/MOD.2000.109031; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Lutcavage M, 1997, FISH B-NOAA, V95, P300; Maunder MN, 2006, ICES J MAR SCI, V63, P1373, DOI 10.1016/j.icesjms.2006.05.008; Mayer L, 2002, ICES J MAR SCI, V59, P216, DOI 10.1006/jmsc.2001.1125; Melvin G, 2002, ICES J MAR SCI, V59, P179, DOI 10.1006/jmsc.2001.1124; Melvin G, 2001, AKSG0104 U AL SEA; Melvin GD, 2016, ICEJ MARINE SCI J; Miquel J, 2006, ACOUSTIC SELECTIVITY; Misund OA, 1997, REV FISH BIOL FISHER, V7, P1, DOI 10.1023/A:1018476523423; O'Driscoll RL, 1998, DEEP-SEA RES PT II, V45, P1295, DOI 10.1016/S0967-0645(98)00035-6; Petitgas P, 2009, AQUAT LIVING RESOUR, V22, P119, DOI 10.1051/alr/2009014; Quinlan JR, 1996, J ARTIF INTELL RES, V4, P77, DOI 10.1613/jair.279; R Core Team, 2021, R LANGUAGE ENV STAT; Rodriguez-Marin E, 2003, ICES J MAR SCI, V60, P1216, DOI 10.1016/S1054-3139(03)00139-5; Santiago J., 2016, COLLECTIVE VOLUME SC, V72, P1694; Simmonds J., 2008, FISHERIES ACOUSTICS; Smith P. E., 1970, P INT S BIOL SOUND S, V31; Standing Committee of theNationalAssembly, 2016, RES URB CLASS VIETN; Stoner AW, 2004, J FISH BIOL, V65, P1445, DOI 10.1111/j.0022-1112.2004.00593.x; Trygonis V, 2016, FISH RES, V177, P39, DOI 10.1016/j.fishres.2016.01.013; Venables W., 2013, MODERN APPL STAT S, V53, P86; Weber TC, 2013, J ACOUST SOC AM, V133, P3802, DOI 10.1121/1.4802646; Witten I.H., 2005, DATA MINING PRACTICA; Wood J. M., 2007, WEB J; Zarauz L, 2008, J PLANKTON RES, V30, P857, DOI 10.1093/plankt/fbn049	58	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171382	10.1371/journal.pone.0171382	http://dx.doi.org/10.1371/journal.pone.0171382			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152032	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000396161200136
J	Guyot, C; Arlettaz, R; Korner, P; Jacot, A				Guyot, Claire; Arlettaz, Raphael; Korner, Pius; Jacot, Alain			Temporal and Spatial Scales Matter: Circannual Habitat Selection by Bird Communities in Vineyards	PLOS ONE			English	Article							INVERTEBRATE-FEEDING BIRDS; SHRIKES LANIUS-COLLURIO; GRANIVOROUS BIRDS; AGRICULTURAL INTENSIFICATION; FARMLAND BIODIVERSITY; BIOLOGICAL-CONTROL; FORAGING HABITAT; FIELD MARGINS; MANAGEMENT; LANDSCAPE	Vineyards are likely to be regionally important for wildlife, but we lack biodiversity studies in this agroecosystem which is undergoing a rapid management revolution. As vine cultivation is restricted to arid and warm climatic regions, biodiversity-friendly management would promote species typical of southern biomes. Vineyards are often intensively cultivated, mostly surrounded by few natural features and offering a fairly mineral appearance with little ground vegetation cover. Ground vegetation cover and composition may further strongly vary with respect to season, influencing patterns of habitat selection by ecological communities. We investigated season-specific bird-habitat associations to highlight the importance of semi-natural habitat features and vineyard ground vegetation cover throughout the year. Given that avian habitat selection varies according to taxa, guilds and spatial scale, we modelled bird-habitat associations in all months at two spatial scales using mixed effects regression models. At the landscape scale, birds were recorded along 10 1-km long transects in Southwestern Switzerland (February 2014-January 2015). At the field scale, we compared the characteristics of visited and unvisited vineyard fields (hereafter called parcels). Bird abundance in vineyards tripled in winter compared to summer. Vineyards surrounded by a greater amount of hedges and small woods harboured higher bird abundance, species richness and diversity, especially during the winter season. Regarding ground vegetation, birds showed a season-specific habitat selection pattern, notably a marked preference for ground-vegetated parcels in winter and for intermediate vegetation cover in spring and summer. These season-specific preferences might be related to species-specific life histories: more insectivorous, ground-foraging species occur during the breeding season whereas granivores predominate in winter. These results highlight the importance of investigating habitat selection at different spatial scales and all along the annual cycle in order to draw practical, season-specific management recommendations for promoting avian biodiversity in farmland.	[Guyot, Claire; Arlettaz, Raphael; Jacot, Alain] Univ Bern, Inst Ecol & Evolut, Div Conservat Biol, Dept Biol, Bern, Switzerland; [Arlettaz, Raphael; Jacot, Alain] Swiss Ornithol Inst, Field Stn Valais, Sion, Switzerland; [Korner, Pius] Swiss Ornithol Inst, Sempach, Switzerland	University of Bern; Swiss Ornithological Institute; Swiss Ornithological Institute	Guyot, C (corresponding author), Univ Bern, Inst Ecol & Evolut, Div Conservat Biol, Dept Biol, Bern, Switzerland.	claire.guyot@iee.unibe.ch	Arlettaz, Raphael/O-2182-2016	Arlettaz, Raphael/0000-0001-6360-5339	University of Bern; Swiss Ornithological Institute; Swiss National Science Foundation [31003A_149780]	University of Bern; Swiss Ornithological Institute; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funding was provided by the University of Bern and the Swiss Ornithological Institute to RA and AJ. This project was supported by a Swiss National Science Foundation Grant to A.J. (No. 31003A_149780). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Arlettaz R, 2012, J ORNITHOL, V153, P229, DOI 10.1007/s10336-011-0737-7; Arlt D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003006; Assandri G, 2016, AGR ECOSYST ENVIRON, V223, P250, DOI 10.1016/j.agee.2016.03.014; Atkinson PW, 2004, IBIS, V146, P99, DOI 10.1111/j.1474-919X.2004.00346.x; BAIRLEIN F, 1983, ORNIS SCAND, V14, P239, DOI 10.2307/3676157; Baker DJ, 2012, J APPL ECOL, V49, P871, DOI 10.1111/j.1365-2664.2012.02161.x; Batary P, 2010, BIOL CONSERV, V143, P2020, DOI 10.1016/j.biocon.2010.05.005; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bouvier JC, 2011, ENVIRON TOXICOL CHEM, V30, P212, DOI 10.1002/etc.377; Brambilla M, 2009, ANIM CONSERV, V12, P71, DOI 10.1111/j.1469-1795.2008.00226.x; Brambilla M, 2008, IBIS, V150, P628, DOI 10.1111/j.1474-919X.2008.00822.x; Brambilla M, 2007, BIRD STUDY, V54, P160, DOI 10.1080/00063650709461471; Brambilla M, 2015, ECOL RES, V30, P597, DOI 10.1007/s11284-015-1260-8; Brambilla M, 2013, ARDEOLA, V60, P73, DOI 10.13157/arla.60.1.2012.73; Brambilla M, 2009, BIOL CONSERV, V142, P2033, DOI 10.1016/j.biocon.2009.03.033; Brambilla M, 2009, ORNIS FENNICA, V86, P41; Buckingham DL, 2011, AGR ECOSYST ENVIRON, V142, P256, DOI 10.1016/j.agee.2011.05.017; Buckingham DL, 2006, AGR ECOSYST ENVIRON, V112, P21, DOI 10.1016/j.agee.2005.06.019; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Caprio E, 2015, AGR SYST, V136, P61, DOI 10.1016/j.agsy.2015.02.009; Ceresa F, 2012, BIRD STUDY, V59, P327, DOI 10.1080/00063657.2012.676623; Cohen M, 2015, AGR ECOSYST ENVIRON, V212, P175, DOI 10.1016/j.agee.2015.06.023; Douglas DJT, 2009, J APPL ECOL, V46, P353, DOI 10.1111/j.1365-2664.2009.01613.x; Duarte J, 2014, BIRD STUDY, V61, P193, DOI 10.1080/00063657.2014.901294; Eggers S, 2011, BIOL CONSERV, V144, P1137, DOI 10.1016/j.biocon.2010.12.033; ESRI (Environmental Systems Resource Institute, 2015, ARCMAP 10 2 2 ESRI R; Evans KL, 2003, BIRD STUDY, V50, P8, DOI 10.1080/00063650309461284; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Fischer J, 2009, BIRD STUDY, V56, P34, DOI 10.1080/00063650802648127; Fournier J, 2001, IBIS, V143, P2, DOI 10.1111/j.1474-919X.2001.tb04163.x; Fuller RJ, 2001, AGR ECOSYST ENVIRON, V84, P79, DOI 10.1016/S0167-8809(00)00194-8; Gabriel D, 2010, ECOL LETT, V13, P858, DOI 10.1111/j.1461-0248.2010.01481.x; Gaigher R, 2015, BIOL CONSERV, V186, P69, DOI 10.1016/j.biocon.2015.03.003; Gelman A., 2021, ARM DATA ANAL USING; George TL, 2001, RESTOR ECOL, V9, P272, DOI 10.1046/j.1526-100x.2001.009003272.x; Gillespie M, 2012, J INSECT CONSERV, V16, P13, DOI 10.1007/s10841-011-9390-y; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; Gilroy JJ, 2010, IBIS, V152, P90, DOI 10.1111/j.1474-919X.2009.00988.x; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Herzon I, 2014, AGR ECOSYST ENVIRON, V183, P78, DOI 10.1016/j.agee.2013.10.015; Hinsley SA, 2000, J ENVIRON MANAGE, V60, P33, DOI 10.1006/jema.2000.0360; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kehinde T, 2014, AGR FOREST ENTOMOL, V16, P95, DOI 10.1111/afe.12038; Korner-Nievergelt F, 2015, BAYESIAN DATA ANAL E; Kosinski Z, 2000, EKOL BRATISLAVA, V19, P307; Kosulic O, 2014, ECOL ENG, V68, P133, DOI 10.1016/j.ecoleng.2014.03.030; Laiolo P, 2005, CONSERV BIOL, V19, P1547, DOI 10.1111/j.1523-1739.2005.004376.x; Low M, 2010, J ANIM ECOL, V79, P214, DOI 10.1111/j.1365-2656.2009.01595.x; MacLeod CJ, 2012, J APPL ECOL, V49, P652, DOI 10.1111/j.1365-2664.2012.02135.x; McCracken DI, 2004, IBIS, V146, P108, DOI 10.1111/j.1474-919X.2004.00360.x; Menz MHM, 2009, ARDEA, V97, P323, DOI 10.5253/078.097.0308; Moorcroft D, 2002, J APPL ECOL, V39, P535, DOI 10.1046/j.1365-2664.2002.00730.x; Morris AJ, 2004, IBIS, V146, P155, DOI 10.1111/j.1474-919X.2004.00361.x; Myczko L, 2013, ECOL RES, V28, P503, DOI 10.1007/s11284-013-1039-8; Nascimbene J, 2012, ENVIRON MANAGE, V49, P1054, DOI 10.1007/s00267-012-9834-5; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Perkins AJ, 2000, BIOL CONSERV, V95, P279, DOI 10.1016/S0006-3207(00)00042-2; Perkins AJ, 2002, AGR ECOSYST ENVIRON, V93, P413, DOI 10.1016/S0167-8809(01)00306-1; Pewsey A., 2013, CIRCULAR STAT R, DOI [10.1080/09332480.2015.1016851, DOI 10.1080/09332480.2015.1016851]; Pickett SRA, 2011, ECOGRAPHY, V34, P955, DOI 10.1111/j.1600-0587.2011.06608.x; Pithon JA, 2016, BASIC APPL ECOL, V17, P240, DOI 10.1016/j.baae.2015.12.004; QGIS Development Team, 2015, QGIS GEOGR INF SYST; R Core Team, 2015, R LANG EVN STAT COMP; Rosin ZM, 2016, PEERJ, V4, DOI 10.7717/peerj.2105; Schaub M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013115, 10.1371/journal.pone.0015046]; Schmid H, 2004, BERWACHUNG BESTANDES; Sierro Antoine, 2003, Nos Oiseaux, V50, P89; Siriwardena GM, 2008, IBIS, V150, P585, DOI 10.1111/j.1474-919X.2008.00828.x; Tagmann-Ioset A, 2012, ACTA OECOL, V39, P25, DOI 10.1016/j.actao.2011.11.003; Trivellone V, 2012, INSECT CONSERV DIVER, V5, P75, DOI 10.1111/j.1752-4598.2011.00151.x; Tscharntke T, 2007, BIOL CONTROL, V43, P294, DOI 10.1016/j.biocontrol.2007.08.006; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; TUCKER GM, 1992, J APPL ECOL, V29, P779, DOI 10.2307/2404488; Verhulst J, 2004, AGR ECOSYST ENVIRON, V104, P465, DOI 10.1016/j.agee.2004.01.043; Vickery J., 2012, BIRDS HABITAT RELATI, P177, DOI DOI 10.1017/CBO9781139021654.009; Vickery JA, 2001, J APPL ECOL, V38, P647, DOI 10.1046/j.1365-2664.2001.00626.x; Vickery JA, 2009, AGR ECOSYST ENVIRON, V133, P1, DOI 10.1016/j.agee.2009.05.012; Weisshaupt N, 2011, BIRD STUDY, V58, P111, DOI 10.1080/00063657.2011.556183; Whittingham MJ, 2004, IBIS, V146, P210, DOI 10.1111/j.1474-919X.2004.00370.x; Wilson JD, 1999, AGR ECOSYST ENVIRON, V75, P13, DOI 10.1016/S0167-8809(99)00064-X; Wilson JD, 2005, IBIS, V147, P453, DOI 10.1111/j.1474-919x.2005.00440.x; Winqvist C, 2011, J APPL ECOL, V48, P570, DOI 10.1111/j.1365-2664.2010.01950.x	87	27	27	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0170176	10.1371/journal.pone.0170176	http://dx.doi.org/10.1371/journal.pone.0170176			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146570	Green Published, Green Submitted, gold			2022-12-27	WOS:000396131700016
J	LaBerge, GS; Duvall, E; Grasmick, Z; Haedicke, K; Pawelek, J				LaBerge, Greggory S.; Duvall, Eric; Grasmick, Zachary; Haedicke, Kay; Pawelek, John			A Melanoma Lymph Node Metastasis with a Donor-Patient Hybrid Genome following Bone Marrow Transplantation: A Second Case of Leucocyte-Tumor Cell Hybridization in Cancer Metastasis	PLOS ONE			English	Article							STR LOCI; FUSION	Background Metastatic disease is the principal cause of mortality in cancer, yet the underlying mechanisms are not fully understood. Macrophage-cancer cell fusion as a cause of metastasis was proposed more than a century ago by German pathologist Prof. Otto Aichel. Since then this theory has been confirmed in numerous animal studies and recently in a patient with metastatic melanoma. Methods Here we analyzed tumor DNA from a 51-year-old man who, 8 years following an allogeneic BMT from his brother for treatment of chronic myelogenous leukemia (CML), developed a nodular malignant melanoma on the upper back with spread to an axillary sentinal lymph node. We used laser microdissection to isolate FFPE tumor cells free of leucocytes. They were genotyped using forensic short tandem repeat (STR) length-polymorphisms to distinguish donor and patient genomes. Tumor and pre-transplant blood lymphocyte DNAs were analyzed for donor and patient alleles at 15 autosomal STR loci and the sex chromosomes. Results DNA analysis of the primary melanoma and the nodal metastasis exhibit alleles at each STR locus that are consistent with both the patient and donor. The doses vary between these samples indicative of the relative amounts of genomic DNA derived from the patient and donor. Conclusion The evidence supports fusion and hybridization between donor and patient cells as the initiator of metastasis in this patient. That this phenomenon has now been seen in a second case suggests that fusion is likely to play a significant role for melanoma and other solid tumor metastasis, perhaps leading to new avenues of treatment for this most problematic disease.	[LaBerge, Greggory S.] Univ Colorado, Sch Med, Human Med Genet & Genom Program, Aurora, CO USA; [LaBerge, Greggory S.; Duvall, Eric] Denver Police Crime Lab, Forens & Evidence Div, Denver, CO USA; [Grasmick, Zachary] Univ Colorado AMC, Dept Pathol, Denver, CO USA; [Haedicke, Kay] Yale Sch Med, Dept Internal Med, Sect Med Oncol, New Haven, CT USA; [Haedicke, Kay; Pawelek, John] Yale Sch Med, Yale Canc Ctr, New Haven, CT 06510 USA; [Pawelek, John] Yale Sch Med, Dept Dermatol, New Haven, CT 06510 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; AMC Cancer Research Center; Yale University; Yale University; Yale University	Pawelek, J (corresponding author), Yale Sch Med, Yale Canc Ctr, New Haven, CT 06510 USA.; Pawelek, J (corresponding author), Yale Sch Med, Dept Dermatol, New Haven, CT 06510 USA.	john.pawelek@yale.edu						Aichel O., 1911, VORTRAGE AUFSATZE EN, P92; ALBINI A, 1985, COLLAGEN REL RES, V5, P283; Boon LK, 2006, INT C SERIES, V1288, P379; Buer J, 1997, BRIT J CANCER, V75, P1373, DOI 10.1038/bjc.1997.232; Chakraborty A, 2004, BONE MARROW TRANSPL, V34, P183, DOI 10.1038/sj.bmt.1704547; Collins PJ, 2004, J FORENSIC SCI, V49, P1265; Dittmar T, 2015, INT J MOL SCI, V16, P30362, DOI 10.3390/ijms161226240; Duelli D, 2007, NAT REV CANCER, V7, P968, DOI 10.1038/nrc2272; GOLDENBERG D M, 1968, European Journal of Cancer, V4, P547, DOI 10.1016/0014-2964(68)90011-X; GOLDENBERG DM, 1974, NATURE, V250, P649, DOI 10.1038/250649a0; Handerson T, 2003, CANCER RES, V63, P5363; Kemeny LV, 2016, INT J MOL SCI, V17; Kurgyis Z, 2016, INT J MOL SCI, V21, P17; LAGARDE AE, 1985, BIOCHIM BIOPHYS ACTA, V823, P81, DOI 10.1016/0304-419X(85)90008-3; Lazova R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066731; Leclair B, 2004, J FORENSIC SCI, V49, P968; Mekler L B, 1971, Vestn Akad Med Nauk SSSR, V26, P80; Mekler LB, 1968, MAT S GEN IMM CLUB I, P91; MUNZAROVA M, 1992, MELANOMA RES, V2, P127; Noubissi FK, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091587; Pawelek JM, 2000, MELANOMA RES, V10, P507, DOI 10.1097/00008390-200012000-00001; Pawelek JM, 2008, NAT REV CANCER, V8, P377, DOI 10.1038/nrc2371; Pawelek JM, 2014, CHIN J CANCER, V33, P133, DOI 10.5732/cjc.013.10243; Pawelek JM, 2008, ADV CANCER RES, V101, P397, DOI 10.1016/S0065-230X(08)00410-7; Platt JL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071118; Shabo I, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1935-0; Vinay DS, 2015, SEMIN CANCER BIOL, V35, pS185, DOI 10.1016/j.semcancer.2015.03.004; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Yilmaz Y, 2005, BONE MARROW TRANSPL, V35, P1021, DOI 10.1038/sj.bmt.1704939	29	36	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0168581	10.1371/journal.pone.0168581	http://dx.doi.org/10.1371/journal.pone.0168581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146572	Green Published, gold, Green Submitted			2022-12-27	WOS:000396131700002
J	Costa, S; Nicosia, A; Cuttitta, A; Gianguzza, F; Ragusa, MA				Costa, Salvatore; Nicosia, Aldo; Cuttitta, Angela; Gianguzza, Fabrizio; Ragusa, Maria Antonietta			An Intronic cis-Regulatory Element Is Crucial for the Alpha Tubulin PI-Tub alpha 1 alpha Gene Activation in the Ciliary Band and Animal Pole Neurogenic Domains during Sea Urchin Development	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; NEURAL DEVELOPMENT; NERVOUS-SYSTEM; ANTERIOR NEUROECTODERM; SPECIFICATION; EXPRESSION; PATTERNS; INSIGHTS; EMBRYOS; COMPETENCE	In sea urchin development, structures derived from neurogenic territory control the swimming and feeding responses of the pluteus as well as the process of metamorphosis. We have previously isolated an alpha tubulin family member of Paracentrotus lividus (PI-Tubal a, formerly known as PI-Talpha2 that is specifically expressed in the ciliary band and animal pole neurogenic domains of the sea urchin embryo. In order to identify cis-regulatory elements controlling its spatio-temporal expression, we conducted gene transfer experiments, transgene deletions and site specific mutagenesis. Thus, a genomic region of about 2.6 Kb of PI-Tubal a, containing four Interspecifically Conserved Regions (ICRs), was identified as responsible for proper gene expression. An enhancer role was ascribed to ICR1 and ICR2, while ICR3 exerted a pivotal role in basal expression, restricting Tuba1a expression to the proper territories of the embryo. Additionally, the mutation of the forkhead box consensus sequence binding site in ICR3 prevented PI-Tubal a expression.	[Costa, Salvatore; Gianguzza, Fabrizio; Ragusa, Maria Antonietta] Univ Palermo, Dept Biol Chem & Pharmaceut Sci & Technol, Palermo, Italy; [Nicosia, Aldo; Cuttitta, Angela] CNR, Inst Marine & Coastal Environm IAMC CNR, Detached Unit Capo Granitola, Lab Mol Ecol & Biotechnol, Torretta Granitola, Trapani, Italy	University of Palermo; Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR)	Ragusa, MA (corresponding author), Univ Palermo, Dept Biol Chem & Pharmaceut Sci & Technol, Palermo, Italy.	maria.ragusa@unipa.it	Cuttitta, Angela/AAK-2097-2020; Nicosia, Aldo/R-4462-2017	Cuttitta, Angela/0000-0002-4896-5114; Nicosia, Aldo/0000-0002-1013-2862; Ragusa, Maria Antonietta/0000-0002-8760-1022; Costa, Salvatore/0000-0003-2798-4401	Universita degli Studi di Palermo FFR - EX [4201/2007, 3098/2012]	Universita degli Studi di Palermo FFR - EX	This work was supported by the Universita degli Studi di Palermo FFR - EX60% [grant numbers 4201/2007 to FG and 3098/2012 to MAR]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angerer LM, 2011, DEVELOPMENT, V138, P3613, DOI 10.1242/dev.058172; Arnone MI, 2004, METHOD CELL BIOL, V74, P621; Barsi JC, 2015, DEVELOPMENT, V142, P953, DOI 10.1242/dev.117986; Bishop CD, 2013, DEV BIOL, V377, P236, DOI 10.1016/j.ydbio.2013.03.006; Burke RD, 2006, DEV BIOL, V300, P434, DOI 10.1016/j.ydbio.2006.08.007; Burke RD, 2014, GENESIS, V52, P208, DOI 10.1002/dvg.22750; Byrne M, 2007, EVOL DEV, V9, P432, DOI 10.1111/j.1525-142X.2007.00189.x; Casano C, 1996, INT J DEV BIOL, V40, P1033; Choksi SP, 2014, DEVELOPMENT, V141, P1427, DOI 10.1242/dev.074666; Cooper GM, 2003, CURR OPIN GENET DEV, V13, P604, DOI 10.1016/j.gde.2003.10.001; Costa S, 2004, BIOCHEM BIOPH RES CO, V316, P446, DOI 10.1016/j.bbrc.2004.02.070; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Davidson EH, 2008, P NATL ACAD SCI USA, V105, P20063, DOI 10.1073/pnas.0806007105; de-Leon SB, 2013, DEV BIOL, V374, P245, DOI 10.1016/j.ydbio.2012.11.013; Domanskyi A, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00275; Dunn EF, 2007, EVOL DEV, V9, P10, DOI 10.1111/j.1525-142X.2006.00134.x; Emanuele M, 2011, INT J DEV BIOL, V55, P591, DOI 10.1387/ijdb.103264me; Garner S, 2016, DEVELOPMENT, V143, P286, DOI 10.1242/dev.124503; GIANGUZZA F, 1995, INT J DEV BIOL, V39, P477; Hirokawa T, 2008, DEV GENES EVOL, V218, P15, DOI 10.1007/s00427-007-0196-6; Israel JW, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002391; Kos R, 2001, DEVELOPMENT, V128, P1467; Lapraz F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9434; Li EH, 2013, DEV BIOL, V382, P268, DOI 10.1016/j.ydbio.2013.07.027; MCMAHON AP, 1985, DEV BIOL, V108, P420, DOI 10.1016/0012-1606(85)90045-4; Murabe N, 2008, J COMP NEUROL, V509, P271, DOI 10.1002/cne.21742; Nakajima Y, 2004, EVOL DEV, V6, P95, DOI 10.1111/j.1525-142X.2004.04011.x; Nakano H, 2006, DEV BIOL, V292, P205, DOI 10.1016/j.ydbio.2005.12.038; Nakano H, 2009, DEV GENES EVOL, V219, P565, DOI 10.1007/s00427-010-0317-5; Nelms B. L., 2010, DEV BIOL, V1, P1; Ochoa-Espinosa A, 2006, CURR OPIN GENET DEV, V16, P165, DOI 10.1016/j.gde.2006.02.014; Poustka AJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r85; Ragusa MA, 2012, MOL BIOL REP, V39, P2633, DOI 10.1007/s11033-011-1016-7; Range R, 2014, GENESIS, V52, P222, DOI 10.1002/dvg.22759; Range RC, 2016, DEVELOPMENT, V143, P1523, DOI 10.1242/dev.128165; Range RC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001467; Saudemont A, 2010, PLOS GENET, V6, DOI [10.1371/journal.pgen.1001259, DOI 10.1371/J0URNAL.PGEN.1001259]; Stewart RA, 2006, DEV BIOL, V292, P174, DOI 10.1016/j.ydbio.2005.12.035; Stott SRW, 2013, J NEUROSCI, V33, P8022, DOI 10.1523/JNEUROSCI.4774-12.2013; Tan Y, 2010, GLOB TELECOMM CONF; Thomas J, 2010, BIOL CELL, V102, P499, DOI 10.1042/BC20100035; Tu Q, 2006, DEV BIOL, V300, P49, DOI 10.1016/j.ydbio.2006.09.031; Wei Z, 2016, DEVELOPMENT, V143, P298, DOI 10.1242/dev.125989; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; Yaguchi J, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006001; Yaguchi S, 2008, DEV CELL, V14, P97, DOI 10.1016/j.devcel.2007.10.012; Yaguchi S, 2006, DEVELOPMENT, V133, P2337, DOI 10.1242/dev.02396; Yaguchi S, 2010, DEV BIOL, V347, P71, DOI 10.1016/j.ydbio.2010.08.009; Yanez-Cuna JO, 2013, TRENDS GENET, V29, P11, DOI 10.1016/j.tig.2012.09.007; Yankura KA, 2013, P NATL ACAD SCI USA, V110, P8591, DOI 10.1073/pnas.1220903110; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111	52	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170969	10.1371/journal.pone.0170969	http://dx.doi.org/10.1371/journal.pone.0170969			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141828	gold, Green Published, Green Submitted			2022-12-27	WOS:000396129500031
J	dos Santos, MD; Kretschmer, R; Frankl-Vilches, C; Bakker, A; Gahr, M; O'Brien, PCM; Ferguson-Smith, MA; de Oliveira, EHC				dos Santos, Michelly da Silva; Kretschmer, Rafael; Frankl-Vilches, Carolina; Bakker, Antje; Gahr, Manfred; O'Brien, Patricia C. M.; Ferguson-Smith, Malcolm A.; de Oliveira, Edivaldo H. C.			Comparative Cytogenetics between Two Important Songbird, Models: The Zebra Finch and the Canary	PLOS ONE			English	Article							CHICKEN GALLUS-GALLUS; AVIAN GENOME EVOLUTION; 5S RDNA; TAENIOPYGIA-GUTTATA; CHROMOSOME; BIRDS; SEQUENCES; ORGANIZATION; MACROCHROMOSOMES; CONSERVATION	Songbird species (order Passeriformes, suborder Oscines) are important models in various experimental fields spanning behavioural genomics to neurobiology. Although the genomes of some songbird species were sequenced recently, the chromosomal organization of these species is mostly unknown. Here we focused on the two most studied songbird species in neuroscience, the zebra finch (Taeniopygia guttata) and the canary (Serinus canaria). In order to clarify these issues and also to integrate chromosome data with their assembled genomes, we used classical and molecular cytogenetics in both zebra finch and canary to define their chromosomal homology, localization of heterochromatic blocks and distribution of rDNA clusters. We confirmed the same diploid number (2n = 80) in both species, as previously reported. FISH experiments confirmed the occurrence of multiple paracentric and pericentric inversions previously found in other species of Passeriformes, providing a cytogenetic signature for this order, and corroborating data from in silico analyses. Additionally, compared to other Passeriformes, we detected differences in the zebra finch karyotype concerning the morphology of some chromosomes, in the distribution of 5S rDNA clusters, and an inversion in chromosome 1.	[dos Santos, Michelly da Silva] UFPA, ICB, Programa Posgrad Genet & Biol Mol, Belem, Para, Brazil; [Kretschmer, Rafael] Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil; [Frankl-Vilches, Carolina; Bakker, Antje; Gahr, Manfred] Max Planck Inst Ornithol, Dept Behav Neurobiol, Seewiesen, Germany; [O'Brien, Patricia C. M.; Ferguson-Smith, Malcolm A.] Univ Cambridge, Dept Vet Med, Cambridge Resource Ctr Comparat Genom, Cambridge, England; [de Oliveira, Edivaldo H. C.] Inst Evandro Chagas, SAMAM, Lab Cultura Tecidos & Citogenet, Ananindeua, PA, Brazil; [de Oliveira, Edivaldo H. C.] Fed Univ Para, ICEN, Fac Ciencias Nat, Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal do Rio Grande do Sul; Max Planck Society; University of Cambridge; Instituto Evandro Chagas; Universidade Federal do Para	de Oliveira, EHC (corresponding author), Inst Evandro Chagas, SAMAM, Lab Cultura Tecidos & Citogenet, Ananindeua, PA, Brazil.; de Oliveira, EHC (corresponding author), Fed Univ Para, ICEN, Fac Ciencias Nat, Belem, Para, Brazil.	ehco@ufpa.br	de Oliveira, Edivaldo H. C./C-3368-2013; Kretschmer, Rafael/M-7293-2019; Kretschmer, Rafael/B-7206-2017	de Oliveira, Edivaldo H. C./0000-0001-6315-3352; Kretschmer, Rafael/0000-0002-6856-2152; Kretschmer, Rafael/0000-0002-6856-2152	PROPESP/UFPA; Max Planck Institute for Ornithology; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [309699/2015-0]; Instituto Evandro Chagas	PROPESP/UFPA; Max Planck Institute for Ornithology(Max Planck Society); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Evandro Chagas	The authors would like to thank PROPESP/UFPA, Max Planck Institute for Ornithology, and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, for financial support (309699/2015-0), as well as Institute Evandro Chagas, for logistical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors would like to thank PROPESP/UFPA, Max Planck Institute for Ornithology, and Instituto Evandro Chagas, for support. We would like to thank Dr. Marcelo Cioffi (UFSC, Sao Carlos, SP-Brazil), for kindly providing the 5S and 18/28S rDNA probes.	Barbosa MD, 2013, GENET MOL BIOL, V36, P70, DOI 10.1590/S1415-47572013000100010; Barker FK, 2014, MOL PHYLOGENET EVOL, V79, P313, DOI 10.1016/j.ympev.2014.06.011; CARRASCAL LM, 1992, J BIOGEOGR, V19, P383, DOI 10.2307/2845566; Cioffi MB, 2011, CYTOGENET GENOME RES, V134, P295, DOI 10.1159/000329481; Oliveira EHC, 2010, CHROMOSOME RES, V18, P349, DOI 10.1007/s10577-010-9117-z; Daniels LM, 2003, CHROMOSOME RES, V11, P305, DOI 10.1023/A:1024008522122; de Oliveira EHC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070071; de Oliveira EHC, 2005, CHROMOSOMA, V114, P338, DOI 10.1007/s00412-005-0009-5; Delany ME, 2000, CYTOGENET CELL GENET, V90, P139, DOI 10.1159/000015649; Demin A, 2015, PREPRINT; Derjusheva S, 2004, CHROMOSOME RES, V12, P715, DOI 10.1023/B:CHRO.0000045779.50641.00; dos Santos MD, 2015, GENETICA, V143, P535, DOI 10.1007/s10709-015-9851-4; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Dyomin AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157464; Farre M, 2016, GENOME BIOL EVOL, V8, P2442, DOI 10.1093/gbe/evw166; Ferreira IA, 2007, CYTOGENET GENOME RES, V118, P78, DOI 10.1159/000106445; Frankl-Vilches C, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0578-9; Gill LF, 2015, ELIFE, V4, DOI 10.7554/eLife.07770; Griffin DK, 2007, CYTOGENET GENOME RES, V117, P64, DOI 10.1159/000103166; Guttenbach M, 2003, CYTOGENET GENOME RES, V103, P173, DOI 10.1159/000076309; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Islam FB, 2014, J POULT SCI, V51, P1, DOI 10.2141/jpsa.0130090; Itoh Y, 2005, CHROMOSOME RES, V13, P47, DOI 10.1007/s10577-005-6602-x; Itoh Y, 2011, CHROMOSOMA, V120, P255, DOI 10.1007/s00412-010-0308-3; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Kretschmer R, 2014, J BIOTECHNOLOGY BIOD, V5, P140; Kretschmer R, 2015, BIOL J LINN SOC, V115, P391, DOI 10.1111/bij.12504; Kretschmer R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103338; Ladjali-Mohammedi K, 1999, CYTOGENET CELL GENET, V86, P271, DOI 10.1159/000015318; Ledesma Mario A., 2006, Revista Brasileira de Ornitologia, V14, P59; Martins Cesar, 2004, P335; McPherson MC, 2014, CHROMOSOME RES, V22, P71, DOI 10.1007/s10577-014-9411-2; Merlo MA, 2013, J MOL EVOL, V76, P83, DOI 10.1007/s00239-013-9541-8; Nanda I, 2011, CYTOGENET GENOME RES, V132, P165, DOI 10.1159/000322358; Nanda I, 2002, CHROMOSOMA, V111, P215, DOI 10.1007/s00412-002-0206-4; Nanda I., 1994, GENOME RES, V65, P190, DOI DOI 10.1159/000133630; OHNO S, 1964, CHROMOSOMA, V15, P280, DOI 10.1007/BF00321513; Pigozzi MI, 1998, CHROMOSOME RES, V6, P105, DOI 10.1023/A:1009234912307; Pinhal D, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-151; Raudsepp T, 2002, CYTOGENET GENOME RES, V98, P54, DOI 10.1159/000068532; Romanov MN, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1060; SEABRIGH.M, 1971, LANCET, V2, P971; Shaw P, 2012, PLANT PHYSIOL, V158, P44, DOI 10.1104/pp.111.188052; Shibusawa M, 2004, CYTOGENET GENOME RES, V106, P111, DOI 10.1159/000078570; Skinner BM, 2012, HEREDITY, V108, P37, DOI 10.1038/hdy.2011.99; Stapley J, 2008, GENETICS, V179, P651, DOI 10.1534/genetics.107.086264; SUMNER AT, 1974, EXP CELL RES, V83, P438, DOI 10.1016/0014-4827(74)90366-8; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Zeigler H., 2002, BEHAV NEUROBIOLOGY B; Zhang GJ, 2014, SCIENCE, V346, P1311, DOI 10.1126/science.1251385	50	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170997	10.1371/journal.pone.0170997	http://dx.doi.org/10.1371/journal.pone.0170997			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129381	Green Published, Green Submitted, gold			2022-12-27	WOS:000396211400013
J	Eibler, D; Abdurahman, H; Ruoff, T; Kaffarnik, S; Steingass, H; Vetter, W				Eibler, Dorothee; Abdurahman, Halima; Ruoff, Tanja; Kaffarnik, Stefanie; Steingass, Herbert; Vetter, Walter			Unexpected Formation of Low Amounts of (R)-Configurated anteiso-Fatty Acids in Rumen Fluid Experiments	PLOS ONE			English	Article							CHAIN AMINO-ACIDS; BACILLUS-SUBTILIS; METHYL-ESTERS; L-ISOLEUCINE; ISO-FATTY; RAT SKIN; MILK-FAT; BIOSYNTHESIS; METABOLISM; BACTERIA	Anteiso-fatty acids (aFA) with odd carbon number are a class of branchedchain fatty acids (BCFA) mainly produced by bacteria. Bacterial sources are also made responsible for their occurrence in the low percentrange in lipids of ruminants (meat and milk) and fish. aFAs are chiral molecules and typically occur predominantly in form of (S)-enantiomers, and their primary precursor has been noted to be isoleucine. Yet, low proportions of (R)-aFAs were also detected in fish and cheese samples. Here we investigated the potential formation of (R)-aFAs by means of incubation experiments with rumen fluid from fistulated cows. Supplementation of rumen fluid with both L- and DL-isoleucine, resulted in a significant (a <0.05) increase of the aFA concentrations but in both cases enantiopure (S)-aFAs were observed. By contrast, incubations without addition of any isoleucine lead to a significant (a <0.05) formation of small proportions of (R)-aFAs similarly to those previously observed in fish and cheese. These results were consistently reproduced in three different years with rumen fluid from different cows fed different diets. All findings point to the existence of a further biosynthesis pathway of aFAs with different stereospecificity than the classic one using isoleucine as primer.	[Eibler, Dorothee; Abdurahman, Halima; Ruoff, Tanja; Kaffarnik, Stefanie; Vetter, Walter] Univ Hohenheim, Inst Food Chem 170B, Stuttgart, Germany; [Steingass, Herbert] Univ Hohenheim, Inst Anim Sci 460A, Stuttgart, Germany	University Hohenheim; University Hohenheim	Vetter, W (corresponding author), Univ Hohenheim, Inst Food Chem 170B, Stuttgart, Germany.	walter.vetter@uni-hohenheim.de		Eibler, Dorothee/0000-0001-6838-8206	Ministry of Science, Research and Art of Baden-Wurttemberg (Germany) [N271]	Ministry of Science, Research and Art of Baden-Wurttemberg (Germany)	This work was supported by the Ministry of Science, Research and Art of Baden-Wurttemberg (Germany); DE; grant N271 (https://www.uni-hohenheim.de/landesgraduiertenfoerderung). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKMAN RG, 1970, COMP BIOCHEM PHYSIOL, V32, P117, DOI 10.1016/0010-406X(70)90160-X; ADAMS E, 1972, ENZYMES, V6, P479; BADA JL, 1972, EARTH PLANET SC LETT, V15, P1, DOI 10.1016/0012-821X(72)90022-2; BADA JL, 1986, NATURE, V319, P314, DOI 10.1038/319314a0; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Deutsche Gesellschaft fur Fettwissenschaft, 2012, FETTS DTSCH EINH UNT; Eibler D, 2015, J AGR FOOD CHEM, V63, P8921, DOI 10.1021/acs.jafc.5b03877; FULCO AJ, 1983, PROG LIPID RES, V22, P133, DOI 10.1016/0163-7827(83)90005-X; GERSON T, 1959, BIOCHEM J, V73, P594, DOI 10.1042/bj0730594; HANSEN RP, 1952, BIOCHEM J, V52, P203, DOI 10.1042/bj0520203; HARFOOT C G, 1978, Progress in Lipid Research, V17, P21, DOI 10.1016/0079-6832(78)90004-6; Hauff S, 2010, LIPIDS, V45, P357, DOI 10.1007/s11745-010-3400-9; Hauff S, 2010, J CHROMATOGR A, V1217, P1683, DOI 10.1016/j.chroma.2010.01.036; Hauff S, 2010, J AGR FOOD CHEM, V58, P707, DOI 10.1021/jf9034805; Hauff S, 2009, ANAL CHIM ACTA, V636, P229, DOI 10.1016/j.aca.2009.01.056; Kaffarnik S, 2015, J AGR FOOD CHEM, V63, P469, DOI 10.1021/jf505452u; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; KANEDA T, 1977, BACTERIOL REV, V41, P391, DOI 10.1128/MMBR.41.2.391-418.1977; KANEDA T, 1966, BIOCHIM BIOPHYS ACTA, V125, P43, DOI 10.1016/0005-2760(66)90142-1; KANEDA T, 1988, BIOCHIM BIOPHYS ACTA, V960, P10, DOI 10.1016/0005-2760(88)90003-3; KANEDA T, 1971, BIOCHEMISTRY-US, V10, P340, DOI 10.1021/bi00778a022; KANEDA T, 1963, J BIOL CHEM, V238, P1229; KEENEY M, 1962, J AM OIL CHEM SOC, V39, P198, DOI 10.1007/BF02635818; LIVINGSTON M, 1957, BIOCHEM J, V65, P438, DOI 10.1042/bj0650438; MAMER OA, 1992, J BIOL CHEM, V267, P22141; Mamer OA, 2001, J CHROMATOGR B, V758, P49, DOI 10.1016/S0378-4347(01)00111-6; MENKE KH, 1979, J AGR SCI, V93, P217, DOI 10.1017/S0021859600086305; MORICE IM, 1956, BIOCHEM J, V64, P461, DOI 10.1042/bj0640461; MORII H, 1982, COMP BIOCHEM PHYS B, V71, P357, DOI 10.1016/0305-0491(82)90395-9; OKU H, 1988, J BIOL CHEM, V263, P18386; OKU H, 1994, BBA-LIPID LIPID MET, V1214, P279; OKU H, 1995, BIOSCI BIOTECH BIOCH, V59, P891, DOI 10.1271/bbb.59.891; Or-Rashid MM, 2007, J ANIM SCI, V85, P1228, DOI 10.2527/jas.2006-385; Ran-Ressler RR, 2014, BRIT J NUTR, V112, P565, DOI 10.1017/S0007114514001081; Sachs L., 2006, ANGEW STAT METHODENS, V12th ed., DOI [10.1007/978-3-540-32161-3, DOI 10.1007/978-3-540-32161-3]; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Singh VK, 2008, APPL ENVIRON MICROB, V74, P5882, DOI 10.1128/AEM.00882-08; SMITH GG, 1978, J ORG CHEM, V43, P1, DOI 10.1021/jo00395a001; SUUTARI M, 1994, CRIT REV MICROBIOL, V20, P285, DOI 10.3109/10408419409113560; Thurnhofer S, 2005, J AGR FOOD CHEM, V53, P8896, DOI 10.1021/jf051468u; Thurnhofer S, 2008, EUR FOOD RES TECHNOL, V226, P975, DOI 10.1007/s00217-007-0619-7; Thurnhofer S, 2007, ANAL CHEM, V79, P4696, DOI 10.1021/ac0702894; Thurnhofer S, 2007, TETRAHEDRON, V63, P1140, DOI 10.1016/j.tet.2006.11.059; TWEEDIE JW, 1966, J SCI FOOD AGR, V17, P241, DOI 10.1002/jsfa.2740170603; Vetter W, 2001, FOOD REV INT, V17, P113, DOI 10.1081/FRI-100000513	45	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170788	10.1371/journal.pone.0170788	http://dx.doi.org/10.1371/journal.pone.0170788			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129363	Green Published, gold, Green Submitted			2022-12-27	WOS:000396211400035
J	Kogo, H; Murata, J; Murata, S; Higashi, T				Kogo, Haruki; Murata, Jun; Murata, Shin; Higashi, Toshio			Validity of a New Quantitative Evaluation Method that Uses the Depth of the Surface Imprint as an Indicator for Pitting Edema	PLOS ONE			English	Article							LYMPHEDEMA; MRI	This study examined the validity of a practical evaluation method for pitting edema by comparing it to other methods, including circumference measurements and ultrasound image measurements. Fifty-one patients (102 legs) from a convalescent ward in Maruyama Hospital were recruited for study 1, and 47 patients (94 legs) from a convalescent ward in Morinaga Hospital were recruited for study 2. The relationship between the depth of the surface imprint and circumferential measurements, as well as the relationship between the depth of the surface imprint and the thickness of the subcutaneous soft tissue on an ultrasonogram, were analyzed using a Spearman correlation coefficient by rank. There was no significant relationship between the surface imprint depth and circumferential measurements. However, there was a significant relationship between the depth of the surface imprint and the thickness of the subcutaneous soft tissue as measured on an ultrasonogram (correlation coefficient 0.736). Our findings suggest that our novel evaluation method for pitting edema, based on a measurement of the surface imprint depth, is both valid and useful.	[Kogo, Haruki] Nishikyushu Univ, Fac Rehabil Sci, Kanzaki, Saga, Japan; [Kogo, Haruki; Murata, Jun; Higashi, Toshio] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki, Japan; [Murata, Shin] Kyoto Tachibana Univ, Fac Hlth Sci, Yamashina Ku, Kyoto, Japan	Nagasaki University; Kyoto Tachibana University	Kogo, H (corresponding author), Nishikyushu Univ, Fac Rehabil Sci, Kanzaki, Saga, Japan.; Kogo, H (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki, Japan.	kogoha@nisikyu-u.ac.jp			Japan Society for the Promotion of Science (JSPS KAKENHI) [JP 16K01807]; Nagasaki University; Grants-in-Aid for Scientific Research [16K01807] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Nagasaki University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS KAKENHI, Grant Number: JP 16K01807) and Nagasaki University, which paid for English proofreading for the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arisawa M, 1996, ACTA OBSTET GYN JPN, V48, P25; Brodovicz KG, 2009, CLIN MED RES, V7, P21, DOI 10.3121/cmr.2009.819; Dimakakos PB, 1997, INT SURG, V82, P411; Gerber LH, 1998, CANCER, V83, P2803, DOI 10.1002/(SICI)1097-0142(19981215)83:12B+<2803::AID-CNCR29>3.3.CO;2-N; Hirota A, 2008, J JPN COLL ANGIOL, V48, P159; Imanaka S, 1997, Nihon Ronen Igakkai Zasshi, V34, P668; Kogo H, 2015, J PHYS THER SCI, V27, P1735, DOI 10.1589/jpts.27.1735; Lu Q, 2014, CLIN RADIOL, V69, P1287, DOI 10.1016/j.crad.2014.08.011; Maihafer George C, 2003, J Hand Ther, V16, P305, DOI 10.1197/S0894-1130(03)00155-8; Mawdsley RH, 2000, J ORTHOP SPORT PHYS, V30, P149, DOI 10.2519/jospt.2000.30.3.149; Niimi Kiyoaki, 2014, Ann Vasc Dis, V7, P369, DOI 10.3400/avd.oa.14-00104; Ohashi Toshio, 2007, Nihon Seirigaku Zasshi, V69, P102; Pellecchia Geraldine L, 2003, J Hand Ther, V16, P300, DOI 10.1197/S0894-1130(03)00154-6; Rutkove SB, 2009, MUSCLE NERVE, V40, P936, DOI 10.1002/mus.21362; Tamaki K, 2006, SOGO RINSHO, V55, P2594; Taylor R, 2006, PHYS THER, V86, P205, DOI 10.1093/ptj/86.2.205; Terada S, 2010, J PHYS THER SCI, V22, P129, DOI 10.1589/jpts.22.129; Yoshida S, 2001, BRIT J RADIOL, V74, P1013, DOI 10.1259/bjr.74.887.741013	18	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170810	10.1371/journal.pone.0170810	http://dx.doi.org/10.1371/journal.pone.0170810			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129366	Green Published, gold, Green Submitted			2022-12-27	WOS:000396211400031
J	Msalya, G; Kim, ES; Laisser, ELK; Kipanyula, MJ; Karimuribo, ED; Kusiluka, LJM; Chenyambuga, SW; Rothschild, MF				Msalya, George; Kim, Eui-Soo; Laisser, Emmanuel L. K.; Kipanyula, Maulilio J.; Karimuribo, Esron D.; Kusiluka, Lughano J. M.; Chenyambuga, Sebastian W.; Rothschild, Max F.			Determination of Genetic Structure and Signatures of Selection in Three Strains of Tanzania Shorthorn Zebu, Boran and Friesian Cattle by Genome- Wide SNP Analyses	PLOS ONE			English	Article							DAIRY-CATTLE; BOS-TAURUS; R-PACKAGE; POPULATIONS; BREEDS; DIVERSITY; MARKERS; TOOL; ASSOCIATION; ANCESTRY	Background More than 90 percent of cattle in Tanzania belong to the indigenous Tanzania Short Horn Zebu (TSZ) population which has been classified into 12 strains based on historical evidence, morphological characteristics, and geographic distribution. However, specific genetic information of each TSZ population has been lacking and has caused difficulties in designing programs such as selection, crossbreeding, breed improvement or conservation. This study was designed to evaluate the genetic structure, assess genetic relationships, and to identify signatures of selection among cattle of Tanzania with the main goal of understanding genetic relationship, variation and uniqueness among them. Methodology/Principal findings The Illumina Bos indicus SNP 80K BeadChip was used to genotype genome wide SNPs in 168 DNA samples obtained from three strains of TSZ cattle namely Maasai, Tarime and Sukuma as well as two comparative breeds; Boran and Friesian. Population structure and signatures of selection were examined using principal component analysis (PCA), admixture analysis, pairwise distances (FST), integrated haplotype score (iHS), identical by state (IBS) and runs of homozygosity (ROH). There was a low level of inbreeding (F similar to 0.01) in the TSZ population compared to the Boran and Friesian breeds. The analyses of FST, IBS and admixture identified no considerable differentiation between TSZ trains. Importantly, common ancestry in Boran and TSZ were revealed based on admixture and IBD, implying gene flow between two populations. In addition, Friesian ancestry was found in Boran. A few common significant iHS were detected, which may reflect influence of recent selection in each breed or strain. Conclusions Population admixture and selection signatures could be applied to develop conservation plan of TSZ cattle as well as future breeding programs in East African cattle.	[Msalya, George; Laisser, Emmanuel L. K.; Chenyambuga, Sebastian W.] Sokoine Univ Agr, Dept Anim Aquaculture & Range Sci, Morogoro, Tanzania; [Kim, Eui-Soo; Rothschild, Max F.] Iowa State Univ, Dept Anim Sci, Ames, IA USA; [Laisser, Emmanuel L. K.] Minist Educ & Vocat Training, Inspectorate Dept Eastern Zone, Morogoro, Tanzania; [Kipanyula, Maulilio J.] SUA, Dept Vet Anat, Morogoro, Tanzania; [Karimuribo, Esron D.; Kusiluka, Lughano J. M.] SUA, Dept Vet Med & Publ Hlth, Morogoro, Tanzania; [Kusiluka, Lughano J. M.] Nelson Mandela African Inst Sci & Technol, Arusha, Tanzania	Sokoine University of Agriculture; Iowa State University; Sokoine University of Agriculture; Sokoine University of Agriculture; Nelson Mandela African Institution of Science & Technology	Msalya, G (corresponding author), Sokoine Univ Agr, Dept Anim Aquaculture & Range Sci, Morogoro, Tanzania.	msalya@suanet.ac.tz		Laisser, Emmanuel/0000-0001-7023-4759; Msalya, George/0000-0001-7005-247X	Norwegian Agency for International Development (NORAD); Ensminger Endowment, College of Agriculture and Life Sciences, Iowa State University; Hatch Funding	Norwegian Agency for International Development (NORAD); Ensminger Endowment, College of Agriculture and Life Sciences, Iowa State University; Hatch Funding	We acknowledge the generous funding of The Norwegian Agency for International Development (NORAD) to the Tarime Zebu cattle project through the programme for Enhancing Pro poor Innovation in Natural Resources and Agricultural Value Chains (EPINAV) at Sokoine University of Agriculture. Additional funding for genotyping at GENESEEK was received from the Ensminger Endowment, College of Agriculture and Life Sciences, Iowa State University and Hatch Funding.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Barbato M, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00109; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen Xing, 2015, Open Journal of Animal Sciences, V5, P358, DOI 10.4236/ojas.2015.54040; Dadi H, 2008, ANIM GENET, V39, P425, DOI 10.1111/j.1365-2052.2008.01748.x; Edea Zewdu, 2012, Genomics & Informatics, V10, P200, DOI 10.5808/GI.2012.10.3.200; Epstein H., 1971, THE ORIGIN OF THE DO, V1, P573; EXCOFFIER L, 1992, GENETICS, V131, P479; Gautier M, 2012, BIOINFORMATICS, V28, P1176, DOI 10.1093/bioinformatics/bts115; Gorbach DM, 2010, J ANIM BREED GENET, V127, P348, DOI 10.1111/j.1439-0388.2010.00864.x; Gu L, 2009, IMMUNOL LETT, V123, P179, DOI 10.1016/j.imlet.2009.03.010; GWAKISA PS, 1994, ANIM GENET, V25, P89, DOI 10.1111/j.1365-2052.1994.tb00085.x; Haegeman A, 2003, ANIM GENET, V34, P290, DOI 10.1046/j.1365-2052.2003.00994.x; Hanotte O, 2002, SCIENCE, V296, P336, DOI 10.1126/science.1069878; Jiang ZH, 2009, INT J BIOL SCI, V5, P528; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kelder T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006447; Keller MC, 2011, GENETICS, V189, P237, DOI 10.1534/genetics.111.130922; Kim ES, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00443; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Kurwijila RL, 2001, P SUA MU ENRECA PROJ, P2; Laisser ELK, 2015, LIVESTOCK RES RURAL, V27, P64; Laisser ELK, 2014, TROP ANIM HEALTH PRO, V46, P1391, DOI 10.1007/s11250-014-0651-0; Lin BZ, 2010, ANIM SCI J, V81, P281, DOI 10.1111/j.1740-0929.2010.00744.x; LOFTUS RT, 1994, P NATL ACAD SCI USA, V91, P2757, DOI 10.1073/pnas.91.7.2757; Lutz TA, 2001, AM J PHYSIOL-REG I, V280, pR1697, DOI 10.1152/ajpregu.2001.280.6.R1697; Mastrangelo S, 2016, ANIMAL, V10, P746, DOI 10.1017/S1751731115002943; Mchau KW, 2006, TANZANIA J AGR SCI, V7, P67; McTavish EJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1469-5; MLDF, 2014, LIV SECT DEV PROGR M, P13; Msanga Y.N., 2001, P SUA MU ENRECA PROJ, P36; Mwambene P. L., 2012, Animal Genetic Resources, P31; Mwatawala HW, 2001, FARM ANIMAL GENETIC, P102; Nishimura R, 2010, J REPROD DEVELOP, V56, P110, DOI 10.1262/jrd.09-162E; O'Brien AMP, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-19; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rege J. E. O., 1999, Animal Genetic Resources Information, P1; REYNOLDS J, 1983, GENETICS, V105, P767; Sambrook J., 2001, MOL CLONING LAB MANU; Sorensen AC, 2005, J DAIRY SCI, V88, P1865, DOI 10.3168/jds.S0022-0302(05)72861-7; Syrstad O, 1998, TROP ANIM HEALTH PRO, V30, P257, DOI 10.1023/A:1005083430140; Syrstad O, 1996, TROP ANIM HEALTH PRO, V28, P223, DOI 10.1007/BF02240940; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Watanabe A, 2001, COMP BIOCHEM PHYS B, V130, P547, DOI 10.1016/S1096-4959(01)00464-X; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zhang L., 2014, HUM VACC IMMUNOTHER, V10, P10, DOI [DOI 10.1371/J0URNAL.P0NE.0111127, DOI 10.2147/NDT.S56020]; Zhang QQ, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0227-7; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	52	14	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0171088	10.1371/journal.pone.0171088	http://dx.doi.org/10.1371/journal.pone.0171088			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129396	Green Published, Green Submitted, gold			2022-12-27	WOS:000396211400008
J	Okoduwa, SIR; Umar, IA; James, DB; Inuwa, HM				Okoduwa, Stanley Irobekhian Reuben; Umar, Ismaila A.; James, Dorcas B.; Inuwa, Hajiya M.			Appropriate Insulin Level in Selecting Fortified Diet-Fed, Streptozotocin-Treated Rat Model of Type 2 Diabetes for Anti-Diabetic Studies	PLOS ONE			English	Article							HIGH-FAT DIET; BETA-CELL MASS; ANIMAL-MODELS; RESISTANCE; FRUCTOSE; GLUCOSE	Background Pathophysiological investigation of disease in a suitable animal model is a classical approach towards development of a credible therapeutic strategy. This study examined appropriate insulin level in selecting animal model for type 2 diabetes (T2D) studies. Method Albino Wistar rats (150-200g) were divided into two groups fed with commercially available normal-diet-feed (NDF) and water or fortified diet feed (FDF) (10g NDF per gram of margarine) with 20% fructose solution as drinking water. After 6 weeks of dietary regimen both groups were divided into 5 sub-groups and injected intraperitoneally with a graded dose of streptozotocin (STZ) (0, 25, 35, 45 & 55mg/kg bw.). Result The result showed that the FDF-fed rats increased significantly in body weight, basal serum insulin, total cholesterol, triglycerides and blood glucose levels as compared to NDF-fed rats. Ten days post STZ induction, the groups treated with STZ (45 & 55 mg/kg) developed frank hyperglycaemia with < 46.8% serum insulin, a severe deficiency typical of diabetes type 1. The NDF25 and NDF35 groups with 75.7% and 64.4% serum insulin respectively presented relative normoglycemia, whereas the FDF35 (85.8% serum insulin) were notably hyperglycaemia (>300 mg/dL) throughout the 6weeks post diabetes confirmation. These FDF35 rats were sensitive to glibenclamide, metformin and pioglitazone in lowering hyperglycaemia, hypertriglyceridemia and hypercholesterolemia Conclusion The hyperglycaemia stability of the FDF35 rats (85.5% insulin) together with their sensitivity to 3 different hypoglycaemic drugs strongly suggests their suitability as a non-genetic model of T2D. Hence the study shows that circulating serum insulin >= 85.8% with overt hyperglycaemia may be utilized as the benchmark in selecting rat models for T2D studies.	[Okoduwa, Stanley Irobekhian Reuben; Umar, Ismaila A.; James, Dorcas B.; Inuwa, Hajiya M.] Ahmadu Bello Univ, Dept Biochem, Zaria, Nigeria; [Okoduwa, Stanley Irobekhian Reuben] Nigerian Inst Leather & Sci Technol, Directorate Res & Dev, Zaria, Nigeria	Ahmadu Bello University	Okoduwa, SIR (corresponding author), Ahmadu Bello Univ, Dept Biochem, Zaria, Nigeria.; Okoduwa, SIR (corresponding author), Nigerian Inst Leather & Sci Technol, Directorate Res & Dev, Zaria, Nigeria.	siroplc@gmail.com	Okoduwa, S.I.R./H-6826-2019	Okoduwa, S.I.R./0000-0002-3542-495X; OKODUWA, Stanley Irobekhian Reuben/0000-0002-5471-6544				Aida Zarfeshani, 2012, Pakistan Journal of Nutrition, V11, P21; Akpaso M. I., 2011, British Journal of Medicine and Medical Research, V1, P24; Al-awar A, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/9051426; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; [Anonymous], 2012, AJMMS, V2, P45, DOI [10.5923/j.ajmms.20120203.04, DOI 10.5923/J.AJMMS.20120203.04]; Atawodi SE, 2005, AFR J BIOTECHNOL, V4, P128; Bantle JP, 2006, NES NUTR WS, V11, P83, DOI 10.1159/000094427; Basciano Heather, 2005, Nutr Metab (Lond), V2, P5, DOI 10.1186/1743-7075-2-5; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Cantley J, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0140-6; de Moura RF, 2009, BRIT J NUTR, V101, P1178, DOI 10.1017/S0007114508066774; Dupas J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146821; Eddouks M, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/142087; Fasola T, 2010, ETHNOBOTANICAL LEAFL, V14, P759; Franconi F, 2008, PHARMACOL RES, V57, P6, DOI 10.1016/j.phrs.2007.11.007; Gajda A. M., 2007, ANIMAL LAB NEWS; Gale EAM, 2002, NEW ENGL J MED, V346, P1740, DOI 10.1056/NEJM200205303462211; Han DH, 1997, DIABETES, V46, P1761, DOI 10.2337/diabetes.46.11.1761; Herold KC, 2015, J CLIN INVEST, V125, P1163, DOI 10.1172/JCI78142; Holman RR, 2013, NAT REV ENDOCRINOL, V9, P67, DOI 10.1038/nrendo.2012.243; HOOGWERF BJ, 1983, J CLIN ENDOCR METAB, V56, P60, DOI 10.1210/jcem-56-1-60; Hu SH, 2013, EXP CLIN ENDOCR DIAB, V121, P220, DOI 10.1055/s-0032-1333277; IDF, 2013, DIABETES ATLAS; IDF, 2015, ATLAS; Kargar C, 2008, DIABETES OBES METAB, V10, P43, DOI 10.1111/j.1463-1326.2008.00940.x; Khan HBH, 2013, INFLAMMOPHARMACOLOGY, V21, P37, DOI 10.1007/s10787-011-0109-1; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; Klinke DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001374; Krishna B. D., 2012, Journal of Indian Veterinary Association, Kerala (JIVA), V10, P22; Kuate D, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0051-0; Leiter EH, 2009, METHODS MOL BIOL, V560, P1, DOI 10.1007/978-1-59745-448-3_1; Mamikutty N, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/263897; Masiello P, 1998, DIABETES, V47, P224, DOI 10.2337/diabetes.47.2.224; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Matveyenko AV, 2008, DIABETES OBES METAB, V10, P23, DOI 10.1111/j.1463-1326.2008.00939.x; Modu S, 2013, IJMPAM S1, V1; Nepton S, 2013, ENDOCRINOL METAB, P115; Reed MJ, 2000, METABOLISM, V49, P1390, DOI 10.1053/meta.2000.17721; Sasidharan SR, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/752870; Schaalan M, 2009, J DIABETES COMPLICAT, V23, P199, DOI 10.1016/j.jdiacomp.2008.02.003; Skovso S, 2014, J DIABETES INVEST, V5, P349, DOI 10.1111/jdi.12235; Srinivasan K, 2007, INDIAN J MED RES, V125, P451; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Stark AH, 2000, EUR J NUTR, V39, P229, DOI 10.1007/s003940070016; Suman RK, 2016, ADV PHARM SCI, V2016, P11; Wang GY, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0892; Willett W C, 2002, Obes Rev, V3, P59, DOI 10.1046/j.1467-789X.2002.00060.x; Wilson RD, 2012, PHARMACOL REP, V64, P129, DOI 10.1016/S1734-1140(12)70739-9; Yoon SS, 2008, J ETHNOPHARMACOL, V118, P396, DOI 10.1016/j.jep.2008.05.014; Zhang M, 2008, EXP DIABETES RES, DOI 10.1155/2008/704045	50	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170971	10.1371/journal.pone.0170971	http://dx.doi.org/10.1371/journal.pone.0170971			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129400	Green Submitted, Green Published, gold			2022-12-27	WOS:000396211400016
J	Buntgen, U; Bagi, I; Fekete, O; Molinier, V; Peter, M; Splivallo, R; Vahdatzadeh, M; Richard, F; Murat, C; Tegel, W; Stobbe, U; Martinez-Pena, F; Sproll, L; Hulsmann, L; Nievergelt, D; Meier, B; Egli, S				Buntgen, Ulf; Bagi, Istvan; Fekete, Oszkar; Molinier, Virginie; Peter, Martina; Splivallo, Richard; Vahdatzadeh, Maryam; Richard, Franck; Murat, Claude; Tegel, Willy; Stobbe, Ulrich; Martinez-Pena, Fernando; Sproll, Ludger; Hulsmann, Lisa; Nievergelt, Daniel; Meier, Barbara; Egli, Simon			New Insights into the Complex Relationship between Weight and Maturity of Burgundy Truffles ( Tuber aestivum)	PLOS ONE			English	Article							ECTOMYCORRHIZAL COMMUNITIES; UNCINATUM; VITTAD.; AROMA; CULTIVATION; DECOMPOSITION; VARIABILITY; MICROBIOME; VOLATILES	Despite an increasing demand for Burgundy truffles (Tuber aestivum), gaps remain in our understanding of the fungus' overall lifecycle and ecology. Here, we compile evidence from three independent surveys in Hungary and Switzerland. First, we measured the weight and maturity of 2,656 T. aestivum fruit bodies from a three-day harvest in August 2014 in a highly productive orchard in Hungary. All specimens ranging between 2 and 755 g were almost evenly distributed through five maturation classes. Then, we measured the weight and maturity of another 4,795 T. aestivum fruit bodies harvested on four occasions between June and October 2015 in the same truffiere. Again, different maturation stages occurred at varying fruit body size and during the entire fruiting season. Finally, the predominantly unrelated weight and maturity of 81 T. aestivum fruit bodies from four fruiting seasons between 2010 and 2013 in Switzerland confirmed the Hungarian results. The spatiotemporal coexistence of 7,532 small-ripe and large-unripe T. aestivum, which accumulate to similar to 182 kg, differs from species-specific associations between the size and ripeness that have been reported for other mushrooms. Although size-independent truffle maturation stages may possibly relate to the perpetual belowground environment, the role of mycelial connectivity, soil property, microclimatology, as well as other abiotic factors and a combination thereof, is still unclear. Despite its massive sample size and proof of concept, this study, together with existing literature, suggests consideration of a wider ecological and biogeographical range, as well as the complex symbiotic fungus-host interaction, to further illuminate the hidden development of belowground truffle fruit bodies.	[Buntgen, Ulf] Univ Cambridge, Dept Geog, Cambridge, England; [Buntgen, Ulf; Molinier, Virginie; Peter, Martina; Hulsmann, Lisa; Nievergelt, Daniel; Meier, Barbara; Egli, Simon] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Buntgen, Ulf] CzechGlobe Res Inst CAS, Brno, Czech Republic; [Buntgen, Ulf] Masaryk Univ Brno, Brno, Czech Republic; [Bagi, Istvan; Fekete, Oszkar] Truffleminers Ltd, Taksony Kinizsi, Hungary; [Splivallo, Richard; Vahdatzadeh, Maryam] Goethe Univ Frankfurt, Inst Mol Bio Sci, Frankfurt, Germany; [Splivallo, Richard; Vahdatzadeh, Maryam] Integrat Fungal Res Cluster IPF, Frankfurt, Germany; [Richard, Franck] Univ Montpellier, UMR CEFE 5175, Montpellier, France; [Murat, Claude] Univ Lorraine, Interact Arbres Microorganismes UMR1136, Vandoeuvre Les Nancy, France; [Murat, Claude] INRA, Interact Arbres Microorganismes UMR1136, Champenoux, France; [Tegel, Willy] Albert Ludwigs Univ, Chair Forest Growth, Freiburg, Germany; [Stobbe, Ulrich; Sproll, Ludger] AlbertLudwigs Univ, Chair Forest Bot, Freiburg, Germany; [Stobbe, Ulrich; Sproll, Ludger] Deutsch Truffelbaume, Radolfzell am Bodensee, Germany; [Martinez-Pena, Fernando] Agrifood Res & Technol Ctr Aragon CITA, Zaragoza, Spain; [Martinez-Pena, Fernando] European Mycol Inst EGTC EMI, Soria, Spain	University of Cambridge; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Czech Academy of Sciences; Global Change Research Centre of the Czech Academy of Sciences; Masaryk University Brno; Goethe University Frankfurt; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Universite de Lorraine; INRAE; Universite de Lorraine; University of Freiburg	Buntgen, U (corresponding author), Univ Cambridge, Dept Geog, Cambridge, England.	buentgen@wsl.ch	Hülsmann, Lisa/B-6680-2017; Simonneau, Thierry/AAI-1230-2019; Nievergelt, Daniel/J-7156-2012; Murat, Claude/AAA-5226-2020; Tegel, Willy/M-8187-2014; Peter, Martina/G-2284-2018; buentgen, ulf/J-6952-2013; MARTINEZ-PENA, FERNANDO/H-9093-2015	Hülsmann, Lisa/0000-0003-4252-2715; Nievergelt, Daniel/0000-0003-0402-9348; Murat, Claude/0000-0003-0685-7307; Peter, Martina/0000-0002-6365-6889; Tegel, Willy/0000-0003-4707-2848; MARTINEZ-PENA, FERNANDO/0000-0002-4402-4237; Splivallo, Richard/0000-0002-7567-6553	WSL-internal DITREC project; Ernst Gohner Foundation; Swiss State Secretariat for Education, Research and Innovation (SERI): COST Action [FP1203]; Ministry of Education, Youth and Sports of CR within the National Sustainability Program I (NPU I) [LO1415]; LOEWE research-funding program of the government of Hessen; German Research Foundation (DFG) [1191/4-1]; French National Research Agency (ANR) as part of the "Investissements d'Avenir program [UMR1136, ANR-11-LABX-0002-01]	WSL-internal DITREC project; Ernst Gohner Foundation; Swiss State Secretariat for Education, Research and Innovation (SERI): COST Action; Ministry of Education, Youth and Sports of CR within the National Sustainability Program I (NPU I); LOEWE research-funding program of the government of Hessen; German Research Foundation (DFG)(German Research Foundation (DFG)); French National Research Agency (ANR) as part of the "Investissements d'Avenir program(French National Research Agency (ANR))	Supported by the WSL-internal DITREC project, the Ernst Gohner Foundation, as well as the Swiss State Secretariat for Education, Research and Innovation (SERI): COST Action FP1203. Moreover, U. Buntgen received funding from the Ministry of Education, Youth and Sports of CR within the National Sustainability Program I (NPU I), grant number LO1415., whereas R. Splivallo and M. Vandatzadeh were supported by the LOEWE research-funding program of the government of Hessen, in the framework of the Integrative Fungal Research Cluster (IPF) and by the German Research Foundation (DFG) - grant number 1191/4-1. The UMR1136 is supported by a grant overseen by the French National Research Agency (ANR) as part of the "Investissements d'Avenir program (ANR-11-LABX-0002-01, Lab of Excellence ARBRE). Truffleminers Ltd provided support in the form of salaries for authors [IB, OF], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funder provided support in the form of salaries for authors [UB, RS, MV, CM, IB, OF], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Antony-Babu S, 2014, ENVIRON MICROBIOL, V16, P2831, DOI 10.1111/1462-2920.12294; Auguie B, 2017, GRIDEXTRA MISCELLANE; Benucci GMN, 2016, MICROB ECOL, V72, P4, DOI 10.1007/s00248-016-0755-3; Benucci GMN, 2012, MYCORRHIZA, V22, P383, DOI 10.1007/s00572-011-0413-z; Benucci GMN, 2011, FEMS MICROBIOL ECOL, V76, P170, DOI 10.1111/j.1574-6941.2010.01039.x; Bonito G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052765; Buntgen U, 2012, NAT CLIM CHANGE, V2, P827, DOI 10.1038/nclimate1733; Buntgen U, 2012, FRONT ECOL ENVIRON, V10, P462, DOI 10.1890/12.WB.021; Buntgen U, 2011, FRONT ECOL ENVIRON, V9, P150, DOI 10.1890/11.WB.004; Callot G., 1999, TERRE VIE; Cullere L, 2010, FOOD CHEM, V122, P300, DOI 10.1016/j.foodchem.2010.02.024; Debuchy R, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P501; Diamandis Stephanos, 2008, Acta Mycologica, V43, P139, DOI 10.5586/am.2008.017; Diaz P, 2009, FOOD SCI TECHNOL, V42, P1253; Ekblad A, 2013, PLANT SOIL, V366, P1, DOI 10.1007/s11104-013-1630-3; Fernandez CW, 2014, SOIL BIOL BIOCHEM, V77, P150, DOI 10.1016/j.soilbio.2014.06.026; Frey-Klett P, 2007, NEW PHYTOL, V176, P22, DOI 10.1111/j.1469-8137.2007.02191.x; Gogan Andrea Csorbai, 2012, Acta Mycologica, V47, P133, DOI 10.5586/am.2012.015; Gryndler M, 2011, FEMS MICROBIOL LETT, V318, P84, DOI 10.1111/j.1574-6968.2011.02243.x; Hall IR, 2003, TRENDS BIOTECHNOL, V21, P433, DOI 10.1016/S0167-7799(03)00204-X; Harki E, 2006, FOOD CHEM, V99, P394, DOI 10.1016/j.foodchem.2005.08.030; Healy RA, 2013, MOL ECOL, V22, P1717, DOI 10.1111/mec.12135; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Kues U, 2000, APPL MICROBIOL BIOT, V54, P141, DOI 10.1007/s002530000396; Le Tacon F, 2016, ANN FOREST SCI, V73, P105, DOI 10.1007/s13595-015-0461-1; Le Tacon F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064626; Martin F, 2011, NEW PHYTOL, V189, P645, DOI 10.1111/j.1469-8137.2010.03618.x; Martinez-Pena F, 2012, FOREST ECOL MANAG, V282, P63, DOI 10.1016/j.foreco.2012.06.034; Mello A, 2010, PLANT BIOSYST, V144, P323, DOI 10.1080/11263500903374724; Mello A, 2002, ENVIRON MICROBIOL, V4, P584, DOI 10.1046/j.1462-2920.2002.00343.x; Molinier V, 2013, DIVERSITY EVOL, V13, P503; Molinier V, 2015, ENVIRON MICROBIOL, V17, P3039, DOI 10.1111/1462-2920.12910; Moore D., 1998, FUNGAL MORPHOGENESIS; Moore-Kucera J, 2008, SOIL BIOL BIOCHEM, V40, P2485, DOI 10.1016/j.soilbio.2008.06.002; Pacioni G, 2014, MYCORRHIZA, V24, pS65, DOI 10.1007/s00572-014-0561-z; Pacioni G, 2015, PHYTOCHEMISTRY, V110, P104, DOI 10.1016/j.phytochem.2014.11.012; Paolocci F, 2006, APPL ENVIRON MICROB, V72, P2390, DOI 10.1128/AEM.72.4.2390-2393.2006; Paolocci F, 2004, FEMS MICROBIOL LETT, V235, P109, DOI 10.1016/femsle.2004.04.029; Rubini A, 2011, NEW PHYTOL, V189, P723, DOI 10.1111/j.1469-8137.2010.03493.x; Salerni E, 2014, FOREST SYST, V23, P329, DOI 10.5424/fs/2014232-04777; Samils N, 2008, ECON BOT, V62, P331, DOI 10.1007/s12231-008-9030-y; Shamekh S, 2014, MYCOL PROG, V13, P373, DOI 10.1007/s11557-013-0923-5; Splivallo R, 2015, ENVIRON MICROBIOL, V17, P2647, DOI 10.1111/1462-2920.12521; Splivallo R, 2015, APPL MICROBIOL BIOT, V99, P2583, DOI 10.1007/s00253-014-6360-9; Splivallo R, 2012, NEW PHYTOL, V194, P823, DOI 10.1111/j.1469-8137.2012.04077.x; Splivallo R, 2011, NEW PHYTOL, V189, P688, DOI 10.1111/j.1469-8137.2010.03523.x; Stobbe U, 2013, MYCORRHIZA, V23, P669, DOI 10.1007/s00572-013-0508-9; Stobbe U, 2013, APPL MICROBIOL BIOT, V97, P5215, DOI 10.1007/s00253-013-4956-0; Stobbe U, 2012, FUNGAL ECOL, V5, P591, DOI 10.1016/j.funeco.2012.02.001; TALOU T, 1992, RECHERCHE, V23, P30; Vahdatzadeh M, 2015, APPL ENVIRON MICROB, V81, P6946, DOI 10.1128/AEM.01098-15; Weden C, 2005, ENVIRON MICROBIOL, V7, P1535, DOI 10.1111/j.1462-2920.2005.00837.x; Weden C, 2004, MYCOL RES, V108, P304, DOI 10.1017/S0953756204009256; Weden C, 2004, MYCORRHIZA, V14, P19, DOI 10.1007/s00572-003-0271-4; Zawirska-Wojtaslak R, 2004, FOOD CHEM, V86, P113, DOI 10.1016/j.foodchem.2003.08.016; Zeppa S, 2004, RAPID COMMUN MASS SP, V18, P199, DOI 10.1002/rcm.1313	56	22	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170375	10.1371/journal.pone.0170375	http://dx.doi.org/10.1371/journal.pone.0170375			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125633	Green Published, gold, Green Submitted			2022-12-27	WOS:000396176100115
J	Huish, S; Thelwell, C; Longstaff, C				Huish, Sian; Thelwell, Craig; Longstaff, Colin			Activity Regulation by Fibrinogen and Fibrin of Streptokinase from Streptococcus Pyogenes	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; CLUSTER 2B STREPTOKINASE; GROUP-A STREPTOCOCCI; M-PROTEIN; KINETIC MECHANISM; BINDING; VARIANTS; COMPLEX; DOMAIN; STAPHYLOKINASE	Streptokinase is a virulence factor of streptococci and acts as a plasminogen activator to generate the serine protease plasmin which promotes bacterial metastasis. Streptokinase isolated from group C streptococci has been used therapeutically as a thrombolytic agent for many years and its mechanism of action has been extensively studied. However, group A streptococci are associated with invasive and potentially fatal infections, but less detail is available on the mechanism of action of streptokinase from these bacteria. We have expressed recombinant streptokinase from a group C strain to investigate the therapeutic molecule (here termed rSK-H46A) and a molecule isolated from a cluster 2a strain from group A (rSK-M1GAS) which is known to produce the fibrinogen binding, M1 protein, and is associated with life-threatening disease. Detailed enzyme kinetic models have been prepared which show how fibrinogen-streptokinase-plasminogen complexes regulate plasmin generation, and also the effect of fibrin interactions. As is the case with rSK-H46A our data with rSK-M1GAS support a "trigger and bullet" mechanism requiring the initial formation of SK center dot plasminogen complexes which are replaced by more active SK center dot plasmin as plasmin becomes available. This model includes the important fibrinogen interactions that stimulate plasmin generation. In a fibrin matrix rSK-M1GAS has a 24 fold higher specific activity than the fibrin-specific thrombolytic agent, tissue plasminogen activator, and 15 fold higher specific activity than rSK-H46A. However, in vivo fibrin specificity would be undermined by fibrinogen stimulation. Given the observed importance of M1 surface receptors or released M1 protein to virulence of cluster 2a strain streptococci, studies on streptokinase activity regulation by fibrin and fibrinogen may provide additional routes to addressing bacterial invasion and infectious diseases.	[Huish, Sian] Cambridge Donor Ctr, NHS Blood & Transplant, Component Dev Lab, Cambridge, England; [Thelwell, Craig; Longstaff, Colin] Natl Inst Biol Stand & Controls, Biotherapeut Sect, South Mimms, Herts, England	National Institute for Biological Standards & Control	Longstaff, C (corresponding author), Natl Inst Biol Stand & Controls, Biotherapeut Sect, South Mimms, Herts, England.	colin.longstaff@nibsc.org	Longstaff, Colin/D-2413-2013; Thelwell, Craig/E-2572-2013	Longstaff, Colin/0000-0001-7608-208X; Thelwell, Craig/0000-0003-4802-2332	NIBSC	NIBSC	The authors received funding from NIBSC as part of their routine work of for PhD research to SH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler D, **DATA OBJECT**; Aziz RK, 2008, EMERG INFECT DIS, V14, P1511, DOI 10.3201/eid1410.071660; BERGE A, 1993, J BIOL CHEM, V268, P25417; BERGE A, 1995, J BIOL CHEM, V270, P9862, DOI 10.1074/jbc.270.17.9862; Bhattacharya S., 2012, J BIOMED BIOTECHNOL, V2012, DOI DOI 10.1155/2012/482096; Boxrud PD, 2000, J BIOL CHEM, V275, P14579, DOI 10.1074/jbc.275.19.14579; Boxrud PD, 2004, J BIOL CHEM, V279, P36633, DOI 10.1074/jbc.M405264200; Boxrud PD, 2004, J BIOL CHEM, V279, P36642, DOI 10.1074/jbc.M405265200; Boyle MDP, 1997, THROMB HAEMOSTASIS, V77, P1; CHIBBER BAK, 1986, J BIOL CHEM, V261, P5289; CHIBBER BAK, 1985, BIOCHEMISTRY-US, V24, P3429, DOI 10.1021/bi00335a006; CHRISTENSEN U, 1992, BIOCHEM J, V285, P419, DOI 10.1042/bj2850419; Commission E., 2013, ALT INJ MON EUR PHAR, P2007; Cook SM, 2014, BIOCHEM J, V458, P23, DOI 10.1042/BJ20131305; Cook SM, 2012, MOL MICROBIOL, V86, P1052, DOI 10.1111/mmi.12037; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Hess JL, 2006, PROTEOMICS, V6, P375, DOI 10.1002/pmic.200500189; Law RHP, 2013, CURR OPIN STRUC BIOL, V23, P836, DOI 10.1016/j.sbi.2013.10.006; LIJNEN HR, 1991, J BIOL CHEM, V266, P11826; Lizano S, 2005, INFECT IMMUN, V73, P4451, DOI 10.1128/IAI.73.7.4451-4453.2005; Longstaff C, 2004, J THROMB HAEMOST, V2, P1416, DOI 10.1111/j.1538-7836.2004.00816.x; Longstaff C., 2016, CLOTLYSISCL PROGRAM; Longstaff C., 2016, ZYMOGENACTNCL PROGRA; Loy JA, 2001, BIOCHEMISTRY-US, V40, P14686, DOI 10.1021/bi011309d; LUCAS MA, 1983, J BIOL CHEM, V258, P4249; Macheboeuf P, 2011, NATURE, V472, P64, DOI 10.1038/nature09967; McArthur JD, 2008, FASEB J, V22, P3146, DOI 10.1096/fj.08-109348; McKay FC, 2004, INFECT IMMUN, V72, P364, DOI 10.1128/IAI.72.1.364-370.2004; Mendes P, 1997, TRENDS BIOCHEM SCI, V22, P361, DOI 10.1016/S0968-0004(97)01103-1; MENDES P, 1993, COMPUT APPL BIOSCI, V9, P563; Nolan M, 2013, J BIOL CHEM, V288, P29482, DOI 10.1074/jbc.M113.477935; Parry MAA, 2000, TRENDS BIOCHEM SCI, V25, P53, DOI 10.1016/S0968-0004(99)01521-2; Ralph AP, 2013, CURR TOP MICROBIOL, V368, P1, DOI 10.1007/82_2012_280; Reed GL, 1999, P NATL ACAD SCI USA, V96, P8879, DOI 10.1073/pnas.96.16.8879; Sanderson-Smith M, 2014, J INFECT DIS, V210, P1325, DOI 10.1093/infdis/jiu260; Sanderson-Smith ML, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003469; Sarkar D, 2008, USE R, P1; Sazonova IY, 2004, J BIOL CHEM, V279, P24994, DOI 10.1074/jbc.M400253200; Silva MMCG, 2012, J THROMB HAEMOST, V10, P2354, DOI 10.1111/j.1538-7836.2012.04925.x; Sinniger V, 1999, J BIOL CHEM, V274, P12414, DOI 10.1074/jbc.274.18.12414; Smeesters PR, 2009, EXPERT REV VACCINES, V8, P1705, DOI 10.1586/ERV.09.133; Stewart RJ, 1998, J BIOL CHEM, V273, P18292, DOI 10.1074/jbc.273.29.18292; STIEF TW, 1989, THROMB RES, V56, P221, DOI 10.1016/0049-3848(89)90164-3; Sun H, 2011, J THROMB HAEMOST, V9, P189, DOI 10.1111/j.1538-7836.2011.04316.x; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Svensson MD, 2002, MICROBIOL-SGM, V148, P3933, DOI 10.1099/00221287-148-12-3933; TAKADA A, 1980, THROMB RES, V19, P767, DOI 10.1016/0049-3848(80)90003-1; Team RC, 2015, LANG ENV STAT COMP; Thelwell C, 2014, J THROMB HAEMOST, V12, P1229, DOI 10.1111/jth.12629; Thelwell C, 2014, SEMIN THROMB HEMOST, V40, P205, DOI 10.1055/s-0033-1364188; Verstraete M, 2000, AM J MED, V109, P52, DOI 10.1016/S0002-9343(00)00380-6; Walker MJ, 2005, TRENDS MICROBIOL, V13, P308, DOI 10.1016/j.tim.2005.05.006; WANG H, 1995, J INFECT DIS, V171, P85, DOI 10.1093/infdis/171.1.85; Wang SG, 1999, BIOCHEMISTRY-US, V38, P5232, DOI 10.1021/bi981915h; Xue Y, 2012, J THROMB HAEMOST, V10, P1385, DOI 10.1111/j.1538-7836.2012.04765.x; Zhang Y, 2013, J MATER CHEM B, V1, P132, DOI 10.1039/c2tb00071g; Zhang Y, 2012, J BIOL CHEM, V287, P19171, DOI 10.1074/jbc.M112.359315; Zhang Y, 2014, BIOCHEM BIOPH RES CO, V444, P595, DOI 10.1016/j.bbrc.2014.01.109; Zhang YL, 2012, J BIOL CHEM, V287, P42093, DOI 10.1074/jbc.M112.417808	59	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170936	10.1371/journal.pone.0170936	http://dx.doi.org/10.1371/journal.pone.0170936			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125743	Green Published, gold, Green Submitted			2022-12-27	WOS:000396176100018
J	Rudenick, PA; Segers, P; Pineda, V; Cuellar, H; Garcia-Dorado, D; Evangelista, A; Bijnens, BH				Rudenick, Paula A.; Segers, Patrick; Pineda, Victor; Cuellar, Hug; Garcia-Dorado, David; Evangelista, Arturo; Bijnens, Bart H.			False Lumen Flow Patterns and their Relation with Morphological and Biomechanical Characteristics of Chronic Aortic Dissections. Computational Model Compared with Magnetic Resonance Imaging Measurements	PLOS ONE			English	Article							SYSTEMIC ARTERIAL TREE; IN-VITRO PHANTOM; BLOOD-FLOW; TEAR SIZE; VALIDATION; HEMODYNAMICS; SIMULATIONS; STIFFNESS; PRESSURE; LOCATION	Aortic wall stiffness, tear size and location and the presence of abdominal side branches arising from the false lumen (FL) are key properties potentially involved in FL enlargement in chronic aortic dissections (ADs). We hypothesize that temporal variations on FL flow patterns, as measured in a cross-section by phase-contrast magnetic resonance imaging (PC-MRI), could be used to infer integrated information on these features. In 33 patients with chronic descending AD, instantaneous flow profiles were quantified in the FL at diaphragm level by PC-MRI. We used a lumped-parameter model to assess the changes in flow profiles induced by wall stiffness, tear size/location, and the presence of abdominal side branches arising from the FL. Four characteristic FL flow patterns were identified in 31/33 patients (94%) based on the direction of flow in systole and diastole: B-A = systolic biphasic flow and primarily diastolic antegrade flow (n = 6); B-R = systolic biphasic flow and primarily diastolic retrograde flow (n = 14); M-A = systolic monophasic flow and primarily diastolic antegrade flow (n = 9); M-R = systolic monophasic flow and primarily diastolic retrograde flow (n = 2). In the computational model, the temporal variation of flow directions within the FL was highly dependent on the position of assessment along the aorta. FL flow patterns (especially at the level of the diaphragm) showed their characteristic patterns due to variations in the cumulative size and the spatial distribution of the communicating tears, and the incidence of visceral side branches originating from the FL. Changes in wall stiffness did not change the temporal variation of the flows whereas it importantly determined intraluminal pressures. FL flow patterns implicitly codify morphological information on key determinants of aortic expansion in ADs. This data might be taken into consideration in the imaging protocol to define the predictive value of FL flows.	[Rudenick, Paula A.; Bijnens, Bart H.] Univ Pompeu Fabra, Physense, Barcelona, Spain; [Rudenick, Paula A.; Pineda, Victor; Cuellar, Hug; Garcia-Dorado, David; Evangelista, Arturo] Univ Autonoma Barcelona, Univ Hosp & Res Inst Vall dHebron, Barcelona, Spain; [Segers, Patrick] Univ Ghent, Inst Biomed Technol, Biofluid Tissue & Solid Mech Med Applicat, Ghent, Belgium; [Bijnens, Bart H.] ICREA, Barcelona, Spain	Pompeu Fabra University; Autonomous University of Barcelona; Ghent University; ICREA	Rudenick, PA (corresponding author), Univ Pompeu Fabra, Physense, Barcelona, Spain.; Rudenick, PA (corresponding author), Univ Autonoma Barcelona, Univ Hosp & Res Inst Vall dHebron, Barcelona, Spain.	paula.rudenick@upf.edu	Bijnens, Bart/AAE-7186-2021; Bijnens, Bart H/C-2955-2008; Segers, Patrick/AAA-7844-2020; Pineda, Victor/ABC-2772-2021; Rudenick, Paula Andrea/D-8100-2014	Bijnens, Bart/0000-0003-3130-6937; Bijnens, Bart H/0000-0003-3130-6937; Segers, Patrick/0000-0003-3870-3409; Rudenick, Paula Andrea/0000-0003-0561-0193; Cuellar-Calabria, Hug/0000-0003-2197-4990	Subprograma de Proyectos de Investigacion en Salud (FIS), Instituto de Salud Carlos III, Spain [PI108/0608, PI11/01709]; Programa de ayudas destinadas a universidades, centros de investigacion y fundaciones hospitalarias para la contratacion de personal investigador novel (FI-DGR), Spain; EU FP7 for research, technological development and demonstration under grant VP2HF [611823]; ICREA Funding Source: Custom	Subprograma de Proyectos de Investigacion en Salud (FIS), Instituto de Salud Carlos III, Spain; Programa de ayudas destinadas a universidades, centros de investigacion y fundaciones hospitalarias para la contratacion de personal investigador novel (FI-DGR), Spain; EU FP7 for research, technological development and demonstration under grant VP2HF; ICREA(ICREA)	The research leading to these results has received funding from the Subprograma de Proyectos de Investigacion en Salud (FIS), Instituto de Salud Carlos III, Spain (ref. PI108/0608, PI11/01709); the Programa de ayudas destinadas a universidades, centros de investigacion y fundaciones hospitalarias para la contratacion de personal investigador novel (FI-DGR 2011), Spain; and the EU FP7 for research, technological development and demonstration under grant agreement VP2HF (no 611823). All authors have reported that they have no relationships relevant to the contents of this paper to disclose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akin I, 2009, EUR J VASC ENDOVASC, V37, P289, DOI 10.1016/j.ejvs.2008.12.004; Amano Y, 2011, MAGN RESON MED SCI, V10, P93, DOI 10.2463/mrms.10.93; Berguer R, 2015, ANN VASC SURG, V29, P167, DOI 10.1016/j.avsg.2014.10.001; Bernard Y, 2001, AM J CARDIOL, V87, P1378, DOI 10.1016/S0002-9149(01)01556-9; CHANG JM, 1991, J COMPUT ASSIST TOMO, V15, P418, DOI 10.1097/00004728-199105000-00013; Clough RE, 2012, J VASC SURG, V55, P914, DOI 10.1016/j.jvs.2011.11.005; Collette M, 2011, HYPERTENS RES, V34, P578, DOI 10.1038/hr.2010.280; Dillon-Murphy D, 2015, BIOMECH MOD IN PRESS; ERBEL R, 1993, CIRCULATION, V87, P1604, DOI 10.1161/01.CIR.87.5.1604; Evangelista A, 2006, THORACIC AORTIC DIS, P33; Evangelista A, 2012, CIRCULATION, V125, P3133, DOI 10.1161/CIRCULATIONAHA.111.090266; Francois CJ, 2013, J THORAC CARDIOV SUR, V145, P1359, DOI 10.1016/j.jtcvs.2012.07.019; Ince H, 2007, HEART, V93, P266, DOI 10.1136/hrt.2005.078550; Inoue T, 2000, JPN CIRC J, V64, P760, DOI 10.1253/jcj.64.760; JAGER GN, 1965, CIRC RES, V16, P121, DOI 10.1161/01.RES.16.2.121; Johnson DA, 2011, J BIOMECH, V44, P869, DOI 10.1016/j.jbiomech.2010.12.003; Juvonen T, 1999, J THORAC CARDIOV SUR, V117, P776, DOI 10.1016/S0022-5223(99)70299-0; LEAROYD BM, 1966, CIRC RES, V18, P278, DOI 10.1161/01.RES.18.3.278; Mensel B, 2013, ACAD RADIOL, V20, P1004, DOI 10.1016/j.acra.2013.03.014; Milisic V, 2004, ESAIM-MATH MODEL NUM, V38, P613, DOI 10.1051/m2an:2004036; Nienaber CA, 2006, ESC TXB CARDIOVASCUL, P993; Nollen GJ, 2004, EUR HEART J, V25, P1146, DOI 10.1016/j.ehj.2004.04.033; Quint LE, 2003, J ENDOVASC THER, V10, P505, DOI 10.1583/1545-1550(2003)010<0505:AITDWS>2.0.CO;2; Reymond P, 2012, ANN BIOMED ENG, V40, P742, DOI 10.1007/s10439-011-0443-x; Reymond P, 2009, AM J PHYSIOL-HEART C, V297, pH208, DOI 10.1152/ajpheart.00037.2009; Rudenick PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124011; Rudenick PA, 2013, J VASC SURG, V57, P464, DOI 10.1016/j.jvs.2012.07.008; Shi YB, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-33; Soudah E, 2015, COMPUT METHOD BIOMEC, V18, P805, DOI 10.1080/10255842.2013.847095; Strotzer M, 2000, ACTA RADIOL, V41, P594; Taylor M, 2011, MCDONALD'S BLOOD FLOW IN ARTERIES: THEORETICAL, EXPERIMENTAL AND CLINICAL PRINCIPLES, 6TH EDITION, P13; Tsai TT, 2008, J VASC SURG, V47, P844, DOI 10.1016/j.jvs.2007.11.059; Veger HTC, 2015, EUR J VASC ENDOVASC, V49, P375, DOI 10.1016/j.ejvs.2014.12.016; WESTERHOF N, 1969, J BIOMECH, V2, P121, DOI 10.1016/0021-9290(69)90024-4; Williams D M, 1993, J Vasc Interv Radiol, V4, P75, DOI 10.1016/S1051-0443(93)71824-2; ZEIHER AM, 1991, CIRCULATION, V83, P391, DOI 10.1161/01.CIR.83.2.391	36	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170888	10.1371/journal.pone.0170888	http://dx.doi.org/10.1371/journal.pone.0170888			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125720	gold, Green Published, Green Submitted			2022-12-27	WOS:000396176100031
J	Verschuuren, M; De Vylder, J; Catrysse, H; Robijns, J; Philips, W; De Vos, WH				Verschuuren, Marlies; De Vylder, Jonas; Catrysse, Hannes; Robijns, Joke; Philips, Wilfried; De Vos, Winnok H.			Accurate Detection of Dysmorphic Nuclei Using Dynamic Programming and Supervised Classification	PLOS ONE			English	Article							FLUORESCENCE MICROSCOPY; IMAGE; ENVELOPE; SHAPE; DISRUPTIONS; ALGORITHM; ENTROPY; SNAKES; SYSTEM	A vast array of pathologies is typified by the presence of nuclei with an abnormal morphology. Dysmorphic nuclear phenotypes feature dramatic size changes or foldings, but also entail much subtler deviations such as nuclear protrusions called blebs. Due to their unpredictable size, shape and intensity, dysmorphic nuclei are often not accurately detected in standard image analysis routines. To enable accurate detection of dysmorphic nuclei in confocal and widefield fluorescence microscopy images, we have developed an automated segmentation algorithm, called Blebbed Nuclei Detector (BleND), which relies on two-pass thresholding for initial nuclear contour detection, and an optimal path finding algorithm, based on dynamic programming, for refining these contours. Using a robust error metric, we show that our method matches manual segmentation in terms of precision and outperforms state-of-the-art nuclear segmentation methods. Its high performance allowed for building and integrating a robust classifier that recognizes dysmorphic nuclei with an accuracy above 95%. The combined segmentation-classification routine is bound to facilitate nucleus-based diagnostics and enable real-time recognition of dysmorphic nuclei in intelligent microscopy workflows.	[Verschuuren, Marlies; Robijns, Joke; De Vos, Winnok H.] Univ Antwerp, Dept Vet Sci, Antwerp, Belgium; [De Vylder, Jonas; Philips, Wilfried] Univ Ghent, Dept Telecommun & Informat Proc, IPI, IMinds, Ghent, Belgium; [Catrysse, Hannes] Inst Agr & Fisheries Res ILVO, Melle, Belgium; [De Vos, Winnok H.] Univ Ghent, Dept Mol Biotechnol, Ghent, Belgium	University of Antwerp; Ghent University; IMEC; Institute For Agricultural & Fisheries Research; Ghent University	De Vos, WH (corresponding author), Univ Antwerp, Dept Vet Sci, Antwerp, Belgium.; De Vos, WH (corresponding author), Univ Ghent, Dept Mol Biotechnol, Ghent, Belgium.	Winnok.DeVos@UAntwerpen.be	de vos, winnok/A-6445-2012	de vos, winnok/0000-0003-0960-6781	Flemish Institute for Scientific Research (FWO) [11ZF116N]; University of Antwerp [BOF/29267, BOF/30112]	Flemish Institute for Scientific Research (FWO)(FWO); University of Antwerp	This work was supported by the Flemish Institute for Scientific Research (FWO PhD Fellowship awarded to MV, Grant No: 11ZF116N; www.fwo.be) and the University of Antwerp (awarded to WDV, Grant BOF/29267 and BOF/30112; www.uantwerpen.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslan S, 2013, IEEE T MED IMAGING, V32, P1121, DOI 10.1109/TMI.2013.2255309; Baggett D, 2005, CYTOM PART A, V67A, P137, DOI 10.1002/cyto.a.20162; Boykov Y, 2006, INT J COMPUT VISION, V70, P109, DOI 10.1007/s11263-006-7934-5; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Choi S, 2014, NUCLEUS, V2, P570; Chow KH, 2012, NAT REV CANCER, V12, P196, DOI 10.1038/nrc3219; Conrad C, 2011, NAT METHODS, V8, P246, DOI [10.1038/nmeth.1558, 10.1038/NMETH.1558]; Cornelissen F, 2013, J BIOMOL SCREEN, V18, P807, DOI 10.1177/1087057113486518; de Noronha CMC, 2001, SCIENCE, V294, P1105, DOI 10.1126/science.1063957; De Vos WH, 2010, CYTOM PART A, V77A, P64, DOI 10.1002/cyto.a.20807; De Vos WH, 2011, HUM MOL GENET, V20, P4175, DOI 10.1093/hmg/ddr344; De Vos WH, 2010, BBA-GEN SUBJECTS, V1800, P448, DOI 10.1016/j.bbagen.2010.01.002; De Vylder J, 2011, CYTOM PART A, V79A, P580, DOI 10.1002/cyto.a.21055; Denais CM, 2016, SCIENCE, V352, P353, DOI 10.1126/science.aad7297; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; DOYLE W, 1962, J ACM, V9, P259, DOI 10.1145/321119.321123; Driscoll MK, 2012, AGING-US, V4, P119, DOI 10.18632/aging.100434; Dubuisson M-P, 1994, C PATT REC C A COMP, V1; FURUTA N, 1995, BREEDING SCI, V45, P315; GLASBEY CA, 1993, CVGIP-GRAPH MODEL IM, V55, P532, DOI 10.1006/cgip.1993.1040; Gudla PR, 2008, CYTOM PART A, V73A, P451, DOI 10.1002/cyto.a.20550; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hatch E, 2014, J CELL BIOL, V205, P133, DOI 10.1083/jcb.201402003; Houben F, 2013, HISTOCHEM CELL BIOL, V139, P119, DOI 10.1007/s00418-012-1005-5; HUANG LK, 1995, PATTERN RECOGN, V28, P41, DOI 10.1016/0031-3203(94)E0043-K; Jackson C, 2011, BIOINFORMATICS, V27, P1854, DOI 10.1093/bioinformatics/btr286; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; KAPUR JN, 1985, COMPUT VISION GRAPH, V29, P273, DOI 10.1016/0734-189X(85)90125-2; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; KITTLER J, 1986, PATTERN RECOGN, V19, P41, DOI 10.1016/0031-3203(86)90030-0; KOCSIS E, 1991, J STRUCT BIOL, V107, P6, DOI 10.1016/1047-8477(91)90025-R; Kubben N, 2016, METHODS, V96, P46, DOI 10.1016/j.ymeth.2015.08.024; Lesko Milan, 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P1485, DOI 10.1109/ICPR.2010.367; Li CH, 1998, PATTERN RECOGN LETT, V19, P771, DOI 10.1016/S0167-8655(98)00057-9; Muchir A, 2003, EXP CELL RES, V291, P352, DOI 10.1016/j.yexcr.2003.07.002; Nandy K, 2007, P 2 WORKSH MICR IM A, P6718; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pepperkok R, 2006, NAT REV MOL CELL BIO, V7, P690, DOI 10.1038/nrm1979; PREWITT JMS, 1966, ANN NY ACAD SCI, V128, P1035; R Core Team, 2018, R LANG ENV STAT COMP; RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630, DOI 10.1109/tsmc.1978.4310039; Robijns J, 2016, SCI REP-UK, V6, DOI 10.1038/srep30325; Rohde GK, 2008, CYTOM PART A, V73A, P341, DOI 10.1002/cyto.a.20506; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHANBHAG AG, 1994, CVGIP-GRAPH MODEL IM, V56, P414, DOI 10.1006/cgip.1994.1037; TSAI WH, 1985, COMPUT VISION GRAPH, V29, P377, DOI 10.1016/0734-189X(85)90133-1; Verstraeten VLRM, 2006, HUM MOL GENET, V15, P2509, DOI 10.1093/hmg/ddl172; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; Wenus J, 2009, BIOTECHNIQUES, V47, P1033, DOI 10.2144/000113247; Xu CY, 1998, IEEE T IMAGE PROCESS, V7, P359, DOI 10.1109/83.661186; YEN JC, 1995, IEEE T IMAGE PROCESS, V4, P370, DOI 10.1109/83.366472; ZACK GW, 1977, J HISTOCHEM CYTOCHEM, V25, P741, DOI 10.1177/25.7.70454; Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430	57	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170688	10.1371/journal.pone.0170688	http://dx.doi.org/10.1371/journal.pone.0170688			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125723	Green Published, gold, Green Submitted			2022-12-27	WOS:000396176100073
J	Charles, M; Skriver, MV; Griffin, SJ; Simmons, RK; Witte, DR; Dalsgaard, EM; Lauritzen, T; Sandbaek, A				Charles, Morten; Skriver, Mette V.; Griffin, Simon J.; Simmons, Rebecca K.; Witte, Daniel R.; Dalsgaard, Else-Marie; Lauritzen, Torsten; Sandbaek, Annelli			Does Training and Support of General Practitioners in Intensive Treatment of People with Screen-Detected Diabetes Improve Medication, Morbidity and Mortality in People with Clinically-Diagnosed Diabetes? Investigation of a Spill-Over Effect in a Cluster RCT	PLOS ONE			English	Article							TRIAL	Introduction Very few studies have examined the potential spill-over effect of a trial intervention in general practice. We investigated whether training and support of general practitioners in the intensive treatment of people with screen-detected diabetes improved rates of redeemed medication, morbidity and mortality in people with clinically-diagnosed diabetes. Methods This is a secondary, post-hoc, register-based analysis linked to a cluster randomised trial. In the ADDITION-Denmark trial, 175 general practices were cluster randomised (i) to routine care, or (ii) to receive training and support in intensive multifactorial treatment of individuals with screen-detected diabetes (2001 to 2009). Using national registers we identified all individuals who were diagnosed with clinically incident diabetes in the same practices over the same time period. (Patients participating in the ADDITION trial were excluded). We compared rates of redeemed medication, a cardiovascular composite endpoint, and all-cause mortality between the routine care and intensive treatment groups. Results In total, 4,107 individuals were diagnosed with clinically incident diabetes in ADDITION-Denmark practices between 2001 and 2009 (2,051 in the routine care group and 2,056 in the intensive treatment group). There were large and significant increases in the proportion of patients redeeming cardio-protective medication in both treatment groups during follow-up. After a median of seven years of follow-up, there was no difference in the incidence of a composite cardiovascular endpoint (HR 1.15, 95% CI 0.95 to 1.38) or all-cause mortality between the two groups (HR 1.08, 95% CI 0.94 to 1.23). Discussion There was no evidence of a spill-over effect from an intervention promoting intensive treatment of people with screen-detected diabetes to those with clinically-diagnosed diabetes. Overall, the proportion of patients redeeming cardio-protective medication during follow-up was similar in both groups.	[Charles, Morten; Simmons, Rebecca K.; Dalsgaard, Else-Marie; Lauritzen, Torsten; Sandbaek, Annelli] Aarhus Univ, Dept Publ Hlth, Sect Gen Practice, Aarhus, Denmark; [Skriver, Mette V.; Witte, Daniel R.] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Griffin, Simon J.] Univ Cambridge, Inst Publ Hlth, Primary Care Unit, Cambridge, England; [Griffin, Simon J.; Simmons, Rebecca K.] Univ Cambridge, Sch Clin Med, MRC Epidemiol Unit, Cambridge, England; [Simmons, Rebecca K.; Witte, Daniel R.] Odense Univ Hosp, Danish Diabet Acad, Odense, Denmark; [Simmons, Rebecca K.] Aarhus Inst Adv Studies, Hoegh Guldbergs Gade 6B, Aarhus C, Denmark	Aarhus University; Aarhus University; University of Cambridge; University of Cambridge; University of Southern Denmark; Odense University Hospital	Charles, M (corresponding author), Aarhus Univ, Dept Publ Hlth, Sect Gen Practice, Aarhus, Denmark.	mc@ph.au.dk	Witte, Daniel/AAF-9535-2019	Witte, Daniel/0000-0002-0769-2922; Dalsgaard, Else-Marie/0000-0003-2115-7480; Skriver, Mette/0000-0002-7017-8221	Novo Nordisk Foundation [NNF140C0008981]; Medical Research Council [MC_UU_12015/4] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0008981] Funding Source: researchfish; MRC [MC_UU_12015/4] Funding Source: UKRI	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MC has received an unrestricted Post Docteral grant to the project: "Type 2 diabetes treatment in Danish Primary Care Are we reaching the Triple AimT from the Novo Nordisk Foundation, NNF140C0008981.	[Anonymous], 2016, DIABETES CARE, V39, pS1, DOI 10.2337/dc16-S001; Cantillon P, 1999, BMJ-BRIT MED J, V318, P1276; Charles M, 2011, DIABETES CARE, V34, P2244, DOI 10.2337/dc11-0903; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Green A, 2015, CLIN EPIDEMIOL, V7, P5, DOI 10.2147/CLEP.S72768; Griffin SJ, 2011, LANCET, V378, P156, DOI 10.1016/S0140-6736(11)60698-3; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Lauritzen T, 2000, INT J OBESITY, V24, pS6, DOI 10.1038/sj.ijo.0801420; Lauritzen T, 2012, PRIM CARE DIABETES, V6, P193, DOI 10.1016/j.pcd.2012.04.005; Rasmussen SS, 2008, SCAND J PRIM HEALTH, V26, P166, DOI 10.1080/02813430802264624; Royal College of General practitioners in Denmark, 2004, TYP 2 DIAB GEN PRACT, DOI [10.1016/S0140-6736(12)60480-2, DOI 10.1016/S0140-6736(12)60480-2]; Royal College of General practitioners in Denmark, 1999, TYP 2 DIAB GEN RPACT; SIBLEY JC, 1982, NEW ENGL J MED, V306, P511, DOI 10.1056/NEJM198203043060904; Tricco AC, 2012, LANCET, V379, P2252, DOI 10.1016/S0140-6736(12)60480-2	16	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170697	10.1371/journal.pone.0170697	http://dx.doi.org/10.1371/journal.pone.0170697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151941	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161200035
J	Li, TT; Xie, Y; Bowe, B; Xian, H; Al-Aly, Z				Li, Tingting; Xie, Yan; Bowe, Benjamin; Xian, Hong; Al-Aly, Ziyad			Serum phosphorus levels and risk of incident dementia	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SMALL VESSEL DISEASE; ALL-CAUSE MORTALITY; DIETARY PHOSPHORUS; CARDIOVASCULAR-DISEASE; ALZHEIMERS-DISEASE; NHANES-III; PHOSPHATE; ADULTS; ATHEROSCLEROSIS	Higher serum phosphorous is associated with cerebral small vessel disease, an important driver of cognitive decline and dementia. Whether serum phosphorous, a potentially modifiable parameter, associates with risk of incident dementia is not known. We aimed to examine the association between serum phosphorous and risk of incident dementia and to determine if the association is modified by age. We used the United States Department of Veterans Affairs national databases to build a longitudinal observational cohort of US veterans without prior history of dementia and with at least one outpatient serum phosphorus between October 2008 and September 2010 and followed them until September 2014. Serum phosphorus was categorized into quintiles: <= 2.9, >2.9 to <= 3.2, >3.2 to <= 3.5, >3.5 to <= 3.9, >3.9 mg/dL. There were 744,235 participants in the overall cohort. Over a median follow-up of 5.07 years (Interquartile range [IQR]: 4.28, 5.63), adjusted Cox models show that compared to quintile 2, the risk of incident dementia was increased in quintile 4 (Hazard Ratio [HR] = 1.05; CI = 1.01-1.10) and quintile 5 (HR = 1.14; CI = 1.09-1.20). In cohort participants <= 60 years old, the risk of incident dementia was increased in quintile 4 (HR = 1.29; CI = 1.12-1.49) and 5 (HR = 1.45; CI = 1.26-1.68). In participants > 60 years old, the risk was not significant in quintile 4, and was attenuated in quintile 5 (HR = 1.10; CI = 1.051.16). Formal interaction analyses showed that the association between phosphorous and dementia was more pronounced in those younger than 60, and attenuated in those older than 60 (P for interaction was 0.004 and <= 0.0001 in quintiles 4 and 5; respectively). We conclude that higher serum phosphorous is associated with increased risk of incident dementia. This association is stronger in younger cohort participants. The identification of serum phosphorous as a risk factor for incident dementia has public health relevance and might inform the design and implementation of risk reduction strategies.	[Li, Tingting; Xie, Yan; Bowe, Benjamin; Xian, Hong; Al-Aly, Ziyad] VA St Louis Hlth Care Syst, Clin Epidemiol Ctr, Res & Educ Serv, St Louis, MO 63106 USA; [Li, Tingting; Al-Aly, Ziyad] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Xian, Hong] St Louis Univ, Dept Biostat, Coll Publ Hlth & Social Justice, St Louis, MO 63103 USA; [Al-Aly, Ziyad] VA St Louis Hlth Care Syst, Dept Med, Div Nephrol, St Louis, MO 63106 USA	Washington University (WUSTL); Saint Louis University	Al-Aly, Z (corresponding author), VA St Louis Hlth Care Syst, Clin Epidemiol Ctr, Res & Educ Serv, St Louis, MO 63106 USA.; Al-Aly, Z (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Al-Aly, Z (corresponding author), VA St Louis Hlth Care Syst, Dept Med, Div Nephrol, St Louis, MO 63106 USA.	zalaly@gmail.com	Al-Aly, Ziyad/S-4439-2016	Al-Aly, Ziyad/0000-0002-2600-0434; Xie, Yan/0000-0002-2457-9382; Li, Tingting/0000-0001-7331-9619	US Department of Veterans Affairs; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development, VA Information Resource Center [Al-Aly-01]	US Department of Veterans Affairs(US Department of Veterans Affairs); Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development, VA Information Resource Center(US Department of Veterans Affairs)	Support was provided by a grant from the US Department of Veterans Affairs (for ZAA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Support for VA/Centers for Medicare and Medicaid Services (CMS) data is provided by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development, VA Information Resource Center (Project ID Al-Aly-01).	Abbasian N, 2015, J AM SOC NEPHROL, V26, P2152, DOI 10.1681/ASN.2014070642; Al-Aly Z, 2012, KIDNEY INT, V82, P1208, DOI 10.1038/ki.2012.276; [Anonymous], 2010, J AM DIET ASSOC, V110, P1549, DOI 10.1016/j.jada.2010.08.022; Antoniucci DM, 2006, J CLIN ENDOCR METAB, V91, P3144, DOI 10.1210/jc.2006-0021; Bharmal MF, 2007, ALZ DIS ASSOC DIS, V21, P92, DOI 10.1097/WAD.0b013e31805c0835; Bowe B, 2016, CLIN J AM SOC NEPHRO; Bowe B XY, 2016, KIDNEY INT REPORTS; Bowe B, 2016, KIDNEY INT, V89, P886, DOI 10.1016/j.kint.2015.12.034; BRETELER MMB, 1994, BRIT MED J, V308, P1604, DOI 10.1136/bmj.308.6944.1604; Breteler MMB, 2000, NEUROBIOL AGING, V21, P153, DOI 10.1016/S0197-4580(99)00110-4; Breteler MMB, 2000, ANN NY ACAD SCI, V903, P457, DOI 10.1111/j.1749-6632.2000.tb06399.x; Bugnicourt JM, 2013, J AM SOC NEPHROL, V24, P353, DOI 10.1681/ASN.2012050536; Burnett SAM, 2006, J BONE MINER RES, V21, P1187, DOI 10.1359/JBMR.060507; Calvo MS, 1996, J NUTR, V126, pS1168, DOI 10.1093/jn/126.suppl_4.1168S; Chang AR, 2014, AM J KIDNEY DIS, V64, P567, DOI 10.1053/j.ajkd.2014.04.028; Chang AR, 2014, AM J CLIN NUTR, V99, P320, DOI 10.3945/ajcn.113.073148; De La Torre JC, 2002, ANN NY ACAD SCI, V977, P196; Dhingra R, 2007, ARCH INTERN MED, V167, P879, DOI 10.1001/archinte.167.9.879; Dursun I, 2009, NEPHROL DIAL TRANSPL, V24, P2511, DOI 10.1093/ndt/gfp066; Ferrari SL, 2005, J CLIN ENDOCR METAB, V90, P1519, DOI 10.1210/jc.2004-1039; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Foley RN, 2008, AM HEART J, V156, P556, DOI 10.1016/j.ahj.2008.05.016; Gutierrez OM, 2013, ADV NUTR, V4, P723, DOI 10.3945/an.113.004812; Khatri M, 2009, J AM SOC NEPHROL, V20, P2427, DOI 10.1681/ASN.2008101090; Kim BJ, 2015, J STROKE, V17, P101, DOI 10.5853/jos.2015.17.2.101; Leon JB, 2013, J RENAL NUTR, V23, P265, DOI 10.1053/j.jrn.2012.12.003; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; McMahon JA, 2006, NEW ENGL J MED, V354, P2764, DOI 10.1056/NEJMoa054025; Murphy Patricia A, 2002, Eff Clin Pract, V5, pE4; Murray AM BE, 2015, J AM SOC NEPHROLOGY, V26; Murray AM, 2008, ADV CHRONIC KIDNEY D, V15, P123, DOI 10.1053/j.ackd.2008.01.010; Oddone Eugene Z, 2008, N C Med J, V69, P35; Onufrak SJ, 2008, ATHEROSCLEROSIS, V199, P424, DOI 10.1016/j.atherosclerosis.2007.11.004; Reis JP, 2013, ATHEROSCLEROSIS, V231, P72, DOI 10.1016/j.atherosclerosis.2013.08.038; Relph Wendy-Ling, 2016, Nurs Older People, V28, P16, DOI 10.7748/nop.28.3.16.s22; Sanders C, 2016, J ALZHEIMERS DIS JAD; Satizabal CL, 2016, NEW ENGL J MED, V374, P523, DOI 10.1056/NEJMoa1504327; Schrijvers EMC, 2012, NEUROLOGY, V78, P1456, DOI 10.1212/WNL.0b013e3182553be6; Seliger SL, 2004, J AM SOC NEPHROL, V15, P1904, DOI 10.1097/01.asn.0000131529.60019.fa; Shuto E, 2009, J AM SOC NEPHROL, V20, P1504, DOI 10.1681/ASN.2008101106; Spaccavento S, 2009, ARCH GERONTOL GERIAT, V48, P356, DOI 10.1016/j.archger.2008.03.002; St Germaine-Smith C, 2012, NEUROLOGY, V79, P1049, DOI 10.1212/WNL.0b013e3182684707; Tonelli M, 2005, CIRCULATION, V112, P2627, DOI 10.1161/CIRCULATIONAHA.105.553198; Toyoda K, 2015, J STROKE, V17, P31, DOI 10.5853/jos.2015.17.1.31; Uribarri J, 2003, SEMIN DIALYSIS, V16, P186, DOI 10.1046/j.1525-139X.2003.16037.x; Vervloet MG, 2011, CLIN J AM SOC NEPHRO, V6, P383, DOI 10.2215/CJN.04730510; Watari E, 2015, J CLIN BIOCHEM NUTR, V56, P35, DOI 10.3164/jcbn.14-96; Wright CB, 2016, STROKE J CEREBRAL CI; Wright CB, 2014, NEUROLOGY, V82, P1700, DOI 10.1212/WNL.0000000000000410; Xie Y, 2016, J AM SOC NEPHROLOGY; Xie Y, 2016, AM J KIDNEY DIS OFFI; Xie Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149283; Xie Y, 2015, CLIN J AM SOC NEPHRO, V10, P1946, DOI 10.2215/CJN.04480415; Yoo KD, 2016, AM J KIDNEY DIS, V67, P79, DOI 10.1053/j.ajkd.2015.06.027	54	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171377	10.1371/journal.pone.0171377	http://dx.doi.org/10.1371/journal.pone.0171377			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152028	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161200135
J	Zilm, PS; Butnejski, V; Rossi-Fedele, G; Kidd, SP; Edwards, S; Vasilev, K				Zilm, Peter S.; Butnejski, Victor; Rossi-Fedele, Giampiero; Kidd, Stephen P.; Edwards, Suzanne; Vasilev, Krasimir			D-amino acids reduce Enterococcus faecalis biofilms in vitro and in the presence of antimicrobials used for root canal treatment	PLOS ONE			English	Article							APICAL PERIODONTITIS; FILLED TEETH; MICROTITER PLATES; SRB BIOFILM; QUANTIFICATION; IDENTIFICATION; STAPHYLOCOCCI; MEDICAMENTS; INFECTIONS; MITIGATION	Enterococcus faecalis is the most frequent species present in post-treatment disease and plays a significant role in persistent periapical infections following root canal treatment. Its ability to persist in stressful environments is inter alia, due to its ability to form biofilms. The presence of certain D-amino acids (DAAs) has previously been shown to reduce formation of Bacillus subtilis biofilms. The aims of this investigation were to determine if DAAs disrupt biofilms in early and late growth stages for clinical E. faecalis strains and to test their efficacy in disrupting E. faecalis biofilms grown in sub-minimum inhibitory concentrations of commonly used endodontic biocides. From thirty-seven E. faecalis strains, the ten "best" biofilm producers were used to test the ability of a mixture containing D-leucine, D-methionine, D-tyrosine and D-tryptophan to reduce biofilm growth over a period of 24, 72 and 144 hours and when compared to their cognate L-Amino Acids (LAAs). We have previously shown that sub-MIC levels of tetracycline and sodium hypochlorite promotes biofilm growth in clinical strains of E. faecalis. DAAs were therefore tested for their effectiveness to reduce biofilm growth in the presence of sub-minimal concentrations of sodium hypochlorite (NaOCl-0.031%) and Odontocide (TM) (0.25% w/v), and in the presence of Odontopaste (TM) (0.25% w/v). DAAs significantly reduced biofilm formation for all strains tested in vitro, while DAAs significantly reduced biofilm formation compared to LAAs. The inhibitory effect of DAAs on biofilm formation was concentration dependent. DAAs were also shown to be effective in reducing E. faecalis biofilms in the presence of Odontopaste (TM) and sub-MIC levels of NaOCl and Odontocide (TM). The results suggest that the inclusion of DAAs into current endodontic procedures may reduce E. faecalis biofilms.	[Zilm, Peter S.; Butnejski, Victor; Rossi-Fedele, Giampiero] Univ Adelaide, Microbiol Lab, Sch Dent, Adelaide, SA, Australia; [Kidd, Stephen P.] Univ Adelaide, Sch Biol Sci, Australian Ctr Antimicrobial Resistance Ecol, Res Ctr Infect Dis, Adelaide, SA, Australia; [Edwards, Suzanne] Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia; [Vasilev, Krasimir] Univ South Australia, Sch Engn, Adelaide, SA, Australia	University of Adelaide; University of Adelaide; University of Adelaide; University of South Australia	Zilm, PS (corresponding author), Univ Adelaide, Microbiol Lab, Sch Dent, Adelaide, SA, Australia.	peter.zilm@adelaide.edu.au	Vasilev, Krasimir/C-5248-2008; kidd, stephen/H-8799-2012	kidd, stephen/0000-0002-2118-1651; Zilm, Peter/0000-0001-7554-9717; Vasilev, Krasimir/0000-0003-3534-4754	Australian Dental Research Foundation	Australian Dental Research Foundation	The authors are very grateful to the Australian Dental Research Foundation for their support in this research through the Colin Cormie Scholarship for V. Butnejski. The authors declare no conflicts of interest with respect to the authorship and/or publication of this article.	Athanassiadis B, 2007, AUST DENT J, V52, pS64, DOI 10.1111/j.1834-7819.2007.tb00527.x; Bui LMG, 2015, INFECT IMMUN, V83, P470, DOI 10.1128/IAI.02702-14; Cathro P, 2016, FEBS OPEN BIO, V6, P586, DOI 10.1002/2211-5463.12075; Creti R, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-60; Dahlen G, 2000, ORAL MICROBIOL IMMUN, V15, P309, DOI 10.1034/j.1399-302x.2000.150507.x; Extremina CI, 2011, J MICROBIOL METH, V84, P167, DOI 10.1016/j.mimet.2010.11.007; Fonseca AP, 2007, INT J ANTIMICROB AG, V30, P236, DOI 10.1016/j.ijantimicag.2007.04.011; HAAPASALO M, 1987, J DENT RES, V66, P1375, DOI 10.1177/00220345870660081801; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Jenkinson HF, 2001, TRENDS MICROBIOL, V9, P9, DOI 10.1016/S0966-842X(00)01891-6; Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628; Lam H, 2009, SCIENCE, V325, P1552, DOI 10.1126/science.1178123; Leiman SA, 2013, J BACTERIOL, V195, P5391, DOI 10.1128/JB.00975-13; Li YC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00896; McLean RJC, 2004, J MICROBIOL METH, V58, P351, DOI 10.1016/j.mimet.2004.04.016; Molander A, 1998, INT ENDOD J, V31, P1, DOI 10.1046/j.1365-2591.1998.t01-1-00111.x; Nair PNR, 2014, INT ENDOD J, V47, P1003, DOI 10.1111/iej.12287; Nair PNR, 2006, INT ENDOD J, V39, P249, DOI 10.1111/j.1365-2591.2006.01099.x; Peciuliene V, 2001, INT ENDOD J, V34, P429, DOI 10.1046/j.1365-2591.2001.00411.x; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Pinheiro ET, 2003, INT ENDOD J, V36, P1, DOI 10.1046/j.1365-2591.2003.00603.x; Ramon-Perez ML, 2014, J MED MICROBIOL, V63, P1369, DOI 10.1099/jmm.0.075796-0; Sarkar S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117613; Singh KV, 2002, ANTIMICROB AGENTS CH, V46, P1845, DOI 10.1128/AAC.46.6.1845-1850.2002; Sjogren U, 1997, INT ENDOD J, V30, P297, DOI 10.1111/j.1365-2591.1997.tb00714.x; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Stepanovic S, 2001, EUR J CLIN MICROBIOL, V20, P502; Stepanovic S, 2007, APMIS, V115, P891, DOI 10.1111/j.1600-0463.2007.apm_630.x; SUNDQVIST G, 1992, ORAL MICROBIOL IMMUN, V7, P257, DOI 10.1111/j.1399-302X.1992.tb00584.x; Toledo-Arana A, 2001, APPL ENVIRON MICROB, V67, P4538, DOI 10.1128/AEM.67.10.4538-4545.2001; Wilson CE, 2015, INT ENDOD J, V48, P210, DOI 10.1111/iej.12301; Xu D, 2012, WORLD J MICROB BIOT, V28, P3067, DOI 10.1007/s11274-012-1116-0; Xu D, 2012, WORLD J MICROB BIOT, V28, P1641, DOI 10.1007/s11274-011-0970-5	33	41	42	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170670	10.1371/journal.pone.0170670	http://dx.doi.org/10.1371/journal.pone.0170670			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151960	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000396161200031
J	Chen, ZY; Jing, YL; Wen, Q; Ding, XP; Wang, T; Mu, XM; Chenzhang, YW; Cao, M				Chen, Zuyi; Jing, Yaling; Wen, Qiang; Ding, Xianping; Wang, Tao; Mu, Xuemei; Chenzhang, Yuwei; Cao, Man			E6 and E7 Gene Polymorphisms in Human Papillomavirus Types-58 and 33 Identified in Southwest China	PLOS ONE			English	Article							CERVICAL-CANCER; RISK; LESIONS; WOMEN; PREVALENCE; PREDICTION; PROVINCE; ASSOCIATION; VARIABILITY; INFECTION	Cancer of the cervix is associated with infection by certain types of human papillomavirus (HPV). The gene variants differ in immune responses and oncogenic potential. The E6 and E7 proteins encoded by high-risk HPV play a key role in cellular transformation. HPV-33 and HPV-58 types are highly prevalent among Chinese women. To study the gene intratypic variations, polymorphisms and positive selections of HPV-33 and HPV-58 E6/E7 in southwest China, HPV-33 (E6, E7: n = 216) and HPV-58 (E6, E7: n = 405) E6 and E7 genes were sequenced and compared to others submitted to GenBank. Phylogenetic trees were constructed by Maximum-likelihood and the Kimura 2-parameters methods by MEGA 6 (Molecular Evolutionary Genetics Analysis version 6.0). The diversity of secondary structure was analyzed by PSIPred software. The selection pressures acting on the E6/E7 genes were estimated by PAML 4.8 (Phylogenetic Analyses by Maximun Likelihood version4.8) software. The positive sites of HPV-33 and HPV-58 E6/E7 were contrasted by ClustalX 2.1. Among 216 HPV-33 E6 sequences, 8 single nucleotide mutations were observed with 6/8 non-synonymous and 2/8 synonymous mutations. The 216 HPV-33 E7 sequences showed 3 single nucleotide mutations that were non-synonymous. The 405 HPV-58 E6 sequences revealed 8 single nucleotide mutations with 4/8 non-synonymous and 4/8 synonymous mutations. Among 405 HPV-58 E7 sequences, 13 single nucleotide mutations were observed with 10/13 non-synonymous mutations and 3/13 synonymous mutations. The selective pressure analysis showed that all HPV-33 and 4/6 HPV-58 E6/E7 major non-synonymous mutations were sites of positive selection. All variations were observed in sites belonging to major histocompatibility complex and/or B-cell predicted epitopes. K93N and R145 (I/N) were observed in both HPV-33 and HPV-58 E6.	[Chen, Zuyi; Jing, Yaling; Wen, Qiang; Ding, Xianping; Wang, Tao; Mu, Xuemei; Chenzhang, Yuwei; Cao, Man] Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Minist Educ, Chengdu, Peoples R China; [Chen, Zuyi; Jing, Yaling; Wen, Qiang; Ding, Xianping; Wang, Tao; Mu, Xuemei; Chenzhang, Yuwei; Cao, Man] Bioresource Res & Utilizat Joint Key Lab Sichuan, Chongqing, Sichuan, Peoples R China; [Chen, Zuyi; Jing, Yaling; Wen, Qiang; Ding, Xianping; Wang, Tao; Mu, Xuemei; Chenzhang, Yuwei; Cao, Man] Sichuan Univ, Inst Med Genet, Coll Life Sci, Chengdu, Peoples R China	Sichuan University; Sichuan University	Ding, XP (corresponding author), Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Minist Educ, Chengdu, Peoples R China.; Ding, XP (corresponding author), Bioresource Res & Utilizat Joint Key Lab Sichuan, Chongqing, Sichuan, Peoples R China.; Ding, XP (corresponding author), Sichuan Univ, Inst Med Genet, Coll Life Sci, Chengdu, Peoples R China.	brainding@scu.edu.cn						Asato T, 2004, J INFECT DIS, V189, P1829, DOI 10.1086/382896; Bae JH, 2009, J MICROBIOL BIOTECHN, V19, P1051, DOI 10.4014/jmb.0812.679; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Burk RD, 2013, VIROLOGY, V445, P232, DOI 10.1016/j.virol.2013.07.018; Calleja-Macias IE, 2005, J VIROL, V79, P13630, DOI 10.1128/JVI.79.21.13630-13640.2005; Cento V, 2011, J MED VIROL, V83, P1752, DOI 10.1002/jmv.22201; Chan PKS, 2013, INT J CANCER, V132, P2528, DOI 10.1002/ijc.27932; Chan PKS, 2009, INT J CANCER, V125, P1671, DOI 10.1002/ijc.24495; Chan PKS, 2002, J NATL CANCER I, V94, P1249, DOI 10.1093/jnci/94.16.1249; Chang JTC, 2010, CANCER GENE THER, V17, P827, DOI 10.1038/cgt.2010.38; Chang YJ, 2011, INT J CANCER, V129, P965, DOI 10.1002/ijc.25724; Chemes LB, 2014, BIOCHEMISTRY-US, V53, P1680, DOI 10.1021/bi401562e; Chen AA, 2014, VIROLOGY, V448, P356, DOI 10.1016/j.virol.2013.10.033; Chen CA, 2006, INT J GYNECOL CANCER, V16, P1801, DOI 10.1111/j.1525-1438.2006.00655.x; Chen ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020183; Chen ZY, 2015, INT J GYNECOL OBSTET, V131, P277, DOI 10.1016/j.ijgo.2015.06.027; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Garbuglia AR, 2007, NEW MICROBIOL, V30, P377; Godinez JM, 2013, INFECT GENET EVOL, V13, P96, DOI 10.1016/j.meegid.2012.09.011; Hamza AA, 2012, SYST APPL MICROBIOL, V35, P183, DOI 10.1016/j.syapm.2011.12.005; Hwang T, 1999, J KOREAN MED SCI, V14, P593, DOI 10.3346/jkms.1999.14.6.593; Iyengar VK, 2002, NATURE, V419, P830, DOI 10.1038/nature01027; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Khouadri S, 2006, J INFECT DIS, V194, P886, DOI 10.1086/507431; Li JK, 2012, J CLIN MICROBIOL, V50, P1079, DOI 10.1128/JCM.06214-11; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Liu JH, 2012, INFECT GENET EVOL, V12, P1466, DOI 10.1016/j.meegid.2012.05.004; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; NEI M, 1986, MOL BIOL EVOL, V3, P418; Rampias T, 2014, ORAL ONCOL, V50, P356, DOI 10.1016/j.oraloncology.2013.07.011; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schiffman M, 2010, CANCER RES, V70, P3159, DOI 10.1158/0008-5472.CAN-09-4179; Shen MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056614; Singh H, 2003, BIOINFORMATICS, V19, P1009, DOI 10.1093/bioinformatics/btg108; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Stewart ACM, 1996, J VIROL, V70, P3127, DOI 10.1128/JVI.70.5.3127-3136.1996; Sun ZR, 2010, INT J GYNECOL OBSTET, V109, P105, DOI 10.1016/j.ijgo.2009.11.026; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas M, 2008, ONCOGENE, V27, P7018, DOI 10.1038/onc.2008.351; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wu EQ, 2009, J GEN VIROL, V90, P1229, DOI 10.1099/vir.0.008227-0; Wu XL, 2009, J MED VIROL, V81, P693, DOI 10.1002/jmv.21435; Yang LJ, 2014, INFECT GENET EVOL, V21, P395, DOI 10.1016/j.meegid.2013.12.009; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yue YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055204; Zhao R, 2009, BRIT J CANCER, V101, P1635, DOI 10.1038/sj.bjc.6605351	53	12	14	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171140	10.1371/journal.pone.0171140	http://dx.doi.org/10.1371/journal.pone.0171140			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141822	Green Published, gold, Green Submitted			2022-12-27	WOS:000396129500042
J	Li, L; Miao, WG; Liu, WB; Zhang, SJ				Li, Le; Miao, Weiguo; Liu, Wenbo; Zhang, Shujian			The signal peptide-like segment of hpaXm is required for its association to the cell wall in transgenic tobacco plants	PLOS ONE			English	Article							ORYZAE PV. ORYZICOLA; HRP PATHOGENICITY ISLAND; HARPIN-ENCODING GENE; DISEASE RESISTANCE; HYPERSENSITIVE RESPONSE; ERWINIA-AMYLOVORA; YERSINIA-ENTEROCOLITICA; ACQUIRED-RESISTANCE; TRANSLOCATORS YOPB; III SECRETION	Harpins, encoded by hrp (hypersensitive response and pathogenicity) genes of Gram-negative plant pathogens, are elicitors of hypersensitive response (HR). HpaXm is a novel harpin-like protein described from cotton leaf blight bacteria, Xanthomonas citri subsp. malvacearum-a synonym of X. campestris pv. malvacearum (Smith 1901-1978). A putative signal peptide (1-MNSLNTQIGANSSFL-15) of hpaXm was predicted in the nitroxyl-terminal (N-terminal) by SignalP (SignalP 3.0 server). Here, we explored the function of the N-terminal leader peptide like segment of hpaXm using transgenic tobacco (Nicotiana tabacum cv. Xanthi nc.). Transgenic tobacco lines expressing the full-length hpaXm and the signal peptide-like segment-deleted mutant hpaXm Delta LP were developed using transformation mediated by Agrobacterium tumefaciens. The target genes were confirmed integrated into the tobacco genomes and expressed normally. Using immune colloidal-gold detection technique, hpaXm protein was found to be transferred to the cytoplasm, the cell membrane, and organelles such as chloroplasts, mitochondria, and nucleus, as well as the cell wall. However, the deletion mutant hpaXm Delta LP expressed in transgenic tobacco was found unable to cross the membrane to reach the cell wall. Additionally, soluble proteins extracted from plants transformed with hpaXm and hpaXm Delta LP were bio-active. Defensive micro-HR induced by the transgene expression of hpaXm and hpaXm Delta LP were observed on transgenic tobacco leaves. Disease resistance bioassays to tobacco mosaic virus (TMV) showed that tobacco plants transformed with hpaXm and with hpaXm Delta LP exhibited enhanced resistance to TMV. In summary, the N-terminal signal peptide-like segment (1-45 bp) in hpaXm sequence is not necessary for transgene expression, bioactivity of hpaXm and resistance to TMV in transgenic tobacco, but is required for the protein to be translocated to the cell wall.	[Li, Le; Miao, Weiguo; Liu, Wenbo] Hainan Univ, Coll Environm & Plant Protect, Haikou, Hainan Province, Peoples R China; [Li, Le; Miao, Weiguo; Liu, Wenbo] Hainan Key Lab Sustainable Utilizat Trop Bioresou, Haikou, Hainan Province, Peoples R China; [Zhang, Shujian] USDA ARS, US Hort Res Lab, Ft Pierce, FL USA	Hainan University; United States Department of Agriculture (USDA)	Miao, WG (corresponding author), Hainan Univ, Coll Environm & Plant Protect, Haikou, Hainan Province, Peoples R China.; Miao, WG (corresponding author), Hainan Key Lab Sustainable Utilizat Trop Bioresou, Haikou, Hainan Province, Peoples R China.	miao@hainu.edu.cn			National agricultural industrial technology system [CARS-34-GW8]; National Natural Science Foundation ofChina [31360029, 31160359]; Doctoral Fund of Ministry of Education [20124601110004, 20104601110004]; National Key Basic Research Plan of China [2011CB111612]; Hainan University [kqd1006]; Doctoral Program of Higher Education of China [20124601110004]; National Natural Science Foundation of China [31360029)]	National agricultural industrial technology system; National Natural Science Foundation ofChina(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education; National Key Basic Research Plan of China(National Basic Research Program of China); Hainan University; Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National agricultural industrial technology system (CARS-34-GW8) to WM; National Natural Science Foundation ofChina under Grant (31360029,31160359) to WM; Doctoral Fund of Ministry of Education (20124601110004, 20104601110004) to WM; National Key Basic Research Plan of China (2011CB111612) to WM and the Research and start-up capital of Hainan University (kqd1006) to WM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (31360029) and The Research Fund for the Doctoral Program of Higher Education of China (20124601110004). The studies were conceived and planned by WG Miao; L Li carried out the molecular genetic studies and the transgenic related works, participated in the sequence alignment, the protein analysis and the TMV inoculation, and simultaneously drafted the manuscript. WG Miao participated in the design of the study. L Li performed the statistical analysis and took part in the protein analysis and the virus inoculation. The manuscript was edited and prepared by L Li, and was reviewed by SJ Zhang along with WG Miao. WB Liu managed the laboratory and custodies all the experimental materials. All authors read and approved the final manuscript. Special thanks to Yunqin Li, ZheJiang University, for helping with the immuno-colloidal gold test.	Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; Berberich T, 1995, PLANT MOL BIOL, V29, P611, DOI 10.1007/BF00020988; Bollag D.M., 1996, PROTEIN METHODS; Brown IR, 2001, MOL PLANT MICROBE IN, V14, P394, DOI 10.1094/MPMI.2001.14.3.394; Charkowski AO, 1998, J BACTERIOL, V180, P5211, DOI 10.1128/JB.180.19.5211-5217.1998; Chen L, 2008, PHYTOPATHOLOGY, V98, P792, DOI 10.1094/PHYTO-98-7-0792; Chen L, 2008, PHYTOPATHOLOGY, V98, P781, DOI 10.1094/PHYTO-98-7-0781; Choi MS, 2012, PLANT PATHOLOGY J, V28, P364, DOI 10.5423/PPJ.OA.09.2012.0136; Choi MS, 2013, MPMI, V1, P54; Clark MS, 1997, PLANT MOL BIOL LAB M; Dong H, 2000, PHYTOPATHOLOGY, V90, P801, DOI 10.1094/PHYTO.2000.90.8.801; Dong HP, 2004, PLANT PHYSIOL, V136, P3628, DOI 10.1104/pp.104.048900; Dong HP, 2005, PLANTA, V221, P313, DOI 10.1007/s00425-004-1444-x; Dong HS, 1999, PLANT J, V20, P207, DOI 10.1046/j.1365-313x.1999.00595.x; DOUGLAS CM, 1987, J BACTERIOL, V169, P4962, DOI 10.1128/jb.169.11.4962-4966.1987; Economou A, 2000, FEBS LETT, V476, P18, DOI 10.1016/S0014-5793(00)01662-8; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fu MQ, 2014, J EXP BOT, V65, P1439, DOI 10.1093/jxb/ert488; Gallie DR, 1998, BIOCHEM BIOPH RES CO, V245, P295, DOI 10.1006/bbrc.1998.8427; Gerhardt P, 1981, MANUAL METHODS GEN B; Hoyos ME, 1996, MOL PLANT MICROBE IN, V9, P608, DOI 10.1094/MPMI-9-0608; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kim JF, 1998, J BACTERIOL, V180, P5203, DOI 10.1128/JB.180.19.5203-5210.1998; Kim JG, 2004, J BACTERIOL, V186, P6239, DOI 10.1128/JB.186.18.6239-6247.2004; Kim JG, 2003, J BACTERIOL, V185, P3155, DOI 10.1128/JB.185.10.3155-3166.2003; Klement Z, 1990, METHODS PHYTOBACTERI, V568; Lambert AM, 1982, PNAS, V79; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; Lee J, 2001, PLANT CELL, V13, P1079, DOI 10.1105/tpc.13.5.1079; Li JG, 2010, MOL PLANT PATHOL, V11, P371, DOI [10.1111/j.1364-3703.2010.00610.x, 10.1111/J.1364-3703.2010.00610.X]; Li L., 2015, THESIS; Li RG, 1999, SCI CHINA SER C, V42, P96, DOI 10.1007/BF02881754; Li X, 2014, BIORESOUR BIOPROCESS, V1, P1, DOI [10.1186/s40643-014-0013-9, DOI 10.1186/S40643-014-0013-9, DOI 10.1007/S10404-014-1340-Z]; Meng Fanbo, 2007, THESIS; Miao W. G., 2009, THESIS; Miao WG, 2010, J EXP BOT, V61, P4263, DOI 10.1093/jxb/erq227; Miao WG, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-67; Miao WG, 2009, AMINO ACIDS, V37, P120; Montagner C, 2011, J BACTERIOL, V193, P6923, DOI 10.1128/JB.05555-11; Mudgett MB, 2000, P NATL ACAD SCI USA, V97, P13324, DOI 10.1073/pnas.230450797; Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x; Noel L, 2002, J BACTERIOL, V184, P1340, DOI 10.1128/JB.184.5.1340-1348.2002; Peng JL, 2004, PHYTOPATHOLOGY, V94, P1048, DOI 10.1094/PHYTO.2004.94.10.1048; Peng JL, 2003, PHYSIOL MOL PLANT P, V62, P317, DOI 10.1016/S0885-5765(03)00078-X; Racape J, 2005, MOL MICROBIOL, V58, P1406, DOI 10.1111/j.1365-2958.2004.04910.x; Sambrook J., 2001, MOL CLONING LAB MANU; Schechter LM, 2004, J BACTERIOL, V186, P543, DOI 10.1128/JB.186.2.543-555.2004; Shao M, 2008, PLANT BIOTECHNOL J, V6, P73, DOI 10.1111/j.1467-7652.2007.00304.x; Sohn S, 2007, MOL CELLS, V24, P232; Strobel NE, 1996, PLANT J, V9, P431, DOI 10.1046/j.1365-313X.1996.09040431.x; Tsunemi K, 2011, MOL PLANT PATHOL, V12, P709, DOI [10.1111/j.1364-3703.2011.00705.x, 10.1111/J.1364-3703.2011.00705.X]; UKNES S, 1992, PLANT CELL, V4, P645, DOI 10.1105/tpc.4.6.645; Walker JM, 2009, SPRINGER PROTOC HAND, P11, DOI 10.1007/978-1-59745-198-7_3; Wang XY, 2008, APPL MICROBIOL BIOT, V81, P359, DOI 10.1007/s00253-008-1651-7; Wang XY, 2007, MOL BIOL REP, V34, P189, DOI 10.1007/s11033-006-9034-6; WEI ZM, 1993, J BACTERIOL, V175, P7958, DOI 10.1128/JB.175.24.7958-7967.1993; WEI ZM, 1992, SCIENCE, V257, P85, DOI 10.1126/science.1621099; Wu XJ, 2007, J BIOSCIENCES, V32, P1119, DOI 10.1007/s12038-007-0113-1; [余云舟 Yu Yunzhou], 2003, [吉林农业大学学报, Journal of Jilin Agricultural University], V25, P257	59	4	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170931	10.1371/journal.pone.0170931	http://dx.doi.org/10.1371/journal.pone.0170931			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141855	gold, Green Published, Green Submitted			2022-12-27	WOS:000396129500028
J	Butt, HI; Yang, ZE; Chen, EY; Zhao, G; Gong, Q; Yang, ZR; Zhang, XY; Li, FG				Butt, Hamama Islam; Yang, Zhaoen; Chen, Eryong; Zhao, Ge; Gong, Qian; Yang, Zuoren; Zhang, Xueyan; Li, Fuguang			Functional Characterization of Cotton GaMYB62L, a Novel R2R3 TF in Transgenic Arabidopsis	PLOS ONE			English	Article							MYB TRANSCRIPTION FACTOR; ABIOTIC STRESS RESPONSES; PLANT ADAPTIVE RESPONSE; CIS-ACTING ELEMENTS; DNA-BINDING DOMAIN; ABSCISIC-ACID; DROUGHT TOLERANCE; GENE FAMILY; DEHYDRATION TOLERANCE; FREEZING TOLERANCE	Drought stress can trigger the production of ABA in plants, in response to adverse conditions, which induces the transcript of stress-related marker genes. The R2R3 MYB TFs are implicated in regulation of various plants developmental, metabolic and multiple environmental stress responses. Here, a R2R3-MYB cloned gene, GaMYB62L, was transformed in Arabidopsis and was functionally characterized. The GaMYB62L protein contains two SANT domains with a conserved R2R3 imperfect repeats. The GaMYB62L cDNA is 1,017 bp with a CDS of 879, encodes a 292-residue polypeptide with MW of 38.78 kD and a pl value of 8.91. Overexpressed GaMYB62L transgenic Arabidopsis have increased proline and chlorophyll content, superior seed germination rate under salt and osmotic stress, less water loss rate with reduced stomatal apertures, high drought avoidance as compared to WT on water deprivation and also significant plant survival rates at low temperature. In addition, overexpressed GaMYB62L lines were more sensitive to ABA mediated germination and root elongation assay. Moreover, ABA induced GaMYB62L overexpression, enhanced the expression of ABA stress related marker genes like RD22, COR15A, ADH1, and RD29A. Together, overexpression of GaMYB62L suggested having developed better drought, salt and cold tolerance in transgenic Arabidopsis and thus presented it as a prospective candidate gene to achieve better abiotic stress tolerance in cotton crop.	[Butt, Hamama Islam; Yang, Zhaoen; Chen, Eryong; Zhao, Ge; Gong, Qian; Yang, Zuoren; Zhang, Xueyan; Li, Fuguang] CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Zhang, XY; Li, FG (corresponding author), CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China.	Zhangxueyan_caas@126.com; aylifug@163.com	Yang, Zuoren/AAF-5040-2020	ge, xiaoyang/0000-0003-4134-4443; Qian, Gong/0000-0003-1724-4653; Yang, Zuoren/0000-0001-5898-6309	National Natural Science Foundation of China [U1303282]; Henan Province [162300410160]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Henan Province	This work was supported by the Major Program of Joint Funds (Sinkiang) of the National Natural Science Foundation of China (grant U1303282) and also supported by a grant from Henan Province (No. 162300410160).	Aasland R, 1996, TRENDS BIOCHEM SCI, V21, P87, DOI 10.1016/S0968-0004(96)30009-1; Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Chen CB, 2005, P NATL ACAD SCI USA, V102, P3459, DOI 10.1073/pnas.0407960102; Chen TZ, 2015, PLANT CELL PHYSIOL, V56, P917, DOI 10.1093/pcp/pcv019; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cominelli E, 2005, CURR BIOL, V15, P1196, DOI 10.1016/j.cub.2005.05.048; Cominelli E, 2008, PLANT J, V53, P53, DOI 10.1111/j.1365-313X.2007.03310.x; Dai XY, 2007, PLANT PHYSIOL, V143, P1739, DOI 10.1104/pp.106.094532; Denekamp M, 2003, PLANT PHYSIOL, V132, P1415, DOI 10.1104/pp.102.019273; Devaiah BN, 2009, MOL PLANT, V2, P43, DOI 10.1093/mp/ssn081; Dhanda SS, 1998, EUPHYTICA, V104, P39, DOI 10.1023/A:1018644113378; DIAZDELEON F, 1993, PLANT PHYSIOL, V101, P1117, DOI 10.1104/pp.101.3.1117; Ding ZH, 2009, J GENET GENOMICS, V36, P17, DOI 10.1016/S1673-8527(09)60003-5; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Gao S, 2014, PLANT SOIL, V376, P433, DOI 10.1007/s11104-013-1992-6; Garg B, 2012, MOL BIOL REP, V39, P10865, DOI 10.1007/s11033-012-1983-3; Hamanishi ET, 2012, J EXP BOT, V63, P4959, DOI 10.1093/jxb/ers177; He QL, 2016, SCI REP-UK, V6, DOI 10.1038/srep22980; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Hoeren FU, 1998, GENETICS, V149, P479; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Huang CJ, 2013, PHYSIOL PLANTARUM, V149, P297, DOI 10.1111/ppl.12031; Huang JY, 2012, PLOS ONE, V7; Hwang OJ, 2014, INT J PHOTOENERGY, V2014, DOI 10.1155/2014/501016; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; Jaglo-Ottosen KR, 1998, SCIENCE, P280; Jakab G, 2005, PLANT PHYSIOL, V139, P267, DOI 10.1104/pp.105.065698; Jamil M, 2006, J CENT EUR AGRIC, V7, P273; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; KISHOR PBK, 1995, PLANT PHYSIOL, V108, P1387, DOI 10.1104/pp.108.4.1387; Kranz HD, 1998, PLANT J, V16, P263, DOI 10.1046/j.1365-313x.1998.00278.x; Lee SC, 2012, PLANT CELL ENVIRON, V35, P53, DOI 10.1111/j.1365-3040.2011.02426.x; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Lippold F, 2009, PLANT PHYSIOL, V149, P1761, DOI 10.1104/pp.108.134874; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masle J, 2005, NATURE, V436, P866, DOI 10.1038/nature03835; Meissner RC, 1999, PLANT CELL, V11, P1827, DOI 10.1105/tpc.11.10.1827; Mo XM, 2005, GENE DEV, V19, P2447, DOI 10.1101/gad.355405; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; Ogata K, 1996, NAT STRUCT BIOL, V3, P178, DOI 10.1038/nsb0296-178; Osakabe Y, 2010, J BIOL CHEM, V285, P9190, DOI 10.1074/jbc.M109.051938; Parida AK, 2007, PLANT BIOTECHNOL REP, V1, P37, DOI 10.1007/s11816-006-0004-1; Pastuglia M, 1997, PLANT CELL, V9, P49, DOI 10.1105/tpc.9.1.49; Pei ZM, 1997, PLANT CELL, V9, P409, DOI 10.1105/tpc.9.3.409; Qin F, 2011, PLANT CELL PHYSIOL, V52, P1569, DOI 10.1093/pcp/pcr106; Qin YX, 2012, MOL BIOL REP, V39, P7183, DOI 10.1007/s11033-012-1550-y; Ramanjulu S, 2002, PLANT CELL ENVIRON, V25, P141, DOI 10.1046/j.0016-8025.2001.00764.x; Rouster J, 1997, PLANT J, V11, P513, DOI 10.1046/j.1365-313X.1997.11030513.x; Sabbagh E, 2014, INT J FARM ALLI SCI, V3, P988; Seki M, 2007, CURR OPIN PLANT BIOL, V10, P296, DOI 10.1016/j.pbi.2007.04.014; Seo PJ, 2011, PLANT CELL, V23, P1138, DOI 10.1105/tpc.111.083485; Simpson SD, 2003, PLANT J, V33, P259, DOI 10.1046/j.1365-313X.2003.01624.x; Smith CW, 1999, COTTON ORIGIN HIST T; Song SY, 2011, PLANTA, V234, P331, DOI 10.1007/s00425-011-1403-2; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Su LT, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1889-5; Su LT, 2014, GENE, V538, P46, DOI 10.1016/j.gene.2014.01.024; Sun X., 2012, ABST APPL ANAL, V2012, P1, DOI DOI 10.1371/J0URNAL.PGEN.1002674; Suo JF, 2003, BBA-GENE STRUCT EXPR, V1630, P25, DOI 10.1016/j.bbaexp.2003.08.009; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Szekely G, 2008, PLANT J, V53, P11, DOI 10.1111/j.1365-313X.2007.03318.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vannini C, 2004, PLANT J, V37, P115, DOI 10.1046/j.1365-313X.2003.01938.x; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Villalobos MA, 2004, PLANT PHYSIOL, V135, P309, DOI 10.1104/pp.103.034199; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Walford SA, 2011, PLANT J, V65, P785, DOI 10.1111/j.1365-313X.2010.04464.x; Wang CX, 2011, J EXP BOT, V62, P1299, DOI 10.1093/jxb/erq377; Wang RK, 2014, PHYSIOL PLANTARUM, V150, P76, DOI 10.1111/ppl.12069; Yamaguchi K, 2007, BIOCHEM BIOPH RES CO, V352, P486, DOI 10.1016/j.bbrc.2006.11.041; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; YAMAGUCHISHINOZAKI K, 1993, PLANT PHYSIOL, V101, P1119, DOI 10.1104/pp.101.3.1119; YAMAGUCHISHINOZAKI K, 1993, MOL GEN GENET, V236, P331, DOI 10.1007/BF00277130; Yang A, 2012, J EXP BOT, V63, P2541, DOI 10.1093/jxb/err431; Yang L, 2016, J INTEGR PLANT BIOL, V58, P67, DOI 10.1111/jipb.12364; Yi SY, 2009, J PLANT BIOL, V52, P560, DOI 10.1007/s12374-009-9072-4; Yu H, 2008, PLANT CELL, V20, P1134, DOI 10.1105/tpc.108.058263; Yuan Y, 2015, PLANT CELL TISS ORG, V120, P973, DOI 10.1007/s11240-014-0686-y; Zhang LC, 2014, PLANT CELL PHYSIOL, V55, P1802, DOI 10.1093/pcp/pcu109; Zhang LN, 2016, FRONT PLANT SCI, P6; [张学清 Zhang Xueqing], 2013, [电工技术学报, Transactions of China Electrotechnical Society], V28, P28; Zhang ZY, 2012, NEW PHYTOL, V196, P1155, DOI 10.1111/j.1469-8137.2012.04353.x; Zhao FL, 2016, GENE, V576, P268, DOI 10.1016/j.gene.2015.10.042; Zhong RQ, 2009, PLANT SIGNAL BEHAV, V4, P1028, DOI 10.4161/psb.4.11.9875; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2	90	18	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170578	10.1371/journal.pone.0170578	http://dx.doi.org/10.1371/journal.pone.0170578			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125637	gold, Green Published, Green Submitted			2022-12-27	WOS:000396176100094
J	Huang, X; Shen, S; Fan, DS				Huang, Xiao; Shen, Shen; Fan, Dongsheng			No Evidence for Pathogenic Role of UBQLN2 Mutations in Sporadic Amyotrophic Lateral Sclerosis in the Mainland Chinese Population	PLOS ONE			English	Article								Mutations in the UBQLN2 gene, which encodes a member of the ubiquitin-like protein family (ubiquilin-2), have been identified in patients with dominant X-linked amyotrophic lateral sclerosis (ALS) and ALS with frontotemporal dementia (FTD). We analyzed mutations in the UBQLN2 gene in a Chinese cohort of 515 patients with sporadic ALS (sALS). A novel missense mutation (p.M392V) was detected in one sALS patient. The p. M392V mutation substitutes a highly conserved residue, has not been reported in the population databases, and previously, at the same residue, a missense mutation p. M392I was detected in two Turkey ALS patients and was considered to be pathogenic, so the M392V is a variant of uncertain significance (VOUS) for ALS. We also found a deletion mutation (p. P500_ G502del), which seems to be benign. In conclusion, our data suggest that mutations in the UBQLN2 gene are rare in Chinese sALS patients.	[Huang, Xiao; Shen, Shen; Fan, Dongsheng] Peking Univ, Dept Neurol, Hosp 3, Beijing, Peoples R China	Peking University	Fan, DS (corresponding author), Peking Univ, Dept Neurol, Hosp 3, Beijing, Peoples R China.	dsfan2010@aliyun.com			National Natural Sciences Foundation of China [81030019]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Sciences Foundation of China [81030019] (URL: http://www.nsfc.gov.cn/). No individuals employed or contracted by the funders (other than the named authors) played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Daoud H, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.03.015; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Gellera C, 2013, J NEUROL NEUROSUR PS, V84, P183, DOI 10.1136/jnnp-2012-303433; Kim HJ, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.03.001; McLaughlin RL, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.07.023; Millecamps S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.11.010; Ozoguz A, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.12.032; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Soong BW, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.05.008; van Doormaal PTC, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.02.032	11	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170943	10.1371/journal.pone.0170943	http://dx.doi.org/10.1371/journal.pone.0170943			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125704	gold, Green Published, Green Submitted			2022-12-27	WOS:000396176100017
J	Shiao, F; Liu, LCO; Huang, N; Lai, YJJ; Barndt, RJ; Tseng, CC; Wang, JK; Jia, B; Johnson, MD; Lin, CY				Shiao, Frank; Liu, Li-Ching O.; Huang, Nanxi; Lai, Ying-Jung J.; Barndt, Robert J.; Tseng, Chun-Che; Wang, Jehng-Kang; Jia, Bailing; Johnson, Michael D.; Lin, Chen-Yong			Selective Inhibition of Prostasin in Human Enterocytes by the Integral Membrane Kunitz-Type Serine Protease Inhibitor HAI-2	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; FACTOR ACTIVATOR INHIBITOR; MATRIPTASE-ACTIVATION; EPIDERMAL DIFFERENTIATION; PLACENTAL DEVELOPMENT; PROTEOLYTIC CASCADE; SECRETORY DIARRHEA; ZYMOGEN ACTIVATION; EPITHELIAL-CELLS; HUMAN TISSUES	Mutations of hepatocyte growth factor activator inhibitor (HAI)-2 in humans cause sodium loss in the gastrointestinal (GI) tract in patients with syndromic congenital sodium diarrhea (SCSD). Aberrant regulation of HAI-2 target protease(s) was proposed as the cause of the disease. Here functional linkage of HAI-2 with two membrane-associated serine proteases, matriptase and prostasin was analyzed in Caco-2 cells and the human GI tract. Immunodepletion- immunoblot analysis showed that significant proportion of HAI-2 is in complex with activated prostasin but not matriptase. Unexpectedly, prostasin is expressed predominantly in activated forms and was also detected in complex with HAI-1, a Kunitz inhibitor highly related to HAI-2. Immunohistochemistry showed a similar tissue distribution of prostasin and HAI-2 immunoreactivity with the most intense labeling near the brush borders of villus epithelial cells. In contrast, matriptase was detected primarily at the lateral plasma membrane, where HAI-1 was also detected. The tissue distribution profiles of immunoreactivity against these proteins, when paired with the species detected suggests that prostasin is under tight control by both HAI-1 and HAI-2 and matriptase by HAI-1 in human enterocytes. Furthermore, HAI-1 is a general inhibitor of prostasin in a variety of epithelial cells. In contrast, HAI-2 was not found to be a significant inhibitor for prostasin in mammary epithelial cells or keratinocytes. The high levels of constitutive prostasin zymogen activation and the selective prostasin inhibition by HAI-2 in enterocytes suggest that dysregulated prostasin proteolysis may be particularly important in the GI tract when HAI-2 function is lost and/or dysregulated.	[Shiao, Frank; Huang, Nanxi; Lai, Ying-Jung J.; Barndt, Robert J.; Tseng, Chun-Che; Jia, Bailing; Johnson, Michael D.; Lin, Chen-Yong] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA; [Liu, Li-Ching O.] Natl Def Med Ctr, Coll Med, Taipei, Taiwan; [Wang, Jehng-Kang] Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan; [Jia, Bailing] Henan Prov Peoples Hosp, Dept Gastroenterol, Zhengzhou, Peoples R China	Georgetown University; National Defense Medical Center; National Defense Medical Center; Zhengzhou University	Lin, CY (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA.; Wang, JK (corresponding author), Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan.	jkwang@ndmctsgh.edu.tw; lincy@georgetown.edu	Lin, Chen/GRR-2799-2022	Tseng, Chun-che/0000-0001-9637-4127; Lin, Chen-Yong/0000-0002-6391-2571	National Cancer Institute (NCI) [R01 CA 123223]; Department of Defense, Taiwan [MAB104-026]; Chi-Mei Medical Center [CM NDMC10506]; Lombardi Comprehensive Cancer Center (NIH/NCI) [P30-CA051008]; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense, Taiwan(United States Department of Defense); Chi-Mei Medical Center; Lombardi Comprehensive Cancer Center (NIH/NCI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Cancer Institute (NCI) Grant R01 CA 123223 (to M. D. Johnson and C.-Y. Lin), Grant (MAB104-026) from the Department of Defense, Taiwan (to J.-K. Wang), Grant CM NDMC10506 from Chi-Mei Medical Center (to J.-K. Wang). We also acknowledge the assistance provided by the Histopathology and Tissue Shared Resource and the Microscopy and Imaging Shared Resource which are supported in part by the Lombardi Comprehensive Cancer Center support grant (NIH/NCI grant P30-CA051008).	Andreasen D, 2006, J AM SOC NEPHROL, V17, P968, DOI 10.1681/ASN.2005060637; [Anonymous], 2010, CLIN DYSMORPHOL; Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Bhatt AS, 2007, P NATL ACAD SCI USA, V104, P5771, DOI 10.1073/pnas.0606514104; BOOTH IW, 1985, LANCET, V1, P1066; Carattino MD, 2014, AM J PHYSIOL-RENAL, V307, pF1080, DOI 10.1152/ajprenal.00157.2014; Carney TJ, 2007, DEVELOPMENT, V134, P3461, DOI 10.1242/dev.004556; Chang HHD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120489; Chen CJ, 2011, AM J PHYSIOL-CELL PH, V300, pC406, DOI 10.1152/ajpcell.00403.2010; Chen LM, 2001, J BIOL CHEM, V276, P21434, DOI 10.1074/jbc.M011423200; Chen LM, 2004, PROSTATE, V59, P1, DOI 10.1002/pros.10346; Chen YW, 2014, J INVEST DERMATOL, V134, P405, DOI 10.1038/jid.2013.320; Chen YW, 2010, J BIOL CHEM, V285, P31755, DOI 10.1074/jbc.M110.150367; Chen YW, 2010, AM J PATHOL, V176, P2986, DOI 10.2353/ajpath.2010.090665; Crisante G, 2014, FASEB J, V28, P4792, DOI 10.1096/fj.14-253781; Faller N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094267; Friis S, 2016, J BIOL CHEM, V291, P2577, DOI 10.1074/jbc.C115.706721; Friis S, 2014, J BIOL CHEM, V289, P22319, DOI 10.1074/jbc.M114.574400; Friis S, 2013, J BIOL CHEM, V288, P19028, DOI 10.1074/jbc.M113.469932; Heinz-Erian P, 2009, AM J HUM GENET, V84, P188, DOI 10.1016/j.ajhg.2009.01.004; HOLMBERG C, 1985, J PEDIATR-US, V106, P56, DOI 10.1016/S0022-3476(85)80465-0; Kataoka H, 1999, J HISTOCHEM CYTOCHEM, V47, P673, DOI 10.1177/002215549904700509; Kataoka H, 2000, CANCER LETT, V148, P127, DOI 10.1016/S0304-3835(99)00322-5; Kato A, 2011, ANNU REV PHYSIOL, V73, P261, DOI 10.1146/annurev-physiol-012110-142244; Kawaguchi T, 1997, J BIOL CHEM, V272, P27558, DOI 10.1074/jbc.272.44.27558; Kirchhofer D, 2005, FEBS LETT, V579, P1945, DOI 10.1016/j.febslet.2005.01.085; Lai CH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152904; Lai YJJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132163; LAWRENCE DA, 1995, J BIOL CHEM, V270, P25309, DOI 10.1074/jbc.270.43.25309; Lee MS, 2005, AM J PHYSIOL-CELL PH, V288, pC932, DOI 10.1152/ajpcell.00497.2004; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; Lin CY, 1997, J BIOL CHEM, V272, P9147; Marlor CW, 1997, J BIOL CHEM, V272, P12202, DOI 10.1074/jbc.272.18.12202; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Shipway A, 2004, BIOCHEM BIOPH RES CO, V324, P953, DOI 10.1016/j.bbrc.2004.09.123; STAMPFER MR, 1985, P NATL ACAD SCI USA, V82, P2394, DOI 10.1073/pnas.82.8.2394; Szabo R, 2007, ONCOGENE, V26, P1546, DOI 10.1038/sj.onc.1209966; Szabo R, 2008, J BIOL CHEM, V283, P29495, DOI 10.1074/jbc.M801970200; Szabo R, 2016, DEVELOPMENT, V143, P2818, DOI 10.1242/dev.137968; Szabo R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002937; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; Szabo R, 2009, AM J PATHOL, V174, P2015, DOI 10.2353/ajpath.2009.090053; Tseng IC, 2010, J BIOL CHEM, V285, P3261, DOI 10.1074/jbc.M109.055640; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; VINCENT JP, 1976, FEBS LETT, V63, P240, DOI 10.1016/0014-5793(76)80103-2; VINCENT JP, 1972, BIOCHEMISTRY-US, V11, P2967, DOI 10.1021/bi00766a007; Xu H, 2012, AM J PHYSIOL-CELL PH, V302, pC453, DOI 10.1152/ajpcell.00344.2011; YU JX, 1995, J BIOL CHEM, V270, P13483, DOI 10.1074/jbc.270.22.13483	52	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170944	10.1371/journal.pone.0170944	http://dx.doi.org/10.1371/journal.pone.0170944			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125689	Green Published, Green Submitted, gold			2022-12-27	WOS:000396176100016
J	Nguyen, TPL; Schuiling-Veninga, CCM; Nguyen, TBY; Vu, TH; Wright, EP; Postma, MJ				Nguyen, Thi-Phuong-Lan; Schuiling-Veninga, Catharina C. M.; Nguyen, Thi Bach Yen; Vu, Thu-Hang; Wright, E. Pamela; Postma, Maarten J.			Adherence to hypertension medication: Quantitative and qualitative investigations in a rural Northern Vietnamese community	PLOS ONE			English	Article							BLOOD-PRESSURE CONTROL; ANTIHYPERTENSIVE MEDICATION; CARDIOVASCULAR-DISEASE; CLINICAL-OUTCOMES; RISK; HOSPITALIZATION; HEALTH; DRUGS; DISCONTINUATION; PERSISTENCE	Objectives The purposes of this study were to assess the adherence to medication of hypertensive patients visiting community health stations in a rural area in Vietnam, to examine the relationship between levels of adherence and cardiovascular risk among hypertensive patients and to further understand factors influencing adherence. Methods This study is part of a prospective one-year study conducted on hypertension management in a population aged 35 to 64 years. Data on age, sex, blood pressure and blood test results were collected at baseline. Cardiovascular risk was based on the Cardiovascular Risk Prediction Model for populations in Asia. To calculate medication adherence, the number of days the drug was taken was divided by the number of days since the first day of the prescription. A threshold of 80% was applied to differentiate between adherence and nonadherence. In-depth interviews were conducted among 18 subjects, including subjects classified as adherent and as non-adherent. Results Among 315 patients analyzed, 49.8% of the patients were adherent. Qualitative investigation revealed discrepancies in classification of adherence and non-adherence based on quantitative analysis and interviews. No significant difference in medication compliance between two cardiovascular disease risk groups (< 10% vs. > 10% risk) was found, also not after controlling for age, sex, and ethnicity ( adjusted odds ratio at 1.068; 95% CI: 0.614 to 1.857). The odds of medication adherence in females was 1.531 times higher than in males but the difference was not statistically significant ( 95% CI: 0.957 to 2.448). Each one-year increase in age resulted in patients being 1.036 times more likely to be compliant (95% CI: 1.002 to 1.072). Awareness of complications related to hypertension was given as the main reason for adherence to therapy. Conclusions Medication adherence rate was relatively low among hypertensive subjects. The data suggest that rather than risk profile, the factor of age should be considered for guiding the choice on who to target for improving medication adherence.	[Nguyen, Thi-Phuong-Lan; Schuiling-Veninga, Catharina C. M.; Postma, Maarten J.] Univ Groningen, Dept Pharm, Unit PharmacoTherapy Epidemiol & Econ PTE2, Groningen, Netherlands; [Nguyen, Thi Bach Yen] Ha Noi Univ Med, Dept Hlth Econ, Hanoi, Vietnam; [Vu, Thu-Hang] Thai Nguyen Univ Med & Pharm, Thai Nguyen, Vietnam; [Wright, E. Pamela] Med Comm Netherlands Vietnam, Amsterdam, Netherlands; [Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Inst Sci Hlth Aging & Hlth CaRE SHARE, Groningen, Netherlands; [Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	University of Groningen; Thai Nguyen University; University of Groningen; University of Groningen	Nguyen, TPL (corresponding author), Univ Groningen, Dept Pharm, Unit PharmacoTherapy Epidemiol & Econ PTE2, Groningen, Netherlands.	ntplan75@gmail.com		Postma, Maarten/0000-0002-6306-3653	NUFFIC (Netherlands)	NUFFIC (Netherlands)(Netherlands Government)	The research was funded by a NUFFIC (Netherlands) project for PhD research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The research was funded by a NUFFIC (Netherlands) project for PhD research. Thanks go to the staff of the community health stations in Trung Thanh, Cu Van, La Hien and Tuc Tranh for their co-operation in the study.	Alsabbagh MHDW, 2014, VALUE HEALTH, V17, P288, DOI 10.1016/j.jval.2013.11.011; Bailey JE, 1996, CLIN THER, V18, P1252, DOI 10.1016/S0149-2918(96)80080-4; Barzi F, 2007, J EPIDEMIOL COMMUN H, V61, P115, DOI 10.1136/jech.2005.044842; Bramley TJ, 2006, J MANAGE CARE PHARM, V12, P239, DOI 10.18553/jmcp.2006.12.3.239; Breekveldt-Postma NS, 2008, CURR MED RES OPIN, V24, P121, DOI 10.1185/030079908X253843; Burnier M, 2011, INT J CLIN PRACT, V65, P127, DOI 10.1111/j.1742-1241.2010.02616.x; Campbell NRC, 2009, HYPERTENSION, V53, P128, DOI 10.1161/HYPERTENSIONAHA.108.119784; Chapman RH, 2005, ARCH INTERN MED, V165, P1147, DOI 10.1001/archinte.165.10.1147; Chen SL, 2014, J ADV NURS, V70, P2031, DOI 10.1111/jan.12361; Choudhry NK, 2009, AM J MANAG CARE, V15, P457; Corrao G, 2011, J HYPERTENS, V29, P610, DOI 10.1097/HJH.0b013e328342ca97; Cuddy Mary Linda Stotter, 2005, J Pract Nurs, V55, P17; Dragomir A, 2010, MED CARE, V48, P418, DOI 10.1097/MLR.0b013e3181d567bd; Esposti LD, 2011, CLINICOECONOMIC OUTC, V3, P47, DOI 10.2147/CEOR.S15619; Fitz-Simon Nicola, 2005, Ther Clin Risk Manag, V1, P93, DOI 10.2147/tcrm.1.2.93.62915; Fongwa MN, 2008, VASC HEALTH RISK MAN, V4, P157, DOI 10.2147/vhrm.2008.04.01.157; Gascon JJ, 2004, FAM PRACT, V21, P125, DOI 10.1093/fampra/cmh202; Grassi G, 2011, BLOOD PRESSURE, V20, P196, DOI 10.3109/08037051.2011.557902; Grosso G, 2011, Ann Ig, V23, P173; Hashmi SK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000280; Hughes D, 2007, VALUE HEALTH, V10, P498, DOI 10.1111/j.1524-4733.2007.00205.x; Iskedjian M, 2002, CLIN THER, V24, P302, DOI 10.1016/S0149-2918(02)85026-3; Khanam MA, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.25028; Krousel-Wood M, 2004, CURR OPIN CARDIOL, V19, P357, DOI 10.1097/01.hco.0000126978.03828.9e; Lagi A, 2006, INTERN EMERG MED, V1, P204, DOI 10.1007/BF02934738; Lee GKY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062775; Lewis LM, 2012, J CARDIOVASC NURS, V27, P208, DOI 10.1097/JCN.0b013e318215bb8f; Lewis LM, 2012, J CLIN HYPERTENS, V14, P250, DOI 10.1111/j.1751-7176.2012.00591.x; Lowy A, 2011, INT J CLIN PRACT, V65, P41, DOI 10.1111/j.1742-1241.2010.02569.x; MARSHALL IJ, 2012, BMJ-BRIT MED J, V345, DOI DOI 10.1136/BMJ.E3953; Matsumura K, 2013, QJM-INT J MED, V106, P909, DOI 10.1093/qjmed/hct121; Naderi SH, 2012, AM J MED, V125, P882, DOI 10.1016/j.amjmed.2011.12.013; Nguyen Thi Phuong Lan, 2014, Value Health Reg Issues, V3, P87, DOI 10.1016/j.vhri.2014.03.003; Osamor PE, 2011, J HEALTH POPUL NUTR, V29, P619; Park JH, 2008, INT J CARDIOL, V128, P392, DOI 10.1016/j.ijcard.2007.04.114; Peterson AM, 2007, VALUE HEALTH, V10, P3, DOI 10.1111/j.1524-4733.2006.00139.x; Nguyen N, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-325; Ramli Azuana, 2012, Patient Prefer Adherence, V6, P613, DOI 10.2147/PPA.S34704; Rimando M, 2013, ETHNIC DIS, V23, P469; Rosenbaum L, 2015, NEW ENGL J MED, V372, P7, DOI 10.1056/NEJMp1413816; Ross S, 2004, J HUM HYPERTENS, V18, P607, DOI 10.1038/sj.jhh.1001721; Schoenthaler A, 2009, PATIENT EDUC COUNS, V75, P185, DOI 10.1016/j.pec.2008.09.018; Shin S, 2013, HYPERTENS RES, V36, P1000, DOI 10.1038/hr.2013.85; Simonyi G, 2013, ORVOSI HETILAP, V154, P1587, DOI 10.1556/OH.2013.29692; Tajeu GS, 2016, HYPERTENSION, V68, P565, DOI 10.1161/HYPERTENSIONAHA.116.07720; Tsiantou V, 2010, PATIENT PREFER ADHER, V4, P335, DOI 10.2147/PPA.S12326; Wilinski Jerzy, 2013, Przegl Lek, V70, P377; Wong MCS, 2011, J CLIN PHARM THER, V36, P179, DOI 10.1111/j.1365-2710.2010.01174.x; Wong MCS, 2013, INT J CARDIOL, V167, P1438, DOI 10.1016/j.ijcard.2012.04.060; World Health Organization, PREV CARD DIS; Wu PH, 2010, AM J HYPERTENS, V23, P155, DOI 10.1038/ajh.2009.210	51	10	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0171203	10.1371/journal.pone.0171203	http://dx.doi.org/10.1371/journal.pone.0171203			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6RS	28146584	Green Published, gold, Green Submitted			2022-12-27	WOS:000396131700026
J	Schnell, NK; Johnson, GD				Schnell, Nalani K.; Johnson, G. David			Evolution of a Functional Head Joint in Deep-Sea Fishes (Stomiidae)	PLOS ONE			English	Article							GULF-OF-MEXICO; DRAGON FISH; TELEOSTEI; BIOMECHANICS; ASSEMBLAGE; BEHAVIOR; PISCES	The head and anterior trunk region of most actinopterygian fishes is stiffened as, uniquely within vertebrates, the pectoral girdles have a direct and often strong connection through the posttemporal to the posterior region of the skull. Members of the mesopelagic fish family Stomiidae have their pectoral girdle separated from the skull. This connection is lost in several teleost groups, but the stomiids have an additional evolutionary novelty-a flexible connection between the occiput and the first vertebra, where only the notochord persists. Several studies suggested that stomiids engulf significantly large prey items and conjectured about the functional role of the anterior part of the vertebral column; however, there has been no precise anatomical description of this complex. Here we describe a unique configuration comprising the occiput and the notochordal sheath in Aristostomias, Eustomias, Malacosteus, Pachystomias, and Photostomias that represents a true functional head joint in teleosts and discuss its potential phylogenetic implications. In these genera, the chordal sheath is folded inward ventrally beneath its connection to the basioccipital and embraces the occipital condyle when in a resting position. In the resting position (wherein the head is not manipulatively elevated), this condyle is completely embraced by the ventral fold of the notochord. A manual manipulative elevation of the head in cleared and stained specimens unfolds the ventral sheath of the notochord. As a consequence, the cranium can be pulled up and back significantly farther than in all other teleost taxa that lack such a functional head joint and thereby can reach mouth gapes up to 120 degrees.	[Schnell, Nalani K.] Sorbonne Univ, Museum Natl Hist Nat, Inst Systemat, Evolut,Biodiversite,ISYEB,UMR 7205,CNRS,UPMC,EPHE, Paris, France; [Johnson, G. David] Smithsonian Inst, Dept Vertebrate Zool, Natl Museum Nat Hist, Washington, DC 20560 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Smithsonian Institution; Smithsonian National Museum of Natural History	Schnell, NK (corresponding author), Sorbonne Univ, Museum Natl Hist Nat, Inst Systemat, Evolut,Biodiversite,ISYEB,UMR 7205,CNRS,UPMC,EPHE, Paris, France.	nschnell@mnhn.fr		Schnell, Nalani/0000-0003-2060-4656; Johnson, G D/0000-0003-4339-6589	NKS in the Division of Fishes at the National Museum of Natural History; Herbert R. and Evelyn Axelrod Endowment Fund for systematic ichthyology in the Division of Fishes	NKS in the Division of Fishes at the National Museum of Natural History; Herbert R. and Evelyn Axelrod Endowment Fund for systematic ichthyology in the Division of Fishes	This study was initiated during a Smithsonian Predoctoral Fellowship of NKS in the Division of Fishes at the National Museum of Natural History and further supported by the Herbert R. and Evelyn Axelrod Endowment Fund for systematic ichthyology in the Division of Fishes (2008/2009).	BERRA TM, 1989, FISHERIES, V14, P2, DOI 10.1577/1548-8446(1989)014<0002:BEBAFM>2.0.CO;2; Brauer A, 1908, ANATOMISCHER TEIL, V15, P1; CLARKE TA, 1982, FISH B-NOAA, V80, P287; CLARKE WD, 1963, NATURE, V198, P1244, DOI 10.1038/1981244a0; DINGERKUS G, 1977, STAIN TECHNOL, V52, P229, DOI 10.3109/10520297709116780; Domagk G., 1933, MEDIZIN CHEMIE, V1, P126; Douglas RH, 1998, NATURE, V393, P423, DOI 10.1038/30871; Eschmeyer WN, CATALOG FISHES GENER; Fink W.L, 1985, MISC PUBL MUS ZOOL, V171, P1; Gunther K., 1959, Dana Reports, VNo. 49, P1; Kenaley CP, 2014, EVOLUTION, V68, P996, DOI 10.1111/evo.12322; Kenaley CP, 2012, BIOL J LINN SOC, V106, P224, DOI 10.1111/j.1095-8312.2012.01854.x; Morrow JE, 1964, FISHES W N ATLANTIC, P351; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; PARTRIDGE JC, 1995, NATURE, V375, P21, DOI 10.1038/375021a0; Regan C.T., 1930, DANA REP, V6, P1; Schnell NK, 2008, J MORPHOL, V269, P513, DOI 10.1002/jmor.10584; Schnell NK, 2012, COPEIA, P394, DOI 10.1643/CG-11-051; Schnell NK, 2010, J MORPHOL, V271, P1006, DOI 10.1002/jmor.10858; SONG JK, 1995, COPEIA, P114; Sutton TT, 1996, MAR BIOL, V127, P179, DOI 10.1007/BF00942102; Sutton TT, 1996, B MAR SCI, V59, P530; TAYLOR W R, 1985, Cybium, V9, P107; Tchernavin V. V., 1953, FEEDING MECH DEEP SE; Westneat MW, 2006, FISH PHYSIOL, V23, P29, DOI 10.1016/S1546-5098(05)23002-9	25	7	7	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0170224	10.1371/journal.pone.0170224	http://dx.doi.org/10.1371/journal.pone.0170224			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146571	Green Submitted, Green Published, gold			2022-12-27	WOS:000396131700017
J	Villenave, R; Wales, SQ; Hamkins-Indik, T; Papafragkou, E; Weaver, JC; Ferrante, TC; Bahinski, A; Elkins, CA; Kulka, M; Ingber, DE				Villenave, Remi; Wales, Samantha Q.; Hamkins-Indik, Tiama; Papafragkou, Efstathia; Weaver, James C.; Ferrante, Thomas C.; Bahinski, Anthony; Elkins, Christopher A.; Kulka, Michael; Ingber, Donald E.			Human Gut-On-A-Chip Supports Polarized Infection of Coxsackie B1 Virus In Vitro	PLOS ONE			English	Article							EPITHELIAL-CELLS; CILIATED CELLS; RELEASE; DISEASE; REPLICATION; ACTIVATION; INTESTINE; STRAINS; SIGNALS; VACCINE	Analysis of enterovirus infection is difficult in animals because they express different virus receptors than humans, and static cell culture systems do not reproduce the physical complexity of the human intestinal epithelium. Here, using coxsackievirus B1 (CVB1) as a prototype enterovirus strain, we demonstrate that human enterovirus infection, replication and infectious virus production can be analyzed in vitro in a human Gut-on-a-Chip microfluidic device that supports culture of highly differentiated human villus intestinal epithelium under conditions of fluid flow and peristalsis-like motions. When CVB1 was introduced into the epithelium-lined intestinal lumen of the device, virions entered the epithelium, replicated inside the cells producing detectable cytopathic effects (CPEs), and both infectious virions and inflammatory cytokines were released in a polarized manner from the cell apex, as they could be detected in the effluent from the epithelial microchannel. When the virus was introduced via a basal route of infection (by inoculating virus into fluid flowing through a parallel lower 'vascular' channel separated from the epithelial channel by a porous membrane), significantly lower viral titers, decreased CPEs, and delayed caspase-3 activation were observed; however, cytokines continued to be secreted apically. The presence of continuous fluid flow through the epithelial lumen also resulted in production of a gradient of CPEs consistent with the flow direction. Thus, the human Gut-on-a-Chip may provide a suitable in vitro model for enteric virus infection and for investigating mechanisms of enterovirus pathogenesis.	[Villenave, Remi; Hamkins-Indik, Tiama; Weaver, James C.; Ferrante, Thomas C.; Bahinski, Anthony; Ingber, Donald E.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Wales, Samantha Q.; Papafragkou, Efstathia; Elkins, Christopher A.; Kulka, Michael] US FDA, Mol Virol Team, Div Mol Biol, Ctr Food Safety & Appl Nutr, Laurel, MD USA; [Ingber, Donald E.] Harvard John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Ingber, Donald E.] Boston Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA; [Ingber, Donald E.] Harvard Med Sch, Boston, MA 02115 USA; [Villenave, Remi] Emulate Inc, Boston, MA USA; [Bahinski, Anthony] GlaxoSmithKline, King Of Prussia, PA USA	Harvard University; US Food & Drug Administration (FDA); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; GlaxoSmithKline	Ingber, DE (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.; Ingber, DE (corresponding author), Harvard John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.; Ingber, DE (corresponding author), Boston Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA.; Ingber, DE (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	don.ingber@wyss.harvard.edu	Ingber, Donald E/AAC-5894-2019; Weaver, James C./AAE-7870-2019	Elkins, Christopher/0000-0002-6029-9812	FDA [HHSF223201310079C]; DARPA [HR0011-15-C-0094]; Wyss Institute for Biologically Inspired Engineering at Harvard University; Food and Drug Administration [HHSF223201310079C]; Defense Advanced Research Projects Agency [HR0011-15-C-0094]	FDA(United States Department of Health & Human Services); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Wyss Institute for Biologically Inspired Engineering at Harvard University; Food and Drug Administration(United States Department of Health & Human Services); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was supported by grants from the Food and Drug Administration (HHSF223201310079C) and The Defense Advanced Research Projects Agency (HR0011-15-C-0094), and by the Wyss Institute for Biologically Inspired Engineering at Harvard University.	[Anonymous], 2009, FIELDS VIROLOGY, P490; Bartlett EJ, 2008, J VIROL, V82, P8965, DOI 10.1128/JVI.00853-08; Blank CA, 2000, J VIROL, V74, P6476, DOI 10.1128/JVI.74.14.6476-6484.2000; Bozym RA, 2011, MOL BIOL CELL, V22, P3010, DOI 10.1091/mbc.E11-02-0094; Cai ZJ, 2015, CIRC-HEART FAIL, V8, P809, DOI 10.1161/CIRCHEARTFAILURE.114.001244; Cifuente JO, 2011, J MED VIROL, V83, P1571, DOI 10.1002/jmv.22133; Conaldi PG, 1997, J INFECT DIS, V175, P693, DOI 10.1093/infdis/175.3.693; Coyne CB, 2007, CELL HOST MICROBE, V2, P181, DOI 10.1016/j.chom.2007.07.003; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; Drummond CG, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00030-15; Fairweather D, 2007, METHODS, V41, P118, DOI 10.1016/j.ymeth.2006.07.009; Gibbons DL, 2011, MUCOSAL IMMUNOL, V4, P148, DOI 10.1038/mi.2010.85; Harris KG, 2015, CELL HOST MICROBE, V18, P221, DOI 10.1016/j.chom.2015.07.007; Ishikawa T, 2011, J THEOR BIOL, V279, P63, DOI 10.1016/j.jtbi.2011.03.026; Katoh H, 2015, J VIROL, V89, P12026, DOI 10.1128/JVI.02048-15; Khetsuriani N, 2006, MMWR-MORBID MORTAL W, P153; Kilpatrick DR, 2009, J CLIN MICROBIOL, V47, P1939, DOI 10.1128/JCM.00702-09; Kim HJ, 2016, P NATL ACAD SCI USA, V113, pE7, DOI 10.1073/pnas.1522193112; Kim HJ, 2013, INTEGR BIOL-UK, V5, P1130, DOI 10.1039/c3ib40126j; Kim HJ, 2012, LAB CHIP, V12, P2165, DOI 10.1039/c2lc40074j; Kulka M, 2009, VIROLOGY, V388, P169, DOI 10.1016/j.virol.2009.03.014; Larsson PG, 2015, DIABETOLOGIA, V58, P346, DOI 10.1007/s00125-014-3436-0; Lentle RG, 2008, J COMP PHYSIOL B, V178, P257, DOI 10.1007/s00360-007-0217-9; Naim HY, 2000, EMBO J, V19, P3576, DOI 10.1093/emboj/19.14.3576; Nasri D, 2007, EXPERT REV MOL DIAGN, V7, P419, DOI 10.1586/14737159.7.4.419; Oberste MS, 2010, J CLIN VIROL, V49, P73, DOI 10.1016/j.jcv.2010.06.022; Pallansch M. A., 2009, Clinical virology manual, P249; Pan JY, 2015, J VIROL, V89, P1324, DOI 10.1128/JVI.02798-14; Racaniello VR, 2006, VIROLOGY, V344, P9, DOI 10.1016/j.virol.2005.09.015; Sin J, 2015, VIROLOGY, V484, P288, DOI 10.1016/j.virol.2015.06.006; Thompson CI, 2006, J VIROL, V80, P8060, DOI 10.1128/JVI.00384-06; Vassileva-Pencheva R, 2010, ANTIVIR RES, V85, P366, DOI 10.1016/j.antiviral.2009.11.003; Villenave R, 2010, J VIROL, V84, P11718, DOI 10.1128/JVI.00798-10; Wang LL, 2014, INT J CLIN EXP PATHO, V7, P858; Wang LL, 2014, INT J CLIN EXP PATHO, V7, P890; Wikswo ME, 2009, CLIN INFECT DIS, V49, pE44, DOI 10.1086/605090; Zhang LQ, 2005, J VIROL, V79, P1113, DOI 10.1128/JVI.79.2.1113-1124.2005; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002	38	100	102	7	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0169412	10.1371/journal.pone.0169412	http://dx.doi.org/10.1371/journal.pone.0169412			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146569	gold, Green Published, Green Submitted			2022-12-27	WOS:000396131700006
J	Yamasaki, T; Maekawa, T; Miyanaga, Y; Takahashi, K; Takamiya, N; Ogata, K; Tobimatsu, S				Yamasaki, Takao; Maekawa, Toshihiko; Miyanaga, Yuka; Takahashi, Kenji; Takamiya, Naomi; Ogata, Katsuya; Tobimatsu, Shozo			Enhanced Fine-Form Perception Does Not Contribute to Gestalt Face Perception in Autism Spectrum Disorder	PLOS ONE			English	Article							SPATIAL-FREQUENCY; NEURAL RESPONSES; FUSIFORM GYRUS; BRAIN; INDIVIDUALS; CHILDREN; COLOR; N170; ACTIVATION; CORTEX	Individuals with autism spectrum disorder (ASD) show superior performance in processing fine detail, but often exhibit impaired gestalt face perception. The ventral visual stream from the primary visual cortex (V1) to the fusiform gyrus (V4) plays an important role in form (including faces) and color perception. The aim of this study was to investigate how the ventral stream is functionally altered in ASD. Visual evoked potentials were recorded in high-functioning ASD adults (n = 14) and typically developing (TD) adults (n = 14). We used three types of visual stimuli as follows: isoluminant chromatic (red/green, RG) gratings, high-contrast achromatic (black/white, BW) gratings with high spatial frequency (HSF, 5.3 cycles/degree), and face (neutral, happy, and angry faces) stimuli. Compared with TD controls, ASD adults exhibited longer N1 latency for RG, shorter N1 latency for BW, and shorter P1 latency, but prolonged N170 latency, for face stimuli. Moreover, a greater difference in latency between P1 and N170, or between N1 for BW and N170 (i.e., the prolongation of cortico-cortical conduction time between V1 and V4) was observed in ASD adults. These findings indicate that ASD adults have enhanced fine-form (local HSF) processing, but impaired color processing at V1. In addition, they exhibit impaired gestalt face processing due to deficits in integration of multiple local HSF facial information at V4. Thus, altered ventral stream function may contribute to abnormal social processing in ASD.	[Yamasaki, Takao; Maekawa, Toshihiko; Miyanaga, Yuka; Takahashi, Kenji; Takamiya, Naomi; Ogata, Katsuya; Tobimatsu, Shozo] Kyushu Univ, Neurol Inst, Grad Sch Med Sci, Dept Clin Neurophysiol, Fukuoka, Japan; [Yamasaki, Takao] Minkodo Minohara Hosp, Dept Neurol, Fukuoka, Japan; [Takamiya, Naomi] Prefectural Univ Hiroshima, Fac Hlth & Welf, Dept Phys Therapy, Hiroshima, Japan	Kyushu University	Yamasaki, T (corresponding author), Kyushu Univ, Neurol Inst, Grad Sch Med Sci, Dept Clin Neurophysiol, Fukuoka, Japan.; Yamasaki, T (corresponding author), Minkodo Minohara Hosp, Dept Neurol, Fukuoka, Japan.	yamasa@neurophy.med.kyushu-u.ac.jp	l_l, CuteBlock/L-4348-2018; Yamasaki, Takao/I-7915-2019	l_l, CuteBlock/0000-0002-7559-9615; Yamasaki, Takao/0000-0002-3449-3988; Maekawa, Toshihiko/0000-0001-8047-7498	JSPS KAKENHI Grant [JP23601010, JP26350931]; KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology [15H05875]; Center of Developmental Education and Research (CODER); Grants-in-Aid for Scientific Research [15H05871] Funding Source: KAKEN	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Center of Developmental Education and Research (CODER); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partly supported by JSPS KAKENHI Grant Numbers JP23601010 and JP26350931 (https://www.jsps.go.jp) to TY, and by a KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas (No. 15H05875), from the Ministry of Education, Culture, Sports, Science and Technology (https://www.jsps.go.tp/), to ST. This work was also supported in part by a grant from the Center of Developmental Education and Research (CODER) (http://www.coder.or.jp/) to TY.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bird G, 2006, NEUROIMAGE, V31, P1614, DOI 10.1016/j.neuroimage.2006.02.037; Bokkon I, 2010, BIOSYSTEMS, V101, P1, DOI 10.1016/j.biosystems.2010.04.008; Bokkon I., 2013, ACTIV NERV SUPER, V55, P15, DOI DOI 10.1007/BF03379594; Corradi-Dell'Acqua C, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00189; Critchley HD, 2000, BRAIN, V123, P2203, DOI 10.1093/brain/123.11.2203; Cygan HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086020; Dakin S, 2005, NEURON, V48, P497, DOI 10.1016/j.neuron.2005.10.018; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Deffke I, 2007, NEUROIMAGE, V35, P1495, DOI 10.1016/j.neuroimage.2007.01.034; Deruelle C, 2004, J AUTISM DEV DISORD, V34, P199, DOI 10.1023/B:JADD.0000022610.09668.4c; Deruelle C, 2008, BRAIN COGNITION, V66, P115, DOI 10.1016/j.bandc.2007.06.001; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; Feuerriegel D, 2015, CLIN NEUROPHYSIOL, V126, P1141, DOI 10.1016/j.clinph.2014.09.015; Franklin A, 2008, J AUTISM DEV DISORD, V38, P1837, DOI 10.1007/s10803-008-0574-6; Franklin A, 2010, DEVELOPMENTAL SCI, V13, P188, DOI 10.1111/j.1467-7687.2009.00869.x; Fujita T, 2013, RES AUTISM SPECT DIS, V7, P710, DOI 10.1016/j.rasd.2013.03.001; Fujita T, 2011, RES AUTISM SPECT DIS, V5, P277, DOI 10.1016/j.rasd.2010.04.009; Golarai G, 2006, CLIN NEUROSCI RES, V6, P145, DOI 10.1016/j.cnr.2006.08.001; Goto Y, 2005, NEUROREPORT, V16, P1329, DOI 10.1097/01.wnr.0000174404.86644.af; Greenblatt RE, 2005, IEEE T SIGNAL PROCES, V53, P3403, DOI 10.1109/TSP.2005.853201; Grelotti DJ, 2005, NEUROPSYCHOLOGIA, V43, P373, DOI 10.1016/j.neuropsychologia.2004.06.015; Hadjikhani N, 2004, NEUROIMAGE, V22, P1141, DOI 10.1016/j.neuroimage.2004.03.025; Hadjikhani N, 2007, HUM BRAIN MAPP, V28, P441, DOI 10.1002/hbm.20283; Hinojosa JA, 2015, NEUROSCI BIOBEHAV R, V55, P498, DOI 10.1016/j.neubiorev.2015.06.002; Ishihara S., 1997, TESTS COLOUR DEFICIE; Jemel B, 2006, J AUTISM DEV DISORD, V36, P91, DOI 10.1007/s10803-005-0050-5; Jolliffe T, 1997, J CHILD PSYCHOL PSYC, V38, P527, DOI 10.1111/j.1469-7610.1997.tb01539.x; Keita L, 2014, SCI REP-UK, V4, DOI 10.1038/srep05475; Kleinhans NM, 2008, BRAIN, V131, P1000, DOI 10.1093/brain/awm334; Klin A, 1999, J AUTISM DEV DISORD, V29, P499, DOI 10.1023/A:1022299920240; Landolt E., 1905, AUGENHEILKUNDE, V13, P519; LIU S, 1995, NEUROSCIENCE, V67, P197, DOI 10.1016/0306-4522(95)00043-I; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; McPartland J, 2004, J CHILD PSYCHOL PSYC, V45, P1235, DOI 10.1111/j.1469-7610.2004.00318.x; Minami T, 2015, NEUROSCIENCE, V311, P341, DOI 10.1016/j.neuroscience.2015.10.019; Mitsudo T, 2011, CLIN NEUROPHYSIOL, V122, P708, DOI 10.1016/j.clinph.2010.10.004; Nakajima K, 2012, NEUROPSYCHOLOGIA, V50, P2499, DOI 10.1016/j.neuropsychologia.2012.06.022; Nakashima T, 2008, NEUROSCI RES, V62, P225, DOI 10.1016/j.neures.2008.08.009; O'Connor K, 2005, BRAIN COGNITION, V59, P82, DOI 10.1016/j.bandc.2005.05.004; O'Connor K, 2012, NEUROSCI BIOBEHAV R, V36, P836, DOI 10.1016/j.neubiorev.2011.11.008; O'Connor K, 2007, INT J PSYCHOPHYSIOL, V63, P283, DOI 10.1016/j.ijpsycho.2006.12.001; O'Riordan MA, 2004, AUTISM, V8, P229, DOI 10.1177/1362361304045219; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pelphrey KA, 2002, J AUTISM DEV DISORD, V32, P249, DOI 10.1023/A:1016374617369; Rellecke J, 2013, BRAIN TOPOGR, V26, P62, DOI 10.1007/s10548-012-0261-y; Rellecke J, 2012, BIOL PSYCHOL, V90, P23, DOI 10.1016/j.biopsycho.2012.02.002; Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136; Rossignol DA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00150; Rossion B, 2008, NEUROIMAGE, V39, P1959, DOI 10.1016/j.neuroimage.2007.10.011; Rousselet GA, 2004, TRENDS COGN SCI, V8, P363, DOI 10.1016/j.tics.2004.06.003; Samson F, 2012, HUM BRAIN MAPP, V33, P1553, DOI 10.1002/hbm.21307; Scherf KS, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00026; SHAH A, 1993, J CHILD PSYCHOL PSYC, V34, P1351, DOI 10.1111/j.1469-7610.1993.tb02095.x; Simmons DR, 2009, VISION RES, V49, P2705, DOI 10.1016/j.visres.2009.08.005; Tobimatsu S, 1996, BRAIN TOPOGR, V8, P241, DOI 10.1007/BF01184777; Tobimatsu S., 2008, PROGR EPILEPTIC DISO, V5, P37; Tobimatsu S, 2006, CLIN NEUROPHYSIOL, V117, P1414, DOI 10.1016/j.clinph.2006.01.004; Vlamings PHJM, 2010, BIOL PSYCHIAT, V68, P1107, DOI 10.1016/j.biopsych.2010.06.024; Webb SJ, 2010, INT J PSYCHOPHYSIOL, V77, P106, DOI 10.1016/j.ijpsycho.2010.04.011; Webb SJ, 2012, SOC COGN AFFECT NEUR, V7, P578, DOI 10.1093/scan/nsp002; Yabuta NH, 1998, J NEUROSCI, V18, P9489; Yamasaki T, 2013, NEUROSCI BIOMED ENG, V1, P5, DOI DOI 10.2174/2213385211301010003; Yamasaki T, 2008, EPILEPSIA, V49, P1611, DOI 10.1111/j.1528-1167.2008.01605.x; Yamasaki T, 2016, J ALZHEIMERS DIS, V53, P661, DOI 10.3233/JAD-150939; Yamasaki T, 2011, RES AUTISM SPECT DIS, V5, P400, DOI 10.1016/j.rasd.2010.06.002; Yip AW, 2002, PERCEPTION, V31, P995, DOI 10.1068/p3376	69	12	13	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0170239	10.1371/journal.pone.0170239	http://dx.doi.org/10.1371/journal.pone.0170239			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6RS	28146575	Green Published, Green Submitted, gold			2022-12-27	WOS:000396131700018
J	den Harder, AM; Sucha, D; van Hamersvelt, RW; Budde, RPJ; de Jong, PA; Schilham, AMR; Bos, C; Breur, JMPJ; Leiner, T				den Harder, A. M.; Sucha, D.; van Hamersvelt, R. W.; Budde, R. P. J.; de Jong, P. A.; Schilham, A. M. R.; Bos, C.; Breur, J. M. P. J.; Leiner, T.			Imaging of pediatric great vessel stents: Computed tomography or magnetic resonance imaging?	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; IN-VITRO; CT; SAFETY; MRI; ANGIOGRAPHY; CHILDREN	Background Complications might occur after great vessel stent implantation in children. Therefore follow-up using imaging is warranted. Purpose To determine the optimal imaging modality for the assessment of stents used to treat great vessel obstructions in children. Material and methods Five different large vessel stents were evaluated in an in-vitro setting. All stents were expanded to the maximal vendor recommended diameter (20mm; n = 4 or 10mm; n = 1), placed in an anthropomorphic chest phantom and imaged with a 256-slice CT-scanner. MRI images were acquired at 1.5T using a multi-slice T(2)(-)weighted turbo spin echo, an RF-spoiled three-dimensional T-1-weighted Fast Field Echo and a balanced turbo field echo 3D sequence. Two blinded observers assessed stent lumen visibility (measured diameter/true diameter *100%) in the center and at the outlets of the stent. Reproducibility of diameter measurements was evaluated using the intraclass correlation coefficient for reliability and 95% limits of agreement for agreement analysis. Results Median stent lumen visibility was 88 (IQR 86-90)% with CT for all stents at both the center and outlets. With MRI, the T-2-weighted turbo spin echo sequence was preferred which resulted in 82 (78-84%) stent lumen visibility. Interobserver reliability and agreement was good for both CT (ICC 0.997, mean difference -0.51 [-1.07-0.05] mm) and MRI measurements ( ICC 0.951, mean difference -0.05 [-2.52--2.41] mm). Conclusion Good in-stent lumen visibility was achievable in this in-vitro study with both CT and MRI in different great vessel stents. Overall reliability was good with clinical acceptable limits of agreement for both CT and MRI. However, common conditions such as in-stent stenosis and associated aneurysms were not tested in this in-vitro study, limiting the value of the in-vitro study.	[den Harder, A. M.; Sucha, D.; van Hamersvelt, R. W.; de Jong, P. A.; Schilham, A. M. R.; Bos, C.; Leiner, T.] Univ Utrecht, Med Ctr, Dept Radiol, Utrecht, Netherlands; [Budde, R. P. J.] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Breur, J. M. P. J.] Univ Utrecht, Med Ctr, Dept Pediat Cardiol, Utrecht, Netherlands	Utrecht University; Erasmus University Rotterdam; Erasmus MC; Utrecht University	den Harder, AM (corresponding author), Univ Utrecht, Med Ctr, Dept Radiol, Utrecht, Netherlands.	a.m.denharder@umcutrecht.nl	van Hamersvelt, Robbert/J-4325-2019; breur, hans/AAY-2340-2020; Harder, Annemarie M. den/J-3266-2019; Budde, Ricardo/E-4252-2015	van Hamersvelt, Robbert/0000-0002-6084-0656; Harder, Annemarie M. den/0000-0002-9679-396X; 				Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Chakrabarti S, 2010, HEART, V96, P1212, DOI 10.1136/hrt.2009.170928; Deak PD, 2010, RADIOLOGY, V257, P158, DOI 10.1148/radiol.10100047; den Harder AM, 2015, AM J ROENTGENOL, V204, P645, DOI 10.2214/AJR.14.12590; Eichhorn JG, 2006, CATHETER CARDIO INTE, V68, P11, DOI 10.1002/ccd.20760; Eichhorn JG, 2008, CATHETER CARDIO INTE, V72, P544, DOI 10.1002/ccd.21680; Erbel Raimund, 2014, Kardiol Pol, V72, P1169, DOI 10.5603/KP.2014.0225; Holton A, 2002, J CARDIOV MAGN RESON, V4, P423, DOI 10.1081/JCMR-120016381; Hug J, 2000, RADIOLOGY, V216, P781, DOI 10.1148/radiology.216.3.r00se03781; Khong P-L., 2013, Annals of the ICRP, V42, P9, DOI 10.1016/j.icrp.2012.10.001; Maintz D, 2006, EUR RADIOL, V16, P818, DOI 10.1007/s00330-005-0062-8; Nordmeyer J, 2010, AM J ROENTGENOL, V195, P865, DOI 10.2214/AJR.09.4166; OLAUGHLIN MP, 1991, CIRCULATION, V83, P1923, DOI 10.1161/01.CIR.83.6.1923; Parker MW, 2015, PEDIATRICS; Quality Assurance in Radiology and Medicine (QRM) GmbH, 2008, ANTHR CARD PHANT; Rutledge JM, 2001, CATHETER CARDIO INTE, V53, P519, DOI 10.1002/ccd.1214; Shih Ming-Chen Paul, 2006, AJR Am J Roentgenol, V187, pW302, DOI 10.2214/AJR.05.0424; Strohm O, 1999, J CARDIOV MAGN RESON, V1, P239, DOI 10.3109/10976649909088336; Strouse PJ, 1996, AM J CARDIOL, V78, P490, DOI 10.1016/0002-9149(97)00004-0; Sun Z, 2010, SINGAP MED J, V51, P457; Taylor AM, 2008, PEDIATR RADIOL, V38, pS433, DOI 10.1007/s00247-008-0843-8; Turner D R, 2007, Semin Intervent Radiol, V24, P153, DOI 10.1055/s-2007-980052; van der Laan MJ, 2004, J ENDOVASC THER, V11, P366, DOI 10.1583/04-1246.1; Yang WJ, 2012, KOREAN J RADIOL, V13, P20, DOI 10.3348/kjr.2012.13.1.20	24	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171138	10.1371/journal.pone.0171138	http://dx.doi.org/10.1371/journal.pone.0171138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141852	Green Published, gold, Green Submitted			2022-12-27	WOS:000396129500041
J	Hindel, S; Sohner, A; Maass, M; Sauerwein, W; Mollmann, D; Baba, HA; Kramer, M; Ludemann, L				Hindel, Stefan; Soehner, Anika; Maass, Marc; Sauerwein, Wolfgang; Moellmann, Dorothe; Baba, Hideo Andreas; Kramer, Martin; Luedemann, Lutz			Validation of Blood Volume Fraction Quantification with 3D Gradient Echo Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Porcine Skeletal Muscle	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ARTERIAL INPUT FUNCTION; CAPILLARY-PERMEABILITY; DCE-MRI; VASCULAR-PERMEABILITY; KINETIC-PARAMETERS; T-1-WEIGHTED MRI; FLOW MEASUREMENT; PERFUSION MRI; STEADY-STATE	The purpose of this study was to assess the accuracy of fractional blood volume (vb) estimates in low-perfused and low-vascularized tissue using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). The results of different MRI methods were compared with histology to evaluate the accuracy of these methods under clinical conditions. vb was estimated by DCE-MRI using a 3D gradient echo sequence with k-space undersampling in five muscle groups in the hind leg of 9 female pigs. Two gadolinium-based contrast agents (CA) were used: a rapidly extravasating, extracellular, gadolinium-based, low-molecular-weight contrast agent (LMCA, gadoterate meglumine) and an extracellular, gadolinium-based, albumin-binding, slowly extravasating blood pool contrast agent (BPCA, gadofosveset trisodium). LMCA data were evaluated using the extended Tofts model (ETM) and the two-compartment exchange model (2CXM). The images acquired with administration of the BPCA were used to evaluate the accuracy of vb estimation with a bolus deconvolution technique (BD) and a method we call equilibrium MRI (EqMRI). The latter calculates the ratio of the magnitude of the relaxation rate change in the tissue curve at an approximate equilibrium state to the height of the same area of the arterial input function (AIF). Immunohistochemical staining with isolectin was used to label endothelium. A light microscope was used to estimate the fractional vascular area by relating the vascular region to the total tissue region (immunohistochemical vessel staining, IHVS). In addition, the percentage fraction of vascular volume was determined by multiplying the microvascular density (MVD) with the average estimated capillary lumen, Pi(d/2)(2), where d = 8 mu m is the assumed capillary diameter (microvascular density estimation, MVDE). Except for ETM values, highly significant correlations were found between most of the MRI methods investigated. In the cranial thigh, for example, the v(b) medians (interquartile range, IQRs) of IHVS, MVDE, BD, EqMRI, 2CXM and ETM were v(b) = 0.7(0.3)%, 1.1(0.4)%, 1.1(0.4)%, 1.4(0.3)%, 1.2(1.8)% and 0.1(0.2)%, respectively. Variances, expressed by the difference between third and first quartiles (IQR) were highest for the 2CXM for all muscle groups. High correlations between the values in four muscle groups-medial, cranial, lateral thigh and lower leg - estimated with MRI and histology were found between BD and EqMRI, MVDE and 2CXM and IHVS and ETM. Except for the ETM, no significant differences between the v(b) medians of all MRI methods were revealed with the Wilcoxon rank sum test. The same holds for all muscle regions using the 2CXM and MVDE. Except for cranial thigh muscle, no significant difference was found between EqMRI and MVDE. And except for the cranial thigh and the lower leg muscle, there was also no significant difference between the v(b) medians of BD and MVDE. Overall, there was good v(b) agreement between histology and the BPCA MRI methods and the 2CXM LMCA approach with the exception of the ETM method. Although LMCA models have the advantage of providing excellent curve fits and can in principle determine more physiological parameters than BPCA methods, they yield more inaccurate results.	[Hindel, Stefan; Soehner, Anika; Sauerwein, Wolfgang; Luedemann, Lutz] Univ Hosp Essen, Dept Radiotherapy, Med Phys, Essen, North Rhine Wes, Germany; [Maass, Marc] Evangel Hosp Wesel, Dept Gen & Visceral Surg, Wesel, North Rhine Wes, Germany; [Moellmann, Dorothe; Baba, Hideo Andreas] Univ Hosp Essen, Dept Pathol, Essen, North Rhine Wes, Germany; [Kramer, Martin] Justus Liebig Univ Giessen, Hosp Vet Med, Dept Small Anim Surg, Giessen, Hesse, Germany	University of Duisburg Essen; University of Duisburg Essen; Justus Liebig University Giessen	Hindel, S (corresponding author), Univ Hosp Essen, Dept Radiotherapy, Med Phys, Essen, North Rhine Wes, Germany.	stefan.hindel@uni-due.de		Hindel, Stefan/0000-0003-0902-4503; Mollmann, Dorothe/0000-0002-7918-9154	Deutsche Forschungsgemeinschaft (DFG) [LU 844/8-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG, http://www.dfg.dei) grant number LU 844/8-1 to LL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0861-6; Ah-See ML, 2005, DYNAMIC CONTRAST ENH, P145; Arevalo-Perez J, 2016, J NEUROIMAGING, V26, P366, DOI 10.1111/jon.12320; Barrett T, 2006, EUR J RADIOL, V60, P353, DOI 10.1016/j.ejrad.2006.06.025; Bauer WR, 1996, MAGNET RESON MED, V35, P43, DOI 10.1002/mrm.1910350107; Bhujwalla ZM, 2003, CLIN CANCER RES, V9, P355; Bode G, 2010, J PHARMACOL TOX MET, V62, P196, DOI 10.1016/j.vascn.2010.05.009; Brix G, 2004, MAGNET RESON MED, V52, P420, DOI 10.1002/mrm.20161; Brix G, 1999, RADIOLOGY, V210, P269, DOI 10.1148/radiology.210.1.r99ja46269; Buckley DL, 2002, MAGN RESON MED, V47, P601, DOI 10.1002/mrm.10080; Calamante F, 2006, MAGN RESON MED, V55, P1180, DOI 10.1002/mrm.20873; Calamante F, 2005, J MAGN RESON IMAGING, V22, P718, DOI 10.1002/jmri.20454; Calamante F, 2000, MAGN RESON MED, V44, P466, DOI 10.1002/1522-2594(200009)44:3<466::AID-MRM18>3.0.CO;2-M; Cao Y, 2006, J MAGN RESON IMAGING, V24, P288, DOI 10.1002/jmri.20634; Cheng HLM, 2007, J MAGN RESON IMAGING, V25, P1073, DOI 10.1002/jmri.20898; Cuenod C A, 2013, Diagn Interv Imaging, V94, P1187, DOI 10.1016/j.diii.2013.10.010; Donahue KM, 1996, MAGNET RESON MED, V36, P858, DOI 10.1002/mrm.1910360608; EISENBERG BR, 1974, J CELL BIOL, V60, P732, DOI 10.1083/jcb.60.3.732; Eldredge HB, 2006, INVEST RADIOL, V41, P229, DOI 10.1097/01.rli.0000199293.86956.48; Faranesh AZ, 2006, MAGN RESON MED, V55, P1114, DOI 10.1002/mrm.20884; Fournier L, 2005, DYNAMIC CONTRAST ENH, P39; Harrer JU, 2004, J MAGN RESON IMAGING, V20, P748, DOI 10.1002/jmri.20182; Henderson E, 2000, J MAGN RESON IMAGING, V12, P991, DOI 10.1002/1522-2586(200012)12:6<991::AID-JMRI26>3.0.CO;2-1; Hindel S, 2017, INVEST RADIOL, V52, P66, DOI 10.1097/RLI.0000000000000309; Hindel S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128060; HJORTDAL VE, 1992, PLAST RECONSTR SURG, V89, P116, DOI 10.1097/00006534-199289010-00024; Johnson G, 2004, MAGN RESON MED, V51, P961, DOI 10.1002/mrm.20049; KAIRENTO AL, 1983, J NUCL MED, V24, P1135; KELLER MW, 1994, AM J PHYSIOL, V266, pH2229, DOI 10.1152/ajpheart.1994.266.6.H2229; Kixmoller M, 2004, THESIS; Kremser C, 2007, J MAGN RESON IMAGING, V26, P662, DOI 10.1002/jmri.21034; Lauffer RB, 1998, RADIOLOGY, V207, P529, DOI 10.1148/radiology.207.2.9577506; Li K L, 2000, J Magn Reson Imaging, V12, P347, DOI 10.1002/1522-2586(200008)12:2<347::AID-JMRI19>3.0.CO;2-7; LINDERKAMP O, 1980, PEDIATR RES, V14, P1324, DOI 10.1203/00006450-198012000-00010; Ludemann L, 2006, ACTA RADIOL, V47, P303, DOI 10.1080/02841850500539033; Ludemann L, 2009, EUR J RADIOL, V70, P465, DOI 10.1016/j.ejrad.2008.02.012; Luypaert R, 2010, PHYS MED BIOL, V55, P6431, DOI 10.1088/0031-9155/55/21/006; Luypaert R, 2011, MAGN RESON MED, V65, P1491, DOI 10.1002/mrm.22728; Maxie MG, 2007, PATHOLOGY DOMESTIC A; Mulisch M, 2010, ROMEIS MIKROSKOPISCH, DOI [10.1007/978-3-642-55190-1, DOI 10.1007/978-3-642-55190-1]; Nerbas E., 2008, THESIS; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; Perles-Barbacaru AT, 2013, MAGN RESON MED, V69, P1451, DOI 10.1002/mrm.24365; Raatschen HJ, 2006, INVEST RADIOL, V41, P860, DOI 10.1097/01.rli.0000246145.25993.d1; Raitakari M, 1995, AM J PHYSIOL-ENDOC M, V269, pE1000, DOI 10.1152/ajpendo.1995.269.6.E1000; Richardson OC, 2012, MAGN RESON MED, V68, P1234, DOI 10.1002/mrm.23316; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Roberts C, 2011, MAGN RESON MED, V65, P108, DOI 10.1002/mrm.22593; Ruotsalainen U, 1997, J NUCL MED, V38, P314; Sauerbrey A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/390506; SCHWARZBAUER C, 1993, MAGNET RESON MED, V29, P709, DOI 10.1002/mrm.1910290521; SENDA M, 1992, EUR J NUCL MED, V19, P166; Server A, 2011, NEURORADIOLOGY, V53, P319, DOI 10.1007/s00234-010-0740-3; Sourbron SP, 2012, PHYS MED BIOL, V57, pR1, DOI 10.1088/0031-9155/57/2/R1; Sourbron S, 2009, MAGN RESON MED, V62, P205, DOI 10.1002/mrm.22005; Sourbron SP, 2011, MAGN RESON MED, V66, P735, DOI 10.1002/mrm.22861; STANTON H, 1986, SWINE CARDIOVASCULAR, V1; Thompson G, 2011, BRIT J RADIOL, V84, pS127, DOI 10.1259/bjr/66316279; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Turetschek K, 2004, J MAGN RESON IMAGING, V20, P138, DOI 10.1002/jmri.20049; Vaupel P, 2000, INT J ONCOL, V17, P869; Versluis B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037756; Waller C, 2000, RADIOLOGY, V215, P189, DOI 10.1148/radiology.215.1.r00ap07189; Yaligar J, 2012, NMR BIOMED, V25, P113, DOI 10.1002/nbm.1723; Zhu X, 2005, DYNAMIC CONTRAST ENH, P117	65	17	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170841	10.1371/journal.pone.0170841	http://dx.doi.org/10.1371/journal.pone.0170841			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141810	Green Submitted, Green Published, gold			2022-12-27	WOS:000396129500022
J	Anderson, BM; Thiele, KR; Krauss, SL; Barrett, MD				Anderson, Benjamin M.; Thiele, Kevin R.; Krauss, Siegfried L.; Barrett, Matthew D.			Genotyping-by-Sequencing in a Species Complex of Australian Hummock Grasses (Triodia): Methodological Insights and Phylogenetic Resolution	PLOS ONE			English	Article							COALESCENT MODEL; EVOLUTIONARY HISTORY; WESTERN-AUSTRALIA; DE-NOVO; TREES; POACEAE; PHYLOGENOMICS; DIVERSITY; LIZARDS; INTROGRESSION	Next-generation sequencing is becoming increasingly accessible to researchers asking bio-systematic questions, but current best practice in both choosing a specific approach and effectively analysing the resulting data set is still being explored. We present a case study for the use of genotyping-by-sequencing (GBS) to resolve relationships in a species complex of Australian arid and semi-arid grasses (Triodia R.Br.), highlighting our solutions to methodological challenges in the use of GBS data. We merged overlapping paired-end reads then optimised locus assembly in the program PyRAD to generate GBS data sets for phylogenetic and distance-based analyses. In addition to traditional concatenation analyses in RAxML, we also demonstrate the novel use of summary species tree analyses (taking gene trees as input) with GBS loci. We found that while species tree analyses were relatively robust to variation in PyRAD assembly parameters, our RAxML analyses resulted in well-supported but conflicting topologies under different assembly settings. Despite this conflict, multiple clades in the complex were consistently supported as distinct across analyses. Our GBS data assembly and analyses improve the resolution of taxa and phylogenetic relationships in the Triodia basedowii complex compared to our previous study based on Sanger sequencing of nuclear (ITS/ETS) and chloroplast (rps16-trnK spacer) markers. The genomic results also partly support previous evidence for hybridization between species in the complex. Our methodological insights for analysing GBS data will assist researchers using similar data to resolve phylogenetic relationships within species complexes.	[Anderson, Benjamin M.; Thiele, Kevin R.; Krauss, Siegfried L.; Barrett, Matthew D.] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia; [Anderson, Benjamin M.; Krauss, Siegfried L.; Barrett, Matthew D.] Bot Gardens & Parks Author, Kings Pk & Bot Garden, Kings Pk, WA, Australia; [Thiele, Kevin R.] Western Australia Herbarium, Dept Pk & Wildlife, Kensington, NSW, Australia	University of Western Australia	Anderson, BM (corresponding author), Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia.; Anderson, BM (corresponding author), Bot Gardens & Parks Author, Kings Pk & Bot Garden, Kings Pk, WA, Australia.	banderson2914@gmail.com	Barrett, Matthew D/H-8435-2012; Thiele, Kevin/W-1876-2019	Barrett, Matthew D/0000-0002-2926-4291; Thiele, Kevin/0000-0002-6658-6636; Anderson, Benjamin/0000-0001-9755-4365; Krauss, Siegfried/0000-0002-7280-6324	Australian Research Council [120100350]; ANZ Trustees Holsworth Wildlife Research Endowment; governments of Australia and Western Australia; International Postgraduate Research Scholarship at the University of Western Australia; Australian Postgraduate Award at the University of Western Australia; UWA Top-up scholarship at the University of Western Australia	Australian Research Council(Australian Research Council); ANZ Trustees Holsworth Wildlife Research Endowment; governments of Australia and Western Australia; International Postgraduate Research Scholarship at the University of Western Australia; Australian Postgraduate Award at the University of Western Australia; UWA Top-up scholarship at the University of Western Australia	This research was partly supported by the Australian Research Council Linkage Project 120100350 (Cls Grierson, Krauss et al. in collaboration with Rio Tinto Iron Ore, Chevron, Botanic Gardens and Parks Authority and the Department of Parks and Wildlife). Fieldwork was partly supported by an ANZ Trustees Holsworth Wildlife Research Endowment to BMA. Sequencing costs were partly covered by the Australasian Systematic Botany Society through a Hansjorg Eichler Scientific Research Grant to BMA. Initial testing of assembly programs was conducted with resources provided by the Pawsey Supercomputing Centre with funding from the governments of Australia and Western Australia. BMA was supported by an International Postgraduate Research Scholarship, Australian Postgraduate Award and UWA Top-up scholarship at the University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2014, NATURE, V511, P83, DOI 10.1038/nature13285; Anderson BM, 2016, MOL PHYLOGENET EVOL, V101, P142, DOI 10.1016/j.ympev.2016.05.014; Armstrong G., 2008, Journal of the Royal Society of Western Australia, V91, P313; Arnold B, 2013, MOL ECOL, V22, P3179, DOI 10.1111/mec.12276; Auguie B, 2017, GRIDEXTRA MISCELLANE; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Baldassarre DT, 2014, EVOLUTION, V68, P2644, DOI 10.1111/evo.12457; Barker WR., 2005, AUST SYST BOT SOC NE, V122, P11; Barrett R.L., 2005, FLORA AUSTR, P458; Barrett Russell L., 2015, Nuytsia, V26, P21; Barrett RL, 2011, TELOPEA, V13, P57; Beadle N., 1981, VEGETATION AUSTR; Bouckaert RR, 2010, BIOINFORMATICS, V26, P1372, DOI 10.1093/bioinformatics/btq110; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Bryant D, 2012, MOL BIOL EVOL, V29, P1917, DOI 10.1093/molbev/mss086; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chifman J, 2014, BIOINFORMATICS, V30, P3317, DOI 10.1093/bioinformatics/btu530; Crisp MD, 2015, PHYTOTAXA, V230, P293; Daly BG, 2008, ECOLOGY, V89, P65, DOI 10.1890/06-1991.1; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; DOYLE JJ, 1987, TAXON, V36, P715, DOI 10.2307/1221122; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Eaton DAR, 2014, BIOINFORMATICS, V30, P1844, DOI 10.1093/bioinformatics/btu121; Eaton DAR, 2013, SYST BIOL, V62, P689, DOI 10.1093/sysbio/syt032; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Edwards SV, 2016, MOL PHYLOGENET EVOL, V94, P447, DOI 10.1016/j.ympev.2015.10.027; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Escudero M, 2014, MOL PHYLOGENET EVOL, V79, P359, DOI 10.1016/j.ympev.2014.06.026; Fu YB, 2014, G3-GENES GENOM GENET, V4, P891, DOI 10.1534/g3.114.010942; Giarla TC, 2015, SYST BIOL, V64, P727, DOI 10.1093/sysbio/syv029; Gohli J, 2015, MOL ECOL, V24, P180, DOI 10.1111/mec.13008; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Grabowski PP, 2014, MOL ECOL, V23, P4059, DOI 10.1111/mec.12845; Greilhuber J, 2005, ANN BOT-LONDON, V95, P255, DOI 10.1093/aob/mci019; GRIFFIN GF, 1990, J VEG SCI, V1, P435, DOI 10.2307/3235776; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hamlin JAP, 2014, ECOL EVOL, V4, P743, DOI 10.1002/ece3.964; Huang HT, 2016, SYST BIOL, V65, P357, DOI 10.1093/sysbio/syu046; Hurry CR, 2012, AUST SYST BOT, V25, P304, DOI 10.1071/SB10044; Ilut DC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/675158; Jarvis A, 2008, HOLE FILLED SEAMLESS; KITCHENER DJ, 1983, AUST J ZOOL, V31, P361, DOI 10.1071/ZO9830361; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Lazarides M, 1997, AUST SYST BOT, V10, P381, DOI 10.1071/SB96012; Leache AD, 2015, SYST BIOL, V64, P1032, DOI 10.1093/sysbio/syv053; Leache AD, 2015, GENOME BIOL EVOL, V7, P706, DOI 10.1093/gbe/evv026; Liu LA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-302; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; Mastretta-Yanes A, 2015, MOL ECOL RESOUR, V15, P28, DOI 10.1111/1755-0998.12291; McCormack JE, 2013, MOL PHYLOGENET EVOL, V66, P526, DOI 10.1016/j.ympev.2011.12.007; Mirarab S, 2015, BIOINFORMATICS, V31, P44, DOI 10.1093/bioinformatics/btv234; MORTON SR, 1988, AM NAT, V132, P237, DOI 10.1086/284847; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pyron RA, 2014, MOL PHYLOGENET EVOL, V81, P221, DOI 10.1016/j.ympev.2014.08.023; Python Software Foundation, 2016, PYTH LANG REF VERS 2; Rambaut A., 2014, FIGTREE WWW DOCUMENT; Rambaut A., 2014, TRACER; Rivers D.M., 2016, CLADISTICS; Rubin BER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033394; Sedeek KEM, 2014, MOL ECOL, V23, P6192, DOI 10.1111/mec.12992; Seo TK, 2008, MOL BIOL EVOL, V25, P960, DOI 10.1093/molbev/msn043; Simmons MP, 2014, MOL PHYLOGENET EVOL, V74, P1, DOI 10.1016/j.ympev.2014.01.030; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; Springer MS, 2016, MOL PHYLOGENET EVOL, V94, P1, DOI 10.1016/j.ympev.2015.07.018; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Streicher JW, 2016, SYST BIOL, V65, P128, DOI 10.1093/sysbio/syv058; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Vachaspati P, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S10-S3; Waters C, 2010, AUST J BOT, V58, P23, DOI 10.1071/BT09138; White TA, 2013, MOL ECOL, V22, P2971, DOI 10.1111/mec.12343; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	74	21	23	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171053	10.1371/journal.pone.0171053	http://dx.doi.org/10.1371/journal.pone.0171053			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135342	Green Published, gold, Green Submitted			2022-12-27	WOS:000396124700043
J	Han, Y; Liu, Y; Wang, HY; Liu, XJ				Han, Ying; Liu, Yuan; Wang, Haoyou; Liu, Xiangjun			The Evolution of Vicia ramuliflora (Fabaceae) at Tetraploid and Diploid Levels Revealed with FISH and RAPD	PLOS ONE			English	Article							GENOME EVOLUTION; POLYPLOIDY; DIVERSITY; GENES	Vicia ramuliflora L. is a widely distributed species in Eurasia with high economic value. For past 200 years, it has evolved a tetraploid cytotype and new subspecies at the diploid level. Based on taxonomy, cytogeography and other lines of evidence, previous studies have provided valuable information about the evolution of V. ramuliflora ploidy level, but due to the limited resolution of traditional methods, important questions remain. In this study, fluorescence in situ hybridization (FISH) and random amplified polymorphic DNA (RAPD) were used to analyze the evolution of V. ramuliflora at the diploid and tetraploid levels. Our aim was to reveal the genomic constitution and parents of the tetraploid V. ramuliflora and the relationships among diploid V. ramuliflora populations. Our study showed that the tetraploid cytotype of V. ramuliflora at Changbai Mountains (M) has identical 18S and 5S rDNA distribution patterns with the diploid Hengdaohezi population (B) and the diploid Dailing population (H). However, UPGMA clustering, Neighbor-Joining clustering and principal coordinates analysis based on RAPD showed that the tetraploid cytotype (M) has more close relationships with Qianshan diploid population T. Based on our results and the fact that inter specific hybridization among Vicia species is very difficult, we think that the tetraploid V. ramuliflora is an autotetraploid and its genomic origin still needs further study. In addition, our study also found that Qianshan diploid population (T) had evolved distinct new traits compared with other diploid populations, which hints that V. ramuliflora evolved further at diploid level. We suggest that diploid population T be re-classified as a new subspecies.	[Han, Ying] Southwest Univ Sci & Technol, Sch Life Sci & Engn, Mianyang, Peoples R China; [Liu, Yuan; Liu, Xiangjun] Tianjin Normal Univ, Coll Life Sci, Tianjin, Peoples R China; [Wang, Haoyou] Harbin Normal Univ, Sch Life Sci & Technol, Harbin, Peoples R China	Southwest University of Science & Technology - China; Tianjin Normal University; Harbin Normal University	Han, Y (corresponding author), Southwest Univ Sci & Technol, Sch Life Sci & Engn, Mianyang, Peoples R China.	hanxx908@umn.edu			National Natural Science Foundation of China [30070060, 31300511]; Science Foundation for The Excellent Youth Scholars of Ministry of Education of China [1692]; China Scholarship Council [201408510074]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation for The Excellent Youth Scholars of Ministry of Education of China; China Scholarship Council(China Scholarship Council)	This work was supported by National Natural Science Foundation of China (30070060): this funder had a role in study design, data collection and analysis, decision to publish; Science Foundation for The Excellent Youth Scholars of Ministry of Education of China (1692): this funder had a role in study design, data collection and analysis, decision to publish; National Natural Science Foundation of China (31300511): this funder had a role in preparation of the manuscript and decision to publish; and China Scholarship Council (201408510074): this funder had a role in preparation of the manuscript and decision to publish.	Abdullah AY, 2010, TROP ANIM HEALTH PRO, V42, P293, DOI 10.1007/s11250-009-9420-x; Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Alzueta C, 2001, J ANIM SCI, V79, P2449; Belling J, 1925, J GENET, V15, P245, DOI 10.1007/BF02983121; Brochmann C, 2004, BIOL J LINN SOC, V82, P521, DOI 10.1111/j.1095-8312.2004.00337.x; Caballero R., 2008, J SUSTAIN AGR, V3, P133; Chen ZJ, 2007, NEW PHYTOL, V174, P717, DOI 10.1111/j.1469-8137.2007.02084.x; Chen ZJ, 2006, BIOESSAYS, V28, P240, DOI 10.1002/bies.20374; Doyle JJ, 2008, ANNU REV GENET, V42, P443, DOI 10.1146/annurev.genet.42.110807.091524; EXCOFFIER L, 1992, GENETICS, V131, P479; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fu PY, 1976, FLORA NE CHINA HERBS; GRANT V, 1952, CHROMOSOMA, V5, P372; Haddad SG, 2006, LIVEST SCI, V99, P221, DOI 10.1016/j.livprodsci.2005.06.014; Han Y, 2010, BIOCHEM GENET, V48, P385, DOI 10.1007/s10528-009-9320-9; Kay Q. O. N, 1969, WATSONIA, V7, P130; Lachmuth S, 2010, MOL ECOL, V19, P3952, DOI 10.1111/j.1365-294X.2010.04797.x; Li RJ, 1996, STUDY BIOSYSTEMATICS; Li RJ, 1993, B BOT RES CHINA, V13, P243; [李骁 Li Xiao], 2015, [中草药, Chinese Traditional and Herbal Drugs], V46, P1814; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu SY, 2011, SCI HORTIC-AMSTERDAM, V127, P411, DOI 10.1016/j.scienta.2010.10.012; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; MCHALE NA, 1983, CAN J GENET CYTOL, V25, P609, DOI 10.1139/g83-091; Plitmann U., 1989, Monographs in Systematic Botany from the Missouri Botanical Garden, V29, P487; Rohlf PJ, 1997, NTSYS PC NUMERICAL T; Traldi JB, 2013, GENET MOL RES, V12, P463, DOI 10.4238/2013.February.8.11; Wei JZ, 1995, GENOME, V38, P1230, DOI 10.1139/g95-161; WELSH J, 1990, NUCLEIC ACIDS RES, V18, P7213, DOI 10.1093/nar/18.24.7213; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531; Xia ZD, 1996, ZHIWU FENLEI XUEBAO, V34, P421; Xu BS, 1984, ACTA BOT YUNNANICA, V7, P425; Yeh F.C, 1999, POPGENE VERSION 3 2; Zhang DM, 1999, AM J BOT, V86, P735, DOI 10.2307/2656583; 刘祥君, 1997, 植物研究, V17, P421	36	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170695	10.1371/journal.pone.0170695	http://dx.doi.org/10.1371/journal.pone.0170695			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135314	Green Submitted, Green Published, gold			2022-12-27	WOS:000396124700019
J	Acerbi, L; Vijayakumar, S; Wolpert, DM				Acerbi, Luigi; Vijayakumar, Sethu; Wolpert, Daniel M.			Target Uncertainty Mediates Sensorimotor Error Correction	PLOS ONE			English	Article							BAYESIAN DECISION-THEORY; FEEDBACK-CONTROL; VISUAL FEEDBACK; PERCEPTION; HAND; NOISE	Human movements are prone to errors that arise from inaccuracies in both our perceptual processing and execution of motor commands. We can reduce such errors by both improving our estimates of the state of the world and through online error correction of the ongoing action. Two prominent frameworks that explain how humans solve these problems are Bayesian estimation and stochastic optimal feedback control. Here we examine the interaction between estimation and control by asking if uncertainty in estimates affects how subjects correct for errors that may arise during the movement. Unbeknownst to participants, we randomly shifted the visual feedback of their finger position as they reached to indicate the center of mass of an object. Even though participants were given ample time to compensate for this perturbation, they only fully corrected for the induced error on trials with low uncertainty about center of mass, with correction only partial in trials involving more uncertainty. The analysis of subjects' scores revealed that participants corrected for errors just enough to avoid significant decrease in their overall scores, in agreement with the minimal intervention principle of optimal feedback control. We explain this behavior with a term in the loss function that accounts for the additional effort of adjusting one's response. By suggesting that subjects' decision uncertainty, as reflected in their posterior distribution, is a major factor in determining how their sensorimotor system responds to error, our findings support theoretical models in which the decision making and control processes are fully integrated.	[Acerbi, Luigi; Vijayakumar, Sethu] Univ Edinburgh, Sch Informat, Inst Percept Act & Behav, Edinburgh, Midlothian, Scotland; [Acerbi, Luigi] Univ Edinburgh, Sch Informat, Doctoral Training Ctr Neuroinformat & Computat Ne, Edinburgh, Midlothian, Scotland; [Wolpert, Daniel M.] Univ Cambridge, Dept Engn, Computat & Biol Learning Lab, Cambridge, England; [Acerbi, Luigi] NYU, Ctr Neural Sci, New York, NY 10003 USA	University of Edinburgh; University of Edinburgh; University of Cambridge; New York University	Acerbi, L (corresponding author), Univ Edinburgh, Sch Informat, Inst Percept Act & Behav, Edinburgh, Midlothian, Scotland.; Acerbi, L (corresponding author), Univ Edinburgh, Sch Informat, Doctoral Training Ctr Neuroinformat & Computat Ne, Edinburgh, Midlothian, Scotland.; Acerbi, L (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	luigi.acerbi@nyu.edu	Acerbi, Luigi/H-3131-2019	Acerbi, Luigi/0000-0001-7471-7336; Wolpert, Daniel/0000-0003-2011-2790	UK Engineering and Physical Sciences Research Council (EPSRC) [EP/F500385/1, BB/F529254/1]; UK Biotechnology and Biological Sciences Research Council (BBSRC); UK Medical Research Council (MRC); Wellcome Trust; Human Frontiers Science Program; Royal Society Noreen Murray Professorship in Neurobiology; Microsoft Research; Royal Academy of Engineering; EU; eDIKT initiative	UK Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Human Frontiers Science Program(Human Frontier Science Program); Royal Society Noreen Murray Professorship in Neurobiology; Microsoft Research(Microsoft); Royal Academy of Engineering(Royal Academy of Engineering - UK); EU(European Commission); eDIKT initiative	This work was supported in part by grants EP/F500385/1 and BB/F529254/1 for the University of Edinburgh School of Informatics Doctoral Training Centre in Neuroinformatics and Computational Neuroscience from the UK Engineering and Physical Sciences Research Council (EPSRC), UK Biotechnology and Biological Sciences Research Council (BBSRC), and the UK Medical Research Council (MRC) to L. Acerbi. This work was also supported by the Wellcome Trust, the Human Frontiers Science Program, and the Royal Society Noreen Murray Professorship in Neurobiology (D. M. Wolpert). S. Vijayakumar is supported through grants from Microsoft Research, Royal Academy of Engineering and EU FP7 programs. The work has made use of resources provided by the Edinburgh Compute and Data Facility, which has support from the eDIKT initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerbi L, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003661; Acerbi L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002771; Berniker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012686; Braun DA, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00001; Burge J, 2008, J VISION, V8, DOI 10.1167/8.4.20; Chalk M, 2010, J VISION, V10, DOI 10.1167/10.8.2; Crevecoeur F, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003177; Dimitriou M, 2013, J NEUROSCI, V33, P10898, DOI 10.1523/JNEUROSCI.5669-12.2013; Drugowitsch J, 2012, J NEUROSCI, V32, P3612, DOI 10.1523/JNEUROSCI.4010-11.2012; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Franklin DW, 2011, NEURON, V72, P425, DOI 10.1016/j.neuron.2011.10.006; Friedenberg J, 2002, PERCEPT PSYCHOPHYS, V64, P531, DOI 10.3758/BF03194724; Girshick AR, 2011, NAT NEUROSCI, V14, P926, DOI 10.1038/nn.2831; Grau-Moya J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002698; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Ho YX, 2007, J VISION, V7, DOI 10.1167/7.1.1; Izawa J, 2008, J NEUROSCI, V28, P11360, DOI 10.1523/JNEUROSCI.3063-08.2008; Jazayeri M, 2010, NAT NEUROSCI, V13, P1020, DOI 10.1038/nn.2590; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Knill DC, 2011, J NEUROSCI, V31, P1219, DOI 10.1523/JNEUROSCI.3522-09.2011; Kording KP, 2006, TRENDS COGN SCI, V10, P319, DOI 10.1016/j.tics.2006.05.003; Kording KP, 2004, P NATL ACAD SCI USA, V101, P9839, DOI 10.1073/pnas.0308394101; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Liu D, 2007, J NEUROSCI, V27, P9354, DOI 10.1523/JNEUROSCI.1110-06.2007; Ma WJ, 2012, TRENDS COGN SCI, V16, P511, DOI 10.1016/j.tics.2012.08.010; Maloney LT, 2009, VISUAL NEUROSCI, V26, P147, DOI 10.1017/S0952523808080905; Mitrovic D, 2010, STUD COMPUT INTELL, V264, P65; Mitrovic D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013601; Nagengast AJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000857; O'Sullivan I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000345; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Orban G, 2011, CURR OPIN NEUROBIOL, V21, P629, DOI 10.1016/j.conb.2011.05.026; Rawlik Konrad, 2013, P 23 INT JOINT C ART; Sarlegna FR, 2014, VISION RES; Saunders JA, 2004, J NEUROSCI, V24, P3223, DOI 10.1523/JNEUROSCI.4319-03.2004; Saunders JA, 2003, EXP BRAIN RES, V152, P341, DOI 10.1007/s00221-003-1525-2; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Seydell A, 2008, J NEUROSCI, V28, P4356, DOI 10.1523/JNEUROSCI.0647-08.2008; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Stevenson IH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000629; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; Tassinari H, 2006, J NEUROSCI, V26, P10154, DOI 10.1523/JNEUROSCI.2779-06.2006; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Trommershauser J, 2003, J OPT SOC AM A, V20, P1419, DOI 10.1364/JOSAA.20.001419; van Dam LCJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078757; Wei KL, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00011; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; Whiteley L, 2008, J VISION, V8, DOI 10.1167/8.3.2	50	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170466	10.1371/journal.pone.0170466	http://dx.doi.org/10.1371/journal.pone.0170466			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7VX	28129323	Green Published, Green Submitted, gold			2022-12-27	WOS:000396211400057
J	Henley, AB; Yang, L; Chuang, KL; Sahuri-Arisoylu, M; Wu, LH; Bligh, SWA; Bell, JD				Henley, Aine Brigette; Yang, Ling; Chuang, Kun-Lin; Sahuri-Arisoylu, Meliz; Wu, Li-Hong; Bligh, S. W. Annie; Bell, Jimmy David			Withania somnifera Root Extract Enhances Chemotherapy through 'Priming'	PLOS ONE			English	Article							CELL LUNG-CARCINOMA; MITOCHONDRIAL DYSFUNCTION; COLON-CANCER; IN-VITRO; WITHAFERIN; ATP; INHIBITION; METABOLISM; GENERATION; QUERCETIN	Withania somnifera extracts are known for their anti-cancerous, anti-inflammatory and antioxidative properties. One of their mechanisms of actions is to modulate mitochondrial function through increasing oxidative stress. Recently `priming' has been suggested as a potential mechanism for enhancing cancer cell death. In this study we demonstrate that `priming', in HT-29 colon cells, with W. somnifera root extract increased the potency of the chemotherapeutic agent cisplatin. We have also showed the W. somnifera root extract enhanced mitochondrial dysfunction and that the underlying mechanism of `priming' was selectively through increased ROS. Moreover, we showed that this effect was not seen in non-cancerous cells.	[Henley, Aine Brigette; Sahuri-Arisoylu, Meliz; Bligh, S. W. Annie; Bell, Jimmy David] Univ Westminster, Fac Sci & Technol, Dept Life Sci, London, England; [Yang, Ling; Chuang, Kun-Lin] China Med Univ, Coll Pharm, Dept Chinese Pharmaceut Sci & Chinese Med Resourc, Taichung, Taiwan; [Wu, Li-Hong] Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, Shanghai, Peoples R China; [Henley, Aine Brigette] Karolinska Inst, Dept Microbiol Tumour & Cell Biol, Stockholm, Sweden	University of Westminster; China Medical University Taiwan; Shanghai University of Traditional Chinese Medicine; Karolinska Institutet	Bligh, SWA (corresponding author), Univ Westminster, Fac Sci & Technol, Dept Life Sci, London, England.	a.bligh@westminster.ac.uk	Bligh, Annie/AAI-9786-2020	Bligh, Annie/0000-0002-4757-2159; Bell, Jimmy/0000-0003-3804-1281	MRC [MC_U120061305] Funding Source: UKRI; Medical Research Council [MC_U120061305] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Arisan ED, 2010, BREAST CANCER RES TR, V119, P271, DOI 10.1007/s10549-009-0343-z; Biswal BM, 2013, INTEGR CANCER THER, V12, P312, DOI 10.1177/1534735412464551; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Caley ACR., 2012, SURGERY, V30, P186, DOI DOI 10.1016/J.MPSUR.2012.01.004; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; Ferber EC, 2012, CELL DEATH DIFFER, V19, P968, DOI 10.1038/cdd.2011.179; Florea Ana-Maria, 2011, Cancers (Basel), V3, P1351, DOI 10.3390/cancers3011351; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Galluzzi L, 2006, ONCOGENE, V25, P4812, DOI 10.1038/sj.onc.1209598; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Gupta SC, 2012, ANTIOXID REDOX SIGN, V16, P1295, DOI 10.1089/ars.2011.4414; Hahm ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023354; Hahm ER, 2011, MOL CARCINOGEN, V50, P614, DOI 10.1002/mc.20760; Halder B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137498; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Huang HY, 2013, J BIOL CHEM, V288, P19870, DOI 10.1074/jbc.M112.448290; Jayaprakasam B, 2003, LIFE SCI, V74, P125, DOI 10.1016/j.lfs.2003.07.007; Jiang K, 2015, ONCOL REP, V33, P2711, DOI 10.3892/or.2015.3915; Kuhar M, 2006, ANTICANCER RES, V26, P1297; Kuhar M., 2007, J CANC MOL, V3, P121, DOI DOI 10.29685/JCM.200708.0004; Kumar A, 2012, MOL CELL BIOCHEM, V371, P43, DOI 10.1007/s11010-012-1421-9; Kumar P, 2009, J MED FOOD, V12, P591, DOI 10.1089/jmf.2008.0028; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Li X, 2015, CANCER LETT, V357, P219, DOI 10.1016/j.canlet.2014.11.026; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Malik F, 2007, APOPTOSIS, V12, P2115, DOI 10.1007/s10495-007-0129-x; Malik F, 2009, EUR J CANCER, V45, P1494, DOI 10.1016/j.ejca.2009.01.034; Mei Y., 2014, BIOCH BIOPHYS ACTA; Muller MF, 2016, VIRCHOWS ARCH, V469, P125, DOI 10.1007/s00428-016-1956-3; Muralikrishnan G, 2010, IMMUNOL INVEST, V39, P688, DOI 10.3109/08820139.2010.487083; Oh J, 2008, APOPTOSIS, V13, P1494, DOI 10.1007/s10495-008-0273-y; Pille JY, 2005, MOL THER, V11, P267, DOI 10.1016/j.ymthe.2004.08.029; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; PRICHARD MN, 1990, ANTIVIR RES, V14, P181, DOI 10.1016/0166-3542(90)90001-N; Rajeswaran A, 2008, LUNG CANCER, V59, P1, DOI 10.1016/j.lungcan.2007.07.012; Samudio I, 2009, CANCER RES, V69, P2163, DOI 10.1158/0008-5472.CAN-08-3722; Sarosiek KA, 2013, TRENDS CELL BIOL, V23, P612, DOI 10.1016/j.tcb.2013.08.003; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Sharma H, 2005, CANCER BIOL THER, V4, P949, DOI 10.4161/cbt.4.9.1908; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tiwari BS, 2002, PLANT PHYSIOL, V128, P1271, DOI 10.1104/pp.010999; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Yadav B, 2010, INDIAN J PHARM SCI, V72, P659, DOI 10.4103/0250-474X.78543; Yu YK, 2010, BIOCHEM PHARMACOL, V79, P542, DOI 10.1016/j.bcp.2009.09.017; Zhang X, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3983	47	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170917	10.1371/journal.pone.0170917	http://dx.doi.org/10.1371/journal.pone.0170917			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129345	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000396211400027
J	Fuentes-Ramirez, A; Jimenez-Soto, M; Castro, R; Romero-Zuniga, JJ; Dolz, G				Fuentes-Ramirez, Alicia; Jimenez-Soto, Mauricio; Castro, Ruth; Jose Romero-Zuniga, Juan; Dolz, Gaby			Molecular Detection of Plasmodium malariae/Plasmodium brasilianum in Non-Human Primates in Captivity in Costa Rica	PLOS ONE			English	Article							MALARIA PARASITES; ATLANTIC FOREST; NATURAL INFECTION; HOWLER MONKEYS; HUMANS; RESERVOIRS; KNOWLESI; REGIONS; AMAZON; SIMIUM	One hundred and fifty-two blood samples of non-human primates of thirteen rescue centers in Costa Rica were analyzed to determine the presence of species of Plasmodium using thick blood smears, semi-nested multiplex polymerase chain reaction (SnM-PCR) for species differentiation, cloning and sequencing for confirmation. Using thick blood smears, two samples were determined to contain the Plasmodium malariae parasite, with SnM-PCR, a total of five (3.3%) samples were positive to P. malariae, cloning and sequencing confirmed both smear samples as P. malariae. One sample amplified a larger and conserved region of 18S rDNA for the genus Plasmodium and sequencing confirmed the results obtained microscopically and through SnM-PCR tests. Sequencing and construction of a phylogenetic tree of this sample revealed that the P. malariae/P. brasilianum parasite (GenBank KU999995) found in a howler monkey (Alouatta palliata) is identical to that recently reported in humans in Costa Rica. The SnM-PCR detected P. malariae/P. brasilianum parasite in different nonhuman primate species in captivity and in various regions of the southern Atlantic and Pacific coast of Costa Rica. The similarity of the sequences of parasites found in humans and a monkey suggests that monkeys may be acting as reservoirs of P. malariae/P. brasilianum, for which reason it is important, to include them in control and eradication programs.	[Fuentes-Ramirez, Alicia; Castro, Ruth; Dolz, Gaby] Univ Nacl UNA, Posgrad Reg Ciencias Vet Trop PCVET, Campus Benjamin Nunez, Barreal De Heredia, Costa Rica; [Jimenez-Soto, Mauricio; Jose Romero-Zuniga, Juan; Dolz, Gaby] UNA, Escuela Med Vet, Campus Benjamin Nunez, Barreal De Heredia, Costa Rica	Universidad Nacional Costa Rica	Fuentes-Ramirez, A; Dolz, G (corresponding author), Univ Nacl UNA, Posgrad Reg Ciencias Vet Trop PCVET, Campus Benjamin Nunez, Barreal De Heredia, Costa Rica.; Dolz, G (corresponding author), UNA, Escuela Med Vet, Campus Benjamin Nunez, Barreal De Heredia, Costa Rica.	alicia.fuentes.ramirez@est.una.ac.cr; gaby.dolz.wiedner@una.cr		Dolz, Gaby/0000-0002-9566-5130	Vicerrectoria de Investigacion, Universidad Nacional; Deutscher Akademischer Austauschdienst (DAAD)	Vicerrectoria de Investigacion, Universidad Nacional; Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	Vicerrectoria de Investigacion, Universidad Nacional provided financial support for translating the article. Deutscher Akademischer Austauschdienst (DAAD) provided the scholarship granted to Alicia Fuentes-Ramirez.	Araujo MS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-180; Avila-Aguero ML, 2008, ACTA MED COSTAR, V50; Bannister LH, 2001, ENCY LIFE SCI; Calvo N., 2015, SCI POSTPRINT, V1; Chinchilla Misael, 2006, Parasitologia Latinoamericana, V61, P192; COATNEY GR, 1971, PRIMATE MALARIAS; Cormier Loretta A., 2010, Diversity, V2, P256; Costa DC, 2014, MEM I OSWALDO CRUZ, V109, P641, DOI 10.1590/0074-0276130578; de Pina-Costa A, 2014, MEM I OSWALDO CRUZ, V109, P618, DOI 10.1590/0074-0276140228; DEANE LM, 1988, AM J TROP MED HYG, V38, P223, DOI 10.4269/ajtmh.1988.38.223; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ESCALANTE AA, 1995, MOL BIOL EVOL, V12, P616; Fandeur T, 2000, PARASITOLOGY, V120, P11, DOI 10.1017/S0031182099005168; Galland G G, 2000, ILAR J, V41, P37; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Kirchgatter K, 2014, REV INST MED TROP SP, V56, P403, DOI 10.1590/S0036-46652014000500006; Lalremruata A, 2015, EBIOMEDICINE, V2, P1186, DOI 10.1016/j.ebiom.2015.07.033; Leclerc MC, 2004, PARASITOLOGY, V129, P677, DOI 10.1017/S0031182004006146; Lopez AC, 2011, REV CIENCIA TECNOLOG, V9, P68; de Alvarenga DAM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0606-6; Maeno Y, 2015, PARASIT VECT, V8, P1473; Mixson-Hayden Tonya, 2010, BMC Res Notes, V3, P88, DOI 10.1186/1756-0500-3-88; Ndao M, 2004, J CLIN MICROBIOL, V42, P2694, DOI 10.1128/JCM.42.6.2694-2700.2004; Noordhuizen JPTM., 2001, APPL QUANTITATIVE ME, V2nd; Rayner JC, 2015, EBIOMEDICINE, V2, P1023, DOI 10.1016/j.ebiom.2015.08.035; Duarte AMRD, 2008, ACTA TROP, V107, P179, DOI 10.1016/j.actatropica.2008.05.020; Rubio JM, 1999, AM J TROP MED HYG, V60, P183, DOI 10.4269/ajtmh.1999.60.183; Singh B, 2013, CLIN MICROBIOL REV, V26, P165, DOI 10.1128/CMR.00079-12; Tazi L, 2011, INFECT GENET EVOL, V11, P209, DOI 10.1016/j.meegid.2010.08.007; Verhulst NO, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00197; Vythilingam I, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P487, DOI 10.5772/54491; White NJ, 2008, CLIN INFECT DIS, V46, P172, DOI 10.1086/524889; Yamasaki T, 2011, J MED PRIMATOL, V40, P392, DOI 10.1111/j.1600-0684.2011.00498.x	33	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170704	10.1371/journal.pone.0170704	http://dx.doi.org/10.1371/journal.pone.0170704			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125696	Green Published, Green Submitted, gold			2022-12-27	WOS:000396176100071
J	Kao, FC; Hsu, YC; Lin, CFJ; Lo, YY; Tu, YK				Kao, Feng-Chen; Hsu, Yao-Chun; Lin, Chien-Fu Jeff; Lo, Ying-Ying; Tu, Yuan-Kun			Corticosteroid Is Associated with Both Hip Fracture and Fracture-Unrelated Arthropathy	PLOS ONE			English	Article							HUMAN FEMORAL-HEAD; RENAL-TRANSPLANTATION; CLINICAL-IMPLICATIONS; AVASCULAR NECROSIS; INDUCED OSTEOPOROSIS; OSTEONECROSIS; BONE; THERAPY; RISK; GLUCOCORTICOIDS	Objective We aimed to investigate whether and how corticosteroid use was associated with serious hip arthropathy. Methods and Materials This population-based cohort study analyzed the Taiwan National Health Insurance Research Database and screened the one-million random sample from the entire population for eligibility. The steroid cohort consisted of 21,995 individuals who had used systemic corticosteroid for a minimum of 6 months between January 1, 1997 and December 31, 2006. They were matched 1: 1 in propensity score on the index calendar date with controls who never used steroid. All participants were followed up until occurrence of serious hip arthropathy that required arthroplasty, withdrawal from the national health insurance, or the end of 2011. Surgical indication was classified as fracture-related and -unrelated. The cumulative incidence of hip arthroplasty was estimated by the Kaplan Meier method. The association with steroid exposure was explored by the Cox proportional hazard model. Results Cumulative incidences of hip arthroplasty after 12 years of follow-up were 2.96% (95% confidence interval [CI], 2.73-3.2%) and 1.34% (95% CI, 1.2-1.51%) in the steroid users and non-users, respectively (P< 0.0001). The difference was evident in fracture-related arthroplasty with 1.89% (95% CI, 1.71-2.09%) versus 1.10% (95% CI, 0.97-1.25%), but more pronounced in fracture-unrelated surgery, 1.09% (95% CI, 0.95-1.24%) versus 0.24% (95% CI, 0.19-0.32%). Multivariate-adjusted Cox regression analysis confirmed steroid use was independently associated with both fracture-related (adjusted hazard ratio [HR], 1.65; 95% CI, 1.43-1.91) and unrelated arthroplasty (adjusted HR, 4.21; 95% CI, 3.2-5.53). Moreover, the risk for fracture-unrelated arthropathy rose with steroid dosage, as the adjusted HR increased from 3.30 (95% CI, 2.44-4.46) in the low-dose subgroup, 4.54 (95% CI, 3.05-6.77) in intermediate-dose users, to 6.54 (95% CI, 4.74-9.02) in the high-dose counterpart (P-trend<0.0001). Conclusions Corticosteroid use is associated with long-term risk of hip arthroplasty, particularly for fracture-unrelated arthropathy.	[Kao, Feng-Chen; Tu, Yuan-Kun] E Da Hosp, Dept Orthopaed, Kaohsiung, Taiwan; [Kao, Feng-Chen; Hsu, Yao-Chun; Tu, Yuan-Kun] I Shou Univ, Sch Med Int Students, Kaohsiung, Taiwan; [Hsu, Yao-Chun] E Da Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Hsu, Yao-Chun] E Da Hosp, Ctr Database Res, Kaohsiung, Taiwan; [Hsu, Yao-Chun] China Med Univ, Grad Inst Clin Med, Taichung, Taiwan; [Lin, Chien-Fu Jeff] Natl Taipei Univ, Dept Stat, Taipei, Taiwan; [Lin, Chien-Fu Jeff] Wan Fang Hosp, Dept Orthoped Surg, Taipei, Taiwan; [Lo, Ying-Ying] I Shou Univ, Dept Healthcare Adm, Kaohsiung, Taiwan	E-Da Hospital; I Shou University; E-Da Hospital; E-Da Hospital; China Medical University Taiwan; National Taipei University; Taipei Municipal WanFang Hospital; I Shou University	Tu, YK (corresponding author), E Da Hosp, Dept Orthopaed, Kaohsiung, Taiwan.; Hsu, YC; Tu, YK (corresponding author), I Shou Univ, Sch Med Int Students, Kaohsiung, Taiwan.; Hsu, YC (corresponding author), E Da Hosp, Dept Internal Med, Kaohsiung, Taiwan.; Hsu, YC (corresponding author), E Da Hosp, Ctr Database Res, Kaohsiung, Taiwan.; Hsu, YC (corresponding author), China Med Univ, Grad Inst Clin Med, Taichung, Taiwan.	holdenhsu@gamil.com; ed100130@edah.org.tw			Center for Database Research, E-Da Hospital [CFDR-B-103-1-1]	Center for Database Research, E-Da Hospital	The work was supported by the Center for Database Research, E-Da Hospital (CFDR-B-103-1-1).	Asano Takeshi, 2003, J Orthop Sci, V8, P329, DOI 10.1007/s10776-003-0646-7; Canalis E, 2007, OSTEOPOROSIS INT, V18, P1319, DOI 10.1007/s00198-007-0394-0; Colwell CW, 1996, ORTHOPEDICS, V19, P941; CRUESS RL, 1981, CAN J SURG, V24, P567; FISHER DE, 1971, J BONE JOINT SURG AM, VA 53, P859, DOI 10.2106/00004623-197153050-00002; Gebhard K L, 2001, Am J Clin Dermatol, V2, P377, DOI 10.2165/00128071-200102060-00004; GLIMCHER MJ, 1979, CLIN ORTHOP RELAT R, P273; GLIMCHER MJ, 1979, CLIN ORTHOP RELAT R, P284; GLIMCHER MJ, 1979, CLIN ORTHOP RELAT R, P283; HARRINGTON KD, 1971, J BONE JOINT SURG AM, VA 53, P203, DOI 10.2106/00004623-197153020-00001; Hsu YC, 2014, HEPATOLOGY, V59, P1293, DOI 10.1002/hep.26892; Hsu YC, 2012, HEPATOLOGY, V56, P698, DOI 10.1002/hep.25684; Hungeford DS, 2002, J ARTHROPLASTY, V17, P121, DOI 10.1054/arth.2002.33300; King KB, 2013, CLIN ORTHOP RELAT R, V471, P3049, DOI 10.1007/s11999-013-3026-3; Kubo T, 1998, TRANSPLANT P, V30, P3039, DOI 10.1016/S0041-1345(98)00920-8; LAUSTEN GS, 1988, ACTA ORTHOP SCAND, V59, P650, DOI 10.3109/17453678809149417; MCNATT LG, 1992, J STEROID BIOCHEM, V42, P687, DOI 10.1016/0960-0760(92)90109-V; Mirzai R, 1999, J ASTHMA, V36, P77, DOI 10.3109/02770909909065152; MONT MA, 1995, J BONE JOINT SURG AM, V77A, P459, DOI 10.2106/00004623-199503000-00018; O'Brien CA, 2004, ENDOCRINOLOGY, V145, P1835, DOI 10.1210/en.2003-0990; Powell ET, 1997, CLIN ORTHOP RELAT R, P181; Russell LA, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0371-x; Sakamoto M, 1997, J BONE JOINT SURG BR, V79B, P213, DOI 10.1302/0301-620X.79B2.7179; SAMBROOK PN, 1984, J RHEUMATOL, V11, P514; Solaymani-Dodaran M, 2006, GASTROENTEROLOGY, V131, P1752, DOI 10.1053/j.gastro.2006.09.012; SOLOMON L, 1981, CAN J SURG, V24, P573; Steinbuch M, 2004, OSTEOPOROSIS INT, V15, P323, DOI 10.1007/s00198-003-1548-3; Van Staa TP, 2003, ARTHRITIS RHEUM, V48, P3224, DOI 10.1002/art.11283; van Staa TP, 2002, OSTEOPOROSIS INT, V13, P777, DOI 10.1007/s001980200108; VREDEN SGS, 1991, NETH J MED, V39, P153; WANG GJ, 1977, J BONE JOINT SURG AM, V59, P729, DOI 10.2106/00004623-197759060-00003; WANG GJ, 1978, CLIN ORTHOP RELAT R, P81; Weinstein RS, 2011, NEW ENGL J MED, V365, P62, DOI 10.1056/NEJMcp1012926; Weinstein RS, 2010, AGING CELL, V9, P147, DOI 10.1111/j.1474-9726.2009.00545.x; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799	35	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0169468	10.1371/journal.pone.0169468	http://dx.doi.org/10.1371/journal.pone.0169468			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125643	Green Published, Green Submitted, gold			2022-12-27	WOS:000396176100139
J	Yang, C; Wang, Y; Xu, H				Yang, Chen; Wang, Yan; Xu, Hui			Fluoride Regulate Osteoblastic Transforming Growth Factor-beta 1 Signaling by Mediating Recycling of the Type I Receptor ALK5	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MESENCHYMAL STEM-CELLS; BONE-FORMATION; TGF-BETA; DIFFERENTIATION; EXPRESSION; PROTEIN; PATHWAYS; TURNOVER; RUNX2	This study aimed to preliminary investigate the role of activin receptor-like kinase (ALK) 5 as one of TGF-beta R1 subtypes in bone turnover and osteoblastic differentiation induced by fluoride. We analyzed bone mineral density and the expression of genes related with transforming growth factor-beta 1(TGF-beta 1) signaling and bone turnover in rats treated by different concentrations of fluoride with or without SB431542 in vivo. Moreover, MTT assay, alkaline phosphatase staining, RT-PCR, immunocytochemical analysis and western blot analysis were used to detect the influence on bone marrow stem cells (BMSC) after stimulating by varying concentration of fluoride with or without SB431542 in vitro. The in vivo study showed SB431542 treatment affected bone density and gene expression of rats, which indicated TGF-beta 1 and ALK5 might take part in fluoride-induced bone turnover and bone formation. The in vitro study showed low concentration of fluoride improved BMSC cells viability, alkaline phosphatase activity, and osteocalcin protein expression which were inhibited by high concentration of fluoride. The gene expression of Runx2 and ALK5 in cells increased after low concentration fluoride treatment which was also inhibited by high concentration of fluoride. Fluoride treatment inhibited gene and protein expression of Samd3 (except 1 mgF(-)/L). Compared with fluoride treatment alone, cells differentiation was inhibited with SB431542 treatment. Moreover, the expression of Runx2, ALK5 and Smad3 were influenced by SB431542 treatment. In conclusion, this preliminary study indicated that fluoride regulated osteoblastic TGF beta 1 signaling in bone turnover and cells differentiation via ALK5.	[Yang, Chen; Wang, Yan; Xu, Hui] Jilin Univ, Sch Pharmaceut Sci, Changchun, Peoples R China	Jilin University	Xu, H (corresponding author), Jilin Univ, Sch Pharmaceut Sci, Changchun, Peoples R China.	huixujilin@163.com			National Natural Science Foundation of China [81673111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant for skeletal fluorosis research from National Natural Science Foundation of China (81673111).	Anastasilakis AD, 2015, METABOLISM, V64, P1291, DOI 10.1016/j.metabol.2015.06.018; Birmingham E, 2012, EUR CELLS MATER, V23, P13, DOI 10.22203/eCM.v023a02; Callahan JF, 2002, J MED CHEM, V45, P999, DOI 10.1021/jm010493y; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Driver J, 2015, J BIOL CHEM, V290, P9959, DOI 10.1074/jbc.M114.616888; Ehnert S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014073; Fang J, 2016, HISTOL HISTOPATHOL, V31, P1161, DOI 10.14670/HH-11-779; Hu Zhen-Yu, 2012, J ORAL MAXILLOFACIAL; KHOKHER MA, 1990, METABOLISM, V39, P1118, DOI 10.1016/0026-0495(90)90081-M; Lai CH, 2014, EVID-BASED COMPL ALT, V2014; Lee KS, 2002, ONCOGENE, V21, P7156, DOI 10.1038/sj.onc.1205937; Li XN, 2014, BIOL TRACE ELEM RES, V158, P113, DOI 10.1007/s12011-014-9897-7; Liu QY, 2016, BIOL TRACE ELEM RES, V171, P380, DOI 10.1007/s12011-015-0555-5; Miles FL, 2015, PROSTATE, V75, P1802, DOI 10.1002/pros.23060; Mohapatra M, 2009, J ENVIRON MANAGE, V91, P67, DOI 10.1016/j.jenvman.2009.08.015; Mousny M, 2008, BONE, V43, P1067, DOI 10.1016/j.bone.2008.07.248; Murakami T, 1998, BIOCHEM BIOPH RES CO, V252, P747, DOI 10.1006/bbrc.1998.9723; Oshimori N, 2012, CELL STEM CELL, V11, P751, DOI 10.1016/j.stem.2012.11.001; Pei J.R., 2012, ENVIRON TOXICOL, V29, P588, DOI DOI 10.1002/T0X.21784; Perumal E, 2013, TOXICOL LETT, V223, P236, DOI 10.1016/j.toxlet.2013.09.005; Quinn JMW, 2001, J BONE MINER RES, V16, P1787, DOI 10.1359/jbmr.2001.16.10.1787; Rodriguez JP, 2001, J CELL BIOCHEM, V83, P607, DOI 10.1002/jcb.1255; Sang Zhi-Cheng, 2010, Zhongguo Gu Shang, V23, P379; Selvamurugan N, 2004, J BIOL CHEM, V279, P19327, DOI 10.1074/jbc.M314048200; Song Yu-e, 2011, Environmental Health and Preventive Medicine, V16, P158, DOI 10.1007/s12199-010-0181-y; Sugiyama K, 2008, CANCER SCI, V99, P1021, DOI 10.1111/j.1349-7006.2008.00761.x; Sun F, 2014, TOXICOLOGY, V325, P52, DOI 10.1016/j.tox.2014.07.006; Suzuki M, 2014, J DENT RES, V93, P1022, DOI 10.1177/0022034514545629; Xu H, 2010, TOXICOLOGY, V277, P1, DOI 10.1016/j.tox.2010.08.006; Yang C, 2015, BIOL TRACE ELEM RES, V168, P453, DOI 10.1007/s12011-015-0374-8	30	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170674	10.1371/journal.pone.0170674	http://dx.doi.org/10.1371/journal.pone.0170674			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125630	Green Published, gold, Green Submitted			2022-12-27	WOS:000396176100077
J	Park, HJ; Park, CH; Lee, SE; Lee, GD; Byun, MK; Lee, S; Lee, KA; Kim, TH; Kim, SH; Yang, SY; Kim, HJ; Ahn, CM				Park, Hye Jung; Park, Chul Hwan; Lee, Sang Eun; Lee, Geun Dong; Byun, Min Kwang; Lee, Sungsoo; Lee, Kyung-A; Kim, Tae Hoon; Kim, Seong Han; Yang, Seo Yeon; Kim, Hyung Jung; Ahn, Chul Min			Birt-Hogg-Dube syndrome prospectively detected by review of chest computed tomography scans	PLOS ONE			English	Article							PRIMARY SPONTANEOUS PNEUMOTHORAX; PULMONARY CYSTS; CT FINDINGS; LUNG CYSTS; FLCN-GENE; HEREDITARY; MANAGEMENT; FAMILIES; MUTATION; FEATURES	Purpose Birt-Hogg-Dube syndrome (BHD) is a rare disorder caused by mutations in the gene that encodes folliculin (FLCN) and is inherited in an autosomal dominant manner. BHD is commonly accompanied by fibrofolliculomas, renal tumors, multiple pulmonary cysts, and spontaneous pneumothorax. The aim of this study was to detect BHD prospectively in patients undergoing chest computed tomography (CT) scans and to evaluate further the characteristics of BHD in Korea. Methods We prospectively checked and reviewed the chest CT scans obtained for 10,883 patients at Gangnam Severance Hospital, Seoul, Korea, from June 1, 2015 to May 31, 2016. Seventeen patients met the study inclusion criteria and underwent screening for FLCN mutation to confirm BHD. We analyzed the characteristics of the patients confirmed to have BHD and those for a further 6 patients who had previously been described in Korea. Results Six (0.06%) of the 10,883 patients reviewed were diagnosed with BHD. There was no difference in demographic or clinical features between the patients with BHD (n = 6) and those without BHD (n = 11). Pneumothorax was present in 50% of the patients with BHD but typical skin and renal lesions were absent. The maximum size of the cysts in the BHD group (median 39.4 mm; interquartile range [IQR] 11.4 mm) was significantly larger than that in the non-BHD group (median 15.8 mm; IQR 7.8 mm; P = 0.001). Variable morphology was seen in 100.0% of the cysts in the BHD group but in only 18.2% of the cysts in the non-BHD group (P = 0.002). Nine (95%) of the total of 12 Korean patients with BHD had experienced pneumothorax. Typical skin and renal lesions were present in 20.0% of patients with BHD. Conclusions Our findings suggest that BHD can be detected if chest CT scans are read in detail.	[Park, Hye Jung; Byun, Min Kwang; Kim, Seong Han; Yang, Seo Yeon; Kim, Hyung Jung; Ahn, Chul Min] Yonsei Univ, Dept Internal Med, Gangnam Severance Hosp, Pulm Div,Coll Med, Seoul, South Korea; [Park, Chul Hwan; Kim, Tae Hoon] Yonsei Univ, Dept Radiol, Gangnam Severance Hosp, Coll Med, Seoul, South Korea; [Lee, Sang Eun] Yonsei Univ, Coll Med, Dept Dermatol, Gangnam Severance Hosp, Seoul, South Korea; [Lee, Geun Dong; Lee, Sungsoo] Yonsei Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Gangnam Severance Hosp, Seoul, South Korea; [Lee, Kyung-A] Yonsei Univ, Coll Med, Dept Lab Med, Gangnam Severance Hosp, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Ahn, CM (corresponding author), Yonsei Univ, Dept Internal Med, Gangnam Severance Hosp, Pulm Div,Coll Med, Seoul, South Korea.	ahn5302@yuhs.ac		/0000-0003-3598-2529; Lee, Sang Eun/0000-0003-4720-9955; Lee, Kyung-A/0000-0001-5320-6705; Byun, Min Kwang/0000-0003-1525-1745; Park, Hye Jung/0000-0002-1862-1003; Lee, Sungsoo/0000-0001-8998-9510; Park, Chul Hwan/0000-0002-0004-9475	Yonsei University College of Medicine [6-2015-0032]	Yonsei University College of Medicine(General Electric)	This study was supported by a faculty research grant of Yonsei University College of Medicine for 2015 (Grant Number: 6-2015-0032). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PP, 2011, AM J ROENTGENOL, V196, P349, DOI 10.2214/AJR.10.4757; BIRT AR, 1977, ARCH DERMATOL, V113, P1674, DOI 10.1001/archderm.113.12.1674; Coleman JA, 2009, CURR OPIN UROL, V19, P478, DOI 10.1097/MOU.0b013e32832f0d40; Ding YB, 2015, AM J MED GENET A, V167, P1125, DOI 10.1002/ajmg.a.36979; Furuya M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151476; Furuya M, 2013, J CLIN PATHOL, V66, P178, DOI 10.1136/jclinpath-2012-201200; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; James W., 2015, ANDREWS DIS SKIN CLI; Johannesma PC, 2015, EUR RESPIR J, V45, P1191, DOI 10.1183/09031936.00196914; Kahnoski K, 2003, J MED GENET, V40, P511, DOI 10.1136/jmg.40.7.511; Kim EH, 2008, J KOREAN MED SCI, V23, P332, DOI 10.3346/jkms.2008.23.2.332; Kim J, 2012, GENE, V499, P339, DOI 10.1016/j.gene.2012.03.037; Kunogi M, 2010, J MED GENET, V47, P281, DOI 10.1136/jmg.2009.070565; Menko FH, 2009, LANCET ONCOL, V10, P1199, DOI 10.1016/S1470-2045(09)70188-3; Murakami Y, 2014, CASE REP DERMATOL, V6, P20, DOI 10.1159/000358216; Park G, 2011, ANN DERMATOL, V23, pS188, DOI 10.5021/ad.2011.23.S2.S188; Pavlovich CP, 2005, J UROLOGY, V173, P1482, DOI 10.1097/01.ju.0000154629.45832.30; Ponti G, 2013, CRIT REV ONCOL HEMAT, V85, P239, DOI 10.1016/j.critrevonc.2012.07.001; Ren HZ, 2008, CLIN GENET, V74, P178, DOI 10.1111/j.1399-0004.2008.01030.x; Shin WW, 2011, ANN DERMATOL, V23, pS193, DOI 10.5021/ad.2011.23.S2.S193; Skolnik K, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0339-2; TADA S, 1983, CLIN RADIOL, V34, P437, DOI 10.1016/S0009-9260(83)80238-4; Tobino K, 2012, EUR J RADIOL, V81, P1340, DOI 10.1016/j.ejrad.2011.03.039; Tobino K, 2011, EUR J RADIOL, V77, P403, DOI 10.1016/j.ejrad.2009.09.004; Tomassetti S, 2011, RESP MED, V105, P768, DOI 10.1016/j.rmed.2011.01.002; Toro JR, 2008, J MED GENET, V45, P321, DOI 10.1136/jmg.2007.054304; Toro JR, 2007, AM J RESP CRIT CARE, V175, P1044, DOI 10.1164/rccm.200610-1483OC; Warren MB, 2004, MODERN PATHOL, V17, P998, DOI 10.1038/modpathol.3800152; Yang CY, 2013, J POSTGRAD MED, V59, P321, DOI 10.4103/0022-3859.123169	29	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170713	10.1371/journal.pone.0170713	http://dx.doi.org/10.1371/journal.pone.0170713			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151982	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200037
J	Pasma, A; Schenk, C; Timman, R; van 't Spijker, A; Appels, C; van der Laan, WH; van den Bemt, B; Goekoop, R; Hazes, JMW; Busschbach, JJV				Pasma, Annelieke; Schenk, Charlotte; Timman, Reinier; van 't Spijker, Adriaan; Appels, Cathelijne; van der Laan, Willemijn H.; van den Bemt, Bart; Goekoop, Robert; Hazes, Johanna M. W.; Busschbach, Jan J. V.			Does non-adherence to DMARDs influence hospital-related healthcare costs for early arthritis in the first year of treatment?	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; MEDICATION ADHERENCE; DRUG-THERAPY; RECOMMENDATIONS; ASSOCIATION; DEPRESSION; ANXIETY; WORK; RISK	Introduction Non-adherence to disease-modifying antirheumatic drugs (DMARDs) is suspected to relate to health care costs. In this study we investigated this relation in the first year of treatment. Methods In a multi-center cohort study with a one year follow up, non-adherence was continuously measured using electronic monitored medication jars. Non-adherence was defined as the number of days with a negative difference between expected and observed opening of the container. Cost measurement focused on hospital costs in the first year: consultations, emergency room visits, hospitalization, medical procedures, imaging modalities, medication costs, and laboratory tests. Cost volumes were registered from patient medical files. We applied multivariate regression analyses for the association between non-adherence and costs, and other variables (age, sex, center, baseline disease activity, diagnosis, socioeconomic status, anxiety and depression) and costs. Results Of the 275 invited patients, 206 were willing to participate. 74.2% had rheumatoid arthritis, 20.9% had psoriatic arthritis and 4.9% undifferentiated arthritis. 23.7% of the patients were more than 20% non-adherent over the follow-up period. Mean costs are epsilon 2117.25 (SD epsilon 3020.32). Non-adherence was positively related to costs in addition to baseline anxiety. Conclusion Non-adherence is associated with health care costs in the first year of treatment for arthritis. This suggests that improving adherence is not only associated with better outcome, but also with savings.	[Pasma, Annelieke; Schenk, Charlotte; Hazes, Johanna M. W.] Univ Med Ctr Rotterdam, Dept Rheumatol, Erasmus MC, Rotterdam, Netherlands; [Pasma, Annelieke; Timman, Reinier; van 't Spijker, Adriaan; Busschbach, Jan J. V.] Univ Med Ctr Rotterdam, Dept Psychiat, Erasmus MC, Sect Med Psychol & Psychotherapy, Rotterdam, Netherlands; [Appels, Cathelijne] Amphia Hosp, Dept Rheumatol, Breda, Netherlands; [van der Laan, Willemijn H.] Sint Maartensklin, Dept Rheumatol, Nijmegen, Netherlands; [van den Bemt, Bart] Sint Maartensklin, Dept Pharm, Nijmegen, Netherlands; [Goekoop, Robert] Haga Hosp, Dept Rheumatol, The Hague, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Amphia Hospital; Sint Maartens Clinic; Sint Maartens Clinic; Haga Hospital	Pasma, A (corresponding author), Univ Med Ctr Rotterdam, Dept Rheumatol, Erasmus MC, Rotterdam, Netherlands.; Pasma, A (corresponding author), Univ Med Ctr Rotterdam, Dept Psychiat, Erasmus MC, Sect Med Psychol & Psychotherapy, Rotterdam, Netherlands.	a.pasma@erasmusmc.nl	Busschbach, Jan/P-1584-2019; Van den Bemt, Bart/Q-2740-2015	Busschbach, Jan/0000-0002-8602-0381; Van den Bemt, Bart/0000-0002-8560-9514	Dutch Arthritis Foundation 'Reumafonds' [10-1-413]	Dutch Arthritis Foundation 'Reumafonds'	This study was funded by the Dutch Arthritis Foundation 'Reumafonds' (funding number 10-1-413). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boers M, 2007, ANN RHEUM DIS, V66, P132, DOI 10.1136/ard.2006.059451; Boulanger L, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-111; CANNER PL, 1980, NEW ENGL J MED, V303, P1038; DiMatteo M Robin, 2004, JAAPA, V17, P18; DiMatteo MR, 2002, MED CARE, V40, P794, DOI 10.1097/01.MLR.0000024612.61915.2D; DiMatteo MR, 2004, MED CARE, V42, P200, DOI 10.1097/01.mlr.0000114908.90348.f9; DOEGLAS D, 1995, ANN RHEUM DIS, V54, P455, DOI 10.1136/ard.54.6.455; Dormuth CR, 2009, CIRCULATION, V119, P2051, DOI 10.1161/CIRCULATIONAHA.108.824151; Geuskens GA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1458, DOI 10.1002/art.24104; Golay Alain, 2011, J Med Econ, V14, P594, DOI 10.3111/13696998.2011.597808; Hakkaart-van Roijen L, 2010, HANDLEIDING KOSTENON; Hovinga CA, 2008, EPILEPSY BEHAV, V13, P316, DOI 10.1016/j.yebeh.2008.03.009; Iuga AO, 2014, RISK MANAG HEALTHC P, V7, P35, DOI 10.2147/RMHP.S19801; JACOBS J, 1988, J CLIN EPIDEMIOL, V41, P215, DOI 10.1016/0895-4356(88)90124-2; Kane S, 2008, DIGEST DIS SCI, V53, P1020, DOI 10.1007/s10620-007-9968-0; Kroot EJJA, 2001, J RHEUMATOL, V28, P1511; Mjaavatten MD, 2014, J RHEUMATOL, V41, P2370, DOI 10.3899/jrheum.140306; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pasma A, 2015, J RHEUMATOL, V42, P379, DOI 10.3899/jrheum.140693; Pasma A, 2013, SEMIN ARTHRITIS RHEU, V43, P18, DOI 10.1016/j.semarthrit.2012.12.001; Poos MJJCVDI, VOLKSGEZONDHEID TOEK; Ruderman EM, 2012, RHEUMATOLOGY, V51, P37, DOI 10.1093/rheumatology/kes283; Simpson SH, 2006, BMJ-BRIT MED J, V333, P15, DOI 10.1136/bmj.38875.675486.55; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Sokol MC, 2005, MED CARE, V43, P521, DOI 10.1097/01.mlr.0000163641.86870.af; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Sutton S, 2014, ANN BEHAV MED, P1; van den Bemt BJF, 2012, EXPERT REV CLIN IMMU, V8, P337, DOI [10.1586/ECI.12.23, 10.1586/eci.12.23]; van Jaarsveld CHM, 1998, BRIT J RHEUMATOL, V37, P837; Vasiliadis HM, 2013, AM J GERIAT PSYCHIAT, V21, P536, DOI 10.1016/j.jagp.2012.12.016; Verstappen SMM, 2004, ANN RHEUM DIS, V63, P817, DOI 10.1136/ard.2003.014340; Wagner S., 2012, AM J PHARM BENEFIST, V4, pE88; Zolnierek KBH, 2009, MED CARE, V47, P826, DOI 10.1097/MLR.0b013e31819a5acc; Zorgautoriteit N, 2011, TARIEFLIJST INSTE S2	35	20	20	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171070	10.1371/journal.pone.0171070	http://dx.doi.org/10.1371/journal.pone.0171070			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152001	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200084
J	Giezendanner, S; Jung, C; Banderet, HR; Otte, IC; Gudat, H; Haller, DM; Elger, BS; Zemp, E; Bally, K				Giezendanner, Stephanie; Jung, Corinna; Banderet, Hans-Ruedi; Otte, Ina Carola; Gudat, Heike; Haller, Dagmar M.; Elger, Bernice S.; Zemp, Elisabeth; Bally, Klaus			General Practitioners' Attitudes towards Essential Competencies in End-of-Life Care: A Cross-Sectional Survey	PLOS ONE			English	Article							PALLIATIVE CARE; QUALITY INDICATORS; BARRIERS; SPIRITUALITY; EUTHANASIA; COMMUNICATION; PROFESSIONALS; FACILITATORS; CONFIDENCE; FRAMEWORK	Background Identifying essential competencies in end-of-life care, as well as general practitioners' (GPs) confidence in these competencies, is essential to guide training and quality improvement efforts in this domain. Aim To determine which competencies in end-of-life care are considered important by GPs, to assess GPs' confidence in these competencies in a European context and their reasons to refer terminally ill patients to a specialist. Design and Setting Cross-sectional postal survey involving a stratified random sample of 2000 GPs in Switzerland in 2014. Method Survey development was informed by a previous qualitative exploration of relevant end-of-life GP competencies. Main outcome measures were GPs' assessment of the importance of and confidence in 18 attributes of end-of-life care competencies, and reasons for transferring care of terminally-ill patients to a specialist. GP characteristics associated with main outcome measures were tested using multivariate regression models. Results The response rate was 31%. Ninety-nine percent of GPs considered the recognition and treatment of pain as important, 86% felt confident about it. Few GPs felt confident in cultural (16%), spiritual (38%) and legal end-of-life competencies such as responding to patients seeking assisted suicide (35%) although more than half of the respondents regarded these competencies as important. Most frequent reasons to refer terminally ill patients to a specialist were lack of time (30%), better training of specialists (23%) and end-of-life care being incompatible with other duties (19%). In multiple regression analyses, confidence in end-of-life care was positively associated with GPs' age, practice size, home visits and palliative training. Conclusions GPs considered non-somatic competencies (such as spiritual, cultural, ethical and legal aspects) nearly as important as pain and symptom control. Yet, few GPs felt confident in these non-somatic competencies. These findings should inform training and quality improvement efforts in this domain, in particular for younger, less experienced GPs.	[Giezendanner, Stephanie; Jung, Corinna; Banderet, Hans-Ruedi; Bally, Klaus] Univ Basel, Ctr Primary Hlth Care, Basel, Switzerland; [Otte, Ina Carola; Elger, Bernice S.] Univ Basel, Inst Biomed Eth, Basel, Switzerland; [Gudat, Heike] Hosp Palliat Care, Hospiz Pk, Arlesheim, Basel District, Switzerland; [Haller, Dagmar M.] Univ Geneva, Primary Care Unit, Geneva, Switzerland; [Haller, Dagmar M.] Univ Melbourne, Dept Gen Practice, Melbourne, Vic, Australia; [Elger, Bernice S.] Univ Geneva, Ctr Legal Med, Geneva, Switzerland; [Zemp, Elisabeth] Univ Basel, Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Zemp, Elisabeth] Univ Basel, Basel, Switzerland	University of Basel; University of Basel; University of Geneva; University of Melbourne; University of Geneva; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Giezendanner, S (corresponding author), Univ Basel, Ctr Primary Hlth Care, Basel, Switzerland.	stephanie.giezendanner@unibas.ch	Elger, Bernice Simone/V-7265-2017; Haller, Dagmar M./AAA-5078-2021	Elger, Bernice Simone/0000-0002-4249-7399; Otte, Ina/0000-0003-0280-0899; Haller, Dagmar/0000-0003-1781-3318; Giezendanner, Stephanie/0000-0001-5660-9446	Swiss National Science Foundation [SNSF: 406740_139341]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by The Swiss National Science Foundation (http://www.snf.ch/D/Seiten/default.aspx) (SNSF: 406740_139341). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, SCHWEIZ ARZTEZTG, V90; Becker G, 2007, WIEN KLIN WOCHENSCHR, V119, P112, DOI 10.1007/s00508-006-0724-9; Blank RH, 2011, J LAW MED ETHICS, V39, P201, DOI 10.1111/j.1748-720X.2011.00589.x; Boerma W., 2003, PROFILES GEN PRACTIC; Borgsteede SD, 2006, BRIT J GEN PRACT, V56, P20; Brauer S, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14142; Claessen SJJ, 2011, J PAIN SYMPTOM MANAG, V42, P169, DOI 10.1016/j.jpainsymman.2010.10.267; Dale J, 2009, QUAL SAF HEALTH CARE, V18, P174, DOI 10.1136/qshc.2007.024836; De Roo ML, 2013, J PAIN SYMPTOM MANAG, V46, P556, DOI 10.1016/j.jpainsymman.2012.09.013; De Vleminck A, 2013, SCAND J PRIM HEALTH, V31, P215, DOI 10.3109/02813432.2013.854590; Dunn TJ, 2014, BRIT J PSYCHOL, V105, P399, DOI 10.1111/bjop.12046; EAPC Task Force on Medical Education, 2007, CURRICULUM IN PALLIA; Economist Intelligence Unit, 2010, RANK END OF LIF CAR, DOI [10.1111/1.1748-720X.2011.00589.x, DOI 10.1111/J.1748-720X.2011.00589.X]; Eychmuller S, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0485-0; Fletcher T. D., 2010, PSYCHOMETRIC APPL PS; Gamondi C., 2013, EUROPEAN J PALLIATIV, V20, P86; Garcia C, 2007, ARCH DERMATOL, V143, P120, DOI 10.1001/archderm.143.1.120-b; Georges JJ, 2008, J MED ETHICS, V34, P150, DOI 10.1136/jme.2007.020909; Gorlen T, 2012, DAN MED J, V59; Groot MM, 2005, PALLIATIVE MED, V19, P111, DOI 10.1191/0269216305pm937oa; Gysels M, 2012, J PAIN SYMPTOM MANAG, V44, P285, DOI 10.1016/j.jpainsymman.2011.09.013; HALLAM L, 1994, BRIT MED J, V308, P249, DOI 10.1136/bmj.308.6923.249; Hansford P, 2007, END LIFE CARE, V1, P56; Helena K, 2015, BMC MED ED, V15; Hirooka K, 2014, JPN J CLIN ONCOL, V44, P249, DOI 10.1093/jjco/hyt204; Hostettler S., 2015, SCHWEIZERISCHE ARZTE, V96, P462; Iversen T, 2011, INT J HEALTH CARE FI, V11, P245, DOI 10.1007/s10754-011-9101-y; Kelley K, 2012, METHODOLOGY; Kelley K, 2012, PSYCHOL METHODS, V17, P137, DOI 10.1037/a0028086; Koller M, 2011, COMPUT STAT DATA AN, V55, P2504, DOI 10.1016/j.csda.2011.02.014; Liddy C, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-22; Lynch T, 2013, J PAIN SYMPTOM MANAG, V45, P1094, DOI 10.1016/j.jpainsymman.2012.05.011; Marr L, 2007, J PALLIAT MED, V10, P169, DOI 10.1089/jpm.2006.0076.R1; McDonald RP, 1999, TEST THEORY UNIFIED; McGlade KJ, 2000, BRIT J GEN PRACT, V50, P794; Mitchell GK, 2011, AUST FAM PHYSICIAN, V40, P517; Mitchell GK, 2004, MED J AUSTRALIA, V180, P207, DOI 10.5694/j.1326-5377.2004.tb05885.x; O'Brien AP, 2012, ASIA-PAC J CLIN ONCO, V8, P3, DOI 10.1111/j.1743-7563.2011.01510.x; Pasman HRW, 2009, J PAIN SYMPTOM MANAG, V38, P145, DOI 10.1016/j.jpainsymman.2008.07.008; Pereira J, 2008, PALLIATIVE MED, V22, P730, DOI 10.1177/0269216308094560; Puchalski CM, 2004, CLIN GERIATR MED, V20, P689, DOI 10.1016/j.cger.2004.07.004; R Core Team, 2018, R LANG ENV STAT COMP; Revelle W., 2014, PSYCH PROCEDURES PER, V1; Rhee JJO, 2008, J PALLIAT MED, V11, P980, DOI 10.1089/jpm.2007.0251; Ruijs CDM, 2011, FAM PRACT, V28, P689, DOI 10.1093/fampra/cmr035; Schnakenberg R, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1257-1; Schweizer Arzteschaft (FMH), 2014, FMH ARZT; Selman L, 2016, BMJ SUPPORT PALLIAT, V6, P231, DOI 10.1136/bmjspcare-2015-000879; Shipman C, 2001, PALLIATIVE MED, V15, P191, DOI 10.1191/026921601678576176; Slort W, 2011, PALLIATIVE MED, V25, P613, DOI 10.1177/0269216310395987; Steinhauser K. E., 2000, JAMA, V284; Theile G, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-24; Todorov V, 2009, J STAT SOFTW, V32, P1; Trizano-Hermosilla I, 2016, BEST ALTERNATIVES CR; van den Berg Michael J, 2006, BMC Fam Pract, V7, P58, DOI 10.1186/1471-2296-7-58; van den Brink-Muinen A, 2003, FAM PRACT, V20, P478, DOI 10.1093/fampra/cmg426; Vermandere M, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X606663; Wasner M, 2005, PALLIATIVE MED, V19, P99, DOI 10.1191/0269216305pm995oa; YOHAI VJ, 1987, ANN STAT, V15, P642, DOI 10.1214/aos/1176350366	59	23	23	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0170168	10.1371/journal.pone.0170168	http://dx.doi.org/10.1371/journal.pone.0170168			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6RS	28146566	Green Published, gold, Green Submitted			2022-12-27	WOS:000396131700015
J	Boniface, S; Scholes, S; Shelton, N; Connor, J				Boniface, Sadie; Scholes, Shaun; Shelton, Nicola; Connor, Jennie			Assessment of Non-Response Bias in Estimates of Alcohol Consumption: Applying the Continuum of Resistance Model in a General Population Survey in England	PLOS ONE			English	Article							NON-RESPONDENTS; HEALTH SURVEYS; FOLLOW-UP; DRINKING; PARTICIPANTS; SAMPLE	Background Previous studies have shown heavier drinkers are less likely to respond to surveys and require extended efforts to recruit. This study applies the continuum of resistance model to explore how survey estimates of alcohol consumption may be affected by non-response bias in three consecutive years of a general population survey in England. Methods Using the Health Survey for England (HSE) survey years 2011-13, number of contact attempts (1-6 and 7+) were explored by socio-demographic and drinking characteristics. The odds of drinking more than various thresholds were modelled using logistic regression. Assuming that non-participants were similar to those who were difficult to contact (the continuum of resistance model), the effect of non-response on measures of drinking was investigated. Results In the fully-adjusted regression model, women who required 7+ calls were significantly more likely to drink more than the UK Government's recommended daily limit (OR 1.19, 95% CI 1.06-1.33, P = 0.003) and to engage in heavy episodic drinking (OR 1.23, 95% CI 1.07-1.42, P = 0.004), however this was not significant in men in the fully-adjusted model. When the continuum of resistance model was applied, there was an increase in average weekly alcohol consumption of 1.8 units among men (a 12.6% relative increase), and an increase of 1.5 units among women (a 20.5% relative increase). There was also an increase in the prevalence of heavy episodic drinking of 2.5% among men (an 12.0% relative increase) and of 2.0% among women (a 15.8% relative increase), although other measures of drinking were less affected. Conclusion Overall alcohol consumption and the prevalence of heavy episodic drinking were higher among HSE participants who required more extended efforts to contact. The continuum of resistance model suggests non-response bias does affect survey estimates of alcohol consumption.	[Boniface, Sadie] Kings Coll London, Inst Psychiat Psychol & Neurosci, Natl Addict Ctr, London, England; [Scholes, Shaun; Shelton, Nicola] UCL, Res Dept Epidemiol & Publ Hlth, London, England; [Connor, Jennie] Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand	University of London; King's College London; University of London; University College London; University of Otago	Boniface, S (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Natl Addict Ctr, London, England.	sadie.boniface@kcl.ac.uk	; Boniface, Sadie/J-8713-2015	Scholes, Shaun/0000-0002-7865-5264; Boniface, Sadie/0000-0003-3492-6402				Boniface S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1297; Caetano R, 2003, ADDICTION, V98, P791, DOI 10.1046/j.1360-0443.2003.00407.x; Craig R, 2013, HLTH SURVEY ENGLAND, V2; Craig R., 2012, HLTH SURVEY ENGLAND, V2; Craig R, 2014, HLTH SURVEY ENGLAND, V2; CRAWFORD A, 1987, ALCOHOL ALCOHOLISM, V22, P167; Dawson DA, 2014, J STUD ALCOHOL DRUGS, V75, P695, DOI 10.15288/jsad.2014.75.695; Fuller E, 2013, HLTH SURVEY ENGLAND; Gmel G, 2000, ADDICTION, V95, P123, DOI 10.1046/j.1360-0443.2000.95112313.x; Goddard E, 2001, NATL STAT METHODOLOG, V24; Gorman E, 2014, AM J EPIDEMIOL, V180, P941, DOI 10.1093/aje/kwu207; Gray L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002647; Jousilahti P, 2005, J EPIDEMIOL COMMUN H, V59, P310, DOI 10.1136/jech.2004.024349; Kypri K, 2004, ALCOHOL CLIN EXP RES, V28, P630, DOI 10.1097/01.ALC.0000121654.99277.26; Kypri K, 2011, PREV MED, V53, P274, DOI 10.1016/j.ypmed.2011.07.017; Lahaut VMHCJ, 2002, ALCOHOL ALCOHOLISM, V37, P256, DOI 10.1093/alcalc/37.3.256; Lahaut VMHCJ, 2003, ALCOHOL ALCOHOLISM, V38, P128, DOI 10.1093/alcalc/agg044; LEMMENS PHHM, 1988, BRIT J ADDICT, V83, P1069; LIN IF, 1995, PUBLIC OPIN QUART, V59, P236, DOI 10.1086/269471; Lynn P, 2002, J ROY STAT SOC D-STA, V51, P319, DOI 10.1111/1467-9884.00321; Meiklejohn J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035527; Messiah A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005791; Mindell J, 2012, INT J EPIDEMIOL, V41, P1585, DOI 10.1093/ije/dyr199; ROWLAND ML, 1993, PUBLIC HEALTH REP, V108, P380; Schneider K. L., 2010, J EPIDEMIOLOGY COMMU, V66, P290, DOI DOI 10.1136/JECH.2009.103861; Studer J, 2013, DRUG ALCOHOL DEPEN, V132, P316, DOI 10.1016/j.drugalcdep.2013.02.029; Wild TC, 2001, J STUD ALCOHOL, V62, P257, DOI 10.15288/jsa.2001.62.257; WILSON P, 1981, STATISTICIAN, V30, P159, DOI 10.2307/2988046; Zhao JH, 2009, DRUG ALCOHOL REV, V28, P648, DOI 10.1111/j.1465-3362.2009.00077.x	29	26	26	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170892	10.1371/journal.pone.0170892	http://dx.doi.org/10.1371/journal.pone.0170892			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6QW	28141834	Green Published, Green Submitted, gold			2022-12-27	WOS:000396129500023
J	Fujita, S; Tanaka, S; Maeda, D; Morita, H; Fujisaka, T; Takeda, Y; Ito, T; Ishizaka, N				Fujita, Shu-ichi; Tanaka, Suguru; Maeda, Daichi; Morita, Hideaki; Fujisaka, Tomohiro; Takeda, Yoshihiro; Ito, Takahide; Ishizaka, Nobukazu			Serum Soluble Urokinase-Type Plasminogen Activator Receptor Is Associated with Low Left Ventricular Ejection Fraction and Elevated Plasma Brain-Type Natriuretic Peptide Level	PLOS ONE			English	Article							HEART-FAILURE; INFLAMMATION; DISEASE; SUPAR; HYPERTROPHY; CANCER; PROGRESSION; POPULATION; ARTHRITIS	Background Recent studies have suggested that soluble urokinase plasminogen activator receptor (suPAR), a biomarker of subclinical levels of inflammation, is significantly correlated with cardiovascular events. Purpose We investigated the association between suPAR and left ventricular ejection fraction (LVEF), left ventricular mass index (LVMI), and plasma B-type natriuretic peptide (BNP) among cardiac inpatients. Methods and Results In total, 242 patients (mean age 71.3 +/- 9.8 years; 70 women) admitted to the cardiology department were enrolled in the study. suPAR was significantly correlated with LVEF (R = -0.24, P<0.001), LVMI (R = 0.16, P = 0.014) and BNP (R = 0.46, P<0.001). In logistic regression analysis, the highest suPAR tertile (> 3236 pg/mL) was associated with low LVEF (< 50%) and elevated BNP (> 300 pg/mL) with an odds ratio of 3.84 (95% confidence interval [CI], 1.22-12.1) and 5.36 (95% CI, 1.32-21.8), respectively, after adjusting for age, sex, log-transformed estimated glomerular filtration rate (log(eGFR)), C-reactive protein, and diuretic use. The association between suPAR and LVMI was not statistically significant. In multivariate receiver operating characteristic analysis, addition of log(suPAR) to the combination of age, sex, log(eGFR) and CRP incrementally improved the prediction of low LVEF (area under the curve [AUC], 0.827 to 0.852, P = 0.046) and BNP >= 300 pg/mL (AUC, 0.869 to 0.906; P = 0.029). Conclusions suPAR was associated with low LVEF and elevated BNP, but not with left ventricular hypertrophy, independent of CRP, renal function, and diuretic use among cardiac inpatients who were not undergoing chronic hemodialysis.	[Fujita, Shu-ichi; Tanaka, Suguru; Maeda, Daichi; Morita, Hideaki; Fujisaka, Tomohiro; Takeda, Yoshihiro; Ito, Takahide; Ishizaka, Nobukazu] Osaka Med Coll, Dept Cardiol, Osaka, Japan	Osaka Medical College	Ishizaka, N (corresponding author), Osaka Med Coll, Dept Cardiol, Osaka, Japan.	ishizaka@osaka-med.ac.jp			Ministry of Education, Science, and Culture of Japan [15K09106]	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants in Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan (No. 15K09106).	Borne Y, 2014, EUR J HEART FAIL, V16, P377, DOI 10.1002/ejhf.49; Briasoulis A, 2016, HEART FAIL REV, V21, P169, DOI 10.1007/s10741-016-9533-z; Cook AD, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2946; DEVEREUX RB, 1977, CIRCULATION, V55, P613, DOI 10.1161/01.CIR.55.4.613; Eapen DJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001118; Edsfeldt A, 2012, STROKE, V43, P3305, DOI 10.1161/STROKEAHA.112.664094; Gyetko MR, 2002, J IMMUNOL, V168, P801, DOI 10.4049/jimmunol.168.2.801; Hahm E, 2016, NAT MED; Han B, 2005, ONCOL REP, V14, P105; Hayek SS, 2015, NEW ENGL J MED, V373, P1916, DOI 10.1056/NEJMoa1506362; Hodges GW, 2015, CAN J CARDIOL, V31, P1293, DOI 10.1016/j.cjca.2015.03.023; Hsu PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049100; Kaneko T, 2003, CANCER SCI, V94, P43, DOI 10.1111/j.1349-7006.2003.tb01350.x; Kruger R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058506; Li L, 2010, MOL CELL BIOCHEM, V342, P183, DOI 10.1007/s11010-010-0482-x; Lyngbaek S, 2013, INT J CARDIOL, V167, P2904, DOI 10.1016/j.ijcard.2012.07.018; Marechaux S, 2016, J CARD FAIL, V22, P3, DOI 10.1016/j.cardfail.2015.09.003; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mehta SK, 2007, HYPERTENSION, V49, P1385, DOI 10.1161/HYPERTENSIONAHA.107.087890; Mekonnen G, 2015, ATHEROSCLEROSIS, V239, P55, DOI 10.1016/j.atherosclerosis.2014.12.025; Nakagomi A, 2012, CIRC J, V76, P2130, DOI 10.1253/circj.CJ-11-1123; Persson M, 2012, ATHEROSCLEROSIS, V220, P502, DOI 10.1016/j.atherosclerosis.2011.10.039; Pliyev BK, 2010, INFLAMMATION, V33, P1, DOI 10.1007/s10753-009-9152-0; Roman MJ, 1996, J AM COLL CARDIOL, V28, P751, DOI 10.1016/0735-1097(96)00225-2; Schulz CA, 2016, SOLUBLE UROKINASE TY; Sola S, 2006, J AM COLL CARDIOL, V47, P332, DOI 10.1016/j.jacc.2005.06.088; Sorensen MH, 2014, ATHEROSCLEROSIS, V237, P60, DOI 10.1016/j.atherosclerosis.2014.08.035; Steins MB, 2004, BLOOD COAGUL FIBRIN, V15, P383, DOI 10.1097/01.mbc.0000114441.59147.56; Theilade S, 2016, EUR J ENDOCRINOL, V174, P745, DOI 10.1530/EJE-15-0986; van der Walt C, 2013, HEART LUNG CIRC, V22, P924, DOI 10.1016/j.hlc.2013.03.075; Wachtell K, 2000, HYPERTENSION, V35, P6, DOI 10.1161/01.HYP.35.1.6; Yndestad A, 2006, HEART FAIL REV, V11, P83, DOI 10.1007/s10741-006-9196-2	32	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170546	10.1371/journal.pone.0170546	http://dx.doi.org/10.1371/journal.pone.0170546			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135310	gold, Green Published, Green Submitted			2022-12-27	WOS:000396124700015
J	Liu, X; Zhang, RS; Liu, QD				Liu, Xin; Zhang, Ruisheng; Liu, Qidong			A Temporal Credential-Based Mutual Authentication with Multiple-Password Scheme for Wireless Sensor Networks	PLOS ONE			English	Article							2-FACTOR USER AUTHENTICATION; MASS-STORAGE DEVICES; CONTROL PROTOCOL; KEY AGREEMENT; SECURITY; CRYPTANALYSIS; CRYPTOGRAPHY; ATTACKS; SERVICE; HWANG	Wireless sensor networks (WSNs), which consist of a large number of sensor nodes, have become among the most important technologies in numerous fields, such as environmental monitoring, military surveillance, control systems in nuclear reactors, vehicle safety systems, and medical monitoring. The most serious drawback for the widespread application of WSNs is the lack of security. Given the resource limitation of WSNs, traditional security schemes are unsuitable. Approaches toward withstanding related attacks with small overhead have thus recently been studied by many researchers. Numerous studies have focused on the authentication scheme for WSNs, but most of these works cannot achieve the security performance and overhead perfectly. Nam et al. proposed a two-factor authentication scheme with lightweight sensor computation for WSNs. In this paper, we review this scheme, emphasize its drawbacks, and propose a temporal credential-based mutual authentication with a multiple-password scheme for WSNs. Our scheme uses multiple passwords to achieve three-factor security performance and generate a session key between user and sensor nodes. The security analysis phase shows that our scheme can withstand related attacks, including a lost password threat, and the comparison phase shows that our scheme involves a relatively small overhead. In the comparison of the overhead phase, the result indicates that more than 95% of the overhead is composed of communication and not computation overhead. Therefore, the result motivates us to pay further attention to communication overhead than computation overhead in future research.	[Liu, Xin; Zhang, Ruisheng; Liu, Qidong] Lanzhou Univ, Sch Informat Sci & Engn, Lanzhou, Peoples R China	Lanzhou University	Zhang, RS (corresponding author), Lanzhou Univ, Sch Informat Sci & Engn, Lanzhou, Peoples R China.	zhangrs@lzu.edu.cn	Liu, Qidong/GNM-7428-2022	Zhang, Ruisheng/0000-0002-6585-2656				Akyildiz IF, 2002, IEEE COMMUN MAG, V40, P102, DOI 10.1109/MCOM.2002.1024422; Amin R, 2016, AD HOC NETW, V36, P58, DOI 10.1016/j.adhoc.2015.05.020; Atzori L, 2010, COMPUT NETW, V54, P2787, DOI 10.1016/j.comnet.2010.05.010; Bakhtiari S., 1995, CRYPTOGRAPHIC HASH F; Bellare M, 2000, LECT NOTES COMPUT SC, V1807, P139; Bellare M, 1995, P 27 ANN ACM S THEOR; Bellare M, 2012, AUTHENTICATED KEY EX; Bellare M, 1993, INT CRYPT C ADV CRYP; Bonneau Joseph, 2012, 2012 IEEE S SEC PRIV; Brouwer AE, 1999, LECT NOTES COMPUT SC, V1716, P321; Burrows M, 1989, P ROYAL SOC LOND MAT; Camaraa C, SECURITY PRIVACY ISS; Cayirci E., 2008, SECURITY WIRELESS AD; Chatterjee K, 2015, WIRELESS PERS COMMUN, V81, P17, DOI 10.1007/s11277-014-2115-2; Chong CY, 2003, P IEEE, V91, P1247, DOI 10.1109/JPROC.2003.814918; Choo K.-K. R., 2004, Security in Communication Networks. 4th International Conference, SCN 2004. Revised Selected Papers (Lecture Notes in Computer Science Vol.3352), P351; Choo KKR, 2006, INFORMATICA-LITHUAN, V17, P467; Choo KKR, 2006, COMPUT COMMUN, V29, P2788, DOI 10.1016/j.comcom.2005.10.030; Choo KKR, 2014, INFORM SCIENCES, V281, P182, DOI 10.1016/j.ins.2014.05.041; Choo KKR, 2005, SECURITY REQUIREMENT, P429; Choo KKR., 1993, COMPUT J, V773, P110; Choo KKR, 2005, SESSION KEY CONSTRUC, P116; Choo KKR, 2005, ERRORS COMPUTATIONAL, P624; Choo KKR, 2005, EXAMINING INDISTINGU, P585; Choo KKR, 2004, IFIP ADV INFORM COMM, V173, P129; Choo KKR., 2008, ADV INFORM SECURITY, P41; Das ML, 2006, COMPUT SECUR, V25, P184, DOI 10.1016/j.cose.2005.09.002; Das ML, 2009, IEEE T WIREL COMMUN, V8, P1086, DOI 10.1109/TWC.2008.080128; Delac K., 2004, EL MAR 2004 P ELM 20; Delgado-Mohatar O, 2011, AD HOC NETW, V9, P727, DOI 10.1016/j.adhoc.2010.08.020; demgard IB, 1990, ADV CRYPTOLOGY CRYPT; DIFFIE W, 1976, IEEE T INFORM THEORY, V22, P644, DOI 10.1109/TIT.1976.1055638; Eschenauer L., 2002, CCS; Ge M, 2014, INT C NETW SYST SEC; Ge MM, 2016, J NETW COMPUT APPL, V63, P24, DOI 10.1016/j.jnca.2016.01.012; Giri D, 2015, J MED SYST, V39, DOI [10.1007/s10916-014-0145-7, 10.1007/s10916-015-0262-y]; Goodrich M. T., 2011, INTRO COMPUTER SECUR; He D, 2015, INFORM SCI; He DB, 2014, IEEE T CONSUM ELECTR, V60, P30, DOI 10.1109/TCE.2014.6780922; Javidi B, 1999, OPT ENG, V38, P9, DOI 10.1117/1.602074; jia C., 2008, WIRELESS SENSOR NETW; Jiang Q, 2015, PEER PEER NETW APPL, V8, P1070, DOI 10.1007/s12083-014-0285-z; Khan MK, 2010, SENSORS-BASEL, V10, P2450, DOI 10.3390/s100302450; Kocher P., 1999, ADV CRYPTOLOGY CRYPT; Krawczyk H., 1997, HMAC KEYED HASHING M; Kumar J. Sathish, 2014, INT J COMPUTER APPL, V90; Lee CC, 2013, IET COMPUT DIGIT TEC, V7, P48, DOI 10.1049/iet-cdt.2012.0073; Li CS, 2011, J STAT COMPUT SIM, V81, P1081, DOI 10.1080/00949651003677410; Liu X, 2013, SENS NETW SEC TECHN; Ma C., 2012, KEY MANAGEMENT HETER, P206; Matthews T, 2012, COMPUT FRAUD SECUR, P18, DOI 10.1016/S1361-3723(12)70044-1; Maymounkov P, 2002, LECT NOTES COMPUT SC, V2429, P53; Messerges TS, 2002, IEEE T COMPUT, V51, P541, DOI 10.1109/TC.2002.1004593; Miorandi D, 2012, AD HOC NETW, V10, P1497, DOI 10.1016/j.adhoc.2012.02.016; Mitnick K., 2011, GHOST WIRES MY ADVEN; Mitnick Kevin D., 2011, ART DECEPTION CONTRO; MORRIS R, 1979, COMMUN ACM, V22, P594, DOI 10.1145/359168.359172; Nam J, 2015, EFFICIENT ANONYMOUS; Nam J, 2013, INT J SECUR APPL, V7, P47; Newsome J., 2004, P 3 INT S INF PROC S; Nguyen K. T., 2015, SURVEY SECURE COMMUN; O'Gorman L, 2003, P IEEE, V91, P2021, DOI 10.1109/JPROC.2003.819611; Padmavathi D.G., 2009, IJCSIS INT J COMPUTE, V4, P4063; Perrig A, 2004, COMMUN ACM, V47, P53, DOI 10.1145/990680.990707; Perrig A, 2002, WIREL NETW, V8, P521, DOI 10.1023/A:1016598314198; PUB F., 1995, PUBLIC LAW, V100, P235; Raymond DR, 2008, IEEE PERVAS COMPUT, V7, P74, DOI 10.1109/MPRV.2008.6; Rogaway P, 2004, FAST SOFTWARE ENCRYP; Roman R, 2011, COMPUT ELECTR ENG, V37, P147, DOI 10.1016/j.compeleceng.2011.01.009; Schneier B., 2007, APPL CRYPTOGRAPHY PR; Subashini S, 2011, J NETW COMPUT APPL, V34, P1, DOI 10.1016/j.jnca.2010.07.006; Sun DZ, 2013, PERS UBIQUIT COMPUT, V17, P895, DOI 10.1007/s00779-012-0540-3; Wang D, 2015, PRESERVING PRIVACY F; Wang D, 2014, AD HOC NETW, V20, P1, DOI 10.1016/j.adhoc.2014.03.003; Wang Y, 2006, SURVEY SECURITY ISSU; Watro R.J., 2004, ACM WORKSH SEC AD HO; Wong KH, 2006, SENS NETW UB TRUSTW; Xue KP, 2013, J NETW COMPUT APPL, V36, P316, DOI 10.1016/j.jnca.2012.05.010; Yang CN, 2014, IEEE T CIRC SYST VID, V24, P189, DOI 10.1109/TCSVT.2013.2276708; Yang G, 2010, SECURITY WIRELESS SE; Yuan JJ, 2014, TELECOMMUN SYST, V55, P105, DOI 10.1007/s11235-013-9755-5; Zeng P, 2010, IEEE T CONSUM ELECTR, V56, P566, DOI 10.1109/TCE.2010.5505971; Zeng P, 2009, IEEE COMMUN LETT, V13, P426, DOI 10.1109/LCOMM.2009.082215; Zhang N, 2010, RES WIRELESS SENSOR; Zhao ZG, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0013-5; Zhou J, 2015, INFORM SCIENCES, V314, P255, DOI 10.1016/j.ins.2014.09.003	86	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170657	10.1371/journal.pone.0170657	http://dx.doi.org/10.1371/journal.pone.0170657			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135288	Green Published, Green Submitted, gold			2022-12-27	WOS:000396124700016
J	Waiho, K; Fazhan, H; Shahreza, MS; Moh, JHZ; Noorbaiduri, S; Wong, LL; Sinnasamy, S; Ikhwanuddin, M				Waiho, Khor; Fazhan, Hanafiah; Shahreza, Md Sheriff; Zhong Moh, Julia Hwei; Noorbaiduri, Shaibani; Wong, Li Lian; Sinnasamy, Saranya; Ikhwanuddin, Mhd			Transcriptome Analysis and Differential Gene Expression on the Testis of Orange Mud Crab, Scylla olivacea, during Sexual Maturation	PLOS ONE			English	Article							CHINESE MITTEN CRAB; SINGLE NUCLEOTIDE POLYMORPHISMS; SHRIMP LITOPENAEUS-VANNAMEI; FRESH-WATER PRAWN; VASA-LIKE GENE; HYPERGLYCEMIC HORMONE; OVARIAN MATURATION; ERIOCHEIR-SINENSIS; WHITE SHRIMP; KURUMA PRAWN	Adequate genetic information is essential for sustainable crustacean fisheries and aqua-culture management. The commercially important orange mud crab, Scylla olivacea, is prevalent in Southeast Asia region and is highly sought after. Although it is a suitable aqua-culture candidate, full domestication of this species is hampered by the lack of knowledge about the sexual maturation process and the molecular mechanisms behind it, especially in males. To date, data on its whole genome is yet to be reported for S. olivacea. The available transcriptome data published previously on this species focus primarily on females and the role of central nervous system in reproductive development. De novo transcriptome sequencing for the testes of S. olivacea from immature, maturing and mature stages were performed. A total of approximately 144 million high-quality reads were generated and de novo assembled into 160,569 transcripts with a total length of 142.2 Mb. Approximately 15-23% of the total assembled transcripts were annotated when compared to public protein sequence databases (i. e. UniProt database, Interpro database, Pfam database and Drosophila melanogaster protein database), and GO-categorised with GO Ontology terms. A total of 156,181 high-quality Single-Nucleotide Polymorphisms (SNPs) were mined from the transcriptome data of present study. Transcriptome comparison among the testes of different maturation stages revealed one gene (beta crystallin like gene) with the most significant differential expression-up-regulated in immature stage and down-regulated in maturing and mature stages. This was further validated by qRT-PCR. In conclusion, a comprehensive transcriptome of the testis of orange mud crabs from different maturation stages were obtained. This report provides an invaluable resource for enhancing our understanding of this species' genome structure and biology, as expressed and controlled by their gonads.	[Waiho, Khor; Fazhan, Hanafiah; Shahreza, Md Sheriff; Zhong Moh, Julia Hwei; Noorbaiduri, Shaibani; Wong, Li Lian; Ikhwanuddin, Mhd] Univ Malaysia Terengganu, Inst Trop Aquaculture, Kuala Terengganu, Terengganu, Malaysia; [Shahreza, Md Sheriff] Univ Malaysia Terengganu, Sch Fisheries & Aquaculture Sci, Kuala Terengganu, Terengganu, Malaysia; [Sinnasamy, Saranya] Univ Malaysia Terengganu, Inst Marine Biotechnol, Kuala Terengganu, Terengganu, Malaysia	Universiti Malaysia Terengganu; Universiti Malaysia Terengganu; Universiti Malaysia Terengganu	Waiho, K; Ikhwanuddin, M (corresponding author), Univ Malaysia Terengganu, Inst Trop Aquaculture, Kuala Terengganu, Terengganu, Malaysia.	waihokhor@gmail.com; ikhwanuddin@umt.edu.my	Wong, Li Lian/AAG-5568-2020; Waiho, Khor/W-6655-2019; WONG, LI LIAN/ABE-1887-2022; Ikhwanuddin, Mhd/L-9136-2019; Fazhan, Hanafiah/I-7329-2018; Fazhan, Hanafiah/J-3553-2019	Wong, Li Lian/0000-0001-9045-4556; Waiho, Khor/0000-0002-2632-3612; Ikhwanuddin, Mhd/0000-0002-6430-0876; Fazhan, Hanafiah/0000-0002-5497-9723; Fazhan, Hanafiah/0000-0002-5497-9723	Ministry of Education Malaysia [53131]	Ministry of Education Malaysia(Ministry of Education, Malaysia)	Support for this project was provided by the Ministry of Education Malaysia (http://www.moe.gov.my/en/home)) under the Niche Research Grant Scheme (NRGS) (grant number: 53131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflalo ED, 2007, MOL REPROD DEV, V74, P172, DOI 10.1002/mrd.20622; Alberts-Hubatsch H, 2015, HYDROBIOLOGIA; Albrechtsen A, 2016, MAR GENOMICS IN PRES; Anbarasu M, 2013, TURK J BIOL, V37, P507, DOI 10.3906/biy-1203-59; Aquiloni L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050047; Badisco L, 2007, GEN COMP ENDOCR, V153, P64, DOI 10.1016/j.ygcen.2007.03.008; Bao CC, 2015, SCI REP-UK, V5, DOI 10.1038/srep17055; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bray W.A., 1992, Developments in Aquaculture and Fisheries Science, V23, P93; Chang ES, 2001, AM ZOOL, V41, P380, DOI 10.1668/0003-1569(2001)041[0380:CHHFOP]2.0.CO;2; Chen XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073218; Christie AE, 2016, GEN COMP ENDOCR, V230, P1, DOI 10.1016/j.ygcen.2016.03.008; Christie AE, 2010, CELL MOL LIFE SCI, V67, P4135, DOI 10.1007/s00018-010-0482-8; Chung JS, 1999, P NATL ACAD SCI USA, V96, P13103, DOI 10.1073/pnas.96.23.13103; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cui J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092502; Cui ZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082156; Cunningham TJ, 2015, REJUV RES, V18, P136, DOI 10.1089/rej.2014.1620; DEJONG WW, 1989, TRENDS BIOCHEM SCI, V14, P365, DOI 10.1016/0968-0004(89)90009-1; DJAKIEW D, 1994, BIOL REPROD, V51, P214, DOI 10.1095/biolreprod51.2.214; Duffy DM, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-131; DuPrey KM, 2007, MOL VIS, V13, P366; Gao J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-585; Gao Q, 2014, BIOCHEM BIOPH RES CO, V453, P37, DOI 10.1016/j.bbrc.2014.09.049; Ghaffari N, 2014, SCI REP-UK, V4, DOI 10.1038/srep07081; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hale MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-203; Hara Y, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2007-1; Harms L, 2013, COMP BIOCHEM PHYS D, V8, P344, DOI 10.1016/j.cbd.2013.09.004; Haussmann IU, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1938; He L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033735, 10.1371/journal.pone.0045607]; Hopkins P.M., 2009, ECDYSONE STRUCTURES, P73, DOI DOI 10.1007/978-1-4020-9112-4_3; Hsu YWA, 2006, J EXP BIOL, V209, P3241, DOI 10.1242/jeb.02372; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang XS, 2014, ANIM REPROD SCI, V150, P139, DOI 10.1016/j.anireprosci.2014.09.004; Ikhwanuddin M, 2011, FISH RES, V108, P299, DOI 10.1016/j.fishres.2011.01.001; Jin SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076840; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; Keenan CP, 1998, RAFFLES B ZOOL, V46, P217; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; Konczal M, 2014, MOL ECOL RESOUR, V14, P381, DOI 10.1111/1755-0998.12186; Kornthong N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115867; Kornthong N, 2014, MICROSC RES TECHNIQ, V77, P189, DOI 10.1002/jemt.22327; LeBlanc GA, 2007, ECOTOXICOLOGY, V16, P61, DOI 10.1007/s10646-006-0115-z; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li CJ, 2013, REPRODUCTION, V145, pR89, DOI 10.1530/REP-12-0466; Li E, 2014, POULT FISH WILDL SCI, V2, P2; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YJ, 2014, DEV BIOL, V394, P129, DOI 10.1016/j.ydbio.2014.07.016; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Luo H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152572; Lv JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094055; Ma HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102668; Magabo KS, 2000, INVEST OPHTH VIS SCI, V41, P3056; Mantione KJ, 2014, MED SCI MONIT BASIC, V20, P138, DOI 10.12659/MSMBR.892101; Meng XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128659; MOREAU R, 1988, ARCH INSECT BIOCHEM, V8, P135, DOI 10.1002/arch.940080207; Morton BR, 2006, GENETICS, V172, P569, DOI 10.1534/genetics.105.049916; Muller D, 2006, HISTOCHEM CELL BIOL, V126, P199, DOI 10.1007/s00418-006-0155-8; Nagaraju GPC, 2011, J EXP BIOL, V214, P3, DOI 10.1242/jeb.047183; Nakkrasae LI, 2007, MOL REPROD DEV, V74, P835, DOI 10.1002/mrd.20680; Nguyen MT, 2010, AQUACULTURE, V301, P7, DOI 10.1016/j.aquaculture.2010.02.001; Oda S, 2005, CHEMOSPHERE, V61, P1168, DOI 10.1016/j.chemosphere.2005.02.075; Ozhan-Kizil G, 2009, DEV BIOL, V327, P230, DOI 10.1016/j.ydbio.2008.10.028; Pervaiz PA, 2014, J ENVIRON BIOL, V35, P821; Pervaiz Pervaiz Ahmed, 2011, World Journal of Zoology, V6, P159; Prasertlux S, 2010, AQUACULTURE, V308, pS83, DOI 10.1016/j.aquaculture.2010.06.038; Qiao H, 2015, GENET MOL RES, V14, P2041, DOI 10.4238/2015.March.20.14; Raz E, 2000, GENOME BIOL, V1, P1, DOI [10.1186/gb-2000-1-3-reviews1017, DOI 10.1186/GB-2000-1-3-REVIEWS1017]; Renaut S, 2010, MOL ECOL, V19, P115, DOI 10.1111/j.1365-294X.2009.04477.x; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosly HAAM, 2013, MOL BIOL REP, V40, P6407, DOI 10.1007/s11033-013-2755-4; Salem M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036264; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen HS, 2015, J WORLD AQUACULT SOC, V46, P421, DOI 10.1111/jwas.12207; Simeo CG, 2011, INVERTEBR REPROD DEV, V55, P91, DOI 10.1080/07924259.2011.553406; SPAZIANI EP, 1993, J COMP PHYSIOL B, V163, P541, DOI 10.1007/BF00302112; Sumiya E, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0060-2; Sun FY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068452; Sweeney AM, 2007, THESIS DUKE U DURHAM; Tagmount A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009327; Tahara D, 2004, COMP BIOCHEM PHYS A, V137, P631, DOI 10.1016/j.cbpb.2003.12.005; Tahara D, 2003, AQUACULTURE, V220, P791, DOI 10.1016/S0044-8486(02)00402-7; Vaca AA, 2000, AQUACULTURE, V182, P373, DOI 10.1016/S0044-8486(99)00267-7; Veenstra JA, 2010, INSECT BIOCHEM MOLEC, V40, P354, DOI 10.1016/j.ibmb.2010.03.001; Vera M, 2013, INT J MOL SCI, V14, P5694, DOI 10.3390/ijms14035694; Waiho K, CRUSTACEANA IN PRESS; Waiho K, 2015, AQUACULT REP, V2, P50, DOI 10.1016/j.aqrep.2015.08.004; Waiho K, 2016, MAR BIOL RES, V12, P726, DOI 10.1080/17451000.2016.1200726; Walton ME, 2006, ESTUAR COAST SHELF S, V66, P493, DOI 10.1016/j.ecss.2005.09.015; Wang Q, 2012, J INSECT PHYSIOL, V58, P960, DOI 10.1016/j.jinsphys.2012.04.012; Wang RJ, 2012, FRESHW SCI, V31, P695, DOI 10.1899/11-149.1; Wang YL, 2012, MOL BIOL REP, V39, P4327, DOI 10.1007/s11033-011-1220-5; Wimuttisuk W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076934; Xu CX, 2015, SCI REP-UK, V5, DOI 10.1038/srep17706; Xu J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048140, 10.1371/journal.pone.0029552]; Yang SP, 2014, FEBS OPEN BIO, V4, P976, DOI 10.1016/j.fob.2014.09.005; Zhang EF, 2010, DEV GENES EVOL, V220, P151, DOI 10.1007/s00427-010-0336-2; Zhang SD, 2005, BIOINFORMATICS, V21, P4378, DOI 10.1093/bioinformatics/bti717; Zhang W, 2011, GENET MOL BIOL, V34, P136, DOI 10.1590/S1415-47572010005000099; Zhou QR, 2010, CHIN J OCEANOL LIMN, V28, P37, DOI 10.1007/s00343-010-9231-y	104	38	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171095	10.1371/journal.pone.0171095	http://dx.doi.org/10.1371/journal.pone.0171095			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135340	Green Published, gold, Green Submitted			2022-12-27	WOS:000396124700048
J	Lieberman-Cribbin, W; Liu, B; Schneider, S; Schwartz, R; Taioli, E				Lieberman-Cribbin, Wil; Liu, Bian; Schneider, Samantha; Schwartz, Rebecca; Taioli, Emanuela			Self-Reported and FEMA Flood Exposure Assessment after Hurricane Sandy: Association with Mental Health Outcomes	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; PSYCHOLOGICAL DISTRESS; PSYCHOMETRIC PROPERTIES; NATURAL DISASTER; PTSD CHECKLIST; GULF-COAST; KATRINA; IMPACT; SURVIVORS; SYMPTOMATOLOGY	Hurricane Sandy caused extensive physical and economic damage; the long-term mental health consequences are unknown. Flooding is a central component of hurricane exposure, influencing mental health through multiple pathways that unfold over months after flooding recedes. Here we assess the concordance in self-reported and Federal Emergency Management (FEMA) flood exposure after Hurricane Sandy and determine the associations between flooding and anxiety, depression, and post-traumatic stress disorder (PTSD). Self-reported flood data and mental health symptoms were obtained through validated questionnaires from New York City and Long Island residents (N = 1231) following Sandy. Self-reported flood data was compared to FEMA data obtained from the FEMA Modeling Task Force Hurricane Sandy Impact Analysis. Multivariable logistic regressions were performed to determine the relationship between flooding exposure and mental health outcomes. There were significant discrepancies between self-reported and FEMA flood exposure data. Self-reported dichotomous flooding was positively associated with anxiety (ORadj: 1.5 [95% CI: 1.1-1.9]), depression (ORadj: 1.7 [1.3-2.2]), and PTSD (ORadj: 2.5 [1.8-3.4]), while self-reported continuous flooding was associated with depression (ORadj: 1.1 [1.01-1.12]) and PTSD (ORadj: 1.2 [1.1-1.2]). Models with FEMA dichotomous flooding (ORadj: 2.1 [1.5-2.8]) or FEMA continuous flooding (ORadj: 1.1 [1.1-1.2]) were only significantly associated with PTSD. Associations between mental health and flooding vary according to type of flood exposure measure utilized. Future hurricane preparedness and recovery efforts must integrate micro and macro-level flood exposures in order to accurately determine flood exposure risk during storms and realize the long-term importance of flooding on these three mental health symptoms.	[Lieberman-Cribbin, Wil; Liu, Bian; Taioli, Emanuela] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA; [Lieberman-Cribbin, Wil; Liu, Bian; Taioli, Emanuela] Icahn Sch Med Mt Sinai, Inst Translat Epidemiol, New York, NY 10029 USA; [Schneider, Samantha; Schwartz, Rebecca] Hofstra Northwell Sch Med, Dept Occupat Med Epidemiol & Prevent, Manhasset, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Northwell Health	Taioli, E (corresponding author), Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA.; Taioli, E (corresponding author), Icahn Sch Med Mt Sinai, Inst Translat Epidemiol, New York, NY 10029 USA.	emanuela.taioli@mountsinai.org		Liu, Bian/0000-0001-9166-693X	Centers for Disease Control and Prevention [U01-TP000573-01]; Office of the Assistant Secretary for Preparedness and Response [HITEP150029-01-00]	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Office of the Assistant Secretary for Preparedness and Response	This work was supported by the The Centers for Disease Control and Prevention under award number U01-TP000573-01 (Emanuela Taioli, http://www.cdc.gov/grants/), and the Office of the Assistant Secretary for Preparedness and Response under HITEP150029-01-00 (Emanuela Taioli, http://www.phe.gov/about/aspr/pages/default.aspx), as well as a private donation given to Northwell Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research reported in this presentation was supported by The Centers for Disease Control and Prevention under award number U01-TP000573-01, and the Office of the Assistant Secretary for Preparedness and Response under HITEP150029-01-00, as well as a private donation given to Northwell Health.	Ahern M, 2005, EPIDEMIOL REV, V27, P36, DOI 10.1093/epirev/mxi004; Bei B, 2013, AGING MENT HEALTH, V17, P992, DOI 10.1080/13607863.2013.799119; Bender MA, 2010, SCIENCE, V327, P454, DOI 10.1126/science.1180568; Blake ES., 2013, NATL HURRICANE CTR, V12, P1; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bonanno GA, 2007, J CONSULT CLIN PSYCH, V75, P671, DOI 10.1037/0022-006X.75.5.671; Bourque LB, 2006, ANN AM ACAD POLIT SS, V604, P129, DOI 10.1177/0002716205284920; Carroll B, 2009, HEALTH PLACE, V15, P540, DOI 10.1016/j.healthplace.2008.08.009; Cieslak R, 2009, ANXIETY STRESS COPIN, V22, P449, DOI 10.1080/10615800802403815; FEMA (Federal Emergency Management Agency), 2015, FEMA MOD TASK FORC M; Fernandez A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119929; First M. B., 1994, DIAGNOSTIC STAT MANU; Foa EB, 2006, J CLIN PSYCHIAT, V67, P15; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Galea S, 2008, J TRAUMA STRESS, V21, P357, DOI 10.1002/jts.20355; Galea S, 2007, ARCH GEN PSYCHIAT, V64, P1427, DOI 10.1001/archpsyc.64.12.1427; Gonzalez R., 2013, WELL DID NYCS FLOOD; Heir T, 2008, PSYCHIATRY, V71, P266, DOI 10.1521/psyc.2008.71.3.266; Heir T, 2009, BRIT J PSYCHIAT, V194, P510, DOI 10.1192/bjp.bp.108.056580; Hirschel MJ, 2009, PSYCHOL SERV, V6, P293, DOI 10.1037/a0017467; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613; Leon KA, 2007, SOC PSYCH PSYCH EPID, V42, P1005, DOI 10.1007/s00127-007-0260-6; Litz B.T, 1993, PTSD CHECKL PCL REL; Lowe B, 2010, J AFFECT DISORDERS, V122, P86, DOI 10.1016/j.jad.2009.06.019; Lowe SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125761; Lowe SR, 2013, J TRAUMA STRESS, V26, P753, DOI 10.1002/jts.21872; Mason V, 2010, PSYCHOL HEALTH MED, V15, P61, DOI 10.1080/13548500903483478; Massengill D, 2010, SAS GLOBAL FORUM 201; Neria Y, 2008, PSYCHOL MED, V38, P467, DOI 10.1017/S0033291707001353; Neria Y, 2012, JAMA-J AM MED ASSOC, V308, P2571, DOI 10.1001/jama.2012.110700; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Norris FH, 1999, ANXIETY STRESS COPIN, V12, P363, DOI 10.1080/10615809908249317; Norris FH, 2009, SOC SCI MED, V68, P2190, DOI 10.1016/j.socscimed.2009.03.043; Paranjothy S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-145; Paxson C, 2012, SOC SCI MED, V74, P150, DOI 10.1016/j.socscimed.2011.10.004; Pietrzak RH, 2013, J PSYCHIATR RES, V47, P520, DOI 10.1016/j.jpsychires.2012.12.005; Pietrzak RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038964; Redlener, 2006, EDGE CHILDREN FAMILI; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Sakuma A, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0440-y; Schwartz R, 2015, DISASTER MED PUBLIC, P1; Shaw A., 2013, PRO PUBLICA 2013; Smith BW, 2000, J TRAUMA STRESS, V13, P349, DOI 10.1023/A:1007745920466; Stanke C, 2012, PLOS CURRENTS DISAST; Sullivan G, 2013, J NERV MENT DIS, V201, P161, DOI 10.1097/NMD.0b013e31827f636d; Taioli E., 2014, AM J DISASTER MED, V10, P339; Tunstall Sylvia, 2006, Journal of Water and Health, V4, P365, DOI 10.2166/wh.2006.031; Weisler RH, 2006, JAMA-J AM MED ASSOC, V296, P585, DOI 10.1001/jama.296.5.585	49	32	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170965	10.1371/journal.pone.0170965	http://dx.doi.org/10.1371/journal.pone.0170965			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7VX	28129410	Green Published, gold, Green Submitted			2022-12-27	WOS:000396211400018
J	Oong, XY; Ng, KT; Tan, JL; Chan, KG; Kamarulzaman, A; Chan, YF; Sam, IC; Tee, KK				Oong, Xiang Yong; Ng, Kim Tien; Tan, Joon Ling; Chan, Kok Gan; Kamarulzaman, Adeeba; Chan, Yoke Fun; Sam, I-Ching; Tee, Kok Keng			Whole-Genome Phylogenetic Analysis of Influenza B/Phuket/3073/2013-Like Viruses and Unique Reassortants Detected in Malaysia between 2012 and 2014	PLOS ONE			English	Article							B VIRUSES; LINEAGES; EVOLUTION; CHINA; GENE; DYNAMICS	Reassortment of genetic segments between and within influenza B lineages (Victoria and Yamagata) has been shown to generate novel reassortants with unique genetic characteristics. Based on hemagglutinin (HA) and neuraminidase (NA) genes, recent surveillance study has identified reassortment properties in B/Phuket/3073/2013-like virus, which is currently used in the WHO-recommended influenza vaccine. To understand the potential reassortment patterns for all gene segments, four B/Phuket/3073/2013-like viruses and two unique reassortants (one each from Yamagata and Victoria) detected in Malaysia from 2012-2014 were subjected to whole-genome sequencing. Each gene was phylogenetically classified into lineages, clades and sub-clades. Three B/Phuket/3073/2013-like viruses from Yamagata lineage were found to be intra-clade reassortants, possessing PA and NA genes derived from Stockholm/12-like sub-clade, while the remaining genes from Wisconsin/ 01-like sub-clade (both sub-clades were within Yamagata Clade 3/Yam-3). However, the other B/Phuket/3073/2013-like virus had NS gene that derived from Stockholm/12-like sub-clade instead of Wisconsin/01-like sub-clade. One inter-clade reassortant had Yamagata Clade 2/Yam-2-derived HA and NP, and its remaining genes were Yam-3-derived. Within Victoria Clade 1/Vic-1 in Victoria lineage, one virus had intra-clade reassortment properties: HA and PB2 from Vic-1B sub-clade, MP and NS from a unique sub-clade "Vic-1C", and the remaining genes from Vic-1A sub-clade. Although random reassortment event may generate unique reassortants, detailed phylogenetic classification of gene segments showed possible genetic linkage between PA and NA genes in B/Phuket/3073/2013-like viruses, which requires further investigation. Understanding on reassortment patterns in influenza B evolution may contribute to future vaccine design.	[Oong, Xiang Yong; Ng, Kim Tien; Kamarulzaman, Adeeba] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia; [Tan, Joon Ling; Chan, Yoke Fun; Sam, I-Ching; Tee, Kok Keng] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Chan, Kok Gan] Univ Malaya, Fac Sci, Inst Biol Sci, Div Genet & Mol Biol, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Tee, KK (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	k2tee@um.edu.my	KAMARULZAMAN, ADEEBA/B-5216-2010; Ng, Kim Tien/K-7667-2013; Sam, Jamal I-Ching/B-8688-2010; Chan, Yoke Fun/B-5351-2010; Chan, Kok Gan/B-8347-2010; Tee, Kok Keng/A-8148-2008	Ng, Kim Tien/0000-0002-4097-9984; Sam, Jamal I-Ching/0000-0002-1296-7898; Chan, Yoke Fun/0000-0001-7089-0510; Chan, Kok Gan/0000-0002-1883-1115; Tee, Kok Keng/0000-0002-7923-5448; Oong, Xiang Yong/0000-0002-1426-1987	Ministry of Education, Malaysia (High Impact Research) [UM.C/625/1/HIR/MOE/CHAN/02/02, UM.C/625/1/HIR/MOHE/MED/42]; sanofi-aventis, Malaysia [FLU29-EXT]; diagnostic virology laboratory in UMMC;  [PG084-2015A]	Ministry of Education, Malaysia (High Impact Research); sanofi-aventis, Malaysia; diagnostic virology laboratory in UMMC; 	This work was supported by grants from the Ministry of Education, Malaysia (High Impact Research UM.C/625/1/HIR/MOE/CHAN/02/02 and UM.C/625/1/HIR/MOHE/MED/42), the Postgraduate Research Fund (PG084-2015A), and sanofi-aventis, Malaysia (FLU29-EXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; We would like to thank Nyoke Pin Wong, See Wie Teoh, Yong Kek Pang, Nik Sherina Hanafi, Tommy Tsan-Yuk Lam, and the diagnostic virology laboratory in UMMC for assistance and support.	[Anonymous], 2015, FEBR 2015 INT REP; Arvia R, 2014, VIRUSES-BASEL, V6, P4437, DOI 10.3390/v6114437; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Byarugaba DK, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-11; Chen RB, 2008, J MOL EVOL, V66, P655, DOI 10.1007/s00239-008-9119-z; Dudas G, 2015, MOL BIOL EVOL, V32, P162, DOI 10.1093/molbev/msu287; Fang QX, 2015, ARCH VIROL, V160, P1083, DOI 10.1007/s00705-015-2362-x; GISAID, 2016, EPIFLU DAT; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; KANEGAE Y, 1990, J VIROL, V64, P2860, DOI 10.1128/JVI.64.6.2860-2865.1990; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; KRYSTAL M, 1982, P NATL ACAD SCI-BIOL, V79, P4800, DOI 10.1073/pnas.79.15.4800; LAMB RA, 1983, ANNU REV BIOCHEM, V52, P467, DOI 10.1146/annurev.bi.52.070183.002343; Loens K, 2007, J CLIN MICROBIOL, V45, P421, DOI 10.1128/JCM.00894-06; McCullers JA, 1999, J VIROL, V73, P7343, DOI 10.1128/JVI.73.9.7343-7348.1999; McCullers JA, 2004, J VIROL, V78, P12817, DOI 10.1128/JVI.78.23.12817-12828.2004; Oong XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136254; Pabbaraju K, 2011, J CLIN MICROBIOL, V49, P1738, DOI 10.1128/JCM.02090-10; Patil KN, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00951-13; ROTA PA, 1990, VIROLOGY, V175, P59, DOI 10.1016/0042-6822(90)90186-U; Sam IC, 2015, J VIROL, V89, P9689, DOI 10.1128/JVI.00708-15; Smith GJD, 2012, INFLUENZA OTHER RESP, V6, P1, DOI 10.1111/j.1750-2659.2011.00298.x; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tan Y, 2013, J VIROL, V87, P12447, DOI 10.1128/JVI.01039-13; Tewawong N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116302; Vijaykrishna D, 2015, ELIFE, V4, DOI 10.7554/eLife.05055; WHO. Influenza Centre London, 2015, SEPT 2014 INT REP; World Health Organization (WHO), 2014, WHO INF MOL DIAGN IN; Yang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047179; Zhu N, 2013, VIRUS GENES, V46, P28, DOI 10.1007/s11262-012-0826-6	30	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170610	10.1371/journal.pone.0170610	http://dx.doi.org/10.1371/journal.pone.0170610			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129386	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000396211400052
J	De Santi, C; Vencken, S; Blake, J; Haase, B; Benes, V; Gemignani, F; Landi, S; Greene, CM				De Santi, Chiara; Vencken, Sebastian; Blake, Jonathon; Haase, Bettina; Benes, Vladimir; Gemignani, Federica; Landi, Stefano; Greene, Catherine M.			Identification of MiR-21-5p as a Functional Regulator of Mesothelin Expression Using MicroRNA Capture Affinity Coupled with Next Generation Sequencing	PLOS ONE			English	Article							MALIGNANT MESOTHELIOMA; GENE-EXPRESSION; CELL; TARGET; SIGNATURE; PROMOTER; MIR-145; SITE	MicroRNAs (miRNAs) are small non-coding RNAs that regulate mRNA expression mainly by silencing target transcripts via binding to miRNA recognition elements (MREs) in the 3'untranslated region (3'UTR). The identification of bona fide targets is challenging for researchers working on the functional aspect of miRNAs. Recently, we developed a method (miR-CATCH) based on biotinylated DNA antisense oligonucleotides that capture the mRNA of interest and facilitates the characterisation of miRNAs:: mRNA interactions in a physiological cellular context. Here, the miR-CATCH technique was applied to the mesothelin (MSLN) gene and coupled with next generation sequencing (NGS), to identify miRNAs that regulate MSLN mRNA and that may be responsible for its increased protein levels found in malignant pleural mesothelioma (MPM). Biotinylated MSLN oligos were employed to isolate miRNA:: MSLN mRNA complexes from a normal cell line (Met-5A) which expresses low levels of MSLN. MiRNAs targeting the MSLN mRNA were identified by NGS and miR-21-5p and miR-100-5p were selected for further validation analyses. MiR-21-5p was shown to be able to modulate MSLN expression in miRNA mimic experiments in a panel of malignant and non-malignant cell lines. Further miRNA inhibitor experiments and luciferase assays in Mero-14 cells validated miR-215p as a true regulator of MSLN. Moreover, in vitro experiments showed that treatment with miR-21-5p mimic reduced proliferation of MPM cell lines. Altogether, this work shows that the miR-CATCH technique, coupled with NGS and in vitro validation, represents a reliable method to identify native miRNA:: mRNA interactions. MiR-21-5p is suggested as novel regulator of MSLN with a possible functional role in cellular growth.	[De Santi, Chiara; Vencken, Sebastian; Greene, Catherine M.] Royal Coll Surgeons Ireland, Dept Med, Resp Res Div, Dublin, Ireland; [Blake, Jonathon; Haase, Bettina; Benes, Vladimir] EMBL European Mol Biol Lab, Genom Core Facil, Heidelberg, Germany; [Gemignani, Federica; Landi, Stefano] Univ Pisa, Dept Biol, Pisa, Italy	Royal College of Surgeons - Ireland; European Molecular Biology Laboratory (EMBL); University of Pisa	Landi, S (corresponding author), Univ Pisa, Dept Biol, Pisa, Italy.	stefano.landi@unipi.it	Greene, Catherine M/D-3513-2012	Greene, Catherine M/0000-0003-2549-2569; GEMIGNANI, Federica/0000-0003-1297-0701; De Santi, Chiara/0000-0003-3856-0858	Science Foundation Ireland [12/TIDA/B2265]; European Respiratory Society/GlaxoSmithKline Rare Disease Award; Ministero della Salute-Bando Ricerca Finalizzata [RF-2009-1529895]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Respiratory Society/GlaxoSmithKline Rare Disease Award; Ministero della Salute-Bando Ricerca Finalizzata	This work was supported by several grants: Science Foundation Ireland 12/TIDA/B2265, The European Respiratory Society/GlaxoSmithKline Rare Disease Award 2013 and Ministero della Salute-Bando Ricerca Finalizzata 2009 (RF-2009-1529895). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen M, 2014, J MOL DIAGN, V16, P418, DOI 10.1016/j.jmoldx.2014.03.002; Argani P, 2001, CLIN CANCER RES, V7, P3862; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Balatti V, 2011, J THORAC ONCOL, V6, P844, DOI 10.1097/JTO.0b013e31820db125; Bera TK, 2000, MOL CELL BIOL, V20, P2902, DOI 10.1128/MCB.20.8.2902-2906.2000; Busacca S, 2010, AM J RESP CELL MOL, V42, P312, DOI 10.1165/rcmb.2009-0060OC; Cappellesso R, 2016, CANCER CYTOPATHOL, V124, P28, DOI 10.1002/cncy.21646; Cioce M, 2014, ONCOGENE, V33, P5319, DOI 10.1038/onc.2013.476; Evers DL, 2011, J MOL DIAGN, V13, P282, DOI 10.1016/j.jmoldx.2011.01.010; Gao W, 2012, BIOMED PHARMACOTHER, V66, P21, DOI 10.1016/j.biopha.2011.09.004; Gao W, 2011, J CANCER RES CLIN, V137, P557, DOI 10.1007/s00432-010-0918-4; Garritano S, 2014, J THORAC ONCOL, V9, P1662, DOI 10.1097/JTO.0000000000000322; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; Hassan R, 2004, CLIN CANCER RES, V10, P3937, DOI 10.1158/1078-0432.CCR-03-0801; Hassan T, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1466; KE Y, 1989, AM J PATHOL, V134, P979; Kelly RJ, 2012, MOL CANCER THER, V11, P517, DOI 10.1158/1535-7163.MCT-11-0454; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kirschner MB, 2015, MOL ONCOL, V9, P715, DOI 10.1016/j.molonc.2014.11.007; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marin-Muller C, 2013, CLIN CANCER RES, V19, P5901, DOI 10.1158/1078-0432.CCR-12-3776; Melaiu O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085935; Melnik BC, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-014-0377-9; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; O'Shannessy DJ, 2013, INT J MOL SCI, V14, P13687, DOI 10.3390/ijms140713687; Obulhasim G, 2010, EUR J GYNAECOL ONCOL, V31, P63; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Piscopo P, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00031; Sato N, 2003, CANCER RES, V63, P4158; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Shi J, 2016, J CLIN MED, V5, DOI 10.3390/jcm5040042; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Tan K, 2010, HUM PATHOL, V41, P1330, DOI 10.1016/j.humpath.2010.03.002; Thomson DW, 2011, NUCLEIC ACIDS RES, V39, P6845, DOI 10.1093/nar/gkr330; Valeri N, 2010, P NATL ACAD SCI USA, V107, P21098, DOI 10.1073/pnas.1015541107; Vencken S, 2015, METHODS MOL BIOL, V1218, P365, DOI 10.1007/978-1-4939-1538-5_23; VERSNEL MA, 1989, CANCER GENET CYTOGEN, V42, P115, DOI 10.1016/0165-4608(89)90014-9; Vo NK, 2010, P NATL ACAD SCI USA, V107, P19231, DOI 10.1073/pnas.1013162107; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033214; Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34	43	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170999	10.1371/journal.pone.0170999	http://dx.doi.org/10.1371/journal.pone.0170999			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125734	gold, Green Published, Green Submitted			2022-12-27	WOS:000396176100010
J	Neto, CN; Maia, SSB; Katz, L; Coutinho, IC; Souza, AR; Amorim, MM				Neto C, Carlos Noronha; Maia, Sabina S. B.; Katz, Leila; Coutinho, Isabela C.; Souza, Alex R.; Amorim, Melania M.			Clonidine versus Captopril for Severe Postpartum Hypertension: A Randomized Controlled Trial	PLOS ONE			English	Article							PREGNANCY; PREECLAMPSIA; MANAGEMENT	Background Changes during the puerperium are still unclear, particularly in women with hypertension. The choice of antihypertensives, both to control very high blood pressure episodes and to keep blood pressure stable, also requires further elucidation. Currently, there are no clear data to guide the decision for the choice of postpartum antihypertensives. Captopril plays an important role in the treatment of very high blood pressure episodes and may be used postpartum. Clonidine has been used as an alternative in pregnant or postpartum women with contraindications to captopril, with satisfactory effect. The objective of the present study was to evaluate the effectiveness and safety of clonidine compared to captopril for treating severe postpartum hypertension. Methods and findings A randomized, drug-controlled, triple-blind clinical trial evaluating postpartum women receiving captopril or clonidine. Inclusion criteria consisted of: women with hypertensive disorders ;of pregnancy systolic blood pressure (SBP) >= 180 mmHg and/or diastolic blood pressure (DBP) >= 110 mmHg], requiring magnesium sulfate. Exclusion criteria were: heart disease, smoking, illicit drug use, contraindications to captopril, clonidine or oral medication, and having used captopril/clonidine previously. The primary outcome was the frequency of very high blood pressure episodes while in the obstetric intensive care unit. A total of 90 postpartum women met the study inclusion criteria, with 45 randomized to each group. There were fewer very high blood pressure episodes during hospitalization (2.1 +/- 2.1 vs. 3.5 +/- 4.7, p = 0.08), greater percentage reduction in SBP (14.0% +/- 8.6% vs. 10.8% +/- 8.8%, p = 0.08) and fewer women requiring sodium nitroprusside (2.3% vs. 13.3%; RR: 0.17; 95% CI: 0.02 +/- 1.39; p = 0.06) in the clonidine group compared to the captopril group; however, these differences were not significant. The groups were similar regarding daily mean SBP or DBP; however, on the third postpartum day, mean SBP was lower in the clonidine compared to the captopril group (151.9 +/- 11.8 mmHg vs. 158.1 +/- 13.6 mmHg, p = 0.02). Although not statistically significant, adverse reactions were more common in the captopril group (28.8%) compared to the clonidine group (18.6%). Conclusion Clonidine and captopril represent safe, effective treatments for severe postpartum hypertension.	[Neto C, Carlos Noronha; Maia, Sabina S. B.; Katz, Leila; Coutinho, Isabela C.; Souza, Alex R.; Amorim, Melania M.] Inst Med Integral Prof Fernando Figueira, Post Grad Program Maternal & Child Hlth, Recife, PE, Brazil	Instituto de Medicina Integral Professor Fernando Figueira (IMIP)	Amorim, MM (corresponding author), Inst Med Integral Prof Fernando Figueira, Post Grad Program Maternal & Child Hlth, Recife, PE, Brazil.	profmelania.amorim@gmail.com	Katz, Leila/M-5291-2013; Amorim, Melania/C-5807-2013; Souza, Alex Sandro Rolland/G-3446-2013	Katz, Leila/0000-0001-9854-7917; Amorim, Melania/0000-0003-1047-2514; Souza, Alex Sandro Rolland/0000-0001-7039-2052; maia, sabina/0000-0003-4974-5073				[Anonymous], 7 REP JOINT NAT COM; Barrilleaux PS, 2002, CLIN OBSTET GYNECOL, V45, P22, DOI 10.1097/00003081-200203000-00005; Fujitani Shigeki, 2005, Crit Care Med, V33, pS354, DOI 10.1097/01.CCM.0000183156.73560.0C; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; HARTIKAINENSORRI AL, 1987, OBSTET GYNECOL, V69, P598; Magee L, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004351.pub3; Marchioli Milton, 2004, Rev. Bras. Ginecol. Obstet., V26, P391, DOI 10.1590/S0100-72032004000500008; MCMAHON FG, 1990, CLIN THER, V12, P88; Neto C Noronha, 2013, REPROD HLTH, V10, P37, DOI [10.1186/1742-4755-10-37, DOI 10.1186/1742-4755-10-37]; Neto CN, 2010, REV BRAS GINECOL OBS, V32, P459, DOI 10.1590/S0100-72032010000900008; Patil PM, 2012, J ORAL MAXIL SURG, V70, P257, DOI 10.1016/j.joms.2011.07.011; de Melo BCP, 2009, REV ASSOC MED BRAS, V55, P175, DOI 10.1590/S0104-42302009000200022; Podymow T, 2011, SEMIN NEPHROL, V31, P70, DOI 10.1016/j.semnephrol.2010.10.007; Souza ASR, 2008, REV ASSOC MED BRAS, V54, P232, DOI 10.1590/S0104-42302008000300016; Serreau R, 2010, Ann Fr Anesth Reanim, V29, pe37, DOI 10.1016/j.annfar.2010.02.016; Sevrez C, 2014, ARCH PEDIATRIE, V21, P198, DOI 10.1016/j.arcped.2013.11.004; Sibai BM, 2012, AM J OBSTET GYNECOL, V206, P470, DOI 10.1016/j.ajog.2011.09.002; Stocche Renato Mestriner, 2002, Rev. Bras. Anestesiol., V52, P426, DOI 10.1590/S0034-70942002000400006; TUIMALA R, 1985, ANN CHIR GYNAECOL FE, V74, P47; van den Born BJH, 2011, NETH J MED, V69, P248; Yilmaz S, 2011, BLOOD PRESSURE, V20, P239, DOI 10.3109/08037051.2011.553934; ZUSPAN FP, 1978, AM J OBSTET GYNECOL, V131, P591, DOI 10.1016/0002-9378(78)90816-5	22	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0168124	10.1371/journal.pone.0168124	http://dx.doi.org/10.1371/journal.pone.0168124			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125624	Green Submitted, Green Published, gold			2022-12-27	WOS:000396176100151
J	Perez-Sancho, M; Vela, AI; Garcia-Seco, T; Gonzalez, S; Dominguez, L; Fernandez-Garayzabal, JF				Perez-Sancho, Marta; Vela, Ana I.; Garcia-Seco, Teresa; Gonzalez, Sergio; Dominguez, Lucas; Francisco Fernandez-Garayzabal, Jose			Usefulness of MALDI-TOF MS as a Diagnostic Tool for the Identification of Streptococcus Species Recovered from Clinical Specimens of Pigs	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; RAPID IDENTIFICATION; SP NOV.; SYSTEM; SUIS	The application of MALDI-TOF MS for identifying streptococcal isolates recovered from clinical specimens of diseased pigs was evaluated. For this proposal, the MALDI BDAL Database (Bruker Daltoniks, Germany) was supplemented with the main spectrum profiles (MSP) of the reference strains of S. porci, S. porcorum and S. plurextorum associated with pneumonia and septicemia. Although these three species showed similar MALDI profiles, several peaks were recognized that can be useful for their differentiation: S. porci (4113, 6133, 7975 and 8228 m/z Da), S. plurextorum (3979, 4078, 4665, 6164, 6491, 6812, 7959 and 9330 m/z Da) and S. porcorum (3385, 3954, 4190, 6772, 7908, and 8381 m/z Da). After adding these MSPs, an evaluation was conducted to determine the accuracy of MALDI-TOF MS for the identification of streptococci from diseased pigs using 74 field isolates. Isolates were identified as S. suis, S. porcinus, S. dysgalactiae, S. hyovaginalis, S. porcorum, S. alactolyticus, S. hyointestinalis and S. orisratti. This is the first time that the latter three species have been reported from clinical specimens of pigs. Overall, there was good concordance (95.9%) between the results obtained from MALDI-TOF MS identification (best hint) and those from genotyping. Our results demonstrate the good performance of MALDI-TOF MS (100% sensitivity and specificity) for identifying most of the species of streptococci that can frequently be isolated from diseased pigs. However, conflicting results were observed in the correct identification of some isolates of S. dysgalactiae and S. alactolyticus.	[Perez-Sancho, Marta; Vela, Ana I.; Garcia-Seco, Teresa; Gonzalez, Sergio; Dominguez, Lucas; Francisco Fernandez-Garayzabal, Jose] Univ Complutense, Ctr Vigilancia Sanitaria Vet VISAVET, Madrid, Spain; [Perez-Sancho, Marta; Dominguez, Lucas] Univ Complutense Madrid, Univ Politecn Madrid, Campus Excelencia Internac CEI Moncloa, Madrid, Spain; [Vela, Ana I.; Francisco Fernandez-Garayzabal, Jose] Univ Complutense, Fac Vet, Dept Sanidad Anim, Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid; Universidad Politecnica de Madrid; Complutense University of Madrid	Fernandez-Garayzabal, JF (corresponding author), Univ Complutense, Ctr Vigilancia Sanitaria Vet VISAVET, Madrid, Spain.; Fernandez-Garayzabal, JF (corresponding author), Univ Complutense, Fac Vet, Dept Sanidad Anim, Madrid, Spain.	garayzab@vet.ucm.es	FERNANDEZ-GARAYZABAL, JOSE FRANCISCO/K-9611-2014; Vela, Ana I/K-8015-2014; Dominguez, Sergio Gonzalez/B-9645-2014; Garcia-Seco Romero, Teresa/K-8589-2014; PEREZ-SANCHO, MARTA/L-4872-2014; Dominguez Rodriguez, Lucas/B-9668-2014	FERNANDEZ-GARAYZABAL, JOSE FRANCISCO/0000-0003-1597-0643; Vela, Ana I/0000-0001-5004-3103; Dominguez, Sergio Gonzalez/0000-0001-6867-7796; Garcia-Seco Romero, Teresa/0000-0002-6162-1025; PEREZ-SANCHO, MARTA/0000-0002-1493-8978; Dominguez Rodriguez, Lucas/0000-0001-8843-0010	Moncloa Campus of International Excellence [CEI09-0019]; Ministerio de Educacion, Cultura y Deporte [Orden PRE/1996/2009 de 20 de Julio]; Regional Government of Madrid; European Union [S2013/ABI-2747]	Moncloa Campus of International Excellence; Ministerio de Educacion, Cultura y Deporte; Regional Government of Madrid; European Union(European Commission)	Marta Perez-Sancho is recipient of a technical support staff for scientific infrastructures of the Moncloa Campus of International Excellence (Programa CEI09-0019) and Ministerio de Educacion, Cultura y Deporte (Orden PRE/1996/2009 de 20 de Julio). This study was supported by Regional Government of Madrid Structural funds and European Union S2013/ABI-2747 (TAVS-CM).	Abramson Joseph H, 2004, Epidemiol Perspect Innov, V1, P6, DOI 10.1186/1742-5573-1-6; Branda JA, 2013, J CLIN MICROBIOL, V51, P3079, DOI 10.1128/JCM.00824-13; Brigante G, 2006, J CLIN MICROBIOL, V44, P3263, DOI 10.1128/JCM.00299-06; Cherkaoui A, 2011, J CLIN MICROBIOL, V49, P3004, DOI 10.1128/JCM.00240-11; FLYNN CE, 1995, J CLIN MICROBIOL, V33, P2704, DOI 10.1128/JCM.33.10.2704-2706.1995; Gottschalk M., 2012, DIS SWINE, P841; Goyette-Desjardins G, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.45; Lau SKP, 2012, J CLIN MICROBIOL, V50, P3142, DOI 10.1128/JCM.01349-12; Lu BH, 2014, INT J INFECT DIS, V27, P44, DOI 10.1016/j.ijid.2014.06.023; Moreno LZ, 2016, DIAGN MICR INFEC DIS, V86, P178, DOI 10.1016/j.diagmicrobio.2016.07.020; Okwumabua O, 2003, FEMS MICROBIOL LETT, V218, P79, DOI 10.1111/j.1574-6968.2003.tb11501.x; Perez-Sancho M, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00202; Plagemann O, 1988, Zentralbl Veterinarmed B, V35, P770; Rettinger A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-185; Romero B, 2011, J CLIN MICROBIOL, V49, P3228, DOI 10.1128/JCM.00524-11; Schulthess B, 2013, J CLIN MICROBIOL, V51, P1834, DOI 10.1128/JCM.02654-12; Singhal N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00791; Vela AI, 2011, INT J SYST EVOL MICR, V61, P1585, DOI 10.1099/ijs.0.022657-0; Vela AI, 2010, INT J SYST EVOL MICR, V60, P104, DOI 10.1099/ijs.0.011171-0; Vela AI, 2009, INT J SYST EVOL MICR, V59, P504, DOI 10.1099/ijs.0.65636-0; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; WESSMAN GE, 1986, VET MICROBIOL, V12, P297, DOI 10.1016/0378-1135(86)90081-7; Whiley RA, 2009, BERGEYS MANUAL SYSTE, P655; Zhu H, 2000, INT J SYST EVOL MICR, V50, P55, DOI 10.1099/00207713-50-1-55	24	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170784	10.1371/journal.pone.0170784	http://dx.doi.org/10.1371/journal.pone.0170784			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125697	Green Published, gold, Green Submitted			2022-12-27	WOS:000396176100051
J	Qiao-Tasserit, E; Quesada, MG; Antico, L; Bavelier, D; Vuilleumier, P; Pichon, S				Qiao-Tasserit, Emilie; Quesada, Maria Garcia; Antico, Lia; Bavelier, Daphne; Vuilleumier, Patrik; Pichon, Swann			Transient emotional events and individual affective traits affect emotion recognition in a perceptual decision-making task	PLOS ONE			English	Article							MAJOR DEPRESSION; FACIAL EXPRESSIONS; MUSIC INFLUENCES; TIME-COURSE; ANXIETY; ATTENTION; BIASES; CONTEXT; FACES; STATE	Both affective states and personality traits shape how we perceive the social world and interpret emotions. The literature on affective priming has mostly focused on brief influences of emotional stimuli and emotional states on perceptual and cognitive processes. Yet this approach does not fully capture more dynamic processes at the root of emotional states, with such states lingering beyond the duration of the inducing external stimuli. Our goal was to put in perspective three different types of affective states (induced affective states, more sustained mood states and affective traits such as depression and anxiety) and investigate how they may interact and influence emotion perception. Here, we hypothesized that absorption into positive and negative emotional episodes generate sustained affective states that outlast the episode period and bias the interpretation of facial expressions in a perceptual decision-making task. We also investigated how such effects are influenced by more sustained mood states and by individual affect traits (depression and anxiety) and whether they interact. Transient emotional states were induced using movie-clips, after which participants performed a forced-choice emotion classification task with morphed facial expressions ranging from fear to happiness. Using a psychometric approach, we show that negative (vs. neutral) clips increased participants' propensity to classify ambiguous faces as fearful during several minutes. In contrast, positive movies biased classification toward happiness only for those clips perceived as most absorbing. Negative mood, anxiety and depression had a stronger effect than transient states and increased the propensity to classify ambiguous faces as fearful. These results provide the first evidence that absorption and different temporal dimensions of emotions have a significant effect on how we perceive facial expressions.	[Qiao-Tasserit, Emilie; Vuilleumier, Patrik] Univ Geneva, Sch Med, Dept Neurosci, Lab Behav Neurol & Imaging Cognit, Geneva, Switzerland; [Qiao-Tasserit, Emilie; Vuilleumier, Patrik; Pichon, Swann] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland; [Quesada, Maria Garcia; Antico, Lia; Bavelier, Daphne; Pichon, Swann] Univ Geneva, Fac Psychol & Educ Sci, Geneva, Switzerland; [Bavelier, Daphne] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY USA	University of Geneva; University of Geneva; University of Geneva; University of Rochester	Qiao-Tasserit, E (corresponding author), Univ Geneva, Sch Med, Dept Neurosci, Lab Behav Neurol & Imaging Cognit, Geneva, Switzerland.; Qiao-Tasserit, E (corresponding author), Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland.	emilie.qiao@gmail.com	Vuilleumier, Patrik/AAJ-1839-2021; pichon, swann JA/M-2966-2014; Garcia Quesada, Maria/HGB-3715-2022	Vuilleumier, Patrik/0000-0002-8198-9214; pichon, swann JA/0000-0001-5697-702X; Garcia Quesada, Maria/0000-0002-0206-7597; Bavelier, Daphne/0000-0002-5904-1240	National Center of Competence in Research (NCCR) for Affective Sciences - Swiss National Science Foundation [51NF40_104897]; Swiss National Science Foundation [323530_145252, PZ00P1_148035]	National Center of Competence in Research (NCCR) for Affective Sciences - Swiss National Science Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the National Center of Competence in Research (NCCR) for Affective Sciences financed by the Swiss National Science Foundation (grant No 51NF40_104897, http://www.snf.ch/en/Pages/default.aspx) and hosted by the University of Geneva, as well as by the Academic Society of Geneva (Fund Foremane, http://www.sacad.ch/). We thank Ms. Nada Knezevic for helping during pilot experiments. EQT is currently supported by a MD-PhD fellowship from the Swiss National Science Foundation (grant No 323530_145252). SP is currently supported by the Swiss National Science Foundation (Ambizione grant No PZ00P1_148035).	Barrett LF, 2011, CURR DIR PSYCHOL SCI, V20, P286, DOI 10.1177/0963721411422522; Beck A.T., 1979, COGNITIVE THERAPY EM; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beevers CG, 2009, COGNITIVE THER RES, V33, P283, DOI 10.1007/s10608-008-9198-6; Benning SD, 2015, PSYCHOPHYSIOLOGY, V52, P1409, DOI 10.1111/psyp.12468; Bocanegra BR, 2009, PSYCHOL SCI, V20, P707, DOI 10.1111/j.1467-9280.2009.02354.x; BOUHUYS AL, 1995, J AFFECT DISORDERS, V33, P215, DOI 10.1016/0165-0327(94)00092-N; Costa T, 2014, SOC COGN AFFECT NEUR, V9, P1690, DOI 10.1093/scan/nst164; DALGLEISH T, 1990, CLIN PSYCHOL REV, V10, P589, DOI 10.1016/0272-7358(90)90098-U; Dalili MN, 2015, PSYCHOL MED, V45, P1135, DOI 10.1017/S0033291714002591; Ekman P., 2008, COGN EMOT; Eryilmaz H, 2014, J NEUROSCI, V34, P7825, DOI 10.1523/JNEUROSCI.0065-14.2014; Eryilmaz H, 2011, NEUROIMAGE, V54, P2481, DOI 10.1016/j.neuroimage.2010.10.021; Esslen M, 2004, NEUROIMAGE, V21, P1189, DOI 10.1016/j.neuroimage.2003.10.001; FORGAS JP, 1995, PSYCHOL BULL, V117, P39, DOI 10.1037/0033-2909.117.1.39; FORGAS JP, 1987, J PERS SOC PSYCHOL, V53, P53, DOI 10.1037/0022-3514.53.1.53; Forgas JP, 1987, PERSONALITY SOCIAL P, P467; Goldberg HD, 1951, J APPL PSYCHOL, V35, P70, DOI 10.1037/h0062192; Greifeneder R, 2011, PERS SOC PSYCHOL REV, V15, P107, DOI 10.1177/1088868310367640; Hasler G, 2004, NEUROPSYCHOPHARMACOL, V29, P1765, DOI 10.1038/sj.npp.1300506; Hasler G, 2011, MOL PSYCHIATR, V16, P604, DOI 10.1038/mp.2011.23; Hermans D, 2001, COGNITION EMOTION, V15, P143, DOI 10.1080/0269993004200033; ISEN AM, 1982, SOC PSYCHOL QUART, V45, P58, DOI 10.2307/3033676; Jeong JW, 2011, NEUROIMAGE, V54, P2973, DOI 10.1016/j.neuroimage.2010.11.017; Jokinen J, 2006, SOCIOL METHODOL, V36, P173, DOI 10.1111/j.1467-9531.2006.00178.x; Joormann J, 2006, J ABNORM PSYCHOL, V115, P705, DOI 10.1037/0021-843X.115.4.705; Kim H, 2004, J COGNITIVE NEUROSCI, V16, P1730, DOI 10.1162/0898929042947865; Klauer KC, 1997, J EXP PSYCHOL LEARN, V23, P246, DOI 10.1037/0278-7393.23.1.246; Lang PJ, 2014, RESTOR NEUROL NEUROS, V32, P63, DOI 10.3233/RNN-139012; Lee TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032987; Liu WH, 2012, PSYCHIAT RES, V197, P217, DOI 10.1016/j.psychres.2011.09.021; Lundqvist D, 1998, THE AVERAGED KAROLIN; MATHEWS A, 1985, BEHAV RES THER, V23, P563, DOI 10.1016/0005-7967(85)90104-4; Mathews A, 2000, J ABNORM PSYCHOL, V109, P602, DOI 10.1037//0021-843X.109.4.602; Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916; Mathews A, 1997, TRENDS COGN SCI, V1, P340, DOI 10.1016/S1364-6613(97)01092-9; Menne-Lothmann C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100925; Mobbs D, 2006, SOC COGN AFFECT NEUR, V1, P95, DOI 10.1093/scan/nsl014; Mogg K, 2006, BEHAV RES THER, V44, P1411, DOI 10.1016/j.brat.2005.10.008; MURPHY ST, 1993, J PERS SOC PSYCHOL, V64, P723, DOI 10.1037/0022-3514.64.5.723; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Phelps EA, 2006, PSYCHOL SCI, V17, P292, DOI 10.1111/j.1467-9280.2006.01701.x; PHILIPPOT P, 1993, COGNITION EMOTION, V7, P171, DOI 10.1080/02699939308409183; Pichon S, 2015, SOC COGN AFFECT NEUR, V10, P180, DOI 10.1093/scan/nsu044; Pichon S, 2012, NEUROIMAGE, V62, P1610, DOI 10.1016/j.neuroimage.2012.06.004; Price JL, 2012, TRENDS COGN SCI, V16, P61, DOI 10.1016/j.tics.2011.12.011; Scherer KR, 2005, SOC SCI INFORM, V44, P695, DOI 10.1177/0539018405058216; Spielberger CD, 1987, STATE TRAIT ANXIETY; Suess F, 2014, SOC COGN AFFECT NEUR; Surguladze SA, 2004, NEUROPSYCHOLOGY, V18, P212, DOI 10.1037/0894-4105.18.2.212; TELLEGEN A, 1974, J ABNORM PSYCHOL, V83, P268, DOI 10.1037/h0036681; Van den Stock J, 2009, BRAIN TOPOGR, V21, P216, DOI 10.1007/s10548-009-0099-0; van Marle HJF, 2009, BIOL PSYCHIAT, V66, P649, DOI 10.1016/j.biopsych.2009.05.014; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; WALLBOTT HG, 1988, BRIT J SOC PSYCHOL, V27, P357, DOI 10.1111/j.2044-8309.1988.tb00837.x; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Watters AJ, 2011, DEPRESS ANXIETY, V28, P703, DOI 10.1002/da.20854; Whalen PJ, 1998, J NEUROSCI, V18, P411; Wieser MJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00471; Winkielman P, 2005, PERS SOC PSYCHOL B, V31, P121, DOI 10.1177/0146167204271309	60	20	20	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171375	10.1371/journal.pone.0171375	http://dx.doi.org/10.1371/journal.pone.0171375			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28151976	Green Submitted, gold, Green Published			2022-12-27	WOS:000396161200133
J	Tang, LQ; Fang, XF; Winesett, SP; Cheng, CY; Binder, HJ; Rivkees, SA; Cheng, SX				Tang, Lieqi; Fang, Xiefan; Winesett, Steven P.; Cheng, Catherine Y.; Binder, Henry J.; Rivkees, Scott A.; Cheng, Sam X.			Bumetanide increases Cl--dependent short-circuit current in late distal colon: Evidence for the presence of active electrogenic Cl- absorption	PLOS ONE			English	Article							CALCIUM-SENSING RECEPTOR; APICAL MEMBRANE-VESICLES; FLUID SECRETION; CHLORIDE COTRANSPORTER; FUNCTIONAL EXPRESSION; ELECTROLYTE SECRETION; POTASSIUM ABSORPTION; MOLECULAR-CLONING; SODIUM-TRANSPORT; PROXIMAL COLON	Mammalian colonic epithelia consist of cells that are capable of both absorbing and secreting Cl-. The present studies employing Ussing chamber technique identified two opposing short-circuit current (I-sc) responses to basolateral bumetanide in rat distal colon. Apart from the transepithelial Cl--secretory I-sc in early distal colon that was inhibited by bumetanide, bumetanide also stimulated I-sc in late distal colon that had not previously been identified. Since bumetanide inhibits basolateral Na+-K+-2Cl(-) cotransporter (NKCC) in crypt cells and basolateral K+-Cl- cotransporter (KCC) in surface epithelium, we proposed this stimulatory I-sc could represent a KCC-mediated Cl- absorptive current. In support of this hypothesis, ion substitution experiments established Cl- dependency of this absorptive I-sc and transport inhibitor studies demonstrated the involvement of an apical Cl- conductance. Current distribution and RNA sequencing analyses revealed that this Cl- absorptive Isc is closely associated with epithelial Na+ channel (ENaC) but is not dependent on ENaC activity. Thus, inhibition of ENaC by 10 mu M amiloride or benzamil neither altered the direction nor its activity. Physiological studies suggested that this Cl- absorptive Isc senses dietary Cl- content; thus when dietary Cl- was low, Cl- absorptive I-sc was up-regulated. In contrast, when dietary Cl- was increased, Cl- absorptive I-sc was down-regulated. We conclude that an active Cl- extrusion mechanism exists in ENaC-expressing late distal colon and likely operates in parallel with ENaC to facilitate NaCl absorption.	[Tang, Lieqi; Fang, Xiefan; Winesett, Steven P.; Cheng, Catherine Y.; Rivkees, Scott A.] Univ Florida, Dept Pediat, Gainesville, FL USA; [Binder, Henry J.] Yale Sch Med, Dept Internal Med, New Haven, CT USA; [Cheng, Sam X.] Univ Florida, Dept Pediat Gastroenterol Hepatol & Nutr, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; Yale University; State University System of Florida; University of Florida	Cheng, SX (corresponding author), Univ Florida, Dept Pediat Gastroenterol Hepatol & Nutr, Gainesville, FL 32611 USA.	sam.cheng@ufl.edu		Cheng, Sam/0000-0003-0252-9357	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health [HD079674]; Children's Digestive Health and Nutrition Foundation [00102979]; Children's Miracle Network (SXC); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD079674] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health; Children's Digestive Health and Nutrition Foundation; Children's Miracle Network (SXC); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health (https://www.nichd.nih.gov/Pages/index.aspx) award number HD079674 (SXC), Children's Digestive Health and Nutrition Foundation (http://www.naspghan.org/content/9/en/NASPGHAN-Foundation) award number 00102979 (SXC), and Children's Miracle Network (SXC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alrefai WA, 2007, AM J PHYSIOL-GASTR L, V293, pG923, DOI 10.1152/ajpgi.00029.2007; Binder HJ, 2010, ANNU REV PHYSIOL, V72, P297, DOI 10.1146/annurev-physiol-021909-135817; Catalan M, 2004, GASTROENTEROLOGY, V126, P1104, DOI 10.1053/j.gastro.2004.01.010; Cheng SX, 2012, AM J PHYSIOL-GASTR L, V303, pG60, DOI 10.1152/ajpgi.00425.2011; Cheng SX, 2016, WORLD J GASTROENTERO, V22, P2711, DOI 10.3748/wjg.v22.i9.2711; Cheng SX, 2004, GASTROENTEROLOGY, V126, P148, DOI 10.1053/j.gastro.2003.10.064; Cheng SX, 2002, AM J PHYSIOL-GASTR L, V283, pG240, DOI 10.1152/ajpgi.00500.2001; Cho JH, 1998, AM J PHYSIOL-CELL PH, V274, pC586, DOI 10.1152/ajpcell.1998.274.3.C586; Dorge A, 1998, PFLUG ARCH EUR J PHY, V436, P280, DOI 10.1007/s004240050633; Ecke D, 1996, PFLUG ARCH EUR J PHY, V431, P984, DOI 10.1007/s004240050095; Fang X, 2016, FASEB J OFFICIAL PUB; FOSTER ES, 1986, AM J PHYSIOL, V251, pG619, DOI 10.1152/ajpgi.1986.251.5.G619; GAMBA G, 1993, P NATL ACAD SCI USA, V90, P2749, DOI 10.1073/pnas.90.7.2749; Geibel J, 2006, P NATL ACAD SCI USA, V103, P9390, DOI 10.1073/pnas.0602996103; Gilda JE, 2013, ANAL BIOCHEM, V440, P186, DOI 10.1016/j.ab.2013.05.027; Gillen CM, 1996, J BIOL CHEM, V271, P16237, DOI 10.1074/jbc.271.27.16237; HAAS M, 1983, AM J PHYSIOL, V245, pC235, DOI 10.1152/ajpcell.1983.245.3.C235; HAMMER HF, 1989, J CLIN INVEST, V84, P1056, DOI 10.1172/JCI114267; Hebert SC, 2004, CELL CALCIUM, V35, P239, DOI 10.1016/j.ceca.2003.10.015; Jakab RL, 2011, AM J PHYSIOL-GASTR L, V300, pG82, DOI 10.1152/ajpgi.00245.2010; Joiner WJ, 2003, AM J PHYSIOL-GASTR L, V285, pG185, DOI 10.1152/ajpgi.00337.2002; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; LARSEN EH, 1991, PHYSIOL REV, V71, P235, DOI 10.1152/physrev.1991.71.1.235; Ohana E, 2009, J PHYSIOL-LONDON, V587, P2179, DOI 10.1113/jphysiol.2008.164863; Pech V, 2007, AM J PHYSIOL-RENAL, V292, pF914, DOI 10.1152/ajprenal.00361.2006; Rajendran VM, 1998, AM J PHYSIOL-GASTR L, V274, pG424, DOI 10.1152/ajpgi.1998.274.2.G424; RAJENDRAN VM, 1989, J BIOL CHEM, V264, P18638; RAJENDRAN VM, 1990, J BIOL CHEM, V265, P8408; REDDY MM, 1994, AM J PHYSIOL-CELL PH, V267, pC1136, DOI 10.1152/ajpcell.1994.267.4.C1136; Rossier BC, 2015, PHYSIOL REV, V95, P297, DOI 10.1152/physrev.00011.2014; Sangan P, 2000, J BIOL CHEM, V275, P30813, DOI 10.1074/jbc.M003931200; Schultheiss G, 1998, ACTA PHYSIOL SCAND, V164, P219; Sheppard DN, 1997, J PHYSIOL-LONDON, V503, P333, DOI 10.1111/j.1469-7793.1997.333bh.x; Talbot C, 2010, AM J PHYSIOL-GASTR L, V299, pG358, DOI 10.1152/ajpgi.00151.2010; Tang LQ, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00245; Tang LQ, 2015, AM J PHYSIOL-GASTR L, V308, pG874, DOI 10.1152/ajpgi.00341.2014; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; USSING HH, 1951, ACTA PHYSIOL SCAND, V23, P110, DOI 10.1111/j.1748-1716.1951.tb00800.x; VOUTE CL, 1978, J MEMBRANE BIOL, V40, P151, DOI 10.1007/BF02026003; WELSH MJ, 1982, SCIENCE, V218, P1219, DOI 10.1126/science.6293054; WILLS NK, 1985, J PHYSIOL-LONDON, V358, P433, DOI 10.1113/jphysiol.1985.sp015560; Zhang ZR, 2000, J MEMBRANE BIOL, V175, P35, DOI 10.1007/s002320001053; Zhu JX, 2011, TRANSL RES, V158, P146, DOI 10.1016/j.trsl.2011.04.003; Zhu JX, 2005, EUR J PHARMACOL, V510, P187, DOI 10.1016/j.ejphar.2005.01.026	44	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171045	10.1371/journal.pone.0171045	http://dx.doi.org/10.1371/journal.pone.0171045			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152000	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200079
J	Gladilin, E				Gladilin, Evgeny			Graph-theoretical model of global human interactome reveals enhanced long-range communicability in cancer networks	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; FUNCTIONAL MODULES; IDENTIFICATION; PATTERNS; ORGANIZATION; MODULARITY; CENTRALITY; COMPLEXES; TOPOLOGY; BIOLOGY	Malignant transformation is known to involve substantial rearrangement of the molecular genetic landscape of the cell. A common approach to analysis of these alterations is a reductionist one and consists of finding a compact set of differentially expressed genes or associated signaling pathways. However, due to intrinsic tumor heterogeneity and tissue specificity, biomarkers defined by a small number of genes/pathways exhibit substantial variability. As an alternative to compact differential signatures, global features of genetic cell machinery are conceivable. Global network descriptors suggested in previous works are, however, known to potentially be biased by overrepresentation of interactions between frequently studied genes-proteins. Here, we construct a cellular network of 74538 directional and differential gene expression weighted protein-protein and gene regulatory interactions, and perform graph-theoretical analysis of global human interactome using a novel, degree independent feature-the normalized total communicability (NTC). We apply this framework to assess differences in total information flow between different cancer (BRCA/COAD/GBM) and non-cancer interactomes. Our experimental results reveal that different cancer interactomes are characterized by significant enhancement of long-range NTC, which arises from circulation of information flow within robustly organized gene subnetworks. Although enhancement of NTC emerges in different cancer types from different genomic profiles, we identified a subset of 90 common genes that are related to elevated NTC in all studied tumors. Our ontological analysis shows that these genes are associated with enhanced cell division, DNA replication, stress response, and other cellular functions and processes typically upregulated in cancer. We conclude that enhancement of long-range NTC manifested in the correlated activity of genes whose tight coordination is required for survival and proliferation of all tumor cells, and, thus, can be seen as a graph-theoretical equivalent to some hallmarks of cancer. The computational framework for differential network analysis presented herein is of potential interest for a wide range of network perturbation problems given by single or multiple gene-protein activation-inhibition.	[Gladilin, Evgeny] German Canc Res Ctr, Div Theoret Bioinformat, Berliner Str 41, D-69120 Heidelberg, Germany; [Gladilin, Evgeny] Heidelberg Univ, BioQuant, Neuenheimer Feld 267, D-69120 Heidelberg, Germany; [Gladilin, Evgeny] Heidelberg Univ, IPMB, Neuenheimer Feld 267, D-69120 Heidelberg, Germany; [Gladilin, Evgeny] Leibniz Inst Plant Genet & Crop Plant Res, Corrensstr 3, D-06466 Gatersleben, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Gladilin, E (corresponding author), German Canc Res Ctr, Div Theoret Bioinformat, Berliner Str 41, D-69120 Heidelberg, Germany.; Gladilin, E (corresponding author), Heidelberg Univ, BioQuant, Neuenheimer Feld 267, D-69120 Heidelberg, Germany.; Gladilin, E (corresponding author), Heidelberg Univ, IPMB, Neuenheimer Feld 267, D-69120 Heidelberg, Germany.; Gladilin, E (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res, Corrensstr 3, D-06466 Gatersleben, Germany.	evgeny.gladilin@gmail.com						Albert R, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.032811; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Banerji CRS, 2013, SCI REP-UK, V3, DOI 10.1038/srep03039; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Benzi M, 2013, J COMPLEX NETW, V1, P124, DOI 10.1093/comnet/cnt007; Cho DY, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002820; Christensen C, 2007, INT J BIFURCAT CHAOS, V17, P2201, DOI 10.1142/S021812740701835X; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; Davis TA, 2006, FUND ALGORITHMS, V2, P1, DOI 10.1137/1.9780898718881; Estrada E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056103; Feng JX, 2011, IEEE ACM T COMPUT BI, V8, P621, DOI 10.1109/TCBB.2010.78; Guney E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094686; Guney E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043557; Hakes L, 2008, NAT BIOTECHNOL, V26, P69, DOI 10.1038/nbt0108-69; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanisch Daniel, 2002, Bioinformatics, V18 Suppl 1, pS145; Heng HHQ, 2011, GENOMICS, V98, P242, DOI 10.1016/j.ygeno.2011.05.008; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Islam Md Fahmid, 2013, J Clin Bioinforma, V3, P19, DOI 10.1186/2043-9113-3-19; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jonsson PF, 2006, BIOINFORMATICS, V22, P2291, DOI 10.1093/bioinformatics/btl390; Komurov K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-154; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li XL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S3; Liu GM, 2009, BIOINFORMATICS, V25, P1891, DOI 10.1093/bioinformatics/btp311; Liu H, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-158; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Milenkovic T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023016; Milenkovic T, 2010, J R SOC INTERFACE, V7, P423, DOI 10.1098/rsif.2009.0192; Pandey G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109130; Platzer A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-224; Rai A, 2014, SCI REP-UK, V4, DOI 10.1038/srep06368; Schaefer MH, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00260; Schramm G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-162; Tanay A, 2004, P NATL ACAD SCI USA, V101, P2981, DOI 10.1073/pnas.0308661100; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Tornow S, 2003, NUCLEIC ACIDS RES, V31, P6283, DOI 10.1093/nar/gkg838; Tuck DP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-236; Ulitsky I, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-8; Weiss JN, 2012, CIRC RES, V111, P493, DOI 10.1161/CIRCRESAHA.112.269084; West J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00802; Yu Donghyeon, 2013, Genomics & Informatics, V11, P200, DOI 10.5808/GI.2013.11.4.200; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	44	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170953	10.1371/journal.pone.0170953	http://dx.doi.org/10.1371/journal.pone.0170953			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141819	gold, Green Submitted, Green Published			2022-12-27	WOS:000396129500030
J	Aguilar, VS; van de Gronde, JJ; Lamoth, CJC; van Diest, M; Maurits, NM; Roerdink, JBTM				Aguilar, Venustiano Soancatl; van de Gronde, Jasper J.; Lamoth, Claudine J. C.; van Diest, Mike; Maurits, Natasha M.; Roerdink, Jos B. T. M.			Visual Data Exploration for Balance Quantification in Real-Time During Exergaming	PLOS ONE			English	Article							POSTURAL CONTROL; OLDER-PEOPLE; BODY SWAY; STABILITY; PATTERNS; FALLS; MANAGEMENT; MOVEMENT; KINECT	Unintentional injuries are among the ten leading causes of death in older adults; falls cause 60% of these deaths. Despite their effectiveness to improve balance and reduce the risk of falls, balance training programs have several drawbacks in practice, such as lack of engaging elements, boring exercises, and the effort and cost of travelling, ultimately resulting in low adherence. Exergames, that is, digital games controlled by body movements, have been proposed as an alternative to improve balance. One of the main challenges for exergames is to automatically quantify balance during game-play in order to adapt the game difficulty according to the skills of the player. Here we perform a multidimensional exploratory data analysis, using visualization techniques, to find useful measures for quantifying balance in real-time. First, we visualize exergaming data, derived from 400 force plate recordings of 40 participants from 20 to 79 years and 10 trials per participant, as heat maps and violin plots to get quick insight into the nature of the data. Second, we extract known and new features from the data, such as instantaneous speed, measures of dispersion, turbulence measures derived from speed, and curvature values. Finally, we analyze and visualize these features using several visualizations such as a heat map, overlapping violin plots, a parallel coordinate plot, a projection of the two first principal components, and a scatter plot matrix. Our visualizations and findings suggest that heat maps and violin plots can provide quick insight and directions for further data exploration. The most promising measures to quantify balance in real-time are speed, curvature and a turbulence measure, because these measures show age-related changes in balance performance. The next step is to apply the present techniques to data of whole body movements as recorded by devices such as Kinect.	[Aguilar, Venustiano Soancatl; van de Gronde, Jasper J.; Roerdink, Jos B. T. M.] Univ Groningen, Johann Bernoulli Inst Math & Comp Sci, Groningen, Netherlands; [Maurits, Natasha M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Lamoth, Claudine J. C.; van Diest, Mike] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [van Diest, Mike] INCAS3, Assen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Aguilar, VS (corresponding author), Univ Groningen, Johann Bernoulli Inst Math & Comp Sci, Groningen, Netherlands.	v.soancatl.aguilar@rug.nl	Roerdink, Jos B.T.M/B-3631-2008; Lamoth, Claudine JC/N-4325-2013	Lamoth, Claudine JC/0000-0002-6495-2823; Maurits, Natasha/0000-0001-6231-7044; Soancatl Aguilar, Venustiano/0000-0001-6833-403X	INCAS3; 8D-Games; Northern Netherlands Provinces Alliance, Course for the North; Mexican National Council of Science and Technology (CONACYT) [313791]	INCAS3; 8D-Games; Northern Netherlands Provinces Alliance, Course for the North; Mexican National Council of Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The exergaming project has been performed on behalf of research center SPRINT of the UMCG and was supported by INCAS3 and 8D-Games. The project was financially supported by the Northern Netherlands Provinces Alliance, Course for the North. Data reported in the presented paper were collected in the realm of this project. Venustiano Soancatl Aguilar was supported by the Mexican National Council of Science and Technology (CONACYT) under scholarship number 313791.r The exergaming project has been performed on behalf of research center SPRINT of the UMCG and was supported by INCAS<SUP>3</SUP> and 8D-Games. The project was financially supported by the Northern Netherlands Provinces Alliance, Course for the North. Data reported in the presented paper were collected in the realm of this project. Venustiano Soancatl Aguilar was supported by the Mexican National Council of Science and Technology (CONACYT) under scholarship number 313791.	Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Abrahamova D, 2008, PHYSIOL RES, V57, P957, DOI 10.33549/physiolres.931238; Aigner W, 2011, HUM-COMPUT INT-SPRIN, P1, DOI 10.1007/978-0-85729-079-3; ALEXANDER BH, 1992, AM J PUBLIC HEALTH, V82, P1020, DOI 10.2105/AJPH.82.7.1020; [Anonymous], 2007, WHO GLOB REP FALLP; [Anonymous], 2021, LANG ENV STAT COMP; Bradshaw P, 1971, INTRO TURBULENCE ITS; Burgers C, 2015, COMPUT HUM BEHAV, V48, P94, DOI 10.1016/j.chb.2015.01.038; Carpman N., 2011, TURBULENCE INTENSITY; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Chiari L, 2000, GAIT POSTURE, V12, P225, DOI 10.1016/S0966-6362(00)00086-2; Clemons TE, 2000, COMPUT STAT DATA AN, V34, P51, DOI 10.1016/S0167-9473(99)00074-2; Donker SF, 2008, EXP BRAIN RES, V184, P363, DOI 10.1007/s00221-007-1105-y; Dowle M, 2015, DATA TABLE EXTENSION; Duarte M, 2010, REV BRAS FISIOTER, V14, P183, DOI 10.1590/S1413-35552010000300003; Fox J., 2019, R COMPANION APPL REG, V.; Franco MR, 2015, BRIT J SPORT MED, V49, P1268, DOI 10.1136/bjsports-2014-094015; GABRIEL KR, 1971, BIOMETRIKA, V58, P453, DOI 10.1093/biomet/58.3.453; Galna B, 2014, GAIT POSTURE, V39, P1062, DOI 10.1016/j.gaitpost.2014.01.008; Gillespie LD, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007146.pub3; Gintautas D, 2013, MULTIDIMENSIONAL DAT; Goldberger AL, 1996, LANCET, V347, P1312, DOI 10.1016/S0140-6736(96)90948-4; Hall KS, 2017, J GERONTOL A-BIOL, V72, P572, DOI 10.1093/gerona/glw120; Heinrich J, 2013, STAR P EUR, V2013, P95, DOI [10.2312/conf/EG2013/stars/095-116, DOI 10.2312/CONF/EG2013/STARS/095-116]; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; Inselberg A., 2009, PARALLEL COORDINATES, V1; Jolliffe I.T., 1986, PRINCIPAL COMPONENT, P487, DOI [DOI 10.1007/B98835, 10.1007/978-1-4757-1904-8_8]; Kosse NM., 2011, J CYBER THERAPY REHA, V4, P399; Lamoth CJC, 2012, GAIT POSTURE, V35, P489, DOI 10.1016/j.gaitpost.2011.11.014; Lamoth CJC, 2009, GAIT POSTURE, V29, P546, DOI 10.1016/j.gaitpost.2008.12.006; Larsen LH, 2013, GAMES HEALTH J, V2, P205, DOI 10.1089/g4h.2013.0036; Legendre P, 1988, NUMERICAL ECOLOGY; Lin DD, 2008, GAIT POSTURE, V28, P337, DOI 10.1016/j.gaitpost.2008.01.005; Lu LF, 2016, J VISUAL LANG COMPUT, V33, P3, DOI 10.1016/j.jvlc.2015.12.001; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; MARTIN JD, 1971, AM SOCIOL REV, V36, P496, DOI 10.2307/2093089; NEWELL KM, 1993, GAIT POSTURE, V1, P225, DOI 10.1016/0966-6362(93)90050-B; Pollock AS, 2000, CLIN REHABIL, V14, P402, DOI 10.1191/0269215500cr342oa; Pratt V., 2011, COLL MATH J, V40, P1; Pressley Andrew, 2001, ELEMENTARY DIFFERENT; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Ramdani S, 2009, MED ENG PHYS, V31, P1023, DOI 10.1016/j.medengphy.2009.06.004; Raymakers JA, 2005, GAIT POSTURE, V21, P48, DOI 10.1016/j.gaitpost.2003.11.006; Ridout MS, 2009, J AGR BIOL ENVIR ST, V14, P322, DOI 10.1198/jabes.2009.08038; Riley MA, 1999, GAIT POSTURE, V9, P65, DOI 10.1016/S0966-6362(98)00044-7; Robinson L, 2014, DISABIL REHABIL, V36, P379, DOI 10.3109/09638288.2013.797507; Roerdink M, 2006, EXP BRAIN RES, V174, P256, DOI 10.1007/s00221-006-0441-7; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Schmit JM, 2006, EXP BRAIN RES, V168, P357, DOI 10.1007/s00221-005-0094-y; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Soancatl V, 2016, EUROVIS 2016 POSTERS, P25; Stergiou UH, 2004, INNOVATIVE ANAL HUMA, P63; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Stull R.B., 1988, ATMOSPHERIC OCEANOGR; Sun TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069471; Tsinober A, 2009, FLUID MECH APPL, V92, P1, DOI 10.1007/978-90-481-3174-7; Tukey JW, 1977, EXPLORATORY DATA ANA; van Diest M, 2016, GAIT POSTURE, V44, P161, DOI 10.1016/j.gaitpost.2015.11.019; van Diest M., 2016, THESIS; van Diest M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134350; van Diest M, 2014, J BIOMECH, V47, P2925, DOI 10.1016/j.jbiomech.2014.07.017; van Diest M, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-101; Wiemeyer J, 2015, GAMES HEALTH J, V4, P58, DOI 10.1089/g4h.2014.0078; Wilkinson L, 2009, AM STAT, V63, P179, DOI 10.1198/tas.2009.0033; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Woollacott MH, 1996, J AGING PHYS ACTIV, V4, P214, DOI 10.1123/japa.4.3.214; Wu S, 2009, PATTERN RECOGN, V42, P194, DOI 10.1016/j.patcog.2008.06.023; Zhou H, 2008, COMPUT GRAPH FORUM, V27, P1047, DOI 10.1111/j.1467-8659.2008.01241.x	70	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170906	10.1371/journal.pone.0170906	http://dx.doi.org/10.1371/journal.pone.0170906			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6PA	28135284	Green Published, gold			2022-12-27	WOS:000396124700029
J	Boccia, G; Moise, P; Franceschi, A; Trova, F; Panero, D; La Torre, A; Rainoldi, A; Schena, F; Cardinale, M				Boccia, Gennaro; Moise, Paolo; Franceschi, Alberto; Trova, Francesco; Panero, Davide; La Torre, Antonio; Rainoldi, Alberto; Schena, Federico; Cardinale, Marco			Career Performance Trajectories in Track and Field Jumping Events from Youth to Senior Success: The Importance of Learning and Development	PLOS ONE			English	Article							LEG EXTENSOR MUSCLES; TALENT IDENTIFICATION; SEX-DIFFERENCES; AGE; CHILDHOOD; GROWTH; SPORT; CHILDREN; PROGRAMS; POWER	Introduction The idea that early sport success can be detrimental for long-term sport performance is still under debate. Therefore, the aims of this study were to examine the career trajectories of Italian high and long jumpers to provide a better understanding of performance development in jumping events. Methods The official long-jump and high-jump rankings of the Italian Track and Field Federation were collected from the age of 12 to career termination, for both genders from the year 1994 to 2014. Top-level athletes were identified as those with a percentile of their personal best performance between 97 and 100. Results The age of entering competitions of top-level athletes was not different than the rest of the athletic population, whereas top-level athletes performed their personal best later than the rest of the athletes. Top-level athletes showed an overall higher rate of improvement in performance from the age of 13 to the age of 18 years when compared to all other individuals. Only 10-25% of the top-level adult athletes were top-level at the age of 16. Around 60% of the top-level young at the age of 16 did not maintain the same level of performance in adulthood. Female high-jump represented an exception from this trend since in this group most top-level young become top-level adult athletes. Conclusions These findings suggest that performance before the age of 16 is not a good predictor of adult performance in long and high jump. The annual rate of improvements from 13 to 18 years should be included as a predictor of success rather than performance per se. Coaches should be careful about predicting future success based on performances obtained during youth in jumping events.	[Boccia, Gennaro; Schena, Federico] CeRiSM Res Ctr Sport Mt & Hlth, Rovereto, TN, Italy; [Boccia, Gennaro; Rainoldi, Alberto] Univ Turin, Sch Exercise & Sport Sci, Motor Sci Res Ctr, SUISM,Dept Med Sci, Turin, Italy; [Moise, Paolo; Franceschi, Alberto; Trova, Francesco; Panero, Davide] Univ Turin, SUISM, Sch Exercise & Sport Sci, Turin, Italy; [La Torre, Antonio] Univ Verona, Dept Neurol & Movement Sci, Sch Sport & Exercise Sci, Verona, Italy; [Schena, Federico] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Cardinale, Marco] Aspire Acad, Doha, Qatar; [Cardinale, Marco] UCL, Dept Comp Sci, London, England; [Cardinale, Marco] Univ St Mark & St John, Plymouth, Devon, England	University of Turin; University of Turin; University of Verona; University of Milan; Aspire Academy for Sports Excellence; University of London; University College London	Boccia, G (corresponding author), CeRiSM Res Ctr Sport Mt & Hlth, Rovereto, TN, Italy.; Boccia, G (corresponding author), Univ Turin, Sch Exercise & Sport Sci, Motor Sci Res Ctr, SUISM,Dept Med Sci, Turin, Italy.	gennaro.boccia@unito.it	Cardinale, Marco/N-3138-2019	Cardinale, Marco/0000-0002-2777-8707; Rainoldi, Alberto/0000-0003-4553-2898; Boccia, Gennaro/0000-0001-8706-4098; Moise, Paolo/0000-0002-3067-3455; Franceschi, Alberto/0000-0002-9830-5640; Schena, Federico/0000-0002-2052-5117				Abbott A, 2004, J SPORT SCI, V22, P395, DOI 10.1080/02640410410001675324; Abbott Angela, 2005, Nonlinear Dynamics Psychol Life Sci, V9, P61; Allen SV, 2014, EUR J SPORT SCI, V14, P643, DOI 10.1080/17461391.2014.893020; Atkinson G, 2012, INT J SPORTS MED, V33, P505, DOI 10.1055/s-0032-1316355; Bosco C, 2002, BIOL SPORT, V19, P189; Breitbach S, 2014, SPORTS MED, V44, P1489, DOI 10.1007/s40279-014-0221-7; Cardinale M, 2006, J STRENGTH COND RES, V20, P103; Costa MJ, 2011, J SPORT SCI, V29, P1183, DOI 10.1080/02640414.2011.587196; De Bellis MD, 2001, CEREB CORTEX, V11, P552, DOI 10.1093/cercor/11.6.552; EATON WO, 1986, PSYCHOL BULL, V100, P19, DOI 10.1037/0033-2909.100.1.19; Eisenmann JC, 2003, J SPORT SCI, V21, P551, DOI 10.1080/0264041031000101845; FERRETTI G, 1994, EUR J APPL PHYSIOL O, V68, P111, DOI 10.1007/BF00244022; Focke A, 2013, EUR J SPORT SCI, V13, P518, DOI 10.1080/17461391.2012.756069; Fransen J, 2012, J SPORT SCI, V30, P379, DOI 10.1080/02640414.2011.642808; Goncalves CEB, 2012, INT J SPORT PHYSIOL, V7, P390, DOI 10.1123/ijspp.7.4.390; Kambouris Marios, 2012, Recent Pat DNA Gene Seq, V6, P229; Kennedy KM, 2005, CORTEX, V41, P560, DOI 10.1016/S0010-9452(08)70196-5; KOMI PV, 1978, MED SCI SPORT EXER, V10, P261; Lee SJ, 2007, TRENDS GENET, V23, P475, DOI 10.1016/j.tig.2007.08.008; MacNamara A, 2010, SPORT PSYCHOL, V24, P52, DOI 10.1123/tsp.24.1.52; Macnamara BN, 2016, PERSPECT PS IN PRESS; MALINA RM, 1988, ANNU REV ANTHROPOL, V17, P187, DOI 10.1146/annurev.an.17.100188.001155; Malina RM, 2001, QUEST, V53, P346, DOI 10.1080/00336297.2001.10491751; Malina RM, 2006, FOOD NUTR B; Malina Robert M, 2007, Med Sport Sci, V50, P67, DOI 10.1159/000101076; Malina RM, 2010, J HUM KINET, V24, P79, DOI 10.2478/v10078-010-0023-4; Moesch K, 2011, SCAND J MED SCI SPOR, V21, pE282, DOI 10.1111/j.1600-0838.2010.01280.x; Moreno-Briseno P, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-74; Nikolaidis P.T., 2014, AM J SPORTS SCI MED, V2, P60, DOI [http://dx.doi.org/10.12691/ajssm-2-2-1, DOI 10.12691/AJSSM-2-2-1]; Nikolaidis PT, 2013, J HUM KINET, V38, P115, DOI 10.2478/hukin-2013-0051; Ostrander EA, 2009, ANNU REV GENOM HUM G, V10, P407, DOI 10.1146/annurev-genom-082908-150058; Piacentini MF, 2014, J SPORT MED PHYS FIT, V54, P410; Reed TE, 2004, NEUROPSYCHOLOGIA, V42, P1709, DOI 10.1016/j.neuropsychologia.2004.02.016; Rees T, 2016, SPORTS MED, V46, P1041, DOI 10.1007/s40279-016-0476-2; Saint-Maurice PF, 2015, RES Q EXERCISE SPORT, V86, pS29, DOI 10.1080/02701367.2015.1042354; Taylor MJD, 2010, J SPORT SCI, V28, P867, DOI 10.1080/02640411003770212; Temfemo A, 2009, EUR J PEDIATR, V168, P457, DOI 10.1007/s00431-008-0771-5; THOMAS JR, 1985, PSYCHOL BULL, V98, P260, DOI 10.1037/0033-2909.98.2.260; Tonnessen E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129014; Vaeyens R, 2008, SPORTS MED, V38, P703, DOI 10.2165/00007256-200838090-00001; Vaeyens R, 2009, J SPORT SCI, V27, P1367, DOI 10.1080/02640410903110974; van Rens FECA, 2015, INT REV SOCIOL SPORT, V50, P64, DOI 10.1177/1012690212468585; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590	43	29	31	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170744	10.1371/journal.pone.0170744	http://dx.doi.org/10.1371/journal.pone.0170744			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7VX	28129370	Green Published, Green Submitted, gold			2022-12-27	WOS:000396211400040
J	de Oliveira, SAR; Lucio, LMC; Modolo, NSP; Hayashi, Y; Braz, MG; de Carvalho, LR; Braz, LG; Braz, JRC				de Oliveira, Sergius A. R.; Lucio, Lorena M. C.; Modolo, Norma S. P.; Hayashi, Yoko; Braz, Mariana G.; de Carvalho, Lidia R.; Braz, Leandro G.; Braz, Jose Reinaldo C.			The Humidity in a Low-Flow Drager Fabius Anesthesia Workstation with or without Thermal Insulation or a Heat and Moisture Exchanger: A Prospective Randomized Clinical Trial	PLOS ONE			English	Article							INSPIRED GAS; HUMIDIFICATION; TEMPERATURE; SYSTEM	Background During anesthesia, as compared with intensive care, the time of the tracheal intubation is much shorter. An inhaled gas minimum humidity of 20 mgH(2)O.L- 1 is recommended to reduce the deleterious effects of dry gas on the airways during anesthesia with tracheal intubation. The Fabius GS Premium (R) anesthesia workstation (Drager Medical, Lubeck, Germany) has a built-in hotplate to heat gases in the breathing circuit. A heat and moisture exchanger (HME) is used to further heat and humidify the inhaled gas. The humidity of the gases in the breathing circuit is influenced by the ambient temperature. We compared the humidity of the inhaled gases from a low-flow Fabius anesthesia workstation with or without thermal insulation (TI) of the breathing circuit and with or without an HME. Methods We conducted a prospective randomized trial in 41 adult female patients who underwent elective abdominal surgery. The patients were allocated into four groups according to the devices used to ventilate their lungs using a Drager Fabius anesthesia workstation with a low gas flow (1 L.min(- 1)): control, with TI, with an HME or with TI and an HME (TIHME). The mean temperature and humidity of the inhaled gases were measured during 2-h after connecting the patients to the breathing circuit. Results The mean inhaled gas temperature and absolute humidity were higher in the HME (29.2 +/- 1.3 degrees C;28.1 +/- 2.3 mgH(2)O.L-1) and TIHME (30.1 +/- 1.2 degrees C; 29.4 +/- 2.0 mgH(2)O.L- 1) groups compared with the control(27.5 +/- 1.0 25.0 +/- 1.8 mgH(2)O.L- 1) and TI (27.2 +/- 1.1 degrees C; 24.9 +/- 1.8 mgH(2)O.L- 1) groups (P=0.003 and P<0.001, respectively). Conclusions The low-flow Fabius GS Premium breathing circuit provides the minimum humidity level of inhaled gases to avoid damage to the tracheobronchial epithelia during anesthesia. TI of the breathing circuit does not increase the humidity of the inhaled gases, whereas inserting an HME increases the moisture of the inhaled gases closer to physiological values.	[de Oliveira, Sergius A. R.; Lucio, Lorena M. C.; Modolo, Norma S. P.; Hayashi, Yoko; Braz, Mariana G.; Braz, Leandro G.; Braz, Jose Reinaldo C.] UNESP Univ Estadual Paulista, Botucatu Med Sch, Dept Anesthesiol, Botucatu, SP, Brazil; [de Carvalho, Lidia R.] UNESP Univ Estadual Paulista, Inst Biosci, Dept Biostat, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Braz, JRC (corresponding author), UNESP Univ Estadual Paulista, Botucatu Med Sch, Dept Anesthesiol, Botucatu, SP, Brazil.	jbraz@fmb.unesp.br	Braz, Leandro/AAK-8378-2021; Módolo, Norma Sueli Pinheiro/W-9448-2019; Carvalho, L.R./C-2973-2013; Braz, Leandro Gobbo/W-4445-2019; Braz, Mariana G/E-7639-2012	Módolo, Norma Sueli Pinheiro/0000-0002-8549-6820; Carvalho, L.R./0000-0003-0575-2263; Braz, Leandro Gobbo/0000-0002-1927-8729; Braz, Mariana G/0000-0003-4413-226X	Coordination of Improvement for Higher Academic Staff (CAPES), Brazil; Sao Paulo Research Foundation (FAPESP), Brazil [2012/10400-3]; Brazilian National Council for Scientific and Technological Development (CNPq)	Coordination of Improvement for Higher Academic Staff (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Research Foundation (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Sergius A.R. de Oliveira was granted a scholarship from Coordination of Improvement for Higher Academic Staff (CAPES), Brazil, and Yoko Hayashi was granted a scholarship (grant #2012/10400-3) from the Sao Paulo Research Foundation (FAPESP), Brazil, and Jose R.C. Braz was granted a scholarship from the Brazilian National Council for Scientific and Technological Development (CNPq).	Bicalho GP, 2014, ANESTH ANALG, V119, P926, DOI 10.1213/ANE.0000000000000353; BICKLER PE, 1990, ANESTH ANALG, V71, P415; Bisinotto FMB, 1999, CAN J ANAESTH, V46, P897, DOI 10.1007/BF03012983; BISSONNETTE B, 1989, ANESTH ANALG, V69, P783; Branson RD, 1998, ANAESTH INTENS CARE, V26, P178, DOI 10.1177/0310057X9802600208; CHALON J, 1979, CAN ANAESTH SOC J, V26, P361, DOI 10.1007/BF03006448; CHALON J, 1972, ANESTHESIOLOGY, V37, P338, DOI 10.1097/00000542-197209000-00010; de Castro J, 2011, ANESTH ANALG, V113, P534, DOI 10.1213/ANE.0b013e31822402df; Dias NH, 2005, ANN OTO RHINOL LARYN, V114, P411, DOI 10.1177/000348940511400514; FOREGGER R, 1948, ANESTHESIOLOGY, V9, P15, DOI 10.1097/00000542-194801000-00003; Gorayb Susane Bruder Silveira, 2004, Rev. Bras. Anestesiol., V54, P20, DOI 10.1590/S0034-70942004000100004; Henriksson BA, 1997, ANAESTHESIA, V52, P144, DOI 10.1111/j.1365-2044.1997.17-az018.x; Hunter T, 2005, PEDIATR ANESTH, V15, P750, DOI 10.1111/j.1460-9592.2005.01559.x; International Standards Organization, 2007, 8115 ISO; Irlbeck D, 1998, Respir Care Clin N Am, V4, P189; Johansson A, 2003, ACTA ANAESTH SCAND, V47, P564, DOI 10.1034/j.1399-6576.2003.00108.x; Kleemann P P, 1990, Acta Anaesthesiol Belg, V41, P189; KLEEMANN PP, 1994, ANAESTH INTENS CARE, V22, P396, DOI 10.1177/0310057X9402200414; Martins RH, 1996, REV BRAS OTORRINOLAR, V62, P206; Poopalalingam R., 2002, SMJ Singapore Medical Journal, V43, P563; Restrepo RD, 2012, RESP CARE, V57, P782, DOI 10.4187/respcare.01766; Sessler DI, 2008, ANESTHESIOLOGY, V109, P318, DOI 10.1097/ALN.0b013e31817f6d76; Torres MLA, 1997, REV BRAS ANESTESIOL, V47, P89; VANOOSTDAM JC, 1986, J APPL PHYSIOL, V61, P312, DOI 10.1152/jappl.1986.61.1.312; Wada Hiroki, 2003, J Anesth, V17, P166, DOI 10.1007/s00540-003-0174-8; Wilkes AR, 2011, ANAESTHESIA, V66, P31, DOI 10.1111/j.1365-2044.2010.06563.x; Williams R, 1996, CRIT CARE MED, V24, P1920, DOI 10.1097/00003246-199611000-00025; Yamashita K, 2007, J ANESTH, V21, P55, DOI 10.1007/s00540-006-0442-5	28	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170723	10.1371/journal.pone.0170723	http://dx.doi.org/10.1371/journal.pone.0170723			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129353	Green Submitted, Green Published, gold			2022-12-27	WOS:000396211400045
J	Degre, D; Serste, T; Lasser, L; Delwaide, J; Starkel, P; Laleman, W; Langlet, P; Reynaert, H; Bourgeois, S; Vanwolleghem, T; Dastis, SN; Gustot, T; Geerts, A; Van Steenkiste, C; De Galocsy, C; Lepida, A; Orlent, H; Moreno, C				Degre, Delphine; Serste, Thomas; Lasser, Luc; Delwaide, Jean; Starkel, Peter; Laleman, Wim; Langlet, Philippe; Reynaert, Hendrik; Bourgeois, Stefan; Vanwolleghem, Thomas; Dastis, Sergio Negrin; Gustot, Thierry; Geerts, Anja; Van Steenkiste, Christophe; De Galocsy, Chantal; Lepida, Antonia; Orlent, Hans; Moreno, Christophe			Sofosbuvir in Combination with Simeprevir plus /- Ribavirin in Genotype 4 Hepatitis C Patients with Advanced Fibrosis or Cirrhosis: A Real-World Experience from Belgium	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; ALL-CAUSE MORTALITY; OPEN-LABEL; CHRONIC HCV; VIRUS; LEDIPASVIR; INFECTION; THERAPY; MULTICENTER; NAIVE	Introduction Hepatitis C virus (HCV) is a major global health issue and successful treatment has been associated with a reduction of risk of all-cause mortality. Advancements have been made in HCV treatment through the use of interferon-free regimens. Most trials have been conducted in HCV genotype (GT) 1 and data for interferon-free regimens in GT4 patients are limited. The aim of this study was to evaluate the safety and efficacy of sofosbuvir plus simeprevir in a real-world cohort of HCV GT4 patients with advanced fibrosis. Patients and Methods Eighty-seven GT4 treatment-naive or -Interferon (IFN) ribavirin (RBV) experienced patients treated with sofosbuvir and simeprevir +/- ribavirin (RBV) were enrolled in this cohort study (41% severe fibrosis, 59% cirrhosis). Results Patients were 51.7% male, 78.2% IFN/RBV treatment-experienced, and 37.9% received RBV treatment. The overall sustained virologic response at least 12 weeks after treatment SVR12) rate was 87.4% while patients treated with and without RBV had rates of 87.9% and 87% (p = 0.593), respectively, and patients with advanced fibrosis (F3) and patients with cirrhosis had SVR12 rates of 94.4% and 82.4% (p = 0.087), respectively. SVR12 rates in treatment-naive patients and in IFN/RBV -experienced patients were 78.9% and 89.7% (p = 0.191), respectively. Treatment failure occurred most commonly in patients with cirrhosis and severe disease. The treatment was well tolerated and no patient died or discontinued treatment due to adverse events. Conclusions Sofosbuvir in combination with simeprevir +/- ribavirin in GT 4 HCV patients with advanced fibrosis achieved high SVR12 rates and was well tolerated. RBV did not appear to increase the rate of SVR12.	[Degre, Delphine; Serste, Thomas; Lepida, Antonia; Moreno, Christophe] Univ Libre Bruxelles, CUB Hop Erasme, Dept Gastroenterol Hepatopancreatol & Digest Onco, Brussels, Belgium; [Serste, Thomas] CHU St Pierre, Dept Hepatogastroenterol, Brussels, Belgium; [Lasser, Luc] Brugmann Univ Hosp, Dept Gastroenterol, Brussels, Belgium; [Delwaide, Jean] Univ Liege, Dept Hepatogastroenterol, CHU Sart Tilman, Liege, Belgium; [Starkel, Peter] Clin Univ St Luc, Dept Hepatogastroenterol, Brussels, Belgium; [Laleman, Wim] Univ Hosp Gasthuisberg, Dept Gastroenterol & Hepatol, Leuven, Belgium; [Langlet, Philippe] CHIREC, Dept Hepatogastroenterol, Brussels, Belgium; [Reynaert, Hendrik] VUB, UZ Brussels, Dept Gastroenterol & Hepatol, Brussels, Belgium; [Bourgeois, Stefan] ZNA, Dept Gastroenterol & Hepatol, Antwerp, Belgium; [Vanwolleghem, Thomas] Univ Antwerp Hosp, Dept Gastroenterol & Hepatol, Edegem, Belgium; [Vanwolleghem, Thomas] Erasmus MC, Dept Gastroenterol & Hepatol, Lab Gastroenterol & Hepatol, Rotterdam, Netherlands; [Dastis, Sergio Negrin] GHdC, Dept Gastroenterol & Hepatol, Charleroi, Belgium; [Geerts, Anja] Univ Hosp Ghent, Dept Gastroenterol & Hepatol, Ghent, Belgium; [Van Steenkiste, Christophe] AZ Maria Middelares, Dept Gastroenterol & Hepatol, Ghent, Belgium; [De Galocsy, Chantal; Lepida, Antonia] Hop IRIS sud, Dept Gastroenterol & Hepatol, Brussels, Belgium; [Orlent, Hans] AZ Bruges, Dept Gastroenterol & Hepatol, Brugge, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of Liege; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; KU Leuven; University Hospital Leuven; Vrije Universiteit Brussel; ZNA Stuivenberg; University of Antwerp; Erasmus University Rotterdam; Erasmus MC; Grand Hopital De Charleroi; Ghent University; Ghent University Hospital	Degre, D (corresponding author), Univ Libre Bruxelles, CUB Hop Erasme, Dept Gastroenterol Hepatopancreatol & Digest Onco, Brussels, Belgium.	delphine.degre@erasme.ulb.ac.be	Stärkel, Peter/AAC-6400-2019; Vanwolleghem, Thomas/AAD-4094-2022; Laleman, Wim/H-7272-2019	Laleman, Wim/0000-0002-0842-7813; Reynaert, Hendrik/0000-0002-2701-5777; Gustot, Thierry/0000-0002-5537-9607; de Galocsy, Chantal/0000-0003-2659-8859; Vanwolleghem, Thomas/0000-0002-0572-8741				Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Al Ashgar HI, 2013, SAUDI J GASTROENTERO, V19, P28, DOI 10.4103/1319-3767.105920; Aqel BA, 2015, HEPATOLOGY, V62, P1004, DOI 10.1002/hep.27937; Asselah T, 2016, LANCET GASTROENTEROL, V1, P25, DOI 10.1016/S2468-1253(16)30001-2; Asselah T, 2015, HEPATOLOGY, V62, p340A; Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Chung RT, 2015, HEPATOLOGY, V62, P932, DOI 10.1002/hep.27950; Curry MP, 2015, NEW ENGL J MED, V373, P2618, DOI 10.1056/NEJMoa1512614; Doss W, 2015, J HEPATOL, V63, P581, DOI 10.1016/j.jhep.2015.04.023; Feld JJ, 2015, NEW ENGL J MED, V373, P2599, DOI 10.1056/NEJMoa1512610; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Ferraioli G, 2012, HEPATOLOGY, V56, P2125, DOI 10.1002/hep.25936; Food and Drug Administration (FDA), 2015, DRUG SAFETY COMMUNIC; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Holmberg SD, 2013, CLIN INFECT DIS, V57, P240, DOI 10.1093/cid/cit245; Kamal SM, 2008, HEPATOLOGY, V47, P1371, DOI 10.1002/hep.22127; Kamal SM, 2009, LIVER INT, V29, P39, DOI 10.1111/j.1478-3231.2008.01930.x; Khattab MA, 2011, J HEPATOL, V54, P1250, DOI 10.1016/j.jhep.2010.11.016; Kohli A, 2015, LANCET INFECT DIS, V15, P1049, DOI 10.1016/S1473-3099(15)00157-7; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Kwo P, 2016, HEPATOLOGY; Lawitz E, 2016, HEPATOLOGY, V64, P360, DOI 10.1002/hep.28422; Lawitz E, 2014, LANCET, V384, P1756, DOI 10.1016/S0140-6736(14)61036-9; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Manns M, 2016, LANCET INFECT DIS, V16, P685, DOI 10.1016/S1473-3099(16)00052-9; Moreno C, 2015, J HEPATOL, V62, P1047, DOI 10.1016/j.jhep.2014.12.031; Nicot F, 2005, J GEN VIROL, V86, P107, DOI 10.1099/vir.0.80409-0; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Ray SC, 2000, J INFECT DIS, V182, P698, DOI 10.1086/315786; Sulkowski MS, 2016, GASTROENTEROLOGY, V150, P419, DOI 10.1053/j.gastro.2015.10.013; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Wantuck JM, 2014, ALIMENT PHARM THER, V39, P137, DOI 10.1111/apt.12551; Wehmeyer MH, 2015, DIGEST LIVER DIS, V47, P811, DOI 10.1016/j.dld.2015.05.018; Willemse SB, 2016, J VIRAL HEPATITIS, V23, P950, DOI 10.1111/jvh.12567; Wise M, 2008, HEPATOLOGY, V47, P1128, DOI 10.1002/hep.22165; Zeuzem S, 2015, ANN INTERN MED, V163, P1, DOI 10.7326/M15-0785; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561	40	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170933	10.1371/journal.pone.0170933	http://dx.doi.org/10.1371/journal.pone.0170933			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125694	Green Published, gold, Green Submitted			2022-12-27	WOS:000396176100020
J	Xiao, LL; Liu, N; Zhang, GF; Zhang, H; Gao, S; Fu, Z; Wang, SZ; Yu, QX; Yu, JM; Yuan, SH				Xiao, Linlin; Liu, Ning; Zhang, Guifang; Zhang, Hui; Gao, Song; Fu, Zheng; Wang, Suzhen; Yu, Qingxi; Yu, Jinming; Yuan, Shuanghu			Late-Course Adaptive Adjustment Based on Metabolic Tumor Volume Changes during Radiotherapy May Reduce Radiation Toxicity in Patients with Non-Small Cell Lung Cancer	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CONCURRENT CHEMORADIOTHERAPY; DOSE-ESCALATION; POTENTIAL IMPACT; MEGAVOLTAGE CT; THERAPY; PET/CT; F-18-FDG	To reduce the high risk of radiation toxicity and enhance the quality of life of patients with non-small cell lung cancer (NSCLC), we quantified the metabolic tumor volumes (MTVs) from baseline to the late-course of radiotherapy (RT) by fluorodeoxyglucose positron emission tomography computerized tomography (FDG PET-CT) and discussed the potential benefit of late-course adaptive plans rather than original plans by dose volume histogram (DVH) comparisons. Seventeen patients with stage II-III NSCLC who were treated with definitive conventionally fractionated RT were eligible for this prospective study. FDG PET-CT scans were acquired within 1 week before RT (pre-RT) and at approximately two-thirds of the total dose during-RT (approximately 40 Gy). MTVs were taken as gross tumor volumes (GTVs) that included the primary tumor and any involved hilar or mediastinal lymph nodes. An original plan based on the baseline MTVs and adaptive plans based on observations during-RT MTVs were generated for each patient. The DVHs for lung, heart, esophagus and spinal cord were compared between the original plans and composite plans at 66 Gy. At the time of approximately 40 Gy during-RT, MTVs were significantly reduced in patients with NSCLC (pre-RT 136.2 +/- 82.3 ml vs. during-RT 64.7 +/- 68.0 ml, p = 0.001). The composite plan of the original plan at 40 Gy plus the adaptive plan at 26 Gy resulted in better DVHs for all the organs at risk that were evaluated compared to the original plan at 66 Gy (p<0.05), including V-5, V-10, V-15, V-20, V-25, V-30 and the mean dose of total lung, V-10, V-20, V-30, V-40, V-50, V-60 and the mean dose of heart, V-35, V-40, V-50, V-55, V-60, the maximum dose and mean dose of the esophagus, and the maximum dose of the spinal-cord. PET-MTVs were reduced significantly at the time of approximately 40 Gy during-RT. Late course adaptive radiotherapy may be an effective way to reduce the dose volume to the organs at risk, thus reducing radiation toxicity in patients with NSCLC.	[Xiao, Linlin] Univ Jinan, Shandong Acad Med Sci, Sch Med & Life Sci, Jinan, Shandong, Peoples R China; [Xiao, Linlin; Liu, Ning; Zhang, Guifang; Wang, Suzhen; Yu, Qingxi; Yu, Jinming; Yuan, Shuanghu] Shandong Univ, Shandong Canc Hosp, Dept Radiat Oncol, Jinan, Shandong, Peoples R China; [Zhang, Hui] Linyi Canc Hosp, Dept Oncol, Linyi, Shandong, Peoples R China; [Gao, Song] Jining Infect Dis Hosp, Dept Oncol, Jining, Shandong, Peoples R China; [Fu, Zheng] Shandong Univ, Shandong Canc Hosp, Dept Radiol, Jinan, Shandong, Peoples R China; [Yuan, Shuanghu] Shandong Acad Med Sci, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Yuan, SH (corresponding author), Shandong Univ, Shandong Canc Hosp, Dept Radiat Oncol, Jinan, Shandong, Peoples R China.; Yuan, SH (corresponding author), Shandong Acad Med Sci, Jinan, Shandong, Peoples R China.	yuanshuanghu@sina.com		, yuan/0000-0002-8327-2524	Natural Science Foundation of China [NSFC81172133, NSFC81372413]; Outstanding Youth Natural Science Foundation of Shandong Province [JQ201423]; projects of the Medical and Health Technology Development Program in Shandong province [2014WS0058]; Scientific Research in the Public Interest [201402011]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Youth Natural Science Foundation of Shandong Province; projects of the Medical and Health Technology Development Program in Shandong province; Scientific Research in the Public Interest	This study was supported by the Natural Science Foundation of China (NSFC81172133, NSFC81372413); the Outstanding Youth Natural Science Foundation of Shandong Province (JQ201423); and the projects of the Medical and Health Technology Development Program in Shandong province (2014WS0058), to SY. It was also supported by the special fund for Scientific Research in the Public Interest (201402011), to JY.	Auperin A, 2010, J CLIN ONCOL, V28, P2181, DOI 10.1200/JCO.2009.26.2543; Barriger RB, 2010, INT J RADIAT ONCOL, V78, P1381, DOI 10.1016/j.ijrobp.2009.09.030; Chi A, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00273; Ding XP, 2012, ASIAN PAC J CANCER P, V13, P319, DOI 10.7314/APJCP.2012.13.1.319; Ding XP, 2013, TECHNOL CANCER RES T, V12, P251, DOI 10.7785/tcrt.2012.500310; Everitt SJ, 2014, J NUCL MED, V55, P1069, DOI 10.2967/jnumed.113.131631; Feng M, 2009, INT J RADIAT ONCOL, V73, P1228, DOI 10.1016/j.ijrobp.2008.10.054; Flentje M, 2016, STRAHLENTHER ONKOL, V192, P216, DOI 10.1007/s00066-016-0941-8; Ford EC, 2009, J NUCL MED, V50, P1655, DOI 10.2967/jnumed.108.055780; Fox J, 2009, INT J RADIAT ONCOL, V74, P341, DOI 10.1016/j.ijrobp.2008.07.063; Gillham C, 2008, RADIOTHER ONCOL, V88, P335, DOI 10.1016/j.radonc.2008.05.004; Guckenberger M, 2011, INT J RADIAT ONCOL, V79, P901, DOI 10.1016/j.ijrobp.2010.04.050; Juweid ME, 2006, NEW ENGL J MED, V354, P496, DOI 10.1056/NEJMra050276; Kong FMS, 2007, J CLIN ONCOL, V25, P3116, DOI 10.1200/JCO.2006.10.3747; Kong FM, 2005, INT J RADIAT ONCOL, V63, P324, DOI 10.1016/j.ijrobp.2005.02.010; Kupelian PA, 2005, INT J RADIAT ONCOL, V63, P1024, DOI 10.1016/j.ijrobp.2005.04.046; Lee P, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00071; Lim G, 2011, J THORAC ONCOL, V6, P531, DOI 10.1097/JTO.0b013e31820b8a52; Mac MMP, 2012, SEMIN NUCL MED, V42, P308, DOI [10.1053/j.semnucimed.2012.04.003, DOI 10.1053/J.SEMNUCIMED.2012.04.003]; Mahasittiwat P, 2013, J RADIOL ONCOL, V2, P191, DOI 10.1007/s13566-013-0091-x; Marta GN, 2011, NUCL MED COMMUN, V32, P903, DOI 10.1097/MNM.0b013e32834a719a; Meng X, 2014, INT J RADIAT ONCOL, V89, P145, DOI 10.1016/j.ijrobp.2014.01.044; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Phernambucq ECJ, 2011, ANN ONCOL, V22, P132, DOI 10.1093/annonc/mdq316; Ramsey CR, 2006, INT J RADIAT ONCOL, V64, P1237, DOI 10.1016/j.ijrobp.2005.11.012; Saitoh JI, 2012, INT J RADIAT ONCOL, V82, P1791, DOI 10.1016/j.ijrobp.2011.03.007; Siker ML, 2006, INT J RADIAT ONCOL, V66, P135, DOI 10.1016/j.ijrobp.2006.03.064; Spratt DE, 2010, CLIN NUCL MED, V35, P237, DOI 10.1097/RLU.0b013e3181d18eb0; Tyldesley S, 2001, INT J RADIAT ONCOL, V49, P973, DOI 10.1016/S0360-3016(00)01401-2; Werner-Wasik M, 2011, CLIN LUNG CANCER, V12, P245, DOI 10.1016/j.cllc.2011.03.026; Yuan SG, 2012, INT J RADIAT ONCOL, V82, pE631, DOI 10.1016/j.ijrobp.2011.07.044; Zheng YD, 2014, ONCOL LETT, V7, P1015, DOI 10.3892/ol.2014.1874	32	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170901	10.1371/journal.pone.0170901	http://dx.doi.org/10.1371/journal.pone.0170901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125698	Green Submitted, gold, Green Published			2022-12-27	WOS:000396176100028
J	Phillips, ZF; Chen, M; Waller, L				Phillips, Zachary F.; Chen, Michael; Waller, Laura			Single-shot quantitative phase microscopy with color-multiplexed differential phase contrast (cDPC)	PLOS ONE			English	Article							HIGH-RESOLUTION; ILLUMINATION; FIELD	We present a new technique for quantitative phase and amplitude microscopy from a single color image with coded illumination. Our system consists of a commercial brightfield microscope with one hardware modification D an inexpensive 3D printed condenser insert. The method, color-multiplexed Differential Phase Contrast (cDPC), is a single-shot variant of Differential Phase Contrast (DPC), which recovers the phase of a sample from images with asymmetric illumination. We employ partially coherent illumination to achieve resolution corresponding to 2x the objective NA. Quantitative phase can then be used to synthesize DIC and phase contrast images or extract shape and density. We demonstrate amplitude and phase recovery at camera-limited frame rates (50 fps) for various in vitro cell samples and c. elegans in a micro-fluidic channel.	[Phillips, Zachary F.; Waller, Laura] Univ Calif Berkeley, Grad Grp Appl Sci & Technol, Berkeley, CA 94720 USA; [Chen, Michael; Waller, Laura] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Phillips, ZF (corresponding author), Univ Calif Berkeley, Grad Grp Appl Sci & Technol, Berkeley, CA 94720 USA.	zkphil@berkeley.edu	; aubertin, rebeckah/O-9624-2015	Waller, Laura/0000-0003-1243-2356; CHEN, MICHAEL/0000-0002-1633-3278; aubertin, rebeckah/0000-0002-0558-7571; Phillips, Zachary/0000-0002-8293-6798	Gordon and Betty Moore Foundation's Data-Driven Discovery Initiative [GBMF4562]; David & Lucille Packard Foundation Fellowship for Science Engineering	Gordon and Betty Moore Foundation's Data-Driven Discovery Initiative; David & Lucille Packard Foundation Fellowship for Science Engineering	This (research, publication, project, Web site, report, etc.) is funded by the Gordon and Betty Moore Foundation's Data-Driven Discovery Initiative through Grant GBMF4562 to Laura Waller (UC Berkeley) and by the David & Lucille Packard Foundation Fellowship for Science & Engineering.	Allman BE, 2005, OPTICAL SYSTEM PRODU; [Anonymous], 2009, QUANTITATIVE PHASE M; Awatsuji Y, 2004, APPL PHYS LETT, V85, P1069, DOI 10.1063/1.1777796; Barone-Nugent ED, 2002, J MICROSC-OXFORD, V206, P194, DOI 10.1046/j.1365-2818.2002.01027.x; Bhaduri B, 2012, OPT LETT, V37, P1094, DOI 10.1364/OL.37.001094; Bon P, 2012, METHOD SYSTEM STRUCT; Claus RA, 2015, OPT EXPRESS, V23, P26672, DOI 10.1364/OE.23.026672; Cui X, 2011, QUANTITATIVE DIFFERE; Donoho DL, 2003, P NATL ACAD SCI USA, V100, P2197, DOI 10.1073/pnas.0437847100; Gross D, 2011, IEEE T INFORM THEORY, V57, P1548, DOI 10.1109/TIT.2011.2104999; HAMILTON DK, 1984, J MICROSC-OXFORD, V133, P27, DOI 10.1111/j.1365-2818.1984.tb00460.x; Hayes M.H., 1996, STAT DIGITAL SIGNAL; Horstmeyer R, 2016, NAT PHOTONICS, V10, P68, DOI 10.1038/nphoton.2015.279; Jingshan Z, 2016, IEEE T COMPUTATIONAL; Johnson MK, 2009, PROC CVPR IEEE, P1070, DOI 10.1109/CVPRW.2009.5206534; Lee D, 2015, BIOMED OPT EXPRESS, V6, P4912, DOI 10.1364/BOE.6.004912; Liu ZJ, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.10.106002; Ma CG, 2015, OPT LETT, V40, P2281, DOI 10.1364/OL.40.002281; Mehta SB, 2009, OPT LETT, V34, P1924, DOI 10.1364/OL.34.001924; Phillips ZF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124938; Popescu G, 2006, OPT LETT, V31, P775, DOI 10.1364/OL.31.000775; Smith F. H., 1955, RESEARCH, V8, P385; Tian L, 2014, OPT LETT, V39, P1326, DOI 10.1364/OL.39.001326; varamonov V, 2016, IEEE C COMP VIS PATT; Wang Z, 2011, OPT EXPRESS, V19, P1016, DOI 10.1364/OE.19.001016; Witte S, 2012, BIOMED OPT EXPRESS, V3, P2184, DOI 10.1364/BOE.3.002184; Yun W, 2010, SYSTEM METHOD QUANTI; Zernike F, 1942, PHYSICA, V9, P686, DOI 10.1016/S0031-8914(42)80035-X; ZERNIKE F, 1955, SCIENCE, V121, P345, DOI 10.1126/science.121.3141.345; Zheng GA, 2013, NAT PHOTONICS, V7, P739, DOI [10.1038/NPHOTON.2013.187, 10.1038/nphoton.2013.187]; Zheng GA, 2011, OPT LETT, V36, P3987, DOI 10.1364/OL.36.003987	32	47	51	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171228	10.1371/journal.pone.0171228	http://dx.doi.org/10.1371/journal.pone.0171228			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152023	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161200110
J	Zachariasse, JM; Seiger, N; Rood, PPM; Alves, CF; Freitas, P; Smit, FJ; Roukema, GR; Moll, HA				Zachariasse, Joany M.; Seiger, Nienke; Rood, Pleunie P. M.; Alves, Claudio F.; Freitas, Paulo; Smit, Frank J.; Roukema, Gert R.; Moll, Henriette A.			Validity of the Manchester Triage System in emergency care: A prospective observational study	PLOS ONE			English	Article							SEVERITY INDEX; ACCURACY; RELIABILITY; POPULATION; MORTALITY; TRAUMA	Objectives To determine the validity of the Manchester Triage System (MTS) in emergency care for the general population of patients attending the emergency department, for children and elderly, and for commonly used MTS flowcharts and discriminators across three different emergency care settings. Methods This was a prospective observational study in three European emergency departments. All consecutive patients attending the emergency department during a 1-year study period (2010-2012) were included. Validity of the MTS was assessed by comparing MTS urgency as determined by triage nurses with patient urgency according to a predefined 3-category reference standard as proxy for true patient urgency. Results 288,663 patients were included in the analysis. Sensitivity of the MTS in the three hospitals ranged from 0.47 (95% CI 0.44-0.49) to 0.87 (95% CI 0.85-0.90), and specificity from 0.84 (95% CI 0.84-0.84) to 0.94 (95% CI 0.94-0.94) for the triage of adult patients. In children, sensitivity ranged from 0.65 (95% CI 0.61-0.70) to 0.83 (95% CI 0.79-0.87), and specificity from 0.83 (95% CI 0.82-0.83) to 0.89 (95% CI 0.88-0.90). The diagnostic odds ratio ranged from 13.5 (95% CI 12.1-15.0) to 35.3 (95% CI 28.4-43.9) in adults and from 9.8 (95% CI 6.7-14.5) to 23.8 (95% CI 17.7-32.0) in children, and was lowest in the youngest patients in 2 out of 3 settings and in the oldest patients in all settings. Performance varied considerably between the different emergency departments. Conclusions Validity of the MTS in emergency care is moderate to good, with lowest performance in the young and elderly patients. Future studies on the validity of triage systems should be restricted to large, multicenter studies to define modifications and improve generalizability of the findings.	[Zachariasse, Joany M.; Seiger, Nienke; Moll, Henriette A.] Sophia Childrens Univ Hosp, Dept Gen Paediat, Erasmus MC, Rotterdam, Netherlands; [Rood, Pleunie P. M.] Erasmus MC, Dept Emergency Med, Rotterdam, Netherlands; [Alves, Claudio F.] Hosp Prof Doutor Fernando da Fonseca, Dept Paediat, Emergency Unit, Amadora, Portugal; [Freitas, Paulo] Hosp Prof Doutor Fernando da Fonseca, Intens Care Unit, Amadora, Portugal; [Smit, Frank J.] Maasstad Hosp, Dept Paediat, Rotterdam, Netherlands; [Roukema, Gert R.] Maasstad Hosp, Dept Surg, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Maasstad Hospital; Maasstad Hospital	Moll, HA (corresponding author), Sophia Childrens Univ Hosp, Dept Gen Paediat, Erasmus MC, Rotterdam, Netherlands.	H.A.Moll@erasmusmc.nl						Australasian College for Emergency Medicine, 2004, ACC BLOCK OV EM DEP; Cooke MW, 1999, J ACCID EMERG MED, V16, P179; FitzGerald G, 2010, EMERG MED J, V27, P86, DOI 10.1136/emj.2009.077081; Graff I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088995; Grouse AI, 2009, EMERG MED J, V26, P484, DOI 10.1136/emj.2008.065508; Inst Med, 2006, ACAD EMERG MED, V13, P1081, DOI 10.1197/j.aem.2006.07.011; Knapp JF, 2004, PEDIATRICS, V114, P878; Mackway-Jones K., 2014, EMERGENCY TRIAGE MAN; Mackway-Jones K, 2006, EMERGENCY TRIAGE; Manchester Triage Groep, 2007, TRIAG VOOR SPOED HUL; Nakamura Y, 2012, ANN EMERG MED, V60, P335, DOI 10.1016/j.annemergmed.2012.04.006; NHS England, 2013, TRANSF URG EM CAR SE; Phillips S, 1996, J TRAUMA, V40, P278, DOI 10.1097/00005373-199602000-00018; Pinto D, 2010, REV PORT CARDIOL, V29, P961; Pinto D, 2012, REV LAT-AM ENFERM, V20, P1041, DOI 10.1590/S0104-11692012000600005; Platts-Mills TF, 2010, ACAD EMERG MED, V17, P238, DOI 10.1111/j.1553-2712.2010.00670.x; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Providencia R, 2011, EMERG MED J, V28, P212, DOI 10.1136/emj.2009.081497; Rutjes A W S, 2007, Health Technol Assess, V11, pix; Santos AP, 2014, EMERG MED J, V31, P148, DOI 10.1136/emermed-2012-201782; Seiger N, 2014, IMPROVEMENTS PAEDIAT; Seiger N, 2013, PEDIATRICS, V132, pE1602, DOI 10.1542/peds.2013-1076; Seiger N, 2013, ANN EMERG MED, V61, P372, DOI 10.1016/j.annemergmed.2012.09.013; Staudenmayer KL, 2013, J AM COLL SURGEONS, V217, P569, DOI 10.1016/j.jamcollsurg.2013.06.017; Storm-Versloot MN, 2009, EMERG MED J, V26, P556, DOI 10.1136/emj.2008.059378; Storm-Versloot MN, 2011, ACAD EMERG MED, V18, P822, DOI 10.1111/j.1553-2712.2011.01122.x; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; van der Wulp I, 2008, EMERG MED J, V25, P431, DOI 10.1136/emj.2007.055228; van der Wulp I, 2009, EMERG MED J, V26, P506, DOI 10.1136/emj.2008.063768; van Veen M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1501; van Veen M, 2012, EMERG MED J, V29, P654, DOI 10.1136/emermed-2011-200562; Whiting P, 2004, ANN INTERN MED, V140, P189, DOI 10.7326/0003-4819-140-3-200402030-00010	32	88	91	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170811	10.1371/journal.pone.0170811	http://dx.doi.org/10.1371/journal.pone.0170811			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151987	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161200044
J	Ebers, A; Stroup, S; Mpagama, S; Kisonga, R; Lekule, I; Liu, J; Heysell, S				Ebers, Andrew; Stroup, Suzanne; Mpagama, Stellah; Kisonga, Riziki; Lekule, Isaack; Liu, Jie; Heysell, Scott			Determination of plasma concentrations of levofloxacin by high performance liquid chromatography for use at a multidrug-resistant tuberculosis hospital in Tanzania	PLOS ONE			English	Article							ANTITUBERCULOSIS DRUGS; PULMONARY TUBERCULOSIS; TREATMENT OUTCOMES; MOXIFLOXACIN	Therapeutic drug monitoring may improve multidrug-resistant tuberculosis (MDR-TB) treatment outcomes. Levofloxacin demonstrates significant individual pharmacokinetic variability. Thus, we sought to develop and validate a high-performance liquid chromatography (HPLC) method with ultraviolet (UV) detection for levofloxacin in patients on MDR-TB treatment. The HPLC-UV method is based on a solid phase extraction (SPE) and a direct injection into the HPLC system. The limit of quantification was 0.25 mu g/mL, and the assay was linear over the concentration range of 0.25(_)15 mu g/mL (y = 0.5668x(_)0.0603, R-2 = 0.9992) for the determination of levofloxacin in plasma. The HPLC-UV methodology achieved excellent accuracy and reproducibility along a clinically meaningful range. The intra-assay RSD% of low, medium, and high quality control samples (QC) were 1.93, 2.44, and 1.90, respectively, while the inter-assay RSD% were 3.74, 5.65, and 3.30, respectively. The mean recovery was 96.84%. This method was then utilized to measure levofloxacin concentrations from patients' plasma samples from a retrospective cohort of consecutive enrolled subjects treated for MDR-TB at the national TB hospital in Tanzania during 5/3/2013-8/31/2015. Plasma was collected at 2 hours after levofloxacin administration, the time of estimated peak concentration (eC(max)) treatment. Forty-one MDR-TB patients had plasma available and 39 had traceable programmatic outcomes. Only 13 (32%) patients had any plasma concentration that reached the lower range of the expected literature derived C-max with the median eC(max) being 5.86 (3.33-9.08 mu g/ml). Using Classification and Regression Tree analysis, an eC(max) >= 7.55 mu g/mL was identified as the threshold which best predicted cure. Analyzing this CART derived threshold on treatment outcome, the time to sputum culture conversion was 38.3 +/- 22.7 days vs. 47.8 +/- 26.5 days (p = 0.27) and a greater proportion were cured, in 10 out of 15 (66.7%) vs. 6 out of 18 (33.3%) (p = 0.06) respectively. Furthermore, one patient with an eC(max)/minimum inhibitory concentration (MIC) of only 1.13 acquired extensively drug resistant (XDR)-TB while undergoing treatment. The individual variability of levofloxacin concentrations in MDR-TB patients from Tanzania supports further study of the application of onsite therapeutic drug monitoring and MIC testing.	[Ebers, Andrew; Stroup, Suzanne; Liu, Jie; Heysell, Scott] Univ Virginia, Div Infect Dis & Int Hlth, Charlottesville, VA 22903 USA; [Mpagama, Stellah; Kisonga, Riziki; Lekule, Isaack] Kibongoto Infect Dis Hosp, Kilimanjaro, Tanzania	University of Virginia	Ebers, A (corresponding author), Univ Virginia, Div Infect Dis & Int Hlth, Charlottesville, VA 22903 USA.	ae7d@hscmail.mcc.virginia.edu			National Institutes of Health [U01 A1115594, K23 A1099019, 5T32A1007046-39]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI099019, T32AI007046, U01AI115594] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health grants U01 A1115594 (to SH), K23 A1099019 (to SH), and 5T32A1007046-39 (to AE). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300; Alffenaar JWC, 2010, THER DRUG MONIT, V32, P97, DOI 10.1097/FTD.0b013e3181cc6d6f; Alsultan A, 2015, ANTIMICROB AGENTS CH, V59, P3800, DOI 10.1128/AAC.00341-15; Alsultan A, 2014, DRUGS, V74, P839, DOI 10.1007/s40265-014-0222-8; Babalik A, 2011, CAN RESPIR J, V18, P225, DOI 10.1155/2011/307150; Cegielski JP, 2016, CLIN INFECT DIS, V62, P418, DOI 10.1093/cid/civ910; Dorman SE, 2015, AM J RESP CRIT CARE, V191, P333, DOI 10.1164/rccm.201410-1843OC; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Han M, 2013, J ANTIMICROB CHEMOTH, V68, P2066, DOI 10.1093/jac/dkt154; Heysell SK, 2015, ANTIMICROB AGENTS CH, V59, P7104, DOI 10.1128/AAC.01117-15; Heysell Scott K, 2013, Tuberc Res Treat, V2013, P129723, DOI 10.1155/2013/129723; Heysell SK, 2010, EMERG INFECT DIS, V16, P1546, DOI 10.3201/eid1610.100374; Holland DP, 2009, PHARMACOTHERAPY, V29, P503, DOI 10.1592/phco.29.5.503; Kumar M.T., 2011, INT J CURRENT RES, V3, P247; Lee SH, 2015, YONSEI MED J, V56, P961, DOI 10.3349/ymj.2015.56.4.961; Li JH, 2004, CHEST, V126, P1770, DOI 10.1378/chest.126.6.1770; Magis-Escurra C, 2012, PULM PHARMACOL THER, V25, P83, DOI 10.1016/j.pupt.2011.12.001; Manika K, 2012, EUR RESPIR J, V40, P1051, DOI 10.1183/09031936.00202411; Mpagama SG, 2014, ANTIMICROB AGENTS CH, V58, P782, DOI 10.1128/AAC.01549-13; Mpagama SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062034; Ndusilo ND, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122769; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Pasipanodya JG, 2013, J INFECT DIS, V208, P1464, DOI 10.1093/infdis/jit352; Pholwat S, 2015, MBIO, V6, DOI 10.1128/mBio.02273-14; Prahl JB, 2014, J ANTIMICROB CHEMOTH, V69, P2841, DOI 10.1093/jac/dku210; Ray J, 2003, INTERN MED J, V33, P229, DOI 10.1046/j.1445-5994.2003.00390.x; Sturkenboom MGG, 2015, ANTIMICROB AGENTS CH, V59, P2474, DOI 10.1128/AAC.05173-14; Van Tongeren L, 2013, INT J TUBERC LUNG D, V17, P221, DOI 10.5588/ijtld.12.0279; Vu DH, 2012, ANTIMICROB AGENTS CH, V56, P5758, DOI 10.1128/AAC.01054-12; Yu X, 2016, J CELL MOL MED, V20, P3, DOI 10.1111/jcmm.12649	30	16	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170663	10.1371/journal.pone.0170663	http://dx.doi.org/10.1371/journal.pone.0170663			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141813	Green Published, Green Submitted, gold			2022-12-27	WOS:000396129500014
J	Xie, LL; Zhang, K; Rasmussen, D; Wang, JP; Wu, DY; Roemmich, JN; Bundy, A; Johnson, WT; Claycombe, K				Xie, Linglin; Zhang, Ke; Rasmussen, Dane; Wang, Junpeng; Wu, Dayong; Roemmich, James N.; Bundy, Amy; Johnson, W. Thomas; Claycombe, Kate			Effects of prenatal low protein and postnatal high fat diets on visceral adipose tissue macrophage phenotypes and IL-6 expression in Sprague Dawley rat offspring	PLOS ONE			English	Article							PREGNANCY INDUCES HYPERTENSION; LOW-BIRTH-WEIGHT; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; GENE-EXPRESSION; CARDIOVASCULAR-DISEASE; MATERNAL NUTRITION; ISLET FUNCTION; IN-UTERO; OBESITY	Adipose tissue macrophages (ATM) are implicated in adipose tissue inflammation and obesity-related insulin resistance. Maternal low protein models result in fetal programming of obesity. The study aims to answer whether maternal undernutrition by protein restriction affects the ATM M1 or M2 phenotype under postnatal high fat diet in F1 offspring. Using a rat model of prenatal low protein (LP, 8% protein) diet followed by a postnatal high fat energy diet (HE, 45% fat) or low fat normal energy diet (NE, 10% fat) for 12 weeks, we investigated the effects of these diets on adiposity, programming of the offspring ATM phenotype, and the associated inflammatory response in adipose tissue. Fat mass in newborn and 12-week old LP fed offspring was lower than that of normal protein (20%; NP) fed offspring; however, the adipose tissue growth rate was higher compared to the NP fed offspring. While LP did not affect the number of CD68(+) or CD206(+) cells in adipose tissue of NE offspring, it attenuated the number of these cells in offspring fed HE. In offspring fed HE, LP offspring had a lower percentage of CD11c(+) CD206(+) ATMs, whose abundancy was correlated with the size of the adipocytes. Noteworthy, similar to HE treatment, LP increased gene expression of IL-6 within ATMs. Two-way ANOVA showed an interaction of prenatal LP and postnatal HE on IL-6 and IL-1 beta transcription. Overall, both LP and HE diets impact ATM phenotype by affecting the ratio of CD11c(+) CD206(+) ATMs and the expression of IL-6.	[Xie, Linglin] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX USA; [Xie, Linglin; Rasmussen, Dane] Univ North Dakota, Sch Med & Hlth Sci, Dept Basic Sci, Grand Forks, ND USA; [Zhang, Ke] Univ North Dakota, Sch Med & Hlth Sci, Dept Pathol, Grand Forks, ND USA; [Zhang, Ke] Univ North Dakota, ND INBRE Bioinformat Core, Grand Forks, ND USA; [Wang, Junpeng; Wu, Dayong] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr, Boston, MA 02111 USA; [Roemmich, James N.; Bundy, Amy; Johnson, W. Thomas; Claycombe, Kate] USDA ARS, Grand Forks Human Nutr Res Ctr, Grand Forks, ND 58202 USA	Texas A&M University System; Texas A&M University College Station; University of North Dakota Grand Forks; University of North Dakota Grand Forks; University of North Dakota Grand Forks; Tufts University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Xie, LL (corresponding author), Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX USA.; Xie, LL (corresponding author), Univ North Dakota, Sch Med & Hlth Sci, Dept Basic Sci, Grand Forks, ND USA.; Claycombe, K (corresponding author), USDA ARS, Grand Forks Human Nutr Res Ctr, Grand Forks, ND 58202 USA.	linglin.xie@tamu.edu; kate.claycombe@ars.usda.gov	Wang, Junpeng/K-9909-2018	Wang, Junpeng/0000-0002-5464-7884; Roemmich, James/0000-0002-6270-9678	National Institutes of Health [NIH-1R15HL117238]; National Center for Research Resources [5P20RR016471-12/8 P20 GM103442-12]; American Heart Association [13SDG14650009]; USDA Agricultural Research Service Project [3062-51000-052-00D]; USDA National Institute of Food and Agriculture, [Hatch] project [1010406]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103442] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Heart Association(American Heart Association); USDA Agricultural Research Service Project; USDA National Institute of Food and Agriculture, [Hatch] project; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by grants from the National Institutes of Health (NIH-1R15HL117238 to author LX, National Center for Research Resources, 5P20RR016471-12/8 P20 GM103442-12 to authors LX and KZ) and the American Heart Association (13SDG14650009 to author LX). This work was also supported by USDA Agricultural Research Service Project #3062-51000-052-00D to author KJC and by the USDA National Institute of Food and Agriculture, [Hatch] project [1010406] to author LX.	Andersen LG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014126; Anderson SE, 2012, PEDIATRICS, V129, P132, DOI 10.1542/peds.2011-0972; Berends LM, 2013, INT J OBESITY, V37, P1051, DOI 10.1038/ijo.2012.196; Claycombe KJ, 2013, J NUTR; Cox AR, 2010, PEDIATR RES, V68, P16, DOI [10.1203/PDR.0b013e3181e17c90, 10.1203/00006450-201011001-00026]; DAHRI S, 1991, DIABETES, V40, P115, DOI 10.2337/diab.40.2.S115; Ferrante AW, 2007, J INTERN MED, V262, P408, DOI 10.1111/j.1365-2796.2007.01852.x; Frankel S, 1996, PUBLIC HEALTH, V110, P139, DOI 10.1016/S0033-3506(96)80066-7; Gaillard R, 2016, OBESITY, V24, P1320, DOI 10.1002/oby.21484; Gangula PRR, 2005, AM J OBSTET GYNECOL, V192, P952, DOI 10.1016/j.ajog.2004.09.008; Gosby AK, 2010, OBESITY, V18, P1593, DOI 10.1038/oby.2009.449; Guan HY, 2005, AM J PHYSIOL-ENDOC M, V288, pE663, DOI 10.1152/ajpendo.00461.2004; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Hales CN, 1996, BIOCHEM SOC T, V24, P341, DOI 10.1042/bst0240341; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; KUSIN JA, 1992, LANCET, V340, P623, DOI 10.1016/0140-6736(92)92168-F; LANGLEY SC, 1994, CLIN SCI, V86, P217, DOI 10.1042/cs0860217; Lindsay RS, 2000, DIABETES, V49, P445, DOI 10.2337/diabetes.49.3.445; Lukaszewski MA, 2011, AM J PHYSIOL-ENDOC M, V301, pE548, DOI 10.1152/ajpendo.00011.2011; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2007, AM J PHYSIOL-ENDOC M, V292, pE166, DOI 10.1152/ajpendo.00284.2006; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Meier JJ, 2009, DIABETES, V58, P1255, DOI 10.2337/db09-0225; Morris DL, 2011, CURR OPIN CLIN NUTR, V14, P341, DOI 10.1097/MCO.0b013e328347970b; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Ong KK, 2002, BEST PRACT RES CL EN, V16, P191, DOI 10.1053/beem.2002.0195; Ortega MT, 2011, CELL IMMUNOL, V271, P124, DOI 10.1016/j.cellimm.2011.06.012; Ozanne SE, 1996, AM J PHYSIOL-ENDOC M, V271, pE1128, DOI 10.1152/ajpendo.1996.271.6.E1128; Poore KR, 2004, DIABETOLOGIA, V47, P340, DOI 10.1007/s00125-003-1305-3; Poore KR, 2002, DIABETOLOGIA, V45, P1247, DOI 10.1007/s00125-002-0849-y; Ramachandran P, 2002, NUTR REV, V60, pS26, DOI 10.1301/00296640260130704; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; Remacle C, 2004, INT J OBESITY, V28, pS46, DOI 10.1038/sj.ijo.0802800; Reynolds CM, 2013, ENDOCRINOLOGY, V154, P2676, DOI 10.1210/en.2013-1146; Sathishkumar K, 2012, BRIT J NUTR, V107, P665, DOI 10.1017/S0007114511003448; Sathishkumar K, 2009, J VASC RES, V46, P229, DOI 10.1159/000166390; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; STRAUS DS, 1990, ENDOCRINOLOGY, V127, P1849, DOI 10.1210/endo-127-4-1849; Tarry-Adkins JL, 2010, FASEB J, V24, P2762, DOI 10.1096/fj.10-156075; Tuchscherer M, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-232; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wilson MR, 1997, J ENDOCRINOL, V154, P177, DOI 10.1677/joe.0.1540177; Woods LL, 2005, AM J PHYSIOL-REG I, V289, pR1131, DOI 10.1152/ajpregu.00037.2003; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	47	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0169581	10.1371/journal.pone.0169581	http://dx.doi.org/10.1371/journal.pone.0169581			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141871	Green Submitted, gold, Green Published			2022-12-27	WOS:000396129500004
J	Lysaght, T; Capps, B; Bailey, M; Bickford, D; Coker, R; Lederman, Z; Watson, S; Tambyah, PA				Lysaght, Tamra; Capps, Benjamin; Bailey, Michele; Bickford, David; Coker, Richard; Lederman, Zohar; Watson, Sangeetha; Tambyah, Paul Anantharajah			Justice Is the Missing Link in One Health: Results of a Mixed Methods Study in an Urban City State	PLOS ONE			English	Article							DISEASE EMERGENCE	Background One Health (OH) is an interdisciplinary collaborative approach to human and animal health that aims to break down conventional research and policy 'silos'. OH has been used to develop strategies for zoonotic Emerging Infectious Diseases (EID). However, the ethical case for OH as an alternative to more traditional public health approaches is largely absent from the discourse. To study the ethics of OH, we examined perceptions of the human health and ecological priorities for the management of zoonotic EID in the Southeast Asia country of Singapore. Methods We conducted a mixed methods study using a modified Delphi technique with a panel of 32 opinion leaders and 11 semi-structured interviews with a sub-set of those experts in Singapore. Panellists rated concepts of OH and priorities for zoonotic EID preparedness planning using a series of scenarios developed through the study. Interview data were examined qualitatively using thematic analysis. Findings We found that panellists agreed that OH is a cross-disciplinary collaboration among the veterinary, medical, and ecological sciences, as well as relevant government agencies encompassing animal, human, and environmental health. Although human health was often framed as the most important priority in zoonotic EID planning, our qualitative analysis suggested that consideration of non-human animal health and welfare was also important for an effective and ethical response. The panellists also suggested that effective pandemic planning demands regional leadership and investment from wealthier countries to better enable international cooperation. Conclusion We argue that EID planning under an OH approach would benefit greatly from an ethical ecological framework that accounts for justice in human, animal, and environmental health.	[Lysaght, Tamra; Lederman, Zohar; Watson, Sangeetha] Natl Univ Singapore, Ctr Biomed Eth, Singapore, Singapore; [Capps, Benjamin] Dalhousie Univ, Dept Bioeth, Halifax, NS, Canada; [Bailey, Michele] Natl Univ Singapore, Dept Physiol, Singapore, Singapore; [Bickford, David] Rimba, 4 Jalan 1-9D, Bandar Baru Bangi, Selangor, Malaysia; [Coker, Richard] London Sch Hyg & Trop Med, London, England; [Tambyah, Paul Anantharajah] Natl Univ Hlth Syst, Dept Med, Singapore, Singapore	National University of Singapore; Dalhousie University; National University of Singapore; University of London; London School of Hygiene & Tropical Medicine; National University of Singapore	Lysaght, T (corresponding author), Natl Univ Singapore, Ctr Biomed Eth, Singapore, Singapore.	tlysaght@nus.edu.sg	Lysaght, Tamra/AAU-9525-2020; Lederman, Zohar/GWZ-3014-2022	Lederman, Zohar/0000-0003-0547-1066; Lysaght, Tamra/0000-0002-7125-4206; Capps, Benjamin/0000-0002-9104-6025	Communicable Diseases-Public Health Research Grant from the Ministry of Health, Singapore [MOH/CDPHRG/0011/2014]	Communicable Diseases-Public Health Research Grant from the Ministry of Health, Singapore	This research was funded with a Communicable Diseases-Public Health Research Grant from the Ministry of Health, Singapore (MOH/CDPHRG/0011/2014) for the project: One Health, Zoonotic Diseases and Pandemic Planning: Creating a Bioethics Framework in Singapore, URL: https://www.moh.gov.sg/content/moh_web/home/Fundings and Medical Research/communicable diseasespublichealthresearchgrant.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agri-Food & Veterinary Authority of Singapore, 2013, AVA MAINT EM PREP DE; Agriculture and Veterinary Authority, 2015, WORK TOG ON ANN REP; American Veterinary Medical Association, 2008, ON HLTH NEW PROF IMP; Atlas RM, 2013, CURR TOP MICROBIOL, V365, P1, DOI 10.1007/82_2012_223; Bioethics Advisory Committee, 2015, ETH GUID HUM BIOM RE; Bolzoni L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000747; Capps B, 2015, J AGR ENVIRON ETHIC, P1; Capps B, 2015, BIOETHICS, V29, P588, DOI 10.1111/bioe.12145; Centers for Disease Control and Prevention, 2013, ONE HLTH; Coker R, 2011, LANCET INFECT DIS, V11, P326, DOI 10.1016/S1473-3099(10)70312-1; Coker RJ, 2011, LANCET, V377, P599, DOI 10.1016/S0140-6736(10)62004-1; Davis L, 2011, CONSIDERING ANIMALS: CONTEMPORARY STUDIES IN HUMAN-ANIMAL RELATIONS, P183; Degeling C, 2016, PUBLIC HLTH ETHICS; Degeling C, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2617-1; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; Faculty of Public Health of the Royal Colleges of Physicians, 2016, WHAT IS PUBL HLTH; Garrett L, 2016, WHOS FAIRY DUST FINA; Goldberg TL, LANCET, V386, pe37; Hazelton B, 2013, FUTURE MICROBIOL, V8, P461, DOI [10.2217/FMB.13.19, 10.2217/fmb.13.19]; Holey EA, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-52; Lai A, 2013, IMPACT DISASTERS DIS; Leach M, 2013, SOC SCI MED, V88, P10, DOI 10.1016/j.socscimed.2013.03.017; Lederman Z, 2016, PUBLIC HEALTH ETH-UK, V9, P5, DOI 10.1093/phe/phw002; Middleton D, 2014, EMERG INFECT DIS, V20, P372, DOI 10.3201/eid2003.131159; Ministry of Health, 2014, PAND READ RESP PLAN; Morse SS, 2004, REV SCI TECH OIE, V23, P443, DOI 10.20506/rst.23.2.1494; Ong CWM, 2009, LANCET INFECT DIS, V9, P397, DOI 10.1016/S1473-3099(09)70159-8; Pang T, 2015, LANCET GLOB HEALTH, V3, pE496, DOI 10.1016/S2214-109X(15)00102-3; Rawls J., 1971, THEORY JUSTICE; Rayens MK., 2000, POLICY POLIT NURS PR, V1, P308, DOI DOI 10.1177/152715440000100409; Sandifer PA, 2015, ECOSYST SERV, V12, P1, DOI 10.1016/j.ecoser.2014.12.007; Singapore Cooperation Program, 2016, OVERVIEW; Siong LG, 2016, ONE 3 MONKEYS BEING; Whitmee S, 2015, LANCET, V386, P1973, DOI 10.1016/S0140-6736(15)60901-1; World Bank, 2012, ZOON DIS PREV CONTR; World Health Organisation, 1931, LEAG NAT HLTH ORG IN; World Health Organization, 2008, REG OFF W PAC ZOON D; World Health Organization, 2016, W AFR EB OUTBR FUND; World Organisation for Animal Health, 2014, WHO OIE OP FRAM GOOD; Zengkun F, 2013, CULL NOT CULL PESKY	40	18	18	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170967	10.1371/journal.pone.0170967	http://dx.doi.org/10.1371/journal.pone.0170967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129409	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000396211400017
J	Castro, JM; Amorim, MCP; Oliveira, AP; Goncalves, EJ; Munday, PL; Simpson, SD; Faria, AM				Castro, Joana M.; Amorim, M. Clara P.; Oliveira, Ana P.; Goncalves, Emanuel J.; Munday, Philip L.; Simpson, Stephen D.; Faria, Ana M.			Painted Goby Larvae under High-CO2 Fail to Recognize Reef Sounds	PLOS ONE			English	Article							CO2-DRIVEN OCEAN ACIDIFICATION; MARINE ANIMAL BEHAVIOR; PELAGIC LARVAE; CARBON-DIOXIDE; CLIMATE-CHANGE; ELEVATED CO2; FISH LARVAE; MOOREA ISLAND; IN-SITU; SETTLEMENT	Atmospheric CO2 levels have been increasing at an unprecedented rate due to anthropogenic activity. Consequently, ocean pCO(2) is increasing and pH decreasing, affecting marine life, including fish. For many coastal marine fishes, selection of the adult habitat occurs at the end of the pelagic larval phase. Fish larvae use a range of sensory cues, including sound, for locating settlement habitat. This study tested the effect of elevated CO2 on the ability of settlement-stage temperate fish to use auditory cues from adult coastal reef habitats. Wild late larval stages of painted goby (Pomatoschistus pictus) were exposed to control pCO(2) (532 mu atm, pH 8.06) and high pCO(2) (1503 mu atm, pH 7.66) conditions, likely to occur in nearshore regions subjected to upwelling events by the end of the century, and tested in an auditory choice chamber for their preference or avoidance to nighttime reef recordings. Fish reared in control pCO(2) conditions discriminated reef soundscapes and were attracted by reef recordings. This behaviour changed in fish reared in the high CO2 conditions, with settlement- stage larvae strongly avoiding reef recordings. This study provides evidence that ocean acidification might affect the auditory responses of larval stages of temperate reef fish species, with potentially significant impacts on their survival.	[Castro, Joana M.; Amorim, M. Clara P.; Goncalves, Emanuel J.; Faria, Ana M.] ISPA Inst Univ, MARE Marine & Environm Sci Ctr, Lisbon, Portugal; [Oliveira, Ana P.] IPMA, Alges, Portugal; [Munday, Philip L.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Simpson, Stephen D.] Univ Exeter, Coll Life & Environm Sci, Biosci, Exeter, Devon, England	Instituto Superior Psicologia Aplicada (ISPA); Instituto Portugues do Mar e da Atmosfera; James Cook University; University of Exeter	Faria, AM (corresponding author), ISPA Inst Univ, MARE Marine & Environm Sci Ctr, Lisbon, Portugal.	afaria@ispa.pt	Munday, Philip L/F-5443-2011; Amorim, M. Clara P./K-1889-2012	Munday, Philip L/0000-0001-9725-2498; Amorim, M. Clara P./0000-0002-2453-6999; Faria, Ana M./0000-0001-7969-3177; Simpson, Stephen/0000-0002-4856-6164; Goncalves, Emanuel/0000-0002-3918-6215; Eugenio de Oliveira, Ana Paula/0000-0003-0152-8141	Fundacao para a Ciencia e a Tecnologia through the project ACIDLARVAE [PTDC/MAR-EST/4627/2012, SFRH/BPD/68673/2010, UID/MAR/04292/2013]; NERC [NE/J500616/2, NE/P001572/1] Funding Source: UKRI; Natural Environment Research Council [NE/J500616/2, NE/P001572/1] Funding Source: researchfish; Fundação para a Ciência e a Tecnologia [PTDC/MAR-EST/4627/2012] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia through the project ACIDLARVAE; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Fundação para a Ciência e a Tecnologia	This study was funded by Fundacao para a Ciencia e a Tecnologia through the project ACIDLARVAE (PTDC/MAR-EST/4627/2012), a post-doc grant to AF (SFRH/BPD/68673/2010), and through the strategic project UID/MAR/04292/2013 granted to MARE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu T, 2002, J ACOUST SOC AM, V112, P3073, DOI 10.1121/1.1515799; Allan BJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058520; Baumann H, 2012, NAT CLIM CHANGE, V2, P38, DOI 10.1038/NCLIMATE1291; Bertucci F, 2016, SCI REP-UK, V6, DOI 10.1038/srep33326; Bignami S, 2013, P NATL ACAD SCI USA, V110, P7366, DOI 10.1073/pnas.1301365110; Bolgan M, 2012, ADV EXP MED BIOL, V730, P109, DOI 10.1007/978-1-4419-7311-5_24; Briffa M, 2012, MAR POLLUT BULL, V64, P1519, DOI 10.1016/j.marpolbul.2012.05.032; Cabec adas L., 2005, J NANNOPLANKT RES, V27, P141; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Cato D, 1992, ACOUST AUST, V20, P76; CATO DH, 1978, J ACOUST SOC AM, V64, P736, DOI 10.1121/1.382038; Checkley DM, 2009, SCIENCE, V324, P1683, DOI 10.1126/science.1169806; Chung WS, 2014, J EXP BIOL, V217, P323, DOI 10.1242/jeb.092478; Clements JC, 2015, MAR ECOL PROG SER, V536, P259, DOI 10.3354/meps11426; Dickson A.G., 2007, GUIDE BEST PRACTICES; Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; DUFOUR V, 1993, MAR ECOL PROG SER, V102, P143, DOI 10.3354/meps102143; Dupont S, 2008, MAR ECOL PROG SER, V373, P285, DOI 10.3354/meps07800; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Ferrari MCO, 2012, FUNCT ECOL, V26, P553, DOI 10.1111/j.1365-2435.2011.01951.x; Ferrari MCO, 2011, GLOBAL CHANGE BIOL, V17, P2980, DOI 10.1111/j.1365-2486.2011.02439.x; Ferrari MCO, 2012, PLOS ONE, V7; Frommel AY, 2012, NAT CLIM CHANGE, V2, P42, DOI 10.1038/nclimate1324; Hamilton TJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2509; Heenan A, 2009, P 11 INT COR REEF S, P554; Heuer RM, 2014, AM J PHYSIOL-REG I, V307, pR1061, DOI 10.1152/ajpregu.00064.2014; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hofmann GE, 2010, ANNU REV ECOL EVOL S, V41, P127, DOI 10.1146/annurev.ecolsys.110308.120227; Huijbers CM, 2012, ECOLOGY, V93, P46, DOI 10.1890/10-2236.1; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Irisson JO, 2008, J FISH BIOL, V72, P2707, DOI 10.1111/j.1095-8649.2008.01868.x; Jutfelt F, 2015, FRONT ZOOL, V12, DOI 10.1186/s12983-015-0104-2; Kennedy EV, 2010, J EXP MAR BIOL ECOL, V395, P85, DOI 10.1016/j.jembe.2010.08.017; Kenyon TN, 1998, J COMP PHYSIOL A, V182, P307, DOI 10.1007/s003590050181; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Lai F, 2015, CONSERV PHYSIOL, V3, DOI 10.1093/conphys/cov018; Lebour ML, 1920, J MAR BIOL ASSOC UK, V12, P253; Leis JM, 2011, INTEGR COMP BIOL, V51, P826, DOI 10.1093/icb/icr004; Leis JM, 2005, B MAR SCI, V76, P715; Leis JM, 1996, MAR FRESHWATER RES, V47, P401, DOI 10.1071/MF9960401; Leis JM, 2003, J FISH BIOL, V63, P724, DOI 10.1046/j.1095-8649.2003.00182.x; Leis JM, 2003, MAR ECOL PROG SER, V252, P239, DOI 10.3354/meps252239; Leis JM, 2002, MAR ECOL PROG SER, V232, P259, DOI 10.3354/meps232259; Lillis A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079337; McCauley RD, 2000, PHILOS T ROY SOC B, V355, P1289, DOI 10.1098/rstb.2000.0686; Millar RB, 2004, FISH RES, V70, P397, DOI 10.1016/j.fishres.2004.08.016; Miller GM, 2012, NAT CLIM CHANGE, V2, P858, DOI 10.1038/NCLIMATE1599; Miller P.J., 1986, P1019; Millero FJ, 2006, MAR CHEM, V100, P80, DOI 10.1016/j.marchem.2005.12.001; Montgomery JC, 2006, ADV MAR BIOL, V51, P143, DOI 10.1016/S0065-2881(06)51003-X; Munday PL, 2011, BIOGEOSCIENCES, V8, P1631, DOI 10.5194/bg-8-1631-2011; Munday PL, 2016, PEERJ, V4, DOI 10.7717/peerj.2501; Munday PL, 2014, NAT CLIM CHANGE, V4, P487, DOI [10.1038/nclimate2195, 10.1038/NCLIMATE2195]; Munday PL, 2011, MAR ECOL PROG SER, V423, P211, DOI 10.3354/meps08990; Munday PL, 2010, P NATL ACAD SCI USA, V107, P12930, DOI 10.1073/pnas.1004519107; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Murray CS, 2014, MAR ECOL PROG SER, V504, P1, DOI 10.3354/meps10791; Nagelkerken I, 2016, GLOBAL CHANGE BIOL, V22, P974, DOI 10.1111/gcb.13167; Nagelkerken I, 2015, P NATL ACAD SCI USA, V112, P13272, DOI 10.1073/pnas.1510856112; Nedelec SL, 2015, MAR ECOL PROG SER, V524, P125, DOI 10.3354/meps11175; Nilsson GE, 2012, NAT CLIM CHANGE, V2, P201, DOI [10.1038/nclimate1352, 10.1038/NCLIMATE1352]; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Parmentier E, 2015, J FISH BIOL, V86, P1507, DOI 10.1111/jfb.12651; Parvulescu A., 1967, MARINE BIOACOUSTICS, P7, DOI DOI 10.3354/MEPS331243.; Petersen CGJ, 1919, REP DAN BIOL STN, V26, P47; Piercy JJB, 2014, MAR ECOL PROG SER, V516, P35, DOI 10.3354/meps10986; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner HO, 2004, J OCEANOGR, V60, P705, DOI 10.1007/s10872-004-5763-0; Radford CA, 2011, CORAL REEFS, V30, P295, DOI 10.1007/s00338-010-0710-6; Radford CA, 2010, MAR ECOL PROG SER, V401, P21, DOI 10.3354/meps08451; Radford C, 2008, MAR ECOL PROG SER, V362, P37, DOI 10.3354/meps07444; Radford CA, 2008, OECOLOGIA, V156, P921, DOI 10.1007/s00442-008-1041-y; Reum JCP, 2015, ICES J MAR SCI, P528; ROBERTSON DR, 1988, ECOLOGY, V69, P370, DOI 10.2307/1940435; Rossi T, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.3046; Rossi T, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0937; Rossi T, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1954; Simpson SD, 2008, ANIM BEHAV, V75, P1861, DOI 10.1016/j.anbehav.2007.11.004; Simpson SD, 2008, CORAL REEFS, V27, P97, DOI 10.1007/s00338-007-0294-y; Simpson SD, 2005, SCIENCE, V308, P221, DOI 10.1126/science.1107406; Simpson SD, 2005, MAR ECOL PROG SER, V287, P201, DOI 10.3354/meps287201; Simpson SD, 2004, MAR ECOL PROG SER, V276, P263, DOI 10.3354/meps276263; Simpson SD, 2011, BIOL LETTERS, V7, P917, DOI 10.1098/rsbl.2011.0293; Smith ME, 2004, J EXP MAR BIOL ECOL, V302, P17, DOI 10.1016/j.jembe.2003.09.021; Stanley JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028572; Stanley JA, 2010, BEHAV ECOL, V21, P113, DOI 10.1093/beheco/arp159; Tolimieri N, 2000, MAR ECOL PROG SER, V207, P219, DOI 10.3354/meps207219; Tolimieri Nicholas, 2002, Bioacoustics, V12, P214; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Weiss R.F., 1974, MAR CHEM, V2, P203, DOI DOI 10.1016/0304-4203(74)90015-2; Welch MJ, 2014, NAT CLIM CHANGE, V4, P1086, DOI 10.1038/NCLIMATE2400; WILLIAMS DM, 1983, MAR ECOL PROG SER, V10, P231, DOI 10.3354/meps010231; Wright KJ, 2011, MAR ECOL PROG SER, V424, P1, DOI 10.3354/meps09004; Wright KJ, 2005, MAR BIOL, V147, P1425, DOI 10.1007/s00227-005-0028-z	95	10	11	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170838	10.1371/journal.pone.0170838	http://dx.doi.org/10.1371/journal.pone.0170838			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125690	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000396176100038
J	Colman, HA; Remington, RW; Kritikos, A				Colman, Hayley A.; Remington, Roger W.; Kritikos, Ada			Handedness and Graspability Modify Shifts of Visuospatial Attention to Near-Hand Objects	PLOS ONE			English	Article							ASYMMETRIES; REPRESENTATION; POSTURE; VISION	We examined how factors related to the internal representation of the hands (handedness and grasping affordances) influence the distribution of visuospatial attention near the body. Left and right handed participants completed a covert visual cueing task, discriminating between two target shapes. In Experiment 1, participants responded with either their dominant or non-dominant hand. In Experiment 2, the non-responding hand was positioned below one of two target placeholders, aligned with the shoulder. In Experiment 3 the nearmonitor hand was positioned under the placeholder in the opposite region of hemispace, crossed over the body midline. For Experiments 2 & 3, in blocked trials the palmar and backof hand surfaces were directed towards the target placeholder such that targets appeared towards either the graspable or non-graspable space of the hand respectively. In Experiment 2, both left and right handers displayed larger accuracy cueing effects for targets near versus distant from the graspable space of the right hand. Right handers also displayed larger response time cueing effects for objects near the graspable versus non-graspable region of their dominant hand but not for their non-dominant hands. These effects were not evident for left-handers. In Experiment 3, for right handers, accuracy biases for near hand targets were still evident when the hand was crossed over the body midline, and reflected hand proximity but not functional orientation biases. These findings suggest that biased visuospatial attention enhances object identity discrimination near hands and that these effects are particularly enhanced for right-handers.	[Colman, Hayley A.; Remington, Roger W.; Kritikos, Ada] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Remington, Roger W.] Univ Minnesota, Dept Psychol, Minneapolis, MN USA	University of Queensland; University of Minnesota System; University of Minnesota Twin Cities	Colman, HA (corresponding author), Univ Queensland, Sch Psychol, Brisbane, Qld, Australia.	h.colman@uq.edu.au						ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Abrams RA, 2008, COGNITION, V107, P1035, DOI 10.1016/j.cognition.2007.09.006; Abrams RA, 2014, ATTEN PERCEPT PSYCHO, V76, P383, DOI 10.3758/s13414-013-0583-1; Adam JJ, 2012, ATTEN PERCEPT PSYCHO, V74, P1533, DOI 10.3758/s13414-012-0339-3; Begliomini C, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00676; Buckingham G, 2011, CORTEX, V47, P432, DOI 10.1016/j.cortex.2009.11.003; CORBALLIS MC, 1980, AM PSYCHOL, V35, P284, DOI 10.1037/0003-066X.35.3.284; Cosman JD, 2010, PSYCHOL SCI; Davoli CC, 2010, MEM COGNITION, V38, P555, DOI 10.3758/MC.38.5.555; de Bruin N, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00004; Festman Y, 2013, FRONT PSYCHOL, P4; Gardner MR, 2010, BRAIN COGNITION, V73, P35, DOI 10.1016/j.bandc.2010.02.002; Gentilucci M, 1998, COGNITIVE BRAIN RES, V6, P185, DOI 10.1016/S0926-6410(97)00034-7; Geschwind N, 1984, BIOL CEREBRAL DOMINA; Gonzalez CLR, 2006, J NEUROPHYSIOL, V95, P3496, DOI 10.1152/jn.01187.2005; Gonzalez CLR, 2007, EXP BRAIN RES, V182, P275, DOI 10.1007/s00221-007-1090-1; Goodale M. A, 1990, VISION ACTION CONTRO; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Holmes Nicholas P, 2004, Cogn Process, V5, P94, DOI 10.1007/s10339-004-0013-3; Le Bigot N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043150; Lloyd DM, 2010, BRAIN COGNITION, V73, P102, DOI 10.1016/j.bandc.2010.03.006; Meegan DV, 1998, Q J EXP PSYCHOL A; Peters M, 1999, J MOTOR BEHAV, V31, P86, DOI 10.1080/00222899909601894; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Reed CL, 2010, ATTEN PERCEPT PSYCHO, V72, P236, DOI 10.3758/APP.72.1.236; Reed CL, 2006, J EXP PSYCHOL HUMAN, V32, P166, DOI 10.1037/0096-1523.32.1.166; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P147, DOI 10.1016/0166-4328(81)90053-X; Roberts KL, 2011, Q J EXP PSYCHOL, V64, P669, DOI 10.1080/17470218.2010.520086; SAGI D, 1985, PERCEPTION, V14, pA27; Soros P, 1999, NEUROSCI LETT, V271, P89, DOI 10.1016/S0304-3940(99)00528-5; Stone KD, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01403; Stone KD, 2014, EXP BRAIN RES, V232, P385, DOI 10.1007/s00221-013-3746-3; Thomas LE, 2015, PSYCHOL SCI, V26, P625, DOI 10.1177/0956797615571418; TIPPER SP, 1992, J EXP PSYCHOL HUMAN, V18, P891, DOI 10.1037/0096-1523.18.4.891; Tipper SP, 1998, PHILOS T R SOC B, V353, P1385, DOI 10.1098/rstb.1998.0292; Tucker M, 1998, J EXP PSYCHOL HUMAN, V24, P830, DOI 10.1037/0096-1523.24.3.830; Volkmann J, 1998, J NEUROPHYSIOL, V79, P2149, DOI 10.1152/jn.1998.79.4.2149	38	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170542	10.1371/journal.pone.0170542	http://dx.doi.org/10.1371/journal.pone.0170542			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7IT	28125635	Green Published, gold, Green Submitted			2022-12-27	WOS:000396176100096
J	Ferri, M; Graen-Heedfeld, J; Bretz, K; Guillon, F; Michelini, E; Calabretta, MM; Lamborghini, M; Gruarin, N; Roda, A; Kraft, A; Tassoni, A				Ferri, Maura; Graen-Heedfeld, Jurgen; Bretz, Karlheinz; Guillon, Fabien; Michelini, Elisa; Calabretta, Maria Maddalena; Lamborghini, Matteo; Gruarin, Nicolo; Roda, Aldo; Kraft, Axel; Tassoni, Annalisa			Peptide Fractions Obtained from Rice By-Products by Means of an Environment-Friendly Process Show In Vitro Health-Related Bioactivities	PLOS ONE			English	Article							TYROSINASE INHIBITOR; ANTIOXIDANT PEPTIDES; CONVERTING-ENZYME; BRAN PROTEIN; IDENTIFICATION; POLYPHENOLS; ASSAY	Recently, the isolation of new health-related bioactive molecules derived from agro-food industrial by-products by means of environment-friendly extraction processes has become of particular interest. In the present study, a protein by-product from the rice starch industry was hydrolysed with five commercial proteolytic enzymes, avoiding the use of solvents or chemicals. The digestion processes were optimised, and the digestates were separated in fractions with four different molecular weight ranges by using a cross-flow membrane filtration technique. Total hydrolysates and fractions were tested in vitro for a wide range of biological activities. For the first time rice-derived peptides were assayed for anti-tyrosinase, anti-inflammatory, cytotoxicity and irritation capacities. Antioxidant and anti-hypertensive activities were also evaluated. Protamex, Alcalase and Neutrase treatments produced peptide fractions with valuable bioactivities without resulting cytotoxic or irritant. Highest levels of bioactivity were detected in Protamex-derived samples, followed by samples treated with Alcalase. Based on the present results, a future direct exploitation of isolated peptide fractions in the nutraceutical, functional food and cosmetic industrial fields may be foreseen.	[Ferri, Maura; Gruarin, Nicolo; Tassoni, Annalisa] Univ Bologna, Dept Biol Geol & Environm Sci, Bologna, Italy; [Graen-Heedfeld, Jurgen; Bretz, Karlheinz; Kraft, Axel] Fraunhofer Inst Environm Safety & Energy Technol, Oberhausen, Germany; [Guillon, Fabien] Sterlab, Cell Culture Lab, Vallauris, France; [Michelini, Elisa; Calabretta, Maria Maddalena; Roda, Aldo] Univ Bologna, Dept Chem G Ciamician, Bologna, Italy; [Lamborghini, Matteo] Carminia Snc, Bologna, Italy	University of Bologna; Fraunhofer Gesellschaft; University of Bologna	Tassoni, A (corresponding author), Univ Bologna, Dept Biol Geol & Environm Sci, Bologna, Italy.	annalisa.tassoni2@unibo.it	Michelini, Elisa/ABD-9692-2020; TASSONI, ANNALISA/G-3981-2012	FERRI, MAURA/0000-0001-5428-4369; Bretz, Karlheinz/0000-0001-5419-5040; CALABRETTA, Maria Maddalena/0000-0002-5673-3073; TASSONI, ANNALISA/0000-0002-3541-4030; Roda, Aldo/0000-0001-7649-4797; Michelini, Elisa/0000-0002-8651-0575	European Union [605285]	European Union(European Commission)	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) managed by REA-Research Executive Agency (http://ec.europa.eu/research/rea) under the grant agreement number 605285, project FP7-SME-2013 BIORICE (www.biorice.eu). Sterlab Laboratories and Carminia snc provided support in the form of salaries for authors [FG] and [ML], and actively took part in the research activities in the frame of the BIORICE project but did not have any role in the study design and decision to publish. Additionally, Sterlab took part in the data collection and analysis and in the preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Branchini BR, 2010, ANAL BIOCHEM, V396, P290, DOI 10.1016/j.ab.2009.09.009; Cavazos A, 2013, COMPR REV FOOD SCI F, V12, P364, DOI 10.1111/1541-4337.12017; Cho JG, 2015, NAT PROD RES, V29, P1052, DOI 10.1080/14786419.2014.968155; CUSHMAN DW, 1971, BIOCHEM PHARMACOL, V20, P1637, DOI 10.1016/0006-2952(71)90292-9; Dei Piu L, 2014, FOOD CHEM, V155, P199, DOI 10.1016/j.foodchem.2014.01.055; Erdmann K, 2008, J NUTR BIOCHEM, V19, P643, DOI 10.1016/j.jnutbio.2007.11.010; Ferri M, 2016, NEW BIOTECHNOL, V33, P338, DOI 10.1016/j.nbt.2015.12.004; Ferri M, 2013, J FOOD COMPOS ANAL, V30, P94, DOI 10.1016/j.jfca.2013.02.004; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemes AC, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060950; Li GH, 2007, ASIA PAC J CLIN NUTR, V16, P275; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maack A, 2016, FITOTERAPIA, V111, P95, DOI 10.1016/j.fitote.2016.04.001; Maestri E, 2016, J PROTEOMICS, V147, P140, DOI 10.1016/j.jprot.2016.03.048; MASAMOTO Y, 1980, PLANTA MED, V40, P361, DOI 10.1055/s-2008-1074986; Miyazawa M, 2003, J AGR FOOD CHEM, V51, P6953, DOI 10.1021/jf030388s; Qiu J, 2016, INT J COSMET SCI; Shih FF, 2012, J AM OIL CHEM SOC, V89, P1, DOI 10.1007/s11746-011-1941-6; Tuntipopipat S, 2015, FOOD FUNCT, V6, P1480, DOI [10.1039/C4FO01194E, 10.1039/c4fo01194e]; Uraipong C, 2016, J SCI FOOD AGR, V96, P1101, DOI 10.1002/jsfa.7182; Van der Borght A, 2006, J CEREAL SCI, V44, P68, DOI 10.1016/j.jcs.2006.03.005; Wattanasiritham L, 2016, FOOD CHEM, V192, P156, DOI 10.1016/j.foodchem.2015.06.057; Zhang JH, 2010, FOOD CHEM, V119, P226, DOI 10.1016/j.foodchem.2009.06.015; Zhao Q, 2012, FOOD CHEM, V134, P1360, DOI 10.1016/j.foodchem.2012.03.033; Zou TB, 2016, MOLECULES, V21, DOI 10.3390/molecules21010072	26	27	30	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170954	10.1371/journal.pone.0170954	http://dx.doi.org/10.1371/journal.pone.0170954			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125712	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000396176100015
J	Fu, YR; Xu, XQ; Xue, JF; Duan, WP; Yi, ZJ				Fu, Yurong; Xu, Xianqin; Xue, Junfang; Duan, Wenping; Yi, Zhengjun			Deregulated lncRNAs in B Cells from Patients with Active Tuberculosis	PLOS ONE			English	Article							LONG NONCODING RNAS; MYCOBACTERIUM-TUBERCULOSIS; EXPRESSION PROFILES; IMMUNE-RESPONSES; GENE-REGULATION; GASTRIC-CANCER; T-CELLS; SOCS3; MACROPHAGES; INFECTION	Role of lncRNAs in human adaptive immune response to TB infection is largely unexplored. To address this issue, here we characterized lncRNA expression profile in primary human B cell response to TB infection using microarray assay. Several lncRNAs and mRNAs were chosen for RT-qPCR validation. Bioinformatics prediction was applied to delineate function of the deregulated mRNAs. We found that 844 lncRNAs and 597 mRNAs were differentially expressed between B cell samples from individuals with or without TB. KEGG pathway analysis for the deregulated mRNAs indicated a number of pathways, such as TB, TLR signaling pathway and antigen processing and presentation. Moreover, corresponding to the dysregulation of many lncRNAs, we also found that their adjacent protein-coding genes were also deregulated. Functional annotation for the corresponding mRNAs showed that these lncRNAs were mainly associated with TLR signaling, TGF-beta signaling. Interestingly, SOCS3, which is a critical negative regulator of cytokine response to TB infection and its nearby lncRNA XLOC_012582, were highly expressed in active TB B cells. Subsequent RT-qPCR results confirmed the changes. Whether upregulated XLOC_012582 causes SOCS3 overexpression and is eventually involved in the context of exacerbations of active TB represents an interesting issue that deserves to be further explored. Taken together, for the first time, we identified a set of deregulated lncRNAs in active TB B cells and their functions were predicted. Such findings provided novel insight into the pathogenesis of TB and further studies should focus on the function and pathogenic mechanisms of the lncRNAs involved in active TB.	[Fu, Yurong] Weifang Med Univ, Clin Med Coll, Dept Med Microbiol, Weifang, Shandong, Peoples R China; [Fu, Yurong; Yi, Zhengjun] Weifang Med Univ, Key Lab Clin Lab Diagnost Univ Shandong, Dept Lab Med, Weifang, Shandong, Peoples R China; [Xu, Xianqin] Weifang Med Univ, Clin Med Coll, Dept Clin Skill Lab, Weifang, Shandong, Peoples R China; [Xue, Junfang] Gaomi City Peoples Hosp, Dept Surg, Weifang, Shandong, Peoples R China; [Duan, Wenping] Weifang Med Univ, Dept Nursing, Affiliated Hosp, Weifang, Shandong, Peoples R China	Weifang Medical University; Weifang Medical University; Weifang Medical University; Weifang Medical University	Fu, YR (corresponding author), Weifang Med Univ, Clin Med Coll, Dept Med Microbiol, Weifang, Shandong, Peoples R China.; Fu, YR; Yi, ZJ (corresponding author), Weifang Med Univ, Key Lab Clin Lab Diagnost Univ Shandong, Dept Lab Med, Weifang, Shandong, Peoples R China.	yifuyurong@163.com; fuyizhengjun@163.com			National Natural Science Foundation of China [81100006, 81470001]; Natural Science Foundation of Shandong Province of China [ZR2016HM09]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province of China(Natural Science Foundation of Shandong Province)	This research was financially supported by the grants from the National Natural Science Foundation of China (Grant No. 81100006, 81470001) and the Natural Science Foundation of Shandong Province of China (Grant No. ZR2016HM09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achkar JM, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a018432; Alam-Faruque Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027541; Ashenafi S, 2014, CLIN IMMUNOL, V151, P84, DOI 10.1016/j.clim.2014.01.010; Baer CE, 2015, IMMUNOL REV, V264, P327, DOI 10.1111/imr.12267; Booty MG, 2016, J IMMUNOL, V196, P1822, DOI 10.4049/jimmunol.1502206; Dang Y, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0706-3; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Goovaerts O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133924; He Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep27051; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Hu P, 2014, CELL SIGNAL, V26, P83, DOI 10.1016/j.cellsig.2013.10.001; Huang X, 2016, J ASSIST REPROD GEN, V33, P111, DOI 10.1007/s10815-015-0630-z; Imam H, 2015, SCI REP-UK, V5, DOI 10.1038/srep08639; Jiang TT, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1436-y; Kazemzadeh M, 2015, J GENET, V94, P771, DOI 10.1007/s12041-015-0561-6; Kleinsteuber K, 2012, BLOOD, V120, P4374, DOI 10.1182/blood-2011-11-392738; Lin XC, 2014, INT J ONCOL, V45, P619, DOI 10.3892/ijo.2014.2431; Narayana Y, 2008, J BIOL CHEM, V283, P12501, DOI 10.1074/jbc.M709960200; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Parida SK, 2015, CLIN INFECT DIS, V61, pS217, DOI 10.1093/cid/civ615; Pawar K, 2016, SCI REP-UK, V6, DOI 10.1038/srep19416; Pollock KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146905; Rao M, 2015, CLIN INFECT DIS, V61, pS225, DOI 10.1093/cid/civ614; Rottenberg ME, 2014, SEMIN IMMUNOL, V26, P518, DOI 10.1016/j.smim.2014.10.004; Sebina I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106796; Torrado E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061681; Uchida S, 2015, CIRC RES, V116, P737, DOI 10.1161/CIRCRESAHA.116.302521; Ueta M, 2012, J ALLERGY CLIN IMMUN, V129, P1413, DOI 10.1016/j.jaci.2012.01.069; Wang NT, 2015, CLIN CANCER RES, V21, P4676, DOI 10.1158/1078-0432.CCR-14-3163; Wang Y, 2015, P NATL ACAD SCI USA, V112, pE3883, DOI 10.1073/pnas.1501662112; Weymouth KS, 2016, CLIN ORTHOP RELAT R, V474, P1726, DOI 10.1007/s11999-016-4788-1; Yang XF, 2016, SCI REP-UK, V6, DOI 10.1038/srep38963; Yao YL, 2014, INT J MOL SCI, V15, P18985, DOI 10.3390/ijms151018985; Yi ZJ, 2014, J INFECTION, V69, P558, DOI 10.1016/j.jinf.2014.06.016; Zheng L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126018; Zhu Q, 2016, IMMUNOBIOLOGY, V221, P558, DOI 10.1016/j.imbio.2015.12.003	36	17	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170712	10.1371/journal.pone.0170712	http://dx.doi.org/10.1371/journal.pone.0170712			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125665	Green Published, Green Submitted, gold			2022-12-27	WOS:000396176100068
J	Giraldo, LF; Passino, KM				Giraldo, Luis Felipe; Passino, Kevin M.			Dynamics of Cooperation in a Task Completion Social Dilemma	PLOS ONE			English	Article							EVOLUTION	We study the situation where the members of a community have the choice to participate in the completion of a common task. The process of completing the task involves only costs and no benefits to the individuals that participate in this process. However, completing the task results in changes that significantly benefit the community and that exceed the participation efforts. A task completion social dilemma arises when the short-term participation costs dissipate any interest in the community members to contribute to the task completion process and therefore to obtain the benefits that result from completing the task. In this work, we model the task completion problem using a dynamical system that characterizes the participation dynamics in the community and the task completion process. We show how this model naturally allows for the incorporation of several mechanisms that facilitate the emergence of cooperation and that have been studied in previous research on social dilemmas, including communication across a network, and indirect reciprocity through relative reputation. We provide mathematical analyses and computer simulations to study the qualitative properties of the participation dynamics in the community for different scenarios.	[Giraldo, Luis Felipe] Univ Los Andes, Dept Elect & Elect Engn, Bogota, Colombia; [Passino, Kevin M.] Ohio State Univ, Dept Elect & Comp Engn, Columbus, OH 43210 USA	Universidad de los Andes (Colombia); University System of Ohio; Ohio State University	Giraldo, LF (corresponding author), Univ Los Andes, Dept Elect & Elect Engn, Bogota, Colombia.	lf.giraldo404@uniandes.edu.co	Giraldo, Luis Felipe/AAV-7534-2020	Giraldo, Luis Felipe/0000-0002-2492-4422				[Anonymous], 1965, LOGIC COLLECTIVE ACT; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Balliet D, 2009, JOURNAL OF CONFLICT; BIDDLE BJ, 1986, ANNU REV SOCIOL, V12, P67, DOI 10.1146/annurev.so.12.080186.000435; Bowles S., 2000, NORDIC J POLITICAL E, V26, P33; Cardillo A, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.052825; Chen XJ, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.036101; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Finke J, 2011, IEEE T AUTOMAT CONTR, V56, P1426, DOI 10.1109/TAC.2011.2112476; Frederiks ER, 2015, RENEW SUST ENERG REV, V41, P1385, DOI 10.1016/j.rser.2014.09.026; Giraldo LF, 2016, IEEE T CYBERNETICS, V46, P2207, DOI 10.1109/TCYB.2015.2470225; Heckathorn D., 2002, ADV GROUP PROCESSES, V19, P37, DOI DOI 10.1016/S0882-6145(02)19003-5; Heckathorn DD, 1996, AM SOCIOL REV, V61, P250, DOI 10.2307/2096334; Homan M.S., 2010, PROMOTING COMMUNITY; Jacquet J, 2013, NAT CLIM CHANGE, V3, P1025, DOI 10.1038/NCLIMATE2024; KARAU SJ, 1993, J PERS SOC PSYCHOL, V65, P681, DOI 10.1037/0022-3514.65.4.681; Katz N., 2005, THEORIES SMALL GROUP, P277, DOI DOI 10.4135/9781483328935.N8; Kemmis D., 1992, COMMUNITY AND THE PO; KERR NL, 1983, J PERS SOC PSYCHOL, V45, P819, DOI 10.1037/0022-3514.45.4.819; KERR NL, 1994, J PERS SOC PSYCHOL, V66, P513, DOI 10.1037/0022-3514.66.3.513; Kerr NL, 2007, PERS SOC PSYCHOL B, V33, P828, DOI 10.1177/0146167207301020; Kerr NL, 2013, GROUP PROCESS INTERG, V16, P257, DOI 10.1177/1368430212453632; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; Marwell G, 1993, JOURNAL OF THE ROYAL, V10, P1, DOI DOI 10.1098/RSIF.2012.0997; MCTAGGART R, 1991, ADULT EDUC QUART, V41, P168, DOI 10.1177/0001848191041003003; Meng XK, 2015, PHYS LETT A, V379, P767, DOI 10.1016/j.physleta.2014.12.051; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Milinski M, 2008, P NATL ACAD SCI USA, V105, P2291, DOI 10.1073/pnas.0709546105; Nowak M, 2011, SIMON AND SCHUSTER, P10429, DOI [10.1073/pnas.1301210110, DOI 10.1073/PNAS.1301210110]; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ostrom E., 1990, GOVERNING THE COMMON; Passino KM., 2015, HUMANITARIAN ENGINEE; Pavlic TP, 2014, IEEE T CYBERNETICS, V44, P774, DOI 10.1109/TCYB.2013.2271776; Perc M, 2016, PHYS LETT A, V380, P2803, DOI 10.1016/j.physleta.2016.06.017; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Rothstein B, 2001, RATION SOC, V13, P213, DOI 10.1177/104346301013002004; SHEPPERD JA, 1993, PSYCHOL BULL, V113, P67, DOI 10.1037/0033-2909.113.1.67; Shepperd JA, 2001, GROUP DYN-THEOR RES, V5, P304, DOI 10.1037//1089-2699.5.4.304; Sugiarto HS, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.062804; Turner R.H., 1987, COLLECTIVE BEHAV, V3rd ed.; Tyler T.R., 2010, WHY PEOPLE COOPERATE; Van Lange PAM, 2013, ORGAN BEHAV HUM DEC, V120, P125, DOI 10.1016/j.obhdp.2012.11.003; VanVugt M, 1996, EUR J SOC PSYCHOL, V26, P373, DOI 10.1002/(SICI)1099-0992(199605)26:3<373::AID-EJSP760>3.0.CO;2-1; Wang Z, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-60270-7; Xia CY, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/58002; Yoeli E, 2013, P NATL ACAD SCI USA, V110, P10424, DOI 10.1073/pnas.1301210110	49	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170604	10.1371/journal.pone.0170604	http://dx.doi.org/10.1371/journal.pone.0170604			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7IT	28125721	gold, Green Published, Green Submitted			2022-12-27	WOS:000396176100089
J	Jiang, YM; Chen, CX; Li, L				Jiang, Yanming; Chen, Changxian; Li, Li			Comparison of Cold-Knife Conization versus Loop Electrosurgical Excision for Cervical Adenocarcinoma In Situ (ACIS): A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							STRAIGHT-WIRE EXCISION; UTERINE CERVIX; CONSERVATIVE TREATMENT; INTRAEPITHELIAL NEOPLASIA; TRANSFORMATION ZONE; RESIDUAL DISEASE; CONE BIOPSY; MANAGEMENT; WOMEN; RISK	Objective The objective of this systematic review was to conduct a more comprehensive literature search and meta-analysis of original studies to evaluate the efficacy and safety of the loop electrosurgical excision procedure (LEEP) versus cold-knife conization (CKC) in conservative surgical treatment of cervical adenocarcinoma in situ (ACIS) for women who have not completed childbearing. Methods Systematic searches were conducted in the PUBMED, EMBASE, Cochrane, and China National Knowledge Infrastructure (CNKI) databases to identify all potential studies involving patients with ACIS treated with LEEP versus CKC published until December 2015. Results Eighteen retrospective studies were included in this systematic review. All the 18 included studies reported the rate of positive margins, and the results of the individual studies varied. The positive margins were 44% (267/607) after LEEP and 29% (274/952) after CKC. The pooled meta-analysis exhibited significantly different outcome (RR, 1.55; 95% CI, 1.34-1.80, P<0.00001) without significant heterogeneity (P = 0.34). The residual rate following LEEP was 9.1% (17/186) and 11% (39/350) after CKC in re-cone or hysterectomy cases. Recurrent ACIS following LEEP was reported in 10 of 142 (7.0%) cases compared to 10 of 177 (5.6%) cases following CKC. There were no significant differences in the residual rate (RR, 1.02; 95% CI, 0.60-1.72, P = 0.95) or recurrence rate (RR, 1.13; 95% CI, 0.46-2.79; P = 0.79) between the two procedures. Conclusions The present systematic review demonstrates that both LEEP and CKC are safe and effective for the conservative treatment of ACIS. LEEP appears to be as equally effective as CKC	[Jiang, Yanming] Liuzhou Peoples Hosp, Dept Gynecol, Liuzhou, Peoples R China; [Chen, Changxian; Li, Li] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Gynecol Oncol, Nanning, Peoples R China	Guangxi Medical University	Li, L (corresponding author), Guangxi Med Univ, Affiliated Tumor Hosp, Dept Gynecol Oncol, Nanning, Peoples R China.	lili2016129@126.com	LI, LI QING/GRR-8855-2022; li, li/HII-4157-2022; LI, LI/GVS-5344-2022; Li, Li/AEM-3636-2022					[Anonymous], 2016, NHSCSP PUBLICATION, V20, P64; Azodi M, 1999, GYNECOL ONCOL, V73, P348, DOI 10.1006/gyno.1999.5395; Baalbergen A, 2015, J LOW GENIT TRACT DI, V19, P239, DOI 10.1097/LGT.0000000000000114; Baalbergen A, 2014, INT J GYNECOL CANCER, V24, P1543, DOI 10.1097/IGC.0000000000000260; Bull-Phelps SL, 2007, GYNECOL ONCOL, V107, P316, DOI 10.1016/j.ygyno.2007.06.021; Camargo MJ, 2015, BJOG-INT J OBSTET GY, V122, P552, DOI 10.1111/1471-0528.13200; Costa S, 2012, GYNECOL ONCOL, V124, P490, DOI 10.1016/j.ygyno.2011.11.039; Costales AB, 2013, GYNECOL ONCOL, V129, P513, DOI 10.1016/j.ygyno.2013.03.015; Denehy TR, 1997, OBSTET GYNECOL, V90, P1, DOI 10.1016/S0029-7844(97)00122-1; DeSimone CP, 2011, J REPROD MED, V56, P376; HEPLER TK, 1952, AM J OBSTET GYNECOL, V63, P800, DOI 10.1016/S0002-9378(16)38860-3; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hwang David M, 2004, J Low Genit Tract Dis, V8, P125, DOI 10.1097/00128360-200404000-00008; Kennedy AW, 2002, GYNECOL ONCOL, V86, P361, DOI 10.1006/gyno.2002.6771; Kietpeerakool C, 2012, INT J GYNECOL OBSTET, V119, P266, DOI 10.1016/j.ijgo.2012.06.013; Krivak TC, 2001, OBSTET GYNECOL SURV, V56, P567, DOI 10.1097/00006254-200109000-00023; Kuohung W, 2000, OBSTET GYNECOL S1, V95, pS50; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Latif NA, 2015, J LOW GENIT TRACT DI, V19, P97, DOI 10.1097/LGT.0000000000000055; Liu Y, 2014, GYNECOL OBSTET INVES, V77, P240, DOI 10.1159/000360538; Massad LS, 2013, J LOW GENIT TRACT DI, V17, pS1, DOI 10.1097/LGT.0b013e318287d329; Munro A, 2015, GYNECOL ONCOL, V137, P258, DOI 10.1016/j.ygyno.2015.02.024; Patel Divya A, 2013, J Registry Manag, V40, P84; Russomano F, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0174-5; Salani R, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.09.012; Shin CH, 2000, GYNECOL ONCOL, V79, P6, DOI 10.1006/gyno.2000.5962; Soutter WP, 2001, BRIT J OBSTET GYNAEC, V108, P1184, DOI 10.1016/S0306-5456(01)00277-7; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Taylor JS, 2014, EUR J GYNAECOL ONCOL, V35, P641; Tierney KE, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.12.030; van Hanegem N, 2012, GYNECOL ONCOL, V124, P72, DOI 10.1016/j.ygyno.2011.09.006; Widrich T, 1996, GYNECOL ONCOL, V61, P304, DOI 10.1006/gyno.1996.0147; Wolf JK, 1996, OBSTET GYNECOL, V88, P82, DOI 10.1016/0029-7844(96)00083-X	33	19	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170587	10.1371/journal.pone.0170587	http://dx.doi.org/10.1371/journal.pone.0170587			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125627	Green Published, gold, Green Submitted			2022-12-27	WOS:000396176100092
J	Leng, JQ; Yang, LH; Liu, WY; Lin, Z				Leng Jun-qiang; Yang Long-hai; Liu, Wei-yi; Lin Zhao			Measuring Road Network Vulnerability with Sensitivity Analysis	PLOS ONE			English	Article							TRAVEL-TIME; RELIABILITY; ROBUSTNESS; CAPACITY; LINKS	This paper focuses on the development of a method for road network vulnerability analysis, from the perspective of capacity degradation, which seeks to identify the critical infrastructures in the road network and the operational performance of the whole traffic system. This research involves defining the traffic utility index and modeling vulnerability of road segment, route, OD (Origin Destination) pair and road network. Meanwhile, sensitivity analysis method is utilized to calculate the change of traffic utility index due to capacity degradation. This method, compared to traditional traffic assignment, can improve calculation efficiency and make the application of vulnerability analysis to large actual road network possible. Finally, all the above models and calculation method is applied to actual road network evaluation to verify its efficiency and utility. This approach can be used as a decision-supporting tool for evaluating the performance of road network and identifying critical infrastructures in transportation planning and management, especially in the resource allocation for mitigation and recovery.	[Leng Jun-qiang; Liu, Wei-yi] Harbin Inst Technol Weihai, Sch Automobile Engn, Weihai, Peoples R China; [Yang Long-hai; Lin Zhao] Harbin Inst Technol, Sch Transportat Sci & Engn, Harbin, Peoples R China	Harbin Institute of Technology; Harbin Institute of Technology	Leng, JQ (corresponding author), Harbin Inst Technol Weihai, Sch Automobile Engn, Weihai, Peoples R China.	lengjunqiang0724@163.com			National Natural Science Foundation of China [71471046]; National Nature Science Foundation of Shandong Province [ZR2014GM003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Nature Science Foundation of Shandong Province	This paper has been supported by the National Natural Science Foundation of China (71471046) and the National Nature Science Foundation of Shandong Province (ZR2014GM003).	Bell MGH, 2008, PHILOS T R SOC A, V366, P1893, DOI 10.1098/rsta.2008.0019; Berdica K, 2002, TRANSPORT POLICY, V9, P117, DOI 10.1016/S0967-070X(02)00011-2; Chen A, 2007, NETW SPAT ECON, V7, P241, DOI 10.1007/s11067-006-9012-5; Chen BY, 2012, TRANSPORT RES A-POL, V46, P501, DOI 10.1016/j.tra.2011.11.018; D'Este GM, 2003, NETWORK RELIABILITY OF TRANSPORT, PROCEEDINGS, P23, DOI 10.1016/B978-008044109-2/50003-3; Du ZP, 1997, TRANSPORT RES B-METH, V31, P225, DOI 10.1016/S0191-2615(96)00023-9; Erath A, 2010, TRANSPORT RES REC, V2137, P118; Guo J, 2004, IEEE SYS MAN CYBERN, P2735; Jenelius E., 2006, NECTAR CLUSTER, P1; Jenelius E, 2006, TRANSPORT RES A-POL, V40, P537, DOI 10.1016/j.tra.2005.11.003; Jenelius E, 2015, COMPUT ENVIRON URBAN, V49, P136, DOI 10.1016/j.compenvurbsys.2014.02.003; Jenelius E, 2009, J TRANSP GEOGR, V17, P234, DOI 10.1016/j.jtrangeo.2008.06.002; Jin HZ, 2005, DYNAM CONT DIS SER B, V1, P32; Leng JQ, 2010, J CENT SOUTH UNIV T, V17, P419, DOI 10.1007/s11771-010-0062-y; Luathep P, 2011, TRANSPORTATION, V38, P799, DOI 10.1007/s11116-011-9350-0; Murray-Tuite PM, 2004, TRANSPORT RES REC, P88, DOI 10.3141/1882-11; Nagurney A, 2008, J GLOBAL OPTIM, V40, P261, DOI 10.1007/s10898-007-9198-1; Nicholson A, 2003, NETWORK RELIABILITY OF TRANSPORT, PROCEEDINGS, P45, DOI 10.1016/B978-008044109-2/50004-5; Quium A S M Abdul, ENG CONCERNS FLOOD; Scott DM, 2006, J TRANSP GEOGR, V14, P215, DOI 10.1016/j.jtrangeo.2005.10.003; Snelder M, 2012, TRANSPORT RES A-POL, V46, P828, DOI 10.1016/j.tra.2012.02.007; Sohn J, 2006, TRANSPORT RES A-POL, V40, P491, DOI 10.1016/j.tra.2005.08.006; Sullivan JL, 2010, TRANSPORT RES A-POL, V44, P323, DOI 10.1016/j.tra.2010.02.003; Tang TQ, 2016, PHYSICA A, V449, P408, DOI 10.1016/j.physa.2016.01.003; Tang TQ, 2015, MOD PHYS LETT B, V29, DOI 10.1142/S0217984915500554; Taylor M.A.P., 2007, CRITICAL INFRASTRUCT, P9, DOI [DOI 10.1007/978-3-540-68056-7_2, 10.1007/978-3-540-68056-7_2]; Taylor MAP, 2006, NETW SPAT ECON, V6, P267, DOI 10.1007/s11067-006-9284-9; von Ferber C, 2009, TRAFFIC AND GRANULAR FLOW '07, P721, DOI 10.1007/978-3-540-77074-9_81; Watling D, 2012, TRANSPORT RES A-POL, V46, P772, DOI 10.1016/j.tra.2012.02.009; Wei Q, 2003, IEEE SYS MAN CYBERN, P3056; [杨露萍 Yang Luping], 2012, [交通运输系统工程与信息, Journal of Transporation Systems Engineering & Information Technology], V12, P105; Zhao J., 2016, PLOS ONE, V11	32	8	9	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e170292	10.1371/journal.pone.0170292	http://dx.doi.org/10.1371/journal.pone.0170292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7IT	28125706	gold, Green Published			2022-12-27	WOS:000396176100121
J	Melo, ATO; Guthrie, RS; Hale, I				Melo, Arthur T. O.; Guthrie, Robert S.; Hale, Iago			GBS-Based Deconvolution of the Surviving North American Collection of Cold-Hardy Kiwifruit (Actinidia spp.) Germplasm	PLOS ONE			English	Article							GENETIC DIVERSITY; POPULATION; ARGUTA; SIMILARITY	Plant germplasm collections can be invaluable resources to plant breeders, provided they are well-characterized. After 140 years of acquisition and curation efforts by a wide and largely non-coordinated array of private and institutional actors, the current US collection of cold-hardy kiwifruit (Actinidia spp.) is rife with misclassifications, misnomers, and mix-ups. To facilitate the systematic improvement and resource-efficient curation of these species of long-recognized horticultural potential, we used genotyping-by-sequencing (GBS) data to deconvolute this historic collection. Evaluation of a total of 138 accessions (103 A. arguta, 28 A. kolomikta, and 7 A. polygama) with an interspecific set of 1,040 high-quality SNPs resulted in clear resolution of the three species. Intraspecific analysis (2,964 SNPs) within A. arguta revealed a significant level of redundancy (41.7%; only 60 unique genotypes out of 103 analyzed) and a sub-population structure reflecting likely geographic provenance, phenotypic classes, and hybrid pedigree. For A. kolomikta (3,425 SNPs), the level of accession redundancy was even higher (53.6%; 13 unique genotypes out of 28 analyzed); but no sub-structure was detected. Numerous instances were discovered of distinct genotypes sharing a common name, different names assigned to the same genotype, mistaken species assignments, and incorrect gender records, all critical information for both breeders and curators. In terms of method, this study demonstrates the practical and cost-effective use of GBS data to characterize plant genetic resources, despite ploidy differences and the lack of reference genomes. With the recent prohibition on further imports of Actinidia plant material into the country and with the active eradication of historic vines looming, this analysis of the US cold-hardy kiwifruit germplasm collection provides a timely assessment of the genetic resource base of an emerging, high-value specialty crop.	[Melo, Arthur T. O.; Hale, Iago] Univ New Hampshire, Coll Life Sci & Agr, Dept Biol Sci, Durham, NH 03824 USA; [Guthrie, Robert S.] Univ Minnesota, Minnesota Landscape Arboretum Hort Res Ctr, Chanhassen, MN USA	University System Of New Hampshire; University of New Hampshire; University of Minnesota System	Hale, I (corresponding author), Univ New Hampshire, Coll Life Sci & Agr, Dept Biol Sci, Durham, NH 03824 USA.	iago.hale@unh.edu	Melo, Arthur/J-2187-2018	Hale, Iago/0000-0002-8558-7861	New Hampshire Agricultural Experiment Station; USDA National Institute of Food and Agriculture Multi-State Hatch Project [233561]	New Hampshire Agricultural Experiment Station; USDA National Institute of Food and Agriculture Multi-State Hatch Project	Partial funding was provided by the New Hampshire Agricultural Experiment Station. This is Scientific Contribution Number 2687. This work is supported by the USDA National Institute of Food and Agriculture Multi-State Hatch Project 233561. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, CASAVA 1 8 2 QUICK R; Bonman JM, 2015, CROP SCI, V55, P1243, DOI 10.2135/cropsci2014.09.0621; Brown C, 2003, AM J ALTERNATIVE AGR, V18, P213, DOI 10.1079/AJAA200353; Darrow GM, 1937, YB AGR, V1, P545; EVREINOFF V. -A., 1949, Revue horticole, V121, P155; Fairchild D, 1927, J HERED, V18, P49, DOI 10.1093/oxfordjournals.jhered.a102803; Fairchild D, 1906, SCIENCE, V24, P498, DOI 10.1126/science.24.616.498-a; Fairchild D., 1913, SOME ASIATIC ACTINID; Farrand B., 1954, REEF POINT GARDENS B, V1, P2; Ferguson A. R., 2008, P235, DOI 10.1007/978-1-4020-6907-9_8; Ferguson AR, 2016, THE KIWIFRUIT GENOME, P55; FERGUSON AR, 1990, KIWIFRUIT SCI MANAGE, P165; Fisk CL, 2006, J FOOD SCI; FLATH RA, 1978, J AGR FOOD CHEM, V26, P835, DOI 10.1021/jf60218a053; Goodale GL, 1891, USEFUL PLANTS FUTURE; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Huang S, 2013, NATURE COMMUNICATION; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Kataoka I, 2010, SCI HORTIC-AMSTERDAM, V124, P409, DOI 10.1016/j.scienta.2010.01.016; Kaufman Lois., 1990, ROUSSEEUW FINDING GR; Keefer JS, 2010, NPSERMNNRR2010196 NA; Kolbasina EI, 2000, BERRY BEARING VINES; Li ZZ, 2013, SCI HORTIC-AMSTERDAM, V161, P259, DOI 10.1016/j.scienta.2013.07.008; Long Island Botanical Society, 2014, Q NEWSL, V24, P7; MCQUITTY LL, 1966, EDUC PSYCHOL MEAS, V26, P825, DOI 10.1177/001316446602600402; Meirmans PG, 2012, J HERED, V103, P744, DOI 10.1093/jhered/ess047; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Melo ATO, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0879-y; Michurin IV., 1949, SELECTED WORKS; Mizugami T, 2007, ACTA HORTIC, P199, DOI 10.17660/ActaHortic.2007.753.22; Murtagh F, 2014, J CLASSIF, V31, P274, DOI 10.1007/s00357-014-9161-z; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; NPGS GRIN, 2016, NATL PLANT GERMPL SY; Odong TL, 2013, THEOR APPL GENET, V289, P305, DOI DOI 10.1007/S00122-012-1971-Y; Orpet E. O., 1892, GARD FOR, V5, P320; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Pollack S, 2001, MARKET TRADE B; Smith RL., 1970, LASCA LEAVES, V20, P8; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Start MA, 2007, ACTA HORT, V753; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Whealy K., 1989, FRUIT BERRY NUT INVE; Yoshida K, 2013, ELIFE, V2, DOI 10.7554/eLife.00731	46	12	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170580	10.1371/journal.pone.0170580	http://dx.doi.org/10.1371/journal.pone.0170580			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125645	Green Published, gold			2022-12-27	WOS:000396176100093
J	Murayama, C; Kawaguchi, AT; Kamijo, A; Naito, K; Kanazawa, M; Tsukada, H				Murayama, Chieko; Kawaguchi, Akira T.; Kamijo, Akemi; Naito, Katsuko; Kanazawa, Masakatsu; Tsukada, Hideo			Monitoring Mitochondrial Complex-I Activity Using Novel PET Probe F-18-BCPP-EF Allows Early Detection of Radiotherapy Effect in Murine Squamous Cell Carcinoma	PLOS ONE			English	Article							OXYGEN SPECIES PRODUCTION; TUMORS	Objectives Aerobic glycolysis, the main pathway of energy production in tumors (Warburg effect) allows detection of tumors by positron emission tomography (PET) using F-18-fluoro-2-deoxy-D-glucose (F-18-FDG). Since ionizing radiation (IR) is reported to switch aerobic glycolysis to mitochondrial oxidative phosphorylation, radiotherapeutic efficacy was monitored by the activity of mitochondrial complex I (MC-I), using a new PET probe F-18-BCPP-EF, F-18-2-tert-butyl-4-chloro-5-{6-[2-(2-fluoro-ethoxy)-ethoxy]-pyridine-3-ylmethoxy}-2H-pyridazin-3-one, compared with F-18-FDG uptake and the apoptosis index. Methods Tumor uptake of F-18-BCPP-EF or F-18-FDG was examined in C3H/HeN mice inoculated with murine squamous cell carcinoma SCCVII at various time points after a single dose of x-ray irradiation at 0, 6, 15, or 30 Gy. Apoptosis incidence was determined by TUNEL staining in excised tumor tissue. Results Tumor growth suppression was dose-dependent; tumor grew 10-fold (0 Gy), 5-fold (6 Gy), 2-fold (15 Gy), and reduced to half in its volume (30 Gy) 14 days after treatment. F-18-BCPPEF uptake was significantly increased as early as 3 days after 15 Gy or 30 Gy, when tumor size and apoptosis index showed no difference among radiation doses. In contrast, F-18-FDG uptake was initially increased dose-dependently, remained elevated up to 7 days, and eventually decreased 10 days after 30 Gy and also 14 days after 15 Gy when tumor size was already reduced. Apoptosis index was increased after irradiation but failed to correlate with tumor response. Conclusion Tumor uptake of F-18-BCPP-EF was increased dose-dependently early after effective doses of IR when F-18-FDG uptake as well as apoptosis incidence were not indicative of tumor response. The results suggest that F-18-BCPP-EF is a promising "positive" MC-I imaging PET probe for early detection of efficacy of tumor radiotherapy.	[Murayama, Chieko] Tokai Univ, Sch Med, Dept Clin Pharmacol, Isehara, Kanagawa, Japan; [Murayama, Chieko] Tokai Univ, Sch Med, Dept Radiat Oncol, Isehara, Kanagawa, Japan; [Kawaguchi, Akira T.] Tokai Univ, Sch Med, Dept Cell Transplantat & Regenerat Med, Isehara, Kanagawa, Japan; [Kamijo, Akemi; Naito, Katsuko] Tokai Univ, Support Ctr Med Res & Educ, Isehara, Kanagawa, Japan; [Kanazawa, Masakatsu; Tsukada, Hideo] Hamamatsu Photon KK, Cent Res Lab, Hamamatsu, Shizuoka, Japan	Tokai University; Tokai University; Tokai University; Tokai University; Hamamatsu Photonics	Kawaguchi, AT (corresponding author), Tokai Univ, Sch Med, Dept Cell Transplantat & Regenerat Med, Isehara, Kanagawa, Japan.	akira@is.icc.u-tokai.ac.jp		Kanazawa, Masakatsu/0000-0002-1444-2630	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP24249086, JP26461871, JP15H2569]; Tokai University School of Medicine Research Aid	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Tokai University School of Medicine Research Aid	This work was supported in part by Japan Society for the Promotion of Science (JSPS) KAKENHI grant numbers JP24249086, JP26461871, JP15H2569, and 2014 Tokai University School of Medicine Research Aid. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study. MK and HT are employees for Hamamatsu Photonics K.K. This did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials. CM, ATK, AK and KN were researchers belonging to Tokai University at the time of the study. They all were involved in animal care, data collection and discussion to summarize the results and prepare and develop the work for publication. MK and HT were employed by Hamamatsu Photonics K.K. PET probe syntheses and PET measurements of this study were performed by MK and HT, respectively. The funder provided support in the form of salaries for authors [MK and HT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzam EI, 2012, CANCER LETT, V327, P48, DOI 10.1016/j.canlet.2011.12.012; Chen HJ, 2015, STRAHLENTHER ONKOL, V191, P141, DOI 10.1007/s00066-014-0744-8; Choi KM, 2007, ONCOL REP, V17, P1183; FU KK, 1984, INT J RADIAT ONCOL, V10, P1473, DOI 10.1016/0360-3016(84)90371-7; Guppy M, 2002, BIOCHEM BIOPH RES CO, V299, P676, DOI 10.1016/S0006-291X(02)02710-9; Harada N, 2013, J LABELLED COMPD RAD, V56, P553, DOI 10.1002/jlcr.3056; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Kitajima K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096999; Kobashigawa S, 2011, BIOCHEM BIOPH RES CO, V414, P795, DOI 10.1016/j.bbrc.2011.10.006; Leach JK, 2001, CANCER RES, V61, P3894; Masunaga S, 2001, INT J RADIAT ONCOL, V49, P1361, DOI 10.1016/S0360-3016(00)01535-2; Motoori S, 2001, CANCER RES, V61, P5382; MURAYAMA C, 1993, INT J RADIAT ONCOL, V26, P433, DOI 10.1016/0360-3016(93)90961-T; Murayama C, 2009, J NUCL MED, V50, P290, DOI 10.2967/jnumed.108.057091; Nakano T, 2010, J RADIAT RES, V51, P1, DOI 10.1269/jrr.09132; Nishida N, 2014, J RADIAT RES, V55, P455, DOI 10.1093/jrr/rrt142; Salto K, 2015, CLIN CANCER RES, V21, P5073, DOI [10.1158/1078-0432.CCR-14-1717, DOI 10.1158/1078-0432.CCR-14-1717]; Tsukada H, 2014, J CEREBR BLOOD F MET, V34, P708, DOI 10.1038/jcbfm.2014.5; Tsukada H, 2014, EUR J NUCL MED MOL I, V41, P755, DOI 10.1007/s00259-013-2628-z; Tsukada H, 2014, J NUCL MED, V55, P473, DOI 10.2967/jnumed.113.125328; Yamamori T, 2012, FREE RADICAL BIO MED, V53, P260, DOI 10.1016/j.freeradbiomed.2012.04.033	21	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170911	10.1371/journal.pone.0170911	http://dx.doi.org/10.1371/journal.pone.0170911			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125711	Green Published, Green Submitted, gold			2022-12-27	WOS:000396176100025
J	Chandler, TL; White, HM				Chandler, Tawny L.; White, Heather M.			Choline and methionine differentially alter methyl carbon metabolism in bovine neonatal hepatocytes	PLOS ONE			English	Article							RUMEN-PROTECTED METHIONINE; LACTATING DAIRY-COWS; BETAINE-HOMOCYSTEINE METHYLTRANSFERASE; CULTURED RAT HEPATOCYTES; SUPPLEMENTARY FOLIC-ACID; OXIDATIVE STRESS; GENE-EXPRESSION; SMARTAMINE M; FATTY-ACIDS; IN-VITRO	Intersections in hepatic methyl group metabolism pathways highlights potential competition or compensation of methyl donors. The objective of this experiment was to examine the expression of genes related to methyl group transfer and lipid metabolism in response to increasing concentrations of choline chloride (CC) and DL-methionine (DLM) in primary neonatal hepatocytes that were or were not exposed to fatty acids (FA). Primary hepatocytes isolated from 4 neonatal Holstein calves were maintained as monolayer cultures for 24 h before treatment with CC (61, 128, 2028, and 4528 mu mol/L) and DLM (16, 30, 100, 300 mu mol/L), with or without a 1 mmol/L FA cocktail in a factorial arrangement. After 24 h of treatment, media was collected for quantification of reactive oxygen species (ROS) and very low-density lipoprotein (VLDL), and cell lysates were collected for quantification of gene expression. No interactions were detected between CC, DLM, or FA. Both CC and DLM decreased the expression of methionine adenosyltransferase 1A (MAT1A). Increasing CC did not alter betaine-homocysteine S-methyltranferase (BHMT) but did increase 5-methyltetrahydrofolate- homocysteine methyltransferase (MTR) and methylenetetrahydrofolate reductase (MTHFR) expression. Increasing DLM decreased expression of BHMT and MTR, but did not affect MTHFR. Expression of both phosphatidylethanolamine N-methyltransferase (PEMT) and microsomal triglyceride transfer protein (MTTP) were decreased by increasing CC and DLM, while carnitine palmitoyltransferase 1A (CPT1A) was unaffected by either. Treatment with FA decreased the expression of MAT1A, MTR, MTHFR and tended to decrease PEMT but did not affect BHMT and MTTP. Treatment with FA increased CPT1A expression. Increasing CC increased secretion of VLDL and decreased the accumulation of ROS in media. Within neonatal bovine hepatocytes, choline and methionine differentially regulate methyl carbon pathways and suggest that choline may play a critical role in donating methyl groups to support methionine regeneration. Stimulating VLDL export and decreasing ROS accumulation suggests that increasing CC is hepato-protective.	[Chandler, Tawny L.; White, Heather M.] Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	White, HM (corresponding author), Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA.	heather.white@wisc.edu		Chandler, Tawny/0000-0001-6299-9436	Real Science Initiative Grant by Balchem Corporation, New Hampton, NY	Real Science Initiative Grant by Balchem Corporation, New Hampton, NY	This research was supported by funding provided through the Real Science Initiative Grant by Balchem Corporation, New Hampton, NY (http://www.balchem com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artegoitia VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103412; Berry M. N. A. M., 1991, LAB TECHNIQUES BIOCH, V21, P121; Berthiaume R, 2006, J DAIRY SCI, V89, P1621, DOI 10.3168/jds.S0022-0302(06)72229-9; Blum JW, 1999, J DAIRY SCI, V82, P1991, DOI 10.3168/jds.S0022-0302(99)75435-4; Bremmer DR, 2000, J DAIRY SCI, V83, P2239, DOI 10.3168/jds.S0022-0302(00)75108-3; Brosnan JT, 2006, J NUTR, V136, p1636S, DOI 10.1093/jn/136.6.1636S; Caballero F, 2010, J BIOL CHEM, V285, P18528, DOI 10.1074/jbc.M109.099333; CadornigaValino C, 1997, J DAIRY SCI, V80, P646, DOI 10.3168/jds.S0022-0302(97)75983-6; Carmel R, 2002, HOMOCYSTEINE HLTH DI; Chatelain F, 1996, EUR J BIOCHEM, V235, P789, DOI 10.1111/j.1432-1033.1996.00789.x; Cole LK, 2012, BBA-MOL CELL BIOL L, V1821, P754, DOI 10.1016/j.bbalip.2011.09.009; Cooke RF, 2007, J DAIRY SCI, V90, P2413, DOI 10.3168/jds.2006-028; Davidson S, 2008, J DAIRY SCI, V91, P1552, DOI 10.3168/jds.2007-0721; de Veth MJ, 2016, J DAIRY SCI, V12, P1; DONKIN SS, 1994, AM J PHYSIOL, V266, pR1229, DOI 10.1152/ajpregu.1994.266.4.R1229; DONKIN SS, 1993, J ANIM SCI, V71, P2218, DOI 10.2527/1993.7182218x; Donkin SS, 1997, J ANIM SCI, V75, P3082; EMMANUEL B, 1984, J DAIRY SCI, V67, P1912, DOI 10.3168/jds.S0022-0302(84)81524-6; FINKELSTEIN JD, 1984, BIOCHEM BIOPH RES CO, V118, P14, DOI 10.1016/0006-291X(84)91060-X; Goselink RMA, 2013, J DAIRY SCI, V96, P1102, DOI 10.3168/jds.2012-5396; GRUMMER RR, 1993, J DAIRY SCI, V76, P3882, DOI 10.3168/jds.S0022-0302(93)77729-2; Herrick KJ, 2014, J DAIRY SCI S1, V97, P1896; KLEPPE BB, 1988, J DAIRY SCI, V71, P1813, DOI 10.3168/jds.S0022-0302(88)79750-7; Lambert BD, 2002, J NUTR, V132, P2004, DOI 10.1093/jn/132.7.2004; Lapierre H, 2012, J DAIRY SCI, V95, P353, DOI 10.3168/jds.2011-4553; Lapierre H, 2011, J DAIRY SCI, V94, P1526, DOI 10.3168/jds.2010-3914; Li P, 2013, J DAIRY SCI, V96, P3840, DOI 10.3168/jds.2012-6160; Li X, 2016, J DAIRY SCI, V99, P4574, DOI 10.3168/jds.2015-10609; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Lobley GE, 1996, BRIT J NUTR, V75, P47, DOI 10.1079/BJN19960109; Loest CA, 2002, J ANIM SCI, V80, P2197; Martinov MV, 2010, BBA-PROTEINS PROTEOM, V1804, P89, DOI 10.1016/j.bbapap.2009.10.004; Mashek DG, 2003, J DAIRY SCI, V86, P2390, DOI 10.3168/jds.S0022-0302(03)73833-8; Mato JM, 2008, ANNU REV NUTR, V28, P273, DOI 10.1146/annurev.nutr.28.061807.155438; Noga AA, 2003, J LIPID RES, V44, P1998, DOI 10.1194/jlr.M300226-JLR200; Osorio JS, 2016, J DAIRY SCI, V99, P234, DOI 10.3168/jds.2015-10157; Osorio JS, 2014, J DAIRY SCI, V97, P7437, DOI 10.3168/jds.2013-7679; Osorio JS, 2014, J DAIRY SCI, V97, P7451, DOI 10.3168/jds.2014-8680; Osorio JS, 2013, J DAIRY SCI, V96, P6248, DOI 10.3168/jds.2012-5790; Pooya S, 2012, J HEPATOL, V57, P344, DOI 10.1016/j.jhep.2012.03.028; Powell CL, 2010, TOXICOL SCI, V115, P131, DOI 10.1093/toxsci/kfq031; Preynat A, 2009, J DAIRY SCI, V92, P677, DOI 10.3168/jds.2008-1525; Preynat A, 2010, J DAIRY SCI, V93, P2130, DOI 10.3168/jds.2009-2796; Preynat A, 2009, J DAIRY SCI, V92, P1685, DOI 10.3168/jds.2008-1572; PRITCHARD PH, 1981, BIOCHEM J, V196, P261, DOI 10.1042/bj1960261; PULLEN DL, 1990, J ANIM SCI, V68, P1395; ROGERS JA, 1987, J DAIRY SCI, V70, P789, DOI 10.3168/jds.S0022-0302(87)80075-9; Sales J, 2010, J DAIRY SCI, V93, P3746, DOI 10.3168/jds.2010-3106; SCHWAB CG, 1992, J DAIRY SCI, V75, P3486, DOI 10.3168/jds.S0022-0302(92)78125-9; SHARMA BK, 1989, J DAIRY SCI, V72, P2772, DOI 10.3168/jds.S0022-0302(89)79421-2; SNOSWELL AM, 1987, COMP BIOCHEM PHYS B, V88, P383, DOI 10.1016/0305-0491(87)90317-8; Sordillo LM, 2016, J DAIRY SCI, V99, P4967, DOI 10.3168/jds.2015-10354; Sordillo LM, 2009, VET IMMUNOL IMMUNOP, V128, P104, DOI 10.1016/j.vetimm.2008.10.305; Spears JW, 2008, VET J, V176, P70, DOI 10.1016/j.tvjl.2007.12.015; Strang BD, 1998, J DAIRY SCI, V81, P740, DOI 10.3168/jds.S0022-0302(98)75630-9; Sutter BM, 2013, CELL, V154, P403, DOI 10.1016/j.cell.2013.06.041; TISDALE MJ, 1984, BRIT J CANCER, V49, P315, DOI 10.1038/bjc.1984.49; Torres L, 2000, FASEB J, V14, P95, DOI 10.1096/fasebj.14.1.95; VANCE JE, 1986, J BIOL CHEM, V261, P4486; White HM, 2012, J DAIRY SCI, V95, P1249, DOI 10.3168/jds.2011-4644; XUE GP, 1985, BIOCHEM INT, V11, P381; XUE GP, 1985, COMP BIOCHEM PHYS B, V80, P489, DOI 10.1016/0305-0491(85)90278-0; XUE GP, 1986, COMP BIOCHEM PHYS B, V85, P601, DOI 10.1016/0305-0491(86)90055-6; Zanton GI, 2014, J DAIRY SCI, V97, P7085, DOI 10.3168/jds.2014-8220; ZEISEL SH, 1981, ANNU REV NUTR, V1, P95, DOI 10.1146/annurev.nu.01.070181.000523; Zhang Q, 2016, J DAIRY SCI S1, V99, P1096; Zhang Q, 2016, J DAIRY SCI, V99, P8451, DOI 10.3168/jds.2016-11312; Zom RLG, 2011, J DAIRY SCI, V94, P4016, DOI 10.3168/jds.2011-4233	68	45	50	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171080	10.1371/journal.pone.0171080	http://dx.doi.org/10.1371/journal.pone.0171080			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152052	Green Published, gold			2022-12-27	WOS:000396161200087
J	Muller, F; Hagedoorn, M; Tuinman, MA				Mueller, Fabiola; Hagedoorn, Mariet; Tuinman, Marrit A.			Chronic multimorbidity impairs role functioning in middle-aged and older individuals mostly when non-partnered or living alone	PLOS ONE			English	Article							QUALITY-OF-LIFE; MENTAL-HEALTH; CHRONIC DISEASES; COMORBIDITY; DISTRESS; PEOPLE; ARRANGEMENTS; DECLINE; ADULTS	Background Due to the aging of the population, society includes a growing proportion of older individuals prone to chronic morbidity. This study aimed to investigate the adverse effects of single and multiple chronic morbidity on psychosocial health and whether these effects are more pronounced in individuals who are non-partnered or living alone. Materials and methods Baseline data from the 'Lifelines Cohort Study' collected between 2006 and 2013 in the Netherlands were used. Individuals aged 50+ (n = 25,214) were categorized according to their health status (healthy, single chronic morbidity, multiple chronic morbidity), relationship status (partnered, non-partnered), and living arrangement (living with someone, living alone). Analyses of covariance (ANCOVA) were performed to study the main- and the interaction-effects on mental health and role functioning as assessed with the RAND-36. Results Irrespective of having chronic morbidity, having a partner was associated with better mental health when partners shared a home. Individuals with single and especially multiple chronic morbidity had impaired role functioning. Having a partner mitigated the adverse effects of multimorbidity on role functioning, but only in individuals who shared a home with their partner. Non-partnered individuals with multimorbidity and those not sharing a home with their partner demonstrated impaired role functioning. Conclusions The results demonstrate that multimorbidity negatively affects role functioning, but not the mental health, of middle-aged and older individuals. Sharing a home with a partner can mitigate these adverse effects, while other combinations of relationship status and living arrangement do not. Offering intervention to those individuals most vulnerable to impaired functioning may relieve some of the increasing pressure on the health care system. An individual's relationship status along with one's living arrangement could foster the identification of a target group for such interventions attempting to sustain physical functioning or to adapt daily goals.	[Mueller, Fabiola; Hagedoorn, Mariet; Tuinman, Marrit A.] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Psychol, Antonius Deusinglaan 1, Groningen, Netherlands	University of Groningen	Muller, F (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Psychol, Antonius Deusinglaan 1, Groningen, Netherlands.	f.muller@umcg.nl	Müller, Fabiola/AFM-7755-2022; Hagedoorn, Mariet/B-5056-2010	Müller, Fabiola/0000-0002-0412-7469; Hagedoorn, Mariet/0000-0003-3444-3662	Dutch Cancer Society [RUG 2009-4442]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by the Dutch Cancer Society (URL: https://www.kwf.nl/english/). The grant number is RUG 2009-4442 (Fellowship Marrit Tuinman). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts S, 2012, J PSYCHOSOM RES, V73, P211, DOI 10.1016/j.jpsychores.2012.05.014; Alonso J, 2004, QUAL LIFE RES, V13, P283, DOI 10.1023/B:QURE.0000018472.46236.05; [Anonymous], 2012, METEN ALGEMENE GEZON; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; BRETTSCHNEIDER C, 2013, PLOS ONE, V0008; Brown CJ, 2013, JAMA-J AM MED ASSOC, V310, P1168, DOI 10.1001/jama.2013.276566; Diener E, 2000, J CROSS CULT PSYCHOL, V31, P419, DOI 10.1177/0022022100031004001; Hagedoorn M, 2006, PSYCHOL AGING, V21, P611, DOI 10.1037/0882-7974.21.3.611; Hays RD, 2001, ANN MED, V33, P350, DOI 10.3109/07853890109002089; Henning-Smith C, 2016, J APPL GERONTOL, V35, P39, DOI 10.1177/0733464814530805; Holden L, 2015, QUAL LIFE RES, V24, P2075, DOI 10.1007/s11136-015-0946-2; Hopman P, 2016, QUAL LIFE RES, V25, P651, DOI 10.1007/s11136-015-1102-8; Hughes ME, 2002, J HEALTH SOC BEHAV, V43, P1, DOI 10.2307/3090242; Ip EH, 2013, J GERONTOL A-BIOL, V68, P426, DOI 10.1093/gerona/gls186; Jayasinghe UW, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-50; Jones SMW, 2016, AGING MENT HEALTH, V20, P309, DOI 10.1080/13607863.2015.1008988; Joutsenniemi K, 2006, J EPIDEMIOL COMMUN H, V60, P468, DOI 10.1136/jech.2005.040741; Kamiya Y, 2013, AGING MENT HEALTH, V17, P349, DOI 10.1080/13607863.2012.747078; Klijs B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137203; Kriegsman DMW, 2004, J CLIN EPIDEMIOL, V57, P55, DOI 10.1016/S0895-4356(03)00258-0; Lewin AC., 2016, J FAM ISSUES, P1; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Matcham F, 2014, SEMIN ARTHRITIS RHEU, V44, P123, DOI 10.1016/j.semarthrit.2014.05.001; Norris SL, 2011, J CLIN EPIDEMIOL, V64, P358, DOI 10.1016/j.jclinepi.2010.04.016; Rijken M, 2005, QUAL LIFE RES, V14, P45, DOI 10.1007/s11136-004-0616-2; Scholtens S, 2015, INT J EPIDEMIOL, V44, P1172, DOI 10.1093/ije/dyu229; Sharpe L, 2006, SOC SCI MED, V62, P1153, DOI 10.1016/j.socscimed.2005.07.010; Singer MA, 1999, QUAL LIFE RES, V8, P687, DOI 10.1023/A:1008917016998; Soulsby L. K., 2015, PSYCHOLOGY, V6, P1349, DOI DOI 10.4236/PSYCH.2015.611132; Sprangers MAG, 2000, J CLIN EPIDEMIOL, V53, P895, DOI 10.1016/S0895-4356(00)00204-3; Strohm CQ, 2009, DEMOGR RES, V21, P177, DOI 10.4054/DemRes.2009.21.7; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Trevisol DJ, 2011, J HYPERTENS, V29, P179, DOI 10.1097/HJH.0b013e328340d76f; Tuinman MA, 2015, PSYCHO-ONCOLOGY, V24, P699, DOI 10.1002/pon.3712; Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983; van Oostrom SH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-715; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wikman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018952	38	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170525	10.1371/journal.pone.0170525	http://dx.doi.org/10.1371/journal.pone.0170525			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28151967	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200024
J	Muench, F; van Stolk-Cooke, K; Kuerbis, A; Stadler, G; Baumel, A; Shao, SJ; McKay, JR; Morgenstern, J				Muench, Frederick; van Stolk-Cooke, Katherine; Kuerbis, Alexis; Stadler, Gertraud; Baumel, Amit; Shao, Sijing; McKay, James R.; Morgenstern, Jon			A Randomized Controlled Pilot Trial of Different Mobile Messaging Interventions for Problem Drinking Compared to Weekly Drink Tracking	PLOS ONE			English	Article							ALCOHOL-USE DISORDERS; INTERNET-BASED INTERVENTION; CLINICAL-TRIAL; HEALTH; METAANALYSIS; BEHAVIOR; OUTCOMES	Introduction Recent evidence suggests that text messaging may help to reduce problem drinking as an extension to in-person services, but very little is known about the effectiveness of remote messaging on problem drinking as a stand-alone intervention, or how different types of messages may improve drinking outcomes in those seeking to moderate their alcohol consumption. Methods We conducted an exploratory, single-blind randomized controlled pilot study comparing four different types of alcohol reduction-themed text messages sent daily to weekly drink self-tracking texts in order to determine their impact on drinking outcomes over a 12-week period in 152 participants (approximate to 30 per group) seeking to reduce their drinking on the internet. Messaging interventions included: weekly drink self-tracking mobile assessment texts (MA), loss-framed texts (LF), gain-framed texts (GF), static tailored texts (ST), and adaptive tailored texts (TA). Poisson and least squares regressions were used to compare differences between each active messaging group and the MA control. Results When adjusting for baseline drinking, participants in all messaging groups except GF significantly reduced the number of drinks consumed per week and the number of heavy drinking days compared to MA. Only the TA and GF groups were significantly different from MA in reducing the number of drinking days. While the TA group yielded the largest effect sizes on all outcome measures, there were no significant differences between active messaging groups on any outcome measure. 79.6% of individuals enrolled in the study wanted to continue receiving messages for an additional 12 weeks at the end of the study. Discussion Results of this pilot study indicate that remote automated text messages delivered daily can help adult problem drinkers reduce drinking frequency and quantity significantly more than once-a-week self-tracking messages only, and that tailored adaptive texts yield the largest effect sizes across outcomes compared to MA. Larger samples are needed to understand differences between messaging interventions and to target their mechanisms of efficacy.	[Muench, Frederick; van Stolk-Cooke, Katherine; Baumel, Amit; Shao, Sijing; Morgenstern, Jon] Northwell Hlth Great Neck, Dept Psychiat, Feinstein Inst Med Res, New York, NY 11021 USA; [Kuerbis, Alexis] CUNY, Hunter Coll, Silberman Sch Social Work, New York, NY 10021 USA; [Stadler, Gertraud] Univ Aberdeen, Dept Appl Hlth Sci, Aberdeen, Scotland; [McKay, James R.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA	Northwell Health; City University of New York (CUNY) System; Hunter College (CUNY); University of Aberdeen; University of Pennsylvania	Muench, F (corresponding author), Northwell Hlth Great Neck, Dept Psychiat, Feinstein Inst Med Res, New York, NY 11021 USA.	fmuench@northwell.edu	Shao, Sijing/W-8402-2019	Shao, Sijing/0000-0003-0813-6060; Stadler, Gertraud/0000-0002-1935-8200	National Institute on Alcohol Abuse and Alcoholism (NIAAA) [R34AA021502]	National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by a grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) R34AA021502. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge John Cunningham Ph.D. for his guidance and recommendations on the study design and review of this manuscript. This study was supported by a grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), R34AA021502. Clinicaltrials.gov identifier: NCT01885312	Agyapong VIO, 2013, J AFFECT DISORDERS, V151, P100, DOI 10.1016/j.jad.2013.05.058; Buller DB, 2014, TELEMED E-HEALTH, V20, P206, DOI 10.1089/tmj.2013.0169; Carver CS, 2001, ON THE SELF REGULATI; Coxe S, 2009, J PERS ASSESS, V91, P121, DOI 10.1080/00223890802634175; Cunningham JA, 2009, ADDICTION, V104, P2023, DOI 10.1111/j.1360-0443.2009.02726.x; De Leon E, 2014, J OF MEDICAL I, V16; Dulin PL, 2014, SUBST ABUS, V35, P168, DOI 10.1080/08897077.2013.821437; Field A, 2009, DISCOVERING STATISTI; First M. B., 2012, STRUCTURED CLINICAL; Gonzalez VM, 2015, J CONSULT CLIN PSYCH, V83, P335, DOI 10.1037/a0038620; Gossop M, 2002, ADDICT BIOL, V7, P37, DOI 10.1080/135562101200100571; Gustafson DH, 2014, JAMA PSYCHIAT, V71, P566, DOI 10.1001/jamapsychiatry.2013.4642; Hall AK, 2015, ANNU REV PUBL HEALTH, V36, P393, DOI 10.1146/annurev-publhealth-031914-122855; Head KJ, 2013, SOC SCI MED, V97, P41, DOI 10.1016/j.socscimed.2013.08.003; Jonas DE, 2012, ANN INTERN MED, V157, P645, DOI 10.7326/0003-4819-157-9-201211060-00544; Krebs P, 2010, PREV MED, V51, P214, DOI 10.1016/j.ypmed.2010.06.004; Leeman RF, 2016, J CONSULT CLIN PSYCH, V84, P1008, DOI 10.1037/ccp0000132; Mason M, 2014, J PRIM PREV, V35, P47, DOI 10.1007/s10935-013-0329-9; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Miller W. R., 1995, THE DRINKER INVENTOR; Miller WR, 2002, ADDICTION, V97, P265, DOI 10.1046/j.1360-0443.2002.00019.x; Miller WR, 1996, FORM 90 A STRUCTURED; Morgenstern J, 2012, PSYCHOL ADDICT BEHAV, V26, P859, DOI 10.1037/a0029674; Muench F, 2013, PSYCHOL ADDICT BEHAV, V27, P315, DOI 10.1037/a0029963; National Institute on Alcohol Abuse and Alcoholism (NIAAA), 2005, HELPING PATIENTS WHO; Noar SM, 2007, PSYCHOL BULL, V133, P673, DOI 10.1037/0033-2909.133.4.673; O' Keefe Daniel, 2011, BENDING OPINION ESSA, P117; Riley WT, 2011, TRANSL BEHAV MED, V1, P53, DOI 10.1007/s13142-011-0021-7; Riper H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099912; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Rothman A, 2011, HANDBOOK OF SELF REG; Rueger SY, 2012, J STUD ALCOHOL DRUGS, V73, P829, DOI 10.15288/jsad.2012.73.829; Smit ES, 2015, EUR HEAL PSYCHOL, V17, P25; Sobell LC, 1992, TECHNIQUES ASSESS AL, P41; Spruijt-Metz D, 2014, IEEE PERVAS COMPUT, V13, P13, DOI 10.1109/MPRV.2014.46; Suffoletto B, 2014, ANN EMERG MED, V64, P664, DOI 10.1016/j.annemergmed.2014.06.010; Webb TL, 2010, J OF MEDICAL I, V12; Weitzel JA, 2007, J STUD ALCOHOL DRUGS, V68, P534, DOI 10.15288/jsad.2007.68.534	38	30	30	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0167900	10.1371/journal.pone.0167900	http://dx.doi.org/10.1371/journal.pone.0167900			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6RS	28146560	gold, Green Submitted, Green Published			2022-12-27	WOS:000396131700001
J	Goldenberg, SM; Krusi, A; Zhang, E; Chettiar, J; Shannon, K				Goldenberg, Shira M.; Krusi, Andrea; Zhang, Emma; Chettiar, Jill; Shannon, Kate			Structural Determinants of Health among Im/Migrants in the Indoor Sex Industry: Experiences of Workers and Managers/Owners in Metropolitan Vancouver	PLOS ONE			English	Article							MASSAGE PARLOR INDUSTRY; CONDOM USE; TRUCK DRIVERS; HIV/STI RISK; HIV RISK; VIOLENCE; MIGRANT; MOBILITY; CONTEXT; ACCULTURATION	Background Globally, im/migrant women are overrepresented in the sex industry and experience disproportionate health inequities. Despite evidence that the health impacts of migration may vary according to the timing and stage of migration (e.g., early arrival vs. long-term migration), limited evidence exists regarding social and structural determinants of health across different stages of migration, especially among im/migrants engaged in sex work. Our aim was to describe and analyze the evolving social and structural determinants of health and safety across the arrival and settlement process for im/migrants in the indoor sex industry. Methods We analyzed qualitative interviews conducted with 44 im/migrant sex workers and managers/owners working in indoor sex establishments (e.g., massage parlours, micro-brothels) in Metropolitan Vancouver, Canada in 2011; quantitative data from AESHA, a larger community-based cohort, were used to describe socio-demographic and social and structural characteristics of im/migrant sex workers. Results Based on quantitative data among 198 im/migrant workers in AESHA, 78.3% were Chinese-born, the median duration in Canada was 6 years, and most (86.4%) serviced clients in formal indoor establishments. Qualitative narratives revealed diverse pathways into sex work upon arrival to Canada, including language barriers to conventional labour markets and the higher pay and relative flexibility of sex work. Once engaged in sex work, fear associated with police raids (e.g., immigration concerns, sex work disclosure) and language barriers to sexual negotiation and health, social and legal supports posed pervasive challenges to health, safety and human rights during long-term settlement in Canada. Conclusions Findings highlight the critical influences of criminalization, language barriers, and stigma and discrimination related to sex work and im/migrant status in shaping occupational health and safety for im/migrants engaged in sex work. Interventions and policy reforms that emphasize human rights and occupational health are needed to promote health and wellbeing across the arrival and settlement process.	[Goldenberg, Shira M.; Krusi, Andrea; Zhang, Emma; Chettiar, Jill; Shannon, Kate] British Columbia Ctr Excellence HIV AIDS, Gender & Sexual Hlth Initiat, Vancouver, BC, Canada; [Goldenberg, Shira M.] Simon Fraser Univ, Fac Hlth Sci, 8888 Univ Dr, Burnaby, BC, Canada; [Krusi, Andrea; Shannon, Kate] Univ British Columbia, Dept Med, Div Aids, Vancouver, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; Simon Fraser University; University of British Columbia	Goldenberg, SM (corresponding author), British Columbia Ctr Excellence HIV AIDS, Gender & Sexual Hlth Initiat, Vancouver, BC, Canada.; Goldenberg, SM (corresponding author), Simon Fraser Univ, Fac Hlth Sci, 8888 Univ Dr, Burnaby, BC, Canada.	gshi-sg@cfenet.ubc.ca	Goldenberg, Shira/C-9627-2009	Goldenberg, Shira/0000-0003-1633-9749	US National Institutes of Health [R01DA033147]; Canadian Institutes of Health Research/Public Health Agency of Canada [HEB-330155]; Canadian Institutes for Health Research New Investigator Award; National Institutes of Health [R01DA028648]; Canadian Institutes of Health Research; Canada Research Chair in Global Sexual Health and HIV/AIDS; Michael Smith Foundation for Health Research Scholar Award; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028648, R01DA033147] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research/Public Health Agency of Canada(Canadian Institutes of Health Research (CIHR)); Canadian Institutes for Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Global Sexual Health and HIV/AIDS; Michael Smith Foundation for Health Research Scholar Award(Michael Smith Foundation for Health Research); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the US National Institutes of Health (R01DA033147) and the Canadian Institutes of Health Research/Public Health Agency of Canada (HEB-330155). SG is supported by a Canadian Institutes for Health Research New Investigator Award and the National Institutes of Health (R01DA028648). AK is supported through the Canadian Institutes of Health Research. KS is partially supported by a Canada Research Chair in Global Sexual Health and HIV/AIDS and Michael Smith Foundation for Health Research Scholar Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all those who contributed their time and expertise to this project, particularly participants, community advisory board members and partner agencies. We wish to acknowledge Andrea Krusi, Jessica Jia, Chrissy Taylor, Solanna Anderson, Elena Argento, Krista Butler, Jane Li, Minshu Mo, Vivian Liu, Helen Wang, Peter Vann, Sarah Allan, and Jill Chettiar for their research and administrative support. This research was supported by the US National Institutes of Health (R01DA033147) and the Canadian Institutes of Health Research/Public Health Agency of Canada (HEB-330155). SG is supported by a Canadian Institutes for Health Research New Investigator Award and the National Institutes of Health (R01DA028648). AK is supported through the Canadian Institutes of Health Research. KS is partially supported by a Canada Research Chair in Global Sexual Health and HIV/AIDS and Michael Smith Foundation for Health Research Scholar Award.	Abraido-Lanza AF, 2005, SOC SCI MED, V61, P1243, DOI 10.1016/j.socscimed.2005.01.016; Acevedo-Garcia D, 2012, SOC SCI MED, V75, P2060, DOI 10.1016/j.socscimed.2012.04.040; Adanu RMK, 2009, INT J GYNECOL OBSTET, V106, P179, DOI 10.1016/j.ijgo.2009.03.036; Anderson S, LICENSING P IN PRESS; Apostolopoulos Yorghos, 2006, J Immigr Minor Health, V8, P291, DOI 10.1007/s10903-006-9334-2; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Benach J, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001043; Benach J, 2010, AM J IND MED, V53, P338, DOI 10.1002/ajim.20717; Brouwer KC, 2009, J IMMIGR MINOR HEALT, V11, P1, DOI 10.1007/s10903-008-9119-5; Bungay V, 2012, HEALTH CARE WOMEN IN, V33, P262, DOI 10.1080/07399332.2011.603868; Canada S, 2011, NAT HOUS SURV FOC GE; Canada S. B. C, 2009, IMM TRENDS 2009 HIGH; Castaneda H, 2013, SOC SCI MED, V84, P94, DOI 10.1016/j.socscimed.2013.02.010; Choi SYP, 2011, SOCIOL HEALTH ILL, V33, P33, DOI 10.1111/j.1467-9566.2010.01265.x; Decker MR, 2014, LANCET; Deering KN, 2014, AM J PUBLIC HEALTH, V104, pE42, DOI 10.2105/AJPH.2014.301909; Derose Kathryn Pitkin, 2009, MED CARE RES REV; Duff P, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-61; Farmer P, 2003, PATHOLOGIES OF POWER; Farmer P., 2010, RACE ETHNICITY MULTI, V3, P11; Fernandez C, 2008, SPAN ECON REV, V10, P83, DOI 10.1007/s10108-007-9032-4; Finch BK, 2004, INT MIGR REV, V38, P236, DOI 10.1111/j.1747-7379.2004.tb00195.x; GALTUNG J, 1971, J PEACE RES, V8, P73, DOI 10.1177/002234337100800108; Global Commission on HIV and the Law, 2012, RIGHTS RIGHTS HLTH; Goldenberg S, 2010, FIELD ACTIONS SCI RE, P1; Goldenberg S, 2013, INT MIGRATION; Goldenberg SM, 2015, J IMMIGR MINOR HEALT, V17, P21, DOI 10.1007/s10903-014-0011-1; Goldenberg SM, 2014, J URBAN HEALTH, V91, P736, DOI 10.1007/s11524-014-9888-1; Goldenberg SM, 2012, J IMMIGR MINOR HEALT, V14, P48, DOI 10.1007/s10903-011-9505-2; Goldenberg SM, 2011, SOC SCI MED, V72, P1185, DOI 10.1016/j.socscimed.2011.02.014; Handlovsky I, 2012, CULT HEALTH SEX, V14, P1007, DOI 10.1080/13691058.2012.712720; Holmes SM, 2006, PLOS MED, V3, P1776, DOI 10.1371/journal.pmed.0030448; Krusi A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005191; Lippman SA, 2007, SOC SCI MED, V65, P2464, DOI 10.1016/j.socscimed.2007.07.002; Magis-Rodriguez C, 2009, JAIDS-J ACQ IMM DEF, V51, pS21, DOI 10.1097/QAI.0b013e3181a26433; Morris MD, 2009, J COMMUN HEALTH, V34, P529, DOI 10.1007/s10900-009-9175-3; Nemoto T, 2005, AIDS EDUC PREV, V17, P444, DOI 10.1521/aeap.2005.17.5.444; Nemoto T, 2004, AIDS BEHAV, V8, P475, DOI 10.1007/s10461-004-7331-4; Oza KK, 2014, INT J GYNECOLOGY OBS; Pivot Legal Society, 2006, DECR SEX WORK HUM RI; Platt L, 2006, AIDS, V20, P2120, DOI 10.1097/01.aids.0000247586.23696.20; Platt L, 2013, SEX TRANSM INFECT, V89, P311, DOI 10.1136/sextrans-2012-050491; Ragsdale Kathleen, 2007, J Cult Divers, V14, P26; Ramesh S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-764; Rhodes T, 2012, RETHINKING SOCIAL EPIDEMIOLOGY: TOWARDS A SCIENCE OF CHANGE, P205, DOI 10.1007/978-94-007-2138-8_10; Shahmanesh M, 2009, SOC SCI MED, V69, P604, DOI 10.1016/j.socscimed.2009.06.020; Shannon K., 2014, LANCET; Shannon Kate, 2007, Harm Reduct J, V4, P20, DOI 10.1186/1477-7517-4-20; Shannon K, 2008, SOC SCI MED, V66, P911, DOI 10.1016/j.socscimed.2007.11.008; Shannon K, 2015, LANCET, V385, P55, DOI 10.1016/S0140-6736(14)60931-4; Shannon K, 2014, CURR OPIN HIV AIDS, V9, P174, DOI 10.1097/COH.0000000000000042; Shannon K, 2010, JAMA-J AM MED ASSOC, V304, P573, DOI 10.1001/jama.2010.1090; Shannon K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2939; Simic M, 2009, SOCIOL HEALTH ILL, V31, P1, DOI 10.1111/j.1467-9566.2008.01112.x; Sou J, 2015, SEX TRANSM DIS, V42, P312, DOI 10.1097/OLQ.0000000000000276; Steen R, 2015, LANCET, V385, P94, DOI 10.1016/S0140-6736(14)60966-1; Sunmola AM, 2005, AIDS CARE, V17, P208, DOI 10.1080/09540120512331325699; UN Human Rights Council, 2021, REP MEANS ADDR HUM R; United Nations Population Division, 2009, INT MIGR STOCK 2008; Viruell-Fuentes EA, 2007, SOC SCI MED, V65, P1524, DOI 10.1016/j.socscimed.2007.05.010; Viruell-Fuentes EA, 2012, SOC SCI MED, V75, P2099, DOI 10.1016/j.socscimed.2011.12.037; Yi HS, 2010, PSYCHOL HEALTH MED, V15, P172, DOI 10.1080/13548501003623914; Zimmerman C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001034	63	73	73	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170642	10.1371/journal.pone.0170642	http://dx.doi.org/10.1371/journal.pone.0170642			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6QW	28141835	gold, Green Submitted, Green Published			2022-12-27	WOS:000396129500013
J	Ortiz-Zapater, E; Lee, RW; Owen, W; Weitsman, G; Fruhwirth, G; Dunn, RG; Neat, MJ; McCaughan, F; Parker, P; Ng, T; Santis, G				Ortiz-Zapater, Elena; Lee, Richard W.; Owen, William; Weitsman, Gregory; Fruhwirth, Gilbert; Dunn, Robert G.; Neat, Michael J.; McCaughan, Frank; Parker, Peter; Ng, Tony; Santis, George			MET-EGFR dimerization in lung adenocarcinoma is dependent on EGFR mtations and altered by MET kinase inhibition	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; GENE COPY NUMBER; HEPATOCYTE GROWTH; ACQUIRED-RESISTANCE; CANCER PATIENTS; MUTATIONS; ACTIVATION; GEFITINIB; ERLOTINIB; OVEREXPRESSION	Advanced lung cancer has poor survival with few therapies. EGFR tyrosine kinase inhibitors (TKIs) have high response rates in patients with activating EGFR mutations, but acquired resistance is inevitable. Acquisition of the EGFR T790M mutation causes over 50% of resistance; MET amplification is also common. Preclinical data suggest synergy between MET and EGFR inhibitors. We hypothesized that EGFR-MET dimerization determines response to MET inhibition, depending on EGFR mutation status, independently of MET copy number. We tested this hypothesis by generating isogenic cell lines from NCI-H1975 cells, which co-express L858R and T790M EGFR mutations, namely H1975(L858R/T790M) (EGFR TKI resistant); H1975(L858R) (sensitized) and H1975(WT) (wild-type). We assessed cell proliferation in vitro and tumor growth/stroma formation in derived xenograft models in response to a MET TKI (SGX523) and correlated with EGFR-MET dimerization assessed by Forster Resonance Energy Transfer (FRET). SGX523 significantly reduced H1975(L858R/T790M) cell proliferation, xenograft tumor growth and decreased ERK phosphorylation. The same was not seen in H1975(L858R) or H1975(WT) cells. SGX523 only reduced stroma formation in H1975(L858R). SGX523 reduced EGFR-MET dimerization in H1975(L858R/T790M) but induced dimer formation in H1975(L858R) with no effect in H1975(WT). Our data suggests that MET inhibition by SGX523 and EGFR-MET heterodimerisation are determined by EGFR genotype. As tumor behaviour is modulated by this interaction, this could determine treatment efficacy.	[Ortiz-Zapater, Elena; Lee, Richard W.; Owen, William; McCaughan, Frank; Santis, George] Kings Coll London, Guys Hosp, Div Asthma Allergy & Lung Biol, London, England; [Weitsman, Gregory; Ng, Tony] Kings Coll London, Randall Div Cell & Mol Biophys, Richard Dimbleby Dept Canc Res, London, England; [Fruhwirth, Gilbert] Kings Coll London, Div Imaging Sci & Biomed Engn, Dept Imaging Chem & Biol, Rayne Inst,St Thomas Hosp, London, England; [Dunn, Robert G.; Neat, Michael J.] Guys & St Thomas NHS Fdn Trust, Guys Hosp, Viapath, Dept Canc Genet, London, England; [Parker, Peter; Ng, Tony] Kings Coll London, Div Canc Studies, London, England; [Parker, Peter] Francis Crick Inst, Prot Phosphorylat Lab, London, England; [Ng, Tony] Kings Coll London, Guys Hosp, Breast Canc Res Unit, London, England; [Ng, Tony] UCL, UCL Canc Inst, London, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Francis Crick Institute; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; University College London	Santis, G (corresponding author), Kings Coll London, Guys Hosp, Div Asthma Allergy & Lung Biol, London, England.	elena.ortiz-zapater@kcl.ac.uk; george.santis@kcl.ac.uk	Fruhwirth, Gilbert/AAP-5559-2021; Ortiz-Zapater, Elena/HCI-3340-2022	Fruhwirth, Gilbert/0000-0002-1438-2674; Ortiz Zapater, Elena/0000-0002-7437-4772; Lee, Richard/0000-0001-8368-3406; parker, peter/0000-0002-6218-2933; Ng, Tony/0000-0003-3894-5619	BBSRC Program; MRC Clinical Training Research Fellowship; National Institute of Health Research Comprehensive Biomedical Research Centre at King's College London in collaboration; Guy's & St Thomas' National Health Service Foundation Trust; Crick Institute; BBSRC [BB/G007160/1] Funding Source: UKRI; MRC [MR/L001772/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G007160/1] Funding Source: researchfish; Cancer Research UK [16463] Funding Source: researchfish; Medical Research Council [MR/L001772/1] Funding Source: researchfish; National Institute for Health Research [ACF-2007-17-016] Funding Source: researchfish	BBSRC Program(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC Clinical Training Research Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research Comprehensive Biomedical Research Centre at King's College London in collaboration; Guy's & St Thomas' National Health Service Foundation Trust; Crick Institute; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by a BBSRC Program grant to GS, PP and TN; an MRC Clinical Training Research Fellowship to RL; a grateful patient to GS; and the National Institute of Health Research Comprehensive Biomedical Research Centre at King's College London in collaboration with Guy's & St Thomas' National Health Service Foundation Trust and the Crick Institute (GS and WO).; We are grateful to Dorota Dudka and Hassan Farah for technical support and Maddy Parsons and Penny Morton for critical discussion of the work. This work was supported by a BBSRC Program grant to GS, PP and TN, an MRC Clinical Training Research Fellowship to RL, a grateful patient to GS and the National Institute of Health Research Comprehensive Biomedical Research Centre at King's College London in collaboration with Guy's & St Thomas' National Health Service Foundation Trust and the Crick Institute (GS and WO).	Alaoui-Jamali MA, 2003, CANCER RES, V63, P3764; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Beau-Faller M, 2008, J THORAC ONCOL, V3, P331, DOI 10.1097/JTO.0b013e318168d9d4; Benedettini E, 2010, AM J PATHOL, V177, P415, DOI 10.2353/ajpath.2010.090863; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Buchanan SG, 2009, MOL CANCER THER, V8, P3181, DOI 10.1158/1535-7163.MCT-09-0477; Camidge DR, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.8001; Cappuzzo F, 2009, ANN ONCOL, V20, P298, DOI 10.1093/annonc/mdn635; Cappuzzo F, 2009, J CLIN ONCOL, V27, P1667, DOI 10.1200/JCO.2008.19.1635; Chen HJ, 2009, PATHOL ONCOL RES, V15, P651, DOI 10.1007/s12253-009-9167-8; Claus J, 2014, BIOCHEM SOC T, V42, P831, DOI 10.1042/BST20140043; Drilon A, 2016, J THORACIC ONCOLOGY, V16, P31179; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Festy F, 2007, MOL BIOSYST, V3, P381, DOI 10.1039/b617204k; Giordano S, 2002, NAT CELL BIOL, V4, P720, DOI 10.1038/ncb843; Godin-Heymann N, 2007, CANCER RES, V67, P7319, DOI 10.1158/0008-5472.CAN-06-4625; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Jo MJ, 2000, J BIOL CHEM, V275, P8806, DOI 10.1074/jbc.275.12.8806; Menis J, 2013, TRANSL LUNG CANCER R, V2, P23, DOI 10.3978/j.issn.2218-6751.2012.12.04; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Ng T, 1999, SCIENCE, V283, P2085, DOI 10.1126/science.283.5410.2085; Okuda K, 2008, CANCER SCI, V99, P2280, DOI 10.1111/j.1349-7006.2008.00916.x; Olivero M, 1996, BRIT J CANCER, V74, P1862, DOI 10.1038/bjc.1996.646; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Parsons M, 2002, MOL CELL BIOL, V22, P5897, DOI 10.1128/MCB.22.16.5897-5911.2002; Rizzino A., IN VITRO, V20, P815; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shi Y, 2014, J THORAC ONCOL, V9, P154, DOI 10.1097/JTO.0000000000000033; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Tanaka A, 2012, LUNG CANCER, V75, P89, DOI 10.1016/j.lungcan.2011.06.004; Tang Z, 2008, BRIT J CANCER, V99, P911, DOI 10.1038/sj.bjc.6604559; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Wang XD, 2010, J CELL MOL MED, V14, P833, DOI 10.1111/j.1582-4934.2010.01040.x; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang YW, 2010, CANCER RES, V70, P6880, DOI 10.1158/0008-5472.CAN-10-0898	35	11	13	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170798	10.1371/journal.pone.0170798	http://dx.doi.org/10.1371/journal.pone.0170798			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141869	Green Published, Green Submitted, gold			2022-12-27	WOS:000396129500021
J	Fisse, AL; Kemmling, A; Teuber, A; Wersching, H; Young, P; Dittrich, R; Ritter, M; Dziewas, R; Minnerup, J				Fisse, Anna Lena; Kemmling, Andre; Teuber, Anja; Wersching, Heike; Young, Peter; Dittrich, Ralf; Ritter, Martin; Dziewas, Rainer; Minnerup, Jens			The Association of Lesion Location and Sleep Related Breathing Disorder in Patients with Acute Ischemic Stroke	PLOS ONE			English	Article							APNEA; DEFINITIONS; INFARCTION	Background and aims Sleep related breathing disorders (SRBD) are common in patients with ischemic stroke and are associated with poor outcome. SRBD after stroke were assumed to be a direct consequence of injury of specific central nervous system structures. However, whether specific locations of ischemic infarcts cause SRBD is yet unknown. We therefore investigated the association of ischemic lesion location with SRBD. Methods Patients with acute ischemic stroke treated on our stroke unit were included in a prospective observational study. All patients underwent magnetic resonance imaging (MRI) and polygraphy in the acute phase after stroke. SRBD was defined by an apnea-hypopnea index (AHI) >= 10. MRI were evaluated using standardized maps to depict voxel-wise probability distribution of infarction for patients with and without SRBD. Groups were compared using logistic regression analysis. Results Of 142 patients included, 86 (59%) had a SRBD. Age, body mass index and prevalence of arterial hypertension were significantly higher in patients with SRBD. There was no statistically significant association between any lesion location and SRBD. Conclusion We found no association of lesion location and SRBD in stroke patients, whereas established risk factors for SRBD, known from general population, were significantly associated with SRBD. Given the high prevalence of SRBD in stroke patients, these findings suggest that cerebral ischemia facilitates the occurrence of SRBD in patients with pre-existing risk factors rather than causing it by damaging specific central nervous system structures. Our findings can be used to identify stroke patients who might benefit from polygraphy screening.	[Fisse, Anna Lena; Dittrich, Ralf; Ritter, Martin; Dziewas, Rainer; Minnerup, Jens] Univ Munster, Dept Neurol, Munster, Germany; [Kemmling, Andre] Univ Lubeck, Dept Neuroradiol, Lubeck, Germany; [Teuber, Anja; Wersching, Heike] Univ Munster, Inst Epidemiol & Social Med, Munster, Germany; [Young, Peter] Dept Sleep Med & Neuromuscular Disorders, Munster, Germany; [Fisse, Anna Lena] Ruhr Univ Bochum, Dept Neurol, Bochum, Germany	University of Munster; University of Lubeck; University of Munster; Ruhr University Bochum	Fisse, AL (corresponding author), Univ Munster, Dept Neurol, Munster, Germany.; Fisse, AL (corresponding author), Ruhr Univ Bochum, Dept Neurol, Bochum, Germany.	a.fisse@uni-muenster.de	Fisse, Anna Lena/Q-7543-2019; Dziewas, Rainer/AAX-9505-2020	Fisse, Anna Lena/0000-0003-0493-8656; Dziewas, Rainer/0000-0003-1592-8461	Else Kroner-Fresenius-Stiftung [2014_EKES.16]; German Federal Ministry of Education and Research (BMBF) [01ER0816, 01GM1511E]; Lowensteinstiftung	Else Kroner-Fresenius-Stiftung; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Lowensteinstiftung	JM is supported by the Else Kroner-Fresenius-Stiftung (2014_EKES.16). HW is supported by a grant from the German Federal Ministry of Education and Research (BMBF, grant 01ER0816). PY is supported by the Lowensteinstiftung and the German Federal Ministry of Education and Research (BMBF, grant 01GM1511E). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson JA, 2015, SLEEP, V38, P1431, DOI 10.5665/sleep.4984; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Ahn SH, 2013, J CLIN NEUROL, V9, P9, DOI 10.3988/jcn.2013.9.1.9; Bonnin-Vilaplana M, 2009, J NEUROL, V256, P2036, DOI 10.1007/s00415-009-5236-x; Broadley SA, 2007, J CLIN NEUROSCI, V14, P328, DOI 10.1016/j.jocn.2006.01.017; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Brown DL, 2014, SLEEP MED, V15, P887, DOI 10.1016/j.sleep.2014.04.003; Chen R, 2010, NEUROIMAGE, V49, P597, DOI 10.1016/j.neuroimage.2009.07.061; Harbison JA, 2000, QJM-MON J ASSOC PHYS, V93, P647, DOI 10.1093/qjmed/93.10.647; Johnson KG, 2010, CHEST, V138, P239, DOI 10.1378/chest.10-0513; Johnson KG, 2010, J CLIN SLEEP MED, V6, P131; Kemmling A, 2012, CLIN NEURORADIOL, V22, P79, DOI 10.1007/s00062-011-0123-0; Minnerup J, 2012, STROKE, V43, P1137, DOI 10.1161/STROKEAHA.111.637611; Stahl SM, 2015, SLEEP MED, V16, P1198, DOI 10.1016/j.sleep.2015.07.003; STRADLING JR, 1995, THORAX, V50, P683, DOI 10.1136/thx.50.6.683; Suntrup S, 2015, EUR J NEUROL, V22, P832, DOI 10.1111/ene.12670	16	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171243	10.1371/journal.pone.0171243	http://dx.doi.org/10.1371/journal.pone.0171243			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135315	Green Published, Green Submitted, gold			2022-12-27	WOS:000396124700055
J	Wetmore, JB; Weinhandl, ED; Zhou, JC; Gilbertson, DT				Wetmore, James B.; Weinhandl, Eric D.; Zhou, Jincheng; Gilbertson, David T.			Relative Incidence of Acute Adverse Events with Ferumoxytol Compared to Other Intravenous Iron Compounds: A Matched Cohort Study	PLOS ONE			English	Article							FERRIC GLUCONATE COMPLEX; HEMODIALYSIS-PATIENTS; DEFICIENCY ANEMIA; NATIONAL-HEALTH; UNITED-STATES; DRUG EVENTS; DEXTRAN; SUCROSE; SAFETY; EFFICACY	Concerns persist about adverse reactions to intravenous (IV) iron. We aimed to determine the relative safety of ferumoxytol compared to other IV iron compounds. This retrospective cohort study with propensity-score matching for patients and drug doses used the Medicare 20% random sample to identify patients (1) without chronic kidney disease (non-CKD) and (2) with non-dialysis-dependent chronic kidney disease (NDD-CKD) who received a first dose of IV iron in 2010-2012. Exposures were ferumoxytol, iron sucrose, sodium ferric gluconate, or iron dextran. Outcomes were hypersensitivity symptoms, anaphylaxis, emergency department (ED) encounters, hospitalizations, and death after acute IV iron exposure. In the primary analysis for reactions on the day of or following exposure, there was no difference in hypersensitivity symptoms (hazard ratio 1.04, 95% confidence interval 0.94-1.16) or hypotension (0.83, 0.52-1.34) between 4289 non-CKD ferumoxytol users and an equal number of users of other compounds; results were similar for 7358 NDD-CKD patients and an equal number of controls. All-cause ED encounters or hospitalizations were less common in both the non-CKD (0.56, 0.45-0.70) and NDD-CKD ferumoxytol- treated patients (0.83, 0.71-0.95). Fewer than 10 deaths occurred in both the non-CKD and NDD-CKD ferumoxytol users and in matched controls; the hazard for death did not differ significantly between ferumoxytol users and controls in the non-CKD patients (2.00, 0.33-11.97) or in the NDD-CKD patients (0.25, 0.04-1.52). Multiple sensitivity analyses showed similar results. Ferumoxytol did not appear to be associated with more adverse reactions than other compounds for the treatment of iron-deficiency anemia in both non-CKD and NDD-CKD patients.	[Wetmore, James B.; Weinhandl, Eric D.; Zhou, Jincheng; Gilbertson, David T.] Minneapolis Med Res Fdn Inc, Chron Dis Res Grp, Minneapolis, MN 55404 USA; [Wetmore, James B.] Hennepin Cty Med Ctr, Div Nephrol, Minneapolis, MN 55415 USA; [Zhou, Jincheng] Univ Minnesota, Div Biostat, Minneapolis, MN USA	Minneapolis Medical Research Foundation; Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities	Wetmore, JB (corresponding author), Minneapolis Med Res Fdn Inc, Chron Dis Res Grp, Minneapolis, MN 55404 USA.; Wetmore, JB (corresponding author), Hennepin Cty Med Ctr, Div Nephrol, Minneapolis, MN 55415 USA.	James.Wetmore@hcmed.org		Wetmore, James/0000-0003-1380-8597	AMAG Pharmaceuticals, Waltham, Massachusetts	AMAG Pharmaceuticals, Waltham, Massachusetts	This study was supported by a research contract from AMAG Pharmaceuticals, Waltham, Massachusetts, to the Chronic Disease Research Group, Minneapolis Medical Research Foundation, which employs JBW and DTG and employed EDW and JZ. The contract provides for the Minneapolis Medical Research Foundation authors to have final determination of manuscript content. The funding source had no role in the design of the study, the collection, analysis, or interpretation of the data, or the decision to approve publication of the finished manuscript.	Airy M, 2015, NEPHROL DIAL TRANSPL, V30, P2068, DOI 10.1093/ndt/gfv305; Astor BC, 2002, ARCH INTERN MED, V162, P1401, DOI 10.1001/archinte.162.12.1401; Auerbach M, 2008, KIDNEY INT, V73, P528, DOI 10.1038/sj.ki.5002779; Auerbach M, 2013, AM J HEMATOL, V88, P944, DOI 10.1002/ajh.23534; Auerbach M, 2012, AM J HEALTH-SYST PH, V69, P922, DOI 10.2146/ajhp120138; Auerbach M, 2010, HEMATOL-AM SOC HEMAT, P338, DOI 10.1182/asheducation-2010.1.338; Bailie GR, 2012, AM J HEALTH-SYST PH, V69, P310, DOI 10.2146/ajhp110262; Bircher AJ, 2014, IMMUNOL ALLERGY CLIN, V34, P707, DOI 10.1016/j.iac.2014.04.013; Chertow GM, 2006, NEPHROL DIAL TRANSPL, V21, P378, DOI 10.1093/ndt/gfi253; Chertow GM, 2004, NEPHROL DIAL TRANSPL, V19, P1571, DOI 10.1093/ndt/gfh185; Cogswell ME, 2009, AM J CLIN NUTR, V89, P1334, DOI 10.3945/ajcn.2008.27151; Coyne DW, 2003, KIDNEY INT, V63, P217, DOI 10.1046/j.1523-1755.2003.00703.x; Critchley J., 2007, TRANSFUS ALTERN TRAN, V9, P8, DOI [DOI 10.1111/J.1778-428X.2007.00042.X, 10.1111/j.1778-428X.2007.00042.x]; Faich G, 1999, AM J KIDNEY DIS, V33, P464, DOI 10.1016/S0272-6386(99)70183-6; Fishbane S, 1996, AM J KIDNEY DIS, V28, P529, DOI 10.1016/S0272-6386(96)90463-1; Fishbane S, 2009, CLIN J AM SOC NEPHRO, V4, P57, DOI 10.2215/CJN.01670408; Fletes R, 2001, AM J KIDNEY DIS, V37, P743, DOI 10.1016/S0272-6386(01)80123-2; Group KAW, 2012, KIDNEY INT, V2, P279, DOI DOI 10.1038/kisup.2012.37; Hetzel D, 2014, AM J HEMATOL, V89, P646, DOI 10.1002/ajh.23712; Hoffman KB, 2014, DRUG SAFETY, V37, P283, DOI 10.1007/s40264-014-0150-2; Hsu CY, 2002, CURR OPIN NEPHROL HY, V11, P337, DOI 10.1097/00041552-200205000-00011; Cancelo-Hidalgo MJ, 2013, CURR MED RES OPIN, V29, P291, DOI 10.1185/03007995.2012.761599; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Kazmi WH, 2001, AM J KIDNEY DIS, V38, P803, DOI 10.1053/ajkd.2001.27699; Kruske SG, 1999, J PAEDIATR CHILD H, V35, P153, DOI 10.1046/j.1440-1754.1999.t01-1-00351.x; Levin A, 2006, AM J KIDNEY DIS, V47, pS9, DOI 10.1053/j.ajkd.2006.04.023; Looker AC, 1997, JAMA-J AM MED ASSOC, V277, P973, DOI 10.1001/jama.277.12.973; Lopez A, 2016, LANCET, V387, P907, DOI 10.1016/S0140-6736(15)60865-0; Macdougall IC, 2014, CLIN J AM SOC NEPHRO, V9, P705, DOI 10.2215/CJN.05320513; McCarthy JT, 2000, AM J NEPHROL, V20, P455, DOI 10.1159/000046199; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Moore R Andrew, 2011, BMC Blood Disord, V11, P4, DOI 10.1186/1471-2326-11-4; Okam MM, 2012, AM J HEMATOL, V87, pE123, DOI 10.1002/ajh.23322; Onken JE, 2014, NEPHROL DIAL TRANSPL, V29, P833, DOI 10.1093/ndt/gft251; Provenzano R, 2009, CLIN J AM SOC NEPHRO, V4, P386, DOI 10.2215/CJN.02840608; Rubin R., 2015, JAMA-J AM MED ASSOC, V313, P1704; Sav T, 2007, RENAL FAILURE, V29, P423, DOI 10.1080/08860220701278208; Schiller B, 2014, CLIN THER, V36, P70, DOI 10.1016/j.clinthera.2013.09.028; Spinowitz BS, 2008, J AM SOC NEPHROL, V19, P1599, DOI 10.1681/ASN.2007101156; Wang CL, 2015, JAMA-J AM MED ASSOC, V314, P2062, DOI 10.1001/jama.2015.15572; Weber J., 1984, ADV INFLAMMATION RES, P1; Weinhandl ED, 2013, AM J KIDNEY DIS, V62, P557, DOI 10.1053/j.ajkd.2013.02.360; WINGARD RL, 1995, AM J KIDNEY DIS, V25, P433, DOI 10.1016/0272-6386(95)90105-1; Wysowski DK, 2010, AM J HEMATOL, V85, P650, DOI 10.1002/ajh.21794	44	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171098	10.1371/journal.pone.0171098	http://dx.doi.org/10.1371/journal.pone.0171098			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135334	gold, Green Submitted, Green Published			2022-12-27	WOS:000396124700050
J	Chen, W; He, Y; Gao, Y; Zhang, CP; Chen, CS; Bi, SY; Yang, P; Wang, YW; Wang, WJ				Chen, Wen; He, Yong; Gao, Yang; Zhang, Cuiping; Chen, Chuansheng; Bi, Suyu; Yang, Pin; Wang, Yiwen; Wang, Wenjing			Long-Term Experience of Chinese Calligraphic Handwriting Is Associated with Better Executive Functions and Stronger Resting-State Functional Connectivity in Related Brain Regions	PLOS ONE			English	Article							INFERIOR FRONTAL GYRUS; RANDOMIZED CONTROLLED-TRIAL; WORKING-MEMORY; SUSTAINED ATTENTION; TEMPORAL-LOBE; NEURAL BASIS; INHIBITION; CHILDREN; PERFORMANCE; CORTEX	Chinese calligraphic handwriting (CCH) is a traditional art form that requires high levels of concentration and motor control. Previous research has linked short-term training in CCH to improvements in attention and memory. Little is known about the potential impacts of longterm CCH practice on a broader array of executive functions and their potential neural substrates. In this cross-sectional study, we recruited 36 practitioners with at least 5 years of CCH experience and 50 control subjects with no more than one month of CCH practice and investigated their differences in the three components of executive functions (i.e., shifting, updating, and inhibition). Valid resting-state fMRI data were collected from 31 CCH and 40 control participants. Compared with the controls, CCH individuals showed better updating (as measured by the Corsi Block Test) and inhibition (as measured by the Stroop WordColor Test), but the two groups did not differ in shifting (as measured by a cue-target task). The CCH group showed stronger resting-state functional connectivity (RSFC) than the control group in brain areas involved in updating and inhibition. These results suggested that long-term CCH training may be associated with improvements in specific aspects of executive functions and strengthened neural networks in related brain regions.	[Chen, Wen; He, Yong; Gao, Yang; Zhang, Cuiping; Wang, Wenjing] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China; [Chen, Wen; Chen, Chuansheng] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA USA; [He, Yong; Wang, Wenjing] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing, Peoples R China; [Bi, Suyu] Beijing Foreign Studies Univ, Sch Int Journalism & Commun, Beijing, Peoples R China; [Bi, Suyu; Wang, Yiwen] Beijing Normal Univ, Sch Arts & Media, Beijing, Peoples R China; [Yang, Pin] Natl Palace Museum, Conservat Dept, Beijing, Peoples R China	Beijing Normal University; University of California System; University of California Irvine; Beijing Normal University; Beijing Foreign Studies University; Beijing Normal University	Wang, WJ (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China.; Wang, WJ (corresponding author), Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing, Peoples R China.; Wang, YW (corresponding author), Beijing Normal Univ, Sch Arts & Media, Beijing, Peoples R China.	wyiw@sina.com; wangwenjing@bnu.edu.cn	Wang, Yijun/GXW-1763-2022; wang, yixuan/GXW-2866-2022; Wang, Yin/HCI-9352-2022; wang, yi/GVT-8516-2022; Wang, Yixuan/GZK-6559-2022; He, Yong/C-2161-2009; He, Yong/Q-5756-2018	Chen, Chuansheng/0000-0002-8224-1005; Chen, Wen/0000-0001-7563-4495; He, Yong/0000-0002-7039-2850	Ministry of Education of China [14YJAZH081]; National Natural Science Foundation of China [31221003]	Ministry of Education of China(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the 14YJAZH081 Project (received by W.J.W.) of the Ministry of Education of China (http://www.moe.edu.cn/publicfiles/business/htmlfiles/moe/moe27921/) and the No. 31221003 Project (received by Y.H.) of the National Natural Science Foundation of China (http://www.nsfc.gov.cn/publish/portal1/). The funding of 14YJAZH081 Project was mainly for study design, data analysis and decision to publish, while the No. 31221003 Project was mainly for data collection.	[Anonymous], 1999, ORIENTAL ART, V45, P106; Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Banich MT, 2000, J COGNITIVE NEUROSCI, V12, P988, DOI 10.1162/08989290051137521; Barbey AK, 2013, CORTEX, V49, P1195, DOI 10.1016/j.cortex.2012.05.022; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Brown LL, 1997, CURR OPIN NEUROBIOL, V7, P157, DOI 10.1016/S0959-4388(97)80003-7; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Chagn KI, 2011, LECT NOTES COMPUT SC, V6524, P432; Chen ZC, 2013, NEUROIMAGE, V66, P577, DOI 10.1016/j.neuroimage.2012.10.028; Chiang Y., 1973, INTRO ITS AESTHETIC, P13; Chikazoe J, 2007, J COGNITIVE NEUROSCI, V19, P69, DOI 10.1162/jocn.2007.19.1.69; Compton RJ, 2000, COGNITION EMOTION, V14, P401, DOI 10.1080/026999300378897; Corsi P.M., 1972, DISS ABSTR INT, V34, p819B, DOI DOI 10.1016/B978-0-12-564350-4.50011-7; Coull JT, 1996, NEUROPSYCHOLOGIA, V34, P1085, DOI 10.1016/0028-3932(96)00029-2; D'Esposito M, 2015, ANNU REV PSYCHOL, V66, P115, DOI 10.1146/annurev-psych-010814-015031; Diamond A, 2011, SCIENCE, V333, P959, DOI 10.1126/science.1204529; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; Durston S, 2002, DEVELOPMENTAL SCI, V5, pF9, DOI 10.1111/1467-7687.00235; Feldman G, 2010, BEHAV RES THER, V48, P1002, DOI 10.1016/j.brat.2010.06.006; Gao DG, 1994, INFORM PROCESSING CH, P191; Gasquoine PG, 2013, NEUROSCI BIOBEHAV R, V37, P340, DOI 10.1016/j.neubiorev.2013.01.002; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Hazy TE, 2007, PHILOS T R SOC B, V362, P1601, DOI 10.1098/rstb.2007.2055; Heijden AHC, 1992, SELECTIVE ATTENTION; Hudetz JA, 2004, PSYCHOL REP, V95, P53, DOI 10.2466/pr0.95.1.53-70; Hudetz JA, 2000, PSYCHOL REP, V86, P15, DOI 10.2466/PR0.86.1.15-20; Jain S, 2007, ANN BEHAV MED, V33, P11, DOI 10.1207/s15324796abm3301_2; Johnson KJ, 2010, COGNITION EMOTION, V24, P299, DOI 10.1080/02699930903384667; Jolles DD, 2013, HUM BRAIN MAPP, V34, P396, DOI 10.1002/hbm.21444; Kao HSR, 2006, INT J PSYCHOL, V41, P282, DOI 10.1080/00207590544000059; KAO HSR, 1976, ERGONOMICS, V19, P667, DOI 10.1080/00140137608931582; Kao HSR, 2004, PERCEPT MOTOR SKILL, V99, P1269, DOI 10.2466/pms.99.3f.1269-1273; Kao HSR, 1986, MODES HANDWRITING CO; Kao HSR, 1986, EXPLORATORY STUDY EE; Kao HSR, 1989, PSYCHOPHYSIOLOGICAL; Kehagia AA, 2010, CURR OPIN NEUROBIOL, V20, P199, DOI 10.1016/j.conb.2010.01.007; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; Kellogg RT., 1999, COGNITIVE DEMANDS WR, P25; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Kundu B, 2013, J NEUROSCI, V33, P8705, DOI 10.1523/JNEUROSCI.5565-12.2013; Kwok TCY, 2011, CLIN INTERV AGING, V6, P269, DOI 10.2147/CIA.S25395; Langley LK, 2005, PSYCHOL AGING, V20, P356, DOI 10.1037/0882-7974.20.2.356; Lao-Kaim NP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124027; Leube DT, 2003, COGNITIVE BRAIN RES, V18, P97, DOI 10.1016/j.cogbrainres.2003.09.008; Lynn MT, 2014, BRAIN STRUCTURE FUNC; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Olive T, 2002, INT J PSYCHOL, V37, P209, DOI 10.1080/00207590244000089; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Owen AM, 1996, BRAIN, V119, P1597, DOI 10.1093/brain/119.5.1597; Pagulayan KF, 2006, J CLIN EXP NEUROPSYC, V28, P1043, DOI 10.1080/13803390500350977; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; POSNER MI, 1984, J NEUROSCI, V4, P1863; POSNER MI, 1985, COGNITIVE NEUROPSYCH, V2, P211, DOI 10.1080/02643298508252866; RAFAL RD, 1989, J EXP PSYCHOL HUMAN, V15, P673, DOI 10.1037/0096-1523.15.4.673; Rapport MD, 2000, J CLIN CHILD PSYCHOL, V29, P555, DOI 10.1207/S15374424JCCP2904_8; Raven JC, 1998, MANUAL RAVENS ADV PR; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Spielberg JM, 2015, HUM BRAIN MAPP, V36, P3194, DOI 10.1002/hbm.22838; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Takeuchi H, 2010, J NEUROSCI, V30, P3297, DOI 10.1523/JNEUROSCI.4611-09.2010; Turkstra LS, 2002, J COMMUN DISORD, V35, P467, DOI 10.1016/S0021-9924(02)00118-1; Ungar L, 2010, PSYCHIAT RES-NEUROIM, V181, P24, DOI 10.1016/j.pscychresns.2009.07.005; Valentijn SAM, 2005, J AM GERIATR SOC, V53, P374, DOI 10.1111/j.1532-5415.2005.53152.x; van Paasschen J, 2013, NEUROREHAB NEURAL RE, V27, P448, DOI 10.1177/1545968312471902; Vandierendonck A, 2004, BRIT J PSYCHOL, V95, P57, DOI 10.1348/000712604322779460; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Xu M, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/975190; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yang XL, 2010, INT J NURS STUD, V47, P550, DOI 10.1016/j.ijnurstu.2009.10.014; Yang Z, 2015, DEV COGN NEUROS-NETH, V15, P67, DOI 10.1016/j.dcn.2015.07.007; Yin SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145826; Ziereis S, 2015, RES DEV DISABIL, V38, P181, DOI 10.1016/j.ridd.2014.12.005; Zoccatelli G, 2010, EXP BRAIN RES, V207, P139, DOI 10.1007/s00221-010-2433-x; Zou QH, 2013, HUM BRAIN MAPP, V34, P3204, DOI 10.1002/hbm.22136	83	8	8	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170660	10.1371/journal.pone.0170660	http://dx.doi.org/10.1371/journal.pone.0170660			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7VX	28129407	Green Published, Green Submitted, gold			2022-12-27	WOS:000396211400049
J	Chua, J; Lim, B; Fenwick, EK; Gan, ATL; Tan, AG; Lamoureux, E; Mitchell, P; Wang, JJ; Wong, TY; Cheng, CY				Chua, Jacqueline; Lim, Blanche; Fenwick, Eva K.; Gan, Alfred Tau Liang; Tan, Ava Grace; Lamoureux, Ecosse; Mitchell, Paul; Wang, Jie Jin; Wong, Tien Yin; Cheng, Ching-Yu			Prevalence, Risk Factors, and Impact of Undiagnosed Visually Significant Cataract: The Singapore Epidemiology of Eye Diseases Study	PLOS ONE			English	Article							LENS OPACITIES; ANDHRA-PRADESH; RURAL CHINESE; SURGERY; POPULATION; IMPAIRMENT; ADULTS; METHODOLOGY; SURVIVAL; PEOPLE	Objective To determine the prevalence, risk factors, and impact of undiagnosed visually significant cataract in an Asian population. Methods The Singapore Epidemiology of Eye Diseases is a population-based study where 8,697 adults of Malay, Indian, and Chinese ethnicities aged > 40 years were invited for an eye examination, including lens photograph, to establish cataract diagnosis. Visually significant cataract was defined by Wisconsin Cataract Grading System and a best-corrected visual acuity <20/40 with cataract as the primary cause of vision impairment. Participants were deemed 'undiagnosed' if they had visually significant cataract and reported no prior physician diagnosis of cataract. Visual functioning (VF) was assessed with the VF-11 questionnaire validated using Rasch analysis. Results Among the 925 participants with visually significant cataract, 636 (68.8%) were unaware of their cataract status. Age-standardized prevalence varied according to ethnicity, with Malays having higher rates than Chinese and Indians. Factors independently associated with having undiagnosed visually significant cataract were: Malay ethnicity, lower educational attainment, in employment, and without a history of diabetes (all P<0.05). In those with undiagnosed visually significant cataract, half had bilateral visual impairment, which was significantly associated with 24.8% poorer visual functioning compared to those with unilateral visual impairment (P<0.001). Conclusions Two-thirds of Singaporean adults with visually significant cataract were previously undiagnosed. Half of these cases had bilateral visual impairment and substantially reduced quality of life. Public health strategies targeting elderly patients, such as regular screening for visual impairment and timely referral to ophthalmologists in order to prevent progression to bilateral visual impairment when visual function is compromised are warranted.	[Chua, Jacqueline; Lim, Blanche; Fenwick, Eva K.; Gan, Alfred Tau Liang; Lamoureux, Ecosse; Wong, Tien Yin; Cheng, Ching-Yu] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Chua, Jacqueline; Fenwick, Eva K.; Lamoureux, Ecosse; Wong, Tien Yin; Cheng, Ching-Yu] Duke NUS Med Sch, Singapore, Singapore; [Fenwick, Eva K.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Tan, Ava Grace; Mitchell, Paul; Wang, Jie Jin] Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Sydney, NSW, Australia; [Tan, Ava Grace; Mitchell, Paul; Wang, Jie Jin] Univ Sydney, Westmead Inst Med Res, Sydney, NSW, Australia; [Lamoureux, Ecosse; Wong, Tien Yin; Cheng, Ching-Yu] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; National University of Singapore; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; University of Sydney; University of Sydney; Westmead Institute for Medical Research; National University of Singapore	Cheng, CY (corresponding author), Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore.; Cheng, CY (corresponding author), Duke NUS Med Sch, Singapore, Singapore.; Cheng, CY (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore, Singapore.	chingyu.cheng@duke-nus.edu.sg	Lamoureux, Ecosse/Z-5482-2019; wang, jie/GRS-0942-2022; Mitchell, Paul/P-1498-2014; Wang, Jie Jin/P-1499-2014; Cheng, Ching-Yu/Y-2229-2019; Wong, Tien Yin/AAC-9724-2020	Wang, Jie Jin/0000-0001-9491-4898; Cheng, Ching-Yu/0000-0003-0655-885X; Wong, Tien Yin/0000-0002-8448-1264; Chua, Jacqueline/0000-0002-6474-5293; Tan, Ava Grace/0000-0003-3344-0339	National Medical Research Council, Singapore [0796/2003, IRG07nov013, IRG09nov014, STaR/0003/2008, CG/SERI/2010]; Biomedical Research Council, Singapore [08/1/35/19/550, 09/1/35/19/616]; Australian National Health and Medical Research Council (NHMRC) Early Career Fellowship [1072987]	National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council, Singapore(Agency for Science Technology & Research (A*STAR)); Australian National Health and Medical Research Council (NHMRC) Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This study is supported by the National Medical Research Council (grants: 0796/2003, IRG07nov013, IRG09nov014, STaR/0003/2008; CG/SERI/2010) and Biomedical Research Council (grants: 08/1/35/19/550, 09/1/35/19/616), Singapore. C-YC is supported by National Medical Research Council (CSA/033/2012). EF is funded by the Australian National Health and Medical Research Council (NHMRC) Early Career Fellowship (#1072987). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourne RRA, 2013, LANCET GLOB HEALTH, V1, pE339, DOI 10.1016/S2214-109X(13)70113-X; Busbee BG, 2002, OPHTHALMOLOGY, V109, P606, DOI 10.1016/S0161-6420(01)00971-X; Chou R, 2016, JAMA-J AM MED ASSOC, V315, P915, DOI 10.1001/jama.2016.0783; Chua J, 2015, OPHTHALMOLOGY; Chua J, 2015, JAMA OPHTHALMOLOGY; Chua J, 2015, OPHTHALMOLOGY, V122, P2169, DOI 10.1016/j.ophtha.2015.06.052; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P487; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; [Department of Statistics MoTaI Republic of Singapore Statistics Do], 2001, CENS POP 2000 STAT R; Duan XR, 2013, GRAEF ARCH CLIN EXP, V251, P203, DOI 10.1007/s00417-012-2012-x; Fong CSU, 2014, AM J OPHTHALMOL, V157, P163, DOI 10.1016/j.ajo.2013.08.018; Fong CSU, 2013, OPHTHALMOLOGY, V120, P1720, DOI 10.1016/j.ophtha.2013.02.009; Fong Timothy W, 2007, Psychiatry (Edgmont), V4, P51; Foong AWP, 2007, OPHTHAL EPIDEMIOL, V14, P25, DOI 10.1080/09286580600878844; Gomersall T, 2011, QUAL HEALTH RES, V21, P853, DOI 10.1177/1049732311402096; Gray CS, 2006, J CATARACT REFR SURG, V32, P60, DOI 10.1016/j.jcrs.2005.07.040; Gupta P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075584; Huang OS, 2013, OPHTHAL EPIDEMIOL, V20, P52, DOI 10.3109/09286586.2012.751429; Huang OS, 2015, BRIT J OPHTHALMOLOGY; Khairallah M, 2015, INVEST OPHTH VIS SCI, V56, P6762, DOI 10.1167/iovs.15-17201; KLEIN BEK, 1990, OPHTHALMOLOGY, V97, P1428; Kovai V, 2014, OPHTHAL EPIDEMIOL, V21, P144, DOI 10.3109/09286586.2014.903980; Krishnaiah S, 2005, INVEST OPHTH VIS SCI, V46, P58, DOI 10.1167/iovs.04-0089; Lamoureux EL, 2011, CURR OPIN OPHTHALMOL, V22, P19, DOI 10.1097/ICU.0b013e3283414284; Lamoureux EL, 2009, INVEST OPHTH VIS SCI, V50, P2607, DOI 10.1167/iovs.08-2359; Lavanya R, 2009, OPHTHAL EPIDEMIOL, V16, P325, DOI 10.3109/09286580903144738; McGwin G, 2003, J CATARACT REFR SURG, V29, P941, DOI 10.1016/S0886-3350(02)01846-1; Mitchell P, 1997, OPHTHALMOLOGY, V104, P581, DOI 10.1016/S0161-6420(97)30266-8; Nirmalan PK, 2003, INVEST OPHTH VIS SCI, V44, P4639, DOI 10.1167/iovs.03-0011; Panday M, 2015, CLIN EXPT OPHTHALMOL; Sabanayagam C, 2016, OPHTHALMOLOGY; Siu AL, 2016, JAMA-J AM MED ASSOC, V315, P908, DOI 10.1001/jama.2016.0763; Tan AG, 2012, OPHTHAL EPIDEMIOL, V19, P380, DOI 10.3109/09286586.2012.733479; Tan Ava Grace, 2006, BMC Ophthalmol, V6, P17, DOI 10.1186/1471-2415-6-17; Tsai SY, 2003, OPHTHALMOLOGY, V110, P1089, DOI 10.1016/S0161-6420(03)00243-4; Varma R, 2008, MED CARE, V46, P497, DOI 10.1097/MLR.0b013e31816080fe; Vashist P, 2011, OPHTHALMOLOGY, V118, pe1; Wong TY, 2001, ARCH OPHTHALMOL-CHIC, V119, P727, DOI 10.1001/archopht.119.5.727; Xu L, 2006, OPHTHALMOLOGY, V113, P747, DOI 10.1016/j.ophtha.2006.01.026; Zhang X, 2012, AM J OPHTHALMOL S, V154, pe1, DOI DOI 10.1016/J.AJ0.2011.08.045	40	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170804	10.1371/journal.pone.0170804	http://dx.doi.org/10.1371/journal.pone.0170804			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129358	Green Published, gold			2022-12-27	WOS:000396211400032
J	Aljebab, F; Choonara, I; Conroy, S				Aljebab, Fahad; Choonara, Imti; Conroy, Sharon			Systematic Review of the Toxicity of LongCourse Oral Corticosteroids in Children	PLOS ONE			English	Review							ACUTE LYMPHOBLASTIC-LEUKEMIA; PROTEIN-LOSING ENTEROPATHY; DOSE DEXAMETHASONE THERAPY; ALTERNATE-DAY PREDNISONE; IDIOPATHIC THROMBOCYTOPENIC PURPURA; POSTERIOR SUBCAPSULAR CATARACTS; PITUITARY-ADRENAL AXIS; STEROID-THERAPY; INFANTILE HEMANGIOMAS; METHYLPREDNISOLONE THERAPY	Background Long courses of oral corticosteroids are commonly used in children in the management of chronic conditions. Various adverse drug reactions (ADRs) are known to occur with their use. This systematic review aimed to identify the most common and serious ADRs and to determine their relative risk levels. Methods A literature search of Embase, Medline, International Pharmaceutical Abstracts, CINAHL, Cochrane Library and PubMed was performed with no language restrictions in order to identify studies where oral corticosteroids were administered to patients aged 28 days to 18 years of age for at least 15 days of treatment. Each database was searched from their earliest dates to January 2016. All studies providing clear information on ADRs were included. Results One hundred and one studies including 33 prospective cohort studies; 21 randomised controlled trials; 21 case series and 26 case reports met the inclusion criteria. These involved 6817 children and reported 4321 ADRs. The three ADRs experienced by the highest number of patients were weight gain, growth retardation and Cushingoid features with respective incidence rates of 21.1%, 18.1% and 19.4% of patients assessed for these ADRs. 21.5% of patients measured showed decreased bone density and 0.8% of patients showed osteoporosis. Biochemical HPA axis suppression was detected in 269 of 487 patients where it was measured. Infection was the most serious ADR, with twenty one deaths. Varicella zoster was the most frequent infection (9 deaths). Conclusions Weight gain, growth retardation and Cushingoid features were the most frequent ADRs seen when long-course oral corticosteroids were given to children. Increased susceptibility to infection was the most serious ADR.	[Aljebab, Fahad; Choonara, Imti; Conroy, Sharon] Univ Nottingham, Royal Derby Hosp Ctr, Div Med Sci & Grad Entry Med, Sch Med, Derby, England	University of Nottingham	Conroy, S (corresponding author), Univ Nottingham, Royal Derby Hosp Ctr, Div Med Sci & Grad Entry Med, Sch Med, Derby, England.	Sharon.conroy@nottingham.ac.uk	Choonara, Imti/I-3559-2019	Choonara, Imti/0000-0002-3069-6323				ABUEKTEISH F, 1995, THORAX, V50, P674, DOI 10.1136/thx.50.6.674; Adams DM, 1996, J PEDIATR-US, V128, P281, DOI 10.1016/S0022-3476(96)70410-9; Ourhroui MA, 2010, ANN DERMATOL VENER, V137, P514, DOI 10.1016/j.annder.2010.06.002; Akyuz C, 2001, PEDIATR HEMAT ONCOL, V18, P47, DOI 10.1080/088800101750059855; Alessandri AJ, 2000, J PEDIAT HEMATOL ONC, V22, P176, DOI 10.1097/00043426-200003000-00020; Aljebab F, 2016, ARCH DIS CHILD, V101, P365, DOI [10.1136/archdischild-2015-309522, 10.1136/archdischild-2016-311535.57]; Aly MMD, 2015, EUR J PEDIATR, V174, P1503, DOI 10.1007/s00431-015-2561-1; Bahat E, 2007, J NEPHROL, V20, P234; BAKCHINE H, 1984, ARCH FR PEDIATR, V41, P261; Bauman NM, 2014, JAMA OTOLARYNGOL, V140, P323, DOI 10.1001/jamaoto.2013.6723; Bertrand J, 2011, PEDIATR DERMATOL, V28, P649, DOI 10.1111/j.1525-1470.2011.01551.x; BLANCHETTE V, 1994, LANCET, V344, P703, DOI 10.1016/S0140-6736(94)92205-5; Boon LM, 1999, PLAST RECONSTR SURG, V104, P1616, DOI 10.1097/00006534-199911000-00002; BorgnaPignatti C, 1997, J PEDIATR-US, V130, P13, DOI 10.1016/S0022-3476(97)70304-4; Bostrom BC, 2003, BLOOD, V101, P3809, DOI 10.1182/blood-2002-08-2454; Broyer M, 1997, PEDIATR NEPHROL, V11, P418, DOI 10.1007/s004670050308; Buyukcelik M, 2006, CLIN NEPHROL, V65, P7; Chen JS, 1997, J PEDIAT HEMATOL ONC, V19, P526, DOI 10.1097/00043426-199711000-00007; CHIEMCHANYA S, 1986, Journal of the Medical Association of Thailand, V69, P6; Citterio F, 2001, TRANSPLANTATION, V72, pSS75; Connolly AM, 2002, NEUROMUSCULAR DISORD, V12, P917, DOI 10.1016/S0960-8966(02)00180-3; Corapcioglu F, 2011, TURKISH J PEDIATR, V53, P137; Cunha CD, 2004, J CLIN ENDOCR METAB, V89, P2797, DOI 10.1210/jc.2003-031165; CURLESS RG, 1986, NEUROLOGY, V36, P872, DOI 10.1212/WNL.36.6.872; Curtis JR, 2006, ARTHRIT RHEUM-ARTHR, V55, P420, DOI 10.1002/art.21984; Delesalle F, 2006, ACTA DERM-VENEREOL, V86, P429, DOI 10.2340/00015555-0119; Demirci K, 2015, J MOOD DISORD, V5, P182, DOI 10.5455/jmood.20141110123157; DOWELL SF, 1993, PEDIATRICS, V92, P223; DRIGAN R, 1992, MED PEDIATR ONCOL, V20, P13, DOI 10.1002/mpo.2950200104; Egunsola O, 2013, EUR J CLIN PHARMACOL, V69, P1211, DOI 10.1007/s00228-012-1468-2; EIGEN H, 1995, J PEDIATR-US, V126, P515, DOI 10.1016/S0022-3476(95)70343-8; Einaudi S, 2008, PEDIATR BLOOD CANCER, V50, P537, DOI 10.1002/pbc.21339; ELLIOTT AJ, 1985, BRIT J OPHTHALMOL, V69, P459, DOI 10.1136/bjo.69.6.459; ENJOLRAS O, 1990, PEDIATRICS, V85, P491; Escher JC, 2004, EUR J GASTROEN HEPAT, V16, P47, DOI 10.1097/00042737-200401000-00008; Felder-Puig R, 2007, CLIN CANCER RES, V13, P7093, DOI 10.1158/1078-0432.CCR-07-0902; Felner EI, 2000, J PEDIATR-US, V137, P21, DOI 10.1067/mpd.2000.107385; FENICHEL GM, 1991, ARCH NEUROL-CHICAGO, V48, P575, DOI 10.1001/archneur.1991.00530180027012; Ferrara M, 2005, HEMATOLOGY, V10, P401, DOI 10.1080/10245330500168740; FOOTE KD, 1985, LANCET, V2, P917; FRIEDMAN M, 1966, LANCET, V2, P568, DOI 10.1016/S0140-6736(66)93038-8; Fujita K, 1983, PEDIATR INT, V25, P322; GARIN EH, 1986, EUR J PEDIATR, V145, P380, DOI 10.1007/BF00439243; GEORGE WE, 1983, NEW ENGL J MED, V308, P316, DOI 10.1056/NEJM198302103080605; Gordijn MS, 2012, PSYCHONEUROENDOCRINO, V37, P1448, DOI 10.1016/j.psyneuen.2012.01.014; GREALLY P, 1994, ARCH DIS CHILD, V71, P35, DOI 10.1136/adc.71.1.35; Greene AK, 2011, PLAST RECONSTR SURG, V128, P743, DOI 10.1097/PRS.0b013e3182221398; Grover C, 2011, PEDIATR DERMATOL, V28, P502, DOI 10.1111/j.1525-1470.2011.01491.x; Grover C, 2010, DERMATOL SURG, V36, P2030, DOI 10.1111/j.1524-4725.2010.01760.x; Gupta MT, 2004, BRIT J DERMATOL, V150, P163, DOI 10.1111/j.1365-2133.2004.05754.x; Gursu HA, 2014, CARDIOL YOUNG, V24, P764, DOI 10.1017/S104795111300125X; Gursu HA, 2014, J CARDIAC SURG, V29, P712, DOI 10.1111/jocs.12355; Hailey D, 2003, INT J TECHNOL ASSESS, V19, P1, DOI 10.1017/S0266462303000011; HARRIS JC, 1986, J AM ACAD CHILD PSY, V25, P120, DOI 10.1016/S0002-7138(09)60608-7; Hawcutt DB, 2015, CLIN ENDOCRINOL, V82, P648, DOI 10.1111/cen.12655; HAWKINS DB, 1984, LARYNGOSCOPE, V94, P633; Hernandez AH, 2007, CLIN TRANSL ONCOL, V9, P262, DOI 10.1007/s12094-007-0050-3; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; HUNDER GG, 1975, ANN INTERN MED, V82, P613, DOI 10.7326/0003-4819-82-5-613; IMBACH P, 1985, LANCET, V2, P464; Ishigaki K, 2009, BRAIN DEV-JPN, V31, P634, DOI 10.1016/j.braindev.2008.08.016; JACKSON LD, 1995, GUT, V36, P459, DOI 10.1136/gut.36.3.459; Jalil A, 2011, J PEDIAT OPHTH STRAB, V48, P218, DOI 10.3928/01913913-20100719-04; JOB JC, 1985, ARCH FR PEDIATR, V42, P765; KANEDA A, 1984, J BONE JOINT SURG AM, V66A, P783, DOI 10.2106/00004623-198466050-00022; Kastner M, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.4.e25; Kelly HW, 2008, PEDIATRICS, V122, pE53, DOI 10.1542/peds.2007-3381; Kenna HA, 2011, PSYCHIAT CLIN NEUROS, V65, P549, DOI 10.1111/j.1440-1819.2011.02260.x; Kim SM, 1999, INT J DERMATOL, V38, P546, DOI 10.1046/j.1365-4362.1999.00623.x; Kim SH, 2013, ALLERGY ASTHMA IMMUN, V5, P62, DOI 10.4168/aair.2013.5.1.62; Kivity S, 2004, EPILEPSIA, V45, P255, DOI 10.1111/j.0013-9580.2004.30503.x; Koay ACA, 2011, J OCUL PHARMACOL TH, V27, P309, DOI 10.1089/jop.2011.0013; Kossoff EH, 2009, EPILEPSY BEHAV, V14, P674, DOI 10.1016/j.yebeh.2009.01.023; Kuhne T, 1997, J PEDIATR-US, V130, P17, DOI 10.1016/S0022-3476(97)70305-6; Kuperman H, 2001, J CLIN ENDOCR METAB, V86, P2993, DOI 10.1210/jc.86.7.2993; Levine A, 2003, J PEDIATR GASTR NUTR, V36, P248, DOI 10.1097/00005176-200302000-00017; Levine A, 2009, INFLAMM BOWEL DIS, V15, P1055, DOI 10.1002/ibd.20881; LEWIS DA, 1983, J AFFECT DISORDERS, V5, P319, DOI 10.1016/0165-0327(83)90022-8; LIGHTNER ES, 1981, AM J DIS CHILD, V135, P790, DOI 10.1001/archpedi.1981.02130330002002; Loke YK, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-32; Mahachoklertwattana P, 2004, J PEDIATR-US, V144, P736, DOI 10.1016/j.jpeds.2004.03.033; Mallo S, 2004, ACTA DERMOSIFILIOGR, V95, P370; MALONE DNS, 1972, BRIT MED J, V3, P202, DOI 10.1136/bmj.3.5820.202; Martindale, COMPLETE DRUG REFERE; Matsuzaki A, 2008, PEDIATR HEMAT ONCOL, V25, P237, DOI 10.1080/08880010801938215; MERRITT RJ, 1986, CLIN PEDIATR, V25, P149, DOI 10.1177/000992288602500304; MILTENYI M, 1983, HELV PAEDIATR ACTA, V38, P141; Mitchell CD, 2005, BRIT J HAEMATOL, V129, P734, DOI 10.1111/j.1365-2141.2005.05509.x; Miura M, 2011, PAED CHILD HEALT-CAN, V16, P479, DOI 10.1093/pch/16.8.479; Morais P, 2011, CUTAN OCUL TOXICOL, V30, P245, DOI 10.3109/15569527.2011.554483; Mytinger JR, 2010, J CHILD NEUROL, V25, P948, DOI 10.1177/0883073809356107; Nammalwar BR, 2006, INDIAN PEDIATR, V43, P39; NASSIF E, 1987, J ALLERGY CLIN IMMUN, V80, P518, DOI 10.1016/0091-6749(87)90002-9; Nieuwenhuis K, 2013, PEDIATR DERMATOL, V30, P64, DOI 10.1111/j.1525-1470.2012.01846.x; Ozturk F, 2011, J ALLERGY CLIN IMMUN, V128, P348, DOI 10.1016/j.jaci.2011.04.045; Pandey A, 2009, J PEDIATR SURG, V44, P688, DOI 10.1016/j.jpedsurg.2008.10.038; Payne DNR, 2002, PEDIATR PULM, V33, P356, DOI 10.1002/ppul.10081; Petersen KB, 2003, MED PEDIATR ONCOL, V41, P110, DOI 10.1002/mpo.10316; Philip Jim, 2014, Open Respir Med J, V8, P66, DOI 10.2174/1874306401408010066; Pope E, 2007, PEDIATRICS, V119, pE1239, DOI 10.1542/peds.2006-2962; Price CJ, 2011, ARCH DERMATOL, V147, P1371, DOI 10.1001/archdermatol.2011.203; REICHLING G, 1961, ARCH DERMATOL, V83, P980, DOI 10.1001/archderm.1961.01580120092023; REJOU F, 1986, ARCH DIS CHILD, V61, P1230, DOI 10.1136/adc.61.12.1230; Rix M, 2005, J PEDIATR-US, V147, P645, DOI 10.1016/j.jpeds.2005.06.006; RIZZONI G, 1986, RIV ITAL PED, V12, P519; ROOKLIN AR, 1979, J ALLERGY CLIN IMMUN, V63, P383, DOI 10.1016/0091-6749(79)90210-0; RUUSKA T, 1994, J PEDIATR GASTR NUTR, V19, P175, DOI 10.1097/00005176-199408000-00006; Sadan N, 1996, J PEDIATR-US, V128, P141, DOI 10.1016/S0022-3476(96)70446-8; Sakurai Y, 1999, INT J PEDIAT HEM ONC, V6, P27; SANDERS BP, 1992, J ALLERGY CLIN IMMUN, V89, P816, DOI 10.1016/0091-6749(92)90436-6; SANSOME A, 1993, NEUROMUSCULAR DISORD, V3, P567, DOI 10.1016/0960-8966(93)90117-3; Schaefer ET, 2008, CLIN GASTROENTEROL H, V6, P165, DOI 10.1016/j.cgh.2007.11.008; Schumacher KR, 2011, PEDIATR CARDIOL, V32, P966, DOI 10.1007/s00246-011-0029-2; Shiff NJ, 2013, ARTHRIT CARE RES, V65, P113, DOI 10.1002/acr.21785; SILK HJ, 1988, J ALLERGY CLIN IMMUN, V81, P47, DOI 10.1016/0091-6749(88)90219-9; Sogo T, 2006, HEPATOL RES, V34, P187, DOI 10.1016/j.hepres.2005.12.002; SPLAIN J, 1992, AM J HEMATOL, V39, P208, DOI 10.1002/ajh.2830390310; Srinivasan A, 2011, ANN TROP PAEDIATR, V31, P273, DOI 10.1179/1465328111Y.0000000027; Sumboonnanonda Achra, 1994, Journal of the Medical Association of Thailand, V77, P126; Tan BH, 2011, NEW ZEAL MED J, V124, P57; Teixeira AL, 2005, PARKINSONISM RELAT D, V11, P327, DOI 10.1016/j.parkreldis.2005.02.007; Thacker D, 2010, ANN THORAC SURG, V89, P837, DOI 10.1016/j.athoracsur.2009.09.063; Torok KS, 2012, J RHEUMATOL, V39, P286, DOI 10.3899/jrheum.110210; Tsuruga Kazushi, 2009, Nihon Jinzo Gakkai Shi, V51, P68; Turner Z, 2012, CONGENIT HEART DIS, V7, P24, DOI 10.1111/j.1747-0803.2011.00593.x; Upadhyay A, 2016, PEDIATR NEPHROL, V31, P233, DOI 10.1007/s00467-015-3216-1; Uysal KM, 2001, PEDIATR HEMAT ONCOL, V18, P335, DOI 10.1080/088800101300312609; VANSTORYLEWIS PE, 1987, J AM DENT ASSOC, V115, P49, DOI 10.14219/jada.archive.1987.0193; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; WALES JKH, 1988, ARCH DIS CHILD, V63, P981, DOI 10.1136/adc.63.8.981; Wali YA, 2002, PEDIATR HEMAT ONCOL, V19, P329, DOI 10.1080/08880010290057345; WATANABE TK, 1994, J ADOLESCENT HEALTH, V15, P345, DOI 10.1016/1054-139X(94)90609-2; Wiersbitzky S, 1982, Arztl Jugendkd, V73, P225; Williams KW, 2013, CLIN PEDIATR, V52, P30, DOI 10.1177/0009922812461441; WOLTHERS OD, 1990, BRIT MED J, V301, P145, DOI 10.1136/bmj.301.6744.145; Woynarowski M, 2013, J PEDIATR-US, V163, P1347, DOI 10.1016/j.jpeds.2013.05.042; Zannolli R, 2012, MOVEMENT DISORD, V27, P1312, DOI 10.1002/mds.25126; Zulian F, 2011, ARTHRITIS RHEUM-US, V63, P1998, DOI 10.1002/art.30264; Zychowicz C, 1982, Wiad Lek, V35, P1177	140	61	67	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e170259	10.1371/journal.pone.0170259	http://dx.doi.org/10.1371/journal.pone.0170259			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125632	Green Submitted, gold, Green Published			2022-12-27	WOS:000396176100122
J	Castellanos, LR; Donado-Godoy, P; Leon, M; Clavijo, V; Arevalo, A; Bernal, JF; Timmerman, AJ; Mevius, DJ; Wagenaar, JA; Hordijk, J				Castellanos, Luis Ricardo; Donado-Godoy, Pilar; Leon, Maribel; Clavijo, Viviana; Arevalo, Alejandra; Bernal, Johan F.; Timmerman, Arjen J.; Mevius, Dik J.; Wagenaar, Jaap A.; Hordijk, Joost			High Heterogeneity of Escherichia coli Sequence Types Harbouring ESBL/AmpC Genes on IncI1 Plasmids in the Colombian Poultry Chain	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; URINARY-TRACT-INFECTIONS; FOOD-PRODUCING ANIMALS; EXTENDED-SPECTRUM; ANTIMICROBIAL RESISTANCE; KLEBSIELLA-PNEUMONIAE; SALMONELLA-ENTERICA; CTX-M; BROILER FARMS; CHICKEN MEAT	Background Escherichia coli producing ESBL/AmpC enzymes are unwanted in animal production chains as they may pose a risk to human and animal health. Molecular characterization of plasmids and strains carrying genes that encode these enzymes is essential to understand their local and global spread. Objectives To investigate the diversity of genes, plasmids and strains in ESBL/AmpC-producing E. coli from the Colombian poultry chain isolated within the Colombian Integrated Program for Antimicrobial Resistance Surveillance (Coipars). Methods A total of 541 non-clinical E. coli strains from epidemiologically independent samples and randomly isolated between 2008 and 2013 within the Coipars program were tested for antimicrobial susceptibility. Poultry isolates resistant to cefotaxime (MIC >= 4 mg/L) were screened for ESBL/AmpC genes including bla(CTX-M), bla(SHV), bla(TEM), bla(CMY) and bla(OXA). Plasmid and strain characterization was performed for a selection of the ESBL/AmpC-producing isolates. Plasmids were purified and transformed into E. coli DH10B cells or transferred by conjugation to E. coli W3110. When applicable, PCR Based Replicon Typing (PBRT), plasmid Multi Locus Sequence Typing (pMLST), plasmid Double Locus Sequence Typing (pDLST) and/or plasmid Replicon Sequence Typing (pRST) was performed on resulting transformants and conjugants. Multi Locus Sequence Typing (MLST) was used for strain characterization. Results In total, 132 of 541 isolates were resistant to cefotaxime and 122 were found to carry ESBL/AmpC genes. Ninety-two harboured bla(CMY-2) (75%), fourteen bla(SHV-12) (11%), three bla(SHV-5) (2%), five bla(CTX-M-2) (4%), one bla(CTX-M-15) (1%), one bla(CTX-M-8) (1%), four a combination of bla(CMY-2) and bla(SHV-12) (4%) and two a combination of bla(CMY-2) and bla(SHV-5) (2%). A selection of 39 ESBL/AmpC-producing isolates was characterized at the plasmid and strain level. ESBL/AmpC genes from 36 isolates were transferable by transformation or conjugation of which 22 were located on IncI1 plasmids. These IncI1 plasmids harboured predominantly blaCMY-2 (16/22), and to a lesser extend bla(SHV-12) (5/22) and bla(CTX-M-8) (1/22). Other plasmid families associated with ESBL/AmpC-genes were IncK (4/33), IncHI2 (3/33), IncA/C (2/33), Inc./O (1/33) and a non-typeable replicon (1/33). Subtyping of IncI1 and IncHI2 demonstrated IncI1/ST12 was predominantly associated with bla(CMY-2) (12/16) and IncHI2/ST7 with bla(CTX-M-2) (2/3). Finally, 31 different STs were detected among the 39 selected isolates. Conclusions Resistance to extended spectrum cephalosporins in E. coli from Colombian poultry is mainly caused by bla(CMY-2) and bla(SHV-12). The high diversity of strain Sequence Types and the dissemination of homogeneous IncI1/ST12 plasmids suggest that spread of the resistance is mainly mediated by horizontal gene transfer.	[Castellanos, Luis Ricardo; Timmerman, Arjen J.; Mevius, Dik J.; Wagenaar, Jaap A.; Hordijk, Joost] Univ Utrecht, Dept Infect Dis & Immunol, Fac Vet Med, Utrecht, Netherlands; [Castellanos, Luis Ricardo; Donado-Godoy, Pilar; Clavijo, Viviana; Arevalo, Alejandra; Bernal, Johan F.] Corp Colombiana Invest Agr Corp, Colombian Integrated Program Antimicrobial Resist, Cundinamarca, Colombia; [Leon, Maribel] ICA, Bogota, Colombia; [Clavijo, Viviana] Univ Los Andes, Dept Biol Sci, Bogota, Colombia; [Mevius, Dik J.; Wagenaar, Jaap A.] Wageningen Biovet Res, Wageningen, Netherlands	Utrecht University; Corporacion Colombiana de Investigacion Agropecuaria, AGROSAVIA; Universidad de los Andes (Colombia); Wageningen University & Research	Hordijk, J (corresponding author), Univ Utrecht, Dept Infect Dis & Immunol, Fac Vet Med, Utrecht, Netherlands.	j.hordijk@uu.nl		Clavijo, Viviana/0000-0003-1442-9791; Castellanos, Luis Ricardo/0000-0003-3580-2719				Aarestrup FM, 2010, MICROB DRUG RESIST, V16, P253, DOI 10.1089/mdr.2010.0036; Abreu R, 2014, FOODBORNE PATHOG DIS, V11, P868, DOI 10.1089/fpd.2014.1796; Agerso Y, 2014, FOODBORNE PATHOG DIS, V11, P740, DOI 10.1089/fpd.2014.1742; Botelho LAB, 2015, MEM I OSWALDO CRUZ, V110, P249, DOI 10.1590/0074-02760140389; Ben Sallem R, 2014, MICROB DRUG RESIST, V20, P495, DOI 10.1089/mdr.2013.0224; Blanco VM, 2016, ENFERM INFECC MICROB; Borjesson S, 2013, CLIN MICROBIOL INFEC, V19, pE309, DOI 10.1111/1469-0691.12192; Braun SD, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01020; Canadian Integrated program for Antimicrobial Resistance Surveillance (CIPARS), 2008, ANN REPORT; CLSI, 2013, PERFORMANCE STANDARD; Correia S, 2012, DIAGN MICR INFEC DIS, V74, P423, DOI 10.1016/j.diagmicrobio.2012.08.017; Dahmen S, 2013, J ANTIMICROB CHEMOTH, V68, P2797, DOI 10.1093/jac/dkt291; de Been M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004776; Dierikx CM, 2012, J ANTIMICROB CHEMOTH, V67, P1368, DOI 10.1093/jac/dks049; Dierikx C, 2013, J ANTIMICROB CHEMOTH, V68, P60, DOI 10.1093/jac/dks349; Dierikx C, 2010, VET MICROBIOL, V145, P273, DOI 10.1016/j.vetmic.2010.03.019; Dierikx CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079005; Doi Y, 2010, CLIN MICROBIOL INFEC, V16, P33, DOI 10.1111/j.1469-0691.2009.03001.x; Donado-Godoy P, 2015, ZOONOSES PUBLIC HLTH, V62, P58, DOI 10.1111/zph.12192; Donado-Godoy P, 2012, J FOOD PROTECT, V75, P874, DOI 10.4315/0362-028X.JFP-11-458; El-Jade MR, 2016, PLOS ONE, P1; Ellis C, 2013, DIAGN MICR INFEC DIS, V76, P399, DOI 10.1016/j.diagmicrobio.2013.04.017; Espinal P, 2010, J CHEMOTHERAPY, V22, P160, DOI 10.1179/joc.2010.22.3.160; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Fadlelmula A, 2016, TROP ANIM HEALTH PRO, V48, P427, DOI 10.1007/s11250-015-0970-9; Ferreira JC, 2014, CLIN MICROBIOL INFEC, V20, pO623, DOI 10.1111/1469-0691.12531; Ferreira JC, 2016, DIAGN MICROBIOL INFE; Ferreira JC, 2014, DIAGN MICR INFEC DIS, V80, P304, DOI 10.1016/j.diagmicrobio.2014.09.012; Garcia-Fernandez A, 2008, J ANTIMICROB CHEMOTH, V61, P1229, DOI 10.1093/jac/dkn131; Garcia-Fernandez A, 2010, J ANTIMICROB CHEMOTH, V65, P1155, DOI 10.1093/jac/dkq101; Glenn LM, 2012, MICROB DRUG RESIST, V18, P453, DOI 10.1089/mdr.2011.0224; Guo YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102718; Hasman H, 2005, J ANTIMICROB CHEMOTH, V56, P115, DOI 10.1093/jac/dki190; Hordijk J, 2013, J ANTIMICROB CHEMOTH, V68, P2468, DOI 10.1093/jac/dkt219; Huijbers PMC, 2014, J ANTIMICROB CHEMOTH, V69, P2669, DOI 10.1093/jac/dku178; Jacoby GA, 1996, J CLIN MICROBIOL, V34, P908, DOI 10.1128/JCM.34.4.908-911.1996; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Jean SS, 2014, INT J ANTIMICROB AG, V44, P222, DOI 10.1016/j.ijantimicag.2014.05.018; Kluytmans JAJW, 2013, CLIN INFECT DIS, V56, P478, DOI 10.1093/cid/cis929; Koga VL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/618752; Koga VL, 2015, FOODBORNE PATHOG DIS, V12, P479, DOI 10.1089/fpd.2014.1888; Lazarus B, 2015, CLIN INFECT DIS, V60, P439, DOI 10.1093/cid/ciu785; Leistner R, 2014, INFECTION, V42; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Leverstein-van Hall MA, 2002, J CLIN MICROBIOL, V40, P3703, DOI 10.1128/JCM.40.10.3703-3711.2002; Leverstein-van Hall MA, 2013, J ANTIMICROB CHEMOTH, V68, P2636, DOI 10.1093/jac/dkt218; Leal AL, 2013, ENFERM INFEC MICR CL, V31, P298, DOI 10.1016/j.eimc.2012.04.007; MacVane SH, 2014, J HOSP MED, V9, P232, DOI 10.1002/jhm.2157; Martinez P, 2012, BRAZ J INFECT DIS, V16, P420, DOI 10.1016/j.bjid.2012.05.001; Meunier D, 2006, INT J ANTIMICROB AG, V28, P402, DOI 10.1016/j.ijantimicag.2006.08.016; Mollenkopf DF, 2014, FOODBORNE PATHOG DIS, V11, P920, DOI 10.1089/fpd.2014.1808; Nilsson O, 2014, J ANTIMICROB CHEMOTH, V69, P1497, DOI 10.1093/jac/dku030; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Park YS, 2012, EMERG INFECT DIS, V18, P515, DOI 10.3201/eid1803.111434; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P4914, DOI 10.1128/AAC.00878-10; Potron A, 2013, EUROSURVEILLANCE, V18, P9, DOI 10.2807/1560-7917.ES2013.18.31.20549; Ruiz SJ, 2011, J CLIN MICROBIOL, V49, P1993, DOI 10.1128/JCM.00045-11; Sheikh AA, 2012, FOODBORNE PATHOG DIS, V9, P625, DOI 10.1089/fpd.2011.1078; Smith H, 2015, ANTIMICROB AGENTS CH, V59, P5357, DOI 10.1128/AAC.05006-14; Teshager T, 2000, ANTIMICROB AGENTS CH, V44, P3483, DOI 10.1128/AAC.44.12.3483-3484.2000; Thomson KS, 2007, J CLIN MICROBIOL, V45, P2380, DOI 10.1128/JCM.00776-07; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347; Villegas MV, 2004, DIAGN MICR INFEC DIS, V49, P217, DOI 10.1016/j.diagmicrobio.2004.03.001; Voets GM, 2013, INT J FOOD MICROBIOL, V167, P359, DOI 10.1016/j.ijfoodmicro.2013.10.001; Vogt D, 2014, MICROB DRUG RESIST, V20, P485, DOI 10.1089/mdr.2013.0210; Wang J, 2014, J ANTIMICROB CHEMOTH, V69, P2658, DOI 10.1093/jac/dku206; Winstanley T, 2011, CLIN MICROBIOL REV, V24, P515, DOI 10.1128/CMR.00061-10; Zhao S, 2012, APPL ENVIRON MICROB, V78, P1701, DOI 10.1128/AEM.07522-11; Zurfluh K, 2015, APPL ENVIRON MICROB, V81, P3115, DOI 10.1128/AEM.00258-15	69	48	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170777	10.1371/journal.pone.0170777	http://dx.doi.org/10.1371/journal.pone.0170777			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125687	Green Published, Green Submitted, gold			2022-12-27	WOS:000396176100054
J	Jeffery, ND; Barker, AK; Alcott, CJ; Levine, JM; Meren, I; Wengert, J; Jergens, AE; Suchodolski, JS				Jeffery, Nick D.; Barker, Andrew K.; Alcott, Cody J.; Levine, Jon M.; Meren, Ilyssa; Wengert, Jane; Jergens, Albert E.; Suchodolski, Jan S.			The Association of Specific Constituents of the Fecal Microbiota with Immune-Mediated Brain Disease in Dogs	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GUT MICROBIOTA; NECROTIZING MENINGOENCEPHALITIS; MULTIPLE-SCLEROSIS; GRANULOMATOUS MENINGOENCEPHALOMYELITIS; VITAMIN-D; RISK; OPPORTUNITY; POPULATION; INDUCTION	Meningoencephalomyelitis of unknown origin (MUO) is a common, naturally-occurring, clinical disease of pet dogs. It is an immune-mediated condition that has many similarities with experimental autoimmune encephalitis (EAE) in rodents and so investigation of its pathogenesis may aid in understanding factors that contribute to development of multiple sclerosis in people. Gut microbiota are known to modulate immune responses that influence susceptibility to immune-mediated brain disease. In this study we aimed to compare abundance of specific constituents of the fecal microbiota, namely Faecalibacterium prausnitzii and Prevotellaceae, between dogs diagnosed with MUO and matched controls. Fecal samples were obtained from 20 dogs diagnosed with MUO and 20 control dogs matched for breed, age and gender. Bacterial abundance was measured using qPCR and 16S rRNA sequencing. We found that Prevotellaceae were significantly less abundant in cases compared with controls (p = 0.003) but there was no difference in abundance of F. prausnitzii. There was no evidence of other differences in gut microbiota between groups. These data, derived from this naturally-occurring canine clinical model, provide strong corroborative evidence that high abundance of Prevotellaceae in the gut is associated with reduced risk for developing immune-mediated brain disease.	[Jeffery, Nick D.; Barker, Andrew K.; Alcott, Cody J.; Meren, Ilyssa; Wengert, Jane; Jergens, Albert E.] Iowa State Univ, Coll Vet Med, Dept Vet Clin Studies, Ames, IA 50011 USA; [Jeffery, Nick D.; Levine, Jon M.; Suchodolski, Jan S.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, College Stn, TX 77843 USA; [Barker, Andrew K.] Toronto Vet Emergency Hosp, Scarborough, ON, Canada; [Alcott, Cody J.] Vet Specialty Ctr Tucson, Tucson, AZ USA	Iowa State University; Texas A&M University System; Texas A&M University College Station	Jeffery, ND (corresponding author), Iowa State Univ, Coll Vet Med, Dept Vet Clin Studies, Ames, IA 50011 USA.; Jeffery, ND (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, College Stn, TX 77843 USA.	njeffery@cvm.tamu.edu	Fiumefreddo, Andrea/T-2977-2019; Alcott, Cody/N-4006-2019	Alcott, Cody/0000-0002-5782-8533; Jeffery, Nick/0000-0002-9812-1788	American Kennel Club [01731]	American Kennel Club	This study was sponsored by the American Kennel Club, grant #01731, awarded to NDJ, JS and AJ. http://www.akcchf.org/research/? referrer=https://www.google.com/. The sponsor provided the funding based on a grant proposal designed by the applicants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Ascherio A, 2010, LANCET NEUROL, V9, P599, DOI 10.1016/S1474-4422(10)70086-7; Barber RM, 2012, J VET INTERN MED, V26, P962, DOI 10.1111/j.1939-1676.2012.00954.x; Barber RM, 2011, J HERED, V102, pS40, DOI 10.1093/jhered/esr048; Barragan-Martinez C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051506; Bell ET, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108729; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Buscarinu MC, 2016, MULT SCLER; Cantarel BL, 2015, J INVEST MED, V63, P729, DOI 10.1097/JIM.0000000000000192; Coates JR, 2014, VET CLIN N AM-SMALL, V44, P1157, DOI 10.1016/j.cvsm.2014.07.009; Confavreux C, 2001, NEW ENGL J MED, V344, P319, DOI 10.1056/NEJM200102013440501; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Galland L, 2014, J MED FOOD, V17, P1261, DOI 10.1089/jmf.2014.7000; Granger N, 2010, VET J, V184, P290, DOI 10.1016/j.tvjl.2009.03.031; Greer KA, 2009, RES VET SCI, V86, P438, DOI 10.1016/j.rvsc.2008.10.002; Grimes DA, 2005, LANCET, V365, P1429, DOI 10.1016/S0140-6736(05)66379-9; Hansen AK, 2014, WORLD J GASTROENTERO, V20, P17727, DOI 10.3748/wjg.v20.i47.17727; Holodniy M, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014764, 10.1371/journal.pone.0025792]; HOW KL, 1994, GEN COMP ENDOCR, V96, P12, DOI 10.1006/gcen.1994.1154; Jeffery ND, 2006, SPINAL CORD, V44, P584, DOI 10.1038/sj.sc.3101912; Jun SM, 2005, J IMMUNOL, V175, P6733, DOI 10.4049/jimmunol.175.10.6733; Knapp DW, 1997, MOL MED TODAY, V3, P8, DOI 10.1016/S1357-4310(96)20031-0; Kwon HK, 2013, CLIN IMMUNOL, V146, P217, DOI 10.1016/j.clim.2013.01.001; Langer-Gould A, 2014, JAMA NEUROL, V71, P1506, DOI 10.1001/jamaneurol.2014.2633; Lassmann H, 2016, ACTA NEUROPATHOL; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Levine JM, 2011, J NEUROTRAUM, V28, P675, DOI 10.1089/neu.2010.1645; Malli C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124064; Mellanby RJ, 2013, VET J, V196, P92, DOI 10.1016/j.tvjl.2012.08.009; Miyake S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137429; Nouri M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106335; Ochoa-Reparaz J, 2010, GUT MICROBES, V1, P103, DOI 10.4161/gmic.1.2.11515; Park ES, 2012, VET PATHOL, V49, P682, DOI 10.1177/0300985811429311; Robinson AP, 2014, HAND CLINIC, V122, P173, DOI 10.1016/B978-0-444-52001-2.00008-X; Rogers MAM, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.10.003; Safra N, 2011, VET J, V189, P220, DOI 10.1016/j.tvjl.2011.06.023; Scheperjans F, 2015, MOVEMENT DISORD, V30, P350, DOI 10.1002/mds.26069; Schrauwen I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112755; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Talarico LR, 2010, J SMALL ANIM PRACT, V51, P138, DOI 10.1111/j.1748-5827.2009.00823.x; Tipold A, 2012, INFECT DIS DOG CAT, P856; Velasquez-Manoff M, 2015, NATURE, V518, pS3, DOI 10.1038/518S3a	43	19	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170589	10.1371/journal.pone.0170589	http://dx.doi.org/10.1371/journal.pone.0170589			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125651	Green Published, Green Submitted, gold			2022-12-27	WOS:000396176100091
J	Kolumam, G; Wu, XM; Lee, WP; Hackney, JA; Zavala-Solorio, J; Gandham, V; Danilenko, DM; Arora, P; Wang, XT; Ouyang, WJ				Kolumam, Ganesh; Wu, Xiumin; Lee, Wyne P.; Hackney, Jason A.; Zavala-Solorio, Jose; Gandham, Vineela; Danilenko, Dimitry M.; Arora, Puneet; Wang, Xiaoting; Ouyang, Wenjun			IL-22R Ligands IL-20, IL-22, and IL-24 Promote Wound Healing in Diabetic db/db Mice	PLOS ONE			English	Article							HOST-DEFENSE; FOOT ULCERS; CYTOKINES; EXPRESSION; SKIN; DIFFERENTIATION; KERATINOCYTES; HOMEOSTASIS; PSORIASIS; SUBFAMILY	Diabetic foot ulcers (DFU) are one of the major complications in type II diabetes patients and can result in amputation and morbidity. Although multiple approaches are used clinically to help wound closure, many patients still lack adequate treatment. Here we show that IL-20 subfamily cytokines are upregulated during normal wound healing. While there is a redundant role for each individual cytokine in this subfamily in wound healing, mice deficient in IL22R, the common receptor chain for IL-20, IL-22, and IL-24, display a significant delay in wound healing. Furthermore, IL-20, IL-22 and IL-24 are all able to promote wound healing in type II diabetic db/db mice. Mechanistically, when compared to other growth factors such as VEGF and PDGF that accelerate wound healing in this model, IL-22 uniquely induced genes involved in reepithelialization, tissue remodeling and innate host defense mechanisms from wounded skin. Interestingly, IL-22 treatment showed superior efficacy compared to PDGF or VEGF in an infectious diabetic wound model. Taken together, our data suggest that IL-20 subfamily cytokines, particularly IL-20, IL-22, and IL-24, might provide therapeutic benefit for patients with DFU.	[Kolumam, Ganesh; Gandham, Vineela] Genentech Inc, Dept Biomed Imaging, San Francisco, CA USA; [Wu, Xiumin; Lee, Wyne P.; Wang, Xiaoting; Ouyang, Wenjun] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Hackney, Jason A.] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA USA; [Zavala-Solorio, Jose] Genentech Inc, Dept Mol Biol, San Francisco, CA USA; [Danilenko, Dimitry M.] Genentech Inc, Dept Safety Assessment Pathol, San Francisco, CA USA; [Arora, Puneet] Genentech Inc, Dept Early Clin Dev, San Francisco, CA USA; [Kolumam, Ganesh] Calico, Dept Res, San Francisco, CA USA; [Wang, Xiaoting] Amgen Inc, Dept Comparat Biol & Safety Sci, San Francisco, CA 94080 USA; [Ouyang, Wenjun] Amgen Inc, Dept Inflammat & Oncol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Amgen; Amgen	Wang, XT; Ouyang, WJ (corresponding author), Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA.; Wang, XT (corresponding author), Amgen Inc, Dept Comparat Biol & Safety Sci, San Francisco, CA 94080 USA.; Ouyang, WJ (corresponding author), Amgen Inc, Dept Inflammat & Oncol, San Francisco, CA 94080 USA.	xiaoting@amgen.com; wouyang@amgen.com	Ouyang, Wenjun/ABA-8763-2020	Hackney, Jason/0000-0002-5922-563X; Ouyang, Wenjun/0000-0002-1811-5864; Danilenko, Dimitry/0000-0002-8326-1921	Genentech	Genentech(Roche HoldingGenentech)	Other than all the authors, Genentech had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received support in the form of salaries. Genentech has reviewed the manuscript, and may potentially file patents and develop therapies based on part of the data in the manuscript.	Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Avitabile S, 2015, J INVESTIGATIVE DERM; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Cavanagh PR, 2005, LANCET, V366, P1725, DOI 10.1016/S0140-6736(05)67699-4; Devalaraja RM, 2000, J INVEST DERMATOL, V115, P234, DOI 10.1046/j.1523-1747.2000.00034.x; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Dumoutier L, 2001, J IMMUNOLOGY, V167; Dworkin S, 2011, ORGANOGENESIS, V7, P202, DOI 10.4161/org.7.3.18431; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fang RC, 2008, BIOL-TARGETS THER, V2, P1; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; GREENHALGH DG, 1990, AM J PATHOL, V136, P1235; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jeffcoate WJ, 2003, LANCET, V361, P1545, DOI 10.1016/S0140-6736(03)13169-8; Kavitha KV, 2014, WORLD J DIABETES, V5, P546, DOI 10.4239/wjd.v5.i4.546; Kishibe M, 2012, J INVEST DERMATOL, V132, P1717, DOI 10.1038/jid.2012.18; LeGrand EK, 1998, AM J SURG, V176, p48S, DOI 10.1016/S0002-9610(98)00177-9; Leung PC, 2007, SURG-J R COLL SURG E, V5, P219, DOI 10.1016/S1479-666X(07)80007-2; [黎继子 LI Jizi], 2007, [系统工程, Systems Engineering], V25, P25; Mcgee HM, 2013, J INVEST DERMATOL, V133, P1321, DOI 10.1038/jid.2012.463; Michaels J, 2007, WOUND REPAIR REGEN, V15, P665, DOI 10.1111/j.1524-475X.2007.00273.x; Monaco JL, 2003, CLIN PLAST SURG, V30, P1, DOI 10.1016/S0094-1298(02)00070-6; Novak JP, 2002, J BIOL CHEM, V277, P47517, DOI 10.1074/jbc.M205114200; Ota N, 2011, NAT IMMUNOL, V12, P941, DOI 10.1038/ni.2089; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Perera GK, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007217; Rutz S, 2014, NAT REV IMMUNOL, V14, P783, DOI 10.1038/nri3766; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Saaristo A, 2006, AM J PATHOL, V169, P1080, DOI 10.2353/ajpath.2006.051251; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Sun DP, 2013, CYTOKINE, V62, P360, DOI 10.1016/j.cyto.2013.03.017; Wang M, 2002, J BIOL CHEM, V277, P7341, DOI 10.1074/jbc.M106043200; Wang XT, 2014, NATURE, V514, P237, DOI 10.1038/nature13564; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Wong V, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/969618; Wu AL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002669; Xie MH, 2000, J BIOL CHEM, V275, P31335, DOI 10.1074/jbc.M005304200; Yazdanpanah L, 2015, WORLD J DIABETES, V6, P37, DOI 10.4239/wjd.v6.i1.37; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	50	39	44	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170639	10.1371/journal.pone.0170639	http://dx.doi.org/10.1371/journal.pone.0170639			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125663	Green Published, Green Submitted, gold			2022-12-27	WOS:000396176100083
J	Jovicic, A; Gitler, AD				Jovicic, Ana; Gitler, Aaron D.			Distinct repertoires of microRNAs present in mouse astrocytes compared to astrocyte-secreted exosomes	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURONS; SPORADIC ALS; CELLS; DETERMINANTS; EXPRESSION; MECHANISM; BIOMARKER; TOXICITY; DISEASE	Background Astrocytes are the most abundant cell type in the central nervous system (CNS) and secrete various factors that regulate neuron development, function and connectivity. microRNAs (miRNAs) are small regulatory RNAs involved in posttranslational gene regulation. Recent findings showed that miRNAs are exchanged between cells via nanovesicles called exosomes. In this study, we sought to define which miRNAs are contained within exosomes secreted by astrocytes. We also explored whether astroglial miRNA secretion via exosomes is perturbed in a mouse model of amyotrophic lateral sclerosis (ALS), a neurodegenerative disease where astrocytes play a crucial role in driving disease progression. Methodology/Principal findings By isolating and profiling the expression of miRNAs from primary mouse astrocytes and from the exosomes that astrocytes secrete, we compared miRNA expression in the cells and secreted vesicles. We established that miRNA expression profiles of astrocytes and their exosomes are vastly different. In addition, we determined that exosomal miRNA expression in astrocytes is not significantly perturbed in a mouse model of ALS. Conclusions Astrocytes secrete numerous miRNAs via exosomes and miRNA species contained in exosomes are considerably different from miRNAs detectable in astrocytes, suggesting the existence of a mechanism to select certain miRNAs for inclusion or exclusion from exosomes. The exosomal miRNA profiling dataset we have generated will provide a resource to aid in the investigation of this selection mechanism. Finally, the miRNA expression profile in astrocyte-secreted exosomes is not perturbed by expression of mutant SOD1-G93A.	[Jovicic, Ana; Gitler, Aaron D.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Jovicic, Ana] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA	Stanford University; Roche Holding; Genentech	Jovicic, A (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.; Jovicic, A (corresponding author), Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA.	jovicic.ana@gene.com		Gitler, Aaron/0000-0001-8603-1526	National Institutes of Health [R01NS065317, R01NS09386501, R01NS073660]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by National Institutes of Health grants R01NS065317, R01NS09386501 and R01NS073660 awarded to A.D.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Lopez-Verrilli MA, 2013, GLIA, V61, P1795, DOI 10.1002/glia.22558; Allen NJ, 2009, NATURE, V457, P675, DOI 10.1038/457675a; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Balakathiresan NS, 2014, J PSYCHIATR RES, V57, P65, DOI 10.1016/j.jpsychires.2014.05.020; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Fields RD, 2015, NEURON, V86, P374, DOI 10.1016/j.neuron.2015.01.014; Fruhbeis C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001604; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Hunsberger JG, 2012, AM J TRANSL RES, V4, P316; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; JOVICIC A, 2013, THE JOURNAL OF NEURO, V33, P5127, DOI DOI 10.1523/JNEUROSCI.0600-12.2013; Kawamata H, 2014, J NEUROSCI, V34, P2331, DOI 10.1523/JNEUROSCI.2689-13.2014; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lai CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021635; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Meyer K, 2014, P NATL ACAD SCI USA, V111, P829, DOI 10.1073/pnas.1314085111; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Sun XY, 2015, AM J MED GENET B, V168, P170, DOI 10.1002/ajmg.b.32292; Thery C, 2006, CURRENT PROTOCOLS CE; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Williams C, 2014, CELL RES, V24, P766, DOI 10.1038/cr.2014.44; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yang SL, 2015, DEV BIOL, V408, P140, DOI 10.1016/j.ydbio.2015.09.020; Zhang L, 2015, NATURE, V527, P100, DOI 10.1038/nature15376; Zuchero JB, 2015, DEVELOPMENT, V142, P3805, DOI 10.1242/dev.129304	34	52	54	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171418	10.1371/journal.pone.0171418	http://dx.doi.org/10.1371/journal.pone.0171418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152040	Green Submitted, gold, Green Published			2022-12-27	WOS:000396161200143
J	LaDuca, H; Farwell, KD; Vuong, H; Lu, HM; Mu, WB; Shahmirzadi, L; Tang, S; Chen, J; Bhide, S; Chao, EC				LaDuca, Holly; Farwell, Kelly D.; Huy Vuong; Lu, Hsiao-Mei; Mu, Wenbo; Shahmirzadi, Layla; Tang, Sha; Chen, Jefferey; Bhide, Shruti; Chao, Elizabeth C.			Exome sequencing covers > 98% of mutations identified on targeted next generation sequencing panels	PLOS ONE			English	Article							PRIMARY CILIARY DYSKINESIA; DYNEIN ARMS; CAPTURE; OUTER; DIAGNOSIS; GENETICS; COMPLEX; ZMYND10; HUMANS; INNER	Background With the expanded availability of next generation sequencing (NGS)-based clinical genetic tests, clinicians seeking to test patients with Mendelian diseases must weigh the superior coverage of targeted gene panels with the greater number of genes included in whole exome sequencing (WES) when considering their first-tier testing approach. Here, we use an in silico analysis to predict the analytic sensitivity of WES using pathogenic variants identified on targeted NGS panels as a reference. Methods Corresponding nucleotide positions for 1533 different alterations classified as pathogenic or likely pathogenic identified on targeted NGS multi-gene panel tests in our laboratory were interrogated in data from 100 randomly-selected clinical WES samples to quantify the sequence coverage at each position. Pathogenic variants represented 91 genes implicated in hereditary cancer, X-linked intellectual disability, primary ciliary dyskinesia, Marfan syndrome/aortic aneurysms, cardiomyopathies and arrhythmias. Results When assessing coverage among 100 individual WES samples for each pathogenic variant (153,300 individual assessments), 99.7% (n = 152,798) would likely have been detected on WES. All pathogenic variants had at least some coverage on exome sequencing, with a total of 97.3% (n = 1491) detectable across all 100 individuals. For the remaining 42 pathogenic variants, the number of WES samples with adequate coverage ranged from 35 to 99. Factors such as location in GC-rich, repetitive, or homologous regions likely explain why some of these alterations were not detected across all samples. To validate study findings, a similar analysis was performed against coverage data from 60,706 exomes available through the Exome Aggregation Consortium (ExAC). Results from this validation confirmed that 98.6% (91,743,296/93,062,298) of pathogenic variants demonstrated adequate depth for detection. Conclusions Results from this in silico analysis suggest that exome sequencing may achieve a diagnostic yield similar to panel-based testing for Mendelian diseases.	[LaDuca, Holly; Farwell, Kelly D.; Huy Vuong; Lu, Hsiao-Mei; Mu, Wenbo; Shahmirzadi, Layla; Tang, Sha; Chen, Jefferey; Bhide, Shruti] Ambry Genet, Dept Clin Diagnost, Aliso Viejo, CA 92656 USA; [Chao, Elizabeth C.] Univ Calif Irvine, Dept Pediat, Div Genet & Genom Med, Irvine, CA 92717 USA	University of California System; University of California Irvine	LaDuca, H; Farwell, KD (corresponding author), Ambry Genet, Dept Clin Diagnost, Aliso Viejo, CA 92656 USA.	hladuca@ambrygen.com; kfarwell@ambrygen.com	Hagman, Kelly/A-4707-2010	Hagman, Kelly/0000-0003-1173-052X	Ambry Genetics	Ambry Genetics	Ambry Genetics provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankala A, 2015, ANN NEUROL, V77, P206, DOI 10.1002/ana.24303; Asan, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r95; Biesecker LG, 2014, NEW ENGL J MED, V371, P1170, DOI 10.1056/NEJMc1408914; Boycott KM, 2013, NAT REV GENET, V14, P681, DOI 10.1038/nrg3555; Chilamakuri CSR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-449; Chong HK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097408; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Consugar MB, 2014, GENETICS MED; Dorschner MO, 2013, AM J HUM GENET, V93, P631, DOI 10.1016/j.ajhg.2013.08.006; Farwell KD, 2014, GENETICS MED OFFICIA; Gandomi SK, 2014, J GENET COUNS, V23, P289, DOI 10.1007/s10897-013-9671-6; Gonzalez KD, 2014, JIMD REPORTS; Hjeij R, 2014, AM J HUM GENET, V95, P257, DOI 10.1016/j.ajhg.2014.08.005; Horani A, 2012, AM J HUM GENET, V91, P685, DOI 10.1016/j.ajhg.2012.08.022; Iglesias A, 2014, GENET MED, V16, P922, DOI 10.1038/gim.2014.58; Knowles MR, 2013, AM J HUM GENET, V93, P711, DOI 10.1016/j.ajhg.2013.07.025; Knowles MR, 2013, AM J HUM GENET, V92, P99, DOI 10.1016/j.ajhg.2012.11.003; Kott E, 2013, AM J HUM GENET, V93, P561, DOI 10.1016/j.ajhg.2013.07.013; Kurkowiak M, 2015, J MED GENET, V52, P1, DOI 10.1136/jmedgenet-2014-102755; Laduca H, 2014, GENETICS MED OFFICIA; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Moore DJ, 2013, AM J HUM GENET, V93, P346, DOI 10.1016/j.ajhg.2013.07.009; National Comprehensive Cancer Network, 2014, NCCN CLIN PRACT GUID; Olbrich H, 2012, AM J HUM GENET, V91, P672, DOI 10.1016/j.ajhg.2012.08.016; Ostrer H, 2011, CLIN GENET, V80, P101, DOI 10.1111/j.1399-0004.2011.01712.x; Park JY, 2014, CLIN CHEM; Patwardhan A, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0197-4; Plon SE, 2008, HUM MUTAT, V29, P1282, DOI 10.1002/humu.20880; Rehm HL, 2013, NAT REV GENET, V14, P295, DOI 10.1038/nrg3463; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Soden SE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010076; Wang J, 2014, INVEST OPHTH VIS SCI, V55, P6213, DOI 10.1167/iovs.14-14936; Wooderchak-Donahue WL, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-50; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zariwala MA, 2013, AM J HUM GENET, V93, P336, DOI 10.1016/j.ajhg.2013.06.007	36	58	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170843	10.1371/journal.pone.0170843	http://dx.doi.org/10.1371/journal.pone.0170843			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152038	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161200049
J	Lima, DF; de Lima, LI; Rocha, JA; de Andrade, IM; Grazina, LG; Villa, C; Meira, L; Veras, LMC; Azevedo, IFS; Biase, AG; Costa, J; Oliveira, MBPP; Mafra, I; Leite, JRDD				Lima, David Fernandes; de Lima, Luiza Ianny; Rocha, Jefferson Almeida; de Andrade, Ivanilza Moreira; Grazina, Liliana Goncalves; Villa, Caterina; Meira, Liliana; Costa Veras, Leiz Maria; Sousa Azevedo, Iabita Fabiana; Biase, Adriele Giaretta; Costa, Joana; Oliveira, Maria Beatriz P. P.; Mafra, Isabel; de Souza de Almeida Leite, Jose Roberto			Seasonal change in main alkaloids of jaborandi (Pilocarpus microphyllus Stapf ex Wardleworth), an economically important species from the Brazilian flora	PLOS ONE			English	Article							EPIISOPILOTURINE; SYSTEM; PLANT	Pilocarpus microphyllus Stapf ex Wardleworth (jaborandi, Rutaceae) is one of the most important Brazilian medicinal species owing to its content of pilocarpine (PIL), an alkaloid used for treating glaucoma and xerostomia. This species contains another alkaloid, epiisopiloturine (EPI), which has demonstrated effectiveness against schistosomiasis. The aim of this work was to assess seasonal changes of PIL and EPI in three populations of cultivated P. microphyllus from northeastern Brazil over one year, including the dry and rainy seasons. Alkaloid profiles were correlated to phenotypic and genetic patterns in the morphological and molecular characterizations. PIL was the primary alkaloid and its levels differed among populations in all months except September. The S01 population (green line) showed an especially high PIL content compared to populations S02 and S03 (traditional line), which had similar alkaloid contents. PIL content gradually decreased in the three populations in the rainy season. EPI content was significantly different between the green line (S01) and the traditional line (S02 and S03). S01 had a significantly lower EPI content in all months, demonstrating that it was not the best source for EPI extraction. Inter simple sequence repeat (ISSR) markers and morphological analyses clearly separated S01 from S02 and S03, in agreement with the alkaloid results. This study shows the first correlation between the chemical, morphological, and molecular markers of P. microphyllus and highlights the potential benefits of a multidisciplinary research approach aimed at supporting both industry and conservation of natural resources.	[Lima, David Fernandes; de Lima, Luiza Ianny; de Andrade, Ivanilza Moreira; Grazina, Liliana Goncalves; Villa, Caterina; Meira, Liliana; Costa Veras, Leiz Maria] Univ Fed Piaui, Nucleo Pesquisa Biodiversidade & Biotecnol, Campus Ministro Reis Velloso, Parnaiba, Piaui, Brazil; [Lima, David Fernandes] Univ Fed Vale Sao Francisco, Fac Med, Paulo Afonso, BA, Brazil; [Lima, David Fernandes] Univ Fed Piaui, Programa Posgrad Biotecnol, Rede Nordeste Biotecnol, Teresina, Piaui, Brazil; [Rocha, Jefferson Almeida] Univ Fed Maranhao, Grp Pesquisa Ciencias Nat & Biotecnol, Grajau, Maranhao, Brazil; [Grazina, Liliana Goncalves; Villa, Caterina; Meira, Liliana; Costa, Joana; Oliveira, Maria Beatriz P. P.; Mafra, Isabel] Univ Porto, Requimte Laqv, Fac Farm, Oporto, Portugal; [Sousa Azevedo, Iabita Fabiana; Biase, Adriele Giaretta] Univ Sao Paulo, Dept Estat & Expt Agron, Escola Super Agr Luiz de Queiroz, Sao Paulo, SP, Brazil; [de Souza de Almeida Leite, Jose Roberto] Univ Brasilia, Fac Med, Brasilia, DF, Brazil	Universidade Federal do Piaui; Universidade Federal do Vale do Sao Francisco; Universidade Federal do Piaui; Universidade Federal do Maranhao; Universidade do Porto; Universidade de Sao Paulo; Universidade de Brasilia	Leite, JRDD (corresponding author), Univ Brasilia, Fac Med, Brasilia, DF, Brazil.	jrsaleite@gmail.com	Mafra, Isabel/D-8207-2013; Villa, Caterina/AAC-9297-2019; Costa, Joana/K-1255-2013; Rocha, Jefferson/AAS-9043-2020; Veras, Leiz M C/H-8873-2013; Oliveira, M. Beatriz PP/D-9025-2013; Grazina, Liliana/AAD-2258-2019	Mafra, Isabel/0000-0001-5311-8895; Villa, Caterina/0000-0002-9471-3612; Costa, Joana/0000-0002-8229-2902; Rocha, Jefferson/0000-0001-6619-2293; Oliveira, M. Beatriz PP/0000-0002-6767-6596; Grazina, Liliana/0000-0001-9033-9486; Lima, Luiza/0000-0002-7912-8175	Marie Curie Actions [612545]	Marie Curie Actions(European Commission)	Funded by Marie Curie Actions. Author: IM. Grant number: FP7-PEOPLE-2013-IRSES through the project no. 612545 entitled "GMOsensor". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu IN, 2007, RAPID COMMUN MASS SP, V21, P1205, DOI 10.1002/rcm.2942; Abreu IN, 2011, PLANTA MED, V77, P293, DOI 10.1055/s-0030-1250314; Agban Y, 2016, INT J PHARMACEUT, V501, P96, DOI 10.1016/j.ijpharm.2016.01.069; AndradeNeto M, 1996, PHYTOCHEMISTRY, V42, P885, DOI 10.1016/0031-9422(95)00852-7; [Anonymous], 1969, DIC PLANT UT BRAS; [Anonymous], 2010, ORIGINPRO 8 5 SOFTW; Archer E., 2016, RFPERMUTE ESTIMATE P; Avancini G, 2003, PHYTOCHEMISTRY, V63, P171, DOI 10.1016/S0031-9422(03)00102-X; Blackith RE., 1971, MULTIVARIATE MORPHOM; Brandao MGL, 2008, J ETHNOPHARMACOL, V120, P141, DOI 10.1016/j.jep.2008.08.004; Brody JR, 2004, ANAL BIOCHEM, V333, P1, DOI 10.1016/j.ab.2004.05.054; Cruz CD, 1990, THESIS; Doyle J. J., 1987, PHYTOCHEM B, P11; EXCOFFIER L, 1992, GENETICS, V131, P479; Flanagan N.S., 2012, COMPREHENSIVE GUIDE; Gil-Montoya JA, 2016, MED ORAL PATOL ORAL; Guimaraes MA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003656; Guimaraes MA, 2014, J NANOSCI NANOTECHNO, V14, P4519, DOI 10.1166/jnn.2014.8248; HARPER DAT, 2001, PALAEONTOLOGIA ELECT, V4; Henderson A, 2006, BOT J LINN SOC, V151, P103, DOI 10.1111/j.1095-8339.2006.00526.x; Liu B, 2001, MOL ECOL NOTES, V1, P205, DOI 10.1046/j.1471-8278.2001.00073.x; Marcus LF, 1990, SPECIAL PUBLICATION, V2, P77; Melo CM, 2014, J THERM ANAL CALORIM, V120, P689, DOI DOI 10.1007/s10973-014-4163-y; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; Monteiro Júlio M., 2006, Rev. bras. farmacogn., V16, P338, DOI 10.1590/S0102-695X2006000300010; Moura E. F., 2005, Revista Brasileira de Plantas Medicinais, V7, P1; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pinheiro CUB, 1997, ECON BOT, V51, P49, DOI 10.1007/BF02910403; Reyment R. A., 1991, MULTIDIMENSIONAL PAL; Rocha JA, 2014, FOREST RES, V3; Samarakoon T, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200236; Sandhu SS, 2006, SCI AGR, V63, P478, DOI 10.1590/S0103-90162006000500010; Santos Ana Paula, 2004, Rev. Bras. Cienc. Farm., V40, P116, DOI 10.1590/S1516-93322004000200002; SAS Institute, 2016, SAS STAT SOFTW REL 9; Silva VG, 2013, J NAT PROD, V76, P1071, DOI 10.1021/np400099m; Skorupa Ladislau A., 2003, Braz. J. Bot., V26, P263, DOI 10.1590/S0100-84042003000200015; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Stevens P.F., 2016, ANGIOSPERM PHYLOGENY; Veras LMC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066702; VOIGTLANDER HW, 1978, ARCH PHARM, V311, P927, DOI 10.1002/ardp.19783111106; Wolfe AD, 1998, MOL ECOL, V7, P1107, DOI 10.1046/j.1365-294x.1998.00425.x; Wolfe AD, 2005, METHOD ENZYMOL, V395, P134, DOI 10.1016/S0076-6879(05)95009-X	42	6	6	13	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170281	10.1371/journal.pone.0170281	http://dx.doi.org/10.1371/journal.pone.0170281			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151972	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200019
J	Stok, FM; Hoffmann, S; Volkert, D; Boeing, H; Ensenauer, R; Stelmach-Mardas, M; Kiesswetter, E; Weber, A; Rohm, H; Lien, N; Brug, J; Holdsworth, M; Renner, B				Stok, F. Marijn; Hoffmann, Stefan; Volkert, Dorothee; Boeing, Heiner; Ensenauer, Regina; Stelmach-Mardas, Marta; Kiesswetter, Eva; Weber, Alisa; Rohm, Harald; Lien, Nanna; Brug, Johannes; Holdsworth, Michelle; Renner, Britta			The DONE framework: Creation, evaluation, and updating of an interdisciplinary, dynamic framework 2.0 of determinants of nutrition and eating	PLOS ONE			English	Article							FOOD CHOICE; BEHAVIOR; HEALTH	The question of which factors drive human eating and nutrition is a key issue in many branches of science. We describe the creation, evaluation, and updating of an interdisciplinary, interactive, and evolving "framework 2.0" of Determinants Of Nutrition and Eating (DONE). The DONE framework was created by an interdisciplinary workgroup in a multiphase, multimethod process. Modifiability, relationship strength, and population-level effect of the determinants were rated to identify areas of priority for research and interventions. External experts positively evaluated the usefulness, comprehensiveness, and quality of the DONE framework. An approach to continue updating the framework with the help of experts was piloted. The DONE framework can be freely accessed (http://uni-konstanz.de/DONE) and used in a highly flexible manner: determinants can be sorted, filtered and visualized for both very specific research questions as well as more general queries. The dynamic nature of the framework allows it to evolve as experts can continually add new determinants and ratings. We anticipate this framework will be useful for research prioritization and intervention development.	[Stok, F. Marijn; Renner, Britta] Univ Konstanz, Dept Psychol Assessment & Hlth Psychol, Constance, Germany; [Hoffmann, Stefan] Univ Kiel, Inst Business Adm, Esp Mkt, Kiel, Germany; [Volkert, Dorothee; Kiesswetter, Eva] Friedrich Alexander Univ Erlangen Nurnberg, Inst Biomed Aging, Erlangen, Germany; [Boeing, Heiner; Stelmach-Mardas, Marta] German Inst Human Nutr, Dept Epidemiol, Potsdam, Germany; [Ensenauer, Regina] Heinrich Heine Univ Dusseldorf, Expt Pediat & Metab, Univ Childrens Hosp, Dusseldorf, Germany; [Stelmach-Mardas, Marta] Poznan Univ Med Sci, Dept Pediat Gastroenterol & Metab Dis, Poznan, Poland; [Weber, Alisa] Ludwig Maximilians Univ Munchen, Inst Social Pediat & Youth Med, Munich, Germany; [Rohm, Harald] Tech Univ Dresden, Chair Food Engn, Dresden, Germany; [Lien, Nanna] Univ Oslo, Fac Med, Oslo, Norway; [Brug, Johannes] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Brug, Johannes] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Holdsworth, Michelle] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England	University of Konstanz; University of Kiel; University of Erlangen Nuremberg; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Heinrich Heine University Dusseldorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Poznan University of Medical Sciences; University of Munich; Technische Universitat Dresden; University of Oslo; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Sheffield	Stok, FM; Renner, B (corresponding author), Univ Konstanz, Dept Psychol Assessment & Hlth Psychol, Constance, Germany.	marijn.stok@uni-konstanz.de; britta.renner@uni-konstanz.de	holdsworth, michelle/AAH-5400-2020; Renner, Britta/AAW-1895-2020; Brug, Johannes/A-8242-2018; Hoffmann, Stefan/O-6170-2015	holdsworth, michelle/0000-0001-6028-885X; Renner, Britta/0000-0001-8385-2839; Brug, Johannes/0000-0002-1904-7349; Hoffmann, Stefan/0000-0001-5307-4060; Briody, Jonathan/0000-0002-0641-1551	DEterminants of DIet and Physical ACtivity (DEDIPAC) knowledge hub; Joint Programming Initiative 'Healthy Diet for a Healthy Life'; Research Foundation Flanders; Finnish Funding Agency for Technology and Innovation (Tekes); Institut National de la Recherche Agronomique (INRA); Federal Ministry of Education and Research (BMBF); Health Research Board (HRB); Ministry of Education, University and Research/Ministry of Agriculture Food and Forestry Policies; Netherlands Organisation for Health Research and Development (ZonMw); Research Council of Norway, Division for Society and Health; National Centre for Research and Development; Carlos III Institute of Health (ISCIII); Medical Research Council (MRC)	DEterminants of DIet and Physical ACtivity (DEDIPAC) knowledge hub; Joint Programming Initiative 'Healthy Diet for a Healthy Life'; Research Foundation Flanders(FWO); Finnish Funding Agency for Technology and Innovation (Tekes)(Finnish Funding Agency for Technology & Innovation (TEKES)); Institut National de la Recherche Agronomique (INRA); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Health Research Board (HRB); Ministry of Education, University and Research/Ministry of Agriculture Food and Forestry Policies; Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Council of Norway, Division for Society and Health(Research Council of Norway); National Centre for Research and Development; Carlos III Institute of Health (ISCIII)(Instituto de Salud Carlos III); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The preparation of this paper was supported by the DEterminants of DIet and Physical ACtivity (DEDIPAC) knowledge hub. This work is supported by the Joint Programming Initiative 'Healthy Diet for a Healthy Life'. The funding agencies supporting this work are (in alphabetical order of participating Member State): Belgium: Research Foundation Flanders; Finland: Finnish Funding Agency for Technology and Innovation (Tekes); France: Institut National de la Recherche Agronomique (INRA); Germany: Federal Ministry of Education and Research (BMBF); Ireland: The Health Research Board (HRB); Italy: Ministry of Education, University and Research/Ministry of Agriculture Food and Forestry Policies; The Netherlands: The Netherlands Organisation for Health Research and Development (ZonMw); Norway: The Research Council of Norway, Division for Society and Health; Poland: The National Centre for Research and Development; Spain: Carlos III Institute of Health (ISCIII); The United Kingdom: The Medical Research Council (MRC).	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Bandura A., 1986, SOCIAL FDN THOUGHT A; Baranowski T, 2003, OBES RES, V11, p23S, DOI 10.1038/oby.2003.222; Bock A. -K., 2014, JRC FORESIGHT STUDY; Booth SL, 2001, NUTR REV, V59, pS21, DOI 10.1111/j.1753-4887.2001.tb06983.x; Buzan T, 2006, MIND MAPPING; Contento IR, 2008, ASIA PAC J CLIN NUTR, V17, P176; Economos CD, 2001, NUTR REV, V59, pS40; Furst T, 1996, APPETITE, V26, P247, DOI 10.1006/appe.1996.0019; Glass TA, 2006, SOC SCI MED, V62, P1650, DOI 10.1016/j.socscimed.2005.08.044; Hofmann W, 2012, PSYCHOL SCI, V23, P582, DOI 10.1177/0956797612437426; Hummel E, 2016, ECOL FOOD N IN PRESS; Koster EP, 2009, FOOD QUAL PREFER, V20, P70, DOI 10.1016/j.foodqual.2007.11.002; Kremers SPJ, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-9; Lakerveld J, 2014, INT J BEHAV NUTR PHY, V11, P1, DOI DOI 10.1186/s12966-014-0143-7; Prochaska J. O., 1984, TRANSTHEORETICAL APP; Renner B, 2003, BLACKW SER HLTH PSYC, P169; Rogers R.W., 1983, SOCIAL PSYCHOPHYSIOL; Schwarzer R, 1999, J Health Psychol, V4, P115, DOI 10.1177/135910539900400208; Sleddens EFC, 2015, NUTR REV, V73, P477, DOI 10.1093/nutrit/nuv007; Symmank C, APPETITE IN PRESS; Vlaev I, 2015, REV GEN PSYCHOL, V19, P69, DOI 10.1037/gpr0000029; Wansink B, 2007, ENVIRON BEHAV, V39, P106, DOI 10.1177/0013916506295573; WEINSTEIN ND, 1988, HEALTH PSYCHOL, V7, P355, DOI 10.1037/0278-6133.7.4.355; Wexler M. N., 2001, J KNOWLEDGE MANAGEME, V5, P249, DOI DOI 10.1108/EUM0000000005868	25	85	85	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171077	10.1371/journal.pone.0171077	http://dx.doi.org/10.1371/journal.pone.0171077			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28152005	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000396161200085
J	Sagulenko, E; Nouwens, A; Webb, RI; Green, K; Yee, B; Morgan, G; Leis, A; Lee, KC; Butler, MK; Chia, N; Pham, UTP; Lindgreen, S; Catchpole, R; Poole, AM; Fuerst, JA				Sagulenko, Evgeny; Nouwens, Amanda; Webb, Richard I.; Green, Kathryn; Yee, Benjamin; Morgan, Garry; Leis, Andrew; Lee, Kuo-Chang; Butler, Margaret K.; Chia, Nicholas; Uyen Thi Phuong Pham; Lindgreen, Stinus; Catchpole, Ryan; Poole, Anthony M.; Fuerst, John A.			Nuclear Pore-Like Structures in a Compartmentalized Bacterium	PLOS ONE			English	Article							PEPTIDOGLYCAN CELL-WALL; GEMMATA-OBSCURIGLOBUS; MOLECULAR ARCHITECTURE; CRYOELECTRON TOMOGRAPHY; BUDDING BACTERIA; OUTER-MEMBRANE; COMPLEX; PLANCTOMYCES; PROTEOME; PLAN	Planctomycetes are distinguished from other Bacteria by compartmentalization of cells via internal membranes, interpretation of which has been subject to recent debate regarding potential relations to Gram-negative cell structure. In our interpretation of the available data, the planctomycete Gemmata obscuriglobus contains a nuclear body compartment, and thus possesses a type of cell organization with parallels to the eukaryote nucleus. Here we show that pore-like structures occur in internal membranes of G. obscuriglobus and that they have elements structurally similar to eukaryote nuclear pores, including a basket, ring-spoke structure, and eight-fold rotational symmetry. Bioinformatic analysis of proteomic data reveals that some of the G. obscuriglobus proteins associated with pore-containing membranes possess structural domains found in eukaryote nuclear pore complexes. Moreover, immunogold labelling demonstrates localization of one such protein, containing a beta-propeller domain, specifically to the G. obscuriglobus pore-like structures. Finding bacterial pores within internal cell membranes and with structural similarities to eukaryote nuclear pore complexes raises the dual possibilities of either hitherto undetected homology or stunning evolutionary convergence.	[Sagulenko, Evgeny; Nouwens, Amanda; Yee, Benjamin; Lee, Kuo-Chang; Butler, Margaret K.; Uyen Thi Phuong Pham; Fuerst, John A.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Webb, Richard I.; Green, Kathryn; Morgan, Garry] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld, Australia; [Leis, Andrew] CSIRO Livestock Ind, Australian Anim Hlth Lab, Biosecur Microscopy Facil ABMF, Geelong, Vic, Australia; [Chia, Nicholas] Univ Illinois, Inst Genom Biol, Urbana, IL USA; [Lindgreen, Stinus; Catchpole, Ryan; Poole, Anthony M.] Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand; [Catchpole, Ryan; Poole, Anthony M.] Univ Canterbury, Biomol Interact Ctr, Christchurch, New Zealand; [Poole, Anthony M.] Univ Canterbury, Wilson Ctr, Christchurch, New Zealand; [Poole, Anthony M.] Univ Auckland, Bioinformat Inst, Sch Biol Sci, Auckland, New Zealand	University of Queensland; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Illinois System; University of Illinois Urbana-Champaign; University of Canterbury; University of Canterbury; University of Canterbury; University of Auckland	Fuerst, JA (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.	j.fuerst@uq.edu.au	Fuerst, John/I-8649-2012; Leis, Andrew/AAH-4344-2020	Fuerst, John/0000-0002-6451-8533; Leis, Andrew/0000-0003-4905-9401; Nouwens, Amanda/0000-0003-4069-8266; Poole, Anthony/0000-0001-9940-2824	Australian Research Council Discovery Project [DP0881485]; Royal Society of New Zealand [RDF-U0C1101]	Australian Research Council Discovery Project(Australian Research Council); Royal Society of New Zealand(Royal Society of New Zealand)	JAF was supported by Australian Research Council Discovery Project DP0881485. AMP was supported by Royal Society of New Zealand RDF-U0C1101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acehan D, 2014, J CELL SCI, V127, P277, DOI 10.1242/jcs.137596; Andersen KR, 2013, ELIFE, V2, DOI 10.7554/eLife.00745; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170; Brochier C, 2002, NATURE, V417, P244, DOI 10.1038/417244a; Brohawn SG, 2009, NAT STRUCT MOL BIOL, V16, P1173, DOI 10.1038/nsmb.1713; Brohawn Stephen G, 2009, Commun Integr Biol, V2, P205; Cyrklaff M, 2005, P NATL ACAD SCI USA, V102, P2772, DOI 10.1073/pnas.0409825102; DeGrasse JA, 2009, MOL CELL PROTEOMICS, V8, P2119, DOI 10.1074/mcp.M900038-MCP200; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; Devos DP, 2014, ANTON LEEUW INT J G, V105, P271, DOI 10.1007/s10482-013-0087-y; Devos DP, 2014, TRENDS MICROBIOL, V22, P14, DOI 10.1016/j.tim.2013.10.008; Fahrenkrog B, 1998, J CELL BIOL, V143, P577, DOI 10.1083/jcb.143.3.577; Field MC, 2014, TRAFFIC, V15, P141, DOI 10.1111/tra.12141; Forterre P, 2010, P NATL ACAD SCI USA, V107, P12739, DOI 10.1073/pnas.1007720107; FRANKE WW, 1966, J CELL BIOL, V31, P619, DOI 10.1083/jcb.31.3.619; FRANKE WW, 1970, J CELL BIOL, V46, P379, DOI 10.1083/jcb.46.2.379; Frenkiel-Krispin D, 2010, J MOL BIOL, V395, P578, DOI 10.1016/j.jmb.2009.11.010; FRIEDMAN MH, 1970, J ULTRA MOL STRUCT R, V32, P226, DOI 10.1016/S0022-5320(70)80003-X; FUERST JA, 1991, P NATL ACAD SCI USA, V88, P8184, DOI 10.1073/pnas.88.18.8184; Fuerst JA, 2013, ANTON LEEUW INT J G, V104, P451, DOI 10.1007/s10482-013-9986-1; Fuerst JA, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00167; Fuerst John A, 2010, Commun Integr Biol, V3, P572, DOI 10.4161/cib.3.6.13061; GALL JG, 1967, J CELL BIOL, V32, P391, DOI 10.1083/jcb.32.2.391; Gottshall EY, 2014, P NATL ACAD SCI USA, V111, P11067, DOI 10.1073/pnas.1409187111; Hieu CX, 2008, PROTEOMICS, V8, P1608, DOI 10.1002/pmic.200701017; Hinshaw JE, 2003, J STRUCT BIOL, V141, P259, DOI 10.1016/S1047-8477(02)00626-3; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; Hirst J, 2014, ELIFE, V3, DOI 10.7554/eLife.02866; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Jeske O, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8116; Jun SR, 2010, P NATL ACAD SCI USA, V107, P133, DOI 10.1073/pnas.0913033107; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KONIG E, 1984, ARCH MICROBIOL, V138, P200, DOI 10.1007/BF00402120; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kuper U, 2010, P NATL ACAD SCI USA, V107, P3152, DOI 10.1073/pnas.0911711107; Lee KC, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-4; Lee KC, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-5; Leksa NC, 2010, NUCLEUS-PHILA, V1, P314, DOI 10.4161/nucl.1.4.11798; LIESACK W, 1986, ARCH MICROBIOL, V145, P361, DOI 10.1007/BF00470872; Lindsay MR, 2001, ARCH MICROBIOL, V175, P413, DOI 10.1007/s002030100280; Lonhienne TGA, 2010, P NATL ACAD SCI USA, V107, P12883, DOI 10.1073/pnas.1001085107; Mahat R, 2015, J BACTERIOL; MARKHAM R, 1963, VIROLOGY, V20, P88, DOI 10.1016/0042-6822(63)90143-0; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; McInerney JO, 2011, BIOESSAYS, V33, P810, DOI 10.1002/bies.201100045; Neumann N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013241; Rachel Reinhard, 2002, Archaea, V1, P9, DOI 10.1155/2002/307480; ROUT MP, 1993, J CELL BIOL, V123, P771, DOI 10.1083/jcb.123.4.771; Sagulenko E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091344; Santarella-Mellwig R, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001565; Santarella-Mellwig R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000281; SCHMIDT JM, 1978, CURR MICROBIOL, V1, P65, DOI 10.1007/BF02605417; Speth DR, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00304; STACKEBRANDT E, 1986, FEMS MICROBIOL LETT, V37, P289, DOI 10.1016/0378-1097(86)90421-0; Stoffler D, 1999, CURR OPIN CELL BIOL, V11, P391, DOI 10.1016/S0955-0674(99)80055-6; STRAMBIODECASTILLIA C, 1995, J CELL BIOL, V131, P19, DOI 10.1083/jcb.131.1.19; UNWIN PNT, 1982, J CELL BIOL, V93, P63, DOI 10.1083/jcb.93.1.63; van Teeseling MCF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7878; Voigt B, 2012, PROTEOMICS, V12, P1781, DOI 10.1002/pmic.201100512; Wang J, 2002, APPL ENVIRON MICROB, V68, P417, DOI 10.1128/AEM.68.1.417-422.2002; WARD N, 2004, PROKARYOTES EVOLVING; Williams TA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0336; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4	66	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0169432	10.1371/journal.pone.0169432	http://dx.doi.org/10.1371/journal.pone.0169432			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146565	gold, Green Published, Green Submitted			2022-12-27	WOS:000396131700008
J	Xue, B; Shao, YY; Saunders, RMK; Tan, YH				Xue, Bine; Shao, Yun-Yun; Saunders, Richard M. K.; Tan, Yun-Hong			Alphonsea glandulosa (Annonaceae), a New Species from Yunnan, China	PLOS ONE			English	Article							MOLECULAR PHYLOGENETIC SUPPORT; POLLINATION; FITZALANIA; EVOLUTION; INFERENCE; REVISION; MEIOGYNE; MRBAYES; FAMILY; GENERA	Alphonsea glandulosa sp. nov. is described from Yunnan Province in south-west China. It is easily distinguished from all previously described Alphonsea species by the possession of glandular tissue at the base of the adaxial surface of the inner petals. Nectar was observed throughout the flowering period, including the pistillate phase and subsequent staminate phase. Small curculionid beetles were observed as floral visitors and are inferred to be effective pollinators since they carry pollen grains. A phylogenetic analysis was conducted to confirm the placement of this new species within Alphonsea and the evolution of the inner petal glands and specialized pollinator reward tissues throughout the family.	[Xue, Bine; Shao, Yun-Yun] Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Xue, Bine; Shao, Yun-Yun] Chinese Acad Sci, Guangdong Prov Key Lab Appl Bot, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Shao, Yun-Yun] Univ Chinese Acad Sci, Beijing, Peoples R China; [Saunders, Richard M. K.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Tan, Yun-Hong] Chinese Acad Sci, Ctr Integrat Conservat, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China; [Tan, Yun-Hong] Chinese Acad Sci, Southeast Asia Biodivers Res Inst, Nay Pyi Taw, Myanmar	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Hong Kong; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS	Tan, YH (corresponding author), Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.	xuebine@scib.ac.cn; tyh@xtbg.org.cn	Saunders, Richard M. K./A-7436-2008	Saunders, Richard M. K./0000-0002-8104-7761; Xue, Bine/0000-0002-4515-4316	National Natural Science Foundation of China [31400199]; special pilot program of the Fourth National Survey on Chinese Materia Medica Resources from Traditional Chinese Medicine Industry Research [201207002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); special pilot program of the Fourth National Survey on Chinese Materia Medica Resources from Traditional Chinese Medicine Industry Research	Financial support was provided by a grant from National Natural Science Foundation of China (www.nstc.gov.cn; grant no. 31400199) awarded to Bine Xue, and a special pilot program of the Fourth National Survey on Chinese Materia Medica Resources from Traditional Chinese Medicine Industry Research (http://www.zyzypc.com.cn/; grant no. 201207002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Abedini M, 2013, PLANT SPEC BIOL, V28, P185, DOI 10.1111/j.1442-1984.2012.00371.x; Ban NT, 2000, FLORA VIETNAM, V1, P5; Brown JM, 2010, SYST BIOL, V59, P145, DOI 10.1093/sysbio/syp081; Chaowasku T, 2013, EUR J TAXON, V64, DOI 10.5852/ejt.2013.64; Chaowasku T, 2013, NORD J BOT, V31, P680, DOI 10.1111/j.1756-1051.2012.01785.x; Chatrou LW, 2012, BOT J LINN SOC, V169, P5, DOI 10.1111/j.1095-8339.2012.01235.x; Doyle J. J., 1987, PHYTOCHEM B, P11; Drummond AJ, 2010, GENEIOUS V5 1; Durkee L. T., 1983, The biology of nectaries, P1; Erkens RHJ, 2014, TAXON, V63, P1244, DOI 10.12705/636.34; Finet A, 1906, BULLETIN DE LA SOCIE, V4, P164; Finet A, 1907, FLORE GENERALE DE LI, P123; Fu L.G., 1992, CHINA PLANT RED DATA, V1; Guo X, 2014, J SYST EVOL, V52, P1, DOI 10.1111/jse.12064; Hooker JD, 1872, THE FLORA OF BRITISH, V1, P90; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IUCN, 2012, IUCN RED LIST CATEGO; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KESSLER PJA, 1990, BLUMEA, V34, P505; KESSLER PJA, 1988, BLUMEA, V33, P1; Kessler PJA., 1995, BOT JB SYST, V118, P81; Li, 1979, FLORA REIPUBLICAE PO, V30, P10; Li PT, 2011, FLORA CHINA, V19, P672; Maas PJM, 2003, FLORA NEOTROPICA MON, V88, P1, DOI DOI 10.2307/4393920; Marshall DC, 2010, SYST BIOL, V59, P108, DOI 10.1093/sysbio/syp080; McNeill J, 2012, REGNUM VEG, V154, P1; Miller M.A., 2010, P GAT COMP ENV WORKS; Miller MA, 2011, P 2011 TERAGRID C EX, P41, DOI DOI 10.1145/2016741.2016785; Mols JB, 2004, AM J BOT, V91, P590, DOI 10.3732/ajb.91.4.590; Mols JB, 2003, BLUMEA, V48, P421; Muller KF, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-58; Murray N.A., 1993, SYSTEMATIC BOT MONOG, V40, P89, DOI [10.2307/25027830, DOI 10.2307/25027830]; Nepi Massimo, 2007, P129, DOI 10.1007/978-1-4020-5937-7_3; NORMAN EM, 1986, B TORREY BOT CLUB, V113, P16, DOI 10.2307/2996229; Nylander JAA., 2004, MRMODELTEST 2 2; Okada Hiroshi, 1996, Acta Phytotaxonomica et Geobotanica, V47, P1; OLESEN JM, 1992, FLORA, V187, P9; Pang CC, 2014, BOT J LINN SOC, V174, P93, DOI 10.1111/boj.12118; Pang CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059951; Pierre, 1881, FLORE FORESTIERE DE, V16; Pirie MD, 2006, J BIOGEOGR, V33, P31, DOI 10.1111/j.1365-2699.2005.01388.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saunders RMK, 2012, BOT J LINN SOC, V169, P222, DOI 10.1111/j.1095-8339.2011.01208.x; Silberbauer-Gottsberger I, 2003, TAXON, V52, P701, DOI 10.2307/3647345; Su Y.C.F., 2006, SYSTEMATIC BOT MONOG, V79, P1; Thiers B., 2015, NEW YORK BOTANICAL G; Thomas DC, 2012, TAXON, V61, P559, DOI 10.1002/tax.613006; Turner IM, 2015, BLUMEA, V59, P206, DOI 10.3767/000651915X688443; Turner I. M., 2009, Gardens' Bulletin (Singapore), V61, P185; van Heusden ECH, 1992, BLUMEA, P1, DOI DOI 10.1111/J.1756-1051.1993.TB00089.X; van Zuilen CM, 1996, THESIS; Westra LYT, 2012, PHYTOKEYS, V12, P1, DOI 10.3897/phytokeys.12.2771; WESTRA LYT, 1985, P K NED AKAD C BIOL, V88, P449; Xu J, 2012, ECOL INDIC, V36, P749; Xue B, 2014, SYST BOT, V39, P396, DOI 10.1600/036364414X680825; Xue B, 2012, TAXON, V61, P1021, DOI 10.1002/tax.615009; Zhou LL, 2009, SYST BIODIVERS, V7, P249, DOI 10.1017/S1477200009003028	57	9	11	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0170107	10.1371/journal.pone.0170107	http://dx.doi.org/10.1371/journal.pone.0170107			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146564	gold, Green Published, Green Submitted			2022-12-27	WOS:000396131700013
J	Da, CJ; Li, F; Shen, BL; Yan, PC; Song, J; Ma, DS				Da, ChaoJiu; Li, Fang; Shen, BingLu; Yan, PengCheng; Song, Jian; Ma, DeShan			Detection of a sudden change of the field time series based on the Lorenz system	PLOS ONE			English	Article							DYNAMIC-MODEL; PRECIPITATION; ALGORITHM; PACIFIC; CHINA; DELAY; FLOW	We conducted an exploratory study of the detection of a sudden change of the field time series based on the numerical solution of the Lorenz system. First, the time when the Lorenz path jumped between the regions on the left and right of the equilibrium point of the Lorenz system was quantitatively marked and the sudden change time of the Lorenz system was obtained. Second, the numerical solution of the Lorenz system was regarded as a vector; thus, this solution could be considered as a vector time series. We transformed the vector time series into a time series using the vector inner product, considering the geometric and topological features of the Lorenz system path. Third, the sudden change of the resulting time series was detected using the sliding t-test method. Comparing the test results with the quantitatively marked time indicated that the method could detect every sudden change of the Lorenz path, thus the method is effective. Finally, we used the method to detect the sudden change of the pressure field time series and temperature field time series, and obtained good results for both series, which indicates that the method can apply to high-dimension vector time series. Mathematically, there is no essential difference between the field time series and vector time series; thus, we provide a new method for the detection of the sudden change of the field time series.	[Da, ChaoJiu; Li, Fang; Ma, DeShan] Northwest Univ Nationalities, Sch Math, Lanzhou, Gansu, Peoples R China; [Da, ChaoJiu; Li, Fang; Ma, DeShan] Northwest Univ Nationalities, Inst Comp Sci, Lanzhou, Gansu, Peoples R China; [Da, ChaoJiu] Lanzhou Univ, Coll Atmospher Sci, Lanzhou, Gansu, Peoples R China; [Shen, BingLu] Chengdu Univ Informat Technol, Coll Atmospher Sci, Chengdu, Sichuan, Peoples R China; [Yan, PengCheng] CMA, Inst Arid Meteorol, Lanzhou, Gansu, Peoples R China; [Song, Jian] Inner Mongolia Univ Technol, Coll Sci, Hohhot, Inner Mongolia, Peoples R China	Northwest Minzu University; Northwest Minzu University; Lanzhou University; Chengdu University of Information Technology; China Meteorological Administration; Inner Mongolia University of Technology	Da, CJ (corresponding author), Northwest Univ Nationalities, Sch Math, Lanzhou, Gansu, Peoples R China.; Da, CJ (corresponding author), Northwest Univ Nationalities, Inst Comp Sci, Lanzhou, Gansu, Peoples R China.; Da, CJ (corresponding author), Lanzhou Univ, Coll Atmospher Sci, Lanzhou, Gansu, Peoples R China.	jtdcj@163.com		Da, ChaoJiu/0000-0003-3171-704X	National Natural Science Foundation of China [41465002, 41530531]; National Basic Research Program of China [2013CB430204]; Science Research Project of the Inner Mongolian Autonomous Region high school [NJZY16006]; Fundamental Research Funds for the Central Universities China [Yxm2015179]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Science Research Project of the Inner Mongolian Autonomous Region high school; Fundamental Research Funds for the Central Universities China(Fundamental Research Funds for the Central Universities)	This project was supported by the National Natural Science Foundation of China (Grant Nos. 41465002, 41530531), the National Basic Research Program of China (Grant No. 2013CB430204), the Science Research Project of the Inner Mongolian Autonomous Region high school (Grant No. NJZY16006) and the Fundamental Research Funds for the Central Universities China (Grant No. Yxm2015179). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Project Supported by the National Natural Science Foundation of China (Grant Nos. 41465002, 41530531), the National Basic Research Program of China (Grant No. 2013CB430204), the Science Research Project of the Inner Mongolian Autonomous Region high school (Grant No.NJZY16006) and the Fundamental Research Funds for the Central Universities China (Grant No. Yxm2015179).	Arnol'd V. I., 1992, GEOMETRICAL METHODS; CHARNEY JG, 1979, J ATMOS SCI, V36, P1205, DOI 10.1175/1520-0469(1979)036<1205:MFEITA>2.0.CO;2; Da CJ, 2014, ACTA PHYS SIN-CH ED, V63, DOI 10.7498/aps.63.029201; Daniell P.J, 1953, LECT CAUCHYS PROBLEM; Feng G L, 1999, Q J APPL METEOROL, V10, P470; Feng GL, 2001, ACTA PHYS SIN-CH ED, V50, P606, DOI 10.7498/aps.50.606; Feng GL, 2013, SCI CHINA EARTH SCI, V56, P1576, DOI 10.1007/s11430-012-4527-8; Fu Z B, 1992, CHINESE J ATMOSPHERI, V16, P482; Gong ZQ, 2006, ACTA PHYS SIN-CH ED, V55, P3180, DOI 10.7498/aps.55.3180; Gong ZQ, 2016, WEATHER FORECAST, V31, P1381, DOI 10.1175/WAF-D-16-0007.1; Gong ZQ, 2006, ACTA PHYS SIN-CH ED, V55, P477, DOI 10.7498/aps.55.477; Hou W, 2006, ACTA PHYS SIN-CH ED, V55, P2663, DOI 10.7498/aps.55.2663; Huang JP, 1996, J ATMOS SCI, V53, P370, DOI 10.1175/1520-0469(1996)053<0370:CSAOFI>2.0.CO;2; HUANG JP, 1992, SCI CHINA SER B, V35, P207; HUANG JP, 1993, Q J ROY METEOR SOC, V119, P547, DOI 10.1002/qj.49711951111; HUANG JP, 1991, SCI CHINA SER B, V34, P1246; Jianping Huang, 1991, SCI CHINA SER B, V34, P331; Li L, 2016, APPL MATH MODEL, V40, P4765, DOI 10.1016/j.apm.2015.12.003; LORENZ EN, 1963, J ATMOS SCI, V20, P130, DOI 10.1175/1520-0469(1963)020<0130:DNF>2.0.CO;2; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; [沈柏竹 Shen Baizhu], 2015, [地理科学, Scientia Geographica Sinica], V35, P1299; Shen Baizhu, 2011, Acta Meteorologica Sinica, V69, P320; Sun GQ, 2016, PHYS LIFE REV, V08; Sun GQ, 2016, NONLINEAR DYNAM, V85, P1, DOI 10.1007/s11071-016-2671-y; Sun GQ, 2016, NONLINEAR DYNAM, V83, P811, DOI 10.1007/s11071-015-2369-6; Sun GQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11246; Sun GQ, 2014, COMMUN NONLINEAR SCI, V19, P1507, DOI 10.1016/j.cnsns.2013.09.016; Sun GQ, 2012, APPL MATH COMPUT, V218, P11151, DOI 10.1016/j.amc.2012.04.071; Thom R., 1974, POETICS, V3, P7, DOI [10.1016/0304-422X(74)90010-2., DOI 10.1016/0304-422X(74)90010-2]; Trenberth K E, 1990, B AM METEOROLOGICAL, V71, P377; Wei F, 2008, MODERN CLIMATIC STAT; Wu YP, 2016, SCI REP-UK, V6, DOI 10.1038/srep26470; Wu YP, 2015, APPL MATH COMPUT, V268, P478, DOI 10.1016/j.amc.2015.06.059; [颜鹏程 Yan Pengcheng], 2014, [大气科学, Chinese Journal of Atmospheric Sciences], V38, P861; Ye D Z, 1958, ACTA METEOROLOGICA S, V29, P249; Yi Lian, 2010, CHINESE J ATMOSPHERI, V34, P429; Zeeman E C., 1975, CATASTROPHE THEORY R; Zheng ZH, 2009, ACTA PHYS SIN-CH ED, V58, P7359, DOI 10.7498/aps.58.7359; Zhi R, 2006, ACTA PHYS SIN-CH ED, V55, P6185, DOI 10.7498/aps.55.6185	39	1	1	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170720	10.1371/journal.pone.0170720	http://dx.doi.org/10.1371/journal.pone.0170720			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141832	Green Published, gold, Green Submitted			2022-12-27	WOS:000396129500015
J	Shevchouk, OT; Ball, GF; Cornil, CA; Balthazart, J				Shevchouk, Olesya T.; Ball, Gregory F.; Cornil, Charlotte A.; Balthazart, Jacques			Studies of HVC Plasticity in Adult Canaries Reveal Social Effects and Sex Differences as Well as Limitations of Multiple Markers Available to Assess Adult Neurogenesis	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; SONG-CONTROL-SYSTEM; HIGH VOCAL CENTER; SINGING BEHAVIOR; CELL-PROLIFERATION; CONTROL NUCLEI; AROMATASE-ACTIVITY; BRAIN AROMATASE; ACUTE STRESS; NEURONS	In songbirds, neurogenesis in the song control nucleus HVC is sensitive to the hormonal and social environment but the dynamics of this process is difficult to assess with a single exogenous marker of new neurons. We simultaneously used three independent markers to investigate HVC neurogenesis in male and female canaries. Males were castrated, implanted with testosterone and housed either alone (M), with a female (M-F) or with another male (M-M) while females were implanted with 17 beta-estradiol and housed with a male (F-M). All subjects received injections of the two thymidine analogues, BrdU and of EdU, respectively 21 and 10 days before brain collection. Cells containing BrdU or EdU or expressing doublecortin (DCX), which labels newborn neurons, were quantified. Social context and sex differentially affected total BrdU(+), EdU(+), BrdU(+) EdU(-) and DCX+ populations. M-M males had a higher density of BrdU(+) cells in the ventricular zone adjacent to HVC and of EdU(+) in HVC than M-F males. M birds had a higher ratio of BrdU(+) EdU(-) to EdU(+) cells than M-F subjects suggesting higher survival of newer neurons in the former group. Total number of HVC DCX+ cells was lower in M-F than in M-M males. Sex differences were also dependent of the type of marker used. Several technical limitations associated with the use of these multiple markers were also identified. These results indicate that proliferation, recruitment and survival of new neurons can be independently affected by environmental conditions and effects can only be fully discerned through the use of multiple neurogenesis markers.	[Shevchouk, Olesya T.; Cornil, Charlotte A.; Balthazart, Jacques] Univ Liege, GIGA Neurosci, Liege, Belgium; [Ball, Gregory F.] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA	University of Liege; University System of Maryland; University of Maryland College Park	Balthazart, J (corresponding author), Univ Liege, GIGA Neurosci, Liege, Belgium.	jbalthazart@ulg.ac.be	Cornil, Charlotte Anne/J-2462-2019; Shevchouk, Olesya/AAB-9955-2022; Balthazart, Jacques/H-6865-2019	Cornil, Charlotte Anne/0000-0002-5536-7753; Shevchouk, Olesya/0000-0003-1870-5749; Balthazart, Jacques/0000-0001-9492-2126; Ball, Gregory/0000-0002-4784-0520	National Institutes of Health/National, Institute of Neurological Disorders and Stroke [R01 35467]; Belgian Science Policy [SSTC IAP P7/17]	National Institutes of Health/National, Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Belgian Science Policy(Belgian Federal Science Policy Office)	Support was provided by: 1) National Institutes of Health/National, Institute of Neurological Disorders and Stroke - Grant R01 35467- to GFB and JB [http://www.ninds.nih.gov/]; 2) Belgian Science Policy - Grant SSTC IAP P7/17 to JB and CAC [http://belspo.be/belspo/index fr.stm]; 3) F.R.S.-FNRS Research Associate to CAC [http://www.fnrs.be/].; This work was supported by National Institutes of Health/National Institute of Neurological Disorders and Stroke (Grant R01 35467) to G.F.B. and J.B. and Grant SSTC IAP P7/17 from the Belgian Science Policy (to J.B. and C.A.C.). C.A.C. is F.R.S.-FNRS Research Associate.	Adar E, 2008, BEHAV BRAIN RES, V187, P178, DOI 10.1016/j.bbr.2007.09.011; ALTMAN J, 1965, NATURE, V207, P953, DOI 10.1038/207953a0; Alvarez-Borda B, 2002, J NEUROSCI, V22, P8684; ALVAREZBUYLLA A, 1988, NATURE, V335, P353, DOI 10.1038/335353a0; ALVAREZBUYLLA A, 1990, NEURON, V5, P101, DOI 10.1016/0896-6273(90)90038-H; AlvarezBuylla A, 1997, J NEUROBIOL, V33, P585, DOI 10.1002/(SICI)1097-4695(19971105)33:5<585::AID-NEU7>3.0.CO;2-0; Alward BA, 2014, EUR J NEUROSCI, V40, P2941, DOI 10.1111/ejn.12658; Alward BA, 2013, P NATL ACAD SCI USA, V110, P19573, DOI 10.1073/pnas.1311371110; Amy M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140196; Appeltants D, 2003, NEUROSCIENCE, V121, P801, DOI 10.1016/S0306-4522(03)00496-2; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Ball Gregory F., 2002, P649; Balthazart J, 2008, EUR J NEUROSCI, V27, P801, DOI 10.1111/j.1460-9568.2008.06059.x; Balthazart J, 2016, FRONT NEUROENDOCRIN, V41, P3, DOI 10.1016/j.yfrne.2016.03.003; Balthazart J, 2014, J COMP NEUROL, V522, P4100, DOI 10.1002/cne.23661; Balthazart J, 2014, BRAIN BEHAV EVOLUT, V84, P1, DOI 10.1159/000362917; BARAMI K, 1995, J NEUROBIOL, V28, P82, DOI 10.1002/neu.480280108; Barker JM, 2014, J CHEM NEUROANAT, V55, P1, DOI 10.1016/j.jchemneu.2013.10.005; Barker JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058826; Barker JM, 2012, FENS M BARC SP; Barnea A, 2006, BEHAV BRAIN RES, V167, P63, DOI 10.1016/j.bbr.2005.08.018; Belnoue L, 2011, J NEUROSCI, V31, P1010, DOI 10.1523/JNEUROSCI.3941-10.2011; Boseret G, 2007, J CHEM NEUROANAT, V33, P140, DOI 10.1016/j.jchemneu.2007.02.002; Boseret G, 2006, J NEUROBIOL, V66, P1044, DOI 10.1002/neu.20268; Brenowitz EA, 2015, COLD SPRING HARB PER, V7, P1; BRENOWITZ EA, 2008, NEUROSCIENCE BIRDSON, P332; BROWN SD, 1993, J NEUROSCI, V13, P2024; CATCHPOLE CK, 1973, BEHAVIOUR, V46, P300, DOI 10.1163/156853973X00067; Cattan A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/126078; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; Chen Q, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/418064; Chen Z, 2013, NEUROSCIENCE, V239, P139, DOI 10.1016/j.neuroscience.2012.12.043; CUTHILL I, 1985, ANIM BEHAV, V33, P326, DOI 10.1016/S0003-3472(85)80146-9; de Bournonville C, 2016, HORM BEHAV, V83, P45, DOI 10.1016/j.yhbeh.2016.05.011; de Bournonville C, 2013, PSYCHONEUROENDOCRINO, V38, P789, DOI 10.1016/j.psyneuen.2012.09.001; DELVILLE Y, 1984, GEN COMP ENDOCR, V55, P295, DOI 10.1016/0016-6480(84)90115-1; Dickens MJ, 2014, HORM BEHAV, V65, P154, DOI 10.1016/j.yhbeh.2013.12.011; Dickens MJ, 2013, J NEUROENDOCRINOL, V25, P329, DOI 10.1111/jne.12012; Dickens MJ, 2012, J NEUROENDOCRINOL, V24, P1322, DOI 10.1111/j.1365-2826.2012.02340.x; Dickens MJ, 2011, ENDOCRINOLOGY, V152, P4242, DOI 10.1210/en.2011-1341; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; GORDONWEEKS PR, 1991, J CELL SCI, P45; GOULD E, 1992, J NEUROSCI, V12, P3642; Guigueno MF, 2016, DEV NEUROBIOL, V76, P1226, DOI 10.1002/dneu.22385; Hall ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040060; HIDALGO A, 1995, J NEUROBIOL, V27, P470, DOI 10.1002/neu.480270404; HINDE RA, 1976, HORM BEHAV, V7, P293, DOI 10.1016/0018-506X(76)90035-0; Jin KL, 2004, FASEB J, V18, P287, DOI 10.1096/fj.03-0973com; Katz A, 2008, EUR J NEUROSCI, V28, P99, DOI 10.1111/j.1460-9568.2008.06303.x; Kirn JR, 1999, J COMP NEUROL, V411, P487; KREBS JR, 1981, ANIM BEHAV, V29, P635, DOI 10.1016/S0003-3472(81)80134-0; Lankford K, 1990, CURR OPIN CELL BIOL, V2, P80, DOI 10.1016/S0955-0674(05)80035-3; Larson TA, 2013, P NATL ACAD SCI USA, V110, P16640, DOI 10.1073/pnas.1310237110; LEBOUCHER G, 1994, ETHOLOGY, V97, P190; Leitner S, 2007, DEV NEUROBIOL, V67, P1478, DOI 10.1002/dneu.20521; Li XC, 2000, P NATL ACAD SCI USA, V97, P8584, DOI 10.1073/pnas.140222497; Liboska R, 2012, PLOS ONE, V7, P1; Lipkind D, 2002, BEHAV BRAIN RES, V133, P31, DOI 10.1016/S0166-4328(01)00416-8; Llorens-Martin M, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00076; Madison FN, 2015, GEN COMP ENDOCR, V215, P61, DOI 10.1016/j.ygcen.2014.09.008; MOORE MC, 1983, J ZOOL, V199, P137, DOI 10.1111/j.1469-7998.1983.tb02085.x; Moores CA, 2004, MOL CELL, V14, P833, DOI 10.1016/j.molcel.2004.06.009; MORTON ML, 1985, COMP BIOCHEM PHYS A, V80, P93, DOI 10.1016/0300-9629(85)90684-X; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Newman AEM, 2010, J COMP NEUROL, V518, P3662, DOI 10.1002/cne.22395; Nottebohm F, 2004, ANN NY ACAD SCI, V1016, P628, DOI 10.1196/annals.1298.027; Nottebohm F, 2005, PLOS BIOL, V3, P759, DOI 10.1371/journal.pbio.0030164; NOTTEBOHM F, 1980, BRAIN RES, V189, P429, DOI 10.1016/0006-8993(80)90102-X; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; Odom KJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4379; PATON JA, 1984, SCIENCE, V225, P1046, DOI 10.1126/science.6474166; Perfito N, 2015, ENDOCRINOLOGY, V156, P694, DOI 10.1210/en.2014-1450; Ponti G, 2013, P NATL ACAD SCI USA, V110, pE1045, DOI 10.1073/pnas.1219563110; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; RASIKA S, 1994, P NATL ACAD SCI USA, V91, P7854, DOI 10.1073/pnas.91.17.7854; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sartor JJ, 2005, HORM BEHAV, V47, P467, DOI 10.1016/j.yhbeh.2004.12.004; Scott BB, 2007, J COMP NEUROL, V502, P202, DOI 10.1002/cne.21296; Stevenson TJ, 2008, GEN COMP ENDOCR, V156, P385, DOI 10.1016/j.ygcen.2008.01.015; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Tramontin AD, 1999, J NEUROBIOL, V40, P316, DOI 10.1002/(SICI)1097-4695(19990905)40:3<316::AID-NEU4>3.0.CO;2-S; Tramontin AD, 2000, TRENDS NEUROSCI, V23, P251, DOI 10.1016/S0166-2236(00)01558-7; Vellema M, 2014, BRAIN BEHAV EVOLUT, V84, P5, DOI 10.1159/000363125; Vellema M, 2010, J COMP NEUROL, V518, P1442, DOI 10.1002/cne.22281; Vermeulen A, 2016, BEHAV ECOL SOCIOBIOL, V70, P585, DOI 10.1007/s00265-016-2077-3; Warren M, 2009, DEV DYNAM, V238, P944, DOI 10.1002/dvdy.21895; Yamaguchi M, 2005, P NATL ACAD SCI USA, V102, P9697, DOI 10.1073/pnas.0406082102; Yamamura T, 2011, J NEUROSCI, V31, P9649, DOI 10.1523/JNEUROSCI.0088-11.2011; Zeng CB, 2010, BRAIN RES, V1319, P21, DOI 10.1016/j.brainres.2009.12.092	91	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170938	10.1371/journal.pone.0170938	http://dx.doi.org/10.1371/journal.pone.0170938			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141859	Green Published, Green Submitted, gold			2022-12-27	WOS:000396129500029
J	Hair, PS; Sass, LA; Krishna, NK; Cunnion, KM				Hair, Pamela S.; Sass, Laura A.; Krishna, Neel K.; Cunnion, Kenji M.			Inhibition of Myeloperoxidase Activity in Cystic Fibrosis Sputum by Peptide Inhibitor of Complement C1 (PIC1)	PLOS ONE			English	Article							ASTROVIRUS COAT PROTEIN; CLASSICAL PATHWAY; ACTIVATION; OXIDANTS; MARKERS	Myeloperoxidase is the major peroxidase enzyme in neutrophil granules and implicated in contributing to inflammatory lung damage in cystic fibrosis. Free myeloperoxidase is present in cystic fibrosis lung fluid and generates hypochlorous acid. Here we report a new inhibitor of myeloperoxidase activity, Peptide Inhibitor of Complement C1 (PIC1). Using TMB as the oxidizing substrate, PIC1 inhibited myeloperoxidase activity in cystic fibrosis sputum soluble fractions by an average of a 3.4-fold decrease (P = 0.02). PIC1 also dose-dependently inhibited myeloperoxidase activity in a neutrophil lysate or purified myeloperoxidase by up to 28 fold (P < 0.001). PIC1 inhibited myeloperoxidase activity similarly, on a molar basis, as the specific myeloperoxidase inhibitor 4-Aminobenzoic acid hydrazide (ABAH) for various oxidizing substrates. PIC1 was able to protect the heme ring of myeloperoxidase from destruction by NaOCI, assayed by spectral analysis. PIC1 incubated with oxidized TMB reversed the oxidation state of TMB, as measured by absorbance at 450 nm, with a 20-fold reduction in oxidized TMB (P = 0.02). This result was consistent with an antioxidant mechanism for PIC1. In summary, PIC1 inhibits the peroxidase activity of myeloperoxidase in CF sputum likely via an antioxidant mechanism.	[Hair, Pamela S.; Sass, Laura A.; Krishna, Neel K.; Cunnion, Kenji M.] Eastern Virginia Med Sch, Dept Pediat, Norfolk, VA 23501 USA; [Sass, Laura A.; Cunnion, Kenji M.] Childrens Specialty Grp, Norfolk, VA USA; [Sass, Laura A.; Cunnion, Kenji M.] Childrens Hosp Kings Daughters, Norfolk, VA USA; [Krishna, Neel K.; Cunnion, Kenji M.] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA	Eastern Virginia Medical School; Eastern Virginia Medical School	Cunnion, KM (corresponding author), Eastern Virginia Med Sch, Dept Pediat, Norfolk, VA 23501 USA.	cunniokm@evms.edu		Cunnion, Kenji/0000-0001-8604-348X				Bonaparte RS, 2008, J VIROL, V82, P817, DOI 10.1128/JVI.01847-07; Carlin JB, 2001, J PAEDIATR CHILD H, V37, P72, DOI 10.1046/j.1440-1754.2001.00634.x; Davies JR, 1999, BIOCHEM J, V344, P321, DOI 10.1042/0264-6021:3440321; Fong Siew Wai, 2015, BMC Res Notes, V8, P679, DOI 10.1186/s13104-015-1677-8; Gronemus JQ, 2010, MOL IMMUNOL, V48, P305, DOI 10.1016/j.molimm.2010.07.012; Hair PS, 2010, INFECT IMMUN, V78, P1717, DOI 10.1128/IAI.01065-09; HARRISON JE, 1976, J BIOL CHEM, V251, P1371; Hasmann A, 2013, ANN CLIN BIOCHEM, V50, P245, DOI 10.1258/acb.2011.010249; JOSEPHY PD, 1982, J BIOL CHEM, V257, P3669; Kato Y, 2016, J CLIN BIOCHEM NUTR, V58, P99, DOI 10.3164/jcbn.15-104; Kettle AJ, 1997, BIOCHEM J, V321, P503, DOI 10.1042/bj3210503; KETTLE AJ, 1993, BIOCHEM PHARMACOL, V45, P2003, DOI 10.1016/0006-2952(93)90010-T; Kim JS, 2006, CHEST, V129, P1148, DOI 10.1378/chest.129.5.1148; Klebanoff SJ, 1999, P ASSOC AM PHYSICIAN, V111, P383, DOI 10.1111/paa.1999.111.5.383; KOLLER DY, 1995, AM J RESP CRIT CARE, V152, P629, DOI 10.1164/ajrccm.152.2.7633718; Kothari N, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.09.001; Kumar PS, 2016, TRANSFUSION, V56, P2133, DOI 10.1111/trf.13674; Maitra D, 2013, FREE RADICAL BIO MED, V63, P90, DOI 10.1016/j.freeradbiomed.2013.04.009; Malle E, 2003, KIDNEY INT, V64, P1956, DOI 10.1046/j.1523-1755.2003.00336.x; Mauriello CT, 2013, MOL IMMUNOL, V53, P132, DOI 10.1016/j.molimm.2012.07.012; MOHAMMED JR, 1988, J LAB CLIN MED, V112, P711; Pulli B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067976; Ruiz-Delgado GJ, 2009, ACTA HAEMATOL-BASEL, V122, P1, DOI 10.1159/000227267; Sass LA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144723; SCHIOTZ PO, 1979, ACTA PATH MICRO IM C, V87, P1; Sharp JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132446; Sharp JA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00406; Thomson E, 2010, FREE RADICAL BIO MED, V49, P1354, DOI 10.1016/j.freeradbiomed.2010.07.010; Tiyerili V, 2016, INT J CARDIOL, V204, P29, DOI 10.1016/j.ijcard.2015.11.128; Vasu VT, 2011, FREE RADICAL RES, V45, P165, DOI 10.3109/10715762.2010.521154; WITKOSARSAT V, 1995, AM J RESP CRIT CARE, V152, P1910, DOI 10.1164/ajrccm.152.6.8520754	31	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170203	10.1371/journal.pone.0170203	http://dx.doi.org/10.1371/journal.pone.0170203			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135312	Green Published, gold, Green Submitted			2022-12-27	WOS:000396124700011
J	Liu, PC; Lu, G; Deng, Y; Wang, CD; Su, XW; Zhou, JY; Chan, TM; Hu, X; Poon, WS				Liu, Pi Chu; Lu, Gang; Deng, Yi; Wang, Cheng Dong; Su, Xian Wei; Zhou, Jing Ye; Chan, Tat Ming; Hu, Xiang; Poon, Wai Sang			Inhibition of NF-kappa B Pathway and Modulation of MAPK Signaling Pathways in Glioblastoma and Implications for Lovastatin and Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) Combination Therapy	PLOS ONE			English	Article							OVARIAN-CANCER CELLS; HUMAN HEPATOMA-CELLS; BREAST-CANCER; DEATH RECEPTORS; MEDIATED APOPTOSIS; UP-REGULATION; EXPRESSION; RESISTANCE; PROTEIN; PROLIFERATION	Glioblastoma is a common malignant brain tumor and it is refractory to therapy because it usually contains a mixture of cell types. The tumor necrosis factor-related apoptosis inducing ligand (TRAIL) has been shown to induce apoptosis in a range of tumor cell types. Previously, we found that two human glioblastoma cell lines are resistant to TRAIL, while lovastatin sensitizes these glioblastoma cells to TRAIL-induced cell death. In this study, we investigated the mechanisms underlying the TRAIL-induced apoptosis in human glioblastoma cell lines by lovastatin. Furthermore, we have confirmed the anti-tumor effect of combination therapy with lovastatin and TRAIL in the subcutaneous brain tumor model. We showed that lovastatin significantly up-regulated the expression of death receptor 5 (DR5) in glioblastoma cell lines as well as in tumor-bearing mice with peri-tumoral administration of lovastatin. Further study in glioblastoma cell lines suggested that lovastatin treatment could inhibit NF-kappa B and Erk/MAPK pathways but activates JNK pathway. These results suggest that lovastatin sensitizes TRAIL-induced apoptosis by up-regulation of DR5 level via NF-kappa B inactivation, but also directly induces apoptosis by dysregulation of MAPK pathway. Our in vivo study showed that local peri-tumoral co-injection of lovastatin and TRAIL substantially reduced tumor growth compared with single injection of lovastatin or TRAIL in subcutaneous nude mice model. This study suggests that combined treatment of lovastatin and TRAIL is a promising therapeutic strategy to TRAIL-resistant glioblastoma.	[Liu, Pi Chu; Lu, Gang; Wang, Cheng Dong; Su, Xian Wei; Zhou, Jing Ye; Chan, Tat Ming; Poon, Wai Sang] Chinese Univ Hong Kong, Div Neurosurg, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Deng, Yi] South Univ Sci & Technol China, Shenzhen Key Lab Cell Microenvironm, Dept Biol, Shenzhen, Guangdong, Peoples R China; [Hu, Xiang] Shenzhen Beike Cell Engn Res Inst, Shenzhen, Peoples R China	Chinese University of Hong Kong; Southern University of Science & Technology	Poon, WS (corresponding author), Chinese Univ Hong Kong, Div Neurosurg, Dept Surg, Hong Kong, Hong Kong, Peoples R China.	wpoon@surgery.cuhk.edu.hk	Poon, Wai Sang/F-1558-2011; Poon, Wai S/HGD-3084-2022	Wang, Chengdong/0000-0001-9891-8765	Hong Kong Government Innovation and Technology Fund [GHX/005/11SZ]	Hong Kong Government Innovation and Technology Fund	This work was partly supported by the Hong Kong Government Innovation and Technology Fund (http://www.itc.gov.hk/en/welcome.htm) with the grant number GHX/005/11SZ to WSP, The Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal B, 1999, CLIN CANCER RES, V5, P2223; Bellail AC, 2009, REV RECENT CLIN TRIA, V4, P34, DOI 10.2174/157488709787047530; Bjarnadottir O, 2013, BREAST CANCER RES TR, V138, P499, DOI 10.1007/s10549-013-2473-6; BOTTI RE, 1991, CLIN NEUROPHARMACOL, V14, P256, DOI 10.1097/00002826-199106000-00010; Braeuer SJ, 2006, MOL CANCER RES, V4, P715, DOI 10.1158/1541-7786.MCR-05-0231; Chan DYL, 2008, J NEURO-ONCOL, V86, P273, DOI 10.1007/s11060-007-9475-3; Chinnaiyan AM, 2000, P NATL ACAD SCI USA, V97, P1754, DOI 10.1073/pnas.030545097; Cimini Annamaria, 2011, ISRN Oncol, V2011, P787490, DOI 10.5402/2011/787490; Di Matola T, 2001, EUR J ENDOCRINOL, V145, P645, DOI 10.1530/eje.0.1450645; Dorsey JF, 2009, MOL CANCER THER, V8, P3285, DOI 10.1158/1535-7163.MCT-09-0415; Eggert A, 2001, CANCER RES, V61, P1314; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; French LE, 2003, CELL DEATH DIFFER, V10, P117, DOI 10.1038/sj.cdd.4401185; Fulda S, 2001, ONCOGENE, V20, P5865, DOI 10.1038/sj.onc.1204750; Higgins MJ, 2012, BREAST CANCER RES TR, V131, P915, DOI 10.1007/s10549-011-1858-7; Hinz S, 2000, ONCOGENE, V19, P5477, DOI 10.1038/sj.onc.1203936; Hus M, 2011, ANN HEMATOL, V90, P1161, DOI 10.1007/s00277-011-1276-2; Jane EP, 2011, MOL CANCER THER, V10, P198, DOI 10.1158/1535-7163.MCT-10-0725; Johnson MD, 2002, J NEURO-ONCOL, V56, P133, DOI 10.1023/A:1014588214966; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kim YS, 2002, HEPATOLOGY, V36, P1498, DOI 10.1053/jhep.2002.36942; Klawitter J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2485; Larner J, 1998, AM J CLIN ONCOL-CANC, V21, P579, DOI 10.1097/00000421-199812000-00010; Lavrik I, 2005, J CELL SCI, V118, P265, DOI 10.1242/jcs.01610; Lee J, 2014, INVEST NEW DRUG, V32, P535, DOI 10.1007/s10637-014-0065-x; Liang SL, 2006, J IMMUNOL, V177, P651, DOI 10.4049/jimmunol.177.1.651; Liu HL, 2009, CANCER CHEMOTH PHARM, V63, P997, DOI 10.1007/s00280-008-0830-7; Martirosyan A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-103; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Shetty S, 2005, MOL CELL BIOL, V25, P5404, DOI 10.1128/MCB.25.13.5404-5416.2005; Shigeno M, 2003, ONCOGENE, V22, P1653, DOI 10.1038/sj.onc.1206139; Wajant H, 2003, ESSAYS BIOCHEM, V39, P53, DOI 10.1042/bse0390053; Wang CY, 2008, TRENDS MOL MED, V14, P37, DOI 10.1016/j.molmed.2007.11.004; Weller M, 2010, NEURO-ONCOLOGY, V12, P319, DOI 10.1093/neuonc/noq027; Yao J, 2015, ONCOL REP, V34, P2011, DOI 10.3892/or.2015.4153; Zhang YQ, 2008, MOL CANCER RES, V6, P1861, DOI 10.1158/1541-7786.MCR-08-0313	37	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171157	10.1371/journal.pone.0171157	http://dx.doi.org/10.1371/journal.pone.0171157			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135339	Green Published, Green Submitted, gold			2022-12-27	WOS:000396124700053
J	Ji, C; Guo, HD; Jin, SQ; Yang, J				Ji, Chen; Guo, Hongdong; Jin, Songqing; Yang, Jin			Outsourcing Agricultural Production: Evidence from Rice Farmers in Zhejiang Province	PLOS ONE			English	Article								China has recorded positive growth rates of grain production for the past eleven consecutive years. This is a remarkable accomplishment given that China's rapid industrialization and urbanization has led to a vast reduction of arable land and agricultural labor to non-agricultural sectors. While there are many factors contributing to this happy outcome, one potential contributing factor that has received increasing attention is the emergence of agricultural production outsourcing, a new rural institution that has emerged in recent years. This study aims to contribute to the limited but growing literature on agricultural production outsourcing in China. Specifically, this study analyzes factors affecting farmers' decisions to outsource any or some production tasks using data from rice farmers in Zhejiang province. Results from a logistic model show that farm size and government subsidy encourages farmers to outsource while ownership of agricultural machines and land fragmentation have negative effects on farmers' decisions to outsource production tasks. Results also showed that determinants of outsourcing decisions vary with the production tasks that farmers outsourced.	[Ji, Chen; Guo, Hongdong; Jin, Songqing] Zhejiang Univ, China Acad Rural Dev, Hangzhou, Zhejiang, Peoples R China; [Jin, Songqing] Michigan State Univ, Dept Agr Food & Resource Econ, E Lansing, MI 48824 USA; [Yang, Jin] Huazhong Univ Technol & Sci, Dept Econ, Sch Econ, Wuhan, Hubei, Peoples R China	Zhejiang University; Michigan State University; Huazhong University of Science & Technology	Yang, J (corresponding author), Huazhong Univ Technol & Sci, Dept Econ, Sch Econ, Wuhan, Hubei, Peoples R China.	yangjin8849@163.com	Jin, Songqing/W-4340-2019	Jin, Songqing/0000-0001-8514-7930	National Science Foundation of China (NSFC) [71473218, 71333011]; Michigan State University's AgBioResearch; Fundamental Research Funds for the Central Universities, HUST [2016AB006]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Michigan State University's AgBioResearch; Fundamental Research Funds for the Central Universities, HUST(Fundamental Research Funds for the Central Universities)	Guo acknowledges funding support from the National Science Foundation of China (NSFC) (No. 71473218 and & No. 71333011). Jin gratefully acknowledges support from Michigan State University's AgBioResearch. Yang acknowledges funding support from the Fundamental Research Funds for the Central Universities, HUST: 2016AB006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, CHINAS GRAIN IND RES; Azadi H, 2013, GLOBAL PLANET CHANGE, V100, P20, DOI 10.1016/j.gloplacha.2012.10.002; Carter CA, 2012, APPL ECON PERSPECT P, V34, P1, DOI 10.1093/aepp/ppr047; FOSTER A. D., 2011, ARE INDIAN FAR UNPUB; Huang JK, 2010, AGR ECON-BLACKWELL, V41, P47, DOI 10.1111/j.1574-0862.2010.00487.x; Jin SQ, 2010, J PROD ANAL, V33, P191, DOI 10.1007/s11123-009-0145-7; Jin SQ, 2009, J COMP ECON, V37, P629, DOI 10.1016/j.jce.2009.04.005; Li YQ, 2015, J AGR MANAGEMENT I M, V18, P17; Liao X, 2011, ISSUES AGR EC, V12, P12; Liu Y, 2016, 01525 IFPRI; NBSC, 2011, REL 6 NAT CENS DAT C; Su SL, 2011, APPL GEOGR, V31, P439, DOI 10.1016/j.apgeog.2010.10.008; Teklemariam D, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8030213; Vandergeten E, 2016, LANDSCAPE ECOL, V31, P1395, DOI 10.1007/s10980-016-0365-y; Wang ZG, 2011, CHINA AGR EC, V9, P4; Yang J, 2013, AM J AGR ECON, V95, P1245, DOI 10.1093/ajae/aat027; Yu WuSheng, 2010, Journal of Agricultural Economics, V61, P343, DOI 10.1111/j.1477-9552.2010.00242.x; Yu XH, 2009, FRONT ECON CHINA, V4, P633, DOI 10.1007/s11459-009-0034-y; Zhan J., 2016, J NANJING AGR U, V16, P117; Zhang X. B., 2015, IFPRI - Discussion Papers; Zhang XD, 2011, J SYST ENG ELECTRON, V22, P22, DOI 10.3969/j.issn.1004-4132.2011.01.003; Zhang YJ, 2011, AGR ECON-BLACKWELL, V42, P495, DOI 10.1111/j.1574-0862.2010.00532.x	22	25	26	6	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170861	10.1371/journal.pone.0170861	http://dx.doi.org/10.1371/journal.pone.0170861			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7VX	28129362	Green Submitted, Green Published, gold			2022-12-27	WOS:000396211400030
J	Moiroux, N; Chandre, F; Hougard, JM; Corbel, V; Pennetier, C				Moiroux, Nicolas; Chandre, Fabrice; Hougard, Jean-Marc; Corbel, Vincent; Pennetier, Cedric			Remote Effect of Insecticide-Treated Nets and the Personal Protection against Malaria Mosquito Bites	PLOS ONE			English	Article							HUMAN SKIN EMANATIONS; ANOPHELES-GAMBIAE; BED NETS; AEDES-ALBOPICTUS; KDR MUTATION; VECTORS; FIELD; BEDNETS; TRANSMISSION; PREVENTION	Experimental huts are part of the WHO process for testing and evaluation of Insecticide Treated Nets (ITN) in semi-field conditions. Experimental Hut Trials (EHTs) mostly focus on two main indicators (i.e., mortality and blood feeding reduction) that serve as efficacy criteria to obtain WHO interim recommendation. However, several other outputs that rely on counts of vectors collected in the huts are neglected although they can give useful information about vectors' behavior and personal protection provided by ITNs. In particular, EHTs allow to measure the deterrent effect and personal protection of ITNs. To provide a better assessment of ITNs efficacy, we performed a retrospective analysis of the deterrence and the personal protection against malaria transmission for 12 unwashed and 13 washed ITNs evaluated through EHTs conducted in West Africa. A significant deterrent effect was shown for six of the 12 unwashed ITNs tested. When washed 20 times, only three ITNs had significant deterrent effect (Rate Ratios (RR)<1; p<0.05) and three showed an apparent "attractiveness" (RR> 1; p<0.01). When compared to the untreated net, all unwashed ITNs showed lower number of blood-fed Anopheles indicating a significant personal protection (RR<1, p<0.05). However, when washed 20 times, three ITNs that were found to be attractive did not significantly reduce human-vector contact (p>0.05). Current WHO efficacy criteria do not sufficiently take into account the deterrence effect of ITNs. Moreover, the deterrence variability is rarely discussed in EHT's reports. Our findings highlighted the long-range effect (deterrent or attractive) of ITNs that may have significant consequences for personal/ community protection against malaria transmission. Indicators measuring the deterrence should be further considered for the evaluation of ITNs.	[Moiroux, Nicolas; Chandre, Fabrice; Hougard, Jean-Marc; Corbel, Vincent; Pennetier, Cedric] Univ Montpellier, IRD, MIVEGEC, IRD 224,CNRS 5290, Montpellier, France; [Moiroux, Nicolas] IRSS, Bobo Dioulasso, Burkina Faso; [Pennetier, Cedric] IPR, Bouake, Cote Ivoire	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Moiroux, N (corresponding author), Univ Montpellier, IRD, MIVEGEC, IRD 224,CNRS 5290, Montpellier, France.; Moiroux, N (corresponding author), IRSS, Bobo Dioulasso, Burkina Faso.	nicolas.moiroux@ird.fr	Moiroux, Nicolas/AFT-2925-2022; Chandre, Fabrice/Q-3429-2019	Moiroux, Nicolas/0000-0001-6755-6167; Chandre, Fabrice/0000-0002-1994-9705; Pennetier, Cedric/0000-0002-3362-6371; corbel, vincent/0000-0003-0995-3257	WHO	WHO(World Health Organization)	Trials listed in Table 1 and used in the analysis received financial support from WHO. All authors are employed by Institut de Recherche pour le Developpement (IRD). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angioy AM, 2003, CHEM SENSES, V28, P279, DOI 10.1093/chemse/28.4.279; [Anonymous], 2010, R LANG ENV STAT COMP; BAKER TC, 1981, ENVIRON ENTOMOL, V10, P211, DOI 10.1093/ee/10.2.211; Barlow SM, 2001, FOOD CHEM TOXICOL, V39, P407, DOI 10.1016/S0278-6915(00)00152-6; Bhatt S, 2015, NATURE; Bomann W, 1995, BAYER PUBLIC HEALTH, V30, P5; Chandre F, 2000, MED VET ENTOMOL, V14, P81, DOI 10.1046/j.1365-2915.2000.00212.x; Churcher TS, 2016, ELIFE, V5, DOI 10.7554/eLife.16090; Clements AN., 1999, SENSORY RECEPTION BE; Corbel V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-113; Djegbe I, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-261; Durnez L, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P671, DOI 10.5772/55925; Erlanger TE, 2004, MED VET ENTOMOL, V18, P153, DOI 10.1111/j.0269-283X.2004.00491.x; Fanello C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P323; Guha L, 2014, PARASITOL RES, V113, P3781, DOI 10.1007/s00436-014-4044-0; Guyatt HL, 2002, TRENDS PARASITOL, V18, P12, DOI 10.1016/S1471-4922(01)02143-2; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-330; Killeen GF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-207; Lindblade KA, 2005, TROP MED INT HEALTH, V10, P1141, DOI 10.1111/j.1365-3156.2005.01501.x; LINDSAY SW, 1991, MED VET ENTOMOL, V5, P477, DOI 10.1111/j.1365-2915.1991.tb00576.x; Logan JG, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-239; Malima RC, 2009, MED VET ENTOMOL, V23, P317, DOI 10.1111/j.1365-2915.2009.00837.x; Malima RC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-38; Mutuku FM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-46; Ngufor C, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad3270; Ngufor C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-343; Okumu FO, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-46; Okumu FO, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-17; Pennetier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075134; Porciani A, 2016, BIORXIV; Seenivasagan T, 2014, PARASITOL RES, V113, P1927, DOI 10.1007/s00436-014-3840-x; Skaug H, 2012, GLMMADMB GEN LINEAR; Strode C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001619; Takken W, 2002, TROP MED INT HEALTH, V7, P1022, DOI 10.1046/j.1365-3156.2002.00983.x; WHO, 2005, WHOCDSWHOPESGCDPP200; WHO, 2011, GUID MON DUR LONG LA; WHO, 2008, 11 WHOPES WORK GROUP; WHO, 2013, WHOHTMNTDWHOPES20133, P89; WHO, 2014, WHOHTMGMPMPAC20145; WHO Pesticide Evaluation Scheme, 2009, 13 13 WHOPES WORK GR; WHO Pesticide Evaluation Scheme, 2012, 15 WHOPES WORK GROUP; WHO Pesticide Evaluation Scheme, 2011, 14 14 WHOPES WORK GR; WHO Pesticide Evaluation Scheme, 2007, 10 WHOPES WORK GROUP; WHO Pesticide Evaluation Scheme, 2009, 12 WHOPES WORK GROUP; World Health Organization, 2015, WORLD MAL REP 2015, P243; World Health Organization, 2012, GEN RISK ASS MOD INS; World Health Organization, 2016, WHO REC LONG LAST IN	48	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170732	10.1371/journal.pone.0170732	http://dx.doi.org/10.1371/journal.pone.0170732			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129371	Green Published, gold, Green Submitted			2022-12-27	WOS:000396211400043
J	Murphy, CD; Roodvoets, MS; Austen, EJ; Dolan, A; Barnett, A; Campbell, DA				Murphy, Cole D.; Roodvoets, Mitchell S.; Austen, Emily J.; Dolan, Allison; Barnett, Audrey; Campbell, Douglas A.			Photoinactivation of Photosystem II in Prochlorococcus and Synechococcus	PLOS ONE			English	Article							ORANGE CAROTENOID PROTEIN; CHLOROPHYLL-A FLUORESCENCE; SINGLET OXYGEN PRODUCTION; PSBA GENE-EXPRESSION; ELECTRON-TRANSPORT; FLAVODIIRON PROTEINS; EXCITATION PRESSURE; ENERGY-DISSIPATION; ACTION SPECTRUM; UV-RADIATION	The marine picocyanobacteria Synechococcus and Prochlorococcus numerically dominate open ocean phytoplankton. Although evolutionarily related they are ecologically distinct, with different strategies to harvest, manage and exploit light. We grew representative strains of Synechococcus and Prochlorococcus and tracked their susceptibility to photoinactivation of Photosystem II under a range of light levels. As expected blue light provoked more rapid photoinactivation than did an equivalent level of red light. The previous growth light level altered the susceptibility of Synechococcus, but not Prochlorococcus, to this photoinactivation. We resolved a simple linear pattern when we expressed the yield of photoinactivation on the basis of photons delivered to Photosystem II photochemistry, plotted versus excitation pressure upon Photosystem II, the balance between excitation and downstream metabolism. A high excitation pressure increases the generation of reactive oxygen species, and thus increases the yield of photoinactivation of Photosystem II. Blue photons, however, retained a higher baseline photoinactivation across a wide range of excitation pressures. Our experiments thus uncovered the relative influences of the direct photoinactivation of Photosystem II by blue photons which dominates under low to moderate blue light, and photoinactivation as a side effect of reactive oxygen species which dominates under higher excitation pressure. Synechococcus enjoyed a positive metabolic return upon the repair or the synthesis of a Photosystem II, across the range of light levels we tested. In contrast Prochlorococcus only enjoyed a positive return upon synthesis of a Photosystem II up to 400 mu mol photons m(-2) s(-1). These differential cost-benefits probably underlie the distinct photoacclimation strategies of the species.	[Murphy, Cole D.; Roodvoets, Mitchell S.] Mt Allison Univ, Biochem & Chem, Sackville, NB, Canada; [Austen, Emily J.; Dolan, Allison; Campbell, Douglas A.] Mt Allison Univ, Biol, Sackville, NB, Canada; [Barnett, Audrey] Michigan Technol Univ, Houghton, MI 49931 USA	Mount Allison University; Mount Allison University; Michigan Technological University	Campbell, DA (corresponding author), Mt Allison Univ, Biol, Sackville, NB, Canada.	dcampbell@mta.ca	Campbell, Douglas A./B-3768-2010	Campbell, Douglas A./0000-0001-8996-5463; Austen, Emily/0000-0002-0087-1338	Canada Research Chair program; Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; New Brunswick Foundation for Innovation; Mount Allison University; NSERC Canada	Canada Research Chair program(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); New Brunswick Foundation for Innovation; Mount Allison University; NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by the Canada Research Chair program (DC) and the Natural Sciences and Engineering Research Council of Canada (DC), using equipment funded by the Canada Foundation for Innovation and the New Brunswick Foundation for Innovation (DC). CM and MR were supported by summer fellowships from Mount Allison University. EA & AB were supported by NSERC Canada Engage funding to write PSIWORX-R scripts for extracting and analyzing chlorophyll fluorescence induction and relaxation parameters from data generated by PSI Fluorometers, with sponsorship from QuBit Systems, Kingston, Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahverdiyeva Y, 2013, P NATL ACAD SCI USA, V110, P4111, DOI 10.1073/pnas.1221194110; Allakhverdiev SI, 2004, BBA-BIOENERGETICS, V1657, P23, DOI 10.1016/j.bbabio.2004.03.003; Amthor JS, 2000, ANN BOT-LONDON, V86, P1, DOI 10.1006/anbo.2000.1175; ANDERSSON B, 1992, J PHOTOCH PHOTOBIO B, V15, P15, DOI 10.1016/1011-1344(92)87003-R; Bachmann KM, 2004, FUNCT PLANT BIOL, V31, P803, DOI 10.1071/FP04022; Bagby SC, 2015, ISME J, V9, P2232, DOI 10.1038/ismej.2015.36; Bailey S, 2005, FEBS LETT, V579, P275, DOI 10.1016/j.febslet.2004.11.091; Bailey S, 2008, BBA-BIOENERGETICS, V1777, P269, DOI 10.1016/j.bbabio.2008.01.002; Bailey S, 2008, PHOTOCHEM PHOTOBIOL, V84, P1410, DOI 10.1111/j.1751-1097.2008.00453.x; Behrenfeld MJ, 2002, MAR ECOL PROG SER, V228, P103, DOI 10.3354/meps228103; Bennett DIG, 2013, J AM CHEM SOC, V135, P9164, DOI 10.1021/ja403685a; Bersanini L, 2014, PLANT PHYSIOL, V164, P805, DOI 10.1104/pp.113.231969; Blot N, 2011, PLANT PHYSIOL, V156, P1934, DOI 10.1104/pp.111.174714; BORNMAN JF, 1989, J PHOTOCH PHOTOBIO B, V4, P145, DOI 10.1016/1011-1344(89)80001-6; Boulay C, 2008, BBA-BIOENERGETICS, V1777, P1344, DOI 10.1016/j.bbabio.2008.07.002; Bruckner RC, 2003, BIOCHEMISTRY-US, V42, P10843, DOI 10.1021/bi034516h; Campbell D, 1999, PHYSIOL PLANTARUM, V105, P746, DOI 10.1034/j.1399-3054.1999.105420.x; Campbell D, 1998, P NATL ACAD SCI USA, V95, P364, DOI 10.1073/pnas.95.1.364; Campbell D, 1996, PHOTOSYNTH RES, V47, P131, DOI 10.1007/BF00016176; Campbell DA, 2013, PHOTOSYNTH RES, V115, P43, DOI 10.1007/s11120-013-9809-2; Campbell DA, 2012, BBA-BIOENERGETICS, V1817, P258, DOI 10.1016/j.bbabio.2011.04.010; Chow WS, 2012, PHOTOSYNTH RES, V113, P63, DOI 10.1007/s11120-012-9740-y; CRESPI JM, 1986, J STRUCT GEOL, V8, P799, DOI 10.1016/0191-8141(86)90026-X; Croce R, 2011, J PHOTOCH PHOTOBIO B, V104, P142, DOI 10.1016/j.jphotobiol.2011.02.015; Dau H, 2009, ACCOUNTS CHEM RES, V42, P1861, DOI 10.1021/ar900225y; Elzhov TV, 2013, LM R INTERFACE LEVEN; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; Finkel Z., 2007, LIGHT ABSORPTION SIZ, P1; Frank HA, 1996, PHOTOCHEM PHOTOBIOL, V63, P257, DOI 10.1111/j.1751-1097.1996.tb03022.x; GANTT E, 1966, J CELL BIOL, V29, P423, DOI 10.1083/jcb.29.3.423; Gao KS, 2012, NAT CLIM CHANGE, V2, P519, DOI 10.1038/NCLIMATE1507; Gomez-Baena G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003416; Gorbunov MY, 2011, BBA-BIOENERGETICS, V1807, P1591, DOI 10.1016/j.bbabio.2011.08.009; Grossman AR, 2010, J PHYCOL, V46, P629, DOI 10.1111/j.1529-8817.2010.00852.x; Hachiya T, 2007, PLANT CELL ENVIRON, V30, P1269, DOI 10.1111/j.1365-3040.2007.01701.x; Hakala M, 2005, BBA-BIOENERGETICS, V1706, P68, DOI 10.1016/j.bbabio.2004.09.001; Herranen M, 2001, PHYSIOL PLANTARUM, V112, P531, DOI 10.1034/j.1399-3054.2001.1120410.x; HOFF AJ, 1981, Q REV BIOPHYS, V14, P599, DOI 10.1017/S0033583500002481; Huner GP, 1996, TRENDS PLANT SCI, V3, P224; Imre V, 2011, PHYSIOL PLANTARUM, V142, P6, DOI 10.1111/j.1399-3054.2011.01454.x; JUNG J, 1990, PHOTOCHEM PHOTOBIOL, V52, P1003, DOI 10.1111/j.1751-1097.1990.tb01817.x; KATZ JJ, 1978, ANNU REV BIOPHYS BIO, V7, P393, DOI 10.1146/annurev.bb.07.060178.002141; Key T, 2010, ENVIRON MICROBIOL, V12, P95, DOI 10.1111/j.1462-2920.2009.02046.x; Kirilovsky D, 2015, PHOTOSYNTH RES, V126, P3, DOI 10.1007/s11120-014-0031-7; Kirilovsky D, 2013, PHOTOCH PHOTOBIO SCI, V12, P1135, DOI 10.1039/c3pp25406b; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Komenda J, 2006, J BIOL CHEM, V281, P1145, DOI 10.1074/jbc.M503852200; Komenda J, 2007, PLANT CELL, V19, P2839, DOI 10.1105/tpc.107.053868; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Krieger-Liszkay A, 2005, J EXP BOT, V56, P337, DOI 10.1093/jxb/erh237; Krieger-Liszkay A, 2008, PHOTOSYNTH RES, V98, P551, DOI 10.1007/s11120-008-9349-3; LaRoche J, 1996, P NATL ACAD SCI USA, V93, P15244; LEY AC, 1982, BIOCHIM BIOPHYS ACTA, V680, P95, DOI 10.1016/0005-2728(82)90320-6; Li G, 2015, NEW PHYTOL, V205, P533, DOI 10.1111/nph.13037; Llabres M, 2006, LIMNOL OCEANOGR, V51, P21, DOI 10.4319/lo.2006.51.1.0021; Llabres M, 2010, AQUAT MICROB ECOL, V59, P151, DOI 10.3354/ame01392; Loebl M, 2010, LIMNOL OCEANOGR, V55, P2150, DOI 10.4319/lo.2010.55.5.2150; Mackey KRM, 2013, PLANT PHYSIOL, V163, P815, DOI 10.1104/pp.113.221937; MAUZERALL D, 1989, BIOCHIM BIOPHYS ACTA, V974, P119, DOI 10.1016/S0005-2728(89)80365-2; MAXWELL DP, 1995, PLANT PHYSIOL, V107, P687, DOI 10.1104/pp.107.3.687; MAYES SR, 1991, BIOCHIM BIOPHYS ACTA, V1060, P1, DOI 10.1016/S0005-2728(05)80112-4; Mella-Flores D, 2012, FRONT MICROBIOL, V3; Miyata K, 2012, PHOTOSYNTH RES, V113, P165, DOI 10.1007/s11120-012-9767-0; MOORE LR, 1995, MAR ECOL PROG SER, V116, P259, DOI 10.3354/meps116259; Moore LR, 2002, LIMNOL OCEANOGR, V47, P989, DOI 10.4319/lo.2002.47.4.0989; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Murphy CD, 2017, LIMNOL OCEANOGR-METH, V15, P54, DOI 10.1002/lom3.10142; Mustila H, 2016, PLANT CELL PHYSIOL, V57, P1468, DOI 10.1093/pcp/pcw047; Neale PJ, 2014, BIOGEOSCIENCES, V11, P2883, DOI 10.5194/bg-11-2883-2014; Neale PJ, 2016, GLOBAL CHANGE BIOLOG; Ni G, 2016, PHOTOSYNTHESIS RES; Nishiyama Y, 2005, PHOTOSYNTH RES, V84, P1, DOI 10.1007/s11120-004-6434-0; Nishiyama Y, 2014, APPL MICROBIOL BIOT, P1; Nishiyama Y, 2006, BBA-BIOENERGETICS, V1757, P742, DOI 10.1016/j.bbabio.2006.05.013; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; Noguchi K, 2001, PLANT CELL ENVIRON, V24, P831, DOI 10.1046/j.1365-3040.2001.00728.x; Not F, 2005, LATE SUMMER COMMUNIT; Oguchi R, 2011, PHYSIOL PLANTARUM, V142, P47, DOI 10.1111/j.1399-3054.2011.01452.x; Ohnishi N, 2005, BIOCHEMISTRY-US, V44, P8494, DOI 10.1021/bi047518q; Oliver RL, 2003, J PLANKTON RES, V25, P1107, DOI 10.1093/plankt/25.9.1107; Oxborough K, 1997, PHOTOSYNTH RES, V54, P1997, DOI DOI 10.1023/A:1005936823310; Park YI, 1997, PLANT PHYSIOL, V115, P151, DOI 10.1104/pp.115.1.151; Park YI, 1996, PHOTOSYNTH RES, V50, P23, DOI 10.1007/BF00018218; Partensky F., 1999, B I OCEANOGRAPHIQUE, V19, P457; Paulsen ML, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00191; PENNINGDEVRIES FWT, 1975, ANN BOT-LONDON, V39, P77; Pessarakli M., 2005, HDB PHOTOSYNTHESIS; R Core Team, 2013, R LANG ENV STAT COMP; Rappaport F, 2002, BIOCHEMISTRY-US, V41, P8518, DOI 10.1021/bi025725p; RAVEN JA, 1984, NEW PHYTOL, V98, P593, DOI 10.1111/j.1469-8137.1984.tb04152.x; Raven JA, 2011, PHYSIOL PLANTARUM, V142, P87, DOI 10.1111/j.1399-3054.2011.01465.x; REDLINGER T, 1982, P NATL ACAD SCI-BIOL, V79, P5542, DOI 10.1073/pnas.79.18.5542; Renger G, 2011, J PHOTOCH PHOTOBIO B, V104, P35, DOI 10.1016/j.jphotobiol.2011.01.023; Rinalducci S, 2004, BBA-BIOENERGETICS, V1608, P63, DOI 10.1016/j.bbabio.2003.10.009; Rippka R, 2000, INT J SYST EVOL MICR, V50, P1833, DOI 10.1099/00207713-50-5-1833; Rova EM, 1996, J BIOL CHEM, V271, P28918, DOI 10.1074/jbc.271.46.28918; Santabarbara S, 2002, PHOTOCHEM PHOTOBIOL, V75, P613, DOI 10.1562/0031-8655(2002)075<0613:PIVAIV>2.0.CO;2; Scanlan DJ, 2003, ADV MICROBIAL PHYSL, P1; SCHATZ GH, 1988, BIOPHYS J, V54, P397, DOI 10.1016/S0006-3495(88)82973-4; Schuback N, 2016, BIOGEOSCIENCES, V13, P1019, DOI 10.5194/bg-13-1019-2016; Schweitzer C, 2003, CHEM REV, V103, P1685, DOI 10.1021/cr010371d; Sicora CI, 2006, BBA-BIOENERGETICS, V1757, P47, DOI 10.1016/j.bbabio.2005.11.002; Sinclair J, 1996, PHOTOSYNTH RES, V50, P33, DOI 10.1007/BF00018219; Six C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001341; Suggett DJ, 2010, DEVEL APPL PHYCOL, V4, P103, DOI 10.1007/978-90-481-9268-7_6; Suggett DJ, 2009, AQUAT MICROB ECOL, V56, P147, DOI 10.3354/ame01303; Ting CS, 2002, TRENDS MICROBIOL, V10, P134, DOI 10.1016/S0966-842X(02)02319-3; Tyystjarvi E, 2008, COORDIN CHEM REV, V252, P361, DOI 10.1016/j.ccr.2007.08.021; Tyystjarvi E, 1996, P NATL ACAD SCI USA, V93, P2213, DOI 10.1073/pnas.93.5.2213; Tyystjarvi E, 2013, INT REV CEL MOL BIO, V300, P243, DOI 10.1016/B978-0-12-405210-9.00007-2; Tyystjarvi T, 1998, FEBS LETT, V436, P483, DOI 10.1016/S0014-5793(98)01181-8; Tyystjarvi T, 1996, PHOTOSYNTH RES, V47, P111, DOI 10.1007/BF00016174; Tyystjarvi T, 2002, FEBS LETT, V516, P167, DOI 10.1016/S0014-5793(02)02537-1; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; VANMIEGHEM F, 1995, BIOCHEMISTRY-US, V34, P4798, DOI 10.1021/bi00014a038; VANMIEGHEM FJE, 1989, BIOCHIM BIOPHYS ACTA, V977, P207, DOI 10.1016/S0005-2728(89)80073-8; VASS I, 1992, P NATL ACAD SCI USA, V89, P1408, DOI 10.1073/pnas.89.4.1408; Vass I, 2012, BBA-BIOENERGETICS, V1817, P209, DOI 10.1016/j.bbabio.2011.04.014; Vass I, 2009, TRENDS PLANT SCI, V14, P200, DOI 10.1016/j.tplants.2009.01.009; VASSILIEV IR, 1994, PHOTOSYNTH RES, V42, P51, DOI 10.1007/BF00019058; Wang WL, 2005, J PHYCOL, V41, P685, DOI 10.1111/j.1529-8817.2005.00089.x; Ware MA, 2015, PHOTOSYNTH RES, V126, P261, DOI 10.1007/s11120-015-0102-4; Wiethaus J, 2010, EUR J CELL BIOL, V89, P1005, DOI 10.1016/j.ejcb.2010.06.017; Wilson A, 2006, PLANT CELL, V18, P992, DOI 10.1105/tpc.105.040121; Wu HY, 2011, PLANT PHYSIOL, V156, P2184, DOI 10.1104/pp.111.178772; Zavafer A, 2015, J PHOTOCH PHOTOBIO B, V152, P247, DOI 10.1016/j.jphotobiol.2015.08.007; Zerihun A, 1998, NEW PHYTOL, V138, P1, DOI 10.1046/j.1469-8137.1998.00893.x; Zhang PP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005331; Zorz Jackie K., 2015, Life-Basel, V5, P403, DOI 10.3390/life5010403; Zwirglmaier K, 2008, ENVIRON MICROBIOL, V10, P147, DOI 10.1111/j.1462-2920.2007.01440.x	132	21	22	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0168991	10.1371/journal.pone.0168991	http://dx.doi.org/10.1371/journal.pone.0168991			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129341	Green Published, Green Submitted, gold			2022-12-27	WOS:000396211400072
J	Cataldo, LR; Mizgier, ML; Sagua, RB; Jana, F; Cardenas, C; Llanos, P; Busso, D; Olmos, P; Galgani, JAE; Santos, JAL; Cortes, VA				Rodrigo Cataldo, Luis; Mizgier, Maria L.; Bravo Sagua, Roberto; Jana, Fabian; Cardenas, Cesar; Llanos, Paola; Busso, Dolores; Olmos, Pablo; Galgani, Jose A. E.; Santos, Jose A. L.; Cortes, Victor A.			Prolonged Activation of the Htr2b Serotonin Receptor Impairs Glucose Stimulated Insulin Secretion and Mitochondrial Function in MIN6 Cells	PLOS ONE			English	Article							PANCREATIC BETA-CELL; 5-HYDROXYTRYPTAMINE; PGC-1-ALPHA; RELEASE; MOUSE; METABOLISM; ISLETS; LINE; RAT; OVEREXPRESSION	Aims Pancreatic beta-cells synthesize and release serotonin (5 hydroxytryptamine, 5HT); however, the role of 5HT receptors on glucose stimulated insulin secretion (GSIS) and the mechanisms mediating this function is not fully understood. The aims of this study were to determine the expression profile of 5HT receptors in murine MIN6 beta-cells and to examine the effects of pharmacological activation of 5HT receptor Htr2b on GSIS and mitochondrial function. Materials and Methods mRNA levels of 5HT receptors in MIN6 cells were quantified by RT qPCR. GSIS was assessed in MIN6 cells in response to global serotonergic activation with 5HT and pharmacological Htr2b activation or inhibition with BW723C86 or SB204741, respectively. In response to Htr2b activation also was evaluated the mRNA and protein levels of PGC1 alpha and PPARy by RT-qPCR and western blotting and mitochondrial function by oxygen consumption rate (OCR) and ATP cellular content. Results We found that mRNA levels of most 5HT receptors were either very low or undetectable in MIN6 cells. By contrast, Htr2b mRNA was present at moderate levels in these cells. Preincubation (6 h) of MIN6 cells with 5HT or BW723C86 reduced GSIS and the effect of 5HT was prevented by SB204741. Preincubation with BW723C86 increased PGC1a and PPARy mRNA and protein levels and decreased mitochondrial respiration and ATP content in MIN6 cells. Conclusions Our results indicate that prolonged Htr2b activation in murine beta-cells decreases glucose-stimulated insulin secretion and mitochondrial activity by mechanisms likely dependent on enhanced PGC1 alpha/PPARy expression.	[Rodrigo Cataldo, Luis; Mizgier, Maria L.; Busso, Dolores; Olmos, Pablo; Galgani, Jose A. E.; Santos, Jose A. L.; Cortes, Victor A.] Pontificia Univ Catolica Chile, Sch Med, Dept Nutr Diabet & Metab, Santiago, Chile; [Bravo Sagua, Roberto] Univ Chile, Inst Nutr & Food Technol INTA, Santiago, Chile; [Jana, Fabian; Cardenas, Cesar] Univ Chile, Inst Biomed Sci, Anat & Dev Biol Program, Santiago, Chile; [Cardenas, Cesar] Gerosci Ctr Brain Hlth & Metab, Santiago, Chile; [Cardenas, Cesar] Buck Inst Res Aging, Novato, CA USA; [Olmos, Pablo] Univ Chile, Inst Res Dent Sci, Sch Odontol, Santiago, Chile; [Galgani, Jose A. E.] Pontificia Univ Catolica Chile, Sch Med, Nutr & Dietet Program, UDA Hlth Sci, Santiago, Chile	Pontificia Universidad Catolica de Chile; Universidad de Chile; Universidad de Chile; Buck Institute for Research on Aging; Universidad de Chile; Pontificia Universidad Catolica de Chile	Cortes, VA (corresponding author), Pontificia Univ Catolica Chile, Sch Med, Dept Nutr Diabet & Metab, Santiago, Chile.	vcortes@med.puc.cl	Busso, Dolores/K-7375-2012; Mizgier, Maria/AAU-7804-2021; Bravo-Sagua, Roberto/K-1103-2018; Bravo-Sagua, Roberto/AAG-1245-2019; Jaña, Fabián/D-9364-2017; Busso, Dolores/AAF-2568-2020; Santos, Jose Luis/D-1818-2017	Busso, Dolores/0000-0003-2113-1926; Bravo-Sagua, Roberto/0000-0001-8873-8699; Bravo-Sagua, Roberto/0000-0001-8873-8699; Jaña, Fabián/0000-0001-7786-4569; Cortes, Victor/0000-0002-1658-0965; Santos, Jose Luis/0000-0003-2895-0369; Mizgier, Maria Luisa/0000-0002-6396-8823; CATALDO, LUIS RODRIGO/0000-0003-1225-414X; Llanos, Paola/0000-0003-1383-7961	Fondo Nacional de Desarrollo Cientifico y Tecnologico [1141134, 1120586, 1120443, 1160332, 1130217]; Fondo de financiamiento de Centros de Investigacion en Areas Prioritarias [15150012]; Comision Nacional de Investigacion en Ciencia y Tecnologia [21140087, 3160226, 3140458]	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondo de financiamiento de Centros de Investigacion en Areas Prioritarias; Comision Nacional de Investigacion en Ciencia y Tecnologia	This research was funded by "Fondo Nacional de Desarrollo Cientifico y Tecnologico" grants; 1141134 (VC), 1120586 (JLS), 1120443 (CC), 1160332 (CC), 1130217 (JEG). "Fondo de financiamiento de Centros de Investigacion en Areas Prioritarias" grant 15150012 (CC). "Comision Nacional de Investigacion en Ciencia y Tecnologia"; doctoral scholarship 21140087 (LRC), postdoctoral fellowship 3160226 (RBS), postdoctoral fellowship 3140458 (FJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amireault P, 2013, ACS CHEM NEUROSCI, V4, P64, DOI 10.1021/cn300154j; BARRADAS MA, 1988, EUR J CLIN INVEST, V18, P399, DOI 10.1111/j.1365-2362.1988.tb01030.x; Bennet H, 2016, DIABETOLOGIA; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Besseiche A, 2015, DIABETES METABOLISM; Cataldo LR, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/3793781; Cataldo LR, 2015, EXP CLIN ENDOCR DIAB, V123, P473, DOI 10.1055/s-0035-1549964; Dalboge LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082813; El-Merahbi R, 2015, FEBS LETT, V589, P1728, DOI 10.1016/j.febslet.2015.05.054; FELDMAN JM, 1972, J CLIN ENDOCR METAB, V35, P307, DOI 10.1210/jcem-35-2-307; FELDMAN JM, 1970, ENDOCRINOLOGY, V86, P66; Fukui M, 2012, DIABETES CARE, V35, P163, DOI 10.2337/dc11-1619; Ho JE, 2013, DIABETES, V62, P2689, DOI 10.2337/db12-0754; HOYER D, 1994, PHARMACOL REV, V46, P157; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; Kim K, 2014, ENDOCRINOLOGY; Kohler M, 1998, FEBS LETT, V441, P97, DOI 10.1016/S0014-5793(98)01539-7; Kulkarni RN, 1997, J CLIN INVEST, V100, P2729, DOI 10.1172/JCI119818; KURSAR JD, 1992, MOL PHARMACOL, V42, P549; LERNMARK A, 1971, HORM METAB RES, V3, P305, DOI 10.1055/s-0028-1094131; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Ling C, 2008, DIABETOLOGIA, V51, P615, DOI 10.1007/s00125-007-0916-5; LUNDQUIST I, 1971, DIABETOLOGIA, V7, P414, DOI 10.1007/BF01212056; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nakamichi Y, 2003, BIOCHEM BIOPH RES CO, V306, P832, DOI 10.1016/S0006-291X(03)01045-3; Nebigil CG, 2003, CIRCULATION, V107, P3223, DOI 10.1161/01.CIR.0000074224.57016.01; Nile DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115433; Oberkofler H, 2004, DIABETES, V53, P1385, DOI 10.2337/diabetes.53.5.1385; Ohara-Imaizumi M, 2013, P NATL ACAD SCI USA, V110, P19420, DOI 10.1073/pnas.1310953110; Ohta Y, 2011, DIABETES, V60, P3208, DOI 10.2337/db10-1192; Oropeza D, 2015, MOL METAB, V4, P811, DOI 10.1016/j.molmet.2015.08.001; Patane G, 2002, DIABETES, V51, P2749, DOI 10.2337/diabetes.51.9.2749; Paulmann N, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000229; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rasbach KA, 2010, J PHARMACOL EXP THER, V332, P632, DOI 10.1124/jpet.109.159947; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; SIREK A, 1970, CAN MED ASSOC J, V102, P846; Soejima A, 1996, J BIOL CHEM, V271, P26194, DOI 10.1074/jbc.271.42.26194; Sumara G, 2012, CELL METAB, V16, P588, DOI 10.1016/j.cmet.2012.09.014; Tsuruzoe K, 1998, DIABETES, V47, P621, DOI 10.2337/diabetes.47.4.621; Valtat B, 2012, DIABETES; Yoon JC, 2003, DEV CELL, V5, P73, DOI 10.1016/S1534-5807(03)00170-9; Zawalich WS, 2004, ENDOCRINE, V23, P11, DOI 10.1385/ENDO:23:1:11; Zawalich WS, 1996, PFLUG ARCH EUR J PHY, V432, P589, DOI 10.1007/s004240050174; Zhang Q, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054250, 10.1371/journal.pone.0059667]	46	15	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170213	10.1371/journal.pone.0170213	http://dx.doi.org/10.1371/journal.pone.0170213			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129327	Green Published, gold, Green Submitted			2022-12-27	WOS:000396211400061
J	Wang, B; Jin, HY; Li, Q; Chen, DD; Zhao, L; Tang, YH; Kato, T; Gu, S				Wang, Bin; Jin, Haiyan; Li, Qi; Chen, Dongdong; Zhao, Liang; Tang, Yanhong; Kato, Tomomichi; Gu, Song			Diurnal and Seasonal Variations in the Net Ecosystem CO2 Exchange of a Pasture in the Three-River Source Region of the Qinghai-Tibetan Plateau	PLOS ONE			English	Article							CARBON-DIOXIDE EXCHANGE; PERENNIAL GRASS MIXTURES; LEYMUS-CHINENSIS STEPPE; WATER-VAPOR EXCHANGE; ALPINE MEADOW; INNER-MONGOLIA; SOIL-TYPE; FLUXES; TEMPERATURE; ATMOSPHERE	Carbon dioxide (CO2) exchange between the atmosphere and grassland ecosystems is very important for the global carbon balance. To assess the CO2 flux and its relationship to environmental factors, the eddy covariance method was used to evaluate the diurnal cycle and seasonal pattern of the net ecosystem CO2 exchange (NEE) of a cultivated pasture in the Three-River Source Region (TRSR) on the Qinghai-Tibetan Plateau from January 1 to December 31, 2008. The diurnal variations in the NEE and ecosystem respiration (R-e) during the growing season exhibited single-peak patterns, the maximum and minimum CO2 uptake observed during the noon hours and night; and the maximum and minimum R-e took place in the afternoon and early morning, respectively. The minimum hourly NEE rate and the maximum hourly R-e rate were -7.89 and 5.03 mu mol CO2 m(-2) s(-1), respectively. The NEE and R-e showed clear seasonal variations, with lower values in winter and higher values in the peak growth period. The highest daily values for C uptake and R-e were observed on August 12 (-2.91 g C m(-2) d(-1)) and July 28 (5.04 g C m(-2) day(-1)), respectively. The annual total NEE and R-e were -140.01 and 403.57 g C m(-2) year(-1), respectively. The apparent quantum yield (alpha) was -0.0275 mu mol mu mol(-1) for the entire growing period, and the alpha values for the pasture's light response curve varied with the leaf area index (LAI), air temperature (T-a), soil water content (SWC) and vapor pressure deficit (VPD). Piecewise regression results indicated that the optimum T-a and VPD for the daytime NEE were 14.1 degrees C and 0.65 kPa, respectively. The daytime NEE decreased with increasing SWC, and the temperature sensitivity of respiration (Q(10)) was 3.0 during the growing season, which was controlled by the SWC conditions. Path analysis suggested that the soil temperature at a depth of 5 cm (T-soil) was the most important environmental factor affecting daily variations in NEE during the growing season, and the photosynthetic photon flux density (PPFD) was the major limiting factor for this cultivated pasture.	[Wang, Bin; Jin, Haiyan] State Ocean Adm, Inst Oceanog 2, Key Lab Marine Ecosyst & Biogeochem, Hangzhou, Zhejiang, Peoples R China; [Wang, Bin] Qiqihar Univ, Coll Life Sci & Agr & Forestry, Qiqihar, Peoples R China; [Li, Qi; Chen, Dongdong; Zhao, Liang] Chinese Acad Sci, Northwest Plateau Inst Biol, Xining, Peoples R China; [Tang, Yanhong] Natl Inst Environm Studies, Tsukuba, Ibaraki, Japan; [Kato, Tomomichi] Univ Tsukuba, Doctoral Program Biol Sci, Tsukuba, Ibaraki, Japan; [Gu, Song] Nankai Univ, Coll Life Sci, Tianjin, Peoples R China	State Oceanic Administration; Qiqihar University; Chinese Academy of Sciences; Northwest Institute of Plateau Biology, CAS; National Institute for Environmental Studies - Japan; University of Tsukuba; Nankai University	Wang, B (corresponding author), State Ocean Adm, Inst Oceanog 2, Key Lab Marine Ecosyst & Biogeochem, Hangzhou, Zhejiang, Peoples R China.; Wang, B (corresponding author), Qiqihar Univ, Coll Life Sci & Agr & Forestry, Qiqihar, Peoples R China.; Gu, S (corresponding author), Nankai Univ, Coll Life Sci, Tianjin, Peoples R China.	wbin03@sina.com; songgu@nankai.edu.cn	Zhao, Liang/T-9147-2019; Li, Qi/H-4374-2011; Kato, Tomomichi/X-7390-2019	Kato, Tomomichi/0000-0003-3757-3243; Li, Qi/0000-0001-5168-2492; Tang, Yanhong/0000-0001-7207-1965	National Natural Science Foundation of China [31570478]; State's Key Project of Research and Development Plan [2016YFC0501905]; Scientific Research Fund of the Second Institute of Oceanography, SOA [JG1506]; State Key Laboratory of the Grassland Agro-ecosystems Open Projects Fund [SKLGAE201506]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State's Key Project of Research and Development Plan; Scientific Research Fund of the Second Institute of Oceanography, SOA; State Key Laboratory of the Grassland Agro-ecosystems Open Projects Fund	This study was supported by the National Natural Science Foundation of China (31570478), the State's Key Project of Research and Development Plan (2016YFC0501905), the Scientific Research Fund of the Second Institute of Oceanography, SOA under contract No. JG1506 and the State Key Laboratory of the Grassland Agro-ecosystems Open Projects Fund (SKLGAE201506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Natural Science Foundation of China (31570478), the State's Key Project of Research and Development Plan (2016YFC0501905), the Scientific Research Fund of the Second Institute of Oceanography, SOA under contract No. JG1506 and the State Key Laboratory of the Grassland Agro-ecosystems Open Projects Fund (SKLGAE201506).	ADAMS JM, 1990, NATURE, V348, P711, DOI 10.1038/348711a0; BALDOCCHI DD, 1995, PLANT CELL ENVIRON, V18, P1157, DOI 10.1111/j.1365-3040.1995.tb00626.x; Chen GM, 2005, SICHUAN CAOYUAN, V10, P37; Dong SK, 2012, SOIL SCI SOC AM J, V76, P2256, DOI 10.2136/sssaj2012.0092; Dong SK, 2010, AFR J AGR RES, V5, P3542; Dong SK, 2005, WEED RES, V45, P114, DOI 10.1111/j.1365-3180.2004.00440.x; Dong SK, 2004, GRASS FORAGE SCI, V59, P298, DOI 10.1111/j.1365-2494.2004.00429.x; Falge E, 2001, AGR FOREST METEOROL, V107, P43, DOI 10.1016/S0168-1923(00)00225-2; Fang C, 2001, SOIL BIOL BIOCHEM, V33, P155, DOI 10.1016/S0038-0717(00)00125-5; Feiziene D, 2012, ACTA AGR SCAND B-S P, V62, P311, DOI 10.1080/09064710.2011.614272; Feng S., 1998, CHINESE SCI BULL, V43, P633, DOI 10.1360/csb1998-43-6-633; Fu Y, 2009, BIOGEOSCIENCES, V6, P2879, DOI 10.5194/bg-6-2879-2009; Fu YL, 2006, AGR FOREST METEOROL, V137, P234, DOI 10.1016/j.agrformet.2006.02.009; Gao X.S., 2006, JOURNAL OF QINGHAI U, V5, P37; Gu S, 2005, PHYTON-ANN REI BOT A, V45, P361; Gu S, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003584; Ham JM, 1998, AGR FOREST METEOROL, V89, P1, DOI 10.1016/S0168-1923(97)00062-2; Hao YB, 2006, SCI CHINA SER D, V49, P186, DOI 10.1007/s11430-006-8186-5; Hunt JE, 2002, AGR FOREST METEOROL, V111, P65, DOI 10.1016/S0168-1923(02)00006-0; Huxman TE, 2003, OECOLOGIA, V134, P537, DOI 10.1007/s00442-002-1131-1; Kang XC, 1996, J GLACIOL GEOCRYOL S, V18, P281; Kato T, 2004, AGR FOREST METEOROL, V124, P121, DOI 10.1016/j.agrformet.2003.12.008; Kato T, 2008, GLOBAL CHANGE BIOL, V14, P2333, DOI 10.1111/j.1365-2486.2008.01646.x; Kato T, 2006, GLOBAL CHANGE BIOL, V12, P1285, DOI 10.1111/j.1365-2486.2006.01153.x; KURAHOTTA M, 1987, PLANT CELL PHYSIOL, V28, P1321; Li SG, 2005, GLOBAL CHANGE BIOL, V11, P1941, DOI 10.1111/j.1365-2486.2005.01047.x; Li YY, 2015, SOIL BIOL BIOCHEM, V80, P306, DOI 10.1016/j.soilbio.2014.10.026; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; McFadden JP, 2003, ECOLOGY, V84, P2762, DOI 10.1890/01-0444; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Novick KA, 2004, OECOLOGIA, V138, P259, DOI 10.1007/s00442-003-1388-z; OGREN E, 1993, PLANT PHYSIOL, V101, P1013, DOI 10.1104/pp.101.3.1013; Polley HW, 2006, GLOBAL CHANGE BIOL, V12, P1390, DOI 10.1111/j.1365-2486.2006.01187.x; POTVIN C, 1986, OECOLOGIA, V69, P499, DOI 10.1007/BF00410354; Reichstein M, 2002, GLOBAL CHANGE BIOL, V8, P999, DOI 10.1046/j.1365-2486.2002.00530.x; Saito M, 2009, GLOBAL CHANGE BIOL, V15, P221, DOI 10.1111/j.1365-2486.2008.01713.x; SCHULZE ED, 1995, ECOPHYSIOLOGY PHOTOS; Shi PL, 2006, SCI CHINA SER D, V49, P207, DOI 10.1007/s11430-006-8207-4; Souza RP, 2004, ENVIRON EXP BOT, V51, P45, DOI 10.1016/S0098-8472(03)00059-5; Su XK, 2015, J MT SCI-ENGL, V12, P582, DOI 10.1007/s11629-014-3043-z; Wan SQ, 2009, ECOLOGY, V90, P2700, DOI 10.1890/08-2026.1; Wang Q. J., 2005, J LANZHOU U, V41, P1; Wang YF, 2011, SCI TOTAL ENVIRON, V410, P182, DOI 10.1016/j.scitotenv.2011.09.067; Wang YL, 2008, AGR FOREST METEOROL, V148, P714, DOI 10.1016/j.agrformet.2008.01.013; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; Wilson K, 2002, AGR FOREST METEOROL, V113, P223, DOI 10.1016/S0168-1923(02)00109-0; Wohlfahrt G, 2008, ECOSYSTEMS, V11, P1338, DOI 10.1007/s10021-008-9196-2; Wu GL, 2010, PLANT SOIL, V333, P469, DOI 10.1007/s11104-010-0363-9; Xie ZB, 2007, GLOBAL CHANGE BIOL, V13, P1989, DOI 10.1111/j.1365-2486.2007.01409.x; Xu LK, 2004, AGR FOREST METEOROL, V123, P79, DOI 10.1016/j.agrformet.2003.10.004; Yang FL, 2011, AGR ECOSYST ENVIRON, V142, P318, DOI 10.1016/j.agee.2011.05.032; Zhao Liang, 2008, Zhiwu Shengtai Xuebao, V32, P544, DOI 10.3773/j.issn.1005-264x.2008.03.003; Zhao L, 2006, GLOBAL CHANGE BIOL, V12, P1940, DOI 10.1111/j.1365-2486.2006.01197.x; Zheng ZM, 2009, SOIL BIOL BIOCHEM, V41, P1531, DOI 10.1016/j.soilbio.2009.04.013; Zhou X, 2007, GLOBAL CHANGE BIOL, V13, P761, DOI 10.1111/j.1365-2486.2007.01333.x	55	11	11	11	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170963	10.1371/journal.pone.0170963	http://dx.doi.org/10.1371/journal.pone.0170963			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129406	Green Published, Green Submitted, gold			2022-12-27	WOS:000396211400020
J	Gazarian, KG; Ramirez-Garcia, LR				Gazarian, Karlen G.; Ramirez-Garcia, Luis R.			Human Deciduous Teeth Stem Cells (SHED) Display Neural Crest Signature Characters	PLOS ONE			English	Article							HUMAN DENTAL-PULP; PERIODONTAL-LIGAMENT; IN-VITRO; DIRECTED DIFFERENTIATION; GROWTH-FACTORS; IDENTIFICATION; TRANSITION; MIGRATION	Human dental tissues are sources of neural crest origin multipotent stem cells whose regenerative potential is a focus of extensive studies. Rational programming of clinical applications requires a more detailed knowledge of the characters inherited from neural crest. Investigation of neural crest cells generated from human pluripotent stem cells provided opportunity for their comparison with the postnatal dental cells. The purpose of this study was to investigate the role of the culture conditions in the expression by dental cells of neural crest characters. The results of the study demonstrate that specific neural crest cells requirements, serum-free, active WNT signaling and inactive SMAD 2/3, are needed for the activity of the neural crest characters in dental cells. Specifically, the decreasing concentration of fetal bovine serum (FBS) from regularly used for dental cells 10% to 2% and below, or using serum-free medium, led to emergence of a subset of epithelial-like cells expressing the two key neural crest markers, p75 and HNK-1. Further, the serum-free medium supplemented with neural crest signaling requirements (WNT inducer BIO and TGF-beta inhibitor REPSOX), induced epithelial-like phenotype, upregulated the p75, Sox10 and E-Cadherin and downregulated the mesenchymal genes (SNAIL1, ZEB1, TWIST). An expansion medium containing 2% FBS allowed to obtain an epithelial/mesenchymal SHED population showing high proliferation, clonogenic, multi-lineage differentiation capacities. Future experiments will be required to determine the effects of these features on regenerative potential of this novel SHED population.	[Gazarian, Karlen G.; Ramirez-Garcia, Luis R.] Mexican Natl Autonomous Univ, Dept Med Genom & Environm Tox, Inst Biomed Res, Univ Campus, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico	Gazarian, KG (corresponding author), Mexican Natl Autonomous Univ, Dept Med Genom & Environm Tox, Inst Biomed Res, Univ Campus, Mexico City, DF, Mexico.	karlen@unam.mx			Mexican Autonomous National University Fund D.G.A.P.A. [IT200313]	Mexican Autonomous National University Fund D.G.A.P.A.	This work was supported by Mexican Autonomous National University Fund D.G.A.P.A. (Grant # IT200313). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez R, 2015, INT J ORAL SCI, V7, P213, DOI 10.1038/ijos.2015.42; Alvarez R, 2015, INT J ORAL SCI, V7, P205, DOI 10.1038/ijos.2015.29; Baggiolini A, 2015, CELL STEM CELL, V16, P314, DOI 10.1016/j.stem.2015.02.017; Ballini A, 2007, INT J IMMUNOPATH PH, V20, P9, DOI 10.1177/039463200702000102; Betters E, 2010, DEV BIOL, V344, P578, DOI 10.1016/j.ydbio.2010.05.012; Briana DD, 2012, CYTOKINE, V60, P157, DOI 10.1016/j.cyto.2012.06.005; BRONNERFRASER M, 1986, DEV BIOL, V115, P44, DOI 10.1016/0012-1606(86)90226-5; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chen FM, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0288-1; Cimadamore F, 2011, CELL STEM CELL, V8, P538, DOI 10.1016/j.stem.2011.03.011; Cordero DR, 2011, AM J MED GENET A, V155A, P270, DOI 10.1002/ajmg.a.33702; Curchoe CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013890; d'Aquino R, 2008, STEM CELL REV, V4, P21, DOI 10.1007/s12015-008-9013-5; d'Aquino R, 2011, EUR CELLS MATER, V21, P304, DOI 10.22203/eCM.v021a23; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dupin E, 2003, P NATL ACAD SCI USA, V100, P5229, DOI 10.1073/pnas.0831229100; Dupin E, 2007, CR BIOL, V330, P521, DOI 10.1016/j.crvi.2007.04.004; Dupin Elisabeth, 2011, Biologie Aujourd hui, V205, P53, DOI 10.1051/jbio/2011008; Estrela Carlos, 2011, Braz. Dent. J., V22, P91, DOI 10.1590/S0103-64402011000200001; Giovannone D, 2015, ACTA HISTOCHEM, V117, P255, DOI 10.1016/j.acthis.2015.03.002; Gong SG, 2014, EXP CELL RES, V325, P90, DOI 10.1016/j.yexcr.2014.03.015; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Hynes K, 2014, STEM CELLS DEV, V23, P1084, DOI 10.1089/scd.2013.0111; Iwata K, 2012, BIOMATERIALS, V33, P444, DOI 10.1016/j.biomaterials.2011.09.056; Jaroonwitchawan T, 2016, BIOCHEM BIOPH RES CO, V481, P176, DOI 10.1016/j.bbrc.2016.10.147; Jeon M, 2014, ARCH ORAL BIOL, V59, P1013, DOI 10.1016/j.archoralbio.2014.06.002; Kaku M, 2012, ARCH ORAL BIOL, V57, P1668, DOI 10.1016/j.archoralbio.2012.04.022; Kashyap R, 2015, J CLIN DIAGN RES, V9, pZE07, DOI 10.7860/JCDR/2015/9871.5636; Kelsh RN, 2006, BIOESSAYS, V28, P788, DOI 10.1002/bies.20445; La Noce M, 2014, EUR CELLS MATER, V28, P348, DOI 10.22203/eCM.v028a24; Le Douarin NM, 2008, CELL CYCLE, V7, P1013, DOI 10.4161/cc.7.8.5641; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Lee RTH, 2013, DEVELOPMENT, V140, P4890, DOI 10.1242/dev.094680; Liu JJ, 2015, STEM CELLS, V33, P627, DOI 10.1002/stem.1909; Lu H, 2016, FEBS J, V283, P3771, DOI 10.1111/febs.13842; Martens W, 2012, CELLS TISSUES ORGANS, V196, P490, DOI 10.1159/000338654; Meeker RB, 2015, NEURAL REGEN RES, V10, P721, DOI 10.4103/1673-5374.156967; Menendez L, 2013, NAT PROTOC, V8, P203, DOI 10.1038/nprot.2012.156; Menendez L, 2011, P NATL ACAD SCI USA, V108, P19240, DOI 10.1073/pnas.1113746108; Mikami Y, 2011, STEM CELLS DEV, V20, P901, DOI 10.1089/scd.2010.0299; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Nam H, 2009, BIOCHEM BIOPH RES CO, V386, P135, DOI 10.1016/j.bbrc.2009.05.141; O'Rahilly R, 2007, J ANAT, V211, P335, DOI 10.1111/j.1469-7580.2007.00773.x; Paino F, 2010, EUR CELLS MATER, V20, P295; Pirozzi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021548; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Tirino Virginia, 2012, Methods Mol Biol, V879, P443, DOI 10.1007/978-1-61779-815-3_26; Verma Kavita, 2014, Dent Res J (Isfahan), V11, P302	49	23	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170321	10.1371/journal.pone.0170321	http://dx.doi.org/10.1371/journal.pone.0170321			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125654	Green Published, gold, Green Submitted			2022-12-27	WOS:000396176100119
J	Yang, Y; Xiao, Y; Li, M; Ji, FN; Hu, CW; Cui, YB				Yang, Yang; Xiao, Yao; Li, Mei; Ji, Funian; Hu, Changwei; Cui, Yibin			Evaluation of Complex Toxicity of Canbon Nanotubes and Sodium Pentachlorophenol Based on Earthworm Coelomocytes Test	PLOS ONE			English	Article							WALLED CARBON NANOTUBES; EISENIA-FOETIDA; DNA-DAMAGE; OXIDATIVE STRESS; BIOMARKER RESPONSES; LIPID-PEROXIDATION; ENDOTHELIAL-CELLS; PRIMARY CULTURES; APOPTOSIS; SOIL	As a standard testing organism in soil ecosystems, the earthworm Eisenia fetida has been used widely in toxicity studies. However, tests at the individual level are time-and animalconsuming, with limited sensitivity. Earthworm coelomocytes are important for the assimilation and elimination of exogenous compounds and play a key role in the processes of phagocytosis and inflammation. In this study, we explored an optimal condition to culture coelomocytes of E. fetida in vitro and investigated the cytotoxicity of multiwalled carbon nanotubes (MWCNTs) and sodium pentachlorophenol (PCP-Na) using coelomocytes via evaluating lethal toxicity, oxidative stress, membrane damage, and DNA damage. The results showed that coelomocytes can be successfully cultured in vitro in primary under the RPMI-1640 medium with 2-4x10 (4) cells/well (1-2x10(5) cells/mL) in 96-well plates at 25 E degrees C without CO2. Both MWCNTs and PCP-Na could cause oxidative damage and produce ROS, an evidence for lipid peroxidation with MDA generation and SOD and CAT activity inhibition at high stress. The two chemicals could separately damage the cell membrane structure, increasing permeability and inhibiting mitochondrial membrane potential (MMP). In addition, our results indicate that PCP-Na may be adsorbed onto MWCNTs and its toxicity on earthworm was accordingly alleviated, while a synergetic effect was revealed when PCP-Na and MWCNTs were added separately. In summary, coelomocyte toxicity in in vitro analysis is a sensitive method for detecting the adverse effects of carbon nanotubes combined with various pollutants.	[Yang, Yang; Xiao, Yao; Li, Mei; Ji, Funian] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing, Jiangsu, Peoples R China; [Hu, Changwei] Linyi Univ, Shandong Prov Key Lab Water & Soil Conservat & En, Linyi, Peoples R China; [Cui, Yibin] Minist Environm Protect, Nanjing Inst Environm Sci, Nanjing, Jiangsu, Peoples R China	Nanjing University; Linyi University	Li, M (corresponding author), Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing, Jiangsu, Peoples R China.	meili@nju.edu.cn	Hu, Changwei/K-9818-2013	Hu, Changwei/0000-0001-7511-0739	National Natural Science Foundation of China [41571468, 21077052]; Science and Technology Support Program of Jiangsu Province [BE2016172, BE2012737]; Shandong Provincial Natural Science Foundation of China [ZR2015CM023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Support Program of Jiangsu Province; Shandong Provincial Natural Science Foundation of China(Natural Science Foundation of Shandong Province)	This research was supported by National Natural Science Foundation of China (No. 41571468, 21077052), the Science and Technology Support Program of Jiangsu Province (No.BE2016172, BE2012737), and the Shandong Provincial Natural Science Foundation of China (No. ZR2015CM023).	Ali D, 2014, CHEMOSPHERE, V104, P134, DOI 10.1016/j.chemosphere.2013.10.081; [Anonymous], 2012, 8503100 OCSPP ESEPA; Chang JC, 2010, WORLD J CARDIOL, V2, P150, DOI 10.4330/wjc.v2.i6.150; Chen SZ, 2014, MAT SCI ENG C-MATER, V43, P330, DOI 10.1016/j.msec.2014.07.029; Cigerci IH, 2016, CHEMOSPHERE, V144, P754, DOI 10.1016/j.chemosphere.2015.09.053; COLLINS AR, 1995, MUTAT RES-DNA REPAIR, V336, P69, DOI 10.1016/0921-8777(94)00043-6; Cui XY, 2009, J SOIL SEDIMENT, V9, P604, DOI 10.1007/s11368-009-0124-7; De Volder MFL, 2013, SCIENCE, V339, P535, DOI 10.1126/science.1222453; Dong YL, 2009, COMP BIOCHEM PHYS C, V150, P179, DOI 10.1016/j.cbpc.2009.04.010; Du L, 2015, ENVIRON SCI POLLUT R, V22, P4660, DOI 10.1007/s11356-014-3716-8; EYAMBE GS, 1991, LAB ANIM, V25, P61, DOI 10.1258/002367791780808095; Garza KM, 2008, INT J NANOMED, V3, P83; Han YN, 2014, ECOTOX ENVIRON SAFE, V107, P214, DOI 10.1016/j.ecoenv.2014.06.006; Hayashi Y, 2013, ENVIRON SCI TECHNOL, V47, P14367, DOI 10.1021/es404132w; Heggelund LR, 2014, NANOTOXICOLOGY, V8, P559, DOI 10.3109/17435390.2013.809808; Hu CW, 2014, SOIL BIOL BIOCHEM, V70, P123, DOI 10.1016/j.soilbio.2013.12.018; Irizar A, 2015, ARCH ENVIRON CON TOX, V68, P181, DOI 10.1007/s00244-014-0060-4; Irizar A, 2015, ECOTOXICOLOGY, V24, P1004, DOI 10.1007/s10646-015-1441-9; Irizar A, 2014, ECOTOXICOLOGY, V23, P1326, DOI 10.1007/s10646-014-1275-x; Jin IK, 2014, ENVIRON RES, V134, P118, DOI [10.1016/j.envres.2014.07.014, DOI 10.1016/J.ENVRES.2014.07.014]; Jin WL, 2016, AQUAT TOXICOL, V171, P9; Kunzmann A, 2011, BBA-GEN SUBJECTS, V1810, P361, DOI 10.1016/j.bbagen.2010.04.007; Lee JW, 2016, AQUAT TOXICOL, V171, P9, DOI 10.1016/j.aquatox.2015.12.005; Li PC, 2015, CARDIOVASC TOXICOL, V15, P172, DOI 10.1007/s12012-014-9281-z; Liu L, 2013, EUR REV MED PHARMACO, V17, P88; Lowe CN, 2005, PEDOBIOLOGIA, V49, P401, DOI 10.1016/j.pedobi.2005.04.005; OECD, 2004, EARTHW REPR TEST; OECD (Organisation for Economic Co-operation and Development), 1984, EARTHW AC TOX TESTS; Martin AP, 2013, EUPHROSYNE, V41, P47; Pereira MM, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/1477-3155-12-15; Petersen EJ, 2009, ENVIRON SCI TECHNOL, V43, P4181, DOI 10.1021/es803023a; Plytycz B, 2011, PEDOBIOLOGIA, V54, pS203, DOI 10.1016/j.pedobi.2011.06.002; Plytycz B, 2010, CHEMOSPHERE, V81, P199, DOI 10.1016/j.chemosphere.2010.06.056; Reinardy HC, 2015, MUTAGENESIS, V30, P829, DOI 10.1093/mutage/gev052; Sabatini SE, 2009, ECOTOX ENVIRON SAFE, V72, P1200, DOI 10.1016/j.ecoenv.2009.01.003; Saez G, 2015, ENVIRON TOXICOL, V30, P918, DOI 10.1002/tox.21966; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Spurgeon DJ, 2000, ENVIRON TOXICOL CHEM, V19, P1800, DOI [10.1897/1551-5028(2000)019&lt;1800:RSOLCA&gt;2.3.CO;2, 10.1002/etc.5620190714]; STOMMER P, 1990, PANCREAS, V5, P114; Sun JH, 2013, BEIJING GONGYE DAXUE, V39, P624; Towell MG, 2011, ENVIRON POLLUT, V159, P706, DOI 10.1016/j.envpol.2010.11.040; Tripathi G, 2010, PESTIC BIOCHEM PHYS, V98, P333, DOI 10.1016/j.pestbp.2010.07.005; Ursini CL, 2012, TOXICOL IN VITRO, V26, P831, DOI 10.1016/j.tiv.2012.05.001; Wei Z, 2014, ENV TOXICOL PHAR, V38, P297; Yang Y, 2016, CHEMOSPHERE, V144, P2476, DOI 10.1016/j.chemosphere.2015.11.023; Zhang FQ, 2007, CHEMOSPHERE, V67, P44, DOI 10.1016/j.chemosphere.2006.10.007; Zhang LJ, 2014, ECOTOX ENVIRON SAFE, V103, P29, DOI 10.1016/j.ecoenv.2014.01.041; Zhang QM, 2015, CHEMOSPHERE, V139, P138, DOI 10.1016/j.chemosphere.2015.05.091; Zhang QM, 2013, ENVIRON SCI POLLUT R, V20, P201, DOI 10.1007/s11356-012-0962-5; Zhou CF, 2013, ENVIRON POLLUT, V180, P71, DOI 10.1016/j.envpol.2013.05.016	50	10	11	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e170092	10.1371/journal.pone.0170092	http://dx.doi.org/10.1371/journal.pone.0170092			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125623	Green Published, gold, Green Submitted			2022-12-27	WOS:000396176100129
J	Nieuwenhuis, JG; Noorthoorn, EO; Nijman, HLI; Naarding, P; Mulder, CL				Nieuwenhuis, Jeanet Grietje; Noorthoorn, Eric Onno; Nijman, Henk Llewellyn Inge; Naarding, Paul; Mulder, Cornelis Lambert			A Blind Spot? Screening for Mild Intellectual Disability and Borderline Intellectual Functioning in Admitted Psychiatric Patients: Prevalence and Associations with Coercive Measures	PLOS ONE			English	Article							DISORDERS; PEOPLE; RATES	Background Failure to detect psychiatric patients' intellectual disabilities may lead to inappropriate treatment and greater use of coercive measures. Aims In this prospective dynamic cohort study we screened for intellectual disabilities in patients admitted to psychiatric wards, and investigated the use of coercive measures with these patients. Methods We used the Screener for Intelligence and Learning disabilities (SCIL) to screen patients admitted to two acute psychiatric wards, and assessed patient characteristics and coercive measures during their stay and over the last 5 years. Results Results on the SCIL suggested that 43.8% of the sample had Mild Intellectual Disability or Borderline Intellectual Functioning (MID/BIF). During their current stay and earlier stays in the previous 5 years, these patients had an increased risk of involuntary admission (OR 2.71; SD 1.28-5.70) and coercive measures (OR 3.95, SD 1.47-10.54). Conclusions This study suggests that functioning on the level of MID/BIF is very prevalent in admitted psychiatric patients and requires specific attention from mental health care staff.	[Nieuwenhuis, Jeanet Grietje] GGNet Mental Hlth Ctr, VGGNet, Warnsveld, Netherlands; [Noorthoorn, Eric Onno] Dutch Informat Ctr Coerc Measures, Bilthoven, Netherlands; [Noorthoorn, Eric Onno; Naarding, Paul] GGNet Mental Hlth Ctr, Apeldoorn, Netherlands; [Nijman, Henk Llewellyn Inge] Altrecht Aventurijn, Den Dolder, Netherlands; [Mulder, Cornelis Lambert] Erasmus MC, Epidemiol & Social Psychiat Res Inst, Prins Constantijnweg 48-54, Rotterdam, Netherlands; [Mulder, Cornelis Lambert] Parnassia Psychiat Inst, Prins Constantijnweg 48-54, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Parnassia Psychiatric Institute	Nieuwenhuis, JG (corresponding author), GGNet Mental Hlth Ctr, VGGNet, Warnsveld, Netherlands.	j.nieuwenhuis@ggnet.nl	Mulder, Cornelis Lambert/HGU-3446-2022	Nieuwenhuis, Jeanet/0000-0002-3781-8709	Oude and Nieuwe Gasthuis foundation, Zutphen	Oude and Nieuwe Gasthuis foundation, Zutphen	The study was funded by the Oude and Nieuwe Gasthuis foundation, Zutphen, whose assets in the Zutphen region provide annual funding for mental-health innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowers L, 2015, INT J NURS STUD, V52, P1412, DOI 10.1016/j.ijnurstu.2015.05.001; Burge P, 2006, J DEV DISABILITIES, V15, P96; Cooper SA, 2006, PSYCHIATRY, V5, p[9, 306], DOI DOI 10.1053/J.MPPSY.2006.06.009; Fernell E, 2010, ACTA PAEDIATR, V99, P748, DOI 10.1111/j.1651-2227.2010.01707.x; Fletcher R, 2007, DIAGNOSTIC MANUAL IN; Gigi K, 2014, EUR NEUROPSYCHOPHARM, V24, P1793, DOI 10.1016/j.euroneuro.2014.07.016; Hurley AD, 2006, CURR OPIN PSYCHIATR, V19, P465, DOI 10.1097/01.yco.0000238471.84206.0a; Janssen WA, 2011, INT J LAW PSYCHIAT, V34, P429, DOI 10.1016/j.ijlp.2011.10.008; Kaal HL, 2015, J INTELLECT DISABIL, V6, P94, DOI 10.1108/JIDOB-04-2015-0008; Kaal HL, SCIL SCREENER INTELL, p[128, 1017]; Moonen X, 2010, ONDERZOEK PRAKTIJK, V8, P8; Morgan VA, 2008, BRIT J PSYCHIAT, V193, P364, DOI 10.1192/bjp.bp.107.044461; Muskett C, 2014, INT J MENT HEALTH NU, V23, P51, DOI 10.1111/inm.12012; Neijmeijer L, 2010, LICHT VERSTANDELIJK; Nijman H., J APPL RES IN PRESS; Pogge DL, 2014, RES DEV DISABIL, V35, P1705, DOI 10.1016/j.ridd.2014.03.012; Prasher VP, 2006, PSYCHIATRY, V5, P3002; Snell ME, 2009, INTELLECT DEV DISAB, V47, P220, DOI 10.1352/1934-9556-47.3.220; Stuurman S, 2008, INTELLIGENETIEONDERZ; Tyrer P, 1999, LANCET, V354, P999; van Duijvenbode N, 2015, RES DEV DISABIL, V38, P319, DOI 10.1016/j.ridd.2014.12.029; von Elm E, 2007, EPIDEMIOLOGY, V18, P800, DOI 10.1097/EDE.0b013e3181577654; Westerinen H, 2007, J INTELL DISABIL RES, V51, P715, DOI 10.1111/j.1365-2788.2007.00970.x; Wullink M, 2007, J INTELL DISABIL RES, V51, P511, DOI 10.1111/j.1365-2788.2006.00917.x	24	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0168847	10.1371/journal.pone.0168847	http://dx.doi.org/10.1371/journal.pone.0168847			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28151977	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200006
J	Perescis, MFJ; de Bruin, N; Heijink, L; Kruse, C; Vinogradova, L; Luttjohann, A; van Luijtelaar, G; van Rijn, CM				Perescis, Martin F. J.; de Bruin, Natasja; Heijink, Liesbeth; Kruse, Chris; Vinogradova, Lyudmila; Luttjohann, Annika; van Luijtelaar, Gilles; van Rijn, Clementina M.			Cannabinoid antagonist SLV326 induces convulsive seizures and changes in the interictal EEG in rats	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; RECEPTOR ANTAGONISTS; BEHAVIORAL-RESPONSES; AUDIOGENIC EPILEPSY; MAZE TASK; CB1; MODEL; RECORDINGS; SPIKES; BRAIN	Cannabinoid CB1 antagonists have been investigated for possible treatment of e.g. obesity-related disorders. However, clinical application was halted due to their symptoms of anxiety and depression. In addition to these adverse effects, we have shown earlier that chronic treatment with the CB1 antagonist rimonabant may induce EEG-confirmed convulsive seizures. In a regulatory repeat-dose toxicity study violent episodes of ''muscle spasms'' were observed in Wistar rats, daily dosed with the CB1 receptor antagonist SLV326 during 5 months. The aim of the present follow-up study was to investigate whether these violent movements were of an epileptic origin. In selected SLV326-treated and control animals, EEG and behavior were monitored for 24 hours. 25% of SLV326 treated animals showed 1 to 21 EEG-confirmed generalized convulsive seizures, whereas controls were seizure-free. The behavioral seizures were typical for a limbic origin. Moreover, interictal spikes were found in 38% of treated animals. The frequency spectrum of the interictal EEG of the treated rats showed a lower theta peak frequency, as well as lower gamma power compared to the controls. These frequency changes were state-dependent: they were only found during high locomotor activity. It is concluded that long term blockade of the endogenous cannabinoid system can provoke limbic seizures in otherwise healthy rats. Additionally, SLV326 alters the frequency spectrum of the EEG when rats are highly active, suggesting effects on complex behavior and cognition.	[Perescis, Martin F. J.; van Luijtelaar, Gilles; van Rijn, Clementina M.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Perescis, Martin F. J.] HAS Univ Appl Sci, Shertogenbosch, Netherlands; [de Bruin, Natasja; Heijink, Liesbeth; Kruse, Chris] Abbott Healthcare Prod BV, Weesp, Netherlands; [Vinogradova, Lyudmila] Russian Acad Sci, Inst Higher Nervous Act & Neurophysiol, Moscow, Russia; [Luttjohann, Annika] Westfal Wilhelms Univ Munster, Inst Physiol 1, Munster, Germany; [de Bruin, Natasja] Goethe Univ Frankfurt, Fraunhofer Inst Mol Biol & Appl Ecol IME, Project Grp Translat Med & Pharmacol TMP, Frankfurt, Germany; [Heijink, Liesbeth] Astellas Pharma Europe R&D, Dept Drug Discovery Sci & Management Europe, Leiden, Netherlands; [Kruse, Chris] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands	Radboud University Nijmegen; Institute of Higher Nervous Activity & Neurophysiology of RAS; Russian Academy of Sciences; University of Munster; Fraunhofer Gesellschaft; Goethe University Frankfurt; Astellas Pharmaceuticals; University of Amsterdam	Perescis, MFJ (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands.; Perescis, MFJ (corresponding author), HAS Univ Appl Sci, Shertogenbosch, Netherlands.	m.perescis@has.nl	van Rijn, Clementina/D-5828-2012; Vinogradova, Ljudmila/F-9578-2017; de Bruin, Natasja/D-8063-2014	de Bruin, Natasja/0000-0002-2456-2783; van Rijn, Clementina/0000-0002-1103-6338; Vinogradova, Lyudmila/0000-0003-0336-606X; Luttjohann, Annika/0000-0002-9248-1264	Abbott Healthcare Products BV, Weesp, The Netherlands	Abbott Healthcare Products BV, Weesp, The Netherlands	This study was funded by Abbott Healthcare Products BV (formerly Solvay Pharmaceuticals), Weesp, The Netherlands. The funder provided support in the form of salaries for authors [NB, LH, CK], but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The funders gave permission to publish the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aghaei I, 2015, EPILEPSY RES, V117, P23, DOI 10.1016/j.eplepsyres.2015.08.010; Alger BE, 2006, NEURON, V51, P393, DOI 10.1016/j.neuron.2006.08.003; Black MD, 2011, PSYCHOPHARMACOLOGY, V215, P149, DOI 10.1007/s00213-010-2124-0; Bourien J, 2005, CLIN NEUROPHYSIOL, V116, P443, DOI 10.1016/j.clinph.2004.08.010; Braakman HMH, 2009, EPILEPSIA, V50, P2171, DOI 10.1111/j.1528-1167.2009.02203.x; Carletti F, 2015, NEUROSCIENCE, V303, P149, DOI 10.1016/j.neuroscience.2015.06.047; COENEN AML, 1975, PHYSIOL BEHAV, V14, P391, DOI 10.1016/0031-9384(75)90053-0; CORCORAN ME, 1978, EPILEPSIA, V19, P47; Cortes-Briones J, 2015, NEUROPSYCHOPHARMACOL; D'Souza DC, 2012, NEUROPSYCHOPHARMACOL, V37, P1632, DOI 10.1038/npp.2012.8; de Bruin NMWJ, 2010, NEUROBIOL LEARN MEM, V93, P522, DOI 10.1016/j.nlm.2010.01.010; Deshpande LS, 2007, NEUROSCI LETT, V411, P11, DOI 10.1016/j.neulet.2006.09.046; *EMEA, 2009, EUR PUBL ASS REP EPA; Hajos M, 2008, BIOL PSYCHIAT, V63, P1075, DOI 10.1016/j.biopsych.2007.12.005; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Hsu DA, 2015, CLIN NEUROPHYSIOLOGY; Huneau C, 2013, EPILEPSIA, V54, P2219, DOI 10.1111/epi.12406; Jetter GM, 2008, SEMIN NEUROL, V28, P336, DOI 10.1055/s-2008-1079338; Karanian DA, 2007, J PHARMACOL EXP THER, V322, P1059, DOI 10.1124/jpet.107.120147; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Koessler L, 2015, BRAIN TOPOGR, V28, P5, DOI 10.1007/s10548-014-0417-z; Kow RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095922; Krishnan B, 2015, CLIN NEUROPHYSIOL, V126, P667, DOI 10.1016/j.clinph.2014.07.014; Krsek P, 2013, EPILEPSIA, V54, P1913, DOI 10.1111/epi.12371; Lange JHM, 2008, CHEM REC, V8, P156, DOI 10.1002/tcr.20147; Le Foll B, 2009, PSYCHOPHARMACOLOGY, V205, P171, DOI 10.1007/s00213-009-1506-7; Lee TTY, 2015, NEUROPHARMACOLOGY, V99, P89, DOI 10.1016/j.neuropharm.2015.07.021; Li SF, 2013, IEEE T NEUR SYS REH, V21, P880, DOI 10.1109/TNSRE.2013.2282153; Lichtman AH, 2000, EUR J PHARMACOL, V404, P175, DOI 10.1016/S0014-2999(00)00615-4; Maheshwari A, 2016, EPILEPSIA, V57, P79, DOI 10.1111/epi.13265; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Mazzola C, 2003, EUR J PHARMACOL, V477, P219, DOI 10.1016/j.ejphar.2003.08.026; McCarthy MM, 2003, EXP NEUROL, V184, P40, DOI 10.1016/j.expneurol.2003.08.020; MEHTA CR, 1993, AM STAT, V47, P91, DOI 10.2307/2685184; Niso G, 2015, NEUROIMAGE-CLIN, V8, P503, DOI 10.1016/j.nicl.2015.05.008; Nottage JF, 2015, PSYCHOPHARMACOLOGY, V232, P519, DOI 10.1007/s00213-014-3684-1; Patrylo PR, 2007, EPILEPSIA, V48, P1964, DOI 10.1111/j.1528-1167.2007.01139.x; Pedreira C, 2014, NEUROIMAGE, V99, P461, DOI 10.1016/j.neuroimage.2014.05.009; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Raver SM, 2013, NEUROPSYCHOPHARMACOL, V38, P2338, DOI 10.1038/npp.2013.164; Rodriguez-Manzo G, 2015, BEHAV PHARMACOL, V26, P607, DOI 10.1097/FBP.0000000000000154; Shafaroodi H, 2013, EUR J PHARMACOL, V714, P1, DOI 10.1016/j.ejphar.2013.05.040; Shan GG, 2013, J BIOPHARM STAT, V23, P1081, DOI 10.1080/10543406.2013.813525; Solbrig MV, 2005, EXP NEUROL, V194, P355, DOI 10.1016/j.expneurol.2005.02.017; Staba RJ, 2014, NEUROTHERAPEUTICS, V11, P334, DOI 10.1007/s13311-014-0259-0; Suleymanova EM, 2016, NEUROSCIENCE, V9, P30367; van Lier H, 2003, J NEUROSCI, V23, P2459; van Rijn CM, 2011, PHARMACOL REP, V63, P165; Vilela LR, 2015, TOXICOL APPL PHARM, V286, P178, DOI 10.1016/j.taap.2015.04.013; Vinogradova LV, 2015, PHARMACOL REP, V67, P501, DOI 10.1016/j.pharep.2014.12.002; Vinogradova LV, 2011, EPILEPSY RES, V96, P250, DOI 10.1016/j.eplepsyres.2011.06.007; Wallace MJ, 2003, J PHARMACOL EXP THER, V307, P129, DOI 10.1124/jpet.103.051920; Wettschureck N, 2006, MOL CELL BIOL, V26, P5888, DOI 10.1128/MCB.00397-06; WILLINSKY MD, 1975, PSYCHOPHARMACOLOGIA, V41, P123, DOI 10.1007/BF00421068; Wolff MC, 2003, EUR J PHARMACOL, V477, P213, DOI 10.1016/j.ejphar.2003.08.025	55	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0165363	10.1371/journal.pone.0165363	http://dx.doi.org/10.1371/journal.pone.0165363			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151935	gold, Green Submitted, Green Published			2022-12-27	WOS:000396161200002
J	Li, FZ; Feng, ZM; Li, P; You, Z				Li, Fangzhou; Feng, Zhiming; Li, Peng; You, Zhen			Measuring directional urban spatial interaction in China: A migration perspective	PLOS ONE			English	Article							MODEL; NETWORKS; MOBILITY; CITIES; DYNAMICS; DISTANCE	The study of urban spatial interaction is closely linked to that of economic geography, urban planning, regional development, and so on. Currently, this topic is generating a great deal of interest among researchers who are striving to find accurate ways to measure urban spatial interaction. Classical spatial interaction models lack theoretical guidance and require complicated parameter-adjusting processes. The radiation model, however, as proposed by Simini et al. with rigorous formula derivation, can simulate directional urban spatial interaction. We applied the radiation model in China to simulate the directional migration number among 337 nationwide research units, comprising 4 municipalities and 333 prefecture-level cities. We then analyzed the overall situation in Chinese cities, the interaction intensity hierarchy, and the prime urban agglomerations from the perspective of migration. This was done to ascertain China's urban spatial interaction and regional development from 2000 to 2010 to reveal ground realities.	[Li, Fangzhou; Feng, Zhiming; Li, Peng; You, Zhen] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Li, Fangzhou] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Feng, ZM (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.	fengzm@igsnrr.ac.cn		Li, Peng/0000-0002-0849-5955	National Natural Science Foundation of China (NNSFC) [41430861, 41401662]	National Natural Science Foundation of China (NNSFC)(National Natural Science Foundation of China (NSFC))	This research is supported by National Natural Science Foundation of China (NNSFC, http://www.nsfc.gov.cn/publish/portal1/) grant 41430861 and grant 41401662. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Chan KW, 2010, POPUL DEV REV, V36, P357, DOI 10.1111/j.1728-4457.2010.00333.x; Cheung C, 2005, J E ASIA SOC TRANSP, V6, P3773; Choi JH, 2006, GLOBAL NETW, V6, P81, DOI 10.1111/j.1471-0374.2006.00134.x; de Vries JJ, 2009, ENVIRON PLANN A, V41, P461, DOI 10.1068/a39369; Dijkstra L, 2013, EUR PLAN STUD, V21, P334, DOI 10.1080/09654313.2012.716245; Fan CC, 2008, EURASIAN GEOGR ECON, V49, P1, DOI 10.2747/1539-7216.49.1.1; Fan J., 2008, REGIONAL PLANNING ST; Harris CD, 1954, ANN ASSOC AM GEOGR, V44, P315; Hou H. P., 2013, CHINA POPULATION RES, V23, P107; Kang CG, 2013, INT J GEOGR INF SCI, V27, P431, DOI 10.1080/13658816.2012.689838; Levinson D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029721; Li H, 2015, INT DEV PLANN REV, V37, P311, DOI 10.3828/idpr.2015.19; Li MT, 2014, MATH BIOSCI ENG, V11, P1115, DOI 10.3934/mbe.2014.11.1115; Liu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086026; Masucci AP, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022812; MILLER E, 1972, J REGIONAL SCI, V12, P475, DOI 10.1111/j.1467-9787.1972.tb00369.x; National Bureau of Statistics of China, 2010, DEF DEMOGR IND; National Bureau of Statistics of China, 2011, PART METH 4 EC REG; National Development and Reform of China, 2008, OUTL PLAN REF DEV PE; National Development and Reform of China, 2011, REG PLANN CHENGD CHO; National Development and Reform of China, 2010, REG PLANN YANGTZ RIV; National Development and Reform of China, 2014, NAT PLAN NEW URB 201; NDRC,, 2015, DEV PLANN MIDDL REAC; Opsahl T, 2009, SOC NETWORKS, V31, P155, DOI 10.1016/j.socnet.2009.02.002; Qi YJ, 2013, J GEOGR SCI, V23, P297, DOI 10.1007/s11442-013-1011-0; Reily WJ, 1929, METHODS STUDY RETAIL; Ren YH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6347; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Stouffer SA, 1940, AM SOCIOL REV, V5, P845, DOI 10.2307/2084520; Sun GQ, 2016, PHYS LIFE REV, V19, P43, DOI 10.1016/j.plrev.2016.08.002; Sun GQ, 2016, NONLINEAR DYNAM, V85, P1, DOI 10.1007/s11071-016-2671-y; Sun GQ, 2016, NONLINEAR DYNAM, V83, P811, DOI 10.1007/s11071-015-2369-6; Susarla A, 2012, INFORM SYST RES, V23, P23, DOI 10.1287/isre.1100.0339; Taylor P. J., 1975, CONCEPTS TECHNIQUES, V2; Taylor PJ, 2007, URBAN GEOGR, V28, P232, DOI 10.2747/0272-3638.28.3.232; Taylor PJ, 2014, ECON GEOGR, V90, P267, DOI 10.1111/ecge.12040; Truscott J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002699; Wang XB, 2016, PLOS ONE, V11; Wang Y, 2014, APPL MATH COMPUT, V244, P726, DOI 10.1016/j.amc.2014.07.051; Wang Y, 2013, PHYSICA A, V392, P5824, DOI 10.1016/j.physa.2013.07.067; Wang Y, 2012, NONLINEAR ANAL-REAL, V13, P543, DOI 10.1016/j.nonrwa.2011.07.033; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu XG, 2004, DEMOGRAPHY, V41, P363, DOI 10.1353/dem.2004.0010; Yu C, 2016, J CLEAN PROD, V134, P42, DOI 10.1016/j.jclepro.2015.09.101; Zhang Jufeng, 2014, Biomed Res Int, V2014, P187105, DOI 10.1155/2014/187105	47	15	16	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171107	10.1371/journal.pone.0171107	http://dx.doi.org/10.1371/journal.pone.0171107			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6QW	28141853	Green Submitted, Green Published, gold			2022-12-27	WOS:000396129500038
J	Ruark, CL; Koenning, SR; Davis, EL; Opperman, CH; Lommel, SA; Mitchum, MG; Sit, TL				Ruark, Casey L.; Koenning, Stephen R.; Davis, Eric L.; Opperman, Charles H.; Lommel, Steven A.; Mitchum, Melissa G.; Sit, Tim L.			Soybean cyst nematode culture collections and field populations from North Carolina and Missouri reveal high incidences of infection by viruses	PLOS ONE			English	Article							HETERODERA-GLYCINES; TRANSMISSION; EXPRESSION; PARTICLES; DISEASE; PLANT	Five viruses were previously discovered infecting soybean cyst nematodes (SCN; Heterodera glycines) from greenhouse cultures maintained in Illinois. In this study, the five viruses [ScNV, ScPV, ScRV, ScTV, and SbCNV-5] were detected within SCN greenhouse and field populations from North Carolina (NC) and Missouri (MO). The prevalence and titers of viruses in SCN from 43 greenhouse cultures and 25 field populations were analyzed using qRT-PCR. Viral titers within SCN greenhouse cultures were similar throughout juvenile development, and the presence of viral anti-genomic RNAs within egg, second-stage juvenile (J2), and pooled J3 and J4 stages suggests active viral replication within the nematode. Viruses were found at similar or lower levels within field populations of SCN compared with greenhouse cultures of North Carolina populations. Five greenhouse cultures harbored all five known viruses whereas in most populations a mixture of fewer viruses was detected. In contrast, three greenhouse cultures of similar descent to one another did not possess any detectable viruses and primarily differed in location of the cultures (NC versus MO). Several of these SCN viruses were also detected in Heterodera trifolii (clover cyst) and Heterodera schachtii (beet cyst), but not the other cyst, root-knot, or reniform nematode species tested. Viruses were not detected within soybean host plant tissue. If nematode infection with viruses is truly more common than first considered, the potential influence on nematode biology, pathogenicity, ecology, and control warrants continued investigation.	[Ruark, Casey L.; Koenning, Stephen R.; Davis, Eric L.; Opperman, Charles H.; Lommel, Steven A.; Sit, Tim L.] North Carolina State Univ, Dept Entomol & Plant Pathol, 2510 Thomas Hall, Raleigh, NC 27695 USA; [Mitchum, Melissa G.] Univ Missouri, Div Plant Sci, Bond Life Sci Ctr 371H, Columbia, MO USA; [Mitchum, Melissa G.] Univ Missouri, Bond Life Sci Ctr, Bond Life Sci Ctr 371H, Columbia, MO USA	University of North Carolina; North Carolina State University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Sit, TL (corresponding author), North Carolina State Univ, Dept Entomol & Plant Pathol, 2510 Thomas Hall, Raleigh, NC 27695 USA.	tim@ncsu.edu		Sit, Tim/0000-0001-7302-823X	NC Soybean Producers Association [12-13]; National Science Foundation Graduate Research Fellowship Grant [DGE-1252376]	NC Soybean Producers Association; National Science Foundation Graduate Research Fellowship Grant	NC Soybean Producers Association, Grant 12-13, http://ncsoy.org/. This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. DGE-1252376 to CLR, https://www.nsfgrfp.org/.	Bekal S, 2014, J GEN VIROL, V95, P1272, DOI 10.1099/vir.0.060889-0; Bekal S, 2011, J GEN VIROL, V92, P1870, DOI 10.1099/vir.0.030585-0; Bernard EC, 2010, J NEMATOL, V42, P139; BROWN DJF, 1995, ANNU REV PHYTOPATHOL, V33, P223, DOI 10.1146/annurev.py.33.090195.001255; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Colgrove AL, 2008, J NEMATOL, V40, P39; Dong K, 1997, GENETICS, V146, P1311; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; FOOR WE, 1972, J PARASITOL, V58, P1065, DOI 10.2307/3278136; Franz CJ, 2014, VIROLOGY, V448, P255, DOI 10.1016/j.virol.2013.09.024; Franz CJ, 2012, J VIROL, V86, P11940, DOI 10.1128/JVI.02025-12; Gardner M, 2017, G3; Gray SM, 1999, MICROBIOL MOL BIOL R, V63, P128, DOI 10.1128/MMBR.63.1.128-148.1999; Hoerauf A, 2001, LANCET, V357, P1415, DOI 10.1016/S0140-6736(00)04581-5; Hooper DJ, 1974, NEMATODE VECTORS PLA, P1; Ithal N, 2007, MOL PLANT MICROBE IN, V20, P293, DOI 10.1094/MPMI-20-3-0293; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Koenning S. R., 1998, Journal of Nematology, V30, P569; LOEWENBERG JR, 1959, NATURE, V184, P1896, DOI 10.1038/1841896a0; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Mitchum MG, 2007, PLANT DIS, V91, P1473, DOI 10.1094/PDIS-91-11-1473; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POINAR GO, 1977, NATURE, V266, P256, DOI 10.1038/266256a0; Rotenberg D, 2009, PHYTOPATHOLOGY, V99, P404, DOI 10.1094/PHYTO-99-4-0404; Skantar AM, 2012, J NEMATOL, V44, P58; TOWNSHEND J. L., 1963, NEMATOLOGICA, V9, P106; Wrather JA, 2006, J NEMATOL, V38, P173; ZUCKERMA.BM, 1973, NEMATOLOGICA, V19, P117, DOI 10.1163/187529273X00187	28	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171514	10.1371/journal.pone.0171514	http://dx.doi.org/10.1371/journal.pone.0171514			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141854	Green Submitted, gold, Green Published			2022-12-27	WOS:000396129500057
J	Casselli, T; Qureshi, H; Peterson, E; Perley, D; Blake, E; Jokinen, B; Abbas, A; Nechaev, S; Watt, JA; Dhasarathy, A; Brissette, CA				Casselli, Timothy; Qureshi, Humaira; Peterson, Elizabeth; Perley, Danielle; Blake, Emily; Jokinen, Bradley; Abbas, Ata; Nechaev, Sergei; Watt, John A.; Dhasarathy, Archana; Brissette, Catherine A.			MicroRNA and mRNA Transcriptome Profiling in Primary Human Astrocytes Infected with Borrelia burgdorferi	PLOS ONE			English	Article							LYME-DISEASE SPIROCHETE; EXPRESSION ANALYSIS; BACTERIAL ADHESION; GENE-EXPRESSION; NEUROBORRELIOSIS; CELLS; INFLAMMATION; ACTIVATION; MICROGLIA; CHITIN	Lyme disease is caused by infection with the bacterium Borrelia burgdorferi (Bb), which is transmitted to humans by deer ticks. The infection manifests usually as a rash and minor systemic symptoms; however, the bacteria can spread to other tissues, causing joint pain, carditis, and neurological symptoms. Lyme neuroborreliosis presents itself in several ways, such as Bell's palsy, meningitis, and encephalitis. The molecular basis for neuroborreliosis is poorly understood. Analysis of the changes in the expression levels of messenger RNAs and non-coding RNAs, including microRNAs, following Bb infection could therefore provide vital information on the pathogenesis and clinical symptoms of neuroborreliosis. To this end, we used cultured primary human astrocytes, key responders to CNS infection and important components of the blood-brain barrier, as a model system to study RNA and microRNA changes in the CNS caused by Bb. Using whole transcriptome RNA-seq, we found significant changes in 38 microRNAs and 275 mRNAs at 24 and 48 hours following Bb infection. Several of the RNA changes affect pathways involved in immune response, development, chromatin assembly (including histones) and cell adhesion. Further, several of the microRNA predicted target mRNAs were also differentially regulated. Overall, our results indicate that exposure to Bb causes significant changes to the transcriptome and microRNA profile of astrocytes, which has implications in the pathogenesis, and hence potential treatment strategies to combat this disease.	[Casselli, Timothy; Qureshi, Humaira; Peterson, Elizabeth; Perley, Danielle; Blake, Emily; Jokinen, Bradley; Abbas, Ata; Nechaev, Sergei; Watt, John A.; Dhasarathy, Archana; Brissette, Catherine A.] Univ North Dakota, Dept Biomed Sci, Sch Med & Hlth Sci, Grand Forks, ND 58201 USA; [Qureshi, Humaira] Habib Univ, Karachi, Pakistan; [Blake, Emily] Nova Southeastern Univ, Ft Lauderdale, FL USA	University of North Dakota Grand Forks; Nova Southeastern University	Dhasarathy, A; Brissette, CA (corresponding author), Univ North Dakota, Dept Biomed Sci, Sch Med & Hlth Sci, Grand Forks, ND 58201 USA.	archana.dhasarathy@med.und.edu; catherine.brissette@med.und.edu	Nechaev, Sergei/AAQ-3450-2021	Casselli, Timothy/0000-0003-1954-2443; Blake, Emily/0000-0001-5556-7061; Abbas, Ata/0000-0001-8272-1853; Brissette, Catherine/0000-0003-0792-1403	NIH [P20GM104360-01, R21A1125775-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI125775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104360] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH P20GM104360-01 to SN, AD and CAB, https:// projectreporter.nih.gov./project_info _description. cfm?aid=9100426& NIH R21A1125775-01 to AD and CAB, hittps://projectreporter.nih.gov/project_info_description. cfm?aid=9164595& and a UND Faculty Seed Grant to CAB and JAW.; The authors thank Adam Scheidegger, Director of the UND Epigenomics core, and members of the Dhasarathy and Brissette laboratories for helpful discussion, critical evaluation and reading of the manuscript. This work was supported by NIH P20GM104360-01 to SN, AD and CAB; NIH R21AI125775-01 to AD and CAB, and a UND Faculty Seed Grant to CAB and JAW.	Adrion ER, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116767; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrews S., 2010, FASTQC QUALITY CONTR; Arden KC, 2008, ONCOGENE, V27, P2345, DOI 10.1038/onc.2008.27; Aucott JN, 2015, INFECT DIS CLIN N AM, V29, P309, DOI 10.1016/j.idc.2015.02.012; Back T, 2013, J NEUROL, V260, P1569, DOI 10.1007/s00415-013-6831-4; Bacon R.M., 2006, MMWR SURVEILL SUMM, V57, P1; Bai Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep35642; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Batheja S, 2013, J NEUROPSYCH CLIN N, V25, P176, DOI 10.1176/appi.neuropsych.12090223; Bohr S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140440; Bonneh-Barkay D, 2008, AM J PATHOL, V173, P130, DOI 10.2353/ajpath.2008.080045; Bonneh-Barkay D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-34; Brenu EW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102783; Brissette CA, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00041; Brissette CA, 2013, ASN NEURO, V5, DOI 10.1042/AN20130010; Brissette CA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-249; Bunikis I, 2011, J MICROBIOL METH, V86, P243, DOI 10.1016/j.mimet.2011.05.004; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Cardoso AL, 2016, CURR OPIN PHARMACOL, V26, P1, DOI 10.1016/j.coph.2015.09.001; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Cuzzocrea S, 2005, FASEB J, V19, P1253, DOI 10.1096/fj.04-3556com; Dela Cruz CS, 2012, CELL HOST MICROBE, V12, P34, DOI 10.1016/j.chom.2012.05.017; Fallon BA, 2010, NEUROBIOL DIS, V37, P534, DOI 10.1016/j.nbd.2009.11.016; Ferracin M, 2011, SEMIN ONCOL, V38, P764, DOI 10.1053/j.seminoncol.2011.08.005; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Gu L, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/265868; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; Hartiala P, 2007, J LEUKOCYTE BIOL, V82, P33, DOI 10.1189/jlb.1106709; Hinckley AF, 2014, CLIN INFECT DIS, V59, P676, DOI 10.1093/cid/ciu397; Hooper M, 2007, J CLIN PATHOL, V60, P466, DOI 10.1136/jcp.2006.042408; Issler O, 2014, NEURON, V83, P344, DOI 10.1016/j.neuron.2014.05.042; Jacek E, 2013, J NEUROIMMUNOL, V255, P85, DOI 10.1016/j.jneuroim.2012.10.011; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Kawada M, 2008, LAB INVEST, V88, P883, DOI 10.1038/labinvest.2008.47; Khan S, 2015, CASE REP NEUROL, V7, P162, DOI 10.1159/000438696; Koedel U, 2015, NAT REV NEUROL, V11, P446, DOI 10.1038/nrneurol.2015.121; Kohm AP, 2004, J IMMUNOL, V172, P4686, DOI 10.4049/jimmunol.172.8.4686; Komaroff AL, 2015, ANN INTERN MED, V162, P871, DOI 10.7326/M15-0647; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; LaFrance ME, 2011, INFECT IMMUN, V79, P3249, DOI 10.1128/IAI.05122-11; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Li F, 2016, CANC RES; Lochhead RB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135142; Lochhead RB, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004212; Magnusson JP, 2016, DEVELOPMENT, V143, P1075, DOI 10.1242/dev.133975; Marion CR, 2016, INFECT IMMUN, V84, P2094, DOI 10.1128/IAI.00055-16; Mead PS, 2015, INFECT DIS CLIN N AM, V29, P187, DOI 10.1016/j.idc.2015.02.010; Michell-Robinson MA, 2015, BRAIN, V138, P1138, DOI 10.1093/brain/awv066; Miller JC, 2003, INFECT IMMUN, V71, P6943, DOI 10.1128/IAI.71.12.6943-6952.2003; Mizoguchi E, 2006, GASTROENTEROLOGY, V130, P398, DOI 10.1053/j.gastro.2005.12.007; Moraga-Amaro R, 2014, J PHYSIOL-PARIS, V108, P240, DOI 10.1016/j.jphysparis.2014.08.005; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Myers TA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000659; Nelson CA, 2015, EMERG INFECT DIS, V21, P1625, DOI 10.3201/eid2109.150417; Ouyang YB, 2014, NEUROSCI LETT, V565, P53, DOI 10.1016/j.neulet.2013.11.015; Parthasarathy G, 2013, APOPTOSIS; Parthasarathy G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0274-z; Parthasarathy G, 2013, NEUROSCI LETT, V556, P200, DOI 10.1016/j.neulet.2013.10.032; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Ramesh G, 2015, AM J PATHOL IN PRESS; Ramesh G, 2008, AM J PATHOL, V173, P1415, DOI 10.2353/ajpath.2008.080483; Ramesh G, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-72; Rao P, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00039; Reczko M, 2012, BIOINFORMATICS, V28, P771, DOI 10.1093/bioinformatics/bts043; Rhodes RG, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-21; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rupprecht TA, 2008, MOL MED, V14, P205, DOI 10.2119/2007-00091.Rupprecht; Schmidt H, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0386-1; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schramm F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040046; Stevanato L, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt437; Su W, 2015, BRAIN BEHAV IMMUN; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wolfrum C, 2003, J CLIN INVEST, V112, P345, DOI 10.1172/JCI18698; You S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007848; Zajkowska J, 2015, INFECT DIS-NOR, V47, P1, DOI 10.3109/00365548.2014.961544; Zuckert WR, 2007, CURR PROTOC MICROBIO	87	18	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170961	10.1371/journal.pone.0170961	http://dx.doi.org/10.1371/journal.pone.0170961			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135303	Green Published, Green Submitted, gold			2022-12-27	WOS:000396124700035
J	Jans, J; Wicht, O; Widjaja, I; Ahout, IML; de Groot, R; Guichelaar, T; Luytjes, W; de Jonge, MI; de Haan, CAM; Ferwerda, G				Jans, Jop; Wicht, Oliver; Widjaja, Ivy; Ahout, Inge M. L.; de Groot, Ronald; Guichelaar, Teun; Luytjes, Willem; de Jonge, Marien I.; de Haan, Cornelis A. M.; Ferwerda, Gerben			Characteristics of RSV-Specific Maternal Antibodies in Plasma of Hospitalized, Acute RSV Patients under Three Months of Age	PLOS ONE			English	Article							SYNCYTIAL VIRUS-INFECTION; NEUTRALIZING ANTIBODIES; FUSION GLYCOPROTEIN; BIRTH-COHORT; INFANTS; RESPONSES; PROTECTION; CHILDREN; IMMUNIZATION; GENERATION	Respiratory syncytial virus (RSV) is the leading cause for respiratory illness that requires hospitalization in infancy. High levels of maternal antibodies can protect against RSV infection. However, RSV-infected infants can suffer from severe disease symptoms even in the presence of high levels of RSV-specific antibodies. This study analyzes several serological characteristics to explore potential deficiencies or surpluses of antibodies that could relate to severe disease symptoms. We compare serum antibodies from hospitalized patients who suffered severe symptoms as well as uninfected infants. Disease severity markers were oxygen therapy, tachypnea, oxygen saturation, admission to the intensive care unit and duration of hospitalization. Antibodies against RSV G protein and a prefusion F epitope correlated with in vitro neutralization. Avidity of RSV-specific IgG antibodies was lower in RSVinfected infants compared to uninfected controls. Severe disease symptoms were unrelated to RSV-specific IgG antibody titers, avidity of RSV-IgG, virus neutralization capacity or titers against pre-and postfusion F or G protein ectodomains and the prefusion F antigenic site O. In conclusion, the detailed serological characterization did not indicate dysfunctional or epitope- skewed composition of serum antibodies in hospitalized RSV-infected infants suffering from severe disease symptoms. It remains unclear, whether specific antibody fractions could diminish disease symptoms.	[Jans, Jop; Wicht, Oliver; Ahout, Inge M. L.; de Groot, Ronald; de Jonge, Marien I.; Ferwerda, Gerben] Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, Dept Pediat,Radboud Inst Mol Life Sci, Nijmegen, Netherlands; [Wicht, Oliver; Guichelaar, Teun; Luytjes, Willem] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [Widjaja, Ivy; de Haan, Cornelis A. M.] Univ Utrecht, Div Virol, Dept Infect Dis & Immunol, Fac Vet Med, Utrecht, Netherlands	Radboud University Nijmegen; Netherlands National Institute for Public Health & the Environment; Utrecht University	Ferwerda, G (corresponding author), Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, Dept Pediat,Radboud Inst Mol Life Sci, Nijmegen, Netherlands.	Gerben.Ferwerda@radboudumc.nl	Guichelaar, Teun/AEQ-7065-2022; de Groot, R./H-8039-2014; Ferwerda, J.G./L-4305-2015; de Jonge, Marien I./P-5869-2015; Ahout, Inge ML/P-8666-2015; Wicht, Oliver/L-8714-2013	Guichelaar, Teun/0000-0002-5112-8923; de Jonge, Marien I./0000-0003-2812-5895; Wicht, Oliver/0000-0003-3266-8075; de Haan, Cornelis/0000-0002-4459-9874	Virgo consortium - Dutch government [FES0908]; Netherlands Genomics Initiative (NGI) [050-060-452]; Dutch Ministry of Health, Welfare and Sport [S112008]	Virgo consortium - Dutch government; Netherlands Genomics Initiative (NGI); Dutch Ministry of Health, Welfare and Sport	GF is supported by the Virgo consortium, funded by the Dutch government project number FES0908, and by the Netherlands Genomics Initiative (NGI) project number 050-060-452. OW and WL are supported by the Strategic Program RIVM (SPR) S112008, Dutch Ministry of Health, Welfare and Sport. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBIZA J, 1992, J GEN VIROL, V73, P2225, DOI 10.1099/0022-1317-73-9-2225; Atwell JE, 2016, J INFECT DIS, V213, P423, DOI 10.1093/infdis/jiv401; Bont L, 2016, INFECT DIS THER, V5, P271, DOI 10.1007/s40121-016-0123-0; Chu HY, 2014, J INFECT DIS, V210, P1582, DOI 10.1093/infdis/jiu316; Cullen LM, 2015, J VIROL, V89, P6835, DOI 10.1128/JVI.00384-15; Eick A, 2008, PEDIATR INFECT DIS J, V27, P207, DOI 10.1097/INF.0b013e31815ac585; Delgado MF, 2009, NAT MED, V15, P34, DOI 10.1038/nm.1894; Freitas GRO, 2011, J MED VIROL, V83, P1826, DOI 10.1002/jmv.22134; GLEZEN WP, 1981, J PEDIATR-US, V98, P708, DOI 10.1016/S0022-3476(81)80829-3; Gomez RS, 2016, IMMUNOLOGY, V147, P55, DOI 10.1111/imm.12541; Habibi MS, 2015, AM J RESP CRIT CARE, V191, P1040, DOI 10.1164/rccm.201412-2256OC; Hancock GE, 1996, J VIROL, V70, P7783, DOI 10.1128/JVI.70.11.7783-7791.1996; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; Krarup A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9143; Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; MURPHY BR, 1986, J CLIN MICROBIOL, V24, P197, DOI 10.1128/JCM.24.2.197-202.1986; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Ngwuta JO, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4241; Nyiro JU, 2015, VACCINE, V33, P1797, DOI 10.1016/j.vaccine.2015.02.039; Polack FP, 2002, J EXP MED, V196, P859, DOI 10.1084/jem.20020781; Rigter A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071072; Shinoff JJ, 2008, J INFECT DIS, V198, P1007, DOI 10.1086/591460; Stensballe LG, 2009, J ALLERGY CLIN IMMUN, V123, P398, DOI 10.1016/j.jaci.2008.10.043; van der Zalm MM, 2009, PEDIATR INFECT DIS J, V28, P472, DOI 10.1097/INF.0b013e318195e26e; van Remmerden Y, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-253; Vermont CL, 2002, INFECT IMMUN, V70, P584, DOI 10.1128/IAI.70.2.584-590.2002; Vissers M, 2014, INFECT IMMUN, V82, P4952, DOI 10.1128/IAI.02150-14; Widjaja I, 2016, J VIROL, V90, P5965, DOI 10.1128/JVI.00235-16; Widjaja I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130829; Widjojoatmodjo MN, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-114; Wright PF, 2002, J INFECT DIS, V185, P1011, DOI 10.1086/339822; Zorc JJ, 2010, PEDIATRICS, V125, P342, DOI 10.1542/peds.2009-2092	33	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170877	10.1371/journal.pone.0170877	http://dx.doi.org/10.1371/journal.pone.0170877			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135305	Green Published, gold, Green Submitted			2022-12-27	WOS:000396124700026
J	Li, M; Carey, J; Cristiano, S; Susztak, K; Coresh, J; Boerwinkle, E; Kao, WHL; Beaty, TH; Kottgen, A; Scharpf, RB				Li, Man; Carey, Jacob; Cristiano, Stephen; Susztak, Katalin; Coresh, Josef; Boerwinkle, Eric; Kao, Wen Hong L.; Beaty, Terri H.; Koettgen, Anna; Scharpf, Robert B.			Genome-Wide Association of Copy Number Polymorphisms and Kidney Function	PLOS ONE			English	Article							SERUM CYSTATIN-C; RENAL-FUNCTION; CNV ANALYSIS; DISEASE; CREATININE; DELETIONS; LINKAGE; GENE; GFR; SNP	Genome-wide association studies (GWAS) using single nucleotide polymorphisms (SNPs) have identified more than 50 loci associated with estimated glomerular filtration rate (eGFR), a measure of kidney function. However, significant SNPs account for a small proportion of eGFR variability. Other forms of genetic variation have not been comprehensively evaluated for association with eGFR. In this study, we assess whether changes in germline DNA copy number are associated with GFR estimated from serum creatinine, eGFRcrea. We used hidden Markov models (HMMs) to identify copy number polymorphic regions (CNPs) from highthroughput SNP arrays for 2,514 African (AA) and 8,645 European ancestry (EA) participants in the Atherosclerosis Risk in Communities (ARIC) study. Separately for the EA and AA cohorts, we used Bayesian Gaussian mixture models to estimate copy number at regions identified by the HMM or previously reported in the HapMap Project. We identified 312 and 464 autosomal CNPs among individuals of EA and AA, respectively. Multivariate models adjusted for SNP-derived covariates of population structure identified one CNP in the EA cohort near genome-wide statistical significance (Bonferroni-adjusted p = 0.067) located on chromosome 5 (876-880kb). Overall, our findings suggest a limited role of CNPs in explaining eGFR variability.	[Li, Man; Carey, Jacob; Coresh, Josef; Kao, Wen Hong L.; Beaty, Terri H.; Koettgen, Anna] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Li, Man] Univ Utah, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Salt Lake City, UT USA; [Cristiano, Stephen] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Susztak, Katalin] Univ Penn, Perelman Sch Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA; [Coresh, Josef; Kao, Wen Hong L.] Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Koettgen, Anna] Univ Freiburg, Fac Med, Med Ctr, Div Genet Epidemiol, Freiburg, Germany; [Scharpf, Robert B.] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Utah System of Higher Education; University of Utah; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Pennsylvania; Pennsylvania Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Freiburg; Johns Hopkins University; Johns Hopkins Medicine	Scharpf, RB (corresponding author), Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD 21205 USA.	rscharpf@jhu.edu	Li, Man/AAX-3400-2020; Susztak, Katalin/ABE-7474-2021	Li, Man/0000-0002-3839-0281; Susztak, Katalin/0000-0002-1005-3726	National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, R01HL087641, R01HL59367, R01HL086694]; National Human Genome Research Institute [U01HG004402]; National Institutes of Health [HHSN268200625226C, T32-HL0072024]; NIH [5RC2HL102419]; German Research Foundation [KO 3598/2-1];  [UL1RR025005]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087635, DP3DK108220] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C), R01HL087641, R01HL59367 and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. Funding support for "Building on GWAS for NHLBI-diseases: the U.S. CHARGE consortium" was provided by the NIH through the American Recovery and Reinvestment Act of 2009 (ARRA) (5RC2HL102419). ML was supported by a National Heart, Lung, and Blood Institute T32-HL0072024 Cardiovascular Epidemiology Training Grant. AK was supported by the Emmy Noether Program (KO 3598/2-1) of the German Research Foundation.	Aerts E, 2016, OBESITY, V24, P970, DOI 10.1002/oby.21435; Bochud M, 2005, KIDNEY INT, V67, P61, DOI 10.1111/j.1523-1755.2005.00055.x; Cao Y, 2016, GENET MED, V18, P1052, DOI 10.1038/gim.2015.216; Cardin N, 2011, GENET EPIDEMIOL, V35, P536, DOI 10.1002/gepi.20604; Caruana G, 2015, PEDIATR NEPHROL, V30, P487, DOI 10.1007/s00467-014-2962-9; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Cox A, 2007, ELAND EFFICIENT LARG; Derks EM, 2013, AM J MED GENET B, V162, P847, DOI 10.1002/ajmg.b.32189; Fernandez-Rozadilla C, 2014, HUM GENET, V133, P525, DOI 10.1007/s00439-013-1390-4; Fox CS, 2004, J AM SOC NEPHROL, V15, P2457, DOI 10.1097/01.ASN.0000135972.13396.6F; Grayson BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015393; Hasstedt SJ, 2015, J OBES, V2015, DOI 10.1155/2015/623431; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Kaminsky EB, EVIDENCE BASED APPRO; Klamt J, 2016, BIRTH DEFECTS RES A, V106, P767, DOI 10.1002/bdra.23539; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Langefeld CD, 2004, AM J KIDNEY DIS, V43, P796, DOI 10.1053/j.ajkd.2003.12.043; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Nahas ME, 2005, KIDNEY INT, V68, P2918, DOI 10.1111/j.1523-1755.2005.00774.x; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Pattaro C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10023; Pattaro C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002584; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Placha G, 2006, DIABETES, V55, P3358, DOI 10.2337/db06-0781; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Sanna-Cherchi S, 2012, AM J HUM GENET, V91, P987, DOI 10.1016/j.ajhg.2012.10.007; Sapkota Y, 2016, CYTOGENETIC GENOME R; Scharpf RB, 2008, ANN APPL STAT, V2, P687, DOI 10.1214/07-AOAS155; Scharpf RB, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-81; Scharpf RB, 2011, J STAT SOFTW, V40, P1; Scharpf RB, 2011, BIOSTATISTICS, V12, P33, DOI 10.1093/biostatistics/kxq043; Shi J, 2016, J INVESTIGATIVE DERM; Stevens LA, 2008, AM J KIDNEY DIS, V51, P395, DOI 10.1053/j.ajkd.2007.11.018; Sutrala SR, 2007, SCHIZOPHR RES, V96, P93, DOI 10.1016/j.schres.2007.07.029; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tin A, GENOME WIDE ASS STUD; Venter JC, 2015, CLIN CHEM, V61, P1207, DOI 10.1373/clinchem.2014.237016; Westland R, 2015, KIDNEY INT, V88, P1402, DOI 10.1038/ki.2015.239; Wheeler E, 2013, NAT GENET, V45, P513, DOI 10.1038/ng.2607; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Younkin SG, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-24; Zhang D, 2009, MOL PSYCHIATR, V14, P376, DOI 10.1038/mp.2008.144; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217	47	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170815	10.1371/journal.pone.0170815	http://dx.doi.org/10.1371/journal.pone.0170815			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135296	Green Published, Green Submitted, gold			2022-12-27	WOS:000396124700022
J	Petrunoff, N; Rissel, C; Wen, LM				Petrunoff, Nick; Rissel, Chris; Wen, Li Ming			"If You Don't Do Parking Management.. Forget Your Behaviour Change, It's Not Going to Work." : Health and Transport Practitioner Perspectives on Workplace Active Travel Promotion	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; BODY-WEIGHT; RE-AIM; PLANS; ASSOCIATIONS; SYDNEY; IMPACT; INTERVENTIONS; AUSTRALIA; BENEFITS	Objectives After having conducted two studies of the effectiveness of workplace travel plans for promot-ing active travel, we investigated health and transport practitioners' perspectives on imple-menting workplace travel plans to share some of the lessons learnt. The objectives of this study were to describe perceived elements of effective workplace travel plans, barriers and enablers to workplace travel planning, their experiences of working with the other profession on travel plan implementation, their recommendations for workplace travel planning, and also to explore similarities and differences in transport and health practitioner perspectives. Materials and Methods Fourteen health and ten transport practitioners who had prior involvement in workplace travel plan programs were purposefully selected from workplaces in Australia. We con-ducted 20 in-depth interviews since data saturation had been reached at this point, and data were subject to framework analysis. Results Perceived essential elements of effective workplace travel plans included parking manage-ment; leadership, organisational commitment and governance; skills and other resources like a dedicated travel plan coordinator; and, pre-conditions including supportive transport infrastructure in the surrounds. Recommendations for promoting travel plans included sup-portive government policy, focusing on business benefits and working at different scales of implementation (e. g. single large worksites and business precincts). Health and transport practitioner perspectives differed, with transport practitioners believing that parking man-agement is the key action for managing travel demand at a worksite. Conclusions Health practitioners implementing travel plans may require training including concepts of travel demand management, and support from transport planners on parking management strategies. Promoting an understanding of the shared travel behaviour change skills of transport and health practitioners may assist further collaboration. For take-up by organisa-tions to be of sufficient scale to create meaningful population level reductions in driving and increases in active travel, promotion and travel plans should be focused on the priorities of the organisations. Supportive government policy is also required.	[Petrunoff, Nick; Rissel, Chris; Wen, Li Ming] Univ Sydney, Sydney Med Sch, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Wen, Li Ming] Sydney Local Hlth Dist, Hlth Promot Serv, Camperdown, NSW, Australia	University of Sydney	Petrunoff, N (corresponding author), Univ Sydney, Sydney Med Sch, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia.	nick.petrunoff@gmail.com	Rissel, Chris/AAH-2423-2019; Wen, Li Ming/ABG-9005-2021; Petrunoff, Nick/O-6190-2019; Rissel, Chris/ABA-5881-2020	Wen, Li Ming/0000-0003-1381-4022; Rissel, Chris/0000-0002-2156-8581; Petrunoff, Nick/0000-0001-9464-2677				[Anonymous], 2016, ACCESS AND PARKING S; [Anonymous], 2016, NSW PREMIERS COUNCIL; [Anonymous], 2016, TRAVEL CHOICES PROGR; Australian Government, 2012, WALKING RIDING AND A; Bamberg S, 2007, TRANSPORTATION, V34, P647, DOI 10.1007/s11116-007-9121-0; Barry Margaret M, 2009, Glob Health Promot, V16, P5, DOI 10.1177/1757975909104097; Brockman R, 2011, PUBLIC HEALTH, V125, P210, DOI 10.1016/j.puhe.2011.01.005; Buehler R, 2016, INTERNATIONAL JOURNA; Buehler R, 2016, TRANSPORT REV, V36, P9, DOI 10.1080/01441647.2015.1069908; Cairns S, 2010, TRANSPORT RES A-POL, V44, P473, DOI 10.1016/j.tra.2010.03.010; Craig P, 2008, DEVELOPING AND EVALU; de Geus B, 2008, SCAND J MED SCI SPOR, V18, P498, DOI 10.1111/j.1600-0838.2007.00729.x; De Gruyter C, 2015, TRANSPORT POLICY, V40, P24, DOI 10.1016/j.tranpol.2015.02.008; De Gruyter C, 2014, TRANSPORT RES REC, P46, DOI 10.3141/2417-06; De Gruyter C, 2014, CITIES, V41, P114, DOI 10.1016/j.cities.2014.06.003; Ding D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094602; Dzewaltowski DA, 2004, ANN BEHAV MED, V28, P75, DOI 10.1207/s15324796abm2802_1; Enoch M, 2012, TRANS MOBIL SER, P1; Enoch M., 2012, TRANSPORT AND MOBILI, P202; Enoch M, 2012, TRANS MOBIL SER, P153; Enoch M, 2012, TRANS MOBIL SER, P125; Glasgow RE, 1999, AM J PUBLIC HEALTH, V89, P1322, DOI 10.2105/AJPH.89.9.1322; Goodman A, 2014, AM J PUBLIC HEALTH, V104, pE38, DOI 10.2105/AJPH.2014.302059; Gordon-Larsen P, 2009, ARCH INTERN MED, V169, P1216, DOI 10.1001/archinternmed.2009.163; Green J., 2018, QUALITATIVE METHODS, VFourth; Grontved A, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004413; Heinen E, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0239-8; Humphreys DK, 2013, PREV MED, V57, P135, DOI 10.1016/j.ypmed.2013.04.008; Keall M, 2015, J EPIDEMIOL COMMUN H, V69, P1184, DOI 10.1136/jech-2015-205466; Macmillan AK, 2013, TRANSPORT POLICY, V29, P249, DOI 10.1016/j.tranpol.2012.06.019; Martin A, 2015, J EPIDEMIOL COMMUN H, V69, P753, DOI 10.1136/jech-2014-205211; Moller NC, 2011, PREV MED, V53, P172, DOI 10.1016/j.ypmed.2011.06.007; Morse JM, 2000, QUAL HEALTH RES, V10, P3, DOI 10.1177/104973200129118183; Mytton OT, 2016, PREV MED, V90, P1, DOI 10.1016/j.ypmed.2016.06.014; Noland RB, 2002, TRANSPORT RES D-TR E, V7, P1, DOI 10.1016/S1361-9209(01)00009-8; Oja P, 2011, SCAND J MED SCI SPOR, V21, P496, DOI 10.1111/j.1600-0838.2011.01299.x; Patrick R, 2011, HEALTH PROMOT J AUST, V22, pS28; Petrunoff N, 2016, PUBLIC HEALTH, V135, P38, DOI 10.1016/j.puhe.2016.02.012; Petrunoff NA, 2013, J ENVIRON PUBLIC HEA, V2013, DOI 10.1155/2013/423035; Petrunoff N, 2016, J TRANSP HEALTH, V3, P61, DOI 10.1016/j.jth.2015.12.001; Petrunoff N, 2015, J TRANSP HEALTH, V2, P563, DOI 10.1016/j.jth.2015.06.007; Petrunoff N, 2013, AUST HEALTH REV, V37, P579, DOI 10.1071/AH13006; Rissel C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-963; Rissel C, 2012, INT J ENV RES PUB HE, V9, P2454, DOI 10.3390/ijerph9072454; Rissel CE, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-8; Ritchie J., 2003, QUALITATIVE RES PRAC, P219, DOI DOI 10.4135/9781452230108; Rye T., 1997, THE IMPLEMENTATION O; Rye T, 2011, J TRANSP GEOGR, V19, P235, DOI 10.1016/j.jtrangeo.2010.05.002; Rye T, 2011, TRANSPORT POLICY, V18, P533, DOI 10.1016/j.tranpol.2010.10.008; Sato KK, 2007, DIABETES CARE, V30, P2296, DOI 10.2337/dc07-0090; Shoup D.C., 1997, TRANSPORT POLICY, V4, P201, DOI [DOI 10.1016/S0967-070X(97)00019-X, 10.1016/S0967-070X(97)00019-X]; Sugiyama T., 2012, J SCI MED SPORT, V15, pS72, DOI DOI 10.1016/J.JSAMS.2012.11.173; Sugiyama T, 2013, AM J PREV MED, V44, P169, DOI 10.1016/j.amepre.2012.09.063; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Wanner M, 2012, AM J PREV MED, V42, P493, DOI 10.1016/j.amepre.2012.01.030; Wen LM, 2006, INT J OBESITY, V30, P782, DOI 10.1038/sj.ijo.0803199; Wennberg P, 2006, EUR J CARDIOV PREV R, V13, P924, DOI 10.1097/01.hjr.0000239470.49003.c3; WILLSON RW, 1990, TRANSPORTATION, V17, P141, DOI 10.1007/BF02125333; Wynne L., 2015, 21 INT C URB TRANSP, P13; Xia T, 2013, J ENVIRON PUBLIC HEA, V2013, DOI 10.1155/2013/797312; Xu HL, 2013, ASIA-PAC J PUBLIC HE, V25, P298, DOI 10.1177/1010539513482965; Yang L, 2012, PREV MED, V55, P453, DOI 10.1016/j.ypmed.2012.08.019; Yeates S, 2012, TRANSPORTATION RESEA	63	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170064	10.1371/journal.pone.0170064	http://dx.doi.org/10.1371/journal.pone.0170064			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6PA	28135301	Green Submitted, gold, Green Published			2022-12-27	WOS:000396124700007
J	Barthel, R; Seidl, R				Barthel, Roland; Seidl, Roman			Interdisciplinary Collaboration between Natural and Social Sciences - Status and Trends Exemplified in Groundwater Research	PLOS ONE			English	Article							MULTIDISCIPLINARY RESEARCH; COCITATION ANALYSIS; CITATION ANALYSIS; WATER; HYDROLOGY; BIBLIOMETRICS; INDICATORS; MANAGEMENT	Interdisciplinary collaboration, particularly between natural and social sciences, is perceived as crucial to solving the significant challenges facing humanity. However, despite the need for such collaboration being expressed more frequently and intensely, it remains unclear to what degree such collaboration actually takes place, what trends and developments there are and which actors are involved. Previous studies, often based on bibliometric analysis of large bodies of literature, partly observed an increase in interdisciplinary collaboration in general, but in particular, the collaboration among distant fields was less explored. Other more qualitative studies found that interdisciplinary collaboration, particularly between natural and social scientists was not well developed, and obstacles abounded. To shed some light on the actual status and developments of this collaboration, we performed an analysis based on a sample of articles on groundwater research. We first identified journals and articles therein that potentially combined natural and social science aspects of groundwater research. Next, we analysed the disciplinary composition of their authors' teams, cited references, titles and keywords, making use of our detailed personal expertise in groundwater research and its interdisciplinary aspects. We combined several indicators developed from this analysis into a final classification of the degree of multidisciplinarity of each article. Covering the period between 1990 and 2014, we found that the overall percentage of multidisciplinary articles was in the low single-digit range, with only slight increases over the past decades. The interdisciplinarity of individuals plays a major role compared to interdisciplinarity involving two or more researchers. If collaboration with natural sciences takes place, social science is represented most often by economists. As a side result, we found that journals publishing multidisciplinary research had lower impact factors on average, and multidisciplinary papers were cited much less than mono-disciplinary ones.	[Barthel, Roland] Univ Gothenburg, Dept Earth Sci, Gothenburg, Sweden; [Seidl, Roman] Swiss Fed Inst Technol, D USYS Transdisciplinar Lab, Zurich, Switzerland	University of Gothenburg; Swiss Federal Institutes of Technology Domain; ETH Zurich	Barthel, R (corresponding author), Univ Gothenburg, Dept Earth Sci, Gothenburg, Sweden.	roland.barthel@gvc.gu.se	Barthel, Roland/F-8723-2011	Barthel, Roland/0000-0003-2004-6199; Seidl, Roman/0000-0002-6658-8789				[Anonymous], 2015, Nature, V525, P305, DOI 10.1038/525305a; ARNSTEIN SR, 1969, J AM I PLANNERS, V35, P216, DOI 10.1080/01944366908977225; Bensman SJ, 2009, J AM SOC INF SCI TEC, V60, P1097, DOI 10.1002/asi.21020; Burell A., 2008, AGRARWIRTSCHAFT, V57, P57; Calatrava Moreno MDC, 2016, SCIENTOMETRICS, V107, P213, DOI 10.1007/s11192-016-1842-4; Campbell LM, 2005, CONSERV BIOL, V19, P574, DOI 10.1111/j.1523-1739.2005.00058.x; Carayol N, 2005, RES EVALUAT, V14, P70, DOI 10.3152/147154405781776355; Cobourn KM, 2015, AM J AGR ECON, V97, P786, DOI 10.1093/ajae/aav001; Fischer ARH, 2011, INTERDISCIPL SCI REV, V36, P341, DOI 10.1179/030801811X13160755918688; Froedeman R, 2010, OXFORD HDB INTERDISC; Galloway DL, 2010, HYDROGEOL J, V18, P807, DOI 10.1007/s10040-010-0585-1; Greaves J, 2010, POLIT STUD-LONDON, V58, P320, DOI 10.1111/j.1467-9248.2009.00828.x; Hadorn G., 2008, HDB TRANSDISCIPLINAR; Hassan SU, 2014, SCIENTOMETRICS, V99, P549, DOI 10.1007/s11192-013-1193-3; HEBERLEIN TA, 1988, SOC NATUR RESOUR, V1, P5, DOI 10.1080/08941928809380634; Hood WW, 2001, SCIENTOMETRICS, V52, P291, DOI 10.1023/A:1017919924342; Huberli R., 2001, TRANSDISCIPLINARITY, P6; Huutoniemi K, 2010, RES POLICY, V39, P79, DOI 10.1016/j.respol.2009.09.011; Jahn T, 2012, ECOL ECON, V79, P1, DOI 10.1016/j.ecolecon.2012.04.017; KANAZAWA MT, 1992, WATER RESOUR RES, V28, P1507, DOI 10.1029/92WR00198; King C, 2012, AMBIO, V41, P490, DOI 10.1007/s13280-012-0255-8; Langevin CD, 2012, GROUND WATER, V50, P333, DOI 10.1111/j.1745-6584.2012.00937.x; Ledford H., 2015, NATURE, V76, P2445; Lerner DN, 2011, WATER ENVIRON J, V25, P345, DOI 10.1111/j.1747-6593.2010.00229.x; Levitt JM, 2008, J AM SOC INF SCI TEC, V59, P1973, DOI 10.1002/asi.20914; Leydesdorff L, 2010, J INFORMETR, V4, P644, DOI 10.1016/j.joi.2010.05.003; Leydesdorff L, 2009, J AM SOC INF SCI TEC, V60, P348, DOI 10.1002/asi.20967; Liu JG, 2007, AMBIO, V36, P639, DOI 10.1579/0044-7447(2007)36[639:CHANS]2.0.CO;2; Lund JR, 2015, WATER RESOUR RES, V51, P5905, DOI 10.1002/2015WR017125; Madani K, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR010849; Merkx F, 2008, RES EVALUAT, V17, P4, DOI 10.3152/095820208X280880; Miller CT, 2002, GROUND WATER, V40, P224, DOI 10.1111/j.1745-6584.2002.tb02650.x; Montanari A, 2013, HYDROLOG SCI J, V58, P1256, DOI 10.1080/02626667.2013.809088; Montanari A, 2015, WATER RESOUR RES, V51, P6797, DOI 10.1002/2015WR017998; Mugabushaka AM, 2016, SCIENTOMETRICS, V107, P593, DOI 10.1007/s11192-016-1865-x; Osareh F, 1996, LIBRI, V46, P149, DOI 10.1515/libr.1996.46.3.149; Osareh F, 1996, LIBRI, V46, P217, DOI 10.1515/libr.1996.46.4.217; Phillipson J, 2006, J AGR ECON, V57, P163, DOI 10.1111/j.1477-9552.2006.00044.x; Porter AL, 2007, SCIENTOMETRICS, V72, P117, DOI 10.1007/s11192-007-1700-5; Porter AL, 2009, SCIENTOMETRICS, V81, P719, DOI 10.1007/s11192-008-2197-2; Pudovkin AI, 2004, P ASIST ANNU, V41, P507, DOI 10.1002/meet.1450410159; Reddy VR, 2014, J HYDROL, V518, P1, DOI 10.1016/j.jhydrol.2014.06.022; Repko A.F., 2011, CASE STUDIES INTERDI; Ross A, 2012, WATER POLICY, V14, P709, DOI 10.2166/wp.2012.129; Roy ED, 2013, BIOSCIENCE, V63, P745, DOI 10.1093/bioscience/63.9.745; Rylance R, 2015, NATURE, V525, P313, DOI 10.1038/525313a; Savenije HHG, 2008, PHYS CHEM EARTH, V33, P290, DOI 10.1016/j.pce.2008.02.003; Schwartz FW, 2013, GROUND WATER, V51, P1, DOI 10.1111/gwat.12008; Shiklomanov IA, 2000, WATER INT, V25, P11, DOI 10.1080/02508060008686794; Sivapalan M, 2012, HYDROL PROCESS, V26, P1270, DOI 10.1002/hyp.8426; Strang V., 2015, EVALUATING INTERDISC; Strang V., 2007, ENV DEV SUSTAIN, V11, P1, DOI DOI 10.1007/S10668-007-9095-2; Szostak R, 2015, NATURE, V526, P506, DOI 10.1038/526506d; Taher TM, 2016, HYDROGEOL J, V24, P1593, DOI 10.1007/s10040-016-1435-6; Taylor RG, 2013, NAT CLIM CHANGE, V3, P322, DOI [10.1038/nclimate1744, 10.1038/NCLIMATE1744]; Uiterkamp AJMS, 2007, J SOC ISSUES, V63, P175, DOI 10.1111/j.1540-4560.2007.00502.x; Van Noorden R, 2015, NATURE, V525, P306, DOI 10.1038/525306a; van Rijnsoever FJ, 2011, RES POLICY, V40, P463, DOI 10.1016/j.respol.2010.11.001; Vasbinder JW, 2010, NATURE, V463, P876, DOI 10.1038/463876a; Viseu A, 2015, NATURE, V525, P291, DOI 10.1038/525291a; Vogel RM, 2015, WATER RESOUR RES, V51, P4409, DOI 10.1002/2015WR017049; Wagener T, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008906; Wagner CS, 2011, J INFORMETR, V5, P14, DOI 10.1016/j.joi.2010.06.004; Wang Q, 2016, J INFORMETR, V10, P347, DOI 10.1016/j.joi.2016.02.003; Wood WW, 2012, GROUND WATER, V50, P167, DOI 10.1111/j.1745-6584.2011.00900.x; Yegros-Yegros A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135095	66	36	37	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170754	10.1371/journal.pone.0170754	http://dx.doi.org/10.1371/journal.pone.0170754			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7VX	28129352	gold, Green Published, Green Submitted			2022-12-27	WOS:000396211400039
J	Yasgar, A; Titus, SA; Wang, YH; Danchik, C; Yang, SM; Vasiliou, V; Jadhav, A; Maloney, DJ; Simeonov, A; Martinez, NJ				Yasgar, Adam; Titus, Steven A.; Wang, Yuhong; Danchik, Carina; Yang, Shyh-Ming; Vasiliou, Vasilis; Jadhav, Ajit; Maloney, David J.; Simeonov, Anton; Martinez, Natalia J.			A High-Content Assay Enables the Automated Screening and Identification of Small Molecules with Specific ALDH1A1-Inhibitory Activity	PLOS ONE			English	Article							HUMAN ALDEHYDE DEHYDROGENASES; HUMAN MITOCHONDRIAL; ALDH1A1; CANCER; INHIBITOR; ALCOHOL; CONTRIBUTES; METASTASIS; VALIDATION; EXPRESSION	Aldehyde dehydrogenase enzymes (ALDHs) have a broad spectrum of biological activities through the oxidation of both endogenous and exogenous aldehydes. Increased expression of ALDH1A1 has been identified in a wide-range of human cancer stem cells and is associated with cancer relapse and poor prognosis, raising the potential of ALDH1A1 as a therapeutic target. To facilitate quantitative high-throughput screening (qHTS) campaigns for the discovery, characterization and structure-activity-relationship (SAR) studies of small molecule ALDH1A1 inhibitors with cellular activity, we show herein the miniaturization to 1536-well format and automation of a high-content cell-based ALDEFLUOR assay. We demonstrate the utility of this assay by generating dose-response curves on a comprehensive set of prior art inhibitors as well as hundreds of ALDH1A1 inhibitors synthesized in house. Finally, we established a screening paradigm using a pair of cell lines with low and high ALDH1A1 expression, respectively, to uncover novel cell-active ALDH1A1-specific inhibitors from a collection of over 1,000 small molecules.	[Yasgar, Adam; Titus, Steven A.; Wang, Yuhong; Danchik, Carina; Yang, Shyh-Ming; Jadhav, Ajit; Maloney, David J.; Simeonov, Anton; Martinez, Natalia J.] NIH, Natl Ctr Adv Translat Sci, Rockville, MD 20852 USA; [Vasiliou, Vasilis] Yale Sch Publ Hlth, Dept Environm Hlth Sci, New Haven, CT USA	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Yale University	Simeonov, A; Martinez, NJ (corresponding author), NIH, Natl Ctr Adv Translat Sci, Rockville, MD 20852 USA.	asimeono@mail.nih.gov; natalia.martinez@nih.gov		Jadhav, Ajit/0000-0001-7955-1451; vasiliou, vasilis/0000-0003-2552-3118; Danchik, Carina/0000-0003-2032-3467; Yasgar, Adam/0000-0001-7350-1402	National Center for Advancing Translational Sciences; NIH grants [M022057, EY11490]; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIATR000192, UL1TR001863] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the intramural research program (IRP) of the National Center for Advancing Translational Sciences and in part by NIH grants M022057 and EY11490.; This work was supported by the intramural research program of the National Center for Advancing Translational Sciences. We thank Carleen Klumpp-Thomas for assistance with assay automation and the compound management group (Paul Shinn, Danielle Bougie, Crystal McKnight, Misha Itkin, and Zina Itkin) for sourcing, quality control, formatting, and plating all compounds.	Arolfo MP, 2009, ALCOHOL CLIN EXP RES, V33, P1935, DOI 10.1111/j.1530-0277.2009.01031.x; Banh A, 2011, CLIN CANCER RES, V17, P7265, DOI 10.1158/1078-0432.CCR-11-0179; Buckanovich RL, 2013, US Patent, Patent No. [US 20150297577, 20150297577]; Chen C.H., 2014, PCT Patent WO, Patent No. [2014160034., 2014160034]; Chen CH, 2014, PHYSIOL REV, V94, P1, DOI 10.1152/physrev.00017.2013; Condello S, 2015, ONCOGENE, V34, P2297, DOI 10.1038/onc.2014.178; Davis MI, 2016, ASSAY DRUG DEV TECHN, V14, P207, DOI 10.1089/adt.2016.706; Haas J, 2004, ASSAY GUIDANCE MANUA; Hong IS, 2015, RECENT PAT ANTI-CANC, V10, P2; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Jackson Brian, 2011, Human Genomics, V5, P283; Kahlert C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-275; KEUNG WM, 1993, P NATL ACAD SCI USA, V90, P1247, DOI 10.1073/pnas.90.4.1247; Khanna M, 2011, J BIOL CHEM, V286, P43486, DOI 10.1074/jbc.M111.293597; Kiefer FW, 2012, ENDOCRINOLOGY, V153, P3089, DOI 10.1210/en.2011-2104; Kiefer FW, 2012, NAT MED, V18, P918, DOI 10.1038/nm.2757; Kim J, 2015, INT J QUAL STUD HEAL, V10, DOI 10.3402/qhw.v10.27501; Kimble-Hill AC, 2014, J MED CHEM, V57, P714, DOI 10.1021/jm401377v; Koppaka V, 2012, PHARMACOL REV, V64, P520, DOI 10.1124/pr.111.005538; Lam JP, 1997, BIOCHEMISTRY-US, V36, P13748, DOI 10.1021/bi970948e; Lowe ED, 2008, J MED CHEM, V51, P4482, DOI 10.1021/jm800488j; Marcato P, 2011, STEM CELLS, V29, P32, DOI 10.1002/stem.563; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI 10.1517/17425255.4.6.697 ; Marchitti SA, 2007, PHARMACOL REV, V59, P125, DOI 10.1124/pr.59.2.1; Ming WY, 2013, ASSAY DRUG DEV TECHN, V11, P388, DOI 10.1089/adt.2013.513; Moreb JS, 2007, CANCER CHEMOTH PHARM, V59, P127, DOI 10.1007/s00280-006-0233-6; Moreb JS, 2012, CHEM-BIOL INTERACT, V195, P52, DOI 10.1016/j.cbi.2011.10.007; Morgan CA, 2015, CHEM-BIOL INTERACT, V234, P18, DOI 10.1016/j.cbi.2014.12.008; Pappa A, 2003, BIOCHEM J, V376, P615, DOI 10.1042/BJ20030810; Parajuli B, 2014, J MED CHEM, V57, P449, DOI 10.1021/jm401508p; Pors K, 2014, DRUG DISCOV TODAY, V19, P1953, DOI 10.1016/j.drudis.2014.09.009; Rodriguez-Torres M, 2016, CLIN EXP METASTAS, V33, P97, DOI 10.1007/s10585-015-9755-9; Sanders TJ, 2014, GASTROENTEROLOGY, V146, P1278, DOI 10.1053/j.gastro.2014.01.057; Schafer A, 2012, NEURO-ONCOLOGY, V14, P1452, DOI 10.1093/neuonc/nos270; Seethala R, 2009, HDB DRUG SCREENING, pxiii; Smith C, 2015, ADV EXP MED BIOL, V815, P349, DOI 10.1007/978-3-319-09614-8_20; Storms RW, 1999, P NATL ACAD SCI USA, V96, P9118, DOI 10.1073/pnas.96.16.9118; Thomas ML, 2016, MOL ONCOLOGY; Tomita H, 2016, ONCOTARGET, DOI 10.18632/oncotarget.6920; Vasiliou V, 2004, DRUG METAB REV, V36, P279, DOI 10.1081/DMR-120034001; Vasiliou V, 2013, CHEM-BIOL INTERACT, V202, P2, DOI 10.1016/j.cbi.2012.10.026; Xiao TL, 2009, J TOXICOL ENV HEAL A, V72, P577, DOI 10.1080/15287390802706371; Xu M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.357707; Xu SL, 2014, INT J CLIN EXP PATHO, V7, P2976; YANG SP, 2015, DYN VEH COUPL SYST, P1, DOI DOI 10.1021/ACS.JMEDCHEM.5B00577; Yao LN, 2010, NAT MED, V16, P1024, DOI 10.1038/nm.2200; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587	48	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170937	10.1371/journal.pone.0170937	http://dx.doi.org/10.1371/journal.pone.0170937			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129349	Green Published, Green Submitted, gold			2022-12-27	WOS:000396211400025
J	Demonte, AM; Diez, MDA; Naleway, C; Iglesias, AA; Ballicora, MA				Demonte, Ana M.; Asencion Diez, Matias D.; Naleway, Conrad; Iglesias, Alberto A.; Ballicora, Miguel A.			Monofluorophosphate Blocks Internal Polysaccharide Synthesis in Streptococcus mutans	PLOS ONE			English	Article							ADP-GLUCOSE PYROPHOSPHORYLASE; IODOPHILIC POLYSACCHARIDE; BIOFILM FORMATION; INTRACELLULAR POLYSACCHARIDE; SODIUM MONOFLUOROPHOSPHATE; GLYCOGEN BIOSYNTHESIS; REGULATORY ENZYME; ORAL STREPTOCOCCI; ESCHERICHIA-COLI; ACID PRODUCTION	Streptococcus mutans is the leading cause of dental caries worldwide by accumulating a glycogen-like internal polysaccharide (IPS) that contributes to cariogenicity when sugars are in excess. Sodium monofluorophosphate (MFP) is an active anticariogenic compound in toothpastes. Herein, we show that MFP inhibits (with an I-0.5 of 1.5 mM) the S. mutans ADPglucose pyrophosphorylase (EC 2.7.7.27), which catalyzes the key step in IPS biosynthesis. Enzyme inhibition by MFP is similar to orthophosphate (Pi), except that the effect caused by MFP is not reverted by fructose-1,6-bisP, as occurs with Pi. Inhibition was correlated with a decrease in acidogenesis and IPS accumulation in S. mutans cells cultured with 2 mM sodium MFP. These effects were not mimicked by sodium fluoride. Considering that glycogen synthesis occurs by different pathways in mammals and bacteria, ADP-glucose pyrophosphorylase could be visualized as a molecular target for controlling S. mutans virulence. Our results strongly suggest that MFP is a suitable compound to affect such a target, inducing an anticariogenic effect primarily by inhibiting a key step in IPS synthesis.	[Demonte, Ana M.; Asencion Diez, Matias D.; Iglesias, Alberto A.] UNL, CONICET, Lab Enzimol Mol, Inst Agrobiotecnol Litoral, Santa Fe, Argentina; [Naleway, Conrad; Ballicora, Miguel A.] Loyola Univ Chicago, Dept Chem & Biochem, Chicago, IL 60611 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the Littoral; Loyola University Chicago	Ballicora, MA (corresponding author), Loyola Univ Chicago, Dept Chem & Biochem, Chicago, IL 60611 USA.	mballic@luc.edu		Asencion Diez, Matias Damian/0000-0001-6495-387X; Ballicora, Miguel/0000-0002-5324-0724; Iglesias, Alberto/0000-0001-9729-7338	Colgate Research Funds; UNL [CAI+D]; ANPCyT [PICT'14 3256, PICT'14 3362]; National Science Foundation [MCB 1024945]	Colgate Research Funds; UNL [CAI+D]; ANPCyT(ANPCyT); National Science Foundation(National Science Foundation (NSF))	This work was supported by Colgate Research Funds (CN) and by grants to AAI from UNL [CAI+D], ANPCyT [PICT'14 3256] and to MDAD [PICT'14 3362] and to MAB from the National Science Foundation [MCB 1024945]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MDAD and AAI are members of the Research Career from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold Wolfgang H, 2007, BMC Oral Health, V7, P14, DOI 10.1186/1472-6831-7-14; Ballicora MA, 2004, PHOTOSYNTH RES, V79, P1, DOI 10.1023/B:PRES.0000011916.67519.58; Ballicora MA, 2003, MICROBIOL MOL BIOL R, V67, P213, DOI 10.1128/MMBR.67.2.213-225.2003; Ballicora MA, 2007, J BACTERIOL, V189, P5325, DOI 10.1128/JB.00481-07; Bonafonte MA, 2000, FEMS MICROBIOL LETT, V191, P31, DOI 10.1016/S0378-1097(00)00366-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Busuioc M, 2009, J BACTERIOL, V191, P7315, DOI 10.1128/JB.00425-09; BUTTERWORTH PJ, 1972, BIOCHIM BIOPHYS ACTA, V289, P251, DOI 10.1016/0005-2744(72)90074-5; CURRAN TM, 1994, FEMS MICROBIOL LETT, V119, P283; Diez MD, 2013, MOL MICROBIOL; DIPERSIO JR, 1974, INFECT IMMUN, V10, P597, DOI 10.1128/IAI.10.3.597-604.1974; ELBEIN AD, 1973, J BACTERIOL, V113, P863, DOI 10.1128/JB.113.2.863-873.1973; HANDELMAN SL, 1973, J DENT RES, V52, P651, DOI 10.1177/00220345730520040301; Hernandez MA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-600; Jackson DW, 2002, J BACTERIOL, V184, P290, DOI 10.1128/JB.184.1.290-301.2002; KAUFMANN M, 1992, CARIES RES, V26, P110, DOI 10.1159/000261494; KIEL JAKW, 1994, MOL MICROBIOL, V11, P203, DOI 10.1111/j.1365-2958.1994.tb00301.x; Klein MI, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00010; Klimek J, 1997, ARCH ORAL BIOL, V42, P181, DOI 10.1016/S0003-9969(96)00118-5; Krzysciak W, 2014, EUR J CLIN MICROBIOL, V33, P499, DOI 10.1007/s10096-013-1993-7; Leme AFP, 2006, J DENT RES, V85, P878, DOI 10.1177/154405910608501002; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; MARQUIS RE, 1995, CAN J MICROBIOL, V41, P955, DOI 10.1139/m95-133; Marquis RE, 2003, FEMS MICROBIOL REV, V26, P493, DOI 10.1111/j.1574-6976.2003.tb00627.x; Pearce Ei D G H, 1995, J DENT RES, V74, P691; Ren Z, 2016, J ORAL MICROBIOL, V8, DOI 10.3402/jom.v8.31095; Saporito RA, 2000, AM J DENT, V13, P221; SPATAFORA G, 1995, INFECT IMMUN, V63, P2556, DOI 10.1128/IAI.63.7.2556-2563.1995; Takahashi N, 2011, J DENT RES, V90, P294, DOI 10.1177/0022034510379602; Takata H, 1997, J BACTERIOL, V179, P4689, DOI 10.1128/jb.179.15.4689-4698.1997; Trinder P., 1969, ANN CLIN BIOCHEM, V6, p24?27, DOI DOI 10.1177/000456326900600108; VANHOUTE J, 1969, ARCH ORAL BIOL, V14, P45, DOI 10.1016/0003-9969(69)90020-X; VANHOUTE J, 1970, ARCH ORAL BIOL, V15, P263, DOI 10.1016/0003-9969(70)90084-1; WEGMAN MR, 1984, J DENT RES, V63, P1126, DOI 10.1177/00220345840630090601; Wiegand A, 2007, DENT MATER, V23, P343, DOI 10.1016/j.dental.2006.01.022; Yep A, 2004, ANAL BIOCHEM, V324, P52, DOI 10.1016/j.ab.2003.09.024	36	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170483	10.1371/journal.pone.0170483	http://dx.doi.org/10.1371/journal.pone.0170483			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125652	Green Published, gold, Green Submitted			2022-12-27	WOS:000396176100104
J	Eick, S; Meier, I; Spoerle, F; Bender, P; Aoki, A; Izumi, Y; Salvi, GE; Sculean, A				Eick, Sigrun; Meier, Ivan; Spoerle, Florian; Bender, Philip; Aoki, Akira; Izumi, Yuichi; Salvi, Giovanni E.; Sculean, Anton			In Vitro-Activity of Er: YAG Laser in Comparison with other Treatment Modalities on Biofilm Ablation from Implant and Tooth Surfaces	PLOS ONE			English	Article							CONTROLLED CLINICAL-TRIAL; PERI-IMPLANTITIS; ERYAG LASER; PERIODONTOPATHIC BACTERIA; PERIODONTITIS TREATMENT; NONSURGICAL TREATMENT; ENDODONTIC PATHOGENS; TITANIUM IMPLANTS; ALUMINUM-GARNET; ER/YAG LASER	Background and Aim Bacterial biofilms play a major role in the etiology of periodontal and peri-implant diseases. The aim of the study was to evaluate the removal of bacterial biofilms and attachment of epithelial cells (EC), gingival fibroblasts (GF) and osteoblast-like cells (OC) to dentin and titanium surfaces after Er: YAG laser (Er: YAG) in comparison with other treatment methods. Material and Methods Multi-species bacterial biofilms were grown on standardized dentin and titanium specimens with a sand-blasted and acid etched (SLA) surface for 3.5 d. Thereafter, the specimens were placed into artificially-created pockets. The following methods for biofilm removal were used: 1) Gracey (dentin) or titanium curettes (CUR), 2) Er: YAG, 3) photodynamic therapy (PDT) and 4) CUR with adjunctive PDT (CUR/PDT). Colony forming units (CFUs) of the remaining biofilms and attachment of EC, GF and OC were determined. Statistical analysis was performed by means of ANOVA with post-hoc LSD. Results All treatment methods decreased statistically significantly (p<0.001) total CFUs in biofilms compared with untreated dentin and titanium surfaces respectively. On dentin, Er: YAG was equally efficient as CUR and PDT but inferior to CUR/PDT (p = 0.005). On titanium, surfaces, the use of Er: YAG resulted in statistically significantly superior biofilm removal compared to the 3 other treatments (each p<0.001). Counts of attached EC, GF and OC were the lowest on untreated contaminated dentin and titanium surfaces each. After CUR/PDT higher EC counts were found on dentin (p = 0.006). On titanium, all decontamination methods statistically significantly increased (p<0.001) the counts of attached EC without differences between groups. Statistically significantly higher counts of GF (p = 0.024) and OC (p<0.001) were observed after Er: YAG decontamination compared with untreated surfaces. Conclusion Ablation of subgingival biofilms and in particular decontamination of titanium implant surfaces with an Er: YAG laser seem to be a promising approach and warrants further investigations.	[Eick, Sigrun; Meier, Ivan; Spoerle, Florian; Bender, Philip; Salvi, Giovanni E.; Sculean, Anton] Univ Bern, Sch Dent, Dept Periodontol, Bern, Switzerland; [Aoki, Akira; Izumi, Yuichi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Tokyo, Japan	University of Bern; Tokyo Medical & Dental University (TMDU)	Eick, S (corresponding author), Univ Bern, Sch Dent, Dept Periodontol, Bern, Switzerland.	sigrun.eick@zmk.unibe.ch		Eick, Sigrun/0000-0002-4619-2461	J. Morita Manufacturing Corporation, Kyoto, Japan; Grants-in-Aid for Scientific Research [16K11825] Funding Source: KAKEN	J. Morita Manufacturing Corporation, Kyoto, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study was supported by a research grant from J. Morita Manufacturing Corporation, Kyoto, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama F, 2011, LASER MED SCI, V26, P193, DOI 10.1007/s10103-010-0763-3; Ando Y, 1996, LASER SURG MED, V19, P190; Aoki A, 2015, PERIODONTOL 2000, V68, P217, DOI 10.1111/prd.12080; Apatzidou Danae A, 2010, Dent Clin North Am, V54, P1, DOI 10.1016/j.cden.2009.08.006; Ayobian-Markazi N, 2015, LASER MED SCI, V30, P561, DOI 10.1007/s10103-013-1361-y; Bassetti M, 2014, CLIN ORAL IMPLAN RES, V25, P279, DOI 10.1111/clr.12155; Brulat Nathalie, 2013, Laser Ther, V22, P187, DOI 10.3136/islsm.22.187; Coluzzi Donald J, 2004, Dent Clin North Am, V48, P751, DOI 10.1016/j.cden.2004.05.003; Correa MG, 2015, LASERS SURG MED; Eick S, 2016, CLIN ORAL IMPLAN RES, V27, P218, DOI 10.1111/clr.12588; Eick S, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-9; Eick S, 2011, DIAGN MICR INFEC DIS, V69, P12, DOI 10.1016/j.diagmicrobio.2010.08.017; Friedmann A, 2006, J BIOMED MATER RES A, V79A, P53, DOI 10.1002/jbm.a.30699; Furst MM, 2007, CLIN ORAL IMPLAN RES, V18, P501, DOI 10.1111/j.1600-0501.2007.01381.x; Giannelli M, 2015, PHOTOMED LASER SURG, V33, P473, DOI 10.1089/pho.2015.3955; GOLDMAN L, 1964, NATURE, V203, P417, DOI 10.1038/203417a0; Green James, 2011, Dent Clin North Am, V55, P585, DOI 10.1016/j.cden.2011.02.017; Hagi TT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131056; Henderson B, 2003, ANNU REV MICROBIOL, V57, P29, DOI 10.1146/annurev.micro.57.030502.090908; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Hubbezoglu I, 2013, PHOTOMED LASER SURG, V31, P201, DOI 10.1089/pho.2012.3411; Hultin M, 2002, CLIN ORAL IMPLAN RES, V13, P349, DOI 10.1034/j.1600-0501.2002.130402.x; Kreisler M, 2005, CLIN ORAL IMPLAN RES, V16, P36, DOI 10.1111/j.1600-0501.2004.01056.x; Krohn-Dale I, 2012, J CLIN PERIODONTOL, V39, P745, DOI 10.1111/j.1600-051X.2012.01912.x; Leja C, 2013, LASER MED SCI, V28, P1435, DOI 10.1007/s10103-012-1215-z; Meire MA, 2012, LASER MED SCI, V27, P695, DOI 10.1007/s10103-011-0940-z; Muthukuru M, 2012, CLIN ORAL IMPLAN RES, V23, P77, DOI 10.1111/j.1600-0501.2012.02542.x; Noiri Y, 2008, J ENDODONT, V34, P826, DOI 10.1016/j.joen.2008.04.010; Persson GR, 2011, J PERIODONTOL, V82, P1267, DOI 10.1902/jop.2011.100660; Quirynen M, 2006, CLIN ORAL IMPLAN RES, V17, P25, DOI 10.1111/j.1600-0501.2005.01194.x; Renvert S, 2008, J CLIN PERIODONTOL, V35, P305, DOI 10.1111/j.1600-051X.2008.01276.x; Sanz-sanchez I, 2015, CLIN ORAL INVEST; Schwarz F, 2005, CLIN ORAL INVEST, V9, P111, DOI 10.1007/s00784-005-0305-8; Schwarz F, 2005, CLIN ORAL IMPLAN RES, V16, P44, DOI 10.1111/j.1600-0501.2004.01051.x; Schwarz F, 2011, J CLIN PERIODONTOL, V38, P276, DOI 10.1111/j.1600-051X.2010.01690.x; Sennhenn-Kirchner S, 2009, LASER MED SCI, V24, P313, DOI 10.1007/s10103-008-0561-3; Shibli JA, 2008, CLIN ORAL IMPLAN RES, V19, P975, DOI 10.1111/j.1600-0501.2008.01566.x; Shin SI, 2011, LASER MED SCI, V26, P767, DOI 10.1007/s10103-010-0819-4; Tomasi C, 2006, J PERIODONTOL, V77, P111, DOI 10.1902/jop.2006.77.1.111; Lopes BMV, 2010, J PERIODONTOL, V81, P682, DOI 10.1902/jop.2010.090300; Yamamoto A, 2013, INT J PERIODONT REST, V33, P21, DOI 10.11607/prd.1593; Yan MD, 2015, LASER MED SCI, V30, P1843, DOI 10.1007/s10103-014-1692-3; Yilmaz S, 2012, PHOTOMED LASER SURG, V30, P325, DOI 10.1089/pho.2010.2762; Zhao YH, 2014, J CLIN PERIODONTOL, V41, P1069, DOI 10.1111/jcpe.12304	44	32	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0171086	10.1371/journal.pone.0171086	http://dx.doi.org/10.1371/journal.pone.0171086			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125700	Green Published, Green Submitted, gold			2022-12-27	WOS:000396176100008
J	Kamradt, M; Krisam, J; Kiel, M; Qreini, M; Besier, W; Szecsenyi, J; Ose, D				Kamradt, Martina; Krisam, Johannes; Kiel, Marion; Qreini, Markus; Besier, Werner; Szecsenyi, Joachim; Ose, Dominik			Health-Related Quality of Life in Primary Care: Which Aspects Matter in Multimorbid Patients with Type 2 Diabetes Mellitus in a Community Setting?	PLOS ONE			English	Article							DISEASE MANAGEMENT PROGRAMS; GENERAL-PRACTICE; PEOPLE; IMPACT; GERMANY; MODEL	Background and Objective Knowledge about predictors of health-related quality of life for multimorbid patients with type 2 diabetes mellitus in primary care could help to improve quality and patient-centeredness of care in this specific group of patients. Thus, the aim of this study was to investigate the impact of several patient characteristics on health-related quality of life of multimorbid patients with type 2 diabetes mellitus in a community setting. Research Design and Methods A cross-sectional study with 32 primary care practice teams in Mannheim, Germany, and randomly selected multimorbid patients with type 2 diabetes mellitus (N = 495) was conducted. In order to analyze associations of various patient characteristics with health-related quality of life (EQ-5D index) a multilevel analysis was applied. Results After excluding patients with missing data, the cohort consisted of 404 eligible patients. The final multilevel model highlighted six out of 14 explanatory patient variables which were significantly associated with health-related quality of life: female gender (r = -0.0494; p = .0261), school education of nine years or less (r = -0.0609; p = .0006), (physical) mobility restrictions (r = -0.1074; p = .0003), presence of chronic pain (r = -0.0916; p = .0004), diabetes-related distress (r = -0.0133; p < .0001), and BMI (r = -0.0047; p = .0045). Conclusion The findings of this study suggest that increased diabetes-related distress, chronic pain, restrictions in (physical) mobility, female gender, as well as lower education and, increased BMI have a noteworthy impact on health-related quality of life in multimorbid patients with type 2 diabetes mellitus seen in primary care practices in a community setting. The highlighted aspects should gain much more attention when treating multimorbid patients with type 2 diabetes mellitus.	[Kamradt, Martina; Kiel, Marion; Qreini, Markus; Szecsenyi, Joachim; Ose, Dominik] Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany; [Krisam, Johannes] Univ Heidelberg Hosp, Dept Med Biometry, Inst Med Biometry & Informat, Heidelberg, Germany; [Besier, Werner] Genossenschaft Gesundheitsprojekt Mannheim eG, Mannheim, Germany; [Ose, Dominik] Univ Utah, Dept Populat Hlth Sci Hlth Syst Innovat & Res, Salt Lake City, UT USA	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Utah System of Higher Education; University of Utah	Kamradt, M (corresponding author), Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany.	martina.kamradt@med.uni-heidelberg.de	Ose, Dominik/L-4250-2019	Ose, Dominik/0000-0002-5079-2152; Kamradt, Martina/0000-0003-3603-5574	German Federal Ministry of Education and Research (Bundesministerium fuer Bildung and Forschung) [01KQ1003B]	German Federal Ministry of Education and Research (Bundesministerium fuer Bildung and Forschung)	This study was funded by the German Federal Ministry of Education and Research (Bundesministerium fuer Bildung and Forschung) (funding code: 01KQ1003B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2010, DIABETES-METAB RES, V26, P75, DOI 10.1002/dmrr.1065; Black N., 2013, BMJ-BRIT MED J, P346; Bowker SL, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-17; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Bozorgmehr K, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-243; Bundesarztekammer Kassenarzliche Bundesvereinigung Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften, 2012, NVL DIAB STRUKT SCHU; Busse R, 2004, HEALTH AFFAIR, V23, P56, DOI 10.1377/hlthaff.23.3.56; Cabases J, 2014, SELF REPORTED POPULA; Clarke JL, 2007, AM J MED QUAL, V22, p5S, DOI 10.1177/1062860607299242; Cochran J, 2008, DIABETES EDUCATOR, V34, P815, DOI 10.1177/0145721708323640; Deshpande Prasanna R, 2011, Perspect Clin Res, V2, P137, DOI 10.4103/2229-3485.86879; EISER C, 1995, PSYCHO-ONCOL, V4, P121, DOI 10.1002/pon.2960040206; Fitzpatrick R, 1998, HEALTH TECHNOL ASSES, V2; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Fortin Martin, 2004, Health Qual Life Outcomes, V2, P51, DOI 10.1186/1477-7525-2-51; Greiner Wolfgang, 2003, Eur J Health Econ, V4, P222, DOI 10.1007/s10198-003-0182-5; Guthrie B, 2012, BMJ-BRIT MED J, P345; Heyworth ITM, 2009, BRIT J GEN PRACT, V59, P833, DOI 10.3399/bjgp09X453990; Hunger M, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-53; Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI DOI 10.17226/10027; Luijks H, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007905; McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5; Moffat K, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0344-4; Moth G, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-52; O'Brien R, 2011, CHRONIC ILLN, V7, P45, DOI 10.1177/1742395310382461; Ose D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051726; Ose D, 2009, DIABETES CARE, V32, P1594, DOI 10.2337/dc08-2223; Papadopoulos AA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-186; Pentakota SR, 2012, DIABETES CARE, V35, P1285, DOI 10.2337/dc11-1569; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; REDELMEIER DA, 1993, JAMA-J AM MED ASSOC, V270, P72, DOI 10.1001/jama.270.1.72; Roux AVD, 2002, J EPIDEMIOL COMMUN H, V56, P588, DOI 10.1136/jech.56.8.588; Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O; Rubin RR, 2001, J CLIN PSYCHOL, V57, P457, DOI 10.1002/jclp.1041; Saarni SI, 2006, QUAL LIFE RES, V15, P1403, DOI 10.1007/s11136-006-0020-1; Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929; Salisbury C, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5004; Sinnott C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003610; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; Szecsenyi J, 2008, DIABETES CARE, V31, P1150, DOI 10.2337/dc07-2104; Szende A, 2007, EQ 5D VALUE SETS INV; van den Akker M, 1996, EUR J GEN PRACT, V2, P65, DOI [DOI 10.3109/13814789609162146, 10.3109/13814789609162146]; van Oostrom SH, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-61; Violan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102149; Wang HM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-246; Wee HL, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-93; Wexler DJ, 2006, DIABETOLOGIA, V49, P1489, DOI 10.1007/s00125-006-0249-9; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59	49	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170883	10.1371/journal.pone.0170883	http://dx.doi.org/10.1371/journal.pone.0170883			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125691	Green Published, Green Submitted, gold			2022-12-27	WOS:000396176100032
J	Rahe, MC; Murtaugh, MP				Rahe, Michael C.; Murtaugh, Michael P.			Interleukin-21 Drives Proliferation and Differentiation of Porcine Memory B Cells into Antibody Secreting Cells	PLOS ONE			English	Article							FOLLICULAR-HELPER-CELLS; PLASMA-CELLS; BONE-MARROW; LYMPHOCYTE RESPONSES; ANIMAL-MODELS; UP-REGULATION; CDNA CLONING; HUMAN NAIVE; HUMAN CD154; IL-21	Immunological prevention of infectious disease, especially viral, is based on antigen-specific long-lived memory B cells. To test for cellular proliferation and differentiation factors in swine, an outbred model for humans, CD21(+) B cells were activated in vitro with CD40L and stimulated with purported stimulatory cytokines to characterize functional responses. IL-21 induced a 3-fold expansion in total cell numbers with roughly 15% of all B cells differentiating to IgM or IgG antibody secreting cells (ASCs.) However, even with robust proliferation, cellular viability rapidly deteriorated. Therefore, a proliferation inducing ligand (APRIL) and B cell activating factor (BAFF) were evaluated as survival and maintenance factors. BAFF was effective at enhancing the viability of mature B cells as well as ASCs, while APRIL was only effective for ASCs. Both cytokines increased approximately two-fold the amount of IgM and IgG which was secreted by IL-21 differentiated ASCs. Mature B cells from porcine reproductive and respiratory virus (PRRSV) immune and naive age-matched pigs were activated and treated with IL-21 and then tested for memory cell differentiation using a PRRSV non-structural protein 7 ELISPOT and ELISA. PRRSV immune pigs were positive on both ELISPOT and ELISA while naive animals were negative on both assays. These results highlight the IL-21-driven expansion and differentiation of memory B cells in vitro without stimulation of the surface immunoglobulin receptor complex, as well as the establishment of a defined memory B cell culture system for characterization of vaccine responses in outbred animals.	[Rahe, Michael C.; Murtaugh, Michael P.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Rahe, MC (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	rahex008@umn.edu		Rahe, Michael/0000-0001-8863-5868	United States Department of Agriculture National Institute of Food and Agriculture [2015-06966]; National Institutes of Health fellowship [T32 OD010993]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD010993] Funding Source: NIH RePORTER	United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Institutes of Health fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by United States Department of Agriculture National Institute of Food and Agriculture grant 2015-06966 (https://nifa.usda.gov/grants) and a National Institutes of Health fellowship to MCR from the training grant T32 OD010993 (http://grants.nih.govt/grants/funding/ac_search_results.htm?text_curr=t32).; We thank Diem Ngo for technical assistance. The research was supported by USDA NIFA grant 2015-06966 and an NIH fellowship to MCR from the training grant T32 OD010993.	Ahmadi T, 2008, IMMUNOLOGY, V124, P129, DOI 10.1111/j.1365-2567.2007.02749.x; Avery DT, 2008, J IMMUNOL, V181, P1767, DOI 10.4049/jimmunol.181.3.1767; Avery DT, 2010, J EXP MED, V207, P155, DOI 10.1084/jem.20091706; Avery DT, 2003, J CLIN INVEST, V112, P286, DOI 10.1172/JCI200318025; Belnoue E, 2008, BLOOD, V111, P2755, DOI 10.1182/blood-2007-09-110858; Benson MJ, 2008, J IMMUNOL, V180, P3655, DOI 10.4049/jimmunol.180.6.3655; Bergamin F, 2007, EUR J IMMUNOL, V37, P3122, DOI 10.1002/eji.200636791; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Bossen C, 2008, BLOOD, V111, P1004, DOI 10.1182/blood-2007-09-110874; Brown E, 2009, CLIN VACCINE IMMUNOL, V16, P628, DOI 10.1128/CVI.00483-08; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; Chaperot L, 1999, EXP HEMATOL, V27, P479, DOI 10.1016/S0301-472X(98)00059-9; Crawley A, 2003, VET IMMUNOL IMMUNOP, V91, P141, DOI 10.1016/S0165-2427(02)00293-3; de Masson A, 2015, BLOOD, V125, P1830, DOI 10.1182/blood-2014-09-599159; Ding BB, 2013, J IMMUNOL, V190, P1827, DOI 10.4049/jimmunol.1201678; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Ferreira RC, 2015, DIABETOLOGIA, V58, P781, DOI 10.1007/s00125-015-3509-8; Good KL, 2006, J IMMUNOL, V177, P5236, DOI 10.4049/jimmunol.177.8.5236; Granato A, 2014, J IMMUNOL, V192, P5761, DOI 10.4049/jimmunol.1300749; Guan ZB, 2007, DEV COMP IMMUNOL, V31, P1211, DOI 10.1016/j.dci.2007.03.006; Hasbold J, 1999, J IMMUNOL, V163, P4175; HOWARD M, 1982, J EXP MED, V155, P914, DOI 10.1084/jem.155.3.914; Jahnmatz M, 2013, J IMMUNOL METHODS, V391, P50, DOI 10.1016/j.jim.2013.02.009; Jin HL, 2004, J IMMUNOL, V173, P657, DOI 10.4049/jimmunol.173.1.657; Kuchen S, 2007, J IMMUNOL, V179, P5886, DOI 10.4049/jimmunol.179.9.5886; LANZAVECCHIA A, 1983, EUR J IMMUNOL, V13, P820, DOI 10.1002/eji.1830131008; LEE F, 1986, P NATL ACAD SCI USA, V83, P2061, DOI 10.1073/pnas.83.7.2061; Leeth CM, 2016, DIABETES; Li Y., 2015, CHINA MODERN ED EQUI, V2015, P61, DOI DOI 10.1002/HEP.27725; Lindqvist M, 2012, J CLIN INVEST, V122, P3271, DOI 10.1172/JCI64314; McGuire HM, 2011, DIABETES, V60, P867, DOI 10.2337/db10-1157; Mehta DS, 2003, J IMMUNOL, V170, P4111, DOI 10.4049/jimmunol.170.8.4111; Mizrahi M, 2013, IMMUNOLOGY, V140, P362, DOI 10.1111/imm.12149; Mulupuri P, 2008, J VIROL, V82, P358, DOI 10.1128/JVI.01023-07; Murtaugh MP, 2009, DEV COMP IMMUNOL, V33, P344, DOI 10.1016/j.dci.2008.06.014; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Peperzak V, 2013, NAT IMMUNOL, V14, P290, DOI 10.1038/ni.2527; Petrelli A, 2011, DIABETES, V60, P3223, DOI 10.2337/db11-0880; Ramadani F, 2016, ALLERGY; Renner S, 2016, THERIOGENOLOGY, V86, P406, DOI 10.1016/j.theriogenology.2016.04.055; Reutner K, 2012, DEV COMP IMMUNOL, V38, P321, DOI 10.1016/j.dci.2012.06.011; Rushworth SA, 2001, TRANSPLANTATION, V72, P127, DOI 10.1097/00007890-200107150-00025; Rushworth SA, 2000, TRANSPLANTATION, V69, P936; Saini AS, 2014, NAT IMMUNOL, V15, P275, DOI 10.1038/ni.2806; Seidl T, 2012, IMMUNOLOGY, V135, P207, DOI 10.1111/j.1365-2567.2011.03524.x; Shui Y, 2008, VET IMMUNOL IMMUNOP, V125, P190, DOI 10.1016/j.vetimm.2008.05.003; Sinkora M, 2013, DEV COMP IMMUNOL, V39, P409, DOI 10.1016/j.dci.2012.10.010; Sutherland APR, 2009, DIABETES, V58, P1144, DOI 10.2337/db08-0882; Takamatsu H, 1999, IMMUNOLOGY, V97, P211, DOI 10.1046/j.1365-2567.1999.00770.x; TROTTER PJ, 1995, BIOCHEM J, V308, P591, DOI 10.1042/bj3080591; Tsuji S, 2011, BLOOD, V118, P5832, DOI 10.1182/blood-2011-05-353961; von Bergwelt-Baildon MS, 2002, BLOOD, V99, P3319, DOI 10.1182/blood.V99.9.3319; Walker LSK, 2016, CLIN EXP IMMUNOL, V183, P16, DOI 10.1111/cei.12672; Young DA, 2007, ARTHRITIS RHEUM, V56, P1152, DOI 10.1002/art.22452	56	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0171171	10.1371/journal.pone.0171171	http://dx.doi.org/10.1371/journal.pone.0171171			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125737	gold, Green Published, Green Submitted			2022-12-27	WOS:000396176100005
J	Cotte, L; Ferry, T; Pugliese, P; Valantin, MA; Allavena, C; Cabie, A; Poizot-Martin, I; Rey, D; Duvivier, C; Cheret, A; Dellamonica, P; Pradat, P; Parienti, JJ				Cotte, Laurent; Ferry, Tristan; Pugliese, Pascal; Valantin, Marc-Antoine; Allavena, Clotilde; Cabie, Andre; Poizot-Martin, Isabelle; Rey, David; Duvivier, Claudine; Cheret, Antoine; Dellamonica, Pierre; Pradat, Pierre; Parienti, Jean-Jacques		Dat'AIDS Study Grp	Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE; FIXED-DOSE COMBINATION; QUALITY-OF-LIFE; PILL BURDEN; ADHERENCE; METAANALYSIS; TENOFOVIR; EMTRICITABINE; RESISTANCE	Objectives Pill burden during antiretroviral treatment (ART) is associated with worse adherence and impaired virological suppression. We compared the effectiveness, tolerance, and persistence on treatment of single tablet regimens (STRs) with non-STR once-daily regimens in patients receiving first-line ART. Methods Retrospective analysis of naive HIV-1 infected patients prospectively enrolled in the French Dat'AIDS cohort and initiating first-line ART with STRs or once-daily non-STRs from 2004 to 2013. The primary outcome was time to treatment discontinuation defined by any change in the treatment regimen. STR and non-STR groups were compared controlling for baseline risk factors by inverse probability weighted treatment Cox analysis (IPWT) and propensity-score matching (PSM). Results Overall, 3212 patients (STR 499, non-STR 2713) were included. Median time to treatment discontinuation was shorter in non-STR patients than in STR patients, both in the IPWT (HR = 0.61, p<0.0001) and the PSM cohort (HR = 0.55, p<0.0001). This difference disappeared when censoring ART modification for simplification, both in the IPWT (HR = 0.97, p = 0.65) and the PSM cohort (HR = 0.91, p = 0.33). A lower rate of virological failure was observed with STRs than with non-STRs in both cohorts (HR = 0.23; p = 0.002 and HR = 0.22, p = 0.003, respectively). A lower rate of treatment modification for adverse event was observed with non-STRs in the IPWT cohort (HR = 1.46, p<0.0001), but not in the PSM cohort (HR = 1.22, p = 0.11). Conclusion First-line therapy with STRs was associated with a longer time to treatment discontinuation than with non-STRs. However, when ART modification for simplification was not considered as a failure, STRs and non-STRs were similar.	[Cotte, Laurent; Ferry, Tristan] Hosp Civils Lyon, Croix Rousse Hosp, Dept Infect Dis, Lyon, France; [Cotte, Laurent; Pradat, Pierre] INSERM, U1052, Lyon, France; [Pugliese, Pascal; Dellamonica, Pierre] Ctr Hosp Univ Nice, Hop Archet, Dept Infect Dis, Nice, France; [Valantin, Marc-Antoine] Hop La Pitie Salpetriere, AP HP, Dept Infect Dis, Paris, France; [Valantin, Marc-Antoine] UPMC Univ, Sorbonne Univ, Paris, France; [Valantin, Marc-Antoine] INSERM, IPLESP, UMRS 1136, Paris, France; [Allavena, Clotilde] Hop Hotel Dieu, Dept Infect Dis, Nantes, France; [Cabie, Andre] CHU Martinique, Dept Infect Dis, Fort De France, France; [Cabie, Andre] Univ Antilles, EA4537, Fort De France, France; [Cabie, Andre] INSERM, CIC1424, Fort De France, France; [Poizot-Martin, Isabelle] Hop St Marguerite, AP HM, Immunohematol Clin, Marseille, France; [Poizot-Martin, Isabelle] Aix Marseille Univ, Marseille, France; [Poizot-Martin, Isabelle] INSERM, U912, SESSTIM, Marseille, France; [Rey, David] Hop Univ, HIV Infect Care Ctr, Strasbourg, France; [Duvivier, Claudine] Hop Necker Enfants Malad, AP HP, Dept Infect Dis, Ctr Infectiol Necker Pasteur,IHU Imagine, Paris, France; [Duvivier, Claudine; Cheret, Antoine] Univ Paris 05, Sorbonne Paris Cite, EA7327, Paris, France; [Cheret, Antoine] Ctr Hosp Univ, Dept Internal Med, Le Kremlin Bicetre, France; [Pradat, Pierre] Hosp Civils Lyon, Croix Rousse Hosp, Clin Res Ctr, Dept Hepatol, Lyon, France; [Parienti, Jean-Jacques] Cote Nacre Univ Hosp, Dept Infect Dis, Caen, France; [Parienti, Jean-Jacques] Cote Nacre Univ Hosp, Dept Biostat, Caen, France	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Nice; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; CHU Martinique; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; CHU Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; CHU Lyon; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie	Cotte, L (corresponding author), Hosp Civils Lyon, Croix Rousse Hosp, Dept Infect Dis, Lyon, France.; Cotte, L (corresponding author), INSERM, U1052, Lyon, France.	laurent.cotte@chu-lyon.fr	Ferry, Tristan/M-5108-2014; Parienti, Jean-Jacques/AAD-1701-2021; Allavena, Clotilde/AAH-4310-2019	Parienti, Jean-Jacques/0000-0002-4774-5590; ferry, tristan/0000-0003-3082-7001; Poizot-Martin, Isabelle/0000-0002-5676-5411; Cabie, Andre/0000-0003-0117-3061				Airoldi M, 2010, PATIENT PREFER ADHER, V4, P115; Aldir I, 2014, CURR MED RES OPIN, V30, P89, DOI 10.1185/03007995.2013.844685; Antinori A, 2012, J INT AIDS SOC S4, V15, P8098; Astuti N, 2014, INFECT DIS THER, V3, P1, DOI 10.1007/s40121-014-0024-z; Bangsberg DR, 2010, AIDS, V24, P2835, DOI 10.1097/QAD.0b013e328340a209; Buscher A, 2012, INT J STD AIDS, V23, P351, DOI 10.1258/ijsa.2011.011292; Claxton AJ, 2001, CLIN THER, V23, P1296, DOI 10.1016/S0149-2918(01)80109-0; Clay PG, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001677; Cohen CJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003028; Eaton EF, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw109; European AIDS clinical society, 2015, GUID CLIN MAN TREATM; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gandhi M, 2014, NEW ENGL J MED, V371, P248, DOI 10.1056/NEJMct1215532; Ganguli A, 2012, RES SOC ADMIN PHARM, V8, P157, DOI 10.1016/j.sapharm.2010.12.004; Goicoechea M, 2007, EXPERT OPIN PHARMACO, V8, P371, DOI 10.1517/14656566.8.3.371; Juday T, 2011, HIV CLIN TRIALS, V12, P71, DOI 10.1310/hct1202-71; Killingley B, 2007, DRUG TODAY, V43, P427, DOI 10.1358/dot.2007.43.7.1086178; Kwiatkowski F, 2007, B CANCER, V94, P680; Lambert-Niclot S, 2013, J ANTIMICROB CHEMOTH, V68, P1237, DOI 10.1093/jac/dkt003; Nachega JB, 2014, CLIN INFECT DIS, V58, P1297, DOI 10.1093/cid/ciu046; Parienti JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002783; Parienti JJ, 2009, CLIN INFECT DIS, V48, P484, DOI 10.1086/596482; Parienti JJ, 2004, CLIN INFECT DIS, V38, P1311, DOI 10.1086/383572; Prinapori R, 2015, PATIENT PREFER ADHER, V9, P1213, DOI 10.2147/PPA.S88490; Pugliese P, 2009, HIV MED, V10, P504, DOI 10.1111/j.1468-1293.2009.00719.x; Raffi F, 2015, J ANTIMICROB CHEMOTH, V70, P2121, DOI 10.1093/jac/dkv083; Sax PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031591; Sax PE, 2011, J INFECT DIS, V204, P1191, DOI 10.1093/infdis/jir505; Sterrantino G, 2012, PATIENT PREFER ADHER, V6, P427, DOI 10.2147/PPA.S31385; Thompson MA, 2012, ANN INTERN MED, V156, P817, DOI 10.7326/0003-4819-156-11-201206050-00419; Wilkins EL, 2016, AIDS CARE, V28, P401, DOI 10.1080/09540121.2015.1096890	31	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170661	10.1371/journal.pone.0170661	http://dx.doi.org/10.1371/journal.pone.0170661			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152047	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161200030
J	Guo, F; Dai, JH; Zhang, JX; Ma, YC; Zhu, GH; Shen, JJ; Niu, GQ				Guo, Fei; Dai, Jianhao; Zhang, Junxiang; Ma, Yichuan; Zhu, Guanghui; Shen, Junjie; Niu, Guoqi			Individualized 3D printing navigation template for pedicle screw fixation in upper cervical spine	PLOS ONE			English	Article							BIOMECHANICAL ANALYSIS; COMPARATIVE ACCURACY; GUIDE TEMPLATE; PLACEMENT; LUMBAR	Purpose Pedicle screw fixation in the upper cervical spine is a difficult and high-risk procedure. The screw is difficult to place rapidly and accurately, and can lead to serious injury of spinal cord or vertebral artery. The aim of this study was to design an individualized 3D printing navigation template for pedicle screw fixation in the upper cervical spine. Methods Using CT thin slices data, we employed computer software to design the navigation template for pedicle screw fixation in the upper cervical spine (atlas and axis). The upper cervical spine models and navigation templates were produced by 3D printer with equal proportion, two sets for each case. In one set (Test group), pedicle screws fixation were guided by the navigation template; in the second set (Control group), the screws were fixed under fluoroscopy. According to the degree of pedicle cortex perforation and whether the screw needed to be refitted, the fixation effects were divided into 3 types: Type I, screw is fully located within the vertebral pedicle; Type II, degree of pedicle cortex perforation is < 1 mm, but with good internal fixation stability and no need to renovate; Type III, degree of pedicle cortex perforation is > 1 mm or with the poor internal fixation stability and in need of renovation. Type I and Type II were acceptable placements; Type III placements were unacceptable. Results A total of 19 upper cervical spine and 19 navigation templates were printed, and 37 pedicle screws were fixed in each group. Type I screw-placements in the test group totaled 32; Type II totaled 3; and Type III totaled 2; with an acceptable rate of 94.60%. Type I screw placements in the control group totaled 23; Type II totaled 3; and Type III totaled 11, with an acceptable rate of 70.27%. The acceptability rate in test group was higher than the rate in control group. The operation time and fluoroscopic frequency for each screw were decreased, compared with control group. Conclusion The individualized 3D printing navigation template for pedicle screw fixation is easy and safe, with a high success rate in the upper cervical spine surgery.	[Guo, Fei; Zhang, Junxiang; Ma, Yichuan; Zhu, Guanghui; Shen, Junjie] Bengbu Med Coll, Affiliated Hosp 1, Dept Radiol, Bengbu, Anhui, Peoples R China; [Dai, Jianhao] First Peoples Hosp Huainan, Dept Orthoped, Huainan, Anhui, Peoples R China; [Niu, Guoqi] Bengbu Med Coll, Affiliated Hosp 1, Dept Orthoped, Bengbu, Anhui, Peoples R China	Bengbu Medical College; Bengbu Medical College	Ma, YC (corresponding author), Bengbu Med Coll, Affiliated Hosp 1, Dept Radiol, Bengbu, Anhui, Peoples R China.; Niu, GQ (corresponding author), Bengbu Med Coll, Affiliated Hosp 1, Dept Orthoped, Bengbu, Anhui, Peoples R China.	horse818@sina.com; ngqdjh7535@163.com			Natural Science Research Project of Anhui Colleges and Universities [KJ2015B100by]	Natural Science Research Project of Anhui Colleges and Universities	The project was funded by the Natural Science Research Project of Anhui Colleges and Universities (Reference No: KJ2015B100by, FG, URL: http://www.ahedu.gov.cn/).	Amiot LP, 2000, SPINE, V25, P606, DOI 10.1097/00007632-200003010-00012; Bergeson RK, 2008, SPINE, V33, pE501, DOI 10.1097/BRS.0b013e31817b61af; CHEN CY, 2013, EVID-BASED COMPL ALT, V2013, P12, DOI DOI 10.1371/J0URNAL.P0NE.0081159; Chen HF, 2016, INT ORTHOP, V40, P827, DOI 10.1007/s00264-015-2813-8; Hecht N, 2016, EUR SPINE J, V25, P716, DOI 10.1007/s00586-015-3814-4; Jones EL, 1997, SPINE, V22, P977, DOI 10.1097/00007632-199705010-00009; Kaneyama S, 2014, J NEUROSURG-SPINE, V21, P231, DOI 10.3171/2014.3.SPINE13730; Kim YJ, 2004, SPINE, V29, P333, DOI 10.1097/01.BRS.0000109983.12113.9B; KOTANI Y, 1994, SPINE, V19, P2529, DOI 10.1097/00007632-199411001-00007; Kothe R, 2004, SPINE, V29, P1869, DOI 10.1097/01.brs.0000137287.67388.0b; Kovanda TJ, 2015, J NEUROSURG-PEDIATR, P1; Lang Z, 2016, SPINE, V41, P39, DOI 10.1097/BRS.0000000000001111; Lu S, 2009, INT J MED ROBOT COMP, V5, P184, DOI 10.1002/rcs.249; Ludwig SC, 2000, SPINE, V25, P2675, DOI 10.1097/00007632-200010150-00022; Ludwig SC, 2000, SPINE, V25, P1655, DOI 10.1097/00007632-200007010-00009; Park JH, 2015, J NEUROSURG-SPINE, V23, P35, DOI 10.3171/2014.11.SPINE14805; Upendra BN, 2008, SPINE, V33, P384, DOI 10.1097/BRS.0b013e3181646ba1; Yeom JS, 2013, SPINE J, V13, P775, DOI 10.1016/j.spinee.2013.04.005; Yoshihara H, 2013, J NEUROSURG-SPINE, V19, P614, DOI 10.3171/2013.8.SPINE13136; Zhang YZ, 2009, CHIN J TRAUMATOL, V12, P214, DOI 10.3760/cma.j.issn.1008-1275.2009.04.005; Zhou YJ, 2016, WSPOLCZESNA ONKOL, V20, P73, DOI 10.5114/wo.2016.58503; Zhou Y, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005557	22	51	58	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171509	10.1371/journal.pone.0171509	http://dx.doi.org/10.1371/journal.pone.0171509			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152039	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161200151
J	Himori, K; Abe, M; Tatebayashi, D; Lee, J; Westerblad, H; Lanner, JT; Yamada, T				Himori, Koichi; Abe, Masami; Tatebayashi, Daisuke; Lee, Jaesik; Westerblad, Hakan; Lanner, Johanna T.; Yamada, Takashi			Superoxide dismutase/catalase mimetic EUK-134 prevents diaphragm muscle weakness in monocrotalin-induced pulmonary hypertension	PLOS ONE			English	Article							SKELETAL-MUSCLE; ARTERIAL-HYPERTENSION; NITRIC-OXIDE; HEART-FAILURE; DYSFUNCTION; MICE; MECHANISMS; MODEL; RAT; PEROXYNITRITE	Patients with pulmonary hypertension (PH) suffer from inspiratory insufficiency, which has been associated with intrinsic contractile dysfunction in diaphragm muscle. Here, we examined the role of redox stress in PH-induced diaphragm weakness by using the novel antioxidant, EUK-134. Male Wistar rats were randomly divided into control (CNT), CNT + EUK-134 (CNT + EUK), monocrotaline-induced PH (PH), and PH + EUK groups. PH was induced by a single intraperitoneal injection of monocrotaline (60 mg/kg body weight). EUK-134 (3 mg/kg body weight/day), a cell permeable mimetic of superoxide dismutase (SOD) and catalase, was daily intraperitoneally administered starting one day after induction of PH. After four weeks, diaphragm muscles were excised for mechanical and biochemical analyses. There was a decrease in specific tetanic force in diaphragm bundles from the PH group, which was accompanied by increases in: protein expression of NADPH oxidase 2/gp91phox, SOD2, and catalase; 3-nitrotyrosine content and aggregation of actin; glutathione oxidation. Treatment with EUK-134 prevented the force decrease and the actin modifications in PH diaphragm bundles. These data show that redox stress plays a pivotal role in PH-induced diaphragm weakness. Thus, antioxidant treatment can be a promising strategy for PH patients with inspiratory failure.	[Himori, Koichi; Abe, Masami; Tatebayashi, Daisuke; Lee, Jaesik; Yamada, Takashi] Sapporo Med Univ, Grad Sch Hlth Sci, Sapporo, Hokkaido, Japan; [Westerblad, Hakan; Lanner, Johanna T.] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden	Sapporo Medical University; Karolinska Institutet	Yamada, T (corresponding author), Sapporo Med Univ, Grad Sch Hlth Sci, Sapporo, Hokkaido, Japan.	takashi.yamada1976@sapmed.ac.jp	Yamada, Takashi/AAZ-6212-2021; Yamada, Takashi/U-8443-2019	Yamada, Takashi/0000-0003-1797-3880; Yamada, Takashi/0000-0003-1797-3880; Westerblad, Hakan/0000-0002-8180-3029	Japan Society for the Promotion of Science [26702021]; Ake Wiberg foundation [M14-0210]; KI Rheumatology fund [2014reum42670, R-481591]; Swedish Research Council [521-2012-1645]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ake Wiberg foundation; KI Rheumatology fund; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by: Japan Society for the Promotion of Science: 26702021: https://www.jsps.go.jp/english/; Ake Wiberg foundation: M14-0210. http://ake-wiberg.set, KI Rheumatology fund: 2014reum42670. https://fonder.ki.se/;Reumatikerforbundet: R-481591. https://www.reumatikerforbundet.org/; Swedish Research Council: 521-2012-1645. https://www.vr.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams V, 2008, J MOL BIOL, V384, P48, DOI 10.1016/j.jmb.2008.08.087; Ahn B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062702; ALLEN DG, 1995, EXP PHYSIOL, V80, P497, DOI 10.1113/expphysiol.1995.sp003864; Baker K, 1998, J PHARMACOL EXP THER, V284, P215; BAKER MA, 1990, ANAL BIOCHEM, V190, P360, DOI 10.1016/0003-2697(90)90208-Q; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruce AJ, 1996, P NATL ACAD SCI USA, V93, P2312, DOI 10.1073/pnas.93.6.2312; Callahan LA, 2001, J APPL PHYSIOL, V90, P45, DOI 10.1152/jappl.2001.90.1.45; de Man FS, 2011, AM J RESP CRIT CARE, V183, P1411, DOI 10.1164/rccm.201003-0354OC; Dutka TL, 2011, J APPL PHYSIOL, V110, P705, DOI 10.1152/japplphysiol.00739.2010; GONZALEZ PK, 1995, J PHARMACOL EXP THER, V275, P798; Hirschfield W, 2000, AM J PHYSIOL-REG I, V278, pR95, DOI 10.1152/ajpregu.2000.278.1.R95; Kabitz HJ, 2008, CLIN SCI, V114, P165, DOI 10.1042/CS20070238; Kim JH, 2012, FREE RADICAL BIO MED, V52, P1597, DOI 10.1016/j.freeradbiomed.2012.01.015; Lawler JM, 2014, AM J PHYSIOL-REG I, V306, pR470, DOI 10.1152/ajpregu.00371.2013; Manders E, 2012, AM J PHYSIOL-LUNG C, V303, pL1070, DOI 10.1152/ajplung.00135.2012; Meyer FJ, 2005, EUR RESPIR J, V25, P125, DOI 10.1183/09031936.04.00095804; Ochala J, 2011, J PHYSIOL-LONDON, V589, P2007, DOI 10.1113/jphysiol.2010.202044; Pal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063989; Pearson T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096378; Pong K, 2000, BRAIN RES, V881, P182, DOI 10.1016/S0006-8993(00)02841-9; Redout EM, 2010, AM J PHYSIOL-HEART C, V298, pH1038, DOI 10.1152/ajpheart.00097.2009; Reid MB, 2011, J PHYSIOL-LONDON, V589, P2171, DOI 10.1113/jphysiol.2010.203356; Sharpe MA, 2002, BIOCHEM J, V366, P97, DOI 10.1042/bj20020154; Stamler JS, 1998, NAT STRUCT BIOL, V5, P247, DOI 10.1038/nsb0498-247; Stasko SA, 2013, J APPL PHYSIOL, V114, P1629, DOI 10.1152/japplphysiol.00871.2012; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009; Sun CG, 2003, J AM COLL CARDIOL, V41, P1028, DOI 10.1016/S0735-1097(02)02964-9; Supinski GS, 2007, J APPL PHYSIOL, V102, P2056, DOI 10.1152/japplphysiol.01138.2006; Susa Y, 2009, CRIT CARE MED, V37, P2619, DOI 10.1097/CCM.0b013e3181a930f7; Tiago T, 2006, BIOCHEM BIOPH RES CO, V342, P44, DOI 10.1016/j.bbrc.2006.01.112; Vassilakopoulos T, 2003, AM J PHYSIOL-LUNG C, V284, pL452, DOI 10.1152/ajplung.00270.2002; Voelkel NF, 2000, J CLIN INVEST, V106, P733, DOI 10.1172/JCI11144; WADA M, 1996, AM J PHYSIOL-CELL PH, V271, pC1250; Westerblad H, 2000, EUR J APPL PHYSIOL, V83, P166, DOI 10.1007/s004210000275; Wust RCI, 2012, AM J PHYSIOL-HEART C, V302, pH402, DOI 10.1152/ajpheart.00653.2011; Yamada T, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0045-7; Yamada T, 2009, ARTHRITIS RHEUM-US, V60, P3280, DOI 10.1002/art.24907	38	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0169146	10.1371/journal.pone.0169146	http://dx.doi.org/10.1371/journal.pone.0169146			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152009	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161200008
J	Martin-Hernandez, R; Higes, M; Sagastume, S; Juarranz, A; Dias-Almeida, J; Budge, GE; Meana, A; Boonham, N				Martin-Hernandez, Raquel; Higes, Mariano; Sagastume, Soledad; Juarranz, Angeles; Dias-Almeida, Joyce; Budge, Giles E.; Meana, Aranzazu; Boonham, Neil			Microsporidia infection impacts the host cell's cycle and reduces host cell apoptosis	PLOS ONE			English	Article							REAL-TIME PCR; NOSEMA-CERANAE; APIS-MELLIFERA; S-PHASE; TRANSCRIPTION FACTOR; PROTOZOAN PARASITES; PROTEASE RECEPTOR-1; MASS-SPECTROMETRY; JUVENILE-HORMONE; PROGRESSION	Intracellular parasites can alter the cellular machinery of host cells to create a safe haven for their survival. In this regard, microsporidia are obligate intracellular fungal parasites with extremely reduced genomes and hence, they are strongly dependent on their host for energy and resources. To date, there are few studies into host cell manipulation by microsporidia, most of which have focused on morphological aspects. The microsporidia Nosema apis and Nosema ceranae are worldwide parasites of honey bees, infecting their ventricular epithelial cells. In this work, quantitative gene expression and histology were studied to investigate how these two parasites manipulate their host's cells at the molecular level. Both these microsporidia provoke infection-induced regulation of genes involved in apoptosis and the cell cycle. The up-regulation of buffy (which encodes a pro-survival protein) and BIRC5 (belonging to the Inhibitor Apoptosis protein family) was observed after infection, shedding light on the pathways that these pathogens use to inhibit host cell apoptosis. Curiously, different routes related to cell cycle were modified after infection by each microsporidia. In the case of N. apis, cyclin B1, dacapo and E2F2 were up-regulated, whereas only cyclin E was up-regulated by N. ceranae, in both cases promoting the G1/S phase transition. This is the first report describing molecular pathways related to parasite-host interactions that are probably intended to ensure the parasite's survival within the cell.	[Martin-Hernandez, Raquel; Higes, Mariano; Sagastume, Soledad] Consejeria Agr Junta Comunidades Castilla La Manc, Lab Patol Apicola, Ctr Invest Apicola & Agroambiental, IRIAF, Marchamalo, Spain; [Martin-Hernandez, Raquel] Fdn Parque Cient & Tecnol Albacete, Inst Recursos Humanos Ciencia & Tecnol INCRECYT, FEDER, Albacete, Spain; [Juarranz, Angeles; Dias-Almeida, Joyce] Univ Autonoma Madrid, Dept Biol, Fac Ciencias, Madrid, Spain; [Budge, Giles E.; Boonham, Neil] Fera, York, N Yorkshire, England; [Budge, Giles E.; Boonham, Neil] Newcastle Univ, Inst Agrifood Res & Innovat, Newcastle Upon Tyne, Tyne & Wear, England; [Meana, Aranzazu] Univ Complutense Madrid, Dept Sanidad Anim, Fac Vet, Madrid, Spain	Autonomous University of Madrid; Food & Environment Research Agency; Newcastle University - UK; Complutense University of Madrid	Martin-Hernandez, R (corresponding author), Consejeria Agr Junta Comunidades Castilla La Manc, Lab Patol Apicola, Ctr Invest Apicola & Agroambiental, IRIAF, Marchamalo, Spain.	rmhernandez@jccm.es	Martin-Hernandez, Raquel/J-7507-2013; Sagastume, Soledad/AAR-5616-2021; Higes, Mariano/N-9380-2017; Mañes, Aránzazu Meana/C-6360-2017	Martin-Hernandez, Raquel/0000-0002-1730-9368; Sagastume, Soledad/0000-0003-1350-2600; Higes, Mariano/0000-0001-7338-5851; Mañes, Aránzazu Meana/0000-0002-7599-7226; Dias de Almeida, Joyce/0000-0001-7144-5435; Boonham, Neil/0000-0002-8886-5708	INIA (FEDER) PROJECT [RTA2012-00072-C02-01]	INIA (FEDER) PROJECT	This work was supported by INIA (FEDER) PROJECT RTA2012-00072-C02-01. The funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of research materials. In fact, this organization only provided funds for acquisition of research materials and they provided no salaries for any author.	Aliferis KA, 2012, J INSECT PHYSIOL, V58, P1349, DOI 10.1016/j.jinsphys.2012.07.010; ALTIERI DC, 1994, BIOCHEMISTRY-US, V33, P13848, DOI 10.1021/bi00250a039; ALTIERI DC, 1994, J BIOL CHEM, V269, P3139; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Ares AM, 2012, J CHROMATOGR B, V899, P146, DOI 10.1016/j.jchromb.2012.05.016; Aufauvre J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091686; Bakowski MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004200; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Botias C, 2012, ENVIRON MICROBIOL, V14, P845, DOI 10.1111/j.1462-2920.2011.02647.x; Bruchhaus I, 2007, TRENDS PARASITOL, V23, P376, DOI 10.1016/j.pt.2007.06.004; Donovan MJ, 2009, EXP PARASITOL, V123, P58, DOI 10.1016/j.exppara.2009.05.012; Duronio RJ, 1998, MOL CELL BIOL, V18, P141, DOI 10.1128/MCB.18.1.141; Dussaubat C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037017; Fries I, 1996, EUR J PROTISTOL, V32, P356, DOI 10.1016/S0932-4739(96)80059-9; Goblirsch M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058165, 10.1371/journal.pone.0069831]; Gupta S, 2005, CURR OPIN MICROBIOL, V8, P428, DOI 10.1016/j.mib.2005.06.011; Heussler VT, 2001, INT J PARASITOL, V31, P1166, DOI 10.1016/S0020-7519(01)00271-5; Higes M, 2007, J INVERTEBR PATHOL, V94, P211, DOI 10.1016/j.jip.2006.11.001; Higes M, 2013, ENV MICROBIOL REP, V5, P530, DOI 10.1111/1758-2229.12059; Higes M, 2010, APIDOLOGIE, V41, P375, DOI 10.1051/apido/2010019; James ER, 2004, TRENDS PARASITOL, V20, P280, DOI 10.1016/j.pt.2004.04.004; Joyce NC, 2004, INVEST OPHTH VIS SCI, V45, P1340, DOI 10.1167/iovs.03-0335; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; Kurze C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140174; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Luder CGK, 2001, TRENDS PARASITOL, V17, P480, DOI 10.1016/S1471-4922(01)02093-1; Ma ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084137; Manque PA, 2011, INFECT IMMUN, V79, P1855, DOI 10.1128/IAI.00643-10; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Martin-Hernandez R, 2012, ENVIRON MICROBIOL, V14, P2127, DOI 10.1111/j.1462-2920.2011.02645.x; Martin-Hernandez R, 2009, APPL ENVIRON MICROB, V75, P2554, DOI 10.1128/AEM.02908-08; Mayack C, 2009, J INVERTEBR PATHOL, V100, P185, DOI 10.1016/j.jip.2008.12.001; Neganova I, 2008, J ANAT, V213, P30, DOI 10.1111/j.1469-7580.2008.00931.x; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; Nelson MM, 2008, INFECT IMMUN, V76, P828, DOI 10.1128/IAI.01115-07; PAN C, 1995, NUCLEIC ACIDS RES, V23, P3673, DOI 10.1093/nar/23.18.3673; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pucci B, 2000, NEOPLASIA, V2, P291, DOI 10.1038/sj.neo.7900101; Quinn L, 2003, EMBO J, V22, P3568, DOI 10.1093/emboj/cdg355; Reis T, 2004, CELL, V117, P253, DOI 10.1016/S0092-8674(04)00247-8; RICHARDSON H, 1995, DEVELOPMENT, V121, P3371; Robinson GE, 1997, ARCH INSECT BIOCHEM, V35, P559, DOI 10.1002/(SICI)1520-6327(1997)35:4<559::AID-ARCH13>3.0.CO;2-9; Rodrigues V, 2012, CELL MICROBIOL, V14, P325, DOI 10.1111/j.1462-5822.2011.01737.x; Royzman I, 1997, GENE DEV, V11, P1999, DOI 10.1101/gad.11.15.1999; Scanlon M, 1999, J EUKARYOT MICROBIOL, V46, p34S; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Szumowski SC, 2015, CURR OPIN MICROBIOL, V26, P10, DOI 10.1016/j.mib.2015.03.006; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vavra Jiri, 1999, P7; Vidau C, 2014, J INVERTEBR PATHOL, V121, P89, DOI 10.1016/j.jip.2014.07.002; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wilkinson JC, 2004, J BIOL CHEM, V279, P51091, DOI 10.1074/jbc.M409623200; Williams BAP, 2009, CELL MICROBIOL, V11, P1551, DOI 10.1111/j.1462-5822.2009.01362.x; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Zander E., 1909, LEIPZ BIENENZTG, V24, P164; Zander E., 1909, LEIPZIGER BIENENZEIT, V24, P147	57	50	50	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170183	10.1371/journal.pone.0170183	http://dx.doi.org/10.1371/journal.pone.0170183			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152065	gold, Green Published			2022-12-27	WOS:000396161200016
J	Yang, XL; Liu, LP; Hao, QF; Zou, DY; Zhang, XL; Zhang, LP; Li, HM; Qiao, Y; Zhao, HS; Zhou, L				Yang, Xiaoli; Liu, Liping; Hao, Qingfang; Zou, Deyong; Zhang, Xiaoli; Zhang, Liping; Li, Hongmei; Qiao, Yong; Zhao, Huansheng; Zhou, Lei			Development and Evaluation of Up Converting Phosphor Technology-Based Lateral Flow Assay for Quantitative Detection of NT-proBNP in Blood	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; HEART-FAILURE; MYOCARDIAL-ISCHEMIA; REPORTERS; IMMUNOASSAY; DYSFUNCTION; INFECTION; ANTIGEN; POINT; SERUM	A newly assay, up-converting phosphor technology-based lateral flow (UPT-LF) assay, was developed for rapid and quantitative detection of N-terminal fragment of B-type natriuretic peptide precursor (NT-proBNP), one of the most important serum molecular maker of heat failure, in plasma samples as a point of care testing (POCT) method for diagnosis of acute heart failure. Human plasma from 197 patients with acute heart failure and 200 healthy controls was assessed using the UPT-LF assay, in a comparison with a Roche Elecsys assay. The limit of detection of the UPT-LF assay, with a coefficient of variation (CV) of less than 15%, was 116 ng/L, which is lower than the clinical diagnosis cutoff (150 ng/mL). The linear range was 50-35,000 ng/L. The CVs were less than 10% for both UPT-LF and Roche Elecsys assays for plasma samples under different storages, demonstrating the good stability and reproducibility. There are certain linear correlations between the results of UPT-LF and Roche Elecsys assay for EDTA-K2 and heparin-anticoagulated plasma, as well as for serum samples. For UPT-LF assay, there is a significant correlation between the values derived from analysis of EDTA-K2 and heparin-anticoagulated plasma samples (R = 0.995). No statistically significant difference was found between serum and plasma samples for UPT-LF assay. Our results demonstrate that NT-proBNP levels in healthy adults are elevated with age and had a relationship with sex, and with the age increase the NT-proBNP levels of females are significantly higher than those of males (p<0.01). The UPT-LF assay has a high reproducibility, stability, sensitivity, specificity, and is consistent with Roche Elecsys assay, and therefore it could be used as a POCT method for the quantitative detection of NT-proBNP in blood for clinical diagnosis and research of acute heart failure.	[Yang, Xiaoli; Liu, Liping; Hao, Qingfang; Zou, Deyong; Zhang, Xiaoli; Zhang, Liping; Li, Hongmei] Chinese Peoples Armed Police Forces, Clin Lab, Gen Hosp, Beijing, Peoples R China; [Qiao, Yong; Zhao, Huansheng] Beijing Hotgen Biotech Co Ltd, Beijing, Peoples R China; [Zhou, Lei] Beijing Inst Microbiol & Epidemiol, Lab Analyt Microbiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Zhou, Lei] POCT Bioemergency & Clin BZ0329, Beijing Key Lab, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Yang, XL (corresponding author), Chinese Peoples Armed Police Forces, Clin Lab, Gen Hosp, Beijing, Peoples R China.; Zhou, L (corresponding author), Beijing Inst Microbiol & Epidemiol, Lab Analyt Microbiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.; Zhou, L (corresponding author), POCT Bioemergency & Clin BZ0329, Beijing Key Lab, Beijing, Peoples R China.	yangxiaolitwins@163.com; ammszhoulei@163.com	liu, li/HGC-0900-2022		National Development and Reform Commission of China [[2013] 2140]; Beijing Municipal Government of China; National High Technology Research and Development Program of China [2013AA032205]; Beijing Nova Programme [Z151100000315086]; National Key Research and Development Program [2016YFC1202502]; Science and Technology Program of Guangzhou, China [2014Y200090]	National Development and Reform Commission of China; Beijing Municipal Government of China; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Beijing Nova Programme(Beijing Municipal Science & Technology Commission); National Key Research and Development Program; Science and Technology Program of Guangzhou, China	This study was supported by Health Program of National Development and Reform Commission of China (grant no. [2013] 2140), Science Innovation Program of Beijing Municipal Government of China (program title "magnetic beads and alkaline phosphatase chemiluminescence-based full-automatic POCT system"), the National High Technology Research and Development Program of China (no. 2013AA032205), Beijing Nova Programme (grant no. Z151100000315086), National Key Research and Development Program (no. 2016YFC1202502), and Science and Technology Program of Guangzhou, China (no. 2014Y200090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskurt M, 2011, CARDIOVASC J AFR, V22, P85, DOI CVJ-21.027; Caselli C, 2016, ARTERIOSCL THROM VAS, V36, P757, DOI 10.1161/ATVBAHA.115.306818; Corstjens P, 2001, CLIN CHEM, V47, P1885; Corstjens PLAM, 2008, CLIN BIOCHEM, V41, P440, DOI 10.1016/j.clinbiochem.2007.12.015; Corstjens PLAM, 2008, J CLIN MICROBIOL, V46, P171, DOI 10.1128/JCM.00877-07; Corstjens PLAM, 2003, ANAL BIOCHEM, V312, P191, DOI 10.1016/S0003-2697(02)00505-5; Di Serio F, 2005, CLIN CHEM LAB MED, V43, P1263, DOI 10.1515/CCLM.2005.217; Dietl A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164060; Galvani M, 2004, CIRCULATION, V110, P128, DOI 10.1161/01.CIR.0000134480.06723.D8; Hampl J, 2001, ANAL BIOCHEM, V288, P176, DOI 10.1006/abio.2000.4902; Hildebrandt P, 2010, EUR HEART J, V31, P1881, DOI 10.1093/eurheartj/ehq163; Hua F, 2015, SCI REP-UK, V5, DOI 10.1038/srep17178; Iqbal N, 2013, EXPERT REV CARDIOVAS, V11, P1155, DOI 10.1586/14779072.2013.832476; Jungbauer CG, 2012, BIOMARK MED, V6, P789, DOI [10.2217/BMM.12.67, 10.2217/bmm.12.67]; Jungbauer CG, 2010, EUR J HEART FAIL, V12, P331, DOI 10.1093/eurjhf/hfq016; Juntunen E, 2016, ANAL BIOCHEM, V492, P13, DOI 10.1016/j.ab.2015.09.009; Karl J, 1999, SCAND J CLIN LAB INV, V59, P177; Leosdottir M, 2011, SCAND CARDIOVASC J, V45, P294, DOI 10.3109/14017431.2011.581763; Liang WB, 2012, BIOSENS BIOELECTRON, V31, P480, DOI 10.1016/j.bios.2011.11.021; Lin CW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147930; Liu X, 2016, SCI REP-UK, V6, DOI 10.1038/srep34926; McDonagh TA, 2004, EUR J HEART FAIL, V6, P269, DOI 10.1016/j.ejheart.2004.01.010; Mladosievicova B, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-86; Mokkapati VK, 2007, ANN NY ACAD SCI, V1098, P476, DOI 10.1196/annals.1384.021; Panagopoulou V, 2013, CURR TOP MED CHEM, V13, P82, DOI 10.2174/1568026611313020002; Riezebos RK, 2005, AM HEART J, V150, P1255, DOI 10.1016/j.ahj.2005.02.003; Riezebos Robert K, 2006, Acute Card Care, V8, P51, DOI 10.1080/14628840600627972; Sarzani R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153759; Seino Y, 2004, EUR J HEART FAIL, V6, P295, DOI 10.1016/j.ejheart.2003.12.009; Taub Pam R, 2010, Congest Heart Fail, V16 Suppl 1, pS19, DOI 10.1111/j.1751-7133.2010.00168.x; Yan ZQ, 2006, SENSOR ACTUAT B-CHEM, V119, P656, DOI 10.1016/j.snb.2006.01.029; Zhang PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105305; Zhao Y, 2016, TALANTA, V161, P297, DOI 10.1016/j.talanta.2016.08.058; Zhao Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep21342; Zuiderwijk M, 2003, CLIN BIOCHEM, V36, P401, DOI 10.1016/S0009-9120(03)00057-2	35	21	21	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171376	10.1371/journal.pone.0171376	http://dx.doi.org/10.1371/journal.pone.0171376			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151978	gold, Green Submitted, Green Published			2022-12-27	WOS:000396161200134
J	Villafranca, A; Kereliuk, S; Hamlin, C; Johnson, A; Jacobsohn, E				Villafranca, Alexander; Kereliuk, Stephanie; Hamlin, Colin; Johnson, Andrea; Jacobsohn, Eric			The Appropriateness of Language Found in Research Consent Form Templates: A Computational Linguistic Analysis	PLOS ONE			English	Article							INFORMED-CONSENT; CLINICAL-TRIALS; READABILITY; LITERACY	Background To facilitate informed consent, consent forms should use language below the grade eight level. Research Ethics Boards (REBs) provide consent form templates to facilitate this goal. Templates with inappropriate language could promote consent forms that participants find difficult to understand. However, a linguistic analysis of templates is lacking. Methods We reviewed the websites of 124 REBs for their templates. These included English language medical school REBs in Australia/New Zealand (n = 23), Canada (n = 14), South Africa (n = 8), the United Kingdom (n = 34), and a geographically-stratified sample from the United States (n = 45). Template language was analyzed using Coh-Metrix linguistic software (v. 3.0, Memphis, USA). We evaluated the proportion of REBs with five key linguistic outcomes at or below grade eight. Additionally, we compared quantitative readability to the REBs' own readability standards. To determine if the template's country of origin or the presence of a local REB readability standard influenced the linguistic variables, we used a MANOVA model. Results Of the REBs who provided templates, 0/94 (0%, 95% CI = 0 - 3.9%) provided templates with all linguistic variables at or below the grade eight level. Relaxing the standard to a grade 12 level did not increase this proportion. Further, only 2/22 (9.1%, 95% CI = 2.5 - 27.8) REBs met their own readability standard. The country of origin (DF = 20, 177.5, F = 1.97, p = 0.01), but not the presence of an REB-specific standard (DF = 5, 84, F = 0.73, p = 0.60), influenced the linguistic variables. Conclusions Inappropriate language in templates is an international problem. Templates use words that are long, abstract, and unfamiliar. This could undermine the validity of participant informed consent. REBs should set a policy of screening templates with linguistic software.	[Villafranca, Alexander; Kereliuk, Stephanie; Hamlin, Colin; Johnson, Andrea; Jacobsohn, Eric] Univ Manitoba, Dept Anesthesiol & Perioperat Med, CR31-42 369 Tache Ave, Winnipeg, MB, Canada	University of Manitoba	Villafranca, A (corresponding author), Univ Manitoba, Dept Anesthesiol & Perioperat Med, CR31-42 369 Tache Ave, Winnipeg, MB, Canada.	avillafranca@sbgh.mb.ca						Aitchison J., 2006, J ED, V39, P90; Andrus MR, 2002, PHARMACOTHERAPY, V22, P282, DOI 10.1592/phco.22.5.282.33191; Bastable S., 2013, NURSE AS ED; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; Doak CC, 1996, TEACHING PATIENTS LO; Foe G, 2016, J EMPIR RES HUM RES, V11, P31, DOI 10.1177/1556264616637483; Ittenbach RF, 2015, J EMPIR RES HUM RES, V10, P444, DOI 10.1177/1556264615615006; LEVINE ROBERT J., 1988, ETHICS REGULATION CL, V2nd; LOVERDE ME, 1989, J GEN INTERN MED, V4, P410, DOI 10.1007/BF02599693; Malan T, 2016, J EMPIR RES HUM RES, V11, P47, DOI 10.1177/1556264616637736; Manta CJ, 2016, J PATIENT SAF; McNamara DS, 2014, AUTOMATED EVALUATION; Moretz M. W., 2008, HDB RES METHODS ABNO, P35; MORROW GR, 1980, JAMA-J AM MED ASSOC, V244, P56, DOI 10.1001/jama.244.1.56; National Health and Medical Research Council, 2012, PICF INT PAR GUARD; Ogloff James R P, 1991, Ethics Behav, V1, P239; Organisation for Economic Co-operation and Development Education, 2015, AD ED LEV; Organization for Economic Co-operation and Development Education, 2011, LIT LIF FURTH RES AD; Paasche-Orlow Michael K, 2013, IRB, V35, P12; Paasche-Orlow MK, 2003, NEW ENGL J MED, V348, P721, DOI 10.1056/NEJMsa021212; Parker RM, 1999, JAMA-J AM MED ASSOC, V281, P552; Pentz RD, 2012, CANCER-AM CANCER SOC, V118, P4571, DOI 10.1002/cncr.27397; Perfetti C, 2007, SCI STUD READ, V11, P357, DOI 10.1080/10888430701530730; Rudd RE, 2010, NEW ENGL J MED, V363, P2283, DOI 10.1056/NEJMp1008755; Samadi A, 2016, J MED ETHICS HIST ME, V9; Shafer SL, 2011, ANESTH ANALG, V112, P491, DOI 10.1213/ANE.0b013e3182095c73; Sharp SM, 2004, AM J CLIN ONCOL-CANC, V27, P570, DOI 10.1097/01.coc.0000135925.83221.b3; Sirico LJ, 2007, QUINNIPIAC L REV, V26, P147; Thong ISK, 2016, CLIN PSYCHOPHARM NEU, V14, P17, DOI 10.9758/cpn.2016.14.1.17; Weiss BD, 1997, NEW ENGL J MED, V337, P272, DOI 10.1056/NEJM199707243370411; Weiss BD, 2003, HLTH LITERACY MANUAL; William L, 2010, UNIVERSAL PRINCIPLES; World Health Organization, 2015, INF CONS TEMPL CLIN	33	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0169143	10.1371/journal.pone.0169143	http://dx.doi.org/10.1371/journal.pone.0169143			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146568	Green Submitted, gold, Green Published			2022-12-27	WOS:000396131700004
J	Qian, XL; Zhang, J; Li, PZ; Lang, RG; Li, WD; Sun, H; Liu, FF; Guo, XJ; Gu, F; Fu, L				Qian, Xiao-Long; Zhang, Jun; Li, Pei-Ze; Lang, Rong-Gang; Li, Wei-Dong; Sun, Hui; Liu, Fang-Fang; Guo, Xiao-Jing; Gu, Feng; Fu, Li			Dasatinib inhibits c-src phosphorylation and prevents the proliferation of Triple-Negative Breast Cancer (TNBC) cells which overexpress Syndecan-Binding Protein (SDCBP)	PLOS ONE			English	Article							GENE-EXPRESSION; KINASE-ACTIVITY; GROWTH; ACTIVATION; MDA-9/SYNTENIN; METASTASIS; SYNTENIN; PATTERNS; ADHESION; RESISTANT	Triple negative breast cancer (TNBC) progresses rapidly but lacks effective targeted therapies. Our previous study showed that downregulating syndecan-binding protein (SDCBP) in TNBC inhibits the proliferation of TNBC cells. Dasatinib is a new small-molecule inhibitor of c-src phosphorylation. The aim of this study was to investigate if SDCBP is a potential marker to indicate whether a TNBC is suitable for dasatinib therapy. This study applied co-immunoprecipitation to identify the interaction between SDCBP and c-src in TNBC cell lines. In addition, immunohistochemistry was used to investigate SDCBP and tyrosine-419 phosphorylated c-src (p-c-src-Y419) expression in TNBC tissues. SDCBP-overexpressing MDA-MB-231 cells were then constructed to evaluate the effects of dasatinib on SDCBP-induced TNBC progression in vitro and tumor formation in nude mice. We found wild-type SDCBP interacted with c-src and promoted the phosphorylation of c-src; this phosphorylation was completely blocked by dasatinib. SDCBP lacking the PDZ domain had no such effect. Among the 52 consecutive random TNBC cases examined, the expression of SDCBP was consistent with that of p-c-src-Y419, and positively correlated with histological grading or Ki-67 levels. SDCBP overexpression significantly accelerated the proliferation and cell cycle progression of the TNBC cell line MDA-MB-231; these effects were prevented by dasatinib treatment. However, the subsequent inhibition of p27 expression partially restored the proliferation and viability of the TNBC cells. The results of this study suggest that SDCBP interacts with c-src, regulates G1/S in TNBC cells, and enhances tumor cell proliferation by promoting the tyrosine phosphorylation of c-src at residue 419. Dasatinib inhibits such phosphorylation and blocks SDCBP-induced cell cycle progression. Therefore, SDCBP might be an important marker for identifying TNBC cases that are suitable for dasatinib therapy.	[Qian, Xiao-Long; Lang, Rong-Gang; Li, Wei-Dong; Sun, Hui; Liu, Fang-Fang; Guo, Xiao-Jing; Gu, Feng; Fu, Li] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Breast Pathol & Lab, Tianjin, Peoples R China; [Qian, Xiao-Long; Zhang, Jun; Lang, Rong-Gang; Li, Wei-Dong; Sun, Hui; Liu, Fang-Fang; Guo, Xiao-Jing; Gu, Feng; Fu, Li] Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Qian, Xiao-Long; Zhang, Jun; Lang, Rong-Gang; Li, Wei-Dong; Sun, Hui; Liu, Fang-Fang; Guo, Xiao-Jing; Gu, Feng; Fu, Li] Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China; [Qian, Xiao-Long; Zhang, Jun; Lang, Rong-Gang; Li, Wei-Dong; Sun, Hui; Liu, Fang-Fang; Guo, Xiao-Jing; Gu, Feng; Fu, Li] Tianjin Med Univ, Key Lab Breast Canc Prevent & Therapy, Minist Educ, Tianjin, Peoples R China; [Zhang, Jun] Tianjin Med Univ Canc Inst & Hosp, Dept Breast Surg, Natl Clin Res Ctr Canc, Tianjin, Peoples R China; [Li, Pei-Ze] Tianjin Polytech Univ, Dept Math, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tiangong University	Qian, XL (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Breast Pathol & Lab, Tianjin, Peoples R China.; Qian, XL (corresponding author), Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China.; Qian, XL (corresponding author), Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China.; Qian, XL (corresponding author), Tianjin Med Univ, Key Lab Breast Canc Prevent & Therapy, Minist Educ, Tianjin, Peoples R China.	xiaolong_qian36@aliyun.com			National Natural Science Foundation of China [81302292, 81272358, 81672637]; National Natural Science Foundation of Tianjin City, China [15JCQNJC45300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Tianjin City, China	This work was supported by National Natural Science Foundation of China (Grant No. 81302292 to XQ, Grant No. 81272358 to FG, Grant No. 81672637 to LF); National Natural Science Foundation of Tianjin City, China (Grant No. 15JCQNJC45300 to FL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JJ, 2003, MOL ENDOCRINOL, V17, P2268, DOI 10.1210/me.2002-0422; Agrawal M, 2010, CURR HEMATOL MALIG R, V5, P70, DOI 10.1007/s11899-010-0045-y; Aissaoui H, 2015, J BIOL CHEM, V290, P3333, DOI 10.1074/jbc.M114.606913; Aleshin A, 2010, NEOPLASIA, V12, P599, DOI 10.1593/neo.10328; Alvarez RH, 2010, CANCER, V107, P1918; Amant F, 2004, GYNECOL ONCOL, V93, P680, DOI 10.1016/j.ygyno.2004.03.021; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Beekman JM, 2008, J CELL SCI, V121, P1349, DOI 10.1242/jcs.026401; Bianchini G, 2016, NAT REV CLIN ONCOL, V13, P674, DOI 10.1038/nrclinonc.2016.66; Boerner RJ, 1996, BIOCHEMISTRY-US, V35, P9519, DOI 10.1021/bi960248u; Boukerche H, 2005, CANCER RES, V65, P10901, DOI 10.1158/0008-5472.CAN-05-1614; Boukerche H, 2010, ONCOGENE, V29, P3054, DOI 10.1038/onc.2010.65; Boukerche H, 2008, P NATL ACAD SCI USA, V105, P15914, DOI 10.1073/pnas.0808171105; Brave M, 2008, CLIN CANCER RES, V14, P352, DOI 10.1158/1078-0432.CCR-07-4175; Chan CM, 2012, CLIN CANCER RES, V18, P3580, DOI 10.1158/1078-0432.CCR-11-3359; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Das SK, 2013, CANCER RES, V73, P844, DOI 10.1158/0008-5472.CAN-12-1681; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Finn RS, 2007, BREAST CANCER RES TR, V105, P319, DOI 10.1007/s10549-006-9463-x; Finn RS, 2011, CLIN CANCER RES, V17, P6905, DOI 10.1158/1078-0432.CCR-11-0288; Fulford LG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1636; Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; Gonzalez L, 2006, J BIOL CHEM, V281, P20851, DOI 10.1074/jbc.M601570200; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; He T, 2015, MOL MED REP, V12, P4063, DOI 10.3892/mmr.2015.4003; Huang F, 2007, CANCER RES, V67, P2226, DOI 10.1158/0008-5472.CAN-06-3633; Hugh J, 2009, J CLIN ONCOL, V27, P1168, DOI 10.1200/JCO.2008.18.1024; Hwangbo C, 2011, J BIOL CHEM, V286, P33601, DOI 10.1074/jbc.M110.206789; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Kanomata N, 2011, J CLIN PATHOL, V64, P578, DOI 10.1136/jclinpath-2011-200042; Keyomarsi K, 2002, NEW ENGL J MED, V347, P1566, DOI 10.1056/NEJMoa021153; Liedtke C, 2015, CURR OPIN OBSTET GYN, V27, P77, DOI 10.1097/GCO.0000000000000137; Liu X, 2013, J NANOMATER, V2013, DOI 10.1155/2013/938370; Morgan L, 2009, CANCER BIOL THER, V8, P1550, DOI 10.4161/cbt.8.16.8954; Murphy CC, 2012, BREAST CANCER RES TR, V134, P459, DOI 10.1007/s10549-012-2114-5; Oakman C, 2010, BREAST, V19, P312, DOI 10.1016/j.breast.2010.03.026; Palma G, 2015, ONCOTARGET, V6, P26560, DOI 10.18632/oncotarget.5306; Pichot CS, 2009, BRIT J CANCER, V101, P38, DOI 10.1038/sj.bjc.6605101; Sanchez-Bailon MP, 2012, CELL SIGNAL, V24, P1276, DOI 10.1016/j.cellsig.2012.02.011; Qian XL, 2016, BREAST CANCER RES TR, V159, P31, DOI 10.1007/s10549-016-3917-6; Qian XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060046; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; SCHONK DM, 1989, HUM GENET, V83, P297, DOI 10.1007/BF00285178; Song LX, 2006, CANCER RES, V66, P5542, DOI 10.1158/0008-5472.CAN-05-4620; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Westhoff MA, 2004, MOL CELL BIOL, V24, P8113, DOI 10.1128/MCB.24.18.8113-8133.2004; Yang Y, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3442; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zhang QX, 2005, FEBS LETT, V579, P3932, DOI 10.1016/j.febslet.2005.06.012	49	26	26	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171169	10.1371/journal.pone.0171169	http://dx.doi.org/10.1371/journal.pone.0171169			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141839	Green Submitted, gold, Green Published			2022-12-27	WOS:000396129500047
J	Demilew, YM; Nigussie, AA				Demilew, Yeshalem Mulugeta; Nigussie, Azezu Asres			Knowledge of Health Professionals on Folic Acid Use and Their Prescribing Practice in Bahir Dar City Administration, Northwest Ethiopia: Cross-Sectional Study	PLOS ONE			English	Article								Background Taking folic acid supplement during periconception period is effective to prevent neural tube defects. Unfortunately, a minority of Ethiopian women took folic acid supplement during this period. Low consumption of folic acid might be correlated with knowledge and prescribing practice of health professionals. Therefore, this study was conducted to assess knowledge and prescribing practice of health professionals. Methods Institution based cross- sectional quantitative study supplemented by qualitative approach using thematic content analysis of in-depth interview was conducted. A total of 424 health professionals were selected by simple random sampling technique. A convenience sam-pling technique was used to generate the qualitative data. Bivariable and multivariable logis-tic regression analysis were used to identify factors associated with knowledge of health professionals. Result About 47.7% of health professionals had sufficient knowledge and 9.7% of them had prescribed folic acid to women during periconception period. Age, having work experience in ANC clinic, and being a general practitioner were independent predictors for knowledge of health professionals. Lack of guideline to use as a reference, refreshment training and clear direction from health bureau, time constraint, differing patient priorities, and competing top-ics were some of the reasons for insufficient knowledge and poor practice. Conclusion The majority of the health professionals had insufficient knowledge and poor prescribing practice on folic acid during periconception period. Lack of guideline to be used as a refer-ence, refreshment training and clear direction from health bureau, time constraint, differing patient priorities, and competing topics were some of the reasons for low level of knowledge and poor prescribing practice. Thus, guideline to use as a reference, refreshment training, incorporate the topic in the curriculum of health professionals and supportive supervision should be given to increase the knowledge and prescribing practice of health professionals. Regional Health Bureau should give priority on prevention of birth defects.	[Demilew, Yeshalem Mulugeta] Bahir Dar Univ, Sch Publ Hlth, Coll Med & Hlth Sci, Bahir Dar, Ethiopia; [Nigussie, Azezu Asres] Bahir Dar Univ, Midwifery Dept, Coll Med & Hlth Sci, Bahir Dar, Ethiopia	Bahir Dar University; Bahir Dar University	Demilew, YM (corresponding author), Bahir Dar Univ, Sch Publ Hlth, Coll Med & Hlth Sci, Bahir Dar, Ethiopia.	yeshalem_mulugeta@yahoo.com						Abedi G., 2011, World Applied Sciences Journal, V12, P944; Abelman S, 2007, HLTH CARE PROVIDERS; Amhara National Regional State finance and economic development Bureau, 2015, REG POP PROJ REP; Bitzer J, 2013, INT J WOMENS HEALTH, V5, P201, DOI 10.2147/IJWH.S40149; Blencowe H, 2010, INT J EPIDEMIOL, V39, P110, DOI 10.1093/ije/dyq028; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Buttriss J., 2004, Nutrition Bulletin, V29, P234, DOI 10.1111/j.1467-3010.2004.00429.x; Eithan A, 2011, KNOWLEDGE ATTITUDES; Gaym A., 2000, Ethiopian Journal of Health Development, V14, P335; Green J., 2018, QUALITATIVE METHODS, VFourth; Hall J G, 1998, Adv Pediatr, V45, P1; Hodgetts V, 2014, BJOG; Kadir RA, 2002, CAN MED ASSOC J, V167, P255; Lassi ZS, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S1-S2; McDonald Sarah D, 2003, J Obstet Gynaecol Can, V25, P115; Mohammed A, 2013, THERAPEUTIC INNOVATI, V47, P417; Muchowski K, 2004, J FAM PRACTICE, V53, P126; Nilsen RM, 2006, AM J CLIN NUTR, V84, P1134, DOI 10.1093/ajcn/84.5.1134; Pitkin RM, 2007, AM J CLIN NUTR, V85, p285S, DOI 10.1093/ajcn/85.1.285S; da Silva CAP, 2010, SAO PAULO MED J, V128, P324, DOI 10.1590/S1516-31802010000600003; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Power ML, 2000, OBSTET GYNECOL, V95, P895, DOI 10.1016/S0029-7844(00)00793-6; Rodrigues Claire R., 2012, Pharmacy Practice (Internet), V10, P168, DOI 10.4321/s1886-36552012000300007; Sean ML, 2001, J NUTR, P439; Sorri Gemechu, 2015, Ethiop Med J, V53, P119; Spencer J, 1994, QUALITATIVE DATA ANA; Strauss A., 1990, BASICS QUALITATIVE R; Talaulikar VS, 2011, OBSTET GYNECOL SURV, V66, P240, DOI 10.1097/OGX.0b013e318223614c; Williams JL, 2006, MATERN CHILD HLTH J, V10, pS67, DOI 10.1007/s10995-006-0088-9	29	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170116	10.1371/journal.pone.0170116	http://dx.doi.org/10.1371/journal.pone.0170116			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135302	Green Published, gold, Green Submitted			2022-12-27	WOS:000396124700009
J	Sollanek, KJ; Burniston, JG; Kavazis, AN; Morton, AB; Wiggs, MP; Ahn, B; Smuder, AJ; Powers, SK				Sollanek, Kurt J.; Burniston, Jatin G.; Kavazis, Andreas N.; Morton, Aaron B.; Wiggs, Michael P.; Ahn, Bumsoo; Smuder, Ashley J.; Powers, Scott K.			Global Proteome Changes in the Rat Diaphragm Induced by Endurance Exercise Training	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; HIGH-INTENSITY EXERCISE; HEAT-SHOCK PROTEINS; SKELETAL-MUSCLE; INTERMYOFIBRILLAR MITOCHONDRIA; HYDROGEN-SULFIDE; DYSFUNCTION; PROTECTS; REVEALS; IDENTIFICATION	Mechanical ventilation (MV) is a life-saving intervention for many critically ill patients. Unfortunately, prolonged MV results in the rapid development of diaphragmatic atrophy and weakness. Importantly, endurance exercise training results in a diaphragmatic phenotype that is protected against ventilator-induced diaphragmatic atrophy and weakness. The mechanisms responsible for this exercise-induced protection against ventilator-induced diaphragmatic atrophy remain unknown. Therefore, to investigate exercise-induced changes in diaphragm muscle proteins, we compared the diaphragmatic proteome from sedentary and exercise-trained rats. Specifically, using label-free liquid chromatography-mass spectrometry, we performed a proteomics analysis of both soluble proteins and mitochondrial proteins isolated from diaphragm muscle. The total number of diaphragm proteins profiled in the soluble protein fraction and mitochondrial protein fraction were 813 and 732, respectively. Endurance exercise training significantly (P< 0.05, FDR < 10%) altered the abundance of 70 proteins in the soluble diaphragm proteome and 25 proteins of the mitochondrial proteome. In particular, key cytoprotective proteins that increased in relative abundance following exercise training included mitochondrial fission process 1 (Mtfp1; MTP18), 3-mercaptopyruvate sulfurtransferase (3MPST), microsomal glutathione S-transferase 3 (Mgst3; GST-III), and heat shock protein 70 kDa protein 1A/1B (HSP70). While these proteins are known to be cytoprotective in several cell types, the cyto-protective roles of these proteins have yet to be fully elucidated in diaphragm muscle fibers. Based upon these important findings, future experiments can now determine which of these diaphragmatic proteins are sufficient and/or required to promote exercise-induced protection against inactivity-induced muscle atrophy.	[Sollanek, Kurt J.; Morton, Aaron B.; Wiggs, Michael P.; Ahn, Bumsoo; Smuder, Ashley J.; Powers, Scott K.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL USA; [Burniston, Jatin G.] Liverpool John Moores Univ, Res Inst Sport & Exercise, Liverpool, Merseyside, England; [Kavazis, Andreas N.] Auburn Univ, Sch Kinesiol, Auburn, AL 36849 USA; [Sollanek, Kurt J.] Sonoma State Univ, Dept Kinesiol, Rohnert Pk, CA 94928 USA; [Wiggs, Michael P.] Univ Texas Tyler, Dept Hlth & Kinesiol, Tyler, TX 75799 USA; [Ahn, Bumsoo] Oklahoma Med Res Fdn, Aging & Metab Res Program, Oklahoma City, OK USA	State University System of Florida; University of Florida; Liverpool John Moores University; Auburn University System; Auburn University; California State University System; Sonoma State University; University of Texas System; University of Texas at Tyler; Oklahoma Medical Research Foundation	Sollanek, KJ (corresponding author), Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL USA.; Sollanek, KJ (corresponding author), Sonoma State Univ, Dept Kinesiol, Rohnert Pk, CA 94928 USA.	sollanek@sonoma.edu	Burniston, Jatin/AAB-8831-2020; Ahn, Bumsoo/AAK-3818-2021; Burniston, Jatin G/B-7833-2008; Ahn, Bumsoo/GNP-7749-2022	Burniston, Jatin/0000-0001-7303-9318; Burniston, Jatin G/0000-0001-7303-9318; Ahn, Bumsoo/0000-0002-2743-7099; Morton, Aaron/0000-0002-9790-705X	National Institutes of Health award [R01 AR064189]; AGSM Foundation Research Grant from the American College of Sports Medicine (ACSM) Foundation award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD043730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064189] Funding Source: NIH RePORTER	National Institutes of Health award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGSM Foundation Research Grant from the American College of Sports Medicine (ACSM) Foundation award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health awarded to SKP (R01 AR064189). Moreover, this research was supported by an AGSM Foundation Research Grant from the American College of Sports Medicine (ACSM) Foundation awarded to KJS.	Adhihetty PJ, 2005, AM J PHYSIOL-CELL PH, V289, pC994, DOI 10.1152/ajpcell.00031.2005; Alves RMP, 2010, J GERONTOL A-BIOL, V65, P832, DOI 10.1093/gerona/glq081; Burniston JG, 2008, BBA-PROTEINS PROTEOM, V1784, P1077, DOI 10.1016/j.bbapap.2008.04.007; Burniston JG, 2014, PROTEOMICS, V14, P2339, DOI 10.1002/pmic.201400118; Burniston JG, 2011, EXPERT REV PROTEOMIC, V8, P361, DOI [10.1586/EPR.11.17, 10.1586/epr.11.17]; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Dasta JF, 2005, CRIT CARE MED, V33, P1266, DOI 10.1097/01.CCM.0000164543.14619.00; de Oliveira BM, 2014, MOL CELL PROTEOMICS, V13, P3001, DOI 10.1074/mcp.M113.032276; Doran P, 2006, PROTEOMICS, V6, P4610, DOI 10.1002/pmic.200600082; Egan B, 2011, PROTEOMICS, V11, P1413, DOI 10.1002/pmic.201000597; ESTEBAN A, 1995, NEW ENGL J MED, V332, P345, DOI 10.1056/NEJM199502093320601; Ferreira R, 2010, PROTEOMICS, V10, P3142, DOI 10.1002/pmic.201000173; Gandra PG, 2012, SCAND J MED SCI SPOR, V22, P207, DOI 10.1111/j.1600-0838.2010.01235.x; Gandra PG, 2012, PROTEOMICS, V12, P2663, DOI 10.1002/pmic.201200137; Guelfi KJ, 2006, CLIN EXP PHARMACOL P, V33, P952, DOI 10.1111/j.1440-1681.2006.04470.x; Hody S, 2013, MED SCI SPORT EXER, V45, P1460, DOI 10.1249/MSS.0b013e3182894a33; Hody S, 2011, MED SCI SPORT EXER, V43, P2281, DOI 10.1249/MSS.0b013e318222edf3; Holloway KV, 2009, PROTEOMICS, V9, P5155, DOI 10.1002/pmic.200900068; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ichinoseki-Sekine N, 2014, J APPL PHYSIOL, V117, P518, DOI 10.1152/japplphysiol.00170.2014; Jakobsson PJ, 1997, J BIOL CHEM, V272, P22934, DOI 10.1074/jbc.272.36.22934; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kavazis AN, 2008, AM J PHYSIOL-HEART C, V294, pH928, DOI 10.1152/ajpheart.01231.2007; Kavazis AN, 2009, FREE RADICAL BIO MED, V46, P842, DOI 10.1016/j.freeradbiomed.2009.01.002; Kimura H, 2011, EXP PHYSIOL, V96, P833, DOI 10.1113/expphysiol.2011.057455; LAWLER JM, 1993, MED SCI SPORT EXER, V25, P1259; Lefort N, 2009, J PROTEOMICS, V72, P1046, DOI 10.1016/j.jprot.2009.06.011; Lewis P, 2016, AM J RESP CELL MOL, V55, P12, DOI 10.1165/rcmb.2015-0272OC; Liping-zhao, 2012, BIOL RES, V45, P75, DOI 10.4067/S0716-97602012000100010; LOCKE M, 1995, AM J PHYSIOL-HEART C, V269, pH320, DOI 10.1152/ajpheart.1995.269.1.H320; Magherini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071839; Magherini F, 2012, J PROTEOMICS, V75, P978, DOI 10.1016/j.jprot.2011.10.017; Maglara AA, 2003, J PHYSIOL-LONDON, V548, P837, DOI 10.1113/jphysiol.2002.034520; MAKINEN MW, 1968, ARCH BIOCHEM BIOPHYS, V126, P75, DOI 10.1016/0003-9861(68)90561-4; Malik ZA, 2013, PROTEOMES, V1, DOI 10.3390/proteomes1030290; Malm C, 2012, HISTOCHEM CELL BIOL, V138, P89, DOI 10.1007/s00418-012-0946-z; Matsumura CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065831; Morton JP, 2006, J APPL PHYSIOL, V101, P176, DOI 10.1152/japplphysiol.00046.2006; Morton JP, 2009, SPORTS MED, V39, P643, DOI 10.2165/00007256-200939080-00003; Naito H, 2000, J APPL PHYSIOL, V88, P359, DOI 10.1152/jappl.2000.88.1.359; Naylor DJ, 1998, J BIOL CHEM, V273, P21169, DOI 10.1074/jbc.273.33.21169; Norheim F, 2011, AM J PHYSIOL-ENDOC M, V301, pE1013, DOI 10.1152/ajpendo.00326.2011; Paulsen G, 2007, AM J PHYSIOL-REG I, V293, pR844, DOI 10.1152/ajpregu.00677.2006; Picard M, 2012, AM J RESP CRIT CARE; Picard M, 2015, J APPL PHYSIOL, V118, P1161, DOI 10.1152/japplphysiol.00873.2014; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Powers SK, 2014, PHYSIOLOGY, V29, P27, DOI 10.1152/physiol.00030.2013; Powers SK, 2013, AM J PHYSIOL-REG I, V305, pR464, DOI 10.1152/ajpregu.00231.2013; Powers SK, 2011, ANTIOXID REDOX SIGN, V15, P2519, DOI 10.1089/ars.2011.3973; Powers SK, 2011, CRIT CARE MED, V39, P1749, DOI 10.1097/CCM.0b013e3182190b62; Powers SK, 2001, MED SCI SPORT EXER, V33, P386, DOI 10.1097/00005768-200103000-00009; Predmore Benjamin L, 2011, Expert Rev Clin Pharmacol, V4, P83, DOI 10.1586/ecp.10.56; Sadler NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047996; Salah H, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf7099; Selsby JT, 2005, AM J PHYSIOL-REG I, V289, pR134, DOI 10.1152/ajpregu.00497.2004; Senf SM, 2008, FASEB J, V22, P3836, DOI 10.1096/fj.08-110163; Shen Y, 2010, BIOCHIMIE, V92, P530, DOI 10.1016/j.biochi.2010.02.001; Smuder AJ, 2012, J APPL PHYSIOL, V112, P501, DOI 10.1152/japplphysiol.01086.2011; Smuder AJ, 2011, J APPL PHYSIOL, V110, P935, DOI 10.1152/japplphysiol.00677.2010; Sollanek KJ, 2015, J APPL PHYSIOL, V118, P849, DOI 10.1152/japplphysiol.00797.2014; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tondera D, 2005, J CELL SCI, V118, P3049, DOI 10.1242/jcs.02415; Tondera D, 2004, J BIOL CHEM, V279, P31544, DOI 10.1074/jbc.M404704200; Vassilakopoulos T, 2004, AM J RESP CRIT CARE, V169, P336, DOI 10.1164/rccm.200304-489CP; Vassilakopoulos T, 2008, INTENS CARE MED, V34, P7, DOI 10.1007/s00134-007-0866-x; Wang C, 2009, INT J FOOD SCI NUTR, V1, P1, DOI DOI 10.1109/IWQ0S.2009.5201385; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Xiao RJ, 2011, APOPTOSIS, V16, P221, DOI 10.1007/s10495-010-0566-9; Yamaguchi W, 2010, J BIOCHEM, V148, P327, DOI 10.1093/jb/mvq073; Yan Z, 2012, EXERC SPORT SCI REV, V40, P159, DOI 10.1097/JES.0b013e3182575599; Zhao XL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000299	71	22	23	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171007	10.1371/journal.pone.0171007	http://dx.doi.org/10.1371/journal.pone.0171007			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135290	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000396124700038
J	Zhang, X; Mu, YN; Mu, PF; Ao, JQ; Chen, XH				Zhang, Xin; Mu, Yinnan; Mu, Pengfei; Ao, Jingqun; Chen, Xinhua			Transcriptome Analysis Reveals Comprehensive Insights into the Early Immune Response of Large Yellow Croaker (Larimichthys crocea) Induced by Trivalent Bacterial Vaccine	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; AEROMONAS-SALMONICIDA; EXPRESSION ANALYSIS; EXOGENOUS ANTIGENS; READ ALIGNMENT; FISH; RECEPTOR; INTERLEUKIN-1-BETA; PATHWAYS; HOMOLOG	Vaccination is an effective and safe strategy for combating bacterial diseases in fish, but the mechanisms underlying the early immune response after vaccination remain to be elucidated. In the present study, we used RNA-seq technology to perform transcriptome analysis of spleens from large yellow croaker (Larimichthys crocea) induced by inactivated trivalent bacterial vaccine (Vibrio parahaemolyticus, Vibrio alginolyticus and Aeromonas hydrophila). A total of 2,789 or 1,511 differentially expressed genes (DEGs) were obtained at 24 or 72 h after vaccination, including 1,132 or 842 remarkably up-regulated genes and 1,657 or 669 remarkably down-regulated genes, respectively. Gene ontology and Kyoto Encyclopedia of Genes and Genomes enrichments revealed that numerous DEGs belong to immune-relevant genes, involved in many immune-relevant pathways. Most of the strongly up-regulated DEGs are innate defense molecules, such as antimicrobial peptides, complement components, lectins, and transferrins. Trivalent bacterial vaccine affected the expressions of many components associated with bacterial ligand-depending Toll-like receptor signaling pathways and inflammasome formation, indicating that multiple innate immune processes were activated at the early period of vaccination in large yellow croaker. Moreover, the expression levels of genes involved in antigen processing were also up-regulated by bacterial vaccine. However, the expression levels of several T cell receptors and related CD molecules and signal transducers were down-regulated, suggesting that the T cell receptor signaling pathway was rapidly suppressed after vaccination. These results provide the comprehensive insights into the early immune response of large yellow croaker to vaccination and valuable information for developing a highly immunogenic vaccine against bacterial infection in teleosts.	[Zhang, Xin; Mu, Yinnan] Ningbo Univ, Sch Marine Sci, Ningbo, Zhejiang, Peoples R China; [Zhang, Xin; Mu, Yinnan; Mu, Pengfei; Ao, Jingqun; Chen, Xinhua] State Ocean Adm, Inst Oceanog 3, Key Lab Marine Biogenet Resources, Xiamen, Peoples R China; [Zhang, Xin; Mu, Yinnan; Mu, Pengfei; Ao, Jingqun; Chen, Xinhua] Fujian Collaborat Innovat Ctr Exploitat & Utiliza, Xiamen, Peoples R China; [Chen, Xinhua] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China	Ningbo University; State Oceanic Administration; Qingdao National Laboratory for Marine Science & Technology	Chen, XH (corresponding author), State Ocean Adm, Inst Oceanog 3, Key Lab Marine Biogenet Resources, Xiamen, Peoples R China.; Chen, XH (corresponding author), Fujian Collaborat Innovat Ctr Exploitat & Utiliza, Xiamen, Peoples R China.; Chen, XH (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.	chenxinhua@tio.org.cn			National Natural Science Foundation of China [31530080, 31372556]; National Basic Research Program of China [2015CB755903]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (31530080 and 31372556) and National Basic Research Program of China (2015CB755903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Ali CER, 2014, FRONT GENET, V5, P1027; Ao JQ, 2015, INT J MOL SCI, V16, P29631, DOI 10.3390/ijms161226175; Ao JQ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005118; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Basu M, 2012, FISH SHELLFISH IMMUN, V32, P121, DOI 10.1016/j.fsi.2011.10.031; Caipang CMA, 2009, COMP BIOCHEM PHYS B, V153, P261, DOI 10.1016/j.cbpb.2009.03.005; Campbell DJ, 2000, J IMMUNOL, V164, P168, DOI 10.4049/jimmunol.164.1.168; [曹军 CAO Jun], 2007, [湖北农业科学, Hubei Agricultural Sciences], V46, P808; Chen Q, 2008, DIS AQUAT ORGAN, V80, P181, DOI 10.3354/dao01933; Compan V, 2012, IMMUNITY, V37, P487, DOI 10.1016/j.immuni.2012.06.013; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dan XM, 2013, FISH SHELLFISH IMMUN, V34, P885, DOI 10.1016/j.fsi.2012.12.011; DEC C, 1990, J FISH DIS, V13, P369, DOI 10.1111/j.1365-2761.1990.tb00795.x; Dijkstra JM, 2001, FISH SHELLFISH IMMUN, V11, P437, DOI 10.1006/fsim.2001.0351; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; ELLISON RT, 1988, INFECT IMMUN, V56, P2774, DOI 10.1128/IAI.56.11.2774-2781.1988; Ewart KV, 2001, ICES J MAR SCI, V58, P380, DOI 10.1006/jmsc.2000.1020; Gomez GD, 2008, FEMS IMMUNOL MED MIC, V52, P145, DOI 10.1111/j.1574-695X.2007.00343.x; Guo BY, 2016, FISH SHELLFISH IMMUN, V51, P211, DOI 10.1016/j.fsi.2016.01.015; Hong WS, 2003, AQUACULTURE, V227, P305, DOI 10.1016/S0044-8486(03)00511-8; Laing KJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-42; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li SY, 2009, DEV COMP IMMUNOL, V33, P1268, DOI 10.1016/j.dci.2009.07.008; Martin SAM, 2006, MOL IMMUNOL, V43, P1900, DOI 10.1016/j.molimm.2005.10.007; Mellman I, 2010, CURR OPIN IMMUNOL, V22, P78, DOI 10.1016/j.coi.2010.01.013; Mu YN, 2015, FISH SHELLFISH IMMUN, V44, P462, DOI 10.1016/j.fsi.2015.03.026; Mu YN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-506; Mu YN, 2010, DEV COMP IMMUNOL, V34, P300, DOI 10.1016/j.dci.2009.10.009; Tran NT, 2015, FISH SHELLFISH IMMUN, V45, P72, DOI 10.1016/j.fsi.2015.01.034; Potter NS, 2001, J IMMUNOL, V167, P2538, DOI 10.4049/jimmunol.167.5.2538; Qi ZT, 2016, FISH SHELLFISH IMMUN, V49, P194, DOI 10.1016/j.fsi.2015.12.029; Rebl A, 2014, MAR BIOTECHNOL, V16, P333, DOI 10.1007/s10126-013-9552-x; Reimann J, 1997, CURR OPIN IMMUNOL, V9, P462, DOI 10.1016/S0952-7915(97)80096-9; Schjorring Susanne, 2011, Int J Microbiol, V2011, P312956, DOI 10.1155/2011/312956; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sommerset I, 2005, EXPERT REV VACCINES, V4, P89, DOI 10.1586/14760584.4.1.89; Tian C, 2010, FISH SHELLFISH IMMUN, V28, P445, DOI 10.1016/j.fsi.2009.11.024; Villumsen KR, 2015, FISH SHELLFISH IMMUN, V42, P193, DOI 10.1016/j.fsi.2014.09.024; Villumsen KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093845; Vojtech LN, 2012, INFECT IMMUN, V80, P2878, DOI 10.1128/IAI.00543-12; Wang HL, 2015, FISH SHELLFISH IMMUN, V42, P272, DOI 10.1016/j.fsi.2014.11.006; [汪玉华 Wang Yuhua], 2013, [应用海洋学学报, Journal of Applied Oceanography], V32, P383; Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821; Wei YC, 2011, VET IMMUNOL IMMUNOP, V141, P173, DOI 10.1016/j.vetimm.2011.02.016; Whyte SK, 2007, FISH SHELLFISH IMMUN, V23, P1127, DOI 10.1016/j.fsi.2007.06.005; Wu Z.P., 2004, J XIAMEN UNIV-NAT SC, V43, P112; Yan Q., 2001, J JIMEI U NAT SCI, V3, P191, DOI [10.19715/j.jmuzr.2001.03.001, DOI 10.19715/J.JMUZR.2001.03.001]; Yang DH, 2013, DEV COMP IMMUNOL, V40, P132, DOI 10.1016/j.dci.2013.01.014; Yang DH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-319; Yang Y, 2016, FISH SHELLFISH IMMUN, V51, P329, DOI 10.1016/j.fsi.2016.02.035; Zhang X, 2015, FISH SHELLFISH IMMUN, V43, P209, DOI 10.1016/j.fsi.2014.11.018; Zheng WB, 2007, IMMUNOL LETT, V113, P107, DOI 10.1016/j.imlet.2007.08.001; Zhu JJ, 2015, FISH SHELLFISH IMMUN, V46, P346, DOI 10.1016/j.fsi.2015.06.027	56	13	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170958	10.1371/journal.pone.0170958	http://dx.doi.org/10.1371/journal.pone.0170958			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135311	Green Published, Green Submitted, gold			2022-12-27	WOS:000396124700034
J	Gosselin, A; Lelievre, E; Ravalihasy, A; Lydie, N; Lert, F; du Lou, AD				Gosselin, Anne; Lelievre, Eva; Ravalihasy, Andrainolo; Lydie, Nathalie; Lert, France; du Lou, Annabel Desgrees		Parcours Study Grp	"Times Are Changing": The Impact of HIV Diagnosis on Sub-Saharan Migrants' Lives in France	PLOS ONE			English	Article							OCCUPATIONAL TRAJECTORIES; EMPLOYMENT; FAMILY; LIFE; NORMALIZATION; IMMIGRANTS; DISEASE; HEALTH; AIDS	Background Migrants account for 35% of HIV diagnoses in the European Union (ECDC/WHO 2014). Little is known about the impact of such a lifelong infection diagnosis on lives that are already disrupted by migration. In this paper, we assess the impact of HIV diagnosis on activity, union, well-being among African migrants living in France, the second group most affected by HIV after MSM. We compare it with the impact of the diagnosis of Hepatitis B, another lifelong infection affecting African migrants. Methods We use the ANRS PARCOURS survey, a retrospective life-event survey led in 2012-2013 in 74 health structures in Paris greater area which collected 926 life histories of Sub-Saharan migrants living with HIV and 779 with Hepatitis B. We modelled the probability year by year since 18 years of age until data collection to lose one's activity, to experience a conjugal break up and degradation of well-being and we estimated the impact of migration and of HIV and Hepatitis B diagnoses on these probabilities, after adjustment on other factors, thanks to discrete-time logistic regressions. Results Migration entailed loss of activity and conjugal break up, though HIV diagnosis after migration did not statistically impact on these outcomes. Yet HIV diagnosis had a massive negative impact on well-being (aOR = 11.31 [4.64-27.56] for men and 5.75 [2.79 -11.86] for women). This negative impact on well-being tended to diminish for persons diagnosed after 2004. The negative impact of HIV diagnosis on African migrants' well-being seems to be attenuated in the last decade, which hints at a normalization of the subjective experience of HIV diagnosis.	[Gosselin, Anne; Ravalihasy, Andrainolo; du Lou, Annabel Desgrees] Univ Paris 05, IRD, UMR 196, CEPED, 45 Rue St Peres, Paris, France; [Gosselin, Anne; Lelievre, Eva] INED French Inst Demog Studies, 133 Bd Devout, Paris, France; [Lydie, Nathalie] Sante Publ France, Site Carrefour Pleyel,42 Bd Liberat, St Denis, France; [Lert, France] Hop Paul Brousse, CESP, INSERM, Villejuif, France; [du Lou, Annabel Desgrees] IRD, 44 Bd Dunkerque, Marseille, France	UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); Institute of Public Health Surveillance; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut de Recherche pour le Developpement (IRD)	Gosselin, A (corresponding author), Univ Paris 05, IRD, UMR 196, CEPED, 45 Rue St Peres, Paris, France.; Gosselin, A (corresponding author), INED French Inst Demog Studies, 133 Bd Devout, Paris, France.	anne.gosselin@ceped.org	Gosselin, Anne/ABA-1571-2020; Le Strat, Yann/C-9848-2013	Gosselin, Anne/0000-0002-6876-8249; Desgrees du Lou, annabel/0000-0002-2223-5316; Ravalihasy, Andrainolo/0000-0003-0880-6319; Le Strat, Yann/0000-0002-6180-4200; Pourette, Dolores/0000-0002-3599-8806; Dray-Spira, Rosemary/0000-0001-7646-3667	French National Agency for research on AIDS and Viral hepatitis (ANRS); General Direction of Health (DGS, French Ministry of Health); National Institute for Prevention and Education for Health (INPES)	French National Agency for research on AIDS and Viral hepatitis (ANRS)(ANRSFrench National Research Agency (ANR)); General Direction of Health (DGS, French Ministry of Health); National Institute for Prevention and Education for Health (INPES)	This study was supported by the French National Agency for research on AIDS and Viral hepatitis (ANRS), the General Direction of Health (DGS, French Ministry of Health) and the National Institute for Prevention and Education for Health (INPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AG had full access to all the data and final responsibility for the decision to submit for publication.; This study was supported by the French National Agency for research on AIDS and Viral hepatitis (ANRS), the General Direction of Health (DGS, French Ministry of Health) and the National Institute for Prevention and Education for Health (INPES). The sponsors of the study had no role in study design, data collection, data analysis, data interpretation or writing of the paper.	Akresh IR, 2008, POPUL DEV REV, V34, P435, DOI 10.1111/j.1728-4457.2008.00231.x; Allison PD., 1982, SOCIOL METHODOL, V13, P61, DOI 10.2307/270718; Annequin M, 2015, AIDS, V29, P1537, DOI 10.1097/QAD.0000000000000722; Atkinson P., 1997, QUAL INQ, V3, P304, DOI DOI 10.1177/107780049700300304; Baizan P, 2014, EUR J POPUL, V30, P65, DOI 10.1007/s10680-013-9305-6; Block L, 2013, EUR J MIGR LAW, V15, P203, DOI 10.1163/15718166-12342031; BOURDIEU P, 1986, ACTES RECHERCHE SCI, V62-63, P69, DOI DOI 10.3406/ARSS.1986.2317; Brou H, 2007, PLOS MED, V4, P1912, DOI 10.1371/journal.pmed.0040342; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; CARRICABURU D, 1995, SOCIOL HLTH ILLN, V17; Cazein F, 2015, B EPIDEMIOLOGIQUE HE, P9; Desclaux A, 2014, Bull Soc Pathol Exot, V107, P244, DOI 10.1007/s13149-014-0347-8; Desgrees-du-Lou A, 2016, AIDS, V30, P645, DOI 10.1097/QAD.0000000000000957; Desgrees-du-Lou A, 2009, SOC SCI MED, V69, P892, DOI 10.1016/j.socscimed.2009.05.045; Dray-Spira R, 2007, AIDS, V21, pS5, DOI 10.1097/01.aids.0000255079.39352.9b; European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2014, HIV AIDS SURV EUR 20; Gaillard P, 2002, AIDS, V16, P937, DOI 10.1097/00002030-200204120-00019; Gerbier-Aublanc M, 2016, THESIS; Heggebo K, 2015, SOC SCI MED, V130, P115, DOI 10.1016/j.socscimed.2015.02.010; Institut national de veille sanitaire, 2009, NUM THEM SURV PREV H; Le Coeur S, 2005, POPULATION, V60, P551, DOI 10.3917/popu.504.0551; Lelievre E, 2016, 33 CEPED; Lellevre E, 2015, B SOCIOL METHODOL, V125, P125; Lert F., 2014, VIVRE AVEC VIH DOM E; Lert F, 2013, 2627 I NAT VEILL SAN; Marsicano E, 2014, AIDS CARE, V26, pS97, DOI 10.1080/09540121.2014.907385; Mazanderani F, 2015, SOC SCI MED, V131, P66, DOI 10.1016/j.socscimed.2015.02.041; Minton JW, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2316; Moyer E, 2014, MED ANTHROPOL, V33, P263, DOI 10.1080/01459740.2014.890618; Obucina O, 2013, DEMOGR RES, V28, P547, DOI 10.4054/DemRes.2013.28.19; Pailhe A, 2013, LONGITUD LIFE COURSE, V4, P196; Pierret J, 2007, SOC SCI MED, V65, P1595, DOI 10.1016/j.socscimed.2007.06.017; Pourette D, 2013, SANTE PUBLIQUE, V25, P561, DOI 10.3917/spub.135.0561; Rabkin JG, 2004, PSYCHOSOM MED, V66, P72, DOI 10.1097/01.PSY.0000108083.43147.6D; Rosen S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012731; Rosenbrock R, 2000, SOC SCI MED, V50, P1607, DOI 10.1016/S0277-9536(99)00469-4; Smith JH, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-47; StataCorp, 2011, STAT STAT SOFTW REL, P173; Tsai AC, 2013, AIDS BEHAV, V17, P2725, DOI 10.1007/s10461-013-0503-3; UNAIDS, 2014, GLOB STAT FACT SHEET	40	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170226	10.1371/journal.pone.0170226	http://dx.doi.org/10.1371/journal.pone.0170226			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7VX	28129342	gold, Green Published, Green Submitted			2022-12-27	WOS:000396211400060
J	Chen, MY; Lo, YC; Chen, WC; Wang, KF; Chan, PC				Chen, Meng-Yu; Lo, Yi-Chun; Chen, Wan-Chin; Wang, Kwei-Feng; Chan, Pei-Chun			Recurrence after Successful Treatment of Multidrug-Resistant Tuberculosis in Taiwan	PLOS ONE			English	Article							TREATMENT OUTCOMES; RISK-FACTORS; TB PATIENTS; FOLLOW-UP; IMPACT; REINFECTION; REGIMEN; RELAPSE; COHORT	Recurrence after successful treatment for multidrug-resistant tuberculosis (MDR-TB) is challenging because of limited retreatment options. This study aimed to determine rates and predictors of MDR-TB recurrence after successful treatment in Taiwan. Recurrence rates were analyzed by time from treatment completion in 295 M DR-TB patients in a national cohort. Factors associated with MDR-TB recurrence were examined using a multivariate Cox regression analysis. Ten (3%) patients experienced MDR-TB recurrence during a median follow-up of 4.8 years. The overall recurrence rate was 0.6 cases per 1000 person-months. Cavitation on chest radiography was an independent predictor of recurrence (adjusted hazard ratio [aHR] = 6.3; 95% CI, 1.2-34). When the analysis was restricted to 215 patients (73%) tested for second-line drug susceptibility, cavitation (aHR = 10.2; 95% CI, 1.2-89) and resistance patterns of extensively drug-resistant TB (XDR-TB) or pre-XDR-TB (aHR = 7.3; 95% CI, 1.2-44) were associated with increased risk of MDR-TB recurrence. In Taiwan, MDR-TB patients with cavitary lesions and resistance patterns of XDR-TB or pre-XDR-TB are at the highest risk of recurrence. These have important implications for MDR-TB programs aiming to optimize post-treatment follow-up and early detection of recurrent MDR-TB.	[Chen, Meng-Yu; Lo, Yi-Chun; Chen, Wan-Chin] Ctr Dis Control, Off Prevent Med, Taipei, Taiwan; [Wang, Kwei-Feng; Chan, Pei-Chun] Ctr Dis Control, Div Chron Infect, Taipei, Taiwan; [Chan, Pei-Chun] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei, Taiwan; [Chan, Pei-Chun] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Pediat, Coll Med,Div Pediat Infect Dis, Taipei, Taiwan	Centers For Disease Control - Taiwan; Centers For Disease Control - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Chan, PC (corresponding author), Ctr Dis Control, Div Chron Infect, Taipei, Taiwan.; Chan, PC (corresponding author), Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei, Taiwan.; Chan, PC (corresponding author), Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Pediat, Coll Med,Div Pediat Infect Dis, Taipei, Taiwan.	pcanita.tw@cdc.gov.tw		Chen, Wan-Chin/0000-0002-2278-6193; CHEN, MENG-YU/0000-0001-7391-4581				Anderson LF, 2013, EURO SURVEILL, V18; Aung KJM, 2014, INT J TUBERC LUNG D, V18, P1180, DOI 10.5588/ijtld.14.0100; Becerra MC, 2010, CLIN INFECT DIS, V51, P709, DOI 10.1086/655892; Benator D, 2002, LANCET, V360, P528, DOI 10.1016/S0140-6736(02)09742-8; Blondal K, 2012, INT J TUBERC LUNG D, V16, P1228, DOI 10.5588/ijtld.12.0037; Brigden G, 2015, INFECT DRUG RESIST, V8, P367, DOI 10.2147/IDR.S68351; Burgos M, 2005, CLIN INFECT DIS, V40, P968, DOI 10.1086/428582; Caminero JA, 2013, EUR RESPIR J, V42, P5, DOI 10.1183/09031936.00206712; Chan PC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057719; Chiang CY, 2006, EUR RESPIR J, V28, P980, DOI 10.1183/09031936.06.00125705; Chiang CY, 2002, INT J TUBERC LUNG D, V6, P974; Corbett EL, 1999, AM J RESP CRIT CARE, V159, P94, DOI 10.1164/ajrccm.159.1.9803048; Falzon D, 2013, EUR RESPIR J, V42, P156, DOI 10.1183/09031936.00134712; Franke MF, 2013, CLIN INFECT DIS, V56, P770, DOI 10.1093/cid/cis1008; Gelmanova IY, 2015, INT J TUBERC LUNG D, V19, P399, DOI 10.5588/ijtld.14.0415; Golub JE, 2006, INT J TUBERC LUNG D, V10, P24; Guerra-Assuncao JA, 2015, J INFECT DIS, V211, P1154, DOI 10.1093/infdis/jiu574; Huang SH, 2012, TAIWAN EPIDEMIOL B, V28, P269; Jacobson KR, 2010, CLIN INFECT DIS, V51, P6, DOI 10.1086/653115; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Karagoz T, 2009, TUBERK TORAK, V57, P383; Kim DH, 2010, AM J RESP CRIT CARE, V182, P113, DOI 10.1164/rccm.200911-1656OC; Kuaban C, 2015, INT J TUBERC LUNG D, V19, P517, DOI 10.5588/ijtld.14.0535; Kwak N, 2015, INT J TUBERC LUNG D, V19, P525, DOI 10.5588/ijtld.14.0739; Lambert ML, 2003, LANCET INFECT DIS, V3, P282, DOI 10.1016/S1473-3099(03)00607-8; Lange C, 2014, EUR RESPIR J, V44, P23, DOI 10.1183/09031936.00188313; Lee J, 2011, INT J TUBERC LUNG D, V15, P1331, DOI [10.5588/ijtld.11.0098, DOI 10.5588/IJTLD.11.0098]; Leung ECC, 2011, EUR RESPIR J, V38, P227, DOI 10.1183/09031936.00186310; Panjabi R, 2007, INT J TUBERC LUNG D, V11, P828; Piubello A, 2014, INT J TUBERC LUNG D, V18, P1188, DOI 10.5588/ijtld.13.0075; Taiwan Centers for Disease Control, 2014, TAIW TUB CONTR REP 2; Taiwan Centers for Disease Control, 2013, TAIW GUID TB DIAGN T; World Health Organization, 2008, GUDI PROGR MAN DRUG; World Health Organization, 2006, GUID PROGR MAN DRUG; World Health Organization, 2004, TOM TUB CAS DET TREA; Wu MH, 2015, 46 UN WORLD C LUNG H, pS505; Yang CH, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-304; Yim JJ, 2015, INT J TUBERC LUNG D, V19, P371, DOI 10.5588/ijtld.15.0117; Yoshiyama T, 2014, T ROY SOC TROP MED H, V108, P589, DOI 10.1093/trstmh/tru080	39	25	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170980	10.1371/journal.pone.0170980	http://dx.doi.org/10.1371/journal.pone.0170980			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125692	gold, Green Submitted, Green Published			2022-12-27	WOS:000396176100011
J	Lund, KT; Riaz, S; Walker, MA				Lund, Karl T.; Riaz, Summaira; Walker, M. Andrew			Population Structure, Diversity and Reproductive Mode of the Grape Phylloxera (Daktulosphaira vitifoliae) across Its Native Range	PLOS ONE			English	Article							LIFE-CYCLE VARIATION; GENETIC-STRUCTURE; HOST-PLANT; HOMOPTERA; APHID; PEST; DNA; SPECIALIZATION; HEMIPTERA; EXPANSION	Grape Phylloxera, Daktulosphaira vitifoliae, is a gall-forming insect that feeds on the leaves and roots of many Vitis species. The roots of the cultivated V. vinifera cultivars and hybrids are highly susceptible to grape phylloxera feeding damage. The native range of this insect covers most of North America, and it is particularly abundant in the eastern and central United States. Phylloxera was introduced from North America to almost all grape-growing regions across five of the temperate zone continents. It devastated vineyards in each of these regions causing large-scale disruptions to grape growers, wine makers and national economies. In order to understand the population diversity of grape phylloxera in its native range, more than 500 samples from 19 States and 34 samples from the introduced range (northern California, Europe and South America) were genotyped with 32 simple sequence repeat markers. STRUCTURE, a model based clustering method identified five populations within these samples. The five populations were confirmed by a neighbor-joining tree and principal coordinate analysis (PCoA). These populations were distinguished by their Vitis species hosts and their geographic locations. Samples collected from California, Europe and South America traced back to phylloxera sampled in the northeastern United States on V. riparia, with some influence from phylloxera collected along the Atlantic Coast and Central Plains on V. vulpina. Reproductive statistics conclusively confirmed that sexual reproduction is common in the native range and is combined with cyclical parthenogenesis. Native grape phylloxera populations were identified to be under Hardy-Weinberg equilibrium. The identification of admixed samples between many of these populations indicates that shared environments facilitate sexual reproduction between different host associated populations to create new genotypes of phylloxera. This study also found that assortative mating might occur across the sympatric range of the V. vulpina west and V. cinerea populations.	[Lund, Karl T.; Riaz, Summaira; Walker, M. Andrew] Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA	University of California System; University of California Davis	Walker, MA (corresponding author), Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA.	awalker@ucdavis.edu		Riaz, Summaira/0000-0001-7739-144X	California Grape Rootstock Improvement Commission [08-004533]	California Grape Rootstock Improvement Commission	This work was supported by the California Grape Rootstock Improvement Commission, 08-004533.	Cao J, 2011, J ECON ENTOMOL, V105, P583; Carletto J, 2009, MOL ECOL, V18, P2198, DOI 10.1111/j.1365-294X.2009.04190.x; Clarke LJ, 2013, J BIOGEOGR, V40, P1071, DOI 10.1111/jbi.12066; Corrie AM, 2004, HEREDITY, V92, P118, DOI 10.1038/sj.hdy.6800393; Corrie AM, 2002, HEREDITY, V88, P203, DOI 10.1038/sj.hdy.6800028; Corrie AM, 2003, B ENTOMOL RES, V93, P193, DOI 10.1079/BER2003232; DEBENEDICTIS JA, 1992, J ECON ENTOMOL, V85, P1527, DOI 10.1093/jee/85.4.1527; Delmotte F, 2014, PROPOSAL SEQUENCE GE; Dickey AM, 2012, ENTOMOL EXP APPL, V143, P127, DOI 10.1111/j.1570-7458.2012.01250.x; Downie D, 1998, SOUTHWEST ENTOMOL, V23, P11; Downie DA, 2000, ENVIRON ENTOMOL, V29, P979, DOI 10.1603/0046-225X-29.5.979; Downie DA, 2002, MOL ECOL, V11, P2013, DOI 10.1046/j.1365-294X.2002.01584.x; Downie DA, 2001, EVOLUTION, V55, P1345, DOI 10.1111/j.0014-3820.2001.tb00657.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ferrari J, 2012, EVOLUTION, V66, P375, DOI 10.1111/j.1558-5646.2011.01436.x; Forneck A, 2000, GENOME, V43, P669, DOI 10.1139/gen-43-4-669; Forneck A, 2009, ENTOMOL EXP APPL, V131, P1, DOI 10.1111/j.1570-7458.2008.00811.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GRANETT J, 1985, J ECON ENTOMOL, V78, P1463, DOI 10.1093/jee/78.6.1463; Granett J, 2001, ANNU REV ENTOMOL, V46, P387, DOI 10.1146/annurev.ento.46.1.387; GRANETT J, 1987, J ECON ENTOMOL, V80, P327, DOI 10.1093/jee/80.2.327; Guillemaud T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021263; Herbert KS, 2010, B ENTOMOL RES, V100, P671, DOI 10.1017/S0007485310000027; Jaquiery J, 2012, MOL ECOL, V21, P5251, DOI 10.1111/mec.12048; LIDER LLOYD A., 1958, HILGARDIA, V27, P287; Lin H, 2006, AM J ENOL VITICULT, V57, P33; Lin H, 1996, VITIS, V35, P87; Lin H, 1999, ANN ENTOMOL SOC AM, V92, P376, DOI 10.1093/aesa/92.3.376; Lund KT, 2013, THESIS; McCormack JE, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-28; Miller NJ, 2003, HEREDITY, V91, P217, DOI 10.1038/sj.hdy.6800331; Mitchell SG, 2013, QUATERNARY RES, V79, P274, DOI 10.1016/j.yqres.2012.11.001; Munson T.V., 1909, FDN AM GRAPE CULTURE; NEI M, 1978, GENETICS, V89, P583; Park SDE, 2001, THESIS; Peccoud J, 2008, MOL ECOL, V17, P4608, DOI 10.1111/j.1365-294X.2008.03949.x; Perrier X., 2006, DARWIN SOFTWARE; Perrier X., 2003, GENETIC DIVERSITY CU, P43; Powell KS, 2008, ROOT FEEDERS: AN ECOSYSTEM PERSPECTIVE, P96, DOI 10.1079/9781845934613.0096; Pritchard JK, 2000, GENETICS, V155, P945; Riaz S, 2014, VITIS, V53, P95; Riaz S, 2016, AM J ENOLOGY VITICUL; Sandrock C, 2011, MOL ECOL, V20, P4165, DOI 10.1111/j.1365-294X.2011.05242.x; Sha QY, 2011, GENET EPIDEMIOL, V35, P671, DOI 10.1002/gepi.20617; Smadja CM, 2012, EVOLUTION, V66, P2723, DOI 10.1111/j.1558-5646.2012.01612.x; Stenberg P, 2003, MOL ECOL NOTES, V3, P329, DOI 10.1046/j.1471-8286.2003.00408.x; Tennessen JA, 2008, COPEIA, P558, DOI 10.1643/CG-06-038; Vorwerk S, 2006, GENOME, V49, P678, DOI 10.1139/G06-028; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Woolaver LG, 2013, CONSERV GENET, V14, P559, DOI 10.1007/s10592-013-0444-4; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157; Zhang B, 2012, MOL ECOL, V21, P2130, DOI 10.1111/j.1365-294X.2012.05517.x	52	15	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170678	10.1371/journal.pone.0170678	http://dx.doi.org/10.1371/journal.pone.0170678			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125736	Green Published, Green Submitted, gold			2022-12-27	WOS:000396176100075
J	Winn, NC; Grunewald, ZI; Liu, Y; Heden, TD; Nyhoff, LM; Kanaley, JA				Winn, Nathan C.; Grunewald, Zachary I.; Liu, Ying; Heden, Timothy D.; Nyhoff, Lauren M.; Kanaley, Jill A.			Plasma Irisin Modestly Increases during Moderate and High-Intensity Afternoon Exercise in Obese Females	PLOS ONE			English	Article							FNDC5 GENE-EXPRESSION; SKELETAL-MUSCLE; CIRCULATING IRISIN; PHYSICAL-ACTIVITY; MOLECULAR-MECHANISMS; INSULIN-RESISTANCE; AEROBIC EXERCISE; ADIPOSE-TISSUE; HEALTHY; HUMANS	Background and Purpose Irisin is an exercise-responsive myokine that has been proposed to exert anti-obesity benefits; yet its response during exercise in obese women is not described. This study characterized plasma irisin levels during a single bout of afternoon isocaloric-exercise of different intensities (moderate-vs high-intensity) in obese females. Methods Eleven obese females participated in 3 randomized study days beginning at 1600h: 1) no exercise (NoEx), 2) moderate exercise (ModEx; 55% VO(2)max) and 3) high intensity interval exercise (IntEx; 4 min (80%VO(2)max)/3 min (50% VO(2)max). Frequent blood samples were analyzed for glucose and lactate (whole-blood), and insulin, c-peptide, glucagon, and irisin (plasma) throughout 190 min of testing. Results Plasma irisin increased above baseline during ModEx and IntEx (P<0.05), but not NoEx (P>0.05). Peak irisin levels during ModEx and IntEx exercise were 11.9 +/- 3.4% and 12.3 +/- 4.1% relative to baseline (P<0.05), respectively, with no differences between exercise intensities (P>0.05). Irisin levels remained elevated above resting for 125 minutes post-exercise during ModEx, whereas levels returned to baseline within 15 minutes post-exercise during IntEx. Similarly, no associations were found between plasma irisin levels and circulating lactate, glucose, insulin, c-peptide, or glucagon among study days (P>0.05). However, there was an inverse association between basal irisin and lean mass (r = -0.70, P = 0.01). Conclusion A single bout of moderate and high intensity afternoon exercise induces modest increases in circulating irisin concentrations during exercise; however the regulation post-exercise appears to be dimorphic between exercise intensity in obese females. Future studies are needed to compare morning and afternoon exercise on irisin secretion.	[Winn, Nathan C.; Grunewald, Zachary I.; Liu, Ying; Nyhoff, Lauren M.; Kanaley, Jill A.] Univ Missouri, Dept Nutr & Exercise Physiol, Columbia, MO USA; [Heden, Timothy D.] East Carolina Univ, East Carolina Diabet & Obes Inst, Greenville, NC USA; [Heden, Timothy D.] East Carolina Univ, Dept Kinesiol, Greenville, NC USA	University of Missouri System; University of Missouri Columbia; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University	Kanaley, JA (corresponding author), Univ Missouri, Dept Nutr & Exercise Physiol, Columbia, MO USA.	kanaleyj@missouri.edu	Winn, Nathan/X-6390-2019	Winn, Nathan/0000-0002-5276-0592	National Institute of Health [R21DK084467-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK084467] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institute of Health R21DK084467-01 (NIDDK.nih.gov) role of sponsor in design etc: no role	Albrecht E, 2015, SCI REP-UK, V5, DOI 10.1038/srep08889; Anastasilakis AD, 2014, J CLIN ENDOCR METAB, V99, P3247, DOI 10.1210/jc.2014-1367; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bouchard C, 1991, SPORTS EI EXERCISE E, V23, P643; Cartee GD, 2015, AM J PHYSIOL-ENDOC M, V309, pE949, DOI 10.1152/ajpendo.00416.2015; Chen JQ, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/1476-511X-14-2; Chtourou H, 2012, J STRENGTH COND RES, V26, P1984, DOI 10.1519/JSC.0b013e31825770a7; Daskalopoulou SS, 2014, EUR J ENDOCRINOL, V171, P343, DOI 10.1530/EJE-14-0204; Ellefsen S, 2014, EUR J APPL PHYSIOL, V114, P1875, DOI 10.1007/s00421-014-2922-x; Erickson HP, 2013, ADIPOCYTE, V2, P289, DOI 10.4161/adip.26082; Fields DA, 2002, AM J CLIN NUTR, V75, P453, DOI 10.1093/ajcn/75.3.453; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Hecksteden A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-235; Hew-Butler T, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12262; Holloszy JO, 2005, J APPL PHYSIOL, V99, P338, DOI 10.1152/japplphysiol.00123.2005; Huh J Young, 2014, J CLIN ENDOCRINOLOGY; Huh JY, 2015, J CLIN ENDOCR METAB, V100, pE453, DOI 10.1210/jc.2014-2416; Huh JY, 2014, J CLIN ENDOCR METAB, V99, pE2154, DOI 10.1210/jc.2014-1437; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Jedrychowski MP, 2015, CELL METAB, V22, P734, DOI 10.1016/j.cmet.2015.08.001; Kanaley JA, 2014, INT J OBESITY, V38, P266, DOI 10.1038/ijo.2013.84; Kraemer RR, 2014, HORM METAB RES, V46, P150, DOI 10.1055/s-0033-1355381; Kurdiova T, 2014, J PHYSIOL-LONDON, V592, P1091, DOI 10.1113/jphysiol.2013.264655; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Loffler D, 2015, J CLIN ENDOCR METAB, V100, P1289, DOI 10.1210/jc.2014-2932; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Neufer PD, 2015, CELL METAB, V22, P4, DOI 10.1016/j.cmet.2015.05.011; Norheim F, 2014, FEBS J, V281, P739, DOI 10.1111/febs.12619; Nygaard H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121367; Nyhoff LM, 2015, PEPTIDES, V71, P94, DOI 10.1016/j.peptides.2015.07.004; Ost M, 2016, FREE RADICAL BIO MED, V98, P78, DOI 10.1016/j.freeradbiomed.2016.02.018; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pekkala S, 2013, J PHYSIOL-LONDON, V591, P5393, DOI 10.1113/jphysiol.2013.263707; Polyzos SA, 2015, METABOLISM, V64, P1611, DOI 10.1016/j.metabol.2015.09.001; Polyzos SA, 2015, METABOLISM, V64, P937, DOI 10.1016/j.metabol.2015.06.005; Qiu SH, 2015, SPORTS MED, V45, P1577, DOI 10.1007/s40279-014-0293-4; Roberts CK, 2013, COMPR PHYSIOL, V3, P1, DOI 10.1002/cphy.c110062; Roca-Rivada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060563; Rohling M, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2868652; Sanchis-Gomar F, 2014, HORM METAB RES, V46, P591, DOI 10.1055/s-0033-1363283; Sanchis-Gomar F, 2014, HORMONE METABOLIC RE; Spiegelman BM, 2013, DIABETES, V62, P1774, DOI 10.2337/db12-1665; Stengel A, 2013, PEPTIDES, V39, P125, DOI 10.1016/j.peptides.2012.11.014; Thyfault JP, 2008, AM J PHYSIOL-REG I, V294, pR1103, DOI [10.1152/ajpregu.00542.2007, 10.1152/ajpregu.00924.2007]; Thyfault JP, 2011, CURR OPIN CLIN NUTR, V14, P374, DOI 10.1097/MCO.0b013e3283468e69; Tsuchiya Y, 2015, METABOLISM, V64, P1042, DOI 10.1016/j.metabol.2015.05.010; Tsuchiya Y, 2014, TOHOKU J EXP MED, V233, P135, DOI 10.1620/tjem.233.135; Wen MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064025; Wojtaszewski JFP, 2006, ESSAYS BIOCHEM, V42, P31, DOI 10.1042/bse0420031; Xin C, 2016, INT J OBESITY, V40, P443, DOI 10.1038/ijo.2015.199; Yang ZG, 2015, INT J CLIN EXP PATHO, V8, P6490; Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106	53	35	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170690	10.1371/journal.pone.0170690	http://dx.doi.org/10.1371/journal.pone.0170690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125733	Green Published, Green Submitted, gold			2022-12-27	WOS:000396176100072
J	Elliott, LS; Henderson, JC; Neradilek, MB; Moyer, NA; Ashcraft, KC; Thirumaran, RK				Elliott, Lindsay S.; Henderson, John C.; Neradilek, Moni B.; Moyer, Nicolas A.; Ashcraft, Kristine C.; Thirumaran, Ranjit K.			Clinical impact of pharmacogenetic profiling with a clinical decision support tool in polypharmacy home health patients: A prospective pilot randomized controlled trial	PLOS ONE			English	Article							ADVERSE DRUG-REACTIONS; EMERGENCY-DEPARTMENT VISITS; HOSPITALIZED-PATIENTS; CYP2D6; CARE; GUIDELINES; GENOTYPES; CYP2C19; EVENTS; ADULTS	Background In polypharmacy patients under home health management, pharmacogenetic testing coupled with guidance from a clinical decision support tool (CDST) on reducing drug, gene, and cumulative interaction risk may provide valuable insights in prescription drug treatment, reducing re-hospitalization and emergency department (ED) visits. We assessed the clinical impact of pharmacogenetic profiling integrating binary and cumulative drug and gene interaction warnings on home health polypharmacy patients. Methods and findings This prospective, open-label, randomized controlled trial was conducted at one hospital-based home health agency between February 2015 and February 2016. Recruitment came from patient referrals to home health at hospital discharge. Eligible patients were aged 50 years and older and taking or initiating treatment with medications with potential or significant drug-gene-based interactions. Subjects (n = 110) were randomized to pharmacogenetic profiling (n = 57). The study pharmacist reviewed drug-drug, drug-gene, and cumulative drug and/or gene interactions using the YouScript (R) CDST to provide drug therapy recommendations to clinicians. The control group (n = 53) received treatment as usual including pharmacist guided medication management using a standard drug information resource. The primary outcome measure was the number of re-hospitalizations and ED visits at 30 and 60 days after discharge from the hospital. The mean number of re-hospitalizations per patient in the tested vs. untested group was 0.25 vs. 0.38 at 30 days (relative risk (RR), 0.65; 95% confidence interval (CI), 0.32-1.28; P = 0.21) and 0.33 vs. 0.70 at 60 days following enrollment (RR, 0.48; 95% CI, 0.27-0.82; P = 0.007). The mean number of ED visits per patient in the tested vs. untested group was 0.25 vs. 0.40 at 30 days (RR, 0.62; 95% CI, 0.31-1.21; P = 0.16) and 0.39 vs. 0.66 at 60 days (RR, 0.58; 95% CI, 0.34-0.99; P = 0.045). Differences in composite outcomes at 60 days (exploratory endpoints) were also found. Of the total 124 drug therapy recommendations passed on to clinicians, 96 (77%) were followed. These findings should be verified with additional prospective confirmatory studies involving real-world applications in larger populations to broaden acceptance in routine clinical practice. Conclusions Pharmacogenetic testing of polypharmacy patients aged 50 and older, supported by an appropriate CDST, considerably reduced re-hospitalizations and ED visits at 60 days following enrollment resulting in potential health resource utilization savings and improved healthcare.	[Elliott, Lindsay S.] Harding Univ, Coll Pharm, Dept Pharm Practice, Unity Hlth White Cty Med Ctr, Searcy, AR 72149 USA; [Henderson, John C.] Unity Hlth White Cty Med Ctr, Searcy, AR USA; [Neradilek, Moni B.] Mt Whisper Light Stat, Seattle, WA USA; [Moyer, Nicolas A.; Ashcraft, Kristine C.; Thirumaran, Ranjit K.] Genelex Corp, Clin Pharmacogen Div, Seattle, WA 98121 USA		Elliott, LS (corresponding author), Harding Univ, Coll Pharm, Dept Pharm Practice, Unity Hlth White Cty Med Ctr, Searcy, AR 72149 USA.; Thirumaran, RK (corresponding author), Genelex Corp, Clin Pharmacogen Div, Seattle, WA 98121 USA.	lselliott@harding.edu; ranjit@genelex.com			Genelex Corporation; Mountain-Whisper-Light Statistics	Genelex Corporation; Mountain-Whisper-Light Statistics	The study was supported by a small non conditional research grant from Genelex Corporation (http://genelex.com/) in the form of compensation for time to author LSE. Genelex Corporation provided in-kind services consisting of buccal swab collection materials, shipping, genotyping all patient DNA and providing the YouScript (R) report. The Genelex Corporation and Mountain-Whisper-Light Statistics provided support in the form of salaries for authors [NAM, KCA, RKT and MBN] and played a role in the design and conduct of the study; management and analysis of data; and the preparation and review of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Alagoz O, 2016, PHARMACOGENOMICS J, V16, P129, DOI 10.1038/tpj.2015.39; [Anonymous], 2010, SEARC ARK POP CENS 2; [Anonymous], 2015, TABLE PHARMACOGENOMI; [Anonymous], 2015, HOM HLTH CAR SERV AS, P213; [Anonymous], 2010, FDA GUID IND PHARM P; Azhar Gohar WJ, 2016, J RES DEV, V4; Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Birdwell KA, 2015, CLIN PHARMACOL THER, V98, P19, DOI 10.1002/cpt.113; Brixner D, 2016, J MED ECON, V19, P213, DOI 10.3111/13696998.2015.1110160; Budnitz DS, 2006, JAMA-J AM MED ASSOC, V296, P1858, DOI 10.1001/jama.296.15.1858; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Cardelli M, 2012, DRUG SAFETY, V35, P3, DOI 10.1007/BF03319099; Caudle KE, 2016, STANDARDIZING TERMS; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Fagerness J, 2014, AM J MANAG CARE, V20, pE146; Gaedigk A, 2016, GENET MED; Hajjar Emily R, 2003, Am J Geriatr Pharmacother, V1, P82; Hajjar Emily R, 2007, Am J Geriatr Pharmacother, V5, P345, DOI 10.1016/j.amjopharm.2007.12.002; Hampton LM, 2014, JAMA PSYCHIAT, V71, P1006, DOI 10.1001/jamapsychiatry.2014.436; HEPLER CD, 1990, AM J HOSP PHARM, V47, P533, DOI 10.1093/ajhp/47.3.533; Hicks JK, 2015, CLIN PHARMACOL THER, V98, P127, DOI 10.1002/cpt.147; Hocum BT, 2016, AM J HEALTH-SYST PH, V73, P61, DOI 10.2146/ajhp150273; Johnson JA, 2011, CLIN PHARMACOL THER, V90, P625, DOI 10.1038/clpt.2011.185; Kahan BC, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-139; Kahan BC, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-99; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Lisbeth P, 2016, EUR J CLIN PHARMACOL, V72, P175, DOI 10.1007/s00228-015-1965-1; MLaC K, 2014, TRENDS HLTH CAR EXP; Qato DM, 2008, JAMA-J AM MED ASSOC, V300, P2867, DOI 10.1001/jama.2008.892; Rizzo E, 2013, BECKERS HOSP REV; SAFRAN DG, 2005, HLTH AFF MILLWOOD S; Sikdar KC, 2012, ANN PHARMACOTHER, V46, P960, DOI 10.1345/aph.1Q529; US Food and Drug Administration, DRUG DEV DRUG INT TA; Verbeurgt P, 2014, PHARMACOGENOMICS, V15, P655, DOI 10.2217/pgs.14.6; Wilkinson GR, 2005, NEW ENGL J MED, V352, P2211, DOI 10.1056/NEJMra032424; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007	36	84	87	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170905	10.1371/journal.pone.0170905	http://dx.doi.org/10.1371/journal.pone.0170905			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151991	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161200058
J	Hogg, R; Nkala, B; Dietrich, J; Collins, A; Closson, K; Cui, ZS; Kanters, S; Chia, J; Barhafuma, B; Palmer, A; Kaida, A; Gray, G; Miller, C				Hogg, Robert; Nkala, Busisiwe; Dietrich, Janan; Collins, Alexandra; Closson, Kalysha; Cui, Zishan; Kanters, Steve; Chia, Jason; Barhafuma, Bernard; Palmer, Alexis; Kaida, Angela; Gray, Glenda; Miller, Cari			Conspiracy beliefs and knowledge about HIV origins among adolescents in Soweto, South Africa	PLOS ONE			English	Article							SEXUAL-BEHAVIOR; CAPE-TOWN; AIDS; YOUTH; PREVENTION; HEALTH; ATTITUDES; EDUCATION; BENEFITS	Purpose We examined adolescents' knowledge regarding the origin of HIV/AIDS and correlates of beliefs surrounding conspiracy theories in Soweto, South Africa. Now, a decade post-AIDS denialism, South Africa has the largest antiretroviral therapy roll-out worldwide. However, conspiracy theories stemming from past AIDS denialism may impact HIV prevention and treatment efforts. Methods Study participants were recruited through the Kganya Motsha Adolescent Health Centre and the Perinatal HIV Research Unit's Botsha Bophelo Adolescent Health Study (BBAHS). Adolescents were eligible to participate if aged 14-19 years and living in Soweto. We calculated the proportion of adolescents who correctly believed that HIV originated from non-human primates, and used contingency table analysis and logistic regression modeling to describe correlates associated with accurate knowledge and beliefs in conspiracy theories. Results Of 830 adolescents, 168 (20.2%) participants correctly identified HIV as originating from chimpanzees and one third (n = 71, 8.6%) believed in a conspiracy theory about the origins of HIV, including that it originated from the US government (2.3%), the pharmaceutical industry (2.2%), a vaccine (2.1%), space (1.5%), and a scientist (0.6%). Participants who were more likely to correctly identify the origin of HIV were older, men, and unemployed. Participants who were men, unemployed or students, and who had a parent or close relative who had died of HIV, were more likely to believe in a conspiracy theory regarding the origins of HIV. Conclusions Adolescents living in Soweto did not have high levels of accurate knowledge regarding the origins of HIV/AIDS and conspiracy beliefs were present among a small minority of participants. Accurate knowledge of the origins of HIV and debunking myths are important for improving uptake of HIV prevention tools in this population.	[Hogg, Robert; Collins, Alexandra; Closson, Kalysha; Barhafuma, Bernard; Palmer, Alexis; Kaida, Angela; Miller, Cari] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada; [Hogg, Robert; Collins, Alexandra; Closson, Kalysha; Cui, Zishan; Chia, Jason; Palmer, Alexis] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Nkala, Busisiwe; Dietrich, Janan; Gray, Glenda] Perinatal HIV Res Unit, Soweto, Gauteng, South Africa; [Dietrich, Janan] Univ Stellenbosch, Stellenbosch, South Africa; [Kanters, Steve] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Gray, Glenda] Univ Witwatersrand, Johannesburg, Johannesburg, South Africa	Simon Fraser University; B.C. Centre for Excellence in HIV/AIDS; Stellenbosch University; University of British Columbia; University of Witwatersrand	Miller, C (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada.	cari_miller@sfu.ca	Hogg, Robert S/B-2783-2012	Hogg, Robert S/0000-0003-3463-5488; Dietrich, Janan/0000-0002-1949-3138; Collins, Alexandra/0000-0002-5076-4653	Canadian Institutes for Health Research [230513]; Simon Fraser University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069453] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Simon Fraser University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to acknowledge the financial support from the Canadian Institutes for Health Research (grant number 230513) and Simon Fraser University, through a President Research award to Dr. Cari Miller; and the in-kind support from Kganya Motsha Adolescent Centre and the Perinatal HIV Research Unit in Soweto,South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, CENS 2011 MAIN PLAC; Ashforth A., 2002, AFRICAN STUDIES, V61, P121, DOI [10.1080/00020180220140109, DOI 10.1080/00020180220140109]; Cameron E, 2005, A WITNESS TO AIDS; Campbell C, 2002, SOC SCI MED, V55, P331, DOI 10.1016/S0277-9536(01)00289-1; Carey MP, 2002, AIDS EDUC PREV, V14, P172, DOI 10.1521/aeap.14.2.172.23902; Catalano RF, 2012, LANCET, V379, P1653, DOI 10.1016/S0140-6736(12)60238-4; Chigwedere P, 2008, JAIDS-J ACQ IMM DEF, V49, P410, DOI 10.1097/QAI.0b013e31818a6cd5; Du Plessis GE, 1993, STUDY KNOWLEDGE ATTI; Duesberg P, 1998, GENETICA, V104, P85, DOI 10.1023/A:1003405220186; DUESBERG P, 1988, SCIENCE, V241, P514, DOI 10.1126/science.3399880; Eaton L, 2003, SOC SCI MED, V56, P149, DOI 10.1016/S0277-9536(02)00017-5; Fassin, 2007, BODIES REMEMBER EXPE; Geffen N., 2010, DEBUNKING DELUSIONS; Gevisser Mark, 2007, T MBEKI DREAM DEFERR; Gilbert A, 1999, URBAN STUD, V36, P2375, DOI 10.1080/0042098992476; Grebe E, 2012, AIDS BEHAV, V16, P761, DOI 10.1007/s10461-011-9958-2; Green L, 2012, S AFR J SCI, V108; Heywood M., 2004, DEV UPDATE, V5, P93; Hodes R, 2013, SCI CULT-UK, V22, P261, DOI 10.1080/09505431.2012.718757; Kleinert S, 2007, LANCET, V369, P1057, DOI 10.1016/S0140-6736(07)60374-2; Kudo Y, 2013, JPN J NURS SCI, V10, P24, DOI 10.1111/j.1742-7924.2012.00207.x; Leclerc-Madlala S, 1997, Med Anthropol, V17, P363, DOI 10.1080/01459740.1997.9966146; Leclerc-Madlala Suzanne, 2002, Afr J AIDS Res, V1, P87, DOI 10.2989/16085906.2002.9626548; Leclerc-Madlala S, 2014, LANCET, V383, P1203, DOI 10.1016/S0140-6736(14)60593-6; Magnani R, 2005, J ADOLESCENT HEALTH, V36, P289, DOI 10.1016/j.jadohealth.2004.02.025; Nattrass, 2007, MORTAL COMBAT STRUGG; Nattrass N, 2008, J PUBLIC HEALTH-UK, V30, P398, DOI 10.1093/pubmed/fdn075; Nattrass N, 2008, AFR AFFAIRS, V107, P157, DOI 10.1093/afraf/adm087; Nattrass Nicoli, 2012, AIDS CONSPIRACY SCI; Niehaus Isak, 2005, Med Anthropol, V24, P179, DOI 10.1080/01459740590933911; Presidential AIDS Advisory Panel, 2001, PRES AIDS ADV PAN RE; Roos J, 1995, J COMP HLTH, V6, P81; Shisana O, 2009, S AFRICAN NATL HIV P; Simbayi LC, 2005, AIDS BEHAV, V9, P53, DOI 10.1007/s10461-005-1681-4; Steinberg J, 2011, 3 LETT PLAGUE YOUNG; STLAWRENCE JS, 1993, J CONSULT CLIN PSYCH, V61, P104, DOI 10.1037/0022-006X.61.1.104; SwartKruger J, 1997, SOC SCI MED, V45, P957, DOI 10.1016/S0277-9536(96)00417-0; Tillotson J., 2001, SOC TRANSITION, V32, P83; UNAIDS, 2014, HIV AIDS EST; Vermund SH, 2014, J INFECT DIS, V209, P483, DOI 10.1093/infdis/jit586; Wood K, 1997, ADOLESCENT SEX CONTR	41	11	11	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0165087	10.1371/journal.pone.0165087	http://dx.doi.org/10.1371/journal.pone.0165087			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28151937	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200001
J	Pogrebnyakov, I; Jendresen, CB; Nielsen, AT				Pogrebnyakov, Ivan; Jendresen, Christian Bille; Nielsen, Alex Toftgaard			Genetic toolbox for controlled expression of functional proteins in Geobacillus spp.	PLOS ONE			English	Article							BACILLUS-STEAROTHERMOPHILUS; SHUTTLE VECTOR; OPERON; SEQUENCE; ETHANOL; DNA; THERMOGLUCOSIDASIUS; TRANSFORMATION; KAUSTOPHILUS; CONVERSION	Species of genus Geobacillus are thermophilic bacteria and play an ever increasing role as hosts for biotechnological applications both in academia and industry. Here we screened a number of Geobacillus strains to determine which industrially relevant carbon sources they can utilize. One of the strains, G. thermoglucosidasius C56-YS93, was then chosen to develop a toolbox for controlled gene expression over a wide range of levels. It includes a library of semi-synthetic constitutive promoters (76-fold difference in expression levels) and an inducible promoter from the xylA gene. A library of synthetic in silico designed ribosome binding sites was also created for further tuning of translation. The P-xylA was further used to successfully express native and heterologous xylanases in G. thermoglucosidasius. This toolbox enables fine-tuning of gene expression in Geobacillus species for metabolic engineering approaches in production of biochemicals and heterologous proteins.	[Pogrebnyakov, Ivan; Jendresen, Christian Bille; Nielsen, Alex Toftgaard] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Lyngby, Denmark	Technical University of Denmark	Nielsen, AT (corresponding author), Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Lyngby, Denmark.	atn@biosustain.dtu.dk		Nielsen, Alex Toftgaard/0000-0001-6616-0187	Novo Nordisk Foundation [NNF15OC0015246]; European Union [317058]; Novo Nordisk Fonden [NNF10CC1016517, NNF16OC0021814, NNF15OC0015246] Funding Source: researchfish; NNF Center for Biosustainability [Bacterial Cell Factory Optimization] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Union(European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); NNF Center for Biosustainability	This work was supported by the Novo Nordisk Foundation (http://novonordiskfonden.dk/en) to CBJ (NNF15OC0015246) and to ATN, and a PhD grant from the People Programme (Marie Curie Actions) of the European Union Seventh Framework Programme FP7-People-2012-ITN, under grant agreement No. 317058, "BACTORY" (http://ec.europa.eu/research/mariecureactions/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchard K, 2014, APPL MICROBIOL BIOT, V98, P6715, DOI 10.1007/s00253-014-5746-z; Bonde MT, 2016, NAT METHODS, V13, P233, DOI [10.1038/NMETH.3727, 10.1038/nmeth.3727]; Borujeni AE, 2014, NUCLEIC ACIDS RES, V42, P2646, DOI 10.1093/nar/gkt1139; Bosma E.F., 2013, CURR BIOTECHNOL, V2, P360, DOI [10.2174/22115501113026660028, DOI 10.2174/18722083113076660028, DOI 10.2174/22115501113026660028]; Braatsch S, 2008, BIOTECHNIQUES, V45, P335, DOI 10.2144/000112907; Brumm PJ, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/s40793-015-0031-z; Brumm PJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00430; Cavaleiro AM, 2015, ACS SYNTH BIOL, V4, P1042, DOI 10.1021/acssynbio.5b00113; Chen XG, 2004, EXTREMOPHILES, V8, P489, DOI 10.1007/s00792-004-0412-5; Leow TC, 2007, EXTREMOPHILES, V11, P527, DOI 10.1007/s00792-007-0069-y; Chung D, 2014, P NATL ACAD SCI USA, V111, P8931, DOI 10.1073/pnas.1402210111; Clark ME, 2006, HYDROMETALLURGY, V83, P3, DOI 10.1016/j.hydromet.2006.03.046; Counago R, 2006, MOL CELL, V22, P441, DOI 10.1016/j.molcel.2006.04.012; Cripps RE, 2009, METAB ENG, V11, P398, DOI 10.1016/j.ymben.2009.08.005; Fong JCN, 2006, EXTREMOPHILES, V10, P363, DOI 10.1007/s00792-006-0507-2; GARTNER D, 1992, MOL GEN GENET, V232, P415; Gu Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-255; Haki GD, 2003, BIORESOURCE TECHNOL, V89, P17, DOI 10.1016/S0960-8524(03)00033-6; IMANAKA T, 1982, J BACTERIOL, V149, P824, DOI 10.1128/JB.149.3.824-830.1982; Ingram LO, 2010, J BIOMED BIOTECHNOL, V2010; Jensen PR, 1998, APPL ENVIRON MICROB, V64, P82; Kananaviciute R, 2015, J MICROBIOL METH, V111, P31, DOI 10.1016/j.mimet.2015.02.002; KRAUS A, 1994, J BACTERIOL, V176, P1738, DOI 10.1128/jb.176.6.1738-1745.1994; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; LIAO H, 1986, P NATL ACAD SCI USA, V83, P576, DOI 10.1073/pnas.83.3.576; Lin PP, 2014, METAB ENG, V24, P1, DOI 10.1016/j.ymben.2014.03.006; Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996; Martin C, 2011, CELL CHEM TECHNOL, V45, P487; Martin RG, 2001, CURR OPIN MICROBIOL, V4, P132, DOI 10.1016/S1369-5274(00)00178-8; MCCARTHY JEG, 1990, TRENDS GENET, V6, P78, DOI 10.1016/0168-9525(90)90098-Q; Mechaly A, 2000, J BIOTECHNOL, V78, P83, DOI 10.1016/S0168-1656(99)00226-6; Mok SC, 2013, ENZYME MICROB TECH, V53, P46, DOI 10.1016/j.enzmictec.2013.03.009; Mota LJ, 1999, MOL MICROBIOL, V33, P476, DOI 10.1046/j.1365-2958.1999.01484.x; Mutalik VK, 2013, NAT METHODS, V10, P354, DOI [10.1038/NMETH.2404, 10.1038/nmeth.2404]; Narumi I, 1992, BIOTECHNOL TECH, V6, P83, DOI 10.1007/BF02438695; Nazina TN, 2001, INT J SYST EVOL MICR, V51, P433, DOI 10.1099/00207713-51-2-433; Nevoigt E, 2006, APPL ENVIRON MICROB, V72, P5266, DOI 10.1128/AEM.00530-06; NOMURA M, 1984, ANNU REV BIOCHEM, V53, P75, DOI 10.1146/annurev.bi.53.070184.000451; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rastogi G, 2010, BIORESOURCE TECHNOL, V101, P8798, DOI 10.1016/j.biortech.2010.06.001; Saier MH, 1996, J BACTERIOL, V178, P3411, DOI 10.1128/jb.178.12.3411-3417.1996; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Sambrook J, 1989, MOL CLONING LAB MANU, P626; Sarrouh B., 2012, J BIOPROCESS BIOTECH, V1, P1, DOI DOI 10.HTTP://CBC.D0L0RG/10.4172/2155-9821.S4-002; SCHON U, 1993, J BACTERIOL, V175, P2465; Shulami S, 2011, J BACTERIOL, V193, P2838, DOI 10.1128/JB.00222-11; Stammen S, 2010, APPL ENVIRON MICROB, V76, P4037, DOI 10.1128/AEM.00431-10; Suzuki H, 2013, APPL ENVIRON MICROB, V79, P5151, DOI 10.1128/AEM.01506-13; Taylor MP, 2008, PLASMID, V60, P45, DOI 10.1016/j.plasmid.2008.04.001; Taylor MP, 2009, TRENDS BIOTECHNOL, V27, P398, DOI 10.1016/j.tibtech.2009.03.006; Tyo KEJ, 2011, METHODS ENZYMOLOGY; Van Zyl LJ, 2014, APPL MICROBIOL BIOT, V98, P1247, DOI 10.1007/s00253-013-5380-1; Wittlich P, 2001, BIOTECHNOL LETT, V23, P463, DOI 10.1023/A:1010329321185; Zeigler DR, 2001, GENUS GEOBACILLUS BA; ZUBER U, 1994, J BACTERIOL, V176, P1359, DOI 10.1128/jb.176.5.1359-1363.1994	57	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171313	10.1371/journal.pone.0171313	http://dx.doi.org/10.1371/journal.pone.0171313			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152017	Green Submitted, gold, Green Published			2022-12-27	WOS:000396161200125
J	Xia, XY; Larios-Valencia, J; Liu, Z; Xiang, F; Kan, BA; Wang, H; Zhu, J				Xia, Xiaoyun; Larios-Valencia, Jessie; Liu, Zhi; Xiang, Fu; Kan, Biao; Wang, Hui; Zhu, Jun			OxyR-activated expression of Dps is important for Vibrio cholerae oxidative stress resistance and pathogenesis	PLOS ONE			English	Article							DNA-BINDING PROTEIN; VIRULENCE GENE-EXPRESSION; ESCHERICHIA-COLI; MULTIPLE STRESSES; HYDROGEN-PEROXIDE; STATIONARY-PHASE; STARVED CELLS; COLONIZATION; DETOXIFICATION; PROMOTER	Vibrio cholerae is the causative agent of cholera, a dehydrating diarrheal disease. This Gram-negative pathogen is able to modulate its gene expression in order to combat stresses encountered in both aquatic and host environments, including stress posed by reactive oxygen species (ROS). In order to further the understanding of V. cholerae's transcriptional response to ROS, we performed an RNA sequencing analysis to determine the transcriptional profile of V. cholerae when exposed to hydrogen hydroperoxide. Of 135 differentially expressed genes, VC0139 was amongst the genes with the largest induction. VC0139 encodes a protein homologous to the DPS (DNA-binding protein from starved cells) protein family, which are widely conserved and are implicated in ROS resistance in other bacteria. Using a promoter reporter assay, we show that during exponential growth, dps is induced by H2O2 in a manner dependent on the ROS-sensing transcriptional regulator, OxyR. Upon entry into stationary phase, the major stationary phase regulator RpoS is required to transcribe dps. Deletion of dps impaired V. cholerae resistance to both inorganic and organic hydroperoxides. Furthermore, we show that Dps is involved in resistance to multiple environmental stresses. Finally, we found that Dps is important for V. cholerae adult mouse colonization, but becomes dispensable in the presence of antioxidants. Taken together, our results suggest that Dps plays vital roles in both V. cholerae stress resistance and pathogenesis.	[Xia, Xiaoyun; Wang, Hui; Zhu, Jun] Nanjing Agr Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China; [Xia, Xiaoyun; Kan, Biao] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Larios-Valencia, Jessie; Liu, Zhi; Zhu, Jun] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Liu, Zhi] Huazhong Univ Sci & Technol, Dept Biotechnol, Wuhan, Peoples R China; [Xiang, Fu] Huanggang Normal Univ, Coll Life Sci, Huanggang, Peoples R China; [Kan, Biao] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Nanjing Agricultural University; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of Pennsylvania; Pennsylvania Medicine; Huazhong University of Science & Technology; Huanggang Normal University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Wang, H; Zhu, J (corresponding author), Nanjing Agr Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China.; Zhu, J (corresponding author), Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	wanghui@njau.edu.cn; junzhu@mail.med.upenn.edu		Larios Valencia, Jessie/0000-0003-2144-8675; WANG, HUI/0000-0001-8865-3599	National Natural Science Foundation of China [81371763]; National Key Basic Research Program of China [2015CB554203, 2015CB554201]; Ministry of Health of China [2016YFC1200103]; NIH/NIAID [R01AI120489]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI120489] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); Ministry of Health of China; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study is supported by National Natural Science Foundation of China 81371763 (to H.W.), National Key Basic Research Program of China 2015CB554203 (to H.W.) and 2015CB554201 (to B.K.), Priority Project from the Ministry of Health of China 2016YFC1200103 (to B.K.), and NIH/NIAID R01AI120489 (to J.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro-Moreno S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004787; ALMIRON M, 1992, GENE DEV, V6, P2646, DOI 10.1101/gad.6.12b.2646; ALTUVIA S, 1994, MOL MICROBIOL, V13, P265, DOI 10.1111/j.1365-2958.1994.tb00421.x; Amrouche-Mekkioui I, 2012, EUR J PHARMACOL, V691, P209, DOI 10.1016/j.ejphar.2012.06.014; Asakura H, 2007, ENVIRON MICROBIOL, V9, P869, DOI 10.1111/j.1462-2920.2006.01206.x; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Bhattacharyya S, 2004, BBA-GEN SUBJECTS, V1670, P69, DOI 10.1016/j.bbagen.2003.10.016; Calhoun LN, 2011, J APPL MICROBIOL, V110, P375, DOI 10.1111/j.1365-2672.2010.04890.x; Chang W, 2005, BMC GENOMICS, V6, P1, DOI 10.1186/1471-2164-6-115; Chiancone E, 2010, BBA-GEN SUBJECTS, V1800, P798, DOI 10.1016/j.bbagen.2010.01.013; Colburn-Clifford JM, 2010, APPL ENVIRON MICROB, V76, P7392, DOI 10.1128/AEM.01742-10; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Gardel CL, 1996, INFECT IMMUN, V64, P2246, DOI 10.1128/IAI.64.6.2246-2255.1996; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Halsey TA, 2004, INFECT IMMUN, V72, P1155, DOI 10.1128/IAI.72.2.1155-1158.2004; Hammer BK, 2007, P NATL ACAD SCI USA, V104, P11145, DOI 10.1073/pnas.0703860104; Harris JB, 2012, LANCET, V379, P2466, DOI 10.1016/S0140-6736(12)60436-X; IWANAGA M, 1986, MICROBIOL IMMUNOL, V30, P1075, DOI 10.1111/j.1348-0421.1986.tb03037.x; Jeong KC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-181; Joelsson A, 2006, INFECT IMMUN, V74, P1141, DOI 10.1128/IAI.74.2.1141-1147.2006; Joelsson A, 2007, APPL ENVIRON MICROB, V73, P3742, DOI 10.1128/AEM.02804-06; Karas VO, 2015, J BACTERIOL, V197, P3206, DOI 10.1128/JB.00475-15; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Liu Z, 2016, MOL MICROBI IN PRESS; Liu Z, 2008, P NATL ACAD SCI USA, V105, P9769, DOI 10.1073/pnas.0802241105; Liu Z, 2016, CELL REP, V14, P347, DOI 10.1016/j.celrep.2015.12.038; Liu Z, 2011, P NATL ACAD SCI USA, V108, P810, DOI 10.1073/pnas.1014640108; LOMOVSKAYA OL, 1994, J BACTERIOL, V176, P3928, DOI 10.1128/JB.176.13.3928-3935.1994; Martinez A, 1997, J BACTERIOL, V179, P5188, DOI 10.1128/jb.179.16.5188-5194.1997; Matson JS, 2007, INFECT IMMUN, V75, P5542, DOI 10.1128/IAI.01094-07; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Nair S, 2004, J BACTERIOL, V186, P4192, DOI 10.1128/JB.186.13.4192-4198.2004; Qadri F, 2002, CLIN DIAGN LAB IMMUN, V9, P221, DOI 10.1128/CDLI.9.2.221-229.2002; Reidl J, 2002, FEMS MICROBIOL REV, V26, P125, DOI 10.1111/j.1574-6976.2002.tb00605.x; ROSZAK DB, 1987, MICROBIOL REV, V51, P365, DOI 10.1128/MMBR.51.3.365-379.1987; Spees AM, 2013, MBIO, V4, DOI 10.1128/mBio.00430-13; Stern AM, 2012, MBIO, V3, DOI 10.1128/mBio.00013-12; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Thieme D, 2010, MICROBIOL RES, V165, P108, DOI 10.1016/j.micres.2008.12.003; Thomas KU, 2006, MAR POLLUT BULL, V52, P1425, DOI 10.1016/j.marpolbul.2006.04.011; Thomson JJ, 2014, J BACTERIOL, V196, P3872, DOI 10.1128/JB.01824-14; Wang HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048307; Wu B, 2015, J MICROBIOL METH, V115, P147, DOI 10.1016/j.mimet.2015.05.016; Yang MH, 2013, P NATL ACAD SCI USA, V110, P2348, DOI 10.1073/pnas.1218039110; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; Zhao GH, 2002, J BIOL CHEM, V277, P27689, DOI 10.1074/jbc.M202094200; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	49	20	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171201	10.1371/journal.pone.0171201	http://dx.doi.org/10.1371/journal.pone.0171201			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151956	Green Submitted, gold, Green Published			2022-12-27	WOS:000396161200102
J	Bonny, JW; Lindberg, JC; Pacampara, MC				Bonny, Justin W.; Lindberg, Jenna C.; Pacampara, Marc C.			Hip Hop Dance Experience Linked to Sociocognitive Ability	PLOS ONE			English	Article							WORKING-MEMORY CAPACITY; DELIBERATE PRACTICE; VIDEO GAMES; MENTAL ROTATION; MOTOR EXPERTISE; OPERATION SPAN; ACHIEVEMENT; PERFORMANCE; TASKS; VERSION	Expertise within gaming (e.g., chess, video games) and kinesthetic (e.g., sports, classical dance) activities has been found to be linked with specific cognitive skills. Some of these skills, working memory, mental rotation, problem solving, are linked to higher performance in science, technology, math, and engineering (STEM) disciplines. In the present study, we examined whether experience in a different activity, hip hop dance, is also linked to cognitive abilities connected with STEM skills as well as social cognition ability. Dancers who varied in hip hop and other dance style experience were presented with a set of computerized tasks that assessed working memory capacity, mental rotation speed, problem solving efficiency, and theory of mind. We found that, when controlling for demographic factors and other dance style experience, those with greater hip hop dance experience were faster at mentally rotating images of hands at greater angle disparities and there was a trend for greater accuracy at identifying positive emotions displayed by cropped images of human faces. We suggest that hip hop dance, similar to other more technical activities such as video gameplay, tap some specific cognitive abilities that underlie STEM skills. Furthermore, we suggest that hip hop dance experience can be used to reach populations who may not otherwise be interested in other kinesthetic or gaming activities and potentially enhance select sociocognitive skills.	[Bonny, Justin W.; Lindberg, Jenna C.; Pacampara, Marc C.] Foundry10, Seattle, WA 98105 USA; [Bonny, Justin W.] Morgan State Univ, Dept Psychol, Baltimore, MD 21239 USA	Morgan State University	Bonny, JW (corresponding author), Foundry10, Seattle, WA 98105 USA.; Bonny, JW (corresponding author), Morgan State Univ, Dept Psychol, Baltimore, MD 21239 USA.	justin@foundry10.org	Bonny, Justin/GWZ-4864-2022	Bonny, Justin/0000-0002-1601-5114				Adachi PJC, 2013, J YOUTH ADOLESCENCE, V42, P1041, DOI 10.1007/s10964-013-9913-9; Appelbaum LG, 2013, ATTEN PERCEPT PSYCHO, V75, P1161, DOI 10.3758/s13414-013-0472-7; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2008, FITTING LINEAR MIXED; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Berg WK, 2010, BRAIN COGNITION, V72, P472, DOI 10.1016/j.bandc.2010.01.002; Berg WK, 2002, J CLIN EXP NEUROPSYC, V24, P586, DOI 10.1076/jcen.24.5.586.1006; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Bo J, 2009, J NEUROPHYSIOL, V101, P3116, DOI 10.1152/jn.00006.2009; Bonny JW, 2017, COMPUT HUM BEHAV, V66, P377, DOI 10.1016/j.chb.2016.10.005; Bonny JW, 2016, P SIGCHI C HUM FACT; Boot WR, 2008, ACTA PSYCHOL, V129, P387, DOI 10.1016/j.actpsy.2008.09.005; Bull R, 2008, DEV NEUROPSYCHOL, V33, P205, DOI 10.1080/87565640801982312; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2010, PSYCHOL RES-PSYCH FO, V74, P400, DOI 10.1007/s00426-009-0262-y; Campitelli G, 2011, CURR DIR PSYCHOL SCI, V20, P280, DOI 10.1177/0963721411421922; CASEY MB, 1995, DEV PSYCHOL, V31, P697, DOI 10.1037/0012-1649.31.4.697; Cherney ID, 2008, SEX ROLES, V59, P776, DOI 10.1007/s11199-008-9498-z; Colzato LS, 2013, PSYCHOL RES-PSYCH FO, V77, P234, DOI 10.1007/s00426-012-0415-2; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; Crook SR, 2014, CHILD DEV, V85, P405, DOI 10.1111/cdev.12129; Durkin K, 2002, J APPL DEV PSYCHOL, V23, P373, DOI 10.1016/S0193-3973(02)00124-7; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; Ericsson KA, 1996, ANNU REV PSYCHOL, V47, P273, DOI 10.1146/annurev.psych.47.1.273; Fertuck EA, 2009, PSYCHOL MED, V39, P1979, DOI 10.1017/S003329170900600X; Fitzgibbon ML, 2006, OBESITY, V14, P1616, DOI 10.1038/oby.2006.186; Foster JL, 2015, MEM COGNITION, V43, P226, DOI 10.3758/s13421-014-0461-7; Furley P, 2010, PERCEPT MOTOR SKILL, V110, P801, DOI 10.2466/PMS.110.3.801-808; Ganis G., 2015, J OPEN PSYCHOL DATA, V3, pe3, DOI [10.5334/jopd.ai, DOI 10.5334/JOPD.AI]; Gobet F, 1996, COGNITIVE PSYCHOL, V31, P1, DOI 10.1006/cogp.1996.0011; Goldstein T. R., 2009, IMAGIN COGN PERS, V29, P115, DOI [10.2190/IC.29.2.c, DOI 10.2190/IC.29.2.C]; Goldstein TR, 2012, J COGN DEV, V13, P19, DOI 10.1080/15248372.2011.573514; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Hambrick DZ, 2014, INTELLIGENCE, V45, P34, DOI 10.1016/j.intell.2013.04.001; Harkness KL, 2005, COGNITION EMOTION, V19, P999, DOI 10.1080/02699930541000110; Hodges NJ, 2004, J EXP PSYCHOL-APPL, V10, P219, DOI 10.1037/1076-898X.10.4.219; Hohmann T, 2011, J COGN PSYCHOL, V23, P403, DOI 10.1080/20445911.2011.525504; Jackson RC, 2006, ACTA PSYCHOL, V123, P355, DOI 10.1016/j.actpsy.2006.02.002; Jansen P., 2013, CREAT ED, V4, P418, DOI [10.4236/ce.2013.46060, DOI 10.4236/CE.2013.46060]; Jola C., 2005, SPAT COGN COMPUT, V5, P217; Judd CM, 2012, J PERS SOC PSYCHOL, V103, P54, DOI 10.1037/a0028347; Kaltner S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00505; Kane MJ, 2004, J EXP PSYCHOL GEN, V133, P189, DOI 10.1037/0096-3445.133.2.189; Kliegl R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2010.00238; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Macnamara BN, 2014, PSYCHOL SCI, V25, P1608, DOI 10.1177/0956797614535810; Mathot S, 2012, BEHAV RES METHODS, V44, P314, DOI 10.3758/s13428-011-0168-7; Meinz EJ, 2012, J APPL RES MEM COGN, V1, P34, DOI 10.1016/j.jarmac.2011.11.001; Milligan K, 2007, CHILD DEV, V78, P622, DOI 10.1111/j.1467-8624.2007.01018.x; Morgan M, 2011, DAEDALUS-US, V140, P176, DOI 10.1162/DAED_a_00086; OECD, 2013, LESS PISA 2012 US ST; Ojofeitimi S, 2012, SCAND J MED SCI SPOR, V22, P347, DOI 10.1111/j.1600-0838.2010.01173.x; Oswald FL, 2014, BEHAV RES METHODS; Ozel S, 2002, PERCEPT MOTOR SKILL, V95, P1141, DOI 10.2466/PMS.95.8.1141-1154; Parsad B., 2012, ARTS ED PUBLIC ELEME; PARSONS LM, 1994, J EXP PSYCHOL HUMAN, V20, P709, DOI 10.1037/0096-1523.20.4.709; Powers KL, 2013, PSYCHON B REV, V20, P1055, DOI 10.3758/s13423-013-0418-z; Quaiser-Pohl C, 2002, BRIT J EDUC PSYCHOL, V72, P245, DOI 10.1348/000709902158874; R Core Team, 2021, R LANGUAGE ENV STAT; Rajakumar M, 2012, HIP HOP DANCE; RANDEL JM, 1992, SIMULAT GAMING, V23, P261, DOI 10.1177/1046878192233001; Redick TS, 2012, EUR J PSYCHOL ASSESS, V28, P164, DOI 10.1027/1015-5759/a000123; Respress T, 2006, RECLAIMING CHILD YOU, V15, P24; Revelle W., 2020, PSYCH PROCEDURES PER; Robinson TN, 2003, ETHN DIS, V13; Sebanz N, 2009, PSYCHON B REV, V16, P170, DOI 10.3758/PBR.16.1.170; Sesma HW, 2009, CHILD NEUROPSYCHOL, V15, P232, DOI 10.1080/09297040802220029; Sevdalis V, 2011, BRAIN COGNITION, V77, P231, DOI 10.1016/j.bandc.2011.08.005; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Shipstead Z, 2012, PSYCHOL BULL, V138, P628, DOI 10.1037/a0027473; Sikora DM, 2010, DEV NEUROPSYCHOL, V21, P243; Sirin SR, 2005, REV EDUC RES, V75, P417, DOI 10.3102/00346543075003417; Spence I, 2010, REV GEN PSYCHOL, V14, P92, DOI 10.1037/a0019491; Steggemann Y, 2011, BRAIN COGNITION, V76, P97, DOI 10.1016/j.bandc.2011.02.013; Subrahmanyam K., 1994, J APPL DEV PSYCHOL, V15, P13, DOI DOI 10.1016/0193-3973(94)90004-3; Tong C, 2002, J NEUROSCI, V22, P1108, DOI 10.1523/JNEUROSCI.22-03-01108.2002; ULRICH R, 1994, J EXP PSYCHOL GEN, V123, P34, DOI 10.1037/0096-3445.123.1.34; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; Unsworth N, 2005, INTELLIGENCE, V33, P67, DOI 10.1016/j.intell.2004.08.003; Unsworth N, 2015, PSYCHOL SCI, V26, P759, DOI 10.1177/0956797615570367; Unterrainer JM, 2006, BRIT J PSYCHOL, V97, P299, DOI 10.1348/000712605X71407; Uttal DH, 2013, CURR DIR PSYCHOL SCI, V22, P367, DOI 10.1177/0963721413484756; Verburgh L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091254; Williams AM, 2011, APPL COGNITIVE PSYCH, V25, P432, DOI 10.1002/acp.1710; Xu RH, 2003, STAT MED, V22, P3527, DOI 10.1002/sim.1572	88	5	5	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0169947	10.1371/journal.pone.0169947	http://dx.doi.org/10.1371/journal.pone.0169947			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6RS	28146562	Green Published, gold, Green Submitted			2022-12-27	WOS:000396131700010
J	Fang, TL; Carver, BF; Hunger, RM; Yan, LL				Fang, Tilin; Carver, Brett F.; Hunger, Robert M.; Yan, Liuling			Mis-Spliced Lr34 Transcript Events in Winter Wheat	PLOS ONE			English	Article							LEAF RUST RESISTANCE; DURABLE RESISTANCE; GENE; DIVERSITY; LR34/YR18; MARKERS; LOCI; QTL	Lr34 in wheat is a non-race-specific gene that confers resistance against multiple fungal pathogens. The resistant allele Lr34 and the susceptible allele Lr34s can be distinguished by three polymorphisms that cause alternation of deduced amino acid sequences of Lr34 at the protein level. In seedlings of a cultivar carrying the resistant Lr34r allele, only a portion (35%) of its transcripts was correctly spliced and the majority (65%) of its transcripts were incorrectly spliced due to multiple mis-splicing events. Lr34 mis-splicing events were also observed at adult plant age when this gene exerts its function. All of the mis-spliced Lr34r cDNA transcripts observed in this study resulted in a premature stop codon due to a shift of the open reading frame; hence, the mis-spliced Lr34r cDNAs were deduced to encode incomplete proteins. Even if a cultivar has a functional Lr34 gene, its transcripts might not completely splice in a correct pattern. These findings suggested that the partial resistance conferred by a quantitative gene might be due to mis-splicing events in its transcripts; hence, the resistance of the gene could be increased by eliminating or mutating regulators that cause mis-splicing events in wheat.	[Fang, Tilin; Carver, Brett F.; Yan, Liuling] Oklahoma State Univ, Dept Plant & Soil Sci, Stillwater, OK 74078 USA; [Hunger, Robert M.] Oklahoma State Univ, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater	Yan, LL (corresponding author), Oklahoma State Univ, Dept Plant & Soil Sci, Stillwater, OK 74078 USA.	liuling.yan@okstate.edu			USDA National Institute of Food and Agriculture [2011-68002-30029]; Oklahoma Center of Advanced Science and Technology [OCAST-131-033]; Oklahoma Agricultural Experiment Station; Oklahoma Wheat Research Foundation	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Oklahoma Center of Advanced Science and Technology; Oklahoma Agricultural Experiment Station; Oklahoma Wheat Research Foundation	This project was supported by the National Research Initiative Competitive Grants CAP project 2011-68002-30029 from the USDA National Institute of Food and Agriculture and from the Oklahoma Center of Advanced Science and Technology (OCAST-131-033). This research project was also partially funded by the Oklahoma Agricultural Experiment Station and the Oklahoma Wheat Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul SD, 1994, THESIS; BJARKO ME, 1988, PHYTOPATHOLOGY, V78, P457, DOI 10.1094/Phyto-78-457; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Bossolini E, 2006, THEOR APPL GENET, V113, P1049, DOI 10.1007/s00122-006-0364-5; CALDWELL RM, 1970, PHYTOPATHOLOGY, V60, P1287, DOI 10.1094/Phyto-60-1696; Cao SH, 2010, THEOR APPL GENET, V121, P385, DOI 10.1007/s00122-010-1317-6; Dakouri A, 2010, THEOR APPL GENET, V121, P373, DOI 10.1007/s00122-010-1316-7; DAS MK, 1993, EUPHYTICA, V68, P99, DOI 10.1007/BF00024159; DYCK PL, 1966, CAN J GENET CYTOL, V8, P665, DOI 10.1139/g66-082; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Fu DL, 2009, SCIENCE, V323, P1357, DOI 10.1126/science.1166289; Kolmer JA, 2011, CROP SCI, V51, P526, DOI 10.2135/cropsci2010.06.0381; Kolmer JA., 2009, WHEAT SCI TRADE, P89, DOI [10.1002/9780813818832.ch5, DOI 10.1002/9780813818832.CH5]; Koscielny G, 2009, GENOMICS, V93, P213, DOI 10.1016/j.ygeno.2008.11.003; Krattinger SG, 2011, PLANT J, V65, P392, DOI 10.1111/j.1365-313X.2010.04430.x; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Kriventseva EV, 2003, TRENDS GENET, V19, P124, DOI 10.1016/S0168-9525(03)00023-4; Kroner A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023331; Lagudah ES, 2009, THEOR APPL GENET, V119, P889, DOI 10.1007/s00122-009-1097-z; Lillemo M, 2008, THEOR APPL GENET, V116, P1155, DOI 10.1007/s00122-008-0743-1; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; McIntosh RA, 2008, MAC GENE; PARLEVLIET JE, 1977, EUPHYTICA, V26, P5, DOI 10.1007/BF00032062; Risk JM, 2012, PLANT BIOTECHNOL J, V10, P477, DOI 10.1111/j.1467-7652.2012.00683.x; RUBIALES D, 1995, PLANT DIS, V79, P1208, DOI 10.1094/PD-79-1208; Schnurbusch T, 2004, THEOR APPL GENET, V108, P477, DOI 10.1007/s00122-003-1444-4; Singh R. P., 2000, Acta Phytopathologica et Entomologica Hungarica, V35, P133; Singh Ravi P., 2007, P109; SINGH RP, 1993, PLANT DIS, V77, P1103, DOI 10.1094/PD-77-1103; Suenaga K, 2003, PHYTOPATHOLOGY, V93, P881, DOI 10.1094/PHYTO.2003.93.7.881; Vergne E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-206	31	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171149	10.1371/journal.pone.0171149	http://dx.doi.org/10.1371/journal.pone.0171149			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135317	Green Published, gold, Green Submitted			2022-12-27	WOS:000396124700052
J	Huang, XY; Zang, XN; Wu, F; Jin, YM; Wang, HT; Liu, C; Ding, YT; He, BX; Xiao, DF; Song, XW; Liu, Z				Huang, Xiaoyun; Zang, Xiaonan; Wu, Fei; Jin, Yuming; Wang, Haitao; Liu, Chang; Ding, Yating; He, Bangxiang; Xiao, Dongfang; Song, Xinwei; Liu, Zhu			Transcriptome Sequencing of Gracilariopsis lemaneiformis to Analyze the Genes Related to Optically Active Phycoerythrin Synthesis	PLOS ONE			English	Article							RED ALGA; RHODOPHYTA; ACCLIMATION; GROWTH; YIELD; GRACILARIACEAE; CULTURE; AGAR	Gracilariopsis lemaneiformis (aka Gracilaria lemaneiformis) is a red macroalga rich in phycoerythrin, which can capture light efficiently and transfer it to photosystemII. However, little is known about the synthesis of optically active phycoerythrinin in G. lemaneiformis at the molecular level. With the advent of high-throughput sequencing technology, analysis of genetic information for G. lemaneiformis by transcriptome sequencing is an effective means to get a deeper insight into the molecular mechanism of phycoerythrin synthesis. Illumina technology was employed to sequence the transcriptome of two strains of G. lemaneiformisthe wild type and a green-pigmented mutant. We obtained a total of 86915 assembled unigenes as a reference gene set, and 42884 unigenes were annotated in at least one public database. Taking the above transcriptome sequencing as a reference gene set, 4041 differentially expressed genes were screened to analyze and compare the gene expression profiles of the wild type and green mutant. By GO and KEGG pathway analysis, we concluded that three factors, including a reduction in the expression level of apo-phycoerythrin, an increase of chlorophyll light-harvesting complex synthesis, and reduction of phycoerythrobilin by competitive inhibition, caused the reduction of optically active phycoerythrin in the green- pigmented mutant.	[Huang, Xiaoyun; Zang, Xiaonan; Wu, Fei; Jin, Yuming; Wang, Haitao; Liu, Chang; Ding, Yating; He, Bangxiang; Xiao, Dongfang; Song, Xinwei; Liu, Zhu] Ocean Univ China, Key Lab Marine Genet & Breeding, Minist Educ, Qingdao, Shandong, Peoples R China	Ocean University of China	Zang, XN (corresponding author), Ocean Univ China, Key Lab Marine Genet & Breeding, Minist Educ, Qingdao, Shandong, Peoples R China.	xnzang@ouc.edu.cn			National Natural Science Foundation of China [31472255]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 31472255).; This work was supported by the National Natural Science Foundation of China (Grant No. 31472255). We thank Dr. John P. van der Meer for his comments and editing of the manuscript. We thank Professor Weizhou Chen for providing the green mutant of Gracilariopsis lemaneiformis.	Ballottari M, 2007, J BIOL CHEM, V282, P8947, DOI 10.1074/jbc.M606417200; Bonente G, 2012, J BIOL CHEM, V287, P5833, DOI 10.1074/jbc.M111.304279; Everroad RC, 2012, MOL PHYLOGENET EVOL, V64, P381, DOI 10.1016/j.ympev.2012.04.013; Freile-Pelegrin Y, 2005, BIORESOURCE TECHNOL, V96, P295, DOI 10.1016/j.biortech.2004.04.010; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; LAPOINTE BE, 1978, AQUACULTURE, V15, P185, DOI 10.1016/0044-8486(78)90030-3; Llansola-Portoles MJ, 2016, BBA-BIOENERGETICS, V1857, P1759, DOI 10.1016/j.bbabio.2016.08.006; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; MacColl R, 2004, BBA-BIOENERGETICS, V1657, P73, DOI 10.1016/j.bbabio.2004.04.005; MacColl R, 1999, POLAR BIOL, V22, P384, DOI 10.1007/s003000050433; Marinho-Soriano E, 2003, BIORESOURCE TECHNOL, V90, P329, DOI 10.1016/S0960-8524(03)00112-3; Marinho-Soriano E, 2001, J BIOTECHNOL, V89, P81, DOI 10.1016/S0168-1656(01)00255-3; Sun XD, 2012, PLANT CELL REP, V31, P1823, DOI 10.1007/s00299-012-1295-z; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Wientjes E, 2013, J PHYS CHEM B, V117, P11200, DOI 10.1021/jp401663w; Wobbe L, 2016, TRENDS PLANT SCI, V21, P55, DOI 10.1016/j.tplants.2015.10.004; Wu HY, 2015, S AFR J BOT, V100, P27, DOI 10.1016/j.sajb.2015.05.017; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang D, 2015, GENE, V565, P252, DOI 10.1016/j.gene.2015.04.013; Zhou Y, 2006, AQUACULTURE, V252, P264, DOI 10.1016/j.aquaculture.2005.06.046	21	23	24	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170855	10.1371/journal.pone.0170855	http://dx.doi.org/10.1371/journal.pone.0170855			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135287	gold, Green Submitted, Green Published			2022-12-27	WOS:000396124700025
J	Jaschinski, W				Jaschinski, Wolfgang			Individual Objective and Subjective Fixation Disparity in Near Vision	PLOS ONE			English	Article							BINOCULAR COORDINATION; RETINAL CORRESPONDENCE; VIEWING DISTANCE; DARK VERGENCE; STIMULI; ACCOMMODATION; MISALIGNMENT; HETEROPHORIA; PARAMETERS; DIRECTION	Binocular vision refers to the integration of images in the two eyes for improved visual perfor-mance and depth perception. One aspect of binocular vision is the fixation disparity, which is a suboptimal condition in individuals with respect to binocular eye movement control and subsequent neural processing. The objective fixation disparity refers to the vergence angle between the visual axes, which is measured with eye trackers. Subjective fixation disparity is tested with two monocular nonius lines which indicate the physical nonius separation required for perceived alignment. Subjective and objective fixation disparity represent the different physiological mechanisms of motor and sensory fusion, but the precise relation between these two is still unclear. This study measures both types of fixation disparity at viewing distances of 40, 30, and 24 cm while observers fixated a central stationary fusion target. 20 young adult subjects with normal binocular vision were tested repeatedly to inves-tigate individual differences. For heterophoria and subjective fixation disparity, this study replicated that the binocular system does not properly adjust to near targets: outward (exo) deviations typically increase as the viewing distance is shortened. This exo proximity effect -however-was not found for objective fixation disparity, which-on the average- was zero. But individuals can have reliable outward (exo) or inward (eso) vergence errors. Cases with eso objective fixation disparity tend to have less exo states of subjective fixation disparity and heterophoria. In summary, the two types of fixation disparity seem to respond in a differ-ent way when the viewing distance is shortened. Motor and sensory fusion-as reflected by objective and subjective fixation disparity-exhibit complex interactions that may differ between individuals (eso versus exo) and vary with viewing distance (far versus near vision).	[Jaschinski, Wolfgang] Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany	Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO)	Jaschinski, W (corresponding author), Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany.	Jaschinski@ifado.de		Jaschinski, Wolfgang/0000-0002-2986-0341	DFG [JA 747/5-2]	DFG(German Research Foundation (DFG))	This research was supported by the grant DFG JA 747/5-2 of the German Research Council.	Blythe HI, 2006, VISION RES, V46, P3898, DOI 10.1016/j.visres.2006.06.006; CARTER DB, 1980, AM J OPTOM PHYS OPT, V57, P610; Collewijn H, 1991, VISION VISUAL DYSF A, V404, P121; Erkelens CJ, 1997, VISION RES, V37, P1735, DOI 10.1016/S0042-6989(96)00323-9; ERKELENS CJ, 1989, PROC R SOC SER B-BIO, V236, P441, DOI 10.1098/rspb.1989.0031; Evans BJW, 2007, PICKWELLS BINOCULAR; Fogt N, 1998, VISION RES, V38, P411, DOI 10.1016/S0042-6989(97)00142-9; Fogt N, 1998, VISION RES, V38, P2711, DOI 10.1016/S0042-6989(97)00448-3; FRANCIS EL, 1983, VISION RES, V23, P13, DOI 10.1016/0042-6989(83)90036-6; Han SJ, 2010, OPHTHAL PHYSL OPT, V30, P95, DOI 10.1111/j.1475-1313.2009.00681.x; Heller D, 1998, CURRENT OCULOMOTOR R; Howard IP, 2012, PERCEIVING IN DEPTH, V1; Howard IP, 2012, PERCEIVING IN DEPTH, V3; Howard IP, 2012, PERCEIVING DEPTH STE, V2; Jainta S, 2010, J EYE MOVEMENT RES, V3; Jainta S, 2012, INVEST OPHTH VIS SCI, V53, P5762, DOI 10.1167/iovs.12-9707; Jainta S, 2011, INVEST OPHTH VIS SCI, V52, P9416, DOI 10.1167/iovs.11-8237; JAMPOLSKY A, 1957, AM J OPHTHALMOL, V43, P97, DOI 10.1016/0002-9394(57)92094-9; Jaschinski W, 2005, OPTOMETRY VISION SCI, V82, P988, DOI 10.1097/01.opx.0000187843.46805.a4; Jaschinski W, 2002, OPTOMETRY VISION SCI, V79, P158, DOI 10.1097/00006324-200203000-00010; Jaschinski W, 1997, OPHTHAL PHYSL OPT, V17, P324, DOI 10.1111/j.1475-1313.1997.tb00064.x; Jaschinski W, 2001, VISION RES, V41, P923, DOI 10.1016/S0042-6989(00)00322-9; Jaschinski W, 2007, OPHTHAL PHYSL OPT, V27, P85, DOI 10.1111/j.1475-1313.2006.00448.x; Jaschinski W, 2016, J EYE MOVEMENT RES, V9, DOI 10.16910/jemr.9.4.2; Jaschinski W, 2010, OPHTHAL PHYSL OPT, V30, P379, DOI 10.1111/j.1475-1313.2010.00753.x; JASCHINSKIKRUZA W, 1994, VISION RES, V34, P1197, DOI 10.1016/0042-6989(94)90301-8; JENKINS TCA, 1989, OPHTHAL PHYSL OPT, V9, P121, DOI 10.1111/j.1475-1313.1989.tb00830.x; Juhasz BJ, 2006, Q J EXP PSYCHOL, V59, P1614, DOI 10.1080/17470210500497722; KERTESZ AE, 1988, VISION RES, V28, P313, DOI 10.1016/0042-6989(88)90159-9; KERTESZ AE, 1987, AM J OPTOM PHYS OPT, V64, P734; Kirkby JA, 2013, BEHAV RES METHODS, V45, P664, DOI 10.3758/s13428-012-0301-2; Kirkby JA, 2008, PSYCHOL BULL, V134, P742, DOI 10.1037/a0012979; Kirkby JA, 2010, VISION RES, V50, P171, DOI 10.1016/j.visres.2009.11.008; Kloke WB, 2006, BIOL PSYCHOL, V73, P220, DOI 10.1016/j.biopsycho.2006.04.004; Le Bigot N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043150; Liversedge SP, 2006, VISION RES, V46, P2363, DOI 10.1016/j.visres.2006.01.013; Mallett RJF, 1974, OPHTHALMIC OPT, V14, P1156; Nuthmann A, 2014, VIS COGN, V22, P259, DOI 10.1080/13506285.2013.876480; Nuthmann A, 2009, J VISION, V9, DOI 10.1167/9.5.31; Ogle KN, 1967, OCULOMOTOR IMBALANCE; OWENS DA, 1975, VISION RES, V15, P1161, DOI 10.1016/0042-6989(75)90016-4; PICKWELL LD, 1991, OPHTHAL PHYSL OPT, V11, P291, DOI 10.1111/j.1475-1313.1991.tb00227.x; Pinheiro J, 2001, MIXED EFFECTS MODELS; REMOLE A, 1985, AM J OPTOM PHYS OPT, V62, P25; REMOLE A, 1986, AM J OPTOM PHYS OPT, V63, P631; REMOLE A, 1984, AM J OPTOM PHYS OPT, V61, P118; ROBERTSON K, 1986, Investigative Ophthalmology and Visual Science, V27, P79; Scheiman M, 2008, CLIN MANAGEMENT BINO; Schor CM, 1991, VISION VISUAL DISFUN, V9, P179; Schroth V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138871; Sheedy JE, 1983, VERGENCE EYE MOVEMEN, P517; Shimono K, 1998, VISION RES, V38, P591, DOI 10.1016/S0042-6989(97)00168-5; Ukwade MT, 2000, OPTOMETRY VISION SCI, V77, P309, DOI 10.1097/00006324-200006000-00011; Vatterott DB, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00533; WICK B, 1991, OPTOMETRY VISION SCI, V68, P146, DOI 10.1097/00006324-199102000-00011; Winter B, 2013, ARXIV13085499	56	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170190	10.1371/journal.pone.0170190	http://dx.doi.org/10.1371/journal.pone.0170190			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6PA	28135308	Green Submitted, Green Published, gold			2022-12-27	WOS:000396124700010
J	Kim, S; Tridane, A				Kim, Sehjeong; Tridane, Abdessamad			Thalassemia in the United Arab Emirates: Why it can be prevented but not eradicated	PLOS ONE			English	Article							BETA-THALASSEMIA; HEALTH; CONSANGUINITY; HEMOGLOBIN; PREVALENCE; DISORDERS; PROGRAMS	Thalassemia is a genetic blood disorder that causes abnormal hemoglobin. Hemoglobin is a protein in red blood cells that carries oxygen and is made of two proteins from four a-globin genes and two beta-globin genes. A defect in one or more of these genes causes thalassemia. The treatment of thalassemia mostly depends on life-long blood transfusions and removal of excessive iron from the blood stream. Such tremendous blood consumption puts pressure on the national blood stock in many countries. In particular, in the United Arab Emirates (UAE), various forms of thalassemia prevention have been used and hence, the substantial reduction of the thalassemia major population has been achieved. However, the thalassemia carrier population still remains high, which leads to the potential increase in the thalassemia major population through carrier-carrier marriages. In this work, we investigate the long-term impact and efficacy of thalassemia prevention measures via mathematical modeling at a population level. To our best knowledge, this type of assessment has not been done before and there is no mathematical model that has investigated such a problem for thalassemia or any blood disorders at a population level. By using UAE data, we perform numerical simulations of our model and conduct sensitivity analysis of parameter values to see which parameter values affect most the dynamics of our model. We discover that the prevention measures can contribute to reduce the prevalence of the disease only in the short term but not eradicate the disease in the long term.	[Kim, Sehjeong; Tridane, Abdessamad] United Arab Emirates Univ, Dept Math Sci, Abu Dhabi, U Arab Emirates	United Arab Emirates University	Kim, S (corresponding author), United Arab Emirates Univ, Dept Math Sci, Abu Dhabi, U Arab Emirates.	sehjung.kim@uaeu.ac.ae	Tridane, Abdessamad/I-3147-2019	Tridane, Abdessamad/0000-0001-8471-7807	United Arab Emirates University [315106, 315105]	United Arab Emirates University	SK is supported in part by the United Arab Emirates University Start-up grant with No. 315106 and AT by the United Arab Emirates University Start-up grant with No. 315105 with www.uaeu.ac.ae. The funder had no role in study design, analysis, decision to publish, or preparation of the manuscript.	Al-Dabbagh B, 2014, HEMOGLOBIN, V38, P56, DOI 10.3109/03630269.2013.848811; Al-Gazali LI, 2005, COMMUNITY GENET, V8, P186, DOI 10.1159/000086764; Al-Gazali L, 2010, HUM MUTAT, V31, P505, DOI 10.1002/humu.21232; Alswaidi FM, 2009, J MED SCREEN, V16, P22, DOI 10.1258/jms.2008.008029; Baysal E, 2005, COMMUNITY GENET, V8, P35, DOI 10.1159/000083336; Baysal E, 2011, HEMOGLOBIN, V35, P581, DOI 10.3109/03630269.2011.634706; Belhoul KM, 2013, HEMOGLOBIN, V37, P359, DOI 10.3109/03630269.2013.791627; Bittles AH, 2010, EARLY HUM DEV, V86, P737, DOI 10.1016/j.earlhumdev.2010.08.003; Bittles AH, 2001, CLIN GENET, V60, P89, DOI 10.1034/j.1399-0004.2001.600201.x; BITTLES AH, 1991, SCIENCE, V252, P789, DOI 10.1126/science.2028254; Cao A, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011775; Cao A, 2010, GENET MED, V12, P61, DOI [10.1097/GIM.0b013e3181cd68ed, 10.1038/gim.2016.173]; Danjou F, 2011, HAEMATOL-HEMATOL J, V96, P1573, DOI 10.3324/haematol.2011.055962; Denic S, 2013, HEMOGLOBIN, V37, P351, DOI 10.3109/03630269.2013.790827; Federal Competitiveness and Statistics Authority, 2015, STAT SUBJ; Hamamy H, 2011, GENET MED, V13, P841, DOI 10.1097/GIM.0b013e318217477f; Health Authority Abu Dhabi, 2013, HLTH STAT 2013; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; R Development Core Team, 2016, R LANG ENV STAT COMP; Saffi M, 2015, PUBLIC HEALTH GENOM, V18, P193, DOI 10.1159/000430837; Sheikh Saud bin Saqr Al Qasimi Foundation for Policy Research, 2015, PUBL HLTH UN AR EM R; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; Tadmouri Ghazi O, 2009, Reprod Health, V6, P17, DOI 10.1186/1742-4755-6-17; Thalassemia Foundation of Canada, 2009, GUID CLIN CAR PAT TH; Vichinsky EP, 2005, ANN NY ACAD SCI, V1054, P18, DOI 10.1196/annals.1345.003; Weatherall DJ, 2010, ANN NY ACAD SCI, V1202, P17, DOI 10.1111/j.1749-6632.2010.05546.x; Weatherall DJ, 2010, BLOOD, V115, P4331, DOI 10.1182/blood-2010-01-251348	27	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170485	10.1371/journal.pone.0170485	http://dx.doi.org/10.1371/journal.pone.0170485			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135306	Green Published, Green Submitted, gold			2022-12-27	WOS:000396124700014
J	del Valle-Mendoza, J; Orellana-Peralta, F; Marcelo-Rodriguez, A; Verne, E; Esquivel-Vizcarra, M; Silva-Caso, W; Aguilar-Luis, MA; Weilg, P; Casabona-Ore, V; Ugarte, C; del Valle, LJ				del Valle-Mendoza, Juana; Orellana-Peralta, Fiorella; Marcelo-Rodriguez, Alvaro; Verne, Eduardo; Esquivel-Vizcarra, Monica; Silva-Caso, Wilmer; Angel Aguilar-Luis, Miguel; Weilg, Pablo; Casabona-Ore, Veronica; Ugarte, Claudia; del Valle, Luis J.			High Prevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in Children with Acute Respiratory Infections from Lima, Peru	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; CHLAMYDOPHILA-PNEUMONIAE; HOSPITALIZED CHILDREN; EPIDEMIOLOGY; ETIOLOGY	Background Mycoplasma pneumoniae and Chlamydia pneumoniae are atypical pathogens responsible for pneumonia and a leading cause of morbidity and mortality in low income countries. The study objective is to determine the prevalence of this pathogens in Peruvian children with acute respiratory infections. Methods A consecutive cross-sectional study was conducted in Lima, Peru from May 2009 to September 2010. A total of 675 children admitted with clinical diagnoses of acute respiratory infections were tested for Mycoplasma pneumoniae and Chlamydia pneumoniae detection by polymerase chain reaction (PCR), and clinical symptoms were registered by the attending physician. Results Mycoplasma pneumonia was detected in 25.19% (170/675) of nasopharyngeal samples and Chlamydia pneumonia in 10.52% (71/675). The most common symptoms in patients with these atypical pathogens were rhinorrhea, cough and fever. A higher prevalence of Mycoplasma pneumoniae cases were registered in summer, between December 2009 and March 2010. Conclusions Mycoplasma pneumoniae and Chlamydia pneumonia are a significant cause of morbidity in Peruvian children with acute respiratory infections (ARI). Further studies should evaluate the use of reliable techniques such as PCR in Peru in order to avoid underdiagnoses of these atypical pathogens.	[del Valle-Mendoza, Juana; Orellana-Peralta, Fiorella; Angel Aguilar-Luis, Miguel; Weilg, Pablo; Casabona-Ore, Veronica; Ugarte, Claudia] Univ Peruana Ciencias Aplicadas UPC, Fac Hlth Sci, Res & Innovat Ctr, Sch Med, Lima, Peru; [del Valle-Mendoza, Juana; Orellana-Peralta, Fiorella; Esquivel-Vizcarra, Monica; Angel Aguilar-Luis, Miguel; Casabona-Ore, Veronica] Inst Invest Nutr, Lima, Peru; [Marcelo-Rodriguez, Alvaro] Univ Nacl Federico Villarreal, Lima, Peru; [Verne, Eduardo; Ugarte, Claudia] Hosp Nacl Cayetano Heredia, Lima, Peru; [del Valle, Luis J.] Univ Politecn Cataluna, Barcelona Tech, ETSEIB, Ctr Biotecnol Mol CEBIM,Dept Engn Quim, Barcelona, Spain	Universidad Peruana de Ciencias Aplicadas (UPC); Universidad Nacional Federico Villarreal; Universitat Politecnica de Catalunya	del Valle-Mendoza, J (corresponding author), Univ Peruana Ciencias Aplicadas UPC, Fac Hlth Sci, Res & Innovat Ctr, Sch Med, Lima, Peru.; del Valle-Mendoza, J (corresponding author), Inst Invest Nutr, Lima, Peru.; del Valle, LJ (corresponding author), Univ Politecn Cataluna, Barcelona Tech, ETSEIB, Ctr Biotecnol Mol CEBIM,Dept Engn Quim, Barcelona, Spain.	jdelvall@upc.edu.pe; luis.javier.del.valle@upc.edu	Del Valle, Luis J./I-1342-2015; Aguilar-Luis, Miguel Angel/C-8686-2018; del Valle Mendoza, Juana/C-9805-2018; Silva, Wilmer Gianfranco/D-2699-2018; CASABONA ORE, VERONICA DANIXA/F-1248-2018	Del Valle, Luis J./0000-0001-9916-1741; Aguilar-Luis, Miguel Angel/0000-0001-7023-3190; del Valle Mendoza, Juana/0000-0002-6011-5040; Silva, Wilmer Gianfranco/0000-0003-1086-8084; CASABONA ORE, VERONICA DANIXA/0000-0002-9922-3786; Weilg Espejo, Pablo Renato/0000-0002-9711-2193	Programa de Ciencia y Tecnologia, Peru [071-FINCyT-PIN-2008]	Programa de Ciencia y Tecnologia, Peru	This work has been supported by Programa de Ciencia y Tecnologia, Contrato No 071-FINCyT-PIN-2008, Peru. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beersma MFC, 2005, J CLIN MICROBIOL, V43, P2277, DOI 10.1128/JCM.43.5.2277-2285.2005; Blystad H, 2012, EURO SURVEILL, V17; Chalker VJ, 2012, EURO SURVEILL, V17; Chen Ling-ling, 2012, Zhonghua Er Ke Za Zhi, V50, P211; Chen ZR, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-34; Chiang WC, 2007, RESPIROLOGY, V12, P254, DOI 10.1111/j.1440-1843.2006.01036.x; Mendoza JD, 2015, J MED VIROL, V87, P917, DOI 10.1002/jmv.24159; Dumke R, 2015, EMERG INFECT DIS, V21, P426, DOI 10.3201/eid2103.140927; Eibach D, 2012, EURO SURVEILL, V17; El Seify MY, 2016, EUR J MICROBIOL IMMU, V6, P206, DOI 10.1556/1886.2016.00022; Grassi T, 2014, J INFECT DEV COUNTR, V8, P379, DOI 10.3855/jidc.4458; He XY, 2013, DIAGN MICR INFEC DIS, V75, P22, DOI 10.1016/j.diagmicrobio.2012.08.027; Huong P, 2015, JPN J INFECT DIS; Kumar S, 2007, CLIN INFECT DIS, V44, P568, DOI 10.1086/511076; Kurz H, 2009, PEDIATR PULM, V44, P873, DOI 10.1002/ppul.21059; Liu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119170; Liu WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096674; Maass V, 2011, J CLIN MICROBIOL, V49, P3681, DOI 10.1128/JCM.01092-11; Mathew JL, 2015, J GLOB HEALTH, V5, P223, DOI 10.7189/jogh.05.020418; Michelow IC, 2004, PEDIATRICS, V113, P701, DOI 10.1542/peds.113.4.701; Miranda J., ACTA MED; Nir-Paz R., 2012, EURO SURVEILL, V17; Pavic-Espinoza I, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1287-z; Huong PLT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1304; Samransamruajkit R, 2008, JPN J INFECT DIS, V61, P36; Schmidt SM, 2003, INFECTION, V31, P410, DOI 10.1007/s15010-003-3159-5; Song Q, 2015, INT J CLIN EXP MED, V8, P15666; Wertheim H, 2015, INFLUENZA OTHER RESP; Xu YC, 2011, WORLD J PEDIATR, V7, P240, DOI 10.1007/s12519-011-0318-0	29	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170787	10.1371/journal.pone.0170787	http://dx.doi.org/10.1371/journal.pone.0170787			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129377	Green Published, gold, Green Submitted			2022-12-27	WOS:000396211400036
J	Eloi, JC; Epifanio, M; de Goncalves, MM; Pellicioli, A; Vieira, PFG; Dias, HB; Bruscato, N; Soder, RB; Santana, JCB; Mouzaki, M; Baldisserotto, M				Eloi, Juliana Cristina; Epifanio, Matias; de Goncalves, Marilia Maia; Pellicioli, Augusto; Giora Vieira, Patricia Froelich; Dias, Henrique Bregolin; Bruscato, Neide; Soder, Ricardo Bernardi; Batista Santana, Joao Carlos; Mouzaki, Marialena; Baldisserotto, Matteo			Quantification of Abdominal Fat in Obese and Healthy Adolescents Using 3 Tesla Magnetic Resonance Imaging and Free Software for Image Analysis	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; BODY-MASS INDEX; TO-HEIGHT RATIO; WAIST CIRCUMFERENCE; ADIPOSE-TISSUE; INSULIN-RESISTANCE; METABOLIC SYNDROME; PUBERTAL CHANGES; CHILDREN; ASSOCIATION	Background and Aims Computed tomography, which uses ionizing radiation and expensive software packages for analysis of scans, can be used to quantify abdominal fat. The objective of this study is to measure abdominal fat with 3T MRI using free software for image analysis and to correlate these findings with anthropometric and laboratory parameters in adolescents. Methods This prospective observational study included 24 overweight/obese and 33 healthy adolescents (mean age 16.55 years). All participants underwent abdominal MRI exams. Visceral and subcutaneous fat area and percentage were correlated with anthropometric parameters, lipid profile, glucose metabolism, and insulin resistance. Student's t test and Mann-Whitney's test was applied. Pearson's chi-square test was used to compare proportions. To determine associations Pearson's linear correlation or Spearman's correlation were used. Results In both groups, waist circumference (WC) was associated with visceral fat area (P = 0.001 and P = 0.01 respectively), and triglycerides were associated with fat percentage (P = 0.046 and P = 0.071 respectively). In obese individuals, total cholesterol/HDL ratio was associated with visceral fat area (P = 0.03) and percentage (P = 0.09), and insulin and HOMA- IR were associated with visceral fat area (P = 0.001) and percentage (P = 0.005). Conclusions 3T MRI can provide reliable and good quality images for quantification of visceral and subcutaneous fat by using a free software package. The results demonstrate that WC is a good predictor of visceral fat in obese adolescents and visceral fat area is associated with total cholesterol/HDL ratio, insulin and HOMA-IR.	[Eloi, Juliana Cristina; Epifanio, Matias] Univ Catolica Rio Grande Sul PUCRS, Hosp Sao Lucas Pontificia, Pediat Gastroenterol Serv, Porto Alegre, RS, Brazil; [de Goncalves, Marilia Maia; Pellicioli, Augusto; Giora Vieira, Patricia Froelich; Dias, Henrique Bregolin] Pontificia Univ Catolica Rio Grande do Sul, Porto Alegre, RS, Brazil; [Soder, Ricardo Bernardi] Pontificia Univ Catolica Rio Grande do Sul, Brain Inst InsCer, Porto Alegre, RS, Brazil; [Batista Santana, Joao Carlos] Univ Fed Rio Grande do Sul, Sch Med, Porto Alegre, RS, Brazil; [Mouzaki, Marialena] Hosp Sick Children, Div Gastroenterol Hepatol & Nutr, Dept Pediat, Toronto, ON, Canada; [Baldisserotto, Matteo] Pontificia Univ Catolica Rio Grande do Sul, Brain Inst InsCer, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Federal do Rio Grande do Sul; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Pontificia Universidade Catolica Do Rio Grande Do Sul	Baldisserotto, M (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Brain Inst InsCer, Porto Alegre, RS, Brazil.	matteob@terra.com.br	Baldisserotto, Matteo/AAD-8447-2022; Epifanio, Matias/M-8561-2013	Epifanio, Matias/0000-0002-7676-8513	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [Universal 14/2012]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The current study was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) grant, resulted of Notice Universal 14/2012 with grant equivalent to US D: 13,000.	ABATE N, 1994, J LIPID RES, V35, P1490; Agredo-Zuniga RA, 2015, BRIT J NUTR, V114, P700, DOI 10.1017/S0007114515002275; Benfield LL, 2008, INT J OBESITY, V32, P91, DOI 10.1038/sj.ijo.0803780; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Brambilla P, 2006, INT J OBESITY, V30, P23, DOI 10.1038/sj.ijo.0803163; Caprio S, 1996, AM J CLIN NUTR, V64, P12, DOI 10.1093/ajcn/64.1.12; Clemente G, 2015, INT J FOOD SCI NUTR, V66, P466, DOI 10.3109/09637486.2015.1042845; Daniels SR, 1999, CIRCULATION, V99, P541, DOI 10.1161/01.CIR.99.4.541; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Du Bois D, 1989, Nutrition, V5, P303; Frayn KN, 2000, BRIT J NUTR, V83, pS71, DOI 10.1017/S0007114500000982; Gonzalez-Casanova I, 2013, REV PANAM SALUD PUBL, V33, P349, DOI 10.1590/S1020-49892013000500006; Grober-Gratz D, 2013, HORM RES PAEDIAT, V80, P170, DOI 10.1159/000354224; Guntsche Z, 2010, J PEDIATR ENDOCR MET, V23, P245; Hu HH, 2011, OBES REV, V12, pe504, DOI 10.1111/j.1467-789X.2010.00824.x; Irving BA, 2007, OBESITY, V15, P370, DOI 10.1038/oby.2007.573; Javed A, 2015, PEDIATR OBES, V10, P234, DOI 10.1111/ijpo.242; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Kabir M, 2005, AM J PHYSIOL-ENDOC M, V288, pE454, DOI 10.1152/ajpendo.00203.2004; Karlsson AK, 2013, OBESITY, V21, P1018, DOI 10.1002/oby.20205; Klopfenstein BJ, 2012, BRIT J RADIOL, V85, pE826, DOI 10.1259/bjr/57987644; Kullberg J, 2009, BRIT J RADIOL, V82, P123, DOI 10.1259/bjr/80083156; Li XJ, 2008, MAGN RESON IMAGING, V26, P188, DOI 10.1016/j.mri.2007.06.006; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Mehmet Sezgin Bu, J ELECT IMAGING, V13, P146; Mook-Kanamori DO, 2009, ULTRASOUND MED BIOL, V35, P1938, DOI 10.1016/j.ultrasmedbio.2009.07.002; Nambiar S, 2013, J PAEDIATR CHILD H, V49, pE281, DOI 10.1111/jpc.12147; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Savva SC, 2013, DIABET METAB SYND OB, V6, P403, DOI 10.2147/DMSO.S34220; Savva SC, 2000, INT J OBESITY, V24, P1453, DOI 10.1038/sj.ijo.0801401; Sottier D, 2013, Diagn Interv Imaging, V94, P879, DOI 10.1016/j.diii.2013.04.006; Tirosh A, 2011, NEW ENGL J MED, V364, P1315, DOI 10.1056/NEJMoa1006992; Tong YB, 2014, MED PHYS, V41, DOI 10.1118/1.4876275	37	26	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0167625	10.1371/journal.pone.0167625	http://dx.doi.org/10.1371/journal.pone.0167625			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129354	Green Published, Green Submitted, gold			2022-12-27	WOS:000396211400073
J	Kreis, C; Lupatsch, JE; Niggli, F; Egger, M; Kuehni, CE; Spycher, BD				Kreis, Christian; Lupatsch, Judith E.; Niggli, Felix; Egger, Matthias; Kuehni, Claudia E.; Spycher, Ben D.		Swiss Paediatric Oncol Grp; Swiss Natl Cohort Study Grp	Space-Time Clustering of Childhood Leukemia: Evidence of an Association with ETV6-RUNX1 (TEL-AML1) Fusion	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CHROMOSOME TRANSLOCATIONS; GREAT-BRITAIN; ETIOLOGY; CANCER; PATTERNS; CLONES	Background Many studies have observed space-time clustering of childhood leukemia (CL) yet few have attempted to elicit etiological clues from such clustering. We recently reported space-time clustering of CL around birth, and now aim to generate etiological hypotheses by comparing clustered and nonclustered cases. We also investigated whether the clustering resulted from many small aggregations of cases or from a few larger clusters. Methods We identified cases of persons born and diagnosed between 1985 and 2014 at age 0-15 years from the Swiss Childhood Cancer Registry. We determined spatial and temporal lags that maximized evidence of clustering based on the Knox test and classified cases born within these lags from another case as clustered. Using logistic regression adjusted for child population density, we determined whether clustering status was associated with age at diagnosis, immunophenotype, cytogenetic subtype, perinatal and socioeconomic characteristics, and pollution sources. Results Analyses included 1,282 cases of which 242 were clustered (born within 1 km and 2 years from another case). Of all investigated characteristics only the t(12; 21)(p13; q22) translocation (resulting in ETV6-RUNX1 fusion) differed significantly in prevalence between clustered and nonclustered cases (40% and 25%, respectively; adjusted OR 2.54 [1.52-4.23]; p = 0.003). Spatio-temporal clustering was driven by an excess of aggregations of two or three children rather than by a few large clusters. Conclusion Our findings suggest ETV6-RUNX1 is associated with space-time clustering of CL and are consistent with an infection interacting with that oncogene in early life leading to clinical leukemia.	[Kreis, Christian; Lupatsch, Judith E.; Egger, Matthias; Kuehni, Claudia E.; Spycher, Ben D.] Univ Bern, ISPM, Bern, Switzerland; [Niggli, Felix] Univ Childrens Hosp Zurich, Zurich, Switzerland	University of Bern; University Children's Hospital Zurich	Spycher, BD (corresponding author), Univ Bern, ISPM, Bern, Switzerland.	ben.spycher@ispm.unibe.ch	Spycher, Ben D/B-3308-2008; Niggli, Felix/L-6547-2017	Spycher, Ben D/0000-0002-1430-5695; Niggli, Felix/0000-0002-7553-3712; Bopp, Matthias/0000-0003-0766-3723; Kreis, Christian/0000-0001-5273-1954; Egger, Matthias/0000-0001-7462-5132	Swiss Cancer Research [3049-08-2012, 3515-08-2014]; Swiss Federal Office of Public Health [08.001616, 10.002946, 12.008357, PZ00P3_147987]; Swiss Cancer League [02224-03-2008]; Swiss Paediatric Oncology Group; Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und -direktoren; Swiss Cancer Research; Kinderkrebshilfe Schweiz; Federal Office of Health (FOH); National Institute of Cancer Epidemiology and Registration; Swiss National Science Foundation [3347CO-108806, 33CS30-134273, 33CS30-148415]	Swiss Cancer Research; Swiss Federal Office of Public Health; Swiss Cancer League; Swiss Paediatric Oncology Group; Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und -direktoren; Swiss Cancer Research; Kinderkrebshilfe Schweiz; Federal Office of Health (FOH); National Institute of Cancer Epidemiology and Registration; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss Cancer Research (https://gap.swisscancer.ch) grants 3049-08-2012 and 3515-08-2014 (BDS); Swiss Federal Office of Public Health (http://www.bag.admin.ch) grants 08.001616, 10.002946 and 12.008357 (CEK); Swiss Cancer League (http://www.krebsliga.ch) grant 02224-03-2008 (CEK) and Swiss National Science Foundation (http://www.snf.ch/) fellowship PZ00P3_147987 (BDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The work of the Swiss Childhood Cancer Registry is supported by the Swiss Paediatric Oncology Group (www.spog.ch), Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und -direktoren (www.gdk-cds.ch), Swiss Cancer Research (www.krebsforschung.ch), Kinderkrebshilfe Schweiz (www.kinderkrebshilfe.ch), the Federal Office of Health (FOH) and the National Institute of Cancer Epidemiology and Registration (www.nicer.ch). The work of the Swiss National Cohort Study was supported by the Swiss National Science Foundation (3347CO-108806, 33CS30-134273, 33CS30-148415).	Alexander FE, 1998, BRIT J CANCER, V77, P812, DOI 10.1038/bjc.1998.132; Baker RD, 1996, J APPL STAT, V23, P543, DOI 10.1080/02664769624080; Bellec S, 2006, BRIT J CANCER, V94, P763, DOI 10.1038/sj.bjc.6602980; Birch JM, 2000, BRIT J CANCER, V82, P1571, DOI 10.1054/bjoc.1999.1072; Bondy JA, 2008, GRAPH THEORY, VXII; Bopp M, 2009, INT J EPIDEMIOL, V38, P379, DOI 10.1093/ije/dyn042; Eden T, 2010, CANCER TREAT REV, V36, P286, DOI 10.1016/j.ctrv.2010.02.004; Filippini T, 2015, J ENVIRON SCI HEAL C, V33, P36, DOI 10.1080/10590501.2015.1002999; GILMAN EA, 1995, J EPIDEMIOL COMMUN H, V49, P158, DOI 10.1136/jech.49.2.158; Gilman EA, 1999, EUR J CANCER, V35, P91, DOI 10.1016/S0959-8049(98)00345-1; Greaves M, 2006, NAT REV CANCER, V6, P193, DOI 10.1038/nrc1816; Greaves M, 2011, BLOOD, V117, P369, DOI 10.1182/blood-2010-09-309351; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Greaves MF, 2003, BLOOD, V102, P2321, DOI 10.1182/blood-2002-12-3817; GREAVES MF, 1988, LEUKEMIA, V2, P120; Gustafsson B, 1999, BRIT J CANCER, V79, P655, DOI 10.1038/sj.bjc.6690103; HOLM S, 1979, SCAND J STAT, V6, P65; Inaba H, 2013, LANCET, V381, P1943, DOI 10.1016/S0140-6736(12)62187-4; KINLEN L, 1988, LANCET, V2, P1323; Kinlen LJ, 2012, BRIT J CANCER, V107, P1163, DOI 10.1038/bjc.2012.402; KNOX EG, 1992, J EPIDEMIOL COMMUN H, V46, P566, DOI 10.1136/jech.46.6.566; KNOX EG, 1964, ROY STAT SOC C-APP, V13, P25; Kreis C, 2016, INT J CANCER, V138, P2127, DOI 10.1002/ijc.29955; Kulldorff M, 1999, BIOMETRICS, V55, P544, DOI 10.1111/j.0006-341X.1999.00544.x; Laurier D, 2014, J RADIOL PROT, V34, pR53, DOI 10.1088/0952-4746/34/3/R53; Lausten-Thomsen U, 2011, BLOOD, V117, P186, DOI 10.1182/blood-2010-05-282764; LITTLE J, 1999, IARC SCI PUBLICATION, V149; McNally RJQ, 2006, INT J CANCER, V118, P2840, DOI 10.1002/ijc.21726; McNally RJQ, 2004, BRIT J HAEMATOL, V127, P243, DOI 10.1111/j.1365-2141.2004.05166.x; McNally RJQ, 2002, BRIT J CANCER, V87, P513, DOI 10.1038/sj.bjc.6600498; Mori H, 2002, P NATL ACAD SCI USA, V99, P8242, DOI 10.1073/pnas.112218799; MORRIS V, 1990, J EPIDEMIOL COMMUN H, V44, P55, DOI 10.1136/jech.44.1.55; Olsen M, 2012, J PEDIAT HEMATOL ONC, V34, P301, DOI 10.1097/MPH.0b013e3182332268; Onozuka D, 2008, EPIDEMIOLOGY, V19, P824, DOI 10.1097/EDE.0b013e3181880eda; Panczak R, 2012, J EPIDEMIOL COMMUN H, V66, P1129, DOI 10.1136/jech-2011-200699; Petridou E, 1996, BRIT J CANCER, V73, P1278, DOI 10.1038/bjc.1996.245; Pui CH, 2011, J CLIN ONCOL, V29, P551, DOI 10.1200/JCO.2010.30.7405; Pyatt D, 2010, CHEM-BIOL INTERACT, V184, P151, DOI 10.1016/j.cbi.2010.01.002; Schindler M, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14225; Smith M, 1997, J IMMUNOTHER, V20, P89, DOI 10.1097/00002371-199703000-00001; Spycher BD, 2015, EUR J EPIDEMIOL, V30, P1263, DOI 10.1007/s10654-015-0091-9; Spycher BD, 2011, INT J EPIDEMIOL, V40, P1247, DOI 10.1093/ije/dyr115; Teuffel O, 2004, LEUKEMIA, V18, P1624, DOI 10.1038/sj.leu.2403462; Wakeford R, 2013, J RADIOL PROT, V33, P1, DOI 10.1088/0952-4746/33/1/1; Wiemels J, 2012, CHEM-BIOL INTERACT, V196, P59, DOI 10.1016/j.cbi.2012.01.007; Williams JR, 2001, J ROY STAT SOC A STA, V164, P49, DOI 10.1111/1467-985X.00185	46	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170020	10.1371/journal.pone.0170020	http://dx.doi.org/10.1371/journal.pone.0170020			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129329	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000396211400066
J	Wu, QX; An, JQ; She, RP; Shi, RH; Hao, WZ; Soomro, M; Yuan, XR; Yang, JL; Wang, JY				Wu, Qiaoxing; An, Junqing; She, Ruiping; Shi, Ruihan; Hao, Wenzhuo; Soomro, MajidHussain; Yuan, Xuerui; Yang, Jinling; Wang, Jingyuan			Detection of Genotype 4 Swine Hepatitis E Virus in Systemic Tissues in Cross-Species Infected Rabbits	PLOS ONE			English	Article								Increasing evidence demonstrates that hepatitis E virus (HEV) can be transmitted across species. According to previous reports, swine HEV has two genotypes, genotype 3 and 4, and both can infect humans by the fecal-oral route. Thus, it is crucial for the control of HEV zoonotic transmission to evaluate the dynamics of viral shedding and distribution in different tissues during cross-species infection by HEV. In this study, rabbits were infected with genotype 4 swine HEV by the intraperitoneal route. The results showed that HEV RNA not only shed in the feces but also in the saliva of some rabbits during infection with swine HEV. Viremia appeared late after infection, and anti-HEV IgG was not obvious until the appearance of high viremia levels. After the rabbits were euthanized, a histopathological examination showed that the livers developed overt hepatitis accompanied by an elevation of alanine aminotransferase (ALT) and aspartate transaminase (AST). Furthermore, HEV RNA was detected in various tissues, especially in the salivary glands and tonsils. Subsequently, negative- stranded HEV RNA was practiced in tissues with positive HEV RNA, which demonstrated that HEV replicated in the tissues. Next, we harvested additional tissues from the liver, salivary gland, tonsil, spleen, thymus gland, lymph node and intestine, which are known as replication sites of swine HEV. Additionally, we also observed the HEV antigen distributed in the organs above through immunohistochemical staining. These results demonstrate that rabbits could be used as an animal model for researching cross-species infection of genotype 4 HEV. It is also noteworthy that HEV can shed in the saliva and presents the risk of droplet transmission. These new data provide valuable information for understanding cross-species infection by HEV.	[Wu, Qiaoxing; An, Junqing; She, Ruiping; Shi, Ruihan; Hao, Wenzhuo; Soomro, MajidHussain; Yuan, Xuerui; Yang, Jinling; Wang, Jingyuan] China Agr Univ, Coll Vet Med, Lab Vet Pathol & Publ Hlth, Beijing, Peoples R China	China Agricultural University	She, RP (corresponding author), China Agr Univ, Coll Vet Med, Lab Vet Pathol & Publ Hlth, Beijing, Peoples R China.	sheruiping@126.com		Wu, Qiaoxing/0000-0001-7362-6424	National Natural Science Foundation of China [31072110, 31272515]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (Grant No.31072110, 31272515).; We thank Wei Li, Heng Li, Yang Zhang, Yifei Yang and Yuanheng Wu for their help with the experiments and Feng Yu at the University of California Davis for language revision of the paper. This study was supported by the National Natural Science Foundation of China (Grant No.31472165, 31272515). The American Journal Experts thoroughly copyedit the manuscript for language.	[Anonymous], 2014, INT J CHEM ENG; [Anonymous], 2005, J CLIN MICROBIOL, V1, P49; Ansari IH, 2000, J MED VIROL, V60, P275, DOI 10.1002/(SICI)1096-9071(200003)60:3<275::AID-JMV5>3.3.CO;2-0; Beyaz F, 2010, VET RES COMMUN, V34, P255, DOI 10.1007/s11259-010-9349-6; Bose PD, 2014, J GEN VIROL, V95, P1266, DOI 10.1099/vir.0.063602-0; Bouwknegt M, 2008, VET RES, V5, P498; Cossaboom CM, 2012, J GEN VIROL, V93, P1687, DOI 10.1099/vir.0.041509-0; Geng YS, 2016, J HEPATOL, V64, P37, DOI 10.1016/j.jhep.2015.08.034; Huang F, 2016, HEPATOLOGY; Huang YW, 2007, J VIROL, V81, P3018, DOI 10.1128/JVI.02259-06; Johne R, 2011, EMERG INFECT DIS, V17, P1982, DOI 10.3201/eid1710.110283; Kasorndorkbua C., 2004, DISSERTATION ABSTR B, V65-12, P6232; Li TC, 2016, VET MICROBIOL, V183, P30, DOI 10.1016/j.vetmic.2015.11.014; Li WG, 2009, J MED VIROL, V81, P1591, DOI 10.1002/jmv.21573; Liu L, 2016, J MED VIROL, V88, P681, DOI 10.1002/jmv.24374; Liu P, 2013, EMERG INFECT DIS, V19, P559, DOI 10.3201/eid1904.120827; Ma H, 2010, PLOS ONE, V2, P1; Mao JD, 2014, ADV METEOROL, V2014, DOI 10.1155/2014/157645; Masuda JI, 2005, HEPATOL RES, V31, P178, DOI 10.1016/j.hepres.2005.01.008; Meng XJ, 2010, VET MICROBIOL, V140, P256, DOI 10.1016/j.vetmic.2009.03.017; Meng XJ, 1998, ARCH VIROL, V143, P1405, DOI 10.1007/s007050050384; Meng XJ, 1998, J VIROL, V72, P9714, DOI 10.1128/JVI.72.12.9714-9721.1998; NANDA SK, 1995, GASTROENTEROLOGY, V108, P225, DOI 10.1016/0016-5085(95)90028-4; Okamoto H, 2007, VIRUS RES, V127, P216, DOI 10.1016/j.virusres.2007.02.002; Payne CJ, 1999, VET MICROBIOL, V68, P119, DOI 10.1016/S0378-1135(99)00067-X; Renou C, 2007, EMERG INFECT DIS, V13, P1094, DOI 10.3201/eid1307.070063; REYES GR, 1990, SCIENCE, V247, P1335, DOI 10.1126/science.2107574; Shi R, 2016, J VIRAL HEPATITIS; Soomro MH, 2015, VIRUS RES, V3, P588; Takagi T, 2010, J CLIN MICROBIOL, V48, P1112, DOI [10.1128/JCM.02002-09, DOI 10.1128/JCM.02002-09]; Takahashi M, 2011, J GEN VIROL, V92, P902, DOI 10.1099/vir.0.029470-0; TAM AW, 1991, VIROLOGY, V185, P120, DOI 10.1016/0042-6822(91)90760-9; Tian DY, 2006, WORLD J GASTROENTERO, V12, P3919, DOI 10.3748/wjg.v12.i24.3919; van de Garde MDB, 2016, J VIROL, V90, P4394, DOI 10.1128/JVI.00114-16; Wang L., 2016, GUT; Wang L, 2016, J INFECTION, V73, P271, DOI 10.1016/j.jinf.2016.06.005; Williams TPE, 2001, J CLIN MICROBIOL, V39, P3040, DOI 10.1128/JCM.39.9.3040-3046.2001; Woo PCY, 2014, EMERG INFECT DIS, V20, P1044, DOI 10.3201/eid2006.140140; Yang YF, 2015, VIRUS RES, V208, P171, DOI 10.1016/j.virusres.2015.06.007; Yang YF, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0375-z; ZHANG W, 2008, EPIDEMIOL INFECT, V08; Zhang YD, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/931256; Zhao CY, 2009, J MED VIROL, V81, P1371, DOI 10.1002/jmv.21536	43	24	24	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0171277	10.1371/journal.pone.0171277	http://dx.doi.org/10.1371/journal.pone.0171277			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129390	Green Submitted, Green Published, gold			2022-12-27	WOS:000396211400003
J	Zhang, QH; Mahapatra, T; Huang, FF; Tang, WM; Guo, YF; Tang, SY; Lei, Y; Feng, L; Wang, AN; Zhang, LY; Zhang, JP				Zhang, Qinghua; Mahapatra, Tanmay; Huang, Feifei; Tang, Weiming; Guo, Yufang; Tang, Songyuan; Lei, Yang; Feng, Lei; Wang, Anni; Zhang, Liuyi; Zhang, Jingping			Association between Anthropometric Measures and Indicators for Hypertension Control among Kazakh-Chinese Hypertension Patients in Xinjiang, China: Results from a Cross-sectional Study	PLOS ONE			English	Article							PULSE PRESSURE INDEX; ANKLE-BRACHIAL INDEX; TO-HEIGHT RATIO; BLOOD-PRESSURE; CARDIOVASCULAR EVENTS; WAIST CIRCUMFERENCE; PRACTICE GUIDELINES; RISK-FACTORS; OBESITY; PREVALENCE	Background Among Kazakh-Chinese population in Xinjiang province of China, prevalence of obesity and hypertension were 40.1% and 50.3% respectively, the highest across all ethnic groups residing in this pastureland. Despite this, there remained a dearth of information regarding the association between the anthropometric measures [body mass index (BMI), waist circumference (WC), waist-hip ratio (WHR), Waist-to-height ratio (WHtR) etc.] and indicators for hypertension control [achieved levels of systolic and diastolic blood pressures (SBP and DBP), pulse pressure index (PPI), ankle-brachial index (ABI) etc.] among them. Method A cross-sectional study was conducted in Xinjiang to determine the distribution and interrelationships of the anthropometric measures and indicators for achieved BP control as well as their predictors among hypertension patients of Kazakh-Chinese ethnicity. Out of 550 randomly selected patients, 516 completed the interview, anthropometry and BP assessments. Results In the sample population, average SBP, DBP and PP were 156.26 +/- 24.40mmHg, 87.55 +/- 14.73mmHg and 68.71 +/- 19.39mmHg respectively. Bivariate analysis identified age, gender, education, duration of hypertension, WC and BMI being factors influencing the achieved levels of BP. Adjusted multiple linear regression models elicited positive associations of age (beta(a) = 0.152, p = 0.001) and duration of hypertension (beta(a) = 0.132, p = 0.003) with achieved level of SBP as well as BMI (beta(a) = 0.135, p = 0.002) with DBP. Age (beta(a) = 0.207, p < 0.001) and WHtR (beta(a) = 0.304, p = 0.005) were positively and WC (beta(a) = -0.406, p < 0.001) was negatively associated with PPI. Increasing age (beta(a) = -0.125, p = 0.005), female gender (beta(a) = -0.122, p = 0.005) and 5years' duration of hypertension (beta(a) = -0.091, p < 0.039) were negatively associated with ABI. After adjustment for socio- demographic variables, hypertensive patients with (reference = without) abdominal obesity had 93% (p = 0.013) higher odds of missing the target BP control. Conclusion Anthropometric measures and indicators for blood pressure control among Kazakh-Chinese patients were far beyond normal. Several anthropometric measures appeared useful for monitoring BP. Using them, regular screening and consequent targeted intervention were required urgently to control hypertension among Kazakh- Chinese.	[Zhang, Qinghua; Guo, Yufang; Wang, Anni; Zhang, Liuyi; Zhang, Jingping] Cent South Univ, Xiang Ya Nursing Sch, Changsha, Hunan, Peoples R China; [Zhang, Qinghua] Xinjiang Med Univ, Sch Nursing, Urumqi, Xinjiang, Peoples R China; [Mahapatra, Tanmay] Univ Calif Los Angeles, Los Angeles, CA USA; [Huang, Feifei] Fujian Med Univ, Sch Nursing, Fuzhou, Fu Jian, Peoples R China; [Tang, Weiming; Tang, Songyuan] Univ North Carolina Project China, Guangzhou, Guangdong, Peoples R China; [Lei, Yang] Chinese Univ Hong Kong, Nethersole Sch Nursing, Hong Kong, Hong Kong, Peoples R China; [Feng, Lei] Peoples Hosp Xinjiang Uyghur Autonomous Reg, Dept Med, Urumqi, Xinjiang, Peoples R China	Central South University; Xinjiang Medical University; University of California System; University of California Los Angeles; Fujian Medical University; Chinese University of Hong Kong	Zhang, JP (corresponding author), Cent South Univ, Xiang Ya Nursing Sch, Changsha, Hunan, Peoples R China.	jpzhang1965@163.com	Anni, Wang/AAH-5183-2019; Zhang, Jingping/ABA-4179-2020	Anni, Wang/0000-0003-3109-7514; Zhang, Jingping/0000-0002-7800-9617	Fundamental Research Funds for the Central South University [2013zzts079]; Research Funds of Humanities & Social Science from the Ministry of Education of the People's Republic of China [15YJCZH223]	Fundamental Research Funds for the Central South University; Research Funds of Humanities & Social Science from the Ministry of Education of the People's Republic of China	This study was supported by the Fundamental Research Funds for the Central South University (number 2013zzts079) and the Research Funds of Humanities & Social Science from the Ministry of Education of the People's Republic of China (number 15YJCZH223) to Qinghua Zhang. The funders had role in study design, data collection, analysis, preparation of the manuscript and decision regarding submission for publication of the article.	Aekplakorn W, 2006, INT J OBESITY, V30, P1782, DOI 10.1038/sj.ijo.0803346; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Alsuwaida A, 2011, CLIN EXP HYPERTENS, V33, P354, DOI 10.3109/10641963.2010.531857; Armstrong C, 2014, AM FAM PHYSICIAN, V90, P503; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Cai AP, 2015, CLIN EXP HYPERTENS, V37, P267, DOI 10.3109/10641963.2014.954713; Criqui MH, 2010, J AM COLL CARDIOL, V56, P1506, DOI 10.1016/j.jacc.2010.04.060; Moraes Suzana Alves de, 2015, Rev. bras. epidemiol., V18, P157, DOI 10.1590/1980-5497201500010013; ESH/ESC, 2013, BLOOD PRESSURE, V22, P193, DOI DOI 10.3109/08037051.2013.812549; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Jayawardana R, 2013, DIABETES RES CLIN PR, V99, P292, DOI 10.1016/j.diabres.2012.12.013; Lamina C, 2006, EUR HEART J, V27, P2580, DOI 10.1093/eurheartj/ehl228; Lee WH, 2014, AM J HYPERTENS, V27, P454, DOI 10.1093/ajh/hpt228; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Li YC, 2014, J AM COLL CARDIOL, V64, pC96; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu Cheng, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P1139; Liu F, 2014, J AM COLL CARDIOL, V64, pC96; Liu Fen, 2010, Zhonghua Yi Xue Za Zhi, V90, P3259; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Mancia G, 2013, J HYPERTENS, V31, P1925, DOI 10.1097/HJH.0b013e328364ca4c; Maximova K, 2011, J HYPERTENS, V29, P2075, DOI 10.1097/HJH.0b013e32834be614; Mello RB, 2011, CIRCULATION, V124; Mi YJ, 2015, AM J PREV MED, V49, P661, DOI 10.1016/j.amepre.2015.05.005; [倪平 NI Pin], 2010, [中华护理杂志, Chinese Journal of Nursing], V45, P378; Nyamdorj R, 2008, J HYPERTENS, V26, P866, DOI 10.1097/HJH.0b013e3282f624b7; Park SH, 2013, J AM SOC HYPERTENS, V7, P420, DOI 10.1016/j.jash.2013.06.002; Pasqualini L, 2012, EUR J INTERN MED, V23, P240, DOI 10.1016/j.ejim.2011.09.004; Peng-Lin Y, 2009, MED HYPOTHESES, V72, P729, DOI 10.1016/j.mehy.2008.12.041; Perkovic V, 2007, HYPERTENSION, V50, P991, DOI 10.1161/HYPERTENSIONAHA.107.095497; Rodea-Montero ER, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/195407; Redon J, 2008, J HYPERTENS, V26, P1757, DOI 10.1097/HJH.0b013e3283077f03; Resnick HE, 2004, CIRCULATION, V109, P733, DOI 10.1161/01.CIR.0000112642.63927.54; Rivera-Soto WT, 2016, P R HEALTH SCI J, V35, P20; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Taylor BC, 2011, J GEN INTERN MED, V26, P685, DOI 10.1007/s11606-011-1660-6; Wang XD, 2015, J AM COLL CARDIOL, V66, pC205, DOI 10.1016/j.jacc.2015.06.783; Yalcin BM, 2005, FAM PRACT, V22, P541, DOI 10.1093/fampra/cmi043	40	6	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170959	10.1371/journal.pone.0170959	http://dx.doi.org/10.1371/journal.pone.0170959			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129402	Green Published, gold, Green Submitted			2022-12-27	WOS:000396211400021
J	Escoriza, D; Ben Hassine, J				Escoriza, Daniel; Ben Hassine, Jihene			Diversity of Guilds of Amphibian Larvae in North-Western Africa	PLOS ONE			English	Article							FUNCTIONAL DIVERSITY; SPECIES RICHNESS; PHYLOGENETIC-RELATIONSHIPS; AGRICULTURAL LANDSCAPE; ECOLOGICAL DATA; HABITAT; CLIMATE; PONDS; FROG; BIODIVERSITY	The composition and diversity of biotic assemblages is regulated by a complex interplay of environmental features. We investigated the influence of climate and the aquatic habitat conditions on the larval traits and the structure of amphibian larval guilds in north-western Africa. We classified the species into morphological groups, based on external traits: body shape, size, and the relative positions of the eyes and oral apparatus. We characterized the guild diversity based on species richness and interspecific phylogenetic/functional relationships. The larvae of the urodeles were classified as typical of either the stream or pond type, and the anurans as typical of either the lentic-benthic or lentic-nektonic type. The variations in the body shapes of both urodeles and anurans were associated with the type of aquatic habitat (lentic vs lotic) and the types of predators present. Most of the urodele guilds (98.9%) contained a single species, whereas the anuran guilds were usually more diverse. Both the phylogenetic and functional diversity of the anuran guilds were positively influenced by the size of the aquatic habitat and negatively by aridity. In anurans, the benthic and nektonic morphological types frequently co-occurred, possibly influenced by their opportunistic breeding strategies.	[Escoriza, Daniel] Univ Girona, Inst Aquat Ecol, GRECO, Campus Montilivi, Girona, Spain; [Ben Hassine, Jihene] Univ Tunis El Manar, Fac Sci Tunis, Tunis, Tunisia; [Ben Hassine, Jihene] Univ Abdelmalek Essaadi, Fac Sci Tetouan, Lab Ecol Biodivers & Environm, El Mhannech II, Tetouan, Morocco	Universitat de Girona; Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); Abdelmalek Essaadi University of Tetouan	Escoriza, D (corresponding author), Univ Girona, Inst Aquat Ecol, GRECO, Campus Montilivi, Girona, Spain.	daniel_escoriza@hotmail.com	Escoriza, Daniel/AAP-9813-2021	Escoriza, Daniel/0000-0002-6853-0134	Mohamed Bin Zayed Conservation funding [140510038]	Mohamed Bin Zayed Conservation funding	The authors received a Mohamed Bin Zayed Conservation funding (project number= 140510038) for this work.	ALTIG R, 1989, HERPETOL MONOGR, V3, P81, DOI [DOI 10.2307/1466987, 10.2307/1466987]; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2010, SALAMANDERS US CANAD; Azeroual A., 2003, THESIS; Babbitt KJ, 2003, CAN J ZOOL, V81, P1539, DOI 10.1139/Z03-131; Beja P, 2003, BIOL CONSERV, V114, P317, DOI 10.1016/S0006-3207(03)00051-X; Ben Hassine Jihene, 2014, Herpetological Bulletin, P22; Ben Hassine Jihene, 2014, Herpetological Review, V45, P193; Ben Hassine J, 2012, REV ECOL-TERRE VIE, V67, P437; Bons J., 1996, AMPHIBIANS REPTILES; Both C, 2009, HYDROBIOLOGIA, V624, P125, DOI 10.1007/s10750-008-9685-5; Buisson L, 2013, GLOBAL CHANGE BIOL, V19, P387, DOI 10.1111/gcb.12056; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cadotte MW, 2012, ECOLOGY, V93, pS223, DOI 10.1890/11-0426.1; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Cantonati M, 2006, HYDROBIOLOGIA, V562, P59, DOI 10.1007/s10750-005-1806-9; Caut S, 2013, OECOLOGIA, V173, P95, DOI 10.1007/s00442-012-2428-3; Cheddadi R, 1998, CLIM DYNAM, V14, P883, DOI 10.1007/s003820050262; Cox N, 1996, STATUS DISTRIBUTION; Cruz MJ, 2005, AMPHIBIA-REPTILIA, V26, P293, DOI 10.1163/156853805774408577; Davidson C, 2001, ECOL APPL, V11, P464, DOI 10.1890/1051-0761(2001)011[0464:DOTCRL]2.0.CO;2; Della Bella V, 2008, HYDROBIOLOGIA, V597, P85, DOI 10.1007/s10750-007-9216-9; DIAZ-PANIAGUA C, 1988, Amphibia-Reptilia, V9, P15, DOI 10.1163/156853888X00161; Doledec S, 2000, ECOLOGY, V81, P2914, DOI 10.1890/0012-9658(2000)081[2914:NSICAA]2.0.CO;2; Dray S., 2007, R NEWS, V7, P47; El Garouani A, 2006, IAHS-AISH P, V308, P447; El Qoraychy Ikram, 2015, AACL Bioflux, V8, P751; Ernst R, 2006, BIOL CONSERV, V133, P143, DOI 10.1016/j.biocon.2006.05.028; Escoriza D, 2006, AMPHIBIA-REPTILIA, V27, P448, DOI 10.1163/156853806778190042; Escoriza D., 2015, THESIS; ESCORIZA D, 2013, THE HERPETOLOGICAL B, V125, P10; Escoriza D, 2016, CONSERV GENET, V17, P1445, DOI 10.1007/s10592-016-0875-9; Escoriza D, 2015, J HERPETOL, V49, P276, DOI 10.1670/13-151; Escoriza D, 2014, AFR J HERPETOL, V63, P152, DOI 10.1080/21564574.2014.948079; Escoriza D, 2014, BIOL CONSERV, V176, P252, DOI 10.1016/j.biocon.2014.05.030; Eterovick PC, 2000, AMPHIBIA-REPTILIA, V21, P439, DOI 10.1163/156853800300059331; Fauth JE, 1996, AM NAT, V147, P282, DOI 10.1086/285850; FOX BJ, 1981, ECOLOGY, V62, P1415, DOI 10.2307/1941497; GALLIEN L., 1957, BULL BIOL FRANCE ET BELGIQUE, V91, P97; Gasc J. P., 1997, ATLAS AMPHIBIANS REP; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; Gorley C.K., 2006, GETTING STARTED PRIM; Gosner K. L., 1960, Herpetologica, V16, P183; Graham CH, 2006, P NATL ACAD SCI USA, V103, P632, DOI 10.1073/pnas.0505754103; GRILLITSCH B, 1989, Amphibia-Reptilia, V10, P215, DOI 10.1163/156853889X00395; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hazell D, 2001, BIOL CONSERV, V102, P155, DOI 10.1016/S0006-3207(01)00096-9; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hedges SB, 2015, MOL BIOL EVOL, V32, P835, DOI 10.1093/molbev/msv037; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Iwata H, 2002, J HERED, V93, P384, DOI 10.1093/jhered/93.5.384; Iwata H., 2002, SHAPE VERSION 1 3; Kerr JT, 1997, NATURE, V385, P252, DOI 10.1038/385252a0; Kulkarni SS, 2011, J EVOLUTION BIOL, V24, P2445, DOI 10.1111/j.1420-9101.2011.02370.x; Laliberte E, 2010, ECOL LETT, V13, P76, DOI 10.1111/j.1461-0248.2009.01403.x; Lanza B, 2007, FAUNA DLTALIA; Lardner B, 2000, OIKOS, V88, P169, DOI 10.1034/j.1600-0706.2000.880119.x; Legendre P, 1997, ECOLOGY, V78, P547; Martinez-Solano I, 2004, J BIOGEOGR, V31, P603, DOI 10.1046/j.1365-2699.2003.01033.x; McCollum SA, 1997, OECOLOGIA, V109, P615, DOI 10.1007/s004420050124; McDiarmid R. W., 1999, TADPOLES BIOL ANURAN; Morgan L. A., 1996, Australian Zoologist, V30, P143; NASA (National Aeronautics and Space Administration), 2016, ADV SPAC THERM EM RE; NEWMAN RA, 1988, EVOLUTION, V42, P774, DOI 10.1111/j.1558-5646.1988.tb02495.x; Pavoine S, 2008, THEOR POPUL BIOL, V73, P79, DOI 10.1016/j.tpb.2007.10.001; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Peltzer PM, 2006, BIODIVERS CONSERV, V15, P3499, DOI 10.1007/s10531-004-2940-9; Peltzer PM, 2004, BIODIVERS CONSERV, V13, P1833, DOI 10.1023/B:BIOC.0000035870.36495.fc; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rasband WS., 2015, IMAGEJ VS 1 50; RCore Team, 2020, R LANG ENV STAT COMP; Recuero E, 2012, MOL PHYLOGENET EVOL, V62, P71, DOI 10.1016/j.ympev.2011.09.008; Recuero E, 2007, J BIOGEOGR, V34, P1207, DOI 10.1111/j.1365-2699.2007.01688.x; Rhazi L, 2009, HYDROBIOLOGIA, V634, P185, DOI 10.1007/s10750-009-9893-7; Rodriguez-Sanchez F, 2008, GLOBAL ECOL BIOGEOGR, V17, P685, DOI 10.1111/j.1466-8238.2008.00410.x; ROSENZWEIG ML, 1970, ECOLOGY, V51, P217, DOI 10.2307/1933657; Sandel B, 2011, SCIENCE, V334, P660, DOI 10.1126/science.1210173; SCHLEICH H. H., 1996, AMPHIBIANS REPTILES; Schleuter D, 2010, ECOL MONOGR, V80, P469, DOI 10.1890/08-2225.1; Skelly DK, 1997, AM SCI, V85, P36; Srivastava DS, 2012, ECOL LETT, V15, P637, DOI 10.1111/j.1461-0248.2012.01795.x; Strauss Axel, 2010, BMC Ecology, V10, P12, DOI 10.1186/1472-6785-10-12; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Suzuki R., 2016, PVCLUST HIERARCHICAL; Tachet H., 2010, INVERTEBRES EAU DOUC, V15; Tingley R, 2009, J BIOGEOGR, V36, P1656, DOI 10.1111/j.1365-2699.2009.02117.x; Trabucco A, 2015, GLOBAL INDEX ARIDITY; USSEGLIOPOLATERA P, 1994, FRESHWATER BIOL, V31, P417, DOI 10.1111/j.1365-2427.1994.tb01749.x; Valentine B. D., 1964, Copeia, V1964, P196, DOI 10.2307/1440850; Van Buskirk J, 2009, ECOL MONOGR, V79, P681, DOI 10.1890/08-1692.1; WARINGER-LOSCHENKOHL A, 1988, Amphibia-Reptilia, V9, P219, DOI 10.1163/156853888X00314; Wassens S, 2013, HYDROBIOLOGIA, V708, P69, DOI 10.1007/s10750-011-0955-2; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; Wells K.D., 2007, ECOLOGY BEHAV AMPHIB, DOI 10.7208/chicago/9780226893334.001.0001; Werner EE, 2007, OIKOS, V116, P1697, DOI 10.1111/j.2007.0030-1299.15935.x; Williams P, 2004, BIOL CONSERV, V115, P329, DOI 10.1016/S0006-3207(03)00153-8; Wilson RS, 2000, PHYSIOL BIOCHEM ZOOL, V73, P142, DOI 10.1086/316730	97	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170763	10.1371/journal.pone.0170763	http://dx.doi.org/10.1371/journal.pone.0170763			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125660	Green Published, gold, Green Submitted			2022-12-27	WOS:000396176100059
J	Gordoa, A; Carreras, G; Sanz, N; Vinas, J				Gordoa, Ana; Carreras, Gustavo; Sanz, Nuria; Vinas, Jordi			Tuna Species Substitution in the Spanish Commercial Chain: A Knock-On Effect	PLOS ONE			English	Article							BLUEFIN TUNA; GENETIC IDENTIFICATION; DNA; FISH; SEAFOOD; HAKE; METHODOLOGY; TECHNOLOGY; PRODUCTS; ATLANTIC	Intentional mislabelling of seafood is a widespread problem, particularly with high-value species like tuna. In this study we examine tuna mislabelling, deliberate species substitution, types of substitution and its impact on prices. The survey covered the commercial chain, from Merca-Barna to fishmongers and restaurants in the Spanish Autonomous Community of Catalonia. To understand the geographic extent of the problem we also sampled Merca-Madrid, Europe's biggest fish market, and Merca-Malaga for its proximity to the bluefin tuna migratory route and trap fishery. Monthly surveys were carried out over one year. The results showed a high deficiency in labelling: 75% of points of sale and 83% of restaurants did not specify the species, and in those cases the name of the species had to be asked. A total of 375 samples were analysed genetically, the largest dataset gathered in Europe so far. The identified species were Thunnus albacares, Thunnus thynnus and Thunnus obesus. Species substitution began at suppliers, with 40% of observed cases, increasing to 58% at fishmongers and 62% at restaurants. The substitution was mainly on bluefin tuna (T. thynnus), 73% of cases. At restaurants, only during the bluefin fishing season, we observed a decrease of Bluefin tuna substitution and an increase of reverse substitution revealing some illegal fishing. The effect of species substitution on species prices was relevant: T. obesus increased its price by around sic 12 kg(-1) when it was sold as bluefin. In view of the deficiency of labelling, the abuse of generic names and the lack of the bluefin catch document, we conclude that the Spanish regulations are ineffective, highlighting the need for policy execution, and the urgent need for information campaigns to Spanish consumers.	[Gordoa, Ana; Carreras, Gustavo] CSIC, Ctr Estudios Avanzados Blanes, Dept Marine Ecol, Blanes, Girona, Spain; [Sanz, Nuria; Vinas, Jordi] Univ Girona, Fac Sci, Dept Biol, Lab Genet Ichthyol, Girona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Universitat de Girona	Gordoa, A (corresponding author), CSIC, Ctr Estudios Avanzados Blanes, Dept Marine Ecol, Blanes, Girona, Spain.	gordoa@ceab.csic.es	Sanz, Nuria/L-3074-2014; Viñas, Jordi/A-5397-2010	Sanz, Nuria/0000-0001-5274-1917; Viñas, Jordi/0000-0003-0193-1141	Balfego Group; Blanes Centre for Advanced Study (CEAB - CSIC)	Balfego Group; Blanes Centre for Advanced Study (CEAB - CSIC)	The study was funded by the Balfego Group under a programme of scientific cooperation with the Blanes Centre for Advanced Study (CEAB - CSIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2013, OFFICIAL J EUROPEAN; [Anonymous], 2001, GLOB COMM UPD TUN; Asensio L, 2008, FOOD ADDIT CONTAM A, V25, P677, DOI 10.1080/02652030701765731; Barbuto M, 2010, FOOD RES INT, V43, P376, DOI 10.1016/j.foodres.2009.10.009; BARTLETT SE, 1992, BIOTECHNIQUES, V12, P408; Becker S, 2011, MITOCHONDR DNA, V22, P3, DOI 10.3109/19401736.2010.535528; Benard-Capelle J, 2015, PEERJ, V2, DOI 10.7717/peerj.714; BOSE S, 1996, MARINE RESOURCE EC, V11, P143, DOI DOI 10.1086/MRE.11.3.42629157; Bostock T, 1985, PESCA UTILIZACION TI; Chow S, 2006, J FISH BIOL, V68, P24, DOI 10.1111/j.0022-1112.2006.00945.x; Cohen NJ, 2009, J FOOD PROTECT, V72, P810, DOI 10.4315/0362-028X-72.4.810; Collette BB, 2011, SCIENCE, V333, P291, DOI 10.1126/science.1208730; Crego-Prieto V, 2010, MISLABELLING MEGRIMS; Curran K, 2009, CHANDOS INTERNET SER, P261; DARBY MR, 1973, J LAW ECON, V16, P67, DOI 10.1086/466756; FAO, 2010, GLOB TUN CATCH STOCK; FAO, 2016, CONTRIBUTING FOOD SE; Filonzi L, 2010, FOOD RES INT, V43, P1383, DOI 10.1016/j.foodres.2010.04.016; Galimberti A, 2013, FOOD RES INT, V50, P55, DOI 10.1016/j.foodres.2012.09.036; Garcia-Vazquez E, 2011, J AGR FOOD CHEM, V59, P475, DOI 10.1021/jf103754r; Garcia-Vazquez E, 2009, T AM FISH SOC, V138, P790, DOI 10.1577/T08-169.1; Garrett A, 2010, YELLOWFIN TUNA GLOBA; Holmes BH, 2009, FISH RES, V95, P280, DOI 10.1016/j.fishres.2008.09.036; HSIEH YHP, 1995, J FOOD QUALITY, V18, P131, DOI 10.1111/j.1745-4557.1995.tb00368.x; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Jacquet JL, 2008, MAR POLICY, V32, P309, DOI 10.1016/j.marpol.2007.06.007; Jennings S, 2016, FISH FISH, V17, P893, DOI 10.1111/faf.12152; Johannes RE, 1998, TRENDS ECOL EVOL, V13, P243, DOI 10.1016/S0169-5347(98)01384-6; Khaksar R, 2015, FOOD CONTROL, V56, P71, DOI 10.1016/j.foodcont.2015.03.007; Lamendin R, 2015, FOOD CONTROL, V47, P436, DOI 10.1016/j.foodcont.2014.07.039; Ling MP, 2009, B ENVIRON CONTAM TOX, V83, P558, DOI 10.1007/s00128-009-9829-y; Lowenstein JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007866; Machado-Schiaffino G, 2008, J AGR FOOD CHEM, V56, P5091, DOI 10.1021/jf800207t; Marko PB, 2004, NATURE, V430, P309, DOI 10.1038/430309b; Mejuto J, 2014, IND PESQUERAS REV MA, P36; Miller DD, 2010, FRONT ECOL ENVIRON, V8, P517, DOI 10.1890/090212; Paquotte P., 2003, Cahiers Options Mediterraneennes, V60, P159; Pascoal A, 2008, ELECTROPHORESIS, V29, P499, DOI 10.1002/elps.200700406; Perez J, 2004, J FOOD PROTECT, V67, P2792, DOI 10.4315/0362-028X-67.12.2792; Rasmussen RS, 2009, COMPR REV FOOD SCI F, V8, P118, DOI 10.1111/j.1541-4337.2009.00073.x; Ravier C, 2001, ICES J MAR SCI, V58, P1299, DOI 10.1006/jmsc.2001.1119; Reglero P, 2013, SCI MAR, V77, P585, DOI 10.3989/scimar.03759.28A; Rodriguez-Roda J., 1967, INVETIGACION PESQUER, V31, P11; Rooker JR, 2008, MAR ECOL PROG SER, V368, P231, DOI 10.3354/meps07602; Smith PJ, 2008, J FISH BIOL, V72, P464, DOI 10.1111/j.1095-8649.2007.01745.x; Steinke D, 2009, MAR BIOL, V156, P2641, DOI 10.1007/s00227-009-1284-0; Streicher-Porte M., 2011, GREENING CHINAS FISH; Vinas J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007606; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Warner K., 2013, OCEANA STUDY REVEALS; Wen J, 2011, FOOD CONTROL, V22, P72, DOI 10.1016/j.foodcont.2010.06.010; Wong EHK, 2008, FOOD RES INT, V41, P828, DOI 10.1016/j.foodres.2008.07.005; Woolfe M, 2004, TRENDS BIOTECHNOL, V22, P222, DOI 10.1016/j.tibtech.2004.03.010; Xiong X, 2016, FOOD CONTROL, V60, P519, DOI 10.1016/j.foodcont.2015.08.028	55	28	28	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170809	10.1371/journal.pone.0170809	http://dx.doi.org/10.1371/journal.pone.0170809			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125686	Green Submitted, Green Published, gold			2022-12-27	WOS:000396176100046
J	Makker, PGS; Duffy, SS; Lees, JG; Perera, CJ; Tonkin, RS; Butovsky, O; Park, SB; Goldstein, D; Moalem-Taylor, G				Makker, Preet G. S.; Duffy, Samuel S.; Lees, Justin G.; Perera, Chamini J.; Tonkin, Ryan S.; Butovsky, Oleg; Park, Susanna B.; Goldstein, David; Moalem-Taylor, Gila			Characterisation of Immune and Neuroinflammatory Changes Associated with Chemotherapy-Induced Peripheral Neuropathy	PLOS ONE			English	Article							REGULATORY T-CELLS; DORSAL-ROOT GANGLIA; INDUCED MECHANICAL ALLODYNIA; SATELLITE GLIAL-CELLS; NERVE INJURY; SPINAL-CORD; SENSORY NEURONS; MACROPHAGE INFILTRATION; PACLITAXEL; PAIN	Chemotherapy-induced peripheral neuropathy (CIPN) and associated neuropathic pain is a debilitating adverse effect of cancer treatment. Current understanding of the mechanisms underpinning CIPN is limited and there are no effective treatment strategies. In this study, we treated male C57BL/6J mice with 4 cycles of either Paclitaxel (PTX) or Oxaliplatin (OXA) over a week and tested pain hypersensitivity and changes in peripheral immune responses and neuroinflammation on days 7 and 13 post 1 st injection. We found that both PTX and OXA caused significant mechanical allodynia. In the periphery, PTX and OXA significantly increased circulating CD4+ and CD8+ T-cell populations. OXA caused a significant increase in the percentage of interleukin-4+ lymphocytes in the spleen and significant down-regulation of regulatory T (T-reg) cells in the inguinal lymph nodes. However, conditional depletion of T-reg cells in OXA-treated transgenic DEREG mice had no additional effect on pain sensitivity. Furthermore, there was no leukocyte infiltration into the nervous system of OXA-or PTX-treated mice. In the peripheral nervous system, PTX induced expression of the neuronal injury marker activating transcription factor-3 in IB4+ and NF200+sensory neurons as well as an increase in the chemokines CCL2 and CCL3 in the lumbar dorsal root ganglion. In the central nervous system, PTX induced significant astrocyte activation in the spinal cord dorsal horn, and both PTX and OXA caused reduction of P2ry12+homeostatic microglia, with no measurable changes in IBA-1+ microglia/macrophages in the dorsal and ventral horns. We also found that PTX induced up-regulation of several inflammatory cytokines and chemokines (TNF-alpha, IFN-beta, CCL11, CCL4, CCL3, IL-12p70 and GM-CSF) in the spinal cord. Overall, these findings suggest that PTX and OXA cause distinct pathological changes in the periphery and nervous system, which may contribute to chemotherapy-induced neuropathic pain.	[Makker, Preet G. S.; Duffy, Samuel S.; Lees, Justin G.; Perera, Chamini J.; Tonkin, Ryan S.; Moalem-Taylor, Gila] Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia; [Butovsky, Oleg] Harvard Med Sch, Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, Boston, MA USA; [Park, Susanna B.] Univ Sydney, Sydney Med Sch, Brain & Mind Ctr, Sydney, NSW, Australia; [Goldstein, David] Prince Wales Hosp, Dept Med Oncol, Randwick, NSW, Australia	University of New South Wales Sydney; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Sydney	Moalem-Taylor, G (corresponding author), Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia.	gila@unsw.edu.au	Moalem-Taylor, Gila/C-3116-2008; goldstein, david/J-6711-2012; Butovsky, Oleg/ABG-9086-2020	Moalem-Taylor, Gila/0000-0003-3828-9527; Butovsky, Oleg/0000-0003-0186-8867; Lees, Justin/0000-0002-0874-2856	Cancer Institute NSW Translational Program Grant Chemotherapy-induced Peripheral Neuropathy: Assessment strategies, Treatment and Risk Factors [14/TPG/1-05]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088137] Funding Source: NIH RePORTER	Cancer Institute NSW Translational Program Grant Chemotherapy-induced Peripheral Neuropathy: Assessment strategies, Treatment and Risk Factors; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the Cancer Institute NSW Translational Program Grant Chemotherapy-induced Peripheral Neuropathy: Assessment strategies, Treatment and Risk Factors (ID # 14/TPG/1-05; http://www.cancerinstitute.org.au) awarded to DG, SP and GMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcindor T, 2011, CURR ONCOL, V18, P18; ALOISI F, 1995, INT J DEV NEUROSCI, V13, P265, DOI 10.1016/0736-5748(94)00071-A; Argyriou AA, 2014, CANCER MANAG RES, V6, P135, DOI 10.2147/CMAR.S44261; Austin PJ, 2012, PAIN, V153, P1916, DOI 10.1016/j.pain.2012.06.005; Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; Boyette-Davis JA, 2013, CANCER CHEMOTH PHARM, V71, P619, DOI 10.1007/s00280-012-2047-z; Braz JM, 2010, PAIN, V150, P290, DOI 10.1016/j.pain.2010.05.005; Butovsky O, 2015, ANN NEUROL, V77, P75, DOI 10.1002/ana.24304; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Cook DN, 1996, J LEUKOCYTE BIOL, V59, P61, DOI 10.1002/jlb.59.1.61; Costigan M, 2009, J NEUROSCI, V29, P14415, DOI 10.1523/JNEUROSCI.4569-09.2009; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; DIXON WJ, 1965, J AM STAT ASSOC, V60, P967, DOI 10.2307/2283398; Dougherty PM, 2004, PAIN, V109, P132, DOI 10.1016/j.pain.2004.01.021; Elson K, 2003, J GEN VIROL, V84, P1079, DOI 10.1099/vir.0.19035-0; Fehrenbacher JC, 2015, PROG MOL BIOL TRANSL, V131, P471, DOI 10.1016/bs.pmbts.2014.12.002; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gornstein E, 2014, NEUROPHARMACOLOGY, V76, P175, DOI 10.1016/j.neuropharm.2013.08.016; GREGG RW, 1992, J CLIN ONCOL, V10, P795, DOI 10.1200/JCO.1992.10.5.795; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Jamieson SMF, 2007, NEUROTOXICOLOGY, V28, P1092, DOI 10.1016/j.neuro.2007.04.009; Janes K, 2015, BRAIN BEHAV IMMUN, V44, P91, DOI 10.1016/j.bbi.2014.08.010; Janes K, 2014, PAIN, V155, P2560, DOI 10.1016/j.pain.2014.09.016; Jin XC, 2006, J NEUROSCI, V26, P246, DOI 10.1523/JNEUROSCI.3858-05.2006; Kiguchi N, 2010, NEUROSCI LETT, V484, P17, DOI 10.1016/j.neulet.2010.07.085; Kim CF, 2011, BRAIN RES, V1405, P95, DOI 10.1016/j.brainres.2011.06.022; Kim D, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-74; Knerlich-Lukoschus F, 2011, J NEUROSURG-SPINE, V14, P583, DOI 10.3171/2010.12.SPINE10480; Krishnan AV, 2005, MUSCLE NERVE, V32, P51, DOI 10.1002/mus.20340; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Ledeboer A, 2007, BRAIN BEHAV IMMUN, V21, P686, DOI 10.1016/j.bbi.2006.10.012; Lees JG, 2015, CYTOKINE, V71, P207, DOI 10.1016/j.cyto.2014.10.028; Li Y, 2015, BRAIN BEHAV IMMUN, V49, P255, DOI 10.1016/j.bbi.2015.06.003; Li YJ, 2014, SUSTAIN ENERGY TECHN, V6, P25, DOI 10.1016/j.seta.2014.01.003; Liaw WJ, 2005, PAIN, V115, P60, DOI 10.1016/j.pain.2005.02.006; Liu FY, 2012, BRAIN RES, V1427, P65, DOI 10.1016/j.brainres.2011.10.016; Liu N, 2011, INT IMMUNOPHARMACOL, V11, P212, DOI 10.1016/j.intimp.2010.11.021; Liu XJ, 2014, CELL RES, V24, P1374, DOI 10.1038/cr.2014.106; Mannelli LD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128080; Mannelli LD, 2013, J PAIN, V14, P1585, DOI 10.1016/j.jpain.2013.08.002; McWhinney SR, 2009, MOL CANCER THER, V8, P10, DOI 10.1158/1535-7163.MCT-08-0840; Menten P, 2002, CYTOKINE GROWTH F R, V13, P455, DOI 10.1016/S1359-6101(02)00045-X; Mika J, 2013, EUR J PHARMACOL, V716, P106, DOI 10.1016/j.ejphar.2013.01.072; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Moalem G, 2004, NEUROSCIENCE, V129, P767, DOI 10.1016/j.neuroscience.2004.08.035; Moalem G, 2006, BRAIN RES REV, V51, P240, DOI 10.1016/j.brainresrev.2005.11.004; Nie H, 2009, J NEUROPHYSIOL, V101, P2041, DOI 10.1152/jn.91138.2008; Ochi-ishi R, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-53; Park SB, 2013, CA-CANCER J CLIN, V63, P419, DOI 10.3322/caac.21204; Peters CM, 2007, BRAIN RES, V1168, P46, DOI 10.1016/j.brainres.2007.06.066; Peters CM, 2007, EXP NEUROL, V203, P42, DOI 10.1016/j.expneurol.2006.07.022; Robinson CR, 2014, NEUROSCIENCE, V274, P308, DOI 10.1016/j.neuroscience.2014.05.051; SAHENK Z, 1994, ARCH NEUROL-CHICAGO, V51, P726, DOI 10.1001/archneur.1994.00540190110024; Saika F, 2012, EUR J PAIN, V16, P1271, DOI 10.1002/j.1532-2149.2012.00146.x; Sandireddy R, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/674987; Seretny M, 2014, PAIN, V155, P2461, DOI 10.1016/j.pain.2014.09.020; Smith SB, 2004, LIFE SCI, V74, P2593, DOI 10.1016/j.lfs.2004.01.002; Ta LE, 2006, NEUROTOXICOLOGY, V27, P992, DOI 10.1016/j.neuro.2006.04.010; Takahashi T, 2003, CURR MOL MED, V3, P693, DOI 10.2174/1566524033479429; Takeda M, 2007, PAIN, V129, P155, DOI 10.1016/j.pain.2006.10.007; Wang XM, 2012, CYTOKINE, V59, P3, DOI 10.1016/j.cyto.2012.03.027; Warwick RA, 2013, EUR J PAIN, V17, P571, DOI 10.1002/j.1532-2149.2012.00219.x; Weir Genevieve M, 2011, Cancers (Basel), V3, P3114, DOI 10.3390/cancers3033114; Whitehead KJ, 2010, BRAIN BEHAV IMMUN, V24, P569, DOI 10.1016/j.bbi.2009.12.007; Wolf S, 2008, EUR J CANCER, V44, P1507, DOI 10.1016/j.ejca.2008.04.018; Xiao WH, 2012, NEUROSCIENCE, V203, P194, DOI 10.1016/j.neuroscience.2011.12.023; Yoon SY, 2013, J PAIN, V14, P205, DOI 10.1016/j.jpain.2012.11.002; Zhang H, 2016, J PAIN OFFICIAL J AM; Zhang H, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-182; Zhang H, 2012, J NANOMATER, V2012, DOI [10.1155/2012/217412, 10.1186/2049-1891-3-26]; Zhang L, 2008, CLIN IMMUNOL, V129, P219, DOI 10.1016/j.clim.2008.07.013; Zhu Y, 2011, SCAND J IMMUNOL, V73, P301, DOI 10.1111/j.1365-3083.2011.02514.x	73	132	141	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170814	10.1371/journal.pone.0170814	http://dx.doi.org/10.1371/journal.pone.0170814			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125674	Green Published, gold			2022-12-27	WOS:000396176100044
J	Skuhrovec, J; Stejskal, R; Trnka, F; di Giulio, A				Skuhrovec, Jiri; Stejskal, Robert; Trnka, Filip; di Giulio, Andrea			Velcro-Like System Used to Fix a Protective Faecal Shield on Weevil Larvae	PLOS ONE			English	Article							IMMATURE STAGES; PHYLOGENETIC RECONSTRUCTION; BIOLOGY COLEOPTERA; MATURE LARVAE; BIONOMIC DATA; LEAF BEETLES; CURCULIONIDAE; CHRYSOMELIDAE; MORPHOLOGY; GENUS	The last instar larva and pupa of Eucoeliodes mirabilis (A. Villa & G.B. Villa, 1835) (Curculionidae: Ceutorhynchini) are described using drawings and SEM images and are compared and keyed with already described larvae of 58 other ceutorhynchinae taxa. The larval body has an effective combination of morphological adaptations that assist a unique biological defensive strategy. All larval stages of E. mirabilis feed ectophytically on leaves of Euonymus europaeus L. (Celastraceae), and the larval body is covered with a thick faecal shield. The fixation of this protective shield on the larval back is performed by a peculiar dorsal microsculpture composed of a dense carpet of microtrichia on the thorax and abdomen, which serves effectively as a velcro system. Because of this strategy, macrosetae on the larval and pupal body of E. mirabilis are completely reduced. Larvae of E. mirabilis also have distinct morphological adaptations for protecting the spiracles against intrusion of faeces and avoiding occlusion of the tracheal system: a) microtrichia around spiracles are slightly shorter, distinctly stronger and are arranged with high-density and in clusters and b) spiracles are protected by an external safety valve. This strategy of E. mirabilis larvae is unique, although somewhat similar to that of Criocerinae and Blepharida-group leave beetles (Galerucinae) (both Coleoptera: Chrysomelidae), but with distinctly different morphological adaptations.	[Skuhrovec, Jiri] Crop Res Inst, Grp Funct Invertebrate & Plant Biodivers Agroecos, Prague 6, Ruzyne, Czech Republic; [Stejskal, Robert] Adm Podyji Natl Pk, Znojmo, Czech Republic; [Trnka, Filip] Palacky Univ, Dept Ecol & Environm Sci, Fac Sci, Olomouc, Czech Republic; [di Giulio, Andrea] Univ Rome Tre, Dept Sci, Rome, Italy	Czech Crop Research Institute (CRI); Palacky University Olomouc; Italfarmaco; Roma Tre University	Skuhrovec, J (corresponding author), Crop Res Inst, Grp Funct Invertebrate & Plant Biodivers Agroecos, Prague 6, Ruzyne, Czech Republic.	jirislavskuhrovec@gmail.com	Skuhrovec, Jiri/E-9699-2016	Skuhrovec, Jiri/0000-0002-7691-5990	Czech Ministry of Agriculture (Mze OR) [R00416]; Palacky University in Olomouc [IGA_PrF_2015008]	Czech Ministry of Agriculture (Mze OR); Palacky University in Olomouc	A grant from the Czech Ministry of Agriculture (Mze OR) R00416 (JS) and a grant from Palacky University in Olomouc (IGA_PrF_2015008) (FT) supported this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrain FA, 2015, ZOOKEYS, P133, DOI 10.3897/zookeys.547.6098; Aiello A, 2006, J NEW YORK ENTOMOL S, V114, P144, DOI 10.1664/0028-7199(2007)114[144:OPTHSL]2.0.CO;2; ANDERSON DM, 1970, ANN ENTOMOL SOC AM, V63, P296, DOI 10.1093/aesa/63.1.296; Anderson DM, 1992, IMMATURE INSECTS, V2, P594; Borowiec L, 2014, HDB ZOOLOGY ARTHROPO, V3, P198; Chaboo CS, 2008, ZOOL J LINN SOC-LOND, V152, P315, DOI 10.1111/j.1096-3642.2007.00343.x; Chaboo CS, 2007, COLEOPTS BULL, V61, P297, DOI 10.1649/0010-065X(2007)61[297:FEILBN]2.0.CO;2; Chaboo CS, 2016, P ENTOMOL SOC WASH, V118, P150, DOI 10.4289/0013-8797.118.1.150; Chamorro ML, 2014, HBK ZOOL, P230; Chamorro ML, 2014, HBK ZOOL, P226; Colonnelli E., 2013, P176; Colonnelli E., 2004, Catalogue of Ceutorhynchinae of the world, with a key to genera. (Insecta: Coleoptera: Curculionidae); Costa JT, 2004, ETHOLOGY, V110, P515, DOI 10.1111/j.1439-0310.2004.00999.x; Cunningham P., 1980, Entomologist's Monthly Magazine, V115, P243; DAMMAN H, 1991, ECOL ENTOMOL, V16, P163, DOI 10.1111/j.1365-2311.1991.tb00205.x; DIECKMANN L, 1972, Beitraege zur Entomologie, V22, P3; EISNER T, 1967, SCIENCE, V158, P1471, DOI 10.1126/science.158.3807.1471; Gosik R, 2016, ZOOTAXA, V4108, P1, DOI 10.11646/zootaxa.4108.1.1; Gosik R, 2010, DEUT ENTOMOL Z, V57, P203, DOI 10.1002/mmnd.201000017; Gosik Rafal, 2009, Genus (Wroclaw), V20, P137; Gosik Rafal, 2008, Genus (Wroclaw), V19, P103; Gunter NL, 2016, AUSTRAL ENTOMOL, V55, P217, DOI 10.1111/aen.12173; Keefover-Ring K, 2013, CHEMOECOLOGY, V23, P1, DOI 10.1007/s00049-012-0117-7; Lawson FA, 1992, IMMATURE INSECTS, V2, P568; Lee CY, 1996, J FAC AGR KYUSHU U, V40, P307; Lohse GA, 1983, KAFER MITTELEUROPAS, V11, P180; Marvaldi Adriana F., 1999, Acta Zoologica Lilloana, V45, P7; Marvaldi AE, 1998, ENTOMOL SCAND, V29, P89; Marvaldi AE, 2003, REV CHIL HIST NAT, V76, P603; Marvaldi AE, 2002, SYST BIOL, V51, P761, DOI 10.1080/10635150290102465; Marvaldi AE, 2014, HDB ZOOLOGY ARTHROPO, V3, P503; May B.M., 1994, AUSTR WEEVILS COLEOP, V2, P533; MAY BM, 1977, J ROY SOC NEW ZEAL, V7, P189, DOI 10.1080/03036758.1977.10427160; May Brenda M., 1993, Fauna of New Zealand, V28, P1; Morton TC, 1998, J CHEM ECOL, V24, P765, DOI 10.1023/A:1022382931766; Nikulina O. N., 2008, ENTOMOLOGICAL REV, V88, P867, DOI DOI 10.1134/S0013873808070117; Nogueira de Sa Flavia, 2004, Chrysomela, V43.2, P8; Nogueira-de-Sa F, 2005, J TROP ECOL, V21, P189, DOI 10.1017/S0266467404002147; Nogueira-de-Sa F, 2002, ENTOMOL EXP APPL, V104, P203, DOI 10.1023/A:1021217719030; Oberprieler RG, 2014, HDB ZOOLOGY ARTHROPO, P483; Oberprieler RG, 2014, HDB ZOOLOGY ARTHROPO, P452; Oberprieler RG, 2014, HBK ZOOL, P285; Oberprieler RG, 2007, ZOOTAXA, P491; Olmstead KL, 1994, NOVEL ASPECTS BIOL C, P311; Orlova-Bienkowskaya M. Ja., 2005, Russian Entomological Journal, V14, P61; Prathapan KD, 2011, ZOOKEYS, P95, DOI 10.3897/zookeys.157.1472; Prena J, 2014, HBK ZOOL, P577; Price P.W., 2011, P1; Rather M., 1989, Bonner Zoologische Beitraege, V40, P109; Root R.B., 1983, Psyche (Cambridge), V90, P67, DOI 10.1155/1983/47471; Ruxton G. D., 2004, AVOIDING ATTACK; Scherf H., 1964, Abhandlungen der Senckenbergischen Naturforschenden Gesellschaft, V506, P1; Skuhrovec J, 2016, ZOOKEYS, P123, DOI 10.3897/zookeys.589.7847; Skuhrovec J, 2015, ZOOTAXA, V3955, P151, DOI 10.11646/zootaxa.3955.2.1; Skuhrovec J, 2014, ZOOTAXA, V3839, P1, DOI 10.11646/zootaxa.3839.1.1; Smreczynski S, 1974, PODRODZINY CURCULION; Stejskal R, 2014, ACTA ENT MUS NAT PRA, V54, P337; Stuben PE, 2013, SNUDEBILLER, V14, P1; Trnka F, 2015, ZOOTAXA, V4021, P433, DOI 10.11646/zootaxa.4021.3.3; Tzanakakis M. E., 1969, Zeitschrift fuer Angewandte Entomologie, V64, P266; VAYSSIERES J-F, 1986, Nouvelle Revue d'Entomologie, V3, P325; VENCL F. V., 2014, HDB ZOOLOGY ARTHROPO, P237; Vencl FV, 2009, J CHEM ECOL, V35, P281, DOI 10.1007/s10886-008-9577-1; Vencl FV, 1999, ADVANCES IN CHRYSOMELIDAE BIOLOGY 1, P217; Vencl FV, 2005, OECOLOGIA, V145, P404, DOI 10.1007/s00442-005-0138-9; Vig K, 1996, NATURAL HIST ORSEG L, VII, P203; Wanat M., 2011, WEEVIL NEWS, V67, P1; Weiss MR, 2006, ANNU REV ENTOMOL, V51, P635, DOI 10.1146/annurev.ento.49.061802.123212	68	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170800	10.1371/journal.pone.0170800	http://dx.doi.org/10.1371/journal.pone.0170800			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125664	Green Published, gold, Green Submitted			2022-12-27	WOS:000396176100048
J	Purcell, RV; Pearson, J; Aitchison, A; Dixon, L; Frizelle, FA; Keenan, JI				Purcell, Rachel V.; Pearson, John; Aitchison, Alan; Dixon, Liane; Frizelle, Frank A.; Keenan, Jacqueline I.			Colonization with enterotoxigenic Bacteroides fragilis is associated with early-stage colorectal neoplasia	PLOS ONE			English	Article							EPITHELIAL-CELLS; CANCER; MICROBIOTA; INTERLEUKIN-8; INFLAMMATION; PROTEIN; DRIVER	Background Enterotoxigenic Bacteroides fragilis (ETBF) is a toxin-producing bacteria thought to possibly promote colorectal carcinogenesis by modulating the mucosal immune response and inducing epithelial cell changes. Here, we aim to examine the association of colonic mucosal colonization with ETBF and the presence of a range of lesions on the colonic neoplastic spectrum. Methods Mucosal tissue from up to four different colonic sites was obtained from a consecutive series of 150 patients referred for colonoscopy. The presence and relative abundance of the B. fragilis toxin gene (bft) in each tissue sample was determined using quantitative PCR, and associations with clinicopathological characteristics were analysed. Findings We found a high concordance of ETBF between different colonic sites (86%). Univariate analysis showed statistically significant associations between ETBF positivity and the presence of low-grade dysplasia (LGD), tubular adenomas (TA), and serrated polyps (P-values of 0.007, 0.027, and 0.007, respectively). A higher relative abundance of ETBF was significantly associated with LGD and TA (P-values of < 0.0001 and 0.025, respectively). Increased ETBF positivity and abundance was also associated with left-sided biopsies, compared to those from the right side of the colon. Conclusion Our results showing association of ETBF positivity and increased abundance with early-stage carcinogenic lesions underlines its importance in the development of colorectal cancer, and we suggest that detection of ETBF may be a potential marker of early colorectal carcinogenesis.	[Purcell, Rachel V.; Aitchison, Alan; Dixon, Liane; Frizelle, Frank A.; Keenan, Jacqueline I.] Univ Otago, Dept Surg, Christchurch, New Zealand; [Pearson, John] Univ Otago, Biostat & Computat Biol Unit, Christchurch, New Zealand	University of Otago; University of Otago	Purcell, RV (corresponding author), Univ Otago, Dept Surg, Christchurch, New Zealand.	rachel.purcell@otago.ac.nz	Pearson, John F/D-7428-2012; Purcell, Rachel/M-2479-2019	Pearson, John F/0000-0001-5607-4517; Aitchison, Alan/0000-0002-0857-1815; Purcell, Rachel/0000-0002-2684-4530				Boleij A, 2015, CLIN INFECT DIS, V60, P208, DOI 10.1093/cid/ciu787; Brucher BLDM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-331; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Chen LA, 2015, EUR J CLIN MICROBIOL, V34, P1871, DOI 10.1007/s10096-015-2425-7; Dejea CM, 2014, P NATL ACAD SCI USA, V111, P18321, DOI 10.1073/pnas.1406199111; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Flanagan L, 2014, EUR J CLIN MICROBIOL, V33, P1381, DOI 10.1007/s10096-014-2081-3; Flemer B, 2016, GUT; Gagniere J, 2016, WORLD J GASTROENTERO, V22, P501, DOI 10.3748/wjg.v22.i2.501; Geng JW, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-26; Hajishengallis G, 2016, TRENDS MICROBIOL, V24, P477, DOI 10.1016/j.tim.2016.02.010; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Hwang Soonjae, 2013, Immune Netw, V13, P213, DOI 10.4110/in.2013.13.5.213; Ismail S, 2003, INFECT IMMUN, V71, P5670, DOI 10.1128/IAI.71.10.5670-5675.2003; Maeda H, 1998, BIOCHEMISTRY-MOSCOW+, V63, P854; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mo Health, 2015, SEL CANC 2012 2013 2; Moncrief JS, 1998, INFECT IMMUN, V66, P1735, DOI 10.1128/IAI.66.4.1735-1739.1998; Purcell RV, 2016, SCI REP-UK, V6, DOI 10.1038/srep34554; Sanfilippo L, 2000, CLIN EXP IMMUNOL, V119, P456, DOI 10.1046/j.1365-2249.2000.01155.x; Sears CL, 2014, J CLIN INVEST, V124, P4166, DOI 10.1172/JCI72334; Sears CL, 2014, CELL HOST MICROBE, V15, P317, DOI 10.1016/j.chom.2014.02.007; Snover DC, 2010, WHO CLASSIFICATION T, P160; Tjalsma H, 2012, NAT REV MICROBIOL, V10, P575, DOI 10.1038/nrmicro2819; Viljoen KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119462; Wu SG, 2004, INFECT IMMUN, V72, P5832, DOI 10.1128/IAI.72.10.5832-5839.2004; Wu SG, 1998, P NATL ACAD SCI USA, V95, P14979, DOI 10.1073/pnas.95.25.14979; Wu SG, 2006, INFECT IMMUN, V74, P5382, DOI 10.1128/IAI.00060-06; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Xie L L, 2016, Zhonghua Yi Xue Za Zhi, V96, P954, DOI 10.3760/cma.j.issn.0376-2491.2016.12.010	30	117	124	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171602	10.1371/journal.pone.0171602	http://dx.doi.org/10.1371/journal.pone.0171602			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151975	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161200158
J	Tang, XJ; Chen, DP; Yu, SQ; Yang, L; Mei, CL				Tang, Xiaojing; Chen, Dongping; Yu, Shengqiang; Yang, Li; Mei, Changlin		ISN AKF 0 25 China Consortium	Acute kidney injury burden in different clinical units: Data from nationwide survey in China	PLOS ONE			English	Article							INTENSIVE-CARE UNITS; EPIDEMIOLOGY; OUTCOMES; PREVALENCE; AKI	Background The inpatient morbidity and mortality of acute kidney injury (AKI) vary considerably in different clinical units, yet studies to compare the difference remain limited. Methods We compared the clinical characteristics of AKI in Intensive Care Unit (ICU), medical and surgical departments by using the data derived from the 2013 nationwide cross-sectional survey of AKI in China to capture variations among different clinical departments in recognition, management, and outcomes of AKI. Suspected AKI patients were identified based on changes in serum creatinine during hospitalization, and confirmed by reviewing medical records. Results The detection rate of AKI was the highest in ICU (22.46%), followed by the rates in medical (1.96%) and surgical departments (0.96%). However, the absolute number of cases was the largest in medical departments, which contributed to 50% of the cases. In medical departments, 78% of AKI cases were extensively distributed in cardiac, nephrology, oncology, gastroenterology, pneumology and neurology departments. In contrast, 87% of AKI cases in surgical departments were mainly from urology, general surgery and cardiothoracic departments. The in-time recognition rates were extremely low in all departments except nephrology. Only 10.5-15.0% AKI patients from non-nephrology departments received renal referral. Among all the death cases, 50% and 39% came from ICU and medical departments while only 11% from surgical departments. Older age, higher AKI stage and renal replacement therapy indication were identified as risk factors for high mortality in all departments. Delayed recognition and no renal referral were significantly associated with increased mortality in medical and ICU patients. Conclusions These findings suggest that ICU and medical departments are major affected departments in China with a large number of AKI cases and subsequent high mortality. The reality is more alarming considering the low awareness of AKI and the paucity of effective interventions in the high-risk patients in these departments.	[Tang, Xiaojing; Chen, Dongping; Yu, Shengqiang; Mei, Changlin] Second Mil Med Univ, Shanghai Changzheng Hosp, Div Nephrol, Shanghai, Peoples R China; [Yang, Li] Peking Univ, Hosp 1, Div Renal, Beijing, Peoples R China	Naval Medical University; Peking University	Mei, CL (corresponding author), Second Mil Med Univ, Shanghai Changzheng Hosp, Div Nephrol, Shanghai, Peoples R China.; Yang, L (corresponding author), Peking Univ, Hosp 1, Div Renal, Beijing, Peoples R China.	li.yang@bjmu.edu.cn; chlmei1954@126.com			Major Fundamental Research Program of Shanghai Committee of Science and Technology [12DJ1400300]; Shanghai Top Priority Key Clinical Disciplines Construction Project; Key Projects in the National Science & Technology Pillar Program in the Twelfth Five-year Plan Period [2011BAI10B07]; National Nature Science Fund of China [81500533]; International Society of Nephrology Research Committee	Major Fundamental Research Program of Shanghai Committee of Science and Technology; Shanghai Top Priority Key Clinical Disciplines Construction Project; Key Projects in the National Science & Technology Pillar Program in the Twelfth Five-year Plan Period; National Nature Science Fund of China(National Natural Science Foundation of China (NSFC)); International Society of Nephrology Research Committee	This study was supported by Major Fundamental Research Program of Shanghai Committee of Science and Technology (12DJ1400300, CM); Shanghai Top Priority Key Clinical Disciplines Construction Project (CM); Key Projects in the National Science & Technology Pillar Program in the Twelfth Five-year Plan Period (2011BAI10B07, SY), National Nature Science Fund of China (No. 81500533) and International Society of Nephrology Research Committee (LY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian G, 2011, AM J KIDNEY DIS, V57, P228, DOI 10.1053/j.ajkd.2010.08.026; Bastin AJ, 2013, J CRIT CARE, V28, P389, DOI 10.1016/j.jcrc.2012.12.008; Caddeo Giacomo, 2013, Nephrourol Mon, V5, P955, DOI 10.5812/numonthly.12721; Silva VTCE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070482; Cox ZL, 2013, CLIN J AM SOC NEPHRO, V8, P1070, DOI 10.2215/CJN.11921112; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Grams ME, 2016, AM J KIDNEY DIS, V67, P872, DOI 10.1053/j.ajkd.2015.07.022; Herrera-Gutierrez ME, 2013, J CRIT CARE, V28, P687, DOI 10.1016/j.jcrc.2013.05.019; Hoste E, 2015, INTENS CARE MED, V41, P1411, DOI 10.1007/s00134-015-3934-7; Li PKT, 2013, KIDNEY INT, V83, P372, DOI 10.1038/ki.2012.427; Liangos O, 2006, CLIN J AM SOC NEPHRO, V1, P43, DOI 10.2215/CJN.00220605; Lunyera J, 2016, AM J KIDNEY DIS, V67, P834, DOI 10.1053/j.ajkd.2015.12.018; MacLeod A, 2009, LANCET, V374, P1405, DOI 10.1016/S0140-6736(09)61843-2; Pang CL, 2014, EUR J INTERN MED, V25, P669, DOI 10.1016/j.ejim.2014.06.005; Rewa O, 2014, NAT REV NEPHROL, V10, P193, DOI 10.1038/nrneph.2013.282; Rosner MH, 2006, CLIN J AM SOC NEPHRO, V1, P19, DOI 10.2215/CJN.00240605; Thakar CV, 2013, ADV CHRONIC KIDNEY D, V20, P67, DOI 10.1053/j.ackd.2012.10.003; Wang HE, 2012, AM J NEPHROL, V35, P349, DOI 10.1159/000337487; Wen Y, 2013, CHINESE MED J-PEKING, V126, P4409, DOI 10.3760/cma.j.issn.0366-6999.20132065; Yang L, 2015, LANCET, V386, P1465, DOI 10.1016/S0140-6736(15)00344-X	20	15	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171202	10.1371/journal.pone.0171202	http://dx.doi.org/10.1371/journal.pone.0171202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152018	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200103
J	Al-dhaqm, A; Razak, S; Othman, SH; Ngadi, A; Ahmed, MN; Mohammed, AA				Al-dhaqm, Arafat; Razak, Shukor; Othman, Siti Hajar; Ngadi, Asri; Ahmed, Mohammed Nazir; Mohammed, Abdulalem Ali			Development and validation of a Database Forensic Metamodel (DBFM)	PLOS ONE			English	Article							REQUIREMENTS; MANAGEMENT; SYSTEMS	Database Forensics (DBF) is a widespread area of knowledge. It has many complex features and is well known amongst database investigators and practitioners. Several models and frameworks have been created specifically to allow knowledge-sharing and effective DBF activities. However, these are often narrow in focus and address specified database incident types. We have analysed 60 such models in an attempt to uncover how numerous DBF activities are really public even when the actions vary. We then generate a unified abstract view of DBF in the form of a metamodel. We identified, extracted, and proposed a common concept and reconciled concept definitions to propose a metamodel. We have applied a metamodelling process to guarantee that this metamodel is comprehensive and consistent.	[Al-dhaqm, Arafat; Razak, Shukor; Othman, Siti Hajar; Ngadi, Asri; Ahmed, Mohammed Nazir; Mohammed, Abdulalem Ali] Univ Teknol Malaysia, Fac Comp, Dept Comp Sci, Skudai, Johor, Malaysia; [Al-dhaqm, Arafat] Aden Community Coll, Dept Comp Sci, Aden, Yemen	Universiti Teknologi Malaysia	Al-dhaqm, A (corresponding author), Univ Teknol Malaysia, Fac Comp, Dept Comp Sci, Skudai, Johor, Malaysia.; Al-dhaqm, A (corresponding author), Aden Community Coll, Dept Comp Sci, Aden, Yemen.	arafataldoqm@gmail.com	razak, shukor abd/AAN-1035-2020; Othman, Siti Hajar/K-5692-2012; razak, shukor abd/F-5651-2011; NGADI, ASRI/G-3174-2011	razak, shukor abd/0000-0002-8824-6069; Othman, Siti Hajar/0000-0002-0205-4948; razak, shukor abd/0000-0002-8824-6069; NGADI, ASRI/0000-0003-4907-6359; Aldhaqm, Dr.Arafat/0000-0002-0729-2654	Universiti Teknologi Malaysia; MOHE through FRGS grant [R.J130000.7813.4F193]	Universiti Teknologi Malaysia; MOHE through FRGS grant	We acknowledge Universiti Teknologi Malaysia and MOHE through FRGS grant no. R.J130000.7813.4F193 for support related to the proofreading service for this paper.; We acknowledge the expert Mr. Daniele Giomo for his assistance and evaluation of this work. We also acknowledge Universiti Teknologi Malaysia and MOHE through FRGS Grant No. R.J130000.7813.4F193 for support related to the proofreading service for this paper.	Ab Rahman NH, 2016, CLOUD INCIDENT HANDL; Ab Rahman NH, 2016, IEEE CLOUD COMPUT, V3, P50, DOI 10.1109/MCC.2016.5; Adedayo OM, 2015, DIGIT INVEST, V12, P27, DOI 10.1016/j.diin.2014.12.002; Adedayo OM, 2015, RECONSTRUCTION DATAB; Al-Dhaqm A, 2016, JURNAL TEKNOLOGI, V78; Al-Dhaqm R, 2014, ADAPTING METAMODELLI, P322; Aldhaqm A, 2016, RES ARTICLE CONCEPTU; Azemovic J, 2009, EFFICIENT MODEL DETE; Azfar A, 2016, MULTIMED TOOLS APPL, P1; Azfar A, 2016, J FORENSIC SCI, V61, P1337, DOI 10.1111/1556-4029.13164; Basu A., 2006, FORENSIC TAMPER DETE; Beate L, 2006, P 2006 ACM S APPL CO; Beibei Wu, 2013, Information and Communication Technology. International Conference, ICT-EurAsia 2013. Proceedings: LNCS 7804, P295, DOI 10.1007/978-3-642-36818-9_30; Beydoun G, 2009, INFORM SOFTWARE TECH, V51, P832, DOI 10.1016/j.infsof.2008.05.003; Beydoun G, 2011, J SYST SOFTWARE, V84, P2363, DOI 10.1016/j.jss.2011.07.010; Beydoun G, 2009, IEEE T SOFTWARE ENG, V35, P841, DOI 10.1109/TSE.2009.34; Beydoun G, 2009, EXPERT SYST APPL, V36, P10952, DOI 10.1016/j.eswa.2009.02.023; Beyers H, 2011, APPROACH EXAMINE MET; Beyers H., 2011, ADV DIGITAL FORENSIC, VVII, P89; Beyers H., 2014, S AFRICAN COMPUTER J, V55, P1; Beyers HQ, 2013, DATABASE FORENSICS I; Bogen A.C., 2005, P 5 ANN DIGITAL FORE; Cahyani NDW, 2016, CONCURRENCY COMPUTAT; Choi J, 2009, EVIDENCE INVESTIGATI, P1; Daryabar F, 2017, AUST J FORENSIC SCI, V49, P344, DOI 10.1080/00450618.2016.1153714; Do Q, 2016, SOFTWARE PRACTICE EX; Do Q, 2015, IEEE CLOUD COMPUT, V2, P60, DOI 10.1109/MCC.2015.71; Do Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138449; Do Q, 2012, PROCEDIA COMPUT SCI, V8, P285, DOI 10.1016/j.procs.2012.01.059; Fasan OM, 2012, DIMENSIONS RECONSTRU, P97; Fatima F, 2011, DETECTING DATABASE A; Flores DA, 2013, J INTERNET SERVICES, V3, P101; Fowler K., 2008, SQL SERVER FORENISC; Fowler K., 2007, REAL WORLD SCENARIO; Fruhwirt P, 2014, DIGIT INVEST, V11, P336, DOI 10.1016/j.diin.2014.09.003; Fruhwirt P, 2012, 2012 SEVENTH INTERNATIONAL CONFERENCE ON AVAILABILITY, RELIABILITY AND SECURITY (ARES), P625, DOI 10.1109/ARES.2012.50; Fruhwirt P, 2010, INT CON ADV INFO NET, P1028, DOI 10.1109/AINA.2010.152; Fruhwirt P., 2013, INF SECUR TECH REP, V17, P227, DOI [DOI 10.1016/J.ISTR.2013.02.003, DOI 10.1016/j.istr.2013.02.003]; Garcia PB, 2007, METAMODEL ANNOTATE K; Gharehdaghli A, 2003, DESIGN GENERIC METAM; Hauger WK, 2014, ROLE TRIGGERS DATABA, P1; Immanuel F, 2015, ANDROID CACHE TAXONO, P1094; Jalali V, 2011, KNOWL INF SYST, V29, P237, DOI 10.1007/s10115-010-0327-7; Jeon S, 2012, PERS UBIQUIT COMPUT, V16, P707, DOI 10.1007/s00779-011-0428-7; Jin R, 2001, STRUCT MULTIDISCIP O, V23, P1, DOI 10.1007/s00158-001-0160-4; Kambire MK, 2015, INT J COMPUT SCI INF, V6, P57; Kelly S, 2009, IEEE SOFTWARE, V26, P22, DOI 10.1109/MS.2009.109; Khanuja H., 2012, INT J COMPUT SCI ENG, V2, P27; Khanuja H. K., 2013, INT J COMPUT TECHNOL, V7, P654; Khanuja H, 2014, IEEE INT ADV COMPUT, P457, DOI 10.1109/IAdCC.2014.6779367; Khanuja HK, 2014, FORENSIC ANAL MONITO, P201; Kok Dd, 2010, FEATURE SELECTION FL; Lawrence A. C., 2014, FORENSIC INVESTIGATI; Lee D, 2009, DATABASE FORENSIC IN; Lee GT, 2007, DISCOVERING METHODOL, P130; Lee K, 2012, WORKFLOW SUPPORT FOR; 최종현, 2013, [Journal of The Korea Institute of Information Security and Cryptology, 정보보호학회논문지], V23, P947, DOI 10.13089/JKIISC.2013.23.5.947; Litchfield D, 2007, ORACLE FORENSICS 2; Litchfield D, 2007, ORACLE FORENSICS 5; Litchfield D, 2007, ORACLE FORENSICS 3; Litchfield D, 2007, ORACLE FORENSICS 6; Litchfield D., 2007, ORACLE HACKERS HDB H; Litchfield D., 2007, ORACLE FORENSICS 4; Litchfield D, 2008, ORACLE FORENSICS 7; Manning CD, 2008, INTRO INFORM RETRIEV; Martini B, 2014, IEEE INT CONF TRUST, P935, DOI 10.1109/TrustCom.2014.124; Martini B, 2014, DIGIT INVEST, V11, P295, DOI 10.1016/j.diin.2014.08.002; Munk-Madsen A., 2005, CONCEPT PROJECT PROP; Nissen HW, 1996, IEEE SOFTWARE, V13, P37, DOI 10.1109/52.506461; Nordstrom G, 1999, METAMODELING RAPID D; Olivier MS, 2009, DIGIT INVEST, V5, P115, DOI 10.1016/j.diin.2008.10.001; OMG, 2001, UN MOD LANG SPEC VER; OMG, 2003, MOD DRIV ARCH MDA GU; OMG, 2002, MET OBJ FAC MOF SPEC; Othman SH, 2010, AUSTR C INF SYST ACI; Othman SH, 2014, INFORM PROCESS MANAG, V50, P235, DOI 10.1016/j.ipm.2013.11.001; Othman SH, 2010, LECT NOTES ARTIF INT, V6232, P111, DOI 10.1007/978-3-642-15037-1_11; Panigrahi PK, 2011, FRAMEWORK DISCOVERIN, P323; Pascot D, 2011, KNOWL INF SYST, V27, P115, DOI 10.1007/s10115-010-0292-1; Pavlou KE, 2013, ACM T DATABASE SYST, V38, DOI 10.1145/2487259.2487264; Pavlou KE, 2008, ACM T DATABASE SYST, V33, DOI 10.1145/1412331.1412342; Pavlou KE, 2010, IEEE T KNOWL DATA EN, V22, P590, DOI 10.1109/TKDE.2009.121; Quick D, 2016, CLUSTER COMPUT, P1; Quick D., 2013, CLOUD STORAGE FORENS; Quick D, 2014, DIGIT INVEST, V11, P273, DOI 10.1016/j.diin.2014.09.002; Quick D, 2013, DIGIT INVEST, V10, P3, DOI 10.1016/j.diin.2013.02.003; Sadraei E, 2007, REQUIR ENG, V12, P145, DOI 10.1007/s00766-007-0042-4; Saleh B, 2011, KNOWL INF SYST, V28, P311, DOI 10.1007/s10115-010-0361-5; Sargent RG, 2013, J SIMUL, V7, P12, DOI [10.1057/jos.2012.20, 10.1109/WSC.1998.744907]; Sargent RG, 2005, P 37 C WINT SIM; Sargent RG, 2015, SIMUL FOUND METH APP, P57, DOI 10.1007/978-1-4471-5634-5_6; Snodgrass RT, 2004, TAMPER DETECTION AUD, P504; Son N, 2011, COMM COM INF SC, V186, P164; Sowa J., 1984, CONCEPTUAL STRUCTURE; Stahl Thomas, 2005, MODEL DRIVEN SOFTWAR; Susaimanickam R, 2012, WORKFLOW SUPPORT FOR; Teing Y-Y, 2016, COMPUTERS ELECT ENG; Tran QNN, 2006, COMPUT SYST SCI ENG, V21, P117; Tripathi S, 2012, DIGITAL EVIDENCE DAT; Wagner J, 2015, DIGIT INVEST, V14, pS106, DOI 10.1016/j.diin.2015.05.013; Wong D, 2004, SYSTEM METHOD INVEST; Wright PM, 2005, ORACLE DATABASE FORE; Xu M, 2014, J COMPUT, V9, P2294, DOI 10.4304/jcp.9.10.2294-2302; Yang TY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150300; Zhang Z, 2011, KNOWL INF SYST, V27, P473, DOI 10.1007/s10115-010-0306-z	106	20	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0170793	10.1371/journal.pone.0170793	http://dx.doi.org/10.1371/journal.pone.0170793			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146585	Green Published, Green Submitted, gold			2022-12-27	WOS:000396131700024
J	Pelletier, D; Lapointe, ME; Wulder, MA; White, JC; Cardille, JA				Pelletier, David; Lapointe, Marc-Elie; Wulder, Michael A.; White, Joanne C.; Cardille, Jeffrey A.			Forest Connectivity Regions of Canada Using Circuit Theory and Image Analysis	PLOS ONE			English	Article							LANDSCAPE CONNECTIVITY; RESISTANCE SURFACES; SPATIAL-PATTERNS; FRAGMENTATION; DISPERSAL; CORRIDORS; MODEL; AREA	Ecological processes are increasingly well understood over smaller areas, yet information regarding interconnections and the hierarchical nature of ecosystems remains less studied and understood. Information on connectivity over large areas with high resolution source information provides for both local detail and regional context. The emerging capacity to apply circuit theory to create maps of omnidirectional connectivity provides an opportunity for improved and quantitative depictions of forest connectivity, supporting the formation and testing of hypotheses about the density of animal movement, ecosystem structure, and related links to natural and anthropogenic forces. In this research, our goal was to delineate regions where connectivity regimes are similar across the boreal region of Canada using new quantitative analyses for characterizing connectivity over large areas (e.g., millions of hectares). Utilizing the Earth Observation for Sustainable Development of forests (EOSD) circa 2000 Landsat-derived land-cover map, we created and analyzed a national-scale map of omnidirectional forest connectivity at 25m resolution over 10000 tiles of 625 km(2) each, spanning the forested regions of Canada. Using image recognition software to detect corridors, pinch points, and barriers to movements at multiple spatial scales in each tile, we developed a simple measure of the structural complexity of connectivity patterns in omnidirectional connectivity maps. We then mapped the Circuitscape resistance distance measure and used it in conjunction with the complexity data to study connectivity characteristics in each forested ecozone. Ecozone boundaries masked substantial systematic patterns in connectivity characteristics that are uncovered using a new classification of connectivity patterns that revealed six clear groups of forest connectivity patterns found in Canada. The resulting maps allow exploration of omnidirectional forest connectivity patterns at full resolution while permitting quantitative analyses of connectivity over broad areas, informing modeling, planning and monitoring efforts.	[Pelletier, David; Cardille, Jeffrey A.] McGill Univ, Dept Nat Resource Sci, Montreal, PQ, Canada; [Pelletier, David; Cardille, Jeffrey A.] McGill Univ, McGill Sch Environm, Montreal, PQ, Canada; [Lapointe, Marc-Elie] Coll Montmorency, Dept Math, Laval, PQ, Canada; [Wulder, Michael A.; White, Joanne C.] Nat Resources Canada, Canadian Forest Serv, Pacific Forestry Ctr, Victoria, BC, Canada	McGill University; McGill University; Natural Resources Canada; Canadian Forest Service	Cardille, JA (corresponding author), McGill Univ, Dept Nat Resource Sci, Montreal, PQ, Canada.; Cardille, JA (corresponding author), McGill Univ, McGill Sch Environm, Montreal, PQ, Canada.	jeffrey.cardille@mcgill.ca	White, Joanne C./Z-1981-2019; Wulder, Michael A/J-5597-2016	White, Joanne C./0000-0003-4674-0373; Wulder, Michael A/0000-0002-6942-1896; Cardille, Jeffrey/0000-0002-4667-9085	Government of Canada, via the Canadian Forest Service of Natural Resources Canada; Canadian Space Agency; Discovery grant from the Natural Sciences and Engineering Research Council	Government of Canada, via the Canadian Forest Service of Natural Resources Canada(Natural Resources CanadaCanadian Forest Service); Canadian Space Agency(Canadian Space Agency); Discovery grant from the Natural Sciences and Engineering Research Council	Aspects of this research were supported through the Government of Canada, via the Canadian Forest Service (http://cfs.nrcan.gc.ca/) of Natural Resources Canada (http://www.nrcan.gc.ca/) and the Canadian Space Agency (http://www.asc-csa.gc.ca/), and a Discovery grant from the Natural Sciences and Engineering Research Council (http://www.nserc-crsng.gc.ca/).	Anderson M., 2012, RESILIENT SITES TERR; Bay H, 2008, COMPUT VIS IMAGE UND, V110, P346, DOI 10.1016/j.cviu.2007.09.014; Breckheimer I, 2014, CONSERV BIOL, V28, P1584, DOI 10.1111/cobi.12362; Canadian Forest Service, STAT CAN FOR ANN REP; Cardille J, 2005, BIOSCIENCE, V55, P983, DOI 10.1641/0006-3568(2005)055[0983:MCSPAS]2.0.CO;2; Cardille JA, 2012, ENVIRON MANAGE, V49, P163, DOI 10.1007/s00267-011-9785-2; Dramstad WE, 2009, NORSK GEOGR TIDSSKR, V63, P246, DOI 10.1080/00291950903368359; FAO, GLOB FOR RES ASS 201; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Fraley C, 2012, 597 U WASH; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Galpern P, 2011, BIOL CONSERV, V144, P44, DOI 10.1016/j.biocon.2010.09.002; Gauthier S, 2014, ENVIRON REV, V22, P256, DOI 10.1139/er-2013-0064; Giroux-Bougard X, 2015, GENE FLOW ARCTIC WET; Gonzalez A, 2011, AM J BOT, V98, P503, DOI 10.3732/ajb.1000424; Guindon L, 2014, CAN J FOREST RES, V44, P1545, DOI 10.1139/cjfr-2014-0229; Hermosilla T, 2016, INT J DIGIT EARTH, V9, P1035, DOI 10.1080/17538947.2016.1187673; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; Kavanagh D.M., 2011, LINKAGE MAPPER CONNE; Keenan RJ, 2015, FOREST ECOL MANAG, V352, P9, DOI 10.1016/j.foreco.2015.06.014; Kindlmann P, 2008, LANDSCAPE ECOL, V23, P879, DOI 10.1007/s10980-008-9245-4; Koen EL, 2014, METHODS ECOL EVOL, V5, P626, DOI 10.1111/2041-210X.12197; Kupfer J.A., 2012, PROGR PHYS GEOGRAPHY, V2012; Lechner AM, 2015, LANDSCAPE URBAN PLAN, V141, P11, DOI 10.1016/j.landurbplan.2015.04.008; Lee-Yaw JA, 2009, MOL ECOL, V18, P1863, DOI 10.1111/j.1365-294X.2009.04152.x; Levey DJ, 2005, SCIENCE, V309, P146, DOI 10.1126/science.1111479; Marrotte RR, 2014, MOL ECOL, V23, P3983, DOI 10.1111/mec.12847; McGarigal K., 2012, TECH REP; McRae B.H., 2009, CIRCUITSCAPE USERS G; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Mcrae BH, 2007, P NATL ACAD SCI USA, V104, P19885, DOI 10.1073/pnas.0706568104; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; McRae BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052604; Mitchell MGE, 2013, ECOSYSTEMS, V16, P894, DOI 10.1007/s10021-013-9647-2; Miura S, 2015, FOREST ECOL MANAG, V352, P35, DOI 10.1016/j.foreco.2015.03.039; Moilanen A, 2001, OIKOS, V95, P147, DOI 10.1034/j.1600-0706.2001.950116.x; Pelletier D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084135; Peterman WE, 2014, MOL ECOL, V23, P2402, DOI 10.1111/mec.12747; Pickell PD, 2016, INT J REMOTE SENS, V37, P138, DOI 10.1080/2150704X.2015.1126375; Pierik ME, 2016, ECOL INDIC, V67, P807, DOI 10.1016/j.ecolind.2016.03.032; R Core Team, 2013, R LANG ENV STAT COMP; Rayfield B, 2011, ECOLOGY, V92, P847, DOI 10.1890/09-2190.1; Shah VB, 2008, 7 PYTH SCI C 2008 PA; Spear SF, 2010, MOL ECOL, V19, P3576, DOI 10.1111/j.1365-294X.2010.04657.x; Tischendorf L, 2000, LANDSCAPE ECOL, V15, P633, DOI 10.1023/A:1008177324187; Turner M.G., 2001, LANDSCAPE ECOLOGY TH; Vogt P, 2009, ECOL INDIC, V9, P64, DOI 10.1016/j.ecolind.2008.01.011; Vogt P, 2007, ECOL INDIC, V7, P481, DOI 10.1016/j.ecolind.2006.11.001; Vogt P, 2007, LANDSCAPE ECOL, V22, P171, DOI 10.1007/s10980-006-9013-2; Walpole AA, 2012, LANDSCAPE ECOL, V27, P761, DOI 10.1007/s10980-012-9728-1; White JC, 2014, CAN J REMOTE SENS, V40, P192, DOI 10.1080/07038992.2014.945827; Wiken E., 1986, ECOLOGICAL LAND CLAS, V19; Wulder MA, 2011, CAN GEOGR-GEOGR CAN, V55, P288, DOI 10.1111/j.1541-0064.2010.00335.x; Wulder MA, 2008, CAN J REMOTE SENS, V34, P563, DOI 10.5589/m08-081; Wulder MA, 2008, CAN J REMOTE SENS, V34, P549, DOI 10.5589/m08-066; Zeller KA, 2012, LANDSCAPE ECOL, V27, P777, DOI 10.1007/s10980-012-9737-0	56	10	10	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0169428	10.1371/journal.pone.0169428	http://dx.doi.org/10.1371/journal.pone.0169428			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146573	Green Submitted, Green Published, gold			2022-12-27	WOS:000396131700007
J	Coffey, LL; Pesavento, PA; Keesler, RI; Singapuri, A; Watanabe, J; Watanabe, R; Yee, J; Bliss-Moreau, E; Cruzen, C; Christe, KL; Reader, JR; von Morgenland, W; Gibbons, AM; Allen, AM; Linnen, J; Gao, K; Delwart, E; Simmons, G; Stone, M; Lanteri, M; Bakkour, S; Busch, M; Morrison, J; Van Rompay, KKA				Coffey, Lark L.; Pesavento, Patricia A.; Keesler, Rebekah I.; Singapuri, Anil; Watanabe, Jennifer; Watanabe, Rie; Yee, JoAnn; Bliss-Moreau, Eliza; Cruzen, Christina; Christe, Kari L.; Reader, J. Rachel; von Morgenland, Wilhelm; Gibbons, Anne M.; Allen, A. Mark; Linnen, Jeff; Gao, Kui; Delwart, Eric; Simmons, Graham; Stone, Mars; Lanteri, Marion; Bakkour, Sonia; Busch, Michael; Morrison, John; Van Rompay, Koen K. A.			Zika Virus Tissue and Blood Compartmentalization in Acute Infection of Rhesus Macaques	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; TRANSMISSION; PATHOGENESIS; TRANSFUSION; VACCINE; BRAZIL; CELLS; MODEL	Animal models of Zika virus (ZIKV) are needed to better understand tropism and pathogenesis and to test candidate vaccines and therapies to curtail the pandemic. Humans and rhesus macaques possess similar fetal development and placental biology that is not shared between humans and rodents. We inoculated 2 non-pregnant rhesus macaques with a 2015 Brazilian ZIKV strain. Consistent with most human infections, the animals experienced no clinical disease but developed short-lived plasma viremias that cleared as neutralizing antibody developed. In 1 animal, viral RNA (vRNA) could be detected longer in whole blood than in plasma. Despite no major histopathologic changes, many adult tissues contained vRNA 14 days post-infection with highest levels in hemolymphatic tissues. These observations warrant further studies to investigate ZIKV persistence and its potential clinical implications for transmission via blood products or tissue and organ transplants.	[Coffey, Lark L.; Pesavento, Patricia A.; Singapuri, Anil; Watanabe, Rie] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Sch Vet Med, Davis, CA 95616 USA; [Keesler, Rebekah I.; Watanabe, Jennifer; Yee, JoAnn; Bliss-Moreau, Eliza; Cruzen, Christina; Christe, Kari L.; Reader, J. Rachel; von Morgenland, Wilhelm; Gibbons, Anne M.; Allen, A. Mark; Morrison, John; Van Rompay, Koen K. A.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Bliss-Moreau, Eliza] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA; [Linnen, Jeff; Gao, Kui] Hologic, San Diego, CA USA; [Delwart, Eric; Simmons, Graham; Stone, Mars; Lanteri, Marion; Bakkour, Sonia; Busch, Michael] Blood Syst Res Inst, San Francisco, CA USA; [Delwart, Eric; Simmons, Graham; Stone, Mars; Lanteri, Marion; Bakkour, Sonia; Busch, Michael] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco	Coffey, LL (corresponding author), Univ Calif Davis, Dept Pathol Microbiol & Immunol, Sch Vet Med, Davis, CA 95616 USA.; Van Rompay, KKA (corresponding author), Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.	lcoffey@ucdavis.edu; kkvanrompay@ucdavis.edu	Christe, Kari/AAD-5929-2022; Simmons, Graham/G-3523-2012	Simmons, Graham/0000-0002-9615-7023; Coffey, Lark/0000-0002-0718-5146	CNPRC; Office of Research Infrastructure Programs/OD [P510D011107]; Pathology, Microbiology and Immunology Department; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	CNPRC; Office of Research Infrastructure Programs/OD; Pathology, Microbiology and Immunology Department; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by a CNPRC pilot research grant to LC and KVR, the Office of Research Infrastructure Programs/OD (P510D011107), and start up funds from the Pathology, Microbiology and Immunology Department to LC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Although JL and KG are employees of Hologic, their role in the study was to test samples from macaques. Hologic did not provide any funding or salary support for other manuscript co-authors.; We acknowledge the research and support staff at CNPRC for their assistance with all aspects of the study, as well as the UC Davis IACUC and Environmental Health and Safety Offices for expedited approval for work on this project. Sarah Mills, Abigail Spinner and the staff of the Pathogen Detection Laboratory and Clinical Laboratories at CNPRC were especially helpful with necropsies and biospecimen processing, and analysis. Kathy West provided illustrations. The Zika research team at the Wisconsin National Primate Research Center provided ongoing advice and data-sharing. The Unite des Virus Emergents, Marseille, France, provided the inactivated French Polynesia 2013 standard. This study was supported by a CNPRC pilot research grant to LC and KVR, the Office of Research Infrastructure Programs/OD (P510D011107), and start up funds from the Pathology, Microbiology and Immunology Department to LC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Although JL and KG are employees of Hologic, their role in the study was to test samples from macaques. Hologic did not provide any funding or salary support for other manuscript co-authors.	Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157; Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI [10.1371/journal.pntd.0004682, 10.1371/journal.pntd.0004750]; [Anonymous], 2016, WHO DIRECTOR GEN SUM; Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158; Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964; Centers for Disease Control and Prevention (CDC), 2016, ZIKA VIRUS; CHIMELLI L, 1990, CLIN NEUROPATHOL, V9, P157; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6; dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015; Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658; Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137; Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036; Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002; Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442; Hologic, 2016, APT ZIK VIR ASS; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Lessler J, 2016, BULLETIN OF THE WORL; Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017; Lustig Y, 2016, EURO SURVEILL, V21; Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9; Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262; Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15; Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206; Pan American Health Organization, 2016, COUNTR TERR AUT TRAN; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111; Scharko AM, 1996, P NATL ACAD SCI USA, V93, P6425, DOI 10.1073/pnas.93.13.6425; Smith DR, 2006, EMERG INFECT DIS, V12, P1190, DOI 10.3201/eid1708.050841; Stone M, 2017, TRANSFUSION IN PRESS; Van Rompay KKA, 2004, J VIROL, V78, P5324, DOI 10.1128/JVI.78.10.5324-5337.2004; Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58	44	70	71	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171148	10.1371/journal.pone.0171148	http://dx.doi.org/10.1371/journal.pone.0171148			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141843	Green Submitted, Green Published, gold			2022-12-27	WOS:000396129500044
J	Waldschmidt, L; Junkereit, V; Bahring, R				Waldschmidt, Lara; Junkereit, Vera; Baehring, Robert			KChIP2 genotype dependence of transient outward current (I-to) properties in cardiomyocytes isolated from male and female mice	PLOS ONE			English	Article							MOUSE VENTRICULAR MYOCYTES; CHANNEL-INTERACTING PROTEIN-2; KV4 ALPHA-SUBUNIT; K+ CHANNEL; POTASSIUM CHANNELS; 3-DIMENSIONAL STRUCTURE; CARDIAC REPOLARIZATION; GENE-EXPRESSION; HEART-FAILURE; MESSENGER-RNA	The transient outward current (I-to) in cardiomyocytes is largely mediated by Kv4 channels associated with Kv Channel Interacting Protein 2 (KChIP2). A knockout model has documented the critical role of KChIP2 in I-to expression. The present study was conducted to characterize in both sexes the dependence of I-to properties, including current magnitude, inactivation kinetics, recovery from inactivation and voltage dependence of inactivation, on the number of functional KChIP2 alleles. For this purpose we performed whole-cell patch-clamp experiments on isolated left ventricular cardiomyocytes from male and female mice which had different KChIP2 genotypes; i.e., wild-type (KChIP2(+/+)), heterozygous knockout (KChIP2(-/-)) or complete knockout of KChIP2 (KChIP2(-/-)). We found in both sexes a KChIP2 gene dosage effect (i.e., a proportionality between number of alleles and phenotype) on I-to magnitude, however, concerning other I-to properties, KChIP2(+/-) resembled KChIP2(+/+.) Only in the total absence of KChIP2 (KChIP2(-/-)) we observed a slowing of I-to kinetics, a slowing of recovery from inactivation and a negative shift of a portion of the voltage dependence of inactivation. In a minor fraction of KChIP2(-/-) myocytes I-to was completely lost. The distinct KChIP2 genotype dependences of I-to magnitude and inactivation kinetics, respectively, seen in cardiomyocytes were reproduced with two-electrode voltage-clamp experiments on Xenopus oocytes expressing Kv4.2 and different amounts of KChIP2. Our results corroborate the critical role of KChIP2 in controlling I-to properties. They demonstrate that the Kv4.2/KChIP2 interaction in cardiomyocytes is highly dynamic, with a clear KChIP2 gene dosage effect on Kv4 channel surface expression but not on inactivation gating.	[Waldschmidt, Lara; Junkereit, Vera; Baehring, Robert] Univ Klinikum Hamburg Eppendorf, Zentrum Expt Med, Inst Zellulare & Integrat Physiol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Bahring, R (corresponding author), Univ Klinikum Hamburg Eppendorf, Zentrum Expt Med, Inst Zellulare & Integrat Physiol, Hamburg, Germany.	r.baehring@uke.de		Bahring, Robert/0000-0002-0406-5958	Deutsche Forschungsgemeinschaft (DFG) [BA2055/3]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by grant BA2055/3 of the Deutsche Forschungsgemeinschaft (DFG) to RB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Bahring R, 2011, J PHYSIOL-LONDON, V589, P461, DOI 10.1113/jphysiol.2010.191965; Bahring R, 2001, J BIOL CHEM, V276, P23888, DOI 10.1074/jbc.M101320200; Barry DM, 1998, CIRC RES, V83, P560, DOI 10.1161/01.RES.83.5.560; Beck EJ, 2002, J PHYSIOL-LONDON, V538, P691, DOI 10.1113/jphysiol.2001.013127; Brouillette J, 2004, J PHYSIOL-LONDON, V559, P777, DOI 10.1113/jphysiol.2004.063446; Brunet S, 2004, J PHYSIOL-LONDON, V559, P103, DOI 10.1113/jphysiol.2004.063347; Clark RB, 2001, J PHYSIOL-LONDON, V537, P979; Costantini DL, 2005, CELL, V123, P347, DOI 10.1016/j.cell.2005.08.004; Decher N, 2004, J PHYSIOL-LONDON, V557, P761, DOI 10.1113/jphysiol.2004.066720; Dixon JE, 1996, CIRC RES, V79, P659, DOI 10.1161/01.RES.79.4.659; Fiset C, 1997, J PHYSIOL-LONDON, V500, P51, DOI 10.1113/jphysiol.1997.sp021998; Foeger NC, 2013, J PHYSIOL-LONDON, V591, P4149, DOI 10.1113/jphysiol.2013.255836; Foeger NC, 2010, J BIOL CHEM, V285, P33413, DOI 10.1074/jbc.M110.145185; Gebauer M, 2004, BIOPHYS J, V86, P210, DOI 10.1016/S0006-3495(04)74097-7; Gonczi M, 2012, GEN PHYSIOL BIOPHYS, V31, P153, DOI 10.4149/gpb_2012_017; Goltz D, 2007, CARDIOVASC RES, V74, P85, DOI 10.1016/j.cardiores.2007.01.001; Grubb S, 2014, J CARDIOVASC ELECTR, V25, P896, DOI 10.1111/jce.12422; Grubb S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00118; Guenette SA, 2013, EXP ANIM TOKYO, V62, P87; Guo WN, 2005, CIRC RES, V97, P1342, DOI 10.1161/01.RES.0000196559.63223.aa; Guo WN, 2002, CIRC RES, V90, P586, DOI 10.1161/01.RES.0000012664.05949.E0; Guo WN, 1999, J PHYSIOL-LONDON, V521, P587, DOI 10.1111/j.1469-7793.1999.00587.x; Guo WN, 2000, CIRC RES, V87, P73, DOI 10.1161/01.RES.87.1.73; Hasdemir B, 2005, J CELL BIOL, V171, P459, DOI 10.1083/jcb.200506005; Isbrandt D, 2000, GENOMICS, V64, P144, DOI 10.1006/geno.2000.6117; Jeyaraj D, 2012, NATURE, V483, P96, DOI 10.1038/nature10852; Johns DC, 1997, J BIOL CHEM, V272, P31598, DOI 10.1074/jbc.272.50.31598; Kim LA, 2004, NEURON, V41, P513, DOI 10.1016/S0896-6273(04)00050-9; Kim LA, 2004, J BIOL CHEM, V279, P5549, DOI 10.1074/jbc.M311332200; Kitazawa M, 2014, J BIOL CHEM, V289, P17597, DOI 10.1074/jbc.M114.563452; Kobayashi T, 2003, J MOL CELL CARDIOL, V35, P1073, DOI 10.1016/S0022-2828(03)00199-8; Kunjilwar K, 2004, J BIOL CHEM, V279, P54542, DOI 10.1074/jbc.M409721200; Kuo HC, 2001, CELL, V107, P801, DOI 10.1016/S0092-8674(01)00588-8; Li HL, 2005, J MOL CELL CARDIOL, V39, P121, DOI 10.1016/j.yjmcc.2005.03.013; Liu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133274; Liu J, 2011, BASIC RES CARDIOL, V106, P189, DOI 10.1007/s00395-010-0134-z; London B, 1998, J PHYSIOL-LONDON, V509, P171, DOI 10.1111/j.1469-7793.1998.171bo.x; MACKINNON R, 1993, SCIENCE, V262, P757, DOI 10.1126/science.7694359; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Niwa N, 2008, J MOL CELL CARDIOL, V44, P95, DOI 10.1016/j.yjmcc.2007.10.007; Niwa N, 2010, J MOL CELL CARDIOL, V48, P12, DOI 10.1016/j.yjmcc.2009.07.013; Patel SP, 2005, J PHYSIOL-LONDON, V569, P7, DOI 10.1113/jphysiol.2005.086223; Pioletti M, 2006, NAT STRUCT MOL BIOL, V13, P987, DOI 10.1038/nsmb1164; Plotnikov AN, 2004, CIRCULATION, V110, P489, DOI 10.1161/01.CIR.0000137823.64947.52; Pruunsild P, 2005, GENOMICS, V86, P581, DOI 10.1016/j.ygeno.2005.07.001; Rosati B, 2003, J PHYSIOL-LONDON, V548, P815, DOI 10.1113/jphysiol.2002.033704; Rosati B, 2001, J PHYSIOL-LONDON, V533, P119, DOI 10.1111/j.1469-7793.2001.0119b.x; Sah R, 2003, J PHYSIOL-LONDON, V546, P5, DOI 10.1113/jphysiol.2002.026468; Saito T, 2009, CIRC RES, V105, P343, DOI 10.1161/CIRCRESAHA.108.190041; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Thomsen MB, 2009, HEART RHYTHM, V6, P370, DOI 10.1016/j.hrthm.2008.11.023; Tozakidou M, 2010, J MOL CELL CARDIOL, V48, P140, DOI 10.1016/j.yjmcc.2009.08.027; Trepanier-Boulay W, 2001, CIRC RES, V89, P437, DOI 10.1161/hh1701.095644; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; Wang L, 1997, CIRC RES, V81, P120, DOI 10.1161/01.RES.81.1.120; Wang YG, 2003, J MOL CELL CARDIOL, V35, P1083, DOI 10.1016/S0022-2828(03)00200-1; Wickenden AD, 1999, CIRC RES, V85, P1067; Xu HD, 1999, J GEN PHYSIOL, V113, P661, DOI 10.1085/jgp.113.5.661; Yamashita T, 2003, CIRCULATION, V107, P1917, DOI 10.1161/01.CIR.0000058752.79734.F0	60	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171213	10.1371/journal.pone.0171213	http://dx.doi.org/10.1371/journal.pone.0171213			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141821	gold, Green Published, Green Submitted			2022-12-27	WOS:000396129500048
J	Andreini, C; Rosato, A; Banci, L				Andreini, Claudia; Rosato, Antonio; Banci, Lucia			The Relationship between Environmental Dioxygen and Iron-Sulfur Proteins Explored at the Genome Level	PLOS ONE			English	Article							FE-S CLUSTER; OXIDATIVE STRESS; BIOGENESIS; EVOLUTION; CHEMISTRY; OXYGEN; MITOCHONDRIA; SUPEROXIDE; MATURATION; INSIGHTS	About 2 billion years ago, the atmosphere of the Earth experienced a great change due to the buildup of dioxygen produced by photosynthetic organisms. This transition caused a reduction of iron bioavailability and at the same time exposed living organisms to the threat of oxidative stress. Iron-sulfur (Fe-S) clusters require iron ions for their biosynthesis and are labile if exposed to reactive oxygen species. To assess how the above transition influenced the usage of Fe-S clusters by organisms, we compared the distribution of the Fe-S proteins encoded by the genomes of more than 400 prokaryotic organisms as a function of their dioxygen requirements. Aerobic organisms use less Fe-S proteins than the majority of anaerobic organisms with a similar genome size. Furthermore, aerobes have evolved specific Fe-S proteins that bind the less iron-demanding and more chemically stable Fe2S2 clusters while reducing the number of Fe4S4-binding proteins in their genomes. However, there is a shared core of Fe-S protein families composed mainly by Fe4S4-binding proteins. Members of these families are present also in humans. The distribution of human Fe-S proteins within cell compartments shows that mitochondrial proteins are inherited from prokaryotic proteins of aerobes, whereas nuclear and cytoplasmic Fe-S proteins are inherited from anaerobic organisms.	[Andreini, Claudia; Rosato, Antonio; Banci, Lucia] Univ Florence, Magnet Resonance Ctr, Sesto Fiorentino, Italy; [Andreini, Claudia; Rosato, Antonio; Banci, Lucia] Univ Florence, Dept Chem, Sesto Fiorentino, Italy	University of Florence; University of Florence	Banci, L (corresponding author), Univ Florence, Magnet Resonance Ctr, Sesto Fiorentino, Italy.; Banci, L (corresponding author), Univ Florence, Dept Chem, Sesto Fiorentino, Italy.	banci@cerm.unifi.it	Andreini, Claudia/D-5614-2014; Rosato, Antonio/D-8548-2011; Rosato, Antonio/M-3250-2019; Andreini, Claudia/AAB-2364-2022	Andreini, Claudia/0000-0003-4329-8225; Rosato, Antonio/0000-0001-6172-0368; Rosato, Antonio/0000-0001-6172-0368; Andreini, Claudia/0000-0003-4329-8225; BANCI, LUCIA/0000-0003-0562-5774	European Commission [284209]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the European Commission (http://ec.europa.eu/index_en.htm) Grant n. 284209 to LB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreini C, 2004, BIOINFORMATICS, V20, P1373, DOI 10.1093/bioinformatics/bth095; Andreini C, 2007, PROTEINS, V67, P317, DOI 10.1002/prot.21324; Andreini C, 2016, J PROTEOME RES, V15, P1308, DOI 10.1021/acs.jproteome.6b00045; Andreini C, 2011, J CHEM INF MODEL, V51, P730, DOI 10.1021/ci100392q; Andreini C, 2009, ACCOUNTS CHEM RES, V42, P1471, DOI 10.1021/ar900015x; Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Bentrop D, 1999, BIOCHEMISTRY-US, V38, P4669, DOI 10.1021/bi982647q; Boyd ES, 2014, BIOCHEMISTRY-US, V53, P5834, DOI 10.1021/bi500488r; Braun V, 2011, CURR OPIN CHEM BIOL, V15, P328, DOI 10.1016/j.cbpa.2011.01.005; Bruska MK, 2015, CHEM-EUR J, V21, P19081, DOI 10.1002/chem.201503008; Capozzi F, 1998, STRUCT BOND, V90, P127; Crack JC, 2014, ACCOUNTS CHEM RES, V47, P3196, DOI 10.1021/ar5002507; Davies KJA, 2000, IUBMB LIFE, V50, P279, DOI 10.1080/15216540051081010; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; FLINT DH, 1993, J BIOL CHEM, V268, P22369; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Han GW, 2010, ACTA CRYSTALLOGR F, V66, P1326, DOI 10.1107/S1744309110037619; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Koumandou VL, 2013, CRIT REV BIOCHEM MOL, V48, P373, DOI 10.3109/10409238.2013.821444; Krewulak KD, 2008, BBA-BIOMEMBRANES, V1778, P1781, DOI 10.1016/j.bbamem.2007.07.026; Ku C, 2015, NATURE, V524, P427, DOI 10.1038/nature14963; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Lill R, 2015, EUR J CELL BIOL, V94, P280, DOI 10.1016/j.ejcb.2015.05.002; Lill R, 2014, CURR OPIN MICROBIOL, V22, P111, DOI 10.1016/j.mib.2014.09.015; Meyer J, 2008, J BIOL INORG CHEM, V13, P157, DOI 10.1007/s00775-007-0318-7; Netz DJA, 2014, TRENDS CELL BIOL, V24, P303, DOI 10.1016/j.tcb.2013.11.005; Outten FW, 2015, BBA-MOL CELL RES, V1853, P1464, DOI 10.1016/j.bbamcr.2014.11.001; Paul VD, 2015, ELIFE, V4, DOI 10.7554/eLife.08231; PRYOR WA, 1986, ANNU REV PHYSIOL, V48, P657, DOI 10.1146/annurev.ph.48.030186.003301; Qi WB, 2011, COORDIN CHEM REV, V255, P688, DOI 10.1016/j.ccr.2010.10.016; Reddy TBK, 2015, NUCLEIC ACIDS RES, V43, pD1099, DOI 10.1093/nar/gku950; Roche B, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005134; Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010; Rouault TA, 2015, NAT REV MOL CELL BIO, V16, P45, DOI 10.1038/nrm3909; Stehling O, 2012, SCIENCE, V337, P195, DOI 10.1126/science.1219723; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tong WH, 2007, BIOMETALS, V20, P549, DOI 10.1007/s10534-006-9047-6; Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518; Treangen TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001284	42	36	36	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171279	10.1371/journal.pone.0171279	http://dx.doi.org/10.1371/journal.pone.0171279			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135316	Green Published, gold, Green Submitted			2022-12-27	WOS:000396124700057
J	Hansen, HB; Damgaard, PB; Margaryan, A; Stenderup, J; Lynnerup, N; Willerslev, E; Allentoft, ME				Hansen, Henrik B.; Damgaard, Peter B.; Margaryan, Ashot; Stenderup, Jesper; Lynnerup, Niels; Willerslev, Eske; Allentoft, Morten E.			Comparing Ancient DNA Preservation in Petrous Bone and Tooth Cementum	PLOS ONE			English	Article							STRONTIUM ISOTOPE RATIOS; GENOME SEQUENCE; PATTERNS	Large-scale genomic analyses of ancient human populations have become feasible partly due to refined sampling methods. The inner part of petrous bones and the cementum layer in teeth roots are currently recognized as the best substrates for such research. We present a comparative analysis of DNA preservation in these two substrates obtained from the same human skulls, across a range of different ages and preservation environments. Both substrates display significantly higher endogenous DNA content (average of 16.4% and 40.0% for teeth and petrous bones, respectively) than parietal skull bone (average of 2.2%). Despite sample-to-sample variation, petrous bone overall performs better than tooth cementum (p = 0.001). This difference, however, is driven largely by a cluster of viking skeletons from one particular locality, showing relatively poor molecular tooth preservation (< 10% endogenous DNA). In the remaining skeletons there is no systematic difference between the two substrates. A crude preservation (good/bad) applied to each sample prior to DNA-extraction predicted the above/below 10% endogenous DNA threshold in 80% of the cases. Interestingly, we observe signficantly higher levels of cytosine to thymine deamination damage and lower proportions of mitochondrial/nuclear DNA in petrous bone compared to tooth cementum. Lastly, we show that petrous bones from ancient cremated individuals contain no measurable levels of authentic human DNA. Based on these findings we discuss the pros and cons of sampling the different elements.	[Hansen, Henrik B.; Damgaard, Peter B.; Margaryan, Ashot; Stenderup, Jesper; Willerslev, Eske; Allentoft, Morten E.] Univ Copenhagen, Nat Hist Museum, Ctr GeoGenet, Copenhagen, Denmark; [Lynnerup, Niels] Univ Copenhagen, Dept Forens Med, Unit Forens Anthropol, Copenhagen, Denmark; [Willerslev, Eske] Univ Cambridge, Dept Zool, Cambridge, England; [Willerslev, Eske] Wellcome Trust Sanger Inst, Cambridge, England	University of Copenhagen; University of Copenhagen; University of Cambridge; Wellcome Trust Sanger Institute	Allentoft, ME (corresponding author), Univ Copenhagen, Nat Hist Museum, Ctr GeoGenet, Copenhagen, Denmark.	morten.allentoft@gmail.com	Willerslev, Eske/AAA-5686-2019; Willerslev, Eske/A-9619-2011	Willerslev, Eske/0000-0002-7081-6748; Allentoft, Morten/0000-0003-4424-3568; Margaryan, Ashot/0000-0002-2576-2429	Centre for GeoGenetics; Danish National Resarch Foundation [DNRF94]; Lundbeck Foundation; University of Copehagen (KU2016 programme); Villum Foundation (Young Investigator Programme) [10120]; Villum Fonden [00010120] Funding Source: researchfish	Centre for GeoGenetics; Danish National Resarch Foundation; Lundbeck Foundation(Lundbeckfonden); University of Copehagen (KU2016 programme); Villum Foundation (Young Investigator Programme); Villum Fonden(Villum Fonden)	This work was supported by Centre for GeoGenetics is supported by The Danish National Resarch Foundation (DNRF94) and the Lundbeck Foundation. The work presented in this study was funded by University of Copehagen (KU2016 programme) and The Villum Foundation (Young Investigator Programme, grant no. 10120 to MEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to express our gratitude to Ceri Falys, Emma Usmanova, Alina Kolbyna, Irina Shevnina, Andrey Logvin, and Vladislav Zhitenev for having provided access to the skeletons included in this study as part of an ongoing collaboration. Centre for GeoGenetics is supported by The Danish National Resarch Foundation (DNRF94) and the Lundbeck Foundation. The work presented in this study was funded by University of Copehagen (KU2016 programme) and The Villum Foundation (Young Investigator Programme, grant no. 10120 to MEA).	Adler CJ, 2011, J ARCHAEOL SCI, V38, P956, DOI 10.1016/j.jas.2010.11.010; Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Allentoft ME, 2012, P ROY SOC B-BIOL SCI, V279, P4724, DOI 10.1098/rspb.2012.1745; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Damgaard PB, 2015, SCI REP-UK, V5, DOI 10.1038/srep11184; Deagle Bruce E, 2006, Front Zool, V3, P11, DOI 10.1186/1742-9994-3-11; Frei KM, 2015, SCI REP-UK, V5, DOI 10.1038/srep10431; Frisch T, 1998, BONE, V22, P677, DOI 10.1016/S8756-3282(98)00050-7; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Gamba C, 2016, MOL ECOL RESOUR, V16, P459, DOI 10.1111/1755-0998.12470; Gamba C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6257; Gilbert MTP, 2007, SCIENCE, V317, P1927, DOI 10.1126/science.1146971; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Haak W., 2015, NATURE; Harvig L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101603; Higgins D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126935; Homoe P, 1996, J LARYNGOL OTOL, V110, P1114; Jeffery N, 2004, J ANAT, V204, P71, DOI 10.1111/j.1469-7580.2004.00250.x; Jonsson H, 2013, BIOINFORMATICS; Jorkov MLS, 2009, AM J PHYS ANTHROPOL, V138, P199, DOI 10.1002/ajpa.20919; Korlevic P, 2015, BIOTECHNIQUES, V59, P87, DOI 10.2144/000114320; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Lazaridis I, 2016, NATURE, V536, P419, DOI 10.1038/nature19310; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; Llorente MG, 2015, SCIENCE, V350, P820, DOI 10.1126/science.aad2879; Martin M, 2011, EMBNET J, V17; Mathieson I, 2015, NATURE, V528, P499, DOI 10.1038/nature16152; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; MOLNAR S, 1971, AM J PHYS ANTHROPOL, V34, P175, DOI 10.1002/ajpa.1330340204; Noren A, 2005, AM J PHYS ANTHROPOL, V128, P318, DOI 10.1002/ajpa.20245; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Pedersen JS, 2014, GENOME RES, V24, P454, DOI 10.1101/gr.163592.113; Pinhasi R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129102; Powell ML, 1985, ANAL DENT WEAR CARIE; Price TD, 2002, ARCHAEOMETRY, V44, P117, DOI 10.1111/1475-4754.00047; Price TD, 2000, J ARCHAEOL SCI, V27, P903, DOI 10.1006/jasc.1999.0504; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; Sarkissian CD, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0387; Scott G. R., 2000, ANTHR MODERN HUMAN T; Skoglund P., 2016, NATURE; Smith CI, 2003, J HUM EVOL, V45, P203, DOI 10.1016/S0047-2484(03)00106-4; Warinner C, 2014, NAT GENET, V46, P336, DOI 10.1038/ng.2906; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813	47	84	90	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170940	10.1371/journal.pone.0170940	http://dx.doi.org/10.1371/journal.pone.0170940			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7VX	28129388	Green Submitted, Green Published, gold			2022-12-27	WOS:000396211400023
J	Huang, L; Duan, CC; Zhao, YJ; Gao, L; Niu, CH; Xu, JB; Li, SY				Huang, Li; Duan, Cuicui; Zhao, Yujuan; Gao, Lei; Niu, Chunhua; Xu, Jingbo; Li, Shengyu			Reduction of Aflatoxin B-1 Toxicity by Lactobacillus plantarum C88: A Potential Probiotic Strain Isolated from Chinese Traditional Fermented Food "Tofu"	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; INTESTINAL-ABSORPTION; OXIDATIVE STRESS; DAIRY STRAINS; BINDING; METABOLISM; ACTIVATION; EXCRETION; IMMUNITY; PROTECT	In this study, we investigated the potential of Lactobacillus plantarum isolated from Chinese traditional fermented foods to reduce the toxicity of aflatoxin B-1 (AFB(1)), and its subsequent detoxification mechanism. Among all the investigated L. plantarum strains, L. plantarum C88 showed the strongest AFB(1) binding capacity in vitro, and was orally administered to mice with liver oxidative damage induced by AFB(1). In the therapy groups, the mice that received L. plantarum C88, especially heat-killed L. plantarum C88, after a single dose of AFB(1) exposure, showed an increase in unabsorbed AFB(1) in the feces. Moreover, the effects of L. plantarum C88 on the enzymes and non-enzymes antioxidant abilities in serum and liver, histological alterations of liver were assayed. The results indicated that compared to the control group, L. plantarum C88 alone administration induced significant increase of antioxidant capacity, but did not induce any significant changes in the histological picture. Compared to the mice that received AFB(1) only, L. plantarum C88 treatment could weaken oxidative stress by enhancing the activity of antioxidant enzymes and elevating the expression of Glutathione S-transferase (GST) A3 through Nuclear factor erythroid (derived factor 2) related factor 2 (Nrf2) pathway. Furthermore, cytochrome P450 (CYP 450) 1A2 and CYP 3A4 expression was inhibited by L. plantarum C88, and urinary aflatoxin B-1-N-7-guanine (AFB-N-7-guanine), a AFB(1) metabolite formed by CYP 1A2 and CYP 3A4, was significantly reduced by the presence of viable L. plantarum C88. Meanwhile, the significant improvements were showed in histological pictures of the liver tissues in mice orally administered with viable L. plantarum C88. Collectively, L. plantarum C88 may alleviate AFB(1) toxicity by increasing fecal AFB(1) excretion, reversing deficits in antioxidant defense systems and regulating the metabolism of AFB(1).	[Huang, Li; Xu, Jingbo] Northeast Normal Univ, Sch Environm, Changchun, Jilin, Peoples R China; [Duan, Cuicui; Zhao, Yujuan; Gao, Lei; Niu, Chunhua; Li, Shengyu] Jilin Acad Agr Sci, Inst Agro Food Technol, Changchun, Jilin, Peoples R China	Northeast Normal University - China; Jilin Academy of Agricultural Sciences	Xu, JB (corresponding author), Northeast Normal Univ, Sch Environm, Changchun, Jilin, Peoples R China.; Li, SY (corresponding author), Jilin Acad Agr Sci, Inst Agro Food Technol, Changchun, Jilin, Peoples R China.	xujb515@nenu.edu.cn; lisy720@126.com			Modern Agroindustrial Technology Research Systems in China [CARS-37]; National Public Benefit Research (Agriculture) Foundation [201303085]; Jilin Agricultural Innovation Project [52110302]	Modern Agroindustrial Technology Research Systems in China; National Public Benefit Research (Agriculture) Foundation; Jilin Agricultural Innovation Project	This work was financially supported by Modern Agroindustrial Technology Research Systems in China (CARS-37), National Public Benefit Research (Agriculture) Foundation (201303085), and Jilin Agricultural Innovation Project (52110302). SL received the fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ben Salah-Abbes J, 2015, J IMMUNOTOXICOL, V12, P40, DOI 10.3109/1547691X.2014.880534; Chang Injeong, 2007, Mycobiology, V35, P76, DOI 10.4489/MYCO.2007.35.2.076; Choi SS, 2006, LETT APPL MICROBIOL, V42, P452, DOI 10.1111/j.1472-765X.2006.01913.x; Eaton DL, 2014, CANCER PREV RES, V7, P653, DOI 10.1158/1940-6207.CAPR-14-0119; El-Nezami H, 1998, FOOD CHEM TOXICOL, V36, P321, DOI 10.1016/S0278-6915(97)00160-9; Gerbaldo GA, 2012, FEMS MICROBIOL LETT, V332, P27, DOI 10.1111/j.1574-6968.2012.02570.x; Gratz S, 2007, APPL ENVIRON MICROB, V73, P3958, DOI 10.1128/AEM.02944-06; Gratz S, 2006, APPL ENVIRON MICROB, V72, P7398, DOI 10.1128/AEM.01348-06; Gross-Steinmeyer K, 2012, TOXICOLOGY, V299, P69, DOI 10.1016/j.tox.2012.05.016; Haskard C, 2000, CHEM-BIOL INTERACT, V128, P39, DOI 10.1016/S0009-2797(00)00186-1; Haskard CA, 2001, APPL ENVIRON MICROB, V67, P3086, DOI 10.1128/AEM.67.7.3086-3091.2001; Hatakka K, 2008, INT J FOOD MICROBIOL, V128, P406, DOI 10.1016/j.ijfoodmicro.2008.09.010; Hathout AS, 2011, TOXICON, V58, P179, DOI 10.1016/j.toxicon.2011.05.015; Hernandez-Mendoza A, 2009, J APPL MICROBIOL, V107, P395, DOI 10.1111/j.1365-2672.2009.04217.x; Hernandez-Mendoza A, 2011, J BASIC MICROB, V51, P263, DOI 10.1002/jobm.201000119; IARC, 2002, MON EV CARC RISKS HU, V82; Ilic Z, 2010, TOXICOL APPL PHARM, V242, P241, DOI 10.1016/j.taap.2009.10.008; Jiang Y, 2005, INT IMMUNOL, V17, P807, DOI 10.1093/intimm/dxh262; Kamdem LK, 2006, CHEM RES TOXICOL, V19, P577, DOI 10.1021/tx050358e; Kumar M, 2012, BRIT J NUTR, V107, P1006, DOI 10.1017/S0007114511003953; Kwak MK, 2001, MUTAT RES-FUND MOL M, V480, P305, DOI 10.1016/S0027-5107(01)00190-7; Li SY, 2012, FOOD CHEM, V135, P1914, DOI 10.1016/j.foodchem.2012.06.048; Meng XY, 2015, EXP THER MED, V10, P2277, DOI 10.3892/etm.2015.2787; Mykkanen H, 2005, INT J CANCER, V115, P879, DOI 10.1002/ijc.20951; Peltonen K, 2001, J DAIRY SCI, V84, P2152, DOI 10.3168/jds.S0022-0302(01)74660-7; Rawal S, 2010, RES VET SCI, V89, P325, DOI 10.1016/j.rvsc.2010.04.011; Samuel MS, 2014, INT BIODETER BIODEGR, V86, P202, DOI 10.1016/j.ibiod.2013.08.026; Wang S, 2012, J DAIRY SCI, V95, P4813, DOI 10.3168/jds.2012-5426; Yang F, 2007, ADV MATER, V19, P4166, DOI 10.1002/adma.200700837; Yunus AW, 2011, TOXINS, V3, P566, DOI 10.3390/toxins3060566	30	56	60	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170109	10.1371/journal.pone.0170109	http://dx.doi.org/10.1371/journal.pone.0170109			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129335	Green Submitted, gold, Green Published			2022-12-27	WOS:000396211400063
J	Schlott, F; Steubl, D; Hoffmann, D; Matevossian, E; Lutz, J; Heemann, U; Hosel, V; Busch, DH; Renders, L; Neuenhahn, M				Schlott, Fabian; Steubl, Dominik; Hoffmann, Dieter; Matevossian, Edouard; Lutz, Jens; Heemann, Uwe; Hoesel, Volker; Busch, Dirk H.; Renders, Lutz; Neuenhahn, Michael			Primary Cytomegalovirus Infection in Seronegative Kidney Transplant Patients Is Associated with Protracted Cold Ischemic Time of Seropositive Donor Organs	PLOS ONE			English	Article							RENAL-TRANSPLANTATION; MEMORY T; RECIPIENTS; DISEASE; CELLS; IMPACT; PROPHYLAXIS; PREVENTION; RISK; MANAGEMENT	Human Cytomegalovirus (CMV) can lead to primary infection or reactivation in CMV-seronegative or-seropositive kidney transplant recipients, respectively. Complications comprise severe end-organ diseases and acute or chronic transplant rejection. Risk for CMV manifestation is stratified according to the CMV-IgG-serostatus, with donor+/recipient-(D+/R-) patients carrying the highest risk for CMV-replication. However, risk factors predisposing for primary infection in CMV-seronegative recipients are still not fully elucidated. Therefore, we monitored D+/R-high-risk patients undergoing kidney transplantation in combination with antiviral prophylaxis for the incidence of CMV-viremia for a median follow-up time of 784 days (156-1155 days). In this period, we analyzed the functional CMV-specific T cell response by intracellular cytokine staining and CMV-serology by ELISA. Only four of eight D +/R-patients developed clinically relevant CMV-viremia followed by seroconversion. Viremia triggered expansion of functional CMV-specific T cells correlating with protection against secondary CMV-reactivations. In contrast, all other patients remained permanently aviremic and showed no immunological correlate of infection after discontinuation of antiviral prophylaxis for up to three years. Comparing cold ischemic times (CIT) of viremic (median = 1020 min; 720-1080 min) and aviremic patients (median = 335 min; 120-660 min) revealed significantly (p = 0.0286) protracted CIT in patients with primary CMV-infection. Taken together, primary CMV-infection affects only a subgroup of D+/R-patients correlating with length of CIT. Therefore, patients with extended CIT should be thoroughly monitored for CMV-replication well beyond discontinuation of antiviral prophylaxis. In contrast, patients with short CIT remained permanently uninfected and might benefit from shorter prophylactic treatment.	[Schlott, Fabian; Busch, Dirk H.; Neuenhahn, Michael] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Schlott, Fabian; Matevossian, Edouard; Heemann, Uwe; Busch, Dirk H.; Renders, Lutz; Neuenhahn, Michael] Partner Site Munich, German Ctr Infect Res DZIF, Munich, Germany; [Steubl, Dominik; Heemann, Uwe; Renders, Lutz] Tech Univ Munich, Klinikum Rechts Isar, Dept Nephrol, Munich, Germany; [Hoffmann, Dieter] Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Virol, Munich, Germany; [Matevossian, Edouard] Tech Univ Munich, Dept Surg, Transplantat Zentrum Munchen, Klinikum Rechts Isar, Munich, Germany; [Lutz, Jens] Johannes Gutenberg Univ Mainz, Dept Med, Nephrol Sect 1, Mainz, Germany; [Hoesel, Volker] Tech Univ Munich, Chair Biomath, Garching, Germany	Technical University of Munich; German Center for Infection Research; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Johannes Gutenberg University of Mainz; Technical University of Munich	Neuenhahn, M (corresponding author), Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany.; Neuenhahn, M (corresponding author), Partner Site Munich, German Ctr Infect Res DZIF, Munich, Germany.	michael.neuenhahn@tum.de			Principles and Applications of Adoptive T Cell Therapy; SFB (Sonderforschungsbereich/Collaborative Research Centre) [TR36 (TP-A10)]; German Center for Infection Research (DZIF), partner site Munich, Munich, Germany	Principles and Applications of Adoptive T Cell Therapy; SFB (Sonderforschungsbereich/Collaborative Research Centre); German Center for Infection Research (DZIF), partner site Munich, Munich, Germany	The work was supported by the following: Principles and Applications of Adoptive T Cell Therapy; SFB (Sonderforschungsbereich/Collaborative Research Centre) TR36 (TP-A10); http://www.sfb-tr36.com/; MN; and German Center for Infection Research (DZIF), partner site Munich, Munich, Germany; http://www.dzif.de/; MN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthurs SK, 2008, CLIN INFECT DIS, V46, P840, DOI 10.1086/528718; Crough T, 2009, CLIN MICROBIOL REV, V22, P76, DOI 10.1128/CMR.00034-08; Helantera I, 2014, TRANSPL INFECT DIS, V16, P568, DOI 10.1111/tid.12247; Humar A, 2010, AM J TRANSPLANT, V10, P1228, DOI 10.1111/j.1600-6143.2010.03074.x; Kanter J, 2009, TRANSPL P, V41, P2156, DOI 10.1016/j.transproceed.2009.06.057; KIDGO, 2009, AM J TRANSPLANT S3, V9, pS1; Klenerman P, 2016, NAT REV IMMUNOL, V16, P367, DOI 10.1038/nri.2016.38; Kotton CN, 2013, TRANSPLANTATION, V96, P333, DOI 10.1097/TP.0b013e31829df29d; Kotton CN, 2010, NAT REV NEPHROL, V6, P711, DOI 10.1038/nrneph.2010.141; Lucia M, 2014, CLIN INFECT DIS, V59, P1537, DOI 10.1093/cid/ciu589; Mengelle C, 2015, J MED VIROL, V87, P836, DOI 10.1002/jmv.23964; Park CO, 2015, NAT MED, V21, P688, DOI 10.1038/nm.3883; Ponticelli CE, 2015, KIDNEY INT, V87, P272, DOI 10.1038/ki.2014.359; Reischig T, 2012, J AM SOC NEPHROL, V23, P1588, DOI 10.1681/ASN.2012010100; Reusser P, 1999, J INFECT DIS, V180, P247, DOI 10.1086/314879; Roman A, 2014, TRANSPLANT REV-ORLAN, V28, P84, DOI 10.1016/j.trre.2014.01.001; Sagedal S, 2004, KIDNEY INT, V66, P329, DOI 10.1111/j.1523-1755.2004.00735.x; Sagedal S, 2002, AM J TRANSPLANT, V2, P850, DOI 10.1034/j.1600-6143.2002.20907.x; Salvadori Maurizio, 2015, World J Transplant, V5, P52, DOI 10.5500/wjt.v5.i2.52; Shabir S, 2013, J AM SOC NEPHROL, V24, P1698, DOI 10.1681/ASN.2013040340; STEIN J, 1993, J GEN VIROL, V74, P2333, DOI 10.1099/0022-1317-74-11-2333; Tennankore KK, 2016, KIDNEY INT, V89, P648, DOI 10.1016/j.kint.2015.09.002; Terrazzini Nadia, 2014, F1000Prime Rep, V6, P28, DOI 10.12703/P6-28; Zhuang Q, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12623	24	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0171035	10.1371/journal.pone.0171035	http://dx.doi.org/10.1371/journal.pone.0171035			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129395	Green Submitted, gold, Green Published			2022-12-27	WOS:000396211400010
J	Yu, SQ; Wang, YW; Yuan, HJ; Zhao, HW; Lv, W; Chen, J; Wan, FC; Liu, DF; Gao, ZL; Wu, JT				Yu, Shengqiang; Wang, Yanwei; Yuan, Hejia; Zhao, Hongwei; Lv, Wei; Chen, Jian; Wan, Fengchun; Liu, Dongfu; Gao, Zhenli; Wu, Jitao			Knockdown of Mediator Complex Subunit 19 Suppresses the Growth and Invasion of Prostate Cancer Cells	PLOS ONE			English	Article							ANDROGEN RECEPTOR; MED19; PROLIFERATION; EXPRESSION; TUMORIGENESIS; METASTASIS; INHIBITOR; CARCINOMA; THERAPY; SHRNA	Prostate cancer (PCa) is one of the most common cancers in elderly men. Mediator Complex Subunit 19 (Med19) is overexpressed and plays promotional roles in many cancers. However, the roles of Med19 in PCa are still obscure. In this study, by using immunohistochemical staining, we found higher expression level of Med19 in PCa tissues than in adjacent benign prostate tissues. We then knocked down the Med19 expression in PCa cell lines LNCaP and PC3 by using lentivirus siRNA. Cell proliferation, anchor-independent growth, migration, and invasion were suppressed in Med19 knockdown PCa cells. In nude mice xenograft model, we found that Med19 knockdown PCa cells formed smaller tumors with lower proliferation index than did control cells. In the mechanism study, we found that Med19 could regulate genes involved in cell proliferation, cell cycle, and epithelial-mesenchymal transition, including P27, pAKT, pPI3K, IGF1R, E-Cadherin, N-Cadherin, Vimentin, ZEB2, Snail-1 and Snail-2. Targeting Med19 in PCa cells could inhibit the PCa growth and metastasis, and might be a therapeutic option for PCa in the future.	[Yu, Shengqiang; Yuan, Hejia; Zhao, Hongwei; Wan, Fengchun; Liu, Dongfu; Gao, Zhenli; Wu, Jitao] Qingdao Univ, Affiliated Yantai Yuhuangding Hosp, Dept Urol, Yantai, Shandong, Peoples R China; [Wang, Yanwei; Chen, Jian] Qingdao Univ, Affiliated Yantai Yuhuangding Hosp, Cent Lab, Yantai, Shandong, Peoples R China; [Lv, Wei] Qingdao Univ, Affiliated Yantai Yuhuangding Hosp, Dept Nephrol, Yantai, Shandong, Peoples R China	Qingdao University; Qingdao University; Qingdao University	Wu, JT (corresponding author), Qingdao Univ, Affiliated Yantai Yuhuangding Hosp, Dept Urol, Yantai, Shandong, Peoples R China.	agourodman@163.com; jtwu1006@163.com	yu, shengqiang/AAT-4994-2020	Yu, Shengqiang/0000-0003-4654-5340	National Natural Science Foundation of China [81302234, 81572835]; Shandong Provincial Natural Science Foundation [ZR2013HL070]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province)	This study was supported by National Natural Science Foundation of China (81302234, http://www.nsfc.gov.cn/); National Natural Science Foundation of China (81572835, http://www.nsfc.gov.cn/); and Shandong Provincial Natural Science Foundation (ZR2013HL070, http://www.sdnsf.gov.cn/portal/).	Botrel TEA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157660; Broster SA, 2015, FUTURE ONCOL, V11, P3197, DOI 10.2217/fon.15.253; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Cui XG, 2011, BMB REP, V44, P547, DOI 10.5483/BMBRep.2011.44.8.547; Ding XF, 2012, GENE, V504, P262, DOI 10.1016/j.gene.2012.04.033; Golabek T, 2016, CENT EUR J UROL, V69, P131, DOI 10.5173/ceju.2016.812; Imberg-Kazdan K, 2013, GENOME RES, V23, P581, DOI 10.1101/gr.144774.112; King D, 2015, J PEDIAT HEMATOL ONC, V37, P245, DOI 10.1097/MPH.0000000000000329; Li XH, 2011, CANCER BIOTHER RADIO, V26, P495, DOI 10.1089/cbr.2010.0863; Liu YT, 2012, MOL MED REP, V6, P1050, DOI 10.3892/mmr.2012.1065; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; Paller Channing J, 2013, Clin Adv Hematol Oncol, V11, P14; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Singh P, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0805-3; Sun M, 2011, MOL CELL BIOCHEM, V355, P27, DOI 10.1007/s11010-011-0835-0; van Duijn PW, 2006, PROSTATE, V66, P749, DOI 10.1002/pros.20398; Wang TJ, 2011, ONCOL RES, V19, P193, DOI 10.3727/096504011X12970940207760; Wei Ling, 2015, Asian Pac J Cancer Prev, V16, P875; Wen H, 2013, ANN DIAGN PATHOL, V17, P259, DOI 10.1016/j.anndiagpath.2012.11.004; Wong MC, 2016, EUR UROL; Xu LL, 2012, ASIAN PAC J CANCER P, V13, P3695, DOI 10.7314/APJCP.2012.13.8.3695; Yu SQ, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0674-9; Zhang H, 2012, UROL ONCOL-SEMIN ORI, V30, P920, DOI 10.1016/j.urolonc.2010.10.003; Zhang XZ, 2016, PROCEEDINGS 2016 IEEE INTERNATIONAL CONFERENCE ON INDUSTRIAL TECHNOLOGY (ICIT), P2016, DOI 10.1109/ICIT.2016.7475077; Zou SW, 2011, ACTA PHARMACOL SIN, V32, P354, DOI 10.1038/aps.2010.223	26	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0171134	10.1371/journal.pone.0171134	http://dx.doi.org/10.1371/journal.pone.0171134			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125713	Green Published, gold, Green Submitted			2022-12-27	WOS:000396176100006
J	Zheng, XB; Fan, JB; Xu, L; Zhou, J				Zheng, Xuebo; Fan, Jianbo; Xu, Lei; Zhou, Jing			Effects of Combined Application of Biogas Slurry and Chemical Fertilizer on Soil Aggregation and C/N Distribution in an Ultisol	PLOS ONE			English	Article							LONG-TERM-FERTILIZATION; ORGANIC-MATTER; PHYSICAL-PROPERTIES; CARBON SEQUESTRATION; MANURE APPLICATION; NO-TILLAGE; STABILITY; NITROGEN; MANAGEMENT; RESIDUES	Unreasonable use of chemical fertilizer (CF) on agricultural soil leads to massive losses of soil organic carbon (SOC) and total nitrogen (TN) in tropical and subtropical areas, where soil conditions are unfavorable for aggregate formation. This study evaluated the effects of combined application of biogas slurry (BS) plus CF on soil aggregation and aggregate-associated C/N concentration and storage in an Ultisol. Six treatments included: no fertilizer (T1), CF only (T2), partial (15% (T3), 30% (T4) and 45% (T5)) substitution of TN with BS and BS only (T6). Soil mechanical-stable aggregates (MSAs) formation and stability as well as MSAs D associated C/N concentration and storage were observed in different aggregate sizes (>5, 5-2, 2-1, 1.0-0.5, 0.50-0.25 and < 0.25 mm). The proportion of MSAs >5 mm significantly increased with BS substitution (T5), while the proportions of MSAs 1.0-0.5 mm, MSAs 0.50-0.25 mm and MSAs <0.25 mm significantly decreased. Both mean weight diameter and geometric mean diameter were highest in T5, which improved soil aggregation stability as well as resulted in significantly higher SOC and TN concentrations and storage in MSAs >0.5 mm that constituted 72-82% of MSAs. Stepwise regression analysis showed that MSAs >5 mm, SOC in MSAs >5 mm and TN in MSAs >5 mm were the dominant variables affecting aggregate stability. Meanwhile SOC in MSAs <0.25 mm and TN in MSAs 2-1 mm were independent variables affecting SOC and TN concentrations in bulk soils. Therefore, certain rate of combined application of BS plus CF is an effective, eco-friendly way to improve soil quality in an Ultisol.	[Zheng, Xuebo; Fan, Jianbo; Xu, Lei; Zhou, Jing] Chinese Acad Sci, Inst Soil Sci, Nanjing, Jiangsu, Peoples R China; [Zheng, Xuebo; Xu, Lei; Zhou, Jing] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhou, Jing] Chinese Acad Sci, Natl Engn Res & Technol Ctr Red Soil Improvement, Red Soil Ecol Expt Stn, Yingtan, Peoples R China; [Zhou, Jing] Jiangxi Acad Sci, Inst Biol Resource, Nanchang, Jiangxi, Peoples R China	Chinese Academy of Sciences; Institute of Soil Science, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences	Fan, JB (corresponding author), Chinese Acad Sci, Inst Soil Sci, Nanjing, Jiangsu, Peoples R China.	jbfan@issas.ac.cn		Zheng, Xuebo/0000-0001-8043-0067; zhou, jing/0000-0002-3426-1300	National Natural Science Foundation of China (NSFC) [41471237]; Key Laboratory of Bio-organic Fertilizer Creation, Ministry of Agriculture, P.R. China [233400]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Key Laboratory of Bio-organic Fertilizer Creation, Ministry of Agriculture, P.R. China	This study was financially supported (partially supported) by National Natural Science Foundation of China (NSFC) General Projects (41471237), and the Open Project Program of Key Laboratory of Bio-organic Fertilizer Creation, Ministry of Agriculture, P.R. China (233400).	Abubaker J, 2012, APPL ENERG, V99, P126, DOI 10.1016/j.apenergy.2012.04.050; Alagoz Z, 2009, SOIL TILL RES, V103, P419, DOI 10.1016/j.still.2008.12.006; Alburquerque JA, 2012, EUR J AGRON, V43, P119, DOI 10.1016/j.eja.2012.06.001; ANGERS DA, 1991, BIOL FERT SOILS, V11, P79, DOI 10.1007/BF00335840; Angers DA, 1998, SOIL TILL RES, V47, P91, DOI 10.1016/S0167-1987(98)00077-4; Alburquerque JA, 2012, BIOMASS BIOENERG, V40, P181, DOI 10.1016/j.biombioe.2012.02.018; Arai M, 2014, GEODERMA, V221, P50, DOI 10.1016/j.geoderma.2014.01.022; Bai WenBo, 2010, Transactions of the Chinese Society of Agricultural Engineering, V26, P69; Benbi DK, 2010, NUTR CYCL AGROECOSYS, V87, P233, DOI 10.1007/s10705-009-9331-2; Bin Z, 2006, PEDOSPHERE, V16, P699, DOI 10.1016/S1002-0160(06)60105-7; Bossuyt H, 2001, APPL SOIL ECOL, V16, P195, DOI 10.1016/S0929-1393(00)00116-5; CHEPIL W. S., 1962, SOIL SCI SOC AMER PROC, V26, P4; Emerson W. W., 1986, Interactions of soil minerals with natural organics and microbes, P521; Focht DD, 1981, SOIL SCI, V132, P317; FORTUN A, 1990, J SOIL SCI, V41, P563, DOI 10.1111/j.1365-2389.1990.tb00226.x; Galvez A, 2012, AGR ECOSYST ENVIRON, V160, P3, DOI 10.1016/j.agee.2011.06.015; Grandy AS, 2002, SOIL SCI SOC AM J, V66, P1311, DOI 10.2136/sssaj2002.1311; GUPTA VVSR, 1988, SOIL BIOL BIOCHEM, V20, P777, DOI 10.1016/0038-0717(88)90082-X; HAYNES RJ, 1990, J SOIL SCI, V41, P73, DOI 10.1111/j.1365-2389.1990.tb00046.x; Haynes RJ, 1998, NUTR CYCL AGROECOSYS, V51, P123, DOI 10.1023/A:1009738307837; Huang S, 2010, GEODERMA, V154, P364, DOI 10.1016/j.geoderma.2009.11.009; Kemper WD, AGGREGATE STABILITY; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R, 2009, FOOD SECUR, V1, P45, DOI 10.1007/s12571-009-0009-z; Marriott EE, 2006, SOIL SCI SOC AM J, V70, P950, DOI 10.2136/sssaj2005.0241; McLean E., 1983, METHODS SOIL ANAL PA, V9, P199, DOI DOI 10.2134/AGRONMONOGR9.2.2ED.C12; Meng QF, 2014, J SOIL SEDIMENT, V14, P1041, DOI 10.1007/s11368-014-0859-7; Naveed M, 2014, GEODERMA, V217, P181, DOI 10.1016/j.geoderma.2013.12.001; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; NWADIALO B E, 1991, Soil Technology, V4, P343, DOI 10.1016/0933-3630(91)90012-C; OADES JM, 1991, AUST J SOIL RES, V29, P815, DOI 10.1071/SR9910815; PAINULI DK, 1990, AGROCHIMICA, V34, P117; Piccolo A, 1999, SOIL SCI SOC AM J, V63, P1801, DOI 10.2136/sssaj1999.6361801x; PUGET P, 1995, EUR J SOIL SCI, V46, P449, DOI 10.1111/j.1365-2389.1995.tb01341.x; Purakayastha TJ, 2008, GEODERMA, V144, P370, DOI 10.1016/j.geoderma.2007.12.006; Rasool R, 2008, SOIL TILL RES, V101, P31, DOI 10.1016/j.still.2008.05.015; Simansky V, 2008, SOIL TILL RES, V100, P125, DOI 10.1016/j.still.2008.05.008; Six J, 2006, SOIL SCI SOC AM J, V70, P555, DOI 10.2136/sssaj2004.0347; Six J, 2000, SOIL BIOL BIOCHEM, V32, P2099, DOI 10.1016/S0038-0717(00)00179-6; Six J, 2000, SOIL SCI SOC AM J, V64, P1042, DOI 10.2136/sssaj2000.6431042x; SOMMER SG, 1992, ACTA AGR SCAND B-S P, V42, P146, DOI 10.1080/09064719209417969; Song ZW, 2015, J AGR SCI-CAMBRIDGE, V153, P236, DOI 10.1017/S0021859614000100; Spohn M, 2011, SOIL BIOL BIOCHEM, V43, P1081, DOI 10.1016/j.soilbio.2011.01.029; TISDALL JM, 1982, J SOIL SCI, V33, P141, DOI 10.1111/j.1365-2389.1982.tb01755.x; Verhulst N, 2011, PLANT SOIL, V340, P453, DOI 10.1007/s11104-010-0618-5; Yang XY, 2011, J PLANT NUTR SOIL SC, V174, P775, DOI 10.1002/jpln.201000134; Yilmaz E, 2014, J ENVIRON MANAGE, V144, P93, DOI 10.1016/j.jenvman.2014.05.023; Zhang B, 2001, GEODERMA, V99, P123, DOI 10.1016/S0016-7061(00)00069-0; Zhang MingKui, 1997, Acta Pedologica Sinica, V34, P359; Zheng XB, 2016, J SOIL SEDIMENT, V16, P449, DOI 10.1007/s11368-015-1254-8; Zheng XueBo, 2015, Transactions of the Chinese Society of Agricultural Engineering, V31, P142; [郑学博 Zheng Xuebo], 2015, [中国农业科学, Scientia Agricultura Sinica], V48, P3201; Zhou H, 2013, GEODERMA, V195, P23, DOI 10.1016/j.geoderma.2012.11.003; Zirkler D, 2014, BIOMASS BIOENERG, V67, P89, DOI 10.1016/j.biombioe.2014.04.021	54	16	17	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170491	10.1371/journal.pone.0170491	http://dx.doi.org/10.1371/journal.pone.0170491			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125647	gold, Green Published, Green Submitted			2022-12-27	WOS:000396176100101
J	Bougneres, P; Le Fur, S; Valtat, S; Kamatani, Y; Lathrop, M; Valleron, AJ				Bougneres, Pierre; Le Fur, Sophie; Valtat, Sophie; Kamatani, Yoichiro; Lathrop, Mark; Valleron, Alain-Jacques		Isis-Diab Collaborative Grp	Using spatio-temporal surveillance data to test the infectious environment of children before type 1 diabetes diagnosis	PLOS ONE			English	Article							ISLET AUTOIMMUNITY; FINNISH CHILDREN; ACUTE DIARRHEA; RISK-FACTORS; EARLY-LIFE; ONSET AGE; PATHOGENESIS; DISEASE; HYGIENE; SUSCEPTIBILITY	The "hygiene hypothesis" postulates that reduced exposure to infections favours the development of autoimmunity and childhood type 1 diabetes (T1D). But on the other side, viruses, notably enteroviruses, are suspected to trigger T1D. The assessment of the possible relationships between infections and T1D still defies the classical tools of epidemiology. We report the methods and results of a geographical approach that maps the addresses of patients to a communicable diseases surveillance database. We mapped the addresses of patients at birth, infancy and T1D diagnosis to the weekly estimates of the regional incidences of 5 frequent communicable diseases routinely collected since 1984 by the French Sentinel network. The pre-diagnostic infectious environment of 3548 patients with T1D diagnosed between 0.5 and 15 years was compared to those of 100 series of age-matched "virtual controls" drawn randomly on the map. Associations were classified as "suggestive" (summer diarrhea, SD, and varicella, V) when p<0.05, or "significant" (influenza-like infections, ILI) when they passed the Bonferroni correction for FDR. Exposure to ILI and SD were associated with T1D risk, while V seemed protective. In the subset of 2521 patients for which we had genome wide data, we used a case-only approach to search for interactions between SNPs and the infectious environment as defined by the Sentinel database. Two SNPs, rs116624278 and rs77232854, showed significant interaction with exposure to V between 1 and 3 years of life. The infectious associations found should be taken as possible markers of patients' environment, not as direct causative factors of T1D. They require replication in other populations. The increasing public availability of geographical environmental databases will expand the present approach to map thousands of environmental factors to the lifeline of patients affected by various diseases.	[Bougneres, Pierre; Le Fur, Sophie; Valtat, Sophie] Univ Paris Sud, Bicetre Hosp, AP HP, Dept Pediat Endocrinol, Le Kremlin Bicetre, France; [Bougneres, Pierre; Le Fur, Sophie; Valleron, Alain-Jacques] Univ Paris Sud, INSERM, U1169, Le Kremlin Bicetre, France; [Kamatani, Yoichiro] RIKEN, Lab Stat Anal, Ctr Integrat Med Sci, Tokyo, Kanagawa, Japan; [Lathrop, Mark] Ctr Natl Genotypage, Evry, France; [Lathrop, Mark] McGill Univ, Genome Quebec Innovat Ctr, Montreal, PQ, Canada	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; RIKEN; CEA; UDICE-French Research Universities; Universite Paris Saclay; McGill University	Bougneres, P (corresponding author), Univ Paris Sud, Bicetre Hosp, AP HP, Dept Pediat Endocrinol, Le Kremlin Bicetre, France.	pierre.bougneres@inserm.fr			NovoNordisk France; Lilly France; Programme Hospitalier de Recherche Clinique (PHRC ISIS-DIAB); Programme Hospitalier de Recherche Clinique (ISIS-VIRUS); Agence Nationale de la Recherche (ANR ENVIROGENEPIG); Association pour la Recherche sur le Diabete (ARD)	NovoNordisk France(Novo Nordisk); Lilly France; Programme Hospitalier de Recherche Clinique (PHRC ISIS-DIAB); Programme Hospitalier de Recherche Clinique (ISIS-VIRUS); Agence Nationale de la Recherche (ANR ENVIROGENEPIG)(French National Research Agency (ANR)); Association pour la Recherche sur le Diabete (ARD)	This study was sponsored by ongoing institutional grants from NovoNordisk France and Lilly France, a specific Inserm support lasting from 2008 to 2014, the Programme Hospitalier de Recherche Clinique (PHRC ISIS-DIAB and ISIS-VIRUS), the Agence Nationale de la Recherche (ANR ENVIROGENEPIG), the Association pour la Recherche sur le Diabete (ARD). The sponsors of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. They also did not have access to the clinical trial database, nor any opportunity to review the manuscript. The corresponding author had full access to all the data in the study and final responsibility for the decision to submit for publication.	Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Arif S, 2014, DIABETES, V63, P3835, DOI 10.2337/db14-0365; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Beyerlein A, 2016, JAMA-J AM MED ASSOC, V315, P1899, DOI 10.1001/jama.2016.2181; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Cardwell CR, 2008, DIABETIC MED, V25, P261, DOI 10.1111/j.1464-5491.2007.02351.x; Chapman NM, 2012, ISLETS, V4, P253, DOI 10.4161/isl.21570; Chauvin P, 1999, AM J PUBLIC HEALTH, V89, P79, DOI 10.2105/AJPH.89.1.79; Chen JJ, 2011, J NEUROVIROL, V17, P578, DOI 10.1007/s13365-011-0070-1; Cooke A, 2009, IMMUNOLOGY, V126, P12, DOI 10.1111/j.1365-2567.2008.03009.x; Dabelea D, 2007, JAMA-J AM MED ASSOC, V297, P2716; Filippi CM, 2008, DIABETES, V57, P2863, DOI 10.2337/db07-1023; Gale EAM, 2002, DIABETES, V51, P3353, DOI 10.2337/diabetes.51.12.3353; Gale EAM, 2002, DIABETOLOGIA, V45, P588, DOI 10.1007/s00125-002-0801-1; Gibbon C, 1997, ARCH DIS CHILD, V77, P384, DOI 10.1136/adc.77.5.384; Gillespie KM, 2004, LANCET, V364, P1699, DOI 10.1016/S0140-6736(04)17357-1; Harjutsalo V, 2008, LANCET, V371, P1777, DOI 10.1016/S0140-6736(08)60765-5; Hummel S, 2011, DIABETES CARE, V34, P1301, DOI 10.2337/dc10-2456; Hyttinen V, 2003, DIABETES, V52, P1052, DOI 10.2337/diabetes.52.4.1052; Karvonen M, 1999, DIABETES CARE, V22, P1066, DOI 10.2337/diacare.22.7.1066; Khoury MJ, 1996, AM J EPIDEMIOL, V144, P207; Lee HS, 2013, DIABETOLOGIA, V56, P1705, DOI 10.1007/s00125-013-2924-y; Letrilliart L, 1997, BRIT MED J, V315, P1645, DOI 10.1136/bmj.315.7123.1645a; Metcalfe KA, 2001, DIABETES CARE, V24, P838, DOI 10.2337/diacare.24.5.838; MIETTINEN OS, 1985, J CHRON DIS, V38, P543, DOI 10.1016/0021-9681(85)90039-6; Patterson CC, 2012, DIABETOLOGIA, V55, P2142, DOI 10.1007/s00125-012-2571-8; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rappaport SM, 2010, SCIENCE, V330, P460, DOI 10.1126/science.1192603; Razavi R, 2006, CELL, V127, P1123, DOI 10.1016/j.cell.2006.10.038; Redondo MJ, 2008, NEW ENGL J MED, V359, P2849, DOI 10.1056/NEJMc0805398; Rewers M, 2008, ANN NY ACAD SCI, V1150, P1, DOI 10.1196/annals.1447.062; Schneider DA, 2014, DIABETOLOGIA; Stefan M, 2014, J AUTOIMMUN, V50, P33, DOI 10.1016/j.jaut.2013.10.001; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Tak YG, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0050-4; Vaarala O, 2008, DIABETES, V57, P2555, DOI 10.2337/db08-0331; VALLERON AJ, 1986, AM J PUBLIC HEALTH, V76, P1289, DOI 10.2105/AJPH.76.11.1289; von Herrath M, 2009, NAT IMMUNOL, V10, P129, DOI 10.1038/ni0209-129; von Herrath M, 2009, DIABETES, V58, P2, DOI 10.2337/db08-9027; Yazdanpanah Y, 2000, EPIDEMIOL INFECT, V124, P409, DOI 10.1017/S0950268899003982; Yeung WCG, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d35; Zhang XY, 2014, TRENDS GENET, V30, P140, DOI 10.1016/j.tig.2014.02.006; Ziegler AG, 2011, J AUTOIMMUN, V37, P3, DOI 10.1016/j.jaut.2011.02.004; Ziegler AG, 2010, IMMUNITY, V32, P468, DOI 10.1016/j.immuni.2010.03.018; Zinkernagel RM, 2001, NEW ENGL J MED, V345, P1331, DOI 10.1056/NEJMra012493	48	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170658	10.1371/journal.pone.0170658	http://dx.doi.org/10.1371/journal.pone.0170658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152013	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200029
J	Kim, J; Shimizu, C; Kingsmore, SF; Veeraraghavan, N; Levy, E; dos Santos, AMR; Yang, H; Flatley, J; Hoang, LT; Hibberd, ML; Tremoulet, AH; Harismendy, O; Ohno-Machado, L; Burns, JC				Kim, Jihoon; Shimizu, Chisato; Kingsmore, Stephen F.; Veeraraghavan, Narayanan; Levy, Eric; dos Santos, Andre M. Ribeiro; Yang, Hai; Flatley, Jay; Hoang, Long Truong; Hibberd, Martin L.; Tremoulet, Adriana H.; Harismendy, Olivier; Ohno-Machado, Lucila; Burns, Jane C.			Whole genome sequencing of an African American family highlights toll like receptor 6 variants in Kawasaki disease susceptibility	PLOS ONE			English	Article							WIDE ASSOCIATION; ANIMAL-MODEL; T-CELLS; LOCI; HOSPITALIZATIONS; EXPRESSION; SNPS; GENE; IDENTIFICATION; INTERLEUKIN-6	Kawasaki disease (KD) is the most common acquired pediatric heart disease. We analyzed Whole Genome Sequences (WGS) from a 6-member African American family in which KD affected two of four children. We sought rare, potentially causative genotypes by sequentially applying the following WGS filters: sequence quality scores, inheritance model (recessive homozygous and compound heterozygous), predicted deleteriousness, allele frequency, genes in KD-associated pathways or with significant associations in published KD genome-wide association studies (GWAS), and with differential expression in KD blood transcriptomes. Biologically plausible genotypes were identified in twelve variants in six genes in the two affected children. The affected siblings were compound heterozygous for the rare variants p. Leu194Pro and p. Arg247Lys in Toll-like receptor 6 (TLR6), which affect TLR6 signaling. The affected children were also homozygous for three common, linked (r(2) = 1) intronic single nucleotide variants (SNVs) in TLR6 (rs56245262, rs56083757 and rs7669329), that have previously shown association with KD in cohorts of European descent. Using transcriptome data from pre-treatment whole blood of KD subjects (n = 146), expression quantitative trait loci (eQTL) analyses were performed. Subjects homozygous for the intronic risk allele (A allele of TLR6 rs56245262) had differential expression of Interleukin-6 (IL-6) as a function of genotype (p = 0.0007) and a higher erythrocyte sedimentation rate at diagnosis. TLR6 plays an important role in pathogen-associated molecular pattern recognition, and sequence variations may affect binding affinities that in turn influence KD susceptibility. This integrative genomic approach illustrates how the analysis of WGS in multiplex families with a complex genetic disease allows examination of both the common disease-common variant and common disease-rare variant hypotheses.	[Kim, Jihoon; Levy, Eric; dos Santos, Andre M. Ribeiro; Yang, Hai; Harismendy, Olivier; Ohno-Machado, Lucila] Univ Calif San Diego, Dept Biomed Informat, La Jolla, CA 92093 USA; [Shimizu, Chisato; Tremoulet, Adriana H.; Burns, Jane C.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Kingsmore, Stephen F.; Veeraraghavan, Narayanan] Rady Childrens Hosp, Rady Childrens Inst Genom Med, San Diego, CA USA; [Levy, Eric] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Flatley, Jay] Illumina, San Diego, CA USA; [Hoang, Long Truong] Genome Inst Singapore, Singapore, Singapore; [Hibberd, Martin L.] London Sch Hyg & Trop Med, Depatment Pathogen Mol Biol, London, England; [Tremoulet, Adriana H.; Burns, Jane C.] Rady Childrens Hosp San Diego, San Diego, CA 92123 USA; [Harismendy, Olivier] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Illumina; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of London; London School of Hygiene & Tropical Medicine; Rady Childrens Hospital San Diego; University of California System; University of California San Diego	Kim, J (corresponding author), Univ Calif San Diego, Dept Biomed Informat, La Jolla, CA 92093 USA.; Burns, JC (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.	j5kim@ucsd.edu; jcburns@ucsd.edu	Harismendy, Olivier/AAM-2072-2021	Harismendy, Olivier/0000-0002-8098-9888; Hibberd, Martin/0000-0001-8587-1849; Kingsmore, Stephen/0000-0001-7180-2527; Shimizu, Chisato/0000-0002-3149-2699	National Institute of Health [U54HL108460]; Gordon and Marilyn Macklin Foundation's private grant; Rady Children's Institute for Genomic Medicine, San Diego; NIH Roadmap for Medical Research [U54HL108460]; Gordon and Marilyn Macklin Foundation	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Marilyn Macklin Foundation's private grant; Rady Children's Institute for Genomic Medicine, San Diego; NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Marilyn Macklin Foundation	National Institute of Health grant U54HL108460 to LOM; Gordon and Marilyn Macklin Foundation's private grant to JCB and AHT; Rady Children's Institute for Genomic Medicine, San Diego. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Although Dr. Flatley was CEO of Illumina at the time that this research was initiated, Illumina did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support for the whole genome sequencing. Dr. Flatley's role was as a contributor to the interpretation of data and review of the manuscript.; We thank the family who donated their whole genome sequences. We also thank Francesca Marrassi PhD. for helpful discussion of the TLR6 exonic variants and the International Kawasaki Disease Genetics consortium for the original GWAS dataset. This work was funded by the NIH Roadmap for Medical Research, Grant U54HL108460, a grant from the Gordon and Marilyn Macklin Foundation and by Rady Children's Institute for Genomic Medicine, San Diego.	Abuhammour WM, 2005, CLIN PEDIATR, V44, P721, DOI 10.1177/000992280504400812; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alphonse MP, 2016, J IMMUNOL; Baranzini SE, 2010, NATURE, V464, P1351, DOI 10.1038/nature08990; Ben-Ali M, 2011, HUM MUTAT, V32, P643, DOI 10.1002/humu.21486; Bruno AE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-44; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; Burns JC, 2015, EXPERT REV CLIN IMMU, V11, P819, DOI 10.1586/1744666X.2015.1044980; Chang CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072037; Cybulsky AV, 2016, BBA-MOL CELL RES, V1863, P2147, DOI 10.1016/j.bbamcr.2016.05.015; Daniels LB, 2012, CIRCULATION, V125, P2447, DOI 10.1161/CIRCULATIONAHA.111.082107; DePaolo RW, 2008, CELL HOST MICROBE, V4, P350, DOI 10.1016/j.chom.2008.09.004; Dinwiddie DL, 2013, GENOMICS, V102, P442, DOI 10.1016/j.ygeno.2013.08.008; Franco A, 2014, AUTOIMMUNITY, V47, P95, DOI 10.3109/08916934.2013.860524; FURUKAWA S, 1992, EUR J PEDIATR, V151, P44, DOI 10.1007/BF02073890; Gibbons RV, 2002, ARCH PEDIAT ADOL MED, V156, P492, DOI 10.1001/archpedi.156.5.492; Gong J, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav029; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Gordon JB, 2016, JACC-CARDIOVASC INTE, V9, P687, DOI 10.1016/j.jcin.2015.12.011; Han H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11432; Hoang LT, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0102-6; Holman RC, 2003, PEDIATRICS, V112, P495, DOI 10.1542/peds.112.3.495; Huang SK, 2013, J PEDIATR-US, V163, P126, DOI 10.1016/j.jpeds.2012.12.011; Kamphans T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070151; Kato H, 1996, CIRCULATION, V94, P1379, DOI 10.1161/01.CIR.94.6.1379; Khor CC, 2011, NAT GENET, V43, P1241, DOI 10.1038/ng.981; Khor CC, 2011, J MED GENET, V48, P467, DOI 10.1136/jmg.2010.086611; Kim JJ, 2011, HUM GENET, V129, P487, DOI 10.1007/s00439-010-0937-x; Labuda LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095241; Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291; Lee YC, 2012, NAT GENET, V44, P522, DOI 10.1038/ng.2227; LEHMAN TJA, 1988, CLIN IMMUNOL IMMUNOP, V48, P108, DOI 10.1016/0090-1229(88)90161-4; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036949, 10.1371/journal.pone.0032127, 10.1371/journal.pone.0040003, 10.1186/1746-1596-7-49]; Miller NA, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0221-8; Nakamura Y, 2015, CIRCULATION S2, V131, P12; Nakamura Y, 2013, J EPIDEMIOL, V23, P429, DOI 10.2188/jea.JE20130048; Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59; Onouchi Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145486; Onouchi Y, 2012, CIRC J, V76, P1581, DOI 10.1253/circj.CJ-12-0568; Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220; Pan F, 2004, J BIOL CHEM, V279, P14477, DOI 10.1074/jbc.C300487200; Rodo X, 2014, P NATL ACAD SCI USA, V111, P7952, DOI 10.1073/pnas.1400380111; Satta N, 2008, MOL IMMUNOL, V46, P145, DOI 10.1016/j.molimm.2008.07.017; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Shea FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050557; Shey MS, 2010, GENES IMMUN, V11, P561, DOI 10.1038/gene.2010.14; Shimizu C, CIRCULATION IN PRESS; Shrestha S, 2015, INT J IMMUNOGENET, V42, P140, DOI 10.1111/iji.12190; Shvartsur Anna, 2015, Genes Cancer, V6, P84; Soden SE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010076; Stittrich Anna B, 2016, Hum Genome Var, V3, P15060, DOI 10.1038/hgv.2015.60; SUZUKI A, 1986, PEDIATR CARDIOL, V7, P3, DOI 10.1007/BF02315475; Takahashi K, 2004, INFLAMM RES, V53, P72, DOI 10.1007/s00011-003-1225-1; Tsai FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016853; Willig LK, 2015, LANCET RESP MED, V3, P377, DOI 10.1016/S2213-2600(15)00139-3; Yan YL, 2013, HUM GENET, V132, P669, DOI 10.1007/s00439-013-1279-2; Yang X, 2006, AM J PHYSIOL-HEART C, V291, pH2334, DOI 10.1152/ajpheart.00252.2006	57	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170977	10.1371/journal.pone.0170977	http://dx.doi.org/10.1371/journal.pone.0170977			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151979	Green Published, Green Accepted, gold			2022-12-27	WOS:000396161200063
J	Prinja, S; Chauhan, AS; Karan, A; Kaur, G; Kumar, R				Prinja, Shankar; Chauhan, Akashdeep Singh; Karan, Anup; Kaur, Gunjeet; Kumar, Rajesh			Impact of Publicly Financed Health Insurance Schemes on Healthcare Utilization and Financial Risk Protection in India: A Systematic Review	PLOS ONE			English	Article							SPREADING BEHAVIOR; ANDHRA-PRADESH; POVERTY; STATE; EXPENDITURES	Several publicly financed health insurance schemes have been launched in India with the aim of providing universalizing health coverage (UHC). In this paper, we report the impact of publicly financed health insurance schemes on health service utilization, out-of-pocket (OOP) expenditure, financial risk protection and health status. Empirical research studies focussing on the impact or evaluation of publicly financed health insurance schemes in India were searched on PubMed, Google scholar, Ovid, Scopus, Embase and relevant websites. The studies were selected based on two stage screening PRISMA guidelines in which two researchers independently assessed the suitability and quality of the studies. The studies included in the review were divided into two groups i.e., with and without a comparison group. To assess the impact on utilization, OOP expenditure and health indicators, only the studies with a comparison group were reviewed. Out of 1265 articles screened after initial search, 43 studies were found eligible and reviewed in full text, finally yielding 14 studies which had a comparator group in their evaluation design. All the studies (n-7) focussing on utilization showed a positive effect in terms of increase in the consumption of health services with introduction of health insurance. About 70% studies (n-5) studies with a strong design and assessing financial risk protection showed no impact in reduction of OOP expenditures, while remaining 30% of evaluations (n-2), which particularly evaluated state sponsored health insurance schemes, reported a decline in OOP expenditure among the enrolled households. One study which evaluated impact on health outcome showed reduction in mortality among enrolled as compared to non-enrolled households, from conditions covered by the insurance scheme. While utilization of healthcare did improve among those enrolled in the scheme, there is no clear evidence yet to suggest that these have resulted in reduced OOP expenditures or higher financial risk protection.	[Prinja, Shankar; Chauhan, Akashdeep Singh; Kaur, Gunjeet; Kumar, Rajesh] Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India; [Karan, Anup] Publ Hlth Fdn India, Indian Inst Publ Hlth, Delhi NCR, New Delhi, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Public Health Foundation of India	Prinja, S (corresponding author), Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India.	shankarprinja@gmail.com	Karan, Anup/AAK-2060-2020	Chauhan, Akashdeep Singh/0000-0001-6791-2221	USAID India [AID-386-A-14-00006]	USAID India(United States Agency for International Development (USAID))	This research was supported by USAID India grant AID-386-A-14-00006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya A., 2012, IMPACT NATL HLTH INS; Aiyar A, 2013, RASHTRIYA SWASTHYA B; Amicus Advisory Private Limited, RASHTR SWASTHV BIM Y; Amicus Advisory Pvt. Ltd, EV STUD RASHTR SWAST; [Anonymous], 2013, RASHTRIYA SWASTHIYA; Arnab Mukherji, 2012, Economic and Political Weekly, V47, P57; Arora D, 2010, ALTERNATIVE HLTH FIN; Asian Development Bank, 2011, REV REC DEV IMP EV; Bajpai V., 2014, ADV PUBLIC HLTH, V2014, DOI [10.1155/2014/898502., DOI 10.1155/2014/898502, 10.1155/2014/898502]; Balarajan Y, 2011, LANCET, V377, P505, DOI 10.1016/S0140-6736(10)61894-6; Bang A, 2011, HIGH LEVEL EXPERT GR; Bergkvist S, 2014, WORLD BANK POLICY RE; Berman P., 2010, Economic and Political Weekly, V45, P65; Berman P, 2004, MULTIPLE PUBLIC PRIV; Chaupal Gramin Vikas Prashikshan Evum Shodh Sansthan (Chaupal), 2013, STUD STAT PUBL UNPUB; Chaupal Gramin Vikas Prashikshan Evum Shodh Sansthan (Chaupal), 2013, STUD PAT EXP A UNPUB; Council for Tribal and Rural Development (CTRD), 2012, FIN REP EV RASHTR SW; CSO, 2014, DAT PC; Das J., 2011, Economic and Political Weekly, V46, P87; De Maeseneer J, 2008, BRIT J GEN PRACT, V58, P806, DOI 10.3399/bjgp08X342697; Devadasan N, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-29; Dhanaraj S, 2014, HLTH SHOCKS COPING S; ESCOBAR ML, 2011, IMPACT HLTH INSURANC; Fan VY, 2012, INT J HEALTH CARE FI, V12, P189, DOI 10.1007/s10754-012-9110-5; Garg CC, 2009, HEALTH POLICY PLANN, V24, P116, DOI 10.1093/heapol/czn046; Ghosh S, 2014, PUBLICLY FINANCED HL; Gill HS, 2010, INT J MULTIDISCIP RE, V2, P155; GIZ, 2012, EV IMPL PROC RASHTR; Government of India, NAT RUR HLTH MISS 20; Government of India,, 2005, NCMH REP NAT COMM MA; Government of India Ministry of Health and Family Welfare, NAT HLTH POL 2015 DR; Government of India Ministry of Health and Family Welfare, FRAM IMPL NAT HLTH M; Hou X, 2011, HOSP PATTERNS RSBY P; Katyal A, 2015, HEALTH POLICY PLANN, V30, pi23, DOI 10.1093/heapol/czu061; Kilaru A, STATE INSURANCE SCHE; Krishnaswamy K, 2011, PERFORMANCE TRENDS P; MacDonald Mott, 2011, PIL POST SURV RSBY P; Majumder A., CELL, V91; Ministry of Health and Family Welfare Directorate General of Health Services Central Bureau of Health Intellegence, 2015, NAT HLTH PROF; Mishra PJ, 2014, INT J, V2, P1036; Mitchell A., 2011, Economic and Political Weekly, V46, P15; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mor N., 2015, BEST WAY ADDRESS MAT; Mott MacDonald. Ministry of Labour & Employment, 2011, PIL POSTENR SURV RSB; Nair KS, 2013, J HEALTH MANAG, V15, P127, DOI 10.1177/0972063413486032; Nandi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066296; Nandi S., 2012, Health, Culture and Society, V2, P40; Narayana D., 2010, ECON POLIT WEEKLY, V45, P13; National Collaborating Centre for Methods and Tools, 2010, QUAL ASS TOOL QUANT; Norheim OF, 2014, MAKING FAIR CHOICES; Patel J, 2013, POSTUTILIZATION SURV; Philip NE, 2012, BMC P; Press Information Bureau Government of India Ministry of Labour & Employment, 2015, HLTH FAM WELF MIN IM; Prinja S, 2016, HLTH POLICY PLANNING; Prinja S, 2012, INDIAN J MED RES, V136, P145; Prinja S, 2015, APPL HEALTH ECON HEA, V13, P595, DOI 10.1007/s40258-015-0201-6; Prinja S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137315; Rajasekhar D, 2011, EC POLITICAL WKLY, V46, P56; Rao M, 2011, NATL MED J INDIA, V24, P335; Rao M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004471; Reddy Sunita, 2013, Indian J Public Health, V57, P254, DOI 10.4103/0019-557X.123264; Sakthivel Selvaraj, 2012, Economic and Political Weekly, V47, P60; Selvavinayagam Ts, 2012, Indian J Community Med, V37, P194, DOI 10.4103/0970-0218.99931; Shaikh M, 2015, SURGERY, V157, P865, DOI 10.1016/j.surg.2015.01.002; Shoree S, EVALUATION RSBYS KEY; Sood N, 2014, BMJ              SEP, V13; Sun C, 2010, ANAL RSBY ENROLMENT; Taneja PK, 2012, ITALIAN J PUBLIC HLT, V8; Thakur H, 2013, SOCIAL EXCLUSION RAS; Universal Health Coverage Project to Revolutionize Health Care Delivery System in Punjab, 2015, DIR INF PUBL REL; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3; WHO, 2010, WOR HEALT REP, P1; Xia Cheng-yi, 2008, Control and Decision, V23, P468; Xia CY, 2008, PROG NAT SCI-MATER, V18, P763, DOI 10.1016/j.pnsc.2007.11.018; Xia CY, 2007, PROG NAT SCI-MATER, V17, P358; Yip W, 2008, HEALTH AFFAIR, V27, P921, DOI 10.1377/hlthaff.27.4.921	76	85	86	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170996	10.1371/journal.pone.0170996	http://dx.doi.org/10.1371/journal.pone.0170996			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28151946	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161200068
J	Song, Y; Jun, JH; Shin, EJ; Kwak, YL; Shin, JS; Shim, JK				Song, Young; Jun, Ji-Hae; Shin, Eun-Jung; Kwak, Young-Lan; Shin, Jeon-Soo; Shim, Jae-Kwang			Effect of pregabalin administration upon reperfusion in a rat model of hyperglycemic stroke: Mechanistic insights associated with high-mobility group box 1	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ISCHEMIC-STROKE; OXIDATIVE STRESS; GLUCOSE; MANAGEMENT; RELEASE; INJURY; DEATH; TRIAL	hyperglycemia Hyperglycemia, which reduces the efficacy of treatments and worsens clinical outcomes, is common in stroke. Ability of pregabalin to reduce neuroexcitotoxicity may provide protection against stroke, even under hyperglycemia. We investigated its protective effect against hyperglycemic stroke and its possible molecular mechanisms. Male Wistar rats administered dextrose to cause hyperglycemia, underwent middle cerebral artery occlusion for 1 h and subsequent reperfusion. Rats were treated with an intraperitoneal injection of 30 mg/kg pregabalin or an equal amount of normal saline at the onset of reperfusion (n = 16 per group). At 24 h after reperfusion, neurological deficit, infarct volume, and apoptotic cell count were assessed. Western blot analysis was performed to determine protein expression of high-mobility group box 1 (HMGB1), toll-like receptor-4 (TLR-4), phosphorylated nuclear factor-kappa B (p-NF-kappa B), interleukin-1beta (IL-1 beta), tumor necrosis factor-alpha (TNF-alpha), phosphorylated inducible and endothelial nitric oxide synthase (p-iNOS, p-eNOS), Bcl-2, Bax, Cytochrome C, and caspase-3 in the brain. Pregabalin-treated rats showed significantly improved neurological function (31% decrease in score), reduced infarct size (by 33%), fewer apoptotic cells (by 63%), and lower expression levels of HMGB1, TLR4, p-NF-kappa B, IL-1 beta, and TNF-alpha, compared with control rats. Decreased p-iNOS and increased p-eNOS expressions were also observed. Expression of Bax, Cytochrome C, and cleaved caspase-3/caspase3 was significantly downregulated, while Bcl-2 expression was increased by pregabalin treatment. Pregabalin administration upon reperfusion decreased neuronal death and improved neurological function in hyperglycemic stroke rats. Cogent mechanisms would include attenuation of HMGB1/TLR-4-mediated inflammation and favorable modulation of the NOS.	[Song, Young; Kwak, Young-Lan; Shim, Jae-Kwang] Yonsei Univ, Coll Med, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Song, Young; Jun, Ji-Hae; Shin, Eun-Jung; Kwak, Young-Lan; Shim, Jae-Kwang] Yonsei Univ, Coll Med, Anesthesia & Pain Res Inst, Seoul, South Korea; [Shin, Jeon-Soo] Yonsei Univ, Coll Med, Dept Microbiol, Seoul, South Korea; [Shin, Jeon-Soo] Yonsei Univ, Coll Med, Brain Korea PLUS Med Sci 21, Seoul, South Korea; [Shin, Jeon-Soo] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea; [Shin, Jeon-Soo] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul, South Korea; [Song, Young] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Shim, JK (corresponding author), Yonsei Univ, Coll Med, Dept Anesthesiol & Pain Med, Seoul, South Korea.; Shim, JK (corresponding author), Yonsei Univ, Coll Med, Anesthesia & Pain Res Inst, Seoul, South Korea.	aneshim@yuhs.ac	Kwak, Young-Lan/AAF-5093-2021	Kwak, Young-Lan/0000-0002-2984-9927; Shin, Jeon-Soo/0000-0002-8294-3234; Shim, Jae-Kwang/0000-0001-9093-9692; Jun, Ji Hae/0000-0002-8080-0715; Song, Young/0000-0003-4597-387X	faculty research grant of Yonsei University College of Medicine (Seoul, Republic of Korea) [6-2013-0069]	faculty research grant of Yonsei University College of Medicine (Seoul, Republic of Korea)	This study was supported by a faculty research grant of Yonsei University College of Medicine (Seoul, Republic of Korea) for 6-2013-0069. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin SA, 2013, J NEUROCHEM, V127, P691, DOI 10.1111/jnc.12334; Balosso S, 2014, ANTIOXID REDOX SIGN, V21, P1726, DOI 10.1089/ars.2013.5349; Bemeur C, 2007, NEUROCHEM INT, V50, P890, DOI 10.1016/j.neuint.2007.03.002; Bruno A, 2008, STROKE, V39, P384, DOI 10.1161/STROKEAHA.107.493544; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Carrillo-Sepulveda MA, 2015, J MOL MED, V93, P1341, DOI 10.1007/s00109-015-1318-7; Davalos A, 1997, STROKE, V28, P708, DOI 10.1161/01.STR.28.4.708; Davis SM, 2000, STROKE, V31, P347, DOI 10.1161/01.STR.31.2.347; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Fabian RH, 2012, TRANSL STROKE RES, V3, P482, DOI 10.1007/s12975-012-0210-9; Gray CS, 2007, LANCET NEUROL, V6, P397, DOI 10.1016/S1474-4422(07)70080-7; Ha KY, 2011, J KOREAN MED SCI, V26, P404, DOI 10.3346/jkms.2011.26.3.404; Hickey MJ, 2001, ACTA PHYSIOL SCAND, V173, P119, DOI 10.1046/j.1365-201X.2001.00892.x; Hirose R, 2008, ANESTHESIOLOGY, V108, P402, DOI 10.1097/ALN.0b013e318164cff8; Hu Q, 2011, STROKE, V42, P1750, DOI 10.1161/STROKEAHA.110.603142; Huang JY, 2013, BRAIN RES, V1535, P148, DOI 10.1016/j.brainres.2013.08.057; Huang MH, 2012, EUR J PHARMACOL, V677, P71, DOI 10.1016/j.ejphar.2011.12.011; Huang ZH, 1996, J CEREBR BLOOD F MET, V16, P981, DOI 10.1097/00004647-199609000-00023; Joshi I, 2006, EUR J PHARMACOL, V553, P82, DOI 10.1016/j.ejphar.2006.09.019; KASTE M, 1994, STROKE, V25, P1348, DOI 10.1161/01.STR.25.7.1348; Kaur H, 2013, PHARMACOLOGY, V92, P324, DOI 10.1159/000356320; Kawai N, 1997, ACT NEUR S, V70, P27; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; Li PA, 2000, STROKE, V31, P183, DOI 10.1161/01.STR.31.1.183; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Luitse MJA, 2012, LANCET NEUROL, V11, P261, DOI 10.1016/S1474-4422(12)70005-4; MacDougall NJJ, 2011, J CEREBR BLOOD F MET, V31, P807, DOI 10.1038/jcbfm.2010.210; Masrur S, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002193; Morigi M, 1998, J CLIN INVEST, V101, P1905, DOI 10.1172/JCI656; Pannu R, 2006, NEUROCHEM INT, V49, P170, DOI 10.1016/j.neuint.2006.04.010; Pedrazzi M, 2006, J NEUROCHEM, V99, P827, DOI 10.1111/j.1471-4159.2006.04120.x; Shim JK, 2014, J THORAC CARDIOV SUR, V148, P298, DOI 10.1016/j.jtcvs.2014.02.076; Suh SW, 2008, ANN NEUROL, V64, P654, DOI 10.1002/ana.21511; SWANSON RA, 1994, J CEREBR BLOOD F MET, V14, P697, DOI 10.1038/jcbfm.1994.88; Toth C, 2014, THER ADV DRUG SAF, V5, P38, DOI 10.1177/2042098613505614; Villalba N, 2016, J NEUROTRAUMA; Won SJ, 2011, ANN NEUROL, V70, P583, DOI 10.1002/ana.22538; Yokoo N, 2004, ANESTH ANALG, V99, P896, DOI 10.1213/01.ANE.0000132973.32387.8B; Yoon JS, 2011, NEUROBIOL DIS, V41, P624, DOI 10.1016/j.nbd.2010.11.011	40	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171147	10.1371/journal.pone.0171147	http://dx.doi.org/10.1371/journal.pone.0171147			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152042	gold, Green Submitted, Green Published			2022-12-27	WOS:000396161200094
J	Gaziv, G; Noy, L; Liron, Y; Alon, U				Gaziv, Guy; Noy, Lior; Liron, Yuvalal; Alon, Uri			A reduced-dimensionality approach to uncovering dyadic modes of body motion in conversations	PLOS ONE			English	Article							JOINT ACTION; INTERACTIONAL SYNCHRONY; DYNAMICS; MOVEMENT; BEHAVIOR; RAPPORT; PSEUDOSYNCHRONY; ASSOCIATION; CONSTRAINTS; LISTENERS	Face-to-face conversations are central to human communication and a fascinating example of joint action. Beyond verbal content, one of the primary ways in which information is conveyed in conversations is body language. Body motion in natural conversations has been difficult to study precisely due to the large number of coordinates at play. There is need for fresh approaches to analyze and understand the data, in order to ask whether dyads show basic building blocks of coupled motion. Here we present a method for analyzing body motion during joint action using depth-sensing cameras, and use it to analyze a sample of scientific conversations. Our method consists of three steps: defining modes of body motion of individual participants, defining dyadic modes made of combinations of these individual modes, and lastly defining motion motifs as dyadic modes that occur significantly more often than expected given the single-person motion statistics. As a proof-of-concept, we analyze the motion of 12 dyads of scientists measured using two Microsoft Kinect cameras. In our sample, we find that out of many possible modes, only two were motion motifs: synchronized parallel torso motion in which the participants swayed from side to side in sync, and still segments where neither person moved. We find evidence of dyad individuality in the use of motion modes. For a randomly selected subset of 5 dyads, this individuality was maintained for at least 6 months. The present approach to simplify complex motion data and to define motion motifs may be used to understand other joint tasks and interactions. The analysis tools developed here and the motion dataset are publicly available.	[Gaziv, Guy; Noy, Lior; Liron, Yuvalal; Alon, Uri] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel; [Gaziv, Guy; Noy, Lior; Liron, Yuvalal; Alon, Uri] Weizmann Inst Sci, Theatre Lab, Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Alon, U (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel.; Alon, U (corresponding author), Weizmann Inst Sci, Theatre Lab, Rehovot, Israel.	urialon@weizmann.ac.il	Noy, Lior/GQZ-3657-2022		EU-FP7-Health-NoE-Systems Microscopy; Rising Tide Foundation; Braginsky Center for the Interface between Science and the Humanities at the Weizmann Institute of Science	EU-FP7-Health-NoE-Systems Microscopy; Rising Tide Foundation; Braginsky Center for the Interface between Science and the Humanities at the Weizmann Institute of Science	This work was supported by EU-FP7-Health-NoE-Systems Microscopy and Rising Tide Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Braginsky Center for the Interface between Science and the Humanities at the Weizmann Institute of Science for support. Uri Alon is the incumbent of the Abisch-Frenkel Professorial Chair. We thank members of our lab for discussions, Yuval Hart, Avi Mayo, Hagar Goldberg, Liron Rozenkrantz, Assi Dahan, and Hila Sheftel. We thank Scott Kelso for insightful comments on the manuscript, Partick Healey, Ido Lavi and Michael Schober for discussions, Tamar Danon and Roxanne Halper for assistance.	Abney DH, 2015, COGN PROCESS, V16, P325, DOI 10.1007/s10339-015-0648-2; Alon U., 2006, INTRO SYSTEMS BIOL D; Argyle M., 1994, PSYCHOL INTERPERSONA; Bavelas JB, 2000, J PERS SOC PSYCHOL, V79, P941, DOI 10.1037/0022-3514.79.6.941; Bavelas JB, 2002, J COMMUN, V52, P566, DOI 10.1111/j.1460-2466.2002.tb02562.x; BERNIERI FJ, 1988, J PERS SOC PSYCHOL, V54, P243, DOI 10.1037/0022-3514.54.2.243; BERNIERI FJ, 1988, J NONVERBAL BEHAV, V12, P120, DOI 10.1007/BF00986930; BERNIERI FJ, 1994, PERS SOC PSYCHOL B, V20, P303, DOI 10.1177/0146167294203008; Black DR, 2007, MOTOR CONTROL, V11, P348, DOI 10.1123/mcj.11.4.348; Boker SM, 2002, PSYCHOL METHODS, V7, P338, DOI 10.1037//1082-989X.7.3.338; Borin, 2012, CONVERSATION, V19, P325; Brennan SE, 2010, PSYCHOL LEARN MOTIV, V53, P301, DOI 10.1016/S0079-7421(10)53008-1; Campbell N, 2007, LECT NOTES COMPUT SC, V4775, P117; Clark Herbert H., 1996, USING LANGUAGE, DOI [10.1017/ CBO9780511620539, DOI 10.1017/CB09780511620539, 10.1017/CBO9780511620539]; Clarke TJ, 2005, PERCEPTION, V34, P1171, DOI 10.1068/p5203; CONDON WS, 1967, J PSYCHIAT RES, V5, P221, DOI 10.1016/0022-3956(67)90004-0; CONDON WS, 1974, SCIENCE, V183, P99, DOI 10.1126/science.183.4120.99; CONDON WS, 1966, J NERV MENT DIS, V143, P338, DOI 10.1097/00005053-196610000-00005; Dahan A, 2016, PLOS ONE, V11, P1, DOI [10.1371/journal.pone.0160747, DOI 10.1371/J0URNAL.P0NE.0160747]; Dale R, 2013, PSYCHOL LEARN MOTIV, V59, P43, DOI 10.1016/B978-0-12-407187-2.00002-2; Dale R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00355; DITTMANN AT, 1968, J PERS SOC PSYCHOL, V9, P79, DOI 10.1037/h0025722; Duarte R, 2013, HUM MOVEMENT SCI, V32, P555, DOI 10.1016/j.humov.2013.01.011; Dumas G, 2014, P NATL ACAD SCI USA, V111, pE3726, DOI 10.1073/pnas.1407486111; Eshghi A., 2012, P 34 ANN C COGN SCI, P479; Eshghi A., 2015, P 11 INT C COMP SEM, P261; Fusaroli R, 2016, COGNITIVE SCI, V40, P145, DOI 10.1111/cogs.12251; Fusaroli R, 2012, PSYCHOL SCI, V23, P931, DOI 10.1177/0956797612436816; Garrod S, 2004, TRENDS COGN SCI, V8, P8, DOI 10.1016/j.tics.2003.10.016; Garrod S, 2009, TOP COGN SCI, V1, P292, DOI 10.1111/j.1756-8765.2009.01020.x; GOODWIN C, 1980, SOCIOL INQ, V50, P272, DOI 10.1111/j.1475-682X.1980.tb00023.x; Grammer K, 1998, J NONVERBAL BEHAV, V22, P3, DOI 10.1023/A:1022986608835; Gregoromichelaki Eleni, 2011, DIALOGUE DISCOURSE, V2, P199; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Hart Y, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01130; Hart Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087213; Howes C., 2011, DIALOGUE DISCOURSE, V2, P279, DOI DOI 10.5087/D&D.V2I1.362; Ingram JN, 2008, EXP BRAIN RES, V188, P223, DOI 10.1007/s00221-008-1355-3; Jerbi K, 2007, P NATL ACAD SCI USA, V104, P7676, DOI 10.1073/pnas.0609632104; Jung C, 2011, EXP BRAIN RES, V211, P471, DOI 10.1007/s00221-011-2665-4; Kelso J, 1984, AM J PHYSIOL-REG I, V15, pR1000, DOI DOI 10.1152/ajpregu.1984.246.6.R1000; Kelso JAS, 2016, TRENDS COGN SCI, V20, P868, DOI 10.1016/j.tics.2016.08.011; Kelso JAS, 2014, IEEE SYS MAN CYBERN, P2240, DOI 10.1109/SMC.2014.6974258; Kelso JAS, 1998, NATURE, V392, P814, DOI 10.1038/33922; KENDON A, 1970, ACTA PSYCHOL, V32, P100; Kendon A, 2010, LECT NOTES COMPUT SC, V5967, P1; Kestenberg Amighi J., 1999, MEANING MOVEMENT DEV; Kimura M, 2006, J NONVERBAL BEHAV, V30, P115, DOI 10.1007/s10919-006-0011-5; Knapp M.L., 2014, CENGAGE LEARNING, VEight; Koiso H, 1998, LANG SPEECH, V41, P295, DOI 10.1177/002383099804100404; Korem Y, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004224; KRAUSS RM, 1977, J PERS SOC PSYCHOL, V35, P523, DOI 10.1037/0022-3514.35.7.523; Kugler P.N., 1980, ADV PSYCHOL, P3, DOI [10.1016/S0166-4115, DOI 10.1016/S0166-4115, 10.1016/S0166-4115(08)61936]; Lavelle M, 2013, SCHIZOPHRENIA BULL, V39, P1150, DOI 10.1093/schbul/sbs091; Magnusson MS, 2000, BEHAV RES METH INS C, V32, P93, DOI 10.3758/BF03200792; Miles LK, 2010, EUR J SOC PSYCHOL, V40, P52, DOI 10.1002/ejsp.721; Miles LK, 2009, J EXP SOC PSYCHOL, V45, P585, DOI 10.1016/j.jesp.2009.02.002; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Monster D, 2016, PHYSIOL BEHAV, V156, P24, DOI 10.1016/j.physbeh.2016.01.004; Nagaoka C, 2008, IEICE T INF SYST, VE91D, P1634, DOI 10.1093/ietisy/e91-d.6.1634; Nordham CA, 2016, INTERPERSONAL COORDINATION AND PERFORMANCE IN SOCIAL SYSTEMS, P32; Noy L, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3339/fnhum.2015.00187, 10.3389/fnhum.2015.00187]; Noy L, 2011, P NATL ACAD SCI USA, V108, P20947, DOI 10.1073/pnas.1108155108; Oullier O, 2008, SOC NEUROSCI, V3, P178, DOI 10.1080/17470910701563392; Pasupathi M, 1998, DISCOURSE PROCESS, V26, P1, DOI 10.1080/01638539809545035; Paxton A, 2013, Q J EXP PSYCHOL, V66, P2092, DOI 10.1080/17470218.2013.853089; Paxton A, 2013, BEHAV RES METHODS, V45, P329, DOI 10.3758/s13428-012-0249-2; Pickering MJ, 2004, BEHAV BRAIN SCI, V27, P169; Purver Matthew, 2009, P SIGDIAL 2009 C 10, P262, DOI 10.3115/1708376.1708413; Ramenzoni VC, 2012, HUM MOVEMENT SCI, V31, P1253, DOI 10.1016/j.humov.2011.12.004; Ramenzoni VC, 2011, EXP BRAIN RES, V211, P447, DOI 10.1007/s00221-011-2653-8; Ramseyer F., 2008, SIMULTANEITY TEMPORA, P329, DOI DOI 10.1142/9789812792426_0020; Ramseyer F, 2011, J CONSULT CLIN PSYCH, V79, P284, DOI 10.1037/a0023419; Reed BS, 2010, CULT STUD SCI EDUCAT, V5, P859, DOI 10.1007/s11422-010-9289-z; Rennung M, 2016, Z PSYCHOL, V224, P168, DOI 10.1027/2151-2604/a000252; Reuzel E, 2013, J NONVERBAL BEHAV, V37, P281, DOI 10.1007/s10919-013-0158-9; Richardson D., 2008, EMBODIED COMMUNICATI, P75, DOI DOI 10.1093/ACPROF:OSO/9780199231751.003.0004; Richardson DC, 2005, COGNITIVE SCI, V29, P1045, DOI 10.1207/s15516709cog0000_29; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Riley MA, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00038; SACKS H, 1974, LANGUAGE, V50, P696, DOI 10.2307/412243; Scheflen A., 1982, INTERACTION RHYTHMS, P13; Schmidt RC, 2012, J NONVERBAL BEHAV, V36, P263, DOI 10.1007/s10919-012-0138-5; SCHMIDT RC, 1994, BIOL CYBERN, V70, P369, DOI 10.1007/BF00200334; Schmidt RC, 2008, UNDERST COMPLEX SYST, P281, DOI 10.1007/978-3-540-74479-5_14; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Sebanz N, 2009, TOP COGN SCI, V1, P353, DOI 10.1111/j.1756-8765.2009.01024.x; Shockley K, 2003, J EXP PSYCHOL HUMAN, V29, P326, DOI 10.1037/0096-1523.29.2.326; Shockley K, 2007, J EXP PSYCHOL HUMAN, V33, P201, DOI 10.1037/0096-1523.33.1.201; Shockley K, 2009, TOP COGN SCI, V1, P305, DOI 10.1111/j.1756-8765.2009.01021.x; Sternad D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000751; Tognoli E, 2014, NEURON, V81, P35, DOI 10.1016/j.neuron.2013.12.022; Won AS, 2014, J NONVERBAL BEHAV, V38, P389, DOI 10.1007/s10919-014-0186-0; Yngve V.H., 1970, 6 REG M CHIC LING SO, P567	95	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170786	10.1371/journal.pone.0170786	http://dx.doi.org/10.1371/journal.pone.0170786			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6QW	28141861	gold, Green Published, Green Submitted			2022-12-27	WOS:000396129500020
J	Sanjurjo-Rodriguez, C; Castro-Vinuelas, R; Hermida-Gomez, T; Fernandez-Vazquez, T; Fuentes-Boquete, IM; de Toro-Santos, FJ; Diaz-Prado, SM; Blanco-Garcia, FJ				Sanjurjo-Rodriguez, Clara; Castro-Vinuelas, Rocio; Hermida-Gomez, Tamara; Fernandez-Vazquez, Tania; Manuel Fuentes-Boquete, Isaac; Javier de Toro-Santos, Francisco; Maria Diaz-Prado, Silvia; Javier Blanco-Garcia, Francisco			Ovine Mesenchymal Stromal Cells: Morphologic, Phenotypic and Functional Characterization for Osteochondral Tissue Engineering	PLOS ONE			English	Article							STEM-CELLS; IN-VITRO; BONE; CARTILAGE; DIFFERENTIATION; SCAFFOLD; GROWTH; BIOMATERIALS; EFFICACY; REPAIR	Introduction Knowledge of ovine mesenchymal stromal cells (oMSCs) is currently expanding. Tissue engineering combining scaffolding with oMSCs provides promising therapies for the treatment of osteochondral diseases. Purpose The aim was to isolate and characterize oMSCs from bone marrow aspirates (oBMSCs) and to assess their usefulness for osteochondral repair using beta-tricalcium phosphate (bTCP) and type I collagen (Col I) scaffolds. Methods Cells isolated from ovine bone marrow were characterized morphologically, phenotypically, and functionally. oBMSCs were cultured with osteogenic medium on bTCP and Col I scaffolds. The resulting constructs were evaluated by histology, immunohistochemistry and electron microscopy studies. Furthermore, oBMSCs were cultured on Col I scaffolds to develop an in vitro cartilage repair model that was assessed using a modified International Cartilage Research Society (ICRS) II scale. Results oBMSCs presented morphology, surface marker pattern and multipotent capacities similar to those of human BMSCs. oBMSCs seeded on Col I gave rise to osteogenic neotissue. Assessment by the modified ICRS II scale revealed that fibrocartilage/hyaline cartilage was obtained in the in vitro repair model. Conclusions The isolated ovine cells were demonstrated to be oBMSCs. oBMSCs cultured on Col I sponges successfully synthesized osteochondral tissue. The data suggest that oBMSCs have potential for use in preclinical models prior to human clinical studies.	[Sanjurjo-Rodriguez, Clara; Castro-Vinuelas, Rocio; Manuel Fuentes-Boquete, Isaac; Javier de Toro-Santos, Francisco; Maria Diaz-Prado, Silvia] Univ A Coruna, Inst Biomed Res A Coruna INIBIC, Cell Therapy & Regenerat Med Unit,Rheumatol Grp, CHUAC,Galician Hlth Serv SERGAS,Dept Med,Fac Hl, La Coruna, Spain; [Castro-Vinuelas, Rocio; Hermida-Gomez, Tamara; Fernandez-Vazquez, Tania; Javier Blanco-Garcia, Francisco] CHUAC, Tissue Bioengn & Cell Therapy Unit GBTTC CHUAC, Inst Biomed Res A Coruna INIBIC, Rheumatol Grp,Galician Hlth Serv SERGAS, La Coruna, Spain	Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC)	Diaz-Prado, SM (corresponding author), Univ A Coruna, Inst Biomed Res A Coruna INIBIC, Cell Therapy & Regenerat Med Unit,Rheumatol Grp, CHUAC,Galician Hlth Serv SERGAS,Dept Med,Fac Hl, La Coruna, Spain.; Blanco-Garcia, FJ (corresponding author), CHUAC, Tissue Bioengn & Cell Therapy Unit GBTTC CHUAC, Inst Biomed Res A Coruna INIBIC, Rheumatol Grp,Galician Hlth Serv SERGAS, La Coruna, Spain.	s.diaz1@udc.es; fblagar@sergas.es	Blanco, Francisco J./C-3192-2014; Sanjurjo-Rodríguez, Clara/ABE-8108-2020; diaz-prado, silvia MA/B-4191-2015; DÍAZ-PRADO, SILVIA MARIA/ABH-6665-2020; Boquete, Isaac Manuel Fuentes/C-8865-2015; Sanjurjo-Rodríguez, Clara/T-2580-2017; de toro, javier/ABH-4217-2020	Blanco, Francisco J./0000-0001-9821-7635; Sanjurjo-Rodríguez, Clara/0000-0003-2702-7804; diaz-prado, silvia MA/0000-0001-9776-2180; DÍAZ-PRADO, SILVIA MARIA/0000-0001-9776-2180; Boquete, Isaac Manuel Fuentes/0000-0003-1056-4507; Sanjurjo-Rodríguez, Clara/0000-0003-2702-7804; Hermida Gomez, Tamara/0000-0001-7405-4595; Castro Vinuelas, Rocio/0000-0003-4881-273X; de-Toro, Javier/0000-0001-6131-1273	Institute Corunes de Implantologia y Rehabilitacion Oral, Servizo Galego de Saude; Universidade da Coruna; Catedra Bioiberica from Universidade da Coruna; Comunidad Autonoma de Madrid [S2009/MAT-1472, 52009/MAT-1472]; Centro de Investigacion Biomedica en Red-Bioingenieria, Biomateriales y Nanomedicina from Institute de Salud Carlos III; Rede de Investigacion en Celulas Nai e Terapia Celular e Grupos con Potencial de Crecemento from Xunta de Galicia [R2014/050, GPC2014/048]; Fundacion Espanola de Reumatologia; Diputacion de A Coruna (Spain)	Institute Corunes de Implantologia y Rehabilitacion Oral, Servizo Galego de Saude; Universidade da Coruna; Catedra Bioiberica from Universidade da Coruna; Comunidad Autonoma de Madrid; Centro de Investigacion Biomedica en Red-Bioingenieria, Biomateriales y Nanomedicina from Institute de Salud Carlos III; Rede de Investigacion en Celulas Nai e Terapia Celular e Grupos con Potencial de Crecemento from Xunta de Galicia; Fundacion Espanola de Reumatologia; Diputacion de A Coruna (Spain)	This study was supported by grants: Institute Corunes de Implantologia y Rehabilitacion Oral, Servizo Galego de Saude; Universidade da Coruna; Catedra Bioiberica from Universidade da Coruna; Comunidad Autonoma de Madrid (S2009/MAT-1472); Centro de Investigacion Biomedica en Red-Bioingenieria, Biomateriales y Nanomedicina from Institute de Salud Carlos III; Rede de Investigacion en Celulas Nai e Terapia Celular e Grupos con Potencial de Crecemento from Xunta de Galicia (R2014/050 and GPC2014/048); Fundacion Espanola de Reumatologia (2014 grant); RCV was beneficiary of a grant from Diputacion de A Coruna (Spain).; We want to thank Bruna Parma from Opocrin, S.P.A. for supplying Col I scaffolds; V. SeoaneMato and J.M. Cruz-Valino from Instituto Corunes de Implantologia y Rehabilitacion Oral (ICIRO) for kindly providing bTCP scaffolds; UCEX (Unit of Experimental Surgery) from CHUAC for providing ovine cartilage samples; Ada Castro-Couceiro, Ph.D. for electron microscopy research support services at the Universidade da Coruna (SAI-UDC); and laboratory staff: Maria Jose Sanchez-Dopico, Purificacion Filgueira-Fernandez, Noa Goyanes-Rey and Ines Seijo-Calvino from INIBIC-CHUAC for their support and assistance. This study was supported by grants: ICIRO, Servizo Galego de Salude; Universidade da Coruna (UDC); Catedra Bioiberica from UDC; CAM (52009/MAT-1472); CIBER-BBN from Instituto de Salud Carlos III; Rede de Investigacion en Celulas Nai e Terapia Celular (REDICENT), Xunta de Galicia (R2014/050); GPC, Xunta de Galicia (GPC2014/048); Fundacion Espanola de Reumatologia (2014 grant); R. Castro-Vinuelas was beneficiary of a grant from Diputacion de A Coruna (Spain).	Adamzyk C, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/387324; Aspberg A, 2012, J HISTOCHEM CYTOCHEM, V60, P987, DOI 10.1369/0022155412464376; Boos AM, 2011, J CELLULAR MOL MED, V15; Bornes TD, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0432-1; Boxall SA, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/975871; Cicione C, 2015, CELL TISSUE BANK, V16, P195, DOI 10.1007/s10561-014-9472-7; Colosimo A, 2013, CYTOTHERAPY, V15, P930, DOI 10.1016/j.jcyt.2013.03.014; Desantis S, 2015, ANN ANAT, V201, P43, DOI 10.1016/j.aanat.2015.06.002; Dhollander AAM, 2012, J KNEE SURG, V25, P179, DOI 10.1055/s-0032-1322596; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; El-Jawhari JJ, 2015, J ORTHOP RES; Endres M, 2012, J ORTHOPAEDIC SURG R, V7; Fadel L, 2011, ACTA CIRURGICA BRASI, V26; Filardo G, 2013, ARTHROSCOPY, V29, P174, DOI 10.1016/j.arthro.2012.05.891; Fuentes-Boquete IM, 2008, OPEN TRANSPLANTATION, V2, P21; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Grogan SP, 2007, ARTHRITIS RHEUM-US, V56, P586, DOI 10.1002/art.22408; Gronthos S, 2006, CALCIFIED TISSUE INT, V79, P310, DOI 10.1007/s00223-006-0040-4; Gupta MC, 2007, SPINE, V32, P720, DOI 10.1097/01.brs.0000258863.40984.32; Hamdan BMYN, 2012, EXPT GERONTOLOGY, V47; Jager M, 2006, IN VIVO, V20, P205; Jahroomishirazi R, 2014, CELLS TISSUES ORGANS, V200, P141, DOI 10.1159/000381534; Jiang Y, 2014, SCIENCE, V344, P1168, DOI 10.1126/science.1252806; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Jones EA, 2002, ARTHRITIS RHEUM-US, V46, P3349, DOI 10.1002/art.10696; Kock L, 2012, CELL TISSUE RES, V347, P613, DOI 10.1007/s00441-011-1243-1; Landa-Solis C, 2015, CELL TISSUE BANK; Liao JF, 2014, J BIOMED NANOTECHNOL, V10, P3085, DOI 10.1166/jbn.2014.1934; Lindroos B, 2010, TISSUE ENG PT A, V16, P2281, DOI [10.1089/ten.tea.2009.0621, 10.1089/ten.TEA.2009.0621]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutianov M, 2011, J THEOR BIOL, V289, P136, DOI 10.1016/j.jtbi.2011.08.007; Lyahyai J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-169; Mainil-Varlet P, 2010, AM J SPORT MED, V38, P880, DOI 10.1177/0363546509359068; McCarty Rosa C, 2010, Open Orthop J, V4, P204, DOI 10.2174/1874325001004010204; McCarty RC, 2009, J CELL PHYSIOL, V219, P324, DOI 10.1002/jcp.21670; Melrose J, 2009, EUR SPINE J, V18, P479, DOI 10.1007/s00586-008-0871-y; Mesallati T, 2014, J TISSUE ENG REGEN M, V8, P152; Mrugala D, 2008, ANN RHEUMATIC DIS, V67; Niemeyer P, 2010, BIOMATERIALS, V31, P3572, DOI 10.1016/j.biomaterials.2010.01.085; Ozen A, 2013, MICROSCOPY RES, V1, P17, DOI DOI 10.4236/MR.2013.13004; Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863; Pearce AI, 2007, EUR CELLS MATER, V13, P1; Perdikouri C, 2015, CALCIFIED TISSUE INT, V96, P11, DOI 10.1007/s00223-014-9930-z; Polo-Corrales L, 2014, J NANOSCI NANOTECHNO, V14, P15, DOI 10.1166/jnn.2014.9127; Reichert JC, 2010, J TISSUE ENG REGENER, V4; Rentsch C, 2010, IN VITRO CELL DEV-AN, V46, P624, DOI 10.1007/s11626-010-9316-0; Rentsch C, 2010, IN VITRO CELLULAR DE, V46; RICHLER C, 1970, DEV BIOL, V23, P1, DOI 10.1016/S0012-1606(70)80004-5; Royo-Canas M, 2009, J ORTHOPAEDIC RES, V27; Rozemuller H, 2010, STEM CELLS DEV, V19, P1911, DOI 10.1089/scd.2009.0510; Sanjurjo-Rodriguez C, 2014, J REGENERATIVE MED, V3; Schmitt SC, 2008, J MATER SCI-MATER M, V19, P1441, DOI 10.1007/s10856-007-3238-8; Schulz RM, 2008, BIOMEDICAL MAT ENG, V18; Sharma S, 2014, J CLIN DIAGN RES, V8, P309, DOI 10.7860/JCDR/2014/7609.3937; Somers P, 2012, GROWTH FACTORS, V30, P37, DOI 10.3109/08977194.2011.634411; Song FL, 2014, INT J CLIN EXP PATHO, V7, P1415; Suarez-Gonzalez D, 2014, TISSUE ENG PT A, V20, P2077, DOI 10.1089/ten.tea.2013.0358; Tian Y., 2015, MEDIAT INFLAMM, V2015, DOI DOI 10.1155/2015/819232; Ude CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098770; van Haaften EE, 2016, J ORTHOP RES; Yang Y, 2015, INT J CLIN EXP MED, V8, P3202; Zannettino ACW, 2010, TISSUE ENG A, V16; Zebisch K, 2012, ANAL BIOCHEM, V425, P88, DOI 10.1016/j.ab.2012.03.005; Zhao Y., 2012, J NANOTECHNOL, V2012, P1, DOI DOI 10.1186/1741-7015-10-3]; Zhao YH, 2013, CHINESE MED J-PEKING, V126, P3130, DOI 10.3760/cma.j.issn.0366-6999.20130212; Zscharnack M, 2010, AM J SPORTS MED, V38	66	18	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171231	10.1371/journal.pone.0171231	http://dx.doi.org/10.1371/journal.pone.0171231			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141815	Green Published, gold			2022-12-27	WOS:000396129500050
J	Walsh, RP; Michaels, HJ				Walsh, Ryan P.; Michaels, Helen J.			When it pays to cheat: Examining how generalized food deception increases male and female fitness in a terrestrial orchid	PLOS ONE			English	Article							POLLINATOR-MEDIATED SELECTION; FLORAL DISPLAY SIZE; INBREEDING DEPRESSION; REPRODUCTIVE SUCCESS; SPUR LENGTH; POLLEN LIMITATION; SUPPLEMENTATION EXPERIMENTS; GYMNADENIA-CONOPSEA; INFLORESCENCE SIZE; FRUIT-SET	Background Experimental manipulations of floral nectar in food deceptive species can reveal insights into the evolutionary consequences of the deceptive strategy. When coupled to pollen tracking, the effects of the deceptive pollination syndrome on both male and female reproductive success may be quantified. Attraction of pollinators in deceit-pollinated species often relies on producing a conspicuous floral display which may increase visibility to pollinators, but inturn may increase within plant selfing. Methodology To understand the role of deception in Orchidaceae reproduction we studied Cypripedium candidum. All species of the Cypripedium genus employ a generalized food deceptive pollination strategy and have been suggested as a model system for the study of pollinator deception. We conducted a nectar addition experiment that randomly assigned the four plants closest to a transect point to receive one of four histochemical dyes. Two individuals selected for nectar addition in each of altogether 25 blocks received 2 mu l of 25% sucrose solution in the labellum of each flower, while two others received no artificial nectar. Number of fruits produced, fruit mass and fruit abortion were scored at the end of the four-month experiment. Results Nectar addition increased (p<0.0001) self-pollination and pollen discounting by nearly 3x, while plants not receiving nectar had greater (p<0.0001) numbers of non-self pollinia deposited and lower rates of pollen discounting. There was a non-significant (p = 0.0645) trend for deceptive plants to set more fruit, while presence of nectar did not affect pollen export. Conclusions This study demonstrates the adaptive advantages of food deception by showing a concurrent reduction in particular male and female functions when a food reward is restored to a deceptive flower. We found generalized food deception to not only decrease inbreeding depression in the system, but concurrently have no effect on pollinator attraction and fruit set when compared with rewarding flowers.	[Walsh, Ryan P.] Toledo Zool Soc, Dept Conservat, Toledo, OH 43609 USA; [Michaels, Helen J.] Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA	University System of Ohio; Bowling Green State University	Walsh, RP (corresponding author), Toledo Zool Soc, Dept Conservat, Toledo, OH 43609 USA.	Ryan.Walsh@ToledoZoo.org		Walsh, Ryan/0000-0001-8040-6032				Ackerman J.D., 1981, Madrono, V28, P101; [Anonymous], 1793, ENTDECKTE GEHEIMNIS, DOI [10.5962/bhl.title.50179, DOI 10.5962/BHL.TITLE.50179]; Aragon Susan, 2001, Lindleyana, V16, P3; Barrett SCH, 2002, HEREDITY, V88, P154, DOI 10.1038/sj/hdy/6800020; Barrett SCH, 1996, TRENDS ECOL EVOL, V11, P73, DOI 10.1016/0169-5347(96)81046-9; Bernhardt P, 2010, BOT REV, V76, P204, DOI 10.1007/s12229-010-9042-z; Borba EL, 2001, ANN BOT-LONDON, V88, P89, DOI 10.1006/anbo.2001.1435; BOWLES M. L., 1983, NAT AREA J, V3, P14; BURD M, 1995, J ECOL, V83, P865, DOI 10.2307/2261423; CALVO RN, 1990, AM J BOT, V77, P1378, DOI 10.2307/2444598; CATLING PM, 1980, CAN FIELD NAT, V94, P435; Chapurlat E, 2015, NEW PHYTOL, V208, P1264, DOI 10.1111/nph.13555; Cheney KL, 2008, BEHAV ECOL, V19, P583, DOI 10.1093/beheco/arn001; CHRISTY JH, 1995, AM NAT, V146, P171, DOI 10.1086/285793; Cozzolino S, 2005, TRENDS ECOL EVOL, V20, P487, DOI 10.1016/j.tree.2005.06.004; CURTIS JT, 1946, J WILDLIFE MANAGE, V10, P303, DOI 10.2307/3796237; Curtis JT, 1943, AM J BOT, V30, P199, DOI 10.2307/2437240; Cusick AW, 1980, CYPRIPEDIUM CANDIDUM; Dafni A, 1990, EVOLUTIONARY BIOL, P193; Darwin C., 1877, VARIOUS CONTRIVANCES; de Jager ML, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2861; DEJONG TJ, 1993, TRENDS ECOL EVOL, V8, P321, DOI 10.1016/0169-5347(93)90239-L; DRESSLER RL, 1982, ANNU REV ECOL SYST, V13, P373, DOI 10.1146/annurev.es.13.110182.002105; Ellis AG, 2010, INT J PLANT SCI, V171, P1010, DOI 10.1086/656351; Faegri K, 1971, PRINCIPLES POLLINATI; Ferdy JB, 1998, AM NAT, V152, P696, DOI 10.1086/286200; Ferdy JB, 2001, CAN J BOT, V79, P1181, DOI 10.1139/cjb-79-10-1181; FRITZ AL, 1990, NORD J BOT, V9, P577, DOI 10.1111/j.1756-1051.1990.tb00548.x; Galloway LF, 2002, INT J PLANT SCI, V163, P133, DOI 10.1086/324556; Garcia CM, 2012, P R SOC B, V279, P2262; Gill DE, 1989, SPECIATION ITS CONSE, V458, P481; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Grindeland JM, 2005, FUNCT ECOL, V19, P383, DOI 10.1111/j.1365-2435.2005.00988.x; Gumbert A, 2001, BIOL J LINN SOC, V72, P419, DOI [10.1111/j.1095-8312.2001.tb01328.x, 10.1006/bijl.2000.0510]; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; HOLSINGER KE, 1994, AM NAT, V144, P799, DOI 10.1086/285707; Jersakova J, 2006, OECOLOGIA, V147, P60, DOI 10.1007/s00442-005-0254-6; Jersakova J, 2006, BIOL REV, V81, P219, DOI 10.1017/S1464793105006986; Jersakova J, 2009, SIGNAL COMMUN PLANTS, P223, DOI 10.1007/978-3-540-89230-4_12; Johnson SD, 2003, ECOLOGY, V84, P2919, DOI 10.1890/02-0471; Johnson SD, 2004, P ROY SOC B-BIOL SCI, V271, P803, DOI 10.1098/rspb.2003.2659; Johnson SD, 2005, BIOL J LINN SOC, V86, P175, DOI 10.1111/j.1095-8312.2005.00541.x; Johnson SD, 2000, PLANT SYST EVOL, V222, P243, DOI 10.1007/BF00984105; Johnson SD, 1999, ECOLOGY, V80, P2607, DOI 10.1890/0012-9658(1999)080[2607:PCGATE]2.0.CO;2; JOHNSTON MO, 1994, EVOLUTION, V48, P1735, DOI 10.1111/j.1558-5646.1994.tb02209.x; Juillet N, 2007, PLANT SYST EVOL, V265, P123, DOI 10.1007/s00606-006-0507-9; Kindlmann P, 2006, FOLIA GEOBOT, V41, P47, DOI 10.1007/BF02805261; Knight TM, 2006, AM J BOT, V93, P271, DOI 10.3732/ajb.93.2.271; Kropf M, 2008, OECOLOGIA, V155, P497, DOI 10.1007/s00442-007-0919-4; LEE TD, 1982, ECOLOGY, V63, P1363, DOI 10.2307/1938864; Li P, 2010, PLANT SYST EVOL, V286, P167, DOI 10.1007/s00606-010-0296-z; Liao WJ, 2014, AM NAT, V184, P580, DOI 10.1086/678117; Lipow SR, 2002, INT J PLANT SCI, V163, P775, DOI 10.1086/342083; LOPEZPORTILLO J, 1993, FUNCT ECOL, V7, P452, DOI 10.2307/2390032; Melendez-Ackerman EJ, 2001, PLANT SYST EVOL, V227, P27, DOI 10.1007/s006060170054; Mitchell RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076312; Mitchell RJ, 2004, FUNCT ECOL, V18, P116, DOI 10.1111/j.1365-2435.2004.00812.x; Ne'eman G, 2006, J INSECT BEHAV, V19, P383, DOI 10.1007/s10905-006-9030-7; Neiland MRM, 1998, AM J BOT, V85, P1657, DOI 10.2307/2446499; NILSSON LA, 1980, BOT NOTISER, V133, P367; NILSSON LA, 1992, NATURE, V360, P666, DOI 10.1038/360666a0; NILSSON LA, 1983, NATURE, V305, P799, DOI 10.1038/305799a0; O'Connell LM, 1998, ECOLOGY, V79, P1246, DOI 10.2307/176740; PEAKALL R, 1989, PLANT SYST EVOL, V167, P137, DOI 10.1007/BF00936402; PRIMACK RB, 1990, AM NAT, V136, P638, DOI 10.1086/285120; Schiestl FP, 2005, NATURWISSENSCHAFTEN, V92, P255, DOI 10.1007/s00114-005-0636-y; Scopece G, 2015, PLANT BIOLOGY, V17, P545, DOI 10.1111/plb.12224; Scopece G, 2010, AM NAT, V175, P98, DOI 10.1086/648555; Shefferson RP, 2001, ECOLOGY, V82, P145, DOI 10.2307/2680092; Sletvold N, 2017, FUNCT ECOL, V31, P135, DOI 10.1111/1365-2435.12757; Sletvold N, 2011, ECOLOGY, V92, P2167, DOI 10.1890/11-0791.1; Sletvold N, 2010, INT J PLANT SCI, V171, P999, DOI 10.1086/656597; Smithson A, 2002, AM J BOT, V89, P1579, DOI 10.3732/ajb.89.10.1579; Smithson A, 2006, NEW PHYTOL, V169, P419, DOI 10.1111/j.1469-8137.2005.01592.x; Smithson A, 1996, J EVOLUTION BIOL, V9, P571, DOI 10.1046/j.1420-9101.1996.9050571.x; Smithson A, 2001, P ROY SOC B-BIOL SCI, V268, P1435, DOI 10.1098/rspb.2001.1705; Snow A. A., 1996, FLORAL BIOL STUDIES, P191; SNOW AA, 1993, ANNU REV ECOL SYST, V24, P331, DOI 10.1146/annurev.es.24.110193.001555; Stoutamire W.P., 1967, MICH BOT, V6, P159; Sun HQ, 2009, ANN BOT-LONDON, V103, P1227, DOI 10.1093/aob/mcp066; Svedarsky W, 1996, RESTORATION MANAGEME, V14, P179; Tremblay Raymond L., 1994, Lindleyana, V9, P161; Tremblay RL, 2005, BIOL J LINN SOC, V84, P1, DOI 10.1111/j.1095-8312.2004.00400.x; Verdu M, 2006, EVOLUTION, V60, P2056, DOI 10.1111/j.0014-3820.2006.tb01843.x; Wake CM, 2007, LANKESTERIANA, V7, P423; Walsh RP, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu031; Wesselingh RA, 2007, NEW PHYTOL, V174, P26, DOI 10.1111/j.1469-8137.2007.01997.x	87	9	9	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171286	10.1371/journal.pone.0171286	http://dx.doi.org/10.1371/journal.pone.0171286			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141838	gold, Green Submitted, Green Published			2022-12-27	WOS:000396129500055
J	Zaheer, R; Dugat-Bony, E; Holman, D; Cousteix, E; Xu, Y; Munns, K; Selinger, LJ; Barbieri, R; Alexander, T; McAllister, TA; Selinger, LB				Zaheer, Rahat; Dugat-Bony, Eric; Holman, Devon; Cousteix, Elodie; Xu, Yong; Munns, Krysty; Selinger, Lorna J.; Barbieri, Rutn; Alexander, Trevor; McAllister, Tim A.; Selinger, L. Brent			Changes in bacterial community composition of Escherichia coli O157:H7 super-shedder cattle occur in the lower intestine	PLOS ONE			English	Article							FEEDLOT CATTLE; GASTROINTESTINAL-TRACT; MICROBIAL-POPULATIONS; RECTOANAL JUNCTION; DIVERSITY; O157-H7; COLONIZATION; GENE; FECES; SALMONELLA	Escherichia coli O157:H7 is a foodborne pathogen that colonizes ruminants. Cattle are considered the primary reservoir of E. coli O157:H7 with super-shedders, defined as individuals excreting > 10(4) E. coli O157:H7 CFU g(-1) feces. The mechanisms leading to the super-shedding condition are largely unknown. Here, we used 16S rRNA gene pyrosequencing to examine the composition of the fecal bacterial community in order to investigate changes in the bacterial microbiota at several locations along the digestive tract (from the duodenum to the rectal-anal junction) in 5 steers previously identified as super-shedders and 5 non-shedders. The overall bacterial community structure did not differ by E. coli O157:H7 shedding status; but several differences in the relative abundance of taxa and OTUs were noted between the two groups. The genus Prevotella was most enriched in the non-shedders while the genus Ruminococcus and the Bacteroidetes phylum were notably enriched in the super-shedders. There was greater bacterial diversity and richness in samples collected from the lower-as compared to the upper gastrointestinal tract (GI). The spiral colon was the only GI location that differed in terms of bacterial diversity between super-shedders and non-shedders. These findings reinforced linkages between E. coli O157:H7 colonization in cattle and the nature of the microbial community inhabiting the digestive tract of supershedders.	[Zaheer, Rahat; Holman, Devon; Munns, Krysty; Selinger, Lorna J.; Barbieri, Rutn; Alexander, Trevor; McAllister, Tim A.] Agr & Agri Food Canada, Lethbridge Res & Dev Ctr, Lethbridge, AB, Canada; [Dugat-Bony, Eric] Univ Paris Saclay, UMR Genie & Microbiol Proc Alimentaires, AgroParisTech, INRA, Thiverval Grignon, France; [Cousteix, Elodie; Xu, Yong; Selinger, L. Brent] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB, Canada	Agriculture & Agri Food Canada; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Lethbridge	Selinger, LB (corresponding author), Agr & Agri Food Canada, Lethbridge Res & Dev Ctr, Lethbridge, AB, Canada.	tim.mcallister@agr.gc.ca; selibl@uleth.ca	Dugat-Bony, Eric/K-2455-2014; Holman, Devin/H-8693-2019; McAllister, Tim A./R-9201-2017	Dugat-Bony, Eric/0000-0002-5182-0063; Holman, Devin/0000-0001-5306-3732; McAllister, Tim A./0000-0002-8266-6513; Zaheer, Rahat/0000-0003-3307-4666	Alberta Livestock and Meat Agency Ltd.; Genome Alberta; Abase program of Agriculture and Agri-Food Canada	Alberta Livestock and Meat Agency Ltd.; Genome Alberta; Abase program of Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada)	This research work was conducted with the funding from the 'Alberta Livestock and Meat Agency Ltd., Genome Alberta as well as the Abase program of Agriculture and Agri-Food Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antharam VC, 2013, J CLIN MICROBIOL, V51, P2884, DOI 10.1128/JCM.00845-13; Armstrong GL, 1996, EPIDEMIOL REV, V18, P29, DOI 10.1093/oxfordjournals.epirev.a017914; Arthur TM, 2009, APPL ENVIRON MICROB, V75, P6515, DOI 10.1128/AEM.00081-09; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Callaway TR, 2006, FOODBORNE PATHOG DIS, V3, P234, DOI 10.1089/fpd.2006.3.234; Callaway TR, 2010, J ANIM SCI, V88, P3977, DOI 10.2527/jas.2010-2900; Callaway TR, 2009, CURR ISSUES MOL BIOL, V11, P67; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carlson BA, 2009, APPL ENVIRON MICROB, V75, P5927, DOI 10.1128/AEM.00972-09; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; CHAO A, 1984, SCAND J STAT, V11, P265; Chase-Topping M, 2008, NAT REV MICROBIOL, V6, P904, DOI 10.1038/nrmicro2029; Chase-Topping ME, 2007, J CLIN MICROBIOL, V45, P1594, DOI 10.1128/JCM.01690-06; Chassaing B, 2014, GUT, V63, P1069, DOI 10.1136/gutjnl-2013-304909; Cobbold RN, 2007, APPL ENVIRON MICROB, V73, P1563, DOI 10.1128/AEM.01742-06; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Duffy G, 2003, J APPL MICROBIOL, V94, p94S; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Ferens WA, 2011, FOODBORNE PATHOG DIS, V8, P465, DOI 10.1089/fpd.2010.0673; Frey JC, 2010, J APPL MICROBIOL, V108, P1982, DOI 10.1111/j.1365-2672.2009.04602.x; Gannon VPJ, 1997, J CLIN MICROBIOL, V35, P656, DOI 10.1128/JCM.35.3.656-662.1997; Hayashi H, 2005, J MED MICROBIOL, V54, P1093, DOI 10.1099/jmm.0.45935-0; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; Kim M, 2014, J ANIM SCI, V92, P683, DOI 10.2527/jas.2013-6841; Lee SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002880; Lim JY, 2007, APPL ENVIRON MICROB, V73, P1380, DOI 10.1128/AEM.02242-06; Lone AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075325; Looft T, 2014, ISME J, V8, P1566, DOI 10.1038/ismej.2014.12; Low JC, 2005, APPL ENVIRON MICROB, V71, P93, DOI 10.1128/AEM.71.1.93-97.2005; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Mao SY, 2015, SCI REP-UK, V5, DOI 10.1038/srep16116; Marteau P, 2001, APPL ENVIRON MICROB, V67, P4939, DOI 10.1128/AEM.67.10.4939-4942.2001; Matthews L, 2006, EPIDEMIOL INFECT, V134, P131, DOI 10.1017/S0950268805004590; Matthews L, 2006, P NATL ACAD SCI USA, V103, P547, DOI 10.1073/pnas.0503776103; Messori S, 2013, VET MICROBIOL, V162, P173, DOI 10.1016/j.vetmic.2012.09.001; Munns KD, 2014, FOODBORNE PATHOG DIS, V11, P329, DOI 10.1089/fpd.2013.1621; Myer PR, 2015, J ANIM SCI, V93, P5327, DOI 10.2527/jas.2015-9415; Myer PR, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1201-6; Nart P, 2008, INFECT IMMUN, V76, P5366, DOI 10.1128/IAI.01223-07; Naylor SW, 2003, INFECT IMMUN, V71, P1505, DOI 10.1128/IAI.71.3.1505-1512.2003; Niu YD, 2009, APPL ENVIRON MICROB, V75, P1271, DOI 10.1128/AEM.02100-08; Pham TAN, 2014, CURR OPIN MICROBIOL, V17, P67, DOI 10.1016/j.mib.2013.12.002; Reinstein S, 2007, APPL ENVIRON MICROB, V73, P1002, DOI 10.1128/AEM.02037-06; Ritchie LE, 2008, FEMS MICROBIOL ECOL, V66, P590, DOI 10.1111/j.1574-6941.2008.00609.x; Schoster Angelika, 2013, BMC Res Notes, V6, P91, DOI 10.1186/1756-0500-6-91; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Stanford K, 2005, J DAIRY SCI, V88, P4441, DOI 10.3168/jds.S0022-0302(05)73131-3; Stanford K, 2005, J FOOD PROTECT, V68, P26, DOI 10.4315/0362-028X-68.1.26; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Stoffregen WC, 2004, J VET DIAGN INVEST, V16, P79, DOI 10.1177/104063870401600114; Sullivan LE, 2015, APPL ENVIRON MICROB, V81, P7460, DOI 10.1128/AEM.01956-15; Thiennimitr P, 2012, CURR OPIN MICROBIOL, V15, P108, DOI 10.1016/j.mib.2011.10.002; Thoetkiattikul H, 2013, CURR MICROBIOL, V67, P130, DOI 10.1007/s00284-013-0336-3; de Oliveira MNV, 2013, VET MICROBIOL, V164, P307, DOI 10.1016/j.vetmic.2013.02.013; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Walle KV, 2013, VET IMMUNOL IMMUNOP, V152, P109, DOI 10.1016/j.vetimm.2012.09.028; Wang M, 2005, FEMS MICROBIOL ECOL, V54, P219, DOI 10.1016/j.femsec.2005.03.012; Wang O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151284; Xu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098115; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	67	21	21	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170050	10.1371/journal.pone.0170050	http://dx.doi.org/10.1371/journal.pone.0170050			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141846	Green Published, gold, Green Submitted			2022-12-27	WOS:000396129500006
J	Inoue, K; Arai, M; Fujisawa, M; Saito, K; Fukushi, M				Inoue, Kazumasa; Arai, Moeko; Fujisawa, Makoto; Saito, Kyouko; Fukushi, Masahiro			Detailed Distribution Map of Absorbed Dose Rate in Air in Tokatsu Area of Chiba Prefecture, Japan, Constructed by Car-Borne Survey 4 Years after the Fukushima Daiichi Nuclear Power Plant Accident	PLOS ONE			English	Article							METROPOLITAN TOKYO; TERRESTRIAL; RADIATION	A car-borne survey was carried out in the northwestern, or Tokatsu, area of Chiba Prefecture, Japan, to make a detailed distribution map of absorbed dose rate in air four years after the Fukushima Daiichi Nuclear Power Plant accident. This area was chosen because it was the most heavily radionuclide contaminated part of Chiba Prefecture and it neighbors metropolitan Tokyo. Measurements were performed using a 3-in x 3-in NaI(Tl) scintillation spectrometer in June 2015. The survey route covered the whole Tokatsu area which includes six cities. A heterogeneous distribution of absorbed dose rate in air was observed on the dose distribution map. Especially, higher absorbed dose rates in air exceeding 80 nGy h(-1) were observed along national roads constructed using high porosity asphalt, whereas lower absorbed dose rates in air were observed along local roads constructed using low porosity asphalt. The difference between these asphalt types resulted in a heterogeneous dose distribution in the Tokatsu area. The mean of the contribution ratio of artificial radionuclides to absorbed dose rate in air measured 4 years after the accident was 29% (9-50%) in the Tokatsu area. The maximum absorbed dose rate in air, 201 nGy h(-1) was observed at Kashiwa City. Radiocesium was deposited in the upper 1 cm surface layer of the high porosity asphalt which was collected in Kashiwa City and the environmental half-life of the absorbed dose rate in air was estimated to be 1.7 years.	[Inoue, Kazumasa; Arai, Moeko; Fujisawa, Makoto; Fukushi, Masahiro] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Radiol Sci, Arakawa ku, Tokyo, Japan; [Saito, Kyouko] Nihon Inst Med Sci, Dept Radiol Technol, Fac Hlth Sci, Saitama, Japan		Inoue, K (corresponding author), Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Radiol Sci, Arakawa ku, Tokyo, Japan.	kzminoue@tmu.ac.jp			Tokyo Metropolitan University	Tokyo Metropolitan University	This work was funded by the strategic research fund of Tokyo Metropolitan University (2014 - 2015).	ABE S, 1981, J NUCL SCI TECHNOL, V18, P21, DOI 10.3327/jnst.18.21; Andoh M, 2015, J ENVIRON RADIOACTIV, V139, P266, DOI 10.1016/j.jenvrad.2014.05.014; Cenh JI, 2007, HEALTH PHYS, V93, P325, DOI [10.1097/01.HP.0000278417.08952.52, DOI 10.1097/01.HP.0000278417.08952.52]; Furukawa M., 2012, RAD EMERG MED, V1, P11; Hosoda M, 2016, JPN J HLTH PHYS, V51, P41, DOI DOI 10.5453/JHPS.51.41; Hosoda M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124433; Hosoda M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00087; Iimoto T, 2015, RADIAT PROT DOSIM, V167, P358, DOI 10.1093/rpd/ncv279; Inoue K, 2015, RADIAT PROT DOSIM, V167, P231, DOI 10.1093/rpd/ncv251; Inoue K, 2016, J ENVIRON RADIOACTIV, V158, P1, DOI 10.1016/j.jenvrad.2016.03.022; Inoue K, 2016, J RADIOANAL NUCL CH, V307, P507, DOI 10.1007/s10967-015-4164-8; Inoue K, 2015, J RADIOANAL NUCL CH, V303, P2159, DOI 10.1007/s10967-014-3669-x; International Atomic Energy Agency, 1979, IAEATECDOC225; Joint committee for guides In measurements 2008 Joint committee for guides In measurements, 2008, JCGM, V100; Kashiwa City Office, 2012, AMB DOS RAT TOK 6 CI; Lai K. K., 1996, RADIOISOT, V45, P696; Machart P, 2007, J ENVIRON RADIOACTIV, V97, P70, DOI 10.1016/j.jenvrad.2007.05.003; Maedera F, 2016, RADIAT PROT DOSIM, V168, P561, DOI 10.1093/rpd/ncv370; Minato S., 2001, Radioisotopes, V50, P463, DOI 10.3769/radioisotopes.50.10_463; Morino Y, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048689; Moriuchi S, 1990, JPN J HLTH PHYS, V25, P121; Nishizawa Kanae, 2004, Nippon Acta Radiologica, V64, P151; Nuclear Regulation Authority, 2011, EXT SIT DISTR MAP RA; Prohl G, 2006, J ENVIRON RADIOACTIV, V91, P41, DOI 10.1016/j.jenvrad.2006.08.004; Roed J., 1998, MECH DECONTAMINATION; Saito K, 2015, J ENVIRON RADIOACTIV, V139, P308, DOI 10.1016/j.jenvrad.2014.02.014; Statistics Bureau Ministry of Internal Affairs and Communications Japan, 2014, FUND ASP SOC LIF 201; Sugino Masato, 2007, Radioisotopes, V56, P315; United Nations Scientific Committee on the Effects of Atomic Radiation, 2013, UNSCEAR 2013 REP ANN; Wessel P, 1991, EOS T AM GEOPHYS UN, V72, P445, DOI [10.1029/90EO00319, DOI 10.1029/90EO00319, DOI 10.1029/90E000319]	30	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0171100	10.1371/journal.pone.0171100	http://dx.doi.org/10.1371/journal.pone.0171100			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129382	Green Submitted, Green Published, gold			2022-12-27	WOS:000396211400007
J	Macianskiene, R; Almanaityte, M; Jekabsone, A; Mubagwa, K				Macianskiene, Regina; Almanaityte, Mante; Jekabsone, Aiste; Mubagwa, Kanigula			Modulation of Human Cardiac TRPM7 Current by Extracellular Acidic pH Depends upon Extracellular Concentrations of Divalent Cations	PLOS ONE			English	Article							HUMAN ATRIAL MYOCYTES; VENTRICULAR-FUNCTION; KINASE TRPM7; CHANNEL; MAGNESIUM; ISCHEMIA; MG2+; CALCIUM; SUPPRESSION; SENSITIVITY	TRPM7 channels participate in a variety of physiological/pathological processes. TRPM7 currents are modulated by protons but opposing effects of external pH (pH(o)) (potentiation vs inhibition) have been reported. TRPM7 has been less studied in human cardiomyocytes than in heart-derived non-cardiomyocyte cells. We used the whole-cell patch-clamp technique on isolated human atrial cardiomyocytes to investigate the impact of an acidic pHo on the TRPM7 current. With voltage-dependent and other ion channels inhibited, cardiomyocytes were challenged with external acidification in either the presence or the absence of extracellular divalent cations. TRPM7 outward and inward currents were increased by acidic pHo in extracellular medium containing Ca2+ and Mg2+, but suppressed by acidic pHo in the absence of extracellular Ca2+ and Mg2+. The potentiating effect in the presence of extracellular divalents occurred at pHo below 6 and was voltage-dependent. The inhibitory effect in the absence of extracellular divalents was already marked at pHo of 6 and was practically voltage-independent. TRPM7 current density was higher in cardiomyocytes from patients with history of coronary vascular disease and the difference compared to cardiomyocytes from patients without history of myocardial ischemia increased with acidic pHo. We demonstrate that proton-induced modification of TRPM7 currents depends on the presence of extracellular Ca2+ and Mg2+. Variability of the TRPM7 current density in human cardiomyocytes is related to the clinical history, being higher in atrial fibrillation and in ischemic cardiomyopathy.	[Macianskiene, Regina; Almanaityte, Mante] Lithuanian Univ Hlth Sci, Inst Cardiol, Kaunas, Lithuania; [Jekabsone, Aiste] Lithuanian Univ Hlth Sci, Neurosci Inst, Kaunas, Lithuania; [Mubagwa, Kanigula] Univ Leuven, Dept Cardiovasc Sci, Leuven, Belgium	Lithuanian University of Health Sciences; Lithuanian University of Health Sciences; KU Leuven	Macianskiene, R (corresponding author), Lithuanian Univ Hlth Sci, Inst Cardiol, Kaunas, Lithuania.	regina.macianskiene@lsmuni.lt	Jekabsone, Aiste/AAY-5182-2020; Jekabsone, Aiste/ABA-3462-2020	Jekabsone, Aiste/0000-0003-1527-6221	European Social Fund [MM NKP FK_VP1-3.1-WM-08-K-01-022]	European Social Fund(European Social Fund (ESF))	This research was supported by the European Social Fund to RM (project code number: MM NKP FK_VP1-3.1-WM-08-K-01-022).	Almanaityte M, 2015, ACTA PHYSIOL, V215, P74; Almanaityte M, 2014, BIOPHYS J, V106, p753A, DOI 10.1016/j.bpj.2013.11.4146; Bae CYJ, 2011, ACTA PHARMACOL SIN, V32, P725, DOI 10.1038/aps.2011.60; Carmeliet E, 1999, PHYSIOL REV, V79, P917, DOI 10.1152/physrev.1999.79.3.917; Chokshi R, 2012, AM J PHYSIOL-CELL PH, V302, pC1004, DOI 10.1152/ajpcell.00422.2011; Chu XP, 2003, J PHYSIOL-LONDON, V550, P385, DOI 10.1113/jphysiol.2003.043091; Chubanov V, 2004, P NATL ACAD SCI USA, V101, P2894, DOI 10.1073/pnas.0305252101; Demir T, 2014, MOL BIOL REP, V41, P2845, DOI 10.1007/s11033-014-3139-0; Du JY, 2010, CIRC RES, V106, P992, DOI 10.1161/CIRCRESAHA.109.206771; Fleig A, 2014, HANDB EXP PHARMACOL, V222, P521, DOI 10.1007/978-3-642-54215-2_21; Fonfria E, 2006, J RECEPT SIG TRANSD, V26, P159, DOI 10.1080/10799890600637506; Guilbert A, 2009, AM J PHYSIOL-CELL PH, V297, pC493, DOI 10.1152/ajpcell.00624.2008; Gwanyanya A, 2004, J PHYSIOL-LONDON, V559, P761, DOI 10.1113/jphysiol.2004.067637; Hara K, 2010, AM J MED GENET B, V153B, P310, DOI 10.1002/ajmg.b.30966; Hermosura MC, 2005, P NATL ACAD SCI USA, V102, P11510, DOI 10.1073/pnas.0505149102; Istrate B, 2012, NONHOMOGENOUS DISTRI; Jiang JM, 2005, J GEN PHYSIOL, V126, P137, DOI 10.1085/jgp.200409185; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Kerschbaum HH, 2003, BIOPHYS J, V84, P2293, DOI 10.1016/S0006-3495(03)75035-8; Kim BJ, 2008, CANCER SCI, V99, P2502, DOI 10.1111/j.1349-7006.2008.00982.x; Komukai K, 2002, AM J PHYSIOL-HEART C, V283, pH715, DOI 10.1152/ajpheart.01000.2001; Krapivinsky G, 2006, NEURON, V52, P485, DOI 10.1016/j.neuron.2006.09.033; Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; Li MJ, 2007, J BIOL CHEM, V282, P25817, DOI 10.1074/jbc.M608972200; Macianskiene R, 2008, CELL PHYSIOL BIOCHEM, V22, P109, DOI 10.1159/000149788; Macianskiene R, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-75; Martisiene I, 2011, CHARACTERIZATION TRP; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Mubagwa K, 1997, J PHYSIOL-LONDON, V502, P235, DOI 10.1111/j.1469-7793.1997.235bk.x; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Numata T, 2008, J BIOL CHEM, V283, P15097, DOI 10.1074/jbc.M709261200; Ortega A, 2016, ESC HEART FAIL, V3, P220, DOI 10.1002/ehf2.12085; Penner R., 2007, V179, P313; Pujadas S, 2010, EUR J RADIOL, V75, pE88, DOI 10.1016/j.ejrad.2009.12.012; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Runnels L, 2002, NATURE CELL BIOL, V4; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Ryazanova LV, 2014, SCI REP-UK, V4, DOI 10.1038/srep07599; Sah R, 2014, P NATL ACAD SCI USA, V111, P6528, DOI 10.1073/pnas.1405727111; Sah R, 2013, CIRCULATION, V128, P101, DOI 10.1161/CIRCULATIONAHA.112.000768; Sontia B, 2008, HYPERTENSION, V51, P915, DOI 10.1161/HYPERTENSIONAHA.107.100339; Sun HS, 2009, NAT NEUROSCI, V12, P1300, DOI 10.1038/nn.2395; Touyz RM, 2008, AM J PHYSIOL-HEART C, V294, pH1103, DOI 10.1152/ajpheart.00903.2007; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Yu Y, 2014, CELL CALCIUM, V55, P252, DOI 10.1016/j.ceca.2014.02.019; Zakharov SI, 2003, BRIT J PHARMACOL, V138, P234, DOI 10.1038/sj.bjp.0705074; Zhang YH, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0282-4	48	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170923	10.1371/journal.pone.0170923	http://dx.doi.org/10.1371/journal.pone.0170923			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129376	Green Published, gold, Green Submitted			2022-12-27	WOS:000396211400026
J	Huerga, H; Ferlazzo, G; Bevilacqua, P; Kirubi, B; Ardizzoni, E; Wanjala, S; Sitienei, J; Bonnet, M				Huerga, Helena; Ferlazzo, Gabriella; Bevilacqua, Paolo; Kirubi, Beatrice; Ardizzoni, Elisa; Wanjala, Stephen; Sitienei, Joseph; Bonnet, Maryline			Incremental Yield of Including Determine-TB LAM Assay in Diagnostic Algorithms for Hospitalized and Ambulatory HIV-Positive Patients in Kenya	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; LIPOARABINOMANNAN LAM; INFECTED ADULTS; XPERT MTB/RIF; URINE; CARE; PERFORMANCE; IMPACT	Background Determine-TB LAM assay is a urine point-of-care test useful for TB diagnosis in HIV-positive patients. We assessed the incremental diagnostic yield of adding LAM to algorithms based on clinical signs, sputum smear-microscopy, chest X-ray and Xpert MTB/RIF in HIV-positive patients with symptoms of pulmonary TB (PTB). Methods Prospective observational cohort of ambulatory (either severely ill or CD4< 200cells/mu l or with Body Mass Index<17Kg/m(2)) and hospitalized symptomatic HIV-positive adults in Kenya. Incremental diagnostic yield of adding LAM was the difference in the proportion of confirmed TB patients (positive Xpert or MTB culture) diagnosed by the algorithm with LAM compared to the algorithm without LAM. The multivariable mortality model was adjusted for age, sex, clinical severity, BMI, CD4, ART initiation, LAM result and TB confirmation. Results Among 474 patients included, 44.1% were severely ill, 69.6% had CD4< 200cells/mu l, 59.9% had initiated ART, 23.2% could not produce sputum. LAM, smear-microscopy, Xpert and culture in sputum were positive in 39.0% (185/474), 21.6% (76/352), 29.1% (102/350) and 39.7% (92/232) of the patients tested, respectively. Of 156 patients with confirmed TB, 65.4% were LAM positive. Of those classified as non-TB, 84.0% were LAM negative. Adding LAM increased the diagnostic yield of the algorithms by 36.6%, from 47.4% (95% CI: 39.4- 55.6) to 84.0% (95% CI: 77.3-89.4%), when using clinical signs and X-ray; by 19.9%, from 62.2% (95% CI: 54.1-69.8) to 82.1% (95% CI: 75.1-87.7), when using clinical signs and microscopy; and by 13.4%, from 74.4% (95% CI: 66.8-81.0) to 87.8% (95% CI: 81.6-92.5), when using clinical signs and Xpert. LAM positive patients had an increased risk of 2-months mortality (aOR: 2.7; 95% CI: 1.5-4.9). Conclusion LAM should be included in TB diagnostic algorithms in parallel to microscopy or Xpert request for HIV-positive patients either ambulatory (severely ill or CD4<200cells/mu l) or hospitalized. LAM allows same day treatment initiation in patients at higher risk of death and in those not able to produce sputum.	[Huerga, Helena; Bevilacqua, Paolo; Bonnet, Maryline] Epictr, Paris, France; [Ferlazzo, Gabriella; Ardizzoni, Elisa] Medecins Sans Frontieres, Paris, France; [Kirubi, Beatrice; Ardizzoni, Elisa] Inst Trop Med, Antwerp, Belgium; [Wanjala, Stephen] Medecins Sans Frontieres, Nairobi, Kenya; [Sitienei, Joseph] Minist Hlth, Nairobi, Kenya; [Bonnet, Maryline] INSERM, U1175, IRD UMI TransVIHMI 233, UM, Montpellier, France	Doctors Without Borders; Institute of Tropical Medicine (ITM); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Huerga, H (corresponding author), Epictr, Paris, France.	helena.huerga@epicentre.msf.org	Kirubi, Beatrice/HHS-5040-2022	Kirubi, Beatrice/0000-0002-6195-1876; Wanjala, Stephen/0000-0002-7001-0605	Medecins Sans Frontieres	Medecins Sans Frontieres	This study was funded by Medecins Sans Frontieres. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, ANN REP 2014; Bjerrum S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1151-1; Davis JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009859; Drain PK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006833; Drain PK, 2015, JAIDS-J ACQ IMM DEF, V68, P274, DOI 10.1097/QAI.0000000000000436; Gupta RK, 2015, AIDS, V29, P1987, DOI 10.1097/QAD.0000000000000802; Gupta-Wright A, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0603-9; Huerga H, 2010, INT J TUBERC LUNG D, V14, P611; Kerkhoff AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103285; Lawn SD, 2015, T ROY SOC TROP MED H, P180; Lawn SD, 2015, JAIDS-J ACQ IMM DEF, V69, pE144, DOI 10.1097/QAI.0000000000000672; Lawn SD, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-407; Lawn SD, 2013, LANCET INFECT DIS, V13, P349, DOI 10.1016/S1473-3099(13)70008-2; Lawn SD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-103; Lawn SD, 2012, CLIN INFECT DIS, V54, P1071, DOI 10.1093/cid/cir1039; Manabe YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101459; Mejia GI, 1999, INT J TUBERC LUNG D, V3, P138; Ministry of Health, 2014, KEN HIV EST; Nakiyingi L, 2014, J ACQUIR IMMUNE DEFI; Nakiyingi L, 2014, JAIDS-J ACQ IMM DEF, V66, P270, DOI 10.1097/QAI.0000000000000151; Peter JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054875; Peter J, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0967-z; Peter JG, 2016, LANCET, V387, P1187, DOI 10.1016/S0140-6736(15)01092-2; Shah M, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011420.pub2; Shah M, 2014, AIDS, V28, P1307, DOI 10.1097/QAD.0000000000000264; Talbot E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032876; van Cleeff MRA, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-111; World Health Organisation, 2015, THE USE OF LATERAL F, P74; World Health Organization, 2016, CONSOLIDATED GUIDELI, P480	29	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170976	10.1371/journal.pone.0170976	http://dx.doi.org/10.1371/journal.pone.0170976			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125693	Green Published, Green Submitted, gold			2022-12-27	WOS:000396176100013
J	Mansouri, S; Agartz, I; Ogren, SO; Patrone, C; Lundberg, M				Mansouri, Shiva; Agartz, Ingrid; Ogren, Sven-Oveo; Patrone, Cesare; Lundberg, Mathias			PACAP Protects Adult Neural Stem Cells from the Neurotoxic Effect of Ketamine Associated with Decreased Apoptosis, ER Stress and mTOR Pathway Activation	PLOS ONE			English	Article							POLYPEPTIDE PACAP; NEURODEGENERATIVE DISEASES; SUBVENTRICULAR ZONE; IN-VIVO; HIPPOCAMPAL-NEURONS; ALZHEIMERS-DISEASE; PROGENITOR CELLS; ANIMAL-MODEL; NEUROGENESIS; BRAIN	Ketamine administration is a well-established approach to mimic experimentally some aspects of schizophrenia. Adult neurogenesis dysregulation is associated with psychiatric disorders, including schizophrenia. The potential role of neurogenesis in the ketamineinduced phenotype is largely unknown. Recent results from human genetic studies have shown the pituitary adenylate cyclase-activating polypeptide (PACAP) gene is a risk factor for schizophrenia. Its potential role on the regulation of neurogenesis in experimental model of schizophrenia remains to be investigated. We aimed to determine whether ketamine affects the viability of adult neural stem cells (NSC). We also investigated whether the detrimental effect mediated by ketamine could be counteracted by PACAP. NSCs were isolated from the subventricular zone of the mouse and exposed to ketamine with/without PACAP. After 24 hours, cell viability, potential involvement of apoptosis, endoplasmic reticulum (ER) stress, mTOR and AMPA pathway activation were assessed by quantitative RT-PCR and Western blot analysis. We show that ketamine impairs NSC viability in correlation with increased apoptosis, ER stress and mTOR activation. The results also suggest that the effect of ketamine occurs via AMPA receptor activation. Finally, we show that PACAP counteracted the decreased NSC viability induced by ketamine via the specific activation of the PAC-1 receptor subtype. Our study shows that the NSC viability may be negatively affected by ketamine with putative importance for the development of a schizophrenia phenotype in the ketamine induced animal model of schizophrenia. The neuroprotective effect via PAC-1 activation suggests a potentially novel pharmacological target for the treatment of schizophrenia, via neurogenesis normalization.	[Mansouri, Shiva; Lundberg, Mathias] Karolinska Inst, Soder Sjukhuset, Dept Clin Sci & Educ, Stockholm, Sweden; [Agartz, Ingrid] Diakonhjemmet Hosp, Dept Psychiat Res, Oslo, Norway; [Agartz, Ingrid] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Agartz, Ingrid] Univ Oslo, Oslo Univ Hosp, NORMENT, Div Mental Hlth & Addict,KG Jebsen Ctr Psychosis, N-0316 Oslo, Norway; [Agartz, Ingrid] Univ Oslo, Inst Clin Med, N-0316 Oslo, Norway; [Agartz, Ingrid; Lundberg, Mathias] Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res, Stockholm, Sweden; [Ogren, Sven-Oveo] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Patrone, Cesare] Karolinska Inst, Soder Sjukhuset, Internal Med, Dept Clin Sci & Educ, Stockholm, Sweden	Karolinska Institutet; Sodersjukhuset Hospital; Diakonhjemmet Hospital; Karolinska Institutet; University of Oslo; University of Oslo; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Sodersjukhuset Hospital	Mansouri, S (corresponding author), Karolinska Inst, Soder Sjukhuset, Dept Clin Sci & Educ, Stockholm, Sweden.	shiva.mansouri@ki.se			Anders Paulssons gavor fond [D0042]; Swedish research council FORMAS	Anders Paulssons gavor fond; Swedish research council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	Support was provided by: 1) Anders Paulssons gavor fond [Grant number: D0042]; 2) "Swedish research council FORMAS". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous D.N., 2015, COLD SPRING HARB PER, V7; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Ayalew M, 2012, MOL PSYCHIATR, V17, P887, DOI 10.1038/mp.2012.37; Becker A, 2003, PROG NEURO-PSYCHOPH, V27, P687, DOI 10.1016/S0278-5846(03)00080-0; Bertilsson G, 2008, J NEUROSCI RES, V86, P326, DOI 10.1002/jnr.21483; Bosnjak ZJ, 2012, CURR DRUG SAF, V7, P106, DOI 10.2174/157488612802715663; Bourgault S, 2009, CURR MED CHEM, V16, P4462, DOI 10.2174/092986709789712899; Braun SMG, 2014, DEVELOPMENT, V141, P1983, DOI 10.1242/dev.104596; Brenneman DE, 2007, PEPTIDES, V28, P1720, DOI 10.1016/j.peptides.2007.04.002; Cadet JL, 2005, NEUROTOX RES, V8, P199, DOI 10.1007/BF03033973; COHEN ML, 1973, ANESTHESIOLOGY, V39, P370, DOI 10.1097/00000542-197310000-00003; Costa L, 2009, HIPPOCAMPUS, V19, P99, DOI 10.1002/hipo.20488; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; Curtis MA, 2007, NAT REV NEUROSCI, V8, P712, DOI 10.1038/nrn2216; Dickerson J, 2006, NEUROPSYCHOPHARMACOL, V31, P1420, DOI 10.1038/sj.npp.1300878; Dong CX, 2014, BIRTH DEFECTS RES B, V101, P355, DOI 10.1002/bdrb.21119; Dong CX, 2012, CRIT CARE MED, V40, P2407, DOI 10.1097/CCM.0b013e318253563c; Duncan EJ, 2001, NEUROPSYCHOPHARMACOL, V25, P72, DOI 10.1016/S0893-133X(00)00240-2; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; Ettinger U, 2015, SCHIZOPHRENIA BULL, V41, pS417, DOI 10.1093/schbul/sbu190; GARTHWAITE G, 1991, EUR J NEUROSCI, V3, P715, DOI 10.1111/j.1460-9568.1991.tb01668.x; Gilda JE, 2013, ANAL BIOCHEM, V440, P186, DOI 10.1016/j.ab.2013.05.027; Hashimoto H, 2001, P NATL ACAD SCI USA, V98, P13355, DOI 10.1073/pnas.231094498; Hashimoto R, 2007, MOL PSYCHIATR, V12, P1026, DOI 10.1038/sj.mp.4001982; Heckers S, 2002, J NEURAL TRANSM, V109, P891, DOI 10.1007/s007020200073; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Keilhoff G, 2004, NEUROSCIENCE, V126, P591, DOI 10.1016/j.neuroscience.2004.03.039; Kempermann G, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018812; Koga M, 2010, PSYCHIAT GENET, V20, P123, DOI 10.1097/YPG.0b013e32833a1f52; Lamine A, 2016, NEUROPHARMACOLOGY, V108, P440, DOI 10.1016/j.neuropharm.2015.05.014; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Mak YT, 2010, MICROSC RES TECHNIQ, V73, P195, DOI 10.1002/jemt.20774; Makela J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011091; Mansouri S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156867; Mansouri S, 2013, J NEUROCHEM, V127, P209, DOI 10.1111/jnc.12396; Mansouri S, 2012, J NEUROSCI RES, V90, P759, DOI 10.1002/jnr.22803; Matsttzaki S, 2008, EXPERT OPIN THER TAR, V12, P1097, DOI [10.1517/14728220802321783, 10.1517/14728222.12.9.1097 ]; Matsuyama S, 2003, NEUROREPORT, V14, P2095, DOI 10.1097/00001756-200311140-00017; Matus S, 2011, CURR OPIN CELL BIOL, V23, P239, DOI 10.1016/j.ceb.2011.01.003; Mercer A, 2004, J NEUROSCI RES, V76, P205, DOI 10.1002/jnr.20038; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Miyamoto S, 2001, BRAIN RES, V894, P167, DOI 10.1016/S0006-8993(01)01991-6; Moberg PJ, 1999, NEUROPSYCHOPHARMACOL, V21, P325, DOI 10.1016/S0893-133X(99)00019-6; Nicot A, 2004, J NEUROSCI, V24, P8786, DOI 10.1523/JNEUROSCI.1910-04.2004; Ohta S, 2006, J NEUROSCI RES, V84, P1177, DOI 10.1002/jnr.21026; Ohtaki H, 2008, J MOL NEUROSCI, V36, P16, DOI 10.1007/s12031-008-9077-3; Otto C, 2001, MOL BRAIN RES, V92, P78, DOI 10.1016/S0169-328X(01)00153-X; Park SW, 2014, INT J NEUROPSYCHOPH, V17, P1831, DOI 10.1017/S1461145714000534; Reglodi D, 2011, CURR PHARM DESIGN, V17, P962, DOI 10.2174/138161211795589355; Rodriguez JJ, 2009, NEUROREPORT, V20, P907, DOI 10.1097/WNR.0b013e32832be77d; Ruan L, 2013, PROG NEUROBIOL; Schobel SA, 2013, NEURON, V78, P81, DOI 10.1016/j.neuron.2013.02.011; Schoenfeld TJ, 2014, NEUROPSYCHOPHARMACOL; Shiva D V Mansouri, 2014, J DIABETES, V5; Soares MBP, 1998, J IMMUNOL, V160, P1811; Tanaka K, 2006, J NEUROSCI, V26, P5091, DOI 10.1523/JNEUROSCI.4376-05.2006; Tang GM, 2014, NEURON, V83, P1131, DOI 10.1016/j.neuron.2014.07.040; Toro CT, 2007, SCHIZOPHR RES, V90, P1, DOI 10.1016/j.schres.2006.09.030; TSAI GC, 1995, ARCH GEN PSYCHIAT, V52, P829; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Vranken JH, 2005, PAIN, V117, P231, DOI 10.1016/j.pain.2005.06.014; Yaksh TL, 2008, ANESTHESIOLOGY, V108, P938, DOI 10.1097/ALN.0b013e31816c902a; Ziabreva I, 2006, J PSYCHOSOM RES, V61, P311, DOI 10.1016/j.jpsychores.2006.07.017	67	21	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170496	10.1371/journal.pone.0170496	http://dx.doi.org/10.1371/journal.pone.0170496			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125634	gold, Green Published			2022-12-27	WOS:000396176100100
J	Martinez, CM; Duplisea, DE; Cerrato, RM; Frisk, MG				Martinez, Christopher M.; Duplisea, Daniel E.; Cerrato, Robert M.; Frisk, Michael G.			Exploration of Trends in Interspecific Abundance-Occupancy Relationships Using Empirically Derived Simulated Communities	PLOS ONE			English	Article							POSITIVE RELATIONSHIP; LOCAL ABUNDANCE; CLIMATE-CHANGE; MARINE	The interspecific abundance-occupancy relationship (AOR) is a widely used tool that describes patterns of habitat utilization and, when evaluated over time, may be used to identify large-scale changes in community structure. Our primary goal for this research was to validate the utility of AORs as temporal indicators of community state. We used long-term survey data in four regions of the northwest Atlantic coastal shelf (NWACS) to estimate the diversity of spatial behaviors in each community, which we modeled with negative binomial (NB) distributions. NB parameters were used to generate time series data for simulated communities, from which AORs were then estimated and evaluated for temporal trends. We found that AORs from simulated communities were similar in year-to-year variation to empirical relationships. In order to further understand the role of spatial diversity in the generation of AOR trends, we did additional simulations where NB parameters were manually manipulated. In one instance, we ran simulations while holding species' parameters constant over time. This treatment effectively removed trends, suggesting that temporal change in community relationships was the result of genuine variation in intraspecific spatial use. In another set of simulations, we conducted a case study to evaluate the impact of a select group of schooling and spatially aggregating species on an especially rapid shift in AORs in the Gulf of Maine from 1973 to 1983. Removals of these species reduced the magnitudes of most trends, demonstrating their importance to observed community changes. This research directly links variation in AORs to distribution and density-related processes and provides a potentially powerful framework to identify community-level change and to test ecological and mechanistic hypotheses.	[Martinez, Christopher M.; Cerrato, Robert M.; Frisk, Michael G.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Duplisea, Daniel E.] Fisheries & Oceans Canada, Inst Maurice Lamontagne, Mont Joli, PQ, Canada; [Martinez, Christopher M.] Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Fisheries & Oceans Canada; University of California System; University of California Davis	Martinez, CM (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA.; Martinez, CM (corresponding author), Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA.	cmimartinez@ucdavis.edu		Duplisea, Daniel/0000-0002-0844-359X	National Science Foundation-National Oceanic and Atmospheric Administration Comparative Analysis of Marine Ecosystem Organization (CAMEO) [1041716]	National Science Foundation-National Oceanic and Atmospheric Administration Comparative Analysis of Marine Ecosystem Organization (CAMEO)	This work was supported by a joint National Science Foundation-National Oceanic and Atmospheric Administration Comparative Analysis of Marine Ecosystem Organization (CAMEO) grant, #1041716. Data for this research comes from a long term survey by NOAA's Northeast Fisheries Science Center. The funders had no role in the study design, data analysis, decision to publish, or preparation of the manuscript.	Borregaard MK, 2010, Q REV BIOL, V85, P3, DOI 10.1086/650265; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Buckley HL, 2010, J ECOL, V98, P645, DOI 10.1111/j.1365-2745.2010.01650.x; Christensen V, 2003, FISH FISH, V4, P1, DOI 10.1046/j.1467-2979.2003.00103.x; Cowley MJR, 2001, J ANIM ECOL, V70, P426, DOI 10.1046/j.1365-2656.2001.00509.x; Dulvy NK, 2008, J APPL ECOL, V45, P1029, DOI 10.1111/j.1365-2664.2008.01488.x; Faulks L, 2015, AM NAT, V186, P272, DOI 10.1086/682004; Fisher JAD, 2004, MAR ECOL PROG SER, V279, P201, DOI 10.3354/meps279201; Frisk MG, 2011, ECOL APPL, V21, P227, DOI 10.1890/09-1698.1; Gaston KJ, 2003, GLOBAL ECOL BIOGEOGR, V12, P373, DOI 10.1046/j.1466-822X.2003.00054.x; Gaston KJ, 1998, J ANIM ECOL, V67, P995, DOI 10.1046/j.1365-2656.1998.6760995.x; Gaston KJ, 1997, J ANIM ECOL, V66, P579, DOI 10.2307/5951; Gaston KJ, 1997, OECOLOGIA, V112, P112, DOI 10.1007/s004420050290; Guedo DD, 2013, J VEG SCI, V24, P607, DOI 10.1111/jvs.12006; Hartley S, 1998, J ANIM ECOL, V67, P992, DOI 10.1046/j.1365-2656.1998.6760992.x; Heino J, 2005, ECOGRAPHY, V28, P345, DOI 10.1111/j.0906-7590.2005.04151.x; Holt AR, 2004, J ANIM ECOL, V73, P841, DOI 10.1111/j.0021-8790.2004.00862.x; Holt AR, 2002, BASIC APPL ECOL, V3, P1, DOI 10.1078/1439-1791-00083; Hoye TT, 2012, ECOL INDIC, V20, P221, DOI 10.1016/j.ecolind.2012.01.017; Lear W.H., 1998, J NW ATLANTIC FISHER, V23, P41, DOI [DOI 10.2960/J.V23.A4, 10.2960/J.v23.a4]; Lucey SM, 2010, MAR ECOL PROG SER, V415, P23, DOI 10.3354/meps08743; McLeod A.I., 2011, PACKAGE KENDALL KEND; Miller TJ, 2010, 1005 NEFSC US DEP CO; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Pauly D, 2005, B MAR SCI, V76, P197; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; R Core Team, 2021, R LANGUAGE ENV STAT; Rindorf A, 2012, CAN J FISH AQUAT SCI, V69, P382, DOI 10.1139/F2011-153; Sosebee KA, 2006, 0605 NEFSC DEP COMM; Storch D, 2004, BASIC APPL ECOL, V5, P389, DOI 10.1016/j.baae.2004.08.001; Topping CJ, 2015, SCI TOTAL ENVIRON, V537, P159, DOI 10.1016/j.scitotenv.2015.07.152; Venables WN., 2002, MODERN APPL STAT S 4; Webb TJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P952, DOI 10.1111/j.1466-8238.2011.00736.x; Webb TJ, 2007, J ECOL, V76, P23; Wilson PD, 2008, GLOBAL ECOL BIOGEOGR, V17, P457, DOI 10.1111/j.1466-8238.2008.00385.x; Wilson PD, 2011, GLOBAL ECOL BIOGEOGR, V20, P193, DOI 10.1111/j.1466-8238.2010.00569.x; WRIGHT DH, 1991, J BIOGEOGR, V18, P463, DOI 10.2307/2845487	41	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170816	10.1371/journal.pone.0170816	http://dx.doi.org/10.1371/journal.pone.0170816			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125670	Green Submitted, Green Published, gold			2022-12-27	WOS:000396176100043
J	Mossbridge, JA; Roney, CJR; Suzuki, S				Mossbridge, Julia A.; Roney, Christopher J. R.; Suzuki, Satoru			Losses and External Outcomes Interact to Produce the Gambler's Fallacy	PLOS ONE			English	Article								When making serial predictions in a binary decision task, there is a clear tendency to assume that after a series of the same external outcome (e. g., heads in a coin flip), the next outcome will be the opposing one (e. g., tails), even when the outcomes are independent of one another. This so-called "gambler's fallacy" has been replicated robustly. However, what drives gambler's fallacy behavior is unclear. Here we demonstrate that a run of the same external outcome by itself does not lead to gambler's fallacy behavior. However, when a run of external outcomes is accompanied by a concurrent run of failed guesses, gambler's fallacy behavior is predominant. These results do not depend on how participants' attention is directed. Thus, it appears that gambler's fallacy behavior is driven by a combination of an external series of events and a concurrent series of failure experiences.	[Mossbridge, Julia A.; Suzuki, Satoru] Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA; [Roney, Christopher J. R.] Univ Western Ontario, Kings Univ Coll, Dept Psychol, London, ON, Canada; [Suzuki, Satoru] Northwestern Univ, Interdept Neurosci Program, Evanston, IL USA	Northwestern University; Western University (University of Western Ontario); Northwestern University	Mossbridge, JA (corresponding author), Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA.	jmossbridge@gmail.com	Roney, Chris/AAX-8482-2021		National Institutes of Health [NIH R01 EY018197]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The National Institutes of Health sponsored this work in grant number NIH R01 EY018197 to Satoru Suzuki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron G, 2010, J BEHAV DECIS MAKING, V23, P117, DOI 10.1002/bdm.676; Boynton DM, 2003, ORGAN BEHAV HUM DEC, V91, P119, DOI 10.1016/S0749-5978(03)00064-5; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Camerer CF, 2004, SCAND J ECON, V106, P555, DOI 10.1111/j.0347-0520.2004.00377.x; De Charms RC., 1968, PERSONAL CAUSATION I; Gigerenzer G, 2009, TOP COGN SCI, V1, P107, DOI 10.1111/j.1756-8765.2008.01006.x; Kerby DS, 2014, COMPREHENSIVE PSYCHO, V1, P11; LANGER EJ, 1975, J PERS SOC PSYCHOL, V32, P311, DOI 10.1037/0022-3514.32.2.311; LaPlace PDD, 1796, PHILOS ESSAY PROBABI; Oskarsson AT, 2009, PSYCHOL BULL, V135, P262, DOI 10.1037/a0014821; Paolacci G., 2010, JUDGM DECIS MAK, V5, P5, DOI DOI 10.2139/SSRN.1626226; Roney C, 2003, CAN J PSYCHOL, V57, P69; Roney CJR, 2009, THINK REASONING, V15, P197, DOI 10.1080/13546780902847137; Roney CJR, 2003, CAN J EXP PSYCHOL, V57, P69, DOI 10.1037/h0087414; Roney CJR, THINKING REASONING, V21, P193; TVERSKY A, 1971, PSYCHOL BULL, V76, P105, DOI 10.1037/h0031322	16	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e170057	10.1371/journal.pone.0170057	http://dx.doi.org/10.1371/journal.pone.0170057			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7IT	28125684	Green Published, Green Submitted, gold			2022-12-27	WOS:000396176100130
J	Rosenwald, M; Efthymiou, V; Opitz, L; Wolfrum, C				Rosenwald, Matthias; Efthymiou, Vissarion; Opitz, Lennart; Wolfrum, Christian			SRF and MKL1 Independently Inhibit Brown Adipogenesis	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; ADIPOSE-TISSUE; PPAR-GAMMA; TRANSCRIPTION FACTOR; INSULIN SENSITIVITY; ACTIN CYTOSKELETON; GENE-EXPRESSION; ACTIVATION; MYOCARDIN; ADIPOCYTES	Active brown adipose tissue is responsible for non-shivering thermogenesis in mammals which affects energy homeostasis. The molecular mechanisms underlying this activation as well as the formation and activation of brite adipocytes have gained increasing interest in recent years as they might be utilized to regulate systemic metabolism. We show here that the transcriptional regulators SRF and MKL1 both act as repressors of brown adipogenesis. Loss-of-function of these transcription factors leads to a significant induction of brown adipocyte differentiation, increased levels of UCP1 and other thermogenic genes as well as increased respiratory function, while SRF induction exerts the opposite effects. Interestingly, we observed that knockdown of MKL1 does not lead to a reduced expression of typical SRF target genes and that the SRF/MKL1 inhibitor CCG-1423 had no significant effects on brown adipocyte differentiation. Contrary, knockdown of MKL1 induces a significant increase in the transcriptional activity of PPAR. target genes and MKL1 interacts with PPAR., suggesting that SRF and MKL1 independently inhibit brown adipogenesis and that MKL1 exerts its effect mainly by modulating PPAR. activity.	[Rosenwald, Matthias; Efthymiou, Vissarion; Opitz, Lennart; Wolfrum, Christian] Swiss Fed Inst Technol, Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Schwerzenbach, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Wolfrum, C (corresponding author), Swiss Fed Inst Technol, Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Schwerzenbach, Switzerland.	christian-wolfrum@ethz.ch		Wolfrum, Christian/0000-0002-3862-6805; Efthymiou, Vissarion/0000-0003-4327-7977	Swiss National Funding Agency (SNF) [31003A_162887]; Swiss National Funding Agency [SNF 31003A_162887]	Swiss National Funding Agency (SNF); Swiss National Funding Agency	This work was supported by Swiss National Funding Agency (SNF) 31003A_162887.; We gratefully acknowledge Matthias Geiger for assisting with cell culture and Elke Kiehlmann for tissue microscopy. The work was supported by the Swiss National Funding Agency (SNF 31003A_162887, CW).	Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Balza RO, 2006, J BIOL CHEM, V281, P6498, DOI 10.1074/jbc.M509487200; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bell JL, 2013, BEILSTEIN J ORG CHEM, V9, P966, DOI 10.3762/bjoc.9.111; Chondronikola M, 2014, DIABETES, V63, P4089, DOI 10.2337/db14-0746; Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; Evelyn CR, 2007, MOL CANCER THER, V6, P2249, DOI 10.1158/1535-7163.MCT-06-0782; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Gineitis D, 2001, J BIOL CHEM, V276, P24531, DOI 10.1074/jbc.M102678200; Huang JH, 2012, J CLIN INVEST, V122, P3678, DOI 10.1172/JCI63635; Klein J, 2002, BIOESSAYS, V24, P382, DOI 10.1002/bies.10058; Koh YJ, 2009, EXP MOL MED, V41, P880, DOI 10.3858/emm.2009.41.12.094; Kovsan J, 2009, AM J PHYSIOL-ENDOC M, V296, pE315, DOI 10.1152/ajpendo.90486.2008; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Lefterova MI, 2014, TRENDS ENDOCRIN MET, V25, P293, DOI 10.1016/j.tem.2014.04.001; Li SJ, 2006, MOL CELL BIOL, V26, P5797, DOI 10.1128/MCB.00211-06; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Lichtenbelt WDV, 2011, AM J PHYSIOL-REG I, V301, pR285, DOI 10.1152/ajpregu.00652.2010; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; McDonald ME, 2015, CELL, V160, P105, DOI 10.1016/j.cell.2014.12.005; Meissburger B, 2011, EMBO MOL MED, V3, P637, DOI 10.1002/emmm.201100172; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Miano JM, 2010, LAB INVEST, V90, P1274, DOI 10.1038/labinvest.2010.104; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Nguyen GH, 2004, CELL SIGNAL, V16, P1141, DOI 10.1016/j.cellsig.2004.03.006; Nobusue H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4368; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Sidossis LS, 2015, CELL METAB, V22, P219, DOI 10.1016/j.cmet.2015.06.022; Vasudevan HN, 2014, DEV CELL, V31, P332, DOI 10.1016/j.devcel.2014.10.005; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang FF, 2013, P NATL ACAD SCI USA, V110, P18656, DOI 10.1073/pnas.1314863110; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	45	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170643	10.1371/journal.pone.0170643	http://dx.doi.org/10.1371/journal.pone.0170643			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125644	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000396176100081
J	Sho, SN; Court, CM; Kim, S; Braxton, DR; Hou, S; Muthusamy, VR; Watson, RR; Sedarat, A; Tseng, HR; Tomlinson, JS				Sho, Shonan; Court, Colin M.; Kim, Stephen; Braxton, David R.; Hou, Shuang; Muthusamy, V. Raman; Watson, Rabindra R.; Sedarat, Alireza; Tseng, Hsian-Rong; Tomlinson, James S.			Digital PCR Improves Mutation Analysis in Pancreas Fine Needle Aspiration Biopsy Specimens	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; RAS GENE MUTATION; DIFFERENTIAL-DIAGNOSIS; CANCER; KRAS; SUBTYPE; NUMBER	Applications of precision oncology strategies rely on accurate tumor genotyping from clinically available specimens. Fine needle aspirations (FNA) are frequently obtained in cancer management and often represent the only source of tumor tissues for patients with metastatic or locally advanced diseases. However, FNAs obtained from pancreas ductal adenocarcinoma (PDAC) are often limited in cellularity and/or tumor cell purity, precluding accurate tumor genotyping in many cases. Digital PCR (dPCR) is a technology with exceptional sensitivity and low DNA template requirement, characteristics that are necessary for analyzing PDAC FNA samples. In the current study, we sought to evaluate dPCR as a mutation analysis tool for pancreas FNA specimens. To this end, we analyzed alterations in the KRAS gene in pancreas FNAs using dPCR. The sensitivity of dPCR mutation analysis was first determined using serial dilution cell spiking studies. Single-cell laser-microdissection (LMD) was then utilized to identify the minimal number of tumor cells needed for mutation detection. Lastly, dPCR mutation analysis was performed on 44 pancreas FNAs (34 formalin-fixed paraffin-embedded (FFPE) and 10 fresh (non-fixed)), including samples highly limited in cellularity (100 cells) and tumor cell purity (1%). We found dPCR to detect mutations with allele frequencies as low as 0.17%. Additionally, a single tumor cell could be detected within an abundance of normal cells. Using clinical FNA samples, dPCR mutation analysis was successful in all preoperative FNA biopsies tested, and its accuracy was confirmed via comparison with resected tumor specimens. Moreover, dPCR revealed additional KRAS mutations representing minor subclones within a tumor that were not detected by the current clinical gold standard method of Sanger sequencing. In conclusion, dPCR performs sensitive and accurate mutation analysis in pancreas FNAs, detecting not only the dominant mutation subtype, but also the additional rare mutation subtypes representing tumor heterogeneity.	[Sho, Shonan; Court, Colin M.; Tomlinson, James S.] Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90024 USA; [Sho, Shonan; Court, Colin M.; Tomlinson, James S.] Greater Los Angeles Vet Affairs Adm, Dept Surg, Los Angeles, CA 90073 USA; [Court, Colin M.; Hou, Shuang; Tseng, Hsian-Rong] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA; [Kim, Stephen; Muthusamy, V. Raman; Watson, Rabindra R.; Sedarat, Alireza; Tomlinson, James S.] Univ Calif Los Angeles, UCLA Ctr Pancreat Dis, Los Angeles, CA USA; [Kim, Stephen; Muthusamy, V. Raman; Watson, Rabindra R.; Sedarat, Alireza] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Los Angeles, CA 90095 USA; [Braxton, David R.] Univ Calif Los Angeles, Dept Pathol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Sho, SN (corresponding author), Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90024 USA.	ssho@mednet.ucla.edu	Hou, Shuang/G-1247-2018; Hou, Shuang/AAM-5055-2021	Hou, Shuang/0000-0001-5487-2427; Hou, Shuang/0000-0001-5487-2427; Tseng, Hsian-Rong/0000-0003-0942-5905; Court, Colin/0000-0002-9357-8957	UCLA Jonsson comprehensive cancer center research grant; NATIONAL CANCER INSTITUTE [U01CA198900, R44CA180482] Funding Source: NIH RePORTER	UCLA Jonsson comprehensive cancer center research grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the UCLA Jonsson comprehensive cancer center research grant to JT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankeny JS, 2016, BRIT J CANCER, V114, P1367, DOI 10.1038/bjc.2016.121; Arvanitakis M, 2004, ENDOSCOPY, V36, P535, DOI 10.1055/s-2004-814401; Azuara D, 2012, CLIN CHEM, V58, P1332, DOI 10.1373/clinchem.2012.186577; Bidshahri R, 2016, J MOL DIAGN, V18, P190, DOI 10.1016/j.jmoldx.2015.09.003; Bournet B, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.18; Bournet B, 2016, EUR J CANCER, V54, P75, DOI 10.1016/j.ejca.2015.11.012; Bournet B, 2014, WORLD J GASTROENTERO, V20, P10758, DOI 10.3748/wjg.v20.i31.10758; Bryant KL, 2014, TRENDS BIOCHEM SCI, V39, P91, DOI 10.1016/j.tibs.2013.12.004; Court CM, 2016, THE JOURNAL OF MOLEC; Court CM, 2015, EXPERT REV MOL DIAGN, V15, P1491, DOI 10.1586/14737159.2015.1091311; de Biase D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087651; de Castro DG, 2012, BRIT J CANCER, V107, P345, DOI 10.1038/bjc.2012.259; Fuccio L, 2013, GASTROINTEST ENDOSC, V78, P596, DOI 10.1016/j.gie.2013.04.162; Garraway LA, 2013, J CLIN ONCOL, V31, P1803, DOI 10.1200/JCO.2013.49.4799; Graham JS, 2015, CLIN GENET, V88, P213, DOI 10.1111/cge.12536; Hamidi H, 2014, BRIT J CANCER, V111, P1788, DOI 10.1038/bjc.2014.475; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huggett JF, 2015, CLIN CHEM, V61, P79, DOI 10.1373/clinchem.2014.221366; Kanagal-Shamanna R, 2014, MODERN PATHOL, V27, P314, DOI 10.1038/modpathol.2013.122; Kinugasa H, 2015, CANCER-AM CANCER SOC, V121, P2271, DOI 10.1002/cncr.29364; Lamy PJ, 2015, J MOL DIAGN, V17, P366, DOI 10.1016/j.jmoldx.2015.02.004; LeBlanc JK, 2004, GASTROINTEST ENDOSC, V59, P475, DOI 10.1016/S0016-5107(03)02863-3; Li J, 2008, NAT MED, V14, P579, DOI 10.1038/nm1708; Lito P, 2016, SCIENCE, V351, P604, DOI 10.1126/science.aad6204; Nikiforova MN, 2013, MODERN PATHOL, V26, P1478, DOI 10.1038/modpathol.2013.91; Ogura T, 2013, J GASTROENTEROL, V48, P640, DOI 10.1007/s00535-012-0664-2; Ogura T, 2012, GASTROINTEST ENDOSC, V75, P769, DOI 10.1016/j.gie.2011.11.012; Perincheri S, 2015, EXPERT REV MOL DIAGN, V15, P375, DOI 10.1586/14737159.2015.986102; Takahashi K, 2005, GASTROINTEST ENDOSC, V61, P76, DOI 10.1016/S0016-5107(04)02224-2; Valero V, 2016, ANN SURG, V263, P153, DOI 10.1097/SLA.0000000000001156	30	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170897	10.1371/journal.pone.0170897	http://dx.doi.org/10.1371/journal.pone.0170897			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125707	gold, Green Published, Green Submitted			2022-12-27	WOS:000396176100029
J	Zanus, C; Battistutta, S; Aliverti, R; Montico, M; Cremaschi, S; Ronfani, L; Monasta, L; Carrozzi, M				Zanus, Caterina; Battistutta, Sara; Aliverti, Renata; Montico, Marcella; Cremaschi, Silvana; Ronfani, Luca; Monasta, Lorenzo; Carrozzi, Marco			Adolescent Admissions to Emergency Departments for Self-Injurious Thoughts and Behaviors	PLOS ONE			English	Article							ATTEMPTED-SUICIDE; YOUNG-PEOPLE; INFLICTED INJURY; COMMUNITY SAMPLE; HARM; CARE; CHILDREN; VISITS; EPIDEMIOLOGY; MULTICENTER	The objective of the present study was to describe the incidence and the characteristics of Self-Injurious Thoughts and Behaviors (SITBs), among adolescents aged 11-18 admitted, over a two year period, to all the Emergency Departments of a Region of North-eastern Italy through a comprehensive analysis of medical records. A two-step search was performed in the regional ED electronic database. First, we identified the cases that had been clearly diagnosed as SITBs by an Emergency Department physician. Secondly, suspect cases were detected through a keyword search of the database, and the medical records of these cases were hand screened to identify SITBs. The mean annual incidence rate of SITBs was 90 per 100,000 adolescents aged 11-18 years. Events were more frequent in females. Drug poisoning was the most frequently adopted method (54%). In 42% of cases a diagnosis of SITB was not explicitly reported by the physician. In 65% of cases adolescents were discharged within hours of admission. Only 9% of patients started a psychiatric assessment and treatment program during hospital stay. This research confirms the high incidence of SITBs among adolescents and highlights the difficulty in their proper diagnosis and management. Such difficulty is confirmed by the fact that only a few patients, even among those with a clear diagnosis, were sent for psychiatric assessment. Correct identification and management of SITB patients needs to be improved, since SITBs are an important public health problem in adolescence and one of the main risk factors for suicide.	[Zanus, Caterina; Battistutta, Sara; Aliverti, Renata; Montico, Marcella; Ronfani, Luca; Monasta, Lorenzo; Carrozzi, Marco] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy; [Cremaschi, Silvana] ASS4 Medio Friuli, Child & Adolescent Neuropsychiat Serv, Udine, Italy	IRCCS Burlo Garofolo	Monasta, L (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy.	lorenzo.monasta@burlo.trieste.it	Ronfani, Luca/B-6668-2013; Monasta, Lorenzo/B-1388-2012; Montico, Marcella/B-5290-2013	Ronfani, Luca/0000-0001-5710-3914; Monasta, Lorenzo/0000-0001-7774-548X; Montico, Marcella/0000-0003-0377-8232; Carrozzi, Marco/0000-0001-6282-4417				Aydin A, 2013, INT J PSYCHIAT CLIN, V17, P110, DOI 10.3109/13651501.2012.697565; Babeva K, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0738-6; Ballard ED, 2016, PREV SCI; Bennewith O, 2005, J AFFECT DISORDERS, V89, P91, DOI 10.1016/j.jad.2005.08.011; Bethell Jennifer, 2009, Health Rep, V20, P35; Betz ME, 2013, DEPRESS ANXIETY, V30, P1005, DOI 10.1002/da.22071; Bossuyt N, 2007, INT J PUBLIC HEALTH, V52, P153, DOI 10.1007/s00038-007-5060-y; Bridge JA, 2012, J AM ACAD CHILD PSY, V51, P213, DOI 10.1016/j.jaac.2011.11.002; Brunner R, 2014, J CHILD PSYCHOL PSYC, V55, P337, DOI 10.1111/jcpp.12166; Chun TH, 2016, PEDIATRICS, V138; Chun TH, 2015, CHILD ADOL PSYCH CL, V24, P21, DOI 10.1016/j.chc.2014.09.003; Clerici CA, 2016, J FORENSIC LEG MED, V37, P15, DOI 10.1016/j.jflm.2015.09.016; Colman Ian, 2004, CJEM, V6, P313; Cooper J, 2005, AM J PSYCHIAT, V162, P297, DOI 10.1176/appi.ajp.162.2.297; Cotter P, 2015, SOC PSYCH PSYCH EPID, V50, P973, DOI 10.1007/s00127-015-1016-3; Cutler GJ, 2015, PEDIATRICS, V136, P28, DOI 10.1542/peds.2014-3573; Di Napoli Wilma Angela, 2015, Psychiatr Danub, V27 Suppl 1, pS279; Dieppe C, 2009, EMERG MED J, V26, P418, DOI 10.1136/emj.2008.062463; Doshi A, 2005, ANN EMERG MED, V46, P369, DOI 10.1016/j.annemergmed.2005.04.018; Ferrara P, 2014, ITAL J PEDIATR, V40, DOI 10.1186/s13052-014-0069-3; Fox KR, 2016, PSYCHIAT RES, V244, P235, DOI 10.1016/j.psychres.2016.07.052; Glenn CR, 2015, J CLIN CHILD ADOLESC, V44, P1, DOI 10.1080/15374416.2014.945211; Hawton K, 2000, J ADOLESCENCE, V23, P47, DOI 10.1006/jado.1999.0290; Hawton K., 2008, RUTTERS CHILD ADOLES, V5th ed, P648; Hawton K, 2007, J CLIN PSYCHIAT, V68, P1574, DOI 10.4088/JCP.v68n1017; Hawton K, 2012, LANCET, V379, P2373, DOI 10.1016/S0140-6736(12)60322-5; Hooley JM, 2008, APPL PREV PSYCHOL, V12, P155, DOI 10.1016/j.appsy.2008.08.001; Horowitz LM, 2012, ARCH PEDIAT ADOL MED, V166, P1170, DOI 10.1001/archpediatrics.2012.1276; Horowitz LM, 2009, CURR OPIN PEDIATR, V21, P620, DOI 10.1097/MOP.0b013e3283307a89; Janssens A, 2013, PEDIATR EMERG CARE, V29, P1041, DOI 10.1097/PEC.0b013e3182a393e7; Jessen G, 1999, ARCH SUICIDE RES, V5, P57, DOI 10.1023/A:1009693123399; Klonsky ED, 2016, ANNU REV CLIN PSYCHO, V12, P307, DOI 10.1146/annurev-clinpsy-021815-093204; Kolves K, 2011, SOC PSYCH PSYCH EPID, V46, P805, DOI 10.1007/s00127-010-0251-x; Larkin GL, 2010, CRISIS, V31, P1, DOI 10.1027/0227-5910/a000001; Levine LJ, 2005, ARCH PEDIAT ADOL MED, V159, P860, DOI 10.1001/archpedi.159.9.860; Madge N, 2008, J CHILD PSYCHOL PSYC, V49, P667, DOI 10.1111/j.1469-7610.2008.01879.x; Mergl R, 2010, EUR ARCH PSY CLIN N, V260, P393, DOI 10.1007/s00406-009-0086-1; Mitchell AJ, 2006, EMERG MED J, V23, P251, DOI 10.1136/emj.2005.027250; Nock MK, 2008, BRIT J PSYCHIAT, V192, P98, DOI 10.1192/bjp.bp.107.040113; Nock MK, 2010, ANNU REV CLIN PSYCHO, V6, P339, DOI 10.1146/annurev.clinpsy.121208.131258; Olfson M, 2005, ARCH GEN PSYCHIAT, V62, P1122, DOI 10.1001/archpsyc.62.10.1122; Olfson M, 2014, JAMA-J AM MED ASSOC, V311, P1107, DOI 10.1001/jama.2014.501; Perry IJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031663; Petrik ML, 2015, GEN HOSP PSYCHIAT, V37, P581, DOI 10.1016/j.genhosppsych.2015.06.018; Polewka Andrzej, 2004, Przegl Lek, V61, P269; Pompili M, 2009, EUR CHILD ADOLES PSY, V18, P525, DOI 10.1007/s00787-009-0007-x; Preti A, 2001, J AFFECT DISORDERS, V65, P253, DOI 10.1016/S0165-0327(00)00232-9; Ribeiro JD, 2016, PSYCHOL MED, V46, P225, DOI 10.1017/S0033291715001804; Rodham K, 2004, J AM ACAD CHILD PSY, V43, P80, DOI 10.1097/00004583-200401000-00017; Rosychuk RJ, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0941-3; Swanepoel A, 2016, ARCH DIS CHILDHOOD-E, V101, P287, DOI 10.1136/archdischild-2016-310782; Ting SA, 2012, GEN HOSP PSYCHIAT, V34, P557, DOI 10.1016/j.genhosppsych.2012.03.020; Ting SA, 2012, ACAD EMERG MED, V19, P239, DOI 10.1111/j.1553-2712.2011.01272.x; Victor SE, 2014, CLIN PSYCHOL REV, V34, P282, DOI 10.1016/j.cpr.2014.03.005; World Health Organization, 2015, MANT HLTH SUIC DAT	55	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170979	10.1371/journal.pone.0170979	http://dx.doi.org/10.1371/journal.pone.0170979			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7IT	28125701	Green Published, Green Submitted, gold			2022-12-27	WOS:000396176100012
J	Zhu, J; Wen, H; Ju, XZ; Bi, R; Zuo, WJ; Wu, XH				Zhu, Jun; Wen, Hao; Ju, Xingzhu; Bi, Rui; Zuo, Wenjia; Wu, Xiaohua			Clinical Significance of Programmed Death Ligand-1 and Intra-Tumoral CD8(+) T Lymphocytes in Ovarian Carcinosarcoma	PLOS ONE			English	Article							CELL LUNG-CANCER; PD-L1 EXPRESSION; INFILTRATING LYMPHOCYTES; PLATINUM; IMMUNOTHERAPY; CHEMOTHERAPY; PROGNOSIS; CARCINOMA; APOPTOSIS; ANTI-PD-1	Ovarian carcinosarcoma (OCS) accounts for high mortality and lacks effective therapeutic methods. So far, we lack reliable biomarkers capable of predicting the risk of aggressive course of the disease. Programmed death ligand-1 (PD-L1) is expressed in various tumors, and antibodies targeting its receptor programmed cell death 1 (PD-1) are emerging cancer therapeutics. This study was designed to evaluate the expression of PD-L1 and intratumoral CD8+ T lymphocytes by immunohistochemistry from 19 OCS patients who underwent primary surgery at Fudan University Shanghai Cancer Center. The correlations between PD-L1 expression and CD8+ T lymphocytes as well as the patients' clinicopathologic characteristics were integrated and statistically analyzed. PD-L1-positive expression was observed in 52.6% of intraepithelial tissues and 47.4% of mesenchymal tissues (p = 0.370). Meanwhile, intraepithelial and mesenchymal CD8+ T lymphocytes were positive in 36.8% and 84.2% of OCS, respectively (p = 0.628). A significantly negative correlation was found between mesenchymal CD8+ T lymphocytes and PD-L1 expression (r = -0.630, p = 0.011). Intraepithelial PD-L1-positive expression was associated only with positive ascitic fluid (p = 0.008). Mesenchymal PD-L1-positive patients had a poorer survival than those with negative expression (p = 0.036). Meanwhile, intraepithelial PD-L1-positive patients had a better survival trend than PD-L1-negative patients, though no statistical significance was found (p = 0.061). There was a better postoperative survival noted in mesenchymal CD8-positive patients (p = 0.024), and allthough a better trend of OS was observed in intraepithelial CD8-positive patients, no statistical significance was found (p = 0.382). Positive tumoral CD8+ T lymphocytes and mesenchymal PD-L1-negative expression seem to be associated with better survival in OCS. It is possible that immunotherapy targeting PD-L1 pathway could be used in OCS.	[Zhu, Jun; Wen, Hao; Ju, Xingzhu; Wu, Xiaohua] Fudan Univ, Shanghai Canc Ctr, Dept Gynecol Oncol, Shanghai, Peoples R China; [Bi, Rui] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai, Peoples R China; [Zuo, Wenjia] Fudan Univ, Shanghai Canc Ctr, Dept Breast Canc, Shanghai, Peoples R China; [Wu, Xiaohua] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Wu, XH (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Gynecol Oncol, Shanghai, Peoples R China.; Wu, XH (corresponding author), Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai, Peoples R China.	docwuxh@yahoo.com		Zhu, Jun/0000-0003-1224-2771	Science and Technology Commission of Shanghai Municipality [12411950300]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the Science and Technology Commission of Shanghai Municipality (Grant No.12411950300). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiko K, 2013, CLIN CANCER RES, V19, P1363, DOI 10.1158/1078-0432.CCR-12-2199; Amant F, 2003, GYNECOL ONCOL, V90, P372, DOI 10.1016/S0090-8258(03)00326-3; Beckers R. K., 2015, HISTOPATHOLOGY; Bernhard H, 2005, METH MOLEC MED, V109, P175; Bindea G, 2010, CURR OPIN IMMUNOL, V22, P215, DOI 10.1016/j.coi.2010.02.006; Bocker W, 2002, VERH DEUT G, V86, P116; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Chen BJ, 2013, CLIN CANCER RES, V19, P3462, DOI 10.1158/1078-0432.CCR-13-0855; Chen YB, 2012, TUMORI, V98, P751, DOI 10.1700/1217.13499; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; Darb-Esfahani S, 2016, ONCOTARGET, V7, P1486, DOI 10.18632/oncotarget.6429; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Duraiswamy J, 2013, CANCER RES, V73, P6900, DOI 10.1158/0008-5472.CAN-13-1550; Faraj SF, 2015, UROLOGY, V85, DOI 10.1016/j.urology.2014.10.020; Farghaly S.A., 2014, ADV DIAGNOSIS MANAGE; GEORGE E, 1991, HUM PATHOL, V22, P215, DOI 10.1016/0046-8177(91)90153-G; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Hamanishi J, 2015, J CLIN ONCOL, V33, P4015, DOI 10.1200/JCO.2015.62.3397; Hwang WT, 2012, GYNECOL ONCOL, V124, P192, DOI 10.1016/j.ygyno.2011.09.039; Inthasorn P, 2003, AUST NZ J OBSTET GYN, V43, P61, DOI 10.1046/j.0004-8666.2003.00003.x; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Kluger HM, 2015, CLIN CANCER RES, V21, P3052, DOI 10.1158/1078-0432.CCR-14-3073; Leiser AL, 2007, GYNECOL ONCOL, V105, P657, DOI 10.1016/j.ygyno.2007.01.037; Lipson EJ, 2013, CANCER IMMUNOL RES, V1, P54, DOI 10.1158/2326-6066.CIR-13-0034; Loizzi V, 2011, ONCOLOGY-BASEL, V80, P102, DOI 10.1159/000328794; Muhlbauer M, 2006, J HEPATOL, V45, P520, DOI 10.1016/j.jhep.2006.05.007; Muenst S, 2014, BREAST CANCER RES TR, V146, P15, DOI 10.1007/s10549-014-2988-5; Nomi T, 2007, CLIN CANCER RES, V13, P2151, DOI 10.1158/1078-0432.CCR-06-2746; Okazaki T, 2007, INT IMMUNOL, V19, P813, DOI 10.1093/intimm/dxm057; Philips GK, 2015, INT IMMUNOL, V27, P39, DOI 10.1093/intimm/dxu095; Phillips T, 2015, APPL IMMUNOHISTO M M, V23, P541, DOI 10.1097/PAI.0000000000000256; Rauh-Hain JA, 2011, GYNECOL ONCOL, V121, P477, DOI 10.1016/j.ygyno.2011.02.023; Rauh-Hain JA, 2016, GYNECOL ONCOL; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Schmidt LH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136023; Shen J, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.2; Shi SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076012; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sit ASY, 2000, GYNECOL ONCOL, V79, P196, DOI 10.1006/gyno.2000.5956; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689	40	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170879	10.1371/journal.pone.0170879	http://dx.doi.org/10.1371/journal.pone.0170879			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125702	Green Published, gold, Green Submitted			2022-12-27	WOS:000396176100033
J	Buchanan, L; Kelly, B; Yeatman, H				Buchanan, Limin; Kelly, Bridget; Yeatman, Heather			Exposure to digital marketing enhances young adults' interest in energy drinks: An exploratory investigation	PLOS ONE			English	Article							FOOD; YOUTH; TELEVISION; CHILDREN; ONLINE; ADOLESCENTS; RECEPTIVITY; AUSTRALIA; ATTITUDES; RESPONSES	Young adults experience faster weight gain and consume more unhealthy food than any other age groups. The impact of online food marketing on "digital native" young adults is unclear. This study examined the effects of online marketing on young adults' consumption behaviours, using energy drinks as a case example. The elaboration likelihood model of persuasion was used as the theoretical basis. A pre-test post-test experimental research design was adopted using mixed-methods. Participants (aged 18-24) were randomly assigned to control or experimental groups (N = 30 each). Experimental group participants' attitudes towards and intended purchase and consumption of energy drinks were examined via surveys and semi-structured interviews after their exposure to two popular energy drink brands' websites and social media sites (exposure time 8 minutes). Exposure to digital marketing contents of energy drinks improved the experimental group participants' attitudes towards and purchase and consumption intention of energy drinks. This study indicates the influential power of unhealthy online marketing on cognitively mature young adults. This study draws public health attentions to young adults, who to date have been less of a focus of researchers but are influenced by online food advertising.	[Buchanan, Limin; Kelly, Bridget; Yeatman, Heather] Univ Wollongong, Fac Social Sci, Sch Hlth & Soc, Early Start Res Inst, Wollongong, NSW, Australia	University of Wollongong	Buchanan, L (corresponding author), Univ Wollongong, Fac Social Sci, Sch Hlth & Soc, Early Start Res Inst, Wollongong, NSW, Australia.	limin@uow.edu.au	Kelly, Bridget/AAW-9549-2021	Kelly, Bridget/0000-0003-3111-6279; Buchanan, Limin/0000-0002-4438-5761	Higher Degree Research (HDR) from the School of Health and Society, Faculty of Social Sciences, University of Wollongong	Higher Degree Research (HDR) from the School of Health and Society, Faculty of Social Sciences, University of Wollongong	This work was supported in part by the Higher Degree Research (HDR) funding from the School of Health and Society, Faculty of Social Sciences, University of Wollongong.	Alan P, 2009, CORPORATE COMMUNICAT, V14, P420; Allman-Farinelli MA, 2008, EUR J CLIN NUTR, V62, P898, DOI 10.1038/sj.ejcn.1602769; Alvy LM, 2008, J AM DIET ASSOC, V108, P710, DOI 10.1016/j.jada.2008.01.006; [Anonymous], 2011, AUSTRALIAN; Arnett J., 2004, EMERGING ADULTHOOD T; Austin EW, 2006, J ADOLESCENT HEALTH, V38, P376, DOI 10.1016/j.jadohealth.2005.08.017; Australia Drug Foundation, 2012, ENERGY DRINKS DO THE; Australian Beverages Council, 2011, ENERGY DRINKS AN IND; Australian Bureau of Statistics (ABS), 2015, 4364 0 55 001 NATION; Ballouli J, 2013, J ISSUES INTERCOLLEG, V6, P268; BATRA R, 1990, J CONSUM RES, V17, P203, DOI 10.1086/208550; Baumgartner E, 2012, INT J PSYCHOL, V47, P154, DOI 10.1080/00207594.2011.597398; Bellman S, 2011, J INTERACT MARK, V25, P191, DOI 10.1016/j.intmar.2011.06.001; Bhutada Nilesh S, 2012, Health Mark Q, V29, P35, DOI 10.1080/07359683.2012.652576; Blatterer H, 2010, CULT SOCIOL-LONDON, V4, P63, DOI 10.1177/1749975509356755; Bogel PM, 2015, CORP COMMUN, V20, P128, DOI 10.1108/CCIJ-11-2013-0095; Buchanan L, DIGITAL MARKETING AN; CACIOPPO JT, 1984, ADV CONSUM RES, V11, P673; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cornish LS, 2014, INT J ADVERT, V33, P437, DOI 10.2501/IJA-33-3-437-473; Dixon HG, 2007, SOC SCI MED, V65, P1311, DOI 10.1016/j.socscimed.2007.05.011; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; FASICK FA, 1978, PUBLIC OPIN QUART, V41, P549; Fogger S, 2011, J PSYCHOSOC NURS MEN, V49, P17, DOI 10.3928/02793695-20111102-03; Food Standard Australia New Zealand, 2013, STANDARD 2 6 4 FORMU; Freeman B, 2015, HEALTH PROMOT INT, V17, P856; Goldfarb A, 2011, J MARKETING RES, V48, P207, DOI 10.1509/jmkr.48.2.207; Gordon R, 2011, ADDICT RES THEORY, V19, P66, DOI 10.3109/16066351003597142; Halcomb EJ, 2006, APPLIED NURSING RESE, P38; Heckman MA, 2010, COMPR REV FOOD SCI F, V9, P303, DOI 10.1111/j.1541-4337.2010.00111.x; Heinrich-Heine-Universitat Dusseldorf, 2016, G POWER STATISTICAL; Hoffman EW, 2014, J AM COLL HEALTH, V62, P328, DOI 10.1080/07448481.2014.902837; Huhtinen H, 2013, ARJA RIMPELA E S1, V23, P304, DOI [10.1016/j.acap.2014.11.006, DOI 10.1016/J.ACAP.2014.11.006]; JAMIESON LF, 1989, J MARKETING RES, V26, P336, DOI 10.2307/3172905; Jones SC, 2011, ALCOHOL ALCOHOLISM, V46, P630, DOI 10.1093/alcalc/agr080; Kelly B, 2008, AUST NZ J PUBL HEAL, V32, P522, DOI 10.1111/j.1753-6405.2008.00303.x; Kim H, 2016, INT J CONSUM STUD, V40, P201, DOI 10.1111/ijcs.12243; McClure A, 2016, PEDIATRICS, V137, P1; McClure AC, 2013, AM J PREV MED, V45, P560, DOI 10.1016/j.amepre.2013.06.011; McClure AC, 2013, ALCOHOL CLIN EXP RES, V37, pE404, DOI 10.1111/j.1530-0277.2012.01932.x; Miller CL, 2006, AUST NZ J PUBL HEAL, V30, P325, DOI 10.1111/j.1467-842X.2006.tb00843.x; Montgomery KC, 2012, PEDIATR CLIN N AM, V59, P659, DOI 10.1016/j.pcl.2012.03.022; Montgomery KC, 2009, J ADOLESCENT HEALTH, V45, pS18, DOI 10.1016/j.jadohealth.2009.04.006; Moore ES, 2007, J PUBLIC POLICY MARK, V26, P202, DOI 10.1509/jppm.26.2.202; Morgenstern M, 2011, ARCH PEDIAT ADOL MED, V165, P610, DOI 10.1001/archpediatrics.2011.12; Nikolaou CK, 2015, INT J OBESITY, V39, P508, DOI 10.1038/ijo.2014.160; Paek HJ, 2011, HEALTH COMMUN, V26, P159, DOI 10.1080/10410236.2010.544281; Perez DA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-429; Pierce JP, 1998, JAMA-J AM MED ASSOC, V279, P511, DOI 10.1001/jama.279.7.511; Piggford T, 2008, SOC MARK Q, V14, P33, DOI 10.1080/15245000802034689; Schwartz DL, 2015, ACAD PEDIATR, V15, P297, DOI 10.1016/j.acap.2014.11.006; Visram S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010380; Wang A, 2011, THE JOURNAL OF CORPO, P50; Warren R, 2008, J BROADCAST ELECTRON, V52, P231, DOI 10.1080/08838150801992037; Yale Rudd Center for Food Policy & Obesity, 2011, SUGARY DRINK FACTS E	55	41	41	0	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171226	10.1371/journal.pone.0171226	http://dx.doi.org/10.1371/journal.pone.0171226			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28152016	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161200109
J	Iribarren, SJ; Cato, K; Falzon, L; Stone, PW				Iribarren, Sarah J.; Cato, Kenrick; Falzon, Louise; Stone, Patricia W.			What is the economic evidence for mHealth? A systematic review of economic evaluations of mHealth solutions	PLOS ONE			English	Article							COST-EFFECTIVENESS; CHRONIC DISEASE; EHEALTH INTERVENTIONS; MEDICATION ADHERENCE; SMOKING-CESSATION; HEALTH-CARE; TELEMEDICINE; HIV; TECHNOLOGIES; SURVEILLANCE	Background Mobile health (mHealth) is often reputed to be cost-effective or cost-saving. Despite optimism, the strength of the evidence supporting this assertion has been limited. In this systematic review the body of evidence related to economic evaluations of mHealth interventions is assessed and summarized. Methods Seven electronic bibliographic databases, grey literature, and relevant references were searched. Eligibility criteria included original articles, comparison of costs and consequences of interventions (one categorized as a primary mHealth intervention or mHealth intervention as a component of other interventions), health and economic outcomes and published in English. Full economic evaluations were appraised using the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist and The PRISMA guidelines were followed. Results Searches identified 5902 results, of which 318 were examined at full text, and 39 were included in this review. The 39 studies spanned 19 countries, most of which were conducted in upper and upper-middle income countries (34, 87.2%). Primary mHealth interventions (35, 89.7%), behavior change communication type interventions (e.g., improve attendance rates, medication adherence) (27, 69.2%), and short messaging system (SMS) as the mHealth function (e.g., used to send reminders, information, provide support, conduct surveys or collect data) (22, 56.4%) were most frequent; the most frequent disease or condition focuses were outpatient clinic attendance, cardiovascular disease, and diabetes. The average percent of CHEERS checklist items reported was 79.6% (range 47.62-100, STD 14.18) and the top quartile reported 91.3-100%. In 29 studies (74.3%), researchers reported that the mHealth intervention was cost-effective, economically beneficial, or cost saving at base case. Conclusions Findings highlight a growing body of economic evidence for mHealth interventions. Although all studies included a comparison of intervention effectiveness of a health-related outcome and reported economic data, many did not report all recommended economic outcome items and were lacking in comprehensive analysis. The identified economic evaluations varied by disease or condition focus, economic outcome measurements, perspectives, and were distributed unevenly geographically, limiting formal meta-analysis. Further research is needed in low and low-middle income countries and to understand the impact of different mHealth types. Following established economic reporting guidelines will improve this body of research.	[Iribarren, Sarah J.] Univ Washington, Sch Nursing, Dept Biobehav Nursing & Hlth Informat, Seattle, WA 98195 USA; [Cato, Kenrick; Stone, Patricia W.] Columbia Univ, Sch Nursing, New York, NY USA; [Cato, Kenrick] New York Presbyterian Hosp, Off Nursing Res EBP & Innovat, New York, NY USA; [Falzon, Louise] Columbia Univ, Dept Med, Ctr Behav Cardiovasc Hlth, Med Ctr,New York Presbyterian Hosp, New York, NY USA; [Stone, Patricia W.] Columbia Univ, Sch Nursing, Ctr Hlth Policy, New York, NY USA	University of Washington; University of Washington Seattle; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University	Iribarren, SJ (corresponding author), Univ Washington, Sch Nursing, Dept Biobehav Nursing & Hlth Informat, Seattle, WA 98195 USA.	sjiribar@uw.edu	Falzon, Louise/AAG-2404-2019; Falzon, Louise/HCI-2175-2022	Falzon, Louise/0000-0002-9449-6056; Iribarren, Sarah/0000-0003-2980-0717	Comparative and Cost-Effectiveness Research Training for Nurse Scientists Award by the National Institute of Nursing Research of the National Institutes of Health [T32NR014205]; NATIONAL INSTITUTE OF NURSING RESEARCH [T32NR014205] Funding Source: NIH RePORTER	Comparative and Cost-Effectiveness Research Training for Nurse Scientists Award by the National Institute of Nursing Research of the National Institutes of Health; NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	Sarah Iribarren is funded by a Comparative and Cost-Effectiveness Research Training for Nurse Scientists Award (T32NR014205) by the National Institute of Nursing Research of the National Institutes of Health. The funding organization had no role in study design, data collection, data analysis, data interpretation, or writing of the report. All authors had full access to all the data and had final responsibility for the decision to submit for publication.	Adepoju OE, 2014, POPUL HEALTH MANAG, V17, P112, DOI 10.1089/pop.2013.0029; Agarwal S, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1174; Aranda-Jan CB, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-188; Armstrong Kathleen A, 2014, J Med Internet Res, V16, pe213, DOI 10.2196/jmir.3528; Au-Yeung KY, 2012, INT J TUBERC LUNG D, V16, P1498, DOI 10.5588/ijtld.11.0868; Badawy SM, 2016, JMIR MHEALTH UHEALTH, V4, DOI 10.2196/mhealth.6425; Bergmo TS, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4521; Bigna JJR, 2014, LANCET INFECT DIS, V14, P600, DOI 10.1016/S1473-3099(14)70741-8; Briggs A, 2006, DECISION MODELLING F; Burn E, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007226; Chang LW, 2013, AIDS CARE, V25, P652, DOI 10.1080/09540121.2012.722600; Chen YF, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16380; Chen ZW, 2008, J ZHEJIANG UNIV-SC B, V9, P34, DOI 10.1631/jzus.B071464; Chib A, 2015, J HEALTH COMMUN, V20, P4, DOI 10.1080/10810730.2013.864735; de la Torre-Diez I, 2015, TELEMED E-HEALTH, V21, P81, DOI 10.1089/tmj.2014.0053; Downer Sean R, 2006, Aust Health Rev, V30, P389; Drummond MFSM, 2005, METHODS FOR THE ECON; Edlin R., 2015, COST EFFECTIVENESS M; Elbert NJ, 2014, J MED INTERNET RES, V16, P182, DOI 10.2196/jmir.2790; Farley JE, 2005, AM J INFECT CONTROL, V33, P444, DOI 10.1016/j.ajic.2005.07.001; Finitsis DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088166; Fiordelli M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2430; Forrest JI, 2015, CURR OPIN HIV AIDS, V10, P464, DOI 10.1097/COH.0000000000000198; Frick K, 2013, OUTCOME ASSESSMENT I; Guerriero C, 2013, EUR J HEALTH ECON, V14, P789, DOI 10.1007/s10198-012-0424-5; Hagberg LA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-38; Hale K, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.4532; Hall AK, 2015, ANNU REV PUBL HEALTH, V36, P393, DOI 10.1146/annurev-publhealth-031914-122855; Henrikson Nora B, 2013, Evid Based Spine Care J, V4, P2, DOI 10.1055/s-0033-1341594; Hunchangsith P, 2012, VALUE HEALTH, V15, pS50, DOI 10.1016/j.jval.2011.11.006; Husereau D, 2013, VALUE HEALTH, V16, pE1, DOI 10.1016/j.jval.2013.02.010; International telecommunication Union, 2015, THE WORLD IN 2015 IC; Jonsson B, 2009, EUR J HEALTH ECON, V10, P357, DOI 10.1007/s10198-009-0173-2; Joo NS, 2010, J TELEMED TELECARE, V16, P63, DOI 10.1258/jtt.2009.090407; Koshy E, 2008, BMC OPHTHALMOL, V8, DOI 10.1186/1471-2415-8-9; Labrique AB, 2013, GLOB HEALTH-SCI PRAC, V1, P160, DOI 10.9745/GHSP-D-13-00031; Larsen-Cooper E, 2016, TELEMED E-HEALTH, V22, P317, DOI 10.1089/tmj.2015.0060; Lee CK, 2014, MHEALTH BASICS INTRO; Levine R, 2015, MHEALTH COMPENDIUM, VFive; Li Y, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2906; Lowres N, 2014, THROMB HAEMOSTASIS, V111, P1167, DOI 10.1160/TH14-03-0231; Lozano-Fuentes S, 2013, J MED ENTOMOL, V50, P879, DOI 10.1603/ME13008; Luxton DD, 2014, J TELEMED TELECARE, V20, P431, DOI 10.1177/1357633X14555616; Maddison R, 2015, EUR J PREV CARDIOL, V22, P701, DOI 10.1177/2047487314535076; Mahmud N, 2010, TECHNOL HEALTH CARE, V18, P137, DOI 10.3233/THC-2010-0576; Mbuagbaw L, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-014-0654-6; McInnes DK, 2014, AM J PUBLIC HEALTH, V104, pS588, DOI 10.2105/AJPH.2014.302061; McLean SM, 2016, PATIENT PREFER ADHER, V10, P479, DOI 10.2147/PPA.S93046; Mendoza G, 2013, MHEALTH COMPENDIUM; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moore JO, 2014, J CLIN OUTCOMES MANA, V21, P110; Naslund JA, 2015, J MENT HEALTH, V24, P320, DOI 10.3109/09638237.2015.1019054; Nieuwlaat R, 2016, JAMA INTERN MED, V176, P350, DOI 10.1001/jamainternmed.2015.7853; Nundy S, 2014, HEALTH AFFAIR, V33, P265, DOI 10.1377/hlthaff.2013.0589; O'Leary ST, 2015, PEDIATRICS, V136, pE1220, DOI 10.1542/peds.2015-1089; Perron NJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-125; Ryan D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1756; Schweitzer J, 2012, J HEALTH COMMUN, V17, P73, DOI 10.1080/10810730.2011.649158; Snooks HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106436; St John Andrew, 2014, Clin Biochem Rev, V35, P155; Steinhubl SR, 2013, JAMA-J AM MED ASSOC, V310, P2395, DOI 10.1001/jama.2013.281078; Thakkar J, 2016, JAMA INTERN MED, V176, P340, DOI 10.1001/jamainternmed.2015.7667; Vashist SK, 2015, TRENDS BIOTECHNOL, V33, P692, DOI 10.1016/j.tibtech.2015.09.001; Whitten PS, 2002, BRIT MED J, V324, P1434, DOI 10.1136/bmj.324.7351.1434; Wong CKH, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/1219581; World Health Organization mHealth, 2011, GLOBAL OBSERVATORY E, V3, P1; Zhai YK, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000312; Zurovac D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052045	68	232	238	7	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170581	10.1371/journal.pone.0170581	http://dx.doi.org/10.1371/journal.pone.0170581			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28152012	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000396161200028
J	Liu, RX; Wang, YL; Shu, ML; Wu, SB				Liu, Ruixia; Wang, Yinglong; Shu, Minglei; Wu, Shangbin			Throughput assurance of wireless body area networks coexistence based on stochastic geometry	PLOS ONE			English	Article							INTERFERENCE; SCHEME	Wireless body area networks (WBANs) are expected to influence the traditional medical model by assisting caretakers with health telemonitoring. Within WBANs, the transmit power of the nodes should be as small as possible owing to their limited energy capacity but should be sufficiently large to guarantee the quality of the signal at the receiving nodes. When multiple WBANs coexist in a small area, the communication reliability and overall throughput can be seriously affected due to resource competition and interference. We show that the total network throughput largely depends on the WBANs distribution density (lambda(p)), transmit power of their nodes (P-t), and their carrier-sensing threshold (gamma). Using stochastic geometry, a joint carrier-sensing threshold and power control strategy is proposed to meet the demand of coexisting WBANs based on the IEEE 802.15.4 standard. Given different network distributions and carrier-sensing thresholds, the proposed strategy derives a minimum transmit power according to varying surrounding environment. We obtain expressions for transmission success probability and throughput adopting this strategy. Using numerical examples, we show that joint carrier-sensing thresholds and transmit power strategy can effectively improve the overall system throughput and reduce interference. Additionally, this paper studies the effects of a guard zone on the throughput using a Matern hard-core point process (HCPP) type II model. Theoretical analysis and simulation results show that the HCPP model can increase the success probability and throughput of networks.	[Liu, Ruixia] Shandong Univ Sci & Technol, Coll Comp Sci & Engn, Qingdao 2666590, Peoples R China; [Liu, Ruixia; Wang, Yinglong; Shu, Minglei] Natl Supercomp Ctr Jina, Shandong Prov Key Lab Comp Networks, Shandong Comp Sci Ctr, Jinan 250014, Peoples R China; [Wu, Shangbin] Heriot Watt Univ, Elect & Comp Engn Sch Engn & Phys Sci, Edinburgh EH14 4AS, Midlothian, Scotland	Shandong University of Science & Technology; Qilu University of Technology; Heriot Watt University	Liu, RX (corresponding author), Shandong Univ Sci & Technol, Coll Comp Sci & Engn, Qingdao 2666590, Peoples R China.; Liu, RX (corresponding author), Natl Supercomp Ctr Jina, Shandong Prov Key Lab Comp Networks, Shandong Comp Sci Ctr, Jinan 250014, Peoples R China.	liurx@sdas.org		liu, ruixia/0000-0002-4044-5384	National Natural Science Foundation of China [61401256]; Shandong Provincial Science and Technology Project [2014GSF118107]; Open Research Fund from Shandong provincial Key Laboratory of Computer Network [SDKLCN-2014-04]; Postdoctoral Innovation Special Fund of Shandong Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Science and Technology Project; Open Research Fund from Shandong provincial Key Laboratory of Computer Network; Postdoctoral Innovation Special Fund of Shandong Province	This research was financially supported by the National Natural Science Foundation of China under Grant No. 61401256, the Shandong Provincial Science and Technology Project under Grant No. 2014GSF118107, the Open Research Fund from Shandong provincial Key Laboratory of Computer Network under Grant No. SDKLCN-2014-04 and the Postdoctoral Innovation Special Fund of Shandong Province.	Ahmadi A, 2014, J SUPERCOMPUT, V68, P599, DOI 10.1007/s11227-013-1054-0; [Anonymous], 2012, 802 IEEE; Baccelli F, 2005, STOCHASTIC GEOMETRY, VI, P13; Banerjee D, 2015, COMPUT COMMUN, V55, P80, DOI 10.1016/j.comcom.2014.09.010; Bhandari S, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16030401; Bouabdallah F, 2012, EFFICIENT REPORTING, P1; Busson A, 2009, INTERFERENCE MODELIN, P3; Cavallari R, 2014, IEEE COMMUN SURV TUT, V16, P1635, DOI 10.1109/SURV.2014.012214.00007; Chiu S, 2013, STOCHASTIC GEOMETRY, P36; EISawy H., 2014, IEEE T MOBILE COMPUT, V13, P1611, DOI DOI 10.1109/TMC.2013.123; Fu L., 2013, P IEEE 10 INT C ASIC, P1; Haenggi M., 2012, STOCHASTIC GEOMETRY; Hwang TH, 2013, SENSORS-BASEL, V13, P375, DOI 10.3390/s130100375; Jacob AK, 2015, INT J DISTRIB SENS N, DOI 10.1155/2015/404182; Jin Z, 2015, INT J DISTRIB SENS N, DOI 10.1155/2015/386842; Lee CH, 2012, IEEE T WIREL COMMUN, V11, P1392, DOI 10.1109/TWC.2012.021512.110131; Li HM, 2010, IEEE T INF TECHNOL B, V14, P44, DOI 10.1109/TITB.2009.2028136; Li M, 2015, IEEE ICC, P6418, DOI 10.1109/ICC.2015.7249347; Lin C, 2016, ANN TELECOMMUN, V71, P465, DOI 10.1007/s12243-016-0498-7; Liu Q, 2014, 2014 9TH INTERNATIONAL SYMPOSIUM ON COMMUNICATION SYSTEMS, NETWORKS & DIGITAL SIGNAL PROCESSING (CSNDSP), P411, DOI 10.1109/CSNDSP.2014.6923864; Mohammadi MS, 2014, IEEE COMMUN LETT, V18, P2193, DOI 10.1109/LCOMM.2014.2364226; Naranjo PGV, 2017, J SUPERCOMPUT, V73, P733, DOI 10.1007/s11227-016-1785-9; Otal B, 2009, IEEE J SEL AREA COMM, V27, P553, DOI 10.1109/JSAC.2009.090516; Proenca C.E.B., 2009, ARACAS GENERO PSIDIU, P1; Ren Z, 2016, IEEE T PARALL DISTR, V27, P546, DOI 10.1109/TPDS.2015.2408611; Rezvani S, 2013, IET WIREL SENS SYST, V3, P16, DOI 10.1049/iet-wss.2012.0100; Shojafar M, 2015, WIRELESS PERS COMMUN, V82, P61, DOI 10.1007/s11277-014-2194-0; Sun ZY, 2017, WIREL NETW, V23, P1201, DOI 10.1007/s11276-016-1213-3; Thorpe C, 2014, IEEE COMMUN SURV TUT, V16, P1266, DOI 10.1109/SURV.2014.031814.00177; Vegad MM, 2015, WIRELESS PERS COMMUN, V81, P445, DOI 10.1007/s11277-014-2138-8; Wireless Medium Access Control (MAC) and Physical Layer (PHY) Specifications for Low-Rate Wireless Personal Area Networks (WPANs), 2006, 802154 IEEE; Xiao S, 2009, IEEE J SEL AREA COMM, V27, P37, DOI 10.1109/JSAC.2009.090105; Yang D, 2011, INT J DISTRIB SENS N, V3, P876; Zhang XC, 2012, IEEE T COMMUN, V60, P2602, DOI 10.1109/TCOMM.2012.071312.110730; Zhang ZY, 2013, IEEE T EMERG TOP COM, V1, P121, DOI 10.1109/TETC.2013.2274430	35	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171123	10.1371/journal.pone.0171123	http://dx.doi.org/10.1371/journal.pone.0171123			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141841	Green Published, Green Submitted, gold			2022-12-27	WOS:000396129500039
J	Wanichthanarak, K; Fan, S; Grapov, D; Barupal, DK; Fiehn, O				Wanichthanarak, Kwanjeera; Fan, Sili; Grapov, Dmitry; Barupal, Dinesh Kumar; Fiehn, Oliver			Metabox: A Toolbox for Metabolomic Data Analysis, Interpretation and Integrative Exploration	PLOS ONE			English	Article							GENE-EXPRESSION; O-GLCNAC; VISUALIZATION; INFORMATION; NETWORKS	Similar to genomic and proteomic platforms, metabolomic data acquisition and analysis is becoming a routine approach for investigating biological systems. However, computational approaches for metabolomic data analysis and integration are still maturing. Metabox is a bioinformatics toolbox for deep phenotyping analytics that combines data processing, statistical analysis, functional analysis and integrative exploration of metabolomic data within proteomic and transcriptomic contexts. With the number of options provided in each analysis module, it also supports data analysis of other `omic' families. The toolbox is an R-based web application, and it is freely available at http://kvvanjeeraw.gthub.io/metabox/undertheGPL-3 license.	[Wanichthanarak, Kwanjeera; Fan, Sili; Grapov, Dmitry; Barupal, Dinesh Kumar; Fiehn, Oliver] Univ Calif Davis, Genome Ctr, West Coast Metab Ctr, Davis, CA 95616 USA; [Fiehn, Oliver] King Abdulaziz Univ, Dept Biochem, Jeddah, Saudi Arabia	University of California System; University of California Davis; King Abdulaziz University	Fiehn, O (corresponding author), Univ Calif Davis, Genome Ctr, West Coast Metab Ctr, Davis, CA 95616 USA.	ofiehn@ucdavis.edu	Fan, Sili/ABA-8666-2020; Barupal, Dinesh K/A-9341-2010; Wanichthanarak, Kwanjeera/AAV-7790-2021	barupal, dinesh/0000-0002-9954-8628; Fiehn, Oliver/0000-0002-6261-8928	National Institutes of Health and National Institute of Diabetes and Digestive and Kidney Diseases [DK097154]	National Institutes of Health and National Institute of Diabetes and Digestive and Kidney Diseases	This work was supported by U24 National Institutes of Health and National Institute of Diabetes and Digestive and Kidney Diseases DK097154. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Barupal DK, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-99; Beisser D, 2010, BIOINFORMATICS, V26, P1129, DOI 10.1093/bioinformatics/btq089; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Borrego SL, 2016, CANCER METAB, V4, DOI 10.1186/s40170-016-0148-6; Cambiaghi A., 2016, BRIEFINGS BIOINFORMA; Castelo R, 2009, J COMPUT BIOL, V16, P213, DOI 10.1089/cmb.2008.08TT; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dittrich MT, 2008, BIOINFORMATICS, V24, pI223, DOI 10.1093/bioinformatics/btn161; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; Feinerer I, 2008, J STAT SOFTW, V25, P1; Fiehn O, 2005, LECT NOTES COMPUT SC, V3615, P224; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Franz M, 2016, BIOINFORMATICS, V32, P309, DOI 10.1093/bioinformatics/btv557; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Kamburov A, 2013, NUCLEIC ACIDS RES, V41, pD793, DOI 10.1093/nar/gks1055; Kamburov A, 2011, BIOINFORMATICS, V27, P2917, DOI 10.1093/bioinformatics/btr499; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Karnovsky A, 2012, BIOINFORMATICS, V28, P373, DOI 10.1093/bioinformatics/btr661; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; Kuo TC, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-64; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lipscomb CE, 2000, B MED LIBR ASSOC, V88, P265; Ma ZY, 2013, AMINO ACIDS, V45, P719, DOI 10.1007/s00726-013-1543-8; Oliveira AP, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-17; Ooms J., 2014, OPENCPU SYSTEM UNIVE; Patil KR, 2005, P NATL ACAD SCI USA, V102, P2685, DOI 10.1073/pnas.0406811102; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Pirhaji L, 2016, NATURE METHODS; Rutherford A, 2004, BRIT J MATH STAT PSY, V57, P185; Selamat SA, 2012, GENOME RES, V22, P1197, DOI 10.1101/gr.132662.111; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Stouffer S. A., 1949, THE AM SOLDIER; Tur I, 2014, GENETICS, V198, P1377, DOI 10.1534/genetics.114.169573; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Varemo L, 2013, NUCLEIC ACIDS RES, V41, P4378, DOI 10.1093/nar/gkt111; Wang SY, 2013, ANAL CHEM, V85, P1037, DOI 10.1021/ac302877x; Wanichthanarak W, 2015, BIOMARK INSIGHTS, V10, P1, DOI 10.4137/BMI.S29511; Wikoff WR, 2015, CANCER PREV RES, V8, P410, DOI 10.1158/1940-6207.CAPR-14-0329; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211; Xia J., 2015, NUCL ACIDS RES; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xia JG, 2010, BIOINFORMATICS, V26, P2342, DOI 10.1093/bioinformatics/btq418; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356	50	61	61	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171046	10.1371/journal.pone.0171046	http://dx.doi.org/10.1371/journal.pone.0171046			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141874	Green Published, Green Submitted, gold			2022-12-27	WOS:000396129500035
J	Hahnloser, RHR; Narula, G				Hahnloser, Richard H. R.; Narula, Gagan			A Bayesian Account of Vocal Adaptation to Pitch-Shifted Auditory Feedback	PLOS ONE			English	Article							RESPONSES; ERROR; VOCALIZATION; FREQUENCY; DYNAMICS; LEVEL	Motor systems are highly adaptive. Both birds and humans compensate for synthetically induced shifts in the pitch (fundamental frequency) of auditory feedback stemming from their vocalizations. Pitch-shift compensation is partial in the sense that large shifts lead to smaller relative compensatory adjustments of vocal pitch than small shifts. Also, compensa-tion is larger in subjects with high motor variability. To formulate a mechanistic description of these findings, we adapt a Bayesian model of error relevance. We assume that vocal-auditory feedback loops in the brain cope optimally with known sensory and motor variability. Based on measurements of motor variability, optimal compensatory responses in our model provide accurate fits to published experimental data. Optimal compensation correctly pre-dicts sensory acuity, which has been estimated in psychophysical experiments as justnoticeable pitch differences. Our model extends the utility of Bayesian approaches to adap-tive vocal behaviors.	[Hahnloser, Richard H. R.; Narula, Gagan] Univ Zurich, Inst Neuroinformat, Zurich, Switzerland; Univ Zurich, Neurosci Ctr Zurich, Zurich, Switzerland; ETH, Zurich, Switzerland	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Hahnloser, RHR; Narula, G (corresponding author), Univ Zurich, Inst Neuroinformat, Zurich, Switzerland.	rich@ini.ethz.ch; gnarula@ini.ethz.ch		Hahnloser, Richard/0000-0002-4039-7773	Swiss National Science Foundation Project [31003A_156976/1]	Swiss National Science Foundation Project(Swiss National Science Foundation (SNSF))	Support was provided by the Swiss National Science Foundation Project, 31003A_156976/1 [http://www.snf.ch/en/funding/projects/projects-in -all-disciplines/Pages/default. aspx]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge Alex Pouget, Homare Yamahachi, and Ryosuke Tachibana for helpful discussions and feedback on the manuscript and the support by the Swiss National Science Foundation, Project 31003A_1569761/1.	Bauer JJ, 2006, J ACOUST SOC AM, V119, P2363, DOI 10.1121/1.2173513; Bauer JJ, 2003, J ACOUST SOC AM, V114, P1048, DOI 10.1121/1.1592161; Bernstein JGW, 2006, J ACOUST SOC AM, V120, P3929, DOI 10.1121/1.2372452; Burnett TA, 1998, J ACOUST SOC AM, V103, P3153, DOI 10.1121/1.423073; Castro LNG, 2014, CURR BIOL, V24, P1050, DOI 10.1016/j.cub.2014.03.049; Eliades SJ, 2008, NATURE, V453, P1102, DOI 10.1038/nature06910; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fine MS, 2006, J NEUROPHYSIOL, V96, P710, DOI 10.1152/jn.00215.2006; Gutfreund Y, 2002, SCIENCE, V297, P1556, DOI 10.1126/science.1073712; Hain TC, 2000, EXP BRAIN RES, V130, P133, DOI 10.1007/s002219900237; Houde JF, 1998, SCIENCE, V279, P1213, DOI 10.1126/science.279.5354.1213; Jones JA, 2000, J ACOUST SOC AM, V108, P1246, DOI 10.1121/1.1288414; Jones JA, 2008, EXP BRAIN RES, V190, P279, DOI 10.1007/s00221-008-1473-y; Keller GB, 2009, NATURE, V457, P187, DOI 10.1038/nature07467; Kelly CW, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00075; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Liu C, 2013, J ACOUST SOC AM, V134, P3011, DOI 10.1121/1.4820887; Liu HJ, 2007, J ACOUST SOC AM, V122, P3671, DOI 10.1121/1.2800254; Marko MK, 2012, J NEUROPHYSIOL, V108, P1752, DOI 10.1152/jn.00177.2012; MARLER P, 1964, SCIENCE, V146, P1483, DOI 10.1126/science.146.3650.1483; Natke U, 2003, J ACOUST SOC AM, V113, P1587, DOI 10.1121/1.1543928; Scheerer NE, 2012, NEUROSCI LETT, V529, P128, DOI 10.1016/j.neulet.2012.09.012; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Sober SJ, 2012, P NATL ACAD SCI USA, P1; Tokarev K, 2014, COLD SPRING HARB APR; van Beers RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049373; van Beers RJ, 2009, NEURON, V63, P406, DOI 10.1016/j.neuron.2009.06.025; van der Kooij K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117901; Wei KL, 2009, J NEUROPHYSIOL, V101, P655, DOI 10.1152/jn.90545.2008; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931	31	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0169795	10.1371/journal.pone.0169795	http://dx.doi.org/10.1371/journal.pone.0169795			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135267	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000396124700005
J	Khayyat, SM; Khayyat, SMS; Alhazmi, RSH; Mohamed, MMA; Hadi, MA				Khayyat, Sarah M.; Saeed Khayyat, Salwa M.; Hyat Alhazmi, Raghda S.; Mohamed, Mahmoud M. A.; Hadi, Muhammad Abdul			Predictors of Medication Adherence and Blood Pressure Control among Saudi Hypertensive Patients Attending Primary Care Clinics: A Cross-Sectional Study	PLOS ONE			English	Article							SCALE	Purpose To assess the level of medication adherence and to investigate predictors of medication adherence and blood pressure control among hypertensive patients attending primary healthcare clinics in Makkah, Saudi Arabia. Patients and methods Hypertensive patients meeting the eligibility criteria were recruited from eight primary care clinics between January and May 2016 for this study. The patients completed Arabic version of Morisky Medication Adherence Scale (MMAS-8), an eight-item validated, self-reported measure to assess medication adherence. A structured data collection form was used to record patients' sociodemographic, medical and medication data. Results Two hundred and four patients, of which 71.6% were females, participated in the study. Patients' mean age was 59.1 (SD 12.2). The mean number of medication used by patients was 4.4 (SD 1.89). More than half (110; 54%) of the patients were non-adherent to their medications (MMAS score < 6). Binary regression analysis showed that highly adherent patients (MMAS score = 8) were about five times (OR 4.91 [95% CI: 1.85-12.93; P = 0.01]) more likely to have controlled blood pressure compared to low adherent patients. Female gender (OR 0.40 [95% CI: 0.20-0.80; P = 0.01]), Age > 65 years (OR 2.0 [95% CI: 1.0-4.2; P = 0.04]), and being diabetic (OR 0.25 [95% CI: 0.1-0.6; P = 0.04]) were found to be independent predictors of medication adherence. Conclusion Medication adherence is alarmingly low among hypertensive patients attending primary care clinics in Saudi Arabia which may partly explain observed poor blood pressure control. There is a clear need to educate patients about the importance of medication adherence and its impact on improving clinical outcomes. Future research should identify barriers to medication adherence among Saudi hypertensive patients.	[Khayyat, Sarah M.; Mohamed, Mahmoud M. A.] Umm Al Qura Univ, Dept Clin Pharm, Fac Pharm, Mecca, Saudi Arabia; [Saeed Khayyat, Salwa M.; Hyat Alhazmi, Raghda S.] Minist Hlth, Publ Hlth Ctr, Mecca, Saudi Arabia; [Mohamed, Mahmoud M. A.] Umm Al Qura Univ, Pharmaceut Res Ctr, Deanship Sci Res, Mecca, Saudi Arabia; [Hadi, Muhammad Abdul] Univ Leeds, Sch Healthcare, Leeds, W Yorkshire, England	Umm Al Qura University; Ministry of Health - Saudi Arabia; Umm Al Qura University; University of Leeds	Khayyat, SM (corresponding author), Umm Al Qura Univ, Dept Clin Pharm, Fac Pharm, Mecca, Saudi Arabia.	smkhayat@uqu.edu.sa	mohamed, mostafa/AFE-7371-2022; Hadi, Muhammad Abdul/AAL-7439-2020	mohamed, mostafa/0000-0002-1421-2667; Hadi, Muhammad Abdul/0000-0003-0108-7833; M. Khayyat, Sarah/0000-0002-0316-1825				Al Solami F.J.A., 2012, CLIN MED DIAGNOSTICS, V2, P27, DOI DOI 10.5923/J.CMD.20120204.02; Al-Nozha MM, 2007, SAUDI MED J, V28, P77; Al-Ramahi R, 2015, J EPIDEMIOL GLOB HEA, V5, P125, DOI 10.1016/j.jegh.2014.05.005; Al-Sowielem LS, 1998, E MEDITERR HEALTH J, V4, P301; Alhewiti Abdullah, 2014, Int J Family Med, V2014, P479596, DOI 10.1155/2014/479596; Burnier M, 2006, AM J HYPERTENS, V19, P1190, DOI 10.1016/j.amjhyper.2006.04.006; De Geest Sabina, 2003, Eur J Cardiovasc Nurs, V2, P323; Fernandez-Arias M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112875; Frisoli TM, 2011, EUR HEART J, V32, P3081, DOI 10.1093/eurheartj/ehr379; Hyre Amanda D, 2007, J Clin Hypertens (Greenwich), V9, P179, DOI 10.1111/j.1524-6175.2007.06372.x; Institute for Health Metrics and Evaluation (IHME), 2013, GBD ARR DIAGR SAUD A; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jin Jing, 2008, Ther Clin Risk Manag, V4, P269; Kang CD, 2015, INT J CARDIOL, V182, P250, DOI 10.1016/j.ijcard.2014.12.064; Khalil SA, 1997, J HYPERTENS, V15, P561, DOI 10.1097/00004872-199715050-00013; Khatib R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084238; Krousel-Wood M, 2009, AM J MANAG CARE, V15, P59; Lehmann A, 2014, INT J CLIN PHARM-NET, V36, P55, DOI 10.1007/s11096-013-9865-x; Mahler C, 2012, J EVAL CLIN PRACT, V18, P409, DOI 10.1111/j.1365-2753.2010.01589.x; Mahmoud MIH, 2012, J TAIBAH UNIV MED SC, V7, P92, DOI 10.1016/j.jtumed.2012.11.004; Manteuffel M, 2014, J WOMENS HEALTH, V23, P112, DOI 10.1089/jwh.2012.3972; Meinema JG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133560; Mohammad Y, 2016, J EPIDEMIOL GLOB HEA, V6, P157, DOI 10.1016/j.jegh.2015.07.002; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Morisky DE, 2011, J CLIN EPIDEMIOL, V64, P255, DOI 10.1016/j.jclinepi.2010.09.002; National Institute for Health and Care Excellence (NICE), 2011, HYP AD DIAGN MAN NIC; Neter JE, 2003, HYPERTENSION, V42, P878, DOI 10.1161/01.HYP.0000094221.86888.AE; Oliveira AD, 2012, ARQ BRAS CARDIOL, V99, P649, DOI 10.1590/S0066-782X2012005000053; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Phatak HM, 2006, ANN PHARMACOTHER, V40, P1737, DOI 10.1345/aph.1H153; Ramli Azuana, 2012, Patient Prefer Adherence, V6, P613, DOI 10.2147/PPA.S34704; Saeed AA, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/174135; WHO, 2013, WHODCOWHD20132; World Health Organization, 2003, ADHERENCE LONG TERM	34	41	44	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171255	10.1371/journal.pone.0171255	http://dx.doi.org/10.1371/journal.pone.0171255			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135324	Green Published, gold			2022-12-27	WOS:000396124700056
J	van den Boomen, C; Peters, JC				van den Boomen, Carlijn; Peters, Judith Carolien			Spatial Frequency Discrimination: Effects of Age, Reward, and Practice	PLOS ONE			English	Article							CONTRAST SENSITIVITY; VISUAL DEVELOPMENT; AREAS V1; CHILDREN; ORIENTATION; MECHANISMS; LUMINANCE; VISION; V2	Social interaction starts with perception of the world around you. This study investigated two fundamental issues regarding the development of discrimination of higher spatial frequen-cies, which are important building blocks of perception. Firstly, it mapped the typical devel-opmental trajectory of higher spatial frequency discrimination. Secondly, it developed and validated a novel design that could be applied to improve atypically developed vision. Specifically, this study examined the effect of age and reward on task performance, practice effects, and motivation (i. e., number of trials completed) in a higher spatial frequency (refer-ence frequency: 6 cycles per degree) discrimination task. We measured discrimination thresholds in children aged between 7 to 12 years and adults (N = 135). Reward was manip-ulated by presenting either positive reinforcement or punishment. Results showed a de-crease in discrimination thresholds with age, thus revealing that higher spatial frequency discrimination continues to develop after 12 years of age. This development continues lon-ger than previously shown for discrimination of lower spatial frequencies. Moreover, thresholds decreased during the run, indicating that discrimination abilities improved. Reward did not affect performance or improvement. However, in an additional group of 5-6 year-olds (N = 28) punishments resulted in the completion of fewer trials compared to reinforcements. In both reward conditions children aged 5-6 years completed only a fourth or half of the run (64 to 128 out of 254 trials) and were not motivated to continue. The design thus needs fur-ther adaptation before it can be applied to this age group. Children aged 7-12 years and adults completed the run, suggesting that the design is successful and motivating for chil-dren aged 7-12 years. This study thus presents developmental differences in higher spatial frequency discrimination thresholds. Furthermore, it presents a design that can be used in future developmental studies that require multiple stimulus presentations such as visual per-ceptual learning.	[van den Boomen, Carlijn] Univ Utrecht, Dept Dev Psychol, Heidelberglaan 1,Room H0-66, Utrecht, Netherlands; [Peters, Judith Carolien] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands; [Peters, Judith Carolien] Inst Royal Netherlands Acad Arts & Sci KNAW, Netherlands Inst Neurosci, Amsterdam, Netherlands; [van den Boomen, Carlijn] Helmholtz Inst, Dept Expt Psychol, Heidelberglaan 1,Room H0-66, Utrecht, Netherlands	Utrecht University; Maastricht University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	van den Boomen, C (corresponding author), Univ Utrecht, Dept Dev Psychol, Heidelberglaan 1,Room H0-66, Utrecht, Netherlands.; van den Boomen, C (corresponding author), Helmholtz Inst, Dept Expt Psychol, Heidelberglaan 1,Room H0-66, Utrecht, Netherlands.	C.vandenboomen@uu.nl		Peters, Judith/0000-0003-0979-1016	Consortium on Individual Development (CID); Gravitation program of the Dutch Ministry of Education, Culture, and Science; Netherlands Organization for Scientific Research (NWO) [024.001.003]	Consortium on Individual Development (CID); Gravitation program of the Dutch Ministry of Education, Culture, and Science; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The work of CB was financed through the Consortium on Individual Development (CID). CID is funded through the Gravitation program of the Dutch Ministry of Education, Culture, and Science and the Netherlands Organization for Scientific Research (NWO Grant Number 024.001.003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 2002, VISION RES, V42, P1205, DOI 10.1016/S0042-6989(02)00038-X; Atkinson J., 1981, DEV PERCEPTION PSYCH, V2, P245; BEAZLEY LD, 1980, BRIT J OPHTHALMOL, V64, P863, DOI 10.1136/bjo.64.11.863; Braddick O, 2011, VISION RES, V51, P1588, DOI 10.1016/j.visres.2011.02.018; CAMPBELL FW, 1970, J OPT SOC AM, V60, P555, DOI 10.1364/JOSA.60.000555; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; Ellemberg D, 1999, VISION RES, V39, P3480, DOI 10.1016/S0042-6989(99)00078-4; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; FOSTER KH, 1985, J PHYSIOL-LONDON, V365, P331, DOI 10.1113/jphysiol.1985.sp015776; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; Gervan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040282; Goffaux V, 2005, J VIS, V5, P540; Gordon GE, 1999, DOC OPHTHALMOL, V99, P1, DOI 10.1023/A:1002171011644; Gwiazda J, 1997, OPTOMETRY VISION SCI, V10, P785; Hammarrenger B, 2003, DOC OPHTHALMOL, V107, P225, DOI 10.1023/B:DOOP.0000005331.66114.05; HIRSCH J, 1982, J OPT SOC AM, V72, P1367, DOI 10.1364/JOSA.72.001367; Huurneman B, 2013, INVEST OPHTH VIS SCI, V54, P6208, DOI 10.1167/iovs.13-12220; Jakel F, 2006, J VISION, V6, P1307, DOI 10.1167/6.11.13; Leonard HC, 2010, J EXP CHILD PSYCHOL, V106, P193, DOI 10.1016/j.jecp.2010.03.005; Lewis TL, 2009, OPTOMETRY VISION SCI, V86, P640, DOI 10.1097/OPX.0b013e3181a7296b; Lewis TL, 2005, DEV PSYCHOBIOL, V46, P163, DOI 10.1002/dev.20055; Morrison DJ, 2001, PSYCHON B REV, V8, P454, DOI 10.3758/BF03196180; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; Patel A, 2010, J VISION, V10, DOI 10.1167/10.14.41; Peng XM, 2005, J NEUROPHYSIOL, V93, P1620, DOI 10.1152/jn.00793.2004; REGAN D, 1985, J OPT SOC AM A, V2, P619, DOI 10.1364/JOSAA.2.000619; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Roelfsema PR, 2010, TRENDS COGN SCI, V14, P64, DOI 10.1016/j.tics.2009.11.005; van den Boomen C, 2012, Front Psychiatry, V3, P16, DOI 10.3389/fpsyt.2012.00016; van den Boomen C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122507; van Duijvenvoorde ACK, 2008, J NEUROSCI, V28, P9495, DOI 10.1523/JNEUROSCI.1485-08.2008; Vlamings PHJM, 2010, CHILD DEV, V81, P1304, DOI 10.1111/j.1467-8624.2010.01470.x; Watanabe T, 2015, ANNU REV PSYCHOL, V66, P197, DOI 10.1146/annurev-psych-010814-015214; WEBSTER MA, 1990, J OPT SOC AM A, V7, P1034, DOI 10.1364/JOSAA.7.001034; WETHERILL GB, 1965, BRIT J MATH STAT PSY, V18, P1, DOI 10.1111/j.2044-8317.1965.tb00689.x	35	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0169800	10.1371/journal.pone.0169800	http://dx.doi.org/10.1371/journal.pone.0169800			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6PA	28135272	Green Published, Green Submitted, gold			2022-12-27	WOS:000396124700006
J	Alsharari, ZD; Riserus, U; Leander, K; Sjogren, P; Carlsson, AC; Vikstrom, M; Laguzzi, F; Gigante, B; Cederholm, T; De Faire, U; Hellenius, ML; Marklund, M				Alsharari, Zayed D.; Riserus, Ulf; Leander, Karin; Sjogren, Per; Carlsson, Axel C.; Vikstrom, Max; Laguzzi, Federica; Gigante, Bruna; Cederholm, Tommy; De Faire, Ulf; Hellenius, Mai-Lis; Marklund, Matti			Serum Fatty Acids, Desaturase Activities and Abdominal Obesity - A Population-Based Study of 60-Year Old Men and Women	PLOS ONE			English	Article							ANTHROPOMETRIC MEASURES; WAIST CIRCUMFERENCE; SEX-DIFFERENCES; ADIPOSE-TISSUE; SATURATED FAT; LIVER FAT; PLASMA; ADULTS; BLOOD; RISK	Abdominal obesity is a key contributor of metabolic disease. Recent trials suggest that dietary fat quality affects abdominal fat content, where palmitic acid and linoleic acid influence abdominal obesity differently, while effects of n-3 polyunsaturated fatty acids are less studied. Also, fatty acid desaturation may be altered in abdominal obesity. We aimed to investigate cross-sectional associations of serum fatty acids and desaturases with abdominal obesity prevalence in a population-based cohort study. Serum cholesteryl ester fatty acids composition was measured by gas chromatography in 60-year old men (n = 1883) and women (n = 2015). Cross-sectional associations of fatty acids with abdominal obesity prevalence and anthropometric measures (e.g., sagittal abdominal diameter) were evaluated in multivariable-adjusted logistic and linear regression models, respectively. Similar models were employed to investigate relations between desaturase activities (estimated by fatty acid ratios) and abdominal obesity. In logistic regression analyses, palmitic acid, stearoyl-CoA- desaturase and Delta 6-desaturase indices were associated with abdominal obesity; multivariable-adjusted odds ratios (95% confidence intervals) for highest versus lowest quartiles were 1.45 (1.19-1.76), 4.06 (3.27-5.05), and 3.07 (2.51-3.75), respectively. Linoleic acid, alpha-linolenic acid, docohexaenoic acid, and Delta 5-desaturase were inversely associated with abdominal obesity; multivariable-adjusted odds ratios (95% confidence intervals): 0.39 (0.32-0.48), 0.74 (0.61-0.89), 0.76 (0.62-0.93), and 0.40 (0.33-0.49), respectively. Eicosapentaenoic acid was not associated with abdominal obesity. Similar results were obtained from linear regression models evaluating associations with different anthropometric measures. Sex-specific and linear associations were mainly observed for n3-polyunsaturated fatty acids, while associations of the other exposures were generally non-linear and similar across sexes. In accordance with findings from short-term trials, abdominal obesity was more common among individuals with relatively high proportions of palmitic acid, whilst the contrary was true for linoleic acid. Further trials should examine the potential role of linoleic acid and its main dietary source, vegetable oils, in abdominal obesity prevention.	[Alsharari, Zayed D.; Riserus, Ulf; Sjogren, Per; Cederholm, Tommy; Marklund, Matti] Uppsala Univ, Dept Publ Hlth & Caring Sci, Clin Nutr & Metab, Uppsala, Sweden; [Leander, Karin; Vikstrom, Max; Laguzzi, Federica; Gigante, Bruna; De Faire, Ulf] Karolinska Inst, Inst Environm Med, Unit Cardiovasc Epidemiol, Stockholm, Sweden; [Carlsson, Axel C.] Karolinska Inst, Div Family Med, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Gigante, Bruna] Karolinska Inst, Danderyds Hosp, Div Cardiovasc Med, Dept Clin Sci, Stockholm, Sweden; [De Faire, Ulf; Hellenius, Mai-Lis] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Cardiol Unit, Stockholm, Sweden	Uppsala University; Karolinska Institutet; Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Marklund, M (corresponding author), Uppsala Univ, Dept Publ Hlth & Caring Sci, Clin Nutr & Metab, Uppsala, Sweden.	matti.marklund@pubcare.uu.se	Sjogren, Per/N-5923-2014; Leander, Karin/C-7261-2017; Marklund, Matti/ABC-3674-2021; Gigante, Bruna/I-9252-2012	Leander, Karin/0000-0002-1404-9222; Marklund, Matti/0000-0002-3320-796X; Sjogren, Per/0000-0003-1824-3193; Gigante, Bruna/0000-0003-4508-7990; Carlsson, Axel C/0000-0001-6113-0472	Stockholm County Council; Swedish Heart and Lung Foundation; Swedish Research Council [09533]; Swedish Research Council for Health, Working Life and Welfare; Excellence of Diabetes Research in Swedish (EXODIAB)	Stockholm County Council(Stockholm County Council); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Excellence of Diabetes Research in Swedish (EXODIAB)	This work was supported by Stockholm County Council, Swedish Heart and Lung Foundation, the Swedish Research Council (grant nr 09533), and the Swedish Research Council for Health, Working Life and Welfare, and Excellence of Diabetes Research in Swedish (EXODIAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aune D, 2012, ANN ONCOL, V23, P843, DOI 10.1093/annonc/mdr398; Becker W, 2002, RIKSMATEN 1997 98 KO; Bjermo H, 2012, AM J CLIN NUTR, V95, P1003, DOI 10.3945/ajcn.111.030114; Bjermo H, 2010, CURR OPIN CLIN NUTR, V13, P703, DOI 10.1097/MCO.0b013e32833ec41b; BOBERG M, 1985, CLIN SCI, V68, P581, DOI 10.1042/cs0680581; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; Carlsson AC, 2013, INT J OBESITY, V37, P1579, DOI 10.1038/ijo.2013.46; Carlsson AC, 2008, AM J HYPERTENS, V21, P771, DOI 10.1038/ajh.2008.167; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; DeLany JP, 2000, AM J CLIN NUTR, V72, P905; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Fekete K, 2015, OBES REV, V16, P488, DOI 10.1111/obr.12280; Ford ES, 2014, JAMA-J AM MED ASSOC, V312, P1151, DOI 10.1001/jama.2014.8362; Freedman DS, 2015, AM J CLIN NUTR, V101, P425, DOI 10.3945/ajcn.114.094672; Gillingham LG, 2013, AM J CLIN NUTR, V97, P195, DOI 10.3945/ajcn.112.043117; Han YY, 2012, BONE, V51, P1000, DOI 10.1016/j.bone.2012.08.127; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Laguzzi F, 2015, J HUMAN NUTR DIETETI; Lee JJ, 2014, J OBES, V2014, DOI 10.1155/2014/697264; Marklund M, 2015, CIRCULATION; Marklund M, 2016, CIRCULATION, V133; Marks KA, 2013, GENES NUTR, V8, P317, DOI 10.1007/s12263-012-0325-3; Ohrvall M, 2000, INT J OBESITY, V24, P497, DOI 10.1038/sj.ijo.0801186; Ohrvall M, 1996, EUR J CLIN NUTR, V50, P381; Pan DA, 1995, J CLIN INVEST, V96, P2802, DOI 10.1172/JCI118350; Petersson H, 2010, DIABETES RES CLIN PR, V87, P379, DOI 10.1016/j.diabres.2009.11.019; Petit JM, 2012, CLIN NUTR, V31, P520, DOI 10.1016/j.clnu.2011.12.007; Petrus P, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0042-1; Rosqvist F, 2014, DIABETES, V63, P2356, DOI 10.2337/db13-1622; Song M, 2015, INT J EPIDEMIOL; Song X, 2015, NUTR METAB CARDIOVAS, V25, P295, DOI 10.1016/j.numecd.2014.09.004; Summers LKM, 2002, DIABETOLOGIA, V45, P369, DOI 10.1007/s00125-001-0768-3; Tran C, 2010, BRIT J NUTR, V104, P1139, DOI 10.1017/S000711451000190X; Vessby B, 2002, ANN NY ACAD SCI, V967, P183; Vinknes KJ, 2013, OBESITY, V21, P20011; Wandell PE, 2011, NUTR METAB CARDIOVAS, V21, P173, DOI 10.1016/j.numecd.2009.09.007; Warensjo E, 2006, NUTR METAB CARDIOVAS, V16, P128, DOI 10.1016/j.numecd.2005.06.001; Warensjo E, 2007, OBESITY, V15, P1732, DOI 10.1038/oby.2007.206; Wikner C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061763; Williams CM, 2004, P NUTR SOC, V63, P153, DOI 10.1079/PNS2003314; Zak A, 2002, ANN NY ACAD SCI, V967, P522; Zheng ZJ, 1999, AM J EPIDEMIOL, V150, P492, DOI 10.1093/oxfordjournals.aje.a010038	42	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170684	10.1371/journal.pone.0170684	http://dx.doi.org/10.1371/journal.pone.0170684			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125662	Green Published, Green Submitted, gold			2022-12-27	WOS:000396176100074
J	Tsuruta, S; Ebina, M; Kobayashi, M; Takahashi, W				Tsuruta, Shin-ichi; Ebina, Masumi; Kobayashi, Makoto; Takahashi, Wataru			Complete Chloroplast Genomes of Erianthus arundinaceus and Miscanthus sinensis: Comparative Genomics and Evolution of the Saccharum Complex	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; GENETIC DIVERSITY; DNA-SEQUENCES; RIBOSOMAL DNA; ANDROPOGONEAE; GRASSES; POACEAE; MARKERS; ORIGIN; DIVERSIFICATION	The genera Erianthus and Miscanthus, both members of the Saccharum complex, are of interest as potential resources for sugarcane improvement and as bioenergy crops. Recent studies have mainly focused on the conservation and use of wild accessions of these genera as breeding materials. However, the sequence data are limited, which hampers the studies of phylogenetic relationships, population structure, and evolution of these grasses. Here, we determined the complete chloroplast genome sequences of Erianthus arundinaceus and Miscanthus sinensis by using 454 GS FLX pyrosequencing and Sanger sequencing. Alignment of the E. arundinaceus and M. sinensis chloroplast genome sequences with the known sequence of Saccharum officinarum demonstrated a high degree of conservation in gene content and order. Using the data sets of 76 chloroplast protein-coding genes, we performed phylogenetic analysis in 40 taxa including E. arundinaceus and M. sinensis. Our results show that S. officinarum is more closely related to M. sinensis than to E. arundinaceus. We estimated that E. arundinaceus diverged from the subtribe Sorghinae before the divergence of Sorghum bicolor and the common ancestor of S. officinarum and M. sinensis. This is the first report of the phylogenetic and evolutionary relationships inferred from maternally inherited variation in the Saccharum complex. Our study provides an important framework for understanding the phylogenetic relatedness of the economically important genera Erianthus, Miscanthus, and Saccharum.	[Tsuruta, Shin-ichi] Japan Int Res Ctr Agr Sci, Trop Agr Res Front JIRCAS TARF, Okinawa, Japan; [Ebina, Masumi; Kobayashi, Makoto; Takahashi, Wataru] Natl Agr & Food Res Org, Inst Livestock & Grassland Sci NARO ILGS, Nasushiobara, Tochigi, Japan	Japan International Research Center for Agricultural Sciences; National Agriculture & Food Research Organization - Japan	Tsuruta, S (corresponding author), Japan Int Res Ctr Agr Sci, Trop Agr Res Front JIRCAS TARF, Okinawa, Japan.	stsuru@affrc.go.jp			National Agriculture and Food Research Organization [220a0]; Japan International Research Center of Agricultural Science [001750]	National Agriculture and Food Research Organization; Japan International Research Center of Agricultural Science	This work was supported by research grants from the National Agriculture and Food Research Organization (#220a0) and the Japan International Research Center of Agricultural Science (#001750). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix K, 1999, THEOR APPL GENET, V99, P962, DOI 10.1007/s001220051403; ALJANABI SM, 1994, THEOR APPL GENET, V88, P933, DOI 10.1007/BF00220799; Amalraj VA, 2006, GENET RESOUR CROP EV, V53, P35, DOI 10.1007/s10722-004-0581-1; Asano T, 2004, DNA RES, V11, P93, DOI 10.1093/dnares/11.2.93; Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; Berding N, 1987, SUGARCANE IMPROVEMEN, P143, DOI DOI 10.1016/B978-0-444-42769-4.50009-6; Besse P, 1996, THEOR APPL GENET, V92, P733, DOI 10.1007/BF00226096; Besse P, 1997, EUPHYTICA, V93, P283, DOI 10.1023/A:1002940701171; Besse P, 1998, GENETICA, V104, P143, DOI 10.1023/A:1003436403678; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Burner DM, 2009, BIOMASS BIOENERG, V33, P610, DOI 10.1016/j.biombioe.2008.10.002; Cai Q, 2005, PLANT SCI, V169, P976, DOI 10.1016/j.plantsci.2005.07.002; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Clark LV, 2015, J EXP BOT, V66, P4213, DOI 10.1093/jxb/eru511; Clayton W. D., 1986, Kew Bulletin Additional Series, V13; Clifton-Brown JC, 2004, GLOBAL CHANGE BIOL, V10, P509, DOI 10.1111/j.1529-8817.2003.00749.x; Clifton-Brown John, 2008, P273, DOI 10.1007/978-0-387-70805-8_10; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Daniels SJ, 1987, SUGARCANE IMPROVEMEN, V11, P7, DOI DOI 10.1016/B978-0-444-42769-4.50007-2; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Cesare M, 2010, MOL BREEDING, V26, P539, DOI 10.1007/s11032-010-9451-z; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duvall Melvin R., 2007, Aliso, V23, P237; Estep MC, 2014, P NATL ACAD SCI USA, V111, P15149, DOI 10.1073/pnas.1404177111; Estep MC, 2012, AM J BOT, V99, pE443, DOI 10.3732/ajb.1200186; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gao G, 2014, BIOCHEM SYST ECOL, V57, P102, DOI 10.1016/j.bse.2014.07.004; Guisinger MM, 2010, J MOL EVOL, V70, P149, DOI 10.1007/s00239-009-9317-3; Hand ML, 2013, G3-GENES GENOM GENET, V3, P607, DOI 10.1534/g3.112.005264; Hodkinson TR, 2002, J PLANT RES, V115, P381, DOI 10.1007/s10265-002-0049-3; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; JACKSON P, 2011, WILD CROP RELATIVES, P97, DOI DOI 10.1007/978-3-642-21102-7_5; Junior TC, 2004, CURR GENET, V46, P366, DOI 10.1007/s00294-004-0542-4; Kim C, 2014, PLANT CELL, V26, P2420, DOI 10.1105/tpc.114.125583; Li LQ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031057, 10.1371/journal.pone.0045115]; Liu Yang, 2013, Biomed Res Int, V2013, P839683, DOI 10.1155/2013/839683; Loman NJ, 2012, NAT REV MICROBIOL, V10, P599, DOI 10.1038/nrmicro2850; Lozsa R, 2015, GENET RESOUR CROP EV, V62, P419, DOI 10.1007/s10722-014-0169-3; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Moore MJ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-17; MUKHERJEE SUNIL KUMAR, 1957, BOT GAZ, V119, P55, DOI 10.1086/335962; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nah G, 2016, MITOCHONDRIAL DNA A, V27, P4359, DOI 10.3109/19401736.2015.1089500; Nair N. V., 2005, Sugar Tech, V7, P55, DOI 10.1007/BF02942418; Nakagawa H, 2011, BIOFUEL'S ENGINEERING PROCESS TECHNOLOGY, P715; NECKERMANN K, 1994, GENE, V146, P177, DOI 10.1016/0378-1119(94)90290-9; Ni Y, 2011, BIOL PLANTARUM, V55, P68, DOI 10.1007/s10535-011-0009-7; Piperidis N, 2010, GENOME, V53, P331, DOI [10.1139/G10-010, 10.1139/g10-010]; Prasad V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1482; Provan J, 2001, TRENDS ECOL EVOL, V16, P142, DOI 10.1016/S0169-5347(00)02097-8; Rambaut A, 2014, FIGTREE V 1 4 2 2014; Rambaut A, TRACER V 1 6 2014; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; Sanchez-Ken JG, 2007, SYST BOT, V32, P71, DOI 10.1600/036364407780360102; Saski C, 2007, THEOR APPL GENET, V115, P571, DOI 10.1007/s00122-007-0595-0; Schwerdt Julian G, 2015, Plant Physiol, V168, P968, DOI 10.1104/pp.15.00140; Selvi A, 2006, GENET RESOUR CROP EV, V53, P831, DOI 10.1007/s10722-004-6376-6; SOBRAL BWS, 1994, THEOR APPL GENET, V87, P843, DOI 10.1007/BF00221137; Suman A, 2012, BIOENERG RES, V5, P197, DOI 10.1007/s12155-011-9123-9; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vicentini A, 2008, GLOBAL CHANGE BIOL, V14, P2963, DOI 10.1111/j.1365-2486.2008.01688.x; Wang XY, 2012, ANN SAUDI MED, V32, P642, DOI 10.5144/0256-4947.2012.01.7.1530; Welker CAD, 2015, AM J BOT, V102, P248, DOI 10.3732/ajb.1400397; Wheeler GL, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1400059; Wu ZQ, 2012, MOL PHYLOGENET EVOL, V62, P573, DOI 10.1016/j.ympev.2011.10.019; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xu B, 2013, MOL BIOL EVOL, V30, P2723, DOI 10.1093/molbev/mst179; Yook MJ, 2014, BIOMASS BIOENERG, V66, P81, DOI 10.1016/j.biombioe.2014.01.025; Young HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023980; Zhang JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080388	75	23	24	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0169992	10.1371/journal.pone.0169992	http://dx.doi.org/10.1371/journal.pone.0169992			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125648	Green Submitted, gold, Green Published			2022-12-27	WOS:000396176100131
J	Liu, LF; Craig, CM; Tolentino, LL; Choi, O; Morton, J; Rivas, H; Cushman, SW; Engleman, EG; McLaughlin, T				Liu, Li Fen; Craig, Colleen M.; Tolentino, Lorna L.; Choi, Okmi; Morton, John; Rivas, Homero; Cushman, Samuel W.; Engleman, Edgar G.; McLaughlin, Tracey			Adipose tissue macrophages impair preadipocyte differentiation in humans	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; HUMAN ADIPOCYTES; INSULIN ACTION; OBESITY; CELLS; EXPRESSION; RISK; MICE	Aim The physiologic mechanisms underlying the relationship between obesity and insulin resistance are not fully understood. Impaired adipocyte differentiation and localized inflammation characterize adipose tissue from obese, insulin-resistant humans. The directionality of this relationship is not known, however. The aim of the current study was to investigate whether adipose tissue inflammation is causally-related to impaired adipocyte differentiation. Methods Abdominal subcutaneous(SAT) and visceral(VAT) adipose tissue was obtained from 20 human participants undergoing bariatric surgery. Preadipocytes were isolated, and cultured in the presence or absence of CD14+ macrophages obtained from the same adipose tissue sample. Adipocyte differentiation was quantified after 14 days via immunofluorescence, Oil-Red O, and adipogenic gene expression. Cytokine secretion by mature adipocytes cultured with or without CD14+ macrophages was quantified. Results Adipocyte differentiation was significantly lower in VAT than SAT by all measures (p<0.001). With macrophage removal, SAT preadipocyte differentiation increased significantly as measured by immunofluorescence and gene expression, whereas VAT preadipocyte differentiation was unchanged. Adipocyte-secreted proinflammatory cytokines were higher and adiponectin lower in media from VAT vs SAT: macrophage removal reduced inflammatory cytokine and increased adiponectin secretion from both SAT and VAT adipocytes. Differentiation of preadipocytes from SAT but not VAT correlated inversely with systemic insulin resistance. Conclusions The current results reveal that proinflammatory immune cells in human SAT are causally-related to impaired preadipocyte differentiation, which in turn is associated with systemic insulin resistance. In VAT, preadipocyte differentiation is poor even in the absence of tissue macrophages, pointing to inherent differences in fat storage potential between the two depots.	[Liu, Li Fen; Craig, Colleen M.; McLaughlin, Tracey] Stanford Univ, Div Endocrinol, Dept Med, Palo Alto, CA 94304 USA; [Tolentino, Lorna L.; Choi, Okmi; Engleman, Edgar G.] Stanford Blood Ctr, Palo Alto, CA USA; [Morton, John; Rivas, Homero] Stanford Univ, Sch Med, Dept Surg, Palo Alto, CA 94304 USA; [Cushman, Samuel W.] NIDDK, NIH, Bethesda, MD 20892 USA; [Engleman, Edgar G.] Stanford Univ, Sch Med, Dept Pathol, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Stanford University	Liu, LF (corresponding author), Stanford Univ, Div Endocrinol, Dept Med, Palo Alto, CA 94304 USA.	lifenliu@stanford.edu		craig, colleen/0000-0003-1308-6440	National Institutes of Health/National Institute of Digestive Diseases and Diabetes [R01 DK080436, R01DK071309, DK096038]	National Institutes of Health/National Institute of Digestive Diseases and Diabetes	Grant support for this study was provided by National Institutes of Health/National Institute of Digestive Diseases and Diabetes, R01 DK080436, R01DK071309 and DK096038. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABATE N, 1995, J CLIN INVEST, V96, P88, DOI 10.1172/JCI118083; Adams M, 1997, J CLIN INVEST, V100, P3149, DOI 10.1172/JCI119870; Baglioni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036569; Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158; Chazenbalk G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017834; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Couturier J, 2012, OBESITY, V20, P253, DOI 10.1038/oby.2011.275; Gustafson B, 2009, AM J PHYSIOL-ENDOC M, V297, pE999, DOI 10.1152/ajpendo.00377.2009; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Lacasa D, 2007, ENDOCRINOLOGY, V148, P868, DOI 10.1210/en.2006-0687; Liu A, 2009, OBES SURG, V19, P1564, DOI 10.1007/s11695-009-9949-9; Liu LS, 1998, DIABETES, V47, P515, DOI 10.2337/diabetes.47.4.515; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2007, AM J PHYSIOL-ENDOC M, V292, pE166, DOI 10.1152/ajpendo.00284.2006; Macotela Y, 2012, DIABETES, V61, P1691, DOI 10.2337/db11-1753; McLaughlin T, 2010, DIABETOLOGIA, V53, P369, DOI 10.1007/s00125-009-1496-3; McLaughlin TM, 2010, OBESITY, V18, P926, DOI 10.1038/oby.2009.380; Mehta R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-39; Perrini S, 2008, DIABETOLOGIA, V51, P155, DOI 10.1007/s00125-007-0841-7; Perrini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057892; RODBELL M, 1964, J BIOL CHEM, V239, P375; Russo V, 2014, STEM CELL TRANSL MED, V3, P206, DOI 10.5966/sctm.2013-0125; Sewter CP, 2002, DIABETES, V51, P718, DOI 10.2337/diabetes.51.3.718; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Vidal-Puig Antonio, 2013, Endocrinol Nutr, V60 Suppl 1, P39; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weyer C, 2000, DIABETOLOGIA, V43, P1498, DOI 10.1007/s001250051560	33	24	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170728	10.1371/journal.pone.0170728	http://dx.doi.org/10.1371/journal.pone.0170728			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151993	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200038
J	Loomis, Z; Eigenberger, P; Redinius, K; Lisk, C; Karoor, V; Nozik-Grayck, E; Ferguson, SK; Hassell, K; Nuss, R; Stenmark, K; Buehler, P; Irwin, DC				Loomis, Zoe; Eigenberger, Paul; Redinius, Katherine; Lisk, Christina; Karoor, Vijaya; Nozik-Grayck, Eva; Ferguson, Scott K.; Hassell, Kathryn; Nuss, Rachelle; Stenmark, Kurt; Buehler, Paul; Irwin, David C.			Hemoglobin induced cell trauma indirectly influences endothelial TLR9 activity resulting in pulmonary vascular smooth muscle cell activation	PLOS ONE			English	Article							MITOCHONDRIAL-DNA DAMAGE; HAPTOGLOBIN PRESERVES; RAT LUNGS; HYPERTENSION; INFLAMMATION; PATHOLOGY; DISEASE; INJURY; HEMOPEXIN; HEMOLYSIS	It is now well established that both inherited and acquired forms of hemolytic disease can promote pulmonary vascular disease consequent of free hemoglobin (Hb) induced NO scavenging, elevations in reactive oxygen species and lipid peroxidation. It has recently been reported that oxidative stress can activate NFkB through a toll-like receptor 9 (TLR9) mediated pathway; further, TLR9 can be activated by either nuclear or mitochondrial DNA liberated by stress induced cellular trauma. We hypothesis that Hb induced lipid peroxidation and subsequent endothelial cell trauma is linked to TLR9 activation, resulting in IL-6 mediated pulmonary smooth muscle cell proliferation. We examined the effects of Hb on rat pulmonary artery endothelial and smooth muscle cells (rPAEC and rPASMC, respectively), and then utilized TLR9 and IL6 inhibitors, as well as the Hb and heme binding proteins (haptoglobin (Hp) and hemopexin (Hpx), respectively) to further elucidate the aforementioned mediators. Further, we explored the effects of Hb in vivo utilizing endothelial cell (EC) specific myeloid differentiation primary response gene-88 (MyD88) and TLR9 null mice. Our data show that oxidized Hb induces lipid peroxidation, cellular toxicity (5.5 +/- 1.7 fold; p <= 0.04), increased TLR9 activation (60%; p = 0.01), and up regulated IL6 expression (1.75 +/- 0.3 fold; p = 0.04) in rPAEC. Rat PASMC exhibited a more proliferative state (13 +/- 1%; p = 0.01) when co-cultured with Hb activated rPAEC. These effects were attenuated with the sequestration of Hb or heme by Hp and Hpx as well as with TLR9 an IL-6 inhibition. Moreover, in both EC-MyD88 and TLR9 null mice Hb-infusion resulted in less lung IL-6 expression compared to WT cohorts. These results demonstrate that Hb-induced lipid peroxidation can initiate a modest TLR9 mediated inflammatory response, subsequently generating an activated SMC phenotype.	[Loomis, Zoe; Eigenberger, Paul; Redinius, Katherine; Lisk, Christina; Karoor, Vijaya; Nozik-Grayck, Eva; Ferguson, Scott K.; Stenmark, Kurt; Irwin, David C.] Univ Colorado Denver, Dept Med, Cardiovasc & Pulm Res Lab, Anschutz Med Campus, Aurora, CO 80045 USA; [Hassell, Kathryn; Nuss, Rachelle] Univ Colorado, Denver Sch Med, Div Hematol, Aurora, CO USA; [Hassell, Kathryn; Nuss, Rachelle] Univ Colorado, Denver Sch Med, Colorado Sickle Cell Treatment & Res Ctr, Aurora, CO USA; [Buehler, Paul] US FDA, Div Hematol, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; US Food & Drug Administration (FDA)	Irwin, DC (corresponding author), Univ Colorado Denver, Dept Med, Cardiovasc & Pulm Res Lab, Anschutz Med Campus, Aurora, CO 80045 USA.	David.irwin@ucdenver.edu	stenmark, kurt/AAH-3124-2022; Nozik, Eva/AAP-5395-2020; stenmark, kurt/AFI-6776-2022		National Heart, Lung and Blood Institute [1R01HL125642-01A1, 1 R01HL086680-07, 5P01HL014985-38, T32HL007171]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125642, P01HL014985, T32HL007171, R01HL086680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Heart, Lung and Blood Institute Grants 1R01HL125642-01A1 (Irwin DC), 1 R01HL086680-07 (Nozik-Grayck E), 5P01HL014985-38(Stenmark KR), and T32HL007171 (Stenmark KR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belcher J. D., 2013, BLOOD; Boretti FS, 2009, J CLIN INVEST, V119, P2271, DOI 10.1172/JCI39115; Buehler PW, 2012, AM J PHYSIOL-LUNG C, V303, pL312, DOI 10.1152/ajplung.00074.2012; Buehler PW, 2009, BLOOD, V113, P2578, DOI 10.1182/blood-2008-08-174466; Chintagari NR, 2016, AM J RESP CELL MOL B; Chouteau JM, 2011, AM J PHYSIOL-LUNG C, V301, pL892, DOI 10.1152/ajplung.00210.2011; Damm J, 2014, J NEUROIMMUNOL, V277, P105, DOI 10.1016/j.jneuroim.2014.10.007; Deuel JW, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.392; Ding ZF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01077; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Gladwin MT, 2008, NEW ENGL J MED, V359, P2254, DOI 10.1056/NEJMra0804411; Gladwin Mark T, 2005, Hematology Am Soc Hematol Educ Program, P51; Gladwin MT, 2015, BLOOD, V126, P695, DOI 10.1182/blood-2015-06-649491; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Gu XL, 2015, FREE RADICAL BIO MED, V83, P149, DOI 10.1016/j.freeradbiomed.2015.02.034; Haase M, 2010, J AM COLL CARDIOL, V55, P2024, DOI 10.1016/j.jacc.2009.12.046; Hiram R, 2015, AM J PHYSIOL-LUNG C, V309, pL776, DOI 10.1152/ajplung.00177.2015; Irwin DC, 2015, FREE RADICAL BIO MED, V82, P50, DOI 10.1016/j.freeradbiomed.2015.01.012; Kato G, 2009, BR J HEMATOL, P1; Kato Gregory J, 2008, Hematology Am Soc Hematol Educ Program, P186, DOI 10.1182/asheducation-2008.1.186; Kelly JJ, 1998, AM J PHYSIOL-LUNG C, V274, pL810, DOI 10.1152/ajplung.1998.274.5.L810; Kuck JL, 2015, AM J PHYSIOL-LUNG C, V308, pL1078, DOI 10.1152/ajplung.00015.2015; Lisk C, 2013, AM J RESP M IN PRESS; Madathilparambil SV, 2016, SHOCK; Mitchell S, 2016, WIRES SYST BIOL MED, V8, P227, DOI 10.1002/wsbm.1331; Opitz B, 2009, THROMB HAEMOSTASIS, V102, P1103, DOI 10.1160/TH09-05-0323; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Pisetsky DS, 2012, CLIN IMMUNOL, V144, P32, DOI 10.1016/j.clim.2012.04.006; Poulain L, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/620258; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Schaer CA, 2016, AM J RESP CRIT CARE, V193, P1111, DOI 10.1164/rccm.201510-2058OC; Schaer DJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00415; Schaer DJ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a013433; Schumacker PT, 2014, AM J PHYSIOL-LUNG C, V306, pL962, DOI 10.1152/ajplung.00073.2014; Shaver CM, 2016, AM J PHYSIOL-LUNG C, V310, pL532, DOI 10.1152/ajplung.00155.2015; Silva G, 2009, J BIOL CHEM, V284, P29582, DOI 10.1074/jbc.M109.045344; Smith A, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00187; Stenmark KR, 2015, J APPL PHYSIOL, V119, P1164, DOI 10.1152/japplphysiol.00283.2015; Tsuji N., 2015, J AM SOC NEPHROL; Tuder RM, 2007, CLIN CHEST MED, V28, P23, DOI 10.1016/j.ccm.2006.11.010; Tuder RM, 2013, J AM COLL CARDIOL, V62, pD4, DOI 10.1016/j.jacc.2013.10.025; Vaidya B, 2015, J CONTROL RELEASE, V211, P118, DOI 10.1016/j.jconrel.2015.05.287; Vallelian F, 2015, FREE RADICAL BIO MED, V85, P259, DOI 10.1016/j.freeradbiomed.2015.04.023; Wallach D, 2016, SCIENCE, V352, DOI 10.1126/science.aaf2154; Zhu J, 2010, MEDIAT INFLAMM, V2010, P7	45	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171219	10.1371/journal.pone.0171219	http://dx.doi.org/10.1371/journal.pone.0171219			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152051	gold, Green Published			2022-12-27	WOS:000396161200106
J	Sadeghi-Bazargani, H; Mohammadi, R; Ayubi, E; Almasi-Hashiani, A; Pakzad, R; Sullman, MJM; Safiri, S				Sadeghi-Bazargani, Homayoun; Mohammadi, Reza; Ayubi, Erfan; Almasi-Hashiani, Amir; Pakzad, Reza; Sullman, Mark J. M.; Safiri, Saeid			Caregiver-related predictors of thermal burn injuries among Iranian children: A case-control study	PLOS ONE			English	Article							RISK-FACTORS; EPIDEMIOLOGY; SELECTION	Purpose Burns are a common and preventable cause of injury in children. The aim of this study was to investigate child and caregiver characteristics which may predict childhood burn injuries among Iranian children and to examine whether confounding exists among these predictors. Methods A hospital based case-control study was conducted using 281 burn victims and 273 hospital-based controls, which were matched by age, gender and place of residence (rural/urban). The characteristics of the children and their caregivers were analyzed using crude and adjusted models to test whether these were predictors of childhood burn injuries. Results The age of the caregiver was significantly lower for burn victims than for the controls (P<0.05). Further, the amount of time the caregiver spent outdoors with the child and their economic status had a significant positive association with the odds of a burn injury (P<0.05). A multivariate logistic regression found that Type A behaviour among caregivers was independently associated with the child's odds of suffering a burn injury (OR = 1.12, 95% CI: 1.04-1.21). The research also found that children with ADHD (Inattentive subscale: Crude OR = 2.14, 95% CI: 1.16-3.95, Adjusted OR = 5.65, 95% CI: 2.53-12.61; Hyperactive subscale: Crude OR = 1.73, 95% CI: 1.23-2.41, Adjusted OR = 2.53, 95% CI: 1.65-3.87) also had increased odds of suffering a burn injury. However, several variables were identified as possible negative confounder variables, as the associations were stronger in the multivariate model than in the crude models. Conclusion The caregiver's characteristics which were predictors of burn injuries among Iranian children were: being younger, high socio-economic status, Type A behavioural pattern and spending more time outdoors. In addition, the relationship between a child's ADHD scores and the odds of a burn injury may be negatively confounded by the caregivers predictor variables.	[Sadeghi-Bazargani, Homayoun] Tabriz Univ Med Sci, Rd Traff Injury Res Ctr, Dept Stat & Epidemiol, Tabriz, Iran; [Sadeghi-Bazargani, Homayoun; Mohammadi, Reza] Karolinska Inst, WHO Collaborating Ctr Community Safety Promot, Stockholm, Sweden; [Ayubi, Erfan] Shahid Beheshti Univ Med Sci, Dept Epidemiol, Sch Publ Hlth, Tehran, Iran; [Almasi-Hashiani, Amir] ACECR, Dept Epidemiol & Reprod Hlth, Reprod Epidemiol Res Ctr, Royan Inst Reprod Biomed, Tehran, Iran; [Pakzad, Reza] Ilam Univ Med Sci, Student Res Comm, Ilam, Iran; [Sullman, Mark J. M.] Cranfield Univ, Driving Res Grp, Cranfield, Beds, England; [Safiri, Saeid] Maragheh Univ Med Sci, Managerial Epidemiol Res Ctr, Dept Publ Hlth, Sch Nursing & Midwifery, Maragheh, Iran; [Safiri, Saeid] Univ Tehran Med Sci, Dept Epidemiol & Biostat, Sch Publ Hlth, Tehran, Iran	Tabriz University of Medical Science; Karolinska Institutet; Shahid Beheshti University Medical Sciences; Academic Center for Education, Culture & Research (ACECR); Cranfield University; Tehran University of Medical Sciences	Safiri, S (corresponding author), Maragheh Univ Med Sci, Managerial Epidemiol Res Ctr, Dept Publ Hlth, Sch Nursing & Midwifery, Maragheh, Iran.; Safiri, S (corresponding author), Univ Tehran Med Sci, Dept Epidemiol & Biostat, Sch Publ Hlth, Tehran, Iran.	saeidsafiri@gmail.com	Safiri, Saeid/A-1678-2017; Almasi-Hashiani, Amir/P-3356-2018; Pakzad, Reza/X-7386-2018; Sadeghi-Bazargani, Homayoun/M-5522-2017; Ayubi, Erfan/AAD-3213-2019	Safiri, Saeid/0000-0001-7986-9072; Almasi-Hashiani, Amir/0000-0003-4434-561X; Pakzad, Reza/0000-0001-8133-3664; Sadeghi-Bazargani, Homayoun/0000-0002-0396-8709; Sullman, Mark/0000-0001-7920-6818; Mohammadi, Reza/0000-0003-2294-9316	Tabriz University of Medical Sciences	Tabriz University of Medical Sciences	This study was funded by the Vice Chancellor of Research and Technology of Tabriz University of Medical Sciences, www.tbzmed.ac.ir.	Alaghehbandan R, 2001, BURNS, V27, P115, DOI 10.1016/S0305-4179(00)00083-8; Ansari-Moghaddam A, 2013, EPIDEMIOLOGY; Arshi S, 2006, BURNS, V32, P366, DOI 10.1016/j.burns.2005.10.026; Arshi S, 2007, IRAN J MED SCI, V7, P248; Arshi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049412; Branche C., 2008, WORLD REPORT CHILD I; Chandran A, 2010, EPIDEMIOL REV; Delgado J, 2002, INJ PREV, V8, P38, DOI 10.1136/ip.8.1.38; Deljavan R, 2012, INT J GEN MED, V5, P621, DOI 10.2147/IJGM.S34394; DuPaul G. J., 1998, ADHD RATING SCALE; Forjuoh SN, 2006, BURNS, V32, P529, DOI 10.1016/j.burns.2006.04.002; FORJUOH SN, 1995, J EPIDEMIOL COMMUN H, V49, P189, DOI 10.1136/jech.49.2.189; Howe LD, 2012, INT J EPIDEMIOL; Hutchings H, 2010, CHILD CARE HLTH DEV, V36, P787, DOI 10.1111/j.1365-2214.2010.01106.x; Jewell N, 2003, STAT EPIDEMIOLOGY; Joseph KE, 2002, BURNS, V28, P455, DOI 10.1016/S0305-4179(02)00035-9; Karimi H, 2012, Ann Burns Fire Disasters, V25, P115; Kaslow NJ, 1994, BEHAV ASPECTS PEDIAT, P193; Kohen D E, 2000, Inj Prev, V6, P223, DOI 10.1136/ip.6.3.223; Laursen B, 2008, EUR J PUBLIC HEALTH, V18, P366, DOI 10.1093/eurpub/ckn034; Ma WJ, 2010, SAFETY SCI, V48, P823, DOI 10.1016/j.ssci.2010.02.021; MATHENY AP, 1986, J PEDIATR PSYCHOL, V11, P163, DOI 10.1093/jpepsy/11.2.163; Mock C, 2008, WHO PLAN BURN PREVEN; Nadjarian B, 1995, J EDUC PSYCHOL, V2, P24; Naghavi M, 2003, POPUL HEALTH METR, V7, P9, DOI DOI 10.1186/1478-7954-7-9; Okoro Philemon E, 2009, Afr J Paediatr Surg, V6, P24, DOI 10.4103/0189-6725.48571; Othman N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-83; Petrass L, 2009, FAM COMMUNITY HEALTH, V32, P123, DOI 10.1097/FCH.0b013e3181994740; Rafii MH, 2012, ARCH TRAUMA RES, V1, P27, DOI [10.5812/atr.5295, 10.5812/atr.5383]; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Sadeghi-Bazargani H, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2799-1; Sadeghi-Bazargani H, 2013, BURNS, V39, P1304, DOI 10.1016/j.burns.2013.02.013; Sadeghi-Bazargani H, 2012, BURNS, V38, P319, DOI 10.1016/j.burns.2011.09.025; Shah M, 2013, BURNS, V39, P1474, DOI 10.1016/j.burns.2013.03.022; SHI H, 2013, J APPL MATH, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0076787; Tung KY, 2005, BURNS, V31, pS12, DOI 10.1016/j.burns.2004.10.006; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1019, DOI 10.1093/oxfordjournals.aje.a116396; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1029, DOI 10.1093/oxfordjournals.aje.a116397; WHO, 2008, DIS INJ REG EST CAUS; World Health Organization, 2008, WHO LAUNCH NEW DOC B	40	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170982	10.1371/journal.pone.0170982	http://dx.doi.org/10.1371/journal.pone.0170982			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28151942	Green Published, gold			2022-12-27	WOS:000396161200064
J	Davey, MG; Riley, JS; Andrews, A; Tyminski, A; Limberis, M; Pogoriler, JE; Partridge, E; Olive, A; Hedrick, HL; Flake, AW; Peranteau, WH				Davey, Marcus G.; Riley, John S.; Andrews, Abigail; Tyminski, Alec; Limberis, Maria; Pogoriler, Jennifer E.; Partridge, Emily; Olive, Aliza; Hedrick, Holly L.; Flake, Alan W.; Peranteau, William H.			Induction of Immune Tolerance to Foreign Protein via Adeno-Associated Viral Vector Gene Transfer in Mid-Gestation Fetal Sheep	PLOS ONE			English	Article							DEVELOPMENTAL-STAGE DETERMINES; IN-UTERO; ANTIGENIC STIMULUS; HEMOPHILIA-B; FACTOR-IX; IMPROVES PHENOTYPE; LENTIVIRAL VECTOR; VIRUS VECTORS; GROWTH-FACTOR; MURINE MODEL	A major limitation to adeno-associated virus (AAV) gene therapy is the generation of host immune responses to viral vector antigens and the transgene product. The ability to induce immune tolerance to foreign protein has the potential to overcome this host immunity. Acquisition and maintenance of tolerance to viral vector antigens and transgene products may also permit repeat administration thereby enhancing therapeutic efficacy. In utero gene transfer (IUGT) takes advantage of the immunologic immaturity of the fetus to induce immune tolerance to foreign antigens. In this large animal study, in utero administration of AAV6.2, AAV8 and AAV9 expressing green fluorescent protein (GFP) to similar to 60 day fetal sheep (term:similar to 150 days) was performed. Transgene expression and postnatal immune tolerance to GFP and viral antigens were assessed. We demonstrate 1) hepatic expression of GFP 1 month following in utero administration of AAV6.2.GFP and AAV8.GFP, 2) in utero recipients of either AAV6.2.GFP or AAV8.GFP fail to mount an anti-GFP antibody response following postnatal GFP challenge and lack inflammatory cellular infiltrates at the intramuscular site of immunization, 3) a serotype specific anti-AAV neutralizing antibody response is elicited following postnatal challenge of in utero recipients of AAV6.2 or AAV8 with the corresponding AAV serotype, and 4) durable hepatic GFP expression was observed up to 6 months after birth in recipients of AAV8.GFP but expression was lost between 1 and 6 months of age in recipients of AAV6.2. GFP. The current study demonstrates, in a preclinical large animal model, the potential of IUGT to achieve host immune tolerance to the viral vector transgene product but also suggests that a single exposure to the vector capsid proteins at the time of IUGT is inadequate to induce tolerance to viral vector antigens.	[Davey, Marcus G.; Riley, John S.; Andrews, Abigail; Tyminski, Alec; Partridge, Emily; Olive, Aliza; Hedrick, Holly L.; Flake, Alan W.; Peranteau, William H.] Childrens Hosp Philadelphia, Ctr Fetal Res, Philadelphia, PA 19104 USA; [Limberis, Maria] Univ Penn, Dept Pathol & Lab Med, Gene Therapy Program, Philadelphia, PA USA; [Pogoriler, Jennifer E.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Peranteau, WH (corresponding author), Childrens Hosp Philadelphia, Ctr Fetal Res, Philadelphia, PA 19104 USA.	peranteauw@email.chop.edu		Riley, John/0000-0001-6642-690X	National Institute of Health [P30DK047757-16]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study received funding in part from the National Institute of Health (P30DK047757-16) and generous family gifts to The Children's Hospital of Philadelphia. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnett ALH, 2013, GENE THER, V20, P497, DOI 10.1038/gt.2012.60; Ashizuka S, 2006, EXP HEMATOL, V34, P359, DOI 10.1016/j.exphem.2005.11.011; Bell P, 2011, HUM GENE THER, V22, P985, DOI 10.1089/hum.2010.194; Boelig MM, 2016, BIOL BLOOD MARROW TR, V22, P991, DOI 10.1016/j.bbmt.2016.01.017; Bouchard S, 2003, J GENE MED, V5, P941, DOI 10.1002/jgm.421; Brantly ML, 2006, HUM GENE THER, V17, P1177, DOI 10.1089/hum.2006.17.1177; Burnet FM, 1960, NOBEL LECT NOBEL PRI; Calcedo R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00341; Calcedo R, 2009, J VIROL, V83, P2623, DOI 10.1128/JVI.02160-08; Carlon MS, 2014, HUM GENE THER, V25, P517, DOI 10.1089/hum.2013.196; Corti M, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.33; CUMMINGS JN, 1963, AM J OBSTET GYNECOL, V86, P504; Davey MG, 2012, GENE THER, V19, P201, DOI 10.1038/gt.2011.83; David AL, 2011, HUM GENE THER, V22, P419, DOI 10.1089/hum.2010.007; Endo M, 2010, GENE THER, V17, P61, DOI 10.1038/gt.2009.115; Ferreira V, 2014, HUM GENE THER, V25, P180, DOI 10.1089/hum.2013.169; FLAKE AW, 1995, EXP HEMATOL, V23, P252; FLAKE AW, 1986, SCIENCE, V233, P776, DOI 10.1126/science.2874611; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Halbert CL, 1997, J VIROL, V71, P5932, DOI 10.1128/JVI.71.8.5932-5941.1997; Halbert CL, 1998, J VIROL, V72, P9795, DOI 10.1128/JVI.72.12.9795-9805.1998; Hyatt MA, 2007, ENDOCRINOLOGY, V148, P4754, DOI 10.1210/en.2007-0303; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Joyeux L, 2014, HUM GENE THER METHOD, V25, P197, DOI 10.1089/hgtb.2013.143; Kaeppel C, 2013, NAT MED, V19, P889, DOI 10.1038/nm.3230; Kay MA, 2000, NAT GENET, V24, P257, DOI 10.1038/73464; Li CW, 2012, J VIROL, V86, P7752, DOI 10.1128/JVI.00675-12; Lloyd LJ, 2012, J PHYSIOL-LONDON, V590, P377, DOI 10.1113/jphysiol.2011.220186; Loukogeorgakis SP, 2014, EUR J PEDIATR SURG, V24, P237, DOI 10.1055/s-0034-1382260; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; McClain LE, 2016, J PEDIATR SURG, V51, P879, DOI 10.1016/j.jpedsurg.2016.02.048; Mendell JR, 2010, ANN NEUROL, V68, P629, DOI 10.1002/ana.22251; Mendell JR, 2010, NEW ENGL J MED, V363, P1429, DOI 10.1056/NEJMoa1000228; Mingozzi F, 2007, NAT MED, V13, P419, DOI 10.1038/nm1549; Mingozzi F, 2013, BLOOD, V122, P23, DOI 10.1182/blood-2013-01-306647; Moss RB, 2004, CHEST, V125, P509, DOI 10.1378/chest.125.2.509; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Nathwani AC, 2011, MOL THER, V19, P876, DOI 10.1038/mt.2010.274; Osburn B I, 1988, Prog Clin Biol Res, V281, P15; Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646; Peranteau WH, 2009, BIOL BLOOD MARROW TR, V15, P293, DOI 10.1016/j.bbmt.2008.11.034; Porada CD, 1998, HUM GENE THER, V9, P1571, DOI 10.1089/hum.1998.9.11-1571; Roybal JL, 2012, GENE THER, V19, P1085, DOI 10.1038/gt.2011.186; Roybal JL, 2011, GENE THER, V18, P719, DOI 10.1038/gt.2011.23; Sabatino DE, 2007, MOL THER, V15, P1677, DOI 10.1038/sj.mt.6300219; Shi Y, 2013, GENE THER, V20, P987, DOI 10.1038/gt.2013.22; SILVERSTEIN AM, 1964, J EXP MED, V119, P955, DOI 10.1084/jem.119.6.955; SILVERSTEIN AM, 1963, J IMMUNOL, V91, P384; SILVERSTEIN AM, 1964, SCIENCE, V144, P1423, DOI 10.1126/science.144.3625.1423; SILVERSTEIN AM, 1963, J EXP MED, V117, P799, DOI 10.1084/jem.117.5.799; Smith BK, 2013, HUM GENE THER, V24, P630, DOI 10.1089/hum.2012.250; Stitelman DH, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.40; Stroes ES, 2008, ARTERIOSCL THROM VAS, V28, P2303, DOI 10.1161/ATVBAHA.108.175620; Tardieu M, 2014, HUM GENE THER, V25, P506, DOI 10.1089/hum.2013.238; Tellez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075142; Themis M, 2005, MOL THER, V12, P763, DOI 10.1016/j.ymthe.2005.07.358; Tran ND, 2001, BLOOD, V97, P3417, DOI 10.1182/blood.V97.11.3417; Vrecenak JD, 2014, BLOOD, V124, P1987, DOI 10.1182/blood-2013-11-537571; Waddington SN, 2004, BLOOD, V104, P2714, DOI 10.1182/blood-2004-02-0627; Waddington SN, 2003, BLOOD, V101, P1359, DOI 10.1182/blood-2002-03-0779; Wang LL, 2010, MOL THER, V18, P126, DOI 10.1038/mt.2009.245; Wang LL, 2010, MOL THER, V18, P118, DOI 10.1038/mt.2009.246; Zanjani ED, 1996, INT J HEMATOL, V63, P179	63	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171132	10.1371/journal.pone.0171132	http://dx.doi.org/10.1371/journal.pone.0171132			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141818	Green Published, Green Submitted, gold			2022-12-27	WOS:000396129500040
J	Myllykoski, M; Kursula, P				Myllykoski, Matti; Kursula, Petri			Structural aspects of nucleotide ligand binding by a bacterial 2H phosphoesterase	PLOS ONE			English	Article							RIBOSE 1,2-CYCLIC PHOSPHATE; ESCHERICHIA-COLI; RNASE-L; MACROMOLECULAR CRYSTALLOGRAPHY; 2',3'-CYCLIC PHOSPHODIESTERASE; CYCLIC PHOSPHODIESTERASE; SOLUTION SCATTERING; MOLECULAR GRAPHICS; CRYSTAL-STRUCTURE; PETRA III	The 2H phosphoesterase family contains enzymes with two His-X-Ser/Thr motifs in the active site. 2H enzymes are found in all kingdoms of life, sharing little sequence identity despite the conserved overall fold and active site. For many 2H enzymes, the physiological function is unknown. Here, we studied the structure of the 2H family member LigT from Escherichia coli both in the apo form and complexed with different active-site ligands, including ATP, 2'-AMP, 3'-AMP, phosphate, and NADP(+). Comparisons to the well-characterized vertebrate myelin enzyme 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNPase) highlight specific features of the catalytic cycle and substrate recognition in both enzymes. The role played by the helix alpha 7, unique to CNPases within the 2H family, is apparently taken over by Arg130 in the bacterial enzyme. Other residues and loops lining the active site groove are likely to be important for RNA substrate binding. We visualized conformational changes related to ligand binding, as well as the position of the nucleophilic water molecule. We also present a low-resolution model of E. coli LigT bound to tRNA in solution, and provide a model for RNA binding by LigT, involving flexible loops lining the active site cavity. Taken together, our results both aid in understanding the common features of 2H family enzymes and help highlight the distinct features in the 2H family members, which must result in different reaction mechanisms. Unique aspects in different 2H family members can be observed in ligand recognition and binding, and in the coordination of the nucleophilic water molecule and the reactive phosphate moiety.	[Myllykoski, Matti; Kursula, Petri] Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland; [Kursula, Petri] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Kursula, Petri] Univ Bergen, Dept Biomed, Bergen, Norway	University of Oulu; University of Oulu; University of Bergen	Kursula, P (corresponding author), Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland.; Kursula, P (corresponding author), Univ Oulu, Bioctr Oulu, Oulu, Finland.; Kursula, P (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	petri.kursula@uib.no	Kursula, Petri/AAF-4563-2020	Kursula, Petri/0000-0001-8529-3751; Myllykoski, Matti/0000-0001-6641-5856	Emil Aaltonen Foundation; Sigrid Juselius Foundation	Emil Aaltonen Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	The study was funded by the Emil Aaltonen Foundation and the Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Arn EA, 1996, J BIOL CHEM, V271, P31145, DOI 10.1074/jbc.271.49.31145; Banerjee S, 2016, CYTOKINE GROWTH F R, V29, P63, DOI 10.1016/j.cytogfr.2016.02.008; Blanchet CE, 2015, J APPL CRYSTALLOGR, V48, P431, DOI 10.1107/S160057671500254X; Bordeleau E, 2014, BIOORG MED CHEM LETT, V24, P4520, DOI 10.1016/j.bmcl.2014.07.080; Bunkoczi G, 2011, ACTA CRYSTALLOGR D, V67, P303, DOI 10.1107/S0907444910051218; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cianci M, 2017, J SYNCHROTRON RADIAT, V24, P323, DOI 10.1107/S1600577516016465; CULVER GM, 1994, J BIOL CHEM, V269, P24928; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Genschik P, 1997, J BIOL CHEM, V272, P13211, DOI 10.1074/jbc.272.20.13211; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GREER CL, 1983, CELL, V33, P899, DOI 10.1016/0092-8674(83)90032-6; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gusho E, 2014, MBIO, V5, DOI 10.1128/mBio.01312-14; Hammarstrom Martin, 2006, Journal of Structural and Functional Genomics, V7, P1, DOI 10.1007/s10969-005-9003-7; Hilcenko C, 2013, BLOOD, V121, P1028, DOI 10.1182/blood-2012-10-461491; Jackson EK, 2016, HDB EXP PHARM; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kanai A, 2009, RNA, V15, P420, DOI 10.1261/rna.1122109; Kato M, 2003, J MOL BIOL, V329, P903, DOI 10.1016/S0022-2836(03)00448-0; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lee J, 2001, J BIOL CHEM, V276, P14804, DOI 10.1074/jbc.M009434200; Li XL, 2008, P NATL ACAD SCI USA, V105, P20816, DOI 10.1073/pnas.0807265105; LIU J, 1986, J BACTERIOL, V165, P1002, DOI 10.1128/jb.165.3.1002-1010.1986; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Majava V, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-10; Margraf T, 2009, NUCLEIC ACIDS RES, V37, pW480, DOI 10.1093/nar/gkp431; Mazumder R, 2002, NUCLEIC ACIDS RES, V30, P5229, DOI 10.1093/nar/gkf645; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Myllykoski M, 2016, BRAIN RES, V1641, P64, DOI 10.1016/j.brainres.2015.09.004; Myllykoski M, 2013, J MOL BIOL, V425, P4307, DOI 10.1016/j.jmb.2013.06.012; Myllykoski M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032336; Myllykoski Matti, 2010, BMC Res Notes, V3, P12, DOI 10.1186/1756-0500-3-12; Nasr F, 2000, NUCLEIC ACIDS RES, V28, P1676, DOI 10.1093/nar/28.8.1676; Ogden KM, 2015, J VIROL, V89, P6633, DOI 10.1128/JVI.00701-15; Pandey M, 2004, BIOCHEM BIOPH RES CO, V317, P586, DOI 10.1016/j.bbrc.2004.03.083; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PHIZICKY EM, 1986, J BIOL CHEM, V261, P2978; Raasakka A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16520; Raasakka A, 2014, NEUROSCI BULL, V30, P956, DOI 10.1007/s12264-013-1437-5; Remus BS, 2014, RNA, V20, P1697, DOI 10.1261/rna.046797.114; Sakamoto Y, 2005, J MOL BIOL, V346, P789, DOI 10.1016/j.jmb.2004.12.024; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Thornbrough JM, 2016, MBIO, V7, DOI 10.1128/mBio.00258-16; TRUJILLO MA, 1987, EUR J BIOCHEM, V169, P167, DOI 10.1111/j.1432-1033.1987.tb13594.x; Unni S, 2011, J COMPUT CHEM, V32, P1488, DOI 10.1002/jcc.21720; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; WESTHOF E, 1988, ACTA CRYSTALLOGR A, V44, P112, DOI 10.1107/S010876738700446X; Yakunin AF, 2004, J BIOL CHEM, V279, P36819, DOI 10.1074/jbc.M405120200; Zhang R, 2013, P NATL ACAD SCI USA, V110, P13114, DOI 10.1073/pnas.1306917110; Zhao L, 2012, CELL HOST MICROBE, V11, P607, DOI 10.1016/j.chom.2012.04.011	57	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170355	10.1371/journal.pone.0170355	http://dx.doi.org/10.1371/journal.pone.0170355			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141848	Green Published, gold			2022-12-27	WOS:000396129500009
J	Wiesner, CD; Lindner, C				Wiesner, Christian Dirk; Lindner, Christoph			Weakening self-control biases the emotional evaluation of appetitive cues	PLOS ONE			English	Article							EGO-DEPLETION; STRENGTH MODEL; RESOURCE	Exerting self-control in a first task weakens self-control in a second completely unrelated task (ego-depletion). It has been proposed that ego-depletion increases approach motivation which would amplify positive emotions to appetitive cues. Here we investigated the effect of the depletion of cognitive self-control on the subsequent emotional evaluation of appetitive cues. Participants of the depletion group copied a text omitting frequent letters and thereby exerting self-control to inhibit automated writing habits. Participants of the control group just copied the text. In a subsequent task participants had to rate valence and arousal of their responses to neutral vs. positive pictures of humans, animals, food, or sceneries. Ego-depletion caused more positive valence ratings of neutral pictures and lower arousal ratings of positive pictures. The findings do not support the notion that ego-depletion increases approach motivation in general. Rather they suggest that-without a specific motivational context-depletion of cognitive self-control differentially alters the immediate emotional evaluation of appetitive cues.	[Wiesner, Christian Dirk] Univ Kiel, Sch Med, Dept Child & Adolescent Psychiat & Psychotherapy, Ctr Integrat Psychiat, Kiel, Germany; [Lindner, Christoph] IPN, Leibniz Inst Sci Math Educ, Kiel, Germany; [Lindner, Christoph] Univ Kiel, Kiel, Germany	University of Kiel; Leibniz Institut fur die Padagogik der Naturwissenschaften und Mathematik an der Universitat Kiel (IPN); University of Kiel	Wiesner, CD (corresponding author), Univ Kiel, Sch Med, Dept Child & Adolescent Psychiat & Psychotherapy, Ctr Integrat Psychiat, Kiel, Germany.; Lindner, C (corresponding author), IPN, Leibniz Inst Sci Math Educ, Kiel, Germany.; Lindner, C (corresponding author), Univ Kiel, Kiel, Germany.	ChristianDirk.Wiesner@uksh.de; CLindner@ipn.uni-kiel.de	Lindner, Christoph/K-6145-2015	Lindner, Christoph/0000-0001-5688-3146; Wiesner, Christian/0000-0003-1287-4955	German Research Foundation [SFB 654]; Land Schleswig-Holstein	German Research Foundation(German Research Foundation (DFG)); Land Schleswig-Holstein	Christian Dirk Wiesner was supported by a grant (SFB 654 Plasticity and Sleep) from the German Research Foundation. We acknowledge financial support by Land Schleswig-Holstein within the funding program Open Access Publikationsfonds. However, neither the German Research Foundation nor the Publikationsfonds had any role in the design of the study, in the collection, analysis, or interpretation of data, in the writing of the paper, or in the decision to submit the paper for publication.	Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Baumeister RF, 2007, CURR DIR PSYCHOL SCI, V16, P351, DOI 10.1111/j.1467-8721.2007.00534.x; Baumeister RF, 2016, PERSPECT PSYCHOL SCI, V11, P574, DOI 10.1177/1745691616652878; Baumeister RF, 2014, NEUROPSYCHOLOGIA, V65, P313, DOI 10.1016/j.neuropsychologia.2014.08.012; Bertrams A, 2015, PERS SOC PSYCHOL B, V41, P311, DOI 10.1177/0146167214564968; Bertrams A, 2013, EMOTION, V13, P668, DOI 10.1037/a0031921; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Carter EC, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00823; Christiansen P, 2012, EXP CLIN PSYCHOPHARM, V20, P118, DOI 10.1037/a0026623; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Hagger MS, 2016, PERSPECT PSYCHOL SCI, V11, P546, DOI 10.1177/1745691616652873; Hagger MS, 2010, PSYCHOL BULL, V136, P495, DOI 10.1037/a0019486; Inzlicht M, 2014, TRENDS COGN SCI, V18, P127, DOI 10.1016/j.tics.2013.12.009; Krohne HW, 1996, DIAGNOSTICA, V42, P139; Muraven M, 1998, J PERS SOC PSYCHOL, V74, P774, DOI 10.1037/0022-3514.74.3.774; Schmeichel BJ, 2007, J EXP PSYCHOL GEN, V136, P241, DOI 10.1037/0096-3445.136.2.241; Schmeichel BJ, 2016, SOC COGN AFFECT NEUR, V11, P282, DOI 10.1093/scan/nsv112; Schmeichel BJ, 2010, J PERS SOC PSYCHOL, V99, P162, DOI 10.1037/a0019797; Vohs KD, 2000, PSYCHOL SCI, V11, P249, DOI 10.1111/1467-9280.00250; Vohs KD, 2012, ENGAGING SELF UNPUB; Wagner DD, 2013, PSYCHOL SCI, V24, P2262, DOI 10.1177/0956797613492985; Wagner DD, 2013, SOC COGN AFFECT NEUR, V8, P410, DOI 10.1093/scan/nss082; Wiesner CD, 2015, NEUROBIOL LEARN MEM, V122, P131, DOI 10.1016/j.nlm.2015.02.008	23	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170245	10.1371/journal.pone.0170245	http://dx.doi.org/10.1371/journal.pone.0170245			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6QW	28141811	Green Published, Green Submitted, gold			2022-12-27	WOS:000396129500008
J	Bonfert, T; Friedel, CC				Bonfert, Thomas; Friedel, Caroline C.			Prediction of Poly(A) Sites by Poly(A) Read Mapping	PLOS ONE			English	Article							3' UNTRANSLATED REGIONS; ALTERNATIVE POLYADENYLATION; RNA-SEQ; GENE-EXPRESSION; MESSENGER-RNAS; CLEAVAGE; CELLS; LANDSCAPE; QUANTIFICATION; TRANSCRIPTION	RNA-seq reads containing part of the poly(A) tail of transcripts (denoted as poly(A) reads) provide the most direct evidence for the position of poly(A) sites in the genome. However, due to reduced coverage of poly(A) tails by reads, poly(A) reads are not routinely identified during RNA-seq mapping. Nevertheless, recent studies for several herpesviruses successfully employed mapping of poly(A) reads to identify herpesvirus poly(A) sites using different strategies and customized programs. To more easily allow such analyses without requiring additional programs, we integrated poly(A) read mapping and prediction of poly(A) sites into our RNA-seq mapping program ContextMap 2. The implemented approach essentially generalizes previously used poly(A) read mapping approaches and combines them with the context-based approach of ContextMap 2 to take into account information provided by other reads aligned to the same location. Poly(A) read mapping using ContextMap 2 was evaluated on real-life data from the ENCODE project and compared against a competing approach based on transcriptome assembly (KLEAT). This showed high positive predictive value for our approach, evidenced also by the presence of poly(A) signals, and considerably lower runtime than KLEAT. Although sensitivity is low for both methods, we show that this is in part due to a high extent of spurious results in the gold standard set derived from RNAPET data. Sensitivity improves for poly(A) sites of known transcripts or determined with a more specific poly(A) sequencing protocol and increases with read coverage on transcript ends. Finally, we illustrate the usefulness of the approach in a high read coverage scenario by a re-analysis of published data for herpes simplex virus 1. Thus, with current trends towards increasing sequencing depth and read length, poly(A) read mapping will prove to be increasingly useful and can now be performed automatically during RNA-seq mapping with ContextMap 2.	[Bonfert, Thomas; Friedel, Caroline C.] Ludwig Maximilians Univ Munchen, Inst Informat, Munich, Germany	University of Munich	Friedel, CC (corresponding author), Ludwig Maximilians Univ Munchen, Inst Informat, Munich, Germany.	caroline.friedel@bio.ifi.lmu.de	Friedel, Caroline/AAG-5017-2019	Friedel, Caroline/0000-0003-3569-4877	Deutsche Forschungsgemeinschaft [FR2938/1-2, FR2938/7-1, CRC 1123 (Z2)]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was partially supported by the Deutsche Forschungsgemeinschaft (www.dfg.de/) (grants FR2938/1-2, FR2938/7-1, CRC 1123 (Z2)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arias C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003847; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; BIROL I, 2015, PACIFIC S BIOCOMPUTI, V20, P347; Boehmer PE, 1997, ANNU REV BIOCHEM, V66, P347, DOI 10.1146/annurev.biochem.66.1.347; Bonfert T, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0557-5; Canny SP, 2014, MBIO, V5, DOI 10.1128/mBio.01033-13; Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110; Graber JH, 1999, P NATL ACAD SCI USA, V96, P14055, DOI 10.1073/pnas.96.24.14055; Haenni S, 2012, NUCLEIC ACIDS RES, V40, P6304, DOI 10.1093/nar/gks282; Hilgers V, 2011, P NATL ACAD SCI USA, V108, P15864, DOI 10.1073/pnas.1112672108; Hoque M, 2013, NAT METHODS, V10, P133, DOI [10.1038/NMETH.2288, 10.1038/nmeth.2288]; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lindner R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052403; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mignone F, 2001, MRNA UNTRANSLATED RE; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Ozsolak F, 2010, CELL, V143, P1018, DOI 10.1016/j.cell.2010.11.020; Pauws E, 2001, NUCLEIC ACIDS RES, V29, P1690, DOI 10.1093/nar/29.8.1690; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Proudfoot NJ, 2011, GENE DEV, V25, P1770, DOI 10.1101/gad.17268411; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Roizman B, 2001, FIELDS VIROLOGY, P2399; Rutkowski AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8126; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Shepard PJ, 2011, RNA, V17, P761, DOI 10.1261/rna.2581711; Shi YS, 2012, RNA, V18, P2105, DOI 10.1261/rna.035899.112; Smibert P, 2012, CELL REP, V1, P277, DOI 10.1016/j.celrep.2012.01.001; Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Ulitsky I, 2012, GENOME RES, V22, P2054, DOI 10.1101/gr.139733.112; Wang QY, 2005, P NATL ACAD SCI USA, V102, P16055, DOI 10.1073/pnas.0505850102; Wilkening S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1249; Xia Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6274; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100	48	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170914	10.1371/journal.pone.0170914	http://dx.doi.org/10.1371/journal.pone.0170914			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135292	gold, Green Submitted, Green Published			2022-12-27	WOS:000396124700031
J	Li, SL; Ye, Y; Yuan, XH				Li, Su-Liang; Ye, Yun; Yuan, Xiao-Hua			Association between Allogeneic or Autologous Blood Transfusion and Survival in Patients after Radical Prostatectomy: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CANCER RECURRENCE; SURGERY; DISEASE; IMPACT; HETEROGENEITY; MORTALITY; QUALITY	Background A number of studies have investigated the effect of perioperative blood transfusion (PBT) for patients after radical prostatectomy (RP), with some reporting conflicting results. A systematic review of the literature and a meta-analysis were conducted to explore the association between PBT (autologous or allogeneic) and biochemical recurrence-free survival (BRFS), overall survival (OS) and cancer-specific survival (CSS) in patients undergoing RP. Methods The PubMed, Medline, Cochrane Library, and Embase databases were searched for published controlled clinical studies on perioperative allogeneic or autologous blood transfusion (BT) and patient survival after RP. STATA software version 12.0 was used for data analysis. We used hazard ratios (HRs) and 95% confidence intervals (CIs) to test the correlation between BT and patient survival after RP. Results Data from a total of 26,698 patients in ten published studies were included in the meta-analysis. The meta-analysis results showed that autologous BT was not associated with BRFS (HR: 1.06; 95% CI: 0.96-1.18; Z = 1.17; P = 0.24), OS (HR: 0.86; 95% CI: 0.71-1.04; Z = 1.58; P = 0.11), or CSS (HR: 0.98; 95% CI: 0.49-1.96; Z = 0.05; P = 0.96). Allogeneic BT exhibited a significant association with worse BRFS (HR: 1.09; 95% CI: 1.01-1.16; Z = 2.37; P = 0.02), OS (HR: 1.43; 95% CI: 1.24-1.64; Z = 4.95; P< 0.01) and CSS (HR: 1.74; 95% CI: 1.18-2.56; Z = 2.81; P = 0.005). Conclusion Our data showed an association between allogeneic BT and reduced BRFS, OS and CSS in patients after RP. These findings indicate that perioperative blood conservation strategies are important for decreasing the allogeneic BT rate.	[Li, Su-Liang; Ye, Yun] Xian Med Univ, Dept Lab Med, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China; [Yuan, Xiao-Hua] Xian Med Univ, Dept Blood Transfus, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China	Xi'an Medical University; Xi'an Medical University	Ye, Y (corresponding author), Xian Med Univ, Dept Lab Med, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China.	yeyun236@163.com						Amato A, 2006, COCHRANE DB SYST REV, V25, DOI DOI 10.1002/14651858.CD005033.PUB2; Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; Boehm K, 2015, WORLD J UROL, V33, P801, DOI 10.1007/s00345-014-1351-0; Cata JP, 2013, BRIT J ANAESTH, V110, P690, DOI 10.1093/bja/aet068; Chalfin HJ, 2014, TRANSFUSION, V54, P2168, DOI 10.1111/trf.12611; Chin JL, 2010, CUAJ-CAN UROL ASSOC, V4, P13, DOI 10.5489/cuaj.08105; EICKHOFF JH, 1991, BRIT J UROL, V68, P608, DOI 10.1111/j.1464-410X.1991.tb15424.x; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ford BS, 2008, UROL ONCOL-SEMIN ORI, V26, P364, DOI 10.1016/j.urolonc.2007.06.004; Gallina A, 2007, BJU INT, V100, P1249, DOI 10.1111/j.1464-410X.2007.07147.x; Ghosh S, 2004, CANCER-AM CANCER SOC, V101, P2058, DOI 10.1002/cncr.20590; Guzzo TJ, 2010, UROLOGY, V76, P553, DOI 10.1016/j.urology.2010.02.069; HEAL JM, 1988, AM J SURG, V156, P374, DOI 10.1016/S0002-9610(88)80190-9; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2011, COCHRANCE HDB SYSTEM; Jackson D, 2012, STAT MED, V31, P3805, DOI 10.1002/sim.5453; Kim JK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154918; Linder BJ, 2013, EUR UROL, V63, P839, DOI 10.1016/j.eururo.2013.01.004; MCCLINTON S, 1990, BRIT J SURG, V77, P140, DOI 10.1002/bjs.1800770208; Motoyama S, 2004, J SURG ONCOL, V87, P26, DOI 10.1002/jso.20064; NESS PM, 1992, TRANSFUSION, V32, P31, DOI 10.1046/j.1537-2995.1992.32192116429.x; OEFELEIN MG, 1995, J UROLOGY, V154, P442, DOI 10.1016/S0022-5347(01)67070-8; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Paul R, 2006, UROLOGY, V67, P137, DOI 10.1016/j.urology.2005.07.020; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Soubra A, 2015, CLIN GENITOURIN CANC, V13, pE173, DOI 10.1016/j.clgc.2014.12.006; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; TARTTER PI, 1985, SURGERY, V97, P225; Vamvakas EC, 2007, BLOOD REV, V21, P327, DOI 10.1016/j.blre.2007.07.003; Wang YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130122; Yeoh TY, 2014, TRANSFUSION, V54, P2175, DOI 10.1111/trf.12595; Zintzaras E, 2005, BIOINFORMATICS, V21, P3672, DOI 10.1093/bioinformatics/bti536	34	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171081	10.1371/journal.pone.0171081	http://dx.doi.org/10.1371/journal.pone.0171081			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135341	Green Submitted, gold, Green Published			2022-12-27	WOS:000396124700047
J	Daneau, G; Aboud, S; Prat, I; Urassa, W; Kestens, L				Daneau, Geraldine; Aboud, Said; Prat, Irena; Urassa, Willy; Kestens, Luc			Performance of FACSPresto Point-of-Care Instrument for CD4-T Cell Enumeration in Human Immunodeficiency Virus (HIV)-Infected Patients Attending Care and Treatment Clinics in Belgium and Tanzania	PLOS ONE			English	Article							PIMA CD4; SETTINGS; AGREEMENT; THERAPY	Background CD4 T-cell counts are widely used to assess treatment eligibility and to follow-up HIV-infected patients. The World Health Organization prequalification of in vitro diagnostics program conducted a performance evaluation of the FACSPresto (BD Biosciences), a new point-of-care instrument to measure absolute CD4-T cell (CD4) counts and percentages in venous and capillary blood samples from HIV-infected patients. Methods Patients were recruited in Belgium (200 patients) and in Tanzania (247 patients). Venous blood samples were analyzed in two nearby reference laboratories. In addition, nurses/technicians collected a capillary blood sample by finger prick directly into a FACSPresto CD4 cartridge. Assay precision was assessed on fresh blood and on external quality control samples. Trueness (bias) was assessed by comparing results from FACSPresto with the reference (single-platform FACSCalibur). Clinical misclassification was measured at 200, 350 and 500 cells/mu L thresholds. Results Intra-assay precision was < 6%, and inter-assay < 8%. CD4 results from FACSPresto and reference method resulted in regression slopes of 0.99-1.11 using either venous or capillary blood. Correlation was better for venous than for capillary blood (minimum 0.97 vs 0.93 respectively). Capillary blood resulted in a larger bias than venous blood, with 24 and 83 cells/mu L for absolute CD4 counts on capillary blood in Antwerp and Dar es Salaam respectively, vs 12 and 41 cells/mu L on venous blood. Bias on CD4% was < 1% on both venous and capillary blood, and was proportionally better than for absolute CD4 counts. Clinical	[Daneau, Geraldine; Kestens, Luc] Inst Trop Med, Dept Biomed Sci, Immunol Lab, Antwerp, Belgium; [Aboud, Said] MUHAS, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania; [Prat, Irena; Urassa, Willy] WHO, Geneva, Switzerland; [Kestens, Luc] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium	Institute of Tropical Medicine (ITM); Muhimbili University of Health & Allied Sciences; World Health Organization; University of Antwerp	Daneau, G; Kestens, L (corresponding author), Inst Trop Med, Dept Biomed Sci, Immunol Lab, Antwerp, Belgium.; Kestens, L (corresponding author), Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium.	gdaneau@itg.be; lkestens@itg.be		Daneau, Geraldine/0000-0002-2570-0893	World Health Organization Prequalification of Diagnostics Programme	World Health Organization Prequalification of Diagnostics Programme	This study was partially funded by the World Health Organization Prequalification of Diagnostics Programme http://www.who.int/diagnostics_laboratory/evaluations/cd4/en/). The funder designed the generic protocol for the evaluation. There was no additional external funding received for this study.	Angira F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157939; [Anonymous], 2016, GUID US ANT AG HIV 1; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bwana P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145586; Clinical and Laboratory Standards Institute, 2010, EP09A2IR CLIN LAB ST, P17; Coetzee LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156266; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Daneau G, 2016, CYTOMETRY B; Daneau G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161891; Diaw PA, 2011, JAIDS-J ACQ IMM DEF, V58, pE103, DOI 10.1097/QAI.0b013e318235b378; Ford N, 2015, LANCET INFECT DIS, V15, P241, DOI 10.1016/S1473-3099(14)70896-5; Galiwango RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088928; Glencross D K, 2001, SADJ, V56, P602; Glynn MT, 2013, LAB CHIP, V13, P2731, DOI 10.1039/c3lc50213a; Jani I, 2010, POINT OF CARE CD4 IM; Makadzange AT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157546; Mandy F, 2008, CYTOM PART B-CLIN CY, V74B, pS27, DOI 10.1002/cyto.b.20414; PASSING H, 1983, J CLIN CHEM CLIN BIO, V21, P709; Peter T, 2008, CYTOM PART B-CLIN CY, V74B, pS123, DOI 10.1002/cyto.b.20416; POLLOCK MA, 1992, ANN CLIN BIOCHEM, V29, P556, DOI 10.1177/000456329202900512; Scott LE, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0396-2; Sukapirom K, 2011, JAIDS-J ACQ IMM DEF, V58, P141, DOI 10.1097/QAI.0b013e31822866a2; UNAIDS, 2014, 90 90 90 AMB TREATM; Wade D, 2014, JAIDS-J ACQ IMM DEF, V66, pE98, DOI 10.1097/QAI.0000000000000214; World Health Organization, 2013, 2013 CONS GUID US AN; World Health Organization, 2013, NUMB PEOPL REC ART P; World Health Organization, 2016, CONS GUID US ANT DRU; World Health Organization, 2015, GLOB SUMM AIDS EP 20	28	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170248	10.1371/journal.pone.0170248	http://dx.doi.org/10.1371/journal.pone.0170248			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129324	Green Published, Green Submitted, gold			2022-12-27	WOS:000396211400059
J	Song, I; Ko, SM; Yi, JG; Chee, HK; Kim, JS				Song, Inyoung; Ko, Sung Min; Yi, Jeong Geun; Chee, Hyun Keun; Kim, Jun Seok			Differences in Aortic Valve and Left Ventricular Parameters Related to the Severity of Myocardial Fibrosis in Patients with Severe Aortic Valve Stenosis	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; LATE GADOLINIUM ENHANCEMENT; VALVULAR HEART-DISEASE; REPLACEMENT; AREA; QUANTIFICATION; CALCIFICATION; REGURGITATION; PREDICTORS; GEOMETRY	Objective This study investigated the morphological and functional characteristics of the aortic valve and the left ventricular (LV) systolic functional parameters and myocardial mass related to the severity of myocardial fibrosis (MF) in patients with severe aortic valve stenosis (AS). Materials and Methods We retrospectively enrolled 81 patients (48 men; mean age: 59 +/- 12 years) with severe AS who underwent transthoracic echocardiography (TTE), cardiac computed tomography (CCT), and cardiovascular magnetic resonance (CMR) within 1 month and subsequent aortic valve surgery. Degree of MF was determined on delayed contrast-enhanced CMR with visual sub-segmental analysis-based quantification and was classified into three groups (no, mild, and severe) for identifying the differences in LV function and characteristics of the aortic valve. One-way ANOVA, Chi-square test or Fisher's exact test were used to compare variables of the three groups. Univariate multinomial logistic regression analysis was performed to determine the association between the severity of MF and variables on imaging modalities. Results Of 81 patients, 34 (42%) had MF (mild, n = 18; severe, n = 16). Aortic valve calcium volume score on CCT, aortic valve area, LV mass index, LV end-diastolic volume index on CMR, presence of mild aortic regurgitation (AR), transaortic mean pressure gradient, and peak velocity on TTE were significantly different among the three groups and were associated with severity of MF on a univariate multinomial logistic regression analysis. Aortic valve calcium grade was different (p = 0.008) among the three groups but not associated with severity of MF (p = 0.375). Conclusions A multi-imaging approach shows that severe AS with MF is significantly associated with more severe calcific AS, higher LV end-diastolic volume, higher LV mass, and higher prevalence of mild AR.	[Song, Inyoung; Ko, Sung Min; Yi, Jeong Geun] Konkuk Univ, Sch Med, Med Ctr, Dept Radiol, Seoul, South Korea; [Chee, Hyun Keun; Kim, Jun Seok] Konkuk Univ, Sch Med, Med Ctr, Dept Thorac Surg, Seoul, South Korea	Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University Medical Center	Ko, SM (corresponding author), Konkuk Univ, Sch Med, Med Ctr, Dept Radiol, Seoul, South Korea.	ksm9723@yahoo.co.kr			Konkuk University	Konkuk University	This work was supported by Konkuk University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This paper was supported by Konkuk University.	Assomull RG, 2006, J AM COLL CARDIOL, V48, P1977, DOI 10.1016/j.jacc.2006.07.049; Azevedo CF, 2010, J AM COLL CARDIOL, V56, P278, DOI 10.1016/j.jacc.2009.12.074; Borer JS, 2002, CIRCULATION, V105, P1837, DOI 10.1161/01.CIR.0000014419.71706.85; Carabello BA, 2012, CIRCULATION, V126, P112, DOI 10.1161/CIRCULATIONAHA.111.079350; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Clavel MA, 2014, J AM COLL CARDIOL, V64, P1202, DOI 10.1016/j.jacc.2014.05.066; Clavel MA, 2013, J AM COLL CARDIOL, V62, P2329, DOI 10.1016/j.jacc.2013.08.1621; Debl K, 2006, HEART, V92, P1447, DOI 10.1136/hrt.2005.079392; Dweck MR, 2011, J AM COLL CARDIOL, V58, P1271, DOI 10.1016/j.jacc.2011.03.064; Fine NM, 2013, J MAGN RESON IMAGING, V38, P1369, DOI 10.1002/jmri.24116; Garcia J, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-25; Honda S, 2012, HEART; Iung B, 2011, NAT REV CARDIOL, V8, P162, DOI 10.1038/nrcardio.2010.202; Kim EK, 2015, KOREAN J RADIOL, V16, P683, DOI 10.3348/kjr.2015.16.4.683; Klumpp BD, 2009, EUR RADIOL, V19, P1124, DOI 10.1007/s00330-008-1248-7; Koos R, 2004, AM J ROENTGENOL, V183, P1813, DOI 10.2214/ajr.183.6.01831813; KRAYENBUEHL HP, 1979, BRIT HEART J, V41, P204; Maganti K, 2010, MAYO CLIN PROC, V85, P483, DOI 10.4065/mcp.2009.0706; Mewton N, 2011, J AM COLL CARDIOL, V57, P891, DOI 10.1016/j.jacc.2010.11.013; Milano AD, 2012, J THORAC CARDIOV SUR, V144, P830, DOI 10.1016/j.jtcvs.2011.11.024; Nigri M, 2009, AM HEART J, V157, P361, DOI 10.1016/j.ahj.2008.09.012; Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537; NITENBERG A, 1988, J AM COLL CARDIOL, V11, P478, DOI 10.1016/0735-1097(88)91520-3; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Otto CM, 1997, CIRCULATION, V95, P2262, DOI 10.1161/01.CIR.95.9.2262; Park J, 2014, KOREAN CIRC J, V44, P312, DOI 10.4070/kcj.2014.44.5.312; Pouleur AC, 2007, RADIOLOGY, V244, P745, DOI 10.1148/radiol.2443061127; Rosenhek R, 2000, NEW ENGL J MED, V343, P611, DOI 10.1056/NEJM200008313430903; Saitoh T, 2012, AM J CARDIOL, V109, P1626, DOI 10.1016/j.amjcard.2012.01.391; Song MG, 2014, ANN THORAC SURG, V97, P1235, DOI 10.1016/j.athoracsur.2013.10.088; Weidemann F, 2009, CIRCULATION, V120, P577, DOI 10.1161/CIRCULATIONAHA.108.847772; Zhao Y, 2013, INT J CARDIOL, V168, P3560, DOI 10.1016/j.ijcard.2013.05.089; Zilberszac R, 2013, J AM COLL CARDIOL, V61, P1489, DOI 10.1016/j.jacc.2012.11.070	33	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170939	10.1371/journal.pone.0170939	http://dx.doi.org/10.1371/journal.pone.0170939			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129367	gold, Green Published, Green Submitted			2022-12-27	WOS:000396211400024
J	Winerdal, M; Urmaliya, V; Winerdal, ME; Fredholm, BB; Winqvist, O; Aring;den, U				Winerdal, Max; Urmaliya, Vijay; Winerdal, Malin E.; Fredholm, Bertil B.; Winqvist, Ola; Aden, Ulrika			Single Dose Caffeine Protects the Neonatal Mouse Brain against Hypoxia Ischemia	PLOS ONE			English	Article								In this randomized blinded study, we investigated caffeine 5 mg/kg treatment given directly after neonatal brain hypoxia ischemia. Brain morphology, behavior and key brain infiltrating immune populations were examined. Caffeine treatment significantly improves outcome when compared to phosphate buffered saline. Flow cytometric analysis of immune responses revealed no persistent immunological alterations. Given its safety caffeine emerges as a candidate for neuroprotective intervention after neonatal brain injury.	[Winerdal, Max; Aden, Ulrika] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Urmaliya, Vijay; Fredholm, Bertil B.] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Winerdal, Malin E.; Winqvist, Ola] Karolinska Inst, Dept Med, Stockholm, Sweden; [Urmaliya, Vijay] Janssen Res & Dev, Discovery Sci, Beerse, Belgium	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Johnson & Johnson; Janssen Pharmaceuticals	Winerdal, M (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.	max.winerdal@medsci.se		winqvist, Ola/0000-0003-0842-4441	Marianne and Marcus Wallenberg foundation; Swedish Brain Foundation; Swedish Order of Freemasons in Stockholm; Medicinska Forskningsradet (SE) regional agreement on medical training and clinical research	Marianne and Marcus Wallenberg foundation; Swedish Brain Foundation; Swedish Order of Freemasons in Stockholm; Medicinska Forskningsradet (SE) regional agreement on medical training and clinical research	This work was supported by Medicinska Forskningsradet (SE) regional agreement on medical training and clinical research, Marianne and Marcus Wallenberg foundation, Swedish Brain Foundation and Swedish Order of Freemasons in Stockholm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aden Ulrika, 2011, Handb Exp Pharmacol, P373, DOI 10.1007/978-3-642-13443-2_14; Albertsson AM, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0153-z; BONA E, 1995, PEDIATR RES, V38, P312, DOI 10.1203/00006450-199509000-00007; Doyle LW, 2010, ANN NEUROL, V68, P734, DOI 10.1002/ana.22098; Hahne F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-106; Hedtjarn M, 2005, NEUROSCI LETT, V373, P16, DOI 10.1016/j.neulet.2004.09.062; Horrigan LA, 2006, PHARMACOL THERAPEUT, V111, P877, DOI 10.1016/j.pharmthera.2006.02.002; Jacobs SE, 2008, EVID BASED CHILD HLT, V3, P1049, DOI DOI 10.1002/EBCH.293; Schmidt B, 2007, NEW ENGL J MED, V357, P1893, DOI 10.1056/NEJMoa073679; Winerdal M, 2016, PURINERG SIGNAL, V12, P89, DOI 10.1007/s11302-015-9482-3	10	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170545	10.1371/journal.pone.0170545	http://dx.doi.org/10.1371/journal.pone.0170545			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129361	Green Published, gold, Green Submitted			2022-12-27	WOS:000396211400055
J	Lee, MB; Martin, JA				Lee, Myung-Bok; Martin, James A.			Avian Species and Functional Diversity in Agricultural Landscapes: Does Landscape Heterogeneity Matter?	PLOS ONE			English	Article							LAND-USE INTENSIFICATION; PHYLOGENETIC DIVERSITY; HABITAT HETEROGENEITY; RICHNESS; CONSERVATION; BIODIVERSITY; FRAGMENTATION; COMMUNITIES; DISTURBANCE; MANAGEMENT	While the positive relationship between avian diversity and habitat heterogeneity is widely accepted, it is primarily based on observed species richness without accounting for imperfect detection. Other facets of diversity such as functional diversity are also rarely explored. We investigated the avian diversity-landscape heterogeneity relationship in agricultural landscapes by considering two aspects of diversity: taxonomic diversity (species richness) estimated from a multi-species dynamic occupancy model, and functional diversity (functional evenness [FEve] and divergence [FDiv]) based on traits of occurring species. We also assessed how agricultural lands enrolled in a conservation program managed on behalf of declining early successional bird species (hereafter CP38 fields, an agri-environment scheme) influenced avian diversity. We analyzed breeding bird data collected at CP38 fields in Mississippi, USA, during 2010-2012, and two principal components of environmental variables: a gradient of heterogeneity (Shannon's landscape diversity index) and of the amount of CP38 fields (percent cover of CP38 fields; CP38). FEve did not show significant responses to environmental variables, whereas FDiv responded positively to heterogeneity and negatively to CP38. However, most FDiv values did not significantly differ from random expectations along an environmental gradient. When there was a significant difference, FDiv was lower than that expected. Unlike functional diversity, species richness showed a clear pattern. Species richness increased with increasing landscape heterogeneity but decreased with increasing amounts of CP38 fields. Only one species responded negatively to heterogeneity and positively to CP38. Our results suggest that the relationships between avian diversity and landscape heterogeneity may vary depending on the aspect of diversity considered: strong positive effects of heterogeneity on taxonomic diversity, but weakly positive or non-significant effects on functional diversity. Our results also indicate that effectiveness of CP38 in conserving avian diversity, particularly, taxonomic diversity, could be limited without the consideration of landscape heterogeneity.	[Lee, Myung-Bok] Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Mississippi State, MS 39762 USA; [Martin, James A.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Savannah River Ecol Lab, Athens, GA 30602 USA; [Lee, Myung-Bok] Guangxi Univ, Coll Forestry, Nanning, Guangxi, Peoples R China	Mississippi State University; United States Department of Energy (DOE); Savannah River Ecology Laboratory; University System of Georgia; University of Georgia; Guangxi University	Lee, MB (corresponding author), Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Mississippi State, MS 39762 USA.; Lee, MB (corresponding author), Guangxi Univ, Coll Forestry, Nanning, Guangxi, Peoples R China.	bok.ecology@outlook.com			Wildlife Mississippi; Mississippi Wildlife Federation; Mississippi State University's Forest and Wildlife Research Center; Mississippi Agriculture and Forestry Experimental Station	Wildlife Mississippi; Mississippi Wildlife Federation; Mississippi State University's Forest and Wildlife Research Center; Mississippi Agriculture and Forestry Experimental Station	The work was funded by Wildlife Mississippi (http://www.wildlifemiss.org/), Mississippi Wildlife Federation, Mississippi State University's Forest and Wildlife Research Center, and Mississippi Agriculture and Forestry Experimental Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2012, P NATL ACAD SCI USA, V109, P17495, DOI 10.1073/pnas.1208652109; [Anonymous], 1988, BIRDERS HDB FIELD GU; Bar-Massada A, 2014, ECOGRAPHY, V37, P528, DOI 10.1111/j.1600-0587.2013.00590.x; Barragan F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017976; Bennett AF, 2006, BIOL CONSERV, V133, P250, DOI 10.1016/j.biocon.2006.06.008; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Best LB, 1997, WILDLIFE SOC B, V25, P864; Brennan JM, 2002, CAM STU LAN, P68, DOI 10.1017/CBO9780511613654.006; Buler JJ, 2007, ECOLOGY, V88, P1789, DOI 10.1890/06-1871.1; Burton AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038007; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Calba S, 2014, GLOBAL ECOL BIOGEOGR, V23, P669, DOI 10.1111/geb.12148; Casanoves F, 2011, METHODS ECOL EVOL, V2, P233, DOI 10.1111/j.2041-210X.2010.00082.x; CODY ML, 1981, BIOSCIENCE, V31, P107, DOI 10.2307/1308252; Coppedge BR, 2001, ECOL APPL, V11, P47, DOI 10.1890/1051-0761(2001)011[0047:ARTLCI]2.0.CO;2; Devictor V, 2007, AGR ECOSYST ENVIRON, V120, P179, DOI 10.1016/j.agee.2006.08.013; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Ding ZF, 2013, J ANIM ECOL, V82, P781, DOI 10.1111/1365-2656.12046; Dorazio RM, 2006, ECOLOGY, V87, P842, DOI 10.1890/0012-9658(2006)87[842:ESRAAB]2.0.CO;2; Duflot R, 2014, ACTA OECOL, V56, P19, DOI 10.1016/j.actao.2014.01.004; Dunning J., 2008, CRC HDB AVIAN BODY M, V2nd; Ekroos J, 2013, ECOL INDIC, V34, P528, DOI 10.1016/j.ecolind.2013.06.015; Elton C.S., 2000, ECOLOGY INVASIONS AN; Evans KO, 2014, CONSERV BIOL, V28, P892, DOI 10.1111/cobi.12311; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Gagic V, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2620; Gotelli NJ, 2002, ECOL LETT, V5, P86, DOI 10.1046/j.1461-0248.2002.00288.x; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Hervia V, 2015, OECOLOGICA; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Kadmon R, 2007, AM NAT, V170, P443, DOI 10.1086/519853; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kleijn D, 2011, TRENDS ECOL EVOL, V26, P474, DOI 10.1016/j.tree.2011.05.009; Laliberte E, 2013, J VEG SCI, V24, P834, DOI 10.1111/jvs.12044; Linden DW, 2012, FOREST ECOL MANAG, V284, P174, DOI 10.1016/j.foreco.2012.08.002; Luck GW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063671; Luck GW, 2012, J ANIM ECOL, V81, P1065, DOI 10.1111/j.1365-2656.2012.01974.x; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Maire E, 2015, GLOBAL ECOL BIOGEOGR, V24, P728, DOI 10.1111/geb.12299; Mason NWH, 2008, J ANIM ECOL, V77, P285, DOI 10.1111/j.1365-2656.2007.01350.x; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; Mayfield MM, 2010, GLOBAL ECOL BIOGEOGR, V19, P423, DOI 10.1111/j.1466-8238.2010.00532.x; Mendez V, 2012, DIVERS DISTRIB, V18, P356, DOI 10.1111/j.1472-4642.2011.00868.x; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Pakeman RJ, 2011, J ECOL, V99, P1143, DOI 10.1111/j.1365-2745.2011.01853.x; Pavoine S, 2011, BIOL REV, V86, P792, DOI 10.1111/j.1469-185X.2010.00171.x; Petchey OL, 2004, ECOLOGY, V85, P847, DOI 10.1890/03-0226; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Pickett SRA, 2011, ECOGRAPHY, V34, P955, DOI 10.1111/j.1600-0587.2011.06608.x; Pla L., 2012, QUANTIFYING FUNCTION; Poole A, 2005, BIRDS N AM ONLINE DA; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Riffell S, 2008, ENVIRON MONIT ASSESS, V146, P309, DOI 10.1007/s10661-007-0082-8; Robledo C., 2018, INFOSTAT VERSION 201; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2007, ECOLOGY, V88, P1813, DOI 10.1890/06-0669.1; Russell RE, 2009, ECOL APPL, V19, P1253, DOI 10.1890/08-0910.1; Sitters H, 2016, ECOL APPL, V26, P115, DOI 10.1890/14-1562; Smith AC, 2011, ECOGRAPHY, V34, P103, DOI 10.1111/j.1600-0587.2010.06201.x; Swenson NG, 2014, USE R, P1, DOI 10.1007/978-1-4614-9542-0; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Thornton DH, 2011, LANDSCAPE ECOL, V26, P7, DOI 10.1007/s10980-010-9549-z; Tilman D, 2001, ENCY BIODIVERSITY, V3, P109, DOI [DOI 10.1016/B0-12-226865-2/00132-2, 10.1006/rwbd.1999.0154]; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Van Meerbeek K, 2014, BIODIVERS CONSERV, V23, P2259, DOI 10.1007/s10531-014-0720-8; Vandewalle M, 2010, BIODIVERS CONSERV, V19, P2921, DOI 10.1007/s10531-010-9798-9; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Zipkin EF, 2010, BIOL CONSERV, V143, P479, DOI 10.1016/j.biocon.2009.11.016; Zipkin EF, 2009, J APPL ECOL, V46, P815, DOI 10.1111/j.1365-2664.2009.01664.x	74	40	43	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170540	10.1371/journal.pone.0170540	http://dx.doi.org/10.1371/journal.pone.0170540			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125653	Green Submitted, Green Published, gold			2022-12-27	WOS:000396176100097
J	Mugo, PM; Micheni, M; Shangala, J; Hussein, MH; Graham, SM; de Wit, TFR; Sanders, EJ				Mugo, Peter M.; Micheni, Murugi; Shangala, Jimmy; Hussein, Mohamed H.; Graham, Susan M.; de Wit, Tobias F. Rinke; Sanders, Eduard J.			Uptake and Acceptability of Oral HIV Self-Testing among Community Pharmacy Clients in Kenya: A Feasibility Study	PLOS ONE			English	Article							COASTAL KENYA; PERSPECTIVES	Background While HIV testing and counselling is a key entry point for treatment as prevention, over half of HIV-infected adults in Kenya are unaware they are infected. Offering HIV self-testing (HST) at community pharmacies may enhance detection of undiagnosed infections. We assessed the feasibility of pharmacy-based HST in Coastal Kenya. Methods Staff at five pharmacies, supported by on-site research assistants, recruited adult clients (>= 18 years) seeking services indicative of HIV risk. Participants were offered oral HST kits (OraQuick (R)) at US$ 1 per test. Within one week of buying a test, participants were contacted for post-test data collection and counselling. The primary outcome was test uptake, defined as the proportion of invited clients who bought tests. Views of participating pharmacy staff were solicited in feedback sessions during and after the study. Results Between November 2015 and April 2016, 463 clients were invited to participate; 174 (38%) were enrolled; and 161 (35% [95% Confidence Interval (CI) 31-39%]) bought a test. Uptake was higher among clients seeking HIV testing compared to those seeking other services (84% vs. 11%, adjusted risk ratio 6.9 [95% CI 4.9-9.8]). Only4% of non-testers (11/302) stated inability to pay as the reason they did not take up the test. All but one tester reported the process was easy (29%) or very easy (70%). Demand for HST kits persisted after the study and participating service providers expressed interest in continuing to offer the service. Conclusions Pharmacy HST is feasible in Kenya and may be in high demand. The uptake pattern observed suggests that a client-initiated approach is more feasible compared to pharmacy-initiated testing. Price is unlikely to be a barrier if set at about US$ 1 per test. Further implementation research is required to assess uptake, yield, and linkage to care on a larger scale.	[Mugo, Peter M.; Micheni, Murugi; Shangala, Jimmy; Graham, Susan M.; Sanders, Eduard J.] Kemri Wellcome Trust Res Programme, Kilifi, Kenya; [Hussein, Mohamed H.] Minist Hlth, Mombasa, Kenya; [Graham, Susan M.] Univ Washington, Seattle, WA 98195 USA; [de Wit, Tobias F. Rinke; Sanders, Eduard J.] Univ Amsterdam, Amsterdam, Netherlands; [Sanders, Eduard J.] Univ Oxford, Headington, England	University of Washington; University of Washington Seattle; University of Amsterdam; University of Oxford	Mugo, PM (corresponding author), Kemri Wellcome Trust Res Programme, Kilifi, Kenya.	PMugo@kemri-wellcome.org		Mugo, Bernard/0000-0002-6373-1893	Wellcome Trust [077092]; NIH [1R34MH099946-01]; University of Washington Center for AIDS Research (CFAR); American people through the United States Agency for International Development (USAID); NATIONAL INSTITUTE OF MENTAL HEALTH [R34MH099946] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Center for AIDS Research (CFAR); American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the International AIDS Vaccine Initiative (IAVI) for funding this study. IAVIs work is made possible by generous support from many donors, www.iavi.org. The KWTRP at the Centre for Geographical Medicine Research-Kilifi is supported by core funding from the Wellcome Trust (#077092). SMG was supported by NIH grant 1R34MH099946-01 and the University of Washington Center for AIDS Research (CFAR). This study is made possible by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of the study authors and do not necessarily reflect the views of USAID, the NIH, or the United States Government. This report was published with permission from KEMRI.	Abuya TO, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-57; [Anonymous], 2016, DAILY NATION NEWSPAP; [Anonymous], 2015, KENY GUID HIV TEST S; Bigogo G, 2010, INT J INFECT DIS, V14, pE967, DOI 10.1016/j.ijid.2010.05.016; Calderon Y, 2013, AIDS PATIENT CARE ST, V27, P467, DOI 10.1089/apc.2013.0076; Cohen MS, 2013, LANCET, V382, P1515, DOI 10.1016/S0140-6736(13)61998-4; Cummings P, 2009, STATA J, V9, P175, DOI 10.1177/1536867X0900900201; Darin KM, 2015, J AM PHARM ASSOC, V55, P81, DOI 10.1331/JAPhA.2015.14070; Darin KM, 2015, J AM PHARM ASSOC, V55, P67, DOI 10.1331/JAPhA.2015.14069; Deas C, 2010, J AM PHARM ASSOC, V50, P411, DOI 10.1331/JAPhA.2010.09039; Gichangi A., 2016, 21 INT AIDS C DURB S; Government of Kenya, 2015, KENY DEM HLTH SURV 2; Heard AC, 2016, AIDS CARE, V28, P1528, DOI 10.1080/09540121.2016.1191602; IGUN UA, 1987, SOC SCI MED, V24, P689, DOI 10.1016/0277-9536(87)90312-1; Kenya Pharmaceutical Association, 2016, PHARMN; Kurth A, 2014, ACCURACY ORAL HIV SE; Msiska R, 1997, HEALTH POLICY PLANN, V12, P248, DOI 10.1093/heapol/12.3.248; Mugo PM, 2015, SEX TRANSM INFECT, V91, P257, DOI 10.1136/sextrans-2014-051751; Mugo PM, 2013, SEX TRANSM INFECT, V89, P583, DOI 10.1136/sextrans-2012-050979; National AIDS and STI Control Programme (NASCOP),, 2014, KENY AIDS IND SURV 2; National Aids and STI Control Programme (NASCOP) Ministry of Health, 2010, KENY NAT GUID HIV TE; Ng'ang'a A, 2014, JAIDS-J ACQ IMM DEF, V66, pS27, DOI 10.1097/QAI.0000000000000102; Ngure K, 2014, AIDS RES HUM RETROV, V30, pA70, DOI 10.1089/aid.2014.5128.abstract; Ochako R, 2014, INSIGHTS POTENTIAL U; Onwujekwe O, 2011, TROP MED INT HEALTH, V16, P1087, DOI 10.1111/j.1365-3156.2011.02821.x; Oqua D, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-525; Pharmaceutical Society of Kenya, 2016, GREEN CROSS; Reniers G, 2011, AIDS BEHAV, V15, P1, DOI 10.1007/s10461-010-9774-0; Rosenberg NE, 2013, JAIDS-J ACQ IMM DEF, V62, P226, DOI 10.1097/QAI.0b013e31827971ca; Ryder PT, 2013, J AM PHARM ASSOC, V53, P595, DOI 10.1331/JAPhA.2013.12240; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Stergachis A, 2014, J AM PHARM ASSOC, V54, P476, DOI 10.1331/JAPhA.2014.14539; Thirumurthy H, 2016, LANCET HIV; Viberg N, 2007, PHARM WORLD SCI, V29, P25, DOI 10.1007/s11096-005-4801-3; Wafula FN, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-223; Weidle PJ, 2014, J AM PHARM ASSOC, V54, P486, DOI 10.1331/JAPhA.2014.14045; Wood BR, 2014, HIV AIDS-RES PALLIAT, V6, P117, DOI 10.2147/HIV.S49083	37	56	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170868	10.1371/journal.pone.0170868	http://dx.doi.org/10.1371/journal.pone.0170868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7IT	28125699	Green Published, gold, Green Submitted			2022-12-27	WOS:000396176100034
J	Patel, B; Ismahil, MA; Hamid, T; Bansal, SS; Prabhu, SD				Patel, Bindiya; Ismahil, Mohamed Ameen; Hamid, Tariq; Bansal, Shyam S.; Prabhu, Sumanth D.			Mononuclear Phagocytes Are Dispensable for Cardiac Remodeling in Established Pressure-Overload Heart Failure	PLOS ONE			English	Article							GENE-EXPRESSION; DENDRITIC CELLS; STEADY-STATE; MACROPHAGES; MONOCYTES; IDENTIFICATION; INFLAMMATION; HYPERTROPHY; DYSFUNCTION; DIVERGENT	Background Although cardiac and splenic mononuclear phagocytes (MPs), i.e., monocytes, macrophages and dendritic cells (DCs), are key contributors to cardiac remodeling after myocardial infarction, their role in pressure-overload remodeling is unclear. We tested the hypothesis that these immune cells are required for the progression of remodeling in pressure-overload heart failure (HF), and that MP depletion would ameliorate remodeling. Methods and Results C57BL/6 mice were subjected to transverse aortic constriction (TAC) or sham operation, and assessed for alterations in MPs. As compared with sham, TAC mice exhibited expansion of circulating LyC6(hi) monocytes and pro-inflammatory CD206(-) cardiac macrophages early (1 w) after pressure-overload, prior to significant hypertrophy and systolic dysfunction, with subsequent resolution during chronic HF. In contrast, classical DCs were expanded in the heart in a biphasic manner, with peaks both early, analogous to macrophages, and late (8 w), during established HF. There was no significant expansion of circulating DCs, or Ly6C(+) monocytes and DCs in the spleen. Periodic systemic MP depletion from 2 to 16 w after TAC in macrophage Fas-induced apoptosis (MaFIA) transgenic mice did not alter cardiac remodeling progression, nor did splenectomy in mice with established HF after TAC. Lastly, adoptive transfer of splenocytes from TAC HF mice into naive recipients did not induce immediate or long-term cardiac dysfunction in recipient mice. Conclusions Mononuclear phagocytes populations expand in a phasic manner in the heart during pressure-overload. However, they are dispensable for the progression of remodeling and failure once significant hypertrophy is evident and blood monocytosis has normalized.	[Patel, Bindiya; Ismahil, Mohamed Ameen; Hamid, Tariq; Bansal, Shyam S.; Prabhu, Sumanth D.] Univ Alabama Birmingham, Div Cardiovasc Dis, Birmingham, AL 35294 USA; [Patel, Bindiya; Ismahil, Mohamed Ameen; Hamid, Tariq; Bansal, Shyam S.; Prabhu, Sumanth D.] Univ Alabama Birmingham, Comprehens Cardiovasc Ctr, Birmingham, AL 35233 USA; [Prabhu, Sumanth D.] Birmingham VA Med Ctr, Med Serv, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Prabhu, SD (corresponding author), Univ Alabama Birmingham, Div Cardiovasc Dis, Birmingham, AL 35294 USA.; Prabhu, SD (corresponding author), Univ Alabama Birmingham, Comprehens Cardiovasc Ctr, Birmingham, AL 35233 USA.; Prabhu, SD (corresponding author), Birmingham VA Med Ctr, Med Serv, Birmingham, AL 35233 USA.	sprabhu@uab.edu		Hamid, Tariq/0000-0002-4588-3754	National Institutes of Health [1R01HL125735]; VA Merit Award [I01BX002706]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125735] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002706] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health grant 1R01HL125735 and a VA Merit Award I01BX002706 (both to SDP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzai A, 2012, CIRCULATION, V125, P1234, DOI 10.1161/CIRCULATIONAHA.111.052126; Arnold CE, 2015, IMMUNOBIOLOGY, V220, P10, DOI 10.1016/j.imbio.2014.09.022; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Burnett SH, 2004, J LEUKOCYTE BIOL, V75, P612, DOI 10.1189/jlb.0903442; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ghassabeh GH, 2006, BLOOD, V108, P575, DOI 10.1182/blood-2005-04-1485; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hamid T, 2009, CIRCULATION, V119, P1386, DOI 10.1161/CIRCULATIONAHA.108.802918; Heidt T, 2014, CIRC RES, V115, P284, DOI 10.1161/CIRCRESAHA.115.303567; Heymans S, 2005, CIRCULATION, V112, P1136, DOI 10.1161/CIRCULATIONAHA.104.516963; Houser SR, 2012, CIRC RES, V111, P131, DOI 10.1161/RES.0b013e3182582523; Ismahil MA, 2014, CIRC RES, V114, P266, DOI 10.1161/CIRCRESAHA.113.301720; Kanellakis P, 2012, CARDIOVASC RES, V95, P77, DOI 10.1093/cvr/cvs142; Kushwah R, 2011, IMMUNOLOGY, V133, P409, DOI 10.1111/j.1365-2567.2011.03457.x; Laroumanie F, 2014, CIRCULATION, V129, P2111, DOI 10.1161/CIRCULATIONAHA.113.007101; Lavine KJ, 2014, P NATL ACAD SCI USA, V111, P16029, DOI 10.1073/pnas.1406508111; Li C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110950; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nevers T, 2015, CIRC-HEART FAIL, V8, P776, DOI 10.1161/CIRCHEARTFAILURE.115.002225; Pelayo R, 2005, BLOOD, V105, P4407, DOI 10.1182/blood-2004-07-2529; Pinto AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043093; Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577; Sansbury BE, 2014, CIRC-HEART FAIL, V7, P634, DOI 10.1161/CIRCHEARTFAILURE.114.001151; Schilling JD, 2012, AM J PHYSIOL-HEART C, V303, pH1366, DOI 10.1152/ajpheart.00111.2012; Seifert HA, 2012, J NEUROIMMUNE PHARM, V7, P1017, DOI 10.1007/s11481-012-9406-8; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Sun M, 2007, CIRCULATION, V115, P1398, DOI 10.1161/CIRCULATIONAHA.106.643585; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Taegtmeyer H, 2010, ANN NY ACAD SCI, V1188, P191, DOI 10.1111/j.1749-6632.2009.05100.x; Usher MG, 2010, J CLIN INVEST, V120, P3350, DOI 10.1172/JCI41080; van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547; Vanderheyden M, 2005, HEART, V91, P926, DOI 10.1136/hrt.2004.035733; Wang G, 2010, ADV INTEL SYS RES, V12, P1; Weisheit C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112710; Xia Y, 2009, HISTOCHEM CELL BIOL, V131, P471, DOI 10.1007/s00418-008-0541-5; Zhao L, 2016, CIRC RES, V118, P1918, DOI 10.1161/CIRCRESAHA.116.308688	37	39	40	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170781	10.1371/journal.pone.0170781	http://dx.doi.org/10.1371/journal.pone.0170781			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125666	Green Published, gold, Green Submitted			2022-12-27	WOS:000396176100052
J	Totzeck, F; Andrade-Navarro, MA; Mier, P				Totzeck, Franziska; Andrade-Navarro, Miguel A.; Mier, Pablo			The Protein Structure Context of PolyQ Regions	PLOS ONE			English	Article							POLYGLUTAMINE AGGREGATION; COILED COILS; HUNTINGTIN; LENGTH; CONFORMATION; EVOLUTION; TOXICITY; REPEATS; DOMAIN	Proteins containing glutamine repeats (polyQ) are known to be structurally unstable. Abnormal expansion of polyQ in some proteins exceeding a certain threshold leads to neurode-generative disease, a symptom of which are protein aggregates. This has led to extensive research of the structure of polyQ stretches. However, the accumulation of contradictory results suggests that protein context might be of importance. Here we aimed to evaluate the structural context of polyQ regions in proteins by analysing the secondary structure of polyQ proteins and their homologs. The results revealed that the secondary structure in polyQ vicinity is predominantly random coil or helix. Importantly, the regions surrounding the polyQ are often not solved in 3D structures. In the few cases where the point of insertion of the polyQ was mapped to a full protein, we observed that these are always located in the surface of the protein. The findings support the hypothesis that polyQ might serve to extend coiled coils at their C-terminus in highly disordered regions involved in protein-protein interactions.	[Totzeck, Franziska; Andrade-Navarro, Miguel A.; Mier, Pablo] Johannes Gutenberg Univ Mainz, Fac Biol, Gresemundweg 2, Mainz, Germany; [Andrade-Navarro, Miguel A.; Mier, Pablo] Inst Mol Biol, Ackermannweg 4, Mainz, Germany	Johannes Gutenberg University of Mainz; Institute of Molecular Biology (IMB)	Mier, P (corresponding author), Johannes Gutenberg Univ Mainz, Fac Biol, Gresemundweg 2, Mainz, Germany.; Mier, P (corresponding author), Inst Mol Biol, Ackermannweg 4, Mainz, Germany.	munoz@uni-mainz.de	Mier, Pablo/P-8916-2019	Mier, Pablo/0000-0003-3663-2352	COST Association (Cost Action) [BM1405]	COST Association (Cost Action)	The authors thank all members of the CBDM group for helpful and constructive discussions. We gratefully acknowledge the support of the COST Association (Cost Action BM1405).	Albrecht M, 2004, EUR J BIOCHEM, V271, P3155, DOI 10.1111/j.1432-1033.2004.04245.x; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Chen S, 2001, J MOL BIOL, V311, P173, DOI 10.1006/jmbi.2001.4850; Davies P, 2008, J MOL ENDOCRINOL, V41, P301, DOI 10.1677/JME-08-0042; de Chiara C, 2005, J MOL BIOL, V354, P883, DOI 10.1016/j.jmb.2005.09.083; Faux NG, 2005, GENOME RES, V15, P537, DOI 10.1101/gr.3096505; Fiumara F, 2010, CELL, V143, P1121, DOI 10.1016/j.cell.2010.11.042; Hands S, 2008, BBA-GENE REGUL MECH, V1779, P507, DOI 10.1016/j.bbagrm.2008.05.008; Hands SL, 2010, ACTA NEUROPATHOL, V120, P419, DOI 10.1007/s00401-010-0703-0; Hildebrandt A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-531; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Klein FAC, 2007, J MOL BIOL, V371, P235, DOI 10.1016/j.jmb.2007.05.028; Kokona B, 2014, BIOCHEMISTRY-US, V53, P6738, DOI 10.1021/bi500449a; Kokona B, 2014, BIOCHEMISTRY-US, V53, P6747, DOI 10.1021/bi501066q; Masino L, 2004, PROTEIN PEPTIDE LETT, V11, P239, DOI 10.2174/0929866043407147; Mier P, 2016, J COMPUT BIOL, V23, P270, DOI 10.1089/cmb.2015.0191; Oma Y, 2007, PROTEIN SCI, V16, P2195, DOI 10.1110/ps.072955307; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Papaleo E, 2011, CURR COMPUT-AID DRUG, V7, P23, DOI 10.2174/157340911793743574; Pelassa I, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00345; Pelassa I, 2014, HUM MOL GENET, V23, P3402, DOI 10.1093/hmg/ddu049; Petrakis S, 2013, BIOESSAYS, V35, P503, DOI 10.1002/bies.201300001; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poirier MA, 2005, HUM MOL GENET, V14, P765, DOI 10.1093/hmg/ddi071; Robertson AL, 2008, BIOPHYS J, V95, P5922, DOI 10.1529/biophysj.108.138487; Ross CA, 2003, P NATL ACAD SCI USA, V100, P1, DOI 10.1073/pnas.0237018100; Ruff KM, 2014, BIOPHYS J, V107, P1226, DOI 10.1016/j.bpj.2014.07.019; Sahoo B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155747; Saunders HM, 2011, PROTEIN SCI, V20, P1675, DOI 10.1002/pro.698; Schaefer MH, 2012, NUCLEIC ACIDS RES, V40, P4273, DOI 10.1093/nar/gks011; Schulte Joost, 2011, Curr Trends Neurol, V5, P65; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Walters RH, 2009, J MOL BIOL, V393, P978, DOI 10.1016/j.jmb.2009.08.034; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	38	26	26	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170801	10.1371/journal.pone.0170801	http://dx.doi.org/10.1371/journal.pone.0170801			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125688	gold, Green Submitted, Green Published			2022-12-27	WOS:000396176100047
J	Valanejad, L; Nadolny, C; Shiffka, S; Chen, Y; You, SM; Deng, RT				Valanejad, Leila; Nadolny, Christina; Shiffka, Stephanie; Chen, Yuan; You, Sangmin; Deng, Ruitang			Differential Feedback Regulation of Delta(4)-3-Oxosteroid 5 beta-Reductase Expression by Bile Acids	PLOS ONE			English	Article							SALT EXPORT PUMP; CHOLESTEROL 7-ALPHA-HYDROXYLASE GENE; PRIMARY RAT HEPATOCYTES; FARNESOID-X-RECEPTOR; NUCLEAR RECEPTOR; STEROID-METABOLISM; LIVER-DISEASE; DELTA-4-3-KETOSTEROID 5-BETA-REDUCTASE; MESSENGER-RNA; INBORN ERROR	Delta(4)-3-oxosteroid 5 beta-reductase is member D1 of the aldo-keto reductase family 1 (AKR1D1), which catalyzes 5 beta-reduction of molecules with a 3-oxo-4-ene structure. Bile acid intermediates and most of the steroid hormones carry the 3-oxo-4-ene structure. Therefore, AKR1D1 plays critical roles in both bile acid synthesis and steroid hormone metabolism. Currently our understanding on transcriptional regulation of AKR1D1 under physiological and pathological conditions is very limited. In this study, we investigated the regulatory effects of primary bile acids, chenodeoxycholic acid (CDCA) and cholic acid (CA), on AKR1D1 expression. The expression levels of AKR1D1 mRNA and protein in vitro and in vivo following bile acid treatments were determined by real-time PCR and Western blotting. We found that CDCA markedly repressed AKR1D1 expression in vitro in human hepatoma HepG2 cells and in vivo in mice. On the contrary, CA significantly upregulated AKR1D1 expression in HepG2 cells and in mice. Further mechanistic investigations revealed that the farnesoid x receptor (FXR) signaling pathway was not involved in regulating AKR1D1 by bile acids. Instead, CDCA and CA regulated AKR1D1 through the mitogen-activated protein kinases/c-Jun N-terminal kinases (MAPK/JNK) signaling pathway. Inhibition of the MAPK/JNK pathway effectively abolished CDCA and CA-mediated regulation of AKR1D1. It was thus determined that AKR1D1 expression was regulated by CDCA and CA through modulating the MAPK/JNK signaling pathway. In conclusion, AKR1D1 expression was differentially regulated by primary bile acids through negative and positive feedback mechanisms. The findings indicated that both bile acid concentrations and compositions play important roles in regulating AKR1D1 expression, and consequently bile acid synthesis and steroid hormone metabolism.	[Valanejad, Leila; Nadolny, Christina; Shiffka, Stephanie; Chen, Yuan; You, Sangmin; Deng, Ruitang] Univ Rhode Isl, Coll Pharm, Dept Biomed & Pharmaceut Sci, Ctr Pharmacogen & Mol Therapy, Kingston, RI 02881 USA	University of Rhode Island	Deng, RT (corresponding author), Univ Rhode Isl, Coll Pharm, Dept Biomed & Pharmaceut Sci, Ctr Pharmacogen & Mol Therapy, Kingston, RI 02881 USA.	dengr@uri.edu	CHEN, YUAN/AAD-6189-2022; Chen, Yuan/AAD-7053-2022	Chen, Yuan/0000-0001-8676-0913	National Institutes of Health [R01DK087755]; American Foundation for Pharmaceutical Education; Institutional Development Award (IDeA) from the National Institutes of General Medical Sciences of the National Institutes of Health [P20 GM103430-13]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Foundation for Pharmaceutical Education; Institutional Development Award (IDeA) from the National Institutes of General Medical Sciences of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grant R01DK087755 (RD). CN is partially supported by the pre-doctoral fellowship from American Foundation for Pharmaceutical Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Institutes of Health Grant R01DK087755. C.N. is partially supported by the pre-doctoral fellowship from American Foundation for Pharmaceutical Education. We thank Dr. Bingfang Yan, University of Rhode Island, for sharing instruments and reagents in his laboratory with us. Instrumental supports from the RI-INBRE Core Facility in the College of Pharmacy, University of Rhode Island are greatly appreciated, which is supported by an Institutional Development Award (IDeA) from the National Institutes of General Medical Sciences of the National Institutes of Health under grant P20 GM103430-13.	Allen K, 2010, TOXICOL APPL PHARM, V243, P63, DOI 10.1016/j.taap.2009.11.013; Ananthanarayanan M, 2001, J BIOL CHEM, V276, P28857, DOI 10.1074/jbc.M011610200; Azer SA, 1996, J GASTROEN HEPATOL, V11, P208, DOI 10.1111/j.1440-1746.1996.tb00064.x; Bauman DR, 2004, DRUG NEWS PERSPECT, V17, P563, DOI 10.1358/dnp.2004.17.9.872570; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Centuori SM, 2014, DIGEST DIS SCI, V59, P2367, DOI 10.1007/s10620-014-3190-7; Chen M, 2014, STEROIDS, V83, P17, DOI 10.1016/j.steroids.2014.01.013; Chen Y, 2015, MOL ENDOCRINOL, V29, P613, DOI 10.1210/me.2015-1014; Chen Y, 2013, HEPATOLOGY, V57, P1530, DOI 10.1002/hep.26187; CLAYTON PT, 1988, LANCET, V1, P1283; DAUGHERTY CC, 1993, HEPATOLOGY, V18, P1096, DOI 10.1016/0270-9139(93)90463-W; De Fabiani E, 2001, J BIOL CHEM, V276, P30708, DOI 10.1074/jbc.M103270200; Deng RT, 2006, J PHARMACOL EXP THER, V317, P317, DOI 10.1124/jpet.105.097758; Deng RT, 2007, J PHARMACOL EXP THER, V320, P1153, DOI 10.1124/jpet.106.113837; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Gupta S, 2001, J BIOL CHEM, V276, P15816, DOI 10.1074/jbc.M010878200; Haeusler RA, 2013, DIABETES, V62, P4184, DOI 10.2337/db13-0639; Houten SM, 2006, EMBO J, V25, P1419, DOI 10.1038/sj.emboj.7601049; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Jin Y, 2014, BIOCHEM J, V462, P163, DOI 10.1042/BJ20140220; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; KONDO KH, 1994, EUR J BIOCHEM, V219, P357, DOI 10.1111/j.1432-1033.1994.tb19947.x; Kullak-Ublick GA, 2004, GASTROENTEROLOGY, V126, P322, DOI 10.1053/j.gastro.2003.06.005; LEISS O, 1984, GASTROENTEROLOGY, V87, P144; Lemonde HA, 2003, GUT, V52, P1494, DOI 10.1136/gut.52.10.1494; Li TG, 2006, HEPATOLOGY, V43, P1202, DOI 10.1002/hep.21183; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; McNeilly AD, 2010, J HEPATOL, V52, P705, DOI 10.1016/j.jhep.2009.10.037; Meier PJ, 2002, ANNU REV PHYSIOL, V64, P635, DOI 10.1146/annurev.physiol.64.082201.100300; Nakahara M, 2002, J BIOL CHEM, V277, P37229, DOI 10.1074/jbc.M206749200; OKUDA A, 1984, J BIOL CHEM, V259, P7519; OKUDA H, 1984, HEPATO-GASTROENTEROL, V31, P168; ONISHI Y, 1991, FEBS LETT, V283, P215, DOI 10.1016/0014-5793(91)80591-P; Palermo M, 2008, STEROIDS, V73, P417, DOI 10.1016/j.steroids.2007.12.001; Pandak WM, 2001, GASTROENTEROLOGY, V120, P1801, DOI 10.1053/gast.2001.24833; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Plass JRM, 2002, HEPATOLOGY, V35, P589, DOI 10.1053/jhep.2002.31724; PONZDELEON M, 1978, AM J DIG DIS, V23, P710, DOI 10.1007/BF01072357; PONZDELEON M, 1979, GASTROENTEROLOGY, V77, P223; Rao YP, 2002, HEPATOLOGY, V35, P307, DOI 10.1053/jhep.2002.31104; REYNIER MO, 1981, J LIPID RES, V22, P467; Rizner TL, 2014, STEROIDS, V79, P49, DOI 10.1016/j.steroids.2013.10.012; Rosales R, 2013, BIOCHEM PHARMACOL, V85, P829, DOI 10.1016/j.bcp.2013.01.001; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; SETCHELL KDR, 1988, J CLIN INVEST, V82, P2148, DOI 10.1172/JCI113837; SHNEIDER BL, 1994, J PEDIATR-US, V124, P234, DOI 10.1016/S0022-3476(94)70310-8; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Song KH, 2009, HEPATOLOGY, V49, P297, DOI 10.1002/hep.22627; Song XL, 2008, J LIPID RES, V49, P973, DOI 10.1194/jlr.M700417-JLR200; Song XL, 2014, HEPATOLOGY, V60, P1993, DOI 10.1002/hep.27171; Song XL, 2013, J LIPID RES, V54, P3030, DOI 10.1194/jlr.M038323; Talukdar S, 2007, J LIPID RES, V48, P2647, DOI 10.1194/jlr.M700189-JLR200; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Vlahcevic ZR, 2000, GASTROENTEROLOGY, V118, P599, DOI 10.1016/S0016-5085(00)70267-8; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Woollett LA, 2004, GASTROENTEROLOGY, V126, P724, DOI 10.1053/j.gastro.2003.11.058; Yashiro T, 2011, BIOCHEM BIOPH RES CO, V409, P155, DOI 10.1016/j.bbrc.2011.04.006	58	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170960	10.1371/journal.pone.0170960	http://dx.doi.org/10.1371/journal.pone.0170960			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125709	Green Published, Green Submitted, gold			2022-12-27	WOS:000396176100014
J	Yotova, I; Hsu, E; Do, C; Gaba, A; Sczabolcs, M; Dekan, S; Kenner, L; Wenzl, R; Tycko, B				Yotova, Iveta; Hsu, Emily; Do, Catherine; Gaba, Aulona; Sczabolcs, Matthias; Dekan, Sabine; Kenner, Lukas; Wenzl, Rene; Tycko, Benjamin			Epigenetic Alterations Affecting Transcription Factors and Signaling Pathways in Stromal Cells of Endometriosis	PLOS ONE			English	Article							STEROIDOGENIC-FACTOR-I; EPITHELIAL-MESENCHYMAL TRANSITION; DNA METHYLATION; EUTOPIC ENDOMETRIUM; NEUROTROPHIC FACTOR; GENE; EXPRESSION; RECEPTOR; KINASE; GROWTH	Endometriosis is characterized by growth of endometrial-like tissue outside the uterine cavity. Since its pathogenesis may involve epigenetic changes, we used Illumina 450K Methylation Beadchips to profile CpG methylation in endometriosis stromal cells compared to stromal cells from normal endometrium. We validated and extended the Beadchip data using bisulfite sequencing (bis-seq), and analyzed differential methylation (DM) at the CpG-level and by an element-level classification for groups of CpGs in chromatin domains. Genes found to have DM included examples encoding transporters (SLC22A23), signaling components (BDNF, DAPK1, ROR1, and WNT5A) and transcription factors (GATA family, HAND2, HOXA cluster, NR5A1, OSR2, TBX3). Intriguingly, among the TF genes with DM we also found JAZF1, a proto-oncogene affected by chromosomal translocations in endometrial stromal tumors. Using RNA-Seq we identified a subset of the DM genes showing differential expression (DE), with the likelihood of DE increasing with the extent of the DM and its location in enhancer elements. Supporting functional relevance, treatment of stromal cells with the hypomethylating drug 5aza-dC led to activation of DAPK1 and SLC22A23 and repression of HAND2, JAZF1, OSR2, and ROR1 mRNA expression. We found that global 5hmC is decreased in endometriotic versus normal epithelial but not stroma cells, and for JAZF1 and BDNF examined by oxidative bis-seq, found that when 5hmC is detected, patterns of 5hmC paralleled those of 5mC. Together with prior studies, these results define a consistent epigenetic signature in endometriosis stromal cells and nominate specific transcriptional and signaling pathways as therapeutic targets.	[Yotova, Iveta; Hsu, Emily; Do, Catherine; Tycko, Benjamin] Columbia Univ, Med Ctr, Inst Canc Genet, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Yotova, Iveta; Gaba, Aulona; Wenzl, Rene] Med Univ Vienna, Univ Clin Obstet & Gynecol, Dept Gynecol & Gynecol Oncol, Vienna, Austria; [Sczabolcs, Matthias; Tycko, Benjamin] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, Dept Pathol & Cell Biol, New York, NY USA; [Dekan, Sabine; Kenner, Lukas] Med Univ Vienna, Univ Clin Obstet & Gynecol, Dept Expt Pathol, Clin Inst Pathol, Vienna, Austria; [Kenner, Lukas] Univ Vet Med Vienna, Pathol Lab Anim Pathol, Vienna, Austria; [Kenner, Lukas] Ludwig Boltzmann Inst Canc Res, Vienna, Austria	Columbia University; Medical University of Vienna; Columbia University; Medical University of Vienna; University of Veterinary Medicine Vienna; Ludwig Boltzmann Institute	Yotova, I (corresponding author), Columbia Univ, Med Ctr, Inst Canc Genet, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA.; Yotova, I (corresponding author), Med Univ Vienna, Univ Clin Obstet & Gynecol, Dept Gynecol & Gynecol Oncol, Vienna, Austria.	iveta.yotova@meduniwien.ac.at	Gaba, Aulona/R-2633-2019; Gaba, Aulona/Q-7871-2018	Gaba, Aulona/0000-0003-1305-764X; Gaba, Aulona/0000-0003-1305-764X; Yotova, Iveta/0000-0003-1810-4951; Kenner, Lukas/0000-0003-2184-1338; do, catherine/0000-0002-9796-4345	Schaefer Scholar Award at Columbia University of New York; NIH [U54 CA163111]; Department of Obstetrics and Gynecology, Medical University of Vienna	Schaefer Scholar Award at Columbia University of New York; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Obstetrics and Gynecology, Medical University of Vienna	This work was supported by a grant from Schaefer Scholar Award at Columbia University of New York, to IY and BT, NIH grant to BT (U54 CA163111) and by institutional support to IY, AG and RW from Department of Obstetrics and Gynecology, Medical University of Vienna.	Ace Christopher I, 2004, Reprod Biol Endocrinol, V2, P54, DOI 10.1186/1477-7827-2-54; Achermann JC, 1999, NAT GENET, V22, P125, DOI 10.1038/9629; Aghajanova L, 2010, SEMIN REPROD MED, V28, P51, DOI 10.1055/s-0029-1242994; Ahn SH, 2015, J IMMUNOL, V195, P2591, DOI 10.4049/jimmunol.1501138; Aran D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r21; Borghese B, 2010, MOL ENDOCRINOL, V24, P1872, DOI 10.1210/me.2010-0160; Browne AS, 2012, FERTIL STERIL, V98, P713, DOI 10.1016/j.fertnstert.2012.05.027; Bulun SE, 2009, MOL CELL ENDOCRINOL, V300, P104, DOI 10.1016/j.mce.2008.12.012; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Burney RO, 2012, FERTIL STERIL, V98, P511, DOI 10.1016/j.fertnstert.2012.06.029; Capo-Chichi CD, 2003, CANCER RES, V63, P4967; Chuang M, 2014, APOPTOSIS, V19, P392, DOI 10.1007/s10495-013-0943-2; Cloke B, 2008, ENDOCRINOLOGY, V149, P4462, DOI 10.1210/en.2008-0356; Conklin CMJ, 2014, ADV ANAT PATHOL, V21, P383, DOI 10.1097/PAP.0000000000000046; Crispi S, 2013, J CELL PHYSIOL, V228, P1927, DOI 10.1002/jcp.24358; Cui B, 2013, CANCER RES, V73, P3649, DOI 10.1158/0008-5472.CAN-12-3832; de Arellano MLB, 2011, REPROD SCI, V18, P1202, DOI 10.1177/1933719111410711; DEISS LP, 1995, GENE DEV, V9, P15, DOI 10.1101/gad.9.1.15; Do C, 2016, AM J HUM GENET, V98, P934, DOI 10.1016/j.ajhg.2016.03.027; Du H, 2015, COLD SPRING HARB PER, V6; Dyson MT, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004158; Eggers S, 2012, CHROMOSOME RES, V20, P215, DOI 10.1007/s10577-012-9274-3; Ernfors P, 1995, INT J DEV BIOL, V39, P799; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Gizard F, 2005, MOL CELL BIOL, V25, P4335, DOI 10.1128/MCB.25.11.4335-4348.2005; Gizard F, 2006, MOL CELL BIOL, V26, P7632, DOI 10.1128/MCB.00326-06; Grum-Schwensen B, 2005, CANCER RES, V65, P3772, DOI 10.1158/0008-5472.CAN-04-4510; Haffner MC, 2011, ONCOTARGET, V2, P627; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hevir N, 2013, MOL CELL ENDOCRINOL, V367, P74, DOI 10.1016/j.mce.2012.12.019; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; Hoivik EA, 2010, MOL CELL ENDOCRINOL, V315, P27, DOI 10.1016/j.mce.2009.07.003; Houshdaran S, 2016, BIOL REPROD, DOI [10.1371/journal.pone.0083612, DOI 10.1371/JOURNAL.PONE.0083612]; HSIEHLI HM, 1995, DEVELOPMENT, V121, P1373; Hu MH, 2013, J SURG ONCOL, V108, P192, DOI 10.1002/jso.23367; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hudelist G, 2005, HUM REPROD, V20, P1695, DOI 10.1093/humrep/deh794; Huyen DV, 2011, REPRODUCTION, V142, P353, DOI 10.1530/REP-11-0060; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Ito K, 2009, AM J PATHOL, V175, P2508, DOI 10.2353/ajpath.2009.090347; Izawa M, 2008, FERTIL STERIL, V89, P1390, DOI 10.1016/j.fertnstert.2007.03.078; Jones A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001551; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kiewisz J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/854056; Kobayashi H, 2014, MOL MED REP, V9, P1483, DOI 10.3892/mmr.2014.2057; Koontz JI, 2001, P NATL ACAD SCI USA, V98, P6348, DOI 10.1073/pnas.101132598; Krizsan-Agbas D, 2003, EUR J NEUROSCI, V18, P2760, DOI 10.1111/j.1460-9568.2003.03029.x; Kyama Cleophas M, 2003, Reprod Biol Endocrinol, V1, P123, DOI 10.1186/1477-7827-1-123; Lan Y, 2004, DEVELOPMENT, V131, P3207, DOI 10.1242/dev.01175; Li H, 2008, SCIENCE, V321, P1357, DOI 10.1126/science.1156725; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li QL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002320; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuoka A, 2010, J CLIN ENDOCR METAB, V95, pE291, DOI 10.1210/jc.2010-0619; Mendioroz M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0827-6; Michie AM, 2010, FEBS J, V277, P74, DOI 10.1111/j.1742-4658.2009.07414.x; Minami Y, 2010, DEV DYNAM, V239, P1, DOI 10.1002/dvdy.21991; Ming GF, 2014, BIOCHEM BIOPH RES CO, V445, P673, DOI 10.1016/j.bbrc.2014.02.088; Monsivais D, 2014, MOL ENDOCRINOL, V28, P1304, DOI 10.1210/me.2013-1421; Monsivais D, 2016, FERTIL STERIL, V105, P1266, DOI 10.1016/j.fertnstert.2016.01.012; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Naqvi H, 2014, REPROD SCI, V21, P1237, DOI 10.1177/1933719114532841; Nassif J, 2013, Minerva Ginecol, V65, P167; Nasu K, 2011, J OBSTET GYNAECOL RE, V37, P683, DOI 10.1111/j.1447-0756.2011.01663.x; Omwandho COA, 2010, HUM REPROD, V25, P101, DOI 10.1093/humrep/dep382; Page A, 2016, J HEPATOL, V64, P661, DOI 10.1016/j.jhep.2015.11.024; Podlasek CA, 1999, DEV DYNAM, V214, P1, DOI 10.1002/(SICI)1097-0177(199901)214:1<1::AID-DVDY1>3.0.CO;2-2; Saare M, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-015-0168-z; Salker MS, 2011, NAT MED, V17, P1509, DOI 10.1038/nm.2498; Shakya R, 2013, CANCER RES, V73, P885, DOI 10.1158/0008-5472.CAN-12-1880; Spitzer TLB, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095885; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tabibzadeh S, 1996, MOL HUM REPROD, V2, P77, DOI 10.1093/molehr/2.2.77; Tang YX, 2009, BLOOD, V113, P744, DOI 10.1182/blood-2008-03-145219; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tulac S, 2006, J CLIN ENDOCR METAB, V91, P1453, DOI 10.1210/jc.2005-0769; Wang DB, 2012, EUR J MED RES, V17, DOI 10.1186/2047-783X-17-12; Wijetunga NA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6195; Xie R, 2009, LAB INVEST, V89, P937, DOI 10.1038/labinvest.2009.52; Xue Q, 2007, BIOL REPROD, V77, P681, DOI 10.1095/biolreprod.107.061804; Xue Q, 2007, J CLIN ENDOCR METAB, V92, P3261, DOI 10.1210/jc.2007-0494; Yamagata Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083612; Yamaguchi T, 2012, CANCER CELL, V21, P348, DOI 10.1016/j.ccr.2012.02.008; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yotova IY, 2011, HUM REPROD, V26, P885, DOI 10.1093/humrep/der010; Yuan L, 2002, DEVELOPMENT, V129, P4797; Zhang QY, 2012, HUM REPROD, V27, P1668, DOI 10.1093/humrep/des094; Zhang S, 2012, AM J PATHOL, V181, P937, DOI 10.1016/j.ajpath.2012.05.035; Zhang SM, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/761637; Zhao ZZ, 2011, MOL HUM REPROD, V17, P92, DOI 10.1093/molehr/gaq084; Zoubina EV, 2001, NEUROSCIENCE, V103, P237, DOI 10.1016/S0306-4522(00)00549-2	95	32	34	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170859	10.1371/journal.pone.0170859	http://dx.doi.org/10.1371/journal.pone.0170859			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125717	Green Published, gold, Green Submitted			2022-12-27	WOS:000396176100035
J	Pellegrini, GG; Cregor, M; McAndrews, K; Morales, CC; McCabe, LD; McCabe, GP; Peacock, M; Burr, D; Weaver, C; Bellido, T				Pellegrini, Gretel Gisela; Cregor, Meloney; McAndrews, Kevin; Morales, Cynthya Carolina; McCabe, Linda Doyle; McCabe, George P.; Peacock, Munro; Burr, David; Weaver, Connie; Bellido, Teresita			Nrf2 regulates mass accrual and the antioxidant endogenous response in bone differently depending on the sex and age	PLOS ONE			English	Article							OXIDATIVE STRESS; OSTEOBLASTIC DIFFERENTIATION; ACTIVATION; DEFENSE; OSTEOCLASTOGENESIS; 17-BETA-ESTRADIOL; MECHANISMS; EXPRESSION; INDUCERS; PATHWAY	Accumulation of reactive oxygen species (ROS) is an important pathogenic mechanism underling the loss of bone mass and strength with aging and other conditions leading to osteoporosis. The transcription factor erythroid 2-related factor2 (Nrf2) plays a central role in activating the cellular response to ROS. Here, we examined the endogenous response of bone regulated by Nrf2, and its relationship with bone mass and architecture in the male and female murine skeleton. Young (3 month-old) and old (15 month-old) Nrf2 knockout (KO) mice of either sex exhibited the expected reduction in Nrf2 mRNA expression compared to wild type (WT) littermates. Nrf2 deletion did not lead to compensatory increase in Nrf1 or Nrf3, other members of this transcription factor family; and instead, Nrf1 expression was lower in KO mice. Compared to the respective WT littermate controls, female KO mice, young and old, exhibited lower expression of both detoxifying and antioxidant enzymes; young male KO mice, displayed lower expression of detoxifying enzymes but not antioxidant enzymes; and old male KO mice showed no differences in either detoxifying or antioxidant enzymes. Moreover, old male WT mice exhibited lower Nrf2 levels, and consequently lower expression of both detoxifying and antioxidant enzymes, compared to old female WT mice. These endogenous antioxidant responses lead to delayed rate of bone acquisition in female KO mice and higher bone acquisition in male KO mice as quantified by DXA and mu CT, demonstrating that Nrf2 is required for full bone accrual in the female skeleton but unnecessary and even detrimental in the male skeleton. Therefore, Nrf2 regulates the antioxidant endogenous response and bone accrual differently depending on sex and age. These findings suggest that therapeutic interventions that target Nrf2 could be developed to enhance the endogenous antioxidant response in a sex-and age-selective manner.	[Pellegrini, Gretel Gisela; Cregor, Meloney; McAndrews, Kevin; Morales, Cynthya Carolina; Burr, David; Bellido, Teresita] Indiana Univ Purdue Univ, Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [McCabe, Linda Doyle; McCabe, George P.] Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA; [Peacock, Munro; Bellido, Teresita] Indiana Univ Purdue Univ, Sch Med, Dept Med, Div Endocrinol, Indianapolis, IN 46202 USA; [Weaver, Connie] Purdue Univ, Dept Nutr Sci, W Lafayette, IN 47907 USA; [Bellido, Teresita] Richard L Roudebush Vet Adm Med Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University-Purdue University Indianapolis; Purdue University System; Purdue University; Purdue University West Lafayette Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Bellido, T (corresponding author), Indiana Univ Purdue Univ, Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA.	tbellido@iupui.edu			National Institutes of Health NIH-NCCAM [R01-AT008754, AT008754-02S1]; Veterans Administration [1 I01 BX002104-01]; Indiana Clinical and Translational Sciences Institute (CTSI)	National Institutes of Health NIH-NCCAM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Veterans Administration(US Department of Veterans Affairs); Indiana Clinical and Translational Sciences Institute (CTSI)	This research was supported by the National Institutes of Health NIH-NCCAM (R01-AT008754 and AT008754-02S1), the Veterans Administration (1 I01 BX002104-01 to TB), and the Indiana Clinical and Translational Sciences Institute (CTSI).	Aleksunes LM, 2010, J PHARMACOL EXP THER, V333, P140, DOI 10.1124/jpet.109.162271; Almeida M, 2010, MOL ENDOCRINOL; Almeida M, 2007, J BIOL CHEM, V282, P27285, DOI 10.1074/jbc.M702810200; Almeida M, 2011, J BIOL CHEM, V286, P44326, DOI 10.1074/jbc.M111.283481; Ambrogini E, 2010, CELL METAB, V11, P136, DOI 10.1016/j.cmet.2009.12.009; Arai M, 2007, IUBMB LIFE, V59, P27, DOI 10.1080/15216540601156188; Bai XC, 2005, J BIOL CHEM, V280, P17497, DOI 10.1074/jbc.M409332200; Bai XC, 2004, BIOCHEM BIOPH RES CO, V314, P197, DOI 10.1016/j.bbrc.2003.12.073; Bartell SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4773; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Callaway DA, 2015, J BONE MINER METAB, V33, P359, DOI 10.1007/s00774-015-0656-4; Chan KM, 1999, P NATL ACAD SCI USA, V96, P12731, DOI 10.1073/pnas.96.22.12731; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chen CS, 2013, NEUROENDOCRINOLOGY, V97, P232, DOI 10.1159/000342692; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Dinkova-Kostova AT, 2008, MOL NUTR FOOD RES, V52, pS128, DOI 10.1002/mnfr.200700195; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hauge E, 1999, BONE, V25, P389, DOI 10.1016/S8756-3282(99)00194-5; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Ibanez L, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/726590; Johnson DA, 2015, FREE RADICAL BIO MED, V88, P253, DOI 10.1016/j.freeradbiomed.2015.07.147; Khor TO, 2006, CANCER RES, V66, P11580, DOI 10.1158/0008-5472.CAN-06-3562; Kim JH, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.33; Lean JM, 2005, ENDOCRINOLOGY, V146, P728, DOI 10.1210/en.2004-1021; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; Mody N, 2001, FREE RADICAL BIO MED, V31, P509, DOI 10.1016/S0891-5849(01)00610-4; Niture SK, 2014, FREE RADICAL BIO MED, V66, P36, DOI 10.1016/j.freeradbiomed.2013.02.008; O'Brien CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002942; Pacheco-Costa R, 2014, J BIOL CHEM, V289, P8508, DOI 10.1074/jbc.M113.529735; Park CK, 2014, BONE, V63, P36, DOI 10.1016/j.bone.2014.01.025; Pepe AE, 2010, CIRC RES, V106, P870, DOI 10.1161/CIRCRESAHA.109.211417; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Rhee Y, 2011, J BONE MINER RES, V26, P1035, DOI 10.1002/jbmr.304; Sakata T, 2004, J BONE MINER RES, V19, P436, DOI 10.1359/JBMR.0301241; Sato AY, 2015, BONE, V73, P60, DOI 10.1016/j.bone.2014.12.012; Sun YX, 2015, BONE, V74, P1, DOI 10.1016/j.bone.2014.12.066; Tebay LE, 2015, FREE RADICAL BIO MED, V88, P108, DOI 10.1016/j.freeradbiomed.2015.06.021; Tu XL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002577; Tu XL, 2012, BONE, V50, P209, DOI 10.1016/j.bone.2011.10.025; Warden SJ, 2014, J BONE MINER RES, V29, P1131, DOI 10.1002/jbmr.2143; Wu JJ, 2014, EXP CELL RES, V328, P351, DOI 10.1016/j.yexcr.2014.08.030; Xu ZS, 2011, FREE RADICAL BIO MED, V50, P1314, DOI 10.1016/j.freeradbiomed.2011.02.016; Yu JJ, 2012, J BIOCHEM MOL TOXIC, V26, P264, DOI 10.1002/jbt.21417; Zhao ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019456	44	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171161	10.1371/journal.pone.0171161	http://dx.doi.org/10.1371/journal.pone.0171161			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152064	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200096
J	Lavu, E; Kave, E; Mosoro, E; Markby, J; Aleksic, E; Gare, J; Elsum, IA; Nano, G; Kaima, P; Dala, N; Gurung, A; Bertagnolio, S; Crowe, SM; Myatt, M; Hearps, AC; Jordan, MR				Lavu, Evelyn; Kave, Ellan; Mosoro, Euodia; Markby, Jessica; Aleksic, Eman; Gare, Janet; Elsum, Imogen A.; Nano, Gideon; Kaima, Petronia; Dala, Nick; Gurung, Anup; Bertagnolio, Silvia; Crowe, Suzanne M.; Myatt, Mark; Hearps, Anna C.; Jordan, Michael R.			High Levels of Transmitted HIV Drug Resistance in a Study in Papua New Guinea	PLOS ONE			English	Article							THERAPY-NAIVE; SURVEILLANCE; IMPACT	Introduction Papua New Guinea is a Pacific Island nation of 7.3 million people with an estimated HIV prevalence of 0.8%. ART initiation and monitoring are guided by clinical staging and CD4 cell counts, when available. Little is known about levels of transmitted HIV drug resistance in recently infected individuals in Papua New Guinea. Methods Surveillance of transmitted HIV drug resistance in a total of 123 individuals recently infected with HIV and aged less than 30 years was implemented in Port Moresby (n = 62) and Mount Hagen (n = 61) during the period May 2013-April 2014. HIV drug resistance testing was performed using dried blood spots. Transmitted HIV drug resistance was defined by the presence of one or more drug resistance mutations as defined by the World Health Organization surveillance drug resistance mutations list. Results The prevalence of non-nucleoside reverse transcriptase inhibitor transmitted HIV drug resistance was 16.1% (95% CI 8.8%-27.4%) and 8.2% (95% CI 3.2%-18.2%) in Port Moresby and Mount Hagen, respectively. The prevalence of nucleoside reverse transcriptase inhibitor transmitted HIV drug resistance was 3.2% (95% CI 0.2%-11.7%) and 3.3% (95% CI 0.2%-11.8%) in Port Moresby and Mount Hagen, respectively. No protease inhibitor transmitted HIV drug resistance was observed. Conclusions The level of non-nucleoside reverse transcriptase inhibitor drug resistance in antiretroviral drug naive individuals recently infected with HIV in Port Moresby is amongst the highest reported globally. This alarming level of transmitted HIV drug resistance in a young sexually active population threatens to limit the on-going effective use of NNRTIs as a component of first-line ART in Papua New Guinea. To support the choice of nationally recommended first-line antiretroviral therapy, representative surveillance of HIV drug resistance among antiretroviral therapy initiators in Papua New Guinea should be urgently implemented.	[Lavu, Evelyn; Kave, Ellan; Mosoro, Euodia] Cent Publ Hlth Lab, Port Moresby, Papua N Guinea; [Markby, Jessica; Aleksic, Eman; Gare, Janet; Elsum, Imogen A.; Crowe, Suzanne M.; Hearps, Anna C.] Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia; [Gare, Janet] Inst Med Res, Goroka, Papua N Guinea; [Nano, Gideon; Dala, Nick] Natl Dept Hlth, Port Moresby, Papua N Guinea; [Kaima, Petronia] Mt Hagen Hosp, Mt Hagen, Papua N Guinea; [Gurung, Anup] World Hlth Org, Port Moresby, Papua N Guinea; [Bertagnolio, Silvia] World Hlth Org, HIV Dept, Geneva, Switzerland; [Myatt, Mark] Brixton Hlth, Llawryglyn, Powys, Wales; [Jordan, Michael R.] Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA 02111 USA; [Jordan, Michael R.] Tufts Univ, Sch Med, Boston, MA 02111 USA	Burnet Institute; PNG Institute Of Medical Research; World Health Organization; World Health Organization; Tufts Medical Center; Tufts University	Jordan, MR (corresponding author), Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA 02111 USA.; Jordan, MR (corresponding author), Tufts Univ, Sch Med, Boston, MA 02111 USA.	mjordan@tuftsmedicalcenter.org		Elsum, Imogen/0000-0003-4525-0727	Bill and Melinda Gates Foundation [38180]; Global Fund; CFAR [1P30A142853]; Christine E. Driscoll O'Neill and James M. Driscoll, Driscoll O'Neill Charitable Foundation; Australian NHMRC Principal Research Fellowship	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Global Fund; CFAR; Christine E. Driscoll O'Neill and James M. Driscoll, Driscoll O'Neill Charitable Foundation; Australian NHMRC Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	Funding for these surveys was provided by the Bill and Melinda Gates Foundation (38180) awarded to the World Health Organization. Staff required for recruitment from Port Moresby was partially supported by funding from the Global Fund awarded to the Burnet Institute. The authors acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program to the Burnet Institute. MRJ is supported by CFAR grant 1P30A142853 and the Christine E. Driscoll O'Neill and James M. Driscoll, Driscoll O'Neill Charitable Foundation. SMC is supported by an Australian NHMRC Principal Research Fellowship. MM was employed by Brixton Health who provided support in the form of salary for MM but Brixton Health did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of MM is articulated in the 'author contributions' section.	Afonso JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042996; [Anonymous], 2009, 2008 STI HIV AND AID; Avila-Rios S, LANCET HIV IN PRESS; Bansi L, 2010, JAIDS-J ACQ IMM DEF, V53, P633, DOI 10.1097/QAI.0b013e3181c070d2; Bennett DE, 2008, ANTIVIR THER, V13, P25; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Cambiano V, 2014, AIDS, V28, pS15, DOI 10.1097/QAD.0000000000000082; Castro H, 2013, J INFECT DIS, V208, P1459, DOI 10.1093/infdis/jit345; Daoni E, 2012, CLIN INFECT DIS, V54, pS303, DOI 10.1093/cid/cir994; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Gare J, 2014, J ANTIMICROB CHEMOTH, V69, P2183, DOI 10.1093/jac/dku089; Grant RM, 2002, JAMA-J AM MED ASSOC, V288, P181, DOI 10.1001/jama.288.2.181; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2016, GLOB AIDS UPD 2016; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; Kelly A, 2011, ASKIM NA SAVE ASK UN; National Institute for Communicable Diseases Division of the National Health Laboratory Service, 2016, COMMUNICABLE DIS COM, V15, P10; Nichols BE, 2014, AIDS, V28, P73, DOI 10.1097/01.aids.0000433239.01611.52; Perez L, 2013, INFECT GENET EVOL, V16, P144, DOI 10.1016/j.meegid.2013.02.002; Phillips A, 2014, LANCET HIV, P2; Rana Y, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0120580, 10.1371/journal.pone.0125187, 10.1371/journal.pone.0121992]; Rhee SY, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001810; Rowley CF, 2016, J ANTIMICROB CHEMOTH, V71, P1361, DOI 10.1093/jac/dkv500; StataCorp, 2013, STAT REL 13; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; WHO, 2015, HIV DRUG RES SURV GU; WHO, 2012, WHO HIV DRUG RES REP; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9; World Health Organization, 2010, WHO HIVRESNET HIV DR; World Health Organization, 2013, CONSOLIDATED GUIDELI; World Health Organization, 2015, CONS STRAT INF GUID; World Health Organization, 2014, SURV HIV DRUG RES AD; World Health Organization, GLOB REP EARL WARN I; World Health Organization, 2012, WHO MAN HIV DRUG RES	33	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0170265	10.1371/journal.pone.0170265	http://dx.doi.org/10.1371/journal.pone.0170265			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146591	Green Published, Green Submitted, gold			2022-12-27	WOS:000396131700019
J	Dizon, MP; Linos, E; Arron, ST; Hills, NK; Chren, MM				Dizon, Matthew P.; Linos, Eleni; Arron, Sarah T.; Hills, Nancy K.; Chren, Mary-Margaret			Comparing the Quality of Ambulatory Surgical Care for Skin Cancer in a Veterans Affairs Clinic and a Fee-For-Service Practice Using Clinical and Patient-Reported Measures	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; MEDICAL-CARE; OF-LIFE; SUNLIGHT EXPOSURE; HEALTH-CARE; RISK; SATISFACTION; PERFORMANCE	The Institute of Medicine has identified serious deficiencies in the measurement of cancer care quality, including the effects on quality of life and patient experience. Moreover, comparisons of quality in Veterans Affairs Medical Centers (VA) and other sites are timely now that many Veterans can choose where to seek care. To compare quality of ambulatory surgical care for keratinocyte carcinoma (KC) between a VA and fee-for-service (FFS) practice, we used unique clinical and patient-reported data from a comparative effectiveness study. Patients were enrolled in 1999-2000 and followed for a median of 7.2 years. The practices differed in a few process measures (e. g., median time between biopsy and treatment was 7.5 days longer at VA) but there were no substantial or consistent differences in clinical outcomes or a broad range of patient-reported outcomes. For example, 5-year tumor recurrence rates were equally low (3.6% [2.3-5.5] at VA and 3.4% [2.3-5.1] at FFS), and similar proportions of patients reported overall satisfaction at one year (78% at VA and 80% at FFS, P = 0.69). These results suggest that the quality of care for KC can be compared comprehensively in different health care systems, and suggest that quality of care for KC was similar at a VA and FFS setting.	[Dizon, Matthew P.; Linos, Eleni; Arron, Sarah T.; Chren, Mary-Margaret] Univ Calif San Francisco, Dept Dermatol, Program Clin Res, San Francisco, CA 94143 USA; [Arron, Sarah T.; Chren, Mary-Margaret] San Francisco VA Med Ctr, San Francisco, CA 94121 USA; [Hills, Nancy K.] Univ Calif San Francisco, Dept Biostat & Epidemiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Chren, MM (corresponding author), Univ Calif San Francisco, Dept Dermatol, Program Clin Res, San Francisco, CA 94143 USA.; Chren, MM (corresponding author), San Francisco VA Med Ctr, San Francisco, CA 94121 USA.	chrenm@ucsf.edu		Dizon, Matthew/0000-0001-6747-5973; Arron, Sarah/0000-0001-5669-0627; Chren, Mary-Margaret/0000-0001-8009-7014	University of California, San Francisco Resource Allocation Program for Trainees (RAPtr); University of California, San Francisco Resource Allocation Program (RAP); National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health [R01 AR054983, K24 AR052667]; NATIONAL INSTITUTE ON AGING [K76AG054631] Funding Source: NIH RePORTER	University of California, San Francisco Resource Allocation Program for Trainees (RAPtr); University of California, San Francisco Resource Allocation Program (RAP); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by the University of California, San Francisco Resource Allocation Program for Trainees (RAPtr), University of California, San Francisco Resource Allocation Program (RAP), and grants from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (http://www.niams.nih.gov/), National Institutes of Health (R01 AR054983 and K24 AR052667). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asgari MM, 2009, DERMATOL SURG, V35, P1041, DOI 10.1111/j.1524-4725.2009.01181.x; Chawla N, 2015, J GEN INTERN MED, V30, P641, DOI 10.1007/s11606-014-3162-9; Chren MM, 2007, J INVEST DERMATOL, V127, P1351, DOI 10.1038/sj.jid.5700740; Chren MM, 2013, J INVEST DERMATOL, V133, P1188, DOI 10.1038/jid.2012.403; Chren MM, 2012, DERMATOL CLIN, V30, P231, DOI 10.1016/j.det.2011.11.003; Chren MM, 2004, MED CARE, V42, P1019, DOI 10.1097/00005650-200410000-00011; DAVIES AR, 1986, HEALTH SERV RES, V21, P429; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Donabedian A, 2005, MILBANK Q, V83, P691, DOI 10.1111/j.1468-0009.2005.00397.x; Dudley RA, 2000, MED CARE RES REV, V57, P116, DOI 10.1177/107755800773743754; GALLAGHER RP, 1995, ARCH DERMATOL, V131, P164, DOI 10.1001/archderm.131.2.164; GALLAGHER RP, 1995, ARCH DERMATOL, V131, P157, DOI 10.1001/archderm.131.2.157; Ganz PA, DELIVERING HIGH QUAL; Institute of Medicine, 2001, CROSSING QUALITY CHA; Jha AK, 2016, JAMA-J AM MED ASSOC, V315, P560, DOI 10.1001/jama.2016.0243; Kent EE, 2015, CANCER-AM CANCER SOC, V121, P758, DOI 10.1002/cncr.29119; Landon BE, 2004, JAMA-J AM MED ASSOC, V291, P1744, DOI 10.1001/jama.291.14.1744; Lehrman WG, 2010, MED CARE RES REV, V67, P38, DOI 10.1177/1077558709341323; Marshall GN, PATIENT SATISFACTION; Matula SR, 2010, J AM COLL SURGEONS, V211, P823, DOI 10.1016/j.jamcollsurg.2010.09.001; ROBERTS JG, 1987, HEALTH SERV RES, V22, P637; Samuel CA, 2015, MED CARE, V53, P54, DOI 10.1097/MLR.0000000000000257; Trivedi AN, 2011, MED CARE, V49, P76, DOI 10.1097/MLR.0b013e3181f53575; Viola KV, 2012, ARCH DERMATOL, V148, P473, DOI 10.1001/archdermatol.2011.2456; VITALIANO PP, 1980, ARCH DERMATOL, V116, P454, DOI 10.1001/archderm.116.4.454; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003	26	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171253	10.1371/journal.pone.0171253	http://dx.doi.org/10.1371/journal.pone.0171253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6QW	28141817	Green Submitted, Green Published, gold			2022-12-27	WOS:000396129500054
J	Torres, DE; Rojas-Martinez, RI; Zavaleta-Mejia, E; Guevara-Fefer, P; Marquez-Guzman, GJ; Perez-Martinez, C				Eduardo Torres, David; Isabel Rojas-Martinez, Reyna; Zavaleta-Mejia, Emma; Guevara-Fefer, Patricia; Judith Marquez-Guzman, G.; Perez-Martinez, Carolina			Cladosporium cladosporioides and Cladosporium pseudocladosporioides as potential new fungal antagonists of Puccinia horiana Henn., the causal agent of chrysanthemum white rust	PLOS ONE			English	Article							PHYLLOPLANE FUNGI; X MORIFOLIUM; IN-VITRO; HYPERPARASITISM; PATHOGENS; UREDINIOSPORES; TENUISSIMUM; INFECTION; FABAE	Puccinia horiana Hennings, the causal agent of chrysanthemum white rust, is a worldwide quarantine organism and one of the most important fungal pathogens of Chrysanthemum x morifolium cultivars, which are used for cut flowers and as potted plants in commercial production regions of the world. It was previously reported to be controlled by Lecanicillium lecanii, Cladosporium sphaerospermum, C. uredinicola and Aphanocladium album, due to their antagonistic and hyperparasitic effects. We report novel antagonist species on Puccinia horiana. Fungi isolated from rust pustules in a commercial greenhouse from Villa Guerrero, Mexico, were identified as Cladosporium cladosporioides and Cladosporium pseudocladosporioides based upon molecular analysis and morphological characters. The antagonism of C. cladosporioides and C. pseudocladosporioides on chrysanthemum white rust was studied using light and electron microscopy in vitro at the host/parasite interface. Cladosporium cladosporioides and C. pseudocladosporioides grew towards the white rust teliospores and colonized the sporogenous cells, but no direct penetration of teliospores was observed; however, the structure and cytoplasm of teliospores were altered. The two Cladosporium spp. were able to grow on media containing laminarin, but not when chitin was used as the sole carbon source; these results suggest that they are able to produce glucanases. Results from the study indicate that both Cladosporium species had potential as biological control agents of chrysanthemum white rust.	[Eduardo Torres, David; Isabel Rojas-Martinez, Reyna; Zavaleta-Mejia, Emma; Perez-Martinez, Carolina] Colegio Postgrad, Inst Fitosanidad, Montecillo, Texcoco, Mexico; [Guevara-Fefer, Patricia] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Ecol & Recursos Nat, Mexico City, DF, Mexico; [Judith Marquez-Guzman, G.] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Biol Comparada, Mexico City, DF, Mexico	Colegio de Postgraduados - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Rojas-Martinez, RI (corresponding author), Colegio Postgrad, Inst Fitosanidad, Montecillo, Texcoco, Mexico.	rojas@colpos.mx		Torres, David/0000-0003-3711-0548	CONACyT	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The first author (David Eduardo Torres) expresses his appreciation to CONACyT for his Master's scholarship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The first author (David Eduardo Torres) expresses his appreciation to CONACyT for his Master's scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank M.C. Monica Perez Pacheco from Laboratorio de Desarrollo en Plantas, Departamento de Biologia Comparada, Facultad de Ciencias, UNAM and Biol. Yolanda Hornelas Cruces from Laboratorio de Microscopia Electronica, Instituto de Ciencias del Mar y Limnologia, and UNAM for the facilities for processing material for LR-White and SEM images.	Akiko K, 1977, NIPPON SHOKUBUTSU BY, V43, P145; Alaei H, 2009, J MICROBIOL METH, V76, P136, DOI 10.1016/j.mimet.2008.10.001; Alaei H, 2009, MYCOL RES, V113, P668, DOI 10.1016/j.mycres.2009.02.003; [Anonymous], 2004, Bulletin OEPP, V34, P209, DOI 10.1111/j.1365-2338.2004.00721.x; Assante G, 2004, MYCOL RES, V108, P170, DOI 10.1017/S0953756203008852; Barros ST, 1999, MYCOLOGIST, V13, P3; Bensch K, 2012, STUD MYCOL, P1, DOI 10.3114/sim0003; Bensch K, 2010, STUD MYCOL, P1, DOI 10.3114/sim.2010.67.01; BOLAND GJ, 1988, CAN J PLANT PATHOL, V10, P172, DOI 10.1080/07060668809501750; Bonde MR, 2015, PHYTOPATHOLOGY, V105, P91, DOI 10.1094/PHYTO-09-13-0266-R; Carbone I, 1999, MYCOLOGIA, V91, P553, DOI 10.2307/3761358; Cook RTA, 2001, PLANT PATHOL, V50, P792, DOI 10.1046/j.1365-3059.2001.00615.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Backer M, 2013, PHYTOPATHOLOGY, V103, P1169, DOI 10.1094/PHYTO-01-13-0007-R; Deising H, 1996, HISTOLOGY ULTRASTRUC, V7, P135; DICKENS JSW, 1990, PLANT PATHOL, V39, P434, DOI 10.1111/j.1365-3059.1990.tb02519.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Ellsworth KT, 2013, CAN J MICROBIOL, V59, P761, DOI 10.1139/cjm-2013-0639; Falcon L, 2007, ECOLOGIA MOL; FIRMAN ID, 1968, ANN APPL BIOL, V62, P429, DOI 10.1111/j.1744-7348.1968.tb05454.x; FREYTAG S, 1991, PROTOPLASMA, V161, P94, DOI 10.1007/BF01322722; Garcia-Velasco Romulo, 2005, Revista Mexicana de Fitopatologia, V23, P79; HARDER DE, 1986, CAN J BOT, V64, P476, DOI 10.1139/b86-062; Hennings P., 1901, HEDWIGIA, V40, P25; Heuchert B., 2005, Schlechtendalia, P1; Hiratsuka N., 1957, SYDOWIA, V2, P34; Jackson AJ, 1997, BIOL CONTROL, V8, P97, DOI 10.1006/bcon.1996.0481; Kiss L, 2003, PEST MANAG SCI, V59, P475, DOI 10.1002/ps.689; Kohl JJ, 2009, EUR J PLANT PATHOL, V123, P401, DOI 10.1007/s10658-008-9377-z; Littlefield L, 1979, ULTRASTRUCTURE RUST, P277; Mims CW, 2007, CAN J BOT, V85, P76, DOI 10.1139/B06-153; MORGANJONES G, 1990, MYCOTAXON, V39, P185; Moricca S, 2001, PHYTOPATHOLOGY, V91, P457, DOI 10.1094/PHYTO.2001.91.5.457; Moricca S, 2005, RUST DISEASES OF WILLOW AND POPLAR, P213, DOI 10.1079/9780851999999.0213; Moricca Salvatore, 2008, V3, P303, DOI 10.1007/978-1-4020-8571-0_15; O'Keefe G, 2015, PLANT DIS; OMAR M, 1979, T BRIT MYCOL SOC, V72, P225, DOI 10.1016/S0007-1536(79)80036-4; PANDEY RR, 1993, MYCOPATHOLOGIA, V124, P31, DOI 10.1007/BF01103054; Punithalingam E, 1968, CMI DESCRIPTIONS PAT, V176; Rodriguez-Navarro J. A., 1996, Fitopatologia, V31, P122; Ruzin SE, 1999, PLANT MICROTECHNIQUE, P315; Schubert K, 2007, STUD MYCOL, P105, DOI 10.3114/sim.2007.58.05; SHARMA JK, 1980, EUR J FOREST PATHOL, V10, P360; SRIVASTAVA AK, 1985, PHYTOPATHOL Z, V114, P73; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TRAQUAIR JA, 1984, CAN J BOT, V62, P181, DOI 10.1139/b84-030; TSUNEDA A, 1979, Canadian Journal of Plant Pathology, V1, P31; Vandermeer J, 2009, PLANT PATHOL, V58, P636, DOI 10.1111/j.1365-3059.2009.02067.x; Voigt K, 2001, GENE, V270, P113, DOI 10.1016/S0378-1119(01)00464-4; Wang XN, 2013, J AGR FOOD CHEM, V61, P4551, DOI 10.1021/jf400212y; WHIPPS JM, 1993, ANN APPL BIOL, V122, P173, DOI 10.1111/j.1744-7348.1993.tb04025.x; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Zalar P, 2007, STUD MYCOL, P157, DOI 10.3114/sim.2007.58.06; ZANDVOORT R, 1968, Netherlands Journal of Plant Pathology, V74, P124, DOI 10.1007/BF02309505; Zhan GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111484	55	45	47	6	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170782	10.1371/journal.pone.0170782	http://dx.doi.org/10.1371/journal.pone.0170782			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141830	Green Published, gold, Green Submitted			2022-12-27	WOS:000396129500019
J	Lazzarino, AI; Mindell, JS				Lazzarino, Antonio Ivan; Mindell, Jennifer S.			Measuring high-sensitivity cardiac troponin T blood concentration in population surveys	PLOS ONE			English	Article							MENTAL STRESS; ASSOCIATION; ELEVATION; RISK; MORTALITY; ASSAY	Introduction The blood test for high-sensitivity cardiac troponin T (HS-CTnT) has been proposed as a marker of cardiovascular risk in the general population, as it is associated with subsequent incidence of cardiovascular events and mortality. We aimed at evaluating the feasibility of HS-CTnT testing within large nationally-representative population surveys in which blood samples are collected during household visits, shipped using the standard civil postal service, and then frozen for subsequent analyses. Methods The Health Survey for England (HSE) consists of a series of annual surveys beginning in 1991. It is designed to provide regular information on various aspects of the nation's health and risk factors. We measured HS-CTnT in the blood of 200 people from the HSE 2016 wave, then froze and stored their blood samples at -40 degrees C for 5-10 weeks, and then thawed and retested them to appreciate the extent of within-person agreement or test-retest reliability of the two measurements. Results The Cronbach's Alpha (Scale Reliability Coefficient) and the Interclass Correlation Coefficient (two-way mixed-effects model for consistency of agreement at individual level) were 0.97 (95% CI = 0.96-0.99) and 0.95 (95% CI =0.94-0.96) respectively. The time delay from blood withdrawal to analysis and storage (1-4 days) did not affect the results, nor did the freezing time before the retest (5-10 weeks). Conclusion The measurement of HS-CTnT plasma concentration within large nationally-representative surveys such as the Health Survey for England is feasible.	[Lazzarino, Antonio Ivan] London Sch Hyg & Trop Med, London, England; [Lazzarino, Antonio Ivan; Mindell, Jennifer S.] UCL, Dept Epidemiol & Publ Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Lazzarino, AI (corresponding author), London Sch Hyg & Trop Med, London, England.; Lazzarino, AI (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	antonio.lazzarino@lshtm.ac.uk	Mindell, Jennifer S/G-2241-2011; Lazzarino, Antonio Ivan/F-9011-2010	Mindell, Jennifer S/0000-0002-7604-6131; Lazzarino, Antonio Ivan/0000-0001-8045-2346	Wellcome Trust Institutional Strategic Support Fund, United Kingdom [105609/Z/14/Z]	Wellcome Trust Institutional Strategic Support Fund, United Kingdom	This research was supported by the Wellcome Trust Institutional Strategic Support Fund (grant code 105609/Z/14/Z), United Kingdom. The funders played no role in any phase of the study.; This research was supported by the Wellcome Trust Institutional Strategic Support Fund (grant code 105609/Z/14/Z awarded to Dr Antonio Ivan Lazzarino), United Kingdom. The funders played no role in any phase of the study. All authors declare no conflict of interest of any kind. All authors have made substantial contribution to the conception and design of the study, the acquisition of data, the interpretation of the results, and the critical review of the article. AIL drafted the article and carried out the data analysis and takes responsibility for the accuracy of the analysis. All authors have approved the final article.	de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; deFilippi CR, 2010, JAMA-J AM MED ASSOC, V304, P2494, DOI 10.1001/jama.2010.1708; Giannitsis E, 2013, NAT REV CARDIOL, V10, P623, DOI 10.1038/nrcardio.2013.129; Gillis JM, 2013, CLIN CHEM, V59, P442, DOI 10.1373/clinchem.2012.192211; Gimenez MR, 2014, EUR HEART J, V35, P2303, DOI 10.1093/eurheartj/ehu188; Gore MO, 2014, J AM COLL CARDIOL, V63, P1441, DOI 10.1016/j.jacc.2013.12.032; Health and Social Care Information Centre 1 Trevelyan Square, 2013, HLTH SURV ENGL HLTH; Lazzarino AI, 2013, J AM COLL CARDIOL, V62, P1694, DOI 10.1016/j.jacc.2013.05.070; Lazzarino AI, 2016, PREV MED, V93, P46, DOI 10.1016/j.ypmed.2016.09.018; Lazzarino AI, 2015, PSYCHONEUROENDOCRINO, V59, P37, DOI 10.1016/j.psyneuen.2015.05.002; Lazzarino AI, 2015, PREV MED, V77, P150, DOI 10.1016/j.ypmed.2015.05.025; Li AH, 2011, CLIN CHEM LAB MED, V49, P335, DOI 10.1515/CCLM.2011.035; Michel M, 2016, CLIN LAB, V62, P743, DOI 10.7754/Clin.Lab.2015.160123; Mindell J, 2012, INT J EPIDEMIOL, V41, P1585, DOI 10.1093/ije/dyr199; National Institute for Health and Care Excellence (NICE), 2014, MYOC IF AC EARL RUL; Rankin G, 1998, CLIN REHABIL, V12, P187, DOI 10.1191/026921598672178340; Rubin J, 2016, CLIN BIOCHEM, V49, P657, DOI 10.1016/j.clinbiochem.2016.01.024; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184	18	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171242	10.1371/journal.pone.0171242	http://dx.doi.org/10.1371/journal.pone.0171242			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141863	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000396129500052
J	Angelone-Alasaad, S; Biebach, I; Perez, JM; Soriguer, RC; Granados, JE				Angelone-Alasaad, Samer; Biebach, Iris; Perez, Jesus M.; Soriguer, Ramon C.; Granados, Jose E.			Molecular Analyses Reveal Unexpected Genetic Structure in Iberian Ibex Populations	PLOS ONE			English	Article							CAPRA-PYRENAICA MAMMALIA; SPANISH IBEX; ARTIODACTYLA; CONSERVATION; PROGRAM; SPAIN; GOAT	Background Genetic differentiation in historically connected populations could be the result of genetic drift or adaptation, two processes that imply a need for differing strategies in population management. The aim of our study was to use neutral genetic markers to characterize C. pyrenaica populations genetically and examine results in terms of (i) demographic history, (ii) subspecific classification and (iii) the implications for the management of Iberian ibex. Methodology/Principal Findings We used 30 neutral microsatellite markers from 333 Iberian ibex to explore genetic diversity in the three main Iberian ibex populations in Spain corresponding to the two persisting subspecies (victoria and hispanica). Our molecular analyses detected recent genetic bottlenecks in all the studied populations, a finding that coincides with the documented demographic decline in C. pyrenaica in recent decades. Genetic divergence between the two C. pyrenaica subspecies (hispanica and victoriae) was substantial (FST between 0.39 and 0.47). Unexpectedly, we found similarly high genetic differentiation between two populations (Sierra Nevada and Maestrazgo) belonging to the subspecies hispanica. The genetic pattern identified in our study could be the result of strong genetic drift due to the severe genetic bottlenecks in the studied populations, caused in turn by the progressive destruction of natural habitat, disease epidemics and/or uncontrolled hunting. Conclusions Previous Capra pyrenaica conservation decision-making was based on the clear distinction between the two subspecies (victoriae and hispanica); yet our paper raises questions about the usefulness for conservation plans of the distinction between these subspecies.	[Angelone-Alasaad, Samer; Biebach, Iris] Univ Zurich, Inst Evolutionary Biol & Environm Studies IEU, Winterthurerstr 190, Zurich, Switzerland; [Angelone-Alasaad, Samer; Soriguer, Ramon C.] CSIC, Estn Biol Donana, Avda Americo Vespucio S-N, Seville, Spain; [Perez, Jesus M.] Univ Jaen, Dept Biol Anim Biol Vegetal & Ecol, Campus Las Lagunillas S-N, Jaen, Spain; [Granados, Jose E.] Espacio Nat Sierra Nevada, Carretera Antigua de Sierra Nevada,Km 7, Granada, Spain	University of Zurich; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidad de Jaen	Angelone-Alasaad, S (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies IEU, Winterthurerstr 190, Zurich, Switzerland.; Angelone-Alasaad, S (corresponding author), CSIC, Estn Biol Donana, Avda Americo Vespucio S-N, Seville, Spain.	sameralasaad@hotmail.com	Torres, José Enrique Granados/AAS-5629-2020; Pérez, Jesús/AAA-6324-2019; Casimiro-Soriguer, Ramon/J-1494-2014; Angelone, Samer/G-4727-2013	Torres, José Enrique Granados/0000-0002-9787-9896; Casimiro-Soriguer, Ramon/0000-0002-9165-7766; Angelone, Samer/0000-0003-0868-7276				Acevedo P, 2009, MAMMAL REV, V39, P17, DOI 10.1111/j.1365-2907.2008.00138.x; Acevedo P, 2007, BIODIVERS CONSERV, V16, P3361, DOI 10.1007/s10531-006-9032-y; Acevedo P, 2011, ECOL MODEL, V222, P814, DOI 10.1016/j.ecolmodel.2010.10.006; Alados C.L., 1985, P204; Alasaad S, 2008, PARASITOL RES, V103, P181, DOI 10.1007/s00436-008-0952-1; Allendorf F, 2013, CONSERV GENET, V2nd; Biebach I, 2009, MOL ECOL, V18, P5046, DOI 10.1111/j.1365-294X.2009.04420.x; Bonferroni CE, 1936, TEORIA STAT CLASSI C, V8, P362; Caballero S, 2013, BIOCHEM SYST ECOL, V48, P263, DOI 10.1016/j.bse.2012.12.016; Cabrera A., 1914, FAUNA IBERICA MAMIFE; CABRERA A, 1911, P ZOOL SOC LOND, V66, P963; CLOUET M, 1979, Bulletin de la Societe d'Histoire Naturelle de Toulouse, V115, P269; Cornuet JM, 1996, GENETICS, V144, P2001; Couturier MAJ, 1962, BOUQUETIN ALPES; Crampe J-P, 1991, DOCUMENTS SCI PARC N, V26, P1; Crampe JP, 2015, 33 RENC GEEFSM BALM; Culver M, 2000, J HERED, V91, P186, DOI 10.1093/jhered/91.3.186; Eizaguirre C, 2014, EVOL APPL, V7, P963, DOI 10.1111/eva.12227; Excoffier L., 2006, ARLEQUIN 3 11 COPYRI; Fandos P, 1991, SERIE TECNICA ICONA; Frankham R, 2011, CONSERV BIOL, V25, P465, DOI 10.1111/j.1523-1739.2011.01662.x; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Gao H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021014; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Giribet G, 2010, ACTA ZOOL-STOCKHOLM, V91, P11, DOI 10.1111/j.1463-6395.2009.00420.x; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Granados JE, 1997, FOLIA ZOOL, P9; GRODINSKY C, 1987, SMITHSONIAN, V18, P68; Groves C, 2011, UNGULATE TAXONOMY; Grubb P, 2005, MAMMAL SPECIES WORLD, P637; Johnson WE, 2010, SCIENCE, V329, P1641, DOI 10.1126/science.1192891; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Manceau V., 1997, THESIS; Manceau V, 1999, ANIM CONSERV, V2, P33, DOI 10.1111/j.1469-1795.1999.tb00046.x; Mao, 1999, POPGENE VERSION 1 3; Maudet C, 2004, MOL ECOL NOTES, V4, P49, DOI 10.1046/j.1471-8286.2003.00563.x; Moco G, 2006, ORYX, V40, P351, DOI 10.1017/S0030605306000718; NEI M, 1978, GENETICS, V89, P583; Perez JM, 2002, MAMMAL REV, V32, P26, DOI 10.1046/j.1365-2907.2002.00097.x; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Sarasa M, 2012, BIODIVERS CONSERV, V21, P1, DOI 10.1007/s10531-011-0172-3; Seal U. S., 1994, PLAN GEN REST MAN FL; Shackleton DM, 1997, WILD SHEEP GOATS THE; Slatkin M, 1996, THEORETICAL POPULATI, V28, P314; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Storfer A, 1999, BIOL CONSERV, V87, P173, DOI 10.1016/S0006-3207(98)00066-4; Whiteley AR, 2015, TRENDS ECOL EVOL, V30, P42, DOI 10.1016/j.tree.2014.10.009; Williamson-Natesan EG, 2005, CONSERV GENET, V6, P4551; [No title captured]	54	8	8	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170827	10.1371/journal.pone.0170827	http://dx.doi.org/10.1371/journal.pone.0170827			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135293	Green Submitted, gold, Green Published			2022-12-27	WOS:000396124700024
J	N'Diaye, A; Haile, JK; Cory, AT; Clarke, FR; Clarke, JM; Knox, RE; Pozniak, CJ				N'Diaye, Amidou; Haile, Jemanesh K.; Cory, Aron T.; Clarke, Fran R.; Clarke, John M.; Knox, Ron E.; Pozniak, Curtis J.			Single Marker and Haplotype-Based Association Analysis of Semolina and Pasta Colour in Elite Durum Wheat Breeding Lines Using a High-Density Consensus Map	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENOME-WIDE ASSOCIATION; YELLOW PIGMENT CONTENT; LINKAGE-DISEQUILIBRIUM; POPULATION-STRUCTURE; COMPLEX TRAITS; MOLECULAR MARKERS; NUCLEOTIDE POLYMORPHISMS; LIPOXYGENASE ACTIVITY; GENETIC ASSOCIATION	Association mapping is usually performed by testing the correlation between a single marker and phenotypes. However, because patterns of variation within genomes are inherited as blocks, clustering markers into haplotypes for genome-wide scans could be a worthwhile approach to improve statistical power to detect associations. The availability of high-density molecular data allows the possibility to assess the potential of both approaches to identify marker-trait associations in durum wheat. In the present study, we used single marker-and haplotype-based approaches to identify loci associated with semolina and pasta colour in durum wheat, the main objective being to evaluate the potential benefits of haplotype-based analysis for identifying quantitative trait loci. One hundred sixty-nine durum lines were genotyped using the Illumina 90K Infinium iSelect assay, and 12,234 polymorphic single nucleotide polymorphism (SNP) markers were generated and used to assess the population structure and the linkage disequilibrium (LD) patterns. A total of 8,581 SNPs previously localized to a high-density consensus map were clustered into 406 haplotype blocks based on the average LD distance of 5.3 cM. Combining multiple SNPs into haplotype blocks increased the average polymorphism information content (PIC) from 0.27 per SNP to 0.50 per haplotype. The haplotype-based analysis identified 12 loci associated with grain pigment colour traits, including the five loci identified by the single marker-based analysis. Furthermore, the haplotype-based analysis resulted in an increase of the phenotypic variance explained (50.4% on average) and the allelic effect (33.7% on average) when compared to single marker analysis. The presence of multiple allelic combinations within each haplotype locus offers potential for screening the most favorable haplotype series and may facilitate marker-assisted selection of grain pigment colour in durum wheat. These results suggest a benefit of haplotype-based analysis over single marker analysis to detect loci associated with colour traits in durum wheat.	[N'Diaye, Amidou; Haile, Jemanesh K.; Cory, Aron T.; Clarke, John M.; Pozniak, Curtis J.] Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK, Canada; [N'Diaye, Amidou; Haile, Jemanesh K.; Cory, Aron T.; Clarke, John M.; Pozniak, Curtis J.] Univ Saskatchewan, Ctr Crop Dev, Saskatoon, SK, Canada; [Clarke, Fran R.; Knox, Ron E.] Agr & Agri Food Canada, Semiarid Prairie Agr Res Ctr, Swift Current, SK, Canada	University of Saskatchewan; University of Saskatchewan; Agriculture & Agri Food Canada	N'Diaye, A (corresponding author), Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK, Canada.; N'Diaye, A (corresponding author), Univ Saskatchewan, Ctr Crop Dev, Saskatoon, SK, Canada.	amidou.ndiaye@usask.ca	Haile, Jemanesh/AAL-7670-2020	Cory, Aron/0000-0002-7215-459X; N'Diaye, Amidou/0000-0001-7769-7801; Knox, Ron/0000-0002-2030-3899	Genome Canada; Western Grains Research Foundation; Province of Saskatchewan; Agriculture and Agri-Food Canada	Genome Canada(Genome Canada); Western Grains Research Foundation; Province of Saskatchewan; Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada)	We gratefully acknowledge funding provided by Genome Canada to the CTAG project, as well as by the Western Grains Research Foundation, the Province of Saskatchewan, and Agriculture and Agri-Food Canada.; We gratefully acknowledge funding provided by Genome Canada to the CTAG project, as well as the by the Western Grains Research Foundation, the Province of Saskatchewan, and Agriculture and Agri-Food Canada. The technical assistance of J. Coulson, Lexie Martin, K. Wiebe and S. Yates is also gratefully acknowledged.	Akey J, 2001, EUR J HUM GENET, V9, P291, DOI 10.1038/sj.ejhg.5200619; Arbelbide M, 2006, THEOR APPL GENET, V112, P885, DOI 10.1007/s00122-005-0190-1; Bardel C, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-24; Barendse W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029601; Barrero RA, 2011, FUNCT INTEGR GENOMIC, V11, P37, DOI 10.1007/s10142-010-0208-x; Barton NH, 2000, HEREDITY, V84, P373, DOI 10.1046/j.1365-2540.2000.00683.x; Beattie AD, 2010, CROP SCI, V50, P1649, DOI 10.2135/cropsci2009.06.0334; Bernardo R, 2008, CROP SCI, V48, P1649, DOI 10.2135/cropsci2008.03.0131; Blanchard G, 2010, JMLR WORKSH CONF PRO, V11, P12; Blanco A, 2011, J CEREAL SCI, V54, P255, DOI 10.1016/j.jcs.2011.07.002; Borner A, 1997, THEOR APPL GENET, V95, P1133, DOI 10.1007/s001220050673; Botta V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093379; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Browning SR, 2006, AM J HUM GENET, V78, P903, DOI 10.1086/503876; Buckler ES, 2002, CURR OPIN PLANT BIOL, V5, P107, DOI 10.1016/S1369-5266(02)00238-8; Calus MPL, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-11; Campoy JA, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0712-9; Cappa EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081267; Carrera A, 2007, J CEREAL SCI, V45, P67, DOI 10.1016/j.jcs.2006.07.001; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Cervigni G, 2005, P 7 INT WHEAT C SAGP; Chen YX, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S45; Choi IY, 2007, GENETICS, V176, P685, DOI 10.1534/genetics.107.070821; Clark AG, 2004, GENET EPIDEMIOL, V27, P321, DOI 10.1002/gepi.20025; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Clarke FR, 2010, CAN J PLANT SCI, V90, P1, DOI 10.4141/CJPS09035; Clarke JM, 2010, CAN J PLANT SCI, V90, P791, DOI 10.4141/CJPS10091; Clarke JM, 2009, CAN J PLANT SCI, V89, P505, DOI 10.4141/CJPS08168; Clarke JM, 2005, CAN J PLANT SCI, V85, P901, DOI 10.4141/P04-189; Clarke JM, 2005, CAN J PLANT SCI, V85, P651, DOI 10.4141/P04-119; Clarke JM, 2000, CAN J PLANT SCI, V80, P343, DOI 10.4141/P99-108; Clarke JM, 1998, CAN J PLANT SCI, V78, P621, DOI 10.4141/P98-002; Courtois B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078037; Cuyabano BCD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1171; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; De Simone V, 2010, J CEREAL SCI, V52, P121, DOI 10.1016/j.jcs.2010.04.003; Diaz A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-111; Durrant C, 2004, AM J HUM GENET, V75, P35, DOI 10.1086/422174; Ellis MH, 2002, THEOR APPL GENET, V105, P1038, DOI 10.1007/s00122-002-1048-4; Elouafi I, 2001, HEREDITAS, V135, P255, DOI 10.1111/j.1601-5223.2001.t01-1-00255.x; Escamilla MA, 1999, AM J HUM GENET, V64, P1670, DOI 10.1086/302400; Feng B, 2010, J CEREAL SCI, V52, P387, DOI 10.1016/j.jcs.2010.06.019; Ferdosi MH, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0253-6; Ficco DBM, 2014, CROP PASTURE SCI, V65, P1, DOI 10.1071/CP13293; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Fu YB, 2014, G3-GENES GENOM GENET, V4, P891, DOI 10.1534/g3.114.010942; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gao Q, 2012, GLOBAL JOURNAL OF SC, V12, P1; Garbus I, 2009, J CEREAL SCI, V50, P67, DOI 10.1016/j.jcs.2009.02.008; Gaunt TR, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-227; Gawenda I, 2015, PLANT BREEDING, V134, P28, DOI 10.1111/pbr.12237; Grapes L, 2006, GENETICS, V172, P1955, DOI 10.1534/genetics.105.048686; Grapes L, 2004, GENETICS, V166, P1561, DOI 10.1534/genetics.166.3.1561; Guo YF, 2009, EUR J HUM GENET, V17, P785, DOI 10.1038/ejhg.2008.244; Gupta PK, 2014, ADV GENET, V85, P109, DOI 10.1016/B978-0-12-800271-1.00002-0; Haile JK, 2013, GENET RESOUR CROP EV, V60, P853, DOI 10.1007/s10722-012-9880-0; Hamblin MT, 2011, PLANT GENOME-US, V4, P145, DOI 10.3835/plantgenome2011.03.0008; Hao CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046444; Hao DR, 2012, THEOR APPL GENET, V124, P447, DOI 10.1007/s00122-011-1719-0; Hayes BJ, 2007, GENET RES, V89, P215, DOI 10.1017/S0016672307008865; Hessler TG, 2002, CROP SCI, V42, P1695, DOI 10.2135/cropsci2002.1695; Hoffman GE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075707; HOISINGTON D, 1994, LAB PROTOCOLS CIMMYT; Holland JB, 2007, CURR OPIN PLANT BIOL, V10, P156, DOI 10.1016/j.pbi.2007.01.003; Hou J, 2014, PLANT PHYSIOL, V164, P1918, DOI 10.1104/pp.113.232454; Howitt CA, 2009, FUNCT INTEGR GENOMIC, V9, P363, DOI 10.1007/s10142-009-0121-3; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Jonas D, 2016, J DAIRY SCI, V99, P4537, DOI 10.3168/jds.2015-10433; Jordan KW, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0606-4; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kollers S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057500; Kraakman ATW, 2004, GENETICS, V168, P435, DOI 10.1534/genetics.104.026831; Kuchel H, 2006, THEOR APPL GENET, V112, P1487, DOI 10.1007/s00122-006-0252-z; Kumagai M, 2013, BIOINFORMATICS, V29, P1806, DOI 10.1093/bioinformatics/btt295; Langewisch T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094150; Lestari P, 2011, J HERED, V102, P735, DOI 10.1093/jhered/esr094; Li CL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/830618; Li Y, 2007, AM J HUM GENET, V80, P705, DOI 10.1086/513205; Li YH, 2009, MOL BREEDING, V24, P63, DOI 10.1007/s11032-009-9272-0; Lipka AE, 2013, G3-GENES GENOM GENET, V3, P1287, DOI 10.1534/g3.113.006148; Littell R.C., 1996, SAS SYSTEM MIXED MOD; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu NJ, 2008, ADV GENET, V60, P335, DOI 10.1016/S0065-2660(07)00414-2; Long AD, 1999, GENOME RES, V9, P720; Lorenz AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014079; Lorenz AJ, 2011, PLOS ONE, V5; Lu YL, 2012, MOL BREEDING, V30, P407, DOI 10.1007/s11032-011-9631-5; Lu YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024861; Ma L, 2016, PLANT BIOTECHNOL J, V14, P1269, DOI 10.1111/pbi.12492; Maccaferri M, 2005, MOL BREEDING, V15, P271, DOI 10.1007/s11032-004-7012-z; Maccaferri M, 2015, PLANT BIOTECHNOL J, V13, P648, DOI 10.1111/pbi.12288; MacLean CJ, 2000, AM J HUM GENET, V66, P1062, DOI 10.1086/302796; Mago R, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0379-z; Malosetti M, 2007, GENETICS, V175, P879, DOI 10.1534/genetics.105.054932; Manna F, 1998, CEREAL RES COMMUN, V26, P23; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Mares DJ, 2001, AUST J AGR RES, V52, P1297, DOI 10.1071/AR01048; Martin ER, 2000, AM J HUM GENET, V67, P383, DOI 10.1086/303003; Mathias RA, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-38; Matthies IE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110046; Meuwissen THE, 2000, GENETICS, V155, P421; Mezmouk S, 2011, THEOR APPL GENET, V122, P1149, DOI 10.1007/s00122-010-1519-y; Minozzi Giulietta, 2014, BMC Proc, V8, pS4, DOI 10.1186/1753-6561-8-S5-S4; Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200; Muller BU, 2011, HEREDITY, V106, P825, DOI 10.1038/hdy.2010.125; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Nachit MM, 2001, THEOR APPL GENET, V102, P177, DOI 10.1007/s001220051633; Pan Y, 2014, SCI REP, V5; Parker GD, 1998, THEOR APPL GENET, V97, P238, DOI 10.1007/s001220050891; Patil G, 2016, SCI REP-UK, V6, DOI 10.1038/srep19199; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Patil RM, 2008, MOL BREEDING, V21, P485, DOI 10.1007/s11032-007-9147-1; Peng ZS, 1999, WHEAT INFORM SERV, V89, P7; Pezzolesi MG, 2006, AM J HUM GENET, V79, P923, DOI 10.1086/508943; Podlich DW, 2004, CROP SCI, V44, P1560, DOI 10.2135/cropsci2004.1560; Pometti CL, 2014, GENET MOL BIOL, V37, P64, DOI 10.1590/S1415-47572014000100012; Pozniak C, 2012, MOL BREEDING, P1; Pozniak CJ, 2007, THEOR APPL GENET, V114, P525, DOI 10.1007/s00122-006-0453-5; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Prins R, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00973; R Core Team, 2021, R LANGUAGE ENV STAT; Racedo J, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0829-x; Randhawa HS, 2013, PLANT BREEDING, V132, P458, DOI 10.1111/pbr.12057; Reimer S, 2008, GENOME, V51, P1016, DOI 10.1139/G08-083; Roncallo PF, 2012, EUPHYTICA, V185, P77, DOI 10.1007/s10681-012-0628-x; Roullier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062707; Rutkoski JE, 2013, G3-GENES GENOM GENET, V3, P427, DOI 10.1534/g3.112.005363; Saade S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32586; Sardouie-Nasab S, 2013, MOL BIOL REP, V40, P4661, DOI 10.1007/s11033-013-2561-z; Schaid DJ, 2004, GENET EPIDEMIOL, V27, P348, DOI 10.1002/gepi.20037; Service SK, 1999, AM J HUM GENET, V64, P1728, DOI 10.1086/302398; Sha Qiuying, 2009, BMC Proc, V3 Suppl 7, pS14; Shao GN, 2013, GENOMICS, V101, P157, DOI 10.1016/j.ygeno.2012.11.010; Sneller CH, 2009, CROP SCI, V49, P363, DOI 10.2135/cropsci2008.07.0420; Somers DJ, 2007, GENOME, V50, P557, DOI 10.1139/G07-031; Stich B, 2008, GENETICS, V178, P1745, DOI 10.1534/genetics.107.079707; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Tachmazidou I, 2007, PLOS GENET, V3, P1163, DOI 10.1371/journal.pgen.0030111; Tang R, 2009, ANN HUM GENET, V73, P631, DOI 10.1111/j.1469-1809.2009.00543.x; Templeton AR, 2005, GENETICS, V169, P441, DOI 10.1534/genetics.104.030080; TEMPLETON AR, 1987, GENETICS, V117, P343; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; TOWNLEYSMITH TF, 1987, CAN J PLANT SCI, V67, P225, DOI 10.4141/cjps87-026; Tsombalova J, 2017, GENET RESOUR CROP EV, V64, P653, DOI 10.1007/s10722-016-0389-9; Tuberosa R, 2014, MOL BREEDING, V34, P1527, DOI 10.1007/s11032-014-0188-y; Van Inghelandt D, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-56; Verlotta A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-263; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wang Y, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S16-S6; Weber AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008227; Weir BS., 1996, GENETIC DATA ANAL; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Yang HC, 2006, GENET EPIDEMIOL, V30, P531, DOI 10.1002/gepi.20165; Yonemaru J, 2014, PLANT CELL PHYSIOL, V55, DOI 10.1093/pcp/pct188; Yonemaru J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032982; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Yu ZX, 2007, GENET EPIDEMIOL, V31, P553, DOI 10.1002/gepi.20228; Zanke CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113287; Zhang W, 2008, THEOR APPL GENET, V117, P1361, DOI 10.1007/s00122-008-0869-1; Zhang W, 2008, THEOR APPL GENET, V116, P635, DOI 10.1007/s00122-007-0697-8; Zhang YL, 2009, EUPHYTICA, V165, P435, DOI 10.1007/s10681-008-9744-z; Zhao HH, 2007, GENETICS, V175, P1975, DOI 10.1534/genetics.106.066480; Zhao HY, 2003, PHARMACOGENOMICS, V4, P171, DOI 10.1517/phgs.4.2.171.22636; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhao LP, 2007, GENET EPIDEMIOL, V31, P154, DOI 10.1002/gepi.20198; Zollner S, 2005, GENETICS, V169, P1071, DOI 10.1534/genetics.104.031799	170	36	37	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170941	10.1371/journal.pone.0170941	http://dx.doi.org/10.1371/journal.pone.0170941			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135299	Green Published, gold			2022-12-27	WOS:000396124700032
J	Adel, M; Yamaguchi, T; Tomita, D; Nakawaki, T; Kim, YI; Hikita, Y; Haga, S; Takahashi, M; Nadim, MA; Kawaguchi, A; Isa, M; El-Kenany, WH; El-Kadi, AA; Park, SB; Ishida, H; Maki, K; Kimura, R				Adel, Mohamed; Yamaguchi, Tetsutaro; Tomita, Daisuke; Nakawaki, Takatoshi; Kim, Yong-Il; Hikita, Yu; Haga, Shugo; Takahashi, Masahiro; Nadim, Mohamed A.; Kawaguchi, Akira; Isa, Mutsumi; El-Kenany, Walid H.; El-Kadi, Abbadi A.; Park, Soo-Byung; Ishida, Hajime; Maki, Koutaro; Kimura, Ryosuke			Contribution of FGFR1 Variants to Craniofacial Variations in East Asians	PLOS ONE			English	Article							RECEPTOR 1 FGFR1; CLEFT-LIP; SYNDROMIC CRANIOSYNOSTOSIS; GROWTH; PALATE; MORPHOLOGY; GENOTYPE; FAMILIES; SKELETAL; PARENTS	FGFR1 plays an important role in the development of the nervous system as well as the regulation of the skeletal development and bone homeostasis. Mutations in FGFR1 genes affect skull development, specifically suture and synchondrosis, resulting in craniosynostosis and facial abnormalities. We examined subjects with normal skull morphology for genetic polymorphisms that might be associated with normal craniofacial variations. Genomic DNA was obtained from 216 Japanese and 227 Korean subjects. Four FGFR1 SNPs, namely, rs881301, rs6996321, rs4647905, and rs13317, were genotyped. These SNPs were tested for association with craniofacial measurements obtained from lateral and posteroanterior cephalometries, in which principle component analysis was performed to compress the data of the craniofacial measurements. We observed that SNPs rs13317 and rs6996321 were correlated with the overall head size and midfacial development, indicating that FGFR1 SNPs played crucial roles in the normal variation of human craniofacial morphology. Subjects with the derived alleles of SNPs rs13317 and rs6996321 had a small face and a facial pattern associated with a retruded midface and relatively wide-set eyes. These facial features were similar to but were milder than those of individuals with Pfeiffer syndrome, which is caused by a dysfunctional mutation in FGFR1.	[Adel, Mohamed; Yamaguchi, Tetsutaro; Tomita, Daisuke; Nakawaki, Takatoshi; Hikita, Yu; Haga, Shugo; Takahashi, Masahiro; Maki, Koutaro] Showa Univ, Dept Orthodont, Tokyo, Japan; [Nadim, Mohamed A.; El-Kadi, Abbadi A.] Suez Canal Univ, Dept Orthodont, Ismailia, Egypt; [Kim, Yong-Il; Park, Soo-Byung] Pusan Natl Univ, Dent Hosp, Dept Orthodont, Dent Res Inst, Yangsan, South Korea; [Kawaguchi, Akira; Isa, Mutsumi; Ishida, Hajime; Kimura, Ryosuke] Univ Ryukyus, Grad Sch Med, Dept Human Biol & Anat, Okinawa, Japan; [El-Kenany, Walid H.] Univ Alexandria, Dept Orthodont, Alexandria, Egypt	Showa University; Egyptian Knowledge Bank (EKB); Suez Canal University; Pusan National University; Pusan National University Hospital; University of the Ryukyus; Egyptian Knowledge Bank (EKB); Alexandria University	Yamaguchi, T (corresponding author), Showa Univ, Dept Orthodont, Tokyo, Japan.; Kimura, R (corresponding author), Univ Ryukyus, Grad Sch Med, Dept Human Biol & Anat, Okinawa, Japan.	tyamaguchi@dent.showa-u.ac.jp; rkimura@med.u-ryukyu.ac.jp	Adel, Mohamed/AAR-9153-2020	Yamaguchi, Tetsutaro/0000-0001-9806-7163; Elkadi, Abbadi/0000-0002-6871-1306; Haga, Shugo/0000-0003-0676-7125; Mohamed, Mohamed/0000-0002-9302-0443	Grants-in-Aid for Scientific Research [16K15843] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Albuisson Juliette, 2005, Hum Mutat, V25, P98, DOI 10.1002/humu.9298; Ali N, 2015, CLEFT PALATE-CRAN J, V52, P506, DOI 10.1597/14-157; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BAUMRIND S, 1971, AMER J ORTHODONTICS, V60, P505, DOI 10.1016/0002-9416(71)90116-3; Bos A, 2003, AM J ORTHOD DENTOFAC, V123, P127, DOI 10.1067/mod.2003.84; Boutros S, 2007, J CRANIOFAC SURG, V18, P146, DOI 10.1097/01.scs.0000248655.53405.a7; Britto JA, 2001, PLAST RECONSTR SURG, V108, P2026, DOI 10.1097/00006534-200112000-00030; Clark Jeremy D, 2016, Am J Ophthalmol Case Rep, V2, P1, DOI 10.1016/j.ajoc.2016.04.001; Coussens AK, 2005, GENOMICS, V85, P563, DOI 10.1016/j.ygeno.2005.02.002; Cunningham ML, 2007, ORTHOD CRANIOFAC RES, V10, P67, DOI 10.1111/j.1601-6343.2007.00389.x; Dahlberg G, 1940, BMJ-BRIT MED J, V14, P358; Dode C, 2003, NAT GENET, V33, P463, DOI 10.1038/ng1122; Dorey K, 2010, DEVELOPMENT, V137, P3731, DOI 10.1242/dev.037689; Gomez-Valdes JA, 2013, AM J HUM BIOL, V25, P12, DOI 10.1002/ajhb.22331; Hajihosseini MK, 2009, DEV DYNAM, V238, P376, DOI 10.1002/dvdy.21648; Harris EF, 2009, ARCH ORAL BIOL, V54, pS107, DOI 10.1016/j.archoralbio.2008.04.010; Hartsfield Jr JK, 2012, GENETIC FACTORS AFFE; Hunemeier T, 2014, AM J HUM BIOL, V26, P164, DOI 10.1002/ajhb.22496; Jacob AL, 2006, DEV BIOL, V296, P315, DOI 10.1016/j.ydbio.2006.05.031; Johannsdottir B, 2005, AM J ORTHOD DENTOFAC, V127, P200, DOI 10.1016/j.ajodo.2004.07.033; MATRAS H, 1977, J MAXILLOFAC SURG, V5, P298, DOI 10.1016/S0301-0503(77)80122-7; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; MOORE MH, 1995, CLEFT PALATE-CRAN J, V32, P62, DOI 10.1597/1545-1569(1995)032<0062:PSACR>2.3.CO;2; Nalcaci R, 2010, DENTOMAXILLOFAC RAD, V39, P100, DOI 10.1259/dmfr/82724776; Nie XG, 2006, ORAL DIS, V12, P102, DOI 10.1111/j.1601-0825.2005.01176.x; Nishida N, 2007, ANAL BIOCHEM, V364, P78, DOI 10.1016/j.ab.2007.02.005; Ornitz DM, 2001, GENOME BIOL, V2; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Peng SN, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003375; Pruzansky S, 1977, Birth Defects Orig Artic Ser, V13, P3; Rafiqdoost Z, 2014, INT J PEDIATR OTORHI, V78, P731, DOI 10.1016/j.ijporl.2014.01.024; Riley BM, 2007, AM J MED GENET A, V143A, P846, DOI 10.1002/ajmg.a.31673; Riley BM, 2007, P NATL ACAD SCI USA, V104, P4512, DOI 10.1073/pnas.0607956104; Robin NH, 1998, GENEREVIEWS; Sato N, 2004, J CLIN ENDOCR METAB, V89, P1079, DOI 10.1210/jc.2003-030476; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Su N, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.3; Swennen G, 2002, INT J ORAL MAX SURG, V31, P13, DOI 10.1054/ijom.2001.0177; WANAKA A, 1990, NEURON, V5, P267, DOI 10.1016/0896-6273(90)90164-B; WARD RE, 1989, CLEFT PALATE J, V26, P318; Wilkie AOM, 1997, HUM MOL GENET, V6, P1647, DOI 10.1093/hmg/6.10.1647; Yoon YJ, 2001, ANGLE ORTHOD, V71, P396	42	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170645	10.1371/journal.pone.0170645	http://dx.doi.org/10.1371/journal.pone.0170645			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129408	Green Published, Green Submitted, gold			2022-12-27	WOS:000396211400050
J	Floros, S; Liakopoulou-Kyriakides, M; Karatasos, K; Papadopoulos, GE				Floros, Stelios; Liakopoulou-Kyriakides, Maria; Karatasos, Kostas; Papadopoulos, Georgios E.			Frequency Dependent Non- Thermal Effects of Oscillating Electric Fields in the Microwave Region on the Properties of a Solvated Lysozyme System: A Molecular Dynamics Study	PLOS ONE			English	Article							HYDROGEN-BOND DYNAMICS; DIELECTRIC-PROPERTIES; COMPUTER-SIMULATIONS; AQUEOUS-SOLUTION; PROTEIN HYDRATION; IONIC SOLUTION; X-RAY; WATER; CONSTANT; RELAXATION	The use of microwaves in every day's applications raises issues regarding the non thermal biological effects of microwaves. In this work we employ molecular dynamics simulations to advance further the dielectric studies of protein solutions in the case of lysozyme, taking into consideration possible frequency dependent changes in the structural and dynamic properties of the system upon application of electric field in the microwave region. The obtained dielectric spectra are identical with those derived in our previous work using the Frohlich-Kirkwood approach in the framework of the linear response theory. Noticeable structural changes in the protein have been observed only at frequencies near its absorption maximum. Concerning C-alpha position fluctuations, different frequencies affected different regions of the protein sequence. Furthermore, the influence of the field on the kinetics of protein-water as well as on the water-water hydrogen bonds in the first hydration shell has been studied; an extension of the Luzar-Chandler kinetic model was deemed necessary for a better fit of the applied field results and for the estimation of more accurate hydrogen bond lifetime values.	[Floros, Stelios; Liakopoulou-Kyriakides, Maria; Karatasos, Kostas] Aristotle Univ Thessaloniki, Dept Chem, Fac Chem Engn, Thessaloniki, Greece; [Papadopoulos, Georgios E.] Univ Thessaly, Dept Biochem & Biotechnol, Fac Hlth Sci, Mezourlo, Larisa, Greece	Aristotle University of Thessaloniki; University of Thessaly	Papadopoulos, GE (corresponding author), Univ Thessaly, Dept Biochem & Biotechnol, Fac Hlth Sci, Mezourlo, Larisa, Greece.	geopap@bio.uth.gr	Karatasos, Konstantinos/D-1525-2013	Karatasos, Konstantinos/0000-0001-7431-5177; Papadopoulos, Georgios/0000-0002-2742-8467; Liakopoulou-Kyriakides, Maria/0000-0003-4629-8765	Department of Biochemistry & Biotechnology "Biotechnology - Quality Assessment in Nutrition and the Environment [3439]; Applications of Molecular Biology - Genetics - Diagnostic Biomarkers [3817]	Department of Biochemistry & Biotechnology "Biotechnology - Quality Assessment in Nutrition and the Environment; Applications of Molecular Biology - Genetics - Diagnostic Biomarkers	This work has been financially supported partly by the postgraduate courses of the Department of Biochemistry & Biotechnology Biotechnology - Quality Assessment in Nutrition and the Environment (Funding number 3439) and Applications of Molecular Biology - Genetics - Diagnostic Biomarkers (Funding number 3817). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, NAMD US GUID VERS 2; ANTOSIEWICZ J, 1994, J MOL BIOL, V238, P415, DOI 10.1006/jmbi.1994.1301; Bandyopadhyay S, 2005, J AM CHEM SOC, V127, P16660, DOI 10.1021/ja054462u; Barteri M, 2005, BIOPHYS CHEM, V113, P245, DOI 10.1016/j.bpc.2004.09.010; Bonincontro A, 2001, COLLOID SURFACE B, V21, P311, DOI 10.1016/S0927-7765(00)00214-9; Boresch S, 1999, BIOPHYS CHEM, V78, P43, DOI 10.1016/S0301-4622(98)00235-X; Boresch S, 2000, J PHYS CHEM B, V104, P8743, DOI 10.1021/jp0008905; Brace Christopher L., 2010, Critical Reviews in Biomedical Engineering, V38, P65, DOI 10.1615/CritRevBiomedEng.v38.i1.60; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CAILLOL JM, 1989, J CHEM PHYS, V91, P5544, DOI 10.1063/1.457557; CAILLOL JM, 1986, J CHEM PHYS, V85, P6645, DOI 10.1063/1.451446; Cametti C, 2011, J PHYS CHEM B, V115, P7144, DOI 10.1021/jp2019389; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; English NJ, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2515315; English NJ, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3184794; Floros S, 2015, EUR BIOPHYS J BIOPHY, V44, P599, DOI 10.1007/s00249-015-1052-7; Frohlich H., 1958, THEORY DIELECTRICS, P8; Hayashi Y, 2002, J NON-CRYST SOLIDS, V305, P328, DOI 10.1016/S0022-3093(02)01113-4; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; KING G, 1991, J CHEM PHYS, V95, P4366, DOI 10.1063/1.461760; Kirkwood JG, 1939, J CHEM PHYS, V7, P911, DOI 10.1063/1.1750343; Knocks A, 2001, J PHYS CHEM B, V105, P3635, DOI 10.1021/jp003700z; Kohler F., 1972, THE LIQUID STATE; Loffler G, 1997, J MOL BIOL, V270, P520, DOI 10.1006/jmbi.1997.1130; Luzar A, 1996, PHYS REV LETT, V76, P928, DOI 10.1103/PhysRevLett.76.928; Luzar A, 2000, J CHEM PHYS, V113, P10663, DOI 10.1063/1.1320826; Luzar A, 2000, CHEM PHYS, V258, P267, DOI 10.1016/S0301-0104(00)00163-4; MIURA N, 1994, BIOPOLYMERS, V34, P357, DOI 10.1002/bip.360340307; MULLER JJ, 1992, J APPL CRYSTALLOGR, V25, P181, DOI 10.1107/S0021889891011421; NAKAMURA H, 1988, PROTEIN ENG, V2, P177, DOI 10.1093/protein/2.3.177; Nandi N, 1998, J PHYS CHEM A, V102, P8217, DOI 10.1021/jp983327j; NEUMANN M, 1984, MOL PHYS, V52, P97, DOI 10.1080/00268978400101081; NEUMANN M, 1983, CHEM PHYS LETT, V102, P508, DOI 10.1016/0009-2614(83)87455-7; NEUMANN M, 1986, J CHEM PHYS, V85, P1567, DOI 10.1063/1.451198; NEUMANN M, 1986, MOL PHYS, V57, P97, DOI 10.1080/00268978600100081; NEUMANN M, 1983, CHEM PHYS LETT, V95, P417, DOI 10.1016/0009-2614(83)80585-5; Onsager L, 1936, J AM CHEM SOC, V58, P1486, DOI 10.1021/ja01299a050; PETHIG R, 1992, ANNU REV PHYS CHEM, V43, P177, DOI 10.1146/annurev.physchem.43.1.177; RAPAPORT DC, 1983, MOL PHYS, V50, P1151, DOI 10.1080/00268978300102931; Rosen A, 2007, IEEE MICROW MAG, V8, P70, DOI 10.1109/MMW.2007.289074; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Semenov S, 2009, PHILOS T R SOC A, V367, P3021, DOI 10.1098/rsta.2009.0092; SIMONSON T, 1995, P NATL ACAD SCI USA, V92, P1082, DOI 10.1073/pnas.92.4.1082; SIMONSON T, 1991, BIOPHYS J, V59, P670, DOI 10.1016/S0006-3495(91)82282-2; SMITH PE, 1993, J PHYS CHEM-US, V97, P2009, DOI 10.1021/j100111a046; SOUTH GP, 1972, PROC R SOC LON SER-A, V328, P371, DOI 10.1098/rspa.1972.0083; Suresh SJ, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2162888; Suzuki M, 1996, J PHYS CHEM-US, V100, P7279, DOI 10.1021/jp953331k; Svergun DI, 1998, P NATL ACAD SCI USA, V95, P2267, DOI 10.1073/pnas.95.5.2267; Weingartner H, 2001, J CHEM PHYS, V115, P1463, DOI 10.1063/1.1380205; YANG LQ, 1995, BIOPHYS J, V69, P1519, DOI 10.1016/S0006-3495(95)80022-6	52	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0169505	10.1371/journal.pone.0169505	http://dx.doi.org/10.1371/journal.pone.0169505			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129348	Green Submitted, gold, Green Published			2022-12-27	WOS:000396211400068
J	Gebreamlak, B; Dadi, AF; Atnafu, A				Gebreamlak, Bisratemariam; Dadi, Abel Fekadu; Atnafu, Azeb			High Adherence to Iron/Folic Acid Supplementation during Pregnancy Time among Antenatal and Postnatal Care Attendant Mothers in Governmental Health Centers in Akaki Kality Sub City, Addis Ababa, Ethiopia: Hierarchical Negative Binomial Poisson Regression	PLOS ONE			English	Article							IRON SUPPLEMENTATION; FOLIC-ACID; WOMEN	Background Iron deficiency during pregnancy is a risk factor for anemia, preterm delivery, and low birth weight. Iron/Folic Acid supplementation with optimal adherence can effectively prevent anemia in pregnancy. However, studies that address this area of adherence are very limited. Therefore, the current study was conducted to assess the adherence and to identify factors associated with a number of Iron/Folic Acid uptake during pregnancy time among mothers attending antenatal and postnatal care follow up in Akaki kality sub city. Methods Institutional based cross-sectional study was conducted on a sample of 557 pregnant women attending antenatal and postnatal care service. Systematic random sampling was used to select study subjects. The mothers were interviewed and the collected data was cleaned and entered into Epi Info 3.5.1 and analyzed by R version 3.2.0. Hierarchical Negative Binomial Poisson Regression Model was fitted to identify the factors associated with a number of Iron/Folic Acid uptake. Adjusted Incidence rate ratio (IRR) with 95% confidence interval (CI) was computed to assess the strength and significance of the association. Result More than 90% of the mothers were supplemented with at least one Iron/Folic Acid supplement from pill per week during their pregnancy time. Sixty percent of the mothers adhered (took four or more tablets per week) (95% CI, 56%-64.1%). Higher IRR of Iron/Folic Acid supplementation was observed among women: who received health education; which were privately employed; who achieved secondary education; and who believed that Iron/Folic Acid supplements increase blood, whereas mothers who reported a side effect, who were from families with relatively better monthly income, and who took the supplement when sick were more likely to adhere. Conclusion Adherence to Iron/Folic Acid supplement during their pregnancy time among mothers attending antenatal and postnatal care was found to be high. Activities that would address the above mentioned factors were highly recommended to ensure the sustainability of mothers' adherence to the supplement.	[Gebreamlak, Bisratemariam] Teklaymanot Gen Hosp, Addis Ababa, Ethiopia; [Dadi, Abel Fekadu; Atnafu, Azeb] Univ Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar	Dadi, AF (corresponding author), Univ Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia.	Fekten@yahoo.com	Dadi, Abel Fekadu/AAU-3433-2020	Dadi, Abel Fekadu/0000-0001-9967-7713				Abdullah H, 2014, ANTENATAL IRON FOLIC, V7; Aguayo VM, 2005, PUBLIC HEALTH NUTR, V8, P33, DOI 10.1079/PHN2004664; [Anonymous], 2012, ETHIOPIA DEMOGRAPHIC; [Anonymous], 2014, RAPID INITIAL ASSESS; Bin Nisar Y, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-305; Bin NY, 2014, BMC PREGNANCY CHILDB, V14, P344, DOI [10.1186/1471-2393-14-344, DOI 10.1186/1471-2393-14-344]; Casey GJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-261; Dinga LA, 2013, FACTORS ASS ADHERENC; Gathigi LN, 2011, FACTORS INFLUENCING; Gebremedhin S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-607; Haidar J, 2010, S AFR J CLIN NUTR, V23, P132; Khattab M.S., 2011, MED J CAIRO U, V79, P115; Mithra P, 2014, AFR HEALTH SCI, V14, P255, DOI 10.4314/ahs.v14i1.39; Ogundipe O, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-481; Oriji Vaduneme K, 2011, Niger J Med, V20, P131; Pratim PP, 2003, INT J PREV MED, V4, P1213; Roy MP, 2013, NATL J COMMUNITY MED, V4; Samuel A, 2012, PAN AFRICAN MED J, V20; Seck BC, 2008, PUBLIC HEALTH NUTR, V11, P596, DOI 10.1017/S1368980007000924; Smitasiri S, 2005, NUTR REV, V63, pS81, DOI 10.1301/nr.2005.dec.S81-S86; Taye B, 2015, PAN AFR MED J, V20, DOI [10.11604/pamj.2015.20.43.4894, 10.11604/pamj.2015.20.276.4243]; Titaley CR, 2014, ASIA PAC J CLIN NUTR, V23, P91, DOI 10.6133/apjcn.2014.23.1.18; Vongvichit P, 2003, J PUBLIC HLTH DEV, p1l; WHO, 2006, IR FOL AC SUPPL INT; World Health Organization, 2012, DAIL IR FOL AC SUPPL; Wulff M, 2003, ACTA OBSTET GYN SCAN, V82, P628, DOI 10.1034/j.1600-0412.2003.00186.x; Zakia M, 2011, MED J CAIRO U, V79, P115	27	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0169415	10.1371/journal.pone.0169415	http://dx.doi.org/10.1371/journal.pone.0169415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129344	Green Submitted, Green Published, gold			2022-12-27	WOS:000396211400069
J	Li, K; Wei, GY; Cao, YM; Li, D; Li, PH; Zhang, J; Bao, HF; Chen, YL; Fu, YF; Sun, P; Bai, XW; Ma, XQ; Lu, ZJ; Liu, ZX				Li, Kun; Wei, Guoyan; Cao, Yimei; Li, Dong; Li, Pinghua; Zhang, Jing; Bao, Huifang; Chen, Yingli; Fu, Yuanfang; Sun, Pu; Bai, Xingwen; Ma, Xueqing; Lu, Zengjun; Liu, Zaixin			The Identification and Distribution of Cattle XCR1 and XCL1 among Peripheral Blood Cells: New Insights into the Design of Dendritic Cells Targeted Veterinary Vaccine	PLOS ONE			English	Article							AFFERENT LYMPH; EXPRESSION; RESPONSES; ADJUVANT; ANTIGEN; CLEC9A; VIRUS	The chemokine (C motif) receptor 1 (XCR1) and its ligandXCL1 have been intensively studied in the mouse and human immune systems. Here, we determined the molecular characteristics of cattle XCR1 and XCL1 and their distribution among peripheral blood cells. Cattle XCR1 mRNA expression was mainly restricted to CD26(+) CADM1(+) CD205(+) MHCII+ CD11b(-) cells in blood that were otherwise lineage marker negative (lin(-)); these represented a subset of classic dendritic cells (DCs), not plasmacytoid DCs. Some of these DCs expressed CD11a, CD44, CD80 and CD86, but they did not express CD4, CD8, CD163 or CD172a. Cattle XCL1 was expressed in quiescent NK cells and in activated CD8 + T cells. Cattle XCR1(+) DCs migrated chemotactically in response to mouse, but not to human, XCL1. The distribution characters of cattle XCR1 and XCL1 suggested a vital role in regulation of acquired immune responses and indicated a potential for a DC targeted veterinary vaccine in cattle using XCL1 fused antigens.	[Li, Kun; Wei, Guoyan; Cao, Yimei; Li, Dong; Li, Pinghua; Zhang, Jing; Bao, Huifang; Chen, Yingli; Fu, Yuanfang; Sun, Pu; Bai, Xingwen; Ma, Xueqing; Lu, Zengjun; Liu, Zaixin] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS	Lu, ZJ; Liu, ZX (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Peoples R China.	luzengjun@caas.cn; liuzaixin@caas.cn	Li, Ping/GYV-4914-2022	Li, Kun/0000-0001-8307-634X	National Natural Science Foundation of China [31372422]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from National Natural Science Foundation of China (31372422).	Auray G, 2016, J IMMUNOL, V11; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Caminschi I, 2008, BLOOD, V112, P3264, DOI 10.1182/blood-2008-05-155176; Contreras V, 2010, J IMMUNOL, V185, P3313, DOI 10.4049/jimmunol.1000824; Crozat K, 2011, J IMMUNOL, V187, P4411, DOI 10.4049/jimmunol.1101717; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Deloizy C, 2016, DEV COMP IMMUNOL, V65, P31, DOI 10.1016/j.dci.2016.06.015; Dorner BG, 2009, IMMUNITY, V31, P823, DOI 10.1016/j.immuni.2009.08.027; Dutertre CA, 2014, J IMMUNOL, V192, P4697, DOI 10.4049/jimmunol.1302448; Epardaud M, 2004, J LEUKOCYTE BIOL, V76, P553, DOI 10.1189/jlb.0404223; Fossum E, 2015, EUR J IMMUNOL, V45, P624, DOI 10.1002/eji.201445080; Fox JC, 2016, BIOCHEMISTRY-US, V55, P1214, DOI 10.1021/acs.biochem.5b01329; Gliddon DR, 2004, IMMUNOLOGY, V111, P262, DOI 10.1111/j.0019-2805.2004.01820.x; Gonzalez-Cano P, 2014, DEV COMP IMMUNOL, V44, P378, DOI 10.1016/j.dci.2014.01.014; Gurka S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00035; Hartung E, 2015, J IMMUNOL, V194, P1069, DOI 10.4049/jimmunol.1401903; Howard CJ, 1997, J IMMUNOL, V159, P5372; Li J, 2015, EUR J IMMUNOL, V45, P854, DOI 10.1002/eji.201445127; Reeves RK, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0109273, DOI 10.1371/JOURNAL.PONE.0109273]; Terhorst D, 2015, J IMMUNOL, V194, P5895, DOI 10.4049/jimmunol.1500564; Tuinstra RL, 2007, BIOCHEMISTRY-US, V46, P2564, DOI 10.1021/bi602365d; Tullett KM, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87102; Tullett KM, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00239; Yoshida T, 1998, J BIOL CHEM, V273, P16551, DOI 10.1074/jbc.273.26.16551	24	3	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170575	10.1371/journal.pone.0170575	http://dx.doi.org/10.1371/journal.pone.0170575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129380	Green Published, gold, Green Submitted			2022-12-27	WOS:000396211400053
J	Woodhall, SC; Wills, GS; Horner, PJ; Craig, R; Mindell, JS; Murphy, G; McClure, MO; Soldan, K; Nardone, A; Johnson, AM				Woodhall, Sarah C.; Wills, Gillian S.; Horner, Patrick J.; Craig, Rachel; Mindell, Jennifer S.; Murphy, Gary; McClure, Myra O.; Soldan, Kate; Nardone, Anthony; Johnson, Anne M.			Chlamydia trachomatis Pgp3 Antibody Population Seroprevalence before and during an Era of Widespread Opportunistic Chlamydia Screening in England (1994-2012)	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; PELVIC-INFLAMMATORY-DISEASE; NATIONAL SURVEYS; LIFE-STYLES; WOMEN; EPIDEMIOLOGY; ATTITUDES; SEROLOGY; BRITAIN; COHORT	Background Opportunistic chlamydia screening of <25 year-olds was nationally-implemented in England in 2008 but its impact on chlamydia transmission is poorly understood. We undertook a population-based seroprevalence study to explore the impact of screening on cumulative incidence of chlamydia, as measured by C.trachomatis- specific antibody. Methods Anonymised sera from participants in the nationally-representative Health Surveys for England (HSE) were tested for C. trachomatis antibodies using two novel Pgp3 enzymelinked immunosorbent assays (ELISAs) as a marker of past infection. Determinants of being seropositive were explored using logistic regression among 16-44 year-old women and men in 2010 and 2012 (years when sexual behaviour questions were included in the survey) (n = 1,402 women; 1,119 men). Seroprevalence trends among 16-24 year-old women (n = 3,361) were investigated over ten time points from 1994-2012. Results In HSE2010/2012, Pgp3 seroprevalence among 16-44 year-olds was 24.4% (95% CI 22.0 - 27.1) in women and 13.9% (11.8-16.2) in men. Seroprevalence increased with age (up to 33.5% [ 27.5-40.2] in 30-34 year-old women, 18.7% [13.4-25.6] in 35-39 year-old men); years since first sex; number of lifetime sexual partners; and younger age at first sex. 76.7% of seropositive 16-24 year-olds had never been diagnosed with chlamydia. Among 16-24 year-old women, a non-significant decline in seroprevalence was observed from 2008-2012 (prevalence ratio per year: 0.94 [0.84-1.05]). Conclusion Our application of Pgp3 ELISAs demonstrates a high lifetime risk of chlamydia infection among women and a large proportion of undiagnosed infections. A decrease in age-specific cumulative incidence following national implementation of opportunistic chlamydia screening has not yet been demonstrated. We propose these assays be used to assess impact of chlamydia control programmes.	[Woodhall, Sarah C.; Murphy, Gary; Soldan, Kate; Nardone, Anthony] Publ Hlth England, Natl Infect Serv, London, England; [Woodhall, Sarah C.; Johnson, Anne M.] UCL, Res Dept Infect & Populat Hlth, London, England; [Wills, Gillian S.; McClure, Myra O.] Imperial Coll London, Jefferiss Res Trust Labs, Fac Med, St Marys Campus, London, England; [Horner, Patrick J.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Craig, Rachel] NatCen Social Res, London, England; [Mindell, Jennifer S.] UCL, Res Dept Epidemiol & Publ Hlth, London, England	Public Health England; University of London; University College London; Imperial College London; University of Bristol; University of London; University College London	Woodhall, SC (corresponding author), Publ Hlth England, Natl Infect Serv, London, England.; Woodhall, SC; Johnson, AM (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	sarah.woodhall@phe.gov.uk; anne.johnson@ucl.ac.uk	Mindell, Jennifer S/G-2241-2011	Mindell, Jennifer S/0000-0002-7604-6131; Johnson, Anne/0000-0003-1330-7100; Horner, Paddy/0000-0003-0411-8332; Nardone, Anthony/0000-0003-1138-0937; Soldan, Kate/0000-0002-0361-3174	Health and Social Care Information Centre; Public Health England; National Institute for Health Research [NF-SI-0508-10244, NF-SI-0513-10078] Funding Source: researchfish	Health and Social Care Information Centre; Public Health England; National Institute for Health Research(National Institute for Health Research (NIHR))	The Health Survey for England was funded by the Health and Social Care Information Centre. Testing of stored sera was funded by the Health Protection Agency (now Public Health England). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen D, 2010, J BACTERIOL, V192, P6017, DOI 10.1128/JB.00847-10; Craig R, 2013, HLTH SURVEY ENGLAND, V2; Gottlieb SL, 2010, J INFECT DIS, V201, pS190, DOI 10.1086/652401; Hafner LM, 2014, VACCINE, V32, P1563, DOI 10.1016/j.vaccine.2013.08.020; Health Protection Agency, 2012, GEN CHLAM TRACH DIAG; Health Protection Agency, 2011, GEN CHLAM TRACH DIAG; Health & Social Care Information Centre, 2009, HLTH SURV ENGL 2008, V2; Horner P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072001; Horner PJ, 2013, SEX TRANSM INFECT, V89, P398, DOI 10.1136/sextrans-2011-050386; Horner PJ, 2015, PLOS ONE UNPUB; Hou SP, 2015, INFECT IMMUN, V83, P4701, DOI 10.1128/IAI.00746-15; Johnson AM, 2008, SEX TRANSM INFECT, V84, P79, DOI 10.1136/sti.2007.028472; Land JA, 2010, HUM REPROD UPDATE, V16, P189, DOI 10.1093/humupd/dmp035; Li Z, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-90; Low N, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11080; Mercer CH, 2013, LANCET, V382, P1781, DOI 10.1016/S0140-6736(13)62035-8; Miller WC, 2008, SEX TRANSM INFECT, V84, P82, DOI 10.1136/sti.2007.028662; Mindell J, 2012, INT J EPIDEMIOL, V41, P1585, DOI 10.1093/ije/dyr199; Myers GSA, 2009, J BACTERIOL, V191, P7225, DOI 10.1128/JB.00746-09; Nicoll A, 2001, SEX TRANSM INFECT, V77, P242, DOI 10.1136/sti.77.4.242; Payne R. A., 2012, Health Statistics Quarterly, P22; Persson K, 2002, BEST PRACT RES CL OB, V16, P801, DOI 10.1053/beog.2002.0321; Prah P, 2014, SEXUALLY TRANSMIT S1, V41; Price MJ, 2014, EPIDEMIOL INFECT, V142, P562, DOI 10.1017/S0950268813001027; Price MJ, 2013, AM J EPIDEMIOL, V178, P484, DOI 10.1093/aje/kws583; Price MJ, 2012, SEX TRANSM DIS, V39, P608, DOI 10.1097/OLQ.0b013e3182572475; Public Health England, 2014, TABL 8 NUMB RAT SEL; Public Health England, 2014, NAT CHLAM SCREEN PRO; Public Health England, 2015, HLTH PROTECTION REPO, V9; Redmond SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115753; Sonnenberg P, 2013, LANCET, V382, P1795, DOI 10.1016/S0140-6736(13)61947-9; Stamm WE, 1999, SEXUALLY TRANSMITTED, V3rd; Stary G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa8205; Turner KME, 2006, SEX TRANSM INFECT, V82, P496, DOI 10.1136/sti.2005.019067; UK Clinical Research Network, 2015, 18521 UKCRN; van Aar F, 2014, SEX TRANSM INFECT, V90, P434, DOI 10.1136/sextrans-2013-051074; Wang Jue, 2010, Sarcoma, V2010, P454792, DOI 10.1155/2010/454792; WANG SP, 1974, J INFECT DIS, V130, P388, DOI 10.1093/infdis/130.4.388; WESTROM L, 1992, SEX TRANSM DIS, V19, P185, DOI 10.1097/00007435-199207000-00001; Wills GS, 2009, CLIN VACCINE IMMUNOL, V16, P835, DOI 10.1128/CVI.00021-09	40	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0152810	10.1371/journal.pone.0152810	http://dx.doi.org/10.1371/journal.pone.0152810			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129328	Green Published, Green Submitted, gold			2022-12-27	WOS:000396211400077
J	Chu, ND; Smith, MB; Perrotta, AR; Kassam, Z; Alm, EJ				Chu, Nathaniel D.; Smith, Mark B.; Perrotta, Allison R.; Kassam, Zain; Alm, Eric J.			Profiling Living Bacteria Informs Preparation of Fecal Microbiota Transplantations	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CLOSTRIDIUM-DIFFICILE INFECTION; ULCERATIVE-COLITIS; FROZEN INOCULUM; SEQUENCES; SAMPLES; BACTERIOTHERAPY; COMMUNITIES; EFFICACY; TAXONOMY	Fecal microbiota transplantation is a compelling treatment for recurrent Clostridium difficile infections, with potential applications against other diseases associated with changes in gut microbiota. But variability in fecal bacterial communities-believed to be the therapeutic agent-can complicate or undermine treatment efficacy. To understand the effects of transplant preparation methods on living fecal microbial communities, we applied a DNA-sequencing method (PMA-seq) that uses propidium monoazide (PMA) to differentiate between living and dead fecal microbes, and we created an analysis pipeline to identify individual bacteria that change in abundance between samples. We found that oxygen exposure degraded fecal bacterial communities, whereas freeze-thaw cycles and lag time between donor defecation and transplant preparation had much smaller effects. Notably, the abundance of Faecalibacterium prausnitzii-an anti-inflammatory commensal bacterium whose absence is linked to inflammatory bowel disease-decreased with oxygen exposure. Our results indicate that some current practices for preparing microbiota transplant material adversely affect living fecal microbial content and highlight PMA-seq as a valuable tool to inform best practices and evaluate the suitability of clinical fecal material.	[Chu, Nathaniel D.] MIT, Microbiol Grad Program, Cambridge, MA 02139 USA; [Chu, Nathaniel D.; Smith, Mark B.; Perrotta, Allison R.; Kassam, Zain; Alm, Eric J.] MIT, Ctr Microbiome Informat & Therapeut, Cambridge, MA 02139 USA; [Smith, Mark B.; Kassam, Zain; Alm, Eric J.] OpenBiome, Medford, MA USA; [Smith, Mark B.; Alm, Eric J.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Perrotta, Allison R.; Alm, Eric J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Alm, EJ (corresponding author), MIT, Ctr Microbiome Informat & Therapeut, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ejalm@mit.edu			Center for Microbiome Informatics and Therapeutics at MIT	Center for Microbiome Informatics and Therapeutics at MIT	This project is supported in part by a grant from the Center for Microbiome Informatics and Therapeutics at MIT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Vercoe E, 2012, CAN J GASTROENTEROL, V26, P457, DOI 10.1155/2012/213828; Anderson JL, 2012, ALIMENT PHARM THER, V36, P503, DOI 10.1111/j.1365-2036.2012.05220.x; Baughn AD, 2004, NATURE, V427, P441, DOI 10.1038/nature02285; Borody TJ, 2008, GASTROENTEROLOGY, V134, pA361; Borody TJ, 2012, NAT REV GASTRO HEPAT, V9, P88, DOI 10.1038/nrgastro.2011.244; BORODY TJ, 1989, MED J AUSTRALIA, V150, P604, DOI 10.5694/j.1326-5377.1989.tb136704.x; Borody TJ, 2004, J CLIN GASTROENTEROL, V38, P475, DOI 10.1097/01.mcg.0000128988.13808.dc; Borody TJ, 2003, J CLIN GASTROENTEROL, V37, P42, DOI 10.1097/00004836-200307000-00012; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carini P., 2016, BIORXIV; Colman RJ, 2014, J CROHNS COLITIS, V8, P1569, DOI 10.1016/j.crohns.2014.08.006; Cui BT, 2015, J GASTROEN HEPATOL, V30, P51, DOI 10.1111/jgh.12727; David LA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-7-r89; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Exterkate RAM, 2015, CLIN ORAL INVEST, V19, P813, DOI 10.1007/s00784-014-1297-z; Gorzelak MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134802; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamilton MJ, 2013, GUT MICROBES, V4, P125, DOI 10.4161/gmic.23571; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kelly CR, 2015, GASTROENTEROLOGY, V149, P223, DOI 10.1053/j.gastro.2015.05.008; Khoruts A, 2015, CLIN GASTROENTEROL H, V13, P246, DOI 10.1016/j.cgh.2014.11.014; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Li SS, 2016, SCIENCE, V352, P586, DOI 10.1126/science.aad8852; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Miquel S, 2013, CURR OPIN MICROBIOL, V16, P255, DOI 10.1016/j.mib.2013.06.003; Moayyedi P, 2015, GASTROENTEROLOGY, V149, P102, DOI 10.1053/j.gastro.2015.04.001; Nocker A, 2010, INT MICROBIOL, V13, P59, DOI 10.2436/20.1501.01.111; Olesen SW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154804; Ott SJ, 2004, DIAGN MICR INFEC DIS, V50, P237, DOI 10.1016/j.diagmicrobio.2004.08.012; Preheim SP, 2013, APPL ENVIRON MICROB, V79, P6593, DOI 10.1128/AEM.00342-13; ROEDIGER WEW, 1980, GUT, V21, P793, DOI 10.1136/gut.21.9.793; Roesch Luiz F W, 2009, Open Microbiol J, V3, P40, DOI 10.2174/1874285800903010040; Satokari R, 2015, ALIMENT PHARM THER, V41, P46, DOI 10.1111/apt.13009; SHAH HN, 1982, ZBL BAKT MIK HYG I C, V3, P394; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Smits LP, 2013, GASTROENTEROLOGY, V145, P946, DOI 10.1053/j.gastro.2013.08.058; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; van Nood E, 2014, CURR OPIN GASTROEN, V30, P34, DOI 10.1097/MOG.0000000000000024; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206; Youngster I, 2014, CLIN INFECT DIS, V58, P1515, DOI 10.1093/cid/ciu135; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071108	48	54	69	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170922	10.1371/journal.pone.0170922	http://dx.doi.org/10.1371/journal.pone.0170922			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125667	Green Submitted, Green Published, gold			2022-12-27	WOS:000396176100024
J	Stadelmann, D; Torgler, B				Stadelmann, David; Torgler, Benno			Voting on Embryonic Stem Cell Research: Citizens More Supportive than Politicians	PLOS ONE			English	Article							DEBATE	As the public debate over stem cell research continues, the observable voting behaviour in Switzerland offers a unique opportunity to compare the voting behaviour of politicians with that of voters. By analysing the outcomes of a referendum on a liberal new bill regulating such research, we reveal an about 10 percentage point lower conditional probability of the bill being accepted by politicians than by voters. Whereas the behaviour of politicians is driven almost entirely by party affiliation, citizen votes are driven not only by party attachment but also by church attendance. Seldom or never attending church increases the probability of bill acceptance by over 15 percentage points, while supporting the Liberal Party and the Social Democratic Party instead of the Christian Democratic Party makes supporting the bill more likely for voters, suggesting that religious observance is important. The observance of these tendencies in Switzerland-an environment that promotes discussion through direct democratic rights-strongly suggests that citizens see the benefits of stem cell research.	[Stadelmann, David] Univ Bayreuth, Bayreuth, Germany; [Torgler, Benno] Queensland Univ Technol, Brisbane, Qld, Australia	University of Bayreuth; Queensland University of Technology (QUT)	Stadelmann, D (corresponding author), Univ Bayreuth, Bayreuth, Germany.	david.stadelmann@uni-bayreuth.de	Stadelmann, David/I-1116-2019; Torgler, Benno/W-4556-2019; Torgler, Benno/J-1140-2012	Stadelmann, David/0000-0002-1211-9936; Torgler, Benno/0000-0002-9809-963X; Torgler, Benno/0000-0002-9809-963X	Australian Research Council [FT110100463]; German Research Foundation (DFG); University of Bayreuth	Australian Research Council(Australian Research Council); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Bayreuth	The authors acknowledge financial support from the Australian Research Council (FT110100463). This publication was funded by the German Research Foundation (DFG) and the University of Bayreuth in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, NAT MED, V19, P820; [Anonymous], 2014, NATURE, V508, P287; Blow N, 2008, NATURE, V451, P855, DOI 10.1038/451855a; Borgelt EL, 2013, CELL STEM CELL, V12, P652, DOI 10.1016/j.stem.2013.05.007; Check E., 2004, NATURE NEWS BLOG; Check E., 2011, NATURE NEWS BLOG; Cyranoski D, 2015, NATURE, V520, P593, DOI 10.1038/520593a; Cyranoski D, 2014, NATURE, V516, P162, DOI 10.1038/516162a; Daley GQ, 2007, SCIENCE, V315, P603, DOI 10.1126/science.1139337; Dasgupta I, 2014, CELL STEM CELL, V14, P9, DOI 10.1016/j.stem.2013.12.006; Gutmann J, 2015, KYKLOS, V68, P153, DOI 10.1111/kykl.12078; Hayden EC, 2014, NATURE, V511, P19, DOI 10.1038/511019a; Hessami Z, 2016, KYKLOS, V69, P263, DOI 10.1111/kykl.12111; Holden C, 2008, SCIENCE, V319, P560, DOI 10.1126/science.319.5863.560; Holden C, 2007, SCIENCE, V315, P315; Hyun I, 2014, NATURE, V509, P27, DOI 10.1038/509027a; Kamenova K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010496; Levine AD, 2011, CELL STEM CELL, V8, P132, DOI 10.1016/j.stem.2011.01.002; Lovell-Badge R, 2001, NATURE, V414, P88, DOI 10.1038/35102150; Moon S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086395; Nisbet M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088473; Nisbet MC, 2003, HARV INT J PRESS-POL, V8, P36, DOI 10.1177/1081180X02251047; Stadelmann D., 2014, J EXPT POLITIC SCI, V1, P16, DOI DOI 10.1017/XPS.2014.1; Stadelmann D, 2013, J COMP ECON, V41, P170, DOI 10.1016/j.jce.2012.05.005; Torgler B, 2006, J ECON BEHAV ORGAN, V61, P81, DOI 10.1016/j.jebo.2004.10.007; Vakili K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120052; Wadman M, 2011, NATURE, V476, P14, DOI 10.1038/476014a; Williams C, 2003, SOCIOL HEALTH ILL, V25, P793, DOI 10.1046/j.1467-9566.2003.00370.x	28	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170656	10.1371/journal.pone.0170656	http://dx.doi.org/10.1371/journal.pone.0170656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7IT	28125626	Green Submitted, Green Published, gold			2022-12-27	WOS:000396176100078
J	Hwang, S; Song, H; Cho, SW; Kim, CE; Kim, CS; Kim, K				Hwang, Seonhee; Song, Hyerin; Cho, Soon-Woo; Kim, Chang Eun; Kim, Chang-Seok; Kim, Kyujung			Optical measurements of paintings and the creation of an artwork database for authenticity	PLOS ONE			English	Article							DIFFUSE-REFLECTANCE SPECTROSCOPY; COHERENCE TOMOGRAPHY; CULTURAL-HERITAGE; RAMAN MICROSCOPY; ART CONSERVATION; PIGMENTS; IDENTIFICATION; SPECTROMETRY; FORGERIES; OBJECTS	Paintings have high cultural and commercial value, so that needs to be preserved. Many techniques have been attempted to analyze properties of paintings, including X-ray analysis and optical coherence tomography (OCT) methods, and enable conservation of paintings from forgeries. In this paper, we suggest a simple and accurate optical analysis system to protect them from counterfeit which is comprised of fiber optics reflectance spectroscopy (FORS) and line laser-based topographic analysis. The system is designed to fully cover the whole area of paintings regardless of its size for the accurate analysis. For additional assessments, a line laser-based high resolved OCT was utilized. Some forgeries were created by the experts from the three different styles of genuine paintings for the experiments. After measuring surface properties of paintings, we could observe the results from the genuine works and the forgeries have the distinctive characteristics. The forgeries could be distinguished maximally 76.5% with obtained RGB spectra by FORS and 100% by topographic analysis. Through the several executions, the reliability of the system was confirmed. We could verify that the measurement system is worthwhile for the conservation of the valuable paintings. To store the surface information of the paintings in micron scale, we created a numerical database. Consequently, we secured the databases of three different famous Korean paintings for accurate authenticity.	[Hwang, Seonhee; Kim, Kyujung] Pusan Natl Univ, Dept Adv Circuit Interconnect, Busan, South Korea; [Song, Hyerin; Cho, Soon-Woo; Kim, Chang-Seok; Kim, Kyujung] Pusan Natl Univ, Dept Cogno Mechatron Engn, Busan, South Korea; [Kim, Chang Eun] Pusan Natl Univ, Dept Fine Arts, Busan, South Korea	Pusan National University; Pusan National University; Pusan National University	Kim, K (corresponding author), Pusan Natl Univ, Dept Adv Circuit Interconnect, Busan, South Korea.; Kim, CS; Kim, K (corresponding author), Pusan Natl Univ, Dept Cogno Mechatron Engn, Busan, South Korea.	ckim@pusan.ac.kr; k.kim@pusan.ac.kr			Convergence Research Grant - Pusan National University (PNU) [PNU-2013-1332-0001]	Convergence Research Grant - Pusan National University (PNU)	This work was supported by the Convergence Research Grant funded by the Pusan National University (PNU, Convergence Research Grant) (PNU-2013-1332-0001).	Adler DC, 2007, OPT EXPRESS, V15, P15972, DOI 10.1364/OE.15.015972; Arecchi T, 2006, OPT SPECTROSC+, V101, P23, DOI 10.1134/S0030400X06070058; BOWER NW, 1994, FRESEN J ANAL CHEM, V348, P402, DOI 10.1007/BF00323143; Caforio L, 2014, EUR PHYS J PLUS, V129, DOI 10.1140/epjp/i2014-14006-6; Castillejo M, 2000, J MOL STRUCT, V550, P191, DOI 10.1016/S0022-2860(00)00386-0; Cheilakou E, 2014, J ARCHAEOL SCI, V41, P541, DOI 10.1016/j.jas.2013.09.020; Chiavari G, 1979, J ANAL APPL PYROL, V24, P227; Cho J, 2014, LASER PHYS, V24, DOI 10.1088/1054-660X/24/4/045605; Conti C, 2015, J RAMAN SPECTROSC, V46, P476, DOI 10.1002/jrs.4673; Correia AM, 2007, J RAMAN SPECTROSC, V38, P1390, DOI 10.1002/jrs.1786; Crilly R, 2015, TELEGRAPH; Dupuis G, 2002, APPL SPECTROSC, V56, P1329, DOI 10.1366/000370202760354803; Duran A, 2011, J RAMAN SPECTROSC, V42, P48, DOI 10.1002/jrs.2644; Fabbri M, 2001, APPL SPECTROSC, V55, P420, DOI 10.1366/0003702011952172; Grieken RV., 2004, CULTURAL HERITAGE CO; Higgs H, 2005, ECON REC, V81, P113, DOI 10.1111/j.1475-4932.2005.00237.x; Howells Richard, 2012, OUTRAGE ART CONTROVE; Khandekar N, 2010, STUD CONSERV, V55, P204, DOI 10.1179/sic.2010.55.3.204; Klockenkamper R, 2000, X-RAY SPECTROM, V29, P119; Lee SW, 2008, IEEE J SEL TOP QUANT, V14, P50, DOI 10.1109/JSTQE.2007.914046; Lee SW, 2007, IEEE PHOTONIC TECH L, V19, P176, DOI 10.1109/LPT.2006.890043; Leona M, 2001, STUD CONSERV, V46, P153, DOI 10.2307/1506806; Lienhardt A-T, 2013, ART FORGERY AUTHENTI; Locatelli-Bley Marilena, 1999, J CULT EC, V23, P209, DOI DOI 10.1023/A:1007551907213; Mei JP, 2002, AM ECON REV, V92, P1656, DOI 10.1257/000282802762024719; Merchant M, 2000, ELECTROPHORESIS, V21, P1164, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1164::AID-ELPS1164>3.0.CO;2-0; PESANDO JE, 1993, AM ECON REV, V83, P1075; Ragai J, 2013, P AM PHILOS SOC, V157, P164; Schreiner M, 2007, ANAL BIOANAL CHEM, V387, P737, DOI 10.1007/s00216-006-0718-5; Shabunya-Klyachkovskaya EV, 2014, J APPL SPECTROSC+, V80, P922, DOI 10.1007/s10812-014-9866-0; Smith K, 2005, TALANTA, V67, P402, DOI 10.1016/j.talanta.2005.06.030; Spilsbury R., 2009, COUNTERFEIT STOPPING; Tam AC, 1998, APPL SURF SCI, V127, P721, DOI 10.1016/S0169-4332(97)00788-5; Targowski P, 2004, STUD CONSERV, V49, P107, DOI 10.1179/sic.2004.49.2.107; Targowski P, 2012, APPL PHYS A-MATER, V106, P265, DOI 10.1007/s00339-011-6687-3; Targowski P, 2010, ACCOUNTS CHEM RES, V43, P826, DOI 10.1021/ar900195d; Targowski Piotr., 2006, LASER CHEM, V2006, P1, DOI [10.1155/2006/35373, DOI 10.1155/2006/35373]	37	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171354	10.1371/journal.pone.0171354	http://dx.doi.org/10.1371/journal.pone.0171354			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EN7DB	28151981	Green Submitted, gold, Green Published			2022-12-27	WOS:000396161200132
J	Liu, WY; Li, Q				Liu, Wenya; Li, Qi			An Efficient Elastic Net with Regression Coefficients Method for Variable Selection of Spectrum Data	PLOS ONE			English	Article							PLS; REGULARIZATION; LASSO	Using the spectrum data for quality prediction always suffers from noise and colinearity, so variable selection method plays an important role to deal with spectrum data. An efficient elastic net with regression coefficients method (Enet-BETA) is proposed to select the significant variables of the spectrum data in this paper. The proposed Enet-BETA method can not only select important variables to make the quality easy to interpret, but also can improve the stability and feasibility of the built model. Enet-BETA method is not prone to overfitting because of the reduction of redundant variables realized by elastic net method. Hypothesis testing is used to further simplify the model and provide a better insight into the nature of process. The experimental results prove that the proposed Enet-BETA method outperforms the other methods in terms of prediction performance and model interpretation.	[Liu, Wenya; Li, Qi] Dalian Univ Technol, Sch Control Sci & Engn, Dalian, Peoples R China	Dalian University of Technology	Li, Q (corresponding author), Dalian Univ Technol, Sch Control Sci & Engn, Dalian, Peoples R China.	qili@dlut.edu.cn		li, qi/0000-0002-0033-6204	National Natural Science Foundation of China [61403058]; Petro China Innovation Foundation [2014D-5006-0601]; Fundamental Research Funds for the Central Universities of China [DUT14LAB15]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Petro China Innovation Foundation; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work is supported by the National Natural Science Foundation of China (61403058), the Petro China Innovation Foundation (2014D-5006-0601), and the Fundamental Research Funds for the Central Universities of China (DUT14LAB15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centner V, 1996, ANAL CHEM, V68, P3851, DOI 10.1021/ac960321m; Chiu CC, 2013, CHEMOMETR INTELL LAB, V125, P153, DOI 10.1016/j.chemolab.2013.04.006; Chong IG, 2005, CHEMOMETR INTELL LAB, V78, P103, DOI 10.1016/j.chemolab.2004.12.011; COSTANZA MC, 1979, J AM STAT ASSOC, V74, P777, DOI 10.2307/2286399; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Fujiwara K, 2012, CHEMOMETR INTELL LAB, V118, P109, DOI 10.1016/j.chemolab.2012.08.007; Gosselin R, 2010, CHEMOMETR INTELL LAB, V100, P12, DOI 10.1016/j.chemolab.2009.09.005; Jolliffe IT, 2003, J COMPUT GRAPH STAT, V12, P531, DOI 10.1198/1061860032148; Kump P, 2012, AUTOMATICA, V48, P2107, DOI 10.1016/j.automatica.2012.06.051; Leardi R, 1998, CHEMOMETR INTELL LAB, V41, P195, DOI 10.1016/S0169-7439(98)00051-3; Park H, 2015, J STAT COMPUT SIM, V86, P1; Phatak A, 1997, J CHEMOMETR, V11, P311, DOI 10.1002/(SICI)1099-128X(199707)11:4<311::AID-CEM478>3.0.CO;2-4; Qi L, 2015, P 27 CHIN CONTR DEC, P754; Reunanen J., 2003, Journal of Machine Learning Research, V3, P1371, DOI 10.1162/153244303322753715; ter Braak CJF, 2009, J CHEMOMETR, V23, P217, DOI 10.1002/cem.1213; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Turlach BA, 2005, TECHNOMETRICS, V47, P349, DOI 10.1198/004017005000000139; Wang XM, 2010, COMPUT STAT DATA AN, V54, P2230, DOI 10.1016/j.csda.2010.03.026; Wang ZX, 2015, J PROCESS CONTR, V26, P56, DOI 10.1016/j.jprocont.2015.01.003; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	20	23	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171122	10.1371/journal.pone.0171122	http://dx.doi.org/10.1371/journal.pone.0171122			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152003	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161200092
J	Mumtaz, W; Xia, LK; Yasin, MAM; Ali, SSA; Malik, AS				Mumtaz, Wajid; Xia, Likun; Mohd Yasin, Mohd Azhar; Azhar Ali, Syed Saad; Malik, Aamir Saeed			A wavelet-based technique to predict treatment outcome for Major Depressive Disorder	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; EVENT-RELATED POTENTIALS; FUNCTIONAL CONNECTIVITY; TREATMENT RESPONSE; FEATURE-EXTRACTION; GENDER-DIFFERENCES; CHAOS METHODOLOGY; EEG DATA; BRAIN; CLASSIFICATION	Treatment management for Major Depressive Disorder (MDD) has been challenging. However, electroencephalogram (EEG)-based predictions of antidepressant's treatment outcome may help during antidepressant's selection and ultimately improve the quality of life for MDD patients. In this study, a machine learning (ML) method involving pretreatment EEG data was proposed to perform such predictions for Selective Serotonin Reuptake Inhibitor (SSRIs). For this purpose, the acquisition of experimental data involved 34 MDD patients and 30 healthy controls. Consequently, a feature matrix was constructed involving time-frequency decomposition of EEG data based on wavelet transform (WT) analysis, termed as EEG data matrix. However, the resultant EEG data matrix had high dimensionality. Therefore, dimension reduction was performed based on a rank-based feature selection method according to a criterion, i.e., receiver operating characteristic (ROC). As a result, the most significant features were identified and further be utilized during the training and testing of a classification model, i.e., the logistic regression (LR) classifier. Finally, the LR model was validated with 100 iterations of 10-fold cross-validation (10-CV). The classification results were compared with short-time Fourier transform (STFT) analysis, and empirical mode decompositions (EMD). The wavelet features extracted from frontal and temporal EEG data were found statistically significant. In comparison with other time-frequency approaches such as the STFT and EMD, the WT analysis has shown highest classification accuracy, i.e., accuracy = 87.5%, sensitivity = 95%, and specificity = 80%. In conclusion, significant wavelet coefficients extracted from frontal and temporal pre-treatment EEG data involving delta and theta frequency bands may predict antidepressant's treatment outcome for the MDD patients.	[Mumtaz, Wajid; Azhar Ali, Syed Saad; Malik, Aamir Saeed] Univ Teknol PETRONAS, CISIR, Bandar Seri Iskandar, Perak, Malaysia; [Xia, Likun] Beijing Inst Technol, Beijing, Peoples R China; [Mohd Yasin, Mohd Azhar] Univ Sains Malaysia, Dept Psychiat, Jalan Hosp Univ Sains Malaysia, Kota Baharu, Kelantan, Malaysia	Universiti Teknologi Petronas; Beijing Institute of Technology; Universiti Sains Malaysia	Malik, AS (corresponding author), Univ Teknol PETRONAS, CISIR, Bandar Seri Iskandar, Perak, Malaysia.	aamir_saeed@utp.edu.my	Malik, Aamir S/C-6904-2009; Mumtaz, Wajid/AAF-2363-2020	Malik, Aamir S/0000-0003-1085-3157; Mumtaz, Wajid/0000-0001-6468-8666; Azhar Ali, Syed Saad/0000-0002-5615-4629	HICoE grant [0153CA-005]; Ministry of Education (MOE), Malaysia; National Natural Science Foundation of China [61572076]; China Postdoctoral Science Foundation [2015M570940]; BIT Fundamental Research Grant [20150442009]	HICoE grant; Ministry of Education (MOE), Malaysia; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); BIT Fundamental Research Grant	This work is supported by the HICoE grant for CISIR (0153CA-005), Ministry of Education (MOE), Malaysia, the National Natural Science Foundation of China (No. 61572076), the China Postdoctoral Science Foundation Grant (No. 2015M570940), and the BIT Fundamental Research Grant (No. 20150442009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya R, 2005, COMPUT METH PROG BIO, V80, P37, DOI 10.1016/j.cmpb.2005.06.011; Acharya UR, 2012, INT J NEURAL SYST, V22, DOI [10.1142/S0129065712500025, 10.1142/S0129065712500116]; ADDISON P. S., 2010, ILLUSTRATED WAVELET; Adeli H, 2003, J NEUROSCI METH, V123, P69, DOI 10.1016/S0165-0270(02)00340-0; Adeli H, 2008, NEUROSCI LETT, V444, P190, DOI 10.1016/j.neulet.2008.08.008; Adeli H, 2007, IEEE T BIO-MED ENG, V54, P205, DOI 10.1109/TBME.2006.886855; Ahmadlou M, 2012, INT J PSYCHOPHYSIOL, V85, P206, DOI 10.1016/j.ijpsycho.2012.05.001; Alhaj H, 2011, J PSYCHOPHARMACOL, V25, P1175, DOI 10.1177/0269881110388323; Andrade AO, 2003, 2003 P 25 ANN INT C; [Anonymous], 2007, J AM PHYS SURG; Association AP, DIAGNOSTIC STAT MANU; Bares M, 2008, EUR PSYCHIAT, V23, P350, DOI 10.1016/j.eurpsy.2008.03.001; Bares M, 2010, EUR NEUROPSYCHOPHARM, V20, P459, DOI 10.1016/j.euroneuro.2010.03.007; BERG P, 1994, ELECTROEN CLIN NEURO, V90, P229, DOI 10.1016/0013-4694(94)90094-9; BRUDER GE, 1995, PSYCHOPHYSIOLOGY, V32, P373, DOI 10.1111/j.1469-8986.1995.tb01220.x; Carvalho A, 2011, J AFFECT DISORDERS, V129, P143, DOI 10.1016/j.jad.2010.08.023; Carvalho AF, 2009, CURR OPIN PSYCHIATR, V22, P7, DOI 10.1097/YCO.0b013e32831be9ef; Coburn KL, 2006, J NEUROPSYCH CLIN N, V18, P460, DOI 10.1176/appi.neuropsych.18.4.460; Cook I A, 2001, Semin Clin Neuropsychiatry, V6, P113, DOI 10.1053/scnp.2001.21844; Cook IA, 2002, NEUROPSYCHOPHARMACOL, V27, P120, DOI 10.1016/S0893-133X(02)00294-4; Cvetkovic D, 2008, DIGIT SIGNAL PROCESS, V18, P861, DOI 10.1016/j.dsp.2007.05.009; DeBattista C, 2008, 228 US PSYCH MENT HL; DeBattista C, 2011, J PSYCHIATR RES, V45, P64, DOI 10.1016/j.jpsychires.2010.05.009; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Desseilles M, 2009, J NEUROSCI, V29, P1395, DOI 10.1523/JNEUROSCI.3341-08.2009; Entsuah AR, 2001, J CLIN PSYCHIAT, V62, P869, DOI 10.4088/JCP.v62n1106; Faust O, 2014, J MECH MED BIOL, V14, DOI 10.1142/S0219519414500353; Fosgate GT, 2009, J VET DIAGN INVEST, V21, P3, DOI 10.1177/104063870902100102; Gallinat J., 2000, PSYCHOPHARMACOLOGY B, V148, P139; Gibbons J. D., 2011, NONPARAMETRIC STAT I; Gold C, 2013, SCAND J PSYCHOL, V54, P118, DOI 10.1111/sjop.12022; Golland P, 2005, LECT NOTES COMPUT SC, V3559, P501, DOI 10.1007/11503415_34; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Hasler G, 2010, WORLD PSYCHIATRY, V9, P155; Hirschfeld Robert M. A., 2001, Prim Care Companion J Clin Psychiatry, V3, P244; Hoechstetter K, 2010, BESA RES TUTORIAL, P1; Hollander M., 2013, NONPARAMETRIC STAT M, VVolume 751; Huang NE., 1998, R SOC, DOI [10.1098/rspa.1998.0193, DOI 10.1098/RSPA.1998.0193]; Hum LC, 2007, PUTRAJAYA HLTH TECHN, P58; Iosifescu DV, 2009, EUR NEUROPSYCHOPHARM, V19, P772, DOI 10.1016/j.euroneuro.2009.06.001; Isintas M, 2012, TURK PSIKIYATR DERG, V23, P33, DOI 10.5080/u6650; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; Khodayari-Rostamabad A, 2010, 32 ANN INT C IEEE EM; Khodayari-Rostamabad A, 2010, 2010 ANN INT C IEEE; Khodayari-Rostamabad A, 2013, CLIN NEUROPHYSIOL, V124, P1975, DOI 10.1016/j.clinph.2013.04.010; Khodayari-Rostamabad A, 2010, CLIN NEUROPHYSIOL, V121, P1998, DOI 10.1016/j.clinph.2010.05.009; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Knott V, 2000, PHARMACOPSYCHIATRY, V33, P201, DOI 10.1055/s-2000-8356; Koolschijn PCMP, 2009, HUM BRAIN MAPP, V30, P3719, DOI 10.1002/hbm.20801; Korb AS, 2009, CLIN NEUROPHYSIOL, V120, P1313, DOI 10.1016/j.clinph.2009.05.008; Kornstein SG, 2000, J AFFECT DISORDERS, V60, P1, DOI 10.1016/S0165-0327(99)00158-5; Labate D, 2013, IEEE SENS J, V13, P2666, DOI 10.1109/JSEN.2013.2257742; Langley P., 1996, ELEMENTS MACHINE LEA; Lee JJ, 1999, TENCON 99 P IEEE REG; Leuchter A F, 1994, Neuroimage, V1, P208, DOI 10.1006/nimg.1994.1006; Leuchter AF, 2010, CURR PSYCHIAT REP, V12, P553, DOI 10.1007/s11920-010-0160-4; Leuchter AF, 2009, PSYCHIAT RES, V169, P124, DOI 10.1016/j.psychres.2009.06.004; Leuchter AF, 2009, PSYCHIAT RES, V169, P132, DOI 10.1016/j.psychres.2009.04.004; Liu H, 2008, CH CRC DATA MIN KNOW, P3; Lo PC, 2003, AM J CHINESE MED, V31, P629, DOI 10.1142/S0192415X03001272; Lorenzetti V, 2009, J AFFECT DISORDERS, V117, P1, DOI 10.1016/j.jad.2008.11.021; Mamitsuka H, 2006, PATTERN RECOGN, V39, P2393, DOI 10.1016/j.patcog.2006.07.010; Marzetti L, 2007, NEUROIMAGE, V36, P48, DOI 10.1016/j.neuroimage.2007.02.034; MILLER LH, 1956, J AM STAT ASSOC, V51, P111, DOI 10.2307/2280807; Mitchell T.M, 2003, MACH LEARN; Miwakeichi F, 2004, NEUROIMAGE, V22, P1035, DOI 10.1016/j.neuroimage.2004.03.039; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; Mukhtar F., 2008, MALAYSIAN J PSYCHIAT, V17, P51; Mulert C, 2007, CLIN EEG NEUROSCI, V38, P78, DOI 10.1177/155005940703800209; Muller KR, 2001, IEEE T NEURAL NETWOR, V12, P181, DOI 10.1109/72.914517; Mumtaz W, 2015, BIOMED SIGNAL PROCES, V22, P85, DOI 10.1016/j.bspc.2015.07.003; Nunez PL, 2010, CLIN NEUROPHYSIOL, V121, P2177, DOI 10.1016/j.clinph.2010.04.029; Ocak H, 2009, EXPERT SYST APPL, V36, P2027, DOI 10.1016/j.eswa.2007.12.065; Ojala M, 2010, J MACH LEARN RES, V11, P1833; Olbrich S, 2015, NEUROPSYCHOBIOLOGY, V72, P229, DOI 10.1159/000437435; Olofsen E, 2008, BRIT J ANAESTH, V101, P810, DOI 10.1093/bja/aen290; Papakostas GI, 2007, BIOL PSYCHIAT, V62, P1217, DOI 10.1016/j.biopsych.2007.03.027; Papakostas GI, 2006, CAN J PSYCHIAT, V51, P783, DOI 10.1177/070674370605101208; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Pizzagalli D, 2001, AM J PSYCHIAT, V158, P405, DOI 10.1176/appi.ajp.158.3.405; Pizzagalli DA, 2011, NEUROPSYCHOPHARMACOL, V36, P183, DOI 10.1038/npp.2010.166; Plante DT, 2013, J AFFECT DISORDERS, V146, P120, DOI 10.1016/j.jad.2012.06.016; Polich J, 2006, INT J PSYCHOPHYSIOL, V60, P172, DOI 10.1016/j.ijpsycho.2005.12.012; Preskorn SH, 2004, SELECTIVE SEROTONIN, P241; Price JL, 2012, TRENDS COGN SCI, V16, P61, DOI 10.1016/j.tics.2011.12.011; Qin Y, 2010, CLIN NEUROPHYSIOL, V121, P1981, DOI 10.1016/j.clinph.2010.03.056; Rato RT, 2008, MECH SYST SIGNAL PR, V22, P1374, DOI 10.1016/j.ymssp.2007.11.028; Ruhe HG, 2006, J CLIN PSYCHIAT, V67, P1836, DOI 10.4088/JCP.v67n1203; Sheline YI, 2003, BIOL PSYCHIAT, V54, P338, DOI 10.1016/S0006-3223(03)00347-0; Shen L, 2005, IEEE ACM T COMPUT BI, V2, P166, DOI 10.1109/TCBB.2005.22; Simpson JR, 2001, P NATL ACAD SCI USA, V98, P683, DOI 10.1073/pnas.98.2.683; Spalletta G, 2014, J AFFECT DISORDERS, V152, P105, DOI 10.1016/j.jad.2013.05.068; Spronk D, 2011, J AFFECT DISORDERS, V128, P41, DOI 10.1016/j.jad.2010.06.021; Subasi A, 2007, EXPERT SYST APPL, V32, P1084, DOI 10.1016/j.eswa.2006.02.005; Thakor N. V., 2009, QUANTITATIVE EEG ANA; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Tzallas AT, 2009, IEEE T INF TECHNOL B, V13, P703, DOI 10.1109/TITB.2009.2017939; Van Rijsbergen C, 1980, INFORM RETRIEVAL; Volkert J, 2013, AGEING RES REV, V12, P339, DOI 10.1016/j.arr.2012.09.004; WADA Y, 1994, CLIN ELECTROENCEPHAL, V25, P81, DOI 10.1177/155005949402500209; Wang J., 2003, J STAT SOFTWARE, V8; Wu T, 2008, MEASUREMENT, V41, P618, DOI 10.1016/j.measurement.2007.07.007; Yusoff N, 2011, ASIAN PAC J CANCER P, V12, P915; Zeng LL, 2014, P NATL ACAD SCI USA, V111, P6058, DOI 10.1073/pnas.1317424111; Zeng LL, 2014, HUM BRAIN MAPP, V35, P1630, DOI 10.1002/hbm.22278; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zhou X.H., 2002, STAT METHODS DIAGNOS, DOI 10.1002/9780470317082	107	60	64	8	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171409	10.1371/journal.pone.0171409	http://dx.doi.org/10.1371/journal.pone.0171409			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28152063	Green Submitted, gold, Green Published			2022-12-27	WOS:000396161200141
J	Witt, KC; Castillo-Menendez, L; Ding, HT; Espy, N; Zhang, SJ; Kappes, JC; Sodroski, J				Witt, Kristen C.; Castillo-Menendez, Luis; Ding, Haitao; Espy, Nicole; Zhang, Shijian; Kappes, John C.; Sodroski, Joseph			Antigenic characterization of the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor incorporated into nanodiscs	PLOS ONE			English	Article							CRYO-EM STRUCTURE; HUMAN MONOCLONAL-ANTIBODY; TYPE-1 ENVELOPE; NEUTRALIZING ANTIBODIES; MUTATIONAL ANALYSIS; 3-DIMENSIONAL STRUCTURE; MOLECULAR ARCHITECTURE; V3-SPECIFIC ANTIBODIES; CYTOPLASMIC DOMAIN; DEPENDENT EPITOPE	The entry of human immunodeficiency virus (HIV-1) into host cells is mediated by the viral envelope glycoproteins (Envs), which are derived by the proteolytic cleavage of a trimeric gp160 Env precursor. The mature Env trimer is a major target for entry inhibitors and vaccine-induced neutralizing antibodies. Env interstrain variability, conformational flexibility and heavy glycosylation contribute to evasion of the host immune response, and create challenges for structural characterization and vaccine development. Here we investigate variables associated with reconstitution of the HIV-1 Env precursor into nanodiscs, nanoscale lipid bilayer discs enclosed by membrane scaffolding proteins. We identified detergents, as well as lipids similar in composition to the viral lipidome, that allowed efficient formation of Env-nanodiscs (Env-NDs). Env-NDs were created with the full-length Env precursor and with an Env precursor with the majority of the cytoplasmic tail intact. The self-association of Env-NDs was decreased by glutaraldehyde crosslinking. The Env-NDs exhibited an antigenic profile expected for the HIV-1 Env precursor. Env-NDs were recognized by broadly neutralizing antibodies. Of note, neutralizing antibody epitopes in the gp41 membrane-proximal external region and in the gp120:gp41 interface were well exposed on Env-NDs compared with Env expressed on cell surfaces. Most Env epitopes recognized by non-neutralizing antibodies were masked on the Env-NDs. This antigenic profile was stable for several days, exhibiting a considerably longer half-life than that of Env solubilized in detergents. Negative selection with weak neutralizing antibodies could be used to improve the antigenic profile of the Env-NDs. Finally, we show that lipid adjuvants can be incorporated into Env-NDs. These results indicate that Env-NDs represent a potentially useful platform for investigating the structural, functional and antigenic properties of the HIV-1 Env trimer in a membrane context.	[Witt, Kristen C.; Castillo-Menendez, Luis; Espy, Nicole; Zhang, Shijian; Sodroski, Joseph] Harvard Med Sch, Dept Canc Immunol & Virol, Dept Microbiol & Immunobiol, Dana Farber Canc Inst, Boston, MA 02115 USA; [Ding, Haitao; Kappes, John C.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Kappes, John C.] Birmingham Vet Affairs Med Ctr, Res Serv, Birmingham, AL USA; [Sodroski, Joseph] Harvard Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; Harvard University; Harvard T.H. Chan School of Public Health	Sodroski, J (corresponding author), Harvard Med Sch, Dept Canc Immunol & Virol, Dept Microbiol & Immunobiol, Dana Farber Canc Inst, Boston, MA 02115 USA.; Sodroski, J (corresponding author), Harvard Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.	joseph_sodroski@dfci.harvard.edu			National Institutes of Health [AI100645, AI24755, AI27767]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM056550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (AI100645) and by the late William F. McCarty-Cooper to J.S. and by the National Institutes of Health (AI24755 and AI27767) to J.C.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamyan LG, 2005, J VIROL, V79, P106, DOI 10.1128/JVI.79.1.106-115.2005; Akkaladevi N, 2013, PROTEIN SCI, V22, P492, DOI 10.1002/pro.2231; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; ALLAN JS, 1985, SCIENCE, V228, P1091, DOI 10.1126/science.2986290; Alsahafi N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122111; Astafieva IV, 1996, J CHROMATOGR A, V740, P215, DOI 10.1016/0021-9673(96)00134-3; Bar KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002721; Bartesaghi A, 2013, NAT STRUCT MOL BIOL, V20, P1352, DOI 10.1038/nsmb.2711; Bayburt TH, 2003, PROTEIN SCI, V12, P2476, DOI 10.1110/ps.03267503; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Bell JM, 2016, METHODS, V100, P25, DOI 10.1016/j.ymeth.2016.02.018; BIBERFELD P, 1974, J IMMUNOL METHODS, V4, P135, DOI 10.1016/0022-1759(74)90056-8; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; BOSCH V, 1990, J VIROL, V64, P2337, DOI 10.1128/JVI.64.5.2337-2344.1990; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; BUGGE TH, 1990, J VIROL, V64, P4123, DOI 10.1128/JVI.64.9.4123-4129.1990; Chakrabarti BK, 2011, J VIROL, V85, P8217, DOI 10.1128/JVI.00756-11; Chakrabarti BK, 2011, AIDS RES HUM RETROV, V27, P877, DOI 10.1089/AID.2010.0281; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chen J, 2015, SCIENCE, V349, P191, DOI 10.1126/science.aaa9804; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; COLLINS JS, 1981, J HISTOCHEM CYTOCHEM, V29, P411, DOI 10.1177/29.3.6787116; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Davis KL, 2009, VIROLOGY, V387, P414, DOI 10.1016/j.virol.2009.02.022; Davis KL, 2009, J VIROL, V83, P1240, DOI 10.1128/JVI.01743-08; Decker JM, 2005, J EXP MED, V201, P1407, DOI 10.1084/jem.20042510; Demento SL, 2009, VACCINE, V27, P3013, DOI 10.1016/j.vaccine.2009.03.034; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; EARL PL, 1994, J VIROL, V68, P3015, DOI 10.1128/JVI.68.5.3015-3026.1994; Edwards TG, 2002, J VIROL, V76, P2683, DOI 10.1128/JVI.76.6.2683-2691.2002; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fester T, 2008, J MICROSC-OXFORD, V231, P342, DOI 10.1111/j.1365-2818.2008.01999.x; Fischer W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012303; Foley B, LAUR1326007 LOS AL N; Frauenfeld J, 2016, NAT METHODS, V13, P345, DOI [10.1038/NMETH.3801, 10.1038/nmeth.3801]; Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026; FREED EO, 1989, J VIROL, V63, P4670, DOI 10.1128/JVI.63.11.4670-4675.1989; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Gao F, 2014, CELL, V158, P481, DOI 10.1016/j.cell.2014.06.022; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Georgiev IS, 2015, J VIROL, V89, P5318, DOI 10.1128/JVI.03451-14; Go EP, 2015, J VIROL, V89, P8245, DOI 10.1128/JVI.00628-15; Gogol EP, 2013, PROTEIN SCI, V22, P586, DOI 10.1002/pro.2241; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Guenaga J, 2016, J VIROL, V90, P2806, DOI 10.1128/JVI.02652-15; Guenaga J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004570; Guttman M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7144; Haim H, 2013, CELL HOST MICROBE, V14, P547, DOI 10.1016/j.chom.2013.10.006; Haim H, 2013, J VIROL, V87, P1884, DOI 10.1128/JVI.02765-12; Haim H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000360; Haynes BF, 2016, CELL HOST MICROBE, V19, P292, DOI 10.1016/j.chom.2016.02.002; Haynes BF, 2013, CURR OPIN HIV AIDS, V8, P326, DOI 10.1097/COH.0b013e328361d178; He Y, 2003, J VIROL, V77, P1666, DOI 10.1128/JVI.77.3.1666-1671.2003; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Herrera C, 2005, VIROLOGY, V338, P154, DOI 10.1016/j.virol.2005.05.002; Hoxie JA, 2010, ANNU REV MED, V61, P135, DOI 10.1146/annurev.med.60.042507.164323; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Jacob RA, 2015, J VIROL, V89, P5264, DOI 10.1128/JVI.00129-15; Jozefowski S, 2011, MICROB PATHOGENESIS, V50, P350, DOI 10.1016/j.micpath.2011.03.001; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Jumel K, 1996, INT J BIOL MACROMOL, V18, P133, DOI 10.1016/0141-8130(95)01071-8; Justesen BH, 2013, J BIOL CHEM, V288, P26419, DOI 10.1074/jbc.M112.446948; Katayama H, 2010, P NATL ACAD SCI USA, V107, P3453, DOI 10.1073/pnas.1000100107; Klasse PJ, 2013, J VIROL, V87, P9873, DOI 10.1128/JVI.01226-13; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Korber B.T., 1998, HUMAN RETROVIRUSES A; Koshiba T, 2003, J BIOL CHEM, V278, P7573, DOI 10.1074/jbc.M211154200; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; Li YX, 2012, J VIROL, V86, P11231, DOI 10.1128/JVI.01543-12; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Lu M, 2001, J VIROL, V75, P11146, DOI 10.1128/JVI.75.22.11146-11156.2001; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mao YD, 2013, P NATL ACAD SCI USA, V110, P12438, DOI 10.1073/pnas.1307382110; Mao YD, 2012, NAT STRUCT MOL BIOL, V19, P893, DOI 10.1038/nsmb.2351; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; McCaffrey RA, 2004, J VIROL, V78, P3279, DOI 10.1128/JVI.78.7.3279-3295.2004; MCCUNE JM, 1988, CELL, V53, P55, DOI 10.1016/0092-8674(88)90487-4; Mo HM, 2004, VIROLOGY, V329, P319, DOI 10.1016/j.virol.2004.08.025; Moody MA, 2015, CELL HOST MICROBE, V18, P354, DOI 10.1016/j.chom.2015.08.006; Moore PL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000598; Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426; Nakatani-Webster E, 2015, J VIROL METHODS, V226, P15, DOI 10.1016/j.jviromet.2015.09.011; Nandi A, 2010, VIROLOGY, V396, P339, DOI 10.1016/j.virol.2009.10.044; Pancera M, 2005, VIROLOGY, V332, P145, DOI 10.1016/j.virol.2004.10.042; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; Ringe RP, 2015, J VIROL, V89, P12189, DOI 10.1128/JVI.01768-15; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; ROBEY WG, 1985, SCIENCE, V228, P593, DOI 10.1126/science.2984774; ROBINSON JE, 1990, J IMMUNOL METHODS, V132, P63, DOI 10.1016/0022-1759(90)90399-G; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; SATTENTAU QJ, 1995, J EXP MED, V182, P185, DOI 10.1084/jem.182.1.185; Schiffner T, 2013, J VIROL, V87, P10163, DOI 10.1128/JVI.01161-13; Schiffner T, 2016, J VIROL, V90, P813, DOI 10.1128/JVI.01942-15; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shen XY, 2009, J VIROL, V83, P3617, DOI 10.1128/JVI.02631-08; Si ZH, 2004, P NATL ACAD SCI USA, V101, P5036, DOI 10.1073/pnas.0307953101; Si ZH, 2003, AIDS RES HUM RETROV, V19, P217, DOI 10.1089/088922203763315722; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weng YK, 1998, J VIROL, V72, P9676, DOI 10.1128/JVI.72.12.9676-9682.1998; Wibmer CK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003738; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wu SR, 2010, P NATL ACAD SCI USA, V107, P18844, DOI 10.1073/pnas.1007227107; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Wyss S, 2005, J VIROL, V79, P12231, DOI 10.1128/JVI.79.19.12231-12241.2005; Xiang SH, 2003, VIROLOGY, V315, P124, DOI 10.1016/S0042-6822(03)00521-X; Yasmeen A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-41	127	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170672	10.1371/journal.pone.0170672	http://dx.doi.org/10.1371/journal.pone.0170672			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151945	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200033
J	Shnorhavorian, M; Schwartz, SM; Stansfeld, B; Sadler-Riggleman, I; Beck, D; Skinner, MK				Shnorhavorian, Margarett; Schwartz, Stephen M.; Stansfeld, Barbara; Sadler-Riggleman, Ingrid; Beck, Daniel; Skinner, Michael K.			Differential DNA Methylation Regions in Adult Human Sperm following Adolescent Chemotherapy: Potential for Epigenetic Inheritance	PLOS ONE			English	Article							ENDOCRINE DISRUPTOR VINCLOZOLIN; COPY NUMBER VARIATIONS; TRANSGENERATIONAL INHERITANCE; CANCER SURVIVORS; CHILDHOOD-CANCER; GENETIC-DISEASE; SEQUENCING DATA; ONSET DISEASE; FERTILITY; INFERTILITY	Background The potential that adolescent chemotherapy can impact the epigenetic programming of the germ line to influence later life adult fertility and promote epigenetic inheritance was investigated. Previous studies have demonstrated a number of environmental exposures such as abnormal nutrition and toxicants can promote sperm epigenetic changes that impact offspring. Methods Adult males approximately ten years after pubertal exposure to chemotherapy were compared to adult males with no previous exposure. Sperm were collected to examine differential DNA methylation regions (DMRs) between the exposed and control populations. Gene associations and correlations to genetic mutations (copy number variation) were also investigated. Methods and Findings A signature of statistically significant DMRs was identified in the chemotherapy exposed male sperm. The DMRs, termed epimutations, were found in CpG desert regions of primarily 1 kilobase size. Observations indicate adolescent chemotherapy exposure can promote epigenetic alterations that persist in later life. Conclusions This is the first observation in humans that an early life chemical exposure can permanently reprogram the spermatogenic stem cell epigenome. The germline (i.e., sperm) epimutations identified suggest chemotherapy has the potential to promote epigenetic inheritance to the next generation.	[Shnorhavorian, Margarett; Stansfeld, Barbara] Seattle Childrens Res Inst, Seattle, WA USA; [Schwartz, Stephen M.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Sadler-Riggleman, Ingrid; Beck, Daniel; Skinner, Michael K.] Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA	Seattle Children's Hospital; Fred Hutchinson Cancer Center; Washington State University	Skinner, MK (corresponding author), Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA.	skinner@wsu.edu			NIH Male Reproductive Health Research Award [K12 HD053984]; Childrens Oncology Group [AFLAC 2009-2010]; NIH [ES012974-12]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012974] Funding Source: NIH RePORTER	NIH Male Reproductive Health Research Award; Childrens Oncology Group; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The research was supported by NIH Male Reproductive Health Research Award K12 HD053984 and Childrens Oncology Group- AFLAC 2009-2010 Young Investigator Award grants to Margarett Shnorhavorian and NIH grant (ES012974-12) to MKS.	Andrews S, FASTQC A QUALITY CON; Anway MD, 2006, ENDOCRINOLOGY, V147, P5515, DOI 10.1210/en.2006-0640; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Aston KI, 2015, FERTILITY AND STERIL; Atsem S., 2016, HUM MOL GENET; Barlow DP, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018382; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Byrne J, 1998, AM J HUM GENET, V62, P45, DOI 10.1086/301677; Chan DV, 2012, TOXICOL SCI, V125, P532, DOI 10.1093/toxsci/kfr307; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Daling JR, 2009, CANCER, V115, P1215, DOI 10.1002/cncr.24159; Dominguez-Salas P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4746; Donkin I, 2015, CELL METABOLISM; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Gapp K, 2014, NAT NEUROSCI, V17, P667, DOI 10.1038/nn.3695; Gapp K, 2014, BIOESSAYS, V36, P491, DOI 10.1002/bies.201300116; Green DM, 2010, J CLIN ONCOL, V28, P2824, DOI 10.1200/JCO.2009.27.2922; Guerrero-Bosagna C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059922; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Guzick DS, 2001, NEW ENGL J MED, V345, P1388, DOI 10.1056/NEJMoa003005; Hammond C, 2007, J CLIN ONCOL, V25, P3511, DOI 10.1200/JCO.2007.10.8993; HAWKINS MM, 1991, J NATL CANCER I, V83, P1643, DOI 10.1093/jnci/83.22.1643; Howlader N, 2011, SEER CANCER STATISTI; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jenkins TG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004458; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kelly WG, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-6; Klambauer G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks003; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kujjo LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017877; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lienhard M, 2014, BIOINFORMATICS, V30, P284, DOI 10.1093/bioinformatics/btt650; Littman AJ, 2009, CANCER CAUSE CONTROL, V20, P1281, DOI 10.1007/s10552-009-9347-6; Manikkam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055387; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031901; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mikhail FM, 2014, CURR OPIN PEDIATR, V26, P646, DOI 10.1097/MOP.0000000000000142; Murphy PJ, 2016, METHOD CELL BIOL, V135, P345, DOI 10.1016/bs.mcb.2016.05.002; Nilsson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036129; Nilsson EE, 2008, REPRODUCTION, V135, P713, DOI 10.1530/REP-07-0542; Pacchierotti F, 2015, BIOMED RES INT, V2015; Pembrey M, 2014, J MED GENET, V51, P563, DOI 10.1136/jmedgenet-2014-102577; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saito K, 2005, CANCER-AM CANCER SOC, V104, P521, DOI 10.1002/cncr.21185; Schover LR, 1999, MED PEDIATR ONCOL, V33, P53, DOI 10.1002/(SICI)1096-911X(199907)33:1<53::AID-MPO10>3.0.CO;2-K; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Skinner MK, 2014, MOL CELL ENDOCRINOL, V398, P4, DOI 10.1016/j.mce.2014.07.019; Skinner MK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-692; Skinner MK, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R91, 10.1186/gb-2012-13-10-r91]; Skinner MK, 2011, EPIGENETICS-US, V6, P838, DOI 10.4161/epi.6.7.16537; Tracey R, 2013, REPROD TOXICOL, V36, P104, DOI 10.1016/j.reprotox.2012.11.011; World Health Organization, 1999, WHO MANUAL FOR THE E; Wyrobek Andrew J, 2005, J Natl Cancer Inst Monogr, P31; Zebrack BJ, 2004, PSYCHO-ONCOL, V13, P689, DOI 10.1002/pon.784	58	33	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0170085	10.1371/journal.pone.0170085	http://dx.doi.org/10.1371/journal.pone.0170085			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146567	Green Published, Green Submitted, gold			2022-12-27	WOS:000396131700011
J	Sanchez, E; Betriu, A; Arroyo, D; Lopez, C; Hernandez, M; Rius, F; Fernandez, E; Lecube, A				Sanchez, Enric; Betriu, Angels; Arroyo, David; Lopez, Carolina; Hernandez, Marta; Rius, Ferran; Fernandez, Elvira; Lecube, Albert			Skin Autofluorescence and Subclinical Atherosclerosis in Mild to Moderate Chronic Kidney Disease: A Case-Control Study	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; CARDIOVASCULAR-DISEASE; VASCULAR COMPLICATIONS; RISK; PROGRESSION; ACCUMULATION; PENTOSIDINE; MORTALITY; STRESS; MARKER	Advanced glycation end-products (AGEs) are increased and predict mortality in patients with chronic kidney disease (CKD) who are undergoing hemodialysis, irrespective of the presence of type 2 diabetes. However, little information exits about the relationship between AGEs and subclinical atherosclerosis at the early stages of CKD. A case-control study was performed including 87 patients with mild-to-moderate stages of CKD (glomerular filtration rate from 89 to 30 ml/min/per 1.73m(2)) and 87 non-diabetic non-CKD subjects matched by age, gender, body mass index, and waist circumference. Skin autofluorescence (AF), a non-invasive assessment of AGEs, was measured. The presence of atheromatous disease in carotid and femoral arteries was evaluated using vascular ultrasound, and vascular age and SCORE risk were estimated. Patients with mild-to-moderate stages of CKD showed an increase in skin AF compared with control subjects (2.5 +/- 0.6 vs. 2.2 +/- 0.4 AU, p<0.001). A skin AF value >2.0 AU was accompanied by a 3-fold increased risk of detecting the presence of an atheromathous plaque (OR 3.0, 95% CI 1.4(_)6.5, p = 0.006). When vascular age was assessed through skin AF, subjects with CKD were almost 12 years older than control subjects (70.3 +/- 25.5 vs. 58.5 +/- 20.2 years, p = 0.001). Skin AF was negatively correlated with glomerular filtration rate (r = -0.354, p<0.001) and LDL-cholesterol (r = -0.269, p = 0.001), and positively correlated with age (r = 0.472, p<0.001), pulse pressure (r = 0.238, p = 0.002), and SCORE risk (r = 0.451, p<0.001). A stepwise multivariate regression analysis showed that age and glomerular filtration rate independently predicted skin AF (R-2 = 0.289, p<0.001). Skin AF is elevated in patients with mild-to-moderate CKD compared with control subjects. This finding may be independently associated with the glomerular filtration rate and the presence of subclinical atheromatous disease. Therefore, the use of skin AF may help to accurately evaluate the real cardiovascular risk at the early stages of CKD.	[Sanchez, Enric; Lopez, Carolina; Hernandez, Marta; Rius, Ferran; Lecube, Albert] Univ Lleida, Inst Recerca Biomed Lleida IRBLleida, Hosp Univ Arnau Vilanova Lleida, Endocrinol & Nutr Dept, Lleida, Catalonia, Spain; [Betriu, Angels; Arroyo, David; Fernandez, Elvira] Univ Lleida, Unit Detect & Treatment Atherothrombot Dis UDETMA, Hosp Univ Arnau Vilanova Lleida, Nephrol Dept,IRBLleida, Lleida, Catalonia, Spain; [Lecube, Albert] ISCIII, CIBER Diabet & Enfermedades Metab Asociadas CIBE, Madrid, Spain	Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida; University Hospital Arnau de Vilanova; Universitat de Lleida; University Hospital Arnau de Vilanova; Instituto de Salud Carlos III	Lecube, A (corresponding author), Univ Lleida, Inst Recerca Biomed Lleida IRBLleida, Hosp Univ Arnau Vilanova Lleida, Endocrinol & Nutr Dept, Lleida, Catalonia, Spain.	alecube@gmail.com	Hernández, Marta/U-9874-2017; Arroyo, David/H-2896-2019; Sánchez, Enric/K-8225-2017; Giráldez, Elvira Dolores Fernández/D-3358-2009; Lecube, Albert/H-3813-2019	Hernández, Marta/0000-0003-1237-298X; Arroyo, David/0000-0003-4652-0311; Sánchez, Enric/0000-0001-7345-1601; Giráldez, Elvira Dolores Fernández/0000-0001-5236-1762; Lecube, Albert/0000-0001-9684-0183; Lopez-Cano, Carolina/0000-0001-7458-5871	Institute de Salud Carlos III ISCIII [14//00008, 14/00008]	Institute de Salud Carlos III ISCIII(Instituto de Salud Carlos III)	This work was supported by grants from de Institute de Salud Carlos III ISCIII (Action Plan 14//00008). This organization had no role in study design, the collection, analysis and interpretation of data, report writing, or the decision to submit the article for publication.; This work was supported by grants from de Instituto de Salud Carlos III ISCIII (Action Plan 14/00008). This organization had no role in study design, the collection, analysis and interpretation of data, report writing, or the decision to submit the article for publication.	Beisswenger PJ, 2013, DIABETES CARE, V36, P3234, DOI 10.2337/dc12-2689; BEISSWENGER PJ, 1995, DIABETES, V44, P824, DOI 10.2337/diabetes.44.7.824; Cerami C, 1997, P NATL ACAD SCI USA, V94, P13915, DOI 10.1073/pnas.94.25.13915; Chilelli NC, 2013, NUTR METAB CARDIOVAS, V23, P913, DOI 10.1016/j.numecd.2013.04.004; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; den Dekker MAM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083084; Friedlander MA, 1996, J CLIN INVEST, V97, P728, DOI 10.1172/JCI118471; Genuth S, 2005, DIABETES, V54, P3103, DOI 10.2337/diabetes.54.11.3103; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hanssen NMJ, 2013, J CLIN ENDOCR METAB, V98, pE1369, DOI 10.1210/jc.2013-1068; Harvey A, 2015, J MOL CELL CARDIOL, V83, P112, DOI 10.1016/j.yjmcc.2015.04.011; Hunt KJ, 2013, ATHEROSCLEROSIS, V231, P315, DOI 10.1016/j.atherosclerosis.2013.09.027; Jandeleit-Dahm K, 2008, CURR PHARM DESIGN, V14, P979, DOI 10.2174/138161208784139684; Junyent M, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-14; Kajikawa M, 2015, DIABETES CARE, V38, P119, DOI 10.2337/dc14-1435; Koetsier M, 2010, DIABETES TECHNOL THE, V12, P399, DOI 10.1089/dia.2009.0113; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li L, 2012, AM J KIDNEY DIS, V59, P504, DOI 10.1053/j.ajkd.2011.12.009; Luo PL, 2015, MOL MED REP, V11, P4447, DOI 10.3892/mmr.2015.3269; Lutgers HL, 2006, DIABETES CARE, V29, P2654, DOI 10.2337/dc05-2173; Lutgers HL, 2010, EUR J CLIN INVEST, V40, P812, DOI 10.1111/j.1365-2362.2010.02329.x; Meerwaldt R, 2005, J AM SOC NEPHROL, V16, P3687, DOI 10.1681/ASN.2005020144; Meerwaldt R, 2004, DIABETOLOGIA, V47, P1324, DOI 10.1007/s00125-004-1451-2; Miyata T, 1996, J AM SOC NEPHROL, V7, P1198; Murphy D, 2016, ANN INTERN MED; Poulianiti KP, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8598253; Raj DSC, 2000, AM J KIDNEY DIS, V35, P365, DOI 10.1016/S0272-6386(00)70189-2; Reiniger N, 2010, DIABETES, V59, P2043, DOI 10.2337/db09-1766; Rojas A, 2004, LIFE SCI, V76, P715, DOI 10.1016/j.lfs.2004.09.011; Sakata N, 2003, NEPHROL DIAL TRANSPL, V18, P1601, DOI 10.1093/ndt/gfg200; SCHMIDT AM, 1994, ARTERIOSCLER THROMB, V14, P1521, DOI 10.1161/01.ATV.14.10.1521; Schroder F, 2006, J VASC SURG, V44, P531, DOI 10.1016/j.jvs.2006.05.016; Shahinian VB, 2013, AM J KIDNEY DIS, V61, P930, DOI 10.1053/j.ajkd.2013.01.018; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Tiessen AH, 2014, CLIN CHEM LAB MED, V52, P121, DOI 10.1515/cclm-2012-0825; Ueno H, 2008, METABOLISM, V57, P1452, DOI 10.1016/j.metabol.2008.05.016; Uribarri J, 2003, J AM SOC NEPHROL, V14, P728, DOI 10.1097/01.ASN.0000051593.41395.B9; Vlassara H, 2002, J INTERN MED, V251, P87, DOI 10.1046/j.1365-2796.2002.00932.x; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wang CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147771; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Yamagishi S, 2015, INT J CARDIOL, V185, P263, DOI 10.1016/j.ijcard.2015.03.167; Yamagishi S, 2010, OXID MED CELL LONGEV, V3, P101, DOI 10.4161/oxim.3.2.11148	44	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170778	10.1371/journal.pone.0170778	http://dx.doi.org/10.1371/journal.pone.0170778			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141808	Green Published, Green Submitted, gold			2022-12-27	WOS:000396129500018
J	Huang, F; Cheng, H; Zhang, YT; Ju, YH; Li, YN				Huang, Fei; Cheng, Hang; Zhang, Yu-tong; Ju, Yang-hua; Li, Ya-nan			Early Postnatal Exposure to Cigarette Smoke Leads to Later Airway Inflammation in Asthmatic Mice	PLOS ONE			English	Article							INDUCED PULMONARY INFLAMMATION; EARLY-LIFE EXPOSURE; REGULATORY T-CELLS; TOBACCO-SMOKE; MOUSE MODEL; DISEASE; HYPERRESPONSIVENESS; METAANALYSIS; SYMPTOMS; CHILDREN	Background and objective Asthma is one of the most common airway inflammatory diseases. In most cases, asthma development is related to ubiquitous harmful environmental exposure factors in early-life. Previous studies have indicated that smoking can promote asthma development and increase the difficulty of asthma control. The aim of this study was to determine the effects of early-life CS exposure on ovalbumin (OVA)-sensitized asthmatic mice. Methods Pathological and immunological functions were analyzed in an adult asthma mice model in which mice were sensitized with OVA combined with early-life CS exposure. Results Mice exposed to CS for only 5 weeks demonstrated significantly reduced pulmonary compliance, increased airway inflammation, and augmented cellular and humoral immune responses. In addition, CS inhalation was sufficient to facilitate OVA sensitization and challenge asthmatic development. Meanwhile, CS exposure amplified regulatory T cell-mediated immunity inhibition, but still did not offset the increased effector T cell-mediated inflammatory response. Conclusion Early-life CS exposure is significantly associated with later pulmonary injury and aggravation of T-cell immunologic derangement in asthmatic mice.	[Huang, Fei] Jilin Univ, China Japan Union Hosp, Dept Orthoped, Changchun, Jilin, Peoples R China; [Cheng, Hang; Zhang, Yu-tong; Ju, Yang-hua; Li, Ya-nan] Jilin Univ, Hosp 1, Dept Pediat, Changchun, Jilin, Peoples R China; [Li, Ya-nan] Jilin Univ, Basic Med Coll, Dept Mol Biol, Changchun, Peoples R China	Jilin University; Jilin University; Jilin University	Li, YN (corresponding author), Jilin Univ, Hosp 1, Dept Pediat, Changchun, Jilin, Peoples R China.; Li, YN (corresponding author), Jilin Univ, Basic Med Coll, Dept Mol Biol, Changchun, Peoples R China.	lyanan2008@sina.com			Bethune Program of Jilin University [2015202]; National Natural Science Foundation of China [81200013]	Bethune Program of Jilin University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was sponsored by the Bethune Program of Jilin University (No. 2015202) and the National Natural Science Foundation of China (No. 81200013).	Barcelo B, 2008, EUR RESPIR J, V31, P555, DOI 10.1183/09031936.00010407; Barrett EG, 2002, AM J RESP CRIT CARE, V165, P1410, DOI 10.1164/rccm.2106029; Bhattacharya P, 2014, CLIN IMMUNOL, V153, P187, DOI 10.1016/j.clim.2014.04.014; Burchiel SW, 2016, INHAL TOXICOL, V28, P61, DOI 10.3109/08958378.2015.1136714; Burke H, 2012, PEDIATRICS, V129, P735, DOI 10.1542/peds.2011-2196; Chaudhuri R, 2008, ALLERGY, V63, P132, DOI 10.1111/j.1398-9995.2007.01538.x; Chen Z, 2013, J IMMUNOL, V190, P5256, DOI 10.4049/jimmunol.1201675; Comhair SAA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018574; D'hulst AI, 2005, EUR RESPIR J, V26, P204, DOI 10.1183/09031936.05.00095204; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Harrison OJ, 2008, IMMUNOL LETT, V121, P13, DOI 10.1016/j.imlet.2008.07.011; Hartigan-O'Connor DJ, 2011, CURR OPIN HIV AIDS, V6, P221, DOI 10.1097/COH.0b013e32834577b3; Herbert C, 2013, DIS MODEL MECH, V6, P479, DOI 10.1242/dmm.010728; Hernandez-Alvidrez E, 2013, J ASTHMA, V50, P347, DOI 10.3109/02770903.2013.773009; Hirahara K, 2016, INT IMMUNOL, V28, P163, DOI 10.1093/intimm/dxw006; Huang F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141717; Kaplan MH, 2015, NAT REV IMMUNOL, V15, P295, DOI 10.1038/nri3824; Khan MA, 2013, MULTIDISCIP RESP MED, V8, DOI 10.1186/2049-6958-8-11; Lanckacker EA, 2013, EUR RESPIR J, V41, P1189, DOI 10.1183/09031936.00096612; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lochte Lene, 2016, BMC Pediatr, V16, P50, DOI 10.1186/s12887-016-0571-4; Ma CH, 2014, PHYTOTHER RES, V28, P231, DOI 10.1002/ptr.4983; Nakamura K, 2009, ANN ALLERG ASTHMA IM, V102, P288, DOI 10.1016/S1081-1206(10)60333-X; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Orton S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112690; Polosa R, 2008, J ALLERGY CLIN IMMUN, V121, P1428, DOI 10.1016/j.jaci.2008.02.041; Polosa R, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-16; Price D, 2014, ALLERGY ASTHMA IMMUN, V6, P114, DOI 10.4168/aair.2014.6.2.114; Saravia J, 2014, MUCOSAL IMMUNOL, V7, P694, DOI 10.1038/mi.2013.88; Singh SP, 2011, J IMMUNOL, V187, P4542, DOI 10.4049/jimmunol.1101567; Smyth LJC, 2007, CHEST, V132, P156, DOI 10.1378/chest.07-0083; Spiess PC, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-107; Stapleton M, 2011, J AM BOARD FAM MED, V24, P313, DOI 10.3122/jabfm.2011.03.100180; Wenzel S E, 2005, Exp Lung Res, V31 Suppl 1, P22; Wenzel SE, 2006, AM J RESP CRIT CARE, V173, P698, DOI 10.1164/rccm.2601007; Wu HX, 2014, BIOCHEM BIOPH RES CO, V450, P110, DOI 10.1016/j.bbrc.2014.05.073; Wu ZX, 2012, AM J PHYSIOL-LUNG C, V302, pL152, DOI 10.1152/ajplung.00071.2011; Wu ZX, 2016, RESP PHYSIOL NEUROBI, V223, P1, DOI 10.1016/j.resp.2015.11.009; Xepapadaki P, 2009, PEDIAT ALLERG IMM-UK, V20, P423, DOI 10.1111/j.1399-3038.2008.00820.x; Yang X, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6470364	40	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171021	10.1371/journal.pone.0171021	http://dx.doi.org/10.1371/journal.pone.0171021			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135326	Green Published, Green Submitted, gold			2022-12-27	WOS:000396124700039
J	Itoh, T; Nishinakamura, H; Kumano, K; Takahashi, H; Kodama, S				Itoh, Takeshi; Nishinakamura, Hitomi; Kumano, Kenjiro; Takahashi, Hiroyuki; Kodama, Shohta			The Spleen Is an Ideal Site for Inducing Transplanted Islet Graft Expansion in Mice	PLOS ONE			English	Article							MEDIATED INFLAMMATORY REACTION; SINGLE-DONOR; INSULIN INDEPENDENCE; STEM-CELLS; AUTOGRAFTS; REVERSAL; ANTIBODY; ORGANS	Alternative islet transplantation sites have the potential to reduce the marginal number of islets required to ameliorate hyperglycemia in recipients with diabetes. Previously, we reported that T cell leukemia homeobox 1 (Tlx1)(+) stem cells in the spleen effectively regenerated into insulin-producing cells in the pancreas of non-obese diabetic mice with endstage disease. Thus, we investigated the spleen as a potential alternative islet transplantation site. Streptozotocin-induced diabetic C57BL/6 mice received syngeneic islets into the portal vein (PV), beneath the kidney capsule (KC), or into the spleen (SP). The marginal number of islets by PV, KC, or SP was 200, 100, and 50, respectively. Some plasma inflammatory cytokine levels in the SP group were significantly lower than those of the PV group after receiving a marginal number of islets, indicating reduced inflammation in the SP group. Insulin contents were increased 280 days after islet transplantation compared with those immediately following transplantation (p< 0.05). Additionally, Tlx1-related genes, including Rrm2b and Pla2g2d, were up-regulated, which indicates that islet grafts expanded in the spleen. The spleen is an ideal candidate for an alternative islet transplantation site because of the resulting reduced inflammation and expansion of the islet graft.	[Itoh, Takeshi; Nishinakamura, Hitomi; Kumano, Kenjiro; Takahashi, Hiroyuki; Kodama, Shohta] Fukuoka Univ, Dept Regenerat Med & Transplantat, Fac Med, Fukuoka, Japan; [Itoh, Takeshi; Kumano, Kenjiro; Takahashi, Hiroyuki; Kodama, Shohta] Fukuoka Univ Hosp, Ctr Regenerat Med, Fukuoka, Japan; [Kumano, Kenjiro] Okayama Univ, Dept Surg Gastroenterol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Takahashi, Hiroyuki] Fukuoka Univ, Dept Surg Gastroenterol, Fac Med, Fukuoka, Japan	Fukuoka University; Fukuoka University; Okayama University; Fukuoka University	Kodama, S (corresponding author), Fukuoka Univ, Dept Regenerat Med & Transplantat, Fac Med, Fukuoka, Japan.	skodama@fukuoka-u.ac.jp			Japan Society of the Promotion of Science; Intramural Foundation of Fukuoka University; Grants-in-Aid for Scientific Research [16K09815] Funding Source: KAKEN	Japan Society of the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Intramural Foundation of Fukuoka University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant in Aids for Scientific Research from the Japan Society of the Promotion of Science (HN, TI, and SK) and the Intramural Foundation of Fukuoka University (SK).	Ahearn AJ, 2015, EXPERT REV CLIN IMMU, V11, P59, DOI 10.1586/1744666X.2015.978291; ALDERSON D, 1984, BRIT J SURG, V71, P756, DOI 10.1002/bjs.1800711007; Balamurugan AN, 2014, AM J TRANSPLANT, V14, P2595, DOI 10.1111/ajt.12872; Bassi R, 2011, CURR DIABETES REP, V11, P355, DOI 10.1007/s11892-011-0211-1; Bellin MD, 2008, AM J TRANSPLANT, V8, P2463, DOI 10.1111/j.1600-6143.2008.02404.x; Bellin MD, 2012, AM J TRANSPLANT, V12, P1576, DOI 10.1111/j.1600-6143.2011.03977.x; Bennet W, 2000, UPSALA J MED SCI, V105, P125, DOI 10.1517/03009734000000059; Cantarelli E, 2011, CURR DIABETES REP, V11, P364, DOI 10.1007/s11892-011-0216-9; Dieguez-Acuna FJ, 2005, MOL CELL PROTEOMICS, V4, P1459, DOI 10.1074/mcp.M500137-MCP200; Farney AC, 2016, PANCREAS, V45, P8, DOI 10.1097/MPA.0000000000000391; Fiorina P, 2008, DIABETES CARE, V31, P436, DOI 10.2337/dc07-1831; Fiorina P, 2007, DIABETES, V56, P912, DOI 10.2337/db06-1445; Froud T, 2005, AM J TRANSPLANT, V5, P2037, DOI 10.1111/j.1600-6143.2005.00957.x; GRAY DWR, 1990, SURG GYNECOL OBSTET, V170, P225; Hering BJ, 2016, DIABETES CARE, V39, P1230, DOI 10.2337/dc15-1988; Hering BJ, 2005, JAMA-J AM MED ASSOC, V293, P830, DOI 10.1001/jama.293.7.830; Hilling DE, 2014, CELL TRANSPLANT, V23, P921, DOI 10.3727/096368913X666412; ITOH I, 2012, CELL TRANSPLANT, V21, P1371, DOI DOI 10.3727/0963689128640592; Itoh T, 2015, PANCREAS, V44, P166, DOI 10.1097/MPA.0000000000000188; Itoh T, 2014, CELL TRANSPLANT, V23, P153, DOI 10.3727/096368912X658980; KAUFMAN DB, 1990, TRANSPLANTATION, V50, P385, DOI 10.1097/00007890-199009000-00006; Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212; Kodama S, 2005, TRENDS MOL MED, V11, P271, DOI 10.1016/j.molmed.2005.04.004; Kodama S, 2004, PEDIATR DIABETES, V5, P38, DOI 10.1111/j.1399-543X.2004.00078.x; Kodama S, 2003, SCIENCE, V302, P1223, DOI 10.1126/science.1088949; Kojima H, 2004, P NATL ACAD SCI USA, V101, P2458, DOI 10.1073/pnas.0308690100; Markmann JF, 2003, ANN SURG, V237, P741, DOI 10.1097/00000658-200306000-00001; Matsumoto S, 2010, CELL TRANSPLANT, V19, P291, DOI 10.3727/096368909X481773; Matsuoka N, 2010, J CLIN INVEST, V120, P735, DOI 10.1172/JCI41360; Melzi R, 2010, CELL TRANSPLANT, V19, P1031, DOI 10.3727/096368910X514639; Merani S, 2008, BRIT J SURG, V95, P1449, DOI 10.1002/bjs.6391; Miki Y, 2013, J EXP MED, V210, P1217, DOI 10.1084/jem.20121887; Ozmen L, 2002, DIABETES, V51, P1779, DOI 10.2337/diabetes.51.6.1779; Piemonti L, 2002, DIABETES, V51, P55, DOI 10.2337/diabetes.51.1.55; Posselt AM, 2010, AM J TRANSPLANT, V10, P1870, DOI 10.1111/j.1600-6143.2010.03073.x; Rajab A, 2010, CURR DIABETES REP, V10, P332, DOI 10.1007/s11892-010-0130-6; Robertson SA, 2008, J PEDIATR SURG, V43, P274, DOI 10.1016/j.jpedsurg.2007.10.013; Ryu S, 2001, J CLIN INVEST, V108, P63, DOI 10.1172/JCI200112335; Sagi B, 2012, STEM CELLS DEV, V21, P814, DOI 10.1089/scd.2011.0551; Shapiro AMJ, 2011, CURR OPIN ORGAN TRAN, V16, P627, DOI 10.1097/MOT.0b013e32834cfb84; Shapiro AMJ, 2004, AM J TRANSPLANT, V4, P295, DOI 10.1046/j.1600-6143.2003.00375.x; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Smink AM, 2013, DIABETES, V62, P1357, DOI 10.2337/db12-1553; SUTTON R, 1989, DIABETES, V38, P182, DOI 10.2337/diab.38.1.S182; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; van der Windt DJ, 2008, CELL TRANSPLANT, V17, P1005, DOI 10.3727/096368908786991515; von Allmen CE, 2009, P NATL ACAD SCI USA, V106, P11673, DOI 10.1073/pnas.0812569106	47	12	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170899	10.1371/journal.pone.0170899	http://dx.doi.org/10.1371/journal.pone.0170899			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135283	Green Published, Green Submitted, gold			2022-12-27	WOS:000396124700028
J	Sha, J; Wang, P; Zhu, BL; Zhu, MH; Li, XL; Gao, F				Sha, Jie; Wang, Pin; Zhu, Bingliang; Zhu, Minghui; Li, Xueliang; Gao, Feng			Acetic Acid Enhanced Narrow Band Imaging for the Diagnosis of Gastric Intestinal Metaplasia	PLOS ONE			English	Article							MAGNIFICATION CHROMOENDOSCOPY; MAGNIFYING ENDOSCOPY; CANCER; LESIONS; EPIDEMIOLOGY; SURVEILLANCE; PREVENTION; ESOPHAGUS; DYSPLASIA; RISK	Gastric intestinal metaplasia (GIM) is a precancerous lesion of the stomach. The detection of GIM using conventional white-light endoscopy (WLE) is difficult. In this study, we determined whether acetic acid-enhanced narrow band imaging (AA-NBI) improves the detection of GIM. A consecutive cohort of 132 individuals aged 40 years or older was subjected to upper gastrointestinal endoscopy using WLE, NBI and AA-NBI. The ability of the three methods to diagnose GIM in patients was compared. Histological assessment (per-patient and per-biopsy) was used for the accuracy assessment. Sixty-six (50.0%) out of the 132 individuals examined were found to have GIM, of which 44 (66.7%) were diagnosed correctly by NBI (sensitivity 66.7% and specificity 68.2%) and 58 (87.9%) were correctly identified by AA-NBI (sensitivity 87.9% and specificity 68.2%), as compared to only 22 (33.3%) by WLE (sensitivity 33.3% and specificity 28.8%). Therefore, the sensitivity of AA-NBI in the diagnosis of GIM was significantly higher than NBI (p<0.05) and WLE (p<0.001). Our study indicates that AA-NBI can improve the accuracy of endoscopy-targeted biopsies for GIM.	[Sha, Jie; Li, Xueliang] Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China; [Sha, Jie; Zhu, Bingliang; Zhu, Minghui; Gao, Feng] Jingjiang Peoples Hosp, Dept Gastroenterol, Jingjiang, Jiangsu, Peoples R China; [Wang, Pin] Nanjing Med Univ, Drum Tower Clin Med Sch, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Li, XL (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China.; Gao, F (corresponding author), Jingjiang Peoples Hosp, Dept Gastroenterol, Jingjiang, Jiangsu, Peoples R China.	ligakur@aliyun.com; 1036060339@qq.com						An JK, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-169; Capelle LG, 2010, DIGEST DIS SCI, V55, P3442, DOI 10.1007/s10620-010-1189-2; CORREA P, 1992, CANCER RES, V52, P6735; Dinis-Ribeiro M, 2003, GASTROINTEST ENDOSC, V57, P498, DOI 10.1067/mge.2003.145; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Fock KM, 2014, ALIMENT PHARM THER, V40, P250, DOI 10.1111/apt.12814; Guelrud M, 2001, GASTROINTEST ENDOSC, V53, P559, DOI 10.1067/mge.2001.114059; Guo T, 2014, GASTRIC CANCER, V17, P122, DOI 10.1007/s10120-013-0250-1; Kikuste I, 2014, EUR J GASTROEN HEPAT, V26, P704, DOI 10.1097/MEG.0000000000000108; Kono Y, 2014, WORLD J GASTROENTERO, V20, P5092, DOI 10.3748/wjg.v20.i17.5092; Lee BE, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-97; Li Z, 2014, ENDOSCOPY, V46, P282, DOI 10.1055/s-0033-1359215; Lim JH, 2013, GUT LIVER, V7, P41, DOI 10.5009/gnl.2013.7.1.41; Meining A, 2004, ENDOSCOPY, V36, P160, DOI 10.1055/s-2004-814183; Nakayoshi T, 2004, ENDOSCOPY, V36, P1080, DOI 10.1055/s-2004-825961; NOMURA H, 1980, IGAKU KENKYU, V50, P525; Olliver JR, 2003, BIOMARKERS, V8, P509, DOI 10.1080/13547500310001644961; Pimentel-Nunes P, 2012, ENDOSCOPY, V44, P236, DOI 10.1055/s-0031-1291537; Sakai Y, 2008, GASTROINTEST ENDOSC, V68, P635, DOI 10.1016/j.gie.2008.03.1065; SAUERBRUCH T, 1984, ENDOSCOPY, V16, P101, DOI 10.1055/s-2007-1018546; Savarino E, 2013, WORLD J GASTROENTERO, V19, P2668, DOI 10.3748/wjg.v19.i17.2668; So J, 2013, DIGEST DIS SCI, V58, P3566, DOI 10.1007/s10620-013-2843-2; Taghavi SA, 2009, CAN J GASTROENTEROL, V23, P105, DOI 10.1155/2009/594983; Tanaka K, 2006, J GASTROENTEROL, V41, P332, DOI 10.1007/s00535-005-1760-3; Whiting JL, 2002, GUT, V50, P378, DOI 10.1136/gut.50.3.378	25	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170957	10.1371/journal.pone.0170957	http://dx.doi.org/10.1371/journal.pone.0170957			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135297	Green Published, Green Submitted, gold			2022-12-27	WOS:000396124700033
J	Russo, J; Lee, JE; Lopez, CM; Anderson, J; Nguyen, TMP; Heck, AM; Wilusz, J; Wilusz, CJ				Russo, Joseph; Lee, Jerome E.; Lopez, Carolina M.; Anderson, John; Nguyen, Thuy-mi P.; Heck, Adam M.; Wilusz, Jeffrey; Wilusz, Carol J.			The CELF1 RNA-Binding Protein Regulates Decay of Signal Recognition Particle mRNAs and Limits Secretion in Mouse Myoblasts	PLOS ONE			English	Article							SKELETAL-MUSCLE; TARGET TRANSCRIPTS; CUG-BP; OVEREXPRESSION; IDENTIFICATION; CELLS; TRANSLATION; DEGRADATION; MECHANISMS; EXPRESSION	We previously identified several mRNAs encoding components of the secretory pathway, including signal recognition particle (SRP) subunit mRNAs, among transcripts associated with theRNA- binding protein CELF1. Through immunoprecipitation of RNAs crosslinked to CELF1 in myoblasts and in vitro binding assays using recombinant CELF1, we now provide evidence that CELF1 directly binds the mRNAs encoding each of the subunits of the SRP. Furthermore, we determined the half-lives of the Srp transcripts in control and CELF1 knockdown myoblasts. Our results indicate CELF1 is a destabilizer of at least five of the six Srp transcripts and that the relative abundance of the SRP proteins is out of balance when CELF1 is depleted. CELF1 knockdown myoblasts exhibit altered secretion of a luciferase reporter protein and are impaired in their ability to migrate and close a wound, consistent with a defect in the secreted extracellular matrix. Importantly, similar defects in wound healing are observed when SRP subunit imbalance is induced by over-expression of SRP68. Our studies support the existence of an RNA regulon containing Srp mRNAs that is controlled by CELF1. One implication is that altered function of CELF1 in myotonic dystrophy may contribute to changes in the extracellular matrix of affected muscle through defects in secretion.	[Russo, Joseph; Lee, Jerome E.; Lopez, Carolina M.; Anderson, John; Nguyen, Thuy-mi P.; Heck, Adam M.; Wilusz, Jeffrey; Wilusz, Carol J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Lee, Jerome E.; Heck, Adam M.; Wilusz, Jeffrey; Wilusz, Carol J.] Colorado State Univ, Program Cell & Mol Biol, Ft Collins, CO 80523 USA; [Lee, Jerome E.] ArcherDX, Boulder, CO USA; [Nguyen, Thuy-mi P.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA	Colorado State University; Colorado State University; Mayo Clinic	Wilusz, CJ (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.; Wilusz, CJ (corresponding author), Colorado State Univ, Program Cell & Mol Biol, Ft Collins, CO 80523 USA.	cwilusz@colostate.edu	Wilusz, Carol/AAC-2901-2021; Wilusz, Carol/F-7241-2017	Heck, Adam/0000-0002-2485-759X	National Institutes of Health [AR059247]; National Science Foundation [MCB-1301983]; American Heart Association [10PRE2610140]; National Science Foundation -NRT Award [1450032]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); National Science Foundation -NRT Award(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health (www.niams.nih.gov) through an award to CJW (AR059247) and by the National Science Foundation (www.nsf.gov) through an award to CJW and JW (MCB-1301983). JEL was supported in part by a pre-doctoral fellowship from the American Heart Association (www.heart.org; 10PRE2610140). AH was supported in part through National Science Foundation -NRT Award # 1450032 to Thomas Chen, Carol Wilusz & Asa Ben-Hur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Badr CE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000571; Bauermeister D, 2015, DEV BIOL, V405, P214, DOI 10.1016/j.ydbio.2015.07.005; Beisang D, 2014, GENE, V550, P93, DOI 10.1016/j.gene.2014.08.021; Beisang D, 2012, J BIOL CHEM, V287, P950, DOI 10.1074/jbc.M111.291658; Benveniste O, 2011, PRESSE MED, V40, P249; BOVIA F, 1995, MOL BIOL CELL, V6, P471, DOI 10.1091/mbc.6.4.471; Charras G, 2014, NAT REV MOL CELL BIO, V15, P813, DOI 10.1038/nrm3897; Corbeil-Girard LP, 2005, NEUROBIOL DIS, V18, P551, DOI 10.1016/j.nbd.2004.10.019; Dasgupta T, 2012, WIRES RNA, V3, P104, DOI 10.1002/wrna.107; Deshmukh AS, 2015, MOL CELL PROTEOMICS, V14, P841, DOI 10.1074/mcp.M114.044222; Dori-Bachash M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r114; Duffy EE, 2015, MOL CELL, V59, P858, DOI 10.1016/j.molcel.2015.07.023; Friedel CC, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp542; Ghirardello A, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0335-1; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; HARROLD S, 1991, ANAL BIOCHEM, V198, P19, DOI 10.1016/0003-2697(91)90500-S; Ho TH, 2005, HUM MOL GENET, V14, P1539, DOI 10.1093/hmg/ddi162; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Kim SY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002512; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Le Tonqueze O, 2016, GENOM DATA, V8, P97, DOI 10.1016/j.gdata.2016.04.009; Lee JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011201; Liu L, 2015, MOL BIOL CELL, V26, P1797, DOI 10.1091/mbc.E14-11-1500; Maekawa S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1358-y; Masuda A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00209; Miller C, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.112; Moraes KCM, 2006, RNA, V12, P1084, DOI 10.1261/rna.59606; Nielsen FC, 2016, BIOESSAYS; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Ohsawa N, 2015, GENES CELLS, V20, P121, DOI 10.1111/gtc.12201; Palumbo MC, 2015, WIRES RNA, V6, P327, DOI 10.1002/wrna.1277; Paul S, 2006, EMBO J, V25, P4271, DOI 10.1038/sj.emboj.7601296; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Politz JC, 2000, P NATL ACAD SCI USA, V97, P55, DOI 10.1073/pnas.97.1.55; Radle B, 2013, JOVE-J VIS EXP, DOI 10.3791/50195; Rahimov F, 2013, J CELL BIOL, V201, P499, DOI 10.1083/jcb.201212142; Rattenbacher B, 2010, MOL CELL BIOL, V30, P3970, DOI 10.1128/MCB.00624-10; Ren YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056950; Ren YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040705; ROOTS R, 1976, CANCER RES, V36, P3654; SAWICKI SG, 1971, J CELL BIOL, V50, P746, DOI 10.1083/jcb.50.3.746; SEISER C, 1995, J BIOL CHEM, V270, P29400, DOI 10.1074/jbc.270.49.29400; Shalem O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002273; Sofola OA, 2007, NEURON, V55, P565, DOI 10.1016/j.neuron.2007.07.021; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Sun M, 2012, GENOME RES; Sun M, 2013, MOL CELL, V52, P52, DOI 10.1016/j.molcel.2013.09.010; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Timchenko NA, 2004, J BIOL CHEM, V279, P13129, DOI 10.1074/jbc.M312923200; Unlu G, 2014, INT J BIOCHEM CELL B, V47, P57, DOI 10.1016/j.biocel.2013.11.005; Vlasova-St Louis I, 2013, BBA-GENE REGUL MECH, V1829, P695, DOI 10.1016/j.bbagrm.2013.01.001; Vlasova-St Louis I, 2011, CURR OPIN GENET DEV, V21, P444, DOI 10.1016/j.gde.2011.03.002; Wang ET, 2015, GENOME RES, V25, P858, DOI 10.1101/gr.184390.114; Ward AJ, 2010, HUM MOL GENET, V19, P3614, DOI 10.1093/hmg/ddq277; Wild K, 2014, RNA BIOL, V11, P1330, DOI 10.1080/15476286.2014.996457; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Yu TX, 2013, MOL BIOL CELL, V24, P85, DOI 10.1091/mbc.E12-07-0531; Zhang LB, 2008, J BIOL CHEM, V283, P22457, DOI 10.1074/jbc.M802803200; Zhang X, 2014, ANNU REV BIOPHYS, V43, P381, DOI 10.1146/annurev-biophys-051013-022653	60	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170680	10.1371/journal.pone.0170680	http://dx.doi.org/10.1371/journal.pone.0170680			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129347	gold, Green Published			2022-12-27	WOS:000396211400046
J	Hendricks, KE; Christman, MC; Roberts, PD				Hendricks, Katherine E.; Christman, Mary C.; Roberts, Pamela D.			A Statistical Evaluation of Methods of In-Vitro Growth Assessment for Phyllosticta citricarpa: Average Colony Diameter vs. Area	PLOS ONE			English	Article							GUIGNARDIA-CITRICARPA; FUNGAL GROWTH; CITRUS; FUNGICIDES; ENDOPHYTE; PLANTS; ASSAY	Fungal growth inhibition on solid media has been historically measured and calculated based on the average of perpendicular diameter measurements of growth on fungicide amended media. We investigated the sensitivity of the calculated area (DA) and the measured area ( MA) for assessing fungicide growth inhibition of the ascomycete, Phyllosticta citricarpa on solid media. Both the calculated, DA and the actual measured area, MA were adequate for distinguishing significant treatment effects of fungicide on fungal growth, however MA was more sensitive at identifying significant differences between the controls and fungicide concentrations below 5 ppm.	[Hendricks, Katherine E.; Roberts, Pamela D.] Univ Florida, Dept Plant Pathol, Immokalee, FL 34142 USA; [Christman, Mary C.] Univ Florida, Dept Stat, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Hendricks, KE (corresponding author), Univ Florida, Dept Plant Pathol, Immokalee, FL 34142 USA.	jinxkat@ufl.edu		Hendricks, Katherine/0000-0003-1125-4658	Florida Specialty Crop Block Grant [22915]	Florida Specialty Crop Block Grant	Florida Specialty Crop Block Grant #22915, Title: Production and Postharvest Treatments to Control Citrus Black Spot (Guignardia citricarpa) on Florida Citrus. Authors: Mark Ritenour, Associate Professor; Pamela D. Roberts, Professor; Jan Narciso, Research Microbiologist. URL: http://www.freshfromflorida.com/Business-Services/Grant-Opportunities/2016-Florida-Specialty-Crop-Block-Grant-Program-Farm-Bill-SCBGP-FB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	As'wad AWM, 2011, CROP PROT, V30, P1438, DOI 10.1016/j.cropro.2011.07.004; Baayen RP, 2002, PHYTOPATHOLOGY, V92, P464, DOI 10.1094/PHYTO.2002.92.5.464; Baldassari RB, 2008, EUR J PLANT PATHOL, V120, P103, DOI 10.1007/s10658-007-9182-0; Bertelsen JR, 2001, PLANT PATHOL, V50, P190, DOI 10.1046/j.1365-3059.2001.00545.x; BRANCATO FP, 1953, MYCOLOGIA, V45, P848, DOI 10.1080/00275514.1953.12024321; BROEKAERT WF, 1990, FEMS MICROBIOL LETT, V69, P55, DOI [10.1111/j.1574-6968.1990.tb04174.x, 10.1016/S0378-1097(98)00477-7]; Feliziani E, 2013, POSTHARVEST BIOL TEC, V78, P133, DOI 10.1016/j.postharvbio.2012.12.004; Flores FJ, 2013, DOSE-RESPONSE, V11, P361, DOI 10.2203/dose-response.12-026.Garzon; Glienke C, 2011, PERSOONIA, V26, P47, DOI 10.3767/003158511X569169; Hendricks K. E. M., 2013, American Journal of Plant Sciences, V4, P282, DOI 10.4236/ajps.2013.42037; Hincapie M, 2014, PLANT DIS, V98, P780, DOI 10.1094/PDIS-03-13-0335-RE; Iacomi-Vasilescu B, 2004, CROP PROT, V23, P481, DOI 10.1016/j.cropro.2003.10.003; KERBS S, 1978, CAN J MICROBIOL, V24, P574, DOI 10.1139/m78-093; Langvad F, 1999, J MICROBIOL METH, V37, P97, DOI 10.1016/S0167-7012(99)00053-6; MAJCHROWICZ I, 1993, BIOCONTROL SCI TECHN, V3, P321, DOI 10.1080/09583159309355287; MATCHAM SE, 1984, APPL BIOCHEM BIOTECH, V9, P387, DOI 10.1007/BF02798989; Meyer L, 2006, PLANT DIS, V90, P97, DOI 10.1094/PD-90-0097; Meyer L, 2001, S AFR J SCI, V97, P191; Mohammedi Z., 2013, Australian Journal of Crop Science, V7, P293; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Taniwaki MH, 2006, ADV EXP MED BIOL, V571, P49, DOI 10.1007/0-387-28391-9_3; Teichert A, 2008, J NAT PROD, V71, P1092, DOI 10.1021/np8000859; TRINCI APJ, 1969, J GEN MICROBIOL, V57, P11, DOI 10.1099/00221287-57-1-11; van Kuijk SJA, 2015, ANIM FEED SCI TECH, V209, P40, DOI 10.1016/j.anifeedsci.2015.07.026; VANDERAA HA, 1973, STUD MYCOL, V5, P1; WAGER V. A., 1952, Science Bulletin. Department of Agriculture and Forestry, Union of South Africa, V303; Wang NY, 2016, PHYTOPATHOLOGY, V106, P1300, DOI 10.1094/PHYTO-12-15-0316-R	27	16	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170755	10.1371/journal.pone.0170755	http://dx.doi.org/10.1371/journal.pone.0170755			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125679	Green Published, Green Submitted, gold			2022-12-27	WOS:000396176100065
J	Ishii, Y; Hayashi, S; Takamura, N				Ishii, Yumiko; Hayashi, Seiji; Takamura, Noriko			Radiocesium Transfer in Forest Insect Communities after the Fukushima Dai-ichi Nuclear Power Plant Accident	PLOS ONE			English	Article							FRESH-WATER FISH; WOODLAND ECOSYSTEM; RADIONUCLIDES; CS-137; CHERNOBYL; RADIOACTIVITY; INVERTEBRATES; EARTHWORMS; BRYOPHYTES; TRANSPORT	To understand radiocesium transfer in the forest insect food web, we investigated the activity concentrations of radiocesium in forest insects in the Fukushima and Ibaraki Prefectures approximately 1.5-2.5 years after the Fukushima Dai-ichi Nuclear Power Plant. We analyzed 34 species of insects sampled from 4 orders and 4 feeding functional groups (herbivore, carnivore, omnivore, and detritivore) from three sites in each prefecture. Cs-137 activity concentrations were lowest in herbivorous species and were especially high in detritivorous and omnivorous species that feed on forest litter and fungi. Radiocesium activity concentrations in any given species reflected the degree of contamination of that species' primary food sources since radiocesium activity concentrations were found to be the lowest in leaves and grass and the highest in litter, bark, and fungi. This study confirmed that litter and other highly contaminated forest components such as fungi, decaying wood, bryophytes, and lichens serve as sources of Cs-137 transfer into the forest insect community.	[Ishii, Yumiko; Hayashi, Seiji] Natl Inst Environm Studies, Environm Impact Assessment Sect, Fukushima Branch, Fukushima, Japan; [Takamura, Noriko] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan	National Institute for Environmental Studies - Japan	Ishii, Y (corresponding author), Natl Inst Environm Studies, Environm Impact Assessment Sect, Fukushima Branch, Fukushima, Japan.	ischii@gmail.com	Ishii, Yumiko/B-8135-2011	Ishii, Yumiko/0000-0003-2712-5244	research program on Disaster Environment, an internal budget of National Institute for Environmental Studies	research program on Disaster Environment, an internal budget of National Institute for Environmental Studies	This work was financially supported by the research program on Disaster Environment, an internal budget of National Institute for Environmental Studies. The internal budget was originally issued by the Ministry of Environment, Japan (http://www.nies.go.jp/shinsal/index-e.html).	Akimoto S, 2014, ECOL EVOL, V4, P355, DOI 10.1002/ece3.949; Ayabe Y, 2014, J ENVIRON RADIOACTIV, V127, P105, DOI 10.1016/j.jenvrad.2013.10.010; Beresford NA, 2013, SCI TOTAL ENVIRON, V463, P284, DOI 10.1016/j.scitotenv.2013.06.013; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bretz F, 2011, MULTIPLE COMP USING, DOI DOI 10.1201/9781420010909; BROWN SL, 1995, ENVIRON POLLUT, V88, P27, DOI 10.1016/0269-7491(95)91045-M; Copplestone D, 1999, SCI TOTAL ENVIRON, V239, P95, DOI 10.1016/S0048-9697(99)00294-6; Dohi T, 2015, J ENVIRON RADIOACTIV, V146, P125, DOI 10.1016/j.jenvrad.2015.04.013; Dragovic S, 2010, ENVIRON MONIT ASSESS, V166, P677, DOI 10.1007/s10661-009-1032-4; Endo I, 2015, J ENVIRON RADIOACTIV, V149, P176, DOI 10.1016/j.jenvrad.2015.07.027; Forest and Forest Product Research Institute, 2012, PREL RES SURV DISTR; Gaso MI, 1995, SCI TOTAL ENVIRON, V173, P41, DOI 10.1016/0048-9697(95)04763-8; GIOVANI C, 1994, SCI TOTAL ENVIRON, V157, P35, DOI 10.1016/0048-9697(94)90563-0; Hasegawa M, 2013, J ENVIRON RADIOACTIV, V126, P8, DOI 10.1016/j.jenvrad.2013.06.006; Hashimoto S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02564; Hiyama A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00570; Kinoshita N, 2011, P NATL ACAD SCI USA, V108, P19526, DOI 10.1073/pnas.1111724108; Koarashi J, 2014, SCI REP-UK, V4, DOI 10.1038/srep06853; Mietelski JW, 2010, J ENVIRON RADIOACTIV, V101, P488, DOI 10.1016/j.jenvrad.2008.04.009; Mietelski JW, 2003, J ENVIRON MONITOR, V5, P296, DOI 10.1039/b212592g; Mietelski JW, 2004, 3 CASE STUDIES, V262, P645; Ministry of Education Culture Sports Science and Technology J, 2011, RES 4 AIRB MON SURV; Moller AP, 2012, ENVIRON POLLUT, V164, P36, DOI 10.1016/j.envpol.2012.01.008; Murakami M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03599; Nishikiori T, 2015, SCI TOTAL ENVIRON, V502, P611, DOI 10.1016/j.scitotenv.2014.09.063; Ohmura Y, 2015, J ENVIRON RADIOACTIV, V141, P38, DOI 10.1016/j.jenvrad.2014.11.014; R Core Team, 2013, R LANG ENV STAT COMP; ROWAN DJ, 1994, CAN J FISH AQUAT SCI, V51, P2388, DOI 10.1139/f94-240; RUDGE SA, 1993, J ENVIRON RADIOACTIV, V19, P199, DOI 10.1016/0265-931X(93)90003-P; Sakai M, 2016, ENVIRON POLLUT, V209, P46, DOI 10.1016/j.envpol.2015.11.025; Shaw G, 2005, J ENVIRON RADIOACTIV, V84, P285, DOI 10.1016/j.jenvrad.2003.09.006; Smith JT, 2005, S-P BKS ENVIRONM SCI, P81; Steiner M, 2002, J ENVIRON RADIOACTIV, V58, P217, DOI 10.1016/S0265-931X(01)00067-4; Sundbom M, 2003, J APPL ECOL, V40, P228, DOI 10.1046/j.1365-2664.2003.00795.x; Toal ME, 2002, J ENVIRON RADIOACTIV, V63, P85, DOI 10.1016/S0265-931X(02)00018-8; Yoshida N, 2012, SCIENCE, V336, P1115, DOI 10.1126/science.1219493; Yoshihara T, 2013, J ENVIRON RADIOACTIV, V115, P60, DOI 10.1016/j.jenvrad.2012.07.002	37	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0171133	10.1371/journal.pone.0171133	http://dx.doi.org/10.1371/journal.pone.0171133			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125745	Green Published, Green Submitted, gold			2022-12-27	WOS:000396176100007
J	Marrano, A; Birolo, G; Prazzoli, ML; Lorenzi, S; Valle, G; Grando, MS				Marrano, Annarita; Birolo, Giovanni; Prazzoli, Maria Lucia; Lorenzi, Silvia; Valle, Giorgio; Grando, Maria Stella			SNP-Discovery by RAD-Sequencing in a Germplasm Collection of Wild and Cultivated Grapevines ( V-vinifera L.)	PLOS ONE			English	Article							WHOLE-GENOME ASSOCIATION; GENETIC DIVERSITY; LINKAGE DISEQUILIBRIUM; MARKERS; IDENTIFICATION; SELECTION; PATTERNS; ORIGINS; PLINK; ARRAY	Whole-genome comparisons of Vitis vinifera subsp. sativa and V. vinifera subsp. sylvestris are expected to provide a better estimate of the valuable genetic diversity still present in grapevine, and help to reconstruct the evolutionary history of a major crop worldwide. To this aim, the increase of molecular marker density across the grapevine genome is fundamental. Here we describe the SNP discovery in a grapevine germplasm collection of 51 cultivars and 44 wild accessions through a novel protocol of restriction-site associated DNA (RAD) sequencing. By resequencing 1.1% of the grapevine genome at a high coverage, we recovered 34K BamHI unique restriction sites, of which 6.8% were absent in the 'PN40024' reference genome. Moreover, we identified 37,748 single nucleotide polymorphisms (SNPs), 93% of which belonged to the 19 assembled chromosomes with an average of 1.8K SNPs per chromosome. Nearly half of the SNPs fell in genic regions mostly assigned to the functional categories of metabolism and regulation, whereas some nonsynonymous variants were identified in genes related with the detection and response to environmental stimuli. SNP validation was carried-out, showing the ability of RAD-seq to accurately determine genotypes in a highly heterozygous species. To test the usefulness of our SNP panel, the main diversity statistics were evaluated, highlighting how the wild grapevine retained less genetic variability than the cultivated form. Furthermore, the analysis of Linkage Disequilibrium (LD) in the two subspecies separately revealed how the LD decays faster within the domesticated grapevine compared to its wild relative. Being the first application of RAD-seq in a diverse grapevine germplasm collection, our approach holds great promise for exploiting the genetic resources available in one of the most economically important fruit crops.	[Marrano, Annarita; Prazzoli, Maria Lucia; Lorenzi, Silvia; Grando, Maria Stella] Fdn Edmund Mach, Res & Innovat Ctr, Grapevine Genet & Breeding, Dept Genom & Biol Fruit Crops, San Michele All Adige, Trentino, Italy; [Birolo, Giovanni; Valle, Giorgio] Univ Padua, CRIBI Biotechnol Ctr, Padua, Italy; [Valle, Giorgio] Univ Padua, Dept Biol, Padua, Italy	Fondazione Edmund Mach; University of Padua; University of Padua	Marrano, A (corresponding author), Fdn Edmund Mach, Res & Innovat Ctr, Grapevine Genet & Breeding, Dept Genom & Biol Fruit Crops, San Michele All Adige, Trentino, Italy.	marrano.annarita@gmail.com	Birolo, Giovanni/ABB-6326-2020; Grando, Maria Stella/D-5448-2011	Birolo, Giovanni/0000-0003-0160-9312; Grando, Maria Stella/0000-0002-6889-1968; Marrano, Annarita/0000-0001-9560-2706	autonomous province of Trento (Italy); GMPF PhD program	autonomous province of Trento (Italy)(Autonomous Province of Trento); GMPF PhD program	This study was funded by the autonomous province of Trento (Italy) and the GMPF PhD program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam-Blondon A-F, 2011, GENETICS GENOMICS BR; Aradhya M, 2013, PLANT SYST EVOL, V299, P317, DOI 10.1007/s00606-012-0723-4; Garcia RAA, 2013, MEDITERRANEAN GENETIC CODE - GRAPEVINE AND OLIVE, P51, DOI 10.5772/52933; Arroyo-Garcia R, 2006, MOL ECOL, V15, P3707, DOI 10.1111/j.1365-294X.2006.03049.x; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bajaj D, 2015, SCI REP-UK, V5, DOI 10.1038/srep12468; Barba P, 2014, THEOR APPL GENET, V127, P73, DOI 10.1007/s00122-013-2202-x; Barchi L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-304; Barnaud A, 2006, THEOR APPL GENET, V112, P708, DOI 10.1007/s00122-005-0174-1; Bodor P, 2015, VITIS, V54, P213; Boursiquot J.M., 2013, P 9 INT S GRAP PHYS, P123; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Buffer S, FRAGMENT LIB PREPARA, V5500, P1; Castaneda-Alvarez NP, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.22, 10.1038/nplants.2016.22]; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen J, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0428-2; Chin C-S, 2016, PHASED DIPLOID GENOM, P56887; Corso M, 2015, J EXP BOT, V66, P5739, DOI 10.1093/jxb/erv274; Da Silva C, 2013, PLANT CELL, V25, P4777, DOI 10.1105/tpc.113.118810; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Davey JL, 2010, BRIEF FUNCT GENOMICS, V9, P416, DOI 10.1093/bfgp/elq031; Davey JW, 2013, MOL ECOL, V22, P3151, DOI 10.1111/mec.12084; De Andres MT, 2012, MOL ECOL, V21, P800, DOI 10.1111/j.1365-294X.2011.05395.x; De Lorenzis G, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0510-9; Deschamps Stephane, 2012, Biology (Basel), V1, P460, DOI 10.3390/biology1030460; Development Core Team R, 2011, R LANG ENV STAT COMP; Di Genova A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-7; Di Vecchi-Staraz M, 2009, J HERED, V100, P66, DOI 10.1093/jhered/esn084; Drori E, 2015, VITIS, V54, P107; Elshire RJ, 2012, GENOTYPING SEQUENCIN; Emanuelli F, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-39; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Grassi F, 2006, CONSERV GENET, V7, P837, DOI 10.1007/s10592-006-9118-9; Grimplet Jerome, 2012, BMC Res Notes, V5, P213, DOI 10.1186/1756-0500-5-213; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Hamilton M.B., 2009, POPULATION GENETICS; Heywood V.H., 1995, FLORA MEDITERRANEAN, V5, P375; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Homer N, 2009, PLOS ONE, V4; Ilut DC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/675158; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Kumar S., 2012, INT J PLANT GENOMICS, V2012; Li Y, 2011, GENOME RES, V21, P940, DOI 10.1101/gr.117259.110; Lijavetzky D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-424; Mammadov J, 2012, INT J PLANT GENOMICS, V2012; Marrano A, 2015, VITIS, V54, P233; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Money D, 2015, G3 GENES GENOMES GEN, V5; Morgante M, 2007, CURR OPIN PLANT BIOL, V10, P149, DOI 10.1016/j.pbi.2007.02.001; Myles S, 2013, TRENDS GENET, V29, P190, DOI 10.1016/j.tig.2013.01.006; Myles S, 2011, P NATL ACAD SCI USA, V108, P3530, DOI 10.1073/pnas.1009363108; Myles S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008219; NCBI, VIT VIN CHLOR COMPL; NCBI, VIT VIN MIT COMPL GE; Nelson JC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-352; Nicolas SD, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0754-z; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Prazzoli ML, 2016, 10 INT S GRAP PHYS B; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; This P, 2006, TRENDS GENET, V22, P511, DOI 10.1016/j.tig.2006.07.008; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Vitti JJ, 2013, ANNU REV GENET, V47, P97, DOI 10.1146/annurev-genet-111212-133526; Vitulo N, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-99; Wales N, 2016, J ARCHAEOL SCI, V72, P57, DOI 10.1016/j.jas.2016.05.014; Wang N, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-148; Wang S, 2012, NAT METHODS, V9, P808, DOI [10.1038/nmeth.2023, 10.1038/NMETH.2023]; Wang Y, 2012, MOL ECOL, V21, P974, DOI 10.1111/j.1365-294X.2011.05413.x; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xin HP, 2013, TREE GENET GENOMES, V9, P1343, DOI 10.1007/s11295-013-0643-7; ZOHARY D, 1995, ORIGINS ANCIENT HIST, P23; Zohary D, 2000, DOMESTICATION PLANTS, DOI DOI 10.1006/ANBO.2001.1505	76	31	31	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170655	10.1371/journal.pone.0170655	http://dx.doi.org/10.1371/journal.pone.0170655			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125640	Green Published, gold, Green Submitted			2022-12-27	WOS:000396176100079
J	Zheng, JP; Zhai, WL; Li, Q; Jia, QX; Lin, DS				Zheng, Jiapeng; Zhai, Wenliang; Li, Qiang; Jia, Qianxin; Lin, Dasheng			A Special Tear Pattern of Anterior Horn of the Lateral Meniscus: Macerated Tear	PLOS ONE			English	Article							ARTHROSCOPIC PARTIAL MENISCECTOMY; DEGENERATIVE TEARS; PHYSICAL-THERAPY; SURGERY; OSTEOARTHRITIS; KNEE; REPAIRS	Background We describe a special, interesting phenomenon found in the anterior horn of the lateral meniscus (AHLM): most tear patterns in the AHLM are distinctive, with loose fibers in injured region and circumferential fiber bundles were separated. We name it as macerated tear. The goal of this study was to bring forward a new type of meniscal tear in the AHLM and investigate its clinical value. Materials and Methods AHLM tears underwent arthroscopic surgery from January 2012 to December 2014 were included. Data regarding the integrity of AHLM were prospectively recorded in a data registry. Tear morphology and treatment received were subsequently extracted by 2 independent reviewers from operative notes and arthroscopic surgical photos. Results A total of 60 AHLM tears in 60 patients (mean age 27.1 years) were grouped into horizontal tears (n = 15, 25%), vertical tears (n = 14, 23%), complex tears (n = 6, 10%), and macerated tears (n = 25, 42%). There were 6 patients with AHLM cysts in macerated tear group and one patient in vertical tear group. 60 patients were performed arthroscopic meniscus repairs and were followed-up with averaged 18.7 months. Each group had significant postoperative improvement in Lysholm and IKDC scores (p < 0.05). However, the macerated tear group showed least functional recovery of Lysholm and IKDC scores compared to other groups (p < 0.05). In addition, there were no differences in postoperative range of motion, return to work, or return to sport/other baseline activities between the four groups (p > 0.05). Conclusions This study demonstrated that the macerated tear is common in the tear pattern of AHLM. However, feasibility of the treatment of this type of meniscal tear, especially the meniscus repairs still requires further study.	[Zheng, Jiapeng; Zhai, Wenliang; Li, Qiang; Lin, Dasheng] Xiamen Univ, Affiliated Southeast Hosp, Dept Orthopaed Surg, Zhangzhou, Peoples R China; [Jia, Qianxin] Xiamen Univ, Affiliated Southeast Hosp, Dept Radiol, Zhangzhou, Peoples R China; [Lin, Dasheng] Ludwig Maximilians Univ Munchen, Dept Surg, Expt Surg & Regenerat Med, Munich, Germany	Xiamen University; Xiamen University; University of Munich	Lin, DS (corresponding author), Xiamen Univ, Affiliated Southeast Hosp, Dept Orthopaed Surg, Zhangzhou, Peoples R China.; Lin, DS (corresponding author), Ludwig Maximilians Univ Munchen, Dept Surg, Expt Surg & Regenerat Med, Munich, Germany.	linds@xmu.edu.cn						Andrews SHJ, 2014, J ANAT, V224, P531, DOI 10.1111/joa.12170; Anz AW, 2014, AM J SPORT MED, V42, P2699, DOI 10.1177/0363546514549445; Barber-Westin SD, 2014, ARTHROSCOPY, V30, P134, DOI 10.1016/j.arthro.2013.10.003; Bhatia S, 2014, AM J SPORT MED, V42, P3016, DOI 10.1177/0363546514524162; Buchbinder R, 2016, BRIT J SPORT MED, V50, P1413, DOI 10.1136/bmj.h2212; Cucchiarini M, 2016, OSTEOARTHR CARTILAGE, V24, P1330, DOI 10.1016/j.joca.2016.03.018; England E, 2015, SKELETAL RADIOL, V44, P369, DOI 10.1007/s00256-014-2043-y; Englund M, 2016, OSTEOARTHR CARTILAGE, V24, P270, DOI 10.1016/j.joca.2015.08.005; Gundle KR, 2010, J BONE JOINT SURG AM, V92A, P2452, DOI 10.2106/JBJS.I.01369; Hutchinson ID, 2014, AM J SPORT MED, V42, P987, DOI 10.1177/0363546513498503; Katz JN, 2014, OSTEOARTHR CARTILAGE, V22, P1749, DOI 10.1016/j.joca.2014.07.016; Katz JN, 2013, NEW ENGL J MED, V369, P677, DOI 10.1056/NEJMc1307177; Katz JN, 2013, NEW ENGL J MED, V368, P1675, DOI 10.1056/NEJMoa1301408; Khan M, 2014, CAN MED ASSOC J, V186, P1057, DOI 10.1503/cmaj.140433; Kise NJ, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3740; Krych AJ, 2014, NEW ENGL J MED, V370, P1259, DOI 10.1056/NEJMc1401128; LaPrade CM, 2014, AM J SPORT MED, V42, P2386, DOI 10.1177/0363546514544678; LaPrade CM, 2014, J BONE JOINT SURG AM, V96A, P471, DOI 10.2106/JBJS.L.01252; Losina E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130256; McDermott I, 2011, BRIT J SPORT MED, V45, P292, DOI 10.1136/bjsm.2010.081257; Monk P, 2016, AM J SPORTS MED; Price A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2382; Rongen JJ, 2015, OSTEOARTHR CARTILAGE, V23, P1242, DOI 10.1016/j.joca.2015.04.025; Sihvonen R, 2016, OSTEOARTHR CARTILAGE, V24, P1367, DOI 10.1016/j.joca.2016.03.013; Sihvonen R, 2013, NEW ENGL J MED, V369, P2515, DOI 10.1056/NEJMoa1305189; Steineman BD, 2016, AM J SPORTS MED; Szarmach A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159156; Thorlund JB, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-h2747rep; Van der Straeten C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156183; Vrancken ACT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133138	30	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170710	10.1371/journal.pone.0170710	http://dx.doi.org/10.1371/journal.pone.0170710			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125675	Green Published, Green Submitted, gold			2022-12-27	WOS:000396176100069
J	Fatseas, G; Stapleton, F; Versace, P				Fatseas, George; Stapleton, Fiona; Versace, Patrick			Role of percent peripheral tissue ablated on refractive outcomes following hyperopic LASIK	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; CENTRAL CORNEAL THICKNESS; FEMTOSECOND LENTICULE EXTRACTION; PHOTOREFRACTIVE KERATECTOMY; INTRAOCULAR-PRESSURE; MECHANICAL MICROKERATOME; ULTRASOUND PACHYMETRY; TOPOGRAPHIC CHANGES; EXCIMER-LASER; ASTIGMATISM	Objectives To determine the effect of hyperopic laser in situ keratomileusis (H-LASIK) on corneal integrity, by investigating relationships between proportionate corneal tissue ablated and refractive outcomes at 3 months. Methods 18 eyes of 18 subjects treated with H-LASIK by Technolas 217c Excimer Laser were included in the study. Orbscan II Topography System was used to determine corneal volume and pachymetry 3mm temporally (3T). The volume of corneal tissue ablated was determined from the laser nomogram. Univariate associations between age, treatment, corneal volume, overall proportion of tissue removed, proportion of tissue removed at 3T, residual bed thickness at 3T and refractive outcomes 3 months post-LASIK were examined and independent factors associated with refractive outcomes determined using linear regression models. Results At 3 months post-LASIK, the mean difference to expected refractive outcome was -0.20 +/- 0.64 (Range -2.00 to +1.00). In univariate analysis, difference to expected refractive outcome was associated with proportion of tissue removed at 3T (P<0.01, r = -0.605) and total number of pulses (P<0.05, r = -0.574). In multivariable analysis, difference to expected refractive outcome was associated with the proportion of tissue removed at 3T only. Conclusion Subjects undergoing H-LASIK, may present as either over or under-corrected at 3 months. The proportion of tissue removed at 3T was the single significant determinant of this outcome, suggesting unexpected biomechanical alterations resulting in corneal steepening. Future hyperopic LASIK procedures could consider proportionate volume of corneal tissue removed at 3T in addition to laser nomograms to achieve improved refractive outcomes.	[Fatseas, George; Stapleton, Fiona] UNSW Australia, Fac Sci, Sch Optometry & Vis Sci, Kensington, NSW, Australia; [Versace, Patrick] Vis Eye Inst, Bondi Jct, NSW, Australia	University of New South Wales Sydney	Fatseas, G (corresponding author), UNSW Australia, Fac Sci, Sch Optometry & Vis Sci, Kensington, NSW, Australia.	George.fatseas@UNSW.edu.au		Stapleton, Fiona/0000-0002-7203-5443; Fatseas, George/0000-0002-6743-3850				Agudelo LM, 2002, J REFRACT SURG, V18, P472; ANSCHUTZ T, 1994, INT OPHTHALMOL CLIN, V34, P107, DOI 10.1097/00004397-199403440-00010; Antonios R, 2015, J CATARACT REFR SURG, V41, P1602, DOI 10.1016/j.jcrs.2014.11.049; Arbelaez MC, 1999, J REFRACT SURG, V15, P406; Baek TM, 2001, OPHTHALMOLOGY, V108, P317, DOI 10.1016/S0161-6420(00)00502-9; Blum M, 2013, GRAEF ARCH CLIN EXP, V251, P349, DOI 10.1007/s00417-012-2064-y; Brandt James D, 2004, Curr Opin Ophthalmol, V15, P85, DOI 10.1097/00055735-200404000-00004; Carones F, 1999, OPHTHALMOLOGY, V106, P1976, DOI 10.1016/S0161-6420(99)90411-6; Cartwright NEK, 2012, J REFRACT SURG, V28, P419, DOI 10.3928/1081597X-20120518-07; Chen CC, 2002, J CATARACT REFR SURG, V28, P1539, DOI 10.1016/S0886-3350(02)01541-9; Cobo-Soriano R, 2002, J CATARACT REFR SURG, V28, P1530, DOI 10.1016/S0886-3350(02)01367-6; Davidorf JM, 2001, OPHTHALMOLOGY, V108, P1261, DOI 10.1016/S0161-6420(01)00588-7; Dimasi DP, 2010, BRIT J OPHTHALMOL, V94, P971, DOI 10.1136/bjo.2009.162735; Ditzen K, 1998, J CATARACT REFR SURG, V24, P42, DOI 10.1016/S0886-3350(98)80073-4; Erie JC, 2002, OPHTHALMOLOGY, V109, P1447, DOI 10.1016/S0161-6420(02)01106-5; Eysteinsson T, 2002, ACTA OPHTHALMOL SCAN, V80, P11, DOI 10.1034/j.1600-0420.2002.800103.x; Feltham Mark H, 2000, Clin Exp Optom, V83, P76; Fiander D C, 1995, J Refract Surg, V11, pS234; Gil-Cazorla R, 2011, AM J OPHTHALMOL, V152, P16, DOI 10.1016/j.ajo.2011.01.009; Gimbel HV, 1998, OPHTHALMOLOGY, V105, P1839, DOI 10.1016/S0161-6420(98)91026-0; Huang D, 1999, J REFRACT SURG, V15, P538; Khaja WA, 2015, CLIN OPHTHALMOL, V9, P1065, DOI 10.2147/OPTH.S81376; Kim T, 2001, CORNEA, V20, P597, DOI 10.1097/00003226-200108000-00008; KOMAI Y, 1991, INVEST OPHTH VIS SCI, V32, P2244; Kozak I, 2003, J REFRACT SURG, V19, P149; Leccisotti A, 2014, J CATARACT REFR SURG, V40, P1122, DOI 10.1016/j.jcrs.2013.11.031; Lindstrom R L, 1999, Trans Am Ophthalmol Soc, V97, P241; Lindstrom RL, 1999, T AM OPHTHAL SOC, V97, P55; Liu Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0106787, 10.1371/journal.pone.0098157, 10.1371/journal.pone.0085323]; Liu YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep29802; Marshall J. J., 2008, AM SOC CAT REFR SURG; Marsich MM, 2000, CORNEA, V19, P792, DOI 10.1097/00003226-200011000-00007; Miyamoto T, 2003, J CATARACT REFR SURG, V29, P153, DOI 10.1016/S0886-3350(02)01450-5; Modis L, 2001, AM J OPHTHALMOL, V132, P517, DOI 10.1016/S0002-9394(01)01109-6; MUNNERLYN CR, 1988, J CATARACT REFR SURG, V14, P46, DOI 10.1016/S0886-3350(88)80063-4; Nawa Y, 2003, J CATARACT REFR SURG, V29, P1543, DOI 10.1016/S0886-3350(03)00460-7; PALLIKARIS IG, 1994, J REFRACT CORNEAL S, V10, P498; Paul T, 2008, J CATARACT REFR SURG, V34, P1906, DOI 10.1016/j.jcrs.2008.07.013; Pineda-Fernandez A, 2001, J REFRACT SURG, V17, P670; PINSKY PM, 1991, J BIOMECH, V24, P907, DOI 10.1016/0021-9290(91)90169-N; Rajpal RK, 2015, OPHTHALMOL THER; Randleman JB, 2007, J REFRACT SURG, V23, P98; Rani A, 2002, OPHTHALMOLOGY, V109, P1991, DOI 10.1016/S0161-6420(02)01238-1; Roberts C, 2000, J REFRACT SURG, V16, P407; Roberts C, 2002, J REFRACT SURG, V18, pS589; Rosa DSA, 1999, J REFRACT SURG, V15, pS212; Roy AS, 2014, J CATARACT REFR SURG, V40, P971, DOI 10.1016/j.jcrs.2013.08.065; Ruberti JW, 2011, ANNU REV BIOMED ENG, V13, P269, DOI 10.1146/annurev-bioeng-070909-105243; Sekundo W, 2008, J CATARACT REFR SURG, V34, P1513, DOI 10.1016/j.jcrs.2008.05.033; Settas G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007112.pub3; Van Gelder RN, 2003, AM J OPHTHALMOL, V135, P577, DOI 10.1016/S0002-9394(02)02228-6; Varley GA, 2004, OPHTHALMOLOGY, V111, P1604, DOI 10.1016/j.ophtha.2004.05.016; Wang Z, 1999, OPHTHALMOLOGY, V106, P406, DOI 10.1016/S0161-6420(99)90083-0; WILSON RS, 1982, BRIT J OPHTHALMOL, V66, P513, DOI 10.1136/bjo.66.8.513; Wilson SE, 1998, CORNEA, V17, P459, DOI 10.1097/00003226-199809000-00001; Zadok D, 2002, OPHTHALMOLOGY, V109, P1659, DOI 10.1016/S0161-6420(02)01161-2	56	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170559	10.1371/journal.pone.0170559	http://dx.doi.org/10.1371/journal.pone.0170559			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151939	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161200027
J	Mroczkowska, A; Zmudzki, J; Marszalek, N; Orczykowska-Kotyna, M; Komorowska, I; Nowak, A; Grzesiak, A; Czyzewska-Dors, E; Dors, A; Pejsak, Z; Hryniewicz, W; Wyszomirski, T; Empel, J				Mroczkowska, Aneta; Zmudzki, Jacek; Marszalek, Natalia; Orczykowska-Kotyna, Monika; Komorowska, Iga; Nowak, Agnieszka; Grzesiak, Anna; Czyzewska-Dors, Ewelina; Dors, Arkadiusz; Pejsak, Zygmunt; Hryniewicz, Waleria; Wyszomirski, Tomasz; Empel, Joanna			Livestock-associated Staphylococcus aureus on Polish pig farms	PLOS ONE			English	Article							METHICILLIN-RESISTANT; GENETIC DIVERSITY; MULTIPLEX PCR; MRSA CC398; ST398; HUMANS; COLONIZATION; PREVALENCE; SWINE; RISK	Background Livestock-associated Staphylococcus aureus (LA-SA) draws increasing attention due to its particular ability to colonize farm animals and be transmitted to people, which in turn leads to its spread in the environment. The aim of the study was to determine the dissemination of LA-SA on pig farms selected throughout Poland, characterize the population structure of identified S. aureus, and assess the prevalence of LA-SA carriage amongst farmers and veterinarians being in contact with pigs. Methods and findings The study was conducted on 123 pig farms (89 farrow-to-finish and 34 nucleus herds), located in 15 out of 16 provinces of Poland. Human and pig nasal swabs, as well as dust samples were analyzed. S. aureus was detected on 79 (64.2%) farms from 14 provinces. Amongst these farms LA-SA-positive farms dominated (71/79, 89.9%, 95% CI [81.0%, 95.5%]). The prevalence of LA-MRSA-positive farms was lower than LA-MSSA-positive (36.6% of LA-SA-positive farms, 95% CI [25.5%, 48.9%] vs. 74.6%, 95% CI [62.9%, 84.2%]). In total, 190 S. aureus isolates were identified: 72 (38%) MRSA and 118 (62%) methicillin-susceptible S. aureus (MSSA), of which 174 (92%) isolates were classified to three livestock-associated lineages: CC398 (73%), CC9 (13%), and CC30/ST433 (6%). All CC398 isolates belonged to the animal clade. Four LA-MRSA clones were detected: ST433-IVa(2B) clone (n = 8, 11%), described to the best of our knowledge for the first time, and three ST398 clones (n = 64, 89%) with the most prevalent being ST398-V(5C2&5)c, followed by ST398-V(5C2), and ST398-IVa(2B). Nasal carriage of LA-SA by pig farmers was estimated at 13.2% (38/283), CC398 carriage at 12.7% (36/283) and ST398-MRSA carriage at 3.2% (9/283), whereas by veterinarians at 21.1% (8/38), 18.4% (7/38) and 10.5% (4/38), respectively. Conclusions The prevalence of LA-MRSA-positive pig farms in Poland has increased considerably since 2008, when the first MRSA EU baseline survey was conducted in Europe. On Polish pig farms CC398 of the animal clade predominates, this being also reflected in the prevalence of CC398 nasal carriage in farmers and veterinarians. However, finding a new ST433-IVa (2B) clone provides evidence for the continuing evolution of LA-MRSA and argues for further monitoring of S. aureus in farm animals.	[Mroczkowska, Aneta; Marszalek, Natalia; Orczykowska-Kotyna, Monika; Komorowska, Iga; Hryniewicz, Waleria; Empel, Joanna] Natl Med Inst, Dept Epidemiol & Clin Microbiol, Warsaw, Poland; [Zmudzki, Jacek; Nowak, Agnieszka; Grzesiak, Anna; Czyzewska-Dors, Ewelina; Dors, Arkadiusz; Pejsak, Zygmunt] Natl Inst Vet Res, Dept Swine Dis, Pulawy, Poland; [Hryniewicz, Waleria] Ctr Qual Control Microbiol, Warsaw, Poland; [Wyszomirski, Tomasz] Univ Warsaw, Biol & Chem Res Ctr, Fac Biol, Warsaw, Poland	National Medicines Institute Lekow (NIL); National Veterinary Institute - National Research Institute; University of Warsaw	Empel, J (corresponding author), Natl Med Inst, Dept Epidemiol & Clin Microbiol, Warsaw, Poland.	jempel@cls.edu.pl	Dors, Arkadiusz/AHE-7159-2022; Dors, Arkadiusz/M-1508-2019; Orczykowska-Kotyna, Monika/X-6004-2018; Wyszomirski, Tomasz/V-8605-2018; Orczykowska-Kotyna, Monika/N-5008-2019	Dors, Arkadiusz/0000-0003-0270-2914; Dors, Arkadiusz/0000-0003-0270-2914; Wyszomirski, Tomasz/0000-0001-8385-2919; Orczykowska-Kotyna, Monika/0000-0002-5382-5343; Mroczkowska, Aneta/0000-0001-8529-5095; Empel, Joanna/0000-0002-1127-4053	Ministry of Science and Higher Education, Poland [5767/B/P01/2010/39]; Ministry of Science and Higher Education, Poland; European Commission [CONCORD-HEALTH-F3-2008-222718]; EU European Regional Development Fund under the Innovative Economy Operational Program; Wellcome Trust	Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); European Commission(European CommissionEuropean Commission Joint Research Centre); EU European Regional Development Fund under the Innovative Economy Operational Program; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was financially supported by the Ministry of Science and Higher Education, Poland, decision number 5767/B/P01/2010/39. The work performed at National Medicines Institute was partially supported by the Mikrobank 2 Programme from the Ministry of Science and Higher Education, Poland. NM was supported by the fellowship from a project CONCORD-HEALTH-F3-2008-222718 from the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Part of this study, performed by TW, was carried out at the Biological and Chemical Research Centre, University of Warsaw, established within a project co-financed by the EU European Regional Development Fund under the Innovative Economy Operational Program, 2007-2013.; We gratefully acknowledge the use of the S. aureus MLST database which was located at Imperial College London and funded by the Wellcome Trust.	Agerso Y, 2012, VET MICROBIOL, V157, P246, DOI 10.1016/j.vetmic.2011.12.023; Aires-de-Sousa M, 2006, J CLIN MICROBIOL, V44, P619, DOI 10.1128/JCM.44.2.619-621.2006; [Anonymous], 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1376; Argudin MA, 2011, APPL ENVIRON MICROB, V77, P3052, DOI 10.1128/AEM.02260-10; Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Aspiroz C, 2010, EMERG INFECT DIS, V16, P157, DOI 10.3201/eid1601.090694; Battisti A, 2010, VET MICROBIOL, V142, P361, DOI 10.1016/j.vetmic.2009.10.008; Brandt KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054425; Broens EM, 2011, PREV VET MED, V102, P41, DOI 10.1016/j.prevetmed.2011.06.005; Cavaco LM, 2010, ANTIMICROB AGENTS CH, V54, P3605, DOI 10.1128/AAC.00058-10; Chuang YY, 2015, INT J ANTIMICROB AG, V45, P334, DOI 10.1016/j.ijantimicag.2014.12.007; Cuny C, 2015, VET MICROBIOL, V177, P219, DOI 10.1016/j.vetmic.2015.02.031; Cuny C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024360; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; Dahms C, 2014, ACTA VET SCAND, V56, DOI 10.1186/s13028-014-0053-3; Denis O, 2009, EMERG INFECT DIS, V15, P1098, DOI 10.3201/eid1507.080652; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Dors A, 2013, POL J VET SCI, V16, P707, DOI 10.2478/pjvs-2013-0100; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; EUCAST,, 2019, BREAKPOINT TABLES IN; Garcia-Graells C, 2012, EPIDEMIOL INFECT, V140, P383, DOI 10.1017/S0950268811002263; Garcia-Graells C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065512; Gilot P, 2002, J CLIN MICROBIOL, V40, P4060, DOI 10.1128/JCM.40.11.4060-4067.2002; Goering RV, 2008, CLIN MICROBIOL INFEC, V14, P964, DOI 10.1111/j.1469-0691.2008.02073.x; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Guardabassi L, 2007, VET MICROBIOL, V122, P384, DOI 10.1016/j.vetmic.2007.03.021; Habrun B, 2011, ACTA VET HUNG, V59, P419, DOI 10.1556/AVet.2011.028; Hallin M, 2011, INFECT GENET EVOL, V11, P290, DOI 10.1016/j.meegid.2010.10.021; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Hasman H, 2010, VET MICROBIOL, V141, P326, DOI 10.1016/j.vetmic.2009.09.025; Higuchi W, 2008, BIOCHEM BIOPH RES CO, V377, P752, DOI 10.1016/j.bbrc.2008.10.009; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Kadlec K, 2009, J ANTIMICROB CHEMOTH, V64, P1156, DOI 10.1093/jac/dkp350; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; Krupa P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/141475; Kumagai R, 2007, VET MICROBIOL, V122, P190, DOI 10.1016/j.vetmic.2007.01.008; Lewis HC, 2008, EMERG INFECT DIS, V14, P1383, DOI 10.3201/eid1409.071576; Lim SK, 2012, VET MICROBIOL, V155, P88, DOI 10.1016/j.vetmic.2011.08.011; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Marszalek N, 1 METHICILLIN RESIST; McCarthy AJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00006; McCarthy AJ, 2012, VET DERMATOL, V23, P267, DOI 10.1111/j.1365-3164.2012.01072.x; McCarthy AJ, 2011, GENOME BIOL EVOL, V3, P1164, DOI 10.1093/gbe/evr092; Mehrotra M, 2000, J CLIN MICROBIOL, V38, P1032, DOI 10.1128/JCM.38.3.1032-1035.2000; Mellmann A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-98; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Moodley A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049344; Moore PCL, 2001, J CLIN MICROBIOL, V39, P2760, DOI 10.1128/JCM.39.8.2760-2767.2001; Moreno LZ, 2016, MEM I OSWALDO CRUZ, V111, P659, DOI 10.1590/0074-02760160276; MURAKAMI K, 1991, J CLIN MICROBIOL, V29, P2240, DOI 10.1128/JCM.29.10.2240-2244.1991; Pan A, 2009, EMERG INFECT DIS, V15, P845, DOI 10.3201/eid1505.081417; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; SAS Institute, 2014, SAS STAT 13 2 US GUI; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smith TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063704; Stegger M, 2011, J CLIN MICROBIOL, V49, P732, DOI 10.1128/JCM.01970-10; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; Tavares A, 2014, EUR J CLIN MICROBIOL, V33, P423, DOI 10.1007/s10096-013-1972-z; van Cleef BAGL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127190; Van Den Broek IVF, 2009, EPIDEMIOL INFECT, V137, P700, DOI 10.1017/S0950268808001507; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Vandendriessche S, 2014, J ANTIMICROB CHEMOTH, V69, P355, DOI 10.1093/jac/dkt366; Vandendriessche S, 2013, J ANTIMICROB CHEMOTH, V68, P1510, DOI 10.1093/jac/dkt047; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Wulf MWH, 2012, EUR J CLIN MICROBIOL, V31, P61, DOI 10.1007/s10096-011-1269-z; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	69	15	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170745	10.1371/journal.pone.0170745	http://dx.doi.org/10.1371/journal.pone.0170745			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151984	gold, Green Submitted, Green Published			2022-12-27	WOS:000396161200039
J	Nelson, N; Szekeres, K; Iclozan, C; Rivera, IO; McGill, A; Johnson, G; Nwogu, O; Ghansah, T				Nelson, Nadine; Szekeres, Karoly; Iclozan, Cristina; Rivera, Ivannie Ortiz; McGill, Andrew; Johnson, Gbemisola; Nwogu, Onyekachi; Ghansah, Tomar			Apigenin: Selective CK2 inhibitor increases Ikaros expression and improves T cell homeostasis and function in murine pancreatic cancer	PLOS ONE			English	Article							CASEIN KINASE-II; PROTEASOME ACTIVITY; FLAVONOID APIGENIN; SUPPRESSOR-CELLS; DENDRITIC CELLS; GENE; PHOSPHORYLATION; GROWTH; IDENTIFICATION; IMMUNOTHERAPY	Pancreatic cancer (PC) evades immune destruction by favoring the development of regulatory T cells (Tregs) that inhibit effector T cells. The transcription factor Ikaros is critical for lymphocyte development, especially T cells. We have previously shown that downregulation of Ikaros occurs as a result of its protein degradation by the ubiquitin-proteasome system in our Panc02 tumor-bearing (TB) mouse model. Mechanistically, we observed a deregulation in the balance between Casein Kinase II (CK2) and protein phosphatase 1 (PP1), which suggested that increased CK2 activity is responsible for regulating Ikaros' stability in our model. We also showed that this loss of Ikaros expression is associated with a significant decrease in CD4(+) and CD8(+) T cell percentages but increased CD4(+) CD25+ Tregs in TB mice. In this study, we evaluated the effects of the dietary flavonoid apigenin (API), on Ikaros expression and T cell immune responses. Treatment of splenocytes from naive mice with (API) stabilized Ikaros expression and prevented Ikaros downregulation in the presence of murine Panc02 cells in vitro, similar to the proteasome inhibitor MG132. In vivo treatment of TB mice with apigenin (TB-API) improved survival, reduced tumor weights and prevented splenomegaly. API treatment also restored protein expression of some Ikaros isoforms, which may be attributed to its moderate inhibition of CK2 activity from splenocytes of TBAPI mice. This partial restoration of Ikaros expression was accompanied by a significant increase in CD4(+) and CD8(+) T cell percentages and a reduction in Treg percentages in TBAPI mice. In addition, CD8(+) T cells from TB-API mice produced more IFN-gamma. and their splenocytes were better able to prime allogeneic CD8(+) T cell responses compared to TB mice. These results provide further evidence that Ikaros is regulated by CK2 in our pancreatic cancer model. More importantly, our findings suggest that API may be a possible therapeutic agent for stabilizing Ikaros expression and function to maintain T cell homeostasis in murine PC.	[Nelson, Nadine; Szekeres, Karoly; Iclozan, Cristina; Rivera, Ivannie Ortiz; McGill, Andrew; Johnson, Gbemisola; Nwogu, Onyekachi; Ghansah, Tomar] Univ S Florida, Dept Mol Med, Tampa, FL 33620 USA; [Ghansah, Tomar] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute	Ghansah, T (corresponding author), Univ S Florida, Dept Mol Med, Tampa, FL 33620 USA.; Ghansah, T (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA.	Tghansah@health.usf.edu		Nwogu, Onyekachi/0000-0003-3602-7857	National Cancer Institute, Center to Reduce Cancer Health Disparities, [1R21 CA179668-01A1]; NATIONAL CANCER INSTITUTE [R21CA179668] Funding Source: NIH RePORTER	National Cancer Institute, Center to Reduce Cancer Health Disparities,(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the National Cancer Institute, Center to Reduce Cancer Health Disparities, 1R21 CA179668-01A1 grants awarded to TG. The graduate training support was from the Florida Education Fund McKnight Dissertation Completion Fellowship awarded to NN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Ahmad KA, 2005, ANTI-CANCER DRUG, V16, P1037, DOI 10.1097/00001813-200511000-00001; Alexandrova A, 2008, CELL BIOCHEM FUNCT, V26, P392, DOI 10.1002/cbf.1459; Bazhin AV, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25736; BOSC DG, 1995, J BIOL CHEM, V270, P25872, DOI 10.1074/jbc.270.43.25872; Caltagirone S, 2000, INT J CANCER, V87, P595, DOI 10.1002/1097-0215(20000815)87:4&lt;595::AID-IJC21&gt;3.0.CO;2-5; Cao MD, 2004, CELL BIOL INT, V28, P223, DOI 10.1016/j.cellbi.2003.12.006; Capece D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068080; Channavajhala P, 2002, ONCOGENE, V21, P5280, DOI 10.1038/sj.onc.1205640; Chen D, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1797; CORBETT TH, 1984, CANCER RES, V44, P717; Dovat S, 2011, MOL CELL BIOCHEM, V356, P201, DOI 10.1007/s11010-011-0964-5; Duncan JS, 2008, BBA-PROTEINS PROTEOM, V1784, P33, DOI 10.1016/j.bbapap.2007.08.017; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Georgopoulos K, 1997, ANNU REV IMMUNOL, V15, P155, DOI 10.1146/annurev.immunol.15.1.155; Ghanekar SA, 2001, CLIN DIAGN LAB IMMUN, V8, P628, DOI 10.1128/CDLI.8.3.628-631.2001; Ghansah T, 2004, J IMMUNOL, V173, P7324, DOI 10.4049/jimmunol.173.12.7324; Ghansah T, 2013, CANCER IMMUNOL IMMUN, V62, P1083, DOI 10.1007/s00262-013-1407-9; Gomez-del Arco P, 2004, MOL CELL BIOL, V24, P2797, DOI 10.1128/MCB.24.7.2797-2807.2004; Gurel Z, 2008, J BIOL CHEM, V283, P8291, DOI 10.1074/jbc.M707906200; Hadrup S, 2013, CANCER MICROENVIRON, V6, P123, DOI 10.1007/s12307-012-0127-6; Hamacher R, 2007, ONCOL REP, V18, P695; Hiraoka N, 2006, CLIN CANCER RES, V12, P5423, DOI 10.1158/1078-0432.CCR-06-0369; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; John LB, 2011, MOL IMMUNOL, V48, P1272, DOI 10.1016/j.molimm.2011.03.006; Kathrein KL, 2005, MOL CELL BIOL, V25, P1645, DOI 10.1128/MCB.25.5.1645-1654.2005; Kennedy R, 2008, IMMUNOL REV, V222, P129, DOI 10.1111/j.1600-065X.2008.00616.x; Kim HJ, 2014, CANCER IMMUNOL RES, V2, P91, DOI 10.1158/2326-6066.CIR-13-0216; Landesman-Bollag E, 1998, ONCOGENE, V16, P2965, DOI 10.1038/sj.onc.1201854; LITCHFIELD DW, 1992, J BIOL CHEM, V267, P13943; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; LITCHFIELD DW, 1991, J BIOL CHEM, V266, P20380; Mafuvadze B, 2012, HORM CANCER-US, V3, P160, DOI 10.1007/s12672-012-0114-x; Morse MA, 2009, EXPERT OPIN BIOL TH, V9, P331, DOI 10.1517/14712590802715756 ; Nelson N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115546; Nelson N, 2012, JOVE-J VIS EXP, DOI 10.3791/3875; Oberstein PE, 2013, THER ADV GASTROENTER, V6, P321, DOI 10.1177/1756283X13478680; Patel D, 2007, INT J ONCOL, V30, P233; Payne KJ, 2003, J IMMUNOL, V170, P3091, DOI 10.4049/jimmunol.170.6.3091; Pilon-Thomas S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027729; Pinna LA, 2009, CELL MOL LIFE SCI, V66, P1797, DOI 10.1007/s00018-009-9148-9; Popescu M, 2009, J BIOL CHEM, V284, P13869, DOI 10.1074/jbc.M900209200; Powers GL, 2010, ONCOGENE, V29, P1509, DOI 10.1038/onc.2009.434; Qin ZH, 2003, CANCER RES, V63, P4095; Rebollo A, 2003, IMMUNOL CELL BIOL, V81, P171, DOI 10.1046/j.1440-1711.2003.01159.x; Seldin DC, 2008, MOL CELL BIOCHEM, V316, P141, DOI 10.1007/s11010-008-9811-8; Shevach EM, 2011, ADV IMMUNOL, V112, P137, DOI 10.1016/B978-0-12-387827-4.00004-8; Song CH, 2015, BLOOD, V126, P1813, DOI 10.1182/blood-2015-06-651505; Song Chunhua, 2011, World J Biol Chem, V2, P126, DOI 10.4331/wjbc.v2.i6.126; Strouch MJ, 2009, PANCREAS, V38, P409, DOI 10.1097/MPA.0b013e318193a074; Sun L, 1999, CLIN CANCER RES, V5, P2112; Ujiki MB, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-76; Urban JA, 2009, J IMMUNOL, V182, P3955, DOI 10.4049/jimmunol.0802869; Wang HJ, 2014, PEDIATR BLOOD CANCER, V61, P2230, DOI 10.1002/pbc.25221; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Xianjun Y, TRANSLATIONAL MED, P2161; Yamamoto T, 2012, PANCREAS, V41, P409, DOI 10.1097/MPA.0b013e3182373a66; Yoon MS, 2006, MOL PHARMACOL, V70, P1033, DOI 10.1124/mol.106.024547	58	29	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170197	10.1371/journal.pone.0170197	http://dx.doi.org/10.1371/journal.pone.0170197			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152014	gold, Green Submitted, Green Published			2022-12-27	WOS:000396161200017
J	Quiroz-Zarate, A; Harshfield, BJ; Hu, R; Knoblauch, N; Beck, AH; Hankinson, SE; Carey, V; Tamimi, RM; Hunter, DJ; Quackenbush, J; Hazra, A				Quiroz-Zarate, Alejandro; Harshfield, Benjamin J.; Hu, Rong; Knoblauch, Nick; Beck, Andrew H.; Hankinson, Susan E.; Carey, Vincent; Tamimi, Rulla M.; Hunter, David J.; Quackenbush, John; Hazra, Aditi			Expression Quantitative Trait loci (QTL) in tumor adjacent normal breast tissue and breast tumor tissue	PLOS ONE			English	Article							CANCER RISK; SUSCEPTIBILITY; ASSOCIATION; VARIANTS; ALLELES; OVARIAN; GENES	We investigate 71 single nucleotide polymorphisms (SNPs) identified in meta-analytic studies of genome-wide association studies (GWAS) of breast cancer, the majority of which are located in intergenic or intronic regions. To explore regulatory impacts of these variants we conducted expression quantitative loci (eQTL) analyses on tissue samples from 376 invasive postmenopausal breast cancer cases in the Nurses' Health Study (NHS) diagnosed from 1990-2004. Expression analysis was conducted on all formalin-fixed paraffin-embedded (FFPE) tissue samples (and on 264 adjacent normal samples) using the Affymetrix Human Transcriptome Array. Significance and ranking of associations between tumor receptor status and expression variation was preserved between NHS FFPE and TCGA fresh-frozen sample sets (Spearman r = 0.85, p<10<^>-10 for 17 of the 21 Oncotype DX recurrence signature genes). At an FDR threshold of 10%, we identified 27 trans-eQTLs associated with expression variation in 217 distinct genes. SNP-gene associations can be explored using an open-source interactive browser distributed in a Bioconductor package. Using a new a procedure for testing hypotheses relating SNP content to expression patterns in gene sets, defined as molecular function pathways, we find that loci on 6q14 and 6q25 affect various gene sets and molecular pathways (FDR < 10%). Although the ultimate biological interpretation of the GWAS-identified variants remains to be uncovered, this study validates the utility of expression analysis of this FFPE expression set for more detailed integrative analyses.	[Quiroz-Zarate, Alejandro] ArcBio LLC, Cambridge, MA USA; [Harshfield, Benjamin J.; Hu, Rong; Hankinson, Susan E.; Carey, Vincent; Tamimi, Rulla M.; Quackenbush, John] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Harshfield, Benjamin J.; Hu, Rong; Knoblauch, Nick; Beck, Andrew H.; Hankinson, Susan E.; Carey, Vincent; Tamimi, Rulla M.; Quackenbush, John; Hazra, Aditi] Harvard Med Sch, Boston, MA 02115 USA; [Hu, Rong; Tamimi, Rulla M.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Knoblauch, Nick; Beck, Andrew H.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Hankinson, Susan E.] Univ Massachusetts, Div Biostat & Epidemiol, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA; [Hunter, David J.; Hazra, Aditi] Harvard TH Chan Sch Publ Hlth, Program Genet Epidemiol & Stat Genet, Boston, MA 02115 USA; [Hunter, David J.; Hazra, Aditi] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Quackenbush, John] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Quackenbush, John] Dana Farber Canc Inst, Ctr Canc Computat Biol, Boston, MA 02115 USA; [Quackenbush, John] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Hazra, Aditi] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; University of Massachusetts System; University of Massachusetts Amherst; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Hazra, A (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	ahazra@bwh.harvard.edu		Knoblauch, Nicholas/0000-0002-2890-6520; Quackenbush, John/0000-0002-2702-5879	National Cancer Institute GAME-ON DRIVE initiative [U19 CA148065, U24 CA180996, CA148065-01]; Susan G. Komen for the Cure [SAC110014]; NATIONAL CANCER INSTITUTE [U24CA180996] Funding Source: NIH RePORTER	National Cancer Institute GAME-ON DRIVE initiative; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Cancer Institute GAME-ON DRIVE initiative U19 CM 48065, U24 CM 80996, CA148065-01 and by Susan G. Komen for the Cure - SAC110014.	Abdueva D, 2010, J MOL DIAGN, V12, P409, DOI 10.2353/jmoldx.2010.090155; Arbustini E, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw172; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atanassov BS, 2005, GENE CHROMOSOME CANC, V44, P429, DOI 10.1002/gcc.20255; Barry WT, 2005, BIOINFORMATICS, V21, P1943, DOI 10.1093/bioinformatics/bti260; Camp NJ, 2016, CANCER RES, V76, P1916, DOI 10.1158/0008-5472.CAN-15-1629; Castro MAA, 2016, NAT GENET, V48, P12, DOI 10.1038/ng.3458; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; CHURCHILL GA, 1994, GENETICS, V138, P963; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; D'Eustachio P, 2011, METHODS MOL BIOL, V694, P49, DOI 10.1007/978-1-60761-977-2_4; Dunning AM, 2016, NAT GENET, V48, P374, DOI 10.1038/ng.3521; EASTON DF, 2007, NATURE; Ghoussaini M, 2016, AM J HUM GENET, V99, P903, DOI 10.1016/j.ajhg.2016.07.017; Ghoussaini M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5999; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Guo YW, 2016, CARBOHYD POLYM, V145, P13, DOI 10.1016/j.carbpol.2016.03.016; Han YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165559; Horne HN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160316; Hu R, 2011, CLIN CANCER RES, V17, P1867, DOI 10.1158/1078-0432.CCR-10-2021; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Kar SP, 2016, CANCER DISCOV, V6, P1052, DOI 10.1158/2159-8290.CD-15-1227; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lawrenson K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12675; Li Q, 2014, HUM MOL GENET; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Lin WY, 2014, HUM MOL GENET; Long JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058350; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; McAllister KA, 2002, CANCER RES, V62, P990; Meeks HD, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv315; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Morimatsu M, 1998, CANCER RES, V58, P3441; Muranen TA, 2016, GENET MED; Muranen TA, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0758-5; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; de Garibay GR, 2014, HUM MUTAT, V35, P53, DOI 10.1002/humu.22456; Seo JH, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0363; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Veeraraghavan J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5577; Wang L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000115; Wang YR, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0422-x; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Wu D, 2010, BIOINFORMATICS, V26, P2176, DOI 10.1093/bioinformatics/btq401; Xu WH, 2011, P NATL ACAD SCI USA, V108, P3707, DOI 10.1073/pnas.1019753108; Zeng C, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0718-0; Zhang X, 2012, BRIT J CANCER, V106, P1335, DOI 10.1038/bjc.2012.76	48	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170181	10.1371/journal.pone.0170181	http://dx.doi.org/10.1371/journal.pone.0170181			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152060	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161200015
J	Tsai, KF; Liou, JM; Chen, MJ; Chen, CC; Kuo, SH; Lai, IR; Yeh, KH; Lin, MT; Wang, HP; Cheng, AL; Lin, JT; Shun, CT; Wu, MS				Tsai, Kun-Feng; Liou, Jyh-Ming; Chen, Mei-Jyh; Chen, Chien-Chuan; Kuo, Sung-Hsin; Lai, I-Rue; Yeh, Kun-Huei; Lin, Ming-Tsan; Wang, Hsiu-Po; Cheng, Ann-Lii; Lin, Jaw-Town; Shun, Chia-Tung; Wu, Ming-Shiang		Taiwan Gastrointestinal Dis	Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer	PLOS ONE			English	Article							ATROPHIC GASTRITIS; INFECTION; TESTS; RISK; EPIDEMIOLOGY; CHEMOTHERAPY; POPULATION; CARCINOMAS; ACCURACY; STOMACH	Background Whether the characteristics and prognosis of gastric cancer (GC) are different in patients with and without Helicobacter pylori (HP) remains controversial. The definitions of HP status in patients with atrophic gastritis but negative tests for HP are heterogeneous. We aimed to assess the impact of HP on the prognosis of GC using different definitions. Methods From 1998 Nov to 2011 Jul, five hundred and sixty-seven consecutive patients with GC were included. HP status was determined by serology and histology. Patients with any positive test were defined as HP infection. Patients without HP infection whose serum pepsinogen (PG) I <70 ng/dl and PG I/II ratio <3.0 were defined as atrophic gastritis and they were categorized into model 1: HP positive; model 2: HP negative; and model 3: exclusion of these patients. Results We found four characteristics of HP negative GC in comparison to HP positive GC: (1) higher proportion of the proximal tumor location (24.0%, P = 0.004), (2) more diffuse histologic type (56.1%, p = 0.008), (3) younger disease onset (58.02 years, p = 0.008) and (4) more stage IV disease (40.6%, p = 0.03). Patients with negative HP had worse overall survival (24.0% vs. 35.8%, p = 0.035). In Cox regression models, the negative HP status is an independent poor prognostic factor (HR: 1.34, CI:1.04-1.71, p = 0.019) in model 1, especially in stage I, II and III patients (HR: 1.62; CI:1.05-2.51, p = 0.026). Conclusion We found the distinct characteristics of HP negative GC. The prognosis of HP negative GC was poor.	[Tsai, Kun-Feng] China Med Univ, An Nan Hosp, Gastroenterol & Hepatol Sect, Dept Internal Med, Tainan, Taiwan; [Tsai, Kun-Feng; Liou, Jyh-Ming; Chen, Mei-Jyh; Chen, Chien-Chuan; Wang, Hsiu-Po; Lin, Jaw-Town; Wu, Ming-Shiang] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan; [Tsai, Kun-Feng; Liou, Jyh-Ming; Chen, Mei-Jyh; Chen, Chien-Chuan; Kuo, Sung-Hsin; Lai, I-Rue; Yeh, Kun-Huei; Lin, Ming-Tsan; Wang, Hsiu-Po; Cheng, Ann-Lii; Lin, Jaw-Town; Wu, Ming-Shiang] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Kuo, Sung-Hsin; Yeh, Kun-Huei; Cheng, Ann-Lii] Natl Taiwan Univ, Coll Med, Dept Oncol, Taipei, Taiwan; [Lai, I-Rue; Lin, Ming-Tsan] Natl Taiwan Univ, Coll Med, Dept Surg, Taipei, Taiwan; [Lin, Ming-Tsan] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan; [Shun, Chia-Tung] Natl Taiwan Univ, Dept Pathol & Forens Med, Natl Taiwan Univ Hosp, Coll Med, Taipei, Taiwan	China Medical University Taiwan; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Fu Jen Catholic University; National Taiwan University; National Taiwan University Hospital	Wu, MS (corresponding author), Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan.; Wu, MS (corresponding author), Natl Taiwan Univ Hosp, Taipei, Taiwan.; Shun, CT (corresponding author), Natl Taiwan Univ, Dept Pathol & Forens Med, Natl Taiwan Univ Hosp, Coll Med, Taipei, Taiwan.	ctshun@ntu.edu.tw; mingshiang@ntu.edu.tw	Shun, Chia-Tung/M-1400-2019; Yeh, Kun-Huei/HGD-3316-2022	Chen, Mei-Jyh/0000-0003-3284-004X; LIN, MING-TSAN/0000-0001-7313-7057; Cheng, Ann-Lii/0000-0002-9152-6512; Kuo, Sung-Hsin/0000-0003-0054-887X; SHUN, CHIA-TUNG/0000-0002-0468-4468; Wu, Ming-Shiang/0000-0002-1940-6428; YEH, Kun-Huei/0000-0002-7306-174X; LIOU, JYH-MING/0000-0002-7945-5408; Lai, I-Rue/0000-0002-3444-8255	Ministry of Science and Technology, Executive Yuan, ROC, Taiwan [MOST 103-2314-B-002-154-MY2]	Ministry of Science and Technology, Executive Yuan, ROC, Taiwan	The study was funded by the Ministry of Science and Technology, Executive Yuan, ROC, Taiwan (Grant Number: MOST 103-2314-B-002-154-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi IK, 2012, CANCER CHEMOTH PHARM, V70, P555, DOI 10.1007/s00280-012-1944-5; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; Feldman M, 1996, GASTROENTEROLOGY, V110, P1043, DOI 10.1053/gast.1996.v110.pm8612992; Fock KM, 2010, J GASTROEN HEPATOL, V25, P479, DOI 10.1111/j.1440-1746.2009.06188.x; Gatta L, 2006, GUT, V55, P457, DOI 10.1136/gut.2005.078626; Graziano F, 2004, CLIN CANCER RES, V10, P2784, DOI 10.1158/1078-0432.CCR-03-0320; Guilford P, 2010, GASTRIC CANCER, V13, P1, DOI 10.1007/s10120-009-0531-x; Hamilton JP, 2006, CLIN GASTROENTEROL H, V4, P416, DOI 10.1016/j.cgh.2006.01.019; Hansen S, 2007, GUT, V56, P918, DOI 10.1136/gut.2006.114504; Hur H, 2012, J KOREAN SURG SOC, V83, P203, DOI 10.4174/jkss.2012.83.4.203; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kakinoki R, 2009, DIGEST DIS SCI, V54, P614, DOI 10.1007/s10620-008-0389-5; Kamineni A, 1999, CANCER CAUSE CONTROL, V10, P77, DOI 10.1023/A:1008849014992; Kang HY, 2006, DIGEST DIS SCI, V51, P2310, DOI 10.1007/s10620-006-9276-0; Kang SY, 2012, INT J CANCER, V130, P948, DOI 10.1002/ijc.26081; Kwak HW, 2014, J GASTROEN HEPATOL, V29, P1671, DOI 10.1111/jgh.12605; Lee SR, 2012, J KOREAN SURG SOC, V82, P211, DOI 10.4174/jkss.2012.82.4.211; Lee YC, 2016, GASTROENTEROLOGY, V150, P1113, DOI 10.1053/j.gastro.2016.01.028; Li GH, 2013, J SURG ONCOL, V108, P421, DOI 10.1002/jso.23417; Marrelli D, 2009, CANCER, V115, P2071, DOI 10.1002/cncr.24253; Matsuo T, 2011, HELICOBACTER, V16, P415, DOI 10.1111/j.1523-5378.2011.00889.x; Meimarakis G, 2006, LANCET ONCOL, V7, P211, DOI 10.1016/S1470-2045(06)70586-1; Miki Kazumasa, 2006, Gastric Cancer, V9, P245, DOI 10.1007/s10120-006-0397-0; Mizoue T, 2000, INT J EPIDEMIOL, V29, P232, DOI 10.1093/ije/29.2.232; Mohri Y, 2012, CLIN ONCOL-UK, V24, P610, DOI 10.1016/j.clon.2011.11.002; Nakao M, 2011, CANCER EPIDEM BIOMAR, V20, P1665, DOI 10.1158/1055-9965.EPI-11-0213; Nardone G, 2005, ALIMENT PHARM THER, V22, P1139, DOI 10.1111/j.1365-2036.2005.02734.x; Ono S, 2012, DIGESTION, V86, P59, DOI 10.1159/000339176; Qiu HB, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-374; Sampieri CL, 2013, J CANCER RES THER, V9, P356, DOI 10.4103/0973-1482.119302; Schlansky B, 2011, AM J GASTROENTEROL, V106, P1978, DOI 10.1038/ajg.2011.213; Shiao YH, 1999, INT J CANCER, V82, P59, DOI 10.1002/(SICI)1097-0215(19990702)82:1<59::AID-IJC11>3.3.CO;2-U; Shikata K, 2006, INT J CANCER, V119, P196, DOI 10.1002/ijc.21822; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Vaira D, 2000, ALIMENT PHARM THER, V14, P13, DOI 10.1046/j.1365-2036.2000.00096.x; vanLoon AJM, 1997, CANCER LETT, V114, P259, DOI 10.1016/S0304-3835(97)04677-6; Wang XQ, 2009, WORLD J GASTROENTERO, V15, P2204, DOI 10.3748/wjg.15.2204; Wang ZW, 2012, INT J MOL SCI, V13, P13308, DOI 10.3390/ijms131013308; Wu MS, 2000, GENE CHROMOSOME CANC, V27, P403, DOI 10.1002/(SICI)1098-2264(200004)27:4<403::AID-GCC10>3.3.CO;2-T; Wu MS, 1997, GASTROENTEROLOGY, V112, P1457, DOI 10.1016/S0016-5085(97)70071-4; Wu MS, 2000, GASTROENTEROLOGY, V118, P1031, DOI 10.1016/S0016-5085(00)70355-6; Xia HHX, 2002, ALIMENT PHARM THERAP, V16, P521, DOI 10.1046/j.1365-2036.2002.01176.x; Yoon H, 2011, HELICOBACTER, V16, P382, DOI 10.1111/j.1523-5378.2011.00859.x	43	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170942	10.1371/journal.pone.0170942	http://dx.doi.org/10.1371/journal.pone.0170942			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152027	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161200060
J	Verdugo, M; Encinar, JR; Costa-Fernandez, JM; Menendez-Miranda, M; Bouzas-Ramos, D; Bravo, M; Quiroz, W				Verdugo, Marcelo; Ruiz Encinar, Jorge; Manuel Costa-Fernandez, Jose; Menendez-Miranda, Mario; Bouzas-Ramos, Diego; Bravo, Manuel; Quiroz, Waldo			Study of conformational changes and protein aggregation of bovine serum albumin in presence of Sb(III) and Sb(V)	PLOS ONE			English	Article							PARTICULATE MATTER; ANTIMONY; GLUTATHIONE; METAL; REDOX; FLUORESCENCE; PLASMA; FIBRILLATION; ENVIRONMENT; SPECIATION	\Antimony is a metalloid that affects biological functions in humans due to a mechanism still not understood. There is no doubt that the toxicity and physicochemical properties of Sb are strongly related with its chemical state. In this paper, the interaction between Sb(III) and Sb (V) with bovine serum albumin (BSA) was investigated in vitro by fluorescence spectroscopy, and circular dichroism (CD) under simulated physiological conditions. Moreover, the coupling of the separation technique, asymmetric flow field-flow fractionation, with elemental mass spectrometry to understand the interaction of Sb(V) and Sb(III) with the BSA was also used. Our results showed a different behaviour of Sb(III) vs. Sb(V) regarding their effects on the interaction with the BSA. The effects in terms of protein aggregates and conformational changes were higher in the presence of Sb(III) compared to Sb(V) which may explain the differences in toxicity between both Sb species in vivo. Obtained results demonstrated the protective effect of GSH that modifies the degree of interaction between the Sb species with BSA. Interestingly, in our experiments it was possible to detect an interaction between BSA and Sb species, which may be related with the presence of labile complex between the Sb and a protein for the first time.	[Verdugo, Marcelo; Bravo, Manuel; Quiroz, Waldo] Pontificia Univ Catolica Valparaiso, Inst Quim, Valparaiso, Chile; [Verdugo, Marcelo; Ruiz Encinar, Jorge; Manuel Costa-Fernandez, Jose; Menendez-Miranda, Mario; Bouzas-Ramos, Diego] Univ Oviedo, Dept Phys & Analyt Chem, Fac Chem, Oviedo, Spain	Pontificia Universidad Catolica de Valparaiso; University of Oviedo	Quiroz, W (corresponding author), Pontificia Univ Catolica Valparaiso, Inst Quim, Valparaiso, Chile.	waldo.quiroz@pucv.cl	COSTA-FERNANDEZ, JOSE/AAN-2527-2020; COSTA-FERNANDEZ, JOSE MANUEL/R-9141-2017; Verdugo, Marcelo/U-9363-2018	COSTA-FERNANDEZ, JOSE/0000-0002-8671-5300; COSTA-FERNANDEZ, JOSE MANUEL/0000-0002-8671-5300; Bravo, Manuel/0000-0002-4548-6265; Verdugo, Marcelo/0000-0002-1537-0560; Bouzas-Ramos, Diego/0000-0002-8063-9589; Ruiz Encinar, Jorge/0000-0001-6245-5770; Menendez-Miranda, Mario/0000-0002-2992-1351	FONDECYT [1150528]; Spanish Ministry of Education [MINECO-13-CTQ2013-49032-C2-1-R]; Principado de Asturias [FC-15-GRUPIN14-092]; CONICYT [21120558]; Principado de Asturias (Spain) [BP14-137, BP12-046]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Spanish Ministry of Education(Spanish Government); Principado de Asturias(Principality of Asturias); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Principado de Asturias (Spain)(Principality of Asturias)	The authors gratefully acknowledge financial support from FONDECYT (project 1150528) and the Spanish Ministry of Education (MINECO-13-CTQ2013-49032-C2-1-R) and Principado de Asturias (FC-15-GRUPIN14-092). Agilent Technologies Foundation is also acknowledged. M. Verdugo also thanks to CONICYT (project 21120558) for doctoral and research-travel fellowships. Diego Bouzas-Ramos and Mario Menendez-Miranda acknowledge the Ph.D. grants (BP14-137 and BP12-046, respectively) from Principado de Asturias (Spain).	Ahmadi SK, 2015, J BIOMOL STRUCT DYN, V33, P1880, DOI 10.1080/07391102.2014.977351; Ajmal MR, 2017, INT J BIOL MACROMOL, V94, P301, DOI 10.1016/j.ijbiomac.2016.10.025; Alberghina D, 2011, J VET DIAGN INVEST, V23, P111, DOI 10.1177/104063871102300119; Anraku M, 2013, BBA-GEN SUBJECTS, V1830, P5465, DOI 10.1016/j.bbagen.2013.04.036; Beyersmann D, 2008, ARCH TOXICOL, V82, P493, DOI 10.1007/s00204-008-0313-y; Burford N, 2005, J INORG BIOCHEM, V99, P1992, DOI 10.1016/j.jinorgbio.2005.06.019; Chai Y, 2005, J INORG BIOCHEM, V99, P2257, DOI 10.1016/j.jinorgbio.2005.08.015; Chen MM, 2015, J LUMIN, V158, P116, DOI 10.1016/j.jlumin.2014.09.021; Clark JI, 1996, P NATL ACAD SCI USA, V93, P15185, DOI 10.1073/pnas.93.26.15185; Cooper Ross G, 2009, Indian J Occup Environ Med, V13, P3, DOI 10.4103/0019-5278.50716; De Boeck M, 2003, MUTAT RES-FUND MOL M, V533, P135, DOI 10.1016/j.mrfmmm.2003.07.012; Demicheli C, 2002, BBA-GEN SUBJECTS, V1570, P192, DOI 10.1016/S0304-4165(02)00198-8; Fernandez SD, 2012, ANAL CHEM, V84, P5851, DOI 10.1021/ac3009516; Fernandes PA, 2004, CHEM-EUR J, V10, P257, DOI 10.1002/chem.200305343; Filella M, 2002, EARTH-SCI REV, V59, P265, DOI 10.1016/S0012-8252(02)00089-2; Furuta N, 2005, J ENVIRON MONITOR, V7, P1155, DOI 10.1039/b513988k; Galano A, 2011, RSC ADV, V1, P1763, DOI 10.1039/c1ra00474c; Giugliarelli A, 2015, J PHYS CHEM B, V119, P13009, DOI 10.1021/acs.jpcb.5b07487; Hansen C, 2011, BIOL TRACE ELEM RES, V144, P234, DOI 10.1007/s12011-011-9079-9; Hernandez LE, 2015, J EXP BOT, V66, P2901, DOI 10.1093/jxb/erv063; Housaindokht MR, 2001, B KOR CHEM SOC, V22, P145; Hubbard R. E., 2001, ENCY LIFE SCI, DOI DOI 10.1002/9780470015902.A0003011.PUB2; Jacobson T, 2012, J CELL SCI, V125, P5073, DOI 10.1242/jcs.107029; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Lopez S, 2015, PLOS ONE, V10; Loukianov AS, 2007, ATLA-ALTERN LAB ANIM, V35, P123, DOI 10.1177/026119290703500116; Mayo JC, 2003, BBA-GEN SUBJECTS, V1620, P139, DOI 10.1016/S0304-4165(02)00527-5; Menendez-Miranda M, 2014, ANAL CHIM ACTA, V839, P8, DOI 10.1016/j.aca.2014.06.034; Moghaddam MM, 2014, LUMINESCENCE, V29, P314, DOI 10.1002/bio.2546; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Murayama K, 2004, BIOCHEMISTRY-US, V43, P11526, DOI 10.1021/bi0489154; Navarra G, 2009, J INORG BIOCHEM, V103, P1729, DOI 10.1016/j.jinorgbio.2009.09.023; Navea S, 2002, ANAL CHEM, V74, P6031, DOI 10.1021/ac025914d; Omidvar Z, 2013, J SOLUTION CHEM, V42, P1005, DOI 10.1007/s10953-013-0009-7; Othmer K., 2001, ENCY CHEM TECHNOLOGY, V4th; Pastore A, 2003, CLIN CHIM ACTA, V333, P19, DOI 10.1016/S0009-8981(03)00200-6; Peacock AFA, 2009, ANGEW CHEM INT EDIT, V48, P7371, DOI 10.1002/anie.200902166; Quiroz W, 2013, MICROCHEM J, V110, P266, DOI 10.1016/j.microc.2013.04.006; Quiroz W, 2013, TALANTA, V115, P902, DOI 10.1016/j.talanta.2013.06.052; Quiroz W, 2009, J ENVIRON MONITOR, V11, P1051, DOI 10.1039/b815838j; Alvarez-Idaboy JR, 2012, J PHYS CHEM B, V116, P9316, DOI 10.1021/jp303116n; Rolinski OJ, 2010, BIOSENS BIOELECTRON, V25, P2249, DOI 10.1016/j.bios.2010.03.005; Sarmiento-Gonzalez A, 2008, ANAL CHEM, V80, P8702, DOI 10.1021/ac801029p; Smichowski P, 2004, J ENVIRON MONITOR, V6, P286, DOI 10.1039/b312446k; Smichowski P, 2008, APPL SPECTROSC REV, V43, P22, DOI 10.1080/05704920701645886; Sun HZ, 2000, EUR J BIOCHEM, V267, P5450, DOI 10.1046/j.1432-1327.2000.01605.x; Tamas MJ, 2014, BIOMOLECULES, V4, P252, DOI 10.3390/biom4010252; Telpoukhovskaia MA, 2013, CHEM SOC REV, V42, P1836, DOI 10.1039/c2cs35236b; Turell L, 2013, FREE RADICAL BIO MED, V65, P244, DOI 10.1016/j.freeradbiomed.2013.05.050; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Verdugo M, 2016, J TOXICOL SCI, V41, P783, DOI 10.2131/jts.41.783; Vetri V, 2011, ARCH BIOCHEM BIOPHYS, V508, P13, DOI 10.1016/j.abb.2011.01.024; von Uexkull O, 2005, J CLEAN PROD, V13, P19, DOI 10.1016/j.jclepro.2003.10.008; Wijayanti HB, 2014, COMPR REV FOOD SCI F, V13, P1235, DOI 10.1111/1541-4337.12105; Wu LZ, 2008, J MOL STRUCT, V877, P44, DOI 10.1016/j.molstruc.2007.07.013; Zheng YH, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-31; Ziyarat FP, 2014, J BIOMOL STRUCT DYN, V32, P613, DOI 10.1080/07391102.2013.785919; Zotov AV, 2003, GEOCHIM COSMOCHIM AC, V67, P1821, DOI 10.1016/S0016-7037(02)01281-4	58	13	13	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170869	10.1371/journal.pone.0170869	http://dx.doi.org/10.1371/journal.pone.0170869			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151990	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161200051
J	Canedo, EO; Santiago, GS; Zurlo, LF; Ribas, CR; Carvalho, RP; Alves, GP; Carvalho, MCS; Souza, B				Canedo-Junior, Ernesto Oliveira; Santiago, Graziele Silva; Zurlo, Luana Fonseca; Ribas, Carla Rodrigues; Carvalho, Rafaela Pereira; Alves, Guilherme Pereira; Silva Carvalho, Mariana Comanucci; Souza, Brigida			Isolated and Community Contexts Produce Distinct Responses by Host Plants to the Presence of Ant-Aphid Interaction: Plant Productivity and Seed Viability	PLOS ONE			English	Article							HYMENOPTERA-FORMICIDAE; EXTRAFLORAL NECTARIES; MUTUALISM; DISPERSAL; TRANSMISSION; DIVERSITY; DAMAGE; L.	Ant-aphid interactions may affect host plants in several ways, however, most studies measure only the amount of fruit and seed produced, and do not test seed viability. Therefore, the aim of this study was to assess the effects of the presence of ant-aphid interactions upon host plant productivity and seed viability in two different contexts: isolated and within an arthropod community. For this purpose we tested the hypothesis that in both isolated and community contexts, the presence of an ant-aphid interaction will have a positive effect on fruit and seed production, seed biomass and rate of seed germination, and a negative effect on abnormal seedling rates, in comparison to plants without ants. We performed a field mesocosm experiment containing five treatments: Ant-aphid, Aphid, Community, Ant-free community and Control. We counted fruits and seeds produced by each treatment, and conducted experiments for seed biomass and germinability. We found that in the community context the presence of an ant-aphid interaction negatively affected fruit and seed production. We think this may be because aphid attendance by tending-ants promotes aphid damage to the host plant, but without an affect on seed weight and viability. On the other hand, when isolated, the presence of an ant-aphid interaction positively affected fruit and seed production. These positive effects are related to the cleaning services offered to aphids by tending-ants, which prevent the development of saprophytic fungi on the surface of leaves, which would cause a decrease in photosynthetic rates. Our study is important because we evaluated some parameters of plant fitness that have not been addressed very well by other studies involving the effects of ant-aphid interactions mainly on plants with short life cycles. Lastly, our context dependent approach sheds new light on how ecological interactions can vary among different methods of crop management.	[Canedo-Junior, Ernesto Oliveira; Santiago, Graziele Silva; Zurlo, Luana Fonseca; Ribas, Carla Rodrigues; Carvalho, Rafaela Pereira; Alves, Guilherme Pereira; Silva Carvalho, Mariana Comanucci] Univ Fed Lavras, Dept Biol, Setor Ecol & Conservacao, Programa Posgrad Ecol Aplicada,Lab Ecol Formigas, Lavras, MG, Brazil; [Canedo-Junior, Ernesto Oliveira; Souza, Brigida] Univ Fed Lavras, Dept Entomol, Programa Posgrad Entomol, Lavras, MG, Brazil; [Zurlo, Luana Fonseca] Univ Fed Lavras, Dept Biol, Setor Ecol & Conservacao, Programa Posgrad Ecol Aplicada,Lab Ecol Subterran, Lavras, MG, Brazil; [Carvalho, Rafaela Pereira] Univ Fed Lavras, Dept Biol, Lab Melhoramento Plantas Visando Resistencia Pato, Setor Genet & Melhoramento Plantas, Lavras, MG, Brazil; [Silva Carvalho, Mariana Comanucci] Univ Fed Lavras, Dept Zootecnia, Nucleo Estudos Manejo Animais Selvagens, Lavras, MG, Brazil	Universidade Federal de Lavras; Universidade Federal de Lavras; Universidade Federal de Lavras; Universidade Federal de Lavras; Universidade Federal de Lavras	Canedo, EO (corresponding author), Univ Fed Lavras, Dept Biol, Setor Ecol & Conservacao, Programa Posgrad Ecol Aplicada,Lab Ecol Formigas, Lavras, MG, Brazil.; Canedo, EO (corresponding author), Univ Fed Lavras, Dept Entomol, Programa Posgrad Entomol, Lavras, MG, Brazil.	canedojr.e.o@gmail.com	Ribas, Carla/AAY-8673-2020; SOUZA, BRIGIDA/AAP-8928-2021	Ribas, Carla/0000-0002-9781-0450; Canedo Junior, Ernesto/0000-0002-9012-0051	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [CRA - PPM - 00243/14]	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was partially supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) - CRA - PPM - 00243/14. (http://www.fapemig.br/ptbr/) to CRR. Dr Carla Ribas received a grant from (Fundagao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) CRA - PPM - 00243/14 (http://www.fapemig.br/ptbr/) WO to CRR. Scholarships were received by the following authors: (GSS) - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes); (EOCJ and GPA) - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); and (MCSC and LFZ) - Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altfeld L, 2006, ENVIRON ENTOMOL, V35, P31, DOI 10.1603/0046-225X-35.1.31; BACH CE, 1991, OECOLOGIA, V87, P233, DOI 10.1007/BF00325261; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BECERRA JXI, 1989, OIKOS, V55, P276, DOI 10.2307/3565432; Billick I, 2007, ANN ENTOMOL SOC AM, V100, P887, DOI 10.1603/0013-8746(2007)100[887:AIAAFE]2.0.CO;2; Bjorkman C, 2008, NEW PHYTOL, V179, P176, DOI 10.1111/j.1469-8137.2008.02442.x; Brasil. Ministerio da Agricultura Pecuaria e Abastecimento, 2009, REGR AN SEM; Delabie Jacques H. C., 2001, Neotropical Entomology, V30, P501, DOI 10.1590/S1519-566X2001000400001; DelClaro K, 1996, J TROP ECOL, V12, P887, DOI 10.1017/S0266467400010142; Delfino M.A., 2000, Zoologica Baetica, V11, P3; DIXON AFG, 1977, ANNU REV ECOL SYST, V8, P329, DOI 10.1146/annurev.es.08.110177.001553; Embrapa, 2013, CAT CULT FEIJ COM; Eriksson O, 1999, ACTA OECOL, V20, P61, DOI 10.1016/S1146-609X(99)80016-2; Gardiner MM, 2005, ECOLOGICAL APPL, V19, P143; Harrington R, 2007, APHID CROP PESTS; Hill DS., 1997, EC IMPORTANCE INSECT; Jakobsson A, 2000, OIKOS, V88, P494, DOI 10.1034/j.1600-0706.2000.880304.x; Jha S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043510; Kaminski Lucas A., 2009, Oecologia Brasiliensis, V13, P27; Katayama N, 2010, APPL ENTOMOL ZOOL, V45, P505, DOI 10.1303/aez.2010.505; Katis NI, 2007, APHIDS AS CROP PESTS, P353, DOI 10.1079/9780851998190.0353; Keen NT, 2000, ANNU REV PHYTOPATHOL, V38, P31, DOI 10.1146/annurev.phyto.38.1.31; Kindlmann P, 2007, OECOLOGIA, V152, P625, DOI 10.1007/s00442-007-0684-4; Lach L, 2010, ANT ECOLOGY, P1; Lemessa D, 2015, LANDSCAPE ECOL, V30, P167, DOI 10.1007/s10980-014-0115-y; LeVan KE, 2015, ECOLOGY, V96, P1620, DOI 10.1890/14-0058.1; Lovett-Doust L., 1988, PLANT REPROD ECOLOGY; McPhee KE, 2008, USDA TECHNICAL B, P199; Minarro M, 2010, ECOL ENTOMOL, V35, P206, DOI 10.1111/j.1365-2311.2010.01173.x; Moraes GJ, 2005, REV USP, V64; Moreira VSS, 2005, NEOTROP ENTOMOL, V34, P881, DOI 10.1590/S1519-566X2005000600002; Moreira X, 2012, P ROY SOC B-BIOL SCI, V279, P4464, DOI 10.1098/rspb.2012.0893; Ng JCK, 2004, MOL PLANT PATHOL, V5, P505, DOI [10.1111/j.1364-3703.2004.00240.x, 10.1111/J.1364-3703.2004.00240.X]; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Offenberg J, 2001, BEHAV ECOL SOCIOBIOL, V49, P304, DOI 10.1007/s002650000303; Ohgushi T, 2008, ENTOMOL EXP APPL, V128, P217, DOI 10.1111/j.1570-7458.2008.00705.x; Olff H, 1998, TREE, V7; Oliver TH, 2007, P ROY SOC B-BIOL SCI, V274, P3127, DOI 10.1098/rspb.2007.1251; Pascov C, 2015, OECOLOGIA, V179, P1123, DOI 10.1007/s00442-015-3400-9; R Core Team, 2021, R LANGUAGE ENV STAT; Rando J.S.S, 2010, Rev. bras. plantas med., V12, P239, DOI 10.1590/S1516-05722010000200018; Raven P.H., 2007, BIOL VEGETAL; Renault CK, 2005, ECOL RES, V20, P71, DOI 10.1007/s11284-004-0015-8; Rice KB, 2013, FLA ENTOMOL, V96, P929, DOI 10.1653/024.096.0329; Rosario-Martinez HD, 2015, ANAL INTERACTIONS FI; Rueda M, 2013, OECOLOGIA, V172, P449, DOI 10.1007/s00442-012-2501-y; Schulze E-D., 2005, PLANT ECOL; Schumacher E, 2009, J APPL ENTOMOL, V133, P33, DOI 10.1111/j.1439-0418.2008.01315.x; Stadler B, 1998, J ANIM ECOL, V67, P454, DOI 10.1046/j.1365-2656.1998.00209.x; Stadler B., 2008, MUTUALISM ANTS THEIR; Stadler B, 2005, ANN REV ECOLOGY EVOL, V36; Stutz S, 2011, BIOL CONTROL, V57, P37, DOI 10.1016/j.biocontrol.2011.01.001; Styrsky JD, 2007, P ROY SOC B-BIOL SCI, V274, P151, DOI 10.1098/rspb.2006.3701; Styrsky JD, 2010, ECOL ENTOMOL, V35, P190, DOI 10.1111/j.1365-2311.2009.01172.x; Suzuki N, 2004, ECOL RES, V19, P275, DOI 10.1111/j.1440-1703.2004.00636.x; Tansley AG., 1993, INTRO PLANT ECOLOGY; Tegelaar K, 2012, OIKOS, V121, P61, DOI 10.1111/j.1600-0706.2011.19387.x; Tiffin P, 2000, EVOL ECOL, V14, P523, DOI 10.1023/A:1010881317261; Tokunaga E, 2008, POPUL ECOL, V50, P45, DOI 10.1007/s10144-007-0065-1; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Pijl L, 1982, PRINCIPLES DISPERSAL, V3; WAY MJ, 1992, ANNU REV ENTOMOL, V37, P479, DOI 10.1146/annurev.en.37.010192.002403; Whitfield AE, 2015, VIROLOGY, V479, P278, DOI 10.1016/j.virol.2015.03.026; Wirth R, 2003, HERBIVORY LEAF CUTTI; Wu D, 2014, J ECON ENTOMOL, V107, P1758, DOI 10.1603/EC14162; Wu H, 2013, APPL SOIL ECOL, V70, P9, DOI 10.1016/j.apsoil.2013.04.004; Zhang S, 2012, BASIC APPL ECOL, V13, P116, DOI 10.1016/j.baae.2012.02.002	67	8	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170915	10.1371/journal.pone.0170915	http://dx.doi.org/10.1371/journal.pone.0170915			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141849	Green Published, Green Submitted, gold			2022-12-27	WOS:000396129500025
J	Fonsah, JY; Njamnshi, AK; Kouanfack, C; Qiu, F; Njamnshi, DM; Tagny, CT; Nchindap, E; Kenmogne, L; Mbanya, D; Heaton, R; Kanmogne, GD				Fonsah, Julius Y.; Njamnshi, Alfred K.; Kouanfack, Charles; Qiu, Fang; Njamnshi, Dora M.; Tagny, Claude T.; Nchindap, Emilienne; Kenmogne, Leopoldine; Mbanya, Dora; Heaton, Robert; Kanmogne, Georgette D.			Adherence to Antiretroviral Therapy (ART) in Yaounde-Cameroon: Association with Opportunistic Infections, Depression, ART Regimen and Side Effects	PLOS ONE			English	Article							ANRS 12110/ESTHER TRIAL; NONADHERENCE; PATTERNS; AFRICA; IMPACT; ADULTS; TIME	Following global efforts to increase antiretroviral therapy (ART) access in Sub-Saharan Africa, ART coverage among HIV-infected Cameroonians increased from 0% in 2003 to 22% in 2014. However, the success of current HIV treatment programs depends not only on access to ART, but also on retention in care and good treatment adherence. This is necessary to achieve viral suppression, prevent virologic failure, and reduce viral transmission and HIV/AIDS-related deaths. Previous studies in Cameroon showed poor adherence, treatment interruption, and loss to follow-up among HIV+ subjects on ART, but the factors that influence ART adherence are not well known. In the current cross-sectional study, patient/self-reported questionnaires and pharmacy medication refill data were used to quantify ART adherence and determine the factors associated with increased risk of non-adherence among HIV-infected Cameroonians. We demonstrated that drug side-effects, low CD4 cell counts and higher viral loads are associated with increased risk of non-adherence, and compared to females, males were more likely to forego ART because of side effects (p< 0.05). Univariate logistic regression analysis demonstrated that subjects with opportunistic infections (on antibiotics) had 2.42-times higher odds of having been non-adherent (p< 0.001). Multivariable analysis controlling for ART regimen, age, gender, and education showed that subjects with opportunistic infections had 3.1-times higher odds of having been non-adherent (p< 0.0003), with significantly longer periods of non-adherence, compared to subjects without opportunistic infections (p = 0.02). We further showed that compared to younger subjects (<= 40 years), older subjects (>40 years) were less likely to be non-adherent (p< 0.01) and had shorter non-adherent periods (p< 0.0001). The presence of depression symptoms correlated with non-adherence to ART during antibiotic treatment (r = 0.53, p = 0.04), and was associated with lower CD4 cell counts (p = 0.04) and longer non-adherent periods (p = 0.04). Change in ART regimen was significantly associated with increased likelihood of non-adherence and increased duration of the non-adherence period. Addressing these underlying risk factors could improve ART adherence, retention in care and treatment outcomes for HIV/AIDS patients in Cameroon.	[Fonsah, Julius Y.; Njamnshi, Alfred K.] Yaounde Cent Hosp, Dept Neurol, Yaounde, Cameroon; [Fonsah, Julius Y.; Njamnshi, Alfred K.; Kouanfack, Charles; Tagny, Claude T.; Mbanya, Dora] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; [Kouanfack, Charles; Njamnshi, Dora M.] Yaounde Cent Hosp, HIV Day Care Serv, Yaounde, Cameroon; [Qiu, Fang] Univ Nebraska Med Ctr, Coll Publ Hlth, Dept Biostat, Omaha, NE USA; [Tagny, Claude T.; Nchindap, Emilienne; Kenmogne, Leopoldine; Mbanya, Dora] Univ Yaounde, Teaching Hosp, Yaounde, Cameroon; [Heaton, Robert] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Kanmogne, Georgette D.] Univ Nebraska Med Ctr, Coll Med, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA	University of Yaounde I; University of Nebraska System; University of Nebraska Medical Center; University of Yaounde I; University of California System; University of California San Diego; University of Nebraska System; University of Nebraska Medical Center	Kanmogne, GD (corresponding author), Univ Nebraska Med Ctr, Coll Med, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.	gkanmogne@unmc.edu			NIMH [RO1 MH094160]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062512, R01MH094160] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIMH RO1 MH094160.	Abah Isaac Okoh, 2016, J Int Assoc Provid AIDS Care, V15, P77, DOI 10.1177/2325957414539197; Al-Dakkak I, 2013, AIDS CARE, V25, P400, DOI 10.1080/09540121.2012.712667; [Anonymous], 2015, GLOB HLTH OBS IND ES; Badiee J, 2012, AIDS PATIENT CARE ST, V26, P388, DOI 10.1089/apc.2011.0447; Bank W, 2016, ANT THER COV PEOPL A; Barroso J, 2001, QUAL HEALTH RES, V11, P491, DOI 10.1177/104973201129119271; Beck A.T., 1996, PSYCHOL ASSESS, V2, DOI DOI 10.1037/T00742-000; Bor J, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001905; Boulle C, 2015, JAIDS-J ACQ IMM DEF, V69, P355, DOI 10.1097/QAI.0000000000000604; Bragard I, 2013, CANCER RADIOTHER, V17, P731, DOI 10.1016/j.canrad.2013.05.014; Cauldbeck MB, 2009, AIDS RES THER, V6, P7, DOI DOI 10.1186/1742-6405-6-7; Chesney MA, 2000, CLIN INFECT DIS, V30, pS171, DOI 10.1086/313849; Chkhartishvili Nikoloz, 2014, J Int AIDS Soc, V17, P18885, DOI 10.7448/IAS.17.1.18885; Corbiere M, 2011, CLIN J PAIN, V27, P62, DOI 10.1097/AJP.0b013e3181eef903; Cornell M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001304; Cunningham S, 2008, J CAN ACAD CHILD ADO, V17, P137; Denison JA, 2015, AIDS, V29, P361, DOI 10.1097/QAD.0000000000000543; Duran S, 2001, HIV Clin Trials, V2, P38; Ehlers Valerie J., 2015, Curationis, V38, P1, DOI [10.4102/curationis.v38i1.1255, 10.4102/CURATIONIS.V38I1.1255]; Ekouevi DK, 2010, TROP MED INT HEALTH, V15, P34, DOI 10.1111/j.1365-3156.2010.02505.x; Fogarty L, 2002, PATIENT EDUC COUNS, V46, P93, DOI 10.1016/S0738-3991(01)00219-1; Fokam J, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0129210, 10.137]; Gaynes BN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140001; Gonzalez-Serna A, 2014, J ANTIMICROB CHEMOTH, V69, P2202, DOI 10.1093/jac/dku112; Gordon LL, 2015, AIDS PATIENT CARE ST, V29, P384, DOI 10.1089/apc.2014.0165; Grimwade K, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003508.pub2; Hsu J., 1996, MULTIPLE COMP THEORY; Johnson MO, 2009, J GEN INTERN MED, V24, P247, DOI 10.1007/s11606-008-0854-z; Kanmogne GD, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-60; Kaplan JE, 1996, AM J TROP MED HYG, V55, P1; Kindzeka ME., 2013, SHORTAGE ARVS HITS C; Kouanfack C, 2008, JAIDS-J ACQ IMM DEF, V48, P216, DOI 10.1097/QAI.0b013e3181743955; Kunutsor S, 2010, AIDS RES TREAT, V2010, DOI 10.1155/2010/872396; Lahlou-Laforet K, 2015, J AFFECT DISORDERS, V184, P256, DOI 10.1016/j.jad.2015.05.056; Lamb MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038443; Langebeek N, 2014, BMC MED, V12, DOI [10.1186/s12916-014-0142-1, 10.1186/PREACCEPT-1453408941291432]; Legrand F, 2007, J SPORT EXERCISE PSY, V29, P348, DOI 10.1123/jsep.29.3.348; Marcotte D, 2014, CIENC SAUDE COLETIVA, V19, P785, DOI 10.1590/1413-81232014193.16072013; Mbuagbaw L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046909; Meloni ST, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu055; Meresse M, 2014, HIV MED, V15, P478, DOI 10.1111/hiv.12140; Meresse M, 2013, ANTIVIR THER, V18, P29, DOI 10.3851/IMP2535; Muula AS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-63; Muya Aisa N, 2015, J Int Assoc Provid AIDS Care, V14, P163, DOI 10.1177/2325957414539193; NACC, 2010, IMP HIV AIDS CAM 202; NACC, 2014, RAPP NAT SUIV DECL P; Newman J, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/725713; Pefura-Yone EW, 2013, J INFECT PUBLIC HEAL, V6, P307, DOI 10.1016/j.jiph.2013.02.003; Perrine R, 2011, JAIDS-J ACQ IMM DEF, V57, pS40, DOI 10.1097/QAI.0b013e318222b5c2; Protopopescu C, 2009, J ANTIMICROB CHEMOTH, V64, P599, DOI 10.1093/jac/dkp232; Reynolds NR, 2007, JAIDS-J ACQ IMM DEF, V46, P402, DOI 10.1097/QAI.0b013e318158a44f; Rougemont Mathieu, 2009, AIDS Res Ther, V6, P21, DOI 10.1186/1742-6405-6-21; Saberi P, 2015, AIDS PATIENT CARE ST, V29, P111, DOI 10.1089/apc.2014.0255; Safren SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104178; Sangeda RZ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1035; Takarinda KC, 2015, INT J INFECT DIS, V30, P98, DOI 10.1016/j.ijid.2014.11.009; UNAIDS, 2014, 2014 PROGR REP GLOB; UNAIDS, 2013, ACC ANT THER AFR STA; UNAIDS, 2015, FACT SHEET 2015 GLOB; Uthman OA, 2014, CURR HIV-AIDS REP, V11, P291, DOI 10.1007/s11904-014-0220-1; World Health Organization, 2015, CONGUID UANT DRU	61	54	54	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170893	10.1371/journal.pone.0170893	http://dx.doi.org/10.1371/journal.pone.0170893			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6QW	28141867	Green Published, Green Submitted, gold			2022-12-27	WOS:000396129500024
J	Goncalves, B; Coutinho, D; Santos, S; Lago-Penas, C; Jimenez, S; Sampaio, J				Goncalves, Bruno; Coutinho, Diogo; Santos, Sara; Lago-Penas, Carlos; Jimenez, Sergio; Sampaio, Jaime			Exploring Team Passing Networks and Player Movement Dynamics in Youth Association Football	PLOS ONE			English	Article							TACTICAL BEHAVIOR; LOSING TEAMS; SUB-PHASE; PERFORMANCE; SOCCER; STATISTICS; SPORT; CYTOSCAPE; POSITION; METRICS	Understanding how youth football players base their game interactions may constitute a solid criterion for fine-tuning the training process and, ultimately, to achieve better individual and team performances during competition. The present study aims to explore how passing networks and positioning variables can be linked to the match outcome in youth elite association football. The participants included 44 male elite players from under-15 and under-17 age groups. A passing network approach within positioning-derived variables was computed to identify the contributions of individual players for the overall team behaviour outcome during a simulated match. Results suggested that lower team passing dependency for a given player (expressed by lower betweenness network centrality scores) and high intra-team well-connected passing relations (expressed by higher closeness network centrality scores) were related to better outcomes. The correlation between the dyads' positioning regularity and the passing density showed a most likely higher correlation in under-15 (moderate effect), indicating a possible more dependence of the ball position rather than in the under-17 teams (small/unclear effects). Overall, this study emphasizes the potential of coupling notational analyses with spatial-temporal relations to produce a more functional and holistic understanding of teams' sports performance. Also, the social network analysis allowed to reveal novel key determinants of collective performance.	[Goncalves, Bruno; Coutinho, Diogo; Santos, Sara; Sampaio, Jaime] Univ Tras Os Montes & Alto Douro, Res Ctr Sports Sci Hlth Sci & Human Dev CIDESD, CreativeLab Res Community, Vila Real, Portugal; [Lago-Penas, Carlos] Univ Vigo, Fac Educ & Sport, Pontevedra, Spain; [Jimenez, Sergio] Univ Europea Madrid, Fac Ciencias Actividad Fis & Deporte, Madrid, Spain	University of Tras-os-Montes & Alto Douro; Universidade de Vigo; European University of Madrid	Goncalves, B (corresponding author), Univ Tras Os Montes & Alto Douro, Res Ctr Sports Sci Hlth Sci & Human Dev CIDESD, CreativeLab Res Community, Vila Real, Portugal.	air.bruno.23@gmail.com	Jiménez, Sergio L./AAD-2148-2020; Sampaio, Jaime/B-7392-2008; Santos, Sara/N-8806-2018; Gonçalves, Bruno/M-5361-2013; Coutinho, D./H-7313-2016; LAGO-PENAS, CARLOS/E-3957-2016	Jiménez, Sergio L./0000-0002-5069-6099; Sampaio, Jaime/0000-0003-2335-9991; Santos, Sara/0000-0002-4090-5790; Gonçalves, Bruno/0000-0001-7874-4104; Coutinho, D./0000-0001-6605-9505; LAGO-PENAS, CARLOS/0000-0002-1626-2035	Portuguese Foundation for Science and Technology (FCT); European Social Fund (ESF) under the Human Potential Operating Program (POPH) [SFRH/BD/86044/2012]; project Symbiotic technology for societal efficiency gains: Deus ex Machina (DEM) [NORTE-01-0145-FEDER-000026]; Fundo Europeu de Desenvolvimento Regional (FEDER); NORTE	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); European Social Fund (ESF) under the Human Potential Operating Program (POPH); project Symbiotic technology for societal efficiency gains: Deus ex Machina (DEM); Fundo Europeu de Desenvolvimento Regional (FEDER)(European Commission); NORTE	This work was supported by the Portuguese Foundation for Science and Technology (FCT) and European Social Fund (ESF), through a Doctoral grant endorsed to the first author (SFRH/BD/86044/2012) under the Human Potential Operating Program (POPH); and through the project Symbiotic technology for societal efficiency gains: Deus ex Machina (DEM), NORTE-01-0145-FEDER-000026, co-financed by Fundo Europeu de Desenvolvimento Regional (FEDER) by NORTE 2020.	Batool K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090283; Carling C, 2009, PERFORMANCE ASSESSME; Carling C., 2005, HDB SOCCER MATCH ANA; Castellano J, 2012, J HUM KINET, V31, P139, DOI 10.2478/v10078-012-0015-7; Cintia P, 2015, 2015 IEEE INT C DAT; Clemente FM, 2015, J HUM KINET, V45, P123, DOI 10.1515/hukin-2015-0013; Clemente Filipe Manuel, 2014, Motriz: rev. educ. fis., V20, P262, DOI 10.1590/S1980-65742014000300004; Clemente FM, 2013, J HUM KINET, V36, P179, DOI 10.2478/hukin-2013-0018; Clemente FM, 2016, INTRO SOCIAL NETWORK, P1; Cotta C, 2013, J SYST SCI COMPLEX, V26, P21, DOI 10.1007/s11424-013-2291-2; Cummings T., 1987, HUMAN SIDE ADV MANUF, P37; Di Salvo V, 2007, INT J SPORTS MED, V28, P222, DOI 10.1055/s-2006-924294; Duarte R, 2013, HUM MOVEMENT SCI, V32, P555, DOI 10.1016/j.humov.2013.01.011; Duarte R, 2012, J SPORT SCI, V30, P871, DOI 10.1080/02640414.2012.675081; Duch J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010937; Evans MB, 2015, SCAND J MED SCI SPOR, V25, pE139, DOI 10.1111/sms.12235; Fewell JH, 2012, PLOS ONE, V7; Folgado H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097145; Fonseca S, 2012, HUM MOVEMENT SCI; Franks I., 2007, ESSENTIALS PERFORMAN, DOI 10.4324/9780203938065; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Gama J, 2016, S AFR J RES SPORT PH, V38, P75; Gama J, 2014, INT J PERF ANAL SPOR, V14, P692, DOI 10.1080/24748668.2014.11868752; Goncalves B, 2016, J SPORT SCI, V34, P1346, DOI 10.1080/02640414.2016.1143111; Goncalves B., 2016, J STRENGTH COND RES; Goncalves BV, 2014, J SPORT SCI, V32, P191, DOI 10.1080/02640414.2013.816761; Grund TU, 2016, AM BEHAV SCI, V60, P1260, DOI 10.1177/0002764216643133; Grund TU, 2012, SOC NETWORKS, V34, P682, DOI 10.1016/j.socnet.2012.08.004; Harbourne RT, 2009, PHYS THER, V89, P284, DOI 10.2522/ptj.20080130.ar; Hopkins W. G., 2007, SPORTSCIENCE SPREADS; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hughes M, 2005, J SPORT SCI, V23, P509, DOI 10.1080/02640410410001716779; Johnston RJ, 2014, J STRENGTH COND RES, V28, P1649, DOI 10.1519/JSC.0000000000000323; Kannekens R, 2011, SCAND J MED SCI SPOR, V21, P846, DOI 10.1111/j.1600-0838.2010.01104.x; Kozlowski SWJ., 2013, HDB PSYCHOL IND ORG, V2, P412; Lago-Penas C, 2011, J HUM KINET, V27, P137; Lago-Penas C, 2010, J SPORT SCI MED, V9, P288; Lopez-Pena J., 2012, SPORTS PHYS, P517, DOI DOI 10.1016/J.HUMOV.2017.08.022; Lusher D, 2010, MEAS PHYS EDUC EXERC, V14, P211, DOI 10.1080/1091367X.2010.495559; McGarry T, 2002, J SPORT SCI, V20, P771, DOI 10.1080/026404102320675620; Memmert D, 2017, SPORTS MED, V47, P1, DOI 10.1007/s40279-016-0562-5; Mohr M, 2003, J SPORT SCI, V21, P519, DOI 10.1080/0264041031000071182; O'Donoghue P, 2010, RES METHODS SPORTS P; Phillips E, 2010, SPORTS MED, V40, P271, DOI 10.2165/11319430-000000000-00000; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Ramos-Villagrasa PJ, 2012, EUR J WORK ORGAN PSY, V21, P778, DOI 10.1080/1359432X.2012.669525; Rein R, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3108-2; Ric A, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyd.2016.01513; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Sampaio J, 2012, INT J SPORTS MED, V33, P395, DOI 10.1055/s-0031-1301320; Sampaio JE, 2014, J SCI MED SPORT, V17, P229, DOI 10.1016/j.jsams.2013.04.005; Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Silva P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107112; Stergiou N., 2004, INNOVATIVE ANAL HUMA; Travassos B, 2013, INT J PERF ANAL SPOR, V13, P83, DOI 10.1080/24748668.2013.11868633; Unnithan V, 2012, J SPORT SCI, V30, P1719, DOI 10.1080/02640414.2012.731515; Yamamoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029638	58	51	52	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171156	10.1371/journal.pone.0171156	http://dx.doi.org/10.1371/journal.pone.0171156			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6QW	28141823	gold, Green Published, Green Submitted			2022-12-27	WOS:000396129500046
J	Park, H; Magee, CL				Park, Hyunseok; Magee, Christopher L.			Tracing Technological Development Trajectories: A Genetic Knowledge Persistence-Based Main Path Approach	PLOS ONE			English	Article							PATENT CITATION NETWORKS; PUBLIC-GOODS GAME; PARADIGMS; SEARCH; INNOVATION; INVENTION; DYNAMICS; PATTERNS; TRENDS; IMPACT	The aim of this paper is to propose a new method to identify main paths in a technological domain using patent citations. Previous approaches for using main path analysis have greatly improved our understanding of actual technological trajectories but nonetheless have some limitations. They have high potential to miss some dominant patents from the identified main paths; nonetheless, the high network complexity of their main paths makes qualitative tracing of trajectories problematic. The proposed method searches backward and forward paths from the high-persistence patents which are identified based on a standard genetic knowledge persistence algorithm. We tested the new method by applying it to the desalination and the solar photovoltaic domains and compared the results to output from the same domains using a prior method. The empirical results show that the proposed method can dramatically reduce network complexity without missing any dominantly important patents. The main paths identified by our approach for two test cases are almost 10x less complex than the main paths identified by the existing approach. The proposed approach identifies all dominantly important patents on the main paths, but the main paths identified by the existing approach miss about 20% of dominantly important patents.	[Park, Hyunseok] Hanyang Univ, Dept Informat Syst, Seoul, South Korea; [Park, Hyunseok; Magee, Christopher L.] MIT, Inst Data Syst & Soc, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Magee, Christopher L.] MIT, SUTD MIT Int Design Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Hanyang University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Singapore University of Technology & Design	Park, H (corresponding author), Hanyang Univ, Dept Informat Syst, Seoul, South Korea.; Park, H (corresponding author), MIT, Inst Data Syst & Soc, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	hp@hanyang.ac.kr	Magee, Christopher L./E-4021-2012		Hanyang University [HY-2016]; Singapore University of Technology and Design [6921538]; SUTD/MIT International Design Center	Hanyang University; Singapore University of Technology and Design; SUTD/MIT International Design Center	This work was supported by Hanyang University (Grant number: HY-2016, http://www.hanyang.ac.kr) and Singapore University of Technology and Design (Grant number: 6921538, http://www.sutd.edu.sg).; We would like to thank Hanyang University and SUTD/MIT International Design Center for supporting the research.	Basnet S, 2016, DESIGN SCI, V2, P1; Batagelj V., 2003, ARXIV; Benson CL, 2015, SCIENTOMETRICS, V102, P1965, DOI 10.1007/s11192-014-1493-2; Benson CL, 2013, SCIENTOMETRICS, V96, P69, DOI 10.1007/s11192-012-0930-3; CARLEY KM, 1993, KNOWLEDGE, V14, P417, DOI 10.1177/107554709301400406; Castellacci F, 2008, RES POLICY, V37, P978, DOI 10.1016/j.respol.2008.03.011; Chen MH, 2016, PHYS LETT A, V380, P40, DOI 10.1016/j.physleta.2015.09.047; Chen MH, 2015, APPL MATH COMPUT, V251, P192, DOI 10.1016/j.amc.2014.11.052; CHRISTENSEN CM, 1995, RES POLICY, V24, P233, DOI 10.1016/0048-7333(93)00764-K; Dahlin KB, 2005, RES POLICY, V34, P717, DOI 10.1016/j.respol.205.03.009; Dosi, 1995, J EVOLUTIONARY EC, V5, P243, DOI DOI 10.1007/BF01198306; DOSI G, 1982, RES POLICY, V11, P147, DOI 10.1016/0048-7333(82)90016-6; Epicoco M, 2014, TECHNOL FORECAST SOC, V81, P388, DOI 10.1016/j.techfore.2013.03.006; Epicoco M, 2013, RES POLICY, V42, P180, DOI 10.1016/j.respol.2012.06.009; EPRI, 2009, SOL PHOT STAT COSTS; Fleming L, 2001, MANAGE SCI, V47, P117, DOI 10.1287/mnsc.47.1.117.10671; Fontana R, 2009, ECON INNOV NEW TECH, V18, P311, DOI 10.1080/10438590801969073; Frenken K, 2000, RES POLICY, V29, P331, DOI 10.1016/S0048-7333(99)00037-2; Funk JL, 2015, RES POLICY, V44, P777, DOI 10.1016/j.respol.2014.11.005; Gao ZK, 2017, INT J NEURAL SYST, V27, DOI 10.1142/S0129065717500058; Gao ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep35622; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Greenlee LF, 2009, WATER RES, V43, P2317, DOI 10.1016/j.watres.2009.03.010; Hall BH, 2001, NBER DISCUSSION PAPE, V3094; Ho JC, 2014, TECHNOL FORECAST SOC, V82, P66, DOI 10.1016/j.techfore.2013.06.004; Ho MHC, 2014, SCIENTOMETRICS, V100, P149, DOI 10.1007/s11192-014-1265-z; Huenteler J, 2016, TECHNOL FORECAST SOC, V104, P102, DOI 10.1016/j.techfore.2015.09.022; HUMMON NP, 1993, SOC NETWORKS, V15, P71, DOI 10.1016/0378-8733(93)90022-D; HUMMON NP, 1989, SOC NETWORKS, V11, P39, DOI 10.1016/0378-8733(89)90017-8; JAFFE AB, 1993, Q J ECON, V108, P577, DOI 10.2307/2118401; Liu JS, 2012, J AM SOC INF SCI TEC, V63, P528, DOI 10.1002/asi.21692; Magee CL, 2016, TECHNOL FORECAST SOC, V104, P237, DOI 10.1016/j.techfore.2015.12.011; Marco AC, 2007, ECON LETT, V94, P290, DOI 10.1016/j.econlet.2006.08.014; Martinelli A, 2014, J EVOL ECON, V24, P623, DOI 10.1007/s00191-014-0349-5; Martinelli A, 2012, RES POLICY, V41, P414, DOI 10.1016/j.respol.2011.10.012; Mina A, 2007, RES POLICY, V36, P789, DOI 10.1016/j.respol.2006.12.007; Nelson R., 1982, EVOL THEOR; Parayil G, 2003, RES POLICY, V32, P971, DOI 10.1016/S0048-7333(02)00106-3; Schilling MA, 2011, RES POLICY, V40, P1321, DOI 10.1016/j.respol.2011.06.009; Schumpeter Joseph, 1934, THEORY EC DEV INQUIR; SOLOW RM, 1957, REV ECON STAT, V39, P312, DOI 10.2307/1926047; Spekkink W, 2015, J CLEAN PROD, V98, P133, DOI 10.1016/j.jclepro.2014.08.028; Sun SW, 2016, SCI REP-UK, V6, DOI 10.1038/srep32983; Trajtenberg, 2002, PATENTS CITATIONS IN, DOI 10.7551/mitpress/5263.001.0001; Verspagen B, 2007, ADV COMPLEX SYST, V10, P93, DOI 10.1142/S0219525907000945; von Tunzelmann N, 2008, IND CORP CHANGE, V17, P467, DOI 10.1093/icc/dtn012; von Wartburg I, 2005, RES POLICY, V34, P1591, DOI 10.1016/j.respol.2005.08.001; Xia CY, 2013, PHYSICA A, V392, P1577, DOI 10.1016/j.physa.2012.11.043; Xia CY, 2012, NONLINEAR DYNAM, V69, P927, DOI 10.1007/s11071-011-0313-y; YABLONOVITCH E, 1982, IEEE T ELECTRON DEV, V29, P300, DOI 10.1109/T-ED.1982.20700; Yeo W, 2014, SCIENTOMETRICS, V98, P633, DOI 10.1007/s11192-013-1140-3; Youn HJ, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0272	52	32	34	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170895	10.1371/journal.pone.0170895	http://dx.doi.org/10.1371/journal.pone.0170895			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6PA	28135304	gold, Green Published, Green Submitted			2022-12-27	WOS:000396124700027
J	Stremmel, W; Schmidt, KV; Schuhmann, V; Kratzer, F; Garbade, SF; Langhans, CD; Fricker, G; Okun, JG				Stremmel, Wolfgang; Schmidt, Kathrin V.; Schuhmann, Vera; Kratzer, Frank; Garbade, Sven F.; Langhans, Claus-Dieter; Fricker, Gert; Okun, Juergen G.			Blood Trimethylamine-N-Oxide Originates from Microbiota Mediated Breakdown of Phosphatidylcholine and Absorption from Small Intestine	PLOS ONE			English	Article							SOLID-PHASE MICROEXTRACTION; ULCERATIVE-COLITIS; GUT MICROBIOTA; POLYMORPHISMS; MANAGEMENT; METABOLISM; URINE; RISK	Elevated serum trimethylamine-N-oxide (TMAO) was previously reported to be associated with an elevated risk for cardiovascular events. TMAO originates from the microbiota-dependent breakdown of food-derived phosphatidylcholine (PC) to trimethylamine (TMA), which is oxidized by hepatic flavin-containing monooxygenases to TMAO. Our aim was to investigate the predominant site of absorption of the bacterial PC-breakdown product TMA. A healthy human proband was exposed to 6.9 g native phosphatidylcholine, either without concomitant treatment or during application with the topical antibiotic rifaximin, or exposed only to 6.9 g of a delayed-release PC formulation. Plasma and urine concentrations of TMA and TMAO were determined by electrospray ionization tandem mass spectrometry (plasma) and gas chromatography-mass spectrometry (urine). Native PC administration without concomitant treatment resulted in peak plasma TMAO levels of 43 +/- 8 mu M at 12 h post-ingestion, which was reduced by concomitant rifaximin treatment to 22 +/- 8 mu M (p < 0.05). TMAO levels observed after delayed-release PC administration were 20 +/- 3 mu M (p < 0.001). Accordingly, the peak urinary concentration at 24 h post-exposure dropped from 252 +/- 33 to 185 +/- 31 mmol/mmol creatinine after rifaximin treatment. In contrast, delayed-release PC resulted in even more suppressed urinary TMAO levels after the initial 12-h observation period (143 +/- 18 mmol/mmol creatinine) and thereafter remained within the control range (24 h: 97 +/- 9 mmol/mmol creatinine, p < 0.001 24 h vs. 12 h), indicating a lack of substrate absorption in distal intestine and large bowel. Our results showed that the microbiota in the small intestine generated the PC breakdown product TMA. The resulting TMAO, as a cardiovascular risk factor, was suppressed by topical-acting antibiotics or when PC was presented in an intestinally delayed release preparation.	[Stremmel, Wolfgang] Univ Clin Heidelberg, Dept Gastroenterol, Heidelberg, Germany; [Schmidt, Kathrin V.; Schuhmann, Vera; Kratzer, Frank; Garbade, Sven F.; Langhans, Claus-Dieter; Okun, Juergen G.] Univ Clin Heidelberg, Dept Pediat, Heidelberg, Germany; [Fricker, Gert] Ruprecht Karls Univ Heidelberg, Inst Pharm & Mol Biotechnol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Stremmel, W (corresponding author), Univ Clin Heidelberg, Dept Gastroenterol, Heidelberg, Germany.	wolfgang.stremmel@med.uni-heidelberg.de	Garbade, Sven F/S-2804-2016; Garbade, Sven F/O-4615-2019; Garbade, Sven Friedrich/HGA-2325-2022	Garbade, Sven F/0000-0002-7420-4757; Garbade, Sven F/0000-0002-7420-4757; Stremmel, Wolfgang/0000-0002-8545-1753				Bass NM, 2010, NEW ENGL J MED, V362, P1071, DOI 10.1056/NEJMoa0907893; Busby MG, 2004, J AM DIET ASSOC, V104, P1836, DOI 10.1016/j.jada.2004.09.027; Cashman JR, 2000, DRUG METAB DISPOS, V28, P169; Chalmers RA, 2006, J INHERIT METAB DIS, V29, P162, DOI 10.1007/s10545-006-0158-6; Cheng G, 2004, WORLD J GASTROENTERO, V10, P1769; Johnson DW, 2008, J MASS SPECTROM, V43, P495, DOI 10.1002/jms.1339; Karner M, 2014, AM J GASTROENTEROL, V109, P1041, DOI 10.1038/ajg.2014.104; Krueger SK, 2005, PHARMACOL THERAPEUT, V106, P357, DOI 10.1016/j.pharmthera.2005.01.001; Mills GA, 1999, J CHROMATOGR B, V723, P281, DOI 10.1016/S0378-4347(98)00542-8; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Serino M, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0540-1; Sitaraman R, 2013, J MED MICROBIOL, V62, P948, DOI 10.1099/jmm.0.053587-0; Stremmel W, 2005, GUT, V54, P966, DOI 10.1136/gut.2004.052316; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Team C, 2016, LANG ENV STAT COMP; Vas G, 2004, J MASS SPECTROM, V39, P233, DOI 10.1002/jms.606; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922	17	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170742	10.1371/journal.pone.0170742	http://dx.doi.org/10.1371/journal.pone.0170742			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129384	Green Submitted, Green Published, gold			2022-12-27	WOS:000396211400041
J	Zhou, CC; Ge, YZ; Yao, WT; Wu, R; Xin, H; Lu, TZ; Li, MH; Song, KW; Wang, M; Zhu, YP; Zhu, M; Geng, LG; Gao, XF; Zhou, LH; Zhang, SL; Zhu, JG; Jia, RP				Zhou, Chang-Cheng; Ge, Yu-Zheng; Yao, Wen-Tao; Wu, Ran; Xin, Hui; Lu, Tian-Ze; Li, Ming-Hao; Song, Kai-Wei; Wang, Min; Zhu, Yun-Peng; Zhu, Meng; Geng, Li-Guo; Gao, Xiao-Fei; Zhou, Liu-Hua; Zhang, Sheng-Li; Zhu, Jia-Geng; Jia, Rui-Peng			Limited Clinical Utility of Remote Ischemic Conditioning in Renal Transplantation: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							KIDNEY-TRANSPLANTATION; REPERFUSION INJURY; GRAFT FUNCTION; MECHANISMS; RECIPIENTS	Objective We conducted this meta-analysis of randomized controlled trials (RCTs) to investigate whether remote ischemic conditioning (RIC) could improve graft functions in kidney transplantation. Methods PubMed, Web of Science, and Cochrane Library were comprehensively searched to identify all eligible studies by October 5, 2016. The treatment effects were examined with risk ratio (RR) and weighted mean difference with the corresponding 95% confidence intervals (CI). The statistical significance and heterogeneity were assessed with both Z-test and Q-test. Results A total of six RCTs including 651 recipients, were eventually identified. Compared to the controls, RIC could reduce the incidence of delayed graft function (DGF) after kidney transplantation (random-effects model: RR = 0.89; fixed-effect model: RR = 0.84). However, the decrease did not reveal statistical significance. The subgroup analysis by RIC type demonstrated no significant difference among the three interventions in protecting renal allografts against DGF. Furthermore, no significant difference could be observed in the incidence of acute rejection, graft loss, 50% fall in serum creatinine, as well as the estimated glomerular filtration rate and hospital stay between the RIC and Control groups. Conclusions This meta-analysis suggested that RIC might exert renoprotective functions in human kidney transplantation, and further well-designed RCTs with large sample size are warranted to assess its clinical efficacy.	[Zhou, Chang-Cheng; Ge, Yu-Zheng; Yao, Wen-Tao; Wu, Ran; Xin, Hui; Lu, Tian-Ze; Li, Ming-Hao; Song, Kai-Wei; Wang, Min; Zhu, Yun-Peng; Zhou, Liu-Hua; Zhang, Sheng-Li; Jia, Rui-Peng] Nanjing Med Univ, Nanjing Hosp 1, Ctr Renal Transplantat, Nanjing, Jiangsu, Peoples R China; [Zhou, Chang-Cheng; Ge, Yu-Zheng; Yao, Wen-Tao; Wu, Ran; Xin, Hui; Lu, Tian-Ze; Li, Ming-Hao; Song, Kai-Wei; Wang, Min; Zhu, Yun-Peng; Zhou, Liu-Hua; Zhang, Sheng-Li; Zhu, Jia-Geng; Jia, Rui-Peng] Nanjing Med Univ, Nanjing Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China; [Zhu, Meng; Geng, Li-Guo] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Gao, Xiao-Fei] Nanjing Med Univ, Nanjing Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Jia, RP (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Ctr Renal Transplantat, Nanjing, Jiangsu, Peoples R China.; Jia, RP (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China.	urojiarp@126.com		Ge, Yu-Zheng/0000-0003-1615-9473	National Natural Science Foundation of China [81070597, 81370853, 81570613]; Science and Education Development Program of the Jiangsu Province Health Board [LJ201107]; Six Talent Peaks of the Jiangsu Province Health Bureau [2011-WS-093]; Research and Innovation Program for Graduates of Jiangsu Province [CXZZ13_0583]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Education Development Program of the Jiangsu Province Health Board; Six Talent Peaks of the Jiangsu Province Health Bureau; Research and Innovation Program for Graduates of Jiangsu Province	This study was supported by grants from the National Natural Science Foundation of China (81070597, 81370853, and 81570613), Science and Education Development Program of the Jiangsu Province Health Board (LJ201107), Six Talent Peaks of the Jiangsu Province Health Bureau (2011-WS-093) to RPJ, and Research and Innovation Program for Graduates of Jiangsu Province (CXZZ13_0583) to YZG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali ZA, 2007, CIRCULATION, V116, pI98, DOI 10.1161/circulationaha.106.679167; Burton JO, 2009, CLIN J AM SOC NEPHRO, V4, P1925, DOI 10.2215/CJN.04470709; Cavaille-Coll M, 2013, AM J TRANSPLANT, V13, P1134, DOI 10.1111/ajt.12210; Chen YL, 2013, TRANSPLANTATION, V95, pE4, DOI 10.1097/TP.0b013e3182782f3a; Crimi G, 2014, INT J CARDIOL, V177, P500, DOI 10.1016/j.ijcard.2014.08.080; Garcia GG, 2012, LANCET, V379, pE36, DOI 10.1016/S0140-6736(12)60202-5; Hausenloy DJ, 2009, ATHEROSCLEROSIS, V204, P334, DOI 10.1016/j.atherosclerosis.2008.10.029; Heusch G, 2015, J AM COLL CARDIOL, V65, P177, DOI 10.1016/j.jacc.2014.10.031; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kim WH, 2014, TRANSPLANTATION, V98, P529, DOI 10.1097/TP.0000000000000098; Krogstrup NV, 2016, AM J TRANSPLANTATION; MacAllister R, 2015, NIHR J LIB; Meybohm P, 2015, NEW ENGL J MED, V373, P1397, DOI 10.1056/NEJMoa1413579; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nicholson ML, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001316; Powell JT, 2013, CLIN TRANSPLANT, V27, P484, DOI 10.1111/ctr.12121; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; Ramalho ALAS, 2013, TRANSPL P, V45, P3234, DOI 10.1016/j.transproceed.2013.05.004; Saat TC, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0767-2; Saxena P, 2010, J CARDIAC SURG, V25, P127, DOI 10.1111/j.1540-8191.2009.00820.x; Selzner N, 2012, TRANSPLANT REV-ORLAN, V26, P115, DOI 10.1016/j.trre.2011.07.003; Soendergaard P, 2012, TRANSPL INT, V25, P1002, DOI 10.1111/j.1432-2277.2012.01522.x; Summers DM, 2015, KIDNEY INT, V88, P241, DOI 10.1038/ki.2015.88; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Thielmann M, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0259-3; Tonelli M, 2011, AM J TRANSPLANT, V11, P2093, DOI 10.1111/j.1600-6143.2011.03686.x; Whittaker P, 2014, DOSE-RESPONSE, V12, P650, DOI 10.2203/dose-response.14-035.Whittaker; Wu JY, 2014, J SURG RES, V188, P303, DOI 10.1016/j.jss.2013.06.058; Xin H, 2015, BIOMED PHARMACOTHER, V69, P29, DOI 10.1016/j.biopha.2014.10.029; Zhang L, 2016, J CRIT CARE, V33, P224, DOI 10.1016/j.jcrc.2016.01.026	32	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170729	10.1371/journal.pone.0170729	http://dx.doi.org/10.1371/journal.pone.0170729			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129389	Green Submitted, Green Published, gold			2022-12-27	WOS:000396211400044
J	Engel, N; Adamus, A; Schauer, N; Kuhn, J; Nebe, B; Seitz, G; Kraft, K				Engel, Nadja; Adamus, Anna; Schauer, Nicolas; Kuehn, Juliane; Nebe, Barbara; Seitz, Guido; Kraft, Karin			Synergistic Action of Genistein and Calcitriol in Immature Osteosarcoma MG-63 Cells by SGPL1 Up-Regulation	PLOS ONE			English	Article							BREAST-CANCER; VITAMIN-D; SPHINGOSINE-1-PHOSPHATE LYASE; PROSTATE-CANCER; PLANT-EXTRACTS; GROWTH; MORTALITY; MCF-7; LINES	Background Phytoestrogens such as genistein, the most prominent isoflavone from soy, show concentration-dependent anti-estrogenic or estrogenic effects. High genistein concentrations (>10 mu M) also promote proliferation of bone cancer cells in vitro. On the other hand, the most active component of the vitamin D family, calcitriol, has been shown to be tumor protective in vitro and in vivo. The purpose of this study was to examine a putative synergism of genistein and calcitriol in two osteosarcoma cell lines MG-63 (early osteoblast), Saos-2 (mature osteoblast) and primary osteoblasts. Methods Thus, an initial screening based on cell cycle phase alterations, estrogen (ER) and vitamin D receptor (VDR) expression, live cell metabolic monitoring, and metabolomics were performed. Results Exposure to the combination of 100 mu M genistein and 10 nM calcitriol reduced the number of proliferative cells to control levels, increased ER beta and VDR expression, and reduced extracellular acidification (40%) as well as respiratory activity (70%), primarily in MG-63 cells. In order to identify the underlying cellular mechanisms in the MG-63 cell line, metabolic profiling via GC/MS technology was conducted. Combined treatment significantly influenced lipids and amino acids preferably, whereas metabolites of the energy metabolism were not altered. The comparative analysis of the log2-ratios revealed that after combined treatment only the metabolite ethanolamine was highly up-regulated. This is the result: a strong overexpression (350%) of the enzyme sphingosine-1-phosphate lyase (SGPL1), which irreversibly degrades sphingosine-1-phosphate (S1P), thereby, generating ethanolamine. S1P production and secretion is associated with an increased capability of migration and invasion of cancer cells. Conclusion From these results can be concluded that the tumor promoting effect of high concentrations of genistein in immature osteosarcoma cells is reduced by the co-administration of calcitriol, primarily by the breakdown of S1P. It should be tested whether this anti-metastatic pathway can be stimulated by combined treatment also in metastatic xenograft mice models.	[Engel, Nadja; Adamus, Anna; Seitz, Guido] Univ Hosp Marburg, Dept Pediat Surg, Marburg, Germany; [Engel, Nadja; Adamus, Anna; Kuehn, Juliane; Nebe, Barbara] Univ Rostock, Med Ctr, Dept Cell Biol, Rostock, Germany; [Schauer, Nicolas] Metabol Discoveries GmbH, Potsdam, Germany; [Kraft, Karin] Univ Rostock, Med Ctr, Complementary Med, Ctr Internal Med, Rostock, Germany	University Hospital of Giessen & Marburg; University of Rostock; University of Rostock	Engel, N (corresponding author), Univ Hosp Marburg, Dept Pediat Surg, Marburg, Germany.	nadja.engel-lutz@gmx.de	Seitz, Guido/AAH-5460-2019	Adamus, Anna/0000-0001-9938-8903; Seitz, Prof. Dr. Guido/0000-0001-9280-1451	Federal Ministry of Education and Research Germany (Women Professors Program); FORUN program of the University Medical Center Rostock [889025]; Women Professors Program	Federal Ministry of Education and Research Germany (Women Professors Program); FORUN program of the University Medical Center Rostock; Women Professors Program	This work is supported by fund from Federal Ministry of Education and Research Germany (Women Professors Program) and FORUN program of the University Medical Center Rostock (no. 889025). Women Professors Program provided the salary for author [NE]. Metabolomic Discoveries GmbH, a commercial company, provided support by measuring the metabolomics samples, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bandhuvula P, 2007, TRENDS MOL MED, V13, P210, DOI 10.1016/j.molmed.2007.03.005; Begagne E, 2014, J CLIN INVEST, V124, P5368, DOI 10.1172/JCI74188; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Engel N, 2011, J ETHNOPHARMACOL, V137, P1003, DOI 10.1016/j.jep.2011.07.023; Engel N, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-334; Engel N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047833; Grant WB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2862; Grant WB, 2011, SCAND J PUBLIC HEALT, V39, P70, DOI 10.1177/1403494810382473; Hilakivi-Clarke L, 2010, J NUTR, V140, p2326S, DOI 10.3945/jn.110.124230; Hsieh CY, 1998, CANCER RES, V58, P3833; Hutchinson MS, 2010, EUR J ENDOCRINOL, V162, P935, DOI 10.1530/EJE-09-1041; Jarvinen T, AMERICAN JOURNAL OF, V156, P29; Kaelin WG, 2010, NATURE, V465, P562, DOI 10.1038/465562a; Keum N, 2014, BRIT J CANCER, V111, P976, DOI 10.1038/bjc.2014.294; Krishnan AV, 2007, NUTR REV, V65, pS121, DOI 10.1111/j.1753-4887.2007.tb00338.x; Kumar A, 2009, EXPERT OPIN THER TAR, V13, P1013, DOI 10.1517/14728220903039722; Lamartiniere CA, 1998, P SOC EXP BIOL MED, V217, P358, DOI 10.3181/00379727-217-44245; Lappe J, 2013, EUR J NUTR, V52, P203, DOI 10.1007/s00394-012-0304-x; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Martinez-Montemayor MM, 2010, CLIN EXP METASTAS, V27, P465, DOI 10.1007/s10585-010-9336-x; Murphy LC, 2002, BIOMED PHARMACOTHER, V56, P65, DOI 10.1016/S0753-3322(01)00157-3; PAGLIACCI MC, 1994, EUR J CANCER, V30A, P1675, DOI 10.1016/0959-8049(94)00262-4; Rao A, 2002, J NUTR, V132, P3191, DOI 10.1093/jn/131.10.3191; Schmitt J, 2014, BRIT J CANCER, V111, P1646, DOI 10.1038/bjc.2014.457; Sirtori CR, 2005, ANN MED, V37, P423, DOI 10.1080/07853890510044586; Swami S., 2005, MOL CELL ENDOCRINOL, V12, P12; Van Veldhoven PP, 2000, BBA-MOL CELL BIOL L, V1487, P128, DOI 10.1016/S1388-1981(00)00079-2; Vuolo Laura, 2012, Front Endocrinol (Lausanne), V3, P58, DOI 10.3389/fendo.2012.00058; Wang D, 2008, MOL CANCER THER, V7, P1993, DOI 10.1158/1535-7163.MCT-08-0088; Warsow G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081784; Yang XJ, 2015, CLIN EXP METASTAS, V32, P323, DOI 10.1007/s10585-015-9709-2	32	14	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0169742	10.1371/journal.pone.0169742	http://dx.doi.org/10.1371/journal.pone.0169742			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125641	Green Published, Green Submitted, gold			2022-12-27	WOS:000396176100135
J	Finnicum, CT; Dolan, CV; Willemsen, G; Weber, ZM; Petersen, JL; Beck, JJ; Codd, V; Boomsma, DI; Davies, GE; Ehli, EA				Finnicum, Casey T.; Dolan, Conor V.; Willemsen, Gonneke; Weber, Zachary M.; Petersen, Jason L.; Beck, Jeffrey J.; Codd, Veryan; Boomsma, Dorret I.; Davies, Gareth E.; Ehli, Erik A.			Relative Telomere Repeat Mass in Buccal and Leukocyte-Derived DNA	PLOS ONE			English	Article							NETHERLANDS TWIN REGISTER; EXTRACTION METHOD IMPLICATIONS; LENGTH VARIES; STEM-CELLS; BIOLOGY; IDENTIFICATION; METAANALYSIS; ASSOCIATION; PARAMETERS; DYNAMICS	Telomere length has garnered interest due to the potential role it may play as a biomarker for the cellular aging process. Telomere measurements obtained from blood-derived DNA are often used in epidemiological studies. However, the invasive nature of blood draws severely limits sample collection, particularly with children. Buccal cells are commonly sampled for DNA isolation and thus may present a non-invasive alternative for telomere measurement. Buccal and leukocyte derived DNA obtained from samples collected at the same time period were analyzed for telomere repeat mass (TRM). TRM was measured in buccal-derived DNA samples from individuals for whom previous TRM data from blood samples existed. TRM measurement was performed by qPCR and was normalized to the single copy 36B4 gene relative to a reference DNA sample (K562). Correlations between TRM from blood and buccal DNA were obtained and also between the same blood DNA samples measured in separate laboratories. Using the classical twin design, TRM heritability was estimated (N = 1892, MZ = 1044, DZ = 775). Buccal samples measured for TRM showed a significant correlation with the blood-1 (R = 0.39, p < 0.01) and blood-2 (R = 0.36, p < 0.01) samples. Sex and age effects were observed within the buccal samples as is the norm within blood-derived DNA. The buccal, blood-1, and blood-2 measurements generated heritability estimates of 23.3%, 47.6% and 22.2%, respectively. Buccal derived DNA provides a valid source for the determination of TRM, paving the way for non-invasive projects, such as longitudinal studies in children.	[Finnicum, Casey T.; Weber, Zachary M.; Petersen, Jason L.; Beck, Jeffrey J.; Boomsma, Dorret I.; Davies, Gareth E.; Ehli, Erik A.] Avera McKennan Hosp & Univ Hlth Ctr, Avera Inst Human Genet, Sioux Falls, SD 57105 USA; [Dolan, Conor V.; Willemsen, Gonneke; Boomsma, Dorret I.; Davies, Gareth E.] Vrije Univ, Dept Biol Psychol, Amsterdam, Netherlands; [Codd, Veryan] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England	Vrije Universiteit Amsterdam; University of Leicester	Finnicum, CT (corresponding author), Avera McKennan Hosp & Univ Hlth Ctr, Avera Inst Human Genet, Sioux Falls, SD 57105 USA.	Casey.Finnicum@avera.org; di.boomsma@vu.nl	Beck, Jeffrey/AAP-2742-2021; Boomsma, Dorret I/AAX-4470-2020	Beck, Jeffrey/0000-0002-1152-9968; Willemsen, Gonneke/0000-0003-3755-0236; Finnicum, Casey/0000-0001-5959-3961; Codd, Veryan/0000-0002-9430-8254				ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Andrew T, 2006, AM J HUM GENET, V78, P480, DOI 10.1086/500052; Aviv A, 2006, INT J EPIDEMIOL, V35, P1424, DOI 10.1093/ije/dyl169; Bakaysa SL, 2007, AGING CELL, V6, P769, DOI 10.1111/j.1474-9726.2007.00340.x; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Beekman M, 2001, GENET RES, V77, P129, DOI 10.1017/S001667230100492X; Blackburn EH, 2015, SCIENCE, V350, P1193, DOI 10.1126/science.aab3389; Boker S, 2011, PSYCHOMETRIKA, V76, P306, DOI 10.1007/s11336-010-9200-6; Boomsma DI, 2006, TWIN RES HUM GENET, V9, P849, DOI 10.1375/183242706779462426; Broer L, 2013, EUR J HUM GENET, V21, P1163, DOI 10.1038/ejhg.2012.303; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Cunningham JM, 2013, CANCER EPIDEM BIOMAR, V22, P2047, DOI 10.1158/1055-9965.EPI-13-0409; Dalgard C, 2015, INT J EPIDEMIOL, V44, P1688, DOI 10.1093/ije/dyv165; Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602; Deelen J, 2014, INT J EPIDEMIOL, V43, P878, DOI 10.1093/ije/dyt267; Dobson AJ, 2008, AN INTRODUCTION TO G; Falconer D. S., 1996, Introduction to quantitative genetics.; Friedrich U, 2000, MECH AGEING DEV, V119, P89, DOI 10.1016/S0047-6374(00)00173-1; Gardner JP, 2007, J GERONTOL A-BIOL, V62, P367, DOI 10.1093/gerona/62.4.367; Gomes NMV, 2011, AGING CELL, V10, P761, DOI 10.1111/j.1474-9726.2011.00718.x; Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109; Hofmann JN, 2014, CANCER EPIDEM BIOMAR, V23, P1129, DOI 10.1158/1055-9965.EPI-14-0145; Keller MC, 2010, BEHAV GENET, V40, P377, DOI 10.1007/s10519-009-9320-x; MARTIN NG, 1977, HEREDITY, V38, P79, DOI 10.1038/hdy.1977.9; MARTIN NG, 1978, HEREDITY, V40, P97, DOI 10.1038/hdy.1978.10; Martin-Ruiz CM, 2015, INT J EPIDEMIOL, V44, P1673, DOI 10.1093/ije/dyu191; Mathur MB, 2016, BRAIN BEHAV IMMUN, V54, P158, DOI 10.1016/j.bbi.2016.02.002; MEULENBELT I, 1995, AM J HUM GENET, V57, P1252; Min JL, 2006, TWIN RES HUM GENET, V9, P501, DOI 10.1375/twin.9.4.501; Minica CC, 2015, EUR J HUM GENET, V23, P388, DOI 10.1038/ejhg.2014.94; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Oliveira BS, 2016, AGEING RES REV, V26, P37, DOI 10.1016/j.arr.2015.12.006; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Plomin R., 2008, BEHAV GENET; Purcell S, 2002, TWIN RES, V5, P554, DOI 10.1375/136905202762342026; Rizvi Saliha, 2014, Curr Aging Sci, V7, P161; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Scheet P, 2012, TWIN RES HUM GENET, V15, P737, DOI 10.1017/thg.2012.61; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Slieker RC, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-26; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846; Willemsen G, 2013, TWIN RES HUM GENET, V16, P271, DOI 10.1017/thg.2012.140; Willemsen G, 2010, TWIN RES HUM GENET, V13, P231, DOI 10.1375/twin.13.3.231	48	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170765	10.1371/journal.pone.0170765	http://dx.doi.org/10.1371/journal.pone.0170765			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125671	Green Published, Green Submitted, gold			2022-12-27	WOS:000396176100058
J	del Rio-Chanona, RM; Grujic, J; Jensen, HJ				Maria del Rio-Chanona, Rita; Grujic, Jelena; Jensen, Henrik Jeldtoft			Trends of the World Input and Output Network of Global Trade	PLOS ONE			English	Article							COMPLEXITY	The international trade naturally maps onto a complex networks. Theoretical analysis of this network gives valuable insights about the global economic system. Although different economic data sets have been investigated from the network perspective, little attention has been paid to its dynamical behaviour. Here we take the World Input Output Data set, which has values of the annual transactions between 40 different countries of 35 different sectors for the period of 15 years, and infer the time interdependence between countries and sectors. As a measure of interdependence we use correlations between various time series of the network characteristics. First we form 15 primary networks for each year of the data we have, where nodes are countries and links are annual exports from one country to the other. Then we calculate the strengths (weighted degree) and PageRank of each country in each of the 15 networks for 15 different years. This leads to sets of time series and by calculating the correlations between these we form a secondary network where the links are the positive correlations between different countries or sectors. Furthermore, we also form a secondary network where the links are negative correlations in order to study the competition between countries and sectors. By analysing this secondary network we obtain a clearer picture of the mutual influences between countries. As one might expect, we find that political and geographical circumstances play an important role. However, the derived correlation network reveals surprising aspects which are hidden in the primary network. Sometimes countries which belong to the same community in the original network are found to be competitors in the secondary networks. E.g. Spain and Portugal are always in the same trade flow community, nevertheless secondary network analysis reveal that they exhibit contrary time evolution.	[Maria del Rio-Chanona, Rita] Univ Nacl Autonoma Mexico, Fac Ciencias, Mexico City, DF, Mexico; [Grujic, Jelena; Jensen, Henrik Jeldtoft] Imperial Coll London, Ctr Complex Sci, South Kensington Campus, London SW7 2AZ, England; [Grujic, Jelena; Jensen, Henrik Jeldtoft] Imperial Coll London, Dept Math, South Kensington Campus, London SW7 2AZ, England; [Grujic, Jelena] Vrije Univ Brussel, Dept Comp Sci, AI Lab, Brussels, Belgium; [Grujic, Jelena] Univ Libre Bruxelles, Dept Informat, MLG, MLG Grp, Brussels, Belgium	Universidad Nacional Autonoma de Mexico; Imperial College London; Imperial College London; Vrije Universiteit Brussel; Universite Libre de Bruxelles	Grujic, J (corresponding author), Imperial Coll London, Ctr Complex Sci, South Kensington Campus, London SW7 2AZ, England.; Grujic, J (corresponding author), Imperial Coll London, Dept Math, South Kensington Campus, London SW7 2AZ, England.; Grujic, J (corresponding author), Vrije Univ Brussel, Dept Comp Sci, AI Lab, Brussels, Belgium.; Grujic, J (corresponding author), Univ Libre Bruxelles, Dept Informat, MLG, MLG Grp, Brussels, Belgium.	jgrujic@vub.ac.be		del Rio-Chanona, R. Maria/0000-0002-0189-7919	Research Foundation Flanders FWO- Fonds Wetenschappelijk Onderzoek [118711 / 12P3315N]	Research Foundation Flanders FWO- Fonds Wetenschappelijk Onderzoek	J.G. is a fellow of Research Foundation Flanders FWO- Fonds Wetenschappelijk Onderzoek http://www.fwo.be/ the grant number 118711 / 12P3315N.	[Anonymous], ARXIV14070225; [Anonymous], COURSE WEB GRAPH; [Anonymous], ARXIV14080443; Bhattacharya K, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/02/P02002; Blochl F, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046127; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Cerina F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134025; Contreras MGA, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.062812; Csardi G., 2006, INT J COMPLEX SYST, V2006, P1695, DOI DOI 10.1093/NAR/; Franceschet M, 2011, COMMUN ACM, V54, P92, DOI 10.1145/1953122.1953146; Garlaschelli D, 2005, PHYSICA A, V355, P138, DOI 10.1016/j.physa.2005.02.075; Gleditsch KS, 2002, J CONFLICT RESOLUT, V46, P712, DOI 10.1177/002200202236171; Hausmann R, 2011, J ECON GROWTH, V16, P309, DOI 10.1007/s10887-011-9071-4; Hidalgo CA, 2007, SCIENCE, V317, P482, DOI 10.1126/science.1144581; Hidalgo CA, 2009, P NATL ACAD SCI USA, V106, P10570, DOI 10.1073/pnas.0900943106; Kali R, 2013, J DEV ECON, V101, P216, DOI 10.1016/j.jdeveco.2012.11.004; Kreyszig E., 1970, INTRO MATH STAT PRIN; Leontief W, 1941, STRUCTURE AM EC; Li X, 2003, PHYSICA A, V328, P287, DOI 10.1016/S0378-4371(03)00567-3; McNerney J, 2013, PHYSICA A, V392, P6427, DOI 10.1016/j.physa.2013.07.063; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Page Lawrence, 1999, 199966 STANF INFOLAB; Prasad NR, 2009, CMC-COMPUT MATER CON, V14, P1, DOI 10.1145/1541880.1541882; Reimann C, 2005, SCI TOTAL ENVIRON, V346, P1, DOI 10.1016/j.scitotenv.2004.11.023; SAHOO PK, 1988, COMPUT VISION GRAPH, V41, P233, DOI 10.1016/0734-189X(88)90022-9; Serrano MA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.015101; Tacchella A, 2013, J ECON DYN CONTROL, V37, P1683, DOI 10.1016/j.jedc.2013.04.006; Timmer M., 2012, IIDE DISCUSSION PAPE; Timmer MP, 2015, REV INT ECON, V23, P575, DOI 10.1111/roie.12178; Zhu Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105496	31	18	18	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170817	10.1371/journal.pone.0170817	http://dx.doi.org/10.1371/journal.pone.0170817			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7IT	28125656	gold, Green Published, Green Submitted			2022-12-27	WOS:000396176100042
J	Dahlin, P; Srivastava, V; Ekengren, S; Mckee, LS; Bulone, V				Dahlin, Paul; Srivastava, Vaibhav; Ekengren, Sophia; Mckee, Lauren S.; Bulone, Vincent			Comparative analysis of sterol acquisition in the oomycetes Saprolegnia parasitica and Phytophthora infestans	PLOS ONE			English	Article							ISOPRENOID BIOSYNTHESIS; APHANOMYCES-EUTEICHES; METABOLIC PATHWAYS; PLANT DEFENSE; GROWTH; CYCLOARTENOL; CHOLESTEROL; ELICITINS; DATABASE; TRITERPENOIDS	The oomycete class includes pathogens of animals and plants which are responsible for some of the most significant global losses in agriculture and aquaculture. There is a need to replace traditional chemical means of controlling oomycete growth with more targeted approaches, and the inhibition of sterol synthesis is one promising area. To better direct these efforts, we have studied sterol acquisition in two model organisms: the sterol-autotrophic Saprolegnia parasitica, and the sterol-heterotrophic Phytophthora infestans. We first present a comprehensive reconstruction of a likely sterol synthesis pathway for S. parasitica, causative agent of the disease saprolegniasis in fish. This pathway shows multiple potential routes of sterol synthesis, and draws on several avenues of new evidence: bioinformatic mining for genes with sterol-related functions, expression analysis of these genes, and analysis of the sterol profiles in mycelium grown in different media. Additionally, we explore the extent to which P. infestans, which causes the late blight in potato, can modify exogenously provided sterols. We consider whether the two very different approaches to sterol acquisition taken by these pathogens represent any specific survival advantages or potential drug targets.	[Dahlin, Paul; Srivastava, Vaibhav; Ekengren, Sophia; Mckee, Lauren S.; Bulone, Vincent] Royal Inst Technol KTH, AlbaNova Univ Ctr, Div Glycosci, Sch Biotechnol, Stockholm, Sweden; [Dahlin, Paul; Ekengren, Sophia] Stockholm Univ, Dept Ecol Environm & Plant Sci, Stockholm, Sweden; [Bulone, Vincent] Univ Adelaide, ARC Ctr Excellence Plant Cell Walls, Waite Campus, Urrbrae, Australia; [Bulone, Vincent] Univ Adelaide, Sch Agr Food & Wine, Waite Campus, Urrbrae, Australia	Royal Institute of Technology; Stockholm University; University of Adelaide; University of Adelaide	Bulone, V (corresponding author), Royal Inst Technol KTH, AlbaNova Univ Ctr, Div Glycosci, Sch Biotechnol, Stockholm, Sweden.; Bulone, V (corresponding author), Univ Adelaide, ARC Ctr Excellence Plant Cell Walls, Waite Campus, Urrbrae, Australia.; Bulone, V (corresponding author), Univ Adelaide, Sch Agr Food & Wine, Waite Campus, Urrbrae, Australia.	bulone@kth.se	Bulone, Vincent/C-8492-2019; Bulone, Vincent/D-7469-2013; McKee, Lauren/A-2782-2013; Srivastava, Vaibhav/H-1320-2015	Bulone, Vincent/0000-0003-2809-4160; McKee, Lauren/0000-0002-3372-8773; Srivastava, Vaibhav/0000-0003-1877-4154	Swedish research Council FORMAS [2013-1427]; Knut and Alice Wallenberg Foundation, via the Wallenberg Wood Science Centre in Sweden	Swedish research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Knut and Alice Wallenberg Foundation, via the Wallenberg Wood Science Centre in Sweden	This work was supported by a grant to VB from the Swedish research Council FORMAS (grant # 2013-1427). The salary of LSM was partly supported by the Knut and Alice Wallenberg Foundation, via the Wallenberg Wood Science Centre in Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe I, 2007, NAT PROD REP, V24, P1311, DOI 10.1039/b616857b; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnqvist L, 2003, PLANT PHYSIOL, V131, P1792, DOI 10.1104/pp.102.018788; Azadmard-Damirchi S, 2006, J CHROMATOGR A, V1108, P183, DOI 10.1016/j.chroma.2006.01.015; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Behmer ST, 2003, ADV INSECT PHYSIOL, V31, P1, DOI 10.1016/S0065-2806(03)31001-X; Benveniste P, 2004, ANNU REV PLANT BIOL, V55, P429, DOI 10.1146/annurev.arplant.55.031903.141616; BERG LR, 1986, EXP MYCOL, V10, P175, DOI 10.1016/0147-5975(86)90001-0; Blein JP, 2002, TRENDS PLANT SCI, V7, P293, DOI 10.1016/S1360-1385(02)02284-7; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CAMPBELL BC, 1983, J INSECT PHYSIOL, V29, P149, DOI 10.1016/0022-1910(83)90138-5; Caspi R, 2014, NUCLEIC ACIDS RES, V42, pD459, DOI 10.1093/nar/gkt1103; Chang A, 2015, NUCLEIC ACIDS RES, V43, pD439, DOI 10.1093/nar/gku1068; Chitwood DJ, 1999, CRIT REV BIOCHEM MOL, V34, P273, DOI 10.1080/10409239991209309; COLE RJ, 1967, EXP PARASITOL, V21, P232, DOI 10.1016/0014-4894(67)90085-9; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dahlin P, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01802; Dufourc Erick J, 2008, J Chem Biol, V1, P63, DOI 10.1007/s12154-008-0010-6; Dutky SR, 1967, NEMATOLOGICA, V91, P369; Fabris M, 2014, NEW PHYTOL, V204, P521, DOI 10.1111/nph.12917; Gaulin E, 2010, PLANT SIGNAL BEHAV, V5, P258, DOI 10.4161/psb.5.3.10551; Gaulin E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001723; Gotz S, 2011, BIOINFORMATICS, V27, P919, DOI 10.1093/bioinformatics/btr059; GOTTLIEB D, 1978, PHYTOPATHOLOGY, V68, P1168, DOI 10.1094/Phyto-68-1168; He JX, 2003, PLANT PHYSIOL, V131, P1258, DOI 10.1104/pp.014605; HENDRIX JW, 1970, ANNU REV PHYTOPATHOL, V8, P111, DOI 10.1146/annurev.py.08.090170.000551; Jiang RHY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003272; Jiang RHY, 2006, MOL BIOL EVOL, V23, P338, DOI 10.1093/molbev/msj039; Kamoun S, 2015, MOL PLANT PATHOL, V16, P413, DOI 10.1111/mpp.12190; KEEN NT, 1975, SCIENCE, V187, P74, DOI 10.1126/science.187.4171.74; Laquitaine L, 2006, MOL PLANT MICROBE IN, V19, P1103, DOI 10.1094/MPMI-19-1103; Lichtenthaler HK, 1997, PHYSIOL PLANTARUM, V101, P643, DOI 10.1111/j.1399-3054.1997.tb01049.x; Lochman J, 2006, PLANT MOL BIOL, V62, P43, DOI 10.1007/s11103-006-9002-5; Lohr M, 2012, PLANT SCI, V185, P9, DOI 10.1016/j.plantsci.2011.07.018; Machlis L, 1953, AM J BOT, V40, P449, DOI 10.2307/2438777; Madoui MA, 2009, NEW PHYTOL, V183, P291, DOI 10.1111/j.1469-8137.2009.02895.x; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Martinez-Prada I, 2015, VITIS, V54, P91; Masse G, 2004, P NATL ACAD SCI USA, V101, P4413, DOI 10.1073/pnas.0400902101; Mikes V, 1998, BIOCHEM BIOPH RES CO, V245, P133, DOI 10.1006/bbrc.1998.8341; Moliner Claire, 2009, BMC Res Notes, V2, P51, DOI 10.1186/1756-0500-2-51; Nes WD, 2011, CHEM REV, V111, P6423, DOI 10.1021/cr200021m; NES WD, 1981, J NAT PROD, V44, P215, DOI 10.1021/np50014a012; NES WD, 1987, ACS SYM SER, V325, P304; Nes WD, 2002, J BIOL CHEM, V277, P42549, DOI 10.1074/jbc.M204223200; NES WD, 1983, P NATL ACAD SCI-BIOL, V80, P3227, DOI 10.1073/pnas.80.11.3227; NES WD, 1986, EXPERIENTIA, V42, P556, DOI 10.1007/BF01946701; Osman H, 2001, FEBS LETT, V489, P55, DOI 10.1016/S0014-5793(01)02078-6; Piironen V, 2000, J SCI FOOD AGR, V80, P939, DOI [10.1002/(SICI)1097-0010(20000515)80:7<939::AID-JSFA644>3.0.CO;2-C, 10.1002/(SICI)1097-0010(20000515)80:7&lt;939::AID-JSFA644&gt;3.0.CO;2-C]; ROTHSTEIN M, 1968, COMP BIOCHEM PHYSIOL, V27, P309, DOI 10.1016/0010-406X(68)90773-1; Schaller H, 2003, PROG LIPID RES, V42, P163, DOI 10.1016/S0163-7827(02)00047-4; Schomburg D. S I, 2006, HDB ENZYMES CLASS 2, P220; Summons RE, 2006, PHILOS T R SOC B, V361, P951, DOI 10.1098/rstb.2006.1837; Tomazic ML, 2011, EUKARYOT CELL, V10, P423, DOI 10.1128/EC.00259-10; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vauthrin S, 1999, BBA-BIOMEMBRANES, V1419, P335, DOI 10.1016/S0005-2736(99)00083-8; Venkatramesh M, 1996, BBA-LIPID LIPID MET, V1299, P313, DOI 10.1016/0005-2760(95)00218-9; WARNER SA, 1982, P NATL ACAD SCI-BIOL, V79, P3769, DOI 10.1073/pnas.79.12.3769; WARNER SA, 1981, EXP MYCOL, V5, P184, DOI 10.1016/0147-5975(81)90021-9; Warrilow AGS, 2014, APPL ENVIRON MICROB, V80, P6154, DOI 10.1128/AEM.01195-14; Waterham HR, 2001, AM J HUM GENET, V69, P685, DOI 10.1086/323473; WOOD SG, 1978, BIOCHEM J, V170, P355, DOI 10.1042/bj1700355; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zhou WX, 2003, ARCH BIOCHEM BIOPHYS, V420, P18, DOI 10.1016/j.abb.2003.08.029; Zuluaga AP, 2016, MOL PLANT PATHOL, V17, P29, DOI 10.1111/mpp.12263	66	17	17	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170873	10.1371/journal.pone.0170873	http://dx.doi.org/10.1371/journal.pone.0170873			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152045	Green Published, gold			2022-12-27	WOS:000396161200053
J	Li, BY; Yang, YM; Liu, Y; Sun, J; Ye, Y; Liu, XN; Liu, HX; Sun, ZQ; Li, M; Cui, J; Sun, DJ; Gao, YH				Li, Bing-Yun; Yang, Yan-Mei; Liu, Yang; Sun, Jing; Ye, Yan; Liu, Xiao-Na; Liu, Hong-Xu; Sun, Zhen-Qi; Li, Mang; Cui, Jing; Sun, Dian-Jun; Gao, Yan-Hui			Prolactin rs1341239 T allele may have protective role against the brick tea type skeletal fluorosis	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; DENTAL FLUOROSIS; RHEUMATOID-ARTHRITIS; IMMUNE-SYSTEM; OSTEOCLAST DIFFERENTIATION; G/T POLYMORPHISM; BONE-FORMATION; RECEPTOR; EXPRESSION; ACTIVATION	Objective Prolactin (PRL) has been reported to be associated with increased bone turnover, and increased bone turnover is also a feature of skeletal fluorosis (SF). Autocrine/paracrine production of PRL is regulated by the extrapituitary promoter and a polymorphism in the extrapituitary PRL promoter at - 1149 (rs1341239) is associated with disturbances of bone metabolism in other diseases. Here, we have investigated the possibility that the rs1341239 polymorphism is associated with SF, which results from the consumption of brick tea. Design We conducted a cross-sectional study in Sinkiang, Qinghai, Inner Mongolia in China. Demography survey questionnaires were completed and physical examination and X-ray diagnoses were used to diagnose SF. Brick tea water fluoride intake (IF) and urinary fluoride (UF) were tested by an F-ion selective electrode method. A Sequenom MassARRAY system was used to determine PRL gene polymorphisms. Results Subjects who were younger than 45 years of age and carried the T allele had a significantly decreased risk of SF [OR = 0.279 (95% CI, 0.094 -0.824)]compared to those carrying the homozygous G allele. This phenomenon was only observed in Kazakh subjects [OR = 0.127 (95% CI, 0.025-0.646)]. Kazakh females who carried T alleles has a decreased risk of SF [OR = 0.410 (95% CI, 0.199-0.847)]. For Kazakh subjects which IF is less than 3.5 mg/d, a decreased risk of SF was observed among the participants who carried T alleles [OR = 0.118 (95% CI, 0.029-0.472)]. Overall, subjects with 1.6-3.2 mg/L UF and carried T alleles had a significantly decreased risk of SF [OR = 0.476 (95% CI, 0.237-0.955)] compared to homozygous G allele carriers. This phenomenon was only observed in Kazakh subjects [OR = 0.324 (95% CI, 0.114-0.923)]. Conclusions Our results suggested that the PRL rs1341239 T allele decreases the risk of brick tea SF.	[Sun, Dian-Jun; Gao, Yan-Hui] Chinese Ctr Dis Control & Prevent, Ctr Endem Dis Control, Key Lab Etiol & Epidemiol, Educ Bur Heilongjiang Prov, Harbin, Heilongjiang Pr, Peoples R China; Minist Hlth 23618504, Harbin, Heilongjiang Pr, Peoples R China	Chinese Center for Disease Control & Prevention	Sun, DJ; Gao, YH (corresponding author), Chinese Ctr Dis Control & Prevent, Ctr Endem Dis Control, Key Lab Etiol & Epidemiol, Educ Bur Heilongjiang Prov, Harbin, Heilongjiang Pr, Peoples R China.	hrbmusdj@163.com; gaoyh411@163.com			National Natural Science Foundation of China [81673110, 81172605]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by National Natural Science Foundation of China (No. 81673110) to Yan-Mei Yang and National Natural Science Foundation of China (No. 81172605) to Yan-Hui Gao. The funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, GBB199652005 MIN HLT; [Anonymous], 2006, WST892006 MIN HLTH P; Aoba T, 2002, CRIT REV ORAL BIOL M, V13, P155, DOI 10.1177/154411130201300206; Ba Y, 2011, BIOL TRACE ELEM RES, V143, P87, DOI 10.1007/s12011-010-8848-1; BatailleSimoneau N, 1996, BIOCHEM BIOPH RES CO, V229, P323, DOI 10.1006/bbrc.1996.1800; BenJonathan N, 1996, ENDOCR REV, V17, P639, DOI 10.1210/er.17.6.639; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cao J, 1997, FOOD CHEM TOXICOL, V35, P827, DOI 10.1016/S0278-6915(97)00049-5; Cao J, 2003, FOOD CHEM TOXICOL, V41, P535, DOI 10.1016/S0278-6915(02)00285-5; Cao Jin, 2003, Wei Sheng Yan Jiu, V32, P141; Clement-Lacroix P, 1999, ENDOCRINOLOGY, V140, P96, DOI 10.1210/en.140.1.96; Coss D, 2000, AM J PHYSIOL-ENDOC M, V279, pE1216, DOI 10.1152/ajpendo.2000.279.6.E1216; CROSS NA, 1995, J BONE MINER RES, V10, P1312; Dawson Deborah V, 2010, J Evid Based Dent Pract, V10, P96, DOI 10.1016/j.jebdp.2010.02.007; Escobar-Garcia D, 2016, COMMUNITY DENT ORAL, V44, P162, DOI 10.1111/cdoe.12201; Everett ET, 2002, J DENT RES, V81, P794, DOI 10.1177/0810794; Fan ZP, 2016, J EPIDEMIOL, V26, P57, DOI 10.2188/jea.JE20150037; Fojtikova M, 2007, ANN RHEUM DIS, V66, P706, DOI 10.1136/ard.2006.061788; Freemark M, 1997, J CLIN INVEST, V99, P1107, DOI 10.1172/JCI119239; GELLERSEN B, 1994, MOL ENDOCRINOL, V8, P356, DOI 10.1210/me.8.3.356; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Huang H, 2008, COMMUNITY DENT ORAL, V36, P517, DOI 10.1111/j.1600-0528.2007.00424.x; Jin C, 2003, ECOTOX ENVIRON SAFE, V56, P222, DOI 10.1016/S0147-6513(03)00065-4; KRISHNAMACHARI KAVR, 1986, PROG FOOD NUTR SCI, V10, P279; Kumar JV, 1998, AM J PUBLIC HEALTH, V88, P1866, DOI 10.2105/AJPH.88.12.1866; Lee YH, 2015, CLIN RHEUMATOL, V34, P683, DOI 10.1007/s10067-015-2904-3; Lee YC, 2009, ARTHRITIS RHEUM, V60, P1250, DOI 10.1002/art.24468; MABELYA L, 1994, COMMUNITY DENT ORAL, V22, P415, DOI 10.1111/j.1600-0528.1994.tb00789.x; Ministry of Health of the People's Republic of China, 2008, 1922008 WST MIN HLTH; Mori G, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/720504; Organization. WH, 2010, FLUORIDE DRINKING WA; PELLEGRINI I, 1992, MOL ENDOCRINOL, V6, P1023, DOI 10.1210/me.6.7.1023; Ray Katrina, 2014, Nat Rev Rheumatol, V10, P382, DOI 10.1038/nrrheum.2014.83; Riddle O, 1933, AM J PHYSIOL, V105, P191, DOI 10.1152/ajplegacy.1933.105.1.191; ROYSTER M, 1995, ENDOCRINOLOGY, V136, P3892, DOI 10.1210/en.136.9.3892; SCHLECHTE JA, 1995, BAILLIERE CLIN ENDOC, V9, P359, DOI 10.1016/S0950-351X(95)80386-6; Seriwatanachai D, 2008, BONE, V42, P535, DOI 10.1016/j.bone.2007.11.008; Sowers MF, 1996, JAMA-J AM MED ASSOC, V276, P549, DOI 10.1001/jama.276.7.549; Stevens A, 2001, ARTHRITIS RHEUM-US, V44, P2358, DOI 10.1002/1529-0131(200110)44:10<2358::AID-ART399>3.0.CO;2-K; [孙殿军 SUN Dian-jun], 2008, [中国地方病学杂志, Chinese Journal of Endemiology], V27, P513; Thomas T, 2010, B ACAD NAT MED PARIS, V194, P1493, DOI 10.1016/S0001-4079(19)32179-X; Tzeng SJ, 1997, MOL REPROD DEV, V48, P45, DOI 10.1002/(SICI)1098-2795(199709)48:1&lt;45::AID-MRD6&gt;3.0.CO;2-P; Velkeniers B, 1998, CELL MOL LIFE SCI, V54, P1102, DOI 10.1007/s000180050239; Vieira APGF, 2005, CALCIFIED TISSUE INT, V76, P17, DOI 10.1007/s00223-004-0075-3; Wang C, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001564; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; Wu J, 2015, BIOMED RES INT, V2015, P1, DOI DOI 10.1371/J0URNAL.P0NE.0128280; Wythe SE, 2014, CALCIFIED TISSUE INT, V94, P98, DOI 10.1007/s00223-013-9764-0	48	7	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171011	10.1371/journal.pone.0171011	http://dx.doi.org/10.1371/journal.pone.0171011			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152004	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161200071
J	Mackin, R; Ben Fadel, N; Feberova, J; Murray, L; Nair, A; Kuehn, S; Barrowman, N; Daboval, T				Mackin, Robin; Ben Fadel, Nadya; Feberova, Jana; Murray, Louise; Nair, Asha; Kuehn, Sally; Barrowman, Nick; Daboval, Thierry			ASQ3 and/or the Bayley-III to support clinicians' decision making	PLOS ONE			English	Article							STAGES QUESTIONNAIRES; PRETERM INFANTS; FOLLOW-UP; BIRTH-WEIGHT; AGES; VALIDITY; CHILDREN; BORN; CARE	Background Appropriate tools are essential to support a clinician's decision to refer very preterm infants to developmental resources. Streamlining the use of developmental assessment or screening tools to make clinical decisions offers an alternative methodology to help to choose the most effective way to assess this very high-risk population. Objective To examine the influence of the Ages and Stages Questionnaire-3rd edition (ASQ3) and the Bayley Scales of Infant Development-3rd edition (Bayley-III) scores within a clinically-based decision-making process. Methods This retrospective cohort study includes children born at less than 29 weeks gestation who had completed both psychologist-administered Bayley-III and physician-observed ASQ3 assessments at 18 months corrected age. Theoretical referral decisions (TRDs) based on each assessment results were formulated, using cut-off scores between the lower first and second standard deviation values and below the lower second standard deviation values. TRDs to refer to developmental resources were evaluated in light of the multidisciplinary team's actual final integrated decisions (FID). Results Complete data was available for 67 children. The ASQ3 and the Bayley-III had similar predictive value for the FID, with comparable kappa values. Comparisons of the physicians' and psychologists' TRDs with the FIDs demonstrated that the ASQ3 in conjunction with the medical and socio-familial findings predicted 93% of referral decisions. Conclusion Taking into consideration potential methodological biases, the results suggest that either ASQ3 or Bayley-III, along with socio-environmental, medical and neurological assessment, are sufficient to guide the majority of clinicians' decisions regarding referral for specialty services. This retrospective study suggests that the physician-supervised ASQ3 may be sufficient to assess children who had been extremely preterm infants for referral purposes. The findings need to be confirmed in a larger, well-designed prospective study to minimize and account for potential sources of bias.	[Mackin, Robin; Ben Fadel, Nadya; Feberova, Jana; Murray, Louise; Nair, Asha; Daboval, Thierry] Univ Ottawa, Ottawa, ON, Canada; [Ben Fadel, Nadya; Feberova, Jana; Murray, Louise; Nair, Asha; Kuehn, Sally; Daboval, Thierry] Childrens Hosp Eastern Ontario, Ottawa Hosp, Dept Obstet & Gynecol, Dept Pediat, Ottawa, ON, Canada; [Barrowman, Nick] Childrens Hosp Eastern Ontario, Clin Res Unit, Res Inst, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; Ottawa Hospital Research Institute; University of Ottawa; Children's Hospital of Eastern Ontario	Daboval, T (corresponding author), Univ Ottawa, Ottawa, ON, Canada.; Daboval, T (corresponding author), Childrens Hosp Eastern Ontario, Ottawa Hosp, Dept Obstet & Gynecol, Dept Pediat, Ottawa, ON, Canada.	tdaboval@cheo.on.ca	Barrowman, Nick/AAL-3166-2020	Barrowman, Nick/0000-0002-4704-9595; Daboval, Thierry/0000-0002-5321-6193	Undergraduate Research Opportunity Program Award (University of Ottawa); Summer Studentship Award (Children's Hospital of Eastern Ontario Research Institute)	Undergraduate Research Opportunity Program Award (University of Ottawa); Summer Studentship Award (Children's Hospital of Eastern Ontario Research Institute)	This work was supported by the Undergraduate Research Opportunity Program Award (University of Ottawa), 2012 Summer Studentship Award (Children's Hospital of Eastern Ontario Research Institute).	Acton BV, 2011, PEDIATRICS, V128, pE794, DOI 10.1542/peds.2011-0331; Bayley N., 2019, BAYLEY SCALES INFANT; Bockli K, 2014, J PERINATOL, V34, P71, DOI 10.1038/jp.2013.136; Byrt T, 1996, EPIDEMIOLOGY, V7, P561, DOI 10.1097/00001648-199609000-00030; Glascoe FP, 2005, MENT RETARD DEV D R, V11, P173, DOI 10.1002/mrdd.20068; Glascoe FP, 2001, ARCH PEDIAT ADOL MED, V155, P54, DOI 10.1001/archpedi.155.1.54; HOLM S, 1979, SCAND J STAT, V6, P65; Jary S, 2013, DEV MED CHILD NEUROL, V55, P1053, DOI 10.1111/dmcn.12208; King TM, 2003, CURR OPIN PEDIATR, V15, P624, DOI 10.1097/00008480-200312000-00014; Lemyre B, 2016, J PERINATOL, V36, P503, DOI 10.1038/jp.2016.81; Ministry of Children and Youth Services, ONT EARL YEARS CTR; Ontario Association for Infant and Child Development, INF DEV PROGR; Orton J, 2009, DEV MED CHILD NEUROL, V51, P851, DOI 10.1111/j.1469-8749.2009.03414.x; Pritchard MA, 2005, J PAEDIATR CHILD H, V41, P191, DOI 10.1111/j.1440-1754.2005.00586.x; R Core Team, R LANG ENV STAT COMP; Schonhaut L, 2013, PEDIATRICS, V131, pE1468, DOI 10.1542/peds.2012-3313; Shoo K Lee, CANADIAN NEONATAL FO; Simard MN, 2012, PEDIATRICS, V130, pE108, DOI 10.1542/peds.2011-3532; Skellern CY, 2001, J PAEDIATR CHILD H, V37, P125, DOI 10.1046/j.1440-1754.2001.00604.x; Spittle A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005495.pub3; Squires J, 1997, J PEDIATR PSYCHOL, V22, P313, DOI 10.1093/jpepsy/22.3.313; Squires J, 2009, AGES STAGES QUESTION; Woodward BJ, 2011, J PERINATOL, V31, P641, DOI 10.1038/jp.2011.1	23	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170171	10.1371/journal.pone.0170171	http://dx.doi.org/10.1371/journal.pone.0170171			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151969	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161200014
J	Park, J; Kwon, YW; Ham, S; Hong, CP; Seo, S; Choe, MK; Shin, SI; Lee, CS; Kim, HS; Roh, TY				Park, Jihwan; Kwon, Yoo-Wook; Ham, Seokjin; Hong, Chang-Pyo; Seo, Seonghye; Choe, Moon Kyung; Shin, So-I; Lee, Choon-Soo; Kim, Hyo-Soo; Roh, Tae-Young			Identification of the early and late responder genes during the generation of induced pluripotent stem cells from mouse fibroblasts	PLOS ONE			English	Article							BREAST-CANCER CELLS; HUMAN SOMATIC-CELLS; HISTONE MODIFICATIONS; CHROMATIN-STRUCTURE; IPS CELLS; EXPRESSION SIGNATURES; IMPRINTED GENES; DEFINED FACTORS; HUMAN GENOME; T-CELLS	Background The generation of induced pluripotent stem cell (iPSC), a substitute for embryonic stem cell (ESC), requires the proper orchestration of a transcription program at the chromatin level. Our recent approach for the induction of pluripotent stem cells from fibroblasts using protein extracts from mouse ESCs could overcome the potential tumorigenicity risks associated with random retroviral integration. Here, we examine the epigenetic modifications and the transcriptome of two types of iPSC and of partially reprogrammed iPSCs (iPSCp) generated independently from adult cardiac and skin fibroblasts to assess any perturbations of the transcription program during reprogramming. Results The comparative dissection of the transcription profiles and histone modification patterns at lysines 4 and 27 of histone H3 of the iPSC, iPSCp, ESC, and somatic cells revealed that the iPSC was almost completely comparable to the ESC, regardless of their origins, whereas the genes of the iPSCp were dysregulated to a larger extent. Regardless of the origins of the somatic cells, the fibroblasts induced using the ESC protein extracts appear to be completely reprogrammed into pluripotent cells, although they show unshared marginal differences in their gene expression programs, which may not affect the maintenance of stemness. A comparative investigation of the iPSCp generated by unwanted reprogramming showed that the two groups of genes on the pathway from somatic cells to iPSC might function as sequential reprogramming-competent early and late responders to the induction stimulus. Moreover, some of the divergent genes expressed only in the iPSCp were associated with many tumor-related pathways. Conclusions Faithful transcriptional reprogramming should follow epigenetic alterations to generate induced pluripotent stem cells from somatic cells. This genome-wide comparison enabled us to define the early and late responder genes during the cell reprogramming process to iPSC. Our results indicate that the cellular responsiveness to external stimuli should be predetermined and sequentially orchestrated through the tight modulation of the chromatin environment during cell reprogramming to prevent unexpected reprogramming.	[Park, Jihwan; Ham, Seokjin; Hong, Chang-Pyo; Seo, Seonghye; Choe, Moon Kyung; Shin, So-I; Roh, Tae-Young] Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, South Korea; [Kwon, Yoo-Wook; Lee, Choon-Soo; Kim, Hyo-Soo] Seoul Natl Univ, Natl Res Lab Stem Cell Niche, Coll Med, Seoul, South Korea; [Kwon, Yoo-Wook; Kim, Hyo-Soo] Seoul Natl Univ Hosp, Innovat Res Inst Cell Therapy, Seoul, South Korea; [Kwon, Yoo-Wook; Kim, Hyo-Soo] Seoul Natl Univ Hosp, Cardiovasc Ctr, Seoul, South Korea; [Kwon, Yoo-Wook; Kim, Hyo-Soo] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Kim, Hyo-Soo] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Kim, Hyo-Soo] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Kim, Hyo-Soo] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Roh, Tae-Young] Pohang Univ Sci & Technol POSTECH, Div Integrat Biosci & Biotechnol, Pohang, South Korea	Pohang University of Science & Technology (POSTECH); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Pohang University of Science & Technology (POSTECH)	Roh, TY (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, South Korea.; Roh, TY (corresponding author), Pohang Univ Sci & Technol POSTECH, Div Integrat Biosci & Biotechnol, Pohang, South Korea.	tyroh@postech.edu	Hong, Chang Pyo/AGR-6554-2022; Ham, SeokJin/A-2948-2012; Hong, Chang Pyo/I-6813-2019	Ham, SeokJin/0000-0002-6950-2848; Roh, Tae-Young/0000-0001-5833-0844	National Research Foundation of Korea [NRF-2015M3A9B4051044, 2011-0030049, NRF-2014M3C9A3064548]; BK21 PLUS fellowship program - Ministry of Education, Korea [10Z20130012243]	National Research Foundation of Korea(National Research Foundation of Korea); BK21 PLUS fellowship program - Ministry of Education, Korea	This work was supported by grants from the National Research Foundation of Korea (NRF-2015M3A9B4051044, 2011-0030049, and NRF-2014M3C9A3064548 to TYR) and BK21 PLUS fellowship program funded by the Ministry of Education, Korea (10Z20130012243 to JP, SH, and SIS).	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Araki Y, 2009, IMMUNITY, V30, P912, DOI 10.1016/j.immuni.2009.05.006; Bae Jae-Bum, 2013, Genomics & Informatics, V11, P7, DOI 10.5808/GI.2013.11.1.7; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Chen JK, 2011, CELL RES, V21, P205, DOI 10.1038/cr.2010.172; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Cho HJ, 2010, BLOOD, V116, P386, DOI 10.1182/blood-2010-02-269589; Choe MK, 2012, BIOCHEM BIOPH RES CO, V418, P475, DOI 10.1016/j.bbrc.2012.01.042; Christodoulou C, 2011, J CLIN INVEST, V121, P2313, DOI 10.1172/JCI43853; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hong Chang Pyo, 2012, Genomics & Informatics, V10, P145, DOI 10.5808/GI.2012.10.3.145; Jin J, 2011, J PROTEOME RES, V10, P977, DOI 10.1021/pr100624f; Kang L, 2011, CELL RES, V21, P546, DOI 10.1038/cr.2010.164; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mattout A, 2011, J MOL CELL BIOL, V3, P341, DOI 10.1093/jmcb/mjr028; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Yavartanoo Maryam, 2013, Genomics & Informatics, V11, P2, DOI 10.5808/GI.2013.11.1.2; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	52	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171300	10.1371/journal.pone.0171300	http://dx.doi.org/10.1371/journal.pone.0171300			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152015	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200123
J	Pitcher, B; Khoja, L; Hamilton, RJ; Abdallah, K; Pintilie, M; Joshua, AM				Pitcher, Bethany; Khoja, Leila; Hamilton, Robert J.; Abdallah, Kald; Pintilie, Melania; Joshua, Anthony M.			Assessment of a prognostic model, PSA metrics and toxicities in metastatic castrate resistant prostate cancer using data from Project Data Sphere (PDS)	PLOS ONE			English	Article							NEUTROPHIL-LYMPHOCYTE RATIO; POPULATION-BASED COHORT; DOWN-REGULATION; SURVIVAL; METFORMIN; CHEMOTHERAPY; TRIALS; CELLS; NOMOGRAM; WARFARIN	Background Prognostic models in metastatic castrate resistant prostate cancer (mCRPC) may have clinical utility. Using data from PDS, we aimed to 1) validate a contemporary prognostic model (Templeton et al., 2014) 2) evaluate prognostic impact of concomitant medications and PSA decrease 3) evaluate factors associated with docetaxel toxicity. Methods We accessed data on 2,449 mCRPC patients in PDS. The existing model was validated with a continuous risk score, time-dependent receiver operating characteristic (ROC) curves, and corresponding time-dependent Area under the Curve (tAUC). The prognostic effects of concomitant medications and PSA response were assessed by Cox proportional hazards models. One year tAUC was calculated for multivariable prognostic model optimized to our data. Conditional logistic regression models were used to assess associations with grade 3/4 adverse events (G3/4 AE) at baseline and after cycle 1 of treatment. Results Despite limitations of the PDS data set, the existing model was validated; one year AUC, was 0.68 (95% CI 95% CI,.66 to.71) to 0.78 (95% CI,.74 to.81) depending on the subset of datasets used. A new model was constructed with an AUC of .74 (.72 to .77). Concomitant medications low molecular weight heparin and warfarin were associated with poorer survival, Metformin and Cox2 inhibitors were associated with better outcome. PSA response was associated with survival, the effect of which was greatest early in follow-up. Age was associated with baseline risk of G3/4 AE. The odds of experiencing G3/4 AE later on in treatment were significantly greater for subjects who experienced a G3/4 AE in their first cycle (OR 3.53, 95% CI 2.53-4.91, p<.0001). Conclusion Despite heterogeneous data collection protocols, PDS provides access to large datasets for novel outcomes analysis. In this paper, we demonstrate its utility for validating existing models and novel model generation including the utility of concomitant medications in outcome analyses, as well as the effect of PSA response on survival and toxicity prediction.	[Pitcher, Bethany; Pintilie, Melania] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Biostat, Toronto, ON, Canada; [Khoja, Leila; Joshua, Anthony M.] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Med Oncol, Toronto, ON, Canada; [Hamilton, Robert J.] Univ Hlth Network, Dept Urol Oncol, Toronto, ON, Canada; [Abdallah, Kald] Project Data Sphere LLC, Cary, NC USA; [Joshua, Anthony M.] St Vincents Hosp, Kinghorn Canc Ctr, Dept Med Oncol, Sydney, NSW, Australia	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; St Vincents Hospital Sydney	Joshua, AM (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Dept Med Oncol, Toronto, ON, Canada.	Anthony.joshua@svha.org.au		Khoja, Leila/0000-0002-9111-3080; Joshua, Anthony/0000-0001-5159-4580	Princess Margaret Cancer Foundation Hold'em for Life Prostate Cancer Research Fund; Stanley Tessis Research Fund	Princess Margaret Cancer Foundation Hold'em for Life Prostate Cancer Research Fund; Stanley Tessis Research Fund	Work presented in this manuscript was supported by the Princess Margaret Cancer Foundation Hold'em for Life Prostate Cancer Research Fund and Stanley Tessis Research Fund. LK is an employee of Astrazeneca plc. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen PC, 2015, CURR OPIN UROL, V25, P232, DOI 10.1097/MOU.0000000000000157; Armstrong AJ, 2007, CLIN CANCER RES, V13, P6396, DOI 10.1158/1078-0432.CCR-07-1036; Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Bieniek J, 2014, PROSTATE, V74, P999, DOI 10.1002/pros.22815; Bishoff JT, 2014, J UROLOGY, V192, P409, DOI 10.1016/j.juro.2014.02.003; Briganti A, 2015, UROL ONCOL-SEMIN ORI, V33, DOI 10.1016/j.urolonc.2014.11.018; Demir U, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-52; Earle CC, 2008, J CLIN ONCOL, V26, P3860, DOI 10.1200/JCO.2007.15.8253; Francini E, 2014, TUMOR BIOL, V35, P10601, DOI 10.1007/s13277-014-2559-8; Halabi S, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.5002; Halabi S, 2014, J CLIN ONCOL, V32, P671, DOI 10.1200/JCO.2013.52.3696; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Inoue D, 2015, JPN J CLIN ONCOL, V45, P61, DOI 10.1093/jjco/hyu159; James ND, 2012, LANCET ONCOL, V13, P549, DOI 10.1016/S1470-2045(12)70088-8; Jendrossek V, 2013, CANCER LETT, V332, P313, DOI 10.1016/j.canlet.2011.01.012; Kato H, 2015, BIOCHEM BIOPH RES CO, V461, P115, DOI 10.1016/j.bbrc.2015.03.178; Knezevic D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-690; Kumar R, 2015, BRIT J CANCER, V112, P1157, DOI 10.1038/bjc.2015.67; Loubiere C, 2015, ONCOTARGET, V6, P15652, DOI 10.18632/oncotarget.3404; Manzano JGM, 2014, J CLIN ONCOL, V32, P3527, DOI 10.1200/JCO.2014.55.3131; O'Rorke MA, 2015, CANCER CAUSE CONTROL, V26, P355, DOI 10.1007/s10552-014-0511-2; Omlin A, 2013, EUR UROL, V64, P300, DOI 10.1016/j.eururo.2012.12.029; Park JC, 2015, CLIN GENITOURIN CANC, V13, P32, DOI 10.1016/j.clgc.2014.04.008; Patrikidou A, 2014, PROSTATE CANCER P D, V17, P348, DOI 10.1038/pcan.2014.35; Rothermundt C, 2014, EUR UROL, V66, P468, DOI 10.1016/j.eururo.2013.12.057; Seah JA, 2015, CLIN GENITOURIN CANC, DOI [10.1016/j.clgc.2014.04.008, DOI 10.1016/J.CLGC.2014.04.008]; Smaletz O, 2002, J CLIN ONCOL, V20, P3972, DOI 10.1200/JCO.2002.11.021; Sonpavde G, 2014, CLIN GENITOURIN CANC, V12, P317, DOI 10.1016/j.clgc.2014.03.005; Stopsack KH, 2016, WORLD J UROL; Tagalakis V, 2013, CANCER CAUSE CONTROL, V24, P1079, DOI 10.1007/s10552-013-0185-1; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Templeton AJ, 2014, CANCER-AM CANCER SOC, V120, P3346, DOI 10.1002/cncr.28890; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242	33	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170544	10.1371/journal.pone.0170544	http://dx.doi.org/10.1371/journal.pone.0170544			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151974	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161200026
J	Rodi, GC; Loreto, V; Tria, F				Rodi, Giovanna Chiara; Loreto, Vittorio; Tria, Francesca			Search strategies of Wikipedia readers	PLOS ONE			English	Article								The quest for information is one of the most common activity of human beings. Despite the the impressive progress of search engines, not to miss the needed piece of information could be still very tough, as well as to acquire specific competences and knowledge by shaping and following the proper learning paths. Indeed, the need to find sensible paths in information networks is one of the biggest challenges of our societies and, to effectively address it, it is important to investigate the strategies adopted by human users to cope with the cognitive bottleneck of finding their way in a growing sea of information. Here we focus on the case of Wikipedia and investigate a recently released dataset about users' click on the English Wikipedia, namely the English Wikipedia Clickstream. We perform a semantically charged analysis to uncover the general patterns followed by information seekers in the multi-dimensional space of Wikipedia topics/categories. We discover the existence of well defined strategies in which users tend to start from very general, i.e., semantically broad, pages and progressively narrow down the scope of their navigation, while keeping a growing semantic coherence. This is unlike strategies associated to tasks with predefined search goals, namely the case of the Wikispeedia game. In this case users first move from the 'particular' to the 'universal' before focusing down again to the required target. The clear picture offered here represents a very important stepping stone towards a better design of information networks and recommendation strategies, as well as the construction of radically new learning paths.	[Rodi, Giovanna Chiara] Polytech Univ Turin, Dept Math Sci, Turin, Italy; [Rodi, Giovanna Chiara; Loreto, Vittorio; Tria, Francesca] ISI Fdn, Turin, Italy; [Loreto, Vittorio; Tria, Francesca] Sapienza Univ Rome, Dept Phys, Rome, Italy	Polytechnic University of Turin; Sapienza University Rome	Rodi, GC (corresponding author), Polytech Univ Turin, Dept Math Sci, Turin, Italy.; Rodi, GC (corresponding author), ISI Fdn, Turin, Italy.	giovannachiara.rodi@polito.it		Rodi, Giovanna Chiara/0000-0003-3661-9334	KREYON project - John Templeton Foundation [51663]	KREYON project - John Templeton Foundation	The authors acknowledge support from the KREYON project funded by the John Templeton Foundation under contract n. 51663. The sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Foerde K, 2006, P NATL ACAD SCI USA, V103, P11778, DOI 10.1073/pnas.0602659103; Giedd JN, 2012, J ADOLESCENT HEALTH, V51, P101, DOI 10.1016/j.jadohealth.2012.06.002; Gwizdka J, 2010, J AM SOC INF SCI TEC, V61, P2167, DOI 10.1002/asi.21385; Just MA, 2008, BRAIN RES, V1205, P70, DOI 10.1016/j.brainres.2007.12.075; Kittur A, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1509; Lamprecht D, 2015, ICWSM WORKSH, P64; Levitin D.J., 2014, ORG MIND THINKING ST; Mastroianni P, 2016, PROCEEDINGS OF THE 1ST INTERNATIONAL CONFERENCE ON COMPLEX INFORMATION SYSTEMS (COMPLEXIS), P81, DOI 10.5220/000590700081; Navarro-Prieto R, 1999, PROCEEDINGS OF THE 5; Novikoff TP, 2012, P NATL ACAD SCI USA, V109, P1868, DOI 10.1073/pnas.1109863109; Ratkiewicz J., 2010, Proceedings of the 2010 IEEE Second International Conference on Social Computing (SocialCom 2010). the Second IEEE International Conference on Privacy, Security, Risk and Trust (PASSAT 2010), P393, DOI 10.1109/SocialCom.2010.63; Rodi GC, 2015, SCI REP-UK, V5, DOI 10.1038/srep10286; Schweizer TA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00053; Singer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102070; Suchecki K, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525912500683; West R., 2012, WWW, P619, DOI DOI 10.1145/2187836.2187920; West R, 2009, 21ST INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-09), PROCEEDINGS, P1598; Wulczyn E, 2015, WIKIPEDIA CLICKSTREA	18	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170746	10.1371/journal.pone.0170746	http://dx.doi.org/10.1371/journal.pone.0170746			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152030	Green Published, gold			2022-12-27	WOS:000396161200040
J	Martin-Espinosa, N; Diez-Fernandez, A; Sanchez-Lopez, M; Rivero-Merino, I; Lucas-De La Cruz, L; Solera-Martinez, M; Martinez-Vizcaino, V				Martin-Espinosa, Noelia; Diez-Fernandez, Ana; Sanchez-Lopez, Mairena; Rivero-Merino, Irene; Lucas-De La Cruz, Lidia; Solera-Martinez, Montserrat; Martinez-Vizcaino, Vicente		Movi-Kids Grp	Prevalence of high blood pressure and association with obesity in Spanish schoolchildren aged 4-6 years old	PLOS ONE			English	Article							BODY-MASS INDEX; WAIST CIRCUMFERENCE; CARDIOVASCULAR-DISEASE; SECULAR TRENDS; PULSE PRESSURE; RISK-FACTORS; US CHILDREN; ADOLESCENTS; OVERWEIGHT; ADIPOSITY	Background The prevalence of high blood pressure in children is increasing worldwide, largely, but not entirely, driven by the concurrent childhood obesity epidemic. The aims of this study were to examine the prevalence of prehypertension and hypertension in 4-to-6-year-old Spanish schoolchildren, and to evaluate the association between different blood pressure (BP) components with different adiposity indicators. Methods Cross-sectional study including a sample of 1.604 schoolchildren aged 4-to-6-years belonging to 21 schools from the provinces of Ciudad Real and Cuenca, Spain. We measured height, weight, body mass index (BMI), fat mass percentage (%FM), triceps skinfold thickness (TST), waist circumference (WC), systolic and diastolic BP, mean arterial pressure and pulse pressure. Results The estimates of prevalence of prehypertension and hypertension were 12.3% and 18.2%, respectively. In both sexes, adiposity indicators were positively and significantly associated with all BP components (p< 0.001), thus schoolchildren in the higher adiposity categories had significantly higher BP levels (p< 0.001). Conclusions Our results show a high prevalence of high blood pressure in Spanish children. Moreover, high levels of adiposity are associated with high blood pressure in early childhood, which support that it could be related to cardiovascular risk later in life.	[Martin-Espinosa, Noelia] Univ Castilla La Mancha, Fac Nursing, Toledo, Spain; [Diez-Fernandez, Ana; Sanchez-Lopez, Mairena; Lucas-De La Cruz, Lidia; Solera-Martinez, Montserrat; Martinez-Vizcaino, Vicente] Univ Castilla La Mancha, Hlth & Social Res Ctr, Cuenca, Spain; [Diez-Fernandez, Ana; Lucas-De La Cruz, Lidia; Solera-Martinez, Montserrat] Univ Castilla La Mancha, Fac Nursing, Cuenca, Spain; [Sanchez-Lopez, Mairena] Univ Castilla La Mancha, Fac Educ, Ciudad Real, Spain; [Rivero-Merino, Irene] Hosp Gen Univ, Ciudad Real, Spain; [Martinez-Vizcaino, Vicente] Univ Autonoma Chile, Fac Ciencias Salud, Talca, Chile	Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Universidad Autonoma de Chile	Martinez-Vizcaino, V (corresponding author), Univ Castilla La Mancha, Hlth & Social Res Ctr, Cuenca, Spain.; Martinez-Vizcaino, V (corresponding author), Univ Autonoma Chile, Fac Ciencias Salud, Talca, Chile.	Vicente.Martinez@uclm.es	Diez-Fernandez, Ana/Z-3348-2019; SANCHEZ-LOPEZ, MAIRENA/J-7933-2016; mota, jorge/B-2980-2013; Suárez Gómez, María/GOH-3088-2022; VIZCAINO, VICENTE MARTINEZ/R-4336-2017; Notario Pacheco, Blanca/G-2583-2016; Arias Palencia, Natalia Maria/Q-5070-2017	Diez-Fernandez, Ana/0000-0002-7673-986X; mota, jorge/0000-0001-7571-9181; Suárez Gómez, María/0000-0002-4806-106X; VIZCAINO, VICENTE MARTINEZ/0000-0001-6121-7893; Notario Pacheco, Blanca/0000-0001-8406-6952; Alvarez-Bueno, Celia/0000-0002-6176-1618; Martin Espinosa, Noelia Maria/0000-0002-1298-6976; Sanchez Lopez, Mairena/0000-0002-0217-0623; Arias Palencia, Natalia Maria/0000-0001-5004-3197; Cerrillo Urbina, Alberto Jose/0000-0001-5854-069X	Ministry of Economy and Competitiveness Carlos III Health Institute and FEDER funds [FIS PI12/02400, FIS PI12/00761]; Research Network on Preventative Activities and Health Promotion [RD12/ 0005/0009]	Ministry of Economy and Competitiveness Carlos III Health Institute and FEDER funds; Research Network on Preventative Activities and Health Promotion	This study was funded by the Ministry of Economy and Competitiveness Carlos III Health Institute and FEDER funds (FIS PI12/02400 and FIS PI12/00761). Additional funding was obtained from the Research Network on Preventative Activities and Health Promotion (Ref. - RD12/ 0005/0009).	Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; Aguirrea CJ, 2012, ATEN PRIM, V44, P16; Almas A, 2011, AM J HYPERTENS, V24, P876, DOI 10.1038/ajh.2011.67; [Anonymous], 1995, AN ESP PEDIATR, V43, P11; Crispim PAA, 2014, ARQ BRAS CARDIOL, V102, P39, DOI 10.5935/abc.20130227; BAO WH, 1995, AM J HYPERTENS, V8, P657, DOI 10.1016/0895-7061(95)00116-7; Chandramohan G, 2012, J AM SOC HYPERTENS, V6, P277, DOI 10.1016/j.jash.2012.05.002; Chen B, 2011, ASIA PAC J CLIN NUTR, V20, P557; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; Chiolero A, 2007, J HUM HYPERTENS, V21, P120, DOI 10.1038/sj.jhh.1002125; Chiolero A, 2009, CIRCULATION, V119, P558, DOI 10.1161/CIRCULATIONAHA.108.796276; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; de Hoog MLA, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-136; Din-Dzietham R, 2007, CIRCULATION, V116, P1488, DOI 10.1161/CIRCULATIONAHA.106.683243; Drozdz D, 2009, PEDIATR NEPHROL, V24, P1735, DOI 10.1007/s00467-009-1207-9; Eisenmann JC, 2005, J HUM HYPERTENS, V19, P675, DOI 10.1038/sj.jhh.1001882; Falkner B, 2006, J PEDIATR-US, V148, P195, DOI 10.1016/j.jpeds.2005.10.030; Flores-Huerta S, 2009, ARCH MED RES, V40, P208, DOI 10.1016/j.arcmed.2009.02.009; Franklin SS, 2009, CIRCULATION, V119, P243, DOI 10.1161/CIRCULATIONAHA.108.797936; Freedman DS, 2012, PEDIATRICS, V130, pE159, DOI 10.1542/peds.2011-3302; Freedman DS, 2009, AM J CLIN NUTR, V90, P210, DOI 10.3945/ajcn.2009.27525; Garcia AG, 2015, NUTR HOSP, V32, P1476, DOI 10.3305/nh.2015.32.4.9508; Jimenez EG, 2011, NUTR HOSP, V26, P1004, DOI [10.3305/nh.2011.26.5.5003, 10.1590/S0212-16112011000500013]; Gopinath B, 2011, ANN EPIDEMIOL, V21, P351, DOI 10.1016/j.annepidem.2011.02.002; Kelishadi R, 2006, EUR J CARDIOV PREV R, V13, P956, DOI 10.1097/01.hjr.0000219109.17791.b6; Lo JC, 2013, PEDIATRICS, V131, pE415, DOI 10.1542/peds.2012-1292; Serrano MDM, 2013, REV ESP CARDIOL, V66, P110, DOI [10.1016/j.recesp.2012.08.007, 10.1016/j.rec.2012.08.007]; Martin S, 2005, CLIN INVEST ARTERIOS, V17, P112; Martinez-Vizcaino V, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1512-0; Martinez-Vizcaino V, 2012, PUBLIC HEALTH NUTR, V15, P2170, DOI 10.1017/S1368980012003473; McNiece KL, 2007, J PEDIATR-US, V150, P640, DOI 10.1016/j.jpeds.2007.01.052; Miqueleiz E, 2014, EUR J CLIN NUTR, V68, P209, DOI 10.1038/ejcn.2013.255; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Ostrowska-Nawarycz L, 2007, KARDIOL POL, V65, P1079; Perez-Farinos N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/163687; Peters H, 2012, J HYPERTENS, V30, P1708, DOI 10.1097/HJH.0b013e3283562a6b; Plachta-Danielzik S, 2008, BRIT J NUTR, V100, P208, DOI 10.1017/S0007114508882980; Rademacher ER, 2009, J HYPERTENS, V27, P1766, DOI 10.1097/HJH.0b013e32832e8cfa; Raj M, 2007, NATL MED J INDIA, V20, P288; Safar ME, 2001, CURR OPIN NEPHROL HY, V10, P257, DOI 10.1097/00041552-200103000-00015; Salvadori M, 2008, PEDIATRICS, V122, pE821, DOI 10.1542/peds.2008-0951; Sorof JM, 2004, PEDIATRICS, V113, P475, DOI 10.1542/peds.113.3.475; Xi B, 2016, AM J HYPERTENS, V29, P217, DOI 10.1093/ajh/hpv091; Yang QH, 2012, PEDIATRICS, V130, P611, DOI 10.1542/peds.2011-3870; Zachariah JP, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000725	45	17	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170926	10.1371/journal.pone.0170926	http://dx.doi.org/10.1371/journal.pone.0170926			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141860	Green Published, gold			2022-12-27	WOS:000396129500026
J	Mokgatle, MM; Madiba, S				Mokgatle, Mathildah Mpata; Madiba, Sphiwe			High Acceptability of HIV Self-Testing among Technical Vocational Education and Training College Students in Gauteng and North West Province: What Are the Implications for the Scale Up in South Africa?	PLOS ONE			English	Article								Background Although HIV self-testing (HIVST) is globally accepted as an important complement to existing HIV testing approaches, South Africa has lagged behind in its adoption. As a result, data on the acceptability and uptake of HIVST testing is limited. The study investigated the acceptability of HIVST among students in Technical Vocational Education and Training (TVET) colleges in two provinces in South Africa. Methods A cross-sectional survey using a self-administered structured questionnaire was used to collect data among 3,662 students recruited from 13 TVET colleges. Results The mean age of the students was 21.9 years. The majority (80.9%) were sexually active; while 66.1% reported that they had one sexual partner, and 33.9% had two or more sexual partners in the past year, and66.5% used condoms during the last sexual act. Three-quarters tested for HIV in the past year but less than half knew about HIVST prior to the survey. The acceptability of HIVST was high; about three-quarters showed a willingness to purchase a self-test kit and a majority would self-test with partners. Acceptability of HIVST was associated with being sexually active (OR = 1.73, p = 0.02, confidence interval (CI): 1.08- 2.75), having ever been tested for HIV (OR = 1.74, p = 0.001, CI: 1.26-2.38), and having multiple sexual partners (OR = 0.61, p = 0.01, CI: 0.42-0.88). Three-quarters would confirm test results at a local health facility. In terms of counselling, telephone hotlines were acceptable to only 39.9%, and less than half felt that test-kit leaflets would provide sufficient information to self-test. Interpretations The high acceptability of HIVST among the students calls for extensive planning and preparation for the scaling up of HIVST in South Africa. In addition, campaigns similar to those conducted to promote HIV counselling and testing (HCT) should be considered to educate communities about HIVST.	[Mokgatle, Mathildah Mpata] Sefako Makgatho Hlth Sci Univ, Sch Publ Hlth, Dept Biostat, Ga Rankuwa, South Africa; [Madiba, Sphiwe] Sefako Makgatho Hlth Sci Univ, Sch Publ Hlth, Dept Environm & Occupat Hlth, Ga Rankuwa, South Africa	Sefako Makgatho Health Sciences University; Sefako Makgatho Health Sciences University	Mokgatle, MM (corresponding author), Sefako Makgatho Hlth Sci Univ, Sch Publ Hlth, Dept Biostat, Ga Rankuwa, South Africa.	mathilda_mokgatle@embanet.com	Mokgatle, Mathildah Mpata/GQH-2926-2022; Madiba, Sphiwe/ABC-5750-2020	Mokgatle, Mathildah Mpata/0000-0001-5807-8212; Madiba, Sphiwe/0000-0002-3735-1248	University of Limpopo;  [MREC/H/46/2014: IR]	University of Limpopo; 	This work was supported by University of Limpopo; MREC/H/46/2014: IR.	Abiodun Olumide, 2014, BMC Res Notes, V7, P639, DOI 10.1186/1756-0500-7-639; Angotti N, 2009, SOC SCI MED, V68, P2263, DOI 10.1016/j.socscimed.2009.02.041; Asante KO, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-17; Brown AN, 2014, AIDS BEHAV, V18, pS445, DOI 10.1007/s10461-014-0831-y; Choko AT, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001873; Choko AT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001102; Cosser M., 2011, FURTHER ED TRAINING; Djibuti M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1760-z; Estem KS, 2016, CURR HIV-AIDS REP, V13, P107, DOI 10.1007/s11904-016-0307-y; Figueroa C, 2015, AIDS BEHAV, V19, P1949, DOI 10.1007/s10461-015-1097-8; Gardner J, 2012, S AFR J BIOETH LAW, V5, P15; Kalibala S, 2014, AIDS BEHAV, V18, pS405, DOI 10.1007/s10461-014-0830-z; Krause J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-735; Kumwenda M, 2014, AIDS BEHAV, V18, pS396, DOI 10.1007/s10461-014-0817-9; Leon N, 2010, SAMJ S AFR MED J, V100, P220, DOI 10.7196/SAMJ.4043; Madiba S, 2015, WORLD J AIDS, V5, P208; Madiba S, 2015, BMC PUBLIC HEALTH, V15, P1; Makusha T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122783; Mavedzenge SN, 2013, CLIN INFECT DIS, V57, P126, DOI 10.1093/cid/cit156; Myers JE, 2013, AIDS, V27, P1687, DOI 10.1097/QAD.0b013e32835fd7a0; Ng OT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045168; Pai N, 2014, AIDS RES TREATMENT, V2014; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Perez GM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152653; Powell L, 2014, 7 EXPLORING VALUE CA, P126; Prazuck T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146755; Richter ML, 2012, S AFR J HIV MED, P186, DOI 10.7196/SAJHIVMED.858; SANAC, 2011, HIV AIDS STI NAT STR; Smith J., 2009, THESIS ROWAN U; Tsegay G, 2013, BMC PUBLIC HLTH, V13, P1; van Dyk AC, 2013, AJAR-AFR J AIDS RES, V12, P41, DOI 10.2989/16085906.2013.815413; van Rooyen H, 2015, J INT AIDS SOC, V18; WHO, 2015, CONSOLIDATED GUIDELI	33	35	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0169765	10.1371/journal.pone.0169765	http://dx.doi.org/10.1371/journal.pone.0169765			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141858	gold, Green Published, Green Submitted			2022-12-27	WOS:000396129500005
J	Belay, E; Hayes, BJ; Blau, CA; Torok-Storb, B				Belay, Eyayu; Hayes, Brian J.; Blau, C. Anthony; Torok-Storb, Beverly			Human Cord Blood and Bone Marrow CD34+Cells Generate Macrophages That Support Erythroid Islands	PLOS ONE			English	Article							ERYTHROBLASTIC ISLANDS; DEFINITIVE ERYTHROPOIESIS; FUNCTIONAL-CHARACTERIZATION; PERIPHERAL-BLOOD; PROTEIN EMP; CELLS; PROLIFERATION; EXPRESSION; ENUCLEATION; HOMEOSTASIS	Recently, we developed a small molecule responsive hyperactive Mpl-based Cell Growth Switch (CGS) that drives erythropoiesis associated with macrophages in the absence of exogenous cytokines. Here, we compare the physical, cellular and molecular interaction between the macrophages and erythroid cells in CGS expanded CD34+ cells harvested from cord blood, marrow or G-CSF-mobilized peripheral blood. Results indicated that macrophage based erythroid islands could be generated from cord blood and marrow CD34+ cells but not from G-CSF-mobilized CD34+ cells. Additional studies suggest that the deficiency resides with the G-CSF-mobilized CD34+ derived monocytes. Gene expression and proteomics studies of the in vitro generated erythroid islands detected the expression of erythroblast macrophage protein (EMP), intercellular adhesion molecule 4 (ICAM-4), CD163 and DNASE2. 78% of the erythroblasts in contact with macrophages reached the pre reticulocyte orthochromatic stage of differentiation within 14 days of culture. The addition of conditioned medium from cultures of CD146+ marrow fibroblasts resulted in a 700-fold increase in total cell number and a 90-fold increase in erythroid cell number. This novel CD34+ cell derived erythroid island may serve as a platform to explore the molecular basis of red cell maturation and production under normal, stress and pathological conditions.	[Belay, Eyayu; Hayes, Brian J.; Torok-Storb, Beverly] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Blau, C. Anthony] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA; [Blau, C. Anthony] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Belay, E (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	ebelay@fhcrc.org		Hayes, Brian J/0000-0002-0930-0160	National Institutes of Health [P30 DK56465, U01 HL099993, UO1 HL099993]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK106829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health grants P30 DK56465, U01 HL099993, B.T.S and Supplement for E. Belay NHLBI / U01 HL099993.; This work was supported by the National Institutes of Health grants P30 DK56465, UO1 HL099993, B.T.S and Supplement for E. Belay NHLBI / U01 HL099993	ALLEN TD, 1982, DIFFERENTIATION, V21, P86, DOI 10.1111/j.1432-0436.1982.tb01201.x; Belay E, 2015, BLOOD, V125, P1025, DOI 10.1182/blood-2014-02-555318; Bessis M, 1958, REV HEMATOLOGIE, V13; Blau CA, 1997, P NATL ACAD SCI USA, V94, P3076, DOI 10.1073/pnas.94.7.3076; Chasis JA, 2008, BLOOD, V112, P470, DOI 10.1182/blood-2008-03-077883; Chasis JA, 2006, CURR OPIN HEMATOL, V13, P137, DOI 10.1097/01.moh.0000219657.57915.30; Choi HS, 2013, STEM CELL RES, V10, P442, DOI 10.1016/j.scr.2013.02.003; Chow A, 2013, NAT MED, V19, P429, DOI 10.1038/nm.3057; de Back DZ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00009; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Eymard N, 2015, J MATH BIOL, V70, P71, DOI 10.1007/s00285-014-0758-y; Fabriek BO, 2007, BLOOD, V109, P5223, DOI 10.1182/blood-2006-08-036467; Fischer S, 2012, J THEOR BIOL, V298, P92, DOI 10.1016/j.jtbi.2012.01.002; Giarratana MC, 2011, BLOOD, V118, P5071, DOI 10.1182/blood-2011-06-362038; Graf L, 2001, BIOL BLOOD MARROW TR, V7, P486, DOI 10.1053/bbmt.2001.v7.pm11669215; HANSPAL M, 1994, BLOOD, V84, P3494; Hanspal M, 1998, BLOOD, V92, P2940, DOI 10.1182/blood.V92.8.2940.420k31_2940_2950; Hu JP, 2013, BLOOD, V121, P3246, DOI 10.1182/blood-2013-01-476390; Iwata M, 2014, STEM CELLS DEV, V23, P729, DOI 10.1089/scd.2013.0300; Jacobsen RN, 2014, EXP HEMATOL, V42, P547, DOI 10.1016/j.exphem.2014.03.009; Kalfa TA, 2011, BLOOD, V117, P748, DOI 10.1182/blood-2010-11-316448; Manwani D, 2008, CURR TOP DEV BIOL, V82, P23, DOI 10.1016/S0070-2153(07)00002-6; McGrath KE, 2008, BLOOD, V111, P2409, DOI 10.1182/blood-2007-08-107581; Migliaccio G, 2010, CELL TRANSPLANT, V19, P453, DOI 10.3727/096368909X485049; Miharada K, 2006, NAT BIOTECHNOL, V24, P1255, DOI 10.1038/nbt1245; Mohandas N, 2010, TRANSFUS CLIN BIOL, V17, P110, DOI 10.1016/j.tracli.2010.05.009; Palis J, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00003; Pishesha N, 2014, P NATL ACAD SCI USA, V111, P4103, DOI 10.1073/pnas.1401598111; Porcu S, 2011, MOL CELL BIOL, V31, P4144, DOI 10.1128/MCB.05532-11; Ramos P, 2013, NAT MED, V19, P437, DOI 10.1038/nm.3126; Rhodes MM, 2008, BLOOD, V111, P1700, DOI 10.1182/blood-2007-06-098178; Ribeil JA, 2013, THESCIENTIFICWORLDJO, V2013, DOI [10.1155/2013/394295, DOI 10.1155/2013/394295PMID:23606813]; ROECKLEIN BA, 1995, BLOOD, V85, P997, DOI 10.1182/blood.V85.4.997.bloodjournal854997; Soni S, 2008, BLOOD CELL MOL DIS, V41, P141, DOI 10.1016/j.bcmd.2008.03.008; Soni S, 2006, J BIOL CHEM, V281, P20181, DOI 10.1074/jbc.M603226200; Spring FA, 2001, BLOOD, V98, P458, DOI 10.1182/blood.V98.2.458; Toda S, 2014, BLOOD, V123, P3963, DOI 10.1182/blood-2014-01-547976; Tordjman R, 2001, BLOOD, V97, P1968, DOI 10.1182/blood.V97.7.1968; Xue L, 2014, DEVELOPMENT, V141, P2245, DOI 10.1242/dev.103960; Zhang DL, 2011, BLOOD, V118, P2868, DOI 10.1182/blood-2011-01-330241	40	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171096	10.1371/journal.pone.0171096	http://dx.doi.org/10.1371/journal.pone.0171096			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135323	Green Submitted, gold, Green Published			2022-12-27	WOS:000396124700049
J	Kuusk, S; Sorlie, M; Valjamae, P				Kuusk, Silja; Sorlie, Morten; Valjamae, Priit			Human Chitotriosidase Is an Endo-Processive Enzyme	PLOS ONE			English	Article							HUMAN MACROPHAGE CHITINASE; SERRATIA-MARCESCENS 2170; SUBSTRATE DEGRADATION; ASPERGILLUS-FUMIGATUS; BETA-GLUCOSIDASES; PRODUCT BINDING; HYDROLYSIS; RESOLUTION; PURIFICATION; EXPRESSION	Human chitotriosidase (HCHT) is involved in immune response to chitin-containing pathogens in humans. The enzyme is able to degrade chitooligosaccharides as well as crystalline chitin. The catalytic domain of HCHT is connected to the carbohydrate binding module (CBM) through a flexible hinge region. In humans, two active isoforms of HCHT are found-the full length enzyme and its truncated version lacking CBM and the hinge region. The active site architecture of HCHT is reminiscent to that of the reducing-end exo-acting processive chitinase ChiA from bacterium Serratia marcescens (SmChiA). However, the presence of flexible hinge region and occurrence of two active isoforms are reminiscent to that of non-processive endo-chitinase from S. marcescens, SmChiC. Although the studies on soluble chitin derivatives suggest the endo-character of HCHT, the mode of action of the enzyme on crystalline chitin is not known. Here, we made a thorough characterization of HCHT in terms of the mode of action, processivity, binding, and rate constants for the catalysis and dissociation using a-chitin as substrate. HCHT efficiently released the end-label from reducing-end labelled chitin and had also high probability (95%) of endo-mode initiation of processive run. These results qualify HCHT as an endo-processive enzyme. Processivity and the rate constant of dissociation of HCHT were found to be in-between those, characteristic to processive exo-enzymes, like SmChiA and randomly acting non-processive endoenzymes, like SmChiC. Apart from increasing the affinity for chitin, CBM had no major effect on kinetic properties of HCHT.	[Kuusk, Silja; Valjamae, Priit] Univ Tartu, Inst Mol & Cell Biol, Tartu, Estonia; [Sorlie, Morten] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway	University of Tartu; Norwegian University of Life Sciences	Kuusk, S (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Tartu, Estonia.	silja.kuusk@ut.ee	Väljamäe, Priit/O-6468-2018	Väljamäe, Priit/0000-0002-1035-9493	Norwegian Financial Mechanism [EMP171]; Estonian Research Council [PUT1024]; Norwegian Research Council [221576]	Norwegian Financial Mechanism; Estonian Research Council(Estonian Research Council); Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was funded by the Norwegian Financial Mechanism, grant EMP171. PV and SK were supported by the Estonian Research Council, grant PUT1024. MS was supported by Norwegian Research Council, grant 221576.	Aguilera B, 2003, J BIOL CHEM, V278, P40911, DOI 10.1074/jbc.M301804200; Artieda M, 2007, CARDIOLOGY, V108, P297, DOI 10.1159/000099099; Baban J, 2010, J PHYS CHEM B, V114, P6144, DOI 10.1021/jp909801x; Bansal P, 2009, BIOTECHNOL ADV, V27, P833, DOI 10.1016/j.biotechadv.2009.06.005; Bargagli E, 2007, RESPIRATION, V74, P548, DOI 10.1159/000100555; Bohlin C, 2013, APPL MICROBIOL BIOT, V97, P159, DOI 10.1007/s00253-012-3875-9; BOOT RG, 1995, J BIOL CHEM, V270, P26252, DOI 10.1074/jbc.270.44.26252; Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Brurberg MB, 1996, MICROBIOL-SGM, V142, P1581, DOI 10.1099/13500872-142-7-1581; Bu LT, 2012, J BIOL CHEM, V287, P24807, DOI 10.1074/jbc.M112.365510; Cruys-Bagger N, 2016, J PHYS CHEM B, V120, P5591, DOI 10.1021/acs.jpcb.6b01877; Di Rosa M, 2016, IMMUNOBIOLOGY, V221, P399, DOI 10.1016/j.imbio.2015.11.014; Di Rosa M, 2014, BONE, V61, P55, DOI 10.1016/j.bone.2014.01.005; Eide KB, 2016, BBA-PROTEINS PROTEOM, V1864, P242, DOI 10.1016/j.bbapap.2015.11.007; Eide KB, 2013, FEBS LETT, V587, P3508, DOI 10.1016/j.febslet.2013.09.004; Eide KB, 2013, THERMOCHIM ACTA, V565, P146, DOI 10.1016/j.tca.2013.04.022; Eide KB, 2012, BIOCHEMISTRY-US, V51, P487, DOI 10.1021/bi2015585; Elmonem Mohamed A, 2016, Enzyme Res, V2016, P2682680, DOI 10.1155/2016/2682680; Fadel F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154190; Fusetti F, 2002, J BIOL CHEM, V277, P25537, DOI 10.1074/jbc.M201636200; GARDNER KH, 1975, BIOPOLYMERS, V14, P1581, DOI 10.1002/bip.1975.360140804; Gavala ML, 2013, CLIN EXP ALLERGY, V43, P187, DOI 10.1111/cea.12032; Hamre AG, 2014, FEBS LETT, V588, P4620, DOI 10.1016/j.febslet.2014.10.034; HOLLAK CEM, 1994, J CLIN INVEST, V93, P1288, DOI 10.1172/JCI117084; Horn SJ, 2004, CARBOHYD POLYM, V56, P35, DOI 10.1016/j.carbpol.2003.11.011; Horn SJ, 2012, METHOD ENZYMOL, V510, P69, DOI 10.1016/B978-0-12-415931-0.00005-7; Hult EL, 2005, BIOCHEM J, V388, P851, DOI 10.1042/BJ20050090; Igarashi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4975; Iyer A, 2009, CLIN IMMUNOL, V131, P501, DOI 10.1016/j.clim.2009.02.003; Jalak J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108181; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Kleywegt GJ, 1997, J MOL BIOL, V272, P383, DOI 10.1006/jmbi.1997.1243; Knott BC, 2014, J AM CHEM SOC, V136, P8810, DOI 10.1021/ja504074g; Koch BEV, 2015, GLYCOBIOLOGY, V25, P469, DOI 10.1093/glycob/cwv005; Kont R, 2016, J BIOL CHEM, V291, P26013, DOI 10.1074/jbc.M116.756007; Kurasin M, 2015, J BIOL CHEM, V290, P29074, DOI 10.1074/jbc.M115.684977; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Kuusk S, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-016-0690-z; Kuusk S, 2015, J BIOL CHEM, V290, P11678, DOI 10.1074/jbc.M114.635631; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Malaguarnera L, 2006, GUT, V55, P1313, DOI 10.1136/gut.2005.075697; MINKE R, 1978, J MOL BIOL, V120, P167, DOI 10.1016/0022-2836(78)90063-3; Moroz OV, 2015, ACTA CRYSTALLOGR F, V71, P114, DOI 10.1107/S2053230X14027307; Nutt A, 1998, EUR J BIOCHEM, V258, P200, DOI 10.1046/j.1432-1327.1998.2580200.x; Overdijk B, 1996, GLYCOBIOLOGY, V6, P627, DOI 10.1093/glycob/6.6.627; Payne CM, 2013, J AM CHEM SOC, V135, P18831, DOI 10.1021/ja407287f; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; RENKEMA GH, 1995, J BIOL CHEM, V270, P2198, DOI 10.1074/jbc.270.5.2198; Renkema GH, 1997, EUR J BIOCHEM, V244, P279, DOI 10.1111/j.1432-1033.1997.00279.x; Sawant S, 2016, J MOL CATAL B-ENZYM, V133, P161, DOI 10.1016/j.molcatb.2016.08.010; Stahlberg J, 1996, J MOL BIOL, V264, P337, DOI 10.1006/jmbi.1996.0644; Stockinger LW, 2015, BBA-PROTEINS PROTEOM, V1854, P1494, DOI 10.1016/j.bbapap.2015.06.008; Synstad B, 2008, BIOSCI BIOTECH BIOCH, V72, P715, DOI 10.1271/bbb.70594; Tjoelker LW, 2000, J BIOL CHEM, V275, P514, DOI 10.1074/jbc.275.1.514; Uchiyama T, 2013, J BIOL CHEM, V288, P18325, DOI 10.1074/jbc.M113.471342; Ujita M, 2003, BIOSCI BIOTECH BIOCH, V67, P2402, DOI 10.1271/bbb.67.2402; Vaaje-Kolstad G, 2013, FEBS J, V280, P3028, DOI 10.1111/febs.12181; van Aalten DMF, 2000, P NATL ACAD SCI USA, V97, P5842, DOI 10.1073/pnas.97.11.5842; van Eijk M, 2005, INT IMMUNOL, V17, P1505, DOI 10.1093/intimm/dxh328; Velleste R, 2010, CELLULOSE, V17, P125, DOI 10.1007/s10570-009-9356-3; Watanabe T, 1997, J BACTERIOL, V179, P7111, DOI 10.1128/jb.179.22.7111-7117.1997; Yang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep17296	62	10	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0171042	10.1371/journal.pone.0171042	http://dx.doi.org/10.1371/journal.pone.0171042			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129403	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000396211400009
J	O'Farrell, AC; Evans, R; Silvola, JMU; Miller, IS; Conroy, E; Hector, S; Cary, M; Murray, DW; Jarzabek, MA; Maratha, A; Alamanou, M; Udupi, GM; Shiels, L; Pallaud, C; Saraste, A; Liljenback, H; Jauhiainen, M; Oikonen, V; Ducret, A; Cutler, P; McAuliffe, FM; Rousseau, JA; Lecomte, R; Gascon, S; Arany, Z; Ky, B; Force, T; Knuuti, J; Gallagher, WM; Roivainen, A; Byrne, AT				O'Farrell, Alice C.; Evans, Rhys; Silvola, Johanna M. U.; Miller, Ian S.; Conroy, Emer; Hector, Suzanne; Cary, Maurice; Murray, David W.; Jarzabek, Monika A.; Maratha, Ashwini; Alamanou, Marina; Udupi, Girish Mallya; Shiels, Liam; Pallaud, Celine; Saraste, Antti; Liljenback, Heidi; Jauhiainen, Matti; Oikonen, Vesa; Ducret, Axel; Cutler, Paul; McAuliffe, Fionnuala M.; Rousseau, Jacques A.; Lecomte, Roger; Gascon, Suzanne; Arany, Zoltan; Ky, Bonnie; Force, Thomas; Knuuti, Juhani; Gallagher, William M.; Roivainen, Anne; Byrne, Annette T.			A Novel Positron Emission Tomography (PET) Approach to Monitor Cardiac Metabolic Pathway Remodeling in Response to Sunitinib Malate	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; ENDOTHELIAL GROWTH-FACTOR; IN-VIVO; MYOCARDIAL-METABOLISM; BLOOD-PRESSURE; CARDIOTOXICITY; HEART; CARDIOMYOCYTES; CANCER; MITOCHONDRIA	Sunitinib is a tyrosine kinase inhibitor approved for the treatment of multiple solid tumors. However, cardiotoxicity is of increasing concern, with a need to develop rational mechanism driven approaches for the early detection of cardiac dysfunction. We sought to interrogate changes in cardiac energy substrate usage during sunitinib treatment, hypothesising that these changes could represent a strategy for the early detection of cardiotoxicity. Balb/CJ mice or Sprague-Dawley rats were treated orally for 4 weeks with 40 or 20 mg/kg/day sunitinib. Cardiac positron emission tomography (PET) was implemented to investigate alterations in myocardial glucose and oxidative metabolism. Following treatment, blood pressure increased, and left ventricular ejection fraction decreased. Cardiac [F-18]-fluorodeoxyglucose (FDG)-PET revealed increased glucose uptake after 48 hours. [C-11] Acetate-PET showed decreased myocardial perfusion following treatment. Electron microscopy revealed significant lipid accumulation in the myocardium. Proteomic analyses indicated that oxidative metabolism, fatty acid beta-oxidation and mitochondrial dysfunction were among the top myocardial signalling pathways perturbed. Sunitinib treatment results in an increased reliance on glycolysis, increased myocardial lipid deposition and perturbed mitochondrial function, indicative of a fundamental energy crisis resulting in compromised myocardial energy metabolism and function. Our findings suggest that a cardiac PET strategy may represent a rational approach to non-invasively monitor metabolic pathway remodeling following sunitinib treatment.	[O'Farrell, Alice C.; Evans, Rhys; Hector, Suzanne; Alamanou, Marina; Saraste, Antti; Oikonen, Vesa; Byrne, Annette T.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin, Ireland; [Silvola, Johanna M. U.; Murray, David W.; Cutler, Paul; McAuliffe, Fionnuala M.] Turku Univ Hosp, Turku PET Ctr, Turku, Finland; [Silvola, Johanna M. U.; Hector, Suzanne; Jarzabek, Monika A.; Shiels, Liam; Jauhiainen, Matti; Cutler, Paul] Abo Akad Univ, Turku, Finland; [Miller, Ian S.; Murray, David W.; Maratha, Ashwini; Saraste, Antti; Liljenback, Heidi] Univ Coll Dublin, UCD Conway Inst, UCD Sch Biomol & Biomed Sci, Dublin, Ireland; [Miller, Ian S.; Cary, Maurice; Shiels, Liam; Liljenback, Heidi] Roche Innovat Ctr Basel, F Hoffman Roche, Basel, Switzerland; [Conroy, Emer; Jarzabek, Monika A.] Pathol Experts GmbH, Basel, Switzerland; [Cary, Maurice; Maratha, Ashwini; Ky, Bonnie; Force, Thomas; Knuuti, Juhani] Oncomark Ltd, Dublin, Ireland; [Cary, Maurice; Cutler, Paul; Ky, Bonnie; Knuuti, Juhani] Heart Ctr Turku Univ Hosp, Turku, Finland; [Silvola, Johanna M. U.; Maratha, Ashwini] Natl Inst Hlth & Welf, Publ Hlth Genom Unit, Helsinki, Finland; [Conroy, Emer; Shiels, Liam] Univ Coll, Sch Med, UCD Obstet & Gynaecol, Dublin, Ireland; [Conroy, Emer; Shiels, Liam; Pallaud, Celine; Rousseau, Jacques A.] Univ Sherbrooke, Quebec City, PQ, Canada; [Hector, Suzanne; McAuliffe, Fionnuala M.] Hosp Univ Penn, Dept Med, Philadelphia, PA USA; [Hector, Suzanne] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Conroy, Emer; Murray, David W.; Arany, Zoltan; Gallagher, William M.] Univ Turku, Turku Ctr Dis Modeling, Turku, Finland	Royal College of Surgeons - Ireland; University of Turku; Abo Akademi University; University College Dublin; Roche Holding; Finland National Institute for Health & Welfare; University College Dublin; University of Sherbrooke; University of Pennsylvania; Pennsylvania Medicine; Vanderbilt University; University of Turku	Byrne, AT (corresponding author), Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin, Ireland.	annettebyrne@rcsi.ie	Knuuti, Juhani/AAA-7472-2019; Conroy, Emer/T-2878-2019	Knuuti, Juhani/0000-0003-3156-9593; Jarzabek, Monika/0000-0001-7008-4797; Miller, Ian/0000-0003-2118-6345; Oikonen, Vesa/0000-0002-1947-0219; Conroy, Emer/0000-0002-6158-229X; Byrne, Annette/0000-0003-0287-8899; O'Farrell, Alice C/0000-0002-6732-2966; Roivainen, Anne/0000-0002-4006-7977; Gallagher, William/0000-0002-4307-5999; Liljenback, Heidi/0000-0001-9372-1584	AngioTox; European Commission FP7 Industry Academia Pathways; Partnerships Marie Curie Award [251528]; British Association of Cancer Research; Oncomark Ltd; Pathology Experts GmBH; Roche Innovation Center Basel; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119234, R01HL133290] Funding Source: NIH RePORTER	AngioTox; European Commission FP7 Industry Academia Pathways; Partnerships Marie Curie Award; British Association of Cancer Research; Oncomark Ltd; Pathology Experts GmBH; Roche Innovation Center Basel; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by AngioTox [www.angiotox.com], a European Commission FP7 Industry Academia Pathways and Partnerships Marie Curie Award (Grant Agreement 251528). Oncomark Ltd, Pathology Experts GmBH and Roche Innovation Center Basel are partner organizations within AngioTox and thus received funding towards salaries and consumables supporting this work. The specific roles of industry co-authors are described in the 'author contributions' section. ACOF received a Travel Fellowship of 2000 pound from the British Association of Cancer Research for travel costs incurred whilst undertaking work at the Turku PET Center, Turku, Finland.	Azizi M, 2008, NEW ENGL J MED, V358, P95, DOI 10.1056/NEJMc072330; Bello CL, 2009, CLIN CANCER RES, V15, P7045, DOI 10.1158/1078-0432.CCR-09-1521; Berardi R, 2013, CRIT REV ONCOL HEMAT, V88, P75, DOI 10.1016/j.critrevonc.2013.02.007; Blasi E, 2012, CARDIOVASC THER, V30, P287, DOI 10.1111/j.1755-5922.2011.00278.x; Bordun KA, 2015, AM J PHYSIOL-HEART C, V309, pH692, DOI 10.1152/ajpheart.00172.2015; Bry M, 2010, CIRCULATION, V122, P1725, DOI 10.1161/CIRCULATIONAHA.110.957332; Chintalgattu V, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005066; Chu TF, 2007, LANCET, V370, P2011, DOI 10.1016/S0140-6736(07)61865-0; Clinicaltrials.gov, 2014, LIST RES SEARCH SUN; Doherty KR, 2013, TOXICOL APPL PHARM, V272, P245, DOI 10.1016/j.taap.2013.04.027; Ewer MS, 2008, J CLIN ONCOL, V26, P1201, DOI 10.1200/JCO.2007.14.8742; Ewer MS, 2014, EUR J CANCER, V50, P2162, DOI 10.1016/j.ejca.2014.05.013; [FDA www.FDA.gov], 2013, SUT MED GUID; Force T, 2011, NAT REV DRUG DISCOV, V10, P111, DOI 10.1038/nrd3252; French KJ, 2010, TOXICOL PATHOL, V38, P691, DOI 10.1177/0192623310373775; Greineder CF, 2011, CURR HYPERTENS REP, V13, P436, DOI 10.1007/s11906-011-0225-8; Hahn VS, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000665; Harvey PA, 2015, CARDIOVASC RES, V107, P66, DOI 10.1093/cvr/cvv152; Hasinoff BB, 2008, MOL PHARMACOL, V74, P1722, DOI 10.1124/mol.108.050104; Heather LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026326; Hundley WG, 2011, HEMONC TODAY; Ibrahim EM, 2013, INT J CLIN ONCOL, V18, P1060, DOI 10.1007/s10147-012-0497-2; Kappers MHW, 2010, HYPERTENSION, V56, P675, DOI 10.1161/HYPERTENSIONAHA.109.149690; Kerkela R, 2009, CTS-CLIN TRANSL SCI, V2, P15, DOI 10.1111/j.1752-8062.2008.00090.x; Kolwicz SC, 2013, CIRC RES, V113, P603, DOI 10.1161/CIRCRESAHA.113.302095; Ky B, 2013, CIRC RES, V113, P754, DOI 10.1161/CIRCRESAHA.113.300218; McFalls EO, 2002, AM J PHYSIOL-HEART C, V282, pH205, DOI 10.1152/ajpheart.2002.282.1.H205; Mellor HR, 2011, TOXICOL SCI, V120, P14, DOI 10.1093/toxsci/kfq378; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Mookadam F, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00259; Morissette P, 2015, J PHARM TOXICOL METH; Nakamaru-Ogiso E, 2010, FEBS LETT, V584, P883, DOI 10.1016/j.febslet.2010.01.004; Naya M, 2014, CURR CARDIOVASC IMAG, V7, DOI 10.1007/s12410-013-9244-y; Peterson LR, 2010, CIRC-CARDIOVASC IMAG, V3, P211, DOI 10.1161/CIRCIMAGING.109.860593; Pfizer, 2013, HIGHL PRESCR INF; Prisco D, 2014, INTERN EMERG MED, V9, P359, DOI 10.1007/s11739-014-1064-9; Rana P, 2012, TOXICOL SCI, V130, P117, DOI 10.1093/toxsci/kfs233; Rees ML, 2015, BIOCHEM BIOPH RES CO, V459, P430, DOI 10.1016/j.bbrc.2015.02.122; Stortecky S, 2010, CURR OPIN ONCOL, V22, P312, DOI 10.1097/CCO.0b013e32833ab6f1; Szczepaniak LS, 2003, MAGN RESON MED, V49, P417, DOI 10.1002/mrm.10372; Timmer SAJ, 2013, EUR HEART J-CARD IMG, V14, P95, DOI 10.1093/ehjci/jes242; Toubert ME, 2011, THYROID, V21, P451, DOI 10.1089/thy.2010.0270; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Will Y, 2008, TOXICOL SCI, V106, P153, DOI 10.1093/toxsci/kfn157; Witteles RM, 2012, J CLIN ONCOL, V30, P1916, DOI 10.1200/JCO.2011.40.4012; Zhong M, 2013, J NUCL MED, V54, P609, DOI 10.2967/jnumed.112.108092	47	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0169964	10.1371/journal.pone.0169964	http://dx.doi.org/10.1371/journal.pone.0169964			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129334	Green Submitted, Green Published, gold			2022-12-27	WOS:000396211400067
J	Shah, RD; Xue, CY; Zhang, HR; Tuteja, S; Li, MY; Reilly, MP; Ferguson, JF				Shah, Rachana D.; Xue, Chenyi; Zhang, Hanrui; Tuteja, Sony; Li, Mingyao; Reilly, Muredach P.; Ferguson, Jane F.			Expression of Calgranulin Genes S100A8, S100A9 and S100A12 Is Modulated by n-3 PUFA during Inflammation in Adipose Tissue and Mononuclear Cells	PLOS ONE			English	Article							CALCIUM-BINDING PROTEINS; TRADITIONAL RISK-FACTORS; RNA-SEQ; EVOKED INFLAMMATION; INSULIN-RESISTANCE; INNATE IMMUNITY; FATTY-ACIDS; COMPLEX; BLOOD; SUPPLEMENTATION	Calgranulin genes (S100A8, S100A9 and S100A12) play key immune response roles in inflammatory disorders, including cardiovascular disease. Long-chain omega-3 polyunsaturated fatty acids (LC n-3 PUFA) may have systemic and adipose tissue-specific anti-inflammatory and cardio-protective action. Interactions between calgranulins and the unsaturated fatty acid arachidonic acid (AA) have been reported, yet little is known about the relationship between calgranulins and the LC n-3 PUFA eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). We explored tissue-specific action of calgranulins in the setting of evoked endotoxemia and n-3 PUFA supplementation. Expression of calgranulins in adipose tissue in vivo was assessed by RNA sequencing (RNASeq) before and after n-3 PUFA supplementation and evoked endotoxemia in the fenofibrate and omega-3 fatty acid modulation of endotoxemia (FFAME) Study. Subjects received n-3 PUFA (n = 8; 3600mg/day EPA/DHA) or matched placebo (n = 6) for 6-8 weeks, before completing an endotoxin challenge (LPS 0.6 ng/kg). Calgranulin genes were up-regulated post-LPS, with greater increase in n-3 PUFA (S100A8 15-fold, p = 0.003; S100A9 7-fold, p = 0.003; S100A12 28-fold, p = 0.01) compared to placebo (S100A8 2-fold, p = 0.01; S100A9 1.4-fold, p = 0.4; S100A12 5-fold, p = 0.06). In an independent evoked endotoxemia study, calgranulin gene expression correlated with the systemic inflammatory response. Through in vivo and in vitro interrogation we highlight differential responses in adipocytes and mononuclear cells during inflammation, with n-3 PUFA leading to increased calgranulin expression in adipose, but decreased expression in circulating cells. In conclusion, we present a novel relationship between n-3 PUFA anti-inflammatory action in vivo and cell-specific modulation of calgranulin expression during innate immune activation.	[Shah, Rachana D.] Childrens Hosp Philadelphia, Div Pediat Endocrinol, Philadelphia, PA USA; [Xue, Chenyi; Zhang, Hanrui; Tuteja, Sony; Reilly, Muredach P.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Xue, Chenyi; Zhang, Hanrui; Reilly, Muredach P.] Columbia Univ, Dept Med, New York, NY USA; [Li, Mingyao] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Ferguson, Jane F.] Vanderbilt Univ, Med Ctr, Div Cardiovasc Med, Nashville, TN 37235 USA; [Ferguson, Jane F.] Vanderbilt Univ, Med Ctr, Vanderbilt Translat & Clin Cardiovasc Res Ctr VTR, Nashville, TN 37235 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Columbia University; University of Pennsylvania; Vanderbilt University; Vanderbilt University	Ferguson, JF (corresponding author), Vanderbilt Univ, Med Ctr, Div Cardiovasc Med, Nashville, TN 37235 USA.	jane.f.ferguson@vanderbilt.edu	Ferguson, Jane/C-7154-2011	Ferguson, Jane/0000-0001-6896-1025; Shah, Rachana/0000-0001-7866-557X; Tuteja, Sony/0000-0001-7007-3289; Reilly, Muredach/0000-0002-3035-9386; Zhang, Hanrui/0000-0001-8655-938X	National Institutes of Health (NIH) [UL1RR024134, P20-DK 019525]; NIH-NHLBI SCCOR Project [P50-HL-083799]; Penn Genomes Frontiers Institute; Postdoctoral Fellowship from the American Heart Association [12POST11840017]; American Heart Association Scientist Development Grant [15SDG24890015]; American Heart Association Postdoctoral Fellowship [15POST25620017];  [K23-DK095913];  [R01-HL-111694];  [R01-HL-113147];  [R01-DK-090505];  [U01-HL-108636];  [K24-HL-107643]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113147, K99HL130574] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NHLBI SCCOR Project; Penn Genomes Frontiers Institute; Postdoctoral Fellowship from the American Heart Association; American Heart Association Scientist Development Grant(American Heart Association); American Heart Association Postdoctoral Fellowship(American Heart Association); ; ; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The project described was supported by the National Institutes of Health (NIH) through Grant UL1RR024134 and P20-DK 019525 (both to the University of Pennsylvania) as well as a NIH-NHLBI SCCOR Project grant (P50-HL-083799) and a pilot grant from Penn Genomes Frontiers Institute to MPR. JFF was supported by a Postdoctoral Fellowship from the American Heart Association (12POST11840017), and is supported by an American Heart Association Scientist Development Grant (15SDG24890015). HZ is supported by the American Heart Association Postdoctoral Fellowship 15POST25620017. RS is supported by K23-DK095913. MPR is also supported by R01-HL-111694, R01-HL-113147, R01-DK-090505, U01-HL-108636 and K24-HL-107643. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. GlaxoSmithKline provided Lovaza and matching placebo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PD, 2007, J CLIN ENDOCR METAB, V92, P2272, DOI 10.1210/jc.2006-2545; Asghari H, 2016, INT J BIOL MACROMOL, V84, P35, DOI 10.1016/j.ijbiomac.2015.11.065; Averill MM, 2012, ARTERIOSCL THROM VAS, V32, P223, DOI 10.1161/ATVBAHA.111.236927; Averill MM, 2011, CIRCULATION, V123, P1216, DOI 10.1161/CIRCULATIONAHA.110.985523; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Cotoi OS, 2014, ARTERIOSCL THROM VAS, V34, P202, DOI 10.1161/ATVBAHA.113.302432; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; EDGEWORTH J, 1991, J BIOL CHEM, V266, P7706; Eue I, 2001, ATHEROSCLEROSIS, V154, P505, DOI 10.1016/S0021-9150(00)00678-X; Farkas G, 2014, PANCREAS, V43, P485, DOI 10.1097/MPA.0000000000000046; Ferguson JF, 2016, J NUTR BIOCHEM, V30, P126, DOI 10.1016/j.jnutbio.2015.12.010; Ferguson JF, 2014, MOL NUTR FOOD RES, V58, P601, DOI 10.1002/mnfr.201300368; Ferguson JF, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-63; Ferguson JF, 2012, J AM COLL CARDIOL, V59, P764, DOI 10.1016/j.jacc.2011.11.019; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Hiroshima Y, 2014, J IMMUNOL, V192, P2800, DOI 10.4049/jimmunol.1302556; Hsu K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103629; Hunter MJ, 1998, J BIOL CHEM, V273, P12427, DOI 10.1074/jbc.273.20.12427; Kerkhoff C, 2012, EXP DERMATOL, V21, P822, DOI 10.1111/j.1600-0625.2012.01571.x; Korndorfer IP, 2007, J MOL BIOL, V370, P887, DOI 10.1016/j.jmb.2007.04.065; Lim SY, 2009, J LEUKOCYTE BIOL, V86, P577, DOI 10.1189/jlb.1008608; Liu Y, 2014, ARTERIOSCLEROSIS THR; Liu YC, 2014, ARTERIOSCL THROM VAS, V34, P902, DOI 10.1161/ATVBAHA.113.303123; Liu YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066883; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; McGillicuddy FC, 2009, J BIOL CHEM, V284, P31936, DOI 10.1074/jbc.M109.061655; Miranda LP, 2001, FEBS LETT, V488, P85, DOI 10.1016/S0014-5793(00)02392-9; Montagnana M, 2014, CLIN BIOCHEM, V47, P996, DOI 10.1016/j.clinbiochem.2014.02.021; Morine MJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002223; Moroz OV, 2009, J MOL BIOL, V391, P536, DOI 10.1016/j.jmb.2009.06.004; Nagareddy PR, 2014, CELL METAB, V19, P821, DOI 10.1016/j.cmet.2014.03.029; Nagareddy PR, 2013, CELL METAB, V17, P695, DOI 10.1016/j.cmet.2013.04.001; Ortega FJ, 2013, J MOL MED, V91, P523, DOI 10.1007/s00109-012-0979-8; Pruenster M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7915; Roulin K, 1999, EXP CELL RES, V247, P410, DOI 10.1006/excr.1998.4382; Schiopu A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/828354; Sekimoto R, 2015, P NATL ACAD SCI USA, V112, pE2058, DOI 10.1073/pnas.1409480112; Shah R, 2011, DIABETES, V60, P1512, DOI 10.2337/db10-0956; Shah R, 2009, DIABETES, V58, P2211, DOI 10.2337/db09-0256; Siegenthaler G, 1997, J BIOL CHEM, V272, P9371; Simard JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072138; Wang J, 2015, FASEB J, V29, P250, DOI 10.1096/fj.14-255992; Yamaoka M, 2013, BIOCHEM BIOPH RES CO, V433, P450, DOI 10.1016/j.bbrc.2013.02.096; Zackular JP, 2015, J BIOL CHEM; Zhang H, 2015, CIRCULATION RES; Zhao P, 2013, J INVEST MED, V61, P861, DOI 10.2310/JIM.0b013e318292fb1e	48	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0169614	10.1371/journal.pone.0169614	http://dx.doi.org/10.1371/journal.pone.0169614			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125622	Green Published, Green Submitted, gold			2022-12-27	WOS:000396176100136
J	Sun, GY; Larsen, CN; Baumgarth, N; Klem, EB; Scheuermann, RH				Sun, Guangyu; Larsen, Christopher N.; Baumgarth, Nicole; Klem, Edward B.; Scheuermann, Richard H.			Comprehensive Annotation of Mature Peptides and Genotypes for Zika Virus	PLOS ONE			English	Article							HEPATITIS-C VIRUS; CLEAVAGE; CLASSIFICATION; INHIBITORS; PROTEASE	The rapid spread of Zika virus (ZIKV) has caused much concern in the global health community, due in part to a link to fetal microcephaly and other neurological illnesses. While an increasing amount of ZIKV genomic sequence data is being generated, an understanding of the virus molecular biology is still greatly lacking. A significant step towards establishing ZIKV proteomics would be the compilation of all proteins produced by the virus, and the resultant virus genotypes. Here we report for the first time such data, using new computational methods for the annotation of mature peptide proteins, genotypes, and recombination events for all ZIKV genomes.	[Sun, Guangyu; Larsen, Christopher N.] Vecna Technol Inc, Greenbelt, MD 20770 USA; [Baumgarth, Nicole] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Baumgarth, Nicole] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Klem, Edward B.] Northrop Grumman Hlth Solut, Rockville, MD USA; [Scheuermann, Richard H.] J Craig Venter Inst, La Jolla, CA USA; [Scheuermann, Richard H.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Scheuermann, Richard H.] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; J. Craig Venter Institute; University of California System; University of California San Diego; La Jolla Institute for Immunology	Larsen, CN (corresponding author), Vecna Technol Inc, Greenbelt, MD 20770 USA.	clarsen@vecna.com	Baumgarth, Nicole/AAI-6949-2020	Larsen, Christopher N/0000-0002-1051-5767	National Institute of Allergy and Infectious Diseases (NIAID) as part of the National Institutes of Health (NIH); USA Department of Health and Human Services (DHHS) [HHSN272201400028C]	National Institute of Allergy and Infectious Diseases (NIAID) as part of the National Institutes of Health (NIH); USA Department of Health and Human Services (DHHS)	This project is funded by the National Institute of Allergy and Infectious Diseases (NIAID) as part of the National Institutes of Health (NIH), USA Department of Health and Human Services (DHHS), under Contract No. HHSN272201400028C and is a collaboration between Northrop Grumman Health IT (Prime), J. Craig Venter Institute (RHS - PI), and Vecna Technologies, Inc. (GS, CNL). NB is a Co-PI. Vecna is an independent privately held woman owned small business, subcontracting along with the J. Craig Venter Institute to the Northrop Grumman corporation under this contracted funding vehicle. The funder provided support in the form of salary support for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Addis SNK, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0375-4; [Anonymous], 2016, CDC DIV VECT BORN DI; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Elshuber S, 2005, J VIROL, V79, P11813, DOI 10.1128/JVI.79.18.11813-11823.2005; Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9; Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636; Hraber P, 2008, J GEN VIROL, V89, P2098, DOI 10.1099/vir.0.83657-0; Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z; Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065; Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419; Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9; SCHECHTER I, 1968, BIOCHEM BIOPH RES CO, V32, P898, DOI 10.1016/0006-291X(68)90326-4; Shiryaev SA, 2006, BIOCHEM J, V393, P503, DOI 10.1042/BJ20051374; Shrinet J, 2016, B WHO; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Stocks CE, 1998, J VIROL, V72, P2141, DOI 10.1128/JVI.72.3.2141-2149.1998; Zhang Y, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6236	19	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170462	10.1371/journal.pone.0170462	http://dx.doi.org/10.1371/journal.pone.0170462			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125631	Green Published, gold, Green Submitted			2022-12-27	WOS:000396176100106
J	Jeong, S; Oh, JM; Oh, KH; Kim, IW				Jeong, Sohyun; Oh, Jung Mi; Oh, Kook-Hwan; Kim, In-Wha			Differentially expressed miR-3680-5p is associated with parathyroid hormone regulation in peritoneal dialysis patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; BONE-MINERAL DENSITY; STAGE RENAL-DISEASE; HEMODIALYSIS-PATIENTS; ADYNAMIC BONE; HIP FRACTURE; INCREASED RISK; PTH; OSTEODYSTROPHY; OSTEOPOROSIS	Mineral and bone disorder (MBD) is observed universally in patients with chronic kidney disease (CKD). Detrimental MBD-related skeletal changes include increased prevalence of fracture, cardiovascular disease, and mortality. MicroRNAs (miRNAs) have been identified as useful biomarkers in various diseases, and the aim of this study was to identify miRNAs associated with parathyroid hormone level in peritoneal dialysis (PD) patients. Fifty-two PD patients were enrolled and grouped by their intact parathyroid hormone (iPTH) level; 11 patients had low iPTH (<150 pg/mL) and 41 patients had high iPTH (>= 150 pg/mL). Total RNA was extracted from whole blood samples. Total RNA from 15 patients (7 and 8 patients in the low and high iPTH groups, respectively) underwent miRNA microarray analysis, and three differentially upregulated (>2-fold change) miRNAs previously associated with human disease were selected for real-time quantitative PCR (qPCR) analysis. Interaction analyses between miRNAs and genes were performed by using TargetScan and the KEGG pathway database. Microarray results revealed 165 miRNAs were differentially expressed between patients with high iPTH levels and low iPTH levels. Of those miRNAs, 81 were upregulated and 84 were downregulated in patients with high iPTH levels. Expression levels of miR-1299, miR-3680-5p, and miR-548b-5p (previously associated with human disease) in 52 patients were analyzed by using qPCR. MiR-3680-5p was differentially expressed in low and high iPTH patients (P < 0.05). The predicted target genes of miR-3680-5p were USP6, USP32, USP46, and DLT, which are involved in the ubiquitin proteolysis pathway. This pathway has roles in PTH and parathyroid hormone related protein degradation and proteolysis. The mechanisms involved in the associations among low PTH, adynamic bone disease, miR-3680-5p, and the target genes should be explored further in order to elucidate their roles in CKD-MBD development.	[Jeong, Sohyun; Oh, Jung Mi; Kim, In-Wha] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Jeong, Sohyun; Oh, Jung Mi; Kim, In-Wha] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul, South Korea; [Oh, Kook-Hwan] Seoul Natl Univ Hosp, Dept Internal Med, Div Nephrol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Kim, IW (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Div Nephrol, Seoul, South Korea.	khoh@snu.ac.kr; iwkim2@hanmail.net	Jeong, Sohyun/ABC-4625-2020	Jeong, Sohyun/0000-0003-3805-4349	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A1A2055734]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2014R1A1A2055734). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alem AM, 2000, KIDNEY INT, V58, P396, DOI 10.1046/j.1523-1755.2000.00178.x; Amizuka N, 1996, DEV BIOL, V175, P166, DOI 10.1006/dbio.1996.0104; AMIZUKA N, 1994, J CELL BIOL, V126, P1611, DOI 10.1083/jcb.126.6.1611; Andress DL, 2008, KIDNEY INT, V73, P1345, DOI 10.1038/ki.2008.60; ANDRESS DL, 1989, KIDNEY INT, V36, P471, DOI 10.1038/ki.1989.219; Atsumi K, 1999, AM J KIDNEY DIS, V33, P287, DOI 10.1016/S0272-6386(99)70302-1; Barreto FC, 2008, KIDNEY INT, V73, P771, DOI 10.1038/sj.ki.5002769; Barreto FC, 2006, KIDNEY INT, V69, P1852, DOI 10.1038/sj.ki.5000311; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Brandenburg VM, 2008, CLIN KIDNEY J, V1, P135, DOI 10.1093/ndtplus/sfn040; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Callis TE, 2008, TRENDS MOL MED, V14, P254, DOI 10.1016/j.molmed.2008.03.006; Cannata-Andia JB, 2013, J NEPHROL, V26, P73, DOI 10.5301/jn.5000212; Coco M, 2000, AM J KIDNEY DIS, V36, P1115, DOI 10.1053/ajkd.2000.19812; Coen G, 1996, NEPHROL DIAL TRANSPL, V11, P813, DOI 10.1093/oxfordjournals.ndt.a027404; Dooley AC, 2008, AM J KIDNEY DIS, V51, P38, DOI 10.1053/j.ajkd.2007.08.019; Eknoyan G, 2003, AM J KIDNEY DIS, V41, pS1, DOI 10.1016/S0272-6386(03)00111-2; Fazi F, 2008, CARDIOVASC RES, V79, P553, DOI 10.1093/cvr/cvn151; Ferreira A, 2008, J AM SOC NEPHROL, V19, P405, DOI 10.1681/ASN.2006101089; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Frazao JM, 2009, CURR OPIN NEPHROL HY, V18, P303, DOI 10.1097/MNH.0b013e32832c4df0; Garrett G, 2013, CLIN J AM SOC NEPHRO, V8, P299, DOI 10.2215/CJN.09580911; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hackl M, 2016, MOL CELL ENDOCRINOL, V432, P93, DOI 10.1016/j.mce.2015.10.015; Holmes David, 2015, Nat Rev Endocrinol, V11, P445, DOI 10.1038/nrendo.2015.104; Hutchison A J, 1996, Perit Dial Int, V16 Suppl 1, pS295; Ingsathit A, 2010, NEPHROL DIAL TRANSPL, V25, P1567, DOI 10.1093/ndt/gfp669; Jamal SA, 2007, AM J KIDNEY DIS, V49, P674, DOI 10.1053/j.ajkd.2007.02.264; Jean G, 2013, NEPHROL THER, V9, P154, DOI 10.1016/j.nephro.2013.02.006; Kalantar-Zadeh K, 2010, KIDNEY INT, V78, pS10, DOI 10.1038/ki.2010.189; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Li N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/524519; LLACH F, 2000, KIDNEY, P2103; Lobao R, 2004, CLIN NEPHROL, V62, P432; London G, 2010, CLIN NEPHROL, V74, P423, DOI 10.2379/CN106512; Malluche HH, 2006, CLIN NEPHROL, V65, P235; Malluche HH, 2004, NEPHROL DIAL TRANSPL, V19, pI9, DOI 10.1093/ndt/gfh1002; Meng QL, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-37; Nickolas TL, 2006, J AM SOC NEPHROL, V17, P3223, DOI 10.1681/ASN.2005111194; Oliveira RB, 2010, CLIN J AM SOC NEPHRO, V5, P286, DOI 10.2215/CJN.05420709; Parfitt AM, 2003, CURR OPIN NEPHROL HY, V12, P387, DOI 10.1097/00041552-200307000-00007; Picton ML, 2000, KIDNEY INT, V58, P1440, DOI 10.1046/j.1523-1755.2000.00306.x; SHERRARD DJ, 1993, KIDNEY INT, V43, P436, DOI 10.1038/ki.1993.64; Shilo V, 2016, CURR OPIN NEPHROL HY, V25, P271, DOI 10.1097/MNH.0000000000000227; Souberbielle JCP, 2010, KIDNEY INT, V77, P93, DOI 10.1038/ki.2009.374; Sprague SM, 2000, SEMIN DIALYSIS, V13, P152, DOI 10.1046/j.1525-139x.2000.00042.x; Stehman-Breen CO, 1999, AM J KIDNEY DIS, V33, P941, DOI 10.1016/S0272-6386(99)70430-0; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; United States Renal Data System, 2014, DIS NIOHNIODADAK; Warnes G.R., 2006, R NEWS, V6, P64; Young EW, 2005, KIDNEY INT, V67, P1179, DOI 10.1111/j.1523-1755.2005.00185.x; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006; Zhu HQ, 2016, BIOMED PHARMACOTHER, V83, P792, DOI 10.1016/j.biopha.2016.07.037	56	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170535	10.1371/journal.pone.0170535	http://dx.doi.org/10.1371/journal.pone.0170535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152049	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161200025
J	Nose, M; Ballette, F; Bighelli, I; Turrini, G; Purgato, M; Tol, W; Priebe, S; Barbui, C				Nose, Michela; Ballette, Francesca; Bighelli, Irene; Turrini, Giulia; Purgato, Marianna; Tol, Wietse; Priebe, Stefan; Barbui, Corrado			Psychosocial interventions for post-traumatic stress disorder in refugees and asylum seekers resettled in high-income countries: Systematic review and meta-analysis	PLOS ONE			English	Article							NARRATIVE EXPOSURE THERAPY; COGNITIVE-BEHAVIOR THERAPY; TREATMENT-RESISTANT PTSD; TRAUMA-FOCUSED THERAPY; MENTAL-HEALTH; IRAQI REFUGEES; HUMANITARIAN SETTINGS; CAMBODIAN REFUGEES; PANIC-ATTACKS; WAR	Treatment of post-traumatic stress disorder (PTSD) in refugees and asylum seekers resettled in high-income countries presents specific challenges. This systematic review examined the effectiveness of psychosocial interventions for this group. We searched the Cochrane Central Register of randomised trials, CINAHL, EMBASE, PILOTS, PsycINFO, PubMed and Web of Science up to July 2016. Studies included randomised and controlled clinical trials comparing psychosocial interventions with waiting list or treatment as usual in adult refugees and asylum seekers with PTSD resettled in high-income countries. PTSD symptoms post-intervention was the primary outcome. We computed standardized mean differences (SMD) with 95% confidence intervals (CI). This study is registered with PROSPERO: CRD4201502 7843. Twelve studies were included in the meta-analysis. Psychosocial interventions were effective in decreasing PTSD symptoms relative to control groups (SMD -1.03, 95% CI -1.55 to -0.51; number needed to treat 4.4; I 2 86%; 95% CI 77 to 91). Narrative exposure therapy, a manualized short-term variant of cognitive behavioural therapy with a trauma focus, was the best-supported intervention (5 RCTs, 187 participants, SMD -0.78, 95% CI -1.18 to -0.38, I 2 37%; 95% CI 0 to 77). Methodological quality of the included studies was limited. Overall, psychosocial interventions for asylum seekers and refugees with PTSD resettled in high-income countries were found to provide significant benefits in reducing PTSD symptoms. Yet, the number of studies is small and their methodological quality limited, so that more rigorous trials should be conducted in the future.	[Nose, Michela; Ballette, Francesca; Bighelli, Irene; Turrini, Giulia; Purgato, Marianna; Barbui, Corrado] Univ Verona, Sect Psychiat, Dept Neurosci Biomed & Movement Sci, WHO Collaborating Ctr Res & Training Mental Hlth, Verona, Italy; [Tol, Wietse] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Priebe, Stefan] Queen Mary Univ London, WHO Collaborating Ctr Mental Hlth Serv Dev, Unit Social & Community Psychiat, London, England	University of Verona; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of London; Queen Mary University London; World Health Organization	Barbui, C (corresponding author), Univ Verona, Sect Psychiat, Dept Neurosci Biomed & Movement Sci, WHO Collaborating Ctr Res & Training Mental Hlth, Verona, Italy.	corrado.barbui@univr.it	Bighelli, Irene/I-1118-2019	Bighelli, Irene/0000-0002-5661-5149	University of Verona	University of Verona	During the study period, the following funding was received: Internal funding from the University of Verona. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adenauer H, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-127; Altman DG, 1996, BRIT MED J, V313, P1200, DOI 10.1136/bmj.313.7066.1200; Barbui C, 2016, EPIDEMIOL P IN PRESS; Barbui C, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0612-8; Barbui C, 2015, LANCET PSYCHIAT, V2, P1054, DOI 10.1016/S2215-0366(15)00456-3; Barbui C, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000322; Bogic M, 2015, BMC INT HEALTH HUM R, V15, DOI 10.1186/s12914-015-0064-9; Buhmann CBC, 2016, BRIT J PSYCHIAT, V208, P252, DOI 10.1192/bjp.bp.114.150961; Crumlish N, 2010, J NERV MENT DIS, V198, P237, DOI 10.1097/NMD.0b013e3181d61258; Drozdek B, 2010, TRAUMATOLOGY, V16, P117, DOI DOI 10.1177/1534765610388298; Ellis BH, 2008, J CONSULT CLIN PSYCH, V76, P184, DOI 10.1037/0022-006X.76.2.184; Ellis BH, 2010, AM J ORTHOPSYCHIAT, V80, P564, DOI 10.1111/j.1939-0025.2010.01061.x; Fazel M, 2005, LANCET, V365, P1309, DOI 10.1016/S0140-6736(05)61027-6; Furukawa TA, 1999, LANCET, V353, P1680, DOI 10.1016/S0140-6736(99)01163-0; Furukawa TA, 2006, J CLIN EPIDEMIOL, V59, P7, DOI 10.1016/j.jclinepi.2005.06.006; Guajardo MGU, 2016, INT J MENT HEALTH SY, V10, DOI 10.1186/s13033-016-0036-z; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Gwozdziewycz Nicolas, 2013, Perm J, V17, P70, DOI 10.7812/TPP/12-058; Hargreaves S, 2002, LANCET, V359, P793, DOI 10.1016/S0140-6736(02)07888-1; Hijazi AM, 2014, J TRAUMA STRESS, V27, P314, DOI 10.1002/jts.21922; Hinton DE, 2005, J TRAUMA STRESS, V18, P617, DOI 10.1002/jts.20070; Hinton DE, 2004, J TRAUMA STRESS, V17, P429, DOI 10.1023/B:JOTS.0000048956.03529.fa; Hollifield M, 2002, JAMA-J AM MED ASSOC, V288, P611, DOI 10.1001/jama.288.5.611; Inter-Agency Standing Committee (IASC), 2007, AM PSYCHOL ASS, DOI [DOI 10.1037/E518422011-002, 10.1037/e518422011-002]; Kruse J, 2009, J TRAUMA STRESS, V22, P585, DOI 10.1002/jts.20477; Lambert JE, 2015, J COUNS PSYCHOL, V62, P28, DOI 10.1037/cou0000048; Liedl A, 2011, PAIN MED, V12, P234, DOI 10.1111/j.1526-4637.2010.01040.x; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Miller KE, 2006, AM J ORTHOPSYCHIAT, V76, P409, DOI 10.1037/0002-9432.76.4.409; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Morath J, 2014, J PSYCHIATR RES, V54, P1, DOI 10.1016/j.jpsychires.2014.03.016; Neuner Frank, 2010, Cognitive Behaviour Therapy, V39, P81, DOI 10.1080/16506070903121042; Nickerson A, 2011, CLIN PSYCHOL REV, V31, P399, DOI 10.1016/j.cpr.2010.10.004; Ostuzzi G, 2015, CANCER TREAT REV, V41, P714, DOI 10.1016/j.ctrv.2015.06.003; Otto MW, 2003, BEHAV RES THER, V41, P1271, DOI 10.1016/S0005-7967(03)00032-9; Patel N, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009317.pub2; Priebe S, 2013, PSYCHOL MED, V43, P1837, DOI 10.1017/S0033291712002681; Priebe S, 2013, PSYCHOPATHOLOGY, V46, P45, DOI 10.1159/000338640; Raphael B, 2015, EPIDEMIOL PSYCH SCI, V24, P500, DOI 10.1017/S204579601500075X; Renner W., 2011, AUSTRALAS J DISASTER, P1, DOI [10.1037/t07469-000, DOI 10.1037/T07469-000]; Robertson CL, 2016, J AM PSYCHI IN PRESS; Sandhu S, 2013, SOC PSYCH PSYCH EPID, V48, P105, DOI 10.1007/s00127-012-0528-3; Schick M, 2016, EUR J PSYCHOTRAUMATO, V7, DOI 10.3402/ejpt.v7.28057; Sijbrandij M, 2015, LANCET PSYCHIAT, V2, P413, DOI 10.1016/S2215-0366(14)00121-7; Slewa-Younan S, 2015, J IMMIGR MINOR HEALT, V17, P1231, DOI 10.1007/s10903-014-0046-3; Stenmark H, 2013, BEHAV RES THER, V51, P641, DOI 10.1016/j.brat.2013.07.002; Szabo CP, 2015, EPIDEMIOL PSYCH SCI, V24, P498, DOI 10.1017/S2045796015000839; Tol WA, 2015, EPIDEMIOL PSYCH SCI, V24, P484, DOI 10.1017/S2045796015000827; Tol WA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001769; Tol WA, 2013, JAMA-J AM MED ASSOC, V310, P477, DOI 10.1001/jama.2013.166723; Ullmann E, 2015, MOL PSYCHIATR, V20, P1483, DOI 10.1038/mp.2015.164; UNHCR, 2016, GLOB TRENDS FORC DIS, P20; Weine S, 2008, J MARITAL FAM THER, V34, P149, DOI 10.1111/j.1752-0606.2008.00061.x; Wessells M, 2015, EPIDEMIOL PSYCH SCI, V24, P495, DOI 10.1017/S204579601500058X; Yaser A, 2016, INT J MENT HEALTH SY, V10, DOI 10.1186/s13033-016-0065-7	55	117	117	4	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171030	10.1371/journal.pone.0171030	http://dx.doi.org/10.1371/journal.pone.0171030			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28151992	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200075
J	Uuskula, A; Raag, M; Marsh, K; Talu, A; Vorobjov, S; Jarlais, DD				Uuskula, Anneli; Raag, Mait; Marsh, Kristina; Talu, Ave; Vorobjov, Sigrid; Jarlais, Don Des			HIV prevalence and gender differences among new injection-drug-users in Tallinn, Estonia: A persisting problem in a stable high prevalence epidemic	PLOS ONE			English	Article							SYRINGE EXCHANGE; RISK BEHAVIORS; HEPATITIS-C; INFECTION; PREVENTION; SEROPREVALENCE; INTERVENTION; ADHERENCE	Introduction New injectors / younger drug users are an important population to target for intervention because they are often at especially high risk of HIV and HCV infection. We examined HIV prevalence and gender differences in HIV prevalence and risk behavior among new injection-drug-users in Tallinn, Estonia. Methods Respondent driven sampling (RDS) interview surveys and HIV testing were conducted in Tallinn in 2009, 2011 and 2013. We classified "new injectors" as persons who reported their first injection as occurring within three years of the study interview. Recruiting trees of the three individual RDS studies were joined to form one RDS dataset and RDS estimates for prevalence and means were derived. Bootstrap tests were used to compare data from men and women, HIV infected and uninfected. Results Among 110 new injectors (34 women and 76 men) the mean age was 24.5 (SD 7.5) years; 63% reported injecting mainly fentanyl, 34% injecting mainly amphetamine, 36% sharing syringes, 89% were sexually active, and, of these, 88% did not always use condoms in the last 6 months. HIV prevalence was 18% (95% CI 8-28%) (41% (95% CI 19-63%) among female and 7% (95% CI 2-12%) among male new injectors). Based on self-reports, 8.1% of all new injectors (and 22% of female new injectors) were HIV positive before starting to inject drugs. 40% of HIV infected reported receiving antiretroviral therapy. In multivariable analysis, gender (male: OR 0.12, 95% CI 0.03-0.45), main drug injected (fentanyl: OR 6.7, 95% CI 1.3-35.7) and syringe sharing (distributive: OR 0.11, 95% CI 0.02-0.55; and receptive: OR 3.7, 95% CI 1.0-13.5) were associated with the HIV seropositivity. Conclusions New injectors exhibit high-risk behavior and correspondingly high HIV prevalence. Sexual transmission of HIV infection, including before injection initiation, is likely to be a significant contributor to HIV risk among female new injectors. This highlights the need to identify and target new injectors and their partners with gender specific interventions in addition to interventions to reduce initiation into injecting and ensuring provision of ART to HIV positive new injectors.	[Uuskula, Anneli; Raag, Mait; Marsh, Kristina; Talu, Ave] Univ Tartu, Dept Family Med & Publ Hlth, Tartu, Estonia; [Vorobjov, Sigrid] Natl Inst Hlth Dev, Tallinn, Estonia; [Jarlais, Don Des] Mt Sinai Beth Israel Med Ctr, Baron Edmond de Rothschild Chem Dependency Inst, New York, NY USA	University of Tartu; National Institute for Health Development - Estonia	Uuskula, A (corresponding author), Univ Tartu, Dept Family Med & Publ Hlth, Tartu, Estonia.	anneli.uuskula@ut.ee	Uusküla, Anneli/H-3303-2015; Talu, Ave/D-7677-2014	Uusküla, Anneli/0000-0002-4036-3856; Talu, Ave/0000-0003-3543-483X	National Institutes of Health, USA [R01A1083035, 1DP1DA039542]; Estonian Ministry of Education and Research [IUT34-17]; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA011041] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grant # R01A1083035 and 1DP1DA039542 from the National Institutes of Health, USA, and by grant # IUT34-17 from the Estonian Ministry of Education and Research.	[Anonymous], 1992, BMJ, V304, P809; [Anonymous], 2011, GUID MON PREGN; [Anonymous], 2014, R LANG ENV STAT COMP; Atkinson John, 2011, Afr J Drug Alcohol Stud, V10, P1; Azim T, 2015, INT J DRUG POLICY, V26, pS16, DOI 10.1016/j.drugpo.2014.09.003; Cedarbaum ER, 2016, DRUG ALCOHOL DEPEN, V158, P102, DOI 10.1016/j.drugalcdep.2015.11.011; Des Jarlais DC, 1999, J ACQ IMMUN DEF SYND, V20, P67, DOI 10.1097/00042560-199901010-00010; Des Jarlais DC, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-54; Des Jarlais DC, 2012, DRUG ALCOHOL DEPEN, V124, P95, DOI 10.1016/j.drugalcdep.2011.12.020; European Centre for Disease Prevention and Control (ECDC), 2009, HIV AIDS SURV EUR; European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2014, HIV AIDS SURV EUR 20; Frajzyngier V, 2007, DRUG ALCOHOL DEPEN, V89, P145, DOI 10.1016/j.drugalcdep.2006.12.021; Fuller CM, 2003, JAIDS, V32, P86, DOI 10.1097/00126334-200301010-00013; Garfein RS, 2007, DRUG ALCOHOL DEPEN, V91, pS4, DOI 10.1016/j.drugalcdep.2007.05.007; Garfein RS, 1996, AM J PUBLIC HEALTH, V86, P655, DOI 10.2105/AJPH.86.5.655; Gile KJ, 2011, J AM STAT ASSOC, V106, P135, DOI 10.1198/jasa.2011.ap09475; Gyarmathy VA, 2009, EUR ADDICT RES, V15, P163, DOI 10.1159/000220344; Hagan H, 2008, AM J EPIDEMIOL, V168, P1099, DOI 10.1093/aje/kwn237; Handcock M.S., 2012, RDS RESPONDENT DRIVE; Handcock M. S., 2014, RDS ANAL SOFTWARE AN; Harocopos A, 2009, INT J DRUG POLICY, V20, P317, DOI 10.1016/j.drugpo.2008.06.003; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; HIV in Estonia, 2016, NARR REP GLOB AIDS R; Johnson M, 2013, ANTIVIR THER, V18, P19, DOI 10.3851/IMP2637; Jolley E, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001465; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Montgomery SB, 2002, AM J DRUG ALCOHOL AB, V28, P453, DOI 10.1081/ADA-120006736; Munoz F, 2015, AIDS BEHAV, V19, P199, DOI 10.1007/s10461-014-0815-y; Neaigus A, 1996, J ACQ IMMUN DEF SYND, V11, P499, DOI 10.1097/00042560-199604150-00011; Platt L, 2006, AIDS, V20, P2120, DOI 10.1097/01.aids.0000247586.23696.20; Riehman KS, 2004, J URBAN HEALTH, V81, P249, DOI 10.1093/jurban/jth111; Robbins CL, 2010, INT J STD AIDS, V21, P489, DOI 10.1258/ijsa.2010.010097; Rondinelli AJ, 2009, DRUG ALCOHOL DEPEN, V104, P167, DOI 10.1016/j.drugalcdep.2009.05.013; Strathdee SA, 2001, ARCH INTERN MED, V161, P1281, DOI 10.1001/archinte.161.10.1281; Tapp C, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-86; Uuskula A, 2015, AIDS CARE, V27, P105, DOI 10.1080/09540121.2014.940271; Uuskula A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-517; Uuskula A, 2008, J PUBLIC HEALTH-UK, V30, P119, DOI 10.1093/pubmed/fdn014; Uuskula A, 2010, J URBAN HEALTH, V87, P304, DOI 10.1007/s11524-009-9427-7; Valdiserri R, 2014, AM J PUBLIC HEALTH, V104, P816, DOI 10.2105/AJPH.2013.301812; Vorobjov S, 2009, HARM REDUCT J, V6, DOI 10.1186/1477-7517-6-3; Wilson TE, 2007, INT J STD AIDS, V18, P389, DOI 10.1258/095646207781024900; Wood E, 2008, HIV MED, V9, P503, DOI 10.1111/j.1468-1293.2008.00582.x	44	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170956	10.1371/journal.pone.0170956	http://dx.doi.org/10.1371/journal.pone.0170956			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28152026	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200061
J	Cilveti, R; Olmo, M; Perez-Jove, J; Picazo, JJ; Arimany, JL; Mora, E; Perez-Porcuna, TM; Aguilar, I; Alonso, A; Molina, F; del Amo, M; Mendez, C				Cilveti, Robert; Olmo, Montserrat; Perez-Jove, Josefa; Picazo, Juan-Jose; Arimany, Josep-Lluis; Mora, Emiliano; Perez-Porcuna, Tomas M.; Aguilar, Ignacio; Alonso, Aurora; Molina, Francesc; del Amo, Maria; Mendez, Cristina		HERMES Study Grp	Epidemiology of Otitis Media with Spontaneous Perforation of the Tympanic Membrane in Young Children and Association with Bacterial Nasopharyngeal Carriage, Recurrences and Pneumococcal Vaccination in Catalonia, Spain - The Prospective HERMES Study	PLOS ONE			English	Article							REAL-TIME PCR; STREPTOCOCCUS-PNEUMONIAE; HAEMOPHILUS-INFLUENZAE; CONJUGATE VACCINE; MIDDLE-EAR; SEROTYPE DISTRIBUTION; DISEASE; ERA; COLONIZATION; IMPACT	The Epidemiology of otitis media with spontaneous perforation of the tympanic membrane and associated nasopharyngeal carriage of bacterial otopathogens was analysed in a county in Catalonia (Spain) with pneumococcal conjugate vaccines (PCVs) not included in the immunization programme at study time. A prospective, multicentre study was performed in 10 primary care centres and 2 hospitals (June 2011-June 2014), including all otherwise healthy children >= 2 months <= 8 years with otitis media presenting spontaneous tympanic perforation within 48h. Up to 521 otitis episodes in 487 children were included, showing by culture/PCR in middle ear fluid (MEF): Haemophilus influenzae [24.2%], both Streptococcus pneumoniae and H. influenzae [24.0%], S. pneumoniae [15.9%], Streptococcus pyogenes [13.6%], and Staphylococcus aureus [6.7%]. Culture-negative/PCR-positive otitis accounted for 31.3% (S. pneumoniae), 30.2% (H. influenzae) and 89.6% (mixed S. pneumoniae/H. influenzae infections). Overall, incidence decreased over the 3-year study period, with significant decreases in otitis by S. pneumoniae and by H. influenzae, but no decreases for mixed S. pneumoniae/H. influenzae infections. Concordance between species in nasopharynx and MEF was found in 58.3% of cases, with maximal rates for S. pyogenes (71.8%), and with identical pneumococcal serotype in 40.5% of cases. Most patients (66.6%) had past episodes. PCV13 serotypes were significantly more frequent in first episodes, in otitis by S. pneumoniae as single agent, and among MEF than nasopharyngeal isolates. All non-PCV13 serotypes separately accounted for <5% in MEF. Up to 73.9% children had received >= 1 dose of PCV, with lower carriage of PCV13 serotypes than among non-vaccinated children. Pooling pneumococcal isolates from MEF and nasopharynx, 30% were multidrug resistant, primarily belonging to serotypes 19A [29.8%], 24A [14.3%], 19F [8.3%] and 15A [6.0%]. Our results suggest that increasing PCV13 vaccination would further reduce transmission of PCV13 serotypes with special benefits for youngest children (with none or uncompleted vaccine schedules), preventing first otitis episodes and subsequent recurrences.	[Cilveti, Robert; Olmo, Montserrat; Mora, Emiliano] Hosp Univ Mutua Terrassa, Dept Paediat, Barcelona, Spain; [Perez-Jove, Josefa] Viladecavalls, Catlab, Barcelona, Spain; [Picazo, Juan-Jose] Univ Complutense, Sch Med, Madrid, Spain; [Arimany, Josep-Lluis] Hosp Gen Cataluna, Barcelona, Spain; [Perez-Porcuna, Tomas M.] CAP Valldoreix, Barcelona, Spain; [Aguilar, Ignacio] CAP Turo de Can Mates, Barcelona, Spain; [Alonso, Aurora] CAP Rambla, Barcelona, Spain; [Molina, Francesc] CAP Terrassa Sud, Barcelona, Spain; [del Amo, Maria; Mendez, Cristina] Pfizer, Dept Med, Madrid, Spain	Hospital Universitario Mutua Terrassa; Complutense University of Madrid; Pfizer	Cilveti, R (corresponding author), Hosp Univ Mutua Terrassa, Dept Paediat, Barcelona, Spain.	rcilveti@mutuaterrassa.es		Cilveti-Portillo, Robert/0000-0002-6315-1071; RUBIO CASINO, ROSA/0000-0003-4022-1820; Perez-Porcuna, Tomas Maria/0000-0002-9951-7768	Pfizer S.L.U., Madrid, Spain	Pfizer S.L.U., Madrid, Spain	R.C., M.O., J.P-J., J-J.P., J-L.A., E.M., T.P-P., I.A., A.A. and F.M. have received research grants from Pfizer S.L.U., Madrid, Spain, for the study. M.d.A. and C.M. are employees of Pfizer S.L. U., Madrid, Spain. The funder played an indirect role through the participation of two co-authors in the study design, coordination of study centres, critical revision and final approval of the manuscript, and the agreement to be accountable for all aspects of the work. However, the contributions of these authors were not determinant nor prioritized in any of phases of the study nor in the major decisions taken throughout the entire process of preparation of the manuscript. In addition, the funder provided support in the form of investigational grants for authors [R.C. M.O. J.PJ. J-J.P. J-L.A. E.M. T.P-P. I.A. A.A. F.M.].	Angoulvant F, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0978-9; Ben-Shimol S, 2014, CLIN INFECT DIS, V59, P1724, DOI 10.1093/cid/ciu683; Brugger SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011638; Camilli R, 2011, EUR J CLIN MICROBIOL, V30, P97, DOI 10.1007/s10096-010-1060-6; Sanz JC, 2010, J CLIN MICROBIOL, V48, P593, DOI 10.1128/JCM.01651-09; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Chonmaitree T, 2008, CLIN INFECT DIS, V46, P815, DOI 10.1086/528685; Clinical and Laboratory Standards Institute, 2009, PERF STAND ANT SUSC; Clinical and Laboratory Standards Institute, 2006, METH DIL ANT SUSC TE, V7; Cohen R, 2015, VACCINE, V33, P5118, DOI 10.1016/j.vaccine.2015.08.010; Cohen R, 2012, PEDIATR INFECT DIS J, V31, P297, DOI 10.1097/INF.0b013e318247ef84; Commisso R, 2000, INT J PEDIATR OTORHI, V56, P23, DOI 10.1016/S0165-5876(00)00402-X; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; Dagan R, 2013, J INFECT DIS, V208, P1152, DOI 10.1093/infdis/jit289; Daly MM, 2004, J CLIN MICROBIOL, V42, P3570, DOI [10.1128/JCM.42.8.3570-3574.2004, 10.1128/jcm.42.8.3570-3574.2004]; del Amo E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151125; Desai AP, 2015, PEDIATR INFECT DIS J, V34, P1168, DOI 10.1097/INF.0000000000000849; Dunne EM, 2013, VACCINE, V31, P2333, DOI 10.1016/j.vaccine.2013.03.024; Gene A, 2013, PEDIATR INFECT DIS J, V32, pE128, DOI 10.1097/INF.0b013e31827c54dc; Hau I, 2014, PEDIATR DRUGS, V16, P1, DOI 10.1007/s40272-013-0044-2; Jacoby P, 2011, PEDIATR INFECT DIS J, V30, P480, DOI 10.1097/INF.0b013e318217dc6e; Picazo JJ, 2013, J MICROBIOL METH, V93, P116, DOI 10.1016/j.mimet.2013.03.001; Kaplan SL, 2015, CLIN INFECT DIS, V60, P1339, DOI 10.1093/cid/civ067; Kaur R, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0640-y; Labout JAM, 2011, EUR J EPIDEMIOL, V26, P61, DOI 10.1007/s10654-010-9500-2; Lau WCY, 2015, VACCINE, V33, P5072, DOI 10.1016/j.vaccine.2015.08.022; Loughlin AM, 2014, PEDIATR INFECT DIS J, V33, P504, DOI 10.1097/INF.0000000000000279; Lysenko ES, 2005, PLOS PATHOG, V1, P3, DOI 10.1371/journal.ppat.0010001; Margolis E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-59; Mills N, 2015, J PAEDIATR CHILD H, V51, P300, DOI 10.1111/jpc.12710; Monasta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036226; Nokso-Koivisto J, 2015, CURR OPIN PEDIATR, V27, P110, DOI 10.1097/MOP.0000000000000184; Ochoa-Gondar O, 2015, INT J PEDIATR OTORHI, V79, P2104, DOI 10.1016/j.ijporl.2015.09.022; Shea KM, 2011, VACCINE, V29, P8042, DOI 10.1016/j.vaccine.2011.08.057; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Skevaki CL, 2015, PEDIATR INFECT DIS J, V34, P1296, DOI 10.1097/INF.0000000000000872; Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P2562, DOI 10.1128/AAC.40.11.2562; Syrjanen RK, 2005, PEDIATR INFECT DIS J, V24, P801, DOI 10.1097/01.inf.0000178072.83531.4f; Tikhomirova A, 2015, INT J MED MICROBIOL, V305, P881, DOI 10.1016/j.ijmm.2015.09.003; van der Linden M, 2015, EUR J PEDIATR, V174, P355, DOI 10.1007/s00431-014-2409-0; van Dongen TMA, 2013, PEDIATR INFECT DIS J, V32, P549, DOI 10.1097/INF.0b013e318280ab45; Vergison A, 2010, LANCET INFECT DIS, V10, P195, DOI 10.1016/S1473-3099(10)70012-8; Wald ER, 2013, PEDIATR INFECT DIS J, V32, P641, DOI 10.1097/INF.0b013e3182868cc8; Weimer KED, 2010, J INFECT DIS, V202, P1068, DOI 10.1086/656046; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Xu QF, 2014, VACCINE, V32, P706, DOI 10.1016/j.vaccine.2013.11.096; Xu QF, 2012, EMERG INFECT DIS, V18, P1738, DOI 10.3201/eid1811.111904; Xu QF, 2012, PEDIATR INFECT DIS J, V31, P638, DOI 10.1097/INF.0b013e31824ba6f7; Zhao AS, 2014, INT J PEDIATR OTORHI, V78, P499, DOI 10.1016/j.ijporl.2013.12.028	49	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0170316	10.1371/journal.pone.0170316	http://dx.doi.org/10.1371/journal.pone.0170316			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146590	Green Published, Green Submitted, gold			2022-12-27	WOS:000396131700020
J	Kim, EK; Kim, KA; Lee, CY; Shim, HS				Kim, Eun Kyung; Kim, Kyung A.; Lee, Chang Young; Shim, Hyo Sup			The frequency and clinical impact of HER2 alterations in lung adenocarcinoma	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; IN-SITU HYBRIDIZATION; GENE COPY NUMBER; PHASE-II TRIAL; PROTEIN EXPRESSION; ACQUIRED-RESISTANCE; KINASE MUTATIONS; BREAST-CANCER; AMPLIFICATION; TRASTUZUMAB	Human epidermal growth factor receptor 2 (HER2 or ErbB2) can be overexpressed, amplified and/or mutated in malignant tumors, and is a candidate for therapeutic targeting. However, molecular associations and clinical significances of these alterations were controversial in lung cancer. In this study, we investigated the frequency and clinicopathological significance of HER2 dysregulation in patients with lung adenocarcinoma. HER2 protein overexpression, gene amplification, and gene mutation were evaluated by immunohistochemistry (IHC), silver in situ hybridization, and direct sequencing, respectively. The H-scoring method and American Society of Clinical Oncology/College of American Pathologists breast cancer guidelines were used to interpret IHC results. Genetic analyses of EGFR and KRAS mutations, and of ALK and ROS1 rearrangements, were also performed. Of the 321 adenocarcinoma patients identified, HER2 overexpression (Hscore >= 200) and gene amplification were found in 6 (1.9%) and 46 (14.3%), respectively. HER2 overexpression was correlated with papillary predominant histology; furthermore, it indicated poor overall survival and was an independent prognostic factor. HER2 amplification was associated with pleural invasion and showed a tendency towards shorter overall and disease-free survival. High-level gene amplification (HER2/CEP17 ratio >= 5 or copy number >= 10) was a poor prognostic factor for disease-free survival. HER2 mutations were detected in 6.7% (7 of 104) of driver oncogene-negative adenocarcinomas. Our study suggests that HER2 overexpression or amplification is a poor prognostic factor in lung adenocarcinoma, although the frequency of such events is low. Since molecular targeted agents are being tested in clinical trials, awareness of the specific HER2 status can influence the prognostic stratification and treatment of patients with molecularly defined subsets of lung adenocarcinoma.	[Kim, Eun Kyung; Kim, Kyung A.; Shim, Hyo Sup] Yonsei Univ, Coll Med, Dept Pathol, Severance Hosp, Seoul, South Korea; [Lee, Chang Young] Yonsei Univ, Coll Med, Dept Cardiovasc & Thorac Surg, Severance Hosp, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Shim, HS (corresponding author), Yonsei Univ, Coll Med, Dept Pathol, Severance Hosp, Seoul, South Korea.	shimhs@yuhs.ac	Shim, Hyo Sup/ABI-6190-2020; Kim, Eun-Kyung/E-5211-2017	Shim, Hyo Sup/0000-0002-5718-3624; Kim, Eun-Kyung/0000-0002-3368-5013	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2015R1C1A1A01051935]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea)	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (http://www.nrf.re.kr/; NRF-2015R1C1A1A01051935). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saad S, 2010, J THORAC ONCOL, V5, P1536, DOI 10.1097/JTO.0b013e3181ea510a; Arcila ME, 2012, CLIN CANCER RES, V18, P4910, DOI 10.1158/1078-0432.CCR-12-0912; Bang YJ, 2010, LANCET, V376, P1302; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Clamon G, 2005, CANCER-AM CANCER SOC, V103, P1670, DOI 10.1002/cncr.20950; De Greve J, 2012, LUNG CANCER, V76, P123, DOI 10.1016/j.lungcan.2012.01.008; Edge SB, 2010, AJCC CANC STAGING MA, P251; Gatzemeier U, 2004, ANN ONCOL, V15, P19, DOI 10.1093/annonc/mdh031; Heinmoller P, 2003, CLIN CANCER RES, V9, P5238; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Hirsch FR, 2002, BRIT J CANCER, V86, P1449, DOI 10.1038/sj.bjc.6600286; Kobyakov DS, 2014, B EXP BIOL MED+, V157, P789, DOI 10.1007/s10517-014-2668-9; Korrapati V, 2001, Clin Lung Cancer, V2, P216, DOI 10.3816/CLC.2001.n.006; Langer CJ, 2004, J CLIN ONCOL, V22, P1180, DOI 10.1200/JCO.2004.04.105; Lara Primo N Jr, 2004, Clin Lung Cancer, V5, P231; Li BW, 2016, ACTA ASTRONAUT, V127, P579, DOI 10.1016/j.actaastro.2016.06.048; Li C, 2012, ANN SURG ONCOL, V7, P7, DOI DOI 10.1504/IJHPCN.2012.046371; Liu LX, 2010, J THORAC ONCOL, V5, P1922, DOI 10.1097/JTO.0b013e3181f26266; Mar N, 2015, LUNG CANCER, V87, P220, DOI 10.1016/j.lungcan.2014.12.018; Mazieres J, 2013, J CLIN ONCOL, V31, P1997, DOI 10.1200/JCO.2012.45.6095; Nakamura H, 2005, CANCER-AM CANCER SOC, V103, P1865, DOI 10.1002/cncr.20957; Pellegrini C, 2003, CLIN CANCER RES, V9, P3645; Planchard D, 2015, ANN ONCOL, V26, P2073, DOI 10.1093/annonc/mdv319; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Suzuki M, 2015, LUNG CANCER, V87, P14, DOI 10.1016/j.lungcan.2014.10.014; Takezawa K, 2012, CANCER DISCOV, V2, P922, DOI 10.1158/2159-8290.CD-12-0108; Travis WD., 2015, WHO CLASSIFICATION T; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yoshizawa A, 2014, LUNG CANCER, V85, P373, DOI 10.1016/j.lungcan.2014.06.007	32	48	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0171280	10.1371/journal.pone.0171280	http://dx.doi.org/10.1371/journal.pone.0171280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146588	gold, Green Published, Green Submitted			2022-12-27	WOS:000396131700029
J	Kovacs, CJ; Perrtree, RM; Cox, TM				Kovacs, Carolyn J.; Perrtree, Robin M.; Cox, Tara M.			Social Differentiation in Common Bottlenose Dolphins (Tursiops truncatus) that Engage in Human-Related Foraging Behaviors	PLOS ONE			English	Article							SARASOTA BAY; ASSOCIATION; TRANSMISSION; PATTERNS; ECOLOGY; CATCH	Both natural and human-related foraging strategies by the common bottlenose dolphin (Tursiops truncatus) have resulted in social segregation in several areas of the world. Bottlenose dolphins near Savannah, Georgia beg at an unprecedented rate and also forage behind commercial shrimp trawlers, providing an opportunity to study the social ramifications of two human-related foraging behaviors within the same group of animals. Dolphins were photo-identified via surveys conducted throughout estuarine waterways around Savannah in the summers of 2009-2011. Mean half-weight indices (HWI) were calculated for each foraging class, and community division by modularity was used to cluster animals based on association indices. Pairs of trawler dolphins had a higher mean HWI (0.20 +/- 0.07) than pairs of non-trawler dolphins (0.04 +/- 0.02) or mixed pairs (0.02 +/- 0.02). In contrast, pairs of beggars, non-beggars, and mixed pairs all had similar means, with HWI between 0.05 +/- 0.07. Community division by modularity produced a useful division (0.307) with 6 clusters. Clusters were predominately divided according to trawler status; however, beggars and non-beggars were mixed throughout clusters. Both the mean HWI and social clusters revealed that the social structure of common bottlenose dolphins near Savannah, Georgia was differentiated based on trawler status but not beg status. This finding may indicate that foraging in association with trawlers is a socially learned behavior, while the mechanisms for the propagation of begging are less clear. This study highlights the importance of taking into account the social parameters of a foraging behavior, such as how group size or competition for resources may affect how the behavior spreads. The positive or negative ramifications of homophily may influence whether the behaviors are exhibited by individuals within the same social clusters and should be considered in future studies examining social relationships and foraging behaviors.	[Kovacs, Carolyn J.; Perrtree, Robin M.; Cox, Tara M.] Savannah State Univ, Marine Sci Program, Dept Marine & Environm Sci, Savannah, GA 31404 USA; [Kovacs, Carolyn J.] Univ S Florida, Sea Mester, Sarasota, FL USA	University System of Georgia; Savannah State University; State University System of Florida; University of South Florida	Perrtree, RM; Cox, TM (corresponding author), Savannah State Univ, Marine Sci Program, Dept Marine & Environm Sci, Savannah, GA 31404 USA.	perrtreer@savannahstate.edu; coxt@savannahstate.edu			NSF GK12 [0841372]; NSF EDGE [GE0-0194680]; NOM Office of Education's Educational Partnership Program [NA050AR4811017]; Department of Education, Title VII [P382G090003]; Oak Foundation	NSF GK12(National Science Foundation (NSF)); NSF EDGE; NOM Office of Education's Educational Partnership Program; Department of Education, Title VII; Oak Foundation	Boat time was provided by the Marine Sciences Program at Savannah State University (www.savannahstate.eduu/marinesciences) CJK RMP TMC. Support was provided by NSF GK12 (www.gk-12.org; award 0841372) CJK; NSF EDGE (www.nsf.gov; award GE0-0194680) TMC RMP; the NOM Office of Education's Educational Partnership Program (http://www.epp.noaa.gov; award NA050AR4811017) RMP; Department of Education, Title VII (http://www.ed.gov/; award P382G090003) CJK RMP TMC; and the Oak Foundation (http://oakfnd.org/) TMC RMP.	Allen J, 2013, SCIENCE, V340, P485, DOI 10.1126/science.1231976; Ansmann IC, 2012, ANIM BEHAV, V84, P575, DOI 10.1016/j.anbehav.2012.06.009; Baird RM, 1992, OECOLOGIA, P89125; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Broadhurst M.K., 1998, MAR FISH REV, V60, P9; CAIRNS SJ, 1987, ANIM BEHAV, V35, P1454, DOI 10.1016/S0003-3472(87)80018-0; Chilvers BL, 2003, CAN J ZOOL, V81, P1947, DOI 10.1139/Z03-195; Chilvers BL, 2001, P ROY SOC B-BIOL SCI, V268, P1901, DOI 10.1098/rspb.2001.1732; Daura-Jorge FG, 2012, BIOL LETTERS, V8, P702, DOI 10.1098/rsbl.2012.0174; Donaldson R, 2012, ANIM CONSERV; Fertl D., 1997, Journal of Northwest Atlantic Fishery Science, V22, P219; Finn Hugh, 2008, Pacific Conservation Biology, V14, P215; Fleming KH, 2004, THESIS; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; GIRALDEAU LA, 1984, AM NAT, V124, P72, DOI 10.1086/284252; Gonzalvo J, 2008, J EXP MAR BIOL ECOL, V367, P47, DOI 10.1016/j.jembe.2008.08.013; Gubbins Cara, 2002, Aquatic Mammals, V28, P24; Jaeggi AV, 2010, AM J PRIMATOL, V72, P62, DOI 10.1002/ajp.20752; Kendal RL, 2010, LEARN BEHAV, V38, P220, DOI 10.3758/LB.38.3.220; Kovacs C, 2014, AQUAT MAMM, V40, P81, DOI 10.1578/AM.40.1.2014.81; Lopez BD, 2008, BEHAV ECOL SOCIOBIOL, V62, P887, DOI 10.1007/s00265-007-0512-1; Mann J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1983; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Nowacek DP, 2002, BEHAVIOUR, V139, P1125, DOI 10.1163/15685390260437290; Pace DS, 2011, BEHAV ECOL, V22, P276; Page RA, 2006, CURR BIOL, V16, P1201, DOI 10.1016/j.cub.2006.04.038; Perrtree RM, 2011, THESIS; Perrtree RM, 2014, MAR MAMMAL SCI, V30, P1320, DOI 10.1111/mms.12114; Powell JR, 2011, MAR MAMMAL SCI, V27, P111, DOI 10.1111/j.1748-7692.2010.00401.x; RODGERS AR, 2007, HRT HOME RANGE TOOLS; Rossbach KA, 1999, CAN J ZOOL, V77, P581, DOI 10.1139/cjz-77-4-581; Samuels Amy, 2004, Journal of Cetacean Research and Management, V6, P69; Sargeant BL, 2007, BEHAV ECOL SOCIOBIOL, V61, P679, DOI 10.1007/s00265-006-0296-8; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; Shane S.H., 1990, P245; SMOLKER RA, 1992, BEHAVIOUR, V123, P38, DOI 10.1163/156853992X00101; Svane I, 2005, FISH RES, V76, P317, DOI 10.1016/j.fishres.2005.07.012; Torres LG, 2009, MAR MAMMAL SCI, V25, P797, DOI 10.1111/j.1748-7692.2009.00297.x; Urian KW, 1999, NMESSEFSC425 NOAA; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y	41	16	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0170151	10.1371/journal.pone.0170151	http://dx.doi.org/10.1371/journal.pone.0170151			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146563	Green Published, Green Submitted, gold			2022-12-27	WOS:000396131700014
J	Flokas, ME; Karanika, S; Alevizakos, M; Mylonakis, E				Flokas, Myrto Eleni; Karanika, Styliani; Alevizakos, Michail; Mylonakis, Eleftherios			Prevalence of ESBL-Producing Enterobacteriaceae in Pediatric Bloodstream Infections: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							SPECTRUM BETA-LACTAMASES; GRAM-NEGATIVE BACTERIA; INTENSIVE-CARE-UNIT; BACTERIOLOGICAL PROFILE; ESCHERICHIA-COLI; NEONATAL SEPSIS; KLEBSIELLA-PNEUMONIAE; RISK-FACTORS; SURVEILLANCE; SEPTICEMIA	Background Pediatric bloodstream infections (BSIs) with Extended-Spectrum Beta-Lactamase-producing Enterobacteriaceae (ESBL-PE) are associated with worse clinical outcomes. We aimed to estimate the prevalence of and the mortality associated with ESBL-PE in this patient population. Methods A systematic review and meta-analysis using PubMed and EMBASE and included studies reporting the prevalence of ESBL-PE among confirmed BSIs in patients <19 years old. Results Twenty three (out of 1,718 non-duplicate reports) studies that provided data on 3,381 pediatric BSIs from 1996 to 2013 were included. The prevalence of ESBL-PE was 9% [95%CI (6, 13)] with an annual increase of 3.2% (P=0.04). The prevalence was 11% [95%CI (6, 17)] among neonates, compared to 5% [95%CI (0, 14)] among children older than 28 days. The pooled prevalence was 15% in Africa [95%CI (8, 23)], 12% in South America [95%CI (5, 23)], 11% in India [95%CI (7, 17)], 7% in the rest of Asia [95%CI (0, 22)], 4% in Europe [95%CI (1, 7)] and 0% in Oceania [95%CI (0, 3)]. Importantly, the mortality in neonates with BSI due to ESBL-PE was 36% [95%CI (22, 51)], compared to 18% [95%CI (15, 22)] among all other neonates with BSI and this difference was statistically significant (P = 0.01). Conclusions In the pediatric population, the prevalence of BSI due to ESBL-PE is significant and is associated with increased mortality in neonates. Further studies are warranted to establish a high-risk group and the evaluation of preventive measures, such as antibiotic stewardship programs and infection control measures, in this population is urgently needed.	[Flokas, Myrto Eleni; Karanika, Styliani; Alevizakos, Michail; Mylonakis, Eleftherios] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Infect Dis, Providence, RI 02903 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Mylonakis, E (corresponding author), Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Infect Dis, Providence, RI 02903 USA.	emylonakis@lifespan.org	Karanika, Styliani/ABH-7576-2020	Karanika, Styliani/0000-0003-2387-6075				Al-Sweedan SA, 2012, J PEDIAT INF DIS-GER, V7, P15, DOI 10.3233/JPI-2012-0343; Ariffin H, 2000, Int J Infect Dis, V4, P21, DOI 10.1016/S1201-9712(00)90061-4; ARSP Working Grp, 2013, CEYLON MED J, V58, P56, DOI 10.4038/cmj.v58i2.5680; Ballot Daynia E, 2012, ISRN Pediatr, V2012, P508512, DOI 10.5402/2012/508512; Bhattacharjee A, 2008, INDIAN J MED MICROBI, V26, P356; Biedenbach DJ, 2004, DIAGN MICR INFEC DIS, V50, P59, DOI 10.1016/j.diagmicrobio.2004.05.003; Blaschke AJ, 2009, AM J INFECT CONTROL, V37, P435, DOI 10.1016/j.ajic.2008.09.019; Blomberg B, 2005, J CLIN MICROBIOL, V43, P745, DOI 10.1128/JCM.43.2.745-749.2005; Centers for Disease Control and Prevention, 2013, ANTIBIOTIC RESISTANC; Chandel DS, 2011, J MED MICROBIOL, V60, P500, DOI 10.1099/jmm.0.027375-0; Cheguirian ML, 2008, REV ARGENT MICROBIOL, V40, P111; Chelliah A, 2014, J CLIN DIAGN RES, V8, pDC24, DOI 10.7860/JCDR/2014/8597.4512; Crivaro V, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0909-9; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dimitrov TS, 2005, MED PRIN PRACT, V14, P417, DOI 10.1159/000088115; Dramowski A, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0354-3; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gajul Shivali V, 2015, J Lab Physicians, V7, P32, DOI 10.4103/0974-2727.151689; Grisaru-Soen G, 2007, MED SCI MONITOR, V13, pCR251; Hawkey PM, 2008, J ANTIMICROB CHEMOTH, V62, pI1, DOI 10.1093/jac/dkn241; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Isendahl J, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0715-9; Jaballah NB, 2007, AM J INFECT CONTROL, V35, P613, DOI 10.1016/j.ajic.2006.09.007; Jain A, 2003, J MED MICROBIOL, V52, P421, DOI 10.1099/jmm.0.04966-0; Kayange N, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-39; Kim YK, 2002, ANTIMICROB AGENTS CH, V46, P1481, DOI 10.1128/AAC.46.5.1481-1491.2002; Kumar C S Vinod, 2004, Indian Pediatr, V41, P97; Latiff Zarina, 2002, Malays J Pathol, V24, P83; Laupland Kevin B, 2015, BMC Res Notes, V8, P123, DOI 10.1186/s13104-015-1051-x; Linkin DR, 2004, INFECT CONT HOSP EP, V25, P781, DOI 10.1086/502477; Logan LK, 2014, J PEDIAT INF DIS SOC, V3, P320, DOI 10.1093/jpids/piu010; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Muley VA, 2015, J GLOB INFECT DIS, V7, P75, DOI 10.4103/0974-777X.154444; Ndir A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0143729; Nyaga VN, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-39; Paterson DL, 2000, CLIN MICROBIOL INFEC, V6, P460, DOI 10.1046/j.1469-0691.2000.00107.x; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Rao YK., 2012, INT J PHARM BIO SCI, V3, pB282; Raymond J, 2000, INFECT CONT HOSP EP, V21, P260, DOI 10.1086/501755; Raymond NJ, 2006, INTERN MED J, V36, P765, DOI 10.1111/j.1445-5994.2006.01213.x; Roy S, 2013, INDIAN J MED RES, V137, P791; Rucker G, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-79; Sehgal R, 2007, ANN TROP PAEDIATR, V27, P45, DOI 10.1179/146532807X170501; Shah AJ, 2012, J CLIN NEONATOL, V1, P72, DOI 10.4103/2249-4847.96753; Stapleton PJM, 2016, ARCH DIS CHILD-FETAL, V101, P72, DOI 10.1136/archdischild-2015-308707; Tariq TM, 2014, JCPSP-J COLL PHYSICI, V24, P396, DOI 06.2014/JCPSP.396399; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Tiwari DK, 2013, J CLIN DIAGN RES, V7, P2732, DOI 10.7860/JCDR/2013/6682.3701; Tumbarello M, 2007, ANTIMICROB AGENTS CH, V51, P1987, DOI 10.1128/AAC.01509-06; Vijayakanthi Nandini, 2013, Biomed Res Int, V2013, P756209, DOI 10.1155/2013/756209; Wells G.A., NEWCASTLE OTTAWA SCA; Wynn JL, 2010, CLIN PERINATOL, V37, P307, DOI 10.1016/j.clp.2010.04.001; Zacharioudakis IM, 2015, AM J GASTROENTEROL, V110, P381, DOI 10.1038/ajg.2015.22; Zaki ME, 2007, J INFECT DEV COUNTR, V1, P269, DOI 10.3855/jidc.363; Zaoutis TE, 2005, PEDIATRICS, V115, P942, DOI 10.1542/peds.2004-1289	55	42	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171216	10.1371/journal.pone.0171216	http://dx.doi.org/10.1371/journal.pone.0171216			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141845	gold, Green Published, Green Submitted			2022-12-27	WOS:000396129500049
J	Hartmann, AK; Nuel, G				Hartmann, Alexander K.; Nuel, Gregory			Using Triplet Ordering Preferences for Estimating Causal Effects in the Analysis of Gene Expression Data	PLOS ONE			English	Article							OBSERVATIONAL DATA; REGULATORY NETWORKS	Triplet ordering preferences are used to perform Monte Carlo sampling of the posterior causal orderings originating from the analysis of gene-expression experiments involving observation as well as, usually few, interventions, like knock-outs. The performance of this sampling approach is compared to a previously used sampling via pairwise ordering preference as well as to the sampling of the full posterior distribution. For a fair comparison, the latter approach is restricted to twice the numerical effort of the triplet-based approach. This is done for artificially generated causal, i.e.,directed acyclic graphs (DAGs)and for actual experimental data taken from the ROSETTA challenge. The sampling using the triplets ordering turns out to be superior to both other approaches.	[Hartmann, Alexander K.] Carl von Ossietzky Univ Oldenburg, Inst Phys, D-26111 Oldenburg, Germany; [Nuel, Gregory] Univ Paris 06, LPMA, CNRS 7599, Paris, France	Carl von Ossietzky Universitat Oldenburg; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Hartmann, AK (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Phys, D-26111 Oldenburg, Germany.	alexander.hartmann@uni-oldenburg.de		Hartmann, Alexander/0000-0001-6865-5474	Graduiertenkolleg 1885 "Molecular Basis of Sensory Biology" - Deutsche Forschungsgemeinschaft (DFG); Foundation Sciences Mathematiques de Paris (FSMP); DFG [INST 184/108-1 FUGG]; ministry of Science and Culture (MWK) of the Lower Saxony State [INST 184/108-1 FUGG]	Graduiertenkolleg 1885 "Molecular Basis of Sensory Biology" - Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Foundation Sciences Mathematiques de Paris (FSMP); DFG(German Research Foundation (DFG)); ministry of Science and Culture (MWK) of the Lower Saxony State	A visit of GN to the University of Oldenburg, during which the project was set up, was supported by the Graduiertenkolleg 1885 "Molecular Basis of Sensory Biology" funded by the Deutsche Forschungsgemeinschaft (DFG). AKH is grateful to the Foundation Sciences Mathematiques de Paris (FSMP) for providing financial support for a three month (February to April 2016) visit at the LPTMA of the Universite Pierre et Marie Curie during which this project was mainly conducted. The simulations were performed on the HERO cluster of the University of Oldenburg jointly funded by the DFG (INST 184/108-1 FUGG) and the ministry of Science and Culture (MWK) of the Lower Saxony State. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A visit of GN to the University of Oldenburg, during which the project was set up, was supported by the Graduiertenkolleg 1885 "Molecular Basis of Sensory Biology" funded by the Deutsche Forschungsgemeinschaft (DFG). AKH is grateful to the Foundation Sciences Mathmatiques de Paris (FSMP) for providing financial support for a three month (February to April 2016) visit at the LPTMA of the Universite Pierre et Marie Curie during which this project mainly conducted.; The simulations were performed on the HERO cluster of the University of Oldenburg jointly funded by the DFG (INST 184/108-1 FUGG) and the ministry of Science and Culture (MWK) of the Lower Saxony State.	CRITCHLOW DE, 1991, J MATH PSYCHOL, V35, P294, DOI 10.1016/0022-2496(91)90050-4; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Hartmann AK, 2015, BIG PRACTICAL GUIDE, DOI [DOI 10.1142/9019, 10.1142/9019]; Hauser A, 2015, J R STAT SOC B, V77, P291, DOI 10.1111/rssb.12071; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jayavelu ND, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0768-9; Joe H, 1993, CELL, V102, P109; Lu T, 2011, J AM STAT ASSOC, V106, P1242, DOI 10.1198/jasa.2011.ap10194; Maathuis MH, 2010, NAT METHODS, V7, P247, DOI 10.1038/nmeth0410-247; Maathuis MH, 2009, ANN STAT, V37, P3133, DOI 10.1214/09-AOS685; Nuel G, 2014, QUAL TECHNOL QUANT M, V11, P23, DOI 10.1080/16843703.2014.11673323; Pe'er D, 2001, Bioinformatics, V17 Suppl 1, pS215; Pearl J.., 2009, CAUSALITY; Rau A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-111; Wang JX, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt147; Wang YQ, 2012, BRIEF BIOINFORM, V13, P162, DOI 10.1093/bib/bbr032; Wu HL, 2014, J AM STAT ASSOC, V109, P700, DOI 10.1080/01621459.2013.859617; Zou M, 2005, BIOINFORMATICS, V21, P71, DOI 10.1093/bioinformatics/bth463	18	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170514	10.1371/journal.pone.0170514	http://dx.doi.org/10.1371/journal.pone.0170514			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141825	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000396129500011
J	Xu, ZR; Yang, W; You, KM; Li, W; Kim, YI				Xu, Zirui; Yang, Wei; You, Kaiming; Li, Wei; Kim, Young-Il			Vehicle autonomous localization in local area of coal mine tunnel based on vision sensors and ultrasonic sensors	PLOS ONE			English	Article							SYSTEM; ENVIRONMENT; ROBOT	This paper presents a vehicle autonomous localization method in local area of coal mine tunnel based on vision sensors and ultrasonic sensors. Barcode tags are deployed in pairs on both sides of the tunnel walls at certain intervals as artificial landmarks. The barcode coding is designed based on UPC-A code. The global coordinates of the upper left inner corner point of the feature frame of each barcode tag deployed in the tunnel are uniquely represented by the barcode. Two on-board vision sensors are used to recognize each pair of barcode tags on both sides of the tunnel walls. The distance between the upper left inner corner point of the feature frame of each barcode tag and the vehicle center point can be determined by using a visual distance projection model. The on-board ultrasonic sensors are used to measure the distance from the vehicle center point to the left side of the tunnel walls. Once the spatial geometric relationship between the barcode tags and the vehicle center point is established, the 3D coordinates of the vehicle center point in the tunnel's global coordinate system can be calculated. Experiments on a straight corridor and an underground tunnel have shown that the proposed vehicle autonomous localization method is not only able to quickly recognize the barcode tags affixed to the tunnel walls, but also has relatively small average localization errors in the vehicle center point's plane and vertical coordinates to meet autonomous unmanned vehicle positioning requirements in local area of coal mine tunnel.	[Xu, Zirui; Yang, Wei; You, Kaiming] Beijing Jiaotong Univ, Sch Elect & Informat Engn, Beijing, Peoples R China; [Li, Wei] Beijing Jiaotong Univ, Sch Mech Elect & Control Engn, Beijing, Peoples R China; [Kim, Young-Il] Elect & Telecommun Res Inst, Daejeon, South Korea	Beijing Jiaotong University; Beijing Jiaotong University; Electronics & Telecommunications Research Institute - Korea (ETRI)	Yang, W (corresponding author), Beijing Jiaotong Univ, Sch Elect & Informat Engn, Beijing, Peoples R China.	wyang@bjtu.edu.cn			Natural Science Foundation of China [51474015]; Key projects of national key Research and Development program [2016YFC0801806]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key projects of national key Research and Development program	This work was supported by the Natural Science Foundation of China under Grant (51474015, 51474015) and the Key projects of national key Research and Development program (2016YFC0801806).	Ahmad R, 2015, INDIACOM; Asmaa L, 2014, 2014 3 IEEE INT C IN; Bansal S, 2013, IJCA, V66; Brown C, 2012, ENG MIN J, V213, P30; Chauhan AS, 2014, 2014 4 INT C COMM SY; Chen KC, 2010, IEEE T VEH TECHNOL, V59, P3261, DOI 10.1109/TVT.2010.2052079; Chen XH, 2014, INT J CONTROL AUTOM, V12, P1313, DOI [10.1007/s12555-013-0076-y, 10.1007/s12555-013-0021-0]; Cheng GL, 2012, PHYSCS PROC, V24, P534, DOI 10.1016/j.phpro.2012.02.078; Cossairt O, 2013, IEEE T IMAGE PROCESS, V22, P447, DOI 10.1109/TIP.2012.2216538; Dirami A, 2013, SIGNAL PROCESS, V93, P139, DOI 10.1016/j.sigpro.2012.07.010; Fabijanska A, 2010, 2010 P 6 INT C PERSP; Fiala M ., 2005, 2005 IEEE COMP SOC C; Forooshani Arghavan Emami, 2013, IEEE Communications Surveys & Tutorials, V15, P1524, DOI 10.1109/SURV.2013.031413.00130; Fu M, 2014, 17 INT IEEE C INT TR; Hirata S, 2009, IEEE INT CONF ROBOT, P3454; Huh S, 2011, CONTR AUT SYST ICCAS; Jun O., 1988, IEEE T SYST MAN CY-S, P62; Karakaya M, 2014, ACM T SENSOR NETWORK, V10, DOI 10.1145/2529999; Lee D, 2013, UB ROB AMB INT URAI; Li W, 2011, IECON 2011 37 ANN C; Liu LA, 2010, IEEE T VEH TECHNOL, V59, P3562, DOI 10.1109/TVT.2009.2031454; Mehta SS, 2008, COMPUT ELECTRON AGR, V63, P28, DOI 10.1016/j.compag.2008.01.013; Niu X, 2007, IEEE GLOBECOM 2007 I; Olson Edwin, 2011, 2011 IEEE International Conference on Robotics and Automation, P3400; Razzak MI, 2010, IJCC, V8; RIGLER R, 1993, EUR BIOPHYS J BIOPHY, V22, P169, DOI 10.1007/BF00185777; Sasmito AP, 2013, TUNN UNDERGR SP TECH, V34, P82, DOI 10.1016/j.tust.2012.09.006; Straw AD, 2010, J ROYAL SOC INTERFAC; Thrun S, 2001, ARTIF INTELL, V128, P99, DOI 10.1016/S0004-3702(01)00069-8; Trivun D, 2015, IND TECHN ICIT 2015; Usha D, 2014, IJCA, V87; Wang H, 2010, IEEE J SEL AREA COMM, V28, P1127, DOI 10.1109/JSAC.2010.100917; Wang J., 2014, INT J COAL SCI TECHN, V1, P253, DOI [DOI 10.1007/S40789-014-0017-2, 10.1007/s40789-014-0017-2]; You KM, 2015, SENSORS-BASEL, V15, P25103, DOI 10.3390/s151025103; Zhang L, 2015, SENSORS-BASEL, V15, P19937, DOI 10.3390/s150819937; Zhang Y, 2014, SENSORS-BASEL, V14, P13149, DOI 10.3390/s140713149; Zhou Y, 2007, P 2007 IEEE INT C RO	37	12	14	5	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171012	10.1371/journal.pone.0171012	http://dx.doi.org/10.1371/journal.pone.0171012			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141829	gold, Green Submitted, Green Published			2022-12-27	WOS:000396129500033
J	List, JM; Greenhill, SJ; Gray, RD				List, Johann-Mattis; Greenhill, Simon J.; Gray, Russell D.			The Potential of Automatic Word Comparison for Historical Linguistics	PLOS ONE			English	Article							LANGUAGES; REVEAL	The amount of data from languages spoken all over the world is rapidly increasing. Traditional manual methods in historical linguistics need to face the challenges brought by this influx of data. Automatic approaches to word comparison could provide invaluable help to pre-analyze data which can be later enhanced by experts. In this way, computational approaches can take care of the repetitive and schematic tasks leaving experts to concentrate on answering interesting questions. Here we test the potential of automatic methods to detect etymologically related words ( cognates) in cross-linguistic data. Using a newly compiled database of expert cognate judgments across five different language families, we compare how well different automatic approaches distinguish related from unrelated words. Our results show that automatic methods can identify cognates with a very high degree of accuracy, reaching 89% for the best-performing method Infomap. We identify the specific strengths and weaknesses of these different methods and point to major challenges for future approaches. Current automatic approaches for cognate detection-although not perfect-could become an important component of future research in historical linguistics.	[List, Johann-Mattis] Ecole Hautes Etud Sci Sociales, Ctr Rech Linguist Asie Orientale, 2 Rue Lille, F-75007 Paris, France; [Greenhill, Simon J.; Gray, Russell D.] Max Planck Inst Sci Human Hist, Dept Linguist & Cultural Evolut, Kahlaische Str 10, D-07743 Jena, Germany; [Greenhill, Simon J.] Australian Natl Univ, ARC Ctr Excellence Dynam Language, Canberra, ACT 2600, Australia	Australian National University	List, JM (corresponding author), Ecole Hautes Etud Sci Sociales, Ctr Rech Linguist Asie Orientale, 2 Rue Lille, F-75007 Paris, France.	mattis.list@lingpy.org	Greenhill, Simon/I-3554-2019; List, Johann-Mattis/G-6279-2016	Greenhill, Simon/0000-0001-7832-6156; List, Johann-Mattis/0000-0003-2133-8919	Max Planck Institute for the Science of Human History; Royal Society of New Zealand Marsden Fund [13-UOA-121]; DFG research fellowship [261553824]; Australian Research Council's Discovery Projects funding scheme [DE120101954]	Max Planck Institute for the Science of Human History; Royal Society of New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); DFG research fellowship(German Research Foundation (DFG)); Australian Research Council's Discovery Projects funding scheme(Australian Research Council)	As part of the GlottoBank Project, this work was supported by the Max Planck Institute for the Science of Human History and the Royal Society of New Zealand Marsden Fund grant 13-UOA-121. This paper was further supported by the DFG research fellowship grant 261553824 Vertical and lateral aspects of Chinese dialect history (JML), and the Australian Research Councils Discovery Projects funding scheme (project number DE120101954, SJG).	Amigo E, 2009, INFORM RETRIEVAL, V12, P461, DOI 10.1007/s10791-008-9066-8; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], 2013, GLOBAL LEXICOSTATIST; [Anonymous], [No title captured], DOI DOI 10.1075/DIA.23.1.04HAM; [Anonymous], 2000, DICT HIST COMP LINGU; [Anonymous], 2015, GLOTTOLOG; [Anonymous], [No title captured]; Bagga A., 1998, P 36 ANN M ASS COMP, V1, P79; Beijing Daxue, 1964, CHINESE DIALECT VOCA; Beinborn Lisa, 2013, P 6 INT JOINT C NAT, P883; Berg-Kirkpatrick Taylor, 2011, P EMNLP, P313; Bergsma S., 2007, P 45 ANN M ASS COMP, P656; Bouchard-Cote A, 2013, P NATL ACAD SCI USA, V110, P4224, DOI 10.1073/pnas.1204678110; Bowern C, 2016, LANG DOC CONSERV, V10, P1; Campbell L., 2011, CURR ANTHROPOL, V52, P866; Ciobanu AM, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 2, P99; Corel E, 2016, TRENDS MICROBIOL, V24, P224, DOI 10.1016/j.tim.2015.12.003; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dolgopolsky A. B., 1964, VOPR YAZYKOZNANIYA, V2, P53; Dunn Michael, 2012, INDOEUROPEAN LEXICAL; Embleton Sheila, 2000, TIME DEPTH HIST LING, P143; Fox Anthony, 1995, LINGUISTIC RECONSTRU; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Greenhill SJ, 2011, COMPUT LINGUIST, V37, P689, DOI 10.1162/COLI_a_00073; Greenhill SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141563; Greenhill SJ, 2008, EVOL BIOINFORM, V4, P271; Hattori S., 1973, DIACHRONIC AREAL TYP, P368; Hauer Bradley, 2011, P 5 INT JOINT C NAT, P865; Holm HJ, 2007, J QUANT LINGUIST, V14, P167, DOI 10.1080/09296170701378916; Holman EW, 2008, FOLIA LINGUIST, V20, P116; Hou J., 2004, PHONOLOGICAL DATABAS; Jager G, 2015, P NATL ACAD SCI USA, V112, P12752, DOI 10.1073/pnas.1500331112; Jager G., 2016, P 13 C NAT LANG PROC, P128; Kessler B., 2001, SIGNIFICANCE WORD LI; Kitchen A, 2009, P ROY SOC B-BIOL SCI, V276, P2703, DOI 10.1098/rspb.2009.0408; Kondrak Grzegorz, 2000, P 1 N AM CHAPT ASS C, P288; LEVENSHT.VI, 1965, DOKL AKAD NAUK SSSR+, V163, P845; List J.-M., 2013, ACL C SYST DEM, P13; List J-M, 2014, SEQUENCE COMP HIST L; List JM, 2016, PROCEEDINGS OF THE 54TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2016), VOL 2, P599; List JM, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0145-2; List Johann-Mattis, 2014, J LANGUAGE RELATIONS; Mackay Wesley, 2005, P 9 C COMPUTATIONAL, P40; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; McElhanon KA, 1967, OCEAN LINGUIST, V6, P1, DOI [10.2307/3622923, DOI 10.2307/3622923]; McMahon A., 2005, LANGUAGE CLASSIFICAT; Meheust R, 2016, PNAS IN PRESS; Rama T, 2013, P QUANT INV THEOR LI, P76; Ross M., 1996, COMP METHOD REV REGU, P3; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Saenko M., 2015, GLOBAL LEXICOSTATIST; Sidwell P., 2011, CURR ANTHROPOL, V52, P869; Sidwell Paul, 2015, MON KHMER STUDIES NO, V44, plxviii; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Starostin G. S., 2011, GLOBAL LEXICOSTATIST; Steiner L, 2011, LANG DYN CHANG, V1, P89, DOI 10.1163/221058211X570358; Syrjanen K, 2013, DIACHRONICA, V30, P323, DOI 10.1075/dia.30.3.02syr; Turchin P., 2010, J LANGUAGE RELATIONS, V3, P117; van Dongen S, 2000, THESIS; Vlasblom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-99; Wahle J., 2016, P LEID WORKSH CAPT P; Wang Feng., 2006, COMP LANGUAGES CONTA; Wheeler WC, 2015, CLADISTICS, V31, P113, DOI 10.1111/cla.12078; Zhivlov Mikhail, 2011, GLOBAL LEXICOSTATIST	66	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170046	10.1371/journal.pone.0170046	http://dx.doi.org/10.1371/journal.pone.0170046			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EN7VX	28129337	Green Published, gold, Green Submitted			2022-12-27	WOS:000396211400065
J	Saldana, RS; Schrem, H; Barthold, M; Kaltenborn, A				Saldana, Ricardo Salinas; Schrem, Harald; Barthold, Marc; Kaltenborn, Alexander			Prognostic Abilities and Quality Assessment of Models for the Prediction of 90-Day Mortality in Liver Transplant Waiting List Patients	PLOS ONE			English	Article							DISEASE SCORE; HEPATITIS-B; SERUM SODIUM; MELD-SCORE; SURVIVAL; ALLOCATION; CIRRHOSIS; FAILURE; GERMANY; INDEX	Background Model of end-stage liver disease (MELD)-score and diverse variants are widely used for prognosis on liver transplant waiting-lists. Methods 818 consecutive patients on the liver transplant waiting-list included to calculate the MELD, MESO Index, MELD-Na, UKELD, iMELD, refitMELD, refitMELD-Na, upMELD and PELDscores. Prognostic abilities for 90-day mortality were investigated applying Receiver-operating-characteristic-curve analysis. Independent risk factors for 90-day mortality were identified with multivariable binary logistic regression modelling. Methodological quality of the underlying development studies was assessed with a systematic assessment tool. Results 74 patients (9%) died on the liver transplant waiting list within 90 days after listing. All but one scores, refitMELD-Na, had acceptable prognostic performance with areas under the ROC-curves (AUROCs)>0.700. The iMELD performed best (AUROC = 0.798). In pediatric cases, the PELD-score just failed to reach the acceptable threshold with an AUROC = 0.699. All scores reached a mean quality score of 72.3%. Highest quality scores could be achieved by the UKELD and PELD-scores. Studies specifically lack statistical validity and model evaluation. Conclusions Inferior quality assessment of prognostic models does not necessarily imply inferior prognostic abilities. The iMELD might be a more reliable tool representing urgency of transplantation than the MELD-score. PELD-score is assumedly not accurate enough to allow graft allocation decision in pediatric liver transplantation.	[Saldana, Ricardo Salinas; Schrem, Harald; Barthold, Marc; Kaltenborn, Alexander] Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat IFB T, Core Facil Qual Management & Hlth Technol Assessm, Hannover, Germany; [Schrem, Harald] Hannover Med Sch, Dept Gen Visceral & Transplant Surg, Hannover, Germany; [Kaltenborn, Alexander] Fed Armed Forces Hosp Westerstede, Dept Trauma & Orthoped Surg, Westerstede, Germany	Hannover Medical School; Hannover Medical School	Kaltenborn, A (corresponding author), Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat IFB T, Core Facil Qual Management & Hlth Technol Assessm, Hannover, Germany.; Kaltenborn, A (corresponding author), Fed Armed Forces Hosp Westerstede, Dept Trauma & Orthoped Surg, Westerstede, Germany.	kaltenborn.alexander@mh-hannover.de			German Federal Ministry of Education and Research [01EO1302]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from the German Federal Ministry of Education and Research (reference number: 01EO1302). The funders had no role in study design, data collection and Analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, EUROTRANSPLANT MANUA, V1, P13; Barber K, 2011, TRANSPLANTATION, V92, P469, DOI 10.1097/TP.0b013e318225db4d; Cai CJ, 2008, CHINESE MED J-PEKING, V121, P2065, DOI 10.1097/00029330-200810020-00023; Collins GS, 2015, BRIT J SURG, V102, P148, DOI 10.1002/bjs.9736; German Medical Association, 2013, DTSCH ARZTEBL, V110; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Huo TI, 2007, LIVER INT, V27, P498, DOI 10.1111/j.1478-3231.2007.01445.x; Jacob M, 2005, LIVER TRANSPLANT, V11, P814, DOI 10.1002/lt.20456; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Lee WC, 2011, J VIRAL HEPATITIS, V18, P193, DOI 10.1111/j.1365-2893.2010.01295.x; Leise MD, 2011, GASTROENTEROLOGY, V140, P1952, DOI 10.1053/j.gastro.2011.02.017; Luca A, 2007, LIVER TRANSPLANT, V13, P1174, DOI 10.1002/lt.21197; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; McDiarmid SV, 2002, TRANSPLANTATION, V74, P173, DOI 10.1097/00007890-200207270-00006; Moylan CA, 2008, JAMA-J AM MED ASSOC, V300, P2371, DOI 10.1001/jama.2008.720; Schlitt HJ, 2011, Z GASTROENTEROL, V49, P30, DOI 10.1055/s-0029-1245946; Schrem H, 2013, NATURE, V498, P37, DOI 10.1038/498037b; Schrem H, 2012, ANN TRANSPL, V17, P5; Schrem H, 2012, LANGENBECK ARCH SURG, V397, P717, DOI 10.1007/s00423-011-0881-9; Seehofer D, 2013, CHIRURG, V84, P391, DOI 10.1007/s00104-012-2413-8; Sharma P, 2008, GASTROENTEROLOGY, V135, P1575, DOI 10.1053/j.gastro.2008.08.004; Siontis GCM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3318; Sun LJ, 2010, J GASTROEN HEPATOL, V25, P583, DOI 10.1111/j.1440-1746.2009.06089.x; Sun QF, 2009, J VIRAL HEPATITIS, V16, P464, DOI 10.1111/j.1365-2893.2008.01046.x; Weismuller TJ, 2011, TRANSPL INT, V24, P91, DOI 10.1111/j.1432-2277.2010.01161.x; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016	27	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170499	10.1371/journal.pone.0170499	http://dx.doi.org/10.1371/journal.pone.0170499			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129338	gold, Green Published, Green Submitted			2022-12-27	WOS:000396211400056
J	Zeng, WP; Zhang, R; Li, R; Luo, JF; Hu, XF				Zeng, Wen-ping; Zhang, Rui; Li, Ran; Luo, Jin-fang; Hu, Xiao-feng			Association of the Endothelial Nitric Oxide Synthase Gene T786C Polymorphism with In-Stent Restenosis in Chinese Han Patients with Coronary Artery Disease Treated with Drug-Eluting Stent	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING-ENZYME; MAJOR RISK-FACTOR; MYOCARDIAL-INFARCTION; T-786C POLYMORPHISM; 5'-FLANKING REGION; CLINICAL-OUTCOMES; GROWTH-FACTOR; BARE-METAL; PREDICTORS; MUTATION	Background and aim Many studies have reported that genetic variants correlate with higher risk for coronary artery disease (CAD) or in-stent restenosis (ISR) after bare metal stent (BMS) implantation. However, there is limited data assessing the impact of these variants on ISR in patients treated with drug-eluting stent (DES). The purpose of this study was to investigate the effects of genetic risk factors on ISR in Chinese Han patients treated with DES. Methods A total of 425 patients with a diagnosis of CAD who underwent successful revascularization in native coronary arteries with DES were included in this retrospective study. Genotyping was performed on six single nucleotide polymorphisms (SNPs) in the endothelial nitric oxide synthase gene (eNOS), the angiotensin converting enzyme gene (ACE), the angiotensin II type 1 receptor gene (AT1R), the transforming growth factor beta gene (TGF-beta), and the vascular endothelial growth factor gene (VEGF). Quantitative coronary angiography (QCA) was performed during the follow-up period to detect ISR. Logistic regression models were used to test for association. Results Fifty-four patients (12.7%) developed ISR during the follow-up period. Of the six analyzed SNPs, the frequency of the C allele of T786C polymorphism in eNOS was significantly higher in the ISR group (22.2%) compared to the non-ISR group (12.7%) (p<0.01). In the ISR group, the frequency of the TT, TC, and CC genotypes was 61.1%, 33.3%, and 5.6%, respectively, and in the non-ISR group, the frequencies were 76.8%, 21.0%, and 2.2%, respectively. The multivariable analysis adjusted for potential confounders and revealed that the T786C polymorphism increased the risk of ISR in both additive and dominant models with odds ratios of 1.870 (95% confidence interval [CI]: 1.079-3.240, p = 0.03) and 2.045 (95% CI: 1.056-3.958, p = 0.03), respectively. Conclusion The eNOS T786C polymorphism was associated with ISR in Chinese Han patients treated with DES. Genotyping may be helpful to identify patients with higher risks of ISR after DES implantation.	[Zeng, Wen-ping; Hu, Xiao-feng] Zhejiang Hosp, Dept Cardiol, Hangzhou, Zhejiang, Peoples R China; [Zhang, Rui; Li, Ran; Luo, Jin-fang] Nanchang Univ, Affiliated Hosp 2, Dept Cardiol, Nanchang, Jiangxi, Peoples R China	Nanchang University	Hu, XF (corresponding author), Zhejiang Hosp, Dept Cardiol, Hangzhou, Zhejiang, Peoples R China.	ncdx2006hu@126.com			Health Bureau of Zhejiang Province [2014KYB002]	Health Bureau of Zhejiang Province	This work is supported by grants from Health Bureau of Zhejiang Province (2014KYB002) (Wen-ping Zeng), http://www.zjwst.gov.cn/. Author Contribution of WPZ: preparation of the manuscript, data analysis and funding acquisition.	Amant C, 1997, CIRCULATION, V96, P56; Cassese S, 2014, HEART, V100, P153, DOI 10.1136/heartjnl-2013-304933; Chung IM, 2002, J AM COLL CARDIOL, V40, P2072, DOI 10.1016/S0735-1097(02)02598-6; Doshi AA, 2010, J CARD FAIL, V16, P314, DOI 10.1016/j.cardfail.2009.12.013; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; Gomma AH, 2002, EUR HEART J, V23, P1955, DOI 10.1053/euhj.2002.3400; Han Y, 2010, PHARMACOLOGY, V85, P211, DOI 10.1159/000275135; Holmes DR, 2004, CIRCULATION, V109, P634, DOI 10.1161/01.CIR.0000112572.57794.22; James SK, 2009, NEW ENGL J MED, V360, P1933, DOI 10.1056/NEJMoa0809902; Jo I, 2006, CLIN CHIM ACTA, V365, P86, DOI 10.1016/j.cca.2005.07.029; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Jorgensen E, 2001, J AM COLL CARDIOL, V38, P1434, DOI 10.1016/S0735-1097(01)01580-7; Katsaros KM, 2014, EUROINTERVENTION, V10, P224, DOI 10.4244/EIJV10I2A36; Kim IJ, 2007, THROMB RES, V119, P579, DOI 10.1016/j.thromres.2006.06.005; Koch W, 2006, ARTERIOSCL THROM VAS, V26, P1114, DOI 10.1161/01.ATV.0000217747.66517.11; Li HG, 2000, J PATHOL, V190, P244, DOI 10.1002/(SICI)1096-9896(200002)190:3<244::AID-PATH575>3.0.CO;2-8; Li HG, 2013, CURR OPIN PHARMACOL, V13, P161, DOI 10.1016/j.coph.2013.01.006; Li YT, 2015, IEEE GLOB COMM CONF, DOI [10.1109/GLOCOM.2015.7417288, 10.1109/GLOCOM.2015.7417682]; LINDPAINTNER K, 1995, NEW ENGL J MED, V332, P706, DOI 10.1056/NEJM199503163321103; Liu DX, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003413; Liu VWT, 2008, CARDIOVASC RES, V77, P19, DOI 10.1016/j.cardiores.2007.06.024; Fragoso JM, 2015, EXP MOL PATHOL, V98, P13, DOI 10.1016/j.yexmp.2014.11.007; Miyamoto Y, 2000, HUM MOL GENET, V9, P2629, DOI 10.1093/hmg/9.18.2629; Morris DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037878; Nakano M, 2013, EUR HEART J, V34, P3304, DOI 10.1093/eurheartj/eht241; Nakayama M, 2000, AM J CARDIOL, V86, P628, DOI 10.1016/S0002-9149(00)01041-9; Nakayama M, 1999, CIRCULATION, V99, P2864, DOI 10.1161/01.CIR.99.22.2864; Nakazawa G, 2011, J AM COLL CARDIOL, V57, P1314, DOI 10.1016/j.jacc.2011.01.011; Osadnik T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150500; Pallero MA, 2010, J VASC RES, V47, P309, DOI 10.1159/000265565; Persu A, 2002, HUM MOL GENET, V11, P229, DOI 10.1093/hmg/11.3.229; Rai H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113363; Ribichini F, 1998, CIRCULATION, V97, P147, DOI 10.1161/01.CIR.97.2.147; Schmidt TS, 2007, CLIN SCI, V113, P47, DOI 10.1042/CS20070108; Shibata M, 2001, HISTOCHEM CELL BIOL, V116, P471, DOI 10.1007/s00418-001-0336-4; Shuvalova YA, 2012, MOL CELL BIOCHEM, V370, P241, DOI 10.1007/s11010-012-1419-3; Souza-Costa DC, 2007, ATHEROSCLEROSIS, V193, P438, DOI 10.1016/j.atherosclerosis.2006.07.020; Suzuki T, 2002, INT J CARDIOL, V86, P71, DOI 10.1016/S0167-5273(02)00192-4; Tesauro M, 2000, P NATL ACAD SCI USA, V97, P2832, DOI 10.1073/pnas.97.6.2832; Welt FGP, 2002, ARTERIOSCL THROM VAS, V22, P1769, DOI 10.1161/01.ATV.0000037100.44766.5B; Wijpkema JS, 2006, PHARMACOGENET GENOM, V16, P331, DOI 10.1097/01.fpc.0000205001.07054.fa; Xu JX, 2015, ANGIOLOGY, V66, P652, DOI 10.1177/0003319714547946	43	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170964	10.1371/journal.pone.0170964	http://dx.doi.org/10.1371/journal.pone.0170964			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129392	Green Published, Green Submitted, gold			2022-12-27	WOS:000396211400019
J	Dahl-Halvarsson, M; Pokrzywa, M; Rauthan, M; Pilon, M; Tajsharghi, H				Dahl-Halvarsson, Martin; Pokrzywa, Malgorzata; Rauthan, Manish; Pilon, Marc; Tajsharghi, Homa			Myosin Storage Myopathy in C. elegans and Human Cultured Muscle Cells	PLOS ONE			English	Article							HYALINE BODY MYOPATHY; ONSET DISTAL MYOPATHY; HEAVY-CHAIN; SKELETAL-MUSCLE; CAENORHABDITIS-ELEGANS; MYH7 MUTATION; ROD; MECHANISMS; DOMAIN	Myosin storage myopathy is a protein aggregate myopathy associated with the characteristic subsarcolemmal accumulation of myosin heavy chain in muscle fibers. Despite similar histological findings, the clinical severity and age of onset are highly variable, ranging from no weakness to severe impairment of ambulation, and usually childhood-onset to onset later in life. Mutations located in the distal end of the tail of slow/beta-cardiac myosin heavy chain are associated with myosin storage myopathy. Four missense mutations (L1793P, R1845W, E1883K and H1901L), two of which have been reported in several unrelated families, are located within or closed to the assembly competence domain. This location is critical for the proper assembly of sarcomeric myosin rod filaments. To assess the mechanisms leading to protein aggregation in myosin storage myopathy and to evaluate the impact of these mutations on myosin assembly and muscle function, we expressed mutated myosin proteins in cultured human muscle cells and in the nematode Caenorhabditis elegans. While L1793P mutant myosin protein efficiently incorporated into the sarcomeric thick filaments, R1845W and H1901L mutants were prone to formation of myosin aggregates without assembly into striated sarcomeric thick filaments in cultured muscle cells. In C. elegans, mutant alleles of the myosin heavy chain gene unc-54 corresponding to R1845W, E1883K and H1901L, were as effective as the wild-type myosin gene in rescuing the null mutant worms, indicating that they retain functionality. Taken together, our results suggest that the basis for the pathogenic effect of the R1845W and H1901L mutations are primarily structural rather than functional. Further analyses are needed to identify the primary trigger for the histological changes seen in muscle biopsies of patients with L1793P and E1883K mutations.	[Dahl-Halvarsson, Martin; Pokrzywa, Malgorzata] Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Pathol, Gothenburg, Sweden; [Rauthan, Manish; Pilon, Marc] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden; [Tajsharghi, Homa] Univ Skovde, Sch Hlth & Educ, Div Biomed & Publ Hlth, Skovde, Sweden	Sahlgrenska University Hospital; University of Gothenburg; University of Gothenburg; University of Skovde	Tajsharghi, H (corresponding author), Univ Skovde, Sch Hlth & Educ, Div Biomed & Publ Hlth, Skovde, Sweden.	homa.tajsharghi@his.se	Pilon, Marc/AAY-4082-2020; Pokrzywa, Małgorzata/GQA-6257-2022	Pilon, Marc/0000-0003-3919-2882; Halvarsson, Martin/0000-0003-4312-0363	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	The study was supported by grants from the Swedish Research Council (H.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Hussein S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072396; Armel TZ, 2010, J MOL CELL CARDIOL, V48, P1007, DOI 10.1016/j.yjmcc.2009.10.011; Armel TZ, 2010, BIOCHEM BIOPH RES CO, V391, P352, DOI 10.1016/j.bbrc.2009.11.062; Armel TZ, 2009, P NATL ACAD SCI USA, V106, P6291, DOI 10.1073/pnas.0900107106; Bohlega S, 2004, NEUROLOGY, V62, P1518, DOI 10.1212/01.WNL.0000123255.92062.37; BRENNER S, 1974, GENETICS, V77, P71; DIBB NJ, 1985, J MOL BIOL, V183, P543, DOI 10.1016/0022-2836(85)90170-6; Dubourg O, 2011, J NEUROL, V258, P1157, DOI 10.1007/s00415-011-5900-9; Dye DE, 2006, NEUROMUSCULAR DISORD, V16, P357, DOI 10.1016/j.nmd.2006.03.011; Kiphuth IC, 2010, FORTSCHR NEUROL PSYC, V78, P219, DOI 10.1055/s-0029-1245145; Laing NG, 2005, NEUROLOGY, V64, P527, DOI 10.1212/01.WNL.0000150581.37514.30; Lamont PJ, 2014, HUM MUTAT, V35, P868, DOI 10.1002/humu.22553; Lamont PJ, 2006, J NEUROL NEUROSUR PS, V77, P208, DOI 10.1136/jnnp.2005.073825; Lecourt S, 2010, EXP CELL RES, V316, P2513, DOI 10.1016/j.yexcr.2010.04.020; Mello C, 1995, METHOD CELL BIOL, V48, P451; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Meredith C, 2004, AM J HUM GENET, V75, P703, DOI 10.1086/424760; Muelas N, 2010, NEUROLOGY, V75, P732, DOI 10.1212/WNL.0b013e3181eee4d5; Pegoraro E, 2007, NEUROMUSCULAR DISORD, V17, P321, DOI 10.1016/j.nmd.2007.01.010; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; Ruppel KM, 1996, ANNU REV CELL DEV BI, V12, P543, DOI 10.1146/annurev.cellbio.12.1.543; Schiaffino S, 2010, ACTA PHYSIOL, V199, P451, DOI 10.1111/j.1748-1716.2010.02130.x; SCHIAFFINO S, 1994, J APPL PHYSIOL, V77, P493, DOI 10.1152/jappl.1994.77.2.493; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Shingde MV, 2006, NEUROMUSCULAR DISORD, V16, P882, DOI 10.1016/j.nmd.2006.09.001; Sohn RL, 1997, J MOL BIOL, V266, P317, DOI 10.1006/jmbi.1996.0790; Tajsharghi H, 2005, ANN NEUROL, V58, P442, DOI 10.1002/ana.20594; Tajsharghi H, 2003, ANN NEUROL, V54, P494, DOI 10.1002/ana.10693; Tajsharghi H, 2007, NEUROLOGY, V68, P962, DOI 10.1212/01.wnl.0000257131.13438.2c; Tajsharghi H, 2013, ACTA NEUROPATHOL, V125, P3, DOI 10.1007/s00401-012-1024-2; Udd B, 2009, Neuromuscul Disord, V19, P429, DOI 10.1016/j.nmd.2009.04.002; Uro-Coste E, 2009, NEUROMUSCULAR DISORD, V19, P163, DOI 10.1016/j.nmd.2008.11.012; Vilquin JT, 2005, GENE THER, V12, P1651, DOI 10.1038/sj.gt.3302565; Voit T, 2001, NEUROMUSCULAR DISORD, V11, P11, DOI 10.1016/S0960-8966(00)00158-9; Weiss A, 1996, ANNU REV CELL DEV BI, V12, P417, DOI 10.1146/annurev.cellbio.12.1.417; Weiss A, 1999, P NATL ACAD SCI USA, V96, P2958, DOI 10.1073/pnas.96.6.2958	37	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170613	10.1371/journal.pone.0170613	http://dx.doi.org/10.1371/journal.pone.0170613			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125727	gold, Green Published, Green Submitted			2022-12-27	WOS:000396176100086
J	Dewi, IS; Hollander, Z; Lam, KK; McManus, JW; Tebbutt, SJ; Ng, RT; Keown, PA; McMaster, RW; McManus, BM; Gidlof, O; Ohman, J				Dewi, Ihdina Sukma; Hollander, Zsuzsanna; Lam, Karen K.; McManus, Janet-Wilson; Tebbutt, Scott J.; Ng, Raymond T.; Keown, Paul A.; McMaster, Robert W.; McManus, Bruce M.; Gidlof, Olof; Ohman, Jenny			Association of Serum MiR-142-3p and MiR-101-3p Levels with Acute Cellular Rejection after Heart Transplantation	PLOS ONE			English	Article							INTERNATIONAL SOCIETY; CIRCULATING MICRORNAS; EXPRESSION; BIOPSY; SURVEILLANCE; BIOMARKERS; MARKERS; CELLS	Background Identifying non-invasive and reliable blood-derived biomarkers for early detection of acute cellular rejection in heart transplant recipients is of great importance in clinical practice. MicroRNAs are small molecules found to be stable in serum and their expression patterns reflect both physiological and underlying pathological conditions in human. Methods We compared a group of heart transplant recipients with histologically-verified acute cellular rejection (ACR, n = 26) with a control group of heart transplant recipients without allograft rejection (NR, n = 37) by assessing the levels of a select set of microRNAs in serum specimens. Results The levels of seven microRNAs, miR-142-3p, miR-101-3p, miR-424-5p, miR-27a-3p, miR-144- 3p, miR-339-3p and miR-326 were significantly higher in ACR group compared to the control group and could discriminate between patients with and without allograft rejection. MiR-142-3p and miR-101-3p had the best diagnostic test performance among the microRNAs tested. Serum levels of miR-142-3p and miR-101-3p were independent of calcineurin inhibitor levels, as measured by tacrolimus and cyclosporin; kidney function, as measured by creatinine level, and general inflammation state, as measured by CRP level. Conclusion This study demonstrated two microRNAs, miR-142-3p and miR-101-3p, that could be relevant as non-invasive diagnostic tools for identifying heart transplant patients with acute cellular rejection.	[Dewi, Ihdina Sukma; Gidlof, Olof; Ohman, Jenny] Lund Univ, Skane Univ Hosp, Dept Cardiol, Lund, Sweden; [Hollander, Zsuzsanna; Lam, Karen K.; Tebbutt, Scott J.; Ng, Raymond T.; McManus, Bruce M.] Prevent Organ Failure PROOF Ctr Excellence, Vancouver, BC, Canada; [Hollander, Zsuzsanna; Tebbutt, Scott J.] UBC James Hogg Res Ctr, Vancouver, BC, Canada; [McManus, Janet-Wilson] Canadian Blood Serv, netCAD, Vancouver, BC, Canada; [Tebbutt, Scott J.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Tebbutt, Scott J.; McManus, Bruce M.] Univ British Columbia, Ctr Heart Lung Innovat, Vancouver, BC, Canada; [Ng, Raymond T.] Univ British Columbia, Dept Comp Sci, Vancouver, BC, Canada; [Keown, Paul A.] Vancouver Gen Hosp, Vancouver, BC, Canada; [McMaster, Robert W.] Vancouver Coastal Hlth Res Inst, Vancouver, BC, Canada; [McManus, Bruce M.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada	Lund University; Skane University Hospital; University of British Columbia; Canadian Blood Services; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute; University of British Columbia	Dewi, IS (corresponding author), Lund Univ, Skane Univ Hosp, Dept Cardiol, Lund, Sweden.	Ihdina.Sukma_Dewi@med.lu.se		Hollander, Zsuzsanna/0000-0003-4889-996X; Tebbutt, Scott/0000-0002-7908-1581; Lam, Karen/0000-0002-7881-3883	Swedish Heart and Lung Foundation [20130543]; Skke University Hospital Funds; Foundation of Anna-Lisa and Sven-Eric Lundgren; Foundation of Kocks; Foundation of Crafoord; Foundation of Lars-Erik Gelin; Foundation of Lars Hierta; Foundation of Tore Nilsson	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Skke University Hospital Funds; Foundation of Anna-Lisa and Sven-Eric Lundgren; Foundation of Kocks; Foundation of Crafoord; Foundation of Lars-Erik Gelin; Foundation of Lars Hierta; Foundation of Tore Nilsson	This study was supported by The Swedish Heart and Lung Foundation (Grant Number: 20130543 to Dr. Jenny Ohman), Skke University Hospital Funds, and the Foundations of Anna-Lisa and Sven-Eric Lundgren, Kocks, Crafoord, Lars-Erik Gelin, Lars Hierta and Tore Nilsson, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Asaoka T, 2012, AM J TRANSPLANT, V12, P458, DOI 10.1111/j.1600-6143.2011.03807.x; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; Costanzo MR, 2010, J HEART LUNG TRANSPL, V29, P914, DOI 10.1016/j.healun.2010.05.034; Danger R, 2012, J AM SOC NEPHROL, V23, P597, DOI 10.1681/ASN.2011060543; Deng MC, 2006, AM J TRANSPLANT, V6, P1086, DOI 10.1111/j.1600-6143.2006.01305.x; Dewi IS, 2013, J HEART LUNG TRANSPL, V32, P463, DOI 10.1016/j.healun.2012.12.007; Etheridge A, 2011, MUTAT RES-FUND MOL M, V717, P85, DOI 10.1016/j.mrfmmm.2011.03.004; Gautam A, 2016, MOL BIOL REP; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Harris A, 2010, AM J TRANSPLANT, V10, P713, DOI 10.1111/j.1600-6143.2010.03032.x; Heidt S, 2011, TRANSPLANTATION, V92, P1, DOI 10.1097/TP.0b013e318218e978; Hollander Z, 2013, J HEART LUNG TRANSPL, V32, P259, DOI 10.1016/j.healun.2012.11.008; Huang B, 2009, EMBO REP, V10, P180, DOI 10.1038/embor.2008.224; Kobashigawa J, 2015, CIRC-HEART FAIL, V8, P557, DOI 10.1161/CIRCHEARTFAILURE.114.001658; Lund LH, 2013, J HEART LUNG TRANSPL, V32, P951, DOI 10.1016/j.healun.2013.08.006; Manolio T, 2003, NEW ENGL J MED, V349, P1587, DOI 10.1056/NEJMp038136; Mas VR, 2013, AM J TRANSPLANT, V13, P11, DOI 10.1111/j.1600-6143.2012.04313.x; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Morrow DA, 2007, CIRCULATION, V115, P949, DOI 10.1161/CIRCULATIONAHA.106.683110; NIELSEN H, 1993, J HEART LUNG TRANSPL, V12, P239; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Pham MX, 2010, NEW ENGL J MED, V362, P1890, DOI 10.1056/NEJMoa0912965; Roedder S, 2011, GENOME MED, V3, DOI 10.1186/gm253; Rounge TB, 2015, CANCER EPIDEM BIOMAR, V24, P1381, DOI 10.1158/1055-9965.EPI-15-0289; Spiegel JC, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002080; Starling RC, 2006, J HEART LUNG TRANSPL, V25, P1389, DOI 10.1016/j.healun.2006.10.002; Stehlik J, 2006, J HEART LUNG TRANSPL, V25, P1402, DOI 10.1016/j.healun.2006.10.003; Sun YP, 2013, J CLIN INVEST, V123, P4739, DOI 10.1172/JCI70013; Van Aelst LN, 2015, AM J TRANSPLANT; Van Huyen JPD, 2014, EUR HEART J, V35, P3194, DOI 10.1093/eurheartj/ehu346; Wei L, 2013, TRANSPL IMMUNOL, V29, P123, DOI 10.1016/j.trim.2013.08.005; Winters GL, 1996, J HEART LUNG TRANSPL, V15, P728	33	39	40	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170842	10.1371/journal.pone.0170842	http://dx.doi.org/10.1371/journal.pone.0170842			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125729	Green Published, Green Submitted, gold			2022-12-27	WOS:000396176100037
J	El Khadir, M; Boukhris, SA; Benajah, DA; El Rhazi, K; Ibrahimi, SA; El Abkari, M; Harmouch, T; Nejjari, C; Mahmoud, M; Benlemlih, M; Bennani, B				El Khadir, Mounia; Boukhris, Samia Alaoui; Benajah, Dafr-Allah; El Rhazi, Karima; Ibrahimi, Sidi Adil; El Abkari, Mohamed; Harmouch, Taoufiq; Nejjari, Chakib; Mahmoud, Mustapha; Benlemlih, Mohamed; Bennani, Bahia			VacA and CagA Status as Biomarker of Two Opposite End Outcomes of Helicobacter pylori Infection (Gastric Cancer and Duodenal Ulcer) in a Moroccan Population	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; INTERMEDIATE REGION; BIOPSY SPECIMENS; GASTRODUODENAL DISEASES; PRENEOPLASTIC LESIONS; CLINICAL-RELEVANCE; GENE POLYMORPHISMS; GENOTYPES; STRAINS; PREVALENCE	Helicobacter pylori (H. pylori) infection induces inflammation of the gastric mucosa, which may progress to precancerous lesions leading to gastric cancer. Pathological determinism is associated to some virulence genes of the bacterium, notably the vacA and cagA genes. The present study aimed to determine the H. pylori genotypes distribution and their association with sex, age and gastric diseases in a Moroccan population. Gastric biopsy was taken from 1079 consenting patients. The specimens were processed by PCR to identify H. pylori and to determine the genotypic profile by PCR characterizing vacA s, vacA m and vacA i regions directly from biopsies H. pylori positives. VacA genotyping revealed the predominance of vacA m2 (53.2%), vacA s2 (52.9%) and vacA i2 (52%). The most virulent vacA alleles (s1, i1 and m1) are more predominant in men (47.3%, 41.9% and 46.1% respectively) than in women (38.3%, 33.3% and 37% respectively). However, the association between vacA genotypes and age did not reach a statistical significant value. Logistic regression analysis results show that vacA i1m1 and vacA i1m2 genotypes were strongly associated with the risk of GC, the Odds Ratio (95% confidence interval) was 29.73 [ 5.08-173.73] and 9.17 [ 2.06-40.82] respectively, while vacAs1/cagA+ seems to be a risk factor for DU since it is inversely associated with GC (OR was 0.13 [0.02-0.75]. The results of this study suggest that vacA i1 genotype independently to vacAm status may be of a clinical usefulness and will help to identify patients at a high risk of GC development.	[El Khadir, Mounia; Boukhris, Samia Alaoui; Bennani, Bahia] USMBA, Lab Microbiol & Biol Mol, Equipe Microorganismes Genom & Facteurs Oncogenes, FMPF, Fes, Morocco; [El Khadir, Mounia; Benlemlih, Mohamed] USMBA, Lab Biotechnol, Fac Sci Dhar El Mehraz, Fes, Morocco; [Benajah, Dafr-Allah; Ibrahimi, Sidi Adil; El Abkari, Mohamed] CHU Hassan II Fes, FMPF, Serv Hepatogastroenterol, Equipe Malad Appareil Digestif, Fes, Morocco; [Benajah, Dafr-Allah; Ibrahimi, Sidi Adil; El Abkari, Mohamed; Bennani, Bahia] USMBA, FMPF, Lab Pathol Humaine Biomed & Environm, Fes, Morocco; [El Rhazi, Karima; Nejjari, Chakib] USMBA, FMPF, Lab Epidemiol & Rech Clin, Fes, Morocco; [Harmouch, Taoufiq] CHU Hassan II, Serv Anat Pathol, Fes, Morocco; [Mahmoud, Mustapha] CHU Hassan II, Serv Bacteriol, Fes, Morocco	Sidi Mohamed Ben Abdellah University of Fez; Sidi Mohamed Ben Abdellah University of Fez; Hassan II University Hospital Center of Fez; Sidi Mohamed Ben Abdellah University of Fez; Sidi Mohamed Ben Abdellah University of Fez; Sidi Mohamed Ben Abdellah University of Fez; Hassan II University Hospital Center of Fez; Hassan II University Hospital Center of Fez	Bennani, B (corresponding author), USMBA, Lab Microbiol & Biol Mol, Equipe Microorganismes Genom & Facteurs Oncogenes, FMPF, Fes, Morocco.; Bennani, B (corresponding author), USMBA, FMPF, Lab Pathol Humaine Biomed & Environm, Fes, Morocco.	bahia.bennani@usmba.ac.ma		, bahia/0000-0002-5509-3991; EL KHADIR, Mounia/0000-0002-8426-5078; EL RHAZI, Karima/0000-0002-8135-9044	University Hospital Hassan II of Fez, Laboratory of Human Pathology, Biomedicine and Environment of the Faculty of Medicine and Pharmacy of Fez; Ministry of Higher Education, Scientific Research and Professional Training, Morocco; National Centre for Scientific and Technical Research (CNRST)	University Hospital Hassan II of Fez, Laboratory of Human Pathology, Biomedicine and Environment of the Faculty of Medicine and Pharmacy of Fez; Ministry of Higher Education, Scientific Research and Professional Training, Morocco; National Centre for Scientific and Technical Research (CNRST)	We would like to express our deep gratitude to the University Hospital Hassan II of Fez, Laboratory of Human Pathology, Biomedicine and Environment of the Faculty of Medicine and Pharmacy of Fez, Ministry of Higher Education, Scientific Research and Professional Training, Morocco and the National Centre for Scientific and Technical Research (CNRST) for the financial support of this study.	Boukhris SA, 2013, EUR J CLIN MICROBIOL, V32, P969, DOI 10.1007/s10096-013-1887-8; Alarcon T, 1999, FEMS IMMUNOL MED MIC, V24, P215, DOI 10.1016/S0928-8244(99)00029-2; Ashour AAR, 2002, FEMS IMMUNOL MED MIC, V33, P173, DOI 10.1111/j.1574-695X.2002.tb00588.x; Asrat D, 2004, J CLIN MICROBIOL, V42, P2682, DOI 10.1128/JCM.42.6.2682-2684.2004; ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; Basso D, 2008, GASTROENTEROLOGY, V135, P91, DOI 10.1053/j.gastro.2008.03.041; Belda S, 2012, CLIN MICROBIOL INFEC, V18, pE251, DOI 10.1111/j.1469-0691.2012.03884.x; Ben Mansour K, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-10; Bolek BK, 2007, DIAGN MICR INFEC DIS, V58, P67, DOI 10.1016/j.diagmicrobio.2006.12.001; Boquet P, 2012, TRENDS MICROBIOL, V20, P165, DOI 10.1016/j.tim.2012.01.008; Boukhris SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082646; Breurec S, 2012, CLIN MICROBIOL INFEC, V18, P153, DOI 10.1111/j.1469-0691.2011.03524.x; Chattopadhyay S, 2004, J CLIN MICROBIOL, V42, P2821, DOI 10.1128/JCM.42.6.2821-2824.2004; Chung C, 2010, J CLIN MICROBIOL, V48, P690, DOI 10.1128/JCM.01815-09; Danon SJ, 1998, HELICOBACTER, V3, P254, DOI 10.1046/j.1523-5378.1998.08010.x; Erzin Y, 2006, HELICOBACTER, V11, P574, DOI 10.1111/j.1523-5378.2006.00461.x; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Fasciana T, 2015, J MED MICROBIOL, V64, P1408, DOI 10.1099/jmm.0.000163; Ferreira RM, 2012, J CLIN MICROBIOL, V50, P3983, DOI 10.1128/JCM.02087-12; Ferreira RM, 2012, AM J GASTROENTEROL, V107, P145, DOI 10.1038/ajg.2011.389; Figueiredo C, 2001, SCAND J GASTROENTERO, V36, P128, DOI 10.1080/003655201750065861; Frenck RW, 2003, MICROBES INFECT, V5, P705, DOI 10.1016/S1286-4579(03)00112-6; Gangwer KA, 2010, J BACTERIOL, V192, P6126, DOI 10.1128/JB.01081-10; Gonzalez CA, 2011, AM J GASTROENTEROL, V106, P867, DOI 10.1038/ajg.2011.1; Hansson LE, 1996, NEW ENGL J MED, V335, P242, DOI 10.1056/NEJM199607253350404; Hussein N. R., 2015, New Microbes and New Infections, V6, P5, DOI 10.1016/j.nmni.2015.02.005; Hussein NR, 2008, J CLIN MICROBIOL, V46, P1774, DOI 10.1128/JCM.01737-07; Jones KR, 2011, J CLIN MICROBIOL, V49, P101, DOI 10.1128/JCM.01782-10; Karlsson A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-129; Kibria KMK, 2015, HELICOBACTER, V20, P397, DOI 10.1111/hel.12213; Kim JJ, 2003, HELICOBACTER, V8, P202, DOI 10.1046/j.1523-5378.2003.00145.x; Koehler CI, 2003, J CLIN PATHOL-MOL PA, V56, P36, DOI 10.1136/mp.56.1.36; Kumar S, 2008, DIAGN MICR INFEC DIS, V62, P366, DOI 10.1016/j.diagmicrobio.2008.07.014; LAGE AP, 1995, J CLIN MICROBIOL, V33, P2752, DOI 10.1128/JCM.33.10.2752-2756.1995; Lai YC, 2003, WORLD J GASTROENTERO, V9, P1537, DOI 10.3748/wjg.v9.i7.1537; Lehours P, 2004, INFECT IMMUN, V72, P880, DOI 10.1128/IAI.72.2.880-888.2004; Letley DP, 2003, J BIOL CHEM, V278, P26734, DOI 10.1074/jbc.M304071200; Lopez-Vidal Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003849; Markovska R, 2011, DIAGN MICR INFEC DIS, V71, P335, DOI 10.1016/j.diagmicrobio.2011.08.008; Miftahussurur M, 2015, PLOS ONE, V10; Mitonga LG, 2015, INT J HLTH SCI RES, V5, P436; Nguyen TL, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-114; Nimri LF, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-27; Ogiwara H, 2009, J CLIN MICROBIOL, V47, P3493, DOI 10.1128/JCM.00887-09; Ortiz-Princz D, 2010, MEM I OSWALDO CRUZ, V105, P331, DOI 10.1590/S0074-02762010000300016; Rhead JL, 2007, GASTROENTEROLOGY, V133, P926, DOI 10.1053/j.gastro.2007.06.056; Schmidt HMA, 2010, EUR J CLIN MICROBIOL, V29, P439, DOI 10.1007/s10096-010-0881-7; Scholte GHA, 2002, AM J GASTROENTEROL, V97, P1687, DOI 10.1111/j.1572-0241.2002.05775.x; Sgouras DN, 2009, J CLIN MICROBIOL, V47, P2426, DOI 10.1128/JCM.00159-09; Sugimoto M, 2009, EUR J CLIN MICROBIOL, V28, P1227, DOI 10.1007/s10096-009-0772-y; Sugimoto M, 2009, CLIN MICROBIOL INFEC, V15, P835, DOI 10.1111/j.1469-0691.2009.02769.x; Talarico S, 2009, J CLIN MICROBIOL, V47, P1680, DOI 10.1128/JCM.00273-09; van Doorn LJ, 1998, J CLIN MICROBIOL, V36, P2597, DOI 10.1128/JCM.36.9.2597-2603.1998; Yamaoka Y, 1999, GASTROENTEROLOGY, V117, P342, DOI 10.1053/gast.1999.0029900342; Yordanov D, 2012, DIAGN MICR INFEC DIS, V74, P253, DOI 10.1016/j.diagmicrobio.2012.07.008	56	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170616	10.1371/journal.pone.0170616	http://dx.doi.org/10.1371/journal.pone.0170616			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125638	Green Published, gold, Green Submitted			2022-12-27	WOS:000396176100084
J	Hu, W; Shao, XJ; Guo, DX; Hao, HR; Zhang, Y; Xia, MF; Gong, YY; Zhou, HW; Fan, YQ; Yu, WN				Hu, Wen; Shao, Xiaojuan; Guo, Dianxuan; Hao, Hairong; Zhang, Yong; Xia, Mingfeng; Gong, Yingyun; Zhou, Hongwen; Fan, Yunqing; Yu, Weinan			Relationship of Serum Betatrophin with Nonalcoholic Fatty Liver in a Chinese Population	PLOS ONE			English	Article							NONINVASIVE ASSESSMENT; LIPID-METABOLISM; DISEASE; STEATOHEPATITIS; ULTRASONOGRAPHY; EPIDEMIOLOGY; STEATOSIS; FIBROSIS; LIPASIN; GLUCOSE	Objective This study aimed to investigate the association of serum betatrophin with the status and progression of nonalcoholic fatty liver disease (NAFLD). Methods A total of 249 subjects who received ultrasonic examination of liver fat content (LFC) were recruited. Anthropometric and biochemical examinations were performed. Serum betatrophin was measured by ELISA. Results Compared with control group, serum betatrophin significantly increased in NAFLD group (P < 0.05). There was significant difference in serum betatrophin among control, low liver fat content (LLFC), and high liver fat content (HLFC) groups (P < 0.01). After adjustment for gender, age, BMI, FPG and HbA1c, the betatrophin positively correlated with LFC (r = 0.185, P < 0.01) and TG (r = 0.195, P < 0.01). Stepwise multiple regression analysis indicated serum betatrophin was independently related to LFC (P < 0.05). Multivariate logistic regression analysis revealed subjects in the highest tertile of serum betatrophin had higher odds of having NAFLD after adjustment for traditional NAFLD risk factors (OR = 2.88, 95% CI: 1.15-7.19) (P<0.05). Conclusion Serum betatrophin is an independent risk factor for NAFLD and potential non-invasive marker for its progression. Serum betatrophin may be helpful for the early diagnosis of NAFLD and improvement of its prognosis.	[Hu, Wen; Shao, Xiaojuan; Hao, Hairong; Zhang, Yong; Yu, Weinan] Xuzhou Med Coll, Huaian Hosp, Dept Endocrinol, Huaian, Jiangsu, Peoples R China; [Hu, Wen; Shao, Xiaojuan; Guo, Dianxuan; Hao, Hairong; Zhang, Yong; Fan, Yunqing; Yu, Weinan] Second Peoples Hosp, Huaian, Jiangsu, Peoples R China; [Guo, Dianxuan] Xuzhou Med Coll, Dept Geriatr, Huaian Hosp, Huaian, Jiangsu, Peoples R China; [Xia, Mingfeng] Fudan Univ, Zhongshan Hosp, Dept Endocrinol, Shanghai, Peoples R China; [Gong, Yingyun; Zhou, Hongwen] Nanjing Med Univ, Dept Endocrinol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Fan, Yunqing] Xuzhou Med Coll, Huaian Hosp, Dept Color Doppler Ultrasound, Huaian, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University; Fudan University; Nanjing Medical University; Xuzhou Medical University	Yu, WN (corresponding author), Xuzhou Med Coll, Huaian Hosp, Dept Endocrinol, Huaian, Jiangsu, Peoples R China.; Fan, YQ; Yu, WN (corresponding author), Second Peoples Hosp, Huaian, Jiangsu, Peoples R China.; Fan, YQ (corresponding author), Xuzhou Med Coll, Huaian Hosp, Dept Color Doppler Ultrasound, Huaian, Jiangsu, Peoples R China.	haeyfyq@163.com; hayuweinan@163.com	Xia, Ming-Feng/AAL-1403-2020	Xia, Ming-Feng/0000-0002-5650-0165; Gong, Yingyun/0000-0002-8570-6904	Bureau of Science and Technology of Huai'an City (CN) [HAS2014005]; Jiangsu Provincial Commission of Health and Family Planning (CN) [Z201317]	Bureau of Science and Technology of Huai'an City (CN); Jiangsu Provincial Commission of Health and Family Planning (CN)	Our work has been funded by Bureau of Science and Technology of Huai'an City (CN) - HAS2014005 and Jiangsu Provincial Commission of Health and Family Planning (CN) - Z201317.	Amarapurkar D N, 2000, J Assoc Physicians India, V48, P311; Angulo P, 2010, HEPATOLOGY, V51, P373, DOI 10.1002/hep.23521; Ballestri S, 2012, LIVER INT, V32, P1242, DOI 10.1111/j.1478-3231.2012.02804.x; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bellentani S, 2010, DIGEST DIS, V28, P155, DOI 10.1159/000282080; Cengiz M, 2016, EUR J GASTROEN HEPAT, V28, P57, DOI 10.1097/MEG.0000000000000502; Chalasani N, 2008, J HEPATOL, V48, P829, DOI 10.1016/j.jhep.2008.01.016; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Ebert T, 2014, J CLIN ENDOCR METAB, V99, pE2510, DOI 10.1210/jc.2013-4349; Edens MA, 2009, OBESITY, V17, P2239, DOI 10.1038/oby.2009.154; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Fu Z, 2014, SCI REPORTS, P4; Lee Y., 2016, SCI REPORTS, V6; Mazhar SM, 2009, CLIN GASTROENTEROL H, V7, P135, DOI 10.1016/j.cgh.2008.11.023; McCullough AJ, 2005, FATTY LIVER DIS NASH, P23, DOI DOI 10.1002/9780470987438.CH3; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; Ong Janus P, 2007, Clin Liver Dis, V11, P1, DOI 10.1016/j.cld.2007.02.009; Ramesh S, 2004, HEPATITIS C NONALCOH; Ren G, 2012, AM J PHYSIOL-ENDOC M, V303, pE334, DOI 10.1152/ajpendo.00084.2012; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Strauss S, 2007, AM J ROENTGENOL, V189, pW320, DOI 10.2214/AJR.07.2123; Arias-Loste MT, 2015, WORLD J GASTROENTERO, V21, P10662, DOI 10.3748/wjg.v21.i37.10662; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wieckowska A, 2008, DIAGNOSIS NONALCOHOL; Xia MF, 2015, OBESITY, V23, P1929, DOI 10.1002/oby.21182; Xia MF, 2012, OBESITY, V20, P444, DOI 10.1038/oby.2011.302; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008; Zhang R, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0133-8; Zhang R, 2012, BIOCHEM BIOPH RES CO, V424, P786, DOI 10.1016/j.bbrc.2012.07.038	29	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170758	10.1371/journal.pone.0170758	http://dx.doi.org/10.1371/journal.pone.0170758			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125672	gold, Green Published, Green Submitted			2022-12-27	WOS:000396176100060
J	Nesti, A; de Winkel, K; Bulthoff, HH				Nesti, Alessandro; de Winkel, Ksander; Buelthoff, Heinrich H.			Accumulation of Inertial Sensory Information in the Perception of Whole Body Yaw Rotation	PLOS ONE			English	Article							VISUAL-VESTIBULAR INTEGRATION; SELF-MOTION PERCEPTION; HUMAN DISCRIMINATION; DIFFUSION-MODELS; VELOCITY STORAGE; CUES; SENSITIVITY; OTOLITH; HUMANS; HEAD	While moving through the environment, our central nervous system accumulates sensory information over time to provide an estimate of our self-motion, allowing for completing crucial tasks such as maintaining balance. However, little is known on how the duration of the motion stimuli influences our performances in a self-motion discrimination task. Here we study the human ability to discriminate intensities of sinusoidal (0.5 Hz) self-rotations around the vertical axis (yaw) for four different stimulus durations (1, 2, 3 and 5s) in darkness. In a typical trial, participants experienced two consecutive rotations of equal duration and different peak amplitude, and reported the one perceived as stronger. For each stimulus duration, we determined the smallest detectable change in stimulus intensity (differential threshold) for a reference velocity of 15 deg/s. Results indicate that differential thresholds decrease with stimulus duration and asymptotically converge to a constant, positive value. This suggests that the central nervous system accumulates sensory information on self-motion over time, resulting in improved discrimination performances. Observed trends in differential thresholds are consistent with predictions based on a drift diffusion model with leaky integration of sensory evidence.	[Nesti, Alessandro; de Winkel, Ksander; Buelthoff, Heinrich H.] Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, Tubingen, Germany	Max Planck Society	Nesti, A; Bulthoff, HH (corresponding author), Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, Tubingen, Germany.	alessandro.nesti@tuebingen.mpg.de; heinrich.buelthoff@tuebingen.mpg.de	Bülthoff, Heinrich H/J-6579-2012; de Winkel, Ksander/ABE-5608-2020; Bülthoff, Heinrich/AAC-8818-2019	Bülthoff, Heinrich H/0000-0003-2568-0607; de Winkel, Ksander/0000-0003-0534-2723; 	Max Planck Society; German Research Foundation (DFG) [SFB/Transregio 161]	Max Planck Society(Max Planck SocietyFoundation CELLEX); German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by funds from the Max Planck Society. AN and HHB were further supported by the German Research Foundation (DFG) within project CO3 of SFB/Transregio 161.	Benson A. J., 1990, PERCEPTION CONTROL S, P145; BENSON AJ, 1989, AVIAT SPACE ENVIR MD, V60, P205; Bertolini G, 2011, J NEUROPHYSIOL, V105, P209, DOI 10.1152/jn.00154.2010; Bigler RS, 2011, 22 IAVSD S DYN VEH R, P1; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Bos JE, 2002, BIOL CYBERN, V86, P191, DOI 10.1007/s00422-001-0289-7; Buinhas S, 2013, AIAA MOD SIM TECHN C, P1; Butler JS, 2015, EXP BRAIN RES, V233, P587, DOI 10.1007/s00221-014-4136-1; Butler JS, 2011, SEEING PERCEIVING, V24, P453, DOI 10.1163/187847511X588070; Butler JS, 2010, J VISION, V10, DOI 10.1167/10.11.23; Coniglio AJ, 2014, JARO-J ASSOC RES OTO, V15, P305, DOI 10.1007/s10162-013-0438-4; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; de Winkel KN, 2013, EXP BRAIN RES, V231, P209, DOI 10.1007/s00221-013-3683-1; de Winkel KN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127104; de Winkel KN, 2010, J VISION, V10, DOI 10.1167/10.12.1; Drugowitsch J, 2014, ELIFE, V3, DOI 10.7554/eLife.03005; Fetsch CR, 2010, EUR J NEUROSCI, V31, P1721, DOI 10.1111/j.1460-9568.2010.07207.x; Gescheider GA, 1997, PSYCHOPHYSICS FUNDAM; Greig GL, 1988, 313 U TOR; Harris LR, 2000, EXP BRAIN RES, V135, P12, DOI 10.1007/s002210000504; Hosman R, 1978, LR265 TU DELFT; Kelly SP, 2013, J NEUROSCI, V33, P19434, DOI 10.1523/JNEUROSCI.3355-13.2013; Kent C, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00412; Kira S, 2015, NEURON, V85, P861, DOI 10.1016/j.neuron.2015.01.007; Li D, 2014, ENCY COMPUT NEUROSCI; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; MacNeilage PR, 2010, J NEUROSCI, V30, P9084, DOI 10.1523/JNEUROSCI.1304-10.2010; Mallery RM, 2010, EXP BRAIN RES, V204, P11, DOI 10.1007/s00221-010-2288-1; Merfeld DM, 2010, J VESTIBUL RES-EQUIL, V20, P71, DOI 10.3233/VES-2010-0347; Mittelstaedt ML, 2001, EXP BRAIN RES, V139, P318, DOI 10.1007/s002210100735; Naseri AR, 2012, EXP BRAIN RES, V218, P455, DOI 10.1007/s00221-012-3035-6; Nesti A, 2015, EXP BRAIN RES, V233, P3553, DOI 10.1007/s00221-015-4426-2; Nesti A, 2015, EXP BRAIN RES, V233, P861, DOI 10.1007/s00221-014-4161-0; Nesti A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094570; Nesti A, 2014, EXP BRAIN RES, V232, P303, DOI 10.1007/s00221-013-3741-8; Newman M.C., 2012, AIAA MOD SIM TECHN C; O'Connell RG, 2012, NAT NEUROSCI, V15, P1729, DOI 10.1038/nn.3248; Pretto P, 2015, RECENT PROG BRAIN CO, P153; Prsa M, 2012, J NEUROPHYSIOL, V108, P2282, DOI 10.1152/jn.00439.2012; Purcell BA, 2010, PSYCHOL REV, V117, P1113, DOI 10.1037/a0020311; Rabbitt RD, 2004, SPR HDB AUD, P153; Ratcliff R, 1999, PSYCHOL REV, V106, P261, DOI 10.1037/0033-295X.106.2.261; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Roditi RE, 2012, JARO-J ASSOC RES OTO, V13, P381, DOI 10.1007/s10162-012-0318-3; Sarkka S., 2013, BAYESIAN FILTERING S, P254; Soyka F, 2012, EXP BRAIN RES, V220, P89, DOI 10.1007/s00221-012-3120-x; Telban RJ, 2001, AIAA MOD SIM TECHN C; Voss A, 2013, EXP PSYCHOL, V60, P385, DOI 10.1027/1618-3169/a000218; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Zaichik LE, 1999, AIAA MODELING AND SIMULATION TECHNOLOGIES CONFERENCE, P512; Zupan LH, 2002, BIOL CYBERN, V86, P209, DOI 10.1007/s00422-001-0290-1	51	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170497	10.1371/journal.pone.0170497	http://dx.doi.org/10.1371/journal.pone.0170497			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7IT	28125681	Green Published, gold, Green Submitted			2022-12-27	WOS:000396176100099
J	Ropiak, HM; Lachmann, P; Ramsay, A; Green, RJ; Mueller-Harvey, I				Ropiak, Honorata M.; Lachmann, Peter; Ramsay, Aina; Green, Rebecca J.; Mueller-Harvey, Irene			Identification of Structural Features of Condensed Tannins That Affect Protein Aggregation	PLOS ONE			English	Article							BOVINE SERUM-ALBUMIN; ISOTHERMAL TITRATION CALORIMETRY; CIRCULAR-DICHROISM SPECTROSCOPY; SECONDARY STRUCTURE ANALYSES; ANTHELMINTIC ACTIVITY; HAEMONCHUS-CONTORTUS; TRANS-CINNAMALDEHYDE; ALPHA-AMYLASE; PROANTHOCYANIDINS; BINDING	A diverse panel of condensed tannins was used to resolve the confounding effects of size and subunit composition seen previously in tannin-protein interactions. Turbidimetry revealed that size in terms of mean degree of polymerisation (mDP) or average molecular weight (amw) was the most important tannin parameter. The smallest tannin with the relatively largest effect on protein aggregation had an mDP of similar to 7. The average size was significantly correlated with aggregation of bovine serum albumin, BSA (mDP: r = -0.916; amw: r = -0.925; p<0.01; df = 27), and gelatin (mDP: r = -0.961; amw: r = -0.981; p<0.01; df = 12). The procyanidin/prodelphinidin and cis-/trans-flavan-3-ol ratios gave no significant correlations. Tryptophan fluorescence quenching indicated that procyanidins and cis-flavan-3-ol units contributed most to the tannin interactions on the BSA surface and in the hydrophobic binding pocket (r = 0.677; p<0.05; df = 9 and r = 0.887; p<0.01; df = 9, respectively). Circular dichroism revealed that higher proportions of prodelphinidins decreased the apparent a-helix content (r = -0.941; p<0.01; df = 5) and increased the apparent beta-sheet content (r = 0.916; p<0.05; df = 5) of BSA.	[Ropiak, Honorata M.; Ramsay, Aina; Mueller-Harvey, Irene] Univ Reading, Sch Agr Policy & Dev, Chem & Biochem Lab, Reading, Berks, England; [Green, Rebecca J.] Univ Reading, Sch Chem Food & Pharm, Reading, Berks, England	University of Reading; University of Reading	Mueller-Harvey, I (corresponding author), Univ Reading, Sch Agr Policy & Dev, Chem & Biochem Lab, Reading, Berks, England.	h.m.ropiak@reading.ac.uk; i.mueller-harvey@reading.ac.uk		Green, Rebecca/0000-0001-6783-549X; mueller-harvey, irene/0000-0001-6613-072X	European Union (Marie Curie Initial Training Network) [PITN GA 2011 289377]	European Union (Marie Curie Initial Training Network)	HMR, AR and IMH acknowledge financial support from the European Union (Marie Curie Initial Training Network; PITN GA 2011 289377, "LegumePlus"). The funder provided support in the form of salaries for authors HMR and AR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Gader A, 2011, BIOINFORMATICS, V27, P1630, DOI 10.1093/bioinformatics/btr234; Bras NF, 2010, BIOCHEMISTRY-US, V49, P5097, DOI 10.1021/bi100410q; Cai X, 2015, FOOD CHEM, V174, P291, DOI 10.1016/j.foodchem.2014.10.131; Chamani J, 2010, J LUMIN, V130, P1160, DOI 10.1016/j.jlumin.2010.02.014; Chamani J, 2011, J PHARMACEUT BIOMED, V55, P114, DOI 10.1016/j.jpba.2010.12.029; Cheynier V, 2015, J AGR FOOD CHEM, V63, P7589, DOI 10.1021/acs.jafc.5b01173; Dancey C., 2004, STAT MATHS PSYCHOL U; de Freitas V, 2002, J SCI FOOD AGR, V82, P113, DOI 10.1002/jsfa.1016; de Freitas V, 2001, J AGR FOOD CHEM, V49, P940, DOI 10.1021/jf000981z; de la Iglesia R, 2010, BIOFACTORS, V36, P159, DOI 10.1002/biof.79; Desrues O, 2016, PARASITOLOGY, V143, P444, DOI 10.1017/S0031182015001912; Dinh NN, 2014, ANAL BIOCHEM, V464, P60, DOI 10.1016/j.ab.2014.07.011; Dobreva MA, 2012, 26 INT C POL 2012; Dobreva MA, 2014, J AGR FOOD CHEM, V62, P9186, DOI 10.1021/jf502174r; Dobreva MA, 2011, BIOMACROMOLECULES, V12, P710, DOI 10.1021/bm101341s; FETTERER RH, 1993, VET PARASITOL, V46, P103, DOI 10.1016/0304-4017(93)90051-N; Frazier RA, 2010, J PHARMACEUT BIOMED, V51, P490, DOI 10.1016/j.jpba.2009.05.035; Gospodarczyk W, 2014, J PHYS CHEM B, V118, P8652, DOI 10.1021/jp5047485; Green RJ, 1999, LANGMUIR, V15, P5102, DOI 10.1021/la981052t; HAGERMAN AE, 1978, J AGR FOOD CHEM, V26, P809, DOI 10.1021/jf60218a027; Hagerman AE, 2012, REC ADV POLYPHEN RES, V3, P71; Han B, 2003, J BIOMED MATER RES A, V65A, P118, DOI 10.1002/jbm.a.10460; Harbertson JF, 2014, FOOD CHEM, V160, P16, DOI 10.1016/j.foodchem.2014.03.026; Hoste H, 2015, VET PARASITOL, V212, P5, DOI 10.1016/j.vetpar.2015.06.026; KAPLAN LJ, 1971, BIOCHEMISTRY-US, V10, P630; Karonen M, 2007, PHYTOCHEM ANALYSIS, V18, P378, DOI 10.1002/pca.992; Kilmister RL, 2016, FOOD CHEM, V190, P173, DOI 10.1016/j.foodchem.2015.04.144; Kommuru DS, 2014, VET PARASITOL, V204, P191, DOI 10.1016/j.vetpar.2014.04.017; Kosinska A, 2011, EUR FOOD RES TECHNOL, V233, P213, DOI 10.1007/s00217-011-1506-9; Lakowicz JR, 1991, TOPICS FLUORESCENCE, V2, P277; Le Bourvellec C, 2012, CRIT REV FOOD SCI, V52, P213, DOI 10.1080/10408398.2010.499808; Li M, 2014, J AGR FOOD CHEM, V62, P3768, DOI 10.1021/jf500246m; Lorenz MM, 2014, J SCI FOOD AGR, V94, P963, DOI 10.1002/jsfa.6344; Maiti TK, 2006, PROTEINS, V64, P355, DOI 10.1002/prot.20995; Martinez-Ortiz-de-Montellano C, 2013, EXP PARASITOL, V133, P281, DOI 10.1016/j.exppara.2012.11.024; Mueller-Harvey I, 2006, J SCI FOOD AGR, V86, P2010, DOI 10.1002/jsfa.2577; Naumann HD, 2014, J PLANT INTERACT, V9, P212, DOI 10.1080/17429145.2013.811547; PAGE A, 2007, THE CUTICLE; Papadopoulou A, 2005, J AGR FOOD CHEM, V53, P158, DOI 10.1021/jf048693g; Poncet-Legrand C, 2006, FOOD HYDROCOLLOID, V20, P687, DOI 10.1016/j.foodhyd.2005.06.009; Quijada J, 2015, J AGR FOOD CHEM, V63, P6346, DOI 10.1021/acs.jafc.5b00831; Ramsay A, 2016, PHYTOCHEMISTRY, V122, P146, DOI 10.1016/j.phytochem.2015.12.005; Rawel HA, 2005, J AGR FOOD CHEM, V53, P4228, DOI 10.1021/jf0480290; Ropiak HM, 2016, J AGR FOOD CHEM, V64, P8795, DOI 10.1021/acs.jafc.6b03842; Ropiak HM, 2016, J PHARMACEUT BIOMED, V121, P225, DOI 10.1016/j.jpba.2015.12.034; Simon C, 2003, BIOCHEMISTRY-US, V42, P10385, DOI 10.1021/bi034354p; Soares S, 2007, J AGR FOOD CHEM, V55, P6726, DOI 10.1021/jf070905x; Soares S, 2016, J AGR FOOD CHEM, V64, P7823, DOI 10.1021/acs.jafc.6b02659; SOGAMI M, 1968, BIOCHEMISTRY-US, V7, P2172, DOI 10.1021/bi00846a020; Takeshita M, 2009, J BIOL CHEM, V284, P21165, DOI 10.1074/jbc.M109.004945; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Williams AR, 2016, RES VET SCI, V105, P209, DOI 10.1016/j.rvsc.2016.02.021; Williams AR, 2015, SCI REP-UK, V5, P1, DOI 10.1038/srep14791; Williams AR, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0518-2; Williams AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097053; Zeller WE, 2015, J AGR FOOD CHEM, V63, P1160, DOI 10.1021/jf504715p; Ziyarat FP, 2014, J BIOMOL STRUCT DYN, V32, P613, DOI 10.1080/07391102.2013.785919	58	38	39	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170768	10.1371/journal.pone.0170768	http://dx.doi.org/10.1371/journal.pone.0170768			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125657	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000396176100056
J	Quintana, DS; Elvsashagen, T; Zak, N; Norbom, LB; Pedersen, PO; Quraishi, SH; Bjornerud, A; Malt, UF; Groote, IR; Kaufmann, T; Andreassen, OA; Westlye, LT				Quintana, Daniel S.; Elvsashagen, Torbjorn; Zak, Nathalia; Norbom, Linn B.; Pedersen, Per O.; Quraishi, Sophia H.; Bjornerud, Atle; Malt, Ulrik F.; Groote, Inge R.; Kaufmann, Tobias; Andreassen, Ole A.; Westlye, Lars T.			Diurnal Variation and Twenty-Four Hour Sleep Deprivation Do Not Alter Supine Heart Rate Variability in Healthy Male Young Adults	PLOS ONE			English	Article							AUTONOMIC NERVOUS-SYSTEM; CIRCADIAN-RHYTHM DISRUPTION; INSULIN-RESISTANCE; DECISION-MAKING; MODULATION; STABILITY; PRESSURE; DURATION; EMOTION; PHOTOPLETHYSMOGRAPHY	Heart rate variability (HRV) has become an increasingly popular index of cardiac autonomic control in the biobehavioral sciences due to its relationship with mental illness and cognitive traits. However, the intraindividual stability of HRV in response to sleep and diurnal disturbances, which are commonly reported in mental illness, and its relationship with executive function are not well understood. Here, in 40 healthy adult males we calculated high frequency HRV-D an index of parasympathetic nervous system (PNS) activity-D using pulse oximetry during brain imaging, and assessed attentional and executive function performance in a subsequent behavioral test session at three time points: morning, evening, and the following morning. Twenty participants were randomly selected for total sleep deprivation whereas the other 20 participants slept as normal. Sleep deprivation and morning-tonight variation did not influence high frequency HRV at either a group or individual level; however, sleep deprivation abolished the relationship between orienting attention performance and HRV. We conclude that a day of wake and a night of laboratory-induced sleep deprivation do not alter supine high frequency HRV in young healthy male adults.	[Quintana, Daniel S.; Elvsashagen, Torbjorn; Zak, Nathalia; Kaufmann, Tobias; Andreassen, Ole A.; Westlye, Lars T.] Univ Oslo, KG Jebsen Ctr Psychosis Res, Div Mental Hlth & Addict, NORMENT, Oslo, Norway; [Quintana, Daniel S.; Elvsashagen, Torbjorn; Zak, Nathalia; Kaufmann, Tobias; Andreassen, Ole A.; Westlye, Lars T.] Oslo Univ Hosp, Oslo, Norway; [Elvsashagen, Torbjorn] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Elvsashagen, Torbjorn; Zak, Nathalia; Pedersen, Per O.; Malt, Ulrik F.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Norbom, Linn B.; Groote, Inge R.; Westlye, Lars T.] Univ Oslo, Dept Psychol, Oslo, Norway; [Quraishi, Sophia H.] Columbia Univ, Barnard Coll, New York, NY USA; [Bjornerud, Atle; Groote, Inge R.] Oslo Univ Hosp, Intervent Ctr, Oslo, Norway; [Bjornerud, Atle] Univ Oslo, Dept Phys, Oslo, Norway; [Malt, Ulrik F.] Oslo Univ Hosp, Div Clin Neurosci, Dept Res & Educ, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Columbia University; University of Oslo; University of Oslo; University of Oslo	Quintana, DS (corresponding author), Univ Oslo, KG Jebsen Ctr Psychosis Res, Div Mental Hlth & Addict, NORMENT, Oslo, Norway.; Quintana, DS (corresponding author), Oslo Univ Hosp, Oslo, Norway.	daniel.quintana@medisin.uio.no	Kaufmann, Tobias/M-8972-2017; Andreassen, Ole A./AAY-7531-2020; Quintana, Daniel S./H-2726-2019	Kaufmann, Tobias/0000-0002-4003-1018; Quintana, Daniel S./0000-0003-2876-0004; Westlye, Lars T./0000-0001-8644-956X; Norbom, Linn/0000-0001-7489-2724; Malt, Ulrik/0000-0002-9881-2511	Novo Nordisk Foundation [NNF160C0019856]; Novo Nordisk Fonden [NNF16OC0019856] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Novo Nordisk Foundation (NNF160C0019856) to DSQ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson A, 2007, PHYSIOL BEHAV, V91, P579, DOI 10.1016/j.physbeh.2007.03.020; AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Alvares GA, 2016, J PSYCHIATR NEUROSCI, V41, P89, DOI 10.1503/jpn.140217; Ayas NT, 2003, ARCH INTERN MED, V163, P205, DOI 10.1001/archinte.163.2.205; Bal E, 2010, J AUTISM DEV DISORD, V40, P358, DOI 10.1007/s10803-009-0884-3; Beauchaine TP, 2015, INT J PSYCHOPHYSIOL, V98, P338, DOI 10.1016/j.ijpsycho.2015.08.004; BERNTSON GG, 1990, PSYCHOPHYSIOLOGY, V27, P586, DOI 10.1111/j.1469-8986.1990.tb01982.x; Bertsch K, 2012, PSYCHOPHYSIOLOGY, V49, P672, DOI 10.1111/j.1469-8986.2011.01341.x; Billman GE, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00086; Blair KS, 2007, NEUROIMAGE, V35, P430, DOI 10.1016/j.neuroimage.2006.11.048; BROWN TE, 1993, J APPL PHYSIOL, V75, P2310, DOI 10.1152/jappl.1993.75.5.2310; Bruce EN, 1996, J APPL PHYSIOL, V80, P1079, DOI 10.1152/jappl.1996.80.4.1079; Burgess HJ, 1997, AM J PHYSIOL-HEART C, V273, pH1761, DOI 10.1152/ajpheart.1997.273.4.H1761; Burgess HJ, 1996, J SLEEP RES, V5, P83, DOI 10.1046/j.1365-2869.1996.00016.x; Camm AJ, 1996, CIRCULATION, V93, P1043; Chalmers JA, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00080; Cuthbert BN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-126; Davies SK, 2014, P NATL ACAD SCI USA, V111, P10761, DOI 10.1073/pnas.1402663111; Denver JW, 2007, BIOL PSYCHOL, V74, P286, DOI 10.1016/j.biopsycho.2005.09.005; Donga E, 2010, J CLIN ENDOCR METAB, V95, P2963, DOI 10.1210/jc.2009-2430; Elvsashagen T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127351; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; FURLAN R, 1990, CIRCULATION, V81, P537, DOI 10.1161/01.CIR.81.2.537; Gil E, 2010, PHYSIOL MEAS, V31, P1271, DOI 10.1088/0967-3334/31/9/015; Glos M, 2014, PHYSIOL BEHAV, V125, P45, DOI 10.1016/j.physbeh.2013.11.011; Goschke T, 2014, INT J METH PSYCH RES, V23, P41, DOI 10.1002/mpr.1410; Hansen AL, 2004, EUR J APPL PHYSIOL, V93, P263, DOI 10.1007/s00421-004-1208-0; Hansen AL, 2003, INT J PSYCHOPHYSIOL, V48, P263, DOI 10.1016/S0167-8760(03)00073-4; Hayley AC, 2015, J SLEEP RES, V24, P621, DOI 10.1111/jsr.12316; Holmes AL, 2002, J APPL PHYSIOL, V92, P2578, DOI 10.1152/japplphysiol.01106.2001; Hu K, 2011, CIRCULATION, V123, P961, DOI 10.1161/CIRCULATIONAHA.110.943019; Jagannath A, 2013, CURR OPIN NEUROBIOL, V23, P888, DOI 10.1016/j.conb.2013.03.008; Jeffreys H., 1939, THEORY PROBABILITY, V1; Kan C, 2013, DIABETES CARE, V36, P480, DOI 10.2337/dc12-1442; Kato M, 2000, HYPERTENSION, V35, P1173, DOI 10.1161/01.HYP.35.5.1173; Kaufmann T, 2016, NEUROIMAGE, V127, P324, DOI 10.1016/j.neuroimage.2015.12.028; Kaufmann T, 2011, BEHAV RES METHODS, V43, P1161, DOI 10.3758/s13428-011-0107-7; Kemp AH, 2010, BIOL PSYCHIAT, V67, P1067, DOI [10.1016/j.biopsych.2009.11.019, 10.1016/j.biopsych.2009.12.012]; Killgore WDS, 2006, J SLEEP RES, V15, P7, DOI 10.1111/j.1365-2869.2006.00487.x; Kirkpatrick B, 2013, SCHIZOPHRENIA BULL, V39, P1174, DOI 10.1093/schbul/sbt141; Kreibig SD, 2007, PSYCHOPHYSIOLOGY, V44, P787, DOI 10.1111/j.1469-8986.2007.00550.x; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Lindmark S, 2003, DIABETIC MED, V20, P399, DOI 10.1046/j.1464-5491.2003.00920.x; Love J, 2015, JASP; Lu G., 2009, Journal of Medical Engineering & Technology, V33, P634, DOI 10.3109/03091900903150998; Martinmaki K, 2006, AM J PHYSIOL-HEART C, V290, pH640, DOI 10.1152/ajpheart.00054.2005; Masi A, 2015, MOL PSYCHIATR, V20, P440, DOI 10.1038/mp.2014.59; McClung CA, 2013, BIOL PSYCHIAT, V74, P242, DOI 10.1016/j.biopsych.2013.02.019; Mitchell AJ, 2013, SCHIZOPHRENIA BULL, V39, P306, DOI 10.1093/schbul/sbr148; Mullington JM, 2009, PROG CARDIOVASC DIS, V51, P294, DOI 10.1016/j.pcad.2008.10.003; Pagani M, 2009, AUTON NEUROSCI-BASIC, V145, P76, DOI 10.1016/j.autneu.2008.10.009; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; Pinna GD, 2007, CLIN SCI, V113, P131, DOI 10.1042/CS20070055; Porges SW, 2011, POLYVAGAL THEORY NEU; Posner MI, 2008, ANN NY ACAD SCI, V1129, P193, DOI 10.1196/annals.1417.011; Quintana DS, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.73; Quintana DS, 2016, SCI REP-UK, V6, DOI 10.1038/srep37212; Quintana Daniel S, 2014, Front Psychol, V5, P805, DOI 10.3389/fpsyg.2014.00805; Quintana DS, 2013, ALCOHOL CLIN EXP RES, V37, pE23, DOI 10.1111/j.1530-0277.2012.01913.x; Quintana DS, 2012, INT J PSYCHOPHYSIOL, V86, P168, DOI 10.1016/j.ijpsycho.2012.08.012; R Development Core team, 2014, R A LANGUAGE AND ENV; Rouder JN, 2012, J MATH PSYCHOL, V56, P356, DOI 10.1016/j.jmp.2012.08.001; Sakakibara M, 1996, PSYCHOSOM MED, V58, P32, DOI 10.1097/00006842-199601000-00006; Sauvet F, 2010, J APPL PHYSIOL, V108, P68, DOI 10.1152/japplphysiol.00851.2009; Schafer A, 2013, INT J CARDIOL, V166, P15, DOI 10.1016/j.ijcard.2012.03.119; Schroeder EB, 2004, J ELECTROCARDIOL, V37, P163, DOI 10.1016/j.jelectrocard.2004.04.004; Segerstrom SC, 2007, PSYCHOL SCI, V18, P275, DOI 10.1111/j.1467-9280.2007.01888.x; Shea SA, 2011, CIRC RES, V108, P980, DOI 10.1161/CIRCRESAHA.110.233668; Sinnreich R, 1998, HEART, V80, P156, DOI 10.1136/hrt.80.2.156; SLOAN RP, 1995, PSYCHOPHYSIOLOGY, V32, P191, DOI 10.1111/j.1469-8986.1995.tb03311.x; SMITH JJ, 1994, J CLIN PHARMACOL, V34, P375, DOI 10.1002/j.1552-4604.1994.tb04977.x; Spengler CM, 2000, AM J RESP CRIT CARE, V161, P1124, DOI 10.1164/ajrccm.161.4.9906026; Spiegelhalder K, 2013, CURR PSYCHIAT REP, V15, P1; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Tsunoda M, 2001, PSYCHIAT CLIN NEUROS, V55, P285, DOI 10.1046/j.1440-1819.2001.00862.x; Vaara J, 2009, EUR J APPL PHYSIOL, V105, P439, DOI 10.1007/s00421-008-0921-5; Virtanen I, 2015, SLEEP MED, V16, P250, DOI 10.1016/j.sleep.2014.10.012; Westlye LT, 2011, CEREB CORTEX, V21, P345, DOI 10.1093/cercor/bhq101; WHITE DP, 1983, AM REV RESPIR DIS, V128, P984; Wulff K, 2010, NAT REV NEUROSCI, V11, P589, DOI 10.1038/nrn2868; Yokoi Mari, 2006, Journal of Physiological Anthropology and Applied Human Science, V25, P153, DOI 10.2114/jpa2.25.153; Zhong X, 2005, J APPL PHYSIOL, V98, P2024, DOI 10.1152/japplphysiol.00620.2004	85	9	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170921	10.1371/journal.pone.0170921	http://dx.doi.org/10.1371/journal.pone.0170921			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28151944	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161200059
J	Waheed, H; Anjum, M; Rehman, M; Khawaja, A				Waheed, Hajra; Anjum, Maria; Rehman, Mariam; Khawaja, Amina			Investigation of user behavior on social networking sites	PLOS ONE			English	Article							SELF-ESTEEM; FACEBOOK; PERSONALITY; MEDIA; NARCISSISM	Social networking sites (SNS) are used for social and professional interaction with people. SNS popularity has encouraged researchers to analyze the relationship of activities performed on SNS with user behavior. In doing so, the term "user behavior" is rather used ambiguously with different interpretations, which makes it difficult to identify studies on user behavior in relation to SNS. This phenomenon has encouraged this thorough research on the characteristics of user behavior being discussed in the literature. Therefore, in this study, we aim to identify, analyze, and classify the characteristics associated with user behavior to answer the research questions designed to conduct this research. A mapping study (also called scoping study), which is a type of systematic literature review, is employed to identify potential studies from digital databases through a developed protocol. Thematic analysis is carried out for the classification of user behavior. We identified 116 primary studies for full analysis. This study found seven characteristics associated with behavior that have direct influence on SNS use and nine factors that have an indirect effect. All studies were conducted largely under seven areas that set the context of these studies. Findings show that the research on SNS is still in its early stage. The range of topics covered in the analyzed studies is quite expansive, although the depth in terms of number of studies under each topic is quite limited. This study reports that activities performed on SNS are either associated with user behavior or reflect personality characteristics. The findings of this study could be used by practitioners to evaluate their SNS platforms and develop more user-centered applications. These studies can also help organizations to understand better the needs of their employees.	[Waheed, Hajra; Anjum, Maria; Rehman, Mariam] Lahore Coll Women Univ, Dept Comp Sci, Lahore, Pakistan; [Khawaja, Amina] Lahore Coll Women Univ, Dept Psychol, Lahore, Pakistan		Anjum, M (corresponding author), Lahore Coll Women Univ, Dept Comp Sci, Lahore, Pakistan.	maria.anjum@gmail.com						Boyd DM, 2007, J COMPUT-MEDIAT COMM, V13, P210, DOI 10.1111/j.1083-6101.2007.00393.x; Budgen D., 2008, PROC 20 ANN M PSYCHO, P195, DOI DOI 10.1007/978-3-642-02152-7_36; Buffardi LE, 2008, PERS SOC PSYCHOL B, V34, P1303, DOI 10.1177/0146167208320061; Constantinides E, 2013, STUD COMPUT INTELL, V444, P221; Dogruer N, 2011, PROCD SOC BEHV, V15, P2642, DOI 10.1016/j.sbspro.2011.04.162; Govani T., 2005, PRIV POST FAIR UNPUB, P9; Grieve R, 2013, COMPUT HUM BEHAV, V29, P604, DOI 10.1016/j.chb.2012.11.017; Gross R., 2005, P WPES 2005, P71, DOI DOI 10.1145/1102199.1102214; Hew KF, 2011, COMPUT HUM BEHAV, V27, P662, DOI 10.1016/j.chb.2010.11.020; Ho Keung Tsoi, 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P457, DOI 10.1109/PASSAT/SocialCom.2011.71; Hollenbaugh EE, 2014, COMPUT HUM BEHAV, V30, P50, DOI 10.1016/j.chb.2013.07.055; Hughes DJ, 2012, COMPUT HUM BEHAV, V28, P561, DOI 10.1016/j.chb.2011.11.001; Kaplan AM, 2010, BUS HORIZONS, V53, P59, DOI 10.1016/j.bushor.2009.09.003; Kim Y, 2011, COMPUT HUM BEHAV, V27, P365, DOI 10.1016/j.chb.2010.08.015; Kitchenham B., 2007, GUIDELINES PERFORMIN, V5; Ku YC, 2013, INFORM MANAGE-AMSTER, V50, P571, DOI 10.1016/j.im.2013.07.011; Lee JER, 2012, COMPUT HUM BEHAV, V28, P1036, DOI 10.1016/j.chb.2012.01.006; Mangold WG, 2009, BUS HORIZONS, V52, P357, DOI 10.1016/j.bushor.2009.03.002; Mehdizadeh S, 2010, CYBERPSYCH BEH SOC N, V13, P357, DOI 10.1089/cyber.2009.0257; Picazo-Vela S, 2012, GOV INFORM Q, V29, P504, DOI 10.1016/j.giq.2012.07.002; Qiu L, 2012, J RES PERS, V46, P710, DOI 10.1016/j.jrp.2012.08.008; Ross C, 2009, COMPUT HUM BEHAV, V25, P578, DOI 10.1016/j.chb.2008.12.024; Ryan T, 2011, COMPUT HUM BEHAV, V27, P1658, DOI 10.1016/j.chb.2011.02.004; Shi N., 2010, SYST SCI HICSS 2010, P1, DOI DOI 10.1109/HICSS.2010.369; Silfverberg S., CSCW, P207, DOI DOI 10.1145/1958824.1958855; Skeels MM, 2009, GROUP 2009 PROCEEDINGS, P95; Stefanone M.A., 2011, P 2011 44 HAW INT C, P1; Steinfield C, 2008, J APPL DEV PSYCHOL, V29, P434, DOI 10.1016/j.appdev.2008.07.002; Strater K., 2007, P 3 S US PRIV SEC, V229, P157, DOI DOI 10.1145/1280680.1280706; Xu CY, 2012, INFORM MANAGE-AMSTER, V49, P210, DOI 10.1016/j.im.2012.05.001	30	15	15	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0169693	10.1371/journal.pone.0169693	http://dx.doi.org/10.1371/journal.pone.0169693			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28151963	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161200010
J	Wernly, B; Lichtenauer, M; Franz, M; Kabisch, B; Muessig, J; Masyuk, M; Hoppe, UC; Kelm, M; Jung, C				Wernly, Bernhard; Lichtenauer, Michael; Franz, Marcus; Kabisch, Bjoern; Muessig, Johanna; Masyuk, Maryna; Hoppe, Uta C.; Kelm, Malte; Jung, Christian			Model for End-stage Liver Disease excluding INR (MELD-XI) score in critically ill patients: Easily available and of prognostic relevance	PLOS ONE			English	Article							CHRONIC HEALTH EVALUATION; CHRONIC HEART-FAILURE; HEPATIC-DYSFUNCTION; ACUTE PHYSIOLOGY; FUNCTION ABNORMALITIES; CARDIOGENIC-SHOCK; MORTALITY; MICROCIRCULATION; TRANSPLANTATION; MORBIDITY	Purpose MELD-XI, an adapted version of Model for End-stage Liver Disease (MELD) score excluding INR, was reported to predict outcomes e.g. in patients with acute heart failure. We aimed to evaluate MELD-XI in critically ill patients admitted to an intensive care unit (ICU) for prognostic relevance. Methods A total of 4381 medical patients (66 +/- 14 years, 2862 male) admitted to a German ICU between 2004 and 2009 were included and retrospectively investigated. Admission diagnoses were e.g. myocardial infarction (n = 2034), sepsis (n = 694) and heart failure (n = 688). We divided our patients in two cohorts basing on their MELD-XI score and evaluated the MELD-XI score for its prognostic relevance regarding short-term and long-term survival. Optimal cut-offs were calculated by means of the Youden-Index. Results Patients with a MELD-XI score > 12 had pronounced laboratory signs of organ failure and more comorbidities. MELD-XI > 12 was associated with an increase in short-term (27% vs 6%; HR 4.82, 95% CI 3.93-5.93; p<0.001) and long-term (HR 3.69, 95% CI 3.20-4.25; p<0.001) mortality. In a univariate Cox regression analysis for all patients MELD-XI was associated with increased long-term mortality (changes per score point: HR 1.06, 95% CI 1.05-1.07; p<0.001) and remained to be associated with increased mortality after correction in a multivariate regression analysis for renal failure, liver failure, lactate concentration, blood glucose concentration, oxygenation and white blood count (HR 1.04, 95% CI 1.03-1.06; p<0.001). Optimal cutoff for the overall cohort was 11 and varied remarkably depending on the admission diagnosis: myocardial infarction (9), pulmonary embolism (9), cardiopulmonary resuscitation (17) and pneumonia (17). We performed ROC-analysis and compared the AUC: SAPS2 (0.78, 95% CI 0.76-0.80; p<0.0001) and APACHE (0.76, 95% CI 0.74-0.78; p<0.003) score were superior to MELD-XI (0.71, 95% CI 0.68-0.73) for prediction of mortality. Conclusions The easily calculable MELD-XI score is a robust and reliable tool to predict both intra-ICU and long-term mortality in critically ill medical patients admitted to an ICU. Optimal cut-off values for MELD-XI scores seem to depend on the primary disease and need to be validated in future prospective studies. Compared to SAPS2 and APACHE score, MELD-XI lacks precision but might have comparable and even additive value, as it is easily available and independent of subjective values.	[Wernly, Bernhard; Lichtenauer, Michael; Hoppe, Uta C.] Paracelsus Med Univ Salzburg, Clin Internal Med 2, Dept Cardiol, Salzburg, Austria; [Franz, Marcus; Kabisch, Bjoern] Jena Univ Hosp, Dept Cardiol, Clin Internal Med 1, Jena, Germany; [Muessig, Johanna; Masyuk, Maryna; Kelm, Malte; Jung, Christian] Univ Duesseldorf, Div Cardiol Pulmonol & Vasc Med, Fac Med, Dusseldorf, Germany	Paracelsus Private Medical University; Friedrich Schiller University of Jena	Jung, C (corresponding author), Univ Duesseldorf, Div Cardiol Pulmonol & Vasc Med, Fac Med, Dusseldorf, Germany.	christian.jung@med.uni-duesseldorf.de	Jung, Christian/AAN-4537-2021; Lichtenauer, Michael/H-5139-2019; Franz, Marcus/ABA-4688-2021; Wernly, Bernhard/AAA-8529-2020	Jung, Christian/0000-0001-8325-250X; Lichtenauer, Michael/0000-0001-8403-3931; Franz, Marcus/0000-0001-6543-4684; Wernly, Bernhard/0000-0003-4024-0220; Masyuk, Maryna/0000-0003-2856-6893				Abe Satoshi, 2014, PLoS One, V9, pe100618, DOI 10.1371/journal.pone.0100618; Allen LA, 2009, EUR J HEART FAIL, V11, P170, DOI 10.1093/eurjhf/hfn031; Assenza GE, 2013, HEART, V99, P491, DOI 10.1136/heartjnl-2012-303347; Bannier K, 2015, J DIABETES COMPLICAT, V29, P1130, DOI 10.1016/j.jdiacomp.2015.08.010; Batin P, 1995, EUR HEART J, V16, P1613, DOI 10.1093/oxfordjournals.eurheartj.a060785; Cannito S, 2014, HISTOL HISTOPATHOL, V29, P33, DOI 10.14670/HH-29.33; Cholongitas E, 2006, LIVER TRANSPLANT, V12, P1049, DOI 10.1002/lt.20824; DUNN GD, 1973, AM J MED SCI, V265, P175, DOI 10.1097/00000441-197303000-00001; Fu QW, 2016, CLIN MED RES, V14, P15, DOI 10.3121/cmr.2015.1282; Fujita B, 2015, CLIN BIOCHEM, V48, P1048, DOI 10.1016/j.clinbiochem.2015.07.011; Giallourakis Cosmas C, 2002, Clin Liver Dis, V6, P947, DOI 10.1016/S1089-3261(02)00056-9; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Grimm JC, 2015, ANN THORAC SURG, V100, P1737, DOI 10.1016/j.athoracsur.2015.07.026; HAWKER F, 1991, ANAESTH INTENS CARE, V19, P165, DOI 10.1177/0310057X9101900203; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Heuman DM, 2007, LIVER TRANSPLANT, V13, P30, DOI 10.1002/lt.20906; Inohara T, 2014, INT J CARDIOL, V176, P571, DOI 10.1016/j.ijcard.2014.08.052; Jung C, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1312-7; Jung C, 2016, CLIN RES CARDIOL, V105, P196, DOI 10.1007/s00392-015-0906-4; Jung C, 2015, CLIN HEMORHEOL MICRO, V61, P213, DOI 10.3233/CH-151994; Jung C, 2015, CLIN RES CARDIOL, V104, P679, DOI 10.1007/s00392-015-0833-4; Jung C, 2010, CRIT CARE, V14, DOI 10.1186/cc9244; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Kim MS, 2013, J AM COLL CARDIOL, V61, P2253, DOI 10.1016/j.jacc.2012.12.056; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KUBO SH, 1987, ARCH INTERN MED, V147, P1227, DOI 10.1001/archinte.147.7.1227; Lau GT, 2002, AM J CARDIOL, V90, P1405, DOI 10.1016/S0002-9149(02)02886-2; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lim H Sern, 2015, EUR HEART J-ACUTE CA; Markgraf R, 2001, CRIT CARE, V5, P31, DOI 10.1186/cc975; Matthews JC, 2010, CIRCULATION, V121, P214, DOI 10.1161/CIRCULATIONAHA.108.838656; McCaughan GW, 2016, INTERN MED J, V46, P404, DOI 10.1111/imj.13025; Murata M, 2016, INT J CARDIOL, V203, P682, DOI 10.1016/j.ijcard.2015.10.181; Pisani Margaret A, 2009, J Intensive Care Med, V24, P83, DOI 10.1177/0885066608329942; Roth C, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1242-4; SHOREY J, 1969, AM J PHYSIOL, V216, P1441, DOI 10.1152/ajplegacy.1969.216.6.1441; Takeda Y, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-22; Wu AH, 2013, AM J CARDIOL, V111, P1192, DOI 10.1016/j.amjcard.2012.12.048; Zheng H, 2014, BIOL RES, V47, DOI 10.1186/0717-6287-47-7	40	30	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170987	10.1371/journal.pone.0170987	http://dx.doi.org/10.1371/journal.pone.0170987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151948	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161200067
J	Matsuo, T; Miyata, Y; Asai, A; Sagara, Y; Furusato, B; Fukuoka, J; Sakai, H				Matsuo, Tomohiro; Miyata, Yasuyoshi; Asai, Akihiro; Sagara, Yuji; Furusato, Bungo; Fukuoka, Junya; Sakai, Hideki			Green Tea Polyphenol Induces Changes in Cancer-Related Factors in an Animal Model of Bladder Cancer	PLOS ONE			English	Article							GROWTH FACTOR-A; EPIGALLOCATECHIN-3-GALLATE EGCG; HEME OXYGENASE-1; BREAST-CANCER; CELL-PROLIFERATION; VEGF INDUCTION; EXPRESSION; HUR; APOPTOSIS; CONSUMPTION	Green tea polyphenol (GTP) suppresses carcinogenesis and aggressiveness in many types of malignancies including bladder cancer. However, the mechanistic basis of these effects is not well understood. This was investigated in the present study using a mouse model of chemically induced bladder cancer. C3H/He mice (8 weeks old; n = 46) were treated with 0.05% N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) solution for 14-24 weeks. Mice in the BBN + GTP group (n = 47) were also treated with 0.5% GTP solution over the same period. Tumor cell proliferation and microvessel density were evaluated along with immunohistochemical analysis of human antigen (Hu)R, vascular endothelial growth factor (VEGF)-A, cyclooxygenase (COX)-2, and hemeoxygenase (H0)-1 expression. Cytoplasmic HuR expression in cancer cells was higher at 14 and 24 weeks in the BBN than in the control group and was associated with increased invasion of tumor cells in muscle. However, these effects were not observed in the BBN + GTP group. A multivariate analysis of GTP intake and cytoplasmic HuR expression revealed that GTP was independently associated with COX-2 and HO-1 expression, while cytoplasmic HuR expression was associated with COX 2 and VEGF-A levels. Expression of COX-2 and HO-1 was associated with cell proliferation and that of VEGF-A and HO-1 was associated with angiogenesis. Nuclear HuR expression was not associated with any parameters such as carcinogenesis, muscle invasion, and GTP intake. These results indicate that GTP intake can suppress tumor progression and malignant behavior in an animal model of bladder cancer. We also speculate that GTP directly and indirectly suppresses tumor cell proliferation and angiogenesis via HuR-related pathways in bladder cancer.	[Matsuo, Tomohiro; Miyata, Yasuyoshi; Asai, Akihiro; Sagara, Yuji; Sakai, Hideki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Urol, Nagasaki, Japan; [Furusato, Bungo; Fukuoka, Junya] Nagasaki Univ, Grad Sch Biomed Sci, Dept Pathol, Nagasaki, Japan	Nagasaki University; Nagasaki University	Miyata, Y (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Urol, Nagasaki, Japan.	int.doc.miya@m3.dion.ne.jp	Fukuoka, Junya/AAT-2924-2021	Fukuoka, Junya/0000-0002-2496-3050; Furusato, Bungo/0000-0003-4614-9882; Matsuo, Tomohiro/0000-0002-9508-0319				Ahn WS, 2003, DNA CELL BIOL, V22, P217, DOI 10.1089/104454903321655846; Annabi B, 2007, LEUKEMIA RES, V31, P1277, DOI 10.1016/j.leukres.2006.10.001; Ashughyan Vahagn R, 2006, Rev Urol, V8, P8; Bernardo C, 2014, ANTICANCER RES, V34, P735; Bettuzzi S, 2006, CANCER RES, V30, P207; Caporali A, 2004, CARCINOGENESIS, V25, P2217, DOI 10.1093/carcin/bgh235; Ding GQ, 2016, AM J TRANSL RES, V8, P578; Espina C, 2015, CANCER EPIDEMIOL, V39, pS84, DOI 10.1016/j.canep.2015.03.017; Filippova N, 2011, MOL CANCER RES, V9, P648, DOI 10.1158/1541-7786.MCR-10-0325; Giaginis C, 2015, TUMOR BIOL, V36, P315, DOI 10.1007/s13277-014-2637-y; Gu JW, 2013, VASC CELL, V5, DOI 10.1186/2045-824X-5-9; Heinonen M, 2007, CLIN CANCER RES, V13, P6959, DOI 10.1158/1078-0432.CCR-07-1432; Inoue M, 2001, CANCER LETT, V167, P175, DOI 10.1016/S0304-3835(01)00486-4; Ji BT, 1997, INT J CANCER, V70, P255, DOI 10.1002/(SICI)1097-0215(19970127)70:3&lt;255::AID-IJC1&gt;3.0.CO;2-W; Jimbo M, 2015, ONCOTARGET, V6, P27312, DOI 10.18632/oncotarget.4743; Jung YD, 2001, BRIT J CANCER, V84, P844, DOI 10.1054/bjoc.2000.1691; Kuwano Y, 2009, MOL CELL BIOL, V29, P2622, DOI 10.1128/MCB.01495-08; Kweon MH, 2006, J BIOL CHEM, V281, P33761, DOI 10.1074/jbc.M604748200; Lecumberri E, 2013, CLIN NUTR, V32, P894, DOI 10.1016/j.clnu.2013.03.008; Lim SJ, 2009, CANCER RES TREAT, V41, P87, DOI 10.4143/crt.2009.41.2.87; Lu Q., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/201462, DOI 10.1155/2012/201462]; Matsuo T, 2011, UROLOGY, V78, DOI 10.1016/j.urology.2011.03.019; Meyer J, 2015, CANCER EPIDEM BIOMAR, V24, P1516, DOI 10.1158/1055-9965.EPI-15-0415; Miyamoto H, 2007, J NATL CANCER I, V99, P558, DOI 10.1093/jnci/djk113; Miyata Y, 2003, CLIN CANCER RES, V9, P1741; Miyata Y, 2006, CLIN CANCER RES, V12, P800, DOI 10.1158/1078-0432.CCR-05-1284; Miyata Y, 2014, TRANSL RES, V164, P468, DOI 10.1016/j.trsl.2014.06.010; Miyata Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059095; Philips BJ, 2009, BIOMED RES-TOKYO, V30, P207, DOI 10.2220/biomedres.30.207; Qin J, 2007, BIOCHEM BIOPH RES CO, V354, P852, DOI 10.1016/j.bbrc.2007.01.003; Riegsecker S, 2013, LIFE SCI, V93, P307, DOI 10.1016/j.lfs.2013.07.006; Sagara Y, 2010, CANCER EPIDEMIOL, V34, P350, DOI 10.1016/j.canep.2010.03.001; Saito Y, 2014, J GASTROENTEROL, V49, P692, DOI 10.1007/s00535-013-0799-9; Sakuma T, 2008, J NEURO-ONCOL, V88, P143, DOI 10.1007/s11060-008-9559-8; Sartippour MR, 2002, J NUTR, V132, P2307, DOI 10.1093/jn/132.8.2307; Shi JL, 2015, ONCOL REP, V33, P2972, DOI 10.3892/or.2015.3889; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Singh T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025224; Stuart EC, 2006, LIFE SCI, V79, P2329, DOI 10.1016/j.lfs.2006.07.036; Wang Jue, 2010, Sarcoma, V2010, P454792, DOI 10.1155/2010/454792; Wang X, 2013, UROL INT, V90, P10, DOI 10.1159/000342804; Wang YQ, 2015, BASIC CLIN PHARMACOL, V117, P164, DOI 10.1111/bcpt.12383; Wu WX, 2015, SCI REP-UK, V5, DOI 10.1038/srep09051; Zhang SY, 2014, NUTR CANCER, V66, P315, DOI 10.1080/01635581.2014.868909; Zhu KW, 2016, TUMOR BIOL, V37, P4373, DOI 10.1007/s13277-015-4187-3	45	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171091	10.1371/journal.pone.0171091	http://dx.doi.org/10.1371/journal.pone.0171091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141864	Green Published, Green Submitted, gold			2022-12-27	WOS:000396129500037
J	Porte, B; Chatelain, C; Hardouin, J; Derambure, C; Zerdoumi, Y; Hauchecorne, M; Dupre, N; Bekri, S; Gonzalez, B; Marret, S; Cosette, P; Leroux, P				Porte, Baptiste; Chatelain, Clemence; Hardouin, Julie; Derambure, Celine; Zerdoumi, Yasmine; Hauchecorne, Michele; Dupre, Nicolas; Bekri, Soumeya; Gonzalez, Bruno; Marret, Stephane; Cosette, Pascal; Leroux, Philippe			Proteomic and transcriptomic study of brain microvessels in neonatal and adult mice	PLOS ONE			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; CEREBRAL-BLOOD-FLOW; LARGE GENE LISTS; PREMATURE-INFANTS; ENERGY-METABOLISM; GERMINAL MATRIX; INTRAVENTRICULAR HEMORRHAGE; PRETERM INFANTS; DATA SUBMISSION; MOUSE-BRAIN	Infants born before 29 weeks gestation incur a major risk of preterm encephalopathy and subependymal/intracerebral/intraventricular haemorrhage. In mice, an ontogenic window of haemorrhage risk was recorded up to 5 days after birth in serpinel knock-out animals. Using proteome and transcriptome approaches in mouse forebrain microvessels, we previously described the remodelling of extracellular matrix and integrins likely strengthening the vascular wall between postnatal day 5 (P5) and P10. Haemorrhage is the ultimate outcome of vessel damage (i.e., during ischaemia), although discreet vessel insults may be involved in the aetiology of preterm encephalopathy. In this study, we examined proteins identified by mass spectrometry and segregating in gene ontology pathways in forebrain microvessels in P5, P10, and adult wild type mice. In parallel, comparative transcript levels were obtained using RNA hybridization microarrays and enriched biological pathways were extracted from genes exhibiting at least a two-fold change in expression. Five major biological functions were observed in those genes detected both as proteins and mRNA expression undergoing at least a two-fold change in expression in one or more age comparisons: energy metabolism, protein metabolism, antioxidant function, ion exchanges, and transport. Adult micro vessels exhibited the highest protein and mRNA expression levels for a majority of genes. Energy metabolism enriched gene ontology pathways pointed to the preferential occurrence of glycolysis in P5 microvessels cells versus P10 and adult preparations enriched in aerobic oxidative enzymes. Age-dependent levels of RNA coding transport proteins at the plasma membrane and mitochondria strengthened our findings based on protein data. The data suggest that immature microvessels have fewer energy supply alternatives to glycolysis than mature structures. In the context of high energy demand, this constraint might account for vascular damage and maintenance of the high bleeding occurrence in specific areas in immature brain.	[Porte, Baptiste; Chatelain, Clemence; Zerdoumi, Yasmine; Hauchecorne, Michele; Dupre, Nicolas; Bekri, Soumeya; Gonzalez, Bruno; Marret, Stephane; Leroux, Philippe] Normandie Univ, UNIROUEN, INSERM, U1245,IRIB, Rouen, France; [Hardouin, Julie; Cosette, Pascal] Normandie Univ, UNIROUEN, UMR 6270, CNRS,IRIB, Mont St Aignan, France; [Hardouin, Julie; Cosette, Pascal] Normandie Univ, UNIROUEN, Prote Facil PISSARO, IRIB, Mont St Aignan, France; [Derambure, Celine] Normandie Univ, UNIROUEN, UMR S905, INSERM,IRIB, Rouen, France; [Bekri, Soumeya] Rouen Univ Hosp, Metab Biochem Dept, Rouen, France; [Marret, Stephane] Rouen Univ Hosp, Neonatal Pediat & Intens Care Dept, Rouen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Rouen; CHU de Rouen	Leroux, P (corresponding author), Normandie Univ, UNIROUEN, INSERM, U1245,IRIB, Rouen, France.	philippe.leroux@univ-rouen.fr	Dupre, Nicolas/Y-1828-2019; Porte, Baptiste/L-7381-2017; Gonzalez, Bruno/E-6103-2016; Leroux, Philippe/M-2002-2018	Gonzalez, Bruno/0000-0002-7176-1320; Porte, Baptiste/0000-0003-3728-6308; Cosette, Pascal/0000-0002-7588-0167; Bekri, Soumeya/0000-0001-6184-7270; Derambure, celine/0000-0002-6722-5955; Marret, Stephane/0000-0002-2858-148X; Hardouin, Julie/0000-0003-4588-9811	INSERM [UMR-5905, UMR-1079]; Region Haute Normandie [ERI28]; CNRS [UMR-6270]; IRIB of PISSARO; European FEDER grant [33245]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Haute Normandie(Region Normandie); CNRS(Centre National de la Recherche Scientifique (CNRS)); IRIB of PISSARO; European FEDER grant	Support was provided by: INSERM and Region Haute Normandie funding of ERI28; INSERM funding of UMR-5905; INSERM funding of UMR-1079; CNRS funding of UMR-6270; IRIB funding of PISSARO proteomics facility; and European FEDER grant 33245.	Adle-Biassette H, 2007, PEDIATR RES, V61, P54, DOI 10.1203/01.pdr.0000250040.61888.61; Ancel PY, 2005, AM J OBSTET GYNECOL, V193, P178, DOI 10.1016/j.ajog.2004.11.057; Baburamani AA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00424; Ballabh P, 2007, NAT MED, V13, P477, DOI 10.1038/nm1558; Ballabh P, 2010, PEDIATR RES, V67, P1, DOI 10.1203/PDR.0b013e3181c1b176; Baud O, 2003, J COMP NEUROL, V465, P445, DOI 10.1002/cne.10853; Beaino G, 2011, ACTA PAEDIATR, V100, P370, DOI 10.1111/j.1651-2227.2010.02064.x; Braun A, 2007, J NEUROSCI, V27, P12012, DOI 10.1523/JNEUROSCI.3281-07.2007; Chun HB, 2011, J CEREBR BLOOD F MET, V31, P2267, DOI 10.1038/jcbfm.2011.104; Cote RG, 2012, MOL CELL PROTEOMICS, V11, P1682, DOI 10.1074/mcp.O112.021543; Culic O, 1997, AM J PHYSIOL-CELL PH, V273, pC205, DOI 10.1152/ajpcell.1997.273.1.C205; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; De Bock K, 2013, CELL METAB, V18, P634, DOI 10.1016/j.cmet.2013.08.001; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; Ek CJ, 2012, NEUROTOXICOLOGY, V33, P586, DOI 10.1016/j.neuro.2011.12.009; Erecinska M, 2004, PROG NEUROBIOL, V73, P397, DOI 10.1016/j.pneurobio.2004.06.003; Fernandez-Lopez D, 2012, J NEUROSCI, V32, P9588, DOI 10.1523/JNEUROSCI.5977-11.2012; Fyfe KL, 2014, SLEEP MED REV, V18, P299, DOI 10.1016/j.smrv.2013.06.002; Giedt RJ, 2012, ANN BIOMED ENG, V40, P1903, DOI 10.1007/s10439-012-0568-6; Guo SZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052665; Haruda FD, 2001, PEDIATRICS, V108, P1050, DOI 10.1542/peds.108.4.1050; Henry VJ, 2013, NEUROBIOL DIS, V50, P201, DOI 10.1016/j.nbd.2012.10.020; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Illsinger S, 2011, J PERINAT MED, V39, P587, DOI [10.1515/jpm.2011.063, 10.1515/JPM.2011.063]; Ivanov Anton, 2011, Front Neuroenergetics, V3, P2, DOI 10.3389/fnene.2011.00002; Ivanov AI, 2014, J CEREBR BLOOD F MET, V34, P397, DOI 10.1038/jcbfm.2013.222; Kamiie J, 2008, PHARM RES-DORDR, V25, P1469, DOI 10.1007/s11095-008-9532-4; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kasischke K, 2011, FRONT NEUROENERGETIC, V3, P1; Kratzer I, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-25; Lauritzen KH, 2014, CEREB CORTEX, V24, P2784, DOI 10.1093/cercor/bht136; Lecointre M, 2014, J CEREB BLOOD FLOW M; Legros H, 2009, J CEREBR BLOOD F MET, V29, P1146, DOI 10.1038/jcbfm.2009.39; Leroux P, 2014, J NEUROPATH EXP NEUR, V73, P387, DOI 10.1097/NEN.0000000000000062; Licht T, 2015, J CLIN INVEST, V125, P1319, DOI 10.1172/JCI79401; Marin-Padilla M, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00038; Marret S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062683; McQuillen PS, 2004, PEDIATR NEUROL, V30, P227, DOI 10.1016/j.pediatrneurol.2003.10.001; Morin J, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3218; OLDENDORF WH, 1975, P SOC EXP BIOL MED, V149, P736; Pellerin L, 1998, P NATL ACAD SCI USA, V95, P3990, DOI 10.1073/pnas.95.7.3990; Perrone S, 2015, J MATERN-FETAL NEO M, V28, P2291, DOI 10.3109/14767058.2013.796170; Porte B, 2016, J CEREB BLOOD FLOW M; Salmina AB, 2015, INT J BIOCHEM CELL B, V64, P174, DOI 10.1016/j.biocel.2015.04.005; Saunders NR, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00404; Saunders NR, 2013, MOL ASPECTS MED, V34, P742, DOI 10.1016/j.mam.2012.11.006; TUOR UI, 1994, AM J PHYSIOL-HEART C, V267, pH2220, DOI 10.1152/ajpheart.1994.267.6.H2220; Vannucci SJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE1127, DOI 10.1152/ajpendo.00187.2003; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Volpe JJ, 2009, SEMIN PEDIATR NEUROL, V16, P167, DOI 10.1016/j.spen.2009.09.005	51	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171048	10.1371/journal.pone.0171048	http://dx.doi.org/10.1371/journal.pone.0171048			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141873	Green Published, gold			2022-12-27	WOS:000396129500036
J	Ullah, A; Chen, W; Khan, MA; Sun, HG				Ullah, Asmat; Chen, Wen; Khan, Mushtaq Ahmad; Sun, HongGuang			A New Variational Approach for Multiplicative Noise and Blur Removal	PLOS ONE			English	Article							FAST ALGORITHM; MODEL; MINIMIZATION; IMAGES	This paper proposes a new variational model for jointmultiplicative denoising and deblurring. It combines a total generalized variation filter (which has been proved to be able to reduce the blocky-effects by being aware of high-order smoothness) and shearlet transform (that effectively preserves anisotropic image features such as sharp edges, curves and so on). The new model takes the advantage of both regularizers since it is able to minimize the staircase effects while preserving sharp edges, textures and other fine image details. The existence and uniqueness of a solution to the proposed variational model is also discussed. The resulting energy functional is then solved by using alternating direction method of multipliers. Numerical experiments showing that the proposed model achieves satisfactory restoration results, both visually and quantitatively in handling the blur (motion, Gaussian, disk, and Moffat) and multiplicative noise (Gaussian, Gamma, or Rayleigh) reduction. A comparison with other recent methods in this field is provided as well. The proposed model can also be applied for restoring both single and multi-channel images contaminated with multiplicative noise, and permit cross-channel blurs when the underlying image has more than one channel. Numerical tests on color images are conducted to demonstrate the effectiveness of the proposed model.	[Ullah, Asmat; Chen, Wen; Khan, Mushtaq Ahmad; Sun, HongGuang] Hohai Univ, Ctr Numer Simulat Software Engn & Sci, State Key Lab Hydrol Water Resources & Hydraul En, Coll Mech & Mat, Nanjing 210098, Jiangsu, Peoples R China	Hohai University	Ullah, A; Chen, W (corresponding author), Hohai Univ, Ctr Numer Simulat Software Engn & Sci, State Key Lab Hydrol Water Resources & Hydraul En, Coll Mech & Mat, Nanjing 210098, Jiangsu, Peoples R China.	asmatullah@hhu.edu.cn; chenwen@hhu.edu.cn	Ullah, Md Asmat/GYU-9827-2022; Heisenberg, X/K-9096-2015	Ullah, Md Asmat/0000-0003-4308-4200; 	National Science Funds of China [11572111, 11372097]; 111 Project [B12032]	National Science Funds of China; 111 Project(Ministry of Education, China - 111 Project)	The work described in this paper was supported by the National Science Funds of China (Grant Nos. 11572111, 11372097) and the 111 Project (Grant No. B12032), Dr. Wen Chen.	Aubert G, 2000, MATH PROBLEMS IMAGE, P147; Aubert G, 2008, SIAM J APPL MATH, V68, P925, DOI 10.1137/060671814; Bioucas D, 2009, P IEEE INT C IM PROC; Boyd Stephen, 2010, Foundations and Trends in Machine Learning, V3, P1, DOI 10.1561/2200000016; Bredies K., 2012, RECOVERING PIECEWISE; Bredies K, 2010, SIAM J IMAGING SCI, V3, P492, DOI 10.1137/090769521; BURCKHARDT CB, 1978, IEEE T SON ULTRASON, V25, P1, DOI 10.1109/T-SU.1978.30978; Candes E, 1999, PHILOS T LONDON ROYA, P357; Candes E, 2006, MULTISCALE MODELING, V05; Chambolle A, 2008, INTRO TOTAL VARIATIO, V4, P2278; Chan T, 2000, SIAM J SCI COMPUT, V22, P503, DOI 10.1137/S1064827598344169; Chen K, 2007, J SCI COMPUT, V33, P115, DOI 10.1007/s10915-007-9145-9; Chen YJ, 2014, IEEE SIGNAL PROC LET, V21, P1370, DOI 10.1109/LSP.2014.2337274; Chumchob N, 2013, INT J COMPUT MATH, V90, P140, DOI 10.1080/00207160.2012.709625; Deng W., 2012, TR1214 CAAM RIC U; Do MN, 2005, IEEE T IMAGE PROCESS, V14, P2091, DOI 10.1109/TIP.2005.859376; Dong YQ, 2013, SIAM J IMAGING SCI, V6, P1598, DOI 10.1137/120870621; Durand S, 2009, MULTIPLICATIVE NOISE, P282; Easley G, 2008, APPL COMPUT HARMON A, V25, P25, DOI 10.1016/j.acha.2007.09.003; Feng WS, 2014, IEEE T IMAGE PROCESS, V23, P1831, DOI 10.1109/TIP.2014.2308432; Glowinski R, 2003, COMPUT PHYS COMMUN, V152, P242, DOI 10.1016/S0010-4655(02)00823-8; GOODMAN JW, 1976, J OPT SOC AM, V66, P1145, DOI 10.1364/JOSA.66.001145; Guang Xial, 2013, MATH PROBL ENG, V2013; Hauser S., 2014, FAST FINITE SHEARLET; He BS, 2002, MATH PROGRAM, V92, P103, DOI 10.1007/s101070100280; He CY, 2015, J INEQUAL APPL, DOI 10.1186/s13660-015-0596-5; Hirakawa K, 2006, IEEE T IMAGE PROCESS, V15, P2730, DOI 10.1109/TIP.2006.877352; Huang LL, 2010, EURASIP J IMAGE VIDE, DOI 10.1155/2010/250768; Huang YM, 2009, SIAM J IMAGING SCI, V2, P20, DOI 10.1137/080712593; Huang YM, 2013, COMMUN COMPUT PHYS, V13, P1066, DOI 10.4208/cicp.310811.090312a; Jin ZM, 2010, J MATH ANAL APPL, V362, P415, DOI 10.1016/j.jmaa.2009.08.036; Knoll F, 2011, MAGN RESON MED, V65, P480, DOI 10.1002/mrm.22595; Labate D., 2005, INT SOC OPTICS PHOTO; Le T, 2007, J MATH IMAGING VIS, V27, P257, DOI 10.1007/s10851-007-0652-y; Liu GJ, 2009, SIGNAL PROCESS, V89, P2233, DOI 10.1016/j.sigpro.2009.04.042; Liu PD, 2014, SPRING CANC RES, P1, DOI [10.1007/978-3-319-05026-3_1, 10.1155/2014/545049]; Longa Z, DENOISING IMAGES MUL; Lysaker M, 2006, INT J COMPUT VISION, V66, P5, DOI 10.1007/s11263-005-3219-7; Lysaker M, 2003, IEEE T IMAGE PROCESS, V12, P1579, DOI 10.1109/TIP.2003.819229; Marquina A, 2000, SIAM J SCI COMPUT, V22, P387, DOI 10.1137/S1064827599351751; MUNSON DC, 1989, IEEE T ACOUST SPEECH, V37, P2131, DOI 10.1109/29.45556; Osher S., 2005, SIMULATION, V02, P460; Rudin L, 2003, GEOMETRIC LEVEL SET METHODS IN IMAGING, VISION AND GRAPHICS, P103, DOI 10.1007/0-387-21810-6_6; RUDIN LI, 1992, PHYSICA D, V60, P259, DOI 10.1016/0167-2789(92)90242-F; Sciacchitano F, 2015, SIAM J IMAGING SCI, V8, P1894, DOI 10.1137/140997816; Shen JH, 2003, PHYSICA D, V175, P241, DOI 10.1016/S0167-2789(02)00734-0; Sheng C, 2005, TOTAL VARIATION BASE, V36, P245; Shi BL, 2012, J VIS COMMUN IMAGE R, V23, P126, DOI 10.1016/j.jvcir.2011.08.003; Shi JN, 2008, SIAM J IMAGING SCI, V1, P294, DOI 10.1137/070689954; Steidl G, 2010, J MATH IMAGING VIS, V36, P168, DOI 10.1007/s10851-009-0179-5; Wang F, 2013, INT J COMPUT MATH, V90, P48, DOI 10.1080/00207160.2012.688821; Wu Y., 2015, MATH PROBL ENG, Va01, P1, DOI DOI 10.1155/2015/395973; Xiao Y, 2011, PATTERN RECOGN, V44, P1708, DOI 10.1016/j.patcog.2011.02.002; Yang JF, 2009, SIAM J IMAGING SCI, V2, P569, DOI 10.1137/080730421; You YL, 2000, IEEE T IMAGE PROCESS, V9, P1723, DOI 10.1109/83.869184; Zhao XL, 2014, SIAM J IMAGING SCI, V7, P456, DOI 10.1137/13092472X	57	19	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0161787	10.1371/journal.pone.0161787	http://dx.doi.org/10.1371/journal.pone.0161787			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141802	Green Published, Green Submitted, gold			2022-12-27	WOS:000396129500001
J	Atkilt, HS; Turago, MG; Tegegne, BS				Atkilt, Helen Siyoum; Turago, Muluken Gizaw; Tegegne, Balewgizie Sileshi			Clinical Characteristics of Diabetic Ketoacidosis in Children with Newly Diagnosed Type 1 Diabetes in Addis Ababa, Ethiopia: A Cross-Sectional Study	PLOS ONE			English	Article								Background Diabetic ketoacidosis (DKA) is one of the most serious acute complications of type 1 diabetes (T1D) and the leading cause of morbidity and mortality in children with T1D. This study was aimed at assessing the prevalence and associated factors of DKA in children with newly diagnosed T1D in Addis Ababa. Methods A hospital based cross-sectional study was conducted in selected hospitals in Addis Ababa. Children below the age of 12 years with DKA who were admitted to the pediatric ward in the selected hospitals between January 2009 and December 2014 and the residence of Addis Ababa were included. DKA was defined as children below the age of 12 years who have blood glucose level >= 250mg/dl, ketonuria, and ketonemia and diagnosed being T1D patient for the first time. Descriptive statistics was performed using frequency distribution, mean, median, tables, and graphs. Logistic regression analysis was used to identify independent factors associated with the prevalence of DKA in children with newly diagnosed T1D. Results Of 395 DKA patients who were hospitalized during the five-year period, 142(35.8%) pre-sented with DKA at first diagnosis of diabetes. On the other hand 253 (64.2%) children with DKA had longstanding T1D. Independent factors associated with DKA include: Age category 2-4.49years, 7-9.49 years and >= 9.5years (Adjusted odd ratio (AOR) = 3.14[1.21,8.06]), 3.44(1.39,8.49) and 4.02(1.68,9.60), respectively); parents' knowledge on the sign and symptoms of DKA (AOR = 0.51[0.27, 0.95]); sign and symptoms of DKA before the onset of DKA (AOR = 0.35[0.21, 0.59]) and infection prior to DKA onset (AOR = 3.45[1.97, 6.04]). Conclusions The overall proportion of children diagnosed with DKA and new onset of T1D in Addis Ababa was high. In particular, children between 9-12 years of age and children whose parents did not know the sign and symptoms of DKA had a high risk of DKA at primary diag-nosis of T1D.	[Atkilt, Helen Siyoum] Bole Hlth Ctr, Addis Ababa, Ethiopia; [Turago, Muluken Gizaw] Univ Addis Ababa, Sch Publ Hlth, Dept Prevent Med, Coll Hlth Sci, Addis Ababa, Ethiopia; [Tegegne, Balewgizie Sileshi] Haramaya Univ, Dept Publ Hlth, Coll Hlth & Med Sci, Harar, Ethiopia	Addis Ababa University; Haramaya University	Atkilt, HS (corresponding author), Bole Hlth Ctr, Addis Ababa, Ethiopia.	helux24@gmail.com	Tegegne, Balewgizie Sileshi/K-6117-2016	Tegegne, Balewgizie Sileshi/0000-0001-9420-0043				Dabelea D, 2014, PEDIATRICS, V133, pE938, DOI 10.1542/peds.2013-2795; Fantahun B., 2008, ETHIOP J PEDIAT CHIL, V4, P1; Federal Democratic Republic of Ethiopia Central Statistical Agency, 2013, POP PROJ ETH ALL REG; Federation ID, 2013, IDF DIABETES ATLAS; Ibekwe MU, 2011, PEDIAT ONCALL, V8, P99; Kitabchi AE, 2009, DIABETES CARE, V32, P1335, DOI 10.2337/dc09-9032; Majaliwa E S, 2010, East Afr Med J, V87, P167; Marigliano M, 2013, EUR J ENDOCRINOL, V168, P107, DOI 10.1530/EJE-12-0541; Mbugua PK, 2005, E AFR MED J, V82; Murunga AN, 2013, TROP MED INT HEALTH, V18, P1357, DOI 10.1111/tmi.12195; Onyiriuka AN, 2013, J DIABETES METABOLIC, V12, P1; Razavi Zahra, 2010, Oman Med J, V25, P114, DOI 10.5001/omj.2010.31; Reddy Y, 2013, S AFR J CHILD HEALTH, V7, P46, DOI 10.7196/SAJCH.500; Usher-Smith JA, 2012, DIABETOLOGIA, V55, P2878, DOI 10.1007/s00125-012-2690-2; Usher-Smith JA, 2011, BMJ-BRIT MED J, V343, pd4092, DOI DOI 10.1136/BMJ.D4092; Van Zyl DG, 2008, S AFR FAM PRACT, V50, P35, DOI 10.1080/20786204.2008.10873664; Wilson J. F, 2010, ANN INTERN MED, V152, DOI DOI 10.7326/0003-4819-152-1-201001050-01001; Wolfsdorf J, 2006, DIABETES CARE, V29, P1150, DOI 10.2337/dc06-9909; Zeitler P, 2015, PEDIATR DIABETES, V16, P392, DOI 10.1111/pedi.12239	19	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0169666	10.1371/journal.pone.0169666	http://dx.doi.org/10.1371/journal.pone.0169666			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135278	Green Submitted, gold, Green Published			2022-12-27	WOS:000396124700004
J	Braune, K; Volkmer, I; Staege, MS				Braune, Katarina; Volkmer, Ines; Staege, Martin S.			Characterization of Alstrom Syndrome 1 (ALMS1) Transcript Variants in Hodgkin Lymphoma Cells	PLOS ONE			English	Article							REED-STERNBERG CELLS; I-TASSER SERVER; ALSTROM-SYNDROME; PROTEIN-STRUCTURE; EXPRESSION; DISEASE; LINES; GENE; PREDICTION; CHILDHOOD	The Alstrom syndrome gene (ALMS1) is one of the largest disease associated genes identified today in the human genome and is implicated in cell cycle control, ciliogenesis, endosome recycling and intracellular transport mechanisms. ALMS1 mutations cause Alstrom syndrome, a rare genetic disorder. However, its function is not completely understood. DNA microarray analysis suggested that ALMS1 might be differentially expressed between Hodgkin lymphoma (HL) cells and normal tissues. By using reverse transcription-polymerase chain reaction (RT-PCR) we detected low but variable expression of ALMS1 in HL cell lines with highest expression in KM-H2 cells. Immunofluorescence indicated centrosomal accumulation of ALMS1 protein in HL cells. Knock-down of ALMS1 in KM-H2 cells had no impact on viability or cytotoxic drug sensitivity of these cells. Sequencing of RT-PCR products from HL cell lines identified three variable regions in ALMS1 transcripts that affect exons 2, 13, and 23. One of these variants was characterized by splicing out of exon 13. The other variants are characterized by two alternative 5 prime ends or alternative 3 prime ends. Structure prediction of the corresponding RNAs and proteins suggest that the different transcript variants might affect post-transcriptional regulation and ligand binding.	[Braune, Katarina; Volkmer, Ines; Staege, Martin S.] Martin Luther Univ Halle Wittenberg, Dept Pediat, Halle, Saale, Germany	Martin Luther University Halle Wittenberg	Staege, MS (corresponding author), Martin Luther Univ Halle Wittenberg, Dept Pediat, Halle, Saale, Germany.	martin.staege@medizin.uni-halle.de	Braune, Katarina/AAC-1690-2019; Staege, Martin S/B-8885-2008; Staege, Martin/AAX-8994-2021	Braune, Katarina/0000-0001-6590-245X; Staege, Martin/0000-0003-3765-7068				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez-Satta M, 2015, APPL CLIN GENET, V8, P171, DOI 10.2147/TACG.S56612; Arya LS, 2005, INDIAN PEDIATR, V42, P1115; Chang TH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S4; Collin GB, 2002, NAT GENET, V31, P74, DOI 10.1038/ng867; DIEHL V, 1981, J CANCER RES CLIN, V101, P111, DOI 10.1007/BF00405072; DREXLER HG, 1986, LEUKEMIA RES, V10, P487, DOI 10.1016/0145-2126(86)90084-6; Feuerborn A, 2006, LEUKEMIA LYMPHOMA, V47, P1932, DOI 10.1080/10428190600667721; Giefing M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084928; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Hearn T, 2005, DIABETES, V54, P1581, DOI 10.2337/diabetes.54.5.1581; Hearn T, 2002, NAT GENET, V31, P79, DOI 10.1038/ng874; Hoennscheidt C, 2009, SCAND J IMMUNOL, V70, P216, DOI 10.1111/j.1365-3083.2009.02286.x; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; KAMESAKI H, 1986, BLOOD, V68, P285; Knorz VJ, 2010, MOL BIOL CELL, V21, P3617, DOI 10.1091/mbc.E10-03-0246; Kochert K, 2011, ONCOGENE, V30, P1831, DOI 10.1038/onc.2010.544; Li G, 2007, PLOS GENET, V5, P3; Lin HMJ, 2005, J PEDIAT HEMATOL ONC, V27, P28, DOI 10.1097/01.mph.0000150740.80690.d4; Liu TY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-32; Liu Y, 2014, LEUKEMIA, V28, P2248, DOI 10.1038/leu.2014.201; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marshall JD, 2007, HUM MUTAT, V28, P1114, DOI 10.1002/humu.20577; Marshall JD, 2011, CURR GENOMICS, V12, P225, DOI 10.2174/138920211795677912; Marshall JD, 2005, ARCH INTERN MED, V165, P675, DOI 10.1001/archinte.165.6.675; Mauz-Korholz C, 2015, J CLIN ONCOL, V33, P2975, DOI 10.1200/JCO.2014.59.4853; Neto ED, 2000, P NATL ACAD SCI USA, V97, P3491; Nishikawa T, 2000, BIOINFORMATICS, V16, P960, DOI 10.1093/bioinformatics/16.11.960; Orlov Yuriy L., 2007, In Silico Biology, V7, P241; Pedersen AG, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P226; Purvis TL, 2010, GENE, V460, P20, DOI 10.1016/j.gene.2010.03.015; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Roth RB, 2006, NEUROGENETICS, V7, P67, DOI 10.1007/s10048-006-0032-6; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schwering I, 2003, BLOOD, V101, P1505, DOI 10.1182/blood-2002-03-0839; Smith MA, 2014, CANCER-AM CANCER SOC, V120, P2497, DOI 10.1002/cncr.28748; Staege MS, 2008, EXP HEMATOL, V36, P886, DOI 10.1016/j.exphem.2008.02.014; Staege MS, 2004, CANCER RES, V64, P8213, DOI 10.1158/0008-5472.CAN-03-4059; Steidl C, 2011, NATURE, V471, P377, DOI 10.1038/nature09754; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wolf J, 1996, BLOOD, V87, P3418, DOI 10.1182/blood.V87.8.3418.bloodjournal8783418; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zulato E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019081	46	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170694	10.1371/journal.pone.0170694	http://dx.doi.org/10.1371/journal.pone.0170694			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135309	Green Submitted, Green Published, gold			2022-12-27	WOS:000396124700018
J	Korenromp, EL; Wi, T; Resch, S; Stover, J; Broutet, N				Korenromp, Eline L.; Wi, Teodora; Resch, Stephen; Stover, John; Broutet, Nathalie			Costing of National STI Program Implementation for the Global STI Control Strategy for the Health Sector, 2016-2021	PLOS ONE			English	Article							TRICHOMONAS-VAGINALIS INFECTIONS; HUMAN-PAPILLOMAVIRUS VACCINATION; MIDDLE-INCOME COUNTRIES; NONGONOCOCCAL URETHRITIS; MYCOPLASMA-GENITALIUM; SYNDROMIC MANAGEMENT; CHLAMYDIA-TRACHOMATIS; DISCHARGE SYNDROMES; CERVICAL-CANCER; SOUTH-AFRICA	Introduction In 2016 the World Health Assembly adopted the global strategy on Sexually Transmitted Infections (STI) 2016-2021 aiming to reduce curable STIs by 90% by 2030. We costed scaling -up priority interventions to coverage targets. Methods Strategy-targeted declines in Chlamydia trachomatis, Neisseria gonorrhoeae, Treponema pallidum and Trichomonas vaginalis were applied to WHO -estimated regional burdens at 2012. Syndromic case management was costed for these curable STIs, symptomatic Herpes Simplex Virus 2 (HSV-2), and non-STI vaginal syndromes, with incrementally expanding etiologic diagnosis. Service unit costs were multiplied with clinic attendances and people targeted for screening or prevention, by income tier. Human papilloma virus (HPV) vaccination and screening were costed for coverage increasing to 60% of 10-year-old girls for vaccination, and 60% of women 30-49 years for twice -lifetime screening (including clinical follow-up for positive screens), by 2021. Results Strategy implementation will cost an estimated US$ 18.1 billion over 2016-2021 in 117 low and middle -income countries. Cost drivers are HPV vaccination ($3.26 billion) and screening ($3.69 billion), adolescent chlamydia screening ($2.54 billion), and antenatal syphilis screening ($1.4 billion). Clinical management of 18 million genital ulcers, 29-39 million urethral discharges and 42-53 million vaginal discharges annually will cost $3.0 billion, including $818 million for service delivery and $1.4 billion for gonorrhea and chlamydia testing. Global costs increase from $2.6 billion to $ 4.0 billion over 2016-2021, driven by HPV services scale -up, despite vaccine price reduction. Sub-Saharan Africa, bearing 40% of curable STI burdens, covers 44% of global service needs and 30% of cost, the Western Pacific 15% of burden/need and 26% of cost, South-East Asia 20% of burden/need and 18% of cost. Conclusions Costs of global STI control depend on price trends for HPV vaccines and chlamydia tests. Middle-income and especially low-income countries need increased investment, innovative financing, and synergizing with other health programs.	[Korenromp, Eline L.; Stover, John] Avenir Hlth, Geneva, Switzerland; [Korenromp, Eline L.; Stover, John] Avenir Hlth, Glastonbury, CT 06033 USA; [Wi, Teodora; Broutet, Nathalie] WHO, Geneva, Switzerland; [Resch, Stephen] Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA	World Health Organization; Harvard University; Harvard T.H. Chan School of Public Health	Korenromp, EL (corresponding author), Avenir Hlth, Geneva, Switzerland.; Korenromp, EL (corresponding author), Avenir Hlth, Glastonbury, CT 06033 USA.	ekorenromp@avenirhealth.org						Alami K, 2002, East Mediterr Health J, V8, P794; [Anonymous], 2016, GUIDELINES TREATMENT; [Anonymous], 2015, WORLD POP PROSP 2015; Atun R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009656; Becker M, 2010, SEX TRANSM DIS, V37, P159, DOI 10.1097/OLQ.0b013e3181bd1007; Bennani A, 2017, PLOS ONE UNPUB   JAN; Bollinger L, 2014, BACKGROUND PAPER UPD; Caceres C, 2006, SEX TRANSM INFECT, V82, pIII3, DOI 10.1136/sti.2005.019489; Campos NG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164000; Campos NG, 2015, INT J CANCER, V137, P2208, DOI 10.1002/ijc.29594; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Novaes HMD, 2015, VACCINE, V33, pA135, DOI 10.1016/j.vaccine.2014.12.031; HIV/AIDS/STI UWG on G, 2012, STRAT LAB METH STREN; Horner P, 2013, SEX TRANSM INFECT, V89, pA23, DOI 10.1136/sextrans-2013-051184.0073; Jit M, 2014, LANCET GLOB HEALTH, V2, pE406, DOI 10.1016/S2214-109X(14)70237-2; Joint United Nations Programme on HIV/AIDS, 2014, FAST TRACK ENDING AI; Kahn JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087510; Korenromp E, 2016, 21 INT AIDS SOC C JU; Korenromp EL, 2002, SEX TRANSM DIS, V29, P228, DOI 10.1097/00007435-200204000-00008; Korenromp EL, 2017, SEX TRANSM IN PRESS; Kularatne R, 2016, 17 IUSTI WORLD C MAY; Lewis DA, 2013, SEX TRANSM INFECT, V89, P523, DOI 10.1136/sextrans-2013-051049; Looker KJ, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0114989, 10.1371/journal.pone.0140765]; Mahiane A G, TRENDS ADULT CHLA MY; Marrazzo JM, 2011, ANAEROBE, V17, P186, DOI 10.1016/j.anaerobe.2011.03.016; Mhlongo S, 2010, SEX TRANSM DIS, V37, P566, DOI 10.1097/OLQ.0b013e3181d877b7; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Newman L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001396; Ng A, 2016, INT J STD AIDS, V27, P63, DOI 10.1177/0956462415571372; Pepin J, 2001, B WORLD HEALTH ORGAN, V79, P118; Pettifor A, 2000, SEX TRANSM DIS, V27, P371, DOI 10.1097/00007435-200008000-00002; Pond MJ, 2014, CLIN INFECT DIS, V58, P631, DOI 10.1093/cid/cit752; Prabhakar P, 2012, SEX TRANSM DIS, V39, P906, DOI 10.1097/OLQ.0b013e3182663e22; Price MA, 2003, SEX TRANSM DIS, V30, P516, DOI 10.1097/00007435-200306000-00009; Rietmeijer KC, 2016, 17 IUSTI WORLD C MAY; Ryan CA, 1998, SEX TRANSM INFECT, V74, pS95; Samarawickrema NA, 2015, INT J STD AIDS, V26, P733, DOI 10.1177/0956462414552813; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Sena AC, 2014, EXPERT REV ANTI-INFE, V12, P673, DOI 10.1586/14787210.2014.887440; Sena AC, 2012, J INFECT DIS, V206, P357, DOI 10.1093/infdis/jis356; STIGMA, 2019, GUID MAN SEX TRANSM; Stop TB Partnership UNOPS., 2015, THE PARADIGM SHIFT 2; Stover J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154893; Stover J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111956; Stover J, 2014, JAIDS-J ACQ IMM DEF, V66, pS170, DOI 10.1097/QAI.0000000000000174; Stover J, 2012, SEX TRANSM INFECT, V88, pI11, DOI 10.1136/sextrans-2012-050640; Takuva S, 2014, SEX TRANSM DIS, V41, P706, DOI 10.1097/OLQ.0000000000000204; Terris-Prestholt F, 2006, SEX TRANSM DIS, V33, pS153, DOI 10.1097/01.olq.0000235177.30718.84; UNAIDS, 2015, UNAIDS STRAT 2016 20; United Nations Department of Economic and Social Affairs Population Division, 2012, WORLD POP PROSP 2012; Vandepitte J, 2006, SEX TRANSM INFECT, V82, pIII18, DOI 10.1136/sti.2006.020081; WHO, 2014, COMPR CERV CANC CONT; WHO, 2013, WHO GUID SCREEN TREA; WHO, 2015, GLOB TECHN STRAT MAL; Wi T, 2015, WORLD STI HIV C JOIN; Wijesooriya NS, 2016, LANCET GLOB HEALTH, V4, pE525, DOI 10.1016/S2214-109X(16)30135-8; WONG ES, 1988, J INFECT DIS, V158, P1098, DOI 10.1093/infdis/158.5.1098; World Health Organisation,, 2016, GLOB HLTH SECT STRAT; World Health Organization, 2014, REP GLOB SEX TANSM I; World Health Organization, 2015, CONS STRAT INF GUID; World Health Organization, 2012, INV CAS EL MOTH TO C; World Health Organization, 2007, 592006A5911 WHO WHA; World Health Organization, 2015, PROGR REP IMPL GLOB; World Health Organization, 2016, GUID TREATM CHALM TR; World Health Organization, 2015, WHOHTMTB201522; World Health Organization, 2012, GLOB ACT PLAN CONTR; World Health Organization, 2011, METH SURV MON COGN S	68	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170773	10.1371/journal.pone.0170773	http://dx.doi.org/10.1371/journal.pone.0170773			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129372	gold, Green Published, Green Submitted			2022-12-27	WOS:000396211400037
J	Pillai, SG; Zhu, PX; Siddappa, CM; Adams, DL; Li, SH; Makarova, OV; Amstutz, P; Nunley, R; Tang, CM; Watson, MA; Aft, RL				Pillai, Sreeraj G.; Zhu, Peixuan; Siddappa, Chidananda M.; Adams, Daniel L.; Li, Shuhong; Makarova, Olga V.; Amstutz, Pete; Nunley, Ryan; Tang, Cha-Mei; Watson, Mark A.; Aft, Rebecca L.			Enrichment and Molecular Analysis of Breast Cancer Disseminated Tumor Cells from Bone Marrow Using Microfiltration	PLOS ONE			English	Article							PERIPHERAL-BLOOD; EXPRESSION; THERAPY; RELAPSE; SYSTEM; RISK; CTC	Purpose Molecular characterization of disseminated tumor cells (DTCs) in the bone marrow (BM) of breast cancer (BC) patients has been hindered by their rarity. To enrich for these cells using an antigen-independent methodology, we have evaluated a size-based microfiltration device in combination with several downstream biomarker assays. Methods BM aspirates were collected from healthy volunteers or BC patients. Healthy BM was mixed with a specified number of BC cells to calculate recovery and fold enrichment by microfiltration. Specimens were pre-filtered using a 70 pm mesh sieve and the effluent filtered through CellSieve microfilters. Captured cells were analyzed by immunocytochemistry (ICC), FISH for HER-2/neu gene amplification status, and RNA in situ hybridization (RISH). Cells eluted from the filter were used for RNA isolation and subsequent qRT-PCR analysis for DTC biomarker gene expression. Results Filtering an average of 14x106 nucleated BM cells yielded approximately 17-21x103 residual BM cells. In the BC cell spiking experiments, an average of 87% (range 84-92%) of tumor cells were recovered with approximately 170- to 400-fold enrichment. Captured BC cells from patients co-stained for cytokeratin and EpCAM, but not CD45 by ICC. RNA yields from 4 ml of patient BM after filtration averaged 135ng per 10 million BM cells filtered with an average RNA Integrity Number (RIN) of 5.3. DTC-associated gene expression was detected by both qRT-PCR and RISH in filtered spiked or BC patient specimens but, not in control filtered normal BM. Conclusions We have tested a microfiltration technique for enrichment of BM DTCs. DTC capture efficiency was shown to range from 84.3% to 92.1% with up to 400-fold enrichment using model BC cell lines. In patients, recovered DTCs can be identified and distinguished from normal BM cells using multiple antibody-, DNA-, and RNA-based biomarker assays.	[Pillai, Sreeraj G.; Siddappa, Chidananda M.; Aft, Rebecca L.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Zhu, Peixuan; Li, Shuhong] Creatv MicroTech Inc, Rockville, MD USA; [Adams, Daniel L.] Creatv MicroTech Inc, Monmouth Jct, NJ USA; [Makarova, Olga V.] Creatv MicroTech Inc, Chicago, IL USA; [Amstutz, Pete; Tang, Cha-Mei] Creatv MicroTech Inc, Potomac, MD USA; [Nunley, Ryan] Washington Univ, Sch Med, Dept Orthoped Surg, St Louis, MO USA; [Watson, Mark A.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Aft, Rebecca L.] John Cochran Vet Adm Hosp, St Louis, MO 63106 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Aft, RL (corresponding author), Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA.; Aft, RL (corresponding author), John Cochran Vet Adm Hosp, St Louis, MO 63106 USA.	aftr@wustl.edu	Pillai, Sreeraj G/M-2369-2013; mudalagiriyappa siddappa, chidananda/B-7851-2015	Pillai, Sreeraj G/0000-0002-0285-0813; mudalagiriyappa siddappa, chidananda/0000-0002-6942-6793	NIH [R01CA172623]; Maryland Technology Development Corporation (TEDCO) MTTCF award; U.S. Army Research Office (ARO); Defense Advanced Research Projects Agency (DARPA) [W911NF-14-C-0098]; Creatv Microtech Inc.; NATIONAL CANCER INSTITUTE [R01CA172623] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Technology Development Corporation (TEDCO) MTTCF award; U.S. Army Research Office (ARO); Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Creatv Microtech Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Grant NIH R01CA172623 (RA and MAW) and a Maryland Technology Development Corporation (TEDCO) MTTCF award and the U.S. Army Research Office (ARO) and the Defense Advanced Research Projects Agency (DARPA) (W911NF-14-C-0098). The content of the information does not necessarily reflect the position or the policy of the US Government. Creatv Microtech Inc. provided support in the form of salaries for authors PZ, DLA, SL, OVM, PA, and CMT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams DL, 2016, RSC ADV, V6, P6405, DOI 10.1039/c5ra21524b; Adams DL, 2014, RSC ADV, V4, P4334, DOI 10.1039/c3ra46839a; Adams DL, 2015, CYTOM PART A, V87A, P137, DOI 10.1002/cyto.a.22613; Adams DL, 2014, P NATL ACAD SCI USA, V111, P3514, DOI 10.1073/pnas.1320198111; Aft R, 2010, LANCET ONCOL, V11, P421, DOI 10.1016/S1470-2045(10)70054-1; Aktas M, 2008, CYTOTHERAPY, V10, P203, DOI 10.1080/14653240701851324; Banys-Paluchowski M, 2016, CRIT REV ONCOL HEMAT, V97, P22, DOI 10.1016/j.critrevonc.2015.10.010; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Coumans FAW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061770; Dolfus C, 2015, CHINESE J CANCER RES, V27, P479, DOI 10.3978/j.issn.1000-9604.2015.09.01; Fehm T, 2006, CANCER-AM CANCER SOC, V107, P885, DOI 10.1002/cncr.22076; Ferreira MM, 2016, MOL ONCOL, V10, P374, DOI 10.1016/j.molonc.2016.01.007; Gabriel MT, 2016, CLIN CHEM, V62, P571, DOI 10.1373/clinchem.2015.249706; Gires O, 2014, CELL MOL LIFE SCI, V71, P4393, DOI 10.1007/s00018-014-1693-1; Gruber I, 2014, BREAST CANCER RES TR, V144, P353, DOI 10.1007/s10549-014-2853-6; Hartkopf AD, 2016, CANCER RES TREAT, V48, P115, DOI 10.4143/crt.2014.287; Hartkopf AD, 2014, EUR J CANCER, V50, P2550, DOI 10.1016/j.ejca.2014.06.025; Jager BAS, 2015, TRANSL ONCOL, V8, P509, DOI 10.1016/j.tranon.2015.11.009; Janni W., 2016, CLIN CANC RES; Janni W, 2011, CLIN CANCER RES, V17, P2967, DOI 10.1158/1078-0432.CCR-10-2515; Kasimir-Bauer S, 2016, SCI REP-UK, V6, DOI 10.1038/srep26355; Kasimir-Bauer S, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0679-3; Korbling M, 2001, BLOOD, V98, P2900, DOI 10.1182/blood.V98.10.2900; Krishnamurthy S, 2013, CANCER MED-US, V2, P226, DOI 10.1002/cam4.70; Ligthart ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067148; Magbanua MJM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141166; Makarova OV, 2016, MAT SCI ENG C-MATER, V66, P193, DOI 10.1016/j.msec.2016.04.075; Moller EK, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00320; Naume B, 2014, J CLIN ONCOL, V32, P3848, DOI 10.1200/JCO.2014.56.9327; Pantel K, 2014, BONEKEY REP, V3; Posel C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050293; Rack B, 2012, ARCH GYNECOL OBSTET, V285, P485, DOI 10.1007/s00404-011-1954-2; Rosenberg R, 2002, CYTOMETRY, V49, P150, DOI 10.1002/cyto.10161; Ross JS, 2009, AM J CLIN PATHOL, V132, P237, DOI 10.1309/AJCPJI7DEOLKCS6F; Schindlbeck C, 2016, J CANC RES CLIN ONCO; Schindlbeck C, 2016, J CANCER RES CLIN, V29, P1; Schindlbeck C, 2008, CLIN EXP METASTAS, V25, P233, DOI 10.1007/s10585-007-9137-z; Schindlbeck C, 2013, J CANCER RES CLIN, V139, P1055, DOI 10.1007/s00432-013-1418-0; Siddappa CM, 2013, BREAST CANCER RES TR, V137, P45, DOI 10.1007/s10549-012-2279-y; Tachtsidis A, 2016, CLIN EXPT METASTASIS, P1; van Beem Rachel T, 2008, EuroIntervention, V4, P133; Watson MA, 2007, CLIN CANCER RES, V13, P5001, DOI 10.1158/1078-0432.CCR-07-0024; Yoshioka T, 2011, INT ORTHOP, V35, P823, DOI 10.1007/s00264-010-1048-y	44	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170761	10.1371/journal.pone.0170761	http://dx.doi.org/10.1371/journal.pone.0170761			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129357	Green Published, gold, Green Submitted			2022-12-27	WOS:000396211400038
J	Sengvilaipaseuth, O; Phommasone, K; de Lamballerie, X; Vongsouvath, M; Phonemixay, O; Blacksell, SD; Mayxay, M; Keomany, S; Souvannasing, P; Newton, PN; Dubot-Peres, A				Sengvilaipaseuth, Onanong; Phommasone, Koukeo; de Lamballerie, Xavier; Vongsouvath, Manivanh; Phonemixay, Ooyanong; Blacksell, Stuart D.; Mayxay, Mayfong; Keomany, Sommay; Souvannasing, Phoutthalavanh; Newton, Paul N.; Dubot-Peres, Audrey			Temperature of a Dengue Rapid Diagnostic Test under Tropical Climatic Conditions: A Follow Up Study	PLOS ONE			English	Article							HEAT-STABILITY; LAOS; INFECTION; ACCURACY; ASSAYS; FEVER; IGG; NS1	The Dengue Duo Rapid Diagnostic Test (SD Dengue RDT) has good specificity and sensitivity for dengue diagnosis in rural tropical areas. In a previous study, using four control sera, we demonstrated that that the diagnostic accuracy of these RDTs remains stable after longterm storage at high temperatures. We extended this study by testing sera from 119 febrile patients collected between July-November 2012 at Salavan Provincial Hospital (southern Laos) with RDTs stored for 6 months at 4 degrees C, 35 degrees and in a hut (miniature traditional house) at Lao ambient temperatures. The dengue NS1 antigen results from RDTs stored at 35 degrees C and in the hut demonstrated 100% agreement with those stored at 4 degrees C. However, lower positive percent agreements, with broad 95% CI, were observed for the tests: IgM, 60% (14.7-94.7) and 40% (5.3-85.3) for RDTs store at 35 degrees C and in the hut, compared to those stored at 4 degrees C, respectively. This study strenghtens the evidence of the robustness of the NS1 antigen detection RDT for the diagnosis of dengue after storage at tropical temperatures.	[Sengvilaipaseuth, Onanong; Phommasone, Koukeo; Vongsouvath, Manivanh; Phonemixay, Ooyanong; Blacksell, Stuart D.; Newton, Paul N.; Dubot-Peres, Audrey] Mahosot Hosp, Microbiol Lab, Lao Oxford Mahosot Hosp Wellcome Trust Res Unit L, Viangchan, Laos; [de Lamballerie, Xavier; Dubot-Peres, Audrey] Aix Marseille Univ, UMR EPV, EHESP, IRD 190,Inserm 1207, Marseille, France; [de Lamballerie, Xavier] Publ Hosp Marseille, AP HM, Inst Hosp Univ Mediterranee Infect, Marseille, France; [Blacksell, Stuart D.; Newton, Paul N.; Dubot-Peres, Audrey] Univ Oxford, Churchill Hosp, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England; [Blacksell, Stuart D.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Mayxay, Mayfong] Univ Hlth Sci, Fac Postgrad Studies, Viangchan, Laos; [Keomany, Sommay; Souvannasing, Phoutthalavanh] Salavan Prov Hosp, Salavan Prov Hlth Dept, Vapi, Salavan Provinc, Laos	Ecole des Hautes Etudes en Sante Publique (EHESP); Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University	Dubot-Peres, A (corresponding author), Mahosot Hosp, Microbiol Lab, Lao Oxford Mahosot Hosp Wellcome Trust Res Unit L, Viangchan, Laos.; Dubot-Peres, A (corresponding author), Aix Marseille Univ, UMR EPV, EHESP, IRD 190,Inserm 1207, Marseille, France.; Dubot-Peres, A (corresponding author), Univ Oxford, Churchill Hosp, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England.	audrey@tropmedres.ac	Blacksell, Stuart/D-5530-2018	Blacksell, Stuart/0000-0001-6576-726X; Newton, Paul/0000-0002-4608-6431	Wellcome Trust, IRD, Standard Diagnostics for supply of dengue RDTs	Wellcome Trust, IRD, Standard Diagnostics for supply of dengue RDTs	This work was supported by the Wellcome Trust, IRD, Standard Diagnostics for supply of dengue RDTs. Standard Diagnostics has no role in the planning, analysis, writing or decision to publish this paper.	Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Blacksell SD, 2006, CLIN INFECT DIS, V42, P1127, DOI 10.1086/501358; Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P2095, DOI 10.1128/CVI.05285-11; Chiodini PL, 2007, T ROY SOC TROP MED H, V101, P331, DOI 10.1016/j.trstmh.2006.09.007; Dubot-Peres A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002360; Food U., 2007, STAT GUID REP RES ST; Learmonth KM, 2011, T ROY SOC TROP MED H, V105, P388, DOI 10.1016/j.trstmh.2011.04.005; Mayxay M, 2015, AM J TROP MED HYG, V93, P517, DOI 10.4269/ajtmh.14-0772; Mayxay M, 2013, LANCET GLOB HEALTH, V1, pE46, DOI 10.1016/S2214-109X(13)70008-1; Mikhail AFW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-169; Osorio L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-361; Pal S, 2015, J CLIN MICROBIOL, V53, P1092, DOI 10.1128/JCM.03042-14; Peyerl-Hoffmann G, 2004, CLIN MICROBIOL INFEC, V10, P181, DOI 10.1111/j.1198-743x.2003.00854.x; Phommasone K, 2015, AM J TROP MED HYG, V93, P33, DOI 10.4269/ajtmh.15-0142; StataCorp L, 2007, STAT DAT AN STAT SOF; Tricou V, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-142; Wang SM, 2010, AM J TROP MED HYG, V83, P690, DOI 10.4269/ajtmh.2010.10-0117	17	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170359	10.1371/journal.pone.0170359	http://dx.doi.org/10.1371/journal.pone.0170359			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129346	Green Submitted, gold, Green Published			2022-12-27	WOS:000396211400058
J	Wagner, BD; Sontag, MK; Harris, JK; Miller, JI; Morrow, L; Robertson, CE; Stephens, M; Poindexter, BB; Abman, SH; Mourani, PM				Wagner, Brandie D.; Sontag, Marci K.; Harris, J. Kirk; Miller, Joshua I.; Morrow, Lindsey; Robertson, Charles E.; Stephens, Mark; Poindexter, Brenda B.; Abman, Steven H.; Mourani, Peter M.			Airway Microbial Community Turnover Differs by BPD Severity in Ventilated Preterm Infants	PLOS ONE			English	Article							CHRONIC LUNG-DISEASE; INFLAMMATION; PREVENTION; DIVERSITY; EXPOSURE; RISK	Preterm birth exposes the developing lung to an environment with direct exposure to bacteria, often facilitated by endotracheal intubation. Despite evidence linking bacterial infections to the pathogenesis of bronchopulmonary dysplasia (BPD), systematic studies of airway microbiota are limited. The objective was to identify specific patterns of the early respiratory tract microbiome from tracheal aspirates of mechanically ventilated preterm infants that are associated with the development and severity of BPD. Infants with gestational age <= 34 weeks, and birth weight 500-1250g were prospectively enrolled. Mechanically ventilated infants had tracheal aspirate samples collected at enrollment, 7, 14, and 21 days of age. BPD was determined by modified NIH criteria with oxygen reduction tests; infants without BPD were excluded due to low numbers. Aspirates were processed for bacterial identification by 16S rRNA sequencing, and bacterial load by qPCR. Cross-sectional analysis was performed using 7 day samples and longitudinal analysis was performed from subjects with at least 2 aspirates. Microbiome analysis was performed on tracheal aspirates from 152 infants (51, 49, and 52 with mild, moderate, and severe BPD, respectively). Seventy-nine of the infants were included in the cross-sectional analysis and 94 in the longitudinal. Shannon Diversity, bacterial load, and relative abundance of individual taxa were not strongly associated with BPD status. Longitudinal analysis revealed that preterm infants who eventually developed severe BPD exhibited greater bacterial community turnover with age, acquired less Staphylococcus in the first days after birth, and had higher initial relative abundance of Ureaplasma. In conclusion, longitudinal changes in the airway microbial communities of mechanically ventilated preterm infants may be associated with BPD severity, whereas cross-sectional analysis of airway ecology at 7 days of age did not reveal an association with BPD severity. Further evaluation is necessary to determine whether the observed longitudinal changes are causal or in response to clinical management or other factors that lead to BPD.	[Wagner, Brandie D.; Morrow, Lindsey] Univ Colorado, Colorado Sch Publ Hlth, Dept Biostat, Aurora, CO USA; [Wagner, Brandie D.; Harris, J. Kirk; Stephens, Mark; Abman, Steven H.] Univ Colorado, Dept Pediat, Sect Pulm, Aurora, CO USA; [Sontag, Marci K.; Miller, Joshua I.] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Robertson, Charles E.] Univ Colorado, Sch Med, Infect Dis Sect, Dept Med, Aurora, CO USA; [Poindexter, Brenda B.] Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Cincinnati, OH 45229 USA; [Abman, Steven H.; Mourani, Peter M.] Univ Colorado, Sch Med, Dept Pediat, Pediat Heart Lung Ctr, Aurora, CO 80309 USA; [Mourani, Peter M.] Univ Colorado, Sch Med, Dept Pediat, Sect Crit Care Med, Aurora, CO 80309 USA	Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Cincinnati Children's Hospital Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Mourani, PM (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Pediat Heart Lung Ctr, Aurora, CO 80309 USA.; Mourani, PM (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Sect Crit Care Med, Aurora, CO 80309 USA.	peter.mourani@childrenscolorado.org		Harris, Jonathan/0000-0002-2378-4202; ROBERTSON, CHARLES/0000-0002-4136-4121; Wagner, brandie/0000-0002-2745-0103; Sontag, Marci/0000-0003-2501-652X	Gerber Foundation; National Institute of Health/National Center Research Resources [K23RR021921]; National Institute of Health National Heart Lung Blood Institute [R01 HL085703]; National Institute of Health/National Center for Advancing Translational Sciences [UL1 TR000154]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER	Gerber Foundation; National Institute of Health/National Center Research Resources; National Institute of Health National Heart Lung Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Health/National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by: Gerber Foundation, http://www.gerberfoundation.org; National Institute of Health/National Center Research Resources K23RR021921; National Institute of Health National Heart Lung Blood Institute R01 HL085703; National Institute of Health/National Center for Advancing Translational Sciences Grant Number UL1 TR000154. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Baier R John, 2003, BMC Pediatr, V3, P10, DOI 10.1186/1471-2431-3-10; Ballard HO, 2011, PEDIATR PULM, V46, P111, DOI 10.1002/ppul.21352; Bancalari Eduardo, 2003, Semin Neonatol, V8, P63, DOI 10.1016/S1084-2756(02)00192-6; Bose CL, 2008, ARCH DIS CHILD-FETAL, V93, P1455, DOI 10.1136/adc.2007.121327; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chao A, 2010, PHILOS T R SOC B, V365, P3599, DOI 10.1098/rstb.2010.0272; Chuang GS, 2008, J AM ACAD DERMATOL, V59, P167, DOI 10.1016/j.jaad.2008.02.017; Dimmitt RA, 2010, J PEDIATR GASTR NUTR, V51, P262, DOI 10.1097/MPG.0b013e3181e1a114; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Groneck P, 2001, PEDIATR PULM, V31, P331, DOI 10.1002/ppul.1055; Hara N, 2012, J IMMUNOL, V189, P3805, DOI 10.4049/jimmunol.1201257; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hiergeist A, 2016, INT J MED MICROBIOL, V306, P334, DOI 10.1016/j.ijmm.2016.03.005; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Hoffman LR, 2006, P NATL ACAD SCI USA, V103, P19890, DOI 10.1073/pnas.0606756104; Jobe AH, 2001, RESP RES, V2, P27, DOI 10.1186/rr35; Jobe AH, 2011, CURR OPIN PEDIATR, V23, P167, DOI 10.1097/MOP.0b013e3283423e6b; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; JONSSON B, 1994, ACTA PAEDIATR, V83, P927, DOI 10.1111/j.1651-2227.1994.tb13174.x; Kallapur SG, 2011, J IMMUNOL, V187, P2688, DOI 10.4049/jimmunol.1100779; Kallopur SG, 2006, ARCH DIS CHILD-FETAL, V91, pF132, DOI 10.1136/adc.2004.068544; Kemp MW, 2016, AM J REPROD IMMUNOL; Lohmann P, 2014, PEDIATR RES, V76, P294, DOI 10.1038/pr.2014.85; Lyon AJ, 1998, ARCH DIS CHILD-FETAL, V78, pF10, DOI 10.1136/fn.78.1.F10; Marcon E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090289; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Mourani PM, 2015, AM J RESP CRIT CARE, V191, P87, DOI 10.1164/rccm.201409-1594OC; Mourani PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025959; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; NORTHWAY WH, 1990, NEW ENGL J MED, V323, P1793, DOI 10.1056/NEJM199012273232603; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; Pettigrew MM, 2011, J CLIN MICROBIOL, V49, P3750, DOI 10.1128/JCM.01186-11; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Qazi S, 2006, INFECT IMMUN, V74, P910, DOI 10.1128/IAI.74.2.910-919.2006; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Robertson CE, 2013, BIOINFORMATICS; Rogers GB, 2006, J CLIN MICROBIOL, V44, P2601, DOI 10.1128/JCM.02282-05; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Schloss Patrick D, 2011, Appl Environ Microbiol, V77, P3219, DOI 10.1128/AEM.02810-10; van Vliet MJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000879; Viscardi RM, 2009, PEDIATR RES, V65, p84R, DOI 10.1203/PDR.0b013e31819dc2f9; Walsh Michele C, 2003, J Perinatol, V23, P451, DOI 10.1038/sj.jp.7210963; Yang LY, 2009, GASTROENTEROLOGY, V137, P588, DOI 10.1053/j.gastro.2009.04.046; Zemanick ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062917; Zemanick ET, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015101	49	46	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170120	10.1371/journal.pone.0170120	http://dx.doi.org/10.1371/journal.pone.0170120			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129336	gold, Green Submitted, Green Published			2022-12-27	WOS:000396211400062
J	Ballard, M; Tran, J; Hersch, F; Lockwood, A; Hartigan, P; Montgomery, P				Ballard, Madeleine; Tran, Jenny; Hersch, Fred; Lockwood, Amy; Hartigan, Pamela; Montgomery, Paul			Supporting Better Evidence Generation and Use within Social Innovation in Health in Low-and Middle-Income Countries: A Qualitative Study	PLOS ONE			English	Article							POLICY	Background While several papers have highlighted a lack of evidence to scale social innovations in health, fewer have explored decision-maker understandings of the relative merit of different types of evidence, how such data are interpreted and applied, and what practical support is required to improve evidence generation. The objectives of this paper are to understand (1) beliefs and attitudes towards the value of and types of evidence in scaling social innovations for health, (2) approaches to evidence generation and evaluation used in systems and policy change, and (3) how better evidence-generation can be undertaken and supported within social innovation in health. Methods Thirty-two one-on-one interviews were conducted between July and November 2015 with purposively selected practitioners, policymakers, and funders from low-and middle-income countries (LMICs). Data were analysed using a Framework Analysis Approach. Results While practitioners, funders, and policymakers said they held outcome evidence in high regard, their practices only bear out this assertion to varying degrees. Few have given systematic consideration to potential unintended consequences, in particular harm, of the programs they implement, fund, or adopt. Stakeholders suggest that better evidence-generation can be undertaken and supported within social innovation in health by supporting the research efforts of emerging community organizations; creating links between practitioners and academia; altering the funding landscape for evidence-generation; providing responsive technical education; and creating accountability for funders, practitioners, and policymakers. Conclusion How better evidence-generation can be undertaken and supported within social innovation in health is a previously under-operationalised aspect of the policy-making process that remains essential in order to refrain from causing harm, enable the optimization of existing interventions, and ultimately, to scale and fund what works.	[Ballard, Madeleine; Montgomery, Paul] Univ Oxford, Ctr Evidence Based Intervent, Oxford, England; [Tran, Jenny] Univ Oxford, George Inst Global Hlth, Oxford Martin Sch, Oxford, England; [Hersch, Fred; Hartigan, Pamela] Univ Oxford, Said Business Sch, Oxford, England; [Lockwood, Amy] Univ Calif San Francisco, Global Hlth Sci, San Francisco, CA 94143 USA	University of Oxford; University of Oxford; University of Oxford; University of California System; University of California San Francisco	Ballard, M (corresponding author), Univ Oxford, Ctr Evidence Based Intervent, Oxford, England.	madeleine.ballard@gmail.com	Ballard, Madeleine/M-8510-2016	Ballard, Madeleine/0000-0003-0107-4047; Montgomery, Paul/0000-0001-8008-1370	Skoll Centre at the Said Business School of the University of Oxford; ESRC [ES/N012267/2] Funding Source: UKRI	Skoll Centre at the Said Business School of the University of Oxford; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was funded by the Skoll Centre at the Said Business School of the University of Oxford (http://www.sbs.ox.ac.uk/faculty-research/skoll). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AidData, 2015, MARK ID POL CHANG; Bhattacharyya O, 2015, RAPID ROUTES SCALE S; Bradley EH, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000987; Chalmers I, 2003, ANN AM ACAD POLIT SS, V589, P22, DOI 10.1177/0002716203254762; Collins LM, 2011, ANN BEHAV MED, V41, P208, DOI 10.1007/s12160-010-9253-x; Dees J.G., 2004, STANFORD SOCIAL INNO, V1, P24, DOI DOI 10.1177/097135571102100107; Frumkin P, 2010, EVALUATION EXCHANGE, V15; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Garber S, 2011, CHALLENGES VALUE ENH; Glasgow RE, 2003, AM J PUBLIC HEALTH, V93, P1261, DOI 10.2105/AJPH.93.8.1261; Milat AJ, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-18; Miller Dale T., 2008, STANFORD SOCIAL INNO, V6; Oliver K, 2015, EUROPEAN J PUBLIC HL; Oliver K, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-2; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; QSR International Pty Ltd, 2014, NVIVO QUAL DAT AN SO; Social Research Unit at Dartington, 2013, REAL AMB LESS REPL E; Sofaer S, 1999, HEALTH SERV RES, V34, P1101; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Yamey G, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-11	20	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170367	10.1371/journal.pone.0170367	http://dx.doi.org/10.1371/journal.pone.0170367			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7IT	28125628	gold, Green Published			2022-12-27	WOS:000396176100117
J	Bedwell, RM; Spielvogel, H; Bellido, D; Vitzthum, VJ				Bedwell, Rebecca M.; Spielvogel, Hilde; Bellido, Diva; Vitzthum, Virginia J.			Factors Influencing the Use of Biomedical Health Care by Rural Bolivian Anemic Women: Structural Barriers, Reproductive Status, Gender Roles, and Concepts of Anemia	PLOS ONE			English	Article							IRON-DEFICIENCY; FOLATE SUPPLEMENTATION; HIGH-ALTITUDES; DETERMINANTS; PREVALENCE; PREGNANCY; AGE	The persistently high prevalence of anemia in rural highland Bolivia argues for targeted iron supplementation. We evaluated the cultural, structural and behavioral factors that may facilitate or impede an anemic woman's decision to secure this biomedical treatment from a rural Bolivian health center. Methods Non-pregnant women from a rural town and its surrounding region were tested for anemia. During phase 1 ( n = 181), anemic women received a written recommendation for low-cost purchase of iron pills at the nearest health center. They were subsequently interviewed on their actions and experiences. Results Estimated anemia prevalence among these non-pregnant women was 50% higher than the national average. Despite holding conceptualizations of anemia generally aligned with biomedical concepts, only 40% of anemic women attempted to obtain iron supplements from the health center. Town residents were about twice as likely to attempt to purchase pills as outside-town residents. Town women who were concurrently breastfeeding and menstruating, considered anemia most serious for women, and considered family health the shared responsibility of spouses were most likely to decide to purchase iron pills. Age, education, or native language did not negatively influence this health care behavior. Conclusions Securing iron supplements involves individual trade-offs in the allocation of time, cost and effort. Nonetheless, suitably tailored programs can potentially harness local perceptions in the service of reducing anemia. Because of their comparatively high motivation to obtain iron supplements, targeting concurrently breastfeeding and menstruating women could have a positive cascade effect such that these women continue attending to their iron needs once they stop breastfeeding and if they become pregnant again. Because a sense of shared responsibility for family health appears to encourage women to attend to their own health, programs for women could involve their spouses. Complementing centralized availability, biomedical and traditional healers could distribute iron supplements on rotating visits to outlying areas and/or at highly attended weekly markets.	[Bedwell, Rebecca M.; Vitzthum, Virginia J.] Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA; [Bedwell, Rebecca M.; Vitzthum, Virginia J.] Indiana Univ, Kinsey Inst, Bloomington, IN 47405 USA; [Spielvogel, Hilde; Bellido, Diva] Inst Boliviano Biol Altura, La Paz, Bolivia; [Bedwell, Rebecca M.] Univ Arizona, Sch Anthropol, Tucson, AZ USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Universidad Mayor de San Andres; University of Arizona	Vitzthum, VJ (corresponding author), Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA.; Vitzthum, VJ (corresponding author), Indiana Univ, Kinsey Inst, Bloomington, IN 47405 USA.	vitzthum@indiana.edu		Vitzthum, Virginia J./0000-0002-6765-4557	U.S. National Science Foundation [SBR 9506107]; Office of the Vice Provost for Research, Indiana University, Bloomington	U.S. National Science Foundation(National Science Foundation (NSF)); Office of the Vice Provost for Research, Indiana University, Bloomington	This work was supported by the U.S. National Science Foundation (SBR 9506107) and the Office of the Vice Provost for Research, Indiana University, Bloomington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2011, FOOD RES INT, V44, P652, DOI 10.1016/j.foodres.2010.12.033; BASTIEN JW, 1985, AM ANTHROPOL, V87, P595, DOI 10.1525/aa.1985.87.3.02a00050; Beall CM, 2014, ANNU REV ANTHROPOL, V43, P251, DOI 10.1146/annurev-anthro-102313-030000; BENDER DE, 1993, SOC SCI MED, V37, P1345, DOI 10.1016/0277-9536(93)90164-Y; Berger J, 1997, NUTR REV, V55, P247, DOI 10.1111/j.1753-4887.1997.tb01612.x; Berti PR, 2014, REV PANAM SALUD PUBL, V36, P314; Bindon JR, 2002, SOC SCI MED, V54, P1299, DOI 10.1016/S0277-9536(01)00097-1; Blackwell D.L., 2014, VITAL HEALTH STAT 10, V260, P1; CIAES (The Center for Health Research Consultation and Education), 1991, 9 CIAES JOHN SNOW IN; Currie Dawn, 2003, Health Care Women Int, V24, P880, DOI 10.1080/07399330390244257; Dary O, 2007, NUTR ANEMIA, P315; Ejidokun OO, 2000, MIDWIFERY, V16, P89, DOI 10.1054/midw.1999.0196; GALLOWAY R, 1994, SOC SCI MED, V39, P381, DOI 10.1016/0277-9536(94)90135-X; Galloway R, 2002, SOC SCI MED, V55, P529, DOI 10.1016/S0277-9536(01)00185-X; Ghanekar J, 2002, INDIA FOOD NUTR B, V23, P65, DOI DOI 10.1177/156482650202300109; Gonzales GF, 2009, AM J PHYSIOL-REG I, V297, pR1477, DOI 10.1152/ajpregu.00275.2009; Horton S, 2003, FOOD POLICY, V28, P51, DOI 10.1016/S0306-9192(02)00070-2; Imhoff-Kunsch B, 2007, J NUTR, V137, P1017, DOI 10.1093/jn/137.4.1017; Jefferds MD, 2002, SOC SCI MED, V55, P1143, DOI 10.1016/S0277-9536(01)00254-4; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Leon-Velarde F, 2000, High Alt Med Biol, V1, P97; Mora JO, 2010, ANEMIA LATIN AM CARB; Mujica-Coopman MF, 2015, FOOD NUTR BULL, V36, pS119, DOI 10.1177/0379572115585775; Nagata JM, 2012, MATERN CHILD NUTR, V8, P1, DOI 10.1111/j.1740-8709.2011.00338.x; Sanghvi T., 2007, Food and Nutrition Bulletin, V28, pS182; Sullivan KM, 2008, TROP MED INT HEALTH, V13, P1267, DOI 10.1111/j.1365-3156.2008.02143.x; Vitzthum VJ, 2009, AM J HUM BIOL, V21, P762, DOI 10.1002/ajhb.20927; Vitzthum VJ, 2009, AM J HUM BIOL, V21, P548, DOI 10.1002/ajhb.20936; WHO (World Health Organization), 2000, REC METH DET HEM PAC; Woldemicael G, 2010, HEALTH CARE WOMEN IN, V31, P599, DOI 10.1080/07399331003599555; Young SL, 2005, MATERN CHILD NUTR, V1, P51, DOI 10.1111/j.1740-8709.2004.00002.x	31	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170475	10.1371/journal.pone.0170475	http://dx.doi.org/10.1371/journal.pone.0170475			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7IT	28125636	Green Published, gold, Green Submitted			2022-12-27	WOS:000396176100105
J	Camlin, NJ; McLaughlin, EA; Holt, JE				Camlin, Nicole J.; McLaughlin, Eileen A.; Holt, Janet E.			Kif4 Is Essential for Mouse Oocyte Meiosis	PLOS ONE			English	Article							KINESIN-LIKE PROTEIN; KINETOCHORE-MICROTUBULE ATTACHMENTS; PHOSPHORYLATION SITES; SPINDLE ORGANIZATION; CHROMOSOME ALIGNMENT; MITOTIC CHROMOSOMES; KLP3A; PROLIFERATION; ANEUPLOIDY; LENGTH	Progression through the meiotic cell cycle must be strictly regulated in oocytes to generate viable embryos and offspring. During mitosis, the kinesin motor protein Kif4 is indispensable for chromosome condensation and separation, midzone formation and cytokinesis. Additionally, the bioactivity of Kif4 is dependent on phosphorylation via Aurora Kinase B and Cdk1, which regulate Kif4 function throughout mitosis. Here, we examine the role of Kif4 in mammalian oocyte meiosis. Kif4 localized in the cytoplasm throughout meiosis I and II, but was also observed to have a dynamic subcellular distribution, associating with both microtubules and kinetochores at different stages of development. Co-localization and proximity ligation assays revealed that the kinetochore proteins, CENP-C and Ndc80, are potential Kif4 interacting proteins. Functional analysis of Kif4 in oocytes via antisense knock-down demonstrated that this protein was not essential for meiosis I completion. However, Kif4 depleted oocytes displayed enlarged polar bodies and abnormal metaphase II spindles, indicating an essential role for this protein for correct asymmetric cell division in meiosis I. Further investigation of the phosphoregulation of meiotic Kif4 revealed that Aurora Kinase and Cdk activity is critical for Kif4 kinetochore localization and interaction with Ndc80 and CENPC. Finally, Kif4 protein but not gene expression was found to be upregulated with age, suggesting a role for this protein in the decline of oocyte quality with age.	[Camlin, Nicole J.; McLaughlin, Eileen A.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW, Australia; [Camlin, Nicole J.; McLaughlin, Eileen A.; Holt, Janet E.] Univ Newcastle, Prior Res Ctr Reprod Sci, Callaghan, NSW, Australia; [McLaughlin, Eileen A.] Univ Auckland, Sch Biol Sci, Auckland, New Zealand; [Holt, Janet E.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia	University of Newcastle; University of Newcastle; University of Auckland; University of Newcastle	Camlin, NJ; McLaughlin, EA (corresponding author), Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW, Australia.; Camlin, NJ; McLaughlin, EA (corresponding author), Univ Newcastle, Prior Res Ctr Reprod Sci, Callaghan, NSW, Australia.; McLaughlin, EA (corresponding author), Univ Auckland, Sch Biol Sci, Auckland, New Zealand.	Nicole.Camlin@uon.edu.au; eileen.mclaughlin@auckland.ac.nz	McLaughlin, Eileen/AAF-5588-2021; McLaughlin, Eileen A/G-7620-2013	Camlin, Nicole/0000-0001-9673-6191; McLaughlin, Eileen/0000-0002-5837-3876	Australian Research Council (ARC) [DP110100418, DP120100946/DE120101242]; Australian Postgraduate award	Australian Research Council (ARC)(Australian Research Council); Australian Postgraduate award(Australian Government)	This work was supported by Australian Research Council (ARC) grants to E A McLaughlin (DP110100418) and J E Holt (DP120100946/DE120101242) and an Australian Postgraduate award to N J Camlin.	Adhikari D, 2012, HUM MOL GENET, V21, P2476, DOI 10.1093/hmg/dds061; Balboula AZ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004194; Bastos RN, 2014, J CELL BIOL, V207, P683, DOI 10.1083/jcb.201409129; Bastos RN, 2013, J CELL BIOL, V202, P605, DOI 10.1083/jcb.201301094; Bieling P, 2010, CURR BIOL, V20, P763, DOI 10.1016/j.cub.2010.02.067; Bringmann H, 2004, SCIENCE, V303, P1519, DOI 10.1126/science.1094838; Camlin NJ, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.135848; Castoldi M, 2006, MOL BIOL CELL, V17, P1451, DOI 10.1091/mbc.e05-04-0271; Cohen Y, 2014, HEMATOLOGY, V19, P286, DOI 10.1179/1607845413Y.0000000125; Davydenko O, 2013, J CELL BIOL, V202, P221, DOI 10.1083/jcb.201303019; Gao J, 2011, TUMOR BIOL, V32, P53, DOI 10.1007/s13277-010-0090-0; Gui LM, 2013, DEV CELL, V25, P43, DOI 10.1016/j.devcel.2013.02.008; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hassold T, 2007, HUM MOL GENET, V16, pR203, DOI 10.1093/hmg/ddm243; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Holt Janet E, 2013, Methods Mol Biol, V957, P91, DOI 10.1007/978-1-62703-191-2_6; Holt JE, 2011, DEVELOPMENT, V138, P905, DOI 10.1242/dev.059022; Hu CK, 2012, MOL BIOL CELL, V23, P1024, DOI 10.1091/mbc.E11-08-0721; Hu CK, 2011, CURR BIOL, V21, P815, DOI 10.1016/j.cub.2011.04.019; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kurasawa Y, 2004, ESSENTIAL ROLES KIF4; Kwon MS, 2007, MOL BIOL CELL, V18, P2155, DOI 10.1091/mbc.E07-01-0045; Lane SIR, 2010, REPRODUCTION, V140, P521, DOI 10.1530/REP-10-0223; Mazumdar M, 2004, J CELL BIOL, V166, P613, DOI 10.1083/jcb.200401142; Mazumdar M, 2006, CURR BIOL, V16, P1559, DOI 10.1016/j.cub.2006.06.029; Mazumdar M, 2011, NUCLEUS-AUSTIN, V2, P591, DOI 10.4161/nucl.2.6.18044; Mitchison TJ, 2013, MOL BIOL CELL, V24, P1559, DOI 10.1091/mbc.E12-12-0850; Morris EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091568; Page SL, 2005, GENETICS, V170, P1797, DOI 10.1534/genetics.105.041194; Pan H, 2008, DEV BIOL, V316, P397, DOI 10.1016/j.ydbio.2008.01.048; Patel J, 2016, BIOL OPEN, V5, P178, DOI 10.1242/bio.016394; Samejima K, 2012, J CELL BIOL, V199, P755, DOI 10.1083/jcb.201202155; Shomper M, 2014, CELL CYCLE, V13, P1171, DOI 10.4161/cc.28046; Shrestha S, 2012, MOL BIOL CELL, V23, P1196, DOI 10.1091/mbc.E11-12-1008; Sun SC, 2011, MICROSC MICROANAL, V17, P431, DOI 10.1017/S1431927611000274; Takahashi M, 2016, BIOMED RES-TOKYO, V37, P161, DOI 10.2220/biomedres.37.161; Tang A, 2016, CELL CYCLE; VERNOS I, 1995, CELL, V81, P117, DOI 10.1016/0092-8674(95)90376-3; Voets E, 2014, SCI REPORTS, V5, P14798; Wandke C, 2012, J CELL BIOL, V198, P847, DOI 10.1083/jcb.201110060; Wei XM, 2014, MOL BIOL REP, V41, P5089, DOI 10.1007/s11033-014-3374-4; Williams BC, 1997, DEVELOPMENT, V124, P2365; WILLIAMS BC, 1995, J CELL BIOL, V129, P709, DOI 10.1083/jcb.129.3.709; Wynne DJ, 2015, J CELL BIOL, V210, P899, DOI 10.1083/jcb.201506020; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; Yoshida S, 2015, DEV CELL, V33, P589, DOI 10.1016/j.devcel.2015.04.020; Yun Y, 2014, CELL CYCLE, V13, P1938, DOI 10.4161/cc.28897; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102; Zielinska AP, 2015, ELIFE, V4, DOI 10.7554/eLife.11389	51	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170650	10.1371/journal.pone.0170650	http://dx.doi.org/10.1371/journal.pone.0170650			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125646	gold, Green Published, Green Submitted			2022-12-27	WOS:000396176100080
J	Guan, Y; Wang, XD; Wong, MH; Sun, GP; An, TC; Guo, J; Zhang, GX				Guan, Ying; Wang, Xiaodong; Wong, Minghung; Sun, Guoping; An, Taicheng; Guo, Jun; Zhang, Guoxia			Evaluation of Genotoxic and Mutagenic Activity of Organic Extracts from Drinking Water Sources	PLOS ONE			English	Article							PEARL RIVER DELTA; ORGANOCHLORINE PESTICIDES OCPS; HOSPITAL WASTE-WATER; RISK-ASSESSMENT; SURFACE WATERS; SOS CHROMOTEST; SOUTH CHINA; SALMONELLA; SEDIMENTS; ESTUARY	An increasing number of industrial, agricultural and commercial chemicals in the aquatic environment lead to various deleterious effects on organisms, which is becoming a serious global health concern. In this study, the Ames test and SOS/umu test were conducted to investigate the potential genotoxicity and mutagenicity caused by organic extracts from drinking water sources. Organic content of source water was extracted with XAD-2 resin column and organic solvents. Four doses of the extract equivalent to 0.25, 0.5, 1 and 2L of source water were tested for toxicity. All the water samples were collected from six different locations in Guangdong province. The results of the Ames test and SOS/umu test showed that all the organic extracts from the water samples could induce different levels of DNA damage and mutagenic potentials at the dose of 2 L in the absence of S9 mix, which demonstrated the existence of genotoxicity and mutagenicity. Additionally, we found that Salmonella typhimurium strain TA98 was more sensitive for the mutagen. Correlation analysis between genotoxicity, Organochlorine Pesticides (OCPs) and Polycyclic Aromatic Hydrocarbons (PAHs) showed that most individual OCPs were frame shift toxicants in drinking water sources, and there was no correlation with total OCPs and PAHs.	[Guan, Ying; Zhang, Guoxia] Southern Med Univ, Sch Publ Hlth & Trop Med, Guangdong Prov Key Lab Trop Dis Res, Guangzhou, Guangdong, Peoples R China; [Wang, Xiaodong] Jiangxi Acad Forestry, Nanchang, Jiangxi, Peoples R China; [Wong, Minghung] Hong Kong Baptist Univ, Croucher Inst Environm Sci, Hong Kong, Hong Kong, Peoples R China; [Wong, Minghung] Hong Kong Baptist Univ, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Sun, Guoping; Guo, Jun] Guangdong Inst Microbiol, Guangdong Open Lab Appl Microbiol, Guangzhou, Guangdong, Peoples R China; [Sun, Guoping; Guo, Jun] Guangdong Prov Key Lab Microbial Culture Collect, Guangzhou, Guangdong, Peoples R China; [An, Taicheng] Chinese Acad Sci, Guangzhou Inst Geochem, State Key Lab Organ Geochemist, Protect, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Hong Kong Baptist University; Hong Kong Baptist University; Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences; Chinese Academy of Sciences; Guangzhou Institute of Geochemistry, CAS	Zhang, GX (corresponding author), Southern Med Univ, Sch Publ Hlth & Trop Med, Guangdong Prov Key Lab Trop Dis Res, Guangzhou, Guangdong, Peoples R China.	guoxiazhang@126.com	Wong, Ming Hung/AAC-6507-2022	Wong, Ming Hung/0000-0001-5615-471X; Zhang, guo-xia Zhang/0000-0003-2530-3238	National Science Foundation of China [NSFC31500076]; Science and Technology Planning Project of Guangdong Province [2012B030800011]; School of Public Health and Tropical Medicine of Southern Medical University, China [GW201517]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province; School of Public Health and Tropical Medicine of Southern Medical University, China	This work was supported by the National Science Foundation of China (NSFC31500076), www.nsfc.gov.cn; Science and Technology Planning Project of Guangdong Province (2012B030800011), www.gdstc.gov.cn; Grant from School of Public Health and Tropical Medicine of Southern Medical University, China (Grant No. GW201517), www.fimmu.com.	Aleem A, 2005, ECOTOX ENVIRON SAFE, V61, P404, DOI 10.1016/j.ecoenv.2004.09.001; de Lima ROA, 2007, MUTAT RES-GEN TOX EN, V626, P53, DOI 10.1016/j.mrgentox.2006.08.002; An TC, 2011, J ENVIRON MONITOR, V13, P1457, DOI 10.1039/c0em00542h; Arnaldos M, 2014, WATER RES C, V70C, P458; Chen GS, 2004, MUTAT RES-REV MUTAT, V567, P151, DOI 10.1016/j.mrrev.2004.08.005; Claxton LD, 1998, MUTAT RES-REV MUTAT, V410, P237, DOI 10.1016/S1383-5742(98)00008-8; Fang D, 2001, ENV MONIT CHINA, V17, P2; FILIPIC M, 1995, MUTAT RES-GENET TOX, V342, P1, DOI 10.1016/0165-1218(95)90084-5; Giuliani F, 1996, MUTAT RES-GENET TOX, V368, P49, DOI 10.1016/S0165-1218(96)90039-7; Guo LL, 2008, ENVIRON POLLUT, V152, P604, DOI 10.1016/j.envpol.2007.06.067; Guo Y, 2009, ENVIRON POLLUT, V157, P1753, DOI 10.1016/j.envpol.2008.12.026; Hartmann A, 1999, ARCH ENVIRON CON TOX, V36, P115, DOI 10.1007/s002449900449; Huang Q, 2014, ENVIRON MONIT ASSESS, V186, P247, DOI 10.1007/s10661-013-3370-5; ISO, 2000, 138292000 ISO; Jolibois B, 2003, CHEMOSPHERE, V51, P539, DOI 10.1016/S0045-6535(02)00867-6; LEGAULT R, 1994, ENVIRON TOXIC WATER, V9, P45, DOI 10.1002/tox.2530090107; Leite ACL, 2005, MUTAT RES-GEN TOX EN, V588, P166, DOI 10.1016/j.mrgentox.2005.10.006; Li HZ, 2011, CHEMOSPHERE, V82, P1373, DOI 10.1016/j.chemosphere.2010.11.074; Li YQ, 2006, J ENVIRON SCI-CHINA, V18, P983, DOI 10.1016/S1001-0742(06)60026-0; Liu XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144729; Luo QY, 2014, INT J CLIN EXP MED, V7, P4260; Maertens RM, 2008, ENVIRON SCI TECHNOL, V42, P1754, DOI 10.1021/es702448x; Mai BX, 2001, APPL GEOCHEM, V16, P1429; MEIER JR, 1985, J WATER POLLUT CON F, V57, P999; Gana JM, 2008, J HAZARD MATER, V155, P403, DOI 10.1016/j.jhazmat.2007.11.080; Ohe T, 2004, MUTAT RES-REV MUTAT, V567, P109, DOI 10.1016/j.mrrev.2004.08.003; Pan E, 2014, JUANGSU ZHONGHUA LIU, V35, P1105; Park JH, 2000, MUTAT RES-GEN TOX EN, V466, P173, DOI 10.1016/S1383-5718(00)00017-6; Penders EJM, 2003, UMU COMET ASSAY QUAL; Pereira Tda S, 2007, MUTAT RES, V629, P71, DOI [10.1016/j.mrgentox.2006.12.008, DOI 10.1016/J.MRGENTOX.2006.12.008]; PROBST GS, 1981, ENVIRON MUTAGEN, V3, P11, DOI 10.1002/em.2860030103; Qiao M, 2010, J ENVIRON MONITOR, V12, P1666, DOI 10.1039/c002019b; RAPPAPORT SM, 1979, ENVIRON SCI TECHNOL, V13, P957, DOI 10.1021/es60156a004; Rosenkranz HS, 1999, MUTAT RES-FUND MOL M, V431, P31, DOI 10.1016/S0027-5107(99)00155-4; Shen L, 2003, CHEMOSPHERE, V52, P1641, DOI 10.1016/S0045-6535(03)00504-6; SIMMON VF, 1979, J NATL CANCER I, V62, P893; Steger-Hartmann T, 1999, ECOTOX ENVIRON SAFE, V42, P274, DOI 10.1006/eesa.1998.1759; Sun HW, 2014, ENVIRON SCI POLLUT R, V21, P10083, DOI 10.1007/s11356-014-3031-4; Tang F, 1999, CHINA WATER WASTEWAT, V15, P20; Thomas KV, 2002, CHEMOSPHERE, V49, P247, DOI 10.1016/S0045-6535(02)00316-8; Vahl HH, 1997, MUTAT RES-GEN TOX EN, V394, P81, DOI 10.1016/S1383-5718(97)00129-0; Wang YP, 2001, CHINA PUBLIC HLTH, V17, P131; Waters M D, 1982, Basic Life Sci, V21, P275; Wei S, 2006, MAR POLLUT BULL, V52, P1682, DOI 10.1016/j.marpolbul.2006.06.009; White PA, 1998, MUTAT RES-REV MUTAT, V410, P223, DOI 10.1016/S1383-5742(98)00002-7; Wu JY, 2005, MAR POLLUT BULL, V50, P1661, DOI 10.1016/j.marpolbul.2005.07.001; Wu JY, 2008, ENVIRON MONIT ASSESS, V98, P225; [杨婉玲 Yang Wanling], 2015, [生态环境学报, Ecology and Environmental Sciences], V24, P831; Zhao ZH, 2010, MUTAT RES-GEN TOX EN, V696, P62, DOI 10.1016/j.mrgentox.2009.12.013; Zhou SH, 2005, 2005 REPORT STATE EN	50	13	14	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170454	10.1371/journal.pone.0170454	http://dx.doi.org/10.1371/journal.pone.0170454			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125725	gold, Green Submitted, Green Published			2022-12-27	WOS:000396176100107
J	Iwamoto, K; Uehara, Y; Inoue, Y; Taguchi, K; Muraoka, D; Ogo, N; Matsuno, K; Asai, A				Iwamoto, Kazunori; Uehara, Yutaka; Inoue, Yukie; Taguchi, Kyoko; Muraoka, Daisuke; Ogo, Naohisa; Matsuno, Kenji; Asai, Akira			Inhibition of STAT3 by Anticancer Drug Bendamustine	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; SIGNAL TRANSDUCERS; INDUCED APOPTOSIS; LYMPHOMA-CELLS; CANCER; ACTIVATORS; RITUXIMAB; TARGETS; DNA	Bendamustine (BENDA), which bears the bis(2-chloroethyl) amino moiety, is an alkylating agent that stops the growth of cancer cells by binding to DNA and interfering with its replication. However, the mechanism of action underlying its excellent clinical efficacy remains unclear. In this work, we report that BENDA inhibits signal transducer and activator of transcription 3 (STAT3). In an AlphaScreen-based biochemical assay using recombinant human STAT3, binding of STAT3-Src homology 2 (SH2) to the phosphotyrosine (pTyr, pY) peptide was inhibited by BENDA but not by the inactive metabolite dihydroxy bendamustine (HP2). When a single point mutation of C550A or C712A was introduced into recombinant human STAT3, its sensitivity to BENDA was substantially reduced, suggesting that these cysteine residues are important for BENDA to inhibit STAT3. Furthermore, BENDA suppressed the function of cellular STAT3 as a transcriptional activator in a human breast cancer cell line, MDA-MB-468, with constitutively activated STAT3. A competitive pull-down assay using biotinylated BENDA (Bio-BENDA) revealed that BENDA bound tightly to cellular STAT3, presumably through covalent bonds. Therefore, our results suggest that the anticancer effects of BENDA may be associated, at least in part, with its inhibitory effect on the SH2 domain of STAT3.	[Iwamoto, Kazunori; Uehara, Yutaka; Inoue, Yukie; Taguchi, Kyoko; Muraoka, Daisuke; Ogo, Naohisa; Matsuno, Kenji; Asai, Akira] Univ Shizuoka, Grad Sch Pharmaceut Sci, Ctr Drug Discovery, Shizuoka, Japan; [Matsuno, Kenji] Kogakuin Univ, Dept Chem & Life Sci, Hachioji, Tokyo, Japan	University of Shizuoka; Kogakuin University	Asai, A (corresponding author), Univ Shizuoka, Grad Sch Pharmaceut Sci, Ctr Drug Discovery, Shizuoka, Japan.	aasai@u-shizuoka-ken.ac.jp		MATSUNO, Kenji/0000-0003-0884-1333	 [23510281/26430166]		This work was supported by Grant-in-Aid for Scientific Research (C) 23510281/26430166. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beeharry N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040342; Bergmann MA, 2005, HAEMATOLOGICA, V90, P1357; Buettner R, 2002, CLIN CANCER RES, V8, P945; Buettner R, 2011, ACS CHEM BIOL, V6, P432, DOI 10.1021/cb100253e; Chow KU, 2003, BIOCHEM PHARMACOL, V66, P711, DOI 10.1016/S0006-2952(03)00410-6; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Debnath B, 2012, J MED CHEM, V55, P6645, DOI 10.1021/jm300207s; Desrivieres S, 2006, J MAMMARY GLAND BIOL, V11, P75, DOI 10.1007/s10911-006-9014-4; Don-Doncow N, 2014, J BIOL CHEM, V289, P15969, DOI 10.1074/jbc.M114.564252; Dubbelman AC, 2013, DRUGS R&D, V13, P17, DOI 10.1007/s40268-012-0001-5; Fields WR, 2001, TOXICOL SCI, V63, P107, DOI 10.1093/toxsci/63.1.107; Friedberg JW, 2008, J CLIN ONCOL, V26, P204, DOI 10.1200/JCO.2007.12.5070; HARTMANN M, 1972, BIOCHIM BIOPHYS ACTA, V287, P386, DOI 10.1016/0005-2787(72)90282-1; Haura EB, 2005, NAT CLIN PRACT ONCOL, V2, P315, DOI 10.1038/ncponc0195; Heidelberger S, 2013, BIOORG MED CHEM LETT, V23, P4719, DOI 10.1016/j.bmcl.2013.05.066; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Hu Y, 2014, APOPTOSIS, V19, P1627, DOI 10.1007/s10495-014-1030-z; Jatiani Shashidhar S, 2010, Genes Cancer, V1, P979, DOI 10.1177/1947601910397187; Klampfer L, 2006, CURR CANCER DRUG TAR, V6, P107, DOI 10.2174/156800906776056491; Knop S, 2005, HAEMATOLOGICA, V90, P1287; Konstantinov SM, 2002, J CANCER RES CLIN, V128, P271, DOI 10.1007/s00432-002-0331-8; Leoni LM, 2008, CLIN CANCER RES, V14, P309, DOI 10.1158/1078-0432.CCR-07-1061; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lin L, 2012, INT J CANCER, V130, P1459, DOI 10.1002/ijc.26152; Matsuno K, 2010, ACS MED CHEM LETT, V1, P371, DOI 10.1021/ml1000273; Nowak D, 2004, LEUKEMIA LYMPHOMA, V45, P1429, DOI 10.1080/1042819042000198858; Ponisch W, 2006, J CANCER RES CLIN, V132, P205, DOI 10.1007/s00432-005-0074-4; Rummel MJ, 2005, J CLIN ONCOL, V23, P3383, DOI 10.1200/JCO.2005.08.100; Schwanen C, 2002, LEUKEMIA, V16, P2096, DOI 10.1038/sj.leu.2402651; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Strumberg D, 1996, ANTI-CANCER DRUG, V7, P415, DOI 10.1097/00001813-199606000-00007; Takakuma K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071646; Taldone T, 2013, BEILSTEIN J ORG CHEM, V9, P544, DOI 10.3762/bjoc.9.60; Uehara Y, 2009, BIOCHEM BIOPH RES CO, V380, P627, DOI 10.1016/j.bbrc.2009.01.137; Watson CJ, 2008, SEMIN CELL DEV BIOL, V19, P401, DOI 10.1016/j.semcdb.2008.07.021; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yu XK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128406; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	39	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170709	10.1371/journal.pone.0170709	http://dx.doi.org/10.1371/journal.pone.0170709			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125678	gold, Green Published, Green Submitted			2022-12-27	WOS:000396176100070
J	Kumar, A; Pandey, V; Singh, M; Pandey, D; Saharan, MS; Marla, SS				Kumar, Anil; Pandey, Vishakha; Singh, Manoj; Pandey, Dinesh; Saharan, M. S.; Marla, Soma S.			Draft genome sequence of Karnal bunt pathogen (Tilletia indica) of wheat provides insights into the pathogenic mechanisms of quarantined fungus	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; TRANSPOSABLE ELEMENTS; ABC TRANSPORTERS; GENE PREDICTION; WEB SERVER; RNA GENES; EUKARYOTES; DATABASE; ANNOTATION; AUGUSTUS	Karnal bunt disease in wheat is caused by hemibiotrophic fungus, Tilletia indica that has been placed as quarantine pest in more than 70 countries. Despite its economic importance, little knowledge about the molecular components of fungal pathogenesis is known. In this study, first time the genome sequence of T. indica has been deciphered for unraveling the effectors' functions of molecular pathogenesis of Karnal bunt disease. The T. indica genome was sequenced employing hybrid approach of PacBio Single Molecule Real Time (SMRT) and Illumina HiSEQ 2000 sequencing platforms. The genome was assembled into 10,957 contigs (N50 contig length 3 kb) with total size of 26.7 Mb and GC content of 53.99%. The number of predicted putative genes were 11,535, which were annotated with Gene Ontology databases. Functional annotation of Karnal bunt pathogen genome and classification of identified effectors into protein families revealed interesting functions related to pathogenesis. Search for effectors' genes using pathogen host interaction database identified 135 genes. The T. indica genome sequence and putative genes involved in molecular pathogenesis would further help in devising novel and effective disease management strategies including development of resistant wheat genotypes, novel biomarkers for pathogen detection and new targets for fungicide development.	[Kumar, Anil; Pandey, Vishakha; Singh, Manoj; Pandey, Dinesh] GB Pant Univ Agr & Technol, Dept Mol Biol & Genet Engn, Pantnagar, Uttarakhand, India; [Saharan, M. S.] Indian Agr Res Inst, Div Plant Pathol, New Delhi, India; [Marla, Soma S.] Natl Bur Plant Genet Resources, Div Genom Resources, New Delhi, India	Govind Ballabh Pant University of Agriculture Technology; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources	Kumar, A (corresponding author), GB Pant Univ Agr & Technol, Dept Mol Biol & Genet Engn, Pantnagar, Uttarakhand, India.	ak_gupta2k@rediffmail.com	Boothapati, Anil Kumar/HHS-1813-2022; KUMAR, ANIL/ACD-8340-2022; Saharan, Mahender/AAI-9831-2020		Department of Biotechnology (Govt. of India), New Delhi [BT/PR/14987/AGR/2/914/2015]; G.B. Pant University of Agriculture and Technology, Pantnagar; Department of Biotechnology	Department of Biotechnology (Govt. of India), New Delhi(Department of Biotechnology (DBT) India); G.B. Pant University of Agriculture and Technology, Pantnagar; Department of Biotechnology	This work is funded by Department of Biotechnology (Govt. of India), New Delhi (BT/PR/14987/AGR/2/914/2015) and G.B. Pant University of Agriculture and Technology, Pantnagar.; This work is funded by G.B. Pant University of Agriculture and Technology, Pantnagar and Department of Biotechnology (Govt. of India), New Delhi (BT/PR/14987/AGR/2/914/2015). The support provided by Director of Experiment Station, G.B. Pant University of Agriculture and Technology, Pantnagar is thankfully acknowleged. The authors also acknowledge Department of Biotechnology, for providing fellowship to Vishakha Pandey as a DBT-JRF and Mr. Ashwani Kumar Mishra for the Next generation sequencing and assembly of the genome.	ATTWOOD TK, 1994, PROTEIN ENG, V7, P195, DOI 10.1093/protein/7.2.195; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; [陈红伟 Chen Hongwei], 2014, [生物技术通报, Biotechnology Bulletin], P25; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; deWaard MA, 1997, PESTIC SCI, V51, P271, DOI 10.1002/(SICI)1096-9063(199711)51:3&lt;271::AID-PS642&gt;3.0.CO;2-#; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Fuentus DG, 1986, CAN J BOT, V8, P1712; Gao SG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-627; Gill K. S., 1993, Karnal bunt and wheat production.; GOATES BJ, 1988, PHYTOPATHOLOGY, V78, P1434, DOI 10.1094/Phyto-78-1434; Gupta A. K., 2011, J PROTEOMIC BIOINFOR, V4, P160, DOI DOI 10.4172//JPB.1000185; Hood ME, 2005, GENETICS, V170, P1081, DOI 10.1534/genetics.105.042564; KOLAKOWSKI LF, 1994, RECEPTOR CHANNEL, V2, P1; Kumar S., 2016, MOL BIOL EVOLUTION; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mills RE, 2007, TRENDS GENET, V23, P183, DOI 10.1016/j.tig.2007.02.006; Mitra M, 1931, ANN APPL BIOL, V18, P178, DOI 10.1111/j.1744-7348.1931.tb02294.x; Ospina-Giraldo MD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-525; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Que YX, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-996; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; Roohparvar R, 2007, FUNGAL GENET BIOL, V44, P378, DOI 10.1016/j.fgb.2006.09.007; Rush CM, 2005, PLANT DIS, V89, P212, DOI 10.1094/PD-89-0212; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Singh D. V., 2005, Indian Phytopathology, V58, P1; Smit A, 1996, REPEATMASKER OPEN 30; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Urban M, 2015, NUCLEIC ACIDS RES, V43, pD645, DOI 10.1093/nar/gku1165; van der Deen M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-59; WARHAM EJ, 1986, TROP PEST MANAGE, V32, P229; Wolfgruber TK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000743; Wostemeyer J, 2002, CURR GENET, V41, P189, DOI 10.1007/s00294-002-0306-y; Xue CY, 2008, FEMS MICROBIOL REV, V32, P1010, DOI 10.1111/j.1574-6976.2008.00131.x; Yang S, 2009, STRUCTURAL BIOINFORM, P561; Zhao ZT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-274; Zheng P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r116	42	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171323	10.1371/journal.pone.0171323	http://dx.doi.org/10.1371/journal.pone.0171323			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152050	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161200127
J	Lacoste, B; Raymond, VA; Cassim, S; Lapierre, P; Bilodeau, M				Lacoste, Benoit; Raymond, Valerie-Ann; Cassim, Shamir; Lapierre, Pascal; Bilodeau, Marc			Highly tumorigenic hepatocellular carcinoma cell line with cancer stem cell-like properties	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; IN-VIVO; EXPRESSION DEFINES; EP-CAM; EPCAM; ACTIVATION; ADHESION; CARCINOGENESIS; TRANSFORMATION; POPULATION	There are limited numbers of models to study hepatocellular carcinoma (HCC) in vivo in immunocompetent hosts. In an effort to develop a cell line with improved tumorigenicity, we derived a new cell line from Hepa1-6 cells through an in vivo passage in C57BL/6 mice. The resulting Dt81Hepa1-6 cell line showed enhanced tumorigenicity compared to Hepa16 with more frequent (28 +/- 12 vs. 0 +/- 0 lesions at 21 days) and more rapid tumor development (21 (100%) vs. 70 days (10%)) in C57BL/6 mice. The minimal Dt81Hepa1-6 cell number required to obtain visible tumors was 100,000 cells. The Dt81Hepa1-6 cell line showed high hepatotropism with subcutaneous injection leading to liver tumors without development of tumors in lungs or spleen. In vitro, Dt81Hepa1-6 cells showed increased anchorage-independent growth (34.7 +/- 6.8 vs. 12.3 +/- 3.3 colonies; P<0.05) and increased EpCAM (8.7 +/- 1.1 folds; P<0.01) and beta-catenin (5.4 +/- 1.0 folds; P<0.01) expression. A significant proportion of Dt81Hepa1-6 cells expressed EpCAM compared to Hepa1-6 (34.8 +/- 1.1% vs 0.9 +/- 0.13%; P<0.001). Enriched EpCAM(+) Dt81Hepa1-6 cells led to higher tumor load than EpCAM -Dt81Hepa1-6 cells (1093 +/- 74 vs 473 +/- 100 tumors; P<0.01). The in vivo selected Dt81Hepa1-6 cell line shows high liver specificity and increased tumorigenicity compared to Hepa1-6 cells. These properties are associated with increased expression of EpCAM and beta-catenin confirming that EpCAM(+) HCC cells comprise a subset with characteristics of tumor-initiating cells with stem/progenitor cell features. The Dt81Hepa1-6 cell line with its cancer stem cell-like properties will be a useful tool for the study of hepatocellular carcinoma in vivo.	[Lacoste, Benoit; Raymond, Valerie-Ann; Cassim, Shamir; Lapierre, Pascal; Bilodeau, Marc] CRCHUM, Lab Hepatol Cellulaire, Montreal, PQ, Canada; [Lapierre, Pascal; Bilodeau, Marc] Univ Montreal, Dept Med, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Bilodeau, M (corresponding author), CRCHUM, Lab Hepatol Cellulaire, Montreal, PQ, Canada.	marc.bilodeau@umontreal.ca	Bilodeau, Marc/L-2822-2017; Lapierre, Pascal/ABD-2247-2021	Lapierre, Pascal/0000-0002-2753-3566; Cassim, Shamir/0000-0003-1072-5868				Blonski W, 2010, WORLD J GASTROENTERO, V16, P3603, DOI 10.3748/wjg.v16.i29.3603; Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109; Boterberg T, 2001, Methods Mol Med, V58, P33, DOI 10.1385/1-59259-137-X:033; Bourbonnais E, 2012, GASTROENTEROLOGY, V142, P130, DOI 10.1053/j.gastro.2011.09.033; Chaves-Perez A, 2013, ONCOGENE, V32, P641, DOI 10.1038/onc.2012.75; Chen Y, 2012, INT J BIOL SCI, V8, P992, DOI 10.7150/ijbs.4454; Curley MD, 2009, STEM CELLS, V27, P2875, DOI 10.1002/stem.236; DARLINGTON GJ, 1980, J NATL CANCER I, V64, P809; Dasari S, 2014, EUR J PHARMACOL, V740, P364, DOI 10.1016/j.ejphar.2014.07.025; Denzel S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-402; Dick JE, 2009, NAT BIOTECHNOL, V27, P44, DOI 10.1038/nbt0109-44; Du WQ, 2009, J CANCER RES CLIN, V135, P1277, DOI 10.1007/s00432-009-0569-5; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Ethier C, 2003, AM J PHYSIOL-GASTR L, V285, pG298, DOI 10.1152/ajpgi.00040.2003; Figueiredo ML, 2010, HEPATOLOGY, V52, P634, DOI 10.1002/hep.23682; Gosens MJEM, 2007, MODERN PATHOL, V20, P221, DOI 10.1038/modpathol.3800733; Heindryckx F, 2009, INT J EXP PATHOL, V90, P367, DOI 10.1111/j.1365-2613.2009.00656.x; Humphries MJ, 2001, MOL BIOTECHNOL, V18, P57, DOI 10.1385/MB:18:1:57; Imrich S, 2012, CELL ADHES MIGR, V6, P30, DOI 10.4161/cam.18953; Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200; Li Y, 2004, J CANCER RES CLIN, V130, P460, DOI 10.1007/s00432-004-0564-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mamo S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-14; Monga SPS, 2011, INT J BIOCHEM CELL B, V43, P1021, DOI 10.1016/j.biocel.2009.09.001; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Qian YW, 2012, GASTROENTEROLOGY, V142, P1547, DOI 10.1053/j.gastro.2012.02.042; Schmits R, 1997, BLOOD, V90, P2217, DOI 10.1182/blood.V90.6.2217.2217_2217_2233; Schnater JM, 2006, J HEPATOL, V45, P377, DOI 10.1016/j.jhep.2006.03.018; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; SUGDEN B, 1977, J VIROL, V23, P503, DOI 10.1128/JVI.23.3.503-508.1977; Tai KY, 2007, ONCOGENE, V26, P3989, DOI 10.1038/sj.onc.1210176; Takata M, 2007, CELL COMMUN ADHES, V14, P157, DOI 10.1080/15419060701557859; Vineis P, 2010, CARCINOGENESIS, V31, P1703, DOI 10.1093/carcin/bgq087; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang WF, 2010, CANCER SCI, V101, P112, DOI 10.1111/j.1349-7006.2009.01370.x; Whiteside TL, 2011, B CANCER, V98, pE25, DOI 10.1684/bdc.2010.1294; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Winter MJ, 2003, EXP CELL RES, V285, P50, DOI 10.1016/S0014-4827(02)00045-9; Xie C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040607; Yamashita T, 2008, CANCER RES, V68, P1451, DOI 10.1158/0008-5472.CAN-07-6013; Yamashita T, 2007, CANCER RES, V67, P10831, DOI 10.1158/0008-5472.CAN-07-0908; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Zhou JJ, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-112	43	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171215	10.1371/journal.pone.0171215	http://dx.doi.org/10.1371/journal.pone.0171215			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152020	Green Submitted, gold, Green Published			2022-12-27	WOS:000396161200105
J	Mosites, E; Sammons, M; Otiang, E; Eng, A; Noecker, C; Manor, O; Hilton, S; Thumbi, SM; Onyango, C; Garland-Lewis, G; Call, DR; Njenga, MK; Wasserheit, JN; Zambriski, JA; Walson, JL; Palmer, GH; Montgomery, J; Borenstein, E; Omore, R; Rabinowitz, PM				Mosites, Emily; Sammons, Matt; Otiang, Elkanah; Eng, Alexander; Noecker, Cecilia; Manor, Ohad; Hilton, Sarah; Thumbi, Samuel M.; Onyango, Clayton; Garland-Lewis, Gemina; Call, Douglas R.; Njenga, M. Kariuki; Wasserheit, Judith N.; Zambriski, Jennifer A.; Walson, Judd L.; Palmer, Guy H.; Montgomery, Joel; Borenstein, Elhanan; Omore, Richard; Rabinowitz, Peter M.			Microbiome sharing between children, livestock and household surfaces in western Kenya	PLOS ONE			English	Article							GUT MICROBIOTA; DIVERSITY; COMMUNITIES; IMPACT; AGE	The gut microbiome community structure and development are associated with several health outcomes in young children. To determine the household influences of gut microbiome structure, we assessed microbial sharing within households in western Kenya by sequencing 16S rRNA libraries of fecal samples from children and cattle, cloacal swabs from chickens, and swabs of household surfaces. Among the 156 households studied, children within the same household significantly shared their gut microbiome with each other, although we did not find significant sharing of gut microbiome across host species or household surfaces. Higher gut microbiome diversity among children was associated with lower wealth status and involvement in livestock feeding chores. Although more research is necessary to identify further drivers of microbiota development, these results suggest that the household should be considered as a unit. Livestock activities, health and microbiome perturbations among an individual child may have implications for other children in the household.	[Mosites, Emily; Garland-Lewis, Gemina; Rabinowitz, Peter M.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Mosites, Emily; Sammons, Matt; Thumbi, Samuel M.; Call, Douglas R.; Njenga, M. Kariuki; Zambriski, Jennifer A.; Palmer, Guy H.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Otiang, Elkanah; Onyango, Clayton; Omore, Richard] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Eng, Alexander; Noecker, Cecilia; Manor, Ohad; Hilton, Sarah; Borenstein, Elhanan] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Wasserheit, Judith N.; Walson, Judd L.; Rabinowitz, Peter M.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Wasserheit, Judith N.; Walson, Judd L.] Univ Washington, Dept Med, Seattle, WA USA; [Wasserheit, Judith N.; Walson, Judd L.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Walson, Judd L.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Montgomery, Joel] Ctr Dis Control & Prevent, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA; [Borenstein, Elhanan] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Borenstein, Elhanan] Santa Fe Inst, Santa Fe, NM 87501 USA; [Rabinowitz, Peter M.] Univ Washington, Dept Family Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Washington State University; Kenya Medical Research Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Centers for Disease Control & Prevention - USA; University of Washington; University of Washington Seattle; The Santa Fe Institute; University of Washington; University of Washington Seattle	Garland-Lewis, G (corresponding author), Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA.	gemina@uw.edu	Walson, Judd/R-7269-2019; Mwangi, Thumbi/L-2216-2019; Noecker, Cecilia/AAF-3859-2020; Walson, Judd/HGC-4359-2022	Walson, Judd/0000-0003-4836-720X; Mwangi, Thumbi/0000-0002-5754-0556; Hilton, Sarah/0000-0001-9278-3644; Noecker, Cecilia/0000-0003-1417-2383; Mosites, Emily/0000-0002-2968-9564	Bill and Melinda Gates Foundation: Grand Challenges Explorations [OPP1098757]; NIH post-doctoral fellowship [NIH T32 AI07025]; Washington State University, College of Veterinary Medicine, Summer Research Scholars Program; UW Center for One Health Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007025] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation: Grand Challenges Explorations(Bill & Melinda Gates Foundation); NIH post-doctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington State University, College of Veterinary Medicine, Summer Research Scholars Program; UW Center for One Health Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Bill and Melinda Gates Foundation: Grand Challenges Explorations Grant Number OPP1098757. http://gcgh.grandchallenges.org/about. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. It also received support from an NIH post-doctoral fellowship (NIH T32 AI07025) for author EM. https://researchtraining.nih.gov/programs/training-grants/T32. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Washington State University, College of Veterinary Medicine, Summer Research Scholars Program (internal) provided support for author MS. http://www.vetmed.wsu.edu/research/student-research/research-scholars. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. UW Center for One Health Research (internal, supplemental) also provided support. http.//deohs.washington.edu/cohr/. Author PR is the director of the Center for One Health Research and played a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. Supplemental funding was provided by the Center only to complete additional data analysis.	Althani A., 2015, J CELLULAR PHYSL; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Avershina E, 2014, FEMS MICROBIOL ECOL, V87, P280, DOI 10.1111/1574-6941.12223; Azad MB, 2013, ALLERGY ASTHMA CL IM, V9, DOI 10.1186/1710-1492-9-15; Bendtsen KM, 2015, INFLUENCE YOUNG MI C; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chong CW, 2015, SCI REP-UK, V5, DOI 10.1038/srep13338; D'Argenio V, 2015, CLIN CHIM ACTA, V451, P97, DOI 10.1016/j.cca.2015.01.003; Dai J, 2015, BIORESOURCE TECHNOL, V175, P23, DOI 10.1016/j.biortech.2014.10.049; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dominianni C, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-103; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Gough EK, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0089-2; Hedin CR, 2014, GUT; Hollister EB, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0101-x; Hospodsky D, 2014, MICROBIOL-SGM, V160, P1144, DOI 10.1099/mic.0.075390-0; Knip M, 2016, NATURE REV ENDOCRINO; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Lin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053838; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Ludvigsen J, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00016; Mahe F, 2015, PEERJ, V3, DOI 10.7717/peerj.1420; Mahe F, 2014, PEERJ, V2, DOI 10.7717/peerj.593; Moeller AH, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500997; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Oakley BB, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00011; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Probst M, 2015, APPL MICROBIOL BIOT, V99, P3029, DOI 10.1007/s00253-015-6414-7; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Ruiz-Calderon JF, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501061; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Seppanen E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062662; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; Thumbi SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120761; Tung J., 2015, ELIFE, V4; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Voreades N, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00494; Westcott SL, 2015, PEERJ, V3, DOI 10.7717/peerj.1487; Wu XK, 2010, CURR MICROBIOL, V61, P69, DOI 10.1007/s00284-010-9582-9; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zackular JP, 2013, MBIO, V4, DOI 10.1128/mBio.00692-13	44	31	31	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171017	10.1371/journal.pone.0171017	http://dx.doi.org/10.1371/journal.pone.0171017			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152044	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161200073
J	Segura, J; Hilker, FM; Franco, D				Segura, Juan; Hilker, Frank M.; Franco, Daniel			Population control methods in stochastic extinction and outbreak scenarios	PLOS ONE			English	Article							ENVIRONMENTAL STOCHASTICITY; PROPAGULE PRESSURE; ALLEE; DYNAMICS; MECHANISMS; INVASION; MODELS	Adaptive limiter control (ALC) and adaptive threshold harvesting (ATH) are two related control methods that have been shown to stabilize fluctuating populations. Large variations in population abundance can threaten the constancy and the persistence stability of ecological populations, which may impede the success and efficiency of managing natural resources. Here, we consider population models that include biological mechanisms characteristic for causing extinctions on the one hand and pest outbreaks on the other hand. These models include Allee effects and the impact of natural enemies (as is typical of forest defoliating insects). We study the impacts of noise and different levels of biological parameters in three extinction and two outbreak scenarios. Our results show that ALC and ATH have an effect on extinction and outbreak risks only for sufficiently large control intensities. Moreover, there is a clear disparity between the two control methods: in the extinction scenarios, ALC can be effective and ATH can be counterproductive, whereas in the outbreak scenarios the situation is reversed, with ATH being effective and ALC being potentially counterproductive.	[Segura, Juan; Franco, Daniel] Univ Nacl Educ Distancia, ETSI Ind, Dept Matemat Aplicada, Madrid, Spain; [Hilker, Frank M.] Univ Osnabruck, Inst Environm Syst Res, Sch Math Comp Sci, Osnabruck, Germany	Universidad Nacional de Educacion a Distancia (UNED); University Osnabruck	Hilker, FM (corresponding author), Univ Osnabruck, Inst Environm Syst Res, Sch Math Comp Sci, Osnabruck, Germany.	frank.hilker@uni-osnabrueck.de	Hilker, Frank/B-8624-2008; Franco, Daniel/A-6480-2008	Hilker, Frank/0000-0001-5470-8889; Franco, Daniel/0000-0002-9819-5664; /0000-0002-8314-3458	Spanish Ministerio de Economia y Competitividad; FEDER [MTM2013-43404-P]; Deutsche Forschungsgemeinschaft (DFG); Open Access Publishing Fund of Osnabruck University	Spanish Ministerio de Economia y Competitividad(Spanish Government); FEDER(European Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Open Access Publishing Fund of Osnabruck University	We acknowledge support by the Spanish Ministerio de Economia y Competitividad and FEDER, grant MTM2013-43404-P, Deutsche Forschungsgemeinschaft (DFG) and the Open Access Publishing Fund of Osnabruck University.	Abrams PA, 2009, ECOL LETT, V12, P462, DOI 10.1111/j.1461-0248.2009.01282.x; Allen LJS, 2005, J DIFFER EQU APPL, V11, P273, DOI 10.1080/10236190412331335373; Astrom M, 1996, OIKOS, V75, P174, DOI 10.2307/3546241; BEDDINGTON JR, 1977, SCIENCE, V197, P463, DOI 10.1126/science.197.4302.463; Berryman, 2002, POPULATION CYCLES CA, DOI 10.1093/oso/9780195140989.001.0001; Boyce MS, 1999, OIKOS, V87, P419, DOI 10.2307/3546808; Brannstrom A, 2006, THEOR POPUL BIOL, V69, P442, DOI 10.1016/j.tpb.2006.01.006; Carmona P, 2011, NONLINEAR ANAL-REAL, V12, P3719, DOI 10.1016/j.nonrwa.2011.07.005; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Cid B, 2014, MATH BIOSCI, V248, P78, DOI 10.1016/j.mbs.2013.12.003; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; Courchamp F, 2000, OIKOS, V91, P311, DOI 10.1034/j.1600-0706.2000.910212.x; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Crisan M., 2008, 2008 International Conference on Computer Engineering & Systems (ICCES '08), P216, DOI 10.1109/ICCES.2008.4772999; Dennis B., 1989, Natural Resource Modeling, V3, P481; Dennis B, 2002, OIKOS, V96, P389, DOI 10.1034/j.1600-0706.2002.960301.x; Drake JM, 2006, BIOL INVASIONS, V8, P365, DOI 10.1007/s10530-004-8122-6; Dwyer G, 2004, NATURE, V430, P341, DOI 10.1038/nature02569; Dwyer G, 2000, AM NAT, V156, P105, DOI 10.1086/303379; Franco D, 2014, SIAM J APPL DYN SYST, V13, P447, DOI 10.1137/13092277X; Franco D, 2013, J THEOR BIOL, V337, P161, DOI 10.1016/j.jtbi.2013.08.018; Groom MJ, 1998, AM NAT, V151, P487, DOI 10.1086/286135; Hilker FM, 2013, ECOL COMPLEX, V14, P95, DOI 10.1016/j.ecocom.2013.02.002; Hilker FM, 2009, AM NAT, V173, P72, DOI 10.1086/593357; Ims RA, 2008, TRENDS ECOL EVOL, V23, P79, DOI 10.1016/j.tree.2007.10.010; Johnson DM, 2006, NATURE, V444, P361, DOI 10.1038/nature05242; Kendall BE, 1999, ECOLOGY, V80, P1789, DOI 10.1890/0012-9658(1999)080[1789:WDPCAS]2.0.CO;2; Kindlmann, 2008, POPULATION SYSTEMS G; Kuussaari M, 1998, OIKOS, V82, P384, DOI 10.2307/3546980; Lande R, 1998, OIKOS, V83, P353, DOI 10.2307/3546849; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Leung B, 2004, ECOLOGY, V85, P1651, DOI 10.1890/02-0571; Liebhold A, 2003, ECOL LETT, V6, P133, DOI 10.1046/j.1461-0248.2003.00405.x; Ludwig D, 1998, OIKOS, V83, P397, DOI 10.2307/3546855; McCarthy MA, 1997, ECOL MODEL, V103, P99, DOI 10.1016/S0304-3800(97)00104-X; Roccati F, 2015, THESIS; Roth G, 2014, J BIOL DYNAM, V8, P187, DOI 10.1080/17513758.2014.962631; Sah P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105861; Sah P, 2013, J THEOR BIOL, V320, P113, DOI 10.1016/j.jtbi.2012.12.014; Scheuring I, 1999, J THEOR BIOL, V199, P407, DOI 10.1006/jtbi.1999.0966; Schreiber SJ, 2003, THEOR POPUL BIOL, V64, P201, DOI 10.1016/S0040-5809(03)00072-8; Schreiber SJ, 2001, J MATH BIOL, V42, P239, DOI 10.1007/s002850000070; Segura J, 2016, J THEOR BIOL, V395, P103, DOI 10.1016/j.jtbi.2016.01.039; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Stoner AW, 2000, MAR ECOL PROG SER, V202, P297, DOI 10.3354/meps202297; Taylor CM, 2005, ECOL LETT, V8, P895, DOI 10.1111/j.1461-0248.2005.00787.x; Tobin PC, 2007, ECOL LETT, V10, P36, DOI 10.1111/j.1461-0248.2006.00991.x; Tobin PC, 2011, ECOL LETT, V14, P615, DOI 10.1111/j.1461-0248.2011.01614.x; Tung S, 2014, J THEOR BIOL, V356, P163, DOI 10.1016/j.jtbi.2014.04.036; van Voorn GAK, 2007, MATH BIOSCI, V209, P451, DOI 10.1016/j.mbs.2007.02.006; Walters C, 1996, CAN J FISH AQUAT SCI, V53, P148, DOI 10.1139/f95-151; Yoshimura A, 1999, ECOLOGY, V80, P1691, DOI 10.2307/176557	52	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170837	10.1371/journal.pone.0170837	http://dx.doi.org/10.1371/journal.pone.0170837			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151983	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200046
J	Tanveer, A; Hayat, T; Alsaedi, A; Ahmad, B				Tanveer, Anum; Hayat, T.; Alsaedi, A.; Ahmad, B.			Numerical simulation for peristalsis of Carreau-Yasuda nanofluid in curved channel with mixed convection and porous space	PLOS ONE			English	Article							TAPERED ASYMMETRIC CHANNEL; RADIAL MAGNETIC-FIELD; CHEMICAL-REACTION; PSEUDOPLASTIC NANOFLUID; HEAT-TRANSFER; MASS-TRANSFER; FLOW; FLUID; TRANSPORT; VELOCITY	Main theme of present investigation is to model and analyze the peristaltic activity of Carraeu-Yasuda nanofluid saturating porous space in a curved channel. Unlike the traditional approach, the porous medium effects are characterized by employing modified Darcy's law for Carreau-Yasuda fluid. To our knowledge this is first attempt in this direction for Carreau-Yasuda fluid. Heat and mass transfer are further considered. Simultaneous effects of heat and mass transfer are examined in presence of mixed convection, viscous dissipation and thermal radiation. The compliant characteristics for channel walls are taken into account. The resulting complex mathematical system has been discussed for small Reynolds number and large wavelength concepts. Numerical approximation to solutions are thus plotted in graphs and the physical description is presented. It is concluded that larger porosity in a medium cause an enhancement in fluid velocity and reduction in concentration.	[Tanveer, Anum; Hayat, T.] Quaid I Azam Univ 45320, Dept Math, Islamabad 44000, Pakistan; [Hayat, T.; Alsaedi, A.; Ahmad, B.] King Abdulaziz Univ, Nonlinear Anal & Appl Math NAAM Res Grp, Dept Math, Fac Sci, Jeddah 21589, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Tanveer, A (corresponding author), Quaid I Azam Univ 45320, Dept Math, Islamabad 44000, Pakistan.	anum@math.qau.edu.pk	Hayat, Tasawar/Y-2524-2019; Alsaedi, Ahmed/A-2094-2013; Ahmad, Bashir/B-1977-2012	Alsaedi, Ahmed/0000-0003-3452-8922; Ahmad, Bashir/0000-0001-5350-2977				Abd-Alla AM, 2014, J MAGN MAGN MATER, V363, P166, DOI 10.1016/j.jmmm.2014.03.023; Ali N, 2016, INT J HEAT MASS TRAN, V94, P500, DOI 10.1016/j.ijheatmasstransfer.2015.11.066; Annimasun I. L., ALEX ENG J; [Anonymous], [No title captured]; Babu MJ, 2016, INT J ENG RES AFR, V25, P58, DOI 10.4028/www.scientific.net/JERA.25.58; Bhatti MM, 2016, J MOL LIQ, V218, P240, DOI 10.1016/j.molliq.2016.02.066; Buongiorno J, 2006, J HEAT TRANS-T ASME, V128, P240, DOI 10.1115/1.2150834; Buongiorno J., 2005, P ICAPP 05 SEOUL, V5, P15; Chamkha A.J., 2016, J MAGN MAGN MATER, V406, P266, DOI [10.1016/j.jmmm.2016.01.039, DOI 10.1016/J.JMMM.2016.01.039]; Darcy H., 1856, FONTAINES PUBLIQUE V, DOI [10.2307/1467138, DOI 10.2307/1467138]; Hayat T, 2016, J MOL LIQ, V223, P469, DOI 10.1016/j.molliq.2016.08.067; Hayat T, 2016, J MOL LIQ, V221, P434, DOI 10.1016/j.molliq.2016.05.072; Hayat T, 2016, J MOL LIQ, V220, P693, DOI 10.1016/j.molliq.2016.04.123; Hayat T, 2016, J MAGN MAGN MATER, V412, P207, DOI 10.1016/j.jmmm.2016.03.046; Hayat T, 2016, J MAGN MAGN MATER, V408, P168, DOI 10.1016/j.jmmm.2016.02.044; Hayat T, 2016, INT J HEAT MASS TRAN, V96, P474, DOI 10.1016/j.ijheatmasstransfer.2016.01.055; Hayat T, 2016, J MAGN MAGN MATER, V407, P321, DOI 10.1016/j.jmmm.2016.02.020; Hayat T, 2014, APPL BIONICS BIOMECH, V11, P221, DOI 10.1155/2014/385821; Hayat T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156995; Hayat T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148002; Hayat T, 2016, J MAGN MAGN MATER, V403, P47, DOI 10.1016/j.jmmm.2015.11.078; Hayat T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095070; Hina S, 2016, INT J HEAT MASS TRAN, V101, P156, DOI 10.1016/j.ijheatmasstransfer.2016.05.034; Kothandapani M, 2015, INT J HEAT MASS TRAN, V81, P234, DOI 10.1016/j.ijheatmasstransfer.2014.09.062; Latham TW., 1996, FLUID MOTION PERISTA; Mekheimer KS, 2013, INT J BIOMATH, V6, DOI 10.1142/S1793524513500265; Narla VK, 2015, PROCEDIA ENGINEER, V127, P869, DOI 10.1016/j.proeng.2015.11.424; Raju CSK, 2016, EUR PHYS J PLUS, V131, DOI 10.1140/epjp/i2016-16267-3; Raju C.S.K., J MOL LIQ; Raju C.S. K., J MAGN MAGN MAT; Selimefendigil F, 2016, INT J HEAT MASS TRAN, V98, P40, DOI 10.1016/j.ijheatmasstransfer.2016.02.092; Selimefendigil F, 2016, J THERM SCI ENG APPL, V8, DOI 10.1115/1.4032760; Sinha A, 2015, ALEX ENG J, V54, P691, DOI 10.1016/j.aej.2015.03.030; Srinivas S, 2011, MATH COMPUT MODEL, V54, P1213, DOI 10.1016/j.mcm.2011.03.032; Thiel GP, 2016, J HEAT TRANS-T ASME, V138, DOI 10.1115/1.4034055; Zheng LC, 2013, J FRANKLIN I, V350, P990, DOI 10.1016/j.jfranklin.2013.01.022	36	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170029	10.1371/journal.pone.0170029	http://dx.doi.org/10.1371/journal.pone.0170029			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151968	Green Submitted, gold, Green Published			2022-12-27	WOS:000396161200012
J	Villalonga-Olives, E; Kawachi, I; Almansa, J; von Steinbuchel, N				Villalonga-Olives, Ester; Kawachi, Ichiro; Almansa, Josue; von Steinbuechel, Nicole			Longitudinal changes in health related quality of life in children with migrant backgrounds	PLOS ONE			English	Article							FOLLOW-UP; BASE-LINE; ADOLESCENTS; COVARIANCE; TRIALS; SCHOOL; KINDL	Background Little is known about longitudinal changes in the Health Related Quality of Life (HRQoL) among children with migrant backgrounds. Methods The sample comprised 350 children with predominantly migrant backgrounds enrolled in 7 kindergartens in Frankfurt and Darmstadt, Germany. At baseline, the participants' mean age was 4.4 years (SD 0.9). Data collection started in May 2009. Two waves of data were collected one year apart (94% response rate). HRQoL was evaluated with the Kiddy-KINDL. The other variables under study were sex, age, socioeconomic status, country of origin, developmental status (WET) and individual behavior (VBV). Data were collected from the children, parents and teachers. Structural equation modeling (SEM) was used to assess the Wilson and Cleary theoretical framework on changes in HRQoL and Generalized Estimated Equations (GEE) to model the longitudinal trend in HRQoL. Results Overall HRQoL remained stable between baseline and follow-up. SEM model fit was chi 2 = 8.51; df = 5; p = 0.13; SRMR = 0.02 RMSEA = 0.06 and indicated that there were differences in kindergarten activities (p<0.05). The GEE model elucidated that the differences in HRQoL between the baseline and follow-up varied according to kindergarten activities that the children were assigned to (music, art, or no activities) (p<0.05), but that there were no differences in terms of country of origin. On average, girls reported better HRQoL. Conclusion Overall HRQoL scores remained stable over follow-up in a sample of migrant children and there were no differences in terms of origin. However, there was heterogeneity in the results depending on the kindergarten activities that the children were assigned to.	[Villalonga-Olives, Ester; von Steinbuechel, Nicole] Georg August Univ Gottingen, Inst Med Psychol & Med Sociol, Gottingen, Germany; [Villalonga-Olives, Ester; Kawachi, Ichiro] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Almansa, Josue] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci Community & Occupat Med, Groningen, Netherlands	University of Gottingen; Harvard University; Harvard T.H. Chan School of Public Health; University of Groningen	Villalonga-Olives, E (corresponding author), Georg August Univ Gottingen, Inst Med Psychol & Med Sociol, Gottingen, Germany.; Villalonga-Olives, E (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA.	ester.villalonga@gmail.com	Almansa, Josue/J-4503-2019	Almansa, Josue/0000-0001-9724-9328	Niedersachsisches Institut fur fruhkindliche Bildung und Entwicklung [nifbe FP17-09]; Albert and Barbara von Metzler Stiftung, Frankfurt/Main; Gemeinnutzigen Hertie-Stiftung, Frankfurt/Main	Niedersachsisches Institut fur fruhkindliche Bildung und Entwicklung; Albert and Barbara von Metzler Stiftung, Frankfurt/Main; Gemeinnutzigen Hertie-Stiftung, Frankfurt/Main	This study was funded by the Niedersachsisches Institut fur fruhkindliche Bildung und Entwicklung (nifbe FP17-09), the Albert and Barbara von Metzler Stiftung, Frankfurt/Main, and the Gemeinnutzigen Hertie-Stiftung, Frankfurt/Main.	Almaz ME, 2014, J CLIN PEDIATR DENT, V38, P263, DOI 10.17796/jcpd.38.3.d032283066403848; Banks BA, 2008, J PEDIAT HEMATOL ONC, V30, P292, DOI 10.1097/MPH.0b013e3181647bda; Barbu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016407; Blance A, 2007, COMMUNITY DENT ORAL, V35, P412, DOI 10.1111/j.1600-0528.2007.00407.x; Boshuizen HC, 2005, J CLIN EPIDEMIOL, V58, P209, DOI 10.1016/j.jclinepi.2004.06.009; Cui W. J., 2013, Preventing Chronic Disease, V10, pE111; DiPrete TA, 2012, SOC SCI RES, V41, P1, DOI 10.1016/j.ssresearch.2011.09.001; Dopfner M, 1993, VERHALTENSBEURTEILUN; European Comission, 2012, EU EMPL SOC SIT Q RE; Finne E, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-1; Ghisletta P, 2004, J EDUC BEHAV STAT, V29, P421, DOI 10.3102/10769986029004421; Gillison F, 2008, BRIT J EDUC PSYCHOL, V78, P149, DOI 10.1348/000709907X209863; Glymour MM, 2005, AM J EPIDEMIOL, V162, P267, DOI 10.1093/aje/kwi187; GUYATT GH, 1989, CAN MED ASSOC J, V140, P1441; Hardin J., 2007, GEN ESTIMATING EQUAT, V2nd; Hoyle R.H., 2012, HDB STRUCTURAL EQUAT; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jozefiak T, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-7; Kastner-Koller U, 2002, WIENER ENTWICKLUNGST; Krampen G., 2008, FI, V27, P11; Kuh D, 2003, J EPIDEMIOL COMMUN H, V57, P778, DOI 10.1136/jech.57.10.778; Malden PE, 2008, COMMUNITY DENT ORAL, V36, P108, DOI 10.1111/j.1600-0528.2007.00374.x; McDougall J, 2011, DEV NEUROREHABIL, V14, P41, DOI 10.3109/17518423.2010.521795; Morawa E, 2014, PSYCHIAT PRAX, V41, P200, DOI 10.1055/s-0033-1343221; Musil CM, 1998, RES NURS HEALTH, V21, P271; Muthen B., 2010, MPLUS USERS GUIDE; Palacio-Vieira JA, 2008, QUAL LIFE RES, V17, P1207, DOI 10.1007/s11136-008-9405-7; Portes A, 2005, ETHNIC RACIAL STUD, V28, P1000, DOI 10.1080/01419870500224117; Puder J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-384; Rajmil L, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-103; Ravens-Sieberer U, 2007, BUNDESGESUNDHEITSBLA, V50, P810, DOI 10.1007/s00103-007-0244-4; Ravens-Sieberer U, 1998, QUAL LIFE RES, V7, P399, DOI 10.1023/A:1008853819715; Simon AE, 2008, PEDIATRICS, V121, pE118, DOI 10.1542/peds.2007-0480; Twisk J, 2005, J CLIN EPIDEMIOL, V58, P211, DOI 10.1016/j.jclinepi.2004.06.010; Villalonga-Olives E, 2015, PUBLIC HEALTH, V129, P889, DOI 10.1016/j.puhe.2015.04.020; Villalonga-Olives E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113166	36	4	4	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170891	10.1371/journal.pone.0170891	http://dx.doi.org/10.1371/journal.pone.0170891			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28151986	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161200056
J	Wu, LL; Ouyang, Q; Wang, HL				Wu, Lili; Ouyang, Qi; Wang, Hongli			Robust network topologies for generating oscillations with temperature-independent periods	PLOS ONE			English	Article							ARABIDOPSIS CIRCADIAN CLOCK; ESCHERICHIA-COLI; THERMAL ROBUSTNESS; MOLECULAR-BASES; FEEDBACK LOOPS; COMPENSATION; DROSOPHILA; RHYTHMS; MODEL; TIME	Nearly all living systems feature a temperature-independent oscillation period in circadian clocks. This ubiquitous property occurs at the system level and is rooted in the network architecture of the clock machinery. To investigate the mechanism of this prominent property of the circadian clock and provide general guidance for generating robust genetic oscillators with temperature-compensated oscillations, we theoretically explored the design principle and core network topologies preferred by oscillations with a temperature-independent period. By enumerating all topologies of genetic regulatory circuits with three genes, we obtained four network motifs, namely, a delayed negative feedback oscillator, repressilator, activator-inhibitor oscillator and substrate-depletion oscillator; hybrids of these motifs constitute the vast majority of target network topologies. These motifs are biased in their capacities for achieving oscillations and the temperature sensitivity of the period. The delayed negative feedback oscillator and repressilator are more robust for oscillations, whereas the activator-inhibitor and substrate-depletion oscillators are superior for maintaining a temperature-independent oscillation period. These results suggest that thermally robust oscillation can be more plausibly achieved by hybridizing these two categories of network motifs. Antagonistic balance and temperature insulation mechanisms for achieving temperature compensation are typically found in these topologies with temperature robustness. In the temperature insulation approach, the oscillation period relies on very few parameters, and these parameters are influenced only slightly by temperature. This approach prevents the temperature from affecting the oscillation period and generates circadian rhythms that are robust against environmental perturbations.	[Wu, Lili; Ouyang, Qi; Wang, Hongli] Peking Univ, Sch Phys, State Key Lab Artificial Microstruct & Mesoscop P, Beijing, Peoples R China; [Ouyang, Qi; Wang, Hongli] Peking Univ, Ctr Quantitat Biol, Beijing, Peoples R China; [Ouyang, Qi] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China	Peking University; Peking University; Peking University	Wang, HL (corresponding author), Peking Univ, Sch Phys, State Key Lab Artificial Microstruct & Mesoscop P, Beijing, Peoples R China.	hlwang@pku.edu.cn			Ministry of Science and Technology of China [2015CB910301, 2012AA02A702]; National Natural Science Foundation of China [11174013, 11434001]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is financially supported by Ministry of Science and Technology of China (2015CB910301 to H.W. and 2012AA02A702 to Q.O.) and National Natural Science Foundation of China grants (11174013 to H.W. and 11434001 to Q.O.).	Alon U., 2006, INTRO SYSTEMS BIOL D; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Bodenstein C, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/3/036011; Bodenstein C, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/5/056007; Cassone VM, 2014, FRONT NEUROENDOCRIN, V35, P76, DOI 10.1016/j.yfrne.2013.10.002; Castillo-Hair Sebastian M, 2015, Syst Synth Biol, V9, P125, DOI 10.1007/s11693-015-9178-6; Cotterell J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.74; Denlinger D. L., 2001, INSECT TIMING CIRCAD; Dunlap JC, 2006, CURR OPIN MICROBIOL, V9, P579, DOI 10.1016/j.mib.2006.10.008; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eckel-Mahan K, 2013, PHYSIOL REV, V93, P107, DOI 10.1152/physrev.00016.2012; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Farewell A, 1998, J BACTERIOL, V180, P4704, DOI 10.1128/JB.180.17.4704-4710.1998; Francois P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002585; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; Gould PD, 2006, PLANT CELL, V18, P1177, DOI 10.1105/tpc.105.039990; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; HASTINGS JW, 1957, P NATL ACAD SCI USA, V43, P804, DOI 10.1073/pnas.43.9.804; Hatakeyama TS, 2012, P NATL ACAD SCI USA, V109, P8109, DOI 10.1073/pnas.1120711109; Hogenesch JB, 2011, NAT REV GENET, V12, P407, DOI 10.1038/nrg2972; Hong CI, 2007, P NATL ACAD SCI USA, V104, P1195, DOI 10.1073/pnas.0601378104; Hong CI, 1997, CHRONOBIOL INT, V14, P521, DOI 10.3109/07420529709001473; Hussain F, 2014, P NATL ACAD SCI USA, V111, P972, DOI 10.1073/pnas.1316298111; Imaizumi T, 2010, CURR OPIN PLANT BIOL, V13, P83, DOI 10.1016/j.pbi.2009.09.007; Iman R.L, 1980, LATIN HYPERCUBE SAMP; Kidd PB, 2015, P NATL ACAD SCI USA, V112, pE6284, DOI 10.1073/pnas.1511215112; Kurosawa G, 2005, J THEOR BIOL, V233, P453, DOI 10.1016/j.jtbi.2004.10.012; Lahiri K, 2005, PLOS BIOL, V3, P2005, DOI 10.1371/journal.pbio.0030351; Lim WA, 2013, MOL CELL, V49, P202, DOI 10.1016/j.molcel.2012.12.020; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Marland E, 2002, COMPUTATIONAL CELL B; McClung CR, 2007, P NATL ACAD SCI USA, V104, P16727, DOI 10.1073/pnas.0708757104; Oleksiuk O, 2011, CELL, V145, P312, DOI 10.1016/j.cell.2011.03.013; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; Peschel N, 2011, FEBS LETT, V585, P1435, DOI 10.1016/j.febslet.2011.02.028; Phong C, 2013, P NATL ACAD SCI USA, V110, P1124, DOI 10.1073/pnas.1212113110; PITTENDRIGH CS, 1954, P NATL ACAD SCI USA, V40, P1018, DOI 10.1073/pnas.40.10.1018; Pokhilko A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.6; Ruoff P, 2005, J THEOR BIOL, V237, P41, DOI 10.1016/j.jtbi.2005.03.030; Ruoff P, 2003, BIOPHYS CHEM, V106, P179, DOI 10.1016/S0301-4622(03)00191-1; Ruoff P, 1997, CHRONOBIOL INT, V14, P499, DOI 10.3109/07420529709001471; Ruoff P, 1996, J THEOR BIOL, V179, P275, DOI 10.1006/jtbi.1996.0067; RUOFF P, 1992, J INTERDISCIPL CYCLE, V23, P92, DOI 10.1080/09291019209360133; Ruoff P, 2007, FEBS J, V274, P940, DOI 10.1111/j.1742-4658.2007.05641.x; Shah NA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002085; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Shimizu H, 2014, CELL, V157, P1160, DOI 10.1016/j.cell.2014.03.050; Takeuchi T, 2007, J THEOR BIOL, V246, P195, DOI 10.1016/j.jtbi.2006.12.028; Ukai-Tadenuma M, 2011, CELL, V144, P268, DOI 10.1016/j.cell.2010.12.019; van Zon JS, 2007, P NATL ACAD SCI USA, V104, P7420, DOI 10.1073/pnas.0608665104; Wagner A, 2005, P NATL ACAD SCI USA, V102, P11775, DOI 10.1073/pnas.0501094102; YAN L, 2012, PLOS ONE, V0007; Yun HS, 1996, BIOTECHNOL BIOENG, V52, P615, DOI 10.1002/(SICI)1097-0290(19961205)52:5<615::AID-BIT9>3.0.CO;2-M	55	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171263	10.1371/journal.pone.0171263	http://dx.doi.org/10.1371/journal.pone.0171263			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152061	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161200120
J	Zhu, Y; Kawaguchi, K; Kiyama, R				Zhu, Yun; Kawaguchi, Kayoko; Kiyama, Ryoiti			Differential and directional estrogenic signaling pathways induced by enterolignans and their precursors	PLOS ONE			English	Article							BREAST-CANCER CELLS; GENE-EXPRESSION; DNA MICROARRAY; ENTEROLACTONE; LIGNANS; ENTERODIOL; RISK; METABOLITES; CHEMICALS; PHYTOESTROGENS	Mammalian lignans or enterolignans are metabolites of plant lignans, an important category of phytochemicals. Although they are known to be associated with estrogenic activity, cell signaling pathways leading to specific cell functions, and especially the differences among lignans, have not been explored. We examined the estrogenic activity of enterolignans and their precursor plant lignans and cell signaling pathways for some cell functions, cell cycle and chemokine secretion. We used DNA microarray-based gene expression profiling in human breast cancer MCF-7 cells to examine the similarities, as well as the differences, among enterolignans, enterolactone and enterodiol, and their precursors, matairesinol, pinoresinol and sesamin. The profiles showed moderate to high levels of correlation (Rvalues: 0.44 to 0.81) with that of estrogen (17 beta-estradiol or E-2). Significant correlations were observed among lignans (Rvalues: 0.77 to 0.97), and the correlations were higher for cell functions related to enzymes, signaling, proliferation and transport. All the enterolignans/ precursors examined showed activation of the Erk1/2 and PI3KIAkt pathways, indicating the involvement of rapid signaling through the non-genomic estrogen signaling pathway. However, when their effects on specific cell functions, cell cycle progression and chemokine (MCP-1) secretion were examined, positive effects were observed only for enterolactone, suggesting that signals are given in certain directions at a position closer to cell functions. We hypothesized that, while estrogen signaling is initiated by the enterolignans/precursors examined, their signals are differentially and directionally modulated later in the pathways, resulting in the differences at the cell function level.	[Zhu, Yun; Kawaguchi, Kayoko; Kiyama, Ryoiti] Natl Inst Adv Ind Sci & Technol, Adv Biomeasurements Res Grp, Biomed Res Inst, 1-1-1 Higashi, Tsukuba, Ibaraki, Japan; [Zhu, Yun] Scinet Co, Minato Ku, 4-21-12 Takanawa, Tokyo, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Kiyama, R (corresponding author), Natl Inst Adv Ind Sci & Technol, Adv Biomeasurements Res Grp, Biomed Res Inst, 1-1-1 Higashi, Tsukuba, Ibaraki, Japan.	kiyama.r@aist.go.jp			Special Coordination Fund for Promoting Science and Technology (Encouraging Development of Strategic Research Centers); Knowledge Cluster Initiative program; Kyushu Sangyo University for promoting basic technologies; Ministry of Education, Culture, Sports, Science and Technology of Japan; Scinet Company	Special Coordination Fund for Promoting Science and Technology (Encouraging Development of Strategic Research Centers); Knowledge Cluster Initiative program; Kyushu Sangyo University for promoting basic technologies; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Scinet Company	This research has been supported partly by a Special Coordination Fund for Promoting Science and Technology (Encouraging Development of Strategic Research Centers), a Knowledge Cluster Initiative program, a grant from Kyushu Sangyo University for promoting basic technologies, and a Grant-in-Aid for Basic Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders and Scinet Company provided support in the form of salaries for authors [YZ and KK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adlercreutz H, 2007, CRIT REV CL LAB SCI, V44, P483, DOI 10.1080/10408360701612942; Aehle E, 2011, PHYTOCHEMISTRY, V72, P2396, DOI 10.1016/j.phytochem.2011.08.013; Arnold A, 2005, J CLIN ONCOL, V23, P4215, DOI 10.1200/JCO.2005.05.064; Azrad M, 2013, J MED FOOD, V16, P357, DOI 10.1089/jmf.2012.0159; Buck K, 2011, J CLIN ONCOL, V29, P3730, DOI 10.1200/JCO.2011.34.6478; Buck K, 2010, AM J CLIN NUTR, V92, P141, DOI 10.3945/ajcn.2009.28573; Carreau C, 2008, J STEROID BIOCHEM, V110, P176, DOI 10.1016/j.jsbmb.2008.03.032; Clavel T, 2005, APPL ENVIRON MICROB, V71, P6077, DOI 10.1128/AEM.71.10.6077-6085.2005; Clavel T, 2006, NUTR RES REV, V19, P187, DOI 10.1017/S0954422407249704; Damdimopoulou P, 2011, J NUTR, V141, P1583, DOI 10.3945/jn.111.140277; Dar AA, 2013, BIOORG CHEM, V50, P1, DOI 10.1016/j.bioorg.2013.06.009; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Dong S, 2013, J AGR FOOD CHEM, V61, P128, DOI 10.1021/jf304546a; Dong S, 2012, MICROBIOL RES, V167, P231, DOI 10.1016/j.micres.2011.09.003; Foster JS, 2001, TRENDS ENDOCRIN MET, V12, P320, DOI 10.1016/S1043-2760(01)00436-2; Frankenfeld CL, 2014, J NUTR, V144, P1445, DOI 10.3945/jn.114.190512; Inoue A, 2007, TOXICOL IN VITRO, V21, P741, DOI 10.1016/j.tiv.2007.01.014; Jansen GHE, 2005, ARCH BIOCHEM BIOPHYS, V435, P74, DOI 10.1016/j.abb.2004.12.015; Jin JS, 2013, MOLECULES, V18, P1122, DOI 10.3390/molecules18011122; Kivama R., 2016, ENV BIOTECH IN PRESS; Kiyama R, 2016, TRENDS FOOD SCI TECH, V54, P186, DOI 10.1016/j.tifs.2016.06.007; Kiyama R, 2014, ENVIRON TECHNOL INNO, V1-2, P16, DOI 10.1016/j.eti.2014.09.001; Kiyama R, 2015, ENVIRON INT, V83, P11, DOI 10.1016/j.envint.2015.05.012; Kiyama R, 2014, CELL MOL LIFE SCI, V71, P2065, DOI 10.1007/s00018-013-1544-5; Kuijsten A, 2006, CANCER EPIDEM BIOMAR, V15, P1132, DOI 10.1158/1055-9965.EPI-05-0991; Lampe JW, 2006, J AOAC INT, V89, P1174; Li S, 2016, CELL MOL IM IN PRESS; Mabrok HB, 2012, CARCINOGENESIS, V33, P203, DOI 10.1093/carcin/bgr256; Martynowicz H, 2014, ADV CLIN EXP MED, V23, P319, DOI 10.17219/acem/37123; Miguel V, 2014, DRUG METAB DISPOS, V42, P943, DOI 10.1124/dmd.113.055970; MOUSAVI Y, 1992, J STEROID BIOCHEM, V41, P615, DOI 10.1016/0960-0760(92)90393-W; Nishihara T, 2000, J HEALTH SCI, V46, P282; Penalvo JL, 2012, J NUTR, V142, P751, DOI 10.3945/jn.111.150516; Penttinen P, 2007, ENDOCRINOLOGY, V148, P4875, DOI 10.1210/en.2007-0289; Prall OWJ, 1997, J BIOL CHEM, V272, P10882; Raffaelli B, 2002, J CHROMATOGR B, V777, P29, DOI 10.1016/S1570-0232(02)00092-2; Reger MK, 2016, EUR J NUTR, V55, P1029, DOI 10.1007/s00394-015-0917-y; Saarinen NM, 2007, MOL NUTR FOOD RES, V51, P857, DOI 10.1002/mnfr.200600240; SATHYAMOORTHY N, 1994, CANCER RES, V54, P957; Skildum AJ, 2002, J BIOL CHEM, V277, P5145, DOI 10.1074/jbc.M109179200; Sonestedt E, 2010, NUTR RES, V30, P667, DOI 10.1016/j.nutres.2010.09.010; Takic MM, 2016, FOOD FUNCT, V7, P1217, DOI [10.1039/c5fo01346a, 10.1039/C5FO01346A]; Tanji Masao, 2004, Current Pharmacogenomics, V2, P255, DOI 10.2174/1570160043377529; Terasaka S, 2004, ENVIRON HEALTH PERSP, V112, P773, DOI 10.1289/ehp.6753; Touillaud MS, 2007, JNCI-J NATL CANCER I, V99, P475, DOI 10.1093/jnci/djk096; van der Schouw YT, 2000, NUTR METAB CARDIOVAS, V10, P154; Wang LQ, 2002, J CHROMATOGR B, V777, P289, DOI 10.1016/S1570-0232(02)00281-7; WELSHONS WV, 1987, BREAST CANCER RES TR, V10, P169, DOI 10.1007/BF01810580	48	25	25	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171390	10.1371/journal.pone.0171390	http://dx.doi.org/10.1371/journal.pone.0171390			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152041	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161200137
J	Migani, V; Ekesi, S; Merkel, K; Hoffmeister, T				Migani, Valentina; Ekesi, Sunday; Merkel, Katharina; Hoffmeister, Thomas			At Lunch with a Killer: The Effect of Weaver Ants on Host-Parasitoid Interactions on Mango	PLOS ONE			English	Article							BACTROCERA-INVADENS DIPTERA; FRUIT-FLIES DIPTERA; OECOPHYLLA-LONGINODA; FORAGING BEHAVIOR; PREDATION RISK; FOPIUS-ARISANUS; OVIPOSITION BEHAVIOR; PATCH EXPLOITATION; CERATITIS-COSYRA; TEPHRITIDAE	Predator-prey interactions can affect the behaviour of the species involved, with consequences for population distribution and competitive interactions. Under predation pressure, potential prey may adopt evasive strategies. These responses can be costly and could impact population growth. As some prey species may be more affected than others, predation pressure could also alter the dynamics among species within communities. In field cages and small observation cages, we studied the interactions between a generalist predator, the African weaver ant, Oecophylla longinoda, two species of fruit flies that are primary pests of mango fruits, Ceratitis cosyra and Bactrocera dorsalis, and their two exotic parasitoids, Fopius arisanus and Diachasmimorpha longicaudata. In all experiments, either a single individual (observation cage experiments) or groups of individuals (field cage experiments) of a single species were exposed to foraging in the presence or absence of weaver ants. Weaver ant presence reduced the number of eggs laid by 75 and 50 percent in B. dorsalis and C. cosyra respectively. Similarly, parasitoid reproductive success was negatively affected by ant presence, with success of parasitism reduced by around 50 percent for both F. arisanus and D. longicaudata. The negative effect of weaver ants on both flies and parasitoids was mainly due to indirect predation effects. Encounters with weaver ant workers increased the leaving tendency in flies and parasitoids, thus reduced the time spent foraging on mango fruits. Parasitoids were impacted more strongly than fruit flies. We discuss how weaver ant predation pressure may affect the population dynamics of the fruit flies, and, in turn, how the alteration of host dynamics could impact parasitoid foraging behaviour and success.	[Migani, Valentina; Merkel, Katharina; Hoffmeister, Thomas] Univ Bremen, Inst Ecol, Fac Biol Chem, Bremen, Germany; [Ekesi, Sunday] ICIPE, Nairobi, Kenya; [Merkel, Katharina] Queensland Univ Technol, Brisbane, Qld, Australia	University of Bremen; International Centre of Insect Physiology & Ecology (ICIPE); Queensland University of Technology (QUT)	Migani, V (corresponding author), Univ Bremen, Inst Ecol, Fac Biol Chem, Bremen, Germany.	migani@uni-bremen.de	Migani, Valentina/AAF-9746-2020; Ekesi, Sunday/P-8944-2019; Hoffmeister, Thomas S./AAH-7796-2020; Hoffmeister, Thomas S/E-2804-2013	Hoffmeister, Thomas S./0000-0003-2840-7278; Hoffmeister, Thomas S/0000-0003-2840-7278	German Ministry for Economic Cooperation and Development (BMZ project) [10.7860.9-001.00]	German Ministry for Economic Cooperation and Development (BMZ project)	This research was supported by funds from the German Ministry for Economic Cooperation and Development (BMZ project No: 10.7860.9-001.00).	Adandonon A, 2009, INT J PEST MANAGE, V55, P285, DOI 10.1080/09670870902878418; Appiah EF, 2014, BIOL CONTROL, V79, P49, DOI 10.1016/j.biocontrol.2014.08.004; Balagawi S, 2005, AUST J ENTOMOL, V44, P97, DOI 10.1111/j.1440-6055.2005.00459.x; Barzman MS, 2001, J ANIM ECOL, V70, P237, DOI 10.1046/j.1365-2656.2001.00483.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Blake CA, 2014, BEHAV ECOL, V25, P871, DOI 10.1093/beheco/aru041; BROWN JS, 1992, ANN ZOOL FENN, V29, P301; Chase JM, 2002, ECOL LETT, V5, P302, DOI 10.1046/j.1461-0248.2002.00315.x; CONNELL JH, 1983, AM NAT, V122, P661, DOI 10.1086/284165; Davies NB, 2012, INTRO BEHAV ECOLOGY; DEJEAN A, 1990, PHYSIOL ENTOMOL, V15, P393, DOI 10.1111/j.1365-3032.1990.tb00528.x; Ekesi S, 2006, B ENTOMOL RES, V96, P379, DOI 10.1079/BER2006442; Ekesi S, 2007, B ENTOMOL RES, V96, P279; Ekesi S, 2009, J ECON ENTOMOL, V102, P981, DOI 10.1603/029.102.0317; Field SA, 1998, ETHOLOGY, V104, P323, DOI 10.1111/j.1439-0310.1998.tb00072.x; HACCOU P, 1991, J ANIM ECOL, V60, P93, DOI 10.2307/5447; Harrison XA, 2014, PEERJ, V2, DOI 10.7717/peerj.616; Heimpel GE, 1997, OECOLOGIA, V110, P346, DOI 10.1007/s004420050168; HOLLDOBLER B, 1977, P NATL ACAD SCI USA, V74, P2072, DOI 10.1073/pnas.74.5.2072; Holldobler B., 1990, pi; Houtman R, 1998, EVOL ECOL, V12, P251, DOI 10.1023/A:1006544031697; Hubner G, 1996, J INSECT BEHAV, V9, P143, DOI 10.1007/BF02213729; Janssen A, 1998, EXP APPL ACAROL, V22, P497, DOI 10.1023/A:1006089924336; Kolss M, 2006, BEHAV ECOL SOCIOBIOL, V61, P291, DOI 10.1007/s00265-006-0259-0; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; MACKAUER M, 1993, OECOLOGIA, V94, P339, DOI 10.1007/BF00317107; Martinez-Ferrer MT, 2003, BIOL CONTROL, V26, P279, DOI 10.1016/S1049-9644(02)00158-5; Messelink GJ, 2012, INTEGRATED PEST MANAGEMENT AND PEST CONTROL - CURRENT AND FUTURE TACTICS, P191; Messing RH, 1997, ENTOMOL EXP APPL, V82, P147, DOI 10.1023/A:1002900111900; Mohamed SA, 2010, BIOCONTROL SCI TECHN, V20, P183, DOI 10.1080/09583150903447794; Montoya P, 2003, BIOCONTROL SCI TECHN, V13, P683, DOI 10.1080/09583150310001606273; Noldus LPJJ, 1991, OBSERVER; Outreman Y, 2005, BEHAV ECOL SOCIOBIOL, V58, P208, DOI 10.1007/s00265-004-0895-1; Peacor SD, 2003, OIKOS, V100, P409, DOI 10.1034/j.1600-0706.2003.12043.x; Peacor SD, 2001, P NATL ACAD SCI USA, V98, P3904, DOI 10.1073/pnas.071061998; Peng RK, 1999, INT J PEST MANAGE, V45, P189, DOI 10.1080/096708799227789; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; R Core Team, 2021, R LANGUAGE ENV STAT; ROITBERG BD, 1990, BEHAVIOUR, V114, P65, DOI 10.1163/156853990X00059; Roitberg BD, 2010, BEHAV ECOL SOCIOBIOL, V64, P627, DOI 10.1007/s00265-009-0880-9; Rwomushana I, 2009, ENTOMOL EXP APPL, V133, P27, DOI 10.1111/j.1570-7458.2009.00897.x; SCHOENER TW, 1983, AM NAT, V122, P240, DOI 10.1086/284133; Sinzogan AAC, 2008, INT J PEST MANAGE, V54, P241, DOI 10.1080/09670870802014940; SKELLY DK, 1992, ECOLOGY, V73, P704, DOI 10.2307/1940779; Suraci JP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10698; Symondson WOC, 2002, ANNU REV ENTOMOL, V47, P561, DOI 10.1146/annurev.ento.47.091201.145240; Therneau T., 2015, PACKAGE SURVIVAL ANA; Thiel A, 2004, BEHAV ECOL, V15, P419, DOI 10.1093/beheco/arh030; van Alphen J.J.M., 1986, P23; Van Mele P, 2007, J ECON ENTOMOL, V100, P695, DOI 10.1603/0022-0493(2007)100[695:EOAAWA]2.0.CO;2; Van Mele P, 2009, PHYSIOL ENTOMOL, V34, P256, DOI 10.1111/j.1365-3032.2009.00685.x; Vayssieres J- F, 2011, INT J BIOL CHEM SCI, V5, P790, DOI DOI 10.4314/IJBCS.V5I2.72153; Volkl W, 1997, ANIM BEHAV, V54, P349, DOI 10.1006/anbe.1996.0462; VOLKL W, 1994, OIKOS, V70, P149, DOI 10.2307/3545710; Wang XG, 2003, J INSECT BEHAV, V16, P593, DOI 10.1023/B:JOIR.0000007698.01714.56; WAY MJ, 1992, ANNU REV ENTOMOL, V37, P479, DOI 10.1146/annurev.en.37.010192.002403; WEISSER WW, 1994, EVOL ECOL, V8, P587, DOI 10.1007/BF01237843; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; Wielgoss A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2144; WOOSTER D, 1995, OIKOS, V73, P3, DOI 10.2307/3545718	61	8	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0170101	10.1371/journal.pone.0170101	http://dx.doi.org/10.1371/journal.pone.0170101			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146561	gold, Green Submitted, Green Published			2022-12-27	WOS:000396131700012
J	Hou, LK; Ma, YS; Han, Y; Lu, GX; Luo, P; Chang, ZY; Xie, RT; Yang, HQ; Chai, L; Cai, MX; Wu, TM; Yu, F; Qin, SS; Lv, ZW; Wu, CY; Fu, D				Hou, Li-Kun; Ma, Yu-Shui; Han, Yang; Lu, Gai-Xia; Luo, Pei; Chang, Zheng-Yan; Xie, Ru-Ting; Yang, Hui-Qiong; Chai, Li; Cai, Ming-Xiang; Wu, Ting-Miao; Yu, Fei; Qin, Shan-Shan; Lv, Zhong-Wei; Wu, Chun-Yan; Fu, Da			Association of microRNA-33a Molecular Signature with Non-Small Cell Lung Cancer Diagnosis and Prognosis after Chemotherapy	PLOS ONE			English	Article							AMERICAN SOCIETY; THERAPY; MIR-33A; METASTASIS; GENOMICS	Objective This study aims to explore the expression pattern and prognostic significance of miR-33a in non-small cell lung cancer (NSCLC) treated with adjuvant chemotherapy. Methods MiR-33aexpression in NSCLC was analyzed in silico using the GEO database and was subsequently confirmed by quantitative RT-PCR in 147 NSCLC biopsies. Among these, 32 of these biopsies were paired with adjacent non-neoplastic tissues. The survival analysis of NSCLC by Kaplan-Meier estimates was stratified based on miR-33a expression. In addition, multivariate survival analysis in corresponding groups of NSCLC patients was conducted by Cox proportional hazards regression model. Results The in silico analysis of miR-33a expression in NSCLC resulted to its down-regulation in different tumor types. The expression level of miR-33a was lower in each grade of NSCLC tumor biopsies than in normal lung tissues. Univariate and multivariate survival analysis further established that low miR-33a expression was an important risk factor for overall survival and disease free survival in NSCLC patients. Conclusion Our study implied that miR-33a expression levels may have an essential role in NSCLC progression, and could act as a specific and sensitive biomarker for NSCLC patients who have undergone adjuvant chemotherapy.	[Hou, Li-Kun; Wu, Chun-Yan] Tongji Univ, Shanghai Pulm Hosp, Dept Pathol, Sch Med, Shanghai, Peoples R China; [Ma, Yu-Shui] East China Normal Univ, Shanghai Engn Res Ctr Mol Therapeut & New Drug De, Coll Chem & Mol Engn, Shanghai, Peoples R China; [Ma, Yu-Shui; Lu, Gai-Xia; Chai, Li; Cai, Ming-Xiang; Wu, Ting-Miao; Yu, Fei; Qin, Shan-Shan; Lv, Zhong-Wei] Tongji Univ, Shanghai Peoples Hosp 10, Dept Nucl Med, Sch Med, Shanghai, Peoples R China; [Han, Yang] Inner Mongolia Med Univ, Dept Radiol, Dept Translat Med Ctr, Cent Hosp Baotou, Hohhot, Inner Mongolia, Peoples R China; [Han, Yang] Inner Mongolia Med Univ, Med Imaging Res Inst, Cent Hosp Baotou, Hohhot, Inner Mongolia, Peoples R China; [Luo, Pei] Hunan Agr Univ, Fac Vet, Coll Vet Med, Changsha, Hunan, Peoples R China; [Chang, Zheng-Yan; Xie, Ru-Ting; Yang, Hui-Qiong] Tongji Univ, Sch Med, Dept Pathol, Shanghai Peoples Hosp 10, Shanghai, Peoples R China; [Fu, Da] Tongji Univ, Cent Lab Med Res, Shanghai Peoples Hosp 10, Sch Med, Shanghai, Peoples R China	Tongji University; East China Normal University; Tongji University; Inner Mongolia Medical University; Inner Mongolia Medical University; Hunan Agricultural University; Tongji University; Tongji University	Wu, CY (corresponding author), Tongji Univ, Shanghai Pulm Hosp, Dept Pathol, Sch Med, Shanghai, Peoples R China.; Fu, D (corresponding author), Tongji Univ, Cent Lab Med Res, Shanghai Peoples Hosp 10, Sch Med, Shanghai, Peoples R China.	chunyan_wu2015@126.com; fu800da900@126.com	han, yang/GRS-2388-2022; ma, yushui/HGC-6206-2022; Fu, Da/GXF-2656-2022		National Natural Science Foundation of China [81372175, 81301993, 81472202, 81302065]; Shanghai health and family planning commission projects [201540228, 201440398]; Shanghai Natural Science Foundation [16ZR1428900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai health and family planning commission projects; Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai)	This study was supported in part by grants from the National Natural Science Foundation of China (81372175, 81301993, 81472202, and 81302065), Shanghai health and family planning commission projects (201540228 and 201440398) and Shanghai Natural Science Foundation (16ZR1428900).	Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cykert S, 2010, JAMA-J AM MED ASSOC, V303, P2368, DOI 10.1001/jama.2010.793; Database resources of the National Center for Biotechnology Information, 2015, NUCL ACIDS RES; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Ettinger DS, 2014, J NATL COMPR CANC NE, V12, P1738, DOI 10.6004/jnccn.2014.0176; Friboulet L, 2013, NEW ENGL J MED, V368, P1101, DOI 10.1056/NEJMoa1214271; Han Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134682; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Ibrahim AF, 2011, CANCER RES, V71, P5214, DOI 10.1158/0008-5472.CAN-10-4645; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Kadara H, 2011, CLIN CANCER RES, V17, P1490, DOI 10.1158/1078-0432.CCR-10-2703; Kim J., 2014, J ELECT MAT, V2014, P1, DOI DOI 10.1167/14.7.1.[; Klopfleisch R, 2015, VET J LONDON ENGLAND; Li X., 2011, J NANOMATER, V2011, P1, DOI [DOI 10.1155/2011/382068, DOI 10.1155/2011/270974]; Liu R, 2011, EUR J CANCER, V47, P784, DOI 10.1016/j.ejca.2010.10.025; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Masters GA, 2015, J CLIN ONCOL, V33, P3488, DOI 10.1200/JCO.2015.62.1342; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Ramnath N, 2013, CHEST, V143, pE314, DOI 10.1378/chest.12-2360; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Rodrigues G, 2015, PRACT RADIAT ONCOL, V5, P149, DOI 10.1016/j.prro.2015.02.013; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang H, 2014, J CLIN INVEST, V124, P4489, DOI 10.1172/JCI75284; Wang R, 2011, ONCOGENE, V30, P2644, DOI 10.1038/onc.2010.642; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang LH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13677; Yates LA, 2013, CELL, V153, P516, DOI 10.1016/j.cell.2013.04.003; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zen K, 2012, MED RES REV, V32, P326, DOI 10.1002/med.20215; Zhang CZ, 2015, INVEST NEW DRUG, V33, P1, DOI 10.1007/s10637-014-0156-8; Zhou Jun, 2015, IEEE T CIRCUITS SYST, VI, P1, DOI DOI 10.1016/J.BMCL.2015.01.016; Zhou Y, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-12	39	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170431	10.1371/journal.pone.0170431	http://dx.doi.org/10.1371/journal.pone.0170431			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141816	Green Published, Green Submitted, gold			2022-12-27	WOS:000396129500010
J	Kowall, B; Rathmann, W; Stang, A; Bongaerts, B; Kuss, O; Herder, C; Roden, M; Quante, A; Holle, R; Huth, C; Peters, A; Meisinger, C				Kowall, Bernd; Rathmann, Wolfgang; Stang, Andreas; Bongaerts, Brenda; Kuss, Oliver; Herder, Christian; Roden, Michael; Quante, Anne; Holle, Rolf; Huth, Cornelia; Peters, Annette; Meisinger, Christa			Perceived risk of diabetes seriously underestimates actual diabetes risk: The KORA FF4 study	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE; GERMAN POPULATION; TYPE-2; ADULTS; PREVALENCE; MELLITUS; PEOPLE; PREVENTION; PREDICTION	Objective Early detection of diabetes and prediabetic states is beneficial for patients, but may be delayed by patients A being overly optimistic about their own health. Therefore, we assessed how persons without known diabetes perceive their risk of having or developing diabetes, and we identified factors associated with perception of diabetes risk. Research design and methods 1,953 participants without previously known diabetes from the population-based, German KORA FF4 Study (59.1 years, 47.8% men) had an oral glucose tolerance test. They estimated their probability of having undiagnosed diabetes mellitus (UDM) on a six category scale, and assessed whether they were at risk of developing diabetes in the future. We cross-tabulated glycemic status with risk perception, and fitted robust Poisson regression models to identify determinants of diabetes risk perception. Results 74% (95% CI: 65-82) of persons with UDM believed that their probability of having undetected diabetes was low or very low. 72% (95% CI: 69-75) of persons with prediabetes believed that they were not at risk of developing diabetes. In people with prediabetes, seeing oneself at risk of diabetes was associated with self-rated poor general health (prevalence ratio (PR) = 3.1 (95% CI: 1.4-6.8), parental diabetes (PR = 2.6, 1.9-3.4), high educational level (PR = 1.9 (1.4-2.5)), lower age (PR = 0.7, 0.6-0.8, per 1 standard deviation increase), female sex (PR = 1.2, 0.9-1.5) and obesity (PR = 1.5, 1.2-2.0). Conclusions People with undiagnosed diabetes or prediabetes considerably underestimate their probability of having or developing diabetes. Contrary to associations with actual diabetes risk, perceived diabetes risk was lower in men, lower educated and older persons.	[Kowall, Bernd; Stang, Andreas] Univ Duisburg Essen, Ctr Clin Epidemiol, Inst Med Informat Biometry & Epidemiol, Fac Med, Essen, Germany; [Rathmann, Wolfgang; Bongaerts, Brenda; Kuss, Oliver] German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany; [Rathmann, Wolfgang; Bongaerts, Brenda; Kuss, Oliver; Herder, Christian; Roden, Michael; Holle, Rolf; Huth, Cornelia; Peters, Annette; Meisinger, Christa] German Ctr Diabet Res DZD, Munich, Germany; [Stang, Andreas] Boston Univ, Dept Epidemiol, Sch Publ Hlth, Talbot Bldg, Boston, MA USA; [Herder, Christian; Roden, Michael] Heinrich Heine Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany; [Roden, Michael] Heinrich Heine Univ, Fac Med, Dept Endocrinol & Diabetol, Dusseldorf, Germany; [Quante, Anne] Ludwig Maximilians Univ Munchen, Chair Genet Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Quante, Anne] Helmholtz Zentrum Munchen, Inst Genet Epidemiol, German Res Ctr Environm Hlth, Neuherberg, Germany; [Holle, Rolf] Helmholtz Zentrum Munchen, Inst Hlth Econ & Hlth Care Management, German Res Ctr Environm Hlth GmbH, Neuherberg, Germany; [Huth, Cornelia; Peters, Annette; Meisinger, Christa] Helmholtz Zentrum Munchen, Inst Epidemiol 2, German Res Ctr Environm Hlth GmbH, Neuherberg, Germany	University of Duisburg Essen; Deutsches Diabetes-Zentrum (DDZ); Boston University; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Kowall, B (corresponding author), Univ Duisburg Essen, Ctr Clin Epidemiol, Inst Med Informat Biometry & Epidemiol, Fac Med, Essen, Germany.	bernd.kowall@uk-essen.de	Huth, Cornelia/B-5350-2014; Peters, Annette/A-6117-2011; Roden, Michael/AAD-3843-2019; Holle, Rolf/D-9333-2013; Meisinger, Christine/B-5358-2014	Huth, Cornelia/0000-0003-2421-433X; Peters, Annette/0000-0001-6645-0985; Holle, Rolf/0000-0001-5395-2695; 	Ministry of Science and Research of the State of North Rhine-Westphalia (MIWF NRW); German Federal Ministry of Health (BMG); German Research Foundation (DFG) [RA 459/3-1]; German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research; Helmholtz Zentrum Munchen; German Research Center for Environmental Health - German Federal Ministry of Science and Research (Berlin, Germany); State of Bavaria; German Diabetes Foundation	Ministry of Science and Research of the State of North Rhine-Westphalia (MIWF NRW); German Federal Ministry of Health (BMG); German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research; Helmholtz Zentrum Munchen(Helmholtz Association); German Research Center for Environmental Health - German Federal Ministry of Science and Research (Berlin, Germany); State of Bavaria; German Diabetes Foundation	This work was supported by the Ministry of Science and Research of the State of North Rhine-Westphalia (MIWF NRW) and the German Federal Ministry of Health (BMG). The diabetes part of the KORA F4 study was funded by a grant from the German Research Foundation (DFG; RA 459/3-1). This study was supported in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). The KORA research platform and the KORA Augsburg studies are financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health, which is funded by the German Federal Ministry of Science and Research (Berlin, Germany) and by the State of Bavaria. The diabetes part of the KORA FF4 study was funded by a grant from the German Diabetes Foundation to WR and C Herder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaanse MC, 2008, PATIENT EDUC COUNS, V73, P307, DOI 10.1016/j.pec.2008.06.009; Adriaanse MC, 2003, DIABETIC MED, V20, P210, DOI 10.1046/j.1464-5491.2003.00901.x; Balkau B, 2008, DIABETES CARE, V31, P2056, DOI 10.2337/dc08-0368; Beagley J, 2014, DIABETES RES CLIN PR, V103, P150, DOI 10.1016/j.diabres.2013.11.001; Bodemer N, 2014, MED DECIS MAKING, V34, P615, DOI 10.1177/0272989X14526305; Boer H, 1996, PREDICTING HLTH BEHA, P95, DOI [10.1080/13548506.2011.579983, DOI 10.1080/13548506.2011.579983]; Colagiuri S, 2009, CURR OPIN ENDOCRINOL, V16, P95, DOI 10.1097/MED.0b013e328329302f; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Genuth S, 2003, DIABETES CARE, V26, P3160; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; Godino JG, 2014, DIABETES RES CLIN PR, V106, P412, DOI 10.1016/j.diabres.2014.10.004; Guess ND, 2015, PRIM CARE DIABETES, V9, P407, DOI 10.1016/j.pcd.2015.04.005; Heidemann C, 2015, DIABETIC MED; Herman WH, 2015, DIABETES CARE, V38, P1449, DOI 10.2337/dc14-2459; Hivert MF, 2009, DIABETES CARE, V32, P1820, DOI 10.2337/dc09-0720; Kengne AP, 2014, LANCET DIABETES ENDO, V2, P19, DOI 10.1016/S2213-8587(13)70103-7; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Koksal Burcu, 2015, Open Access Maced J Med Sci, V3, P380, DOI 10.3889/oamjms.2015.093; Kowall B, 2011, EUR J EPIDEMIOL, V26, P637, DOI 10.1007/s10654-011-9609-y; Olafsdottir E, 2016, ACTA OPHTHALMOL, V94, P232, DOI 10.1111/aos.12954; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Plantinga LC, 2010, CLIN J AM SOC NEPHRO, V5, P673, DOI 10.2215/CJN.07891109; Rathmann W, 2003, DIABETOLOGIA, V46, P182, DOI 10.1007/s00125-002-1025-0; Rathmann W, 2010, DIABETIC MED, V27, P1116, DOI 10.1111/j.1464-5491.2010.03065.x; Rathmann W, 2009, DIABETIC MED, V26, P1212, DOI 10.1111/j.1464-5491.2009.02863.x; Reyes-Velazquez Wanda, 2015, Diabetes Spectr, V28, P5, DOI 10.2337/diaspect.28.1.5; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Stringhini S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5452; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Tiller D, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2210-7; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Valdes S, 2009, REV ESP CARDIOL, V62, P528, DOI 10.1016/S0300-8932(09)71033-4; WEINSTEIN ND, 1982, J BEHAV MED, V5, P441, DOI 10.1007/BF00845372	34	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171152	10.1371/journal.pone.0171152	http://dx.doi.org/10.1371/journal.pone.0171152			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141837	Green Published, Green Submitted, gold			2022-12-27	WOS:000396129500045
J	Ge, CZ; Wang, RQ; Chai, YC; Wang, HQ; Kan, MM; Liu, J				Ge, Changzi; Wang, Renqing; Chai, Yanchao; Wang, Haiqing; Kan, Manman; Liu, Jian			High Colonization Possibility of Some Species of Weeds in Suaeda salsa Community: From an Ecological Stoichiometry Perspective	PLOS ONE			English	Article							YELLOW-RIVER ESTUARY; PLANT SPARTINA-ALTERNIFLORA; ORGANIC-CARBON DYNAMICS; N P STOICHIOMETRY; PHOSPHORUS STOICHIOMETRY; NUTRIENT LIMITATION; COASTAL WETLAND; LEAF NITROGEN; SEEDLING EMERGENCE; INTERTIDAL ZONE	Suaeda salsa community is a vegetation type in saline-alkali areas. Weed invasion and colonization in S. salsa communities lead to fragmentationsof S. salsa communities. The colonization of invaded weeds in S. salsa communities is related to community succession of saline-alkali zones. The fragmented S. salsa community may be restored if the mechanism of invaded weed colonization in S. salsa communities is clearly elucidated. Thus, we studied the ecological stoichiometric characteristics of soils and plants in a salt marsh to explain the high colonization possibility of invaded weeds in S. salsa communities. In October 2014, soils and plants were collected from Dongfeng Salt Marsh, Jiaozhou Bay, Shandong Province, China. The ratio of Ex-N/Ex-P in soil was less than 13, which suggests a relative nitrogen limitation for the primary production in the zone. The minimum phosphorus content in plants was higher than 1 mg g(-1), whereas the maximum nitrogen content in plants was less than 13 mg g(-1). These results imply that phosphorus was abundant, whereas nitrogen was deficient in the area. The plants in the salt marsh may be limited by nitrogen. Given the relatively lower nitrogen contents in Cyperus glomeratus, Echinochloa crusgalli, and Aster subulatus than that in S. salsa, these three species exhibited higher competitiveness than S. salsa did when nitrogen was limited in primary production. These weed species may colonize highly in S. salsa communities. Moreover, nitrogen fertilization might be effective to maintain S. salsa community in Dongfeng Salt Marsh, whereas its effects on controlling weeds colonization in S. salsa communities need more studies to verify.	[Ge, Changzi; Wang, Renqing] Shandong Univ, Inst Ecol & Biodivers, Sch Life Sci, Jinan, Peoples R China; [Ge, Changzi; Chai, Yanchao; Wang, Haiqing; Kan, Manman] Shandong Univ, Marine Coll, Weihai, Peoples R China; [Liu, Jian] Shandong Univ, Inst Environm Res, Jinan, Peoples R China	Shandong University; Shandong University; Shandong University	Wang, RQ (corresponding author), Shandong Univ, Inst Ecol & Biodivers, Sch Life Sci, Jinan, Peoples R China.	wrq@sdu.edu.cn	Liu, Jian/AAG-9184-2019; Liu, Jian/T-1760-2017	Liu, Jian/0000-0003-1920-2641; Liu, Jian/0000-0003-1920-2641	Science & Technology Project of Shandong Province [2010GHZ0801, 2012GSF11609, 2014GSF117042]; Independent Innovation Foundation of Shandong University [2011DX008]; National Natural Science Foundation of China [31200426]; China Postdoctoral Science Foundation [2013M541905]; Science & Technology Project of Shenzhen [JCYJ2014041811549187]	Science & Technology Project of Shandong Province; Independent Innovation Foundation of Shandong University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Science & Technology Project of Shenzhen	The work used in this study was jointly funded by the Science & Technology Project of Shandong Province (Nos. 2010GHZ0801, 2012GSF11609 and 2014GSF117042), Independent Innovation Foundation of Shandong University (No. 2011DX008), National Natural Science Foundation of China (No. 31200426), China Postdoctoral Science Foundation (No. 2013M541905), the Science & Technology Project of Shenzhen (No. JCYJ2014041811549187). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek SH, 2015, ESTUAR COAST SHELF S, V163, P265, DOI 10.1016/j.ecss.2014.12.035; Bott T, 2008, NEW PHYTOL, V180, P631, DOI 10.1111/j.1469-8137.2008.02575.x; Chen XinWei, 2016, Research of Environmental Sciences, V29, P538; [崔保山 CUI BaoShan], 2008, [生态学报, Acta Ecologica Sinica], V28, P1408; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; Fang Yong, 2008, Journal of Northeast Forestry University, V36, P89; Figueroa-Espinoza B, 2014, ATMOSFERA, V27, P77, DOI 10.1016/S0187-6236(14)71102-6; Gao YC, 2014, CHEMOSPHERE, V117, P486, DOI 10.1016/j.chemosphere.2014.08.070; Glasby TM, 2015, AQUAT BOT, V120, P251, DOI 10.1016/j.aquabot.2014.09.003; Goloran JB, 2015, ECOL INDIC, V57, P32, DOI 10.1016/j.ecolind.2015.04.018; Guo XH, 2015, APPL SOIL ECOL, V95, P1, DOI 10.1016/j.apsoil.2015.05.010; Gusewell S, 2003, FUNCT ECOL, V17, P754, DOI 10.1111/j.1365-2435.2003.00784.x; Gusewell S, 2002, PERSPECT PLANT ECOL, V5, P37, DOI 10.1078/1433-8319-0000022; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; Hu Wei-Fang, 2014, Chinese Journal of Plant Ecology, V38, P1041, DOI 10.3724/SP.J.1258.2014.00098; Huang LB, 2012, ECOL INFORM, V10, P49, DOI 10.1016/j.ecoinf.2011.11.001; Huang LD, 2015, ESTUAR COAST SHELF S, V157, P93, DOI 10.1016/j.ecss.2014.09.027; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; Li Zheng, 2012, Chinese Journal of Plant Ecology, V36, P1054, DOI 10.3724/SP.J.1258.2012.01054; [林威鹏 Lin Weipeng], 2014, [生态环境学报, Ecology and Environmental Sciences], V23, P1593; Liu SJ, 2012, PROCEDIA ENVIRON SCI, V16, P293, DOI 10.1016/j.proenv.2012.10.041; Ma J. S., 2013, CHECKLIST CHINESE IN; Ma MingRui, 2014, China Environmental Science, V34, P1531; Ma RenTian, 2016, Acta Pedologica Sinica, V53, P1170; [毛培利 MAO Peili], 2011, [生态环境学报, Ecology and Environmental Sciences], V20, P1214; [莫良玉 Mo Liangyu], 2002, [生态学报, Acta Ecologica Sinica], V22, P118; Mou XJ, 2011, J ENVIRON SCI, V23, P958, DOI 10.1016/S1001-0742(10)60530-X; Roth T, 2013, AGR ECOSYST ENVIRON, V178, P121, DOI 10.1016/j.agee.2013.07.002; Song J, 2008, AQUAT BOT, V88, P331, DOI 10.1016/j.aquabot.2007.11.004; Sun PP, 2015, EUR J SOIL BIOL, V70, P58, DOI 10.1016/j.ejsobi.2015.07.004; Sun ZG, 2016, ECOL ENG, V93, P175, DOI 10.1016/j.ecoleng.2016.05.024; Sun ZG, 2015, CATENA, V126, P43, DOI 10.1016/j.catena.2014.10.037; Sun ZG, 2014, J ENVIRON MANAGE, V135, P27, DOI 10.1016/j.jenvman.2014.01.017; [谭向峰 Tan Xiangfeng], 2012, [生态学报, Acta Ecologica Sinica], V32, P5998; Wang Mei, 2014, China Environmental Science, V34, P720; [王顺忠 Wang Shunzhong], 2003, [西北植物学报, Acta Botanica Boreali-Occidentalla Sinica], V23, P550; WASSEN MJ, 1995, J VEG SCI, V6, P5, DOI 10.2307/3236250; Wu TG, 2012, BIOCHEM SYST ECOL, V44, P255, DOI 10.1016/j.bse.2012.06.002; Xi NX, 2014, SOIL BIOL BIOCHEM, V71, P40, DOI 10.1016/j.soilbio.2014.01.008; Xu SJ, 2015, BIOCHEM SYST ECOL, V62, P58, DOI 10.1016/j.bse.2015.07.037; Yang W, 2013, ECOL ENG, V61, P50, DOI 10.1016/j.ecoleng.2013.09.056; Zeng QC, 2016, CATENA, V147, P481, DOI 10.1016/j.catena.2016.07.047; Zhan SX, 2017, ENVIRON EXP BOT, V134, P21, DOI 10.1016/j.envexpbot.2016.10.014; Zhang Ren-yi, 2014, Huanjing Kexue, V35, P1131; Zhang YH, 2010, ATMOS ENVIRON, V44, P4588, DOI 10.1016/j.atmosenv.2010.08.012; Zhang YH, 2010, SOIL BIOL BIOCHEM, V42, P1712, DOI 10.1016/j.soilbio.2010.06.006; Zhao LY, 2008, TIANJING AGR SCI, V14, P56; [赵振勇 Zhao Zhenyong], 2013, [中国沙漠, Journal of Desert Research], V33, P1420; Zhou Fanqi, 2014, Hupo Kexue, V26, P401	50	2	2	6	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170401	10.1371/journal.pone.0170401	http://dx.doi.org/10.1371/journal.pone.0170401			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135313	Green Published, gold, Green Submitted			2022-12-27	WOS:000396124700013
J	Raimi, KT; Stern, PC; Maki, A				Raimi, Kaitlin T.; Stern, Paul C.; Maki, Alexander			The Promise and Limitations of Using Analogies to Improve Decision-Relevant Understanding of Climate Change	PLOS ONE			English	Article							FRAMEWORK; MODELS; BELIEF	To make informed choices about how to address climate change, members of the public must develop ways to consider established facts of climate science and the uncertainties about its future trajectories, in addition to the risks attendant to various responses, including non-response, to climate change. One method suggested for educating the public about these issues is the use of simple mental models, or analogies comparing climate change to familiar domains such as medical decision making, disaster preparedness, or courtroom trials. Two studies were conducted using online participants in the U.S.A. to test the use of analogies to highlight seven key decision-relevant elements of climate change, including uncertainties about when and where serious damage may occur, its unprecedented and progressive nature, and tradeoffs in limiting climate change. An internal meta-analysis was then conducted to estimate overall effect sizes across the two studies. Analogies were not found to inform knowledge about climate literacy facts. However, results suggested that people found the medical analogy helpful and that it led people-especially political conservatives-to better recognize several decision-relevant attributes of climate change. These effects were weak, perhaps reflecting a well-documented and overwhelming effect of political ideology on climate change communication and education efforts in the U.S.A. The potential of analogies and similar education tools to improve understanding and communication in a polarized political environment are discussed.	[Raimi, Kaitlin T.] Univ Michigan, Gerald R Ford Sch Publ Policy, Ann Arbor, MI 48109 USA; [Stern, Paul C.] US Natl Acad Sci Engn & Med, Board Environm Change & Soc, Washington, DC USA; [Stern, Paul C.] Norwegian Univ Sci & Technol, Trondheim, Norway; [Maki, Alexander] Vanderbilt Univ, Vanderbilt Inst Energy & Environm, 221 Kirkland Hall, Nashville, TN 37235 USA; [Maki, Alexander] Vanderbilt Univ, Vanderbilt Climate Change Res Network, 221 Kirkland Hall, Nashville, TN 37235 USA	University of Michigan System; University of Michigan; National Academies of Sciences, Engineering & Medicine; Norwegian University of Science & Technology (NTNU); Vanderbilt University; Vanderbilt University	Raimi, KT (corresponding author), Univ Michigan, Gerald R Ford Sch Publ Policy, Ann Arbor, MI 48109 USA.	kraimi@umich.edu	Raimi, Kaitlin T/N-1872-2013	Raimi, Kaitlin T/0000-0002-3301-9520	Climate Change Research Network	Climate Change Research Network	These studies were funded by the Climate Change Research Network. Funders approved the initial study design, but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, WASHINGTON POST; Belluck P., 2016, NY TIMES; Bessette DL, 2014, ENVIRON SCI TECHNOL, V48, P1401, DOI 10.1021/es4036286; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Broockman D, 2016, SCIENCE, V352, P220, DOI 10.1126/science.aad9713; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Clifford S., 2015, RES POLITICS, V2, DOI [10.1177/2053168015622072, DOI 10.1177/2053168015622072]; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; Dunlap RE, 2016, ENVIRONMENT, V58, P4, DOI 10.1080/00139157.2016.1208995; Feldman L, 2014, J COMMUN, V64, P590, DOI 10.1111/jcom.12108; Gentner D., 2013, OXFORD HDB COGNITIVE, P668; Guy S, 2014, EUR J SOC PSYCHOL, V44, P421, DOI 10.1002/ejsp.2039; Hamilton L. C., 2014, ENVIRON POLIT, P1, DOI [10.1080/09644016.2014.976485, DOI 10.1080/09644016.2014.976485]; Hornsey MJ, 2016, NAT CLIM CHANGE, V6, P622, DOI [10.1038/nclimate2943, 10.1038/NCLIMATE2943]; Kahan DM, 2015, POLIT PSYCHOL, V36, P1, DOI 10.1111/pops.12244; Lewandowsky S, 2012, NATURE CLIMATE CHANG, V2, P1; Maibach EW, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/9/091003; McCright AM, 2016, ENERGY RES SOC SCI, V21, P180, DOI 10.1016/j.erss.2016.08.003; McCright AM, 2016, TOP COGN SCI, V8, P76, DOI 10.1111/tops.12171; McCright AM, 2011, SOCIOL QUART, V52, P155, DOI 10.1111/j.1533-8525.2011.01198.x; Myers TA, 2013, NAT CLIM CHANGE, V3, P343, DOI [10.1038/nclimate1754, 10.1038/NCLIMATE1754]; Nordhaus William D., 2013, CLIM CASINO; Pidgeon N, 2011, NAT CLIM CHANGE, V1, P35, DOI [10.1038/NCLIMATE1080, 10.1038/nclimate1080]; Pielke R.A., 2010, CLIMATE FIX WHAT SCI; Schulz K., 2015, NEW YORKER, DOI [10.7312/asme16957-009, DOI 10.7312/ASME16957-009]; Sifferlin A., 2016, TIME; Sopory P, 2002, HUM COMMUN RES, V28, P382, DOI 10.1093/hcr/28.3.382; StataCorp, 2015, STATA STATISTICAL SO; Sterman JD, 2007, CLIMATIC CHANGE, V80, P213, DOI 10.1007/s10584-006-9107-5; Stern PC, 2015, SOC RES, V82, P581; van der Linden SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118489; van der Linden SL, 2014, CLIMATIC CHANGE, V126, P255, DOI 10.1007/s10584-014-1190-4; Zaval L, 2014, NAT CLIM CHANGE, V4, P143, DOI 10.1038/NCLIMATE2093	34	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171130	10.1371/journal.pone.0171130	http://dx.doi.org/10.1371/journal.pone.0171130			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6PA	28135337	gold, Green Submitted, Green Published			2022-12-27	WOS:000396124700051
J	Kim, J; Jung, I				Kim, Jiyu; Jung, Inkyung			Evaluation of the Gini Coefficient in Spatial Scan Statistics for Detecting Irregularly Shaped Clusters	PLOS ONE			English	Article							LIKELIHOOD	Spatial scan statistics with circular or elliptic scanning windows are commonly used for cluster detection in various applications, such as the identification of geographical disease clusters from epidemiological data. It has been pointed out that the method may have difficulty in correctly identifying non-compact, arbitrarily shaped clusters. In this paper, we evaluated the Gini coefficient for detecting irregularly shaped clusters through a simulation study. The Gini coefficient, the use of which in spatial scan statistics was recently proposed, is a criterion measure for optimizing the maximum reported cluster size. Our simulation study results showed that using the Gini coefficient works better than the original spatial scan statistic for identifying irregularly shaped clusters, by reporting an optimized and refined collection of clusters rather than a single larger cluster. We have provided a real data example that seems to support the simulation results. We think that using the Gini coefficient in spatial scan statistics can be helpful for the detection of irregularly shaped clusters.	[Kim, Jiyu; Jung, Inkyung] Yonsei Univ, Coll Med, Dept Biostat & Med Informat, Seoul, South Korea	Yonsei University; Yonsei University Health System	Jung, I (corresponding author), Yonsei Univ, Coll Med, Dept Biostat & Med Informat, Seoul, South Korea.	ijung@yuhs.ac		Jung, Inkyung/0000-0003-3780-3213	National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea [1420230]	National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (1420230), https://ncc.re.kr/main.nccuri=english/sub04_ControlPrograms.	Abrams AM, 2010, INT J HEALTH GEOGR, V9, P1; Assuncao R, 2006, STAT MED, V25, P723, DOI 10.1002/sim.2411; Cancado ALF, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-55; Costa MA, 2012, COMPUT STAT DATA AN, V56, P1771, DOI 10.1016/j.csda.2011.11.001; Duczmal L, 2006, J COMPUT GRAPH STAT, V15, P428, DOI 10.1198/106186006X112396; Duczmal L, 2004, COMPUT STAT DATA AN, V45, P269, DOI 10.1016/S0167-9473(02)00302-X; Duczmal L, 2007, COMPUT STAT DATA AN, V52, P43, DOI 10.1016/j.csda.2007.01.016; Fei S., 2010, INT J FORESTRY RES; Han J, 2016, INT J HEALTH GEOGR, V15, DOI 10.1186/s12942-016-0056-6; Huang L, 2007, BIOMETRICS, V63, P109, DOI 10.1111/j.1541-0420.2006.00661.x; Jung I, 2007, STAT MED, V26, P1594, DOI 10.1002/sim.2607; Jung IY, 2015, STAT MED, V34, P504, DOI 10.1002/sim.6347; Jung I, 2012, STAT MED, V31, P4040, DOI 10.1002/sim.5475; Jung I, 2010, STAT MED, V29, P1910, DOI 10.1002/sim.3951; Kaza N, 2013, URBAN STUD, V50, P3262, DOI 10.1177/0042098013484540; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M., 2016, SATSCANTM V9 3 SOFTW; Kulldorff M, 2006, STAT MED, V25, P3929, DOI 10.1002/sim.2490; Kulldorff M, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-58; Leitner M, 2011, CARTOGR GEOGR INF SC, V38, P214, DOI 10.1559/15230406382214; Minamisava R, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-66; Bidin CM, 2010, ASTRON ASTROPHYS, V510, DOI 10.1051/0004-6361/200912761; Orozco CV, 2012, GEOINFORMATICA, V16, P653, DOI 10.1007/s10707-012-0161-z; Patil GP, 2004, ENVIRON ECOL STAT, V11, P183, DOI 10.1023/B:EEST.0000027208.48919.7e; Ribeiro SHR, 2012, SPAT SPATIO-TEMPORAL, V3, P107, DOI 10.1016/j.sste.2012.04.004; Takahashi K, 2006, STAT MED, V25, P841, DOI 10.1002/sim.2419; Takahashi K, 2010, FLEXSCAN V3 1 SOFTWA; Tango T, 2000, STAT MED, V19, P191, DOI 10.1002/(SICI)1097-0258(20000130)19:2<191::AID-SIM281>3.0.CO;2-Q; Tango T., 2008, JAPAN J BIOM, V29, P75, DOI [10.5691/jjb.29.75, DOI 10.5691/JJB.29.75]; Tango T, 2012, STAT MED, V31, P4207, DOI 10.1002/sim.5478; Tango Toshiro, 2005, Int J Health Geogr, V4, P11, DOI 10.1186/1476-072X-4-11	31	10	10	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170736	10.1371/journal.pone.0170736	http://dx.doi.org/10.1371/journal.pone.0170736			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129368	Green Submitted, Green Published, gold			2022-12-27	WOS:000396211400042
J	Lee, J; Shin, JS; Lee, YJ; Kim, MR; Choi, A; Lee, JH; Shin, KM; Shin, BC; Cho, JH; Ha, IH				Lee, Jinho; Shin, Joon-Shik; Lee, Yoon Jae; Kim, Me-riong; Choi, Areum; Lee, Jun-Hwan; Shin, Kyung-Min; Shin, Byung-Cheul; Cho, Jae-Heung; Ha, In-Hyuk			Long-Term Course of Failed Back Surgery Syndrome (FBSS) Patients Receiving Integrative Korean Medicine Treatment: A 1 Year Prospective Observational Multicenter Study	PLOS ONE			English	Article							SPINAL-CORD STIMULATION; RANDOMIZED CONTROLLED-TRIAL; NEUROPATHIC PAIN; TRADITIONAL MEDICINE; HEALTH SURVEY; MANAGEMENT; QUALITY; COMPLEMENTARY; ACUPUNCTURE; HERNIATION	Background With increase of spine surgeries, failed back surgery syndrome (FBSS) prevalence is also rising. While complementary and alternative medicine (CAM) is commonly used for low back pain (LBP), there are no studies reporting use of integrative Korean medicine in FBSS patients. Methods Patients with pain continuing after back surgery or recurring within 1 year and visual analogue scale (VAS) of LBP or leg pain of >= 6 (total n = 120) were recruited at 2 hospital sites from November 2011 to September 2014. Weekly sessions of integrative Korean medicine treatment were conducted for 16 weeks (herbal medicine, acupuncture/electroacupuncture, pharmacopuncture/bee venom pharmacopuncture, and Chuna manual therapy) with additional follow-ups at 24 weeks and 1 year. Outcome measures included VAS of LBP and leg pain (primary outcome), Oswestry Disability Index (ODI), Short-Form 36 (SF-36), medical use, and patient global impression of change (PGIC). Results VAS of LBP and leg pain improved at 6 months (LBP from 6.1 +/- 2.0 at baseline to 2.9 +/- 2.3; and leg pain from 5.4 +/- 2.6 to 2.4 +/- 2.5, respectively). Eighty patients (66.7%) showed improvement of 50% or more in main pain of LBP or leg pain from baseline. Disability and quality of life also improved at 6 months (ODI from 41.3 +/- 12.3 at baseline to 23.6 +/- 13.6; and SF-36 from 42.8 +/- 14.5 to 62.7 +/- 16.8). At 1 year follow-up, conventional medical management use decreased, improvement in pain and disability was maintained, and 79.2% reported improvement of PGIC. Conclusions Despite limitations as an observational study, integrative Korean medicine treatment showed positive results in pain, function, and quality of life of FBSS patients.	[Lee, Jinho; Shin, Joon-Shik; Lee, Yoon Jae; Kim, Me-riong; Choi, Areum; Ha, In-Hyuk] Jaseng Med Fdn, Jaseng Spine & Joint Res Inst, Seoul, South Korea; [Lee, Jun-Hwan; Shin, Kyung-Min] Korea Inst Oriental Med, Div Clin Res, Daejeon, South Korea; [Lee, Jun-Hwan] Univ Sci & Technol, Korean Med Life Sci, Campus Korea Inst Oriental Med, Daejeon, South Korea; [Shin, Kyung-Min] Pusan Natl Univ, Sch Korean Med, Div Clin Med, Yangsan, South Korea; [Cho, Jae-Heung] Kyung Hee Univ, Dept Korean Rehabil Med, Seoul, South Korea	Korea Institute of Oriental Medicine (KIOM); Korea Institute of Oriental Medicine (KIOM); University of Science & Technology (UST); Pusan National University; Kyung Hee University	Ha, IH (corresponding author), Jaseng Med Fdn, Jaseng Spine & Joint Res Inst, Seoul, South Korea.	hanihata@gmail.com	Shin, Kyung-Min/AAO-9382-2020; Lee, Yoon Jae/ABA-8808-2020	Lee, Yoon Jae/0000-0002-1532-0942; Shin, Joon-Shik/0000-0001-5488-3273; Lee, Jinho/0000-0003-0672-6892; HA, IN-HYUK/0000-0002-5020-6723	Korea Institute of Oriental Medicine [K16123]	Korea Institute of Oriental Medicine	This study was supported by a grant from the Korea Institute of Oriental Medicine (K16123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant from the Korea Institute of Oriental Medicine (K16123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank Ki Byung Park for his help in statistical analysis.	[Anonymous], 1991, GUIDE CLIN TRIALS, P565; Brox JI, 2006, PAIN, V122, P145, DOI 10.1016/j.pain.2006.01.027; Brunelli B, 2004, J NEUROL SCI, V218, P59, DOI 10.1016/j.jns.2003.10.013; Chung HJ, 2010, J ETHNOPHARMACOL, V130, P450, DOI 10.1016/j.jep.2010.05.020; Deyo RA, 2006, CLIN ORTHOP RELAT R, P139, DOI 10.1097/01.blo.0000198726.62514.75; Deyo RA, 2009, EUR SPINE J, V18, pS331, DOI 10.1007/s00586-009-0908-x; Doth AH, 2010, PAIN, V149, P338, DOI 10.1016/j.pain.2010.02.034; Eldabe S, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-189; Evidence-based Korean Medicine Clinical Practice Guideline Development Committee for Lumbar Herniated Intervertebral Disc(Korea Institute of Oriental Medicine and the Society of Korean Medicine Rehabilitation), 2014, KOREAN MEDICINE CLIN; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Fritzell P, 2003, EUR SPINE J, V12, P178, DOI 10.1007/s00586-002-0493-8; Furlan AD, 2005, SPINE, V30, P944, DOI 10.1097/01.brs.0000158941.21571.01; Han CW, 2004, TOHOKU J EXP MED, V203, P189, DOI 10.1620/tjem.203.189; Hussain A, 2014, PAIN PRACT, V14, P64, DOI 10.1111/papr.12035; Jeon CH, 2006, J KOREAN MED SCI, V21, P1092, DOI 10.3346/jkms.2006.21.6.1092; Kim JK, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/730907; Kim Tae, 2011, Open Neuroimag J, V5, P136, DOI 10.2174/1874440001105010136; Kumar K, 2007, PAIN, V132, P179, DOI 10.1016/j.pain.2007.07.028; Kvachadze I, 2015, Georgian Med News, P102; Lee MS, 2008, J PAIN, V9, P289, DOI 10.1016/j.jpain.2007.11.012; Manca A, 2008, EUR J PAIN, V12, P1047, DOI 10.1016/j.ejpain.2008.01.014; Moon TW, 2013, CHIN J INTEGR MED, V19, P228, DOI 10.1007/s11655-012-1238-0; National Center for Health Statistics, 1997, NAT HOSP DISCH SURV, V13; NORTH RB, 1991, NEUROSURGERY, V28, P685, DOI 10.1227/00006123-199105000-00008; Park JJ, 2010, COMPLEMENT THER MED, V18, P78, DOI 10.1016/j.ctim.2010.02.003; Park YG, 2013, J ETHNOPHARMACOL, V149, P816, DOI 10.1016/j.jep.2013.08.008; Peul WC, 2007, NEW ENGL J MED, V356, P2245, DOI 10.1056/NEJMoa064039; Rahimzadeh P, 2014, PAIN PHYSICIAN, V17, pE75; Rigoard P, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-376; Robinson N, 2012, EUR J INTEGR MED, V4, pE363, DOI 10.1016/j.eujim.2012.10.001; Rubinstein SM, 2010, EUR SPINE J, V19, P1213, DOI 10.1007/s00586-010-1356-3; Shin JS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005801; Shin JS, 2016, SPINE PHILA PA 1976; Shin YS, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0956-1; Stevens L, 2007, J ALTERN COMPLEM MED, V13, P481, DOI 10.1089/acm.2007.6263; Taylor RS, 2012, BRIT J PAIN, V6, P174, DOI 10.1177/2049463712470887; TURK DC, 1993, PAIN, V53, P3, DOI 10.1016/0304-3959(93)90049-U; VANTULDER MW, 1995, PAIN, V62, P233, DOI 10.1016/0304-3959(94)00272-G; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WEBER H, 1983, SPINE, V8, P131, DOI 10.1097/00007632-198303000-00003; Wilkinson HA., 1991, FAILED BACK SYNDROME; World Health Organization, 2005, US WHO UMC SYST STAN	43	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170972	10.1371/journal.pone.0170972	http://dx.doi.org/10.1371/journal.pone.0170972			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129399	gold, Green Published, Green Submitted			2022-12-27	WOS:000396211400015
J	Tung, YC; Chang, GM; Chang, HY; Yu, TH				Tung, Yu-Chi; Chang, Guann-Ming; Chang, Hsien-Yen; Yu, Tsung-Hsien			Relationship between Early Physician Follow-Up and 30-Day Readmission after Acute Myocardial Infarction and Heart Failure	PLOS ONE			English	Article							PRIMARY-CARE PHYSICIAN; EMERGENCY-DEPARTMENT; CHEST-PAIN; OUTCOMES; RISK; ASSOCIATION; TAIWAN; CONTINUITY; ADMISSIONS; MANAGEMENT	Background Thirty-day readmission rates after acute myocardial infarction (AMI) and heart failure are important patient outcome metrics. Early post-discharge physician follow-up has been promoted as a method of reducing 30-day readmission rates. However, the relationships between early post-discharge follow-up and 30-day readmission for AMI and heart failure are inconclusive. We used nationwide population-based data to examine associations between 7-day physician follow-up and 30-day readmission, and further associations of 7-day same physician (during the index hospitalization and at follow-up) and cardiologist follow- up with 30-day readmission for non-ST-segment-elevation myocardial infarction (NSTEMI) or heart failure. Methods We analyzed all patients 18 years or older with NSTEMI and heart failure and discharged from hospitals in 2010 in Taiwan through Taiwan's National Health Insurance Research Database. Cox proportional hazard models with robust sandwich variance estimates and propensity score weighting were performed after adjustment for patient and hospital characteristics to test associations between 7-day physician follow-up and 30-day readmission. Results The study population for NSTEMI and heart failure included 5,008 and 13,577 patients, respectively. Early physician follow-up was associated with a lower hazard ratio of readmission compared with no early physician follow-up for patients with NSTEMI (hazard ratio [HR], 0.47; 95% confidence interval [CI], 0.39-0.57), and for patients with heart failure (HR, 0.54; 95% CI, 0.48-0.60). Same physician follow-up was associated with a reduced hazard ratio of readmission compared with different physician follow-up for patients with NSTEMI (HR, 0.56; 95% CI, 0.48-0.65), and for patients with heart failure (HR, 0.69; 95% CI, 0.62-0.76). Conclusions For each condition, patients who have an outpatient visit with a physician within 7 days of discharge have a lower risk of 30- day readmission. Moreover, patients who have an outpatient visit with the same physician within 7 days of discharge have a much lower risk of 30-day readmission.	[Tung, Yu-Chi] Natl Taiwan Univ, Inst Hlth Policy & Management, Taipei, Taiwan; [Chang, Guann-Ming] Cardinal Tien Hosp, Dept Family Med, New Taipei, Taiwan; [Chang, Guann-Ming] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan; [Chang, Hsien-Yen] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Drug Safety & Effectiveness, Baltimore, MD USA; [Yu, Tsung-Hsien] Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan	National Taiwan University; Fu Jen Catholic University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Taipei University of Nursing & Health Science (NTUNHS)	Yu, TH (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan.	ericthyu@ntu.edu.tw	Chang, Hsien-Yen/E-4627-2014; Tung, Yu-Chi/V-1036-2019	Chang, Hsien-Yen/0000-0002-7997-4822; Tung, Yu-Chi/0000-0001-9031-8749; CHANG, HAO-YUAN/0000-0001-5810-7562; Yu, Tsung-Hsien/0000-0002-6874-989X	Taiwan Ministry of Science and Technology [MOST 103-2410-H-002-209-MY2, MOST 105-2410-H-002-220-MY2]	Taiwan Ministry of Science and Technology	Taiwan Ministry of Science and Technology provides the financial support (MOST 103-2410-H-002-209-MY2 and MOST 105-2410-H-002-220-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam EA, 2014, J AM COLL CARDIOL, V64, P2645, DOI [10.1016/j.jacc.2014.09.016, 10.1016/j.jacc.2014.09.017]; Andersson C, 2014, J AM COLL CARDIOL, V64, P247, DOI 10.1016/j.jacc.2014.04.042; Centers for Medicare and Medicaid Services, 2015, OUTC MEAS 2015; Centers for Medicare & Medicaid Services, 2014, READM RED PROGR; Chang HY, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1585; Chang HY, 2015, ASIA-PAC J PUBLIC HE, V27, pNP958, DOI 10.1177/1010539512471073; Chiu HY, 2016, TAIWAN J PUBLIC HLTH, V35, P66; Ciccone MM, 2010, VASC HEALTH RISK MAN, V6, P297; Coleman EA, 2007, J HOSP MED, V2, P287, DOI 10.1002/jhm.276; Czarnecki A, 2014, AM HEART J, V168, P289, DOI 10.1016/j.ahj.2014.05.016; Czarnecki A, 2013, CIRCULATION, V127, P1386, DOI 10.1161/CIRCULATIONAHA.112.000737; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Ezekowitz JA, 2005, CAN MED ASSOC J, V172, P189, DOI 10.1503/cmaj.1032017; Field TS, 2015, J GEN INTERN MED, V30, P565, DOI 10.1007/s11606-014-3106-4; Geronimus AT, 1996, J AM STAT ASSOC, V91, P529, DOI 10.2307/2291645; Glickman SW, 2012, AM HEART J, V163, P372, DOI 10.1016/j.ahj.2011.10.021; Hernandez AF, 2010, JAMA-J AM MED ASSOC, V303, P1716, DOI 10.1001/jama.2010.533; Hess CN, 2013, CIRCULATION, V128, P1206, DOI 10.1161/CIRCULATIONAHA.113.004569; Huang IC, 2005, HEALTH SERV RES, V40, P253, DOI 10.1111/j.1475-6773.2005.00352.x; Institute of Medicine, 2007, REW PROV PERF AL INC; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Krumholz HM, 2013, JAMA-J AM MED ASSOC, V309, P587, DOI 10.1001/jama.2013.333; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; Lee KK, 2016, MED CARE, V54, P365, DOI 10.1097/MLR.0000000000000492; Leendertse AJ, 2008, ARCH INTERN MED, V168, P1890, DOI 10.1001/archinternmed.2008.3; Lin YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062492; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; McAlister FA, 2013, CAN MED ASSOC J, V185, pE681, DOI 10.1503/cmaj.130048; Medicare Payment Advisory Commission, 2007, PROM GREAT EFF MED R; O'Gara PT, 2013, CIRCULATION, V127, P529, DOI 10.1161/CIR.0b013e3182742c84; Roux AVD, 2004, EPIDEMIOL REV, V26, P104, DOI 10.1093/epirev/mxh006; Ryan J, 2013, AM J MED, V126, P989, DOI 10.1016/j.amjmed.2013.06.027; SCHWARTZ S, 1994, AM J PUBLIC HEALTH, V84, P819, DOI 10.2105/AJPH.84.5.819; SUSSER M, 1994, AM J PUBLIC HEALTH, V84, P825, DOI 10.2105/AJPH.84.5.825; Tung YC, 2015, CIRC-CARDIOVASC QUAL, V8, P30, DOI 10.1161/CIRCOUTCOMES.114.001086; Tung YC, 2014, MED CARE, V52, P519, DOI 10.1097/MLR.0000000000000132; Tung YC, 2009, MED CARE, V47, P1018, DOI 10.1097/MLR.0b013e3181a81144; van Walraven C, 2004, J GEN INTERN MED, V19, P624, DOI 10.1111/j.1525-1497.2004.30082.x; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yang G, 2015, REV PROPENSITY SCORE; Yeung DF, 2012, CAN MED ASSOC J, V184, pE765, DOI 10.1503/cmaj.111958; Yu TH, 2015, INT J QUAL HEALTH C, V27, P361, DOI 10.1093/intqhc/mzv050; Zhang YT, 2014, AM J MANAG CARE, V20, pE498	45	46	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170061	10.1371/journal.pone.0170061	http://dx.doi.org/10.1371/journal.pone.0170061			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7VX	28129332	Green Submitted, gold, Green Published			2022-12-27	WOS:000396211400064
J	Barauna, RA; Ramos, RTJ; Veras, AAO; Pinheiro, KC; Benevides, LJ; Viana, MVC; Guimaraes, LC; Edman, JM; Spier, SJ; Azevedo, V; Silva, A				Barauna, Rafael A.; Ramos, Rommel T. J.; Veras, Adonney A. O.; Pinheiro, Kenny C.; Benevides, Leandro J.; Viana, Marcus V. C.; Guimaraes, Luis C.; Edman, Judy M.; Spier, Sharon J.; Azevedo, Vasco; Silva, Artur			Assessing the Genotypic Differences between Strains of Corynebacterium pseudotuberculosis biovar equi through Comparative Genomics	PLOS ONE			English	Article							PIGEON FEVER; PAN-GENOME; SEQUENCE; INFECTION; HORSES; TOOL; VISUALIZATION; NETWORKS; INSIGHTS; ARTEMIS	Seven genomes of Corynebacterium pseudotuberculosis biovar equi were sequenced on the Ion Torrent PGM platform, generating high-quality scaffolds over 2.35 Mbp. This bacterium is the causative agent of disease known as "pigeon fever" which commonly affects horses worldwide. The pangenome of biovar equi was calculated and two phylogenomic approaches were used to identify clustering patterns within Corynebacterium genus. Furthermore, other comparative analyses were performed including the prediction of genomic islands and prophages, and SNP-based phylogeny. In the phylogenomic tree, C. pseudotuberculosis was divided into two distinct clades, one formed by nitrate non-reducing species (biovar ovis) and another formed by nitrate-reducing species (biovar equi). In the latter group, the strains isolated from California were more related to each other, while the strains CIP 52.97 and 1/06-A formed the outermost clade of the biovar equi. A total of 1,355 core genes were identified, corresponding to 42.5% of the pangenome. This pangenome has one of the smallest core genomes described in the literature, suggesting a high genetic variability of biovar equi of C. pseudotuberculosis. The analysis of the similarity between the resistance islands identified a higher proximity between the strains that caused more severe infectious conditions (infection in the internal organs). Pathogenicity islands were largely conserved between strains. Several genes that modulate the pathogenicity of C. pseudotuberculosis were described including peptidases, recombination enzymes, micoside synthesis enzymes, bacteriocins with antimicrobial activity and several others. Finally, no genotypic differences were observed between the strains that caused the three different types of infection (external abscess formation, infection with abscess formation in the internal organs, and ulcerative lymphangitis). Instead, it was noted that there is a higher phenetic correlation between strains isolated at California compared to the other strains. Additionally, high variability of resistance islands suggests gene acquisition through several events of horizontal gene transfer.	[Barauna, Rafael A.; Ramos, Rommel T. J.; Veras, Adonney A. O.; Pinheiro, Kenny C.; Guimaraes, Luis C.; Silva, Artur] Fed Univ Para, Inst Biol Sci, Ctr Genom & Syst Biol, Lab Genom & Bioinformat, Belem, Para, Brazil; [Benevides, Leandro J.; Viana, Marcus V. C.; Azevedo, Vasco] Univ Fed Minas Gerais, Inst Biol Sci, Lab Cellular & Mol Genet, Belo Horizonte, MG, Brazil; [Edman, Judy M.; Spier, Sharon J.] Univ Calif Davis, Dept Med & Epidemiol, Sch Vet Med, Davis, CA 95616 USA	Universidade Federal do Para; Universidade Federal de Minas Gerais; University of California System; University of California Davis	Barauna, RA (corresponding author), Fed Univ Para, Inst Biol Sci, Ctr Genom & Syst Biol, Lab Genom & Bioinformat, Belem, Para, Brazil.	rabarauna@ufpa.br	Ramos, Rommel Thiago Juca/L-9329-2013; Luiz Silva, Artur da Costa da/AAI-3516-2021; Azevedo, Vasco A.C/F-4315-2011; Veras, Adonney Allan de Oliveira/AAK-6488-2020; Guimarães, Luis/T-7186-2019; Azevedo, Vasco/B-1556-2019; Guimaraes, Luis Carlos/J-5689-2015	Ramos, Rommel Thiago Juca/0000-0002-8032-1474; Luiz Silva, Artur da Costa da/0000-0002-4082-1132; Azevedo, Vasco A.C/0000-0002-4775-2280; Veras, Adonney Allan de Oliveira/0000-0002-7227-0590; Azevedo, Vasco/0000-0002-4775-2280; Canario Viana, Marcus Vinicius/0000-0002-7017-6437; Guimaraes, Luis Carlos/0000-0002-7147-9448	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039107; Aleman M, 1996, J AM VET MED ASSOC, V209, P804; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Almeida S, 2016, STAND GENOMIC SCI, V11, DOI 10.1186/s40793-016-0149-7; Araujo CLD, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00176-16; Azad AK, 1996, P NATL ACAD SCI USA, V93, P4787, DOI 10.1073/pnas.93.10.4787; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Barauna RA, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00977-14; BIBERSTEIN EL, 1971, VET REC, V89, P691, DOI 10.1136/vr.89.26.691; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Boysen C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140666; Britz E, 2014, VET J, V200, P282, DOI 10.1016/j.tvjl.2014.03.009; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cavalcante ALQ, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01385-15; Cerdeira LT, 2011, J BACTERIOL, V193, P7025, DOI 10.1128/JB.06293-11; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Deng XY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-500; Doherr MG, 1998, PREV VET MED, V35, P229, DOI 10.1016/S0167-5877(98)00071-3; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; Gorminet M, 2001, MOL MICROBIOL, V40, P963; Grabowska M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14833; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Hall K, 2001, J EQUINE VET SCI, V21, P284, DOI 10.1016/S0737-0806(01)70058-5; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kilcoyne I, 2014, JAVMA-J AM VET MED A, V245, P309, DOI 10.2460/javma.245.3.309; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; McMullan G, 2004, BIOCHEM SOC T, V32, P214, DOI 10.1042/BST0320214; Pacheco LGC, 2007, J MED MICROBIOL, V56, P480, DOI 10.1099/jmm.0.46997-0; Parret AHA, 2002, TRENDS MICROBIOL, V10, P107, DOI 10.1016/S0966-842X(02)02307-7; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Rhodes DM, 2015, J VET INTERN MED, V29, P327, DOI 10.1111/jvim.12534; Rissman AI, 2009, BIOINFORMATICS, V25, P2071, DOI 10.1093/bioinformatics/btp356; RUIMY R, 1995, INT J SYST BACTERIOL, V45, P740, DOI 10.1099/00207713-45-4-740; Sahl JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054287; Santos AR, 2013, GENET MOL RES, V12, P2982, DOI 10.4238/2013.August.16.2; Silva A, 2012, J BACTERIOL, V194, P6663, DOI 10.1128/JB.01782-12; Silva A, 2011, J BACTERIOL, V193, P323, DOI 10.1128/JB.01211-10; Soares SC, 2015, J BIOTECHNOL; Soares SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053818; Spier SJ, 2012, VET REC, V170, DOI 10.1136/vr.100543; Spier SJ, 2004, AM J VET RES, V65, P829, DOI 10.2460/ajvr.2004.65.829; Sutherland SS, 1996, VET MICROBIOL, V49, P1, DOI 10.1016/0378-1135(95)00146-8; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; Szonyi B, 2014, J EQUINE VET SCI, V34, P281, DOI 10.1016/j.jevs.2013.06.006; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Trost E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-728; Veltri D, 2016, NUCLEIC ACIDS RES, V44, pW41, DOI 10.1093/nar/gkw330; Wang CH, 2005, INFECT IMMUN, V73, P2881, DOI 10.1128/IAI.73.5.2881-2890.2005; Yeruham I, 1996, VET QUART, V18, P87, DOI 10.1080/01652176.1996.9694623; Zhao YB, 2012, BIOINFORMATICS, V28, P416, DOI 10.1093/bioinformatics/btr655; Zhou Y, 2011, NUCL ACIDS RES	53	11	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170676	10.1371/journal.pone.0170676	http://dx.doi.org/10.1371/journal.pone.0170676			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125655	gold, Green Published			2022-12-27	WOS:000396176100076
J	Lin, IH; Chen, YF; Hsu, MT				Lin, I-Hsuan; Chen, Yi-Fan; Hsu, Ming-Ta			Correlated 5-Hydroxymethylcytosine (5hmC) and Gene Expression Profiles Underpin Gene and Organ-Specific Epigenetic Regulation in Adult Mouse Brain and Liver	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; DNA DEMETHYLATION; GENOMIC FEATURES; BASE-RESOLUTION; DYNAMICS; CANCER; DIFFERENTIATION; METHYLATION; NEURONS; TRANSCRIPTION	Background DNA methylation is an epigenetic mechanism essential for gene regulation and vital for mammalian development. 5-hydroxymethylcytosine (5hmC) is the first oxidative product of the TET-mediated 5-methylcytosine (5mC) demethylation pathway. Aside from being a key intermediate in cytosine demethylation, 5hmC may have potential regulatory functions with emerging importance in mammalian biology. Methods Here, we investigate the global 5hmC enrichment in five brain structures, including cerebellum, cerebral cortex, hippocampus, hypothalamus and thalamus, as well as liver tissues from female and male adult mice by using chemical capture-based technique coupled with next-generation sequencing. At the same time, we carried out total RNA sequencing (RNAseq) to analyze the transcriptomes of brain regions and liver tissues. Results Our results reveal preferential 5hmC enrichment in the gene bodies of expressed genes, and 5hmC levels of many protein-coding genes are positively correlated with RNA expression intensity. However, more than 75% of genes with low or no 5hmC enrichment are genes encode for mitochondrial proteins and ribosomal proteins despite being actively transcribed, implying different transcriptional regulation mechanisms of these housekeeping genes. Brain regions developed from the same embryonic structures have more similar 5hmC profiles. Also, the genic 5hmC enrichment pattern is highly tissue-specific, and 5hmC marks genes involving in tissue-specific biological processes. Sex chromosomes are mostly depleted of 5hmC, and the X inactive specific transcript (Xist) gene located on the X chromosome is the only gene to show sex-specific 5hmC enrichment. Conclusions This is the first report of the whole-genome 5hmC methylome of five major brain structures and liver tissues in mice of both sexes. This study offers a comprehensive resource for future work of mammalian cytosine methylation dynamics. Our findings offer additional evidence that suggests 5hmC is an active epigenetic mark stably maintained after the global reprogramming event during early embryonic development.	[Lin, I-Hsuan; Chen, Yi-Fan] Natl Yang Ming Univ, VYM Genome Res Ctr, Taipei, Taiwan; [Lin, I-Hsuan] Taipei Med Univ, Ctr Translat Med, Taipei, Taiwan; [Chen, Yi-Fan] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Translat Med, Taipei, Taiwan; [Hsu, Ming-Ta] Natl Yang Ming Univ, Inst Biomed Informat, Taipei, Taiwan; [Hsu, Ming-Ta] Chien Tien Hsu Canc Res Fdn, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei Medical University; Taipei Medical University; National Yang Ming Chiao Tung University	Hsu, MT (corresponding author), Natl Yang Ming Univ, Inst Biomed Informat, Taipei, Taiwan.	mth@ym.edu.tw	Chen, Yi-Fan/AAP-1427-2020; Lin, I-Hsuan/N-6501-2013	Chen, Yi-Fan/0000-0002-0793-8769; Lin, I-Hsuan/0000-0002-6207-1299	Ministry of Education; National Core Facility Program for Biotechnology (NCFPB), Ministry of Science and Technology, Taiwan [MOST 104-2319-B-010-001]	Ministry of Education; National Core Facility Program for Biotechnology (NCFPB), Ministry of Science and Technology, Taiwan	This work was supported by a grant from the Ministry of Education, Aim for the Top University Plan. The Core Facility of VYM Genome Research Center is supported by the National Core Facility Program for Biotechnology (NCFPB), Ministry of Science and Technology, Taiwan (MOST 104-2319-B-010-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Amouroux R, 2016, NAT CELL BIOL, V18, P225, DOI 10.1038/ncb3296; Bachman M, 2014, NAT CHEM, V6, P1049, DOI [10.1038/nchem.2064, 10.1038/NCHEM.2064]; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chapman CG, 2015, SCI REP-UK, V5, DOI 10.1038/srep17568; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Colquitt BM, 2013, P NATL ACAD SCI USA, V110, P14682, DOI 10.1073/pnas.1302759110; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Frauer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021306; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Greco CM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12418; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo F, 2014, CELL STEM CELL, V15, P447, DOI 10.1016/j.stem.2014.08.003; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hahn MA, 2013, CELL REP, V3, P291, DOI 10.1016/j.celrep.2013.01.011; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Jin SG, 2011, NUCLEIC ACIDS RES, V39, P5015, DOI 10.1093/nar/gkr120; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WW, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/870726; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lunnon K, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0871-x; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Mariani Christopher J, 2013, Cancers (Basel), V5, P786, DOI 10.3390/cancers5030786; Maurano MT, 2015, CELL REP, V12, P1184, DOI 10.1016/j.celrep.2015.07.024; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Nestor CE, 2012, GENOME RES, V22, P467, DOI 10.1101/gr.126417.111; Pfeifer GP, 2014, CELL TISSUE RES, V356, P631, DOI 10.1007/s00441-014-1896-7; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruzov A, 2011, CELL RES, V21, P1332, DOI 10.1038/cr.2011.113; Saksouk N, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/1756-8935-8-3; Seisenberger S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0330; Serandour AA, 2011, GENOME RES, V21, P555, DOI 10.1101/gr.111534.110; Shen L, 2014, CELL STEM CELL, V15, P459, DOI 10.1016/j.stem.2014.09.002; Shi XJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153100; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Szulwach KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002154; Taylor SEB, 2016, J BONE MINER RES, V31, P524, DOI 10.1002/jbmr.2711; Tekpli X, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0070-8; Tsagaratou A, 2014, P NATL ACAD SCI USA, V111, pE3306, DOI 10.1073/pnas.1412327111; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vasanthakumar A, 2015, CANCER GENET-NY, V208, P167, DOI 10.1016/j.cancergen.2015.02.009; Weber AR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10806; Wen L, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r49; Wu H, 2015, NAT STRUCT MOL BIOL, V22, P1, DOI 10.1038/nsmb.3071; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Yamaguchi S, 2012, NATURE, V492, P443, DOI 10.1038/nature11709; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67; Yang Q, 2013, J BIOMED NANOTECHNOL, V9, P1607, DOI 10.1166/jbn.2013.1713; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang LY, 2016, JPN J CLIN ONCOL, V46, P427, DOI 10.1093/jjco/hyw002	62	41	42	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170779	10.1371/journal.pone.0170779	http://dx.doi.org/10.1371/journal.pone.0170779			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125731	Green Published, gold, Green Submitted			2022-12-27	WOS:000396176100053
J	Secore, S; Wang, S; Doughtry, J; Xie, JF; Miezeiewski, M; Rustandi, RR; Horton, M; Xoconostle, R; Wang, B; Lancaster, C; Kristopeit, A; Wang, SC; Christanti, S; Vitelli, S; Gentile, MP; Goerke, A; Skinner, J; Strable, E; Thiriot, DS; Bodmer, JL; Heinrichs, JH				Secore, Susan; Wang, Su; Doughtry, Julie; Xie, Jinfu; Miezeiewski, Matt; Rustandi, Richard R.; Horton, Melanie; Xoconostle, Rachel; Wang, Bei; Lancaster, Catherine; Kristopeit, Adam; Wang, Sheng-Ching; Christanti, Sianny; Vitelli, Salvatore; Gentile, Marie-Pierre; Goerke, Aaron; Skinner, Julie; Strable, Erica; Thiriot, David S.; Bodmer, Jean-Luc; Heinrichs, Jon H.			Development of a Novel Vaccine Containing Binary Toxin for the Prevention of Clostridium difficile Disease with Enhanced Efficacy against NAP1 Strains	PLOS ONE			English	Article							MEASURE NEUTRALIZING ANTIBODIES; ADP-RIBOSYLTRANSFERASE; ENZYMATIC COMPONENT; CLINICAL-FEATURES; TOXOID VACCINE; EPIDEMIC; ACTIN; OPTIMIZATION; INFECTIONS; GUIDELINES	Clostridium difficile infections (CDI) are a leading cause of nosocomial diarrhea in the developed world. The main virulence factors of the bacterium are the large clostridial toxins (LCTs), TcdA and TcdB, which are largely responsible for the symptoms of the disease. Recent outbreaks of CDI have been associated with the emergence of hypervirulent strains, such as NAP1/BI/027, many strains of which also produce a third toxin, binary toxin (CDTa and CDTb). These hypervirulent strains have been associated with increased morbidity and higher mortality. Here we present pre-clinical data describing a novel tetravalent vaccine composed of attenuated forms of TcdA, TcdB and binary toxin components CDTa and CDTb. We demonstrate, using the Syrian golden hamster model of CDI, that the inclusion of binary toxin components CDTa and CDTb significantly improves the efficacy of the vaccine against challenge with NAP1 strains in comparison to vaccines containing only TcdA and TcdB antigens, while providing comparable efficacy against challenge with the prototypic, non-epidemic strain VPI10463. This combination vaccine elicits high neutralizing antibody titers against TcdA, TcdB and binary toxin in both hamsters and rhesus macaques. Finally we present data that binary toxin alone can act as a virulence factor in animal models. Taken together, these data strongly support the inclusion of binary toxin in a vaccine against CDI to provide enhanced protection from epidemic strains of C. difficile.	[Secore, Susan; Wang, Su; Doughtry, Julie; Xie, Jinfu; Horton, Melanie; Xoconostle, Rachel; Skinner, Julie; Bodmer, Jean-Luc; Heinrichs, Jon H.] Merck & Co Inc, Vaccine Basic Res, Merck Res Labs, West Point, PA USA; [Miezeiewski, Matt] Eurofins Labs, Lancaster, PA USA; [Rustandi, Richard R.; Lancaster, Catherine] Merck & Co Inc, Vaccine Analyt Dev, Merck Res Labs, West Point, PA USA; [Wang, Bei; Thiriot, David S.] Merck & Co Inc, Vaccine Drug Prod Dev, Merck Res Labs, West Point, PA USA; [Kristopeit, Adam; Wang, Sheng-Ching; Christanti, Sianny; Gentile, Marie-Pierre; Goerke, Aaron] Merck & Co Inc, Vaccine Proc Dev, Merck Res Labs, West Point, PA USA; [Wang, Su] Meso Scale Diagnost, Dept Clin Biodef, Gaithersburg, MD USA; [Doughtry, Julie] Bristol Myers Squibb, Translat Res & Dev, Princeton, NJ USA; [Miezeiewski, Matt] Janssen Res & Dev, Dept Large Mol Analyt Dev, Malvern, PA USA; [Xoconostle, Rachel] Merck & Co Inc, Proc Dev & Analyt, Durham, NC USA; [Gentile, Marie-Pierre; Goerke, Aaron] Genentech Inc, Dept Global Biol Mfg Sci & Technol, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA; [Bodmer, Jean-Luc] Seres Therapeut Inc, CMC Analyt Dev & QC, Cambridge, MA USA; [Heinrichs, Jon H.] Sanofi Pasteur, Global Project Leadership, Swiftwater, PA USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company; Bristol-Myers Squibb; Merck & Company; Roche Holding; Genentech; Sanofi-Aventis	Secore, S (corresponding author), Merck & Co Inc, Vaccine Basic Res, Merck Res Labs, West Point, PA USA.	susan_secore1@merck.com		Horton, Melanie/0000-0003-4996-9042	Merck and Co., Inc.	Merck and Co., Inc.(Merck & Company)	The research was fully funded by Merck and Co., Inc. The funder provided support in the form of salaries for authors SS, SW, JD, JX, RRR, MH, RX, BW, CL, AK, SCW, SC, SV, MPG, AG, JS, ES, DST, JLB, and JHH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aboudola S, 2003, INFECT IMMUN, V71, P1608, DOI 10.1128/IAI.71.3.1608-1610.2003; Akerlund T, 2008, J CLIN MICROBIOL, V46, P1530, DOI 10.1128/JCM.01964-07; Anosova NG, 2013, J MED MICROBIOL, V62, P1394, DOI 10.1099/jmm.0.056796-0; Bacci S, 2011, EMERG INFECT DIS, V17, P976, DOI [10.3201/eid1706.101483, 10.3201/eid/1706.101483]; Barbut F, 2005, J MED MICROBIOL, V54, P181, DOI 10.1099/jmm.0.45804-0; Barbut F, 2007, INFECT CONT HOSP EP, V28, P131, DOI 10.1086/511794; Bassetti M, 2012, EXPERT REV ANTI-INFE, V10, P1405, DOI [10.1586/ERI.12.135, 10.1586/eri.12.135]; Boquet P, 1998, CURR OPIN MICROBIOL, V1, P66, DOI 10.1016/S1369-5274(98)80144-6; Busch C, 2000, J BIOL CHEM, V275, P13228, DOI 10.1074/jbc.275.18.13228; Busch C, 1998, J BIOL CHEM, V273, P19566, DOI 10.1074/jbc.273.31.19566; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Donald RGK, 2013, MICROBIOL-SGM, V159, P1254, DOI 10.1099/mic.0.066712-0; Drudy D, 2007, EMERG INFECT DIS, V13, P504, DOI 10.3201/eid1303.060771; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Egerer M, 2009, J BIOL CHEM, V284, P3389, DOI 10.1074/jbc.M806002200; Foglia G, 2012, VACCINE, V30, P4307, DOI 10.1016/j.vaccine.2012.01.056; Gerding DN, 2014, GUT MICROBES, V5, P15, DOI 10.4161/gmic.26854; Gerhard R, 2008, J MED MICROBIOL, V57, P765, DOI 10.1099/jmm.0.47769-0; Geric B, 2006, J INFECT DIS, V193, P1143, DOI 10.1086/501368; Geric B, 2003, J CLIN MICROBIOL, V41, P5227, DOI 10.1128/JCM.41.11.5227-5232.2003; Goldenberg SD, 2011, J INFECTION, V62, P355, DOI 10.1016/j.jinf.2011.03.001; Goncalves C, 2004, J CLIN MICROBIOL, V42, P1933, DOI 10.1128/JCM.42.5.1933-1939.2004; Gulke I, 2001, INFECT IMMUN, V69, P6004, DOI 10.1128/IAI.69.10.6004-6011.2001; Heinrichs JH, 2014, SEMIN COLON RECTAL S, V25, P153, DOI 10.1053/j.scrs.2014.05.011; Hippenstiel S, 2002, AM J PHYSIOL-LUNG C, V283, pL830, DOI 10.1152/ajplung.00467.2001; Jank T, 2007, J BIOL CHEM, V282, P35222, DOI 10.1074/jbc.M703138200; Kotloff KL, 2001, INFECT IMMUN, V69, P988, DOI 10.1128/IAI.69.2.988-995.2001; Kuehne SA, 2014, J INFECT DIS, V209, P83, DOI 10.1093/infdis/jit426; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; Martirosian Gayane, 2004, Polish Journal of Microbiology, V53, P197; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; McEllistrem MC, 2005, CLIN INFECT DIS, V40, P265, DOI 10.1086/427113; Miller BA, 2011, INFECT CONT HOSP EP, V32, P387, DOI 10.1086/659156; Miller M, 2010, CLIN INFECT DIS, V50, P194, DOI 10.1086/649213; Nagahama M, 2000, J BACTERIOL, V182, P2096, DOI 10.1128/JB.182.8.2096-2103.2000; Pruitt RN, 2009, J BIOL CHEM, V284, P21934, DOI 10.1074/jbc.M109.018929; Schwan C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000626; Siddiqui F, 2012, J INFECT DIS, V80, P2678; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; Spyres LM, 2003, INFECT IMMUN, V71, P3294, DOI 10.1128/IAI.71.6.3294-3301.2003; Stewart DB, 2013, J GASTROINTEST SURG, V17, P118, DOI 10.1007/s11605-012-2056-6; Stubbs S, 2000, FEMS MICROBIOL LETT, V186, P307, DOI 10.1016/S0378-1097(00)00162-2; Sundriyal A, 2009, J BIOL CHEM, V284, P28713, DOI 10.1074/jbc.M109.043018; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; Teichert M, 2006, INFECT IMMUN, V74, P6006, DOI 10.1128/IAI.00545-06; VANDEKERCKHOVE J, 1987, FEBS LETT, V225, P48, DOI 10.1016/0014-5793(87)81129-8; VANDEKERCKHOVE J, 1988, J BIOL CHEM, V263, P696; Walk ST, 2012, CLIN INFECT DIS, V55, P1661, DOI 10.1093/cid/cis786; Wang HY, 2012, INFECT IMMUN, V80, P2678, DOI 10.1128/IAI.00215-12; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Wilson V, 2010, CLIN INFECT DIS, V50, pE77, DOI 10.1086/653012; Xie JF, 2014, CLIN VACCINE IMMUNOL, V21, P689, DOI 10.1128/CVI.00038-14; Xie JF, 2013, CLIN VACCINE IMMUNOL, V20, P517, DOI 10.1128/CVI.00549-12	54	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170640	10.1371/journal.pone.0170640	http://dx.doi.org/10.1371/journal.pone.0170640			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125650	gold, Green Submitted, Green Published			2022-12-27	WOS:000396176100082
J	Navarese, EP; Gurbel, PA; Andreotti, F; Kolodziejczak, MM; Palmer, SC; Dias, S; Buffon, A; Kubica, J; Kowalewski, M; Jadczyk, T; Laskiewicz, M; Jedrzejek, M; Brockmeyer, M; Airoldi, F; Ruospo, M; De Servi, S; Wojakowski, W; O'Connor, C; Strippoli, GFM				Navarese, Eliano P.; Gurbel, Paul A.; Andreotti, Felicita; Kolodziejczak, Michalina Marta; Palmer, Suetonia C.; Dias, Sofia; Buffon, Antonino; Kubica, Jacek; Kowalewski, Mariusz; Jadczyk, Tomasz; Laskiewicz, Michal; Jedrzejek, Marek; Brockmeyer, Maximillian; Airoldi, Flavio; Ruospo, Marinella; De Servi, Stefano; Wojakowski, Wojciech; O'Connor, Christopher; Strippoli, Giovanni F. M.			Prevention of contrast-induced acute kidney injury in patients undergoing cardiovascular procedures-a systematic review and network meta-analysis	PLOS ONE			English	Article							INDUCED NEPHROPATHY; PATHOGENESIS; ADAPTATION; EFFICACY; OUTCOMES; HYPOXIA; DISEASE; SAFETY; STENTS; RISK	Background Interventional diagnostic and therapeutic procedures requiring intravascular iodinated contrast steadily increase patient exposure to the risks of contrast-induced acute kidney injury (CIAKI), which is associated with death, nonfatal cardiovascular events, and prolonged hospitalization. The aim of this study was to investigate the efficacy of pharmacological and non-pharmacological treatments for CIAKI prevention in patients undergoing cardiovascular invasive procedures with iodinated contrast. Methods and findings MEDLINE, Google Scholar, EMBASE and Cochrane databases as well as abstracts and presentations from major cardiovascular and nephrology meetings were searched, up to 22 April 2016. Eligible studies were randomized trials comparing strategies to prevent CIAKI (alone or in combination) when added to saline versus each other, saline, placebo, or no treatment in patients undergoing cardiovascular invasive procedures with administration of iodinated contrast. Two reviewers independently extracted trial-level data including number of patients, duration of follow-up, and outcomes. Eighteen strategies aimed at CIAKI prevention were identified. The primary outcome was the occurrence of CIAKI. Secondary outcomes were mortality, myocardial infarction, dialysis and heart failure. The data were pooled using network meta-analysis. Treatment estimates were calculated as odds ratios (ORs) with 95% credible intervals (CrI). 147 RCTs involving 33,463 patients were eligible. Saline plus N-acetylcysteine (OR 0.72, 95% CrI 0.57-0.88), ascorbic acid (0.59, 0.34-0.95), sodium bicarbonate plus N-acetylcysteine (0.59, 0.36-0.89), probucol (0.42, 0.15-0.91), methylxanthines (0.39, 0.20-0.66), statin (0.36, 0.21-0.59), device-guided matched hydration (0.35, 0.12-0.79), prostaglandins (0.26, 0.08-0.62) and trimetazidine (0.26, 0.09-0.59) were associated with lower odds of CIAKI compared to saline. Methylxanthines (0.12, 0.01- 0.94) or left ventricular end-diastolic pressure-guided hydration (0.09, 0.01-0.59) were associated with lower mortality compared to saline. Conclusions Currently recommended treatment with saline as the only measure to prevent CIAKI during cardiovascular procedures may not represent the optimal strategy. Vasodilators, when added to saline, may significantly reduce the odds of CIAKI following cardiovascular procedures.	[Navarese, Eliano P.; Airoldi, Flavio; De Servi, Stefano] Multimed IRCCS, Dept Cardiol, Milan, Italy; [Navarese, Eliano P.; Gurbel, Paul A.; Andreotti, Felicita; Kolodziejczak, Michalina Marta; Dias, Sofia; Buffon, Antonino; Jadczyk, Tomasz; Laskiewicz, Michal; Jedrzejek, Marek; Brockmeyer, Maximillian; Wojakowski, Wojciech; O'Connor, Christopher] Systemat Invest & Res Intervent & Outcomes SIRIO, Milan, Italy; [Gurbel, Paul A.; O'Connor, Christopher] Inova Heart & Vasc Inst, Fairfax, VA USA; [Andreotti, Felicita; Buffon, Antonino] Catholic Univ, Inst Cardiol, Rome, Italy; [Kolodziejczak, Michalina Marta] Univ Nicolaus Copernicus, Coll Med Bydgoszcz, Torun, Poland; [Palmer, Suetonia C.] Univ Otago Christchurch, Dept Med, Christchurch, New Zealand; [Dias, Sofia] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Kubica, Jacek] Nicolaus Copernicus Univ, Dept Cardiol & Internal Med, Coll Med, Bydgoszcz, Poland; [Kowalewski, Mariusz] Dr Antoni Jurasz Mem Univ Hosp, Dept Cardiac Surg, Bydgoszcz, Poland; [Jadczyk, Tomasz; Laskiewicz, Michal; Jedrzejek, Marek; Wojakowski, Wojciech] Med Univ Silesia, Dept Cardiol, Katowice, Poland; [Brockmeyer, Maximillian] Univ Duesseldorf, Dept Cardiol, Dusseldorf, Germany; [Ruospo, Marinella; Strippoli, Giovanni F. M.] Diaverum Sweden AB, Diaverum Med Sci Off, Lund, Sweden; [Strippoli, Giovanni F. M.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia; [Strippoli, Giovanni F. M.] Univ Bari, Dept Emergency & Organ Transplantat, Bari, Italy	IRCCS Multimedica; Inova Fairfax Hospital; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Nicolaus Copernicus University; University of Otago; University of Bristol; Nicolaus Copernicus University; Medical University Silesia; Diaverum; University of Sydney; Universita degli Studi di Bari Aldo Moro	Navarese, EP (corresponding author), Multimed IRCCS, Dept Cardiol, Milan, Italy.	elianonavarese@gmail.com	Airoldi, Flavio/AAY-4492-2021; Andreotti, Felicita/A-9962-2019; Kowalewski, Mariusz/AAA-6845-2020; Dias, Sofia/F-1922-2010; De+Servi, Stefano/AAT-2631-2021; Kubica, Jacek/D-6906-2014; Jędrzejek, Marek/W-5861-2018	Andreotti, Felicita/0000-0002-1456-6430; Dias, Sofia/0000-0002-2172-0221; Kubica, Jacek/0000-0001-8250-754X; Jędrzejek, Marek/0000-0001-9473-4491; Jadczyk, Tomasz/0000-0002-7955-9100; Navarese, Eliano/0000-0002-2355-4589; Buffon, Antonino/0000-0001-8144-6597	MRC [MR/M005232/1] Funding Source: UKRI; Medical Research Council [MR/M005232/1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2012, KDIGO CLINICAL PRACT; Arakawa K, 1996, KIDNEY INT, V49, P1199, DOI 10.1038/ki.1996.173; Bagshaw SM, 2005, ARCH INTERN MED, V165, P1087, DOI 10.1001/archinte.165.10.1087; Berwanger O, 2011, CIRCULATION, V124, P1250, DOI 10.1161/CIRCULATIONAHA.111.038943; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Dias S., 2011, NICE DSU TECHNICAL S; Dias S, 2013, MED DECIS MAKING, V33, P657, DOI 10.1177/0272989X13485155; Dias S, 2013, MED DECIS MAKING, V33, P597, DOI 10.1177/0272989X13487604; Heyman SN, 2008, AM J NEPHROL, V28, P998, DOI 10.1159/000146075; Heyman SN, 2010, INVEST RADIOL, V45, P188, DOI 10.1097/RLI.0b013e3181d2eed8; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; Jansen MAM, 2002, KIDNEY INT, V62, P1046, DOI 10.1046/j.1523-1755.2002.00505.x; Langham RG, 2014, NEPHROLOGY, V19, P261, DOI 10.1111/nep.12220; Laville M, 2010, J NEPHROL, V23, P387; Leggate P., 2000, EDTNA ERCA J, V26, P7; Levin A, 2012, KIDNEY INT S, V2013, P1, DOI DOI 10.1038/kisup.2012.73; Levine G.N., 2011, CATHETER CARDIOVASC, V82, pE266, DOI DOI 10.1002/CCD.23390; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; McCullough PA, 2008, NEPHRON PHYSIOL, V109, pP61, DOI 10.1159/000142938; Murphy SW, 2000, J AM SOC NEPHROL, V11, P177, DOI 10.1681/ASN.V111177; Nadkarni GN, 2015, J CARDIOVASC PHARM T, V20, P539, DOI 10.1177/1074248415573320; Navarese EP, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6530; Osswald Hartmut, 2011, Handb Exp Pharmacol, P391, DOI 10.1007/978-3-642-13443-2_15; Palmer SC, 2015, LANCET, V385, P2047, DOI 10.1016/S0140-6736(14)62459-4; Rosenberger C, 2006, CLIN EXP PHARMACOL P, V33, P980, DOI 10.1111/j.1440-1681.2006.04472.x; Seeliger E, 2009, AM J PHYSIOL-RENAL, V296, pF1334, DOI 10.1152/ajprenal.90476.2008; Spiegelhalter DJ, 2004, BAYESIAN APPROACHES, DOI DOI 10.1002/0470092602; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Su XF, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/7279361; Sulowicz W, 2006, KIDNEY INT, V70, pS36, DOI 10.1038/sj.ki.5001975; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; van Valkenhoef G, 2015, GEMTC NETWORK META A; Welton N, 2012, EVIDENCE SYNTHESIS F; Windecker S, 2014, EUROINTERVENTION, V10, P299, DOI 10.4244/EIJV10I3A52	35	26	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0168726	10.1371/journal.pone.0168726	http://dx.doi.org/10.1371/journal.pone.0168726			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151965	Green Published, Green Accepted, gold			2022-12-27	WOS:000396161200005
J	Nlooto, M				Nlooto, Manimbulu			Comorbidities of HIV infection and health care seeking behavior among HIV infected patients attending public sector healthcare facilities in KwaZulu-Natal: A cross sectional study	PLOS ONE			English	Article							AGE-RELATED COMORBIDITIES; SOUTH-AFRICA; ANTIRETROVIRAL THERAPY; ALTERNATIVE MEDICINE; DRUG INTERACTIONS; COMPLEMENTARY; POPULATION; DISEASE; PEOPLE	Background HIV-infected people may present with co-infections, comorbidities, and side effects associated with antiretroviral therapy. This study explored the prevalence of comorbid health problems and determined the extent of the use of traditional medicine for treatment of coinfections, comorbidities of HIV infection and side effects. Methods A cross sectional study, using researcher-administered questionnaires, was carried out among HIV-infected patients in eight public sector healthcare facilities in KwaZulu-Natal between April and October 1024. Self-reports of comorbidities, co-infections and side effects were analyzed with respect to factors such as age, gender, race, and health care seeking behavior including the use of traditional medicine. Cross-tabulations were conducted to test the association between factors and the use of traditional medicine, using Pearson chi-squared (chi(2)) test. Simple and multiple logistic regression models tested the association of the use of traditional medicine with age, gender, race, side effects and comorbidities. Odds ratios with 95% confidence intervals were estimated. Missing values were handled, defined and treated as missing values in the final analysis. Results Overall, 29.5% (n = 516) of the survey participants reported having other comorbidities and or co-infections besides their HIV condition. Same participants reported two or more comorbidities. Almost forty percent of participants (208/531, 39.17%) reported having hypertension as the most noninfectious comorbidity while 21.65% of participants (115/531) had tuberculosis accounting for the most infectious comorbidity. Almost eight percent of participants (142/1748, 8.12%) reported using traditional medicine after starting with cART. Sixty out of 142 participants (60/142, 42.25%) on cART resorted to the use of traditional medicine for the management of comorbidities and or co-infections of their HIV infection. Overall, 311 out of 1748 participants (17.80%) complained of ARVs related side-effects. Forty-five percent of those with side-effects (141/311, 45.34%) reported taking various types of medicines for treating side-effects, with 90.07% of them (127/141) using medicines prescribed by bio-medically trained doctors or by pharmacy personnel as over-the -counter medicines, p<0. 001. Very few participants (14/141, 9.93%) resorted to the use of traditional medicine for treating side effects associated with antiretroviral therapy with no significant difference (p=0.293). In a multiple logistic regression, after adjusting for age, gender, race and side-effects due to antiretroviral therapy, odds for using traditional medicine were almost two times higher [odds ratio = 1.884, 95% Confidence Interval 1.317-2.695] with those participants having comorbidities and co-infections, with a significant difference p-value<0.001. Conclusions Comorbidities, co-infections and side effects are prevalent among HIV-infected patients attending public sector healthcare facilities. Odds of using traditional medicine were almost two times higher and significantly associated with the presence of comorbidities and co-infections than for other factors. The presence of such comorbid health problems does not explain the increased use of traditional medicine among HIV-infected patients on antiretroviral therapy. Findings from this study should be interpreted cautiously as they cannot be generalized to the entire population of HIV-infected patients in KwaZulu-Natal. Studies on safety and efficacy of herbal traditional medicines are needed for beneficiation of the minority of patients who still resort to them for co-treatment with combination antiretroviral therapy.	[Nlooto, Manimbulu] Univ KwaZulu Natal, Sch Hlth Sci, Discipline Pharmaceut Sci, Durban, South Africa	University of Kwazulu Natal	Nlooto, M (corresponding author), Univ KwaZulu Natal, Sch Hlth Sci, Discipline Pharmaceut Sci, Durban, South Africa.	Nlooto@ukzn.ac.za			DST-NRF-Excellence Centre Indigenous Knowledge Systems, University of KwaZulu-Natal; Victor Daitz Information Gateway; Victor Daitz Foundation; University of KwaZulu-Natal	DST-NRF-Excellence Centre Indigenous Knowledge Systems, University of KwaZulu-Natal; Victor Daitz Information Gateway; Victor Daitz Foundation; University of KwaZulu-Natal	The author received running expenses from the College of Health Sciences and a stipend from the DST-NRF-Excellence Centre Indigenous Knowledge Systems, University of KwaZulu-Natal, during the time this study was conducted. Open access publication of this article has been made possible through support from the Victor Daitz Information Gateway, an initiative of Victor Daitz Foundation and the University of KwaZulu-Natal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audet CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070326; Bajunirwe F, 2013, ANTIRETROVIRAL TREAT, P39; Bessong PO, 2008, T ROY SOC TROP MED H, V102, P209, DOI 10.1016/j.trstmh.2007.11.009; Boyer S, 2011, HLTH POLICY PLANNING; Capeau J, 2011, CLIN INFECT DIS, V53, P1127, DOI 10.1093/cid/cir628; Chinggwaru W, 2006, EUR J INTEGR MED; Cichello S., 2014, AUSTR J HERBAL MED, V26, P100; Deebii N, 2015, J BIOSCIENCES MED, V4, P54; Fasinu PS, 2016, CURR DRUG METAB, V17, P52, DOI 10.2174/1389200216666151103115053; Fasinu PS, 2013, PHARM BIOL, V51, P1499, DOI 10.3109/13880209.2013.796393; Grundy C., 2005, WHO GLOBAL ATLAS TRA; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Gustafsson M, 2010, COSTS ILLITERACY S A; Hamza Omar J M, 2006, BMC Oral Health, V6, P12; Hasan SS, 2011, MED PRIN PRACT, V20, P265, DOI 10.1159/000321274; Kendall CE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-161; Levin Kate Ann, 2006, Evid Based Dent, V7, P24, DOI 10.1038/sj.ebd.6400375; Littlewood RA, 2008, AIDS CARE, V20, P1002, DOI 10.1080/09540120701767216; Machin D, 2011, SAMPLE SIZE TABLES C; Mbatha N, 2012, SAMJ S AFR MED J, V102, P129, DOI 10.7196/SAMJ.5295; McInerney PA, 2008, NURS HEALTH SCI, V10, P266, DOI 10.1111/j.1442-2018.2008.00410.x; Mosha F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-38; National Department of Health Republic of South Africa, 2014, NAT CONS GUID PREV M; Nlooto M, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1101-5; PageShafer K, 1996, ANN EPIDEMIOL, V6, P420, DOI 10.1016/S1047-2797(96)00064-6; Peltzer K, 2009, AFR J TRADIT COMPLEM, V6, P175; Peltzer K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-255; Reed R., 2012, HORIZ ENFERM, V1, P81; Simbayi L, 2014, S AFRICAN NATL HIV P; Souhami RL, 1997, LANCET, V350, P911, DOI 10.1016/S0140-6736(97)02307-6; UNAIDS, 2014, HIV AIDS EST; Venter F, 2012, S AFRICAN HLTH REV, V2012, P37; WHO (The World Health Organization), 2008, TRADITIONAL MED; Young F, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-9	34	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170983	10.1371/journal.pone.0170983	http://dx.doi.org/10.1371/journal.pone.0170983			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151951	gold, Green Published			2022-12-27	WOS:000396161200065
J	Paraiso, LF; Goncalves-e-Oliveira, AFM; Cunha, LM; Neto, OPD; Pacheco, AG; Araujo, KBG; Garrote, RD; Neto, MB; Penha-Silva, N				Paraiso, Lara Ferreira; Mayrink Goncalves-e-Oliveira, Ana Flavia; Cunha, Lucas Moreira; de Almeida Neto, Omar Pereira; Pacheco, Adriana Garcia; Goncalves Araujo, Karinne Beatriz; Garrote-Filho, Rio da Silva; Bernardino Neto, Morun; Penha-Silva, Nilson			Effects of acute and chronic exercise on the osmotic stability of erythrocyte membrane of competitive swimmers	PLOS ONE			English	Article							RED-BLOOD-CELLS; INDUCED OXIDATIVE STRESS; PHYSICAL-EXERCISE; MULTIVARIATE ANALYSES; EXHAUSTIVE EXERCISE; SKELETAL-MUSCLE; FLUIDITY; DAMAGE; RELEVANCE; FRAGILITY	This study aimed to evaluate the influence of acute and chronic exercise on erythrocyte membrane stability and various blood indices in a population consisting of five national-level male swimmers, over 18 weeks of training. The evaluations were made at the beginning and end of the 1st, 7th, 13th and 18th weeks, when volume and training intensity have changed. The effects manifested at the beginning of those weeks were considered due to chronic adaptations, while the effects observed at the end of the weeks were considered due to acute manifestations of the exercise load of that week. Acute changes resulting from the exercise comprised increases in creatine kinase activity (CK) and leukocyte count (Leu), and decrease in hematocrit (Ht) and mean corpuscular volume (MCV), at the end of the first week; increase in the activities of CK and lactate dehydrogenase (LDH), in the uric acid (UA) concentration and Leu count, at the end of the seventh week; increases in CK and LDH activities and in the mean corpuscular hemoglobin concentration (MCHC), at the end of the 13th week; and decrease in the value of the osmotic stability index 1/H-50 and increases in the CK activity and platelets (Plt) count, at the end of the 18th week. Chronic changes due to training comprised increase in the values of 1/H-50, CK, LDH, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), serum iron (Fe), MCV and Plt. Although acute training has resulted in decrease in the osmotic stability of erythrocytes, possibly associated with exacerbation of the oxidative processes during intense exercise, chronic training over 18 weeks resulted in increased osmotic stability of erythrocytes, possibly by modulation in the membrane cholesterol content by low and high density lipoproteins.	[Paraiso, Lara Ferreira; Mayrink Goncalves-e-Oliveira, Ana Flavia; Cunha, Lucas Moreira; Pacheco, Adriana Garcia; Goncalves Araujo, Karinne Beatriz; Garrote-Filho, Rio da Silva; Penha-Silva, Nilson] Univ Fed Uberlandia, Inst Genet & Biochem, Uberlandia, MG, Brazil; [de Almeida Neto, Omar Pereira] Univ Fed Goias, Dept Hlth Sci, Jatai, Go, Brazil; [Bernardino Neto, Morun] Univ Sao Paulo, Dept Basic & Environm Sci, Sao Paulo, Brazil	Universidade Federal de Uberlandia; Universidade Federal de Goias; Universidade de Sao Paulo	Penha-Silva, N (corresponding author), Univ Fed Uberlandia, Inst Genet & Biochem, Uberlandia, MG, Brazil.	nspenha@ufu.br	Neto, Morun Bernardino/L-7381-2015; Penha-Silva, Nilson/E-5730-2010; de Almeida Neto, Omar Pereira/AAJ-1704-2021; Garrote Filho, Mario da Silva/U-3043-2017	Neto, Morun Bernardino/0000-0003-4292-7800; Penha-Silva, Nilson/0000-0002-8205-6213; Garrote Filho, Mario da Silva/0000-0003-2332-6567	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, FAPEMIG [PPM-00485-12]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES [PE-PNPD AUX2718/2011]; Conselho Nacional de Pesquisa e Desenvolvimento, CNPq [307705/2012-9, 306608/2015-4]; FAPEMIG [PPM-00485-12]; CAPES [PE-PNPD AUX2718/2011]; CNPq [306608/2015-4]	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Pesquisa e Desenvolvimento, CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by: Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, FAPEMIG (PPM-00485-12); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES (PE-PNPD AUX2718/2011); Conselho Nacional de Pesquisa e Desenvolvimento, CNPq (307705/2012-9 and 306608/2015-4). The fundershad no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank FAPEMIG (PPM-00485-12), CAPES (PE-PNPD AUX2718/2011) and CNPq (306608/2015-4) for the financial support that enabled the development of this study.	Aguilo A., 2000, Biofactors, V11, P27; Ashton T, 1998, EUR J APPL PHYSIOL O, V77, P498, DOI 10.1007/s004210050366; BALABAN EP, 1992, CLIN SPORT MED, V11, P313; Neto MB, 2013, BIORHEOLOGY, V50, P305, DOI 10.3233/BIR-130641; Berzosa C, 2011, EUR J APPL PHYSIOL, V111, P1127, DOI 10.1007/s00421-010-1738-6; Bishop C., 1964, RED BLOOD CELL; Bloomer RJ, 2007, INT J SPORTS MED, V28, P21, DOI 10.1055/s-2006-924140; Bloomer RJ, 2008, GENDER MED, V5, P218, DOI 10.1016/j.genm.2008.07.002; Brancaccio P, 2007, BRIT MED BULL, V81-82, P209, DOI 10.1093/bmb/ldm014; Brun JF, 2007, SCI SPORT, V22, P251, DOI 10.1016/j.scispo.2007.09.010; Brun JF, 1998, CLIN HEMORHEOL MICRO, V19, P89; Brun JF, 2002, CLIN HEMORHEOL MICRO, V26, P155; Brzeszczynska J, 2008, APPL PHYSIOL NUTR ME, V33, P1223, DOI 10.1139/H08-125; Cazzola R, 2003, EUR J CLIN INVEST, V33, P924, DOI 10.1046/j.1365-2362.2003.01227.x; COOPER RA, 1978, J SUPRAMOL STR CELL, V8, P413, DOI 10.1002/jss.400080404; de Arvelos LR, 2013, J MEMBRANE BIOL, V246, P231, DOI 10.1007/s00232-013-9524-0; de Freitas MV, 2008, TOXICOL IN VITRO, V22, P219, DOI 10.1016/j.tiv.2007.07.010; de Freitas MV, 2014, HEMATOLOGY, V19, P424, DOI 10.1179/1607845413Y.0000000145; de Freitas MV, 2010, J MEMBRANE BIOL, V233, P127, DOI 10.1007/s00232-010-9232-y; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Lemos GSD, 2011, CELL BIOCHEM BIOPHYS, V61, P531, DOI 10.1007/s12013-011-9235-z; El-Sayed MS, 2005, SPORTS MED, V35, P649, DOI 10.2165/00007256-200535080-00001; Fisher-Wellman Kelsey, 2009, Dyn Med, V8, P1, DOI 10.1186/1476-5918-8-1; Freedman JE, 2008, ARTERIOSCL THROM VAS, V28, pS11, DOI 10.1161/ATVBAHA.107.159178; Goto C, 2003, CIRCULATION, V108, P530, DOI 10.1161/01.CIR.0000080893.55729.28; Goto C, 2007, AM J HYPERTENS, V20, P825, DOI 10.1016/j.amjhyper.2007.02.014; Gwozdzinski K, 2013, SCI WORLD J, DOI 10.1155/2013/168376; HALLIWELL B, 1991, AM J MED, V91, pS14, DOI 10.1016/0002-9343(91)90279-7; Jackson MJ, 2000, HDB OXIDANTS ANTIOXI, P57, DOI DOI 10.1016/B978-044482650-3/50002-X; JAIN NC, 1973, CORNELL VET, V63, P411; Jensen FB, 2009, J EXP BIOL, V212, P3387, DOI 10.1242/jeb.023697; KAMADA T, 1993, J APPL PHYSIOL, V74, P354, DOI 10.1152/jappl.1993.74.1.354; KAYASHIMA S, 1995, EUR J APPL PHYSIOL O, V70, P413, DOI 10.1007/BF00618492; Kayatekin BM, 2010, BIOL SPORT, V27, P99, DOI 10.5604/20831862.913075; Klinken SP, 2002, INT J BIOCHEM CELL B, V34, P1513, DOI 10.1016/S1357-2725(02)00087-0; Knez WL, 2007, MED SCI SPORT EXER, V39, P283, DOI 10.1249/01.mss.0000246999.09718.0c; Koter M, 2004, INT J BIOCHEM CELL B, V36, P205, DOI 10.1016/S1357-2725(03)00195-X; Li JX, 1999, EUR J APPL PHYSIOL, V80, P113, DOI 10.1007/s004210050566; Netto RDM, 2014, PARASITOL RES, V113, P863, DOI 10.1007/s00436-013-3717-4; MASSALDI HA, 1988, BIOPHYS J, V54, P301, DOI 10.1016/S0006-3495(88)82960-6; MCCARTHY DA, 1988, SPORTS MED, V6, P333, DOI 10.2165/00007256-198806060-00002; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; NAGASAWA T, 1976, TOHOKU J EXP MED, V120, P277; Paraiso LF, 2014, INT J SPORTS MED, V35, P1072, DOI 10.1055/s-0034-1371834; Radak Z, 2001, EXERC IMMUNOL REV, V7, P90; Radak Z, 1999, FREE RADICAL BIO MED, V27, P69, DOI 10.1016/S0891-5849(99)00038-6; Robinson Y, 2006, MED SCI SPORT EXER, V38, P480, DOI 10.1249/01.mss.0000188448.40218.4c; Santos-Silva A, 2001, CLIN CHIM ACTA, V306, P119, DOI 10.1016/S0009-8981(01)00406-5; Senturk UK, 2005, J APPL PHYSIOL, V99, P1434, DOI 10.1152/japplphysiol.01392.2004; SHIGA T, 1990, CRIT REV ONCOL HEMAT, V10, P9, DOI 10.1016/1040-8428(90)90020-S; SHIRAKI K, 1977, JPN J PHYSIOL, V27, P413; Sies H, 2005, J NUTR, V135, P969, DOI 10.1093/jn/135.5.969; SJODIN B, 1990, SPORTS MED, V10, P236; SMITH JA, 1995, SPORTS MED, V19, P9, DOI 10.2165/00007256-199519010-00002; SMITH JA, 1995, EUR J APPL PHYSIOL O, V70, P427, DOI 10.1007/BF00618494; Spodaryk K, 2002, PHYSIOL BEHAV, V75, P201, DOI 10.1016/S0031-9384(01)00640-0; SPODARYK K, 1990, MECH AGEING DEV, V55, P199, DOI 10.1016/0047-6374(90)90027-D; STECK TL, 1974, J CELL BIOL, V62, P1, DOI 10.1083/jcb.62.1.1; Tozzi-Ciancarelli MG, 2002, EUR J APPL PHYSIOL, V86, P266, DOI 10.1007/s00421-001-0542-8; Tsuda K, 2003, CLIN EXP PHARMACOL P, V30, P382, DOI 10.1046/j.1440-1681.2003.03846.x; Vollaard NBJ, 2005, SPORTS MED, V35, P1045, DOI 10.2165/00007256-200535120-00004; Walski T, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/162102	62	12	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171318	10.1371/journal.pone.0171318	http://dx.doi.org/10.1371/journal.pone.0171318			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151958	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161200126
J	Wu, JL; Ravikumar, P; Nguyen, KT; Hsia, CCW; Hong, Y				Wu, Jinglei; Ravikumar, Priya; Nguyen, Kytai T.; Hsia, Connie C. W.; Hong, Yi			Lung protection by inhalation of exogenous solubilized extracellular matrix	PLOS ONE			English	Article							GROWTH-FACTOR; CELL-DEATH; MACROPHAGE PHENOTYPE; DE-CELLULARIZATION; IN-VITRO; HYPEROXIA; HYDROGEL; TISSUE; INJURY; DAMAGE	Decellularized extracellular matrix (ECM) contains complex tissue-specific components that work in concert to promote tissue repair and constructive remodeling and has been used experimentally and clinically to accelerate epithelial wound repair, leading us to hypothesize that lung-derived ECM could mitigate acute lung injury. To explore the therapeutic potential of ECM for noninvasive delivery to the lung, we decellularized and solubilized porcine lung ECM, then characterized the composition, concentration, particle size and stability of the preparation. The ECM preparation at 3.2 mg/mL with average particle size <3 mu m was tested in vitro on human A549 lung epithelial cells exposed to 95% O-2 for 24 hours, and in vivo by tracheal instillation or nebulization into the lungs of rats exposed intermittently or continuously to 90% O-2 for a cumulative 72 hours. Our results showed that the preparation was enriched in collagen, reduced in glycosaminoglycans, and contained various bioactive molecules. Particle size was concentration-dependent. Compared to the respective controls treated with cell culture medium in vitro or saline in vivo, ECM inhalation normalized cell survival and alveolar morphology, and reduced hyperoxia-induced apoptosis and oxidative damage. This proof-of-concept study established the methodology, feasibility and therapeutic potential of exogenous solubilized ECM for pulmonary cytoprotection, possibly as an adjunct or potentiator of conventional therapy.	[Wu, Jinglei; Nguyen, Kytai T.; Hong, Yi] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA; [Wu, Jinglei; Nguyen, Kytai T.; Hsia, Connie C. W.; Hong, Yi] Joint Grad Program Biomed Engn Univ Texas Arlingt, Dallas, TX USA; [Ravikumar, Priya; Hsia, Connie C. W.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med Pulm & Crit Care Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Arlington; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hong, Y (corresponding author), Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.; Hsia, CCW; Hong, Y (corresponding author), Joint Grad Program Biomed Engn Univ Texas Arlingt, Dallas, TX USA.; Hsia, CCW (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med Pulm & Crit Care Med, Dallas, TX 75390 USA.	Connie.Hsia@utsouthwestern.edu; yihong@uta.edu	Hong, Yi/AAA-8971-2022; Wu, Jinglei/AFW-1416-2022; Wu, Jinglei/AFW-1414-2022	Wu, Jinglei/0000-0001-9549-3992; Wu, Jinglei/0000-0001-9549-3992; Hong, Yi/0000-0002-5846-2596	University of Texas at Arlington; National Heart, Lung and Blood Institute [R01 HL40070, U01 HL111146]; Mentored Clinical and Translational Research Scholar Award from the National Center for Advancing Translational Science of the National Institutes of Health [KL2TR001103]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL040070, R01HL134373, U01HL111146] Funding Source: NIH RePORTER	University of Texas at Arlington; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Mentored Clinical and Translational Research Scholar Award from the National Center for Advancing Translational Science of the National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We gratefully acknowledge the support from a new faculty start-up fund (YH) at the University of Texas at Arlington, and the National Heart, Lung and Blood Institute grants R01 HL40070 (CCH) and U01 HL111146 (CCH and KTN). RP is the recipient of a Mentored Clinical and Translational Research Scholar Award (KL2TR001103) from the National Center for Advancing Translational Science of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264; Barker GF, 2006, AM J RESP CELL MOL, V35, P277, DOI 10.1165/rcmb.2005-0340OC; Booth AJ, 2012, AM J RESP CRIT CARE, V186, P866, DOI 10.1164/rccm.201204-0754OC; Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040; Budinger GRS, 2011, AM J RESP CRIT CARE, V183, P1043, DOI 10.1164/rccm.201002-0181OC; Cepkova Magda, 2006, J Intensive Care Med, V21, P119, DOI 10.1177/0885066606287045; Chow CW, 2003, AM J RESP CELL MOL, V29, P427, DOI 10.1165/rcmb.F278; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; DeQuach JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013039; Franek WR, 2004, FREE RADICAL BIO MED, V37, P1670, DOI 10.1016/j.freeradbiomed.2004.08.007; Gilbert TW, 2009, J SURG RES, V152, P135, DOI 10.1016/j.jss.2008.02.013; Gilpin SE, 2014, J HEART LUNG TRANSPL, V33, P298, DOI 10.1016/j.healun.2013.10.030; HEREMANS A, 1988, J BIOL CHEM, V263, P4731; Jain D, 2008, AM J RESP CRIT CARE, V178, P805, DOI 10.1164/rccm.200804-582OC; Jeffords ME, 2015, ACS APPL MATER INTER, V7, P11053, DOI 10.1021/acsami.5b03195; Jensen T, 2012, TISSUE ENG PART C-ME, V18, P632, DOI [10.1089/ten.tec.2011.0584, 10.1089/ten.TEC.2011.0584]; Johnson ER, 2010, J AEROSOL MED PULM D, V23, P243, DOI 10.1089/jamp.2009.0775; Lee JS, 2014, BIOMACROMOLECULES, V15, P206, DOI 10.1021/bm4015039; Liu FF, 2013, TOXICOLOGY, V304, P158, DOI 10.1016/j.tox.2012.12.020; Mach WJ, 2011, NURS RES PRACT, V2011, DOI 10.1155/2011/260482; Manni ML, 2011, TISSUE ENG PT A, V17, P2795, DOI 10.1089/ten.tea.2011.0023; Mendez JJ, 2014, TISSUE ENG PT A, V20, P1735, DOI [10.1089/ten.tea.2013.0647, 10.1089/ten.TEA.2013.0647]; Merna N, 2015, TISSUE ENG PT A, V21, P2195, DOI [10.1089/ten.TEA.2014.0337, 10.1089/ten.tea.2014.0337]; O'Neill JD, 2013, ANN THORAC SURG, V96, P1046, DOI 10.1016/j.athoracsur.2013.04.022; Okamoto T, 2013, J THORAC CARDIOV SUR, V145, P1108, DOI 10.1016/j.jtcvs.2012.04.006; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345; Price AP, 2010, TISSUE ENG PT A, V16, P2581, DOI [10.1089/ten.tea.2009.0659, 10.1089/ten.TEA.2009.0659]; Ravikumar P, 2016, NANOMED-NANOTECHNOL, V12, P811, DOI 10.1016/j.nano.2015.10.004; Ravikumar P, 2014, AM J PHYSIOL-LUNG C, V307, pL566, DOI 10.1152/ajplung.00306.2013; Ren X, 2015, NAT BIOTECHNOL, V33, P1097, DOI 10.1038/nbt.3354; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888; Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045; Struber M, 2007, J THORAC CARDIOV SUR, V133, P1620, DOI 10.1016/j.jtcvs.2006.12.057; Thebaud B, 2005, CIRCULATION, V112, P2477, DOI 10.1161/CIRCULATIONAHA.105.541524; VLODAVSKY I, 1987, P NATL ACAD SCI USA, V84, P2292, DOI 10.1073/pnas.84.8.2292; Wallis JM, 2012, TISSUE ENG PART C-ME, V18, P420, DOI [10.1089/ten.tec.2011.0567, 10.1089/ten.TEC.2011.0567]; Williams C, 2014, ACTA BIOMATER, V10, P194, DOI 10.1016/j.actbio.2013.08.037; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Wolf MT, 2012, BIOMATERIALS, V33, P7028, DOI 10.1016/j.biomaterials.2012.06.051; Wu JL, 2015, ACTA BIOMATER, V16, P49, DOI 10.1016/j.actbio.2015.01.027; Xu D, 2008, AM J PHYSIOL-LUNG C, V294, pL17, DOI 10.1152/ajplung.00178.2007; Xu D, 2006, AM J PHYSIOL-LUNG C, V291, pL966, DOI 10.1152/ajplung.00045.2006; Zaher TE, 2007, FREE RADICAL BIO MED, V42, P897, DOI 10.1016/j.freeradbiomed.2007.01.021	45	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171165	10.1371/journal.pone.0171165	http://dx.doi.org/10.1371/journal.pone.0171165			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151947	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161200098
J	McDougal, L; Atmavilas, Y; Hay, K; Silverman, JG; Tarigopula, UK; Raj, A				McDougal, Lotus; Atmavilas, Yamini; Hay, Katherine; Silverman, Jay G.; Tarigopula, Usha K.; Raj, Anita			Making the continuum of care work for mothers and infants: Does gender equity matter? Findings from a quasi-experimental study in Bihar, India	PLOS ONE			English	Article							COMMUNITY-HEALTH WORKERS; MIDDLE-INCOME COUNTRIES; QUALITY-OF-CARE; NEONATAL-MORTALITY; PREVENTIVE INTERVENTIONS; REPRODUCTIVE HEALTH; CHILD MARRIAGE; NEWBORN HEALTH; UTTAR-PRADESH; IMPACT	Background Improvements in continuum of care (CoC) utilization are needed to address inadequate reductions in neonatal and infant mortality in India and elsewhere. This study examines the effect of Ananya, a health system training and community outreach intervention, on reproductive, maternal and newborn health continuum of care (RMNH CoC) utilization in Bihar, India, and explores whether that effect is moderated by gender equity factors (child marriage, restricted mobility and low decision-making control). Methods A two-armed quasi-experimental design compared districts in Bihar that did/did not implement Ananya. Cross-sections of married women aged 15-49 with a 0-5 month old child were surveyed at baseline and two year follow-up (baseline n = 7191 and follow-up n = 6143; response rates 88.9% and 90.7%, respectively). Difference-in-difference analyses assessed program impact on RMNH CoC co-coverage, defined by 9 health services/behaviors for the index pregnancy (e.g.,antenatal care, skin-to-skin care). Three-way interactions assessed gender equity as a moderator of Ananya's impact. Findings Participants reported low RMNH CoC co-coverage at baseline (on average 3.2 and 3.0 of the 9 RMNH services/behaviors for Ananya and control groups, respectively). The Ananya group showed a significantly greater increase in RMNH CoC co-coverage (. 41 services) compared with the control group over time (p< 0.001), with the primary drivers being increases in clean cord care, skin-to-skin care and postpartum contraceptive use. Gender equity interaction analyses revealed diminished intervention effects on antenatal care, skilled birth attendance and exclusive breastfeeding for women married as minors. Conclusion Ananya improved RMNH CoC co-coverage among these recent mothers, largely through positive health behavior changes. Child marriage attenuated Ananya's impact on utilization of key health services and behaviors. Supporting the health system with training and community outreach can be beneficial to RMNH CoC utilization; additional support is needed to adequately address the unique issues faced by women married as minors.	[McDougal, Lotus; Silverman, Jay G.; Raj, Anita] Univ Calif San Diego, Dept Med, Ctr Gender Equ & Hlth, Div Global Publ Hlth,Sch Med, San Diego, CA 92103 USA; [Atmavilas, Yamini; Hay, Katherine; Tarigopula, Usha K.] Bill & Melinda Gates Fdn, New Delhi, India	University of California System; University of California San Diego	McDougal, L (corresponding author), Univ Calif San Diego, Dept Med, Ctr Gender Equ & Hlth, Div Global Publ Hlth,Sch Med, San Diego, CA 92103 USA.	lmcdouga@ucsd.edu	Hay, Katherine/ABB-7795-2021		Bill and Melinda Gates Foundation (BMGF); BMGF [OPP1163682]; Sambodhi Research and Communications Private Limited [UCSD 2016-3182]	Bill and Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); BMGF; Sambodhi Research and Communications Private Limited	This manuscript and the Ananya Program and data collection were supported by the Bill and Melinda Gates Foundation (BMGF www.gatesfoundation.org). LM, JGS and AR received funding from BMGF directly [OPP1163682] and via Sambodhi Research and Communications Private Limited [UCSD 2016-3182]. KH, YA and UKT are BMGF staff who participated in the development of this study and the generation of this manuscript, and are recognized as coauthors. In their roles with BMGF, they were involved with the design and conduct of the Ananya Program and evaluation study design from which data for this study were obtained. They provided some oversight of data collection and management, and gave input into analyses included in this manuscript. They assisted with the interpretation of this paper and reviewed and approved this final manuscript.	Agrawal PK, 2012, J EPIDEMIOL COMMUN H, V66, P755, DOI 10.1136/jech-2011-200362; Anand S, 2010, INT J HEALTH CARE Q, V23, P718, DOI 10.1108/09526861011081859; Arregoces L, 2015, LANCET GLOB HEALTH, V3, pE410, DOI 10.1016/S2214-109X(15)00057-1; Baqui AH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2826; Baqui AH, 2009, PEDIATR INFECT DIS J, V28, P304, DOI 10.1097/INF.0b013e31819069e8; Barros AJD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001390; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Bhutta ZA, 2010, SEMIN PERINATOL, V34, P434, DOI 10.1053/j.semperi.2010.09.002; Black R., 2013, LANCET; Borkum E, 2014, MIDLINE FINDINGS EVA; Countdown to 2015, 2015, 9789280648140 WHO; Darmstadt GL, 2008, HEALTH POLICY PLANN, V23, P101, DOI 10.1093/heapol/czn001; Gilmore B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-847; Glenton C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010414.pub2; Graham WJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001368; IIPS and Macro International, 2007, NATL FAMILY HLTH SUR, V1; IIPS and MoHFW, 2016, NATL FAMILY HLTH SUR; Jejeebhoy SJ, 2014, STUD FAMILY PLANN, V45, P183, DOI 10.1111/j.1728-4465.2014.00384.x; Kamiya Y, 2013, SOC SCI MED, V83, P34, DOI 10.1016/j.socscimed.2013.01.035; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Kikuchi K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139288; Kraft JM, 2014, J HEALTH COMMUN, V19, P122, DOI 10.1080/10810730.2014.918216; Kumar GA, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-357; Lassi ZS, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007754.pub3; Lassi ZS, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S1-S5; Lassi ZS, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S2-S2; Lassi ZS, 2013, J MATERN-FETAL NEO M, V26, P3, DOI 10.3109/14767058.2013.784737; Lassi ZS, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007754.pub2; Lawn JE, 2011, INT J EPIDEMIOL, V40, P525, DOI 10.1093/ije/dyq172; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS5, DOI 10.1016/j.ijgo.2009.07.016; McCurdy RJ, 2011, ACTA OBSTET GYN SCAN, V90, P779, DOI 10.1111/j.1600-0412.2011.01133.x; Moran AC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001415; National Family Health Survey (NFHS-3), 2007, NAT FAM HLTH SURV NF, VI; National Health Mission MoHFW Government of India, 2015, STAT WIS INF; Pervin J, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-111; Peterman A., 2015, IFPRI - Discussion Papers; Raj A, 2014, INT J GYNECOL OBSTET, V124, P86, DOI 10.1016/j.ijgo.2013.07.027; Raj A, 2010, ARCH DIS CHILD, V95, P931, DOI 10.1136/adc.2009.178707; Raj A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4258; Randive B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067452; Scott VK, 2015, STUD FAMILY PLANN, V46, P241, DOI 10.1111/j.1728-4465.2015.00028.x; Shengelia B, 2005, SOC SCI MED, V61, P97, DOI 10.1016/j.socscimed.2004.11.055; Singh A, 2013, MATERN CHILD HLTH J, V17, P493, DOI 10.1007/s10995-012-1023-x; Singh K, 2015, HEALTH CARE WOMEN IN, V36, P57, DOI 10.1080/07399332.2013.824971; Singh S, 2012, ADDING IT COSTS BENE; Smith K, 2011, MEASUREMENT LEARNING; Sudhinaraset M, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0942-8; UNICEF WHO & World Bank Group., 2021, LEVELS TRENDS CHILD; van den Broek NR, 2009, BJOG-INT J OBSTET GY, V116, P18, DOI 10.1111/j.1471-0528.2009.02333.x; Victora C, 2015, LANCET; Victora CG, 2005, LANCET, V366, P1460, DOI 10.1016/S0140-6736(05)67599-X; Wall SN, 2010, SEMIN PERINATOL, V34, P395, DOI 10.1053/j.semperi.2010.09.009; Wendt A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120404; WHO, 2009, WHO UNICEF JOINT STA; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; World Health Organization, 2010, NEWBORN CHILD HLTH; Yakoob MY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S7; Yeji F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142849	58	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0171002	10.1371/journal.pone.0171002	http://dx.doi.org/10.1371/journal.pone.0171002			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6RS	28146586	Green Published, Green Submitted, gold			2022-12-27	WOS:000396131700025
J	Kochanowicz, A; Sawczyn, S; Niespodzinski, B; Mieszkowski, J; Kochanowicz, K; Zychowska, M				Kochanowicz, Andrzej; Sawczyn, Stanislaw; Niespodzinski, Bartlomiej; Mieszkowski, Jan; Kochanowicz, Kazimierz; Zychowska, Malgorzata			Cellular Stress Response Gene Expression During Upper and Lower Body High Intensity Exercises	PLOS ONE			English	Article							WINGATE ANAEROBIC TEST; HEAT-SHOCK PROTEINS; WHITE BLOOD-CELLS; SIGNALING PATHWAY; HUMAN-LEUKOCYTES; SKELETAL-MUSCLE; MESSENGER-RNA; HSP27 HSPB1; HSPA1A; PERFORMANCE	Objectives The aim was to compare the effect of upper and lower body high-intensity exercise on chosen genes expression in athletes and non-athletes. Method Fourteen elite male artistic gymnasts (EAG) aged 20.6 +/- 3.3 years and 14 physically active men (PAM) aged 19.9 +/- 1.0 years performed lower and upper body 30 s Wingate Tests. Blood samples were collected before, 5 and 30 minutes after each effort to assess gene expression via PCR. Results Significantly higher mechanical parameters after lower body exercise was observed in both groups, for relative power (8.7 +/- 1.2 W/kg in gymnasts, 7.2 +/- 1.2 W/kg in controls, p = 0.01) and mean power (6.7 +/- 0.7 W/kg in gymnasts, 5.4 +/- 0.8 W/kg in controls, p = 0.01). No differences in lower versus upper body gene expression were detected for all tested genes as well as between gymnasts and physical active man. For IL-6 m-RNA time-dependent effect was observed. Conclusions Because of no significant differences in expression of genes associated with cellular stress response the similar adaptive effect to exercise may be obtained so by lower and upper body exercise.	[Kochanowicz, Andrzej] Gdansk Univ Phys Educ & Sport, Dept Gymnast & Dance, Gdansk, Poland; [Sawczyn, Stanislaw] Gdansk Univ Phys Educ & Sport, Dept Sport All, Gdansk, Poland; [Niespodzinski, Bartlomiej; Mieszkowski, Jan] Kazimierz Wielki Univ, Inst Phys Educ, Dept Anat & Biomech, Bydgoszcz, Poland; [Kochanowicz, Kazimierz] Gdansk Univ Phys Educ & Sport, Dept Theory Sport & Human Motor, Gdansk, Poland; [Zychowska, Malgorzata] Gdansk Univ Phys Educ & Sport, Dept Life Sci, Gdansk, Poland	Gdansk University of Physical Education & Sport; Gdansk University of Physical Education & Sport; Kazimierz Wielki University; Gdansk University of Physical Education & Sport; Gdansk University of Physical Education & Sport	Zychowska, M (corresponding author), Gdansk Univ Phys Educ & Sport, Dept Life Sci, Gdansk, Poland.	zychowska.m@gmail.com	Żychowska, Małgorzata/GZM-7973-2022; Mieszkowski, Jan/AAI-1173-2021; Ż, Gośka/AAK-6463-2021; Niespodziński, Bartłomiej/F-7619-2017; Mieszkowski, Jan/AAX-8948-2021	Żychowska, Małgorzata/0000-0002-9475-0448; Niespodziński, Bartłomiej/0000-0001-8992-3730; Mieszkowski, Jan/0000-0001-6753-5139; Kochanowicz, Andrzej/0000-0002-5104-827X; sawczyn, stanislaw/0000-0002-1974-3248; Kochanowicz, Kazimierz/0000-0002-8481-6335	Foundation for Polish Science [0018 RS3/2015/53]	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission)	This work was supported by the Foundation for Polish Science, Grant Nr 0018 RS3/2015/53.	Acunzo J, 2012, INT J BIOCHEM CELL B, V44, P1622, DOI 10.1016/j.biocel.2012.04.002; BAROR O, 1987, SPORTS MED, V4, P381, DOI 10.2165/00007256-198704060-00001; Bassa H, 2002, ISOKINET EXERC SCI, V10, P137, DOI 10.3233/IES-2002-0094; Bencke J, 2002, SCAND J MED SCI SPOR, V12, P171, DOI 10.1034/j.1600-0838.2002.01128.x; Buchheit M, 2013, SPORTS MED, V43, P927, DOI 10.1007/s40279-013-0066-5; Buttner P, 2007, J APPL PHYSIOL, V102, P26, DOI 10.1152/japplphysiol.00066.2006; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Dallas G, 2013, J PHYS ED SPORT, V13, P27, DOI DOI 10.7752/JPES.2013.01005; Donnikov AE, 2008, B EXP BIOL MED+, V146, P462, DOI 10.1007/s10517-009-0334-4; DOTAN R, 1983, EUR J APPL PHYSIOL O, V51, P409, DOI 10.1007/BF00429077; Driessler F, 2004, CLIN EXP IMMUNOL, V135, P64, DOI 10.1111/j.1365-2249.2004.02342.x; Ecochard L, 2000, PFLUG ARCH EUR J PHY, V440, P918, DOI 10.1007/s004240000362; Farzad B, 2011, J STRENGTH COND RES, V25, P2392, DOI 10.1519/JSC.0b013e3181fb4a33; Fehrenbach E, 2000, MED SCI SPORT EXER, V32, P592, DOI 10.1097/00005768-200003000-00007; Franchini E, 2005, BIOL SPORT, V22, P315; Franchini E, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00268; Fuqua JS, 2013, METABOLISM, V62, P911, DOI 10.1016/j.metabol.2013.01.016; Gierczuk D, 2012, BIOL SPORT, V29, P235, DOI 10.5604/20831862.1003449; Gjevestad GO, 2015, CURR CARDIOVASC RISK, V9, DOI 10.1007/s12170-015-0463-4; Goswami A, 1998, J SPORT MED PHYS FIT, V38, P317; Hovsepian E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079445; Jastrzebski Z, 2015, GENET MOL RES, V14, P7538, DOI 10.4238/2015.July.3.29; Jastrzebski Z, 2014, BALT J HEALTH PHYS A, V6, P252, DOI 10.2478/bjha-2014-0023; Jemni M, 2000, J STRENGTH COND RES, V14, P389; Jemni M, 2006, J STRENGTH COND RES, V20, P899; Kimsa Magdalena C, 2014, Prague Med Rep, V115, P24; Leggate M, 2010, CELL STRESS CHAPERON, V15, P827, DOI 10.1007/s12192-010-0192-z; Lira FS, 2015, EUR J APPL PHYSIOL, V115, P1467, DOI 10.1007/s00421-015-3127-7; Maltseva DV, 2012, B EXP BIOL MED+, V153, P867, DOI 10.1007/s10517-012-1846-x; MORIMOTO RI, 1994, BIOL HEAT SHOCK PROT; Morton JP, 2009, SPORTS MED, V39, P643, DOI 10.2165/00007256-200939080-00003; Nagaraja GM, 2012, CURR MOL MED, V12, P1142, DOI 10.2174/156652412803306701; Neubauer O, 2013, J APPL PHYSIOL, V114, P1677, DOI 10.1152/japplphysiol.00143.2013; Nieman DC, 2006, J INTERF CYTOK RES, V26, P668, DOI 10.1089/jir.2006.26.668; Osawa Y, 2014, OPEN ACCESS J SPORTS, V5, P257, DOI 10.2147/OAJSM.S68932; Periard JD, 2012, CELL STRESS CHAPERON, V17, P375, DOI 10.1007/s12192-011-0313-3; Radom-Aizik S, 1985, J APPL PHYSIOL, V104, P236; Ravier G, 2009, SCAND J MED SCI SPOR, V19, P687, DOI 10.1111/j.1600-0838.2008.00807.x; Robbesyn F, 2004, FREE RADICAL RES, V38, P541, DOI 10.1080/10715760410001665244; RYAN AJ, 1991, J APPL PHYSIOL, V70, P466, DOI 10.1152/jappl.1991.70.1.466; Sakharov DA, 2012, EUR J APPL PHYSIOL, V112, P963, DOI 10.1007/s00421-011-2048-3; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Skrzydlewska E., 2005, ALERG ASTMA IMMUNOL, V10, P125; Szoltysek K, 2011, POSTEPY BIOL KOMORKI, V38, P159; WANG P, 1995, J BIOL CHEM, V270, P9558, DOI 10.1074/jbc.270.16.9558; WELCH WJ, 1992, PHYSIOL REV, V72, P1063, DOI 10.1152/physrev.1992.72.4.1063; Zeibig J, 2005, EUR J APPL PHYSIOL, V95, P96, DOI 10.1007/s00421-005-1334-3; Ziemann E, 2013, J SPORT SCI MED, V12, P282; Zychowska M, 2016, BALT J HEALTH PHYS A, V8, P18, DOI 10.29359/BJHPA.08.1.02	49	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171247	10.1371/journal.pone.0171247	http://dx.doi.org/10.1371/journal.pone.0171247			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141870	gold, Green Published, Green Submitted			2022-12-27	WOS:000396129500053
J	Ramzan, M; Bilal, M; Chung, JD				Ramzan, Muhammad; Bilal, Muhammad; Chung, Jae Dong			Radiative Flow of Powell-Eyring MagnetoNanofluid over a Stretching Cylinder with Chemical Reaction and Double Stratification near a Stagnation Point	PLOS ONE			English	Article							CONVECTIVE BOUNDARY-CONDITION; POROUS-MEDIUM; THERMAL-RADIATION; FLUID-FLOW; LAYER-FLOW; MHD FLOW; NANOFLUID; SORET; PLATE; SHEET	This exploration addresses MHD stagnation point Powell Eyring nanofluid flow with double stratification. The effects of thermal radiation and chemical reaction are added in temperature and nanoparticle concentration fields respectively. Furthermore, appropriate transformations are betrothed to obtain nonlinear differential equations from the system of partial differential equations and an analytical solution of system of coupled differential equations is obtained by means of the renowned Homotopy Analysis method. Through graphical illustrations, momentum, energy and concentration distributions are conversed for different prominent parameters. Comparison in limiting case is also part of present study to validate the obtained results. It is witnessed that nanoparticle concentration is diminishing function of chemical reaction parameter. Moreover, mounting values of thermal and solutal stratification lowers the temperature and concentration fields respectively.	[Ramzan, Muhammad] Bahria Univ, Dept Comp Sci, Islamabad Campus, Islamabad 44000, Pakistan; [Bilal, Muhammad] Capital Univ Sci & Technol, Fac Comp, Dept Math, Islamabad, Pakistan; [Chung, Jae Dong] Sejong Univ, Dept Mech Engn, Seoul 143747, South Korea	Capital University of Science & Technology; Sejong University	Ramzan, M (corresponding author), Bahria Univ, Dept Comp Sci, Islamabad Campus, Islamabad 44000, Pakistan.	mramzan@bahria.edu.pk	Ramzan, M./AAH-9959-2020	Ramzan, M./0000-0002-9523-5800	World Class 300 Project of the SMBA (Korea) [S2367878]	World Class 300 Project of the SMBA (Korea)	This work was supported by the World Class 300 Project (No. S2367878) of the SMBA (Korea).	Abbas Z, 2016, ENERGY, V95, P12, DOI 10.1016/j.energy.2015.11.039; Abbasi FM, 2016, J MAGN MAGN MATER, V404, P159, DOI 10.1016/j.jmmm.2015.11.090; Akbar NS, 2015, J MAGN MAGN MATER, V382, P355, DOI 10.1016/j.jmmm.2015.01.088; Dogonchi AS, 2016, J MOL LIQ, V220, P592, DOI 10.1016/j.molliq.2016.05.022; Hayat T, 2016, APPL MATH MECH-ENGL, V37, P919, DOI 10.1007/s10483-016-2093-9; Hayat T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156955; Hayat T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152555; Hayat T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133831; Hayat T, 2016, J AEROSPACE ENG, V29, DOI 10.1061/(ASCE)AS.1943-5525.0000501; Hayat T., 2016, THERMAL SCI; Hayat T, 2017, J AEROSPACE ENG, V30, DOI 10.1061/(ASCE)AS.1943-5525.0000674; Hayat T, 2017, THERM SCI, V21, P849, DOI 10.2298/TSCI141106052H; Hayat T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145332; Hayat T, 2016, INT J HEAT MASS TRAN, V92, P100, DOI 10.1016/j.ijheatmasstransfer.2015.08.013; Hayat T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127646; Hussain T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103719; Hussanan A, 2016, J TEKNOL, V78, P121; Hussanan A, 2015, MAEJO INT J SCI TECH, V9, P224; Hussanan A, 2014, EUR PHYS J PLUS, V129, DOI 10.1140/epjp/i2014-14046-x; Kaladhar K, 2017, COMPUT APPL MATH, V36, P611, DOI 10.1007/s40314-015-0248-x; Khan NA, 2015, INT J CHEM REACT ENG, V13, DOI 10.1515/ijcre-2014-0090; Liao S, 2004, APPL MATH COMPUT, V147, P499, DOI [10.1016/S0096-3003(02)00790-7, 10.1016/50096-3003(02)00790-7]; Powell RE, 1944, NATURE, V154, P427, DOI 10.1038/154427a0; Qasim M, 2014, EUR PHYS J PLUS, V129, DOI 10.1140/epjp/i2014-14024-4; Qasim M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083930; Ramzan M, 2016, J MOL LIQ, V221, P394, DOI 10.1016/j.molliq.2016.05.091; Ramzan M, 2016, ALEX ENG J, V55, P311, DOI 10.1016/j.aej.2015.09.012; Ramzan M, 2016, J MOL LIQ, V215, P212, DOI 10.1016/j.molliq.2015.12.036; Ramzan M, 2015, AIP ADV, V5, DOI 10.1063/1.4921312; Ramzan M, 2015, J CENT SOUTH UNIV, V22, P707, DOI 10.1007/s11771-015-2574-y; Ramzan M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124699; Shehzad SA, 2015, J CENT SOUTH UNIV, V22, P360, DOI 10.1007/s11771-015-2530-x; Sk MT, 2016, APPL THERM ENG, V104, P758, DOI 10.1016/j.applthermaleng.2016.05.129	33	49	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170790	10.1371/journal.pone.0170790	http://dx.doi.org/10.1371/journal.pone.0170790			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129356	Green Published, Green Submitted, gold			2022-12-27	WOS:000396211400034
J	Caudell, MA; Quinlan, MB; Subbiah, M; Call, DR; Roulette, CJ; Roulette, JW; Roth, A; Matthews, L; Quinlan, RJ				Caudell, Mark A.; Quinlan, Marsha B.; Subbiah, Murugan; Call, Douglas R.; Roulette, Casey J.; Roulette, Jennifer W.; Roth, Adam; Matthews, Louise; Quinlan, Robert J.			Antimicrobial Use and Veterinary Care among Agro-Pastoralists in Northern Tanzania	PLOS ONE			English	Article							ANTIBIOTIC USE; RESISTANCE; FOOD; PASTORALISTS; PERSPECTIVE; RESILIENCE; KNOWLEDGE; WORLDWIDE; FARMERS; ARUSHA	Frequent and unregulated use of antimicrobials (AM) in livestock requires public health attention as a likely selection pressure for resistant bacteria. Studies among small-holders, who own a large percentage of the world's livestock, are vital for understanding how practices involving AM use might influence resistance. We present a cultural-ecological mixedmethods analysis to explore sectors of veterinary care, loosely regulated AM use, and human exposure to AMs through meat and milk consumption across three rural to periurban Tanzanian ethnic groups (N = 415 households). Reported use of self-administered AMs varied by ethnic group (Maasai: 74%, Arusha: 21%, Chagga: 1%) as did consultation with professional veterinarians (Maasai: 36%, Arusha: 45%, Chagga: 96%) and observation of withdrawal of meat and milk from consumption during and following AM treatment (Maasai: 7%, Arusha: 72%, Chagga: 96%). The antibiotic oxytetracycline was by far the most common AM in this sample. Within ethnic groups, herd composition differences, particularly size of small-stock and cattle herds, were most strongly associated with differences in lay AM use. Among the Arusha, proxies for urbanization, including owning transportation and reliance on "zero-grazing" herds had the strongest positive associations with veterinarian consultation, while distance to urban centers was negatively associated. For Maasai, consultation was negatively associated with use of traditional healers or veterinary drug-shops. Observation of withdrawal was most strongly associated with owning technology among Maasai while Arusha observance displayed seasonal differences. This "One-Health" analysis suggests that livelihood and cultural niche factors, through their association with practices in smallholder populations, provide insight into the selection pressures that may contribute to the evolution and dissemination of antimicrobial resistance.	[Caudell, Mark A.; Quinlan, Marsha B.; Subbiah, Murugan; Call, Douglas R.; Quinlan, Robert J.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Caudell, Mark A.; Quinlan, Marsha B.; Roulette, Jennifer W.; Quinlan, Robert J.] Washington State Univ, Dept Anthropol, Pullman, WA 99164 USA; [Roulette, Casey J.] San Diego State Univ, Dept Anthropol, San Diego, CA 92182 USA; [Roth, Adam] Washington State Univ, Dept Sociol, Pullman, WA 99164 USA; [Matthews, Louise] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland	Washington State University; Washington State University; California State University System; San Diego State University; Washington State University; University of Glasgow	Quinlan, RJ (corresponding author), Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.; Quinlan, RJ (corresponding author), Washington State Univ, Dept Anthropol, Pullman, WA 99164 USA.	rquinlan@wsu.edu	Roulette, Casey J/HGB-9551-2022	Roulette, Jennifer/0000-0002-4362-4927; Quinlan, Marsha/0000-0002-9311-9494	National Science Foundation: Ecology and Evolution of Infectious Diseases [DEB1216040]; BBRSC [BB/K01126X/1]; BBSRC [BB/P004202/1, BB/K01126X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/P004202/1, 1371607, BB/K01126X/1, 1096845] Funding Source: researchfish	National Science Foundation: Ecology and Evolution of Infectious Diseases; BBRSC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	National Science Foundation: Ecology and Evolution of Infectious Diseases: DEB1216040 DRC, RJQ, MBQ, LM https://urldefense.proofpoint.com/v2/url?u=http-3A_www.nsf.gov_funding_com/v2/url?u=http-3A_www.nsf.gov_funding_pgm-5Fsumm.jsp-3Fpims-5Fid-3D5269&d=DgIGaQ&c=C3yme8gMkxg_ihJNXSO6ZyWk4EJm8LdrrvxQb-Je7sw&r=_jmO53oaugwTxQtMBRzTrg&m=dm11xz98owEqtCiC4GSdhnMeD-iwt6WCLXOOW42_MCQ&s=s4bsaZlglhMdSoGxRKCX6s6HRTv3mvGFdsnDAk01QoU&e-. BBRSC grant BB/K01126X/1.	Ahmed H, 201617 WASH STAT U S; [Anonymous], 2011, RES METHODS ANTHR; ANYINAM C, 1987, SOC SCI MED, V25, P803, DOI 10.1016/0277-9536(87)90038-4; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Campbell DJ, 2004, COMPARING KENYAN TAN; Carlet J, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-11; Caudell M, 2015, SOC NETWORKS, V40, P34, DOI 10.1016/j.socnet.2014.07.003; Colquhoun D, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140216; Darwish WS, 2013, JPN J VET RES, V61, pS13; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Eltayb A, 2012, ZOONOSES PUBLIC HLTH, V59, P330, DOI 10.1111/j.1863-2378.2012.01458.x; FAO, 2013, WORLD AGR 2015 2030; Fratkin E., 2001, AFR STUD REV, V44, P1, DOI [10.2307/525591, DOI 10.2307/525591]; Fratkin E., 2011, LAIBON; Galvin KA, 2009, ANNU REV ANTHROPOL, V38, P185, DOI 10.1146/annurev-anthro-091908-164442; Graeub BE, WORLD DEV; Helman CG, 2007, CULTURE HLTH ILLNESS; Hodgson Dorothy., 2001, ONCE INTREPID WARRIO, P48; Kioko J, 2015, VET WORLD, V8, P755, DOI 10.14202/vetworld.2015.755-762; Kleinman A., 1981, PATIENTS HEALERS CON; Landers TF, 2012, PUBLIC HEALTH REP, V127, P4, DOI 10.1177/003335491212700103; Leslie P, 2013, CURR ANTHROPOL, V54, P114, DOI 10.1086/669563; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; McCabe JT, 2010, HUM ECOL, V38, P322, DOI 10.1007/s10745-010-9312-8; McCabe J. Terrence, 2004, CATTLE BRING US OUR; McCorkle C. M., 1992, Africa (London), V62, P59, DOI 10.2307/1160064; McCorkle C. M., 1995, Agriculture and Human Values, V12, P52, DOI 10.1007/BF02217297; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Norval RAI., 1992, EPIDEMIOLOGY THEILER; Omulo S, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-014-0041-4; Palmer GH, 2013, ANTIMICROBIAL RESIST; Quinlan RJ, 2016, ETHNOBIOL LETT, V7, P76; Quinlan RJ, 2015, J ETHNOBIOL, V35, P314, DOI 10.2993/etbi-35-02-314-336.1; Redding LE, 2014, PREV VET MED, V113, P88, DOI 10.1016/j.prevetmed.2013.10.012; Roderick S, 2000, TROP ANIM HEALTH PRO, V32, P361, DOI 10.1023/A:1005277518352; Roth EA, 2005, PASTORALISTS SETTLE; Roulette C, MAASAI DIETARY ADDIT; Rugumisa B. T., 2016, African Journal of Microbiology Research, V10, P1422; Rugumisa BT, 2016, J FOOD PROTECT, V79, P1424, DOI 10.4315/0362-028X.JFP-15-584; Sarmah AK, 2006, CHEMOSPHERE, V65, P725, DOI 10.1016/j.chemosphere.2006.03.026; Sato A, 2012, SOC SCI MED, V75, P1450, DOI 10.1016/j.socscimed.2012.05.032; Silbergeld EK, 2008, ANNU REV PUBL HEALTH, V29, P151, DOI 10.1146/annurev.publhealth.29.020907.090904; SPEAR T, 1992, INT J AFR HIST STUD, V25, P481, DOI 10.2307/219022; Spear Thomas, 1997, MOUNTAIN FARMERS MOR; Stahl K.M., 1964, HIST CHAGGA PEOPLE K; Steinfeld H, 2004, VET PARASITOL, V125, P19, DOI 10.1016/j.vetpar.2004.05.003; Thumbi SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120761; Turnidge J, 2005, LANCET, V365, P548; Wasserstein RL, 2016, AM STAT	49	59	59	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170328	10.1371/journal.pone.0170328	http://dx.doi.org/10.1371/journal.pone.0170328			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7IT	28125722	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000396176100118
J	Ma, C; Pi, CC; Yang, Y; Lin, L; Shi, YG; Li, Y; Li, YL; He, X				Ma, Cao; Pi, Chenchen; Yang, Yue; Lin, Lin; Shi, Yingai; Li, Yan; Li, Yulin; He, Xu			Nampt Expression Decreases Age-Related Senescence in Rat Bone Marrow Mesenchymal Stem Cells by Targeting Sirt1	PLOS ONE			English	Article							NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; DNA-DAMAGE; CELLULAR SENESCENCE; BETA-GALACTOSIDASE; IN-VIVO; OXIDATIVE STRESS; NAD BIOSYNTHESIS; LIFE-SPAN; TELOMERASE; METABOLISM	Senescence restricts the development of applications involving mesenchymal stem cells (MSCs) in research fields, such as tissue engineering, and stem cell therapeutic strategies. Understanding the mechanisms underlying natural aging processes may contribute to the development of novel approaches to preventing age-related diseases or slowing individual aging processes. Nampt is a rate-limiting NAD biosynthetic enzyme that plays critical roles in energy metabolism, cell senescence and maintaining life spans. However, it remains unknown whether Nampt influences stem cell senescence. In this study, the function of Nampt was investigated using a rat model of natural aging. Our data show that Nampt expression was significantly lower in MSCs obtained from aged rats than in those obtained from young rats during physiological aging. Reducing the level of Nampt in aged MSCs resulted in lower intracellular concentrations of NAD+ and downregulated Sirt1 expression and activity. After the Nampt inhibitor FK866 was added, young MSCs were induced to become aged cells. The enhanced senescence was correlated with NAD+ depletion and Sirt1 activity attenuation. In addition, Nampt overexpression attenuated cell senescence in aged MSCs. Our findings provide a new explanation for the mechanisms underlying stem cell senescence and a novel target for delaying stem cell senescence and preventing and treating age-related diseases.	[Ma, Cao; Pi, Chenchen; Yang, Yue; Lin, Lin; Shi, Yingai; Li, Yulin; He, Xu] Jilin Univ, Coll Basic Med Sci, Minist Educ, Key Lab Pathobiol, Changchun, Peoples R China; [Ma, Cao] Southeast Univ, Sch Med, Zhongda Hosp, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Li, Yan] Sahlgrens Univ Hosp, CARE, Molndal, Sweden	Jilin University; Southeast University - China; Sahlgrenska University Hospital	He, X (corresponding author), Jilin Univ, Coll Basic Med Sci, Minist Educ, Key Lab Pathobiol, Changchun, Peoples R China.	hexu@jlu.edu.cn		Pi, Chenchen/0000-0002-5177-4108	National Natural Science Foundation of China [81571370]; Jilin Provincial Science and Technology Projects [20150414029GH, 20130101130JC]; Norman Bethune Program of Jilin University [2012204]; Science and Technology Projects of the Education Department of Jilin Province [447]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin Provincial Science and Technology Projects; Norman Bethune Program of Jilin University; Science and Technology Projects of the Education Department of Jilin Province	This study was supported by National Natural Science Foundation of China (81571370, to XH), Jilin Provincial Science and Technology Projects (20150414029GH and 20130101130JC, to XH), Norman Bethune Program of Jilin University (2012204, to XH), and Science and Technology Projects of the Education Department of Jilin Province (Code (2016) 447, to XH). The funders had roles in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016; Boyette LB, 2014, J CLIN MED, V3, P88, DOI 10.3390/jcm3010088; Chen HQ, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00103; Choudhery MS, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-8; de Lapuente J, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00180; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dobbin MM, 2013, NAT NEUROSCI, V16, P1008, DOI 10.1038/nn.3460; Droge W, 2003, ADV EXP MED BIOL, V543, P191; El-Fadaly AB, 2014, ANN ANAT, V196, P336, DOI 10.1016/j.aanat.2014.06.005; Feng XM, 2014, MECH AGEING DEV, V141, P46, DOI 10.1016/j.mad.2014.09.004; Gruber HE, 2007, SPINE, V32, P321, DOI 10.1097/01.brs.0000253960.57051.de; Huang PX, 2015, ONCOTARGET, V6, P10812, DOI 10.18632/oncotarget.3580; Imai S, 2013, DIABETES OBES METAB, V15, P26, DOI 10.1111/dom.12171; Imai S, 2011, FEBS LETT, V585, P1657, DOI 10.1016/j.febslet.2011.04.060; Imai SI, 2010, PHARMACOL RES, V62, P42, DOI 10.1016/j.phrs.2010.01.006; Imai SI, 2010, BBA-PROTEINS PROTEOM, V1804, P1584, DOI 10.1016/j.bbapap.2009.10.024; Imai S, 2009, CURR PHARM DESIGN, V15, P20, DOI 10.2174/138161209787185814; Koltai E, 2010, MECH AGEING DEV, V131, P21, DOI 10.1016/j.mad.2009.11.002; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Nakamura AJ, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-6; Naylor RM, 2013, CLIN PHARMACOL THER, V93, P105, DOI 10.1038/clpt.2012.193; Oh J, 2014, NAT MED, V20, P870, DOI 10.1038/nm.3651; Palacios JA, 2010, J CELL BIOL, V191, P1299, DOI 10.1083/jcb.201005160; PREISS J, 1957, J BIOL CHEM, V225, P759; Rehan L, 2014, LIFE SCI, V105, P1, DOI 10.1016/j.lfs.2014.03.015; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Serakinci N, 2008, BIOCHIMIE, V90, P33, DOI 10.1016/j.biochi.2007.09.005; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Sikora E, 2011, AGEING RES REV, V10, P146, DOI 10.1016/j.arr.2010.10.002; Song J, 2014, J GERONTOL A-BIOL, V69, P44, DOI 10.1093/gerona/glt122; Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Takeuchi S, 2010, CANCER RES, V70, P9381, DOI 10.1158/0008-5472.CAN-10-0801; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200; Zeng Y, 2015, BIOCHEM BIOPH RES CO, V468, P167, DOI 10.1016/j.bbrc.2015.10.139; Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693; Zhou D, 2015, MED SCI MONITOR, V21, P3728, DOI 10.12659/MSM.895596; Zvereva MI, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1563, DOI 10.1134/S0006297910130055	41	39	40	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170930	10.1371/journal.pone.0170930	http://dx.doi.org/10.1371/journal.pone.0170930			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125705	Green Submitted, Green Published, gold			2022-12-27	WOS:000396176100022
J	Carbia, C; Cadaveira, F; Caamano-Isorna, F; Rodriguez-Holguin, S; Corral, M				Carbia, Carina; Cadaveira, Fernando; Caamano-Isorna, Francisco; Rodriguez-Holguin, Socorro; Corral, Montse			Binge drinking during adolescence and young adulthood is associated with deficits in verbal episodic memory	PLOS ONE			English	Article							ALCOHOL-USE; HIPPOCAMPAL FUNCTION; WEEKEND ALCOHOLISM; ETHANOL EXPOSURE; PERSISTENT LOSS; LEARNING TEST; NEUROGENESIS; BRAIN; PERFORMANCE; CONSUMPTION	Binge drinking (BD), a harmful pattern of alcohol consumption, is common during adolescence. Young adults with alcohol use disorders exhibit hippocampal alterations and episodic memory deficits. However, it is not known how these difficulties progress in community BD adolescents. Our objective was to analyze the relationship between BD trajectory and verbal episodic memory during the developmental period spanning from adolescence and to early adulthood. An initial sample of 155 male and female first-year university students with no other risk factors were followed over six years. Participants were classified as stable nonBDs, stable BDs and ex-BDs according to the third AUDIT item. At baseline, participants comprised 36 male/40 female non-BDs (18.58 years), 40 male/39 female BDs (18.87 years), and at the third follow-up, they comprised 8 cf/8 9 stable non-BDs (25.49 years), 2 male/2 female stable BDs (25.40) and 8 male/12 female ex-BDs (24.97 years). Episodic memory was assessed four times with the Logical Memory subtest (WMS-III) and the Rey Auditory Verbal Learning Test (RAVLT). Generalized linear mixed models were applied. The results showed that, relative to non-BDs, stable BDs presented difficulties in immediate and delayed recall in the Logical Memory subtest. These difficulties remained stable over time. The short-term ex-BDs continued to display difficulties in immediate and delayed recall in the Logical Memory subtest, but long-term ex-BDs did not. The effects were not influenced by age of alcohol onset, frequency of cannabis use, tobacco use or psychopathological distress. In conclusion, BD during adolescence and young adulthood is associated with episodic memory deficits. Abandoning the BD pattern may lead to partial recovery. These findings are consistent with the vulnerability of the adolescent hippocampus to the neurotoxic effects of alcohol.	[Carbia, Carina; Cadaveira, Fernando; Rodriguez-Holguin, Socorro; Corral, Montse] Univ Santiago de Compostela, Dept Clin Psychol & Psychobiol, Santiago De Compostela, Spain; [Caamano-Isorna, Francisco] Univ Santiago de Compostela, Consortium Biomed Res Epidemiol & Publ Hlth CIBER, Dept Prevent Med, Santiago De Compostela, Spain	Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universidade de Santiago de Compostela	Carbia, C (corresponding author), Univ Santiago de Compostela, Dept Clin Psychol & Psychobiol, Santiago De Compostela, Spain.	carina.carbia@usc.es	Cadaveira, Fernando/ABE-7827-2021; Varela, Montserrat Corral/AEP-7949-2022; Cadaveira, Fernando/C-5981-2011; Holguín, Socorro Rodríguez/D-1800-2010; Caamano-Isorna, Francisco/AAL-3770-2020; Varela, Montserrat Corral/A-6384-2012	Cadaveira, Fernando/0000-0001-6198-1541; Varela, Montserrat Corral/0000-0003-3068-3415; Cadaveira, Fernando/0000-0001-6198-1541; Holguín, Socorro Rodríguez/0000-0003-1502-987X; Carbia, Carina/0000-0001-7921-8966; Caamano-Isorna, Francisco/0000-0001-8995-3673	Spanish Ministerio de Ciencia e Innovacion [EDU2008-03400, PSI2011-22575]; Spanish Ministerio de Educacion [FPU13/04569]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Spanish Ministerio de Educacion(Spanish Government)	The study was supported by grants from the Spanish Ministerio de Ciencia e Innovacion (EDU2008-03400; PSI2011-22575). Carina Carbia was supported by the FPU program (FPU13/04569) of the Spanish Ministerio de Educacion.	Alexander MP, 2003, BRAIN, V126, P1493, DOI 10.1093/brain/awg128; Baldo JV, 2002, J INT NEUROPSYCH SOC, V8, P539, DOI 10.1017/S135561770281428X; Bava S, 2010, NEUROPSYCHOL REV, V20, P398, DOI 10.1007/s11065-010-9146-6; Bernardin F, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00078; Broadwater MA, 2014, DEV NEUROSCI-BASEL, V36, P297, DOI 10.1159/000362874; Brooks BL, 2006, CLIN NEUROPSYCHOL, V20, P230, DOI 10.1080/13854040590947461; Brown H., APPL MIXED MODELS ME; Brown SA, 2000, ALCOHOL CLIN EXP RES, V24, P164, DOI 10.1111/j.1530-0277.2000.tb04586.x; Brown SA, 2004, ANN NY ACAD SCI, V1021, P234, DOI 10.1196/annals.1308.028; Buhler M, 2011, ALCOHOL CLIN EXP RES, V35, P1771, DOI 10.1111/j.1530-0277.2011.01540.x; Caamano-Isorna F, 2008, J STUD ALCOHOL DRUGS, V69, P308, DOI 10.15288/jsad.2008.69.308; Chin VS, 2010, ALCOHOL, V44, P3, DOI 10.1016/j.alcohol.2009.10.015; Consonni M, 2015, J NEUROPSYCHOL, V242, DOI [10.1080/13854040590947461, DOI 10.1080/13854040590947461]; Crews FT, 2000, ALCOHOL CLIN EXP RES, V24, P1712, DOI 10.1111/j.1530-0277.2000.tb01973.x; Crews FT, 2006, NEUROSCIENCE, V137, P437, DOI 10.1016/j.neuroscience.2005.08.090; Crews F, 2007, PHARMACOL BIOCHEM BE, V86, P189, DOI 10.1016/j.pbb.2006.12.001; De Bellis MD, 2000, AM J PSYCHIAT, V157, P737, DOI 10.1176/appi.ajp.157.5.737; Degoratis LR, 1983, SCL90R; Doallo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096380; Ferrett HL, 2010, DRUG ALCOHOL DEPEN, V110, P8, DOI 10.1016/j.drugalcdep.2010.01.019; FRISK V, 1990, NEUROPSYCHOLOGIA, V28, P349, DOI 10.1016/0028-3932(90)90061-R; Garcioa-Moreno L M, 2009, NEUROPSICOLOGIA NEUR, V9, P75; GERSHBERG FB, 1995, NEUROPSYCHOLOGIA, V33, P1305, DOI 10.1016/0028-3932(95)00103-A; Gibbons RD, 2010, ANNU REV CLIN PSYCHO, V6, P79, DOI 10.1146/annurev.clinpsy.032408.153550; Guerri C, 2010, ALCOHOL, V44, P15, DOI 10.1016/j.alcohol.2009.10.003; Hanson KL, 2011, PSYCHOL ADDICT BEHAV, V25, P127, DOI 10.1037/a0022350; Hanson KL, 2010, AM J DRUG ALCOHOL AB, V36, P161, DOI 10.3109/00952991003736397; Hartley DE, 2004, PHARMACOL BIOCHEM BE, V78, P611, DOI 10.1016/j.pbb.2004.04.027; He J, 2007, PHARMACOL BIOCHEM BE, V86, P327, DOI 10.1016/j.pbb.2006.11.003; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; HIRST W, 1988, BRAIN COGNITION, V8, P379, DOI 10.1016/0278-2626(88)90060-7; Howell NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074164; Kuntsche E, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13826; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Lundervold AJ, 2015, J ATTEN DISORD; Marshall EJ, 2014, ALCOHOL ALCOHOLISM, V49, P160, DOI 10.1093/alcalc/agt180; Medina KL, 2007, NEUROTOXICOL TERATOL, V29, P141, DOI 10.1016/j.ntt.2006.10.010; Garcia-Moreno L, 2008, ADICCIONES, V20, P271, DOI 10.20882/adicciones.269; Mitrushina M., 2005, HDB NORMATIVE DATA N; Morris SA, 2010, HIPPOCAMPUS, V20, P596, DOI 10.1002/hipo.20665; Moscovitch M, 2016, ANNU REV PSYCHOL, V67, P105, DOI 10.1146/annurev-psych-113011-143733; Mota N, 2013, DRUG ALCOHOL DEPEN, V133, P108, DOI 10.1016/j.drugalcdep.2013.05.024; Nagel BJ, 2005, PSYCHIAT RES-NEUROIM, V139, P181, DOI 10.1016/j.pscychresns.2005.05.008; National Institute on Alcohol Abuse and Alcoholism, 2004, NIAAA NEWSLETTER, V3, P3, DOI DOI 10.1037/E306662005-004; Nguyen-Louie TT, 2016, ALCOHOL CLIN EXP RES, V40, p303A, DOI 10.1111/acer.13160; Nixon K, 2010, CURR OPIN PSYCHIATR, V23, P227, DOI 10.1097/YCO.0b013e32833864fe; Nixon K, 2010, ALCOHOL, V44, P39, DOI 10.1016/j.alcohol.2009.11.001; Oliveira ACA, 2015, J PSYCHOPHARMACOL, V29, P712, DOI 10.1177/0269881115581960; Oscar-Berman M, 2007, NEUROPSYCHOL REV, V17, P239, DOI 10.1007/s11065-007-9038-6; Parada M, 2012, ADDICT BEHAV, V37, P167, DOI 10.1016/j.addbeh.2011.09.015; Parada M, 2011, ALCOHOL CLIN EXP RES, V35, P1475, DOI 10.1111/j.1530-0277.2011.01484.x; Pascual M, 2014, ALCOHOL ALCOHOLISM, V49, P187, DOI 10.1093/alcalc/agt164; R Core Team, 2013, R LANG ENV STAT COMP; Rey A, 1964, LEXAMEN CLINIQUE PSY; Rouleau I, 2001, BRAIN COGNITION, V46, P244, DOI 10.1016/S0278-2626(01)80076-2; Salas-Gomez D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166834; Sanhueza C, 2011, PSICOTHEMA, V23, P209; Sawrie SM, 2001, EPILEPSIA, V42, P651, DOI 10.1046/j.1528-1157.2001.30200.x; Scaife JC, 2009, PHARMACOL BIOCHEM BE, V93, P354, DOI 10.1016/j.pbb.2009.05.015; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; SHIMAMURA AP, 1995, J COGNITIVE NEUROSCI, V7, P144, DOI 10.1162/jocn.1995.7.2.144; Shing YL, 2010, NEUROSCI BIOBEHAV R, V34, P1080, DOI 10.1016/j.neubiorev.2009.11.002; Silveri MM, 2016, NEUROSCI BIOBEHAV R, V70, P244, DOI 10.1016/j.neubiorev.2016.06.042; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Sneider JT, 2013, J ADDICT RES THER S7; Spear LP, 2013, J ADOLESCENT HEALTH, V52, pS7, DOI 10.1016/j.jadohealth.2012.05.006; Squeglia LM, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0689-y; Squeglia Lindsay M, 2012, Psychopharmacology (Berl), V220, P529, DOI 10.1007/s00213-011-2500-4; Stuss D.T., 1994, NEUROPSYCHOLOGY, V8, P355, DOI [10.1037/0894-4105.8.3.355, DOI 10.1037/0894-4105.8.3.355, https://doi.org/10.1037/0894-4105.8.3.355]; Substance Abuse and Mental Health, 2013, USITC PUBL; Substance Abuse and Mental Health Services Administration, 2013, NSDUH SER H, VH-46; Taffe MA, 2010, P NATL ACAD SCI USA, V107, P11104, DOI 10.1073/pnas.0912810107; Tremont G, 2000, CLIN NEUROPSYCHOL, V14, P295, DOI 10.1076/1385-4046(200008)14:3;1-P;FT295; Vargas WM, 2014, J NEUROSCI, V34, P14777, DOI 10.1523/JNEUROSCI.3189-13.2014; Vetreno RP, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00035; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wechsler D., 1997, WECHSLER ADULT INTEL; White AM, 2004, ANN NY ACAD SCI, V1021, P206, DOI 10.1196/annals.1308.026; White AM, 2000, HIPPOCAMPUS, V10, P88, DOI 10.1002/(SICI)1098-1063(2000)10:1<88::AID-HIPO10>3.0.CO;2-L; Winward JL, 2014, J INT NEUROPSYCH SOC, V20, P218, DOI 10.1017/S1355617713001410; Woodard JL, 1999, J CLIN EXP NEUROPSYC, V21, P553, DOI 10.1076/jcen.21.4.553.878	81	43	44	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171393	10.1371/journal.pone.0171393	http://dx.doi.org/10.1371/journal.pone.0171393			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28152062	Green Submitted, gold, Green Published			2022-12-27	WOS:000396161200139
J	Elaish, M; Ngunjiri, JM; Ali, A; Xia, M; Ibrahim, M; Jang, H; Hiremath, J; Dhakal, S; Helmy, YA; Jiang, X; Renukaradhya, GJ; Lee, CW				Elaish, Mohamed; Ngunjiri, John M.; Ali, Ahmed; Xia, Ming; Ibrahim, Mahmoud; Jang, Hyesun; Hiremath, Jagadish; Dhakal, Santosh; Helmy, Yosra A.; Jiang, Xi; Renukaradhya, Gourapura J.; Lee, Chang-Won			Supplementation of inactivated influenza vaccine with norovirus P particle-M2e chimeric vaccine enhances protection against heterologous virus challenge in chickens	PLOS ONE			English	Article							INTEGRAL MEMBRANE-PROTEIN; IMPROVED CROSS-PROTECTION; INFECTED-CELL SURFACE; A VIRUS; M2 PROTEIN; EXTRACELLULAR DOMAIN; MONOCLONAL-ANTIBODY; FUSION PROTEIN; EPITOPE; H5	The current inactivated influenza vaccines provide satisfactory protection against homologous viruses but limited cross-protection against antigenically divergent strains. Consequently, there is a need to develop more broadly protective vaccines. The highly conserved extracellular domain of the matrix protein 2 (M2e) has shown promising results as one of the components of a universal influenza vaccine in different animal models. As an approach to overcome the limited, strain specific, protective efficacy of inactivated influenza vaccine (IIV), a combination of recombinant M2e expressed on the surface of norovirus P particle (M2eP) and IIV was tested in chickens. Co-immunization of birds with both vaccines did not affect the production of M2e-specific IgG antibodies compared to the group vaccinated with M2eP alone. However, the co-immunized birds developed significantly higher pre-challenge hemagglutination inhibition antibody titers against the homologous IIV antigen and heterologous challenge virus. These combined vaccine groups also had cross reactive antibody responses against different viruses (H5, H6, and H7 subtypes) compared to the IIV alone vaccinated group. Upon intranasal challenge with homologous and heterologous viruses, the combined vaccine groups showed greater reduction in viral shedding in tracheal swabs compared to those groups receiving IIV alone. Moreover, M2eP antisera from vaccinated birds were able to bind to the native M2 expressed on the surface of whole virus particles and infected cells, and inhibit virus replication in vitro. Our results support the potential benefit of supplementing IIV with M2eP, to expand the vaccine cross protective efficacy.	[Elaish, Mohamed; Ngunjiri, John M.; Ali, Ahmed; Ibrahim, Mahmoud; Jang, Hyesun; Hiremath, Jagadish; Dhakal, Santosh; Helmy, Yosra A.; Renukaradhya, Gourapura J.; Lee, Chang-Won] Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Wooster, OH 44691 USA; [Elaish, Mohamed; Jang, Hyesun; Hiremath, Jagadish; Dhakal, Santosh; Renukaradhya, Gourapura J.; Lee, Chang-Won] Ohio State Univ, Coll Vet Med, Dept Vet Prevent Med, Columbus, OH 43210 USA; [Xia, Ming; Jiang, Xi] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH USA; [Ali, Ahmed] Beni Suef Univ, Fac Vet Med, Poultry Dis Dept, Bani Suwayf, Egypt; [Ibrahim, Mahmoud] Univ Sadat City, Fac Vet Med, Dept Birds & Rabbit Med, Menoufia, Egypt	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Egyptian Knowledge Bank (EKB); Beni Suef University; Egyptian Knowledge Bank (EKB); University of Sadat City	Lee, CW (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Wooster, OH 44691 USA.	lee.2854@osu.edu	Elaish, Mohamed/AAT-4642-2020; Helmy, Yosra A./I-9426-2019; Dhakal, Santosh/J-2906-2019; Ngunjiri, John/AAB-3798-2021; Xia, Ming/AAY-7154-2021; Jang, Hyesun/AAG-7814-2021; Ali, Ahmed/B-5108-2013	Helmy, Yosra A./0000-0003-1470-5418; Dhakal, Santosh/0000-0002-4494-8608; Ngunjiri, John/0000-0002-2131-1698; Ali, Ahmed/0000-0002-2576-2031; Elaish, Mohamed/0000-0003-3628-5856; Ibrahim, Mahmoud/0000-0002-8259-7706; Jang, Hyesun/0000-0002-8142-8222	Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture [2013-67015-20476]; Ohio Agricultural Research and Development Center, The Ohio State University; Egyptian Ministry of Higher Education	Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture; Ohio Agricultural Research and Development Center, The Ohio State University(Ohio State University); Egyptian Ministry of Higher Education(Science and Technology Development Fund (STDF))	This study was supported by Agriculture and Food Research Initiative Competitive Grant no. 2013-67015-20476 from the USDA National Institute of Food and Agriculture and funds appropriated to the Ohio Agricultural Research and Development Center, The Ohio State University. Mohamed Elaish is supported by a PhD scholarship from the Egyptian Ministry of Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babapoor S, 2011, INFLUENZA RES TREAT, V2011; Chande C, 1996, Indian J Pathol Microbiol, V39, P27; Dabaghian M, 2014, VET MICROBIOL, V174, P116, DOI 10.1016/j.vetmic.2014.09.009; De Filette M, 2006, VACCINE, V24, P6597, DOI 10.1016/j.vaccine.2006.05.082; De Filette M, 2008, VACCINE, V26, P6503, DOI 10.1016/j.vaccine.2008.09.038; Deng L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126650; Du LY, 2010, MICROBES INFECT, V12, P280, DOI 10.1016/j.micinf.2010.01.001; Ebrahimi SM, 2010, MOL BIOL REP, V37, P2877, DOI 10.1007/s11033-009-9846-2; El Bakkouri K, 2011, J IMMUNOL, V186, P1022, DOI 10.4049/jimmunol.0902147; Elaish M, 2015, VACCINE, V33, P4901, DOI 10.1016/j.vaccine.2015.07.049; Ernst WA, 2006, VACCINE, V24, P5158, DOI 10.1016/j.vaccine.2006.04.008; Fan JA, 2004, VACCINE, V22, P2993, DOI 10.1016/j.vaccine.2004.02.021; Fiers W, 2009, VACCINE, V27, P6280, DOI 10.1016/j.vaccine.2009.07.007; Gabbard J, 2009, PROTEIN ENG DES SEL, V22, P189, DOI 10.1093/protein/gzn070; Hashemi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045765; HOLSINGER LJ, 1991, VIROLOGY, V183, P32, DOI 10.1016/0042-6822(91)90115-R; HUGHEY PG, 1995, VIROLOGY, V212, P411, DOI 10.1006/viro.1995.1498; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Jang H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156603; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Kapczynski DR, 2009, CURR TOP MICROBIOL, V333, P133, DOI 10.1007/978-3-540-92165-3_6; Kim MC, 2014, VACCINE; Kim MC, 2014, MOL THER, V22, P1364, DOI 10.1038/mt.2014.33; Kim MC, 2013, MOL THER, V21, P485, DOI 10.1038/mt.2012.246; LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9; Layton SL, 2009, POULTRY SCI, V88, P2244, DOI 10.3382/ps.2009-00251; Lee CW, 2004, J VIROL METHODS, V119, P151, DOI 10.1016/j.jviromet.2004.03.014; 박형록, 2013, [Journal of Preventive Veterinary Medicine, 예방수의학회지], V37, P169; Lee YN, 2015, IMMUNE NETW, V15, P213, DOI 10.4110/in.2015.15.5.213; Lee YN, 2015, ANTIVIR RES, V122, P82, DOI 10.1016/j.antiviral.2015.08.001; Liu WL, 2004, VACCINE, V23, P366, DOI 10.1016/j.vaccine.2004.05.028; Liu WL, 2004, IMMUNOL LETT, V93, P131, DOI 10.1016/j.imlet.2004.03.003; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Park JK, 2014, VET MICROBIOL, V169, P211, DOI 10.1016/j.vetmic.2014.01.001; Pawar SD, 2015, J VIROL METHODS, V222, P28, DOI 10.1016/j.jviromet.2015.05.004; Pedersen Janice C., 2008, V436, P53, DOI 10.1007/978-1-59745-279-3_8; Perdue ML, 2005, AVIAN DIS, V49, P317, DOI 10.1637/7390-060305R.1; Pica N, 2013, ANNU REV MED, V64, P189, DOI [10.1146/annurev-med-120611-145115, 10.1146/annure]; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; RYANPOIRIER KA, 1991, J VIROL, V65, P389, DOI 10.1128/JVI.65.1.389-395.1991; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Song BM, 2016, VACCINE, V34, P678, DOI 10.1016/j.vaccine.2015.11.074; Song JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014538; Song JM, 2011, P NATL ACAD SCI USA, V108, P757, DOI 10.1073/pnas.1012199108; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Stepanova LA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119520; Swayne DE, 1999, AVIAN PATHOL, V28, P245, DOI 10.1080/03079459994731; Tan M, 2008, VIROLOGY, V382, P115, DOI 10.1016/j.virol.2008.08.047; Tan M, 2012, NANOMEDICINE-UK, V7, P889, DOI [10.2217/nnm.12.62, 10.2217/NNM.12.62]; Tan M, 2011, J VIROL, V85, P753, DOI 10.1128/JVI.01835-10; TREANOR JJ, 1990, J VIROL, V64, P1375, DOI 10.1128/JVI.64.3.1375-1377.1990; Tumpey TM, 2005, J CLIN MICROBIOL, V43, P676, DOI 10.1128/JCM.43.2.676-683.2005; Wu F, 2007, VACCINE, V25, P8868, DOI 10.1016/j.vaccine.2007.09.056; Wu F, 2009, VACCINE, V27, P6095, DOI 10.1016/j.vaccine.2008.11.037; Xia M, 2011, VACCINE, V29, P7670, DOI 10.1016/j.vaccine.2011.07.139; Yong CY, 2015, INT J NANOMED, V10, P2751, DOI 10.2147/IJN.S77405; ZEBEDEE SL, 1985, J VIROL, V56, P502, DOI 10.1128/JVI.56.2.502-511.1985; ZEBEDEE SL, 1989, P NATL ACAD SCI USA, V86, P1061, DOI 10.1073/pnas.86.3.1061; ZEBEDEE SL, 1988, J VIROL, V62, P2762, DOI 10.1128/JVI.62.8.2762-2772.1988; Zhang XT, 2011, INTERVIROLOGY, V54, P290, DOI 10.1159/000319440; Zou P, 2005, INT IMMUNOPHARMACOL, V5, P631, DOI 10.1016/j.intimp.2004.12.005	61	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171174	10.1371/journal.pone.0171174	http://dx.doi.org/10.1371/journal.pone.0171174			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151964	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161200099
J	Engelmann, I; Dewilde, A; Lazrek, M; Batteux, M; Hamissi, A; Yakoub-Agha, I; Hober, D				Engelmann, Ilka; Dewilde, Anny; Lazrek, Mouna; Batteux, Mathilde; Hamissi, Aminati; Yakoub-Agha, Ibrahim; Hober, Didier			In Vivo Persistence of Human Rhinoviruses in Immunosuppressed Patients	PLOS ONE			English	Article							RESPIRATORY-TRACT; ENTEROVIRAL RNA; VIRAL-INFECTION; MYOCARDIUM; REPLICATION; PATHOGENESIS; VIRUS; ADULT	Several species of the genus Enterovirus cause persistent infections in humans. Human rhinovirus (HRV) infections are generally self-limiting but occasionally persistent infections have been described. This study aimed to identify persistent HRV infections and investigate the clinical and virologic characteristics of patients with persistent infections. From January 2012 to March 2015, 3714 respiratory specimens from 2608 patients were tested for respiratory viruses by using a multiplex reverse transcription-polymerase chain reaction. A retrospective study was performed. Patients with at least two specimens positive for HRV/enterovirus taken 45 days or longer apart were identified and the HRV/enteroviruses were typed. Patients with persistent infection were compared to patients with reinfection and patients with cleared infection. Phylogenetic analysis of the viral protein(VP)4/VP2 region was performed. 18 patients with persistent HRV/enterovirus infection were identified. Minimum median duration of persistence was 92 days (range 50-455 days). All but one patients with persistence were immunosuppressed. Immunosuppression and hematologic disorders were more frequent in patients with persistence (n = 18) than in patients with reinfection (n = 33) and with cleared infection (n = 25) (p = 0.003 and p = 0.001, respectively). In conclusion, this retrospective study identified HRV persistence in vivo which occurred mainly in immunosuppressed patients.	[Engelmann, Ilka; Dewilde, Anny; Lazrek, Mouna; Batteux, Mathilde; Hamissi, Aminati; Hober, Didier] Univ Lille, Lab Virol EA 3610, Fac Med, Lille, France; [Engelmann, Ilka; Dewilde, Anny; Lazrek, Mouna; Batteux, Mathilde; Hamissi, Aminati; Hober, Didier] CHU Lille, Lille, France; [Yakoub-Agha, Ibrahim] CHU Lille, Malad Sang, Lille, France; [Yakoub-Agha, Ibrahim] Univ Lille, Fac Med, Lille, France; [Yakoub-Agha, Ibrahim] INSERM, U995, LIRIC, Lille, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille	Engelmann, I (corresponding author), Univ Lille, Lab Virol EA 3610, Fac Med, Lille, France.; Engelmann, I (corresponding author), CHU Lille, Lille, France.	ilka.engelmann@chru-lille.fr	Yakoub-Agha, Ibrahim/R-7872-2018	Yakoub-Agha, Ibrahim/0000-0003-4524-8782	Ministere de l'Education Nationale, de l'Enseignement superieure et de la Recherche, Universite Lille 2 [3610]; Centre Hospitalier Regional et Universitaire de Lille	Ministere de l'Education Nationale, de l'Enseignement superieure et de la Recherche, Universite Lille 2; Centre Hospitalier Regional et Universitaire de Lille	This work was supported by Ministere de l'Education Nationale, de l'Enseignement superieure et de la Recherche, Universite Lille 2 (Equipe d'accueil 3610) and Centre Hospitalier Regional et Universitaire de Lille. The funding sources had no involvement in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alidjinou EK, 2015, EUR J CLIN INVEST, V45, P918, DOI 10.1111/eci.12485; Alidjinou EK, 2014, DISCOV MED, V18, P273; Andreoletti L, 2000, J INFECT DIS, V182, P1222, DOI 10.1086/315818; Engelmann I, 2013, AM J RESP CRIT CARE, V188, P1165, DOI 10.1164/rccm.201303-0585LE; Fine PEM, 1999, AM J EPIDEMIOL, V150, P1001, DOI 10.1093/oxfordjournals.aje.a009924; Flight WG, 2013, J CLIN MICROBIOL, V51, P3893, DOI 10.1128/JCM.01604-13; Fujioka S, 2000, J AM COLL CARDIOL, V36, P1920, DOI 10.1016/S0735-1097(00)00955-4; Fujioka S, 2004, AM J CARDIOL, V94, P602, DOI 10.1016/j.amjcard.2004.05.023; Goffard A, 2014, J CLIN VIROL, V60, P147, DOI 10.1016/j.jcv.2014.02.005; Hober D, 2013, CURR OPIN INFECT DIS, V26, P263, DOI 10.1097/QCO.0b013e3283608300; Jacobs SE, 2013, CLIN MICROBIOL REV, V26, P135, DOI 10.1128/CMR.00077-12; Julien J, 1999, J NEUROL, V246, P472, DOI 10.1007/s004150050386; Kainulainen L, 2010, J ALLERGY CLIN IMMUN, V126, P120, DOI 10.1016/j.jaci.2010.04.016; Kaiser L, 2006, AM J RESP CRIT CARE, V174, P1392, DOI 10.1164/rccm.200604-489OC; Loeffelholz MJ, 2014, PEDIATRICS, V134, P1144, DOI 10.1542/peds.2014-2132; Mallia P, 2011, AM J RESP CRIT CARE, V183, P734, DOI 10.1164/rccm.201006-0833OC; McIntyre CL, 2013, J GEN VIROL, V94, P1791, DOI 10.1099/vir.0.053686-0; Pathak AK, 2013, BONE MARROW TRANSPL, V48, P747, DOI 10.1038/bmt.2012.226; Pauschinger M, 1999, CIRCULATION, V99, P889, DOI 10.1161/01.CIR.99.7.889; Peltola V, 2013, CLIN MICROBIOL INFEC, V19, pE322, DOI 10.1111/1469-0691.12193; Piralla A, 2015, J CLIN VIROL, V67, P38, DOI 10.1016/j.jcv.2015.03.022; Principi N, 2015, J CLIN VIROL, V66, P83, DOI 10.1016/j.jcv.2015.03.013; Richardson SJ, 2009, DIABETOLOGIA, V52, P1143, DOI 10.1007/s00125-009-1276-0; Royston L, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8010016; Satoh M, 2004, LAB INVEST, V84, P173, DOI 10.1038/labinvest.3700031; Seemungal TAR, 2000, EUR RESPIR J, V16, P677, DOI 10.1034/j.1399-3003.2000.16d19.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tapparel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021163; WHY HJF, 1994, CIRCULATION, V89, P2582, DOI 10.1161/01.CIR.89.6.2582; Wisdom A, 2009, J CLIN MICROBIOL, V47, P3958, DOI 10.1128/JCM.00993-09	30	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170774	10.1371/journal.pone.0170774	http://dx.doi.org/10.1371/journal.pone.0170774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151988	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161200043
J	Silva, LAF; Couto, MIV; Magliaro, FCL; Tsuji, RK; Bento, RF; de Carvalho, ACM; Matas, CG				Fagundes Silva, Liliane Aparecida; Vieira Couto, Maria Ines; Magliaro, Fernanda C. L.; Tsuji, Robinson Koji; Bento, Ricardo Ferreira; Martinho de Carvalho, Ana Claudia; Matas, Carla Gentile			Cortical maturation in children with cochlear implants: Correlation between electrophysio-logical and behavioral measurement	PLOS ONE			English	Article							CENTRAL AUDITORY DEVELOPMENT; EVOKED POTENTIALS; SPEECH-PERCEPTION; NORMAL-HEARING; OUTCOMES; INFANTS; LANGUAGE; LATENCY; AGE; REORGANIZATION	Central auditory pathway maturation in children depends on auditory sensory stimulation. The objective of the present study was to monitor the cortical maturation of children with cochlear implants using electrophysiological and auditory skills measurements. The study was longitudinal and consisted of 30 subjects, 15 (8 girls and 7 boys) of whom had a cochlear implant, with a mean age at activation time of 36.4 months (minimum, 17 months; maximum, 66 months), and 15 of whom were normal-hearing children who were matched based on gender and chronological age. The auditory and speech skills of the children with cochlear implants were evaluated using GASP, IT-MAIS and MUSS measures. Both groups underwent electrophysiological evaluation using long-latency auditory evoked potentials. Each child was evaluated at three and nine months after cochlear implant activation, with the same time interval adopted for the hearing children. The results showed improvements in auditory and speech skills as measured by IT-MAIS and MUSS. Similarly, the long-latency auditory evoked potential evaluation revealed a decrease in P1 component latency; however, the latency remained significantly longer than that of the hearing children, even after nine months of cochlear implant use. It was observed that a shorter P1 latency corresponded to more evident development of auditory skills. Regarding auditory behavior, it was observed that children who could master the auditory skill of discrimination showed better results in other evaluations, both behavioral and electrophysiological, than those who had mastered only the speech-detection skill. Therefore, cochlear implant auditory stimulation facilitated auditory pathway maturation, which decreased the latency of the P1 component and advanced the development of auditory and speech skills. The analysis of the long-latency auditory evoked potentials revealed that the P1 component was an important biomarker of auditory development during the rehabilitation process.	[Fagundes Silva, Liliane Aparecida; Martinho de Carvalho, Ana Claudia; Matas, Carla Gentile] FMUSP, Dept Phys Speech & Occupat, Sao Paulo, SP, Brazil; [Vieira Couto, Maria Ines; Magliaro, Fernanda C. L.; Tsuji, Robinson Koji; Bento, Ricardo Ferreira] FMUSP, Dept Otorhinolaryngol, Clin Hosp, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Silva, LAF (corresponding author), FMUSP, Dept Phys Speech & Occupat, Sao Paulo, SP, Brazil.	liliane.fagundes@usp.br	Silva, Liliane Aparecida Fagundes/D-6320-2015; Magliaro, Fernanda C Leite/A-9225-2013; MATAS, CARLA GENTILE/K-4806-2016	Magliaro, Fernanda C Leite/0000-0003-0627-4320; MATAS, CARLA GENTILE/0000-0002-9408-7172				Agrawal D, 2013, NEUROIMAGE-CLIN, V2, P229, DOI 10.1016/j.nicl.2013.01.001; Alvarenga KD, 2013, CODAS, V25, P521, DOI 10.1590/S2317-17822014000100004; Alvarenga KF, 2012, INT J PEDIATR OTORHI, V76, P1332, DOI 10.1016/j.ijporl.2012.06.001; Anderson I, 2004, INT J PEDIATR OTORHI, V68, P425, DOI 10.1016/j.ijporl.2003.11.013; Bauer PW, 2006, ARCH OTOLARYNGOL, V132, P1133, DOI 10.1001/archotol.132.10.1133; Bento RF, 2004, REV BRAS OTORRINOLAR, V70, P632; Bevilacqua M C, 1996, TOPICOS FONOAUDIOLOG, P411; Bevilacqua MC, 2011, TRATADO AUDIOLOGIA, P407; Bevilacqua MC, 2010, TRATADO FONOAUDILOGI, P220; Bhatnagar SC., 2004, NEUROCIENCIA ESTUDO, P185; Biever A., 2007, SOUND FDN EARLY AMPL, P43; Boechat EM, 2010, PLASTICIDADE AMPLIFI, P160; Cardon G, 2013, INT J AUDIOL, V52, P577, DOI 10.3109/14992027.2013.799786; Castiquini E AT, 1998, THESIS; Chen XQ, 2010, ACTA OTO-LARYNGOL, V130, P263, DOI 10.3109/00016480903150528; Clark GM, 2003, AIP SER MOD AC SIG, P160; Dinces E, 2009, INT J PEDIATR OTORHI, V73, P843, DOI 10.1016/j.ijporl.2009.03.002; Dorman MF, 2007, J COMMUN DISORD, V40, P284, DOI 10.1016/j.jcomdis.2007.03.007; Eggermont JJ, 2003, ACTA OTO-LARYNGOL, V123, P249, DOI 10.1080/0036554021000028098; Erber N., 1982, AUDITORY TRAINING; Silva LAF, 2014, BRAZ J OTORHINOLAR, V80, P131, DOI 10.5935/1808-8694.20140028; Silva LAF, 2013, CODAS, V25, P595, DOI 10.1590/S2317-17822013.05000009; Fallon JB, 2008, HEARING RES, V238, P110, DOI 10.1016/j.heares.2007.08.004; Fallon JB, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/6/065008; Geers AE, 2004, ARCH OTOLARYNGOL, V130, P634, DOI 10.1001/archotol.130.5.634; Geers Ann E, 2007, Audiol Med, V5, P262, DOI 10.1080/16513860701659404; Gilley PM, 2008, BRAIN RES, V1239, P56, DOI 10.1016/j.brainres.2008.08.026; Gilley PM, 2006, CLIN NEUROPHYSIOL, V117, P1772, DOI 10.1016/j.clinph.2006.04.018; Gordon KA, 2005, HEARING RES, V204, P78, DOI 10.1016/j.heares.2005.01.003; Jang JH, 2010, CLIN EXP OTORHINOLAR, V3, P194, DOI 10.3342/ceo.2010.3.4.194; JERGER J, 1970, ARCHIV OTOLARYNGOL, V92, P311; Kelly AS, 2005, CLIN NEUROPHYSIOL, V116, P1235, DOI 10.1016/j.clinph.2005.02.011; Kileny PR, 1997, OTOLARYNG HEAD NECK, V117, P161, DOI 10.1016/S0194-5998(97)70169-4; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kral A, 2001, AUDIOL NEURO-OTOL, V6, P346, DOI 10.1159/000046845; Kral A, 2012, TRENDS NEUROSCI, V35, P111, DOI 10.1016/j.tins.2011.09.004; Kubo T, 2008, ORL-J OTO-RHIN-LARYN, V70, P224, DOI 10.1159/000130869; Lesinski-Schiedat A, 2004, Cochlear Implants Int, V5, P146, DOI 10.1179/cim.2004.5.4.146; Martines F, 2013, INT J PEDIATR OTORHI, V77, P707, DOI 10.1016/j.ijporl.2013.01.023; Maurer J, 2002, LARYNGOSCOPE, V112, P2220, DOI 10.1097/00005537-200212000-00017; Melo Tatiana Mendes de, 2012, J Soc Bras Fonoaudiol, V24, P390; Moog JS, 2010, OTOL NEUROTOL, V31, P1315, DOI 10.1097/MAO.0b013e3181eb3226; Moore DR, 2009, NAT NEUROSCI, V12, P686, DOI 10.1038/nn.2326; Moret Adriane Lima Mortari, 2007, Pró-Fono R. Atual. Cient., V19, P295, DOI 10.1590/S0104-56872007000300008; Nascimento LT, PROPOSTA AVALIAC LIN; Nikolopoulos TP, 1999, INT J PEDIATR OTORHI, V49, pS189; Northen J., 2005, AUDICAO INFANCIA, V., P3; Ouellet C, 1999, J NEUROLINGUIST, V12, P271, DOI 10.1016/S0911-6044(99)00018-4; Pinto Elaine Soares Monteiro, 2008, Rev. Bras. Otorrinolaringol., V74, P91, DOI 10.1590/S0034-72992008000100015; Robbins AM, 2004, ARCH OTOLARYNGOL, V130, P570; Robbins AM, CONVERSION IT MAIS S; Robbins AM, 1990, MEANINGFUL USE SPEEC; SHALLOP JK, 1993, EAR HEARING, V14, P58, DOI 10.1097/00003446-199302000-00008; Sharma A, 2005, HEARING RES, V203, P134, DOI 10.1016/j.heares.2004.12.010; Sharma A, 2004, ARCH OTOLARYNGOL, V130, P511, DOI 10.1001/archotol.130.5.511; Sharma A, 2002, NEUROREPORT, V13, P1365, DOI 10.1097/00001756-200207190-00030; Sharma A., 2007, AUDIOL MED, V5, P218, DOI DOI 10.1080/16513860701659479; Sharma A, 2007, INT J AUDIOL, V46, P494, DOI 10.1080/14992020701524836; Sharma Anu, 2006, Adv Otorhinolaryngol, V64, P66, DOI 10.1159/000094646; Sharma Anu, 2005, J Am Acad Audiol, V16, P564, DOI 10.3766/jaaa.16.8.5; Sharma A, 2011, INT J AUDIOL, V50, P98, DOI 10.3109/14992027.2010.542492; Sharma Anu, 2002, Ear and Hearing, V23, P532, DOI 10.1097/00003446-200212000-00004; Sharma A, 2009, J COMMUN DISORD, V42, P272, DOI 10.1016/j.jcomdis.2009.03.003; Tanamati LF, 2011, INT ARCH OTORHINOLAR, V15, P365; Thai-Van H, 2010, ACTA OTO-LARYNGOL, V130, P333, DOI 10.3109/00016480903258024; Ventura LMP, 2008, THESIS; Wunderlich JL, 2006, HEARING RES, V212, P212, DOI 10.1016/j.heares.2005.11.008; Yucel E, 2009, INT J PEDIATR OTORHI, V73, P1043, DOI 10.1016/j.ijporl.2009.04.009; Zimmerman-Phillips S., 1997, INFANT TODDLER MEANI	69	11	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171177	10.1371/journal.pone.0171177	http://dx.doi.org/10.1371/journal.pone.0171177			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151961	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161200100
J	Gunawardena, S; Kapilananda, GMG; Samarakoon, D; Maddevithana, S; Wijesundera, S; Goonaratne, LV; Karunaweera, ND				Gunawardena, Sharmini; Kapilananda, G. M. G.; Samarakoon, Dilhani; Maddevithana, Sashika; Wijesundera, Sulochana; Goonaratne, Lallindra V.; Karunaweera, Nadira D.			Prevalence of G6PD deficiency in selected populations from two previously high malaria endemic areas of Sri Lanka	PLOS ONE			English	Article							METHEMOGLOBIN REDUCTION TEST; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; X-CHROMOSOME; PRIMAQUINE; VARIANTS; GENE; DAPSONE; MUTATIONS; HEMOLYSIS; PROVINCE	Glucose-6-Phosphate Dehydrogenase (G6PD) enzyme deficiency is known to offer protection against malaria and an increased selection of mutant genes in malaria endemic regions is expected. However, anti-malarial drugs such as primaquine can cause haemolytic anaemia in persons with G6PD deficiency. We studied the extent of G6PD deficiency in selected persons attending Teaching Hospitals of Anuradhapura and Kurunegala, two previously high malaria endemic districts in Sri Lanka. A total of 2059 filter-paper blood spots collected between November 2013 and June 2014 were analysed for phenotypic G6PD deficiency using the modified WST-8/1-methoxy PMS method. Each assay was conducted with a set of controls and the colour development assessed visually as well as with a microplate reader at OD 450-630 nm. Overall, 142/1018 (13.95%) and 83/1041 (7.97%) were G6PD deficient in Anuradhapura and Kurunegala districts respectively. The G6PD prevalence was significantly greater in Anuradhapura when compared to Kurunegala (P<0.0001). Surprisingly, females were equally affected as males in each district: 35/313 (11.18%) males and 107/705 (15.18%) females were affected in Anuradhapura (P = 0.089); 25/313 (7.99%) males and 58/728 (7.97%) females were affected in Kurunegala (P = 0.991). Prevalence was greater among females in Anuradhapura than in Kurunegala (P<0.05), while no such difference was observed between the males (P>0.05). Severe deficiency (<10% normal) was seen among 28/1018 (2.75%) in Anuradhapura (7 males; 21 females) and 17/1041 (1.63%) in Kurunegala (7 males; 10 females). Enzyme activity between 10-30% was observed among 114/1018 (11.20%; 28 males; 86 females) in Anuradhapura while it was 66/1041 (6.34%; 18 males; 48 females) in Kurunegala. Screening and educational programmes for G6PD deficiency are warranted in these high risk areas irrespective of gender for the prevention of disease states related to this condition.	[Gunawardena, Sharmini; Kapilananda, G. M. G.; Samarakoon, Dilhani; Maddevithana, Sashika; Karunaweera, Nadira D.] Univ Colombo, Dept Parasitol, Fac Med, Colombo, Sri Lanka; [Wijesundera, Sulochana] Univ Colombo, Dept Biochem, Fac Med, Colombo, Sri Lanka; [Goonaratne, Lallindra V.] Univ Colombo, Dept Pathol, Fac Med, Colombo, Sri Lanka	University of Colombo; University of Colombo; University of Colombo	Gunawardena, S (corresponding author), Univ Colombo, Dept Parasitol, Fac Med, Colombo, Sri Lanka.	sharmini@parasit.cmb.ac.lk		Karunaweera, Nadira/0000-0003-3985-1817	National Science Foundation, Sri Lanka [RG/2011/HS/09]	National Science Foundation, Sri Lanka(National Science Foundation (NSF))	The work was supported by National Science Foundation, Sri Lanka, Grant No: RG/2011/HS/09, http://www.nsf.ac.lk/.	ABEYARATNE K P, 1968, Ceylon Medical Journal, V13, P134; ABEYARATNE KP, 1976, AM J PHYS ANTHROPOL, V44, P135, DOI 10.1002/ajpa.1330440119; [Anonymous], ANTIMALARIA CAMP; Arai M, 2006, ACTA MED OKAYAMA, V60, P127; BEUTLER E, 1994, BLOOD, V84, P3613, DOI 10.1182/blood.V84.11.3613.bloodjournal84113613; Beutler E, 2002, BLOOD CELL MOL DIS, V28, P93, DOI 10.1006/bcmd.2002.0490; BEUTLER E, 1979, BRIT J HAEMATOL, V43, P465, DOI 10.1111/j.1365-2141.1979.tb03774.x; BEUTLER E, 1962, P NATL ACAD SCI USA, V48, P9, DOI 10.1073/pnas.48.1.9; BEUTLER E, 1992, ANNU REV MED, V43, P47, DOI 10.1146/annurev.me.43.020192.000403; Beutler E, 2008, BLOOD, V111, P16, DOI 10.1182/blood-2007-04-077412; Beutler E, 2007, AM J TROP MED HYG, V77, P779, DOI 10.4269/ajtmh.2007.77.779; BREWER GJ, 1962, JAMA-J AM MED ASSOC, V180, P386, DOI 10.1001/jama.1962.03050180032008; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; De Niz M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-210; Denic S, 2007, HUM BIOL, V79, P145, DOI 10.1353/hub.2007.0030; Dewasurendra RL, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0603-9; Espino FE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148172; Fanello CI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004031; Fernando P, 2011, 100 YEARS MALARIA CO; Fernando P., 2014, J COLL COMMUNITY PHY, V19, P27, DOI DOI 10.4038/JCCPSL.V19I1.7624; Fernando V.N, 2020, INT J SCI RES, V9, P1310; GANCZAKOWSKI M, 1995, AM J HUM GENET, V56, P294; GILLES HM, 1967, LANCET, V1, P138; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; Howes RE, 2013, ADV PARASIT, V81, P133, DOI 10.1016/B978-0-12-407826-0.00004-7; Howes RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001339; Kuwahata M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-223; Leslie T, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000283; Louicharoen C, 2009, SCIENCE, V326, P1546, DOI 10.1126/science.1178849; Luzzatto L, ONLINE METABOLIC MOL; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Mal E. R., 2011, PLOS MED, V8, DOI [10.1371/journal.pmed.1000402, DOI 10.1371/JOURNAL.PMED.1000402]; MARTINI G, 1986, EMBO J, V5, P1849, DOI 10.1002/j.1460-2075.1986.tb04436.x; Minucci A, 2012, BLOOD CELL MOL DIS, V48, P154, DOI 10.1016/j.bcmd.2012.01.001; NAGARATNAM N, 1969, INDIAN J MED RES, V57, P569; Nkhoma ET, 2009, BLOOD CELL MOL DIS, V42, P267, DOI 10.1016/j.bcmd.2008.12.005; Ramos WM, 2010, BRAZ J INFECT DIS, V14, P410, DOI 10.1590/S1413-86702010000400017; Ranawaka RR, 2008, LEPROSY REV, V79, P436; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Sandakumari GVN, 2015, GALLE MED J, V20, P36; Saunders MA, 2002, GENETICS, V162, P1849; Senaratne R, 2016, LANCET, V388, P1038, DOI 10.1016/S0140-6736(16)31572-0; Shanks GD, 2001, CLIN INFECT DIS, V33, P1968, DOI 10.1086/324081; Silva Kalinga Tudor, 2014, DECOLONISATION DEV D; Singh A. K., 2013, African Journal of Agricultural Research, V8, P6634; Sugathadasa R, 2006, J DIAGNOSTIC PATHOLO, V5, P30; Tantular IS, 2003, TROP MED INT HEALTH, V8, P569, DOI 10.1046/j.1365-3156.2003.01055.x; von Seidlein L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-112; WHO Working Group, 1989, B WORLD HEALTH ORGAN, V67, P601; World Health Organization, WHO MULT THER MDT; World Health Organization, 2015, GUID TREATM MAL, Vthird; Wozel G, 2014, ARCH DERMATOL RES, V306, P103, DOI 10.1007/s00403-013-1409-7	52	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171208	10.1371/journal.pone.0171208	http://dx.doi.org/10.1371/journal.pone.0171208			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152025	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161200104
J	Mastropasqua, R; Toto, L; Borrelli, E; Di Antonio, L; Mattei, PA; Senatore, A; Di Nicola, M; Mariotti, C				Mastropasqua, Rodolfo; Toto, Lisa; Borrelli, Enrico; Di Antonio, Luca; Mattei, Peter A.; Senatore, Alfonso; Di Nicola, Marta; Mariotti, Cesare			Optical Coherence Tomography Angiography Findings in Stargardt Disease	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; MACULAR DEGENERATION; CHOROIDAL THICKNESS; GEOGRAPHIC ATROPHY; VASCULAR LAYERS; LIPOFUSCIN; AUTOFLUORESCENCE; PROGRESSION; SEQUENCE; EYES	Background to assess vessel density of superficial capillary plexus (SCP), deep capillary plexus (DCP) and choriocapillaris (CC) in advanced Stargardt disease (STGD) using optical coherence tomography angiography (OCTA) and correlate these findings with macular function using pattern electroretinogram (PERG) and multifocal electroretinogram (mfERG). Methods Twelve patients (24 eyes) with advanced STGD underwent vessel densities and macular thickness measurements using OCTA. A control group of 24 healthy controls (24 eyes) was chosen for comparison. In the STGD group correlation between vessel density and macular thickness and between macular function and morphologic parameters were evaluated. Results Whole parafoveal vessel density (VD) of SCP was significantly lower in STGD group compared to the control group (p<0.05). Foveal VD and whole parafoveal VD of the DCP were significantly lower in STGD group compared to the controls (p<0.05). CC was significantly decreased in STGD compared to controls (p<0.05). Foveal macular thickness (MT), full parafoveal MT, and inner limiting membrane (ILM)-inner plexiform layer (IPL) parafoveal MT thickness were decreased in STGD eyes compared to controls (p<0.001). PERG and mfERG were both significantly reduced in STGD compared to controls (p<0.001). A direct correlation was found between full parafoveal MT and vessel density in the STGD group. Conclusions Patients with advanced STGD showed a reduction of SCP, DCP and CC compared to healthy eyes related to a reduction of total and ILM-IPL macular thickness. These results suggest that both retinal capillaris plexuses and choriocapillaris reduction occur in STDG along with inner and outer retinal thinning.	[Mastropasqua, Rodolfo] NHS Fdn Trust, Moorfields Eye Hosp, London, England; [Toto, Lisa; Borrelli, Enrico; Di Antonio, Luca; Mattei, Peter A.; Senatore, Alfonso] Univ G dAnnunzio, Dept Med & Sci Ageing, Ophthalmol Clin, Chieti, Italy; [Di Nicola, Marta] Univ G dAnnunzio, Dept Expt & Clin Sci, Lab Biostat, Chieti, Italy; [Mariotti, Cesare] Univ Marche, Dept Surg & Biomed Sci, Ophthalmol Clin, Ancona, Italy	Oxford University Hospitals NHS Foundation Trust; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Marche Polytechnic University	Toto, L (corresponding author), Univ G dAnnunzio, Dept Med & Sci Ageing, Ophthalmol Clin, Chieti, Italy.	l.toto@unich.it	Senatore, Alfonso/T-3105-2019; Mastropasqua, Rodolfo/AAC-6453-2022; Borrelli, Enrico/AAR-3693-2020; Toto, Lisa/K-3473-2018	Senatore, Alfonso/0000-0002-8190-8269; Borrelli, Enrico/0000-0003-2815-5031; Toto, Lisa/0000-0001-5311-5184; DI NICOLA, MARTA/0000-0003-1748-1931				Ablonczy Z, 2007, EXP EYE RES, V85, P762, DOI 10.1016/j.exer.2007.08.010; Adhi M, 2015, AM J OPHTHALMOL, V160, P1276, DOI 10.1016/j.ajo.2015.08.025; Agemy SA, 2015, RETINA-J RET VIT DIS, V35, P2353, DOI 10.1097/IAE.0000000000000862; Alten F1, 2016, GRAEFES ARCH CLIN EX, V18; Bach M, 2013, DOC OPHTHALMOL, V126, P1, DOI 10.1007/s10633-012-9353-y; Battaglia Parodi M, 2016, BR J OPHTHALMOL; Bird AC, 2014, JAMA OPHTHALMOL, V132, P338, DOI 10.1001/jamaophthalmol.2013.5799; Blaauwgeers HGT, 1999, AM J PATHOL, V155, P421, DOI 10.1016/S0002-9440(10)65138-3; Carpineto P, 2016, BRIT J OPHTHALMOL, V100, P671, DOI 10.1136/bjophthalmol-2015-307330; Cideciyan AV, 2004, HUM MOL GENET, V13, P525, DOI 10.1093/hmg/ddh048; FISHMAN GA, 1976, ARCH OPHTHALMOL-CHIC, V94, P2061, DOI 10.1001/archopht.1976.03910040721003; Fujinami K, 2015, OPHTHALMOLOGY, V122, P326, DOI 10.1016/j.ophtha.2014.08.012; Genead MA, 2009, INVEST OPHTH VIS SCI, V50, P5867, DOI 10.1167/iovs.09-3611; Giani A, 2012, INVEST OPHTH VIS SCI, V53, P3999, DOI 10.1167/iovs.11-9258; Gomes NL, 2009, INVEST OPHTH VIS SCI, V50, P3953, DOI 10.1167/iovs.08-2657; Hood DC, 2012, DOC OPHTHALMOL, V124, P1, DOI 10.1007/s10633-011-9296-8; Jia YL, 2012, BIOMED OPT EXPRESS, V3, DOI 10.1364/BOE.3.003127; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; Kamba T, 2007, BRIT J CANCER, V96, P1788, DOI 10.1038/sj.bjc.6603813; Lambertus S, 2015, OPHTHALMOLOGY, V122, P335, DOI 10.1016/j.ophtha.2014.08.032; Lee JY, 2013, INVEST OPHTH VIS SCI, V54, P7812, DOI 10.1167/iovs.13-12284; Lenassi E, 2009, BRIT J OPHTHALMOL, V93, P1600, DOI 10.1136/bjo.2009.158725; McBain VA, 2012, AM J OPHTHALMOL, V154, P146, DOI 10.1016/j.ajo.2012.01.019; Nunes RP, 2015, OSLI RETINA, V46, P814, DOI 10.3928/23258160-20150909-05; Smith RT, 2009, INVEST OPHTH VIS SCI, V50, P3907, DOI 10.1167/iovs.08-2448; Spaide RF, 2015, RETINA-J RET VIT DIS, V35, P2163, DOI 10.1097/IAE.0000000000000765; Spaide RF, 2015, JAMA OPHTHALMOL, V133, P45, DOI 10.1001/jamaophthalmol.2014.3616; Sparrow JR, 2008, ADV EXP MED BIOL, V613, P393, DOI 10.1007/978-0-387-74904-4_46; Spraul CW, 1999, SURV OPHTHALMOL, V44, pS10, DOI 10.1016/S0039-6257(99)00086-7; Stargardt K., 1909, GRAEFES ARCH CLIN EX, V71, P534, DOI DOI 10.1007/BF01961301; Testa F, 2012, INVEST OPHTH VIS SCI, V53, P4409, DOI 10.1167/iovs.11-8201; Toto L, 2016, RETINA; Toto L, 2016, INVEST OPHTH VIS SCI, V57, pOCT268, DOI 10.1167/iovs.15-18872; Waheed NK, 2016, DEV OPHTHALMOL, V56, P91, DOI 10.1159/000442784; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Westeneng-van Haaften SC, 2012, OPHTHALMOLOGY, V119, P1199, DOI 10.1016/j.ophtha.2012.01.005; Yeoh J, 2010, GRAEF ARCH CLIN EXP, V248, P1719, DOI 10.1007/s00417-010-1437-3	37	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170343	10.1371/journal.pone.0170343	http://dx.doi.org/10.1371/journal.pone.0170343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151966	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200020
J	Poh, AH; Moghavvemi, M; Leong, CS; Lau, YL; Ghandari, AS; Apau, A; Adikan, FRM				Poh, Abdul Halim; Moghavvemi, Mahmoud; Leong, Cherng Shii; Lau, Yee Ling; Ghandari, Alireza Safdari; Apau, Alexlee; Adikan, Faisal Rafiq Mahamd			Collective behavior quantification on human odor effects against female Aedes aegypti mosquitoes-Open source development	PLOS ONE			English	Article							TRACKING; MOVEMENT	Classifying and quantifying mosquito activity includes a plethora of categories, ranging from measuring flight speeds, repellency, feeding rates, and specific behaviors such as home entry, swooping and resting, among others. Entomologists have been progressing more toward using machine vision for efficiency for this endeavor. Digital methods have been used to study the behavior of insects in labs, for instance via three-dimensional tracking with specialized cameras to observe the reaction of mosquitoes towards human odor, heat and CO2, although virtually none was reported for several important fields, such as repellency studies which have a significant need for a proper response quantification. However, tracking mosquitoes individually is a challenge and only limited number of specimens can be studied. Although tracking large numbers of individual insects is hailed as one of the characteristics of an ideal automated image-based tracking system especially in 3D, it also is a costly method, often requiring specialized hardware and limited access to the algorithms used for mapping the specimens. The method proposed contributes towards (a) unlimited open source use, (b) a low-cost setup, (c) complete guide for any entomologist to adapt in terms of hardware and software, (d) simple to use, and (e) a lightweight data output for collective behavior analysis of mosquitoes. The setup is demonstrated by testing a simple response of mosquitoes in the presence of human odor versus control, one session with continuous human presence as a stimuli and the other with periodic presence. A group of female Aedes aegypti (Linnaeus) mosquitoes are released into a white-background chamber with a transparent acrylic panel on one side. The video feed of the mosquitoes are processed using filtered contours in a threshold-adjustable video. The mosquitoes in the chamber are mapped on the raster where the coordinates of each mosquito are recorded with the corresponding timestamp. The average distance of the blobs within the frames against time forms a spectra where behavioral patterns can be observed directly, whether any collective effect is observed. With this method, 3D tracking will not be required and a more straightforward data output can be obtained.	[Poh, Abdul Halim; Moghavvemi, Mahmoud; Ghandari, Alireza Safdari; Apau, Alexlee; Adikan, Faisal Rafiq Mahamd] Univ Malaya, Dept Elect Engn, Fac Engn, Kuala Lumpur, Malaysia; [Poh, Abdul Halim; Moghavvemi, Mahmoud; Ghandari, Alireza Safdari; Apau, Alexlee] Univ Malaya, Ctr Res Appl Elect, Fac Engn, Kuala Lumpur, Malaysia; [Moghavvemi, Mahmoud] Univ Sci & Culture, Tehran, Iran; [Leong, Cherng Shii; Lau, Yee Ling] Univ Malaya, Dept Parasitol, Fac Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Moghavvemi, M (corresponding author), Univ Malaya, Dept Elect Engn, Fac Engn, Kuala Lumpur, Malaysia.; Moghavvemi, M (corresponding author), Univ Malaya, Ctr Res Appl Elect, Fac Engn, Kuala Lumpur, Malaysia.; Moghavvemi, M (corresponding author), Univ Sci & Culture, Tehran, Iran.	mahmoud@um.edu.my	Moghavvemi, Mahmoud/B-8912-2010; ADIKAN, FAISAL RAFIQ MAHAMD/B-8038-2010; Lau, Yee Ling/C-6996-2009	Moghavvemi, Mahmoud/0000-0001-6447-4203; Lau, Yee Ling/0000-0002-2037-2165	Malaysia's Ministry of Higher Education's Fundamental Research Grant Scheme (FRGS) [FP003-2014B, HIR UM.00000005/HIR. C1]	Malaysia's Ministry of Higher Education's Fundamental Research Grant Scheme (FRGS)	This study was supported by Malaysia's Ministry of Higher Education's Fundamental Research Grant Scheme (FRGS, grant number FP003-2014B), website: https://jpt.mohe.gov.my/menupenyelidik.php (authors who received funding: Prof Dr. Mahmoud Moghawemi (MM), role: study design, decision to publish and preparation of manuscript) and Malaysia's High Impact Research Grant (HIR UM.00000005/HIR. C1), website: http://hir.um.edu.my/ (authors who received funding: Prof Dr Faisal Rafiq Mahamd Adikan (FRMA), role: preparation of manuscript).	Angarita-Jaimes NC, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2015.0974; Attanasi A, 2015, IEEE T PATTERN ANAL, V37, P2451, DOI 10.1109/TPAMI.2015.2414427; Bezerra-Silva PC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150008; Bibbs CS, 2016, J MED ENTOMOL, V53, P480, DOI 10.1093/jme/tjv200; Bradski G., 2008, LEARNING OPENCV COMP; Butail S, 2011, ENG MED BIOL SOC EMB; Butail S, 2012, J R SOC INTERFACE, V9, P2624, DOI 10.1098/rsif.2012.0150; Catteruccia F, 2003, SCIENCE, V299, P1225, DOI 10.1126/science.1081453; Chambers EW, 2013, MED VET ENTOMOL, V27, P332, DOI 10.1111/j.1365-2915.2012.01065.x; Chareonviriyaphap T, 2002, J VECTOR ECOL, V27, P250; Cheng XE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132101; Cheng XE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129657; Crall JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136487; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; Dell AI, 2014, TRENDS ECOL EVOL, V29, P417, DOI 10.1016/j.tree.2014.05.004; Enayati AA, 2007, COCHRANE DATABASE SY, V2; Fry SN, 2000, J NEUROSCI METH, V101, P59, DOI 10.1016/S0165-0270(00)00253-3; Hoffmann WC, 2010, J AM MOSQUITO CONTR, V26, P167, DOI 10.2987/09-0008.1; Jacoby DMP, 2016, TRENDS ECOL EVOL, V31, P301, DOI 10.1016/j.tree.2016.01.011; Khan B, 2015, INT C NEUR INF PROC; Lee SC, 2006, ATMOS ENVIRON, V40, P2128, DOI 10.1016/j.atmosenv.2005.11.047; Manoukis NC, 2009, J MED ENTOMOL, V46, P227, DOI 10.1603/033.046.0207; Mullen ER, 2016, OPT EXPRESS, V24, P1828, DOI 10.1364/OE.24.011828; Nguyen NM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004667; Orsborne J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152805; Parker JEA, 2015, SCI REP-UK, V5, DOI 10.1038/srep13392; Spitzen J, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1293-7; Spitzen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062995; SUZUKI S, 1985, COMPUT VISION GRAPH, V30, P32, DOI 10.1016/0734-189X(85)90016-7; Turley AP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000516; van Breugel F, 2015, CURR BIOL, V25, P2123, DOI 10.1016/j.cub.2015.06.046; Webster B, 2015, J CHEM ECOL, V41, P59, DOI 10.1007/s10886-014-0542-x; Wilkinson DA, 2014, J INSECT PHYSIOL, V71, P114, DOI 10.1016/j.jinsphys.2014.10.005; World Health Organization, 2013, GUID EFF TEST SPAT R; Wotodjo AN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126187; Yokoi S., 1975, COMPUT GRAPHICS IMAG, V4, P63, DOI DOI 10.1016/0146-664X(75)90022-2; Zou D, 2009, COMP VIS 2009 IEEE 1	37	3	3	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171555	10.1371/journal.pone.0171555	http://dx.doi.org/10.1371/journal.pone.0171555			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152031	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161200155
J	Strumylaite, L; Kregzdyte, R; Poskiene, L; Bogusevicius, A; Pranys, D; Norkute, R				Strumylaite, Loreta; Kregzdyte, Rima; Poskiene, Lina; Bogusevicius, Algirdas; Pranys, Darius; Norkute, Roberta			Association between lifetime exposure to passive smoking and risk of breast cancer subtypes defined by hormone receptor status among non-smoking Caucasian women	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; ESTROGEN-RECEPTOR; ACTIVE SMOKING; CIGARETTE-SMOKING; CADMIUM EXPOSURE; ALPHA; POPULATION; EXPRESSION; METALS; JAPAN	Tobacco smoking is inconsistently associated with breast cancer. Although some studies suggest that breast cancer risk is related to passive smoking, little is known about the association with breast cancer by tumor hormone receptor status. We aimed to explore the association between lifetime passive smoking and risk of breast cancer subtypes defined by estrogen receptor and progesterone receptor status among non-smoking Caucasian women. A hospital-based case-control study was performed in 585 cases and 1170 controls aged 28-90 years. Information on lifetime passive smoking and other factors was collected via a self-administered questionnaire. Logistic regression was used for analyses restricted to the 449 cases and 930 controls who had never smoked actively. All statistical tests were two-sided. Adjusted odds ratio of breast cancer was 1.01 (95% confidence interval (CI): 0.72-1.41) in women who experienced exposure to passive smoking at work, 1.88 (95% CI: 1.38-2.55) in women who had exposure at home, and 2.80 (95% CI: 1.84-4.25) in women who were exposed at home and at work, all compared with never exposed regularly. Increased risk was associated with longer exposure: women exposed <= 20 years and > 20 years had 1.27 (95% CI: 0.97-1.66) and 2.64 (95% CI: 1.87-3.74) times higher risk of breast cancer compared with never exposed (P-trend < 0.001). The association of passive smoking with hormone receptor-positive breast cancer did not differ from that with hormone receptor-negative breast cancer (P-heterogeneity > 0.05). There was evidence of interaction between passive smoking intensity and menopausal status in both overall group (P = 0.02) and hormone receptor-positive breast cancer group (P < 0.05). In Caucasian women, lifetime exposure to passive smoking is associated with the risk of breast cancer independent of tumor hormone receptor status with the strongest association in postmenopausal women.	[Strumylaite, Loreta; Kregzdyte, Rima] Lithuanian Univ Hlth Sci, Neurosci Inst, Kaunas, Lithuania; [Poskiene, Lina; Pranys, Darius] Lithuanian Univ Hlth Sci, Med Acad, Dept Pathol Anat, Kaunas, Lithuania; [Bogusevicius, Algirdas] Lithuanian Univ Hlth Sci, Med Acad, Dept Surg, Kaunas, Lithuania; [Norkute, Roberta] Lithuanian Univ Hlth Sci, Med Acad, Dept Obstet & Gynecol, Kaunas, Lithuania	Lithuanian University of Health Sciences; Lithuanian University of Health Sciences; Lithuanian University of Health Sciences; Lithuanian University of Health Sciences	Strumylaite, L (corresponding author), Lithuanian Univ Hlth Sci, Neurosci Inst, Kaunas, Lithuania.	loreta.strumylaite@lsmuni.lt						Ahern TP, 2009, CANCER CAUSE CONTROL, V20, P1837, DOI 10.1007/s10552-009-9376-1; Anderson LN, 2012, AM J EPIDEMIOL, V175, P289, DOI 10.1093/aje/kwr324; Bjerkaas E, 2015, PREV MED, V73, P125, DOI 10.1016/j.ypmed.2015.01.004; Borgerding M.F., 2000, MASSACHUSETTS BENCHM; Chen C, 2014, CHIN J CANCER, V33, P306, DOI 10.5732/cjc.013.10248; Chen CZ, 2005, ENVIRON HEALTH PERSP, V113, P412, DOI 10.1289/ehp.7436; Chen ZH, 2015, ASIA-PAC J PUBLIC HE, V27, pNP58, DOI 10.1177/1010539513481493; Conlon MSC, 2010, CANCER EPIDEMIOL, V34, P142, DOI 10.1016/j.canep.2010.02.001; DAKO, 1996, REF IMM BREAST CANC, P9; Dossus L, 2014, INT J CANCER, V134, P1871, DOI 10.1002/ijc.28508; Gao CM, 2013, ASIAN PAC J CANCER P, V14, P993, DOI 10.7314/APJCP.2013.14.2.993; Gram IT, 2015, AM J EPIDEMIOL, V182, P917, DOI 10.1093/aje/kwv092; Hammond MEH, 2010, J ONCOL PRACT, V6, P195, DOI 10.1200/JOP.777003; Hanaoka T, 2005, INT J CANCER, V114, P317, DOI 10.1002/ijc.20709; IARC, LIST CLASS CANC SIT, V1-123; IARC, 2017, AG CLASS IARC MON, V1e117; International Agency for Research on Cancer (IARC), 2004, IARC MONOGRAPHS EVAL; International Agency for Research on Cancer (IARC) Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC MONOGR EVAL CAR; Ionescu JG, 2006, NEUROENDOCRINOL LETT, V27, P36; Johnson KC, 2005, INT J CANCER, V117, P619, DOI 10.1002/ijc.21150; Johnson KC, 2000, CANCER CAUSE CONTROL, V11, P211, DOI 10.1023/A:1008906105790; Joseph P, 2009, TOXICOL APPL PHARM, V238, P272, DOI 10.1016/j.taap.2009.01.011; Kabat GC, 2011, CANCER CAUSE CONTROL, V22, P775, DOI 10.1007/s10552-011-9750-7; Kropp S, 2002, AM J EPIDEMIOL, V156, P616, DOI 10.1093/aje/kwf093; Larsson SC, 2015, AM J EPIDEMIOL, V182, P375, DOI 10.1093/aje/kwv085; Lash TL, 1999, AM J EPIDEMIOL, V149, P5; Li B, 2015, PLOS ONE; Li L, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-167; Lin Y, 2008, J EPIDEMIOL, V18, P77, DOI 10.2188/jea.18.77; Liu Longjian, 2000, Asian Pac J Cancer Prev, V1, P131; Luo J, 2011, BMJ; Macacu A, 2015, BREAST CANCER RES TR, V154, P213, DOI 10.1007/s10549-015-3628-4; Martin MB, 2007, ENDOCRINOLOGY, V148, P4676, DOI 10.1210/en.2007-0208; Martin MB, 2003, ENDOCRINOLOGY, V144, P2425, DOI 10.1210/en.2002-221054; McElroy JA, 2006, JNCI-J NATL CANCER I, V98, P869, DOI 10.1093/jnci/djj233; Miller MD, 2007, PREV MED, V44, P93, DOI 10.1016/j.ypmed.2006.08.015; Nagata C, 2013, BREAST CANCER RES TR, V138, P235, DOI 10.1007/s10549-013-2414-4; Nishino Y, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-65; Nordberg GF, 2007, HANDBOOK ON THE TOXICOLOGY OF METALS, 3RD EDITION, P445, DOI 10.1016/B978-012369413-3/50078-1; Pirie K, 2008, INT J EPIDEMIOL, V37, P1069, DOI 10.1093/ije/dyn110; Reynolds P, 2004, JNCI-J NATL CANCER I, V96, P29, DOI 10.1093/jnci/djh002; Reynolds P, 2009, CANCER EPIDEM BIOMAR, V18, P3389, DOI 10.1158/1055-9965.EPI-09-0936; Roddam AW, 2007, BRIT J CANCER, V97, P434, DOI 10.1038/sj.bjc.6603859; Rosenberg L, 2013, CANCER CAUSE CONTROL, V24, P2207, DOI 10.1007/s10552-013-0298-6; Shrubsole MJ, 2004, INT J CANCER, V110, P605, DOI 10.1002/ijc.20168; Slattery ML, 2008, BREAST CANCER RES TR, V109, P101, DOI 10.1007/s10549-007-9629-1; Stoica A, 2000, MOL ENDOCRINOL, V14, P545, DOI 10.1210/me.14.4.545; Stoica A, 2000, ENDOCRINOLOGY, V141, P3595, DOI 10.1210/en.141.10.3595; Strumylaite L, 2008, MEDICINA-LITHUANIA, V44, P415, DOI 10.3390/medicina44060054; Strumylaite L, 2014, BREAST CANCER RES TR, V145, P225, DOI 10.1007/s10549-014-2918-6; Strumylaite L, 2013, ASIAN PAC J CANCER P, V14, P2777, DOI 10.7314/APJCP.2013.14.5.2777; Strumylaite L, 2011, BREAST CANCER RES TR, V125, P511, DOI 10.1007/s10549-010-1007-8; Tong JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097498; Wada K, 2015, CANCER SCI, V106, P455, DOI 10.1111/cas.12619; Yang Y., 2013, PLOS ONE	55	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171198	10.1371/journal.pone.0171198	http://dx.doi.org/10.1371/journal.pone.0171198			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151962	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161200101
J	Yu, SH; Huang, CY				Yu, Shu-Han; Huang, Cheng-Ya			Improving posture-motor dual-task with a supraposture-focus strategy in young and elderly adults	PLOS ONE			English	Article							AGE-RELATED DIFFERENCES; OLDER-ADULTS; VISUAL FEEDBACK; EXTERNAL FOCUS; HEALTHY-YOUNG; REACTION-TIME; WALKING; PERFORMANCE; ATTENTION; RESOURCES	In a postural-suprapostural task, appropriate prioritization is necessary to achieve task goals and maintain postural stability. A "posture-first" principle is typically favored by elderly people in order to secure stance stability, but this comes at the cost of reduced suprapostural performance. Using a postural-suprapostural task with a motor suprapostural goal, this study investigated differences between young and older adults in dual-task cost across varying task prioritization paradigms. Eighteen healthy young (mean age: 24.8 +/- 5.2 years) and 18 older (mean age: 68.8 +/- 3.7 years) adults executed a designated force-matching task from a stabilometer board using either a stabilometer stance (posture-focus strategy) or force-matching (supraposture-focus strategy) as the primary task. The dual-task effect (DTE: % change in dual-task condition; positive value: dual-task benefit, negative value: dual-task cost) of force-matching error and reaction time (RT), posture error, and approximate entropy (ApEn) of stabilometer movement were measured. When using the supraposture-focus strategy, young adults exhibited larger DTE values in each behavioral parameter than when using the posture-focus strategy. The older adults using the supraposture-focus strategy also attained larger DTE values for posture error, stabilometer movement ApEn, and force-matching error than when using the posture-focus strategy. These results suggest that the supraposture-focus strategy exerted an increased dual-task benefit for posturemotor dual-tasking in both healthy young and elderly adults. The present findings imply that the older adults should make use of the supraposture-focus strategy for fall prevention during dual-task execution.	[Yu, Shu-Han; Huang, Cheng-Ya] Natl Taiwan Univ Hosp, Phys Therapy Ctr, Taipei, Taiwan; [Huang, Cheng-Ya] Natl Taiwan Univ, Sch & Grad Inst Phys Therapy, Coll Med, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University	Huang, CY (corresponding author), Natl Taiwan Univ Hosp, Phys Therapy Ctr, Taipei, Taiwan.; Huang, CY (corresponding author), Natl Taiwan Univ, Sch & Grad Inst Phys Therapy, Coll Med, Taipei, Taiwan.	rcyhuang@ntu.edu.tw		Yu, Shu-Han/0000-0002-9522-1740; HUANG, CHENG-YA/0000-0001-6946-2105	Ministry of Science and Technology, R.O.C. Taiwan [MOST 103-2314-B-002-007-MY3]	Ministry of Science and Technology, R.O.C. Taiwan	This research was supported by a grant from the Ministry of Science and Technology, R.O.C. Taiwan, under grant no. MOST 103-2314-B-002-007-MY3.	Abellaneda S, 2009, J APPL PHYSIOL, V106, P169, DOI 10.1152/japplphysiol.90577.2008; [Anonymous], 2011, J SPORTS SCI, V29, P539, DOI [10.1080/02640414.2010.544046, DOI 10.1080/02640414.2010.544046]; BARRETT G, 1985, ELECTROEN CLIN NEURO, V60, P276, DOI 10.1016/0013-4694(85)90042-2; Berger L, 2011, GAIT POSTURE, V33, P300, DOI 10.1016/j.gaitpost.2010.10.082; Bernard-Demanze L, 2009, Curr Aging Sci, V2, P139; Beurskens R, 2016, NEURAL PLAST, V2016, DOI [10.1155/2016/8032180, DOI 10.1155/2016/8032180]; Bock O, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-27; Boisgontier MP, 2013, NEUROSCI BIOBEHAV R, V37, P1824, DOI 10.1016/j.neubiorev.2013.07.014; Borel L, 2014, NEUROPHYSIOL CLIN, V44, P95, DOI 10.1016/j.neucli.2013.10.129; Chen FC, 2015, NEUROSCI LETT, V605, P69, DOI 10.1016/j.neulet.2015.08.016; Critchley K, 2014, EUR J APPL PHYSIOL, V114, P1925, DOI 10.1007/s00421-014-2916-8; Deviterne D, 2005, BRAIN RES BULL, V64, P487, DOI 10.1016/j.brainresbull.2004.10.007; Donker SF, 2007, EXP BRAIN RES, V181, P1, DOI 10.1007/s00221-007-0905-4; Endrass T, 2012, BIOL PSYCHOL, V89, P426, DOI 10.1016/j.biopsycho.2011.12.005; Hartley AA, 2001, PSYCHOL AGING, V16, P47, DOI 10.1037//0882-7974.16.1.47; HORAK FB, 1989, NEUROBIOL AGING, V10, P727, DOI 10.1016/0197-4580(89)90010-9; Huxhold O, 2006, BRAIN RES BULL, V69, P294, DOI 10.1016/j.brainresbull.2006.01.002; Jehu DA, 2015, INT J NEUROSCI, V125, P100, DOI 10.3109/00207454.2014.907573; Kelly VE, 2010, EXP BRAIN RES, V207, P65, DOI 10.1007/s00221-010-2429-6; Lacour M, 2008, NEUROPHYSIOL CLIN, V38, P411, DOI 10.1016/j.neucli.2008.09.005; Laessoe U, 2008, HUM MOVEMENT SCI, V27, P496, DOI 10.1016/j.humov.2007.12.001; Li KZH, 2001, PSYCHOL SCI, V12, P230, DOI 10.1111/1467-9280.00341; Lindenberger U, 2000, PSYCHOL AGING, V15, P417, DOI 10.1037//0882-7974.15.3.417; Lion A, 2014, INT J NEUROSCI, V124, P558, DOI 10.3109/00207454.2013.864288; Marone JR, 2014, GAIT POSTURE, V40, P243, DOI 10.1016/j.gaitpost.2014.04.188; McNevin NH, 2003, PSYCHOL RES-PSYCH FO, V67, P22, DOI 10.1007/s00426-002-0093-6; Mitra S, 2004, HUM MOVEMENT SCI, V23, P1, DOI 10.1016/j.humov.2004.03.003; Mitra S, 2004, J EXP PSYCHOL HUMAN, V30, P28, DOI 10.1037/0096-1523.30.1.28; NAVON D, 1984, PSYCHOL REV, V91, P216, DOI 10.1037/0033-295X.91.2.216; Nordez A, 2009, J APPL PHYSIOL, V106, P1970, DOI 10.1152/japplphysiol.00221.2009; PINCUS S, 1995, CHAOS, V5, P110, DOI 10.1063/1.166092; Polskaia N, 2015, GAIT POSTURE, V41, P454, DOI 10.1016/j.gaitpost.2014.11.009; Prado JM, 2007, GERONTOLOGY, V53, P274, DOI 10.1159/000102938; RABBITT P, 1979, BRIT J PSYCHOL, V70, P305, DOI 10.1111/j.2044-8295.1979.tb01687.x; Schaefer S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01167; Sherafat S, 2014, J MANIP PHYSIOL THER, V37, P170, DOI 10.1016/j.jmpt.2014.02.003; Siu KC, 2007, GAIT POSTURE, V25, P121, DOI 10.1016/j.gaitpost.2006.02.002; Sosnoff JJ, 2006, J GERONTOL B-PSYCHOL, V61, pP117, DOI 10.1093/geronb/61.2.P117; Stins JF, 2009, GAIT POSTURE, V30, P106, DOI 10.1016/j.gaitpost.2009.04.001; Termoz N, 2008, GAIT POSTURE, V27, P463, DOI 10.1016/j.gaitpost.2007.05.015; Therrien AS, 2010, EXP BRAIN RES, V201, P673, DOI 10.1007/s00221-009-2084-y; TOMBERG C, 1991, ELECTROEN CLIN NEURO, V81, P269, DOI 10.1016/0168-5597(91)90013-N; Tomporowski PD, 2014, J AGING PHYS ACTIV, V22, P557, DOI [10.1123/JAPA.2012-0241, 10.1123/japa.2012-0241]; Tsang PS, 2013, Q J EXP PSYCHOL, V66, P1517, DOI 10.1080/17470218.2012.752019; Tsang PS, 1996, ACTA PSYCHOL, V91, P175, DOI 10.1016/0001-6918(94)00055-7; Van Impe A, 2011, NEUROPSYCHOLOGIA, V49, P2400, DOI 10.1016/j.neuropsychologia.2011.04.016; Verghese J, 2007, ARCH PHYS MED REHAB, V88, P50, DOI 10.1016/j.apmr.2006.10.007; Vieluf S, 2013, EXP BRAIN RES, V224, P107, DOI 10.1007/s00221-012-3292-4; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Woollacott MH, 2000, J GERONTOL A-BIOL, V55, pM424, DOI 10.1093/gerona/55.8.M424; Wulf G, 2001, Q J EXP PSYCHOL-A, V54, P1143, DOI 10.1080/02724980143000118; Yogev-Seligmann G, 2012, MOVEMENT DISORD, V27, P765, DOI 10.1002/mds.24963; Yogev-Seligmann G, 2010, PHYS THER, V90, P177, DOI 10.2522/ptj.20090043; Zaepffel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060060; Zaepffel M, 2012, PSYCHOPHYSIOLOGY, V49, P17, DOI 10.1111/j.1469-8986.2011.01277.x; Zwergal A, 2012, NEUROBIOL AGING, V33, P1073, DOI 10.1016/j.neurobiolaging.2010.09.022	56	17	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170687	10.1371/journal.pone.0170687	http://dx.doi.org/10.1371/journal.pone.0170687			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28151943	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161200034
J	Angulo, DF; Amarilla, LD; Anton, AM; Sosa, V				Angulo, Diego F.; Amarilla, Leonardo D.; Anton, Ana M.; Sosa, Victoria			Colonization in North American Arid Lands: The Journey of Agarito (Berberis trifoliolata) Revealed by Multilocus Molecular Data and Packrat Midden Fossil Remains	PLOS ONE			English	Article							EVOLUTIONARY HISTORY; CHIHUAHUAN DESERT; LATE PLEISTOCENE; NEOGENE VICARIANCE; NEUTRALITY TESTS; CLIMATIC-CHANGE; SPECIES GROUP; WARM DESERTS; PHYLOGEOGRAPHY; PLANT	Here we conduct research to understand the evolutionary history of a shrubby species known as Agarito (Berberis trifoliolata), an endemic species to the Chihuahuan Desert. We identify genetic signatures based on plastid DNA and AFLP markers and perform niche modelling and spatial connectivity analyses as well as niche modelling based on records in packrats to elucidate whether orogenic events such as mountain range uplift in the Miocene or the contraction/expansion dynamics of vegetation in response to climate oscillations in the Pliocene/Pleistocene had an effect on evolutionary processes in Agarito. Our results of current niche modelling and palaeomodelling showed that the area currently occupied by Berberis trifoliolata is substantially larger than it was during the Last Interglacial period and the Last Glacial Maximum. Agarito was probably confined to small areas in the Northeastern and gradually expanded its distribution just after the Last Glacial Maximum when the weather in the Chihuahuan Desert and adjacent regions became progressively warmer and drier. The most contracted range was predicted for the Interglacial period. Populations remained in stable areas during the Last Glacial Maximum and expanded at the beginning of the Holocene. Most genetic variation occured in populations from the Sierra Madre Oriental. Two groups of haplotypes were identified: the Mexican Plateau populations and certain Northeastern populations. Haplogroups were spatially connected during the Last Glacial Maximum and separated during interglacial periods. The most important prediction of packrat middens palaeomodelling lies in the Mexican Plateau, a finding congruent with current and past niche modelling predictions for agarito and genetic results. Our results corroborate that these climate changes in the Pliocene/Pleistocene affected the evolutionary history of agarito. The journey of agarito in the Chihuahuan Desert has been dynamic, expanding and contracting its distribution range and currently occupying the largest area in its history.	[Angulo, Diego F.; Sosa, Victoria] Inst Ecol AC, Biol Evolut, Xalapa, Veracruz, Mexico; [Amarilla, Leonardo D.; Anton, Ana M.] Univ Nacl Cordoba, CONICET, Inst Multidisciplinario Biol Vegetal, Cordoba, Argentina	Instituto de Ecologia - Mexico; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Angulo, DF (corresponding author), Inst Ecol AC, Biol Evolut, Xalapa, Veracruz, Mexico.		Sosa, Victoria/A-5798-2013; Angulo, Diego F./B-3152-2015	Sosa, Victoria/0000-0002-0584-1672; Angulo, Diego F./0000-0002-5678-4946	CONACyT [106060, 204519]; Instituto Multidisciplinario de Biologia Vegetal; CONICET-Universidad Nacional de Cordoba; CONACyT-MINCyT [MX/11/08]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Instituto Multidisciplinario de Biologia Vegetal; CONICET-Universidad Nacional de Cordoba(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONACyT-MINCyT	This research was supported by CONACyT, grant no. 106060 to VS, and grant no. 204519 to DFA, by the Institute Multidisciplinario de Biologia Vegetal, CONICET-Universidad Nacional de Cordoba (to AMA), and by a grant from CONACyT-MINCyT (Bilateral project MX/11/08) to AMA and VS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDE M, 1985, SOUTHWEST NAT, V30, P533, DOI 10.2307/3671047; Angulo DF, 2014, BOTANY, V92, P195, DOI 10.1139/cjb-2013-0213; Angulo DF, 2014, BOT SCI, V92, P141, DOI 10.17129/botsci.46; [Anonymous], 2004, K 1 COUPLED GCM MIRO; ARCHER S, 1989, AM NAT, V134, P545, DOI 10.1086/284996; Assis J, 2014, MOL ECOL, V23, P2797, DOI 10.1111/mec.12772; Axelrod D. I., 1950, CARNEGIE I WASHINGTO, V590, P215; AXELROD DI, 1958, BOT REV, V24, P433, DOI 10.1007/BF02872570; Axelrod DI, 1979, ARID LAND PLANT RESO, P3; Bonetti MF, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3229; BOX TW, 1969, J RANGE MANAGE, V22, P373, DOI 10.2307/3895845; Bryson RW, 2011, J BIOGEOGR, V38, P697, DOI 10.1111/j.1365-2699.2010.02431.x; Calvino-Cancela M, 2012, J BIOGEOGR, V39, P1996, DOI 10.1111/j.1365-2699.2012.02732.x; Carstens BC, 2007, EVOLUTION, V61, P1439, DOI 10.1111/j.1558-5646.2007.00117.x; Castoe TA, 2007, MOL PHYLOGENET EVOL, V42, P193, DOI 10.1016/j.ympev.2006.07.002; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Colwell RK, 2013, ESTIMATES STAT ESTIM; Cordellier M, 2009, MOL ECOL, V18, P534, DOI 10.1111/j.1365-294X.2008.04042.x; Dorsey RJ, 2007, GEOLOGY, V35, P57, DOI 10.1130/G23139A.1; Douglas ME, 2006, MOL ECOL, V15, P3353, DOI 10.1111/j.1365-294X.2006.03007.x; Dregne HE, 1984, DESERTS ARID LANDS, P145; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fehlberg SD, 2009, MOL PHYLOGENET EVOL, V50, P326, DOI 10.1016/j.ympev.2008.11.011; Ferrusquia-Villafranca I., 1993, BIOL DIVERSITY MEXIC, P3, DOI [DOI 10.1007/BF02908211, 10.1007/BF02908211]; Fu YX, 1997, GENETICS, V147, P915; Galbreath KE, 2009, EVOLUTION, V63, P2848, DOI 10.1111/j.1558-5646.2009.00803.x; Graham A, 1999, AM J BOT, V86, P17, DOI 10.2307/2656951; Graham MR, 2013, MOL PHYLOGENET EVOL, V69, P502, DOI 10.1016/j.ympev.2013.07.028; Graham RW, 1987, N AM ADJACENT OCEANS; Gugger PF, 2013, MOL ECOL, V22, P3598, DOI 10.1111/mec.12317; Guo YP, 2012, BMC EVOL BIOL, V12; Hafner DJ, 2011, PALAEOGEOGR PALAEOCL, P239; Hammer O, 2022, SOFTWARE NATURAL HIS; Henrickson J., 1986, 2 S RES CHIH DES REG, P20; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holmgren CA, 2007, J QUATERNARY SCI, V22, P141, DOI 10.1002/jqs.1023; Holt JW, 2000, GEOL SOC AM BULL, V112, P540, DOI 10.1130/0016-7606(2000)112<540:AACOGO>2.0.CO;2; Hunter KL, 2001, GLOBAL ECOL BIOGEOGR, V10, P521, DOI 10.1046/j.1466-822X.2001.00254.x; Inoue K, 2015, MOL ECOL, V24, P1910, DOI 10.1111/mec.13156; JAEGER EC, 1957, N AM DESERTS; Jaeger JR, 2005, MOL ECOL, V14, P3033, DOI 10.1111/j.1365-294X.2005.02645.x; Jezkova T, 2016, ECOGRAPHY, V39, P437, DOI 10.1111/ecog.01464; Jezkova T, 2009, J MAMMAL, V90, P306, DOI 10.1644/08-MAMM-A-243.1; Kozak KH, 2010, ECOL LETT, V13, P1378, DOI 10.1111/j.1461-0248.2010.01530.x; Kropf M, 2009, MOL ECOL, V18, P697, DOI 10.1111/j.1365-294X.2008.04053.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mackay William P., 1992, Psyche (Cambridge), V99, P169, DOI 10.1155/1992/82014; MCPHERSON GR, 1988, AM MIDL NAT, V120, P391, DOI 10.2307/2426011; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Mcrae BH, 2007, P NATL ACAD SCI USA, V104, P19885, DOI 10.1073/pnas.0706568104; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Metcalfe S, 2002, QUATERNARY RES, V57, P91, DOI 10.1006/qres.2001.2292; Metcalfe SE, 2006, ANN MO BOT GARD, V93, P258, DOI 10.3417/0026-6493(2006)93[258:LQEOTN]2.0.CO;2; Metcalfe SE, 2000, QUATERNARY SCI REV, V19, P699, DOI 10.1016/S0277-3791(99)00022-0; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; Moore MJ, 2006, MOL PHYLOGENET EVOL, V39, P668, DOI 10.1016/j.ympev.2006.01.020; Morafka D. J, 1989, YB LOUISIANA STATE U, P23; Morafka D. J, 1977, BIOGEOGRAPHICA, V9, P1; Musgrove M, 2001, GEOL SOC AM BULL, V113, P1532, DOI 10.1130/0016-7606(2001)113<1532:GOLPTH>2.0.CO;2; Nakazato T, 2010, AM J BOT, V97, P680, DOI 10.3732/ajb.0900216; Nei M., 1987, MOL EVOLUTIONARY GEN; NEILSON RP, 1986, SCIENCE, V232, P27, DOI 10.1126/science.232.4746.27; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pritchard JK, 2000, GENETICS, V155, P945; Ramirez JL, 2000, REV PALAEOBOT PALYNO, V110, P247, DOI 10.1016/S0034-6667(00)00015-4; Ramirez-Soriano A, 2008, GENETICS, V179, P555, DOI 10.1534/genetics.107.083006; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Rebernig CA, 2010, MOL ECOL, V19, P3421, DOI 10.1111/j.1365-294X.2010.04754.x; Rebernig CA, 2010, MOL PHYLOGENET EVOL, V54, P594, DOI 10.1016/j.ympev.2009.10.010; Riddle BR, 2006, J ARID ENVIRON, V66, P435, DOI 10.1016/j.jaridenv.2006.01.014; Riddle BR, 2000, MOL PHYLOGENET EVOL, V17, P145, DOI 10.1006/mpev.2000.0841; Riddle BR, 2000, P NATL ACAD SCI USA, V97, P14438, DOI 10.1073/pnas.250413397; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013674; Rudolf PO, 1974, SEED WOODY PLANTS US, P247; Schmidt Jr R. H., 1986, 2 S RES CHIH DES REG, P40; SCHMIDT RH, 1979, J ARID ENVIRON, V2, P243, DOI 10.1016/S0140-1963(18)31774-9; Schneider S, 1999, GENETICS, V152, P1079; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; SHREVE F., 1942, BOT REV, V8, P195, DOI 10.1007/BF02882228; Sosa V, 2009, J BIOGEOGR, V36, P18, DOI 10.1111/j.1365-2699.2008.01957.x; Stewart JR, 2009, J EVOLUTION BIOL, V22, P2363, DOI 10.1111/j.1420-9101.2009.01859.x; Surina B, 2014, MOL ECOL, V23, P2861, DOI 10.1111/mec.12779; TAJIMA F, 1989, GENETICS, V123, P597; Thompson RS, 2000, J BIOGEOGR, V27, P555, DOI 10.1046/j.1365-2699.2000.00427.x; TOOMEY RS, 1993, GLOBAL PLANET CHANGE, V7, P299, DOI 10.1016/0921-8181(93)90003-7; Van Devender T.R., 1990, PACKRAT MIDDENS LAST, P104; Van Devender TR, 1978, NATL PARK SERV T P 3, V3, P85; VANDEVENDER TR, 1977, SCIENCE, V198, P189, DOI 10.1126/science.198.4313.189; VANDEVENDER TR, 1979, SCIENCE, V204, P701, DOI 10.1126/science.204.4394.701; Velo-Anton G, 2013, MOL ECOL, V22, P3261, DOI 10.1111/mec.12310; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; WEBB SD, 1977, ANNU REV ECOL SYST, V8, P355, DOI 10.1146/annurev.es.08.110177.002035; WELLS PV, 1966, SCIENCE, V153, P970, DOI 10.1126/science.153.3739.970; Wilson JS, 2010, PROG PHYS GEOG, V34, P419, DOI 10.1177/0309133310363991; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wroblewska A, 2013, BOT J LINN SOC, V173, P64, DOI 10.1111/boj.12073; Zink RM, 2001, CONDOR, V103, P1, DOI 10.1650/0010-5422(2001)103[0001:CPOSAB]2.0.CO;2	105	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0168933	10.1371/journal.pone.0168933	http://dx.doi.org/10.1371/journal.pone.0168933			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146559	Green Published, Green Submitted, gold			2022-12-27	WOS:000396131700003
J	Doherty, A; Jackson, D; Hammerla, N; Plotz, T; Olivier, P; Granat, MH; White, T; van Hees, VT; Trenell, MI; Owen, CG; Preece, SJ; Gillions, R; Sheard, S; Peakman, T; Brage, S; Wareham, NJ				Doherty, Aiden; Jackson, Dan; Hammerla, Nils; Plotz, Thomas; Olivier, Patrick; Granat, Malcolm H.; White, Tom; van Hees, Vincent T.; Trenell, Michael I.; Owen, Christoper G.; Preece, Stephen J.; Gillions, Rob; Sheard, Simon; Peakman, Tim; Brage, Soren; Wareham, Nicholas J.			Large Scale Population Assessment of Physical Activity Using Wrist Worn Accelerometers: The UK Biobank Study	PLOS ONE			English	Article								Background Physical activity has not been objectively measured in prospective cohorts with sufficiently large numbers to reliably detect associations with multiple health outcomes. Technological advances now make this possible. We describe the methods used to collect and analyse accelerometer measured physical activity in over 100,000 participants of the UK Biobank study, and report variation by age, sex, day, time of day, and season. Methods Participants were approached by email to wear a wrist-worn accelerometer for seven days that was posted to them. Physical activity information was extracted from 100Hz raw triaxial acceleration data after calibration, removal of gravity and sensor noise, and identification of wear / non-wear episodes. We report age-and sex-specific wear-time compliance and accelerometer measured physical activity, overall and by hour-of-day, week-weekend day and season. Results 103,712 datasets were received (44.8% response), with a median wear-time of 6.9 days (IQR: 6.5 - 7.0). 96,600 participants (93.3%) provided valid data for physical activity analyses. Vector magnitude, a proxy for overall physical activity, was 7.5% (2.35mg) lower per decade of age (Cohen's d = 0.9). Women had a higher vector magnitude than men, apart from those aged 45-54yrs. There were major differences in vector magnitude by time of day (d = 0.66). Vector magnitude differences between week and weekend days (d = 0.12 for men, d = 0.09 for women) and between seasons (d = 0.27 for men, d = 0.15 for women) were small. Conclusions It is feasible to collect and analyse objective physical activity data in large studies. The summary measure of overall physical activity is lower in older participants and age-related differences in activity are most prominent in the afternoon and evening. This work lays the foundation for studies of physical activity and its health consequences. Our summary variables are part of the UK Biobank dataset and can be used by researchers as exposures, confounding factors or outcome variables in future analyses.	[Doherty, Aiden] Univ Oxford, Big Data Inst, Nuffield Dept Populat Hlth, BHF Ctr Res Excellence, Oxford, England; [Doherty, Aiden] Univ Oxford, Inst Biomed Engn, Dept Engn Sci, Oxford, England; [Jackson, Dan; Hammerla, Nils; Plotz, Thomas; Olivier, Patrick] Newcastle Univ, Open Lab, Newcastle Upon Tyne, Tyne & Wear, England; [Granat, Malcolm H.; Preece, Stephen J.] Univ Salford, Sch Hlth Sci, Manchester, Lancs, England; [White, Tom; Brage, Soren; Wareham, Nicholas J.] Univ Cambridge, MRC, Epidemiol Unit, Cambridge, England; [van Hees, Vincent T.; Trenell, Michael I.] Newcastle Univ, Inst Cellular Med, MoveLab, Newcastle Upon Tyne, Tyne & Wear, England; [Owen, Christoper G.] St Georges Univ London, Populat Hlth Res Inst, London, England; [Gillions, Rob; Sheard, Simon; Peakman, Tim] UK Biobank, Stockport, Lancs, England	University of Oxford; University of Oxford; Newcastle University - UK; University of Salford; University of Cambridge; Newcastle University - UK; St Georges University London	Doherty, A (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, BHF Ctr Res Excellence, Big Data Inst, Oxford, England.; Doherty, A (corresponding author), Univ Oxford, Inst Biomed Engn, Dept Engn Sci, Oxford, England.	aiden.doherty@ndph.ox.ac.uk	Olivier, Patrick/B-2909-2011; OLIVIER, PATRICK/V-5367-2019; Brage, Soren/C-6415-2013	Olivier, Patrick/0000-0003-2841-7580; Brage, Soren/0000-0002-1265-7355; Trenell, Michael/0000-0001-8253-5620; van Hees, Vincent/0000-0003-0182-9008; White, Thomas/0000-0001-8456-0803; Doherty, Aiden/0000-0003-1840-0451; Jackson, Daniel/0000-0002-6349-5026; Owen, Christopher/0000-0003-1135-5977; Sheard, Simon/0000-0002-8925-8280; Granat, Malcolm/0000-0002-0722-2760	Wellcome Trust; Medical Research Council; British Heart Foundation Centre of Research Excellence at Oxford [RE/13/1/30181]; Li Ka Shing Foundation; UK Medical Research Council [MC_UU_12015/1, MC_UU_12015/3]; RCUK Digital Economy Research Hub on Social Inclusion through the Digital Economy (SiDE) [EP/G066019/1]; EPSRC Centre for Doctoral Training in Digital Civics [EP/L016176/1]; National Institute for Health Research [SRF-2011-04-017]; EPSRC [EP/M023001/1] Funding Source: UKRI; ESRC [ES/K007688/1] Funding Source: UKRI; MRC [MC_U106179473, MR/L016354/1, MC_UU_12015/3, G0700718, MC_UU_12015/1] Funding Source: UKRI; Economic and Social Research Council [ES/K007688/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/M023001/1] Funding Source: researchfish; Medical Research Council [MR/L016354/1, MC_UU_12015/1, MC_U106179473, MC_U106179471, MC_qA137853, G0700718, MC_UU_12015/3] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10135] Funding Source: researchfish; Alzheimer&quot;s Society [189] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation Centre of Research Excellence at Oxford; Li Ka Shing Foundation; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); RCUK Digital Economy Research Hub on Social Inclusion through the Digital Economy (SiDE); EPSRC Centre for Doctoral Training in Digital Civics(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Alzheimer&quot;s Society	The UK Biobank Activity Project and the collection of activity data from participants was funded by the Wellcome Trust (https://wellcome.ac.uk/) and the Medical Research Council (http://www.mrc.ac.uk/). The analysis was supported by the British Heart Foundation Centre of Research Excellence at Oxford (http://www.cardioscience.ox.ac.uk/bhf-centre-of-research-excellence) [grant number RE/13/1/30181 to AD], the Li Ka Shing Foundation (http://www.lksf.org/) [to AD], the UK Medical Research Council (http://www.mrc.ac.uk/) [grant numbers MC_UU_12015/1 and MC_UU_12015/3 to NW and SB], the RCUK Digital Economy Research Hub on Social Inclusion through the Digital Economy (SiDE) (http://www.rcuk.ac.uk/) [EP/G066019/1 to NH], the EPSRC Centre for Doctoral Training in Digital Civics (https://www.epsrc.ac.uk/)[EP/L016176/1 to DJ], and the National Institute for Health Research (http://www.nihr.ac.uk/) [SRF-2011-04-017 to MIT]. The MRC and Wellcome Trust played a key role in the decision to establish UK Biobank, and the accelerometer data collection. No funding bodies had any role in the analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Berkemeyer K, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-015-0316-z; Chief Medical Officers of England Scotland Wales and Northern Ireland, 2011, START ACT STAY ACT R; Colley RC, 2011, HLTH REP, V22, P7; Craig RJM, 2008, HLTH SURVEY ENGLAND; da Silva ICM, 2014, INT J EPIDEMIOL, V43, P1959, DOI 10.1093/ije/dyu203; Esliger DW, 2011, MED SCI SPORT EXER, V43, P1085, DOI 10.1249/MSS.0b013e31820513be; Hammerla Nils Y, 2013, P 2013 INT S WEARABL, P65; Ladha C, 2013, 3 INT C AMB MON PHYS, P69; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Sabia S, 2014, AM J EPIDEMIOL, V179, P781, DOI 10.1093/aje/kwt330; Sartini C, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1976-y; Steene-Johannessen J, 2016, MED SCI SPORT EXER, P48; Strath SJ, 2013, CIRCULATION, V128, P2259, DOI 10.1161/01.cir.0000435708.67487.da; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Troiano RP, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093546; van Hees VT, 2014, J APPL PHYSIOL, V117, P738, DOI 10.1152/japplphysiol.00421.2014; van Hees VT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022922; White T, 2016, PLOS ONE IN PRESS; Wijndaele K, 2015, MED SCI SPORTS EXERC; Wolff-Hughes DL, 2015, J PHYS ACT HEALTH, V12, P447, DOI 10.1123/jpah.2013-0464	22	393	394	7	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0169649	10.1371/journal.pone.0169649	http://dx.doi.org/10.1371/journal.pone.0169649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146576	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000396131700009
J	Eriksen, VR; Rasmussen, MB; Hahn, GH; Greisen, G				Eriksen, Vibeke Ramsgaard; Rasmussen, Martin Bo; Hahn, Gitte Holst; Greisen, Gorm			Dopamine therapy does not affect cerebral autoregulation during hypotension in newborn piglets	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; ARTERIAL-BLOOD-PRESSURE; PRETERM INFANTS; LASER-DOPPLER; FLOW; HEMODYNAMICS; PERFUSION; BRAIN	Background Hypotensive neonates who have been treated with dopamine have poorer neurodevelopmental outcome than those who have not been treated with dopamine. We speculate that dopamine stimulates adrenoceptors on cerebral arteries causing cerebral vasoconstriction. This vasoconstriction might lead to a rightward shift of the cerebral autoregulatory curve; consequently, infants treated with dopamine would have a higher risk of low cerebral blood flow at a blood pressure that is otherwise considered "safe". Methods In anaesthetized piglets, perfusion of the brain, monitored with laser-doppler flowmetry, and cerebral venous saturation was measured at different levels of hypotension. Each piglet was studied in two phases: a phase with stepwise decreases in MAP and a phase with stepwise increases in MAP. We randomized the order of the two phases, whether dopamine was given in the first or second phase, and the infusion rate of dopamine (10, 25, or 40 mu g/kg/min). In/deflation of a balloon catheter, placed in vena cava, induced different levels of hypotension. At each level of hypotension, fluctuations in MAP were induced by in/deflations of a balloon catheter in descending aorta. Results During measurements, PaCO(2)and arterial saturation were stable. MAP levels ranged between 14 and 82 mmHg. Cerebral autoregulation (CA) capacity was calculated as the ratio between %-change in cerebrovascular resistance and %-change in MAP induced by the in/deflation of the arterial balloon. A breakpoint in CA capacity was identified at a MAP of 38 +/- 18 mmHg without dopamine and at 44 +/- 18, 31 +/- 14, and 24 +/- 14 mmHg with dopamine infusion rates of 10, 25, and 40 mu g/kg/min (p = 0.057). Neither the index of steady-state cerebral perfusion nor cerebral venous saturation were affected by dopamine infusion. Conclusion Dopamine infusion tended to improve CA capacity at low blood pressures while an index of steady-state cerebral blood flow and cerebral venous saturation were unaffected by dopamine infusion. Thus, dopamine does not appear to impair CA in newborn piglets.	[Eriksen, Vibeke Ramsgaard; Rasmussen, Martin Bo; Hahn, Gitte Holst; Greisen, Gorm] Copenhagen Univ Hosp, Rigshosp, Dept Neonatol, Copenhagen, Denmark; [Eriksen, Vibeke Ramsgaard; Rasmussen, Martin Bo] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Hahn, Gitte Holst] Copenhagen Univ Hosp, Hvidovre Hosp, Dept Pediat, Hvidovre, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen	Eriksen, VR (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Neonatol, Copenhagen, Denmark.	vibeke.eriksen@dadlnet.dk	Greisen, Gorm/AAA-6463-2022; Hahn, Gitte/AAN-4967-2020	Greisen, Gorm/0000-0001-8042-3262; Eriksen, Vibeke/0000-0002-8544-8626	Lundbeck Foundation; University of Copenhagen; Lundbeck Foundation [R77-2010-7200, R151-2013-14782] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); University of Copenhagen; Lundbeck Foundation(Lundbeckfonden)	The Lundbeck Foundation and University of Copenhagen financially supported this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Tawil KI, 2012, PEDIATR NEUROL, V46, P149, DOI 10.1016/j.pediatrneurol.2011.12.008; Amenta F, 2000, CLIN EXP HYPERTENS, V22, P277, DOI 10.1081/CEH-100100077; Armstead WM, 2013, PEDIATR CRIT CARE ME, V14, pE103, DOI 10.1097/PCC.0b013e3182712b44; Barrington KJ, 2008, SEMIN FETAL NEONAT M, V13, P16, DOI 10.1016/j.siny.2007.09.002; Batton B, 2016, ARCH DIS CHILD-FETAL, V101, pF201, DOI 10.1136/archdischild-2015-308899; Bishai JM, 2003, J PHYSIOL-LONDON, V546, P869, DOI 10.1113/jphysiol.2002.025270; Borch K, 2010, ACTA PAEDIATR, V99, P1489, DOI 10.1111/j.1651-2227.2010.01856.x; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Brady KM, 2010, ANESTH ANALG, V111, P191, DOI 10.1213/ANE.0b013e3181e054ba; Bruins B, 2013, ANESTH ANALG, V116, P838, DOI 10.1213/ANE.0b013e3182860fe7; Dempsey EM, 2009, ARCH DIS CHILD-FETAL, V94, pF241, DOI 10.1136/adc.2007.124263; Eriksen VR, 2014, ACTA PAEDIATR, V103, P1221, DOI 10.1111/apa.12817; Fanaroff AA, 2006, SEMIN PERINATOL, V30, P151, DOI 10.1053/j.semperi.2006.04.006; Fanaroff JM, 2006, PEDIATRICS, V117, P1131, DOI 10.1542/peds.2005-1230; FERRARA JJ, 1995, ANN SURG, V221, P531, DOI 10.1097/00000658-199505000-00011; GRAHAM DI, 1979, STROKE, V10, P724, DOI 10.1161/01.STR.10.6.724; Hahn GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063069; Hahn GH, 2012, ACTA PAEDIATR, V101, P736, DOI 10.1111/j.1651-2227.2012.02666.x; Kissack CM, 2005, J CEREBR BLOOD F MET, V25, P545, DOI 10.1038/sj.jcbfm.9600046; LOW JA, 1993, ACTA PAEDIATR, V82, P433, DOI 10.1111/j.1651-2227.1993.tb12717.x; Meek JH, 1999, ARCH DIS CHILD-FETAL, V81, pF15, DOI 10.1136/fn.81.1.F15; MIALLALLEN VM, 1987, ARCH DIS CHILD, V62, P1068, DOI 10.1136/adc.62.10.1068; Muller T, 2002, J PHYSIOL-LONDON, V539, P957, DOI 10.1013/jphysiol.2001.012590; Munro MJ, 2004, PEDIATRICS, V114, P1591, DOI 10.1542/peds.2004-1073; Nachar RA, 2011, PEDIATR RES, V70, P473, DOI 10.1203/PDR.0b013e31822e178e; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Pellicer A, 2005, PEDIATRICS, V115, P1501, DOI 10.1542/peds.2004-1396; Rios DR, 2014, J PEDIATR-US, V165, P697, DOI 10.1016/j.jpeds.2014.06.009; Sassano-Higgins S, 2011, J PERINATOL, V31, P647, DOI 10.1038/jp.2011.2; SERI I, 1984, J PEDIATR-US, V105, P489, DOI 10.1016/S0022-3476(84)80035-9; STREBEL S, 1995, ANESTHESIOLOGY, V83, P66, DOI 10.1097/00000542-199507000-00008; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; TODA N, 1983, EXPERIENTIA, V39, P1131, DOI 10.1007/BF01943144; Tonnesen J, 2005, EXP PHYSIOL, V90, P349, DOI 10.1113/expphysiol.2004.029512; Tsuji M, 1998, PEDIATR RES, V44, P591, DOI 10.1203/00006450-199810000-00020; Zhang J, 1999, ARCH DIS CHILD-FETAL, V81, pF99, DOI 10.1136/fn.81.2.F99	36	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170738	10.1371/journal.pone.0170738	http://dx.doi.org/10.1371/journal.pone.0170738			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141842	Green Submitted, Green Published, gold			2022-12-27	WOS:000396129500017
J	Mulders-Jones, B; Mitchison, D; Girosi, F; Hay, P				Mulders-Jones, Brittany; Mitchison, Deborah; Girosi, Federico; Hay, Phillipa			Socioeconomic Correlates of Eating Disorder Symptoms in an Australian Population-Based Sample	PLOS ONE			English	Article							SEX-DIFFERENCES; DAILY STRESS; PREVALENCE; UNEMPLOYMENT; BEHAVIOR; THERAPY; ADOLESCENTS; ACHIEVEMENT; FEATURES; NERVOSA	Background Recent research has challenged the stereotype that eating disorders are largely limited to young, White, upper-class females. This study investigated the association between indicators of socioeconomic status and eating disorder features. Methods and Findings Data were merged from cross-sectional general population surveys of adults in South Australia in 2008 (n = 3034) and 2009 (n = 3007) to give a total sample of 6041 participants. Multivariate logistic regressions were employed to test associations between indicators of socioeconomic status (household income, educational level, employment status, indigenous status and urbanicity) and current eating disorder features (objective binge eating, subjective binge eating, purging, strict dieting and overvaluation of weight/shape). Eating disorder features occurred at similar rates across all levels of income, education, indigenous status, and urbanicity (p > 0.05). However, compared to working full-time, not working due to disability was associated with an increased risk of objective binge eating (odds ratio (OR) = 2.30, p < 0.01) and purging (OR = 4.13, p < 0.05), engagement in home-duties with an increased risk of overvaluation of weight/shape (OR = 1.39, p < 0.05), and unemployment with an increased risk of objective binge eating (OR = 2.02, p < 0.05) and subjective binge eating (OR = 2.80, p < 0.05). Furthermore, participants with a trade or certificate qualification were at a significantly increased risk of reporting strict dieting compared to participants without a tertiary qualification (OR = 1.58, p < 0.01). Limitations included the small numbers of indigenous participants (n = 115) and participants who reported purging (n = 54), exclusion of excessive exercise (which is associated with eating disorders, particularly in males), and the conduct of interviews by laypersons. Conclusions Overall, symptoms of eating disorders are distributed equally across levels of socioeconomic status. This study highlights the need for universal access to specialised services, to train healthcare workers in the detection and diagnosis of eating disorders in diverse subgroups, and to combat barriers to help-seeking experienced by people who do not conform to the demographic stereotype of an eating disorder. The increased prevalence of various eating disorder features in those who are not working could be addressed by providing support to help sufferers join the workforce, or engage in meaningful social or community activities to improve resilience against the development of eating disorders.	[Mulders-Jones, Brittany; Mitchison, Deborah; Hay, Phillipa] Univ Western Sydney, Sch Med, Sydney, NSW, Australia; [Mitchison, Deborah] Macquarie Univ, Ctr Emot Hlth, Sydney, NSW, Australia; [Girosi, Federico; Hay, Phillipa] Univ Western Sydney, Ctr Hlth Res, Sydney, NSW, Australia; [Girosi, Federico] Capital Markets CRC, Sydney, NSW, Australia	Western Sydney University; Macquarie University; Western Sydney University	Mitchison, D (corresponding author), Univ Western Sydney, Sch Med, Sydney, NSW, Australia.; Mitchison, D (corresponding author), Macquarie Univ, Ctr Emot Hlth, Sydney, NSW, Australia.	deborah.mitchison@westernsydney.edu.au	Mitchison, Deborah/AAH-4842-2021	MITCHISON, DEBORAH/0000-0002-6736-7937; Girosi, Federico/0000-0003-3937-2285				Agh T, 2016, EAT WEIGHT DISORD-ST, V21, P353, DOI 10.1007/s40519-016-0264-x; Agras WS, 2001, PSYCHIAT CLIN N AM, V24, P371, DOI 10.1016/S0193-953X(05)70232-X; Allen KL, 2013, J ABNORM PSYCHOL, V122, P720, DOI 10.1037/a0034004; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Australian Bureau of Statistics, 2002, 41020 AUSTR BUR STAT; Australian Bureau of Statistics, 2011, HLTH WELF AUSTR AB T; Bardone-Cone AM, 2007, CLIN PSYCHOL REV, V27, P384, DOI 10.1016/j.cpr.2006.12.005; Becker AE, 2003, INT J EAT DISORDER, V34, P423, DOI 10.1002/eat.10225; Becker AE, 2003, INT J EAT DISORDER, V33, P205, DOI 10.1002/eat.10129; Bentley C, 2014, EAT BEHAV, V15, P609, DOI 10.1016/j.eatbeh.2014.08.015; Bruch H., 1973, EVOLUTION PSYCHOTHER; Butterfly Foundation, 2012, PAYING PRIC EC SOC I; DURA JR, 1989, J CLIN PSYCHOL, V45, P433, DOI 10.1002/1097-4679(198905)45:3<433::AID-JCLP2270450313>3.0.CO;2-X; Fairburn CG, 2003, BEHAV RES THER, V41, P509, DOI 10.1016/S0005-7967(02)00088-8; Fairburn Christopher G., 1993, P317; Fergusson DM, 1997, PSYCHOL MED, V27, P371, DOI 10.1017/S0033291796004412; Fragkos KC, 2013, NUTRIENTS, V5, P811, DOI 10.3390/nu5030811; Freeman LMY, 2004, INT J EAT DISORDER, V36, P204, DOI 10.1002/eat.20012; Gard MCE, 1996, INT J EAT DISORDER, V20, P1, DOI 10.1002/(SICI)1098-108X(199607)20:1&lt;1::AID-EAT1&gt;3.0.CO;2-M; Gentile Katie, 2007, Eat Disord, V15, P405, DOI 10.1080/10640260701667904; Green MW, 1996, J PSYCHIAT RES, V30, P401, DOI 10.1016/0022-3956(96)00026-X; Griffiths S, 2015, INT J EAT DISORDER, V48, P767, DOI 10.1002/eat.22353; Hart LM, 2011, CLIN PSYCHOL REV, V31, P727, DOI 10.1016/j.cpr.2011.03.004; Hay P, 2015, J EAT DISORD, V3, DOI 10.1186/s40337-015-0056-0; Hay P, 2014, AUST NZ J PSYCHIAT, V48, P977, DOI 10.1177/0004867414555814; Hay PJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-233; HOEK HW, 1995, AM J PSYCHIAT, V152, P1272; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Kjelsas Einar, 2004, Eat Behav, V5, P13, DOI 10.1016/S1471-0153(03)00057-6; Mitchell JE, 2008, BEHAV RES THER, V46, P581, DOI 10.1016/j.brat.2008.02.004; Mitchison D, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-943; Mitchison D, 2014, CLIN EPIDEMIOL, V6, P89, DOI 10.2147/CLEP.S40841; Mitchison D, 2013, INT J EAT DISORDER, V46, P375, DOI 10.1002/eat.22097; Morgan JF, 2000, WESTERN J MED, V172, P164, DOI 10.1136/ewjm.172.3.164; Fernandez MAP, 2007, J PSYCHOSOM RES, V62, P681, DOI 10.1016/j.jpsychores.2006.12.010; POPE HG, 1987, J NERV MENT DIS, V175, P620, DOI 10.1097/00005053-198710000-00007; Shaw H, 2004, PSYCHOL ADDICT BEHAV, V18, P12, DOI 10.1037/0893-164X.18.1.12; Swanson SA, 2011, ARCH GEN PSYCHIAT, V68, P714, DOI 10.1001/archgenpsychiatry.2011.22; Theodossiou I, 1998, J HEALTH ECON, V17, P85, DOI 10.1016/S0167-6296(97)00018-0; Weich S, 1998, BMJ-BRIT MED J, V317, P115, DOI 10.1136/bmj.317.7151.115; Wolff GE, 2000, ADDICT BEHAV, V25, P205, DOI 10.1016/S0306-4603(99)00049-0	41	48	49	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0170603	10.1371/journal.pone.0170603	http://dx.doi.org/10.1371/journal.pone.0170603			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6QW	28141807	Green Submitted, gold, Green Published			2022-12-27	WOS:000396129500012
J	Su, T; Zhang, HF				Su, Ting; Zhang, Haifeng			Electrical Study of Trapped Charges in Copper-Doped Zinc Oxide Films by Scanning Probe Microscopy for Nonvolatile Memory Applications	PLOS ONE			English	Article							THIN-FILMS; ELECTRONIC CHARACTERIZATION; EPITAXIAL-GROWTH; ZNO FILMS; FORCE; CU; MICROSTRUCTURE	Charge trapping properties of electrons and holes in copper-doped zinc oxide (ZnO:Cu) films have been studied by scanning probe microscopy. We investigated the surface potential dependence on the voltage and duration applied to the copper-doped ZnO films by Kelvin probe force microscopy. It is found that the Fermi Level of the 8 at.% Cu-doped ZnO films shifted by 0.53 eV comparing to undoped ZnO films. This shift indicates significant change in the electronic structure and energy balance in Cu-doped ZnO films. The Fermi Level (work function) of zinc oxide films can be tuned by Cu doping, which are important for developing this functional material. In addition, Kelvin probe force microscopy measurements demonstrate that the nature of contact at Pt-coated tip/ZnO: Cu interface is changed from Schottky contact to Ohmic contact by increasing sufficient amount of Cu ions. The charge trapping property of the ZnO films enhance greatly by Cu doping (similar to 10 at.%). The improved stable bipolar charge trapping properties indicate that copper-doped ZnO films are promising for nonvolatile memory applications.	[Su, Ting] Fudan Univ, State Key Lab Surface Phys, Shanghai, Peoples R China; [Su, Ting] Fudan Univ, Dept Phys, Shanghai, Peoples R China; [Zhang, Haifeng] Jiamusi Univ, Dept Phys, Jiamusi, Peoples R China	Fudan University; Fudan University; Jiamusi University	Su, T (corresponding author), Fudan Univ, State Key Lab Surface Phys, Shanghai, Peoples R China.; Su, T (corresponding author), Fudan Univ, Dept Phys, Shanghai, Peoples R China.	14110190063@fudan.edu.cn						Ando M, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4901946; Barth C, 2011, ADV MATER, V23, P477, DOI 10.1002/adma.201002270; Chen CC, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4768921; Chen XQ, 1999, J VAC SCI TECHNOL B, V17, P1930, DOI 10.1116/1.590851; Dai W, 2014, RSC ADV, V4, P31969, DOI 10.1039/c4ra04249b; DINGLE R, 1969, PHYS REV LETT, V23, P579, DOI 10.1103/PhysRevLett.23.579; Faraji N, 2016, ADV ELECTRON MATER, V2, DOI 10.1002/aelm.201600138; Guo DY, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4890524; Jin CM, 2005, MAT SCI ENG B-SOLID, V117, P348, DOI 10.1016/j.mseb.2004.12.003; Kalinin SV, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.125411; Kim Y, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3046786; Kumar M, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4922732; Maragliano C, 2014, SCI REP-UK, V4, DOI 10.1038/srep04203; Melitz W, 2011, SURF SCI REP, V66, P1, DOI 10.1016/j.surfrep.2010.10.001; Min CH, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3432398; Mishra YK, 2015, ACS APPL MATER INTER, V7, P14303, DOI 10.1021/acsami.5b02816; Musumeci C, 2014, MATER TODAY, V17, P504, DOI 10.1016/j.mattod.2014.05.010; NONNENMACHER M, 1991, APPL PHYS LETT, V58, P2921, DOI 10.1063/1.105227; Palermo V, 2006, ADV MATER, V18, P145, DOI 10.1002/adma.200501394; Recker MC, 2014, J APPL PHYS, V115, DOI 10.1063/1.4885439; Shi YM, 2010, ACS NANO, V4, P2689, DOI 10.1021/nn1005478; Singh S, 2007, J PHYS D APPL PHYS, V40, P6312, DOI 10.1088/0022-3727/40/20/S15; Snure M, 2007, J APPL PHYS, V101, DOI 10.1063/1.2749487; Tiwari A, 2004, J APPL PHYS, V96, P3827, DOI 10.1063/1.1783591; Tiwari A, 2002, J MATER RES, V17, P2480, DOI 10.1557/JMR.2002.0361; Tiwari A, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2857481; Wang XB, 2005, J PHYS D APPL PHYS, V38, P4104, DOI 10.1088/0022-3727/38/22/014; Wen L, 2015, SURF COAT TECH, V284, P85, DOI 10.1016/j.surfcoat.2015.06.084; Younas M, 2015, RSC ADV, V5, P55648, DOI 10.1039/c5ra09002d	29	12	12	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171050	10.1371/journal.pone.0171050	http://dx.doi.org/10.1371/journal.pone.0171050			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135335	Green Published, Green Submitted, gold			2022-12-27	WOS:000396124700042
J	Cai, KP; Xu, H; Guan, H; Zhu, WL; Jiang, JY; Cui, Y; Zhang, JC; Liu, T; Wen, W				Cai, Kunpeng; Xu, Hong; Guan, Hao; Zhu, Wanlin; Jiang, Jiyang; Cui, Yue; Zhang, Jicong; Liu, Tao; Wen, Wei			Identification of Early-Stage Alzheimer's Disease Using Sulcal Morphology and Other Common Neuroimaging Indices	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; VOXEL-BASED MORPHOMETRY; REDUCED CORTICAL FEATURES; MEDIAL TEMPORAL-LOBE; ENTORHINAL CORTEX; CEREBRAL-CORTEX; HIPPOCAMPUS; AD; AMYGDALA; SYSTEM	Identifying Alzheimer's disease (AD) at its early stage is of major interest in AD research. Previous studies have suggested that abnormalities in regional sulcal width and global sulcal index (g-SI) are characteristics of patients with early-stage AD. In this study, we investigated sulcal width and three other common neuroimaging morphological measures (cortical thickness, cortical volume, and subcortical volume) to identify early-stage AD. These measures were evaluated in 150 participants, including 75 normal controls (NC) and 75 patients with early-stage AD. The global sulcal index (g-SI) and the width of five individual sulci (the superior frontal, intra-parietal, superior temporal, central, and Sylvian fissure) were extracted from 3D T1-weighted images. The discriminative performances of the other three traditional neuroimaging morphological measures were also examined. Information Gain (IG) was used to select a subset of features to provide significant information for separating NC and early-stage AD subjects. Based on the four modalities of the individual measures, i.e.,sulcal measures, cortical thickness, cortical volume, subcortical volume, and combinations of these individual measures, three types of classifiers (Naive Bayes, Logistic Regression and Support Vector Machine) were applied to compare the classification performances. We observed that sulcal measures were either superior than or equal to the other measures used for classification. Specifically, the g- SI and the width of the Sylvian fissure were two of the most sensitive sulcal measures and could be useful neuroanatomical markers for detecting early-stage AD. There were no significant differences between the three classifiers that we tested when using the same neuroanatomical features.	[Cai, Kunpeng; Xu, Hong] Beihang Univ, Sch Comp Sci & Engn, Beijing, Peoples R China; [Cai, Kunpeng; Guan, Hao; Zhu, Wanlin; Zhang, Jicong; Liu, Tao] Beihang Univ, Int Res Inst Multidisciplinary Sci, Beijing, Peoples R China; [Guan, Hao; Zhang, Jicong; Liu, Tao] Beihang Univ, Sch Biol Sci & Med Engn, Beijing, Peoples R China; [Zhu, Wanlin; Jiang, Jiyang; Wen, Wei] Univ New South Wales, Sch Psychiat, Ctr Hlth Brain Ageing, Sydney, NSW, Australia; [Jiang, Jiyang; Wen, Wei] Prince Wales Hosp, Neuropsychiat Inst, Randwick, NSW, Australia; [Cui, Yue] Chinese Acad Sci, Inst Automat, Brainnetome Ctr, Beijing, Peoples R China; [Cui, Yue] Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, Beijing, Peoples R China; [Liu, Tao] Beijing Key Lab Rehabil Engn Elderly, Beijing, Peoples R China	Beihang University; Beihang University; Beihang University; University of New South Wales Sydney; Chinese Academy of Sciences; Institute of Automation, CAS; Chinese Academy of Sciences; Institute of Automation, CAS	Liu, T (corresponding author), Beihang Univ, Int Res Inst Multidisciplinary Sci, Beijing, Peoples R China.; Liu, T (corresponding author), Beihang Univ, Sch Biol Sci & Med Engn, Beijing, Peoples R China.; Liu, T (corresponding author), Beijing Key Lab Rehabil Engn Elderly, Beijing, Peoples R China.	tao.liu@buaa.edu.cn	Jiang, Jiyang/AAD-6296-2019	Jiang, Jiyang/0000-0002-2147-6302; Wen, Wei/0000-0003-2753-3870; Liu, Tao/0000-0002-7783-3073	Natural Science Foundation of China [81401476, 61301005]; National Key Research and Development Program of China [2016YFF0201002]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This research received support from the Natural Science Foundation of China (http://www.nsfc .gov.cn/, Grant No. 81401476 and Grant No. 61301005) and the National Key Research and Development Program of China (Grant No. 2016YFF0201002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Beach TG, 2012, J NEUROPATH EXP NEUR, V71, P266, DOI 10.1097/NEN.0b013e31824b211b; Braak H, 1996, ACTA NEUROL SCAND, V93, P3; Bubitzky W, 2007, FUNDAMENTALS DATA MI, Vxxii; Bunea F, 2011, NEUROIMAGE, V55, P1519, DOI 10.1016/j.neuroimage.2010.12.028; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Chetelat G, 2005, NEUROIMAGE, V27, P934, DOI 10.1016/j.neuroimage.2005.05.015; Cohen NJ, 2010, MEMORY AMNESIA HIPPO, pXiii; Cui Y, 2012, NEUROIMAGE, V60, P894, DOI 10.1016/j.neuroimage.2012.01.084; Davatzikos C, 2009, BRAIN, V132, P2026, DOI 10.1093/brain/awp091; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; Dolcos F, 2004, NEURON, V42, P855, DOI 10.1016/S0896-6273(04)00289-2; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Eskildsen SF, 2015, NEUROBIOL AGING, V36, pS23, DOI 10.1016/j.neurobiolaging.2014.04.034; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hamalainen A, 2007, NEUROIMAGE, V37, P1122, DOI 10.1016/j.neuroimage.2007.06.016; Hall M., 2009, ACM SIGKDD; Hamelin L, 2015, NEUROBIOL AGING, V36, P2932, DOI 10.1016/j.neurobiolaging.2015.04.019; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Im K, 2008, NEUROIMAGE, V43, P103, DOI 10.1016/j.neuroimage.2008.07.016; Im K, 2008, NEUROSCI LETT, V436, P227, DOI 10.1016/j.neulet.2008.03.032; Kochunov P, 2005, HUM BRAIN MAPP, V26, P210, DOI 10.1002/hbm.20198; Kochunov P, 2008, HUM BRAIN MAPP, V29, P36, DOI 10.1002/hbm.20369; Kochunov P, 2012, NEUROINFORMATICS, V10, P81, DOI 10.1007/s12021-011-9127-9; Kodaz H, 2009, EXPERT SYST APPL, V36, P3086, DOI 10.1016/j.eswa.2008.01.026; Lemaitre H, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.07.013; Li S, 2008, ACTA RADIOL, V49, P84, DOI 10.1080/02841850701627181; Liu T, 2013, NEUROIMAGE, V83, P12, DOI 10.1016/j.neuroimage.2013.06.058; Liu T, 2011, NEUROIMAGE, V56, P865, DOI 10.1016/j.neuroimage.2011.03.015; Liu T, 2010, NEUROIMAGE, V51, P19, DOI 10.1016/j.neuroimage.2010.02.016; Liu TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031001; Mangin J, 1995, 14 INT C 14 INT C; Mangin JF, 2004, NEUROIMAGE, V23, pS129, DOI 10.1016/j.neuroimage.2004.07.019; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Miller MI, 2014, NEUROBIOL AGING, V36; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; Mosconi L, 2005, NEUROLOGY, V64, P1860, DOI 10.1212/01.WNL.0000163856.13524.08; Mucke L, 2009, NATURE, V461, P895, DOI 10.1038/461895a; Ota K, 2016, J ALZHEIMERS DIS, V52, P1385, DOI 10.3233/JAD-160145; Park H, 2013, NEUROSCI LETT, V550, P17, DOI 10.1016/j.neulet.2013.06.042; Park H, 2012, NEUROSCI LETT, V529, P123, DOI 10.1016/j.neulet.2012.09.011; Pennanen C, 2004, NEUROBIOL AGING, V25, P303, DOI 10.1016/S0197-4580(03)00084-8; Penttilae J, 2009, J PSYCHIATR NEUROSCI, V34, P127; Riviere D, 2002, MED IMAGE ANAL, V6, P77, DOI 10.1016/S1361-8415(02)00052-X; Rogan Shannon, 2002, Am J Alzheimers Dis Other Demen, V17, P11, DOI 10.1177/153331750201700106; Savio A, 2009, LECT NOTES COMPUT SC, V5788, P641, DOI 10.1007/978-3-642-04394-9_78; Shi F, 2009, HIPPOCAMPUS, V19, P1055, DOI 10.1002/hipo.20573; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Taylor P, 1998, NEUROLOGY, V51, pS30, DOI 10.1212/WNL.51.1_Suppl_1.S30; Teipel SJ, 2006, J NEUROL, V253, P794, DOI 10.1007/s00415-006-0120-4; Weiner Michael W, 2015, Alzheimers Dement, V11, pe1, DOI 10.1016/j.jalz.2014.11.001; Wolz R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025446; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Yu L, 2003, MACH LEARN P 20 INT; Zhang DQ, 2012, NEUROIMAGE, V59, P895, DOI 10.1016/j.neuroimage.2011.09.069; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008	60	22	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170875	10.1371/journal.pone.0170875	http://dx.doi.org/10.1371/journal.pone.0170875			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129351	Green Published, Green Submitted, gold			2022-12-27	WOS:000396211400029
J	Ehrmann, W; Schmiedl, G; Beuscher, S; Krueger, S				Ehrmann, Werner; Schmiedl, Gerhard; Beuscher, Sarah; Krueger, Stefan			Intensity of African Humid Periods Estimated from Saharan Dust Fluxes	PLOS ONE			English	Article							EASTERN MEDITERRANEAN SEA; LAST GLACIAL MAXIMUM; LATE-QUATERNARY; SURFACE SEDIMENTS; CLAY-MINERALS; AEGEAN SEA; SIMULATED CLIMATE; NORTHERN AFRICA; MODERN HUMANS; HOLOCENE	North Africa experienced dramatic changes in hydrology and vegetation during the late Quaternary driven by insolation-induced shifts of the tropical rain belt and further modulated by millennial-scale droughts and vegetation-climate feedbacks. While most past proxy and modelling studies concentrated on the temporal and spatial dynamics of the last African humid period, little is known about the intensities and characteristics of pre-Holocene humid periods. Here we present a high-resolution record of fine-grained eastern Saharan dust from the Eastern Mediterranean Sea spanning the last 180 kyr, which is based on the clay mineral composition of the marine sediments, especially the kaolinite/chlorite ratio. Minimum aeolian kaolinite transport occurred during the African Humid Periods because kaolinite deflation was hampered by increased humidity and vegetation cover. Instead, kaolinite weathering from kaolinite-bearing Cenozoic rocks was stored in lake basins, river beds and soils during these periods. During the subsequent dry phases, fine-grained dust was mobilised from the desiccated lakes, rivers and soils resulting in maximum aeolian uptake and transport of kaolinite. The kaolinite transport decreased again when these sediment sources exhausted. We conclude that the amount of clay-sized dust blown out of the Sahara into the Eastern Mediterranean Sea is proportional to the intensity of the kaolinite weathering and accumulation in soils and lake sediments, and thus to the strength of the preceding humid period. These humid periods provided the windows for the migration of modern humans out of Africa, as postulated previously. The strongest humid period occurred during the Eemian and was followed by two weaker phases centred at ca. 100 ka and ca. 80 ka.	[Ehrmann, Werner; Beuscher, Sarah; Krueger, Stefan] Univ Leipzig, Inst Geol & Geophys, Talstr 35, Leipzig, Germany; [Schmiedl, Gerhard] Univ Hamburg, Ctr Erdsyst Forsch & Nachhaltigkeit, Bundesstr 55, Hamburg, Germany	Leipzig University; University of Hamburg	Ehrmann, W (corresponding author), Univ Leipzig, Inst Geol & Geophys, Talstr 35, Leipzig, Germany.	ehrmann@rz.uni-leipzig.de	Schmiedl, Gerhard/E-6644-2017	Schmiedl, Gerhard/0000-0002-2177-6858	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG); DFG; University of Leipzig	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); University of Leipzig	We thank the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) for providing financial support to carry out the project, and also acknowledge the support of the DFG and the University of Leipzig within the programme of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage SJ, 2011, SCIENCE, V331, P453, DOI 10.1126/science.1199113; Bar-Matthews M, 2003, GEOCHIM COSMOCHIM AC, V67, P3181, DOI 10.1016/S0016-7037(02)01031-1; Baumhauer R., 2004, ERDE, V135, P289; BISCAYE PE, 1965, GEOL SOC AM BULL, V76, P803, DOI 10.1130/0016-7606(1965)76[803:MASORD]2.0.CO;2; Blome MW, 2012, J HUM EVOL, V62, P563, DOI 10.1016/j.jhevol.2012.01.011; Bolle MP, 2000, ECLOGAE GEOL HELV, V93, P33; Bout-Roumazeilles V, 2007, QUATERNARY SCI REV, V26, P3197, DOI 10.1016/j.quascirev.2007.07.015; Breeze PS, 2016, QUATERNARY SCI REV, V144, P155, DOI 10.1016/j.quascirev.2016.05.012; Brooks K, 2005, PALAEOGEOGR PALAEOCL, V216, P235, DOI 10.1016/j.palaeo.2004.10.005; Brovkin V, 2008, SCIENCE, V322, DOI 10.1126/science.1163381; Bullard J, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033928; Bullard JE, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2011JF002061; Caquineau S, 1998, GEOPHYS RES LETT, V25, P983, DOI 10.1029/98GL00569; Castaneda IS, 2009, P NATL ACAD SCI USA, V106, P20159, DOI 10.1073/pnas.0905771106; CHESTER R, 1977, MAR GEOL, V24, P201, DOI 10.1016/0025-3227(77)90028-7; Claussen M, 2013, NAT GEOSCI, V6, P954, DOI [10.1038/ngeo1962, 10.1038/NGEO1962]; Claussen M, 1997, GLOBAL ECOL BIOGEOGR, V6, P369, DOI 10.2307/2997337; Coulthard TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074834; Crouvi O, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052145; De Rijk S, 2000, MAR MICROPALEONTOL, V40, P151, DOI 10.1016/S0377-8398(00)00037-2; De Vivo B, 2001, MINER PETROL, V73, P47, DOI 10.1007/s007100170010; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; Drake NA, 2011, P NATL ACAD SCI USA, V108, P458, DOI 10.1073/pnas.1012231108; Ehrmann W, 2007, PALAEOGEOGR PALAEOCL, V249, P36, DOI 10.1016/j.palaeo.2007.01.004; Ehrmann W, 2007, INT J EARTH SCI, V96, P769, DOI 10.1007/s00531-006-0119-1; Ehrmann W, 2016, CLIM PAST, V12, P713, DOI 10.5194/cp-12-713-2016; Ehrmann W, 2013, GLOBAL PLANET CHANGE, V107, P186, DOI 10.1016/j.gloplacha.2013.05.010; Engelstaedter S, 2006, EARTH-SCI REV, V79, P73, DOI 10.1016/j.earscirev.2006.06.004; Felix-Henningsen P, 2000, CATENA, V41, P43, DOI 10.1016/S0341-8162(00)00108-9; Foucault A, 2000, PALAEOGEOGR PALAEOCL, V158, P311, DOI 10.1016/S0031-0182(00)00056-0; Gallego-Torres D, 2010, PALAEOGEOGR PALAEOCL, V293, P76, DOI 10.1016/j.palaeo.2010.05.001; Gasse F, 2000, QUATERNARY SCI REV, V19, P189, DOI 10.1016/S0277-3791(99)00061-X; Goudie AS, 2001, EARTH-SCI REV, V56, P179, DOI 10.1016/S0012-8252(01)00067-8; Grant KM, 2016, QUATERNARY SCI REV, V140, P125, DOI 10.1016/j.quascirev.2016.03.026; Hamann Y, 2008, MAR GEOL, V248, P97, DOI 10.1016/j.margeo.2007.10.009; Hamann Y, 2009, QUATERNARY RES, V71, P453, DOI 10.1016/j.yqres.2009.01.001; Hieke W, 1997, MITTELMEER 1998 99 C, P99; HILLAIREMARCEL C, 1986, QUATERNARY RES, V25, P312, DOI 10.1016/0033-5894(86)90004-9; Jennings RP, 2015, QUATERN INT, V382, P181, DOI 10.1016/j.quaint.2015.01.006; Jolly D, 1998, QUATERNARY SCI REV, V17, P629, DOI 10.1016/S0277-3791(98)00015-8; KELLER J, 1978, GEOL SOC AM BULL, V89, P591, DOI 10.1130/0016-7606(1978)89<591:EVAITM>2.0.CO;2; Kohfeld K., 2001, EARTH-SCI REV, V54, P114, DOI DOI 10.1016/S0012-8252(01)00042-3; Kraml M., 1997, THESIS; Kropelin S, 2008, SCIENCE, V320, P765, DOI 10.1126/science.1154913; Krom MD, 1999, MAR GEOL, V155, P319, DOI 10.1016/S0025-3227(98)00130-3; Kuper R, 2006, SCIENCE, V313, P803, DOI 10.1126/science.1130989; Larrasoana JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076514; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Lezine AM, 2011, QUATERNARY SCI REV, V30, P3001, DOI 10.1016/j.quascirev.2011.07.006; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Liu Z, 2007, QUATERNARY SCI REV, V26, P1818, DOI 10.1016/j.quascirev.2007.03.002; McTainsh G, 2013, TREATISE GEOMORPHOLO, P23; Mikolajewicz U, 2011, CLIM PAST, V7, P161, DOI 10.5194/cp-7-161-2011; Moreno A, 2002, QUATERNARY RES, V58, P318, DOI 10.1006/qres.2002.2383; Mulitza S, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2008PA001637; Narcisi B, 1999, GLOBAL PLANET CHANGE, V21, P31, DOI 10.1016/S0921-8181(99)00006-5; NIHLEN T, 1995, Z GEOMORPHOL, V39, P341; Osborne AH, 2008, P NATL ACAD SCI USA, V105, P16444, DOI 10.1073/pnas.0804472105; Pachur H.J., 2001, NOVA ACTA LEOPOLDINA, VNF88, P109; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; Parton A, 2015, QUATERN INT, V382, P82, DOI 10.1016/j.quaint.2015.01.005; PYE K, 1992, EARTH SURF PROCESSES, V17, P271, DOI 10.1002/esp.3290170306; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Renssen H, 2006, QUATERN INT, V150, P95, DOI 10.1016/j.quaint.2005.01.001; Revel M, 2010, QUATERNARY SCI REV, V29, P1342, DOI 10.1016/j.quascirev.2010.02.006; Rohling EJ, 2015, EARTH-SCI REV, V143, P62, DOI 10.1016/j.earscirev.2015.01.008; Rohling EJ, 2003, CLIM DYNAM, V20, P257, DOI 10.1007/s00382-002-0266-4; Rosenberg TM, 2011, GEOLOGY, V39, P1115, DOI 10.1130/G32281.1; ROSSIGNOLSTRICK M, 1983, NATURE, V304, P46, DOI 10.1038/304046a0; Scerri EML, 2014, QUATERNARY SCI REV, V101, P207, DOI 10.1016/j.quascirev.2014.07.019; Scheuvens D, 2013, EARTH-SCI REV, V116, P170, DOI 10.1016/j.earscirev.2012.08.005; Schmiedl G, 1998, PALEOCEANOGRAPHY, V13, P447, DOI 10.1029/98PA01864; Shanahan TM, 2015, NAT GEOSCI, V8, P140, DOI [10.1038/ngeo2329, 10.1038/NGEO2329]; Stanley DJ, 1996, J COASTAL RES, V12, P911; Stuut JB, 2009, QUATERN INT, V198, P234, DOI 10.1016/j.quaint.2008.10.007; Tegen I, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000963; Timmermann A, 2016, NATURE, V538, P92, DOI 10.1038/nature19365; Tjallingii R, 2008, NAT GEOSCI, V1, P670, DOI 10.1038/ngeo289; Trauth MH, 2003, EARTH PLANET SC LETT, V206, P297, DOI 10.1016/S0012-821X(02)01105-6; VENKATARATHNAM K, 1971, MAR GEOL, V11, P261, DOI 10.1016/0025-3227(71)90028-4; Washington R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025827; WEAVER CE, 1977, SEDIMENT GEOL, V17, pR9, DOI 10.1016/0037-0738(77)90062-8; Weldeab S, 2003, PALAEOGEOGR PALAEOCL, V191, P169, DOI 10.1016/S0031-0182(02)00711-3; Weldeab S, 2002, CHEM GEOL, V186, P139, DOI 10.1016/S0009-2541(01)00415-6; Weldeab S, 2007, SCIENCE, V316, P1303, DOI 10.1126/science.1140461; Wulf S, 2004, QUATERN INT, V122, P7, DOI 10.1016/j.quaint.2004.01.028	86	40	41	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170989	10.1371/journal.pone.0170989	http://dx.doi.org/10.1371/journal.pone.0170989			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129378	Green Submitted, Green Published, gold			2022-12-27	WOS:000396211400014
J	Voros, J; Marton, O; Schmidt, BR; Gal, JT; Jelic, D				Voros, Judit; Marton, Orsolya; Schmidt, Benedikt R.; Gal, Julia Tunde; Jelic, Dusan			Surveying Europe's Only Cave-Dwelling Chordate Species (Proteus anguinus) Using Environmental DNA	PLOS ONE			English	Article							GROUNDWATER BIODIVERSITY; EUPROCTUS-ASPER; EDNA; CONSERVATION; PROTEIDAE; SALAMANDER; EVOLUTION; RICHNESS; TOOL	In surveillance of subterranean fauna, especially in the case of rare or elusive aquatic species, traditional techniques used for epigean species are often not feasible. We developed a non-invasive survey method based on environmental DNA (eDNA) to detect the presence of the red-listed cave-dwelling amphibian, Proteus anguinus, in the caves of the Dinaric Karst. We tested the method in fifteen caves in Croatia, from which the species was previously recorded or expected to occur. We successfully confirmed the presence of P. anguinus from ten caves and detected the species for the first time in five others. Using a hierarchical occupancy model we compared the availability and detection probability of eDNA of two water sampling methods, filtration and precipitation. The statistical analysis showed that both availability and detection probability depended on the method and estimates for both probabilities were higher using filter samples than for precipitation samples. Combining reliable field and laboratory methods with robust statistical modeling will give the best estimates of species occurrence.	[Voros, Judit; Gal, Julia Tunde] Hungarian Nat Hist Museum, Dept Zool, Budapest, Hungary; [Voros, Judit] Hungarian Nat Hist Museum, Mol Taxon Lab, Budapest, Hungary; [Marton, Orsolya] Hungarian Acad Sci, Agr Res Ctr, Inst Soil Sci & Agr Chem, Budapest, Hungary; [Schmidt, Benedikt R.] Univ Zurich, Dept Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Schmidt, Benedikt R.] Koordinat Stelle Amphibien & Reptilienschutz Schw, Neuchatel, Switzerland; [Jelic, Dusan] Croatian Inst Biodivers, Zagreb, Croatia	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; University of Zurich; University of Zagreb	Voros, J (corresponding author), Hungarian Nat Hist Museum, Dept Zool, Budapest, Hungary.; Voros, J (corresponding author), Hungarian Nat Hist Museum, Mol Taxon Lab, Budapest, Hungary.	voros.judit@nhmus.hu	Jelić, Dušan/Q-3779-2017; Schmidt, Benedikt R./B-8491-2008	Jelić, Dušan/0000-0003-2790-1522; Schmidt, Benedikt R./0000-0002-4023-1001; Voros, Judit/0000-0001-9707-1443	MAVA Foundation; Zoological Society of London; Krka National Park; Bolyai Janos Research Scholarship of the Hungarian Academy of Sciences [BO/00579/14/8]	MAVA Foundation; Zoological Society of London; Krka National Park; Bolyai Janos Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	DJ was supported by the MAVA Foundation, Zoological Society of London and Krka National Park. JV was supported by the Bolyai Janos Research Scholarship of the Hungarian Academy of Sciences (BO/00579/14/8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arntzen JW, 2009, IUCN RED LIST THREAT; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Bendik NF, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-201; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Boitani L, 2011, PHILOS T R SOC B, V366, P2623, DOI 10.1098/rstb.2011.0117; Boulton AJ, 2008, INVERTEBR SYST, V22, P103, DOI 10.1071/IS07024; Bozic V, 2014, ILLUSTRATED HIST SPE; Cristescu ME, 2014, TRENDS ECOL EVOL, V29, P566, DOI 10.1016/j.tree.2014.08.001; Culver David C., 2000, Journal of Caves and Karst Studies, V62, P11; Culver DC, 2000, CONSERV BIOL, V14, P386, DOI 10.1046/j.1523-1739.2000.99026.x; curcic BPM, 2008, MONOGRAPHS, V12, P35; Deharveng L, 2009, FRESHWATER BIOL, V54, P709, DOI 10.1111/j.1365-2427.2008.01972.x; Deiner K, 2015, BIOL CONSERV, V183, P53, DOI 10.1016/j.biocon.2014.11.018; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Dumas P, 1998, BEHAV PROCESS, V43, P107, DOI 10.1016/S0376-6357(98)00002-3; DURAND JP, 1987, BEHAV PROCESS, V15, P285, DOI 10.1016/0376-6357(87)90013-1; DURAND JP, 1981, J THERM BIOL, V6, P53, DOI 10.1016/0306-4565(81)90044-9; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; Fitzinger LJ, 1850, SITZ BER AKAD WISS M, V5, P291; Gal JT, 2013, THESIS SZENT ISTVAN; Gibert J, 2002, BIOSCIENCE, V52, P473, DOI 10.1641/0006-3568(2002)052[0473:SEATFB]2.0.CO;2; Gibert J, 2009, FRESHWATER BIOL, V54, P930, DOI 10.1111/j.1365-2427.2009.02201.x; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Herder J., 2014, ENV DNA A REV POSSIB; Hervant F, 2001, J EXP BIOL, V204, P269; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Hofreiter M, 2003, CURR BIOL, V13, pR693, DOI 10.1016/j.cub.2003.08.039; HOLSINGER JR, 1993, J NAT HIST, V27, P821, DOI 10.1080/00222939300770501; HOWARTH FG, 1983, ANNU REV ENTOMOL, V28, P365, DOI 10.1146/annurev.en.28.010183.002053; Jelic D., 2012, RED BOOK AMPHIBIANS; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kery M, 2008, COMMUNITY ECOL, V9, P207, DOI 10.1556/ComEc.9.2008.2.10; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kletecki Eduard, 1996, Memoires de Biospeologie, V23, P227; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; Kovacevic T., 1984, 9 YUG C SPEL, P539; Lahoz-Monfort JJ, 2016, MOL ECOL RESOUR, V16, P673, DOI 10.1111/1755-0998.12486; Lefebure T, 2006, MOL ECOL, V15, P1797, DOI 10.1111/j.1365-294X.2006.02888.x; MARMONIER P, 1993, TRENDS ECOL EVOL, V8, P392, DOI 10.1016/0169-5347(93)90039-R; Matocec Sanja Gottstein, 2002, Natura Croatica, V11, P1; Parzefall J, 1993, HDB REPTILIEN AMPHIB, V4, P57; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, APPL ENV DNA INVENTO, V2012-3146; Rees HC, 2014, J APPL ECOL, V51, P1450, DOI 10.1111/1365-2664.12306; Romero A., 2009, CAVE BIOL LIFE DARKN; Romero A, 2011, AM SCI, V99, P144, DOI 10.1511/2011.89.144; Rouch R, 1997, INT REV GES HYDROBIO, V82, P121, DOI 10.1002/iroh.19970820202; Royle JA, 2007, ECOLOGY, V88, P1813, DOI 10.1890/06-0669.1; Safi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063582; Schlegel P, 1997, J PHYSIOLOGY-PARIS, V91, P75, DOI 10.1016/S0928-4257(97)88941-3; Schmidt BR, 2013, METHODS ECOL EVOL, V4, P646, DOI 10.1111/2041-210X.12052; Schneider K, 2004, J CAVE KARST STUD, V66, P39; Shaw JLA, 2016, BIOL CONSERV, V197, P131, DOI 10.1016/j.biocon.2016.03.010; Sket B, 2004, BALKAN BIODIVERSITY: PATTERN AND PROCESS IN THE EUROPEAN HOTSPOT, P309; Sket B, 1999, BIODIVERS CONSERV, V8, P1319, DOI 10.1023/A:1008916601121; Sket B, 1997, J BIOGEOGR, V24, P263, DOI 10.1046/j.1365-2699.1997.00103.x; Soares D, 2013, BIOSCIENCE, V63, P274, DOI 10.1525/bio.2013.63.4.7; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; UIBLEIN F, 1992, BEHAV PROCESS, V28, P33, DOI 10.1016/0376-6357(92)90046-G; Voituron Y, 2011, BIOL LETTERS, V7, P105, DOI 10.1098/rsbl.2010.0539	66	48	51	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170945	10.1371/journal.pone.0170945	http://dx.doi.org/10.1371/journal.pone.0170945			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129383	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000396211400022
J	Yang, FM; Du, J; Zhang, H; Ruan, GR; Xiang, JF; Wang, LX; Sun, HX; Guan, AJ; Shen, G; Liu, Y; Guo, XM; Li, Q; Tang, YL				Yang, Fengmin; Du, Jie; Zhang, Hong; Ruan, Guorui; Xiang, Junfeng; Wang, Lixia; Sun, Hongxia; Guan, Aijiao; Shen, Gang; Liu, Yan; Guo, Xiaomeng; Li, Qian; Tang, Yalin			Serum Metabolomics of Burkitt Lymphoma Mouse Models	PLOS ONE			English	Article							CHOLINE PHOSPHOLIPID-METABOLISM; MAGNETIC-RESONANCE-SPECTROSCOPY; H-1-NMR SPECTROSCOPY; NMR-SPECTROSCOPY; CELL CARCINOMA; CANCER; CLASSIFICATION; PROFILES; BIOLOGY; URINE	Burkitt lymphoma (BL) is a rare and highly aggressive type of non-Hodgkin lymphoma. The mortality rate of BL patients is very high due to the rapid growth rate and frequent systemic spread of the disease. A better understanding of the pathogenesis, more sensitive diagnostic tools and effective treatment methods for BL are essential. Metabolomics, an important aspect of systems biology, allows the comprehensive analysis of global, dynamic and endogenous biological metabolites based on their nuclear magnetic resonance (NMR) and mass spectrometry (MS). It has already been used to investigate the pathogenesis and discover new biomarkers for disease diagnosis and prognosis. In this study, we analyzed differences of serum metabolites in BL mice and normal mice by NMR-based metabolomics. We found that metabolites associated with energy metabolism, amino acid metabolism, fatty acid metabolism and choline phospholipid metabolism were altered in BL mice. The diagnostic potential of the metabolite differences was investigated in this study. Glutamate, glycerol and choline had a high diagnostic accuracy; in contrast, isoleucine, leucine, pyruvate, lysine, a-ketoglutarate, betaine, glycine, creatine, serine, lactate, tyrosine, phenylalanine, histidine and formate enabled the accurate differentiation of BL mice from normal mice. The discovery of abnormal metabolism and relevant differential metabolites may provide useful clues for developing novel, noninvasive approaches for the diagnosis and prognosis of BL based on these potential biomarkers.	[Yang, Fengmin; Zhang, Hong; Xiang, Junfeng; Wang, Lixia; Sun, Hongxia; Guan, Aijiao; Shen, Gang; Liu, Yan; Guo, Xiaomeng; Li, Qian; Tang, Yalin] Chinese Acad Sci, Inst Chem, State Key Lab Struct Chem Unstable & Stable Speci, Natl Lab Mol Sci,Ctr Mol Sci, Beijing, Peoples R China; [Du, Jie] JOINN Labs Inc, Beijing, Peoples R China; [Ruan, Guorui] Peking Univ, Peoples Hosp, Beijing, Peoples R China; [Ruan, Guorui] Peking Univ, Inst Hematol, Beijing, Peoples R China; [Li, Qian; Tang, Yalin] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Chemistry, CAS; Peking University; Peking University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, Q; Tang, YL (corresponding author), Chinese Acad Sci, Inst Chem, State Key Lab Struct Chem Unstable & Stable Speci, Natl Lab Mol Sci,Ctr Mol Sci, Beijing, Peoples R China.; Li, Q; Tang, YL (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	qianlee@iccas.ac.cn; tangyl@iccas.ac.cn		sun, hong xia/0000-0002-4487-1823	General Program of the National Natural Science Foundation of China [21472197]; Major National Basic Research Projects (973) [2013CB733701]; National Natural Science Foundation of China [21305145]; "Strategic Priority Research Program" of the Chinese Academy of Sciences [XDA09030307]	General Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major National Basic Research Projects (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Strategic Priority Research Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the General Program of the National Natural Science Foundation of China (Grant Number 21472197), the Major National Basic Research Projects (973) (Grant Number 2013CB733701), the National Natural Science Foundation of China (Grant Number 21305145) and "Strategic Priority Research Program" of the Chinese Academy of Sciences (Grant Number XDA09030307). Funding for open access charge: General Program of the National Natural Science Foundation of China (Grant Number 21472197).; This work was supported by the Major National Basic Research Projects (973) (Grant Number 2013CB733701), the General Program of the National Natural Science Foundation of China (Grant Number 21472197), the National Natural Science Foundation of China (Grant Number 21305145) and "Strategic Priority Research Program" of the Chinese Academy of Sciences (Grant Number XDA09030307). Funding for open access charge comes from General Program of the National Natural Science Foundation of China (Grant Number 21472197).	Aboagye EO, 1999, CANCER RES, V59, P80; Ackerstaff E, 2003, J CELL BIOCHEM, V90, P525, DOI 10.1002/jcb.10659; AlaKorpela M, 1995, PROG NUCL MAG RES SP, V27, P475, DOI 10.1016/0079-6565(95)01013-0; Baracos VE, 2006, J NUTR, V136, p237S, DOI 10.1093/jn/136.1.237S; Beckwith-Hall BM, 2003, ANALYST, V128, P814, DOI 10.1039/b302360p; Bornkamm GW, 2009, INT J CANCER, V124, P1745, DOI 10.1002/ijc.24223; Braziel RM, 2001, BLOOD, V97, P3713, DOI 10.1182/blood.V97.12.3713; Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802; BURKITT D, 1958, BRIT J SURG, V46, P218, DOI 10.1002/bjs.18004619704; Chan ECY, 2009, J PROTEOME RES, V8, P352, DOI 10.1021/pr8006232; Chen WL, 2016, CANC CELL; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Denkert C, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-72; Eriksson L, 2006, MOL DIVERS, V10, P169, DOI 10.1007/s11030-006-9024-6; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; Estrela JM, 2006, CRIT REV CL LAB SCI, V43, P143, DOI 10.1080/10408360500523878; Gao HC, 2008, ANAL CHIM ACTA, V624, P269, DOI 10.1016/j.aca.2008.06.051; GRIBBESTAD IS, 1993, ANTICANCER RES, V13, P1973; Halton JM, 1998, CANCER, V83, P379, DOI 10.1002/(SICI)1097-0142(19980715)83:2<379::AID-CNCR24>3.0.CO;2-P; Harris NL, 1999, J CLIN ONCOL, V17, P3835, DOI 10.1200/JCO.1999.17.12.3835; HARRIS NL, 1994, BLOOD, V84, P1361; Holmes E, 1998, NMR BIOMED, V11, P235, DOI 10.1002/(SICI)1099-1492(199806/08)11:4/5<235::AID-NBM507>3.0.CO;2-V; Huang Q, 2013, CANCER RES, V73, P4992, DOI 10.1158/0008-5472.CAN-13-0308; Iorio E, 2005, CANCER RES, V65, P9369, DOI 10.1158/0008-5472.CAN-05-1146; Jouret F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163021; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; LAZO PA, 1981, FEBS LETT, V135, P229, DOI 10.1016/0014-5793(81)80788-0; MacIntyre DA, 2010, LEUKEMIA, V24, P788, DOI 10.1038/leu.2009.295; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Molyneux EM, 2012, LANCET, V379, P1234, DOI 10.1016/S0140-6736(11)61177-X; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Onda T, 2006, BRIT J CANCER, V94, P698, DOI 10.1038/sj.bjc.6602986; Pirhaji L, 2016, NAT METHODS, V13, P770, DOI [10.1038/NMETH.3940, 10.1038/nmeth.3940]; Plathow C, 2008, J NUCL MED, V49, p43S, DOI 10.2967/jnumed.107.045930; Podo F, 1999, NMR BIOMED, V12, P413, DOI 10.1002/(SICI)1099-1492(199911)12:7<413::AID-NBM587>3.0.CO;2-U; Ronen SM, 2001, BREAST CANCER RES, V3, P36, DOI 10.1186/bcr268; Soeters PB, 1997, BAILLIERE CLIN ENDOC, V11, P659, DOI 10.1016/S0950-351X(97)80942-1; Somashekar BS, 2011, J PROTEOME RES, V10, P5232, DOI 10.1021/pr200800w; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Tang HR, 2004, ANAL BIOCHEM, V325, P260, DOI 10.1016/j.ab.2003.10.033; Tong XM, 2009, CURR OPIN GENET DEV, V19, P32, DOI 10.1016/j.gde.2009.01.002; Wadhera A, 2013, J CANCER RES THER, V9, P751, DOI 10.4103/0973-1482.126488; Waters NJ, 2001, CHEM RES TOXICOL, V14, P1401, DOI 10.1021/tx010067f; Weber T, 2016, EUR J NUCL MED MOL I, V43, P489, DOI 10.1007/s00259-015-3175-6; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; WOLD S, 1978, TECHNOMETRICS, V20, P397, DOI 10.2307/1267639; Yang YX, 2007, J PROTEOME RES, V6, P2605, DOI 10.1021/pr070063h; ZEISEL SH, 1994, ANNU REV NUTR, V14, P269, DOI 10.1146/annurev.nu.14.070194.001413; Zeng J, 2014, J PROTEOME RES, V13, P3420, DOI 10.1021/pr500390y; Zhang L, 2008, CANCER LETT, V269, P26, DOI 10.1016/j.canlet.2008.04.024; Zheng H, 2016, ONCOTARGET, V7, P59189, DOI 10.18632/oncotarget.10830; Zira AN, 2010, J PROTEOME RES, V9, P4038, DOI 10.1021/pr100226m	54	11	11	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170896	10.1371/journal.pone.0170896	http://dx.doi.org/10.1371/journal.pone.0170896			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129369	gold, Green Submitted, Green Published			2022-12-27	WOS:000396211400028
J	Aukema, JE; Pricope, NG; Husak, GJ; Lopez-Carr, D				Aukema, Juliann E.; Pricope, Narcisa G.; Husak, Gregory J.; Lopez-Carr, David			Biodiversity Areas under Threat: Overlap of Climate Change and Population Pressures on the World's Biodiversity Priorities	PLOS ONE			English	Article							LAND-USE CHANGE; MANGROVE FORESTS; GLOBAL 200; CONSERVATION; DEFORESTATION; VULNERABILITY; IMPACT; FUTURE; CARBON; LIVELIHOODS	Humans and the ecosystem services they depend on are threatened by climate change. Places with high or growing human population as well as increasing climate variability, have a reduced ability to provide ecosystem services just as the need for these services is most critical. A spiral of vulnerability and ecosystem degradation often ensues in such places. We apply different global conservation schemes as proxies to examine the spatial relation between wet season precipitation, population change over three decades, and natural resource conservation. We pose two research questions: 1) Where are biodiversity and ecosystem services vulnerable to the combined effects of climate change and population growth? 2) Where are human populations vulnerable to degraded ecosystem services? Results suggest that globally only about 20% of the area between 50 degrees latitude North and South has experienced significant change-largely wetting-in wet season precipitation. Approximately 40% of rangelands and 30% of rainfed agriculture lands have experienced significant precipitation changes, with important implications for food security. Over recent decades a number of critical conservation areas experienced high population growth concurrent with significant wetting or drying (e.g. the Horn of Africa, Himalaya, Western Ghats, and Sri Lanka), posing challenges not only for human adaptation but also to the protection and sustenance of biodiversity and ecosystem services. Identifying areas of climate and population risk and their overlap with conservation priorities can help to target activities and resources that promote biodiversity and ecosystem services while improving human well-being.	[Aukema, Juliann E.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Pricope, Narcisa G.] Univ North Carolina Wilmington, Dept Earth & Ocean Sci, Wilmington, NC USA; [Husak, Gregory J.; Lopez-Carr, David] Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA; [Aukema, Juliann E.] US Agcy Int Dev, Global Climate Change Off, Washington, DC 20523 USA	National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; University of North Carolina; University of North Carolina Wilmington; University of California System; University of California Santa Barbara; United States Agency for International Development (USAID)	Aukema, JE (corresponding author), Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA.; Aukema, JE (corresponding author), US Agcy Int Dev, Global Climate Change Off, Washington, DC 20523 USA.	jaukema@alumni.brown.edu	PRICOPE, NARCISA/D-7123-2015	PRICOPE, NARCISA/0000-0002-6591-7237	David and Lucile Packard Foundation; USGS	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); USGS(United States Geological Survey)	The Climate Hazards Group InfraRed Precipitation with Stations development process was carried out through U.S. Geological Survey (USGS) cooperative agreement #G09AC000001 and #G14AC00042. JEA was supported by a grant to NCEAS from The David and Lucile Packard Foundation. The two grants from USGS supported the creation of the CHIRPS dataset, and the customized trend analysis that supported this paper. While these grants provided the resources for the above activities, the influence of USGS in these activities was minimal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aide TM, 2013, BIOTROPICA, V45, P262, DOI 10.1111/j.1744-7429.2012.00908.x; Biazin B, 2013, AGR ECOSYST ENVIRON, V164, P100, DOI 10.1016/j.agee.2012.09.012; Boisier JP, 2015, NAT CLIM CHANGE, V5, P656, DOI [10.1038/NCLIMATE2658, 10.1038/nclimate2658]; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Carr D, 2009, PROG HUM GEOG, V33, P355, DOI 10.1177/0309132508096031; Center for International Earth Science Information Network (CIESIN) Food and Agriculture Organization of the United Nations (FAO) and Centro Internacional de Agricultura Tropical (CIAT), 2005, GRIDD POP WORLD VERS; Dale VH, 1997, ECOL APPL, V7, P753, DOI 10.1890/1051-0761(1997)007[0753:TRBLUC]2.0.CO;2; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; Dobrovolski R, 2011, BIODIVERS CONSERV, V20, P2445, DOI 10.1007/s10531-011-9997-z; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Dong BW, 2015, NAT CLIM CHANGE, V5, P757, DOI [10.1038/nclimate2664, 10.1038/NCLIMATE2664]; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Fernandes K, 2015, GEOPHYS RES LETT, V42; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Funk CC, 2014, US GEOLOGICAL SURVEY, V832, P4; Funk C, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.50; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Giri C, 2011, GLOBAL ECOL BIOGEOGR, V20, P154, DOI 10.1111/j.1466-8238.2010.00584.x; Heubes J, 2013, J ARID ENVIRON, V96, P48, DOI 10.1016/j.jaridenv.2013.04.008; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Hof C, 2011, GLOBAL CHANGE BIOL, V17, P2987, DOI 10.1111/j.1365-2486.2011.02418.x; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Husak GJ, 2007, INT J CLIMATOL, V27, P935, DOI 10.1002/joc.1441; Jankowska MM, 2012, APPL GEOGR, V33, P4, DOI 10.1016/j.apgeog.2011.08.009; Koziell I., 2001, LIVING BIODIVERSITY; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Laurance WF, 2014, TRENDS ECOL EVOL, V29, P107, DOI 10.1016/j.tree.2013.12.001; Lawler JJ, 2013, ECOL LETT, V16, P1014, DOI 10.1111/ele.12132; Lopez-Carr D, 2013, ENVIRONMENT, V55, P3, DOI 10.1080/00139157.2013.748385; MCKEE TB, 1993, P 8 C APPL CLIM AN C; Mittermeier R. A., 1999, CHELONIAN CONSERV BI; Morand P, 2012, CLIMATIC CHANGE, V115, P463, DOI 10.1007/s10584-012-0492-7; Moreland S., 2012, MODELING CLIMATE CHA; Moritz C, 2013, SCIENCE, V341, P504, DOI 10.1126/science.1237190; Mwampamba TH, 2007, ENERG POLICY, V35, P4221, DOI 10.1016/j.enpol.2007.02.010; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; O'Neill BC, 2010, P NATL ACAD SCI USA, V107, P17521, DOI 10.1073/pnas.1004581107; OJIMA DS, 1994, BIOSCIENCE, V44, P300, DOI 10.2307/1312379; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Paavola J, 2008, ENVIRON SCI POLICY, V11, P642, DOI 10.1016/j.envsci.2008.06.002; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Patz JA, 2006, ANN TROP MED PARASIT, V100, P535, DOI 10.1179/136485906X97426; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Pricope NG, 2013, GLOBAL ENVIRON CHANG, V23, P1525, DOI 10.1016/j.gloenvcha.2013.10.002; Rangel TFLVB, 2007, APPL GEOGR, V27, P14, DOI 10.1016/j.apgeog.2006.09.009; Samson J, 2011, GLOBAL ECOL BIOGEOGR, V20, P532, DOI 10.1111/j.1466-8238.2010.00632.x; Sayer J, 2013, P NATL ACAD SCI USA, V110, P8345, DOI 10.1073/pnas.1208054110; Schlenker W, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014010; Searchinger TD, 2015, NAT CLIM CHANGE, V5, P481, DOI [10.1038/nclimate2584, 10.1038/NCLIMATE2584]; Secchi S, 2009, ENVIRON MANAGE, V44, P732, DOI 10.1007/s00267-009-9365-x; Shackleton C, 2004, S AFR J SCI, V100, P658; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tingley MW, 2012, GLOBAL CHANGE BIOL, V18, P3279, DOI 10.1111/j.1365-2486.2012.02784.x; Travis JMJ, 2003, P ROY SOC B-BIOL SCI, V270, P467, DOI 10.1098/rspb.2002.2246; Tsegaye D, 2010, AGR ECOSYST ENVIRON, V139, P174, DOI 10.1016/j.agee.2010.07.017; VALIELA I, 2001, BIOSCIENCE, V51, P807, DOI DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; Webb EL, 2014, GLOBAL ENVIRON CHANG, V24, P321, DOI 10.1016/j.gloenvcha.2013.10.007; Weeks ES, 2013, ENVIRON CONSERV, V40, P84, DOI 10.1017/S0376892912000343; Wheeler T, 2013, SCIENCE, V341, P508, DOI 10.1126/science.1239402; Wilcove DS, 2010, BIODIVERS CONSERV, V19, P999, DOI 10.1007/s10531-009-9760-x; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Wright CK, 2013, P NATL ACAD SCI USA, V110, P4134, DOI 10.1073/pnas.1215404110; Zak MR, 2004, BIOL CONSERV, V120, P589, DOI 10.1016/j.biocon.2004.03.034; Zhou LM, 2014, NATURE, V509, P86, DOI 10.1038/nature13265	69	24	24	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170615	10.1371/journal.pone.0170615	http://dx.doi.org/10.1371/journal.pone.0170615			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7IT	28125659	Green Published, gold, Green Submitted			2022-12-27	WOS:000396176100085
J	Bonfiglio, T; Olivero, G; Merega, E; Di Prisco, S; Padolecchia, C; Grilli, M; Milanese, M; Mannelli, LD; Ghelardini, C; Bonanno, G; Marchi, M; Pittaluga, A				Bonfiglio, Tommaso; Olivero, Guendalina; Merega, Elisa; Di Prisco, Silvia; Padolecchia, Cristina; Grilli, Massimo; Milanese, Marco; Mannelli, Lorenzo Di Cesare; Ghelardini, Carla; Bonanno, Giambattista; Marchi, Mario; Pittaluga, Anna			Prophylactic versus Therapeutic Fingolimod: Restoration of Presynaptic Defects in Mice Suffering from Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; GLUTAMATE RELEASE; ANIMAL-MODEL; CORTEX SYNAPTOSOMES; FTY720 FINGOLIMOD; NMDA RECEPTORS; FRONTAL-CORTEX; RATS; SPHINGOSINE-1-PHOSPHATE; SYSTEM	Fingolimod, the first oral, disease-modifying therapy for MS, has been recently proposed to modulate glutamate transmission in the central nervous system (CNS) of mice suffering from Experimental Autoimmune Encephalomyelitis (EAE) and in MS patients. Our study aims at investigating whether oral fingolimod recovers presynaptic defects that occur at different stages of disease in the CNS of EAE mice. In vivo prophylactic (0.3 mg/kg for 14 days, from the 7 th day post immunization, d.p.i, the drug dissolved in the drinking water) fingolimod significantly reduced the clinical symptoms and the anxiety-related behaviour in EAE mice. Spinal cord inflammation, demyelination and glial cell activation are markers of EAE progression. These signs were ameliorated following oral fingolimod administration. Glutamate exocytosis was shown to be impaired in cortical and spinal cord terminals isolated from EAE mice at 21 +/- 1 d.p.i., while GABA alteration emerged only at the spinal cord level. Prophylactic fingolimod recovered these presynaptic defects, restoring altered glutamate and GABA release efficiency. The beneficial effect occurred in a dose-dependent, region-specific manner, since lower (0.1-0.03 mg/kg) doses restored, although to a different extent, synaptic defects in cortical but not spinal cord terminals. A delayed reduction of glutamate, but not of GABA, exocytosis was observed in hippocampal terminals of EAE mice at 35 d.p.i. Therapeutic (0.3 mg/kg, from 21 d.p.i. for 14 days) fingolimod restored glutamate exocytosis in the cortex and in the hippocampus of EAE mice at 35 +/- 1 d.p.i. but not in the spinal cord, where also GABAergic defects remained unmodified. These results improve our knowledge of the molecular events accounting for the beneficial effects elicited by fingolimod in demyelinating disorders.	[Bonfiglio, Tommaso; Olivero, Guendalina; Merega, Elisa; Di Prisco, Silvia; Padolecchia, Cristina; Grilli, Massimo; Milanese, Marco; Bonanno, Giambattista; Marchi, Mario; Pittaluga, Anna] Univ Genoa, Dept Pharm, Pharmacol & Toxicol Sect, Sch Med & Pharmaceut Sci, Genoa, Italy; [Grilli, Massimo; Milanese, Marco; Bonanno, Giambattista; Marchi, Mario; Pittaluga, Anna] Univ Genoa, Ctr Excellence Biomed Res, Genoa, Italy; [Mannelli, Lorenzo Di Cesare; Ghelardini, Carla] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth, Neurofarba Pharmacol & Toxicol Sect, Florence, Italy	University of Genoa; University of Genoa; University of Florence	Pittaluga, A (corresponding author), Univ Genoa, Dept Pharm, Pharmacol & Toxicol Sect, Sch Med & Pharmaceut Sci, Genoa, Italy.; Pittaluga, A (corresponding author), Univ Genoa, Ctr Excellence Biomed Res, Genoa, Italy.	pittalug@difar.unige.it	Milanese, Marco/AAB-2238-2021; Bonfiglio, Tommaso/AAB-2579-2019; Grilli, Massimo/C-4217-2008; Bonanno, Giambattista/C-5856-2008; Olivero, Guendalina/AAL-7489-2020; Milanese, Marco/C-4444-2013; Di Cesare Mannelli, Lorenzo/A-1641-2015	Milanese, Marco/0000-0003-3384-0666; Grilli, Massimo/0000-0003-1046-7897; Milanese, Marco/0000-0003-3384-0666; Olivero, Guendalina/0000-0001-8571-3736; Di Cesare Mannelli, Lorenzo/0000-0001-8374-4432; GHELARDINI, CARLA/0000-0001-9856-8144; Bonanno, Giambattista/0000-0003-3744-5786	Novartis Pharma [PO 3900006436]	Novartis Pharma	AP was recipient of a grant from Novartis Pharma (PO 3900006436). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Vilcaes AA, 2009, J NEUROCHEM, V108, P881, DOI 10.1111/j.1471-4159.2008.05809.x; Batista S, 2012, J NEUROL, V259, P139, DOI 10.1007/s00415-011-6147-1; Brinkmann V, 2004, AM J TRANSPLANT, V4, P1019, DOI 10.1111/j.1600-6143.2004.00476.x; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Brinkmann V, 2009, BRIT J PHARMACOL, V158, P1173, DOI 10.1111/j.1476-5381.2009.00451.x; Camoletto PG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005310; Centonze D, 2009, J NEUROSCI, V29, P3442, DOI 10.1523/JNEUROSCI.5804-08.2009; Chanaday NL, 2016, NEUROSCIENCE, V314, P160, DOI 10.1016/j.neuroscience.2015.11.060; Chiba K, 2011, INT IMMUNOPHARMACOL, V11, P366, DOI 10.1016/j.intimp.2010.10.005; Chiba S, 2012, PROG NEURO-PSYCHOPH, V39, P112, DOI 10.1016/j.pnpbp.2012.05.018; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Cid MP, 2011, NEUROSCIENCE, V189, P337, DOI 10.1016/j.neuroscience.2011.05.005; Darios F, 2009, NEURON, V62, P683, DOI 10.1016/j.neuron.2009.04.024; de Bruin NMWJ, 2016, BEHAV BRAIN RES, V300, P160, DOI 10.1016/j.bbr.2015.12.006; Demakova E. V., 2003, Klinicheskaya Laboratornaya Diagnostika, P15; Di Prisco S, 2016, J NEUROIMMUNE PHARM, V11, P645, DOI 10.1007/s11481-016-9677-6; Di Prisco S, 2016, BRIT J PHARMACOL, V173, P1465, DOI 10.1111/bph.13442; Di Prisco S, 2014, SYNAPSE, V68, P529, DOI 10.1002/syn.21774; Di Prisco S, 2014, BRIT J PHARMACOL, V171, P2457, DOI 10.1111/bph.12631; Di Prisco S, 2013, NEUROPHARMACOLOGY, V75, P337, DOI 10.1016/j.neuropharm.2013.07.037; Di Prisco S, 2012, J NEUROCHEM, V121, P428, DOI 10.1111/j.1471-4159.2012.07720.x; Eltayeb S, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-14; Errede M, 2012, J NEUROPATH EXP NEUR, V71, P840, DOI 10.1097/NEN.0b013e31826ac110; Furlan R, 2005, J NEUROIMMUNOL, V165, P192, DOI 10.1016/j.jneuroim.2005.04.012; Gillingwater TH, 2012, BRIT J PHARMACOL, V165, P858, DOI 10.1111/j.1476-5381.2011.01612.x; GODISKA R, 1995, J NEUROIMMUNOL, V58, P167, DOI 10.1016/0165-5728(95)00008-P; GOTTESFELD Z, 1976, J NEUROCHEM, V27, P695, DOI 10.1111/j.1471-4159.1976.tb10396.x; Grilli M, 2012, NEUROPHARMACOLOGY, V63, P916, DOI 10.1016/j.neuropharm.2012.06.049; Grilli M, 2009, J NEUROCHEM, V110, P1598, DOI 10.1111/j.1471-4159.2009.06265.x; Groom AJ, 2003, ANN NY ACAD SCI, V993, P229, DOI 10.1111/j.1749-6632.2003.tb07533.x; Haji N, 2012, EXP NEUROL, V237, P296, DOI 10.1016/j.expneurol.2012.07.010; Hou HQ, 2016, INT IMMUNOPHARMACOL, V30, P171, DOI 10.1016/j.intimp.2015.11.024; Kajimoto T, 2007, MOL CELL BIOL, V27, P3429, DOI 10.1128/MCB.01465-06; Landi D, 2015, CLIN NEUROPHYSIOL, V126, P165, DOI 10.1016/j.clinph.2014.05.031; Lanz M, 2007, J NEUROL, V254, P43, DOI 10.1007/s00415-007-2011-8; Luccini E, 2007, J NEUROSCI RES, V85, P3657, DOI 10.1002/jnr.21446; Mandolesi G, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2015.222; Mangiardi M, 2011, BRAIN PATHOL, V21, P263, DOI 10.1111/j.1750-3639.2010.00444.x; Mannelli LD, 2013, J PAIN, V14, P1585, DOI 10.1016/j.jpain.2013.08.002; Musante V, 2011, J NEUROCHEM, V117, P516, DOI 10.1111/j.1471-4159.2011.07223.x; Nistico R, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0162; Novkovic T, 2015, NEUROSCIENCE, V309, P100, DOI 10.1016/j.neuroscience.2015.03.008; Okada T, 2009, CELL SIGNAL, V21, P7, DOI 10.1016/j.cellsig.2008.07.011; Olechowski CJ, 2013, EXP NEUROL, V241, P113, DOI 10.1016/j.expneurol.2012.12.012; Orlando R, 2014, NEUROPHARMACOLOGY, V86, P133, DOI 10.1016/j.neuropharm.2014.07.009; Peruga I, 2011, BEHAV BRAIN RES, V220, P20, DOI 10.1016/j.bbr.2011.01.018; Pittaluga A, 2007, NEUROPHARMACOLOGY, V53, P27, DOI 10.1016/j.neuropharm.2007.04.006; Polak PE, 2005, J NEUROIMMUNOL, V168, P65, DOI 10.1016/j.jneuroim.2005.07.006; RAITERI M, 1974, EUR J PHARMACOL, V25, P411, DOI 10.1016/0014-2999(74)90272-6; Riganti L, 2016, J NEUROSCI, V36, P4624, DOI 10.1523/JNEUROSCI.3588-15.2016; Rossi S, 2012, BRIT J PHARMACOL, V165, P861, DOI 10.1111/j.1476-5381.2011.01579.x; Rossi S, 2011, BRAIN BEHAV IMMUN, V25, P947, DOI 10.1016/j.bbi.2010.10.004; Ruffini F, 2013, MULT SCLER J, V19, P1084, DOI 10.1177/1352458512469698; Sarchielli P, 2003, ARCH NEUROL-CHICAGO, V60, P1082, DOI 10.1001/archneur.60.8.1082; Schaier M, 2009, AM J PHYSIOL-RENAL, V297, pF769, DOI 10.1152/ajprenal.90530.2008; SCHIFFER RB, 1990, AM J PSYCHIAT, V147, P1493; Schwartz M, 2003, TRENDS NEUROSCI, V26, P297, DOI 10.1016/S0166-2236(03)00126-7; Sheridan GK, 2014, SCI REP-UK, V4, DOI 10.1038/srep05051; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Storch MK, 1998, BRAIN PATHOL, V8, P681, DOI 10.1111/j.1750-3639.1998.tb00194.x; Sulkowski G, 2009, FOLIA NEUROPATHOL, V47, P329; Summa M, 2013, NEUROPHARMACOLOGY, V66, P215, DOI 10.1016/j.neuropharm.2012.04.020; Sun JJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14235; Trkov S, 2012, GLIA, V60, P1406, DOI 10.1002/glia.22361; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zhang J, 2015, NEUROBIOL DIS, V76, P57, DOI 10.1016/j.nbd.2015.01.006	66	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e170825	10.1371/journal.pone.0170825	http://dx.doi.org/10.1371/journal.pone.0170825			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125677	Green Published, gold, Green Submitted			2022-12-27	WOS:000396176100040
J	Hwang, IS; Lin, YT; Huang, WM; Yang, ZR; Hu, CL; Chen, YC				Hwang, Ing-Shiou; Lin, Yen-Ting; Huang, Wei-Min; Yang, Zong-Ru; Hu, Chia-Ling; Chen, Yi-Ching			Alterations in Neural Control of Constant Isometric Contraction with the Size of Error Feedback	PLOS ONE			English	Article							COMMON SYNAPTIC INPUT; HUMAN MOTOR UNITS; MEDIAL FRONTAL-CORTEX; SURFACE EMG SIGNALS; FORCE VARIABILITY; MANUAL TRACKING; DISCHARGE RATE; MUSCLE FORCE; RANGE; DECOMPOSITION	Discharge patterns from a population of motor units (MUs) were estimated with multi-channel surface electromyogram and signal processing techniques to investigate parametric differences in low-frequency force fluctuations, MU discharges, and force-discharge relation during static force-tracking with varying sizes of execution error presented via visual feedback. Fourteen healthy adults produced isometric force at 10% of maximal voluntary contraction through index abduction under three visual conditions that scaled execution errors with different amplification factors. Error-augmentation feedback that used a high amplification factor (HAF) to potentiate visualized error size resulted in higher sample entropy, mean frequency, ratio of high-frequency components, and spectral dispersion of force fluctuations than those of error-reducing feedback using a low amplification factor (LAF). In the HAF condition, MUs with relatively high recruitment thresholds in the dorsal interosseous muscle exhibited a larger coefficient of variation for inter-spike intervals and a greater spectral peak of the pooled MU coherence at 13-35 Hz than did those in the LAF condition. Manipulation of the size of error feedback altered the force-discharge relation, which was characterized with non-linear approaches such as mutual information and cross sample entropy. The association of force fluctuations and global discharge trace decreased with increasing error amplification factor. Our findings provide direct neurophysiological evidence that favors motor training using error-augmentation feedback. Amplification of the visualized error size of visual feedback could enrich force gradation strategies during static force-tracking, pertaining to selective increases in the discharge variability of higher-threshold MUs that receive greater common oscillatory inputs in the beta-band.	[Hwang, Ing-Shiou; Yang, Zong-Ru] Natl Cheng Kung Univ, Inst Allied Hlth Sci, Coll Med, Tainan, Taiwan; [Hwang, Ing-Shiou; Hu, Chia-Ling] Natl Cheng Kung Univ, Dept Phys Therapy, Coll Med, Tainan, Taiwan; [Lin, Yen-Ting] Asian Univ, Phys Educ Off, Taichung, Taiwan; [Huang, Wei-Min] Natl Chung Cheng Univ, Dept Management Informat Syst, Chiayi, Taiwan; [Chen, Yi-Ching] Chung Shan Med Univ, Sch Phys Therapy, Coll Med Sci & Technol, Taichung, Taiwan; [Chen, Yi-Ching] Chung Shan Med Univ Hosp, Physical Therapy Room, Taichung, Taiwan	National Cheng Kung University; National Cheng Kung University; Asia University Taiwan; National Chung Cheng University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Chen, YC (corresponding author), Chung Shan Med Univ, Sch Phys Therapy, Coll Med Sci & Technol, Taichung, Taiwan.; Chen, YC (corresponding author), Chung Shan Med Univ Hosp, Physical Therapy Room, Taichung, Taiwan.	yiching@csmu.edu.tw			Ministry of Science and Technology, Taiwan, R.O.C. [MOST 103-2410-H-040-010-MY2, MOST 104-2314-B-006-016-MY3]	Ministry of Science and Technology, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This research was supported by a grant from the Ministry of Science and Technology, Taiwan, R.O.C. (https://www.most.gov.tw/), under Grant No. MOST 103-2410-H-040-010-MY2 and MOST 104-2314-B-006-016-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi F, 2014, NEUROREHAB NEURAL RE, V28, P120, DOI 10.1177/1545968313498649; Adam A, 1998, J NEUROPHYSIOL, V80, P1373, DOI 10.1152/jn.1998.80.3.1373; Amjad AM, 1997, J NEUROSCI METH, V73, P69, DOI 10.1016/S0165-0270(96)02214-5; Baker SN, 2003, J NEUROPHYSIOL, V89, P1941, DOI 10.1152/jn.00832.2002; Baweja HS, 2010, EUR J APPL PHYSIOL, V108, P935, DOI 10.1007/s00421-009-1301-5; Casellato C, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-46; Castronovo AM, 2015, J APPL PHYSIOL, V119, P1337, DOI 10.1152/japplphysiol.00255.2015; Chen YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074273; Contessa P, 2013, J NEUROPHYSIOL, V109, P1548, DOI 10.1152/jn.00237.2012; Coombes SA, 2011, NEUROIMAGE, V54, P2226, DOI 10.1016/j.neuroimage.2010.10.003; Coombes SA, 2010, J NEUROPHYSIOL, V103, P2114, DOI 10.1152/jn.00920.2009; Day SJ, 2001, J NEUROPHYSIOL, V86, P2144, DOI 10.1152/jn.2001.86.5.2144; De Luca CJ, 2006, J NEUROPHYSIOL, V96, P1646, DOI 10.1152/jn.00009.2006; De Luca CJ, 2014, J NEUROPHYSIOL, V112, P962, DOI 10.1152/jn.00619.2013; De Luca CJ, 2011, J NEUROPHYSIOL, V105, P983, DOI 10.1152/jn.01060.2010; DE LUCA CJ, 1982, J PHYSIOL-LONDON, V329, P129, DOI 10.1113/jphysiol.1982.sp014294; Dideriksen JL, 2012, J NEUROPHYSIOL, V107, P3357, DOI 10.1152/jn.00938.2011; Emken JL, 2005, IEEE T NEUR SYS REH, V13, P33, DOI 10.1109/TNSRE.2004.843173; Farina D, 2016, PHYSIOLOGY, V31, P83, DOI 10.1152/physiol.00040.2015; Farina D, 2015, EXERC SPORT SCI REV, V43, P23, DOI 10.1249/JES.0000000000000032; Farina Dario, 2012, IEEE Rev Biomed Eng, V5, P3, DOI 10.1109/RBME.2012.2183586; Farina D, 2012, J NEUROPHYSIOL, V107, P958, DOI 10.1152/jn.00304.2011; Fox EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055970; Gallego JA, 2015, J NEUROSCI, V35, P8925, DOI 10.1523/JNEUROSCI.0106-15.2015; Gehring WJ, 2001, J NEUROSCI, V21, P9430, DOI 10.1523/JNEUROSCI.21-23-09430.2001; Hong SL, 2008, EXP BRAIN RES, V189, P61, DOI 10.1007/s00221-008-1403-z; Hu XG, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/2/026015; Hu XG, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-99; Hu XG, 2013, J NEUROPHYSIOL, V110, P1205, DOI 10.1152/jn.00301.2012; Hu XG, 2011, EXP BRAIN RES, V212, P497, DOI 10.1007/s00221-011-2760-6; Jordan K, 2013, EXP PHYSIOL, V98, P546, DOI 10.1113/expphysiol.2012.067975; Kobayashi H, 2014, SCAND J MED SCI SPOR, V24, P98, DOI 10.1111/j.1600-0838.2012.01460.x; Kristeva R, 2007, NEUROIMAGE, V36, P785, DOI 10.1016/j.neuroimage.2007.03.025; Kristeva-Feige R, 2002, CLIN NEUROPHYSIOL, V113, P124, DOI 10.1016/S1388-2457(01)00722-2; Kuznetsov NA, 2010, NEUROSCI LETT, V470, P121, DOI 10.1016/j.neulet.2009.12.068; Laine CM, 2014, ACTA PHYSIOL, V211, P229, DOI 10.1111/apha.12255; Lin YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085578; Luu P, 2000, J NEUROSCI, V20, P464, DOI 10.1523/JNEUROSCI.20-01-00464.2000; Marmon AR, 2011, MED SCI SPORT EXER, V43, P560, DOI 10.1249/MSS.0b013e3181f3f3ab; Matthews PBC, 1996, J PHYSIOL-LONDON, V492, P597, DOI 10.1113/jphysiol.1996.sp021332; MIALL RC, 1986, BEHAV BRAIN RES, V20, P185, DOI 10.1016/0166-4328(86)90003-3; Moon H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109202; Moritz CT, 2005, J NEUROPHYSIOL, V93, P2449, DOI 10.1152/jn.01122.2004; NAVAS F, 1968, BIOPHYS J, V8, P252, DOI 10.1016/S0006-3495(68)86488-4; Nawab SH, 2010, CLIN NEUROPHYSIOL, V121, P1602, DOI 10.1016/j.clinph.2009.11.092; Negro F, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/2/026027; Negro F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044894; Negro F, 2009, J PHYSIOL-LONDON, V587, P5925, DOI 10.1113/jphysiol.2009.178509; Ofori E, 2010, EXP BRAIN RES, V203, P299, DOI 10.1007/s00221-010-2229-z; Pasalar S, 2005, EXP BRAIN RES, V163, P214, DOI 10.1007/s00221-004-2169-6; Patton JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0046466; Perez MA, 2006, J PHYSIOL-LONDON, V573, P843, DOI 10.1113/jphysiol.2006.105361; Prodoehl J, 2010, EXP BRAIN RES, V200, P67, DOI 10.1007/s00221-009-1966-3; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rosenbaum R, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00058; Slifkin AB, 2000, J NEUROPHYSIOL, V84, P1708, DOI 10.1152/jn.2000.84.4.1708; Sosnoff JJ, 2006, EXP BRAIN RES, V170, P423, DOI 10.1007/s00221-005-0225-5; Tracy BL, 2007, HUM MOVEMENT SCI, V26, P796, DOI 10.1016/j.humov.2007.07.001; Vaillancourt DE, 2006, EXP BRAIN RES, V173, P742, DOI 10.1007/s00221-006-0454-2; Vaillancourt DE, 2003, J APPL PHYSIOL, V94, P903, DOI 10.1152/japplphysiol.00166.2002; Vaillancourt DE, 2002, CLIN NEUROPHYSIOL, V113, P1325, DOI 10.1016/S1388-2457(02)00167-0; Witte M, 2007, EUR J NEUROSCI, V26, P3564, DOI 10.1111/j.1460-9568.2007.05942.x	62	13	13	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170824	10.1371/journal.pone.0170824	http://dx.doi.org/10.1371/journal.pone.0170824			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125658	Green Submitted, Green Published, gold			2022-12-27	WOS:000396176100041
J	Lagrutta, LC; Montero-Villegas, S; Layerenza, JP; Sisti, MS; de Bravo, MMG; Ves-Losada, A				Lagrutta, Lucia C.; Montero-Villegas, Sandra; Layerenza, Juan P.; Sisti, Martin S.; Garcia de Bravo, Margarita M.; Ves-Losada, Ana			Reversible Nuclear-Lipid-Droplet Morphology Induced by Oleic Acid: A Link to Cellular-Lipid Metabolism	PLOS ONE			English	Article							ACYL-COA SYNTHETASE; FATTY-ACIDS; PHOSPHATIDYLCHOLINE SYNTHESIS; CYTIDYLYLTRANSFERASE-ALPHA; HUMAN HEPATOCYTE; GROWTH; PROTEINS; LIVER; ACCUMULATION; CELLS	Neutral lipids-involved in many cellular processes D are stored as lipid droplets (LD), those mainly cytosolic (cLD) along with a small nuclear population (nLD). nLD could be involved in nuclear-lipid homeostasis serving as an endonuclear buffering system that would provide or incorporate lipids and proteins involved in signalling pathways as transcription factors and as enzymes of lipid metabolism and nuclear processes. Our aim was to determine if nLD constituted a dynamic domain. Oleic-acid (OA) added to rat hepatocytes or HepG2 cells in culture produced cellular-phenotypic LD modifications: increases in TAG, CE, C, and PL content and in cLD and nLD numbers and sizes. LD increments were reversed on exclusion of OA and were prevented by inhibition of acyl-CoA synthetase (with Triacsin C) and thus lipid biosynthesis. Under all conditions, nLD corresponded to a small population (2-10%) of total cellular LD. The anabolism triggered by OA, involving morphologic and size changes within the cLD and nLD populations, was reversed by a net balance of catabolism, upon eliminating OA. These catabolic processes included lipolysis and the mobilization of hydrolyzed FA from the LD to cytosolic-oxidation sites. These results would imply that nLD are actively involved in nuclear processes that include lipids. In conclusion, nLD are a dynamic nuclear domain since they are modified by OA through a reversible mechanism in combination with cLD; this process involves acyl-CoA-synthetase activity; ongoing TAG, CE, and PL biosynthesis. Thus, liver nLD and cLD are both dynamic cellular organelles.	[Lagrutta, Lucia C.; Montero-Villegas, Sandra; Layerenza, Juan P.; Sisti, Martin S.; Garcia de Bravo, Margarita M.; Ves-Losada, Ana] Inst Invest Bioqum La Plata Prof Doctor Rodolf R, La Plata, Buenos Aires, Argentina; [Garcia de Bravo, Margarita M.] Univ Nacl La Plata, Catedra Biol, Fac Ciencias Med, La Plata, Buenos Aires, Argentina; [Ves-Losada, Ana] Univ Nacl La Plata, Dept Ciencias Biol, Fac Ciencias Exactas, La Plata, Buenos Aires, Argentina	National University of La Plata; National University of La Plata	Ves-Losada, A (corresponding author), Inst Invest Bioqum La Plata Prof Doctor Rodolf R, La Plata, Buenos Aires, Argentina.; Ves-Losada, A (corresponding author), Univ Nacl La Plata, Dept Ciencias Biol, Fac Ciencias Exactas, La Plata, Buenos Aires, Argentina.	avlosada@biol.unlp.edu.ar		Sisti, Martin Sebastian/0000-0003-2561-3324	PICT (Proyecto de Investigacion Cientifica y Tecnologica (Argentina)) [00762]; CONICET PIP [11220100100037]; UNP [11/M149, 11/M177]	PICT (Proyecto de Investigacion Cientifica y Tecnologica (Argentina)); CONICET PIP(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UNP	Support was provided by PICT (Proyecto de Investigacion Cientifica y Tecnologica (Argentina)) 2007 Tipo A No 00762; CONICET PIP 2013 No11220100100037; and UNP 2010-2013, 11/M149; UNP 2014-2017, 11/M177 (UNLP: Universidad Nacional de La Plata (Argentina)).	Aitchison AJ, 2015, MOL BIOL CELL, V26, P2927, DOI 10.1091/mbc.E15-03-0159; Alvarez HM, 2016, BIOCHIMIE, V120, P28, DOI 10.1016/j.biochi.2015.08.016; Barneda D, 2013, BBA-MOL CELL BIOL L, V1831, P924, DOI 10.1016/j.bbalip.2013.01.015; Bi JF, 2012, J CELL SCI, V125, P3568, DOI 10.1242/jcs.101329; Boschi F, 2015, EXP CELL RES, V336, P253, DOI 10.1016/j.yexcr.2015.06.001; Caire-Brandli I, 2014, INFECT IMMUN, V82, P476, DOI 10.1128/IAI.01196-13; Choudhary V, 2015, J CELL BIOL, V211, P261, DOI 10.1083/jcb.201505067; Crespo R, 2013, BIOCHEM CELL BIOL, V91, P131, DOI 10.1139/bcb-2012-0076; Ding YF, 2012, J LIPID RES, V53, P399, DOI 10.1194/jlr.M021899; Dundr M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000711; Farese RV, 2016, J CELL BIOL, V212, P7, DOI 10.1083/jcb.201512056; Farooqui AA, 2005, REPROD NUTR DEV, V45, P613, DOI 10.1051/rnd:2005049; Favale NO, 2010, BBA-MOL CELL BIOL L, V1801, P1184, DOI 10.1016/j.bbalip.2010.07.003; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fujimoto Y, 2007, J LIPID RES, V48, P1280, DOI 10.1194/jlr.M700050-JLR200; Fujimoto Y, 2006, BIOL PHARM BULL, V29, P2174, DOI 10.1248/bpb.29.2174; Gaveglio VL, 2013, FEBS LETT, V587, P950, DOI 10.1016/j.febslet.2013.01.074; Gehrig K, 2008, MOL BIOL CELL, V19, P237, DOI 10.1091/mbc.E07-02-0179; Georgiadi A, 2012, ADV NUTR, V3, P127, DOI 10.3945/an.111.001602; GIBBONS GF, 1994, J LIPID RES, V35, P1801; GIBBONS GF, 1992, BIOCHEM J, V287, P749, DOI 10.1042/bj2870749; Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142; Green CJ, 2015, AM J PHYSIOL-ENDOC M, V308, pE1, DOI 10.1152/ajpendo.00192.2014; HILLMAN N, 1975, J EMBRYOL EXP MORPH, V33, P685; Igal RA, 1997, BIOCHEM J, V324, P529, DOI 10.1042/bj3240529; Iglesias NG, 2015, TRAFFIC, V16, P962, DOI 10.1111/tra.12305; Kory N, 2015, DEV CELL, V34, P351, DOI 10.1016/j.devcel.2015.06.007; Layerenza JP, 2013, BBA-MOL CELL BIOL L, V1831, P327, DOI 10.1016/j.bbalip.2012.10.005; Le Lay S, 2015, ADIPOCYTE, V4, P158, DOI 10.4161/21623945.2014.973774; Liefhebber JMP, 2014, J BIOL CHEM, V289, P21276, DOI 10.1074/jbc.M114.582999; Mao YTS, 2011, TRENDS GENET, V27, P295, DOI 10.1016/j.tig.2011.05.006; Marcinkiewicz A, 2006, J BIOL CHEM, V281, P11901, DOI 10.1074/jbc.M600171200; Mate SM, 2007, LIPIDS, V42, P589, DOI 10.1007/s11745-007-3063-3; Muoio DM, 2000, AM J PHYSIOL-ENDOC M, V279, pE1366, DOI 10.1152/ajpendo.2000.279.6.E1366; Ohsaki Y, 2016, J CELL BIOL, V212, P29, DOI 10.1083/jcb.201507122; Opie EL, 1944, J EXP MED, V80, P231, DOI 10.1084/jem.80.3.231; Paar M, 2012, J BIOL CHEM, V287, P11164, DOI 10.1074/jbc.M111.316794; Sahini N, 2014, PROG LIPID RES, V54, P86, DOI 10.1016/j.plipres.2014.02.002; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Somwar R, 2011, FEBS LETT, V585, P1946, DOI 10.1016/j.febslet.2011.05.016; Uzbekov Rustem, 2013, BMC Res Notes, V6, P386, DOI 10.1186/1756-0500-6-386; VesLosada A, 1996, MOL CELL BIOCHEM, V159, P1; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Wang L, 2013, SCI REP-UK, V3, DOI 10.1038/srep02174; Welte MA, 2015, CURR BIOL, V25, pR470, DOI 10.1016/j.cub.2015.04.004; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Wolins NE, 2001, J BIOL CHEM, V276, P5101, DOI 10.1074/jbc.M006775200; Xu WY, 2016, J BIOL CHEM, V291, P4282, DOI 10.1074/jbc.M115.701094; Zhao Jing, 2013, ISRN Neurosci, V2013, P579216, DOI 10.1155/2013/579216	49	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170608	10.1371/journal.pone.0170608	http://dx.doi.org/10.1371/journal.pone.0170608			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125673	gold, Green Published, Green Submitted			2022-12-27	WOS:000396176100087
J	Rios, VP; Kraenkel, RA				Rios, Vitor Passos; Kraenkel, Roberto Andre			Do I Know You? How Individual Recognition Affects Group Formation and Structure	PLOS ONE			English	Article							SOCIAL RECOGNITION; SYSTEMS; VASOPRESSIN; OXYTOCIN; EVOLUTION	Groups in nature can be formed by interactions between individuals, or by external pressures like predation. It is reasonable to assume that groups formed by internal and external conditions have different dynamics and structures. We propose a computational model to investigate the effects of individual recognition on the formation and structure of animal groups. Our model is composed of agents that can recognize each other and remember previous interactions, without any external pressures, in order to isolate the effects of individual recognition. We show that individual recognition affects the number and size of groups, and the modularity of the social networks. This model can be used as a null model to investigate the effects of external factors on group formation and persistence.	[Rios, Vitor Passos] Univ Sao Paulo, Programa Posgrad Ecol, Sao Paulo, SP, Brazil; [Kraenkel, Roberto Andre] Univ Estadual Paulista, Inst Fis Teor, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista	Rios, VP (corresponding author), Univ Sao Paulo, Programa Posgrad Ecol, Sao Paulo, SP, Brazil.	vrios81@gmail.com	Kraenkel, Roberto A/B-5479-2010	Kraenkel, Roberto A/0000-0001-5602-5184	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/13779-3]; Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	VPR has received financial support via grants by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP http://www.fapesp.br/, grant number 2012/13779-3) and Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior (CAPES http://www.capes.gov.br/, Cota Institucional - Demanda Social). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R. D., 1974, ANNU REV ECOL SYST, V488, P325, DOI DOI 10.1146/ANNUREV.ES.05.110174.001545; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Breed MD, 1998, BIOSCIENCE, V48, P463, DOI 10.2307/1313244; CLARK CW, 1986, THEOR POPUL BIOL, V30, P45, DOI 10.1016/0040-5809(86)90024-9; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dluzen DE, 2000, EUR J NEUROSCI, V12, P760, DOI 10.1046/j.1460-9568.2000.00952.x; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Ebenspherger LA, 2001, BEHAV ECOL, V12, P227, DOI 10.1093/beheco/12.2.227; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Gherardi F, 2012, ANIM COGN, V15, P745, DOI 10.1007/s10071-012-0513-y; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V., 2005, INDIVIDUAL BASED MOD, DOI [10.1515/9781400850624, DOI 10.1515/9781400850624]; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Gruber CW, 2014, EXP PHYSIOL, V99, P55, DOI 10.1113/expphysiol.2013.072561; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Hemelrijk CK, 2000, ANIM BEHAV, V59, P1035, DOI 10.1006/anbe.2000.1400; Hildenbrandt H, 2010, BEHAV ECOL, V21, P1349, DOI 10.1093/beheco/arq149; Johnson DDP, 2002, TRENDS ECOL EVOL, V17, P563, DOI 10.1016/S0169-5347(02)02619-8; Johnstone RA, 2000, ETHOLOGY, V106, P5, DOI 10.1046/j.1439-0310.2000.00529.x; Kerth G, 2011, P ROY SOC B-BIOL SCI, V278, P2761, DOI 10.1098/rspb.2010.2718; King AJ, 2011, ANIM BEHAV, V82, P1337, DOI 10.1016/j.anbehav.2011.09.017; Lacey EA, 2003, J MAMMAL, V84, P1198, DOI 10.1644/BLe-014; Martins AB, 2013, P NATL ACAD SCI USA, V110, P5080, DOI 10.1073/pnas.1217034110; Mateo JM, 2004, ANN ZOOL FENN, V41, P729; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; NOWAK MA, 1994, P NATL ACAD SCI USA, V91, P4877, DOI 10.1073/pnas.91.11.4877; Palagi E, 2006, AM J PHYS ANTHROPOL, V129, P418, DOI 10.1002/ajpa.20289; R Core Team, 2013, R LANG ENV STAT COMP; Sheehan MJ, 2016, BEHAV ECOL, V27, P2, DOI 10.1093/beheco/arv109; Sheehan MJ, 2014, ETHOLOGY, V120, P169, DOI 10.1111/eth.12191; SHERMAN PW, 1995, BEHAV ECOL, V6, P102, DOI 10.1093/beheco/6.1.102; Spiliopoulou M., 2006, P 12 ACM SIGKDD INT, P706, DOI [10.1145/1150402.1150491, DOI 10.1145/1150402.1150491]; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; Young LJ, 1999, NATURE, V400, P766, DOI 10.1038/23475	35	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170737	10.1371/journal.pone.0170737	http://dx.doi.org/10.1371/journal.pone.0170737			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125708	gold, Green Published, Green Submitted			2022-12-27	WOS:000396176100067
J	Shimoshige, H; Nakajima, Y; Kobayashi, H; Yanagisawa, K; Nagaoka, Y; Shimamura, S; Mizuki, T; Inoue, A; Maekawa, T				Shimoshige, Hirokazu; Nakajima, Yoshikata; Kobayashi, Hideki; Yanagisawa, Keiichi; Nagaoka, Yutaka; Shimamura, Shigeru; Mizuki, Toru; Inoue, Akira; Maekawa, Toru			Formation of Core-Shell Nanoparticles Composed of Magnetite and Samarium Oxide in Magnetospirillum magneticum Strain RSS-1	PLOS ONE			English	Article							RARE-EARTH-ELEMENTS; MAGNETOTACTIC BACTERIA; MAGNETOSOME FORMATION; BIOGENIC MAGNETITE; NANOCRYSTALS; ADSORPTION; BIOMINERALIZATION; GRYPHISWALDENSE; ACCUMULATION; SEDIMENTS	Magnetotactic bacteria (MTB) synthesize magnetosomes composed of membrane-enveloped magnetite (Fe3O4) or greigite (Fe3S4) particles in the cells. Recently, several studies have shown some possibilities of controlling the biomineralization process and altering the magnetic properties of magnetosomes by adding some transition metals to the culture media under various environmental conditions. Here, we successfully grow Magnetospirillum magneticum strain RSS-1, which are isolated from a freshwater environment, and find that synthesis of magnetosomes are encouraged in RSS-1 in the presence of samarium and that each core magnetic crystal composed of magnetite is covered with a thin layer of samarium oxide (Sm2O3). The present results show some possibilities of magnetic recovery of transition metals and synthesis of some novel structures composed of magnetic particles and transition metals utilizing MTB.	[Shimoshige, Hirokazu; Nakajima, Yoshikata; Yanagisawa, Keiichi; Nagaoka, Yutaka; Mizuki, Toru; Inoue, Akira; Maekawa, Toru] Toyo Univ, Bionano Elect Res Ctr, Kawagoe, Saitama, Japan; [Nakajima, Yoshikata; Mizuki, Toru; Inoue, Akira; Maekawa, Toru] Toyo Univ, Grad Sch Interdisciplinary New Sci, Kawagoe, Saitama, Japan; [Kobayashi, Hideki; Shimamura, Shigeru] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa, Japan	Toyo University; Toyo University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Maekawa, T (corresponding author), Toyo Univ, Bionano Elect Res Ctr, Kawagoe, Saitama, Japan.; Maekawa, T (corresponding author), Toyo Univ, Grad Sch Interdisciplinary New Sci, Kawagoe, Saitama, Japan.	maekawa@toyo.jp	Nakajima, Yoshikata/Y-8403-2019	Nakajima, Yoshikata/0000-0002-0302-7386; Shimoshige, Hirokazu/0000-0002-0583-6160; Mizuki, Toru/0000-0003-2744-881X	Strategic Research Foundation at Private Universities, Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [S1101017]; Grants-in-Aid for Scientific Research [15K18056] Funding Source: KAKEN	Strategic Research Foundation at Private Universities, Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by S1101017, grant for the Program for the Strategic Research Foundation at Private Universities, Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, http://www.mext.go.jp/en/.	ANDRES Y, 1993, APPL MICROBIOL BIOT, V39, P413, DOI 10.1007/BF00192103; BAYER ME, 1991, J BACTERIOL, V173, P141, DOI 10.1128/jb.173.1.141-149.1991; Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; BAZYLINSKI DA, 1995, APPL ENVIRON MICROB, V61, P3232, DOI 10.1128/AEM.61.9.3232-3239.1995; BAZYLINSKI DA, 1994, MICROSC RES TECHNIQ, V27, P389, DOI 10.1002/jemt.1070270505; BAZYLINSKI DA, 1993, ARCH MICROBIOL, V160, P35; BLAKEMORE RP, 1979, J BACTERIOL, V140, P720, DOI 10.1128/JB.140.2.720-729.1979; Charilaou M, 2016, J APPL PHYS, V109; Cotton S.A., 2006, LANTHANIDE ACTINIDE; De Silva CR, 2009, J AM CHEM SOC, V131, P6336, DOI 10.1021/ja9014277; Duguet E, 2006, NANOMEDICINE-UK, V1, P157, DOI 10.2217/17435889.1.2.157; Dunin-Borkowski RE, 1998, SCIENCE, V282, P1868, DOI 10.1126/science.282.5395.1868; Faivre D, 2008, CHEM REV, V108, P4875, DOI 10.1021/cr078258w; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gehring AU, 2011, GEOPHYS J INT, V187, P1215, DOI 10.1111/j.1365-246X.2011.05175.x; Hammond C.R., 2000, ELEMENTS HDB CHEM PH, V81st ed.; Heyen U, 2003, APPL MICROBIOL BIOT, V61, P536, DOI 10.1007/s00253-002-1219-x; Jabeen F, 2015, ANAL CHEM, V87, P4726, DOI 10.1021/ac504818s; Jogler C, 2009, APPL ENVIRON MICROB, V75, P3972, DOI 10.1128/AEM.02701-08; Keim CN, 2009, FEMS MICROBIOL LETT, V292, P250, DOI 10.1111/j.1574-6968.2009.01499.x; Komeili A, 2004, P NATL ACAD SCI USA, V101, P3839, DOI 10.1073/pnas.0400391101; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Kundu S, 2009, BIOMATERIALS, V30, P4211, DOI 10.1016/j.biomaterials.2009.04.039; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li JH, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0355; Li JH, 2013, GEOCHEM GEOPHY GEOSY, V14, P3887, DOI 10.1002/ggge.20228; Li JH, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004384; Liang X, 2006, ADV FUNCT MATER, V16, P1805, DOI 10.1002/adfm.200500884; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Liu T, 2003, LANGMUIR, V19, P7569, DOI 10.1021/la034350l; MANN S, 1990, ADV MICROB PHYSIOL, V31, P125; Miyazaki S, 2003, NUCLEIC ACIDS RES, V31, P13, DOI 10.1093/nar/gkg088; MOSKOWITZ BM, 1993, EARTH PLANET SC LETT, V120, P283, DOI 10.1016/0012-821X(93)90245-5; Ngwenya BT, 2010, ENVIRON SCI TECHNOL, V44, P650, DOI 10.1021/es9014234; Pan YX, 2005, EARTH PLANET SC LETT, V237, P311, DOI 10.1016/j.epsl.2005.06.029; Pang XC, 2016, SCIENCE, V353, P1268, DOI 10.1126/science.aad8279; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Posfai M, 1998, AM MINERAL, V83, P1469, DOI 10.2138/am-1998-11-1235; Prozorov T, 2014, EUR J MINERAL, V26, P457, DOI 10.1127/0935-1221/2014/0026-2388; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shimoshige H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127481; Song HP, 2008, CHEMOSPHERE, V72, P616, DOI 10.1016/j.chemosphere.2008.02.064; Song HP, 2007, CHINESE J CHEM ENG, V15, P847, DOI 10.1016/S1004-9541(08)60013-0; SOROKIN PP, 1979, IBM J RES DEV, V23, P476, DOI 10.1147/rd.235.0476; SPARKS NHC, 1986, FEMS MICROBIOL LETT, V37, P305, DOI 10.1016/0378-1097(86)90424-6; Staniland S, 2008, NAT NANOTECHNOL, V3, P158, DOI 10.1038/nnano.2008.35; Sun JB, 2010, NANOTOXICOLOGY, V4, P271, DOI 10.3109/17435391003690531; Takahashi Y, 2005, CHEM GEOL, V219, P53, DOI 10.1016/j.chemgeo.2005.02.009; Tanaka M, 2012, EUR J MINERAL, V22, P11919; Tanaka M, 2010, APPL ENVIRON MICROB, V76, P5526, DOI 10.1128/AEM.00589-10; TOWE KM, 1981, EARTH PLANET SC LETT, V52, P213, DOI 10.1016/0012-821X(81)90222-3; Tsuruta T, 2006, COLLOID SURFACE B, V52, P117, DOI 10.1016/j.colsurfb.2006.04.014; Wang YH, 2011, DESALINATION, V270, P258, DOI 10.1016/j.desal.2010.11.053; Xiang L, 2007, LETT APPL MICROBIOL, V45, P75, DOI 10.1111/j.1472-765X.2007.02143.x; Xie J, 2009, NANO RES, V2, P261, DOI [10.1007/s12274-009-9025-8, 10.1007/S12274-009-9025-8]; Xu H., 2015, BIOMED RES INT, V2015, P1, DOI DOI 10.1016/J.CECA.2015.02.006; Yamashita T, 2008, APPL SURF SCI, V254, P2441, DOI 10.1016/j.apsusc.2007.09.063; Yang CD, 2001, ENZYME MICROB TECH, V29, P13, DOI 10.1016/S0141-0229(01)00343-X; Yang D, 2015, ANGEW CHEM INT EDIT, V54, P12091, DOI 10.1002/anie.201504676	60	11	11	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170932	10.1371/journal.pone.0170932	http://dx.doi.org/10.1371/journal.pone.0170932			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125741	Green Submitted, Green Published, gold			2022-12-27	WOS:000396176100021
J	Fu, LY; Koganti, PP; Wang, J; Wang, L; Wang, CL; Yao, JB				Fu, Liyuan; Koganti, Prasanthi P.; Wang, Jian; Wang, Lei; Wang, Cheng-Lun; Yao, Jianbo			Lhx8 interacts with a novel germ cell-specific nuclear factor containing an Nbl1 domain in rainbow trout (Oncorhynchus mykiss)	PLOS ONE			English	Article							LIM HOMEOBOX GENE; PROTEIN; EXPRESSION; FOLLICULOGENESIS; IDENTIFICATION; BOREALIN; L3/LHX8; CLONING	Lhx8 is an important transcription factor that is preferentially expressed in germ cells. Lhx8 null mice are infertile due to lack of oocytes and impairment of the transition from primordial follicles to primary follicles. Lhx8 deficiency also affects the expression of many important oocyte-specific genes. In this study, we report the characterization of rainbow trout lhx8 genes and identification of a novel germ cell-specific nuclear factor that interacts with Lhx8. Two lhx8 genes, lhx8a and lhx8b, were identified, encoding proteins of 344 and 361 amino acids, respectively. The two proteins share 83% sequence identity and both transcripts are specifically expressed in the ovary. Quantitative real time PCR analysis demonstrated that both genes are expressed highly in pre-vitellogenic ovaries as well as in early stage embryos. Using a yeast two-hybrid screening system, a novel protein (Borealin-2) interacting with Lhx8 was identified. The interaction between either Lhx8a or Lhx8b and Borealin-2 was further confirmed by a bimolecular fluorescence complementation (BiFC) assay. Borealin-2 is a protein of 255 amino acids containing an Nbl1 domain, and its mRNA expression is restricted to the ovary and testis. A GFP reporter assay revealed that Borealin-2 is a nuclear protein. Collectively, results indicate that both Lhx8a and Lhx8b function through interaction with Borealin-2, which may play an important role during oogenesis and early embryogenesis in rainbow trout.	[Fu, Liyuan; Koganti, Prasanthi P.; Wang, Jian; Wang, Lei; Wang, Cheng-Lun; Yao, Jianbo] West Virginia Univ, Div Anim & Nutr Sci, Morgantown, WV 26506 USA	West Virginia University	Yao, JB (corresponding author), West Virginia Univ, Div Anim & Nutr Sci, Morgantown, WV 26506 USA.	jianbo.yao@mail.wvu.edu	Wang, Jian/M-4594-2018; Koganti, Prasanthi/ABB-2730-2020	Koganti, Prasanthi/0000-0002-5452-389X	USDA-ARS [58-1930-0-059]	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was supported by the USDA-ARS Cooperative Agreement No. 58-1930-0-059 (JY). It is published with the approval of the director of the West Virginia Agricultural and Forestry Experiment Station as scientific paper No. 3297. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 1984, TETRAPLOIDY EVOLUTIO, P55; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Breen JJ, 1998, J BIOL CHEM, V273, P4712, DOI 10.1074/jbc.273.8.4712; Cho H, 2014, J APPL MATH, DOI 10.1155/2014/951214; Choi Y, 2008, BIOL REPROD, V79, P442, DOI 10.1095/biolreprod.108.069393; Fang W, 2009, AGR SCI CHINA, V8, P1503, DOI 10.1016/S1671-2927(08)60365-X; Fu LY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164671; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Inoue M, 2006, ANAT EMBRYOL, V211, P247, DOI 10.1007/s00429-006-0078-0; Miller John, 2004, Methods Mol Biol, V261, P247; Mori T, 2004, EUR J NEUROSCI, V19, P3129, DOI 10.1111/j.0953-816X.2004.03415.x; Pangas SA, 2006, P NATL ACAD SCI USA, V103, P8090, DOI 10.1073/pnas.0601083103; Qiu GF, 2008, MOL REPROD DEV, V75, P723, DOI 10.1002/mrd.20827; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; Ramachandra RK, 2007, MOL REPROD DEV, V74, P502, DOI 10.1002/mrd.20628; Ren Y, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0151-3; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; Soyal SM, 2000, DEVELOPMENT, V127, P4645; Thorgaard GH, 2002, COMP BIOCHEM PHYS B, V133, P609, DOI 10.1016/S1096-4959(02)00167-7; Toyama R, 1998, MECH DEVELOP, V71, P197, DOI 10.1016/S0925-4773(97)00202-5; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang L, 2014, MOL REPROD DEV, V81, P1136, DOI 10.1002/mrd.22433; Wang L, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-86; Yamanaka Y, 2008, MECH DEVELOP, V125, P441, DOI 10.1016/j.mod.2008.01.011; Zhang QJ, 2009, MOL BIOL REP, V36, P603, DOI 10.1007/s11033-008-9220-9; Zhao H, 2008, AM J HUM GENET, V82, P1342, DOI 10.1016/j.ajhg.2008.04.018; Zheng P, 2007, SEMIN REPROD MED, V25, P243, DOI 10.1055/s-2007-980218	28	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170760	10.1371/journal.pone.0170760	http://dx.doi.org/10.1371/journal.pone.0170760			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151980	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161200042
J	Schmukler, E; Wolfson, E; Elazar, Z; Kloog, Y; Pinkas-Kramarski, R				Schmukler, Eran; Wolfson, Eya; Elazar, Zvulun; Kloog, Yoel; Pinkas-Kramarski, Ronit			Continuous treatment with FTS confers resistance to apoptosis and affects autophagy	PLOS ONE			English	Article							AURORA KINASE; TUMOR-GROWTH; RAS; INHIBITION; DEATH; DEGRADATION; MECHANISMS	High percentage of human cancers involves alteration or mutation in Ras proteins, including the most aggressive malignancies, such as lung, colon and pancreatic cancers. FTS (Salirasib) is a farnesylcysteine mimetic, which acts as a functional Ras inhibitor, and was shown to exert anti-tumorigenic effects in vitro and in vivo. Previously, we have demonstrated that short-term treatment with FTS also induces protective autophagy in several cancer cell lines. Drug resistance is frequently observed in cancer cells exposed to prolonged treatment, and is considered a major cause for therapy inefficiency. Therefore, in the present study, we examined the effect of a prolonged treatment with FTS on drug resistance of HCT-116 human colon cancer cells, and the involvement of autophagy in this process. We found that cells grown in the presence of FTS for 6 months have become resistant to FTSinduced cell growth inhibition and cell death. Furthermore, we discovered that the resistant cells exhibit altered autophagy, reduced apoptosis and changes in Ras-related signaling pathways following treatment with FTS. Moreover we found that while FTS induces an apoptosis-related cleavage of p62, the FTS-resistant cells were more resistant to apoptosis and p62 cleavage.	[Schmukler, Eran; Wolfson, Eya; Kloog, Yoel; Pinkas-Kramarski, Ronit] Tel Aviv Univ, Dept Neurobiol, Ramat Aviv, Israel; [Elazar, Zvulun] Weizmann Inst Sci, Dept Biol Chem, Rehovot, Israel	Tel Aviv University; Weizmann Institute of Science	Pinkas-Kramarski, R (corresponding author), Tel Aviv Univ, Dept Neurobiol, Ramat Aviv, Israel.	lironit@post.tau.ac.il		Pinkas-Kramarski, Ronit/0000-0002-1000-369X	Israel Science Foundation [848/12]; Israel Cancer Association; Kauffman Prostate Cancer Research Fund	Israel Science Foundation(Israel Science Foundation); Israel Cancer Association; Kauffman Prostate Cancer Research Fund	This work was supported by the Israel Science Foundation (grant No. 848/12), the Israel Cancer Association and by the Kauffman Prostate Cancer Research Fund.	Ahmed D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.35; Baines AT, 2011, FUTURE MED CHEM, V3, P1787, DOI [10.4155/FMC.11.121, 10.4155/fmc.11.121]; Biran A, 2011, INT J CANCER, V128, P691, DOI 10.1002/ijc.25367; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Erlich S, 2006, BIOCHEM PHARMACOL, V72, P427, DOI 10.1016/j.bcp.2006.05.007; Garraway LA, 2012, CANCER DISCOV, V2, P214, DOI 10.1158/2159-8290.CD-12-0012; Haklai R, 1998, BIOCHEMISTRY-US, V37, P1306, DOI 10.1021/bi972032d; Haklai R, 2008, CANCER CHEMOTH PHARM, V61, P89, DOI 10.1007/s00280-007-0451-6; Halaschek-Wiener J, 2000, MOL MED, V6, P693, DOI 10.1007/BF03402049; He W, 2013, AM J TRANSL RES, V5, P359; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang ZH, 2014, ONCOL REP, V31, P1249, DOI 10.3892/or.2014.2986; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kollareddy M, 2012, INVEST NEW DRUG, V30, P2411, DOI 10.1007/s10637-012-9798-6; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Matallanas D, 2003, J BIOL CHEM, V278, P4572, DOI 10.1074/jbc.M209807200; Moscat J, 2009, EMBO REP, V10, P804, DOI 10.1038/embor.2009.172; Norman JM, 2010, AUTOPHAGY, V6, P1042, DOI 10.4161/auto.6.8.13337; Rotblat B, 2008, METHOD ENZYMOL, V439, P467, DOI 10.1016/S0076-6879(07)00432-6; Sahani MH, 2014, AUTOPHAGY, V10, P431, DOI 10.4161/auto.27344; Schmukler E, 2014, ONCOTARGET, V5, P173, DOI 10.18632/oncotarget.1500; Schmukler E, 2013, ONCOTARGET, V4, P145; Shi J, 2014, CELL DEATH DIFFER, V21, P1432, DOI 10.1038/cdd.2014.58; Sridharan Savitha, 2011, Cancers (Basel), V3, P2630, DOI 10.3390/cancers3022630; Wolfson E, 2015, BIOL CELL, V107, P130, DOI 10.1111/boc.201400087; Yuan CX, 2015, DRUG DES DEV THER, V9, P487, DOI 10.2147/DDDT.S74127; Zeng RX, 2014, CELL BIOL INT, V38, P1221, DOI 10.1002/cbin.10311	31	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171351	10.1371/journal.pone.0171351	http://dx.doi.org/10.1371/journal.pone.0171351			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28151959	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200131
J	Yamagishi, T; Yamaguchi, H; Suzuki, S; Horie, Y; Tatarazako, N				Yamagishi, Takahiro; Yamaguchi, Haruyo; Suzuki, Shigekatsu; Horie, Yoshifumi; Tatarazako, Norihisa			Cell reproductive patterns in the green alga Pseudokirchneriella subcapitata (=Selenastrum capricornutum) and their variations under exposure to the typical toxicants potassium dichromate and 3,5-DCP	PLOS ONE			English	Article							ANKISTRODESMUS-GRACILIS; COLONY FORMATION; FLOW-CYTOMETRY; LIFE-CYCLE; SCENEDESMUS; CHLORELLA; TOXICITY; COPPER; DIVISION; CADMIUM	Pseudokirchneriella subcapitata is a sickle-shaped freshwater green microalga that is normally found in unicellular form. Currently, it is the best known and most frequently used species of ecotoxicological bioindicator because of its high growth rate and sensitivity to toxicants. However, despite this organism's, our knowledge of its cell biology for example, the patterns of nuclear and cytoplasmic division in the mitotic stage is limited. Although it has been reported that P. subcapitata proliferates by popularity forming four daughter cells (autospores) through multiple fission after two nuclear divisions, here, we report two additional reproductive patterns by which two autospores are formed by binary fission ("twoautospore type") and eight autospores are formed by multiple fission ("eight-autospore type"). Moreover, we found that cell reproductive patterns differed markedly with the culture conditions or with exposure to either of two typical toxicants, potassium dichromate (K2Cr2O7) and 3,5-dichlorophenol (3,5-DCP). The eight-autospore type occurred at the highest frequency in the early phase of culture, but it disappeared under 3,5-DCP at 2.0 mg/L. Under 0.3 mg/L K2CrO7 (Cr(VI)) the eight-autospore type took substantially longer to appear than in control culture. The two-autospore type occurred only in the late phase of culture. To our knowledge, this is the first detailed evaluation of the reproductive patterns of P. subcapitata, which changed dramatically in the presence of toxicants. These findings suggest that observation of the reproductive patterns of P. subcapitata will help to elucidate different cell reactions to toxicants.	[Yamagishi, Takahiro; Horie, Yoshifumi; Tatarazako, Norihisa] Natl Inst Environm Studies, Risk Assessment Sci Collaborat Off, Ctr Hlth & Environm Risk Res, Ecotox Reference Lab, Tsukuba, Ibaraki, Japan; [Yamaguchi, Haruyo; Suzuki, Shigekatsu] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan	National Institute for Environmental Studies - Japan; National Institute for Environmental Studies - Japan	Tatarazako, N (corresponding author), Natl Inst Environm Studies, Risk Assessment Sci Collaborat Off, Ctr Hlth & Environm Risk Res, Ecotox Reference Lab, Tsukuba, Ibaraki, Japan.	tatarazako.norihisa@nies.go.jp	Horie, Yoshifumi/AAT-1955-2021; Yoshifumi, Horie/Y-1627-2019	Yoshifumi, Horie/0000-0002-4558-8624				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2011, OECD GUID TEST CHEM; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bisova K, 2003, FOLIA MICROBIOL, V48, P805, DOI 10.1007/BF02931518; Bisova K, 2014, J EXP BOT, V65, P2585, DOI 10.1093/jxb/ert466; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cid A, 1996, CYTOMETRY, V25, P32, DOI 10.1002/(SICI)1097-0320(19960901)25:1<32::AID-CYTO4>3.3.CO;2-A; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Franklin NM, 2002, ENVIRON TOXICOL CHEM, V21, P2412, DOI 10.1897/1551-5028(2002)021<2412:TOMMTA>2.0.CO;2; Franklin NM, 2001, ENVIRON TOXICOL CHEM, V20, P160, DOI [10.1002/etc.5620200118, 10.1897/1551-5028(2001)020&lt;0160:DOFCBA&gt;2.0.CO;2]; GRIFFITH.DJ, 1967, PLANTA, V75, P161, DOI 10.1007/BF00387131; Hanstveit AO, 1982, 147SC5WG5 ISOTC NED; HESSEN DO, 1993, ARCH HYDROBIOL, V127, P129; Hindak F., 1990, BIOL PRACE, V36, P1; KOBAYASHI M, 1977, BOT MAG TOKYO, V90, P211, DOI 10.1007/BF02488358; KOBAYASHI M, 1974, PLANT CELL PHYSIOL, V15, P1017; Komarek J., 1983, BINNENGEWASSER, V16, P1; Komarek J., 1969, STUDIES PHYCOLOGY, P262; Komarkova-Legnerova J., 1969, STUDIES IN PHYCOLOGY, P75; Krienitz L, 2011, J PHYCOL, V47, P880, DOI 10.1111/j.1529-8817.2011.01010.x; Kumar S., 2016, MEGA7 MOL EVOLUTIONA; LAMPERT W, 1994, LIMNOL OCEANOGR, V39, P1543, DOI 10.4319/lo.1994.39.7.1543; Le Faucheur S, 2005, ENVIRON TOXICOL CHEM, V24, P1731, DOI 10.1897/04-394R.1; Lurling M, 2000, OIKOS, V88, P111, DOI 10.1034/j.1600-0706.2000.880113.x; Lurling M, 1996, DAPHNIA, V108, P432; Machado MD, 2014, AQUAT TOXICOL, V147, P1, DOI 10.1016/j.aquatox.2013.11.017; MARVAN P, 1984, ALGOL STUD, V37, P363; MORIMURA Y, 1959, PLANT CELL PHYSIOL, V1, P49; Nishikawa K, 2003, FEMS MICROBIOL ECOL, V44, P253, DOI 10.1016/S0168-6496(03)00049-7; Nygaard G, 1987, OPERA BOT, V90, P1; PFAU J, 1972, BER DEUT BOT GES, V85, P409; SETLIK I, 1972, Algological Studies, V7, P172; STAUBER JL, 1990, MAR BIOL, V105, P519, DOI 10.1007/BF01316323; TRAINOR FR, 1970, ANN NY ACAD SCI, V175, P749, DOI 10.1111/j.1749-6632.1970.tb45189.x; Vitova M, 2005, FOLIA MICROBIOL, V50, P141, DOI 10.1007/BF02931463; Wilde KL, 2006, ARCH ENVIRON CON TOX, V51, P174, DOI 10.1007/s00244-004-0256-0	36	23	24	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171259	10.1371/journal.pone.0171259	http://dx.doi.org/10.1371/journal.pone.0171259			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152022	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161200118
J	Girard, O; Brocherie, F; Morin, JB; Racinais, S; Millet, GP; Periard, JD				Girard, Olivier; Brocherie, Franck; Morin, Jean-Benoit; Racinais, Sebastien; Millet, Gregoire P.; Periard, Julien D.			Mechanical Alterations Associated with Repeated Treadmill Sprinting under Heat Stress	PLOS ONE			English	Article							GROUND REACTION FORCE; MASS MODEL; RUNNING SPEED; TEAM SPORT; PERFORMANCE; FREQUENCY; EXERCISE; FATIGUE; TEMPERATURE; STIFFNESS	Purpose Examine the mechanical alterations associated with repeated treadmill sprinting performed in HOT ( 38 degrees C) and CON ( 25 degrees C) conditions. Methods Eleven recreationally active males performed a 30-min warm-up followed by three sets of five 5-s sprints with 25-s recovery and 3-min between sets in each environment. Constantvelocity running for 1-min at 10 and 20 km.h(-1) was also performed prior to and following sprinting. Results Mean skin (37.2 +/- 0.7 vs. 32.7 +/- 0.8 E C; P< 0.001) and core (38.9 +/- 0.2 vs. 38.8 +/- 0.3 degrees C; P< 0.05) temperatures, together with thermal comfort (P< 0.001) were higher following repeated sprinting in HOT vs. CON. Step frequency and vertical stiffness were lower (-2.6 +/- 1.6% and -5.5 +/- 5.5%; both P< 0.001) and contact time (+ 3.2 +/- 2.4%; P< 0.01) higher in HOT for the mean of sets 1-3 compared to CON. Running distance per sprint decreased from set 1 to 3 (-7.0 +/- 6.4%; P< 0.001), with a tendency for shorter distance covered in HOT vs. CON (-2.7 +/- 3.4%; P = 0.06). Mean vertical (-2.6 +/- 5.5%; P< 0.01), horizontal (-9.1 +/- 4.4%; P< 0.001) and resultant ground reaction forces (-3.0 +/- 2.8%; P< 0.01) along with vertical stiffness (-12.9 +/- 2.3%; P< 0.001) and leg stiffness (-8.4 +/- 2.7%; P< 0.01) decreased from set 1 to 3, independently of conditions. Propulsive power decreased from set 1 to 3 (-16.9 +/- 2.4%; P< 0.001), with lower propulsive power values in set 2 (-6.6%; P< 0.05) in HOT vs. CON. No changes in constant-velocity running patterns occurred between conditions, or from pre-to-post repeated-sprint exercise. Conclusions Thermal strain alters step frequency and vertical stiffness during repeated sprinting; however without exacerbating mechanical alterations. The absence of changes in constantvelocity running patterns suggests a strong link between fatigue-induced velocity decrements during sprinting and mechanical alterations.	[Girard, Olivier; Racinais, Sebastien; Periard, Julien D.] Aspetar Orthopaed & Sports Med Hosp, Athlete Hlth & Performance Res Ctr, Doha, Qatar; [Girard, Olivier; Brocherie, Franck; Millet, Gregoire P.] Univ Lausanne, Inst Sports Sci, ISSUL, Lausanne, Switzerland; [Brocherie, Franck] French Inst Sport INSEP, Lab Sport Expertise & Performance EA 7370, Res Dept, Paris, France; [Morin, Jean-Benoit] Univ Cote Azur, LAMHESS, Nice, France	Aspetar Orthopaedic & Sports Medicine Hospital; University of Lausanne; UDICE-French Research Universities; Universite Cote d'Azur	Girard, O (corresponding author), Aspetar Orthopaed & Sports Med Hosp, Athlete Hlth & Performance Res Ctr, Doha, Qatar.; Girard, O (corresponding author), Univ Lausanne, Inst Sports Sci, ISSUL, Lausanne, Switzerland.	oliv.girard@gmail.com	Racinais, Sebastien/N-3052-2019; Millet, Gregoire P/F-4104-2012	Millet, Gregoire P/0000-0001-8081-4423; girard, olivier/0000-0002-4797-182X; Brocherie, Franck/0000-0002-0808-7986; Morin, Jean-Benoit/0000-0003-3808-6762; Periard, Julien/0000-0002-6266-4246	QNRF [NPRP 4 - 760 - 3 - 217, NPRP 4-760-3-217]; Aspire Zone Foundation Research Grant [AF/C/ASP1905/11]	QNRF(National Research Foundation of KoreaQatar National Research Fund (QNRF)); Aspire Zone Foundation Research Grant	This project was funded by QNRF (NPRP 4 - 760 - 3 - 217) and Aspire Zone Foundation Research Grant (AF/C/ASP1905/11). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is based on research funded by QNRF (NPRP 4-760-3-217).	Arampatzis A, 2000, J BIOMECH, V33, P457, DOI 10.1016/S0021-9290(99)00187-6; Bedford T, 1936, WARMTH FACTOR COMFOR, P102; BLICKHAN R, 1989, J BIOMECH, V22, P1217, DOI 10.1016/0021-9290(89)90224-8; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Brocherie F, 2016, MED SCI SPORT EXER, V48, P1570, DOI 10.1249/MSS.0000000000000937; Brughelli M, 2011, J STRENGTH COND RES, V25, P933, DOI 10.1519/JSC.0b013e3181c64308; Cheuvront SN, 2010, J APPL PHYSIOL, V109, P1989, DOI 10.1152/japplphysiol.00367.2010; Christian RJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00115; Cohen J.E., 1988, STAT POWER ANAL BEHA; Drust B, 2005, ACTA PHYSIOL SCAND, V183, P181, DOI 10.1111/j.1365-201X.2004.01390.x; Farley CT, 1996, J BIOMECH, V29, P181, DOI 10.1016/0021-9290(95)00029-1; Faude O, 2012, J SPORT SCI, V30, P625, DOI 10.1080/02640414.2012.665940; Girard O, 2015, SCAND J MED SCI SPOR, V25, P79, DOI 10.1111/sms.12437; Girard O, 2016, J SCI MED S IN PRESS; Girard O, 2014, BR J SPORTS MED S1, V48, pi52, DOI DOI 10.1136/BJSPORTS-2013-093286; Girard O, 2016, INT J SPORT PHYSIOL, V11, P432, DOI 10.1123/ijspp.2015-0145; Girard O, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00097; Girard O, 2013, EUR J APPL PHYSIOL, V113, P359, DOI 10.1007/s00421-012-2444-3; Girard O, 2011, EUR J APPL PHYSIOL, V111, P125, DOI 10.1007/s00421-010-1638-9; Hobara H, 2012, INT J SPORTS MED, V33, P310, DOI 10.1055/s-0031-1291232; Hunter JP, 2005, J APPL BIOMECH, V21, P31, DOI 10.1123/jab.21.1.31; Kawamori N, 2013, J STRENGTH COND RES, V27, P568, DOI 10.1519/JSC.0b013e318257805a; Kulmala JP, 2013, MED SCI SPORT EXER, V45, P2306, DOI 10.1249/MSS.0b013e31829efcf7; Maughan RJ, 2012, EUR J APPL PHYSIOL, V112, P2313, DOI 10.1007/s00421-011-2206-7; Morin JB, 2010, J BIOMECH, V43, P1970, DOI 10.1016/j.jbiomech.2010.03.012; Morin JB, 2005, J APPL BIOMECH, V21, P167, DOI 10.1123/jab.21.2.167; Morin JB, 2012, EUR J APPL PHYSIOL, V112, P1419, DOI 10.1007/s00421-011-2103-0; Morin JB, 2011, J BIOMECH, V44, P2719, DOI 10.1016/j.jbiomech.2011.07.020; Nicol C, 2006, SPORTS MED, V36, P977, DOI 10.2165/00007256-200636110-00004; Nummela A, 2007, INT J SPORTS MED, V28, P655, DOI 10.1055/s-2007-964896; Periard JD, 2014, MUSCLE NERVE, V50, P822, DOI 10.1002/mus.24228; Periard JD, 2011, EXP PHYSIOL, V96, P134, DOI 10.1113/expphysiol.2010.054213; Rabita G, 2015, SCAND J MED SCI SPOR, V25, P583, DOI 10.1111/sms.12389; Racinais S, 2008, J PHYSIOL-LONDON, V586, P4751, DOI 10.1113/jphysiol.2008.157420; RAMANATHAN NL, 1964, J APPL PHYSIOL, V19, P531, DOI 10.1152/jappl.1964.19.3.531; Schimpchen J, 2016, J SPORT SCI, V34, P519, DOI 10.1080/02640414.2015.1112023; Serpiello FR, 2011, EUR J APPL PHYSIOL, V111, P669, DOI 10.1007/s00421-010-1687-0; Slawinski J, 2008, J STRENGTH COND RES, V22, P930, DOI 10.1519/JSC.0b013e31816a4475; van der Worp H, 2016, BRIT J SPORT MED, V50, P450, DOI 10.1136/bjsports-2015-094924; Waldron M, 2014, SPORTS MED, V44, P1645, DOI 10.1007/s40279-014-0230-6; Weyand PG, 2010, J APPL PHYSIOL, V108, P950, DOI 10.1152/japplphysiol.00947.2009; Zadpoor AA, 2012, P I MECH ENG H, V226, P579, DOI 10.1177/0954411912447021	42	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2017	12	2							e0170679	10.1371/journal.pone.0170679	http://dx.doi.org/10.1371/journal.pone.0170679			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6RS	28146582	gold, Green Published			2022-12-27	WOS:000396131700023
J	Chen, XQ; Li, Y; Blankson, S; Liu, M; Huang, DP; Redmond, HP; Huang, J; Wang, JH; Wang, J				Chen, Xuqin; Li, Yan; Blankson, Siobhan; Liu, Min; Huang, Danping; Redmond, H. Paul; Huang, Jing; Wang, Jiang Huai; Wang, Jian			B7-H3 Augments Inflammatory Responses and Exacerbates Brain Damage via Amplifying NF-kappa B p65 and MAPK p38 Activation during Experimental Pneumococcal Meningitis	PLOS ONE			English	Article							BACTERIAL-MENINGITIS; STREPTOCOCCUS-PNEUMONIAE; RECEPTOR 2; PROGNOSTIC-FACTORS; CELL ACTIVATION; IMMUNE-RESPONSE; INNATE IMMUNITY; UNITED-STATES; CUTTING EDGE; T-CELLS	The costimulatory protein B7-H3 has been shown to play a contributory role in the development and progression of experimental pneumococcal meningitis by augmentation of the innate immunity-associated inflammatory response via a TLR2-dependent manner. This study aimed to clarify the component(s) of TLR2-mediated signal transduction pathways responsible for B7-H3-augmented inflammatory response and subsequent brain damage during experimental pneumococcal meningitis. Administration of B7-H3 did not augment expression of TLR2 and other TLR2 upstream components, but led to an enhanced formation of MyD88-IRAK immunocomplex in the brain of S. pneumoniae-infected mice. Furthermore, B7-H3 substantially augmented S. pneumoniae-induced activation of TLR2 downstream NF-kappa B p65 and MAPK p38 pathways in the brain of S. pneumoniae-infected mice. Notably, blockage of NF-kappa B p65 and/or MAPK p38 with their specific inhibitors strongly attenuated B7-H3-amplified inflammatory response with significantly reduced proinflammatory cytokine and chemokine production, and markedly ameliorated B7-H3-exacerbated disruption of blood-brain barrier and severity of disease status in S. pneumoniae-infected mice. These results indicate that targeting NF-kappa B p65 and/or MAPK p38 may represent a promising therapeutic option for amelioration of overwhelming inflammatory response-associated brain injury frequently observed during pneumococcal meningitis.	[Chen, Xuqin; Li, Yan; Liu, Min; Huang, Danping; Huang, Jing] Soochow Univ, Childrens Hosp, Dept Neurol, Suzhou, Peoples R China; [Chen, Xuqin; Wang, Jian] Soochow Univ, Pediat Res Inst, Suzhou, Peoples R China; [Blankson, Siobhan; Redmond, H. Paul; Wang, Jiang Huai] Cork Univ Hosp, Univ Coll Cork, Acad Dept Surg, Cork, Ireland	Soochow University - China; Soochow University - China; University College Cork	Wang, J (corresponding author), Soochow Univ, Pediat Res Inst, Suzhou, Peoples R China.; Wang, JH (corresponding author), Cork Univ Hosp, Univ Coll Cork, Acad Dept Surg, Cork, Ireland.	jh.wang@ucc.ie; wj196312@gmail.com			National Natural Science Foundation of China [81273242, 81272143]; Natural Science Foundation of Jiangsu Province [BK20161227]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by the National Natural Science Foundation of China (Grants 81273242 and 81272143) and the Natural Science Foundation of Jiangsu Province (Grant BK20161227).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Auburtin M, 2006, CRIT CARE MED, V34, P2758, DOI 10.1097/01.CCM.0000239434.26669.65; Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09; Chapoval AI, 2001, NAT IMMUNOL, V2, P269, DOI 10.1038/85339; Chen XQ, 2015, EXP THER MED, V9, P1984, DOI 10.3892/etm.2015.2333; Chen XQ, 2012, J IMMUNOL, V189, P347, DOI 10.4049/jimmunol.1103715; Chen XQ, 2009, J MOL NEUROSCI, V37, P86, DOI 10.1007/s12031-008-9133-z; de Gans J, 2002, NEW ENGL J MED, V347, P1549, DOI 10.1056/NEJMoa021334; Echchannaoui H, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-25; Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7; Ferlazzo G, 2002, EUR J IMMUNOL, V32, P3092, DOI 10.1002/1521-4141(200211)32:11<3092::AID-IMMU3092>3.0.CO;2-0; Kastenbauer S, 2003, BRAIN, V126, P1015, DOI 10.1093/brain/awg113; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Klein M, 2008, J INFECT DIS, V198, P1028, DOI 10.1086/591626; Klein M, 2006, PROG NEUROBIOL, V80, P269, DOI 10.1016/j.pneurobio.2006.11.008; Koedel U, 2004, BRAIN, V127, P1437, DOI 10.1093/brain/awh171; Koedel U, 2003, J IMMUNOL, V170, P438, DOI 10.4049/jimmunol.170.1.438; Leib SL, 2001, BRAIN, V124, P1734, DOI 10.1093/brain/124.9.1734; Li CH, 2006, J LEUKOCYTE BIOL, V79, P867, DOI 10.1189/jlb.0905505; Luo LQ, 2004, J IMMUNOL, V173, P5445, DOI 10.4049/jimmunol.173.9.5445; MacNeil JR, 2015, PEDIATRICS, V135, pE305, DOI 10.1542/peds.2014-2035; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Prasad DVR, 2004, J IMMUNOL, V173, P2500, DOI 10.4049/jimmunol.173.4.2500; Saez-Llorens X, 2003, LANCET, V361, P2139, DOI 10.1016/S0140-6736(03)13693-8; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Suh WK, 2003, NAT IMMUNOL, V4, P899, DOI 10.1038/ni967; Sun MY, 2002, J IMMUNOL, V168, P6294, DOI 10.4049/jimmunol.168.12.6294; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; Wang JH, 2002, J BIOL CHEM, V277, P36068, DOI 10.1074/jbc.M205584200; Yoshimura A, 1999, J IMMUNOL, V163, P1; Zhang GB, 2010, J IMMUNOL, V185, P3677, DOI 10.4049/jimmunol.0904020	34	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0171146	10.1371/journal.pone.0171146	http://dx.doi.org/10.1371/journal.pone.0171146			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141831	Green Published, Green Submitted, gold			2022-12-27	WOS:000396129500043
J	Hardy, DS; Stallings, DT; Garvin, JT; Xu, HY; Racette, SB				Hardy, Dale S.; Stallings, Devita T.; Garvin, Jane T.; Xu, Hongyan; Racette, Susan B.			Best anthropometric discriminators of incident type 2 diabetes among white and black adults: A longitudinal ARIC study	PLOS ONE			English	Article							VISCERAL ADIPOSE-TISSUE; WAIST CIRCUMFERENCE; ABDOMINAL OBESITY; RISK-FACTORS; BMI; PREDICTION; INDEXES; FAT	Objective To determine which anthropometric measures are the strongest discriminators of incident type 2 diabetes (T2DM) among White and Black males and females in a large U.S. cohort. Methods We used Atherosclerosis Risk in Communities study data from 12,121 participants aged 45-64 years without diabetes at baseline who were followed for over 11 years. Anthropometric measures included a body shape index (ABSI), body adiposity index (BAI), body mass index (BMI), waist circumference (WC), waist to hip ratio (WHR), waist to height ratio (WHtR), and waist to hip to height ratio (WHHR). All anthropometric measures were repeated at each visit and converted to Z-scores. Hazard ratios and 95% confidence intervals adjusted for age were calculated using repeated measures Cox proportional hazard regression analysis. Akaike Information Criteria was used to select best-fit models. The magnitude of the hazard ratio effect sizes and the Harrell's C-indexes were used to rank the highest associations and discriminators, respectively. Results There were 1,359 incident diabetes cases. Higher values of all anthropometric measures increased the risk for development of T2DM (p < 0.0001) except ABSI, which was not significant in White and Black males. Statistically significant hazard ratios ranged from 1.26-1.63 for males and 1.15-1.88 for females. In general, the largest hazard ratios were those that corresponded to the highest Harrell's C-Index and lowest Akaike Information Criteria values. Among White and Black males and females, BMI, WC, WHR, and WHtR were comparable in discriminating cases from non-cases of T2DM. ABSI, BAI, and WHHR were inferior discriminators of incident T2DM across all race-gender groups. Conclusions BMI, the most commonly used anthropometric measure, and three anthropometric measures that included waist circumference (i.e., WC, WHR, WHtR) were the best anthropometric discriminators of incident T2DM across all race- gender groups in the ARIC cohort.	[Hardy, Dale S.] Augusta Univ, Inst Publ & Prevent Hlth, Augusta, GA USA; [Stallings, Devita T.] St Louis Univ, Sch Nursing, St Louis, MO 63103 USA; [Garvin, Jane T.] Augusta Univ, Coll Nursing, Augusta, GA USA; [Xu, Hongyan] Augusta Univ, Dept Biostat & Epidemiol, Augusta, GA USA; [Racette, Susan B.] Washington Univ, Sch Med, Program Phys Therapy, St Louis, MO USA; [Racette, Susan B.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	University System of Georgia; Augusta University; Saint Louis University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Washington University (WUSTL); Washington University (WUSTL)	Hardy, DS (corresponding author), Augusta Univ, Inst Publ & Prevent Hlth, Augusta, GA USA.	dhardy@augusta.edu	Racette, Susan B/GLS-6669-2022; Racette, Susan/GXV-8800-2022	Racette, Susan B/0000-0002-6932-1887; Garvin, Jane/0000-0001-6023-3269; Hardy, Dale/0000-0001-8778-5661	NIH/NHLBI [1K01HL127278-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL127278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092950] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study is supported by a career development grant sponsored by the NIH/NHLBI (Grant ID: 1K01HL127278-01A1).	Adegbija O, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009185; Adegbija O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123788; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; ARIC Investigators, 2016, ATH RISK COMM STUD P; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Bi X, 2015, EUR J CLIN NUTR, V69, P329, DOI 10.1038/ejcn.2014.227; BioLINCC: National Heart Lung and Blood Institute, 2015, WEB ACC NHLBI BIOSP; Camhi SM, 2011, OBESITY, V19, P402, DOI 10.1038/oby.2010.248; CDC, 2020, AD OB PREV MAPS; Freemantle N, 2008, INT J CLIN PRACT, V62, P1391, DOI 10.1111/j.1742-1241.2008.01805.x; Hardy DS, 2016, J DIABETES; Hardy OT, 2012, CURR OPIN ENDOCRINOL, V19, P81, DOI 10.1097/MED.0b013e3283514e13; Hartwig S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009266; He S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050573; Hofso Dag, 2009, Diabetes Res Clin Pract, V86, pe9, DOI 10.1016/j.diabres.2009.06.016; Huxley R, 2008, OBES REV, V9, P53, DOI 10.1111/j.1467-789X.2007.00439.x; Jackson R, 1996, J CLIN EPIDEMIOL, V49, P1441, DOI 10.1016/0895-4356(95)00047-X; Katzmarzyk PT, 2013, OBESITY, V21, P2221, DOI 10.1002/oby.20519; KAYE SA, 1991, J CLIN EPIDEMIOL, V44, P329, DOI 10.1016/0895-4356(91)90044-A; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; MacKay MF, 2009, DIABETES CARE, V32, P956, DOI 10.2337/dc08-1663; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Motamed N, 2016, METAB SYNDR RELAT D, V14, P249, DOI 10.1089/met.2015.0133; Newson RB, 2010, STATA J, V10, P339, DOI 10.1177/1536867X1001000303; Onat A, 2004, INT J OBESITY, V28, P1018, DOI 10.1038/sj.ijo.0802695; Perry AC, 2000, J APPL PHYSIOL, V89, P636, DOI 10.1152/jappl.2000.89.2.636; Salkind N., 2007, ENCY MEASUREMENT STA; Schulze MB, 2006, DIABETES CARE, V29, P1921, DOI 10.2337/dc06-0895; SEIDELL JC, 1987, AM J CLIN NUTR, V45, P7, DOI 10.1093/ajcn/45.1.7; Shuster A, 2012, BRIT J RADIOL, V85, P1, DOI 10.1259/bjr/38447238; Stevens J, 2001, OBES RES, V9, P696, DOI 10.1038/oby.2001.94; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	33	19	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2017	12	1							e0168282	10.1371/journal.pone.0168282	http://dx.doi.org/10.1371/journal.pone.0168282			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QW	28141847	Green Published, gold, Green Submitted			2022-12-27	WOS:000396129500002
J	El Missiry, M; Hjorth-Hansen, H; Richter, J; Olson-Stromberg, U; Stenke, L; Porkka, K; Kreutzman, A; Mustjoki, S				El Missiry, Mohamed; Hjorth-Hansen, Henrik; Richter, Johan; Olson-Stromberg, Ulla; Stenke, Leif; Porkka, Kimmo; Kreutzman, Anna; Mustjoki, Satu			Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid Leukemia	PLOS ONE			English	Article							CHRONIC-PHASE; STEM-CELLS; IMATINIB; DASATINIB; NILOTINIB; CML; RECOMMENDATIONS; HYDROXYUREA; MANAGEMENT; QUIESCENT	In chronic myeloid leukemia (CML), early treatment prediction is important to identify patients with inferior overall outcomes. We examined the feasibility of using reductions in BCR-ABL1 transcript levels after 1 month of tyrosine kinase inhibitor (TKI) treatment to predict therapy response. Fifty-two first-line TKI-treated CML patients were included (imatinib n = 26, dasatinib n = 21, nilotinib n = 5), and BCR-ABL1 transcript levels were measured at diagnosis (dg) and 1, 3, 6, 12, 18, 24, and 36 months. The fold change of the BCR-ABL1 transcripts at 1 month compared to initial BCR-ABL1 transcript levels was used to indicate early therapy response. In our cohort, 21% of patients had no decrease in BCR-ABL1 transcript levels after 1 month and were classified as poor responders. Surprisingly, these patients had lower BCR-ABL1 transcript levels at dg compared to responders (31% vs. 48%, p = 0.0083). Poor responders also significantly more often had enlarged spleen (55% vs. 15%; p< 0.01) and a higher percentage of Ph+ CD34+CD38- cells in the bone marrow (91% vs. 75%, p< 0.05). The major molecular response rates were inferior in the poor responders (at 12m 18% vs. 64%, p< 0.01; 18m 27% vs. 75%, p< 0.01; 24m 55% vs. 87%, p< 0.01). In conclusion, early treatment response analysis defines a biologically distinct patient subgroup with inferior long-term outcomes.	[El Missiry, Mohamed; Porkka, Kimmo; Kreutzman, Anna; Mustjoki, Satu] Univ Helsinki, Hematol Res Unit Helsinki, Dept Hematol, Helsinki, Finland; [El Missiry, Mohamed; Porkka, Kimmo; Kreutzman, Anna; Mustjoki, Satu] Univ Helsinki, Cent Hosp, Ctr Comprehens Canc, Helsinki, Finland; [Hjorth-Hansen, Henrik] St Olavs Hosp, Dept Hematol, Trondheim, Norway; [Hjorth-Hansen, Henrik] Norwegian Univ Sci & Technol NTNU, St Olavs Hosp, Dept Canc Res & Mol Med, Trondheim, Norway; [Richter, Johan] Skane Univ Hosp, Dept Hematol & Vasc Disorders, Lund, Sweden; [Olson-Stromberg, Ulla] Univ Uppsala Hosp, Dept Hematol, Uppsala, Sweden; [Stenke, Leif] Karolinska Univ Hosp, Dept Hematol, Stockholm, Sweden; [Stenke, Leif] Karolinska Inst, Stockholm, Sweden; [Mustjoki, Satu] Univ Helsinki, Dept Clin Chem, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Lund University; Skane University Hospital; Uppsala University; Uppsala University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Helsinki	Mustjoki, S (corresponding author), Univ Helsinki, Hematol Res Unit Helsinki, Dept Hematol, Helsinki, Finland.; Mustjoki, S (corresponding author), Univ Helsinki, Cent Hosp, Ctr Comprehens Canc, Helsinki, Finland.; Mustjoki, S (corresponding author), Univ Helsinki, Dept Clin Chem, Helsinki, Finland.	satu.mustjoki@helsinki.fi	Mustjoki, Satu/AAD-9974-2020; Kreutzman, Anna/V-5769-2019; Porkka, Kimmo/O-2323-2016	Mustjoki, Satu/0000-0002-0816-8241; Kreutzman, Anna/0000-0002-5587-8844; Porkka, Kimmo/0000-0003-4112-5902	Academy of Finland; Finnish Cancer Societies; Sigrid Juselius Foundation; Finnish Cancer Institute; Signe and Ane Gyllenberg Foundation; Otto A. Malm Foundation; Cancer Foundation Finland sr [160102, 100118, 110101] Funding Source: researchfish	Academy of Finland(Academy of Finland); Finnish Cancer Societies; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Institute; Signe and Ane Gyllenberg Foundation; Otto A. Malm Foundation; Cancer Foundation Finland sr	This work was supported by the Academy of Finland (SM, http://www.aka.fi/en/); the Finnish Cancer Societies (SM, https://www.cancersociety.fi/); Sigrid Juselius Foundation (AK, SM, http://www.sigridjuselius.fi/foundation); Finnish Cancer Institute (SM); Signe and Ane Gyllenberg Foundation (SM, http://gyllenbergs.fi/en/); Otto A. Malm Foundation (MEM, http://en.ottomalm.fi.kotisivukone.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Personnel at the Hematology Research Unit Helsinki are acknowledged for their expert clinical and technical assistance. This work was supported by the Academy of Finland, the Finnish Cancer Societies, the Sigrid Juselius Foundation, the Finnish Cancer Institute, the Signe and Ane Gyllenberg Foundation, and the Otto A. Malm Foundation.	Agarwal MB, 2014, INDIAN J MED PAEDIAT, V35, P10, DOI 10.4103/0971-5851.133704; Baccarani M, 2006, BLOOD, V108, P1809, DOI 10.1182/blood-2006-02-005686; Baccarani M, 2013, BLOOD, V122, P872, DOI 10.1182/blood-2013-05-501569; Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; Bonecker Simone, 2015, Rev. Bras. Hematol. Hemoter., V37, P142, DOI 10.1016/j.bjhh.2014.08.003; Branford S, 2014, BLOOD, V124, P511, DOI 10.1182/blood-2014-03-566323; Copland M, 2006, BLOOD, V107, P4532, DOI 10.1182/blood-2005-07-2947; Cortes JE, 2010, J CLIN ONCOL, V28, P392, DOI 10.1200/JCO.2009.25.4896; Crews LA, 2012, CURR HEMATOL MALIG R, V7, P125, DOI 10.1007/s11899-012-0121-6; Fabbro D, 2012, NAT CHEM BIOL, V8, P228, DOI 10.1038/nchembio.900; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Hamilton A, 2012, BLOOD, V119, P1501, DOI 10.1182/blood-2010-12-326843; Hanfstein B, 2014, LEUKEMIA, V28, P1988, DOI 10.1038/leu.2014.153; Hanfstein B, 2012, LEUKEMIA, V26, P2096, DOI 10.1038/leu.2012.85; Hasford J, 1996, BONE MARROW TRANSPL, V17, pS49; Hasford J, 2011, BLOOD, V118, P686, DOI 10.1182/blood-2010-12-319038; Hjorth-Hansen H, 2014, EUR J HAEMATOL; Hoffbrand AV, 2011, POSTGRADUATE HEMATOL; Huet S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106250; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; KOLITZ JE, 1992, SEMIN ONCOL, V19, P27; Marin D, 2012, J CLIN ONCOL, V30, P232, DOI 10.1200/JCO.2011.38.6565; Mustjoki S, 2013, LEUKEMIA, V27, P1520, DOI 10.1038/leu.2013.19; Mustjoki S, 2010, LEUKEMIA, V24, P219, DOI 10.1038/leu.2009.190; Neelakantan P, 2013, BLOOD, V121, P2739, DOI 10.1182/blood-2012-11-466037; Pavey T, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16420; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Shami PJ, 2012, LEUKEMIA, V26, P214, DOI 10.1038/leu.2011.217; Signorovitch J, 2014, CANCER TREAT REV, V40, P285, DOI 10.1016/j.ctrv.2013.09.004; Silver RT, 1999, BLOOD, V94, P1517; SOKAL JE, 1984, BLOOD, V63, P789, DOI 10.1182/blood.V63.4.789.789	31	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0171041	10.1371/journal.pone.0171041	http://dx.doi.org/10.1371/journal.pone.0171041			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135325	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000396124700041
J	Nandan, D; Thomas, SA; Nguyen, A; Moon, KM; Foster, LJ; Reiner, NE				Nandan, Devki; Thomas, Sneha A.; Nguyen, Anne; Moon, Kyung-Mee; Foster, Leonard J.; Reiner, Neil E.			Comprehensive Identification of mRNABinding Proteins of Leishmania donovani by Interactome Capture	PLOS ONE			English	Article							ZINC-FINGER PROTEINS; RNA-BINDING PROTEINS; GENE-EXPRESSION; COMPARATIVE GENOMICS; TRYPANOSOMA-BRUCEI; MESSENGER-RNAS; NUCLEIC-ACIDS; CROSS-LINKING; PROTEOME; HSP70	Leishmania are unicellular eukaryotes responsible for leishmaniasis in humans. Like other trypanosomatids, leishmania regulate protein coding gene expression almost exclusively at the post-transcriptional level with the help of RNA binding proteins (RBPs). Due to the pres-ence of polycystronic transcription units, leishmania do not regulate RNA polymerase II-dependent transcription initiation. Recent evidence suggests that the main control points in gene expression are mRNA degradation and translation. Protein-RNA interactions are involved in every aspect of RNA biology, such as mRNA splicing, polyadenylation, localiza-tion, degradation, and translation. A detailed picture of these interactions would likely prove to be highly informative in understanding leishmania biology and virulence. We developed a strategy involving covalent UV cross-linking of RBPs to mRNA in vivo, followed by interac-tome capture using oligo(dT) magnetic beads to define comprehensively the mRNA interactome of growing L. donovani amastigotes. The protein mass spectrometry analysis of captured proteins identified 79 mRNA interacting proteins which withstood very stringent washing conditions. Strikingly, we found that 49 of these mRNA interacting proteins had no orthologs or homologs in the human genome. Consequently, these may represent high quality candidates for selective drug targeting leading to novel therapeutics. These results show that this unbiased, systematic strategy has the promise to be applicable to study the mRNA interactome during various biological settings such as metabolic changes, stress (low pH environment, oxidative stress and nutrient deprivation) or drug treatment.	[Nandan, Devki; Thomas, Sneha A.; Nguyen, Anne; Reiner, Neil E.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Moon, Kyung-Mee; Foster, Leonard J.] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC, Canada; [Moon, Kyung-Mee; Foster, Leonard J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada; [Reiner, Neil E.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Reiner, NE (corresponding author), Univ British Columbia, Dept Med, Vancouver, BC, Canada.	nreiner@mail.ubc.ca			MOP [125879]; NER [77688]; Canadian Institutes for Health Research	MOP; NER; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by Grants MOP 125879 to NER and 77688 to LJF from the Canadian Institutes for Health Research. The funding agencies had no role in design, collection, analysis, or interpretation of data; neither were they involved in writing the manuscript; or in the decision to submit the manuscript for publication.	Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Beck S, 2015, MOL CELL PROTEOMICS, V14, P2014, DOI 10.1074/mcp.M114.047407; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BRIMACOMBE R, 1988, METHOD ENZYMOL, V164, P287; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chritton JJ, 2010, RNA, V16, P1217, DOI 10.1261/rna.2070110; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Collingridge PW, 2010, PARASITOLOGY, V137, P1467, DOI 10.1017/S0031182010000259; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Daniels JP, 2010, MICROBIOL MOL BIOL R, V74, P552, DOI 10.1128/MMBR.00024-10; De Gaudenzi J, 2005, EUKARYOT CELL, V4, P2106, DOI 10.1128/EC.4.12.2106-2114.2005; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Erben ED, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004178; Fernandez-Moya SM, 2010, WIRES RNA, V1, P34, DOI 10.1002/wrna.6; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Henics T, 1999, J BIOL CHEM, V274, P17318, DOI 10.1074/jbc.274.24.17318; Hieronymus H, 2003, NAT GENET, V33, P155, DOI 10.1038/ng1080; HOCKENSMITH JW, 1986, J BIOL CHEM, V261, P3512; Ishihama Y, 2002, J CHROMATOGR A, V979, P233, DOI 10.1016/S0021-9673(02)01402-4; Justice MC, 1998, J BIOL CHEM, V273, P3148, DOI 10.1074/jbc.273.6.3148; Keene JD, 2007, COLD SH Q B, V72, P157; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kim S, 2010, NAT REV MOL CELL BIO, V11, P75, DOI 10.1038/nrm2818; Kishor A, 2013, MOL CELL BIOL, V33, P71, DOI 10.1128/MCB.01275-12; Kramer S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-283; Kwon SC, 2013, NAT STRUCT MOL BIOL, V20, P1122, DOI 10.1038/nsmb.2638; Lee I, 2004, TRENDS BIOCHEM SCI, V29, P567, DOI 10.1016/j.tibs.2004.09.005; Liang XH, 2003, EUKARYOT CELL, V2, P830, DOI 10.1128/EC.2.5.830-840.2003; Lueong S, 2016, MOL MICROBIOL, V100, P457, DOI 10.1111/mmi.13328; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; Mittal N, 2013, MOL BIOCHEM PARASIT, V187, P21, DOI 10.1016/j.molbiopara.2012.11.001; Najafabadi HS, 2013, NUCLEIC ACIDS RES, V41, P8591, DOI 10.1093/nar/gkt647; Nandan D, 2002, J BIOL CHEM, V277, P50190, DOI 10.1074/jbc.M209210200; Nandan D, 2007, BIOCHEM BIOPH RES CO, V364, P601, DOI 10.1016/j.bbrc.2007.10.065; Niessing D, 2004, CELL, V119, P491, DOI 10.1016/j.cell.2004.10.018; Noble CG, 2008, CELL MOL LIFE SCI, V65, P1335, DOI 10.1007/s00018-008-7495-6; Ouellette Marc, 2009, Journal of Biology (London), V8, P8, DOI 10.1186/jbiol203; Parker R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r81; PASHEV IG, 1991, TRENDS BIOCHEM SCI, V16, P323, DOI 10.1016/0968-0004(91)90133-G; Preusser C, 2012, INT J MED MICROBIOL, V302, P221, DOI 10.1016/j.ijmm.2012.07.004; Ramirez CA, 2013, J PROTEOMICS, V94, P124, DOI 10.1016/j.jprot.2013.09.008; Rammelt C, 2011, RNA, V17, P1737, DOI 10.1261/rna.2787011; Reichel M, 2016, PLANT CELL, V28, P2435, DOI 10.1105/tpc.16.00562; Scherrer T, 2014, INVESTIGATIONS IN YEAST FUNCTIONAL GENOMICS AND MOLECULAR BIOLOGY, P233, DOI 10.1371/journal.pone.0015499; Silverman JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r35; Silverman JM, 2010, J IMMUNOL, V185, P5011, DOI 10.4049/jimmunol.1000541; Silverman JM, 2010, J CELL SCI, V123, P842, DOI 10.1242/jcs.056465; Singh R, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0072-z; Suchanek M, 2005, NAT METHODS, V2, P261, DOI 10.1038/NMETH752; Tsvetanova NG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012671; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang Y, 2013, BBA-MOL CELL RES, V1833, P2673, DOI 10.1016/j.bbamcr.2013.06.017; Yang QS, 2005, BIOCHEMISTRY-US, V44, P13591, DOI 10.1021/bi0508946; Zalfa F, 2005, J BIOL CHEM, V280, P33403, DOI 10.1074/jbc.M504286200	61	41	41	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2017	12	1							e0170068	10.1371/journal.pone.0170068	http://dx.doi.org/10.1371/journal.pone.0170068			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PA	28135300	gold, Green Submitted, Green Published			2022-12-27	WOS:000396124700008
J	Cho, C; Choi, JY; Jeong, J; Chung, TM				Cho, Chulhee; Choi, Jae-Young; Jeong, Jongpil; Chung, Tai-Myoung			Performance Analysis of Inter-Domain Handoff Scheme Based on Virtual Layer in PMIPv6 Networks for IP-Based Internet of Things	PLOS ONE			English	Article								Lately, we see that Internet of things (IoT) is introduced in medical services for global connection among patients, sensors, and all nearby things. The principal purpose of this global connection is to provide context awareness for the purpose of bringing convenience to a patient's life and more effectively implementing clinical processes. In health care, monitoring of biosignals of a patient has to be continuously performed while the patient moves inside and outside the hospital. Also, to monitor the accurate location and biosignals of the patient, appropriate mobility management is necessary to maintain connection between the patient and the hospital network. In this paper, a binding update scheme on PMIPv6, which reduces signal traffic during location updates by Virtual LMA (VLMA) on the top original Local Mobility Anchor (LMA) Domain, is proposed to reduce the total cost. If a Mobile Node (MN) moves to a Mobile Access Gateway (MAG)-located boundary of an adjacent LMA domain, the MN changes itself into a virtual mode, and this movement will be assumed to be a part of the VLMA domain. In the proposed scheme, MAGs eliminate global binding updates for MNs between LMA domains and significantly reduce the packet loss and latency by eliminating the handoff between LMAs. In conclusion, the performance analysis results show that the proposed scheme improves performance significantly versus PMIPv6 and HMIPv6 in terms of the binding update rate per user and average handoff latency.	[Cho, Chulhee; Choi, Jae-Young; Chung, Tai-Myoung] Sungkyunkwan Univ, Coll Informat & Commun Engn, Suwon 440745, Kyunggi Do, South Korea; [Jeong, Jongpil] Sungkyunkwan Univ, Dept Human ICT Convergence, Suwon 440745, Kyunggi Do, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU)	Chung, TM (corresponding author), Sungkyunkwan Univ, Coll Informat & Commun Engn, Suwon 440745, Kyunggi Do, South Korea.	tmchung@ece.skku.ac.kr	Jeong, Jongpil/ABC-5414-2021; Cho, Chulhee/A-2907-2019	Jeong, Jongpil/0000-0002-4061-9532; Cho, Chulhee/0000-0002-2915-2572	Technology Innovation Program - Ministry of Trade, industry & Energy (MI, Korea) [10054486]; "The Components & Materials Technology Development Program" - Ministry of Trade, Industry & Energy (MI, Korea) [10043800]; Energy Technology Development Program - Ministry of Trade, Industry & Energy (MOTIE, Korea) [2013T100200078]; Global Creative Software (GCS) Project - Ministry of Science, ICT & Future Planning (MSIP) [2014-044-028-001]	Technology Innovation Program - Ministry of Trade, industry & Energy (MI, Korea); "The Components & Materials Technology Development Program" - Ministry of Trade, Industry & Energy (MI, Korea); Energy Technology Development Program - Ministry of Trade, Industry & Energy (MOTIE, Korea); Global Creative Software (GCS) Project - Ministry of Science, ICT & Future Planning (MSIP)	This work was supported by the Technology Innovation Program (10054486, Development of Open Industry IoT (IIoT) Smart Factory Platform and Factory-Thing Hardware Technology) funded By the Ministry of Trade, industry & Energy (MI, Korea). This work was supported by "The Components & Materials Technology Development Program (10043800, Development of Micro Smart Environmental Sensor Measurement Module, Control Chip, and Application Program)" funded by the Ministry of Trade, Industry & Energy (MI, Korea). This work was supported by the Energy Technology Development Program (2013T100200078, development of integrated demand response system technology for co-residential resources and demonstration of business model) funded by the Ministry of Trade, Industry & Energy (MOTIE, Korea). This work was supported by Global Creative Software (GCS) Project (No. 2014-044-028-001, Development of ICT Convergence Technology for Design Optimization and Construction Technology Innovation of the Structural Frame and Envelope) funded by the Ministry of Science, ICT & Future Planning (MSIP).; This work was supported by the Technology Innovation Program (10054486, Development of Open Industry IoT (IIoT) Smart Factory Platform and Factory-Thing Hardware Technology) funded By the Ministry of Trade, industry & Energy (MI, Korea).; This work was supported by "The Components & Materials Technology Development Program (10043800, Development of Micro Smart Environmental Sensor Measurement Module, Control Chip, and Application Program)" funded by the Ministry of Trade, Industry & Energy (MI, Korea).; This work was supported by the Energy Technology Development Program (2013T100200078, development of integrated demand response system technology for co-residential resources and demonstration of business model) funded by the Ministry of Trade, Industry & Energy (MOTIE, Korea).; This work was supported by Global Creative Software (GCS) Project (No. 2014-044-028-001, Development of ICT Convergence Technology for Design Optimization and Construction Technology Innovation of the Structural Frame and Envelope) funded by the Ministry of Science, ICT & Future Planning (MSIP).	DOrazio C.J., DATA EXFILTRATION IN; Fathi H, 2007, IEEE T VEH TECHNOL, V56, P260, DOI 10.1109/TVT.2006.883806; Fu ZJ, 2015, IEICE T COMMUN, VE98B, P190, DOI 10.1587/transcom.E98.B.190; Ge M, 2014, INT C NETW SYST SEC; Gundavelli S., 2008, PROXY MOBILE 113V6, DOI DOI 10.17487/RFC5213; Jang H-n, 2012, INT J ADV SMART CONV, V1, P1, DOI [10.7236/JASC2012.1.2.1, DOI 10.7236/JASC2012.1.2.1]; Jara A.J., 2010, INITIAL APPROACH SUP; Jara AJ, 2014, MOB INF SYST, V10, P37, DOI 10.1155/2014/563274; Jeong J, 2011, HIGH PERF COMP SIM H; Jeong J, 2008, BROADB COMM INF TECH; Johnson D., 2004, MOBILITY SUPPORT IPV; Khan RA, 2014, COMM SIGN PROC ICCSP; Koodli R., 2005, FAST HANDOVERS MOBIL; Lee JH, 2010, IEEE T CONSUM ELECTR, V56, P1010, DOI 10.1109/TCE.2010.5506033; Lee JH, 2010, ANN TELECOMMUN, V65, P233, DOI 10.1007/s12243-009-0127-9; Montenegro G., 2007, IPV6 LOW POER WIRELE; Nam J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116709; Pack S, 2009, IEEE T VEH TECHNOL, V58, P3627, DOI 10.1109/TVT.2009.2015328; Petrescu A., 2005, NETWORK; Shahamabadi MS, 2013, INN MOB INT SERV UB; Soliman H, 2005, HIERARCHICAL MOBILE; Song M, 2014, INT J ADV CULTURE TE, V2, P1, DOI 10.17703/IJACT.2014.2.1.001	22	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170566	10.1371/journal.pone.0170566	http://dx.doi.org/10.1371/journal.pone.0170566			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129355	Green Published, gold, Green Submitted			2022-12-27	WOS:000396211400054
J	De Serres, G; Skowronski, DM; Ward, BJ; Gardam, M; Lemieux, C; Yassi, A; Patrick, DM; Krajden, M; Loeb, M; Collignon, P; Carrat, F				De Serres, Gaston; Skowronski, Danuta M.; Ward, Brian J.; Gardam, Michael; Lemieux, Camille; Yassi, Annalee; Patrick, David M.; Krajden, Mel; Loeb, Mark; Collignon, Peter; Carrat, Fabrice			Influenza Vaccination of Healthcare Workers: Critical Analysis of the Evidence for Patient Benefit Underpinning Policies of Enforcement	PLOS ONE			English	Article							LONG-TERM-CARE; ELDERLY-PEOPLE; SURVEILLANCE NETWORK; UNITED-STATES; HOME STAFF; MORTALITY; VIRUS; ILLNESS; PREVENTION; MORBIDITY	Background Four cluster randomized controlled trials (cRCTs) conducted in long-term care facilities (LTCFs) have reported reductions in patient risk through increased healthcare worker (HCW) influenza vaccination. This evidence has led to expansive policies of enforcement that include all staff of acute care hospitals and other healthcare settings beyond LTCFs. We critique and quantify the cRCT evidence for indirect patient benefit underpinning policies of mandatory HCW influenza vaccination. Methods Plausibility of the four cRCT findings attributing indirect patient benefits to HCW influenza vaccination was assessed by comparing percentage reductions in patient risk reported by the cRCTs to predicted values. Plausibly predicted values were derived according to the basic mathematical principle of dilution, taking into account HCW influenza vaccine coverage and the specificity of patient outcomes for influenza. Accordingly, predicted values were calculated as a function of relevant compound probabilities including vaccine efficacy (ranging 40-60% in HCWs and favourably assuming the same indirect protection conferred through them to patients) x change in proportionate HCW influenza vaccine coverage (as reported by each cRCT) x percentage of a given patient outcome (e.g. influenza-like illness (ILI) or all-cause mortality) plausibly due to influenza virus. The number needed to vaccinate (NNV) for HCWs to indirectly prevent patient death was recalibrated based on real patient data of hospital-acquired influenza, with adjustment for potential under-detection (5.2-fold), and using favourable assumptions of HCW-attributable risk (ranging 60-80%). Results In attributing patient benefit to increased HCW influenza vaccine coverage, each cRCT was found to violate the basic mathematical principle of dilution by reporting greater percentage reductions with less influenza-specific patient outcomes (i.e., all-cause mortality > ILI > laboratory-confirmed influenza) and/or patient mortality reductions exceeding even favourably-derived predicted values by at least 6- to 15-fold. If extrapolated to all LTCF and hospital staff in the United States, the prior cRCT-claimed NNV of 8 would implausibly mean >200,000 and >675,000 patient deaths, respectively, could be prevented annually by HCW influenza vaccination, inconceivably exceeding total US population mortality estimates due to seasonal influenza each year, or during the 1918 pandemic, respectively. More realistic recalibration based on actual patient data instead shows that at least 6000 to 32,000 hospital workers would need to be vaccinated before a single patient death could potentially be averted. Conclusions The four cRCTs underpinning policies of enforced HCW influenza vaccination attribute implausibly large reductions in patient risk to HCW vaccination, casting serious doubts on their validity. The impression that unvaccinated HCWs place their patients at great influenza peril is exaggerated. Instead, the HCW-attributable risk and vaccine-preventable fraction both remain unknown and the NNV to achieve patient benefit still requires better understanding. Although current scientific data are inadequate to support the ethical implementation of enforced HCW influenza vaccination, they do not refute approaches to support voluntary vaccination or other more broadly protective practices, such as staying home or masking when acutely ill.	[De Serres, Gaston] Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada; [De Serres, Gaston] Univ Laval, Quebec City, PQ, Canada; [Skowronski, Danuta M.; Patrick, David M.; Krajden, Mel] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Skowronski, Danuta M.; Yassi, Annalee; Patrick, David M.; Krajden, Mel] Univ British Columbia, Vancouver, BC, Canada; [Ward, Brian J.] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ, Canada; [Gardam, Michael; Lemieux, Camille] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada; [Loeb, Mark] McMaster Univ, Fac Hlth Sci, Hamilton, ON, Canada; [Collignon, Peter] Australian Natl Univ, Acton, Australia; [Collignon, Peter] Canberra Hosp, Garran, ACT, Australia; [Carrat, Fabrice] Inst Pierre Louis Epidemiol & Sante Publ, Inst Natl Sante & Rech Med, Paris, France; [Carrat, Fabrice] Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ, Paris, France; [Carrat, Fabrice] Hop St Antoine, AP HP, Unite Sante Publ, Paris, France	Institut national de sante publique du Quebec (INSPQ); Laval University; University of British Columbia; McGill University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; McMaster University; Australian National University; Australian National University; Canberra Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	De Serres, G (corresponding author), Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada.; De Serres, G (corresponding author), Univ Laval, Quebec City, PQ, Canada.	gaston.deserres@inspq.qc.ca	Collignon, Peter/U-4846-2019; Carrat, Fabrice/AAU-8480-2020	Carrat, Fabrice/0000-0002-8672-7918; Collignon, Peter/0000-0001-8648-9203	Quebec Public Health Institute (Institut national de sante publique du Quebec), Quebec, Canada; Ontario Nurses' Association	Quebec Public Health Institute (Institut national de sante publique du Quebec), Quebec, Canada; Ontario Nurses' Association	Funding support in the form of wages for Dr. Gaston De Serres was provided foremost by the Quebec Public Health Institute (Institut national de sante publique du Quebec), Quebec, Canada and in part by the Ontario Nurses' Association. Coauthors were supported by their respective institutions and no other external funding was provided. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed F, 2014, CLIN INFECT DIS, V58, P50, DOI 10.1093/cid/cit580; American Health Care association, 2011, STAT LONG TERM HLTH; Andrews N., 2014, EUROSURVEILLANCE, V19, P20851; [Anonymous], 2014, INFLUENZA COVERAGE B; Babcock HM, 2010, CLIN INFECT DIS, V50, P459, DOI 10.1086/650752; Belongia EA, 2016, LANCET INFECT DIS, V16, P942, DOI 10.1016/S1473-3099(16)00129-8; Benet T, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-30; Bodewes R, 2012, VACCINE, V30, P7407, DOI 10.1016/j.vaccine.2012.04.086; Bodewes R, 2009, LANCET INFECT DIS, V9, P784, DOI 10.1016/S1473-3099(09)70263-4; Carman WF, 2000, LANCET, V355, P93, DOI 10.1016/S0140-6736(99)05190-9; Carrat F, 2006, EPIDEMIOL INFECT, V134, P63, DOI 10.1017/S0950268805005479; Centers for Disease Control and Prevention (CDC), 2011, MMWR MORB MORTAL WKL, V60, P8; Cheng VCC, 2010, J HOSP INFECT, V74, P271, DOI 10.1016/j.jhin.2009.09.009; Coleman BL, 2011, INFLUENZA OTHER RESP, V5, P404, DOI 10.1111/j.1750-2659.2011.00245.x; Cowling BJ, 2016, VACCINE, V34, P61, DOI 10.1016/j.vaccine.2015.11.016; De Villiers PJT, 2009, VACCINE, V28, P228, DOI 10.1016/j.vaccine.2009.09.092; Elder AG, 1996, BRIT MED J, V313, P1241, DOI 10.1136/bmj.313.7067.1241; Elliot AJ, 2006, EURO SURVEILL, V11, ppii=651; Enserink R, 2011, J AM GERIATR SOC, V59, P2301, DOI 10.1111/j.1532-5415.2011.03715.x; Flannery B, 2015, MMWR-MORBID MORTAL W, V64, P10; Harris Katherine M., 2011, Morbidity and Mortality Weekly Report, V60, P1073; Hayward AC, 2006, BRIT MED J, V333, P1241, DOI 10.1136/bmj.39010.581354.55; Health Protection Agency, 2006, HPA NAT INFL SEAS SU; Health Protection Agency, 2005, HPA NAT INFL SEAS SU; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jain VK, 2013, NEW ENGL J MED, V369, P2481, DOI 10.1056/NEJMoa1215817; Jhung MA, 2014, AM J INFECT CONTROL, V42, P7, DOI 10.1016/j.ajic.2013.06.018; Ksienski DS, 2014, CAN J PUBLIC HEALTH, V105, pE312, DOI 10.17269/cjph.105.4346; Kuster SP, 2013, EMERG INFECT DIS, V19, P606, DOI 10.3201/eid1904.111812; Lemaitre M, 2009, J AM GERIATR SOC, V57, P1580, DOI 10.1111/j.1532-5415.2009.02402.x; Madhi SA, 2014, NEW ENGL J MED, V371, P918, DOI 10.1056/NEJMoa1401480; Madhi SA, 2011, CLIN INFECT DIS, V52, P128, DOI 10.1093/cid/ciq004; McLean HQ, 2015, J INFECT DIS, V211, P1529, DOI 10.1093/infdis/jiu647; McLean HQ, 2014, CLIN INFECT DIS, V59, P1375, DOI 10.1093/cid/ciu680; Mereckiene J, 2014, EUROSURVEILLANCE, V19, P29, DOI 10.2807/1560-7917.ES2014.19.16.20780; Ohmit SE, 2015, J INFECT DIS, V211, P1519, DOI 10.1093/infdis/jiu650; Ohmit SE, 2014, CLIN INFECT DIS, V58, P319, DOI 10.1093/cid/cit736; Ohmit SE, 2013, CLIN INFECT DIS, V56, P1363, DOI 10.1093/cid/cit060; Oshitani H, 2000, INFECT CONT HOSP EP, V21, P728, DOI 10.1086/501725; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Paget W J, 2005, Euro Surveill, V10, P107, DOI 10.2807/esm.10.04.00529-en; Pebody R, 2013, EUROSURVEILLANCE, V18, DOI DOI 10.2807/ESE.18.05.20389-EN; Pebody RG, 2015, EUROSURVEILLANCE, V20, P6, DOI [10.2807/1560-7917.ES2015.20.5.21025, 10.2807/1560-7917.ES.2015.20.36.30013]; Potter J, 1997, J INFECT DIS, V175, P1, DOI 10.1093/infdis/175.1.1; Public Health Toronto, 2015, TOR 2015 INFL UPD; Reed C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118369; Regis C, 2010, 20 EUR C CLIN MICR I; Regis C, 2008, BEH, V34, P308; Ridgway JP, 2015, CLIN INFECT DIS, V60, P1591, DOI 10.1093/cid/civ163; Riphagen-Dalhuisen J, 2013, EUROSURVEILLANCE, V18, P10, DOI 10.2807/1560-7917.ES2013.18.26.20512; Rothman KJ, 2008, MODERN EPIDEMIOLOGY, P148; Simonsen L, 2007, LANCET INFECT DIS, V7, P658, DOI 10.1016/S1473-3099(07)70236-0; Skowronski DM, 2016, CLIN INFECT DIS, V63, P21, DOI 10.1093/cid/ciw176; Skowronski DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086555; Skowronski DM, 2012, CLIN INFECT DIS, V55, P332, DOI 10.1093/cid/cis431; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Skowronski DM, 2012, CAN MED ASS J; Talbot TR, 2010, INFECT CONT HOSP EP, V31, P889, DOI 10.1086/656211; Taylor G, 2014, INFECT CONT HOSP EP, V35, P169, DOI 10.1086/674858; Thomas RE, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005187.pub5; Thomas RE, 2014, VACCINE, V32, P2143, DOI 10.1016/j.vaccine.2014.02.059; Thomas RE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005187.pub4; Thomas RE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005187.pub3; Thompson MG, 2016, VACCINE, V34, P981, DOI 10.1016/j.vaccine.2015.10.119; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Turnberg W, 2010, AM J INFECT CONTROL, V38, P486, DOI 10.1016/j.ajic.2009.12.006; United States Centers for Disease Control and Prevention, 2013, MMWR-MORBID MORTAL W, V62, P28; United States Centers for Disease Control and Prevention, 2015, EST SEAS INFL ASS DE; United States Department of Health and Human Services, GREAT PAND US 1918 1; Valenciano M, 2016, EURO SURVEILL, V21; Van Buynder PG, 2013, VACCINE, V31, P6122, DOI 10.1016/j.vaccine.2013.07.059; van den Dool C, 2009, VACCINE, V27, P6261, DOI 10.1016/j.vaccine.2009.07.104; van den Dool C, 2008, PLOS MED, V5, P1453, DOI 10.1371/journal.pmed.0050200; Vanhems P, 2011, ARCH INTERN MED, V171, P151, DOI 10.1001/archinternmed.2010.500; Wendelboe AM, 2011, INFECT CONT HOSP EP, V32, P990, DOI 10.1086/661916; World Health Organization, 2012, WKLY EPIDEMIOL REC, V87, P207	76	44	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0163586	10.1371/journal.pone.0163586	http://dx.doi.org/10.1371/journal.pone.0163586			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129360	Green Published, Green Submitted, gold			2022-12-27	WOS:000396211400076
J	Ghadimi, S; Mohtasebi, M; Moghaddam, HA; Grebe, R; Gity, M; Wallois, F				Ghadimi, Sona; Mohtasebi, Mehrana; Moghaddam, Hamid Abrishami; Grebe, Reinhard; Gity, Masoumeh; Wallois, Fabrice			A Neonatal Bimodal MR-CT Head Template	PLOS ONE			English	Article							IMAGE REGISTRATION; AUTOMATIC SEGMENTATION; SPATIOTEMPORAL ATLAS; BRAIN; CONSTRUCTION; INFANT; NORMALIZATION; PROBABILITY; NEWBORNS; FONTANEL	Neonatal MR templates are appropriate for brain structural analysis and spatial normalization. However, they do not provide the essential accurate details of cranial bones and fontanels-sutures. Distinctly, CT images provide the best contrast for bone definition and fontanels- sutures. In this paper, we present, for the first time, an approach to create a fully registered bimodal MR-CT head template for neonates with a gestational age of 39 to 42 weeks. Such a template is essential for structural and functional brain studies, which require precise geometry of the head including cranial bones and fontanels- sutures. Due to the special characteristics of the problem (which requires inter-subject inter-modality registration), a two-step intensity-based registration method is proposed to globally and locally align CT images with an available MR template. By applying groupwise registration, the new neonatal CT template is then created in full alignment with the MR template to build a bimodal MR-CT template. The mutual information value between the CT and the MR template is 1.17 which shows their perfect correspondence in the bimodal template. Moreover, the average mutual information value between normalized images and the CT template proposed in this study is 1.24 +/- 0.07. Comparing this value with the one reported in a previously published approach (0.63 +/- 0.07) demonstrates the better generalization properties of the new created template and the superiority of the proposed method for the creation of CT template in the standard space provided by MR neonatal head template. The neonatal bimodal MR-CT head template is freely downloadable from https://www.u-picardie.fr/labo/GRAMFC.	[Ghadimi, Sona; Mohtasebi, Mehrana; Moghaddam, Hamid Abrishami] KN Toosi Univ Technol, Fac Elect Engn, Tehran, Iran; [Ghadimi, Sona; Moghaddam, Hamid Abrishami; Grebe, Reinhard; Wallois, Fabrice] Univ Picardie Jules Verne, Fac Med, INSERM, UMR 1105, Amiens, France; [Gity, Masoumeh] Univ Tehran Med Sci, Tehran, Iran; [Wallois, Fabrice] Ctr Hosp Univ Amiens, INSERM, UMR 1105, Amiens, France	K. N. Toosi University of Technology; Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV); Tehran University of Medical Sciences; Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens	Moghaddam, HA (corresponding author), KN Toosi Univ Technol, Fac Elect Engn, Tehran, Iran.	hamid.abrishami@u-picardie.fr	Mohtasebi, Mehrana/AAB-7110-2019; Mohtasebi, Mehrana/AAX-7672-2020; Abrishami Moghaddam, Hamid/AAW-9288-2021	Mohtasebi, Mehrana/0000-0002-4689-990X; Ghadimi, Sona/0000-0001-8612-4757	EGIDE France; CISSC Iran [961/93-9-2]	EGIDE France; CISSC Iran	This work was partially supported by EGIDE France and CISSC Iran under the grant number 961/93-9-2 (Jundi Shapour scientific collaboration program).	Aljabar P, 2008, NEUROIMAGE, V39, P348, DOI 10.1016/j.neuroimage.2007.07.067; Altaye M, 2008, NEUROIMAGE, V43, P721, DOI 10.1016/j.neuroimage.2008.07.060; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Avants BB, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00044; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Boardman JP, 2007, ANN NEUROL, V62, P185, DOI 10.1002/ana.21171; Christensen GE, 2001, IEEE T MED IMAGING, V20, P568, DOI 10.1109/42.932742; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Cunningham ML, 2007, CURR OPIN PEDIATR, V19, P645, DOI 10.1097/MOP.0b013e3282f1581a; De Nigris D, 2012, IEEE T MED IMAGING, V31, P2343, DOI 10.1109/TMI.2012.2218116; Dehaes M, 2013, HUM BRAIN MAPP, V34, P878, DOI 10.1002/hbm.21483; Evans AC, 2006, NEUROIMAGE, V30, P184, DOI 10.1016/j.neuroimage.2005.09.068; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Gallagher ER, 2013, CONT PEDIAT, V30, P12; Gargiulo P, 2015, CLIN NEUROPHYSIOL, V126, P1703, DOI 10.1016/j.clinph.2014.12.002; Ghadimi S, 2016, IEEE J BIOMED HEALTH, V20, P563, DOI 10.1109/JBHI.2015.2391991; Habas PA, 2010, NEUROIMAGE, V53, P460, DOI 10.1016/j.neuroimage.2010.06.054; Hartkens T., 2002, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2002. 5th International Conference. Proceedings, Part II (Lecture Notes in Computer Science Vol.2489), P565; Heinrich MP, 2012, MED IMAGE ANAL, V16, P1423, DOI 10.1016/j.media.2012.05.008; Holden M, 2000, IEEE T MED IMAGING, V19, P94, DOI 10.1109/42.836369; Hsu LY, 2001, IMAGE VISION COMPUT, V19, P75, DOI 10.1016/S0262-8856(00)00058-5; Huppi PS, 1998, ANN NEUROL, V43, P224, DOI 10.1002/ana.410430213; Jafarian N, 2014, SIGNAL IMAGE VIDEO P, V8, P377, DOI 10.1007/s11760-012-0300-x; Jia HJ, 2010, NEUROIMAGE, V51, P1057, DOI 10.1016/j.neuroimage.2010.03.010; Joshi S, 2004, NEUROIMAGE, V23, pS151, DOI 10.1016/j.neuroimage.2004.07.068; Kazemi K, ENG MED BIOL SOC 200, P3892; Kazemi K, 2007, NEUROIMAGE, V37, P463, DOI 10.1016/j.neuroimage.2007.05.004; Kiesler J, 2003, AM FAM PHYSICIAN, V67, P2547; Kikinis R, 1996, IEEE T VIS COMPUT GR, V2, P232, DOI 10.1109/2945.537306; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kuijf Hugo J., 2013, Multimodal Brain Image Analysis. Third International Workshop, MBIA 2013. Held in Conjunction with MICCAI 2013. Proceedings: LNCS 8159, P119, DOI 10.1007/978-3-319-02126-3_12; Kuklisova-Murgasova M, 2011, NEUROIMAGE, V54, P2750, DOI 10.1016/j.neuroimage.2010.10.019; Law W, 2004, PROCEEDINGS OF THE 2004 INTERNATIONAL SYMPOSIUM ON INTELLIGENT MULTIMEDIA, VIDEO AND SPEECH PROCESSING, P350, DOI 10.1109/ISIMP.2004.1434072; Lemieux L, 1998, Med Image Anal, V2, P227, DOI 10.1016/S1361-8415(98)80021-2; Leroy F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027128; Lew S, 2013, NEUROIMAGE, V76, P282, DOI 10.1016/j.neuroimage.2013.03.017; Loeckx D, 2010, IEEE T MED IMAGING, V29, P19, DOI 10.1109/TMI.2009.2021843; Meyer J, 2007, PROCEEDINGS OF THE 7TH IEEE INTERNATIONAL SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, VOLS I AND II, P1118; Momeni M, 2015, CURR MED IMAGING, V11, P38, DOI 10.2174/157340561101150423104958; Oishi K, 2011, NEUROIMAGE, V56, P8, DOI 10.1016/j.neuroimage.2011.01.051; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Prastawa M, 2005, MED IMAGE ANAL, V9, P457, DOI 10.1016/j.media.2005.05.007; Roche-Labarbe N, 2008, HUM BRAIN MAPP, V29, P167, DOI 10.1002/hbm.20376; Rorden C, 2012, NEUROIMAGE, V61, P957, DOI 10.1016/j.neuroimage.2012.03.020; Rutherford M., 2002, MRI NEONATAL BRAIN; Sabuncu MR, 2009, IEEE T MED IMAGING, V28, P1473, DOI 10.1109/TMI.2009.2017942; Serag A, 2012, NEUROIMAGE, V59, P2255, DOI 10.1016/j.neuroimage.2011.09.062; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shen DG, 2002, IEEE T MED IMAGING, V21, P1421, DOI 10.1109/TMI.2002.803111; Shi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018746; Shi F, 2010, NEUROIMAGE, V51, P684, DOI 10.1016/j.neuroimage.2010.02.025; Shi F, 2010, NEUROIMAGE, V49, P391, DOI 10.1016/j.neuroimage.2009.07.066; Thompson PM, 2000, NATURE, V404, P190, DOI 10.1038/35004593; van den Elsen P.A., 1994, P SOC PHOTO-OPT INS, V2359, P227; Vercauteren T, 2009, NEUROIMAGE, V45, pS61, DOI 10.1016/j.neuroimage.2008.10.040; Wang Q, 2009, SPIE MED IMAGING 200; Whitwell JL, 2001, AM J NEURORADIOL, V22, P1483; Xie ZY, 2004, IEEE T VIS COMPUT GR, V10, P85, DOI 10.1109/TVCG.2004.1260760; Yasuda M, 1998, AM J PSYCHIAT, V155, P779	61	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0166112	10.1371/journal.pone.0166112	http://dx.doi.org/10.1371/journal.pone.0166112			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129340	Green Published, gold, Green Submitted			2022-12-27	WOS:000396211400075
J	Xu, G; Liang, XF; Yao, SB; Chen, DW; Li, ZW				Xu, Gang; Liang, Xifeng; Yao, Shuanbao; Chen, Dawei; Li, Zhiwei			Multi-Objective Aerodynamic Optimization of the Streamlined Shape of High-Speed Trains Based on the Kriging Model	PLOS ONE			English	Article							FLOW	Minimizing the aerodynamic drag and the lift of the train coach remains a key issue for highspeed trains. With the development of computing technology and computational fluid dynamics (CFD) in the engineering field, CFD has been successfully applied to the design process of high-speed trains. However, developing a new streamlined shape for high-speed trains with excellent aerodynamic performance requires huge computational costs. Furthermore, relationships between multiple design variables and the aerodynamic loads are seldom obtained. In the present study, the Kriging surrogate model is used to perform a multi objective optimization of the streamlined shape of high-speed trains, where the drag and the lift of the train coach are the optimization objectives. To improve the prediction accuracy of the Kriging model, the cross-validation method is used to construct the optimal Kriging model. The optimization results show that the two objectives are efficiently optimized, indicating that the optimization strategy used in the present study can greatly improve the optimization efficiency and meet the engineering requirements.	[Xu, Gang; Liang, Xifeng; Li, Zhiwei] Cent S Univ, Minist Educ, Key Lab Rail Traff Safety, Changsha, Hunan, Peoples R China; [Xu, Gang; Liang, Xifeng; Li, Zhiwei] Cent S Univ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China; [Xu, Gang; Yao, Shuanbao; Chen, Dawei] CSR Qingdao Sifang Co Ltd, Qingdao, Peoples R China	Central South University; Central South University	Li, ZW (corresponding author), Cent S Univ, Minist Educ, Key Lab Rail Traff Safety, Changsha, Hunan, Peoples R China.; Li, ZW (corresponding author), Cent S Univ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China.	lzhw1205@163.com			National Basic Research Program of China (973 Program) [2011CB711101]; CRRC QINGDAO SIFANG CO., LTD	National Basic Research Program of China (973 Program)(National Basic Research Program of China); CRRC QINGDAO SIFANG CO., LTD	The funding of National Basic Research Program of China (973 Program, No. 2011CB711101, http://program.most.gov.cn/) provided full support for the study design, data collection and analysis, the research materials, the manuscript preparation and publication. CRRC QINGDAO SIFANG CO., LTD provided support in the form of salaries for authors [G. Xu, S. B. Yao, D. W. Chen], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker C, 2010, J WIND ENG IND AEROD, V98, P277, DOI 10.1016/j.jweia.2009.11.002; Baker CJ, 2004, J WIND ENG IND AEROD, V92, P547, DOI 10.1016/j.jweia.2004.03.002; CHIU TW, 1992, J WIND ENG IND AEROD, V45, P47, DOI 10.1016/0167-6105(92)90005-U; COPLEY JM, 1987, J WIND ENG IND AEROD, V26, P21, DOI 10.1016/0167-6105(87)90034-1; Cui K., 2012, P 1 INT WORKSH HIGH, V148, P187; Hemida H, 2010, COMPUT FLUIDS, V39, P1944, DOI 10.1016/j.compfluid.2010.06.026; Hemida H, 2010, J FLUID ENG-T ASME, V132, DOI 10.1115/1.4001447; Krajnovic S., 2009, AERODYNAMICS HEAVY V, P197; Ku YC, 2010, STRUCT MULTIDISCIP O, V42, P965, DOI 10.1007/s00158-010-0550-6; Lee J, 2008, STRUCT MULTIDISCIP O, V35, P79, DOI 10.1007/s00158-007-0111-9; [李明 Li Ming], 2013, [铁道学报, Journal of the China Railway Society], V35, P14; Liao Yanping, 2012, Journal of Mechanical Engineering, V48, P132, DOI 10.3901/JME.2012.13.132; Liu JL, 2013, CHIN SCI TECHNOL, V43, P689; Raghunathan RS, 2002, PROG AEROSP SCI, V38, P469, DOI 10.1016/S0376-0421(02)00029-5; Schetz JA, 2001, ANNU REV FLUID MECH, V33, P371, DOI 10.1146/annurev.fluid.33.1.371; Sun ZX, 2010, SCI CHINA TECHNOL SC, V53, P3356, DOI 10.1007/s11431-010-4163-5; Tian H., 2007, AERODYNAMICS TRAIN M; Tian HQ, 2009, J CENT SOUTH UNIV T, V16, P166, DOI 10.1007/s11771-009-0028-0; Tian HQ, 2003, ELECT DRIVE LOCOMOTI, P40; Vytla VV, 2010, AIAA APPL AERODYNAMI, V15, P25; [王英学 Wang Yingxue], 2004, [西南交通大学学报, Journal of Southwest Jiaotong University], V39, P20; Yang GW, 2012, SCI CHINA TECHNOL SC, V55, P1923, DOI 10.1007/s11431-012-4863-0; Yao SB, 2012, SCI CHINA TECHNOL SC, V55, P3118, DOI 10.1007/s11431-012-4934-2; Yu Mengge, 2014, Journal of Mechanical Engineering, V50, P122, DOI 10.3901/JME.2014.24.122	24	19	19	5	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0170803	10.1371/journal.pone.0170803	http://dx.doi.org/10.1371/journal.pone.0170803			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7VX	28129365	Green Published, gold, Green Submitted			2022-12-27	WOS:000396211400033
J	Dalton, PS; Jimenez, VHG; Noussair, CN				Dalton, Patricio S.; Jimenez, Victor H. Gonzalez; Noussair, Charles N.			Exposure to Poverty and Productivity	PLOS ONE			English	Article							POSITIVE AFFECT; NEGATIVE AFFECT; CONSEQUENCES; EXPRESSIONS; EMOTION	We study whether exposure to poverty can induce affective states that decrease productivity. In a controlled laboratory setting, we find that subjects randomly assigned to a treatment, in which they view a video featuring individuals that live in extreme poverty, exhibit lower subsequent productivity compared to subjects assigned to a control treatment. Questionnaire responses, as well as facial recognition software, provide quantitative measures of the affective state evoked by the two treatments. Subjects exposed to images of poverty experience a more negative affective state than those in the control treatment. Further analysis shows that individuals in a more positive emotional state exhibit less of a treatment effect. Also, those who exhibit greater attentiveness upon viewing the poverty video are less productive. The results are consistent with the notion that exposure to poverty can induce a psychological state in individuals that adversely affects productivity.	[Dalton, Patricio S.; Jimenez, Victor H. Gonzalez] Tilburg Univ, Dept Econ, Tilburg, Netherlands; [Noussair, Charles N.] Univ Arizona, Dept Econ, Eller Coll Management, Tucson, AZ 85721 USA	Tilburg University; University of Arizona	Noussair, CN (corresponding author), Univ Arizona, Dept Econ, Eller Coll Management, Tucson, AZ 85721 USA.	cnoussair@email.arizona.edu	Gonzalez-Jimenez, Victor/GNP-6738-2022	Gonzalez-Jimenez, Victor/0000-0001-5309-5523; Dalton, Patricio/0000-0003-3506-1092	Center for Economic Research at Tilburg University	Center for Economic Research at Tilburg University	We received funding to conduct the experiments from the Center for Economic Research at Tilburg University.	Ashby FG, 1999, PSYCHOL REV, V106, P529, DOI 10.1037/0033-295X.106.3.529; Banerjee AV, 2008, AM ECON REV, V98, P489, DOI 10.1257/aer.98.2.489; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; BULL C, 1987, J POLIT ECON, V95, P1, DOI 10.1086/261439; Card D, 2001, ECONOMETRICA, V69, P1127, DOI 10.1111/1468-0262.00237; Chetty R, 2015, IMPACTS NEIGHBORHOOD, P1; Chetty R, 2016, AM ECON REV, V106, P855, DOI 10.1257/aer.20150572; Cutler D, 2010, AM ECON J-APPL ECON, V2, P72, DOI 10.1257/app.2.2.72; Dalton PS, 2016, ECON J, V126, P165, DOI 10.1111/ecoj.12210; DASGUPTA P, 1986, ECON J, V96, P1011, DOI 10.2307/2233171; Duflo E, 2001, AM ECON REV, V91, P795, DOI 10.1257/aer.91.4.795; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; Ekman P., 2003, EMOTIONS REVEALED RE, Vsecond; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Frechette GR, 2012, EXP ECON, V15, P485, DOI 10.1007/s10683-011-9309-1; Gallup JL, 1998, AM J AGR ECON, V82, P731; Genicot G, 2014, ASPIRATIONS INEQUALI, P1; Gill D, 2012, AM ECON REV, V102, P469, DOI 10.1257/aer.102.1.469; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Harmon-Jones E, 2013, CURR DIR PSYCHOL SCI, V22, P301, DOI 10.1177/0963721413481353; Haushofer J, 2014, SCIENCE, V344, P862, DOI 10.1126/science.1232491; Imai K, 2010, STAT SCI, V25, P51, DOI 10.1214/10-STS321; Isen AM, 2002, PSYCHOL INQ, V13, P57; King G, 2000, AM J POLIT SCI, V44, P347, DOI 10.2307/2669316; Mani A, 2013, SCIENCE, V341, P976, DOI 10.1126/science.1238041; Matsumoto D, 2009, J PERS SOC PSYCHOL, V96, P1, DOI 10.1037/a0014037; Oswald AJ, 2015, J LABOR ECON, V33, P789, DOI 10.1086/681096; Shah AK, 2012, SCIENCE, V338, P682, DOI 10.1126/science.1222426; STRAUSS J, 1986, J POLIT ECON, V94, P297, DOI 10.1086/261375; Tiedens LZ, 2001, J PERS SOC PSYCHOL, V80, P86, DOI 10.1037//0022-3514.80.1.86; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Watson D, 1999, PANAS X MANUAL POSIT, DOI DOI 10.17077/48VT-M4T2	32	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e170231	10.1371/journal.pone.0170231	http://dx.doi.org/10.1371/journal.pone.0170231			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7IT	28125621	Green Published, Green Submitted, gold			2022-12-27	WOS:000396176100123
J	Hojland, DH; Kristensen, M				Hojland, Dorte H.; Kristensen, Michael			Analysis of Differentially Expressed Genes Related to Resistance in Spinosad- and Neonicotinoid-Resistant Musca domestica L. (Diptera: Muscidae) Strains	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; INSECTICIDE RESISTANCE; HOUSE-FLIES; CROSS-RESISTANCE; NATURAL-PRODUCTS; CYTOCHROMES P450; POPULATIONS; FAMILY; SUSCEPTIBILITY; TRANSFERASES	Background The housefly is a global pest that has developed resistance to most insecticides applied against it. Resistance of the spinosad-resistant strain 791 spin and the neonicotinoid-resistant 766b strain is believed to be due to metabolism. We investigate differentially expressed genes in these two resistant strains related to metabolism in comparison with an insecticide-susceptible reference strain. Results Genes involved in metabolism of xenobiotics were primarily up-regulated in resistant flies with some differences between resistant strains. The cyp4g98 and cyp6g4 genes proved interesting in terms of neonicotinoid resistance, while cyp4d9 was overexpressed in 791spin compared to spinosad-susceptible strains. GSTs, ESTs and UGTs were mostly overexpressed, but not to the same degree as P450s. We present a comprehensive and comparative picture of gene expression in three housefly strains differing significantly in their response to insecticides. High differential expression of P450s and genes coding for cuticle protein indicates a combination of factors involved in metabolic neonicotinoid and spinosad resistance. Conclusion Resistance in these strains is apparently not linked to the alteration of a single gene but is composed of several changes including differential expression of genes encoding metabolic detoxification enzymes.	[Hojland, Dorte H.; Kristensen, Michael] Aarhus Univ, Dept Agroecol, Slagelse, Denmark	Aarhus University	Kristensen, M (corresponding author), Aarhus Univ, Dept Agroecol, Slagelse, Denmark.	mikr@agro.au.dk	Kristensen, Michael/F-5536-2016	Kristensen, Michael/0000-0001-7332-3490	Innovation Fund Denmark [0603-00516B]	Innovation Fund Denmark	This work was supported by the Innovation Fund Denmark. Grant 0603-00516B. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass C, 2014, INSECT BIOCHEM MOLEC, V51, P41, DOI 10.1016/j.ibmb.2014.05.003; BULL DL, 1972, J AGR FOOD CHEM, V20, P561, DOI 10.1021/jf60181a061; CARINO F, 1992, ACS SYM SER, V505, P31; Chao SL, 1997, PESTIC BIOCHEM PHYS, V58, P77; Coelho A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117328; Daborn P, 2001, MOL GENET GENOMICS, V266, P556, DOI 10.1007/s004380100531; David JP, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0429; Dermauw W, 2014, INSECT BIOCHEM MOLEC, V45, P89, DOI 10.1016/j.ibmb.2013.11.001; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Epis S, 2014, SCI REP-UK, V4, DOI 10.1038/srep07435; FEYEREISEN R, 1989, P NATL ACAD SCI USA, V86, P1465, DOI 10.1073/pnas.86.5.1465; ffrench-Constant R, 2006, BIOESSAYS, V28, P6, DOI 10.1002/bies.20354; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; Gao Q, 2012, PESTIC BIOCHEM PHYS, V104, P252, DOI 10.1016/j.pestbp.2012.09.006; Geng Hua, 2004, Acta Genetica Sinica, V31, P1344; GEORGHIOU GP, 1990, ACS SYM SER, V421, P18; Gullan P.J., 2010, INSECTS OUTLINE ENTO; Hojland DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103689; Hojland DH, 2014, PEST MANAG SCI, V70, P1114, DOI 10.1002/ps.3655; Hojland DH, 2014, PEST MANAG SCI, V70, P1237, DOI 10.1002/ps.3681; Hojland DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085965; Joussen N, 2008, PEST MANAG SCI, V64, P65, DOI 10.1002/ps.1472; Kasai S, 2001, INSECT BIOCHEM MOLEC, V32, P1, DOI 10.1016/S0965-1748(01)00073-X; Kasai S, 2000, PESTIC BIOCHEM PHYS, V68, P34, DOI 10.1006/pest.2000.2492; Kavi LAK, 2014, PESTIC BIOCHEM PHYS, V109, P64, DOI 10.1016/j.pestbp.2014.01.006; Keiding J, 1986, VECTOR CONTROL SERIE; Kirst HA, 2010, J ANTIBIOT, V63, P101, DOI 10.1038/ja.2010.5; KRAMER KJ, 1987, ARCH INSECT BIOCHEM, V6, P279, DOI 10.1002/arch.940060406; Kristensen M, 2004, PEST MANAG SCI, V60, P894, DOI 10.1002/ps.883; Kristensen M, 2005, J ECON ENTOMOL, V98, P1341, DOI 10.1603/0022-0493-98.4.1341; Kristensen M, 2004, J ECON ENTOMOL, V97, P1042, DOI 10.1603/0022-0493(2004)097[1042:SOSIMD]2.0.CO;2; Kristensen M, 2001, PEST MANAG SCI, V57, P82, DOI 10.1002/1526-4998(200101)57:1<82::AID-PS251>3.0.CO;2-8; Kristensen M, 2008, PEST MANAG SCI, V64, P126, DOI 10.1002/ps.1481; Kristensen M, 2006, PEST MANAG SCI, V62, P738, DOI 10.1002/ps.1231; Landis GN, 2005, MECH AGEING DEV, V126, P365, DOI 10.1016/j.mad.2004.08.012; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liu N, 1998, INSECT BIOCHEM MOLEC, V28, P531, DOI 10.1016/S0965-1748(98)00039-3; Mahmood K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151434; Markussen MDK, 2012, PEST MANAG SCI, V68, P75, DOI 10.1002/ps.2223; Markussen MDK, 2010, PEST MANAG SCI, V66, P1257, DOI 10.1002/ps.2007; Markussen MDK, 2010, PESTIC BIOCHEM PHYS, V98, P50, DOI 10.1016/j.pestbp.2010.04.012; Meisel RP, 2015, TRANSCRIPTOME DIFFER; Mitchell CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093489; Montella IR, 2012, MEM I OSWALDO CRUZ, V107, P437, DOI 10.1590/S0074-02762012000400001; Nauen R, 2003, PESTIC BIOCHEM PHYS, V76, P55, DOI 10.1016/S0048-3575(03)00065-8; Nelson DR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0430; Orr N, 2009, PESTIC BIOCHEM PHYS, V95, P1, DOI 10.1016/j.pestbp.2009.04.009; Perry T, 2007, INSECT BIOCHEM MOLEC, V37, P184, DOI 10.1016/j.ibmb.2006.11.009; Salgado VL, 1998, PESTIC BIOCHEM PHYS, V60, P91, DOI 10.1006/pest.1998.2332; Scott H.G., 1962, FLIES PUBLIC HLTH IM; Scott JG, 2008, J PESTIC SCI, V33, P221, DOI 10.1584/jpestics.R08-04; Scott JG, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0466-3; Scott JG, 1998, COMP BIOCHEM PHYS C, V121, P147, DOI 10.1016/S0742-8413(98)10035-X; Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7; Shi J, 2011, PEST MANAG SCI, V67, P335, DOI 10.1002/ps.2073; Sparks TC, 2001, PEST MANAG SCI, V57, P896, DOI 10.1002/ps.358; Steppuhn A, 2004, PLOS BIOL, V2, P1074, DOI 10.1371/journal.pbio.0020217; Tao XY, 2012, MOL ECOL, V21, P4371, DOI 10.1111/j.1365-294X.2012.05548.x; Veal EA, 2002, J BIOL CHEM, V277, P35523, DOI 10.1074/jbc.M111548200; Ware G., 2004, PESTICIDE BOOK MEIST; Watson GB, 2001, PESTIC BIOCHEM PHYS, V71, P20, DOI 10.1006/pest.2001.2559; Zhu Fang, 2008, BMC Physiology, V8, P18, DOI 10.1186/1472-6793-8-18; Zimmer CT, 2014, INSECT BIOCHEM MOLEC, V45, P18, DOI 10.1016/j.ibmb.2013.11.008	63	14	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170935	10.1371/journal.pone.0170935	http://dx.doi.org/10.1371/journal.pone.0170935			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125739	gold, Green Published, Green Submitted			2022-12-27	WOS:000396176100019
